PT	AU	BA	BE	GP	AF	BF	CA	TI	SO	SE	BS	LA	DT	CT	CY	CL	SP	HO	DE	ID	AB	C1	C3	RP	EM	RI	OI	FU	FP	FX	CR	NR	TC	Z9	U1	U2	PU	PI	PA	SN	EI	BN	J9	JI	PD	PY	VL	IS	PN	SU	SI	MA	BP	EP	AR	DI	DL	D2	EA	PG	WC	WE	SC	GA	PM	OA	HC	HP	DA	UT
J	Civaner, MM; Vatansever, K; Pala, K				Civaner, M. Murat; Vatansever, Kevser; Pala, Kayihan			Ethical problems in an era where disasters have become a part of daily life: A qualitative study of healthcare workers in Turkey	PLOS ONE			English	Article							HUMANITARIANISM; PROFESSIONALS; DONATIONS	Background Natural disasters, armed conflict, migration, and epidemics today occur more frequently, causing more death, displacement of people and economic loss. Their burden on health systems and healthcare workers (HCWs) is getting heavier accordingly. The ethical problems that arise in disaster settings may be different than the ones in daily practice, and can cause preventable harm or the violation of basic human rights. Understanding the types and the determinants of ethical challenges is crucial in order to find the most benevolent action while respecting the dignity of those affected people. Considering the limited scope of studies on ethical challenges within disaster settings, we set upon conducting a qualitative study among local HCWs. Methods Our study was conducted in six cities of Turkey, a country where disasters are frequent, including armed conflict, terrorist attacks and a massive influx of refugees. In-depth interviews were carried out with a total of 31 HCWs working with various backgrounds and experience. Data analysis was done concurrently with ongoing interviews. Results Several fundamental elements currently hinder ethics in relief work. Attitudes of public authorities, politicians and relief organizations, the mismanagement of impromptu humanitarian action and relief and the media's mindset create ethical problems on the macro-level such as discrimination, unjust resource allocation and violation of personal rights, and can also directly cause or facilitate the emergence of problems on the micro-level. An important component which prevents humanitarian action towards victims is insufficient competence. The duty to care during epidemics and armed conflicts becomes controversial. Many participants defend a paternalistic approach related to autonomy. Confidentiality and privacy are either neglected or cannot be secured. Conclusion Intervention in factors on the macro-level could have a significant effect in problem prevention. Improving guidelines and professional codes as well as educating HCWs are also areas for improvement. Also, ethical questions exposed within this study should be deliberated and actualized with universal consensus in order to guide HCWs and increase humane attitudes.	[Civaner, M. Murat] Uludag Univ, Sch Med, Dept Med Eth, Bursa, Turkey; [Vatansever, Kevser] Ege Univ, Sch Med, Dept Med Educ, Izmir, Turkey; [Pala, Kayihan] Uludag Univ, Sch Med, Dept Publ Hlth, Bursa, Turkey	Uludag University; Ege University; Uludag University	Civaner, MM (corresponding author), Uludag Univ, Sch Med, Dept Med Eth, Bursa, Turkey.	mcivaner@gmail.com	Pala, Kayihan/F-7816-2013; /S-4188-2019	Pala, Kayihan/0000-0002-0983-4904; /0000-0001-5376-3499	Uludag Universitesi Fund for Scientific Researches [KUAP-T 2014/1]	Uludag Universitesi Fund for Scientific Researches	The study was financially supported by Uludag Universitesi Fund for Scientific Researches (www.uludag.edu.tr) (KUAP-T 2014/1) to M MC, KV and KP. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bjerneld Magdalena, 2004, Disaster Manag Response, V2, P101, DOI 10.1016/j.dmr.2004.08.009; Borovecki A, 2015, LANCET, V385, P1391, DOI 10.1016/S0140-6736(15)60710-3; Clarinval C, 2014, PLOS CURR, V6; CRED, 2016, INT DIS DAT 2016; CRED, 2016, EM DAT GLOSS 2009; CRED, 2016, DIS TRENDS 2016; Donini A, 2010, DISASTERS, V34, pS220, DOI 10.1111/j.1467-7717.2010.01155.x; Du Y, 2015, MILITARY MED RES, V2, DOI 10.1186/s40779-015-0059-9; Elgafi S, 2014, EMERGENCY PHYS INT, P29; Europe Co, 2016, ETH PRINC DIS RISK R; Fofana Umaru, 2014, REUTERS; Fraser V, 2015, PREHOSP DISASTER MED, V30, P412, DOI 10.1017/S1049023X1500480X; Geale SK, 2012, DISASTER PREV MANAG, V21, P445, DOI 10.1108/09653561211256152; Grimaldi Mary Elizabeth, 2007, J Trauma Nurs, V14, P163; Hall John, 2015, DAILY MAIL; Harbaugh WT, 1998, J PUBLIC ECON, V67, P269, DOI 10.1016/S0047-2727(97)00062-5; Holt GR, 2008, OTOLARYNG HEAD NECK, V139, P181, DOI 10.1016/j.otohns.2008.04.027; Hunt M, 2014, PLOS CURR, V6; Hunt MR, 2008, DEV WORLD BIOETH, V8, P59, DOI 10.1111/j.1471-8847.2006.00153.x; Hunt MR, 2009, PREHOSP DISASTER MED, V24, DOI 10.1017/S1045023X00007445; Hunt Matthew R, 2009, Am J Disaster Med, V4, P261; ICRC, 2016, COD COND INT RED CRO; IFRC, 2007, LAW LEG ISS INT DIS; Iserson KV, 2008, ANN EMERG MED, V51, P345, DOI 10.1016/j.annemergmed.2007.07.024; Jonsen AR, 2000, SHORT HIST MED; Kirisci K., 2014, SYRIAN REFUGEES TURK; Lennquist S, 2005, SCAND J SURG, V94, P300, DOI 10.1177/145749690509400409; Lepora C, 2014, INT S DIS ETH DUBL 2; Lepora C, 2013, DISASTERS EXPOSE LIM; Lyon AJ, 2007, FOREIGN POL ANAL-US, V3, P46, DOI 10.1111/j.1743-8594.2007.00041.x; Michael Markus, 2002, Dev World Bioeth, V2, P109; MSF, 2016, CHART PRINC 1971; Noji EK, 1997, PUBLIC HLTH CONSEQUE, P3; O'Math' una DP, 2014, HDB GLOBAL BIOETHICS, P616; Pollard Katherine A, 2015, Am J Disaster Med, V10, P51, DOI 10.5055/ajdm.2015.0188; Reid J, 2010, J INTERV STATEBUILD, V4, P391, DOI 10.1080/17502971003700985; Roberts M, 2016, ETHICAL CONSIDERATIO; Sabri AA, 2006, PLOS MED, V3, P1452, DOI 10.1371/journal.pmed.0030382; Schwartz L., 2010, AM J BIOETHICS PRIMA, V1, P45, DOI DOI 10.1080/21507716.2010.505898; Schweitzer F, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001458; Sevimli S, 2016, J PAK MED ASSOC, V66, P129; Sokol DK, 2011, BRIT MED J, V343, DOI 10.1136/bmj.d5528; Stehrenberger CS, 2014, SOC SCI MED, V120, P317, DOI 10.1016/j.socscimed.2014.05.017; Stylianou N, 2014, BBC NEWS; Su T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067041; The Sphere Project, 2016, HUM CHART MINI STAND; Uejima T, 2011, ASA MONITOR, V75, P22; UNDP, 2016, DIS MAN ETH 1997; UNHCR, 2016, UNHCR OP WORLDW TURK; UNISDR, 2016, DIS NUMB 2015; UNOCHA, 2016, WORLD HUM DAT TRENDS; WMA, 2016, STAT MED ETH EV DIS; Yavuz CI, 2005, DEPREM DENEYIMI TOPL, V20, P274	53	6	6	4	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 20	2017	12	3							e0174162	10.1371/journal.pone.0174162	http://dx.doi.org/10.1371/journal.pone.0174162			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	ER6VC	28319151	gold, Green Submitted, Green Published			2022-12-27	WOS:000398945800055
J	Liu, A; Archer, AM; Biggs, MB; Papin, JA				Liu, Angela; Archer, Anne M.; Biggs, Matthew B.; Papin, Jason A.			Growth-altering microbial interactions are responsive to chemical context	PLOS ONE			English	Article							HUMAN GUT MICROBIOME; PSEUDOMONAS-AERUGINOSA; BENZO<A>PYRENE; MICROORGANISMS	Microbial interactions are ubiquitous in nature, and are equally as relevant to human wellbeing as the identities of the interacting microbes. However, microbial interactions are difficult to measure and characterize. Furthermore, there is growing evidence that they are not fixed, but dependent on environmental context. We present a novel workflow for inferring microbial interactions that integrates semi-automated image analysis with a colony stamping mechanism, with the overall effect of improving throughput and reproducibility of colony interaction assays. We apply our approach to infer interactions among bacterial species associated with the normal lung microbiome, and how those interactions are altered by the presence of benzo[a] pyrene, a carcinogenic compound found in cigarettes. We found that the presence of this single compound changed the interaction network, demonstrating that microbial interactions are indeed dynamic and responsive to local chemical context.	[Liu, Angela; Biggs, Matthew B.; Papin, Jason A.] Univ Virginia, Dept Biomed Engn, Charlottesville, VA 22903 USA; [Archer, Anne M.] Univ Virginia, Dept Biol, Charlottesville, VA USA	University of Virginia; University of Virginia	Biggs, MB; Papin, JA (corresponding author), Univ Virginia, Dept Biomed Engn, Charlottesville, VA 22903 USA.	mb3ad@virginia.edu; papin@virginia.edu		Biggs, Matthew/0000-0001-6492-8180; Papin, Jason/0000-0002-2769-5805	University of Virginia by a Harrison Undergraduate Research Award; NIH [5R01GM108501]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM108501] Funding Source: NIH RePORTER	University of Virginia by a Harrison Undergraduate Research Award; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We gratefully acknowledge funding for this work through the University of Virginia by a Harrison Undergraduate Research Award to AL and AMA. This work was further supported by NIH grant [5R01GM108501] to JP. We also acknowledge the help and advice of Dr. Glynis Kolling in obtaining and culturing the strains used in this study.	[Anonymous], 2021, LANG ENV STAT COMP; Blom H, 1997, INT J FOOD MICROBIOL, V38, P103, DOI 10.1016/S0168-1605(97)00098-6; Buffie CG, 2015, NATURE, V517, P205, DOI 10.1038/nature13828; Coleman HN, 2003, J CLIN MICROBIOL, V41, P4408, DOI 10.1128/JCM.41.9.4408-4410.2003; Comolli L. R, 2014, FRONT MICROBIOL, P5; David LA, 2014, NATURE, V505, P559, DOI 10.1038/nature12820; de Muinck EJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067210; Denissenko MF, 1996, SCIENCE, V274, P430, DOI 10.1126/science.274.5286.430; Erb-Downward JR, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016384; Faust K, 2012, NAT REV MICROBIOL, V10, P538, DOI 10.1038/nrmicro2832; Garbeva P, 2014, FRONT MICROBIOL, V5, DOI 10.3389/fmicb.2014.00289; Harcombe WR, 2014, CELL REP, V7, P1104, DOI 10.1016/j.celrep.2014.03.070; Hayes CS, 2014, COLD SPRING HARB PER, V4; Hibbing ME, 2010, NAT REV MICROBIOL, V8, P15, DOI 10.1038/nrmicro2259; KAISERMAN MJ, 1992, AM J PUBLIC HEALTH, V82, P1023, DOI 10.2105/AJPH.82.7.1023; Klitgord N, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1001002; Lamprecht MR, 2007, BIOTECHNIQUES, V42, P71, DOI 10.2144/000112257; Lawrence D, 2012, PLOS BIOL, V10, DOI 10.1371/journal.pbio.1001330; Marino S, 2014, P NATL ACAD SCI USA, V111, P439, DOI 10.1073/pnas.1311322111; Maurice CF, 2013, CELL, V152, P39, DOI 10.1016/j.cell.2012.10.052; Michelsen CF, 2014, J BACTERIOL, V196, P3903, DOI 10.1128/JB.02006-14; Morris JD, 2011, APPL ENVIRON MICROB, V77, P8310, DOI 10.1128/AEM.06644-11; Philippot L, 2013, NAT REV MICROBIOL, V11, P789, DOI 10.1038/nrmicro3109; RILEY TV, 1986, FEMS MICROBIOL LETT, V33, P55; Schwab U, 2014, INFECT IMMUN, V82, P4729, DOI 10.1128/IAI.01876-14; Simon-Soro A, 2013, J DENT RES, V92, P616, DOI 10.1177/0022034513488119; Stein RR, 2013, PLOS COMPUT BIOL, V9, DOI 10.1371/journal.pcbi.1003388; Steinway SN, 2015, PLOS COMPUT BIOL, V11, DOI 10.1371/journal.pcbi.1004338; Tashiro Y, 2013, MICROBES ENVIRON, V28, P13, DOI 10.1264/jsme2.ME12167; Traxler MF, 2013, MBIO, V4, DOI 10.1128/mBio.00459-13; Voriskova J, 2013, ISME J, V7, P477, DOI 10.1038/ismej.2012.116	31	9	9	2	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 20	2017	12	3							e0164919	10.1371/journal.pone.0164919	http://dx.doi.org/10.1371/journal.pone.0164919			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ER6VC	28319121	Green Submitted, Green Published, gold			2022-12-27	WOS:000398945800001
J	Liu, XY; Jiang, JW; Zhang, K; Long, EP; Cui, JT; Zhu, MM; An, YY; Zhang, J; Liu, ZZ; Lin, ZL; Li, XY; Chen, JJ; Cao, QZ; Li, J; Wu, XH; Wang, DN; Lin, HT				Liu, Xiyang; Jiang, Jiewei; Zhang, Kai; Long, Erping; Cui, Jiangtao; Zhu, Mingmin; An, Yingying; Zhang, Jia; Liu, Zhenzhen; Lin, Zhuoling; Li, Xiaoyan; Chen, Jingjing; Cao, Qianzhong; Li, Jing; Wu, Xiaohang; Wang, Dongni; Lin, Haotian			Localization and diagnosis framework for pediatric cataracts based on slit-lamp images using deep features of a convolutional neural network	PLOS ONE			English	Article								Slit-lamp images play an essential role for diagnosis of pediatric cataracts. We present a computer vision-based framework for the automatic localization and diagnosis of slit-lamp images by identifying the lens region of interest (ROI) and employing a deep learning convolutional neural network (CNN). First, three grading degrees for slit-lamp images are proposed in conjunction with three leading ophthalmologists. The lens ROI is located in an automated manner in the original image using two successive applications of Candy detection and the Hough transform, which are cropped, resized to a fixed size and used to form pediatric cataract datasets. These datasets are fed into the CNN to extract high-level features and implement automatic classification and grading. To demonstrate the performance and effectiveness of the deep features extracted in the CNN, we investigate the features combined with support vector machine (SVM) and softmax classifier and compare these with the traditional representative methods. The qualitative and quantitative experimental results demonstrate that our proposed method offers exceptional mean accuracy, sensitivity and specificity: classification (97.07%, 97.28%, and 96.83%) and a three-degree grading area (89.02%, 86.63%, and 90.75%), density (92.68%, 91.05%, and 93.94%) and location (89.28%, 82.70%, and 93.08%). Finally, we developed and deployed a potential automatic diagnostic software for ophthalmologists and patients in clinical applications to implement the validated model.	[Liu, Xiyang; Jiang, Jiewei; Zhang, Kai; Cui, Jiangtao; An, Yingying; Zhang, Jia] Xidian Univ, Sch Comp Sci & Technol, Xian, Peoples R China; [Liu, Xiyang] Xidian Univ, Sch Software, Xian, Peoples R China; [Long, Erping; Liu, Zhenzhen; Lin, Zhuoling; Li, Xiaoyan; Chen, Jingjing; Cao, Qianzhong; Li, Jing; Wu, Xiaohang; Wang, Dongni; Lin, Haotian] Sun Yat Sen Univ, Zhongshan Ophthalm Ctr, State Key Lab Ophthalmol, Guangzhou, Guangdong, Peoples R China; [Zhu, Mingmin] Xidian Univ, Sch Math & Stat, Xian, Peoples R China	Xidian University; Xidian University; Sun Yat Sen University; Xidian University	Liu, XY (corresponding author), Xidian Univ, Sch Comp Sci & Technol, Xian, Peoples R China.; Liu, XY (corresponding author), Xidian Univ, Sch Software, Xian, Peoples R China.; Lin, HT (corresponding author), Sun Yat Sen Univ, Zhongshan Ophthalm Ctr, State Key Lab Ophthalmol, Guangzhou, Guangdong, Peoples R China.	xyliu@xidian.edu.cn; gddlht@gmail.com	li, xiao/GSN-6181-2022; li, xiaofeng/GXF-9442-2022	liu, zhenzhen/0000-0002-4853-2474; Long, Erping/0000-0002-3502-5596; Zhang, Kai/0000-0001-9054-288X; Lin, Haotian/0000-0003-4672-9721	NSFC [91546101, 11401454]; Guangdong Provincial Natural Science Foundation [YQ2015006, 2014A030306030, 2014TQ01R573, 20136020400003]; Natural Science Foundation of Guangzhou City [2014J2200060]; State Key Laboratory of Ophthalmology, Zhongshan Ophthalmic Center, Sun Yat-sen University [2015ykzd11, 2015QN01]; Fundamental Research Funds for the Central Universities [BDZ011401, JB151005]; Novel Technology Research of Universities Cooperation Project; State Key Laboratory of Satellite Navigation System and Equipment Technology [KX152600027]; Special Program for Applied Research on Super Computation of the NSFC-Guangdong Joint Fund	NSFC(National Natural Science Foundation of China (NSFC)); Guangdong Provincial Natural Science Foundation(National Natural Science Foundation of Guangdong Province); Natural Science Foundation of Guangzhou City; State Key Laboratory of Ophthalmology, Zhongshan Ophthalmic Center, Sun Yat-sen University; Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities); Novel Technology Research of Universities Cooperation Project; State Key Laboratory of Satellite Navigation System and Equipment Technology; Special Program for Applied Research on Super Computation of the NSFC-Guangdong Joint Fund	This study was funded by the NSFC (91546101,11401454); the Guangdong Provincial Natural Science Foundation (YQ2015006, 2014A030306030, 2014TQ01R573, 20136020400003); the Natural Science Foundation of Guangzhou City (2014J2200060); the State Key Laboratory of Ophthalmology, Zhongshan Ophthalmic Center, Sun Yat-sen University (2015ykzd11, 2015QN01); the Fundamental Research Funds for the Central Universities (BDZ011401, JB151005); the Novel Technology Research of Universities Cooperation Project, the State Key Laboratory of Satellite Navigation System and Equipment Technology (KX152600027); and the Special Program for Applied Research on Super Computation of the NSFC-Guangdong Joint Fund (the second phase). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amaya L, 2003, SURV OPHTHALMOL, V48, P125, DOI 10.1016/S0039-6257(02)00462-9; Andrew Zisserman, 2015, Arxiv, DOI arXiv:1409.1556; Bottou L, 2010, COMPSTAT'2010: 19TH INTERNATIONAL CONFERENCE ON COMPUTATIONAL STATISTICS, P177, DOI 10.1007/978-3-7908-2604-3_16; BROWN NAP, 1987, EYE-T OPHTH SOC UK, V1, P234, DOI 10.1038/eye.1987.43; Chang CC, 2011, ACM T INTEL SYST TEC, V2, DOI 10.1145/1961189.1961199; Chiu SJ, 2012, INVEST OPHTH VIS SCI, V53, P53, DOI 10.1167/iovs.11-7640; Ciresan D, 2012, PROC CVPR IEEE, P3642, DOI 10.1109/CVPR.2012.6248110; Daugman J, 2007, IEEE T SYST MAN CY B, V37, P1167, DOI 10.1109/TSMCB.2007.903540; Essock EA, 2005, INVEST OPHTH VIS SCI, V46, P2838, DOI 10.1167/iovs.04-1156; Fan SH, 2003, LECT NOTES COMPUT SC, V2878, P592; Guo LY, 2015, COMPUT IND, V69, P72, DOI 10.1016/j.compind.2014.09.005; Hihn J, 2016, AEROSP CONF PROC; Huang W, 2011, IEEE T MED IMAGING, V30, P94, DOI 10.1109/TMI.2010.2062197; HUBEL DH, 1962, J PHYSIOL-LONDON, V160, P106, DOI 10.1113/jphysiol.1962.sp006837; Jia YQ, 2014, PROCEEDINGS OF THE 2014 ACM CONFERENCE ON MULTIMEDIA (MM'14), P675, DOI 10.1145/2647868.2654889; Jiao Z, 2016, NEUROCOMPUTING; Kang MJ, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0155781; Kawaguchi T, 2003, PATTERN RECOGN, V36, P549, DOI 10.1016/S0031-3203(02)00066-3; Kohavi R., 1995, IJCAI-95. Proceedings of the Fourteenth International Joint Conference on Artificial Intelligence, P1137; Krizhevsky A., 2012, ADV NEURAL INF PROCE; Lambert SR, 2015, J AAPOS, V19, P393, DOI [10.1016/j.jaapos.2015.01.013, 10.1016/j.jaapos.2015.05.008]; Li HQ, 2010, IEEE T BIO-MED ENG, V57, P1690, DOI 10.1109/TBME.2010.2041454; Lin DR, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0142298; Lin H., 2015, SCIENCE, V349, P6252; Liu ZX, 2016, SCI REP-UK, V6, DOI 10.1038/srep39808; Marc RE, 2013, PROG RETIN EYE RES, V37, P141, DOI 10.1016/j.preteyeres.2013.08.002; Martonyi Csaba L, 2007, SLIT LAMP EXAMINATIO; Masek L, 2003, RECOGNITION HUMAN IR, P2; Medsinge Anagha, 2015, Clin Ophthalmol, V9, P77, DOI 10.2147/OPTH.S59009; Nair V., 2010, P 27 INT C INT C MAC, P807; Resnikoff S, 2012, INDIAN J OPHTHALMOL, V60, P387, DOI 10.4103/0301-4738.100532; Schmidhuber J, 2015, NEURAL NETWORKS, V61, P85, DOI 10.1016/j.neunet.2014.09.003; Shin KY, 2012, PATTERN RECOGN LETT, V33, P991, DOI 10.1016/j.patrec.2011.08.016; Singh A, 2016, COMPUT METH PROG BIO, V124, P108, DOI 10.1016/j.cmpb.2015.10.010; Srivastava N, 2014, J MACH LEARN RES, V15, P1929; WEST SK, 1988, INVEST OPHTH VIS SCI, V29, P73; Wildes RP, 1994, APPL COMP VIS 1994 P; Wu XH, 2016, SCI REP-UK, V6, DOI 10.1038/srep28564; Ypsilantis PP, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0137036; Zeiler MD, 2014, LECT NOTES COMPUT SC, V8689, P818, DOI 10.1007/978-3-319-10590-1_53; Zhang ZQ, 2014, J INSECT SCI, V14, DOI 10.1673/031.014.114	41	43	47	1	36	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 17	2017	12	3							e0168606	10.1371/journal.pone.0168606	http://dx.doi.org/10.1371/journal.pone.0168606			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EO5CJ	28306716	Green Published, Green Submitted, gold			2022-12-27	WOS:000396710300001
J	Kao, SC; Tsai, HI; Cheng, CW; Lin, TW; Chen, CC; Lin, CS				Kao, Sheng-Chin; Tsai, Hsin-I; Cheng, Chih-Wen; Lin, Ta-Wei; Chen, Chien-Chuan; Lin, Chia-Shiang			The association between frequent alcohol drinking and opioid consumption after abdominal surgery: A retrospective analysis	PLOS ONE			English	Article							CHRONIC ETHANOL-CONSUMPTION; POSTOPERATIVE NAUSEA; RISK-FACTORS; NEUROPATHIC PAIN; SPINAL-CORD; RECEPTOR; REDUCTION; INTENSITY; TRIAL	Aims It is perceived that patients with a history of frequent alcohol consumption require more opi-oids for postoperative pain control and experience less postoperative nausea and vomiting than patients without such a history. However, there is scarce evidence supporting this notion. The aim of this study was to assess association between frequent alcohol consump-tion and opioid requirement for postoperative pain control and occurrence of postoperative nausea and vomiting. Methods The medical records for 4143 patients using intravenous patient-control analgesia with opioids after abdominal surgery between January 2010 and September 2013 were obtained, and associations were sought between the cumulative opioid consumption (in intravenous morphine equivalence) per body weight (mg/kg) in the first 2 days after abdominal operation and several demographic and clinical variables by multiple regres-sion analysis. The association between the occurrence of postoperative nausea and vomiting and several demographic and clinical variables was also sought by multiple logistic regression analysis. Results Frequent alcohol drinking, among other previously reported factors, was associated with increased opioid consumption for postoperative pain control (p < 0.001). The estimate effect of frequent alcohol drinking was 0.117 mg/kg. Frequent alcohol drinking was also associ-ated with decreased risks of postoperative nausea (odds ratio = 0.59, p = 0.003) and vomiting (odds ratio = 0.49, p = 0.026). Conclusions Frequent alcohol drinking was associated with increased opioid consumption for postoperative pain control and decreased risks of postoperative nausea and vomiting after abdominal surgery.	[Kao, Sheng-Chin; Chen, Chien-Chuan; Lin, Chia-Shiang] Mackay Mem Hosp, Dept Anesthesiol, Taipei, Taiwan; [Kao, Sheng-Chin] Natl Yang Ming Univ, Sch Med, Taipei, Taiwan; [Tsai, Hsin-I; Cheng, Chih-Wen] Chang Gung Mem Hosp, Dept Anesthesiol, Taoyuan, Taiwan; [Lin, Ta-Wei] Natl Yang Ming Univ Hosp, Dept Anesthesiol, Yilan City, Yilan County, Taiwan	Mackay Memorial Hospital; National Yang Ming Chiao Tung University; Chang Gung Memorial Hospital	Lin, CS (corresponding author), Mackay Mem Hosp, Dept Anesthesiol, Taipei, Taiwan.	seancslin@gmail.com		Kao, Sheng-Chin/0000-0003-1035-7815				Apfel CC, 2012, BRIT J ANAESTH, V109, P742, DOI 10.1093/bja/aes276; Apfel CC, 2002, BRIT J ANAESTH, V88, P659, DOI 10.1093/bja/88.5.659; Aydogan MS, 2013, J ANESTH, V27, P569, DOI 10.1007/s00540-013-1565-0; Brettner F, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0146746; Campbell VC, 2007, ALCOHOL CLIN EXP RES, V31, P1435, DOI 10.1111/j.1530-0277.2007.00432.x; Chung KC, 2014, PAIN MED, V15, P225, DOI 10.1111/pme.12299; Fletcher D, 2014, BRIT J ANAESTH, V112, P991, DOI 10.1093/bja/aeu137; Gan TJ, 2006, ANESTH ANALG, V102, P1884, DOI 10.1213/01.ANE.0000219597.16143.4D; Gatch MB, 2009, CURR DRUG ABUSE REV, V2, P41; Gerbershagen HJ, 2013, ANESTHESIOLOGY, V118, P934, DOI 10.1097/ALN.0b013e31828866b3; He L, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019372; Hwang IC, 2014, ANESTHESIOLOGY, V121, P825, DOI 10.1097/ALN.0000000000000405; Ip HYV, 2009, ANESTHESIOLOGY, V111, P657, DOI 10.1097/ALN.0b013e3181aae87a; Koike H, 2006, CURR OPIN NEUROL, V19, P481, DOI 10.1097/01.wco.0000245371.89941.eb; Mayer DJ, 1999, P NATL ACAD SCI USA, V96, P7731, DOI 10.1073/pnas.96.14.7731; Miyoshi K, 2007, EUR J PHARMACOL, V562, P208, DOI 10.1016/j.ejphar.2007.01.091; MOGIL JS, 1993, BRAIN RES, V602, P126, DOI 10.1016/0006-8993(93)90251-H; Morino R, 2013, J ANESTH, V27, P18, DOI 10.1007/s00540-012-1468-5; Morisot N, 2016, GENES BRAIN BEHAV; Narita M, 2007, NEUROSCIENCE, V144, P777, DOI 10.1016/j.neuroscience.2006.10.028; Narita M, 2007, LIFE SCI, V80, P852, DOI 10.1016/j.lfs.2006.11.015; Rodgers A, 2000, BMJ-BRIT MED J, V321, P1493, DOI 10.1136/bmj.321.7275.1493; Ryu Junnosuke, 1993, Bulletin Hospital for Joint Diseases, V53, P35; Shaheen PE, 2009, J PAIN SYMPTOM MANAG, V38, P409, DOI 10.1016/j.jpainsymman.2009.06.004; Smith HS, 2014, EUR J PHARMACOL, V722, P67, DOI 10.1016/j.ejphar.2013.09.074; Stadler M, 2003, ANESTHESIOLOGY, V98, P46, DOI 10.1097/00000542-200301000-00011; Treskatsch S, 2014, EUR J ANAESTH, V31, P41, DOI 10.1097/01.EJA.0000434967.03790.0e; Wang H, 2002, REGION ANESTH PAIN M, V27, P139, DOI 10.1053/rapm.2002.29253; Weingarten TN, 2011, OBES SURG, V21, P1407, DOI 10.1007/s11695-010-0217-9; Wu CL, 2011, LANCET, V377, P2215, DOI 10.1016/S0140-6736(11)60245-6; Yoshida K, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0116885	31	4	5	2	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 16	2017	12	3							e0171275	10.1371/journal.pone.0171275	http://dx.doi.org/10.1371/journal.pone.0171275			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN9KE	28301483	Green Published, gold, Green Submitted			2022-12-27	WOS:000396318300011
J	Matsuyama, R; Miura, F; Nishiura, H				Matsuyama, Ryota; Miura, Fuminari; Nishiura, Hiroshi			The transmissibility of noroviruses: Statistical modeling of outbreak events with known route of transmission in Japan	PLOS ONE			English	Article							GASTROENTERITIS OUTBREAKS; EMERGENCE; VARIANT; EVOLUTION; STRAIN; IMMUNITY; IMPACT; VIRUS	In Japan, the fraction of norovirus outbreaks attributable to human-to-human transmission has increased with time, and the timing of the increased fraction has coincided with the increase in the observed fraction of genogroup II genotype 4 (GII.4). The present study aimed to estimate the time-dependent changes in the transmissibility of noroviruses. The effective reproduction number (R-y), for year y, was estimated by analyzing the time series surveillance data for outbreak events from 2000 to 2016. R-y was estimated by using the fraction of outbreak events that were attributable to human-to-human transmission and by employing three different statistical models that are considered to mechanistically capture the possible data-generating process in different ways. The R-y estimates ranged from 0.14 to 4.15 in value, revealing an overall increasing trend (p< 0.05 for all three models). The proportion of outbreaks caused by GII and GII.4 viruses among the total events also increased with time, and positive correlations were identified between transmissibility and these proportions. Parametric modeling of R-y indicated that the time-dependent patterns of R-y were better described by a step function plus linear trend rather than the step function alone that reflects the widespread use of reverse transcriptase PCR (RT-PCR) in and after 2007 for laboratory diagnosis. Accordingly, we conclude that norovirus transmissibility has increased over the past 16 years in Japan. The change is at least partially explained by the time-dependent domination of the contagious GII genogroup (e.g., GII.4), indicating that noroviruses better fitted to humans have selectively caused the human-to-human transmissions, thereby altering the epidemiology of this pathogen.	[Matsuyama, Ryota; Miura, Fuminari; Nishiura, Hiroshi] Hokkaido Univ, Grad Sch Med, Kita Ku, Kita 15 Jo Nishi 7 Chome, Sapporo, Hokkaido, Japan; [Matsuyama, Ryota; Nishiura, Hiroshi] Japan Sci & Technol Agcy, CREST, 4-1-8 Honcho, Kawaguchi, Saitama, Japan; [Miura, Fuminari] Univ Tokyo, Grad Sch Engn, Dept Urban Engn, Bunkyo Ku, 7-3-1 Hongo, Tokyo, Japan	Hokkaido University; Japan Science & Technology Agency (JST); University of Tokyo	Nishiura, H (corresponding author), Hokkaido Univ, Grad Sch Med, Kita Ku, Kita 15 Jo Nishi 7 Chome, Sapporo, Hokkaido, Japan.; Nishiura, H (corresponding author), Japan Sci & Technol Agcy, CREST, 4-1-8 Honcho, Kawaguchi, Saitama, Japan.	nishiurah@med.hokudai.ac.jp	Matsuyama, Ryota/AAX-8909-2021; Matsuyama, Ryota/AAF-5208-2021; Matsuyama, Ryota/ABH-7126-2020	Matsuyama, Ryota/0000-0002-7296-0129; Miura, Fuminari/0000-0001-8235-757X	Japan Agency for Medical Research and Development; Japan Society for the Promotion of Science (JSPS) KAKENHI [16KT0130, 16K15356, 26700028]; Program for Advancing Strategic International Networks to Accelerate the Circulation of Talented Researchers; Japan Science and Technology Agency (JST); JSPS [16H06581]; Grants-in-Aid for Scientific Research [16KT0130, 26700028] Funding Source: KAKEN	Japan Agency for Medical Research and Development(Japan Agency for Medical Research and Development (AMED)); Japan Society for the Promotion of Science (JSPS) KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Program for Advancing Strategic International Networks to Accelerate the Circulation of Talented Researchers; Japan Science and Technology Agency (JST)(Japan Science & Technology Agency (JST)); JSPS(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	HN received funding support from the Japan Agency for Medical Research and Development, the Japan Society for the Promotion of Science (JSPS) KAKENHI (Grant numbers 16KT0130, 16K15356 and 26700028), the Program for Advancing Strategic International Networks to Accelerate the Circulation of Talented Researchers, the Japan Science and Technology Agency (JST) CREST program and RISTEX program for Science of Science, Technology and Innovation Policy. RM also received funding support from JSPS KAKENHI (Grant number 16H06581). The funders played no roles in the study design, data collection and analysis, decision to publish, or manuscript preparation.	[Anonymous], EURO SURVEILL; Bitler EJ, 2013, EPIDEMIOL INFECT, V141, P1563, DOI 10.1017/S095026881300006X; Bull RA, 2006, J CLIN MICROBIOL, V44, P327, DOI 10.1128/JCM.44.2.327-333.2006; Bull RA, 2011, TRENDS MICROBIOL, V19, P233, DOI 10.1016/j.tim.2011.01.002; Cauchemez S, 2013, PLOS MED, V10, DOI 10.1371/journal.pmed.1001399; Chan MCW, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms10061; Chan-It W, 2012, J MED VIROL, V84, P1089, DOI 10.1002/jmv.23309; de Graaf M, 2015, EUROSURVEILLANCE, V20, P8, DOI 10.2807/1560-7917.ES2015.20.26.21178; Debbink K, 2013, J INFECT DIS, V208, P1877, DOI 10.1093/infdis/jit370; Dey SK, 2011, CLIN LAB, V57, P193; Eden JS, 2013, J VIROL, V87, P6270, DOI 10.1128/JVI.03464-12; Eden JS, 2010, J CLIN VIROL, V49, P265, DOI 10.1016/j.jcv.2010.09.001; Gao ZY, 2015, BMC INFECT DIS, V15, DOI 10.1186/s12879-015-1315-z; Hall AJ, 2013, EMERG INFECT DIS, V19, P1198, DOI 10.3201/eid1908.130465; Harris T. E., 1963, THEORY BRANCHING PRO; Hay AJ, 2001, PHILOS T R SOC B, V356, P1861, DOI 10.1098/rstb.2001.0999; Heijne JCM, 2009, EMERG INFECT DIS, V15, P24, DOI [10.3201/1501.080299, 10.3201/eid1501.080299]; Infectious Disease Surveillance Center National Institute of Infectious Diseases, 2014, IASR, V35, P161; Kumazaki M, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0142568; Lindesmith LC, 2008, PLOS MED, V5, P269, DOI 10.1371/journal.pmed.0050031; Lindesmith LC, 2013, J VIROL, V87, P2803, DOI 10.1128/JVI.03106-12; Lindesmith LC, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002705; Lopman B, 2004, LANCET, V363, P682, DOI 10.1016/S0140-6736(04)15641-9; Lopman B, 2014, AM J EPIDEMIOL, V179, P507, DOI 10.1093/aje/kwt287; Lopman B, 2012, CURR OPIN VIROL, V2, P96, DOI 10.1016/j.coviro.2011.11.005; Lopman BA, 2016, PLOS MED, V13, DOI 10.1371/journal.pmed.1001999; Nishiura H, 2013, THEOR BIOL MED MODEL, V10, DOI 10.1186/1742-4682-10-30; Nishiura H, 2012, J THEOR BIOL, V294, P48, DOI 10.1016/j.jtbi.2011.10.039; Sakon N, 2015, J INFECT DIS, V211, P879, DOI 10.1093/infdis/jiu496; Siebenga JJ, 2007, J VIROL, V81, P9932, DOI 10.1128/JVI.00674-07; Simmons K, 2013, EMERG INFECT DIS, V19, P1260, DOI 10.3201/eid1908.130472; Sukhrie FHA, 2012, CLIN INFECT DIS, V54, P931, DOI 10.1093/cid/cir971; Teunis PFM, 2008, J MED VIROL, V80, P1468, DOI 10.1002/jmv.21237; Vanderpas J, 2009, J HOSP INFECT, V71, P214, DOI 10.1016/j.jhin.2008.11.024; Vega E, 2014, J CLIN MICROBIOL, V52, P147, DOI 10.1128/JCM.02680-13; Vega E, 2011, EMERG INFECT DIS, V17, P1389, DOI 10.3201/eid1708.101837; Verhoef L, 2015, EMERG INFECT DIS, V21, P592, DOI 10.3201/eid2104.141073; White P, 2002, J MED VIROL, V68, P113, DOI 10.1002/jmv.10177; White PA, 2014, CLIN MICROBIOL INFEC, V20, P741, DOI 10.1111/1469-0691.12746; Yen C, 2011, CLIN INFECT DIS, V53, P568, DOI 10.1093/cid/cir478	40	13	13	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 15	2017	12	3							e0173996	10.1371/journal.pone.0173996	http://dx.doi.org/10.1371/journal.pone.0173996			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN9HQ	28296972	gold, Green Published, Green Submitted			2022-12-27	WOS:000396311700087
J	Balducci, S; D'Errico, V; Haxhi, J; Sacchetti, M; Orlando, G; Cardelli, P; Di Biase, N; Bollanti, L; Conti, F; Zanuso, S; Nicolucci, A; Pugliese, G				Balducci, Stefano; D'Errico, Valeria; Haxhi, Jonida; Sacchetti, Massimo; Orlando, Giorgio; Cardelli, Patrizia; Di Biase, Nicolina; Bollanti, Lucilla; Conti, Francesco; Zanuso, Silvano; Nicolucci, Antonio; Pugliese, Giuseppe		Italian Diabetes Exercise Study 2	Level and correlates of physical activity and sedentary behavior in patients with type 2 diabetes: A cross-sectional analysis of the Italian Diabetes and Exercise Study_2	PLOS ONE			English	Article							RANDOMIZED CONTROLLED-TRIAL; TELEVISION VIEWING TIME; ALL-CAUSE MORTALITY; MYWELLNESS KEY; SITTING TIME; RISK-FACTORS; LIFE-STYLE; CARDIOVASCULAR-DISEASE; MEN; PEOPLE	Objective Patients with type 2 diabetes usually show reduced physical activity (PA) and increased sedentary (SED)-time, though to a varying extent, especially for low-intensity PA (LPA), a major determinant of daily energy expenditure that is not accurately captured by questionnaires. This study assessed the level and correlates of PA and SED-time in patients from the Italian Diabetes and Exercise Study_2 (IDES_2). Methods Three-hundred physically inactive and sedentary patients with type 2 diabetes were enrolled in the IDES_2 to be randomized to an intervention group, receiving theoretical and practical exercise counseling, and a control group, receiving standard care. At baseline, LPA, moderate-to-vigorous-intensity PA (MVPA), and SED-time were measured by accelerometer. Physical fitness and cardiovascular risk factors and scores were also assessed. Results LPA was 3.93 +/- 1.35 hours.day(-1), MVPA was 12.4 +/- 4.6 min.day(-1), and SED-time was 11.6 +/- 1.2 hours.day(-1), with a large range of values (0.89-7.11 hours.day(-1), 0.6-21.0 min.day(-1), and 9.14-15.28 hours.day(-1), respectively). At bivariate analysis, LPA and MVPA correlated with better cardiovascular risk profile and fitness parameters, whereas the opposite was observed for SED-time. Likewise, values of LPA, MVPA, and SED-time falling in the best tertile were associated with optimal or acceptable levels of cardiovascular risk factors and scores. At multivariate analysis, age, female gender, HbA(1c), BMI or waist circumference, and high-sensitivity C reactive protein (for LPA and SED-time only) were negatively associated with LPA and MPA and positively associated with SED-time in an independent manner. Conclusions Physically inactive and sedentary patients with type 2 diabetes from the IDES_2 show a low level of PA, though values of LPA, MVPA, and SED-time vary largely. Furthermore, there is a strong correlation of these measures with glycemic control, adiposity and inflammation, thus suggesting that even small improvements in LPA, MVPA, and SED-time might be associated with significant improvement in cardiovascular risk profile.	[Balducci, Stefano; D'Errico, Valeria; Haxhi, Jonida; Cardelli, Patrizia; Bollanti, Lucilla; Conti, Francesco; Pugliese, Giuseppe] Univ Roma La Sapienza, Dept Clin & Mol Med, Rome, Italy; [Balducci, Stefano; D'Errico, Valeria; Haxhi, Jonida; Bollanti, Lucilla; Conti, Francesco; Pugliese, Giuseppe] St Andrea Hosp, Diabet Unit, Rome, Italy; [Balducci, Stefano; D'Errico, Valeria; Haxhi, Jonida] Metab Fitness Assoc, Monterotondo, Italy; [Sacchetti, Massimo; Orlando, Giorgio] Foro Italico Univ, Dept Human Movement & Sport Sci, Rome, Italy; [Cardelli, Patrizia] St Andrea Hosp, Clin Chem Lab, Rome, Italy; [Di Biase, Nicolina] Fatebenefratelli San Pietro Hosp, Diabet Unit, Rome, Italy; [Zanuso, Silvano] Coventry Univ, Fac Hlth Life Sci, Ctr Appl Biol Exercise Sci, Coventry, W Midlands, England; [Nicolucci, Antonio] Ctr Outcomes Res & Clin Epidemiol CORE, Pescara, Italy	Sapienza University Rome; Sapienza University Rome; Azienda Ospedaliera Sant'Andrea; Foro Italico University of Rome; Sapienza University Rome; Azienda Ospedaliera Sant'Andrea; Coventry University	Pugliese, G (corresponding author), Univ Roma La Sapienza, Dept Clin & Mol Med, Rome, Italy.	giuseppe.pugliese@uniroma1.it	Orlando, Giorgio/AAK-9159-2020; haxhi, jonida/M-4545-2013	Orlando, Giorgio/0000-0001-6721-8248; haxhi, jonida/0000-0003-2319-869X; Sacchetti, Massimo/0000-0002-5365-5161	Metabolic Fitness Association, Monterotondo, Rome, Italy	Metabolic Fitness Association, Monterotondo, Rome, Italy	The work was supported by Metabolic Fitness Association, Monterotondo, Rome, Italy, http://www.metabolicfitness.it/. Grant Number: NA. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Balducci S, 2010, NUTR METAB CARDIOVAS, V20, P608, DOI 10.1016/j.numecd.2009.04.015; Balducci S, 2015, TRIALS, V16, DOI 10.1186/s13063-015-1088-0; Balducci S, 2014, DIABETES-METAB RES, V30, P13, DOI 10.1002/dmrr.2514; Balducci S, 2010, ARCH INTERN MED, V170, P1794, DOI 10.1001/archinternmed.2010.380; Balducci S, 2008, NUTR METAB CARDIOVAS, V18, P585, DOI 10.1016/j.numecd.2007.07.006; Bergamin M, 2012, J SPORT SCI MED, V11, P57; Church TS, 2004, DIABETES CARE, V27, P83, DOI 10.2337/diacare.27.1.83; Cooper AR, 2012, DIABETOLOGIA, V55, P589, DOI 10.1007/s00125-011-2408-x; Cooper AJM, 2014, DIABETOLOGIA, V57, P73, DOI 10.1007/s00125-013-3069-8; Di Loreto C, 2003, DIABETES CARE, V26, P404, DOI 10.2337/diacare.26.2.404; Dunstan DW, 2010, CIRCULATION, V121, P384, DOI 10.1161/CIRCULATIONAHA.109.894824; Ekelund U, 2015, AM J CLIN NUTR, V101, P613, DOI 10.3945/ajcn.114.100065; Febbraio MA, 2007, J APPL PHYSIOL, V103, P376, DOI 10.1152/japplphysiol.00414.2007; Healy GN, 2007, DIABETES CARE, V30, P1384, DOI 10.2337/dc07-0114; Healy GN, 2015, EUR HEART J, V36, P2643, DOI 10.1093/eurheartj/ehv308; Healy GN, 2011, EUR HEART J, V32, P590, DOI 10.1093/eurheartj/ehq451; Herrmann SD, 2011, BRIT J SPORT MED, V45, P109, DOI 10.1136/bjsm.2009.062182; Huffman MD, 2012, CIRCULATION, V125, P2595, DOI 10.1161/CIRCULATIONAHA.111.070722; Inoue M, 2008, ANN EPIDEMIOL, V18, P522, DOI 10.1016/j.annepidem.2008.03.008; Katzmarzyk PT, 2010, DIABETES, V59, P2717, DOI 10.2337/db10-0822; Katzmarzyk PT, 2009, MED SCI SPORT EXER, V41, P998, DOI 10.1249/MSS.0b013e3181930355; Kokkinos P, 2009, DIABETES CARE, V32, P623, DOI 10.2337/dc08-1876; Korkiakangas EE, 2009, HEALTH PROMOT INT, V24, P416, DOI 10.1093/heapro/dap031; Ladabaum U, 2014, AM J MED, V127, P717, DOI 10.1016/j.amjmed.2014.02.026; McGinley SK, 2015, APPL PHYSIOL NUTR ME, V40, P1193, DOI 10.1139/apnm-2015-0169; Morrato EH, 2007, DIABETES CARE, V30, P203, DOI 10.2337/dc06-1128; Myers J, 2002, NEW ENGL J MED, V346, P793, DOI 10.1056/NEJMoa011858; Nicolucci A, 2012, DIABETOLOGIA, V55, P579, DOI 10.1007/s00125-011-2425-9; Owen N, 2010, EXERC SPORT SCI REV, V38, P105, DOI 10.1097/JES.0b013e3181e373a2; Penno G, 2013, J INTERN MED, V274, P176, DOI 10.1111/joim.12073; Sacchetti MS, 2013, MED SCI SPORT EXER, V45, P52, DOI 10.1249/MSS.0b013e318269f9bb; Sedentary Behaviour Research Network, 2012, APPL PHYSIOL NUTR ME, V37, P540, DOI [10.1139/h2012-024, DOI 10.1139/H2012-024]; Shephard RJ, 2003, BRIT J SPORT MED, V37, P197, DOI 10.1136/bjsm.37.3.197; Sieverdes John C, 2013, Clin Epidemiol, V5, P13, DOI 10.2147/CLEP.S38370; Sigal RJ, 2004, DIABETES CARE, V27, P2518, DOI 10.2337/diacare.27.10.2518; Sigal RJ, 2010, DIABETES CARE, V33, P147, DOI DOI 10.2337/DC10-9990; Thorp AA, 2010, DIABETES CARE, V33, P327, DOI 10.2337/dc09-0493; Wei M, 2000, ANN INTERN MED, V132, P605, DOI 10.7326/0003-4819-132-8-200004180-00002; Yates T, 2009, DIABETES CARE, V32, P1404, DOI 10.2337/dc09-0130	39	17	20	0	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 14	2017	12	3							e0173337	10.1371/journal.pone.0173337	http://dx.doi.org/10.1371/journal.pone.0173337			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN6DM	28291838	Green Published, Green Submitted, gold			2022-12-27	WOS:000396094700020
J	Te, ALD; Higa, S; Chung, FP; Lin, CY; Lo, MT; Liu, CA; Lin, C; Chang, YC; Chang, SL; Lo, LW; Hu, YF; Tuan, TC; Chao, TF; Liao, JN; Chang, YT; Lin, CH; Hung, Y; Yamada, S; Pan, KL; Lin, YJ; Chen, SA				Te, Abigail Louise D.; Higa, Satoshi; Chung, Fa-Po; Lin, Chin-Yu; Lo, Men-Tzung; Liu, Che-An; Lin, Chen; Chang, Yi-Chung; Chang, Shih-Lin; Lo, Li-Wei; Hu, Yu-Feng; Tuan, Ta-Chuan; Chao, Tze-Fan; Liao, Jonan; Chang, Yao-Ting; Lin, Chung-Hsing; Hung, Yuan; Yamada, Shinya; Pan, Kuo-Li; Lin, Yenn-Jiang; Chen, Shih-Ann			The use of a novel signal analysis to identify the origin of idiopathic right ventricular outflow tract ventricular tachycardia during sinus rhythm: Simultaneous amplitude frequency electrogram transformation mapping	PLOS ONE			English	Article							CATHETER ABLATION; ELECTROPHYSIOLOGIC CHARACTERISTICS; SUBSTRATE-MODIFICATION; SITE; ARRHYTHMIAS; CARDIOMYOPATHY; ACTIVATION	Introduction The signal characteristics of intracardiac bipolar electrograms at the origin of idiopathic RVOT-VT during sinus rhythm remain unclear. Objective The study sought to develop a novel real-time/online technique, simultaneous amplitude frequency electrogram transformation (SAFE-T), to quantify and localize the diseased ventricular substrate in idiopathic RVOT-VT. Methods We retrospectively investigated the intracardiac bipolar recordings in 70 consecutive patients (26% male, mean age 42 +/- 12 years) who underwent successful radiofrequency catheter ablation of idiopathic RVOT-VT. We quantified the extent of the frequency fraction of ventricular potentials during sinus rhythm or ventricular pacing using a novel formula, the product of instantaneous amplitude and frequency, and showed that in a 3D geometry as an online SAFE-T map. Results The characteristics of the HHT spectra of electrograms derived from VT origins demonstrated high frequency components (>70 Hz), which were independent of the rhythm. The density of the abnormal potentials at the VT origins were higher (VT origins, 7.5 +/- 2.3 sites/cm(2) vs. surrounding myocardium, 1.5 +/- 1.3 sites/cm(2), p<0.001), and were significantly decreased after ablation (0.7 +/- 0.6 sites/cm(2), p<0.001). A small region of abnormal potentials were observed in the VT origins (mean area of 1.5 +/- 0.8 cm(2)). The SAFE-T maps predicted the VT origins with 92% sensitivity, 78% specificity with optimal cut-off value of >3.0 Hz.mV. Conclusion The online SAFE-T map was feasible for quantifying the diseased ventricular substrate, irrespective of the rhythm of activation, and can be used to identify the optimal ablation targets for idiopathic RVOT-VT. We found a limited region of abnormal potentials where the RVOT-VT origins were successfully ablated.	[Te, Abigail Louise D.; Chung, Fa-Po; Lin, Chin-Yu; Liu, Che-An; Chang, Shih-Lin; Lo, Li-Wei; Hu, Yu-Feng; Tuan, Ta-Chuan; Chao, Tze-Fan; Liao, Jonan; Chang, Yao-Ting; Lin, Chung-Hsing; Hung, Yuan; Yamada, Shinya; Pan, Kuo-Li; Lin, Yenn-Jiang; Chen, Shih-Ann] Taipei Vet Gen Hosp, Div Cardiol, Dept Med, Taipei, Taiwan; [Higa, Satoshi] Makiminato Cent Hosp, Cardiac Electrophysiol & Pacing Lab, Div Cardiovasc Med, Urasoe, Okinawa, Japan; [Chung, Fa-Po; Chang, Shih-Lin; Lo, Li-Wei; Hu, Yu-Feng; Tuan, Ta-Chuan; Chao, Tze-Fan; Liao, Jonan; Lin, Yenn-Jiang; Chen, Shih-Ann] Natl Yang Ming Univ, Fac Med, Taipei, Taiwan; [Lo, Men-Tzung; Lin, Chen; Chang, Yi-Chung] Natl Cent Univ, Res Ctr Adapt Data Anal, Jhongli, Taiwan; [Lo, Men-Tzung; Lin, Chen; Chang, Yi-Chung] Natl Cent Univ, Ctr Dynam Biomarkers & Translat Med, Jhongli, Taiwan	Taipei Veterans General Hospital; National Yang Ming Chiao Tung University; National Central University; National Central University	Lin, YJ (corresponding author), Taipei Vet Gen Hosp, Div Cardiol, Dept Med, Taipei, Taiwan.; Lin, YJ (corresponding author), Natl Yang Ming Univ, Fac Med, Taipei, Taiwan.	linyennjiang@gmail.com	huang, yuting/T-4341-2019; Hu, Yu-Feng/V-1401-2019; Wang, Pa-Chun/AAD-4094-2019	Hu, Yu-Feng/0000-0001-5715-2070; Te, Abigail Louise/0000-0002-7461-2793; Chang, Shu-chuan/0000-0002-7087-0744; HIGA, SATOSHI/0000-0002-5735-6249; Lin, Chin-Yu/0000-0003-3282-7523; Lin, Chen/0000-0001-6261-8509; Hung, Yuan/0000-0002-2199-8338	Ministry of Science and Technology of Taiwan [MOST 104-2314-B-010-063-MY2]; Grant of Taipei Veterans General Hospital [V105C-122]; Joint foundation of Taipei Veterans General Hospital; National Taiwan University Hospital [105AC-D710, VGHUST105-G7-4-1]	Ministry of Science and Technology of Taiwan(Ministry of Science and Technology, Taiwan); Grant of Taipei Veterans General Hospital(Taipei Veterans General Hospital); Joint foundation of Taipei Veterans General Hospital; National Taiwan University Hospital(National Taiwan University)	This work was supported by Ministry of Science and Technology of Taiwan support for National Yang-Ming University (MOST 104-2314-B-010-063-MY2); Grant of Taipei Veterans General Hospital (V105C-122); Joint foundation of Taipei Veterans General Hospital and National Taiwan University Hospital (105AC-D710, VGHUST105-G7-4-1).	Azegami K, 2005, J CARDIOVASC ELECTR, V16, P823, DOI 10.1111/j.1540-8167.2005.50041.x; Bogun F, 2006, J AM COLL CARDIOL, V47, P2013, DOI 10.1016/j.jacc.2005.12.062; BUXTON AE, 1983, CIRCULATION, V68, P917, DOI 10.1161/01.CIR.68.5.917; Campos B, 2015, HEART RHYTHM, V12, P95, DOI 10.1016/j.hrthm.2014.10.002; Chung FP, 2015, J CARDIOL, V65, P441, DOI 10.1016/j.jjcc.2014.12.023; Chung FP, 2014, HEART RHYTHM, V11, P1760, DOI 10.1016/j.hrthm.2014.06.011; Corrado D, 2008, J AM COLL CARDIOL, V51, P731, DOI 10.1016/j.jacc.2007.11.027; Deneke T, 2005, Z KARDIOL, V94, P453, DOI 10.1007/s00392-005-0240-3; Do VBD, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0140167; Fisher WG, 1997, PACE, V20, P2188, DOI 10.1111/j.1540-8159.1997.tb04235.x; Flemming MA, 1999, AM J CARDIOL, V84, P1266, DOI 10.1016/S0002-9149(99)00546-9; Friedman PA, 2002, J AM COLL CARDIOL, V39, P1808, DOI 10.1016/S0735-1097(02)01864-8; Furushima H, 2012, J INTERV CARD ELECTR, V33, P135, DOI 10.1007/s10840-011-9623-8; Higa S, 2004, CIRCULATION, V109, P84, DOI 10.1161/01.CIR.0000109481.73788.2E; Huang NE, 1998, P ROY SOC A-MATH PHY, V454, P903, DOI 10.1098/rspa.1998.0193; Jais P, 2012, CIRCULATION, V125, P2184, DOI 10.1161/CIRCULATIONAHA.111.043216; Kuteszko R, 2015, EUROPACE, V17, P1428, DOI 10.1093/europace/euu392; Lee SH, 2002, PACE, V25, P1346, DOI 10.1046/j.1460-9592.2002.01346.x; LERMAN BB, 1995, CIRCULATION, V92, P421, DOI 10.1161/01.CIR.92.3.421; Lin Chin-Yu, 2016, JACC Clin Electrophysiol, V2, P459, DOI 10.1016/j.jacep.2016.01.013; Lin CY, 2016, HEART RHYTHM, V13, P111, DOI 10.1016/j.hrthm.2015.08.030; LIN JL, 1991, CIRCULATION, V84, P1319, DOI 10.1161/01.CIR.84.3.1319; Lu YY, 2014, J CELL MOL MED, V18, P1540, DOI 10.1111/jcmm.12329; Man KC, 1997, J CARDIOVASC ELECTR, V8, P974, DOI 10.1111/j.1540-8167.1997.tb00619.x; MORET L, 1993, REV EPIDEMIOL SANTE, V41, P179; O'Donnell D, 2003, EUR HEART J, V24, P801, DOI 10.1016/S0195-668X(02)00654-1; Pachon JC, 2004, EUROPACE, V6, P590, DOI 10.1016/j.eupc.2004.08.005; Sacher F, 2015, J CARDIOVASC ELECTR, V26, P464, DOI 10.1111/jce.12565; Sorgente A, 2016, HEART RHYTHM, V13, P519, DOI 10.1016/j.hrthm.2015.11.005; Tsai CF, 1997, INT J CARDIOL, V62, P143, DOI 10.1016/S0167-5273(97)00198-8	30	4	4	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 10	2017	12	3							e0173189	10.1371/journal.pone.0173189	http://dx.doi.org/10.1371/journal.pone.0173189			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN6CJ	28282453	Green Submitted, Green Published, gold			2022-12-27	WOS:000396091800018
J	Drury, C; Manzello, D; Lirman, D				Drury, Crawford; Manzello, Derek; Lirman, Diego			Genotype and local environment dynamically influence growth, disturbance response and survivorship in the threatened coral, Acropora cervicornis	PLOS ONE			English	Article							REGION-WIDE DECLINES; REEF-BUILDING CORAL; WHITE-BAND DISEASE; PHENOTYPIC PLASTICITY; POCILLOPORA-DAMICORNIS; GENETIC DIVERSITY; CARBONIC-ACID; TEMPERATURE; SEAWATER; RESTORATION	The relationship between the coral genotype and the environment is an important area of research in degraded coral reef ecosystems. We used a reciprocal outplanting experiment with 930 corals representing ten genotypes on each of eight reefs to investigate the influence of genotype and the environment on growth and survivorship in the threatened Caribbean staghorn coral, Acropora cervicornis. Coral genotype and site were strong drivers of coral growth and individual genotypes exhibited flexible, non- conserved reaction norms, complemented by ten- fold differences in growth between specific G- E combinations. Growth plasticity may diminish the influence of local adaptation, where foreign corals grew faster than native corals at their home sites. Novel combinations of environment and genotype also significantly affected disturbance response during and after the 2015 bleaching event, where these factors acted synergistically to drive variation in bleaching and recovery. Importantly, small differences in temperature stress elicit variable patterns of survivorship based on genotype and illustrate the importance of novel combinations of coral genetics and small differences between sites representing habitat refugia. In this context, acclimatization and flexibility is especially important given the long lifespan of corals coping with complex environmental change. The combined influence of site and genotype creates shortterm differences in growth and survivorship, contributing to the standing genetic variation needed for adaptation to occur over longer timescales and the recovery of degraded reefs through natural mechanisms.	[Drury, Crawford; Lirman, Diego] Rosenstiel Sch Marine & Atmospher Sci, Marine Biol & Ecol Div, Miami, FL 33149 USA; [Manzello, Derek] NOAA, Atlantic Oceanog & Meteorol Labs, Miami, FL USA	National Oceanic Atmospheric Admin (NOAA) - USA; Atlantic Oceanographic & Meteorological Laboratory (AOML)	Drury, C (corresponding author), Rosenstiel Sch Marine & Atmospher Sci, Marine Biol & Ecol Div, Miami, FL 33149 USA.	cdrury@rsmas.miami.edu	Manzello, Derek P/A-8661-2014; Drury, Crawford/AAR-5935-2020	Manzello, Derek P/0000-0002-0720-3041; Drury, Crawford/0000-0001-8853-416X	Garden Club of America Ecological Restoration Fellowship; National Oceanic and Atmospheric Administration's Coral Reef Conservation Program; Ocean Acidification Program	Garden Club of America Ecological Restoration Fellowship; National Oceanic and Atmospheric Administration's Coral Reef Conservation Program; Ocean Acidification Program	This work was funded by the Garden Club of America Ecological Restoration Fellowship (https://www.gcamerica.org/) in 2015 to CD. DM is supported by National Oceanic and Atmospheric Administrations Coral Reef Conservation Program and Ocean Acidification Program. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agudo-Adriani EA, 2016, PEERJ, V4, DOI 10.7717/peerj.1861; Aitken SN, 2013, ANNU REV ECOL EVOL S, V44, P367, DOI 10.1146/annurev-ecolsys-110512-135747; Alvarez-Filip L, 2009, P ROY SOC B-BIOL SCI, V276, P3019, DOI 10.1098/rspb.2009.0339; Anthony KRN, 2007, LIMNOL OCEANOGR, V52, P716, DOI 10.4319/lo.2007.52.2.0716; Aronson RB, 1998, CORAL REEFS, V17, P223, DOI 10.1007/s003380050122; Aronson RB, 2001, HYDROBIOLOGIA, V460, P25, DOI 10.1023/A:1013103928980; Aronson RB, 2008, IUCN RED LIST THREAT; Baker AC, 2004, NATURE, V430, P741, DOI 10.1038/430741a; Baker AC, 1997, PRACTICAL ADHESIVE B, P1; Baums IB, 2008, MOL ECOL, V17, P2796, DOI 10.1111/j.1365-294X.2008.03787.x; Baums IB, 2006, LIMNOL OCEANOGR, V51, P1969, DOI 10.4319/lo.2006.51.5.1969; Berkelmans R, 2006, P ROY SOC B-BIOL SCI, V273, P2305, DOI 10.1098/rspb.2006.3567; BRADSHAW A. D., 1965, ADVANCE GENET, V13, P115, DOI 10.1016/S0065-2660(08)60048-6; Bruno JF, 1997, ECOLOGY, V78, P2177, DOI 10.2307/2265954; Chevin LM, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000357; Chevin LM, 2010, EVOLUTION, V64, P1143, DOI 10.1111/j.1558-5646.2009.00875.x; Cooper TF, 2012, SCIENCE, V335, P593, DOI 10.1126/science.1214570; Cunning R, 2013, NAT CLIM CHANGE, V3, P259, DOI [10.1038/NCLIMATE1711, 10.1038/nclimate1711]; D'Croz L, 2004, CORAL REEFS, V23, P473, DOI 10.1007/s00338-004-0397-7; Devlin-Durante MK, 2016, MOL ECOL, V25, P5628, DOI 10.1111/mec.13865; DICKSON AG, 1987, DEEP-SEA RES, V34, P1733, DOI 10.1016/0198-0149(87)90021-5; DICKSON AG, 1990, DEEP-SEA RES, V37, P755, DOI 10.1016/0198-0149(90)90004-F; Dixon GB, 2015, SCIENCE, V348, P1460, DOI 10.1126/science.1261224; Drury C, 2016, BMC GENOMICS, V17, DOI 10.1186/s12864-016-2583-8; Elshire RJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019379; Enochs IC, 2014, CORAL REEFS, V33, P477, DOI 10.1007/s00338-014-1132-7; Forrester GE, 2013, MAR ECOL-EVOL PERSP, V34, P186, DOI 10.1111/maec.12000; Gardner TA, 2003, SCIENCE, V301, P958, DOI 10.1126/science.1086050; Gibson G, 2004, NAT REV GENET, V5, P681, DOI 10.1038/nrg1426; GILMORE MD, 1976, J SEDIMENT PETROL, V46, P519; GLADFELTER WB, 1982, B MAR SCI, V32, P639; Hawkins TD, 2016, ENVIRON MICROBIOL, V18, P5204, DOI 10.1111/1462-2920.13535; Hellberg ME, 2007, CORAL REEFS, V26, P463, DOI 10.1007/s00338-007-0205-2; Hemond EM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008652; Hereford J, 2009, AM NAT, V173, P579, DOI 10.1086/597611; HIGHSMITH RC, 1982, MAR ECOL PROG SER, V7, P207, DOI 10.3354/meps007207; Hoegh-Guldberg O, 1999, MAR ECOL PROG SER, V183, P73, DOI 10.3354/meps183073; Hogarth W.T., 2006, FED REGISTER, V71, P26852; HUGHES TP, 1994, SCIENCE, V265, P1547, DOI 10.1126/science.265.5178.1547; Jaap WC, 1988, P 6 INT COR REEF S, V2; Jones AM, 2011, J MARINE BIOL, V2011; Jones RJ, 1998, PLANT CELL ENVIRON, V21, P1219, DOI 10.1046/j.1365-3040.1998.00345.x; Kassen R, 2002, J EVOLUTION BIOL, V15, P173, DOI 10.1046/j.1420-9101.2002.00377.x; Kawecki TJ, 2004, ECOL LETT, V7, P1225, DOI 10.1111/j.1461-0248.2004.00684.x; Kawecki TJ, 2008, ANNU REV ECOL EVOL S, P321; Kenkel CD, 2015, ECOLOGY, V96, P3197, DOI 10.1890/14-2297.1; LESSER MP, 1990, CORAL REEFS, V8, P225, DOI 10.1007/BF00265015; LESSIOS HA, 1984, SCIENCE, V226, P335, DOI 10.1126/science.226.4672.335; Lewis ER, 1998, ESS-DIVE, DOI 10.15485/1464255; Lirman D, 2010, CORAL REEFS, V29, P729, DOI 10.1007/s00338-010-0621-6; Lirman D, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0107253; Lirman D, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023047; Lohr KE, 2017, J EXP MAR BIOL ECOL, V486, P87, DOI 10.1016/j.jembe.2016.10.005; Manzello D, 2013, J GEOPHYS RES-OCEANS, V118, P5312, DOI 10.1002/jgrc.20378; Manzello DP, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041715; Manzello DP, 2010, LIMNOL OCEANOGR, V55, P239, DOI 10.4319/lo.2010.55.1.0239; Marshall DJ, 2010, ECOL LETT, V13, P128, DOI 10.1111/j.1461-0248.2009.01408.x; Matesanz S, 2010, ANN NY ACAD SCI, V1206, P35, DOI 10.1111/j.1749-6632.2010.05704.x; MEHRBACH C, 1973, LIMNOL OCEANOGR, V18, P897, DOI 10.4319/lo.1973.18.6.0897; Miller MW, 2002, CORAL REEFS, V21, P179, DOI 10.1007/s00338-002-0228-7; Murren CJ, 2014, AM NAT, V183, P453, DOI 10.1086/675302; Nicotra AB, 2010, TRENDS PLANT SCI, V15, P684, DOI 10.1016/j.tplants.2010.09.008; Paaby AB, 2014, NAT REV GENET, V15, P247, DOI 10.1038/nrg3688; Palumbi SR, 2004, ANNU REV ENV RESOUR, V29, P31, DOI 10.1146/annurev.energy.29.062403.102254; Palumbi SR, 2014, SCIENCE, V344, P895, DOI 10.1126/science.1251336; Pandolfi JM, 2003, SCIENCE, V301, P955, DOI 10.1126/science.1085706; Parkinson JE, 2016, GENOME BIOL EVOL, V8, P665, DOI 10.1093/gbe/evw019; Parkinson JE, 2014, FRONT MICROBIOL, V5, DOI 10.3389/fmicb.2014.00445; Parkinson JE, 2015, SCI REP-UK, V5, DOI 10.1038/srep15667; Polato NR, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011221; Putnam HM, 2015, J EXP BIOL, V218, P2365, DOI 10.1242/jeb.123018; Randall CJ, 2015, NAT CLIM CHANGE, V5, P375, DOI 10.1038/nclimate2530; Reusch TBH, 2005, P NATL ACAD SCI USA, V102, P2826, DOI 10.1073/pnas.0500008102; Rowan R, 1997, NATURE, V388, P265, DOI 10.1038/40843; Sampayo EM, 2008, P NATL ACAD SCI USA, V105, P10444, DOI 10.1073/pnas.0708049105; Sanford E, 2011, ANNU REV MAR SCI, V3, P509, DOI 10.1146/annurev-marine-120709-142756; SCHLICHTING CD, 1986, ANNU REV ECOL SYST, V17, P667, DOI 10.1146/annurev.es.17.110186.003315; SCHLICHTING CD, 1989, BIOSCIENCE, V39, P460, DOI 10.2307/1311138; Schopmeyer SA, 2012, RESTOR ECOL, V20, P696, DOI 10.1111/j.1526-100X.2011.00836.x; Silverstein RN, 2012, P ROY SOC B-BIOL SCI, V279, P2609, DOI 10.1098/rspb.2012.0055; Smith LW, 2007, CORAL REEFS, V26, P559, DOI 10.1007/s00338-007-0216-z; Smith-Keune C, 2006, CORAL REEFS, V25, P493, DOI 10.1007/s00338-006-0129-2; STEARNS SC, 1989, BIOSCIENCE, V39, P436, DOI 10.2307/1311135; Teece MA, 2011, LIMNOL OCEANOGR, V56, P1285, DOI 10.4319/lo.2011.56.4.1285; Todd PA, 2008, BIOL REV, V83, P315, DOI 10.1111/j.1469-185X.2008.00045.x; Ulstrup KE, 2006, MAR ECOL PROG SER, V314, P135, DOI 10.3354/meps314135; Valladares F, 2014, ECOL LETT, V17, P1351, DOI 10.1111/ele.12348; van Oppen MJH, 2015, P NATL ACAD SCI USA, V112, P2307, DOI 10.1073/pnas.1422301112; Young CN, 2012, B MAR SCI, V88, P1075, DOI 10.5343/bms.2011.1143	89	79	78	2	51	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 20	2017	12	3							e0174000	10.1371/journal.pone.0174000	http://dx.doi.org/10.1371/journal.pone.0174000			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ER6VC	28319134	Green Published, Green Submitted, gold			2022-12-27	WOS:000398945800040
J	Larsen, DA; Lane, S; Jennings-Bey, T; Haygood-El, A; Brundage, K; Rubinstein, RA				Larsen, David A.; Lane, Sandra; Jennings-Bey, Timothy; Haygood-El, Arnett; Brundage, Kim; Rubinstein, Robert A.			Spatio-temporal patterns of gun violence in Syracuse, New York 2009-2015	PLOS ONE			English	Article							SOCIAL CONTAGION; UNITED-STATES; INJURIES; HOMICIDE; TRANSMISSION; STREET; TRENDS; RISK; LIFE	Gun violence in the United States of America is a large public health problem that disproportionately affects urban areas. The epidemiology of gun violence reflects various aspects of an infectious disease including spatial and temporal clustering. We examined the spatial and temporal trends of gun violence in Syracuse, New York, a city of 145,000. We used a spatial scan statistic to reveal spatio-temporal clusters of gunshots investigated and corroborated by Syracuse City Police Department for the years 2009-2015. We also examined predictors of areas with increased gun violence using a multi-level zero-inflated Poisson regression with data from the 2010 census. Two space-time clusters of gun violence were revealed in the city. Higher rates of segregation, poverty and the summer months were all associated with increased risk of gun violence. Previous gunshots in the area were associated with a 26.8% increase in the risk of gun violence. Gun violence in Syracuse, NY is both spatially and temporally stable, with some neighborhoods of the city greatly afflicted.	[Larsen, David A.; Lane, Sandra] Syracuse Univ, Dept Publ Hlth Food Studies & Nutr, Syracuse, NY 13244 USA; [Lane, Sandra; Rubinstein, Robert A.] Syracuse Univ, Dept Anthropol, Syracuse, NY USA; [Jennings-Bey, Timothy; Haygood-El, Arnett] St Addict Inst, Syracuse, NY USA; [Brundage, Kim] Syracuse City Police Dept, Syracuse, NY USA	Syracuse University; Syracuse University	Larsen, DA (corresponding author), Syracuse Univ, Dept Publ Hlth Food Studies & Nutr, Syracuse, NY 13244 USA.	dalarsen@syr.edu	Larsen, David/D-4027-2016	Larsen, David/0000-0002-1876-6536; Rubinstein, Robert/0000-0003-4789-0496				BANDURA A, 1961, J ABNORM SOC PSYCH, V63, P575, DOI 10.1037/h0045925; Bergen-Cico DK, 2014, ADDICT RES THEORY, V22, P15, DOI 10.3109/16066359.2012.759942; BURT RS, 1987, AM J SOCIOL, V92, P1287, DOI 10.1086/228667; Fagan J, 2007, CAMB HANDB PSYCHOL, P688; Fowler KA, 2015, PREV MED, V79, P5, DOI 10.1016/j.ypmed.2015.06.002; Gino F, CONTAGION DIFFERENTI; Green B, 2017, JAMA INT MED; Groff ER, 2010, J QUANT CRIMINOL, V26, P7, DOI 10.1007/s10940-009-9081-y; Harper S, 2007, JAMA-J AM MED ASSOC, V297, P1224, DOI 10.1001/jama.297.11.1224; Heron M, 2007, NATL VITAL STAT REPO; Jargowsky PA., 2015, ARCHITECTURE SEGREGA; Jena AB, 2014, J GEN INTERN MED, V29, P1065, DOI 10.1007/s11606-014-2779-z; Jennings-Bey T, 2015, J URBAN HEAL J URBAN, P1; Jones-Webb R, 2008, J URBAN HEALTH, V85, P662, DOI 10.1007/s11524-008-9302-y; Kellermann AL, 1996, NEW ENGL J MED, V335, P1438, DOI 10.1056/NEJM199611073351906; Kulldorff, 2009, INFORM MANAGEMENT SE; Kulldorff M, 2006, STAT MED, V25, P3929, DOI 10.1002/sim.2490; Lane Sandra., 2015, WHY ARE OUR BABIES D; Lee J, 2014, SURGERY, V155, P894, DOI 10.1016/j.surg.2014.02.011; Margolin G, 2000, ANNU REV PSYCHOL, V51, P445, DOI 10.1146/annurev.psych.51.1.445; Morenoff JD, 2003, AM J SOCIOL, V108, P976, DOI 10.1086/374405; Mueller Benjamin, 2017, NY TIMES; Papachristos AV, 2014, AM J PUBLIC HEALTH, V104, P143, DOI 10.2105/AJPH.2013.301441; Papachristos AV, 2012, J URBAN HEALTH, V89, P992, DOI 10.1007/s11524-012-9703-9; Saul J., 2016, NEWSWEEK; Sharkey AB, 2012, T ROY SOC TROP MED H, V106, P110, DOI 10.1016/j.trstmh.2011.10.008; Weisburd D, 2004, CRIMINOLOGY, V42; Wintemute GJ, 2015, ANNU REV PUBL HEALTH, V36, P5, DOI 10.1146/annurev-publhealth-031914-122535; Woolhouse MEJ, 1997, P NATL ACAD SCI USA, V94, P338, DOI 10.1073/pnas.94.1.338; Zeoli AM, 2015, AM J PUBLIC HEALTH, V105, P2035, DOI 10.2105/AJPH.2015.302732; Zeoli AM, 2014, JUSTICE Q, V31, P609, DOI 10.1080/07418825.2012.732100	31	18	18	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 20	2017	12	3							e0173001	10.1371/journal.pone.0173001	http://dx.doi.org/10.1371/journal.pone.0173001			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	ER6VC	28319125	Green Submitted, Green Published, gold			2022-12-27	WOS:000398945800008
J	Lei, WY; Wang, JH; Wen, SH; Yi, CH; Hung, JS; Liu, TT; Orr, WC; Chen, CL				Lei, Wei-Yi; Wang, Jen-Hung; Wen, Shu-Hui; Yi, Chih-Hsun; Hung, Jui-Sheng; Liu, Tso-Tsai; Orr, William C.; Chen, Chien-Lin			Risk of acute myocardial infarction in patients with gastroesophageal reflux disease: A nationwide population- based study	PLOS ONE			English	Article							CORONARY-ARTERY-DISEASE; PROTON-PUMP INHIBITORS; INTERLEUKIN-8; CLOPIDOGREL; EXPRESSION; COMMON	Objective Gastroesophageal reflux disease (GERD) is a common disease which can cause troublesome symptoms and affect quality of life. In addition to esophageal complications, GERD may also be a risk factor for extra- esophageal complications. Both GERD and coronary artery disease (CAD) can cause chest pain and frequently co- exist. However, the association between GERD and acute myocardial infarction (AMI) remain unclear. The purpose of the study was to compare the incidence of acute myocardial infarction in GERD patients with an age-, gender-, and comorbidity matched population free of GERD. We also examine the association of the risk of AMI and the use of acid suppressing agents in GERD patients. Methods We identified patients with GERD from the Taiwan National Health Insurance Research Database. The study cohort comprised 54,422 newly diagnosed GERD patients; 269,572 randomly selected age-, gender-, comorbidity- matched subjects comprised the comparison cohort. Patients with any prior CAD, AMI or peripheral arterial disease were excluded. Incidence of new AMI was studied in both groups. Results A total 1,236 (0.5%) of the patients from the control group and 371 (0.7%) patients from the GERD group experienced AMI during a mean follow- up period of 3.3 years. Based on Cox proportional- hazard model analysis, GERD was independently associated with increased risk of developing AMI (hazard ratio (HR) = 1.48; 95% confidence interval (CI): 1.31 _ 1.66, P < 0.001). Within the GERD group, patients who were prescribed proton pump inhibitors (PPIs) for more than one year had slightly decreased the risk of developing AMI, compared with those without taking PPIs (HR = 0.57; 95% CI: 0.31 _ 1.04, P = 0.066). Conclusions This large population_ based Studt demonstrates an association between GERD and future development of AMI,however,PPIs use only achieved marginal signification in reducing the occurance of AMI in GERD patients.Further prospective studies are needed to evaluate whether anti refliux medication may reduce the occurance if acute ischemic event in GERD patients	[Lei, Wei-Yi; Yi, Chih-Hsun; Hung, Jui-Sheng; Liu, Tso-Tsai; Chen, Chien-Lin] Buddhist Tzu Chi Med Fdn, Hualien Tzu Chi Hosp, Dept Med, Hualien, Taiwan; [Lei, Wei-Yi; Yi, Chih-Hsun; Hung, Jui-Sheng; Liu, Tso-Tsai; Chen, Chien-Lin] Tzu Chi Univ, Hualien, Taiwan; [Lei, Wei-Yi; Wen, Shu-Hui; Chen, Chien-Lin] Tzu Chi Univ, Inst Med Sci, Hualien, Taiwan; [Wang, Jen-Hung] Buddhist Tzu Chi Med Fdn, Hualien Tzu Chi Hosp, Dept Med Res, Hualien, Taiwan; [Wen, Shu-Hui] Dept Publ Hlth Tzu Chi Univ, Hualien, Taiwan; [Orr, William C.] Univ Oklahoma, Hlth Sci Ctr, Lynn Inst Healthcare Res, Oklahoma City, OK USA	Buddhist Tzu Chi General Hospital; Hualien Tzu Chi Hospital; Tzu Chi University; Tzu Chi University; Buddhist Tzu Chi General Hospital; Hualien Tzu Chi Hospital; University of Oklahoma System; University of Oklahoma Health Sciences Center	Chen, CL (corresponding author), Buddhist Tzu Chi Med Fdn, Hualien Tzu Chi Hosp, Dept Med, Hualien, Taiwan.; Chen, CL (corresponding author), Tzu Chi Univ, Hualien, Taiwan.; Chen, CL (corresponding author), Tzu Chi Univ, Inst Med Sci, Hualien, Taiwan.	harry.clchen@msa.hinet.net	Lei, Wei-Yi/AAW-8292-2020	Chen, Chien-Lin/0000-0002-9084-8210; Wen, Shu-Hui/0000-0003-1402-9114	Hualien Tzu Chi Hospital [TCRD 103-36]; Buddhist Tzu Chi Medical Foundation; Hualien, Taiwan	Hualien Tzu Chi Hospital; Buddhist Tzu Chi Medical Foundation; Hualien, Taiwan	Gant support:This study was supported by a grant, TCRD 103-36 , from Hualien Tzu Chi Hospital, Buddhist Tzu Chi Medical Foundation, Hualien, Taiwan.The funders had no role in study design,data collection and analysis,decision to publish,or preparation of the manuscript.	[Anonymous], 2012, J CLIN EXP CARDIOLOG, V3; Bhatt DL, 2010, NEW ENGL J MED, V363, P1909, DOI 10.1056/NEJMoa1007964; Biswas Santanu, 2010, Korean Journal of Internal Medicine, V25, P44, DOI 10.3904/kjim.2010.25.1.44; Cardoso RN, 2015, OPEN HEART, V2, DOI 10.1136/openhrt-2015-000248; Chang FY, 2012, J CHIN MED ASSOC, V75, P91, DOI 10.1016/j.jcma.2012.02.003; Charlot M, 2010, ANN INTERN MED, V153, P378, DOI 10.7326/0003-4819-153-6-201009210-00005; CHAUHAN A, 1993, LANCET, V341, P1309, DOI 10.1016/0140-6736(93)90817-Z; Chauhan A, 1996, EUR HEART J, V17, P407; Chen KY, 2009, AM J MED SCI, V338, P453, DOI 10.1097/MAJ.0b013e3181b51fbd; CUNNINGHAM ET, 1992, ANN INTERN MED, V116, P575, DOI 10.7326/0003-4819-116-7-575; DAVIES HA, 1985, LANCET, V1, P1011; Dobrzycki S, 2005, INT J CARDIOL, V104, P67, DOI 10.1016/j.ijcard.2004.10.018; Fang L, 2015, J GERIATR CARDIOL, V12, P305, DOI 10.11909/j.issn.1671-5411.2015.03.020; Ghebremariam YT, 2013, CIRCULATION, V128, P845, DOI 10.1161/CIRCULATIONAHA.113.003602; Isomoto H, 2004, AM J GASTROENTEROL, V99, P589, DOI 10.1111/j.1572-0241.2004.04110.x; Johansson S, 2003, ALIMENT PHARM THER, V18, P973, DOI 10.1046/j.1365-2036.2003.01798.x; Katz PO, 2000, AM J GASTROENTEROL, V95, pS4, DOI 10.1016/S0002-9270(00)01072-8; Liu YJ, 2013, INTERNAL MED, V52, P1165, DOI 10.2169/internalmedicine.52.0031; LUX G, 1995, NEUROGASTROENT MOTIL, V7, P23; Malfertheiner P, 2005, INT J CLIN PRACT, V59, P346, DOI 10.1111/j.1742-1241.2005.00370.x; Mehta AJ, 1996, EUR J GASTROEN HEPAT, V8, P973, DOI 10.1097/00042737-199610000-00007; MELLOW MH, 1983, GASTROENTEROLOGY, V85, P306; Monkemuller K, 2009, DIGESTION, V79, P186, DOI 10.1159/000211714; Mohammed I, 2005, ALIMENT PHARM THER, V21, P821, DOI 10.1111/j.1365-2036.2005.02426.x; Ruigomez A, 2004, ALIMENT PHARM THERAP, V20, P751, DOI 10.1111/j.1365-2036.2004.02169.x; Shah NH, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0124653; SMITH KS, 1962, BRIT MED J, P1425, DOI 10.1136/bmj.2.5317.1425; Souza RF, 2009, GASTROENTEROLOGY, V137, P1776, DOI 10.1053/j.gastro.2009.07.055; Swerdlow DI, 2012, LANCET, V379, P1214, DOI 10.1016/S0140-6736(12)60110-X; Tack J, 2012, ALIMENT PHARM THER, V35, P1257, DOI 10.1111/j.1365-2036.2012.05086.x; VADDI K, 1994, CIRCULATION, V90, P694, DOI 10.1161/01.CIR.90.2.694	31	7	8	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 20	2017	12	3							0173899	10.1371/journal.pone.0173899	http://dx.doi.org/10.1371/journal.pone.0173899			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ER6VC	28319162	gold, Green Published, Green Submitted			2022-12-27	WOS:000398945800033
J	Waelti, MA; Orts, J; Riek, R				Waelti, Marielle Aulikki; Orts, Julien; Riek, Roland			Quenched hydrogen-deuterium exchange NMR of a disease-relevant A beta(1-42) amyloid polymorph	PLOS ONE			English	Article							ATOMIC-RESOLUTION STRUCTURE; ALZHEIMERS-DISEASE; AMYLOID-BETA(1-42) FIBRILS; PROTEIN; HETEROGENEITY; SENSITIVITY; CORE	Alzheimer's disease is associated with the aggregation into amyloid fibrils of A beta(1-42) and A beta(1-40) peptides. Interestingly, these fibrils often do not obtain one single structure but rather show different morphologies, so-called polymorphs. Here, we compare quenched hydrogen-deuterium (H/D) exchange of a disease-relevant A beta(1-42) fibril for which the 3D structure has been determined by solid-state NMR with H/D exchange previously determined on another structural polymorph. This comparison reveals secondary structural differences between the two polymorphs suggesting that the two polymorphisms can be classified as segmental polymorphs.	[Waelti, Marielle Aulikki; Orts, Julien; Riek, Roland] Swiss Fed Inst Technol, Chem Phys Lab, Zurich, Switzerland	Swiss Federal Institutes of Technology Domain; ETH Zurich	Riek, R (corresponding author), Swiss Fed Inst Technol, Chem Phys Lab, Zurich, Switzerland.	roland.riek@phys.chem.ethz.ch	Walti, Marielle/AAK-4652-2020; orts, julien/V-5511-2017	orts, julien/0000-0003-3287-1532	SNF; ETH	SNF; ETH(ETH Zurich)	This work was supported by funding from the SNF and ETH internal grants.	Alexandrescu A T, 2001, Pac Symp Biocomput, P67; Andrews ME, 2009, J STRUCT BIOL, V166, P116, DOI 10.1016/j.jsb.2008.12.011; Bertini I, 2011, J AM CHEM SOC, V133, P16013, DOI 10.1021/ja2035859; Carulla N, 2005, NATURE, V436, P554, DOI 10.1038/nature03986; Colletier JP, 2011, P NATL ACAD SCI USA, V108, P16938, DOI 10.1073/pnas.1112600108; Colvin MT, 2016, J AM CHEM SOC, V138, P9663, DOI 10.1021/jacs.6b05129; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; Eisenberg DS, 2016, P NATL ACAD SCI USA, V113, P9398, DOI 10.1073/pnas.1610806113; Glabe CG, 2008, J BIOL CHEM, V283, P29639, DOI 10.1074/jbc.R800016200; GLENNER GG, 1984, BIOCHEM BIOPH RES CO, V122, P1131, DOI 10.1016/0006-291X(84)91209-9; Greenwald J, 2010, STRUCTURE, V18, P1244, DOI 10.1016/j.str.2010.08.009; GRZESIEK S, 1992, J MAGN RESON, V96, P432, DOI 10.1016/0022-2364(92)90099-S; Hoshino M, 2007, BBA-BIOMEMBRANES, V1768, P1886, DOI 10.1016/j.bbamem.2007.03.001; Kheterpal I, 2001, BIOCHEMISTRY-US, V40, P11757, DOI 10.1021/bi010805z; Komatsu H, 2010, J BIOL CHEM, V285, P41843, DOI 10.1074/jbc.M110.165068; Lu JX, 2013, CELL, V154, P1257, DOI 10.1016/j.cell.2013.08.035; Luhrs T, 2005, P NATL ACAD SCI USA, V102, P17342, DOI 10.1073/pnas.0506723102; MASTERS CL, 1985, P NATL ACAD SCI USA, V82, P4245, DOI 10.1073/pnas.82.12.4245; Meinhardt J, 2009, J MOL BIOL, V386, P869, DOI 10.1016/j.jmb.2008.11.005; MUHANDIRAM DR, 1994, J MAGN RESON SER B, V103, P203, DOI 10.1006/jmrb.1994.1032; Nelson R, 2005, NATURE, V435, P773, DOI 10.1038/nature03680; Paravastu AK, 2008, P NATL ACAD SCI USA, V105, P18349, DOI 10.1073/pnas.0806270105; Petkova AT, 2005, SCIENCE, V307, P262, DOI 10.1126/science.1105850; Ravotti F, 2016, BIOMOL NMR ASSIGN; Riek R, 2016, NATURE, V539, P227, DOI 10.1038/nature20416; Schanda P, 2005, J BIOMOL NMR, V33, P199, DOI 10.1007/s10858-005-4425-x; Schmidt M, 2015, P NATL ACAD SCI USA, V112, P11858, DOI 10.1073/pnas.1503455112; Tycko R, 2016, NATURE, V537, P492, DOI 10.1038/nature19470; Vilar M, 2012, METHODS MOL BIOL, V849, P185, DOI 10.1007/978-1-61779-551-0_13; Vranken WF, 2005, PROTEINS, V59, P687, DOI 10.1002/prot.20449; Walti MA, 2015, CHEMBIOCHEM, V16, P659, DOI 10.1002/cbic.201402595; Walti MA, 2016, P NATL ACAD SCI USA, V113, pE4976, DOI 10.1073/pnas.1600749113; WITTEKIND M, 1993, J MAGN RESON SER B, V101, P201, DOI 10.1006/jmrb.1993.1033; Yamaguchi KI, 2004, J MOL BIOL, V338, P559, DOI 10.1016/j.jmb.2004.02.067	34	5	5	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 20	2017	12	3							e0172862	10.1371/journal.pone.0172862	http://dx.doi.org/10.1371/journal.pone.0172862			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ER6VC	28319116	Green Submitted, gold, Green Published			2022-12-27	WOS:000398945800006
J	Almeida, FM; Ventura, TLB; Amaral, EP; Ribeiro, SCM; Calixto, SD; Manhaes, MR; Rezende, AL; Souzal, GS; de Carvalho, IS; Silva, EC; da Silva, JA; Carvalho, ECQ; Kritski, AL; Lasunskaia, EB				Almeida, Fabricio M.; Ventura, Thatiana L. B.; Amaral, Eduardo P.; Ribeiro, Simone C. M.; Calixto, Sanderson D.; Manhaes, Marcelle R.; Rezende, Andreza L.; Souzal, Giliane S.; de Carvalho, Igor S.; Silva, Elisangela C.; da Silva, Juliana Azevedo; Carvalho, Eulogio C. Q.; Kritski, Afranio L.; Lasunskaia, Elena B.			Hypervirulent Mycobacterium tuberculosis strain triggers necrotic lung pathology associated with enhanced recruitment of neutrophils in resistant C57BL/6 mice	PLOS ONE			English	Article							PULMONARY TUBERCULOSIS; SUPPRESSOR-CELLS; INFECTION; PATHOGENESIS; VIRULENT; IL-17; RESPONSES; RELEASE; AEROSOL; AIRWAYS	Tuberculosis (TB) is a chronic infectious disease caused by Mycobacterium tuberculosis (Mtb) that in most cases induces irreversible necrosis of lung tissue as a result of excessive inflammatory reactions. The murine model of TB in resistant C57BL/6 mice infected with reference Mtb strains is widely used in TB studies; however, these mice do not show a necrotic pathology, which restricts their use in studies of irreversible tissue damage. Recently, we demonstrated that necrotic lung lesions could be induced in the C57BL/6 mice by highly virulent Mtb strains belonging to the modern Beijing sublineage. However, the pathogenic mechanisms leading to necrosis in this model were not elucidated. In this study, we investigated the dynamics of lung lesions in mice infected with highly virulent Beijing Mtb strain M299, compared with those infected with laboratory Mtb strain H37Rv. The data demonstrate that necrotic lung lesions in mice infected by the strain M299 were associated with enhanced recruitment of myeloid cells, especially neutrophils, and increased levels of proin-flammatory cytokines, consistent with exacerbated inflammation. High levels of IFN-gamma production contributed to the control of bacterial growth. Further progression to chronic disease was associated with a reduction in the levels of inflammatory mediators in the lungs, the accumulation of foamy macrophages and partial healing of the necrotic tissue by fibrosis. At a late stage of disease, degradation of foamy cells resulted in the liberation of accumulated lipids and persisting bacilli and further activation of inflammation, which promoted lung consolidation. Overall, our studies show that C57BL/6 mice infected with highly virulent Mtb strain may serve as a TB model reproducing an exacerbated inflammatory response in a resistant host to hypervirulent mycobacteria, leading to irreversible necrotic lung lesions.	[Almeida, Fabricio M.; Ventura, Thatiana L. B.; Ribeiro, Simone C. M.; Calixto, Sanderson D.; Manhaes, Marcelle R.; Rezende, Andreza L.; Souzal, Giliane S.; de Carvalho, Igor S.; Silva, Elisangela C.; da Silva, Juliana Azevedo; Lasunskaia, Elena B.] Univ Estadual Norte Fluminense, Lab Biol Recognit, Rio De Janeiro, Brazil; [Amaral, Eduardo P.] Univ Sao Paulo, Biomed Sci Inst ICB, Dept Immunol, Sao Paulo, Brazil; [Silva, Elisangela C.] Fed Univ Rio Janeiro, Clementino Fraga Filho Univ Hosp, Sch Med, Mol MIcobacteriol Lab, Rio De Janeiro, Brazil; [Carvalho, Eulogio C. Q.] Univ Estadual Norte Fluminense, Lab Anim Morphol & Pathol, Rio De Janeiro, Brazil; [Kritski, Afranio L.] Fed Univ Rio Janeiro, TB Acad Program, Rio De Janeiro, Brazil	Universidade Estadual do Norte Fluminense; Universidade de Sao Paulo; Universidade Federal do Rio de Janeiro; Universidade Estadual do Norte Fluminense; Universidade Federal do Rio de Janeiro	Lasunskaia, EB (corresponding author), Univ Estadual Norte Fluminense, Lab Biol Recognit, Rio De Janeiro, Brazil.	elena@uenf.br	Silva, Elisangela/AAW-5193-2020; Kritski, Afranio/I-6760-2016; Lasunskaia, Elena/M-6259-2019; Lasunskaia, Elena B/J-6691-2014; Pinheiro Amaral, Eduardo/M-2456-2014	Silva, Elisangela/0000-0001-9833-1825; Lasunskaia, Elena/0000-0002-6726-273X; Lasunskaia, Elena B/0000-0002-6726-273X; Santiago-Carvalho, Igor/0000-0002-8482-436X; Lopes Bia Ventura Simao, Thatiana/0000-0001-7563-1833; Pinheiro Amaral, Eduardo/0000-0001-5465-8113; kritski, afranio/0000-0002-5900-6007	Fundacao de Amparo a Pesquisa do Rio de Janeiro (FAPERJ), Brazil [E - 26/010.002030/2014]; Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq) [473453/2011-8-]	Fundacao de Amparo a Pesquisa do Rio de Janeiro (FAPERJ), Brazil(Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio De Janeiro (FAPERJ)); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ))	Fundacao de Amparo a Pesquisa do Rio de Janeiro (FAPERJ), Brazil- research grant E - 26/010.002030/2014 - to EL; Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq)research grant 473453/2011-8- to EL. The funders had no role in study design, data collection and	Amaral E.P., 2015, BIO-PROTOCOL, V5; Amaral EP, 2016, MICROBES INFECT, V18, P11, DOI 10.1016/j.micinf.2015.09.005; Amaral EP, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004188; Antonelli LRV, 2010, J CLIN INVEST, V120, P1674, DOI 10.1172/JCI40817; Beamer GL, 2008, CLIN VACCINE IMMUNOL, V15, P474, DOI 10.1128/CVI.00408-07; Condamine T, 2011, TRENDS IMMUNOL, V32, P19, DOI 10.1016/j.it.2010.10.002; Cruz A, 2009, IMMUNITY, V31, P974; Davis SL, 2009, ANTIMICROB AGENTS CH, V53, P4879, DOI 10.1128/AAC.00789-09; Di Pietrantonio Tania, 2005, Briefings in Functional Genomics & Proteomics, V4, P277, DOI 10.1093/bfgp/4.3.277; Gil O, 2006, MICROBES INFECT, V8, P628, DOI 10.1016/j.micinf.2005.08.014; Hunter RL, 2006, AM J PATHOL, V168, P1249, DOI 10.2353/ajpath.2006.050848; Hunter RL, 2007, TUBERCULOSIS, V87, P267, DOI 10.1016/j.tube.2006.11.003; Hunter RL, 2016, TUBERCULOSIS, V97, P8, DOI 10.1016/j.tube.2015.11.010; Irwin SM, 2015, DIS MODEL MECH, V8, P591, DOI 10.1242/dmm.019570; Keller C, 2006, INFECT IMMUN, V74, P4295, DOI 10.1128/IAI.00057-06; Knaul JK, 2014, AM J RESP CRIT CARE, V190, P1053, DOI 10.1164/rccm.201405-0828OC; Kramnik I, 2000, P NATL ACAD SCI USA, V97, P8560, DOI 10.1073/pnas.150227197; Laan M, 1999, J IMMUNOL, V162, P2347; Lasunskaia E, 2010, MICROBES INFECT, V12, P467, DOI 10.1016/j.micinf.2010.02.008; Marakalala MJ, 2016, NAT MED, V22, P531, DOI 10.1038/nm.4073; Mills KHG, 2013, J LEUKOCYTE BIOL, V93, P489, DOI 10.1189/jlb.1012543; Miyamoto M, 2003, J IMMUNOL, V170, P4665, DOI 10.4049/jimmunol.170.9.4665; Nandi B, 2011, J EXP MED, V208, P2251, DOI 10.1084/jem.20110919; NORTH RJ, 1995, J INFECT DIS, V172, P1550, DOI 10.1093/infdis/172.6.1550; Obregon-Henao A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080669; Orme IM, 2014, TUBERCULOSIS, V94, P8, DOI 10.1016/j.tube.2013.07.004; Orme IM, 2003, TUBERCULOSIS, V83, P112, DOI 10.1016/S1472-9792(02)00069-0; Poe SL, 2013, MUCOSAL IMMUNOL, V6, P189, DOI 10.1038/mi.2012.62; Repasy T, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003190; Rhoades ER, 1997, TUBERCLE LUNG DIS, V78, P57, DOI 10.1016/S0962-8479(97)90016-2; Ribeiro SCM, 2014, J CLIN MICROBIOL, V52, P2615, DOI 10.1128/JCM.00498-14; Torrado E, 2010, CYTOKINE GROWTH F R, V21, P455, DOI 10.1016/j.cytogfr.2010.10.004; Tsiganov EN, 2014, J IMMUNOL, V192, P4718, DOI 10.4049/jimmunol.1301365; Vollbrecht T, 2012, AIDS, V26, pF31, DOI 10.1097/QAD.0b013e328354b43f; Youn JI, 2012, J LEUKOCYTE BIOL, V91, P167, DOI 10.1189/jlb.0311177	35	23	24	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 17	2017	12	3							e0173715	10.1371/journal.pone.0173715	http://dx.doi.org/10.1371/journal.pone.0173715			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EO5CJ	28306733	Green Published, gold, Green Submitted			2022-12-27	WOS:000396710300015
J	Gwak, JH; Sohn, SY				Gwak, Jae Ha; Sohn, So Young			Identifying the trends in wound-healing patents for successful investment strategies	PLOS ONE			English	Article							TECHNOLOGY; TEXT	Background Recently, the need for rapid wound-healing has significantly increased because of the increasing number of patients who are diagnosed with diabetes and obesity. These conditions have contributed to a surge in the number of patients with chronic wounds worldwide. Furthermore, many cost-effective wound-healing technologies have been developed in order to keep up with the increased demand. In this paper, we performed a quantitative study of the trends associated with wound-healing technologies using patent data. Methodology We analyzed the trends considering four different groups of patent applicants: firms, universities, research institutes, and individuals using a structural topic model. In addition, we analyzed the knowledge flow between patent applicants using citation analysis, and confirmed the role of applicants in the knowledge-flow network using k-means clustering. As a result, the primary wound-healing technology patents applied for by the four groups varied considerably, and we classified the roles of patent applicants were found in the knowledge-flow network. Conclusions Our results showed the organizations that are leading each area of wound-healing technology. Furthermore, from the results, we identified specific institutions that are efficient for spreading knowledge related to wound-healing technology based on the patents. This information can contribute to the planning of investment strategies and technology policies related to wound-healing.	[Gwak, Jae Ha; Sohn, So Young] Yonsei Univ, Dept Informat & Ind Engn, 134 Shinchon Dong, Seoul, South Korea	Yonsei University	Sohn, SY (corresponding author), Yonsei Univ, Dept Informat & Ind Engn, 134 Shinchon Dong, Seoul, South Korea.	sohns@yonsei.ac.kr		Sohn, So Young/0000-0002-3958-2269	National Research Foundation of Korea (NRF) - Korea government (MSIP) [2016R1A2A1A05005270]	National Research Foundation of Korea (NRF) - Korea government (MSIP)	This work was supported by the National Research Foundation of Korea (NRF) grant funded by the Korea government (MSIP) (2016R1A2A1A05005270). URLs: http://www.nrf. re.kr/nrf_tot_crns/index.jsp?pmi-sso-return2=none. Pf. Sohn, S. Y. received the funding.	[Anonymous], PLASTIC SURG INT; Boateng J, 2015, J PHARM SCI-US, V104, P3653, DOI 10.1002/jps.24610; Chen N, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0136953; Cheng AC, 2012, TECHNOVATION, V32, P163, DOI 10.1016/j.technovation.2011.10.008; Chu Y.-J., 2014, INT WOUND J; Clerici G., 2016, ULCERS LOWER EXTREMI, P181; FREEMAN LC, 1979, SOC NETWORKS, V1, P215, DOI 10.1016/0378-8733(78)90021-7; Gupta S, 2015, INT WOUND J; Han EJ, 2015, J TECHNOL TRANSFER, V40, P821, DOI 10.1007/s10961-014-9367-6; Hu YJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077247; Jee SJ, 2015, TECHNOL FORECAST SOC, V101, P338, DOI 10.1016/j.techfore.2015.09.018; Ju YH, 2015, SCIENTOMETRICS, V102, P389, DOI 10.1007/s11192-014-1382-8; Kim DH, 2016, TECHNOL FORECAST SOC, V105, P140, DOI 10.1016/j.techfore.2016.01.025; Kim YG, 2008, EXPERT SYST APPL, V34, P1804, DOI 10.1016/j.eswa.2007.01.033; Lee S, 2016, TECHNOL ANAL STRATEG, V28, P411, DOI 10.1080/09537325.2015.1096336; Lee WS, 2015, TECHNOL FORECAST SOC, V100, P317, DOI 10.1016/j.techfore.2015.07.022; Lucas C., 2015, POLIT ANAL; Queen Douglas, 2004, Int Wound J, V1, P59, DOI 10.1111/j.1742-4801.2004.0009.x; Richmond NA, 2013, WOUND REPAIR REGEN, V21, P789, DOI 10.1111/wrr.12099; Roberts ME, 2014, STM R PACKAGE STRUCT, V1, P12; Sasanka SC, 2012, INDIAN J PLAST SURG, V45, P266, DOI 10.4103/0970-0358.101294; Sen CK, 2009, WOUND REPAIR REGEN, V17, P763, DOI 10.1111/j.1524-475X.2009.00543.x; Tsuji YS, 2012, TECHNOL ANAL STRATEG, V24, P299, DOI 10.1080/09537325.2012.655417; VisionGain, 2011, ADV WOUND CAR WORLD; Yoon J, 2013, SCIENTOMETRICS, V94, P313, DOI 10.1007/s11192-012-0830-6	25	17	17	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 17	2017	12	3							e0174203	10.1371/journal.pone.0174203	http://dx.doi.org/10.1371/journal.pone.0174203			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EO5CJ	28306732	Green Published, Green Submitted, gold			2022-12-27	WOS:000396710300026
J	Alvarez-Davila, E; Cayuela, L; Gonzalez-Caro, S; Aldana, AM; Stevenson, PR; Phillips, O; Cogollo, A; Penuela, MC; von Hildebrand, P; Jimenez, E; Melo, O; Londono-Vega, AC; Mendoza, I; Velasquez, O; Fernandez, F; Serna, M; Velazquez-Rua, C; Benitez, D; Rey-Benayas, JAM				Alvarez-Davila, Esteban; Cayuela, Luis; Gonzalez-Caro, Sebastian; Aldana, Ana M.; Stevenson, Pablo R.; Phillips, Oliver; Cogollo, Alvaro; Penuela, Maria C.; von Hildebrand, Patricio; Jimenez, Eliana; Melo, Omar; Londono-Vega, Ana Catalina; Mendoza, Irina; Velasquez, Oswaldo; Fernandez, Fernando; Serna, Marcela; Velazquez-Rua, Cesar; Benitez, Doris; Rey-Benayas, Jose A. M.			Forest biomass density across large climate gradients in northern South America is related to water availability but not with temperature	PLOS ONE			English	Article							ABOVEGROUND LIVE BIOMASS; ELEVATIONAL TRANSECT; CARBON-DENSITY; GROWTH; PRODUCTIVITY; COVARIATION; PATTERNS; STOCKS	Understanding and predicting the likely response of ecosystems to climate change are crucial challenges for ecology and for conservation biology. Nowhere is this challenge greater than in the tropics as these forests store more than half the total atmospheric carbon stock in their biomass. Biomass is determined by the balance between biomass inputs (i.e., growth) and outputs (mortality). We can expect therefore that conditions that favor high growth rates, such as abundant water supply, warmth, and nutrient-rich soils will tend to correlate with high biomass stocks. Our main objective is to describe the patterns of above ground biomass (AGB) stocks across major tropical forests across climatic gradients in Northwestern South America. We gathered data from 200 plots across the region, at elevations ranging between 0 to 3400 m. We estimated AGB based on allometric equations and values for stem density, basal area, and wood density weighted by basal area at the plot level. We used two groups of climatic variables, namely mean annual temperature and actual evapotranspiration as surrogates of environmental energy, and annual precipitation, precipitation seasonality, and water availability as surrogates of water availability. We found that AGB is more closely related to water availability variables than to energy variables. In northwest South America, water availability influences carbon stocks principally by determining stand structure, i.e. basal area. When water deficits increase in tropical forests we can expect negative impact on biomass and hence carbon storage.	[Alvarez-Davila, Esteban; Rey-Benayas, Jose A. M.] Univ Alcala, Dept Ciencias Vida, Alcala De Henares, Spain; [Alvarez-Davila, Esteban; Mendoza, Irina; Velazquez-Rua, Cesar] Fdn Convida, Grp Serv Ecosistem & Cambio Climat, Medellin, Colombia; [Alvarez-Davila, Esteban] Univ Nacl Abierta & Distancia, Escuela Ciencias Agr Pecuarias & Medio Ambiente, Medellin, Colombia; [Cayuela, Luis] Univ Rey Juan Carlos, Area Biodiversidad & Conservac, Escuela Super Ciencias Expt & Tecnol, Dept 1, Madrid, Spain; [Gonzalez-Caro, Sebastian; Cogollo, Alvaro; Benitez, Doris] Jardin Bot Medellin, Herbario JAUM, Medellin, Colombia; [Aldana, Ana M.; Stevenson, Pablo R.] Univ Los Andes, Dept Ciencias Biol, Bogota, Colombia; [Phillips, Oliver] Univ Leeds, Sch Geog, Leeds, W Yorkshire, England; [Penuela, Maria C.] Univ Reg Amazon, Napo, Ecuador; [von Hildebrand, Patricio] Fdn Puerto Rastrojo, Bogota, Colombia; [Jimenez, Eliana] Univ Nacl Colombia, Grp Ecol Ecosistemas Terr Trop, Bogota, Colombia; [Melo, Omar; Fernandez, Fernando] Univ Tolima, Fac Ingn Forestal, Ibague, Colombia; [Velasquez, Oswaldo] Univ Nacl Colombia, Fac Ciencias Agron, Medellin, Colombia; [Serna, Marcela] Inst Univ Tecnol Antioquia, Fac Ingn, Medellin, Colombia	Universidad de Alcala; Universidad Rey Juan Carlos; Universidad de los Andes (Colombia); University of Leeds; Universidad Nacional de Colombia; Universidad del Tolima; Universidad Nacional de Colombia	Alvarez-Davila, E (corresponding author), Univ Alcala, Dept Ciencias Vida, Alcala De Henares, Spain.; Alvarez-Davila, E (corresponding author), Fdn Convida, Grp Serv Ecosistem & Cambio Climat, Medellin, Colombia.; Alvarez-Davila, E (corresponding author), Univ Nacl Abierta & Distancia, Escuela Ciencias Agr Pecuarias & Medio Ambiente, Medellin, Colombia.	esalvarez3000@gmail.com	Phillips, Oliver/A-1523-2011; Gonzalez-Caro, Sebastian/T-3532-2019; Cayuela, Luis/K-7255-2015; Aldana, Ana/AAW-1784-2021; Mendoza, Inés/T-4733-2017; Alvarez-Davila, Esteban/AAP-4231-2020	Phillips, Oliver/0000-0002-8993-6168; Cayuela, Luis/0000-0003-3562-2662; Aldana, Ana/0000-0003-3439-6245; Mendoza, Inés/0000-0002-8266-2598; Alvarez-Davila, Esteban/0000-0001-9032-0099; Serna Gonzalez, Marcela/0000-0001-6729-403X; Penuela Mora, Maria Cristina/0000-0002-9611-1359; Jimenez, Eliana M./0000-0002-8610-1771	Medellin Botanical Garden of Medellin; Leeds University (UK); Gordon and Betty Moore Foundation [1656, 3000]; Natural Environment Research Council (NERC Urgency Grant) [NE/D01025X/1]; European Research Council [291585]; Royal Society [CH160091]; ERC [291585]; Royal Society Wolfson Research Merit Award [WM120076]; "Universidad Nacional Abierta y a Distancia" from Colombia (UNAD); "Fundacion Convida" from Medellin, Colombia; Natural Environment Research Council [NE/B504630/1, NE/B503384/1, NE/I02982X/1] Funding Source: researchfish; NERC [NE/I02982X/1] Funding Source: UKRI	Medellin Botanical Garden of Medellin; Leeds University (UK); Gordon and Betty Moore Foundation(Gordon and Betty Moore Foundation); Natural Environment Research Council (NERC Urgency Grant)(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); European Research Council(European Research Council (ERC)European Commission); Royal Society(Royal Society of London); ERC(European Research Council (ERC)European Commission); Royal Society Wolfson Research Merit Award(Royal Society of London); "Universidad Nacional Abierta y a Distancia" from Colombia (UNAD); "Fundacion Convida" from Medellin, Colombia; Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))	Colciencias partially financed the data analysis, through agreement 393 of 2011 with the Medellin Botanical Garden of Medellin and the support of the Leeds University (UK). The work of RAINFOR and ForestPlots in Colombia has been supported by grants to OLP from the Gordon and Betty Moore Foundation (grant numbers 1656 and 3000), the Natural Environment Research Council (NERC Urgency Grant, 'Assessing the impacts of the recent Amazonian drought', NE/D01025X/1), the European Research Council ('Tropical Forests in the Changing Earth System', T-FORCES, project number 291585), and most recently in 2016-2017 the Royal Society (Global Challenge Research Award 'Sensitivity of tropical Forest Services to Climate Changes', project number CH160091). OLP is supported by an ERC Advanced Grant (291585) and a Royal Society Wolfson Research Merit Award (WM120076). EAD is supported by "Universidad Nacional Abierta y a Distancia" from Colombia (UNAD) and "Fundacion Convida" from Medellin, Colombia.	Aldana AM, 2017, FOREST ECOL MANAG, V389, P86, DOI 10.1016/j.foreco.2016.12.023; Alvarez E, 2012, FOREST ECOL MANAG, V267, P297, DOI 10.1016/j.foreco.2011.12.013; Alves LF, 2010, FOREST ECOL MANAG, V260, P679, DOI 10.1016/j.foreco.2010.05.023; Anderegg WRL, 2012, P NATL ACAD SCI USA, V109, P233, DOI 10.1073/pnas.1107891109; Asner GP, 2014, REMOTE SENS ENVIRON, V140, P614, DOI 10.1016/j.rse.2013.09.023; Baccini A, 2012, NAT CLIM CHANGE, V2, P182, DOI [10.1038/NCLIMATE1354, 10.1038/nclimate1354]; Baker TR, 2004, GLOBAL CHANGE BIOL, V10, P545, DOI 10.1111/j.1365-2486.2004.00751.x; Banin L, 2014, J ECOL, V102, P1025, DOI 10.1111/1365-2745.12263; Baraloto C, 2011, GLOBAL CHANGE BIOL, V17, P2677, DOI 10.1111/j.1365-2486.2011.02432.x; Beer C, 2010, SCIENCE, V329, P834, DOI 10.1126/science.1184984; Carvalhais N, 2014, NATURE, V514, P213, DOI 10.1038/nature13731; Chambers J. M., 1991, STAT MODELS S; Chave J, 2005, OECOLOGIA, V145, P87, DOI 10.1007/s00442-005-0100-x; Chave J, 2014, GLOBAL CHANGE BIOL, V20, P3177, DOI 10.1111/gcb.12629; Chave J, 2009, ECOL LETT, V12, P351, DOI 10.1111/j.1461-0248.2009.01285.x; Choat B, 2012, NATURE, V491, P752, DOI 10.1038/nature11688; Clark DA, 2003, P NATL ACAD SCI USA, V100, P5852, DOI 10.1073/pnas.0935903100; Culmsee H, 2010, J BIOGEOGR, V37, P960, DOI 10.1111/j.1365-2699.2009.02269.x; Detto M, 2013, PLOS ONE, P8; DeWalt SJ, 2004, BIOTROPICA, V36, P7, DOI 10.1646/02115; Diaz D, 2011, FOREST CARBON MARKET, P93; Doughty CE, 2008, J GEOPHYS RES-BIOGEO, V113, DOI [10.1029/2007JG000632, 10.1029/2007JG000590]; Feldpausch TR, 2012, BIOGEOSCIENCES, V9, P3381, DOI 10.5194/bg-9-3381-2012; Girardin CAJ, 2010, GLOBAL CHANGE BIOL, V16, P3176, DOI 10.1111/j.1365-2486.2010.02235.x; Gloor M, 2013, GEOPHYS RES LETT, V40, P1729, DOI 10.1002/grl.50377; Hijmans R. J., 2016, PACKAGE RASTER CRAN; Hijmans RJ, 2005, INT J CLIMATOL, V25, P1965, DOI 10.1002/joc.1276; Kates L, 2012, PROTO PROTOTYPE OBJE, P1; Keeling HC, 2007, GLOBAL ECOL BIOGEOGR, V16, P618, DOI 10.1111/j.1466-8238.2007.00314.x; Leuschner C, 2007, BASIC APPL ECOL, V8, P219, DOI 10.1016/j.baae.2006.02.004; Lewis SL, 2013, PHILOS T R SOC B, V368, DOI 10.1098/rstb.2012.0295; Malhi Y, 2006, GLOBAL CHANGE BIOL, V12, P1107, DOI 10.1111/j.1365-2486.2006.01120.x; Marvin DC, 2014, AMAZONIAN LANDSCAPES; McCain CM, 2011, ECOL LETT, V14, P1236, DOI 10.1111/j.1461-0248.2011.01695.x; Mevik B., 2015, PARTIAL LEAST SQUARE; Mitchard ETA, 2014, GLOBAL ECOL BIOGEOGR, V23, P935, DOI 10.1111/geb.12168; Nepstad DC, 2007, ECOLOGY, V88, P2259, DOI 10.1890/06-1046.1; Pan YD, 2013, ANNU REV ECOL EVOL S, V44, P593, DOI 10.1146/annurev-ecolsys-110512-135914; Pan YD, 2011, SCIENCE, V333, P988, DOI 10.1126/science.1201609; Phillips OL, 2010, NEW PHYTOL, V187, P631, DOI 10.1111/j.1469-8137.2010.03359.x; Phillips OL, 2009, SCIENCE, V323, P1344, DOI 10.1126/science.1164033; Pinheiro J., 2013, R PACKAGE3, P1; Quesada CA, 2012, BIOGEOSCIENCES, V9, P2203, DOI 10.5194/bg-9-2203-2012; R Core Team, 2021, R LANGUAGE ENV STAT; Reich PB, 2014, P NATL ACAD SCI USA, V111, P13721, DOI 10.1073/pnas.1216053111; Saatchi SS, 2007, GLOBAL CHANGE BIOL, V13, P816, DOI 10.1111/j.1365-2486.2007.01323.x; Saatchi SS, 2011, P NATL ACAD SCI USA, V108, P9899, DOI 10.1073/pnas.1019576108; Selmants PC, 2014, GLOB CHANG BIOL; Slik JWF, 2010, GLOBAL ECOL BIOGEOGR, V19, P50, DOI 10.1111/j.1466-8238.2009.00489.x; Stegen JC, 2011, GLOBAL ECOL BIOGEOGR, V20, P744, DOI 10.1111/j.1466-8238.2010.00645.x; Unger M, 2012, OECOLOGIA, V170, P263, DOI 10.1007/s00442-012-2295-y; Vallejo-Joyas M. I., 2005, METODOS ESTUDIOS ECO, V1; Venables W.N., 2003, MODERN APPL STAT S T, P111, DOI [10.1198/tech.2003.s33, DOI 10.1198/TECH.2003.S33]; Way DA, 2010, TREE PHYSIOL, V30, P669, DOI 10.1093/treephys/tpq015; Zanne A.E., 2009, DRYAD DATA REPOS, DOI [10.5061/dryad.234, DOI 10.5061/DRYAD.234]; Zorner RJ, 2008, AGR ECOSYST ENVIRON, V126, P67, DOI 10.1016/j.agee.2008.01.014	56	50	52	1	37	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 16	2017	12	3							e0171072	10.1371/journal.pone.0171072	http://dx.doi.org/10.1371/journal.pone.0171072			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN9KE	28301482	Green Published, gold			2022-12-27	WOS:000396318300008
J	Busch, G; Weary, DM; Spiller, A; von Keyserlingk, MAG				Busch, Gesa; Weary, Daniel M.; Spiller, Achim; von Keyserlingk, Marina A. G.			American and German attitudes towards cowcalf separation on dairy farms	PLOS ONE			English	Article							ANIMAL-WELFARE; CONSUMER PREFERENCES; ONLINE ENGAGEMENT; SUCKLING SYSTEMS; CALF; COW; VIEWS; EXPERIENCE; BELIEF; CALVES	Public concerns regarding the quality of life of farm animals are often focused on specific practices such as separating the cow and calf immediately after birth. The available scientific literature provides some evidence in support of this practice (including reduced acute responses to separation when it does occur), as well as evidence of disadvantages (such as increased risk of uterine disease in cows). The aim of this study is to systematically examine public views around this practice. Specifically, this study analyzes the views of American and German citizens to separation of cow and calf at birth using a quantitative segmentation approach. Although the majority of participants opposed early separation, a small proportion of our sample supported the practice. According to participants' preference for early and later separation and their evaluation of different arguments for both practices, three clusters were identified. US participants were more likely to support early separation compared to German participants. The arguments presented for and against both practices caused different reactions in the three clusters, but did not appear to sway the opinions of most participants. The results show considerable opposition to the practice of early separation in large parts of the sample and suggest that the dairy industry should consider approaches to address this concern.	[Busch, Gesa; Weary, Daniel M.; von Keyserlingk, Marina A. G.] Univ British Columbia, Anim Welf Program, Fac Land & Food Syst, Vancouver, BC, Canada; [Busch, Gesa; Spiller, Achim] Georg August Univ Gottingen, Mkt Food & Agr Prod, Dept Agr Econ & Rural Dev, Fac Agr Sci, Niedersachsen, Germany; [Busch, Gesa] Free Univ Bolzano, Agr & Food Econ, Fac Sci & Technol, South Tyrol, Italy	University of British Columbia; Free University of Bozen-Bolzano	Busch, G (corresponding author), Univ British Columbia, Anim Welf Program, Fac Land & Food Syst, Vancouver, BC, Canada.; Busch, G (corresponding author), Georg August Univ Gottingen, Mkt Food & Agr Prod, Dept Agr Econ & Rural Dev, Fac Agr Sci, Niedersachsen, Germany.; Busch, G (corresponding author), Free Univ Bolzano, Agr & Food Econ, Fac Sci & Technol, South Tyrol, Italy.	gesabusch@web.de	Busch, Gesa/AAI-1529-2020; Weary, Daniel M/A-8868-2010; Spiller, Achim/CAJ-5518-2022; von Keyserlingk, Marina/AAB-6353-2019	Weary, Daniel M/0000-0002-0917-3982; von Keyserlingk, Marina/0000-0002-1427-3152	Ministry of Science and Arts" in Lower Saxony, Germany	Ministry of Science and Arts" in Lower Saxony, Germany	Gesa Busch and Achim Spiller are grateful to the Ministry of Science and Arts in Lower Saxony, Germany, for funding the PhD Program Animal Welfare in Intensive Livestock Production Systems which led to this work being completed. The work at UBC was made possible by donations made to the Animal Welfare Program. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bastian B, 2012, PERS SOC PSYCHOL B, V38, P247, DOI 10.1177/0146167211424291; Boogaard BK, 2008, LIVEST SCI, V117, P24, DOI 10.1016/j.livsci.2007.11.004; Boogaard BK, 2006, LIVEST SCI, V104, P13, DOI 10.1016/j.livsci.2006.02.010; Boogaard BK, 2011, J AGR ENVIRON ETHIC, V24, P259, DOI 10.1007/s10806-010-9256-4; CLOUD J, 1970, SOCIOMETRY, V33, P193, DOI 10.2307/2786329; Daros RR, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0098429; de Barcellos MD, 2011, INT J CONSUM STUD, V35, P391, DOI 10.1111/j.1470-6431.2010.00978.x; Driessen C, 2012, J AGR ENVIRON ETHIC, V25, P163, DOI 10.1007/s10806-010-9293-z; Duffy B, 2005, INT J MARKET RES, V47, P615, DOI 10.1177/147078530504700602; Ellis KA, 2009, ANIM WELFARE, V18, P267; FIELD A., 2009, DESCOBRINDO ESTATIST, V2; Flower FC, 2003, ANIM WELFARE, V12, P339; Flower FC, 2001, APPL ANIM BEHAV SCI, V70, P275, DOI 10.1016/S0168-1591(00)00164-7; Hansen J, 2003, APPETITE, V41, P111, DOI 10.1016/S0195-6663(03)00079-5; Hills AM, 1995, ANTHROZOOS, V8, P132, DOI 10.2752/089279395787156347; Jonas E, 2001, J PERS SOC PSYCHOL, V80, P557, DOI 10.1037/0022-3514.80.4.557; KAFER R, 1992, ANTHROZOOS, V5, P93, DOI 10.2752/089279392787011476; Kendall HA, 2006, RURAL SOCIOL, V71, P399, DOI 10.1526/003601106778070617; Knight S, 2008, ANTHROZOOS, V21, P31, DOI 10.2752/089279308X274047; Krohn CC, 1999, ACTA AGR SCAND A-AN, V49, P57, DOI 10.1080/090647099421540; Krohn CC, 2001, APPL ANIM BEHAV SCI, V72, P271, DOI 10.1016/S0168-1591(01)00117-4; Krystallis A, 2009, LIVEST SCI, V126, P46, DOI 10.1016/j.livsci.2009.05.016; Lidfors LM, 1996, APPL ANIM BEHAV SCI, V49, P269, DOI 10.1016/0168-1591(96)01053-2; Lindeman M, 2005, J PERS ASSESS, V85, P170, DOI 10.1207/s15327752jpa8502_09; Marce C, 2011, PREV VET MED, V100, P116, DOI 10.1016/j.prevetmed.2011.02.004; Maria GA, 2006, LIVEST SCI, V103, P250, DOI 10.1016/j.livsci.2006.05.011; Mason W, 2012, BEHAV RES METHODS, V44, P1, DOI 10.3758/s13428-011-0124-6; MATELL MS, 1972, J APPL PSYCHOL, V56, P506, DOI 10.1037/h0033601; Meagher RK, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0132828; Meuwissen MPM, 2007, NJAS-WAGEN J LIFE SC, V54, P293, DOI 10.1016/S1573-5214(07)80021-2; Mooi E, 2011, CONCISE GUIDE TO MARKET RESEARCH: THE PROCESS, DATA, AND METHODS USING IBM SPSS STATISTICS, P1, DOI 10.1007/978-3-642-12541-6; Morris P, 2012, SOC ANIM, V20, P211, DOI 10.1163/15685306-12341234; Nickerson R.S., 1998, REV GEN PSYCHOL, V2, P175, DOI [10.1037/1089-2680.2.2.175, DOI 10.1037/1089-2680.2.2.175]; Nilsson T, 2006, CAN J AGR ECON, V54, P567, DOI 10.1111/j.1744-7976.2006.00067.x; Prickett RW, 2010, ANIM WELFARE, V19, P335; RAY JJ, 1979, J PERS ASSESS, V43, P638, DOI 10.1207/s15327752jpa4306_14; Robbins JA, 2016, FOOD POLICY, V61, P121, DOI 10.1016/j.foodpol.2016.02.008; Robbins JA, 2015, ANIM WELFARE, V24, P399, DOI 10.7120/09627286.24.4.399; Savory CJ, 2004, ANIM WELFARE, V13, pS153; Schroder M. J. A., 2004, INT J CONSUM STUD, V28, P168, DOI [10.1111/j.1470-6431.2003.00357.x, DOI 10.1111/J.1470-6431.2003.00357.X, 10.1111/J.1470-6431.2003.00357.X]; Schuppli CA, 2014, J ANIM SCI, V92, P5185, DOI 10.2527/jas.2014-7725; Shank D.B., 2016, AM SOCIOL, V47, P47, DOI [10.1007/s12108-015-9266-9, DOI 10.1007/S12108-015-9266-9]; Statistisches Bundesamt, 2015, BEV DEUTSCHL STICH A; Statistisches Bundesamt, 2015, BEV DEUTSCHL STICHT; Statistisches Bundesamt, 2015, GEB BUND STICHT; Tonsor G. T., 2009, Journal of Agricultural and Applied Economics, V41, P713; US Census Bureau, 2014, ANN EST RES POP US R; US Census Bureau, 2015, ANN EST RES POP SING; Vanhonacker F, 2009, ANIM WELFARE, V18, P371; Vanhonacker F., 2007, International Journal of Sociology of Agriculture and Food, V15, P91; Vanhonacker F, 2014, J AGR ENVIRON ETHIC, V27, P153, DOI 10.1007/s10806-013-9479-2; Veissier I, 2008, APPL ANIM BEHAV SCI, V113, P279, DOI 10.1016/j.applanim.2008.01.008; Velde H. te, 2002, Journal of Agricultural & Environmental Ethics, V15, P203, DOI 10.1023/A:1015012403331; Ventura BA, 2013, J DAIRY SCI, V96, P6105, DOI 10.3168/jds.2012-6040; Ventura BA, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0154733; Verbeke W, 2000, J AGR ENVIRON ETHIC, V12, P141, DOI 10.1023/A:1009538613588; von Keyserlingk MAG, 2015, J AGR ENVIRON ETHIC, V28, P179, DOI 10.1007/s10806-014-9518-7; Wagenaar JPTM, 2007, NJAS-WAGEN J LIFE SC, V54, P375, DOI 10.1016/S1573-5214(07)80010-8; Wagner K, 2015, APPL ANIM BEHAV SCI, V164, P1, DOI 10.1016/j.applanim.2014.12.010; Wagner K, 2013, APPL ANIM BEHAV SCI, V147, P43, DOI 10.1016/j.applanim.2013.04.010; Walker JK, 2014, ANIM WELFARE, V23, P71, DOI 10.7120/09627286.23.1.071; WARD JH, 1963, J AM STAT ASSOC, V58, P236, DOI 10.2307/2282967; WBA (Wissenschaftlicher Beirat fur Agrarpolitik beim Bundesministerium fur Ernahrung und Land-wirtschaft), 2015, BER LANDWIRTSCH, P221; Weary DM, 2016, ANIMAL, V10, P309, DOI 10.1017/S1751731115001160; Weary DM, 2011, J ANIM SCI, V89, P3831, DOI 10.2527/jas.2011-3858; Weary DM, 2000, APPL ANIM BEHAV SCI, V69, P177, DOI 10.1016/S0168-1591(00)00128-3; Weinrich R, 2014, INT FOOD AGRIBUS MAN, V17, P205; Woodward J, 2007, J PHYSL, P179	69	56	57	4	35	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 16	2017	12	3							e0174013	10.1371/journal.pone.0174013	http://dx.doi.org/10.1371/journal.pone.0174013			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EN9KE	28301604	gold, Green Published			2022-12-27	WOS:000396318300111
J	Corado, ADG; Bello, G; Leao, RAC; Granja, F; Naveca, FG				Guerra Corado, Andre de Lima; Bello, Gonzalo; Carvalho Leao, Renato Augusto; Granja, Fabiana; Naveca, Felipe Gomes			HIV-1 genetic diversity and antiretroviral drug resistance among individuals from Roraima state, northern Brazil	PLOS ONE			English	Article							SUBTYPE-C; TREATMENT-NAIVE; MUTATIONS; PREVALENCE; SURVEILLANCE; AMAZONAS; THERAPY; NETWORK	The HIV-1 epidemic in Brazil has spread towards the Northern country region, but little is known about HIV-1 subtypes and prevalence of HIV strains with resistance mutations to antiretrovirals in some of the Northern states. HIV-1 protease (PR) and reverse transcriptase (RT) sequences were obtained from 73 treatment-naive and -experienced subjects followed between 2013 and 2014 at a public health reference unit from Roraima, the northernmost Brazilian state. The most prevalent HIV-1 clade observed in the study population was the subtype B (91%), followed by subtype C (9%). Among 12 HIV-1 strains from treatment-naive patients, only one had a transmitted drug resistance mutation for NNRTI. Among 59 treatment-experienced patients, 12 (20%) harbored HIV-1 strains with acquired drug resistance mutations (ADRM) that reduce the susceptibility to two classes of antiretroviral drugs (NRTI and NNRTI or NRTI and PI), and five (8%) harbored HIV-1 strains with ADRM that reduced susceptibility to only one class of antiretroviral drugs (NNRTI or PI). No patients harboring HIV strains with reduced susceptibility to all three classes of antiretroviral drugs were detected. A substantial fraction of treatment-experienced patients with (63%) and without (70%) ADRM had undetectable plasma viral loads (<40 copies/ml) at the time of sampling. Among treatment-experienced with plasma viral loads above 2,000 copies/ml, 44% displayed no ADRM. This data showed that the HIV-1 epidemic in Roraima displayed a much lower level of genetic diversity and a lower prevalence of ADRM than that described in other Brazilian states.	[Guerra Corado, Andre de Lima; Naveca, Felipe Gomes] Fiocruz MS, Inst Leonidas Maria Deane, Manaus, Amazonas, Brazil; [Bello, Gonzalo] Fiocruz MS, Inst Oswaldo Cruz, Lab AIDS Imunol Mol, Rio De Janeiro, Brazil; [Carvalho Leao, Renato Augusto] LACEN RR, Lab Cent Saude Publ Roraima, Roraima, Brazil; [Granja, Fabiana] Univ Fed Roraima UFRR, Lab Biol Mol, Roraima, Brazil	Fundacao Oswaldo Cruz; Fundacao Oswaldo Cruz; Universidade Federal de Roraima	Corado, ADG; Naveca, FG (corresponding author), Fiocruz MS, Inst Leonidas Maria Deane, Manaus, Amazonas, Brazil.	andrecorado@gmail.com; felipe.naveca@fiocruz.br	Naveca, Felipe/H-1130-2012; Granja, Fabiana/AAS-5763-2021; Bentancor, Gonzalo Jose Bello/N-7377-2019; Bello, Gonzalo/E-6842-2013	Naveca, Felipe/0000-0002-2888-1060; Bentancor, Gonzalo Jose Bello/0000-0002-2724-2793; 	Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES) - Fundacao Oswaldo Cruz/ILMD - POM	Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES) - Fundacao Oswaldo Cruz/ILMD - POM	ALGC was supported by Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES) (www.capes.gov.br), financial supported was provided by Fundacao Oswaldo Cruz/ILMD (www.amazonia.fiocruz.br) - POM 2014-15. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alencar CS, 2013, JAIDS-J ACQ IMM DEF, V63, P387, DOI 10.1097/QAI.0b013e31828ff979; Anisimova M, 2006, SYST BIOL, V55, P539, DOI 10.1080/10635150600755453; Bahia Fabianna, 2004, Braz J Infect Dis, V8, P281; Bello G, 2008, AIDS, V22, P1993, DOI 10.1097/QAD.0b013e328315e0aa; Brazilian, 2015, AIDS EP B; Brindeiro RM, 2003, AIDS, V17, P1063, DOI 10.1097/00002030-200305020-00016; Carvalho BC, 2011, AIDS RES HUM RETROV, V27, P1081, DOI [10.1089/aid.2010.0334, 10.1089/AID.2010.0334]; Couto-Fernandez JC, 2005, MEM I OSWALDO CRUZ, V100, P73, DOI 10.1590/S0074-02762005000100014; Cunha LKH, 2012, BRAZ J MED BIOL RES, V45, P104, DOI 10.1590/S0100-879X2012007500003; da Costa CM, 2016, AIDS RES HUM RETROV, V32, P918, DOI [10.1089/aid.2016.0044, 10.1089/AID.2016.0044]; Soares CMPD, 2014, J INT AIDS SOC, V17, DOI 10.7448/IAS.17.1.19042; de Oliveira T, 2005, BIOINFORMATICS, V21, P3797, DOI 10.1093/bioinformatics/bti607; Delgado E, 2001, AIDS RES HUM RETROV, V17, P753, DOI 10.1089/088922201750237022; Diaz RS, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0139677; Diniz A.M.A., 2005, CAD GEOGRAFIA, V15, P23; Divino F, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0162112; Gifford RJ, 2009, BIOINFORMATICS, V25, P1197, DOI 10.1093/bioinformatics/btp134; Guindon S, 2005, NUCLEIC ACIDS RES, V33, pW557, DOI 10.1093/nar/gki352; Guindon S, 2010, SYST BIOL, V59, P307, DOI 10.1093/sysbio/syq010; Hacker MA, 2007, CAD SAUDE PUBLICA, V23, pS345, DOI 10.1590/S0102-311X2007001500003; Inocencio LA, 2009, J INT AIDS SOC, V12, DOI 10.1186/1758-2652-12-20; Liu TF, 2006, CLIN INFECT DIS, V42, P1608, DOI 10.1086/503914; Lopes CAF, 2015, BIOMED RES INT, V2015, DOI 10.1155/2015/738528; Macedo O, 2012, REV PAN-AMAZ SAUDE, V3, P11, DOI [10.5123/S2176-62232012000200002, DOI 10.5123/S2176-62232012000200002]; Machado LFA, 2009, AIDS RES HUM RETROV, V25, P961, DOI 10.1089/aid.2009.0027; Toledo PV, 2010, BRAZ J INFECT DIS, V14, P360, DOI 10.1590/S1413-86702010000400009; Pessoa R, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0152499; Rangel HR, 2009, MEM I OSWALDO CRUZ, V104, P522, DOI 10.1590/S0074-02762009000300020; Saad FF, 2010, INT J MOL MED, V26, P585, DOI 10.3892/ijmm_00000503; Salustiano Cavalcanti AM, 2007, MEM I OSWALDO CRUZ, V102, P785, DOI 10.1590/S0074-02762007005000109; Silva LD, 2016, AIDS RES HUM RETROV, V32, P373, DOI [10.1089/aid.2015.0280, 10.1089/AID.2015.0280]; Sprinz E, 2009, AIDS RES HUM RETROV, V25, P861, DOI 10.1089/aid.2009.0012; Stefani MMA, 2007, J CLIN VIROL, V39, P205, DOI 10.1016/j.jcv.2007.04.012; Tanuri A, 2002, J CLIN VIROL, V25, P39, DOI 10.1016/S1386-6532(01)00249-9; Cardoso LPV, 2009, AIDS RES HUM RETROV, V25, P943, DOI 10.1089/aid.2009.0060	35	10	10	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 16	2017	12	3							e0173894	10.1371/journal.pone.0173894	http://dx.doi.org/10.1371/journal.pone.0173894			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN9KE	28301548	gold, Green Published, Green Submitted			2022-12-27	WOS:000396318300090
J	Hayward, CPM; Liang, MG; Tasneem, S; Soomro, A; Waye, JS; Paterson, AD; Rivard, GE; Wilson, MD				Hayward, Catherine P. M.; Liang, Minggao; Tasneem, Subia; Soomro, Asim; Waye, John S.; Paterson, Andrew D.; Rivard, Georges E.; Wilson, Michael D.			The duplication mutation of Quebec platelet disorder dysregulates PLAU, but not C10orf55, selectively increasing production of normal PLAU transcripts by megakaryocytes but not granulocytes	PLOS ONE			English	Article							UROKINASE PLASMINOGEN-ACTIVATOR; EXPRESSION; PATHWAY; DEGRADATION; MEMBRANE; THROMBUS; RECEPTOR; CONTAIN; GENE	Quebec Platelet disorder (QPD) is a unique bleeding disorder that markedly increases urokinase plasminogen activator (uPA) in megakaryocytes and platelets but not in plasma or urine. The cause is tandem duplication of a 78 kb region of chromosome 10 containing PLAU (the uPA gene) and C10orf55, a gene of unknown function. QPD increases uPA in platelets and megakaryocytes >100 fold, far more than expected for a gene duplication. To investigate the tissue-specific effect that PLAU duplication has on gene expression and transcript structure in QPD, we tested if QPD leads to: 1) overexpression of normal or unique PLAU transcripts; 2) increased uPA in leukocytes; 3) altered levels of C10orf55 mRNA and/or protein in megakaryocytes and leukocytes; and 4) global changes in megakaryocyte gene expression. Primary cells and cultured megakaryocytes from donors were prepared for quantitative reverse polymerase chain reaction analyses, RNA-seq and protein expression analyses. Rapidly isolated blood leukocytes from QPD subjects showed only a 3.9 fold increase in PLAU transcript levels, in keeping with the normal to minimally increased uPA in affinity purified, QPD leukocytes. All subjects had more uPA in granulocytes than monocytes and minimal uPA in lymphocytes. QPD leukocytes expressed PLAU alleles in proportions consistent with an extra copy of PLAU on the disease chromosome, unlike QPD megakaryocytes. QPD PLAU transcripts were consistent with reference gene models, with a much higher proportion of reads originating from the disease chromosome in megakaryocytes than granulocytes. QPD and control megakaryocytes contained minimal reads for C10orf55, and C10orf55 protein was not increased in QPD megakaryocytes or platelets. Finally, our QPD megakaryocyte transcriptome analysis revealed a global down regulation of the interferon type 1 pathway. We suggest that the low endogenous levels of uPA in blood are actively regulated, and that the regulatory mechanisms are disrupted in QPD in a megakaryocyte-specific manner.	[Hayward, Catherine P. M.; Tasneem, Subia; Soomro, Asim; Waye, John S.] McMaster Univ, Dept Pathol & Mol Med, Hamilton, ON, Canada; [Hayward, Catherine P. M.] McMaster Univ, Dept Med, Hamilton, ON, Canada; [Hayward, Catherine P. M.; Waye, John S.] Hamilton Reg Lab Med Program, Hamilton, ON, Canada; [Liang, Minggao; Paterson, Andrew D.; Wilson, Michael D.] Hosp Sick Children, Genet & Genome Biol, Toronto, ON, Canada; [Liang, Minggao; Wilson, Michael D.] Univ Toronto, Mol Genet, Toronto, ON, Canada; [Paterson, Andrew D.] Univ Toronto, Dalla Lana Sch Publ Hlth, Toronto, ON, Canada; [Paterson, Andrew D.] Univ Toronto, Inst Med Sci, Toronto, ON, Canada; [Rivard, Georges E.] Ctr Hosp Univ St Justine, Hematol Oncol, Montreal, PQ, Canada; [Wilson, Michael D.] Heart & Stroke Richard Lewar Ctr Excellence Cardi, Toronto, ON, Canada	McMaster University; McMaster University; University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); University of Toronto; University of Toronto; University of Toronto; Universite de Montreal; Centre Hospitalier Universitaire Sainte-Justine	Hayward, CPM (corresponding author), McMaster Univ, Dept Pathol & Mol Med, Hamilton, ON, Canada.; Hayward, CPM (corresponding author), McMaster Univ, Dept Med, Hamilton, ON, Canada.; Hayward, CPM (corresponding author), Hamilton Reg Lab Med Program, Hamilton, ON, Canada.; Wilson, MD (corresponding author), Hosp Sick Children, Genet & Genome Biol, Toronto, ON, Canada.; Wilson, MD (corresponding author), Univ Toronto, Mol Genet, Toronto, ON, Canada.; Wilson, MD (corresponding author), Heart & Stroke Richard Lewar Ctr Excellence Cardi, Toronto, ON, Canada.	haywrdc@mcmaster.ca; michael.wilson@sickids.ca	Wilson, Michael D/K-6294-2014; Paterson, Andrew/AAQ-7511-2020; Paterson, Andrew D/A-4088-2011	Wilson, Michael D/0000-0002-4015-3066; Paterson, Andrew/0000-0002-9169-118X; Paterson, Andrew D/0000-0002-9169-118X; Hayward, Catherine/0000-0002-2843-0817	Canadian Institutes of Health Research [MOP 97942]; Heart and Stroke Foundation of Canada [7486]; Heart and Stroke Foundation of Ontario; Bayer Canada; Natural Sciences and Engineering Research Council of Canada [436194-2013]; Restracomp trainee scholarship; Canada Research Chairs; Faculty of Health Sciences, McMaster University	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Heart and Stroke Foundation of Canada(Heart & Stroke Foundation of Canada); Heart and Stroke Foundation of Ontario(Heart & Stroke Foundation of Ontario); Bayer Canada(Bayer AG); Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); Restracomp trainee scholarship; Canada Research Chairs(Canada Research ChairsCGIAR); Faculty of Health Sciences, McMaster University	Canadian Institutes of Health Research (grant MOP 97942, CPMH, ADP, JSW), Heart and Stroke Foundation of Canada (bridge grant 7486, MDW), Heart and Stroke Foundation of Ontario (Career Investigator Award, CPMH), Bayer Canada (GER), Natural Sciences and Engineering Research Council of Canada (grant 436194-2013, MDW), Restracomp trainee scholarship (ML), Canada Research Chairs (CPM, ADP, MDW) and funding from the Faculty of Health Sciences, McMaster University (CPMH).	Anders S, 2015, BIOINFORMATICS, V31, P166, DOI 10.1093/bioinformatics/btu638; Chand HS, 2005, THROMB HAEMOSTASIS, V94, P1122, DOI 10.1160/TH05-07-0509; Chen L, 2014, SCIENCE, V345; Dejouvencel T, 2010, BLOOD, V115, P2048, DOI 10.1182/blood-2009-06-228817; Deloukas P, 2004, NATURE, V429, P375, DOI 10.1038/nature02462; Diamandis M, 2006, J THROMB HAEMOST, V4, P1086, DOI 10.1111/j.1538-7836.2006.01877.x; Diamandis M, 2009, BLOOD, V113, P1543, DOI 10.1182/blood-2008-08-175216; Diarnandis M, 2008, BLOOD COAGUL FIBRIN, V19, P463, DOI 10.1097/MBC.0b013e328304e099; Dobin A, 2013, BIOINFORMATICS, V29, P15, DOI 10.1093/bioinformatics/bts635; Dumler I, 1999, J BIOL CHEM, V274, P24059, DOI 10.1074/jbc.274.34.24059; Ervin AL, 2001, BLOOD COAGUL FIBRIN, V12, P415, DOI 10.1097/00001721-200109000-00001; GRAU E, 1989, THROMB RES, V53, P145, DOI 10.1016/0049-3848(89)90375-7; Harrow J, 2012, GENOME RES, V22, P1760, DOI 10.1101/gr.135350.111; Hartley SW, 2016, NUCLEIC ACIDS RES, V44, DOI 10.1093/nar/gkw501; Hayward CPM, 2011, EXPERT REV HEMATOL, V4, P137, DOI [10.1586/EHM.11.5, 10.1586/ehm.11.5]; Hayward CPM, 1997, BRIT J HAEMATOL, V97, P497, DOI 10.1046/j.1365-2141.1997.862903.x; Hayward CPM, 1997, BLOOD, V89, P1243, DOI 10.1182/blood.V89.4.1243; Hindson CM, 2013, NAT METHODS, V10, P1003, DOI 10.1038/nmeth.2633; Ivashkiv LB, 2014, NAT REV IMMUNOL, V14, P36, DOI 10.1038/nri3581; Kahr WHA, 2001, BLOOD, V98, P257, DOI 10.1182/blood.V98.2.257; Koshelnick Y, 1997, J BIOL CHEM, V272, P28563, DOI 10.1074/jbc.272.45.28563; Kufrin D, 2003, BLOOD, V102, P926, DOI 10.1182/blood-2003-01-0054; Loehlin DW, 2016, P NATL ACAD SCI US; Love MI, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0550-8; Madsen JGS, 2015, NUCLEIC ACIDS RES, V43, DOI 10.1093/nar/gku1365; Matsunoshita Y, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016234; Maynard DM, 2007, J THROMB HAEMOST, V5, P1945, DOI 10.1111/j.1538-7836.2007.02690.x; McKay H, 2004, BLOOD, V104, P159, DOI 10.1182/blood-2003-11-4077; Moir E, 2001, BRIT J HAEMATOL, V113, P72, DOI 10.1046/j.1365-2141.2001.02696.x; Mutch NJ, 2002, THROMB HAEMOSTASIS, V88, P996; Osato N, 2007, GENETICS, V176, P1299, DOI 10.1534/genetics.106.069484; Ota T, 2004, NAT GENET, V36, P40, DOI 10.1038/ng1285; Paterson AD, 2010, BLOOD, V115, P1264, DOI 10.1182/blood-2009-07-233965; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; PLESNER T, 1994, BLOOD, V83, P808; Psaila B, 2016, GENOME BIOL, V17, DOI 10.1186/s13059-016-0939-7; Rainen L, 2002, CLIN CHEM, V48, P1883; Reich M, 2006, NAT GENET, V38, P500, DOI 10.1038/ng0506-500; RINDER HM, 1991, BLOOD, V78, P1760; Schmidt SF, 2015, GENOME RES, V25, P1281, DOI 10.1101/gr.188300.114; Sheth PM, 2003, THROMB HAEMOSTASIS, V90, P293, DOI 10.1160/TH02-12-0323; Singh I, 2003, CIRCULATION, V107, P869, DOI 10.1161/01.CIR.0000050149.22928.39; STEPHENS RW, 1984, EUR J BIOCHEM, V139, P253, DOI 10.1111/j.1432-1033.1984.tb08001.x; Van der Auwera Geraldine A, 2013, Curr Protoc Bioinformatics, V43, DOI [10.1002/0471250953.bi1201s43, 10.1002/0471250953.bi1110s43]; Teruel-Montoya R, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0102259; Torres-Garcia W, 2014, BIOINFORMATICS, V30, P2224, DOI 10.1093/bioinformatics/btu169; Vadivel K, 2014, J BIOL CHEM, V289, P31647, DOI 10.1074/jbc.M114.569665; Van der Auwera GA, CALLING VARIANTS RNA; Veljkovic DK, 2009, BLOOD, V113, P1535, DOI 10.1182/blood-2008-08-172338	49	14	14	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 16	2017	12	3							e0173991	10.1371/journal.pone.0173991	http://dx.doi.org/10.1371/journal.pone.0173991			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN9KE	28301587	Green Submitted, Green Published, gold			2022-12-27	WOS:000396318300107
J	Kong, P; Richardson, P; Hong, CX				Kong, Ping; Richardson, Patricia; Hong, Chuanxue			Diversity and community structure of cyanobacteria and other microbes in recycling irrigation reservoirs	PLOS ONE			English	Article							IDENTIFICATION; SURVIVAL; ECOLOGY; STRESS; BLOOMS; WATER; LAKES	Recycling irrigation reservoirs (RIRs) are emerging aquatic environments of global significance to crop production, water conservation and environmental sustainability. This study characterized the diversity and population structure of cyanobacteria and other detected microbes in water samples from eight RIRs and one adjacent runoff-free stream at three ornamental crop nurseries in eastern (VA1 and VA3) and central (VA2) Virginia after cloning and sequencing the 16S rRNA gene targeting cyanobacteria and chloroplast of eukaryotic phytoplankton. VA1 and VA2 utilize a multi-reservoir recycling irrigation system with runoff channeled to a sedimentation reservoir which then overflows into transition and retention reservoirs where water was pumped for irrigation. VA3 has a single sedimentation reservoir which was also used for irrigation. A total of 208 operational taxonomic units (OTU) were identified from clone libraries of the water samples. Among them, 53 OTUs (358 clones) were cyanobacteria comprising at least 12 genera dominated by Synechococcus species; 59 OTUs (387 clones) were eukaryotic phytoplankton including green algae and diatoms; and 96 were other bacteria (111 clones). Overall, cyanobacteria were dominant in sedimentation reservoirs, while eukaryotic phytoplankton and other bacteria were dominant in transition/ retention reservoirs and the stream, respectively. These results are direct evidence demonstrating the negative impact of nutrient-rich horticultural runoff, if not contained, on natural water resources. They also help in understanding the dynamics of water quality in RIRs and have practical implications. Although both single-and multi-reservoir recycling irrigation systems reduce the environmental footprint of horticultural production, the former is expected to have more cyanobacterial blooming, and consequently water quality issues, than the latter. Thus, a multi-reservoir recycling irrigation system should be preferred where feasible.	[Kong, Ping; Richardson, Patricia; Hong, Chuanxue] Virginia Tech, Hampton Rd Agr Res & Extens Ctr, Virginia Beach, VA 23455 USA	Virginia Polytechnic Institute & State University	Kong, P (corresponding author), Virginia Tech, Hampton Rd Agr Res & Extens Ctr, Virginia Beach, VA 23455 USA.	pkong@vt.edu			Specialty Crop Research Initiative (SCRI) [2010-51181-21140]; Hatch Program of the United States USDA National Institute of Food and the Agriculture; Virginia Agricultural Experiment Station	Specialty Crop Research Initiative (SCRI); Hatch Program of the United States USDA National Institute of Food and the Agriculture; Virginia Agricultural Experiment Station	This study was supported in part by the Specialty Crop Research Initiative (SCRI, Agreement #: 2010-51181-21140), the Hatch Program of the United States USDA National Institute of Food and the Agriculture Virginia Agricultural Experiment Station. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acinas SG, 2009, ISME J, V3, P31, DOI 10.1038/ismej.2008.78; Argo WR, 2002, UNDERSTANDING PH MAN; Barranguet C, 2005, EUR J PHYCOL, V40, P1, DOI 10.1080/09670260400009882; Bruno L, 2012, J APPL MICROBIOL, V113, P1052, DOI 10.1111/j.1365-2672.2012.05416.x; Burja AM, 2001, FEMS MICROBIOL LETT, V202, P195, DOI 10.1016/S0378-1097(01)00306-8; Buttner C., 2014, BIOL DETECTION MANAG; Diaz RJ, 2008, SCIENCE, V321, P926, DOI 10.1126/science.1156401; Eiler A, 2004, ENVIRON MICROBIOL, V6, P1228, DOI 10.1111/j.1462-2920.2004.00657.x; GLOVER HE, 1981, ARCH MICROBIOL, V129, P42, DOI 10.1007/BF00417177; Guo L, 2007, SCIENCE, V317, P1166, DOI 10.1126/science.317.5842.1166; Hall TA., 1999, NUCL ACIDS S SERIES, V41, P95; Holdren JP, 2008, SCIENCE, V319, P424, DOI 10.1126/science.1153386; Hong CX, 2009, IRRIGATION SCI, V27, P485, DOI 10.1007/s00271-009-0161-4; Hong CX, 2005, CRIT REV PLANT SCI, V24, P189, DOI 10.1080/07352680591005838; Kaiser J., 2005, SCIENCE, V308, P195; Katsiapi M, 2013, FUND APPL LIMNOL, V182, P219, DOI 10.1127/1863-9135/2013/0362; Kim SG, 2006, APPL ENVIRON MICROB, V72, P3252, DOI 10.1128/AEM.72.5.3252-3258.2006; Kong P, 2012, PLANT PATHOL, V61, P1179, DOI 10.1111/j.1365-3059.2012.02614.x; Kong P, 2014, BIOL DETECTION MANAG, P333; Kong P, 2014, BMC MICROBIOL, V14, DOI 10.1186/1471-2180-14-124; Kong P, 2012, FEMS MICROBIOL LETT, V332, P54, DOI 10.1111/j.1574-6968.2012.02574.x; Kong P, 2009, APPL ENVIRON MICROB, V75, P4307, DOI 10.1128/AEM.00119-09; Leao PN, 2012, NAT PROD REP, V29, P372, DOI 10.1039/c2np00075j; Lindstrom ES, 2000, MICROBIAL ECOL, V40, P104; Lindstrom ES, 2001, MICROBIAL ECOL, V42, P598, DOI 10.1007/s00248-001-0031-y; Marshall HG, 2013, VIRGINIA J SCI, V64, P1; Nedelcu AM, 2001, J MOL EVOL, V53, P670, DOI 10.1007/s002390010254; Nubel U, 1997, APPL ENVIRON MICROB, V63, P3327; Okamoto N, 2005, SCIENCE, V310, P287, DOI 10.1126/science.1116125; Oksanen J, 2015, PACKAGE VEGAN COMMUN, P2; Pruesse E, 2012, BIOINFORMATICS, V28, P1823, DOI 10.1093/bioinformatics/bts252; R Core Team, 2021, R LANGUAGE ENV STAT; Rozon RM, 2013, FRESHWATER BIOL, V58, P2648, DOI 10.1111/fwb.12241; Sahin U, 2005, J ENVIRON MANAGE, V76, P338, DOI 10.1016/j.jenvman.2005.02.003; Schloss PD, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027310; Shih PM, 2013, P NATL ACAD SCI USA, V110, P1053, DOI 10.1073/pnas.1217107110; Singh Y, 2014, J BIOSCIENCES, V39, P643, DOI 10.1007/s12038-014-9458-4; Soo RM, 2014, GENOME BIOL EVOL, V6, P1031, DOI 10.1093/gbe/evu073; Sorensen KB, 2005, APPL ENVIRON MICROB, V71, P7352, DOI 10.1128/AEM.71.11.7352-7365.2005; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; Whitton B.A., 2000, ECOLOGY CYANOBACTERI; Wright ES, 2012, APPL ENVIRON MICROB, V78, P717, DOI 10.1128/AEM.06516-11	42	7	7	0	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 16	2017	12	3							e0173903	10.1371/journal.pone.0173903	http://dx.doi.org/10.1371/journal.pone.0173903			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN9KE	28301562	gold, Green Submitted, Green Published			2022-12-27	WOS:000396318300092
J	Liu, CL; Xi, Y; Li, M; Jiao, Q; Zhang, HZ; Yang, QC; Yao, WW				Liu, Chenglei; Xi, Yan; Li, Mei; Jiao, Qiong; Zhang, Huizhen; Yang, Qingcheng; Yao, Weiwu			Dedifferentiated chondrosarcoma: Radiological features, prognostic factors and survival statistics in 23 patients	PLOS ONE			English	Article							CHEMOTHERAPY; EXPERIENCE; MRI	Background Dedifferentiated chondrosarcoma is a rare, highly malignant tumor with a poor survival. There are many confusing issues concerning the imaging feature that can facilitate early diagnosis and the factors that might be related to outcomes. Methods Twenty-three patients with dedifferentiated chondrosarcoma confirmed by pathology were retrospectively reviewed from 2008 to 2015. The patients' clinical information, images from radiographs (n = 17), CT (n = 19), and MRI (n = 17), histological features, treatment and prognosis were analyzed. Results There were 12 males and 11 females, and the mean age was 50.39 years old. Fourteen cases affected the axial bone (pelvis, spine), and 9 cases involved the appendicular bone. Seven (41.17%), 9 (47.36), and 12 (66.66%) lesions showed a biphasic nature on radiograph, CT and MRI, respectively. Of the lesions, 17.39% (4/23) were accompanied by pathological fractures. Histologically, the cartilage component was considered histological Grade1 in 12 patients and Grade 2 in 11 patients. The dedifferentiated component showed features of osteosarcoma in 8 cases, malignant fibrous histiocytoma in3 cases, myofibroblastic sarcoma in 1 case and spindle cell sarcoma in 11cases. Twenty-two cases were treated with surgical resection, and 17 cases achieved adequate (wide or radical) surgical margin. In 8 cases, surgery was combined with adjuvant chemotherapy. The overall median survival time was nine months; 17.4% of patients survived to five years. Conclusion Axial bone location, lung metastasis at diagnosis, inadequate surgical margin, incorrect diagnosis before surgery and pathological fractures was related to poorer outcome. Pre- or postoperative chemotherapy had no definitively effect on improved survival.	[Liu, Chenglei; Xi, Yan; Li, Mei; Yao, Weiwu] Shanghai Jiao Tong Univ, Peoples Hosp 6, Dept Radiol, Shanghai, Peoples R China; [Jiao, Qiong; Zhang, Huizhen] Shanghai Jiao Tong Univ, Peoples Hosp 6, Dept Pathol, Shanghai, Peoples R China; [Yang, Qingcheng] Shanghai Jiao Tong Univ, Peoples Hosp 6, Dept Orthoped, Shanghai, Peoples R China	Shanghai Jiao Tong University; Shanghai Jiao Tong University; Shanghai Jiao Tong University	Yao, WW (corresponding author), Shanghai Jiao Tong Univ, Peoples Hosp 6, Dept Radiol, Shanghai, Peoples R China.	yaoweiwuhuan@163.com	Zhang, Hui/HHN-8494-2022; zhang, hui/GXH-6098-2022		Scientific Research Plan Project of Shanghai [16511101100];  [2016YFC0106802]	Scientific Research Plan Project of Shanghai; 	This research was supported by the Scientific Research Plan Project of Shanghai (Grant # 16511101100, Funding Institution: Shanghai Science and Technology, url: http://www.stcsm.gov.cn/) and the Major Project Fund of Minister of Science and Technology (Grant # 2016YFC0106802, Funding Institution: Ministry of Science and Technology of the People's Republic of China, URL: http://www.most.gov.cn/). All external funding was secured by WY. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bergh P, 2001, CANCER-AM CANCER SOC, V91, P1201, DOI 10.1002/1097-0142(20010401)91:7<1201::AID-CNCR1120>3.0.CO;2-W; Bruns J, 2005, J CANCER RES CLIN, V131, P333, DOI 10.1007/s00432-004-0648-6; CHMELEVSKY D, 1988, RADIAT ENVIRON BIOPH, V27, P103, DOI 10.1007/BF01214600; DAHLIN DC, 1971, CANCER, V28, P461, DOI 10.1002/1097-0142(197108)28:2<461::AID-CNCR2820280227>3.0.CO;2-U; DALY PJ, 1989, ORTHOPEDICS, V12, P763; DELANGE EE, 1986, RADIOLOGY, V161, P489, DOI 10.1148/radiology.161.2.3763920; Dickey ID, 2004, J BONE JOINT SURG AM, V86A, P2412, DOI 10.2106/00004623-200411000-00008; Eustace S, 1997, CLIN IMAG, V21, P170, DOI 10.1016/S0899-7071(96)00016-2; FRASSICA FJ, 1986, J BONE JOINT SURG AM, V68A, P1197, DOI 10.2106/00004623-198668080-00008; Gelderblom H, 2008, ONCOLOGIST, V13, P320, DOI 10.1634/theoncologist.2007-0237; Grimer RJ, 2007, EUR J CANCER, V43, P2060, DOI 10.1016/j.ejca.2007.06.016; Italiano A, 2013, ANN ONCOL, V24, P2916, DOI 10.1093/annonc/mdt374; JOHNSON S, 1986, CANCER, V58, P278, DOI 10.1002/1097-0142(19860715)58:2<278::AID-CNCR2820580213>3.0.CO;2-6; Littrell LA, 2004, RADIOGRAPHICS, V24, P1397, DOI 10.1148/rg.245045009; MacSweeney F, 2003, SKELETAL RADIOL, V32, P671, DOI 10.1007/s00256-003-0706-1; Malchenko Sergey, 2012, Sarcoma, V2012, P820254, DOI 10.1155/2012/820254; Masciocchi C, 1998, EUR J RADIOL, V27, pS86, DOI 10.1016/S0720-048X(98)00048-5; MERCURI M, 1995, SKELETAL RADIOL, V24, P409, DOI 10.1007/BF00941235; Milchgrub S, 2002, TUMOURS SOFT TISSUE, P252; Mitchell AD, 2000, J BONE JOINT SURG BR, V82B, P55, DOI 10.1302/0301-620X.82B1.9020; Mohseny AB, 2011, STEM CELLS, V29, P397, DOI 10.1002/stem.596; Nota Sjoerd P. F. T., 2015, Sarcoma, V2015, P623746, DOI 10.1155/2015/623746; Obid P, 2015, GLOB SPINE J, V5, pE74, DOI 10.1055/s-0035-1546953; Saifuddin A, 2004, CLIN RADIOL, V59, P268, DOI 10.1016/j.crad.2003.08.009; Sopta J, 2008, J CANCER RES CLIN, V134, P147, DOI 10.1007/s00432-007-0262-5; Staals EL, 2006, CANCER-AM CANCER SOC, V106, P2682, DOI 10.1002/cncr.21936; Yokota K, 2012, J ORTHOP SURG RES, V7, DOI 10.1186/1749-799X-7-38	27	22	23	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 16	2017	12	3							e0173665	10.1371/journal.pone.0173665	http://dx.doi.org/10.1371/journal.pone.0173665			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN9KE	28301537	Green Published, gold, Green Submitted			2022-12-27	WOS:000396318300058
J	Murtaza, G; Mermer, P; Goldenberg, A; Pfeil, U; Paddenberg, R; Weissmann, N; Lochnit, G; Kummer, W				Murtaza, Ghulam; Mermer, Petra; Goldenberg, Anna; Pfeil, Uwe; Paddenberg, Renate; Weissmann, Nobert; Lochnit, Guenter; Kummer, Wolfgang			TASK-1 potassium channel is not critically involved in mediating hypoxic pulmonary vasoconstriction of murine intra-pulmonary arteries	PLOS ONE			English	Article							DOMAIN K+ CHANNEL; SMOOTH-MUSCLE-CELLS; OXYGEN; HYPERTENSION; RAT; KCNK3; MICE; MODULATION; EXPRESSION; ANTIBODIES	The two-pore domain potassium channel KCNK3 (TASK-1) is expressed in rat and human pulmonary artery smooth muscle cells. There, it is associated with hypoxia-induced signalling, and its dysfunction is linked to pathogenesis of human pulmonary hypertension. We here aimed to determine its role in hypoxic pulmonary vasoconstriction (HPV) in the mouse, and hence the suitability of this model for further mechanistic investigations, using appropriate inhibitors and TASK-1 knockout (KO) mice. RT-PCR revealed expression of TASK-1 mRNA in murine lungs and pre-acinar pulmonary arteries. Protein localization by immunohistochemistry and western blot was unreliable since all antibodies produced labelling also in TASK-1 KO organs/tissues. HPV was investigated by videomorphometric analysis of intra-(inner diameter: 25-40 mu m) and pre-acinar pulmonary arteries (inner diameter: 41-60 mu m). HPV persisted in TASK-1 KO intra-acinar arteries. Pre-acinar arteries developed initial HPV, but the response faded earlier (after 30 min) in KO vessels. This HPV pattern was grossly mimicked by the TASK-1 inhibitor anandamide in wild-type vessels. Hypoxia-provoked rise in pulmonary arterial pressure (PAP) in isolated ventilated lungs was affected neither by TASK-1 gene deficiency nor by the TASK-1 inhibitor A293. TASK-1 is dispensable for initiating HPV of murine intra-pulmonary arteries, but participates in sustained HPV specifically in pre-acinar arteries. This does not translate into abnormal rise in PAP. While there is compelling evidence that TASK-1 is involved in the pathogenesis of pulmonary arterial hypertension in humans, the mouse does not appear to serve as a suitable model to study the underlying molecular mechanisms.	[Murtaza, Ghulam; Mermer, Petra; Goldenberg, Anna; Pfeil, Uwe; Paddenberg, Renate; Kummer, Wolfgang] Justus Liebig Univ, Inst Anat & Cell Biol, Giessen, Germany; [Weissmann, Nobert] Justus Liebig Univ, Univ Giessen & Marburg Lung Ctr, Giessen, Germany; [Weissmann, Nobert; Kummer, Wolfgang] Justus Liebig Univ, German Ctr Lung Res Excellence Cluster Cardiopulm, Giessen, Germany; [Lochnit, Guenter] Justus Liebig Univ, Inst Biochem, Fac Med, Giessen, Germany	Justus Liebig University Giessen; Justus Liebig University Giessen; Justus Liebig University Giessen; Justus Liebig University Giessen	Murtaza, G (corresponding author), Justus Liebig Univ, Inst Anat & Cell Biol, Giessen, Germany.	gmurtazay@yahoo.com		Weissmann, Norbert/0000-0003-2675-3871; Kummer, Wolfgang/0000-0002-3946-0683				Aller MI, 2005, J NEUROSCI, V25, P11455, DOI 10.1523/JNEUROSCI.3153-05.2005; Antigny F, 2016, CIRCULATION, V133, P1371, DOI 10.1161/CIRCULATIONAHA.115.020951; Baker M, 2015, NATURE, V521, P274, DOI 10.1038/521274a; Berg AP, 2004, J NEUROSCI, V24, P6693, DOI 10.1523/JNEUROSCI.1408-04.2004; Buckler KJ, 2000, J PHYSIOL-LONDON, V525, P135, DOI 10.1111/j.1469-7793.2000.00135.x; Decher N, 2011, CELL PHYSIOL BIOCHEM, V28, P77, DOI 10.1159/000331715; Donner BC, 2011, BASIC RES CARDIOL, V106, P75, DOI 10.1007/s00395-010-0128-x; Girerd B, 2016, EUR RESPIR J, V47, P541, DOI 10.1183/13993003.00717-2015; Graham V, 2006, DEV DYNAM, V235, P143, DOI 10.1002/dvdy.20558; Gurney AM, 2003, CIRC RES, V93, P957, DOI 10.1161/01.RES.0000099883.68414.61; Jeffery TK, 2001, PHARMACOL THERAPEUT, V92, P1, DOI 10.1016/S0163-7258(01)00157-7; Johnson RP, 2004, AM J PHYSIOL-CELL PH, V286, pC391, DOI 10.1152/ajpcell.00401.2003; Kim D, 2009, J PHYSIOL-LONDON, V587, P2963, DOI 10.1113/jphysiol.2009.171181; Kim Y, 2000, J BIOL CHEM, V275, P9340, DOI 10.1074/jbc.275.13.9340; Krasteva G, 2007, INT J BIOCHEM CELL B, V39, P615, DOI 10.1016/j.biocel.2006.10.019; Kummer Wolfgang, 2011, Proc Am Thorac Soc, V8, P471, DOI 10.1513/pats.201101-013MW; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Lee YM, 2006, CELL SIGNAL, V18, P499, DOI 10.1016/j.cellsig.2005.05.025; Linden AM, 2006, J PHARMACOL EXP THER, V317, P615, DOI 10.1124/jpet.105.098525; Ma L, 2013, NEW ENGL J MED, V369, P351, DOI 10.1056/NEJMoa1211097; Maingret F, 2001, EMBO J, V20, P47, DOI 10.1093/emboj/20.1.47; Manoury B, 2009, BRIT J PHARMACOL, V158, P848, DOI 10.1111/j.1476-5381.2009.00353.x; Manoury B, 2011, J PHYSIOL-LONDON, V589, P3231, DOI 10.1113/jphysiol.2011.206748; Medhurst AD, 2001, MOL BRAIN RES, V86, P101, DOI 10.1016/S0169-328X(00)00263-1; Navas Tejedor P, 2016, CLIN GENET; Olschewski A, 2006, CIRC RES, V98, P1072, DOI 10.1161/01.RES.0000219677.12988.e9; Paddenberg R, 2006, RESP RES, V7, DOI 10.1186/1465-9921-7-93; Paddenberg R, 2014, JOVE-J VIS EXP, DOI 10.3791/50970; Paddenberg R, 2012, CARDIOVASC RES, V93, P702, DOI 10.1093/cvr/cvr359; Pandit LM, 2014, HYPERTENSION, V64, P1260, DOI 10.1161/HYPERTENSIONAHA.114.03406; Papreck JR, 2012, PFLUG ARCH EUR J PHY, V464, P471, DOI 10.1007/s00424-012-1159-y; Patel AJ, 2001, EUR RESPIR J, V18, P221, DOI 10.1183/09031936.01.00204001; Putzke C, 2007, CARDIOVASC RES, V75, P59, DOI 10.1016/j.cardiores.2007.02.025; Reyes R, 1998, J BIOL CHEM, V273, P30863, DOI 10.1074/jbc.273.47.30863; Rommel FR, 2015, J HISTOCHEM CYTOCHEM, V63, P329, DOI 10.1369/0022155415575028; Tabuchi A, 2008, J APPL PHYSIOL, V104, P338, DOI 10.1152/japplphysiol.00348.2007; Timm T, 2016, PARASITOL RES; Trapp S, 2008, J NEUROSCI, V28, P8844, DOI 10.1523/JNEUROSCI.1810-08.2008; Turner PJ, 2013, J PHYSIOL-LONDON, V591, P5977, DOI 10.1113/jphysiol.2013.262022; Weissmann N, 2004, RESP PHYSIOL NEUROBI, V139, P191, DOI 10.1016/j.resp.2003.10.003	40	21	22	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 16	2017	12	3							e0174071	10.1371/journal.pone.0174071	http://dx.doi.org/10.1371/journal.pone.0174071			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN9KE	28301582	Green Published, Green Submitted, gold			2022-12-27	WOS:000396318300122
J	Krzemien, KM; Beckers, M; Quack, S; Michaelis, J				Krzemien, Katarzyna M.; Beckers, Maximilian; Quack, Salina; Michaelis, Jens			Atomic force microscopy of chromatin arrays reveal non-monotonic salt dependence of array compaction in solution	PLOS ONE			English	Article							NUCLEOSOME CORE PARTICLE; HIGHER-ORDER; HISTONE; DNA; FIBER; VISUALIZATION; ORGANIZATION; CHROMOSOMES; ELASTICITY; TRANSITION	Compaction of DNA in chromatin is a hallmark of the eukaryotic cell and unravelling its structure is required for an understanding of DNA involving processes. Despite strong experimental efforts, many questions concerning the DNA packing are open. In particular, it is heavily debated whether an ordered structure referred to as the "30 nm fibre" exist in vivo. Scanning probe microscopy has become a cutting edge technology for the high-resolution imaging of DNA-protein complexes. Here, we perform high-resolution atomic force microscopy of non-cross-linked chromatin arrays in liquid, under different salt conditions. A statistical analysis of the data reveals that array compaction is salt dependent in a non-monotonic fashion. A simple physical model can qualitatively explain the observed findings due to the opposing effects of salt dependent stiffening of DNA, nucleosome stability and histone-histone interactions. While for different salt concentrations different compaction states are observed, our data do not provide support for the existence of regular chromatin fibres. Our studies add new insights into chromatin structure, and with that contribute to a further understanding of the DNA condensation.	[Krzemien, Katarzyna M.; Beckers, Maximilian; Quack, Salina; Michaelis, Jens] Univ Ulm, Inst Biophys, Ulm, Germany; [Beckers, Maximilian] EMBL, Struct & Computat Biol Unit, Heidelberg, Germany	Ulm University; European Molecular Biology Laboratory (EMBL)	Michaelis, J (corresponding author), Univ Ulm, Inst Biophys, Ulm, Germany.	jens.michaelis@uni-ulm.de		Michaelis, Jens/0000-0002-2739-4172; Beckers, Maximilian/0000-0001-5988-1322	European Research Council	European Research Council(European Research Council (ERC)European Commission)	This work was supported by European Research Council Starting Grant "Remodelling", JM (https://erc.europa.eu/funding-and-grants/funding-schemes/starting-grants). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akitaya T, 2007, BIOMACROMOLECULES, V8, P273, DOI 10.1021/bm060634j; Allahverdi A, 2015, SCI REP-UK, V5, DOI 10.1038/srep08512; Ricci MA, 2015, CELL, V160, P1145, DOI 10.1016/j.cell.2015.01.054; Bash RC, 2001, J BIOL CHEM, V276, P48362, DOI 10.1074/jbc.M104916200; Baumann CG, 1997, P NATL ACAD SCI USA, V94, P6185, DOI 10.1073/pnas.94.12.6185; BELMONT AS, 1994, J CELL BIOL, V127, P287, DOI 10.1083/jcb.127.2.287; Bian Q, 2012, CURR OPIN CELL BIOL, V24, P359, DOI 10.1016/j.ceb.2012.03.003; Bonisch C, 2012, NUCLEIC ACIDS RES, V40, P5951, DOI 10.1093/nar/gks267; Bollobas B., 1998, MODERN GRAPH THEORY; Bussiek M, 2003, NUCLEIC ACIDS RES, V31, DOI 10.1093/nar/gng137; Bussiek M, 2005, J MOL BIOL, V345, P695, DOI 10.1016/j.jmb.2004.11.016; Bustamante C, 1997, METHODS, V12, P73, DOI 10.1006/meth.1997.0449; Cano S, 2006, EUR BIOPHYS J BIOPHY, V35, P495, DOI 10.1007/s00249-006-0057-7; d'Erme M, 2001, BIOCHEMISTRY-US, V40, P10947, DOI 10.1021/bi002742a; Di Cerbo V, 2014, ELIFE, V3, DOI 10.7554/eLife.01632; Dorigo B, 2003, J MOL BIOL, V327, P85, DOI 10.1016/S0022-2836(03)00025-1; Elbel T, 2015, J PHYS-CONDENS MAT, V27, DOI 10.1088/0953-8984/27/6/064105; Fan JY, 2002, NAT STRUCT BIOL, V9, P172, DOI 10.1038/nsb767; Faye G, 2005, J BIOL CHEM, V280, P33701, DOI 10.1074/jbc.M507048200; Fussner E, 2012, EMBO REP, V13, P992, DOI 10.1038/embor.2012.139; Gansen A, 2015, NUCLEIC ACIDS RES, V43, P1433, DOI 10.1093/nar/gku1354; Goldberg D.E., 1989, GENETIC ALGORITHMS S; Grigoryev SA, 2012, EXP CELL RES, V318, P1448, DOI 10.1016/j.yexcr.2012.02.014; HANSEN JC, 1989, BIOCHEMISTRY-US, V28, P9129, DOI 10.1021/bi00449a026; Hansen JC, 2012, EMBO J, V31, P1621, DOI 10.1038/emboj.2012.66; Hazan NP, 2015, BIOPHYS J, V109, P1676, DOI 10.1016/j.bpj.2015.07.004; Hizume K, 2009, ULTRAMICROSCOPY, V109, P868, DOI 10.1016/j.ultramic.2009.03.014; Hsieh THS, 2015, CELL, V162, P108, DOI 10.1016/j.cell.2015.05.048; Huynh VAT, 2005, J MOL BIOL, V345, P957, DOI 10.1016/j.jmb.2004.10.075; Klinker H, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0104029; Klinker H, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088411; KORNBERG RD, 1977, ANNU REV BIOCHEM, V46, P931, DOI 10.1146/annurev.bi.46.070177.004435; Korolev N, 2012, SOFT MATTER, V8, P9322, DOI 10.1039/c2sm25662b; Korolev N, 2012, BIOCHEM BIOPH RES CO, V418, P205, DOI 10.1016/j.bbrc.2011.12.112; Korolev N, 2010, BIOPHYS J, V99, P1896, DOI 10.1016/j.bpj.2010.07.017; Lee C. Y., 1961, IRE T ELECTRON COMPU, P346, DOI DOI 10.1109/TEC.1961.5219222; Lee W, 2007, NAT GENET, V39, P1235, DOI 10.1038/ng2117; LEUBA SH, 1994, P NATL ACAD SCI USA, V91, P11621, DOI 10.1073/pnas.91.24.11621; Lowary PT, 1998, J MOL BIOL, V276, P19, DOI 10.1006/jmbi.1997.1494; Luger K, 1997, J MOL BIOL, V272, P301, DOI 10.1006/jmbi.1997.1235; Luger K, 1997, NATURE, V389, P251, DOI 10.1038/38444; Luger K, 1999, METH MOL B, V119, P1; Luger K, 2012, NAT REV MOL CELL BIO, V13, P436, DOI 10.1038/nrm3382; Lyubchenko YL, 2016, CRITICAL REV EUKARYO, V26; Maeshima K, 2016, EMBO J, V35, P1115, DOI 10.15252/embj.201592660; Menshikova Irina, 2011, Int J Biochem Mol Biol, V2, P129; Nazarov I, 2016, BIOCHIMIE, V121, P5, DOI 10.1016/j.biochi.2015.11.010; Nishino Y, 2012, EMBO J, V31, P1644, DOI 10.1038/emboj.2012.35; Perisic O, 2010, J MOL BIOL, V403, P777, DOI 10.1016/j.jmb.2010.07.057; Poirier MG, 2008, J MOL BIOL, V379, P772, DOI 10.1016/j.jmb.2008.04.025; Robinson PJJ, 2006, P NATL ACAD SCI USA, V103, P6506, DOI 10.1073/pnas.0601212103; Routh A, 2008, P NATL ACAD SCI USA, V105, P8872, DOI 10.1073/pnas.0802336105; SCHWARZ PM, 1994, J BIOL CHEM, V269, P16284; SEN D, 1986, BIOCHEMISTRY-US, V25, P1495, DOI 10.1021/bi00355a004; Simon M, 2011, P NATL ACAD SCI USA, V108, P12711, DOI 10.1073/pnas.1106264108; Soille P, 2004, MORPHOLOGICAL IMAGE, DOI 10.1007/978-3-662-05088-0; THOMA F, 1979, J CELL BIOL, V83, P403, DOI 10.1083/jcb.83.2.403; Toth K, 2013, CYTOM PART A, V83, P839, DOI 10.1002/cyto.a.22320; Tremethick DJ, 2007, CELL, V128, P651, DOI 10.1016/j.cell.2007.02.008; Vergani L, 2002, PROTEIN EXPRES PURIF, V24, P420, DOI 10.1006/prep.2001.1601; Wacker DA, 2007, MOL CELL BIOL, V27, P7475, DOI 10.1128/MCB.01314-07; Wang H, 2004, BIOPHYS J, V87, P1964, DOI 10.1529/biophysj.104.042606; Wang HD, 2002, BIOPHYS J, V83, P3619, DOI 10.1016/S0006-3495(02)75362-9; Wei SJ, 2015, NUCLEIC ACIDS RES, V43, pE111, DOI 10.1093/nar/gkv549; Wenner JR, 2002, BIOPHYS J, V82, P3160, DOI 10.1016/S0006-3495(02)75658-0; WIDOM J, 1986, J MOL BIOL, V190, P411, DOI 10.1016/0022-2836(86)90012-4; WIDOM J, 1992, P NATL ACAD SCI USA, V89, P1095, DOI 10.1073/pnas.89.3.1095; Wu CY, 2016, FEBS LETT, V590, P935, DOI 10.1002/1873-3468.12128; Zhu P, 2016, CURR OPIN STRUC BIOL, V36, P106, DOI 10.1016/j.sbi.2016.01.013	69	5	5	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 15	2017	12	3							e0173459	10.1371/journal.pone.0173459	http://dx.doi.org/10.1371/journal.pone.0173459			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN9HQ	28296908	Green Submitted, Green Published, gold			2022-12-27	WOS:000396311700038
J	Woods, AL; Garvican-Lewis, LA; Lundy, B; Rice, AJ; Thompson, KG				Woods, Amy L.; Garvican-Lewis, Laura A.; Lundy, Bronwen; Rice, Anthony J.; Thompson, Kevin G.			New approaches to determine fatigue in elite athletes during intensified training: Resting metabolic rate and pacing profile	PLOS ONE			English	Article							INDIRECT CALORIMETRY; ENERGY HOMEOSTASIS; BODY-COMPOSITION; CONSENSUS STATEMENT; PHYSICAL-ACTIVITY; EXERCISE; STRESS; LEPTIN; EXPENDITURE; RESISTANCE	Background Elite rowers complete a high volume of training across a number of modalities to prepare for competition, including periods of intensified load, which may lead to fatigue and short-term performance decrements. As yet, the influence of substantial fatigue on resting metabolic rate (RMR) and exercise regulation (pacing), and their subsequent utility as monitoring parameters, has not been explicitly investigated in elite endurance athletes. Method Ten National-level rowers completed a four-week period of intensified training. RMR, body composition and energy intake were assessed PRE and POST the four-week period using indirect calorimetry, Dual-Energy X-Ray Densitometry (DXA), and three-day food diary, respectively. On-water rowing performance and pacing strategy was evaluated from 5 km time trials. Wellness was assessed weekly using the Multicomponent Training Distress Scale (MTDS). Results Significant decreases in absolute (mean +/- SD of difference, p-value: -466 +/- 488 kj.day(-1), p = 0.01) and relative RMR (-8.0 +/- 8.1 klkg.FFM-1, p = 0.01) were observed. Significant reductions in body mass (-1.6 +/- 1.3 kg, p = 0.003) and fat mass (-2.2 +/- 1.2 kg, p = 0.0001) were detected, while energy intake was unchanged. On -water 5 km rowing performance worsened (p < 0.05) and an altered pacing strategy was evident. Fatigue and total mood disturbance significantly increased across the cycle (p < 0.05), and trends were observed for reduced vigour and increased sleep disturbance (p < 0.1). Conclusion Four weeks of heavy training decreased RMR and body composition variables in elite rowers and induced substantial fatigue, likely related to an imbalance between energy intake and output. This study demonstrates that highly experienced athletes do not necessarily select the correct energy intake during periods of intensified training, and this can be assessed by reductions in RMR and body composition. The shortfall in energy availability likely affected recovery from training and altered 5 km time trial pacing strategy, resulting in reduced performance.	[Woods, Amy L.; Garvican-Lewis, Laura A.; Thompson, Kevin G.] Univ Canberra, Res Inst Sport & Exercise, Bruce, ACT, Australia; [Woods, Amy L.; Garvican-Lewis, Laura A.; Lundy, Bronwen; Rice, Anthony J.] Australian Inst Sport, Bruce, ACT, Australia; [Garvican-Lewis, Laura A.] Australian Catholic Univ, Mary Mackillop Inst Hlth Res, Melbourne, Vic, Australia	University of Canberra; Australian Institute of Sport; Australian Catholic University	Woods, AL (corresponding author), Univ Canberra, Res Inst Sport & Exercise, Bruce, ACT, Australia.; Woods, AL (corresponding author), Australian Inst Sport, Bruce, ACT, Australia.	u3095542@uni.canberra.edu.au		Thompson, Kevin/0000-0003-3985-1622				Akbulut G, 2012, TURK FIZ TIP REHAB D, V58, P1, DOI 10.4274/tftr.88156; Amann M, 2008, J PHYSIOL-LONDON, V586, P161, DOI 10.1113/jphysiol.2007.141838; [Anonymous], J SPORTS SCI; [Anonymous], OVERTRAINING SPORT; BINGHAM SA, 1989, BRIT J NUTR, V61, P155, DOI 10.1079/BJN19890106; BORG G, 1970, Scandinavian Journal of Rehabilitation Medicine, V2, P92; BROEDER CE, 1992, AM J CLIN NUTR, V55, P802, DOI 10.1093/ajcn/55.4.802; Compher C, 2006, J AM DIET ASSOC, V106, P881, DOI 10.1016/j.jada.2006.02.009; Crouter SE, 2006, EUR J APPL PHYSIOL, V98, P139, DOI 10.1007/s00421-006-0255-0; de Koning JJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0015863; Desgorces FD, 2004, EUR J APPL PHYSIOL, V91, P677, DOI 10.1007/s00421-003-1030-0; Dolezal BA, 2000, MED SCI SPORT EXER, V32, P1202, DOI 10.1097/00005768-200007000-00003; Donahoo WT, 2004, CURR OPIN CLIN NUTR, V7, P599, DOI 10.1097/00075197-200411000-00003; Drenowatz C, 2013, EUR J SPORT SCI, V13, P422, DOI 10.1080/17461391.2011.635707; Garland SW, 2005, BRIT J SPORT MED, V39, P39, DOI 10.1136/bjsm.2003.010801; Gibson AS, 2004, BRIT J SPORT MED, V38, P797, DOI 10.1136/bjsm.2003.009852; Gleeson M, 2000, INT J SPORTS MED, V21, pS44, DOI 10.1055/s-2000-1451; Halson Shona L, 2014, Sports Med, V44 Suppl 2, pS139, DOI 10.1007/s40279-014-0253-z; Halson SL, 2004, SPORTS MED, V34, P967, DOI 10.2165/00007256-200434140-00003; Haugen HA, 2007, NUTR CLIN PRACT, V22, P377, DOI 10.1177/0115426507022004377; Henry CJK, 2003, BRIT J NUTR, V89, P811, DOI 10.1079/BJN2003839; Ihle R, 2004, J BONE MINER RES, V19, P1231, DOI 10.1359/JBMR.040410; Joy Elizabeth A, 2005, Curr Sports Med Rep, V4, P323; Jurimae J, 2011, METABOLISM, V60, P335, DOI 10.1016/j.metabol.2010.02.009; Jurimae J, 2004, J SCI MED SPORT, V7, P335, DOI 10.1016/S1440-2440(04)80028-8; Jurimae J, 2003, EUR J APPL PHYSIOL, V90, P533, DOI 10.1007/s00421-003-0879-2; Kelly B, 2013, EUR J APPL PHYSIOL, V113, P3039, DOI 10.1007/s00421-013-2741-5; Kentta G, 2006, EUR J SPORT SCI, V6, P245, DOI 10.1080/17461390601012652; Laforgia J, 2006, J SPORT SCI, V24, P1247, DOI 10.1080/02640410600552064; LaForgia J, 1999, EUR J CLIN NUTR, V53, P126, DOI 10.1038/sj.ejcn.1600689; Lee MG, 2009, MED SCI SPORT EXER, V41, P1444, DOI 10.1249/MSS.0b013e31819bd617; LENNON D, 1985, INT J OBESITY, V9, P39; Maestu J, 2005, SPORTS MED, V35, P597; Main L, 2009, EUR J SPORT SCI, V9, P195, DOI 10.1080/17461390902818260; Matarese LE, 1997, J AM DIET ASSOC, V97, pS154, DOI 10.1016/S0002-8223(97)00754-2; McMurray RG, 2005, SPORTS MED, V35, P393, DOI 10.2165/00007256-200535050-00003; Meeusen R, 2013, MED SCI SPORT EXER, V45, P186, DOI 10.1249/MSS.0b013e318279a10a; Melin A, 2015, SCAND J MED SCI SPOR, V25, P610, DOI 10.1111/sms.12261; Meuret J., 2007, PAPER 2461; Mountjoy M, 2014, BRIT J SPORT MED, V48, P491, DOI 10.1136/bjsports-2014-093502; POEHLMAN ET, 1989, MED SCI SPORT EXER, V21, P515; Popovic V, 2005, HORM METAB RES, V37, P533, DOI 10.1055/s-2005-870418; Potteiger JA, 2008, INT J SPORT NUTR EXE, V18, P79, DOI 10.1123/ijsnem.18.1.79; Ramson R, 2008, EUR J APPL PHYSIOL, V104, P839, DOI 10.1007/s00421-008-0839-y; Rauch HGL, 2005, BRIT J SPORT MED, V39, P34, DOI 10.1136/bjsm.2003.010645; Renfree A, 2014, SPORTS MED, V44, P147, DOI 10.1007/s40279-013-0107-0; Saris WHM, 2001, CAN J APPL PHYSIOL, V26, pS167, DOI 10.1139/h2001-051; Speakman JR, 2003, P NUTR SOC, V62, P621, DOI 10.1079/PNS2003282; Tenforde AS, 2016, SPORTS MED, V46, P171, DOI 10.1007/s40279-015-0411-y; Thompson KG, 2015, PACING INDIVIDUAL ST; Tran J, 2015, J SPORT SCI, V33, P268, DOI 10.1080/02640414.2014.942686; Ulmer HV, 1996, EXPERIENTIA, V52, P416, DOI 10.1007/BF01919309; Vogler Andrew J, 2010, Int J Sports Physiol Perform, V5, P342; WESTERTERP KR, 1994, EUR J APPL PHYSIOL O, V69, P203, DOI 10.1007/BF01094789; Woods A, 2016, INTERNATIONAL JOURNA; Woods AL, 2016, INT J SPORT NUTR EXE, V26, P454, DOI 10.1123/ijsnem.2015-0315	56	44	44	0	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 15	2017	12	3							e0173807	10.1371/journal.pone.0173807	http://dx.doi.org/10.1371/journal.pone.0173807			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN9HQ	28296943	gold, Green Published, Green Submitted			2022-12-27	WOS:000396311700066
J	Heuser, F; Schulz, C; Saglam, M; Ramaioli, C; Heuberger, M; Wagner, KJ; Jahn, K; Schneider, E; Brandt, T; Glasauer, S; Lehnen, N				Heuser, Fabian; Schulz, Christian; Saglam, Murat; Ramaioli, Cecilia; Heuberger, Maria; Wagner, Klaus J.; Jahn, Klaus; Schneider, Erich; Brandt, Thomas; Glasauer, Stefan; Lehnen, Nadine			Preventing opioid-induced nausea and vomiting: Rest your head and close your eyes?	PLOS ONE			English	Article							POSTOPERATIVE NAUSEA; MOTION SICKNESS; MECHANISMS; RECEPTORS	Although opioid-induced nausea and vomiting (OINV) is common and debilitating, its mechanism is still unclear. Recently, we suggested that opioids affect semicircular canal function and that this leads to a mismatch between canal input and other sensory information during head motion, which triggers OINV. Here, we assess if visual input is relevant for this mismatch. In a randomized-controlled crossover study 14 healthy men (26.9 +/- 3.4 years, mean +/- SD) were tested twice, once blindfolded and once with eyes open, with at least one-day washout. The opioid remifentanil was administered intravenously (0.15 mu g/kg/min) for 60 minutes. After a thirty-minutes resting period, subjects' head and trunk were passively moved. Nausea was rated before remifentanil start (T-0), before the movement intervention (T-30) and after 60 minutes (T-60) of administration. At rest (T-0, T-30), median nausea ratings were zero whether subjects were blindfolded or not. Movement triggered nausea independently of visual input (nausea rating 1.5/3.0 (median/interquartile range) in the blindfolded, 2.5/6 in the eyes-open condition, chi(2) (1) = 1.3, p = 0.25). As movement exacerbates OINV independently of visual input, a clash between visual and semicircular canal information is not the relevant trigger for OINV. To prevent OINV, emphasis should be put on head-rest, eye-closure is less important.	[Heuser, Fabian; Schulz, Christian; Wagner, Klaus J.] Tech Univ Munich, Klinikum Rechts Isar, Dept Anaesthesiol, Munich, Germany; [Saglam, Murat; Ramaioli, Cecilia; Heuberger, Maria; Jahn, Klaus; Brandt, Thomas; Glasauer, Stefan; Lehnen, Nadine] Klinikum Univ Munchen, German Ctr Vertigo & Balance Disorders, Munich, Germany; [Heuberger, Maria; Glasauer, Stefan; Lehnen, Nadine] Klinikum Univ Munchen, Dept Neurol, Munich, Germany; [Jahn, Klaus] Schon Klin, Bad Aibling, Germany; [Schneider, Erich] Brandenburg Tech Univ Cottbus, Cottbus Senftenberg, Germany; [Brandt, Thomas] Klinikum Univ Munchen, Inst Clin Neurosci, Munich, Germany; [Lehnen, Nadine] Tech Univ Munich, Klinikum Rechts Isar, Dept Psychosomat Med & Psychotherapy, Munich, Germany	Technical University of Munich; University of Munich; University of Munich; Brandenburg University of Technology Cottbus; University of Munich; Technical University of Munich	Ramaioli, C (corresponding author), Klinikum Univ Munchen, German Ctr Vertigo & Balance Disorders, Munich, Germany.	cecilia.ramaioli@lrz.uni-muenchen.de	Glasauer, Stefan/A-5898-2008; Jahn, Klaus/AAC-4969-2021; Jahn, Klaus/F-9902-2010; Heuberger, Manfred P/D-1582-2012; Saglam, Murat/L-3123-2014	Glasauer, Stefan/0000-0002-4313-6210; Jahn, Klaus/0000-0002-1669-3652; Saglam, Murat/0000-0001-8766-3883	German Federal Ministry of Education and Research [01 E0 0901, 01 E0 0914]; Schon Klinik Bad Aibling	German Federal Ministry of Education and Research(Federal Ministry of Education & Research (BMBF)); Schon Klinik Bad Aibling	This work was supported by the German Federal Ministry of Education and Research (Grants 01 E0 0901 and 01 E0 0914). The funder "Schon Klinik Bad Aibling" provided support in the form of salaries for author KJ, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of this author are articulated in the 'author contributions' section.	Apfel CC, 1999, ANESTHESIOLOGY, V91, P693, DOI 10.1097/00000542-199909000-00022; Bertolini G, 2016, FRONT NEUROL, V7, DOI 10.3389/fneur.2016.00014; CARPENTER DO, 1992, ANN NY ACAD SCI, V656, P668, DOI 10.1111/j.1749-6632.1992.tb25244.x; Gan TJ, 2002, JAMA-J AM MED ASSOC, V287, P1233, DOI 10.1001/jama.287.10.1233; Golding JF, 1998, BRAIN RES BULL, V47, P507, DOI 10.1016/S0361-9230(98)00091-4; Habib AS, 2006, CURR MED RES OPIN, V22, P1093, DOI 10.1185/030079906X104830; Heuser F, 2016, BMC ANESTHESIOL, V16, DOI 10.1186/s12871-016-0263-5; Ishiyama A, 2001, ADDICTION, V96, P1363; Lehnen N, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0135263; Myles PS, 2000, BRIT J ANAESTH, V84, P6, DOI 10.1093/oxfordjournals.bja.a013383; Popper P, 2004, NEUROSCIENCE, V129, P225, DOI 10.1016/j.neuroscience.2004.08.008; Porreca F, 2009, PAIN MED, V10, P654, DOI 10.1111/j.1526-4637.2009.00583.x; Ramaioli C, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0110322; Rottach KG, 2002, J NEUROL, V249, P1200, DOI 10.1007/s00415-002-0806-1; RUBIN A, 1950, J CLIN INVEST, V29, P1261, DOI 10.1172/JCI102363; Thornton WE, 2013, AVIAT SPACE ENVIR MD, V84, P716, DOI 10.3357/ASEM.3449.2013	16	1	1	1	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 14	2017	12	3							e0173925	10.1371/journal.pone.0173925	http://dx.doi.org/10.1371/journal.pone.0173925			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN6DM	28291842	Green Published, gold, Green Submitted			2022-12-27	WOS:000396094700050
J	Song, YN; Dong, S; Wei, B; Liu, P; Zhang, YY; Su, SB				Song, Ya-Nan; Dong, Shu; Wei, Bin; Liu, Ping; Zhang, Yong-Yu; Su, Shi-Bing			Metabolomic mechanisms of gypenoside against liver fibrosis in rats: An integrative analysis of proteomics and metabolomics data	PLOS ONE			English	Article							AMINO-ACID; ALDEHYDE DEHYDROGENASES; CARBON-TETRACHLORIDE; ENERGY-METABOLISM; GLYCOLYSIS; DISEASE; FIBROGENESIS; ACTIVATION; PROFILES; PATHWAY	Aims To investigate mechanisms and altered pathways of gypenoside against carbon tetrachloride (CCl4)-induced liver fibrosis based on integrative analysis of proteomics and metabolomics data. Methods CCl4-induced liver fibrosis rats were administrated gypenoside. The anti-fibrosis effects were evaluated by histomorphology and liver hydroxyproline (Hyp) content. Protein profiling and metabolite profiling of rats liver tissues were examined by isobaric tags for relative and absolute quantitation (iTRAQ) approach and gas chromatography-mass spectrometer (GCMS) technology. Altered pathways and pivotal proteins and metabolites were searched by integrative analysis of proteomics and metabolomics data. The levels of some key proteins in altered pathways were determined by western blot. Results Histopathological changes and Hyp content in gypenoside group had significant improvements (P<0.05). Compared to liver fibrosis model group, we found 301 up-regulated and 296 down-regulated proteins, and 9 up-regulated and 8 down-regulated metabolites in gypenoside group. According to integrative analysis, some important pathways were found, including glycolysis or gluconeogenesis, fructose and mannose metabolism, glycine, serine and threonine metabolism, lysine degradation, arginine and proline metabolism, glutathione metabolism, and sulfur metabolism. Furthermore, the levels of ALDH1B1, ALDH2 and ALDH7A1 were found increased and restored to normal levels after gypenoside treated (P<0.05). Conclusions Gypenoside inhibited CCl4-induced liver fibrosis, which may be involved in the alteration of glycolysis metabolism and the protection against the damage of aldehydes and lipid peroxidation by up-regulating ALDH.	[Song, Ya-Nan; Dong, Shu; Wei, Bin; Su, Shi-Bing] Shanghai Univ Tradit Chinese Med, Res Ctr Tradit Chinese Med Complex Syst, Shanghai, Peoples R China; [Liu, Ping] Shanghai Univ Tradit Chinese Med, Shanghai Municipal Educ Commiss, E Inst Tradit Chinese Internal Med, Shanghai, Peoples R China; [Zhang, Yong-Yu] Shanghai Univ Tradit Chinese Med, Res Ctr Tradit Chinese Med & Syst Biol, Shanghai, Peoples R China	Shanghai University of Traditional Chinese Medicine; Shanghai Municipal Education Commission (SHMEC); Shanghai University of Traditional Chinese Medicine; Shanghai University of Traditional Chinese Medicine	Su, SB (corresponding author), Shanghai Univ Tradit Chinese Med, Res Ctr Tradit Chinese Med & Syst Biol, Shanghai, Peoples R China.	dryyz@sina.com; shibingsu07@163.com			Key Program of National Natural Science Foundation of China [81330084]; National Science and Technology Major Project of China [2009ZX09311-003]; E-institutes of Shanghai Municipal Education Commission [E03008]	Key Program of National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Science and Technology Major Project of China; E-institutes of Shanghai Municipal Education Commission	This work was supported by Key Program of National Natural Science Foundation of China (81330084), National Science and Technology Major Project of China (2009ZX09311-003), and E-institutes of Shanghai Municipal Education Commission (E03008).	Arthur MJP, 2000, AM J PHYSIOL-GASTR L, V279, pG245; Bataller R, 2005, J CLIN INVEST, V115, P209, DOI 10.1172/JCI200524282; Cao W, 2015, TOXICOL LETT, V232, P233, DOI 10.1016/j.toxlet.2014.11.009; Chen JC, 2000, AM J CHINESE MED, V28, P175, DOI 10.1142/S0192415X00000222; Dong S, 2016, J TOXICOL SCI, V41, P561, DOI 10.2131/jts.41.561; Fang HL, 2008, CLIN NUTR, V27, P900, DOI 10.1016/j.clnu.2008.08.004; Friedman SL, 2008, GASTROENTEROLOGY, V134, P1655, DOI 10.1053/j.gastro.2008.03.003; Gohil VM, 2010, NAT BIOTECHNOL, V28, P249, DOI 10.1038/nbt.1606; Holecek M, 2015, NUTRITION, V31, P14, DOI 10.1016/j.nut.2014.03.016; Hu YY, 1997, CHINESE J INTEGRATED, V7, P87; Hu YY, 1997, CHINESE J INTEGRATED, V7, P92; Huang THW, 2006, J BIOMED SCI, V13, P535, DOI 10.1007/s11373-006-9076-8; JAMALL IS, 1981, ANAL BIOCHEM, V112, P70, DOI 10.1016/0003-2697(81)90261-X; Jeong DW, 2004, BIOCHEM BIOPH RES CO, V313, P984, DOI 10.1016/j.bbrc.2003.12.033; Jiang Y, 2014, J ETHNOPHARMACOL, V158, P230, DOI 10.1016/j.jep.2014.10.028; Karthikeyan S, 2015, BIOCHEMICAL AND BIOP; Lake AD, 2015, AMINO ACIDS, V47, P603, DOI 10.1007/s00726-014-1894-9; Meierhofer D, 2014, J PROTEOME RES; Muzio G, 2012, FREE RADICAL BIO MED, V52, P735, DOI 10.1016/j.freeradbiomed.2011.11.033; Nishikawa T, 2014, J HEPATOL, V60, P1203, DOI 10.1016/j.jhep.2014.02.014; Qin RA, 2012, ARCH PHARM RES, V35, P1241, DOI 10.1007/s12272-012-0715-5; Ruan Z, 2014, AMINO ACIDS, V46, P2219, DOI 10.1007/s00726-014-1762-7; Singh S, 2013, FREE RADICAL BIO MED, V56, P89, DOI 10.1016/j.freeradbiomed.2012.11.010; Song YN, 2012, EVID-BASED COMPL ALT, V2012, DOI 10.1155/2012/626320; Song YN, 2015, PROTEOMICS CLINICAL; Su SL, 2015, SCI REP-UK, V5, DOI 10.1038/srep13668; Vellaichamy A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010936; Vellaichamy A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007075; Wang XJ, 2013, MOL CELL PROTEOMICS, V12, P1226, DOI 10.1074/mcp.M112.021683; Zhang FT, 2015, SCI REP-UK, V5, DOI 10.1038/srep10298; Zhao J, 2014, EXP THER MED, V7, P1388, DOI 10.3892/etm.2014.1569	31	31	33	1	41	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 14	2017	12	3							e0173598	10.1371/journal.pone.0173598	http://dx.doi.org/10.1371/journal.pone.0173598			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN6DM	28291813	Green Published, Green Submitted, gold			2022-12-27	WOS:000396094700033
J	Egashira, A; Morita, M; Kumagai, R; Taguchi, K; Ueda, M; Yamaguchi, S; Yamamoto, M; Minami, K; Ikeda, Y; Toh, Y				Egashira, Akinori; Morita, Masaru; Kumagai, Reiko; Taguchi, Ken-ichi; Ueda, Masanobu; Yamaguchi, Shohei; Yamamoto, Manabu; Minami, Kazuhito; Ikeda, Yasuharu; Toh, Yasushi			Neuroendocrine carcinoma of the esophagus: Clinicopathological and immunohistochemical features of 14 cases	PLOS ONE			English	Article							SMALL-CELL CARCINOMA; CANCER; PDGFRA; KIT; P53	Background Neuroendocrine carcinoma (NEC) of the esophagus is a rare and highly aggressive disease but the biological features are poorly understood. The objective of this study was to analyze the clinicopathological and immunohistochemical features of NEC of the esophagus. Methods Fourteen patients diagnosed with NEC of the esophagus from 1998 to 2013 were included in this study. Clinicopathologic features, therapeutic outcomes and immunohistochemical results were analyzed. Results Eleven out of 14 cases showed protruding or localized type with or without ulceration. Only three patients were negative for both lymph node and organ metastasis and seven cases were positive for metastases to distant organs and/or distant lymph nodes. Of the six patients with limited disease (LD), three patients were treated by surgery. Three patients with LD and seven patients with extensive disease (ED) were initially treated with chemotherapy, except for one who underwent concurrent chemo-radiotherapy due to passage disturbance. The median survival of patients with LD was 8.5 months, whereas that of patients with LD was 17 months. Among the 14 cases, 12 cases (83.3%), 13 cases (91.7%) and 12 cases (83.3%) showed positive immunostaining for choromogranin A, synaptophysin and CD56, respectively. Nine of 14 cases (64.2%) presented positive staining for c-kit and most (8/9, 88%) simultaneously showed p53 protein abnormality. Two cases were negative for c-kit and p53, and positive for CK20. Conclusion Consistent with previous reports, the prognosis of NEC of esophagus is dismal. From the results of immunohistochemical study, NEC of esophagus might be divided into two categories due to the staining positivity of c-kit and p53. This study provides new insight into the biology of NEC of the esophagus.	[Egashira, Akinori; Morita, Masaru; Yamaguchi, Shohei; Yamamoto, Manabu; Minami, Kazuhito; Ikeda, Yasuharu; Toh, Yasushi] Kyushu Natl Canc Ctr, Dept Surg Gastroenterol, Fukuoka, Japan; [Kumagai, Reiko; Taguchi, Ken-ichi] Kyushu Natl Canc Ctr, Dept Canc Pathol, Fukuoka, Japan; [Ueda, Masanobu] Kyushu Natl Canc Ctr, Dept Radiol, Fukuoka, Japan; [Egashira, Akinori] Natl Kyushu Med Ctr, Dept Surg Gastroenterol, Fukuoka, Japan		Egashira, A (corresponding author), Kyushu Natl Canc Ctr, Dept Surg Gastroenterol, Fukuoka, Japan.; Egashira, A (corresponding author), Natl Kyushu Med Ctr, Dept Surg Gastroenterol, Fukuoka, Japan.	egashira.a@kyumed.jp			Ministry of Education, Culture, Sports, Science and Technology of Japan [15K10126]; Grants-in-Aid for Scientific Research [15K10125, 15K10126] Funding Source: KAKEN	Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was financially supported by the Grants-in-Aid for Scientific Research from the Ministry of Education, Culture, Sports, Science and Technology of Japan (15K10126). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Asayama M, 2011, CANCER CHEMOTH PHARM, V68, P1325, DOI 10.1007/s00280-011-1619-7; Egashira A, 2011, J SURG ONCOL, V104, P169, DOI 10.1002/jso.21920; Harmse JL, 1999, J PATHOL, V189, P176, DOI 10.1002/(SICI)1096-9896(199910)189:2<176::AID-PATH416>3.0.CO;2-U; Hou X, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069259; Huang Q, 2013, AM J SURG PATHOL, V37, P467, DOI 10.1097/PAS.0b013e31826d2639; Kukar M, 2013, ANN SURG ONCOL; MCKEOWN F, 1952, J PATHOL BACTERIOL, V64, P889, DOI 10.1002/path.1700640420; Micke P, 2002, LUNG CANCER, V37, P271, DOI 10.1016/S0169-5002(02)00072-7; Onuki N, 1999, CANCER, V85, P600, DOI 10.1002/(SICI)1097-0142(19990201)85:3<600::AID-CNCR10>3.0.CO;2-W; Rice TW, 2009, ESOPHAGUS ESOPHAGAST; Sadanaga N, 2009, ESOPHAGUS-TOKYO, V6, P161, DOI 10.1007/s10388-009-0197-9; Schmid M, 1997, VIRCHOWS ARCH, V430, P233, DOI 10.1007/BF01324807; Situ DR, 2013, ANN THORAC SURG, V95, P1057, DOI 10.1016/j.athoracsur.2012.11.014; Tanaka T, 2010, DIS ESOPHAGUS, V23, P502, DOI 10.1111/j.1442-2050.2009.01045.x; Terada T, 2013, INT J CLIN EXP PATHO, V6, P485; Terada T, 2011, INT J CLIN EXP PATHO, V4, P718; Theise ND, 2010, NEUROENDOCRINE NEOPL; U.I.U.A. Cancer, 2009, TNM CLASSIFICATION M; Yun JP, 2007, BMC CANCER, V7, DOI 10.1186/1471-2407-7-38	19	31	35	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 13	2017	12	3							e0173501	10.1371/journal.pone.0173501	http://dx.doi.org/10.1371/journal.pone.0173501			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN6CP	28288180	Green Published, gold, Green Submitted			2022-12-27	WOS:000396092400017
J	Karajamaki, AJ; Kettunen, O; Lepojarvi, S; Koivurova, OP; Kesaniemi, YA; Huikuri, H; Ukkola, O				Karajamaki, Aki Juhani; Kettunen, Olli; Lepojarvi, Samuli; Koivurova, Olli-Pekka; Kesaniemi, Y. Antero; Huikuri, Heikki; Ukkola, Olavi			Presence of atrial fibrillation is associated with liver stiffness in an elderly Finnish population	PLOS ONE			English	Article							NONALCOHOLIC FATTY LIVER; OXIDATIVE STRESS; FIBROSIS; INFLAMMATION; DISEASE; ACTIVATION; GALECTIN-3; HYPERCOAGULABILITY; MECHANISMS; NAFLD	Background Chronic liver injury from different etiologies drives liver fibrosis. However, little is known about the associated factors, systemic factors in particular. Recently, non-alcoholic fatty liver disease (NAFLD) and atrial fibrillation have been shown to be associated with each other. Thereby, we aimed to study the association between atrial fibrillation and liver stiffness. Study Extensive clinical measurements including echocardiography of the heart, transient elastography (TE) of the liver and the presence of atrial fibrillation were determined in elderly Finnish study subjects (n = 76, mean age 73 years) from OPERA (Oulu Project Elucidating the Risk of Atherosclerosis) study cohort. Half of the study subjects had non-alcoholic fatty liver disease, whereas others did not have any known hepatic morbidity. The present study was cross-sectional by nature. Results The subjects with atrial fibrillation had higher TE values (with atrial fibrillation TE = 9.3kPa, without atrial fibrillation TE = 6.3kPa, p = 0.018). When the cohort was divided to four subgroups (those without NAFLD or atrial fibrillation, with NAFLD but without atrial fibrillation, with both conditions, and with atrial fibrillation but without NAFLD), the TE value was the highest in the subjects with both conditions (5.3kPa, 7.4kPa, 10.8kPa and 7.8kPa, respectively, p = 0.019). Moreover, the higher the TE value, the more prevalent atrial fibrillation was (the atrial fibrillation prevalence by tertiles of TE 27% / 36% / 77%, p = 0.001). Likewise, the greater the TE value, the greater the left atrial diameter, a collateral of atrial fibrillation (left atrial diameters by tertiles of TE 39mm / 45mm / 48mm, p<0.001) was. All these p-values for continuous variables remained statistically significant even after adjustment for common clinically relevant risk factors. Conclusions There is an association between atrial fibrillation and liver stiffness. This novel association may have multiple explanations and mechanistic links, which are discussed here and need further studies, prospective studies in particular.	[Karajamaki, Aki Juhani; Lepojarvi, Samuli; Koivurova, Olli-Pekka; Kesaniemi, Y. Antero; Huikuri, Heikki; Ukkola, Olavi] Oulu Univ Hosp, Res Unit Internal Med, Med Res Ctr Oulu, Oulu, Finland; [Karajamaki, Aki Juhani; Lepojarvi, Samuli; Koivurova, Olli-Pekka; Kesaniemi, Y. Antero; Huikuri, Heikki; Ukkola, Olavi] Univ Oulu, Oulu, Finland; [Karajamaki, Aki Juhani; Kettunen, Olli; Koivurova, Olli-Pekka] Oulu Univ Hosp, Dept Internal Med, Abdominal Ctr, Oulu, Finland	University of Oulu; University of Oulu; University of Oulu	Karajamaki, AJ (corresponding author), Oulu Univ Hosp, Res Unit Internal Med, Med Res Ctr Oulu, Oulu, Finland.; Karajamaki, AJ (corresponding author), Univ Oulu, Oulu, Finland.; Karajamaki, AJ (corresponding author), Oulu Univ Hosp, Dept Internal Med, Abdominal Ctr, Oulu, Finland.	aki.karajamaki@vshp.fi			Medical Association of Vaasa, Vaasa, Finland; Finnish Foundation for Cardiovascular Research	Medical Association of Vaasa, Vaasa, Finland; Finnish Foundation for Cardiovascular Research	AJK was granted from the Medical Association of Vaasa, Vaasa, Finland. The study was funded by the Finnish Foundation for Cardiovascular Research.	Alonso A, 2009, AM HEART J, V158, P111, DOI 10.1016/j.ahj.2009.05.010; Angulo P, 2007, HEPATOLOGY, V45, P846, DOI 10.1002/hep.21496; Anstee QM, 2008, J THROMB HAEMOST, V6, P1336, DOI 10.1111/j.1538-7836.2008.03015.x; Anstee QM, 2011, CLIN RES HEPATOL GAS, V35, P526, DOI 10.1016/j.clinre.2011.03.011; Atta HM, 2015, WORLD J GASTROENTERO, V21, P5138, DOI 10.3748/wjg.v21.i17.5138; Bacigalupo ML, 2013, WORLD J GASTROENTERO, V19, P8831, DOI 10.3748/wjg.v19.i47.8831; Ballestri S, 2015, EXPERT REV GASTROENT, V9, P603, DOI 10.1586/17474124.2015.1007955; Buzzetti E, 2016, METABOLISM, V65, P1038, DOI 10.1016/j.metabol.2015.12.012; Czaja AJ, 2014, WORLD J GASTROENTERO, V20, P2515, DOI 10.3748/wjg.v20.i10.2515; EASL, 2016, DIABETOLOGIA, V59, P1121, DOI 10.1007/s00125-016-3902-y; Ekstedt M, 2015, HEPATOLOGY, V61, P1547, DOI 10.1002/hep.27368; Friedman SL, 2008, GASTROENTEROLOGY, V134, P1655, DOI 10.1053/j.gastro.2008.03.003; Friedrich-Rust M, 2008, GASTROENTEROLOGY, V134, P960, DOI 10.1053/j.gastro.2008.01.034; Fu RB, 2011, EUROPACE, V13, P31, DOI 10.1093/europace/euq346; Gonzalez-Reimers E, 2016, WORLD J GASTROENTERO, V22, P4427, DOI 10.3748/wjg.v22.i18.4427; Guo YT, 2012, J AM COLL CARDIOL, V60, P2263, DOI 10.1016/j.jacc.2012.04.063; Gurses KM, 2015, AM J CARDIOL, V115, P647, DOI 10.1016/j.amjcard.2014.12.021; Henderson NC, 2006, P NATL ACAD SCI USA, V103, P5060, DOI 10.1073/pnas.0511167103; HILL AB, 1965, P ROY SOC MED, V58, P295, DOI 10.1177/003591576505800503; Ho JE, 2014, AM HEART J, V167, P729, DOI 10.1016/j.ahj.2014.02.009; Iredale JP, 2014, GASTROENTEROLOGY, V146, P1160, DOI 10.1053/j.gastro.2014.03.019; Jensen PN, 2012, PHARMACOEPIDEM DR S, V21, P141, DOI 10.1002/pds.2317; Joseph P, 2016, INT J CARDIOVAS IMAG, V32, P113, DOI 10.1007/s10554-015-0766-z; Kallergis EM, 2008, HEART, V94, P200, DOI 10.1136/hrt.2006.108688; Karajamaki AJ, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0142937; Knight V, 2012, HEPATOLOGY, V55, P879, DOI 10.1002/hep.24784; Koehler EM, 2016, HEPATOLOGY, V63, P138, DOI 10.1002/hep.27981; Kornej J, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0123574; Lang RM, 2015, EUR HEART J-CARD IMG, V16, P233, DOI 10.1093/ehjci/jev014; Lee UE, 2011, BEST PRACT RES CL GA, V25, P195, DOI 10.1016/j.bpg.2011.02.005; Levey AS, 2009, ANN INTERN MED, V150, P604, DOI 10.7326/0003-4819-150-9-200905050-00006; Li LC, 2014, J PHARMACOL EXP THER, V351, P336, DOI 10.1124/jpet.114.218370; Liang S, 2016, FRONT PHYSIOL, V7, DOI 10.3389/fphys.2016.00017; Lip GYH, 2012, LANCET, V379, P648, DOI 10.1016/S0140-6736(11)61514-6; Lippi G, 2015, CLIN BIOCHEM, V48, P818, DOI 10.1016/j.clinbiochem.2015.04.021; Miyasaka Y, 2006, CIRCULATION, V114, P119, DOI 10.1161/CIRCULATIONAHA.105.595140; Nascimbeni F, 2013, J HEPATOL, V59, P859, DOI 10.1016/j.jhep.2013.05.044; Patel P, 2010, J CARDIOVASC ELECTR, V21, P1064, DOI 10.1111/j.1540-8167.2010.01774.x; Pavlov CS, 2015, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD010542.pub2; Petta S, 2011, ALIMENT PHARM THER, V33, P1350, DOI 10.1111/j.1365-2036.2011.04668.x; Rantala AO, 1999, J INTERN MED, V245, P163, DOI 10.1046/j.1365-2796.1999.00429.x; Rullier A, 2008, AM J PHYSIOL-GASTR L, V294, pG226, DOI 10.1152/ajpgi.00444.2007; Sanchez-Valle V, 2012, CURR MED CHEM, V19, P4850, DOI 10.2174/092986712803341520; Singh S, 2015, CLIN GASTROENTEROL H, V13, P643, DOI 10.1016/j.cgh.2014.04.014; Spronk HMH, 2017, EUR HEART J, V38, P38, DOI 10.1093/eurheartj/ehw119; Targher G, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057183; Tripodi A, 2011, J THROMB HAEMOST, V9, P1713, DOI 10.1111/j.1538-7836.2011.04429.x; Watson T, 2009, LANCET, V373, P155, DOI 10.1016/S0140-6736(09)60040-4; Wijesurendra RS, 2015, CARDIOVASC RES, V105, P238, DOI 10.1093/cvr/cvv001; Wong VWS, 2010, HEPATOLOGY, V51, P454, DOI 10.1002/hep.23312; Youn JY, 2013, J MOL CELL CARDIOL, V62, P72, DOI 10.1016/j.yjmcc.2013.04.019; Younossi ZM, 2016, HEPATOLOGY, V64, P73, DOI 10.1002/hep.28431; Zhang J, 2012, FRONT PHYSIOL, V3, DOI 10.3389/fphys.2012.00140	53	13	13	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 13	2017	12	3							e0173855	10.1371/journal.pone.0173855	http://dx.doi.org/10.1371/journal.pone.0173855			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN6CP	28288202	Green Submitted, Green Published, gold			2022-12-27	WOS:000396092400039
J	Shang, Y; Sikorski, J; Bonkowski, M; Fiore-Donno, AM; Kandeler, E; Marhan, S; Boeddinghaus, RS; Solly, EF; Schrumpf, M; Schoning, I; Wubet, T; Buscot, F; Overmann, J				Shang, Yu; Sikorski, Johannes; Bonkowski, Michael; Fiore-Donno, Anna-Maria; Kandeler, Ellen; Marhan, Sven; Boeddinghaus, Runa S.; Solly, Emily F.; Schrumpf, Marion; Schoening, Ingo; Wubet, Tesfaye; Buscot, Francois; Overmann, Joerg			Inferring interactions in complex microbial communities from nucleotide sequence data and environmental parameters	PLOS ONE			English	Article							DIVERSITY; SOIL; BIODIVERSITY; NETWORKS	Interactions occur between two or more organisms affecting each other. Interactions are decisive for the ecology of the organisms. Without direct experimental evidence the analysis of interactions is difficult. Correlation analyses that are based on co-occurrences are often used to approximate interaction. Here, we present a new mathematical model to estimate the interaction strengths between taxa, based on changes in their relative abundances across environmental gradients.	[Shang, Yu; Sikorski, Johannes; Overmann, Joerg] Leibniz Inst DSMZ German Collect Microorganisms &, Inhoffenstr 7B, D-38124 Braunschweig, Germany; [Bonkowski, Michael; Fiore-Donno, Anna-Maria] Univ Cologne, Dept Terr Ecol, Inst Zool, Zulpicher Str 47b, D-50674 Cologne, Germany; [Kandeler, Ellen; Marhan, Sven; Boeddinghaus, Runa S.] Univ Hohenheim, Inst Soil Sci & Land Evaluat, Soil Biol Sect 310b, Emil Wolff Str 27, D-70593 Stuttgart, Germany; [Solly, Emily F.; Schrumpf, Marion; Schoening, Ingo] Max Planck Inst Biogeochem, Hans Knoll Str 10, D-07745 Jena, Germany; [Wubet, Tesfaye; Buscot, Francois] UFZ Helmholtz Ctr Environm Res, Dept Soil Ecol, Theodor Lieser Str 4, D-06120 Halle, Germany; [Sikorski, Johannes; Wubet, Tesfaye; Buscot, Francois; Overmann, Joerg] German Ctr Integrat Biodivers Res IDiv Jena Halle, Deutsch Pl 5e, D-04103 Leipzig, Germany	Leibniz Institut fur Deutsche Sammlung von Mikroorganismen und Zellkulturen (DSMZ); University of Cologne; University Hohenheim; Max Planck Society; Helmholtz Association; Helmholtz Center for Environmental Research (UFZ)	Shang, Y (corresponding author), Leibniz Inst DSMZ German Collect Microorganisms &, Inhoffenstr 7B, D-38124 Braunschweig, Germany.	yus14@dsmz.de	Bonkowski, Michael/C-3700-2013; Schöning, Ingo/D-3341-2009; Schrumpf, Marion/C-1671-2013; Buscot, Francois/A-4125-2016; Sikorski, Johannes/AAD-9775-2019; Sikorski, Johannes/AAX-1960-2020; Wubet, Tesfaye/C-6241-2012	Bonkowski, Michael/0000-0003-2656-1183; Schöning, Ingo/0000-0002-9830-5026; Buscot, Francois/0000-0002-2364-0006; Sikorski, Johannes/0000-0002-1890-5540; Wubet, Tesfaye/0000-0001-8572-4486; Solly, Emily/0000-0002-3157-1805; Schrumpf, Marion/0000-0003-4219-4125; Fiore-Donno, Anna Maria/0000-0001-6265-1907; Kandeler, Ellen/0000-0002-2854-0012	Deutsche Forschungsgemeinschaft (DFG) [OV 20/21-1, OV 20/22-1]	Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG))	The work has been (partly) funded by the Deutsche Forschungsgemeinschaft (DFG) Priority Program 1374 "Infrastructure-Biodiversity-Exploratories" (Grants No. OV 20/21-1, 22-1 http://gepris.dfg.de/gepris/projekt/252263987). J.O. received the funding. Field work permits were issued by the responsible state environmental offices of Baden-Wurttemberg, Thuringen, and Brandenburg (according to 72 BbgNatSchG).	[Anonymous], 2015, BIORXIV; Ban YG, 2015, BIOINFORMATICS, V31, P3322, DOI 10.1093/bioinformatics/btv364; Biswas S, 2015, LECT N BIOINFORMAT, V9029, P32, DOI 10.1007/978-3-319-16706-0_6; Bodelier PLE, 2013, ISME J, V7, P2214, DOI 10.1038/ismej.2013.99; Borcard D, 2011, USE R, P1, DOI 10.1007/978-1-4419-7976-6; Bucci V, 2014, J MOL BIOL, V426, P3907, DOI 10.1016/j.jmb.2014.03.017; Chaffron S, 2010, GENOME RES, V20, P947, DOI 10.1101/gr.104521.109; Coyte KZ, 2015, SCIENCE, V350, P663, DOI 10.1126/science.aad2602; Crowther TW, 2014, GLOBAL CHANGE BIOL, V20, P2983, DOI 10.1111/gcb.12565; Daniel B, 2011, NUMERICAL ECOLOGY R; Draper N.R., 1998, APPL REGRESSION ANAL; Ellis S, 2000, IEE CONF PUBL, P1, DOI 10.1049/cp:20000093; Everitt B. S., 2002, CAMBRIDGE DICT STAT; Fang HY, 2015, BIOINFORMATICS, V31, P3172, DOI 10.1093/bioinformatics/btv349; Faust K, 2012, NAT REV MICROBIOL, V10, P538, DOI 10.1038/nrmicro2832; Fierer N, 2012, P NATL ACAD SCI USA, V109, P21390, DOI 10.1073/pnas.1215210110; Fiore-Donno AM, 2016, SCI REP-UK, V6, DOI 10.1038/srep19068; Fischer M, 2010, BASIC APPL ECOL, V11, P473, DOI 10.1016/j.baae.2010.07.009; Friedman J, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002687; Goldmann K, 2015, FRONT MICROBIOL, V6, DOI 10.3389/fmicb.2015.01300; Golub GH., 2013, MATRIX COMPUTATIONS; Halsey LG, 2015, NAT METHODS, V12, P179, DOI 10.1038/nmeth.3288; Hazewinkel M., 2001, ENCY MATH; Hoppener-Ogawa S, 2009, ISME J, V3, P190, DOI 10.1038/ismej.2008.97; Hortal J, 2015, ANNU REV ECOL EVOL S, V46, P523, DOI 10.1146/annurev-ecolsys-112414-054400; Huber PJ, 2009, WILEY SERIES PROBABI; Ives AR, 2003, ECOL MONOGR, V73, P301, DOI 10.1890/0012-9615(2003)073[0301:ECSAEI]2.0.CO;2; Jansen F, 2013, J VEG SCI, V24, P1108, DOI 10.1111/jvs.12050; Jousset A, 2008, FUNCT ECOL, V22, P714, DOI 10.1111/j.1365-2435.2008.01411.x; Kurtz ZD, 2015, PLOS COMPUT BIOL, V11, DOI 10.1371/journal.pcbi.1004226; Kuzyakov Y, 2015, SOIL BIOL BIOCHEM, V83, P184, DOI 10.1016/j.soilbio.2015.01.025; Levine UY, 2011, ISME J, V5, P1683, DOI 10.1038/ismej.2011.40; Ling LL, 2015, NATURE, V517, P455, DOI 10.1038/nature14098; Lozupone CA, 2007, P NATL ACAD SCI USA, V104, P11436, DOI 10.1073/pnas.0611525104; MERCHUK JC, 1995, BIOTECHNOL BIOENG, V45, P91, DOI 10.1002/bit.260450113; MONOD J, 1949, ANNU REV MICROBIOL, V3, P371, DOI 10.1146/annurev.mi.03.100149.002103; Murray J.D., 2007, INTERDISCIPLINARY AP, V2, P1; Nayfach S, 2016, CELL, V166, P1103, DOI 10.1016/j.cell.2016.08.007; Pankaj M, 2014, PLOS ONE, V9; Pearson K., 1896, P ROY SOC LONDON, V60, P489, DOI DOI 10.1098/RSPL.1896.0076; Power DA, 2015, BIOL DIRECT, V10, DOI 10.1186/s13062-015-0094-1; Regan KM, 2014, SOIL BIOL BIOCHEM, V71, P21, DOI 10.1016/j.soilbio.2013.12.024; Roesch LF, 2007, ISME J, V1, P283, DOI 10.1038/ismej.2007.53; Rossello-Mora R, 2001, FEMS MICROBIOL REV, V25, P39, DOI 10.1016/S0168-6445(00)00040-1; Scherber C, 2010, NATURE, V468, P553, DOI 10.1038/nature09492; Schmidt R, 2015, ISME J, V9, P2329, DOI 10.1038/ismej.2015.42; Solly EF, 2014, PLANT SOIL, V382, P203, DOI 10.1007/s11104-014-2151-4; Stenseth NC, 1997, P NATL ACAD SCI USA, V94, P5147, DOI 10.1073/pnas.94.10.5147; Strickland MS, 2009, ECOLOGY, V90, P441, DOI 10.1890/08-0296.1; Sugihara G, 2012, SCIENCE, V338, P496, DOI 10.1126/science.1227079; Thompson F., 2013, PROKARYOTES PROKARYO, P149, DOI DOI 10.1007/978-3-642-30194-0; Torsvik V, 2002, CURR OPIN MICROBIOL, V5, P240, DOI 10.1016/S1369-5274(02)00324-7; Tveit AT, 2015, P NATL ACAD SCI USA, V112, pE2507, DOI 10.1073/pnas.1420797112; Uroz S, 2010, ENV MICROBIOL REP, V2, P281, DOI 10.1111/j.1758-2229.2009.00117.x; Weiss S, 2016, ISME J, V10, P1669, DOI 10.1038/ismej.2015.235; West SA, 2006, NAT REV MICROBIOL, V4, P597, DOI 10.1038/nrmicro1461; Williams P, 2007, PHILOS T R SOC B, V362, P1119, DOI 10.1098/rstb.2007.2039; Wust PK, 2016, APPL ENVIRON MICROB	59	8	8	1	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 13	2017	12	3							e0173765	10.1371/journal.pone.0173765	http://dx.doi.org/10.1371/journal.pone.0173765			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN6CP	28288199	Green Submitted, gold, Green Published, Green Accepted			2022-12-27	WOS:000396092400037
J	Domsch, K; Acs, A; Obermeier, C; Nguyen, HT; Reim, I				Domsch, Katrin; Acs, Andreas; Obermeier, Claudia; Nguyen, Hanh T.; Reim, Ingolf			Identification of the essential protein domains for Mib2 function during the development of the Drosophila larval musculature and adult flight muscles	PLOS ONE			English	Article							E3 UBIQUITIN LIGASES; MIND BOMB; MYOBLAST FUSION; SOMATIC MUSCULATURE; MELANOGASTER; DELTA; ZEBRAFISH; MORPHOGENESIS; ACTIVATION; MYOGENESIS	The proper differentiation and maintenance of myofibers is fundamental to a functional musculature. Disruption of numerous mostly structural factors leads to perturbations of these processes. Among the limited number of known regulatory factors for these processes is Mind bomb2 (Mib2), a muscle-associated E3 ubiquitin ligase, which was previously established to be required for maintaining the integrity of larval muscles. In this study, we have examined the mechanistic aspects of Mib2 function by performing a detailed functional dissection of the Mib2 protein. We show that the ankyrin repeats, in its entirety, and the hitherto uncharacterized Mib-specific domains (MIB), are important for the major function of Mib2 in skeletal and visceral muscles in the Drosophila embryo. Furthermore, we characterize novel mib2 alleles that have arisen from a forward genetic screen aimed at identifying regulators of myogenesis. Two of these alleles are viable, but flightless hypomorphic mib2 mutants, and harbor missense mutations in the MIB domain and RING finger, respectively. Functional analysis of these new alleles, including in vivo imaging, demonstrates that Mib2 plays an additional important role in the development of adult thorax muscles, particularly in maintaining the larval templates for the dorsal longitudinal indirect flight muscles during metamorphosis.	[Domsch, Katrin; Acs, Andreas; Obermeier, Claudia; Nguyen, Hanh T.; Reim, Ingolf] Friedrich Alexander Univ Erlangen Nurnberg, Dept Biol, Div Dev Biol, Erlangen, Germany; [Domsch, Katrin] Heidelberg Univ, COS Heidelberg, Heidelberg, Germany; [Acs, Andreas] Friedrich Alexander Univ Erlangen Nurnberg, Ctr Mol Med, Div Genet, Erlangen, Germany	University of Erlangen Nuremberg; Ruprecht Karls University Heidelberg; University of Erlangen Nuremberg	Reim, I (corresponding author), Friedrich Alexander Univ Erlangen Nurnberg, Dept Biol, Div Dev Biol, Erlangen, Germany.	ingolf.reim@fau.de	Reim, Ingolf/H-7873-2017	Reim, Ingolf/0000-0001-8069-5532; Domsch, Katrin/0000-0003-1040-4474	Deutsche Forschungemeinschaft [NG 92/1-1, RE 2985/1-1]; Friedrich-Alexander University of Erlangen-Nurnberg; Friedrich-Alexander Universitat Erlangen-Nurnberg (FAU)	Deutsche Forschungemeinschaft(German Research Foundation (DFG)); Friedrich-Alexander University of Erlangen-Nurnberg; Friedrich-Alexander Universitat Erlangen-Nurnberg (FAU)	This research was supported by grants (NG 92/1-1 to HTN and RE 2985/1-1 to IR) from the Deutsche Forschungemeinschaft (www.dfg.de). KD received additional support provided by the "Fakultatsfrauenpreis" from the Friedrich-Alexander University of Erlangen-Nurnberg (www.fau.de). The authors acknowledge support by the Deutsche Forschungsgemeinschaft and Friedrich-Alexander Universitat Erlangen-Nurnberg (FAU) within the funding program Open Access Publishing. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anant S, 1998, DEVELOPMENT, V125, P1361; BAINBRIDGE SP, 1981, J EMBRYOL EXP MORPH, V66, P57; BATE M, 1993, DEV DROSOPHILA METAN, V2, P1013; Bernard F, 2006, DEV BIOL, V295, P164, DOI 10.1016/j.ydbio.2006.03.022; Bloor JW, 2001, DEV BIOL, V239, P215, DOI 10.1006/dbio.2001.0452; Cajanek L, 2015, J CELL SCI, V128, P1674, DOI 10.1242/jcs.166496; Carrasco-Rando M, 2008, DEVELOPMENT, V135, P849, DOI 10.1242/dev.015529; Chen EH, 2001, DEV CELL, V1, P705, DOI 10.1016/S1534-5807(01)00084-3; Chen WB, 2004, DEV BIOL, V267, P361, DOI 10.1016/j.ydbio.2003.11.010; Choe EA, 2007, J NEUROSCI, V27, P9503, DOI 10.1523/JNEUROSCI.1408-07.2007; COSTELLO WJ, 1986, DEV BIOL, V118, P247, DOI 10.1016/0012-1606(86)90092-8; CURRIE DA, 1991, DEVELOPMENT, V113, P91; Daskalaki A, 2011, J CELL BIOL, V195, P1017, DOI 10.1083/jcb.201105166; Dickinson M, 2006, CURR BIOL, V16, pR309, DOI 10.1016/j.cub.2006.03.087; Dobi KC, 2015, WIRES DEV BIOL, V4, P357, DOI 10.1002/wdev.182; Domsch K, 2013, J CELL SCI, V126, P3314, DOI 10.1242/jcs.122366; Dutta D, 2004, DEVELOPMENT, V131, P3761, DOI 10.1242/dev.01249; Dutta D, 2006, MOL B INT U, P125, DOI 10.1007/0-387-32963-3_11; Fernandes JJ, 1996, DEV BIOL, V176, P166, DOI 10.1006/dbio.1996.0125; Gildor B, 2012, DEVELOPMENT, V139, P4040, DOI 10.1242/dev.077495; Guruharsha KG, 2011, CELL, V147, P690, DOI 10.1016/j.cell.2011.08.047; Hollfelder D, 2014, BMC DEV BIOL, V14, DOI 10.1186/1471-213X-14-26; HOMYK T, 1988, GENETICS, V119, P105; Itoh M, 2003, DEV CELL, V4, P67, DOI 10.1016/S1534-5807(02)00409-4; Jin YJ, 2002, J BIOL CHEM, V277, P46980, DOI 10.1074/jbc.M208585200; Kim JH, 2015, CURR OPIN GENET DEV, V32, P162, DOI 10.1016/j.gde.2015.03.006; KIMURA K, 1990, J NEUROSCI, V10, P403; Kocherlakota KS, 2008, GENETICS, V178, P1371, DOI 10.1534/genetics.107.083808; Koo BK, 2005, J BIOL CHEM, V280, P22335, DOI 10.1074/jbc.M501631200; Koo BK, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001221; Lai EC, 2005, DEVELOPMENT, V132, P2319, DOI 10.1242/dev.01825; Le Borgne R, 2005, PLOS BIOL, V3, P688, DOI 10.1371/journal.pbio.0030096; LEE JC, 1995, P NATL ACAD SCI USA, V92, P10344, DOI 10.1073/pnas.92.22.10344; McMillan BJ, 2015, MOL CELL, V57, P912, DOI 10.1016/j.molcel.2015.01.019; Menon SD, 2001, DEV CELL, V1, P691, DOI 10.1016/S1534-5807(01)00075-2; Mertz J, 2015, MOL CELL PROTEOMICS, V14, P1898, DOI 10.1074/mcp.M114.045898; Metzger MB, 2012, J CELL SCI, V125, P531, DOI 10.1242/jcs.091777; Michelet X, 2010, BIOL CELL, V102, P191, DOI 10.1042/BC20090145; Mikami S, 2015, BIOL OPEN, V4, P1576, DOI 10.1242/bio.014225; Mosavi LK, 2004, PROTEIN SCI, V13, P1435, DOI 10.1110/ps.03554604; Nguyen HT, 2007, J CELL BIOL, V179, P219, DOI 10.1083/jcb.200708135; Nguyen HT, 1998, DEV BIOL, V204, P550, DOI 10.1006/dbio.1998.9081; Pitsouli C, 2005, DEVELOPMENT, V132, P4041, DOI 10.1242/dev.01979; Ponting CP, 1996, TRENDS BIOCHEM SCI, V21, P11, DOI 10.1016/0968-0004(96)80878-4; Popichenko D, 2013, DEVELOPMENT, V140, P3156, DOI 10.1242/dev.094466; Schnorrer F, 2010, NATURE, V464, P287, DOI 10.1038/nature08799; Schroter RH, 2004, DEVELOPMENT, V131, P4501, DOI 10.1242/dev.01309; Schulman VK, 2015, WIRES DEV BIOL, V4, P313, DOI 10.1002/wdev.180; Schweitzer R, 2010, DEVELOPMENT, V137, P2807, DOI 10.1242/dev.047498; Tixier V, 2010, EXP CELL RES, V316, P3019, DOI 10.1016/j.yexcr.2010.07.013; Vigoreaux JO, 2001, BIOESSAYS, V23, P1047, DOI 10.1002/bies.1150; VOLK T, 1994, DEVELOPMENT, V120, P59; Wang WD, 2005, DEVELOPMENT, V132, P2883, DOI 10.1242/dev.01860; Weitkunat M, 2014, METHODS, V68, P2, DOI 10.1016/j.ymeth.2014.02.037; Weitkunat M, 2014, CURR BIOL, V24, P705, DOI 10.1016/j.cub.2014.02.032; Zhang CJ, 2007, J MOL BIOL, V366, P1115, DOI 10.1016/j.jmb.2006.11.096; Zhang CJ, 2007, DEV BIOL, V305, P14, DOI 10.1016/j.ydbio.2007.01.034	57	2	3	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 10	2017	12	3							e0173733	10.1371/journal.pone.0173733	http://dx.doi.org/10.1371/journal.pone.0173733			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN6CJ	28282454	Green Published, gold, Green Submitted			2022-12-27	WOS:000396091800074
J	Pawling, R; Cannon, PR; McGlone, FP; Walker, SC				Pawling, Ralph; Cannon, Peter R.; McGlone, Francis P.; Walker, Susannah C.			C-tactile afferent stimulating touch carries a positive affective value	PLOS ONE			English	Article							HUMAN HAIRY SKIN; PLEASANT TOUCH; PHYSIOLOGICAL CONDITION; UNMYELINATED AFFERENTS; BLOOD-PRESSURE; HEART-RATE; INTEROCEPTION; RESPONSES; OXYTOCIN; STROKING	The rewarding sensation of touch in affiliative interactions is hypothesized to be underpinned by a specialized system of nerve fibers called C-Tactile afferents (CTs), which respond optimally to slowly moving, gentle touch, typical of a caress. However, empirical evidence to support the theory that CTs encode socially relevant, rewarding tactile information in humans is currently limited. While in healthy participants, touch applied at CT optimal velocities (1-10cm/sec) is reliably rated as subjectively pleasant, neuronopathy patients lacking large myelinated afferents, but with intact C-fibres, report that the conscious sensation elicited by stimulation of CTs is rather vague. Given this weak perceptual impact the value of self-report measures for assessing the specific affective value of CT activating touch appears limited. Therefore, we combined subjective ratings of touch pleasantness with implicit measures of affective state (facial electromyography) and autonomic arousal (heart rate) to determine whether CT activation carries a positive affective value. We recorded the activity of two key emotion-relevant facial muscle sites (zygomaticus major- smile muscle, positive affect & corrugator supercilii-frown muscle, negative affect) while participants evaluated the pleasantness of experimenter administered stroking touch, delivered using a soft brush, at two velocities (CT optimal 3cm/sec & CT non-optimal 30cm/sec), on two skin sites (CT innervated forearm & non-CT innervated palm). On both sites, 3cm/sec stroking touch was rated as more pleasant and produced greater heart rate deceleration than 30cm/sec stimulation. However, neither self-report ratings nor heart rate responses discriminated stimulation on the CT innervated arm from stroking of the non-CT innervated palm. In contrast, significantly greater activation of the zygomaticus major (smiling muscle) was seen specifically to CT optimal, 3cm/sec, stroking on the forearm in comparison to all other stimuli. These results offer the first empirical evidence in humans that tactile stimulation that optimally activates CTs carries a positive affective valence that can be measured implicitly.	[Pawling, Ralph; McGlone, Francis P.; Walker, Susannah C.] Liverpool John Moores Univ, Sch Nat Sci & Psychol, Res Ctr Brain & Behav, Liverpool, Merseyside, England; [Cannon, Peter R.] Massey Univ, Sch Psychol, Auckland, New Zealand; [McGlone, Francis P.] Univ Liverpool, Inst Psychol Hlth & Soc, Liverpool, Merseyside, England	Liverpool John Moores University; Massey University; University of Liverpool	Walker, SC (corresponding author), Liverpool John Moores Univ, Sch Nat Sci & Psychol, Res Ctr Brain & Behav, Liverpool, Merseyside, England.	s.c.walker@ljmu.ac.uk	McGlone, Francis Philip/AAA-5058-2022; Pawling, Ralph/V-6370-2019; McGlone, Francis/F-8349-2011	McGlone, Francis/0000-0002-0881-635X; Cannon, Peter/0000-0001-9462-4292	Leverhulme Trust [RPG-2013-058]	Leverhulme Trust(Leverhulme Trust)	This work was supported by The Leverhulme Trust (https://www.leverhulme.ac.uk/) under Grant number RPG-2013-058 awarded to FM & SW. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abraira VE, 2013, NEURON, V79, P618, DOI 10.1016/j.neuron.2013.07.051; Ackerley R, 2014, J NEUROSCI, V34, P2879, DOI 10.1523/JNEUROSCI.2847-13.2014; Ackerley R, 2014, FRONT BEHAV NEUROSCI, V8, DOI 10.3389/fnbeh.2014.00054; Ackerley R, 2014, FRONT BEHAV NEUROSCI, V8, DOI 10.3389/fnbeh.2014.00034; Bjornsdotter M, 2010, EXP BRAIN RES, V207, P149, DOI 10.1007/s00221-010-2408-y; Bradley MM, 2001, EMOTION, V1, P276, DOI 10.1037//1528-3542.1.3.276; Burgdorf J, 2006, NEUROSCI BIOBEHAV R, V30, P173, DOI 10.1016/j.neubiorev.2005.06.001; CABANAC M, 1971, SCIENCE, V173, P1103, DOI 10.1126/science.173.4002.1103; CACIOPPO JT, 1986, J PERS SOC PSYCHOL, V50, P260, DOI 10.1037/0022-3514.50.2.260; Chapman HA, 2009, BAD TASTE EVIDENCE O, V1222, P1222; Coan JA, 2006, PSYCHOL SCI, V17, P1032, DOI 10.1111/j.1467-9280.2006.01832.x; Craig AD, 2003, CURR OPIN NEUROBIOL, V13, P500, DOI 10.1016/S0959-4388(03)00090-4; Craig AD, 2002, NAT REV NEUROSCI, V3, P655, DOI 10.1038/nrn894; Croy I, 2016, BEHAV BRAIN RES, V297, P37, DOI 10.1016/j.bbr.2015.09.038; de Groot JHB, 2015, PSYCHOL SCI, V26, P684, DOI 10.1177/0956797614566318; Ditzen B, 2007, PSYCHONEUROENDOCRINO, V32, P565, DOI 10.1016/j.psyneuen.2007.03.011; Djouhri L, 2016, NEUROSCI LETT, V613, P25, DOI 10.1016/j.neulet.2015.12.040; Dunbar RIM, 2010, NEUROSCI BIOBEHAV R, V34, P260, DOI 10.1016/j.neubiorev.2008.07.001; Eisenberger NI, 2011, P NATL ACAD SCI USA, V108, P11721, DOI 10.1073/pnas.1108239108; Essick GK, 1999, NEUROREPORT, V10, P2083, DOI 10.1097/00001756-199907130-00017; Essick GK, 2010, NEUROSCI BIOBEHAV R, V34, P192, DOI 10.1016/j.neubiorev.2009.02.003; Fairhurst MT, 2014, PSYCHOL SCI, V25, P1124, DOI 10.1177/0956797614527114; Francis S, 1999, NEUROREPORT, V10, P453, DOI 10.1097/00001756-199902250-00003; FRIDLUND AJ, 1986, PSYCHOPHYSIOLOGY, V23, P567, DOI 10.1111/j.1469-8986.1986.tb00676.x; Gallace A, 2010, NEUROSCI BIOBEHAV R, V34, P246, DOI 10.1016/j.neubiorev.2008.10.004; Grewen KM, 2005, PSYCHOSOM MED, V67, P531, DOI 10.1097/01.psy.0000170341.88395.47; Hertenstein MJ, 2006, GENET SOC GEN PSYCH, V132, P5, DOI 10.3200/MONO.132.1.5-94; Hertenstein MJ, 2006, EMOTION, V6, P528, DOI 10.1037/1528-3542.6.3.528; Hietanen JK, 1998, PSYCHOPHYSIOLOGY, V35, P530, DOI 10.1017/S0048577298970445; HOFER MA, 1994, ACTA PAEDIATR, V83, P9, DOI 10.1111/j.1651-2227.1994.tb13260.x; Kramer HH, 2007, PAIN, V133, P72, DOI 10.1016/j.pain.2007.03.001; Light KC, 2005, BIOL PSYCHOL, V69, P5, DOI 10.1016/j.biopsycho.2004.11.002; Loken LS, 2011, BRAIN RES, V1417, P9, DOI 10.1016/j.brainres.2011.08.011; Loken LS, 2009, NAT NEUROSCI, V12, P547, DOI 10.1038/nn.2312; McCall C, 2012, NAT NEUROSCI, V15, P681, DOI 10.1038/nn.3084; McGlone F, 2012, EUR J NEUROSCI, V35, P1782, DOI 10.1111/j.1460-9568.2012.08092.x; McGlone F, 2014, NEURON, V82, P737, DOI 10.1016/j.neuron.2014.05.001; Morrison I, 2010, EXP BRAIN RES, V204, P305, DOI 10.1007/s00221-009-2007-y; NORDIN M, 1990, J PHYSIOL-LONDON, V426, P229, DOI 10.1113/jphysiol.1990.sp018135; Olausson H, 2002, NAT NEUROSCI, V5, P900, DOI 10.1038/nn896; Olausson H, 2008, EXP BRAIN RES, V184, P135, DOI 10.1007/s00221-007-1175-x; Olausson H, 2010, NEUROSCI BIOBEHAV R, V34, P185, DOI 10.1016/j.neubiorev.2008.09.011; Perini I, 2015, FRONT BEHAV NEUROSCI, V9, DOI 10.3389/fnbeh.2015.00008; Rolls ET, 2003, CEREB CORTEX, V13, P308, DOI 10.1093/cercor/13.3.308; Uvnas-Moberg K, 2015, FRONT PSYCHOL, V5, DOI 10.3389/fpsyg.2014.01529; Vallbo AB, 1999, J NEUROPHYSIOL, V81, P2753, DOI 10.1152/jn.1999.81.6.2753; Van Boxtel A, 2001, PSYCHOPHYSIOLOGY, V38, P22, DOI 10.1017/S004857720199016X; Vrontou S, 2013, NATURE, V493, P669, DOI 10.1038/nature11810; Walker SC, 2013, NEUROPEPTIDES, V47, P379, DOI 10.1016/j.npep.2013.10.008; Zimmerman A, 2014, SCIENCE, V346, P950, DOI 10.1126/science.1254229; Zuccolotto AP, 2013, USERS GUIDE EPRIME 2	51	95	96	5	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 10	2017	12	3							e0173457	10.1371/journal.pone.0173457	http://dx.doi.org/10.1371/journal.pone.0173457			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EN6CJ	28282451	Green Published, gold, Green Submitted, Green Accepted			2022-12-27	WOS:000396091800043
J	Pitti, A; Gaussier, P; Quoy, M				Pitti, Alexandre; Gaussier, Philippe; Quoy, Mathias			Iterative free-energy optimization for recurrent neural networks (INFERNO)	PLOS ONE			English	Article							BASAL GANGLIA; DECISION-MAKING; SERIAL ORDER; GAIN-FIELD; MODEL; BEHAVIOR; DYNAMICS; REPRESENTATION; ORGANIZATION; SEQUENCES	The intra-parietal lobe coupled with the Basal Ganglia forms a working memory that demonstrates strong planning capabilities for generating robust yet flexible neuronal sequences. Neurocomputational models however, often fails to control long range neural synchrony in recurrent spiking networks due to spontaneous activity. As a novel framework based on the free-energy principle, we propose to see the problem of spikes' synchrony as an optimization problem of the neurons sub-threshold activity for the generation of long neuronal chains. Using a stochastic gradient descent, a reinforcement signal (presumably dopaminergic) evaluates the quality of one input vector to move the recurrent neural network to a desired activity; depending on the error made, this input vector is strengthened to hill-climb the gradient or elicited to search for another solution. This vector can be learned then by one associative memory as a model of the basal-ganglia to control the recurrent neural network. Experiments on habit learning and on sequence retrieving demonstrate the capabilities of the dual system to generate very long and precise spatio-temporal sequences, above two hundred iterations. Its features are applied then to the sequential planning of arm movements. In line with neurobiological theories, we discuss its relevance for modeling the cortico-basal working memory to initiate flexible goal-directed neuronal chains of causation and its relation to novel architectures such as Deep Networks, Neural Turing Machines and the Free-Energy Principle.	[Pitti, Alexandre; Gaussier, Philippe; Quoy, Mathias] Univ Cergy Pontoise, ENSEA, CNRS UMR 8051, ETIS Lab, Paris, Cergy Pontoise, France	CY Cergy Paris Universite	Pitti, A (corresponding author), Univ Cergy Pontoise, ENSEA, CNRS UMR 8051, ETIS Lab, Paris, Cergy Pontoise, France.	alexandre.pitti@u-cergy.fr	Pitti, Alex/GYV-0908-2022	Pitti, Alex/0000-0002-6541-578X	EQUIPEX-ROBOTEX (CNRS); chaire d'excellence CNRS-UCP; project Labex MME-DII [ANR11-LBX-0023-01]	EQUIPEX-ROBOTEX (CNRS); chaire d'excellence CNRS-UCP; project Labex MME-DII	This work was partially funded by EQUIPEX-ROBOTEX (CNRS), chaire d'excellence CNRS-UCP and project Labex MME-DII (ANR11-LBX-0023-01). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We thank Souheil Hanoune and Karl Friston as well as the reviewers for interesting comments and fruitful feedback on anterior versions of the paper. This work was partially funded by EQUIPEX-ROBOTEX (CNRS), chaire d'excellence CNRS-UCP and project Labex MME-DII (ANR11-LBX-0023-01).	Abbott LF, 2000, NAT NEUROSCI, V3, P1178, DOI 10.1038/81453; ALEXANDER GE, 1986, ANNU REV NEUROSCI, V9, P357, DOI 10.1146/annurev.ne.09.030186.002041; Andersen RA, 2002, ANNU REV NEUROSCI, V25, P189, DOI 10.1146/annurev.neuro.25.112701.142922; Andersen RA, 2009, NEURON, V63, P568, DOI 10.1016/j.neuron.2009.08.028; BAK P, 1987, PHYS REV LETT, V59, P381, DOI 10.1103/PhysRevLett.59.381; Barto A.G., 1997, ADV PSYCHOL, V121, P358; Benedek M, 2016, SCI REP-UK, V6, DOI 10.1038/srep22959; Blohm G, 2009, NEURON, V64, P598, DOI 10.1016/j.neuron.2009.11.022; Botvinick M, 2007, J NEUROSCI, V27, P8636, DOI 10.1523/JNEUROSCI.2110-07.2007; BURNOD Y, 1992, J NEUROSCI, V12, P1435; Buschman TJ, 2014, PHILOS T R SOC B, V369, DOI 10.1098/rstb.2013.0471; Chang SWC, 2009, NEURON, V64, P744, DOI 10.1016/j.neuron.2009.11.005; Chersi F, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027652; Clark A., 2015, SURFING UNCERTAINTY, VReprint; Cohen YE, 2002, NAT REV NEUROSCI, V3, P553, DOI 10.1038/nrn873; Cui H, 2007, NEURON, V56, P552, DOI 10.1016/j.neuron.2007.09.031; Daw ND, 2005, NAT NEUROSCI, V8, P1704, DOI 10.1038/nn1560; Dehaene S, 2015, NEURON, V88, P2, DOI 10.1016/j.neuron.2015.09.019; den Ouden HEM, 2012, FRONT PSYCHOL, V3, DOI 10.3389/fpsyg.2012.00548; Deneve S, 2008, NEURAL COMPUT, V20, P91, DOI 10.1162/neco.2008.20.1.91; Diederich A, 2014, FRONT HUM NEUROSCI, V8, DOI 10.3389/fnhum.2014.00697; Doya K, 2002, NEURAL NETWORKS, V15, P495, DOI 10.1016/S0893-6080(02)00044-8; Eliasmith C, 2012, SCIENCE, V338, P1202, DOI 10.1126/science.1225266; Friston Karl, 2012, Front Neurorobot, V6, P11, DOI 10.3389/fnbot.2012.00011; Friston KJ, 2006, J PHYSIOL-PARIS, V100, P70, DOI 10.1016/j.jphysparis.2006.10.001; Friston KJ, 2012, FRONT PSYCHOL, V3, DOI 10.3389/fpsyg.2012.00130; Friston KJ, 2009, TRENDS COGN SCI, V13, P293, DOI 10.1016/j.tics.2009.04.005; Friston KJ, 2009, PHILOS T R SOC B, V364, P1211, DOI 10.1098/rstb.2008.0300; Friston KJ, 2005, PHILOS T R SOC B, V360, P815, DOI 10.1098/rstb.2005.1622; Gabbiani F, 2002, NATURE, V420, P320, DOI 10.1038/nature01190; Gallese V., 2005, PHENOMENOLOGY COGNIT, V4, P23, DOI [10.1007/s11097-005-4737-z, DOI 10.1007/S11097-005-4737-Z]; Gershman SJ, 2014, J EXP PSYCHOL GEN, V143, P182, DOI 10.1037/a0030844; Gold JI, 2001, TRENDS COGN SCI, V5, P10, DOI 10.1016/S1364-6613(00)01567-9; Gold JI, 2007, ANNU REV NEUROSCI, V30, P535, DOI 10.1146/annurev.neuro.29.051605.113038; Graves A, 2014, 1410541V2 ARXIV; Graves A, 2016, NATURE, V538, P471, DOI 10.1038/nature20101; Griffiths TL, 2010, TRENDS COGN SCI, V14, P357, DOI 10.1016/j.tics.2010.05.004; Guthrie M, 2013, J NEUROPHYSIOL, V109, P3025, DOI 10.1152/jn.00026.2013; Hawkins J, 2016, FRONT NEURAL CIRCUIT, V10, DOI 10.3389/fncir.2016.00023; Hinaut X, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0052946; Hirel J, 2013, NEURAL NETWORKS, V43, P8, DOI 10.1016/j.neunet.2013.01.023; Humphries MD, 2012, FRONT NEUROSCI-SWITZ, V6, DOI 10.3389/fnins.2012.00009; Izhikevich EM, 2007, CEREB CORTEX, V17, P2443, DOI 10.1093/cercor/bhl152; JAEGER D, 1993, EXP BRAIN RES, V95, P51; KANEKO K, 2000, COMPLEX SYSTEMS CHAO; Kelso S., 1995, DYNAMIC PATTERNS SEL; Khamassi M, 2005, ADAPT BEHAV, V13, P131, DOI 10.1177/105971230501300205; Koechlin E, 2016, CURR OPIN NEUROBIOL, V37, P1, DOI 10.1016/j.conb.2015.11.004; KOHONEN T, 1982, BIOL CYBERN, V43, P59, DOI 10.1007/BF00337288; Kording KP, 2006, TRENDS COGN SCI, V10, P319, DOI 10.1016/j.tics.2006.05.003; Kuniyoshi Y, 2011, P INT JOINT C NEUR N, P1; Laje R, 2013, NAT NEUROSCI, V16, P925, DOI 10.1038/nn.3405; LeCun Y, 2015, NATURE, V521, P436, DOI 10.1038/nature14539; Ma WJ, 2006, NAT NEUROSCI, V9, P1432, DOI 10.1038/nn1790; Maass W, 2016, CURR OPIN BEHAV SCI, V11, P81, DOI 10.1016/j.cobeha.2016.06.003; Mannella F, 2015, BIOL CYBERN, V109, P575, DOI 10.1007/s00422-015-0662-6; Miller E, 2015, DIALOGUES CLIN NEURO, V15, P411; Orban G, 2011, CURR OPIN NEUROBIOL, V21, P629, DOI 10.1016/j.conb.2011.05.026; Pezzulo G, 2016, TRENDS COGN SCI, V20, P414, DOI 10.1016/j.tics.2016.03.013; Pezzulo G, 2014, TRENDS COGN SCI, V18, P647, DOI 10.1016/j.tics.2014.06.011; Pitti A, 2008, EUR PHYS J B, V63, P239, DOI 10.1140/epjb/e2008-00238-2; Pitti A, 2009, NEURAL NETWORKS, V22, P144, DOI 10.1016/j.neunet.2009.01.007; Pitti A, 2013, FRONT PSYCHOL, V4, DOI 10.3389/fpsyg.2013.00771; Platt ML, 1999, NATURE, V400, P233, DOI 10.1038/22268; Poldrack RA, 2002, ANNU REV NEUROSCI, V25, P563; Rabinovich MI, 2006, REV MOD PHYS, V78, P1213, DOI 10.1103/RevModPhys.78.1213; Rabinovich MI, 2011, FRONT COMPUT NEUROSC, V5, DOI 10.3389/fncom.2011.00024; Rajan K, 2016, NEURON, V90, P128, DOI 10.1016/j.neuron.2016.02.009; Rao RPN, 1999, NAT NEUROSCI, V2, P79, DOI 10.1038/4580; Rigotti M, 2013, NATURE, V497, P585, DOI 10.1038/nature12160; Rolfe J, 2013, 3775V4 ARXIV; Rorie AE, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009308; Rueckert E, 2016, SCI REP-UK, V6, DOI 10.1038/srep21142; Sakai K, 2002, NAT NEUROSCI, V5, P479, DOI 10.1038/nn846; Salinas E, 2001, NEUROSCIENTIST, V7, P430, DOI 10.1177/107385840100700512; Sandamirskaya Y, 2010, NEURAL NETWORKS, V23, P1164, DOI 10.1016/j.neunet.2010.07.012; Seger CA, 2010, ANNU REV NEUROSCI, V33, P203, DOI 10.1146/annurev.neuro.051508.135546; Spratling MW, 2016, COGN PROCESS, V17, P279, DOI 10.1007/s10339-016-0765-6; Stanley KO, 2002, EVOL COMPUT, V10, P99, DOI 10.1162/106365602320169811; Sutton RS, 2018, ADAPT COMPUT MACH LE, P1; Tani J, 2004, NEURAL NETWORKS, V17, P1273, DOI 10.1016/j.neunet.2004.05.007; Tenenbaum JB, 2011, SCIENCE, V331, P1279, DOI 10.1126/science.1192788; Thelen E., 1994, DYNAMIC SYSTEMS APPR; Thorpe S, 2001, NEURAL NETWORKS, V14, P715, DOI 10.1016/S0893-6080(01)00083-1; Topalidou M, 2015, RESCIENCE; Tsuda I, 2001, BEHAV BRAIN SCI, V24, P793, DOI 10.1017/S0140525X01000097; Tsuda I., 1991, WORLD FEATURE, V31, P105; Tsuda Ichiro, 2004, Journal of Integrative Neuroscience, V3, P159, DOI 10.1142/S021963520400049X; Tsuda I, 2015, CURR OPIN NEUROBIOL, V31, P67, DOI 10.1016/j.conb.2014.08.011; van Hateren JH, 2015, BIOL CYBERN, V109, P33, DOI 10.1007/s00422-014-0622-6; VanRullen R, 2002, VISION RES, V42, P2593, DOI 10.1016/S0042-6989(02)00298-5; Varona P, 2016, P ROY SOC B-BIOL SCI, V283, DOI 10.1098/rspb.2016.0475; Verstraeten D, 2007, NEURAL NETWORKS, V20, P391, DOI 10.1016/j.neunet.2007.04.003; Watts DJ, 1998, NATURE, V393, P440, DOI 10.1038/30918; Yin HH, 2006, NAT REV NEUROSCI, V7, P464, DOI 10.1038/nrn1919; Zylberberg A, 2013, PAP PHYS-LA PLATA, V5, DOI 10.4279/PIP.050006; Zylberberg A, 2011, TRENDS COGN SCI, V15, P293, DOI 10.1016/j.tics.2011.05.007	98	7	7	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 10	2017	12	3							e0173684	10.1371/journal.pone.0173684	http://dx.doi.org/10.1371/journal.pone.0173684			33	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN6CJ	28282439	gold, Green Published, Green Submitted			2022-12-27	WOS:000396091800068
J	Poonai, N; Canton, K; Ali, S; Hendrikx, S; Shah, A; Miller, M; Joubert, G; Rieder, M; Hartling, L				Poonai, Naveen; Canton, Kyle; Ali, Samina; Hendrikx, Shawn; Shah, Amit; Miller, Michael; Joubert, Gary; Rieder, Michael; Hartling, Lisa			Intranasal ketamine for procedural sedation and analgesia in children: A systematic review	PLOS ONE			English	Review							NORKETAMINE PLASMA-CONCENTRATIONS; PEDIATRIC DENTAL PATIENTS; EMERGENCY-DEPARTMENT; PAIN MANAGEMENT; CROSSOVER TRIAL; MIDAZOLAM; BLIND; ADOLESCENTS; VALIDATION; DISTRESS	Background Ketamine is commonly used for procedural sedation and analgesia (PSA) in children. Evidence suggests it can be administered intranasally (IN). We sought to review the evidence for IN ketamine for PSA in children. Methods We performed a systematic review of randomized trials of IN ketamine in PSA that reported any sedation- related outcome in children 0 to 19 years. Trials were identified through electronic searches of MEDLINE (1946-2016), EMBASE (194-016), Google Scholar (2016), CINAHL (1981-2016), The Cochrane Library (2016), Web of Science (2016), Scopus (2016), clinical trial registries, and conference proceedings (2000-2016) without language restrictions. The methodological qualities of studies and the overall quality of evidence were evaluated using the Cochrane Collaboration's Risk of Bias tool, and the Grading of Recommendations Assessment, Development, and Evaluation (GRADE) system, respectively. Results The review included 7 studies (n = 264) of children ranging from 0 to 14 years. Heterogeneity in study design precluded meta- analysis. Most studies were associated with a low or unclear risk of bias and outcome- specific ratings for quality of evidence were low or very low. In four of seven studies, IN ketamine provided superior sedation to comparators and resulted in adequate sedation for 148/175 (85%) of participants. Vomiting was the most common adverse effect; reported by 9/91 (10%) of participants. Conclusions IN ketamine administration is well tolerated and without serious adverse effects. Although most participants were deemed adequately sedated with IN ketamine, effectiveness of sedation with respect to superiority over comparators was inconsistent, precluding a recommendation for PSA in children.	[Poonai, Naveen; Hendrikx, Shawn; Miller, Michael; Joubert, Gary; Rieder, Michael] Schulich Sch Med & Dent, Dept Pediat, London, ON, Canada; [Poonai, Naveen; Canton, Kyle; Shah, Amit; Joubert, Gary] London Hlth Sci Ctr, Div Emergency Med, London, ON, Canada; [Poonai, Naveen; Miller, Michael; Joubert, Gary; Rieder, Michael] London Hlth Sci Ctr, Childrens Hlth Res Inst, London, ON, Canada; [Ali, Samina] Univ Alberta, Dept Pediat, Fac Med Dent, Edmonton, AB, Canada; [Ali, Samina] Univ Alberta, Women & Childrens Hlth Res Inst, Edmonton, AB, Canada; [Hartling, Lisa] Univ Alberta, Dept Pediat, Alberta Res Ctr Hlth Evidence, Edmonton, AB, Canada	London Health Sciences Centre; London Health Sciences Centre; University of Alberta; University of Alberta; University of Alberta	Poonai, N (corresponding author), Schulich Sch Med & Dent, Dept Pediat, London, ON, Canada.; Poonai, N (corresponding author), London Hlth Sci Ctr, Div Emergency Med, London, ON, Canada.; Poonai, N (corresponding author), London Hlth Sci Ctr, Childrens Hlth Res Inst, London, ON, Canada.	naveen.poonai@lhsc.on.ca	Rieder, Michael J/L-2397-2013	Hendrikx, Shawn/0000-0001-7438-9440				Abrams R, 1993, Anesth Prog, V40, P63; Andolfatto G, 2013, ACAD EMERG MED, V20, P1050, DOI 10.1111/acem.12229; Atkins D, 2004, BMJ-BRIT MED J, V328, P1490; Bahetwar SK, 2011, J CLIN PEDIATR DENT, V35, P415, DOI 10.17796/jcpd.35.4.l43h3354705u2574; Bellolio MF, 2016, ACAD EMERG MED, V23, P119, DOI 10.1111/acem.12875; Bhargava R, 2007, ACAD EMERG MED, V14, P479, DOI 10.1197/j.aem.2006.12.006; Brennan F, 2007, ANESTH ANALG, V105, P205, DOI 10.1213/01.ane.0000268145.52345.55; Buonsenso D, 2014, BMC PEDIATR, V14, DOI 10.1186/1471-2431-14-67; Correll DJ, 2014, J PAIN RES, V7, P199, DOI 10.2147/JPR.S60842; Couloures KG, 2011, PEDIATRICS, V127, pE1154, DOI 10.1542/peds.2010-2960; Cravero JP, 2005, ANESTH ANALG, V100, P1614, DOI 10.1213/01.ANE.0000150605.43251.84; Del Pizzo J, 2014, PEDIATR EMERG CARE, V30, P496, DOI 10.1097/PEC.0000000000000171; ELLIOTT CH, 1987, J PEDIATR PSYCHOL, V12, P543, DOI 10.1093/jpepsy/12.4.543; Fallahinejad Ghajari Masoud, 2015, J Dent Res Dent Clin Dent Prospects, V9, P61, DOI 10.15171/joddd.2015.013; Fein JA, 2012, PEDIATRICS, V130, pE1391, DOI 10.1542/peds.2012-2536; FRADET C, 1990, PAIN, V40, P53, DOI 10.1016/0304-3959(90)91050-S; Goodenough B, 1999, PAIN, V80, P179, DOI 10.1016/S0304-3959(98)00201-2; Grassin-Delyle S, 2012, PHARMACOL THERAPEUT, V134, P366, DOI 10.1016/j.pharmthera.2012.03.003; Graudins A, 2015, ANN EMERG MED, V65, P248, DOI 10.1016/j.annemergmed.2014.09.024; GREEN SM, 1990, ANN EMERG MED, V19, P1033, DOI 10.1016/S0196-0644(05)82569-7; Green SM, 2009, ANN EMERG MED, V54; Green SM, 2009, ANN EMERG MED, V54; Green SM, 2011, ANN EMERG MED, V57, P449, DOI 10.1016/j.annemergmed.2010.11.030; Hartling L, 2016, ACAD EMERG MED, V23, P519, DOI 10.1111/acem.12938; Higgins JPT, 2011, BMJ-BRIT MED J, V343, DOI 10.1136/bmj.d5928; HUMPHREY GB, 1992, PEDIATRICS, V90, P87; Ibrahim Mohamed, 2014, Anesth Essays Res, V8, P179, DOI 10.4103/0259-1162.134495; Malinovsky JM, 1996, BRIT J ANAESTH, V77, P203, DOI 10.1093/bja/77.2.203; Manworren Renee C B, 2003, Pediatr Nurs, V29, P140; Merchant Richard, 2016, Can J Anaesth, V63, P86, DOI 10.1007/s12630-015-0470-4; Murphy AP, 2016, EUROPEAN J EMERGENCY; Nelson R, 2003, LANCET, V362, P1129, DOI 10.1016/S0140-6736(03)14505-9; Pandey RK, 2011, J CLIN PEDIATR DENT, V36, P79, DOI 10.17796/jcpd.36.1.1774746504g28656; Panic N, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0083138; RAMSAY MAE, 1974, BRIT MED J, V2, P656, DOI 10.1136/bmj.2.5920.656; Schofield S, 2013, EMERG MED AUSTRALAS, V25, P241, DOI 10.1111/1742-6723.12074; Sener S, 2011, ANN EMERG MED, V57, P109, DOI 10.1016/j.annemergmed.2010.09.010; SPLINTER WM, 1994, ANESTH ANALG, V78, pU220; Surendar MN, 2014, J CLIN PEDIATR DENT, V38, P255; Tricco AC, 2009, J CLIN EPIDEMIOL, V62; Tsze DS, 2012, PEDIATR EMERG CARE, V28, P767, DOI 10.1097/PEC.0b013e3182624935; Van Cleve L, 1996, J Pediatr Nurs, V11, P161; Weber F, 2004, PEDIATR ANESTH, V14, P983, DOI 10.1111/j.1460-9592.2004.01358.x; Wilson GAM, 1996, ANAESTHESIA, V51, P1005, DOI 10.1111/j.1365-2044.1996.tb14991.x; Wong D L, 1988, Pediatr Nurs, V14, P9	45	30	31	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 20	2017	12	3							e0173253	10.1371/journal.pone.0173253	http://dx.doi.org/10.1371/journal.pone.0173253			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ER6VC	28319161	gold, Green Submitted, Green Published			2022-12-27	WOS:000398945800011
J	Clausius, E; McMahon, CR; Hindell, MA				Clausius, Ella; McMahon, Clive R.; Hindell, Mark A.			Five decades on: Use of historical weaning size data reveals that a decrease in maternal foraging success underpins the long-term decline in population of southern elephant seals (Mirounga leonina)	PLOS ONE			English	Article							MILK CONSUMPTION; BODY-COMPOSITION; GROWTH; PUPS; SURVIVAL; DURATION; MOVEMENTS; RESPONSES; BEHAVIOR; SYSTEM		[Clausius, Ella; Hindell, Mark A.] Univ Tasmania, Inst Marine & Antarcti Studies, Ctr Ecol & Biodivers, Hobart, Tas, Australia; [McMahon, Clive R.] Sydney Inst Marine Sci, Mosman, NSW, Australia; [Hindell, Mark A.] Univ Tasmania, Antarctic Climate & Ecosyst CRC, Hobart, Tas, Australia	University of Tasmania; Sydney Institute of Marine Science; University of Tasmania	Hindell, MA (corresponding author), Univ Tasmania, Inst Marine & Antarcti Studies, Ctr Ecol & Biodivers, Hobart, Tas, Australia.; Hindell, MA (corresponding author), Univ Tasmania, Antarctic Climate & Ecosyst CRC, Hobart, Tas, Australia.	mark.hindell@utas.edu.au	McMahon, Clive R/D-5713-2013	McMahon, Clive R/0000-0001-5241-8917; Hindell, Mark/0000-0002-7823-7185	Australian Antarctic Division through the National Antarctic Research Expeditions (ANARE)	Australian Antarctic Division through the National Antarctic Research Expeditions (ANARE)	The Australian Antarctic Division through the National Antarctic Research Expeditions (ANARE) supported this research. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ARNBOM T, 1993, CAN J ZOOL, V71, P1772, DOI 10.1139/z93-252; Arnbom T, 1997, ECOLOGY, V78, P471, DOI 10.1890/0012-9658(1997)078[0471:FAMEIS]2.0.CO;2; Arnould JPY, 1996, CAN J ZOOL, V74, P254, DOI 10.1139/z96-032; Arnould JPY, 2002, J ZOOL, V256, P351, DOI 10.1017/S0952836902000389; Bailleul F, 2010, ECOGRAPHY, V33, P709, DOI 10.1111/j.1600-0587.2009.06034.x; Biuw M, 2007, P NATL ACAD SCI USA, V104, P13705, DOI 10.1073/pnas.0701121104; Bornemann H, 2000, ANTARCT SCI, V12, P3, DOI 10.1017/S095410200000002X; BRYDEN MM, 1972, J ZOOL, V167, P265; BRYDEN MM, 1969, GROWTH, V33, P69; Carlini AR, 2000, POLAR BIOL, V23, P437, DOI 10.1007/s003000050465; Carlini AR, 2001, PHYSIOL BIOCHEM ZOOL, V74, P531, DOI 10.1086/322168; Carrick R., 1962, CSIRO Wildlife Research, V7, P161; Cotte C, 2015, PROG OCEANOGR, V131, P46, DOI 10.1016/j.pocean.2014.11.011; CROXALL JP, 1992, PHILOS T ROY SOC B, V338, P319, DOI 10.1098/rstb.1992.0152; de Bruyn PJN, 2011, ANIM BEHAV, V82, P445, DOI 10.1016/j.anbehav.2011.06.006; Desprez M, 2014, BIOL LETTERS, V10, DOI 10.1098/rsbl.2014.0264; Fedak MA, 1996, PHYSIOL ZOOL, V69, P887, DOI 10.1086/physzool.69.4.30164234; Field IC, 2005, OECOLOGIA, V142, P127, DOI 10.1007/s00442-004-1704-2; Grosbois V, 2008, BIOL REV, V83, P357, DOI 10.1111/j.1469-185X.2008.00047.x; Hindell M, DECADAL CHANGE UNPUB; Hindell M, 2016, ECOSPHERE, V7, P1; HINDELL MA, 1988, J MAMMAL, V69, P81, DOI 10.2307/1381750; HINDELL MA, 1991, J ANIM ECOL, V60, P119, DOI 10.2307/5449; Hindell MA, 2016, ECOSPHERE, V7, DOI 10.1002/ecs2.1213; Jenouvrier S, 2014, NAT CLIM CHANGE, V4, P715, DOI 10.1038/NCLIMATE2280; Laws R. M., 1953, Scientific Reports Falkland Islands Dependencies Survey, P1; LAWS RM, 1956, NATURE, V178, P193, DOI 10.1038/178193a0; McConnell B, 2002, J ANIM ECOL, V71, P65, DOI 10.1046/j.0021-8790.2001.00576.x; McMahon CR, 2005, MAR ECOL PROG SER, V288, P273, DOI 10.3354/meps288273; McMahon CR, 2005, MAMMAL REV, V35, P82, DOI 10.1111/j.1365-2907.2005.00055.x; McMahon CR, 1999, POLAR BIOL, V21, P279, DOI 10.1007/s003000050363; McMahon CR, 2003, J ANIM ECOL, V72, P61, DOI 10.1046/j.1365-2656.2003.00685.x; McMahon CR, 2000, ANTARCT SCI, V12, P149, DOI 10.1017/S0954102000000195; McMahon CR, 1997, MARINE MAMMAL RESEARCH IN THE SOUTHERN HEMISPHERE, VOL 1, P92; McMahon CR, 2016, J ANIMAL ECOLOGY; McMahon CR, 2016, J ANIM ECOL; Oosthuizen WC, 2015, ECOSPHERE, V6, DOI 10.1890/ES14-00508.1; Parmesan C, 2006, ANNU REV ECOL EVOL S, V37, P637, DOI 10.1146/annurev.ecolsys.37.091305.110100; Pinheiro J., 2016, NLME LINEAR NONLINEA; Poloczanska ES, 2013, NAT CLIM CHANGE, V3, P919, DOI [10.1038/nclimate1958, 10.1038/NCLIMATE1958]; Saefken B, 2014, CONDITIONAL AKAIKE I; Saefken B, 2014, ELECTRON J STAT, V8, P201, DOI 10.1214/14-EJS881; SCHEFFER VB, 1967, J MAMMAL, V48, P459; Thums M, 2011, ECOLOGY, V92, P1258, DOI 10.1890/09-1299.1; van den Hoff J, 2002, ANTARCT SCI, V14, P134, DOI 10.1017/S095410200200069X; van den Hoff J, 2014, P ROY SOC B-BIOL SCI, V281, DOI 10.1098/rspb.2013.2842; Walther GR, 2002, NATURE, V416, P389, DOI 10.1038/416389a; Weimerskirch H, 2003, ANTARCT SCI, V15, P249, DOI 10.1017/S0954102003001202; WILKINSON IS, 1990, J ZOOL, V222, P591, DOI 10.1111/j.1469-7998.1990.tb06016.x	49	12	12	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 16	2017	12	3							e0173427	10.1371/journal.pone.0173427	http://dx.doi.org/10.1371/journal.pone.0173427			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN9KE	28301546	gold, Green Accepted, Green Published			2022-12-27	WOS:000396318300036
J	Das, K; Eisel, D; Lenkl, C; Goyal, A; Diederichs, S; Dickes, E; Osen, W; Eichmueller, SB				Das, Krishna; Eisel, David; Lenkl, Clarissa; Goyal, Ashish; Diederichs, Sven; Dickes, Elke; Osen, Wolfram; Eichmueller, Stefan B.			Generation of murine tumor cell lines deficient in MHC molecule surface expression using the CRISPR/Cas9 system	PLOS ONE			English	Article							NATURAL-KILLER-CELLS; CLASS-I; TRANSGENIC MICE; T-CELLS; ANTIGEN; IDENTIFICATION; SPECIFICITY; NUCLEASES; MELANOMA; CANCER	In this study, the CRISPR/Cas9 technology was used to establish murine tumor cell lines, devoid of MHC I or MHC II surface expression, respectively. The melanoma cell line B16F10 and the murine breast cancer cell line EO-771, the latter stably expressing the tumor antigen NY-BR-1 (EO-NY), were transfected with an expression plasmid encoding a beta(2)m-specific single guide (sg) RNA and Cas9. The resulting MHC I negative cells were sorted by flow cytometry to obtain single cell clones, and loss of susceptibility of peptide pulsed MHC I negative clones to peptide-specific CTL recognition was determined by IFN gamma ELISpot assay. The beta(2)m knockout (KO) clones did not give rise to tumors in syngeneic mice (C57BL/6N), unless NK cells were depleted, suggesting that outgrowth of the beta(2)m KO cell lines was controlled by NK cells. Using sgRNAs targeting the beta-chain encoding locus of the IA(b) molecule we also generated several B16F10 MHC II KO clones. Peptide loaded B16F10 MHC II KO cells were insusceptible to recognition by OT-II cells and tumor growth was unaltered compared to parental B16F10 cells. Thus, in our hands the CRISPR/Cas9 system has proven to be an efficient straight forward strategy for the generation of MHC knockout cell lines. Such cell lines could serve as parental cells for co-transfection of compatible HLA alleles together with human tumor antigens of interest, thereby facilitating the generation of HLA matched transplantable tumor models, e.g. in HLAtg mouse strains of the newer generation, lacking cell surface expression of endogenous H2 molecules. In addition, our tumor cell lines established might offer a useful tool to investigate tumor reactive T cell responses that function independently from MHC molecule surface expression by the tumor.	[Das, Krishna; Eisel, David; Lenkl, Clarissa; Dickes, Elke; Osen, Wolfram; Eichmueller, Stefan B.] German Canc Res Ctr, GMP & T Cell Therapy Unit, Heidelberg, Germany; [Goyal, Ashish; Diederichs, Sven] German Canc Res Ctr, Div RNA Biol & Canc, Heidelberg, Germany; [Diederichs, Sven] Univ Freiburg, Fac Med, Dept Thorac Surg, Med Ctr,Div Canc Res, Freiburg, Germany; [Diederichs, Sven] German Canc Consortium DKTK, Freiburg, Germany	Helmholtz Association; German Cancer Research Center (DKFZ); Helmholtz Association; German Cancer Research Center (DKFZ); University of Freiburg; Helmholtz Association; German Cancer Research Center (DKFZ)	Eichmueller, SB (corresponding author), German Canc Res Ctr, GMP & T Cell Therapy Unit, Heidelberg, Germany.	s.eichmueller@dkfz.de	Eichmüller, Stefan B/A-5053-2008; Diederichs, Sven/J-6237-2012	Eichmüller, Stefan B/0000-0002-3497-6904; Diederichs, Sven/0000-0001-7901-4752				Abrahimi P, 2015, CIRC RES, V117, P121, DOI 10.1161/CIRCRESAHA.117.306290; ALLEN H, 1986, P NATL ACAD SCI USA, V83, P7447, DOI 10.1073/pnas.83.19.7447; Bernal M, 2012, IMMUNOTHERAPY, V61, P1359; BIX M, 1992, J EXP MED, V176, P829, DOI 10.1084/jem.176.3.829; Bohm W, 1998, J IMMUNOL, V161, P897; CARPINO LA, 1972, J ORG CHEM, V37, P3404, DOI 10.1021/jo00795a005; Clay TM, 2001, CLIN CANCER RES, V7, P1127; Cong L, 2013, SCIENCE, V339, P819, DOI 10.1126/science.1231143; DURSO CM, 1991, J CLIN INVEST, V87, P284, DOI 10.1172/JCI114984; EVAN GI, 1983, EUR J IMMUNOL, V13, P160, DOI 10.1002/eji.1830130213; Fu YF, 2014, NAT BIOTECHNOL, V32, P279, DOI 10.1038/nbt.2808; Fu YF, 2013, NAT BIOTECHNOL, V31, P822, DOI 10.1038/nbt.2623; Gardyan A, 2015, INT J CANCER, V136, P2588, DOI 10.1002/ijc.29322; Haabeth OAW, 2014, FRONT IMMUNOL, V5, DOI 10.3389/fimmu.2014.00174; Horii T, 2013, PEERJ, V1, DOI 10.7717/peerj.230; Horvath P, 2010, SCIENCE, V327, P167, DOI 10.1126/science.1179555; Jager D, 2007, APPL IMMUNOHISTO M M, V15, P77; Jiang WY, 2013, NAT BIOTECHNOL, V31, P233, DOI 10.1038/nbt.2508; Jinek M, 2012, SCIENCE, V337, P816, DOI 10.1126/science.1225829; KARRE K, 1986, NATURE, V319, P675, DOI 10.1038/319675a0; Kleinstiver BP, 2016, NATURE, V529, P490, DOI 10.1038/nature16526; Lei J, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0138458; LEMKE H, 1979, IMMUNOL REV, V47, P175, DOI 10.1111/j.1600-065X.1979.tb00293.x; Mandal PK, 2014, CELL STEM CELL, V15, P643, DOI 10.1016/j.stem.2014.10.004; MERRIFIELD RB, 1963, J AM CHEM SOC, V85, P2149, DOI 10.1021/ja00897a025; Neefjes J, 2011, NAT REV IMMUNOL, V11, P823, DOI 10.1038/nri3084; Osen W, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014137; Pajot A, 2004, INT IMMUNOL, V16, P1275, DOI 10.1093/intimm/dxh129; Parkhurst MR, 1998, CANCER RES, V58, P4895; Pipkin ME, 2007, CURR OPIN IMMUNOL, V19, P301, DOI 10.1016/j.coi.2007.04.011; Pol J, 2015, ONCOIMMUNOLOGY, V4, DOI 10.4161/2162402X.2014.974411; Sander JD, 2014, NAT BIOTECHNOL, V32, P347, DOI 10.1038/nbt.2842; Sawada Y, 2014, ONCOL REP, V31, P1051, DOI 10.3892/or.2013.2941; SEGE K, 1981, BIOCHEMISTRY-US, V20, P4523, DOI 10.1021/bi00519a003; Slaymaker IM, 2016, SCIENCE, V351, P84, DOI 10.1126/science.aad5227; Speidel K, 1997, EUR J IMMUNOL, V27, P2391, DOI 10.1002/eji.1830270938; TADA N, 1980, IMMUNOGENETICS, V11, P441, DOI 10.1007/BF01567813; Tveita A, 2016, ONCOTARGET; Vivier E, 2008, NAT IMMUNOL, V9, P503, DOI 10.1038/ni1582; Vivier E, 2012, NAT REV IMMUNOL, V12, P239, DOI 10.1038/nri3174; Wang HY, 2013, CELL, V153, P910, DOI 10.1016/j.cell.2013.04.025; Wiedenheft B, 2012, NATURE, V482, P331, DOI 10.1038/nature10886; Xie Y, 2010, J EXP MED, V207, P651, DOI 10.1084/jem.20091921	43	16	16	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 16	2017	12	3							e0174077	10.1371/journal.pone.0174077	http://dx.doi.org/10.1371/journal.pone.0174077			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN9KE	28301575	gold, Green Published, Green Submitted			2022-12-27	WOS:000396318300123
J	Duque, J; Gaga, S; Clark, D; Muller, M; Kuwane, B; Cohen, C; Walaza, S; Tempia, S; Ramatoboe, P; Furumele, T; Widdowson, MA; McMorrow, ML; Cohen, AL				Duque, Jazmin; Gaga, Sisanda; Clark, David; Muller, Madeleine; Kuwane, Bulenani; Cohen, Cheryl; Walaza, Sibongile; Tempia, Stefano; Ramatoboe, Puleng; Furumele, Tsakani; Widdowson, Marc-Alain; McMorrow, Meredith L.; Cohen, Adam L.			Knowledge, attitudes and practices of South African healthcare workers regarding the prevention and treatment of influenza among HIV-infected individuals	PLOS ONE			English	Article							UNITED-STATES	Background The South African Department of Health (DOH) publishes annual guidelines identifying priority groups, including immunosuppressed individuals and healthcare workers (HCW), for influenza vaccination and treatment. How these guidelines have impacted HCW and their patients, particularly those infected with HIV, remains unknown. Methods We aimed to describe the knowledge, attitudes and practices regarding influenza and the vaccine among South African HCW. Surveys were distributed by two local non-governmental organizations in public health clinics and hospitals in 21 districts/municipalities (5 of 9 provinces). Results There were 1164 respondents; median age 41 years; 978/1126 (87%) female; 801/1122 (71%) nurses. One-third (34%) of HCW reported getting influenza vaccine 2013/2014 and most (94%) recommended influenza vaccine to patients infected with HIV. Ability to get vaccine free of charge (aOR 1.69; 95% CI 1.21 +/- 2.37) and having received influenza government training (aOR 1.50; 95% CI 1.04 +/- 2.15) were significantly associated with self-reported vaccination in 2013/2014. Self-reported 2013/2014 vaccination (aOR 3.76; 95% CI 1.28 +/- 11.03) and availability of influenza vaccine during the healthcare visit (aOR 2.56; 95% CI 1.18-5.57) were significantly associated with recommending influenza vaccine to patients infected with HIV/AIDS. Conclusion Only one-third of participants were vaccinated in 2013-2014 but those who were vaccinated were more likely to recommend vaccination to their patients. Free and close access to influenza vaccine were associated with a higher likelihood of getting vaccinated in 2013/2014. HCW who reported getting the influenza vaccine themselves, had vaccine to offer during the patient consult and were familiar with DOH guidelines/trainings were more likely to recommend vaccine to HIV-infected patients.	[Duque, Jazmin; Tempia, Stefano; Widdowson, Marc-Alain; McMorrow, Meredith L.; Cohen, Adam L.] US Ctr Dis Control & Prevent, Atlanta, GA 30333 USA; [Duque, Jazmin] Battelle Atlanta, Atlanta, GA 30329 USA; [Gaga, Sisanda; Muller, Madeleine] Beyond Zero, Port Elizabeth, South Africa; [Clark, David; Kuwane, Bulenani] Aurum Inst, Johannesburg, South Africa; [Cohen, Cheryl; Walaza, Sibongile; Tempia, Stefano] Natl Inst Communicable Dis, Ctr Resp Dis & Meningitis, Johannesburg, South Africa; [Cohen, Cheryl; Walaza, Sibongile] Univ Witwatersrand, Sch Publ Hlth, Fac Hlth Sci, Johannesburg, South Africa; [Tempia, Stefano; Ramatoboe, Puleng; McMorrow, Meredith L.; Cohen, Adam L.] US Ctr Dis Control & Prevent South Africa, Pretoria, South Africa; [Furumele, Tsakani] Natl Dept Hlth, Pretoria, South Africa; [McMorrow, Meredith L.; Cohen, Adam L.] US PHS, Rockville, MD USA	Centers for Disease Control & Prevention - USA; National Institute for Communicable Diseases (NICD); University of Witwatersrand; United States Public Health Service	Duque, J (corresponding author), US Ctr Dis Control & Prevent, Atlanta, GA 30333 USA.; Duque, J (corresponding author), Battelle Atlanta, Atlanta, GA 30329 USA.	JDuque@cdc.gov	McMorrow, Meredith/M-1274-2019	Cohen, Cheryl/0000-0003-0376-2302; McMorrow, Meredith/0000-0001-6363-4033; Duque, Jazmin/0000-0003-3484-276X	NCIRD CDC HHS [U01 IP001048] Funding Source: Medline; National Center for Immunization and Respiratory Diseases (NCIRD) [U01IP001048] Funding Source: NIH RePORTER	NCIRD CDC HHS; National Center for Immunization and Respiratory Diseases (NCIRD)(United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA)		Black CL, 2014, MMWR-MORBID MORTAL W, V63, P805; Christini AB, 2007, INFECT CONT HOSP EP, V28, P171, DOI 10.1086/511796; Cohen C, 2015, PEDIATR INFECT DIS J, V34, P66, DOI 10.1097/INF.0000000000000478; Cohen C, 2013, EMERG INFECT DIS, V19, P1766, DOI 10.3201/eid1911.130546; Cohen C, 2012, CLIN INFECT DIS, V55, P996, DOI 10.1093/cid/cis549; Green RJ, 2008, SAMJ S AFR MED J, V98, P224; McAnerney JM, 2015, EFFECTIVENESS KNOWLE; McAnerney JM, 2012, J INFECT DIS, V206, pS153, DOI 10.1093/infdis/jis575; Otieno NA, 2014, VACCINE, V32, P6699, DOI 10.1016/j.vaccine.2013.10.089; Palache A, 2011, VACCINE, V29, P9459, DOI 10.1016/j.vaccine.2011.10.030; Ramkrishna W, 2013, OPTIONS CONTROL INFL; Sanchez-Paya J, 2011, GAC SANIT, V25, P29, DOI 10.1016/j.gaceta.2010.09.018	12	5	6	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 16	2017	12	3							e0173983	10.1371/journal.pone.0173983	http://dx.doi.org/10.1371/journal.pone.0173983			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN9KE	28301593	Green Published, Green Submitted, gold			2022-12-27	WOS:000396318300104
J	Geng, X; Zhao, HL; Zhang, SM; Li, J; Tian, F; Feng, N; Fan, R; Jia, M; Guo, HT; Cheng, L; Liu, JC; Chen, WS; Pei, JM				Geng, Xiao; Zhao, Honglin; Zhang, Shumiao; Li, Juan; Tian, Fei; Feng, Na; Fan, Rong; Jia, Min; Guo, Haitao; Cheng, Liang; Liu, Jincheng; Chen, Wensheng; Pei, Jianming			K-opioid receptor is involved in the cardioprotection induced by exercise training	PLOS ONE			English	Article							IMPROVES MYOCARDIAL TOLERANCE; ISCHEMIA-REPERFUSION INJURY; CORONARY-ARTERY OCCLUSION; ACTIVATED PROTEIN-KINASE; SKELETAL-MUSCLE; RAT-HEART; IN-VIVO; AEROBIC EXERCISE; NITRIC-OXIDE; APOPTOSIS	The present study was designed to test the hypothesis that exercise training elicited a cardioprotective effect against ischemia and reperfusion (I/R) via the K-opioid receptor (K-OR) mediated signaling pathway. Rats were randomly divided into four groups: the control group, the moderate intensity exercise (ME) group, the high intensity exercise (HE) group, and the acute exercise (AE) group. For the exercise training protocols, the rats were subjected to one week of adaptive treadmill training, while from the second week, the ME and HE groups were subjected to eight weeks of exercise training, and the AE group was subjected to three days of adaptive treadmill training and one day of vigorous exercise. After these protocols, the three exercise training groups were divided into different treatment groups, and the rats were subjected to 30 min of ischemia and 120 min of reperfusion. Changes in infarct size and serum cTnT (cardiac troponin T) caused by I/R were reduced by exercise training. Moreover, cardiac dysfunction caused by I/R was also alleviated by exercise training. These effects of exercise training were reversed by nor-BNI (a selective K-OR antagonist), Compound C (a selective AMPK inhibitor), Akt inhibitor and L-NAME (a nonselective eNOS inhibitor). Expression of K-OR and phosphorylation of AMPK, Akt and eNOS were significantly increased in the ME, HE and AE groups. These findings demonstrated that the cardioprotective effect of exercise training is possibly mediated by the K-ORAMPK-Akt-eNOS signaling pathway.	[Geng, Xiao; Zhang, Shumiao; Li, Juan; Tian, Fei; Feng, Na; Fan, Rong; Jia, Min; Guo, Haitao; Pei, Jianming] Fourth Mil Med Univ, Natl Key Discipline Cell Biol, Dept Physiol, Xian, Shaanxi Provinc, Peoples R China; [Geng, Xiao] Changan Univ, Dept Phys Educ, Xian, Shaanxi Provinc, Peoples R China; [Zhao, Honglin] Lanzhou Univ, Hosp 1, Dept Cardiovasc Surg, Lanzhou, Gansu, Peoples R China; [Cheng, Liang; Liu, Jincheng; Chen, Wensheng] Fourth Mil Med Univ, Xijing Hosp, Dept Cardiovasc Surg, Xian, Shaanxi Provinc, Peoples R China	Air Force Military Medical University; Chang'an University; Lanzhou University; Air Force Military Medical University	Pei, JM (corresponding author), Fourth Mil Med Univ, Natl Key Discipline Cell Biol, Dept Physiol, Xian, Shaanxi Provinc, Peoples R China.; Chen, WS (corresponding author), Fourth Mil Med Univ, Xijing Hosp, Dept Cardiovasc Surg, Xian, Shaanxi Provinc, Peoples R China.	chenws@fmmu.edu.cn; jmpei8@fmmu.edu.cn			National Natural Science Foundation of China [81270402]; National Natural Science Foundation of Shaanxi Province [2016KTCL03]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Natural Science Foundation of Shaanxi Province	This work was supported by the grants from the National Natural Science Foundation of China (No. 81270402) and Shaanxi Province (No. 2016KTCL03). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arida RM, 2015, J NEUROCHEM, V132, P206, DOI 10.1111/jnc.12976; Babai L, 2002, CLIN SCI, V102, P435, DOI 10.1042/CS20010296; BEDFORD TG, 1979, J APPL PHYSIOL, V47, P1278, DOI 10.1152/jappl.1979.47.6.1278; Birk JB, 2006, J PHYSIOL-LONDON, V577, P1021, DOI 10.1113/jphysiol.2006.120972; Borges JP, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0113541; Brown DA, 2005, J PHYSIOL-LONDON, V564, P619, DOI 10.1113/jphysiol.2004.081323; Cheng L, 2007, HEART VESSELS, V22, P335, DOI 10.1007/s00380-007-0983-z; Demirel HA, 2001, J APPL PHYSIOL, V91, P2205, DOI 10.1152/jappl.2001.91.5.2205; Dickson EW, 2008, AM J PHYSIOL-HEART C, V294, pH402, DOI 10.1152/ajpheart.00280.2007; French JP, 2006, AM J PHYSIOL-HEART C, V290, pH128, DOI 10.1152/ajpheart.00739.2005; Galvao TFG, 2011, CLINICS, V66, P151, DOI 10.1590/S1807-59322011000100026; Grijalva J, 2008, CARDIOVASC DIABETOL, V7, DOI 10.1186/1475-2840-7-34; Guo HT, 2011, J CARDIOVASC PHARM, V58, P207, DOI 10.1097/FJC.0b013e318220e37f; HUTTER MM, 1994, CIRCULATION, V89, P355, DOI 10.1161/01.CIR.89.1.355; Jensen TE, 2009, ACTA PHYSIOL, V196, P155, DOI 10.1111/j.1748-1716.2009.01979.x; Ji L L, 1995, Exerc Sport Sci Rev, V23, P135; Ji LL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069910; JI LL, 1994, ACTA PHYSIOL SCAND, V151, P279, DOI 10.1111/j.1748-1716.1994.tb09747.x; Kumar R, 2011, J ETHNOPHARMACOL, V136, P260, DOI 10.1016/j.jep.2011.04.040; Laughlin MH, 1998, MED SCI SPORT EXER, V30, P352, DOI 10.1097/00005768-199803000-00004; Lee Y, 2012, MED SCI SPORT EXER, V44, P397, DOI 10.1249/MSS.0b013e318231c037; Loomis A L, 1889, Trans Am Climatol Assoc Meet, V6, P253; Lu K, 2015, MOL MED REP, V12, P2374, DOI 10.3892/mmr.2015.3669; Marini M, 2011, LIPIDS HEALTH DIS, V10, DOI 10.1186/1476-511X-10-188; MCELROY CL, 1978, CIRCULATION, V57, P958, DOI 10.1161/01.CIR.57.5.958; Miller LE, 2015, EXP PHYSIOL, V100, P410, DOI 10.1113/expphysiol.2014.083436; Nakamura M, 2000, CARDIOVASC RES, V45, P661, DOI 10.1016/S0008-6363(99)00393-4; Paiva MA, 2010, CARDIOVASC DRUG THER, V24, P25, DOI 10.1007/s10557-010-6222-3; Powers SK, 2014, PHYSIOLOGY, V29, P27, DOI 10.1152/physiol.00030.2013; Powers SK, 1998, AM J PHYSIOL-REG I, V275, pR1468, DOI 10.1152/ajpregu.1998.275.5.R1468; PUGSLEY MK, 1992, EUR J PHARMACOL, V212, P15, DOI 10.1016/0014-2999(92)90066-D; Quindry JC, 2010, AM J PHYSIOL-HEART C, V299, pH175, DOI 10.1152/ajpheart.01211.2009; Rodrigues F, 2014, BMC CARDIOVASC DISOR, V14, DOI 10.1186/1471-2261-14-84; Russell RR, 2004, J CLIN INVEST, V114, P495, DOI 10.1172/JCI200419297; SELVAKUMARAN M, 1994, MOL CELL BIOL, V14, P2352, DOI 10.1128/MCB.14.4.2352; Shi QX, 2013, AM J THER, V20, P493, DOI 10.1097/MJT.0b013e3182456676; Solskov L, 2012, MOL CELL BIOCHEM, V360, P353, DOI 10.1007/s11010-011-1075-z; Steinberg GR, 2009, PHYSIOL REV, V89, P1025, DOI 10.1152/physrev.00011.2008; TAI KK, 1992, LIFE SCI, V51, P909, DOI 10.1016/0024-3205(92)90398-9; Tong GA, 2011, LIFE SCI, V88, P31, DOI 10.1016/j.lfs.2010.10.018; Treebak JT, 2007, AM J PHYSIOL-ENDOC M, V292, pE715, DOI 10.1152/ajpendo.00380.2006; Wang QM, 2014, EUR J PHARMACOL, V737, P177, DOI 10.1016/j.ejphar.2014.05.006; Xiao XY, 2010, J NUTR BIOCHEM, V21, P621, DOI 10.1016/j.jnutbio.2009.03.011; Xiu J, 2013, AM J MED SCI, V345, P129, DOI 10.1097/MAJ.0b013e31824ceba7; Yang KC, 2012, J MOL CELL CARDIOL, V53, P532, DOI 10.1016/j.yjmcc.2012.07.004; Yang L, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0096892; Zhang KR, 2007, APOPTOSIS, V12, P1579, DOI 10.1007/s10495-007-0090-8; Zhang QJ, 2007, CARDIOVASC RES, V75, P369, DOI 10.1016/j.cardiores.2007.04.015; Zhang QY, 2010, CRIT CARE MED, V38, P2365, DOI 10.1097/CCM.0b013e3181fa0437	49	9	9	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 16	2017	12	3							e0170463	10.1371/journal.pone.0170463	http://dx.doi.org/10.1371/journal.pone.0170463			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN9KE	28301473	Green Submitted, Green Published, gold			2022-12-27	WOS:000396318300005
J	Gu, LT; Sun, CH; Gong, YZ; Yu, M; Li, SJ				Gu, Lantao; Sun, Chenghao; Gong, Yangzhang; Yu, Mei; Li, Shijun			Novel copy number variation of the TGF beta 3 gene is associated with TGF beta 3 gene expression and duration of fertility traits in hens	PLOS ONE			English	Article							GROWTH-FACTOR-BETA; UTERO-VAGINAL JUNCTION; T-CELL GROWTH; SPERM-STORAGE; ARTIFICIAL-INSEMINATION; ANAS-PLATYRHYNCHOS; BROILER BREEDERS; CAIRINA-MOSCHATA; POTENTIAL ROLE; MESSENGER-RNA	Improvements in the duration of fertility (DF) could increase the interval between successive artificial inseminations, thereby decreasing the cost associated with production of hatching eggs. The molecular mechanisms involved in DF in hens remains under-explored. In this study, expression levels of the transforming growth factor-/3 genes (TGF/3s: TGF/31, TGFI32, TGFI33) were investigated in utero-vaginal junctions (UVJs) of hens with long DF (Group L, n = 10) and short DF (Group S, n = 1 0). TGFI31 and 2 tended to exhibit higher expression levels in UVJs from Group L hens. The expression levels of TGFI33 mRNA and protein were significantly increased in UVJs of hens from Group L compared to hens in Group S. Consistently, six TGF/3s downstream genes (DAXX, MEKK1, T-BET, GATA-3, TAK1, and FOXP3) associated with the immune response were found to be significantly differentially expressed in UVJs of Group L than Group S hens. In addition, four SNPs were identified in intron 1 of TGFI33, and these SNPs were significantly associated with DF traits (P< 0.05). Furthermore, we identified multi-copy and copy number variants (CNVs) in chicken TGF/33 and later determined significant associations between TGF/33 CNVs and DF traits in hens. Specifically, TGF/33 copy number exhibited a significant positive correlation with its expression (P < 0.05). Collectively, our results suggest that chicken DF traits may be regulated by the expression of TGFI33 in UVJ. Meanwhile, the copy number variation in the TGF/33 gene identified in this study seems to be one marker for DF traits.	[Gu, Lantao; Gong, Yangzhang; Yu, Mei; Li, Shijun] HuaZhong Agr Univ, Coll Anim Sci & Technol, Minist Educ, Key Lab Agr Anim Genet Breeding & Reprod, Wuhan, Hubei, Peoples R China; [Sun, Chenghao] Huadu Yukou Poultry Ind Co Ltd, Beijing, Peoples R China	Huazhong Agricultural University	Li, SJ (corresponding author), HuaZhong Agr Univ, Coll Anim Sci & Technol, Minist Educ, Key Lab Agr Anim Genet Breeding & Reprod, Wuhan, Hubei, Peoples R China.	lishijun@mail.hzau.edu.cn			National Nature Scientific Foundation of China [31372301]; Fundamental Research Funds for the Central Universities of China [2662015PY145]	National Nature Scientific Foundation of China(National Natural Science Foundation of China (NSFC)); Fundamental Research Funds for the Central Universities of China(Fundamental Research Funds for the Central Universities)	The current research was financially supported by the National Nature Scientific Foundation of China (31372301) and the Fundamental Research Funds for the Central Universities of China (No. 2662015PY145). The funders did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the "author contributions" section.	Aldred PMR, 2005, HUM MOL GENET, V14, P2045, DOI 10.1093/hmg/ddi209; Bakst MR, 2011, J ANIM SCI, V89, P1323, DOI 10.2527/jas.2010-3663; Bakst MR, 2010, POULTRY SCI, V89, P986, DOI 10.3382/ps.2009-00481; BAKST MR, 1993, REPROD FERT DEVELOP, V5, P595, DOI 10.1071/RD9930595; BAKST MR, 1987, SCANNING MICROSCOPY, V1, P1257; Birkhead TR, 2007, TRENDS ECOL EVOL, V22, P266, DOI 10.1016/j.tree.2007.02.004; BRILLARD JP, 1990, BRIT POULTRY SCI, V31, P635, DOI 10.1080/00071669008417294; Brun JM, 2012, ANIMAL, V6, P1731, DOI 10.1017/S1751731112001206; Burgtorf C, 2003, GENOME RES, V13, P2717, DOI 10.1101/gr.1442303; Burt David W., 1994, Progress in Growth Factor Research, V5, P99; Cheng YS, 2002, GENET SEL EVOL, V34, P597, DOI [10.1051/gse:2002025, 10.1186/1297-9686-34-5-597]; Cheng YS, 2009, GENET SEL EVOL, V41, DOI 10.1186/1297-9686-41-32; Das SC, 2005, J REPROD DEVELOP, V51, P683, DOI 10.1262/jrd.17027; Das SC, 2008, AM J REPROD IMMUNOL, V60, P477, DOI 10.1111/j.1600-0897.2008.00651.x; Das SC, 2006, REPRODUCTION, V132, P781, DOI 10.1530/rep.1.01177; Goerzen PR, 1996, POULTRY SCI, V75, P962, DOI 10.3382/ps.0750962; Higaki Kuniaki, 1995, Japanese Poultry Science, V32, P387; KEHRL JH, 1986, J EXP MED, V163, P1037, DOI 10.1084/jem.163.5.1037; KEHRL JH, 1991, J IMMUNOL, V146, P4016; Kehrl JH, 2014, J IMMUNOL, V192, P2939; KOSBA MA, 1983, BEITR TROP LANDWIRT, V21, P365; Lake P.E., 1975, Symposia Zool Soc Lond, VNo. 35, P225; Liu GQ, 2008, BRIT POULTRY SCI, V49, P770, DOI 10.1080/00071660802433131; NOCERA M, 1995, AM J REPROD IMMUNOL, V33, P282, DOI 10.1111/j.1600-0897.1995.tb00897.x; OTTINGER MA, 1989, BRIT POULTRY SCI, V30, P431, DOI 10.1080/00071668908417167; Piek E, 1999, FASEB J, V13, P2105, DOI 10.1096/fasebj.13.15.2105; PINGEL M, 1985, MONATSHEFTEFUR VET M, V40, P129; Schmidt-Weber CB, 2004, CURR OPIN IMMUNOL, V16, P709, DOI 10.1016/j.coi.2004.09.008; Shi T, 2016, ANIM SCI J, V87, P336, DOI 10.1111/asj.12531; Silber S, 2010, FERTIL STERIL, V94, P2191, DOI 10.1016/j.fertnstert.2009.12.073; SPORN MB, 1992, J CELL BIOL, V119, P1017, DOI 10.1083/jcb.119.5.1017; WISHART GJ, 1987, J REPROD FERTIL, V80, P493, DOI 10.1530/jrf.0.0800493; Zheng WM, 2001, REPRODUCTION, V122, P581, DOI 10.1530/reprod/122.4.581	33	5	6	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 16	2017	12	3							e0173696	10.1371/journal.pone.0173696	http://dx.doi.org/10.1371/journal.pone.0173696			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN9KE	28301526	Green Published, Green Submitted, gold			2022-12-27	WOS:000396318300063
J	Iloh, AC; Schmidt, M; Muellner-Riehl, AN; Ogundipe, OT; Paule, J				Iloh, Andrew Chibuzor; Schmidt, Marco; Muellner-Riehl, Alexandra Nora; Ogundipe, Oluwatoyin Temitayo; Paule, Juraj			Pleistocene refugia and genetic diversity patterns in West Africa: Insights from the liana Chasmanthera dependens (Menispermaceae)	PLOS ONE			English	Article							RAIN-FOREST TREES; DAHOMEY GAP; ENVIRONMENTAL-CHANGE; MAXIMUM-LIKELIHOOD; TROPICAL AFRICA; HISTORY; CLIMATE; PHYLOGEOGRAPHY; EVOLUTION; FRAGMENTATION	Processes shaping the African Guineo-Congolian rain forest, especially in the West African part, are not well understood. Recent molecular studies, based mainly on forest tree species, confirmed the previously proposed division of the western African Guineo-Congolian rain forest into Upper Guinea (UG) and Lower Guinea (LG) separated by the Dahomey Gap (DG). Here we studied nine populations in the area of the DG and the borders of LG and UG of the widespread liana species, Chasmanthera dependens (Menispermaceae) by amplified fragment length polymorphism (AFLP), a chloroplast DNA sequence marker, and modelled the distribution based on current as well as paleoclimatic data (Holocene Climate Optimum, ca. 6 kyr BP and Last Glacial Maximum, ca. 22 kyr BP). Current population genetic structure and geographical pattern of cpDNA was related to present as well as historical modelled distributions. Results from this study show that past historical factors played an important role in shaping the distribution of C. dependens across West Africa. The Cameroon Volcanic Line seems to represent a barrier for gene flow in the present as well as in the past. Distribution modelling proposed refugia in the Dahomey Gap, supported also by higher genetic diversity. This is in contrast with the phylogeographic patterns observed in several rainforest tree species and could be explained by either diverging or more relaxed ecological requirements of this liana species.	[Iloh, Andrew Chibuzor; Schmidt, Marco; Muellner-Riehl, Alexandra Nora] Senckenberg Biodivers & Climate Res Ctr BiK F, Senckenberganlage 25, Frankfurt, Germany; [Schmidt, Marco; Paule, Juraj] Senckenberg Res Inst, Dept Bot & Mol Evolut, Senckenberganlage 25, Frankfurt, Germany; [Schmidt, Marco; Paule, Juraj] Nat Hist Museum Frankfurt, Senckenberganlage 25, Frankfurt, Germany; [Muellner-Riehl, Alexandra Nora] Univ Leipzig, Inst Biol, Dept Mol Evolut & Plant Systemat, Johannisallee 21-23, Leipzig, Germany; [Muellner-Riehl, Alexandra Nora] Univ Leipzig, Herbarium LZ, Johannisallee 21-23, Leipzig, Germany; [Muellner-Riehl, Alexandra Nora] German Ctr Integrat Biodivers Res iDiv, Deutsch Pl 5e, Leipzig, Germany; [Ogundipe, Oluwatoyin Temitayo] Univ Lagos, Dept Bot, Mol Systemat Lab, Lagos, Nigeria; [Iloh, Andrew Chibuzor] Sheda Sci & Technol Complex, Ctr Adv Res Biotechnol, Biodivers & Climate Res Lab, Abuja, Nigeria	Senckenberg Biodiversitat & Klima- Forschungszentrum (BiK-F); Senckenberg Gesellschaft fur Naturforschung (SGN); Senckenberg Gesellschaft fur Naturforschung (SGN); Leipzig University; Leipzig University; University of Lagos	Iloh, AC (corresponding author), Senckenberg Biodivers & Climate Res Ctr BiK F, Senckenberganlage 25, Frankfurt, Germany.; Iloh, AC (corresponding author), Sheda Sci & Technol Complex, Ctr Adv Res Biotechnol, Biodivers & Climate Res Lab, Abuja, Nigeria.	chibaziloh@gmail.com	Muellner-Riehl, Alexandra N/C-6261-2013; Paule, Juraj/A-2998-2017; Schmidt, Marco/C-3821-2009	Muellner-Riehl, Alexandra N/0000-0002-2710-469X; Paule, Juraj/0000-0001-5375-7689; Schmidt, Marco/0000-0001-6087-6117; ILOH, Andrew Chibuzor/0000-0001-5052-3430	Alexander von Humboldt Foundation, Germany	Alexander von Humboldt Foundation, Germany(Alexander von Humboldt Foundation)	Funding was provided by the Alexander von Humboldt Foundation, Germany in the scope of International Climate Protection Fellowship granted to Andrew Chibuzor Iloh.	Anhuf D, 2006, PALAEOGEOGR PALAEOCL, V239, P510, DOI 10.1016/j.palaeo.2006.01.017; BAWA KS, 1977, EVOLUTION, V31, P64, DOI 10.1111/j.1558-5646.1977.tb00982.x; Bonin A, 2004, MOL ECOL, V13, P3261, DOI 10.1111/j.1365-294X.2004.02346.x; BOOTH AH, 1958, EVOLUTION, V12, P48, DOI 10.2307/2405903; Budde KB, 2013, HEREDITY, V111, P66, DOI 10.1038/hdy.2013.21; Burkill HM, 1997, USEFUL PLANTS W TROP, V4; Charlesworth B, 2009, NATURE REV GENETICS, V10, P1; Chave J, 2001, J TROP ECOL, V17, P79, DOI 10.1017/S0266467401001055; Clement M, 2000, MOL ECOL, V9, P1657, DOI 10.1046/j.1365-294x.2000.01020.x; Convention on Biological Diversity (CBD), 2007, EM ISS BIOD CONS CHA; Dainou K, 2010, MOL ECOL, V19, P4462, DOI 10.1111/j.1365-294X.2010.04831.x; Dauby G, 2014, MOL ECOL, V23, P2299, DOI 10.1111/mec.12724; Demenou BB, 2016, J BIOGEOGR, V43, P1020, DOI 10.1111/jbi.12688; Dick C. W., 2008, Tropical Plant Biology, V1, P20, DOI 10.1007/s12042-007-9006-6; Doyle JJ, 1987, PHYTOCHEM B, V19, P11, DOI 10.1016/j.bse.2009.07.003; Duminil J, 2010, MOL ECOL, V19, P5469, DOI 10.1111/j.1365-294X.2010.04917.x; Duminil J, 2015, J BIOGEOGR, V42, P1443, DOI 10.1111/jbi.12510; Duminil J, 2013, BMC EVOL BIOL, V13, DOI 10.1186/1471-2148-13-195; Dupont LM, 2001, GEOLOGY, V29, P195, DOI 10.1130/0091-7613(2001)029<0195:MPECIT>2.0.CO;2; Ehrich D, 2006, MOL ECOL NOTES, V6, P603, DOI 10.1111/j.1471-8286.2006.01380.x; EXCOFFIER L, 1992, GENETICS, V131, P479; Excoffier L, 2005, EVOL BIOINFORM, V1, P47, DOI 10.1177/117693430500100003; Gerwing JJ, 2000, J TROP ECOL, V16, P327, DOI 10.1017/S0266467400001437; Gerwing JJ, 2004, FOREST ECOL MANAG, V190, P57, DOI 10.1016/j.foreco.2003.10.006; Global Biodiversity Information Facility (GBIF, 2016, CHASM DEP DAT BAS; Gnoumou A, 2015, CHECK LIST, V11, P1, DOI DOI 10.15560/11.1.1557; HAMILTON AC, 1991, CLIMATIC CHANGE, V19, P65, DOI 10.1007/BF00142215; Hamilton MB, 2002, GENETICS, V162, P1897; Hammer Oyvind, 2001, Palaeontologia Electronica, V4, pUnpaginated; HANLEY JA, 1982, RADIOLOGY, V143, P29, DOI 10.1148/radiology.143.1.7063747; Hardy OJ, 2013, CR GEOSCI, V345, P284, DOI 10.1016/j.crte.2013.05.001; Heuertz M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0084307; Hijmans RJ, 2005, INT J CLIMATOL, V25, P1965, DOI 10.1002/joc.1276; Iwu M. M., 2014, HDB AFRICAN MED PLAN; Klopper RR, 2007, TAXON, V56, P201, DOI 10.2307/25065751; Ley AC, 2016, BIOTROPICA, V48, P618, DOI 10.1111/btp.12341; Ley AC, 2014, FRONT GENET, V5, DOI 10.3389/fgene.2014.00403; Lowe A. J., 2010, Tropical Plant Biology, V3, P50, DOI 10.1007/s12042-010-9045-2; Maley J, 1996, P ROYAL SOC EDINBURG, V104B, P31, DOI 10.1017/S0269727000006114; Mannah A, 2009, HEILTRADITIONEN BIOD; Martin PH, 2004, BIOTROPICA, V36, P297; Matallana G, 2005, AM J BOT, V92, P1513, DOI 10.3732/ajb.92.9.1513; Miller CS, 2014, QUATERNARY SCI REV, V84, P7, DOI 10.1016/j.quascirev.2013.10.027; Mogensen HL, 1996, AM J BOT, V83, P383, DOI 10.2307/2446172; Mosango DM, 2008, PROTA PLANT RESOURCE, P23; Myers N, 2000, NATURE, V403, P853, DOI 10.1038/35002501; Nason JD, 1996, J BIOGEOGR, V23, P501, DOI 10.1111/j.1365-2699.1996.tb00012.x; NEI M, 1983, GENETICS, V105, P207; Nei M., 1987, MOL EVOLUTIONARY GEN; Brandes AFN, 2011, TREES-STRUCT FUNCT, V25, P133, DOI 10.1007/s00468-010-0529-3; Normand S, 2011, P ROY SOC B-BIOL SCI, V278, P3644, DOI 10.1098/rspb.2010.2769; Petit RJ, 2006, ANNU REV ECOL EVOL S, V37, P187, DOI 10.1146/annurev.ecolsys.37.091305.110215; Petit RJ, 2003, SCIENCE, V300, P1563, DOI 10.1126/science.1083264; Petit RJ, 2005, MOL ECOL, V14, P689, DOI 10.1111/j.1365-294X.2004.02410.x; Phillips SJ, 2006, ECOL MODEL, V190, P231, DOI 10.1016/j.ecolmodel.2005.03.026; Plana V, 2004, PHILOS T ROY SOC B, V359, P1585, DOI 10.1098/rstb.2004.1535; Rozas J, 2009, METHODS MOL BIOL, V537, P337, DOI 10.1007/978-1-59745-251-9_17; Salzmann U, 2005, HOLOCENE, V15, P190, DOI 10.1191/0959683605hl799rp; Schnitzer SA, 2002, TRENDS ECOL EVOL, V17, P223, DOI 10.1016/S0169-5347(02)02491-6; Shaw J, 2005, AM J BOT, V92, P142, DOI 10.3732/ajb.92.1.142; Simmons MP, 2000, SYST BIOL, V49, P369, DOI 10.1093/sysbio/49.2.369; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; Troupin G, 1962, MONOGRAPHIE MENISPER; Vollmert P, 2004, ERDE, V134, P375; VOS P, 1995, NUCLEIC ACIDS RES, V23, P4407, DOI 10.1093/nar/23.21.4407; Wefferling KM, 2013, AM J BOT, V100, P883, DOI 10.3732/ajb.1200556; WHITE F, 1979, Bulletin du Jardin Botanique National de Belgique, V49, P11, DOI 10.2307/3667815; Yao XH, 2007, NEW PHYTOL, V176, P472, DOI 10.1111/j.1469-8137.2007.02175.x; Zeng XQ, 2012, J PLANT ECOL-UK, V5, P270, DOI 10.1093/jpe/rtr029	69	6	6	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 16	2017	12	3							e0170511	10.1371/journal.pone.0170511	http://dx.doi.org/10.1371/journal.pone.0170511			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN9KE	28301470	Green Published, Green Submitted, gold			2022-12-27	WOS:000396318300007
J	Mandraffino, G; Aragona, CO; Cairo, V; Scuruchi, M; Lo Gullo, A; D'Ascola, A; Alibrandi, A; Loddo, S; Quartuccio, S; Morace, C; Mormina, E; Basile, G; Saitta, A; Imbalzano, E				Mandraffino, Giuseppe; Aragona, Caterina Oriana; Cairo, Valentina; Scuruchi, Michele; Lo Gullo, Alberto; D'Ascola, Angela; Alibrandi, Angela; Loddo, Saverio; Quartuccio, Sebastiano; Morace, Carmela; Mormina, Enricomaria; Basile, Giorgio; Saitta, Antonino; Imbalzano, Egidio			Circulating progenitor cells in hypertensive subjects: Effectiveness of a treatment with olmesartan in improving cell number and miR profile in addition to expected pharmacological effects	PLOS ONE			English	Article							ANGIOTENSIN-II; CARDIOVASCULAR RISK; OXIDATIVE STRESS; NADPH OXIDASE; ENDOTHELIAL-CELLS; TYPE-1 RECEPTOR; CD34(+) CELLS; MICRORNAS; EXPRESSION; ATHEROSCLEROSIS	CD34+ circulating progenitor cells (CD34+ CPCs) are a population of multipotent cells which can delay the development of atherosclerosis and cardiovascular disease (CVD) in conditions of increased CV risk. MicroRNAs (miRs) 221 and 222 modulate different genes regulating angiogenesis and inflammation; moreover, miR221/22 have beenshown to participate in differentiation and proliferation of CD34+ CPCs, inhibiting cell migration and homing. miR221/222 in CD34+ CPCs from hypertensive subjects are also increased and associated with CD34+ cell number and reactive oxygen species (ROS). We evaluated CD34+ CPC number, intracellular miR221/222 and ROS levels, arterial stiffness (AS) and echocardiography indices at baseline (T0). Then, after a six-month treatment with olmesartan, 20 mg/day (T1), in 57 hypertensive patients with left ventricular hypertrophy (LVH) and with no additional risk factor for CVD, and in 29 healthy controls (baseline), fibrinogen, C-reactive protein (CRP), glucose and lipid profiles were also evaluated. At T1, blood pressure values, CRP and fibrinogen levels, ROS and miR221/222 were significantly decreased (all p < 0.001), as were AS indices and LV mass index (p< 0.001), while cell number was increased (p< 0.001). Olmesartan is effective in reducing miR and ROS levels in CD34+ CPCs from hypertensive subjects, as well as in increasing CD34+ CPC number, providing multilevel CV protection, in addition to its expected pharmacological effects.	[Mandraffino, Giuseppe; Aragona, Caterina Oriana; Cairo, Valentina; Lo Gullo, Alberto; Quartuccio, Sebastiano; Morace, Carmela; Basile, Giorgio; Saitta, Antonino; Imbalzano, Egidio] Univ Messina, Dept Clin & Expt Med, Messina, Italy; [Scuruchi, Michele; D'Ascola, Angela; Loddo, Saverio] Univ Messina, Dept Biochem Physiol & Nutr Sci, Messina, Italy; [Alibrandi, Angela] Univ Messina, Dept Stat, Messina, Italy; [Mormina, Enricomaria] Univ Messina, Dept Biomed Sci & Morphol & Funct Images, Messina, Italy	University of Messina; University of Messina; University of Messina; University of Messina	Mandraffino, G (corresponding author), Univ Messina, Dept Clin & Expt Med, Messina, Italy.	gmandraffino@unime.it	Imbalzano, Egidio/A-2063-2015; Scuruchi, Michele/K-2533-2018; Mandraffino, Giuseppe/K-4346-2018; Gullo, Alberto Lo/AAC-2766-2019; Mormina, Enricomaria/K-4664-2016	Imbalzano, Egidio/0000-0003-2656-5467; Mandraffino, Giuseppe/0000-0003-0272-2237; Mormina, Enricomaria/0000-0003-2716-5772; SCURUCHI, Michele/0000-0002-5282-1690; Lo Gullo, Alberto/0000-0003-4383-0314; CAIRO, VALENTINA/0000-0001-6921-3037; d'ascola, angela/0000-0001-7530-1316; BASILE, Giorgio/0000-0002-0040-8618	Clinical and Experimental Medicine Department, University of Messina	Clinical and Experimental Medicine Department, University of Messina	This study has been carried out with a support of funds allocated by our Department (Clinical and Experimental Medicine Department, University of Messina) for Clinical Research. These funding are annually assigned by the University of Messina. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albinsson S, 2010, ARTERIOSCL THROM VAS, V30, P1118, DOI 10.1161/ATVBAHA.109.200873; Bahlmann FH, 2005, HYPERTENSION, V45, P526, DOI 10.1161/01.HYP.0000159191.98140.89; Barnett D, 1999, CLIN LAB HAEMATOL, V21, P301, DOI 10.1046/j.1365-2257.1999.00253.x; Bartel DP, 2009, CELL, V136, P215, DOI 10.1016/j.cell.2009.01.002; Batkai S, 2012, CURR HYPERTENS REP, V14, P79, DOI 10.1007/s11906-011-0235-6; Bo S, 2012, NUTR METAB CARDIOVAS, V22, P668, DOI 10.1016/j.numecd.2010.11.004; Bonauer A, 2010, CURR DRUG TARGETS, V11, P943, DOI 10.2174/138945010791591313; Brandes RP, 2005, CARDIOVASC RES, V65, P16, DOI 10.1016/j.cardiores.2004.08.007; Calo LA, 2014, J HYPERTENS, V32, P193, DOI 10.1097/HJH.0b013e32836522c3; Chao H, 2010, MICROVASC RES, V79, P169, DOI 10.1016/j.mvr.2010.02.003; Chappell MC, 2016, AM J PHYSIOL-HEART C, V310, pH137, DOI 10.1152/ajpheart.00618.2015; Chobanian AV., 2003, HYPERTENSION, V42, P1206, DOI [10.1161/01.HYP.0000107251, DOI 10.1161/01.HYP.9.2_PT_2.II36, DOI 10.1161/01.HYP.0000107251.49515.C2]; de Boer HC, 2011, ARTERIOSCL THROM VAS, V31, P408, DOI 10.1161/ATVBAHA.110.216879; Ebert MS, 2012, CELL, V149, P515, DOI 10.1016/j.cell.2012.04.005; Endtmann C, 2011, HYPERTENSION, V58, P394, DOI 10.1161/HYPERTENSIONAHA.110.169193; Fadini GP, 2006, EUR HEART J, V27, P2247, DOI 10.1093/eurheartj/ehl198; Fadini GP, 2012, CIRC RES, V110, P624, DOI 10.1161/CIRCRESAHA.111.243386; Felli N, 2005, P NATL ACAD SCI USA, V102, P18081, DOI 10.1073/pnas.0506216102; Fliser D, 2004, CIRCULATION, V110, P1103, DOI 10.1161/01.CIR.0000140265.21608.8E; Gong X, 2015, MED SCI MONITOR, V21, P1189, DOI 10.12659/MSM.892996; Gutierrez-Fernandez M, 2015, J NEUROSCI RES, V93, P806, DOI 10.1002/jnr.23532; Heggermont WA, 2012, HYPERTENSION, V60, P1088, DOI 10.1161/HYPERTENSIONAHA.111.187104; Hill JM, 2003, NEW ENGL J MED, V348, P593, DOI 10.1056/NEJMoa022287; Hirschi KK, 2008, ARTERIOSCL THROM VAS, V28, P1584, DOI 10.1161/ATVBAHA.107.155960; Hwang J, 2003, CIRC RES, V93, P1225, DOI 10.1161/01.RES.0000104087.29395.66; Imanishi T, 2005, J HYPERTENS, V23, P1831, DOI 10.1097/01.hjh.0000183524.73746.1b; Imanishi T, 2005, J HYPERTENS, V23, P97, DOI 10.1097/00004872-200501000-00018; Lang RM, 2005, J AM SOC ECHOCARDIOG, V18, P1440, DOI 10.1016/j.echo.2005.10.005; LEBEL CP, 1992, CHEM RES TOXICOL, V5, P227, DOI 10.1021/tx00026a012; Leung A, 2013, CIRC RES, V113, P266, DOI 10.1161/CIRCRESAHA.112.300849; Lo Gullo A, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0134602; Mandraffino G, 2014, J HUM HYPERTENS, V28, P543, DOI 10.1038/jhh.2014.7; Mandraffino G, 2014, J HUM HYPERTENS; Mandraffino G, 2012, EXP GERONTOL, V47, P394, DOI 10.1016/j.exger.2012.03.007; Mandraffino G, 2010, CLIN BIOCHEM, V43, P1436, DOI 10.1016/j.clinbiochem.2010.09.023; Mendell JT, 2012, CELL, V148, P1172, DOI 10.1016/j.cell.2012.02.005; Minami Y, 2009, EUR J CLIN INVEST, V39, P359, DOI 10.1111/j.1365-2362.2009.02110.x; Miura S, 2006, J BIOL CHEM, V281, P19288, DOI 10.1074/jbc.M602144200; Mollnau H, 2002, CIRC RES, V90, pE58, DOI 10.1161/01.RES.0000012569.55432.02; Morris BJ, 2015, HYPERTENSION, V65, P956, DOI 10.1161/HYPERTENSIONAHA.114.04366; Nazari-Jahantigh M, 2012, THROMB HAEMOSTASIS, V107, P611, DOI 10.1160/TH11-12-0826; Norata GD, 2013, ATHEROSCLEROSIS, V227, P209, DOI 10.1016/j.atherosclerosis.2012.11.019; Paravicini TM, 2008, DIABETES CARE, V31, pS170, DOI 10.2337/dc08-s247; Pesarin F., 2010, PERMUTATION TESTS CO; Pillai RS, 2007, TRENDS CELL BIOL, V17, P118, DOI 10.1016/j.tcb.2006.12.007; Pirro M, 2007, J HYPERTENS, V25, P2093, DOI 10.1097/HJH.0b013e32828e506d; Poliseno L, 2006, BLOOD, V108, P3068, DOI 10.1182/blood-2006-01-012369; Quiat D, 2013, J CLIN INVEST, V123, P11, DOI 10.1172/JCI62876; Richardson MR, 2011, J MOL CELL CARDIOL, V50, P266, DOI 10.1016/j.yjmcc.2010.07.009; Rigato M, 2015, J CLIN ENDOCR METAB, V100, P2666, DOI 10.1210/jc.2015-1687; Roks AJM, 2011, CURR OPIN PHARMACOL, V11, P162, DOI 10.1016/j.coph.2011.01.002; Shi LJ, 2015, DRUG DISCOV TODAY, V20, P1188, DOI 10.1016/j.drudis.2015.05.007; Shilo S, 2008, ARTERIOSCL THROM VAS, V28, P471, DOI 10.1161/ATVBAHA.107.160655; Sidney LE, 2014, STEM CELLS, V32, P1380, DOI 10.1002/stem.1661; Singh K. D., 2016, J CELL SIGNAL, V1; Suarez Y, 2007, CIRC RES, V100, P1164, DOI 10.1161/01.RES.0000265065.26744.17; Touyz RM, 2004, HYPERTENSION, V44, P248, DOI 10.1161/01.HYP.0000138070.47616.9d; Tsuda M, 2005, HYPERTENSION, V45, P545, DOI 10.1161/01.HYP.0000157409.88971.fc; Urbich C, 2008, CARDIOVASC RES, V79, P581, DOI 10.1093/cvr/cvn156; Ushio-Fukai M, 2009, ANTIOXID REDOX SIGN, V11, P2517, DOI [10.1089/ars.2009.2582, 10.1089/ARS.2009.2582]; Werner N, 2006, ARTERIOSCL THROM VAS, V26, P257, DOI 10.1161/01.ATV.0000198239.41189.5d; Xue YX, 2015, ATHEROSCLEROSIS, V241, P671, DOI 10.1016/j.atherosclerosis.2015.06.031; Yatabe J, 2009, AM J PHYSIOL-RENAL, V296, pF1052, DOI 10.1152/ajprenal.00580.2007; Yoder MC, 2013, J MOL MED, V91, P285, DOI 10.1007/s00109-013-1002-8; Zhu N, 2011, ATHEROSCLEROSIS, V215, P286, DOI 10.1016/j.atherosclerosis.2010.12.024	65	17	17	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 16	2017	12	3							e0173030	10.1371/journal.pone.0173030	http://dx.doi.org/10.1371/journal.pone.0173030			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN9KE	28301500	Green Submitted, Green Published, gold			2022-12-27	WOS:000396318300023
J	Miller, AL; Elam, WA; Johnson, BH; Khan, SH; Kumar, R; Thompson, EB				Miller, Aaron L.; Elam, W. Austin; Johnson, Betty H.; Khan, Shagufta H.; Kumar, Raj; Thompson, E. Brad			Restored mutant receptor: Corticoid binding in chaperone complexes by trimethylamine N-oxide	PLOS ONE			English	Article							HUMAN GLUCOCORTICOID-RECEPTOR; RESISTANT; PROTEINS; CELLS; EXPRESSION; OSMOLYTES; DOMAIN; GENE	Without a glucocorticoid (GC) ligand, the transcription factor glucocorticoid receptor (GR) is largely cytoplasmic, with its GC-binding domain held in high affinity conformation by a cluster of chaperones. Binding a GC causes serial dis- and re-associations with chaperones, translocation of the GR to the nucleus, where it binds to DNA sites and associates with coregulatory proteins and basic transcription complexes. Herein, we describe the effects of a potent protective osmolyte, trimethylamine N-oxide (TMAO), on a conditions-dependent "activation-labile" mutant GR (GR(act/l)), which under GR-activating conditions cannot bind GCs in cells or in cell cytosols. In both cells and cytosols, TMAO restores binding to GR(act/l) by stabilizing it in complex with chaperones. Cells bathed in much lower concentrations of TMAO than those required in vitro show restoration of GC binding, presumably due to intracellular molecular crowding effects.	[Miller, Aaron L.; Elam, W. Austin; Johnson, Betty H.; Thompson, E. Brad] Univ Texas Med Branch, Sealy Ctr Struct Biol, Dept Biochem & Mol Biol, Galveston, TX 77555 USA; [Khan, Shagufta H.; Kumar, Raj] Geisinger Commonwealth Sch Med, Dept Basic Sci, Scranton, PA USA; [Miller, Aaron L.] Univ Texas Med Branch, Dept Pediat Vaccinol, Galveston, TX 77555 USA; [Elam, W. Austin] C4 Therapeutics, Dept Biophys & Biochem, Cambridge, MA USA; [Thompson, E. Brad] Univ Houston, Dept Biol & Biochem, Ctr Nucl Receptors & Cell Signaling, Houston, TX 77004 USA	University of Texas System; University of Texas Medical Branch Galveston; University of Texas System; University of Texas Medical Branch Galveston; University of Houston System; University of Houston	Thompson, EB (corresponding author), Univ Texas Med Branch, Sealy Ctr Struct Biol, Dept Biochem & Mol Biol, Galveston, TX 77555 USA.; Thompson, EB (corresponding author), Univ Houston, Dept Biol & Biochem, Ctr Nucl Receptors & Cell Signaling, Houston, TX 77004 USA.	bthompso@utmb.edu			National Institute of Health [5RO1 CA]	National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported in whole or part by National Institute of Health Grant 5RO1 CA (to EBT). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANTAKLY T, 1990, CANCER RES, V50, P1337; ASHRAF J, 1993, MOL ENDOCRINOL, V7, P631, DOI 10.1210/me.7.5.631; Auton M, 2011, BIOPHYS CHEM, V159, P90, DOI 10.1016/j.bpc.2011.05.012; Baskakov I, 1998, BIOPHYS J, V74, P2666, DOI 10.1016/S0006-3495(98)77972-X; Baskakov IV, 1999, J BIOL CHEM, V274, P10693, DOI 10.1074/jbc.274.16.10693; Breydo L, 2015, ARCH BIOCHEM BIOPHYS, V570, P66, DOI 10.1016/j.abb.2015.02.021; Brown CR, 1997, J CLIN INVEST, V99, P1432, DOI 10.1172/JCI119302; Chebotareva NA, 2007, BIOCHEMISTRY-MOSCOW+, V72, P1478, DOI 10.1134/S0006297907130056; Chen DWC, 2013, ONCOGENE, V32, P3039, DOI 10.1038/onc.2012.321; Fan YQ, 2012, INT J BIOL MACROMOL, V51, P845, DOI 10.1016/j.ijbiomac.2012.07.026; HARMON JM, 1981, MOL CELL BIOL, V1, P512, DOI 10.1128/MCB.1.6.512; Hilser VJ, 2007, P NATL ACAD SCI USA, V104, P8311, DOI 10.1073/pnas.0700329104; Kumar R, 2001, J BIOL CHEM, V276, P18146, DOI 10.1074/jbc.M100825200; Li J, 2012, J BIOL CHEM, V287, P26777, DOI 10.1074/jbc.M112.355651; Medh RD, 2003, GENOMICS, V81, P543, DOI 10.1016/S0888-7543(03)00045-4; Minton AP, 2006, J CELL SCI, V119, P2863, DOI 10.1242/jcs.03063; Mittal S, 2015, BBA-GEN SUBJECTS, V1850, P1822, DOI 10.1016/j.bbagen.2015.05.002; Powers ET, 2009, ANNU REV BIOCHEM, V78, P959, DOI 10.1146/annurev.biochem.052308.114844; Pratt WB, 2004, ESSAYS BIOCHEM, V40, P41, DOI 10.1042/bse0400041; SCATCHARD G, 1949, ANN NY ACAD SCI, V51, P660, DOI 10.1111/j.1749-6632.1949.tb27297.x; Simons SS, 2014, MOL ENDOCRINOL, V28, P173, DOI 10.1210/me.2013-1334; Stepanenko OV, 2016, J BIOMOL STRUCT DYN, V34, P2155, DOI 10.1080/07391102.2015.1109554; Street TO, 2010, PROTEIN SCI, V19, P57, DOI 10.1002/pro.282; ten Wolde PR, 2014, INT REV CEL MOL BIO, V307, P419, DOI 10.1016/B978-0-12-800046-5.00012-6; Uversky VN, 2009, PROTEIN J, V28, P305, DOI 10.1007/s10930-009-9201-4; Vandevyver S, 2012, TRAFFIC, V13, P364, DOI 10.1111/j.1600-0854.2011.01288.x; Zhang Z, 2003, AM J PHYSIOL-RENAL, V285, pF688, DOI 10.1152/ajprenal.00028.2003	27	2	2	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 16	2017	12	3							e0174183	10.1371/journal.pone.0174183	http://dx.doi.org/10.1371/journal.pone.0174183			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN9KE	28301576	Green Submitted, Green Published, gold			2022-12-27	WOS:000396318300131
J	Vischer, N; Pfeiffer, C; Limacher, M; Burri, C				Vischer, Nerina; Pfeiffer, Constanze; Limacher, Manuela; Burri, Christian			"You can save time if ..."-A qualitative study on internal factors slowing down clinical trials in Sub-Saharan Africa	PLOS ONE			English	Article							OPERATIONAL CHALLENGES; VACCINE TRIALS; CONDUCT	Background The costs, complexity, legal requirements and number of amendments associated with clinical trials are rising constantly, which negatively affects the efficient conduct of trials. In Sub-Saharan Africa, this situation is exacerbated by capacity and funding limitations, which further increase the workload of clinical trialists. At the same time, trials are critically important for improving public health in these settings. The aim of this study was to identify the internal factors that slow down clinical trials in Sub-Saharan Africa. Here, factors are limited to those that exclusively relate to clinical trial teams and sponsors. These factors may be influenced independently of external conditions and may significantly increase trial efficiency if addressed by the respective teams. Methods We conducted sixty key informant interviews with clinical trial staff working in different positions in two clinical research centres in Kenya, Ghana, Burkina Faso and Senegal. The study covered English-and French-speaking, and Eastern and Western parts of Sub-Saharan Africa. We performed thematic analysis of the interview transcripts. Results We found various internal factors associated with slowing down clinical trials; these were summarised into two broad themes, "planning" and "site organisation". These themes were consistently mentioned across positions and countries. "Planning" factors related to budget feasibility, clear project ideas, realistic deadlines, understanding of trial processes, adaptation to the local context and involvement of site staff in planning. "Site organisation" factors covered staff turnover, employment conditions, career paths, workload, delegation and management. Conclusions We found that internal factors slowing down clinical trials are of high importance to trial staff. Our data suggest that adequate and coherent planning, careful assessment of the setting, clear task allocation and management capacity strengthening may help to overcome the identified internal factors and allow clinical trials to proceed more efficiently.	[Vischer, Nerina; Limacher, Manuela; Burri, Christian] Swiss Trop & Publ Hlth Inst, Dept Med Res, Basel, Switzerland; [Vischer, Nerina; Pfeiffer, Constanze; Limacher, Manuela; Burri, Christian] Univ Basel, Basel, Switzerland; [Pfeiffer, Constanze] Swiss Trop & Publ Hlth Inst, Dept Epidemiol & Publ Hlth, Basel, Switzerland	University of Basel; Swiss Tropical & Public Health Institute; University of Basel; University of Basel; Swiss Tropical & Public Health Institute	Vischer, N (corresponding author), Swiss Trop & Publ Hlth Inst, Dept Med Res, Basel, Switzerland.; Vischer, N (corresponding author), Univ Basel, Basel, Switzerland.	nerina.vischer@unibas.ch		Vischer, Nerina/0000-0002-1030-6359; Pfeiffer, Constanze/0000-0002-9487-2867; Burri, Christian/0000-0001-5418-1984	R. Geigy Foundation; Burckhardt-Burgin-Stiftung; Freiwillige Akademische Gesellschaft	R. Geigy Foundation; Burckhardt-Burgin-Stiftung; Freiwillige Akademische Gesellschaft	This study was financially supported by the R. Geigy Foundation (http://www.geigystiftung.ch/en/), the Burckhardt-Burgin-Stiftung (https://www.unibas.ch/de/Universitaet/Administration-Services/Vizerektorat-Forschung/Nachwuchsfoerderung/Finanzierung/Foerderbeitraege/Burckhardt-Buergin-Stiftung.html) and the Freiwillige Akademische Gesellschaft (http://www.fag-basel.ch/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Angwenyi V, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0124554; [Anonymous], 2004, PLoS Med, V1, pe71; [Anonymous], 2015, INT ADD GOOD CLIN PR; Bollyky TJ, 2010, CLIN TRIALS, V7, P719, DOI 10.1177/1740774510386390; Bonenberger M, 2016, BMC HEALTH SERV RES, V16, DOI 10.1186/s12913-016-1271-3; Bonenberger M, 2014, HUM RESOUR HEALTH, V12, DOI 10.1186/1478-4491-12-43; Braun V., 2006, QUAL RES PSYCHOL, V3, P77, DOI [DOI 10.1191/1478088706QP063OA, 10.1191/1478088706qp063oa]; Brock-Utne J, 2015, CLIN RES CASE STUDIE; Brosteanu O, 2009, CLIN TRIALS, V6, P585, DOI 10.1177/1740774509347398; Burt RS, 2005, BROKERAGE CLOSURE IN; Council on Health Research for Development (COHRED), 2013, THER IS NO LAW GUID; Cutts FT, 2006, PLOS CLIN TRIALS, V1, DOI 10.1371/journal.pctr.0010016; Devasenapathy N, 2009, CURR OPIN CARDIOL, V24, P295, DOI 10.1097/HCO.0b013e32832af21b; Dolgin E, 2010, NAT MED, V16, P8, DOI 10.1038/nm0110-8a; European and Developing Countries Clinical Trials Partnership, 2014, EDCTP STAK M CAP DEV; European Science Foundation, 2009, FORW LOOK INV DRIV C; Farrell B, 2010, TRIALS, V11, DOI 10.1186/1745-6215-11-78; Fekadu A, 2014, TRIALS, V15, DOI 10.1186/1745-6215-15-493; Franzen SRP, 2013, BMJ OPEN, V3, DOI 10.1136/bmjopen-2013-003616; G-FINDER, 2015, NEGL DIS RES DEV EB; Geldenhuys H, 2012, VACCINE, V30, P5839, DOI 10.1016/j.vaccine.2012.07.026; Getz K, 2014, INT J ENV RES PUB HE, V11, P5069, DOI 10.3390/ijerph110505069; Global Health Trials, PROC MAP; Idoko OT, 2013, AM J TROP MED HYG, V88, P414, DOI 10.4269/ajtmh.12-0576; Institute of Medicine (US) Forum on Drug Discovery Development and Translation, 2010, TRANSF RES US CHALL; International conference on harmonisation of technical requirements for registration of pharmaceuticals for human use, 1996, GUID GOOD CLIN PRACT; KFPE, 2012, GUID TRANSB RES PART; Koita OA, 2016, AM J TROP MED HYG, V94, P253, DOI 10.4269/ajtmh.15-0366; Lang TD, 2012, PLOS MED, V9, DOI 10.1371/journal.pmed.1001228; Lang T, 2011, LANCET, V377, P1553, DOI 10.1016/S0140-6736(10)62052-1; Marchetti E, 2012, VACCINE, V30, P6859, DOI 10.1016/j.vaccine.2012.09.008; Mbuagbaw L, 2011, TRIALS, V12, DOI 10.1186/1745-6215-12-145; McMahon AD, 2009, PLOS MED, V6, DOI 10.1371/journal.pmed.1000131; McMullen H, 2015, TRIALS, V16, DOI 10.1186/s13063-015-0755-5; Mwangoka G, 2013, MALARIA J, V12, DOI 10.1186/1475-2875-12-86; Ndebele P, 2014, JAIDS-J ACQ IMM DEF, V65, pS29, DOI 10.1097/QAI.0000000000000037; Postion Statement from the Instiute of Cancer Research London and The Royal Marsden NHS Foudation Trust, 2013, CLIN TRIALS REG TRAN; Ravinetto R, 2015, BMC INT HEALTH HUM R, V15, DOI 10.1186/s12914-015-0073-8; Ravinetto RM, 2013, TROP MED INT HEALTH, V18, P237, DOI 10.1111/tmi.12036; Sayinzoga F, 2016, BMC HEALTH SERV RES, V16, DOI 10.1186/s12913-016-1351-4; Senge P. M., 1999, 5 DISCIPLINE ART PRA; Smith A, 2009, STILL RELEVANT ALL T; Thielman NM, 2016, CLIN TRIALS, V13, P83, DOI 10.1177/1740774515619897; Thomason M. J., 2015, Clinical Investigation, V5, P585; Toe LP, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080800; Tong A, 2007, INT J QUAL HEALTH C, V19, P349, DOI 10.1093/intqhc/mzm042; Tufts Center for the Study of Drug Development, 2014, COST DEV WIN MARK AP; Vischer N, 2016, TROP MED INT HEALTH, V21, P1040, DOI 10.1111/tmi.12734; White NJ, 2006, TROP MED INT HEALTH, V11, P1483, DOI 10.1111/j.1365-3156.2006.01765.x; Whitworth JAG, 2008, LANCET, V372, P1590, DOI 10.1016/S0140-6736(08)61660-8; World Health Association, 2006, WORLD HLTH REP 2006; World Health Association, 2005, STRENGTH MAN LOW INC; World Health Organisation, 2015, AFR VACC REG FOR AVA; Yusur S, 2008, CLIN TRIALS, V5, P38, DOI 10.1177/1740774507088099	54	7	7	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 16	2017	12	3							e0173796	10.1371/journal.pone.0173796	http://dx.doi.org/10.1371/journal.pone.0173796			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN9KE	28301530	Green Published, Green Accepted, gold, Green Submitted			2022-12-27	WOS:000396318300074
J	Crittenden, AN; Sorrentino, J; Moonie, SA; Peterson, M; Mabulla, A; Ungar, PS				Crittenden, Alyssa N.; Sorrentino, John; Moonie, Sheniz A.; Peterson, Mika; Mabulla, Audax; Ungar, Peter S.			Oral health in transition: The Hadza foragers of Tanzania	PLOS ONE			English	Article							DENTAL-CARIES PREVALENCE; SEX-DIFFERENCES; HUNTER-GATHERERS; ANTIMICROBIAL ACTIVITY; XAVANTE INDIANS; LENGUA INDIANS; AGRICULTURE; WEAR; MICROBIOME; OCCLUSAL	Conventional wisdom holds that a decline in oral health accompanies the transition from hunting and gathering to agriculture, given increased consumption of carbohydrates. This widely touted example of the mismatch between our biology and modern lifestyle has been intuited largely from the bioarchaeological record of the Neolithic Revolution in the New World. Recent studies of other populations have, however, challenged the universality of this assertion. Here, we present the first comprehensive study of oral health among a living population in transition from the bush to village life, the Hadza hunter-gatherers of Tanzania, to test the hypothesis that the shift from foraging to farming, or agricultural intensification, inevitably leads to increased periodontal disease, caries, and orthodontic disorders. Our results showed that women living in villages consuming a mostly agricultural diet exhibited more caries and periodontal disease than those living in the bush consuming a mostly wild-food diet. Furthermore, men living in the bush consuming mostly a wild-food diet had more than those living in the village consuming a mostly agricultural diet. These findings are explained by the high incidence of maize consumption in village settings, along with previously recognized variation in rate of caries between men and women. The unexpected discovery of high caries incidences for men in the bush is likely explained by heavy reliance on honey, and perhaps differential access to tobacco and marijuana. These data support the notions that mechanisms of cariogenesis are multifactorial and that the relationships between oral health and the shift from a predominantly wild-food diet to one dominated by cultigens are nuanced.	[Crittenden, Alyssa N.] Univ Nevada, Dept Anthropol, Metab Anthropometry & Nutr Lab, Las Vegas, NV 89154 USA; [Sorrentino, John] DMD Family & Cosmet Dent, New York, NY USA; [Moonie, Sheniz A.] Univ Nevada, Epidemiol & Biostat, Sch Community Hlth Sci, Las Vegas, NV 89154 USA; [Peterson, Mika] Dorobo Fund, Arusha, Tanzania; [Mabulla, Audax] Univ Dar Es Salaam, Dept Archaeol, Dar Es Salaam, Tanzania; [Ungar, Peter S.] Univ Arkansas, Dept Anthropol, Fayetteville, AR 72701 USA	Nevada System of Higher Education (NSHE); University of Nevada Las Vegas; Nevada System of Higher Education (NSHE); University of Nevada Las Vegas; University of Dar es Salaam; University of Arkansas System; University of Arkansas Fayetteville	Ungar, PS (corresponding author), Univ Arkansas, Dept Anthropol, Fayetteville, AR 72701 USA.	pungar@uark.edu	Moonie, Sheniz/R-6215-2016; Mabulla, Audax ZP/ABE-2455-2020	Moonie, Sheniz/0000-0002-3192-9205; Ungar, Peter/0000-0002-5936-471X	National Science Foundation [1539843, 1539841]; University of Nevada, Las Vegas; D.M.D. Family and Cosmetic Dentistry	National Science Foundation(National Science Foundation (NSF)); University of Nevada, Las Vegas; D.M.D. Family and Cosmetic Dentistry	This work was supported by the National Science Foundation (grant # 1539843 to ANC and # 1539841 to PSU) and the University of Nevada, Las Vegas (Individual Investigator Award to ANC). D.M.D. Family and Cosmetic Dentistry provided support in the form of salary for author JS but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific role of this author is articulated in the 'author contributions' section.	Ahmadi-Motamayel Fatemeh, 2013, J Dent (Tehran), V10, P10; Al-Bayati FA, 2008, TURK J BIOL, V32, P57; Alves P, 2009, CAD SAUDE PUBLICA, V25, P37, DOI 10.1590/S0102-311X2009000100004; Anderson Max, 2002, Pediatr Dent, V24, P377; [Anonymous], 2012, MOSBYS MED DICT; Arantes R, 2003, SAUDE BUCAL POVOS IN, P49; Arantes R, 2009, ANN HUM BIOL, V36, P162, DOI 10.1080/03014460802672844; Armelagos GJ, 1984, PALEOPATHOLOGY ORIGI, P235; Axelsson P, 1998, J CLIN PERIODONTOL, V25, P297, DOI 10.1111/j.1600-051X.1998.tb02444.x; Barnes S, 1998, P SOC EXP BIOL MED, V217, P386; Berbesque JC, 2012, HUM NATURE-INT BIOS, V23, P270, DOI 10.1007/s12110-012-9145-9; Berbesque JC, 2011, AM J HUM BIOL, V23, P339, DOI 10.1002/ajhb.21139; Berbesque JC, 2016, EVOL HUM BEHAV, DOI DOI 10.1016/J.EVOLHUMBEHAY.2016.01.003; Berbesque JC, 2009, EVOL PSYCHOL-US, V7, P601, DOI 10.1177/147470490900700409; Blurton Jones N, 2016, DEMOGRAPHY EVOLUTION; BORGOGNINITARLI SM, 1985, J HUM EVOL, V14, P241; Bowen WH, 2005, PEDIATRICS, V116, P921, DOI 10.1542/peds.2004-2462; Cho CM, 2005, AUST DENT J, V50, P70, DOI 10.1111/j.1834-7819.2005.tb00343.x; Collins HB, 1932, AM J PHYS ANTHROPOL, V16, P451, DOI 10.1002/ajpa.1330160415; CORRUCCINI RS, 1990, AM J PHYS ANTHROPOL, V82, P257, DOI 10.1002/ajpa.1330820304; Corruccini RS, 1999, ANTHR INFORM ORTHODO; Crittenden A. N., 2016, WILD HARVEST PLANTS, P319; Crittenden AN, 2013, EVOL HUM BEHAV, V34, P299, DOI 10.1016/j.evolhumbehav.2013.04.004; Crittenden AN, 2014, CUNA HUMANIDAD, P209; Darling M R, 1992, Int Dent J, V42, P19; de Souza BS, 2015, ARCH ORAL BIOL, V60, P1177, DOI 10.1016/j.archoralbio.2015.04.007; Demirtas H, 2016, COMMUN STAT-SIMUL C, V45, P2744, DOI 10.1080/03610918.2014.920883; Deter CA, 2009, AM J PHYS ANTHROPOL, V138, P247, DOI 10.1002/ajpa.20922; Dewhirst FE, 2010, J BACTERIOL, V192, P5002, DOI 10.1128/JB.00542-10; Ditmyer M, 2013, J ADOLESCENT HEALTH, V52, P641, DOI 10.1016/j.jadohealth.2012.11.002; Domett KM, 2001, BRITISH ARCHAEOLOGIC, V946; Dominy NJ, 2008, EVOL BIOL, V35, P159, DOI 10.1007/s11692-008-9026-7; Eshed V, 2006, AM J PHYS ANTHROPOL, V130, P145, DOI 10.1002/ajpa.20362; Ettinger R L, 1999, Dent Clin North Am, V43, P679; Ezoddini-Ardakani F., 2010, Health, V2, P499, DOI 10.4236/health.2010.25074; Fields M., 2009, J DENT ORAL HYG, V1, P42; Fosbrooke H. A., 1956, S AFRICAN ARCHEOLOGI, V11, P3; Fyfe DM., 1993, INT J OSTEOARCHAEOL, V3, P29; Gadegaard E, EPIDEMIOLOGIC DATA C; Gordon AJ, 2013, CURR PSYCHIAT REP, V15, DOI 10.1007/s11920-013-0419-7; Hara Anderson T, 2010, Dent Clin North Am, V54, P455, DOI 10.1016/j.cden.2010.03.008; HILDEBOLT CF, 1988, AM J PHYS ANTHROPOL, V75, P1, DOI 10.1002/ajpa.1330750102; Hillson S, 2001, INT J OSTEOARCHAEOL, V11, P249; Hillson S, 2008, DENT PATHOLOGY BIOL, P299; Humphrey LT, 2014, P NATL ACAD SCI USA, V111, P954, DOI 10.1073/pnas.1318176111; Jin JS, 2010, INT J SYST EVOL MICR, V60, P1721, DOI 10.1099/ijs.0.016774-0; Johnson GK, 2004, J PERIODONTOL, V75, P196, DOI 10.1902/jop.2004.75.2.196; Khan MN, 2000, PHARM BIOL, V38, P235, DOI 10.1076/1388-0209(200007)3831-SFT235; KIESER JA, 1984, COMMUNITY DENT ORAL, V12, P406, DOI 10.1111/j.1600-0528.1984.tb01481.x; KIESER JA, 1985, AM J PHYS ANTHROPOL, V66, P21, DOI 10.1002/ajpa.1330660103; Kornbrot D., POINT BISERIAL CORRE; Laine MA, 2002, ACTA ODONTOL SCAND, V60, P257, DOI 10.1080/00016350260248210; Lampe JW, 2009, AM J CLIN NUTR, V89, pS1664, DOI 10.3945/ajcn.2009.26736T; Larmas M, 2010, CARIES RES, V44, P81, DOI 10.1159/000279327; Larsen C. S., 1991, ADV DENT ANTHR, P179; Larsen C.S, 2015, BIOARCHAEOLOGY INTER, DOI DOI 10.1016/j.bone.2012.05.023; LARSEN CS, 1995, ANNU REV ANTHROPOL, V24, P185, DOI 10.1146/annurev.an.24.100195.001153; LARSEN CS, 1981, CURR ANTHROPOL, V22, P422, DOI 10.1086/202697; LEMBARITI BS, 1988, COMMUNITY DENT ORAL, V16, P240, DOI 10.1111/j.1600-0528.1988.tb01763.x; LEVERETT DH, 1982, SCIENCE, V217, P26, DOI 10.1126/science.7089534; LUBELL D, 1994, J ARCHAEOL SCI, V21, P201, DOI 10.1006/jasc.1994.1022; Lukacs JR, 2008, CURR ANTHROPOL, V49, P901, DOI 10.1086/592111; Lukacs JR, 2006, AM J HUM BIOL, V18, P540, DOI 10.1002/ajhb.20530; Lukacs JR, 1996, CURR ANTHROPOL, V37, P147, DOI 10.1086/204481; Lukacs JR, 2008, TECHNIQUE APPL DENT; Maat GJR, 2000, INT J OSTEOARCHAEOL, V10, P142, DOI 10.1002/(SICI)1099-1212(200003/04)10:2<142::AID-OA519>3.0.CO;2-L; Marlowe F., 2010, HADZA HUNTER GATHERE, DOI DOI 10.1152/physiol.00027.2018; Marlowe FW, 2014, J HUM EVOL, V71, P119, DOI 10.1016/j.jhevol.2014.03.006; Marlowe FW, 2004, ENCY MED ANTHROPOLOG, P689; Martin-Frances L, 2014, CR PALEVOL, V13, P189, DOI 10.1016/j.crpv.2013.10.007; MAYHALL JT, 1970, ARCTIC ANTHROPOL, V7, P117; Mazengo MC, 1996, COMMUNITY DENT ORAL, V24, P169, DOI 10.1111/j.1600-0528.1996.tb00836.x; Mbatia J, 2009, INT J ENV RES PUB HE, V6, P1991, DOI 10.3390/ijerph6071991; Meiklejohn C., 1992, INT J ANTHR, V7, P17, DOI DOI 10.1007/BF02445038; MILNER GR, 1984, COLLEGIUM ANTROPOL, V8, P77; Moynihan P., 2000, BNF Nutrition Bulletin, V25, P281, DOI 10.1046/j.1467-3010.2000.00033.x; Nassar HM, 2012, APPL ENVIRON MICROB, V78, P536, DOI 10.1128/AEM.05538-11; NEEL JV, 1964, AM J HUM GENET, V16, P52; Prodan A, 2015, EUR J ORAL SCI, V123, P149, DOI 10.1111/eos.12182; Schnorr SL, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4654; Schoeninger MJ, 2001, J FOOD COMPOS ANAL, V14, P15, DOI 10.1006/jfca.2000.0961; SCOTT EC, 1979, AM J PHYS ANTHROPOL, V51, P213, DOI 10.1002/ajpa.1330510208; Selwitz RH, 2007, LANCET, V369, P51, DOI 10.1016/S0140-6736(07)60031-2; Setchell KDR, 2010, J NUTR, V140, p1355S, DOI 10.3945/jn.109.119776; Shaffer JR, 2015, CARIES RES, V49, P133, DOI 10.1159/000369103; SHANNON IL, 1979, J DENT CHILD, V46, P29; Shearer DM, 2011, J DENT RES, V90, P672, DOI 10.1177/0022034510393349; Steckel RH, 2002, BACKBONE HIST LONG T; Struzycka I, 2014, POL J MICROBIOL, V63, P127; TURNER CG, 1979, AM J PHYS ANTHROPOL, V51, P619, DOI 10.1002/ajpa.1330510413; Turroni S, 2016, FRONT MICROBIOL, V7, DOI 10.3389/fmicb.2016.00865; Vellappally Sajith, 2007, Acta Medica (Hradec Kralove), V50, P161; WALKER PL, 1990, AM ANTHROPOL, V92, P383, DOI 10.1525/aa.1990.92.2.02a00080; Walker PL, 1998, U OREGON ANTHR PAPER, V54, P355; Watson JT, 2008, INT J OSTEOARCHAEOL, V18, P202, DOI 10.1002/oa.917; Watson JT, 2010, AM J HUM BIOL, V22, P92, DOI 10.1002/ajhb.20958; WOLINSKY LE, 1984, CARIES RES, V18, P216, DOI 10.1159/000260768; Woodburn J., 1970, HUNTERS GATHERERS MA; Yatsuka H., 2015, African Study Monographs, V36, P27	99	25	25	1	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 15	2017	12	3							e0172197	10.1371/journal.pone.0172197	http://dx.doi.org/10.1371/journal.pone.0172197			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EN9HQ	28296885	Green Submitted, Green Published, gold			2022-12-27	WOS:000396311700005
J	Ge, QM; Huang, CM; Zhu, XY; Bian, F; Pan, SM				Ge, Qin-Min; Huang, Chun-Mei; Zhu, Xiang-Yang; Bian, Fan; Pan, Shu-Ming			Differentially expressed miRNAs in sepsisinduced acute kidney injury target oxidative stress and mitochondrial dysfunction pathways	PLOS ONE			English	Article							CRITICALLY-ILL PATIENTS; SEPSIS; PATHOPHYSIOLOGY; MICRORNAS; BIOGENESIS; METABOLISM; BIOMARKERS; MODEL	Objective To identify specific miRNAs involved in sepsis-induced AKI and to explore their targeting pathways. Methods The expression profiles of miRNAs in serum from patients with sepsis-induced AKI (n = 6), sepsis-non AKI (n = 6), and healthy volunteers (n = 3) were investigated by microarray assay and validated by quantitative PCR (qPCR). The targets of the differentially expressed miRNAs were predicted by Target Scan, mirbase and Miranda. Then the significant functions and involvement in signaling pathways of gene ontology (GO) and KEGG pathways were analyzed. Furthermore, eight miRNAs were randomly selected out of the differentially expressed miRNAs for further testing by qPCR. Results qPCR analysis confirmed that the expressions levels of hsa-miR-23a-3p, hsa-miR-4456, hsa-miR-142-5p, hsa-miR-22-3p and hsa-miR-191-5p were significantly lower in patients with sepsis compared with the healthy volunteers, while hsa-miR-4270, hsa-miR-4321, hsa-miR-3165 were higher in the sepsis patients. Statistically, miR-4321; miR-4270 were significantly upregulated in the sepsis-induced AKI compared with sepsis-non AKI, while only miR-4321 significantly overexpressed in the sepsis groups compared with control groups. GO analysis showed that biological processes regulated by the predicted target genes included diverse terms. They were related to kidney development, regulation of nitrogen compound metabolic process, regulation of cellular metabolic process, cellular response to oxidative stress, mitochondrial outer membrane permeabilization, etc. Pathway analysis showed that several significant pathways of the predicted target genes related to oxidative stress. miR-4321 was involved in regulating AKT1, mTOR and NOX5 expression while miR-4270 was involved in regulating PPARGC1A, AKT3, NOX5, PIK3C3, WNT1 expression. Function and pathway analysis highlighted the possible involvement of miRNA-deregulated mRNAs in oxidative stress and mitochondrial dysfunction. Conclusion This study might help to improve understanding of the relationship between serum miRNAs and sepsis-induced AKI, and laid an important foundation for further identification of the potential mechanisms of sepsis-induced AKI and oxidative stress and mitochondrial dysfunction.	[Ge, Qin-Min; Huang, Chun-Mei; Pan, Shu-Ming] Shanghai Jiao Tong Univ, Sch Med, Xinhua Hosp, Dept Emergency, Shanghai, Peoples R China; [Zhu, Xiang-Yang] Mayo Clin, Coll Med, Dept Internal Med, Div Nephrol & Hypertens, Rochester, MN USA; [Bian, Fan] Shanghai Jiao Tong Univ, Sch Med, Xinhua Hosp, Dept Nephrol, Shanghai, Peoples R China	Shanghai Jiao Tong University; Mayo Clinic; Shanghai Jiao Tong University	Pan, SM (corresponding author), Shanghai Jiao Tong Univ, Sch Med, Xinhua Hosp, Dept Emergency, Shanghai, Peoples R China.	drpanshuming@163.com			National Natural Science Foundation of China [81000354]; Shanghai Nature Science Foundation [14ZR1427000]; National clinical key specialty construction project	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Shanghai Nature Science Foundation; National clinical key specialty construction project	This study was supported by National Natural Science Foundation of China (No.81000354), Shanghai Nature Science Foundation (14ZR1427000) and 2013-2014 National clinical key specialty construction project.	Aguado-Fraile E, 2013, NEFROLOGIA, V33, P826, DOI 10.3265/Nefrologia.pre2013.Aug.12198; Ardekani Ali M., 2010, Avicenna Journal of Medical Biotechnology, V2, P161; Aziz M, 2013, J LEUKOCYTE BIOL, V93, P329, DOI 10.1189/jlb.0912437; Bagshaw SM, 2007, INTENS CARE MED, V33, P1285, DOI 10.1007/s00134-007-0656-5; Bagshaw SM, 2007, CLIN J AM SOC NEPHRO, V2, P431, DOI 10.2215/CJN.03681106; Basile David P., 2014, Cardiovascular & Hematological Disorders - Drug Targets, V14, P3; Bellinger MA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0093297; Benes J, 2011, CRIT CARE, V15, DOI 10.1186/cc10517; Chaudhuri AD, 2013, FASEB J, V27, P3720, DOI 10.1096/fj.13-232678; Chawla LS, 2007, CLIN J AM SOC NEPHRO, V2, P22, DOI 10.2215/CJN.02510706; Chertow GM, 2005, J AM SOC NEPHROL, V16, P3365, DOI 10.1681/ASN.2004090740; Cho E, 2014, NEPHROLOGY, V19, P318, DOI 10.1111/nep.12230; Christian P, 2014, AM J PHYSIOL-ENDOC M, V307, pE729, DOI 10.1152/ajpendo.00194.2014; Essandoh K, 2014, BBA-MOL BASIS DIS, V1842, P2155, DOI 10.1016/j.bbadis.2014.07.021; Fourcade S, 2015, FREE RADICAL BIO MED, V88, P18, DOI 10.1016/j.freeradbiomed.2015.05.041; Haden DW, 2007, AM J RESP CRIT CARE, V176, P768, DOI 10.1164/rccm.200701-161OC; Holly MK, 2006, KIDNEY INT, V70, P496, DOI 10.1038/sj.ki.5001575; Keir I, 2015, J VET EMERG CRIT CAR, V25, P200, DOI 10.1111/vec.12297; Lan YF, 2012, J AM SOC NEPHROL, V23, P2012, DOI 10.1681/ASN.2012050438; Lorenzen JM, 2011, CLIN J AM SOC NEPHRO, V6, P1540, DOI 10.2215/CJN.00430111; Murugan R, 2010, KIDNEY INT, V77, P527, DOI 10.1038/ki.2009.502; Parikh SM, 2015, SEMIN NEPHROL, V35, P108, DOI 10.1016/j.semnephrol.2015.01.011; Pinto CF, 2012, REV ESC ENFERM USP, V46, P86, DOI 10.1590/S0080-62342012000700013; Quoilin C, 2014, BBA-BIOENERGETICS, V1837, P1790, DOI 10.1016/j.bbabio.2014.07.005; Reid G, 2011, CRIT REV ONCOL HEMAT, V80, P193, DOI 10.1016/j.critrevonc.2010.11.004; Rossaint J, 2011, KIDNEY INT, V80, P493, DOI 10.1038/ki.2011.125; Saikumar J, 2012, TOXICOL SCI, V129, P256, DOI 10.1093/toxsci/kfs210; Sun L., 2014, MATH PROBL ENG, V2014, P1, DOI DOI 10.1111/MPP.12078; Sweeney E, 2010, PLOS ONE, V5, DOI [10.1371/journal.pone.0011606, 10.1371/journal.pone.0009518]; Tran M, 2014, NEPHRON CLIN PRACT, V127, P42, DOI 10.1159/000363715; Uchino S, 2005, JAMA-J AM MED ASSOC, V294, P813, DOI 10.1001/jama.294.7.813; Wan L, 2008, CRIT CARE MED, V36, pS198, DOI 10.1097/CCM.0b013e318168ccd5; Wen XY, 2010, CONTRIB NEPHROL, V165, P39, DOI 10.1159/000313743; Xue YX, 2015, ATHEROSCLEROSIS, V241, P671, DOI 10.1016/j.atherosclerosis.2015.06.031	34	76	83	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 15	2017	12	3							e0173292	10.1371/journal.pone.0173292	http://dx.doi.org/10.1371/journal.pone.0173292			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN9HQ	28296904	gold, Green Published, Green Submitted			2022-12-27	WOS:000396311700032
J	Ki, M; Lee, YH; Kim, YS; Shin, JY; Lim, J; Nazroo, J				Ki, Myung; Lee, Yo Han; Kim, Yong-Soo; Shin, Ji-Yeon; Lim, Jiseun; Nazroo, James			Socioeconomic inequalities in health in the context of multimorbidity: A Korean panel study	PLOS ONE			English	Article							FOLLOW-UP; OLD-AGE; EDUCATIONAL INEQUALITIES; CHRONIC DISEASES; UNITED-STATES; MORTALITY; COHORT; PREVALENCE; PATTERNS; POSITION	Socioeconomic inequalities in health are commonly known to decrease at late age. Yet, it remains unclear whether socioeconomic inequalities in health at late age appear in relation to multimorbidity, particularly in Korea where social support remains unsatisfactory for older people. Using three waves of Korea Health Panel, data of 19,942 observations with repeated measure were constructed to ensure a temporal sequence between three socioeconomic measures (i.e., poverty, employment status, and education) and multimorbidity with a t to t+1 year transition. A multilevel multinomial model was applied to quantify the socioeconomic impact across different age, diseases and disease groups, both separately and in combination. There were associations between socioeconomic position (SEP) and multimorbidity, and increasing trends of socioeconomic inequalities not only with greater number of morbidity but also with age. The latter result was only observed with employment status through mid-to-early old age; i.e., between the 40s (odds ratio (OR) = 2.45, 95% confidence interval (CI): 1.08-5.57) and 70s (OR = 3.48, 95% CI: 1.24-9.74). The patterns of socioeconomic inequalities in multimorbidity varied for particular pairs of diseases and were stronger in the disease pairs co-occurring with mental and cardiovascular diseases but weaker in the disease pairs co-occurring with cancer. Accumulation of adversity tended to intensify with increase in number of diseases and older age, though this finding was not consistently supported. The labour market should be encouraged to actively participate in actions to promote healthy aging needs to be complemented by the provision of more generous and universal income support to the elderly in Korea.	[Ki, Myung] Korea Univ, Dept Prevent Med, Coll Med, Seoul, South Korea; [Lee, Yo Han] Konyang Univ, Dept Prevent Med, Coll Med, Daejeon, South Korea; [Kim, Yong-Soo] Seoul Metropolitan Govt, Publ Hlth Policy Inst, Seoul, South Korea; [Shin, Ji-Yeon; Lim, Jiseun] Eulji Univ, Sch Med, Dept Prevent Med, Daejeon, South Korea; [Nazroo, James] Univ Manchester, Cathie Marsh Inst Social Res, Sch Social Sci, Manchester, Lancs, England	Korea University; Korea University Medicine (KU Medicine); Konyang University; Konyang University Hospital; Eulji University; University of Manchester	Lee, YH (corresponding author), Konyang Univ, Dept Prevent Med, Coll Med, Daejeon, South Korea.	vionic@konyang.ac.kr	Lee, Yo Han/J-1911-2019	Lee, Yo Han/0000-0002-9631-9969; Ki, Myung/0000-0001-8479-0254; Kim, Yong-Soo/0000-0002-7486-9089	Basic Science Program through the National Research Foundation of Korea (NRF) - Ministry of Education [NRF-2015014308, NRF-2015R1C1A1A02037283]; Social Science Program through the NRF [NRF-2014S1A3A2035458]	Basic Science Program through the National Research Foundation of Korea (NRF) - Ministry of Education(Ministry of Education (MOE), Republic of KoreaNational Research Foundation of Korea); Social Science Program through the NRF(National Research Foundation of Korea)	This research was supported by the Basic Science Program through the National Research Foundation of Korea (NRF) funded by the Ministry of Education awarded to MK (grant number: NRF-2015014308) and to JSL (grant number: NRF-2015R1C1A1A02037283). MK was also supported by the Social Science Program (grant number: NRF-2014S1A3A2035458) through the NRF.	Alaba O, 2013, INT J EQUITY HEALTH, V12, DOI 10.1186/1475-9276-12-63; Albano JD, 2007, JNCI-J NATL CANCER I, V99, P1384, DOI 10.1093/jnci/djm127; ARBER S, 1993, SOC SCI MED, V36, P33, DOI 10.1016/0277-9536(93)90303-L; Baillargeon J, 2001, OCCUP MED-STATE ART, V16, P359; Banjare P, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0097832; Barnett K, 2012, LANCET, V380, P37, DOI 10.1016/S0140-6736(12)60240-2; Chandola T, 2007, BRIT MED J, V334, P990, DOI 10.1136/bmj.39167.439792.55; Dalstra JAA, 2005, INT J EPIDEMIOL, V34, P316, DOI 10.1093/ije/dyh386; Elstad JI, 2012, EUR J PUBLIC HEALTH, V22, P771, DOI 10.1093/eurpub/ckr181; Elstad JI, 2011, INT J EQUITY HEALTH, V10, DOI 10.1186/1475-9276-10-7; France EF, 2012, BRIT J GEN PRACT, V62, DOI 10.3399/bjgp12X636146; Goodman RA, 2013, PREV CHRONIC DIS, V10, DOI 10.5888/pcd10.120239; Grundy E, 2003, SOC SCI MED, V56, P935, DOI 10.1016/S0277-9536(02)00093-X; Guilley E, 2010, ARCH GERONTOL GERIAT, V51, pE37, DOI 10.1016/j.archger.2009.12.009; Hammig O, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-1170; Hemming JP, 2011, ARCH NEUROL-CHICAGO, V68, P498, DOI 10.1001/archneurol.2010.326; Herd P, 2006, RES AGING, V28, P375, DOI 10.1177/0164027505285845; Herd P, 2008, MILBANK Q, V86, P5, DOI 10.1111/j.1468-0009.2007.00512.x; Hsiao C, 2007, TEST-SPAIN, V16, P1, DOI 10.1007/s11749-007-0046-x; Huijts T, 2010, SOC SCI MED, V71, P1964, DOI 10.1016/j.socscimed.2010.09.021; Huisman M, 2003, SOC SCI MED, V57, P861, DOI 10.1016/S0277-9536(02)00454-9; Huisman M, 2013, EPIDEMIOLOGIC REV; Huisman M, 2013, EPIDEMIOL REV, V35, P84, DOI 10.1093/epirev/mxs010; Hung WW, 2011, BMC GERIATR, V11, DOI 10.1186/1471-2318-11-47; Hwang W, 2001, HEALTH AFFAIR, V20, P267, DOI 10.1377/hlthaff.20.6.267; Karlamangla AS, 2005, SOC SCI MED, V60, P999, DOI 10.1016/j.socscimed.2004.06.056; Kelaher M, 2008, ANN EPIDEMIOL, V18, P351, DOI 10.1016/j.annepidem.2007.12.006; Kim MH, 2015, J KOREAN MED SCI, V30, P1, DOI 10.3346/jkms.2015.30.1.1; Kuo RN, 2013, INT J EQUITY HEALTH, V12, DOI 10.1186/1475-9276-12-69; Laaksonen M, 2008, EUR J PUBLIC HEALTH, V18, P38, DOI 10.1093/eurpub/ckm051; Lawlor DA, 2005, J EPIDEMIOL COMMUN H, V59, P785, DOI 10.1136/jech.2004.029991; Marengoni A, 2008, AM J PUBLIC HEALTH, V98, P1198, DOI 10.2105/AJPH.2007.121137; Marengoni A, 2011, AGEING RES REV, V10, P430, DOI 10.1016/j.arr.2011.03.003; Marmot MG, 1996, BRIT MED J, V313, P1177, DOI 10.1136/bmj.313.7066.1177; McLean G, 2014, BRIT J GEN PRACT, V64, pE440, DOI 10.3399/bjgp14X680545; Nagel G, 2008, BMC PUBLIC HEALTH, V8, DOI 10.1186/1471-2458-8-384; Organization for Economic Cooperation and Development, 2013, PENS AT A GLANC; Organization for Economic Cooperation and Development, 2015, OECD LAB FORC STAT; Organization for Economic Cooperation and Development, 2015, INCOME DISTRIBUTION; Prados-Torres A, 2014, J CLIN EPIDEMIOL, V67, P254, DOI 10.1016/j.jclinepi.2013.09.021; Rasbash J., 2004, USERS GUIDE MLWIN VE; Rasbash J., 2012, USERS GUIDE MLWIN; Robert S, 1996, J AGING HEALTH, V8, P359, DOI 10.1177/089826439600800304; Salive ME, 2013, EPIDEMIOL REV, V35, P75, DOI 10.1093/epirev/mxs009; Schafer I, 2012, BMC HEALTH SERV RES, V12, DOI 10.1186/1472-6963-12-89; Stringhini S, 2010, JAMA-J AM MED ASSOC, V303, P1159, DOI 10.1001/jama.2010.297; Sulander T, 2006, INT J EPIDEMIOL, V35, P1255, DOI 10.1093/ije/dyl183; van den Akker M, 1998, J CLIN EPIDEMIOL, V51, P367, DOI 10.1016/S0895-4356(97)00306-5; van den Akker M, 2001, J CLIN EPIDEMIOL, V54, P675, DOI 10.1016/S0895-4356(00)00358-9; van Oort FVA, 2005, J EPIDEMIOL COMMUN H, V59, P214, DOI 10.1136/jech.2003.016493; Violan C, 2014, BMC PUBLIC HEALTH, V14, DOI 10.1186/1471-2458-14-530	51	11	11	2	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 15	2017	12	3							e0173770	10.1371/journal.pone.0173770	http://dx.doi.org/10.1371/journal.pone.0173770			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EN9HQ	28296975	gold, Green Published, Green Submitted			2022-12-27	WOS:000396311700059
J	Yang, YL; Zhang, L; Wang, XF; Lu, Q; He, L; Wang, J; Wang, B; Li, L; Yuan, L; Liu, JF; Ge, SP; Xie, MX				Yang, Yali; Zhang, Li; Wang, Xinfang; Lu, Qing; He, Lin; Wang, Jing; Wang, Bin; Li, Ling; Yuan, Li; Liu, Jinfeng; Ge, Shuping; Xie, Mingxing			Echocardiographic diagnosis of rare pathological patterns of sinus of Valsalva aneurysm	PLOS ONE			English	Article							LEFT CORONARY-SINUS; CONGENITAL ANEURYSM; LEFT-VENTRICLE; EXPERIENCE; RUPTURE	Objective To evaluate the value and improve the diagnostic accuracy of echocardiography in the diagnosis of a sinus of Valsalva aneurysm (SVA) with rare pathological patterns. Methods Echocardiographic features and surgical findings from 270 Chinese patients with SVA treated in the last 18 years (1995-2013) at the Union Hospital were compared retrospectively; 22 of 270 cases had rare patterns. Results The patients with SVA, a rare origin, a rare extending position, or a rare course accounted for 3.4%, 7.4%, and 0.4% of the 270 cases, respectively. The three most common aneurysmal complications of the patients with rare patterns were severe aortic regurgitation (16), obstruction of the ventricular outflow tract or valvular orifice (3), and conduction disturbance (3). The origin, course, extending position and rupture status of the SVAs determined by echocardiography were entirely consistent with surgical findings in 81.8% of the 22 cases. With the exception of one failed diagnosis of an aneurysmal wall dissection and one misdiagnosis of a descending aortic dissection, the echocardiographic results of SVA complications and associated cardiovascular lesions were also confirmed. Conclusion We could accurately diagnose SVAs with rare pathological patterns by echocardiographic identification of distinguishing features. However, for several conditions, we could not accurately identify the origin or course of the aneurysm or define its relationship to adjacent structures using conventional echocardiography alone. Therefore, we recommend combining conventional echocardiography with different imaging techniques, such as transesophageal echocardiography, three-dimensional echocardiography, computed tomography angiography, and aortic angiography.	[Yang, Yali; Zhang, Li; Wang, Xinfang; Lu, Qing; He, Lin; Wang, Jing; Wang, Bin; Li, Ling; Yuan, Li; Liu, Jinfeng; Ge, Shuping; Xie, Mingxing] Huazhong Univ Sci & Technol, Dept Ultrasound, Union Hosp, Tongji Med Coll, Wuhan, Hubei, Peoples R China; [Yang, Yali; Zhang, Li; Wang, Xinfang; Lu, Qing; He, Lin; Wang, Jing; Wang, Bin; Li, Ling; Yuan, Li; Liu, Jinfeng; Ge, Shuping; Xie, Mingxing] Hubei Prov Key Lab Mol Imaging, Wuhan, Hubei, Peoples R China; [Ge, Shuping] St Christophers Hosp Children, Ctr Heart, Philadelphia, PA 19133 USA; [Ge, Shuping] Drexel Univ, Coll Med, Philadelphia, PA 19104 USA	Huazhong University of Science & Technology; Drexel University	Ge, SP; Xie, MX (corresponding author), Huazhong Univ Sci & Technol, Dept Ultrasound, Union Hosp, Tongji Med Coll, Wuhan, Hubei, Peoples R China.; Ge, SP; Xie, MX (corresponding author), Hubei Prov Key Lab Mol Imaging, Wuhan, Hubei, Peoples R China.; Ge, SP (corresponding author), St Christophers Hosp Children, Ctr Heart, Philadelphia, PA 19133 USA.; Ge, SP (corresponding author), Drexel Univ, Coll Med, Philadelphia, PA 19104 USA.	shuping.ge@drexelmed.edu; xiemx64@126.com	Lang, Ming/HIK-0758-2022; Yang, Ya-Li/GYU-4320-2022; Zhang, L/ABG-4378-2020; Zhang, L/A-8465-2019; yang, yang/HGT-7999-2022	Zhang, L/0000-0003-1620-1512; Zhang, L/0000-0003-1620-1512; Xie, Mingxing/0000-0003-4984-1567; Yang, Yali/0000-0002-6778-3869	National Natural Science Foundation of China [81000615, 81530056, 81671705]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This manuscript is supported by the National Natural Science Foundation of China (Grant No. 81000615 received by YLY, No. 81530056 received by MXX and No. 81671705 received by LZ). The URL of National Natural Science Foundation of China is: https://isisn.nsfc.gov.cn/egrantindex/funcindex/prjsearch-list. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. We confirm that there are no known conflicts of interest associated with this publication and these financial supports have no influence on our outcome.	Abe T, 2012, CIRCULATION, V125, pE389, DOI 10.1161/CIRCULATIONAHA.111.058701; Cheng TO, 2014, INT J CARDIOL, V173, P33, DOI 10.1016/j.ijcard.2014.02.003; Choudhary SK, 2012, IND J THORAC CARDIOV, V16, P93; CHU SH, 1990, J THORAC CARDIOV SUR, V99, P288; Desurkar VN, 2006, J CARDIOTHOR VASC AN, V20, P276, DOI 10.1053/j.jvca.2005.11.019; El Hattaoui Mustapha, 2008, Can J Cardiol, V24, pe28; Gaitan-Roman D, 2010, REV ESP CARDIOL, V63, P745, DOI 10.1016/S0300-8932(10)70171-8; GLOCK Y, 1990, J CARDIOVASC SURG, V31, P235; Morais H, 2009, CARDIOVASC J AFR, V20, P192; RIES M, 1994, Z KARDIOL, V83, P519; SAKAKIBARA S, 1962, AM HEART J, V63, P405, DOI 10.1016/0002-8703(62)90287-9; Tian JW, 2001, CHINESE J ULTRASONOG, V10, P573; Tsukui H, 2000, HEART VESSELS, V15, P289, DOI 10.1007/s003800070007; XU QB, 1995, AM HEART J, V130, P1265, DOI 10.1016/0002-8703(95)90153-1; Yang YL, 2011, INT J CARDIOL, V151, pE35, DOI 10.1016/j.ijcard.2010.05.049; Yildirim SV, 2006, INT J CARDIOVAS IMAG, V22, P399, DOI 10.1007/s10554-005-9071-6; 夏家红, 2006, [中华胸心血管外科杂志, Chinese Journal of Thoracic and Cardiovascular Surgery], V22, P111	17	7	9	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 14	2017	12	3							e0173122	10.1371/journal.pone.0173122	http://dx.doi.org/10.1371/journal.pone.0173122			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN6DM	28291779	Green Published, gold, Green Submitted			2022-12-27	WOS:000396094700014
J	Courtney, CR; Mayr, L; Nanfack, AJ; Banin, AN; Tuen, M; Pan, RM; Jiang, XQ; Kong, XP; Kirkpatrick, AR; Bruno, D; Martens, CA; Sykora, L; Porcella, SF; Redd, AD; Quinn, TC; Nyambi, PN; Durr, R				Courtney, Colleen R.; Mayr, Luzia; Nanfack, Aubin J.; Banin, Andrew N.; Tuen, Michael; Pan, Ruimin; Jiang, Xunqing; Kong, Xiang-Peng; Kirkpatrick, Allison R.; Bruno, Daniel; Martens, Craig A.; Sykora, Lydia; Porcella, Stephen F.; Redd, Andrew D.; Quinn, Thomas C.; Nyambi, Phillipe N.; Duerr, Ralf			Contrasting antibody responses to intrasubtype superinfection with CRF02_AG	PLOS ONE			English	Article							IMMUNODEFICIENCY-VIRUS TYPE-1; HIV-1 SUPERINFECTION; NEUTRALIZING ANTIBODIES; DUAL INFECTIONS; IMMUNE PRESSURE; IDENTIFICATION; FREQUENCY; INDIVIDUALS; PREVALENCE; RESISTANCE	HIV superinfection describes the sequential infection of an individual with two or more unrelated HIV strains. Intersubtype superinfection has been shown to cause a broader and more potent heterologous neutralizing antibody response when compared to singly infected controls, yet the effects of intrasubtype superinfection remain controversial. Longitudinal samples were analyzed phylogenetically for pol and env regions using Next-Generation Sequencing and envelope cloning. The impact of CRF02_AG intrasubtype superinfection was assessed for heterologous neutralization and antibody binding responses. We compared two cases of CRF02_AG intrasubtype superinfection that revealed complete replacement of the initial virus by superinfecting CRF02_AG variants with signs of recombination. NYU6564, who became superinfected at an early time point, exhibited greater changes in antibody binding profiles and generated a more potent neutralizing antibody response post-superinfection compared to NYU6501. In contrast, superinfection occurred at a later time point in NYU6501 with strains harboring significantly longer V1V2 regions with no observable changes in neutralization patterns. Here we show that CRF02_AG intrasubtype superinfection can induce a cross-subtype neutralizing antibody response, and our data suggest timing and/or superinfecting viral envelope characteristics as contributing factors. These results highlight differential outcomes in intrasubtype superinfection and provide the first insight into cases with CRF02_AG, the fourth most prevalent HIV-1 strain worldwide.	[Courtney, Colleen R.] NYU, Sch Med, Dept Microbiol, New York, NY 10016 USA; [Mayr, Luzia; Nanfack, Aubin J.; Banin, Andrew N.; Tuen, Michael; Nyambi, Phillipe N.; Duerr, Ralf] NYU, Sch Med, Dept Pathol, New York, NY 10016 USA; [Banin, Andrew N.] Univ Yaounde, Fac Med & Biomed Sci, Yaounde, Cameroon; [Pan, Ruimin; Jiang, Xunqing; Kong, Xiang-Peng] NYU, Sch Med, Dept Biochem & Mol Pharmacol, New York, NY USA; [Kirkpatrick, Allison R.; Quinn, Thomas C.] NIAID, Immunoregulat Lab, NIH, Bldg 10, Bethesda, MD 20892 USA; [Bruno, Daniel; Martens, Craig A.; Sykora, Lydia; Porcella, Stephen F.] NIAID, Genom Unit, Res Technol Branch, Rocky Mt Labs,Div Intramural Res,NIH, Hamilton, MT USA; [Redd, Andrew D.; Quinn, Thomas C.] Johns Hopkins Sch Med, Dept Pathol, Baltimore, MD USA; [Nyambi, Phillipe N.] Vet Affairs New York Harbor Healthcare Syst, New York, NY USA; [Mayr, Luzia] Univ Strasbourg, Strasbourg, France; [Mayr, Luzia] Dept Virol, 4 Rue Blaise Pascal, Strasbourg, France	New York University; New York University; University of Yaounde I; New York University; National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); Johns Hopkins University; Johns Hopkins Medicine; UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg	Durr, R (corresponding author), NYU, Sch Med, Dept Pathol, New York, NY 10016 USA.	ralf.duerr@nyumc.org		Duerr, Ralf/0000-0001-9569-9237; Holloway, Courtney Jean/0000-0003-3661-1957; Kong, Xiang-Peng/0000-0001-5773-2681	National Institutes of Health [R01 AI083142, D43 TW009604, AI100151]; Division of Intramural Research, NIAID, NIH; FOGARTY INTERNATIONAL CENTER [D43TW009604] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P01AI100151, P30AI094189, R01AI083142, ZIAAI000361] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Division of Intramural Research, NIAID, NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); FOGARTY INTERNATIONAL CENTER(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by the National Institutes of Health (R01 AI083142, D43 TW009604; PNN) to PNN, RD, CRC, LM, AJN and ANB; (AI100151; XK) to XK, XJ, RP; and in part by the Division of Intramural Research, NIAID, NIH (TCQ) to TCQ, ADR, ARK, DB, CAM, LS, SFP.	Agyingi L, 2014, J MED VIROL, V86, P385, DOI 10.1002/jmv.23846; Andrabi R, 2015, IMMUNITY, V43, P959, DOI 10.1016/j.immuni.2015.10.014; Basu D, 2012, RETROVIROLOGY, V9, DOI 10.1186/1742-4690-9-76; Bhiman JN, 2015, NAT MED, V21, P1332, DOI 10.1038/nm.3963; Blish CA, 2008, J VIROL, V82, P12094, DOI 10.1128/JVI.01730-08; Chaillon A, 2013, J VIROL, V87, P12737, DOI 10.1128/JVI.02260-13; Cortez V, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1004973; Cortez V, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002611; Courtney CR, 2016, AIDS RES HUM RETROV, V32, P381, DOI 10.1089/aid.2015.0286; Curlin ME, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001228; Doria-Rose NA, 2014, NATURE, V509, P55, DOI 10.1038/nature13036; Georgiev IS, 2015, J VIROL, V89, P5318, DOI 10.1128/JVI.03451-14; Gordon K, 2016, AIDS RES HUM RETROV, V32, P303, DOI [10.1089/aid.2014.0100, 10.1089/AID.2014.0100]; Hemelaar J, 2011, AIDS, V25, P679, DOI 10.1097/QAD.0b013e328342ff93; Huang CC, 2005, SCIENCE, V310, P1025, DOI 10.1126/science.1118398; Jiang XQ, 2010, NAT STRUCT MOL BIOL, V17, P955, DOI 10.1038/nsmb.1861; Klein F, 2014, J EXP MED, V211, P2361, DOI 10.1084/jem.20141050; Kraft CS, 2012, RETROVIROLOGY, V9, DOI 10.1186/1742-4690-9-22; Landais E, 2016, PLOS PATHOG, V12, DOI 10.1371/journal.ppat.1005369; Lehman DA, 2012, JAIDS-J ACQ IMM DEF, V60, P225, DOI 10.1097/QAI.0b013e3182515730; Li M, 2005, J VIROL, V79, P10108, DOI 10.1128/JVI.79.16.10108-10125.2005; Li Y, 2008, J VIROL, V82, P638, DOI 10.1128/JVI.01691-07; Liao HX, 2013, IMMUNITY, V38, P176, DOI 10.1016/j.immuni.2012.11.011; Mayr LM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038989; McLellan JS, 2011, NATURE, V480, P336, DOI 10.1038/nature10696; Moore PL, 2011, J VIROL, V85, P3128, DOI 10.1128/JVI.02658-10; Pacold ME, 2012, AIDS, V26, P157, DOI 10.1097/QAD.0b013e32834dcd26; Pernas B, 2014, AIDS, V28, P1837, DOI 10.1097/QAD.0000000000000326; Pernas M, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0134054; Piantadosi A, 2009, J VIROL, V83, P10269, DOI 10.1128/JVI.01149-09; Powell RLR, 2008, AIDS RES HUM RETROV, V24, P100, DOI 10.1089/aid.2007.0162; Powell RLR, 2010, J VIROL, V84, P9415, DOI 10.1128/JVI.02732-09; Powell RLR, 2009, JAIDS-J ACQ IMM DEF, V50, P84, DOI 10.1097/QAI.0b013e31818d5a40; Rambaut A., 2012, FIGTREE MOL EVOLUTIO; Redd AD, 2014, AIDS, V28, P2147, DOI 10.1097/QAD.0000000000000365; Redd AD, 2013, LANCET INFECT DIS, V13, P622, DOI 10.1016/S1473-3099(13)70066-5; Redd AD, 2012, J INFECT DIS, V206, P267, DOI 10.1093/infdis/jis325; Redd AD, 2011, J CLIN MICROBIOL, V49, P2859, DOI 10.1128/JCM.00804-11; Ringe R, 2012, VIROLOGY, V426, P34, DOI 10.1016/j.virol.2012.01.011; ROBERTSON DL, 1995, J MOL EVOL, V40, P249, DOI 10.1007/BF00163230; Rolland M, 2012, NATURE, V490, P417, DOI 10.1038/nature11519; Ronen K, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003593; Sather DN, 2009, J VIROL, V83, P757, DOI 10.1128/JVI.02036-08; Scharf L, 2014, CELL REP, V7, P785, DOI 10.1016/j.celrep.2014.04.001; Sheward DJ, 2015, J INFECT DIS, V212, P904, DOI 10.1093/infdis/jiv136; Smith DM, 2006, VIROLOGY, V355, P1, DOI 10.1016/j.virol.2006.08.009; Smith DM, 2005, J INFECT DIS, V192, P438, DOI 10.1086/431682; Smith DM, 2004, JAMA-J AM MED ASSOC, V292, P1177, DOI 10.1001/jama.292.10.1177; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; Wagner GA, 2014, J INFECT DIS, V209, P1032, DOI 10.1093/infdis/jit633; West AP, 2013, P NATL ACAD SCI USA, V110, P10598, DOI 10.1073/pnas.1309215110; Zolla-Pazner S, 2016, J VIROL, V90, P636, DOI 10.1128/JVI.01645-15; Zolla-Pazner S, 2014, EBIOMEDICINE, V1, P37, DOI 10.1016/j.ebiom.2014.10.022	53	19	19	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 13	2017	12	3							e0173705	10.1371/journal.pone.0173705	http://dx.doi.org/10.1371/journal.pone.0173705			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN6CP	28288209	Green Submitted, gold, Green Published			2022-12-27	WOS:000396092400030
J	Maeo, S; Yamamoto, M; Kanehisa, H; Nosaka, K				Maeo, Sumiaki; Yamamoto, Masayoshi; Kanehisa, Hiroaki; Nosaka, Kazunori			Prevention of downhill walking-induced muscle damage by non-damaging downhill walking	PLOS ONE			English	Article							ECCENTRIC EXERCISE; CONTRACTIONS; BOUT; FREQUENCY; STRENGTH; SORENESS	Purpose Mountain trekking involves level, uphill, and downhill walking (DW). Prolonged DW induces damage to leg muscles, reducing force generating ability and muscle coordination. These increase risks for more serious injuries and accidents in mountain trekking, thus a strategy to minimize muscle damage is warranted. It has been shown that low-intensity eccentric contractions confer protective effect on muscle damage induced by high-intensity eccentric contractions. This study tested the hypothesis that 5-min non-damaging DW would attenuate muscle damage induced by 40-min DW, but 5-min level walking (LW) would not. Methods Untrained young men were allocated (n = 12/group) to either a control or one of the two preconditioning groups (PRE-DW or PRE-LW). The PRE-DW and PRE-LW groups performed 5-min DW (-28%) and 5-min LW, respectively, at 5 km/h with a load of 10% body mass, 1 week before 40-min DW (-28%, 5 km/h, 10% load). The control group performed 40-min DW only. Maximal knee extension strength, plasma creatine kinase (CK) activity, and muscle soreness (0-100 mm visual analogue scale) were measured before and 24 h after 5-min DW and 5-min LW, and before and 24, 48, and 72 h after 40-min DW. Results No significant changes in any variables were evident after 5-min DW and 5-min LW. After 40 min DW, the control and PRE-LW groups showed significant (P<0.05) changes in the variables without significant differences between groups (control vs. PRE-LW; peak strength reduction:-19.2 6.9% vs.-18.7 11.0%, peak CK: 635.5 306.0 vs. 639.6 405.4 U/L, peak soreness: 81.4 14.8 vs. 72.0 29.2 mm). These changes were significantly (P<0.05) attenuated (47-64%) for the PRE-DW group (-9.9 9.6%, 339.3 148.4 U/L, 27.8 16.8 mm). Conclusions The results supported the hypothesis and suggest that performing small volume of downhill walking is crucial in preparation for trekking.	[Maeo, Sumiaki] Waseda Univ, Fac Sport Sci, Tokorozawa, Saitama, Japan; [Maeo, Sumiaki] Japan Soc Promot Sci, Chiyoda Ku, Tokyo, Japan; [Yamamoto, Masayoshi; Kanehisa, Hiroaki] Natl Inst Fitness & Sports Kanoya, Sports & Life Sci, Kanoya, Kagoshima, Japan; [Nosaka, Kazunori] Edith Cowan Univ, Sch Med & Hlth Sci, Joondalup, WA, Australia	Waseda University; Japan Society for the Promotion of Science; National Institute Fitness & Sports Kanoya; Edith Cowan University	Maeo, S (corresponding author), Waseda Univ, Fac Sport Sci, Tokorozawa, Saitama, Japan.; Maeo, S (corresponding author), Japan Soc Promot Sci, Chiyoda Ku, Tokyo, Japan.	smaeo1985@gmail.com	Nosaka, Kazunori/H-4412-2011	Nosaka, Kazunori/0000-0001-7373-4994; Maeo, Sumiaki/0000-0003-0919-4799	Promotion of Science Research Fellow [15J03228]	Promotion of Science Research Fellow	This work was supported by a Grant-in-Aid for Japan Society for the Promotion of Science Research Fellow (15J03228) to SM. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmadi S, 2008, CLIN PHYSIOL FUNCT I, V28, P55, DOI 10.1111/j.1475-097X.2007.00777.x; Burt D, 2015, EUR J APPL PHYSIOL, V115, P1523, DOI 10.1007/s00421-015-3131-y; Byrne C, 2004, SPORTS MED, V34, P49, DOI 10.2165/00007256-200434010-00005; Byrne C, 2001, SCAND J MED SCI SPOR, V11, P134, DOI 10.1046/j.1524-4725.2001. 110302.x; Chen HL, 2012, EUR J APPL PHYSIOL, V112, P555, DOI 10.1007/s00421-011-1999-8; Chen TC, 2013, EUR J APPL PHYSIOL, V113, P1005, DOI 10.1007/s00421-012-2517-3; ESTON RG, 1995, BRIT J SPORT MED, V29, P89, DOI 10.1136/bjsm.29.2.89; Eston RG, 2002, J PHYSIOL-LONDON, V539, p75P; Farr T, 2002, J SCI MED SPORT, V5, P297, DOI 10.1016/S1440-2440(02)80018-4; Heggie TW, 2009, J TRAVEL MED, V16, P23, DOI 10.1111/j.1708-8305.2008.00269.x; Howatson G, 2011, MED SCI SPORT EXER, V43, P140, DOI 10.1249/MSS.0b013e3181e4b649; Isner-Horobeti ME, 2013, SPORTS MED, V43, P483, DOI 10.1007/s40279-013-0052-y; Lay AN, 2006, J BIOMECH, V39, P1621, DOI 10.1016/j.jbiomech.2005.05.005; Lima LCR, 2015, FRONT PHYSIOL, V6, DOI 10.3389/fphys.2015.00300; Maeo S, 2015, INT J SPORTS MED, V36, P150, DOI 10.1055/s-0034-1385885; Maeo S, 2016, J SPORT SCI, V34, P2018, DOI 10.1080/02640414.2016.1149607; Maeo S, 2015, APPL PHYSIOL NUTR ME, V40, P274, DOI 10.1139/apnm-2014-0390; McArdle A, 2001, AM J PHYSIOL-CELL PH, V280, pC621, DOI 10.1152/ajpcell.2001.280.3.C621; McHugh MP, 2003, SCAND J MED SCI SPOR, V13, P88, DOI 10.1034/j.1600-0838.2003.02477.x; Morgan DL, 2006, J PHYSIOL-LONDON, V574, P627, DOI 10.1113/jphysiol.2006.574201; Penailillo L, 2015, MED SCI SPORT EXER, V47, P708, DOI 10.1249/MSS.0000000000000473; Raastad T, 2010, MED SCI SPORT EXER, V42, P86, DOI 10.1249/MSS.0b013e3181ac7afa; Soares S, 2015, J STRENGTH COND RES, V29, P2594, DOI 10.1519/JSC.0000000000000899; Takagi R, 2016, PFLUG ARCH EUR J PHY, V468, P1565, DOI 10.1007/s00424-016-1860-3; Warren GL, 2000, MED SCI SPORT EXER, V32, P820, DOI 10.1097/00005768-200004000-00015; Yamamoto M, 2003, JPN J PHYS FIT SPORT, V52, P543, DOI 10.7600/jspfsm1949.52.543	26	12	12	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 13	2017	12	3							e0173909	10.1371/journal.pone.0173909	http://dx.doi.org/10.1371/journal.pone.0173909			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN6CP	28288187	Green Published, gold, Green Submitted			2022-12-27	WOS:000396092400041
J	Murray, GM; O'Neill, RG; Lee, AM; McElroy, MC; More, SJ; Monagle, A; Earley, B; Cassidy, JP				Murray, Gerard M.; O'Neill, Ronan G.; Lee, Alison M.; McElroy, Maire C.; More, Simon J.; Monagle, Aisling; Earley, Bernadette; Cassidy, Joseph P.			The bovine paranasal sinuses: Bacterial flora, epithelial expression of nitric oxide and potential role in the in-herd persistence of respiratory disease pathogens	PLOS ONE			English	Article							PARA-INFLUENZA-3 VIRUS; PARAINFLUENZA-3 VIRUS; SYNCYTIAL VIRUSES; MAXILLARY SINUS; DAIRY-CATTLE; ANTIBODIES; PNEUMONIA; CALVES; INFECTION; OUTBREAKS	The bovine paranasal sinuses are a group of complex cavernous air-filled spaces, lined by respiratory epithelium, the exact function of which is unclear. While lesions affecting these sinuses are occasionally reported in cattle, their microbial flora has not been defined. Furthermore, given that the various bacterial and viral pathogens causing bovine respiratory disease (BRD) persist within herds, we speculated that the paranasal sinuses may serve as a refuge for such infectious agents. The paranasal sinuses of clinically normal cattle (n = 99) and of cattle submitted for post-mortem examination (PME : n = 34) were examined by microbial culture, PCR and serology to include bacterial and viral pathogens typically associated with BRD: Mycoplasma bovis, Histophilus somni, Mannheimia haemolytica and Pasteurella multocida, bovine respiratory syncytial virus (BRSV) and bovine parainfluenza-3 virus (BPIV-3). Overall, the paranasal sinuses were either predominantly sterile or did not contain detectable microbes (83.5%: 94.9% of clinically normal and 50.0% of cattle submitted for PME). Bacteria, including BRD causing pathogens, were identified in relatively small numbers of cattle (<10%). While serology indicated widespread exposure of both clinically normal and cattle submitted for PME to BPIV-3 and BRSV (seroprevalences of 91.6% and 84.7%, respectively), PCR identified BPIV-3 in only one animal. To further explore these findings we investigated the potential role of the antimicrobial molecule nitric oxide (NO) within paranasal sinus epithelium using immunohistochemistry. Expression of the enzyme responsible for NO synthesis, inducible nitric oxide synthase (iNOS), was detected to varying degrees in 76.5% of a sub-sample of animals suggesting production of this compound plays a similar protective role in the bovine sinus as it does in humans.	[Murray, Gerard M.] Dept Agr Food & Marine, Sligo Reg Vet Lab, Doonally, Sligo, Ireland; [O'Neill, Ronan G.; McElroy, Maire C.] Dept Agr Food & Marine, Cent Vet Res Lab, Celbridge, Kildare, Ireland; [Lee, Alison M.; Monagle, Aisling; Cassidy, Joseph P.] Univ Coll Dublin, Sch Vet Med, Dublin, Ireland; [More, Simon J.] Univ Coll Dublin, UCD Sch Vet Med, Ctr Vet Epidemiol & Risk Anal, Dublin, Ireland; [Earley, Bernadette] TEAGASC, Anim & Biosci Res Dept, Anim & Grassland Res & Innovat Ctr, Dunsany, Meath, Ireland	University College Dublin; University College Dublin; Teagasc	Murray, GM (corresponding author), Dept Agr Food & Marine, Sligo Reg Vet Lab, Doonally, Sligo, Ireland.	gerard.murray@agriculture.gov.ie		Cassidy, Joseph/0000-0002-9229-1831; More, Simon/0000-0002-4270-0385; Lee, Alison/0000-0002-2224-5549; Earley, Bernadette/0000-0002-9772-2813				Abou Hamad W, 2009, AM J RHINOL ALLERGY, V23, P261, DOI 10.2500/ajra.2009.23.3317; Abreu NA, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003783; Albu S, 2013, AM J OTOLARYNG, V34, P327, DOI 10.1016/j.amjoto.2013.01.001; ALLAN EM, 1978, RES VET SCI, V24, P339, DOI 10.1016/S0034-5288(18)33045-5; Anand VK, 2004, ANN OTO RHINOL LARYN, V113, P3, DOI 10.1177/00034894041130S502; Andersson JA, 2002, ACTA OTO-LARYNGOL, V122, P861, DOI 10.1080/003655402/000028053; Bidokhti MRM, 2012, ARCH VIROL, V157, P601, DOI 10.1007/s00705-011-1209-3; BROOK I, 1981, LARYNGOSCOPE, V91, P372; BRYSON DG, 1990, J COMP PATHOL, V103, P433, DOI 10.1016/S0021-9975(08)80031-X; Budras K.D., 2011, BOVINE ANATOMY ILLUS, V1st; CASTRUCCI G, 1983, COMP IMMUNOL MICROB, V6, P193, DOI 10.1016/0147-9571(83)90010-3; Caswell JL, 2014, VET PATHOL, V51, P393, DOI 10.1177/0300985813502821; Crilly J. P., 2013, Livestock, V18, P230, DOI 10.12968/live.2013.18.6.230; Crocker CB, 1998, J AM VET MED ASSOC, V213, P1472; DEGROOTE MA, 1995, CLIN INFECT DIS, V21, pS162, DOI 10.1093/clinids/21.Supplement_2.S162; Dyce KM., 2002, TXB VET ANATOMY, V3rd ed.; ELVANDER M, 1995, J VET DIAGN INVEST, V7, P177, DOI 10.1177/104063879500700202; Farke AA, 2010, ZOOL J LINN SOC-LOND, V159, P988, DOI 10.1111/j.1096-3642.2009.00586.x; FRANK GH, 1973, J AM VET MED ASSOC, V163, P858; FRANK GH, 1971, AM J VET RES, V32, P1707; Graham DA, 1997, J VET DIAGN INVEST, V9, P24, DOI 10.1177/104063879700900105; Griffin D, 2010, VET CLIN N AM-FOOD A, V26, P381, DOI 10.1016/j.cvfa.2010.04.004; GUSTAFSSON LE, 1991, BIOCHEM BIOPH RES CO, V181, P852, DOI 10.1016/0006-291X(91)91268-H; Guterbock WM, 2014, ANIM HEALTH RES REV, V15, P130, DOI 10.1017/S1466252314000140; Hauser LJ, 2015, INT FORUM ALLERGY RH, V5, P3, DOI 10.1002/alr.21428; Jiang RS, 1999, J LARYNGOL OTOL, V113, P825, DOI 10.1017/S0022215100145311; Kim JW, 2001, LARYNGOSCOPE, V111, P246, DOI 10.1097/00005537-200102000-00011; Klima CL, 2014, CAN J VET RES, V78, P38; Larsen LE, 2000, J CLIN MICROBIOL, V38, P4222, DOI 10.1128/JCM.38.11.4222-4227.2000; Lewandowski K, 1998, J APPL PHYSIOL, V85, P405, DOI 10.1152/jappl.1998.85.2.405; Lima SF, 2016, SCI REP-UK, V6, DOI 10.1038/srep29050; Lindberg S, 1997, ACTA OTO-LARYNGOL, V117, P113, DOI 10.3109/00016489709118001; Lindberg S, 1997, ACTA OTO-LARYNGOL, V117, P728, DOI 10.3109/00016489709113468; Liu DY, 2004, J MICROBIOL METH, V58, P263, DOI 10.1016/j.mimet.2004.04.008; Lundberg JON, 1996, EUR RESPIR J, V9, P1344, DOI 10.1183/09031936.96.09071344; LUNDBERG JON, 1995, NAT MED, V1, P370, DOI 10.1038/nm0495-370; LUNDBERG JON, 1994, ACTA PHYSIOL SCAND, V152, P431, DOI 10.1111/j.1748-1716.1994.tb09826.x; Meltzer Eli O, 2004, J Allergy Clin Immunol, V114, P155, DOI 10.1016/j.jaci.2004.09.029; Mugera GM, 2000, VET PATHOLOGY TROPIC; Mundell LDM, 1996, J AM VET MED ASSOC, V209, P127; Murray GM, 2017, J VET DIAGN INVEST, V29, P20, DOI 10.1177/1040638716674757; Naraghi M, 2007, AM J OTOLARYNG, V28, P334, DOI 10.1016/j.amjoto.2006.10.014; O'Neill R, 2014, VET REC, V175, DOI 10.1136/vr.102574; Regev-Shoshani G, 2013, RES VET SCI, V95, P606, DOI 10.1016/j.rvsc.2013.06.016; Regev-Shoshani G, 2013, J APPL MICROBIOL, V114, P536, DOI 10.1111/jam.12047; Regev-Shoshani G, 2015, PREV VET ME IN PRESS; Rodriguez F, 1996, J COMP PATHOL, V115, P151, DOI 10.1016/S0021-9975(96)80037-5; Schedin U, 1997, ACTA ANAESTH SCAND, V41, P1133; Serrano C, 2004, ARCH BRONCONEUMOL, V40, P222; SOBIN J, 1992, SCAND J INFECT DIS, V24, P633, DOI 10.3109/00365549209054650; SU WY, 1983, LARYNGOSCOPE, V93, P931; WARD JL, 1992, J AM VET MED ASSOC, V201, P326	52	3	4	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 10	2017	12	3							e0173845	10.1371/journal.pone.0173845	http://dx.doi.org/10.1371/journal.pone.0173845			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN6CJ	28282443	Green Published, Green Submitted, gold			2022-12-27	WOS:000396091800084
J	Reyes-Aldasoro, CC				Reyes-Aldasoro, Constantino Carlos			The proportion of cancer-related entries in PubMed has increased considerably; is cancer truly "The Emperor of All Maladies"?	PLOS ONE			English	Article							BREAST-CANCER; NEGLECTED DISEASES; MATHEMATICAL-MODEL; NORDIC COUNTRIES; INCIDENCE RATES; UNITED-STATES; DECREASE; GENE; CELL; AWARENESS	In this work, the public database of biomedical literature PubMed was mined using queries with combinations of keywords and year restrictions. It was found that the proportion of Cancer-related entries per year in PubMed has risen from around 6% in 1950 to more than 16% in 2016. This increase is not shared by other conditions such as AIDS, Malaria, Tuberculosis, Diabetes, Cardiovascular, Stroke and Infection some of which have, on the contrary, decreased as a proportion of the total entries per year. Organ-related queries were performed to analyse the variation of some specific cancers. A series of queries related to incidence, funding, and relationship with DNA, Computing and Mathematics, were performed to test correlation between the keywords, with the hope of elucidating the cause behind the rise of Cancer in PubMed. Interestingly, the proportion of Cancer-related entries that contain "DNA", "Computational" or "Mathematical" have increased, which suggests that the impact of these scientific advances on Cancer has been stronger than in other conditions. It is important to highlight that the results obtained with the data mining approach here presented are limited to the presence or absence of the keywords on a single, yet extensive, database. Therefore, results should be observed with caution. All the data used for this work is publicly available through PubMed and the UK's Office for National Statistics. All queries and figures were generated with the software platform Matlab and the files are available as supplementary material.	[Reyes-Aldasoro, Constantino Carlos] Univ London, Sch Math Comp Sci & Engn City, London, England	University of London	Reyes-Aldasoro, CC (corresponding author), Univ London, Sch Math Comp Sci & Engn City, London, England.	reyes@city.ac.uk	Reyes-Aldasoro, Constantino/S-5093-2019	Reyes-Aldasoro, Constantino/0000-0002-9466-2018				Abbasi K, 2005, J ROY SOC MED, V98, P389, DOI 10.1258/jrsm.98.9.389; Akachi Y, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021309; Anders ME, 2010, RESP CARE, V55, P578; Anderson JL, 2007, CIRCULATION, V116, P2563, DOI 10.1161/CIRCULATIONAHA.107.737312; ANDERSON S, 1981, NATURE, V290, P457, DOI 10.1038/290457a0; Annertz K, 2012, ACTA OTO-LARYNGOL, V132, P552, DOI 10.3109/00016489.2011.649146; Aschebrook-Kilfoy B, 2013, CANCER EPIDEM BIOMAR, V22, P1252, DOI 10.1158/1055-9965.EPI-13-0242; Barbolosi D, 2016, NAT REV CLIN ONCOL, V13, P242, DOI 10.1038/nrclinonc.2015.204; Byrne HM, 2010, NAT REV CANCER, V10, P221, DOI 10.1038/nrc2808; Centers for Disease Control (CDC), 1989, MMWR Morb Mortal Wkly Rep, V38, P269; Chaplain MAJ, 1996, INVAS METAST, V16, P222; Choices NHS, 2016, PREDICTIVE GENETIC T; Crocetti E, 2010, J MED SCREEN, V17, P50, DOI 10.1258/jms.2009.009123; Crowell HL, 2016, J THEOR BIOL, V401, P43, DOI 10.1016/j.jtbi.2016.04.002; CZERNILOFSKY AP, 1980, NATURE, V287, P198, DOI 10.1038/287198a0; Dehlendorff C, 2014, JAMA NEUROL, V71, P978, DOI 10.1001/jamaneurol.2014.1017; Dikshit RP, 2012, CANCER EPIDEMIOL, V36, pE215, DOI 10.1016/j.canep.2012.03.009; Doms A, 2005, NUCLEIC ACIDS RES, V33, pW783, DOI 10.1093/nar/gki470; Evans CJ, 2009, J THEOR BIOL, V257, P598, DOI 10.1016/j.jtbi.2008.11.031; Figueredo GP, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0095150; Fitchett JR, 2014, INT HEALTH, V6, P74, DOI 10.1093/inthealth/iht036; Ford ES, 2007, NEW ENGL J MED, V356, P2388, DOI 10.1056/NEJMsa053935; Frick M, FLATLINED US GOVERNM; Gerszten RE, 2008, NATURE, V451, P949, DOI 10.1038/nature06802; Giles GG, 2009, MED J AUSTRALIA, V190, P164, DOI 10.5694/j.1326-5377.2009.tb02329.x; Gompel A, 2010, ANN NY ACAD SCI, V1205, P268, DOI 10.1111/j.1749-6632.2010.05664.x; Gonzalez-Gomez FJ, 2016, REV CLIN ESP, V216, P345, DOI 10.1016/j.rce.2016.05.008; Grimmett C, 2014, PERSPECT PUBLIC HEAL, V134, P268, DOI 10.1177/1757913914534840; Groh CM, 2014, J R SOC INTERFACE, V11, DOI 10.1098/rsif.2013.1173; Guo Y, 2016, J STROKE CEREBROVASC, V25, P2995, DOI 10.1016/j.jstrokecerebrovasdis.2016.08.018; Gupta A, 2015, EUR J CANCER, V51, P2058, DOI 10.1016/j.ejca.2015.07.008; GUSELLA JF, 1983, NATURE, V306, P234, DOI 10.1038/306234a0; Haley MJ, 2016, J CEREBR BLOOD F MET, V36, P2007, DOI 10.1177/0271678X16670411; HARRIS MI, 1987, DIABETES, V36, P523, DOI 10.2337/diabetes.36.4.523; Harris MI, 1998, DIABETES CARE, V21, P518, DOI 10.2337/diacare.21.4.518; Hayden EC, 2009, NATURE, V460, P940, DOI 10.1038/460940a; Hedley AA, 2004, JAMA-J AM MED ASSOC, V291, P2847, DOI 10.1001/jama.291.23.2847; Hou NQ, 2013, BREAST CANCER RES TR, V138, P633, DOI 10.1007/s10549-013-2434-0; Hull D., TWENTY MILLION PAPER; Jacobsen R, 2006, INT J ANDROL, V29, P199, DOI 10.1111/j.1365-2605.2005.00605.x; JENKINS JR, 1985, NATURE, V317, P816, DOI 10.1038/317816a0; Kershaw SK, 2013, IET SYST BIOL, V7, P57, DOI 10.1049/iet-syb.2012.0019; Kyle RG, 2013, TRIALS, V14, DOI 10.1186/1745-6215-14-286; LEBEAU MM, 1985, NATURE, V316, P826, DOI 10.1038/316826a0; Lozano R, 2012, LANCET, V380, P2095, DOI 10.1016/S0140-6736(12)61728-0; Lyrdal D, 2013, SCAND J UROL, V47, P302, DOI 10.3109/00365599.2012.732608; MacLean AL, 2014, P NATL ACAD SCI USA, V111, P3883, DOI 10.1073/pnas.1317072111; MARSH K, 1992, PARASITOLOGY, V104, pS53, DOI 10.1017/S0031182000075247; McAuley PA, 2011, J SPORT SCI, V29, P773, DOI 10.1080/02640414.2011.553965; Mitchell AB, 2015, STROKE, V46, P1690, DOI 10.1161/STROKEAHA.115.008940; Molarius A, 2016, EUR J PUBLIC HEALTH, V26, P622, DOI 10.1093/eurpub/ckw042; Morel CM, 2003, EMBO REP, V4, pS35, DOI 10.1038/sj.embor.embor851; Mukherjee S., 2011, THE EMPEROR OF ALL M; Murphy CC, 2016, CLIN GASTROENTEROL H; Pandeya N, 2016, CLIN ENDOCRINOL, V84, P257, DOI 10.1111/cen.12724; Perez-Gomez B, 2010, ANN ONCOL, V21, piii61, DOI 10.1093/annonc/mdq093; Pigott DM, 2012, MALARIA J, V11, DOI 10.1186/1475-2875-11-246; Plank MJ, 2004, J THEOR BIOL, V229, P435, DOI 10.1016/j.jtbi.2004.04.012; Polednak AP, 2015, J CANCER EPIDEMIOL, V2015, DOI 10.1155/2015/710106; Powathil GG, 2015, SEMIN CANCER BIOL, V30, P13, DOI 10.1016/j.semcancer.2014.02.003; Ramos JM, 2008, INT J TUBERC LUNG D, V12, P1461; Rebbeck TR, 2016, BREAST CANCER RES, V18, DOI 10.1186/s13058-016-0768-3; RICHMAN DD, 1988, AIDS, V2, pS137, DOI 10.1097/00002030-198800001-00021; RIESENBERG DE, 1985, JAMA-J AM MED ASSOC, V254, P2521, DOI 10.1001/jama.254.18.2521; RUZICKA T, 1987, LANCET, V2, P1469; SAIKI RK, 1988, SCIENCE, V239, P487, DOI 10.1126/science.2448875; Sanz J, 2008, NATURE, V451, P953, DOI 10.1038/nature06803; Schiermeier Q, 2016, NATURE, V532, P18, DOI [10.1038/nature.2016.19672, 10.1038/nature.2016.20893]; Scott JG, 2016, PLOS COMPUT BIOL, V12, DOI 10.1371/journal.pcbi.1004712; Sogaard M, 2012, AM J INFECT CONTROL, V40, P237, DOI 10.1016/j.ajic.2011.03.011; Starke JR, 2014, PEDIATRICS, V133, pE725, DOI 10.1542/peds.2013-4139; STEHELIN D, 1976, NATURE, V260, P170, DOI 10.1038/260170a0; SZABO CI, 1995, HUM MOL GENET, V4, P1811, DOI 10.1093/hmg/4.suppl_1.1811; Theodosiou T, 2011, J BIOMED INFORM, V44, P919, DOI 10.1016/j.jbi.2011.05.009; van Weert H, 2016, EUR J GEN PRACT, V22, P69, DOI 10.1080/13814788.2016.1180361; Vanteru BC, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-S1-S10; Wang Y, 2016, EUR J CLIN NUTR; WEISS SR, 1981, VIROLOGY, V110, P476; World Health Organization, 2003, Midwifery, V19, P72; Yamey G, 2002, BRIT MED J, V325, P176, DOI 10.1136/bmj.325.7357.176; Youlden DR, 2012, CANCER EPIDEMIOL, V36, P237, DOI 10.1016/j.canep.2012.02.007	82	13	14	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 10	2017	12	3							e0173671	10.1371/journal.pone.0173671	http://dx.doi.org/10.1371/journal.pone.0173671			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN6CJ	28282418	Green Submitted, Green Published, gold, Green Accepted			2022-12-27	WOS:000396091800067
J	Sharma, S; Ryndak, MB; Aggarwal, AN; Yadav, R; Sethi, S; Masih, S; Laal, S; Verma, I				Sharma, Sumedha; Ryndak, Michelle B.; Aggarwal, Ashutosh N.; Yadav, Rakesh; Sethi, Sunil; Masih, Shet; Laal, Suman; Verma, Indu			Transcriptome analysis of mycobacteria in sputum samples of pulmonary tuberculosis patients	PLOS ONE			English	Article							2-COMPONENT SYSTEM; VIRULENCE FACTORS; EXPRESSION; GENES; LUNG; ATTENUATION; MICROARRAYS; ADAPTATION; INFECTION; TRANSPORT	Pulmonary tuberculosis, the disease caused by Mycobacterium tuberculosis, still retains a top rank among the deadliest communicable diseases. Sputum expectorated during the disease continues to be a primary diagnostic specimen and also serves as a reservoir of bacteria. The expression pattern of mycobacteria in sputum will lead to an insight into bacterial adaptation at the most highly transmissible stage of infection and can also help in identifying newer diagnostic as well as drug targets. Thus, in the present study, a whole genome microarray of Mycobacterium tuberculosis was used to elucidate the transcriptional profile of mycobacteria in the sputum samples of smear positive pulmonary tuberculosis patients. Overall, the mycobacteria in sputum appeared to be in a low energy and low replicative state as compared to in vitro grown log phase M. tb with downregulation of genes involved in ATP synthesis, aerobic respiration and translational machinery. Simultaneously, downregulation was also seen in the genes involved in secretion machinery of mycobacteria along with the downregulation of genes involved in the synthesis of phthiocerol dimycocerosate and phenol glycolipids. In contrast, the majority of the genes which showed an upregulation in sputum mycobacteria were of unknown function. Further identification of these genes may provide new insights into the mycobacterial behavior during this phase of infection and may help in deciphering candidates for development of better diagnostic and drug candidates.	[Sharma, Sumedha; Verma, Indu] Post Grad Inst Med Educ & Res, Dept Biochem, Chandigarh, India; [Ryndak, Michelle B.; Laal, Suman] NYU, Dept Pathol, Langone Med Ctr, 550 1St Ave, New York, NY 10016 USA; [Aggarwal, Ashutosh N.] Post Grad Inst Med Educ & Res, Dept Pulm Med, Chandigarh, India; [Yadav, Rakesh; Sethi, Sunil] Post Grad Inst Med Educ & Res, Dept Med Microbiol, Chandigarh, India; [Masih, Shet] MDRL Pvt Ltd, Chandigarh, India; [Laal, Suman] Vet Affairs New York Harbor Healthcare Syst, New York, NY USA	Post Graduate Institute of Medical Education & Research (PGIMER), Chandigarh; New York University; NYU Langone Medical Center; Post Graduate Institute of Medical Education & Research (PGIMER), Chandigarh; Post Graduate Institute of Medical Education & Research (PGIMER), Chandigarh	Verma, I (corresponding author), Post Grad Inst Med Educ & Res, Dept Biochem, Chandigarh, India.	induvemabio@gmail.com	Verma, Indu/AAF-3514-2020		NIH/FIC AIDS International Training and Research Program (AITRP) grant [TW001409]; Council of Scientific and Industrial Research [09/141(0180)2011-EMR-I]; FOGARTY INTERNATIONAL CENTER [D43TW009588] Funding Source: NIH RePORTER	NIH/FIC AIDS International Training and Research Program (AITRP) grant; Council of Scientific and Industrial Research(Council of Scientific & Industrial Research (CSIR) - India); FOGARTY INTERNATIONAL CENTER(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC))	The current study is funded by NIH/FIC AIDS International Training and Research Program (AITRP) grant TW001409 awarded to Dr. Suman Laal and Council of Scientific and Industrial Research 09/141(0180)2011-EMR-I which provided salary for author SS. The funders did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The company MDRL Pvt. Ltd. was not a funder in the current study. Dr Shet Masih, Founder and Director of the MDRL was involved in planning and execution of some part of the study and also provided materials required for some experiments in this study.	Abdallah AM, 2009, MOL MICROBIOL, V73, P329, DOI 10.1111/j.1365-2958.2009.06783.x; Abdallah AM, 2006, MOL MICROBIOL, V62, P667, DOI 10.1111/j.1365-2958.2006.05409.x; Barrios-Payan J, 2012, J INFECT DIS, V206, P1194, DOI 10.1093/infdis/jis381; Berthet FX, 1998, MICROBIOL-UK, V144, P3195, DOI 10.1099/00221287-144-11-3195; Betts JC, 2002, MOL MICROBIOL, V43, P717, DOI 10.1046/j.1365-2958.2002.02779.x; Daum LT, 2014, INT J TUBERC LUNG D, V18, P847, DOI 10.5588/ijtld.13.0021; Daum LT, 2011, EPIDEMIOL INFECT, V139, P1764, DOI 10.1017/S0950268810002384; Dudoit S, 2000, 578 U CAL DEP STAT; Fan WC, 2014, LUNG CANCER, V85, P472, DOI 10.1016/j.lungcan.2014.07.001; Fisher MA, 2002, J BACTERIOL, V184, P4025, DOI 10.1128/JB.184.14.4025-4032.2002; Fontan P, 2008, INFECT IMMUN, V76, P717, DOI 10.1128/IAI.00974-07; Forrellad MA, 2013, VIRULENCE, V4, P3, DOI 10.4161/viru.22329; Garton NJ, 2008, PLOS MED, V5, P634, DOI 10.1371/journal.pmed.0050075; Gonzalo-Asensio J, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003496; Guinn KM, 2004, MOL MICROBIOL, V51, P359, DOI 10.1046/j.1365-2958.2003.03844.x; He HJ, 2006, J BACTERIOL, V188, P2134, DOI 10.1128/JB.188.6.2134-2143.2006; Honeyborne I, 2016, BMC MED, V14, DOI 10.1186/s12916-016-0609-3; Houben ENG, 2014, BBA-MOL CELL RES, V1843, P1707, DOI 10.1016/j.bbamcr.2013.11.003; Hsu T, 2003, P NATL ACAD SCI USA, V100, P12420, DOI 10.1073/pnas.1635213100; Kane MD, 2000, NUCLEIC ACIDS RES, V28, P4552, DOI 10.1093/nar/28.22.4552; Kendall SL, 2004, TUBERCULOSIS, V84, P247, DOI 10.1016/j.tube.2003.12.007; Keren I, 2011, MBIO, V2, DOI 10.1128/mBio.00100-11; Kinhikar AG, 2010, MOL MICROBIOL, V75, P92, DOI 10.1111/j.1365-2958.2009.06959.x; Mannhalter C, 2000, CLIN CHEM LAB MED, V38, P171, DOI 10.1515/CCLM.2000.026; Matsunaga I, 2004, J EXP MED, V200, P1559, DOI 10.1084/jem.20041429; Okkels LM, 2004, J BACTERIOL, V186, P2487, DOI 10.1128/JB.186.8.2487-2491.2004; Onwueme KC, 2005, PROG LIPID RES, V44, P259, DOI 10.1016/j.plipres.2005.07.001; Pallen MJ, 2002, TRENDS MICROBIOL, V10, P209, DOI 10.1016/S0966-842X(02)02345-4; Pang XH, 2013, J BACTERIOL, V195, P66, DOI 10.1128/JB.01067-12; Parish T, 2014, MICROBIOL SPECTR, V2, DOI 10.1128/microbiolspec.MGM2-0010-2013; Quadri LEN, 2014, CRIT REV BIOCHEM MOL, V49, P179, DOI 10.3109/10409238.2014.896859; Reed MB, 2004, NATURE, V431, P84, DOI 10.1038/nature02837; Renshaw PS, 2005, EMBO J, V24, P2491, DOI 10.1038/sj.emboj.7600732; Ryndak M, 2008, TRENDS MICROBIOL; Ryndak MB, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0123745; Ryndak MB, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094939; Schlingemann J, 2005, NUCLEIC ACIDS RES, V33, DOI 10.1093/nar/gni029; Schnappinger D, 2003, J EXP MED, V198, P693, DOI 10.1084/jem.20030846; Serafini A, 2009, J BACTERIOL, V191, P6340, DOI 10.1128/JB.00756-09; Sherman DR, 2001, P NATL ACAD SCI USA, V98, P7534, DOI 10.1073/pnas.121172498; Shi LB, 2005, P NATL ACAD SCI USA, V102, P15629, DOI 10.1073/pnas.0507850102; Simeone R, 2015, TUBERCULOSIS, P1; Simeone R, 2009, CURR OPIN MICROBIOL, V12, P4, DOI 10.1016/j.mib.2008.11.003; Sirakova TD, 2003, INFECT IMMUN, V71, P3794, DOI 10.1128/IAI.71.7.3794-3801.2003; Sirakova TD, 2003, J BACTERIOL, V185, P2999, DOI 10.1128/JB.185.10.2999-3008.2003; Talaat AM, 2004, P NATL ACAD SCI USA, V101, P4602, DOI 10.1073/pnas.0306023101; Tsenova L, 2005, J INFECT DIS, V192, P98, DOI 10.1086/430614; Tusher VG, 2001, P NATL ACAD SCI USA, V98, P5116, DOI 10.1073/pnas.091062498; Voskuil MI, 2011, FRONT MICROBIOL, V2, DOI 10.3389/fmicb.2011.00105; Voskuil MI, 2003, J EXP MED, V198, P705, DOI 10.1084/jem.20030205; Walter ND, 2015, J INFECT DIS, V212, P990, DOI 10.1093/infdis/jiv149; Walters SB, 2006, MOL MICROBIOL, V60, P312, DOI 10.1111/j.1365-2958.2006.05102.x; Zahrt TC, 2001, P NATL ACAD SCI USA, V98, P12706, DOI 10.1073/pnas.221272198	53	24	24	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 10	2017	12	3							e0173508	10.1371/journal.pone.0173508	http://dx.doi.org/10.1371/journal.pone.0173508			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN6CJ	28282458	Green Published, Green Submitted, gold			2022-12-27	WOS:000396091800046
J	Costa, DS; Classen, A; Ferger, S; Helbig-Bonitz, M; Peters, M; Bohning-Gaese, K; Steffan-Dewenter, I; Kleyer, M				Costa, David Schellenberger; Classen, Alice; Ferger, Stefan; Helbig-Bonitz, Maria; Peters, Marcell; Boehning-Gaese, Katrin; Steffan-Dewenter, Ingolf; Kleyer, Michael			Relationships between abiotic environment, plant functional traits, and animal body size at Mount Kilimanjaro, Tanzania	PLOS ONE			English	Article							BERGMANNS RULE; LEAF ECONOMICS; CLIMATE-CHANGE; TRADE-OFFS; PATTERNS; PRODUCTIVITY; COMMUNITIES; TEMPERATURE; ECOLOGY; DISTRIBUTIONS	The effect-response framework states that plant functional traits link the abiotic environment to ecosystem functioning. One ecosystem property is the body size of the animals living in the system, which is assumed to depend on temperature or resource availability, among others. For primary consumers, resource availability may directly be related to plant traits, while for secondary consumers the relationship is indirect. We used plant traits to describe resource availability along an elevational gradient on Mount Kilimanjaro, Tanzania. Using structural equation models, we determined the response of plant traits to changes in precipitation, temperature and disturbance with and assessed whether abiotic conditions or community-weighted means of plant traits are stronger predictors of the mean size of bees, moths, frugivorous birds, and insectivorous birds. Traits indicating tissue density and nutrient content strongly responded to variations in precipitation, temperature and disturbance. They had direct effects on pollination and fruit traits. However, the average body sizes of the animal groups considered could only be explained by temperature and habitat structure, not by plant traits. Our results demonstrate a strong link between traits and the abiotic environment, but suggest that temperature is the most relevant predictor of mean animal body size. Community-weighted means of plant traits and body sizes appear unsuitable to capture the complexity of plant-animal interactions.	[Costa, David Schellenberger; Kleyer, Michael] Carl von Ossietzky Univ Oldenburg, Dept Biol & Environm Sci, Oldenburg, Germany; [Classen, Alice; Peters, Marcell; Steffan-Dewenter, Ingolf] Univ Wurzburg, Dept Anim Ecol & Trop Biol, Wurzburg, Germany; [Ferger, Stefan; Boehning-Gaese, Katrin] Senckenberg Gesell Nat Forsch, Biodivers & Climate Res Ctr, Frankfurt, Germany; [Helbig-Bonitz, Maria] Univ Ulm, Inst Expt Ecol, Ulm, Germany; [Boehning-Gaese, Katrin] Goethe Univ Frankfurt, Inst Ecol Evolut & Divers, Frankfurt, Germany	Carl von Ossietzky Universitat Oldenburg; University of Wurzburg; Senckenberg Gesellschaft fur Naturforschung (SGN); Ulm University; Goethe University Frankfurt	Costa, DS (corresponding author), Carl von Ossietzky Univ Oldenburg, Dept Biol & Environm Sci, Oldenburg, Germany.	david.schellenberger.costa@uni-oldenburg.de	Schellenberger Costa, David/AAT-5413-2020; Classen, Alice/H-7655-2013; Böhning-Gaese, Katrin/W-2601-2019	Schellenberger Costa, David/0000-0003-1747-1506; Böhning-Gaese, Katrin/0000-0003-0477-5586; Classen, Alice/0000-0002-7813-8806; Peters, Marcell/0000-0002-1262-0827	German Science Foundation [KL 756/5-1, FOR 1246]	German Science Foundation(German Research Foundation (DFG))	This research was made possible by a grant from the German Science Foundation (grant number KL 756/5-1) in the framework of the Collaborative Research Unit FOR 1246 "Kilimanjaro ecosystems under global change: Linking	Agosta SJ, 2005, OIKOS, V108, P183, DOI 10.1111/j.0030-1299.2005.13504.x; Allen CR, 2006, ECOL LETT, V9, P630, DOI 10.1111/j.1461-0248.2006.00902.x; Anderson-Teixeira Kristina J., 2012, P280; [Anonymous], 2014, R LANG ENV STAT COMP; [Anonymous], [No title captured]; Arim M, 2010, OIKOS, V119, P147, DOI 10.1111/j.1600-0706.2009.17768.x; Ashton KG, 2002, GLOBAL ECOL BIOGEOGR, V11, P505, DOI 10.1046/j.1466-822X.2002.00313.x; ATKINSON D, 1994, ADV ECOL RES, V25, P1, DOI 10.1016/s0065-2504(08)60212-3; Awmack CS, 2002, ANNU REV ENTOMOL, V47, P817, DOI 10.1146/annurev.ento.47.091201.145300; Barr DJ, 2013, J MEM LANG, V68, P255, DOI 10.1016/j.jml.2012.11.001; Bates D, 2008, THE LME4 PACKAGE; Bergmann C., 1848, VERHALTNISSE WARMEOK; Blanckenhorn WU, 2000, Q REV BIOL, V75, P385, DOI 10.1086/393620; BOYCE MS, 1978, OECOLOGIA, V36, P1, DOI 10.1007/BF00344567; Brehm G, 2004, GLOBAL ECOL BIOGEOGR, V13, P7, DOI 10.1111/j.1466-882X.2004.00069.x; Brown JH, 2004, ECOLOGY, V85, P1771, DOI 10.1890/03-9000; CANE JH, 1987, J KANSAS ENTOMOL SOC, V60, P145; Churkina G, 1998, ECOSYSTEMS, V1, P206, DOI 10.1007/s100219900016; Classen A, 2017, FUNCT ECOL, V31, P768, DOI 10.1111/1365-2435.12786; Classen A, 2015, GLOBAL ECOL BIOGEOGR, V24, P642, DOI 10.1111/geb.12286; Diaz S, 1999, J VEG SCI, V10, P651, DOI 10.2307/3237080; Diaz S, 2004, J VEG SCI, V15, P295, DOI 10.1111/j.1654-1103.2004.tb02266.x; Dunning Jr JB, 1992, CRC HDB AVIAN BODY M; Ensslin A, 2015, ECOSPHERE, V6, DOI 10.1890/ES14-00492.1; Ferger SW, 2014, GLOBAL ECOL BIOGEOGR, V23, P541, DOI 10.1111/geb.12151; Freschet GT, 2010, J ECOL, V98, P362, DOI 10.1111/j.1365-2745.2009.01615.x; GARDNER WR, 1965, ANN REV PLANT PHYSIO, V16, P323, DOI 10.1146/annurev.pp.16.060165.001543; Garnier E, 2007, ANN BOT-LONDON, V99, P967, DOI 10.1093/aob/mcl215; GEIST V, 1987, CAN J ZOOL, V65, P1035, DOI 10.1139/z87-164; Greenleaf SS, 2007, OECOLOGIA, V153, P589, DOI 10.1007/s00442-007-0752-9; Grime JP, 2006, J VEG SCI, V17, P255, DOI 10.1111/j.1654-1103.2006.tb02444.x; Hemp A, 2001, PLANT BIOLOGY, V3, P493, DOI 10.1055/s-2001-17729; Hemp A, 2009, AFR J ECOL, V47, P3, DOI 10.1111/j.1365-2028.2008.01043.x; Hilderbrand GV, 1999, CAN J ZOOL, V77, P132, DOI 10.1139/cjz-77-1-132; Holling CS, 1994, ECOSYSTEM MANAGEMENT, P351; HONEK A, 1993, OIKOS, V66, P483, DOI 10.2307/3544943; HOWE HF, 1982, ANNU REV ECOL SYST, V13, P201, DOI 10.1146/annurev.es.13.110182.001221; Huston MA, 2011, ECOL MONOGR, V81, P349, DOI 10.1890/10-1523.1; IWASA Y, 1994, SERIES ENTOM, V52, P69; KASPARI M, 1995, AM NAT, V145, P610, DOI 10.1086/285758; Kleyer M, 2008, J ECOL, V96, P1266, DOI 10.1111/j.1365-2745.2008.01430.x; Kleyer M, 2015, BASIC APPL ECOL, V16, P1, DOI 10.1016/j.baae.2014.11.002; Kleyer M, 2012, J VEG SCI, V23, P805, DOI 10.1111/j.1654-1103.2012.01402.x; Kuhner A, 2008, J VEG SCI, V19, P681, DOI 10.3170/2008-8-18436; Lavorel S, 1997, TRENDS ECOL EVOL, V12, P474, DOI 10.1016/S0169-5347(97)01219-6; Lavorel S, 2002, FUNCT ECOL, V16, P545, DOI 10.1046/j.1365-2435.2002.00664.x; Lavorel S, 2013, J VEG SCI, V24, P942, DOI 10.1111/jvs.12083; Lavorel S, 2012, J ECOL, V100, P128, DOI 10.1111/j.1365-2745.2011.01914.x; Lienin P, 2012, BASIC APPL ECOL, V13, P301, DOI 10.1016/j.baae.2012.05.002; Lienin P, 2011, AGR ECOSYST ENVIRON, V145, P67, DOI 10.1016/j.agee.2011.03.015; Marcondes CB, 1999, MEM I OSWALDO CRUZ, V94, P693, DOI 10.1590/S0074-02761999000500026; Markl JS, 2012, CONSERV BIOL, V26, P1072, DOI 10.1111/j.1523-1739.2012.01927.x; McNab BK, 2010, OECOLOGIA, V164, P13, DOI 10.1007/s00442-010-1621-5; MCNAUGHTON SJ, 1989, NATURE, V341, P142, DOI 10.1038/341142a0; Meiri S, 2003, J BIOGEOGR, V30, P331, DOI 10.1046/j.1365-2699.2003.00837.x; Milcu A, 2014, ECOL LETT, V17, P435, DOI 10.1111/ele.12243; Millien V, 2006, ECOL LETT, V9, P853, DOI 10.1111/j.1461-0248.2006.00928.x; Moles AT, 2014, J VEG SCI, V25, P1167, DOI 10.1111/jvs.12190; Mwangomo E, 2014, MONTHLY ANN CLIMATE; NIKLAS KJ, 1994, EVOLUTION, V48, P44, DOI 10.1111/j.1558-5646.1994.tb01293.x; Olson VA, 2009, ECOL LETT, V12, P249, DOI 10.1111/j.1461-0248.2009.01281.x; Peters MK, 2016, J BIOGEOGR, V43, P2040, DOI 10.1111/jbi.12768; Peters RH, 1986, ECOLOGICAL IMPLICATI; Raich JW, 2006, ECOLOGY, V87, P76, DOI 10.1890/05-0023; Regal PJ, 1982, ANNUAL REVIEW OF ECO, V13; Renner S.S., 1998, P339; Ricketts TH, 2004, CONSERV BIOL, V18, P1262, DOI 10.1111/j.1523-1739.2004.00227.x; Ritchie ME, 1999, NATURE, V400, P557, DOI 10.1038/23010; Schleuning M, 2015, ECOGRAPHY, V38, P380, DOI 10.1111/ecog.00983; Shelomi M, 2012, AM NAT, V180, P511, DOI 10.1086/667595; Shipley B, 2006, ECOLOGY, V87, P535, DOI 10.1890/05-1051; Shipley B, 2000, STRUCT EQU MODELING, V7, P206, DOI 10.1207/S15328007SEM0702_4; Shipley B, 2009, ECOLOGY, V90, P363, DOI 10.1890/08-1034.1; Smith FA, 2011, PHILOS T R SOC B, V366, P2364, DOI 10.1098/rstb.2011.0067; Stang M, 2009, ANN BOT-LONDON, V103, P1459, DOI 10.1093/aob/mcp027; Steffan-Dewenter I, 1999, OECOLOGIA, V121, P432, DOI 10.1007/s004420050949; THOMPSON JN, 1991, ANNU REV ENTOMOL, V36, P65, DOI 10.1146/annurev.en.36.010191.000433; TURRILL WB, 1952, FLORA TROPICAL E AFR; Wikelski M, 1997, EVOLUTION, V51, P922, DOI 10.1111/j.1558-5646.1997.tb03673.x; Winkler H., 1985, P415; Wolverton S, 2009, AM MIDL NAT, V162, P403, DOI 10.1674/0003-0031-162.2.403; Woodward G, 2005, TRENDS ECOL EVOL, V20, P402, DOI 10.1016/j.tree.2005.04.005; Wright IJ, 2004, NATURE, V428, P821, DOI 10.1038/nature02403; Zimmerman M., 1988, Plant reproductive ecology: patterns and strategies., P157; Zuur Alain F., 2009, P1	85	10	13	6	36	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 20	2017	12	3							e0174157	10.1371/journal.pone.0174157	http://dx.doi.org/10.1371/journal.pone.0174157			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ER6VC	28319155	Green Submitted, Green Published, Green Accepted, gold			2022-12-27	WOS:000398945800054
J	James, PD; Meng, ZW; Zhang, M; Belletrutti, PJ; Mohamed, R; Ghali, W; Roberts, DJ; Martel, G; Heitman, SJ				James, Paul D.; Meng, Zhao Wu; Zhang, Mei; Belletrutti, Paul J.; Mohamed, Rachid; Ghali, William; Roberts, Derek J.; Martel, Guillaume; Heitman, Steven J.			The incremental benefit of EUS for identifying unresectable disease among adults with pancreatic adenocarcinoma: A meta-analysis	PLOS ONE			English	Article							FINE-NEEDLE-ASPIRATION; ENDOSCOPIC ULTRASOUND; COMPUTED-TOMOGRAPHY; CANCER; MANAGEMENT; MASSES; IMPACT; ULTRASONOGRAPHY; RESECTABILITY; MALIGNANCIES	Background and study aims It is unclear to what extent EUS influences the surgical management of patients with pancreatic adenocarcinoma. This systematic review sought to determine if EUS evaluation improves the identification of unresectable disease among adults with pancreatic adenocarcinoma. Patients and methods We searched MEDLINE, EMBASE, bibliographies of included articles and conference proceedings for studies reporting original data regarding surgical management and/or survival among patients with pancreatic adenocarcinoma, from inception to January 7th 2017. Our main outcome was the incremental benefit of EUS for the identification of unresectable disease (IBEUS). The pooled IBEUS were calculated using random effects models. Heterogeneity was explored using stratified meta-analysis and meta-regression. Results Among 4,903 citations identified, we included 8 cohort studies (study periods from 1992 to 2007) that examined the identification of unresectable disease (n = 795). Random effects meta-analysis suggested that EUS alone identified unresectable disease in 19% of patients (95% confidence interval [CI], 10-33%). Among those studies that considered portal or mesenteric vein invasion as potentially resectable, EUS alone was able to identify unresectable disease in 14% of patients (95% CI 8-24%) after a CT scan was performed. Limitations The majority of the included studies were retrospective. Conclusions EUS evaluation is associated with increased identification of unresectable disease among adults with pancreatic adenocarcinoma.	[James, Paul D.; Meng, Zhao Wu] Univ Ottawa, Dept Med, Ottawa, ON, Canada; [James, Paul D.; Meng, Zhao Wu] Univ Ottawa, Ottawa Hosp Res Inst, Dept Med, Ottawa, ON, Canada; [James, Paul D.; Zhang, Mei; Belletrutti, Paul J.; Mohamed, Rachid; Ghali, William; Heitman, Steven J.] Univ Calgary, Dept Community Hlth Sci, Calgary, AB, Canada; [James, Paul D.; Belletrutti, Paul J.; Mohamed, Rachid; Ghali, William; Heitman, Steven J.] Univ Calgary, Dept Med, Calgary, AB, Canada; [James, Paul D.; Belletrutti, Paul J.; Mohamed, Rachid; Heitman, Steven J.] CREATE, Calgary, AB, Canada; [Roberts, Derek J.] Univ Calgary, Dept Surg, Calgary, AB, Canada; [Martel, Guillaume] Univ Ottawa, Dept Surg, Ottawa, ON, Canada	University of Ottawa; University of Ottawa; Ottawa Hospital Research Institute; University of Calgary; University of Calgary; University of Calgary; University of Ottawa	James, PD (corresponding author), Univ Ottawa, Dept Med, Ottawa, ON, Canada.; James, PD (corresponding author), Univ Ottawa, Ottawa Hosp Res Inst, Dept Med, Ottawa, ON, Canada.; James, PD (corresponding author), Univ Calgary, Dept Community Hlth Sci, Calgary, AB, Canada.; James, PD (corresponding author), Univ Calgary, Dept Med, Calgary, AB, Canada.; James, PD (corresponding author), CREATE, Calgary, AB, Canada.	pjames@toh.on.ca	Martel, Guillaume/H-7356-2019; Roberts, Derek J./L-6229-2019	Martel, Guillaume/0000-0002-1242-2601; Roberts, Derek J./0000-0001-6111-6291; Belletrutti, Paul/0000-0001-9968-9650	Canadian Association of Gastroenterology; Canadian Institutes for Health Research; Alberta Innovates Health Solutions	Canadian Association of Gastroenterology; Canadian Institutes for Health Research(Canadian Institutes of Health Research (CIHR)); Alberta Innovates Health Solutions	Paul James was supported by Clinical Research Fellowship Awards from the Canadian Association of Gastroenterology, the Canadian Institutes for Health Research and Alberta Innovates Health Solutions.The funders had no role in study design, data collection and analysis, decision to publish,or preparation of the manuscript.	Agarwal B, 2004, AM J GASTROENTEROL, V99, P844, DOI 10.1111/j.1572-0241.2004.04177.x; American Cancer Society, 2016, CANC FACTS FIGURES 2; [Anonymous], 2008, SYSTEMATIC REV HLTH; Baxter NN, 2007, ANN SURG ONCOL, V14, P1320, DOI 10.1245/s10434-006-9249-8; Buscail L, 1999, GASTROINTEST ENDOSC, V50, P34, DOI 10.1016/S0016-5107(99)70341-X; Cahn M, 1996, AM J SURG, V172, P470, DOI 10.1016/S0002-9610(96)00222-X; Chen J, 2012, J CANCER RES CLIN, V138, P1433, DOI 10.1007/s00432-012-1268-1; Croome KP, 2010, CAN J SURG, V53, P171; David M, 2009, BRIT J CANCER, V101, P215, DOI 10.1038/sj.bjc.6605150; DERSIMONIAN R, 1986, CONTROL CLIN TRIALS, V7, P177, DOI 10.1016/0197-2456(86)90046-2; DeWitt J, 2004, ANN INTERN MED, V141, P753, DOI 10.7326/0003-4819-141-10-200411160-00006; Eloubeidi MA, 2007, J GASTROINTEST SURG, V11, P813, DOI 10.1007/s11605-007-0151-x; Ferrante di Ruffano L, 2012, BMJ-BRIT MED J, V344, DOI 10.1136/bmj.e686; Fristrup C W, 2006, HPB (Oxford), V8, P57, DOI 10.1080/13651820500465972; Imazu H, 2010, SCAND J GASTROENTERO, V45, P732, DOI 10.3109/00365521003690269; James PD, 2015, GASTROINTEST ENDOSC, V81, P848, DOI 10.1016/j.gie.2014.12.031; Kliment M, 2010, SCAND J GASTROENTERO, V45, P1372, DOI 10.3109/00365521.2010.503966; Lau J, 2006, BMJ-BRIT MED J, V333, P5979; Lipsey M. W., 2000, PRACTICAL METAANALAY; Mortensen MB, 2001, ENDOSCOPY, V33, P478, DOI 10.1055/s-2001-14966; National Comprehensive Cancer Network, 2015, NCCN CLIN PRACT GUID; Nawaz H, 2013, J PANCREAS, V14, P484, DOI 10.6092/1590-8577/1512; Queneau P E, 2001, JOP, V2, P98; Shami VM, 2011, PANCREAS, V40, P567, DOI 10.1097/MPA.0b013e3182153b8c; Sohn TA, 2000, J GASTROINTEST SURG, V4, P567, DOI 10.1016/S1091-255X(00)80105-5; Soriano A, 2004, AM J GASTROENTEROL, V99, P492, DOI 10.1111/j.1572-0241.2004.04087.x; Stroup DF, 2000, JAMA-J AM MED ASSOC, V283, P2008, DOI 10.1001/jama.283.15.2008; Suits J, 1999, ARCH SURG-CHICAGO, V134, P639, DOI 10.1001/archsurg.134.6.639; Tamburrino D, 2016, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD011515.pub2; Tamm EP, 2007, ABDOM IMAGING, V32, P660, DOI 10.1007/s00261-007-9298-x; Wang KX, 2011, GASTROINTEST ENDOSC, V73, P283, DOI 10.1016/j.gie.2010.10.045; Xu W, 2013, EUR J GASTROEN HEPAT, V25, P218, DOI 10.1097/MEG.0b013e32835a7f7c	32	8	8	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 20	2017	12	3							e0173687	10.1371/journal.pone.0173687	http://dx.doi.org/10.1371/journal.pone.0173687			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ER6VC	28319148	Green Published, Green Submitted, gold			2022-12-27	WOS:000398945800024
J	Tewes, S; Gueler, F; Chen, RJ; Gutberlet, M; Jang, MS; Meier, M; Mengel, M; Hartung, D; Wacker, F; Rong, S; Hueper, K				Tewes, Susanne; Gueler, Faikah; Chen, Rongjun; Gutberlet, Marcel; Jang, Mi-Sun; Meier, Martin; Mengel, Michael; Hartung, Dagmar; Wacker, Frank; Rong, Song; Hueper, Katja			Functional MRI for characterization of renal perfusion impairment and edema formation due to acute kidney injury in different mouse strains	PLOS ONE			English	Article							RENIN GENES; MEDULLARY CIRCULATION; ENDOTHELIAL INJURY; RELAXATION-TIME; MICE; FAILURE; DISEASE; ISCHEMIA; MODEL; SUSCEPTIBILITY	Purpose The purpose was to characterize acute kidney injury (AKI) in C57BL/6 (B6)-and 129/Sv (Sv)-mice by noninvasive measurement of renal perfusion and tissue edema using functional MRI. Methods Different severities of AKI were induced in B6-and Sv-mice by renal ischemia reperfusion injury (IRI). Unilateral clamping of the renal pedicle for 35 min (moderate AKI) or 45 min (severe AKI) was done. MRI (7-Tesla) was performed 1, 7 and 28 days after surgery using a flow alternating inversion recovery (FAIR) arterial spin labeling (ASL) sequence. Maps of perfusion and T1-relaxation time were calculated. Relative MRI-parameters of the IRI kidney compared to the contralateral not-clipped kidney were compared between AKI severities and between mouse strains using unpaired t-tests. In addition, fibrosis was assessed by Masson Trichrome and collagen IV staining. Results After moderate AKI relative perfusion impairment was significantly higher in B6-than in Svmice at d7 (55 +/- 7% vs. 82 +/- 8%, p<0.05) and d28 (76 +/- 7% vs. 102 +/- 3%, p<0.01). T1-values increased in the early phase after AKI in both mouse strains. T1-increase was more severe after prolonged ischemia times of 45 min compared to 35 min in both mouse strains, measured in the renal cortex and outer stripe of outer medulla. Kidney volume loss (compared to the contralateral kidney) occurred already after 7 days but proceeded markedly towards weeks in severe AKI. Early renal perfusion impairment was predictive for later kidney volume loss. The progression to chronic kidney disease (CKD) in the severe AKI model was similar in both mouse strains as revealed by histology. Conclusion Quantification of renal perfusion and tissue edema by functional MRI allows characterization of strain differences upon AKI. Renal perfusion impairment was stronger in B6-compared to Sv-animals following moderate AKI. Prolonged ischemia times were associated with more severe perfusion impairment and edema formation in the early phase and progression to CKD within 4 weeks of observation.	[Tewes, Susanne; Gutberlet, Marcel; Wacker, Frank; Hueper, Katja] Hannover Med Sch, Diagnost & Intervent Radiol, Hannover, Germany; [Gueler, Faikah; Chen, Rongjun; Jang, Mi-Sun; Rong, Song] Hannover Med Sch, Nephrol, Hannover, Germany; [Meier, Martin] Hannover Med Sch, Lab Anim Sci, Hannover, Germany; [Mengel, Michael] Univ Alberta, Dept Lab Med Pathol, Edmonton, AB, Canada; [Rong, Song] Affiliated Hosp, Zunyi Med Coll, Transplantat Ctr, Zunyi, Peoples R China	Hannover Medical School; Hannover Medical School; Hannover Medical School; University of Alberta; Zunyi Medical University	Tewes, S (corresponding author), Hannover Med Sch, Diagnost & Intervent Radiol, Hannover, Germany.	Tewes.Susanne@mh.hannover.de	Meier, Martin/AAH-3367-2019	Meier, Martin/0000-0001-8642-0409; /0000-0001-9985-1515	German Science Foundation [GU613/1-1, HU2232/1-1]; rogramme "Junge Akademie" of Hannover Medical School (Hueper, Tewes)	German Science Foundation(German Research Foundation (DFG)); rogramme "Junge Akademie" of Hannover Medical School (Hueper, Tewes)	Parts of this study have been supported by funding of the German Science Foundation (Gueler GU613/1-1, Hueper HU2232/1-1) and the programme "Junge Akademie" of Hannover Medical School (Hueper, Tewes). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Artz NS, 2011, INVEST RADIOL, V46, P124, DOI 10.1097/RLI.0b013e3181f5e101; Bankir L, 2012, KIDNEY INT, V81, P1179, DOI 10.1038/ki.2012.67; Basile DP, 2001, AM J PHYSIOL-RENAL, V281, pF887, DOI 10.1152/ajprenal.0050.2001; Burne MJ, 2000, TRANSPLANTATION, V69, P1023; Chawla LS, 2012, KIDNEY INT, V82, P516, DOI 10.1038/ki.2012.208; DEMIGUEL MH, 1994, J AM SOC NEPHROL, V4, P1861; DICKINSON DP, 1984, GENETICS, V108, P651; FIELD LJ, 1985, P NATL ACAD SCI USA, V82, P6196, DOI 10.1073/pnas.82.18.6196; Fujii M, 1997, STROKE, V28, P1805, DOI 10.1161/01.STR.28.9.1805; Gerlai R, 1996, TRENDS NEUROSCI, V19, P177, DOI 10.1016/S0166-2236(96)20020-7; Gueler F, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0115709; Hammon M, 2016, MEDICINE, V95, DOI 10.1097/MD.0000000000003083; Hueper K, 2016, INVEST RADIOL, V51, P58, DOI 10.1097/RLI.0000000000000205; Hueper K, 2014, EUR RADIOL, V24, P2252, DOI 10.1007/s00330-014-3250-6; Hueper K, 2014, RADIOLOGY, V270, P117, DOI 10.1148/radiol.13130367; Hueper K, 2013, INVEST RADIOL, V48, P834, DOI 10.1097/RLI.0b013e31829d0414; Jolley CD, 1999, AM J PHYSIOL-GASTR L, V276, pG1117, DOI 10.1152/ajpgi.1999.276.5.G1117; Kaissling B, 1996, ANAT EMBRYOL, V193, P303; KARLBERG L, 1983, ACTA PHYSIOL SCAND, V118, P11, DOI 10.1111/j.1748-1716.1983.tb07234.x; KRIZ W, 1982, KLIN WOCHENSCHR, V60, P1063, DOI 10.1007/BF01715836; KUNDEL HL, 1986, INVEST RADIOL, V21, P12, DOI 10.1097/00004424-198601000-00002; Layton AT, 2011, AM J PHYSIOL-RENAL, V301, pF1047, DOI 10.1152/ajprenal.00620.2010; Leung KCW, 2013, NAT REV NEPHROL, V9, P77, DOI 10.1038/nrneph.2012.280; Ma LJ, 2003, KIDNEY INT, V64, P350, DOI 10.1046/j.1523-1755.2003.00058.x; Molitoris BA, 2004, KIDNEY INT, V66, P496, DOI 10.1111/j.1523-1755.2004.761_5.x; O'Neal JB, 2016, CRIT CARE, V20, DOI 10.1186/s13054-016-1352-z; Ritt M, 2010, NEPHROL DIAL TRANSPL, V25, P1126, DOI 10.1093/ndt/gfp639; Shin SR, 2016, BIOMED RES INT, V2016, DOI 10.1155/2016/2985148; SIGMUND CD, 1991, HYPERTENSION, V18, P446, DOI 10.1161/01.HYP.18.4.446; Srisawat N, 2011, CURR OPIN CRIT CARE, V17, P548, DOI 10.1097/MCC.0b013e32834cd349; Sutton TA, 2002, KIDNEY INT, V62, P1539, DOI 10.1046/j.1523-1755.2002.00631.x; Tanaka-Kagawa T, 1998, J PHARMACOL EXP THER, V285, P335; Thadhani R, 1996, NEW ENGL J MED, V334, P1448, DOI 10.1056/NEJM199605303342207; Wang Q, 2002, J AM SOC NEPHROL, V13, DOI 10.1097/01.ASN.0000017902.77985.84; Wen XY, 2010, CONTRIB NEPHROL, V165, P39, DOI 10.1159/000313743	35	26	30	3	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 20	2017	12	3							e0173248	10.1371/journal.pone.0173248	http://dx.doi.org/10.1371/journal.pone.0173248			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ER6VC	28319118	Green Submitted, Green Published, gold			2022-12-27	WOS:000398945800010
J	Wang, J; Chang, SY; Zhao, LY; Yu, WT; Zhang, J; Man, QQ; He, L; Duan, YF; Wang, H; Scherpbier, R; Yin, SA				Wang, Jie; Chang, Suying; Zhao, Liyun; Yu, Wentao; Zhang, Jian; Man, Qingqing; He, Li; Duan, Yifan; Wang, Hui; Scherpbier, Robert; Yin, Shi-an			Effectiveness of community-based complementary food supplement (Yingyangbao) distribution in children aged 6-23 months in poor areas in China	PLOS ONE			English	Article							MULTIPLE MICRONUTRIENT POWDER; YOUNG-CHILDREN; MONTHS OLD; VITAMIN-A; CONTROLLED-TRIAL; RISK-FACTORS; ANEMIA; GROWTH; IRON; FORTIFICATION	Background Poor growth and micronutrient deficiency mainly attack older infants and young children. Some countries have adopted clinically effective measures to combat malnutrition, but the compliance and improvement in efficacy of intervention vehicles in national programs require evaluation. Methods Baseline and follow-up cross-sectional surveys were conducted before and after a nutrition intervention program in 3 national poverty counties in China. Soybean-based complementary food supplements called Yingyangbao (YYB) in Chinese and training materials on child feeding were distributed to households with children aged 6-23 months for 18 months. Representative children were selected by probability proportional to size sampling methods to assess compliance of YYB and the intervention efficacy. A questionnaire was designed to collect data on basic characteristics of children, breastfeeding, 24-hour dietary intake, and consumption and appetite of YYB. Anthropometrics and hemoglobin were measured in the field, and anemia prevalence was evaluated. Venous blood was drawn from children aged 12-35 months to evaluate micronutrient status. Logistic regression was used to identify the risk factors for children's anemia. Results Of the children involved in the follow-up survey (n = 693), the P50 (P25, P75) intake of YYB was 6.7 (3.5, 7.0) sachets weekly, and 54.7% of the children liked the taste of YYB. Compared with the baseline situation (n = 823), the proportion of children fed a diverse diet and foods rich in iron or vitamin A increased (P < 0.01) in the follow-up study. The prevalence of stunting and underweight decreased (P<0.05), the prevalence of anemia decreased from 28.0% to 19.9% (P < 0.01), and the prevalence of vitamin B-12 deficiency decreased from 26.8% to 15.4% (P < 0.01). For children aged 12-23 months, those who liked YYB and consumed 6 or more sachets of YYB weekly were at lower risk for anemia (OR = 0.34, 95% CI 0.13-0.90, P < 0.05), but the risk of stunting was associated with a non-diverse diet (OR = 1.48, 95% CI 1.06-2.07, P < 0.05). Conclusion The quality of diet and nutritional status of children aged 6-23 months are significantly improved by the intervention of YYB and nutrition education, and good compliance to YYB contributes to a low risk for anemia.	[Wang, Jie; Duan, Yifan; Yin, Shi-an] Natl Inst Nutr & Hlth, Chinese Ctr Dis Control & Prevent, Dept Maternal & Child Nutr, Beijing, Peoples R China; [Chang, Suying; Scherpbier, Robert] United Nations Childrens Fund, Sect Hlth & Nutr & Water Environm & Sanitat, Beijing, Peoples R China; [Zhao, Liyun; Yu, Wentao] Natl Inst Nutr & Hlth, Chinese Ctr Dis Control & Prevent, Dept Nutr Surveillance, Beijing, Peoples R China; [Zhang, Jian; Man, Qingqing] Natl Inst Nutr & Hlth, Chinese Ctr Dis Control & Prevent, Dept Nutr Aging, Beijing, Peoples R China; [He, Li] Natl Inst Nutr & Hlth, Chinese Ctr Dis Control & Prevent, Dept Sci & Technol, Beijing, Peoples R China; [Wang, Hui] China Populat & Dev Res Ctr, Dept Populat Res, Beijing, Peoples R China	Chinese Center for Disease Control & Prevention; Chinese Center for Disease Control & Prevention; Chinese Center for Disease Control & Prevention; Chinese Center for Disease Control & Prevention	Yin, SA (corresponding author), Natl Inst Nutr & Hlth, Chinese Ctr Dis Control & Prevent, Dept Maternal & Child Nutr, Beijing, Peoples R China.	shianyin@126.com			Millennium Development Goals Spanish Achievement Fund (MDG-F)	Millennium Development Goals Spanish Achievement Fund (MDG-F)	This study was one part of the programme of "Improving nutrition and food safety for China's most vulnerable women and children" funded by the Millennium Development Goals Spanish Achievement Fund (MDG-F [http://mdgfund.org/page/ourprogrammes]), and SY received the funding. The funder had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript.	Angdembe MR, 2015, BMC PUBLIC HEALTH, V15, DOI 10.1186/s12889-015-1752-z; ATTANASIO OP, 2014, BMJ-BRIT MED J, V349, DOI DOI 10.1136/BMJ.G5785; Ayoya MA, 2013, ANEMIA, V2013, DOI 10.1155/2013/502968; Chhagan MK, 2010, BMC PUBLIC HEALTH, V10, DOI 10.1186/1471-2458-10-145; de Romana GL, 2005, J NUTR, V135, p646S, DOI 10.1093/jn/135.3.646S; Hess S, 2016, NUTRIENTS, V8, DOI 10.3390/nu8020088; Huo JS, 2015, FOOD NUTR BULL, V36, P405, DOI 10.1177/0379572115616001; International Food Policy Research Institute, 2015, GLOB NUTR REP 2015 A; Ip H, 2009, EUR J CLIN NUTR, V63, P165, DOI 10.1038/sj.ejcn.1602917; Kassebaum NJ, 2014, BLOOD, V123, P615, DOI 10.1182/blood-2013-06-508325; Kounnavong S, 2011, NUTR J, V10, DOI 10.1186/1475-2891-10-129; Leyvraz M, 2015, NUTRIENTS, V7, P9960, DOI [10.3390/nu7125511, 10.3390/nu8090541]; Majamanda J, 2014, MALAWI MED J, V26, P115; Nagpal J, 2004, J HEALTH POPUL NUTR, V22, P203; National Health and Family Planning Commission of the People's Republic of China, 2015, CHIN NAT NUTR CHRON; Perignon M, 2016, NUTRIENTS, V8, DOI 10.3390/nu8010029; Salam RA, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-S3-S22; Sazawal S, 2014, J HEALTH POPUL NUTR, V32, P217; Schauer Claudia, 2003, Paediatr Child Health, V8, P87; Schumann K, 2009, EUR J CLIN NUTR, V63, P355, DOI 10.1038/sj.ejcn.1602930; Smith G, 2015, J NUTR SCI VITAMINOL, V61, pS183, DOI 10.3177/jnsv.61.S183; Smuts CM, 2005, J NUTR, V135, p653S, DOI 10.1093/jn/135.3.653S; Smuts CM, 2005, J NUTR, V135, p631S; Soofi S, 2013, LANCET, V382, P29, DOI 10.1016/S0140-6736(13)60437-7; Suchdev PS, 2013, MATERN CHILD NUTR, V9, P78, DOI 10.1111/j.1740-8709.2012.00450.x; Suchdev PS, 2012, AM J CLIN NUTR, V95, P1223, DOI 10.3945/ajcn.111.030072; Sun J., 2011, WEA FORECASTING REV, V3, P7; Tran VK, 2015, J NUTR SCI VITAMINOL, V61, pS198, DOI 10.3177/jnsv.61.S198; UNICEF WHO World Bank Group (United Nations Children's Fund WHO and World Bank), 2015, JOINT CHILD MALN EST; Wacker M, 2013, DERM-ENDOCRINOL, V5, DOI [10.4161/derm.24476, 10.4161/derm.24494]; Wang J, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0140840; WHO, PROGR ACT COUNTR GLO; WHO, GUIDELINES CONDUCTIN; WHO, 2001, IRON DEFICIENCY ANAE; WHO, 2006, WHO CHILD GROWTH STA; World Health Organization, 2010, IND ASS INF YOUNG CH; Yousafzai AK, 2014, LANCET, V384, P1282, DOI 10.1016/S0140-6736(14)60455-4; Zhao A, 2012, AM J TROP MED HYG, V87, P306, DOI 10.4269/ajtmh.2012.11-0660; Ziemann M, 2011, TRANSFUSION, V51, P2714, DOI 10.1111/j.1537-2995.2011.03183.x	39	18	21	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 20	2017	12	3							e0174302	10.1371/journal.pone.0174302	http://dx.doi.org/10.1371/journal.pone.0174302			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ER6VC	28319154	gold, Green Published, Green Submitted			2022-12-27	WOS:000398945800066
J	Chen, YZ; Lu, HJ; Li, LJ				Chen, YunZhi; Lu, HuiJuan; Li, LanJuan			Automatic ICD-10 coding algorithm using an improved longest common subsequence based on semantic similarity	PLOS ONE			English	Article							SYSTEM	ICD-10(International Classification of Diseases 10th revision) is a classification of a disease, symptom, procedure, or injury. Diseases are often described in patients' medical records with free texts, such as terms, phrases and paraphrases, which differ significantly from those used in ICD-10 classification. This paper presents an improved approach based on the Longest Common Subsequence (LCS) and semantic similarity for automatic Chinese diagnoses, mapping from the disease names given by clinician to the disease names in ICD-10. LCS refers to the longest string that is a subsequence of every member of a given set of strings. The proposed method of improved LCS in this paper can increase the accuracy of processing in Chinese disease mapping.	[Chen, YunZhi; Li, LanJuan] Zhejiang Univ, Sch Med, Hangzhou, Zhejiang, Peoples R China; [Chen, YunZhi] Hangzhou Vocat & Tech Coll, Hangzhou, Zhejiang, Peoples R China; [Lu, HuiJuan] China Jiliang Univ, Coll Informat Engn, Hangzhou, Zhejiang, Peoples R China; [Li, LanJuan] Zhejiang Univ, Affiliated Hosp 1, Hangzhou, Zhejiang, Peoples R China	Zhejiang University; Hangzhou Vocational & Technical College; China Jiliang University; Zhejiang University	Li, LJ (corresponding author), Zhejiang Univ, Sch Med, Hangzhou, Zhejiang, Peoples R China.; Li, LJ (corresponding author), Zhejiang Univ, Affiliated Hosp 1, Hangzhou, Zhejiang, Peoples R China.	ljli@zju.edu.cn			National Natural Science Foundation of China [61272315]; Priority Academic Program Development of Jiangsu Higher Education Institutions (PAPD); Jiangsu Collaborative Innovation Center on Atmospheric Environment and Equipment Technology (CICAEET); Hangzhou "131" middle-aged and young talent training plan	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Priority Academic Program Development of Jiangsu Higher Education Institutions (PAPD); Jiangsu Collaborative Innovation Center on Atmospheric Environment and Equipment Technology (CICAEET); Hangzhou "131" middle-aged and young talent training plan	This study is supported by National Natural Science Foundation of China (No. 61272315). It is also supported by the Priority Academic Program Development of Jiangsu Higher Education Institutions (PAPD), Jiangsu Collaborative Innovation Center on Atmospheric Environment and Equipment Technology (CICAEET) and Hangzhou "131" middle-aged and young talent training plan.	[Anonymous], 2016, OPEN SOURCE TOOLKIT; Arifoglu D, 2014, INFORMATION SCIENCES AND SYSTEMS 2014, P259, DOI 10.1007/978-3-319-09465-6_27; Benson G, 2014, COMPUTER SCI, V8199, P257; Boytcheva S., 2011, P 2 WORKSH BIOM NAT, P11; Chen YZ, 2016, J BIOL RES-THESSALON, V23, DOI 10.1186/s40709-016-0044-9; Cheng Xianyi, 2010, J CONVERGENCE INFORM, V5, P17; Crammer K., 2007, BIOLOGICAL TRANSLATI, P129; Dai LL, 2008, PROCEEDINGS OF THE INTERNATIONAL CONFERENCE ON COMPUTER SCIENCE AND INFORMATION TECHNOLOGY, P601, DOI 10.1109/ICCSIT.2008.101; Fang LY, 2015, BIOMED SIGNAL PROCES, V15, P60, DOI 10.1016/j.bspc.2014.09.010; Farkas R, 2008, BMC BIOINFORMATIC S3, V9, P268; Goldstein Ira, 2007, AMIA Annu Symp Proc, P279; Heja G, 2003, INT J MED INFORM, V70, P229, DOI 10.1016/S1386-5056(03)00049-2; HIRSCHBERG DS, 1975, COMMUN ACM, V18, P341, DOI 10.1145/360825.360861; Koopman B, 2015, INT J MED INFORM, V84, P956, DOI 10.1016/j.ijmedinf.2015.08.004; Li S.J., 2002, COMPUT LINGUIST, V7, P59; Lin CP, 2016, J HUA QIAO U NATURE, V37, P201; Liu JH, 2007, COMPUTER ENG DESIGN, V28, P13; [刘群 Liu Qun], 2004, [计算机研究与发展, Journal of Computer Research and Development], V41, P1421; Mousavi SR, 2012, COMPUT OPER RES, V39, P512, DOI 10.1016/j.cor.2011.02.026; Nie J. Y., 2000, P 5 INT WORKSH INF R, P141, DOI DOI 10.1145/355214.355235; Ning WX, 2016, BMC MED INFORM DECIS, V16, DOI 10.1186/s12911-016-0269-4; Nitsuwat S, 2012, METHOD INFORM MED, V51, P519, DOI 10.3414/ME11-02-0024; Niu Y., 2012, COMPUTER DIGITAL ENG, V40, P14; O'Malley KJ, 2005, HEALTH SERV RES, V40, P1620, DOI 10.1111/j.1475-6773.2005.00444.x; Pakhomov SVS, 2006, J AM MED INFORM ASSN, V13, P516, DOI 10.1197/jamia.M2077; Patrick J., 2007, P WORKSH BIONLP 2007, P191; WAGNER RA, 1974, J ACM, V21, P168, DOI 10.1145/321796.321811; Zhao C. X., 2014, THESIS; Zhou Shui-Geng, 2001, Wuhan University Journal of Natural Sciences, V6, P416, DOI 10.1007/BF03160278; Zweigenbaum P., 2016, P 7 INT WORKSH HLTH, V2016, P96	30	39	40	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 17	2017	12	3							e0173410	10.1371/journal.pone.0173410	http://dx.doi.org/10.1371/journal.pone.0173410			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EO5CJ	28306739	gold, Green Published, Green Submitted			2022-12-27	WOS:000396710300008
J	Koen, EL; Tosa, MI; Nielsen, CK; Schauber, EM				Koen, Erin L.; Tosa, Marie I.; Nielsen, Clayton K.; Schauber, Eric M.			Does landscape connectivity shape local and global social network structure in white-tailed deer?	PLOS ONE			English	Article							CHRONIC WASTING DISEASE; HOME-RANGE OVERLAP; GENETIC RELATEDNESS; ODOCOILEUS-VIRGINIANUS; INFECTIOUS-DISEASES; GREGARIOUS UNGULATE; DENSITY-DEPENDENCE; SPATIAL PROXIMITY; AFRICAN BUFFALO; CIRCUIT-THEORY	Intraspecific social behavior can be influenced by both intrinsic and extrinsic factors. While much research has focused on how characteristics of individuals influence their roles in social networks, we were interested in the role that landscape structure plays in animal sociality at both individual (local) and population (global) levels. We used female white-tailed deer (Odocoileus virginianus) in Illinois, USA, to investigate the potential effect of landscape on social network structure by weighting the edges of seasonal social networks with association rate (based on proximity inferred from GPS collar data). At the local level, we found that sociality among female deer in neighboring social groups (n = 36) was mainly explained by their home range overlap, with two exceptions: 1) during fawning in an area of mixed forest and grassland, deer whose home ranges had low forest connectivity were more social than expected; and 2) during the rut in an area of intensive agriculture, deer inhabiting home ranges with high amount and connectedness of agriculture were more social than expected. At the global scale, we found that deer populations (n = 7) in areas with highly connected forest-agriculture edge, a high proportion of agriculture, and a low proportion of forest tended to have higher weighted network closeness, although low sample size precluded statistical significance. This result implies that infectious disease could spread faster in deer populations inhabiting such landscapes. Our work advances the general understanding of animal social networks, demonstrating how landscape features can underlie differences in social behavior both within and among wildlife social networks.	[Koen, Erin L.; Tosa, Marie I.; Nielsen, Clayton K.; Schauber, Eric M.] Southern Illinois Univ, Cooperat Wildlife Res Lab, Carbondale, IL 62901 USA; [Tosa, Marie I.; Schauber, Eric M.] Southern Illinois Univ, Dept Zool, Carbondale, IL USA; [Tosa, Marie I.; Schauber, Eric M.] Southern Illinois Univ, Ctr Ecol, Carbondale, IL USA; [Nielsen, Clayton K.] Southern Illinois Univ, Dept Forestry, Carbondale, IL USA	Southern Illinois University System; Southern Illinois University; Southern Illinois University System; Southern Illinois University; Southern Illinois University System; Southern Illinois University; Southern Illinois University System; Southern Illinois University	Koen, EL (corresponding author), Southern Illinois Univ, Cooperat Wildlife Res Lab, Carbondale, IL 62901 USA.	erinkoen@hotmail.com	Schauber, Eric/K-4043-2019	Schauber, Eric/0000-0002-0667-2604; Tosa, Marie/0000-0002-9020-5098	Federal Aid in Wildlife Restoration [W-87-R]	Federal Aid in Wildlife Restoration	This research was funded by Federal Aid in Wildlife Restoration Project W-87-R, administered through the Illinois Department of Natural Resources. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altizer S, 2003, ANNU REV ECOL EVOL S, V34, P517, DOI 10.1146/annurev.ecolsys.34.030102.151725; Anderson CW, 2013, WILDLIFE SOC B, V37, P146, DOI 10.1002/wsb.231; Barton K., 2012, MUMIN MULTIMODEL INF; Beyer H. L, 2012, GEOSPATIAL MODELLING; BOX GEP, 1964, J ROY STAT SOC B, V26, P211, DOI 10.1111/j.2517-6161.1964.tb00553.x; Brashares JS, 2002, J ANIM ECOL, V71, P626, DOI 10.1046/j.1365-2656.2002.00633.x; Brent LJN, 2013, SCI REP-UK, V3, DOI 10.1038/srep01042; Burnham K. P., 2002, MODEL SELECTION MULT, V2nd; Calenge C, 2006, ECOL MODEL, V197, P516, DOI 10.1016/j.ecolmodel.2006.03.017; Cameron EZ, 2009, P NATL ACAD SCI USA, V106, P13850, DOI 10.1073/pnas.0900639106; Clay CA, 2009, P R SOC B, V276, P1305, DOI 10.1098/rspb.2008.1693; Comer CE, 2005, J WILDLIFE MANAGE, V69, P332, DOI 10.2193/0022-541X(2005)069&lt;0332:FGSASO&gt;2.0.CO;2; Craft ME, 2015, PHILOS T R SOC B, V370, DOI 10.1098/rstb.2014.0107; Craft ME, 2011, J R SOC INTERFACE, V8, P776, DOI 10.1098/rsif.2010.0511; Cross PC, 2004, ANN ZOOL FENN, V41, P879; Daszak P, 2000, SCIENCE, V287, P443, DOI 10.1126/science.287.5452.443; Dijkstra E. W., 1959, NUMERISCHE MATH, V1, P269, DOI [DOI 10.1007/BF01386390, 10.1007/BF01386390]; Doyle P.G., 1984, RANDOM WALKS ELECT N; Felix AB, 2007, J WILDLIFE MANAGE, V71, P804, DOI 10.2193/2006-366; Fieberg J, 2005, J WILDLIFE MANAGE, V69, P1346, DOI 10.2193/0022-541X(2005)69[1346:QHOTIO]2.0.CO;2; Fletcher RJ, 2011, P NATL ACAD SCI USA, V108, P19282, DOI 10.1073/pnas.1107549108; Fortin D, 2009, ECOLOGY, V90, P2480, DOI 10.1890/08-0345.1; FREEMAN LC, 1979, SOC NETWORKS, V1, P215, DOI 10.1016/0378-8733(78)90021-7; Garroway CJ, 2013, BEHAV ECOL SOCIOBIOL, V67, P113, DOI 10.1007/s00265-012-1431-3; GERARD JF, 1995, J THEOR BIOL, V176, P511, DOI 10.1006/jtbi.1995.0217; Gobush K, 2009, MOL ECOL, V18, P722, DOI 10.1111/j.1365-294X.2008.04043.x; Grear DA, 2006, J WILDLIFE MANAGE, V70, P546, DOI 10.2193/0022-541X(2006)70[546:DPAHVO]2.0.CO;2; Grear DA, 2010, J APPL ECOL, V47, P532, DOI 10.1111/j.1365-2664.2010.01813.x; Greer AL, 2008, J ANIM ECOL, V77, P364, DOI 10.1111/j.1365-2656.2007.01330.x; Habib TJ, 2011, ECOL MODEL, V222, P2722, DOI 10.1016/j.ecolmodel.2011.05.007; HAMILTON WD, 1971, J THEOR BIOL, V31, P295, DOI 10.1016/0022-5193(71)90189-5; HAWKINS RE, 1970, J WILDLIFE MANAGE, V34, P407, DOI 10.2307/3799027; Hirsch BT, 2013, ANIM BEHAV, V85, P463, DOI 10.1016/j.anbehav.2012.12.011; Hirth DH, 1977, WILDLIFE MONOGR, V53, P3, DOI DOI 10.2307/3830446; Holekamp KE, 1997, J MAMMAL, V78, P55, DOI 10.2307/1382638; Illinois Department of Natural Resources, 2014, ILL CHRON WAST DIS 2; Jacoby DMP, 2014, BEHAV ECOL SOCIOBIOL, V68, P1995, DOI 10.1007/s00265-014-1805-9; Kappeler PM, 2015, PHILOS T R SOC B, V370, DOI 10.1098/rstb.2014.0116; Kelley JL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024280; Kilpatrick HJ, 2001, CAN J ZOOL, V79, P949, DOI 10.1139/cjz-79-6-949; Kjaer LJ, 2008, J WILDLIFE MANAGE, V72, P1819, DOI 10.2193/2007-489; Kjellander P, 2004, OECOLOGIA, V139, P478, DOI 10.1007/s00442-004-1529-z; Koen EL, 2014, METHODS ECOL EVOL, V5, P626, DOI 10.1111/2041-210X.12197; Korte LM, 2008, J ZOOL, V275, P229, DOI 10.1111/j.1469-7998.2008.00430.x; Krause J, 2010, PHILOS T R SOC B, V365, P4099, DOI 10.1098/rstb.2010.0216; Kurvers RHJM, 2013, ANIM BEHAV, V86, P993, DOI 10.1016/j.anbehav.2013.09.001; Lesage L, 2000, CAN J ZOOL, V78, P1930, DOI 10.1139/cjz-78-11-1930; LONG J. A., 2014, WILDLIFEDI CALCULATE; Magle SB, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056568; McDonald DB, 2007, P NATL ACAD SCI USA, V104, P10910, DOI 10.1073/pnas.0701159104; McRae B.H., 2009, CIRCUITSCAPE USERS G; Mcrae BH, 2008, ECOLOGY, V89, P2712, DOI 10.1890/07-1861.1; Mcrae BH, 2007, P NATL ACAD SCI USA, V104, P19885, DOI 10.1073/pnas.0706568104; Midwest Regional Climate Center, 2015, 2015 ILL WEATH ARCH; Miller BF, 2010, J MAMMAL, V91, P681, DOI 10.1644/09-MAMM-A-258.1; Miller MW, 2004, EMERG INFECT DIS, V10, P1003, DOI 10.3201/eid1006.040010; MOHR CO, 1947, AM MIDL NAT, V37, P223, DOI 10.2307/2421652; Mokross K, 2014, P ROY SOC B-BIOL SCI, V281, DOI 10.1098/rspb.2013.2599; NELSON ME, 1993, J MAMMAL, V74, P316, DOI 10.2307/1382386; NIXON C.M, 1991, WILDLIFE MONOGR, V118, P3; Nobert BR, 2016, J APPL ECOL; Oh KP, 2010, AM NAT, V176, pE80, DOI 10.1086/655216; Olson AK, 2015, AM MIDL NAT, V174, P96, DOI 10.1674/0003-0031-174.1.96; Opsahl T., 2009, STRUCTURE EVOLUTION, P104; Opsahl T, 2010, SOC NETWORKS, V32, P245, DOI 10.1016/j.socnet.2010.03.006; Osnas EE, 2009, ECOL APPL, V19, P1311, DOI 10.1890/08-0578.1; Pike TW, 2008, P ROY SOC B-BIOL SCI, V275, P2515, DOI 10.1098/rspb.2008.0744; Pinter-Wollman N, 2009, P ROY SOC B-BIOL SCI, V276, P1009, DOI 10.1098/rspb.2008.1538; Pinter-Wollman N, 2014, BEHAV ECOL, V25, P242, DOI 10.1093/beheco/art047; Podgorski T, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0099875; PULLIAM HR, 1973, J THEOR BIOL, V38, P419, DOI 10.1016/0022-5193(73)90184-7; R Core Team, 2013, R LANG ENV STAT COMP; Robert K, 2013, J ZOOL, V290, P199, DOI 10.1111/jzo.12027; Robinson SJ, 2012, MOL ECOL, V21, P4190, DOI 10.1111/j.1365-294X.2012.05681.x; Saunders SE, 2012, EMERG INFECT DIS, V18, P369, DOI 10.3201/eid1803.110685; Schauber EM, 2007, J WILDLIFE MANAGE, V71, P155, DOI 10.2193/2005-546; Schauber EM, 2015, J MAMMAL, V96, P16, DOI 10.1093/jmammal/gyu027; SCHWEDE G, 1993, ANIM BEHAV, V45, P1007, DOI 10.1006/anbe.1993.1118; Silk JB, 2003, SCIENCE, V302, P1231, DOI 10.1126/science.1088580; Silk JB, 2007, PHILOS T R SOC B, V362, P539, DOI 10.1098/rstb.2006.1994; Southwell CJ., 1984, WILDLIFE RES, V11, P423; Stanton MA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047508; Stein RA, 2011, INT J INFECT DIS, V15, pE510, DOI 10.1016/j.ijid.2010.06.020; Sundaresan SR, 2007, OECOLOGIA, V151, P140, DOI 10.1007/s00442-006-0553-6; Tosa MI, 2015, J WILDLIFE DIS, V51, P79, DOI 10.7589/2013-06-139; Vander Wal E, 2015, ECOLOGY, V96, P631, DOI 10.1890/14-1320.1; Vander Wal E, 2012, ECOLOGY, V93, P206, DOI 10.1890/11-0020.1; Vander Wal E, 2014, BEHAV ECOL SOCIOBIOL, V68, P383, DOI 10.1007/s00265-013-1652-0; Vander Wal E, 2012, MOL ECOL, V21, P1271, DOI 10.1111/j.1365-294X.2011.05431.x; Venables WN., 2002, MODERN APPL STAT S 4; Walter WD, 2009, LANDSCAPE ECOL, V24, P1405, DOI 10.1007/s10980-009-9374-4; WALTHER F R, 1972, Zeitschrift fuer Tierpsychologie, V31, P348; Williams ES, 2002, J WILDLIFE MANAGE, V66, P551, DOI 10.2307/3803123; Wittemyer G, 2009, P ROY SOC B; WORTON BJ, 1989, ECOLOGY, V70, P164, DOI 10.2307/1938423	95	13	13	0	49	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 17	2017	12	3							e0173570	10.1371/journal.pone.0173570	http://dx.doi.org/10.1371/journal.pone.0173570			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EO5CJ	28306748	gold, Green Submitted, Green Published			2022-12-27	WOS:000396710300011
J	Bevacqua, RJ; Fernandez-Martin, R; Canel, NG; Gibbons, A; Texeira, D; Lange, F; Landschoot, GV; Savy, V; Briski, O; Hiriart, MI; Grueso, E; Ivics, Z; Taboga, O; Kues, WA; Ferraris, S; Salamone, DF				Bevacqua, R. J.; Fernandez-Martin, R.; Canel, N. G.; Gibbons, A.; Texeira, D.; Lange, F.; Vans Landschoot, G.; Savy, V.; Briski, O.; Hiriart, M. I.; Grueso, E.; Ivics, Z.; Taboga, O.; Kues, W. A.; Ferraris, S.; Salamone, D. F.			Assessing Tn5 and Sleeping Beauty for transpositional transgenesis by cytoplasmic injection into bovine and ovine zygotes	PLOS ONE			English	Article							HUMAN POLYCLONAL ANTIBODIES; FETAL FIBROBLASTS; NUCLEAR TRANSFER; GENE-TRANSFER; HUMAN-CELLS; FACTOR IX; IN-VITRO; EMBRYOS; TRANSPOSASE; EXPRESSION	Transgenic domestic animals represent an alternative to bioreactors for large-scale production of biopharmaceuticals and could also provide more accurate biomedical models than rodents. However, their generation remains inefficient. Recently, DNA transposons allowed improved transgenesis efficiencies in mice and pigs. In this work, Tn5 and Sleeping Beauty (SB) transposon systems were evaluated for transgenesis by simple cytoplasmic injection in livestock zygotes. In the case of Tn5, the transposome complex of transposon nucleic acid and Tn5 protein was injected. In the case of SB, the supercoiled plasmids encoding a transposon and the SB transposase were co-injected. In vitro produced bovine zygotes were used to establish the cytoplasmic injection conditions. The in vitro cultured blastocysts were evaluated for reporter gene expression and genotyped. Subsequently, both transposon systems were injected in seasonally available ovine zygotes, employing transposons carrying the recombinant human factor IX driven by the beta-lactoglobulin promoter. The Tn5 approach did not result in transgenic lambs. In contrast, the Sleeping Beauty injection resulted in 2 lambs (29%) carrying the transgene. Both animals exhibited cellular mosaicism of the transgene. The extraembryonic tissues (placenta or umbilical cord) of three additional animals were also transgenic. These results show that transpositional transgenesis by cytoplasmic injection of SB transposon components can be applied for the production of transgenic lambs of pharmaceutical interest.	[Bevacqua, R. J.; Fernandez-Martin, R.; Canel, N. G.; Vans Landschoot, G.; Savy, V.; Briski, O.; Hiriart, M. I.; Salamone, D. F.] Univ Buenos Aires, Anim Biotechnol Lab, Fac Agron, INPA,CONICET, Buenos Aires, DF, Argentina; [Gibbons, A.] INTA, Expt Stn Bariloche, San Carlos De Bariloche, Rio Negro, Argentina; [Texeira, D.] Univ Estadual Ceara, Lab Fisiol & Controle Reprod, FAVET, Fortaleza, Ceara, Brazil; [Lange, F.; Vans Landschoot, G.; Ferraris, S.] Maimonides Univ, Cloning & Transgenesis Lab, Buenos Aires, DF, Argentina; [Grueso, E.; Ivics, Z.] Paul Ehrlich Inst, Langen, Germany; [Taboga, O.] INTA Castelar, CICVyA Biotechnol Inst, Buenos Aires, DF, Argentina; [Kues, W. A.] Friedrich Loeffler Inst, Neustadt, Germany	Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); University of Buenos Aires; Instituto Nacional de Tecnologia Agropecuaria (INTA); Universidade Estadual do Ceara; Paul Ehrlich Institute; Instituto Nacional de Tecnologia Agropecuaria (INTA); Friedrich Loeffler Institute	Salamone, DF (corresponding author), Univ Buenos Aires, Anim Biotechnol Lab, Fac Agron, INPA,CONICET, Buenos Aires, DF, Argentina.	salamone@agro.uba.ar	Briski, Olinda/AAM-3972-2020; Bevacqua, Romina/AAU-9227-2021; Salamone, Daniel F/G-1096-2019; Hierro, Esther Grueso/C-8107-2019	Briski, Olinda/0000-0002-6574-4479; Salamone, Daniel F/0000-0003-0858-0313; Bevacqua, Romina J/0000-0002-3903-6508; Grueso, Esther/0000-0002-5365-5129; , Oscar/0000-0001-9575-3045; Kues, Wilfried/0000-0002-0850-8103; canel, natalia/0000-0002-6154-2132; Fernandez-Martin, Rafael/0000-0002-4838-407X	Agencia Nacional de Promocion Cientifica y Tecnologica [PICT-2013-2375]	Agencia Nacional de Promocion Cientifica y Tecnologica(ANPCyT)	This work was supported by Grant: Agencia Nacional de Promocion Cientifica y Tecnologica PICT-2013-2375 received by Daniel Salamone (DS); http://www.agencia.mincyt.gob.ar/. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bevacqua RJ, 2013, THERIOGENOLOGY, V80, P104, DOI 10.1016/j.theriogenology.2013.03.017; Bevacqua RJ, 2012, THERIOGENOLOGY, V78, P57, DOI 10.1016/j.theriogenology.2012.01.020; Bevacqua RJ, 2010, THERIOGENOLOGY, V74, P922, DOI 10.1016/j.theriogenology.2010.04.017; BRACKETT BG, 1975, BIOL REPROD, V12, P260, DOI 10.1095/biolreprod12.2.260; Carlson DF, 2011, TRANSGENIC RES, V20, P29, DOI 10.1007/s11248-010-9386-5; CHURCH GM, 1984, P NATL ACAD SCI-BIOL, V81, P1991, DOI 10.1073/pnas.81.7.1991; Cibelli JB, 1998, SCIENCE, V280, P1256, DOI 10.1126/science.280.5367.1256; Cueto MI, 2011, REPROD DOMEST ANIM, V46, P770, DOI 10.1111/j.1439-0531.2010.01738.x; Cunningham F, 2015, NUCLEIC ACIDS RES, V43, pD662, DOI 10.1093/nar/gku1010; Davies DR, 2000, SCIENCE, V289, P77, DOI 10.1126/science.289.5476.77; Dupuy AJ, 2002, P NATL ACAD SCI USA, V99, P4495, DOI 10.1073/pnas.062630599; Dyck MK, 2003, TRENDS BIOTECHNOL, V21, P394, DOI 10.1016/S0167-7799(03)00190-2; Garrels W, 2011, PLOS ONE, V6; Garrels W, 2014, REPROD FERT DEVELOP, V27, P266; Gomez MC, 1998, THERIOGENOLOGY, V49, P1143, DOI 10.1016/S0093-691X(98)00062-4; GORDON JW, 1980, P NATL ACAD SCI-BIOL, V77, P7380, DOI 10.1073/pnas.77.12.7380; Goryshin IY, 1998, P NATL ACAD SCI USA, V95, P10716, DOI 10.1073/pnas.95.18.10716; Goryshin IY, 2003, GENOME RES, V13, P644, DOI 10.1101/gr.611403; Goryshin IY, 2000, NAT BIOTECHNOL, V18, P97, DOI 10.1038/72017; GOSSLER A, 1986, P NATL ACAD SCI USA, V83, P9065, DOI 10.1073/pnas.83.23.9065; Grabundzija I, 2010, MOL THER, V18, P1200, DOI 10.1038/mt.2010.47; Habermann FA, 2007, THERIOGENOLOGY, V68, pS116, DOI 10.1016/j.theriogenology.2007.05.055; Hackett CS, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-S1-S12; HAMMER RE, 1985, NATURE, V315, P680, DOI 10.1038/315680a0; Henikoff S, 1998, CELL, V93, P329, DOI 10.1016/S0092-8674(00)81161-7; Houdebine LM, 2009, COMP IMMUNOL MICROB, V32, P107, DOI 10.1016/j.cimid.2007.11.005; IKAWA M, 1995, FEBS LETT, V375, P125, DOI 10.1016/0014-5793(95)01162-8; Iqbal K, 2009, BIOTECHNIQUES, V47, P959, DOI 10.2144/000113270; Ivics Z, 1997, CELL, V91, P501, DOI 10.1016/S0092-8674(00)80436-5; Jacobsen JC, 2010, HUM MOL GENET, V19, P1873, DOI 10.1093/hmg/ddq063; Jakobsen JE, 2011, TRANSGENIC RES, V20, P533, DOI 10.1007/s11248-010-9438-x; Kues WA, 2006, FASEB J, V20, P1200, DOI 10.1096/fj.05-5415fje; Kuroiwa Y, 2002, GENE THER, V9, P708, DOI 10.1038/sj.gt.3301754; Kuroiwa Y, 2009, NAT BIOTECHNOL, V27, P173, DOI 10.1038/nbt.1521; Lois C, 2002, SCIENCE, V295, P868, DOI 10.1126/science.1067081; Marh J, 2012, P NATL ACAD SCI USA, V109, P19184, DOI 10.1073/pnas.1216473109; Mates L, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-S1-S1; Mates L, 2009, NAT GENET, V41, P753, DOI 10.1038/ng.343; MAXWELL WMC, 1984, J AGR SCI-CAMBRIDGE, V102, P233, DOI 10.1017/S002185960004168X; Meissner A, 2006, DEV DYNAM, V235, P2460, DOI 10.1002/dvdy.20915; Memili E, 1999, BIOL REPROD, V61, P1198, DOI 10.1095/biolreprod61.5.1198; Naumann TA, 2002, J BACTERIOL, V184, P233, DOI 10.1128/JB.184.1.233-240.2002; Naumann TA, 2002, J BIOL CHEM, V277, P17623, DOI 10.1074/jbc.M200742200; Nowak-Imialek M, 2013, REPROD FERT DEVELOP, V25, P103, DOI 10.1071/RD12265; Nowak-Imialek M, 2011, STEM CELLS DEV, V20, P1564, DOI 10.1089/scd.2010.0399; Pereyra-Bonnet F, 2008, REPROD FERT DEVELOP, V20, P741, DOI 10.1071/RD07172; Pereyra-Bonnet F, 2009, REPROD FERT DEVELOP, V21, P250, DOI 10.1071/RDv21n1Ab307; Pereyra-Bonnet F, 2011, TRANSGENIC RES, V20, P1379, DOI 10.1007/s11248-011-9503-0; Robl JM, 2007, CLONING STEM CELLS, V9, P12, DOI 10.1089/clo.2006.0083; Rossant J, 2011, P NATL ACAD SCI USA, V108, P7659, DOI 10.1073/pnas.1104844108; Rostovskaya M, 2012, NUCLEIC ACIDS RES, V40, DOI 10.1093/nar/gks643; Santos C, 2006, J BIOTECHNOL, V124, P469; SAS Institute Inc. SAS/STAT, 1989, US GUID VERS 6, V1, P943; Schnieke AE, 1997, SCIENCE, V278, P2130, DOI 10.1126/science.278.5346.2130; Suganuma R, 2005, BIOL REPROD, V73, P1157, DOI 10.1095/biolreprod.105.044669; TERVIT HR, 1972, J REPROD FERTIL, V30, P493, DOI 10.1530/jrf.0.0300493; Van Thuan N, 2010, J REPROD DEVELOP, V56, P20, DOI 10.1262/jrd.09-221A; Yant SR, 2005, MOL CELL BIOL, V25, P2085, DOI 10.1128/MCB.25.6.2085-2094.2005; Yekta AA, 2013, TRANSGENIC RES, V22, P131, DOI 10.1007/s11248-012-9634-y	59	5	7	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 16	2017	12	3							e0174025	10.1371/journal.pone.0174025	http://dx.doi.org/10.1371/journal.pone.0174025			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN9KE	28301581	Green Published, gold, Green Submitted			2022-12-27	WOS:000396318300114
J	King, W; Lacey, A; White, J; Farewell, D; Dunstan, F; Fone, D				King, William; Lacey, Arron; White, James; Farewell, Daniel; Dunstan, Frank; Fone, David			Equity in healthcare for coronary heart disease, Wales (UK) 2004-2010: A populationbased electronic cohort study	PLOS ONE			English	Article							ARTERY-BYPASS GRAFT; REVASCULARIZATION RATES; OUTCOMES FRAMEWORK; GENERAL PRACTICES; CARDIAC SERVICES; MORTALITY-RATES; BLOOD-PRESSURE; DEPRIVATION; INEQUALITIES; QUALITY	Background Despite substantial falls in coronary heart disease (CHD) mortality in the United Kingdom (UK), marked socioeconomic inequalities in CHD risk factors and CHD mortality persist. We investigated whether inequity in CHD healthcare in Wales (UK) could contribute to the observed social gradient in CHD mortality. Methods and findings Linking data from primary and secondary care we constructed an electronic cohort of indivi-duals (n = 1199342) with six year follow-up, 2004-2010. We identified indications for recom-mended CHD interventions, measured time to their delivery, and estimated risk of receiving the interventions for each of five ordered deprivation groups using a time-to-event approach with Cox regression frailty models. Interventions in primary and secondary prevention in-cluded risk-factor measurement, smoking management, statins and antihypertensive therapy, and in established CHD included medication and revascularization. For primary prevention, five of the 11 models favoured the more deprived and one favoured the less deprived. For medication in secondary prevention and established CHD, one of the 15 models favoured the more deprived and one the less deprived. In relation to revascularization, six of the 12 models favoured the less deprived and none favoured the more deprived-this evidence of inequity exemplified by a hazard ratio for revascularization in stable angina of 0.79 (95% confidence interval 0.68, 0.92). The main study limitation is the possibility of under-ascertainment or mis-classification of clinical indications and treatment from variability in coding. Conclusions Primary care components of CHD healthcare were equitably delivered. Evidence of inequity was found for revascularization procedures, although this inequity is likely to have only a modest effect on social gradients in CHD mortality. Policymakers should focus on reducing inequalities in CHD risk factors, particularly smoking, as these, rather than inequity in health-care, are likely to be key drivers of inequalities in CHD mortality.	[King, William] Publ Hlth Wales, Aneurin Bevan Gwent Local Publ Hlth Team, Newport, Gwent, Wales; [Lacey, Arron] Swansea Univ, Coll Med, Swansea, W Glam, Wales; [White, James] Cardiff Univ, Ctr Dev & Evaluat Complex Publ Hlth Intervent, Cardiff, S Glam, Wales; [White, James] Cardiff Univ, South East Wales Trials Unit, Cardiff, S Glam, Wales; [Farewell, Daniel; Dunstan, Frank; Fone, David] Cardiff Univ, Div Populat Med, Cardiff, S Glam, Wales	Swansea University; Cardiff University; Cardiff University; Cardiff University	Fone, D (corresponding author), Cardiff Univ, Div Populat Med, Cardiff, S Glam, Wales.	foned@cardiff.ac.uk	Lacey, Arron/AAO-5415-2021	White, James/0000-0001-8371-8453; Farewell, Daniel/0000-0002-8871-1653; Lacey, Arron/0000-0001-7983-8073	Medical Research Council Methodology Fellowship; Health and Care Research Wales; Medical Research Council [G0902108, MR/K006525/1, MR/K023233/1, G1000744] Funding Source: researchfish; MRC [MR/K006525/1, G0902108, MR/K023233/1] Funding Source: UKRI	Medical Research Council Methodology Fellowship(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Health and Care Research Wales; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	The authors received no specific funding for this work. WK was funded as a Welsh Clinical Academic Track Fellow. AL was employed by the Cardiovascular Research Group Cymru, funded by a grant from Health and Care Research Wales (formerly National Institute for Social Care and Health Research). Part of DFa's work was supported by a Medical Research Council Methodology Fellowship.	ANDERSON KM, 1991, AM HEART J, V121, P293, DOI 10.1016/0002-8703(91)90861-B; [Anonymous], 2014, BRIT CARD INT SOC NA; [Anonymous], 2001, NAT SERV FRAM COR HE; Ashworth M, 2008, BMJ-BRIT MED J, V337, DOI 10.1136/bmj.a2030; Bajekal M, 2010, J EPIDEMIOL COMMUN H, V64, pA2, DOI 10.1136/jech.2010.120956.5; Bajekal M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059608; Bajekal M, 2012, PLOS MED, V9, DOI 10.1371/journal.pmed.1001237; BENSHLOMO Y, 1995, J EPIDEMIOL COMMUN H, V49, P200, DOI 10.1136/jech.49.2.200; Bradshaw NS, 1998, PHARM J, V261, pR11; Campbell SE, 2001, J PUBLIC HEALTH MED, V23, P205, DOI 10.1093/pubmed/23.3.205; Capewell S, 2000, CIRCULATION, V102, P1511, DOI 10.1161/01.CIR.102.13.1511; Capewell S, 2009, AM J EPIDEMIOL; CHARLSON ME, 1987, J CHRON DIS, V40, P373, DOI 10.1016/0021-9681(87)90171-8; Cosh H, 2008, THESIS; D'Agostino RB, 2008, CIRCULATION, V117, P743, DOI 10.1161/CIRCULATIONAHA.107.699579; *DEP HLTH, 2000, NAT SERV FRAM COR HE; DOLISZNY KM, 1994, J AM COLL CARDIOL, V24, P95, DOI 10.1016/0735-1097(94)90547-9; Doran T, 2006, NEW ENGL J MED, V355, P375, DOI 10.1056/NEJMsa055505; Ford DV, 2009, BMC HEALTH SERV RES, V9, DOI 10.1186/1472-6963-9-157; Ford ES, 2007, NEW ENGL J MED, V356, P2388, DOI 10.1056/NEJMsa053935; Gardner K, 1999, BRIT MED J, V319, P418, DOI 10.1136/bmj.319.7207.418; Gatrell A, 2002, HEALTH PLACE, V8, P147, DOI 10.1016/S1353-8292(01)00044-2; Hamilton FL, 2010, J AMBUL CARE MANAG, V33, P336, DOI 10.1097/JAC.0b013e3181f68f1d; Hawkins NM, 2013, CIRC-CARDIOVASC QUAL, V6, P208, DOI 10.1161/CIRCOUTCOMES.111.000058; Hippisley-Cox J, 2004, BRIT MED J, V329, P1267, DOI 10.1136/bmj.38279.588125.7C; Hippisley-Cox J, 2000, BRIT J GEN PRACT, V50, P449; Hotchkiss JW, 2014, BMJ-BRIT MED J, V348, DOI 10.1136/bmj.g1088; Hughes J, 2013, EUR J PREV CARDIOL, V20, P310, DOI 10.1177/2047487312441725; JARMAN B, 1991, BRIT MED J, V303, P523, DOI 10.1136/bmj.303.6801.523-a; Jefferis BJMH, 2004, J PUBLIC HEALTH-UK, V26, P13, DOI 10.1093/pubmed/fdh110; Jordan K, 2004, FAM PRACT, V21, P396, DOI 10.1093/fampra/cmh409; Langham S, 2003, J PUBLIC HEALTH MED, V25, P202, DOI 10.1093/pubmed/fdg054; Lester J, 2004, WRITING CHILDREN OTH; Leyland AH, 2004, J EPIDEMIOL COMMUN H, V58, P296, DOI 10.1136/jech.2003.007278; Lyons RA, 2009, BMC MED INFORM DECIS, V9, DOI 10.1186/1472-6947-9-3; Lyratzopoulos G, 2006, HEART, V92, P1198, DOI 10.1136/hrt.2005.081042; Manson-Siddle CJ, 1998, J EPIDEMIOL COMMUN H, V52, P507, DOI 10.1136/jech.52.8.507; Manson-Siddle CJ, 1999, J EPIDEMIOL COMMUN H, V53, P572, DOI 10.1136/jech.53.9.572; McCartney D, 2012, BMJ OPEN, V2, DOI 10.1136/bmjopen-2011-000737; McGovern MP, 2008, DIABETIC MED, V25, P1083, DOI 10.1111/j.1464-5491.2008.02544.x; McLean G, 2006, J EPIDEMIOL COMMUN H, V60, P917, DOI 10.1136/jech.2005.044628; National Federation of the Blind Facing the Truth, 2009, TECHNICAL REPORT; National Institute for Clinical Excellence, 2002, MAN TYP 2 DIAB MAN B; National Institute for Clinical Excellence, 2001, PROPH PAT WHO HAV EX; National Institute for Health and Clinical Excellence, 2004, HYP MAN HYP AD PRIM; National Institute for Health and Clinical Excellence, 2008, LIP MOD CARD RISK AS; National Institute for Health and Clinical Excellence, 2006, HYP MAN HYP AD PRIM; O'Flaherty M, 2013, HEART, V99, P159, DOI 10.1136/heartjnl-2012-302300; Packham C, 2000, BMJ-BRIT MED J, V320, P1583, DOI 10.1136/bmj.320.7249.1583; Packham C, 1999, J PUBLIC HEALTH MED, V21, P60, DOI 10.1093/pubmed/21.1.60; Payne N, 1997, BRIT MED J, V314, P257, DOI 10.1136/bmj.314.7076.257; Saxena S, 2007, BMC HEALTH SERV RES, V7, DOI 10.1186/1472-6963-7-96; Simpson CR, 2010, BRIT J GEN PRACT, V60, DOI 10.3399/bjgp10X483544; Therneau T, 2012, R PACKAGE VERSION, V2; Unal B, 2004, CIRCULATION, V109, P1101, DOI 10.1161/01.CIR.0000118498.35499.B2; van Buuren S, 2011, J STAT SOFTW, V45, P1; Ward Paul R, 2005, Int J Equity Health, V4, P3, DOI 10.1186/1475-9276-4-3; Ward PR, 2004, J EPIDEMIOL COMMUN H, V58, P89, DOI 10.1136/jech.58.2.89; Wilmot KA, 2015, CIRCULATION, V132, P997, DOI 10.1161/CIRCULATIONAHA.115.015293	59	6	6	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 16	2017	12	3							e0172618	10.1371/journal.pone.0172618	http://dx.doi.org/10.1371/journal.pone.0172618			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN9KE	28301496	Green Published, gold, Green Accepted, Green Submitted			2022-12-27	WOS:000396318300018
J	Kozuki, N; Oseni, L; Mtimuni, A; Sethi, R; Rashidi, T; Kachale, F; Rawlins, B; Gupta, S				Kozuki, Naoko; Oseni, Lolade; Mtimuni, Angella; Sethi, Reena; Rashidi, Tambudzai; Kachale, Fannie; Rawlins, Barbara; Gupta, Shivam			Health facility service availability and readiness for intrapartum and immediate postpartum care in Malawi: A cross-sectional survey	PLOS ONE			English	Article							PROGRAM	This analysis seeks to identify strengths and gaps in the existing facility capacity for intrapar-tum and immediate postpartum fetal and neonatal care, using data collected as a part of Malawi's Helping Babies Breath program evaluation. From August to September 2012, the Maternal and Child Health Integrated Program (MCHIP) conducted a cross-sectional survey in 84 Malawian health facilities to capture current health facility service availability and readi-ness and health worker capacity and practice pertaining to labor, delivery, and immediate postpartum care. The survey collected data on availability of equipment, supplies, and medi-cations, and health worker knowledge and performance scores on intrapartum care simula-tion and actual management of real clients at a subset of facilities. We ran linear regression models to identify predictors of high simulation performance of routine delivery care and management of asphyxiated newborns across all facilities surveyed. Key supplies for infec-tion prevention and thermal care of the newborn were found to be missing in many of the surveyed facilities. At the health center level, 75% had no clinician trained in basic emer-gency obstetric care or newborn care and 39% had no midwife trained in the same. We observed that there were no proportional increases in available transport and staff at a facility as catchment population increased. In simulations of management of newborns with breathing problems, health workers were able to complete a median of 10 out of 16 tasks for a full-term birth case scenario and 20 out of 30 tasks for a preterm birth case scenario. Health workers who had more years of experience appeared to perform worse. Our study provides a benchmark and highlights gaps for future evaluations and studies as Malawi con-tinues to make strides in improving facility-based care. Further progress in reducing the bur-den of neonatal and fetal death in Malawi will be partly predicated on guaranteeing properly equipped and staffed facilities in addition to ensuring the presence of skilled health workers.	[Kozuki, Naoko; Gupta, Shivam] Johns Hopkins Bloomberg Sch Publ Hlth, Dept Int Hlth, Baltimore, MD 21205 USA; [Oseni, Lolade; Rashidi, Tambudzai] Jhpiego, Lilongwe, Malawi; [Mtimuni, Angella] USAID, Lilongwe, Malawi; [Sethi, Reena; Rawlins, Barbara] Jhpiego, Washington, DC USA; [Kachale, Fannie] Malawi Minist Hlth, Lilongwe, Malawi	Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; Jhpiego; United States Agency for International Development (USAID); Jhpiego	Gupta, S (corresponding author), Johns Hopkins Bloomberg Sch Publ Hlth, Dept Int Hlth, Baltimore, MD 21205 USA.	sgupta23@jhu.edu		Kozuki, Naoko/0000-0003-2850-3956	USAID through the Maternal and Child Health Integrated Program; SSDI-Services bilateral program in Malawi	USAID through the Maternal and Child Health Integrated Program(United States Agency for International Development (USAID)); SSDI-Services bilateral program in Malawi	We acknowledge support from USAID through the Maternal and Child Health Integrated Program and the SSDI-Services bilateral program in Malawi.	American Academy of Pediatrics, HELP BAB BREATH; American Academy of Pediatrics, HELP BAB BREATH FAC, V2 nd; [Anonymous], 1985, LANCET, V2, P436; [Anonymous], 2015, COUNTDOWN 2015 COUNT; [Anonymous], 2007, MAN COMPL PREGN CHIL; [Anonymous], 2010, MAL DEM HLTH SURV 20; Berg A BL, 2012, EVALUATION KANGAROO; Blencowe H, 2016, LANCET GLOBAL HLTH; Blencowe H, 2013, PEDIATR RES, V74, P17, DOI 10.1038/pr.2013.204; Brenner S, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0123968; Callaghan-Koru JA, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-1052; Demographic and Health Survey, SPA OV; Ersdal HL, 2013, RESUSCITATION, V84, P1422, DOI 10.1016/j.resuscitation.2013.04.005; Goggin K, 2016, AIDS BEHAV, V20, P2141, DOI 10.1007/s10461-016-1404-z; Lawn JE, 2011, LANCET, V377, P1448, DOI 10.1016/S0140-6736(10)62187-3; Lee ACC, 2013, PEDIATR RES, V74, P50, DOI 10.1038/pr.2013.206; Liu L, 2012, LANCET, V379, P2151, DOI 10.1016/S0140-6736(12)60560-1; Malawi Ministry of Health, EV NEWB ACT PLAN ACT; McPherson RA, 2013, PROCESS DOCUMENTATIO; Sethi R, 2015, MEASUREMENT QUALITY; Thorsen VC, 2011, BMC NURS, V10, DOI 10.1186/1472-6955-10-9; Tibshirani R, 1996, J ROY STAT SOC B MET, V58, P267, DOI 10.1111/j.2517-6161.1996.tb02080.x; USAID, 2015, USAID MAL HLTH COMM; van Lettow M, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-426; Wendo D, 2015, SUPPORT SERVICE DELI; Zimba E, 2012, HEALTH POLICY PLANN, V27, P88, DOI 10.1093/heapol/czs043	26	11	11	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 16	2017	12	3							e0172492	10.1371/journal.pone.0172492	http://dx.doi.org/10.1371/journal.pone.0172492			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN9KE	28301484	Green Published, Green Submitted, gold			2022-12-27	WOS:000396318300015
J	Ranjha, R; Meena, NK; Singh, A; Ahuja, V; Paul, J				Ranjha, Raju; Meena, Naresh Kumar; Singh, Abhiraman; Ahuja, Vineet; Paul, Jaishree			Association of miR-196a-2 and miR-499 variants with ulcerative colitis and their correlation with expression of respective miRNAs	PLOS ONE			English	Article							INFLAMMATORY-BOWEL-DISEASE; GENETIC-VARIANTS; CANCER-RISK; FUNCTIONAL POLYMORPHISMS; COLORECTAL-CANCER; PRE-MICRORNAS; SUSCEPTIBILITY; RS3746444	Background and aim MicroRNAs are small non-coding RNAs that play an important role in regulating the gene expression of their target genes. SNP miR-196a-2 rs11614913 and miR-499 rs3746444 are reported to have association with the risk and prognosis of multiple-types of inflammatory diseases including IBD. This study was conducted to show if any association of SNP miR-196a- 2rs11614913 and miR-499 rs3746444 exists with ulcerative colitis (UC) patients of north Indian population and how these polymorphisms modulate the expression profile of the respective miRNAs. Methods A total of 638 participants including 197 UC patients and 441 controls were included in this study. Polymorphisms were genotyped by PCR-RFLP and the miRNA expression was measured using qRT-PCR. Genotypes and allele frequencies were calculated using SPSS 16 software. Results MiR-196a-2 rs11614913 (C> T) and miR-499 rs3746444 (T> C) were found to be associated with UC. TT genotype of miR-196a-2 rs11614913 (p = 0.03) was negatively associated with UC whereas the heterozygous TC genotype of miR-499 rs3746444 (p = 0.003) was showing positive association with UC. Patients having a combination of both SNPs, developed disease at older age and they suffered from severe disease extent. Genotype that showed association with the disease also showed correlation with the changes in miRNA expression. Conclusion In this study we found miR-196a-2 rs11614913 and miR-499 rs3746444 were associated with UC in north Indian population. We found the genotype that showed association with UC also altered the expression of respective miRNA in the patient harboring the genotype. There was correlation between associated genotype and altered miRNA expression.	[Ranjha, Raju; Meena, Naresh Kumar; Singh, Abhiraman; Paul, Jaishree] Jawaharlal Nehru Univ, Sch Life Sci, New Delhi, India; [Ahuja, Vineet] All India Inst Med Sci, Dept Gastroenterol, New Delhi, India; [Ranjha, Raju] Natl Inst Malaria Res, New Delhi, India	Jawaharlal Nehru University, New Delhi; All India Institute of Medical Sciences (AIIMS) New Delhi; Indian Council of Medical Research (ICMR); ICMR - National Institute of Malaria Research (NIMR)	Paul, J (corresponding author), Jawaharlal Nehru Univ, Sch Life Sci, New Delhi, India.	jpaul33@hotmail.com	Ahuja, Vineet/N-1705-2019	Ahuja, Vineet/0000-0002-5474-9709; Meena, Naresh Kumar/0000-0001-5450-5184	Department of Biotechnology, New Delhi [BT/PR8348/MED/30/1023/2013]; Department of Science and Technology in the form of DST PURSE [6(54)/SLS/JP/DST PURSE/2016-17]; CSIR, New Delhi	Department of Biotechnology, New Delhi(Department of Biotechnology (DBT) India); Department of Science and Technology in the form of DST PURSE; CSIR, New Delhi(Council of Scientific & Industrial Research (CSIR) - India)	JP acknowledges the financial support received from the Department of Biotechnology, New Delhi through a research grant (No.BT/PR8348/MED/30/1023/2013) and partial support from Department of Science and Technology in the form of DST PURSE Grant II-File No. 6(54)/SLS/JP/DST PURSE/2016-17 to the university. RR received JRF/SRF fellowship from CSIR, New Delhi. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alshatwi AA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030049; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Baumgart DC, 2007, LANCET, V369, P1627, DOI 10.1016/S0140-6736(07)60750-8; Bloomston M, 2007, JAMA-J AM MED ASSOC, V297, P1901, DOI 10.1001/jama.297.17.1901; Chen CF, 2005, NUCLEIC ACIDS RES, V33, DOI 10.1093/nar/gni178; Chen C, 2014, BMC MED GENET, V15, DOI 10.1186/s12881-014-0126-1; Dai ZJ, 2015, CURR PHARM DESIGN, V21, P1455, DOI 10.2174/1381612821666141208143533; Du M, 2014, CARCINOGENESIS; Garud Sagar, 2009, Therap Adv Gastroenterol, V2, P99, DOI 10.1177/1756283X09102329; Gazouli M, 2013, DIGEST DIS SCI, V58, P2324, DOI 10.1007/s10620-013-2640-y; Guo J, 2012, PLOS ONE, P7; Hu XJ, 2014, TUMOR BIOL, V35, P2151, DOI 10.1007/s13277-013-1285-y; Hu ZB, 2008, J CLIN INVEST, V118, P2600, DOI 10.1172/JCI34934; Jazdzewski K, 2009, P NATL ACAD SCI USA, V106, P1502, DOI 10.1073/pnas.0812591106; Kulshreshtha R, 2007, MOL CELL BIOL, V27, P1859, DOI 10.1128/MCB.01395-06; Li LJ, 2011, CLIN BIOCHEM, V44, P813, DOI 10.1016/j.clinbiochem.2011.04.021; Matricon J, 2010, SELF NONSELF, V1, P299, DOI DOI 10.4161/SELF.1.4.13560; MILLER SA, 1988, NUCLEIC ACIDS RES, V16, P1215, DOI 10.1093/nar/16.3.1215; Mittal RD, 2011, DNA CELL BIOL, V30, P401, DOI 10.1089/dna.2010.1159; Obernosterer G, 2006, RNA, V12, P1161, DOI 10.1261/rna.2322506; Okubo M, 2011, J CLIN IMMUNOL, V31, P69, DOI 10.1007/s10875-010-9461-y; Ranjha R, 2013, INFLAMM RES, V62, P343, DOI 10.1007/s00011-013-0600-9; Satsangi J, 2006, GUT, V55, P749, DOI 10.1136/gut.2005.082909; Tursi A, 2010, AM J GASTROENTEROL, V105, P2218, DOI 10.1038/ajg.2010.218; Wang F, 2013, MOL BIOL REP, V40, P109, DOI 10.1007/s11033-012-2039-4; Wang G, 2014, TUMOR BIOL, V35, P2693, DOI 10.1007/s13277-013-1355-1; Xiang Y, 2012, MOL BIOL REP, V39, P7019, DOI 10.1007/s11033-012-1532-0; Xu Y, 2013, PLOS ONE, V8; Yang B, 2012, HUM IMMUNOL, V73, P101, DOI 10.1016/j.humimm.2011.10.005; Zhan JF, 2011, ARCH MED RES, V42, P144, DOI 10.1016/j.arcmed.2011.04.001; Zhang M, 2012, EUR J CANCER CARE, V21, P274, DOI 10.1111/j.1365-2354.2011.01308.x; Zhang YG, 2013, ASIAN PAC J CANCER P, V14, P2337, DOI 10.7314/APJCP.2013.14.4.2337; Zou MN, 2012, MOL BIOL REP, V39, P3385, DOI 10.1007/s11033-011-1109-3	33	14	15	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 16	2017	12	3							e0173447	10.1371/journal.pone.0173447	http://dx.doi.org/10.1371/journal.pone.0173447			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN9KE	28301487	gold, Green Published, Green Submitted			2022-12-27	WOS:000396318300040
J	Howle, LE; Weber, PW; Hada, EA; Vann, RD; Denoble, PJ				Howle, Laurens E.; Weber, Paul W.; Hada, Ethan A.; Vann, Richard D.; Denoble, Petar J.			The probability and severity of decompression sickness	PLOS ONE			English	Article							ILLNESS; MODELS; RISK	Decompression sickness (DCS), which is caused by inert gas bubbles in tissues, is an injury of concern for scuba divers, compressed air workers, astronauts, and aviators. Case reports for 3322 air and N-2-O-2 dives, resulting in 190 DCS events, were retrospectively analyzed and the outcomes were scored as (1) serious neurological, (2) cardiopulmonary, (3) mild neurological, (4) pain, (5) lymphatic or skin, and (6) constitutional or nonspecific manifestations. Following standard U.S. Navy medical definitions, the data were grouped into mild-Type I (manifestations 4-6)-and serious-Type II (manifestations 1-3). Additionally, we considered an alternative grouping of mild-Type A (manifestations 3-6)-and serious-Type B (manifestations 1 and 2). The current U.S. Navy guidance allows for a 2% probability of mild DCS and a 0.1% probability of serious DCS. We developed a hierarchical trinomial (3-state) probabilistic DCS model that simultaneously predicts the probability of mild and serious DCS given a dive exposure. Both the Type I/II and Type A/B discriminations of mild and serious DCS resulted in a highly significant (p << 0.01) improvement in trinomial model fit over the binomial (2-state) model. With the Type I/II definition, we found that the predicted probability of 'mild' DCS resulted in a longer allowable bottom time for the same 2% limit. However, for the 0.1% serious DCS limit, we found a vastly decreased allowable bottom dive time for all dive depths. If the Type A/B scoring was assigned to outcome severity, the no decompression limits (NDL) for air dives were still controlled by the acceptable serious DCS risk limit rather than the acceptable mild DCS risk limit. However, in this case, longer NDL limits were allowed than with the Type I/II scoring. The trinomial model mild and serious probabilities agree reasonably well with the current air NDL only with the Type A/B scoring and when 0.2% risk of serious DCS is allowed.	[Howle, Laurens E.; Weber, Paul W.] Duke Univ, Dept Mech Engn & Mat Sci, Hudson Hall,Res Dr, Durham, NC 27706 USA; [Howle, Laurens E.; Hada, Ethan A.] Duke Univ, Med Ctr, Dept Radiol, Durham, NC 27710 USA; [Howle, Laurens E.; Weber, Paul W.] BelleQuant Engn PLLC, Mebane, NC 27302 USA; [Vann, Richard D.; Denoble, Petar J.] Divers Alert Network, 6 West Colony Pl, Durham, NC USA	Duke University; Duke University	Howle, LE (corresponding author), Duke Univ, Dept Mech Engn & Mat Sci, Hudson Hall,Res Dr, Durham, NC 27706 USA.; Howle, LE (corresponding author), Duke Univ, Med Ctr, Dept Radiol, Durham, NC 27710 USA.; Howle, LE (corresponding author), BelleQuant Engn PLLC, Mebane, NC 27302 USA.	laurens.howle@duke.edu	Denoble, Petar/AAU-5109-2021; Howle, Laurens/AAJ-2238-2021	Denoble, Petar/0000-0002-6770-8674; Howle, Laurens/0000-0002-1495-2788	Naval Sea Systems Command [NAVSEA-00C, N61331-06-C-0014, N00024-13-C-4104]; National Defense Science & Engineering Graduate Fellowship	Naval Sea Systems Command; National Defense Science & Engineering Graduate Fellowship	This work was supported by Naval Sea Systems Command (NAVSEA-00C - http://www.navsea.navy.mil/) under contracts #N61331-06-C-0014 and #N00024-13-C-4104. BelleQuant Engineering, PLLC provided computational resources. Neither the funding agency nor the commercial entity played any role in designing this study, data collection and analysis, decision to publish, interpreting the results, or writing the manuscript. BelleQuant Engineering, PLLC did not provide salary support to any author. The funding agency provided salary support to LH and RV. PW received salary support for a National Defense Science & Engineering Graduate Fellowship. The specific roles of the authors are articulated in the 'author contributions section.	[Anonymous], 1969, RANDOM HOUSE DICT EN; [Anonymous], 2008, US NAVY DIVING MANUA; BERGHAGE T E, 1974, Undersea Biomedical Research, V1, P189; Blatteau JE, 2005, SCI SPORT, V20, P119, DOI 10.1016/j.scispo.2005.04.001; Boycott AE, 1908, J HYG-CAMBRIDGE, V8, P342, DOI 10.1017/S0022172400003399; Cantais E, 2003, CRIT CARE MED, V31, P84, DOI 10.1097/00003246-200301000-00013; Francis TJR, 1991, DESCRIBING DECOMPRES; Howle LE, 2013, COMPUT BIOL MED, V43, P1739, DOI 10.1016/j.compbiomed.2013.07.026; Howle LE, 2009, COMPUT BIOL MED, V39, P1117, DOI 10.1016/j.compbiomed.2009.09.006; Howle LE, 2009, J APPL PHYSIOL, V107, P1539, DOI 10.1152/japplphysiol.00185.2009; Lang MA, 1992, P REP DIV WORKSH AM; Lowrance WW, 1976, J ELECTROCHEMICAL SO, DOI DOI 10.1149/1.2132690; McKimmon RC., 2000, CAUSE EFFECT CONTROL; MOON RE, 1995, SCI AM, V273, P70, DOI 10.1038/scientificamerican0895-70; Operational Risk Management (ORM), 3500 ORM; Ozyigit T, 2010, AVIAT SPACE ENVIR MD, V81, P3, DOI 10.3357/ASEM.2495.2010; Parker E.C., 1992, 9273 NMRI; Parker EC, 1998, J APPL PHYSIOL, V84, P1096, DOI 10.1152/jappl.1998.84.3.1096; Shields TG, 1986, 9322147 OTO R GORD I; Stein J, 1969, RANDOM HOUSE DICT EN; Temple DJ, 1999, 9902 NMRC DEP NAV, VII; Temple DJ, 1999, 9902 NMRC DEP NAV, VI; Thalmann ED, 1997, UNDERSEA HYPERBAR M, V24, P255; Van Liew HD, 2005, UNDERSEA HYPERBAR M, V32, P187; Vann RD, 2005, REPORT DECOMPRESSION; Vann RD, 2009, AVIAT SPACE ENVIR MD, V80, P466, DOI 10.3357/ASEM.2471.2009; Weathersby P. K., 2002, 51 WORKSH UND HYP ME; WEATHERSBY PK, 1992, J APPL PHYSIOL, V72, P1541, DOI 10.1152/jappl.1992.72.4.1541; WEATHERSBY PK, 1984, J APPL PHYSIOL, V57, P815, DOI 10.1152/jappl.1984.57.3.815; Weathersby PK, 1992, 9285 NMRI	30	9	10	1	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 15	2017	12	3							e0172665	10.1371/journal.pone.0172665	http://dx.doi.org/10.1371/journal.pone.0172665			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN9HQ	28296928	Green Published, gold, Green Submitted			2022-12-27	WOS:000396311700012
J	Ng, CG; Mohamed, S; Kaur, K; Sulaiman, AH; Zainal, NZ; Taib, NA				Ng, Chong Guan; Mohamed, Salina; Kaur, Kiran; Sulaiman, Ahmad Hatim; Zainal, Nor Zuraida; Taib, Nur Aishah		MyBCC Study Grp	Perceived distress and its association with depression and anxiety in breast cancer patients	PLOS ONE			English	Article							QUALITY-OF-LIFE; PSYCHOLOGICAL DISTRESS; 1ST YEAR; WOMEN; DIAGNOSIS; SURGERY; STRESS; PREVALENCE; MORTALITY; SYMPTOMS	Background Breast cancer patients often experience a high level of distress. Psychological distress is a broad construct encompass both depression and anxiety. Previous studies in examining which of these psychological symptoms (either anxiety or depression) were more significantly associated with the distress level in breast cancer patients is lacking. This study aims to compare the level of depression and anxiety between patients with different level of distress. The correlation between the changes in distress level with depression or anxiety over 12 months was also examined. Methods This study is from the MyBCC cohort study. Two hundred and twenty one female breast cancer patients were included into the study. They were assessed at the time of diagnosis, 6 months and 12 month using Hospital Anxiety and Depression Scale (HADS) and distress thermometer. The information on age, ethnicity, treatment types and staging of cancer were collected. Results 50.2%, 51.6% and 40.3% of patients had perceived high level of distress at baseline, 6 months and 1 year after diagnosis. Those with high perceived level of distress had significant higher anxiety scores even after adjusted for the underlying depressive scores (Adjusted OR at baseline = 1.28, 95% CI = 1.13-1.44; adjusted OR at 6 months = 1.27, 95% CI = 1.11-1.45; adjusted OR at 12 months = 1.51, 95% CI = 1.29-1.76). There were no significant differences in the depressive scores between the subjects with either low or high distress level. There was reduction in perceived level of distress, anxiety and depression scores at 12 months after the diagnosis. The decrease of distress was positively correlated with the reduction of anxiety scores but not the changes of depressive scores (r' = 0.25). Conclusion Anxiety is a more significant psychological state that contributed to the feeling of distress in breast cancer as compared with depression. Levels of anxiety at diagnosis in this study would justify screening for anxiety, early identification and therapy for maintaining the psychological well-being of breast cancer patients. Further studies will be needed to measure the effectiveness of therapeutic interventions.	[Ng, Chong Guan; Sulaiman, Ahmad Hatim; Zainal, Nor Zuraida] Univ Malaya, Med Ctr, Dept Psychol Med, Kuala Lumpur, Malaysia; [Mohamed, Salina] Univ Teknol MARA, Fac Med, Dept Psychiat, Kuala Lumpur, Malaysia; [Kaur, Kiran; Taib, Nur Aishah] Univ Malaya, Med Ctr, Dept Surg, Kuala Lumpur, Malaysia	Universiti Malaya; Universiti Teknologi MARA; Universiti Malaya	Ng, CG (corresponding author), Univ Malaya, Med Ctr, Dept Psychol Med, Kuala Lumpur, Malaysia.	chong_guan@um.edu.my	ZAINAL, NOR ZURAIDA/B-9329-2010; SULAIMAN, AHMAD HATIM/B-8156-2010; Taib, Nur Aishah Mohd/B-2370-2010; Ng, Chong Guan/G-6170-2010; Kiran, Kaur/B-8793-2010	SULAIMAN, AHMAD HATIM/0000-0002-8364-4594; Taib, Nur Aishah Mohd/0000-0001-8419-0478; Kiran, Kaur/0000-0003-3021-2576	HIR grant from the Ministry of Higher Education of Malaysia [UM.C/HIR/MOHE/06]; UM [UM-QUB3C-2011]; University Malaya [RP046A- 15HTM]; Queen's University Belfast [UM-QUB3C-2011]	HIR grant from the Ministry of Higher Education of Malaysia; UM; University Malaya(Universiti Malaya); Queen's University Belfast	This study was supported by the HIR grant (HIR Grant UM.C/HIR/MOHE/06) from the Ministry of Higher Education of Malaysia and joint grant from UM and Queen's University Belfast (UM-QUB3C-2011). This study was also supported in part by the University Malaya Research Grant (RP046A- 15HTM) from the University Malaya, for the Promotion of Health Science. The grantors were not involved in the study design, subject enrolment, study analysis or interpretation or decision to submit this manuscript.	[Anonymous], 2003, J NATL COMPR CANC NE, V1, P344, DOI [DOI 10.6004/JNCCN.2003.0031, 10.6004/jnccn.2003.0031]; Badger TA, 2004, RES NURS HEALTH, V27, P19, DOI 10.1002/nur.20002; Bailey RK, 2005, INT J GYNECOL CANCER, V15, P203, DOI 10.1111/j.1525-1438.2005.15204.x; Barlow DH, 2000, AM PSYCHOL, V55, P1247, DOI 10.1037/0003-066X.55.11.1247; Burgess C, 2005, BRIT MED J, V330, P702, DOI 10.1136/bmj.38343.670868.D3; BURGESS C, 1988, J PSYCHOSOM RES, V32, P263, DOI 10.1016/0022-3999(88)90067-0; CARLSON LE, 2010, SCREENING DEPRESSION, P265; Carlson Linda E, 2003, Health Qual Life Outcomes, V1, P8, DOI 10.1186/1477-7525-1-8; Colleoni M, 2000, LANCET, V356, P1326, DOI 10.1016/S0140-6736(00)02821-X; DEROGATIS LR, 1983, PSYCHOL MED, V13, P595, DOI 10.1017/S0033291700048017; Donovan KA, 2014, PSYCHO-ONCOLOGY, V23, P241, DOI 10.1002/pon.3430; Fallowfield L, 2001, BRIT J CANCER, V84, P1011, DOI 10.1054/bjoc.2001.1724; Golden-Kreutz DM, 2004, PSYCHO-ONCOLOGY, V13, P211, DOI 10.1002/pon.736; Hall A, 1999, EUR J CANCER, V35, P79, DOI 10.1016/S0959-8049(98)00308-6; Hirschfeld Robert M. A., 2001, Prim Care Companion J Clin Psychiatry, V3, P244; Islam T, 2015, BMJ OPEN, V5, DOI 10.1136/bmjopen-2015-008643; Iwamitsu Y, 2005, PSYCHOSOMATICS, V46, P19, DOI 10.1176/appi.psy.46.1.19; Jacobsen PB, 2007, J CLIN ONCOL, V25, P4526, DOI 10.1200/JCO.2007.13.1367; Jemal A, 2008, CA-CANCER J CLIN, V58, P71, DOI 10.3322/CA.2007.0010; Kirsh Kenneth L, 2004, Palliat Support Care, V2, P33; Liao MN, 2008, CANCER NURS, V31, P274, DOI 10.1097/01.NCC.0000305744.64452.fe; Linden W, 2012, J AFFECT DISORDERS, V141, P343, DOI 10.1016/j.jad.2012.03.025; MAGUIRE GP, 1978, BMJ-BRIT MED J, V1, P963, DOI 10.1136/bmj.1.6118.963; Manne SL, 2006, PSYCHO-ONCOL, V15, P234, DOI 10.1002/pon.941; Massie Mary Jane, 2004, J Natl Cancer Inst Monogr, P57; McGregor BA, 2009, BRAIN BEHAV IMMUN, V23, P159, DOI 10.1016/j.bbi.2008.08.002; Millar K, 2005, J PSYCHOSOM RES, V58, P335, DOI 10.1016/j.jpsychores.2004.10.005; Mols F, 2013, J CANCER SURVIV, V7, P484, DOI 10.1007/s11764-013-0286-6; Montgomery GH, 2003, J BEHAV MED, V26, P153, DOI 10.1023/A:1023034706298; National Comprehensive Cancer Network, 2013, J NATL COMPR CANC NE, V1, P344; Pandey M, 2007, PSYCHO-ONCOL, V16, P582, DOI 10.1002/pon.1123; Pasquini Massimo, 2007, Clin Pract Epidemiol Ment Health, V3, P2, DOI 10.1186/1745-0179-3-2; Pirl William F, 2004, J Natl Cancer Inst Monogr, P32; Reich M, 2008, BREAST CANCER RES TR, V110, P9, DOI 10.1007/s10549-007-9706-5; Saboonchi F, 2014, EUR J ONCOL NURS, V18, P598, DOI 10.1016/j.ejon.2014.06.007; Satin JR, 2009, CANCER-AM CANCER SOC, V115, P5349, DOI 10.1002/cncr.24561; Shapiro SL, 2001, J CLIN PSYCHOL, V57, P501, DOI 10.1002/jclp.1026; Stark DPH, 2000, BRIT J CANCER, V83, P1261, DOI 10.1054/bjoc.2000.1405; von Heymann-Horan AB, 2013, ACTA ONCOL, V52, P382, DOI 10.3109/0284186X.2012.746468; Voogt E, 2005, PSYCHO-ONCOLOGY, V14, P262, DOI 10.1002/pon.842; Voorwinden J S, 2015, J CLIN ONCOL, V31, P2724; Walker LG, 1999, EUR J CANCER, V35, P1783, DOI 10.1016/S0959-8049(99)00169-0; Yen JY, 2006, PSYCHIAT CLIN NEUROS, V60, P147, DOI 10.1111/j.1440-1819.2006.01479.x; Yusoff N, 2011, ASIAN PAC J CANCER P, V12, P915; Zabora J, 2001, PSYCHO-ONCOL, V10, P19, DOI 10.1002/1099-1611(200101/02)10:1<19::AID-PON501>3.3.CO;2-Y; ZIGMOND AS, 1983, ACTA PSYCHIAT SCAND, V67, P361, DOI 10.1111/j.1600-0447.1983.tb09716.x	46	66	69	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 15	2017	12	3							e0172975	10.1371/journal.pone.0172975	http://dx.doi.org/10.1371/journal.pone.0172975			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EN9HQ	28296921	Green Published, Green Submitted, gold			2022-12-27	WOS:000396311700019
J	Tripathi, P; Behera, MD; Roy, PS				Tripathi, Poonam; Behera, Mukund Dev; Roy, Partha Sarathi			Optimized grid representation of plant species richness in India-Utility of an existing national database in integrated ecological analysis	PLOS ONE			English	Article							BIODIVERSITY INVENTORIES; MONSOON RAINFALL; WINTER MONSOON; BIAS; COMPLETENESS; PERFORMANCE; ESTIMATORS; DIVERSITY	Data on the distribution of plant species at spatial (grid) scales are required as input for integrative analysis along with related climate, environment, topography and soil data. Although the world's scientific community is increasingly generating data on plant species at various spatial grids and statistically interpolating and extrapolating the available information, data on plant diversity from the Asian continent are scant. Such data are unavailable for India, the mainland of which has part of three of the world's 36 biodiversity hotspots. Although sufficient field sampling is always impossible and impractical, it is essential to utilize fully any available database by adjudging the sampling sufficiency at a given scale. In this work, we used an exhaustive database of the plant species of the Indian mainland that was sufficient in terms of sampling vegetation types. We transformed the data, obtained the distribution at the 1 and 2 spatial grid levels and evaluated the sampling sufficiency at acceptable threshold limits (60% to 80%). The greatest species richness values recorded in the 0.04 ha quadrant, 1 degrees grid and 2 degrees grid were 59, 623 and 1244, respectively. Clench model was significantly (p value < 0.001) fitted using the plant species data at both the grid levels with a very high coefficient of determination (>0.95). At an acceptable threshold limit of 70%, almost all the grids at the 2 level and more than 80% of the grids at the 1 level were found to be sufficiently sampled. Sampling sufficiency was observed to be highly scale-dependent as a greater number of 2 grids attained asymptotic behaviour following the species area curve. Grid-level sampling insufficiency was attributed to lower numbers of sampling quadrats in forests with poor approachability, which coincided with the world biodiversity hotspots', suggesting that additional sampling was required. We prescribe the use of the 1 degrees and 2 degrees spatial grids with sufficient sampling for any ecological analysis in conjunction with other data and thereby offer grid-level plant species richness data for the Indian mainland for the first time.	[Tripathi, Poonam; Behera, Mukund Dev] Indian Inst Technol Kharagpur, Ctr Oceans Rivers Atmosphere & Land Sci CORAL, Kharagpur, W Bengal, India; [Roy, Partha Sarathi] Univ Hyderabad, Ctr Earth & Space Sci, Hyderabad, Andhra Pradesh, India	Indian Institute of Technology System (IIT System); Indian Institute of Technology (IIT) - Kharagpur; University of Hyderabad	Tripathi, P (corresponding author), Indian Inst Technol Kharagpur, Ctr Oceans Rivers Atmosphere & Land Sci CORAL, Kharagpur, W Bengal, India.	tripathy.poonam@gmail.com	Roy, Parth Sarathi/O-8586-2019	Roy, Parth Sarathi/0000-0002-6803-6785; Behera, Mukunda/0000-0002-9976-6270; tripathi, poonam/0000-0003-1534-4650				Gomez-Anaya JA, 2014, REV MEX BIODIVERS, V85, P218, DOI 10.7550/rmb.36978; CHAO A, 1984, SCAND J STAT, V11, P265; Colwell RK, 2004, ECOLOGY, V85, P2717, DOI 10.1890/03-0557; COLWELL RK, 1994, PHILOS T R SOC B, V345, P101, DOI 10.1098/rstb.1994.0091; Diaz-Frances E, 2005, CONSERV BIOL, V19, P569, DOI 10.1111/j.1523-1739.2005.00453.x; Dimri AP, 2014, CLIM DYNAM, V42, P1793, DOI 10.1007/s00382-013-1797-6; Dimri AP, 2013, INT J CLIMATOL, V33, P2185, DOI 10.1002/joc.3584; Gaston KJ, 2000, NATURE, V405, P220, DOI 10.1038/35012228; Gaston KJ, 2000, PATTERN PROCESS MACR; Gotelli Nicholas J., 2011, P39; Hortal J, 2006, J ANIM ECOL, V75, P274, DOI 10.1111/j.1365-2656.2006.01048.x; Hortal J, 2005, BIODIVERS CONSERV, V14, P2913, DOI 10.1007/s10531-004-0224-z; Sanchez-Reyes UJ, 2014, ZOOKEYS, P103, DOI 10.3897/zookeys.417.7551; Jimenez-Valverde A, 2006, BIODIVERS CONSERV, V15, P177, DOI 10.1007/s10531-004-5016-y; Jimenez-Valverde A, 2008, DIVERS DISTRIB, V14, P885, DOI 10.1111/j.1472-4642.2008.00496.x; KODRICBROWN A, 1993, ECOL APPL, V3, P736, DOI 10.2307/1942104; Kripalani RH, 2003, THEOR APPL CLIMATOL, V74, P1, DOI 10.1007/s00704-002-0699-z; Kumar P, 2007, CLIM DYNAM, V28, P649, DOI [10.1007/s00382-006-0210-0, 10.1007/S00382-006-0210-0]; Lawton JH, 1998, NATURE, V391, P72, DOI 10.1038/34166; Lobo JM, 2008, BIODIVERS CONSERV, V17, P873, DOI 10.1007/s10531-008-9333-4; Longino JT, 2002, ECOLOGY, V83, P689, DOI 10.1890/0012-9658(2002)083[0689:TAFOAT]2.0.CO;2; Mora C, 2008, P ROY SOC B-BIOL SCI, V275, P149, DOI 10.1098/rspb.2007.1315; Moreno CE, 2000, J APPL ECOL, V37, P149, DOI 10.1046/j.1365-2664.2000.00483.x; Myers N, 2000, NATURE, V403, P853, DOI 10.1038/35002501; Pardo I, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0052786; Reddy S, 2003, J BIOGEOGR, V30, P1719, DOI 10.1046/j.1365-2699.2003.00946.x; Rodgers W.A., 1988, PLANNING WILDLIFE PR; Roy PS, 2015, INT J APPL EARTH OBS, V39, P142, DOI 10.1016/j.jag.2015.03.003; Roy P.S, 2012, BIODIVERSITY CHARACT; Sanchez-Fernandez D, 2008, DIVERS DISTRIB, V14, P754, DOI 10.1111/j.1472-4642.2008.00474.x; Simova I, 2013, J ECOL, V101, P161, DOI 10.1111/1365-2745.12011; SMITH EP, 1984, BIOMETRICS, V40, P119, DOI 10.2307/2530750; SOBERON J, 1993, CONSERV BIOL, V7, P480, DOI 10.1046/j.1523-1739.1993.07030480.x; Ulrich W, 2010, OIKOS, V119, P1149, DOI 10.1111/j.1600-0706.2009.18236.x; Walther BA, 2005, ECOGRAPHY, V28, P815, DOI 10.1111/j.2005.0906-7590.04112.x; Wei SG, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0095890; Williams PH, 2002, J BIOSCIENCES, V27, P327, DOI 10.1007/BF02704963; Yoccoz NG, 2001, TRENDS ECOL EVOL, V16, P446, DOI 10.1016/S0169-5347(01)02205-4	38	11	11	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 15	2017	12	3							e0173774	10.1371/journal.pone.0173774	http://dx.doi.org/10.1371/journal.pone.0173774			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN9HQ	28296954	gold, Green Submitted, Green Published			2022-12-27	WOS:000396311700061
J	Royall, DR; Al-Rubaye, S; Bishnoi, R; Palmer, RF				Royall, Donald R.; Al-Rubaye, Safa; Bishnoi, Ram; Palmer, Raymond F.			Few serum proteins mediate APOE's association with dementia	PLOS ONE			English	Article							C-REACTIVE PROTEIN; DEFAULT MODE NETWORK; ALZHEIMERS-DISEASE; APOLIPOPROTEIN-E; COGNITIVE DECLINE; MISSING DATA; BRAIN; BIOMARKERS; GENOTYPE; RISK	The latent variable "delta"(for "dementia ") appears to be uniquely responsible for the dementing aspects of cognitive impairment. Age, depression, gender and the apolipoprotein E (APOE) e4 allele are independently associated with delta. In this analysis, we explore serum proteins as potential mediators of APOE's specific association with delta in a large, ethnically diverse longitudinal cohort, the Texas Alzheimer's Research and Care Consortium (TARCC). APOE was associated only with C-Reactive Protein (CRP), Adiponectin (APN) and Amphiregulin (AREG), although the latter two's associations did not survive Bonferroni correction for multiple comparisons. All three proteins were associated with delta and had weak potential mediation effects on APOE's association with that construct. Our findings suggest that APOE's association with cognitive performance is specific to delta and partially mediated by serum inflammatory proteins. The majority of APOE's significant unadjusted effect on delta is unexplained. It may instead arise from direct central nervous system effects, possibly on native intelligence. If so, then APOE may exert a life-long influence over delta and therefore all-cause dementia risk.	[Royall, Donald R.; Al-Rubaye, Safa] Univ Texas Hlth Sci Ctr San Antonio, Dept Psychiat, San Antonio, TX 78229 USA; [Royall, Donald R.] Univ Texas Hlth Sci Ctr San Antonio, Dept Med, San Antonio, TX 78229 USA; [Royall, Donald R.; Palmer, Raymond F.] Univ Texas Hlth Sci Ctr San Antonio, Dept Family & Community Med, San Antonio, TX 78229 USA; [Royall, Donald R.] Res Educ & Clin Care Ctr, S Texas Vet Hlth Syst Audie L Murphy Div, San Antonio, TX USA; [Royall, Donald R.] South Texas Vet Hlth Syst Audie L Murphy Div Geri, San Antonio, TX USA; [Bishnoi, Ram] Med Coll Georgia, Dept Psychiat, Augusta, GA 30912 USA	University of Texas System; University of Texas Health San Antonio; University of Texas System; University of Texas Health San Antonio; University of Texas System; University of Texas Health San Antonio; University System of Georgia; Augusta University	Royall, DR (corresponding author), Univ Texas Hlth Sci Ctr San Antonio, Dept Psychiat, San Antonio, TX 78229 USA.; Royall, DR (corresponding author), Univ Texas Hlth Sci Ctr San Antonio, Dept Med, San Antonio, TX 78229 USA.; Royall, DR (corresponding author), Univ Texas Hlth Sci Ctr San Antonio, Dept Family & Community Med, San Antonio, TX 78229 USA.; Royall, DR (corresponding author), Res Educ & Clin Care Ctr, S Texas Vet Hlth Syst Audie L Murphy Div, San Antonio, TX USA.; Royall, DR (corresponding author), South Texas Vet Hlth Syst Audie L Murphy Div Geri, San Antonio, TX USA.	royall@uthscsa.edu	Bishnoi, Ram/P-4019-2014	Bishnoi, Ram/0000-0002-5202-5117	state of Texas through the Texas Council on Alzheimer's Disease and Related Disorders	state of Texas through the Texas Council on Alzheimer's Disease and Related Disorders	This study was made possible by the Texas Alzheimer's Research Consortium (TARCC) funded by the state of Texas through the Texas Council on Alzheimer's Disease and Related Disorders. The TARCC funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arbuckle JL, 2006, ANAL MOMENT STRUCTUR; Austin MA, 2004, ANN HUM GENET, V68, P179, DOI 10.1046/j.1529-8817.2004.00078.x; BENTLER PM, 1990, PSYCHOL BULL, V107, P238, DOI 10.1037/0033-2909.88.3.588; Benton AL., 1983, MULTILINGUAL APHASIA; Bishnoi RJ, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0117282; Bishnoi RJ, 2015, J ALZHEIMERS DIS, V43, P37, DOI 10.3233/JAD-140042; Bollen K. A., 1993, TESTING STRUCTURAL E; Browne M.W., 1992, SOCIOL METHOD RES, V21, P230, DOI 10.1177/0049124192021002005; Buckner RL, 2009, J NEUROSCI, V29, P1860, DOI 10.1523/JNEUROSCI.5062-08.2009; Calderon-Garciduenas L, 2015, J ALZHEIMERS DIS, V45, P757, DOI 10.3233/JAD-142685; Carlson JOE, 2015, J NEUROPATH EXP NEUR, V74, P1061, DOI 10.1097/NEN.0000000000000251; Chetelat G, 2013, REV NEUROL-FRANCE, V169, P729, DOI 10.1016/j.neurol.2013.07.025; Chu AY, 2012, CIRC-CARDIOVASC GENE, V5, P58, DOI 10.1161/CIRCGENETICS.111.961847; Czarees A, 1994, NIDA RES MONOGR, V139, P137; Davies G, 2015, MOL PSYCHIATR, V20, P183, DOI 10.1038/mp.2014.188; Falk A, 2002, J NEUROSCI RES, V69, P757, DOI 10.1002/jnr.10410; Gavett BE, 2016, J ALZHEIMERS DIS, V49, P531, DOI 10.3233/JAD-150252; Gavett BE, 2015, NEUROPSYCHOLOGY, V29, P344, DOI 10.1037/neu0000128; Graham JW, 2009, ANNU REV PSYCHOL, V60, P549, DOI 10.1146/annurev.psych.58.110405.085530; Grice JW, 2001, PSYCHOL METHODS, V6, P430, DOI 10.1037//1082-989X.6.4.430; Haan MN, 2008, NEUROBIOL AGING, V29, P1774, DOI 10.1016/j.neurobiolaging.2007.04.020; Hubacek JA, 2010, HUM IMMUNOL, V71, P304, DOI 10.1016/j.humimm.2010.01.008; HUGHES CP, 1982, BRIT J PSYCHIAT, V140, P566, DOI 10.1192/bjp.140.6.566; Khachaturian AS, 2004, ARCH GEN PSYCHIAT, V61, P518, DOI 10.1001/archpsyc.61.5.518; Kleiman T, 2006, DEMENT GERIATR COGN, V22, P73, DOI 10.1159/000093316; Koch W, 2002, CLIN CHEM LAB MED, V40, P1123, DOI 10.1515/CCLM.2002.197; Kraemer HC, 2001, AM J PSYCHIAT, V158, P848, DOI 10.1176/appi.ajp.158.6.848; LAWTON MP, 1969, GERONTOLOGIST, V9, P179, DOI 10.1093/geront/9.3_Part_1.179; Lima TAS, 2014, AGE AGEING, V43, P289, DOI 10.1093/ageing/aft193; Lyall DM, 2014, TRANSL PSYCHIAT, V4, DOI 10.1038/tp.2014.89; Metti AL, 2014, NEUROBIOL AGING, V35, P2785, DOI 10.1016/j.neurobiolaging.2014.05.030; METZ CE, 1978, SEMIN NUCL MED, V8, P283, DOI 10.1016/S0001-2998(78)80014-2; Morgan AR, 2016, J ALZHEIMER IN PRESS; Novak U, 2001, J CLIN NEUROSCI, V8, P106, DOI 10.1054/jocn.2000.0799; Palmer RF, 2016, J ALZHEIMERS DIS, V49, P521, DOI 10.3233/JAD-150254; Palmer RF, 2010, J AM GERIATR SOC, V58, pS343, DOI 10.1111/j.1532-5415.2010.03053.x; Royall Donald R, 2016, Alzheimers Dement (Amst), V3, P35, DOI 10.1016/j.dadm.2016.02.003; Royall DR, 2015, J ALZHEIMERS DIS, V43, P275, DOI 10.3233/JAD-140264; Royall DR, 2012, J ALZHEIMERS DIS, V32, P467, DOI 10.3233/JAD-2012-120424; Royall DR, J PREVENTION ALZHEIM; Schafer JL, 2002, PSYCHOL METHODS, V7, P147, DOI 10.1037//1082-989X.7.2.147; Sharma M, 2016, J AM GERIATR SOC, V64, P1171, DOI 10.1111/jgs.14140; Shi J, 2014, J ALZHEIMERS DIS, V38, P1, DOI 10.3233/JAD-130623; Song HQ, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0133179; Spearman C, 1951, HUMAN ABILITY; SPSS Inc, 2009, PASW STAT WIND VERS; Su YY, 2015, MEDICINE, V94, DOI 10.1097/MD.0000000000001734; Tucker-Drob EM, 2014, PSYCHOL AGING, V29, P236, DOI 10.1037/a0036187; US Food and Drug Administration, 2012, FDA DRUG SAF COMM IM; Waring S., 2008, TEX PUBLIC HLTH J, V60, P9; Wechsler D., 1997, WECHSLER MEMORY SCAL, Vthird; Wheaton B, 1977, SOCIOLOGY METHODOLOG; Wolters FJ, 2016, NEUROSCI LETT, V617, P139, DOI 10.1016/j.neulet.2016.02.018; Yeo RA, 2011, CURR ALZHEIMER RES, V8, P345; ZWEIG MH, 1993, CLIN CHEM, V39, P561	55	12	12	2	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 14	2017	12	3							e0172268	10.1371/journal.pone.0172268	http://dx.doi.org/10.1371/journal.pone.0172268			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EN6DM	28291794	Green Published, gold, Green Submitted			2022-12-27	WOS:000396094700004
J	Maier, IL; Behme, D; Schnieder, M; Tsogkas, I; Schregel, K; Bahr, M; Knauth, M; Liman, J; Psychogios, MN				Maier, Ilko L.; Behme, Daniel; Schnieder, Marlena; Tsogkas, Ioannis; Schregel, Katharina; Baehr, Mathias; Knauth, Michael; Liman, Jan; Psychogios, Marios-Nikos			Early computed tomography-based scores to predict decompressive hemicraniectomy after endovascular therapy in acute ischemic stroke	PLOS ONE			English	Article							MIDDLE CEREBRAL-ARTERY; CT PERFUSION; ALBERTA STROKE; INFARCTION; THROMBECTOMY; METAANALYSIS; MANAGEMENT; OCCLUSION; TRIALS; MAPS	Background Identification of patients requiring decompressive hemicraniectomy (DH) after endovascular therapy (EVT) is crucial as clinical signs are not reliable and early DH has been shown to improve clinical outcome. The aim of our study was to identify imaging-based scores to predict the risk for space occupying ischemic stroke and DH. Methods Prospectively derived data from patients with acute large artery occlusion within the anterior circulation and EVT was analyzed in this monocentric study. Predictive value of non-contrast cranial computed tomography (ncCT) and cerebral blood volume (CBV) Alberta Stroke Program Early CT score (ASPECTS) were investigated for DH using logistic regression models and Receiver Operating Characteristic Curve analysis. Results From 218 patients with EVT, DH was performed in 20 patients (9.2%). Baseline- (7 vs. 9; p = 0.009) and follow-up ncCT ASPECTS (1 vs. 7, p< 0.001) as well as baseline CBV ASPECTS (5 vs. 7, p< 0.001) were significantly lower in patients with DH. ncCT (baseline: OR 0.71, p = 0.018; follow-up: OR 0.32, p = < 0.001) and CBV ASPECTS (OR 0.63, p = 0.008) predicted DH. Cut-off ncCT-ASPECTS on baseline was 7-, ncCT- ASPECTS on follow-up was 4- and CBV ASPECTS on baseline was 5 points. Conclusions ASPECTS could be useful to early identify patients requiring DH after EVT for acute large vessel occlusion.	[Maier, Ilko L.; Schnieder, Marlena; Baehr, Mathias; Liman, Jan] Univ Med Ctr Goettingen, Dept Neurol, Gottingen, Germany; [Behme, Daniel; Tsogkas, Ioannis; Schregel, Katharina; Knauth, Michael; Psychogios, Marios-Nikos] Univ Med Ctr Goettingen, Dept Neuroradiol, Gottingen, Germany	University of Gottingen; University of Gottingen	Maier, IL (corresponding author), Univ Med Ctr Goettingen, Dept Neurol, Gottingen, Germany.	ilko.maier@med.uni-goettingen.de	Behme, Daniel/H-4551-2019; Mingmei, Zhao/N-7178-2014	Mingmei, Zhao/0000-0002-0047-5220	German Research Foundation; Gottingen University	German Research Foundation(German Research Foundation (DFG)); Gottingen University	The authors acknowledge support by the German Research Foundation and the Open Access Publication Funds of the Gottingen University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barber PA, 2000, LANCET, V355, P1670, DOI 10.1016/S0140-6736(00)02237-6; Berkhemer OA, 2015, NEW ENGL J MED, V372, P11, DOI 10.1056/NEJMoa1411587; Campbell BCV, 2015, NEW ENGL J MED, V372, P1009, DOI 10.1056/NEJMoa1414792; Eames PJ, 2002, J NEUROL NEUROSUR PS, V72, P467; Fahmi F, 2012, AM J NEURORADIOL, V33, P2074, DOI 10.3174/ajnr.A3110; Geuskens RREG, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0141571; Goyal M, 2015, NEW ENGL J MED, V372, P1019, DOI 10.1056/NEJMoa1414905; Goyal M, 2016, LANCET, V387, P1723, DOI 10.1016/S0140-6736(16)00163-X; Grotta J, 1997, STROKE, V28, P2338, DOI 10.1161/01.STR.28.12.2338; Jovin TG, 2015, NEW ENGL J MED, V372, P2296, DOI 10.1056/NEJMoa1503780; Jovin TG, 2003, STROKE, V34, P2426, DOI 10.1161/01.STR.0000091232.81947.C9; Kasner SE, 2001, STROKE, V32, P2117, DOI 10.1161/hs0901.095719; Krieger DW, 1999, STROKE, V30, P287, DOI 10.1161/01.STR.30.2.287; Kudo K, 2010, RADIOLOGY, V254, P200, DOI 10.1148/radiol.254082000; Leyhe J. R., 2016, J NEUROINTERV SURG; MacCallum C, 2014, CEREBROVASC DIS, V38, P39, DOI 10.1159/000363619; Mori K, 2004, SURG NEUROL, V62, P420, DOI 10.1016/j.surneu.2003.12.017; Pexman JHW, 2001, AM J NEURORADIOL, V22, P1534; Qureshi AI, 2003, CRIT CARE MED, V31, P272, DOI 10.1097/00003246-200301000-00043; Saver JL, 2016, JAMA-J AM MED ASSOC, V316, P1279, DOI 10.1001/jama.2016.13647; Saver JL, 2015, NEW ENGL J MED, V372, P2285, DOI 10.1056/NEJMoa1415061; Schregel K, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0169192; Schwab S, 1998, STROKE, V29, P1888, DOI 10.1161/01.STR.29.9.1888; Sporns PB, 2015, CLIN NEURORADIOL; Treadwell SD, 2010, POSTGRAD MED J, V86, P235, DOI 10.1136/pgmj.2009.094292; Tsogkas I, 2016, EUR RADIOL, V26, P4213, DOI 10.1007/s00330-016-4257-y; Vagal A, 2016, STROKE, V47, P535, DOI 10.1161/STROKEAHA.115.011461; Vahedi K, 2007, LANCET NEUROL, V6, P215, DOI 10.1016/S1474-4422(07)70036-4; VONKUMMER R, 1994, AM J NEURORADIOL, V15, P9; Wijdicks EFM, 2004, CRIT CARE MED, V32, P2332, DOI 10.1097/01.CCM.0000145949.34618.E1; Zaidat OO, 2013, STROKE, V44, P2650, DOI 10.1161/STROKEAHA.113.001972	31	4	5	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 10	2017	12	3							e0173737	10.1371/journal.pone.0173737	http://dx.doi.org/10.1371/journal.pone.0173737			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN6CJ	28282456	Green Published, gold, Green Submitted			2022-12-27	WOS:000396091800075
J	Miles, M; Dung, KTK; Ha, LT; Liem, NT; Ha, K; Hunt, RW; Mulholland, K; Morgan, C; Russell, FM				Miles, Merinda; Khu Thi Khanh Dung; Le Thi Ha; Nguyen Thanh Liem; Khu Ha; Hunt, Rod W.; Mulholland, Kim; Morgan, Chris; Russell, Fiona M.			The cause-specific morbidity and mortality, and referral patterns of all neonates admitted to a tertiary referral hospital in the northern provinces of Vietnam over a one year period	PLOS ONE			English	Article							COMMUNITY-BASED TRIAL; QUANG NINH PROVINCE; DEATHS; INTERVENTIONS; INFECTIONS; PRIORITIES; OUTCOMES; AUDIT; UNIT	Objective To describe the cause-specific morbidity and mortality, and referral patterns of all neonates admitted to a tertiary referral hospital in the northern provinces of Vietnam. Design A prospective hospital based observational study. Setting The Neonatal Department, National Hospital of Pediatrics, Hanoi, Vietnam. Patients All admissions to the Neonatal Department over a 12 month period. Main outcome measures Cause-specific morbidity and mortality; deaths. Results There were 5064 admissions with the commonest discharge diagnoses being infection (32%) and prematurity (29%). The case fatality ratio (CFR) was 13.9% (n = 703). Infection (38%), cardio/respiratory disorders (27%), congenital abnormalities (20%) and neurological conditions (10%) were the main causes of death. Of all the deaths, 38% had an admissionweight >= 2500g. Higher CFR were associated with lower admission weights. Very few deaths (3%) occurred in the first 24 hours of life. Most referrals and deaths came from Hanoi and neighbouring provincial hospitals, with few from the most distant provinces. Two distant referral provinces had the highest CFR. Conclusions The CFR was high and few deaths occurred in neonates < 24 hours old. The high rates of infection call for an improvement in infection control practices and peripartum antibiotic use at provincial and tertiary level. Understanding provincial hospital capacity and referral pathways is crucial to improving the outcomes at tertiary centres. A quality of care audit tool would enable more targeted interventions and monitoring of health outcomes.	[Miles, Merinda] Monash Univ, Fac Med Nursing & Hlth Sci, Melbourne, Vic, Australia; [Khu Thi Khanh Dung; Le Thi Ha; Nguyen Thanh Liem; Khu Ha] Natl Hosp Pediat, Hanoi, Vietnam; [Hunt, Rod W.; Russell, Fiona M.] Royal Childrens Hosp, Murdoch Childrens Res Inst, Melbourne, Vic, Australia; [Hunt, Rod W.] Royal Childrens Hosp, Dept Neonatal Med, Melbourne, Vic, Australia; [Hunt, Rod W.; Russell, Fiona M.] Univ Melbourne, Dept Paediat, Ctr Int Child Hlth, Melbourne, Vic, Australia; [Mulholland, Kim] Menzies Sch Hlth Res, Darwin, NT, Australia; [Mulholland, Kim] London Sch Hyg & Trop Med, London, England; [Morgan, Chris] Burnet Inst, Ctr Int Hlth, Melbourne, Vic, Australia; [Morgan, Chris] Univ Melbourne, Melbourne Sch Populat & Global Hlth, Melbourne, Vic, Australia; [Morgan, Chris] Monash Univ, Sch Publ Hlth & Prevent Med, Melbourne, Vic, Australia	Monash University; Murdoch Children's Research Institute; Royal Children's Hospital Melbourne; Royal Children's Hospital Melbourne; University of Melbourne; Charles Darwin University; Menzies School of Health Research; University of London; London School of Hygiene & Tropical Medicine; Burnet Institute; University of Melbourne; Monash University	Russell, FM (corresponding author), Royal Childrens Hosp, Murdoch Childrens Res Inst, Melbourne, Vic, Australia.; Russell, FM (corresponding author), Univ Melbourne, Dept Paediat, Ctr Int Child Hlth, Melbourne, Vic, Australia.	fmruss@unimelb.edu.au	Morgan, Chris/L-1613-2019	Morgan, Chris/0000-0003-0931-5474; Russell, Fiona/0000-0002-3077-9639	National Health and Medical Research Council [1035863]	National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia)	Fiona Russell held a National Health and Medical Research Council Early in Career Fellowship 2012-2015 (1035863). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We would like to thank the staff of the Neonatal Department, NHP, Hanoi. Fiona Russell held a National Health and Medical Research Council Early in Career Fellowship 2012-2015 (1035863).	Ahmed Siham H, 2004, J Egypt Public Health Assoc, V79, P399; Almroth S, 2008, ACTA PAEDIATR, V97, P1066, DOI 10.1111/j.1651-2227.2008.00844.x; [Anonymous], 2015, ATT SPANK; Bhutta ZA, 2005, PEDIATRICS, V115, P519, DOI 10.1542/peds.2004-1441; Bhutta ZA, 2014, LANCET, V384, P347, DOI 10.1016/S0140-6736(14)60792-3; Darmstadt GL, 2014, LANCET, V384, P174, DOI 10.1016/S0140-6736(14)60458-X; Darmstadt GL, 2000, PEDIATR INFECT DIS J, V19, P739, DOI 10.1097/00006454-200008000-00014; Duke Trevor, 2000, Papua New Guinea Medical Journal, V43, P127; Ganatra HA, 2010, SEMIN PERINATOL, V34, P416, DOI 10.1053/j.semperi.2010.09.004; General Statistics Office of Viet Nam, 2012, POP EMPL; Graner S, 2010, PAEDIATR PERINAT EP, V24, P535, DOI 10.1111/j.1365-3016.2010.01135.x; Hogan D., 2015, LANCET, V385, P430, DOI DOI 10.1016/S0140-6736(14)61698-6; Jimmy Stella, 2003, Papua New Guinea Medical Journal, V46, P8; Kerber KJ, 2007, LANCET, V370, P1358, DOI 10.1016/S0140-6736(07)61578-5; Kruse AY, 2014, ACTA PAEDIATR, V103, P139, DOI 10.1111/apa.12423; Kruse AY, 2012, BMC PEDIATR, V12, DOI 10.1186/1471-2431-12-199; Lawn JE, 2014, LANCET, V384, P189, DOI 10.1016/S0140-6736(14)60496-7; Lawn JE, 2010, SEMIN PERINATOL, V34, P371, DOI 10.1053/j.semperi.2010.09.011; Malqvist Mats, 2008, BMC Int Health Hum Rights, V8, P4, DOI 10.1186/1472-698X-8-4; March of Dimes PMNCH Save the Children WHO, 2012, BORN TOO SOON GLOBAL; Mmbaga BT, 2012, BMC PEDIATR, V12, DOI 10.1186/1471-2431-12-116; Mukhtar-Yola M, 2007, TROP DOCT, V37, P130, DOI 10.1258/004947507781524683; Neogi SB, 2011, J HEALTH POPUL NUTR, V29, P500; Nga NT, 2012, ACTA PAEDIATR, V101, P368, DOI 10.1111/j.1651-2227.2011.02513.x; Omoigberale AI, 2010, NIGER J CLIN PRACT, V13, P321; Pattinson R, 2009, INT J GYNECOL OBSTET, V107, pS113, DOI 10.1016/j.ijgo.2009.07.011; Save the Children, 2006, SIT AN NEWB HLTH INT; Sutton J, 2007, CAN J DIET PRACT RES, V68, P195, DOI 10.3148/68.4.2007.195; Toda K, CONGENITAL RUBELLA S; Tran HT, 2015, J PERINATOL, V35, P846, DOI 10.1038/jp.2015.78; UNICEF/WHO, 2012, LOW BIRTHW COUNTR RE; Wallin L, 2011, BMC HEALTH SERV RES, V11, DOI 10.1186/1472-6963-11-239	32	6	6	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 10	2017	12	3							e73407	10.1371/journal.pone.0173407	http://dx.doi.org/10.1371/journal.pone.0173407			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN6CJ	28282433	Green Accepted, gold, Green Published			2022-12-27	WOS:000396091800037
J	Toscani, AM; Sampayo, RG; Barabas, FM; Fuentes, F; Simian, M; Leskow, FC				Martin Toscani, Andres; Sampayo, Rocio G.; Martin Barabas, Federico; Fuentes, Federico; Simian, Marina; Coluccio Leskow, Federico			Distinct ErbB2 receptor populations differentially interact with beta1 integrin in breast cancer cell models	PLOS ONE			English	Article							FOCAL ADHESION KINASE; LIPID RAFTS; ALTERED GLYCOSYLATION; TYROSINE KINASES; BETA-1-INTEGRIN; ASSOCIATION; EXPRESSION; SURVIVAL; INDUCTION; MECHANISM	ErbB2 is a member of the ErbB family of tyrosine kinase receptors that plays a major role in breast cancer progression. Located at the plasma membrane, ErbB2 forms large clusters in spite of the presence of growth factors. Beta1 integrin, membrane receptor of extracellular matrix proteins, regulates adhesion, migration and invasiveness of breast cancer cells. Physical interaction between beta1 integrin and ErbB2 has been suggested although published data are contradictory. The aim of the present work was to study the interaction between ErbB2 and beta1 integrin in different scenarios of expression and activation. We determined that beta1 integrin and ErbB2 colocalization is dependent on the expression level of both receptors exclusively in adherent cells. In suspension cells, lack of focal adhesions leave integrins free to diffuse on the plasma membrane and interact with ErbB2 even at low expression levels of both receptors. In adherent cells, high expression of beta1 integrin leaves unbound receptors outside focal complexes that diffuse within the plasma membrane and interact with ErbB2 membrane domains. Superresolution imaging showed the existence of two distinct populations of ErbB2: a major population located in large clusters and a minor population outside these structures. Upon ErbB2 overexpression, receptors outside large clusters can freely diffuse at the membrane and interact with integrins. These results reveal how expression levels of beta1 integrin and ErbB2 determine their frequency of colocalization and show that extracellular matrix proteins shape membrane clusters distribution, regulating ErbB2 and beta1 integrin activity in breast cancer cells.	[Martin Toscani, Andres; Fuentes, Federico; Coluccio Leskow, Federico] Univ Buenos Aires, Fac Ciencias Exactas & Nat, Dept Quim Biol, Buenos Aires, DF, Argentina; [Martin Toscani, Andres; Fuentes, Federico; Coluccio Leskow, Federico] Univ Buenos Aires, CONICET, Inst Quim Biol, Fac Ciencias Exactas & Nat IQUIBICEN, Buenos Aires, DF, Argentina; [Sampayo, Rocio G.; Simian, Marina] Univ Buenos Aires, Inst Oncol Angel H Roffo, Area Invest, Buenos Aires, DF, Argentina; [Martin Barabas, Federico] Consejo Nacl Invest Cient & Tecn, Ctr Invest Bionanociencias CIBION, Godoy Cruz 2390,C1425FQD, Buenos Aires, DF, Argentina; [Coluccio Leskow, Federico] Univ Nacl Lujan, Dept Ciencias Basicas, Lujan, Buenos Aires, Argentina; [Martin Toscani, Andres] Univ Nacl La Plata, Fac Ciencias Med, Inst Invest Bioquim La Plata INIBIOLP CONICET, La Plata, Buenos Aires, Argentina; [Simian, Marina] Univ Nacl San Martin, Inst Nanosistemas, Campus Miguelete, San Martin, Buenos Aires, Argentina; [Simian, Marina] Univ Nacl San Martin, CEDSI, Campus Miguelete, San Martin, Buenos Aires, Argentina	University of Buenos Aires; Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); University of Buenos Aires; University of Buenos Aires; Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); Universidad Nacional de Lujan; National University of La Plata	Leskow, FC (corresponding author), Univ Buenos Aires, Fac Ciencias Exactas & Nat, Dept Quim Biol, Buenos Aires, DF, Argentina.; Leskow, FC (corresponding author), Univ Buenos Aires, CONICET, Inst Quim Biol, Fac Ciencias Exactas & Nat IQUIBICEN, Buenos Aires, DF, Argentina.; Leskow, FC (corresponding author), Univ Nacl Lujan, Dept Ciencias Basicas, Lujan, Buenos Aires, Argentina.	federico@fbmc.fcen.uba.ar		Simian, Marina/0000-0003-2070-3793; Toscani, Andres Martin/0000-0003-0243-1667	Universidad Nacional de Lujan [CDD-CB: 006-14]; Universidad de Buenos Aires [UBACyT 2014-2017 20020130200025BA]; Consejo Nacional de Investigaciones Cientificas y Tecnicas [PIP 11220110100573]; UBACyT [20020130200025BA]; CONICET PIP [11220110100573]	Universidad Nacional de Lujan; Universidad de Buenos Aires(University of Buenos Aires); Consejo Nacional de Investigaciones Cientificas y Tecnicas(Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET)); UBACyT; CONICET PIP(Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET))	This work was supported by the Universidad Nacional de Lujan (CDD-CB: 006-14): Universidad de Buenos Aires (UBACyT 2014-2017 20020130200025BA); Consejo Nacional de Investigaciones Cientificas y Tecnicas (PIP 11220110100573). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This work was supported by Grants from Universidad Nacional de Lujan (CDD-CB: 006-14), UBACyT 2014-2017 20020130200025BA and CONICET PIP 11220110100573. Preparation of this manuscript was supported by a CONICET PhD fellowship granted to Andres M. Toscani. We thank Dr. Tom Jovin and Dr. Donna Arndt-Jovin (Max Planck Institute for Biophysical Chemistry, Gottingen, Germany) for providing A4-HeLa cells, ErbB2-mYFP construct and trastuzumab-Alexa Fluor 488. We also thank Dr. Arnoud Sonnenberg (Netherlands Cancer Institute, Amsterdam, The Netherlands) for the alpha6 Integrin expression vector and Lautaro Zubeldia-Brenner for kindly providing mouse cDNA.	Arteaga CL, 2014, CANCER CELL, V25, P282, DOI 10.1016/j.ccr.2014.02.025; Bellis SL, 2004, BBA-BIOMEMBRANES, V1663, P52, DOI 10.1016/j.bbamem.2004.03.012; Boivin B, 2013, J BIOL CHEM, V288, P36926, DOI 10.1074/jbc.M113.527564; Boudreau J, 1999, BIOCHEM J, V339, P481, DOI 10.1042/0264-6021:3390481; Brakebusch C, 1997, J CELL SCI, V110, P2895; Cabodi S, 2006, CANCER RES, V66, P4672, DOI 10.1158/0008-5472.CAN-05-2909; Cabodi S, 2010, FASEB J, V24, P3796, DOI 10.1096/fj.10-157347; Calderwood DA, 2004, J CELL SCI, V117, P657, DOI 10.1242/jcs.01014; Campbell ID, 2011, CSH PERSPECT BIOL, V3, DOI 10.1101/cshperspect.a004994; CARTER P, 1992, P NATL ACAD SCI USA, V89, P4285, DOI 10.1073/pnas.89.10.4285; Cerami E, 2012, CANC DISCOV, V2; Chung A, 2013, CLIN BREAST CANCER, V13, P223, DOI 10.1016/j.clbc.2013.04.001; Ciriello G, 2015, CELL, V163, P506, DOI 10.1016/j.cell.2015.09.033; Costes SV, 2004, BIOPHYS J, V86, P3993, DOI [10.1529/biophysj.103.038422, 10.1529/biophysi.103.038422]; de Laurentiis Angela, 2007, Open Biochem J, V1, P12, DOI 10.2174/1874091X00701010012; Del Pozo MA, 2004, CELL CYCLE, V3, P725; del Pozo MA, 2004, SCIENCE, V303, P839, DOI 10.1126/science.1092571; Falcioni R, 1997, EXP CELL RES, V236, P76, DOI 10.1006/excr.1997.3695; Fazekas Z, 2008, CYTOM PART A, V73A, P209, DOI 10.1002/cyto.a.20489; Goddard KAB, 2012, PUBLIC HEALTH GENOM, V15, P1, DOI 10.1159/000325746; Guan JL, 2004, SCIENCE, V303, P773, DOI 10.1126/science.1094376; Harburger DS, 2009, J CELL SCI, V122, P159, DOI 10.1242/jcs.018093; Holbro T, 2004, ANNU REV PHARMACOL, V44, P195, DOI 10.1146/annurev.pharmtox.44.101802.121440; Holden SJ, 2011, NAT METHODS, V8, P279, DOI 10.1038/nmeth0411-279; Huck L, 2010, P NATL ACAD SCI USA, V107, P15559, DOI 10.1073/pnas.1003034107; Humphries JD, 2006, J CELL SCI, V119, P3901, DOI 10.1242/jcs.03098; Hynes NE, 2005, NAT REV CANCER, V5, P341, DOI 10.1038/nrc1609; Iqbal Nida, 2014, Mol Biol Int, V2014, P852748, DOI 10.1155/2014/852748; Irwin ME, 2011, J CELL PHYSIOL, V226, P2316, DOI 10.1002/jcp.22570; Janik ME, 2010, BBA-GEN SUBJECTS, V1800, P545, DOI 10.1016/j.bbagen.2010.03.013; Kennecke H, 2010, J CLIN ONCOL, V28, P3271, DOI 10.1200/JCO.2009.25.9820; KIM LT, 1992, J CELL SCI, V103, P743; Kuramochi Y, 2006, J MOL CELL CARDIOL, V41, P228, DOI 10.1016/j.yjmcc.2006.04.007; Lahlou H, 2012, BREAST CANCER RES, V14, DOI 10.1186/bcr3131; Lesniak D, 2008, CANCER RES, V68, P5826; Lesniak D, 2009, CANCER RES, V69, P8620, DOI 10.1158/0008-5472.CAN-09-1591; Mocanu MM, 2005, CANCER LETT, V227, P201, DOI 10.1016/j.canlet.2005.01.028; Nagy P, 2002, J CELL SCI, V115, P4251, DOI 10.1242/jcs.00118; Nagy P, 2010, P NATL ACAD SCI USA, V107, P16524, DOI 10.1073/pnas.1002642107; Nahta R, 2006, BREAST CANCER RES, V8, DOI 10.1186/bcr1612; Naipauer J, 2013, BIOCHEM J, V454, P345, DOI 10.1042/BJ20130062; Nistico P, 2014, BREAST CANCER RES, V16, DOI 10.1186/s13058-014-0459-x; Olayioye MA, 2000, EMBO J, V19, P3159, DOI 10.1093/emboj/19.13.3159; Owen DM, 2012, BIOESSAYS, V34, P739, DOI 10.1002/bies.201200044; Pankov R, 2005, ARCH BIOCHEM BIOPHYS, V442, P160, DOI 10.1016/j.abb.2005.08.003; Parsons M, 2008, J CELL SCI, V121, P265, DOI 10.1242/jcs.018440; Patra SK, 2008, BBA-REV CANCER, V1785, P182, DOI 10.1016/j.bbcan.2007.11.002; Peres C, 2003, FEBS LETT, V534, P164, DOI 10.1016/S0014-5793(02)03832-2; Pike LJ, 2003, J LIPID RES, V44, P655, DOI 10.1194/jlr.R200021-JLR200; Pontier SM, 2010, ONCOGENE, V29, P3374, DOI 10.1038/onc.2010.86; Ramirez-Villegas JF, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017060; Romer LH, 2006, CIRC RES, V98, P606, DOI 10.1161/01.RES.0000207408.31270.db; Roskoski R, 2014, PHARMACOL RES, V79, P34, DOI 10.1016/j.phrs.2013.11.002; Rust MJ, 2006, NAT METHODS, V3, P793, DOI 10.1038/nmeth929; Shimizu H, 2002, INT J ONCOL, V21, P1073; Simons K, 2000, NAT REV MOL CELL BIO, V1, P31, DOI 10.1038/35036052; SLAMON DJ, 1987, SCIENCE, V235, P177, DOI 10.1126/science.3798106; Sottocornola E, 2006, FEBS J, V273, P1821, DOI 10.1111/j.1742-4658.2006.05203.x; Soung YH, 2010, BMB REP, V43, P311, DOI 10.5483/BMBRep.2010.43.5.311; Steinkamp MP, 2014, MOL CELL BIOL, V34, P965, DOI 10.1128/MCB.01605-13; Streuli CH, 2009, J CELL SCI, V122, P171, DOI 10.1242/jcs.018945; Szabo A, 2008, BIOPHYS J, V95, P2086, DOI 10.1529/biophysj.108.133371; Taherian A, 2011, BMC CANCER, V11, DOI 10.1186/1471-2407-11-293; Vu T, 2012, FRONT ONCOL, V2, P1, DOI 10.3389/fonc.2012.00062; VONLAMPE B, 1993, GUT, V34, P829, DOI 10.1136/gut.34.6.829; Wang SE, 2009, CANCER RES, V69, P475, DOI 10.1158/0008-5472.CAN-08-2649; Xu M, 2010, ALCOHOL CLIN EXP RES, V34, P751, DOI 10.1111/j.1530-0277.2010.01147.x; Yao ES, 2007, CANCER RES, V67, P659, DOI 10.1158/0008-5472.CAN-06-2768; Yarden Y, 2012, NAT REV CANCER, V12, P553, DOI 10.1038/nrc3309	69	8	8	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 17	2017	12	3							e0174230	10.1371/journal.pone.0174230	http://dx.doi.org/10.1371/journal.pone.0174230			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EO5CJ	28306722	Green Published, gold			2022-12-27	WOS:000396710300027
J	Tabatabaei, SRM; Sadjadi, SJ; Makui, A				Tabatabaei, Seyed Reza Moosavi; Sadjadi, Seyed Jafar; Makui, Ahmad			Optimal pricing and marketing planning for deteriorating items	PLOS ONE			English	Article							GEOMETRIC-PROGRAMMING APPROACH; ORDER QUANTITY MODEL; INVENTORY MODEL; SUPPLY CHAIN; PERMISSIBLE DELAY; DEMAND; COST; STRATEGIES; DECISIONS; PAYMENTS	Optimal pricing and marketing planning plays an essential role in production decisions on deteriorating items. This paper presents a mathematical model for a three-level supply chain, which includes one producer, one distributor and one retailer. The proposed study considers the production of a deteriorating item where demand is influenced by price, marketing expenditure, quality of product and after-sales service expenditures. The proposed model is formulated as a geometric programming with 5 degrees of difficulty and the problem is solved using the recent advances in optimization techniques. The study is supported by several numerical examples and sensitivity analysis is performed to analyze the effects of the changes in different parameters on the optimal solution. The preliminary results indicate that with the change in parameters influencing on demand, inventory holding, inventory deteriorating and set-up costs change and also significantly affect total revenue.	[Tabatabaei, Seyed Reza Moosavi; Sadjadi, Seyed Jafar; Makui, Ahmad] Iran Univ Sci & Technol, Dept Ind Engn, Ctr Excellence Optimizat & Mfg, Tehran, Iran	Iran University Science & Technology	Tabatabaei, SRM; Sadjadi, SJ (corresponding author), Iran Univ Sci & Technol, Dept Ind Engn, Ctr Excellence Optimizat & Mfg, Tehran, Iran.	sr_tabatabaei@iust.ac.ir; sjsadjadi@iust.ac.ir	makui, ahmad/S-6038-2018; Sadjadi, Seyed Jafar/S-8969-2018	makui, ahmad/0000-0001-6249-530X; Sadjadi, Seyed Jafar/0000-0002-9069-5453				Abuo-El-Ata MO, 2003, INT J PROD ECON, V83, P223, DOI 10.1016/S0925-5273(02)00327-4; Aron R, 2006, DECIS SUPPORT SYST, V41, P764, DOI 10.1016/j.dss.2004.10.007; BAHARIKASHANI H, 1989, J OPER RES SOC, V40, P75, DOI 10.1057/palgrave.jors.0400106; Chen CK, 2000, PROD PLAN CONTROL, V11, P706, DOI 10.1080/095372800432179; CHENG TCE, 1989, EUR J OPER RES, V40, P252, DOI 10.1016/0377-2217(89)90334-2; Chun SH, 2005, DECIS SUPPORT SYST, V40, P375, DOI 10.1016/j.dss.2004.04.012; Chung CJ, 2013, COMPUT IND ENG, V64, P31, DOI 10.1016/j.cie.2012.08.016; Chung KJ, 2001, COMPUT OPER RES, V28, P67, DOI 10.1016/S0305-0548(99)00087-8; Dai Y, 2005, INT J PROD ECON, V98, P1, DOI 10.1016/j.ijpe.2004.06.056; Duffin R. J., GEOMETRIC PROGRAMMIN; Dye CY, 2007, COMPUT IND ENG, V52, P29, DOI 10.1016/j.cie.2006.10.009; Dye CY, 2012, SWARM EVOL COMPUT, V5, P37, DOI 10.1016/j.swevo.2012.03.002; Fathian M, 2009, COMPUT IND ENG, V56, P255, DOI 10.1016/j.cie.2008.05.013; Ghosh P, 2013, J IND ENG INT, V9, P1; GRANT M., CVX MATLAB SOFTWARE; Gupta A, 2004, DECIS SUPPORT SYST, V38, P347, DOI 10.1016/j.dss.2003.08.002; Hou KL, 2006, EUR J OPER RES, V168, P463, DOI 10.1016/j.ejor.2004.05.011; Huang CK, 2010, APPL MATH MODEL, V34, P1352, DOI 10.1016/j.apm.2009.08.015; Huang Y, 2011, TRANSPORT RES E-LOG, V47, P115, DOI 10.1016/j.tre.2010.09.011; Jung H, 2005, EUR J OPER RES, V165, P108, DOI 10.1016/j.ejor.2002.01.001; Kim D, 1998, EUR J OPER RES, V109, P212, DOI 10.1016/S0377-2217(97)00100-8; Kochenberger G. A., 1971, DECISION SCI, V2, P193, DOI 10.1111/j.1540-5915.1971.tb01454.x; Lee CF, 2012, PROCD SOC BEHV, V40, P41, DOI 10.1016/j.sbspro.2012.03.159; LEE WJ, 1993, DECISION SCI, V24, P76, DOI 10.1111/j.1540-5915.1993.tb00463.x; LEE WJ, 1993, DECISION SCI, V24, P1203, DOI 10.1111/j.1540-5915.1993.tb00511.x; Lilien GL, 1992, MARKETING MODELS PRE; Liu ST, 2007, APPL MATH COMPUT, V190, P1723, DOI 10.1016/j.amc.2007.02.047; Maihami R, 2012, MATH COMPUT MODEL, V55, P1722, DOI 10.1016/j.mcm.2011.11.017; Mandal NK, 2005, FUZZY SET SYST, V150, P87, DOI 10.1016/j.fss.2004.07.020; Parlar M, 2006, EUR J OPER RES, V170, P211, DOI 10.1016/j.ejor.2004.06.026; POLATOGLU LH, 1991, INT J PROD ECON, V23, P175, DOI 10.1016/0925-5273(91)90060-7; Rau H, 2004, INT J SYST SCI, V35, P293, DOI 10.1080/00207720410001714833; Sadjadi SJ, 2010, AFR J BUS MANAGE, V4, P3632; Sadjadi SJ, 2005, COMPUT OPTIM APPL, V30, P195, DOI 10.1007/s10589-005-4564-8; Sajadieh MS, 2009, TRANSPORT RES E-LOG, V45, P564, DOI 10.1016/j.tre.2008.12.002; Tsao YC, 2008, COMPUT OPER RES, V35, P3562, DOI 10.1016/j.cor.2007.01.024; Venkatesan R, 2006, DECIS SUPPORT SYST, V42, P1759, DOI 10.1016/j.dss.2006.03.012; Wee HM, 1999, INT J PROD ECON, V59, P511, DOI 10.1016/S0925-5273(98)00113-3; Yang PC, 2004, EUR J OPER RES, V157, P389, DOI 10.1016/S0377-2217(03)00241-8	39	3	3	4	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 17	2017	12	3							e0172758	10.1371/journal.pone.0172758	http://dx.doi.org/10.1371/journal.pone.0172758			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EO5CJ	28306750	Green Submitted, gold, Green Published			2022-12-27	WOS:000396710300003
J	Chao, JY; Zhang, YM; Kong, M; Zhuang, W; Wang, LM; Shao, KQ; Gao, G				Chao, Jian-Ying; Zhang, Yi-Min; Kong, Ming; Zhuang, Wei; Wang, Long-Mian; Shao, Ke-Qiang; Gao, Guang			Long-term moderate wind induced sediment resuspension meeting phosphorus demand of phytoplankton in the large shallow eutrophic Lake Taihu	PLOS ONE			English	Article								The objective of this study was to investigate the impact of sediment resuspension and phosphorus (P) release on phytoplankton growth under different kinds of wind-wave disturbance conditions in the large and shallow eutrophic Lake Taihu in China. Short-term strong wind (STSW) conditions, long-term moderate wind (LTMW) conditions, and static/calm conditions were investigated. To address this objective, we (1) monitored changes in surface water P composition during field-based sediment resuspension caused by STSW conditions in Lake Taihu, and also conducted (2) a series of laboratory-based sediment resuspension experiments to simulate LTMW and calm conditions. The results showed that under both strong and moderate wind-wave conditions, suspended solids (SS) and total phosphorus (TP) in the water column increased significantly, but total dissolved phosphorus (TDP) and soluble reactive phosphorus (SRP) remained low throughout the experiments, indicating that the P released from sediments mainly existed in particulate forms. In STSW conditions, alkaline phosphatase activity (APA) and enzymatically hydrolysable phosphorus (EHP) increased rapidly, with the peak value occurring following the peak value of wind speed for 1-2 days, and then rapidly decreased after the wind stopped. Under LTMW conditions, APA and EHP increased steadily, and by the end of the laboratory experiments, APA increased by 11 times and EHP increased by 5 times. Chlorophyll a (Chl-a) in LTMW conditions increased significantly, but remained low under STSW conditions, demonstrating that the former type of sediment P release promoted phytoplankton growth more effectively, and the latter type did not. Despite the fact that STSW conditions resulted in the release of more TP, TP settled to the bottom rapidly with SS after the wind stopped, and did not promote algal growth. Under LTMW conditions, suspended particulate P was hydrolyzed to SRP by phosphatase and promoted algae growth. Algal growth in turn secreted more phosphatase and accelerated particulate P regeneration, which may be the main mechanism of sediment bioavailable P release that promotes phytoplankton growth in shallow lakes.	[Chao, Jian-Ying; Shao, Ke-Qiang; Gao, Guang] Chinese Acad Sci, Nanjing Inst Geog & Limnol, State Key Lab Lake Sci & Environm, Nanjing, Jiangsu, Peoples R China; [Chao, Jian-Ying; Zhang, Yi-Min; Kong, Ming; Zhuang, Wei; Wang, Long-Mian] Nanjing Inst Environm Sci, Minist Environm Protect, Nanjing, Jiangsu, Peoples R China; [Chao, Jian-Ying] Univ Chinese Acad Sci, Beijing, Peoples R China	Chinese Academy of Sciences; Nanjing Institute of Geography & Limnology, CAS; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS	Gao, G (corresponding author), Chinese Acad Sci, Nanjing Inst Geog & Limnol, State Key Lab Lake Sci & Environm, Nanjing, Jiangsu, Peoples R China.	guanggao@niglas.ac.cn	Wang, Longmian/AAR-3970-2021		Chinese National Science Foundation [41301556]; Water Pollution Control and Management of Major Projects committee of China [2014ZX07101-011, JC.2012ZX07101-007]	Chinese National Science Foundation(National Natural Science Foundation of China (NSFC)); Water Pollution Control and Management of Major Projects committee of China	This work was supported by 1) Chinese National Science Foundation, URL: http://www.nsfc.gov.cn/, grant numbers: 41301556, JC; 2) The Water Pollution Control and Management of Major Projects committee of China, URL:http://nwpcp.mep.gov.cn/, grant number: 2014ZX07101-011, JC; and 3) The Water Pollution Control and Management of Major Projects committee of China, URL: http://nwpcp.mep.gov.cn/, grant number: JC.2012ZX07101-007, YZ.	ANDERSEN JM, 1976, WATER RES, V10, P329, DOI 10.1016/0043-1354(76)90175-5; Aubriot L, 2012, AQUAT MICROB ECOL, V67, P251, DOI 10.3354/ame01596; Bai X, 2009, ENVIRON POLLUT, V8-9, P2507; BOON PI, 1989, ARCH HYDROBIOL, V115, P339; Burkhardt BG, 2014, MAR CHEM, V163, P1, DOI 10.1016/j.marchem.2014.03.007; CHROST RJ, 1986, LIMNOL OCEANOGR, V31, P662, DOI 10.4319/lo.1986.31.3.0662; Couceiro F, 2013, BIOGEOCHEMISTRY, V113, P37, DOI 10.1007/s10533-012-9710-7; EBINA J, 1983, WATER RES, V17, P1721, DOI 10.1016/0043-1354(83)90192-6; EVANS RD, 1994, HYDROBIOLOGIA, V284, P5, DOI 10.1007/BF00005727; Gao L, 2012, PROCEDIA ENV SCI, P2077; Graneli W, 1999, HYDROBIOLOGIA, V404, P19, DOI 10.1023/A:1003705520085; Huang JY, 2015, EURASIP J WIREL COMM, DOI 10.1186/s13638-015-0317-2; Hudson JJ, 1999, NATURE, V400, P659, DOI 10.1038/23240; JENSEN HS, 1992, HYDROBIOLOGIA, V235, P731, DOI 10.1007/BF00026261; Jiang X, 2008, WATER RES, V42, P2251, DOI 10.1016/j.watres.2007.12.003; Kang YH, 2013, HYDROBIOLOGIA, V710, P117, DOI 10.1007/s10750-012-1221-y; Li DP, 2011, CHEM ENG J, V168, P1049, DOI 10.1016/j.cej.2011.01.082; Linge KL, 2004, APPL GEOCHEM, V19, P1377, DOI 10.1016/j.apgeochem.2003.12.009; Matisoff G, 2014, J GREAT LAKES RES, V40, P532, DOI 10.1016/j.jglr.2014.02.001; Morgan B, 2012, SCI TOTAL ENVIRON, V432, P47, DOI 10.1016/j.scitotenv.2012.05.065; MORTIMER CH, 1971, LIMNOL OCEANOGR, V16, P387, DOI 10.4319/lo.1971.16.2.0387; Papista E, 2002, HYDROBIOLOGIA, V485, P191, DOI 10.1023/A:1021329602685; Puttonen I, 2014, ESTUARINE COASTAL SH, P9; Qian J, 2011, J HYDRODYN, V23, P826, DOI 10.1016/S1001-6058(10)60182-5; Qin B, 2006, SCI CHINA, V1, P38; Qin B, 2008, CHINA DYNAMICS ENV C; Qin BQ, 2004, CHINESE SCI BULL, V49, P54, DOI 10.1360/03wd0174; Rice E.W., 2012, STANDARD METHODS EXA; Sannigrahi P, 2006, GEOCHIM COSMOCHIM AC, V70, P5868, DOI 10.1016/j.gca.2006.08.037; Schindler DW, 2008, P NATL ACAD SCI USA, V105, P11254, DOI 10.1073/pnas.0805108105; Shinohara R, 2012, ENVIRON SCI TECHNOL, V46, P10572, DOI 10.1021/es301887z; Shinohara R, 2012, MAR FRESHWATER RES, V63, P119, DOI 10.1071/MF11182; Simon M, 2002, AQUAT MICROB ECOL, V28, P175, DOI 10.3354/ame028175; Stahlberg C, 2006, ESTUARINE COASTAL SH, V1-2, P317; Stuart G, 1984, DEEP-SEA RES PT 1, V5, P509; Sun XJ, 2006, SCI CHINA SER D, V49, P92, DOI 10.1007/s11430-006-8109-5; Tammeorg O, 2013, AQUAT SCI, V75, P559, DOI 10.1007/s00027-013-0300-0; Wang J, 2015, ENVIRON SCI POLLUT R, P10471; Wetzel R.G., 2001, LIMNOLOGY LAKE RIVER, DOI DOI 10.1046/J.1529-8817.2001.37602.X; Wu D, 2014, ECOL ENG, V69, P55, DOI 10.1016/j.ecoleng.2014.03.059; Wu QLL, 2007, HYDROBIOLOGIA, V581, P241, DOI 10.1007/s10750-006-0500-x; Xie P, 2006, SCI CHINA SER D, V49, P14, DOI 10.1007/s11430-006-8102-z; Xu H, 2010, LIMNOL OCEANOGR, V55, P420, DOI 10.4319/lo.2010.55.1.0420; You BS, 2007, J ENVIRON SCI, V9, P1055; Zhang R, 2008, ENVIRON POLLUT, V2, P366; Zhang T, 2007, ENVIRON POLLUT, P288; Zheng SS, 2015, INT J SEDIMENT RES, V30, P48, DOI 10.1016/S1001-6279(15)60005-1; Zhu GW, 2007, HYDROBIOLOGIA, V581, P53, DOI 10.1007/s10750-006-0519-z; Zhu GW, 2005, CHINESE SCI BULL, V50, P577, DOI 10.1360/04wd0083; Zhu YR, 2013, ENVIRON SCI TECHNOL, V47, P7679, DOI 10.1021/es305277g	50	18	20	3	47	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 16	2017	12	3							e0173477	10.1371/journal.pone.0173477	http://dx.doi.org/10.1371/journal.pone.0173477			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN9KE	28301502	gold, Green Published, Green Submitted			2022-12-27	WOS:000396318300044
J	Vasina, DV; Moiseenko, KV; Fedorova, TV; Tyazhelova, TV				Vasina, Daria V.; Moiseenko, Konstantin V.; Fedorova, Tatiana V.; Tyazhelova, Tatiana V.			Lignin-degrading peroxidases in white-rot fungus Trametes hirsuta 072. Absolute expression quantification of full multigene family	PLOS ONE			English	Article							DROPLET DIGITAL PCR; DNA COPY NUMBER; MANGANESE PEROXIDASE; PLEUROTUS-OSTREATUS; GENE-EXPRESSION; PHANEROCHAETE-CHRYSOSPORIUM; DIFFERENTIAL REGULATION; SULFONPHTHALEIN DYES; MOLECULAR-STRUCTURE; CORIOLUS-HIRSUTUS	Ligninolytic heme peroxidases comprise an extensive family of enzymes, which production is characteristic for white-rot Basidiomycota. The majority of fungal heme peroxidases are encoded by multigene families that differentially express closely related proteins. Currently, there were very few attempts to characterize the complete multigene family of heme peroxidases in a single fungus. Here we are focusing on identification and characterization of peroxidase genes, which are transcribed and secreted by basidiomycete Trametes hirsuta 072, an efficient lignin degrader. The T. hirsuta genome contains 18 ligninolytic peroxidase genes encoding 9 putative lignin peroxidases (LiP), 7 putative short manganese peroxidases (MnP) and 2 putative versatile peroxidases (VP). Using ddPCR method we have quantified the absolute expression of the 18 peroxidase genes under different culture conditions and on different growth stages of basidiomycete. It was shown that only two genes (one MnP and one VP) were prevalently expressed as well as secreted into cultural broth under all conditions investigated. However their transcriptome and protein profiles differed in time depending on the effector used. The expression of other peroxidase genes revealed a significant variability, so one can propose the specific roles of these enzymes in fungal development and lifestyle.	[Vasina, Daria V.; Moiseenko, Konstantin V.; Fedorova, Tatiana V.; Tyazhelova, Tatiana V.] Russian Acad Sci, Biotechnol Res Ctr, AN Bach Inst Biochem, 33,bld. 2 Leninsky Ave, Moscow, Russia	Research Center of Biotechnology RAS; Russian Academy of Sciences	Moiseenko, KV (corresponding author), Russian Acad Sci, Biotechnol Res Ctr, AN Bach Inst Biochem, 33,bld. 2 Leninsky Ave, Moscow, Russia.	mr.moiseenko@gmail.com	Moiseenko, Konstantin V/F-9802-2015; Vasina, Daria V/R-4644-2016	Vasina, Daria V/0000-0003-1965-0700	Russian Science Foundation [14-14-00620]	Russian Science Foundation(Russian Science Foundation (RSF))	This work was supported by the Russian Science Foundation, project no. 14-14-00620. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alfaro M, 2014, J PROTEOMICS, V102, P28, DOI 10.1016/j.jprot.2014.03.001; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; BAO WL, 1994, FEBS LETT, V354, P297, DOI 10.1016/0014-5793(94)01146-X; Bodeker ITM, 2009, ISME J, V3, P1387, DOI 10.1038/ismej.2009.77; Brzonova I, 2014, BIORESOURCE TECHNOL, V173, P352, DOI 10.1016/j.biortech.2014.09.057; Castanera R, 2015, APPL ENVIRON MICROB, V81, P4120, DOI 10.1128/AEM.00402-15; Castresana J, 2000, MOL BIOL EVOL, V17, P540, DOI 10.1093/oxfordjournals.molbev.a026334; Christian VV, 2003, FOLIA MICROBIOL, V48, P771, DOI 10.1007/BF02931512; Darriba D, 2012, NAT METHODS, V9, P772, DOI 10.1038/nmeth.2109; Dreo T, 2014, ANAL BIOANAL CHEM, V406, P6513, DOI 10.1007/s00216-014-8084-1; Fedorova TV, 2013, APPL BIOCHEM MICRO+, V49, P570, DOI 10.1134/S0003683813060082; Fernandez-Fueyo E, 2014, FUNGAL GENET BIOL, V72, P150, DOI 10.1016/j.fgb.2014.02.003; Fernandez-Fueyo E, 2014, BIOTECHNOL BIOFUELS, V7, DOI 10.1186/1754-6834-7-114; Fernandez-Fueyo E, 2014, BIOTECHNOL BIOFUELS, V7, DOI 10.1186/1754-6834-7-2; Floudas D, 2012, SCIENCE, V336, P1715, DOI 10.1126/science.1221748; Gasteiger E., 2005, PROTEOMICS PROTOC HD, P571, DOI [10.1385/1-59259-890-0:571, DOI 10.1385/1-59259-890-0:571]; Giardina P, 2000, ARCH BIOCHEM BIOPHYS, V376, P171, DOI 10.1006/abbi.1999.1691; Guindon S, 2010, SYST BIOL, V59, P307, DOI 10.1093/sysbio/syq010; Gupta Ramneek, 2002, Pac Symp Biocomput, P310; Hammel KE, 2008, CURR OPIN PLANT BIOL, V11, P349, DOI 10.1016/j.pbi.2008.02.003; Hilden K, 2005, FUNGAL GENET BIOL, V42, P403, DOI 10.1016/j.fgb.2005.01.008; Hilden L, 2000, FEBS LETT, V477, P79, DOI 10.1016/S0014-5793(00)01757-9; Hindson BJ, 2011, ANAL CHEM, V83, P8604, DOI 10.1021/ac202028g; Hofrichter M, 2010, APPL MICROBIOL BIOT, V87, P871, DOI 10.1007/s00253-010-2633-0; Hollox EJ, 2014, HUM GENET, V133, P1217, DOI 10.1007/s00439-014-1457-x; Janusz G, 2013, ENZYME MICROB TECH, V52, P1, DOI 10.1016/j.enzmictec.2012.10.003; Kapich AN, 1999, FEBS LETT, V461, P115, DOI 10.1016/S0014-5793(99)01432-5; Kim TG, 2014, APPL MICROBIOL BIOT, V98, P6105, DOI 10.1007/s00253-014-5794-4; Kniemeyer O, 2006, CURR GENET, V49, P178, DOI 10.1007/s00294-005-0047-9; Koroleva OV, 2002, J BIOSCI BIOENG, V93, P449, DOI 10.1263/jbb.93.449; Koroljova-Skorobogat'ko OV, 1998, BIOTECHNOL APPL BIOC, V28, P47; Korripally P, 2015, APPL ENVIRON MICROB, V81, P7802, DOI 10.1128/AEM.02064-15; Kues U, 2015, CURR OPIN BIOTECH, V33, P268, DOI 10.1016/j.copbio.2015.03.006; Kulikova NA, 2011, APPL BIOCHEM MICRO+, V47, P565, DOI 10.1134/S000368381106007X; Lundell TK, 2010, J BASIC MICROB, V50, P5, DOI 10.1002/jobm.200900338; Manubens A, 2003, CURR GENET, V43, P433, DOI 10.1007/s00294-003-0410-7; Miki Y, 2006, J FAC AGR KYUSHU U, V51, P99; OFARRELL PH, 1975, J BIOL CHEM, V250, P4007; Olson A, 2012, NEW PHYTOL, V194, P1001, DOI 10.1111/j.1469-8137.2012.04128.x; Passardi F, 2007, PHYTOCHEMISTRY, V68, P1605, DOI 10.1016/j.phytochem.2007.04.005; Pavlov AR, 2015, GENOME ANNOUNC, V3; Pinheiro LB, 2012, ANAL CHEM, V84, P1003, DOI 10.1021/ac202578x; Raffaello T, 2014, ENVIRON MICROBIOL, V16, P1654, DOI 10.1111/1462-2920.12321; Ruiz-Duenas FJ, 2013, MYCOLOGIA, V105, P1428, DOI 10.3852/13-059; Ruiz-Duenas FJ, 2011, CR BIOL, V334, P795, DOI 10.1016/j.crvi.2011.06.004; Sedlak RH, 2014, J CLIN MICROBIOL, V52, P2844, DOI 10.1128/JCM.00803-14; Shrivastava R, 2005, ENZYME MICROB TECH, V36, P333, DOI 10.1016/j.enzmictec.2004.09.004; Stanke M, 2004, NUCLEIC ACIDS RES, V32, pW309, DOI 10.1093/nar/gkh379; Steffen KT, 2002, APPL ENVIRON MICROB, V68, P3442, DOI 10.1128/AEM.68.7.3442-3448.2002; Stothard P, 2000, BIOTECHNIQUES, V28, P1102, DOI 10.2144/00286ir01; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Untergasser A, 2012, NUCLEIC ACIDS RES, V40, DOI 10.1093/nar/gks596; Vasina DV, 2016, BMC MICROBIOL, V16, DOI 10.1186/s12866-016-0729-0; Vasina DV, 2015, BIOCHIMIE, V116, P154, DOI 10.1016/j.biochi.2015.07.015; Vincent ME, 2010, CHEM SOC REV, V39, P974, DOI 10.1039/b917851a; Yakovlev IA, 2013, FUNGAL GENET BIOL, V56, P17, DOI 10.1016/j.fgb.2013.04.011; Yang RC, 2014, INT J PARASITOL, V44, P1105, DOI 10.1016/j.ijpara.2014.08.004; Zhang JZ, 2003, TRENDS ECOL EVOL, V18, P292, DOI 10.1016/S0169-5347(03)00033-8; Zhu H, 2009, APPL BIOCHEM BIOTECH, V152, P366, DOI 10.1007/s12010-008-8236-x; Zmienko A, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0118226	60	18	20	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 16	2017	12	3							e0173813	10.1371/journal.pone.0173813	http://dx.doi.org/10.1371/journal.pone.0173813			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN9KE	28301519	Green Published, Green Submitted, gold			2022-12-27	WOS:000396318300076
J	Bu, DP; Bionaz, M; Wang, MZ; Nan, XM; Ma, L; Wang, JQ				Bu, Dengpan; Bionaz, Massimo; Wang, Mengzhi; Nan, Xuemei; Ma, Lu; Wang, Jiaqi			Transcriptome difference and potential crosstalk between liver and mammary tissue in mid-lactation primiparous dairy cows	PLOS ONE			English	Article							GROWTH-FACTOR; GENE-EXPRESSION; MICRORNA EXPRESSION; MILK-PRODUCTION; GLAND; LACTATION; RUMINANT; METABOLISM; INSULIN; CATTLE	Liver and mammary gland are among the most important organs during lactation in dairy cows. With the purpose of understanding both the different and the complementary roles and the crosstalk of those two organs during lactation, a transcriptome analysis was performed on liver and mammary tissues of 10 primiparous dairy cows in mid-lactation. The analysis was performed using a 4x44K Bovine Agilent microarray chip. The transcriptome difference between the two tissues was analyzed using SAS JMP Genomics using ANOVA with a false discovery rate correction (FDR). The analysis uncovered >9,000 genes differentially expressed (DEG) between the two tissues with a FDR<0.001. The functional analysis of the DEG uncovered a larger metabolic (especially related to lipid) and inflammatory response capacity in liver compared with mammary tissue while the mammary tissue had a larger protein synthesis and secretion, proliferation/differentiation, signaling, and innate immune system capacity compared with the liver. A plethora of endogenous compounds, cytokines, and transcription factors were estimated to control the DEG between the two tissues. Compared with mammary tissue, the liver transcriptome appeared to be under control of a large array of ligand-dependent nuclear receptors and, among endogenous chemical, fatty acids and bacteria-derived compounds. Compared with liver, the transcriptome of the mammary tissue was potentially under control of a large number of growth factors and miRNA. The in silico crosstalk analysis between the two tissues revealed an overall large communication with a reciprocal control of lipid metabolism, innate immune system adaptation, and proliferation/differentiation. In summary the transcriptome analysis confirmed prior known differences between liver and mammary tissue, especially considering the indication of a larger metabolic activity in liver compared with the mammary tissue and the larger protein synthesis, communication, and proliferative capacity in mammary tissue compared with the liver. Relatively novel is the indication by the data that the transcriptome of the liver is highly regulated by dietary and bacteria-related compounds while the mammary transcriptome is more under control of hormones, growth factors, and miRNA. A large crosstalk between the two tissues with a reciprocal control of metabolism and innate immune-adaptation was indicated by the network analysis that allowed uncovering previously unknown crosstalk between liver and mammary tissue for several signaling molecules.	[Bu, Dengpan; Nan, Xuemei; Ma, Lu; Wang, Jiaqi] Chinese Acad Agr Sci, Inst Anim Sci, State Key Lab Anim Nutr, Beijing, Peoples R China; [Bu, Dengpan] World Agroforestry Ctr, CAAS ICRAF Joint Lab Agroforestry & Sustainable A, Beijing, Peoples R China; [Bu, Dengpan] Synerget Innovat Ctr Food Safety & Nutr, Harbin, Peoples R China; [Bionaz, Massimo] Oregon State Univ, Dept Anim & Rangeland Sci, Corvallis, OR 97331 USA; [Wang, Mengzhi] Yangzhou Univ, Coll Anim Sci & Technol, Yangzhou, Jiangsu, Peoples R China	Chinese Academy of Agricultural Sciences; Institute of Animal Science, CAAS; Chinese Academy of Agricultural Sciences; Oregon State University; Yangzhou University	Wang, JQ (corresponding author), Chinese Acad Agr Sci, Inst Anim Sci, State Key Lab Anim Nutr, Beijing, Peoples R China.; Bionaz, M (corresponding author), Oregon State Univ, Dept Anim & Rangeland Sci, Corvallis, OR 97331 USA.	massimo.bionaz@oregonstate.edu; wang-jia-qi@263.net	Bionaz, Massimo/I-4222-2018	Bionaz, Massimo/0000-0002-0674-1892	"Natural Science Foundation of China [31372341]; Ministry of Science and Technology of China [2012BAD12B02-5]; Agriculture Science and Technology Innovation Program [ASTIP-IAS07]; USDA NEFA Multistate Project [NE-1048]	"Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Ministry of Science and Technology of China(Ministry of Science and Technology, China); Agriculture Science and Technology Innovation Program; USDA NEFA Multistate Project	This research was supported by the "Natural Science Foundation of China (31372341), the Ministry of Science and Technology of China (2012BAD12B02-5), the Agriculture Science and Technology Innovation Program (ASTIP-IAS07), and the USDA NEFA Multistate Project (NE-1048). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akers RM, 2006, J DAIRY SCI, V89, P1222, DOI 10.3168/jds.S0022-0302(06)72191-9; Aschenbach JR, 2010, IUBMB LIFE, V62, P869, DOI 10.1002/iub.400; Basham KJ, 2015, TOXICOL SCI, V143, P36, DOI 10.1093/toxsci/kfu203; Bauman DE, 2006, J DAIRY SCI, V89, P1235, DOI 10.3168/jds.S0022-0302(06)72192-0; BAUMAN DE, 1980, J DAIRY SCI, V63, P1514, DOI 10.3168/jds.S0022-0302(80)83111-0; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; BERGMAN EN, 1974, FED PROC, V33, P1849; BERNAERT D, 1977, J CELL BIOL, V74, P878, DOI 10.1083/jcb.74.3.878; Bian YJ, 2015, J CELL PHYSIOL, V230, P2152, DOI 10.1002/jcp.24944; Bionaz M, 2015, J ANIM SCI; Bionaz M, 2013, PPAR RES, V2013, DOI DOI 10.1155/2013/684159; Bionaz M, 2007, PHYSIOL GENOMICS, V29, P312, DOI 10.1152/physiolgenomics.00223.2006; Bionaz M, 2012, MILK PROTEIN, P285, DOI 10.5772/46054; Bionaz M, 2012, GENE REGUL SYST BIO, V6, P109, DOI 10.4137/GRSB.S9852; Bionaz M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032455; Bionaz M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033268; Bloise E, 2010, J DAIRY SCI, V93, P4592, DOI 10.3168/jds.jds.2009-2981; Burgos SA, 2010, DOMEST ANIM ENDOCRIN, V38, P211, DOI 10.1016/j.domaniend.2009.10.005; Capuco AV, 2001, J DAIRY SCI, V84, P2177, DOI 10.3168/jds.S0022-0302(01)74664-4; Drackley JK, 1999, J DAIRY SCI, V82, P2259, DOI 10.3168/jds.S0022-0302(99)75474-3; Edgerton DS, 2009, DIABETES, V58, P2766, DOI 10.2337/db09-0328; Gotze A, 2010, J DAIRY SCI, V93, P38, DOI 10.3168/jds.2008-1781; Gressner OA, 2008, LIVER INT, V28, P1065, DOI 10.1111/j.1478-3231.2008.01826.x; Han RW, 2014, ARCH ANIM NUTR, V68, P63, DOI 10.1080/1745039X.2013.869986; Hou ZH, 2014, LIVER INT, V34, P58, DOI 10.1111/liv.12244; Hu M, 2014, CELL CYCLE, V13, P2349, DOI 10.4161/cc.29298; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; HUGHES JP, 1962, AM J VET RES, V23, P1111; INGLE DL, 1972, J NUTR, V102, P617, DOI 10.1093/jn/102.5.617; INGLE DL, 1972, J NUTR, V102, P609, DOI 10.1093/jn/102.5.609; Ito S, 2003, ADV DRUG DELIVER REV, V55, P653, DOI 10.1016/S0169-409X(03)00031-0; Jabed A, 2012, P NATL ACAD SCI USA, V109, P16811, DOI 10.1073/pnas.1210057109; Jiang L, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-443; Jiang SM, 2015, J HEPATOL, V62, P371, DOI 10.1016/j.jhep.2014.09.026; Jin WW, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-181; Ju YF, 2012, ENDOCRINOLOGY, V153, P5522, DOI 10.1210/en.2012-1334; Kim KH, 2014, CANCER GENET-NY, V207, P365, DOI 10.1016/j.cancergen.2014.04.004; Kuhn C, 1999, ANIM GENET, V30, P333, DOI 10.1046/j.1365-2052.1999.00487.x; Lametsch R, 2000, J BIOL CHEM, V275, P19469, DOI 10.1074/jbc.M002550200; Le Provost F, 2003, GENE, V313, P83, DOI 10.1016/S0378-1119(03)00632-2; Lecchi C, 2015, VET J, V203, P296, DOI 10.1016/j.tvjl.2015.01.009; Liu YP, 2003, J CLIN INVEST, V112, P1678, DOI 10.1172/JCI200318945; Loor JJ, 2013, ANNU REV ANIM BIOSCI, V1, P365, DOI 10.1146/annurev-animal-031412-103728; Macias H, 2012, WIRES DEV BIOL, V1, P533, DOI 10.1002/wdev.35; Minuti A, 2015, PHYSIOL REP, V3, DOI 10.14814/phy2.12388; Moyes KM, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0157480; MUNDAY MR, 1987, BIOCHEM J, V242, P905, DOI 10.1042/bj2420905; Mysickova A, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-S1-S2; Nakamura MT, 2014, PROG LIPID RES, V53, P124, DOI 10.1016/j.plipres.2013.12.001; Odom DT, 2004, SCIENCE, V303, P1378, DOI 10.1126/science.1089769; Pavek P, 2008, CURR DRUG METAB, V9, P129, DOI 10.2174/138920008783571774; Piantoni P, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-331; Rawson P, 2012, J PROTEOMICS, V75, P4429, DOI 10.1016/j.jprot.2012.04.019; REYNOLDS CK, 1992, J NUTR, V122, P850, DOI 10.1093/jn/122.suppl_3.850; Rodriguez-Ortigosa CM, 2014, GASTROENTEROLOGY, V147, P1084, DOI 10.1053/j.gastro.2014.07.030; Rudolph MC, 2007, PHYSIOL GENOMICS, V28, P323, DOI 10.1152/physiolgenomics.00020.2006; Samdani P, 2015, SCI REP-UK, V5, DOI 10.1038/srep12340; Schingoethe DJ, 1988, RUMINANT ANIMAL DIGE, P421; Sciascia Q, 2013, J DAIRY SCI, V96, P2327, DOI 10.3168/jds.2012-6267; Serra Rosa, 2003, Breast Dis, V18, P61; Sood AK, 2009, CANCER EPIDEM BIOMAR, V18, P1899, DOI 10.1158/1055-9965.EPI-09-0055; Sulman FG, 1970, HYPOTHALAMIC CONTROL, Vxii, P235; Supek F, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021800; Sureshbabu A, 2011, INT J DEV BIOL, V55, P781, DOI 10.1387/ijdb.113364as; Tanioka N, 2014, BIOMED REP, V2, P359, DOI 10.3892/br.2014.235; Trevisi E, 2011, ACUTE PHASE PROTEINS AS EARLY NON-SPECIFIC BIOMARKERS OF HUMAN AND VETERINARY DISEASES, P355; Tucker HA, 2000, J DAIRY SCI, V83, P874, DOI 10.3168/jds.S0022-0302(00)74951-4; Veitia Reiner A, 2000, GENOME BIOL, V2; Wagner M, 2011, HEPATOLOGY, V53, P1023, DOI 10.1002/hep.24148; Wang W, 2008, J CELL PHYSIOL, V214, P38, DOI 10.1002/jcp.21159; Wang YF, 2010, BIOTECHNOL LETT, V32, P1789, DOI 10.1007/s10529-010-0359-9	71	13	16	1	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 14	2017	12	3							e0173082	10.1371/journal.pone.0173082	http://dx.doi.org/10.1371/journal.pone.0173082			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN6DM	28291785	Green Published, Green Submitted, gold			2022-12-27	WOS:000396094700010
J	Aas, A; Isakson, P; Bindesboll, C; Alemu, EA; Klungland, A; Simonsen, A				Aas, Aleksander; Isakson, Pauline; Bindesboll, Christian; Alemu, Endalkachew A.; Klungland, Arne; Simonsen, Anne			Nucleocytoplasmic Shuttling of FTO Does Not Affect Starvation-Induced Autophagy	PLOS ONE			English	Article							FAT MASS; OBESITY; GENE; RNA; EXPRESSION; CHILDHOOD; SUBSTRATE; VARIANTS	Polymorphic variants of the FTO (fat mass and obesity) gene associate with body mass index in humans, but the underlying molecular mechanisms have not been firmly determined. FTO is linked to energy homeostasis via amino acid sensing and is thought to activate the mammalian target of rapamycin complex 1, a negative regulator of autophagy. FTO localises both to the nucleus and the cytoplasm, and in this study we identify a functional nuclear localisation signal (NLS) in the N-terminus of FTO, as well as nuclear localization information in its very C-terminus. Inhibition of FTO nuclear transport has no effect on autophagy and in contrast to a previously proposed role of FTO in autophagy, we find no difference in starvation-induced autophagy in control cells compared to a panel of cell types depleted of FTO. Future studies that further characterise the cellular functions of FTO will be important to understand why variants in FTO are associated with body weight.	[Aas, Aleksander; Isakson, Pauline; Bindesboll, Christian; Simonsen, Anne] Univ Oslo, Inst Basic Med Sci, Dept Mol Med, Oslo, Norway; [Alemu, Endalkachew A.; Klungland, Arne] Natl Hosp Norway, Oslo Univ Hosp, Dept Mol Microbiol, A3-3021,Sognsvannsveien 20, Oslo, Norway	University of Oslo; University of Oslo; National Hospital Norway	Simonsen, A (corresponding author), Univ Oslo, Inst Basic Med Sci, Dept Mol Med, Oslo, Norway.	anne.simonsen@medisin.uio.no	Klungland, Arne/X-1233-2019	Klungland, Arne/0000-0001-7274-3661	Medical Faculty, University of Oslo; Research Council of Norway; Norwegian Cancer Society; European Union Seventh Framework Programme (FP7-PEOPLE-COFUND) [609020]	Medical Faculty, University of Oslo; Research Council of Norway(Research Council of Norway); Norwegian Cancer Society(Norwegian Cancer Society); European Union Seventh Framework Programme (FP7-PEOPLE-COFUND)	This research was supported by the MD PhD program of the Medical Faculty, University of Oslo(AA), the Research Council of Norway (AS, CB), the Norwegian Cancer Society(AS, PI) and the European Union Seventh Framework Programme (EA,AK) (FP7-PEOPLE-2013-COFUND) under grant agreement no 609020 - Scientia Fellows. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This research was supported by the MD PhD program of the Medical Faculty, University of Oslo (AA), the Research Council of Norway (AS,CB), the Norwegian Cancer Society (AS,PI) and the European Union Seventh Framework Programme (EA,AK)(FP7-PEOPLE-2013COFUND) under grant agreement no 609020-Scientia Fellows. The authors declare no competing financial interests.	Berulava T, 2013, EUR J HUM GENET, V21, P317, DOI 10.1038/ejhg.2012.168; Bjorkoy G, 2005, J CELL BIOL, V171, P603, DOI 10.1083/jcb.200507002; Cheung MK, 2012, INT J OBESITY, P1; Church C, 2010, NAT GENET, V42, P1086, DOI 10.1038/ng.713; Dina C, 2007, NAT GENET, V39, P724, DOI 10.1038/ng2048; Hernandez-Caballero ME, 2015, MOL BIOL REP, V42, P699, DOI 10.1007/s11033-014-3817-y; Elks Cathy E, 2012, Front Endocrinol (Lausanne), V3, P29, DOI 10.3389/fendo.2012.00029; Fischer J, 2009, NATURE, V458, P894, DOI 10.1038/nature07848; Frayling TM, 2007, SCIENCE, V316, P889, DOI 10.1126/science.1141634; Gerken T, 2007, SCIENCE, V318, P1469, DOI 10.1126/science.1151710; Gulati P, 2014, BIOSCIENCE REP, V34, P621, DOI 10.1042/BSR20140111; Gulati P, 2013, P NATL ACAD SCI USA, V110, P2557, DOI 10.1073/pnas.1222796110; Han ZF, 2010, NATURE, V464, P1205, DOI 10.1038/nature08921; Jia GF, 2008, FEBS LETT, V582, P3313, DOI 10.1016/j.febslet.2008.08.019; Jia GF, 2011, NAT CHEM BIOL, V7, P885, DOI [10.1038/NCHEMBIO.687, 10.1038/nchembio.687]; Karra E, 2013, J CLIN INVEST, V123, P3539, DOI 10.1172/JCI44403; Lonsdale J, 2013, NAT GENET, V45, P580, DOI 10.1038/ng.2653; Loos RJF, 2014, NAT REV ENDOCRINOL, V10, P51, DOI 10.1038/nrendo.2013.227; McMurray F, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003166; Merkestein M, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7792; Sanchez-Pulido Luis, 2007, BMC Biochemistry, V8, P23, DOI 10.1186/1471-2091-8-23; Scuteri A, 2007, PLOS GENET, V3, P1200, DOI 10.1371/journal.pgen.0030115; Smemo S, 2014, NATURE, V507, P371, DOI 10.1038/nature13138; Tews D, 2013, ENDOCRINOLOGY, V154, P3141, DOI 10.1210/en.2012-1873; Tung YCL, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008771; Wu Q, 2010, BIOCHEM BIOPH RES CO, V401, P390, DOI 10.1016/j.bbrc.2010.09.064; Yang ZF, 2010, CURR OPIN CELL BIOL, V22, P124, DOI 10.1016/j.ceb.2009.11.014; Zhu JX, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0131782; Zimmet P, 2001, NATURE, V414, P782, DOI 10.1038/414782a	29	23	24	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 13	2017	12	3							e0168182	10.1371/journal.pone.0168182	http://dx.doi.org/10.1371/journal.pone.0168182			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN6CP	28288181	Green Published, Green Submitted, gold			2022-12-27	WOS:000396092400001
J	Chandler, CIR; Webb, EL; Maiteki-Sebuguzi, C; Nayiga, S; Nabirye, C; DiLiberto, DD; Ssemmondo, E; Dorsey, G; Kamya, MR; Staedke, SG				Chandler, Clare I. R.; Webb, Emily L.; Maiteki-Sebuguzi, Catherine; Nayiga, Susan; Nabirye, Christine; DiLiberto, Deborah D.; Ssemmondo, Emmanuel; Dorsey, Grant; Kamya, Moses R.; Staedke, Sarah G.			The impact of an intervention to introduce malaria rapid diagnostic tests on fever case management in a high transmission setting in Uganda: A mixed-methods cluster-randomized trial (PRIME)	PLOS ONE			English	Article							PUBLIC-HEALTH CENTERS; FEBRILE ILLNESS; MICROSCOPY; ACCURACY; CHILDREN; TANZANIA; PROTOCOL; TORORO	Background Rapid diagnostic tests for malaria (mRDTs) have been scaled-up widely across Africa. The PRIME study evaluated an intervention aiming to improve fever case management using mRDTs at public health centers in Uganda. Methods A cluster-randomized trial was conducted from 2010-13 in Tororo, a high malaria transmission setting. Twenty public health centers were randomized in a 1: 1 ratio to intervention or control. The intervention included training in health center management, fever case management with mRDTs, and patient-centered services; plus provision of mRDTs and artemether-lumefantrine (AL) when stocks ran low. Three rounds of Interviews were conducted with caregivers of children under five years of age as they exited health centers (N = 1400); reference mRDTs were done in children with fever (N = 1336). Health worker perspectives on mRDTs were elicited through semi-structured questionnaires (N = 49) and in-depth interviews (N = 10). The primary outcome was inappropriate treatment of malaria, defined as the proportion of febrile children who were not treated according to guidelines based on the reference mRDT. Findings There was no difference in inappropriate treatment of malaria between the intervention and control arms (24.0% versus 29.7%, adjusted risk ratio 0.81 [95% CI: 0.56, 1.17] p = 0.24). Most children (76.0%) tested positive by reference mRDT, but many were not prescribed AL (22.5% intervention versus 25.9% control, p = 0.53). Inappropriate treatment of children testing negative by reference mRDT with AL was also common (31.3% invention vs 42.4% control, p = 0.29). Health workers appreciated mRDTs but felt that integrating testing into practice was challenging given constraints on time and infrastructure. Conclusions The PRIME intervention did not have the desired impact on inappropriate treatment of malaria for children under five. In this high transmission setting, use of mRDTs did not lead to the reductions in antimalarial prescribing seen elsewhere. Broader investment in health systems, including infrastructure and staffing, will be required to improve fever case management.	[Chandler, Clare I. R.; Webb, Emily L.; DiLiberto, Deborah D.; Staedke, Sarah G.] London Sch Hyg & Trop Med, London, England; [Maiteki-Sebuguzi, Catherine; Nayiga, Susan; Nabirye, Christine; Ssemmondo, Emmanuel; Kamya, Moses R.; Staedke, Sarah G.] Infect Dis Res Collaborat, Kampala, Uganda; [Dorsey, Grant] Univ Calif San Francisco, Dept Med, San Francisco, CA USA; [Kamya, Moses R.] Makerere Univ, Coll Hlth Sci, Kampala, Uganda	University of London; London School of Hygiene & Tropical Medicine; University of California System; University of California San Francisco; Makerere University	Staedke, SG (corresponding author), London Sch Hyg & Trop Med, London, England.; Staedke, SG (corresponding author), Infect Dis Res Collaborat, Kampala, Uganda.	sarah.staedke@lshtm.ac.uk		Chandler, Clare/0000-0001-6499-7522; DiLiberto, Deborah/0000-0003-0528-5773	ACT Consortium through Bill and Melinda Gates Foundation [ITGBVG01]; Medical Research Council [MR/K012126/1] Funding Source: researchfish	ACT Consortium through Bill and Melinda Gates Foundation(Bill & Melinda Gates Foundation); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This work was supported by the ACT Consortium (http://www.actconsortium.org/) through a grant from the Bill and Melinda Gates Foundation to the London School of Hygiene & Tropical Medicine (ITGBVG01). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2012, T3 TEST TREAT TRACK; [Anonymous], 2011, UN ACC MAL DIAGN TES; Bhatt S, 2015, NATURE; Biehl J, 2006, GLOBAL PHARM ETHICS; Bisoffi Z, 2009, TROP MED INT HEALTH, V14, P491, DOI 10.1111/j.1365-3156.2009.02246.x; Bruxvoort K, 2013, TROP MED INT HEALTH, V18, P1269, DOI 10.1111/tmi.12168; Chandler CIR, 2013, IMPLEMENT SCI, V8, DOI 10.1186/1748-5908-8-113; Cundill B, 2015, BMC MED, V13, DOI 10.1186/s12916-015-0346-z; D'Acremont V, 2009, PLOS MED, V6, P4, DOI 10.1371/journal.pmed.0050252; Davies R., 2005, MOST SIGNIFICANT CHA; DiLiberto DD, 2015, GLOBAL HEALTH ACTION, V8, DOI 10.3402/gha.v8.29067; Elfving K, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0146054; Hamer DH, 2007, JAMA-J AM MED ASSOC, V297, P2227, DOI 10.1001/jama.297.20.2227; Hayes RJ, 2009, INTERD STAT, P3; Hildenwall H, 2016, TROP MED INT HEALTH, V21, P149, DOI 10.1111/tmi.12635; Hopkins H., 2008, EFFECTIVENESS SAFETY; Kilama M, 2014, MALARIA J, V13, DOI 10.1186/1475-2875-13-111; Kyabayinze DJ, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-695; Kyabayinze DJ, 2008, MALARIA J, V7, DOI 10.1186/1475-2875-7-221; Lubell Y, 2008, MALARIA J, V7, DOI 10.1186/1475-2875-7-21; Mbabazi P, 2015, AM J TROP MED HYG, V92, P530, DOI 10.4269/ajtmh.14-0180; Mbacham WF, 2014, LANCET GLOB HEALTH, V2, pE346, DOI 10.1016/S2214-109X(14)70201-3; Mbonye AK, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0129545; Namagembe A, 2012, MALARIA J, V11, DOI 10.1186/1475-2875-11-44; Nankabirwa JI, 2015, MALARIA J, V14, DOI 10.1186/s12936-015-1056-x; ONeill J., 2016, TACKLING DRUG RESIST; Rafael Maria E, 2006, Nature, V444 Suppl 1, P39, DOI 10.1038/nature05445; Reyburn H, 2007, BRIT MED J, V334, P403, DOI 10.1136/bmj.39073.496829.AE; Skarbinski J, 2009, AM J TROP MED HYG, V80, P919; Ssekabira U, 2008, AM J TROP MED HYG, V79, P826, DOI 10.4269/ajtmh.2008.79.826; Staedke S. G., 2010, PHASE 1 REPORT TOROR; Staedke SG, 2013, IMPLEMENT SCI, V8, DOI 10.1186/1748-5908-8-114; Staedke SG, 2016, AM J TROP MED HYG; The Longitude Prize, 2016, ANTIBIOTICS; WHO, 2015, GLOB TECHN STRAT MAL; WHO, 2010, GUID TREATM MAL, V2nd; WHO, 2015, WORLD MAL REP 2015	37	8	8	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 13	2017	12	3							e0170998	10.1371/journal.pone.0170998	http://dx.doi.org/10.1371/journal.pone.0170998			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN6CP	28288172	Green Published, Green Submitted, gold, Green Accepted			2022-12-27	WOS:000396092400004
J	Hernandez-Mir, G; McGeachy, MJ				Hernandez-Mir, Gerard; McGeachy, Mandy J.			CD73 is expressed by inflammatory Th17 cells in experimental autoimmune encephalomyelitis but does not limit differentiation or pathogenesis	PLOS ONE			English	Article							REGULATORY T-CELLS; CENTRAL-NERVOUS-SYSTEM; CYTOKINE GM-CSF; TGF-BETA; CUTTING EDGE; T(H)17 CELLS; IN-VIVO; NEUROINFLAMMATION; ADENOSINE; CD39	CD73 works together with CD39 to convert extracellular ATP to immunoregulatory adenosine, thus inhibiting inflammation. TGF beta-mediated CD73 expression on 'regulatory' Th17 cells limits their ability to eradicate tumors, similar to the immunosuppressive mechanism described for CD73 on Tregs. However, CD73 is also expressed on Th17 cells thought to be inflammatory in Crohn's disease. CD73 has previously been reported to contribute to inflammation in the central nervous system (CNS). In experimental autoimmune encephalomyelitis (EAE), we found that inflammatory cytokine-producing Th17 cells showed increased CD73 expression as disease progressed. We therefore hypothesized that CD73 could be important for limiting the expansion or pathogenic function of Th17 cells in autoimmune inflammation of the CNS. Surprisingly, EAE development was not enhanced or inhibited by CD73 deficiency; there was correspondingly no difference in induction of Th17-associated cytokines IL-17, IFN gamma or GM-CSF or recruitment of either inflammatory or regulatory cells to the central nervous system. We confirmed that CD73 was similarly not required for differentiation of Th17 cells in vitro. These data show that while CD73 expression is regulated during EAE, this enzyme is not absolutely required to either promote or limit Th17 cell expansion or EAE severity.	[Hernandez-Mir, Gerard; McGeachy, Mandy J.] Univ Pittsburgh, Dept Med, Div Rheumatol & Clin Immunol, Pittsburgh, PA 15260 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	McGeachy, MJ (corresponding author), Univ Pittsburgh, Dept Med, Div Rheumatol & Clin Immunol, Pittsburgh, PA 15260 USA.	mandymcgeachy@pitt.edu	Hernández Mir, Gerard/AAH-1971-2022; Hernández Mir, Gerard/AEP-4408-2022	Hernández Mir, Gerard/0000-0002-8934-4875; Hernández Mir, Gerard/0000-0002-8934-4875	NIH [AI110822]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R56AI110822, R01AI110822] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by the NIH AI110822 (to MJM). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; Funding for this study provided by NIH AI110822 (to MJM). Thanks to Sarah Gaffen and Partha Biswas for helpful comments and suggestions.	Alam MS, 2009, J INFECT DIS, V199, P494, DOI 10.1086/596205; Antonioli L, 2016, TRENDS CANCER, V2, P95, DOI 10.1016/j.trecan.2016.01.003; Bettelli E, 2006, NATURE, V441, P235, DOI 10.1038/nature04753; Chalmin F, 2012, IMMUNITY, V36, P362, DOI 10.1016/j.immuni.2011.12.019; Chatterjee S, 2014, CANCER RES, V74, P6048, DOI 10.1158/0008-5472.CAN-14-1450; Chen Y, 2011, IMMUNITY, V34, P409, DOI 10.1016/j.immuni.2011.02.011; Codarri L, 2011, NAT IMMUNOL, V12, P560, DOI 10.1038/ni.2027; Doherty GA, 2012, EUR J IMMUNOL, V42, P3062, DOI 10.1002/eji.201242623; Duhen R, 2013, J IMMUNOL, V190, P4478, DOI 10.4049/jimmunol.1203172; El-Behi M, 2011, NAT IMMUNOL, V12, P568, DOI 10.1038/ni.2031; Fernandez D, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0157889; Gaffen SL, 2014, NAT REV IMMUNOL, V14, P585, DOI 10.1038/nri3707; Gaublomme JT, 2015, CELL, V163, DOI 10.1016/j.cell.2015.11.009; Ghoreschi K, 2010, NATURE, V467, P967, DOI 10.1038/nature09447; Gutcher I, 2011, IMMUNITY, V34, P396, DOI 10.1016/j.immuni.2011.03.005; Haines CJ, 2013, CELL REP, V3, P1378, DOI 10.1016/j.celrep.2013.03.035; Hirota K, 2011, NAT IMMUNOL, V12, P255, DOI 10.1038/ni.1993; Huizinga R, 2012, J NEUROINFLAMM, V9, DOI 10.1186/1742-2094-9-266; Ingwersen J, 2016, J NEUROINFLAMM, V13, DOI 10.1186/s12974-016-0512-z; Ivanov II, 2007, SEMIN IMMUNOL, V19, P409, DOI 10.1016/j.smim.2007.10.011; Ivanov II, 2009, CELL, V139, P485, DOI 10.1016/j.cell.2009.09.033; Kobie JJ, 2006, J IMMUNOL, V177, P6780, DOI 10.4049/jimmunol.177.10.6780; Kohm AP, 2002, J IMMUNOL, V169, P4712, DOI 10.4049/jimmunol.169.9.4712; Korn T, 2007, NAT MED, V13, P423, DOI 10.1038/nm1564; Martin BN, 2016, NAT IMMUNOL, V17, P583, DOI 10.1038/ni.3389; Mascanfroni ID, 2013, NAT IMMUNOL, V14, P1054, DOI 10.1038/ni.2695; McGeachy MJ, 2007, NAT IMMUNOL, V8, P1390, DOI 10.1038/ni1539; McGeachy MJ, 2012, J IMMUNOL, V189, P3285, DOI 10.4049/jimmunol.1201834; McGeachy MJ, 2005, J IMMUNOL, V175, P3025, DOI 10.4049/jimmunol.175.5.3025; Mills JH, 2008, P NATL ACAD SCI USA, V105, P9325, DOI 10.1073/pnas.0711175105; Mills JH, 2012, J NEUROINFLAMM, V9, DOI 10.1186/1742-2094-9-193; Mills JH, 2012, J IMMUNOL, V188, P5713, DOI 10.4049/jimmunol.1200545; Pandiyan P, 2011, IMMUNITY, V34, P422, DOI 10.1016/j.immuni.2011.03.002; Patel DD, 2015, IMMUNITY, V43, P1040, DOI 10.1016/j.immuni.2015.12.003; Takenaka MC, 2016, TRENDS IMMUNOL, V37, P427, DOI 10.1016/j.it.2016.04.009; Veldhoen M, 2006, IMMUNITY, V24, P179, DOI 10.1016/j.immuni.2006.01.001; Wang Y, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5432; Yosef N, 2013, NATURE, V496, P461, DOI 10.1038/nature11981	38	9	9	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 13	2017	12	3							e0173655	10.1371/journal.pone.0173655	http://dx.doi.org/10.1371/journal.pone.0173655			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN6CP	28288184	Green Submitted, gold, Green Published			2022-12-27	WOS:000396092400024
J	Korhonen, M; Parkkonen, J; Hedman, M; Muuronen, A; Onatsu, J; Mustonen, P; Vanninen, R; Taina, M				Korhonen, Miika; Parkkonen, Johannes; Hedman, Marja; Muuronen, Antti; Onatsu, Juha; Mustonen, Pirjo; Vanninen, Ritva; Taina, Mikko			Morphological features of the left atrial appendage in consecutive coronary computed tomography angiography patients with and without atrial fibrillation	PLOS ONE			English	Article							INDEPENDENT RISK-FACTOR; THROMBOEMBOLIC RISK; THROMBUS FORMATION; VOLUME OVERLOAD; STROKE; ANATOMY; AGE; REGURGITATION; PRESSURE; DISEASE	The majority of intracardiac thrombi form in the left atrial appendage (LAA). Enlargement of this structure, together with certain morphological features, may indicate a predisposition to the formation of thrombi and subsequent cardioembolic stroke. Thus far, studies on LAA morphology have largely focused on those patients with atrial fibrillation (AF). Taking a different approach, we investigated the variation in LAA morphology in a consecutive patient population with and without AF. We evaluated 808 consecutive patients (529 females; mean age 52.5 +/- 9.9 years) who underwent coronary artery computed tomography angiography (CCTA), the majority of whom (749) had no history of AF. We assessed the length, lobe number, and morphological classification of their LAAs. Demographic data and medical histories were collated from medical records and then correlated with LAA morphology. The proportions of each of the four morphological classes of LAA for the overall vs. non-AF population were: WindSock, 62.3/61.5%; Cactus, 18.6/18.8%; ChickenWing, 10.0/10.0%; and CauliFlower, 9.2/9.6%. Age (p<0.001; r = 0.156) and female gender (p<0.001) were both found to be associated with an increased body surface area (BSA)-related LAA length. Male patients were more likely to manifest multi-lobed (p = 0.003) LAAs, and overweight patients with a greater number of multi-lobed LAA morphological classes (p = 0.010). No associations with morphological LAA features could be found for patients with diabetes, hypertension, or dyslipidemia. Nor did the size of the left atrium exhibit any correlation with BSA-related LAA length. In the overall and non-AF populations, aging and female gender were associated with longer BSA-indexed LAAs.	[Korhonen, Miika; Parkkonen, Johannes; Muuronen, Antti; Vanninen, Ritva; Taina, Mikko] Kuopio Univ Hosp, Dept Clin Radiol, Kuopio, Finland; [Korhonen, Miika; Parkkonen, Johannes; Muuronen, Antti; Vanninen, Ritva; Taina, Mikko] Univ Eastern Finland, Inst Clin Med, Radiol Unit, Kuopio, Finland; [Hedman, Marja] Kuopio Univ Hosp, Ctr Heart, Kuopio, Finland; [Onatsu, Juha] Kuopio Univ Hosp, Neuro Ctr, Kuopio, Finland; [Mustonen, Pirjo] Keski Suomi Cent Hosp, Dept Cardiol, Jyvaskyla, Finland	Kuopio University Hospital; University of Eastern Finland; University of Eastern Finland; Kuopio University Hospital; University of Eastern Finland; Kuopio University Hospital; University of Eastern Finland; Central Finland Central Hospital	Korhonen, M (corresponding author), Kuopio Univ Hosp, Dept Clin Radiol, Kuopio, Finland.; Korhonen, M (corresponding author), Univ Eastern Finland, Inst Clin Med, Radiol Unit, Kuopio, Finland.	miika.korhonen@kuh.fi		Korhonen, Miika/0000-0001-5280-1772	Kuopio University Hospital [5063519]; Finnish Cultural Foundation [65151616, 65161521]; Instrumentarium Science Foundation; Finnish Medical Foundation; Aarne Koskelo Foundation; Mauri and Sirkka Wiljasalo Fund	Kuopio University Hospital; Finnish Cultural Foundation(Finnish Cultural FoundationFinnish IT center for science); Instrumentarium Science Foundation; Finnish Medical Foundation; Aarne Koskelo Foundation; Mauri and Sirkka Wiljasalo Fund	This study was supported by the Kuopio University Hospital (5063519; www.kuh.fi), the Finnish Cultural Foundation (65151616 and 65161521; https://skr.fi/en), the Instrumentarium Science Foundation (no grant number available, granted on Jan 15th 2016; http://www.instrufoundation.fi/en.php), the Finnish Medical Foundation (no grant number available, applicant number and grant years: 3887/2015 and 3887/2016; http://www.laaketieteensaatio.fi/fin/in_english/), the Aarne Koskelo Foundation (no grant number available, granted on Dec 8th 2015; http://www.aamekoskelonsaatio.fi/) and the Mauri and Sirkka Wiljasalo Fund (no grant number available, granted on Apr 7th 2016; http://hae.uef.fi/en/web/guest/news-and-events/foundation-contacts-kuo). The funders had no role in study design, data collection and analysis, the decision to publish, or the preparation of this manuscript.	Aurigemma GP, 2009, CIRC-CARDIOVASC IMAG, V2, P282, DOI 10.1161/CIRCIMAGING.108.826602; Beigel R, 2014, JACC-CARDIOVASC IMAG, V7, P1251, DOI 10.1016/j.jcmg.2014.08.009; Boucebci S, 2016, EUR RADIOL, V26, P1512, DOI 10.1007/s00330-015-3962-2; Casaclang-Verzosa G, 2008, J AM COLL CARDIOL, V51, P1, DOI 10.1016/j.jacc.2007.09.026; Cohoon KP, 2015, J THROMB THROMBOLYS, V141, P1; Di Biase L, 2012, J AM COLL CARDIOL, V60, P531, DOI 10.1016/j.jacc.2012.04.032; Di Biase L, 2010, CIRCULATION, V122, P109, DOI 10.1161/CIRCULATIONAHA.109.928903; Faustino A, 2014, CARDIOVASC ULTRASOUN, V12, DOI 10.1186/1476-7120-12-28; Fukushima K, 2016, EUR HEART J-CARD IMG, V17, P59, DOI 10.1093/ehjci/jev117; GEHL LG, 1982, AM J CARDIOL, V49, P33, DOI 10.1016/0002-9149(82)90274-0; Gotzmann M, 2012, AM HEART J, V163, P903, DOI 10.1016/j.ahj.2012.03.017; Hart RG, 2014, LANCET NEUROL, V13, P429, DOI 10.1016/S1474-4422(13)70310-7; Holmes DR, 2009, LANCET, V374, P534, DOI 10.1016/S0140-6736(09)61343-X; Ilercil A, 2001, CLIN CARDIOL, V24, P39, DOI 10.1002/clc.4960240107; Imada M, 2007, INT J CARDIOL, V119, P384, DOI 10.1016/j.ijcard.2006.07.162; Iozzo P, 2011, DIABETES CARE, V34, pS371, DOI 10.2337/dc11-s250; KENNEDY JW, 1970, CIRCULATION, V41, P817, DOI 10.1161/01.CIR.41.5.817; Khurram IM, 2013, HEART RHYTHM, V10, P1843, DOI 10.1016/j.hrthm.2013.09.065; Kimura T, 2013, HEART RHYTHM, V10, P921, DOI 10.1016/j.hrthm.2013.01.036; Korhonen M, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0118822; Li CY, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0126818; Ma XJ, 2009, CLIN CARDIOL, V32, P264, DOI 10.1002/clc.20449; Maceira AM, 2010, J CARDIOVASC MAGN R, V12, DOI 10.1186/1532-429X-12-65; MOSTELLER RD, 1987, NEW ENGL J MED, V317, P1098, DOI 10.1056/nejm198710223171717; Movahed Mohammad Reza, 2008, Exp Clin Cardiol, V13, P89; Mozaffarian D, 2016, CIRCULATION, V133, pE38, DOI 10.1161/CIR.0000000000000350; Nedios S, 2014, HEART RHYTHM, V11, P2239, DOI 10.1016/j.hrthm.2014.08.016; Pan NH, 2008, CHEST, V133, P190, DOI 10.1378/chest.07-1769; Patel DA, 2009, OCHSNER J, V9, P191; Ploumen MAM, 2010, NETH HEART J, V18, P243, DOI 10.1007/BF03091770; Popescu BA, 2004, AM J CARDIOL, V93, P1156, DOI 10.1016/j.amjcard.2004.01.046; Romero J, 2014, NAT REV CARDIOL, V11, P470, DOI 10.1038/nrcardio.2014.77; Sabarudin A, 2013, WORLD J CARDIOL, V5, P459, DOI 10.4330/wjc.v5.i12.459; SANFILIPPO AJ, 1990, CIRCULATION, V82, P792, DOI 10.1161/01.CIR.82.3.792; Shirani J, 2000, CARDIOVASC PATHOL, V9, P95, DOI 10.1016/S1054-8807(00)00030-2; Tabata T, 1996, J Am Soc Echocardiogr, V9, P857, DOI 10.1016/S0894-7317(96)90478-2; Taina M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079519; Telman G, 2008, ACTA NEUROL SCAND, V117, P311, DOI 10.1111/j.1600-0404.2007.00953.x; Tsao Hsuan-Ming, 2016, Medicine (Baltimore), V95, pe3260, DOI 10.1097/MD.0000000000003260; Veinot JP, 1997, CIRCULATION, V96, P3112, DOI 10.1161/01.CIR.96.9.3112; Wang Y, 2010, J CARDIOVASC ELECTR, V21, P973, DOI 10.1111/j.1540-8167.2010.01814.x; Weigner MJ, 1999, HEART, V82, P555, DOI 10.1136/hrt.82.5.555; WOLF PA, 1991, STROKE, V22, P983, DOI 10.1161/01.STR.22.8.983; Yamamoto M, 2014, CIRC-CARDIOVASC IMAG, V7, P337, DOI 10.1161/CIRCIMAGING.113.001317	44	11	13	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 13	2017	12	3							e0173703	10.1371/journal.pone.0173703	http://dx.doi.org/10.1371/journal.pone.0173703			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN6CP	28288200	Green Published, Green Submitted, gold			2022-12-27	WOS:000396092400029
J	Lee, S; Zhao, MH; No, JG; Nam, Y; Im, GS; Hur, TY				Lee, Seunghoon; Zhao, Minghui; No, Jingu; Nam, Yoonseok; Im, Gi-Sun; Hur, Tai-Young			Dog cloning with in vivo matured oocytes obtained using electric chemiluminescence immunoassay-predicted ovulation method	PLOS ONE			English	Article							CELL NUCLEAR TRANSFER; ADULT SOMATIC-CELLS; SERUM PROGESTERONE; EARLY-PREGNANCY; ANTIBODIES; DIAGNOSIS; COWS; AGE	Radioactive immunoassay (RIA) is a traditional serum hormone assay method, but the application of the method in reproductive studies is limited by the associated radioactivity. The aim of present study was to evaluate the reliability of RIA and to compare its canine serum progesterone concentration determination accuracy to that of the electric chemiluminescence immunoassay (ECLI). In vivo matured oocytes were utilized for canine somatic cell nuclear transfer (SCNT), and serum progesterone levels were assessed to accurately determine ovulation and oocyte maturation. Canine serum progesterone concentrations during both proestrus and estrus were analyzed by RIA and ECLI to determine the ovulation day. Although both methods detected similar progesterone levels before ovulation, the mean progesterone concentration determined using ECLI was significantly higher than of RIA three days before ovulation. Following ovulation, oocytes were collected by surgery, and a lower percentage of mature oocytes were observed using ECLI (39%) as compared to RIA (67%) if 4-8ng/ml of progesterone were used for determination of ovulation. A high percentage of mature oocytes was observed using ECLI when 6-15 ng/mL of progesterone was used for ovulation determination. To determine whether ECLI could be used for canine cloning, six canines were selected as oocyte donors, and two puppies were obtained after SCNT and embryo transfer. In conclusion, compared to the traditional RIA method, the ECLI method is a safe and reliable method for canine cloning.	[Lee, Seunghoon; Zhao, Minghui; No, Jingu; Nam, Yoonseok; Im, Gi-Sun; Hur, Tai-Young] RDA, Natl Inst Anim Sci, Wonju, South Korea	National Institute of Animal Science, Republic of Korea; Rural Development Administration (RDA), Republic of Korea	Hur, TY (corresponding author), RDA, Natl Inst Anim Sci, Wonju, South Korea.	tyohur@gmail.com			Rural Development Administration, Republic of Korea [PJ01092802]	Rural Development Administration, Republic of Korea(Rural Development Administration (RDA), Republic of Korea)	This work was supported by a fund of Project No. PJ01092802 from Rural Development Administration, Republic of Korea. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2000, Nat Biotechnol, V18, P365; Campbell KHS, 1996, NATURE, V380, P64, DOI 10.1038/380064a0; Chapwanya A, 2008, THERIOGENOLOGY, V70, P795, DOI 10.1016/j.theriogenology.2008.05.047; Chastant-Maillard S, 2011, REPROD FERT DEVELOP, V23, P391, DOI 10.1071/RD10064; Chesne P, 2002, NAT BIOTECHNOL, V20, P366, DOI 10.1038/nbt0402-366; DIONYSIUS DA, 1991, AUST VET J, V68, P14, DOI 10.1111/j.1751-0813.1991.tb09832.x; Forster RJ, 2009, ANNU REV ANAL CHEM, V2, P359, DOI 10.1146/annurev-anchem-060908-155305; HUNT B, 1978, J AM VET MED ASSOC, V172, P1298; Ismail N, 2004, J CLIN MICROBIOL, V42, P610, DOI 10.1128/JCM.42.2.610-617.2004; Kato Y, 1998, SCIENCE, V282, P2095, DOI 10.1126/science.282.5396.2095; Kikuchi K, 2000, BIOL REPROD, V63, P715, DOI 10.1095/biolreprod63.3.715; Lee BC, 2005, NATURE, V436, P641, DOI 10.1038/436641a; Lee JH, 2008, CLONING STEM CELLS, V10, P381, DOI 10.1089/clo.2007.0091; MALLER JL, 1989, J CELL SCI, P53; Miao YL, 2009, HUM REPROD UPDATE, V15, P573, DOI 10.1093/humupd/dmp014; Moon J, 2014, J VET SCI, V15, P167, DOI 10.4142/jvs.2014.15.1.167; Ozturk OA, 2010, THERIOGENOLOGY, V73, P568, DOI 10.1016/j.theriogenology.2009.10.012; RISS PA, 1989, EUR J OBSTET GYN R B, V32, P71, DOI 10.1016/0028-2243(89)90186-X; Rousell R H, 1979, Ric Clin Lab, V9, P185; Schnieke AE, 1997, SCIENCE, V278, P2130, DOI 10.1126/science.278.5346.2130; Su L, 2012, REPROD DOMEST ANIM, V47, P184, DOI 10.1111/j.1439-0531.2009.01349.x; VERSTEGEN JP, 1993, J REPROD FERTIL, P165; Wakayama T, 1998, NATURE, V394, P369, DOI 10.1038/28615; Wani NA, 2010, BIOL REPROD, V82, P373, DOI 10.1095/biolreprod.109.081083; WEEKS I, 1983, CLIN CHEM, V29, P1474; Wood WG, 2008, CLIN LAB, V54, P423; Wu J. T., 2000, QUANTITATIVE IMMUNOA; You J, 2010, MOL REPROD DEV, V77, P149, DOI 10.1002/mrd.21115; Zhang SL, 2015, MEDICINE, V94, DOI 10.1097/MD.0000000000002059; Zhou Q, 2003, SCIENCE, V302, P1179, DOI 10.1126/science.1088313	30	7	7	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 13	2017	12	3							e0173735	10.1371/journal.pone.0173735	http://dx.doi.org/10.1371/journal.pone.0173735			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN6CP	28288197	gold, Green Published, Green Submitted			2022-12-27	WOS:000396092400034
J	Wieczorek, K; Lachowska-Cierlik, D; Kajtoch, L; Kanturski, M				Wieczorek, Karina; Lachowska-Cierlik, Dorota; Kajtoch, Lukasz; Kanturski, Mariusz			The relationships within the Chaitophorinae and Drepanosiphinae (Hemiptera, Aphididae) inferred from molecular-based phylogeny and comprehensive morphological data	PLOS ONE			English	Article							NUCLEAR GENE EF-1-ALPHA; SYCAMORE APHID; BAYESIAN-INFERENCE; MITOCHONDRIAL; HOMOPTERA; SYSTEMATICS; EVOLUTION; TRIBE; INSECTA; HOST	The Chaitophorinae is a bionomically diverse Holarctic subfamily of Aphididae. The current classification includes two tribes: the Chaitophorini associated with deciduous trees and shrubs, and Siphini that feed on monocotyledonous plants. We present the first phylogenetic hypothesis for the subfamily, based on molecular and morphological datasets. Molecular analyses were based on the mitochondrial gene cytochrome oxidase subunit I (COI) and the nuclear gene elongation factor-1 alpha (EF-1 alpha). Phylogenetic inferences were obtained individually on each of genes and joined alignments using Bayesian inference (BI) and Maximum likelihood (ML). In phylogenetic trees reconstructed on the basis of nuclear and mitochondrial genes as well as a morphological dataset, the monophyly of Siphini and the genus Chaitophorus was supported. Periphyllus forms independent lineages from Chaitophorus and Siphini. Within this genus two clades comprising European and Asiatic species, respectively, were indicated. Concerning relationships within the subfamily, EF-1 alpha and joined COI and EF-1 alpha genes analysis strongly supports the hypothesis that Chaitophorini do not form a monophyletic clade. Periphyllus is a sister group to a clade containing Chaitophorus and Siphini. The Asiatic unit of Periphyllus also includes Trichaitophorus koyaensis. The analysis of morphological dataset under equally weighted parsimony also supports the view that Chaitophorini is an artificial taxon, as Lambersaphis pruinosae and Pseudopterocomma hughi, both traditionally included in the Chaitophorini, formed independent lineages. COI analyses support consistent groups within the subfamily, but relationships between groups are poorly resolved. These analyses were extended to include the species of closely related and phylogenetically unstudied subfamily Drepanosiphinae, which produced congruent results. Genera Drepanosiphum and Depanaphis are monophyletic and sister. The position of Yamatocallis tokyoensis differs in the molecular and morphological analyses, i.e. it is either an independent lineage (EF-1 alpha, COI, joined COI and EF-1 alpha genes) or is nested inside this unit (morphology). Our data also support separation of Chaitophorinae from Drepanosiphinae.	[Wieczorek, Karina; Kanturski, Mariusz] Univ Silesia, Fac Biol & Environm Protect, Dept Zool, Katowice, Poland; [Lachowska-Cierlik, Dorota] Jagiellonian Univ, Inst Zool, Dept Entomol, Krakow, Poland; [Kajtoch, Lukasz] Polish Acad Sci, Inst Systemat & Evolut Anim, Krakow, Poland	University of Silesia in Katowice; Jagiellonian University; Polish Academy of Sciences; Institute of Systematics & Evolution of Animals of the Polish Academy of Sciences	Wieczorek, K (corresponding author), Univ Silesia, Fac Biol & Environm Protect, Dept Zool, Katowice, Poland.	karina.wieczorek@us.edu.pl	Kajtoch, Łukasz/B-4236-2012	Kajtoch, Łukasz/0000-0001-7345-9400; Wieczorek, Karina/0000-0002-8331-5731; Kanturski, Mariusz/0000-0002-1674-1028	National Science Centre, Poland [2011/01/B/NZ8/00157]	National Science Centre, Poland(National Science Centre, Poland)	This research was supported by the National Science Centre, Poland, grant no. 2011/01/B/NZ8/00157.	Basu AN, 1966, ENTOMOLOGISCHE BERIC, V26, P27; Blackman R. L., 2016, APHIDS WORLDS PLANTS; Blackman R.L., 2021, APHIDS WORLDS PLANTS; Blackman R.L., 2006, APHIDS WORLDS HERBAC, V1; Borner C., 1944, FAUNA DEUTSCHLAND BE; Borner C, 1957, HDB PFLANZENKRANKHEI, VV; Borner C., 1952, SCHRIFTEN THURINGISC, V3, P1; CHAKRABARTI S, 1986, ZOOL J LINN SOC-LOND, V88, P329, DOI 10.1111/j.1096-3642.1986.tb02250.x; Chen J, 2014, CLADISTICS, V30, P26, DOI 10.1111/cla.12024; Chen R, 2015, CLADISTICS; Chen R, 2013, SYST ENTOMOL, V38, P615, DOI 10.1111/syen.12018; Coeur d'Acier A, 2007, MOL PHYLOGENET EVOL, V42, P598, DOI 10.1016/j.ympev.2006.10.006; Coeur d'Acier A, 2008, ZOOL SCR, V37, P175, DOI 10.1111/j.1463-6409.2007.00317.x; Damgaard J, 2000, INSECT SYST EVOL, V31, P71, DOI 10.1163/187631200X00327; Dixon A.F.G., 1990, P11; DIXON AFG, 1966, J ANIM ECOL, V35, P105, DOI 10.2307/2692; DIXON AFG, 1969, J ANIM ECOL, V38, P585, DOI 10.2307/3037; DIXON AFG, 1972, J ANIM ECOL, V41, P689, DOI 10.2307/3203; Dixon AFG, 1998, APHID ECOLOGY OPTIMI; Durak R, 2014, J APPL GENET, V55, P89, DOI 10.1007/s13353-013-0184-7; Essig EO, 1952, APHID GENUS PERIPHYL; Favret C., 2011, REGISTERS FAMILY GRO; Favret C., 2016, APHID SPECIES FILE V; FELSENSTEIN J, 1985, EVOLUTION, V39, P783, DOI 10.1111/j.1558-5646.1985.tb00420.x; Folmer O., 1994, Molecular Marine Biology and Biotechnology, V3, P294; Foottit RG, 2008, MOL ECOL RESOUR, V8, P1189, DOI 10.1111/j.1755-0998.2008.02297.x; Friedrich F, 2014, ENTOMOL SCI, V17, P1, DOI 10.1111/ens.12053; Fukatsu T, 2001, APPL ENVIRON MICROB, V67, P5315, DOI 10.1128/AEM.67.11.5315-5320.2001; GHOSH AK, 1980, FAUNA INDIA ADJACE 1; Goloboff PA, 2008, CLADISTICS, V24, P774, DOI 10.1111/j.1096-0031.2008.00217.x; Hall T.A., 1999, NUCL ACIDS S SER, V41, P95; Heie O. E., 1967, Spolia Zoologica Musei Hauniensis, V26, P1; Heie OE, 1987, APHIDS THEIR BIOL NA, P392; HEIE OE, 1995, ENTOMOL MEDD, V63, P17; Heie OE, 1982, FAUNA ENTOMOLOGICA S; Heie Ole E., 2009, Redia, V92, P69; Higuchi H., 1972, Insecta Matsum, V35, P19; Hille Ris Lambers D, 1960, TIJDSCHR ENTOMOL, V103, P1; Holman J, 2009, HOST PLANT CATALOG A; Huang XL, 2012, ZOOL J LINN SOC-LOND, V165, P73, DOI 10.1111/j.1096-3642.2011.00795.x; Huelsenbeck JP, 2001, SCIENCE, V294, P2310, DOI 10.1126/science.1065889; Huelsenbeck JP, 2001, BIOINFORMATICS, V17, P754, DOI 10.1093/bioinformatics/17.8.754; Jousselin E, 2013, FRONT ZOOL, V10, DOI 10.1186/1742-9994-10-56; Kanturski M, 2016, ZOOTAXA IN PRESS; Kanturski MZ, 2015, MICRON, V76, P23, DOI 10.1016/j.micron.2015.05.004; Kim H, 2008, SYST ENTOMOL, V33, P711, DOI 10.1111/J.1365-3113.2008.00440.x; Kim H, 2008, MOL CELLS, V25, P510; Li XY, 2014, TURK J ZOOL, V38, P285, DOI 10.3906/zoo-1303-15; Lozier JD, 2008, ZOOTAXA, P1; MacGILLIVRAY M. E., 1963, CANADIAN ENTOMOL, V95, P941; MACKAUER M, 1965, CAN ENTOMOL, V97, P1016, DOI 10.4039/Ent971016-10; Martinez-Torres D, 2001, MOL PHYLOGENET EVOL, V20, P437, DOI 10.1006/mpev.2001.0983; Mier-Durante MP, 1998, FAUNA IBERICA, P11; MORDVILKO AK, 1948, OPREDELITEL NASEKOMY, P187; NARZIKULOV M. N., 1961, DOKL AKAD NAUK TADZHIKSK SSR, V4, P49; Normark BB, 2000, MOL PHYLOGENET EVOL, V14, P131, DOI 10.1006/mpev.1999.0699; Novakova E, 2014, MOL PHYLOGENET EVOL, V68, P12; Nylander J., 2004, MRMODELTEST V2, V2; Ortiz-Rivas B, 2004, MOL PHYLOGENET EVOL, V30, P24, DOI 10.1016/S1055-7903(03)00155-6; Ortiz-Rivas B, 2010, MOL PHYLOGENET EVOL, V55, P305, DOI 10.1016/j.ympev.2009.12.005; Ortiz-Rivas B, 2009, SYST ENTOMOL, V34, P293, DOI 10.1111/j.1365-3113.2008.00464.x; Page RDM, 1996, COMPUT APPL BIOSCI, V12, P357; Papasotiropoulos V, 2014, J BIOL RES IN PRESS, V20; Perez-Brocal Vicente, 2011, International Journal of Evolutionary Biology, V2011, P1, DOI 10.4061/2011/250154; PINTERA A, 1987, DEUT ENTOMOL Z, V34, P219, DOI 10.1002/mmnd.19870340402; PONSEN M B, 1983, Mededelingen Landbouwhogeschool Wageningen, V83, P1; Quednau F.W., 2010, MEMOIRS AM ENTOMOLOG, V83; QUEDNAU FW, 1976, CAN ENTOMOL, V108, P461, DOI 10.4039/Ent108461-5; RAMBAUT A., 2009, TRACER VERSION 1 5 M; Remaudiere G., 1997, CATALOGUE WORLDS APH; Richards WR, 1972, CHAITOPHORINAE CANAD, V87; Shaposhnikov G.C., 1985, P19; Shaposhnikov G.Kh, 1964, OPREDELITELNASEKOMYK, V1, P489; Shingleton AW, 2003, MOL PHYLOGENET EVOL, V26, P26, DOI 10.1016/S1055-7903(02)00328-7; SIMPSON Kathryn Mary, 2013, THESIS, P292; SMITH CF, 1968, ANN ENTOMOL SOC AM, V61, P185, DOI 10.1093/aesa/61.1.185; SORIN M, 1979, Kontyu, V47, P117; Stamatakis A, 2008, SYST BIOL, V57, P758, DOI 10.1080/10635150802429642; Stamatakis A, 2006, BIOINFORMATICS, V22, P2688, DOI 10.1093/bioinformatics/btl446; STARY P, 1970, ACTA ENTOMOL BOHEMOS, V67, P351; Stern DL, 1997, SYST ENTOMOL, V22, P81, DOI 10.1046/j.1365-3113.1997.d01-20.x; Sucimoto Shun'ichiro, 2013, Insecta Matsumurana, V69, P27; Swofford DL, 2002, PAUP PHYLOGENETIC AN; Szelegiewicz H., 1985, Klucze do Oznaczania Owadow Polski, V17, P1; SZELEGIEWICZ HENRYK, 1961, ANN ZOOL [POLAND], V19, P229; Takahashi R., 1923, GOVT RES I FORMOSA R, V4, P1; Takahashi R., 1927, DEP AGR GOVT RES I F, V22, P1; Thompson JD, 1997, NUCLEIC ACIDS RES, V25, P4876, DOI 10.1093/nar/25.24.4876; VANDERGOOT P, 1915, BEITRAGE KENNTNIS HO; von Dohlen Carol D., 2009, Redia, V92, P39; von Dohlen CD, 2006, MOL PHYLOGENET EVOL, V38, P316, DOI 10.1016/j.ympev.2005.04.035; von Dohlen CD, 2002, MOL PHYLOGENET EVOL, V23, P257, DOI 10.1016/S1055-7903(02)00025-8; Von Dohlen CD, 2000, BIOL J LINN SOC, V71, P689, DOI 10.1006/bijl.2000.0470; Wieczorek K, 2004, INSECT SYST EVOL, V35, P317, DOI 10.1163/187631204788920158; Wieczorek K, 2010, MONOGRAPH SIPHINI MO; Wieczorek K, 2016, ZOOL ANZ, V263, P92, DOI 10.1016/j.jcz.2016.04.005; Wieczorek K, 2016, ZOOTAXA, V4092, P583, DOI 10.11646/zootaxa.4092.4.8; Wieczorek K, 2015, ZOOL ANZ, V257, P39, DOI 10.1016/j.jcz.2015.04.002; Wieczorek K, 2014, AGR FOREST ENTOMOL, V16, P434, DOI 10.1111/afe.12073; Wieczorek K, 2013, ZOOTAXA, V3731, P324, DOI 10.11646/zootaxa.3731.3.2; Wieczorek K, 2011, ZOOMORPHOLOGY, V130, P289, DOI 10.1007/s00435-011-0134-z; Wieczorek K, 2011, SYST ENTOMOL, V36, P164, DOI 10.1111/j.1365-3113.2010.00550.x; Wojciechowski W., 1992, STUDIES SYSTEMATIC S; Yang ZX, 2010, ENTOMOL SCI, V13, P351, DOI 10.1111/j.1479-8298.2010.00391.x; Zhang HC, 2008, B ENTOMOL RES, V98, P499, DOI 10.1017/S0007485308005828; Zhang HC, 2007, B ENTOMOL RES, V97, P379, DOI 10.1017/S0007485307005020; Zhang RL, 2011, CURR ZOOL, V57, P806, DOI 10.1093/czoolo/57.6.806	107	7	7	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 13	2017	12	3							e0173608	10.1371/journal.pone.0173608	http://dx.doi.org/10.1371/journal.pone.0173608			31	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN6CP	28288166	Green Published, gold			2022-12-27	WOS:000396092400021
J	Zhou, N; Swamy, KBS; Leu, JY; McDonald, MJ; Galafassi, S; Compagno, C; Piskur, J				Zhou, Nerve; Swamy, Krishna B. S.; Leu, Jun-Yi; McDonald, Michael J.; Galafassi, Silvia; Compagno, Concetta; Piskur, Jure			Coevolution with bacteria drives the evolution of aerobic fermentation in Lachancea kluyveri	PLOS ONE			English	Article							SACCHAROMYCES-CEREVISIAE; CELL-WALL; METABOLISM; MITOCHONDRIA; DUPLICATION; YEASTS; DOA1; GENE	The Crabtree positive yeasts, such as Saccharomyces cerevisiae, prefer fermentation to respiration, even under fully aerobic conditions. The selective pressures that drove the evolution of this trait remain controversial because of the low ATP yield of fermentation compared to respiration. Here we propagate experimental populations of the weak-Crabtree yeast Lachancea kluyveri, in competitive co-culture with bacteria. We find that L. kluyveri adapts by producing quantities of ethanol lethal to bacteria and evolves several of the defining characteristics of Crabtree positive yeasts. We use precise quantitative analysis to show that the rate advantage of fermentation over aerobic respiration is insufficient to provide an overall growth advantage. Thus, the rapid consumption of glucose and the utilization of ethanol are essential for the success of the aerobic fermentation strategy. These results corroborate that selection derived from competition with bacteria could have provided the impetus for the evolution of the Crabtree positive trait.	[Zhou, Nerve; Piskur, Jure] Lund Univ, Dept Biol, Lund, Sweden; [Swamy, Krishna B. S.; Leu, Jun-Yi] Acad Sinica, Inst Mol Biol, Taipei, Taiwan; [McDonald, Michael J.] Monash Univ, Sch Biol Sci, Melbourne, Vic, Australia; [Galafassi, Silvia; Compagno, Concetta] Univ Milan, Dept Food Environm & Nutr Sci, Milan, Italy	Lund University; Academia Sinica - Taiwan; Monash University; University of Milan	Swamy, KBS (corresponding author), Lund Univ, Dept Biol, Lund, Sweden.	Nerve.Zhou@biol.lu.se; swamykrishnabs@gate.sinica.edu.tw	Galafassi, Silvia/ABI-7576-2020; SWAMY, KRISHNA/AAE-2637-2019; Leu, Jun-Yi/A-7364-2009	Galafassi, Silvia/0000-0001-5392-0271; SWAMY, KRISHNA/0000-0002-3868-6699; Leu, Jun-Yi/0000-0001-5445-2799; Zhou, Nerve/0000-0002-8822-1347	Cornucopia Project [264717]; Fysiografen Foundation; Lindstrom Foundation; Academia Sinica distinguished postdoctoral fellowship; Marie Curie Foundation; Academia Sinica of Taiwan [100-CDA-L04]; Taiwan Ministry of Science and Technology [NSC103-2321-B-001-001]	Cornucopia Project; Fysiografen Foundation; Lindstrom Foundation; Academia Sinica distinguished postdoctoral fellowship(Academia Sinica - Taiwan); Marie Curie Foundation(European Commission); Academia Sinica of Taiwan(Academia Sinica - Taiwan); Taiwan Ministry of Science and Technology	NZ was funded by the Marie Curie, Cornucopia Project (264717), Fysiografen and Lindstrom Foundations. KBSS was funded by an Academia Sinica distinguished postdoctoral fellowship. JYL was supported by Academia Sinica of Taiwan (100-CDA-L04) and the Taiwan Ministry of Science and Technology (NSC103-2321-B-001-001).	Altshuler D, 2000, NATURE, V407, P513, DOI 10.1038/35035083; Cherry JM., 2015, COLD SPRING HARB PRO, V2015; Crabtree HG, 1929, BIOCHEM J, V23, P536, DOI 10.1042/bj0230536; Dashko S, 2014, FEMS YEAST RES, V14, P826, DOI 10.1111/1567-1364.12161; DEDEKEN RH, 1966, J GEN MICROBIOL, V44, P149, DOI 10.1099/00221287-44-2-149; Hagman A, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0116942; Hagman A, 2014, FEBS J, V281, P4805, DOI 10.1111/febs.13019; Hagman A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068734; Hansen SK, 2007, NATURE, V445, P533, DOI 10.1038/nature05514; Ishchenko AA, 2005, MOL CELL BIOL, V25, P6380, DOI 10.1128/MCB.25.15.6380-6390.2005; Jung US, 1999, MOL MICROBIOL, V34, P1049, DOI 10.1046/j.1365-2958.1999.01667.x; KATAOKA T, 1984, CELL, V37, P437, DOI 10.1016/0092-8674(84)90374-X; Kellis M, 2004, NATURE, V428, P617, DOI 10.1038/nature02424; Merico A, 2007, FEBS J, V274, P976, DOI 10.1111/j.1742-4658.2007.05645.x; Moller K, 2002, BIOTECHNOL BIOENG, V77, P186, DOI 10.1002/bit.10122; Mortazavi A, 2008, NAT METHODS, V5, P621, DOI 10.1038/nmeth.1226; Mrsa V, 1999, YEAST, V15, P813, DOI 10.1002/(SICI)1097-0061(199907)15:10A<813::AID-YEA421>3.0.CO;2-Y; Mullally JE, 2006, MOL CELL BIOL, V26, P822, DOI 10.1128/MCB.26.3.822-830.2006; Okada N, 2014, FEMS YEAST RES, V14, P425, DOI 10.1111/1567-1364.12136; Pal C, 2007, NATURE, V450, P1079, DOI 10.1038/nature06350; Pardo M, 1999, YEAST, V15, P459, DOI 10.1002/(SICI)1097-0061(199904)15:6<459::AID-YEA387>3.0.CO;2-L; Pfeiffer T, 2001, SCIENCE, V292, P504, DOI 10.1126/science.1058079; Pfeiffer Thomas, 2014, Front Mol Biosci, V1, P17, DOI 10.3389/fmolb.2014.00017; PHILIPPSEN P, 1991, METHOD ENZYMOL, V194, P169; Piskur J, 2006, TRENDS GENET, V22, P183, DOI 10.1016/j.tig.2006.02.002; Rozpedowska E, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1305; SEEBOTH PG, 1990, J BACTERIOL, V172, P678, DOI 10.1128/jb.172.2.678-685.1990; Shulman RG, 2015, P NATL ACAD SCI USA, V112, P10902, DOI 10.1073/pnas.1510730112; Thomson JM, 2005, NAT GENET, V37, P630, DOI 10.1038/ng1553; Tkach JM, 2012, NAT CELL BIOL, V14, P966, DOI 10.1038/ncb2549; van Dijken JP, 2000, ENZYME MICROB TECH, V26, P706, DOI 10.1016/S0141-0229(00)00162-9; van Hoek P, 2000, ENZYME MICROB TECH, V26, P724, DOI 10.1016/S0141-0229(00)00164-2; VERDUYN C, 1992, YEAST, V8, P501, DOI 10.1002/yea.320080703; Vongsamphanh R, 2001, MOL CELL BIOL, V21, P1647, DOI 10.1128/MCB.21.5.1647-1655.2001; Warburg O, 1927, J GEN PHYSIOL, V8, P519, DOI 10.1085/jgp.8.6.519; Wolfe KH, 1997, NATURE, V387, P708, DOI 10.1038/42711; Wu X, 2016, J CELL BIOL, V213, P49, DOI 10.1083/jcb.201510098	37	18	18	0	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 10	2017	12	3							e0173318	10.1371/journal.pone.0173318	http://dx.doi.org/10.1371/journal.pone.0173318			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN6CJ	28282411	Green Published, gold			2022-12-27	WOS:000396091800029
J	Gutierrez-de-Juan, V; de Davalillo, SL; Fernandez-Ramos, D; Barbier-Torres, L; Zubiete-Franco, I; Fernandez-Tussy, P; Simon, J; Lopitz-Otsoa, F; de las Heras, J; Iruzubieta, P; Arias-Loste, MT; Villa, E; Crespo, J; Andrade, R; Lucena, MI; Varela-Rey, M; Lu, SC; Mato, JM; Delgado, TC; Martinez-Chantar, ML				Gutierrez-de-Juan, Virginia; Lopez de Davalillo, Sergio; Fernandez-Ramos, David; Barbier-Torres, Lucia; Zubiete-Franco, Imanol; Fernandez-Tussy, Pablo; Simon, Jorge; Lopitz-Otsoa, Fernando; de las Heras, Javier; Iruzubieta, Paula; Teresa Arias-Loste, Maria; Villa, Erica; Crespo, Javier; Andrade, Raul; Isabel Lucena, M.; Varela-Rey, Marta; Lu, Shelly C.; Mato, Jose M.; Cardoso Delgado, Teresa; Martinez-Chantar, Maria-Luz			A morphological method for ammonia detection in liver	PLOS ONE			English	Article							HEPATIC-ENCEPHALOPATHY; ARTERIAL AMMONIA; CIRRHOSIS; HYPERAMMONEMIA; FAILURE; COMPLICATIONS; HYPERTENSION; DISEASE; CELLS; RISK	Hyperammonemia is a metabolic condition characterized by elevated levels of ammonia and a common event in acute liver injury/ failure and chronic liver disease. Even though hepatic ammonia levels are potential predictive factors of patient outcome, easy and inexpensive methods aiming at the detection of liver ammonia accumulation in the clinical setting remain unavailable. Thus, herein we have developed a morphological method, based on the utilization of Nessler A s reagent, to accurately and precisely detect the accumulation of ammonia in biological tissue. We have validated our method against a commercially available kit in mouse tissue samples and, by using this modified method, we have confirmed the hepatic accumulation of ammonia in clinical and animal models of acute and chronic advanced liver injury as well as in the progression of fatty liver disease. Overall, we propose a morphological method for ammonia detection in liver that correlates well with the degree of liver disease severity and therefore can be potentially used to predict patient outcome.	[Gutierrez-de-Juan, Virginia; Lopez de Davalillo, Sergio; Fernandez-Ramos, David; Barbier-Torres, Lucia; Zubiete-Franco, Imanol; Fernandez-Tussy, Pablo; Simon, Jorge; Lopitz-Otsoa, Fernando; Varela-Rey, Marta; Mato, Jose M.; Cardoso Delgado, Teresa; Martinez-Chantar, Maria-Luz] Ctr Invest Biomed Red Enfermedades Hepat & Digest, CIC bioGUNE Ctr Cooperat Res Biosci, Derio, Bizkaia, Spain; [de las Heras, Javier; Crespo, Javier] Univ Basque Country, UPV EHU, BioCruces Hlth Res Inst, Div Pediat Metab,Univ Hosp Cruces, Baracaldo, Bizkaia, Spain; [Iruzubieta, Paula; Teresa Arias-Loste, Maria; Crespo, Javier] Ctr Invest Biomed Red Enfermedades Hepat & Digest, Dept Gastroenterol & Hepatol, Marques de Valdecilla Univ Hosp, Santander, Spain; [Iruzubieta, Paula; Teresa Arias-Loste, Maria] Res Inst Marques de Valdecilla IDIVAL, Infect Immun & Digest Pathol Grp, Santander, Spain; [Villa, Erica] Azienda Osped Univ, Dept Gastroenterol, Modena, Italy; [Villa, Erica] Univ Modena & Reggio Emilia, Modena, Italy; [Andrade, Raul; Isabel Lucena, M.] Univ Malaga, Ctr Invest Biomed Red Enfermedades Hepat & Digest, Hosp Univ Virgen de la Victoria,Inst Invest Biome, Unidad Gest Clin Aparato Digest,Serv Farmacol Cli, Malaga, Spain; [Lu, Shelly C.] Cedars Sinai Med Ctr, Div Digest & Liver Dis, Los Angeles, CA 90048 USA	CIBER - Centro de Investigacion Biomedica en Red; CIBEREHD; CIC bioGUNE; Hospital Universitario Cruces; University of Basque Country; CIBER - Centro de Investigacion Biomedica en Red; CIBEREHD; Hospital Universitario Marques de Valdecilla (HUMV); Hospital Universitario Marques de Valdecilla (HUMV); Universita di Modena e Reggio Emilia; Universita di Modena e Reggio Emilia Hospital; Universita di Modena e Reggio Emilia; CIBER - Centro de Investigacion Biomedica en Red; CIBEREHD; Universidad de Malaga; Cedars Sinai Medical Center	Delgado, TC; Martinez-Chantar, ML (corresponding author), Ctr Invest Biomed Red Enfermedades Hepat & Digest, CIC bioGUNE Ctr Cooperat Res Biosci, Derio, Bizkaia, Spain.	tcardoso@cicbiogune.es; mlmartinez@cicbiogune.es	Delgado, Teresa/ABF-9171-2020; Chantar, Maria Luz Martinez/F-5190-2011; Blanco, Leire/O-5114-2017; De Las Heras, Javier/G-6864-2013; Varela-Rey, Marta/C-5460-2019; Fernández-Ramos, David/ABD-1274-2021; Delgado, Teresa C/L-1681-2014; Lu, Shelly/AAH-5937-2021; Simon, Jorge/E-8663-2019; Fernández-Ramos, David/S-5231-2016; MATO, JOSE/A-5187-2011; Villa, Erica/A-7576-2012; Lopitz-Otsoa, Fernando/A-1966-2017	Delgado, Teresa/0000-0001-9204-581X; Chantar, Maria Luz Martinez/0000-0002-6446-9911; De Las Heras, Javier/0000-0001-5663-537X; Fernández-Ramos, David/0000-0003-4651-195X; Delgado, Teresa C/0000-0001-9204-581X; Lu, Shelly/0000-0003-2128-5407; Fernández-Ramos, David/0000-0003-4651-195X; MATO, JOSE/0000-0003-1264-3153; Villa, Erica/0000-0001-6388-7022; Lopitz-Otsoa, Fernando/0000-0001-8452-6939; Simon, Jorge/0000-0003-0404-6244; Crespo, Javier/0000-0001-8248-0172; Varela-Rey, Marta/0000-0002-2413-8659; IRUZUBIETA, PAULA/0000-0001-9476-1801; Arias-Loste, Maria Teresa/0000-0001-8864-3833	NIH (USDepartment of Health and Human services) [R01AT001576]; Gobierno Vasco-Departamento de Salud [2013111114]; MINECO [SAF20145 4658-R, SAF2014-52097-R]; Instituto de Salud Carlos III [PIE14/00031]; integrado en el Plan Estatal de Investigacion Cientifica y Tecnica y Innovacion 2013-2016 cofinanciado con Fondos FEDER; EITB; Asociacion Espanola contra el Cancer; Instituto de Salud Carlos III; National Center for Complementary & Integrative Health [R01AT001576] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK048522] Funding Source: NIH RePORTER	NIH (USDepartment of Health and Human services)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Gobierno Vasco-Departamento de Salud; MINECO(Spanish Government); Instituto de Salud Carlos III(Instituto de Salud Carlos IIIEuropean Commission); integrado en el Plan Estatal de Investigacion Cientifica y Tecnica y Innovacion 2013-2016 cofinanciado con Fondos FEDER; EITB; Asociacion Espanola contra el Cancer; Instituto de Salud Carlos III(Instituto de Salud Carlos IIIEuropean Commission); National Center for Complementary & Integrative Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by grants from NIH (USDepartment of Health and Human services)-R01AT001576 (to S.C.L., J.M.M and M.L.M-C.), Gobierno Vasco-Departamento de Salud 2013111114 (to M.L.M.-C), MINECO: SAF20145 4658-R and SAF2014-52097-R integrado en el Plan Estatal de Investigacion Cientifica y Tecnica y Innovacio 2013-2016 cofinanciado con Fondos FEDER to M.L.M.-C and J.M.M. respectively, Instituto de Salud Carlos III:PIE14/00031, integrado en el Plan Estatal de Investigacion Cientifica y Tecnica y Innovacion 2013-2016 cofinanciado con Fondos FEDER (toM.L.M.-C and J.M.M),EITB. BIO15/CA/014, Asociacion Espanola contra el Cancer (T.C.D, P.F-Tand M.L.M-C). Ciberehd_ISCIII_MINECO is funded by the Instituto de Salud Carlos III.Thefunders had no role in study design,datacollection and analysis,decision to publish,or preparation of the manuscript.	Bernal W, 2007, HEPATOLOGY, V46, P1844, DOI 10.1002/hep.21838; Bhatia V, 2006, GUT, V55, P98, DOI 10.1136/gut.2004.061754; Brannelly NT, 2016, CRIT REV ANAL CHEM, P1; Butterworth RF, 2009, LIVER INT, V29, P783, DOI 10.1111/j.1478-3231.2009.02034.x; Carpenter AE, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-10-r100; Drolz A, 2013, INTENS CARE MED, V39, P1227, DOI 10.1007/s00134-013-2926-8; Fernandez-Alyarezl S, 2015, LAB INVEST, V95, P223, DOI 10.1038/labinvest.2014.151; Fickert P, 2013, HEPATOLOGY, V58, P2056, DOI 10.1002/hep.26599; Ghabril M, 2013, CLIN PHARM DRUG DEV, V2, P278, DOI 10.1002/cpdd.18; Hashim IA, 2014, CLIN BIOCHEM, V47, P233, DOI 10.1016/j.clinbiochem.2014.08.013; Jalan R, 2007, MED HYPOTHESES, V69, P1064, DOI 10.1016/j.mehy.2006.12.061; Jalan R, 2016, J HEPATOL, V64, P823, DOI 10.1016/j.jhep.2015.11.019; Khan A, 2016, INT J HEPATOL, V2016, DOI 10.1155/2016/6741754; Kircheis G, 1997, HEPATOLOGY, V25, P1351, DOI 10.1002/hep.510250609; Kleiner DE, 2005, HEPATOLOGY, V41, P1313, DOI 10.1002/hep.20701; Kristiansen RG, 2014, AM J PHYSIOL-GASTR L, V307, pG1024, DOI 10.1152/ajpgi.00244.2014; Kumar A, 2017, HEPATOLOGY; Ling H, 1998, KIDNEY INT, V53, P1706, DOI 10.1046/j.1523-1755.1998.00952.x; MUNOZ SJ, 1988, GASTROENTEROL CLIN N, V17, P265; Niranjan-Azadi Ashwini M, 2016, Ann Transplant, V21, P479; Pacana T, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0136822; Popov Y, 2005, J HEPATOL, V43, P1045, DOI 10.1016/j.jhep.2005.06.025; Qiu J, 2013, P NATL ACAD SCI USA, V110, P18162, DOI 10.1073/pnas.1317049110; Tag CG, 2015, JOVE-J VIS EXP, DOI 10.3791/52438; Tapper EB, 2015, MAYO CLIN PROC, V90, P646, DOI 10.1016/j.mayocp.2015.03.003; Vierling JM, 2016, CLIN GASTROENTEROL H, V14, P903, DOI 10.1016/j.cgh.2015.11.018; Vogel AI, 1979, VOGELS TXB MACRO SEM; Walker V, 2014, ADV CLIN CHEM, V67, P73, DOI 10.1016/bs.acc.2014.09.002; Wright G, 2012, LIVER INT, V32, P410, DOI 10.1111/j.1478-3231.2011.02698.x	29	19	21	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 20	2017	12	3							0173914	10.1371/journal.pone.0173914	http://dx.doi.org/10.1371/journal.pone.0173914			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ER6VC	28319158	Green Published, gold			2022-12-27	WOS:000398945800034
J	Lukacisin, M; Landon, M; Jajoo, R				Lukacisin, Martin; Landon, Matthieu; Jajoo, Rishi			Sequence-specific thermodynamic properties of nucleic acids influence both transcriptional pausing and backtracking in yeast	PLOS ONE			English	Article							RNA-POLYMERASE-II; NUCLEOTIDE RESOLUTION; GENOME INSTABILITY; ELONGATION COMPLEX; PREDICT STABILITY; STRUCTURAL BASIS; DNA HYBRID; IN-VIVO; DYNAMICS; DUPLEXES	RNA Polymerase II pauses and backtracks during transcription, with many consequences for gene expression and cellular physiology. Here, we show that the energy required to melt double-stranded nucleic acids in the transcription bubble predicts pausing in Saccharomyces cerevisiae far more accurately than nucleosome roadblocks do. In addition, the same energy difference also determines when the RNA polymerase backtracks instead of continuing to move forward. This data-driven model corroborates-in a genome wide and quantitative manner-previous evidence that sequence-dependent thermodynamic features of nucleic acids influence both transcriptional pausing and backtracking.	[Lukacisin, Martin; Landon, Matthieu; Jajoo, Rishi] Harvard Med Sch, Dept Syst Biol, Boston, MA 02115 USA; [Lukacisin, Martin] IST Austria, Klosterneuburg, Austria; [Landon, Matthieu] Harvard Med Sch, Dept Genet, Boston, MA USA; [Landon, Matthieu] Mines Paristech, Ecole Mines Paris, Paris, France	Harvard University; Harvard Medical School; Institute of Science & Technology - Austria; Harvard University; Harvard Medical School; UDICE-French Research Universities; PSL Research University Paris; MINES ParisTech	Jajoo, R (corresponding author), Harvard Med Sch, Dept Syst Biol, Boston, MA 02115 USA.	rjajoo@uci.edu		Lukacisin, Martin/0000-0001-6549-4177	National Institutes of Health [GM08017]; Lynch Foundation	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Lynch Foundation	RJ has received support from National Institutes of Health Training Grant GM08017 and is a fellow of the Jane Coffin Childs Memorial Fund. MLa is a Lynch Fellow, supported by The Lynch Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbondanzieri EA, 2005, NATURE, V438, P460, DOI 10.1038/nature04268; Alexander RD, 2010, MOL CELL, V40, P582, DOI 10.1016/j.molcel.2010.11.005; Bai L, 2004, J MOL BIOL, V344, P335, DOI 10.1016/j.jmb.2004.08.107; Bai L, 2006, ANNU REV BIOPH BIOM, V35, P343, DOI 10.1146/annurev.biophys.35.010406.150153; Bintu L, 2012, CELL, V151, P738, DOI 10.1016/j.cell.2012.10.009; Brogaard K, 2012, NATURE, V486, P496, DOI 10.1038/nature11142; Cheung ACM, 2011, NATURE, V471, P249, DOI 10.1038/nature09785; Churchman LS, 2011, NATURE, V469, P368, DOI 10.1038/nature09652; Depken M, 2013, CELL REP, V5, P521, DOI 10.1016/j.celrep.2013.09.007; Depken M, 2009, BIOPHYS J, V96, P2189, DOI 10.1016/j.bpj.2008.12.3918; Dutta D, 2011, CELL, V146, P533, DOI 10.1016/j.cell.2011.07.034; Epshtein V, 2003, EMBO J, V22, P4719, DOI 10.1093/emboj/cdg452; Gnatt AL, 2001, SCIENCE, V292, P1876, DOI 10.1126/science.1059495; Hein PP, 2014, NAT STRUCT MOL BIOL, V21, P794, DOI 10.1038/nsmb.2867; Helmrich A, 2013, NAT STRUCT MOL BIOL, V20, P412, DOI 10.1038/nsmb.2543; HYMAN LE, 1993, MOL CELL BIOL, V13, P5159, DOI 10.1128/MCB.13.9.5159; Imashimizu M, 2015, GENOME BIOL, V16, DOI 10.1186/s13059-015-0666-5; Kireeva ML, 2000, J BIOL CHEM, V275, P6530, DOI 10.1074/jbc.275.9.6530; Landick R, 2006, BIOCHEM SOC T, V34, P1062, DOI 10.1042/BST0341062; Larson MH, 2014, SCIENCE, V344, P1042, DOI 10.1126/science.1251871; Lucks JB, 2011, P NATL ACAD SCI USA, V108, P11063, DOI 10.1073/pnas.1106501108; Mavrich TN, 2008, GENOME RES, V18, P1073, DOI 10.1101/gr.078261.108; Mayer A, 2015, CELL, V161, P541, DOI 10.1016/j.cell.2015.03.010; Nechaev S, 2010, SCIENCE, V327, P335, DOI 10.1126/science.1181421; Nudler E, 1997, CELL, V89, P33, DOI 10.1016/S0092-8674(00)80180-4; Nudler E, 2012, CELL, V149, P1438, DOI 10.1016/j.cell.2012.06.003; OMAOILEIDIGH D, 2011, BIOPHYS J, V100, P1157; Proctor JR, 2013, NUCLEIC ACIDS RES, V41, DOI 10.1093/nar/gkt174; SantaLucia J, 1998, P NATL ACAD SCI USA, V95, P1460, DOI 10.1073/pnas.95.4.1460; Sugimoto N, 1996, NUCLEIC ACIDS RES, V24, P4501, DOI 10.1093/nar/24.22.4501; SUGIMOTO N, 1995, BIOCHEMISTRY-US, V34, P11211, DOI 10.1021/bi00035a029; Sydow JF, 2009, CURR OPIN STRUC BIOL, V19, P732, DOI 10.1016/j.sbi.2009.10.009; Sydow JF, 2009, MOL CELL, V34, P710, DOI 10.1016/j.molcel.2009.06.002; Tadigotla VR, 2006, P NATL ACAD SCI USA, V103, P4439, DOI 10.1073/pnas.0600508103; Thomas MJ, 1998, CELL, V93, P627, DOI 10.1016/S0092-8674(00)81191-5; Vvedenskaya IO, 2014, SCIENCE, V344, P1285, DOI 10.1126/science.1253458; Watkins NE, 2011, NUCLEIC ACIDS RES, V39, P1894, DOI 10.1093/nar/gkq905; Weber CM, 2014, MOL CELL, V53, P819, DOI 10.1016/j.molcel.2014.02.014; Weilbaecher RG, 2003, J BIOL CHEM, V278, P24189, DOI 10.1074/jbc.M211197200; Zamft B, 2012, P NATL ACAD SCI USA, V109, P8948, DOI 10.1073/pnas.1205063109; Zhao Y, 2012, GENETICS, V191, P781, DOI 10.1534/genetics.112.138685	41	3	3	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 16	2017	12	3							e0174066	10.1371/journal.pone.0174066	http://dx.doi.org/10.1371/journal.pone.0174066			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN9KE	28301878	Green Submitted, Green Published, gold			2022-12-27	WOS:000396318300121
J	Adedokun, ST; Adekanmbi, VT; Uthman, OA; Lilford, RJ				Adedokun, Sulaimon T.; Adekanmbi, Victor T.; Uthman, Olalekan A.; Lilford, Richard J.			Contextual factors associated with health care service utilization for children with acute childhood illnesses in Nigeria	PLOS ONE			English	Article							SEEKING; FEVER; DETERMINANTS; MALARIA; MODEL	Objective To examine the independent contribution of individual, community and state-level factors to health care service utilization for children with acute childhood illnesses in Nigeria. Materials and methods The study was based on secondary analyses of cross-sectional population-based data from the 2013 Nigeria Demographic and Health Survey (DHS). Multilevel logistic regression models were applied to the data on 6,427 under-five children who used or did not use health care service when they were sick (level 1), nested within 896 communities (level 2) from 37 states (level 3). Results About one-quarter of the mothers were between 15 and 24 years old and almost half of them did not have formal education (47%). While only 30% of the children utilized health service when they were sick, close to 67% lived in the rural area. In the fully adjusted model, mothers with higher education attainment (Adjusted odds ratio [aOR] = 1.63; 95% credible interval [CrI] = 1.31-2.03), from rich households (aOR = 1.76; 95% CrI = 1.35-2.25), with access to media (radio, television or magazine) (aOR = 1.18; 95% CrI = 1.08-1.29), and engaging in employment (aOR = 1.18; 95% CrI = 1.02-1.37) were significantly more likely to have used healthcare services for acute childhood illnesses. On the other hand, women who experienced difficulty getting to health facilities (aOR = 0.87; 95% CrI = 0.75-0.99) were less likely to have used health service for their children. Conclusions Our findings highlight that utilization of healthcare service for acute childhood illnesses was influenced by not only maternal factors but also community-level factors, suggesting that public health strategies should recognise this complex web of individual composition and contextual composition factors to guide provision of healthcare services. Such interventions could include: increase in female school enrolment, provision of interest-free loans for small and medium scale enterprises, introduction of mobile clinics and establishment of more primary health care centres.	[Adedokun, Sulaimon T.; Uthman, Olalekan A.; Lilford, Richard J.] Univ Warwick, Sch Med, Div Hlth Sci, WCAHRD, Coventry, W Midlands, England; [Adedokun, Sulaimon T.] Obafemi Awolowo Univ, Dept Demog & Social Stat, Ife, Nigeria; [Adekanmbi, Victor T.] Univ Warwick, Sch Med, NIHR Collaborat Leadership Appl Hlth Res & Care, West Midlands CLAHRC WM, Coventry, W Midlands, England	University of Warwick; Obafemi Awolowo University; University of Warwick	Adedokun, ST (corresponding author), Univ Warwick, Sch Med, Div Hlth Sci, WCAHRD, Coventry, W Midlands, England.; Adedokun, ST (corresponding author), Obafemi Awolowo Univ, Dept Demog & Social Stat, Ife, Nigeria.	s.adedokun@warwick.ac.uk	Uthman, Olalekan/N-5584-2019	Uthman, Olalekan/0000-0002-8567-3081; Lilford, Richard/0000-0002-0634-984X; Adekanmbi, Victor/0000-0002-7394-1640	Consortium for Advanced Research Training in Africa (CARTA); Wellcome Trust (UK) [087547/Z/08/Z]; Carnegie Corporation of New York [B 8606.R02]; Sida [54100029]	Consortium for Advanced Research Training in Africa (CARTA); Wellcome Trust (UK)(Wellcome Trust); Carnegie Corporation of New York; Sida	This study was supported by the Consortium for Advanced Research Training in Africa (CARTA) through the fund for the Postdoctoral Fellowship of the first author at University of Warwick Medical School. CARTA is jointly led by the African Population and Health Research Center and the University of the Witwatersrand and funded by the Wellcome Trust (UK) (Grant No: 087547/Z/08/Z), the Carnegie Corporation of New York (Grant No: B 8606.R02), Sida (Grant No: 54100029). The funder had no role in the design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adika VO, 2013, J RES NURSING MIDWIF, V2, P6; Akogun OB, 2005, MALARIA J, V4, DOI 10.1186/1475-2875-4-13; Alegana VA, 2012, INT J HEALTH GEOGR, V11, DOI 10.1186/1476-072X-11-6; ANDERSEN RM, 1995, J HEALTH SOC BEHAV, V36, P1, DOI 10.2307/2137284; Aremu O, 2011, ITAL J PEDIATR, V37, DOI 10.1186/1824-7288-37-13; Beiersmann C, 2007, MALARIA J, V6, DOI 10.1186/1475-2875-6-106; Bennett A., 2015, DHS WORKING PAPERS; Benova L, 2015, SOCIOECONOMIC INEQUA, V15; Chandwani H, 2015, INDIA ELECT PHYS, V7, P990; Ewing VL, 2011, MALARIA J, V10, DOI 10.1186/1475-2875-10-32; Filmer D, 2001, DEMOGRAPHY, V38, P115, DOI 10.2307/3088292; Gao WL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043103; Gebretsadik A, 2015, INT J FAMILY MED; Geldsetzer P, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0093427; Goldstein H, 1995, MULTILEVEL STAT MODE, V2nd; Grace MM, 2005, AFR HEALTH SCI, V3, P322; Hu Y, 2013, INT J ENV RES PUB HE, V10, P2845, DOI 10.3390/ijerph10072845; Kassile T, 2014, MALARIA J, V13, DOI 10.1186/1475-2875-13-348; Kenny A, 2015, J GLOB HEALTH, V5, P48, DOI 10.7189/jogh.05.020401; Khun S, 2008, INT J EQUITY HEALTH, V7, DOI 10.1186/1475-9276-7-10; Larsen K, 2000, BIOMETRICS, V56, P909, DOI 10.1111/j.0006-341X.2000.00909.x; Larsen K, 2005, AM J EPIDEMIOL, V161, P81, DOI 10.1093/aje/kwi017; Montgomery MR, 2000, DEMOGRAPHY, V37, P155, DOI 10.2307/2648118; National Population Commission (NPC) [Nigeria] and ICF International, 2014, NIG DEM HLTH SURV 20; Ndugwa RP, 2008, J CHILD HEALTH CARE, V12, P314, DOI 10.1177/1367493508096206; Nilanjana Ghosh, 2013, International Journal of Medicine and Public Health, V3, P12; Odu BP, 2015, INFECT DIS POVERTY, V4, DOI 10.1186/2049-9957-4-1; Okeke TA, 2009, HEALTHPOL; Ombaka JH., 2015, AM J PUBLIC HLTH RES, V3, P21, DOI DOI 10.12691/AJPHR-3-1-4; Omore R, 2013, AM J TROP MED HYG, V89, P29, DOI 10.4269/ajtmh.12-0755; Rasbash Jon., 2015, USERS GUIDE MLWIN VE; Ruhul A, 2010, INT J EQUITY HLTH, V9; Shaikh Babar T, 2011, World Health Popul, V12, P24; Sreeramareddy Chandrashekhar T, 2006, BMC Int Health Hum Rights, V6, P7, DOI 10.1186/1472-698X-6-7; StataCorp, 2015, STAT STAT SOFTW; Taffa N, 2005, TROP MED INT HEALTH, V10, P240, DOI 10.1111/j.1365-3156.2004.01381.x; Teerawichitchainan B, 2008, SOC SCI MED, V66, P1118, DOI 10.1016/j.socscimed.2007.10.020; UNICEF WHO & World Bank Group., 2021, LEVELS TRENDS CHILD; USAID, 2016, AFR KEY FACTS FIG CH; USAID/POLICY, 2002, CHILD SURV NIG SIT R; Uzochukwu BSC, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001788; Vyas S, 2006, HEALTH POLICY PLANN, V21, P459, DOI 10.1093/heapol/czl029; WHO, 2016, CAUS CHILDMORT COUNT	43	18	18	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 15	2017	12	3							e0173578	10.1371/journal.pone.0173578	http://dx.doi.org/10.1371/journal.pone.0173578			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EN9HQ	28296905	Green Published, Green Accepted, gold			2022-12-27	WOS:000396311700043
J	Boulanger, M; Giraudet, G; Faubert, J				Boulanger, Mathieu; Giraudet, Guillaume; Faubert, Jocelyn			Interaction between the oculomotor and postural systems during a dual-task: Compensatory reductions in head sway following visually-induced postural perturbations promote the production of accurate double-step saccades in standing human adults	PLOS ONE			English	Article							NECK MUSCLE RESPONSES; TRANSCRANIAL MAGNETIC STIMULATION; MONKEY SUPERIOR COLLICULUS; EYE-MOVEMENTS; GAZE SHIFTS; VESTIBULOOCULAR REFLEX; UNRESTRAINED MONKEY; FEEDBACK-CONTROL; BODY SWAY; COORDINATION	Humans routinely scan their environment for useful information using saccadic eye movements and/or coordinated movements of the eyes and other body segments such the head and the torso. Most previous eye movement studies were conducted with seated subject and showed that single saccades and sequences of saccades (e.g. double-step saccades) made to briefly flashed stimuli were equally accurate and precise. As one can easily appreciate, most gaze shifts performed daily by a given person are not produced from a seated position, but rather from a standing position either as subjects perform an action from an upright stance or as they walk from one place to another. In the experiments presented here, we developed a new dual-task paradigm in order to study the interaction between the gaze control system and the postural system. Healthy adults (n = 12) were required to both maintain balance and produce accurate single-step and double-step eye saccades from a standing position. Visually-induced changes in head sway were evoked using wide-field background stimuli that either moved in the mediolateral direction or in the anteroposterior direction. We found that, as in the seated condition, single-and double-step saccades were very precise and accurate when made from a standing position, but that a tighter control of head sway was necessary in the more complex double-step saccades condition for equivalent results to be obtained. Our perturbation results support the "common goal" hypothesis that state that if necessary, as was the case during the more complex oculomotor task, context-dependent modulations of the postural system can be triggered to reduced instability and therefore support the accomplishment of a suprapostural goal.	[Boulanger, Mathieu; Giraudet, Guillaume; Faubert, Jocelyn] Univ Montreal, Ecole Optometrie, Montreal, PQ, Canada; [Boulanger, Mathieu] McGill Univ, Jewish Rehabil Hosp, Laval, PQ, Canada	Universite de Montreal; McGill University	Boulanger, M (corresponding author), Univ Montreal, Ecole Optometrie, Montreal, PQ, Canada.; Boulanger, M (corresponding author), McGill Univ, Jewish Rehabil Hosp, Laval, PQ, Canada.	mathieu.boulanger@mail.mcgill.ca	Faubert, Jocelyn/E-2207-2011		Natural Sciences and Engineering Research Council of Canada (NSERC) [IRCPJ 305729-13]	Natural Sciences and Engineering Research Council of Canada (NSERC)(Natural Sciences and Engineering Research Council of Canada (NSERC))	This work was supported by Natural Sciences and Engineering Research Council of Canada (NSERC). NSERC-ESSILOR Industrial Chair IRCPJ 305729-13; www.nserc-crsng.gc.ca/index_eng.asp. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anastasopoulos D, 2011, MOVEMENT DISORD, V26, P2201, DOI 10.1002/mds.23798; Anastasopoulos D, 2009, EXP BRAIN RES, V193, P323, DOI 10.1007/s00221-008-1627-y; ANDREDESHAYS C, 1988, EXP BRAIN RES, V69, P399; ANDREDESHAYS C, 1991, EXP BRAIN RES, V84, P359; BECKER W, 1979, VISION RES, V19, P967, DOI 10.1016/0042-6989(79)90222-0; Bernstein NA., 1967, COORDINATION REGULAT; BIZZI E, 1971, SCIENCE, V173, P452, DOI 10.1126/science.173.3995.452; Bonnet CT, 2014, J MOTOR BEHAV, V46, P397, DOI 10.1080/00222895.2014.924472; Bonnet CT, 2012, HUM MOVEMENT SCI, V31, P1541, DOI 10.1016/j.humov.2012.05.001; Boulanger M, 2012, J NEUROPHYSIOL, V108, P39, DOI 10.1152/jn.01092.2011; Buonocore A, 2015, EXP BRAIN RES, V233, P1893, DOI 10.1007/s00221-015-4261-5; Carpenter MG, 2001, GAIT POSTURE, V13, P35, DOI 10.1016/S0966-6362(00)00093-X; Chapman BB, 2012, J NEUROPHYSIOL, V107, P1694, DOI 10.1152/jn.00487.2011; Choi WY, 2006, NEURON, V50, P491, DOI 10.1016/j.neuron.2006.03.032; Choi WY, 2009, J NEUROSCI, V29, P7166, DOI 10.1523/JNEUROSCI.5038-08.2009; Corneil BD, 2002, J NEUROPHYSIOL, V88, P2000, DOI 10.1152/jn.2002.88.4.2000; Corneil BD, 2002, J NEUROPHYSIOL, V88, P1980, DOI 10.1152/jn.2002.88.4.1980; Corneil BD, 2014, NEURON, V82, P1230, DOI 10.1016/j.neuron.2014.05.040; Cullen KE, 2004, J NEUROPHYSIOL, V92, P3408, DOI 10.1152/jn.01156.2003; DASSONVILLE P, 1992, EXP BRAIN RES, V89, P300; Elsley JK, 2007, J NEUROPHYSIOL, V98, P1333, DOI 10.1152/jn.00386.2007; Faubert J, 2004, PROC SPIE, V5291, P491, DOI 10.1117/12.527017; Gandhi NJ, 2005, J NEUROPHYSIOL, V93, P1718, DOI 10.1152/jn.00854.2004; GELLMAN RS, 1991, EXP BRAIN RES, V87, P433; Giveans MR, 2011, ECOL PSYCHOL, V23, P247, DOI 10.1080/10407413.2011.617215; Goonetilleke SC, 2015, J NEUROPHYSIOL, V114, P902, DOI 10.1152/jn.00230.2015; Goonetilleke SC, 2011, EUR J NEUROSCI, V33, P2155, DOI 10.1111/j.1460-9568.2011.07711.x; Goossens HHLM, 2010, J NEUROPHYSIOL, V103, P1685, DOI 10.1152/jn.00788.2009; Goossens HHLM, 1997, J NEUROPHYSIOL, V78, P533, DOI 10.1152/jn.1997.78.1.533; Goossens HHLM, 2000, J NEUROPHYSIOL, V83, P3411, DOI 10.1152/jn.2000.83.6.3411; Goossens HHLM, 1997, EXP BRAIN RES, V114, P542, DOI 10.1007/PL00005663; Greffou S, 2008, J VISION, V8, DOI 10.1167/8.11.15; Gu C, 2014, J NEUROSCI, V34, P14803, DOI 10.1523/JNEUROSCI.2907-14.2014; GUITTON D, 1987, J NEUROPHYSIOL, V58, P427, DOI 10.1152/jn.1987.58.3.427; HALLETT PE, 1976, VISION RES, V16, P107, DOI 10.1016/0042-6989(76)90084-5; Hanssens JM, 2013, EXP BRAIN RES, V229, P75, DOI 10.1007/s00221-013-3592-3; Hunter MC, 2001, GAIT POSTURE, V13, P41, DOI 10.1016/S0966-6362(00)00089-8; Huxhold O, 2006, BRAIN RES BULL, V69, P294, DOI 10.1016/j.brainresbull.2006.01.002; Jahn K, 2006, EXP BRAIN RES, V174, P152, DOI 10.1007/s00221-006-0431-9; Kikukawa M., 1985, VESTIBULAR VISUAL CO, P355; Lacour M, 2008, NEUROPHYSIOL CLIN, V38, P411, DOI 10.1016/j.neucli.2008.09.005; Laurens J, 2010, GAIT POSTURE, V31, P37, DOI 10.1016/j.gaitpost.2009.08.241; LAURUTIS VP, 1986, J PHYSIOL-LONDON, V373, P209, DOI 10.1113/jphysiol.1986.sp016043; Legrand A, 2013, EXP BRAIN RES, V227, P397, DOI 10.1007/s00221-013-3519-z; Lehnen N, 2009, EXP BRAIN RES, V194, P495, DOI 10.1007/s00221-009-1708-6; Marino AC, 2016, FRONT SYST NEUROSCI, V10, DOI 10.3389/fnsys.2016.00003; MAYS LE, 1980, SCIENCE, V208, P1163, DOI 10.1126/science.6769161; McCluskey MK, 2007, J NEUROPHYSIOL, V97, P2976, DOI 10.1152/jn.00822.2006; Medendorp WP, 2006, J NEUROPHYSIOL, V95, P1645, DOI 10.1152/jn.00905.2005; Monzani D, 2005, Acta Otorhinolaryngol Ital, V25, P224; Oblak B., 1985, VESTIBULAR VISUAL CO, P122; Oommen BS, 2005, BRAIN RES, V1065, P68, DOI 10.1016/j.brainres.2005.10.029; PELISSON D, 1989, EXP BRAIN RES, V78, P654; PELISSON D, 1995, EXP BRAIN RES, V106, P196; PELISSON D, 1988, J NEUROPHYSIOL, V59, P997, DOI 10.1152/jn.1988.59.3.997; Piponnier JC, 2009, J VISION, V9, DOI 10.1167/9.1.13; Quaia C, 2010, J VISION, V10, DOI 10.1167/10.14.28; Ray S, 2004, VISION RES, V44, P2707, DOI 10.1016/j.visres.2004.05.029; Rey F, 2008, AURIS NASUS LARYNX, V35, P185, DOI 10.1016/j.anl.2007.07.001; Rodrigues ST, 2015, NEUROSCI LETT, V584, P292, DOI 10.1016/j.neulet.2014.10.045; Roll J. P., 1987, EYE MOVEMENTS PHYSL, P57; ROLL JP, 1988, INT CONGR SER, V812, P155; Rougier P, 2006, NEUROPHYSIOL CLIN, V36, P235, DOI 10.1016/j.neucli.2006.09.003; Rougier P, 2007, MOTOR CONTROL, V11, P213, DOI 10.1123/mcj.11.3.213; Saglam M, 2011, J NEUROSCI, V31, P16185, DOI 10.1523/JNEUROSCI.3721-11.2011; Scharli AM, 2013, EXP BRAIN RES, V227, P523, DOI 10.1007/s00221-013-3528-y; Scharli AM, 2012, GAIT POSTURE, V36, P78, DOI 10.1016/j.gaitpost.2012.01.008; SCHLAGREY M, 1989, EXP BRAIN RES, V76, P537, DOI 10.1007/BF00248910; Sommer MA, 2004, J NEUROPHYSIOL, V91, P1403, DOI 10.1152/jn.00740.2003; Sommer MA, 2008, ANNU REV NEUROSCI, V31, P317, DOI 10.1146/annurev.neuro.31.060407.125627; SPARKS DL, 1983, J NEUROPHYSIOL, V49, P45, DOI 10.1152/jn.1983.49.1.45; Stahl JS, 2001, EXP BRAIN RES, V136, P200, DOI 10.1007/s002210000593; Stahl JS, 1999, EXP BRAIN RES, V126, P41, DOI 10.1007/s002210050715; Stoffregen TA, 2000, HUM MOVEMENT SCI, V19, P203, DOI 10.1016/S0167-9457(00)00009-9; Stoffregen TA, 1999, J EXP PSYCHOL HUMAN, V25, P1641; Stoffregen TA, 2007, J MOTOR BEHAV, V39, P126, DOI 10.3200/JMBR.39.2.126-138; Stoffregen TA, 2006, ECOL PSYCHOL, V18, P191, DOI 10.1207/s15326969eco1803_3; Sylvestre PA, 2006, J NEUROSCI, V26, P4922, DOI 10.1523/JNEUROSCI.4099-05.2006; Tabak S, 1996, J NEUROPHYSIOL, V76, P3249, DOI 10.1152/jn.1996.76.5.3249; TEASDALE N, 1993, EXP AGING RES, V19, P1, DOI 10.1080/03610739308253919; Todorov E, 2004, NAT NEUROSCI, V7, P907, DOI 10.1038/nn1309; Todorov E, 2002, NAT NEUROSCI, V5, P1226, DOI 10.1038/nn963; TOMLINSON RD, 1986, J NEUROPHYSIOL, V56, P1542, DOI 10.1152/jn.1986.56.6.1542; TOMLINSON RD, 1990, J NEUROPHYSIOL, V64, P1873, DOI 10.1152/jn.1990.64.6.1873; UCHIDA T, 1980, NEUROSCI LETT, V18, P219, DOI 10.1016/0304-3940(80)90329-8; UCHIDA T, 1979, NEUROSCI LETT, V13, P253, DOI 10.1016/0304-3940(79)91503-9; van der Kooij H, 2011, GAIT POSTURE, V34, P19, DOI 10.1016/j.gaitpost.2011.02.025; VIDAL PP, 1982, EXP BRAIN RES, V46, P448; Vliegen J, 2005, J NEUROPHYSIOL, V94, P4300, DOI 10.1152/jn.00027.2005; WHITE KD, 1980, SCIENCE, V208, P621, DOI 10.1126/science.7367888; Wolsley CJ, 1996, EXP BRAIN RES, V111, P283; Wolsley CJ, 1996, BRAIN RES BULL, V40, P437, DOI 10.1016/0361-9230(96)00139-6; Woollacott M, 2002, GAIT POSTURE, V16, P1, DOI 10.1016/S0966-6362(01)00156-4	93	8	8	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 15	2017	12	3							e0173678	10.1371/journal.pone.0173678	http://dx.doi.org/10.1371/journal.pone.0173678			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EN9HQ	28296958	Green Published, gold, Green Submitted			2022-12-27	WOS:000396311700049
J	El Dib, R; Gomaa, H; Ortiz, A; Politei, J; Kapoor, A; Barreto, F				El Dib, Regina; Gomaa, Huda; Ortiz, Alberto; Politei, Juan; Kapoor, Anil; Barreto, Fellype			Enzyme replacement therapy for Anderson-Fabry disease: A complementary overview of a Cochrane publication through a linear regression and a pooled analysis of proportions from cohort studies	PLOS ONE			English	Article							AGALSIDASE BETA TREATMENT; NATURAL-HISTORY DATA; QUALITY-OF-LIFE; ALPHA-GALACTOSIDASE; OPEN-LABEL; GASTROINTESTINAL SYMPTOMS; CLINICAL-MANIFESTATIONS; PEDIATRIC-PATIENTS; EARLY INITIATION; RENAL-FUNCTION	Background Anderson-Fabry disease (AFD) is an X-linked recessive inborn error of glycosphingolipid metabolism caused by a deficiency of alpha-galactosidase A. Renal failure, heart and cerebrovascular involvement reduce survival. A Cochrane review provided little evidence on the use of enzyme replacement therapy (ERT). We now complement this review through a linear regression and a pooled analysis of proportions from cohort studies. Objectives To evaluate the efficacy and safety of ERT for AFD. Materials and methods For the systematic review, a literature search was performed, from inception to March 2016, using Medline, EMBASE and LILACS. Inclusion criteria were cohort studies, patients with AFD on ERT or natural history, and at least one patient-important outcome (all-cause mortality, renal, cardiovascular or cerebrovascular events, and adverse events) reported. The pooled proportion and the confidence interval (CI) are shown for each outcome. Simple linear regressions for composite endpoints were performed. Results 77 cohort studies involving 15,305 participants proved eligible. The pooled proportions were as follows: a) for renal complications, agalsidase alfa 15.3% [95% CI 0.048, 0.303; I-2 = 77.2%, p = 0.0005]; agalsidase beta 6% [95% CI 0.04, 0.07; I-2 = not applicable]; and untreated patients 21.4% [95% CI 0.1522, 0.2835; I-2 = 89.6%, p<0.0001]. Effect differences favored agalsidase beta compared to untreated patients; b) for cardiovascular complications, agalsidase alfa 28% [95% CI 0.07, 0.55; I-2 = 96.7%, p<0.0001]; agalsidase beta 7% [95% CI 0.05, 0.08; I-2 = not applicable]; and untreated patients 26.2% [95% CI 0.149, 0.394; I-2 = 98.8%, p<0.0001]. Effect differences favored agalsidase beta compared to untreated patients; and c) for cerebrovascular complications, agalsidase alfa 11.1% [95% CI 0.058, 0.179; I-2 = 70.5%, p = 0.0024]; agalsidase beta 3.5% [95% CI 0.024, 0.046; I-2 = 0%, p = 0.4209]; and untreated patients 18.3% [95% CI 0.129, 0.245; I-2 = 95% p<0.0001]. Effect differences favored agalsidase beta over agalsidase alfa or untreated patients. A linear regression showed that Fabry patients receiving agalsidase alfa are more likely to have higher rates of composite endpoints compared to those receiving agalsidase beta. Conclusions Agalsidase beta is associated to a significantly lower incidence of renal, cardiovascular and cerebrovascular events than no ERT, and to a significantly lower incidence of cerebrovascular events than agalsidase alfa. In view of these results, the use of agalsidase beta for preventing major organ complications related to AFD can be recommended.	[El Dib, Regina] Unesp Univ Estadual Paulista, Inst Sci & Technol, Sao Jose Dos Campos, Brazil; [El Dib, Regina; Kapoor, Anil] McMaster Univ, McMaster Inst Urol, Hamilton, ON, Canada; [Gomaa, Huda] Tanta Chest Hosp, Dept Pharm, Tanta, Egypt; [Ortiz, Alberto] Univ Autonoma Madrid, IIS Fdn Jimenez Diaz, Madrid, Spain; [Politei, Juan] Dr Nestor Chamoles Lab Neurochem, Neurol Serv, Buenos Aires, DF, Argentina; [Barreto, Fellype] Univ Fed Parana, Serv Nephrol, Dept Internal Med, Curitiba, Parana, Brazil	Universidade Estadual Paulista; McMaster University; Egyptian Knowledge Bank (EKB); Tanta University; Autonomous University of Madrid; Fundacion Jimenez Diaz; Universidade Federal do Parana	El Dib, R (corresponding author), Unesp Univ Estadual Paulista, Inst Sci & Technol, Sao Jose Dos Campos, Brazil.; El Dib, R (corresponding author), McMaster Univ, McMaster Inst Urol, Hamilton, ON, Canada.	eldib@ict.unesp.br	Dib, Regina El/ABC-8178-2020; ortiz, alberto/Y-7582-2018; Barreto, Fellype C/C-6517-2012; Kapoor, Anil/AAQ-7184-2021	Dib, Regina El/0000-0002-4081-803X; ortiz, alberto/0000-0002-9805-9523; Barreto, Fellype C/0000-0002-6394-9227; Kapoor, Anil/0000-0001-9180-8029; Gomaa, Huda/0000-0002-6500-1106	Spanish Government; FEDER funds Intensificacion and RETIC REDINREN [RD016/0021]; Brazilian Research Council (CNPq) [310953/2015-4]	Spanish Government(Spanish GovernmentEuropean Commission); FEDER funds Intensificacion and RETIC REDINREN; Brazilian Research Council (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ))	Alberto Ortiz has been funded by Spanish Government and FEDER funds Intensificacion and RETIC REDINREN RD016/0021. Regina El Dib received a Brazilian Research Council (CNPq) scholarship (#310953/2015-4). The funding agencies played no role in the conduct of the research or preparation of the manuscript.	Aerts JM, 2008, P NATL ACAD SCI USA, V105, P2812, DOI 10.1073/pnas.0712309105; Alderson P, 2003, BRIT MED J, V326, P475, DOI 10.1136/bmj.326.7387.475; Anderson LJ, 2014, J INHERIT METAB DIS, V37, P969, DOI 10.1007/s10545-014-9717-4; Arash-Kaps L, 2014, C PUBLICATION VAR S1, V37, pS145; Baehner F, 2003, J INHERIT METAB DIS, V26, P617, DOI 10.1023/B:BOLI.0000005658.14563.77; Banikazemi M, 2007, ANN INTERN MED, V146, P77, DOI 10.7326/0003-4819-146-2-200701160-00148; Barba-Romero MA, 2011, INT J CLIN PRACT, V65, P903, DOI 10.1111/j.1742-1241.2011.02695.x; Beer M, 2006, AM J CARDIOL, V97, P1515, DOI 10.1016/j.amjcard.2005.11.087; Borgwardt L, 2013, CLIN GENET, V83, P432, DOI 10.1111/j.1399-0004.2012.01947.x; Branton MH, 2002, MEDICINE, V81, P122, DOI 10.1097/00005792-200203000-00003; Choi JH, 2008, J KOREAN MED SCI, V23, P243, DOI 10.3346/jkms.2008.23.2.243; Collin C, 2012, EUR J PREV CARDIOL, V19, P43, DOI 10.1177/1741826710391118; Cook DJ, 1997, ANN INTERN MED, V126, P376, DOI 10.7326/0003-4819-126-5-199703010-00006; Crutchfield KE, 1998, NEUROLOGY, V50, P1746, DOI 10.1212/WNL.50.6.1746; Cybulla M, 2013, NEPHROL DIAL TRANSPL, V28, P287; Dehout F, 2004, J INHERIT METAB DIS, V27, P499, DOI 10.1023/B:BOLI.0000037342.59612.69; DERSIMONIAN R, 1986, CONTROL CLIN TRIALS, V7, P177, DOI 10.1016/0197-2456(86)90046-2; Dominguez RO, 2006, REV NEUROLOGIA, V43, P201, DOI 10.33588/rn.4304.2005610; DONATI D, 1987, NEPHRON, V46, P353, DOI 10.1159/000184389; Douglas GJ McKechine, 2015, MOL GENET METAB, V114, pS11; El Dib R, 2016, COCHRANE DB SYST REV; El Dib R, 2013, ACTA CIR BRAS, V28, P870, DOI 10.1590/S0102-86502013001200010; El Dib R, 2012, BJU INT, V110, P510, DOI 10.1111/j.1464-410X.2011.10885.x; El Dib RP, 2007, J EVAL CLIN PRACT, V13, P689, DOI 10.1111/j.1365-2753.2007.00886.x; Elliott PM, 2006, HEART, V92, P357, DOI 10.1136/hrt.2004.054015; Eng CM, 2007, J INHERIT METAB DIS, V30, P184, DOI 10.1007/s10545-007-0521-2; Eng CM, 2001, NEW ENGL J MED, V345, P9, DOI 10.1056/NEJM200107053450102; Eto Y, 2005, J INHERIT METAB DIS, V28, P575, DOI 10.1007/s10545-005-0575-y; Feriozzi S, 2012, CLIN J AM SOC NEPHRO, V7, P60, DOI 10.2215/CJN.03130411; Boas PJFV, 2013, J EVAL CLIN PRACT, V19, P633, DOI 10.1111/j.1365-2753.2012.01877.x; Fujiwara M, 2007, TOKYO JIKEIKAI MED J, V122, P295; Germain DP, 2013, GENET MED, V15, P958, DOI 10.1038/gim.2013.53; Goto H, 2013, C PUBLICATION VAR S1, V36, pS261; Guffon N, 2004, J INHERIT METAB DIS, V27, P221, DOI 10.1023/B:BOLI.0000028726.11177.8b; Guffon N, 2003, J MED GENET, V40, DOI 10.1136/jmg.40.4.e38; Hebert A, 2013, MOL GENET METAB, V108, pS47, DOI 10.1016/j.ymgme.2012.11.109; Hilz MJ, 2010, J HYPERTENS, V28, P1438, DOI 10.1097/HJH.0b013e328336a077; Hoffmann B, 2007, CLIN GASTROENTEROL H, V5, P1447, DOI 10.1016/j.cgh.2007.08.012; Hopkin R, 2013, MOL GENET METAB, V108, pS49, DOI 10.1016/j.ymgme.2012.11.113; Hopkin R, 2012, MOL GENET METAB, V105, pS36, DOI 10.1016/j.ymgme.2011.11.079; Hughes DA, 2011, MOL GENET METAB, V103, P207, DOI 10.1016/j.ymgme.2011.03.022; Imbriaco M, 2009, HEART, V95, P1103, DOI 10.1136/hrt.2008.162800; Jardim LB, 2006, J INHERIT METAB DIS, V29, P653, DOI 10.1007/s10545-006-0339-3; Johnson FK, 2016, MOL GENET METAB, V117, pS63, DOI 10.1016/j.ymgme.2015.12.307; Kalliokoski RJ, 2006, J INHERIT METAB DIS, V29, P112, DOI 10.1007/s10545-006-0221-3; Kampmann C, 2008, INT J CARDIOL, V130, P367, DOI 10.1016/j.ijcard.2008.03.007; Kampmann C, 2015, ORPHANET J RARE DIS, V10, DOI 10.1186/s13023-015-0338-2; Kantola I, 2012, CLIN THER, V1, pe21; Kim JH, 2015, C PUBLICATION VAR S1, V38, pS265; Kisinovsky I, 2013, MEDICINA-BUENOS AIRE, V73, P31; Kobayashi M, 2008, J Inherit Metab Dis, V31 Suppl 3, P483, DOI 10.1007/s10545-007-0740-6; Kobayashi M, 2005, J INHERIT METAB D S1, V28; Koskenvuo JW, 2008, J INHERIT METAB DIS, V31, P432, DOI 10.1007/s10545-008-0848-3; Lin DY, 2009, AM J HUM GENET, V85, P862, DOI 10.1016/j.ajhg.2009.11.001; Lin HY, 2013, BMJ OPEN, V3, DOI 10.1136/bmjopen-2013-003146; Linhart A, 2007, EUR HEART J, V28, P1228, DOI 10.1093/eurheartj/ehm153; Linthorst GE, 2004, KIDNEY INT, V66, P1589, DOI 10.1111/j.1523-1755.2004.00924.x; Lobo T, 2008, INTERN MED J, V38, P407, DOI 10.1111/j.1445-5994.2008.01669.x; Lubanda JC, 2009, GENET MED, V11, P256, DOI 10.1097/GIM.0b013e3181981d82; MacDermot KD, 2001, J MED GENET, V38, P769, DOI 10.1136/jmg.38.11.769; Martins AM, 2013, GENET MOL RES, V12, P136, DOI 10.4238/2013.January.24.5; Martins AM, 2014, J YMGME; Mehta A, 2009, LANCET, V12, P374; Meikle PJ, 1999, JAMA-J AM MED ASSOC, V281, P249, DOI 10.1001/jama.281.3.249; Moher David, 2009, Ann Intern Med, V151, P264, DOI [10.1136/bmj.b2535, 10.1016/j.ijsu.2010.02.007]; Motwani M, 2012, MOL GENET METAB, V107, P197, DOI 10.1016/j.ymgme.2012.05.011; Ortiz A, 2016, J MED GENET, V53, P495, DOI 10.1136/jmedgenet-2015-103486; Ortiz A, 2010, NEPHROL DIAL TRANSPL, V25, P769, DOI 10.1093/ndt/gfp554; Pano A, 2014, MOL GENET METAB, V111, pS84, DOI 10.1016/j.ymgme.2013.12.201; Parini R, 2008, CLIN GENET, V74, P260, DOI 10.1111/j.1399-0004.2008.01012.x; Pastores GM, 2007, NEPHROL DIAL TRANSPL, V22, P1920, DOI 10.1093/ndt/gfm096; Patel MR, 2011, J AM COLL CARDIOL, V57, P1093, DOI 10.1016/j.jacc.2010.11.018; Pisani A, 2005, AM J KIDNEY DIS, V46, P120, DOI 10.1053/j.ajkd.2005.03.016; Prabakaran T, 2014, NEPHROL DIAL TRANSPL, V29, P619, DOI 10.1093/ndt/gft452; Ramaswami U, 2012, CLIN GENET, V81, P485, DOI 10.1111/j.1399-0004.2011.01671.x; Ries M, 2006, PEDIATRICS, V118, P924, DOI 10.1542/peds.2005-2895; Gallego AR, 2006, MED CLIN-BARCELONA, V127, P481, DOI 10.1157/13093265; Rombach SM, 2014, J INHERIT METAB DIS, V37, P341, DOI 10.1007/s10545-014-9677-8; Rombach SM, 2013, ORPHANET J RARE DIS, V8, DOI 10.1186/1750-1172-8-47; Sanchez-Nino MD, 2015, HUM MOL GENET, V24, P5720, DOI 10.1093/hmg/ddv291; Schiffmann R, 2001, JAMA-J AM MED ASSOC, V285, P2743, DOI 10.1001/jama.285.21.2743; Schiffmann R, 2007, J AM SOC NEPHROL, V18, P1576, DOI 10.1681/ASN.2006111263; Schiffmann R, 2014, ORPHANET J RARE DIS, V9, DOI 10.1186/s13023-014-0169-6; Schiffmann R, 2009, NEPHROL DIAL TRANSPL, V24, P2102, DOI 10.1093/ndt/gfp031; Schwarting A, 2006, CLIN NEPHROL, V66, P77; Shemesh E, 2015, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD010324.pub2; Sims K, 2009, STROKE, V40, P788, DOI 10.1161/STROKEAHA.108.526293; Sirrs SM, 2014, MOL GENET METAB, V111, P499, DOI 10.1016/j.ymgme.2014.01.014; Spada M, 2006, AM J HUM GENET, V79, P31, DOI 10.1086/504601; Spinelli L, 2004, CLIN GENET, V66, P158, DOI 10.1111/j.1399-0004.2004.00284.x; Stroup DF, 2000, JAMA-J AM MED ASSOC, V283, P2008, DOI 10.1001/jama.283.15.2008; Talbot AS, 2015, HEART, V101, P287, DOI 10.1136/heartjnl-2014-306278; Thofehrn S, 2009, RENAL FAILURE, V31, P773, DOI 10.3109/08860220903150296; Tondel C, 2013, J AM SOC NEPHROL, V24, P137, DOI 10.1681/ASN.2012030316; Tsuboi K, 2015, C PUBLICATION VAR S1, V38, pS291; Tsuboi K, 2015, C PUBLICATION VAR S1, V38, pS292; Vedder AC, 2007, J INHERIT METAB DIS, V30, P68, DOI 10.1007/s10545-006-0484-8; Vedder AC, 2008, MOL GENET METAB, V94, P319, DOI 10.1016/j.ymgme.2008.03.003; Warnock DG, 2012, NEPHROL DIAL TRANSPL, V27, P1042, DOI 10.1093/ndt/gfr420; Watt T, 2010, GENET MED, V12, P703, DOI 10.1097/GIM.0b013e3181f13a4a; Weidemann F, 2013, J INTERN MED, V274, P331, DOI 10.1111/joim.12077; WEST M, 2013, MOL GENET METAB, V108, pS97; West M, CANADIAN FABRY DISEA; Whybra C, 2009, GENET MED, V11, P441, DOI 10.1097/GIM.0b013e3181a23bec; Wraith JE, 2008, J PEDIATR-US, V152, P563, DOI 10.1016/j.jpeds.2007.09.007; Wu JC, 2010, EUR HEART J, V31, P1088, DOI 10.1093/eurheartj/ehp588	106	53	55	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 15	2017	12	3							e0173358	10.1371/journal.pone.0173358	http://dx.doi.org/10.1371/journal.pone.0173358			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN9HQ	28296917	Green Submitted, Green Published, gold			2022-12-27	WOS:000396311700035
J	Hradec, M; Linhart, P; Bartos, L; Bolechova, P				Hradec, Michal; Linhart, Pavel; Bartos, Ludek; Bolechova, Petra			The traits of the great calls in the juvenile and adolescent gibbon males Nomascus gabriellae	PLOS ONE			English	Article							HYLOBATES-GABRIELLAE	Knowledge about vocal ontogeny and vocal plasticity during ontogeny in primate species is central to understanding the evolution of human speech. Vocalizations in gibbons (Hominoidea) are very interesting and contain complex species-and sex-specific patterns. However, ontogeny of gibbon songs is little studied. Here, we document regular production and ontogenetic changes of female-specific "great call" in 4 immature (2 juvenile-c.a. 3 years old; and 2 adolescent-c.a. 5 years old) males of southern yellow-cheeked gibbon (N. gabriellae) over nine months. None of the males produced fully developed adult-like "great call" and little ontogenetic changes to "great calls" occurred. "Great calls" of sons were shorter, started higher and ended lower than those of their mothers. Regular production of twitter part of great call likely appears around 4th year as it was observed in adolescent but not in juvenile males.	[Hradec, Michal; Bartos, Ludek; Bolechova, Petra] Czech Univ Life Sci Prague, Dept Anim Sci & Ethol, Prague, Czech Republic; [Linhart, Pavel; Bartos, Ludek] Inst Anim Sci, Dept Ethol, Prague, Czech Republic; [Bolechova, Petra] Zoo Liberec, Liberec, Czech Republic	Czech University of Life Sciences Prague; Czech Research Institute of Animal Science	Hradec, M (corresponding author), Czech Univ Life Sci Prague, Dept Anim Sci & Ethol, Prague, Czech Republic.	hradecm@af.czu.cz	Hradec, Michal/Y-7786-2018; Linhart, Pavel/AAZ-7474-2021; Bolechova, Petra/Z-1214-2018	Hradec, Michal/0000-0002-0961-9921; Linhart, Pavel/0000-0002-6097-5892; Bolechova, Petra/0000-0001-9007-1213	Ministry of Agriculture of Czech Republic [MZeRO 0714]; Czech University of Life Sciences Prague [SV15-70-21370]	Ministry of Agriculture of Czech Republic(Ministry of Agriculture, Czech Republic); Czech University of Life Sciences Prague	This work was supported by the Ministry of Agriculture of Czech Republic (MZeRO 0714) and the Czech University of Life Sciences Prague (SV15-70-21370). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bartlett TQ, 2003, INT J PRIMATOL, V24, P239, DOI 10.1023/A:1023088814263; Burns BL, 2016, AM J PRIMATOL, V78, P610, DOI 10.1002/ajp.22523; Burns BL, 2011, PRIMATES, V52, P271, DOI 10.1007/s10329-011-0247-5; COWLISHAW G, 1992, BEHAVIOUR, V121, P131, DOI 10.1163/156853992X00471; Deppute B., 1982, COMMUNICATION; Fitch WT, 2010, EVOLUTION OF LANGUAGE, PROCEEDINGS, P137; Geissmann T, 2002, BIOL REV, V77, P57, DOI 10.1017/S1464793101005826; GEISSMANN T, 1995, PRIMATES, V36, P447, DOI 10.1007/BF02382867; Haimoff E, 1984, LESSER APES EVOLUTIO; Hradec M, 2016, PRIMATES, V57, P445, DOI 10.1007/s10329-016-0569-4; Koda H, 2014, PRIMATES, V55, P13, DOI 10.1007/s10329-013-0390-2; Koda H, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071432; Konrad R, 2006, INT J PRIMATOL, V27, P713, DOI 10.1007/s10764-006-9042-3; Leighton DR., 1987, PRIMATES SOC, P135; MARSHALL JT, 1976, SCIENCE, V193, P235, DOI 10.1126/science.193.4249.235; Merker B, 1999, FOLIA PRIMATOL, V70, P97, DOI 10.1159/000021680; MITANI JC, 1987, BEHAV ECOL SOCIOBIOL, V20, P265, DOI 10.1007/BF00292179; Reichard U. H., 2003, MONOGAMY MATING STRA; Schilling D, 1984, LESSER APES EVOLUTIO; Tao J., 2002, MIXED MODEL ANAL USI	20	7	7	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 15	2017	12	3							e0173959	10.1371/journal.pone.0173959	http://dx.doi.org/10.1371/journal.pone.0173959			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN9HQ	28296969	gold, Green Published, Green Submitted			2022-12-27	WOS:000396311700082
J	Morrison, PK; Harris, PA; Maltin, CA; Grove-White, D; Argo, CM				Morrison, Philippa K.; Harris, Patricia A.; Maltin, Charlotte A.; Grove-White, Dai; Argo, Caroline McG.			EQUIFAT: A novel scoring system for the semi-quantitative evaluation of regional adipose tissues in Equidae	PLOS ONE			English	Article							BODY-FAT; INSULIN-RESISTANCE; METABOLIC SYNDROME; EPICARDIAL FAT; RISK-FACTORS; HORSES; OBESITY; PONIES; COMPARTMENTS; ASSOCIATION	Anatomically distinct adipose tissues represent variable risks to metabolic health in man and some other mammals. Quantitative-imaging of internal adipose depots is problematic in large animals and associations between regional adiposity and health are poorly understood. This study aimed to develop and test a semi-quantitative system (EQUIFAT) which could be applied to regional adipose tissues. Anatomically-defined, photographic images of adipose depots (omental, mesenteric, epicardial, rump) were collected from 38 animals immediately post-mortem. Images were ranked and depot-specific descriptors were developed (1 = no fat visible; 5 = excessive fat present). Nuchal-crest and ventro-abdominalretroperitoneal adipose depot depths (cm) were transformed to categorical 5 point scores. The repeatability and reliability of EQUIFAT was independently tested by 24 observers. When half scores were permitted, inter-observer agreement was substantial (average kappa(w): mesenteric, 0.79; omental, 0.79; rump 0.61) or moderate (average. w; epicardial, 0.60). Intra-observer repeatability was tested by 8 observers on 2 occasions. Kappa analysis indicated perfect (omental and mesenteric) and substantial agreement (epicardial and rump) between attempts. A further 207 animals were evaluated ante-mortem (age, height, breed-type, gender, body condition score [BCS]) and again immediately post-mortem (EQUIFAT scores, carcass weight). Multivariable, random effect linear regression models were fitted (breed as random effect; BCS as outcome variable). Only height, carcass weight, omental and retroperitoneal EQUIFAT scores remained as explanatory variables in the final model. The EQUIFAT scores developed here demonstrate clear functional differences between regional adipose depots and future studies could be directed towards describing associations between adiposity and disease risk in surgical and post-mortem situations.	[Morrison, Philippa K.; Argo, Caroline McG.] Univ Surrey, Sch Vet Med, Fac Hlth & Med Sci, Guildford, England; [Harris, Patricia A.] WALTHAM Ctr Pet Nutr, Equine Studies Grp, Freeby Lane, Melton Mowbray, Leics, England; [Maltin, Charlotte A.; Grove-White, Dai] Univ Liverpool, Fac Hlth & Life Sci, Dept Obes & Endocrinol, Leahurst Campus,Chester High Rd, Wirral, Merseyside, England; [Maltin, Charlotte A.] Biomics Ltd, Inverurie, Aberdeen, Scotland	University of Surrey; Mars; WALTHAM Petcare Science Institute; University of Liverpool	Argo, CM (corresponding author), Univ Surrey, Sch Vet Med, Fac Hlth & Med Sci, Guildford, England.	c.argo@surrey.ac.uk		Morrison, Philippa/0000-0003-4187-0371; Argo, Caroline/0000-0002-8279-6350	WALTHAM	WALTHAM	This research was funded by a PhD scholarship from WALTHAM. The funders (with the exception of Patricia A. Harris, co-author and collaborator) had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The lead author was funded by a PhD studentship provided by WALTHAM. The authors wish to thank all those who participated in using the EQUIFAT scoring system to enable the repeatability and reliability to be assessed. In addition, the authors wish to acknowledge the statistical advice regarding kappa analysis from Dr Joeeph Angell. Finally, the authors wish to acknowledge the kind support for research activities offered by the UK equine slaughter industry.	Argo CM, 2012, VET J; Argo CM, 2014, FARM ANIMAL IMAGING, P12; Bailey SR, 2008, AM J VET RES, V69, P122, DOI 10.2460/ajvr.69.1.122; Bruynsteen L, 2013, BMC VET RES, V9, DOI 10.1186/1746-6148-9-240; Burns TA, 2010, J VET INTERN MED, V24, P932, DOI 10.1111/j.1939-1676.2010.0551.x; Burrows AM, 2013, J EQUINE VET SCI, V33, P361; CARROLL CL, 1988, EQUINE VET J, V20, P41, DOI 10.1111/j.2042-3306.1988.tb01451.x; Catalano KJ, 2010, DIABETES, V59, P1416, DOI 10.2337/db08-0675; Chapados N, 2008, BRIT J NUTR, V100, P518, DOI 10.1017/S0007114508921735; Chaston TB, 2008, INT J OBESITY, V32, P619, DOI 10.1038/sj.ijo.0803761; Cohen CA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066477; Dugdale AHA, 2011, EQUINE VET J, V43, P552, DOI 10.1111/j.2042-3306.2010.00330.x; Dugdale AHA, 2012, VET J, V194, P173, DOI 10.1016/j.tvjl.2012.03.024; Fain JN, 2004, ENDOCRINOLOGY, V145, P2273, DOI 10.1210/en.2003-1336; Fox CS, 2007, CIRCULATION, V116, P39, DOI 10.1161/CIRCULATIONAHA.106.675355; Geer EB, 2009, GENDER MED, V6, P60, DOI 10.1016/j.genm.2009.02.002; Geor RJ, 2008, J EQUINE VET SCI, V28, P753, DOI 10.1016/j.jevs.2008.10.016; Giles SL, 2014, PEERJ, V2, DOI 10.7717/peerj.299; Gjerlaug-Enger E, 2012, ANIMAL, V6, P9, DOI 10.1017/S1751731111001455; Goodpaster BH, 2005, ARCH INTERN MED, V165, P777, DOI 10.1001/archinte.165.7.777; HENNEKE DR, 1983, EQUINE VET J, V15, P371, DOI 10.1111/j.2042-3306.1983.tb01826.x; Holbrook TC, 2012, VET IMMUNOL IMMUNOP, V145, P283, DOI 10.1016/j.vetimm.2011.11.013; Hung CS, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0112355; Kearns CF, 2002, VET J, V163, P260, DOI 10.1053/tvjl.2001.0656; Kohnke JR., 1992, FEEDING NUTR MAKING, P163; LANDIS JR, 1977, BIOMETRICS, V33, P159, DOI 10.2307/2529310; Lottati M, 2009, OBESITY, V17, P674, DOI 10.1038/oby.2008.642; Mair TS, 2005, EQUINE VET J, V37, P296, DOI 10.2746/0425164054529409; Martin-Gimenez T, 2016, J EQUINE VET SCI, V39, P69, DOI 10.1016/j.jevs.2016.01.010; Mottet R., 2009, J EQUINE VET SCI, V29, P417, DOI [DOI 10.1016/j.jevs.2009.04.116, 10.1016/j.jevs.2009.04.116, DOI 10.1016/J.JEVS.2009.04.116]; Newkirk K. M., 2014, Open Journal of Veterinary Medicine, V4, P190, DOI 10.4236/ojvm.2014.49022; Okada K, 2014, J CARDIOVASC MED, V15, P384, DOI 10.2459/JCM.0b013e32836094da; Robin CA, 2015, EQUINE VET J, V47, P196, DOI 10.1111/evj.12275; Ross R, 1992, QUANTIFICATION ADIPO, P787; Sacks HS, 2009, J CLIN ENDOCR METAB, V94, P3611, DOI 10.1210/jc.2009-0571; Smith SR, 2001, METABOLISM, V50, P425, DOI 10.1053/meta.2001.21693; Speakman JR, 2003, AGING CELL, V2, P265, DOI 10.1046/j.1474-9728.2003.00061.x; Trayhurn Paul, 2011, Archives of Physiology and Biochemistry, V117, P47, DOI 10.3109/13813455.2010.535835; Vick MM, 2007, J ANIM SCI, V85, P1144, DOI 10.2527/jas.2006-673; Wang CP, 2009, CLIN ENDOCRINOL, V70, P876, DOI 10.1111/j.1365-2265.2008.03411.x; WESTERVELT RG, 1976, J ANIM SCI, V43, P781, DOI 10.2527/jas1976.434781x; Wronska A, 2012, ACTA PHYSIOL, V205, P194, DOI 10.1111/j.1748-1716.2012.02409.x; Wylie CE, 2013, RES VET SCI, V95, P410, DOI 10.1016/j.rvsc.2013.05.004	44	5	5	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 15	2017	12	3							e0173753	10.1371/journal.pone.0173753	http://dx.doi.org/10.1371/journal.pone.0173753			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN9HQ	28296956	Green Published, gold, Green Submitted			2022-12-27	WOS:000396311700056
J	Trojan, K; Unterrainer, C; Weimer, R; Bulut, N; Morath, C; Aly, M; Zhu, L; Opelz, G; Daniel, V				Trojan, Karina; Unterrainer, Christian; Weimer, Rolf; Bulut, Nuray; Morath, Christian; Aly, Mostafa; Zhu, Li; Opelz, Gerhard; Daniel, Volker			Helios expression and Foxp3 TSDR methylation of IFNy plus and IFNy- Treg from kidney transplant recipients with good long-term graft function	PLOS ONE			English	Article							REGULATORY T-CELLS; IN-VITRO; IMMUNOSUPPRESSIVE DRUGS; ORGAN-TRANSPLANTATION; INTERFERON-GAMMA; DNA METHYLATION; SURVIVAL; VIVO	Background There is circumstantial evidence that IFNy+ Treg might have clinical relevance in transplantation. IFNy+ Treg express IFNy receptors and are induced by IFNy. In the present study we investigated in kidney transplant recipients with good long-term stable graft function the absolute cell counts of IFNy+ Treg subsets and whether their expression of Foxp3 is stable or transient. Method Helios expression determined by eight-color-fluorescence flow cytometry and methylation status of the Foxp3 Treg specific demethylation region (TSDR) served as indicators for stability of Foxp3 expression. Methylation status was investigated in enriched IFNy+ and IFNy-Treg preparations originating from peripheral blood using high resolution melt analysis. A total of 136 transplant recipients and 52 healthy controls were studied. Results Proportions of IFNy+ Treg were similar in patients and healthy controls (0.05% and 0.04% of all CD4+ lymphocytes; p = n.s.). Patients also had similar absolute counts of IFNy producing Helios+ and Helios-Treg (p = n.s.). Most of the IFNy+ and IFNy-Treg in transplant recipients had a methylated Foxp3 TSDR, however, there was a sizeable proportion of IFNy+ and IFNy-Treg with demethylated Foxp3 TSDR. Male and female patients showed more frequently methylated IFNy+ and IFNy-Treg than male and female controls (all p<0.05). Conclusions Kidney transplant recipients with good long-term stable graft function have similar levels of IFNy+ Treg as healthy controls. IFNy+ and IFNy-Treg subsets in patients consist of cells with stable and cells with transient Foxp3 expression; however, patients showed more frequently methylated IFNy+ and IFNy- Treg than controls. The data show increased levels of Treg subsets with stable as well as transient Foxp3 expression in patients with stable allograft acceptance compared to healthy controls.	[Trojan, Karina; Unterrainer, Christian; Aly, Mostafa; Zhu, Li; Opelz, Gerhard; Daniel, Volker] Univ Heidelberg Hosp, Transplantat Immunol Inst Immunol, Heidelberg, Germany; [Weimer, Rolf; Bulut, Nuray] Univ Giessen, Dept Internal Med, Giessen, Germany; [Morath, Christian] Heidelberg Univ, Dept Nephrol, Heidelberg, Germany; [Aly, Mostafa] Assiut Univ, Dept Internal Med, Nephrol Unit, Assiut, Egypt; [Zhu, Li] Huazhong Univ Sci & Technol, Tongji Hosp, Dept Hematol, Wuhan, Peoples R China	Ruprecht Karls University Heidelberg; Justus Liebig University Giessen; Ruprecht Karls University Heidelberg; Egyptian Knowledge Bank (EKB); Assiut University; Huazhong University of Science & Technology	Daniel, V (corresponding author), Univ Heidelberg Hosp, Transplantat Immunol Inst Immunol, Heidelberg, Germany.	Volker.Daniel@med.uni-heidelberg.de	Morath, Christian/ABC-5091-2021	Daniel, Volker/0000-0001-8345-1031				Akimova T, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024226; Daniel V, 2008, TRANSPL INT, V21, P646, DOI 10.1111/j.1432-2277.2008.00662.x; Daniel V, 2016, HUM IMMUNOL, V77, P146, DOI 10.1016/j.humimm.2015.11.006; Daniel V, 2015, BMC IMMUNOL, V16, DOI 10.1186/s12865-015-0111-2; Daniel V, 2014, INT REV IMMUNOL, V33, P195, DOI 10.3109/08830185.2013.845181; Daniel V, 2013, HUM IMMUNOL, V74, P151, DOI 10.1016/j.humimm.2012.09.010; Daniel V, 2012, TRANSPL IMMUNOL, V27, P114, DOI 10.1016/j.trim.2012.08.003; Daniel V, 2012, BMC IMMUNOL, V13, DOI 10.1186/1471-2172-13-47; Daniel V, 2011, HUM IMMUNOL, V72, P699, DOI 10.1016/j.humimm.2011.05.020; Floess S, 2007, PLOS BIOL, V5, P169, DOI 10.1371/journal.pbio.0050038; Getnet D, 2010, MOL IMMUNOL, V47, P1595, DOI 10.1016/j.molimm.2010.02.001; Gottschalk RA, 2012, J IMMUNOL, V188, P976, DOI 10.4049/jimmunol.1102964; Greenland JR, 2016, TRANSPLANTATION; Grzanka J, 2013, INT IMMUNOPHARMACOL, V16, P343, DOI 10.1016/j.intimp.2013.02.004; Hall BM, 2013, FRONT IMMUNOL, V4, DOI 10.3389/fimmu.2013.00208; Himmel ME, 2013, J IMMUNOL, V190, P2001, DOI 10.4049/jimmunol.1201379; Kim J, 2012, AM J RESP CRIT CARE, V185, P330, DOI 10.1164/rccm.201106-1026OC; Marcen R, 2009, DRUGS, V69, P2227, DOI 10.2165/11319260-000000000-00000; Mellor AL, 2011, J IMMUNOL, V186, P4535, DOI 10.4049/jimmunol.1002937; Nakagawa H, 2016, P NATL ACAD SCI USA, V113, P6248, DOI 10.1073/pnas.1604765113; Polansky JK, 2008, EUR J IMMUNOL, V38, P1654, DOI 10.1002/eji.200838105; Schmitt EG, 2013, FRONT IMMUNOL, V4, DOI 10.3389/fimmu.2013.00152; Sebastian M, 2016, J IMMUNOL, V196, P144, DOI 10.4049/jimmunol.1501704; Sela U, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0146412; Tahvildari M, 2016, TRANSPLANTATION, V100, P525, DOI 10.1097/TP.0000000000001044; Thornton AM, 2010, J IMMUNOL, V184, P3433, DOI 10.4049/jimmunol.0904028; van der Net JB, 2016, TRANSPL INT, V29, P3, DOI 10.1111/tri.12608; Wang LQ, 2013, MOL CELL BIOL, V33, P4106, DOI 10.1128/MCB.00144-13; Zabransky DJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034547	29	10	10	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 15	2017	12	3							e0173773	10.1371/journal.pone.0173773	http://dx.doi.org/10.1371/journal.pone.0173773			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN9HQ	28296931	Green Submitted, gold, Green Published			2022-12-27	WOS:000396311700060
J	Jia, PF; Li, F; Gu, WT; Zhang, WF; Cai, Y				Jia, Pifeng; Li, Feng; Gu, Weiting; Zhang, Weifeng; Cai, Yu			Gab3 overexpression in human glioma mediates Akt activation and tumor cell proliferation	PLOS ONE			English	Article							MALIGNANT GLIOMA; CANCER STATISTICS; PROTEIN; INHIBITION; EXPRESSION; THERAPY	This current study tested expression and potential biological functions of Gab3 in human glioma. Gab3 mRNA and protein expression was significantly elevated in human glioma tissues and glioma cells. Its level was however low in normal brain tissues and primary human astrocytes. In both established (U251MG cell line) and primary human glioma cells, Gab3 knockdown by shRNA/siRNA significantly inhibited Akt activation and cell proliferation. Reversely, forced Gab3 overexpression in U251MG cells promoted Akt activation and cell proliferation. In vivo, the growth of U251MG tumors in nude mice was inhibited following expressing Gab3 shRNA. Akt activation in cancer tissues was also suppressed by Gab3 shRNA. Together, we conclude that Gab3 overexpression in human glioma mediates Akt activation and cancer cell proliferation.	[Jia, Pifeng; Li, Feng; Gu, Weiting; Zhang, Weifeng; Cai, Yu] Shanghai Jiao Tong Univ, Sch Med, RuiJin Hosp North, Dept Neurosurg, Shanghai, Peoples R China	Shanghai Jiao Tong University	Cai, Y (corresponding author), Shanghai Jiao Tong Univ, Sch Med, RuiJin Hosp North, Dept Neurosurg, Shanghai, Peoples R China.	aihaozuqiu22@163.com			RuiJin Hospital Scientific Funds [RJ20140121]	RuiJin Hospital Scientific Funds	This study was supported by RuiJin Hospital Scientific Funds (RJ20140121 to Yu Cai). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bourgin C, 2002, MOL CELL BIOL, V22, P3744, DOI 10.1128/MCB.22.11.3744-3756.2002; Brunn GJ, 1996, EMBO J, V15, P5256, DOI 10.1002/j.1460-2075.1996.tb00911.x; Cao C, 2013, PLOS BIOL, V11, DOI 10.1371/journal.pbio.1001478; Cao C, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.2000118; Chautard E, 2014, J NEURO-ONCOL, V117, P205, DOI 10.1007/s11060-014-1382-9; Chen MB, 2016, ONCOTARGET, V7, P17047, DOI 10.18632/oncotarget.7742; Gu HH, 2003, TRENDS CELL BIOL, V13, P122, DOI 10.1016/S0962-8924(03)00002-3; Hambardzumyan D, 2008, STEM CELL REV, V4, P203, DOI 10.1007/s12015-008-9021-5; He XY, 2013, BIOCHEM BIOPH RES CO, V435, P397, DOI 10.1016/j.bbrc.2013.04.099; Huang TT, 2009, NEUROTHERAPEUTICS, V6, P500, DOI 10.1016/j.nurt.2009.04.008; Jiang H, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0161017; Khasraw M, 2009, NAT REV NEUROL, V5, P646, DOI 10.1038/nrneurol.2009.194; Kondapaka SB, 2003, MOL CANCER THER, V2, P1093; Lefranc F, 2009, ADV TECH STAND NEURO, V34, P3, DOI 10.1007/978-3-211-78741-0_1; Li X, 2016, PI3K AKT MTOR SIGNAL; Li ZW, 2016, OVEREXPRESSION OF GA; Lu PH, 2016, AQUEOUS OLDENLANDIA; Pan SJ, 2015, INT J MOL SCI, V16, P5363, DOI 10.3390/ijms16035363; Pan SJ, 2015, BIOCHEM BIOPH RES CO, V458, P476, DOI 10.1016/j.bbrc.2015.01.128; Pollack IF, 2010, NAT REV NEUROL, V6, P533, DOI 10.1038/nrneurol.2010.144; Sarmay G, 2006, IMMUNOL LETT, V104, P76, DOI 10.1016/j.imlet.2005.11.017; Seiffert M, 2003, MOL CELL BIOL, V23, P2415, DOI 10.1128/MCB.23.7.2415-2424.2003; Shioyama W, 2011, CIRC RES, V108, P664, DOI 10.1161/CIRCRESAHA.110.232223; Siegel R, 2014, CA-CANCER J CLIN, V64, P9, DOI 10.3322/caac.21208; Siegel R, 2012, CA-CANCER J CLIN, V62, P10, DOI 10.3322/caac.20138; Wang YZ, 2013, CANCER LETT, V331, P139, DOI 10.1016/j.canlet.2012.12.024; Westphal M, 2011, NAT REV NEUROSCI, V12, P495, DOI 10.1038/nrn3060; Wolf I, 2002, MOL CELL BIOL, V22, P231, DOI 10.1128/MCB.22.1.231-244.2002; Xu FL, 2015, TUMOR BIOL, V36, P9553, DOI 10.1007/s13277-015-3724-4; Yart A, 2003, CURR CANCER DRUG TAR, V3, P177, DOI 10.2174/1568009033481976; Zhu J, 2016, BIOCHEM BIOPH RES CO, V476, P522, DOI 10.1016/j.bbrc.2016.05.156	31	9	9	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 14	2017	12	3							e0173473	10.1371/journal.pone.0173473	http://dx.doi.org/10.1371/journal.pone.0173473			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN6DM	28291820	gold, Green Published, Green Submitted			2022-12-27	WOS:000396094700027
J	Seegers, J; Hnatkova, K; Friede, T; Malik, M; Zabel, M				Seegers, Joachim; Hnatkova, Katerina; Friede, Tim; Malik, Marek; Zabel, Markus			T-wave loop area from a pre-implant 12-lead ECG is associated with appropriate ICD shocks	PLOS ONE			English	Article							SUDDEN CARDIAC DEATH; CARDIOVERTER-DEFIBRILLATOR; RISK STRATIFICATION; MORPHOLOGY; SUBDISTRIBUTION; INTERVAL	Aims In implantable cardioverter-defibrillator (ICD) patients, predictors of ICD shocks and mortality are needed to improve patient selection. Electrocardiographic (ECG) markers are simple to obtain and have been demonstrated to predict mortality. We aimed to assess the association of T-wave loop area and circularity with ICD shocks. Methods The study investigated patients with ICDs implanted between 1998 and 2010 for whom digital 12-lead ECGs (Schiller CS200 ECG-Network) of sufficient quality were obtained within 1 month prior to the implantation. T-wave loop area and circularity were calculated. Follow-up data of appropriate shocks were obtained during ICD clinic visits that included reviews of device stored electrograms. Results A total of 605 patients (82% males) were included; 68% had ischemic cardiomyopathy and 72% were treated for primary prevention. Over 3.8 +/- 1.4 years of follow-up, 114 patients (19%) experienced appropriate shock(s). Those with smaller T-wave loop area received fewer shocks (TLA, hazard ratio, HR, per increase of 1 technical unit, 0.71; [95% confidence interval, 0.53-0.94]; P = 0.02) and those with larger T-wave loop circularity (TLC) representing rounder T wave loop received more shocks (HR per 1% TLC increase 2.96; [0.85- 10.36]; P = 0.09). When the quartile containing the largest TLA and TLC values, respectively, were compared to the remaining cases, TLA remained significantly associated with fewer and TLC with more frequent shocks also after multivariate adjustment for clinical variables (HR, 0.59 [0.35-0.99], P = 0.044; and 1.64 [1.08-2.49], P = 0.021, respectively). Conclusions The size and shape of the T-wave loop calculated from pre-implantation 12-lead ECGs are associated with appropriate ICD shocks.	[Seegers, Joachim; Zabel, Markus] Univ Med Ctr Gottingen, Div Clin Electrophysiol, Dept Cardiol & Pneumol, Gottingen, Germany; [Seegers, Joachim] Univ Hosp Regensburg, Dept Internal Med 2, Div Cardiol, Sect Electrophysiol, Regensburg, Germany; [Hnatkova, Katerina; Malik, Marek] Imperial Coll, Natl Heart & Lung Inst, London, England; [Friede, Tim] Univ Med Ctr Gottingen, Dept Med Stat, Gottingen, Germany; [Friede, Tim] DZHK German Ctr Cardiovasc Res, Partner Site Gottingen, Gottingen, Germany	University of Gottingen; University of Regensburg; Imperial College London; University of Gottingen; German Centre for Cardiovascular Research	Seegers, J (corresponding author), Univ Med Ctr Gottingen, Div Clin Electrophysiol, Dept Cardiol & Pneumol, Gottingen, Germany.; Seegers, J (corresponding author), Univ Hosp Regensburg, Dept Internal Med 2, Div Cardiol, Sect Electrophysiol, Regensburg, Germany.	joachim.seegers@ukr.de	Friede, Tim/ABF-1132-2021	Friede, Tim/0000-0001-5347-7441; Malik, Marek/0000-0002-3792-1407	European Community [602299]; British Heart Foundation [PG/12/77/29857, PG/13/54/30358]	European Community(European Commission); British Heart Foundation(British Heart Foundation)	The research leading to the results has received funding from the European Community's Seventh Framework Programme FP7/2007-2013 under grant agreement no 602299, EU-CERT-ICD. KH and MM also receive funding from British Heart Foundation Grants PG/12/77/29857 and PG/13/54/30358.	Acar B, 1999, MED BIOL ENG COMPUT, V37, P574, DOI 10.1007/BF02513351; Bardy GH, 2005, NEW ENGL J MED, V352, P225, DOI 10.1056/NEJMoa043399; Daubert JP, 2008, J AM COLL CARDIOL, V51, P1357, DOI 10.1016/j.jacc.2007.09.073; Fine JP, 1999, J AM STAT ASSOC, V94, P496, DOI 10.2307/2670170; Goldenberg I, 2008, J AM COLL CARDIOL, V51, P288, DOI 10.1016/j.jacc.2007.08.058; Hnatkova K, 2001, J ELECTROCARDIOL, V34, P113, DOI 10.1054/jelc.2001.28836; Huikuri HV, 2001, NEW ENGL J MED, V345, P1473, DOI 10.1056/NEJMra000650; Katritsis DG, 2012, EUROPACE, V14, P787, DOI 10.1093/europace/eus001; Kohl M, 2015, COMPUT METH PROG BIO, V118, P218, DOI 10.1016/j.cmpb.2014.11.009; Laguna P, 2016, P IEEE, V104, P392, DOI 10.1109/JPROC.2015.2500501; Malik M, 2000, J CARDIOVASC ELECTR, V11, P835, DOI 10.1111/j.1540-8167.2000.tb00061.x; Poole JE, 2008, NEW ENGL J MED, V359, P1009, DOI 10.1056/NEJMoa071098; Porthan K, 2013, CIRC-ARRHYTHMIA ELEC, V6, P690, DOI 10.1161/CIRCEP.113.000356; Pueyo E, 2011, BIOPHYS J, V101, P2892, DOI 10.1016/j.bpj.2011.09.060; Strauss DG, 2011, HEART RHYTHM, V8, P38, DOI 10.1016/j.hrthm.2010.09.071; Tracy CM, 2012, J AM COLL CARDIOL, V60, P1297, DOI 10.1016/j.jacc.2012.07.009; Tung R, 2008, J AM COLL CARDIOL, V52, P1111, DOI 10.1016/j.jacc.2008.05.058; Wellens HJJ, 2014, EUR HEART J, V35, P1642, DOI 10.1093/eurheartj/ehu176; Xue JQ, 2009, ANN NONINVAS ELECTRO, V14, pS35, DOI 10.1111/j.1542-474X.2008.00264.x; Zabel M, 2000, CIRCULATION, V102, P1252, DOI 10.1161/01.CIR.102.11.1252; Zabel M, 2002, CIRCULATION, V105, P1066, DOI 10.1161/hc0902.104598	21	7	7	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 14	2017	12	3							e0173868	10.1371/journal.pone.0173868	http://dx.doi.org/10.1371/journal.pone.0173868			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN6DM	28291831	gold, Green Published			2022-12-27	WOS:000396094700046
J	Zhang, XN; Gao, FX; Fu, JB; Zhang, P; Wang, YQ; Zeng, XH				Zhang, Xiaoning; Gao, Fengxin; Fu, Jianbo; Zhang, Peng; Wang, Yuqing; Zeng, Xuhui			Systematic identification and characterization of long non-coding RNAs in mouse mature sperm	PLOS ONE			English	Article							EXPRESSION; INSIGHTS; DELIVERY	Increasing studies have shown that mature spermatozoa contain many transcripts including mRNAs and miRNAs. However, the expression profile of long non-coding RNAs (lncRNAs) in mammalian sperm has not been systematically investigated. Here, we used highly purified RNA to investigate lncRNA expression profiles in mouse mature sperm by stranded-specific RNA-seq. We identified 20,907 known and 4,088 novel lncRNAs transcripts, and the existence of intact lncRNAs was confirmed by RT-PCR and fluorescence in situ hybridization on two representative lncRNAs. Compared to round spermatids, 1,794 upregulated and 165 downregulated lncRNAs and 4,435 upregulated and 3,920 downregulated mRNAs were identified in sperm. Based on the "Cis and Trans" RNA-RNA interaction principle, we found 14,259 targeted coding genes of differently expressed lncRNAs. In terms of Gene ontology (GO) analysis, differentially expressed lncRNAs targeted genes mainly related to nucleic acid metabolic, protein modification, chromatin and histone modification, heterocycle compound metabolic, sperm function, spermatogenesis and other processes. In contrast, differentially expressed transcripts of mRNAs were highly enriched for protein metabolic process and RNA metabolic, spermatogenesis, sperm motility, cell cycle, chromatin organization, heterocycle and aromatic compound metabolic processes. Kyoto encyclopedia of genes and genomes (KEGG) pathway analysis showed that the differentially expressed lncRNAs were involved in RNA transport, mRNA surveillance pathway, PI3K-Akt signaling pathway, AMPK signaling pathway, protein processing in endoplasmic reticulum. Metabolic pathways, mRNA surveillance pathway, AMPK signaling pathway, cell cycle, RNA transport splicesome and endocytosis incorporated with the differentially expressed mRNA. Furthermore, many lncRNAs were specifically expressed in testis/sperm, and 880 lncRNAs were conserved between human and mouse. In summary, this study provides a preliminary database valuable for identifying lncRNAs critical in the late stage of spermatogenesis or important for sperm function regulation, fertilization and early embryo development.	[Zeng, Xuhui] Nanchang Univ, Inst Life Sci, Nanchang, Jiangxi, Peoples R China; Nanchang Univ, Sch Life Sci, Nanchang, Jiangxi, Peoples R China	Nanchang University; Nanchang University	Zeng, XH (corresponding author), Nanchang Univ, Inst Life Sci, Nanchang, Jiangxi, Peoples R China.	zengxuhui@ncu.edu.cn	Zhang, Xiaoning/GQB-3524-2022; Wang, yuqing/HIR-1604-2022	gao, fengxin/0000-0002-8986-5785	National Basic Research Program of China [2015C6943000]; National Natural Science Foundation of China [31230034]; Jiangxi Provincial Funding [20121BBG70021, 20133BBG70033]	National Basic Research Program of China(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Jiangxi Provincial Funding	This research was supported by the National Basic Research Program of China (2015C6943000), the National Natural Science Foundation of China (31230034), and the Jiangxi Provincial Funding (20121BBG70021 and 20133BBG70033). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adiconis X, 2013, NAT METHODS, V10, P623, DOI 10.1038/nmeth.2483; Bao JQ, 2013, BIOL REPROD, V89, DOI 10.1095/biolreprod.113.113308; Boerke A, 2007, THERIOGENOLOGY, V68, pS147, DOI 10.1016/j.theriogenology.2007.05.058; Cappallo-Obermann H, 2011, MOL HUM REPROD, V17, P669, DOI 10.1093/molehr/gar037; Chalmel F, 2014, BIOL REPROD, V91, DOI 10.1095/biolreprod.114.118166; Chen FC, 2014, EVOL BIOINFORM, V10, P219, DOI 10.4137/EBO.S20772; Chen Q, 2016, SCIENCE, V351, P397, DOI 10.1126/science.aad7977; CONCHA II, 1993, EXP CELL RES, V204, P378, DOI 10.1006/excr.1993.1046; Du Y, 2014, MOL REPROD DEV, V81, P1042, DOI 10.1002/mrd.22426; Fang P, 2014, BIOL REPROD, V90, DOI 10.1095/biolreprod.114.117788; Grandjean V, 2015, SCI REP-UK, V5, DOI 10.1038/srep18193; Hamatani T, 2011, REPROD BIOMED ONLINE, V22, P103, DOI 10.1016/j.rbmo.2010.12.001; Jiang GJ, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0154028; Jodar M, 2015, SCI TRANSL MED, V7, DOI 10.1126/scitranslmed.aab1287; Johnson GD, 2011, MOL HUM REPROD, V17, P721, DOI 10.1093/molehr/gar054; Kawano M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044542; Kour S, 2016, J MOL NEUROSCI, V58, P266, DOI 10.1007/s12031-015-0671-x; Krawetz SA, 2005, NAT REV GENET, V6, P633, DOI 10.1038/nrg1654; Krawetz SA, 2011, HUM REPROD, V26, P3401, DOI 10.1093/humrep/der329; Lalancette C, 2008, J CELL BIOCHEM, V104, P1570, DOI 10.1002/jcb.21756; Lin XW, 2016, RNA BIOL, V13, P1011, DOI 10.1080/15476286.2016.1218588; Luk ACS, 2015, DATABASE-OXFORD, DOI 10.1093/database/bav044; Luk ACS, 2014, REPRODUCTION, V147, pR131, DOI 10.1530/REP-13-0594; Marquardt S, 2014, MOL CELL, V54, P156, DOI 10.1016/j.molcel.2014.03.026; Naz RK, 1998, ARCH ANDROLOGY, V41, P135, DOI 10.3109/01485019808987955; Necsulea A, 2014, NATURE, V505, P635, DOI 10.1038/nature12943; PESSOT CA, 1989, BIOCHEM BIOPH RES CO, V158, P272, DOI 10.1016/S0006-291X(89)80208-6; Roodbari F, 2015, INT J REPROD BIOMED, V13, P703; Sciamanna I, 2003, BIOCHEM BIOPH RES CO, V312, P1039, DOI 10.1016/j.bbrc.2003.11.024; Sendler E, 2013, NUCLEIC ACIDS RES, V41, P4104, DOI 10.1093/nar/gkt132; Shafeeque CM, 2014, ANIM REPROD SCI, V149, P259, DOI 10.1016/j.anireprosci.2014.06.032; Sun J, 2015, DATA BRIEF, V4, P322, DOI 10.1016/j.dib.2015.06.004; Tafer H, 2008, BIOINFORMATICS, V24, P2657, DOI 10.1093/bioinformatics/btn193; Trapnell C, 2012, NAT PROTOC, V7, P562, DOI 10.1038/nprot.2012.016; Tripathi V, 2015, METHODS MOL BIOL, V1206, P123, DOI 10.1007/978-1-4939-1369-5_11; Wen K, 2016, GENOME RES; Xue ZG, 2013, NATURE, V500, P593, DOI 10.1038/nature12364; Yu J, 2014, J INTEGR AGR, V13, P394, DOI 10.1016/S2095-3119(13)60294-4; Zhang Z, 2011, AGR SCI CHINA, V10, P1958, DOI 10.1016/S1671-2927(11)60197-1	39	38	42	1	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 14	2017	12	3							e0173402	10.1371/journal.pone.0173402	http://dx.doi.org/10.1371/journal.pone.0173402			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN6DM	28291811	gold, Green Published, Green Submitted			2022-12-27	WOS:000396094700024
J	Azad, AKM; Lawen, A; Keith, JM				Azad, A. K. M.; Lawen, Alfons; Keith, Jonathan M.			Bayesian model of signal rewiring reveals mechanisms of gene dysregulation in acquired drug resistance in breast cancer	PLOS ONE			English	Article							GROWTH-FACTOR RECEPTOR; TYROSINE KINASE INHIBITORS; CELL LUNG-CANCER; MOLECULAR-MECHANISMS; LAPATINIB RESISTANCE; EGFR; NETWORK; PATHWAY; APOPTOSIS; HER2	Small molecule inhibitors, such as lapatinib, are effective against breast cancer in clinical trials, but tumor cells ultimately acquire resistance to the drug. Maintaining sensitization to drug action is essential for durable growth inhibition. Recently, adaptive reprogramming of signaling circuitry has been identified as a major cause of acquired resistance. We developed a computational framework using a Bayesian statistical approach to model signal rewiring in acquired resistance. We used the p1-model to infer potential aberrant gene-pairs with differential posterior probabilities of appearing in resistant-vs-parental networks. Results were obtained using matched gene expression profiles under resistant and parental conditions. Using two lapatinib-treated ErbB2-positive breast cancer cell-lines: SKBR3 and BT474, our method identified similar dysregulated signaling pathways including EGFRrelated pathways as well as other receptor-related pathways, many of which were reported previously as compensatory pathways of EGFR-inhibition via signaling cross-talk. A manual literature survey provided strong evidence that aberrant signaling activities in dysregulated pathways are closely related to acquired resistance in EGFR tyrosine kinase inhibitors. Our approach predicted literature-supported dysregulated pathways complementary to both node-centric (SPIA, DAVID, and GATHER) and edge-centric (ESEA and PAGI) methods. Moreover, by proposing a novel pattern of aberrant signaling called V-structures, we observed that genes were dysregulated in resistant-vs-sensitive conditions when they were involved in the switch of dependencies from targeted to bypass signaling events. A literature survey of some important V-structures suggested they play a role in breast cancer metastasis and/or acquired resistance to EGFR-TKIs, where the mRNA changes of TGFBR2, LEF1 and TP53 in resistant-vs-sensitive conditions were related to the dependency switch from targeted to bypass signaling links. Our results suggest many signaling pathway structures are compromised in acquired resistance, and V-structures of aberrant signaling within/among those pathways may provide further insights into the bypass mechanism of targeted inhibition.	[Azad, A. K. M.; Keith, Jonathan M.] Monash Univ, Sch Math Sci, Clayton, Vic, Australia; [Lawen, Alfons] Monash Univ, Sch Biomed Sci, Dept Biochem & Mol Biol, Clayton, Vic, Australia	Monash University; Monash University	Azad, AKM (corresponding author), Monash Univ, Sch Math Sci, Clayton, Vic, Australia.	aaza7@student.monash.edu	; Lawen, Alfons/A-6598-2008	Keith, Jonathan/0000-0002-9675-3976; Lawen, Alfons/0000-0001-6553-9945	Monash International Postgraduate Research Scholarship at the Monash University, Australia; Monash Graduate Scholarship at the Monash University, Australia	Monash International Postgraduate Research Scholarship at the Monash University, Australia; Monash Graduate Scholarship at the Monash University, Australia	This research was supported by Monash International Postgraduate Research Scholarship and Monash Graduate Scholarship at the Monash University, Australia. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams S., 2008, CONNECTIONS, p[28, 17], DOI DOI 10.1007/978-0-8176-4749-0; Akhavan D, 2013, CANCER DISCOV, V3, P534, DOI 10.1158/2159-8290.CD-12-0502; Al-Hussaini H, 2011, MOL CANCER THER, V10, P9, DOI 10.1158/1535-7163.MCT-10-0677; Amin DN, 2010, SCI TRANSL MED, V2, DOI 10.1126/scitranslmed.3000389; Awan A, 2007, IET SYST BIOL, V1, P292, DOI 10.1049/iet-syb:20060068; Azad AKM, 2015, BMC SYST BIOL, V9, DOI 10.1186/s12918-014-0135-x; Azuaje F, 2015, CELL COMMUN SIGNAL, V13, DOI 10.1186/s12964-015-0098-6; Azuma K, 2014, ONCOTARGET, V5, P5908, DOI 10.18632/oncotarget.1866; Azuma K, 2011, BIOCHEM BIOPH RES CO, V407, P219, DOI 10.1016/j.bbrc.2011.03.002; Baker AT, 2014, FRONT ONCOL, V4, DOI 10.3389/fonc.2014.00360; Ballas MS, 2011, ONCOTARGETS THER, V4, P43, DOI 10.2147/OTT.S18155; Baselga J, 2005, J CLIN ONCOL, V23, P2445, DOI 10.1200/JCO.2005.11.890; Bean J, 2008, CLIN CANCER RES, V14, P7519, DOI 10.1158/1078-0432.CCR-08-0151; Bertotti A, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.2102er11; Bianco R, 2008, CLIN CANCER RES, V14, P5069, DOI 10.1158/1078-0432.CCR-07-4905; Boeckx C, 2013, ONCOLOGIST, V18, P850, DOI 10.1634/theoncologist.2013-0013; Bouchalova K, 2010, BIOMED PAP, V154, P281, DOI 10.5507/bp.2010.043; Brivanlou AH, 2002, SCIENCE, V295, P813, DOI 10.1126/science.1066355; Bulashevska S, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-46; Canfield K, 2015, CELL CYCLE, V14, P648, DOI 10.4161/15384101.2014.994966; Carpenter RL, 2013, J CARCINOGENESIS MUT, P1; Carson C, 2012, PIGM CELL MELANOMA R, V25, P514, DOI 10.1111/j.1755-148X.2012.01010.x; Cerami E, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008918; Chang JT, 2006, BIOINFORMATICS, V22, P2926, DOI 10.1093/bioinformatics/btl483; Chatterjee S, 2013, J CLIN INVEST, V123, P1732, DOI 10.1172/JCI65385; Chen ZB, 2005, NATURE, V436, P725, DOI 10.1038/nature03918; Cheung HW, 2011, CANC DISCOVERY; Chikazawa N, 2010, ANTICANCER RES, V30, P2041; Chuang HY, 2007, MOL SYST BIOL, V3, DOI 10.1038/msb4100180; CLARK GJ, 1995, BREAST CANCER RES TR, V35, P133, DOI 10.1007/BF00694753; Costa DB, 2007, PLOS MED, V4, P1669, DOI 10.1371/journal.pmed.0040315; Croft D, 2014, NUCLEIC ACIDS RES, V42, pD472, DOI 10.1093/nar/gkt1102; Debatin KM, 2004, CANCER IMMUNOL IMMUN, V53, P153, DOI 10.1007/s00262-003-0474-8; Deckers M, 2006, CANCER RES, V66, P2202, DOI 10.1158/0008-5472.CAN-05-3560; Dhomen Nathalie S., 2012, Critical Reviews in Oncogenesis, V17, P31; Du Ge, 2015, Zhonghua Yi Xue Za Zhi, V95, P2264; Eichhorn PJA, 2008, CANCER RES, V68, P9221, DOI 10.1158/0008-5472.CAN-08-1740; Elo LL, 2007, BIOINFORMATICS, V23, P2096, DOI 10.1093/bioinformatics/btm309; Ennen M, 2013, CANCER RES, V73, P5040, DOI 10.1158/0008-5472.CAN-12-3655; Futreal PA, 2004, NAT REV CANCER, V4, P177, DOI 10.1038/nrc1299; Garrett JT, 2011, P NATL ACAD SCI USA, V108, P5021, DOI 10.1073/pnas.1016140108; Guix M, 2008, J CLIN INVEST, V118, P2609, DOI 10.1172/JCI34588; Guney E, 2012, UNDERSTANDING CANC P, P167; Han CH, 2014, MOL CANCER RES, V12, P784, DOI 10.1158/1541-7786.MCR-13-0638; Han JW, 2015, SCI REP-UK, V5, DOI 10.1038/srep13044; Han JW, 2015, J R SOC INTERFACE, V12, DOI 10.1098/rsif.2014.0937; He YH., 2012, THESIS; Hegde PS, 2007, MOL CANCER THER, V6, P1629, DOI 10.1158/1535-7163.MCT-05-0399; Heiden MGV, 2009, SCIENCE, V324, P1029, DOI 10.1126/science.1160809; HOLLAND PW, 1981, J AM STAT ASSOC, V76, P33, DOI 10.2307/2287037; Hu JF, 2014, BIOINFORMATICS, V30, P141, DOI 10.1093/bioinformatics/btt627; Huang C, 2011, BREAST CANCER RES, V13, DOI 10.1186/bcr2936; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Huang JM, 2013, ONCOGENE, V32, P2220, DOI 10.1038/onc.2012.231; Huang LH, 2015, ACTA PHARM SIN B, V5, P390, DOI 10.1016/j.apsb.2015.07.001; Huang S, 2011, CANCER RES, V71, P7071, DOI 10.1158/0008-5472.CAN-11-0128; Jung S, 2014, NUCLEIC ACIDS RES, V42, DOI 10.1093/nar/gku099; Kanehisa M, 2002, NOVART FDN SYMP, V247, P91; Karakashev SV, 2015, ONCOTARGET, V6, P1967, DOI 10.18632/oncotarget.2806; Kattan Z, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002002; Kechagioglou P, 2014, ANTICANCER RES, V34, P1387; Kelder T, 2012, NUCLEIC ACIDS RES, V40, pD1301, DOI 10.1093/nar/gkr1074; Khalil S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033421; Kim HK, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016694; Kobayashi S, 2005, NEW ENGL J MED, V352, P786, DOI 10.1056/NEJMoa044238; Kolch W, 2015, NAT REV CANCER, V15, P515, DOI 10.1038/nrc3983; Komurov K, 2012, MOL SYST BIOL, V8, DOI 10.1038/msb.2012.25; Lamb R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067811; Landi L, 2013, EXPERT REV ANTICANC, V13, P1219, DOI 10.1586/14737140.2013.846830; Liu L, 2009, CANCER RES, V69, P6871, DOI 10.1158/0008-5472.CAN-08-4490; Liu NN, 2014, TUMOR BIOL, V35, P641, DOI 10.1007/s13277-013-1088-1; Locasale JW, 2012, MOL SYST BIOL, V8, DOI 10.1038/msb.2012.30; Logue JS, 2012, GENE DEV, V26, P641, DOI 10.1101/gad.186965.112; Loh YN, 2013, BMC CANCER, V13, DOI 10.1186/1471-2407-13-174; Lunn DJ, 2000, STAT COMPUT, V10, P325, DOI 10.1023/A:1008929526011; Luo M, 2014, AM J CANCER RES, V4, P608; Lynch MA, 2001, GENE EXPRESSION, V9, P157, DOI 10.3727/000000001783992560; Maglott DR, 2000, NUCLEIC ACIDS RES, V28, P126, DOI 10.1093/nar/28.1.126; Mao H, 2012, CANCER INVEST, V30, P48, DOI 10.3109/07357907.2011.630050; McCleary-Wheeler AL, 2012, MOL CARCINOGEN, V51, P25, DOI 10.1002/mc.20827; Ng CP, 2002, ADV CANCER RES, V85, P145, DOI 10.1016/S0065-230X(02)85005-9; Nieto-Sampedro M, 2011, CLIN MED INSIGHTS-ON, V5, P265, DOI 10.4137/CMO.S7685; Peled N, 2013, CELL ONCOL, V36, P277, DOI 10.1007/s13402-013-0133-9; Qin HX, 2009, BMC SYST BIOL, V3, DOI 10.1186/1752-0509-3-73; Rexer Brent N., 2012, Critical Reviews in Oncogenesis, V17, P1; Roberts CG, 2011, ONCOGENE, V30, P3186, DOI 10.1038/onc.2011.36; Sarkar S, 2009, BREAST CANCER-BASIC, V3, P47; Sasaki T, 2003, CANCER RES, V63, P801; Saul ZM, 2007, BIOINFORMATICS, V23, P2604, DOI 10.1093/bioinformatics/btm370; Schmidt M, 2002, MOL CELL BIOL, V22, P7842, DOI 10.1128/MCB.22.22.7842-7852.2002; Serizawa M, 2013, J THORAC ONCOL, V8, P259, DOI 10.1097/JTO.0b013e318279e942; Serra V, 2013, J CLIN INVEST, V123, P2551, DOI 10.1172/JCI66343; Sharifnia T, 2014, P NATL ACAD SCI USA, V111, P18661, DOI 10.1073/pnas.1412228112; Shi I, 2011, CANCER INFORM, V10, P273, DOI 10.4137/CIN.S8283; Stuhlmiller TJ, 2015, CELL REP, V11, P390, DOI 10.1016/j.celrep.2015.03.037; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Sun NK, 2010, J BIOMED SCI, V17, DOI 10.1186/1423-0127-17-27; Takano Y, 1999, J PATHOL, V189, P194; Tarca AL, 2009, BIOINFORMATICS, V25, P75, DOI 10.1093/bioinformatics/btn577; Tian Y, 2014, BMC SYST BIOL, V8, DOI 10.1186/s12918-014-0087-1; Toyooka S, 2007, CLIN CANCER RES, V13, P3431, DOI 10.1158/1078-0432.CCR-07-0070; Wang E., 2014, DATABASE CANC SYSTEM; Wang E., 2017, COSMIC CANC GENE CEN; Wang ZW, 2010, BBA-REV CANCER, V1806, P258, DOI 10.1016/j.bbcan.2010.06.001; Wasserman S, 1996, PSYCHOMETRIKA, V61, P401, DOI 10.1007/BF02294547; Wee KB, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004407; Xia WL, 2010, MOL CANCER THER, V9, P292, DOI 10.1158/1535-7163.MCT-09-1041; Yamaguchi H, 2014, ONCOGENE, V33, P1073, DOI 10.1038/onc.2013.74; Yang WJ, 2013, NUCLEIC ACIDS RES, V41, pD955, DOI 10.1093/nar/gks1111; Yun JY, 2009, SCIENCE, V325, P1555, DOI 10.1126/science.1174229; Zhang JM, 2009, NAT CELL BIOL, V11, P1444, DOI 10.1038/ncb1993; Zhao YL, 2015, INT J CANCER, V137, P2767, DOI 10.1002/ijc.29293	112	10	11	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 13	2017	12	3							e0173331	10.1371/journal.pone.0173331	http://dx.doi.org/10.1371/journal.pone.0173331			37	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN6CP	28288164	Green Published, gold, Green Submitted			2022-12-27	WOS:000396092400013
J	Bardach, AE; Caporale, JE; Rubinstein, AL; Danaei, G				Esteban Bardach, Ariel; Enzo Caporale, Joaquin; Luis Rubinstein, Adolfo; Danaei, Goodarz			Impact of level and patterns of alcohol drinking on coronary heart disease and stroke burden in Argentina	PLOS ONE			English	Article							COMPARATIVE RISK-ASSESSMENT; GLOBAL BURDEN; CARDIOVASCULAR-DISEASE; LATIN-AMERICA; MORTALITY; CONSUMPTION; MORBIDITY; ANGINA; INJURY; HEALTH	Background Deaths from cardiovascular disease (CVD), including coronary heart disease (CHD) and stroke are expected to increase in Latin America. Moderate and regular alcohol consumption confers cardiovascular protection, while binge drinking increases risk. We estimated the effects of alcohol use on the number of annual CHD and stroke deaths and disability-adjusted life years (DALYs) in Argentina. Methods Alcohol use data were obtained from a nationally representative survey (EnPreCosp 2011), and etiological effect sizes from meta-analyses of epidemiological studies. Cause-specific mortality rates were from the vital registration system. Results There were 291,475 deaths in 2010 including 24,893 deaths from CHD and 15,717 from stroke. 62.7% of men and 38.7% of women reported drinking alcohol in the past year. All heavy drinkers (i.e. women who drank >20g/day and men who drank >40g/day of alcohol) met the definition of binge drinking and therefore did not benefit from cardioprotective effects. Alcohol drinking prevented 1,424 CHD deaths per year but caused 935 deaths from stroke (121 ischemic and 814 hemorrhagic), leading to 448 CVD deaths prevented (58.3% in men). Alcohol use was estimated to save 85,772 DALYs from CHD, but was responsible for 52,171 lost from stroke. Conclusions In Argentina, the cardioprotective effect of regular and moderate alcohol drinking is slightly larger than the harmful impact of binge drinking on CVD. However, considering global deleterious effects of alcohol in public health, policies to reduce binge drinking should be enforced, especially for young people. Studies are still needed to elucidate effects on cardiovascular health.	[Esteban Bardach, Ariel; Enzo Caporale, Joaquin; Luis Rubinstein, Adolfo] Inst Clin Effectiveness & Hlth Policy, Buenos Aires, DF, Argentina; [Esteban Bardach, Ariel; Enzo Caporale, Joaquin; Luis Rubinstein, Adolfo] Natl Sci & Tech Res Council CONICET, Buenos Aires, DF, Argentina; [Danaei, Goodarz] Harvard Sch Publ Hlth, Dept Epidemiol, Dept Global Hlth & Populat, Boston, MA USA; [Esteban Bardach, Ariel] Inst Clin Effectiveness & Hlth Policy IECS, Dr Emilio Ravignani 2024 C1014CPV, Buenos Aires, DF, Argentina; [Danaei, Goodarz] Harvard Sch Publ Hlth, 677 Huntington Ave,Bldg 1, Boston, MA USA	Centro Nacional Patagonico (CENPAT); Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Harvard T.H. Chan School of Public Health	Bardach, AE (corresponding author), Inst Clin Effectiveness & Hlth Policy, Buenos Aires, DF, Argentina.; Bardach, AE (corresponding author), Natl Sci & Tech Res Council CONICET, Buenos Aires, DF, Argentina.; Bardach, AE (corresponding author), Inst Clin Effectiveness & Hlth Policy IECS, Dr Emilio Ravignani 2024 C1014CPV, Buenos Aires, DF, Argentina.	abardach@iecs.org.ar	Bardach, Ariel/H-9566-2019; Danaei, Goodarz/B-6085-2008	Bardach, Ariel/0000-0003-4437-0073; 	Promoting Capacity Building in Chronic Diseases Research in South America; FOGARTY INTERNATIONAL CENTER [4D43TW009126-02]	Promoting Capacity Building in Chronic Diseases Research in South America; FOGARTY INTERNATIONAL CENTER(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC))	This work was supported by funding from Promoting Capacity Building in Chronic Diseases Research in South America. FOGARTY INTERNATIONAL CENTER. Grant # 4D43TW009126-02.	Aleman A, 2014, NEUROLOGOIA ARGENTIN, V7, P3; Americas Udl, 2008, PROYECC EST CARG ENF; Anderson P, 2009, LANCET, V373, P2234, DOI 10.1016/S0140-6736(09)60744-3; Argentinean Ministry of Health D Directorate of Statistics and Health Information (DEIS), 2011, ARG 2010 VIT STAT; Bagnardi V, 2008, J EPIDEMIOL COMMUNIT, V63, P615; Barendregt Jan J, 2003, Popul Health Metr, V1, P4, DOI 10.1186/1478-7954-1-4; Bazzino O, 1999, AM HEART J, V137, P322, DOI 10.1053/hj.1999.v137.93029; Borras X, 2012, REV ESP CARDIOL, V65, P734, DOI 10.1016/j.rec.2012.03.010; Borruel M., 2010, ESTUDIO CARGO ENFERM; Chisholm D, 2004, J STUD ALCOHOL, V65, P782, DOI 10.15288/jsa.2004.65.782; Connor J, 2005, NEW ZEAL MED J, V118; Corrao G, 2004, PREV MED, V38, P613, DOI 10.1016/j.ypmed.2003.11.027; Cremonte M, 2016, INT J PSYCHOL; Eidelman Rachel S, 2002, Semin Vasc Med, V2, P253, DOI 10.1055/s-2002-35393; Feigin VL, 2009, LANCET NEUROL, V8, P355, DOI 10.1016/S1474-4422(09)70025-0; Ferlay J, 2013, CANCER; Fernando L, 2014, PROG CARDIOVASC DIS, V57, P262, DOI 10.1016/j.pcad.2014.07.007; Forouzanfar MH, 2012, GLOB HEART, V7, P331, DOI 10.1016/j.gheart.2012.10.003; Gersh BJ, 2010, EUR HEART J, V31, P642, DOI 10.1093/eurheartj/ehq030; Gutjahr E, 2001, EUR ADDICT RES, V7, P117, DOI 10.1159/000050729; Insitute of Health Metrics, 2015, GBD HEAETM; Institute for Health Metrics and Evaluation (IHME), 2013, GBD HEATM; Instituto Nacional de Estadisticas y Censos (INDEC), 2011, ENC NAC PREV CONS SU; Lim SS, 2012, LANCET, V380, P2224, DOI 10.1016/S0140-6736(12)61766-8; Maredza M, 2015, BMC NEUROL, V15, DOI 10.1186/s12883-015-0311-7; Martin J, 2010, ALCOHOL ALCOHOLISM, V45, P379, DOI 10.1093/alcalc/agq032; Mazzaglia G, 2001, ADDICTION, V96, P1743, DOI 10.1046/j.1360-0443.2001.961217434.x; Ministerio de Salud de Argentina, 2012, BAS EGR HOSP 2012 M; Ministerio de Salud de Argentina, 2011, BAS DAT MORT 2010 M; Ministerio de Salud de Argentina, 2011, EST VIT INF BAS AN 5, V5; Ministerio de Salud de Argentina. Direccion de Estadistica e Informacion en Salud (DEIS), 2010, BAS DAT MORT 2010 MI; Ministerio de Salud de Argentina. Direccion de Estadistica e Informacion en Salud (DEIS), 2014, BAS EGR HOSP 2012 MI; Ministry of Health Argentina, 2013, TERC ENC NAC FACT RI; Ministry of Health-Directorate of Statistics and Health Information (DEIS), 2012, HOSP DISCH DAT ARG; Monteiro MG, 2013, ADICCIONES, V25, P99; Murray Christopher JL, 2003, Popul Health Metr, V1, P1, DOI 10.1186/1478-7954-1-1; Murray CJL, 1997, J HEALTH ECON, V16, P703, DOI 10.1016/S0167-6296(97)00004-0; O'Donnell MJ, 2010, LANCET, V376, P112, DOI 10.1016/S0140-6736(10)60834-3; Rehm J, 2004, COMP QUANTIFICATION, P959; Rehm J, 2011, DRUG ALCOHOL REV, V30, P335, DOI 10.1111/j.1465-3362.2011.00338.x; Rehm J, 2009, LANCET, V373, P2223, DOI 10.1016/S0140-6736(09)60746-7; Ridolfo B, 2001, QUANTIFICATION DRUG; Robaina K, 2017, ADDICTION, V112, P122, DOI 10.1111/add.13625; Roerecke M, 2011, AM J EPIDEMIOL, V173, P245, DOI 10.1093/aje/kwq364; Roerecke M, 2010, AM J EPIDEMIOL, V171, P633, DOI 10.1093/aje/kwp451; Rubinstein A, 2010, REV PANAM SALUD PUBL, V27, P237, DOI 10.1590/S1020-49892010000400001; Rushby JF, 2001, HEALTH POLICY PLANN, V16, P326, DOI 10.1093/heapol/16.3.326; Salomon JA, 2012, LANCET, V380, P2129, DOI 10.1016/S0140-6736(12)61680-8; Saposnik G, 2003, STROKE, V34, P2103, DOI 10.1161/01.STR.0000088063.74250.DB; Saposnik G, 2000, STROKE, V31, P2385, DOI 10.1161/01.STR.31.10.2385; Shield KD, 2013, ADDICTION, V108, P912, DOI 10.1111/add.12112; Single E, 1999, AM J PUBLIC HEALTH, V89, P385, DOI 10.2105/AJPH.89.3.385; Velasqeuz Valdivia A, 2008, CARGA ENFERMEDAD LES; Wong MD, 2006, PUBLIC HEALTH REP, V121, P746, DOI 10.1177/003335490612100615; World Health Organization, 2008, GLOB BURD DIS 2004 U; Yusuf S, 2004, LANCET, V364, P937, DOI 10.1016/S0140-6736(04)17018-9	56	12	12	1	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 10	2017	12	3							e0173704	10.1371/journal.pone.0173704	http://dx.doi.org/10.1371/journal.pone.0173704			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EN6CJ	28282416	gold, Green Published, Green Submitted			2022-12-27	WOS:000396091800071
J	Sominsky, L; Ziko, I; Spencer, SJ				Sominsky, Luba; Ziko, Ilvana; Spencer, Sarah J.			Neonatal overfeeding disrupts pituitary ghrelin signalling in female rats long-term; Implications for the stress response	PLOS ONE			English	Article							GENDER-DIFFERENCES; MATERNAL-CARE; SEX-DIFFERENCES; MESSENGER-RNA; ADRENAL AXIS; PSYCHOLOGICAL STRESS; CIRCULATING GHRELIN; HORMONAL-REGULATION; IMMUNE CHALLENGE; DESACYL GHRELIN	The hypothalamic-pituitary-adrenal (HPA) axis responses to psychological stress are exacerbated in adult female but not male rats made obese due to overfeeding in early life. Ghrelin, traditionally known for its role in energy homeostasis, has been recently recognised for its role in coordinating the HPA responses to stress, particularly by acting directly at the anterior pituitary where the growth hormone secretagogue receptor (GHSR), the receptor for acyl ghrelin, is abundantly expressed. We therefore hypothesised that neonatal overfeeding in female rats would compromise pituitary responsiveness to ghrelin, contributing to a hyperactive central stress responsiveness. Unlike in males where hypothalamic ghrelin signalling is compromised by neonatal overfeeding, there was no effect of early life diet on circulating ghrelin or hypothalamic ghrelin signalling in females, indicating hypothalamic feeding and metabolic ghrelin circuitry remains intact. However, neonatal overfeeding did lead to long-term alterations in the pituitary ghrelin system. The neonatally overfed females had increased neonatal and reduced adult expression of GHSR and ghrelin-O-acyl transferase (GOAT) in the pituitary as well as reduced pituitary responsiveness to exogenous acyl ghrelin-induced adrenocorticotropic hormone (ACTH) release in vitro. These data suggest that neonatal overfeeding dysregulates pituitary ghrelin signalling long-term in females, potentially accounting for the hyper-responsive HPA axis in these animals. These findings have implications for how females may respond to stress throughout life, suggesting the way ghrelin modifies the stress response at the level of the pituitary may be less efficient in the neonatally overfed.	[Sominsky, Luba; Ziko, Ilvana; Spencer, Sarah J.] RMIT Univ, Sch Hlth & Biomed Sci, Melbourne, Vic, Australia	Royal Melbourne Institute of Technology (RMIT)	Sominsky, L (corresponding author), RMIT Univ, Sch Hlth & Biomed Sci, Melbourne, Vic, Australia.	Luba.Sominsky@rmit.edu.au	Spencer, Sarah J/D-5777-2018	Sominsky, Luba/0000-0002-0674-8824; Spencer, Sarah/0000-0001-8832-4824	Discovery Project Grant from the Australian Research Council (ARC) [DP130100508]; ARC Future Fellowship [FT110100084]; RMIT University VC Senior Research Fellowship	Discovery Project Grant from the Australian Research Council (ARC)(Australian Research Council); ARC Future Fellowship(Australian Research Council); RMIT University VC Senior Research Fellowship	This work was supported by a Discovery Project Grant from the Australian Research Council (ARC) www.arc.gov.au to SJS (DP130100508), an ARC Future Fellowship (FT110100084) and an RMIT University VC Senior Research Fellowship to SJS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This work was supported by a Discovery Project Grant from the Australian Research Council (ARC) to SJS (DP130100508), an ARC Future Fellowship (FT110100084) and an RMIT University VC Senior Research Fellowship to SJS.	Abizaid A, 2006, J CLIN INVEST, V116, P3229, DOI 10.1172/JCI29867; Andrews ZB, 2011, PEPTIDES, V32, P2248, DOI 10.1016/j.peptides.2011.05.014; Arvat E, 2001, J CLIN ENDOCR METAB, V86, P1169, DOI 10.1210/jc.86.3.1169; AUTELITANO DJ, 1989, ANNU REV PHYSIOL, V51, P715, DOI 10.1146/annurev.physiol.51.1.715; Barkan AL, 2003, J CLIN ENDOCR METAB, V88, P2180, DOI 10.1210/jc.2002-021169; Barry D, 2008, ANN EPIDEMIOL, V18, P458, DOI 10.1016/j.annepidem.2007.12.009; Becker JB, 2016, BIOL SEX DIFFER, V7, DOI 10.1186/s13293-016-0087-5; Bilbo SD, 2010, FASEB J, V24, P2104, DOI 10.1096/fj.09-144014; Boullu-Ciocca S, 2005, DIABETES, V54, P197, DOI 10.2337/diabetes.54.1.197; Bouret SG, 2013, FRONT NEUROENDOCRIN, V34, P18, DOI 10.1016/j.yfrne.2013.01.001; Cabral A, 2014, J NEUROENDOCRINOL, V26, P542, DOI 10.1111/jne.12168; Cabral A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031462; Cai G, 2016, SCI REP-UK, V6, DOI 10.1038/srep21097; Caldji C, 1998, P NATL ACAD SCI USA, V95, P5335, DOI 10.1073/pnas.95.9.5335; Champagne FA, 2003, PHYSIOL BEHAV, V79, P359, DOI 10.1016/S0031-9384(03)00149-5; Chuang JC, 2011, J CLIN INVEST, V121, P2684, DOI 10.1172/JCI57660; Clarke MA, 2012, J NEUROENDOCRINOL, V24, P511, DOI 10.1111/j.1365-2826.2011.02269.x; Cohen EP, 2011, TRANSL RES, V157, P38, DOI 10.1016/j.trsl.2010.09.007; Collden G, 2015, MOL METAB, V4, P15, DOI 10.1016/j.molmet.2014.10.003; Currie PJ, 2005, AM J PHYSIOL-REG I, V289, pR353, DOI 10.1152/ajpregu.00756.2004; Daee A, 2002, SOUTH MED J, V95, P1032, DOI 10.1097/00007611-200209000-00021; De Luca SN, 2016, J NEUROINFLAMM, V13, DOI 10.1186/s12974-016-0578-7; DEKLOET ER, 1987, PSYCHONEUROENDOCRINO, V12, P83, DOI 10.1016/0306-4530(87)90040-0; Del Cerro MCR, 2010, BEHAV BRAIN RES, V208, P593, DOI 10.1016/j.bbr.2010.01.003; Delahaye F, 2008, ENDOCRINOLOGY, V149, P470, DOI 10.1210/en.2007-1263; DENENBERG VH, 1963, J REPROD FERTIL, V5, P133, DOI 10.1530/jrf.0.0050133; Dimitsantos E, 2007, PHYSIOL BEHAV, V92, P708, DOI 10.1016/j.physbeh.2007.05.066; Espelund U, 2005, J CLIN ENDOCR METAB, V90, P741, DOI 10.1210/jc.2004-0604; FIOROTTO ML, 1991, AM J PHYSIOL, V260, pR1104, DOI 10.1152/ajpregu.1991.260.6.R1104; Fowler-Brown AG, 2009, OBESITY; Gahete MD, 2010, MOL CELL ENDOCRINOL, V317, P154, DOI 10.1016/j.mce.2009.12.023; Gayle DA, 2006, LIFE SCI, V79, P1531, DOI 10.1016/j.lfs.2006.04.015; Hagobian TA, 2010, EXERC SPORT SCI REV, V38, P25, DOI 10.1097/JES.0b013e3181c5cd98; Hellstrom IC, 2012, PHILOS T R SOC B, V367, P2495, DOI 10.1098/rstb.2012.0223; Hosoda H, 2004, CLIN CHEM, V50, P1077, DOI 10.1373/clinchem.2003.025841; Howard AD, 1996, SCIENCE, V273, P974, DOI 10.1126/science.273.5277.974; HUNT SP, 1987, NATURE, V328, P632, DOI 10.1038/328632a0; Irving LM, 2002, PREV MED, V34, P299, DOI 10.1006/pmed.2001.0997; Iwasaki-Sekino A, 2009, PSYCHONEUROENDOCRINO, V34, P226, DOI 10.1016/j.psyneuen.2008.09.003; Jaaskelainen A, 2014, BMC PUBLIC HEALTH, V14, DOI 10.1186/1471-2458-14-321; Jaremka LM, 2014, PSYCHONEUROENDOCRINO, V48, P178, DOI 10.1016/j.psyneuen.2014.06.018; Johnstone LE, 2005, STRESS, V8, P59, DOI 10.1080/10253890500095283; KESSLER RC, 1993, J AFFECT DISORDERS, V29, P85, DOI 10.1016/0165-0327(93)90026-G; Kojima M, 1999, NATURE, V402, P656, DOI 10.1038/45230; Lopez M, 2007, INT J OBESITY, V31, P371, DOI 10.1038/sj.ijo.0803425; Lutter M, 2008, NAT NEUROSCI, V11, P752, DOI 10.1038/nn.2139; Makovey J, 2007, CLIN ENDOCRINOL, V66, P530, DOI 10.1111/j.1365-2265.2007.02768.x; Marcus SM, 2005, J AFFECT DISORDERS, V87, P141, DOI 10.1016/j.jad.2004.09.008; Meyer RM, 2013, MOL PSYCHIAT; Monteleone P, 2012, NEUROPSYCHOBIOLOGY, V66, P230, DOI 10.1159/000341877; Moriyama C, 2013, EPILEPSY BEHAV, V29, P19, DOI 10.1016/j.yebeh.2013.06.017; Nakazato M, 2001, NATURE, V409, P194, DOI 10.1038/35051587; Ochi M, 2008, LIFE SCI, V82, P862, DOI 10.1016/j.lfs.2008.01.020; Ostergard T, 2003, DIABETOLOGIA, V46, P134, DOI 10.1007/s00125-002-0985-4; Patterson ZR, 2010, EUR J NEUROSCI, V32, P632, DOI 10.1111/j.1460-9568.2010.07310.x; Pryce CR, 2001, DEV PSYCHOBIOL, V38, P239, DOI 10.1002/dev.1018; Raspopow K, 2014, APPETITE, V74, P35, DOI 10.1016/j.appet.2013.11.018; Raspopow K, 2010, HORM BEHAV, V58, P677, DOI 10.1016/j.yhbeh.2010.06.003; Reichenbach A, 2012, ENDOCRINOLOGY, V153, P5452, DOI 10.1210/en.2012-1622; Rouach V, 2007, PSYCHONEUROENDOCRINO, V32, P693, DOI 10.1016/j.psyneuen.2007.04.010; Schaeffer M, 2013, P NATL ACAD SCI USA, V110, P1512, DOI 10.1073/pnas.1212137110; Schmid DA, 2005, NEUROPSYCHOPHARMACOL, V30, P1187, DOI 10.1038/sj.npp.1300670; Schmidt I, 2001, INT J OBESITY, V25, P1168, DOI 10.1038/sj.ijo.0801669; Schmittgen TD, 2008, NAT PROTOC, V3, P1101, DOI 10.1038/nprot.2008.73; Smith JT, 2012, BIOL REPROD, V86, DOI 10.1095/biolreprod.111.097758; Soares VM, 2012, REGUL PEPTIDES, V174, P6, DOI 10.1016/j.regpep.2011.11.002; Sominsky L, 2017, NEUROPHARMACOLOGY, V113, P21, DOI 10.1016/j.neuropharm.2016.09.023; Sominsky L, 2016, MOL CELL ENDOCRINOL, V431, P24, DOI 10.1016/j.mce.2016.05.001; Soriano-Guillen L, 2016, CLIN CHEM LAB MED, V54, P1371, DOI 10.1515/cclm-2015-0555; Spencer SJ, 2015, BIOL PSYCHIAT, V78, P19, DOI 10.1016/j.biopsych.2014.10.021; Spencer SJ, 2012, BIOL PSYCHIAT, V72, P457, DOI 10.1016/j.biopsych.2012.03.010; Spencer SJ, 2009, PSYCHONEUROENDOCRINO, V34, P1133, DOI 10.1016/j.psyneuen.2009.02.013; Stark R, 2016, ENDOCRINOLOGY, V157, P3946, DOI 10.1210/en.2016-1306; Steculorum SM, 2015, J CLIN INVEST; Steculorum SM GMaBS, 2010, 7 INT C NEUR; Steculorum SM, 2011, PEPTIDES, V32, P2362, DOI 10.1016/j.peptides.2011.06.021; Stefanidis A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052130; Stengel A, 2011, PEPTIDES, V32, P2208, DOI 10.1016/j.peptides.2011.07.002; Suckow MA, 2006, AM COLL LAB, pXI, DOI 10.1016/B978-012074903-4/50001-7; Takaya K, 2000, J CLIN ENDOCR METAB, V85, P4908, DOI 10.1210/jc.85.12.4908; Ter Horst GJ, 2009, PHYSIOL BEHAV, V97, P239, DOI 10.1016/j.physbeh.2009.02.036; Tschop M, 2000, NATURE, V407, P908, DOI 10.1038/35038090; Whitaker RC, 1997, NEW ENGL J MED, V337, P869, DOI 10.1056/NEJM199709253371301; Windle RJ, 1998, ENDOCRINOLOGY, V139, P443, DOI 10.1210/en.139.2.443; Young EA, 1996, MOL PSYCHIATR, V1, P313; Zelena D, 2011, STRESS, V14, P420, DOI 10.3109/10253890.2011.552991; Zigman JM, 2016, TRENDS ENDOCRIN MET, V27, P54, DOI 10.1016/j.tem.2015.09.010; Zigman JM, 2006, J COMP NEUROL, V494, P528, DOI 10.1002/cne.20823; Ziko I, 2014, BRAIN BEHAV IMMUN, V41, P32, DOI 10.1016/j.bbi.2014.06.014	89	11	11	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 10	2017	12	3							e0173498	10.1371/journal.pone.0173498	http://dx.doi.org/10.1371/journal.pone.0173498			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN6CJ	28282447	Green Submitted, gold, Green Published			2022-12-27	WOS:000396091800045
J	Nani, BD; de Lima, PO; Marcondes, FK; Groppo, FC; Rolim, GS; de Moraes, ABA; Cogo-Muller, K; Franz-Montan, M				Nani, Bruno Dias; de Lima, Patricia Oliveira; Marcondes, Fernanda Klein; Groppo, Francisco Carlos; Rolim, Gustavo Sattolo; Alves de Moraes, Antonio Bento; Cogo-Mueller, Karina; Franz-Montan, Michelle			Changes in salivary microbiota increase volatile sulfur compounds production in healthy male subjects with academic-related chronic stress	PLOS ONE			English	Article							HYDROGEN-SULFIDE; METHYL MERCAPTAN; BACTERIA; GROWTH; IDENTIFICATION; ASSOCIATION; GINGIVALIS; PREVALENCE; HALITOSIS; STUDENTS	Objective To investigate the associations among salivary bacteria, oral emanations of volatile sulfur compounds, and academic-related chronic stress in healthy male subjects. Materials and methods Seventy-eight healthy male undergraduate dental students were classified as stressed or not by evaluation of burnout, a syndrome attributed to academic-related chronic stress. This evaluation was carried out using the Maslach Burnout Inventory-Student Survey questionnaire. Oral emanations of hydrogen sulfide, methyl mercaptan, and dimethyl sulfide were measured using an Oral Chroma(TM) portable gas chromatograph. The amounts in saliva of total bacteria and seven bacteria associated with halitosis were quantified by qPCR. The in vitro production of H2S by S. moorei and/or F. nucleatum was also measured with the Oral Chroma(TM) instrument. Results The stressed students group showed increased oral emanations of hydrogen sulfide and dimethyl sulfide, together with higher salivary Solobacterium moorei levels (p < 0.05, Mann Whitney test). There were moderate positive correlations between the following pairs of variables: Fusobacterium nucleatum and S. moorei; F. nucleatum and hydrogen sulfide; Tannerella forsythia and F. nucleatum; T. forsythia and S. moorei. These correlations only occurred for the stressed group (p < 0.05, Spearman correlation). The in vitro experiment demonstrated that S. moorei increased H2S production by F. nucleatum (p < 0.05, ANOVA and Tukey's test). Conclusion The increased amount of S. moorei in saliva, and its coexistence with F. nucleatum and T. forsythia, seemed to be responsible for increased oral hydrogen sulfide in the healthy male stressed subjects.	[Nani, Bruno Dias; de Lima, Patricia Oliveira; Marcondes, Fernanda Klein; Groppo, Francisco Carlos; Alves de Moraes, Antonio Bento; Cogo-Mueller, Karina; Franz-Montan, Michelle] Univ Campinas UNICAMP, Piracicaba Dent Sch, Dept Physiol Sci, Piracicaba, SP, Brazil; [Rolim, Gustavo Sattolo] UFJF, Dept Basic Hlth Appl Psychol, Governador Valadares, MG, Brazil	Universidade Estadual de Campinas	Cogo-Muller, K; Franz-Montan, M (corresponding author), Univ Campinas UNICAMP, Piracicaba Dent Sch, Dept Physiol Sci, Piracicaba, SP, Brazil.	karicogo@hotmail.com; michelle@fop.unicamp.br	Muller, Karina/ABA-1819-2021; Franz-Montan, Michelle/AAN-1071-2021; Nani, Bruno/A-6723-2018; groppo, francisco carlos/HIK-2053-2022; Franz-Montan, Michelle/E-2865-2010; Muller, Karina Cogo/H-2365-2012; Marcondes, Fernanda Klein/AAF-2048-2020; Franz-Montan, Michelle/V-3301-2019	Franz-Montan, Michelle/0000-0003-0760-1389; groppo, francisco carlos/0000-0002-8513-773X; Muller, Karina Cogo/0000-0002-9048-8702; Franz-Montan, Michelle/0000-0003-0760-1389; Marcondes, Fernanda/0000-0001-6326-057X	Sao Paulo Research Foundation (FAPESP) [2011/50419-2]; FAPESP [2013/26691-0]	Sao Paulo Research Foundation (FAPESP)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); FAPESP(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP))	Financial support was provided by the Sao Paulo Research Foundation (FAPESP,grant #2011/50419-2). Bruno Dias Nani acknowledges the scholarship provided by FAPESP (grant#2013/26691-0). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Calil CM, 2008, ARCH ORAL BIOL, V53, P1107, DOI 10.1016/j.archoralbio.2008.06.008; Calil CM, 2006, LIFE SCI, V79, P660, DOI 10.1016/j.lfs.2006.02.010; Calil CM, 2014, BRAZ ORAL RES, V28, P189, DOI 10.1590/1807-3107BOR-2014.vol28.0008; Casarin RCV, 2010, J PERIODONTAL RES, V45, P635, DOI 10.1111/j.1600-0765.2010.01278.x; Deinzer R, 2005, BRIT J HEALTH PSYCH, V10, P269, DOI 10.1348/135910705X26858; Freestone PPE, 2008, TRENDS MICROBIOL, V16, P55, DOI 10.1016/j.tim.2007.11.005; Graziano TS, 2013, J PERIODONTAL RES; Haraszthy VI, 2008, J BREATH RES, V2, DOI 10.1088/1752-7155/2/1/017002; Haraszthy VI, 2007, J AM DENT ASSOC, V138, P1113, DOI 10.14219/jada.archive.2007.0325; Harvey-Woodworth CN, 2013, BRIT DENT J, V214, DOI 10.1038/sj.bdj.2013.329; Igarashi E, 2009, ORAL MICROBIOL IMMUN, V24, P310, DOI 10.1111/j.1399-302X.2009.00513.x; Jakubovics NS, 2015, J MOL BIOL, V427, P3662, DOI 10.1016/j.jmb.2015.09.022; Johannsen A, 2010, INT J DENT HYG, V8, P22, DOI 10.1111/j.1601-5037.2009.00397.x; Kazor CE, 2003, J CLIN MICROBIOL, V41, P558, DOI 10.1128/JCM.41.2.558-563.2003; Kuboniwa M, 2004, ORAL MICROBIOL IMMUN, V19, P168, DOI 10.1111/j.0902-0055.2004.00135.x; Kurata H, 2008, J MED MICROBIOL, V57, P636, DOI 10.1099/jmm.0.47706-0; Lima PO, 2013, ORAL DIS, V19, P366, DOI 10.1111/odi.12011; Mafla AC, 2015, EUR J DENT EDUC, V19, P242, DOI 10.1111/eje.12128; Mager DL, 2003, J CLIN PERIODONTOL, V30, P1031, DOI 10.1046/j.0303-6979.2003.00418.x; Martin Claire A, 2007, J Med Case Rep, V1, P40, DOI 10.1186/1752-1947-1-40; Nakano Y, 2002, INT DENT J, V52, P217, DOI 10.1002/j.1875-595X.2002.tb00928.x; Park SN, 2013, ARCH MICROBIOL, V195, P473, DOI 10.1007/s00203-013-0896-4; PERSSON S, 1990, ORAL MICROBIOL IMMUN, V5, P195, DOI 10.1111/j.1399-302X.1990.tb00645.x; Queiroz CS, 2002, EUR J ORAL SCI, V110, P337, DOI 10.1034/j.1600-0722.2002.21320.x; Roberts A, 2002, ORAL MICROBIOL IMMUN, V17, P296, DOI 10.1034/j.1399-302X.2002.170506.x; Rosenberg M, 2007, J DENT RES, V86, P997, DOI 10.1177/154405910708601015; Saito T, 2011, ARCH ORAL BIOL, V56, P244, DOI 10.1016/j.archoralbio.2010.09.014; Salako NO, 2011, MED PRIN PRACT, V20, P75, DOI 10.1159/000319760; Schaufeli WB, 2002, J CROSS CULT PSYCHOL, V33, P464, DOI 10.1177/0022022102033005003; Schirrmeister JF, 2009, J ENDODONT, V35, P169, DOI 10.1016/j.joen.2008.10.024; Scully C, 2008, PERIODONTOL 2000, V48, P66, DOI 10.1111/j.1600-0757.2008.00266.x; Stephen AS, 2014, ANAEROBE, V26, P53, DOI 10.1016/j.anaerobe.2014.01.007; Sterer N, 2006, J DENT RES, V85, P910, DOI 10.1177/154405910608501007; Suarez F, 1999, AM J PHYSIOL-GASTR L, V276, pG425, DOI 10.1152/ajpgi.1999.276.2.G425; Suzuki N, 2005, CLIN MED RES, V3, P176, DOI 10.3121/cmr.3.3.176; Tanaka M, 2004, MICROBES INFECT, V6, P1078, DOI 10.1016/j.micinf.2004.05.021; Tangerman A, 2007, J CLIN PERIODONTOL, V34, P748, DOI 10.1111/j.1600-051X.2007.01116.x; Untergasser A, 2012, NUCLEIC ACIDS RES, V40, DOI 10.1093/nar/gks596; Van den Velde S, 2009, J DENT RES, V88, P285, DOI 10.1177/0022034508329741; Vancauwenberghe F, 2013, J BREATH RES, V7, DOI 10.1088/1752-7155/7/4/046006; Washio J, 2005, J MED MICROBIOL, V54, P889, DOI 10.1099/jmm.0.46118-0; Wong BKJ, 2016, J CLIN PERIODONTOL, V43, P503, DOI 10.1111/jcpe.12554; Yaegaki K, 2000, J Can Dent Assoc, V66, P257; Yang Ran, 2007, Hua Xi Kou Qiang Yi Xue Za Zhi, V25, P568; Yang S, 2002, J CLIN MICROBIOL, V40, P3449, DOI 10.1128/JCM.40.9.3449-3454.2002; Ye J., 2006, NUCL ACIDS RES, V34; Zheng G, 2010, INFORM SECURITY IET, V6, P6, DOI DOI 10.1128/JCM.01381-09; Zou KH, 2003, RADIOLOGY, V227, P617, DOI 10.1148/radiol.2273011499; Zscheppank C, 2014, ANAL BIOANAL CHEM, V406, P6617, DOI 10.1007/s00216-014-8111-2	49	20	21	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 20	2017	12	3							e0173686	10.1371/journal.pone.0173686	http://dx.doi.org/10.1371/journal.pone.0173686			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ER6VC	28319129	Green Submitted, Green Published, gold			2022-12-27	WOS:000398945800023
J	Thompson, A; Ashcroft, DM; Owens, L; van Staa, TP; Pirmohamed, M				Thompson, Andrew; Ashcroft, Darren M.; Owens, Lynn; van Staa, Tjeerd P.; Pirmohamed, Munir			Drug therapy for alcohol dependence in primary care in the UK: A Clinical Practice Research Datalink study	PLOS ONE			English	Article							GENERAL-PRACTICE; USE DISORDERS; PHARMACOTHERAPY; PERSISTENCE; INITIATION; TRENDS	Aim To evaluate drug therapy for alcohol dependence in the 12 months after first diagnosis in UK primary care. Design Open cohort study. Setting General practices contributing data to the UK Clinical Practice Research Database. Participants 39,980 people with an incident diagnosis of alcohol dependence aged 16 years or older between 1 January 1990 and 31 December 2013. Main outcome measure Use of pharmacotherapy (acamprosate, disulfiram, naltrexone, baclofen and topiramate) to promote abstinence from alcohol or reduce drinking to safe levels in the first 12 months after a recorded diagnosis of alcohol dependence. Findings Only 4,677 (11.7%) of the cohort received relevant pharmacotherapy in the 12 months following diagnosis. Of the 35,303 that did not receive pharmacotherapy, 3,255 (9.2%) received psychosocial support. The remaining 32,048 (80.2%) did not receive either mode of treatment in the first 12 months. Factors that independently reduced the likelihood of receiving pharmacotherapy included: being male (Odds Ratio [ OR] 0.74; 95% CI 0.69 to0.78); older (65-74 years: OR 0.61; 95% CI 0.49 to 0.77); being from a practice based in the most deprived quintile (OR 0.58; 95% CI 0.53 to 0.64); and being located in Northern Ireland (OR 0.78; 95% CI 0.67 to 0.91). The median duration to initiation of pharmacotherapy was 0.80 months (95% CI 0.70 to 1.00) for acamprosate and 0.60 months (95% CI 0.43 to 0.73) for disulfiram. Persistence analysis for those receiving acamprosate and disulfiram revealed that many patients never received a repeat prescription; persistence at 6 months was 27.7% for acomprosate and 33.2% for disulfiram. The median duration of therapy was 2.10 months (95% CI 1.87 to 2.53) for acamprosate and 3.13 months (95% CI 2.77 to 3.36) for disulfiram. Conclusion Drug therapy to promote abstinence in alcohol dependent patients was low, with the majority of patients receiving no therapy, either psychological or pharmacological. When drug therapy was prescribed, persistence was low with most patients receiving only one prescription. Our data show that treatment for alcohol dependence is haphazard, and there is an urgent need to explore strategies for improving clinical management of this patient group.	[Thompson, Andrew; Owens, Lynn; Pirmohamed, Munir] Univ Liverpool, Inst Translat Med, Wolfson Ctr Personalised Med, Liverpool, Merseyside, England; [Ashcroft, Darren M.] Univ Manchester, Manchester Acad Hlth Sci Ctr, Ctr Pharmacoepidemiol & Drug Safety, Manchester, Lancs, England; [Owens, Lynn] Royal Liverpool Univ Hosp Trust, Hepatol, Ward 5z Link,Prescot St, Liverpool, Merseyside, England; [van Staa, Tjeerd P.] Univ Manchester, Farr Inst, Hlth eRes Ctr, Manchester, Lancs, England; [van Staa, Tjeerd P.] Univ Utrecht, Div Pharmacoepidemiol & Clin Pharmacol, Utrecht, Netherlands	University of Liverpool; University of Manchester; University of Manchester; Utrecht University	Thompson, A (corresponding author), Univ Liverpool, Inst Translat Med, Wolfson Ctr Personalised Med, Liverpool, Merseyside, England.	andrew.thompson@liverpool.ac.uk	Pirmohamed, Munir/H-6004-2011; Ashcroft, Darren/G-3244-2015	Pirmohamed, Munir/0000-0002-7534-7266; van Staa, Tjeerd/0000-0001-9363-742X; Ashcroft, Darren/0000-0002-2958-915X; Owens, Lynn/0000-0001-7549-9350	Alcohol Research UK [SG 14/15207]; Liverpool Health Partners and Mersey Care NHS Foundation Trust; MRC [MR/K006665/1] Funding Source: UKRI; Medical Research Council [MR/K006665/1, MC_PC_13042] Funding Source: researchfish; National Institute for Health Research [PB-PG-0408-15077, NF-SI-0512-10064] Funding Source: researchfish	Alcohol Research UK; Liverpool Health Partners and Mersey Care NHS Foundation Trust; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); National Institute for Health Research(National Institute for Health Research (NIHR))	This work was supported by Alcohol Research UK via their small grants programme [SG 14/15207], http://alcoholresearchuk.org/, awarded to AT. The funders did not engage in the design and conduct of the study; collection, management, analysis, and interpretation of the data; or preparation, review, and approval of the manuscript. AT is supported in his role by Liverpool Health Partners and Mersey Care NHS Foundation Trust. The views expressed are those of the authors and not necessarily those of Liverpool Health Partners or Mersey Care NHS Foundation Trust.	[Anonymous], 2021, LANG ENV STAT COMP; ASHLEY MJ, 1977, ARCH INTERN MED, V137, P883, DOI 10.1001/archinte.137.7.883; Baser O, 2011, AM J MANAG CARE, V17, pS6; Bellis MA, 2016, BMC PUBLIC HEALTH, V16, DOI 10.1186/s12889-016-2766-x; Brady T. M., 2005, WOMEN SUBSTANCE ABUS; Brown MT, 2011, MEDICATION ADHERENCE; Department of Health, 2015, STAT ALC ENGL 2015; Gallagher AM, 2008, J THROMB HAEMOST, V6, P1500, DOI 10.1111/j.1538-7836.2008.03059.x; Gastfriend DR, 2014, ANN NY ACAD SCI, V1327, P112, DOI 10.1111/nyas.12538; Harris AHS, 2013, PSYCHOL SERV, V10, P410, DOI 10.1037/a0030949; Harris AHS, 2010, PSYCHIAT SERV, V61, P392, DOI 10.1176/ps.2010.61.4.392; Herrett E, 2015, INT J EPIDEMIOL, V44, P827, DOI 10.1093/ije/dyv098; HUNT WA, 1971, J CLIN PSYCHOL, V27, P455, DOI 10.1002/1097-4679(197110)27:4<455::AID-JCLP2270270412>3.0.CO;2-R; Jonas DE, 2014, JAMA-J AM MED ASSOC, V311, P1889, DOI 10.1001/jama.2014.3628; Kranzler HR, 2008, ADDICTION, V103, P1801, DOI 10.1111/j.1360-0443.2008.02345.x; Mark TL, 2010, AM J MANAG CARE, V16, P879; Mark TL, 2009, DRUG ALCOHOL DEPEN, V99, P345, DOI 10.1016/j.drugalcdep.2008.07.018; Miller WR, 2002, ADDICTION, V97, P265, DOI 10.1046/j.1360-0443.2002.00019.x; Morley KC, 2016, J SUBSTANCE ABUSE TR; Morley KC, 2016, DRUG ALCOHOL DEPEN, V166, P254, DOI 10.1016/j.drugalcdep.2016.06.027; NICE, 2009, DIAGN ASS MAN HARMF; Nolen-Hoeksema S, 2004, CLIN PSYCHOL REV, V24, P981, DOI 10.1016/j.cpr.2004.08.003; Raistrick D, 2006, REV EFFECTIVENESS TR; Rehm J, 2015, ANN FAM MED, V13, P28, DOI 10.1370/afm.1742; Rubinsky AD, 2015, J PSYCHIATR RES, V69, P150, DOI 10.1016/j.jpsychires.2015.07.016; Schuckit MA, 2009, LANCET, V373, P492, DOI 10.1016/S0140-6736(09)60009-X; Springate DA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0099825; Thomas CP, 2013, J SUBST ABUSE TREAT, V45, P11, DOI 10.1016/j.jsat.2013.01.004; Thompson A, 2015, PHARMACOL THERAPEUT, V153, P10, DOI 10.1016/j.pharmthera.2015.05.010; Ustun TB, MENTAL ILLNESS GEN H; Weisner C, 2001, ADDICTION, V96, P705, DOI 10.1046/j.1360-0443.2001.9657056.x; WHO, 2010, LEX ALC DRUG TERMS P; Williams T, 2012, THER ADV DRUG SAF, V3, P89, DOI 10.1177/2042098611435911	33	17	18	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 20	2017	12	3							e0173272	10.1371/journal.pone.0173272	http://dx.doi.org/10.1371/journal.pone.0173272			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	ER6VC	28319159	Green Published, gold			2022-12-27	WOS:000398945800012
J	Jordan, A; Zhang, XR; Li, JQ; Laulicht-Glick, F; Sun, H; Costa, M				Jordan, Ashley; Zhang, Xiaoru; Li, Jinquan; Laulicht-Glick, Freda; Sun, Hong; Costa, Max			Nickel and cadmium-induced SLBP depletion: A potential pathway to metal mediated cellular transformation	PLOS ONE			English	Article							LOOP-BINDING-PROTEIN; HISTONE MESSENGER-RNA; BLOOD MONONUCLEAR-CELLS; GENE-EXPRESSION; INDUCED CARCINOGENESIS; CYCLE PROGRESSION; PHOSPHORYLATION; CHROMIUM; PROLIFERATION; LOCALIZATION	Both nickel and cadmium compounds have been established as group I carcinogens for several decades. Despite over-whelming evidence of these compounds' carcinogenicity in humans, the specific underlying molecular mechanisms that govern metal induced cellular transformation remain unclear. In this study, we found that there were slightly different effects on decreased SLBP mRNA and protein as well as increased polyA H3.1 in our nickel exposed cells. This suggested that nickel and arsenic have similar effects on canonical histone mRNA transcription and translation. We also saw that the depletion of SLBP protein was reversed by inhibiting the proteosome. Finally, we showed that inhibiting the SLBP mRNA and protein levels were rescued by epigenetic modifiers suggesting that nickel's effects on SLBP may be mediated via epigenetic mechanisms. Taken together these results suggest a similar mechanism by which both arsenic and nickel may exert their carcinogenic effects.	[Jordan, Ashley; Zhang, Xiaoru; Laulicht-Glick, Freda; Sun, Hong; Costa, Max] NYU, Sch Med, Dept Environm Med, Tuxedo Pk, NY 10987 USA; [Jordan, Ashley; Costa, Max] NYU, Sch Med, Dept Mol Pharmacol & Biochem, New York, NY USA; [Li, Jinquan] Cent China Normal Univ, Hubei Key Lab Genet Regulat & Integrat Biol, Sch Life Sci, Wuhan, Hubei, Peoples R China	New York University; New York University; Central China Normal University	Costa, M (corresponding author), NYU, Sch Med, Dept Environm Med, Tuxedo Pk, NY 10987 USA.; Costa, M (corresponding author), NYU, Sch Med, Dept Mol Pharmacol & Biochem, New York, NY USA.	Max.Costa@nyumc.org		li, jinquan/0000-0003-0498-5399; costa, max/0000-0003-0000-3028	National Institute of Environmental Health Sciences [ES000260]; National Institute of Environmental Health Science [ES023174, ES022935, ES026138]; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R01ES022935, R01ES023174, R01ES026138] Funding Source: NIH RePORTER	National Institute of Environmental Health Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); National Institute of Environmental Health Science(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This study was supported by the National Institute of Environmental Health Sciences, ES000260, MC; National Institute of Environmental Health Sciences, ES023174, MC; National Institute of Environmental Health Sciences, ES022935, MC; National Institute of Environmental Health Sciences, ES026138, MC. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 1933, J SOC CHEM IND, V52, P690; Arita A, 2013, CANCER EPIDEM BIOMAR, V22, P261, DOI 10.1158/1055-9965.EPI-12-1011; Arita A, 2012, J TRACE ELEM MED BIO, V26, P174, DOI 10.1016/j.jtemb.2012.03.012; Arita A, 2012, ENVIRON HEALTH PERSP, V120, P198, DOI 10.1289/ehp.1104140; Arita A, 2009, METALLOMICS, V1, P222, DOI 10.1039/b903049b; Asara Y, 2013, INT J MOL SCI, V14, P16600, DOI 10.3390/ijms140816600; Baader EW, 1937, VORTRAEGE; Brocato J, 2015, BIOL TRACE ELEM RES, V166, P72, DOI 10.1007/s12011-015-0296-5; Brocato J, 2014, J BIOL CHEM, V289, P31751, DOI 10.1074/jbc.M114.591883; Brocato J, 2013, CRIT REV TOXICOL, V43, P493, DOI 10.3109/10408444.2013.794769; Brownell JE, 1996, CELL, V84, P843, DOI 10.1016/S0092-8674(00)81063-6; Chan O Y, 1982, Ann Acad Med Singap, V11, P122; Chen HB, 2010, CARCINOGENESIS, V31, P2136, DOI 10.1093/carcin/bgq197; Chervona Y, 2012, METALLOMICS, V4, P619, DOI 10.1039/c2mt20033c; Clancy HA, 2012, METALLOMICS, V4, P784, DOI 10.1039/c2mt20074k; Ding J, 2009, CANCER EPIDEM BIOMAR, V18, P1720, DOI 10.1158/1055-9965.EPI-09-0115; Doll R, 1977, BR J IND MED, V34; Dominski Z, 1999, MOL CELL BIOL, V19, P3561; Erkmann JA, 2005, MOL BIOL CELL, V16, P2960, DOI 10.1091/mbc.E04-11-1023; FLETCHER GG, 1994, ENVIRON HEALTH PERSP, V102, P69, DOI 10.2307/3431766; Frezza M, 2009, INORG CHEM, V48, P5928, DOI 10.1021/ic900276g; Gorgoni B, 2005, RNA, V11, P1030, DOI 10.1261/rna.7281305; IARC, 1993, IARC MONOGRAPHS EVAL, V58, P1; IARC, 1990, IARC MONOGRAPHS EVAL; Kang J, 2003, TOXICOL SCI, V74, P279, DOI 10.1093/toxsci/kfg137; KARGACIN B, 1993, MUTAT RES, V300, P63, DOI 10.1016/0165-1218(93)90141-Y; Koseoglu MM, 2008, MOL CELL BIOL, V28, P4469, DOI 10.1128/MCB.01416-07; Lanzotti DJ, 2004, MOL BIOL CELL, V15, P1112, DOI 10.1091/mbc.E03-09-0649; Luevano J, 2014, J ENVIRON PATHOL TOX, V33, P183, DOI 10.1615/JEnvironPatholToxicolOncol.2014011075; Morgan JG, 1958, BR J IND MED, P15; Pedersen E, 1973, INT J CANC, V12; Roberts RS, 1989, TOXICOLOGY IND HLTH, V5; Siemiatycki J, 2004, ENVIRON HEALTH PERSP, V112, P1447, DOI 10.1289/ehp.7047; Sullivan KD, 2009, RNA, V15, P459, DOI 10.1261/rna.1205409; Wang B, 2012, CURR MED CHEM, V19, P2611, DOI 10.2174/092986712800492913; Zhang MY, 2012, BIOCHEMISTRY-US, V51, P3215, DOI 10.1021/bi2018255; Zhao XJ, 2004, J CELL SCI, V117, P6043, DOI 10.1242/jcs.01523	37	7	7	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 17	2017	12	3							e0173624	10.1371/journal.pone.0173624	http://dx.doi.org/10.1371/journal.pone.0173624			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EO5CJ	28306745	Green Published, Green Submitted, gold			2022-12-27	WOS:000396710300014
J	van Eeden, R; Whitfield, DP; Botha, A; Amar, A				van Eeden, Rowen; Whitfield, D. Philip; Botha, Andre; Amar, Arjun			Ranging behaviour and habitat preferences of the Martial Eagle: Implications for the conservation of a declining apex predator	PLOS ONE			English	Article							GOLDEN EAGLES; NATIONAL-PARK; HOME-RANGE; SPACE-USE; SOUTH-AFRICA; POPULATION; SELECTION; AVAILABILITY; PATTERNS; TRACKING	Understanding the ranging behaviours of species can be helpful in effective conservation planning. However, for many species that are rare, occur at low densities, or occupy challenging environments, this information is often lacking. The Martial Eagle (Polemaetus belli-cosus) is a low density apex predator declining in both non-protected and protected areas in southern Africa, and little is known about its ranging behaviour. We use GPS tags fitted to Martial Eagles (n = 8) in Kruger National Park (KNP), South Africa to describe their ranging behaviour and habitat preference. This represents the first time that such movements have been quantified in adult Martial Eagles. Territorial eagles (n = 6) held home ranges averaging ca. 108 km(2). Home range estimates were similar to expectations based on inter-nest distances, and these large home range sizes could constrain the carrying capacity of even the largest conservation areas. Two tagged individuals classed as adults on plumage apparently did not hold a territory, and accordingly ranged more widely (ca. 44,000 km(2)), and beyond KNP boundaries as floaters. Another two territorial individuals abandoned their territories and joined the 'floater' population, and so ranged widely after leaving their territories. These unexpected movements after territory abandonment could indicate underlying environmental degradation. Relatively high mortality of these wide-ranging 'floaters' due to anthropogenic causes (three of four) raises further concerns for the species' persistence. Habitat preference models suggested Martial Eagles used areas preferentially that were closer to rivers, had higher tree cover, and were classed as dense bush rather than open bush or grassland. These results can be used by conservation managers to help guide actions to preserve breeding Martial Eagles at an appropriate spatial scale.	[van Eeden, Rowen; Amar, Arjun] Univ Cape Town, Dept Biol Sci, DST NRF Ctr Excellence, Percy Fitzpatrick Inst African Ornithol, Cape Town, South Africa; [Whitfield, D. Philip] Banchory Business Ctr, Nat Res, Burn OBennie Rd, Banchory, Aberdeen, Scotland; [Botha, Andre] Endangered Wildlife Trust, Birds Prey Programme, Modderfontein, South Africa	National Research Foundation - South Africa; University of Cape Town	van Eeden, R (corresponding author), Univ Cape Town, Dept Biol Sci, DST NRF Ctr Excellence, Percy Fitzpatrick Inst African Ornithol, Cape Town, South Africa.	rowen.vaneeden@uct.ac.za	Botha, Andre/Y-2304-2019; Amar, Arjun/L-4493-2019	Botha, Andre/0000-0003-1077-1215	DSTNRF Centre of Excellence; National Geographic Society Conservation Trust [C258-13]; Columbus Zoo and Aquarium; Natural Research Ltd.; Riverbanks Zoo and Garden; African Bird Club; Raptor Research Foundation Leslie Brown Memorial Award; ABAX Investments Charitable Trust	DSTNRF Centre of Excellence(Department of Science & Technology (India)); National Geographic Society Conservation Trust(National Geographic Society); Columbus Zoo and Aquarium; Natural Research Ltd.; Riverbanks Zoo and Garden; African Bird Club; Raptor Research Foundation Leslie Brown Memorial Award; ABAX Investments Charitable Trust	This research was funded by the DSTNRF Centre of Excellence, Natural Research Ltd. (www.natural-research.org), National Geographic Society Conservation Trust (Grant number: C258-13), Columbus Zoo and Aquarium (www.columbuszoo.org), Riverbanks Zoo and Garden (www.riverbanks.org), African Bird Club, Raptor Research Foundation Leslie Brown Memorial Award (www.raptorresearchfoundation.org), ABAX Investments Charitable Trust (www.abax.co.za). Toyota Phalaborwa provided courtesy vehicle services. Bushlore 4x4 vehicle hire provided reduced vehicle hire rates. External funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. Commercial funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aarts G, 2008, ECOGRAPHY, V31, P140, DOI 10.1111/j.2007.0906-7590.05236.x; Amar A, 2016, OSTRICH, V87, P1, DOI 10.2989/00306525.2015.1089333; Anderson MD, 1999, OSTRICH, V70, P139, DOI 10.1080/00306525.1999.9634530; [Anonymous], 2013, POLEMAETUS BELLICOSU; Asner GP, 2012, ECOL LETT, V15, P1211, DOI 10.1111/j.1461-0248.2012.01842.x; Bastille-Rousseau G, 2016, MOV ECOL, V4, DOI 10.1186/s40462-016-0080-y; Bates D, 2015, J STAT SOFTW, V67, P1, DOI 10.18637/jss.v067.i01; Bautista LM, 2004, CONSERV BIOL, V18, P726, DOI 10.1111/j.1523-1739.2004.00499.x; Berger D. D., 1959, Bird-Banding, V30, P18, DOI 10.2307/4510726; Berger-Tal O, 2011, BEHAV ECOLOGY; Beyer HL, 2010, PHILOS T R SOC B, V365, P2245, DOI 10.1098/rstb.2010.0083; Bisson IA, 2002, J FIELD ORNITHOL, V73, P298, DOI 10.1648/0273-8570-73.3.298; Bloom Peter H., 2007, P193; Boshoff A., 1997, ATLAS SO AFRICAN BIR, V1; Boshoff A., 1993, ANN MUSEE ROYAL AFRI; Braham M, 2015, BIOL CONSERV, V186, P225, DOI 10.1016/j.biocon.2015.03.020; Bridge ES, 2011, BIOSCIENCE, V61, P689, DOI 10.1525/bio.2011.61.9.7; Broomhall LS, 2003, J ZOOL, V261, P119, DOI 10.1017/S0952836903004059; BROWN CJ, 1991, BIOL CONSERV, V56, P49, DOI 10.1016/0006-3207(91)90088-Q; Brown L.H., 1982, BIRDS AFRICA, V1; Bucini G., 2010, ECOSYSTEM FUNCTION S, P219, DOI DOI 10.1201/B10275; Bunnefeld N, 2011, J ANIM ECOL, V80, P466, DOI 10.1111/j.1365-2656.2010.01776.x; Burger AE, 2008, AUK, V125, P253, DOI 10.1525/auk.2008.1408; Burt W. H., 1943, Journal of Mammalogy, V24, P346, DOI 10.2307/1374834; Cagnacci F, 2010, PHILOS T R SOC B, V365, P2157, DOI 10.1098/rstb.2010.0107; Calenge C, 2006, ECOL MODEL, V197, P516, DOI 10.1016/j.ecolmodel.2006.03.017; Caro T, 2007, TRENDS ECOL EVOL, V22, P394, DOI 10.1016/j.tree.2007.06.003; Carrete M, 2002, BIODIVERS CONSERV, V11, P975, DOI 10.1023/A:1015856924451; CHANDLER SK, 1995, J WILDLIFE MANAGE, V59, P325, DOI 10.2307/3808946; Cloete D., 2013, INVESTIGATING DECLIN; Coelho CM, 2007, APPL ANIM BEHAV SCI, V105, P259, DOI 10.1016/j.applanim.2006.04.024; Cooke SJ, 2004, TRENDS ECOL EVOL, V19, P334, DOI 10.1016/j.tree.2004.04.003; Cresswell W, 1996, IBIS, V138, P684, DOI 10.1111/j.1474-919X.1996.tb04770.x; Cullum C, 2011, 49811 WRC TT; Eckhardt HC, 2000, AFR J ECOL, V38, P108, DOI 10.1046/j.1365-2028.2000.00217.x; Fernandez M, 2009, ACTA ORNITHOL, V44, P17, DOI 10.3161/000164509X464849; Ferrer M, 2015, IBIS, V157, P849, DOI 10.1111/ibi.12289; Forero MG, 1999, ECOLOGY, V80, P1298, DOI 10.1890/0012-9658(1999)080[1298:CACOTC]2.0.CO;2; Gertenbach W.P.D., 1984, Koedoe, V26, P9; [Global Land Cover Facility UoM USGS], 2008, GLOB LAND COV FAC UO; Haworth PF, 2006, BIRD STUDY, V53, P265, DOI 10.1080/00063650609461442; Herholdt JJ, 1998, T ROY SOC S AFR, V53, P201, DOI 10.1080/00359199809520387; Herholdt JJ, 1997, OSTRICH, V68, P80, DOI 10.1080/00306525.1997.9639717; Hunt WG, 2015, IBIS, V157, P888, DOI 10.1111/ibi.12283; Hunt WG, 1998, OIKOS, V82, P191, DOI 10.2307/3546929; HUSTLER K, 1990, J TROP ECOL, V6, P343, DOI 10.1017/S0266467400004624; Jimenez-Franco MV, 2011, OECOLOGIA, V166, P507, DOI 10.1007/s00442-010-1857-0; Katzenberger J, 2015, J ORNITHOL, V156, P903, DOI 10.1007/s10336-015-1199-0; Katzner TE, 2012, J APPL ECOL, V49, P1178, DOI 10.1111/j.1365-2664.2012.02185.x; Kruger S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0114920; Lambertucci SA, 2014, BIOL CONSERV, V170, P145, DOI 10.1016/j.biocon.2013.12.041; Laver PN, 2008, J WILDLIFE MANAGE, V72, P290, DOI 10.2193/2005-589; Lehner B., 2006, HYDROSHEDS TECHNICAL, V1, P1; Lian XM, 2011, WILDLIFE RES, V38, P141, DOI 10.1071/WR10158; Machange RW, 2005, J ARID ENVIRON, V63, P223, DOI 10.1016/j.jaridenv.2005.03.031; Perez-Garcia JM, 2013, J ORNITHOL, V154, P63, DOI 10.1007/s10336-012-0871-x; Martinez JA, 2003, ECOGRAPHY, V26, P21, DOI 10.1034/j.1600-0587.2003.03368.x; Marzluff JM, 1997, AUK, V114, P673, DOI 10.2307/4089287; Meyburg BU, 2007, J ORNITHOL, V148, P157, DOI 10.1007/s10336-006-0113-1; Morales JM, 2010, PHILOS T R SOC B, V365, P2289, DOI 10.1098/rstb.2010.0082; Mucina L., 2006, VEGETATION S AFRICA; MuMIn K., 2015, MUMIN MULTIMODEL INF; Murgatroyd M, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0163378; Newton I., 1979, POPULATION ECOLOGY R; Ogada DL, 2008, OECOLOGIA, V156, P387, DOI 10.1007/s00442-008-0994-1; Ong CD., 2000, HOME RANGE MARTIAL E; Penteriani V, 2005, OIKOS, V108, P523, DOI 10.1111/j.0030-1299.2005.13514.x; Penteriani V, 2011, ANIM CONSERV, V14, P233, DOI 10.1111/j.1469-1795.2010.00433.x; Penteriani V, 2013, NATURWISSENSCHAFTEN, V100, P935, DOI 10.1007/s00114-013-1093-7; QGIS Development Team, 2015, QGIS GEOGR INF SYST; R Core Team, 2021, R LANGUAGE ENV STAT; Reid T, 2015, J APPL ECOL, V52, P881, DOI 10.1111/1365-2664.12468; Robertson A, 1998, BIODIVERS CONSERV, V7, P495, DOI 10.1023/A:1008827628666; Rohner C, 1998, AUK, V115, P694, DOI 10.2307/4089417; Rosenfield RN, 2015, J FIELD ORNITHOL, V86, P144, DOI 10.1111/jofo.12097; Rutz C, 2006, P ROY SOC B-BIOL SCI, V273, P2069, DOI 10.1098/rspb.2006.3507; Schofield G, 2007, J EXP MAR BIOL ECOL, V347, P58, DOI 10.1016/j.jembe.2007.03.009; Sexton JO, 2013, INT J DIGIT EARTH, V6, P427, DOI 10.1080/17538947.2013.786146; Simmons R., 2005, ROBERTS BIRDS SO AFR, P1296; Sing T, 2005, BIOINFORMATICS, V21, P3940, DOI 10.1093/bioinformatics/bti623; Smit IPJ, 2012, J ARID ENVIRON, V80, P74, DOI 10.1016/j.jaridenv.2011.11.026; Steyn P, 1982, BIRDS PREY SO AFRICA; Suarez S, 2000, J APPL ECOL, V37, P215, DOI 10.1046/j.1365-2664.2000.00503.x; Sumasgutner P, 2016, BIRD STUDY, V63, P430, DOI 10.1080/00063657.2016.1214814; SWETS JA, 1988, SCIENCE, V240, P1285, DOI 10.1126/science.3287615; Tarboton WR, 1984, STATUS CONSERVATION; Taylor MR., 2015, ESKOM RED DATA BOOK, P113; Tomkiewicz SM, 2010, PHILOS T R SOC B, V365, P2163, DOI 10.1098/rstb.2010.0090; van Niekerk JH, 2011, OSTRICH, V82, P43, DOI 10.2989/00306525.2010.515398; van Niekerk JH, 2003, S AFR J WILDL RES, V33, P59; van Rooyen C. S., 1999, BIRDS POWER LINES CO, P205; Vanak AT, 2012, ECOGRAPHY, V35, P315, DOI 10.1111/j.1600-0587.2011.07213.x; Watson JW, 2014, J WILDLIFE MANAGE, V78, P1012, DOI 10.1002/jwmg.745; Wilson Rory P., 2008, Endangered Species Research, V4, P123, DOI 10.3354/esr00064; WORTON BJ, 1989, ECOLOGY, V70, P164, DOI 10.2307/1938423	95	16	16	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 17	2017	12	3							e0173956	10.1371/journal.pone.0173956	http://dx.doi.org/10.1371/journal.pone.0173956			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EO5CJ	28306744	Green Published, Green Submitted, gold			2022-12-27	WOS:000396710300018
J	Cox, AJ; Darbro, BW; Laxer, RM; Velez, G; Bing, X; Finer, AL; Erives, A; Mahajan, VB; Bassuk, AG; Ferguson, PJ				Cox, Allison J.; Darbro, Benjamin W.; Laxer, Ronald M.; Velez, Gabriel; Bing, Xinyu; Finer, Alexis L.; Erives, Albert; Mahajan, Vinit B.; Bassuk, Alexander G.; Ferguson, Polly J.			Recessive coding and regulatory mutations in FBLIM1 underlie the pathogenesis of chronic recurrent multifocal osteomyelitis (CRMO)	PLOS ONE			English	Article							AUTOINFLAMMATORY DISEASE; MAJEED-SYNDROME; GENOME; DIFFERENTIATION; DATABASE; MIGFILIN; FILAMIN; BONE; INFLAMMATION; DEFICIENCY	Chronic recurrent multifocal osteomyelitis (CRMO) is a rare, pediatric, autoinflammatory disease characterized by bone pain due to sterile osteomyelitis, and is often accompanied by psoriasis or inflammatory bowel disease. There are two syndromic forms of CRMO, Majeed syndrome and DIRA, for which the genetic cause is known. However, for the majority of cases of CRMO, the genetic basis is unknown. Via whole-exome sequencing, we detected a homozygous mutation in the filamin-binding domain of FBLIM1 in an affected child with consanguineous parents. Microarray analysis of bone marrow macrophages from the CRMO murine model (cmo) determined that the Fblim1 ortholog is the most differentially expressed gene, downregulated over 20 -fold in the cmo mouse. We sequenced FBLIM1 in 96 CRMO subjects and found a second proband with a novel frameshift mutation in exon 6 and a rare regulatory variant. In SaOS2 cells, overexpressing the regulatory mutation showed the flanking region acts as an enhancer, and the mutation ablates enhancer activity. Our data implicate FBLIM1 in the pathogenesis of sterile bone inflammation and our findings suggest CRMO is a disorder of chronic inflammation and imbalanced bone remodeling.	[Cox, Allison J.; Darbro, Benjamin W.; Bing, Xinyu; Finer, Alexis L.; Bassuk, Alexander G.; Ferguson, Polly J.] Univ Iowa, Dept Pediat, Iowa City, IA 52242 USA; [Cox, Allison J.; Darbro, Benjamin W.; Erives, Albert; Bassuk, Alexander G.] Univ Iowa, Interdisciplinary Grad Program Genet, Iowa City, IA USA; [Laxer, Ronald M.] Univ Toronto, Dept Pediat, Div Pediat Rheumatol, Toronto, ON, Canada; [Laxer, Ronald M.] Univ Toronto, Dept Med, Div Pediat Rheumatol, Toronto, ON, Canada; [Laxer, Ronald M.] Hosp Sick Children, Toronto, ON, Canada; [Velez, Gabriel] Univ Iowa, Med Scientist Training Program, Iowa City, IA USA; [Velez, Gabriel; Mahajan, Vinit B.] Univ Iowa, Dept Ophthalmol & Visual Sci, Iowa City, IA USA; [Velez, Gabriel; Mahajan, Vinit B.] Univ Iowa, Om Lab, Iowa City, IA USA; [Erives, Albert] Univ Iowa, Dept Biol, Iowa City, IA 52242 USA	University of Iowa; University of Iowa; University of Toronto; University of Toronto; University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); University of Iowa; University of Iowa; University of Iowa; University of Iowa	Ferguson, PJ (corresponding author), Univ Iowa, Dept Pediat, Iowa City, IA 52242 USA.	polly-ferguson@uiowa.edu		Darbro, Benjamin/0000-0001-9279-356X; Mahajan, Vinit/0000-0003-1886-1741; Bassuk, Alexander/0000-0002-4067-2157; Velez, Gabriel/0000-0003-0819-5933	NIH/NIAMS [R01AR059703]; NIH Predoctoral Training Grant in Genetics [T32GM008629]; NIH Predoctoral Training Grant in Bioinformatics [T32GM082729-01]; National Institutes of Health [T32GM007337]; NATIONAL EYE INSTITUTE [R01EY024665] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR059703] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM008629, T32GM007337] Funding Source: NIH RePORTER	NIH/NIAMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NIH Predoctoral Training Grant in Genetics(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH Predoctoral Training Grant in Bioinformatics(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by NIH/NIAMS R01AR059703 (PF, AB, VM), by the NIH Predoctoral Training Grants in Genetics T32GM008629 (AC), and Bioinformatics T32GM082729-01 (AC), as well as National Institutes of Health grant T32GM007337 to Gabriel Velez.	Aherne CM, 2009, MOL IMMUNOL, V46, P3345, DOI 10.1016/j.molimm.2009.07.019; Aksentijevich I, 2009, NEW ENGL J MED, V360, P2426, DOI 10.1056/NEJMoa0807865; Altshuler D, 2005, NATURE, V437, P1299, DOI 10.1038/nature04226; Altshuler D, 2010, NATURE, V467, P1061, DOI 10.1038/nature09534; Auton A, GLOBAL REFERENCE HUM, P1476; Baker NA, ELECTROSTATICS NANOS; Berman HM, 2000, NUCLEIC ACIDS RES, V28, P235, DOI 10.1093/nar/28.1.235; Blanchette M, ALIGNING MULTIPLE GE, P1088; Boyle WJ, 2003, NATURE, V423, P337, DOI 10.1038/nature01658; Cassel SL, 2014, P NATL ACAD SCI USA, V111, P1072, DOI 10.1073/pnas.1318685111; Chitu V, 2012, BLOOD, V120, P3126, DOI 10.1182/blood-2012-04-425595; Chitu V, 2009, BLOOD, V114, P2497, DOI 10.1182/blood-2009-02-204925; Cingolani P, 2012, FLY, V6, P80, DOI 10.4161/fly.19695; Das M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026355; Dolinsky TJ, PDB2PQR AUTOMATED PI, P1362; Ferguson PJ, 2005, J MED GENET, V42, P551, DOI 10.1136/jmg.2005.030759; Ferguson PJ, 2006, BONE, V38, P41, DOI 10.1016/j.bone.2005.07.009; Ferguson PJ, 2012, CURR RHEUMATOL REP, V14, DOI 10.1007/s11926-012-0239-5; Gerstein MB, 2012, NATURE, V489, P91, DOI 10.1038/nature11245; Ghonime MG, 2014, J IMMUNOL, V192, P3881, DOI 10.4049/jimmunol.1301974; Gkretsi V, 2005, J CELL SCI, V118, P697, DOI 10.1242/jcs.01638; Grosse J, 2006, BLOOD, V107, P3350, DOI 10.1182/blood-2005-09-3556; Gurung P, 2016, P NATL ACAD SCI USA, V113, P4452, DOI 10.1073/pnas.1601636113; Hamel J, PILOT STUDY POSSIBLE, P1437; Hedrich CM, 2013, PEDIATR RHEUMATOL, V11, DOI 10.1186/1546-0096-11-47; Herlin T, 2013, ANN RHEUM DIS, V72, P410, DOI 10.1136/annrheumdis-2012-201818; Hofmann SR, CHRONIC NONBACTERIAL, P1521; Huo LL, 2013, BIOL TRACE ELEM RES, V155, P142, DOI 10.1007/s12011-013-9770-0; Hutchins AP, 2012, BLOOD, V119, pE110, DOI 10.1182/blood-2011-09-381483; Ithychanda SS, 2009, J BIOL CHEM, V284, P4713, DOI 10.1074/jbc.M807719200; Kawana Nea, 2014, AUSTIN J CLIN IMMUNO, V1; Kelley LA-O, PHYRE2 WEB PORTAL PR, P1750; Lee MK, REGULATION OSTEOBLAS; Lek M, 2015, BIORXIV; Li H, 2010, BIOINFORMATICS, V26, P589, DOI 10.1093/bioinformatics/btp698; Lopez-Dee Z, 2011, MEDIAT INFLAMM, V2011, DOI 10.1155/2011/296069; Lukens JR, 2014, P NATL ACAD SCI USA, V111, P1066, DOI 10.1073/pnas.1318688111; Marzaioli V, 2012, ARTHRITIS RHEUM-US, V64, P3290, DOI 10.1002/art.34554; Mathelier A, 2016, NUCLEIC ACIDS RES, V44, pD110, DOI 10.1093/nar/gkv1176; McGuffin LJ, PSIPRED PROTEIN STRU, P1367; McKenna A, 2010, GENOME RES, V20, P1297, DOI 10.1101/gr.107524.110; McMorrow JP, 2013, AM J PATHOL, V183, P1243, DOI 10.1016/j.ajpath.2013.06.029; McMorrow JP, 2011, BIOCHEM SOC T, V39, P688, DOI 10.1042/BST0390688; Moller JC, IL10 PROMOTER POLYMO; Pirih FQ, NUCL ORPHAN RECEPTOR; SHARMA CP, 1995, J IMMUNOL, V154, P3461; Sherry ST, 2001, NUCLEIC ACIDS RES, V29, P308, DOI 10.1093/nar/29.1.308; Shlyueva D, 2014, NAT REV GENET, V15, P272, DOI 10.1038/nrg3682; Sievers F, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.75; Takayanagi H, 2012, NAT REV RHEUMATOL, V8, P684, DOI 10.1038/nrrheum.2012.167; Teer JK, 2012, BIOINFORMATICS, V28, P599, DOI 10.1093/bioinformatics/btr711; Teitelbaum SL, 2003, NAT REV GENET, V4, P638, DOI 10.1038/nrg1122; Tompa P, INTRINSICALLY DISORD; Tu YZ, 2003, CELL, V113, P37, DOI 10.1016/S0092-8674(03)00163-6; Volmering S, 2016, IMMUNITY, V44, P73, DOI 10.1016/j.immuni.2015.11.011; Walsh MC, 2014, FRONT IMMUNOL, V5, DOI 10.3389/fimmu.2014.00511; Wang J, 2013, NUCLEIC ACIDS RES, V41, pD171, DOI 10.1093/nar/gks1221; Wang J, 2012, GENOME RES, V22, P1798, DOI 10.1101/gr.139105.112; Ward JJ, DISOPRED SERVER PRED, P1367; Wu CY, 2005, J CELL SCI, V118, P659, DOI 10.1242/jcs.01639; Xiao GZ, 2012, J BIOL CHEM, V287, P21450, DOI 10.1074/jbc.M111.331249	61	36	37	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 16	2017	12	3							e0169687	10.1371/journal.pone.0169687	http://dx.doi.org/10.1371/journal.pone.0169687			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN9KE	28301468	gold, Green Published, Green Submitted			2022-12-27	WOS:000396318300002
J	de Cassia-Pires, R; de Melo, MDAD; Barbosa, RD; Roque, ALR				de Cassia-Pires, Renata; Alheiros Dias de Melo, Myllena de Fatima; Barbosa, Raquel da Hora; Rodrigues Roque, Andrea Luiz			Multiplex PCR as a tool for the diagnosis of Leishmania spp. kDNA and the gapdh housekeeping gene of mammal hosts	PLOS ONE			English	Article							REAL-TIME PCR; INFECTION; WILD	Background The PCR assays usually employed for Leishmania diagnosis does not simultaneously detect a constitutive gene that would certify the viability of the DNA sample. We present a multiplex PCR approach for the simultaneous diagnosis of the Leishmania sp. kDNA fragment and a catalytic domain segment of a conserved region of the mammalian gapdh gene. Methodology The proposed multiplex protocol was designed through in silico PCR. The annealing temperature, concentration of primer pairs, number of cycles, distinct polymerase enzymes and premix kit were defined to achieve an optimal reaction. The DNA detection sensitivity was tested with different concentrations of known L. tropica DNA, and the reproducibility of the assay was confirmed using samples from 106 wild mammals that were previously subject to Leishmania sp. kDNA analysis through singleplex reactions. Principal findings The following optimal conditions were established: 95 degrees C for 1 min followed by 30 cycles of 95 degrees C for 30 s, 61 degrees C for 30 s, and 72 degrees C for 30 s and a final extension at 72 degrees C for 1 min. The multiplex PCR system was capable of detecting 0.1 ng of L. tropica diluted in 100 ng of mammalian DNA. Of 51 kDNA samples that were previously found to be positive, 45 (88.2%) were positive for both targets, two were positive only for kDNA and four were negative for both. Of 55 kDNA samples that were previously identified as negative, 38 (69.1%) were positive for gapdh whereas the other 17 were negative for both targets. Conclusions/Significance The proposed multiplex PCR system allows the simultaneous detection of the gapdh gene and Leishmania sp. kDNA in tissue samples derived from distinct wild mammal species. The amplification of the gapdh mammalian gene in the same reaction ensures the quality and viability of the DNA in the sample, eliminating the possibility of false-negative results that would impair an accurate description of the infection rates in a given population.	[de Cassia-Pires, Renata; Rodrigues Roque, Andrea Luiz] Fiocruz MS, Inst Oswaldo Cruz, Lab Trypanosomatid Biol, Rio De Janeiro, RJ, Brazil; [Alheiros Dias de Melo, Myllena de Fatima] Fiocruz MS, Inst Oswaldo Cruz, Lab Mol Biol & Endem Dis, Rio De Janeiro, RJ, Brazil; [Barbosa, Raquel da Hora] Univ Fed Fluminense, Inst Biomed, Ctr Med Sci, Niteroi, RJ, Brazil	Fundacao Oswaldo Cruz; Fundacao Oswaldo Cruz; Universidade Federal Fluminense	Roque, ALR (corresponding author), Fiocruz MS, Inst Oswaldo Cruz, Lab Trypanosomatid Biol, Rio De Janeiro, RJ, Brazil.	roque@ioc.fiocruz.br	Roque, André Luiz Rodrigues/W-7528-2019	Roque, Andre/0000-0002-8740-052X	FAPERJ [E-26/102.172/2013]; PAPES-FIOCRUZ [401764/2015-0]; CNPq [446468/2014-2]	FAPERJ(Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio De Janeiro (FAPERJ)); PAPES-FIOCRUZ; CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ))	FAPERJ (E-26/102.172/2013), PAPES-FIOCRUZ (401764/2015-0) and CNPq (446468/2014-2) supported this study through research grants provided to ALRR, while RCP had scholarship supported by CNPq. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akhavan AA, 2010, EXP PARASITOL, V126, P552, DOI 10.1016/j.exppara.2010.06.003; Brazil R.P., 2015, ENTOMOLOGY ORNITHOLO, V04, P4, DOI [10.4172/2161, DOI 10.1089/VBZ.2007.0180.V, DOI 10.4172/2161-0983.1000144]; Brito MEF, 2009, TROP MED INT HEALTH, V14, P1278, DOI 10.1111/j.1365-3156.2009.02361.x; Cassia-Pires R, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0003389; Castilho TM, 2003, J CLIN MICROBIOL, V41, P540, DOI 10.1128/JCM.41.2.540-546.2003; de Assis J, 2010, REV BRAS PARASITOL V, V19, P17, DOI 10.1590/S1984-29612010000100005; de Pita-Pereira D, 2008, ACTA TROP, V107, P66, DOI 10.1016/j.actatropica.2008.04.015; DEGRAVE W, 1994, MEM I OSWALDO CRUZ, V89, P463, DOI 10.1590/S0074-02761994000300032; Desjeux P, 2004, COMP IMMUNOL MICROB, V27, P305, DOI 10.1016/j.cimid.2004.03.004; ERCOLANI L, 1988, J BIOL CHEM, V263, P15335; Floeter-Winter Lucile M., 1993, Ciencia e Cultura (Sao Paulo), V45, P210; Gilsbach R, 2006, BIOTECHNIQUES, V40, P173, DOI 10.2144/000112052; Goncalves SC, 2012, J VENOM ANIM TOXINS, V18, P188, DOI 10.1590/S1678-91992012000200009; Goncalves-de-Albuquerque SD, 2014, J VENOM ANIM TOXINS, V20, DOI 10.1186/1678-9199-20-16; Jorquera A, 2005, MEM I OSWALDO CRUZ, V100, P43, DOI 10.1590/S0074-02762005000100008; Korbie DJ, 2008, NAT PROTOC, V3, P1452, DOI 10.1038/nprot.2008.133; Paiva-Cavalcanti M, 2010, J VENOM ANIM TOXINS, V16, P537, DOI 10.1590/S1678-91992010000400004; Roque ALR, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000589; Roque Andre Luiz R., 2014, International Journal for Parasitology Parasites and Wildlife, V3, P251, DOI 10.1016/j.ijppaw.2014.08.004; Rozen S, 2000, Methods Mol Biol, V132, P365; Shi CH, 2016, INT J MOL SCI, V17, DOI 10.3390/ijms17071034; SIMPSON L, 1973, J PROTOZOOL, V20, P2, DOI 10.1111/j.1550-7408.1973.tb05993.x; Stephens Alexandre S, 2011, BMC Res Notes, V4, P410, DOI 10.1186/1756-0500-4-410	23	13	14	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 16	2017	12	3							e0173922	10.1371/journal.pone.0173922	http://dx.doi.org/10.1371/journal.pone.0173922			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN9KE	28301553	Green Published, gold, Green Submitted			2022-12-27	WOS:000396318300096
J	Ogawa, K; Minai, K; Kawai, M; Tanaka, T; Nagoshi, T; Ogawa, T; Yoshimura, M				Ogawa, Kazuo; Minai, Kosuke; Kawai, Makoto; Tanaka, Toshikazu; Nagoshi, Tomohisa; Ogawa, Takayuki; Yoshimura, Michihiro			Parallel comparison of risk factors between progression of organic stenosis in the coronary arteries and onset of acute coronary syndrome by covariance structure analysis	PLOS ONE			English	Article							LOW-DENSITY-LIPOPROTEIN; HEART-DISEASE; SPASM; PATHOGENESIS; MECHANISMS	Background It is widely accepted that progression of organic stenosis in the coronary arteries and onset of acute coronary syndrome (ACS) are similar in the development of atherosclerosis. However, the extent of the association of each risk factor with the respective pathological conditions has not been fully elucidated. Objectives We investigated the differences in risk factors between these conditions using a statistical procedure. Methods The study population consisted of 1,029 patients with ischemic heart disease (IHD). We divided the study population into two groups (ACS and non-ACS) and by diseased vessels (organic stenosis). Covariance structure analysis was simultaneously performed in one equation model for determination and comparison of the risk factors for organic stenosis and ACS. Results The analysis revealed that age (standardized regression coefficient, beta: 0.206, P < 0.001), male gender (beta: 0.126, P < 0.001), HbA1c level (beta: 0.109, P < 0.001), HDL level (beta: -0.109, P < 0.001) and LDL level (beta: 0.127, P = 0.002) were significant for the advancement of organic stenosis. HDL level (beta: 0100, P = 0.002) and MDA-LDL level (beta: 0.335, P < 0.001) were significant for the onset of ACS, but age, HbA1c and LDL (P = NS or beta < 0.1, respectively) were not. Among the risk factors, age, HbA1c and LDL were significantly more strongly associated with organic stenosis than ACS, while MDA-LDL was significantly more strongly associated with ACS than organic stenosis. Conclusions The current statistical analysis revealed clear differences among the risk factors between the progression of organic stenosis and the onset of ACS. Among them, the MDA-LDL level should be considered to indicate a substantial risk of ACS.	[Ogawa, Kazuo; Minai, Kosuke; Kawai, Makoto; Tanaka, Toshikazu; Nagoshi, Tomohisa; Ogawa, Takayuki; Yoshimura, Michihiro] Jikei Univ, Sch Med, Dept Internal Med, Div Cardiol, Tokyo, Japan	Jikei University	Ogawa, K (corresponding author), Jikei Univ, Sch Med, Dept Internal Med, Div Cardiol, Tokyo, Japan.	oga-n@jikei.ac.jp	Tanaka, Toshikazu D/K-5989-2018	Tanaka, Toshikazu D/0000-0002-0711-7880	Grants-in-Aid for Scientific Research [17K09531] Funding Source: KAKEN	Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))		Aikawa M, 1995, J Atheroscler Thromb, V2, P14; Annema W, 2016, J CLIN LIPIDOL, V10, P1318, DOI 10.1016/j.jacl.2016.08.003; Bekkering S, 2014, ARTERIOSCL THROM VAS, V34, P1731, DOI 10.1161/ATVBAHA.114.303887; CARALIS DG, 1992, CIRCULATION, V85, P905, DOI 10.1161/01.CIR.85.3.905; FALK E, 1995, CIRCULATION, V92, P657, DOI 10.1161/01.CIR.92.3.657; Feletou M, 2006, AM J PHYSIOL-HEART C, V291, pH985, DOI 10.1152/ajpheart.00292.2006; Franklin SS, 1999, CIRCULATION, V100, P354, DOI 10.1161/01.CIR.100.4.354; FUSTER V, 1992, NEW ENGL J MED, V326, P242, DOI 10.1056/NEJM199201233260406; Kinoshita K, 2016, INT J CARDIOL, V215, P283, DOI 10.1016/j.ijcard.2016.04.111; KOTANI K, 1994, BBA-LIPID LIPID MET, V1215, P121, DOI 10.1016/0005-2760(94)90100-7; LEVY D, 1990, AM HEART J, V119, P712, DOI 10.1016/S0002-8703(05)80050-X; Levy D, 1990, AM HEART J 2, V119; LIBBY P, 1995, CIRCULATION, V91, P2844, DOI 10.1161/01.CIR.91.11.2844; Libby P, 2013, NEW ENGL J MED, V368, P2004, DOI 10.1056/NEJMra1216063; Malik S, 2004, CIRCULATION, V110, P1245, DOI 10.1161/01.CIR.0000140677.20606.0E; Maseri A, 2009, CIRC J, V73, P394, DOI 10.1253/circj.CJ-09-0033; Mizuno Y, 2015, CIRCULATION, V131, P1665, DOI 10.1161/CIRCULATIONAHA.114.013120; Mora S, 2005, CIRCULATION, V111, P1871, DOI 10.1161/01.CIR.0000161956.75255.7B; Moretto P, 2015, J DIABETES RES, V2015, DOI 10.1155/2015/167283; Muniyappa R, 2013, REV ENDOCR METAB DIS, V14, P5, DOI 10.1007/s11154-012-9229-1; Ogawa K, 2015, BMJ OPEN, V5, DOI 10.1136/bmjopen-2014-005455; Potter CMF, 2014, ARTERIOSCL THROM VAS, V34, P2184, DOI 10.1161/ATVBAHA.114.303423; Psaltis PJ, 2015, CIRC RES, V116, P1392, DOI 10.1161/CIRCRESAHA.116.305368; Selvin E, 2010, NEW ENGL J MED, V362, P800, DOI 10.1056/NEJMoa0908359; Shigematsu S, 2007, CIRC J, V71, P1697, DOI 10.1253/circj.71.1697; Takaoka K, 2000, INT J CARDIOL, V72, P121, DOI 10.1016/S0167-5273(99)00172-2; Tanaga K, 2002, ARTERIOSCL THROM VAS, V22, P662, DOI 10.1161/01.ATV.0000012351.63938.84; Thygesen K, 2012, GLOB HEART, V7, DOI 10.1016/j.gheart.2012.08.001; Yagi H, 2010, J CARDIOL, V55, P345, DOI 10.1016/j.jjcc.2009.12.010; Yasue H, 2008, J CARDIOL, V51, P2, DOI 10.1016/j.jjcc.2008.01.001	30	8	8	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 16	2017	12	3							e0173898	10.1371/journal.pone.0173898	http://dx.doi.org/10.1371/journal.pone.0173898			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN9KE	28301565	Green Submitted, Green Published, gold			2022-12-27	WOS:000396318300091
J	Winther, TL; Torp, SH				Winther, Theo L.; Torp, Sverre H.			DNA topoisomerase IIa and mitosin expression predict meningioma recurrence better than histopathological grade and MIB-1 after initial surgery	PLOS ONE			English	Article							CENTRAL-NERVOUS-SYSTEM; TISSUE MICROARRAY TECHNIQUE; INTRACRANIAL MENINGIOMAS; CELL-PROLIFERATION; PROGNOSTIC-SIGNIFICANCE; MALIGNANT MENINGIOMAS; LABELING INDEX; GENETIC MODEL; CANCER; MARKER	Background The 2016 WHO histopathological grade or conventional biomarker MIB-1 is insufficient for predicting meningioma recurrence after initial treatment and alternative strategies are required. In this study, we investigated whether DNA topoisomerase IIa and/or mitosin expression can predict tumor recurrence with greater accuracy than conventional methods. Methods The expression of MIB-1, topoisomerase IIa, and mitosin were determined as proliferation indices in tissue microarrays using immunohistochemistry. The accuracy of prognostication was assessed with receiver operating characteristic (ROC) analyses and standard survival analyses. Results Expression of topoisomerase IIa and mitosin was significantly higher in recurrent meningioma than in non-recurrent meningioma (P <= 0.031), but no difference in MIB-1 expression was observed (P = 0.854). ROC analysis found topoisomerase IIa and mitosin expression to be the most reliable predictors of recurrence compared to WHO histopathological grade and MIB-1 expression. This result was supported by the multivariate survival analysis, in which mitosin expression was a significant predictor of recurrence-free survival (P < 0.001) and no association was found with histopathological grade or MIB-1 expression (P >= 0.158). Conclusions The results suggest that topoisomerase IIa and mitosin improve prognostication of patients resected for meningioma. Tumors with higher topoisomerase IIa and/or mitosin expression have a higher risk of recurrence after initial treatment, and these patients may benefit from adjuvant treatment and closer radiological follow-up.	[Winther, Theo L.; Torp, Sverre H.] Norwegian Univ Sci & Technol NTNU, Dept Lab Med Childrens & Womens Hlth, Trondheim, Norway; [Torp, Sverre H.] St Olavs Hosp, Dept Pathol & Med Genet, Trondheim, Norway	Norwegian University of Science & Technology (NTNU); Norwegian University of Science & Technology (NTNU)	Winther, TL (corresponding author), Norwegian Univ Sci & Technol NTNU, Dept Lab Med Childrens & Womens Hlth, Trondheim, Norway.	theolw@stud.ntnu.no	Torp, Sverre Helge/AAN-4229-2020	Torp, Sverre Helge/0000-0001-8345-6852	Norwegian University of Science and Technology	Norwegian University of Science and Technology	This study was funded by the Norwegian University of Science and Technology (website: http://www.ntnu.no/), and 50 000 kr was received by TLW. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abry E, 2010, PATHOL RES PRACT, V206, P810, DOI 10.1016/j.prp.2010.09.002; Aghi MK, 2009, NEUROSURGERY, V64, P56, DOI 10.1227/01.NEU.0000330399.55586.63; Alahmadi H, 2011, SEMIN DIAGN PATHOL, V28, P314, DOI 10.1053/j.semdp.2011.01.002; Alama A, 2007, J CLIN NEUROSCI, V14, P355, DOI 10.1016/j.jocn.2006.04.001; Backer-Grondahl T, 2014, APMIS, V122, P856, DOI 10.1111/apm.12248; Backer-Grondahl T, 2012, INT J CLIN EXP PATHO, V5, P231; Bruna J, 2007, NEUROPATHOLOGY, V27, P114, DOI 10.1111/j.1440-1789.2007.00750.x; Clark GM, 1997, CANCER RES, V57, P5505; Dolecek TA, 2012, NEURO-ONCOLOGY, V14, pv1, DOI 10.1093/neuonc/nos218; Engellau J, 2001, APPL IMMUNOHISTO M M, V9, P358, DOI 10.1097/00022744-200112000-00012; Fernebro E, 2002, ARCH PATHOL LAB MED, V126, P702; Fontaine B, 1991, ANN NY ACAD SCI, V615, P338; Ho DMT, 2002, CANCER, V94, P1538, DOI 10.1002/cncr.10351; Hong Y, 2012, NEUROSCI LETT, V518, P138, DOI 10.1016/j.neulet.2012.04.071; Hoos A, 2001, AM J PATHOL, V158, P1245, DOI 10.1016/S0002-9440(10)64075-8; Hwang WL, 2016, NEURO-ONCOLOGY, V18, P863, DOI 10.1093/neuonc/nov285; Joachim T, 2001, INT J CANCER, V94, P218, DOI 10.1002/ijc.1467; Kasuya H, 2006, NEUROSURG REV, V29, P293, DOI 10.1007/s10143-006-0039-3; Kaur G, 2014, NEURO-ONCOLOGY, V16, P628, DOI 10.1093/neuonc/nou025; Konstantinidou AE, 2003, HISTOL HISTOPATHOL, V18, P67, DOI 10.14670/HH-18.67; Konstantinidou AE, 2001, HISTOPATHOLOGY, V39, P402, DOI 10.1046/j.1365-2559.2001.01229.x; Korkolopoulou P, 2001, APPL IMMUNOHISTO M M, V9, P207, DOI 10.1097/00022744-200109000-00003; Korshunov A, 2002, ARCH PATHOL LAB MED, V126, P1079; Kunishio K, 2000, Brain Tumor Pathol, V17, P105, DOI 10.1007/BF02484281; Leone PE, 1999, ONCOGENE, V18, P2231, DOI 10.1038/sj.onc.1202531; Louis DN, 2007, ACTA NEUROPATHOL, V114, P97, DOI 10.1007/s00401-007-0243-4; Louis DN, 2016, ACTA NEUROPATHOL, V131, P803, DOI 10.1007/s00401-016-1545-1; Lu BH, 2016, THORAC CANCER, V7, P486, DOI 10.1111/1759-7714.12359; Ma L, 2006, J BIOMED SCI, V13, P205, DOI 10.1007/s11373-005-9057-3; Matsuno A, 1996, ACTA NEUROPATHOL, V91, P504, DOI 10.1007/s004010050458; MUNAKATA S, 1993, J HISTOCHEM CYTOCHEM, V41, P1241, DOI 10.1177/41.8.8331288; Nakasu S, 2001, AM J SURG PATHOL, V25, P472, DOI 10.1097/00000478-200104000-00006; Perry A, 1997, AM J SURG PATHOL, V21, P1455, DOI 10.1097/00000478-199712000-00008; Perry A, 1998, CANCER-AM CANCER SOC, V82, P2262, DOI 10.1002/(SICI)1097-0142(19980601)82:11<2262::AID-CNCR23>3.3.CO;2-O; Perry A, 2016, WHO CLASSIFICATION T, P231; Raspollini MR, 2016, HUM PATHOL; Riemenschneider MJ, 2006, LANCET NEUROL, V5, P1045, DOI 10.1016/S1474-4422(06)70625-1; Roessler K, 2002, NEUROL RES, V24, P241, DOI 10.1179/016164102101199855; Rubin MA, 2002, AM J SURG PATHOL, V26, P312, DOI 10.1097/00000478-200203000-00004; Sahin S, 2016, INT J SURG PATHOL; SIMON M, 1995, CANCER RES, V55, P4696; SIMPSON D, 1957, J NEUROL NEUROSUR PS, V20, P22, DOI 10.1136/jnnp.20.1.22; Terzi A, 2008, PATHOL RES PRACT, V204, P305, DOI 10.1016/j.prp.2008.01.013; Torp SH, 2001, CLIN NEUROPATHOL, V20, P190; van Alkemade H, 2012, NEURO-ONCOLOGY, V14, P658, DOI 10.1093/neuonc/nos013; Vankalakunti M, 2007, NEUROPATHOLOGY, V27, P407, DOI 10.1111/j.1440-1789.2007.00801.x; Varis A, 2006, CHROMOSOMA, V115, P288, DOI 10.1007/s00412-005-0046-0; Varughese RK, 2016, J CLIN PATHOL, V69, P26, DOI 10.1136/jclinpath-2015-202983; Weber RG, 1997, P NATL ACAD SCI USA, V94, P14719, DOI 10.1073/pnas.94.26.14719; Wester K, 2000, APPL IMMUNOHISTO M M, V8, P61, DOI 10.1097/00022744-200003000-00010	50	6	6	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 16	2017	12	3							e0172316	10.1371/journal.pone.0172316	http://dx.doi.org/10.1371/journal.pone.0172316			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN9KE	28301542	Green Published, gold, Green Submitted			2022-12-27	WOS:000396318300014
J	Yang, Y; Qiu, S; Qian, L; Tian, Y; Chen, YN; Bi, L; Chen, WP				Yang, Ye; Qiu, Shuang; Qian, Lei; Tian, Yuan; Chen, Yingna; Bi, Lei; Chen, Weiping			OCF can repress tumor metastasis by inhibiting epithelial-mesenchymal transition involved in PTEN/PI3K/AKT pathway in lung cancer cells	PLOS ONE			English	Article							SALVIANOLIC ACIDS; SIGNALING PATHWAY; PTEN; EXPRESSION; RADIATION; PI3K/AKT; ROLES; EMT	A component formula with definite compositions provides a new approach to treat various diseases. Salvia miltiorrhiza and Panax ginseng are widely used in China because of their antitumor properties. In the previous study, the optimizing component formula (OCF), prepared with salvianolic acids, ginsenosides, and ginseng polysaccharides (5, 10, and 5 mg.L-1, respectively) extracted from S. miltiorrhiza and P. ginseng on the basis of IC50 in lung cancer A549 cells and damage minimization on human bronchial epithelial cells in vitro. Currently, we also have demonstrated the inhibitory effect of OCF on A549 cell migration and invasion in vitro. According to Lewis lung cancer cells (LLC) allograft in C57BL/6 mice and A549 xenograft in nude mice experiment, we found that the anti-tumor and anti-metastasis effects of OCF treatment were related to the inhibition of epithelial-mesenchymal transition (EMT). Further studies showed that the inhibitory effect of OCF on EMT was associated with the PTEN/ PI3K/ AKT pathway. Therefore, all studies revealed that OCF could prevent cancer progression and tumor metastasis by inhibiting EMT involved PTEN/PI3K/ AKT signaling pathway in lung cancer cells.	[Yang, Ye; Qiu, Shuang; Qian, Lei; Tian, Yuan; Chen, Yingna; Bi, Lei; Chen, Weiping] Nanjing Univ Chinese Med, Dept Preclin Med, Nanjing, Jiangsu, Peoples R China	Nanjing University of Chinese Medicine	Bi, L; Chen, WP (corresponding author), Nanjing Univ Chinese Med, Dept Preclin Med, Nanjing, Jiangsu, Peoples R China.	bella_nj@163.com; wp2002123@163.com	Lang, Ming/HIK-0758-2022; yang, yang/GWB-9426-2022; Chen, Wei/GZK-7348-2022	Bi, Lei/0000-0002-2951-0966	National Natural Sciences Foundation of China [81273638, 81503486]; Key Project of Science and Technology from Administration of Traditional Chinese Medicine in Jiangsu Province [ZD201502]; scientific innovation research of college graduate in Jiangsu province [KYLX15_0997, KYLX16_1153]; Priority Academic Program Development of Jiangsu Higher Education Institutions (integration of traditional Chinese and western medicine)	National Natural Sciences Foundation of China(National Natural Science Foundation of China (NSFC)); Key Project of Science and Technology from Administration of Traditional Chinese Medicine in Jiangsu Province; scientific innovation research of college graduate in Jiangsu province; Priority Academic Program Development of Jiangsu Higher Education Institutions (integration of traditional Chinese and western medicine)	This work was supported by: grants from National Natural Sciences Foundation of China (No. 81273638 and 81503486); the Key Project of Science and Technology from Administration of Traditional Chinese Medicine in Jiangsu Province (ZD201502); scientific innovation research of college graduate in Jiangsu province (No. KYLX15_0997 and KYLX16_1153); and a project funded by the Priority Academic Program Development of Jiangsu Higher Education Institutions (integration of traditional Chinese and western medicine).	Carnero A, 2008, CURR CANCER DRUG TAR, V8, P187, DOI 10.2174/156800908784293659; Casas E, 2011, CANCER RES, V71, P245, DOI 10.1158/0008-5472.CAN-10-2330; Chalhoub N, 2009, ANNU REV PATHOL-MECH, V4, P127, DOI 10.1146/annurev.pathol.4.110807.092311; Chang L, 2014, CANCER METAST REV, V33, P469, DOI 10.1007/s10555-014-9493-5; Cho YJ, 2014, J TRANSL MED, V12, DOI 10.1186/s12967-014-0283-1; Du GJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072044; Gerets HHJ, 2012, CELL BIOL TOXICOL, V28, P69, DOI 10.1007/s10565-011-9208-4; Hellevik T, 2012, RADIAT ONCOL, V7, DOI 10.1186/1748-717X-7-59; Ho JHC, 2011, J BIOMED SCI, V18, DOI 10.1186/1423-0127-18-30; Hotulainen P, 2005, MOL BIOL CELL, V16, P649, DOI 10.1091/mbc.E04-07-0555; Jemal A, 2011, CA-CANCER J CLIN, V61, P133, DOI [10.3322/caac.20105, 10.3322/caac.20073]; Karamitopoulou E, 2011, HUM PATHOL, V42, P1888, DOI 10.1016/j.humpath.2010.06.020; Kharbanda A, 2014, ONCOTARGET, V5, P8893, DOI 10.18632/oncotarget.2360; Kim RH, 2006, BRIT J CANCER, V94, P620, DOI 10.1038/sj.bjc.6602994; Kim YJ, 2014, J GINSENG RES, V38, P66, DOI 10.1016/j.jgr.2013.11.001; Langdon SP, 2012, CURR DRUG TARGETS, V13, P1535; Larue L, 2005, ONCOGENE, V24, P7443, DOI 10.1038/sj.onc.1209091; Li CL, 2015, BMC GENOMICS, V16, DOI 10.1186/s12864-015-1411-x; Li SJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078902; Ma XH, 2015, MOLECULES, V20, P16235, DOI 10.3390/molecules200916235; Martinelli E, 2013, INT J CANCER, V133, P2089, DOI 10.1002/ijc.28236; Pan Fuqiang, 2015, Drug Des Devel Ther, V9, P4779, DOI 10.2147/DDDT.S84628; Perez-Ramirez C, 2015, PHARMACOGENOMICS, V16, P1843, DOI 10.2217/pgs.15.122; Rammah M, 2012, TOXICOL LETT, V211, P220, DOI 10.1016/j.toxlet.2012.04.003; Schmalhofer O, 2009, CANCER METAST REV, V28, P151, DOI 10.1007/s10555-008-9179-y; Shi SH, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089123; Shimamura T, 2004, CANCER RES, V64, P6989, DOI 10.1158/0008-5472.CAN-04-1166; Song MS, 2012, NAT REV MOL CELL BIO, V13, P283, DOI 10.1038/nrm3330; Thiery JP, 2009, CELL, V139, P871, DOI 10.1016/j.cell.2009.11.007; Tu KS, 2016, INT J ONCOL, V48, P965, DOI 10.3892/ijo.2015.3309; Wu WY, 2012, ACTA PHARMACOL SIN, V33, P1119, DOI 10.1038/aps.2012.126; Xu WT, 2015, CELL ADHES MIGR, V9, P317, DOI 10.1080/19336918.2015.1016686; Xu XY, 2014, PLOS ONE, V9, DOI [10.1371/journal.pone.0096780, 10.1371/journal.pone.0109950]; [颜晓静 Yan Xiaojing], 2014, [中国中药杂志, China Journal of Chinese Materia Medica], V39, P4436; Yoo DG, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033678; Yoshioka H, 2012, TOXICOL LETT, V211, P257, DOI 10.1016/j.toxlet.2012.04.005; Yuan X, 2014, J HEMATOL ONCOL, V7, DOI 10.1186/s13045-014-0087-z; Zhang LG, 2014, J ETHNOPHARMACOL, V155, P1424, DOI 10.1016/j.jep.2014.07.011; Zhou GJ, 2014, MOLECULES, V19, P7207, DOI 10.3390/molecules19067207	39	13	13	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 16	2017	12	3							e0174021	10.1371/journal.pone.0174021	http://dx.doi.org/10.1371/journal.pone.0174021			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN9KE	28301605	Green Published, Green Submitted, gold			2022-12-27	WOS:000396318300112
J	Beutel, ME; Tibubos, AN; Klein, EM; Schmutzer, G; Reiner, I; Kocalevent, RD; Brahler, E				Beutel, Manfred E.; Tibubos, Ana N.; Klein, Eva M.; Schmutzer, Gabriele; Reiner, Iris; Kocalevent, Rueya-Daniela; Braehler, Elmar			Childhood adversities and distress - The role of resilience in a representative sample	PLOS ONE			English	Article							INDIVIDUAL-DIFFERENCES; MENTAL-DISORDERS; MALTREATMENT; DEPRESSION; STRESS; CHILDREN; LIFE; PSYCHOPATHOLOGY; ATTACHMENT; SYMPTOMS	While adverse childhood experiences have been shown to contribute to adverse health outcomes in adulthood, specifically distress and somatic symptoms, few studies have examined their joint effects with resilient coping style on adult adjustment. Hence, we aim to determine the association between resilient coping and distress in participants with and without reported childhood adversities. A representative German community sample (N=2508) between 14-92 years (1334 women; 1174 men) was examined by the short form of the Childhood Trauma Questionnaire, the Brief Resilience Coping Scale, standardized scales of distress and somatoform symptoms. Childhood adversity was associated with reduced adjustment, social support and resilience. It was also strongly associated with increased distress and somatoform complaints. Resilient coping was not only associated with lower distress, it also buffered the effects of childhood adversity on distress. Our study corroborates the buffering effect of resilience in a representative German sample. High trait resilient subjects show less distress and somatoform symptoms despite reported childhood adversities in comparison to those with low resilient coping abilities.	[Beutel, Manfred E.; Tibubos, Ana N.; Klein, Eva M.; Reiner, Iris; Braehler, Elmar] Johannes Gutenberg Univ Mainz, Univ Med Ctr, Dept Psychosomat Med & Psychotherapy, Mainz, Germany; [Schmutzer, Gabriele] Univ Leipzig, Dept Med Psychol & Med Sociol, Leipzig, Germany; [Kocalevent, Rueya-Daniela] Univ Hosp Hamburg Eppendorf, Dept Med Psychol, Hamburg, Germany	Johannes Gutenberg University of Mainz; Leipzig University; University of Hamburg; University Medical Center Hamburg-Eppendorf	Tibubos, AN (corresponding author), Johannes Gutenberg Univ Mainz, Univ Med Ctr, Dept Psychosomat Med & Psychotherapy, Mainz, Germany.	AnaNanette.Tibubos@unimedizin-mainz.de	Braehler, Elmar/C-6535-2009	Braehler, Elmar/0000-0002-2648-2728	Department for Medical Psychology and Medical Sociology of the University Clinic of Leipzig	Department for Medical Psychology and Medical Sociology of the University Clinic of Leipzig	The study was financed by internal funds of the Department for Medical Psychology and Medical Sociology of the University Clinic of Leipzig.	Anyan F, 2016, J AFFECT DISORDERS, V203, P213, DOI 10.1016/j.jad.2016.05.031; Barth J, 2013, INT J PUBLIC HEALTH, V58, P469, DOI 10.1007/s00038-012-0426-1; Bethell C, 2016, CHILD ADOL PSYCH CL, V25, P139, DOI 10.1016/j.chc.2015.12.001; Beutel ME, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0148054; Block JH, 1980, DEV COGNITION AFFECT, P39; Bonanno GA, 2013, J CHILD PSYCHOL PSYC, V54, P378, DOI 10.1111/jcpp.12021; Bonanno GA, 2011, ANNU REV CLIN PSYCHO, V7, P511, DOI 10.1146/annurev-clinpsy-032210-104526; Brahler E, 2014, GIESSENER BESCHWERDE, P97; Brodsky BS, 2016, CURR PSYCHIAT REP, V18, DOI 10.1007/s11920-016-0716-z; Campbell-Sills L, 2006, BEHAV RES THER, V44, P585, DOI 10.1016/j.brat.2005.05.001; Carver CS, 1998, J SOC ISSUES, V54, P245, DOI 10.1111/0022-4537.641998064; Catalano D, 2011, REHABIL PSYCHOL, V56, P200, DOI 10.1037/a0024571; Cheng C, 2014, PSYCHOL BULL, V140, P1582, DOI 10.1037/a0037913; Collishaw S, 2007, CHILD ABUSE NEGLECT, V31, P211, DOI 10.1016/j.chiabu.2007.02.004; Conger RD, 2002, J MARRIAGE FAM, V64, P361, DOI 10.1111/j.1741-3737.2002.00361.x; Connor KM, 2003, DEPRESS ANXIETY, V18, P76, DOI 10.1002/da.10113; Cosco TD, 2016, HEALTH QUAL LIFE OUT, V14, DOI 10.1186/s12955-016-0418-6; Daskalakis NP, 2013, PSYCHONEUROENDOCRINO, V38, P1858, DOI 10.1016/j.psyneuen.2013.06.008; Davydov DM, 2010, CLIN PSYCHOL REV, V30, P479, DOI 10.1016/j.cpr.2010.03.003; Fletcher D, 2013, EUR PSYCHOL, V18, P12, DOI 10.1027/1016-9040/a000124; Furniss, 2006, PREVENTING CHILD MAL; GARMEZY N, 1991, AM BEHAV SCI, V34, P416, DOI 10.1177/0002764291034004003; Gilbert R, 2009, LANCET, V373, P68, DOI 10.1016/S0140-6736(08)61706-7; Glaesmer H, 2013, PSYCHIAT PRAX, V40, P220, DOI 10.1055/s-0033-1343116; Grabe HJ, 2012, PSYCHIAT PRAX, V39, P109, DOI 10.1055/s-0031-1298984; Grabe HJ, 2010, AM J MED GENET B, V153B, P1483, DOI 10.1002/ajmg.b.31131; Grossmann K.E., 1991, ATTACHMENT LIFE CYCL, P93; Herke M, 2013, PSYCHOTHER PSYCH MED, V63, P101, DOI 10.1055/s-0032-1332862; Holt-Lunstad J, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000316; Johnson J, 2011, CLIN PSYCHOL REV, V31, P563, DOI 10.1016/j.cpr.2010.12.007; Kim J, 2015, J KOREAN MED SCI, V30, P1667, DOI 10.3346/jkms.2015.30.11.1667; Klein EM, 2016, BMC PSYCHIATRY, V16, DOI 10.1186/s12888-016-0875-9; Kliem S, 2015, J CLIN EPIDEMIOL, V68, P551, DOI 10.1016/j.jclinepi.2014.11.003; Kocalevent RD, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0140322; Koch A, 2000, STICHPROBEN UMFRAGEP, P99; Kroenke K, 2009, PSYCHOSOMATICS, V50, P613, DOI 10.1176/appi.psy.50.6.613; Lazarus R.S., 1984, EMOTION ADAPTATION; Little R., 2014, STAT ANAL MISSING DA, V2; Liu RT, 2015, J ABNORM PSYCHOL, V124, P80, DOI 10.1037/abn0000043; Lutz PE, 2015, CURR PHARM DESIGN, V21, P1413, DOI 10.2174/1381612821666150105124928; Mache S, 2009, BMC HEALTH SERV RES, V9, DOI 10.1186/1472-6963-9-148; Mancini AD, 2009, J PERS, V77, P1805, DOI 10.1111/j.1467-6494.2009.00601.x; Masten AS, RESILIENCE DEV IMPOR; Min JA, 2015, COMPR PSYCHIAT, V56, P103, DOI 10.1016/j.comppsych.2014.07.022; Norman RE, 2012, PLOS MED, V9, DOI 10.1371/journal.pmed.1001349; Norris F. H., 2011, RESILIENCE MENTAL HL; Oral R, 2016, PEDIATR RES, V79, P227, DOI 10.1038/pr.2015.197; Polk LV, 1997, ADV NURS SCI, V19, P1, DOI 10.1097/00012272-199703000-00002; Reiner I, 2016, J AFFECT DISORDERS, V195, P163, DOI 10.1016/j.jad.2016.02.024; Ritchie K, 2009, J CLIN PSYCHIAT, V70, P1281, DOI 10.4088/JCP.08m04510; RUTTER M, 1989, J AM ACAD CHILD PSY, V28, P633, DOI 10.1097/00004583-198909000-00001; RUTTER M, 1990, DEV PSYCHOL, V26, P60, DOI 10.1037/h0092669; Rutter M, 2012, DEV PSYCHOPATHOL, V24, P335, DOI 10.1017/S0954579412000028; Schilling C, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0159510; Scott KM, 2012, BRIT J PSYCHIAT, V200, P469, DOI 10.1192/bjp.bp.111.103267; Scott KM, 2010, ARCH GEN PSYCHIAT, V67, P712, DOI 10.1001/archgenpsychiatry.2010.71; Seery MD, 2013, PSYCHOL SCI, V24, P1181, DOI 10.1177/0956797612469210; Sethi D., 2013, EUROPEAN REPORT PREV; Shonkoff JP, 2012, PEDIATRICS, V129, pE232, DOI 10.1542/peds.2011-2663; Sinclair VG, 2004, ASSESSMENT, V11, P94, DOI 10.1177/1073191103258144; Southwick SM, 2012, SCIENCE, V338, P79, DOI 10.1126/science.1222942; Sroufe LA, 2005, ATTACH HUM DEV, V7, P349, DOI 10.1080/14616730500365928; Tedeschi RG, 1996, J TRAUMA STRESS, V9, P455, DOI 10.1007/BF02103658; Teicher M. H., 2016, J CHILD PSYCHOL PSYC; Tuscher O., 2015, BEHAV BRAIN SCI, V38; Ungar M, 2013, TRAUMA VIOLENCE ABUS, V14, P255, DOI 10.1177/1524838013487805; Waters E, 2000, CHILD DEV, V71, P684, DOI 10.1111/1467-8624.00176; Waugh CE, 2008, J RES PERS, V42, P1031, DOI 10.1016/j.jrp.2008.02.005; Werner E.E., 1992, OVERCOMING ODDS HIGH; WERNER EE, 1992, J ADOLESCENT HEALTH, V13, P262, DOI 10.1016/1054-139X(92)90157-7; Werner EE, 1996, EUR CHILD ADOLES PSY, V5, P47, DOI 10.1007/BF00538544; Wingo AP, 2010, J AFFECT DISORDERS, V126, P411, DOI 10.1016/j.jad.2010.04.009; Yang B, 2000, SUICIDE LIFE-THREAT, V30, P183	74	60	60	2	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 15	2017	12	3							e0173826	10.1371/journal.pone.0173826	http://dx.doi.org/10.1371/journal.pone.0173826			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EN9HQ	28296938	Green Published, gold, Green Submitted			2022-12-27	WOS:000396311700070
J	Cheon, YH; Kim, HO; Suh, YS; Kim, MG; Yoo, WH; Kim, RB; Yang, HS; Lee, SI; Park, KS				Cheon, Yun-Hong; Kim, Hyun-Ok; Suh, Young Sun; Kim, Min Gyo; Yoo, Wan-Hee; Kim, Rock Bum; Yang, Hyun-Su; Lee, Sang-Il; Park, Ki-Soo			Relationship between decreased lower extremity muscle mass and knee pain severity in both the general population and patients with knee osteoarthritis: Findings from the KNHANES V 1-2	PLOS ONE			English	Article							QUALITY-OF-LIFE; NATIONAL-HEALTH; CARTILAGE LOSS; PREVALENCE; OBESITY; MEN; COMMUNITY; STRENGTH; RISK; ASSOCIATION	Objective To identify the prevalence of and risk factors for knee pain and radiographic knee osteoarthritis (RKOA) and to investigate the relationship between decreased lower extremity muscle mass (DLEM) and knee pain severity. Methods Using data from the Korea National Health and Nutrition Examination Survey, 3,278 participants who were >= 50 years old and who underwent dual x-ray absorptiometry, plain knee radiographs and completed a knee pain questionnaire were enrolled. Lower extremity muscle mass (LEM) was defined as the sum of the fat-free soft tissue mass of the legs, and lower extremity muscle mass index (LMI) was calculated as LEM/body weight (%). DLEM was defined as an LMI more than two standard deviations below the mean of a gender-matched young reference group. Categorical variables were presented as numbers (weighted %). Results The prevalence of knee pain and RKOA were 22% (n = 721) and 34.7% (n = 1,234), respectively. Multivariate logistic regression analysis showed being female (OR 2.15, 95% CI 1.67-2.79), older (OR 1.03, 95% CI 1.01-1.04), less educated (OR 1.72, 95% CI 1.09-2.71), stiffness (OR 16.15, 95% CI 12.04-21.66), bed rest (OR 2.49, 95% CI 1.81-3.43), RKOA (OR 2.20, 95% CI 1.78-2.74) and DLEM (OR 1.54, 95% CI 1.09-2.17) were associated with knee pain. Participants with simultaneous RKOA and DLEM complained of more severe pain (pain score 7.18 +/- 2.48) than those with knee pain without RKOA or DLEM (5.02 +/- 2.44), those with only RKOA (6.29 +/- 2.50), or those with only DLEM (6.78 +/- 2.18) (P<0.001). These results remained after multivariate analyses of variance (MANOVAs). Conclusion The prevalence of knee pain and RKOA were 22% and 34.7%, respectively, in the general Korean population. DLEM was an independent risk factor for knee pain and it was associated with increased pain severity, regardless of RKOA.	[Cheon, Yun-Hong; Kim, Hyun-Ok; Suh, Young Sun; Kim, Min Gyo; Lee, Sang-Il] Gyeongsang Natl Univ, Sch Med, Internal Med & Inst Hlth Sci, Jinju, South Korea; [Yoo, Wan-Hee] Chonbuk Natl Univ, Sch Med, Dept Rheumatol, Internal Med, Chonju, South Korea; [Kim, Rock Bum; Yang, Hyun-Su; Park, Ki-Soo] Gyeongsang Natl Univ, Sch Med, Dept Prevent Med, Jinju, South Korea	Gyeongsang National University; Jeonbuk National University; Gyeongsang National University	Lee, SI (corresponding author), Gyeongsang Natl Univ, Sch Med, Internal Med & Inst Hlth Sci, Jinju, South Korea.; Park, KS (corresponding author), Gyeongsang Natl Univ, Sch Med, Dept Prevent Med, Jinju, South Korea.	goldgu@gnu.ac.kr; kisoo1030@gmail.com		Kim, Mingyo/0000-0003-3744-8522	National Research Foundation of Korea (NRF) - the Korean government (MSIP) [NRF-2014R1A2A1A11051360, NRF-2015R1A5A2008833]; Korea Health Industry Development Institute (KHIDI) - Ministry of Health & Welfare, Republic of Korea [HI15C2497]	National Research Foundation of Korea (NRF) - the Korean government (MSIP); Korea Health Industry Development Institute (KHIDI) - Ministry of Health & Welfare, Republic of Korea	This work was supported by grants NRF-2014R1A2A1A11051360 and NRF-2015R1A5A2008833 from the National Research Foundation of Korea (NRF) funded by the Korean government (MSIP), and (HI15C2497) from Korea Health Industry Development Institute (KHIDI) funded by the Ministry of Health & Welfare, Republic of Korea.	Amin S, 2007, ANN RHEUM DIS, V66, P18, DOI 10.1136/ard.2006.056697; ANDERSON JJ, 1988, AM J EPIDEMIOL, V128, P179, DOI 10.1093/oxfordjournals.aje.a114939; Boling M, 2010, SCAND J MED SCI SPOR, V20, P725, DOI 10.1111/j.1600-0838.2009.00996.x; Chang CJ, 2003, INT J OBESITY, V27, P253, DOI 10.1038/sj.ijo.802197; Cruz-Jentoft AJ, 2010, AGE AGEING, V39, P412, DOI 10.1093/ageing/afq034; Dawson J, 2004, RHEUMATOLOGY, V43, P497, DOI 10.1093/rheumatology/keh086; FELSON DT, 1988, ANN INTERN MED, V109, P18, DOI 10.7326/0003-4819-109-1-18; FELSON DT, 1989, ARTHRITIS RHEUM, V32, P166, DOI 10.1002/anr.1780320209; Frilander H, 2016, EUR J PAIN, V20, P1278, DOI 10.1002/ejp.852; FRONTERA WR, 1991, J APPL PHYSIOL, V71, P644, DOI 10.1152/jappl.1991.71.2.644; HEYMSFIELD SB, 1990, AM J CLIN NUTR, V52, P214, DOI 10.1093/ajcn/52.2.214; Ho-Pham LT, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094563; Holick MF, 2009, ANN EPIDEMIOL, V19, P73, DOI 10.1016/j.annepidem.2007.12.001; Jhun HJ, 2013, J KOREAN MED SCI, V28, P1807, DOI 10.3346/jkms.2013.28.12.1807; KELLGREN JH, 1957, ANN RHEUM DIS, V16, P494, DOI 10.1136/ard.16.4.494; Kiadaliri AA, 2016, SCAND J RHEUMATOL, V6, P1; Kim IJ, 2011, J KOREAN MED SCI, V26, P1140, DOI 10.3346/jkms.2011.26.9.1140; Lanyon P, 1998, ANN RHEUM DIS, V57, P595, DOI 10.1136/ard.57.10.595; Lee JC, 2016, AIP CONF PROC, V1774, DOI 10.1063/1.4965062; Lee S, 2012, ARTHRITIS RHEUM-US, V64, P3947, DOI 10.1002/art.37696; Matsuzawa Y, 2002, CIRC J, V66, P987, DOI 10.1253/circj.66.987; Mendieta EDM, 2006, OSTEOARTHR CARTILAGE, V14, P540, DOI 10.1016/j.joca.2005.12.012; Michaud M, 2013, J AM MED DIR ASSOC, V14, P877, DOI 10.1016/j.jamda.2013.05.009; Muraki S, 2009, OSTEOARTHR CARTILAGE, V17, P1137, DOI 10.1016/j.joca.2009.04.005; Muraki S, 2015, BMC MUSCULOSKEL DIS, V16, DOI 10.1186/s12891-015-0737-5; Nguyen USDT, 2011, ANN INTERN MED, V155, P725, DOI 10.7326/0003-4819-155-11-201112060-00004; Oh SW, 2011, DIABETES METAB J, V35, P561, DOI 10.4093/dmj.2011.35.6.561; Reid KF, 2015, ARTHRITIS RHEUMATOL, V67, P3166, DOI 10.1002/art.39336; Riddle DL, 2015, OSTEOARTHR CARTILAGE, V23, P391, DOI 10.1016/j.joca.2014.12.013; Roos EM, 2011, NAT REV RHEUMATOL, V7, P57, DOI 10.1038/nrrheum.2010.195; Ruhdorfer A, 2014, ARTHRIT CARE RES, V66, P1344, DOI 10.1002/acr.22317; Sattler M, 2012, OSTEOARTHR CARTILAGE, V20, P532, DOI 10.1016/j.joca.2012.02.635; Schaible HG, 2002, ANN NY ACAD SCI, V966, P343, DOI 10.1111/j.1749-6632.2002.tb04234.x; Schiphof D, 2013, ARTHRIT CARE RES, V65, P695, DOI 10.1002/acr.21886; Silverwood V, 2015, OSTEOARTHR CARTILAGE, V23, P507, DOI 10.1016/j.joca.2014.11.019; Soni A, 2012, ARTHRITIS RHEUM-US, V64, P1145, DOI 10.1002/art.33434; Suh DH, 2016, OSTEOARTHR CARTILAGE, V24, P605, DOI 10.1016/j.joca.2015.10.011; Turkiewicz A, 2015, RHEUMATOLOGY, V54, P827, DOI 10.1093/rheumatology/keu409; Wang YY, 2012, ARTHRITIS RHEUM-US, V64, P3917, DOI 10.1002/art.34681; World Health Organization, 2008, WHO TECH REP SER 200, P1; Zhai GJ, 2006, ARTHRIT RHEUM-ARTHR, V55, P264, DOI 10.1002/art.21835	41	13	13	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 15	2017	12	3							e0173036	10.1371/journal.pone.0173036	http://dx.doi.org/10.1371/journal.pone.0173036			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN9HQ	28296926	Green Published, Green Submitted, gold			2022-12-27	WOS:000396311700022
J	Radhakrishnan, S; Literman, R; Neuwald, J; Severin, A; Valenzuela, N				Radhakrishnan, Srihari; Literman, Robert; Neuwald, Jennifer; Severin, Andrew; Valenzuela, Nicole			Transcriptomic responses to environmental temperature by turtles with temperature-dependent and genotypic sex determination assessed by RNAseq inform the genetic architecture of embryonic gonadal development	PLOS ONE			English	Article							EARED SLIDER TURTLE; NF-KAPPA-B; APALONE-MUTICA TURTLES; CHRYSEMYS-PICTA; DIFFERENTIAL EXPRESSION; TRACHEMYS-SCRIPTA; MESSENGER-RNA; STEROIDOGENIC FACTOR-1; MOLECULAR-MECHANISMS; TESTIS DETERMINATION	Vertebrate sexual fate is decided primarily by the individual's genotype (GSD), by the environmental temperature during development (TSD), or both. Turtles exhibit TSD and GSD, making them ideal to study the evolution of sex determination. Here we analyze temperature-specific gonadal transcriptomes (RNA-sequencing validated by qPCR) of painted turtles (Chrysemys picta TSD) before and during the thermosensitive period, and at equivalent stages in soft-shell turtles (Apalone spinifera-GSD), to test whether TSD's and GSD's transcriptional circuitry is identical but deployed differently between mechanisms. Our data show that most elements of the mammalian urogenital network are active during turtle gonadogenesis, but their transcription is generally more thermoresponsive in TSD than GSD, and concordant with their sex-specific function in mammals [e.g., upregulation of Amh, Ar, Esr1, Fog2, Gata4, Igf1r, Insr, and Lhx9 at male-producing temperature, and of beta-catenin, Foxl2, Aromatase (Cyp19a1), Fst, Nf-kb, Crabp2 at female-producing temperature in Chrysemys]. Notably, antagonistic elements in gonadogenesis (e.g., beta-catenin and Insr) were thermosensitive only in TSD early-embryos. Cirbp showed warm-temperature upregulation in both turtles disputing its purported key TSD role. Genes that may convert thermal inputs into sex-specific development (e.g., signaling and hormonal pathways, RNA-binding and heat-shock) were differentially regulated. Jak-Stat, Nf-kappa B, retinoic-acid, Wnt, and Mapk-signaling (not Akt and Ras-signaling) potentially mediate TSD thermosensitivity. Numerous species-specific ncRNAs (including Xist) were differentially-expressed, mostly upregulated at colder temperatures, as were unannotated loci that constitute novel TSD candidates. Cirbp showed warm-temperature upregulation in both turtles. Consistent transcription between turtles and alligator revealed putatively-critical reptilian TSD elements for male (Sf1, Amh, Amhr2) and female (Crabp2 and Hspb1) gonadogenesis. In conclusion, while preliminary, our data helps illuminate the regulation and evolution of vertebrate sex determination, and contribute genomic resources to guide further research into this fundamental biological process.	[Radhakrishnan, Srihari] Iowa State Univ, Bioinformat & Computat Biol Program, Ames, IA USA; [Radhakrishnan, Srihari; Literman, Robert; Neuwald, Jennifer; Severin, Andrew; Valenzuela, Nicole] Iowa State Univ, Dept Ecol Evolut & Organismal Biol, Ames, IA 50011 USA; [Literman, Robert] Iowa State Univ, Ecol & Evolutionary Biol Program, Ames, IA USA; [Severin, Andrew] Iowa State Univ, Genome Informat Facil, Ames, IA USA; [Neuwald, Jennifer] Colorado State Univ, Dept Biol, Ft Collins, CO 80523 USA	Iowa State University; Iowa State University; Iowa State University; Iowa State University; Colorado State University	Valenzuela, N (corresponding author), Iowa State Univ, Dept Ecol Evolut & Organismal Biol, Ames, IA 50011 USA.	nvalenzu@iastate.edu	Neuwald, Jennifer/AAH-3468-2021	Neuwald, Jennifer/0000-0002-8850-5534; Valenzuela, Nicole/0000-0003-1148-631X; Literman, Robert/0000-0002-1784-0407	Sigma Xi [G20120315162029]; US National Science Foundation [IOS-0743284, MCB-1244355]	Sigma Xi; US National Science Foundation(National Science Foundation (NSF))	This work was supported by Sigma Xi grant G20120315162029 to S.R. and US National Science Foundation grants IOS-0743284 and MCB-1244355 to NV.	Al Seesi S, 2014, BMC GENOMICS, V15; Anders S., 2014, HTSEQ PYTHON FRAMEWO; Anders S, 2012, ANAL RNA SEQ DATA DE, P1; Ashman TL, 2014, SCI DATA, V1, DOI 10.1038/sdata.2014.15; Auer PL, 2010, GENETICS, V185, P405, DOI 10.1534/genetics.110.114983; Ayers KL, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-3-r26; Bachtrog D, 2014, PLOS BIOL, V12, DOI 10.1371/journal.pbio.1001899; Bachvarova RF, 2009, EVOL DEV, V11, P525, DOI 10.1111/j.1525-142X.2009.00360.x; Badenhorst D, 2015, GENOME BIOL EVOL, V7, P2038, DOI 10.1093/gbe/evv119; Badenhorst D, 2013, CHROMOSOME RES, V21, P137, DOI 10.1007/s10577-013-9343-2; Barske LA, 2010, DEV BIOL, V341, P305, DOI 10.1016/j.ydbio.2010.02.010; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bergeron JM, 1998, DEV GROWTH DIFFER, V40, P243; Bernard P, 2012, ENDOCRINOLOGY, V153, P901, DOI 10.1210/en.2011-1347; Bieser KL, 2014, SEX DEV, V8, P364, DOI 10.1159/000369116; Boeckmann B, 2003, NUCLEIC ACIDS RES, V31, P365, DOI 10.1093/nar/gkg095; Bogani D, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000196; Bolger AM, 2014, BIOINFORMATICS, V30, P2114, DOI 10.1093/bioinformatics/btu170; Bott RC, 2008, REPROD DOMEST ANIM, V43, P310, DOI 10.1111/j.1439-0531.2008.01179.x; BULL JJ, 1981, J EXP ZOOL, V218, P435, DOI 10.1002/jez.1402180315; BULL JJ, 1979, SCIENCE, V206, P1186, DOI 10.1126/science.505003; Bull JJ, 1983, EVOLUTION SEX DETERM, P173; Bullard JH, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-94; Camacho C, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-421; Carmi I, 1998, NATURE, V396, P168, DOI 10.1038/24164; Castro LFC, 2005, BMC EVOL BIOL, V5, DOI 10.1186/1471-2148-5-43; Chandel NS, 2000, J IMMUNOL, V165, P1013, DOI 10.4049/jimmunol.165.2.1013; CHARNOV EL, 1977, NATURE, V266, P828, DOI 10.1038/266828a0; Chassot AA, 2012, WNT4 RSPO1 TOGETHER; Chavez B, 2009, GEN COMP ENDOCR, V162, P203, DOI 10.1016/j.ygcen.2009.02.010; Chocu S, 2012, SYST BIOL REPROD MED, V58, P179, DOI 10.3109/19396368.2012.691943; Costanzo JP, 2001, J COMP PHYSIOL B, V171, P335, DOI 10.1007/s003600100181; Crews D, 2001, J EXP ZOOL, V290, P597, DOI 10.1002/jez.1110; Cristino AS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019350; Czerwinski M, 2016, DEV BIOL; Deeming D.C., 1991, P147, DOI 10.1017/CBO9780511585739.011; Devonshire AS, 2013, METHODS, V59, P89, DOI 10.1016/j.ymeth.2012.07.021; Disteche CM, 2012, ANNU REV GENET, V46, P537, DOI 10.1146/annurev-genet-110711-155454; Eggers S, 2014, NAT REV ENDOCRINOL, V10, P673, DOI 10.1038/nrendo.2014.163; Fish EN, 2008, NAT REV IMMUNOL, V8, P737, DOI 10.1038/nri2394; GEORGE FW, 1978, J CLIN ENDOCR METAB, V47, P550, DOI 10.1210/jcem-47-3-550; Girondot Marc, 2004, P148; Gomez-Saldarriaga C, 2016, CHELONIAN CONSERV BI, V15, P43, DOI 10.2744/CCB-1170.1; Grabherr MG, 2011, NAT BIOTECHNOL, V29, P644, DOI 10.1038/nbt.1883; Graves JAM, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-4-205; Grayson KL, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094214; Haas BJ, 2013, NAT PROTOC, V8, P1494, DOI 10.1038/nprot.2013.084; Hayden MS, 2006, ONCOGENE, V25, P6758, DOI 10.1038/sj.onc.1209943; Hedges SB, 2015, MOL BIOL EVOL, V32, P835, DOI 10.1093/molbev/msv037; Holleley CE, 2015, NATURE, V523, P79, DOI 10.1038/nature14574; Hou SX, 2002, JAK STAT PATHWAY MOD, P765; Huang DW, 2007, NUCLEIC ACIDS RES, V35, pW169, DOI 10.1093/nar/gkm415; Hughes IA, 1999, ACTA PAEDIATR, V88, P23, DOI 10.1111/j.1651-2227.1999.tb14347.x; James S, 2012, PALGRAVE STUD EUR UN, P8; Janes DE, 2014, BIOL LETTERS, V10, DOI 10.1098/rsbl.2014.0809; Kamiya T, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002798; Kanehisa M, 2002, NOVART FDN SYMP, V247, P91; Kaplinsky NJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066357; Kawagoshi T, 2009, CYTOGENET GENOME RES, V125, P125, DOI 10.1159/000227837; Keenan SW, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0131669; Kettlewell JR, 2000, GENESIS, V26, P174, DOI 10.1002/(SICI)1526-968X(200003)26:3<174::AID-GENE2>3.0.CO;2-J; Kohno S, 2010, SEX DEV, V4, P73, DOI 10.1159/000260374; Korus M, 2002, ONCOGENE, V21, P4601, DOI 10.1038/sj.onc.1205678; Kuroki S, 2013, SCIENCE, V341, P1106, DOI 10.1126/science.1239864; Langfelder P, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-559; Literman R, 2014, METHODS ECOL EVOL, V5, P872, DOI 10.1111/2041-210X.12228; Liu C, 2016, DEVELOPMENT, V143, P3700, DOI 10.1242/dev.135756; Liu CF, 2010, CURR TOP DEV BIOL, V90, P263, DOI 10.1016/S0070-2153(10)90007-0; Liu CF, 2009, HUM MOL GENET, V18, P405, DOI 10.1093/hmg/ddn362; Liu YW, 2014, BIOINFORMATICS, V30, P301, DOI 10.1093/bioinformatics/btt688; Maldonado LCT, 2002, GEN COMP ENDOCR, V129, P20, DOI 10.1016/S0016-6480(02)00511-7; Matsumoto Y, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063599; Matsumoto Y, 2013, J MOL ENDOCRINOL, V50, P389, DOI 10.1530/JME-12-0260; Meeks JJ, 2003, NAT GENET, V34, P32, DOI 10.1038/ng1141; Merchant-Larios H, 2010, SEX DEV, V4, P50, DOI 10.1159/000276768; Minkina A, 2014, DEV CELL, V29, P511, DOI 10.1016/j.devcel.2014.04.017; Miqueloto CA, 2007, J ANAT, V211, P16, DOI 10.1111/j.1469-7580.2007.00741.x; Mitchell NJ, 2010, SEX DEV, V4, P129, DOI 10.1159/000282494; Mittwoch U, 2004, J THEOR BIOL, V228, P359, DOI 10.1016/j.jtbi.2004.02.001; Mittwoch U, 2013, EMBO REP, V14, P588, DOI 10.1038/embor.2013.84; Mizoguchi BA, 2016, SEX DEV; Morian CL, 2001, J HERPETOL, V35, P668, DOI 10.2307/1565908; Morjan CL, 2003, BEHAV ECOL SOCIOBIOL, V53, P254, DOI 10.1007/s00265-002-0570-3; Morrish BC, 2002, REPRODUCTION, V124, P447, DOI 10.1530/rep.0.1240447; Mu XY, 2013, J CELL PHYSIOL, V228, P627, DOI 10.1002/jcp.24172; Munger SC, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003630; Nanda I, 2002, CYTOGENET GENOME RES, V99, P178, DOI 10.1159/000071591; Nef S, 2003, NATURE, V426, P291, DOI 10.1038/nature02059; Nef Serge, 2009, Journal of Biology (London), V8, P74, DOI 10.1186/jbiol173; Neuwald JL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018117; Oreal E, 2002, DEV DYNAM, V225, P221, DOI 10.1002/dvdy.10153; Organ CL, 2008, INTEGR COMP BIOL, V48, P512, DOI 10.1093/icb/icn041; Palmieri F, 2013, MITOCHONDRIAL TRANSP, P465; Parker KL, 1997, ENDOCR REV, V18, P361, DOI 10.1210/er.18.3.361; PELLETIER J, 1991, GENE DEV, V5, P1345, DOI 10.1101/gad.5.8.1345; Pieau C, 2004, J ENDOCRINOL, V181, P367, DOI 10.1677/joe.0.1810367; Pires-daSilva A, 2003, NAT REV GENET, V4, P39, DOI 10.1038/nrg977; Pokorna MJ, 2016, BIOL REV; *R COR DEV TEAM, 2012, R LANG ENV STAT COMP; Ramkissoon Y, 1996, CURR OPIN GENET DEV, V6, P316, DOI 10.1016/S0959-437X(96)80008-6; Ramsey M, 2007, DIFFERENTIATION, V75, P978, DOI 10.1111/j.1432-0436.2007.00182.x; Ramsey M, 2007, J EXP ZOOL PART A, V307A, P463, DOI 10.1002/jez.399; Ramsey M, 2009, SEMIN CELL DEV BIOL, V20, P283, DOI 10.1016/j.semcdb.2008.10.004; Rhen T, 2007, SEX DEV, V1, P255, DOI 10.1159/000104775; Rhen T, 2010, SEX DEV, V4, P16, DOI 10.1159/000282495; Ricken A, 2002, ENDOCRINOLOGY, V143, P2741, DOI 10.1210/en.143.7.2741; Robinson MD, 2007, BIOINFORMATICS, V23, P2881, DOI 10.1093/bioinformatics/btm453; Robinson MD, 2010, BIOINFORMATICS, V26, P139, DOI 10.1093/bioinformatics/btp616; Roos-Mattjus P, 2004, ANN MED, V36, P285, DOI 10.1080/07853890310016324; Sabath N, 2016, ECOLOGY EVOLUTION; Sarre SD, 2004, BIOESSAYS, V26, P639, DOI 10.1002/bies.20050; Schroeder AL, 2016, GENETICS, V115; Shaffer HB, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-3-r28; Shedlock AM, 2007, P NATL ACAD SCI USA, V104, P2767, DOI 10.1073/pnas.0606204104; Shine R, 2002, ECOL LETT, V5, P486, DOI 10.1046/j.1461-0248.2002.00351.x; Shoemaker C, 2007, DEV DYNAM, V236, P1055, DOI 10.1002/dvdy.21096; Shoemaker-Daly CM, 2010, DEV DYNAM, V239, P1061, DOI 10.1002/dvdy.22266; Smith CA, 2001, J EXP ZOOL, V290, P691, DOI 10.1002/jez.1119; Smith CA, 2009, NATURE, V461, P267, DOI 10.1038/nature08298; Smith CA, 2008, BMC DEV BIOL, V8, DOI 10.1186/1471-213X-8-72; Spotila LD, 1998, J EXP ZOOL, V281, P417, DOI 10.1002/(SICI)1097-010X(19980801)281:5<417::AID-JEZ7>3.0.CO;2-R; Sundaram M, 1996, DEVELOPMENT, V122, P2823; Szymanski M, 2003, NUCLEIC ACIDS RES, V31, P429, DOI 10.1093/nar/gkg124; Valenzuela N, 2001, EVOL ECOL RES, V3, P779; Valenzuela N, 2003, AM NAT, V161, P676, DOI 10.1086/368292; Valenzuela N, 2010, SEX DEV, V4, P39, DOI 10.1159/000277935; Valenzuela N, 2001, ECOLOGY, V82, P3010, DOI 10.2307/2679831; Valenzuela N, 2009, COLD SPRING HARB PRO, V4, P1, DOI DOI 10.1101/PDB.EMO124:1-9; Valenzuela N., 2004, TEMPERATURE DEPENDEN; Valenzuela N, 2008, INTEGR COMP BIOL, V48, P476, DOI 10.1093/icb/icn031; Valenzuela N, 2008, EVOLUTION, V62, P234, DOI 10.1111/j.1558-5646.2007.00279.x; Valenzuela N, 2007, DEV GENES EVOL, V217, P55, DOI 10.1007/s00427-006-0106-3; Valenzuela N, 2006, EVOL DEV, V8, P424, DOI 10.1111/j.1525-142X.2006.00116.x; Valenzuela N, 2014, CYTOGENET GENOME RES, V144, P39, DOI 10.1159/000366076; Valenzuela N, 2013, DEV DYNAM, V242, P307, DOI 10.1002/dvdy.23897; Valenzuela N, 2011, EVOLUTION, V65, P1808, DOI 10.1111/j.1558-5646.2011.01258.x; VOGT RC, 1982, COPEIA, P699, DOI 10.2307/1444672; Wainwright EN, 2010, CURR TOP DEV BIOL, V90, P231, DOI 10.1016/S0070-2153(10)90006-9; Wang C, 2015, ZOOL SCI, V32, P151, DOI 10.2108/zs140246; Wang Z, 2013, NAT GENET, V45, P701, DOI 10.1038/ng.2615; Warr N, 2012, DEV CELL, V23, P1020, DOI 10.1016/j.devcel.2012.09.016; Washietl S, 2005, NAT BIOTECHNOL, V23, P1383, DOI 10.1038/nbt1144; Weiner SA, 2013, NATURWISSENSCHAFTEN, V100, P795, DOI 10.1007/s00114-013-1064-z; Wu TD, 2005, BIOINFORMATICS, V21, P1859, DOI 10.1093/bioinformatics/bti310; Wu TD, 2010, BIOINFORMATICS, V26, P873, DOI 10.1093/bioinformatics/btq057; Yamamoto Y., 2014, PLOS ONE, V9; Yatsu R, 2016, BMC GENOMICS, V17, DOI 10.1186/s12864-016-2396-9; Zhang WH, 2003, P NATL ACAD SCI USA, V100, P16012, DOI 10.1073/pnas.2534856100; Zhou J, 2007, J BIOL CHEM, V282, P7482, DOI 10.1074/jbc.M608289200	149	40	42	2	58	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 15	2017	12	3							e0172044	10.1371/journal.pone.0172044	http://dx.doi.org/10.1371/journal.pone.0172044			34	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN9HQ	28296881	Green Published, Green Submitted, gold			2022-12-27	WOS:000396311700004
J	Schmied, V; Black, E; Naidoo, N; Dahlen, HG; Liamputtong, P				Schmied, Virginia; Black, Emma; Naidoo, Norell; Dahlen, Hannah G.; Liamputtong, Pranee			Migrant women's experiences, meanings and ways of dealing with postnatal depression: A meta-ethnographic study	PLOS ONE			English	Article							POSTPARTUM DEPRESSION; HELP-SEEKING; HEALTH-SERVICES; IMMIGRANT WOMEN; MENTAL-HEALTH; QUALITATIVE RESEARCH; LIVED EXPERIENCES; RISK-FACTORS; REFUGEE; BARRIERS	Aim To conduct a meta-ethnographic study of the experiences, meanings and ways of 'dealing with' symptoms or a diagnosis of postnatal depression amongst migrant women living in high income countries. Background Prevalence of postnatal depression is highest amongst women who are migrants. Yet many women do not seek help for their symptoms and health services do not always respond appropriately to migrant women's needs. Studies have reported migrant women's experiences of postnatal depression and it is timely to synthesise findings from these studies to understand how services can be improved. Design A meta-ethnographic synthesis of 12 studies reported in 15 papers Data sources Five databases were searched for papers published between January 1999 and February 2016 Review methods The quality of included studies was assessed using the Critical Appraisal Skills Program tool. The synthesis process was guided by the seven steps of meta-ethnography outlined by Noblit and Hare. Findings Four key metaphors were identified: "I am alone, worried and angry-this is not me!"; 'Making sense of my feelings' 'Dealing with my feelings' and 'What I need to change the way I feel!'. Primarily women related their feelings to their position as a migrant and as women, often living in poor socio-economic circumstances and they were exhausted keeping up with expected commitments. Many women were resourceful, drawing on their personal strengths and family / community resources. All the studies reported that women experienced difficulties in accessing appropriate services. Conclusion The meta-ethnographic study demonstrates the impact of migration on perinatal mental health, particularly for women lacking family support, who have no employment, a precarious migration status and/or relationship conflict. Migrant women are resourceful and this requires support through appropriate services. Further research is needed to evaluate effective support strategies for migrant women in the perinatal period.	[Schmied, Virginia; Naidoo, Norell; Dahlen, Hannah G.] Univ Western Sydney, Sch Nursing & Midwifery, Sydney, NSW, Australia; [Black, Emma] St John God Hlth Care, Perinatal & Womens Mental Hlth Unit, Burwood, NSW, Australia; [Black, Emma] Univ New South Wales, Sch Psychiat, Burwood, NSW, Australia; [Dahlen, Hannah G.] Ingham Inst Hlth & Med Res, Liverpool, NSW, Australia; [Liamputtong, Pranee] Univ Western Sydney, Sch Sci & Hlth, Sydney, NSW, Australia	Western Sydney University; St John of God Health Care; University of New South Wales Sydney; Ingham Institute for Applied Medical Research; Western Sydney University	Schmied, V (corresponding author), Univ Western Sydney, Sch Nursing & Midwifery, Sydney, NSW, Australia.	v.schmied@westernsydney.edu.au	Dahlen, Hannah/V-1034-2019	Dahlen, Hannah/0000-0002-4450-3078; Schmied, Virginia/0000-0002-4066-1781; Black, Emma/0000-0002-3936-2434				Abrams LS, 2011, QUAL HEALTH RES, V21, P373, DOI 10.1177/1049732310385123; Ahmed A, 2008, ARCH WOMEN MENT HLTH, V11, P295, DOI 10.1007/s00737-008-0025-6; Almeida L, 2013, MATERN CHILD HLTH J, V17, P1346, DOI 10.1007/s10995-012-1149-x; Bandyopadhyay M, 2010, AUST NZ J PUBL HEAL, V34, P412, DOI 10.1111/j.1753-6405.2010.00575.x; Beck CT, 1998, ARCH PSYCHIAT NURS, V12, P12, DOI 10.1016/S0883-9417(98)80004-6; Beck CT, 2002, QUAL HEALTH RES, V12, P453, DOI 10.1177/104973202129120016; Benza S, 2014, MIDWIFERY, V30, P575, DOI 10.1016/j.midw.2014.03.005; Britten Nicky, 2002, J Health Serv Res Policy, V7, P209, DOI 10.1258/135581902320432732; Burns E, 2010, MATERN CHILD NUTR, V6, P201, DOI 10.1111/j.1740-8709.2009.00209.x; Burr J, 2004, SOCIOL HEALTH ILL, V26, P433, DOI 10.1111/j.0141-9889.2004.00398.x; Callister LC, 2011, JOGNN-J OBST GYN NEO, V40, P440, DOI 10.1111/j.1552-6909.2011.01254.x; Campbell R, 2003, SOC SCI MED, V56, P671, DOI 10.1016/S0277-9536(02)00064-3; Chisholm D, 2004, BRIT J PSYCHIAT, V184, pS45, DOI 10.1192/bjp.184.46.s45; Collins CH, 2011, ARCH WOMEN MENT HLTH, V14, P3, DOI 10.1007/s00737-010-0198-7; Critical Appraisal Skills Programme (CASP), 2013, QUAL RES CHECKL VERS; Dahlen HG, 2015, BMC PREGNANCY CHILDB, V15, DOI 10.1186/s12884-015-0681-2; Dennis CL, 2006, BIRTH-ISS PERINAT C, V33, P323, DOI 10.1111/j.1523-536X.2006.00130.x; Elmir R, 2016, MIDWIFERY, V32, P66, DOI 10.1016/j.midw.2015.09.008; Evagorou O, 2015, PSYCHIAT QUART; Falah-Hassani K, 2015, J PSYCHIATR RES, V70, P67, DOI 10.1016/j.jpsychires.2015.08.010; Fellmeth G, 2016, BJOG; Foulkes M, 2011, JOGNN-J OBST GYN NEO, V40, P450, DOI 10.1111/j.1552-6909.2011.01264.x; France EF, 2014, BMC MED RES METHODOL, V14, DOI 10.1186/1471-2288-14-119; Fung K, 2010, CURR OPIN PSYCHIATR, V23, P342, DOI 10.1097/YCO.0b013e32833ad721; Gardner PL, 2014, MIDWIFERY, V30, P756, DOI 10.1016/j.midw.2013.08.001; Goodman JH, 2009, BIRTH-ISS PERINAT C, V36, P60, DOI 10.1111/j.1523-536X.2008.00296.x; Henderson S, 2011, AUST J PRIM HEALTH, V17, P195, DOI 10.1071/PY10065; Kim JJ, 2010, AM J OBSTET GYNECOL, V202, DOI 10.1016/j.ajog.2010.01.004; Kim JJ, 2010, J OBSTET GYNECOLOGY, V202; Kingston D, 2012, CHILD PSYCHIAT HUM D, V43, P683, DOI 10.1007/s10578-012-0291-4; Knudson-Martin C, 2009, J MARITAL FAM THER, V35, P145, DOI 10.1111/j.1752-0606.2009.00112.x; Letourneau N, 2011, INT J MENT HEALTH NU, V20, P345, DOI 10.1111/j.1447-0349.2010.00736.x; Liamputtong P., 2006, QUAL SOCIOL, V29, P25, DOI [DOI 10.1007/S11133-005-9006-5, 10.1007/s11133-005-9006-5]; Mamisachvili L, 2013, J TRANSCULT NURS, V24, P162, DOI 10.1177/1043659612472197; Matthey S, 2009, EVID-BASED MENT HEAL, V12, P82, DOI 10.1136/ebmh.12.3.82; McCarthy R., 2013, BRIT J MIDWIFERY, V21, P404, DOI [10.12968/bjom.2013.21.6.404, DOI 10.12968/BJOM.2013.21.6.404, DOI 10.12968/bjom.2013.21.6.404]; McGarry J, 2009, J MIDWIFERY WOM HEAL, V54, P50, DOI 10.1016/j.jmwh.2008.07.003; McLeish J., 2005, BRIT J MIDWIFERY, V13, P782, DOI [DOI 10.12968/BJ0M.2005.13.12.20125, 10.12968/BJOM.2005.13.12.20125, DOI 10.12968/BJOM.2005.13.12.20125]; Mollard EK, 2014, ISSUES MENT HEALTH N, V35, P656, DOI 10.3109/01612840.2014.893044; Morrow M, 2008, HEALTH CARE WOMEN IN, V29, P593, DOI 10.1080/07399330802089156; Nahas V, 1999, J Transcult Nurs, V10, P37, DOI 10.1177/104365969901000113; Nahas VL, 1999, J NURSE-MIDWIFERY, V44, P65, DOI 10.1016/S0091-2182(98)00083-4; Nilaweera I, 2014, J AFFECT DISORDERS, V166, P213, DOI 10.1016/j.jad.2014.05.021; Noblit G. W., 1988, METAETHNOGRAPHY SYNT; Norhayati MN, 2015, J AFFECT DISORDERS, V175, P34, DOI 10.1016/j.jad.2014.12.041; O'Mahony J, 2010, J PSYCHIATR MENT HLT, V17, P917, DOI 10.1111/j.1365-2850.2010.01625.x; O'Mahony JM, 2013, J PSYCHIATR MENT HLT, V20, P714, DOI 10.1111/jpm.12005; O'Mahony JM, 2013, J IMMIGR MINOR HEALT, V15, P300, DOI 10.1007/s10903-012-9663-x; O'Mahony Joyce Maureen, 2012, Issues Ment Health Nurs, V33, P735, DOI 10.3109/01612840.2012.701707; O'Mahony JM, 2012, ADV NURS SCI, V35, pE42, DOI 10.1097/ANS.0b013e3182626137; Ornelas IJ, 2009, J FAM ISSUES, V30, P1556, DOI 10.1177/0192513X09336651; Parvin A, 2004, FAM PRACT, V21, P254, DOI 10.1093/fampra/cmh307; Priddis H, 2013, J ADV NURS, V69, P748, DOI 10.1111/jan.12005; Raman S, 2014, MIDWIFERY, V30, P130, DOI 10.1016/j.midw.2013.03.003; Raymond JE, 2009, MIDWIFERY, V25, P39, DOI 10.1016/j.midw.2007.01.005; Reay R, 2008, 2 YEAR OUTCOMES MOTH; Rodrigues M, 2003, SOC SCI MED, V57, P1797, DOI 10.1016/S0277-9536(03)00062-5; Rollans M, 2013, MIDWIFERY, V29, P935, DOI 10.1016/j.midw.2012.11.013; Sandelowski M., 2007, HDB SYNTHESIZING QUA; Schmied V, 2013, WOMEN BIRTH, V26, P167, DOI 10.1016/j.wombi.2013.02.006; Shafiei T, 2015, MIDWIFERY, V31, P671, DOI 10.1016/j.midw.2015.03.011; Smith MV, 2009, GEN HOSP PSYCHIAT, V31, P155, DOI 10.1016/j.genhosppsych.2008.10.002; Stapleton H, 2013, WOMEN BIRTH, V26, P260, DOI 10.1016/j.wombi.2013.07.004; Templeton L, 2003, ETHNIC HEALTH, V8, P207, DOI 10.1080/1355785032000136425; Tobin C, 2015, J IMMIGR MINOR HEALT, V17, P1019, DOI 10.1007/s10903-014-0041-8; Vogel DL, 2003, J COUNS PSYCHOL, V50, P351, DOI 10.1037/0022-0167.50.3.351; Walsh D, 2005, J ADV NURS, V50, P204, DOI 10.1111/j.1365-2648.2005.03380.x; Westall C, 2011, MOTHERHOOD AND POSTNATAL DEPRESSION: NARRATIVES OF WOMEN AND THEIR PARTNERS, P1, DOI 10.1007/978-94-007-1694-0; Woolhouse H, 2015, BJOG-INT J OBSTET GY, V122, P312, DOI 10.1111/1471-0528.12837; Youssef J, 2006, MENT HEALTH RELIG CU, V9, P43, DOI 10.1080/13674670512331335686	70	39	39	3	43	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 15	2017	12	3							e0172385	10.1371/journal.pone.0172385	http://dx.doi.org/10.1371/journal.pone.0172385			27	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EN9HQ	28296887	gold, Green Published			2022-12-27	WOS:000396311700007
J	Ades, F; Senterre, C; Zardavas, D; de Azambuja, E; Popescu, R; Piccart, M				Ades, Felipe; Senterre, Christelle; Zardavas, Dimitrios; de Azambuja, Evandro; Popescu, Razvan; Piccart, Martine			Are life-saving anticancer drugs reaching all patients? Patterns and discrepancies of trastuzumab use in the European Union and the USA	PLOS ONE			English	Article							METASTATIC BREAST-CANCER; ADJUVANT CHEMOTHERAPY; MORTALITY; SURVIVAL; TRENDS; PLUS; DOCETAXEL; HEALTH	Background The development of trastuzumab is considered to be one of the greatest improvements in breast cancer treatment in recent years. This study aims to evaluate changes in the uptake of trastuzumab over the last 12 years and to determine whether its use is proportional to patient needs in the European Union and the USA. Methods Using national registry data, the number of new cases of HER2-positive breast cancer patients per year was estimated. The number of likely trastuzumab treatments per year was estimated using trastuzumab procurement data for each country. Results Western Europe and the USA show increasing procurement level of trastuzumab over the years studied, reaching proportional of use of trastuzumab few years after its marketing authorization in the early 2000's. After the approval in the adjuvant setting, in the year 2006, it was observed underuse of trastuzumab given the increase of the number of patients in need of treatment. Proportional use was shortly met after a couple of years. Few countries in Eastern Europe acquired the needed quantity of trastuzumab, with procurement levels starting to increase only after approval in the adjuvant setting in 2006. Conclusion Significant differences in trastuzumab procurement are observed between Western Europe, the USA and Eastern Europe, with the latter geographic region acquiring insufficient amounts of the drug required to treat all patients in need.	[Ades, Felipe; de Azambuja, Evandro; Piccart, Martine] Univ Libre Bruxelles, Inst Jules Bordet, Dept Med Oncol, Brussels, Belgium; [Ades, Felipe] Hosp Israelita Albert Einstein, Ctr Oncol & Hematol, Sao Paulo, Brazil; [Senterre, Christelle] Univ Libre Bruxelles, Sch Publ Hlth, Res Ctr Epidemiol Biostat & Clin Res, Brussels, Belgium; [Zardavas, Dimitrios] Breast Int Grp Headquarters BIG Aisbl, Brussels, Belgium; [Popescu, Razvan] Hirslanden Clin Aarau, Dept Med Oncol, Aarau, Switzerland	Institut Jules Bordet; Universite Libre de Bruxelles; Hospital Israelita Albert Einstein; Universite Libre de Bruxelles; Breast International Group	Ades, F (corresponding author), Univ Libre Bruxelles, Inst Jules Bordet, Dept Med Oncol, Brussels, Belgium.	felipeades@gmail.com	Popescu, Razvan/AAP-9418-2021	de Azambuja, Evandro/0000-0001-9501-4509; Ades, Felipe/0000-0002-6074-6133	IMS Health; ESMO Head Office, ESMO Executive Board and ESMO National Representatives	IMS Health; ESMO Head Office, ESMO Executive Board and ESMO National Representatives	ESMO financed the acquisition of the trastuzumab procurement data from IMS Health.; We would like to express our sincere gratitude to the ESMO Head Office, ESMO Executive Board and ESMO National Representatives for their scientific input, and their logistical and financial support for the acquisition of the IMS database. We extend our gratitude to Carolyn Straehle for the valuable language editing support.	Abe O, 2005, LANCET, V365, P1687, DOI 10.1016/s0140-6736(05)66544-0; Ades F, 2013, ANN ONCOL, V24, P2897, DOI 10.1093/annonc/mdt352; Ades F, 2014, EUR J CANCER, V50, P3089, DOI 10.1016/j.ejca.2014.09.011; Albain K, 2012, LANCET, V379, P432, DOI 10.1016/S0140-6736(11)61625-5; [Anonymous], 2008, CYPRUS CANSER REGIST; [Anonymous], 2008, NATIONAL HEALTH STAT; Arnold M, 2013, EUR J CANCER OXF ENG; Autier P, 2010, BMJ-BRIT MED J, V341, DOI 10.1136/bmj.c3620; Bartsch R, 2007, J CLIN ONCOL, V25, P3853, DOI 10.1200/JCO.2007.11.9776; Baselga J, 2012, LANCET, V379, P633, DOI 10.1016/S0140-6736(11)61847-3; Baselga J, 2012, NEW ENGL J MED, V366, P109, DOI 10.1056/NEJMoa1113216; Bosetti C, 2013, ANN ONCOL, V24, P2657, DOI 10.1093/annonc/mdt301; Davies C, 2011, LANCET, V378, P771, DOI 10.1016/S0140-6736(11)60993-8; Dawood S, 2010, J CLIN ONCOL, V28, P92, DOI 10.1200/JCO.2008.19.9844; De Angelis R, 2014, LANCET ONCOL, V15, P23, DOI 10.1016/S1470-2045(13)70546-1; Edwards BK, 2013, CANCER; Finucane MM, LANCET, V12, P557; Gelmon Karen A, 2004, Clin Breast Cancer, V5, P52, DOI 10.3816/CBC.2004.n.010; Joensuu H, 2006, NEW ENGL J MED, V354, P809, DOI 10.1056/NEJMoa053028; Joensuu H, 2009, J CLIN ONCOL, V27, P5685, DOI 10.1200/JCO.2008.21.4577; Karim-Kos HE, 2008, EUR J CANCER, V44, P1345, DOI 10.1016/j.ejca.2007.12.015; Kaufman B, 2009, J CLIN ONCOL, V27, P5529, DOI 10.1200/JCO.2008.20.6847; Leopold C, 2013, HEALTH POLICY, V113, P313, DOI 10.1016/j.healthpol.2013.09.018; Lichtenberg Frank R, 2005, Int J Health Care Finance Econ, V5, P47, DOI 10.1007/s10754-005-6601-7; Luengo-Fernandez R, 2013, LANCET ONCOL, V14, P1165, DOI 10.1016/S1470-2045(13)70442-X; Mackenbach JP, 2013, LANCET, V381, P1125, DOI 10.1016/S0140-6736(12)62082-0; Moss SM, 1999, LANCET, V353, P1909, DOI 10.1016/S0140-6736(98)07412-1; Munro AJ, 2014, BRIT MED BULL, V110, P5, DOI 10.1093/bmb/ldu009; Neyt MJ, 2005, INT J TECHNOL ASSESS, V21, P132, DOI 10.1017/S0266462305050178; Nystrom L, 2002, LANCET, V359, P909, DOI 10.1016/S0140-6736(02)08020-0; Perou CM, 2000, NATURE, V406, P747, DOI 10.1038/35021093; Piccart-Gebhart MJ, 2005, NEW ENGL J MED, V353, P1659, DOI 10.1056/NEJMoa052306; Romond EH, 2005, NEW ENGL J MED, V353, P1673, DOI 10.1056/NEJMoa052122; Slamon D, 2011, NEW ENGL J MED, V365, P1273, DOI 10.1056/NEJMoa0910383; Slamon DJ, 2001, NEW ENGL J MED, V344, P783, DOI 10.1056/NEJM200103153441101; Spielmann M, 2009, J CLIN ONCOL, V27, P6129, DOI 10.1200/JCO.2009.23.0946; Staff DI, US CENSUS BUREAU HEA; Tripathy D, 2004, J CLIN ONCOL, V22, P1063, DOI 10.1200/JCO.2004.06.557; VANDIJCK JAAM, 1994, J NATL CANCER I, V86, P934, DOI 10.1093/jnci/86.12.934; Verdecchia A, 2007, LANCET ONCOL, V8, P784, DOI 10.1016/S1470-2045(07)70246-2; von Minckwitz G, 2011, EUR J CANCER, V47, P2273, DOI 10.1016/j.ejca.2011.06.021; von Minckwitz G, 2009, J CLIN ONCOL, V27, P1999, DOI 10.1200/JCO.2008.19.6618; Vostakolaei FA, 2011, EUR J PUBLIC HEALTH, V21, P573, DOI 10.1093/eurpub/ckq120; Walpole SC, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-439; Wolff AC, 2013, J CLIN ONCOL, V31, P3997, DOI 10.1200/JCO.2013.50.9984	45	8	8	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 14	2017	12	3							e0172351	10.1371/journal.pone.0172351	http://dx.doi.org/10.1371/journal.pone.0172351			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN6DM	28291814	Green Submitted, Green Published, gold			2022-12-27	WOS:000396094700005
J	Leung, PWL; Chan, JKY; Chen, LH; Lee, CC; Hung, SF; Ho, TP; Tang, CP; Moyzis, RK; Swanson, JM				Leung, Patrick Wing-leung; Chan, Janice Ka Yan; Chen, Lu Hua; Lee, Chi Chiu; Hung, Se Fong; Ho, Ting Pong; Tang, Chun Pan; Moyzis, Robert K.; Swanson, James M.			Family-based association study of DRD4 gene in methylphenidate-responded Attention Deficit/Hyperactivity Disorder	PLOS ONE			English	Article							DEFICIT-HYPERACTIVITY DISORDER; GENOME-WIDE ASSOCIATION; DOPAMINE-D4 RECEPTOR LOCUS; ALLELE FREQUENCIES; MOLECULAR-GENETICS; CHINESE CHILDREN; 2-REPEAT ALLELE; MATTER VOLUME; ADHD; PREVALENCE	The 48-basepair (48-bp) variable number tandem repeat (VNTR) polymorphism in exon 3 of the dopamine receptor D4 gene (DRD4) is implicated in the etiology of attention-deficit/ hyperactivity disorder (ADHD). In particular, ADHD in European-ancestry population is associated with an increased prevalence of the 7-repeat (7R) allele of the exon 3 VNTR. However, it is intriguing to note that the 7R allele has been found to be of very low prevalence in the Chinese general population. In a previous case-control study, our research team had found that the 7R allele was similarly absent in Chinese ADHD children in Hong Kong. Instead, there was an increased prevalence of the 2R allele in Chinese ADHD children. Interestingly, in Asian samples, the 2R allele had been found to be an evolutionary derivative of the 7R allele with equivalent biochemical functionality. So, the finding of an association between ADHD and 2R allele in Chinese population does not exactly contradict the original 7R allele finding in European-ancestry population. However, given the potential pitfall of population stratification in the previous case-control design, this current study tested the 2R allele and ADHD association using a methodologically more rigorous family-based approach on 33 Chinese ADHD probands who had favorable clinical responses to stimulant medication (methylphenidate). Haplotype Relative Risk (HRR) analysis and Transmission Disequilibrium Test (TDT) both showed a significant preferential transmission of the 2R allele from the biological parents to ADHD probands (p(one-tailed) = 0.038, OR = 2.04; p(one-tailed) = 0.048, OR = 2.29, respectively). A second hypothesis speculates that it is the deviation, including 7R and 2R alleles, from the conserved ancestral 4R allele which confers risk to ADHD. Thus, a preferential transmission of non-4R alleles, against the 4R allele, from biological parents to their ADHD probands is predicted. Both HRR analysis and TDT confirmed such prediction (p(one-tailed) = 0.029, OR = 2.07; p(one-tailed) = 0.032, OR = 2.43, respectively). This study re-confirmed the original finding of a previous study that in Chinese population, the 2R allele of the DRD4 exon 3 VNTR was related to ADHD. This endorses the general thesis that DRD4 exon 3 VNTR polymorphism is related to ADHD, despite that the exact length or number of repeats of the associated alleles varies across ethnicity. This in turn supports the dopamine dysregulation theory of ADHD.	[Leung, Patrick Wing-leung; Chen, Lu Hua] Chinese Univ Hong Kong, Dept Psychol, Hong Kong, Hong Kong, Peoples R China; [Chan, Janice Ka Yan] Hosp Author, Duchess Kent Childrens Hosp Sandy Bay, Hong Kong, Hong Kong, Peoples R China; [Chen, Lu Hua; Ho, Ting Pong] Univ Hong Kong, Dept Psychiat, Hong Kong, Hong Kong, Peoples R China; [Lee, Chi Chiu; Tang, Chun Pan] Kwai Chung Hosp, Hong Kong, Hong Kong, Peoples R China; [Hung, Se Fong] Chinese Univ Hong Kong, Dept Psychiat, Hong Kong, Hong Kong, Peoples R China; [Moyzis, Robert K.] Univ Calif Irvine, Dept Biol Chem, Irvine, CA 92717 USA; [Moyzis, Robert K.; Swanson, James M.] Univ Calif Irvine, Dept Pediat, Irvine, CA 92717 USA	Chinese University of Hong Kong; University of Hong Kong; Chinese University of Hong Kong; University of California System; University of California Irvine; University of California System; University of California Irvine	Leung, PWL (corresponding author), Chinese Univ Hong Kong, Dept Psychol, Hong Kong, Hong Kong, Peoples R China.	pleung@cuhk.edu.hk			General Research Fund (GRF); Research Grants Council (RGC) in Hong Kong [RGC 449511]	General Research Fund (GRF); Research Grants Council (RGC) in Hong Kong	This study is funded by a General Research Fund (GRF) grant to the first/corresponding author, Patrick WL Leung, from the Research Grants Council (RGC) (RGC 449511) in Hong Kong (http://www.ugc.edu .hk/eng/rgc/index.htm). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This study is funded by a General Research Fund (GRF) grant to the first/corresponding author, Patrick WL Leung, from the Research Grants Council (RGC) (RGC 449511) in Hong Kong.	Akutagava-Martins GC, 2016, EXPERT REV NEUROTHER, V16, P145, DOI 10.1586/14737175.2016.1130626; Anderson JC, 1996, LANCET, V348, P73, DOI 10.1016/S0140-6736(05)64598-9; ASGHARI V, 1995, J NEUROCHEM, V65, P1157, DOI 10.1046/j.1471-4159.1995.65031157.x; Brookes KJ, 2005, BMC MED GENET, V6, DOI 10.1186/1471-2350-6-31; Chang FM, 1996, HUM GENET, V98, P91, DOI 10.1007/s004390050166; Cheuk DKL, 2006, AM J MED GENET B, V141B, P907, DOI 10.1002/ajmg.b.30397; Ding YC, 2002, P NATL ACAD SCI USA, V99, P309, DOI 10.1073/pnas.012464099; EWENS WJ, 1995, AM J HUM GENET, V57, P455; Faraone SV, 2005, BIOL PSYCHIAT, V57, P1313, DOI 10.1016/j.biopsych.2004.11.024; Ferreira MAR, 2008, NAT GENET, V40, P1056, DOI 10.1038/ng.209; Gizer IR, 2009, HUM GENET, V126, P51, DOI 10.1007/s00439-009-0694-x; Grady DL, 2003, MOL PSYCHIATR, V8, P536, DOI 10.1038/sj.mp.4001350; Hinney A, 2011, AM J MED GENET B, V156B, P888, DOI 10.1002/ajmg.b.31246; Kaiser R, 2002, CLIN BIOCHEM, V35, P49, DOI 10.1016/S0009-9120(02)00273-4; Kidd KK, 2014, HUM GENET, V133, P431, DOI 10.1007/s00439-013-1386-0; LaHoste GJ, 1996, MOL PSYCHIATR, V1, P121; Lesch KP, 2008, J NEURAL TRANSM, V115, P1573, DOI 10.1007/s00702-008-0119-3; Leung PWL, 2008, EUR CHILD ADOLES PSY, V17, P452, DOI 10.1007/s00787-008-0687-7; Leung PW, 1996, BRIT J PSYCHIAT, V168, P486, DOI 10.1192/bjp.168.4.486; Leung PWL, 2005, AM J MED GENET B, V133B, P54, DOI 10.1002/ajmg.b.30129; Li DW, 2006, HUM MOL GENET, V15, P2276, DOI 10.1093/hmg/ddl152; Li YL, 2013, PSYCHIAT RES, V205, P143, DOI 10.1016/j.psychres.2012.08.016; Li Z, 2014, PSYCHIAT RES, V219, P10, DOI 10.1016/j.psychres.2014.05.005; Lidow MS, 1998, SYNAPSE, V28, P10, DOI 10.1002/(SICI)1098-2396(199801)28:1<10::AID-SYN2>3.0.CO;2-F; McAlonan GM, 2007, PSYCHIAT RES-NEUROIM, V154, P171, DOI 10.1016/j.pscychresns.2006.09.006; McAlonan GM, 2009, BRIT J PSYCHIAT, V194, P123, DOI 10.1192/bjp.bp.108.051359; Mick E, 2010, J AM ACAD CHILD PSY, V49, P898, DOI 10.1016/j.jaac.2010.02.014; Neale BM, 2010, J AM ACAD CHILD PSY, V49, P906, DOI 10.1016/j.jaac.2010.06.007; Neale BM, 2010, J AM ACAD CHILD PSY, V49, P884, DOI 10.1016/j.jaac.2010.06.008; Neale BM, 2008, AM J MED GENET B, V147B, P1337, DOI 10.1002/ajmg.b.30866; Noain D, 2006, EUR J NEUROSCI, V24, P2429, DOI 10.1111/j.1460-9568.2006.05148.x; Oak JN, 2000, EUR J PHARMACOL, V405, P303, DOI 10.1016/S0014-2999(00)00562-8; Polanczyk G, 2007, AM J PSYCHIAT, V164, P942, DOI 10.1176/appi.ajp.164.6.942; Qian Q, 2004, AM J MED GENET B, V128B, P84, DOI 10.1002/ajmg.b.30079; Qian QJ, 2007, AM J MED GENET B, V144B, P200, DOI 10.1002/ajmg.b.30422; Reist C, 2007, AM J MED GENET B, V144B, P453, DOI 10.1002/ajmg.b.30473; Riethman HC, 2001, NATURE, V409, P948, DOI 10.1038/35057180; Shaffer D, 2000, J AM ACAD CHILD PSY, V39, P28, DOI 10.1097/00004583-200001000-00014; SPIELMAN RS, 1993, AM J HUM GENET, V52, P506; Stergiakouli E, 2012, AM J PSYCHIAT, V169, P186, DOI 10.1176/appi.ajp.2011.11040551; Tahir E, 2000, MOL PSYCHIATR, V5, P396, DOI 10.1038/sj.mp.4000744; Turic D, 2010, PHARMACOGEN PERS MED, V3, P61, DOI 10.2147/PGPM.S6800; Wang E, 2004, AM J HUM GENET, V74, P931, DOI 10.1086/420854; Zeggini E, 2008, NAT GENET, V40, P638, DOI 10.1038/ng.120	44	9	9	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 10	2017	12	3							e0173748	10.1371/journal.pone.0173748	http://dx.doi.org/10.1371/journal.pone.0173748			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN6CJ	28282463	Green Published, gold			2022-12-27	WOS:000396091800078
J	Okuda-Tanino, A; Sugawara, D; Tashiro, T; Iwashita, M; Obara, Y; Moriya, T; Tsushima, C; Saigusa, D; Tomioka, Y; Ishii, K; Nakahata, N				Okuda-Tanino, Asa; Sugawara, Daiki; Tashiro, Takumi; Iwashita, Masaya; Obara, Yutaro; Moriya, Takahiro; Tsushima, Chisato; Saigusa, Daisuke; Tomioka, Yoshihisa; Ishii, Kuniaki; Nakahata, Norimichi			Licochalcones extracted from Glycyrrhiza inflata inhibit platelet aggregation accompanied by inhibition of COX-1 activity	PLOS ONE			English	Article							THROMBOXANE A(2) RECEPTOR; ENDOPEROXIDE-H SYNTHASE-1; ANTIINFLAMMATORY ACTIVITY; CYCLOOXYGENASE; ACTIVATION; ANTAGONIST; LICORICE; CELLS	Licochalcones extracted from Glycyrrhiza inflata are known to have a variety of biological properties such as anti-inflammatory, anti-bacterial, and anti-tumor activities, but their action on platelet aggregation has not yet been reported. Therefore, in this study we investigated the effects of licochalcones on platelet aggregation. Collagen and U46619, a thromboxane A(2) receptor agonist, caused rabbit platelet aggregation, which was reversed by pretreatment with licochalcones A, C and D in concentration-dependent manners. Among these compounds, licochalcone A caused the most potent inhibitory effect on collagen-induced platelet aggregation. However, the licochalcones showed marginal inhibitory effects on thrombin or ADP-induced platelet aggregation. In addition to rabbit platelets, licochalcone A attenuated collagen-induced aggregation in human platelets. Because licochalcone A also inhibited arachidonic acid-induced platelet aggregation and production of thromboxane A2 induced by collagen in intact platelets, we further examined the direct interaction of licochalcone A with cyclooxygenase (COX)-1. As expected, licochalcone A caused an inhibitory effect on both COX-1 and COX-2 in vitro. Regarding the effect of licochalcone A on COX-1 enzyme reaction kinetics, although licochalcone A showed a stronger inhibition of prostaglandin E-2 synthesis induced by lower concentrations of arachidonic acid, Vmax values in the presence or absence of licochalcone A were comparable, suggesting that it competes with arachidonic acid at the same binding site on COX-1. These results suggest that licochalcones inhibit collagen-induced platelet aggregation accompanied by inhibition of COX-1 activity.	[Okuda-Tanino, Asa; Iwashita, Masaya; Obara, Yutaro; Moriya, Takahiro; Tsushima, Chisato; Nakahata, Norimichi] Tohoku Univ, Grad Sch Pharmaceut Sci, Dept Cellular Signaling, Sendai, Miyagi, Japan; [Sugawara, Daiki; Tashiro, Takumi; Saigusa, Daisuke; Tomioka, Yoshihisa] Tohoku Univ, Grad Sch Pharmaceut Sci, Dept Oncol Pharm Practice & Sci, Sendai, Miyagi, Japan; [Obara, Yutaro; Ishii, Kuniaki] Yamagata Univ, Dept Pharmacol, Sch Med, Yamagata, Japan	Tohoku University; Tohoku University; Yamagata University	Obara, Y (corresponding author), Tohoku Univ, Grad Sch Pharmaceut Sci, Dept Cellular Signaling, Sendai, Miyagi, Japan.; Obara, Y (corresponding author), Yamagata Univ, Dept Pharmacol, Sch Med, Yamagata, Japan.	obaray@med.id.yamagata-u.ac.jp		Saigusa, Daisuke/0000-0001-9484-9870	Minophagen Pharmaceutical Co. Ltd (Shinjuku, Japan); Grants-in-Aid for Scientific Research [26670118] Funding Source: KAKEN	Minophagen Pharmaceutical Co. Ltd (Shinjuku, Japan); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported in part by Minophagen Pharmaceutical Co. Ltd (Shinjuku, Japan). There was no additional external funding received for this study. The funder had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Armstrong PC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020062; Cao HM, 2011, J PHARMACEUT BIOMED, V54, P230, DOI 10.1016/j.jpba.2010.08.001; Choi J, 2011, MOL INTERV, V11, P111, DOI 10.1124/mi.11.2.9; Cui YM, 2008, Z NATURFORSCH C, V63, P361; De la Cruz JP, 2002, BRIT J PHARMACOL, V137, P1082, DOI 10.1038/sj.bjp.0704963; Fontana P, 2011, J THROMB HAEMOST, V9, P2109, DOI 10.1111/j.1538-7836.2011.04446.x; Friis-Moller A, 2002, PLANTA MED, V68, P416, DOI 10.1055/s-2002-32087; Funakoshi-Tago M, 2010, INT IMMUNOPHARMACOL, V10, P562, DOI 10.1016/j.intimp.2010.02.003; Funakoshi-Tago M, 2009, MOL PHARMACOL, V76, P745, DOI 10.1124/mol.109.057448; Grewal S, 2003, J CELL SCI, V116, P2303, DOI 10.1242/jcs.00446; Iwashita M, 2007, EUR J PHARMACOL, V570, P38, DOI 10.1016/j.ejphar.2007.05.073; Kim JK, 2010, J MOL MED, V88, P829, DOI 10.1007/s00109-010-0625-2; Kim YH, 2010, BIOCHEM PHARMACOL, V80, P1152, DOI 10.1016/j.bcp.2010.07.006; Mauricio I, 1997, BIOCHEM BIOPH RES CO, V235, P259, DOI 10.1006/bbrc.1997.6735; McNicol A, 1997, J PHARMACOL EXP THER, V281, P861; Mori K, 2010, PHYTOMEDICINE, V17, P1082, DOI 10.1016/j.phymed.2010.05.004; MORITA I, 1995, J BIOL CHEM, V270, P10902, DOI 10.1074/jbc.270.18.10902; Moroi M, 2004, THROMB RES, V114, P221, DOI 10.1016/j.thromres.2004.06.046; Nagatomo T, 2004, PHARMACOL THERAPEUT, V104, P59, DOI 10.1016/j.pharmthera.2004.08.005; NAITO J, 1983, EUR J PHARMACOL, V91, P41, DOI 10.1016/0014-2999(83)90359-X; Nakahata N, 2008, PHARMACOL THERAPEUT, V118, P18, DOI 10.1016/j.pharmthera.2008.01.001; Nakatani K, 2002, BIOCHEM PHARMACOL, V63, P73, DOI 10.1016/S0006-2952(01)00810-3; Nieswandt B, 2009, J THROMB HAEMOST, V7, P206, DOI 10.1111/j.1538-7836.2009.03370.x; Park HG, 2012, J NUTR BIOCHEM, V23, P759, DOI 10.1016/j.jnutbio.2011.03.021; Rivera J, 2009, HAEMATOL-HEMATOL J, V94, P700, DOI 10.3324/haematol.2008.003178; Song NR, 2015, INT J MOL SCI, V16, P4453, DOI 10.3390/ijms16034453; Surin WR, 2008, THROMB RES, V122, P786, DOI 10.1016/j.thromres.2007.10.005; Thuresson ED, 2001, J BIOL CHEM, V276, P10347, DOI 10.1074/jbc.M009377200; Ting HJ, 2010, ACTA PHARMACOL SIN, V31, P150, DOI 10.1038/aps.2009.195; Xu YB, 2010, J GENET GENOMICS, V37, P117, DOI 10.1016/S1673-8527(09)60030-8; Yacoub D, 2006, J BIOL CHEM, V281, P30024, DOI 10.1074/jbc.M604504200	31	16	17	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 10	2017	12	3							e0173628	10.1371/journal.pone.0173628	http://dx.doi.org/10.1371/journal.pone.0173628			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN6CJ	28282426	Green Submitted, gold, Green Published			2022-12-27	WOS:000396091800058
J	Walsh, NM; Wuthrich, M; Wang, HF; Klein, B; Hull, CM				Walsh, Naomi M.; Wuthrich, Marcel; Wang, Huafeng; Klein, Bruce; Hull, Christina M.			Characterization of C-type lectins reveals an unexpectedly limited interaction between Cryptococcus neoformans spores and Dectin-1	PLOS ONE			English	Article							BETA-GLUCAN RECEPTOR; MEDIATED PHAGOCYTOSIS; HOST-DEFENSE; SCAVENGER RECEPTORS; RECOGNITION; MACROPHAGES; ACTIVATION; DIFFERENTIATION; MECHANISMS; REDUNDANCY	Phagocytosis by innate immune cells is an important process for protection against multiple pathologies and is particularly important for resistance to infection. However, phagocytosis has also been implicated in the progression of some diseases, including the dissemination of the human fungal pathogen, Cryptococcus neoformans. Previously, we identified Dectin-1 as a likely phagocytic receptor for C. neoformans spores through the use of soluble components in receptor-ligand blocking experiments. In this study, we used gain-of-function and loss-of-function assays with intact cells to evaluate the in vivo role of Dectin-1 and other C-type lectins in interactions with C. neoformans spores and discovered stark differences in outcome when compared with previous assays. First, we found that non-phagocytic cells expressing Dectin-1 were unable to bind spores and that highly sensitive reporter cells expressing Dectin-1 were not stimulated by spores. Second, we determined that some phagocytes from Dectin-1(-/-) mice interacted with spores differently than wild type (WT) cells, but the effects varied among assays and were modest overall. Third, while we detected small but statistically significant reductions in phagocytosis by primary alveolar macrophages from Dectin-1(-/-) mice compared to WT, we found no differences in survival between WT and Dectin-1(-/-) mice challenged with spores. Further analyses to assess the roles of other C-type lectins and their adapters revealed very weak stimulation of Dectin-2 reporter cells by spores and modest differences in binding and phagocytosis by Dectin-2(-/-) bone marrow-derived phagocytes. There were no discernable defects in binding or phagocytosis by phagocytes lacking Mannose Receptor, Mincle, Card-9, or FcR gamma. Taken together, these results lead to the conclusion that Dectin-1 and other C-type lectins do not individually play a major roles in phagocytosis and innate defense by phagocytes against C. neoformans spores and highlight challenges in using soluble receptor/ligand blocking experiments to recapitulate biologically relevant interactions.	[Walsh, Naomi M.; Hull, Christina M.] Univ Wisconsin, Sch Med & Publ Hlth, Dept Biomol Chem, Madison, WI 53706 USA; [Wuthrich, Marcel; Wang, Huafeng; Klein, Bruce; Hull, Christina M.] Univ Wisconsin, Sch Med & Publ Hlth, Dept Med Microbiol & Immunol, Madison, WI 53706 USA; [Klein, Bruce] Univ Wisconsin, Sch Med & Publ Hlth, Dept Pediat, Madison, WI USA	University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison	Hull, CM (corresponding author), Univ Wisconsin, Sch Med & Publ Hlth, Dept Biomol Chem, Madison, WI 53706 USA.	cmhull@wisc.edu			NIH [R01AI089370, R01AI035681, R01AI040996, R01AI93553]; NIH National Research Service Award [T32 GM07215]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI093553] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007215] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH National Research Service Award(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by NIH grants R01AI089370 (to CMH), R01AI035681 (to BK), R01AI040996 (to BK), and R01AI93553 (to MW). NW was supported by NIH National Research Service Award T32 GM07215. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alanio A, 2011, MBIO, V2, DOI 10.1128/mBio.00158-11; Astarie-Dequeker C, 1999, INFECT IMMUN, V67, P469, DOI 10.1128/IAI.67.2.469-477.1999; Botts MR, 2010, CURR OPIN MICROBIOL, V13, P437, DOI 10.1016/j.mib.2010.05.003; Botts MR, 2009, EUKARYOT CELL, V8, P595, DOI 10.1128/EC.00352-08; Brown GD, 2002, J EXP MED, V196, P407, DOI 10.1084/jem.20020470; Brown GD, 2003, J EXP MED, V197, P1119, DOI 10.1084/jem.20021890; Brubaker SW, 2015, ANN REV IMMUN    MAR; Casadevall A, 1998, CRYPTOCOCCUS NEOFORM; Court N, 2010, J IMMUNOL, V184, P7057, DOI 10.4049/jimmunol.1000164; Dagenais TRT, 2010, INFECT IMMUN, V78, P823, DOI 10.1128/IAI.00980-09; Deng ZH, 2015, NAT IMMUNOL, V16, P642, DOI 10.1038/ni.3155; DUNNETT CW, 1955, J AM STAT ASSOC, V50, P1096, DOI 10.2307/2281208; Dykstra T, 2011, INNATE IMMUN-LONDON, V17, P388, DOI 10.1177/1753425910374889; Filler SG, 2013, TRENDS MICROBIOL, V21, P389, DOI 10.1016/j.tim.2013.05.006; Fisher RA, 1922, J R STAT SOC, V85, P87, DOI 10.2307/2340521; Fuentes AL, 2011, INT IMMUNOPHARMACOL, V11, P1939, DOI 10.1016/j.intimp.2011.08.005; Giles SS, 2009, INFECT IMMUN, V77, P3491, DOI 10.1128/IAI.00334-09; Ginhoux F, 2014, NAT REV IMMUNOL, V14, P392, DOI 10.1038/nri3671; Graham LM, 2012, J BIOL CHEM, V287, P25964, DOI 10.1074/jbc.M112.384164; Helft J, 2015, IMMUNITY, V42, P1197, DOI 10.1016/j.immuni.2015.05.018; Herre J, 2004, BLOOD, V104, P4038, DOI 10.1182/blood-2004-03-1140; Jozefowski S, 2012, INFLAMM RES, V61, P113, DOI 10.1007/s00011-011-0395-5; Lee Ji Eun, 2012, Environmental Engineering Research, V17, P17; Luther K, 2007, CELL MICROBIOL, V9, P368, DOI 10.1111/j.1462-5822.2006.00796.x; Lutz MB, 1999, J IMMUNOL METHODS, V223, P77, DOI 10.1016/S0022-1759(98)00204-X; McGreal EP, 2006, GLYCOBIOLOGY, V16, P422, DOI 10.1093/glycob/cwj077; Means TK, 2009, J EXP MED, V206, P637, DOI 10.1084/jem.20082109; Nagelkerke SQ, 2014, BLOOD, V124, P3709, DOI 10.1182/blood-2014-05-576835; Nakamura K, 2007, MICROBIOL IMMUNOL, V51, P1115, DOI 10.1111/j.1348-0421.2007.tb04007.x; Nakamura Y, 2015, INFECT IMMUN, V83, P671, DOI 10.1128/IAI.02835-14; Neher JJ, 2013, P NATL ACAD SCI USA, V110, pE4098, DOI 10.1073/pnas.1308679110; Nish S, 2011, IMMUNITY, V34, P629, DOI 10.1016/j.immuni.2011.05.009; Park BJ, 2009, AIDS, V23, P525, DOI 10.1097/QAD.0b013e328322ffac; Perfect JR, 2005, FEMS IMMUNOL MED MIC, V45, P395, DOI 10.1016/j.femsim.2005.06.005; Sabiiti W, 2014, J CLIN INVEST, V124, P2000, DOI 10.1172/JCI72950; Saijo S, 2010, IMMUNITY, V32, P681, DOI 10.1016/j.immuni.2010.05.001; Sathish JG, 2013, NAT REV DRUG DISCOV, V12, P306, DOI 10.1038/nrd3974; Sato K, 2006, J BIOL CHEM, V281, P38854, DOI 10.1074/jbc.M606542200; Sherman F., 1987, LAB COURSE MANUAL ME; Taylor PR, 2007, NAT IMMUNOL, V8, P31, DOI 10.1038/ni1408; Tseng D, 2013, P NATL ACAD SCI USA, V110, P11103, DOI 10.1073/pnas.1305569110; Wang HF, 2014, J IMMUNOL, V192, P1107, DOI 10.4049/jimmunol.1302314; Wuthrich M, 2015, EUR J IMMUNOL, V45, P2542, DOI 10.1002/eji.201545591; Yadav M, 2006, BLOOD, V108, P3168, DOI 10.1182/blood-2006-05-024406; Zhang X, 2009, THE EXPRESSION OF EX	45	22	22	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 10	2017	12	3							e0173866	10.1371/journal.pone.0173866	http://dx.doi.org/10.1371/journal.pone.0173866			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN6CJ	28282442	Green Published, Green Submitted, gold			2022-12-27	WOS:000396091800085
J	Martins, RB; Rocha, LP; Prates, MM; Gagliardi, TB; Biasoli, B; Leite, MJ; Buzatto, G; Hyppolito, MA; Aragon, DC; Tamashiro, E; Valera, FCP; Arruda, E; Anselmo-Lima, WT				Martins, Ronaldo Braganca; Rocha, Lucas Penna; Prates, Mirela Moreira; Gagliardi, Talita Bianca; Biasoli, Balduino; Leite, Marcelo Junqueira; Buzatto, Guilherme; Hyppolito, Miguel Angelo; Aragon, Davi Casale; Tamashiro, Edwin; Pereira Valera, Fabiana Cardoso; Arruda, Eurico; Anselmo-Lima, Wilma Terezinha			Respiratory DNA viruses are undetectable in nasopharyngeal secretions from adenotonsillectomized children	PLOS ONE			English	Article							RHINOVIRUS INFECTION; ADENOVIRUS DNA; HUMAN TONSIL; TISSUES; QUANTITATION; LYMPHOCYTES; PREVALENCE; EPITHELIUM; SYMPTOMS	Respiratory viruses are frequently detected in association with chronic tonsillar hypertrophy in the absence of symptoms of acute respiratory infection (ARI). The present analysis was done in follow-up to a previous clinical study done by this same group. Nasopharyngeal washes (NPWs) were obtained from 83 of 120 individuals at variable times post adenotonsillectomy, in the absence of ARI symptoms. A look back at virus detection results in NPWs from the same 83 individuals at the time of tonsillectomy revealed that 73.5% (61/83) were positive for one or more viruses. The overall frequency of respiratory virus detection in posttonsillectomy NPWs was 58.8%. Rhinovirus (RV) was the agent most frequently detected, in 38 of 83 subjects (45.8%), followed by enterovirus in 7 (8.4%), human metapneumovirus in 6 (7.2%), human respiratory syncytial virus in 3 (3.6%) and human coronavirus in 1 (1.2%). Remarkably, there was no detection of adenovirus (HAdV) or human bocavirus (HBoV) in asymptomatic individuals in follow-up of adenotonsillectomy. In keeping with persistence of respiratory DNA viruses in human tonsils, tonsillectomy significantly reduces asymptomatic shedding of HAdV and HBoV in NPWs.	[Martins, Ronaldo Braganca; Gagliardi, Talita Bianca; Biasoli, Balduino; Arruda, Eurico] Univ Sao Paulo, Sch Med Ribeirao Preto, Dept Cell Biol, Ribeirao Preto, Brazil; [Rocha, Lucas Penna; Prates, Mirela Moreira; Leite, Marcelo Junqueira; Buzatto, Guilherme; Hyppolito, Miguel Angelo; Tamashiro, Edwin; Pereira Valera, Fabiana Cardoso; Anselmo-Lima, Wilma Terezinha] Univ Sao Paulo, Sch Med Ribeirao Preto, Ophthalmol Otorhinolaryngol & Head & Neck Surg, Ribeirao Preto, Brazil; [Aragon, Davi Casale] Univ Sao Paulo, Sch Med Ribeirao Preto, Dept Pediat, Ribeirao Preto, Brazil	Universidade de Sao Paulo; Universidade de Sao Paulo; Universidade de Sao Paulo; Universidade Federal de Sao Paulo (UNIFESP)	Martins, RB (corresponding author), Univ Sao Paulo, Sch Med Ribeirao Preto, Dept Cell Biol, Ribeirao Preto, Brazil.	rb.mj@hotmail.com	Hyppolito, Miguel A/H-5299-2012; Valera, Fabiana Cardoso Pereira/D-3787-2012; Gagliardi, Talita/V-1342-2019; Tamashiro, Edwin/C-5062-2012; Aragon, Davi C/R-6604-2016; Martins, Ronaldo/U-1118-2017	Hyppolito, Miguel A/0000-0001-9688-782X; Valera, Fabiana Cardoso Pereira/0000-0002-6605-5317; Gagliardi, Talita/0000-0003-4953-7135; Tamashiro, Edwin/0000-0002-3153-6292; Aragon, Davi C/0000-0003-1019-3654; Martins, Ronaldo/0000-0002-8902-5962	FAPESP-Sao Paulo Research Foundation [2013/16349-2]	FAPESP-Sao Paulo Research Foundation(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP))	This study was supported by FAPESP-Sao Paulo Research Foundation (Grant No.2013/16349-2).	Alkhalaf MA, 2013, J MED VIROL, V85, P1947, DOI 10.1002/jmv.23678; Arruda E, 1997, J CLIN MICROBIOL, V35, P2864, DOI 10.1128/JCM.35.11.2864-2868.1997; Primo OVB, 2014, INT ARCH OTORHINOLAR, V18, P150, DOI 10.1055/s-0034-1368135; Cook James, 2017, F1000Res, V6, P90, DOI 10.12688/f1000research.10152.1; DEARRUDA E, 1991, J MED VIROL, V34, P38, DOI 10.1002/jmv.1890340107; Flunker G, 1998, MED MICROBIOL IMMUN, V186, P189, DOI 10.1007/s004300050063; Garnett CT, 2009, J VIROL, V83, P2417, DOI 10.1128/JVI.02392-08; Garnett CT, 2002, J VIROL, V76, P10608, DOI 10.1128/JVI.76.21.10608-10616.2002; Jansen RR, 2011, J CLIN MICROBIOL, V49, P2631, DOI 10.1128/JCM.02094-10; Jartti T, 2014, ALLERGY, V69, P658, DOI 10.1111/all.12396; Kapoor A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021362; Lima JT, 2015, AM J RHINOL ALLERGY, V29, P19, DOI 10.2500/ajra.2015.29.4129; Mosser AG, 2005, AM J RESP CRIT CARE, V171, P645, DOI 10.1164/rccm.200407-970OC; Norja P, 2012, J MED VIROL, V84, P1267, DOI 10.1002/jmv.23335; Pitkaranta A, 1998, PEDIATRICS, V102, P291, DOI 10.1542/peds.102.2.291; Pitkaranta A, 2001, CLIN INFECT DIS, V33, P909, DOI 10.1086/322678; Proenca-Modena JL, 2014, J CLIN MICROBIOL, V52, P3030, DOI 10.1128/JCM.00870-14; Proenca-Modena JL, 2014, INT J PEDIATR OTORHI, V78, P1655, DOI 10.1016/j.ijporl.2014.07.015; Proenca-Modena JL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042136; Qiu JM, 2017, CLIN MICROBIOL REV, V30, P43, DOI 10.1128/CMR.00040-16; ROWE WP, 1953, P SOC EXP BIOL MED, V84, P570, DOI 10.3181/00379727-84-20714; van der Zalm MM, 2009, J PEDIATR-US, V154, P396, DOI 10.1016/j.jpeds.2008.08.036; VELTRI RW, 1976, J GEN VIROL, V32, P455, DOI 10.1099/0022-1317-32-3-455; Winther B, 2002, ARCH OTOLARYNGOL, V128, P131, DOI 10.1001/archotol.128.2.131; Zhao H, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048980	25	3	3	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 17	2017	12	3								10.1371/journal.pone.0174188	http://dx.doi.org/10.1371/journal.pone.0174188			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EO5CJ	28306724	Green Published, Green Submitted, gold			2022-12-27	WOS:000396710300025
J	Andrei, JV; Mieila, M; Panait, M				Andrei, Jean Vasile; Mieila, Mihai; Panait, Mirela			The impact and determinants of the energy paradigm on economic growth in European Union	PLOS ONE			English	Article							CARBON EMISSIONS; PANEL-DATA; CONSUMPTION; INCOME; COINTEGRATION; TAXATION; TESTS; GDP	Contemporary economies are strongly reliant on energy and analyzing the determining factors that trigger the changes in energy paradigm and their impact upon economic growth is a topical research subject. Our contention is that energy paradigm plays a major role in achieving the sustainable development of contemporary economies. In order to prove this the panel data methodology of research was employed, namely four panel unit root tests (LLC, IPS, F-ADF and F-PP) aiming to reveal the connections and relevance among 17 variables denoting energy influence on economic development. Moreover, it was introduced a specific indicator to express energy consumption per capita. Our findings extend the classical approach of the changes in energy paradigm and their impact upon economic growth and offer a comprehensive analysis which surpasses the practices and policy decisions in the field.	[Andrei, Jean Vasile] Petr Gas Univ Ploiesti, Dept Business Adm, Ploiesti, Prahova, Romania; [Mieila, Mihai] Valahia Univ Targoviste, Accounting Banking & Finance Dept, Targoviste, Dambovita, Romania; [Panait, Mirela] Petr Gas Univ Ploiesti, Cybernet Econ Informat Finance & Accounting Dept, Ploiesti, Prahova, Romania	Oil & Gas University of Ploiesti; Valahia University of Targoviste; Oil & Gas University of Ploiesti	Andrei, JV (corresponding author), Petr Gas Univ Ploiesti, Dept Business Adm, Ploiesti, Prahova, Romania.	andrei_jeanvasile@yahoo.com	Jean-Vasile, Andrei/A-5270-2011; Panait, Mirela/K-3300-2019	Jean-Vasile, Andrei/0000-0002-8332-6537; Panait, Mirela/0000-0002-5158-753X				Abdullah S, 2014, ENERG ECON, V42, P27, DOI 10.1016/j.eneco.2013.11.013; Akinlo AE, 2008, ENERG ECON, V30, P2391, DOI 10.1016/j.eneco.2008.01.008; Andrei J, 2016, ENERGIES, V9, DOI 10.3390/en9110902; Apergis N, 2010, ENERG POLICY, V38, P650, DOI 10.1016/j.enpol.2009.08.029; Apergis N, 2009, ENERG ECON, V31, P211, DOI 10.1016/j.eneco.2008.09.002; ARELLANO M, 1991, REV ECON STUD, V58, P277, DOI 10.2307/2297968; ARELLANO M, 1995, J ECONOMETRICS, V68, P29, DOI 10.1016/0304-4076(94)01642-D; Asafu-Adjaye J, 2000, ENERG ECON, V22, P615, DOI 10.1016/S0140-9883(00)00050-5; Baltagi B. H., 2005, ECONOMETRIC ANAL PAN; Boboc D, 2017, AMFITEATRU ECON, V19, P315; Caiazza R., 2011, KAYA IDENTITY ANAL D; Carley S, 2011, RENEW SUST ENERG REV, V15, P282, DOI 10.1016/j.rser.2010.08.006; Choi I, 2001, J INT MONEY FINANC, V20, P249, DOI 10.1016/S0261-5606(00)00048-6; Costantini V, 2010, ENERG ECON, V32, P591, DOI 10.1016/j.eneco.2009.09.013; Duro JA, 2006, ENERG ECON, V28, P170, DOI 10.1016/j.eneco.2005.12.004; Dusmanescu D, 2016, ENERGIES, V9, DOI 10.3390/en9090703; ENGLE RF, 1987, ECONOMETRICA, V55, P251, DOI 10.2307/1913236; Esso LJ, 2016, ENERGY, V114, P492, DOI 10.1016/j.energy.2016.08.010; Granger C.W., 2000, Q REV ECON FINANC, V40, P337, DOI DOI 10.1016/S1062-9769(00)00042-9; GRANGER CWJ, 1988, J ECONOMETRICS, V39, P199, DOI 10.1016/0304-4076(88)90045-0; Greene, 2011, ECONOMETRIE; Gutierrez L, 2003, ECON LETT, V80, P105, DOI 10.1016/S0165-1765(03)00066-1; Hannesson R, 2009, INT J ENERGY SECT MA, V3, P157, DOI 10.1108/17506220910970560; Im KS, 2003, J ECONOMETRICS, V115, P53, DOI 10.1016/S0304-4076(03)00092-7; Kao C, 1999, J ECONOMETRICS, V90, P1, DOI 10.1016/S0304-4076(98)00023-2; KRAFT J, 1978, J ENERGY DEV, V3, P401; Lee CC, 2005, ENERG ECON, V27, P415, DOI 10.1016/j.eneco.2005.03.003; Levin A, 2002, J ECONOMETRICS, V108, P1, DOI 10.1016/S0304-4076(01)00098-7; Maddala GS, 1999, OXFORD B ECON STAT, V61, P631, DOI 10.1111/1468-0084.0610s1631; Mehrara M, 2007, ENERG POLICY, V35, P2939, DOI 10.1016/j.enpol.2006.10.018; Nica Elvira, 2015, J SELF GOVERNANCE MA, V3, P24; Oh W, 2004, J POLICY MODEL, V26, P973, DOI 10.1016/j.jpolmod.2004.06.003; Ozturk I, 2010, ENERG POLICY, V38, P4422, DOI 10.1016/j.enpol.2010.03.071; Pani R, 2013, ENERG POLICY, V52, P639, DOI 10.1016/j.enpol.2012.10.024; Pedroni P, 2000, ADV ECONOMETRICS, V15, P93; Pedroni P, 2004, ECON THEOR, P653; Pesaran MH, 1999, J AM STAT ASSOC, V94, P621, DOI 10.2307/2670182; Pirlogea C, 2012, RENEW SUST ENERG REV, V16, P5718, DOI 10.1016/j.rser.2012.06.010; Popescu Gheorghe H, 2015, J SELF GOV MANAG EC, V3, P66; Richmond AK, 2006, ECOL ECON, V56, P176, DOI 10.1016/j.ecolecon.2005.01.011; Richter WF, 2003, EUR ECON REV, V47, P461, DOI 10.1016/S0014-2921(01)00167-2; SAIKKONEN P, 1991, ECONOMET THEOR, V7, P1, DOI 10.1017/S0266466600004217; Soytas U, 2007, ECOL ECON, V62, P482, DOI 10.1016/j.ecolecon.2006.07.009; Soytas U, 2006, J POLICY MODEL, V28, P739, DOI 10.1016/j.jpolmod.2006.02.003; Soytas U, 2009, ECOL ECON, V68, P1667, DOI 10.1016/j.ecolecon.2007.06.014; Tang CF, 2014, QUAL QUANT, V48, P781, DOI 10.1007/s11135-012-9802-4; Wang CH, 2013, ENERGY, V53, P230, DOI 10.1016/j.energy.2013.02.044; Zaman K, 2011, INT J GREEN ENERGY, V8, P820, DOI 10.1080/15435075.2011.602157	48	25	25	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 16	2017	12	3							e0173282	10.1371/journal.pone.0173282	http://dx.doi.org/10.1371/journal.pone.0173282			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EN9KE	28301505	gold, Green Published, Green Submitted			2022-12-27	WOS:000396318300031
J	Arif, S; Thomson, PC; Hernandez-Jover, M; McGill, DM; Warriach, HM; Heller, J				Arif, Shumaila; Thomson, Peter C.; Hernandez-Jover, Marta; McGill, David M.; Warriach, Hassan Mahmood; Heller, Jane			Knowledge, attitudes and practices (KAP) relating to brucellosis in smallholder dairy farmers in two provinces in Pakistan	PLOS ONE			English	Article							RISK-FACTORS; SEROPREVALENCE; CATTLE; LIVESTOCK; HERDS	The present study aimed to assess the extent of knowledge and understanding of brucellosis in smallholder dairy farmers and identify practices at the farm and household level that might pose a risk for humans contracting brucellosis. Between February and June 2015 a cross-sectional study was conducted among smallholder farms (n = 420) in five districts of Punjab and two districts of Sindh province. Farmers were interviewed using a questionnaire to obtain information on farmers' knowledge about brucellosis and the potential risks for contracting the disease that are present for dairy farmers and their families. Logistic regression and ordinal logistic models were used to investigate potential predictors for risky behaviours. The results show almost all farmers (97%) were not aware of the modes of transmission of brucellosis. Relating to risk, the majority (66%) of the farmers' families were reported to consume raw milk and its products, live in shared housing with animals (49%) and not cover hand cuts during contact with animals (74%). All farmers performed at least one risky practice on a regular basis for brucellosis transmission from animal to human. A multivariable analysis highlighted that the respondents with no formal education and those who had not heard of the disease displayed greater risky behaviour. Poor understanding of the disease, presence of multiple risky practices on farm and at the household, and incorrect perception supports the need for an educational awareness program in order to ensure uptake of improved practices.	[Arif, Shumaila; Hernandez-Jover, Marta; Heller, Jane] Charles Sturt Univ, Sch Anim & Vet Sci, Wagga Wagga, NSW, Australia; [Arif, Shumaila; Thomson, Peter C.; Hernandez-Jover, Marta; Heller, Jane] Charles Sturt Univ, Graham Ctr Agr Innovat, Wagga Wagga, NSW, Australia; [Thomson, Peter C.] Univ Sydney, Sch Life & Environm Sci, Camden, Australia; [Thomson, Peter C.; Warriach, Hassan Mahmood] Univ Vet & Anim Sci, ASLP Dairy Project, Lahore, Pakistan; [McGill, David M.] Univ Melbourne, Fac Vet & Agr Sci, Melbourne, Vic, Australia	Charles Sturt University; Charles Sturt University; University of Sydney; University of Veterinary & Animal Science - Pakistan; University of Melbourne	Arif, S (corresponding author), Charles Sturt Univ, Sch Anim & Vet Sci, Wagga Wagga, NSW, Australia.; Arif, S (corresponding author), Charles Sturt Univ, Graham Ctr Agr Innovat, Wagga Wagga, NSW, Australia.	sarif@csu.edu.au	Hernandez-Jover, Marta/F-8688-2016; Heller, Jane/H-9596-2016; Thomson, Peter/V-7290-2019	Heller, Jane/0000-0003-3993-0160; Thomson, Peter/0000-0003-4428-444X; Arif, Shumaila/0000-0002-1103-333X; Hernandez-Jover, Marta/0000-0001-8803-9062; McGill, David/0000-0002-9621-9626	ACIAR (Australian Centre for International Agriculture Research); ACIAR	ACIAR (Australian Centre for International Agriculture Research)(Australian Ctr Intl Agr Res); ACIAR	This study was part of a PhD project by SA, funded by a scholarship from ACIAR (Australian Centre for International Agriculture Research). Field work for this study was supported by the ASLP Dairy Project in Pakistan which is also funded through ACIAR. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abubakkar M, 2011, PAKIATAN VET J, V32, P147; Afzal M, 2009, PAK VET J, V30, P187; Akinci E, 2006, INT J INFECT DIS, V10, P171, DOI 10.1016/j.ijid.2005.02.006; Al-Shamahy HA, 2000, EPIDEMIOL INFECT, V125, P309, DOI 10.1017/S0950268899004458; Ali S, 2013, FOODBORNE PATHOG DIS, V10, P500, DOI 10.1089/fpd.2012.1360; ASLP dairy project, AUSTR PAK AGR SECT L; Bercovich Z, 1998, VET QUART, V20, P81, DOI 10.1080/01652176.1998.9694845; Boschiroli ML, 2001, CURR OPIN MICROBIOL, V4, P58, DOI 10.1016/S1369-5274(00)00165-X; Coelho A.C., 2015, DOMESTIC WILD ANIMAL; Corbel M.J., 2006, BRUCELLOSIS HUMANS A; Dasari S, 2013, ASIAN PAC J TROP MED, V6, P823, DOI 10.1016/S1995-7645(13)60145-5; Diez JG, 2013, J INFECT PUBLIC HEAL, V6, P363, DOI 10.1016/j.jiph.2013.04.008; Doganay Mehmet, 2003, International Journal of Infectious Diseases, V7, P173, DOI 10.1016/S1201-9712(03)90049-X; England T, 2004, PREV VET MED, V63, P63, DOI 10.1016/j.prevetmed.2004.01.009; Ficht TA, 2003, VET MICROBIOL, V92, P213, DOI 10.1016/S0378-1135(02)00367-X; Gul S. T., 2007, Pakistan Veterinary Journal, V27, P145; Holt HR, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-341; Kang'ethe E K, 2007, East Afr Med J, V84, pS96; Kansiime C, 2014, BMC PUBLIC HEALTH, V14, DOI 10.1186/1471-2458-14-242; Kozukeev Turatbek B, 2006, MMWR Suppl, V55, P31; Lindahl E, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0117318; Mai HM, 2012, BMC VET RES, V8, DOI 10.1186/1746-6148-8-144; McDermott J, 2013, REV SCI TECH OIE, V32, P249; Mukhtar F, 2010, J PAK MED ASSOC, V60, P1031; Musallam II, 2015, AM J TROPICAL MED HY; Pappas G, 2006, LANCET INFECT DIS, V6, P91, DOI 10.1016/S1473-3099(06)70382-6; Park MY, 2005, J KOREAN MED SCI, V20, P941, DOI 10.3346/jkms.2005.20.6.941; R Core Team, 2013, R LANG ENV STAT COMP; Sammartino L.E., 2005, CAPACITY BUILDING SU; Schelling E, 2003, PREV VET MED, V61, P279, DOI 10.1016/j.prevetmed.2003.08.004; Sofian M, 2008, INT J INFECT DIS, V12, P157, DOI 10.1016/j.ijid.2007.04.019; World Animal Health Information Database, 2016, LIST COUNTR DIS SIT; Yagupsky P, 2005, EMERG INFECT DIS, V11, P1180, DOI 10.3201/eid1108.041197; YOUNG EJ, 1995, CLIN INFECT DIS, V21, P283, DOI 10.1093/clinids/21.2.283; Zia U., 2011, DAIRY DEV PAKISTAN	35	38	39	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 16	2017	12	3							e0173365	10.1371/journal.pone.0173365	http://dx.doi.org/10.1371/journal.pone.0173365			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN9KE	28301498	Green Published, gold			2022-12-27	WOS:000396318300034
J	Martini, K; Baessler, M; Baumueller, S; Frauenfelder, T				Martini, Katharina; Baessler, Marco; Baumueller, Stephan; Frauenfelder, Thomas			Diagnostic accuracy and added value of dual-energy subtraction radiography compared to standard conventional radiography using computed tomography as standard of reference	PLOS ONE			English	Article							CHEST RADIOGRAPHY; PULMONARY NODULES; PNEUMONIA; ICU	Purpose To retrospectively evaluate diagnostic performance of dual-energy subtraction radiography (DESR) for interpretation of chest radiographs compared to conventional radiography (CR) using computed tomography (CT) as standard of reference. Material and methods A total of 199 patients (75 female, median age 67) were included in this institutional review board (IRB)-approved clinical trial. All patients were scanned in posteroanterior and lateral direction with dual-shot DE-technique. Chest CT was performed within +/- 72 hours. The system provides three types of images: bone weighted-image, soft tissue weighted-image, herein termed as DESR-images, and a standard image, termed CR-image (marked as CR-image). Images were evaluated by two radiologists for presence of inserted life support lines, pneumothorax, pleural effusion, infectious consolidation, interstitial lung changes, tumor, skeletal alterations, soft tissue alterations, aortic or tracheal calcification and pleural thickening. Inter-observer agreement between readers and diagnostic performance were calculated. McNemar's test was used to test for significant differences. Results Mean inter-observer agreement throughout the investigated parameters was higher in DESR images compared to CR-images (k(DESR) = 0.935 vs. k(CR) = 0.858). DESR images provided significantly increased sensitivity compared to CR-images for the detection of infectious consolidations (42% vs. 62%), tumor (46% vs. 57%), interstitial lung changes (69% vs. 87%) and aortic or tracheal calcification (25 vs. 73%) (p<0.05). There were no significant differences in sensitivity for the detection of inserted life support lines, pneumothorax, pleural effusion, skeletal alterations, soft tissue alterations or pleural thickening (p>0.05). Conclusion DESR increases significantly the sensibility without affecting the specificity evaluating chest radiographs, with emphasis on the detection of interstitial lung diseases.	[Martini, Katharina; Baumueller, Stephan; Frauenfelder, Thomas] Univ Zurich Hosp, Inst Diagnost & Intervent Radiol, Zurich, Switzerland; [Martini, Katharina; Baessler, Marco; Baumueller, Stephan; Frauenfelder, Thomas] Univ Zurich, Zurich, Switzerland	University of Zurich; University Zurich Hospital; University of Zurich	Martini, K (corresponding author), Univ Zurich Hosp, Inst Diagnost & Intervent Radiol, Zurich, Switzerland.; Martini, K (corresponding author), Univ Zurich, Zurich, Switzerland.	katharina.martini@usz.ch	Martini, Katharina/AAW-7995-2020; Frauenfelder, Thomas/O-1734-2016	Frauenfelder, Thomas/0000-0002-3295-6619				Canella C, 2011, RADIOLOGY, V258, P199, DOI 10.1148/radiol.10100791; Franquet T, 2001, EUR RESPIR J, V18, P196, DOI 10.1183/09031936.01.00213501; Graat M, 2005, CHEST, V128, P1; Heussel CP, 1999, J CLIN ONCOL, V17, P796, DOI 10.1200/JCO.1999.17.3.796; Hill JR, 2008, CLIN CHEST MED, V29, P59, DOI 10.1016/j.ccm.2007.11.005; Khan AN, 2009, ANN THORAC MED, V4, P75, DOI 10.4103/1817-1737.49416; Kuhlman JE, 2006, RADIOGRAPHICS, V26, P79, DOI 10.1148/rg.261055034; Landis J, 1977, BIOMETRICS, P16; Li F, 2008, AM J ROENTGENOL, V190, P886, DOI 10.2214/AJR.07.2875; Manji F, 2016, QUANT IMAG MED SURG, V6, P1, DOI 10.3978/j.issn.2223-4292.2015.10.09; Martini K, 2016, EUR J RADIOL, V85, P360, DOI 10.1016/j.ejrad.2015.11.036; McMahon H., 2003, RSNA CATEGORICAL COU, VIII, P8; Riel SJv, RADIOLOGY; Rubinowitz AN, 2007, CRIT CARE CLIN, V23, P539, DOI 10.1016/j.ccc.2007.06.001; Shkumat NA, 2008, MED PHYS, V35, P629, DOI 10.1118/1.2828186; Uemura Masahiko, 2005, Radiat Med, V23, P391; Whitman Gary J, 2002, Curr Probl Diagn Radiol, V31, P48, DOI 10.1067/mdr.2002.122856	17	8	9	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 16	2017	12	3							e0174285	10.1371/journal.pone.0174285	http://dx.doi.org/10.1371/journal.pone.0174285			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN9KE	28301584	gold, Green Published, Green Submitted, Green Accepted			2022-12-27	WOS:000396318300132
J	Robinson, JL; Fordyce, JA				Robinson, Jason L.; Fordyce, James A.			Species-free species distribution models describe macroecological properties of protected area networks	PLOS ONE			English	Article							CLIMATE-CHANGE; BIODIVERSITY; CONSERVATION; GEOGRAPHY; RICHNESS; IMPACTS; MANAGEMENT; RESPONSES; FUTURE	Among the greatest challenges facing the conservation of plants and animal species in protected areas are threats from a rapidly changing climate. An altered climate creates both challenges and opportunities for improving the management of protected areas in networks. Increasingly, quantitative tools like species distribution modeling are used to assess the performance of protected areas and predict potential responses to changing climates for groups of species, within a predictive framework. At larger geographic domains and scales, protected area network units have spatial geoclimatic properties that can be described in the gap analysis typically used to measure or aggregate the geographic distributions of species (stacked species distribution models, or S-SDM). We extend the use of species distribution modeling techniques in order to model the climate envelope (or "footprint") of individual protected areas within a network of protected areas distributed across the 48 conterminous United States and managed by the US National Park System. In our approach we treat each protected area as the geographic range of a hypothetical endemic species, then use MaxEnt and 5 uncorrelated BioClim variables to model the geographic distribution of the climatic envelope associated with each protected area unit (modeling the geographic area of park units as the range of a species). We describe the individual and aggregated climate envelopes predicted by a large network of 163 protected areas and briefly illustrate how macroecological measures of geodiversity can be derived from our analysis of the landscape ecological context of protected areas. To estimate trajectories of change in the temporal distribution of climatic features within a protected area network, we projected the climate envelopes of protected areas in current conditions onto a dataset of predicted future climatic conditions. Our results suggest that the climate envelopes of some parks may be locally unique or have narrow geographic distributions, and are thus prone to future shifts away from the climatic conditions in these parks in current climates. In other cases, some parks are broadly similar to large geographic regions surrounding the park or have climatic envelopes that may persist into near-term climate change. Larger parks predict larger climatic envelopes, in current conditions, but on average the predicted area of climate envelopes are smaller in our single future conditions scenario. Individual units in a protected area network may vary in the potential for climate adaptation, and adaptive management strategies for the network should account for the landscape contexts of the geodiversity or climate diversity within individual units. Conservation strategies, including maintaining connectivity, assessing the feasibility of assisted migration and other landscape restoration or enhancements can be optimized using analysis methods to assess the spatial properties of protected area networks in biogeographic and macroecological contexts.	[Robinson, Jason L.] Univ Illinois, Illinois Nat Hist Survey, Prairie Res Inst, Champaign, IL 61820 USA; [Fordyce, James A.] Univ Tennessee, Dept Ecol & Evolutionary Biol, Knoxville, TN USA	Illinois Natural History Survey; University of Illinois System; University of Illinois Urbana-Champaign; University of Tennessee System; University of Tennessee Knoxville	Robinson, JL (corresponding author), Univ Illinois, Illinois Nat Hist Survey, Prairie Res Inst, Champaign, IL 61820 USA.	jrob@illinois.edu		Fordyce, James/0000-0002-2731-0418	University of Tennessee; Illinois Natural History Survey Postdoctoral Fellowship; Illinois Natural History Survey IDOT Further Studies Group	University of Tennessee; Illinois Natural History Survey Postdoctoral Fellowship; Illinois Natural History Survey IDOT Further Studies Group	This study was supported by University of Tennessee graduate student teaching assistantship; Illinois Natural History Survey Postdoctoral Fellowship; Illinois Natural History Survey IDOT Further Studies Group. The funders have had no role in the study design, data collection and analysis or decisions to prepare or publish this manuscript.	Ackerly DD, 2010, DIVERS DISTRIB, V16, P476, DOI 10.1111/j.1472-4642.2010.00654.x; Anderson MG, CONSERVATION BIOLGOY, V29, P680; Anderson MG, 2010, CONSERVING STAGE CLI; [Anonymous], 2011, ECOLOGICAL NICHES GE; Araujo MB, 2005, GLOBAL CHANGE BIOL, V11, P1504, DOI 10.1111/j.1365-2486.2005.01000.x; Bahn V, 2007, GLOBAL ECOL BIOGEOGR, V16, P733, DOI 10.1111/j.1466-8238.2007.00331.x; Bailey RG, 1995, ECOREGIONS ECOSYSTEM, V2; Beier P, 2010, CONSERV BIOL, V24, P701, DOI 10.1111/j.1523-1739.2009.01422.x; Bellard C, 2012, ECOL LETT, V15, P365, DOI 10.1111/j.1461-0248.2011.01736.x; Beyer H.L., 2015, GEOSPATIAL MODELLING; Bjorholm Stine, 2008, BMC Ecology, V8, P11, DOI 10.1186/1472-6785-8-11; Botkin DB, 2007, BIOSCIENCE, V57, P227, DOI 10.1641/B570306; Brown DG, 2016, PROF GEOGR, V58, P369; Cabeza M, 2013, ANIM CONSERV, V16, P381, DOI 10.1111/acv.12070; Cardoso P, 2011, BIOL CONSERV, V144, P2647, DOI 10.1016/j.biocon.2011.07.024; Connor EF, 2013, ECOLOGY, V94, P2403, DOI 10.1890/12-1471.1; CONNOR EF, 1978, ECOL MONOGR, V48, P219, DOI 10.2307/2937300; Distler T, 2015, J BIOGEOGR, V42, P976, DOI 10.1111/jbi.12479; Elith J, 2011, DIVERS DISTRIB, V17, P43, DOI 10.1111/j.1472-4642.2010.00725.x; ESRI, 2011, ARCGIS DESKT REL 10; Faith DP, 1996, BIODIVERS CONSERV, V5, P399, DOI 10.1007/BF00056387; Ferrier S, 2006, J APPL ECOL, V43, P393, DOI 10.1111/j.1365-2664.2006.01149.x; Gill JL, 2015, CONSERV BIOL, V29, P640, DOI 10.1111/cobi.12504; Gillingham PK, 2015, BIOL J LINN SOC, V115, P707, DOI 10.1111/bij.12506; Godsoe W, 2010, SYST BIOL, V59, P298, DOI 10.1093/sysbio/syq005; Godsoe W, 2010, OIKOS, V119, P53, DOI 10.1111/j.1600-0706.2009.17630.x; Gross JE, 2016, CLIMATE CHANGE WILDL; Guay K, 2016, CLIMATE CHANGE WILDL; Guisan A, 2011, J BIOGEOGR, V38, P1433, DOI 10.1111/j.1365-2699.2011.02550.x; Hallfors MH, 2016, ECOL APPL, V26, P1154, DOI 10.1890/15-0926; Hannah L, 2007, FRONT ECOL ENVIRON, V5, P131, DOI 10.1890/1540-9295(2007)5[131:PANIAC]2.0.CO;2; Hansen AJ, 2016, CLIMATE CHANGE WILDL, P480; Heller NE, 2009, BIOL CONSERV, V142, P14, DOI 10.1016/j.biocon.2008.10.006; Hijmans RJ, 2005, INT J CLIMATOL, V25, P1965, DOI 10.1002/joc.1276; Hjort J, 2015, CONSERV BIOL, V29, P630, DOI 10.1111/cobi.12510; Hortal J, 2008, J BIOGEOGR, V35, P1335, DOI 10.1111/j.1365-2699.2008.01955.x; HUNTER ML, 1988, CONSERV BIOL, V2, P375, DOI 10.1111/j.1523-1739.1988.tb00202.x; Keppel G, 2012, GLOBAL ECOL BIOGEOGR, V21, P393, DOI 10.1111/j.1466-8238.2011.00686.x; Koch R, 2017, J NAT CONSERV, V35, P24, DOI 10.1016/j.jnc.2016.11.004; Lise W, 2002, CLIMATIC CHANGE, V55, P429, DOI 10.1023/A:1020728021446; Morelli TL, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0159909; Nadeau CP, 2015, ECOSPHERE, V6, DOI 10.1890/ES15-00069.1; Orme CDL, 2005, NATURE, V436, P1016, DOI 10.1038/nature03850; Parker Charles R., 1998, Insecta Mundi, V12, P227; Parker CR, 2007, SOUTHEAST NAT, V6, P159, DOI 10.1656/1528-7092(2007)6[159:EPMATO]2.0.CO;2; Parker CR, 2000, AQUAT INSECT, V22, P271, DOI 10.1076/0165-0424(200010)22:4;1-Y;FT271; Parmesan C, 2003, NATURE, V421, P37, DOI 10.1038/nature01286; Parmesan C, 2006, ANNU REV ECOL EVOL S, V37, P637, DOI 10.1146/annurev.ecolsys.37.091305.110100; Rodriguez JP, 2007, DIVERS DISTRIB, V13, P243, DOI 10.1111/j.1472-4642.2007.00356.x; Pearson RG, 2003, GLOBAL ECOL BIOGEOGR, V12, P361, DOI 10.1046/j.1466-822X.2003.00042.x; Pearson RG, 2007, J BIOGEOGR, V34, P102, DOI 10.1111/j.1365-2699.2006.01594.x; Phillips SJ, 2008, ECOGRAPHY, V31, P161, DOI 10.1111/j.0906-7590.2008.5203.x; Pineda E, 2009, J ANIM ECOL, V78, P182, DOI 10.1111/j.1365-2656.2008.01471.x; Pottier J, 2013, GLOBAL ECOL BIOGEOGR, V22, P52, DOI 10.1111/j.1466-8238.2012.00790.x; Pouteau R, 2015, DIVERS DISTRIB, V21, P1329, DOI 10.1111/ddi.12374; Ramirez J, 2008, HIGH RESOLUTION DOWN; Robinson JL, 2016, J INSECT CONSERV, V20, P565, DOI 10.1007/s10841-016-9889-3; Schneider RR, 2015, RESERVE DESIGN CLIMA; Scott D, 2004, CLIMATE RES, V27, P105, DOI 10.3354/cr027105; Scott JM, 2010, CONSERV LETT, V3, P91, DOI 10.1111/j.1755-263X.2010.00096.x; Simberloff D.S., 1979, Statistical Ecology Series, V12, P123; Stagl J, 2015, REG ENVIRON CHANGE, V15, P1409, DOI 10.1007/s10113-014-0704-y; Thomas CD, 2015, BIOL J LINN SOC, V115, P718, DOI 10.1111/bij.12510; TOBLER WR, 1970, ECON GEOGR, V46, P234, DOI 10.2307/143141; Trotta-Moreu N, 2010, ENVIRON ENTOMOL, V39, P42, DOI 10.1603/EN08179; Virah-Sawmy M, 2016, LANDSCAPE ECOL, V31, P637, DOI 10.1007/s10980-015-0269-2; Walther GR, 2002, NATURE, V416, P389, DOI 10.1038/416389a; Warren DL, 2014, TRENDS ECOL EVOL, V29, P572, DOI 10.1016/j.tree.2014.08.003; Warren DL, 2012, TRENDS ECOL EVOL, V27, P497, DOI 10.1016/j.tree.2012.03.010; Wiens JA, 2010, CONSERV BIOL, V24, P51, DOI 10.1111/j.1523-1739.2009.01409.x	70	3	3	2	35	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 16	2017	12	3							e0173443	10.1371/journal.pone.0173443	http://dx.doi.org/10.1371/journal.pone.0173443			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN9KE	28301488	gold, Green Submitted, Green Published			2022-12-27	WOS:000396318300038
J	Sakipova, Z; Wong, NSH; Bekezhanova, T; Sadykova; Shukirbekova, A; Boylan, F				Sakipova, Zuriyadda; Wong, Nikki Siu Hai; Bekezhanova, Tolkyn; Sadykova; Shukirbekova, Alma; Boylan, Fabio			Quantification of santonin in eight species of Artemisia from Kazakhstan by means of HPLC-UV: Method development and validation	PLOS ONE			English	Article							EXTRACT	Santonin, a powerful anthelmintic drug that was formely used to treat worms, is Artemisia cina's main constituent. However, due to its toxicity to humans, it is no longer in use. Kazakhstan is looking to introduce this plant as an anthelmintic drug for veterinary purposes, despite the known toxic properties of the santonin. The objective of this study was to develop a fast and specific method for the identification of santonin and its precise quantitation using HPLC-UV in order to avoid unnecessary intoxication, which is paramount for the development of veterinary medicines. The results obtained showed that santonin appears at around 5.7 minutes in this very reliable HPLC method. The validation of the method was performed by the investigation of parameters such as precision, accuracy, reproducibility and recovery. The method was used to identify and quantify santonin in leaves of A. scoparia, A. foetida, A. gmelinni, A. schrenkiana, A. frigida, A. sublesingiana, A terra-albae, and A. absinthium from Kazakhstan as well as in three different extracts of leaves of A. cina. This study has provided a faster and simpler method for the identification and quantification of this compound in other species of Artemisia of economic importance.	[Sakipova, Zuriyadda; Bekezhanova, Tolkyn; Sadykova; Shukirbekova, Alma] Kazakh Natl Med Univ, Alma Ata, Kazakhstan; [Wong, Nikki Siu Hai; Boylan, Fabio] Trinity Coll Dublin, Trinity Biomed Sci Inst, Sch Pharm & Pharmaceut Sci, Dublin, Ireland	Asfendiyarov Kazakh National Medical University; Trinity College Dublin	Boylan, F (corresponding author), Trinity Coll Dublin, Trinity Biomed Sci Inst, Sch Pharm & Pharmaceut Sci, Dublin, Ireland.	fabio.boylan@tcd.ie	Bekezhanova, Tolkyn/G-9314-2017; Shukirbekova, Alma/AAZ-4292-2020; Shukirbekova, Alma/ABG-7380-2021; Boylan, Fabio/K-9707-2015	Shukirbekova, Alma/0000-0002-3530-0535; Shukirbekova, Alma/0000-0003-3316-5584; Bekezhanova, Tolkyn/0000-0002-6088-5002; Boylan, Fabio/0000-0001-5531-1787; Sakipova, Zuriyadda/0000-0003-1400-1971	High Education Authority's Programme for Research in Third Level Institutions Cycle 5's; KazNMU	High Education Authority's Programme for Research in Third Level Institutions Cycle 5's; KazNMU	FB wishes to acknowledge the High Education Authority's Programme for Research in Third Level Institutions Cycle 5's funding support for TBSI. ZS, AS and TB want to acknowledge KazNMU for the financial support allowed to the execution of this work.	AMATE Y, 1990, TETRAHEDRON, V46, P6939, DOI 10.1016/S0040-4020(01)87881-9; [Anonymous], 1982, DRUGS JAP ETH DRUGS, V6, P301; Arnold W.N., 1992, NEW ENGL J MED, P228; Asghari G, 2014, JUNDISHAPUR J NAT PH, V9, P35, DOI 10.17795/jjnpp-12229; Bora KS, 2011, PHARM BIOL, V49, P101, DOI 10.3109/13880209.2010.497815; Figueiredo AC, 2008, FLAVOUR FRAG J, V23, P213, DOI 10.1002/ffj.1875; Gouvea DR, 2012, QUIM NOVA, V35, P2139, DOI 10.1590/S0100-40422012001100007; GRANGE JM, 1990, J APPL BACTERIOL, V68, P587, DOI 10.1111/j.1365-2672.1990.tb05224.x; Grant W.M, 1993, TOXICOLOGY EYE EFFEC, P1253; Habib M, 2013, J ETHNOPHARMACOL, V145, P18, DOI 10.1016/j.jep.2012.10.022; Harper JK, 2007, J MAGN RESON, V189, P20, DOI 10.1016/j.jmr.2007.06.017; Khares, 2007, INDIAN MED PLANTS IL, P64; Konczol A, 2012, J PHARMACEUT BIOMED, V59, P83, DOI 10.1016/j.jpba.2011.10.012; Liu XC, 2014, TROP J PHARM RES, V13, P587, DOI 10.4314/tjpr.v13i4.15; Miraldi E, 1998, PHYTOCHEM ANALYSIS, V9, P296, DOI 10.1002/(SICI)1099-1565(199811/12)9:6&lt;296::AID-PCA421&gt;3.0.CO;2-M; Morsy Tosson A., 1998, Journal of the Egyptian Society of Parasitology, V28, P699; Oettingen W.F., 1929, J PHARMACOL EXP THER, V36, P335; Hernandez YS, 2011, PHYTOCHEM LETT, V4, P134, DOI 10.1016/j.phytol.2011.02.001; Tyler V.E., 1988, PHARMACOGNOSY, P75; VARDANYAN SA, 1978, TERAPEVT ARKH, V50, P133; Vasiliev A.N., 1966, NAUKA; Woerdenbag H.J, 1997, ARTEMISIA CINA, V3, P15, DOI [10.1007/978-3-642-60367-9_2, DOI 10.1007/978-3-642-60367-9_2]	22	11	11	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 16	2017	12	3							e0173714	10.1371/journal.pone.0173714	http://dx.doi.org/10.1371/journal.pone.0173714			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN9KE	28301522	Green Submitted, Green Published, gold			2022-12-27	WOS:000396318300066
J	Waite, RD; Qureshi, MR; Whiley, RA				Waite, Richard D.; Qureshi, Muhammad R.; Whiley, Robert A.			Modulation of behaviour and virulence of a high alginate expressing Pseudomonas aeruginosa strain from cystic fibrosis by oral commensal bacterium Streptococcus anginosus	PLOS ONE			English	Article							LUNG-INFECTIONS; MICROBIAL COMPLEXITY; RESPIRATORY-TRACT; DISEASE; SPUTUM; BIOFILMS; CONVERSION; ADAPTATION; DIVERSITY; MECHANISM	Cystic fibrosis (CF) airways harbour complex and dynamic polymicrobial communities that include many oral bacteria. Despite increased knowledge of CF airway microbiomes the interaction between established CF pathogens and other resident microbes and resulting impact on disease progression is poorly understood. Previous studies have demonstrated that oral commensal streptococci of the Anginosus group (AGS) can establish chronic pulmonary infections and become numerically dominant in CF sputa indicating that they play an important role in CF microbiome dynamics. In this study a strain of Pseudomonas aeruginosa (DWW2) of the mucoid alginate overproducing phenotype associated with chronic CF airway infection and a strain of the oral commensal AGS species Streptococcus anginosus (3a) from CF sputum were investigated for their ability to co -exist and their responses to biofilm co -culture. Bacteria in biofilms were quantified, pyocyanin expression by DWW2 was measured and the effect of AGS strain 3a on reversion of DWW2 to a non-mucoidal phenotype investigated. The virulence of DWW2, 3a and colony variant phenotypes of DWW2 in mono- and co -culture were compared in a Galleria mellonella infection model. Co -culture biofilms were formed in normoxic, hypercapnic (10% CO2) and anoxic atmospheres with the streptococcus increasing in number in co -culture, indicating that these bacteria would be able to co -exist and thrive within the heterogeneous microenvironments of the CF airway. The streptococcus caused increased pyocyanin expression by DWW2 and colony variants by stimulating reversion of the mucoid phenotype to the high pyocyanin expressing non-mucoid phenotype. The latter was highly virulent in the infection model with greater virulence when in co-culture with the streptococcus. The results of this study demonstrate that the oral commensal S. anginosus benefits from interaction with P. aeruginosa of the CF associated mucoid phenotype and modulates the behaviour of the pseudomonad in ways that may be clinically relevant.	[Waite, Richard D.] Queen Mary Univ London, Barts & London Sch Med & Dent, Blizard Inst, Ctr Immunobiol, London, England; [Qureshi, Muhammad R.; Whiley, Robert A.] Queen Mary Univ London, Barts & London Sch Med & Dent, Inst Dent, Ctr Clin & Diagnost Oral Sci, London, England	University of London; Queen Mary University London; University of London; Queen Mary University London	Whiley, RA (corresponding author), Queen Mary Univ London, Barts & London Sch Med & Dent, Inst Dent, Ctr Clin & Diagnost Oral Sci, London, England.	r.a.whiley@qmul.ac.uk						Barnard E, 2016, J PHYSL; Belkaid Y, 2013, NAT IMMUNOL, V14, P646, DOI 10.1038/ni.2604; Bjarnsholt T, 2009, PEDIATR PULM, V44, P547, DOI 10.1002/ppul.21011; Boucher JC, 1996, J BACTERIOL, V178, P511, DOI 10.1128/jb.178.2.511-523.1996; Bradley S, 1999, CHEST, V116, P647, DOI 10.1378/chest.116.3.647; Bragonzi A, 2009, AM J RESP CRIT CARE, V180, P138, DOI 10.1164/rccm.200812-1943OC; Briaconi I, 2011, PLOS PATHOG, V7; Brogden KA, 2005, LANCET, V365, P253, DOI 10.1016/S0140-6736(05)70155-0; Ciofu O, 2008, MICROBIOL-SGM, V154, P103, DOI 10.1099/mic.0.2007/010421-0; Conrad D, 2013, AM J RESP CELL MOL, V48, P150, DOI 10.1165/rcmb.2012-0059PS; DOGGETT RG, 1964, J BACTERIOL, V87, P427, DOI 10.1128/JB.87.2.427-431.1964; DOGGETT RG, 1969, APPL MICROBIOL, V18, P936, DOI 10.1128/AEM.18.5.936-937.1969; Duan KM, 2003, MOL MICROBIOL, V50, P1477, DOI 10.1046/j.1365-2958.2003.03803.x; ESSAR DW, 1990, J BACTERIOL, V172, P884, DOI 10.1128/jb.172.2.884-900.1990; Filkins LM, 2012, J BACTERIOL, V194, P4709, DOI 10.1128/JB.00566-12; Fothergill JL, 2010, J MED MICROBIOL, V59, P472, DOI 10.1099/jmm.0.015875-0; Parazzi PLF, 2015, BMC PULM MED, V15, DOI 10.1186/s12890-015-0056-5; Gilchrist FJ, 2011, ARCH DIS CHILD, V96, P215, DOI 10.1136/adc.2009.177618; Goulet O, 2015, NUTR REV, V73, P32, DOI 10.1093/nutrit/nuv039; Hall-Stoodley L, 2004, NAT REV MICROBIOL, V2, P95, DOI 10.1038/nrmicro821; HASSAN HM, 1980, J BACTERIOL, V141, P156, DOI 10.1128/JB.141.1.156-163.1980; Hauser AR, 2011, CLIN MICROBIOL REV, V24, P29, DOI 10.1128/CMR.00036-10; Hogardt M, 2010, INT J MED MICROBIOL, V300, P557, DOI 10.1016/j.ijmm.2010.08.008; HOIBY N, 1974, ACTA PATH MICRO IM B, VB 82, P551; Hunter RC, 2012, AM J RESP CELL MOL, V47, P738, DOI 10.1165/rcmb.2012-0088OC; Kaidonis J, 2016, ANN ANAT, V203, P85, DOI 10.1016/j.aanat.2015.02.002; KOCH C, 1993, LANCET, V341, P1065, DOI 10.1016/0140-6736(93)92422-P; Kolak M, 2003, INT J MED MICROBIOL, V293, P309, DOI 10.1078/1438-4221-00265; Line L, 2014, FRONT MICROBIOL, V5, DOI 10.3389/fmicb.2014.00554; Lynch SV, 2013, CSH PERSPECT MED, V3, DOI 10.1101/cshperspect.a009738; Maeda Y, 2011, J CYST FIBROS, V10, P133, DOI 10.1016/j.jcf.2010.11.003; MARTIN DW, 1993, P NATL ACAD SCI USA, V90, P8377, DOI 10.1073/pnas.90.18.8377; Mathee K, 1999, MICROBIOL-SGM, V145, P1349, DOI 10.1099/13500872-145-6-1349; Mayer-Hamblett N, 2014, AM J RESP CRIT CARE, V190, P289, DOI 10.1164/rccm.201404-0681OC; Parkins MD, 2008, PEDIATR PULM, V43, P490, DOI 10.1002/ppul.20809; Paun A, 2015, CURR OPIN IMMUNOL, V37, P34, DOI 10.1016/j.coi.2015.09.004; Pedersen S S, 1992, APMIS Suppl, V28, P1; PEDERSEN SS, 1990, INFECT IMMUN, V58, P3363, DOI 10.1128/IAI.58.10.3363-3368.1990; Peters BM, 2012, CLIN MICROBIOL REV, V25, P193, DOI 10.1128/CMR.00013-11; Potera C, 1996, SCIENCE, V273, P1795, DOI 10.1126/science.273.5283.1795; Rogers GB, 2006, J CLIN MICROBIOL, V44, P2601, DOI 10.1128/JCM.02282-05; Rogers GB, 2005, RESP RES, V6, DOI 10.1186/1465-9921-6-49; Rogers GB, 2004, J CLIN MICROBIOL, V42, P5176, DOI 10.1128/JCM.42.11.5176-5183.2004; Rogers GB, 2003, J CLIN MICROBIOL, V41, P3548, DOI 10.1128/JCM.41.8.3548-3558.2003; Rogers GB, 2010, EXPERT REV MOL DIAGN, V10, P187, DOI 10.1586/ERM.09.81; Ryall B, PLOS ONE, V9; Salli KM, 2015, J ORAL MICROBIOL, V7, DOI 10.3402/jom.v7.26149; Sibley CD, 2006, FUTURE MICROBIOL, V1, P53, DOI 10.2217/17460913.1.1.53; Sibley CD, 2008, P NATL ACAD SCI USA, V105, P15070, DOI 10.1073/pnas.0804326105; Sibley CD, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000184; Smith DL, 1998, J INFECTION, V37, P41, DOI 10.1016/S0163-4453(98)90475-3; Smith EE, 2006, P NATL ACAD SCI USA, V103, P8487, DOI 10.1073/pnas.0602138103; Stacy A, 2016, NAT REV MICROBIOL, V14, P93, DOI 10.1038/nrmicro.2015.8; Stressmann FA, 2011, J CYST FIBROS, V10, P357, DOI 10.1016/j.jcf.2011.05.002; THOMASSEN MJ, 1979, J INFECT DIS, V140, P873, DOI 10.1093/infdis/140.6.873; Tunney MM, 2008, AM J RESP CRIT CARE, V177, P995, DOI 10.1164/rccm.200708-1151OC; Ulrich M, 2010, THORAX, V65, P978, DOI 10.1136/thx.2010.137745; van der Gast CJ, 2011, ISME J, V5, P780, DOI 10.1038/ismej.2010.175; Waite RD, 2012, J BACTERIOL, V194, P4521, DOI 10.1128/JB.06678-11; Waite RD, 2012, J CLIN MICROBIOL, V50, P1430, DOI 10.1128/JCM.06184-11; Waite RD, 2009, J BACTERIOL, V191, P1349, DOI 10.1128/JB.01458-08; Whiley RA, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0115513; Whiley RA, 2014, J INFECT DIS, V209, P769, DOI 10.1093/infdis/jit568; Willner D, 2012, ISME J, V6, P471, DOI 10.1038/ismej.2011.104; Worlitzsch D, 2002, J CLIN INVEST, V109, P317, DOI 10.1172/JCI0213870; Yang L, 2011, ENVIRON MICROBIOL, V13, P1682, DOI 10.1111/j.1462-2920.2011.02459.x	66	12	12	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 16	2017	12	3							e0173741	10.1371/journal.pone.0173741	http://dx.doi.org/10.1371/journal.pone.0173741			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN9KE	28301571	Green Published, gold, Green Submitted			2022-12-27	WOS:000396318300069
J	Weldehaweria, NB; Abreha, EH; Weldu, MG; Misgina, KH				Weldehaweria, Negassie Berhe; Abreha, Elsa Hagos; Weldu, Meresa Gebremedhin; Misgina, Kebede Haile			Psychosocial correlates of nutritional status among people living with HIV on antiretroviral therapy: A matched case-control study in Central zone of Tigray, Northern Ethiopia	PLOS ONE			English	Article							ALCOHOL-USE DISORDERS; QUALITY-OF-LIFE; SOUTH-WEST ETHIOPIA; DEPRESSIVE SYMPTOMS; CIGARETTE-SMOKING; FOOD INSECURITY; HIV/AIDS; MORTALITY; ADHERENCE; INFECTION	Background Malnutrition hastens progression to Acquired Human Immunodeficiency Syndromes (AIDS) related illnesses; undermines adherence and response to antiretroviral therapy (ART) in resource-poor settings. However, nutritional status of people living with HIV (PLHIV) can be affected by various psychosocial factors which have not been well explored in Ethiopia. Therefore, the objective of this study was to determine psychosocial correlates of nutritional status among people living with HIV (PLHIV) on ART in Central zone of Tigray, Northern Ethiopia. Methods A matched case-control study design was conducted to assess psychosocial correlates of nutritional status among PLHIV on ART. Data were collected by an interviewer-administered technique using structured pre-tested questionnaire, record review using a checklist and anthropometric measurements. Cases were selected by simple random sampling and controls purposively to match the selected cases. Conditional logistic regression was used to compute relevant associations by STATA version 12. Results The psychosocial factors independently associated with malnutrition were ever consuming alcohol after starting ART [AOR = 4.7, 95% CI: 1.8.12.3], ever smoking cigarette after starting ART [AOR = 7.6, 95% CI: 2.3.25.5], depression [AOR = 2.8, 95% CI: 1.3, 6.1], not adhering to ART [AOR = 6.8,95% CI: 2.0.23.0] and being in the second lowest wealth quintile [AOR = 4.3,95% CI: 1.1.17.7]. Conclusion Ever consuming alcohol and ever smoking cigarette after starting ART, depression, not adhering to ART and being in the second lowest wealth quintile were significantly associated with malnutrition. Therefore; policies, strategies, and programs targeting people living with HIV should consider psychosocial factors that can impact nutritional status of people living with HIV enrolled on ART.	[Weldehaweria, Negassie Berhe; Weldu, Meresa Gebremedhin; Misgina, Kebede Haile] Aksum Univ, Dept Publ Hlth, Coll Hlth Sci, Aksum, Tigray, Ethiopia; [Abreha, Elsa Hagos] Samara Univ, Dept Biomed Sci, Coll Hlth Sci, Semara, Afar, Ethiopia	Samara University	Weldehaweria, NB (corresponding author), Aksum Univ, Dept Publ Hlth, Coll Hlth Sci, Aksum, Tigray, Ethiopia.	negelsa5960@gmail.com	Weldu, Meresa Gebremedhin/ABA-5452-2020		Aksum University	Aksum University	Funding body: Aksum University. Grant Amount: 20 000 ETB	Agudelo M, 2014, CURR HIV RES, V12, P234, DOI 10.2174/1570162X12666140721115045; Amedee AM, 2014, CURR HIV RES, V12, P243, DOI 10.2174/1570162X12666140721115717; Amico KR, 2009, MONITORING PATIENT A; [Anonymous], 2014, COUNTRY PROGR REPORT; [Anonymous], ETHIOPIAN J HLTH BIO; Azar MM, 2010, DRUG ALCOHOL DEPEN, V112, P178, DOI 10.1016/j.drugalcdep.2010.06.014; Bagby GJ, 2015, ALCOHOL RES-CURR REV, V37, P287; Bailey KV, 1995, B WORLD HEALTH ORGAN, V73, P673; Berhe N, 2013, BMC INFECT DIS, V13, DOI 10.1186/1471-2334-13-233; Braitstein P, 2006, LANCET, V367, P817, DOI 10.1016/S0140-6736(06)68337-2; Bukusuba J, 2007, BRIT J NUTR, V98, P211, DOI 10.1017/S0007114507691806; Burkey MD, 2014, JAIDS-J ACQ IMM DEF, V66, P41, DOI 10.1097/QAI.0000000000000094; Chan KCW, 2006, HIV MED, V7, P186, DOI 10.1111/j.1468-1293.2006.00352.x; Charles B, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-463; Coetzee D, 2004, AIDS, V18, P887, DOI 10.1097/00002030-200404090-00006; Crothers K, 2009, AIDS EDUC PREV, V21, P40, DOI 10.1521/aeap.2009.21.3_supp.40; Custodio JM, 2014, J CLIN PHARMACOL, V54, P378, DOI 10.1002/jcph.210; Daniel M., 2013, SCI J PUBL HLTH, V1, P24, DOI DOI 10.11648/J.SJPH.20130101.14; Demeke B, 2014, INT J PHARM SCI RES, V5, P572; EFDR MOH, 2008, NATL GUIDELINES HIVA, P1; Etard JF, 2006, AIDS, V20, P1181, DOI 10.1097/01.aids.0000226959.87471.01; Ethiopian Ministry of Agriculture and rural development FAO, 2005, NUTR CAR SUPP PLHIV; FERROLUZZI A, 1992, EUR J CLIN NUTR, V46, P173; Food and Nutrition Technical Assistance (FANTA) Project and World Food Programme (WFP), 2007, FOOD ASS PROGR CONT; Fufa H, 2009, FOOD NUTR BULL, V30, P227, DOI 10.1177/156482650903000303; Gedle D., 2015, BMC NUTR, V1, P5, DOI [10.1186/2055-0928-1-5, DOI 10.1186/2055-0928-1-5]; Godfrey X, 2004, HLTH EATING BETTER L; Hadgu TH, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-943; Hailemariam S, 2013, ARCH PUBLIC HEALTH, V71, DOI 10.1186/0778-7367-71-13; Helleberg M, 2015, AIDS, V29, P221, DOI 10.1097/QAD.0000000000000540; Hendershot CS, 2009, JAIDS-J ACQ IMM DEF, V52, P180, DOI 10.1097/QAI.0b013e3181b18b6e; Idindili B, 2012, TANZANIA J HLTH RES, V14; Ivers LC, 2009, CLIN INFECT DIS, V49, P1096, DOI 10.1086/605573; Jaquet A, 2010, ADDICTION, V105, P1416, DOI 10.1111/j.1360-0443.2010.02978.x; Kalichman SC, 2015, INFECT DIS THER; Koethe JR, 2010, AM J CLIN NUTR, V91, p1138S, DOI 10.3945/ajcn.2010.28608D; Kroenke K, 2001, J GEN INTERN MED, V16, P606, DOI 10.1046/j.1525-1497.2001.016009606.x; Leserman J, 1999, PSYCHOSOM MED, V61, P397, DOI 10.1097/00006842-199905000-00021; Lifson AR, 2010, AM J PUBLIC HEALTH, V100, P1896, DOI 10.2105/AJPH.2009.188664; Mekuria A, 2015, ETHIOPIA OPEN ACCESS, V2, P1; Miguez-Burbano MJ, 2005, INT J INFECT DIS, V9, P208, DOI 10.1016/j.ijid.2004.07.010; Ministry of Health ICF International, ETH DEM HLTH SURV 20; Molina PE, 2014, CURR HIV RES, V12, P265, DOI 10.2174/1570162X12666140721121849; Musumari PM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0085327; Oka F, 2013, J INFECT CHEMOTHER, V19, P542, DOI 10.1007/s10156-012-0489-1; Palermo T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062353; Petrosillo N, 2013, BMC MED, V11, DOI 10.1186/1741-7015-11-16; Reis RK, 2011, REV LAT-AM ENFERM, V19, P874, DOI 10.1590/S0104-11692011000400004; Riley ED, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035207; Shuter J, 2012, AM J HEALTH BEHAV, V36, P75, DOI 10.5993/AJHB.36.1.8; Sieleunou I, 2009, TROP MED INT HEALTH, V14, P36, DOI 10.1111/j.1365-3156.2008.02183.x; Smit RNV, 2010, EUR RESPIR J, V35, P27, DOI 10.1183/09031936.00072909; Soboka M, 2015, BMC PSYCHIATRY, V15, DOI 10.1186/s12888-015-0446-5; Soboka Matiwos, 2014, BMC Res Notes, V7, P828, DOI 10.1186/1756-0500-7-828; Soysa NS, 2005, ORAL DIS, V11, P268, DOI 10.1111/j.1601-0825.2005.01115.x; Thapa R, 2015, AIDS RES THER, V12, DOI 10.1186/s12981-015-0056-9; Tirivayi Nyasha, 2012, J AIDS Clin Res, V3, P171; Tiyou A, 2010, AIDS RES THER, V7, DOI 10.1186/1742-6405-7-39; Tshingani K. S. C, 2013, HIV AIDS REV, V13; UNAIDS UN, 2014, GAP REP; Valiathan R, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0097698; van Lettow M, 2003, NUTR REV, V61, P81, DOI 10.1301/nr.2003.marr.81-90; Vogenthaler NS, 2011, AIDS BEHAV, V15, P1520, DOI 10.1007/s10461-010-9668-1; Wasti SP, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035547; Weiser SD, 2009, AIDS BEHAV, V13, P841, DOI 10.1007/s10461-009-9597-z; WFP WHO UNAIDS, 2008, HIV FOOD SEC NUTR PO; WHO U, 2013, GLOB UPD HIV TREATM; Yaya I, 2014, BMC PUBLIC HEALTH, V14, DOI 10.1186/1471-2458-14-1308; Zachariah R, 2006, AIDS, V20, P2355, DOI 10.1097/QAD.0b013e32801086b0	69	9	10	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 16	2017	12	3							e0174082	10.1371/journal.pone.0174082	http://dx.doi.org/10.1371/journal.pone.0174082			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EN9KE	28301592	Green Published, gold, Green Submitted			2022-12-27	WOS:000396318300124
J	Chen, MW; Wu, JH; Sun, M				Chen, Mao Wei; Wu, Jiang Hao; Sun, Mao			Generation of the pitch moment during the controlled flight after takeoff of fruitflies	PLOS ONE			English	Article							INSECT FLIGHT; HOVERING FLIGHT; KINEMATICS MEASUREMENT; STEERING MUSCLES; WING KINEMATICS; DYNAMIC FLIGHT; AERODYNAMICS; DROSOPHILA; BODY; STABILITY	In the present paper, the controlled flight of fruitflies after voluntary takeoff is studied. Wing and body kinematics of the insects after takeoff are measured using high-speed video techniques, and the aerodynamic force and moment are calculated by the computational fluid dynamics method based on the measured data. How the control moments are generated is analyzed by correlating the computed moments with the wing kinematics. A fruit-fly has a large pitch-up angular velocity owing to the takeoff jump and the fly controls its body attitude by producing pitching moments. It is found that the pitching moment is produced by changes in both the aerodynamic force and the moment arm. The change in the aerodynamic force is mainly due to the change in angle of attack. The change in the moment arm is mainly due to the change in the mean stroke angle and deviation angle, and the deviation angle plays a more important role than the mean stroke angle in changing the moment arm ( note that change in deviation angle implies variation in the position of the aerodynamic stroke plane with respect to the anatomical stroke plane). This is unlike the case of fruitflies correcting pitch perturbations in steady free flight, where they produce pitching moment mainly by changes in mean stroke angle.	[Chen, Mao Wei; Wu, Jiang Hao] Beihang Univ, Sch Transportat Sci & Engn, Beijing, Peoples R China; [Sun, Mao] Beihang Univ, Inst Fluid Mech, Beijing, Peoples R China	Beihang University; Beihang University	Chen, MW (corresponding author), Beihang Univ, Sch Transportat Sci & Engn, Beijing, Peoples R China.	aspenchen@buaa.edu.cn			National Natural Science Foundation of China [11232002]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	Funded by National Natural Science Foundation of China (11232002) http://www.nsfc.gov.cn/ (MS). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aono H, 2008, J EXP BIOL, V211, P239, DOI 10.1242/jeb.008649; Beatus T, 2015, PHYS REV E, V92, DOI 10.1103/PhysRevE.92.022712; Beatus T, 2015, J R SOC INTERFACE, V12, DOI 10.1098/rsif.2015.0075; Bergou AJ, 2010, PHYS REV LETT, V104, DOI 10.1103/PhysRevLett.104.148101; Card G, 2008, J EXP BIOL, V211, P341, DOI 10.1242/jeb.012682; Chen MW, 2013, J R SOC INTERFACE, V10, DOI 10.1098/rsif.2013.0808; Chen MW, 2014, ACTA MECH SINICA-PRC, V30, P495, DOI 10.1007/s10409-014-0059-0; Cheng B, 2011, J EXP BIOL, V214, P4092, DOI 10.1242/jeb.062760; Cheng B, 2011, IEEE T ROBOT, V27, P849, DOI 10.1109/TRO.2011.2156170; Combes SA, 2009, P NATL ACAD SCI USA, V106, P9105, DOI 10.1073/pnas.0902186106; Dickinson MH, 1997, COMP BIOCHEM PHYS A, V116, P223, DOI 10.1016/S0300-9629(96)00162-4; ELLINGTON CP, 1984, PHILOS T ROY SOC B, V305, P41, DOI 10.1098/rstb.1984.0051; Etkin B., 1996, DYNAMICS FLIGHT STAB, V3rd; Faruque I, 2010, J THEOR BIOL, V264, P538, DOI 10.1016/j.jtbi.2010.02.018; Fontaine EI, 2009, J EXP BIOL, V212, P1307, DOI 10.1242/jeb.025379; Fry SN, 2005, J EXP BIOL, V208, P2303, DOI 10.1242/jeb.01612; Fry SN, 2003, SCIENCE, V300, P495, DOI 10.1126/science.1081944; Greeter JSM, 2016, BIOL OPEN, V5, P72, DOI 10.1242/bio.012922; Hilgenstock A., 1988, NUM GRID GENERATION; Lehmann FO, 1996, J COMP PHYSIOL A, V179, P311, DOI 10.1007/BF00194985; Liang B, 2011, CHINESE J AERONAUT, V24, P396, DOI 10.1016/S1000-9361(11)60047-2; Liu YP, 2008, J EXP BIOL, V211, P2014, DOI 10.1242/jeb.016931; Meng XG, 2015, PHYS FLUIDS, V27, DOI 10.1063/1.4914042; Meng XG, 2011, J BIONIC ENG, V8, P140, DOI 10.1016/S1672-6529(11)60015-2; Mou XL, 2011, J EXP BIOL, V214, P2832, DOI 10.1242/jeb.054874; Muijres FT, 2015, J EXP BIOL, V218, P864, DOI 10.1242/jeb.114280; Ortega-Jimenez VM, 2013, J EXP BIOL, V216, P4567, DOI 10.1242/jeb.089672; Ravi S, 2013, J EXP BIOL, V216, P4299, DOI 10.1242/jeb.090845; Ribak G, 2016, J EXP BIOL, V219, P1639, DOI 10.1242/jeb.127886; Ristroph L, 2013, J R SOC INTERFACE, V10, DOI 10.1098/rsif.2013.0237; Ristroph L, 2010, P NATL ACAD SCI USA, V107, P4820, DOI 10.1073/pnas.1000615107; Rogers S. E., 1994, 940523 AIAA; ROGERS SE, 1991, AIAA J, V29, P603, DOI 10.2514/3.10627; Sun M, 2005, J EXP BIOL, V208, P447, DOI 10.1242/jeb.01407; Sun M, 2006, AIAA J, V44, P1532, DOI 10.2514/1.17356; Sun M, 2014, REV MOD PHYS, V86, P615, DOI 10.1103/RevModPhys.86.615; Tu MS, 1996, J COMP PHYSIOL A, V178, P813, DOI 10.1007/BF00225830; Vance JT, 2013, BIOINSPIR BIOMIM, V8, DOI 10.1088/1748-3182/8/1/016004; Whitehead SC, 2015, J EXP BIOL, V218, P3508, DOI 10.1242/jeb.122622; Xu N, 2013, J THEOR BIOL, V319, P102, DOI 10.1016/j.jtbi.2012.11.033; Yu X, 2009, ACTA MECH SINICA-PRC, V25, P421, DOI 10.1007/s10409-009-0266-2; Zhang YL, 2010, ACTA MECH SINICA-PRC, V26, P371, DOI 10.1007/s10409-010-0339-2; Zhang YL, 2010, ACTA MECH SINICA-PRC, V26, P175, DOI 10.1007/s10409-009-0303-1	43	2	2	1	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 15	2017	12	3							e0173481	10.1371/journal.pone.0173481	http://dx.doi.org/10.1371/journal.pone.0173481			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN9HQ	28296907	Green Published, gold, Green Submitted			2022-12-27	WOS:000396311700039
J	Thamri, A; Letourneau, M; Djoboulian, A; Chatenet, D; Deziel, E; Castonguay, A; Perreault, J				Thamri, Amal; Letourneau, Myriam; Djoboulian, Alex; Chatenet, David; Deziel, Eric; Castonguay, Annie; Perreault, Jonathan			Peptide modification results in the formation of a dimer with a 60-fold enhanced antimicrobial activity	PLOS ONE			English	Article							PSEUDOMONAS-AERUGINOSA BIOFILM; IN-VITRO; RESISTANCE; IDENTIFICATION; LL-37; DATABASE; LIBRARY; AGENTS; STATE	Cationic antimicrobial peptides (CAMPs) occur naturally in numerous organisms and are considered as a class of antibiotics with promising potential against multi-resistant bacteria. Herein, we report a strategy that can lead to the discovery of novel small CAMPs with greatly enhanced antimicrobial activity and retained antibiofilm potential. We geared our efforts towards i) the N-terminal cysteine functionalization of a previously reported small synthetic cationic peptide (peptide 1037, KRFRIRVRV-NH2), its dimerization through a disulfide bond, and a preliminary antimicrobial activity assessment of the newly prepared dimer against Pseudomonas aeruginosa and Burkholderia cenocepacia, pathogens responsible for the formation of biofilms in lungs of individuals with cystic fibrosis. This dimer is of high interest as it does not only show greatly enhanced bacterial growth inhibition properties compared to its pep1037 precursor (up to 60 times), but importantly, also displays antibiofilm potential at sub-MICs. Our results suggest that the reported dimer holds promise for its use in future adjunctive therapy, in combination with clinically -relevant antibiotics.	[Thamri, Amal; Letourneau, Myriam; Djoboulian, Alex; Chatenet, David; Deziel, Eric; Castonguay, Annie; Perreault, Jonathan] Univ Quebec, INRS, Inst Armand Frappier, Laval, PQ, Canada	University of Quebec; Institut national de la recherche scientifique (INRS)	Castonguay, A; Perreault, J (corresponding author), Univ Quebec, INRS, Inst Armand Frappier, Laval, PQ, Canada.	annie.castonguay@iaf.inrs.ca; jonathan.perreault@iaf.inrs.ca	Déziel, Eric/A-7678-2008	Déziel, Eric/0000-0002-4609-0115; Castonguay, Annie/0000-0001-5705-6353; Perreault, Jonathan/0000-0003-4726-6319	Fonds de recherche du Quebec - Sante [29164, 31227]; Natural Sciences and Engineering Research Council of Canada; Armand-Frappier Foundation of INRS University; Tunisia-INRS	Fonds de recherche du Quebec - Sante(Fonds de la Recherche en Sante du Quebec); Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); Armand-Frappier Foundation of INRS University; Tunisia-INRS	JP and AC both received a Junior 1 Research Scholar Award from Fonds de recherche du Quebec - Sante (29164 & 31227; http://www.frqs.gouv.qc.ca). JP, AC, ED and DC are supported by the Natural Sciences and Engineering Research Council of Canada (http://www.nserc-crsng.gc.ca). AT is supported by an Excellence Scholarship from The Armand-Frappier Foundation of INRS University (http://www.fondation-afrappier-inrs.ca) and a Tunisia-INRS agreement. ED holds the Canada Research Chair in Sociomicrobiology (http://www.chairs-chaires.gc.ca). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bahar AA, 2013, PHARMACEUTICALS-BASE, V6, P1543, DOI 10.3390/ph6121543; Begolo D, 2014, ANTIMICROB AGENTS CH, V58, P6260, DOI 10.1128/AAC.03338-14; Chandrasekhar S, 2016, PHARM RES-DORDR, V33, P1370, DOI 10.1007/s11095-016-1879-3; Crusca E, 2011, BIOPOLYMERS, V96, P41, DOI 10.1002/bip.21454; Datta A, 2016, J COLLOID INTERF SCI, V461, P335, DOI 10.1016/j.jcis.2015.09.036; Davies D, 2003, NAT REV DRUG DISCOV, V2, P114, DOI 10.1038/nrd1008; de la Fuente-Nunez C, 2014, ANTIBIOTICS-BASEL, V3, P509, DOI 10.3390/antibiotics3040509; de la Fuente-Nunez C, 2012, ANTIMICROB AGENTS CH, V56, P2696, DOI 10.1128/AAC.00064-12; Dean SN, 2011, FRONT MICROBIOL, V2, DOI 10.3389/fmicb.2011.00128; Di Luca M, 2015, BIOFOULING, V31, P193, DOI 10.1080/08927014.2015.1021340; Durham-Colleran MW, 2010, MICROB ECOL, V59, P457, DOI 10.1007/s00248-009-9586-9; Franklin R. I Cockerill, 2012, CONTRACT NO 2; Godballe T, 2011, CHEM BIOL DRUG DES, V77, P107, DOI 10.1111/j.1747-0285.2010.01067.x; GORDON CA, 1988, J ANTIMICROB CHEMOTH, V22, P667, DOI 10.1093/jac/22.5.667; Guiot E, 2002, PHOTOCHEM PHOTOBIOL, V75, P570, DOI 10.1562/0031-8655(2002)075<0570:HODIMB>2.0.CO;2; Haisma EM, 2014, ANTIMICROB AGENTS CH, V58, P4411, DOI 10.1128/AAC.02554-14; Horswill AR, 2007, ANAL BIOANAL CHEM, V387, P371, DOI 10.1007/s00216-006-0720-y; JORDAN GM, 1994, J PHARM PHARMACOL, V46, P182, DOI 10.1111/j.2042-7158.1994.tb03774.x; Leclercq R, 2008, M S-MED SCI, V24, P32; Liu SP, 2010, INT J PEPT RES THER, V16, P199, DOI 10.1007/s10989-010-9230-z; Marston HD, 2016, JAMA-J AM MED ASSOC, V316, P1193, DOI 10.1001/jama.2016.11764; Matthew A. M Wikler, 2012, CONTRACT NO 2; Moreau-Marquis S, 2008, PULM PHARMACOL THER, V21, P595, DOI 10.1016/j.pupt.2007.12.001; Morrison GM, 2002, MAMM GENOME, V13, P445, DOI 10.1007/s00335-002-3014-5; Mosca DA, 2000, ANTIMICROB AGENTS CH, V44, P1803, DOI 10.1128/AAC.44.7.1803-1808.2000; Nagant C, 2012, ANTIMICROB AGENTS CH, V56, P5698, DOI 10.1128/AAC.00918-12; O'Toole GA, 2011, JOVE-J VIS EXP, DOI 10.3791/2437; Overhage J, 2008, INFECT IMMUN, V76, P4176, DOI 10.1128/IAI.00318-08; Paulsen VS, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053326; Reffuveille F, 2014, ANTIMICROB AGENTS CH, V58, P5363, DOI 10.1128/AAC.03163-14; Romling U, 2012, J INTERN MED, V272, P541, DOI 10.1111/joim.12004; Schwartz T, 2003, FEMS MICROBIOL ECOL, V43, P325, DOI 10.1111/j.1574-6941.2003.tb01073.x; Shigeta M, 1997, CHEMOTHERAPY, V43, P340, DOI 10.1159/000239587; Singh PK, 2002, NATURE, V417, P552, DOI 10.1038/417552a; Tomlin KL, 2001, CAN J MICROBIOL, V47, P949, DOI 10.1139/cjm-47-10-949; Wang GS, 2016, NUCLEIC ACIDS RES, V44, pD1087, DOI 10.1093/nar/gkv1278; Wu SL, 2000, INT J PHARM, V200, P1, DOI 10.1016/S0378-5173(99)00469-X; Yomogida S, 1996, ARCH BIOCHEM BIOPHYS, V328, P219, DOI 10.1006/abbi.1996.0166; YOSHIOKA S, 1993, PHARMACEUT RES, V10, P687, DOI 10.1023/A:1018951530927	39	15	16	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 15	2017	12	3							e0173783	10.1371/journal.pone.0173783	http://dx.doi.org/10.1371/journal.pone.0173783			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN9HQ	28296935	gold, Green Published, Green Submitted			2022-12-27	WOS:000396311700063
J	Doyle, MF; Tracy, RP; Parikh, MA; Hoffman, EA; Shimbo, D; Austin, JHM; Smith, BM; Hueper, K; Vogel-Claussen, J; Lima, J; Gomes, A; Watson, K; Kawut, S; Barr, RG				Doyle, Margaret F.; Tracy, Russell P.; Parikh, Megha A.; Hoffman, Eric A.; Shimbo, Daichi; Austin, John H. M.; Smith, Benjamin M.; Hueper, Katja; Vogel-Claussen, Jens; Lima, Joao; Gomes, Antoinette; Watson, Karol; Kawut, Steven; Barr, R. Graham			Endothelial progenitor cells in chronic obstructive pulmonary disease and emphysema	PLOS ONE			English	Article							CORONARY-ARTERY-DISEASE; CONGESTIVE-HEART-FAILURE; BONE-MARROW; CARDIOVASCULAR-DISEASE; STATIN THERAPY; LUNG-FUNCTION; UP-REGULATION; COPD; ATHEROSCLEROSIS; APOPTOSIS	Endothelial injury is implicated in the pathogenesis of COPD and emphysema; however the role of endothelial progenitor cells (EPCs), a marker of endothelial cell repair, and circulating endothelial cells (CECs), a marker of endothelial cell injury, in COPD and its subphenotypes is unresolved. We hypothesized that endothelial progenitor cell populations would be decreased in COPD and emphysema and that circulating endothelial cells would be increased. Associations with other subphenotypes were examined. The Multi-Ethnic Study of Atherosclerosis COPD Study recruited smokers with COPD and controls age 50(_)79 years without clinical cardiovascular disease. Endothelial progenitor cell populations (CD34+KDR+ and CD34+KDR+CD133+cells) and circulating endothelial cells (CD45dimCD31+CD146+CD133-) were measured by flow cytometry. COPD was defined by standard spirometric criteria. Emphysema was assessed qualitatively and quantitatively on CT. Full pulmonary function testing and expiratory CTs were measured in a subset. Among 257 participants, both endothelial progenitor cell populations, and particularly CD34+KDR+ endothelial progenitor cells, were reduced in COPD. The CD34+KDR+CD133+ endothelial progenitor cells were associated inversely with emphysema extent. Both endothelial progenitor cell populations were associated inversely with extent of panlobular emphysema and positively with diffusing capacity. Circulating endothelial cells were not significantly altered in COPD but were inversely associated with pulmonary microvascular blood flow on MRI. There was no consistent association of endothelial progenitor cells or circulating endothelial cells with measures of gas trapping. These data provide evidence that endothelial repair is impaired in COPD and suggest that this pathological process is specific to emphysema.	[Doyle, Margaret F.; Tracy, Russell P.] Univ Vermont, Dept Pathol & Lab Med, Burlington, VT USA; [Parikh, Megha A.; Shimbo, Daichi; Smith, Benjamin M.; Barr, R. Graham] Columbia Univ, Dept Med, New York, NY 10027 USA; [Hoffman, Eric A.] Univ Iowa, Dept Radiol, Iowa City, IA 52242 USA; [Austin, John H. M.] Columbia Univ, Dept Radiol, Coll Phys & Surg, New York, NY USA; [Hueper, Katja; Vogel-Claussen, Jens] Hannover Med Sch, Dept Radiol, Hannover, Germany; [Lima, Joao] Johns Hopkins Univ, Dept Cardiol, Baltimore, MD USA; [Gomes, Antoinette] Univ Calif Los Angeles, Sch Med, Dept Radiol, Los Angeles, CA 90024 USA; [Watson, Karol] Univ Calif Los Angeles, Sch Med, Div Cardiol, Los Angeles, CA 90024 USA; [Kawut, Steven] Univ Penn, Sch Med, Penn Cardiovasc Inst, Pulm Allergy & Crit Care Div,Ctr Clinical Epidemi, Philadelphia, PA 19104 USA; [Barr, R. Graham] Columbia Univ, Mailman Sch Publ Hlth, Dept Epidemiol, New York, NY 10027 USA	University of Vermont; Columbia University; University of Iowa; Columbia University; Hannover Medical School; Johns Hopkins University; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of Pennsylvania; Columbia University	Barr, RG (corresponding author), Columbia Univ, Dept Med, New York, NY 10027 USA.	rgb9@mail.cumc.columbia.edu	Watson, Karol/ABD-7425-2021; Vogel-Claussen, Jens/Q-3374-2019	Vogel-Claussen, Jens/0000-0001-5595-6948; Hoffman, Eric/0000-0001-8456-9437; Doyle, Margaret/0000-0001-6769-5386	National Institutes of Health / National Heart Lung and Blood Institute [R01-HL083091, HL077612, N01 HC 95159-95169]; Harold S. Geneen Charitable Trust Award Program; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL112986, K24HL103844, R01HL093081, R01HL077612] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK054759] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [P30ES005605] Funding Source: NIH RePORTER	National Institutes of Health / National Heart Lung and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); Harold S. Geneen Charitable Trust Award Program; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This study was supported by the National Institutes of Health / National Heart Lung and Blood Institute R01-HL083091, HL077612, N01 HC 95159-95169 and the Harold S. Geneen Charitable Trust Award Program (MFD). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alam S, 2014, AM J RESP CRIT CARE, V189, P909, DOI 10.1164/rccm.201308-1458OC; Asahara T, 1997, SCIENCE, V275, P964, DOI 10.1126/science.275.5302.964; Barbera Joan Albert, 2011, Proc Am Thorac Soc, V8, P528, DOI 10.1513/pats.201101-010MW; Barr RG, 2007, AM J RESP CRIT CARE, V176, P1200, DOI 10.1164/rccm.200707-980OC; Barr RG, 2014, PEDIATR RADIOL, V44, P559, DOI 10.1007/s00247-014-3100-3; Bild DE, 2002, AM J EPIDEMIOL, V156, P871, DOI 10.1093/aje/kwf113; Bonsignore Maria R, 2006, Proc Am Thorac Soc, V3, P537, DOI 10.1513/pats.200603-090MS; Boos CJ, 2008, J THROMB HAEMOST, V6, P1841, DOI 10.1111/j.1538-7836.2008.03148.x; Boos CJ, 2006, J AM COLL CARDIOL, V48, P1538, DOI 10.1016/j.jacc.2006.02.078; Brittan M, 2013, AM J PHYSIOL-LUNG C, V305, pL964, DOI 10.1152/ajplung.00183.2013; Burkart K.M., 2010, B37 CHRONIC OBSTRUCT, pA2878; Celli BR, 2004, EUR RESPIR J, V23, P932, DOI 10.1183/09031936.04.00014304; Demedts IK, 2006, RESP RES, V7, DOI 10.1186/1465-9921-7-53; Diller GP, 2008, CIRCULATION, V117, P3020, DOI 10.1161/CIRCULATIONAHA.108.769646; Eickhoff P, 2008, AM J RESP CRIT CARE, V178, P1211, DOI 10.1164/rccm.200709-1412OC; Fadini GP, 2006, STEM CELLS, V24, P1806, DOI 10.1634/stemcells.2005-0440; Fadini GP, 2006, AM J RESP CELL MOL, V35, P403, DOI 10.1165/rcmb.F319; Gordon C, 2011, AM J RESP CRIT CARE, V184, P224, DOI 10.1164/rccm.201012-2061OC; Hankinson JL, 2010, CHEST, V137, P138, DOI 10.1378/chest.09-0919; Hirsch JA, 2015, J NEUROINTERV SURG, V7, P309, DOI 10.1136/neurintsurg-2014-011156; Hoyert Donna L, 2012, Natl Vital Stat Rep, V61, P1; Hristov M, 2003, ARTERIOSCL THROM VAS, V23, P1185, DOI 10.1161/01.ATV.0000073832.49290.B5; Hueper K, 2013, INVEST RADIOL, V48, P223, DOI 10.1097/RLI.0b013e318281057d; Huertas A, 2011, EUR RESPIR J, V37, P426, DOI 10.1183/09031936.00034810; Huertas A, 2010, RESP PHYSIOL NEUROBI, V170, P23, DOI 10.1016/j.resp.2009.10.003; Imai K, 2005, EUR RESPIR J, V25, P250, DOI 10.1183/09031936.05.00023704; Ito K, 2001, J BIOL CHEM, V276, P38108; Janssen WJ, 2014, COPD, V11, P277, DOI 10.3109/15412555.2013.841668; Kasahara Y, 2000, J CLIN INVEST, V106, P1311, DOI 10.1172/JCI10259; Kasahara Y, 2001, AM J RESP CRIT CARE, V163, P737, DOI 10.1164/ajrccm.163.3.2002117; Kawasaki T, 2015, AM J RESP CELL MOL B; KIM WD, 1991, AM REV RESPIR DIS, V144, P1385, DOI 10.1164/ajrccm/144.6.1385; Kissel CK, 2007, J AM COLL CARDIOL, V49, P2341, DOI 10.1016/j.jacc.2007.01.095; Liu XR, 2013, EXPERT OPIN THER TAR, V17, P485, DOI 10.1517/14728222.2013.773975; Liu XR, 2012, MOL CELL BIOCHEM, V363, P53, DOI 10.1007/s11010-011-1157-y; Llevadot J, 2001, J CLIN INVEST, V108, P399, DOI 10.1172/JCI200113131; Lockett AD, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0093979; Lockett AD, 2012, MOL MED, V18, P445, DOI 10.2119/molmed.2011.00207; MacIntyre N, 2005, EUR RESPIR J, V26, P720, DOI 10.1183/09031936.05.00034905; Makin AJ, 2004, EUR HEART J, V25, P371, DOI 10.1016/j.ehj.2003.04.001; Miller MR, 2005, EUR RESPIR J, V26, P319, DOI 10.1183/09031936.05.00034805; Nonaka-Sarukawa M, 2007, INT J CARDIOL, V119, P344, DOI 10.1016/j.ijcard.2006.07.191; Olson NC, 2013, J CARDIOVASC TRANSL, V6, P772, DOI 10.1007/s12265-013-9496-6; Olson NC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071498; Palange P, 2006, EUR RESPIR J, V27, P529, DOI 10.1183/09031936.06.00120604; Paschalaki KE, 2013, STEM CELLS, V31, P2813, DOI 10.1002/stem.1488; Peichev M, 2000, BLOOD, V95, P952, DOI 10.1182/blood.V95.3.952.003k27_952_958; Peinado VI, 2006, AM J RESP CELL MOL, V34, P257, DOI 10.1165/rcmb.2005-0255OC; Peinado VI, 2008, CHEST, V134, P808, DOI 10.1378/chest.08-0820; Petrache I, 2005, NAT MED, V11, P491, DOI 10.1038/nm1238; PSATY BM, 1992, J CLIN EPIDEMIOL, V45, P683, DOI 10.1016/0895-4356(92)90143-B; Putcha N, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0114438; Rodriguez J, 2010, ANN INTERN MED, V152, P201, DOI 10.7326/0003-4819-152-4-201002160-00004; Sabatier F, 2009, J CELL MOL MED, V13, P454, DOI 10.1111/j.1582-4934.2008.00639.x; SAETTA M, 1994, EUR RESPIR J, V7, P664, DOI 10.1183/09031936.94.07040664; Sala E, 2010, LUNG, V188, P331, DOI 10.1007/s00408-009-9225-8; Salven P, 2003, BLOOD, V101, P168, DOI 10.1182/blood-2002-03-0755; Schmidt-Lucke C, 2005, CIRCULATION, V111, P2981, DOI 10.1161/CIRCULATIONAHA.104.504340; Segura-Valdez L, 2000, CHEST, V117, P684, DOI 10.1378/chest.117.3.684; Sieren JP, 2011, CT IMAGING PROTOCOL; Smith BM, 2014, CHEST, V145, P1305, DOI 10.1378/chest.13-1884; Smith BM, 2014, AM J MED, V127, DOI 10.1016/j.amjmed.2013.09.020; Stroncek JD, 2009, TISSUE ENG PT A, V15, P3473, DOI [10.1089/ten.tea.2008.0673, 10.1089/ten.TEA.2008.0673]; Takahashi T, 2012, THORAX, V67, P1067, DOI 10.1136/thoraxjnl-2011-201395; Takahashi T, 2011, RESPIROLOGY, V16, P680, DOI 10.1111/j.1440-1843.2011.01959.x; Thomashow MA, 2013, AM J RESP CRIT CARE, V188, P60, DOI 10.1164/rccm.201209-1697OC; Thyagarajan B, 2014, RESP RES, V15, DOI 10.1186/s12931-014-0134-x; Tracy RP, 2013, J AM HEART ASSOC, V2, DOI 10.1161/JAHA.113.000117; Valgimigli M, 2004, CIRCULATION, V110, P1209, DOI 10.1161/01.CIR.0000136813.89036.21; Vasa M, 2001, CIRC RES, V89, pE1, DOI 10.1161/hh1301.093953; Vasa M, 2001, CIRCULATION, V103, P2885, DOI 10.1161/hc2401.092816; Vestbo J, 2013, AM J RESP CRIT CARE, V187, P347, DOI 10.1164/rccm.201204-0596PP; Walter DH, 2002, CIRCULATION, V105, P3017, DOI 10.1161/01.CIR.0000018166.84319.55; Wang HY, 2007, HYPERTENS RES, V30, P133, DOI 10.1291/hypres.30.133; Wanger J, 2005, EUR RESPIR J, V26, P511, DOI 10.1183/09031936.05.00035005; Werner N, 2002, ARTERIOSCL THROM VAS, V22, P1567, DOI 10.1161/01.ATV.0000036417.43987.D8; Yang Y, 2013, CHINESE MED J-PEKING, V126, P3222, DOI 10.3760/cma.j.issn.0366-6999.20122633; Zhu JH, 2008, RESP MED, V102, P1073, DOI 10.1016/j.rmed.2007.12.030	78	17	21	2	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 14	2017	12	3							e0173446	10.1371/journal.pone.0173446	http://dx.doi.org/10.1371/journal.pone.0173446			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN6DM	28291826	Green Published, gold, Green Submitted			2022-12-27	WOS:000396094700026
J	Nannyonga, B; Sumpter, DJT				Nannyonga, Betty; Sumpter, David J. T.			Modelling optimal allocation of resources in the context of an incurable disease	PLOS ONE			English	Article							TIME	Nodding syndrome has affected and led to the deaths of children between the ages of 5 and 15 in Northern Uganda since 2009. There is no reliable explanation of the disease, and currently the only treatment is through a nutritional programme of vitamins, combined with medication to prevent symptoms. In the absence of a proper medical treatment, we develop a dynamic compartmental model to plan the management of the syndrome and to curb its effects. We use incidence data from 2012 and 2013 from Pader, Lamwo and Kitgum regions of Uganda to parameterize the model. The model is then used to look at how to best plan the nutritional programme in terms of first getting children on to the programme through outreach, and then making sure they remain on the programme, through follow-up. For the current outbreak of nodding disease, we estimate that about half of available resources should be put into outreach. We show how to optimize the balance between outreach and follow-up in this particular example, and provide a general methodology for allocating resources in similar situations. Given the uncertainty of parameter estimates in such situations, we perform a robustness analysis to identify the best investment strategy. Our analysis offers a way of using available data to determine the best investment strategy of controlling nodding syndrome.	[Nannyonga, Betty] Makerere Univ, Coll Nat Sci, Sch Phys Sci, Dept Math, Kampala, Uganda; [Sumpter, David J. T.] Uppsala Univ, Math Inst, Ctr Interdisciplinary Math, Dept Math, Uppsala, Sweden	Makerere University; Uppsala University	Nannyonga, B (corresponding author), Makerere Univ, Coll Nat Sci, Sch Phys Sci, Dept Math, Kampala, Uganda.	bnk@cns.mak.a.ug			Faculty for the Future, Mathematics Institution, Uppsala University, Sweden; Center for Interdisciplinary Mathematics, Mathematics Institution, Uppsala University, Sweden	Faculty for the Future, Mathematics Institution, Uppsala University, Sweden; Center for Interdisciplinary Mathematics, Mathematics Institution, Uppsala University, Sweden	BN acknowledges funding from the Faculty for the Future and the Center for Interdisciplinary Mathematics, Mathematics Institution, Uppsala University, Sweden. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; BN acknowledges funding from the Faculty for the Future and the Center for Interdisciplinary Mathematics, Mathematics Institution, Uppsala University, Sweden. BN thanks the Ministry of Health Uganda for the data. The authors extend gratitude to the constructive comments from the reviewers.	Abraham C., 2011, NEW SCI; [Anonymous], 2012, BBC NEWS; [Anonymous], 2005, MONITOR; Butagira T., 2014, NODDING DIS CRYSTALS; Castillo-Chavez C, 2004, MATH BIOSCI ENG, V1, P361, DOI 10.3934/mbe.2004.1.361; Castillo-Chavez C, 2002, HIST SEXUALITY, P229; Chester P, 1984, CLIN PARASITOLOGY; Chitnis N, 2008, B MATH BIOL, V70, P1272, DOI 10.1007/s11538-008-9299-0; Deng Y, 2013, MATH BIOSCI, V246, P213, DOI 10.1016/j.mbs.2013.09.007; Dugdale DC, 1999, J GEN INTERN MED, V14, pS34, DOI 10.1046/j.1525-1497.1999.00263.x; Fleming W.H., 2012, DETERMINISTIC STOCHA; Foltz JL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066419; Garcia LS, 1997, DIAGNOSTIC MED PARAS, V3rd ed; Harding A., 2003, BBC NEWS; Kamien M. I., 1991, DYNAMIC OPTIMIZATION; Kar TK, 2012, BIOSYSTEMS, V109, P220, DOI 10.1016/j.biosystems.2012.02.003; Kobayashi M, 2007, PREV VET MED, V79, P274, DOI 10.1016/j.prevetmed.2007.01.001; Lacy M., 2014, LANCET NEUROL, V12, P714; Makumbi C., 2014, PARENTS NEGLECT NODD; Nannyonga B, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041135; Ocungi J., 2014, SCH BARS NODDING CHI; Osei-Atweneboano MY, 2007, LANCET, V369, P2021, DOI 10.1016/S0140-6736(07)60942-8; Pontryagin LS, 1962, MATH THEORY OPTIMAL; Rodrigues Helena Sofia Ferreira, 2012, THESIS; ROLAND MO, 1986, BRIT MED J, V292, P874, DOI 10.1136/bmj.292.6524.874; Ross E., 2004, CBS NEWS; Sejvar JJ, 2013, LANCET NEUROL, V12, P166, DOI 10.1016/S1474-4422(12)70321-6; Wadman M., 2011, NATURE	28	2	2	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 13	2017	12	3							e0172401	10.1371/journal.pone.0172401	http://dx.doi.org/10.1371/journal.pone.0172401			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN6CP	28288182	Green Published, gold, Green Submitted			2022-12-27	WOS:000396092400006
J	Radaszkiewicz, KA; Sykorova, D; Bino, L; Kudova, J; Bebarova, M; Prochazkova, J; Kotasova, H; Kubala, L; Pachernik, J				Radaszkiewicz, Katarzyna Anna; Sykorova, Dominika; Bino, Lucia; Kudova, Jana; Bebarova, Marketa; Prochazkova, Jirina; Kotasova, Hana; Kubala, Lukas; Pachernik, Jiri			The acceleration of cardiomyogenesis in embryonic stem cells in vitro by serum depletion does not increase the number of developed cardiomyocytes	PLOS ONE			English	Article							NEURAL DIFFERENTIATION; RETINOIC ACID; CARCINOMA-CELLS; EXPRESSION; DEPRIVATION; GENERATION; MESODERM; 3-KINASE; STRAIN	The differentiation of pluripotent embryonic stem (ES) cells into various lineages in vitro represents an important tool for studying the mechanisms underlying mammalian embryogenesis. It is a key technique in studies evaluating the molecular mechanisms of cardiomyogenesis and heart development and also in embryotoxicology. Herein, modest modifications of the basic protocol for ES cell differentiation into cardiomyocytes were evaluated in order to increase the yield and differentiation status of developed cardiomyocytes. Primarily, the data show that ES cell cultivation in the form of non-adherent embryoid bodies (EBs) for 5 days compared to 8 days significantly improved cardiomyogenic differentiation. This is illustrated by the appearance of beating foci in the adherent EBs layer at earlier phases of differentiation from day 10 up to day 16 and by the significantly higher expression of genes characteristic of cardiomyogenic differentiation (sarcomeric alpha actinin, myosin heavy chain alpha and beta, myosin light chain 2 and 7, and transcriptional factor Nkx2.5) in EBs cultivated under non- adherent conditions for 5 days. The ratio of cardiomyocytes per other cells was also potentiated in EBs cultivated in non- adherent conditions for only 5 days followed by cultivation in adherent serumfree culture conditions. Nevertheless, the alteration in the percentage of beating foci among these two tested cultivation conditions vanished at later phases and also did not affect the total number of cardiomyocytes determined as myosin heavy chain positive cells at the end of the differentiation process on day 20. Thus, although these modifications of the conditions of ES cells differentiation may intensify cardiomyocyte differentiation, the final count of cardiomyocytes might not change. Thus, serum depletion was identified as a key factor that intensified cardiomyogenesis. Further, the treatment of EBs with N-acetylcysteine, a reactive oxygen species scavenger, did not affect the observed increase in cardiomyogenesis under serum depleted conditions. Interestingly, a mild induction of the ventricular-like phenotype of cardiomyocytes was observed in 5-day-old EBs compared to 8-day-old EBs. Overall, these findings bring crucial information on the mechanisms of ES cells differentiation into cardiomyocytes and on the establishment of efficient protocols for the cardiomyogenic differentiation of ES cells. Further, the importance of determining the absolute number of formed cardiomyocyte-like cells per seeded pluripotent cells in contrast to the simple quantification of the ratios of cells is highlighted.	[Radaszkiewicz, Katarzyna Anna; Sykorova, Dominika; Bino, Lucia; Kudova, Jana; Pachernik, Jiri] Masaryk Univ, Dept Expt Biol, Fac Sci, Brno, Czech Republic; [Sykorova, Dominika; Bino, Lucia; Kudova, Jana; Kubala, Lukas] Acad Sci Czech Republ, Inst Biophys, Dept Free Radical Pathophysiol, Brno, Czech Republic; [Bino, Lucia; Prochazkova, Jirina; Kotasova, Hana; Kubala, Lukas] St Annes Univ Hosp, Ctr Biomol & Cellular Engn, Int Clin Res Ctr, Brno, Czech Republic; [Bebarova, Marketa] Masaryk Univ, Dept Physiol, Fac Med, Brno, Czech Republic; [Prochazkova, Jirina; Kotasova, Hana] Masaryk Univ, Dept Histol & Embryol, Fac Med, Brno, Czech Republic	Masaryk University Brno; Czech Academy of Sciences; Institute of Biophysics of the Czech Academy of Sciences; St Anne's University Hospital Brno (FNUSA-ICRC); Masaryk University Brno; Masaryk University Brno	Pachernik, J (corresponding author), Masaryk Univ, Dept Expt Biol, Fac Sci, Brno, Czech Republic.	jipa@sci.muni.cz	Kubala, Lukas/H-6329-2014; Kotasova, Hana/F-6222-2012; Prochazkova, Jirina/D-4403-2015	Kubala, Lukas/0000-0002-7729-7338; Prochazkova, Jirina/0000-0003-2738-8546; Pereckova, Jana/0000-0002-7565-993X	Czech Grant Agency [GA13-29358S]; MEYS of the Czech Republick [LQ1605 NPU II]	Czech Grant Agency(Grant Agency of the Czech Republic); MEYS of the Czech Republick	This work was supported by the Czech Grant Agency (GA13-29358S) and by MEYS of the Czech Republick (LQ1605 NPU II).	Ao A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041627; Bebarova M, 2016, N-S ARCH PHARMACOL, V389, P1049, DOI 10.1007/s00210-016-1265-z; Boheler KR, 2002, CIRC RES, V91, P189, DOI 10.1161/01.RES.0000027865.61704.32; Bruce SJ, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-365; David R, 2012, PHYSIOLOGY, V27, P119, DOI 10.1152/physiol.00044.2011; England J, 2013, CELL MOL LIFE SCI, V70, P1221, DOI 10.1007/s00018-012-1131-1; Franco D, 1998, CARDIOVASC RES, V38, P25, DOI 10.1016/S0008-6363(97)00321-0; Garbern JC, 2013, CSH PERSPECT MED, V3, DOI 10.1101/cshperspect.a014019; Gissel Cornelia, 2006, V330, P191; Gopalan SM, 2003, BIOTECHNOL BIOENG, V81, P578, DOI 10.1002/bit.10506; Hao JJ, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002904; Hsiao EC, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002532; Klug MG, 1996, J CLIN INVEST, V98, P216, DOI 10.1172/JCI118769; Kolossov E, 2005, FASEB J, V19, P577, DOI 10.1096/fj.03-1451fje; Konopka R, 2010, FOLIA BIOL-PRAGUE, V56, P66; Konopka R, 2008, NEUROENDOCRINOL LETT, V29, P770; Kotasova H, 2012, J CELL BIOCHEM, V113, P563, DOI 10.1002/jcb.23380; Kudova J, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0158358; Kwon C, 2007, P NATL ACAD SCI USA, V104, P10894, DOI 10.1073/pnas.0704044104; Lee SB, 2010, APOPTOSIS, V15, P204, DOI 10.1007/s10495-009-0411-1; Liao SY, 2013, STEM CELL RES THER, V4, DOI 10.1186/scrt381; Mahmoud AI, 2012, TRENDS CARDIOVAS MED, V22, P128, DOI 10.1016/j.tcm.2012.07.008; Mansour H, 2004, CIRC RES, V94, P642, DOI 10.1161/01.RES.0000121101.32286.C8; Moretti A., 2013, COLD SPRING HARB PER, V3; Pachernik J, 2005, PHYSIOL RES, V54, P115, DOI 10.33549/physiolres.930526; Pachernik J, 2002, REPROD NUTR DEV, V42, P317, DOI 10.1051/rnd:2002028; Passier R, 2005, STEM CELLS, V23, P772, DOI 10.1634/stemcells.2004-0184; Prochazkova J, 2013, TOXICOL SCI, V134, P258, DOI 10.1093/toxsci/kft110; Radaszkiewicz KA, 2016, REV SCI INSTRUM, V87, DOI 10.1063/1.4941776; Rajasingh J, 2007, CIRC RES, V101, P910, DOI 10.1161/CIRCRESAHA.107.156786; Satoh T, 1996, BRAIN RES, V733, P9, DOI 10.1016/0006-8993(96)00527-6; Sauer H, 2004, EXP CELL RES, V294, P313, DOI 10.1016/j.yexcr.2003.10.032; Sauer H, 2000, FEBS LETT, V476, P218, DOI 10.1016/S0014-5793(00)01747-6; Sauer Heinrich, 2008, V477, P397, DOI 10.1007/978-1-60327-517-0_30; Schmelter M, 2006, FASEB J, V20, P1182, DOI 10.1096/fj.05-4723fje; Stummann TC, 2008, ASSAY DRUG DEV TECHN, V6, P375, DOI 10.1089/adt.2008.129; Taha MF, 2007, INT J CARDIOL, V120, P92, DOI 10.1016/j.ijcard.2006.08.118; Tran TH, 2009, STEM CELLS, V27, P1869, DOI 10.1002/stem.95; Vesela I, 2010, FOLIA BIOL-PRAGUE, V56, P165; Wiles MV, 1999, EXP CELL RES, V247, P241, DOI 10.1006/excr.1998.4353; Yamasaki S, 2013, INT J DEV BIOL, V57, P715, DOI 10.1387/ijdb.130173to; Zeineddine D, 2005, METH MOLEC MED, V112, P175	42	6	6	2	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 13	2017	12	3							e0173140	10.1371/journal.pone.0173140	http://dx.doi.org/10.1371/journal.pone.0173140			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN6CP	28288171	Green Published, gold, Green Submitted			2022-12-27	WOS:000396092400008
J	Kassas-Guediri, A; Coudrat, J; Pacreau, E; Launay, P; Monteiro, RC; Blank, U; Charles, N; Benhamou, M				Kassas-Guediri, Asma; Coudrat, Julie; Pacreau, Emeline; Launay, Pierre; Monteiro, Renato C.; Blank, Ulrich; Charles, Nicolas; Benhamou, Marc			Phospholipid scramblase 1 amplifies anaphylactic reactions in vivo	PLOS ONE			English	Article							MAST-CELL ACTIVATION; UV-INDUCED APOPTOSIS; IGE RECEPTOR; MACROPHAGE PHAGOCYTOSIS; VIRUS-REPLICATION; PROTEIN; INTERFERON; INHIBITION; EXPRESSION; PHOSPHORYLATION	Mast cells are critical actors of hypersensitivity type I (allergic) reactions by the release of vasoactive and proinflammatory mediators following their activation by aggregation of the high-affinity receptor for immunoglobulin E (Fc epsilon RI). We have previously identified Phospholipid Scramblase 1 (PLSCR1) as a new molecular intermediate of FceRI signaling that amplifies degranulation of the rat mast cell line RBL-2H3. Here we characterized primary mast cells from Plscr1(-/-) mice. The absence of PLSCR1 expression did not impact mast cell differentiation as evidenced by unaltered Fc epsilon RI expression, general morphology, amount of histamine stored and expression of Fc epsilon RI signal effector molecules. No detectable mast cell deficiency was observed in Plscr1(-/-) adult mice. In dose-response and time-course experiments, primary cultures of mast cells (bone marrow-derived mast cells and peritoneal cell-derived mast cells) generated from Plscr1(-/-) mice exhibited a reduced release of beta-hexosaminidase upon Fc epsilon RI engagement as compared to their wild-type counterparts. In vivo, Plscr1(-/-) mice were protected in a model of passive systemic anaphylaxis when compared to wild-type mice, which was consistent with an observed decrease in the amounts of histamine released in the serum of Plscr1(-/-) mice during the reaction. Therefore, PLSCR1 aggravates anaphylactic reactions by increasing Fc epsilon RI-dependent mast cell degranulation. PLSCR1 could be a new therapeutic target in allergy.	[Kassas-Guediri, Asma; Coudrat, Julie; Pacreau, Emeline; Launay, Pierre; Monteiro, Renato C.; Blank, Ulrich; Charles, Nicolas; Benhamou, Marc] INSERM U1149, Fac Med Xavier Bichat, Paris, France; [Kassas-Guediri, Asma; Coudrat, Julie; Pacreau, Emeline; Launay, Pierre; Monteiro, Renato C.; Blank, Ulrich; Charles, Nicolas; Benhamou, Marc] Univ Paris Diderot, Lab Excellence INFLAMEX, Sorbonne Paris Cite, DHU FIRE, Paris, France	Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Bichat-Claude Bernard - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; Universite Paris Cite	Benhamou, M (corresponding author), INSERM U1149, Fac Med Xavier Bichat, Paris, France.; Benhamou, M (corresponding author), Univ Paris Diderot, Lab Excellence INFLAMEX, Sorbonne Paris Cite, DHU FIRE, Paris, France.	marc.benhamou@inserm.fr	Launay, Pierre/AAH-7076-2019; CHARLES, Nicolas/P-5430-2014; CHARLES, Nicolas/S-2214-2019; Monteiro, Renato C/U-8633-2017	CHARLES, Nicolas/0000-0002-5416-5834; CHARLES, Nicolas/0000-0002-5416-5834; Monteiro, Renato C/0000-0001-5202-5646; Benhamou, Marc/0000-0001-7763-3795; Blank, Ulrich/0000-0002-2661-2983	Investissements d'Avenir programme, Sorbonne Paris Cite, Laboratoire d'excellence INFLAMEX [ANR-11-IDEX-0005-02]	Investissements d'Avenir programme, Sorbonne Paris Cite, Laboratoire d'excellence INFLAMEX(French National Research Agency (ANR))	AKG was supported by Investissements d'Avenir programme ANR-11-IDEX-0005-02, Sorbonne Paris Cite, Laboratoire d'excellence INFLAMEX (http://inflamex.fr/). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amir-Moazami O, 2008, J BIOL CHEM, V283, P25514, DOI 10.1074/jbc.M705320200; Bailey K, 2005, BBA-MOL CELL BIOL L, V1733, P199, DOI 10.1016/j.bbalip.2004.12.013; BENHAMOU M, 1986, J IMMUNOL, V136, P1385; Chen CW, 2011, J LEUKOCYTE BIOL, V90, P221, DOI 10.1189/jlb.0111006; Cui W, 2012, HEPATOB PANCREAT DIS, V11, P393, DOI 10.1016/S1499-3872(12)60197-0; Dahdah A, 2014, J CLIN INVEST, V124, P4577, DOI 10.1172/JCI75212; Dong BH, 2004, J VIROL, V78, P8983, DOI 10.1128/JVI.78.17.8983-8993.2004; Feyerabend TB, 2011, IMMUNITY, V35, P832, DOI 10.1016/j.immuni.2011.09.015; Galli SJ, 2016, ALLERGOL INT, V65, P3, DOI 10.1016/j.alit.2015.09.002; Galli SJ, 2010, EUR J IMMUNOL, V40, P1843, DOI 10.1002/eji.201040559; Gilfillan AM, 2006, NAT REV IMMUNOL, V6, P218, DOI 10.1038/nri1782; Goren MA, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6115; Herate C, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0145617; Huang Y, 2006, ONCOGENE, V25, P6618, DOI 10.1038/sj.onc.1209677; Kalesnikoff J, 2010, CHEM IMMUNOL ALLERGY, V95, P45, DOI 10.1159/000315937; Kantari C, 2007, BLOOD, V110, P4086, DOI 10.1182/blood-2007-03-080457; Kassas A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0109800; Kasukabe T, 1997, BLOOD, V89, P2975, DOI 10.1182/blood.V89.8.2975; Kraft S, 2007, NAT REV IMMUNOL, V7, P365, DOI 10.1038/nri2072; Kubo S, 2003, J IMMUNOL, V170, P775, DOI 10.4049/jimmunol.170.2.775; Kusano S, 2013, BIOCHEM BIOPH RES CO, V433, P438, DOI 10.1016/j.bbrc.2013.02.098; Kusano S, 2012, VIROLOGY, V432, P343, DOI 10.1016/j.virol.2012.06.019; Launay P, 1998, J LEUKOCYTE BIOL, V63, P636, DOI 10.1002/jlb.63.5.636; Li Yabin, 2006, POW EL MOT CONTR C 2, V1, P1, DOI DOI 10.1016/JJHAZMAT2006.02.011; Lizak M, 2012, CELL HOST MICROBE, V11, P70, DOI 10.1016/j.chom.2011.12.004; Malbec O, 2007, J IMMUNOL, V178, P6465, DOI 10.4049/jimmunol.178.10.6465; Metcalfe DD, 2009, J ALLERGY CLIN IMMUN, V124, P639, DOI 10.1016/j.jaci.2009.08.035; Metz P, 2012, HEPATOLOGY, V56, P2082, DOI 10.1002/hep.25908; Mukai K, 2016, SEMIN IMMUNOPATHOL, V38, P581, DOI 10.1007/s00281-016-0565-1; Nakamaki T, 2002, EXP HEMATOL, V30, P421, DOI 10.1016/S0301-472X(02)00779-8; Nanjundan M, 2003, J BIOL CHEM, V278, P37413, DOI 10.1074/jbc.M306182200; Palm NW, 2012, NATURE, V484, P465, DOI 10.1038/nature11047; Pastorelli C, 2001, J BIOL CHEM, V276, P20407, DOI 10.1074/jbc.M100790200; Silverman RH, 2002, CANCER RES, V62, P397; Siraganian RP, 2003, CURR OPIN IMMUNOL, V15, P639, DOI 10.1016/j.coi.2003.09.010; STRACKE ML, 1987, MOL IMMUNOL, V24, P347, DOI 10.1016/0161-5890(87)90176-3; Suzuki J, 2013, SCIENCE, V341, P403, DOI 10.1126/science.1236758; Suzuki J, 2013, J BIOL CHEM, V288, P13305, DOI 10.1074/jbc.M113.457937; Talukder AH, 2012, CELL RES, V22, P1129, DOI 10.1038/cr.2012.45; Yang J, 2012, ANTIVIR RES, V94, P9, DOI 10.1016/j.antiviral.2012.01.010; Yu A, 2004, BIOCHEM J, V381, P609, DOI 10.1042/BJ20031857; Yuan YZ, 2015, J PROTEOME RES, V14, P154, DOI 10.1021/pr500943x; Zhou QS, 2002, BLOOD, V99, P4030, DOI 10.1182/blood-2001-12-0271; Zhou QS, 1997, J BIOL CHEM, V272, P18240, DOI 10.1074/jbc.272.29.18240	44	6	6	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 10	2017	12	3							e0173815	10.1371/journal.pone.0173815	http://dx.doi.org/10.1371/journal.pone.0173815			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN6CJ	28282470	Green Published, Green Submitted, gold			2022-12-27	WOS:000396091800081
J	Wlodarczyk, A; Sonakowska, L; Kaminska, K; Marchewka, A; Wilczek, G; Wilczek, P; Student, S; Rost-Roszkowska, M				Wlodarczyk, Agnieszka; Sonakowska, Lidia; Kaminska, Karolina; Marchewka, Angelika; Wilczek, Grazyna; Wilczek, Piotr; Student, Sebastian; Rost-Roszkowska, Magdalena			The effect of starvation and re-feeding on mitochondrial potential in the midgut of Neocaridina davidi (Crustacea, Malacostraca)	PLOS ONE			English	Article							CELL-DEATH; AUTOPHAGY; APOPTOSIS; EPITHELIUM; PHALANGIIDAE; STRESS; PARKIN; GLAND	The midgut in the freshwater shrimp Neocaridina davidi (previously named N. heteropoda) (Crustacea, Malacostraca) is composed of a tube-shaped intestine and a large hepatopancreas that is formed by numerous blind-ended tubules. The precise structure and ultrastructure of these regions were presented in our previous papers, while here we focused on the ultrastructural changes that occurred in the midgut epithelial cells (D-cells in the intestine, Band F-cells in the hepatopancreas) after long-term starvation and re-feeding. We used transmission electron microscopy, light and confocal microscopes and flow cytometry to describe all of the changes that occurred due to the stressor with special emphasis on mitochondrial alterations. A quantitative assessment of cells with depolarized mitochondria helped us to establish whether there is a relationship between starvation, re-feeding and the inactivation/activation of mitochondria. The results of our studies showed that in the freshwater shrimp N. davidi that were analyzed, long-term starvation activates the degeneration of epithelial cells at the ultrastructural level and causes an increase of cells with depolarized (non-active) mitochondria. The process of re-feeding leads to the gradual regeneration of the cytoplasm of the midgut epithelial cells; however, these changes were observed at the ultrastructural level. Additionally, re-feeding causes the regeneration of mitochondrial ultrastructure. Therefore, we can state that the increase in the number of cells with polarized mitochondria occurs slowly and does not depend on ultrastructural alterations.	[Wlodarczyk, Agnieszka; Sonakowska, Lidia; Kaminska, Karolina; Marchewka, Angelika; Rost-Roszkowska, Magdalena] Univ Silesia, Dept Anim Histol & Embryol, Katowice, Poland; [Wilczek, Grazyna] Univ Silesia, Dept Anim Physiol & Ecotoxicol, Katowice, Poland; [Wilczek, Piotr] Heart Prosthesis Inst, Bioengn Lab, Zabrze, Poland; [Student, Sebastian] Silesian Tech Univ, Inst Automat Control, Fac Automat Control Elect & Comp Sci, Gliwice, Poland	University of Silesia in Katowice; University of Silesia in Katowice; Silesian University of Technology	Rost-Roszkowska, M (corresponding author), Univ Silesia, Dept Anim Histol & Embryol, Katowice, Poland.	magdalena.rost-roszkowska@us.edu.pl	Student, Sebastian/H-7895-2013; Rost-Roszkowska, Magdalena/AAM-7005-2020	Student, Sebastian/0000-0003-1812-5496; Wilczek, Piotr/0000-0002-4968-6512; Wlodarczyk, Agnieszka/0000-0002-2374-4892; Wilczek, Grazyna/0000-0002-3276-0333; Rost-Roszkowska, Magdalena/0000-0001-7124-8423	GCONiI - Upper - Silesian Center for Scientific Computation [POIG.02.03.01-24-099/13]	GCONiI - Upper - Silesian Center for Scientific Computation	This work was supported by POIG.02.03.01-24-099/13 grant: GCONiI - Upper - Silesian Center for Scientific Computation (SS).; We would like to express our gratitude to Professor Jerzy Klag (University of Silesia, Poland) for his substantive advice and Drs. Danuta Urbanska-Jasik, Alina Chachulska-Zymelka and Lukasz Chajec (University of Silesia, Poland) for their technical assistance. This work was performed using the infrastructure supported by POIG.02.03.01-24-099/13 grant: "GCONiI-Upper-Silesian Center for Scientific Computation".	AFZELIUS BA, 1966, EXP CELL RES, V42, P10, DOI 10.1016/0014-4827(66)90314-4; Cano M, 2014, FREE RADICAL BIO MED, V69, P1, DOI 10.1016/j.freeradbiomed.2014.01.004; DEPAZ O, 1986, MAMMALIA, V50, P243, DOI 10.1515/mamm.1986.50.2.243; Pantaleao JAF, 2015, J CRUSTACEAN BIOL, V35, P676, DOI 10.1163/1937240X-00002357; Faron J, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0117187; Fernandez-Checa JC, 2003, BIOCHEM BIOPH RES CO, V304, P471, DOI 10.1016/S0006-291X(03)00619-3; Franzetti E, 2012, APOPTOSIS, V17, P305, DOI 10.1007/s10495-011-0675-0; Frezza C, 2006, CELL, V126, P177, DOI 10.1016/j.cell.2006.06.025; Greene JC, 2003, P NATL ACAD SCI USA, V100, P4078, DOI 10.1073/pnas.0737556100; KALASHNIKOVA MM, 1979, B EXP BIOL MED+, V88, P771, DOI 10.1007/BF00804791; Karpeta-Kaczmarek J, 2016, ARTHROPOD STRUCT DEV, V45, P253, DOI 10.1016/j.asd.2016.02.002; Klionsky DJ, 2000, SCIENCE, V290, P1717, DOI 10.1126/science.290.5497.1717; Kourtis N, 2009, CELL DEATH DIFFER, V16, P21, DOI 10.1038/cdd.2008.120; Lignot J.-H., 2012, COMP PHYSL FASTING S, P7; Lipovsek S, 2016, PROTOPLASMA, V253, P457, DOI 10.1007/s00709-015-0824-3; Lipovsek S, 2015, ARTHROPOD STRUCT DEV, V44, P131, DOI 10.1016/j.asd.2014.12.002; Lipovsek S, 2014, ARTHROPOD STRUCT DEV, V43, P493, DOI 10.1016/j.asd.2014.06.001; Martin LJ, 2010, PHARMACEUTICALS, V3, P839, DOI 10.3390/ph3040839; Moyes CD, 1998, J EXP BIOL, V201, P299; Narendra D, 2008, J CELL BIOL, V183, P795, DOI 10.1083/jcb.200809125; Orrenius S, 2004, TOXICOL LETT, V149, P19, DOI 10.1016/j.toxlet.2003.12.017; RATCLIFFE NA, 1969, Z ZELLFORSCH MIK ANA, V99, P459, DOI 10.1007/BF00337615; Richter C, 1996, FEBS LETT, V378, P107, DOI 10.1016/0014-5793(95)01431-4; Rost-Roszkowska MM, 2015, MICRON, V68, P130, DOI 10.1016/j.micron.2014.10.003; Rost-Roszkowska MM, 2012, ARTHROPOD STRUCT DEV, V41, P271, DOI 10.1016/j.asd.2012.01.001; Saleh RA, 2003, FERTIL STERIL, V79, P1597, DOI 10.1016/S0015-0282(03)00337-6; Salvioli S, 1997, FEBS LETT, V411, P77, DOI 10.1016/S0014-5793(97)00669-8; Sanchez-Paz A, 2007, J EXP MAR BIOL ECOL, V340, P184, DOI 10.1016/j.jembe.2006.09.006; Sonakowska L, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0147582; Sonakowska L, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0126900; SOUTY C, 1981, REPROD NUTR DEV, V21, P95, DOI 10.1051/rnd:19810108; Wilczek G, 2005, COMP BIOCHEM PHYS C, V141, P194, DOI 10.1016/j.cca.2005.06.007; Wilczek G, 2014, ECOTOX ENVIRON SAFE, V101, P157, DOI 10.1016/j.ecoenv.2013.09.034; Yang J, 1997, SCIENCE, V275, P1129, DOI 10.1126/science.275.5303.1129; Youle RJ, 2011, NAT REV MOL CELL BIO, V12, P9, DOI 10.1038/nrm3028	35	17	18	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 10	2017	12	3							e0173563	10.1371/journal.pone.0173563	http://dx.doi.org/10.1371/journal.pone.0173563			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN6CJ	28282457	Green Published, gold, Green Submitted			2022-12-27	WOS:000396091800050
J	Kim, J; Yoon, SJ; Woo, MH; Kim, SH; Kim, NK; Kim, J; Kim, OJ; Oh, SH				Kim, Jonguk; Yoon, Seung-Jae; Woo, Min-Hee; Kim, Sang-Heum; Kim, Nam-Keun; Kim, Jinkwon; Kim, Ok-Joon; Oh, Seung-Hun			Differential impact of serum total bilirubin level on cerebral atherosclerosis and cerebral small vessel disease	PLOS ONE			English	Article							CAROTID ATHEROSCLEROSIS; STROKE SUBTYPES; RISK-FACTORS; ASSOCIATION; LEUKOARAIOSIS; INFARCTION; LACUNAR	Background A low serum total bilirubin (T-bil) level is associated with an increased risk of atherosclerosis. However, the differential impact of the serum T-bil level on cerebral atherosclerosis and cerebral small vessel disease (SVD) is still unclear. Methods We evaluated serum T-bil levels from 1,128 neurologically healthy subjects. Indices of cerebral atherosclerosis (extracranial arterial stenosis [ECAS] and intracranial arterial stenosis [ICAS]), and indices of SVD (silent lacunar infarct [SLI], and moderate-to-severe white matter hyperintensities [msWMH]) were evaluated by the use of brain magnetic resonance imaging (MRI) and MR angiography. Results In logistic regression analysis after adjusting for confounding variables, subjects within middle T-bil (odds ratio [ OR]: 0.63; 95% CI: 0.41-0.97) and high T-bil tertiles (OR: 0.54; 95% CI: 0.33-0.86) showed a lower prevalence of ECAS than those in a low T-bil tertile. Although subjects with a high T-bil tertile had a lower prevalence of ICAS than those with a low T-bil tertile, the statistical significance was marginal after adjusting for confounding variables. There were no significant differences in the proportions of subjects with SLI and msWMH across serum T-bil tertile groups. Conclusions The serum T-bil level is negatively associated with cerebral atherosclerosis, especially extracranial atherosclerosis, but not with SVD.	[Kim, Jonguk; Yoon, Seung-Jae; Woo, Min-Hee; Kim, Jinkwon; Kim, Ok-Joon; Oh, Seung-Hun] CHA Univ, CHA Bundang Med Ctr, Dept Neurol, Seongnam, South Korea; [Kim, Sang-Heum] CHA Univ, CHA Bundang Med Ctr, Dept Radiol, Seongnam, South Korea; [Kim, Nam-Keun] CHA Univ, CHA Bundang Med Ctr, Inst Clin Res, Seongnam, South Korea	Pochon Cha University; Pochon Cha University; Pochon Cha University	Oh, SH (corresponding author), CHA Univ, CHA Bundang Med Ctr, Dept Neurol, Seongnam, South Korea.	ohsh72@chamc.co.kr		Kim, Jonguk/0000-0002-3026-9532	Basic Science Research Program through National Research Foundation of Korea (NRF) - Ministry of Education, Science and Technology [NRF-20151D1A1A01060263]	Basic Science Research Program through National Research Foundation of Korea (NRF) - Ministry of Education, Science and Technology	This study was supported by grants of Basic Science Research Program through the National Research Foundation of Korea (NRF) funded by the Ministry of Education, Science and Technology (NRF-20151D1A1A01060263).	Aboyans V, 2007, PROG CARDIOVASC DIS, V50, P112, DOI 10.1016/j.pcad.2007.04.001; Akboga MK, 2015, ATHEROSCLEROSIS, V240, P110, DOI 10.1016/j.atherosclerosis.2015.02.051; Amarenco P, 2009, CEREBROVASC DIS, V27, P493, DOI 10.1159/000210432; Baranano DE, 2002, P NATL ACAD SCI USA, V99, P16093, DOI 10.1073/pnas.252626999; CAPLAN LR, 1986, STROKE, V17, P648, DOI 10.1161/01.STR.17.4.648; Chimowitz MI, 2005, NEW ENGL J MED, V352, P1305, DOI 10.1056/NEJMoa043033; Clase CM, 2002, J AM SOC NEPHROL, V13, DOI 10.1097/01.ASN.0000013291.78621.26; Erdogan D, 2006, ATHEROSCLEROSIS, V184, P431, DOI 10.1016/j.atherosclerosis.2005.05.011; FAZEKAS F, 1987, AM J ROENTGENOL, V149, P351, DOI 10.2214/ajr.149.2.351; FISHER CM, 1969, ACTA NEUROPATHOL, V12, P1, DOI 10.1007/BF00685305; Fisher M, 1993, STROKE, V24, pI31; Hassan A, 2003, BRAIN, V126, P424, DOI 10.1093/brain/awg040; Ishizaka N, 2001, STROKE, V32, P581, DOI 10.1161/01.STR.32.2.580-b; Kawamoto R, 2016, CLIN EXP HYPERTENS, V38, P107, DOI 10.3109/10641963.2015.1060990; Kawamoto R, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0114281; Kim ES, 2015, ENDOCRINE, V50, P405, DOI 10.1007/s12020-015-0583-0; Kim JS, 2014, J STROKE, V16, P105, DOI 10.5853/jos.2014.16.3.105; Kim JS, 2012, STROKE, V43, P3313, DOI 10.1161/STROKEAHA.112.658500; Kim YD, 2009, NEUROEPIDEMIOLOGY, V32, P201, DOI 10.1159/000195690; KULLER L, 1971, AM J EPIDEMIOL, V93, P1; Kwak Jae Hyuk, 2011, Neurointervention, V6, P78, DOI 10.5469/neuroint.2011.6.2.78; Lee HB, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0143355; Li RY, 2014, ARTERIOSCL THROM VAS, V34, P946, DOI 10.1161/ATVBAHA.113.303003; Park BJ, 2012, CLIN BIOCHEM, V45, P289, DOI 10.1016/j.clinbiochem.2011.12.023; Perlstein T., 2008, ARTERIOSCLER THROMB, V28, P166, DOI DOI 10.1161/ATVBAHA.107.153262; STOCKER R, 1987, SCIENCE, V235, P1043, DOI 10.1126/science.3029864; Wardlaw JM, 2008, STROKE, V39, P1327, DOI 10.1161/STROKEAHA.107.500124; Yang XF, 2009, INTERNAL MED, V48, P1595, DOI 10.2169/internalmedicine.48.2286	28	6	6	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 20	2017	12	3							e0173736	10.1371/journal.pone.0173736	http://dx.doi.org/10.1371/journal.pone.0173736			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ER6VC	28319156	Green Submitted, Green Published, gold			2022-12-27	WOS:000398945800028
J	Berli, M; Borau, C; Decco, O; Adams, G; Cook, RB; Aznar, JMG; Zioupos, P				Berli, Marcelo; Borau, Carlos; Decco, Oscar; Adams, George; Cook, Richard B.; Garcia Aznar, Jose Manuel; Zioupos, Peter			Localized tissue mineralization regulated by bone remodelling: A computational approach	PLOS ONE			English	Article							FINITE-ELEMENT MODELS; TRABECULAR BONE; DENSITY DISTRIBUTION; COMPUTED-TOMOGRAPHY; CORTICAL BONE; ADAPTATION; SIMULATION; SURFACE; STRAIN; COMMUNICATION	Bone is a living tissue whose main mechanical function is to provide stiffness, strength and protection to the body. Both stiffness and strength depend on the mineralization of the organic matrix, which is constantly being remodelled by the coordinated action of the bone multicellular units (BMUs). Due to the dynamics of both remodelling and mineralization, each sample of bone is composed of structural units (osteons in cortical and packets in cancellous bone) created at different times, therefore presenting different levels of mineral content. In this work, a computational model is used to understand the feedback between the remodelling and the mineralization processes under different load conditions and bone porosities. This model considers that osteoclasts primarily resorb those parts of bone closer to the surface, which are younger and less mineralized than older inner ones. Under equilibrium loads, results show that bone volumes with both the highest and the lowest levels of porosity (cancellous and cortical respectively) tend to develop higher levels of mineral content compared to volumes with intermediate porosity, thus presenting higher material densities. In good agreement with recent experimental measurements, a boomerang-like pattern emerges when plotting apparent density at the tissue level versus material density at the bone material level. Overload and disuse states are studied too, resulting in a translation of the apparent-material density curve. Numerical results are discussed pointing to potential clinical applications.	[Berli, Marcelo; Decco, Oscar] Univ Nacl Entre Rios, Fac Ingn, Ruta 11, Oro Verde, Entre Rios, Argentina; [Borau, Carlos; Garcia Aznar, Jose Manuel] Univ Zaragoza, I3A, Dept Ingn Mecan, Zaragoza, Spain; [Adams, George; Zioupos, Peter] DA UK, Cranfield Forens Inst, Musculoskeletal & Medicolegal Res, Shrivenham, England; [Cook, Richard B.] Univ Southampton, nCATS, Southampton, Hants, England	University of Zaragoza; University of Southampton	Zioupos, P (corresponding author), DA UK, Cranfield Forens Inst, Musculoskeletal & Medicolegal Res, Shrivenham, England.	p.zioupos@cranfield.ac.uk	ZIOUPOS, PETER/S-4342-2019; Garcia-Aznar, Jose Manuel/F-8256-2010; Borau, Carlos/A-7688-2018	ZIOUPOS, PETER/0000-0002-0123-2706; Garcia-Aznar, Jose Manuel/0000-0002-9864-7683; Borau, Carlos/0000-0002-3784-1140; Cook, Richard/0000-0002-2468-5820; Adams, George J/0000-0001-6108-1324	National Ministry Cabinet Headship of Argentina; European Research Council (ERC) [ERC-2012-StG306751]; Spanish Ministry of Economy and Competitiveness [DPI-2015-64221-C21-R.P]; Engineering and Physical Sciences Research Council [EP/K020196/1]; EPSRC [EP/F034296/1] Funding Source: UKRI; Engineering and Physical Sciences Research Council [EP/F034296/1] Funding Source: researchfish	National Ministry Cabinet Headship of Argentina; European Research Council (ERC)(European Research Council (ERC)European Commission); Spanish Ministry of Economy and Competitiveness(Spanish Government); Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC))	M. Berli acknowledges the National Ministry Cabinet Headship of Argentina for supporting his fellowship through the BEC.AR program and Universidad Tecnologica Nacional (Facultad Regional Santa Fe) of Argentina for allowing him to participate in this work. C. Borau and J.M. Garcia Aznar acknowledge the European Research Council (ERC) for supporting this work through Project ERC-2012-StG306751 and the Spanish Ministry of Economy and Competitiveness through the research project DPI-2015-64221-C21-R.P. Zioupos and G. Adams acknowledge the support of the Engineering and Physical Sciences Research Council (grant: EP/K020196/1 Point-of Care High Accuracy Fracture Risk Prediction).	Adams G, 7 WORLD C BIOM WCB 2; Avval PT, 2016, MED ENG PHYS, V38, P171, DOI 10.1016/j.medengphy.2015.11.013; BEAUPRE GS, 1990, J ORTHOPAED RES, V8, P662, DOI 10.1002/jor.1100080507; Birkhold AI, 2015, BONE, V75, P210, DOI 10.1016/j.bone.2015.02.027; Boivin G, 2008, BONE, V43, P532, DOI 10.1016/j.bone.2008.05.024; CARTER DR, 1987, J BIOMECH, V20, P785, DOI 10.1016/0021-9290(87)90058-3; Chen G, 2010, J BIOMECH, V43, P1011, DOI 10.1016/j.jbiomech.2009.10.040; Currey JD, 2004, J BIOMECH, V37, P549, DOI 10.1016/j.jbiomech.2003.08.008; Doblare M, 2002, J BIOMECH, V35, P1, DOI 10.1016/S0021-9290(01)00178-6; Doblare M, 2001, J BIOMECH, V34, P1157, DOI 10.1016/S0021-9290(01)00069-0; Elsyad MA, 2016, J PROSTHET DENT; Garcia JM, 2002, COMP MATER SCI, V25, P100, DOI 10.1016/S0927-0256(02)00254-9; Garcia-Aznar JM, 2005, BIOMECH MODEL MECHAN, V4, P147, DOI 10.1007/s10237-005-0067-x; Grimm D, 2016, BONE, V87, P44, DOI 10.1016/j.bone.2015.12.057; Hartmann MA, 2011, J MECH BEHAV BIOMED, V4, P879, DOI 10.1016/j.jmbbm.2011.03.005; Helgason B, 2008, CLIN BIOMECH, V23, P135, DOI 10.1016/j.clinbiomech.2007.08.024; Huiskes R, 2000, NATURE, V405, P704, DOI 10.1038/35015116; Jacobs CR, 1997, J BIOMECH, V30, P603, DOI 10.1016/S0021-9290(96)00189-3; Koehne T, 2014, BONE, V66, P31, DOI 10.1016/j.bone.2014.05.010; Lukas C, 2013, BONE, V56, P55, DOI 10.1016/j.bone.2013.05.005; Martin RB, 2000, BONE, V26, P1, DOI 10.1016/S8756-3282(99)00241-0; MARTIN RB, 1984, CRIT REV BIOMED ENG, V10, P179; Martinez-Reina J, 2008, J THEOR BIOL, V254, P704, DOI 10.1016/j.jtbi.2008.06.007; Martinez-Reina J, 2014, J MECH BEHAV BIOMED, V32, P99, DOI 10.1016/j.jmbbm.2013.12.025; Matsuo K, 2008, ARCH BIOCHEM BIOPHYS, V473, P201, DOI 10.1016/j.abb.2008.03.027; MIKIC B, 1995, J BIOMECH, V28, P465, DOI 10.1016/0021-9290(94)00085-I; Morin C, 2013, J THEOR BIOL, V335, P185, DOI 10.1016/j.jtbi.2013.06.018; Oh TS, 2016, J PLAST RECONSTR AES, V69, P487, DOI 10.1016/j.bjps.2015.11.002; Reina JM, 2007, J BIOMECH, V40, P828, DOI 10.1016/j.jbiomech.2006.03.007; Roschger P, 2008, BONE, V42, P456, DOI 10.1016/j.bone.2007.10.021; Roschger P, 2003, BONE, V32, P316, DOI 10.1016/S8756-3282(02)00973-0; Ruimerman R, 2005, J BIOMECH, V38, P931, DOI 10.1016/j.jbiomech.2004.03.037; Sansalone V, 2012, BONE, V50, P876, DOI 10.1016/j.bone.2011.12.020; Schileo E, 2008, J BIOMECH, V41, P2483, DOI 10.1016/j.jbiomech.2008.05.017; Schileo E, 2008, J BIOMECH, V41, P356, DOI 10.1016/j.jbiomech.2007.09.009; Schileo E, 2009, J BIOMECH, V42, P793, DOI 10.1016/j.jbiomech.2009.01.013; Sims NA, 2014, ARCH BIOCHEM BIOPHYS, V561, P22, DOI 10.1016/j.abb.2014.05.015; van Oers RFM, 2008, BONE, V42, P250, DOI 10.1016/j.bone.2007.10.009; Weatherholt AM, 2013, BONE, V52, P372, DOI 10.1016/j.bone.2012.10.026; WEINANS H, 1992, J BIOMECH, V25, P1425, DOI 10.1016/0021-9290(92)90056-7; Weinkamer R, 2004, PHYS REV LETT, V93, DOI 10.1103/PhysRevLett.93.228102; Zioupos P, 2008, J BIOMED MATER RES A, V86A, P627, DOI 10.1002/jbm.a.31576; Zioupos P, 2000, P C EUR SOC BIOM 200; Zioupos P, 2008, J BIOMECH, V41, P1961, DOI 10.1016/j.jbiomech.2008.03.025; Zioupos P, 2009, J BIOMECH, V42, P794, DOI 10.1016/j.jbiomech.2009.01.014	45	13	13	1	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 17	2017	12	3							e0173228	10.1371/journal.pone.0173228	http://dx.doi.org/10.1371/journal.pone.0173228			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EO5CJ	28306746	gold, Green Published, Green Submitted, Green Accepted			2022-12-27	WOS:000396710300006
J	Thean, LF; Wong, YH; Lo, M; Loi, C; Chew, MH; Tang, CL; Cheah, PY				Thean, Lai Fun; Wong, Yu Hui; Lo, Michelle; Loi, Carol; Chew, Min Hoe; Tang, Choong Leong; Cheah, Peh Yean			Chromosome 19q13 disruption alters expressions of CYP2A7, MIA and MIA-RAB4B lncRNA and contributes to FAP-like phenotype in APC mutation-negative familial colorectal cancer patients	PLOS ONE			English	Article							MELANOMA INHIBITORY-ACTIVITY; ADENOMATOUS POLYPOSIS; COLON-CANCER; CHROMATIN INSULATORS; GENE; IDENTIFICATION; TUMORIGENESIS; HOMOLOG; CELLS; INCREASES	Familial adenomatous polyposis (FAP) is an autosomal-dominantly inherited form of colorectal cancer (CRC) caused by mutation in the adenomatous polyposis coli (APC) gene. Our ability to exhaustively screen for APC mutations identify microsatellite-stable and APC-mutation negative familial CRC patients, enabling us to search for novel genes. We performed genome-wide scan on two affected siblings of one family and 88 ethnicity-and gender-matched healthy controls to identify deletions shared by the siblings. Combined loss of heterozygosity, copy number and allelic-specific copy number analysis uncovered 5 shared deletions. Long-range polymerase chain reaction (PCR) confirmed chromosome 19q13 deletion, which was subsequently found in one other family. The 32 kb deleted region harbors the CYP2A7 gene and was enriched with enhancer, repressor and insulator sites. The wildtype allele was lost in the polyps of the proband. Further, real-time RT-PCR assays showed that expressions of MIA and MIA-RAB4B located 35 kb upstream of the deletion, were up-regulated in the polyps compared to the matched mucosa of the proband. MIA-RAB4B, the read-through long non-coding RNA (lncRNA), RAB4B, PIM2 and TAOK1 share common binding site of a microRNA, miR-24, in their 3'UTRs. PIM2 and TAOK1, two target oncogenes of miR-24, were co-ordinately up-regulated with MIA-RAB4B in the polyps, suggesting that MIA-RAB4B could function as competitive endogenous RNA to titrate miR-24 away from its other targets. The data suggest that the 19.13 deletion disrupted chromatin boundary, leading to altered expression of several genes and lncRNA, could contribute to colorectal cancer via novel genetic and epigenetic mechanisms.	[Thean, Lai Fun; Wong, Yu Hui; Lo, Michelle; Loi, Carol; Chew, Min Hoe; Tang, Choong Leong; Cheah, Peh Yean] Singapore Gen Hosp, Dept Colorectal Surg, Singapore, Singapore; [Cheah, Peh Yean] Natl Univ Singapore, Saw Swee Hock Sch Publ Hlth, Singapore, Singapore; [Cheah, Peh Yean] Natl Univ Singapore, Duke NUS Med Sch, Singapore, Singapore	Singapore General Hospital; National University of Singapore; National University of Singapore	Cheah, PY (corresponding author), Singapore Gen Hosp, Dept Colorectal Surg, Singapore, Singapore.; Cheah, PY (corresponding author), Natl Univ Singapore, Saw Swee Hock Sch Publ Hlth, Singapore, Singapore.; Cheah, PY (corresponding author), Natl Univ Singapore, Duke NUS Med Sch, Singapore, Singapore.	cheah.peh.yean@sgh.com.sg			National Medical Research Council Singapore [NMRC/1193/2008, NMRC/OFIRG/0004/2016]; Singapore General Hospital	National Medical Research Council Singapore(National Medical Research Council, SingaporeUK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Singapore General Hospital	This study was funded in part by the National Medical Research Council Singapore (NMRC/1193/2008 and NMRC/OFIRG/0004/2016). The rest of the funding was from the host institution, Singapore General Hospital. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aguirre E, 2014, FRONT ONCOL, V4, DOI 10.3389/fonc.2014.00109; Aung PP, 2006, ONCOGENE, V25, P2546, DOI 10.1038/sj.onc.1209279; BRONNER CE, 1994, NATURE, V368, P258, DOI 10.1038/368258a0; Cao X, 2001, HUM GENET, V108, P436, DOI 10.1007/s004390100492; Cao X, 2006, AM J GASTROENTEROL, V101, P2810, DOI 10.1111/j.1572-0241.2006.00842.x; Cheah PY, 2009, AM J GASTROENTEROL, V104, P3027, DOI 10.1038/ajg.2009.542; Chetverina D A, 2013, Genetika, V49, P429; El Fitori J, 2005, CANCER CELL INT, V5, DOI 10.1186/1475-2867-5-3; Godoy W, 2002, CARCINOGENESIS, V23, P611, DOI 10.1093/carcin/23.4.611; GRODEN J, 1991, CELL, V66, P589, DOI 10.1016/0092-8674(81)90021-0; Heger P, 2014, TRENDS GENET, V30, P161, DOI 10.1016/j.tig.2014.03.004; Hong Y, 2007, CLIN CANCER RES, V13, P1107, DOI 10.1158/1078-0432.CCR-06-1633; Hong Y, 2010, CLIN EXP METASTAS, V27, P83, DOI 10.1007/s10585-010-9305-4; JOSLYN G, 1991, CELL, V66, P601, DOI 10.1016/0092-8674(81)90022-2; KINZLER KW, 1991, SCIENCE, V253, P661, DOI 10.1126/science.1651562; Kumar MS, 2014, NATURE, V505, P212, DOI 10.1038/nature12785; LEACH FS, 1993, CELL, V75, P1215, DOI 10.1016/0092-8674(93)90330-S; MILLER SA, 1988, NUCLEIC ACIDS RES, V16, P1215, DOI 10.1093/nar/16.3.1215; Narlik-Grassow M, 2014, MED RES REV, V34, P136, DOI 10.1002/med.21284; PAPADOPOULOS N, 1994, SCIENCE, V263, P1625, DOI 10.1126/science.8128251; Phillips-Cremins JE, 2013, MOL CELL, V50, P461, DOI 10.1016/j.molcel.2013.04.018; Segui N, 2014, HUM MUTAT, V35, P50, DOI 10.1002/humu.22454; Stephen AG, 2014, CANCER CELL, V25, P272, DOI 10.1016/j.ccr.2014.02.017; Tavares IA, 2013, J BIOL CHEM, V288, P15418, DOI 10.1074/jbc.M112.448183; Thean LF, 2010, GENE CHROMOSOME CANC, V49, P99, DOI 10.1002/gcc.20724; Thean LF, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042407; Tomlinson I, 2015, ANN CLIN BIOCHEM, V52, P690, DOI 10.1177/0004563215597944; Wala J, 2016, SCIENCE, V351, P1398, DOI 10.1126/science.aaf5542; Yang RX, 2014, CARCINOGENESIS, V35, P315, DOI 10.1093/carcin/bgt344; Yao J, 1999, INT J CANCER, V80, P667, DOI 10.1002/(SICI)1097-0215(19990301)80:5<667::AID-IJC6>3.0.CO;2-0; Yu M, 2014, ONCOGENE, V33, P1538, DOI 10.1038/onc.2013.102; Yu ZH, 2013, J BIOL CHEM, V288, P35406, DOI 10.1074/jbc.M113.508226; Zhang Q, 2009, CANCER CELL, V16, P413, DOI 10.1016/j.ccr.2009.09.029; Zihni C, 2006, J BIOL CHEM, V281, P7317, DOI 10.1074/jbc.M513769200	34	10	11	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 17	2017	12	3							e0173772	10.1371/journal.pone.0173772	http://dx.doi.org/10.1371/journal.pone.0173772			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EO5CJ	28306719	Green Submitted, Green Published, gold			2022-12-27	WOS:000396710300016
J	Bashir, A; Attie, O; Sullivan, M; Sebra, R; Singh, KV; Altman, D; Pak, T; Dutta, J; Chacko, K; Webster, E; Lewis, M; Hamula, C; Carpini, KWD; Murray, BE; Kasarskis, A; van Bakel, H; Huprikar, S				Bashir, Ali; Attie, Oliver; Sullivan, Mitchell; Sebra, Robert; Singh, Kavindra V.; Altman, Deena; Pak, Theodore; Dutta, Jayeeta; Chacko, Kieran; Webster, Elizabeth; Lewis, Martha; Hamula, Camille; Delli Carpini, Kristin W.; Murray, Barbara E.; Kasarskis, Andrew; van Bakel, Harm; Huprikar, Shirish			Genomic confirmation of vancomycin-resistant Enterococcus transmission from deceased donor to liver transplant recipient	PLOS ONE			English	Article							MOLECULAR EPIDEMIOLOGY; ALIGNMENT; INFECTIONS; ASSEMBLIES; SEQUENCE	In a liver transplant recipient with vancomycin-resistant Enterococcus (VRE) surgical site and bloodstream infection, a combination of pulsed-field gel electrophoresis, multilocus sequence typing, and whole genome sequencing identified that donor and recipient VRE isolates were highly similar when compared to time-matched hospital isolates. Comparison of de novo assembled isolate genomes was highly suggestive of transplant transmission rather than hospital-acquired transmission and also identified subtle internal rearrangements between donor and recipient missed by other genomic approaches. Given the improved resolution, whole-genome assembly of pathogen genomes is likely to become an essential tool for investigation of potential organ transplant transmissions.	[Bashir, Ali; Attie, Oliver; Sullivan, Mitchell; Sebra, Robert; Pak, Theodore; Dutta, Jayeeta; Chacko, Kieran; Webster, Elizabeth; Lewis, Martha; Kasarskis, Andrew; van Bakel, Harm] Icahn Sch Med Mt Sinai, Inst & Dept Genet & Genom Sci, New York, NY 10029 USA; [Singh, Kavindra V.; Murray, Barbara E.] Univ Texas Med Sch, Div Infect Dis, Dept Med, Houston, TX USA; [Altman, Deena; Huprikar, Shirish] Icahn Sch Med Mt Sinai, Dept Med, Div Infect Dis, New York, NY 10029 USA; [Hamula, Camille] Icahn Sch Med, Dept Pathol, New York, NY USA; [Delli Carpini, Kristin W.] LiveOnNY, New York, NY USA	Icahn School of Medicine at Mount Sinai; University of Texas System; University of Texas Health Science Center Houston; Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai	Huprikar, S (corresponding author), Icahn Sch Med Mt Sinai, Dept Med, Div Infect Dis, New York, NY 10029 USA.	shirish.huprikar@mssm.edu	van Bakel, Harm/N-9561-2017	van Bakel, Harm/0000-0002-1376-6916; Sullivan, Mitchell/0000-0001-9076-6963; Webster, Elizabeth/0000-0003-3467-3863; Pak, Theodore/0000-0002-1676-2523	Icahn Institute for Genomics and Multiscale Biology; National Institute of Allergy and Infectious Diseases [R01AI119145]; NRSA Institutional Research Training Grant for Global Health Research (DRA) [5 T32 AI 7647-13];  [F30AI122673]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [F30AI122673, R01AI119145] Funding Source: NIH RePORTER	Icahn Institute for Genomics and Multiscale Biology; National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NRSA Institutional Research Training Grant for Global Health Research (DRA); ; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by the Icahn Institute for Genomics and Multiscale Biology, and also in part by the National Institute of Allergy and Infectious Diseases, grant R01AI119145 and NRSA Institutional Research Training Grant (5 T32 AI 7647-13) for Global Health Research (DRA), and F30AI122673. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altman DR, 2014, AM J TRANSPLANT; Bankevich A, 2012, J COMPUT BIOL, V19, P455, DOI 10.1089/cmb.2012.0021; Bashir A, 2012, NAT BIOTECHNOL, V30, P701, DOI 10.1038/nbt.2288; Bruen TC, 2006, GENETICS, V172, P2665, DOI 10.1534/genetics.105.048975; Camacho C, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-421; Chin CS, 2013, NAT METHODS, V10, P563, DOI [10.1038/NMETH.2474, 10.1038/nmeth.2474]; Damani A, 2010, EUR J CLIN MICROBIOL, V29, P329, DOI 10.1007/s10096-009-0847-9; Darling ACE, 2004, GENOME RES, V14, P1394, DOI 10.1101/gr.2289704; Delcher AL, 2003, CURR PROTOC BIOINFOR; Didelot X, 2012, GENOME BIOL, V13, DOI 10.1186/gb-2012-13-12-r118; Freitas AR, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060589; GARNER JS, 1988, AM J INFECT CONTROL, V16, P128, DOI 10.1016/0196-6553(88)90053-3; HANDWERGER S, 1995, ANTIMICROB AGENTS CH, V39, P2446, DOI 10.1128/AAC.39.11.2446; HANDWERGER S, 1995, ANTIMICROB AGENTS CH, V39, P362, DOI 10.1128/AAC.39.2.362; Homan WL, 2002, J CLIN MICROBIOL, V40, P1963, DOI 10.1128/JCM.40.6.1963-1971.2002; Hunt M, 2015, GENOME BIOL, V16, DOI 10.1186/s13059-015-0849-0; Ison MG, 2013, AM J TRANSPLANT, V13, P22, DOI 10.1111/ajt.12095; Koren S, 2012, NAT BIOTECHNOL, V30, P692, DOI 10.1038/nbt.2280; Lam MMC, 2012, J BACTERIOL, V194, P2334, DOI 10.1128/JB.00259-12; Li H., 2013, ARXIV13033997 Q BIO; Li H, 2011, BIOINFORMATICS, V27, P2987, DOI 10.1093/bioinformatics/btr509; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Lopez M, 2010, J ANTIMICROB CHEMOTH, V65, P1570, DOI 10.1093/jac/dkq192; McArthur AG, 2013, ANTIMICROB AGENTS CH, V57, P3348, DOI 10.1128/AAC.00419-13; McCracken M, 2013, J ANTIMICROB CHEMOTH, V68, P1505, DOI 10.1093/jac/dkt054; MURRAY BE, 1990, J CLIN MICROBIOL, V28, P2059, DOI 10.1128/JCM.28.9.2059-2063.1990; Ochoa SA, 2013, BMC MICROBIOL, V13, DOI 10.1186/1471-2180-13-291; Page AJ, 2015, BIOINFORMATICS, V31, P3691, DOI 10.1093/bioinformatics/btv421; Palazzo ICV, 2011, J HOSP INFECT, V79, P70, DOI 10.1016/j.jhin.2011.04.016; da Silva LPP, 2012, DIAGN MICR INFEC DIS, V74, P267, DOI 10.1016/j.diagmicrobio.2012.07.012; Rasko DA, 2011, NEW ENGL J MED, V365, P709, DOI 10.1056/NEJMoa1106920; Seemann T, 2014, BIOINFORMATICS, V30, P2068, DOI 10.1093/bioinformatics/btu153; TENOVER FC, 1995, J CLIN MICROBIOL, V33, P2233, DOI 10.1128/JCM.33.9.2233-2239.1995; Treangen TJ, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0524-x; Turner KME, 2007, BMC MICROBIOL, V7, DOI 10.1186/1471-2180-7-30	35	11	11	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 16	2017	12	3							e0170449	10.1371/journal.pone.0170449	http://dx.doi.org/10.1371/journal.pone.0170449			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN9KE	28301471	Green Published, gold, Green Submitted			2022-12-27	WOS:000396318300004
J	Chiu, HW; Chen, CH; Chen, YJ; Hsu, YH				Chiu, Hui-Wen; Chen, Cheng-Hsien; Chen, Yi-Jie; Hsu, Yung-Ho			Far-infrared suppresses skin photoaging in ultraviolet B-exposed fibroblasts and hairless mice	PLOS ONE			English	Article							MOLECULAR-MECHANISMS; AUTOPHAGY; MTOR; CANCER; KERATINOCYTES; INHIBITION; ACTIVATION; RADIATION; APOPTOSIS; CELLS	Ultraviolet (UV) induces skin photoaging, which is characterized by thickening, wrinkling, pigmentation, and dryness. Collagen, which is one of the main building blocks of human skin, is regulated by collagen synthesis and collagen breakdown. Autophagy was found to block the epidermal hyperproliferative response to UVB and may play a crucial role in preventing skin photoaging. In the present study, we investigated whether far-infrared (FIR) therapy can inhibit skin photoaging via UVB irradiation in NIH 3T3 mouse embryonic fibroblasts and SKH-1 hairless mice. We found that FIR treatment significantly increased procollagen type I through the induction of the TGF-beta/Smad axis. Furthermore, UVB significantly enhanced the expression of matrix metalloproteinase-1 (MMP-1) and MMP-9. FIR inhibited UVB-induced MMP-1 and MMP-9. Treatment with FIR reversed UVB-decreased type I collagen. In addition, FIR induced autophagy by inhibiting the Akt/mTOR signaling pathway. In UVB-induced skin photoaging in a hairless mouse model, FIR treatment resulted in decreased skin thickness in UVB irradiated mice and inhibited the degradation of collagen fibers. Moreover, FIR can increase procollagen type I via the inhibition of MMP-9 and induction of TGF-beta in skin tissues. Therefore, our study provides evidence for the beneficial effects of FIR exposure in a model of skin photoaging.	[Chiu, Hui-Wen; Chen, Cheng-Hsien; Chen, Yi-Jie; Hsu, Yung-Ho] Taipei Med Univ, Shuang Ho Hosp, Div Nephrol, Dept Internal Med, New Taipei, Taiwan; [Chiu, Hui-Wen] Taipei Med Univ, Grad Inst Clin Med, Coll Med, Taipei, Taiwan; [Chen, Cheng-Hsien] Taipei Med Univ, Wan Fang Hosp, Div Nephrol, Dept Internal Med, Taipei, Taiwan; [Chen, Cheng-Hsien; Hsu, Yung-Ho] Taipei Med Univ, Sch Med, Dept Internal Med, Coll Med, Taipei, Taiwan	Taipei Medical University; Shuang Ho Hospital; Taipei Medical University; Taipei Medical University; Taipei Municipal WanFang Hospital; Taipei Medical University	Hsu, YH (corresponding author), Taipei Med Univ, Shuang Ho Hosp, Div Nephrol, Dept Internal Med, New Taipei, Taiwan.; Hsu, YH (corresponding author), Taipei Med Univ, Sch Med, Dept Internal Med, Coll Med, Taipei, Taiwan.	yhhsu@tmu.edu.tw			Taipei Medical University-Shuang Ho Hospital [105TMU-SHH-12]; Ministry of Science and Technology, Taiwan [MOST 105-2320-B-038-021-MY3]	Taipei Medical University-Shuang Ho Hospital; Ministry of Science and Technology, Taiwan(Ministry of Science and Technology, Taiwan)	This study was supported by the Taipei Medical University-Shuang Ho Hospital (105TMU-SHH-12) and the Ministry of Science and Technology, Taiwan (MOST 105-2320-B-038-021-MY3). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bridgeman BB, 2016, CELL SIGNAL, V28, P460, DOI 10.1016/j.cellsig.2016.02.008; Capon A, 2003, AM J CLIN DERMATOL, V4, P1, DOI 10.2165/00128071-200304010-00001; Carr TD, 2012, CANCER PREV RES, V5, P1394, DOI 10.1158/1940-6207.CAPR-12-0272-T; Chang JC, 2016, SCI REP-UK, V6, DOI 10.1038/srep30436; Chen CH, 2017, SCI REP-UK, V7, DOI 10.1038/srep40442; Chen YC, 2012, J PHOTOCH PHOTOBIO B, V106, P61, DOI 10.1016/j.jphotobiol.2011.10.006; Chiu HW, 2016, J MOL MED, V94, P809, DOI 10.1007/s00109-016-1389-0; Chiu HW, 2009, AUTOPHAGY, V5, P472, DOI 10.4161/auto.5.4.7759; Choi AMK, 2013, NEW ENGL J MED, V368, P1845, DOI 10.1056/NEJMc1303158; Cimino F, 2007, BIOFACTORS, V30, P129, DOI 10.1002/biof.5520300206; Einspahr JG, 2012, CANCER PREV RES, V5, P403, DOI 10.1158/1940-6207.CAPR-11-0427; Fisher GJ, 1996, NATURE, V379, P335, DOI 10.1038/379335a0; FLEISCHMAJER R, 1988, J HISTOCHEM CYTOCHEM, V36, P1425, DOI 10.1177/36.11.3049791; Hendershot LM, 2000, CURR BIOL, V10, pR912, DOI 10.1016/S0960-9822(00)00850-2; Hsu YH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030674; INOUE S, 1989, INT J BIOMETEOROL, V33, P145, DOI 10.1007/BF01084598; Kang S, 2003, J INVEST DERMATOL, V120, P835, DOI 10.1046/j.1523-1747.2003.12122.x; Kim MA, 2009, ONCOGENE, V28, P1241, DOI 10.1038/onc.2008.487; Leung TK, 2011, J MED BIOL ENG, V31, P345, DOI 10.5405/jmbe.777; Levine B, 2004, DEV CELL, V6, P463, DOI 10.1016/S1534-5807(04)00099-1; Makrantonaki E, 2007, ANN NY ACAD SCI, V1119, P40, DOI 10.1196/annals.1404.027; Mizushima N, 2007, AUTOPHAGY, V3, P542, DOI 10.4161/auto.4600; Mouw JK, 2014, NAT REV MOL CELL BIO, V15, P771, DOI 10.1038/nrm3902; Mukherjee PK, 2011, PHYTOMEDICINE, V19, P64, DOI 10.1016/j.phymed.2011.10.003; Park WH, 2013, ONCOL LETT, V5, P1633, DOI 10.3892/ol.2013.1216; Peng PL, 2008, INT J RADIAT ONCOL, V70, P529, DOI 10.1016/j.ijrobp.2007.08.034; Quan TH, 2010, J INVEST DERMATOL, V130, P415, DOI 10.1038/jid.2009.224; Rubinsztein DC, 2011, CELL, V146, P682, DOI 10.1016/j.cell.2011.07.030; Scharffetter-Kochanek K, 1997, BIOL CHEM, V378, P1247; Shimobayashi M, 2014, NAT REV MOL CELL BIO, V15, P155, DOI 10.1038/nrm3757; Thomes PG, 2016, INT J BIOCHEM CELL B, V81, P137, DOI 10.1016/j.biocel.2016.11.007; Toyokawa H, 2003, EXP BIOL MED, V228, P724, DOI 10.1177/153537020322800612; Vincenti MP, 2002, ARTHRITIS RES, V4, P157, DOI 10.1186/ar401; Wang HW, 2016, PLOS ONE, V11; Wang L, 2016, SCI REP-UK, V6, DOI 10.1038/srep18987; Wang M, 2012, AGING CELL, V11, P668, DOI 10.1111/j.1474-9726.2012.00833.x; WEISS JS, 1988, JAMA-J AM MED ASSOC, V259, P527, DOI 10.1001/jama.259.4.527; Yang YH, 2013, APOPTOSIS, V18, P1363, DOI 10.1007/s10495-013-0867-x; Yu SY, 2006, PHOTODERMATOL PHOTO, V22, P78, DOI 10.1111/j.1600-0781.2006.00208.x; Zhang JA, 2016, MIR 23A DEPRESSED AU	40	20	21	3	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 16	2017	12	3							e0174042	10.1371/journal.pone.0174042	http://dx.doi.org/10.1371/journal.pone.0174042			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN9KE	28301572	Green Submitted, gold, Green Published			2022-12-27	WOS:000396318300117
J	Feldacker, C; Bochner, AF; Herman-Roloff, A; Holec, M; Murenje, V; Stepaniak, A; Xaba, S; Tshimanga, M; Chitimbire, V; Makaure, S; Hove, J; Barnhart, S; Makunike, B				Feldacker, Caryl; Bochner, Aaron F.; Herman-Roloff, Amy; Holec, Marrianne; Murenje, Vernon; Stepaniak, Abby; Xaba, Sinokuthemba; Tshimanga, Mufata; Chitimbire, Vuyelwa; Makaure, Shingirai; Hove, Joseph; Barnhart, Scott; Makunike, Batsirai			Is it all about the money? A qualitative exploration of the effects of performance-based financial incentives on Zimbabwe's voluntary male medical circumcision program	PLOS ONE			English	Article							HEALTH-CARE; SERVICES; PAYMENT; IMPACT	Background In 2013, Zimbabwe's voluntary medical male circumcision (VMMC) program adopted performance- based financing (PBF) to speed progress towards ambitious VMMC targets. The $25 USD PBF intended to encourage low-paid healthcare workers to remain in the public sector and to strengthen the public healthcare system. The majority of the incentive supports healthcare workers (HCWs) who perform VMMC alongside other routine services; a small portion supports province, district, and facility levels. Methods This qualitative study assessed the effect of the PBF on HCW motivation, satisfaction, and professional relationships. The study objectives were to: 1) Gain understanding of the advantages and disadvantages of PBF at the HCW level; 2) Gain understanding of the advantages and disadvantages of PBF at the site level; and 3) Inform scale up, modification, or discontinuation of PBF for the national VMMC program. Sixteen focus groups were conducted: eight with HCWs who received PBF for VMMC and eight with HCWs in the same clinics who did not work in VMMC and, therefore, did not receive PBF. Fourteen key informant interviews ascertained administrator opinion. Results Findings suggest that PBF appreciably increased motivation among VMMC teams and helped improve facilities where VMMC services are provided. However, PBF appears to contribute to antagonism at the workplace, creating divisiveness that may reach beyond VMMC. PBF may also cause distortion in the healthcare system: HCWs prioritized incentivized VMMC services over other routine duties. To reduce workplace tension and improve the VMMC program, participants suggested increasing HCW training in VMMC to expand PBF beneficiaries and strengthening integration of VMMC services into routine care. Conclusion In the low-resource, short-staffed context of Zimbabwe, PBF enabled rapid VMMC scale up and achievement of ambitious targets; however, side effects make PBF less advantageous and sustainable than envisioned. Careful consideration is warranted in choosing whether, and how, to implement PBF to prioritize a public health program.	[Feldacker, Caryl; Bochner, Aaron F.; Holec, Marrianne; Stepaniak, Abby; Barnhart, Scott] I TECH, Seattle, WA 98104 USA; [Feldacker, Caryl; Barnhart, Scott] Univ Washington, Dept Global Hlth, Seattle, WA 98195 USA; [Herman-Roloff, Amy] US Ctr Dis Control & Prevent, Harare, Zimbabwe; [Murenje, Vernon; Makunike, Batsirai] I TECH, Harare, Zimbabwe; [Xaba, Sinokuthemba] Minist Hlth & Child Care, Harare, Zimbabwe; [Tshimanga, Mufata; Makaure, Shingirai] Zimbabwe Community Hlth Intervent Project ZiCHIRe, Harare, Zimbabwe; [Chitimbire, Vuyelwa; Hove, Joseph] ZACH, Harare, Zimbabwe; [Barnhart, Scott] Univ Washington, Dept Med, Seattle, WA USA	University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle	Feldacker, C (corresponding author), I TECH, Seattle, WA 98104 USA.; Feldacker, C (corresponding author), Univ Washington, Dept Global Hlth, Seattle, WA 98195 USA.	cfeld@uw.edu		Bochner, Aaron/0000-0001-8348-3375; Feldacker, Caryl/0000-0002-8152-6754; Murenje, Vernon/0000-0002-0715-9837	President's Emergency Plan for AIDS Relief (PEPFAR) through US Centers for Disease Control and Prevention (CDC), Division of Global HIV/AIDS (DGHA) [5U2GGH000972]	President's Emergency Plan for AIDS Relief (PEPFAR) through US Centers for Disease Control and Prevention (CDC), Division of Global HIV/AIDS (DGHA)	This project was supported by the Presidents Emergency Plan for AIDS Relief (PEPFAR) through US Centers for Disease Control and Prevention (CDC), Division of Global HIV/AIDS (DGHA) under the terms of CDC Cooperative agreement 5U2GGH000972 to I-TECH. Authors CF BM AB MH VM MT VC SM JH and SB received funding under this grant for a portion of this project. The funders, specifically AHR, contributed to design of the study and preparation of the manuscript.	Basinga P, 2011, B WORLD HEALTH ORGAN, V89, P698, DOI 10.2471/BLT.11.089912; Basinga P, 2011, LANCET, V377, P1421, DOI 10.1016/S0140-6736(11)60177-3; Binyaruka P, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0135013; Bonfrer I, 2013, LANCET, V381, P19; Chikwinya B, 2016, ADVERSE EVENT PROFIL; Chikwinya B, 2016, IMPLEMENTING PEPFAR; Chimhutu V, 2014, BMC HEALTH SERV RES, V14, DOI 10.1186/1472-6963-14-23; de Walque D, 2015, J HEALTH ECON, V40, P1, DOI 10.1016/j.jhealeco.2014.12.001; Eichler R., 2007, PERFORMANCE BASED IN; Eldridge C, 2009, HEALTH POLICY PLANN, V24, P160, DOI 10.1093/heapol/czp002; Fretheim A, 2012, B WORLD HEALTH ORGAN, V90, P559, DOI 10.2471/BLT.12.106468; Gertler PJ, 2012, WORLD BANK POLICY RE; Hanefeld J, 2009, HUM RESOUR HEALTH, V7, DOI 10.1186/1478-4491-7-8; Ireland M, 2011, B WORLD HEALTH ORGAN, V89, P695, DOI [10.2471/BLT.11.87379, 10.2471/BLT.11.087379]; Low-Beer D, 2007, PLOS MED, V4, P1308, DOI 10.1371/journal.pmed.0040219; Magrath P, 2012, SOC SCI MED, V75, P1778, DOI 10.1016/j.socscimed.2012.07.025; Mathauer Inke, 2006, Hum Resour Health, V4, P24, DOI 10.1186/1478-4491-4-24; Meessen B, 2011, B WORLD HEALTH ORGAN, V89, P153, DOI 10.2471/BLT.10.077339; Miller G., 2013, PAY FOR PERFORMANCE; Ministry of Health and Child Care Zimbabwe, 2014, ACC STRAT OP PLAN 20; Mutabazi V, 2013, JAIDS-J ACQ IMM DEF, V63, P315, DOI 10.1097/QAI.0b013e31828e6412; Oxman AD, 162008  NAS KUNNSK H; Oxman Andrew D, 2009, J Evid Based Med, V2, P70, DOI 10.1111/j.1756-5391.2009.01020.x; Paul E, 2015, DEV POLICY REV, V33, P313, DOI 10.1111/dpr.12115; Soeters R, 2011, HEALTH AFFAIR, V30, P1518, DOI 10.1377/hlthaff.2009.0019; Ssengooba F, 2012, SOC SCI MED, V75, P377, DOI 10.1016/j.socscimed.2012.02.050; Stover J, 2016, EVALUATING IMPACT VO; Witter S, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD007899.pub2; ZAZIC, 2016, ZAZIC MONTHL V UNPUB; Zimbabwe Ministry of Health and Child Care, 2014, ACC STRAT OP PLAN 20	30	7	7	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 16	2017	12	3							e0174047	10.1371/journal.pone.0174047	http://dx.doi.org/10.1371/journal.pone.0174047			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EN9KE	28301588	Green Submitted, gold, Green Published			2022-12-27	WOS:000396318300119
J	Franceschi, S; Lessi, F; Panebianco, F; Tantillo, E; La Ferla, M; Menicagli, M; Aretini, P; Apollo, A; Naccarato, AG; Marchetti, I; Mazzanti, CM				Franceschi, Sara; Lessi, Francesca; Panebianco, Federica; Tantillo, Elena; La Ferla, Marco; Menicagli, Michele; Aretini, Paolo; Apollo, Alessandro; Naccarato, Antonio Giuseppe; Marchetti, Ivo; Mazzanti, Chiara Maria			Loss of c-KIT expression in thyroid cancer cells	PLOS ONE			English	Article							CARCINOMA; MUTATIONS; RECEPTOR; TUMORS; RECURRENCE; NEOPLASMS; DIAGNOSIS; CYTOLOGY; PATHWAY; NODULES	Papillary thyroid carcinoma is the most frequent histologic type of thyroid tumor. Few studies investigated the role of c-KIT expression in thyroid tumors, suggesting a role for this receptor and its ligand in differentiation and growth control of thyroid epithelium and a receptor loss following malignant transformation. We investigated and correlated c-KIT expression levels and two known markers of thyrocytes differentiation, PAX8 and TTF-1, in malignant and benign cytological thyroid samples. Moreover, we performed functional studies on human papillary thyroid carcinoma cell line to associated c-KIT expression to thyrocytes differentiation and tumor proliferation. c-KIT and PAX8 expression resulted higher in benign samples compared to the malignant ones, and the expression levels of these two genes were significantly correlated to each other. We also observed that c-KIT overexpression led to an increase of PAX8 expression level together with a decrease of proliferation. Furthermore, c-KIT overexpressing cells showed a regression of typical morphological features of malignancy. Taken together these results suggest that c-KIT could be involved in the differentiation of thyroid cells and in tumor progression.	[Franceschi, Sara; Lessi, Francesca; Tantillo, Elena; La Ferla, Marco; Menicagli, Michele; Aretini, Paolo; Mazzanti, Chiara Maria] FPS Pisa Sci Fdn, Pisa, Italy; [Panebianco, Federica; Apollo, Alessandro; Naccarato, Antonio Giuseppe; Marchetti, Ivo] Univ Hosp Pisa, Dept Translat Res & New Technol Med & Surg, Pisa, Italy; [Panebianco, Federica] Univ Pittsburgh, Sch Med, Dept Pathol, Pittsburgh, PA USA; [Apollo, Alessandro] Ist Toscano Tumori, Core Res Lab, Florence, Italy	University of Pisa; Azienda Ospedaliero Universitaria Pisana; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; ISPRO Istituto per lo studio, la prevenzione e la rete oncologica	Franceschi, S (corresponding author), FPS Pisa Sci Fdn, Pisa, Italy.	s.franceschi@fpscience.it	Mazzanti, Chiara/AAX-6539-2021; Lessi, Francesca/AAE-6812-2022; Aretini, Paolo/AAF-1205-2020	Lessi, Francesca/0000-0002-3346-4296; Aretini, Paolo/0000-0003-1075-4319; Franceschi, Sara/0000-0002-4246-4407; Panebianco, Federica/0000-0003-2301-7916				Broecker-Preuss M, 2008, HORM METAB RES, V40, P685, DOI 10.1055/s-2008-1080895; Chen EC, 2015, GASTROENTEROLOGY, V149, P705, DOI 10.1053/j.gastro.2015.05.042; Chitikova Z, 2015, ONCOTARGET, V6, P10978, DOI 10.18632/oncotarget.3452; Czarniecka A, 2016, GLAND SURG, V5, P495, DOI 10.21037/gs.2016.09.09; Dahl C, 2015, J INVEST DERMATOL, V135, P516, DOI 10.1038/jid.2014.372; di Magliano MP, 2000, P NATL ACAD SCI USA, V97, P13144; Doddi S, 2015, G CHIR, V36, P122, DOI 10.11138/gchir/2015.36.3.122; Fabbri M, 2009, CARCINOGENESIS, V30, P912, DOI 10.1093/carcin/bgp063; Fernandez LP, 2015, NAT REV ENDOCRINOL, V11, P29, DOI 10.1038/nrendo.2014.186; Guerra A, 2014, THYROID, V24, P254, DOI 10.1089/thy.2013.0235; Hajmanoochehri F, 2015, J CYTOL, V32, P238, DOI 10.4103/0970-9371.171234; Kwon H, 2016, ENDOCRINOL METAB, V31, P586, DOI 10.3803/EnM.2016.31.4.586; Lau ST, 2015, ONCOGENE, V34, P1019, DOI 10.1038/onc.2014.24; Lennartsson J, 2006, CURR CANCER DRUG TAR, V6, P65, DOI 10.2174/156800906775471725; Matsumura Y, 2015, J CANCER RES CLIN, V141, P2159, DOI 10.1007/s00432-015-1989-z; Mazzanti C, 2004, CANCER RES, V64, P2898, DOI 10.1158/0008-5472.CAN-03-3811; Miettinen M, 2000, MODERN PATHOL, V13, P536, DOI 10.1038/modpathol.3880093; Murakawa T, 2005, PATHOL INT, V55, P757, DOI 10.1111/j.1440-1827.2005.01902.x; NATALI PG, 1995, CANCER RES, V55, P1787; Nonaka D, 2008, MODERN PATHOL, V21, P192, DOI 10.1038/modpathol.3801002; Panebianco F, 2015, BMC CANCER, V15, DOI 10.1186/s12885-015-1917-2; Pusztaszeri MP, 2014, CANCER CYTOPATHOL, V122, P596, DOI 10.1002/cncy.21437; Rago T, 2014, J CLIN ENDOCR METAB, V99, P3700, DOI 10.1210/jc.2013-4401; Rizzo FM, 2016, BMC CANCER, V16, DOI 10.1186/s12885-016-2111-x; Sanlorenzo M, 2016, J PROTEOMICS, V144, P140, DOI 10.1016/j.jprot.2016.05.019; Sehitoglu I, 2016, AN BRAS DERMATOL, V91, P430, DOI 10.1590/abd1806-4841.20164331; TANAKA T, 1995, ENDOCR J, V42, P723, DOI 10.1507/endocrj.42.723; Tomei S, 2012, J TRANSL MED, V10, DOI 10.1186/1479-5876-10-7; Tramm T, 2016, VIRCHOWS ARCH, V469, P285, DOI 10.1007/s00428-016-1966-1; Yamashita AS, 2013, TRANSL ONCOL, V6, P197, DOI 10.1593/tlo.12442; Yu GP, 2016, ONCOL REP, V36, P1626, DOI 10.3892/or.2016.4963; Zou MJ, 2014, THYROID, V24, P1256, DOI 10.1089/thy.2013.0610	32	9	10	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 16	2017	12	3							e0173913	10.1371/journal.pone.0173913	http://dx.doi.org/10.1371/journal.pone.0173913			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN9KE	28301608	Green Submitted, Green Published, gold			2022-12-27	WOS:000396318300093
J	Stothers, L; Macnab, AJ; Bajunirwe, F; Mutabazi, S; Berkowitz, J				Stothers, Lynn; Macnab, Andrew J.; Bajunirwe, Francis; Mutabazi, Sharif; Berkowitz, Jonathan			Associations between the severity of obstructive lower urinary tract symptoms and care-seeking behavior in rural Africa: A cross-sectional survey from Uganda	PLOS ONE			English	Article							BENIGN PROSTATIC HYPERPLASIA; QUALITY-OF-LIFE; INDEX; MEN	Study type A cross sectional survey. Background Global estimates indicate that by 2018 2.3 billion individuals worldwide will suffer from lower urinary tract symptoms (LUTS), with 1.1 billion having LUTS related to bladder outlet obstruction (BOO). Left untreated BOO in men causes irreversible changes to the urinary tract leading to urinary retention, the need for catheterization, renal failure and even death. Estimates suggest that Africa will be one of the continents with the greatest increase in (LUTS) by 2018 however direct measures in Africa are lacking. The objectives were to: (1) measure of prevalence of LUTS/BOO in a community-based sample of men in Africa, (2) compare community-based LUTS/BOO frequency to those seeking care for LUTS in a local clinic (3) quantify bother, interference with daily living, worry and quality of life related to LUTS/BOO between community and clinic settings and (4) examine relationships between socioeconomic and demographics related to LUTS/BOO. Methods and findings 473 men from a rural Ugandan community (238 residents living with their symptoms and 177 presenting at a clinic for care) completed the International Prostate Symptom Scale (IPSS) and a 53-item validated LUTS symptom, bother and quality of life index. Severity of symptoms was categorized based on reference ranges for mild, moderate and severe levels of the IPSS, comparing those in the community versus those seeking care for symptoms. IPSS indicated that 55.9% of men in the community versus 17.5% of those at the clinic had mild symptoms, 31.5% in the community versus 52.5% of those at the clinic had moderate symptoms and 12.6% of those in the community versus 29.9% of those at the clinic had severe symptoms (p< 0.001). Men seeking care for LUTS/BOO had a lower quality of life (p< 0.05), were more bothered by their urinary symptoms (p< 0.05), had more interference with daily activity and worry (p< 0.05) but this did not have an impact on their general sense of wellbeing. Conclusions The burden of disease of LUTS/BOO in this rural African cohort is high and significantly higher among those seeking care due to the bother of their symptoms. One in 4 men will spend money for transport to clinic due to LUTS/BOO despite low economic resources. Educational tools for patients structured to the level of literacy are justified.	[Stothers, Lynn; Macnab, Andrew J.] Univ British Columbia, Dept Urol Sci, Vancouver, BC, Canada; [Stothers, Lynn] Univ British Columbia, Sch Populat & Publ Hlth, Vancouver, BC, Canada; [Stothers, Lynn] Univ British Columbia, ICORD, Vancouver, BC, Canada; [Macnab, Andrew J.] Wallenberg Res Ctr, Stellenbosch Inst Adv Study, Stellenbosch, South Africa; [Bajunirwe, Francis] Mbarara Univ Sci & Technol, Dept Community Hlth, Mbarara, Uganda; [Mutabazi, Sharif] Cure Med Ctr Ishaka, Hlth & Dev Agcy HEADA, Ishaka, Uganda; [Berkowitz, Jonathan] Univ British Columbia, Dept Family Practice, Vancouver, BC, Canada; [Berkowitz, Jonathan] Univ British Columbia, Sauder Sch Business, Vancouver, BC, Canada	University of British Columbia; University of British Columbia; University of British Columbia; Stellenbosch University; Mbarara University of Science & Technology; University of British Columbia; University of British Columbia	Stothers, L (corresponding author), Univ British Columbia, Dept Urol Sci, Vancouver, BC, Canada.; Stothers, L (corresponding author), Univ British Columbia, Sch Populat & Publ Hlth, Vancouver, BC, Canada.; Stothers, L (corresponding author), Univ British Columbia, ICORD, Vancouver, BC, Canada.	lynns@mail.ubc.ca			Grand Challenges Canada Stars in Global Health program [0382-01]	Grand Challenges Canada Stars in Global Health program	This study was made possible through a competitive grant from Grand Challenges Canada Stars in Global Health program: award number 0382-01.	[Anonymous], 2010, AM UROLOGIC ASS GUID; BARRY MJ, 1992, J UROLOGY, V148, P1549, DOI 10.1016/S0022-5347(17)36966-5; BOSCH JLHR, 1995, BRIT J UROL, V75, P622, DOI 10.1111/j.1464-410X.1995.tb07421.x; Boyle P, 1996, J UROLOGY, V155, P176, DOI 10.1016/S0022-5347(01)66587-X; Diener E, 2012, AM PSYCHOL, V67, P590, DOI 10.1037/a0029541; EPSTEIN RS, 1992, J CLIN EPIDEMIOL, V45, P1431, DOI 10.1016/0895-4356(92)90205-2; Fowke JH, 2011, J GEN INTERN MED, V26, P1305, DOI 10.1007/s11606-011-1776-8; Irwin DE, 2011, BJU INT, V108, P1132, DOI 10.1111/j.1464-410X.2010.09993.x; Latz I, 2013, WORLD J UROL, V31, P673, DOI 10.1007/s00345-012-0937-7; MacDonald D, 2003, DRUGS, V63, P1947, DOI 10.2165/00003495-200363180-00004; Pinto JDO, 2015, J CLIN NURS, V24, P511, DOI 10.1111/jocn.12636; SAGNIER PP, 1994, J UROLOGY, V151, P1266, DOI 10.1016/S0022-5347(17)35229-1; Wei JT, 2008, J UROLOGY, V179, pS75, DOI 10.1016/j.juro.2008.03.141	13	9	9	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 16	2017	12	3							e0173631	10.1371/journal.pone.0173631	http://dx.doi.org/10.1371/journal.pone.0173631			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN9KE	28301527	Green Published, Green Submitted, gold			2022-12-27	WOS:000396318300056
J	Yang, J; Bai, SY; Qu, Z; Chang, H				Yang, Jian; Bai, Shuying; Qu, Zhao; Chang, Hui			Investigation on law and economics of listed companies' financing preference based on complex network theory	PLOS ONE			English	Article							TIME-SERIES; ATTACK VULNERABILITY; COOPERATION	In this paper, complex network theory is used to make time-series analysis of key indicators of governance structure and financing data. We analyze scientific listed companies' governance data from 2010 to 2014 and divide them into groups in accordance with the similarity they share. Then we select sample companies to analyze their financing data and explore the influence of governance structure on financing decision and the financing preference they display. This paper reviews relevant laws and regulations of financing from the perspective of law and economics, then proposes reasonable suggestions to consummate the law for the purpose of regulating listed companies' financing. The research provides a reference for making qualitative analysis on companies' financing.	[Yang, Jian; Bai, Shuying; Chang, Hui] Tianjin Univ, Sch Law, Tianjin 300072, Peoples R China; [Qu, Zhao] Tianjin Univ, Sch Foreign Languages & Literature, Tianjin 300072, Peoples R China	Tianjin University; Tianjin University	Chang, H (corresponding author), Tianjin Univ, Sch Law, Tianjin 300072, Peoples R China.	changhui@tju.edu.cn						[Anonymous], [No title captured]; [Anonymous], [No title captured]; [Anonymous], [No title captured]; [Anonymous], [No title captured]; [Anonymous], [No title captured]; [Anonymous], [No title captured]; [Anonymous], [No title captured]; [Anonymous], [No title captured]; Barth JR, 2011, ATLANTIC ECON J, V39, P19, DOI 10.1007/s11293-010-9260-0; Boccaletti S, 2014, PHYS REP, V544, P1, DOI 10.1016/j.physrep.2014.07.001; DAW CS, 1995, PHYS REV LETT, V75, P2308, DOI 10.1103/PhysRevLett.75.2308; Donges JF, 2012, PHYS REV E, V85, DOI 10.1103/PhysRevE.85.046105; Donges JF, 2011, P NATL ACAD SCI USA, V108, P20422, DOI 10.1073/pnas.1117052108; Drake D, 2014, J CORP ACCOUNT FINAN, V25, P29, DOI 10.1002/jcaf.21951; Gao ZK, 2017, INT J NEURAL SYST, V27, DOI 10.1142/S0129065717500058; Gao ZK, 2016, SCI REP-UK, V6, DOI 10.1038/srep35622; Gao ZK, 2016, CHEM ENG J, V291, P74, DOI 10.1016/j.cej.2016.01.039; Gao ZK, 2015, EPL-EUROPHYS LETT, V109, DOI 10.1209/0295-5075/109/30005; Gao ZK, 2015, SCI REP-UK, V5, DOI 10.1038/srep08222; Gao ZK, 2015, EXP THERM FLUID SCI, V60, P157, DOI 10.1016/j.expthermflusci.2014.09.008; Gao ZK, 2012, NONLINEAR ANAL-REAL, V13, P947, DOI 10.1016/j.nonrwa.2011.08.029; Gao ZK, 2009, PHYS REV E, V79, DOI 10.1103/PhysRevE.79.066303; Hong Z, 2013, CHINA FINANC REV INT, V3, P353, DOI 10.1108/CFRI-08-2012-0094; Li RQ, 2015, CHAOS SOLITON FRACT, V80, P109, DOI 10.1016/j.chaos.2015.06.022; Meng XK, 2015, PHYS LETT A, V379, P767, DOI 10.1016/j.physleta.2014.12.051; Newman MEJ, 2006, P NATL ACAD SCI USA, V103, P8577, DOI 10.1073/pnas.0601602103; Newman MEJ, 2004, PHYS REV E, V70, DOI [10.1103/PhysRevE.70.056131, 10.1103/PhysRevE.69.026113]; Podobnik B, 2008, PHYS REV LETT, V100, DOI 10.1103/PhysRevLett.100.084102; Sun SW, 2016, SCI REP-UK, V6, DOI 10.1038/srep32983; Tang JJ, 2016, PHYSICA A, V450, P635, DOI 10.1016/j.physa.2016.01.012; Wang WX, 2011, PHYS REV LETT, V106, DOI 10.1103/PhysRevLett.106.154101; Xia CY, 2009, INT J MOD PHYS B, V23, P2203, DOI 10.1142/S021797920905211X; Xia CY, 2015, EPL-EUROPHYS LETT, V109, DOI 10.1209/0295-5075/109/58002; Xia CY, 2013, PHYSICA A, V392, P1577, DOI 10.1016/j.physa.2012.11.043; Xia CY, 2014, APPL MATH COMPUT, V246, P389, DOI 10.1016/j.amc.2014.08.006; Xia CY, 2012, NONLINEAR DYNAM, V69, P927, DOI 10.1007/s11071-011-0313-y; Yang J, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0127001; Zhang J, 2006, PHYS REV LETT, V96, DOI 10.1103/PhysRevLett.96.238701	38	1	1	7	51	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 16	2017	12	3							e0173514	10.1371/journal.pone.0173514	http://dx.doi.org/10.1371/journal.pone.0173514			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN9KE	28301510	Green Published, Green Submitted, gold			2022-12-27	WOS:000396318300048
J	Ito, K; Nakajima, A; Fukushima, Y; Suzuki, K; Sakamoto, K; Hamazaki, Y; Ogasawara, K; Minato, N; Hattori, M				Ito, Koyu; Nakajima, Akira; Fukushima, Yuji; Suzuki, Keiichiro; Sakamoto, Keiko; Hamazaki, Yoko; Ogasawara, Kouetsu; Minato, Nagahiro; Hattori, Masakazu			The potential role of Osteopontin in the maintenance of commensal bacteria homeostasis in the intestine	PLOS ONE			English	Article							MEMORY T-CELLS; INNATE IMMUNE-RESPONSE; INTRAEPITHELIAL LYMPHOCYTES; PEYERS-PATCHES; GUT MICROBIOTA; IGA SYNTHESIS; CRUCIAL ROLE; EXPRESSION; PROGRESSION; INFECTION	Osteopontin (Opn), a multifunctional extracellular matrix protein, is implicated in the pathogenesis of various inflammatory disorders. Under physiologic conditions, its expression is restricted to certain tissues including bone and kidney tubule. However, cellular activation during disease development induces Opn expression in various immune cells. In this study, using Opn-EGFP knock-in (KI) mice we found that CD8 alpha(+) T cells in the intestinal tissues, including Peyer's patch, lamina propria and epithelium, express Opn under steady state conditions. Therefore, we examined the role of Opn-expressing CD8 alpha(+) T cells in intestinal homeostasis. Interestingly, Opn knockout (KO) mice had altered fecal microflora concordant with a reduction of TCR gamma delta(+) intraepithelial lymphocytes (IELs). Consistent with this result, both treatment with anti-Opn blocking antibody and deficiency of Opn resulted in decreased survival of TCR gamma delta(+) and TCR alpha beta(+) IELs. This data suggests that a possibility that Opn may function as a survival factor for IELs in the intestinal tissue. Collectively, these data suggest the possibility that Opn might regulate the homeostasis of intestinal microflora through maintenance of TCR gamma delta(+) IELs, possibly by support of IEL survival.	[Ito, Koyu; Nakajima, Akira; Fukushima, Yuji; Suzuki, Keiichiro; Hattori, Masakazu] Kyoto Univ, Grad Sch Med, Ctr Innovat Immunoregulat Technol & Therapeut, Sakyo Ku, Yoshida Konoe Cho, Kyoto, Japan; [Ito, Koyu; Ogasawara, Kouetsu] Tohoku Univ, Dept Immunobiol, Inst Dev Ageing & Canc, Aoba Ku, Sendai, Miyagi, Japan; [Sakamoto, Keiko; Hamazaki, Yoko; Minato, Nagahiro] Kyoto Univ, Grad Sch Med, Dept Immunol & Cell Biol, Sakyo Ku, Yoshida Konoe Cho, Kyoto, Japan	Kyoto University; Tohoku University; Kyoto University	Ito, K; Hattori, M (corresponding author), Kyoto Univ, Grad Sch Med, Ctr Innovat Immunoregulat Technol & Therapeut, Sakyo Ku, Yoshida Konoe Cho, Kyoto, Japan.; Ito, K (corresponding author), Tohoku Univ, Dept Immunobiol, Inst Dev Ageing & Canc, Aoba Ku, Sendai, Miyagi, Japan.	koyu.ito.c6@tohoku.ac.jp; hattori@ak.med.kyoto-u.ac.jp	Ito, Koyu/CAH-5669-2022; Hamazaki, Y*/Q-3076-2019	Hamazaki, Y*/0000-0001-5866-7340	Astellas Pharma Inc. in the Creation of Innovation Centers for Advanced Interdisciplinary Research Areas Program; Japan Societies for the Promotion of Sciences [15K19075]; Grants-in-Aid for Scientific Research [24111008] Funding Source: KAKEN	Astellas Pharma Inc. in the Creation of Innovation Centers for Advanced Interdisciplinary Research Areas Program; Japan Societies for the Promotion of Sciences; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported from grants from Astellas Pharma Inc. in the Creation of Innovation Centers for Advanced Interdisciplinary Research Areas Program and from Japan Societies for the Promotion of Sciences, Grant-in-Aid for Young Scientists (B) (Grant Number: 15K19075 to K. I. https://kaken.nii.ac.jp/grant/KAKENHI-PROJECT-15K19075/). Publication of this article was approved by an intellectual property committee composed of representatives from Kyoto University and Astellas Pharma Inc. The funders had no role in study design, data collection and analysis, decision to publish.	Beura LK, 2014, CELL, V157, P1488, DOI 10.1016/j.cell.2014.05.026; Cash HL, 2006, SCIENCE, V313, P1126, DOI 10.1126/science.1127119; Chagan-Yasutan H, 2014, THROMB RES, V134, P449, DOI 10.1016/j.thromres.2014.05.003; CHEN JK, 1993, MATRIX, V13, P113, DOI 10.1016/S0934-8832(11)80070-3; Chen Q, 2014, STEM CELLS, V32, P327, DOI 10.1002/stem.1567; Chu VT, 2014, IMMUNITY, V40, P582, DOI 10.1016/j.immuni.2014.02.014; Corbin BD, 2008, SCIENCE, V319, P962, DOI 10.1126/science.1152449; Daft JG, 2015, MICROBIOME, V3, DOI 10.1186/s40168-015-0080-y; Damo SM, 2013, P NATL ACAD SCI USA, V110, P3841, DOI 10.1073/pnas.1220341110; Diao HY, 2004, IMMUNITY, V21, P539, DOI 10.1016/j.immuni.2004.08.012; Fagarasan S, 2003, NAT REV IMMUNOL, V3, P63, DOI 10.1038/nri982; Flo TH, 2004, NATURE, V432, P917, DOI 10.1038/nature03104; Gerard P, 2016, CELL MOL LIFE SCI, V73, P147, DOI 10.1007/s00018-015-2061-5; Gotoh M, 2002, PATHOL INT, V52, P19, DOI 10.1046/j.1440-1827.2002.01316.x; Hamamoto S, 2011, J BONE MINER RES, V26, P2967, DOI 10.1002/jbmr.495; Heilmann K, 2009, J CELL MOL MED, V13, P1162, DOI 10.1111/j.1582-4934.2008.00428.x; Holm E, 2014, BIOCHEM J, V464, P355, DOI 10.1042/BJ20140702; Hur EM, 2007, NAT IMMUNOL, V8, P74, DOI 10.1038/ni1415; Ismail AS, 2011, P NATL ACAD SCI USA, V108, P8743, DOI 10.1073/pnas.1019574108; Kamada N, 2013, NAT REV IMMUNOL, V13, P321, DOI 10.1038/nri3430; Kawamoto S, 2012, SCIENCE, V336, P485, DOI 10.1126/science.1217718; Kourepini E, 2014, P NATL ACAD SCI USA, V111, pE856, DOI 10.1073/pnas.1316447111; LAGOO AS, 1994, EUR J IMMUNOL, V24, P3087, DOI 10.1002/eji.1830241226; Lai YK, 2013, SCI REP-UK, V3, DOI 10.1038/srep03009; Laky K, 2000, J EXP MED, V191, P1569, DOI 10.1084/jem.191.9.1569; Leavenworth JW, 2015, P NATL ACAD SCI USA, V112, P494, DOI 10.1073/pnas.1423011112; Liaw L, 1997, ARTERIOSCL THROM VAS, V17, P188, DOI 10.1161/01.ATV.17.1.188; Liaw L, 1998, J CLIN INVEST, V101, P1468; Liu JZ, 2012, CELL HOST MICROBE, V11, P227, DOI 10.1016/j.chom.2012.01.017; Lycke NY, 2012, FRONT IMMUNOL, V3, DOI 10.3389/fimmu.2012.00329; Mackay LK, 2013, NAT IMMUNOL, V14, P1294, DOI 10.1038/ni.2744; Oz HS, 2012, DIGEST DIS SCI, V57, P1554, DOI 10.1007/s10620-011-2009-z; Rangaswami H, 2006, TRENDS CELL BIOL, V16, P79, DOI 10.1016/j.tcb.2005.12.005; Sato T, 2005, GUT, V54, P1254, DOI 10.1136/gut.2004.048298; Sheridan BS, 2014, IMMUNITY, V40, P747, DOI 10.1016/j.immuni.2014.03.007; Shinohara ML, 2005, P NATL ACAD SCI USA, V102, P17101, DOI 10.1073/pnas.0508666102; Shitara S, 2013, J IMMUNOL, V190, P6173, DOI 10.4049/jimmunol.1202573; Suzuki K, 2014, INT IMMUNOL, V26, P489, DOI 10.1093/intimm/dxu059; Tahir S, 2015, J IMMUNOL, V194, P5725, DOI 10.4049/jimmunol.1500319; Thelemann C, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086844; van der Windt GJW, 2011, J INFECT DIS, V203, P1850, DOI 10.1093/infdis/jir185; Zhong J, 2006, INFLAMM BOWEL DIS, V12, P790, DOI 10.1097/00054725-200608000-00015	42	10	13	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 15	2017	12	3							e0173629	10.1371/journal.pone.0173629	http://dx.doi.org/10.1371/journal.pone.0173629			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN9HQ	28296922	gold, Green Published, Green Submitted			2022-12-27	WOS:000396311700047
J	Noel, SJ; Attwood, GT; Rakonjac, J; Moon, CD; Waghorn, GC; Janssen, PH				Noel, Samantha J.; Attwood, Graeme T.; Rakonjac, Jasna; Moon, Christina D.; Waghorn, Garry C.; Janssen, Peter H.			Seasonal changes in the digesta-adherent rumen bacterial communities of dairy cattle grazing pasture	PLOS ONE			English	Article							RUMINAL CELLULOLYTIC BACTERIA; DIVERSITY; DIET; POPULATION; MICROBIOME; DILUTION; ECOLOGY; COWS	The complex microbiota that resides within the rumen is responsible for the break-down of plant fibre. The bacteria that attach to ingested plant matter within the rumen are thought to be responsible for initial fibre degradation. Most studies examining the ecology of this important microbiome only offer a 'snapshot' in time. We monitored the diversity of rumen bacteria in four New Zealand dairy cows, grazing a rye-grass and clover pasture over five consecutive seasons, using high throughput pyrosequencing of bacterial 16S rRNA genes. We chose to focus on the digesta-adherent bacterial community to learn more about the stability of this community over time. 16S rRNA gene sequencing showed a high level of bacterial diversity, totalling 1539 operational taxonomic units (OTUs, grouped at 96% sequence similarity) across all samples, and ranging from 653 to 926 OTUs per individual sample. The nutritive composition of the pasture changed with the seasons as did the production phase of the animals. Sequence analysis showed that, overall, the bacterial communities were broadly similar between the individual animals. The adherent bacterial community was strongly dominated by members of Firmicutes (82.1%), followed by Bacteroidetes (11.8%). This community differed between the seasons, returning to close to that observed in the same season one year later. These seasonal differences were only small, but were statistically significant (p < 0.001), and were probably due to the seasonal differences in the diet. These results demonstrate a general invariability of the ruminal bacterial community structure in these grazing dairy cattle.	[Noel, Samantha J.; Attwood, Graeme T.; Moon, Christina D.; Janssen, Peter H.] AgResearch Ltd, Grasslands Res Ctr, Palmerston North, New Zealand; [Noel, Samantha J.; Rakonjac, Jasna] Massey Univ, Inst Fundamental Sci, Palmerston North, New Zealand; [Noel, Samantha J.] Aarhus Univ, Dept Anim Sci, Tjele, Denmark; [Waghorn, Garry C.] DairyNZ, Hamilton, New Zealand	AgResearch - New Zealand; Massey University; Aarhus University; DairyNZ	Noel, SJ (corresponding author), AgResearch Ltd, Grasslands Res Ctr, Palmerston North, New Zealand.; Noel, SJ (corresponding author), Massey Univ, Inst Fundamental Sci, Palmerston North, New Zealand.; Noel, SJ (corresponding author), Aarhus Univ, Dept Anim Sci, Tjele, Denmark.	Samantha.noel@anis.au.dk	Rakonjac, Jasna V/E-6836-2011; Noel, Samantha/AAM-4090-2021	Rakonjac, Jasna V/0000-0002-6756-4682; Noel, Samantha Joan/0000-0003-4529-9598; Moon, Christina/0000-0001-9692-9559	New Zealand Ministry of Business, Innovation and Employment [C10X0803]	New Zealand Ministry of Business, Innovation and Employment(New Zealand Ministry of Business, Innovation and Employment (MBIE))	This work was supported by the New Zealand Ministry of Business, Innovation and Employment New Economy Research Fund (contract C10X0803). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	An DD, 2005, ANAEROBE, V11, P207, DOI 10.1016/j.anaerobe.2005.02.001; BERGMAN EN, 1990, PHYSIOL REV, V70, P567, DOI 10.1152/physrev.1990.70.2.567; Brulc JM, 2009, P NATL ACAD SCI USA, V106, P1948, DOI 10.1073/pnas.0806191105; Callaway TR, 2010, J ANIM SCI, V88, P3977, DOI 10.2527/jas.2010-2900; Caporaso JG, 2010, NAT METHODS, V7, P335, DOI 10.1038/nmeth.f.303; Caporaso JG, 2010, BIOINFORMATICS, V26, P266, DOI 10.1093/bioinformatics/btp636; Corson D. C., 1999, Proceedings of the New Zealand Grassland Association, V61, P127; Edgar RC, 2010, BIOINFORMATICS, V26, P2460, DOI 10.1093/bioinformatics/btq461; Edwards JE, 2004, ANTON LEEUW INT J G, V86, P263, DOI 10.1023/B:ANTO.0000047942.69033.24; Fouts DE, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048289; Gado HM, 2009, ANIM FEED SCI TECH, V154, P36, DOI 10.1016/j.anifeedsci.2009.07.006; Henderson G, 2015, SCI REP-UK, V5, DOI 10.1038/srep14567; Jami E, 2013, ISME J, V7, P1069, DOI 10.1038/ismej.2013.2; Jami E, 2012, ANAEROBE, V18, P338, DOI 10.1016/j.anaerobe.2012.04.003; Jami E, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033306; Jewell KA, 2015, APPL ENVIRON MICROB, V81, P4697, DOI 10.1128/AEM.00720-15; Kenters N, 2011, J MICROBIOL METH, V84, P52, DOI 10.1016/j.mimet.2010.10.011; Kim M, 2011, FEMS MICROBIOL ECOL, V76, P49, DOI 10.1111/j.1574-6941.2010.01029.x; Kim M, 2011, J MICROBIOL METH, V84, P81, DOI 10.1016/j.mimet.2010.10.020; Kocherginskaya SA, 2001, ANAEROBE, V7, P119, DOI 10.1006/anae.2001.0378; Koike S, 2003, J DAIRY SCI, V86, P1429, DOI 10.3168/jds.S0022-0302(03)73726-6; Kong YH, 2010, FEMS MICROBIOL ECOL, V74, P612, DOI 10.1111/j.1574-6941.2010.00977.x; Kuczynski Justin, 2012, Curr Protoc Microbiol, VChapter 1, DOI [10.1002/0471250953.bi1007s36, 10.1002/9780471729259.mc01e05s27]; Lane D.J., 1991, NUCL ACID TECH BACT, P115, DOI [DOI 10.4135/9781446279281.N7, DOI 10.1271/BBB.67.1048]; Li M, 2009, J APPL MICROBIOL, V107, P1924, DOI 10.1111/j.1365-2672.2009.04376.x; Li RG, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0037127, 10.1371/journal.pone.0029392, 10.1371/journal.pone.0051897]; Li WZ, 2012, BRIEF BIOINFORM, V13, P656, DOI 10.1093/bib/bbs035; Liu ZZ, 2008, NUCLEIC ACIDS RES, V36, DOI 10.1093/nar/gkn491; Lozupone C, 2005, APPL ENVIRON MICROB, V71, P8228, DOI 10.1128/AEM.71.12.8228-8235.2005; Machado CF, 2005, NEW ZEAL J AGR RES, V48, P265, DOI 10.1080/00288233.2005.9513655; McEwan NR, 2005, LETT APPL MICROBIOL, V41, P97, DOI 10.1111/j.1472-765X.2005.01707.x; Oksanen J., 2007, COMMUN ECOL PACK, P631; Pinheiro J, R PACKAGE VERSION; Pitta DW, 2010, MICROB ECOL, V59, P511, DOI 10.1007/s00248-009-9609-6; Price MN, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009490; Ramsak A, 2000, FEMS MICROBIOL ECOL, V33, P69, DOI 10.1111/j.1574-6941.2000.tb00728.x; Sait M, 2002, ENVIRON MICROBIOL, V4, P654, DOI 10.1046/j.1462-2920.2002.00352.x; Tajima K, 2001, APPL ENVIRON MICROB, V67, P2766, DOI 10.1128/AEM.67.6.2766-2774.2001; Tajima K, 2000, ANAEROBE, V6, P273, DOI 10.1006/anae.2000.0353; Tajima K, 2007, ANAEROBE, V13, P57, DOI 10.1016/j.anaerobe.2006.12.001; Uyeno Y, 2009, ANAEROBE; Waghorn GC, 2007, OCCASIONAL PUBLICATI, V14, P35; Wanapat M, 2009, ANIM FEED SCI TECH, V151, P205, DOI 10.1016/j.anifeedsci.2009.01.017; WEIMER PJ, 1993, ARCH MICROBIOL, V160, P288, DOI 10.1007/BF00292079; Weimer PJ, 1999, J DAIRY SCI, V82, P122, DOI 10.3168/jds.S0022-0302(99)75216-1; Welkie DG, 2010, ANAEROBE, V16, P94, DOI 10.1016/j.anaerobe.2009.07.002; Wu S., 2012, METAGENOMICS, V1, P1	47	26	28	3	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 15	2017	12	3							e0173819	10.1371/journal.pone.0173819	http://dx.doi.org/10.1371/journal.pone.0173819			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN9HQ	28296930	Green Published, gold, Green Submitted			2022-12-27	WOS:000396311700069
J	Xu, NL; Zhao, S; Xue, HX; Fu, WY; Liu, L; Zhang, TQ; Huang, R; Zhang, N				Xu, Neili; Zhao, Shuai; Xue, HongXia; Fu, Wenyi; Liu, Li; Zhang, TianQi; Huang, Rui; Zhang, Ning			Associations of perceived social support and positive psychological resources with fatigue symptom in patients with rheumatoid arthritis	PLOS ONE			English	Article							QUALITY-OF-LIFE; BREAST-CANCER PATIENTS; CHRONIC ILLNESS; INVENTORY MFI; SELF-EFFICACY; RESILIENCE; HOPE; OPTIMISM; THERAPY; HEALTH	Objective This study aimed to assess the association between perceived social support (PSS) and fatigue and the roles of hope, optimism, general self-efficacy and resilience as mediators or moderators on PSS-fatigue association among Rheumatoid Arthritis (RA) patients in China. Methods A multi-center, cross-sectional study was conducted withinpatients diagnosed with RA in northeast China, in which 305 eligible inpatients were enrolled. The Multidimensional Fatigue Inventory, Multidimensional Scale of Perceived Social Support, Herth Hope Index, Life Orientation Test Revised, General Self-Efficacy Scale and Ego-Resiliency Scale were completed. The associations of PSS, hope, optimism, general self-efficacy and resilience with fatigue and the moderating roles of these positive psychological constructs were tested by hierarchical linear regression. Asymptotic and resampling strategies were utilized to assess the mediating roles of hope, optimism, general self-efficacy and resilience. Results The mean score of the MFI was 57.88 (SD = 9.50). PSS, hope, optimism and resilience were negatively associated with RA-related fatigue, whereas DAS28-CRP was positively associated. Only resilience positively moderated the PSS-fatigue association (B = 0.03, beta = 0.13, P<0.01). Hope, optimism and resilience may act as partial mediators in the association between PSS and fatigue symptoms (hope: a*b = -0.16, BCa 95%CI: -0.27, -0.03; optimism: a*b = -0.20, BCa 95%CI: -0.30, -0.10; resilience: a*b = -0.12, BCa 95% CI: -0.21-0.04). Conclusions Fatigue is a severe symptom among RA patients. Resilience may positively moderate the PSS-fatigue association. Hope, optimism and resilience may act as partial mediators in the association. PSS, hope, optimism and resilience may contribute as effective recourses to alleviate fatigue, upon which PSS probably has the greatest effect.	[Xu, Neili; Zhang, TianQi; Huang, Rui] China Med Univ, Clin Acad 2, Shenyang, Liaoning, Peoples R China; [Zhao, Shuai; Xue, HongXia; Fu, Wenyi; Zhang, Ning] China Med Univ, Shengjing Hosp, Dept Rheumatol, Shenyang, Liaoning, Peoples R China; [Liu, Li] China Med Univ, Sch Publ Hlth, Dept Social Med, Shenyang, Liaoning, Peoples R China	China Medical University; China Medical University; China Medical University	Zhang, N (corresponding author), China Med Univ, Shengjing Hosp, Dept Rheumatol, Shenyang, Liaoning, Peoples R China.	nzhang55@cmu.edu.cn			program of the Science & Technology Department in Liaoning Province [2014021081]	program of the Science & Technology Department in Liaoning Province	The fund was provided by the program of the Science & Technology Department in Liaoning Province. The grant number is 2014021081, and the corresponding author, Ning Zhang, is the author who received the funding. Ning Zhang participated in the study design and made the final decisions to publish.	Abd El-Kader SM, 2015, AFR HEALTH SCI, V15, P1142, DOI 10.4314/ahs.v15i4.13; Avvenuti G, 2016, FRONT PSYCHOL, V7, DOI 10.3389/fpsyg.2016.00295; Block J, 1996, J PERS SOC PSYCHOL, V70, P349, DOI 10.1037/0022-3514.70.2.349; BRONFENBRENNER U, 1994, PSYCHOL REV, V101, P568, DOI 10.1037/0033-295X.101.4.568; Buitinga L, 2012, MUSCULOSKELET CARE, V10, P240, DOI 10.1002/msc.1026; Carver CS, 2010, CLIN PSYCHOL REV, V30, P879, DOI 10.1016/j.cpr.2010.01.006; DUFAULT K, 1985, NURS CLIN N AM, V20, P379; Feldthusen C, 2016, ARCH PHYS MED REHAB, V97, P26, DOI 10.1016/j.apmr.2015.09.022; Fournier M, 2002, BRIT J HEALTH PSYCH, V7, P409, DOI 10.1348/135910702320645390; Gong GL, 2016, NURS RES, V65, P55, DOI 10.1097/NNR.0000000000000137; Graninger M, 2015, Z RHEUMATOL, V74, P579, DOI 10.1007/s00393-014-1554-1; Heidari M, 2015, INDIAN J PALLIAT CAR, V21, P198, DOI 10.4103/0973-1075.156500; Herth K, 1991, Sch Inq Nurs Pract, V5, P39; Hewlett S, 2005, ARTHRIT RHEUM-ARTHR, V53, P697, DOI 10.1002/art.21450; Hewlett S, 2011, ARTHRIT CARE RES, V63, pS263, DOI 10.1002/acr.20579; Hirsch JK, 2006, SUICIDE LIFE-THREAT, V36, P661, DOI 10.1521/suli.2006.36.6.661; Hirsch JK, 2016, J HEALTH PSYCHOL, V21, P451, DOI 10.1177/1359105314527142; Irving LM, 1997, J TRAUMA STRESS, V10, P465, DOI 10.1002/jts.2490100311; Kim DS, 2006, INT J NURS STUD, V43, P547, DOI 10.1016/j.ijnurstu.2005.07.010; Kim J, 2010, J HEALTH PSYCHOL, V15, P543, DOI 10.1177/1359105309355338; Kostova Z, 2015, PAIN RES MANAG, V20, P199, DOI 10.1155/2015/497512; Kostova Z, 2014, PSYCHOL HEALTH, V29, P1283, DOI 10.1080/08870446.2014.925895; Kreis S, 2015, HEALTH QUAL LIFE OUT, V13, DOI 10.1186/s12955-015-0268-7; Lakey B, 2010, PERS SOC PSYCHOL B, V36, P132, DOI 10.1177/0146167209349375; Lawford J, 2001, Pediatr Rehabil, V4, P209; Li MY, 2016, HEALTH QUAL LIFE OUT, V14, DOI 10.1186/s12955-016-0481-z; Lim JW, 2014, SUPPORT CARE CANCER, V22, P3209, DOI 10.1007/s00520-014-2334-9; Liu L, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0145103; Loppenthin K, 2015, RHEUMATOL INT, V35, P1655, DOI 10.1007/s00296-015-3274-5; Losoi H, 2015, J HEAD TRAUMA REHAB, V30, pE24, DOI 10.1097/HTR.0000000000000055; Luszczynska A, 2005, J PSYCHOL, V139, P439, DOI 10.3200/JRLP.139.5.439-457; Matcham F, 2015, CLIN PSYCHOL REV, V39, P16, DOI 10.1016/j.cpr.2015.03.004; Mayoux-Benhamou M. A., 2006, Annales de Readaptation et de Medecine Physique, V49, P385, DOI 10.1016/j.annrmp.2006.04.012; McBain H, 2013, MUSCULOSKELET CARE, V11, P19, DOI 10.1002/msc.1020; McInnes IB, 2013, CLIN EXP RHEUMATOL, V31, P350; Mortada M, 2015, HEALTH QUAL LIFE OUT, V13, DOI 10.1186/s12955-015-0304-7; Nasilowska-Barud Alicja, 2015, Wiad Lek, V68, P279; Nikolaus S, 2013, ARTHRIT CARE RES, V65, P1128, DOI 10.1002/acr.21949; Rasmussen CL, 2015, CANCER-AM CANCER SOC, V121, P3727, DOI 10.1002/cncr.29563; Repping-Wuts H, 2008, INT J NURS STUD, V45, P995, DOI 10.1016/j.ijnurstu.2007.06.007; Rupp I, 2004, ARTHRIT RHEUM-ARTHR, V51, P578, DOI 10.1002/art.20539; SCHEIER MF, 1985, HEALTH PSYCHOL, V4, P219, DOI 10.1037/0278-6133.4.3.219; SCHEIER MF, 1994, J PERS SOC PSYCHOL, V67, P1063, DOI 10.1037/0022-3514.67.6.1063; Schwarz R, 2003, ONKOLOGIE, V26, P140, DOI 10.1159/000069834; Schwarzer R, 1995, GEN SELF EFFICACY SC, P35; Schwarzer R., 1997, WORLD PSYCHOL, V3, P177; Schwarzer R, 1997, PSYCHOL INT J PSYCHO; Shrivastava A, 2016, INDIAN J PSYCHIAT, V58, P38, DOI 10.4103/0019-5545.174365; SMETS EMA, 1995, J PSYCHOSOM RES, V39, P315, DOI 10.1016/0022-3999(94)00125-O; Smith TW, 2004, HEALTH PSYCHOL, V23, P476, DOI 10.1037/0278-6133.23.5.476; Strauss B, 2007, J CANCER RES CLIN, V133, P511, DOI 10.1007/s00432-007-0195-z; Tack B B, 1990, Arthritis Care Res, V3, P65, DOI 10.1002/1529-0131(199006)3:2<65::AID-ANR1790030203>3.0.CO;2-6; Taylor PC, 2016, RHEUMATOL INT, V36, P685, DOI 10.1007/s00296-015-3415-x; Tian J, 2012, SUPPORT CARE CANCER, V20, P2379, DOI 10.1007/s00520-011-1357-8; Treharne GJ, 2005, J HEALTH PSYCHOL, V10, P457, DOI 10.1177/1359105305051416; van Hoogmoed D, 2013, SCAND J RHEUMATOL, V42, P15, DOI 10.3109/03009742.2012.709878; van Hoogmoed D, 2010, RHEUMATOLOGY, V49, P1294, DOI 10.1093/rheumatology/keq043; van Steenbergen HW, 2015, RMD OPEN, V1, DOI 10.1136/rmdopen-2014-000041; Weissflog G, 2015, BREAST CANCER RES TR, V152, P581, DOI 10.1007/s10549-015-3494-0; Xiang YJ, 2009, RHEUMATOL INT, V29, P481, DOI 10.1007/s00296-008-0809-z; Xiao CH, 2016, BRAIN BEHAV IMMUN, V52, P145, DOI 10.1016/j.bbi.2015.10.016; Yang HF, 2014, PSYCHOL REP, V115, P467, DOI 10.2466/08.21.PR0.115c22z8; Yang YL, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0155607; Yang YL, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094804; Yi JP, 2005, J BEHAV MED, V28, P257, DOI 10.1007/s10865-005-4662-1; Zhai JX, 2014, INT J DERMATOL, V53, P450, DOI 10.1111/j.1365-4632.2012.05734.x; Zhang J. X., 1995, PSYCHOL INT J PSYCHO; ZIMET GD, 1990, J PERS ASSESS, V55, P610, DOI 10.1207/s15327752jpa5503&4_17	68	21	22	1	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 14	2017	12	3							e0173293	10.1371/journal.pone.0173293	http://dx.doi.org/10.1371/journal.pone.0173293			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EN6DM	28291837	Green Published, Green Submitted, gold			2022-12-27	WOS:000396094700019
J	Rochat, N; Hauw, D; Philippe, RA; von Roten, FC; Seifert, L				Rochat, Nadege; Hauw, Denis; Philippe, Roberta Antonini; von Roten, Fabienne Crettaz; Seifert, Ludovic			Comparison of vitality states of finishers and withdrawers in trail running: An enactive and phenomenological perspective	PLOS ONE			English	Article							SUBJECTIVE VITALITY; 2ND-PERSON METHODS; SITUATED ANALYSIS; PERFORMANCE; MARATHON; SELF; EXPERIENCES; EMOTIONS; PARTICIPATION; PERSONALITY	Studies on ultra-endurance suggest that during the races, athletes typically experience three vitality states (i.e., preservation, loss, and revival) at the phenomenological level. Nevertheless, how these states contribute to the management and outcome of performance remains unclear. The aim of this study was to determine whether and how the vitality states experienced by runners and their evolution during a trail race can be used to distinguish finishers from withdrawers. From an enactive and phenomenological framework, we processed enactive interviews and blog posts of race narratives. We distinguished units of meaning, which were grouped into sequences of experience; each sequence was then categorized as one of the three vitality states: state of vitality preservation (SVP), state of vitality loss (SVL) or state of vitality revival (SVR). We analyzed the distribution of these vitality states and their temporal organization at the beginning, in the second and third quarters, and at the end of the races, and we qualitatively characterized runners' adaptations to SVL. Results showed that finishers completed the race in SVP, with overall significantly more sequences in SVP and significantly fewer sequences in SVL than withdrawers. SVR did not discriminate finishers from withdrawers. The temporal organization of the vitality states showed a significant difference in the emergence of SVP from the second quarter of the race, as well as a significant difference in the emergence of SVL from the third quarter of the race. The analysis of adaptations to SVL confirmed that finishers were more capable of exiting SVL by enacting a preservation world when they felt physical or psychological alerts, whereas withdrawers remained in SVL. Our results showed that finishers and withdrawers did not enact the same phenomenological worlds in the race situation, especially in the organization of vitality adaptations and their relationships to difficulties; the cumulative effect of the succession of experienced vitality states differed, as well.	[Rochat, Nadege; Hauw, Denis; Philippe, Roberta Antonini; von Roten, Fabienne Crettaz] Univ Lausanne, Inst Sport Sci, Lausanne, Switzerland; [Rochat, Nadege] Raidlight Vert SAS Outdoor Lab, St Pierre De Chartreuse, France; [Rochat, Nadege; Seifert, Ludovic] Univ Rouen, Fac Sports Sci, EA 3832, CETAPS Lab, Rouen, France	University of Lausanne; Universite de Rouen Normandie	Rochat, N (corresponding author), Univ Lausanne, Inst Sport Sci, Lausanne, Switzerland.; Rochat, N (corresponding author), Raidlight Vert SAS Outdoor Lab, St Pierre De Chartreuse, France.; Rochat, N (corresponding author), Univ Rouen, Fac Sports Sci, EA 3832, CETAPS Lab, Rouen, France.	nadege.rochat@unil.ch	Crettaz von Roten, Fabienne/AGI-7967-2022; SEIFERT, Ludovic/AAI-7486-2020; Hauw, Denis/L-3093-2019	Crettaz von Roten, Fabienne/0000-0003-1186-5854; SEIFERT, Ludovic/0000-0003-1712-5013; Hauw, Denis/0000-0002-3189-9499; Antonini Philippe, Roberta/0000-0001-9650-5174; Rochat, Nadege/0000-0001-5100-3736	ANRT (National association of research and technology) under the CIFRE agreement (Industrial Convention of Learning by Research); Raidlight compagny; swissuniversities	ANRT (National association of research and technology) under the CIFRE agreement (Industrial Convention of Learning by Research); Raidlight compagny; swissuniversities	Grants from ANRT (National association of research and technology) (http://www.anrt.asso.fr/fr/espace_cifre/accuell.jsp#VyTPoXAjF019) under the CIFRE agreement (Industrial Convention of Learning by Research) with the Raidlight compagny, http://www.raidlight.com/fr/ and swissuniversities (NR). We have read and understood PLOS ONE policies on Financial Disclosure and Conflicts of Interest and declare the employment of one author (NR) in Raidlight-Vertical SAS Outdoorlab Company, Saint-Pierre-de Chartreuse, France. The funder provided support in the form of salaries for the author (NR), but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of this author are articulated in the "author contributions" section.	Adler JM, 2007, PSYCHOL INQ, V18, P97, DOI 10.1080/10478400701416145; Akin U, 2016, PSYCHOL REP, V119, P516, DOI 10.1177/0033294116661273; Baker J, 2005, PSYCHOL SPORT EXERC, V6, P551, DOI 10.1016/j.psychsport.2004.04.005; Bargh JA, 2002, J SOC ISSUES, V58, P33, DOI 10.1111/1540-4560.00247; Berteloot A, 2010, STAPS, V4, P7; Block BA, 2013, QUEST, V65, P498, DOI 10.1080/00336297.2013.814576; Bortree D. S., 2005, ED COMMUNICATION INF, V5, P25, DOI DOI 10.1080/14636310500061102; Bostic TJ, 2000, SOC INDIC RES, V52, P313, DOI 10.1023/A:1007136110218; Brown MR, 2010, J SCI MED SPORT, V13, P613, DOI 10.1016/j.jsams.2010.01.002; Bruner J., 2000, ACTS MEANING; Carless D, 2013, SPORT PSYCHOL, V27, P27, DOI 10.1123/tsp.27.1.27; Carmona G, 2015, INT J SPORT PHYSIOL, V10, P1041, DOI 10.1123/ijspp.2014-0267; Cejka N, 2014, J SPORT SCI, V32, P354, DOI 10.1080/02640414.2013.825729; Cerin E, 2006, PSYCHOL SPORT EXERC, V7, P287, DOI 10.1016/j.psychsport.2005.07.002; Cona G, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0132943; Crust L, 2011, J APPL SPORT PSYCHOL, V23, P243, DOI 10.1080/10413200.2010.548848; Damasio A.R., 2000, FEELING WHAT HAPPENS; Davidsen AS, 2013, QUAL RES PSYCHOL, V10, P318, DOI 10.1080/14780887.2011.608466; Di Paolo E. A., 2011, ENACTION NEW PARADIG, P33; Ducate LC, 2008, COMPUT ASSIST LANG L, V21, P9, DOI 10.1080/09588220701865474; Evans AB, 2015, LEISURE STUD, V34, P335, DOI 10.1080/02614367.2014.923492; Ezzyat Y, 2011, PSYCHOL SCI, V22, P243, DOI 10.1177/0956797610393742; Froese T, 2011, J CONSCIOUSNESS STUD, V18, P38; Froese T, 2012, PHENOMENOL COGN SCI, V11, P205, DOI 10.1007/s11097-012-9254-2; Froese T, 2011, PRAGMAT COGN, V19, P1, DOI 10.1075/pc.19.1.01fro; Gallagher S., 1997, J CONSCIOUSNESS STUD, V4, P195; Gibbs R., 2005, EMBODIMENT COGNITIVE, DOI DOI 10.1017/CBO97805118058; Greimas AJ, 1963, LHOMME, V3, P51; Hauw D, 2004, PERCEPT MOTOR SKILL, V98, P1139, DOI 10.2466/pms.98.3c.1139-1152; Hauw D., 2009, B PSYCHOL, V502, P365, DOI DOI 10.3917/BUPSY.502.0365; Hauw D., 2017, ADV HUM FACTORS SPOR, V2017, P49, DOI [10.1007/978-3-319-41953-4_5, DOI 10.1007/978-3-319-41953-4_5]; Hauw D, 2008, J SPORT SCI MED, V7, P8; Hauw D, 2007, J SPORT SCI, V25, P173, DOI 10.1080/02640410600624269; Hauw D, 2012, J SUBST USE, V17, P183, DOI 10.3109/14659891.2010.545858; Hespanhol LC, 2013, J PHYSIOTHER, V59, P263, DOI 10.1016/S1836-9553(13)70203-0; Hoffman MD, 2012, RES SPORTS MED, V20, P59, DOI 10.1080/15438627.2012.634707; Hoffman MD, 2011, INT J SPORT PHYSIOL, V6, P25, DOI 10.1123/ijspp.6.1.25; Hoffman MD, 2010, INT J HIST SPORT, V27, P1877, DOI 10.1080/09523367.2010.494385; Holt NL, 2014, SPORT PSYCHOL, V28, P22, DOI 10.1123/tsp.2013-0008; Hughes SL, 2003, J APPL SPORT PSYCHOL, V15, P256, DOI 10.1080/10413200305385; Hurdiel R, 2015, J SPORT SCI, V33, P670, DOI 10.1080/02640414.2014.960883; Johnson U, 2016, INT J SPORT EXERC PS, V14, P72, DOI 10.1080/1612197X.2015.1035736; Jones Michael, 2008, Journal of Issues in Informing Science and Information Technology Journal, V5, P433; Kahneman D, 2004, SCIENCE, V306, P1776, DOI 10.1126/science.1103572; Krouse RZ, 2011, J STRENGTH COND RES, V25, P2835, DOI 10.1519/JSC.0b013e318204caa0; Kruseman M, 2005, EUR J APPL PHYSIOL, V94, P151, DOI 10.1007/s00421-004-1234-y; Lahart IM, 2013, J SPORT SCI MED, V12, P481; Lambert MI, 2004, J SPORT SCI MED, V3, P167; Lane AM, 2011, J SCI MED SPORT, V14, P358, DOI 10.1016/j.jsams.2011.03.001; Langdridge D., 2007, PHENOMENOLOGICAL PSY; Leblanc S, 2001, COMPUT EDUC, V36, P59, DOI 10.1016/S0360-1315(00)00053-1; LeBreton D, 2002, CONDUITES A RISQUE; Legrand D., 2006, PHENOMENOL COGN SCI, V5, P89, DOI DOI 10.1007/S11097-005-9015-6; Legrand D, 2007, CONSCIOUS COGN, V16, P583, DOI 10.1016/j.concog.2007.04.002; Lekes N, 2016, PERS INDIV DIFFER, V98, P48, DOI 10.1016/j.paid.2016.03.093; Magliano JP, 2014, J COGN PSYCHOL, V26, P649, DOI 10.1080/20445911.2014.930042; MANGAN B, 1993, CONSCIOUS COGN, V2, P89, DOI 10.1006/ccog.1993.1008; McGann M, 2013, REV GEN PSYCHOL, V17, P203, DOI 10.1037/a0032935; McMahon J, 2013, PHYS EDUC SPORT PEDA, V18, P317, DOI 10.1080/17408989.2012.666786; Mohamed S, 2015, J SPORT SCI MED, V14, P340; Norman D., 1988, PSYCHOL EVERYDAY THI; Olivares FA, 2015, FRONT PSYCHOL, V6, DOI 10.3389/fpsyg.2015.00673; Owton H, 2015, CHEST, V148, P288, DOI 10.1378/chest.14-2630; Philippe RA, 2016, SPORT PSYCHOL, V30, P361, DOI 10.1123/tsp.2016-0039; Popova YB, 2014, FRONT PSYCHOL, V5, DOI 10.3389/fpsyg.2014.00895; Propp V., 1973, MORPHOLOGIE DU CONTE; Reimer JF, 2015, J EXP PSYCHOL LEARN, V41, P1374, DOI 10.1037/xlm0000105; Rosch E., 1978, COGNITION CATEGORIZA, P27, DOI DOI 10.1037/0012-1649.16.5.391; Rousanoglou EN, 2016, J SPORT SCI MED, V15, P277; Ryan RM, 1997, J PERS, V65, P529, DOI 10.1111/j.1467-6494.1997.tb00326.x; Saugy J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065596; Saury J., 2013, ACTIONS SIGNIFICATIO; Seifert L, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089865; Seve C, 2013, SCAND J MED SCI SPOR, V23, P576, DOI 10.1111/j.1600-0838.2011.01421.x; Seve C, 2005, EUR REV APPL PSYCHOL, V55, P45; Sheets-Johnstone M., 2010, ENACTION NEW PARADIG, P165; Simpson D, 2014, SPORT PSYCHOL, V28, P176, DOI 10.1123/tsp.2013-0064; Starks H, 2007, QUAL HEALTH RES, V17, P1372, DOI 10.1177/1049732307307031; Tenenbaum G, 2003, J SPORT EXERCISE PSY, V25, P323, DOI 10.1123/jsep.25.3.323; THARION WJ, 1988, J SPORT EXERCISE PSY, V10, P229, DOI 10.1123/jsep.10.2.229; Theureau J, 2003, HUM FAC ER, P55; Theureau J., 2015, COURS ACTION ENACTIO; Theureau J., 2004, COURS ACTION METHODE; Theureau J, 2006, COURS ACTION METHODE; Theureau J, 2010, REV ANTHROPOL CONNAI, V4, P287, DOI 10.3917/rac.010.0287; Thompson E., 2005, PHENOMENOL COGN SCI, V4/, P407, DOI [10.1007/s11097-005--9003-x, DOI 10.1007/S11097-005-9003-X]; Tversky B, 2008, UNDERSTANDING EVENTS; Vaismoradi M, 2013, NURS HEALTH SCI, V15, P398, DOI 10.1111/nhs.12048; Varela FJ, 2017, EMBODIED MIND COGNIT; Zacks JM, 2007, CURR DIR PSYCHOL SCI, V16, P80, DOI 10.1111/j.1467-8721.2007.00480.x	90	25	25	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 10	2017	12	3							e0173667	10.1371/journal.pone.0173667	http://dx.doi.org/10.1371/journal.pone.0173667			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EN6CJ	28282421	Green Published, gold, Green Submitted			2022-12-27	WOS:000396091800064
J	Wang, LF; Shen, DX; Wu, H; Ma, YN				Wang, Lifeng; Shen, Dingxia; Wu, Hua; Ma, Yanning			Resistance of hypervirulent Klebsiella pneumoniae to both intracellular and extracellular killing of neutrophils	PLOS ONE			English	Article							BACTERICIDAL ACTIVITY; LIVER-ABSCESS; TRAPS; CAPSULE; DISEASE; CHINA	Hypervirulent Klebsiella pneumoniae (HvKP) is hypermucoviscous organism, carrying genes of rmpA and aerobactin, causing serious community-acquired infection and metastatically spread in young healthy hosts. Neutrophils play an important role during innate immune response against bacterial infection by phagocytosis and neutrophil extracellular traps (NETs). Whether neutrophils can effectively defend against HvKP remains unclear. In this study, we observed that the HvKP was significantly more resistant to neutrophil-mediated phagocytosis and intracellular killing than classic Klebsiella pneumoniae (cKP) isolates. Although both HvKP and cKP induced NETs under scanning electron microscopy and confocal microscopy, more cKP than HvKP were trapped in NETs, and the killing by intracellular and extracellular mechanisms of neutrophils was detected only on cKP. Together, our results demonstrated that HvKP resisted to both intracellular and extracellular killing of neutrophils.	[Wang, Lifeng; Shen, Dingxia; Wu, Hua; Ma, Yanning] Chinese Gen Hosp Peoples Liberat Army, Dept Microbiol, Beijing, Peoples R China		Shen, DX (corresponding author), Chinese Gen Hosp Peoples Liberat Army, Dept Microbiol, Beijing, Peoples R China.	shendx301@sina.com			National Natural Science Foundation of China [81472012]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by the National Natural Science Foundation of China (grant number 81472012). DXS acquired the funder, who participated in study design, decision to publish, and preparation of the manuscript.	Amulic B, 2012, ANNU REV IMMUNOL, V30, P459, DOI 10.1146/annurev-immunol-020711-074942; Bachiega TF, 2016, IMMUNOBIOLOGY, V221, P228, DOI 10.1016/j.imbio.2015.09.003; Berends ETM, 2010, J INNATE IMMUN, V2, P576, DOI 10.1159/000319909; Brinkmann V, 2004, SCIENCE, V303, P1532, DOI 10.1126/science.1092385; Brinkmann V, 2012, J CELL BIOL, V198, P773, DOI 10.1083/jcb.201203170; Casutt-Meyer S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015159; Fuchs TA, 2007, J CELL BIOL, V176, P231, DOI 10.1083/jcb.200606027; Fung CP, 2011, LAB INVEST, V91, P1029, DOI 10.1038/labinvest.2011.52; Fung CP, 2002, GUT, V50, P420, DOI 10.1136/gut.50.3.420; Grinberg N, 2008, INFECT IMMUN, V76, P2802, DOI 10.1128/IAI.00051-08; Kobayashi SD, 2003, P NATL ACAD SCI USA, V100, P10948, DOI 10.1073/pnas.1833375100; Lee HC, 2006, J INTERN MED, V259, P606, DOI 10.1111/j.1365-2796.2006.01641.x; Lin JC, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015005; Lin YT, 2012, BMC MICROBIOL, V12, DOI 10.1186/1471-2180-12-13; Nordenfelt P, 2011, J LEUKOCYTE BIOL, V90, P271, DOI 10.1189/jlb.0810457; Papayannopoulos V, 2010, J CELL BIOL, V191, P677, DOI 10.1083/jcb.201006052; Sun YF, 2016, J MOL MICROB BIOTECH, V26, P245, DOI 10.1159/000444367; TOMAS JM, 1986, INFECT IMMUN, V54, P85; Wartha F, 2007, CELL MICROBIOL, V9, P1162, DOI 10.1111/j.1462-5822.2006.00857.x; Yan Q, 2016, EUR J CLIN MICROBIOL, V35, P387, DOI 10.1007/s10096-015-2551-2	20	22	33	3	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 10	2017	12	3							e0173638	10.1371/journal.pone.0173638	http://dx.doi.org/10.1371/journal.pone.0173638			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN6CJ	28282434	Green Published, Green Submitted, gold			2022-12-27	WOS:000396091800059
J	Yao, Q; Liu, KB				Yao, Qiang; Liu, Kam-biu			Dynamics of marsh-mangrove ecotone since the mid-Holocene: A palynological study of mangrove encroachment and sea level rise in the Shark River Estuary, Florida	PLOS ONE			English	Article							EVERGLADES-NATIONAL-PARK; CLIMATE-CHANGE; COASTAL EVERGLADES; CARIBBEAN COAST; WATER FLOW; HOLOCENE; VEGETATION; RECORD; USA; HISTORY	Sea level rise and the associated inland shift of the marsh-mangrove ecotone in south Florida have raised many scientific and management concerns in recent years. Holocene paleoecological records can provide an important baseline to shed light on the long-term dynamics of vegetation changes across this ecotone in the past, which is needed to predict the future. In this study, we present palynological, X-ray fluorescence, and loss-on ignition data from four sedimentary cores recovered from a 20-km marine-to-freshwater transect along the Shark River Estuary, southwest Everglades, to document the patterns and processes of coastal vegetation changes in response to sea level rise since the mid-Holocene. Our record indicates that freshwater marsh progressively replaced marl prairies at the Shark River Estuary between 5700 and 4400 cal yr BP. As marine transgression continued, marine influence reached the threshold necessary for mangroves to establish at the current mouth of the Shark River Slough at 3800 cal yr BP. During the next 3000 years, although sea level rise in the Western North Atlantic slowed down to 0.4 mm/yr, a spatial and temporal gradient was evident as the marshmangrove ecotone shifted inland by 20 km from 3800 to 800 cal yr BP, accompanied by a gradual landward replacement of freshwater marsh by mangrove forest. If sea level continues to rise at 2.33 mm/yr in the 21(st) century in south Florida, it is possible that marine influence will reach the threshold for mangroves to establish in the central Everglades, and we could expect a much more aggressive mangrove encroachment toward the northern and interior parts of south Florida in the next few centuries.	[Yao, Qiang; Liu, Kam-biu] Louisiana State Univ, Sch Coast & Environm, Dept Oceanog & Coastal Sci, Baton Rouge, LA 70803 USA	Louisiana State University System; Louisiana State University	Yao, Q (corresponding author), Louisiana State Univ, Sch Coast & Environm, Dept Oceanog & Coastal Sci, Baton Rouge, LA 70803 USA.	qyao4@lsu.edu	Liu, Kam-Biu/B-4966-2012; Lu, houyuan/AAD-3100-2019	Liu, Kam-Biu/0000-0002-0038-2198; Lu, houyuan/0000-0001-5721-6679; Yao, Qiang/0000-0003-4833-7510	National Science Foundation (NSF DDRI Grant) [BCS-1303114]; Inter-American Institute for Global Change Research (IAI) [SGP-CRA-2050]; Division Of Environmental Biology [1237517] Funding Source: National Science Foundation	National Science Foundation (NSF DDRI Grant)(National Science Foundation (NSF)); Inter-American Institute for Global Change Research (IAI); Division Of Environmental Biology(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	Funded by National Science Foundation (NSF DDRI Grant No. BCS-1303114). KBL QY and the Inter-American Institute for Global Change Research (IAI #SGP-CRA-2050). KBL.	Armentano T.V., 1995, J COASTAL RES, P111; Bernhardt CE, 2009, ECOL APPL, V19, P1723, DOI 10.1890/08-0779.1; Blaauw M., 2013, BACON MANUAL V233 BE; Castaneda-Moya E, 2013, FOREST ECOL MANAG, V307, P226, DOI 10.1016/j.foreco.2013.07.011; Castaneda-Moya E, 2010, ESTUAR COAST, V33, P45, DOI 10.1007/s12237-009-9242-0; Cavanaugh KC, 2014, P NATL ACAD SCI USA, V111, P723, DOI 10.1073/pnas.1315800111; DEAN WE, 1974, J SEDIMENT PETROL, V44, P242; Donders TH, 2005, P NATL ACAD SCI USA, V102, P10904, DOI 10.1073/pnas.0505015102; Gabriel JJ, 2009, J PALEOLIMNOL, V42, P199, DOI 10.1007/s10933-008-9271-x; Gilman EL, 2008, AQUAT BOT, V89, P237, DOI 10.1016/j.aquabot.2007.12.009; Giri CP, 2014, P NATL ACAD SCI USA, V111, pE1447, DOI 10.1073/pnas.1400687111; Gleason Patrick J., 1994, P149; GRIMM EC, 1993, SCIENCE, V261, P198, DOI 10.1126/science.261.5118.198; Hendy IL, 2016, QUATERNARY SCI REV, V145, P152, DOI 10.1016/j.quascirev.2016.05.039; Islebe G, 2002, PLANT ECOL, V160, P187, DOI 10.1023/A:1015865932012; Joo-Chang JC, 2015, HOLOCENE, V25, P651, DOI 10.1177/0959683614566217; Krauss KW, 2011, J COAST CONSERV, V15, P629, DOI 10.1007/s11852-011-0153-4; Langevin C, 2005, J HYDROL, V314, P212, DOI 10.1016/j.jhydrol.2005.04.015; Light Stephen S., 1994, P47; Liu KB, 2011, J COASTAL RES, P1866; LIU KB, 1990, ECOL MONOGR, V60, P179, DOI 10.2307/1943044; Lodge TE, 2010, EVERGLADES HDB UNDER; MCANDREWS J H, 1966, Memoirs of the Torrey Botanical Club, V22, P1; McAndrews JH, 1973, LIFE SCI MISCELLANEO, V64; McCloskey TA, 2012, QUATERNARY RES, V78, P454, DOI 10.1016/j.yqres.2012.07.003; McLean A. R., 2002, COMPREHENSIVE EVERGL; MILLER R, 1945, AM MINERAL, V30, P65; Monacci NM, 2009, PALAEOGEOGR PALAEOCL, V280, P37, DOI 10.1016/j.palaeo.2009.05.013; Osland MJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0099604; Osland MJ, 2013, GLOBAL CHANGE BIOL, V19, P1482, DOI 10.1111/gcb.12126; Parkinson RW, 2015, CLIMATIC CHANGE, V128, P85, DOI 10.1007/s10584-014-1301-2; PARKINSON RW, 1989, J SEDIMENT PETROL, V59, P960; Peros MC, 2007, QUATERNARY RES, V67, P69, DOI 10.1016/j.yqres.2006.08.004; Platt William J., 1999, P23; Robbin D. M., 1984, ENV S FLORIDA PRESEN, V2, P437; Ross MS, 2000, J VEG SCI, V11, P101, DOI 10.2307/3236781; Saha AK, 2012, ESTUAR COAST, V35, P459, DOI 10.1007/s12237-011-9454-y; Schmitz M, 2002, PLANT ECOL, V160, P137, DOI 10.1023/A:1015848300802; SCHOLL DW, 1967, GEOL SOC AM BULL, V78, P437, DOI 10.1130/0016-7606(1967)78[437:RSOSFA]2.0.CO;2; SCHOLL DW, 1969, SCIENCE, V163, P562, DOI 10.1126/science.163.3867.562; Simard M, 2006, PHOTOGRAMM ENG REM S, V72, P299, DOI 10.14358/PERS.72.3.299; Slocum MG, 2003, RESTOR ECOL, V11, P91, DOI 10.1046/j.1526-100X.2003.00115.x; Smith TJ, 2013, FIRE ECOL, V9, P66, DOI 10.4996/fireecology.0901066; Solomon S., 2014, CONTRIBUTION WORKING; Stuiver M., 2010, CALIB RADIOCARBON CA; van Soelen EE, 2012, HOLOCENE, V22, P929, DOI 10.1177/0959683611434226; van Soelen EE, 2010, ESTUAR COAST SHELF S, V86, P216, DOI 10.1016/j.ecss.2009.11.010; Wanless Harold R., 1994, P199; WATTS WA, 1980, SCIENCE, V210, P325, DOI 10.1126/science.210.4467.325; WATTS WA, 1994, PALAEOGEOGR PALAEOCL, V109, P163, DOI 10.1016/0031-0182(94)90174-0; Webb T., 1986, PLANT ECOL, V67, P75, DOI DOI 10.1007/BF00037359; Willard DA, 2001, REV PALAEOBOT PALYNO, V113, P213, DOI 10.1016/S0034-6667(00)00042-7; Willard Debra A., 2004, Palynology, V28, P175, DOI 10.2113/28.1.175; Willard DA, 2011, CLIMATIC CHANGE, V107, P59, DOI 10.1007/s10584-011-0078-9; WOODROFFE CD, 1985, NATURE, V317, P711, DOI 10.1038/317711a0; Wooller MJ, 2007, HOLOCENE, V17, P1129, DOI 10.1177/0959683607082553; Yao Q, 2015, QUATERNARY RES, V83, P449, DOI 10.1016/j.yqres.2015.03.005	57	36	36	1	47	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 10	2017	12	3							e0173670	10.1371/journal.pone.0173670	http://dx.doi.org/10.1371/journal.pone.0173670			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN6CJ	28282415	Green Published, gold, Green Submitted			2022-12-27	WOS:000396091800066
J	Devkota, SR; Kwon, E; Ha, SC; Chang, HW; Kim, DY				Devkota, Shankar Raj; Kwon, Eunju; Ha, Sung Chul; Chang, Hyeun Wook; Kim, Dong Young			Structural insights into the regulation of Bacillus subtilis SigW activity by anti-sigma RsiW	PLOS ONE			English	Article							STRESS-RESPONSE; INTRAMEMBRANE PROTEOLYSIS; STREPTOMYCES-COELICOLOR; OXIDATIVE STRESS; FACTOR RSRA; ZINC; RESISTANCE; PROTEIN; IDENTIFICATION; REFINEMENT	Bacillus subtilis SigW is localized to the cell membrane and is inactivated by the tight interaction with anti-sigma RsiW under normal growth conditions. Whereas SigW is discharged from RsiW binding and thus initiates the transcription of its regulon under diverse stress conditions such as antibiotics and alkaline shock. The release and activation of SigW in response to extracytoplasmic signals is induced by the regulated intramembrane proteolysis of RsiW. As a ZAS (Zinc-containing anti-sigma) family protein, RsiW has a CHCC zinc binding motif, which implies that its anti-sigma activity may be regulated by the state of zinc coordination in addition to the proteolytic cleavage of RsiW. To understand the regulation mode of SigW activity by RsiW, we determined the crystal structures of SigW in complex with the cytoplasmic domain of RsiW, and compared the conformation of the CHCC motif in the reduced/zinc binding and the oxidized states. The structures revealed that RsiW inhibits the promoter binding of SigW by interacting with the surface groove of SigW. The interaction between SigW and RsiW is not disrupted by the oxidation of the CHCC motif in RsiW, suggesting that SigW activity might not be regulated by the zinc coordination states of the CHCC motif.	[Devkota, Shankar Raj; Kwon, Eunju; Chang, Hyeun Wook; Kim, Dong Young] Yeungnam Univ, Coll Pharm, Gyongsan, Gyeongbuk, South Korea; [Ha, Sung Chul] Pohang Univ Sci & Technol, Pohang Accelerator Lab, Pohang, Gyeongbuk, South Korea	Yeungnam University; Pohang University of Science & Technology (POSTECH)	Kim, DY (corresponding author), Yeungnam Univ, Coll Pharm, Gyongsan, Gyeongbuk, South Korea.	dyokim@ynu.ac.kr		Kim, Dong Young/0000-0001-7594-9083; Devkota, Shankar Raj/0000-0002-3154-7928	Basic Science Research Programs through the National Research Foundation of Korea (NRF) - Ministry of Science, ICT & Future Planning [2014R1A4A1071040]	Basic Science Research Programs through the National Research Foundation of Korea (NRF) - Ministry of Science, ICT & Future Planning	DYK and HWC were supported by Basic Science Research Programs through the National Research Foundation of Korea (NRF; WWW.nrf.re.kr) funded by the Ministry of Science, ICT & Future Planning (2014R1A4A1071040). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This work was supported by Basic Science Research Programs through the National Research Foundation of Korea (NRF) funded by the Ministry of Science, ICT & Future Planning (2014R1A4A1071040). We thank the laboratory of Hyun Ho Park for sharing SEC-MALLS instrument.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Ades SE, 1999, GENE DEV, V13, P2449, DOI 10.1101/gad.13.18.2449; Afonine PV, 2012, ACTA CRYSTALLOGR D, V68, P352, DOI 10.1107/S0907444912001308; Alba BM, 2002, GENE DEV, V16, P2156, DOI 10.1101/gad.1008902; [Anonymous], 2015, PYMOL MOL GRAPH SYST; Anthony JR, 2005, P NATL ACAD SCI USA, V102, P6502, DOI 10.1073/pnas.0502225102; Bae JB, 2004, J MOL BIOL, V335, P425, DOI 10.1016/j.jmb.2003.10.065; Baker NA, 2001, P NATL ACAD SCI USA, V98, P10037, DOI 10.1073/pnas.181342398; Butcher BG, 2006, MOL MICROBIOL, V60, P765, DOI 10.1111/j.1365-2958.2006.05131.x; Campagne S, 2014, NAT STRUCT MOL BIOL, V21, P269, DOI 10.1038/nsmb.2777; Campbell EA, 2002, MOL CELL, V9, P527, DOI 10.1016/S1097-2765(02)00470-7; Campbell EA, 2003, MOL CELL, V11, P1067, DOI 10.1016/S1097-2765(03)00148-5; Campbell EA, 2007, MOL CELL, V27, P793, DOI 10.1016/j.molcel.2007.07.009; Cao M, 2002, MOL MICROBIOL, V45, P1267, DOI 10.1046/j.1365-2958.2002.03050.x; Cao M, 2001, J BACTERIOL, V183, P2380, DOI 10.1128/JB.183.7.2380-2383.2001; Ellermeier CD, 2006, GENE DEV, V20, P1911, DOI 10.1101/gad.1440606; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Feklistov A, 2014, ANNU REV MICROBIOL, V68, P357, DOI 10.1146/annurev-micro-092412-155737; Feklistov A, 2011, CELL, V147, P1257, DOI 10.1016/j.cell.2011.10.041; Holm L, 2010, NUCLEIC ACIDS RES, V38, pW545, DOI 10.1093/nar/gkq366; Hughes KT, 1998, ANNU REV MICROBIOL, V52, P231, DOI 10.1146/annurev.micro.52.1.231; Jung YG, 2011, NUCLEIC ACIDS RES, V39, P7586, DOI 10.1093/nar/gkr477; Kanehara K, 2002, GENE DEV, V16, P2147, DOI 10.1101/gad.1002302; Kang JG, 1999, EMBO J, V18, P4292, DOI 10.1093/emboj/18.15.4292; Krissinel E, 2007, J MOL BIOL, V372, P774, DOI 10.1016/j.jmb.2007.05.022; Lane WJ, 2006, PLOS BIOL, V4, P1491, DOI 10.1371/journal.pbio.0040269; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Laskowski RA, 2011, J CHEM INF MODEL, V51, P2778, DOI 10.1021/ci200227u; Li W, 2003, J MOL BIOL, V333, P461, DOI 10.1016/j.jmb.2003.08.038; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Paget MSB, 2001, MOL MICROBIOL, V42, P1007, DOI 10.1046/j.1365-2958.2001.02675.x; Petersohn A, 2001, J BACTERIOL, V183, P5617, DOI 10.1128/JB.183.19.5617-5631.2001; Rajasekar KV, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms12194; Schobel S, 2004, MOL MICROBIOL, V52, P1091, DOI 10.1111/j.1365-2958.2004.04031.x; Wiegert T, 2001, MOL MICROBIOL, V41, P59, DOI 10.1046/j.1365-2958.2001.02489.x; Winn MD, 2011, ACTA CRYSTALLOGR D, V67, P235, DOI 10.1107/S0907444910045749; Winn MD, 2003, METHOD ENZYMOL, V374, P300, DOI 10.1016/S0076-6879(03)74014-2; Yoshimura M, 2004, MICROBIOL-SGM, V150, P591, DOI 10.1099/mic.0.26712-0; Zdanowski K, 2006, BIOCHEMISTRY-US, V45, P8294, DOI 10.1021/bi060711v; Zellmeier S, 2006, MOL MICROBIOL, V61, P1569, DOI 10.1111/j.1365-2958.2006.05323.x	41	15	17	3	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 20	2017	12	3							e0174284	10.1371/journal.pone.0174284	http://dx.doi.org/10.1371/journal.pone.0174284			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ER6VC	28319136	Green Published, Green Submitted, gold			2022-12-27	WOS:000398945800064
J	Rotevatn, TA; Boggild, H; Olesen, CR; Torp-Pedersen, C; Mortensen, RN; Jensen, PF; Overgaard, C				Rotevatn, Torill A.; Boggild, Henrik; Olesen, Christinna R.; Torp-Pedersen, Christian; Mortensen, Rikke N.; Jensen, Per F.; Overgaard, Charlotte			Alcohol consumption and the risk of postoperative mortality and morbidity after primary hip or knee arthroplasty - A register-based cohort study	PLOS ONE			English	Article							CHARLSON COMORBIDITY INDEX; SOCIOECONOMIC-STATUS; COMPLICATIONS; OUTCOMES; SMOKING; REPLACEMENT; INFECTION; SURGERY; DRINKING	Objective To investigate the implications of low and moderate preoperative alcohol consumption on postoperative mortality and morbidity after primary hip and knee arthroplasty. Methods A total of 30,799 patients who underwent primary hip or knee arthroplasty between January 1(st), 2005 and October 8(th), 2011 with information on preoperative alcohol consumption (0 grams of pure alcohol/week, >0-168 g/week, >168-252 g/week, and >252 g/week) were identified through the Danish Anesthesia Database. The 90-day and 1-year risks of mortality (primary outcomes), 1-year risk of prosthetic infection, and 30-day risks of cardiovascular disease and deep venous thrombosis (secondary outcomes) were estimated by Cox regression analysis. Results We identified 285 (0.9%) deaths within the first 90 days and 694 (2.3%) within the first year. Within the first 30 days, 209 (0.7%) and 270 (0.9%) patients had acquired cardiovascular disease and deep venous thrombosis, respectively, and 514 (1.7%) patients developed prosthetic infection within the first year. The adjusted mortality models yielded hazard ratios of 0.55 (95% confidence interval [CI] 0.41 to 0.74) at 90 days and 0.61 (95% CI 0.51 to 0.73) at 1 year for the group consuming >0-168 g/week when compared to abstainers. Adjusted hazard ratios showed that the group consuming >0-168 g/week had a 0.91 (95% CI 0.75 to 1.11) risk of prosthetic infection, 0.68 (95% CI 0.50 to 0.92) risk of cardiovascular disease and 0.88 (95% CI 0.67 to 1.15) risk of deep venous thrombosis when compared to abstainers. Conclusions This study demonstrates that low-to-moderate alcohol consumption prior to primary hip or knee arthroplasty is associated with lower risks of mortality at both 90 days and 1 year after surgery and of cardiovascular disease after 30 days. More research from longitudinal studies is needed to identify specific causal relations and explanations.	[Rotevatn, Torill A.; Boggild, Henrik; Olesen, Christinna R.; Torp-Pedersen, Christian; Overgaard, Charlotte] Aalborg Univ, Dept Hlth Sci & Technol, Aalborg, Denmark; [Torp-Pedersen, Christian; Mortensen, Rikke N.] Aalborg Univ Hosp, Dept Clin Epidemiol, Aalborg, Denmark; [Jensen, Per F.] Naestved Hosp, Dept Anesthesia, Naestved, Denmark	Aalborg University; Aalborg University; Aalborg University Hospital; Naestved Hospital	Rotevatn, TA (corresponding author), Aalborg Univ, Dept Hlth Sci & Technol, Aalborg, Denmark.	torill_rot@hotmail.com; torp@rn.dk	Overgaard, Charlotte/D-8083-2011; Overgaard, Charlotte/Q-2032-2019; Bøggild, Henrik/O-4385-2019	Overgaard, Charlotte/0000-0002-3370-2338; Overgaard, Charlotte/0000-0002-3370-2338; Bøggild, Henrik/0000-0001-8934-5002; Rotevatn, Torill Alise/0000-0003-2170-8991				Abdel MP, 2014, J ARTHROPLASTY, V29, P1430, DOI 10.1016/j.arth.2014.02.013; Agabiti N, 2007, INT J QUAL HEALTH C, V19, P37, DOI 10.1093/intqhc/mzl065; Berstock JR, 2014, BONE JOINT RES, V3, P175, DOI 10.1302/2046-3758.36.2000239; Bobo JK, 2000, ALCOHOL RES HEALTH, V24, P225; Bozic KJ, 2013, CLIN ORTHOP RELAT R, V471, P574, DOI 10.1007/s11999-012-2605-z; CHARLSON ME, 1987, J CHRON DIS, V40, P373, DOI 10.1016/0021-9681(87)90171-8; Clement ND, 2011, J BONE JOINT SURG BR, V93B, P464, DOI 10.1302/0301-620X.93B4.25717; Daabiss M, 2011, INDIAN J ANAESTH, V55, P111, DOI 10.4103/0019-5049.79879; Davis CG, 2010, ADDICT BEHAV, V35, P302, DOI 10.1016/j.addbeh.2009.11.001; Della Valle AG, 2012, J ARTHROPLASTY, V27, P1743, DOI 10.1016/j.arth.2012.04.011; Ekholm O, 2011, EUR J CLIN NUTR, V65, P520, DOI 10.1038/ejcn.2011.1; Eliasen M, 2013, ANN SURG, V258, P930, DOI 10.1097/SLA.0b013e3182988d59; Fu KMG, 2011, J NEUROSURG-SPINE, V14, P470, DOI 10.3171/2010.12.SPINE10486; Gacouin A, 2008, CRIT CARE MED, V36, P1735, DOI 10.1097/CCM.0b013e318174dd75; Gmel G, 2003, EUR J EPIDEMIOL, V18, P631, DOI 10.1023/A:1024805021504; GRAMBSCH PM, 1994, BIOMETRIKA, V81, P515; Gronkjaer M, 2014, ANN SURG, V259, P52, DOI 10.1097/SLA.0b013e3182911913; Helweg-Larsen K, 2011, SCAND J PUBLIC HEALT, V39, P26, DOI 10.1177/1403494811399958; Jammer I, 2015, EUR J ANAESTH, V32, P88, DOI 10.1097/EJA.0000000000000118; Jorgensen CC, 2013, ACTA ANAESTH SCAND, V57, P631, DOI 10.1111/aas.12086; Kildemoes HW, 2011, SCAND J PUBLIC HEALT, V39, P38, DOI 10.1177/1403494810394717; Lund CA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0099308; Lynge E, 2011, SCAND J PUBLIC HEALT, V39, P30, DOI 10.1177/1403494811401482; Mason K, 2012, ACTA NEUROL SCAND, V125, P213, DOI 10.1111/j.1600-0404.2011.01558.x; Moller AM, 2003, J BONE JOINT SURG BR, V85B, P178, DOI 10.1302/0301-620X.85B2.13717; Nath B, 2010, J GASTROINTEST SURG, V14, P1732, DOI 10.1007/s11605-010-1350-4; Nordic Centre for Classifications in Health Care, NOMESCO CLASS SURG P; Oppedal K, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD008343.pub2; Papanikolaou PN, 2006, CAN MED ASSOC J, V174, P635, DOI 10.1503/cmaj.050873; Pedersen CB, 2011, SCAND J PUBLIC HEALT, V39, P22, DOI 10.1177/1403494810387965; Ponce BA, 2015, J SHOULDER ELB SURG, V24, P167, DOI 10.1016/j.jse.2014.05.019; Rehm J, 2003, ALCOHOL RES HEALTH, V27, P39; Ronksley PE, 2011, BMJ-BRIT MED J, V342, DOI 10.1136/bmj.d671; Rubinsky AD, 2013, DRUG ALCOHOL DEPEN, V132, P521, DOI 10.1016/j.drugalcdep.2013.03.022; Singh JA, 2011, ARTHRIT CARE RES, V63, P1365, DOI 10.1002/acr.20555; Spies CD, 2004, ANESTHESIOLOGY, V100, P1088, DOI 10.1097/00000542-200405000-00010; Steering committee of The Danish Anesthesia Database, 2013, DANSK AN DAT NAT ARS; Stockwell T, 2014, ADDICTION, V109, P1657, DOI 10.1111/add.12609; Thygesen LC, 2011, SCAND J PUBLIC HEALT, V39, P12, DOI 10.1177/1403494811399956; TIRET L, 1988, STAT MED, V7, P947, DOI 10.1002/sim.4780070906; Tonnesen H, 2003, DAN MED BULL, V50, P139; Tonnesen H, 1999, BRIT J SURG, V86, P869, DOI 10.1046/j.1365-2168.1999.01181.x; Tonnesen H, 2009, BRIT J ANAESTH, V102, P297, DOI 10.1093/bja/aen401; Voskuijl T, 2014, CLIN ORTHOP RELAT R, V472, P1638, DOI 10.1007/s11999-013-3394-8; White IR, 2002, BRIT MED J, V325, P191, DOI 10.1136/bmj.325.7357.191; WHITINGOKEEFE QE, 1991, AM J MED, V90, P711; Whitmore RG, 2014, SPINE J, V14, P31, DOI 10.1016/j.spinee.2013.03.011; WHO, AN THER CHEM CLASS S; WHO, WHO TECHN REP SER	49	15	16	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 17	2017	12	3							e0173083	10.1371/journal.pone.0173083	http://dx.doi.org/10.1371/journal.pone.0173083			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EO5CJ	28306737	Green Published, Green Submitted, gold			2022-12-27	WOS:000396710300005
J	Heng, JF; Guo, XW; Wu, WH; Wang, Y; Li, GL; Chen, M; Peng, LM; Wang, SM; Dai, LZ; Tang, LL; Wang, J				Heng, Jianfu; Guo, Xinwu; Wu, Wenhan; Wang, Yue; Li, Guoli; Chen, Ming; Peng, Limin; Wang, Shouman; Dai, Lizhong; Tang, Lili; Wang, Jun			Integrated analysis of promoter mutation, methylation and expression of AKT1 gene in Chinese breast cancer patients	PLOS ONE			English	Article							ABERRANT METHYLATION; PATHWAY; ASSOCIATION; AKT1(E17K); REGIONS	Background As downstream mediators of PI3K/PTEN/AKT/mTORC1 pathway, the AKT isoforms play critical roles in tumorgenesis. Although the pleiotropic effects of AKT1 in breast cancer have been reported, the genetic and epigenetic characteristics of AKT1 promoter region in breast cancer remains to be identified. In this study we aimed to investigate the promoter mutation spectrum, methylation and gene expression pattern of AKT1 and their relationship with breast cancer. Methods By using PCR target sequence enrichment and next-generation sequencing technology, we sequenced AKT1 promoter region in pairs of breast tumor and normal tissues from 95 unselected Chinese breast cancer patients. The methylation of the promoter region and the expression profile of AKT1 in the same cohort were detected with bisulfite next-generation sequencing and qPCR, respectively. Results We identified 28 somatic mutations in 23 of the 95 (24.2%) breast cancer samples. And 19 of the 28 mutations were located in transcription factor (TF) binding sites. In the 23 patients with somatic mutations, no significant change of methylation or expression was found comparing with other patients. AKT1 promoter region was significantly hypo-methylated in tumor compared with matched normal tissue (P = 0.0014) in the 95 patients. The expression of AKT1 was significantly suppressed in tumor tissue (P = 0.0375). In clinicopathological factor analysis, AKT1 showed significant hypo-methylation (P = 0.0249) and suppressed expression (P = 0.0375) in HER2 negative subtype. And a trend of decrease in expression level (P = 0.0624) of AKT1 in the ER negative subtype was observed, which is significantly decreased in basal-like breast tumor ( P = 0.0328). Conclusions Hypo-methylation and suppressed expression of AKT1 was observed to be associated with breast cancer in our cohort. The methylation and expression of AKT1 were both significantly associated with HER2 status. The promoter mutation of AKT1 did not show significant association with its methylation and expression status. These results suggested that the promoter mutation, methylation and gene expression of AKT1 may play distinct roles in tumorgenesis of breast cancer and the integrated analysis of methylation and expression of AKT1 might serve as potential biomarkers for diagnosis and classification of breast cancer.	[Heng, Jianfu; Wu, Wenhan; Wang, Yue; Li, Guoli; Wang, Jun] Cent S Univ, State Key Lab Med Genet, Changsha, Hunan, Peoples R China; [Heng, Jianfu; Wu, Wenhan; Wang, Yue; Li, Guoli; Wang, Jun] Cent S Univ, Sch Life Sci, Changsha, Hunan, Peoples R China; [Guo, Xinwu; Chen, Ming; Peng, Limin; Dai, Lizhong] Sanway Gene Technol Inc, Changsha, Hunan, Peoples R China; [Wang, Shouman; Tang, Lili] Cent S Univ, Dept Breast Surg, Xiangya Hosp, Changsha, Hunan, Peoples R China; [Dai, Lizhong; Wang, Jun] Res Ctr Technol Nucle Acid Based Diagnost, Changsha, Hunan, Peoples R China; [Dai, Lizhong; Wang, Jun] Res Ctr Technol Nucle Acid Based Diagnost & Thera, Changsha, Hunan, Peoples R China	Central South University; Central South University; Central South University	Wang, J (corresponding author), Cent S Univ, State Key Lab Med Genet, Changsha, Hunan, Peoples R China.; Wang, J (corresponding author), Cent S Univ, Sch Life Sci, Changsha, Hunan, Peoples R China.; Tang, LL (corresponding author), Cent S Univ, Dept Breast Surg, Xiangya Hosp, Changsha, Hunan, Peoples R China.; Wang, J (corresponding author), Res Ctr Technol Nucle Acid Based Diagnost, Changsha, Hunan, Peoples R China.; Wang, J (corresponding author), Res Ctr Technol Nucle Acid Based Diagnost & Thera, Changsha, Hunan, Peoples R China.	tlli77@medmail.com.cn; junwang@csu.edu.cn			Natural Science Foundation of China [81272296, 81372228]; Major Special Projects of the Science and Technology Bureau of Changsha, China [K1204017-31, K1306011-31]	Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Major Special Projects of the Science and Technology Bureau of Changsha, China	This work was supported in part by grants from the Natural Science Foundation of China (No. 81272296 and 81372228), and the Major Special Projects of the Science and Technology Bureau of Changsha, China (No. K1204017-31 and K1306011-31).	Banerji S, 2012, NATURE, V486, P405, DOI 10.1038/nature11154; Bleeker FE, 2008, ONCOGENE, V27, P5648, DOI 10.1038/onc.2008.170; Bock C, 2005, BIOINFORMATICS, V21, P4067, DOI 10.1093/bioinformatics/bti652; Bolger AM, 2014, BIOINFORMATICS, V30, P2114, DOI 10.1093/bioinformatics/btu170; Chin YR, 2010, MOL CELL, V38, P333, DOI 10.1016/j.molcel.2010.02.031; Chin YR, 2009, CELL SIGNAL, V21, P470, DOI 10.1016/j.cellsig.2008.11.015; Cibulskis K, 2013, NAT BIOTECHNOL, V31, P213, DOI 10.1038/nbt.2514; Colebatch AJ, 2016, ONCOTARGET; Davis NM, 2014, ONCOTARGET, V5, P4603, DOI 10.18632/oncotarget.2209; Fan L, 2014, LANCET ONCOL, V15, pE279, DOI 10.1016/S1470-2045(13)70567-9; Ferlay J, 2015, INT J CANCER, V136, pE359, DOI 10.1002/ijc.29210; Flatley E, 2013, HUM PATHOL, V44, P1320, DOI 10.1016/j.humpath.2012.10.018; Garber JE, 2005, J CLIN ONCOL, V23, P276, DOI 10.1200/JCO.2005.10.042; Goldhirsch A, 2013, ANN ONCOL, V24, P2206, DOI 10.1093/annonc/mdt303; Grant CE, 2011, BIOINFORMATICS, V27, P1017, DOI 10.1093/bioinformatics/btr064; Gray J, 2012, NATURE, V486, P328, DOI 10.1038/486328a; Hon GC, 2012, GENOME RES, V22, P246, DOI 10.1101/gr.125872.111; Jones PA, 2007, CELL, V128, P683, DOI 10.1016/j.cell.2007.01.029; Kostroma II, 2016, TERAPEVT ARKH, V88, P31, DOI 10.17116/terarkh201688731-36; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Li Z, 2016, BREAST CANC RES TREA; Li ZB, 2016, BREAST CANCER RES TR, V160, P371, DOI 10.1007/s10549-016-4004-8; Liang J, 2002, NAT MED, V8, P1153, DOI 10.1038/nm761; Lin FDL, 2014, REV BRAS GINECOL OBS, V36, P340, DOI 10.1509/SO100-720320140005034; Manning BD, 2007, CELL, V129, P1261, DOI 10.1016/j.cell.2007.06.009; McKenna A, 2010, GENOME RES, V20, P1297, DOI 10.1101/gr.107524.110; Miller TW, 2011, BREAST CANCER RES, V13, DOI 10.1186/bcr3039; Nishizawa D, 2015, BIOMED RES INT, V2015, DOI 10.1155/2015/316829; Paplomata E, 2014, THER ADV MED ONCOL, V6, P154, DOI 10.1177/1758834014530023; Pharoah PDP, 2004, NAT REV CANCER, V4, P850, DOI 10.1038/nrc1476; Rahat B, 2016, EPIGENOMICS-UK, V8, P767, DOI 10.2217/epi.16.7; Rudolph M, 2016, BMC CANCER, V16, DOI 10.1186/s12885-016-2626-1; Stemke-Hale K, 2008, CANCER RES, V68, P6084, DOI 10.1158/0008-5472.CAN-07-6854; Stephens PJ, 2012, NATURE, V486, P400, DOI 10.1038/nature11017; Tokunaga E, 2006, INT J CANCER, V118, P284, DOI 10.1002/ijc.21358; Troxell ML, 2012, J CLIN EXPT PATHOL S, VS1; Wang MY, 2016, SCI REPORTS, V6; Yang W, 2011, CELL SIGNAL, V23, P19, DOI 10.1016/j.cellsig.2010.07.016; Yoeli-Lerner M, 2006, CELL CYCLE, V5, P603, DOI 10.4161/cc.5.6.2561	39	12	13	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 16	2017	12	3							e0174022	10.1371/journal.pone.0174022	http://dx.doi.org/10.1371/journal.pone.0174022			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN9KE	28301567	gold, Green Submitted, Green Published			2022-12-27	WOS:000396318300113
J	Morais, DB; Puga, LCHP; De Paula, TAR; Freitas, MBD; Da Matta, SLP				Morais, Danielle Barbosa; Porcaro Puga, Luciano Carlos Heringer; Rego de Paula, Tarcizio Antonio; Duca Freitas, Mariella Bontempo; Pinto da Matta, Sergio Luis			The spermatogenic process of the common vampire bat Desmodus rotundus under a histomorphometric view	PLOS ONE			English	Article							SEMINIFEROUS EPITHELIUM CYCLE; MOLOSSUS-MOLOSSUS CHIROPTERA; DAILY SPERM PRODUCTION; INTERTUBULAR COMPARTMENT; TUBULAR COMPARTMENT; TESTIS; ORGANIZATION; DURATION; LENGTH; QUANTIFICATION	Among all bat species, Desmodus rotundus stands out as one of the most intriguing due to its exclusively haematophagous feeding habits. However, little is known about their spermatogenic cycle. This study aimed at describing the spermatogenic process of common vampire bats through testicular histomorphometric characterization of adult specimens, spermatogenic production indexes, description of stages of the seminiferous epithelium cycle and estimative of the spermatogenic process duration. Morphometrical and immunohistochemical analyzes for bromodeoxiuridine were conducted under light microscopy and ultrastructural analyzes were performed under transmission electron microscopy. Vampire bats showed higher investment in gonadal tissue (gonadosomatic index of 0.54%) and in seminiferous tubules (tubulesomatic index of 0.49%) when compared to larger mammals. They also showed a high tubular length per gram of testis (34.70 m). Approximately half of the intertubular compartment was found to be comprised by Leydig cells (51.20%), and an average of 23.77x10(6) of these cells was found per gram of testis. The germline cells showed 16.93% of mitotic index and 2.51% of meiotic index. The overall yield of spermatogenesis was 60% and the testicular spermatic reserve was 71.44x10(7) spermatozoa per gram of testis. With a total spermatogenesis duration estimated at 37.02 days, vampire bats showed a daily sperm production of 86.80x10(6) gametes per gram of testis. These findings demonstrate a high sperm production, which is commonly observed in species with promiscuous mating system.	[Morais, Danielle Barbosa] Univ Fed Rio Grande do Norte, Dept Morphol, BR-59072970 Natal, RN, Brazil; [Porcaro Puga, Luciano Carlos Heringer; Rego de Paula, Tarcizio Antonio] Univ Fed Vicosa, Dept Veterinary, BR-36570 Vicosa, MG, Brazil; [Duca Freitas, Mariella Bontempo] Univ Fed Vicosa, Dept Anim Biol, BR-36570 Vicosa, MG, Brazil; [Pinto da Matta, Sergio Luis] Univ Fed Vicosa, Dept Gen Biol, BR-36570 Vicosa, MG, Brazil	Universidade Federal do Rio Grande do Norte; Universidade Federal de Vicosa; Universidade Federal de Vicosa; Universidade Federal de Vicosa	Morais, DB (corresponding author), Univ Fed Rio Grande do Norte, Dept Morphol, BR-59072970 Natal, RN, Brazil.	daniellebmorais@gmail.com	Freitas, Mariella B/H-9512-2015	Freitas, Mariella/0000-0001-5132-242X; Morais, Danielle/0000-0003-3277-1857	CAPES Foundation, Ministry of Education - Brazil	CAPES Foundation, Ministry of Education - Brazil(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES))	The authors acknowledge CAPES Foundation, Ministry of Education - Brazil, for the scholarship provided to DBM. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABERCROMBIE M, 1946, ANAT REC, V94, P239, DOI 10.1002/ar.1090940210; Acha P. N., 1988, Natural history of vampire bats., P207; Alencar A. O, 1994, PESQUI VET BRASIL, V14, P95; AMANN RP, 1962, J DAIRY SCI, V45, P774, DOI 10.3168/jds.S0022-0302(62)89487-9; Balarini MK, 2012, THERIOGENOLOGY, V77, P873, DOI 10.1016/j.theriogenology.2011.09.011; Barros JBG, 2005, THESIS; Beguelini MR, 2012, MICROSC RES TECHNIQ, V75, P856, DOI 10.1002/jemt.22005; Beguelini MR, 2011, MICRON, V42, P586, DOI 10.1016/j.micron.2011.02.004; Beguelini MR, 2009, J MORPHOL, V270, P943, DOI 10.1002/jmor.10731; BERNDTSON WE, 1977, J ANIM SCI, V44, P818, DOI 10.2527/jas1977.445818x; Bitencourt VL, 2007, MICRON, V38, P584, DOI 10.1016/j.micron.2006.10.004; Bittencourt V. L., 2004, Revista Brasileira de Reproducao Animal, V28, P108; Bittencourt VL, 2007, CERES, V54, P329; Caldeira Bianca Cabral, 2010, Rev. Ceres, V57, P569; Costa KLC, 2011, ANIM REPROD SCI, V127, P202, DOI 10.1016/j.anireprosci.2011.07.016; Costa DS, 2007, ANIM REPROD SCI, V98, P322, DOI 10.1016/j.anireprosci.2006.03.014; Costa DS, 2006, ANIM REPROD SCI, V91, P173, DOI 10.1016/j.anireprosci.2005.03.013; Costa GMJ, 2008, THERIOGENOLOGY, V70, P1136, DOI 10.1016/j.theriogenology.2008.06.035; Costa GMJ, 2010, J ANDROL, V31, P221, DOI 10.2164/jandrol.109.008524; Crichton E. G., 2000, LIFE HIST REPROD STR, P364; de Barros JBG, 2007, ANIM REPROD SCI, V102, P350, DOI 10.1016/j.anireprosci.2007.04.002; Duarte A, 2012, PLOS ONE, V7; Farias TO, 2015, ANAT HISTOL EMBRYOL, V44, P361, DOI 10.1111/ahe.12148; Azevedo MHF, 2008, MICRON, V39, P1166, DOI 10.1016/j.micron.2008.05.005; de Azevedo MHF, 2010, ANIM REPROD SCI, V118, P83, DOI 10.1016/j.anireprosci.2009.05.018; Franca LR, 1998, BIOL REPROD, V59, P1371, DOI 10.1095/biolreprod59.6.1371; Franca LR, 2003, BIOL REPROD, V68, P1554, DOI 10.1095/biolreprod.102.010652; Franca LR, 1998, MALE REPROD MULTIDIS, V197, P219; GREENHALL A M, 1983, Mammalian Species, P1, DOI 10.2307/3503895; Guiao-Leite F. L., 2003, Revista Brasileira de Reproducao Animal, V27, P21; Hess RA, 2008, ADV EXP MED BIOL, V636, P1, DOI 10.1007/978-0-387-09597-4_1; KARNOVSKY MJ, 1965, J CELL BIOL, V27, pA137; KENAGY GJ, 1986, J MAMMAL, V67, P1, DOI 10.2307/1380997; KUNZ TH, 1982, J MAMMAL, V63, P23, DOI 10.2307/1380667; Leal MC, 2006, BIOL REPROD, V74, P616, DOI 10.1095/biolreprod.105.048074; Leite FLG, 2006, ANIM REPROD SCI, V91, P307, DOI 10.1016/j.anireprosci.2005.04.003; Mayen F, 2003, J VET MED B, V50, P469, DOI 10.1046/j.1439-0450.2003.00713.x; Melo FCSA, 2010, BIOL RES, V43, P445, DOI [/S0716-97602010000400009, 10.4067/S0716-97602010000400009]; Miranda DC, 2012, THESIS; Morais AC., 2016, IOSR J PHARM BIOL SC, V11, P61; Morais DB, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0101759; Morais DB, 2014, ANIM REPROD SCI, V147, P180, DOI 10.1016/j.anireprosci.2014.03.008; Morais DB, 2013, ANIM REPROD SCI, V140, P268, DOI 10.1016/j.anireprosci.2013.06.003; Morais DB, 2013, J ANAT, V222, P372, DOI 10.1111/joa.12016; Morais DB, 2013, MICROSC RES TECHNIQ, V76, P94, DOI 10.1002/jemt.22141; Morais DB, 2012, ASIAN PAC J REPROD, V1, P303, DOI DOI 10.1016/S2305-0500(13)60097-4; Neves ES, 2002, BIOL REPROD, V67, P247, DOI 10.1095/biolreprod67.1.247; ORSI A M, 1990, Revista Brasileira de Biologia, V50, P221; Orsi Antonio Marcos, 1993, Revista Brasileira de Biologia, V53, P583; Paula T. A. R. C., 2002, J BIOSCIENCES, V18, P121; Paula TAR, 1999, TISSUE CELL, V31, P327, DOI 10.1054/tice.1999.0039; QUEIROZ GF, 1992, REPROD FERT DEVELOP, V4, P213, DOI 10.1071/RD9920213; Russell L. D., 1990, HISTOLOGICAL HISTOPA; Sarti P, 2011, ARQ BRAS MED VET ZOO, V63, P1060, DOI 10.1590/S0102-09352011000500003; Taddei VA, DESMODUS ROTUNDUS ES; Morais ACT, 2014, ANIM REPROD SCI, V149, P249, DOI 10.1016/j.anireprosci.2014.06.027; WILKINSON GS, 1985, BEHAV ECOL SOCIOBIOL, V17, P111; Yang ZW, 1998, J CLIN ENDOCR METAB, V83, P1284; Zhengwei Y, 1997, J Androl, V18, P681	59	10	10	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 16	2017	12	3							e0173856	10.1371/journal.pone.0173856	http://dx.doi.org/10.1371/journal.pone.0173856			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN9KE	28301534	gold, Green Published, Green Submitted			2022-12-27	WOS:000396318300081
J	Rauzan, M; Chuah, CTH; Ko, TK; Ong, T				Rauzan, Muhammad; Chuah, Charles T. H.; Ko, Tun Kiat; Ong, Tiong			The HDAC inhibitor SB939 overcomes resistance to BCR-ABL kinase Inhibitors conferred by the BIM deletion polymorphism in chronic myeloid leukemia	PLOS ONE			English	Article							HISTONE DEACETYLASE INHIBITORS; CHAPERONE FUNCTION; CANCER; ACETYLATION; IMATINIB; CML; COMBINATION; THERAPY; DOMAIN; CELLS	Chronic myeloid leukemia (CML) treatment has been improved by tyrosine kinase inhibitors (TKIs) such as imatinib mesylate (IM) but various factors can cause TKI resistance in patients with CML. One factor which contributes to TKI resistance is a germline intronic deletion polymorphism in the BCL2-like 11 (BIM) gene which impairs the expression of pro-apoptotic splice isoforms of BIM. SB939 (pracinostat) is a hydroxamic acid based HDAC inhibitor with favorable pharmacokinetic, physicochemical and pharmaceutical properties, and we investigated if this drug could overcome BIM deletion polymorphism-induced TKI resistance. We found that SB939 corrects BIM pre-mRNA splicing in CML cells with the BIM deletion polymorphism, and induces apoptotic cell death in CML cell lines and primary cells with the BIM deletion polymorphism. More importantly, SB939 both decreases the viability of CML cell lines and primary CML progenitors with the BIM deletion and restores TKI-sensitivity. Our results demonstrate that SB939 overcomes BIM deletion polymorphism-induced TKI resistance, and suggest that SB939 may be useful in treating CML patients with BIM deletion-associated TKI resistance.	[Rauzan, Muhammad; Chuah, Charles T. H.; Ko, Tun Kiat; Ong, Tiong] Duke NUS Med Sch, Canc & Stem Cell Biol Signature Res Programme, Singapore, Singapore; [Chuah, Charles T. H.; Ong, Tiong] Singapore Gen Hosp, Dept Haematol, Singapore, Singapore; [Ong, Tiong] Natl Canc Ctr Singapore, Dept Med Oncol, Singapore, Singapore; [Ong, Tiong] Duke Univ, Med Ctr, Dept Med, Durham, NC 27710 USA	National University of Singapore; Singapore General Hospital; National Cancer Centre Singapore (NCCS); Duke University	Ko, TK; Ong, T (corresponding author), Duke NUS Med Sch, Canc & Stem Cell Biol Signature Res Programme, Singapore, Singapore.; Ong, T (corresponding author), Singapore Gen Hosp, Dept Haematol, Singapore, Singapore.; Ong, T (corresponding author), Natl Canc Ctr Singapore, Dept Med Oncol, Singapore, Singapore.; Ong, T (corresponding author), Duke Univ, Med Ctr, Dept Med, Durham, NC 27710 USA.	tunkiat.ko@duke-nus.edu.sg; sintiong.ong@duke-nus.edu.sg		Ong, S. Tiong/0000-0001-9460-3483	Singapore Ministry of Health's National Medical Research Council [NMRC/CIRG/1330/2012, NMRC/CSA/0051/2013]	Singapore Ministry of Health's National Medical Research Council(National Medical Research Council, Singapore)	STO was supported by the Singapore Ministry of Health's National Medical Research Council under its Clinician Scientists Individual Research Grant (NMRC/CIRG/1330/2012), and the Clinician Scientist Award (NMRC/CSA/0051/2013) (URL: http://www.nmrc.gov.sg/content/nmrc_internet/home.html). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bali P, 2005, J BIOL CHEM, V280, P26729, DOI 10.1074/jbc.C500186200; Carlesso N, 1996, J EXP MED, V183, P811, DOI 10.1084/jem.183.3.811; Copland M, 2006, BLOOD, V107, P4532, DOI 10.1182/blood-2005-07-2947; Druker BJ, 2008, BLOOD, V112, P4808, DOI 10.1182/blood-2008-07-077958; Fraga MF, 2005, NAT GENET, V37, P391, DOI 10.1038/ng1531; Lee SM, 2007, J PHARMACOL EXP THER, V322, P1084, DOI 10.1124/jpet.107.124461; Lim S, 2013, P NATL ACAD SCI USA, V110, pE2298, DOI 10.1073/pnas.1301838110; Marks PA, 2001, CURR OPIN ONCOL, V13, P477, DOI 10.1097/00001622-200111000-00010; Nakagawa T, 2013, CANCER RES, V73, P2428, DOI 10.1158/0008-5472.CAN-12-3479; Ng KP, 2012, NAT MED, V18, P521, DOI 10.1038/nm.2713; Novotny-Diermayr V, 2010, MOL CANCER THER, V9, P642, DOI 10.1158/1535-7163.MCT-09-0689; Okabe S, 2013, CANCER CELL INT, V13, DOI 10.1186/1475-2867-13-32; PENDERGAST AM, 1993, MOL CELL BIOL, V13, P1728, DOI 10.1128/MCB.13.3.1728; Quintas-Cardama A, 2009, NAT REV CLIN ONCOL, V6, P535, DOI 10.1038/nrclinonc.2009.112; Redaelli S, 2009, J CLIN ONCOL, V27, P469, DOI 10.1200/JCO.2008.19.8853; Scroggins BT, 2007, MOL CELL, V25, P151, DOI 10.1016/j.molcel.2006.12.008; Shuai K, 1996, ONCOGENE, V13, P247	17	15	15	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 16	2017	12	3							e0174107	10.1371/journal.pone.0174107	http://dx.doi.org/10.1371/journal.pone.0174107			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN9KE	28301600	Green Published, Green Submitted, gold			2022-12-27	WOS:000396318300127
J	Tashiro, T; Okuyama, H; Endo, H; Kawada, K; Ashida, Y; Ohue, M; Sakai, Y; Inoue, M				Tashiro, Takahiro; Okuyama, Hiroaki; Endo, Hiroko; Kawada, Kenji; Ashida, Yasuko; Ohue, Masayuki; Sakai, Yoshiharu; Inoue, Masahiro			In vivo and ex vivo cetuximab sensitivity assay using three-dimensional primary culture system to stratify KRAS mutant colorectal cancer	PLOS ONE			English	Article							EGFR MONOCLONAL-ANTIBODY; GROWTH-FACTOR RECEPTOR; RAS MUTATIONS; ACQUIRED-RESISTANCE; PATHWAY ACTIVATION; TUMOR XENOGRAFTS; DRUG DEVELOPMENT; CHEMOTHERAPY; SPHEROIDS; THERAPIES	In clinic, cetuximab, an anti-EGFR antibody, improves treatment outcomes in colorectal cancer (CRC). KRAS-mutant CRC is generally resistant to cetuximab, although difference of the sensitivity among KRAS-mutants has not been studied in detail. We previously developed the cancer tissue-originated spheroid (CTOS) method, a primary culture method for cancer cells. We applied CTOS method to investigate whether ex vivo cetuximab sensitivity assays reflect the difference in sensitivity in the xenografts. Firstly, in vivo cetuximab treatment was performed with xenografts derived from 10 CTOS lines (3 KRAS-wildtype and 7 KRAS mutants). All two CTOS lines which exhibited tumor regression were KRAS-wildtype, meanwhile all KRAS-mutant CTOS lines grew more than the initial size: were resistant to cetuximab according to the clinical evaluation criteria, although the sensitivity was quite diverse. We divided KRAS-mutants into two groups; partially responsive group in which cetuximab had a substantial growth inhibitory effect, and resistant group which exhibited no effect. The ex vivo signaling assay with EGF stimulation revealed that the partially responsive group, but not the resistant group, exhibited suppressed ERK phosphorylation ex vivo. Furthermore, two lines from the partially responsive group, but none of the lines in the resistant group, exhibited a combinatory effect of cetuximab and trametinib, a MEK inhibitor, ex vivo and in vivo. Taken together, the results indicate that ex vivo signaling assay reflects the difference in sensitivity in vivo and stratifies KRAS mutant CTOS lines by sensitivity. Therefore, coupling the in vivo and ex vivo assays with CTOS can be a useful platform for understanding the mechanism of diversity in drug sensitivity.	[Tashiro, Takahiro; Okuyama, Hiroaki; Endo, Hiroko; Inoue, Masahiro] Osaka Med Ctr Canc & Cardiovasc Dis, Dept Biochem, Osaka, Osaka, Japan; [Tashiro, Takahiro; Kawada, Kenji; Sakai, Yoshiharu] Kyoto Univ, Dept Surg, Grad Sch Med, Kyoto, Kyoto, Japan; [Ashida, Yasuko] Charles River Labs Japan, Yokohama, Kanagawa, Japan; [Ohue, Masayuki] Osaka Med Ctr Canc & Cardiovasc Dis, Dept Surg, Osaka, Osaka, Japan	Osaka Medical Center for Cancer & Cardiovascular Diseases; Kyoto University; Osaka Medical Center for Cancer & Cardiovascular Diseases	Inoue, M (corresponding author), Osaka Med Ctr Canc & Cardiovasc Dis, Dept Biochem, Osaka, Osaka, Japan.	inoue-ma2@mc.pref.osaka.jp			Japan Agency for Medical Research and Development [15cm0106155h0002, 16cm0106203h0001]; Takeda Science Foundation; Charles River Laboratory Japans; Ministry of Education, Culture, Sports, Science, and Technology (MEXT), Japan; Grants-in-Aid for Scientific Research [26111005] Funding Source: KAKEN	Japan Agency for Medical Research and Development(Japan Agency for Medical Research and Development (AMED)); Takeda Science Foundation(Takeda Science Foundation (TSF)); Charles River Laboratory Japans; Ministry of Education, Culture, Sports, Science, and Technology (MEXT), Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported in part by grants-in-aid from P-DIRECT (15cm0106155h0002), and P-CREATE (16cm0106203h0001), Japan Agency for Medical Research and Development (MI, HO, and HE) and the Takeda Science Foundation (MI). Charles River Laboratory Japans provided support in the form of salaries for YA, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors thank A. Mizukoshi, N. Kanto, and T. Yasuda for technical assistance and M. Izutsu for secretarial assistance. The SCADS Inhibitor Kit was kindly provided by the Screening Committee of Anticancer Drugs supported by a Grant-in-Aid for Scientific Research on Innovative Areas, Scientific Support Programs for Cancer Research, from The Ministry of Education, Culture, Sports, Science, and Technology (MEXT), Japan.	Bardelli A, 2013, CANCER DISCOV, V3, P658, DOI 10.1158/2159-8290.CD-12-0558; Benvenuti S, 2007, CANCER RES, V67, P2643, DOI 10.1158/0008-5472.CAN-06-4158; Bertotti A, 2015, NATURE, V526, P263, DOI 10.1038/nature14969; Bertotti A, 2011, CANCER DISCOV, V1, P508, DOI 10.1158/2159-8290.CD-11-0109; Buck E, 2008, CANCER RES, V68, P8322, DOI 10.1158/0008-5472.CAN-07-6720; Chung KY, 2005, J CLIN ONCOL, V23, P1803, DOI 10.1200/JCO.2005.08.037; Daniel VC, 2009, CANCER RES, V69, P3364, DOI 10.1158/0008-5472.CAN-08-4210; De Roock W, 2010, JAMA-J AM MED ASSOC, V304, P1812, DOI 10.1001/jama.2010.1535; Douillard JY, 2013, NEW ENGL J MED, V369, P1023, DOI 10.1056/NEJMoa1305275; Endo H, 2013, J THORAC ONCOL, V8, P131, DOI 10.1097/JTO.0b013e3182779ccf; Gillet JP, 2011, P NATL ACAD SCI USA, V108, P18708, DOI 10.1073/pnas.1111840108; Hidalgo M, 2014, CANCER DISCOV, V4, P998, DOI 10.1158/2159-8290.CD-14-0001; Julien S, 2012, CLIN CANCER RES, V18, P5314, DOI 10.1158/1078-0432.CCR-12-0372; Karapetis CS, 2008, NEW ENGL J MED, V359, P1757, DOI 10.1056/NEJMoa0804385; Khambata-Ford S, 2007, J CLIN ONCOL, V25, P3230, DOI 10.1200/JCO.2006.10.5437; Kiyohara Y, 2016, CANCER SCI, V107, P452, DOI 10.1111/cas.12898; Kondo J, 2011, P NATL ACAD SCI USA, V108, P6235, DOI 10.1073/pnas.1015938108; Krumbach R, 2011, EUR J CANCER, V47, P1231, DOI 10.1016/j.ejca.2010.12.019; Misale S, 2014, SCI TRANSL MED, V6, DOI 10.1126/scitranslmed.3007947; Nakajima A, 2015, INT J CANCER, V136, P2949, DOI 10.1002/ijc.29349; Napolitano S, 2015, CLIN CANCER RES, V21, P2975, DOI 10.1158/1078-0432.CCR-15-0020; Normanno N, 2009, NAT REV CLIN ONCOL, V6, P519, DOI 10.1038/nrclinonc.2009.111; Nunes M, 2015, CANCER RES, V75, P1560, DOI 10.1158/0008-5472.CAN-14-1590; Okuyama H, 2013, J UROLOGY, V190, P302, DOI 10.1016/j.juro.2012.12.106; Peeters M, 2013, CLIN CANCER RES, V19, P1902, DOI 10.1158/1078-0432.CCR-12-1913; Sorich MJ, 2015, ANN ONCOL, V26, P13, DOI 10.1093/annonc/mdu378; Tabernero J, 2015, LANCET ONCOL, V16, P499, DOI 10.1016/S1470-2045(15)70127-0; Tejpar S, 2012, J CLIN ONCOL, V30, P3570, DOI 10.1200/JCO.2012.42.2592; Tentler JJ, 2012, NAT REV CLIN ONCOL, V9, P338, DOI 10.1038/nrclinonc.2012.61; Troiani T, 2014, CLIN CANCER RES, V20, P3775, DOI 10.1158/1078-0432.CCR-13-2181; Van Cutsem E, 2014, ANN ONCOL, V25, P1, DOI 10.1093/annonc/mdu260; Van Cutsem E, 2009, NEW ENGL J MED, V360, P1408, DOI 10.1056/NEJMoa0805019; van de Wetering M, 2015, CELL, V161, P933, DOI 10.1016/j.cell.2015.03.053; Wheeler DL, 2010, NAT REV CLIN ONCOL, V7, P493, DOI 10.1038/nrclinonc.2010.97; Yamaki T, 2013, SCI REP-UK, V3, DOI 10.1038/srep01160; Yonesaka K, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3002442; Yoon J, 2011, CANCER RES, V71, P445, DOI 10.1158/0008-5472.CAN-10-3058; Yoshii Y, 2015, BIOMATERIALS, V51, P278, DOI 10.1016/j.biomaterials.2015.02.008; Zanella ER, 2015, SCI TRANSL MED, V7, DOI 10.1126/scitranslmed.3010445	39	19	19	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 16	2017	12	3							e0174151	10.1371/journal.pone.0174151	http://dx.doi.org/10.1371/journal.pone.0174151			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN9KE	28301591	Green Published, Green Submitted, gold			2022-12-27	WOS:000396318300130
J	Sato, K; Kanazawa, S; Yamaguchi, MK				Sato, Kazuki; Kanazawa, So; Yamaguchi, Masami K.			Infants' perception of lightness changes related to cast shadows	PLOS ONE			English	Article							WALLACHS RATIO RULE; 4-MONTH-OLD INFANTS; DEPTH; CONSTANCY; SHAPE; DISCRIMINATION; CONTRAST; FIGURES	When humans perceive the lightness of an object's surface in shadows there is an implicit assumption that cast shadows dim the surface. In two experiments, we investigated whether 5- to 8-month-old infants make this assumption about shadows. According to this shadow assumption, the apparent change in lightness produced by shadows on an object's surface are attributed to blocked light sources. If infants can use the shadow assumption to perceive the object's lightness in shadows, they will also be able to detect unnatural lightness changes in shadows. We compared the infants' looking times to the unnatural and the natural lightness changes in the shadow when an object (duck) goes through the cast shadow. In Experiment 1, we examined whether infants could detect the unnatural lightness changes of the object's surface in shadows. We created computer-graphic movies of unnatural and natural lightness changes to the duck's surface. Our results showed that 7- to 8-month-olds but not 5- to 6-month-olds significantly preferred the movie with the unnatural changes in lightness, indicating that only the older infants could detect these changes. In Experiment 2, we confirmed that the infants' preference was based on the detection of unnatural lightness changes according to the shadow assumption. The natural and the unnatural lightness changes of Experiment 1 were presented without cast shadows. Under these conditions, neither younger nor older infants showed a significant preference. Taken together, the experiments showed that 7- to 8-month-old infants could detect the unnaturalness of a surface's lightness changes produced by shadows. In conclusion, our findings suggest that 7- to 8-month-old infants can perceive an object's lightness in shadows by using an assumption that cast shadows dim the surface of an object.	[Sato, Kazuki; Yamaguchi, Masami K.] Chuo Univ, Dept Psychol, Hachioji, Tokyo, Japan; [Sato, Kazuki] Japan Soc Promot Sci, Tokyo, Japan; [Kanazawa, So] Japan Womens Univ, Dept Psychol, Kawasaki, Kanagawa, Japan	Chuo University; Japan Society for the Promotion of Science; Japan Womens University	Sato, K (corresponding author), Chuo Univ, Dept Psychol, Hachioji, Tokyo, Japan.; Sato, K (corresponding author), Japan Soc Promot Sci, Tokyo, Japan.	a12.rrx5@g.chuo-u.ac.jp			MEXT, Japan [25135729, 16H01677]; Japan Society for the Promotion of Science [26.6887]	MEXT, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	This research was supported by a Grant in-Aid for Scientific Research on Innovative Areas "Shitsukan" (25135729, and 16H01677) from MEXT, Japan to MKY, and Japan and a Grant-in-Aid for JSPS Fellows (26.6887) from Japan Society for the Promotion of Science to KS.	Adelson E. H, 1995, CHECKER SHADOW ILLUS; Chien SHL, 2006, VISION RES, V46, P2139, DOI 10.1016/j.visres.2005.11.027; Chien SHL, 2005, VISION RES, V45, P2854, DOI 10.1016/j.visres.2004.07.035; Chien SHL, 2003, PSYCHOL SCI, V14, P291, DOI 10.1111/1467-9280.14411; Csibra G, 2001, DEVELOPMENTAL SCI, V4, pF7, DOI 10.1111/1467-7687.00179; Elder JH, 2004, PERCEPTION, V33, P1319, DOI 10.1068/p5323; GILCHRIST A, 2006, SEEING BLACK WHITE, P180; GILCHRIST AL, 1988, PERCEPT PSYCHOPHYS, V43, P415, DOI 10.3758/BF03207877; GRANRUD CE, 1985, PERCEPT PSYCHOPHYS, V37, P415, DOI 10.3758/BF03202872; HERSHBERGER W, 1970, J COMP PHYSIOL PSYCH, V73, P407, DOI 10.1037/h0030223; HESS EH, 1950, J COMP PHYSIOL PSYCH, V43, P112, DOI 10.1037/h0059235; Hillis JM, 2007, CURR BIOL, V17, P1714, DOI 10.1016/j.cub.2007.09.012; Imura T, 2006, VISION RES, V46, P652, DOI 10.1016/j.visres.2005.07.028; Kersten D, 1997, PERCEPTION, V26, P171, DOI 10.1068/p260171; Kingdom FAA, 2011, VISION RES, V51, P652, DOI 10.1016/j.visres.2010.09.012; KLEFFNER DA, 1992, PERCEPT PSYCHOPHYS, V52, P18, DOI 10.3758/BF03206757; Logvinenko AD, 1999, PERCEPTION, V28, P803, DOI 10.1068/p2801; RAMACHANDRAN VS, 1988, SCI AM, V259, P76, DOI 10.1038/scientificamerican0888-76; RAMACHANDRAN VS, 1988, NATURE, V331, P163, DOI 10.1038/331163a0; Sato K, 2016, ATTEN PERCEPT PSYCHO, V78, P1453, DOI 10.3758/s13414-016-1114-7; Sato K, 2015, I-PERCEPTION, V6, P91, DOI 10.1068/i0681; Shuwairi SM, 2007, PSYCHOL SCI, V18, P303, DOI 10.1111/j.1467-9280.2007.01893.x; Shuwairi SM, 2009, J EXP CHILD PSYCHOL, V104, P115, DOI 10.1016/j.jecp.2008.10.001; Van de Walle GA, 1998, COGNITIVE DEV, V13, P387, DOI 10.1016/S0885-2014(98)90001-6; WALLACH H, 1948, J EXP PSYCHOL, V38, P310, DOI 10.1037/h0053804; WHITE M, 1982, PERCEPTION, V11, P103, DOI 10.1068/p110103; WHITE M, 1981, PERCEPTION, V10, P215, DOI 10.1068/p100215; Yonas A, 2006, PERCEPT PSYCHOPHYS, V68, P154, DOI 10.3758/BF03193665	28	3	3	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 15	2017	12	3							e0173591	10.1371/journal.pone.0173591	http://dx.doi.org/10.1371/journal.pone.0173591			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EN9HQ	28296912	Green Published, Green Submitted, gold			2022-12-27	WOS:000396311700044
J	Peters, DL; Stothard, P; Dennis, JJ				Peters, Danielle L.; Stothard, Paul; Dennis, Jonathan J.			The isolation and characterization of Stenotrophomonas maltophilia T4-like bacteriophage DLP6	PLOS ONE			English	Article							BURKHOLDERIA-CEPACIA COMPLEX; PSEUDOMONAS-AERUGINOSA; PHAGE THERAPY; SEQUENCE; INFECTION; GENOME; ALGORITHMS; DEFINITION; PREDICTION; DIVERSITY	Increasing isolation of the extremely antibiotic resistant bacterium Stenotrophomonas maltophilia has caused alarm worldwide due to the limited treatment options available. A potential treatment option for fighting this bacterium is 'phage therapy', the clinical application of bacteriophages to selectively kill bacteria. Bacteriophage DLP6 (vB_SmoM-DLP6) was isolated from a soil sample using clinical isolate S. maltophilia strain D1571 as host. Host range analysis of phage DLP6 against 27 clinical S. maltophilia isolates shows successful infection and lysis in 13 of the 27 isolates tested. Transmission electron microscopy of DLP6 indicates that it is a member of the Myoviridae family. Complete genome sequencing and analysis of DLP6 reveals its richly recombined evolutionary history, featuring a core of both T4-like and cyanophage genes, which suggests that it is a member of the T4-superfamily. Unlike other T4-superfamily phages however, DLP6 features a transposase and ends with 229 bp direct terminal repeats. The isolation of this bacteriophage is an exciting discovery due to the divergent nature of DLP6 in relation to the T4-superfamily of phages.	[Peters, Danielle L.; Dennis, Jonathan J.] Univ Alberta, Dept Biol Sci, Centennial Ctr Interdisciplinary Sci 6 065, Edmonton, AB, Canada; [Stothard, Paul] Univ Alberta, Dept Agr Food & Nutr Sci, Edmonton, AB, Canada	University of Alberta; University of Alberta	Dennis, JJ (corresponding author), Univ Alberta, Dept Biol Sci, Centennial Ctr Interdisciplinary Sci 6 065, Edmonton, AB, Canada.	jon.dennis@ualberta.ca		Dennis, Jonathan/0000-0002-3925-9533; Peters, Danielle/0000-0003-0176-9463	Natural Sciences and Engineering Research Council of Canada (NSERC) [238414]; NSERC PGS-D graduate scholarship	Natural Sciences and Engineering Research Council of Canada (NSERC)(Natural Sciences and Engineering Research Council of Canada (NSERC)); NSERC PGS-D graduate scholarship	This study was supported by Operating grant #238414 to JJD from the Natural Sciences and Engineering Research Council of Canada (NSERC) and The authors also acknowledge funding supportfor DLP by a NSERC PGS-D graduate scholarship. http://www.nserc-crsng.gc.ca/index_eng.asp. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abedon Stephen T, 2011, Bacteriophage, V1, P66; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Aziz RK, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-75; Bateman A, 2004, NUCLEIC ACIDS RES, V32, pD138, DOI [10.1093/nar/gkt1223, 10.1093/nar/gkr1065, 10.1093/nar/gkp985]; Beeton ML, 2015, INT J ANTIMICROB AG, V46, P196, DOI 10.1016/j.ijantimicag.2015.04.005; Besemer J, 2001, NUCLEIC ACIDS RES, V29, P2607, DOI 10.1093/nar/29.12.2607; Brettin T, 2015, SCI REP-UK, V5, DOI 10.1038/srep08365; Brewer TE, 2014, VIROLOGY, V450, P84, DOI 10.1016/j.virol.2013.11.027; Brooke JS, 2012, CLIN MICROBIOL REV, V25, P2, DOI 10.1128/CMR.00019-11; Crooks GE, 2004, GENOME RES, V14, P1188, DOI 10.1101/gr.849004; Delcher AL, 2002, NUCLEIC ACIDS RES, V30, P2478, DOI 10.1093/nar/30.11.2478; Delcher AL, 2007, BIOINFORMATICS, V23, P673, DOI 10.1093/bioinformatics/btm009; Dreher TW, 2011, ENVIRON MICROBIOL, V13, P1858, DOI 10.1111/j.1462-2920.2011.02502.x; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Fuller NJ, 1998, APPL ENVIRON MICROB, V64, P2051; Gautheret D, 2001, J MOL BIOL, V313, P1003, DOI 10.1006/jmbi.2001.5102; Golshahi L, 2011, J APPL MICROBIOL, V110, P106, DOI 10.1111/j.1365-2672.2010.04863.x; Guindon S, 2010, SYST BIOL, V59, P307, DOI 10.1093/sysbio/syq010; Hagens S, 2004, ANTIMICROB AGENTS CH, V48, P3817, DOI 10.1128/AAC.48.10.3817-3822.2004; Hermoso JA, 2007, CURR OPIN MICROBIOL, V10, P461, DOI 10.1016/j.mib.2007.08.002; Holguin AV, 2015, VIRUSES-BASEL, V7, P4602, DOI 10.3390/v7082835; Hyatt D, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-119; Kearse M, 2012, BIOINFORMATICS, V28, P1647, DOI 10.1093/bioinformatics/bts199; Koch Thomas, 1995, Gene Expression, V4, P253; Kumari S, 2011, J MED MICROBIOL, V60, P205, DOI 10.1099/jmm.0.018580-0; Lavigne R, 2004, BIOINFORMATICS, V20, P629, DOI 10.1093/bioinformatics/btg456; Lavigne Rob, 2009, V502, P113, DOI 10.1007/978-1-60327-565-1_8; Lesnik EA, 2001, NUCLEIC ACIDS RES, V29, P3583, DOI 10.1093/nar/29.17.3583; Lynch KH, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-574; Lynch KH, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-223; Macke TJ, 2001, NUCLEIC ACIDS RES, V29, P4724, DOI 10.1093/nar/29.22.4724; Marchler-Bauer Aron, 2011, Nucleic Acids Res, V39, pD225, DOI 10.1093/nar/gkq1189; Merabishvili M, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004944; Miller ES, 2003, MICROBIOL MOL BIOL R, V67, P86, DOI 10.1128/MMBR.67.1.86-156.2003; Morello E, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016963; Olaitan AO, 2016, INT J ANTIMICROB AG, V47, P1, DOI 10.1016/j.ijantimicag.2015.11.009; Overbeek R, 2014, NUCLEIC ACIDS RES, V42, pD206, DOI 10.1093/nar/gkt1226; Peters DL, 2015, BMC GENOMICS, V16, DOI 10.1186/s12864-015-1848-y; Petrov VM, 2010, VIROL J, V7, DOI 10.1186/1743-422X-7-292; Pincus NB, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0124280; Price MN, 2009, MOL BIOL EVOL, V26, P1641, DOI 10.1093/molbev/msp077; Promega Corporation, 2006, DNA IS LAMBD LYS US; Rhoads D D, 2009, J Wound Care, V18, P237; Rose T, 2014, INT J BURNS TRAUMA, V4, P66; Schattner P, 2005, NUCLEIC ACIDS RES, V33, pW686, DOI 10.1093/nar/gki366; Seed KD, 2009, ANTIMICROB AGENTS CH, V53, P2205, DOI 10.1128/AAC.01166-08; Semler DD, 2014, ANTIMICROB AGENTS CH, V58, P4005, DOI 10.1128/AAC.02388-13; Shueh CS, 2013, J MICROBIOL METH, V94, P141, DOI 10.1016/j.mimet.2013.06.001; Sullivan MB, 2008, ENVIRON MICROBIOL, V10, P2810, DOI 10.1111/j.1462-2920.2008.01702.x; Sullivan MB, 2010, ENVIRON MICROBIOL, V12, P3035, DOI 10.1111/j.1462-2920.2010.02280.x; Tiemann B, 2004, J BACTERIOL, V186, P7262, DOI 10.1128/JB.186.21.7262-7272.2004; Wainwright CE, 2009, THORAX, V64, P926, DOI 10.1136/thx.2008.112466; Waseh S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013904; Waters V, 2013, J CYST FIBROS, V12, P482, DOI 10.1016/j.jcf.2012.12.006; World Health Organization, 2014, ANT RES GLOB REP SUR, DOI DOI 10.1007/S13312-014-0374-3; Wright A, 2009, CLIN OTOLARYNGOL, V34, P349, DOI 10.1111/j.1749-4486.2009.01973.x; Zhong Y, 2002, APPL ENVIRON MICROB, V68, P1576, DOI 10.1128/AEM.68.4.1576-1584.2002	57	13	13	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 14	2017	12	3							e0173341	10.1371/journal.pone.0173341	http://dx.doi.org/10.1371/journal.pone.0173341			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN6DM	28291834	Green Submitted, Green Published, gold			2022-12-27	WOS:000396094700021
J	Lewis, A; Felice, C; Kumagai, T; Lai, C; Singh, K; Jeffery, RR; Feakins, R; Giannoulatou, E; Armuzzi, A; Jawad, N; Lindsay, JO; Silver, A				Lewis, Amy; Felice, Carla; Kumagai, Tomoko; Lai, Cecilia; Singh, Kriti; Jeffery, Rosemary R.; Feakins, Roger; Giannoulatou, Eleni; Armuzzi, Alessandro; Jawad, Noor; Lindsay, James O.; Silver, Andrew			The miR-200 family is increased in dysplastic lesions in ulcerative colitis patients	PLOS ONE			English	Article							LOW-GRADE DYSPLASIA; INFLAMMATORY-BOWEL-DISEASE; COLORECTAL-CANCER; CROHNS-DISEASE; RISK; SURVEILLANCE; MICRORNAS; MLL3; METAANALYSIS; PROGRESSION	Background Colorectal cancer (CRC) is a life-threatening complication of ulcerative colitis (UC), and patients are routinely screened for the development of precancerous lesions (dysplasia). However, rates of CRC development in patients with confirmed low-grade dysplasia vary widely between studies, suggesting a large degree of heterogeneity between these lesions that is not detectable macroscopically. A better understanding of the underlying molecular changes that occur in dysplasia will help to identify lesions at higher risk of malignancy. MicroRNAs (miRNAs) post-transcriptionally regulate protein expression and cell-signalling networks. Aberrant miRNA expression is a feature of sporadic CRC but much less is known about the changes that occur in dysplasia and in UC. Methods Comprehensive microRNA profiling was performed on RNA extracted from UC dysplastic lesions (n = 7) and UC controls (n = 10). The expression of miRNAs in UC post inflammatory polyps (n = 7) was also assessed. Candidate miRNAs were further validated by qPCR, and miRNA in situ hybridization. Serum levels of miRNAs were also assessed with a view to identification of non-invasive biomarkers of dysplasia. Results UC dysplasia was associated with a shift in miRNA expression profiles that was not seen in inflammatory polyps. In particular, levels of miR-200b-3p were increased in dysplasia, and this miRNA was localised to epithelial cells in dysplastic lesions and in UC cancers. No changes in miRNA levels were detected in the serum. Conclusion UC-Dysplasia is linked to altered miRNA expression in the mucosa and elevated miR-200b-3p levels.	[Lewis, Amy; Felice, Carla; Kumagai, Tomoko; Lai, Cecilia; Singh, Kriti; Jeffery, Rosemary R.; Silver, Andrew] Barts & London Queen Marys Sch Med & Dent, Ctr Genom & Child Hlth, Blizard Inst, London E1 2AT, England; [Felice, Carla; Armuzzi, Alessandro] Catholic Univ Fdn, Gemelli Hosp, IBD Unit, Complesso Integrato Columbus, Rome, Italy; [Feakins, Roger] Royal London Hosp, Dept Histopathol, London E1 1BB, England; [Giannoulatou, Eleni] Victor Chang Cardiac Res Inst, Darlinghurst, NSW, Australia; [Giannoulatou, Eleni] Univ New South Wales, Sydney, NSW, Australia; [Jawad, Noor] Barts & London Queen Marys Sch Med & Dent, Barts Canc Inst, London EC1M 6BQ, England; [Lindsay, James O.] Barts & London Queen Marys Sch Med & Dent, Ctr Immunobiol, Blizard Inst, London E1 2AT, England	University of London; Queen Mary University London; Catholic University of the Sacred Heart; IRCCS Policlinico Gemelli; Barts Health NHS Trust; Royal London Hospital; Victor Chang Cardiac Research Institute; University of New South Wales Sydney; University of London; Queen Mary University London; University of London; Queen Mary University London	Silver, A (corresponding author), Barts & London Queen Marys Sch Med & Dent, Ctr Genom & Child Hlth, Blizard Inst, London E1 2AT, England.; Lindsay, JO (corresponding author), Barts & London Queen Marys Sch Med & Dent, Ctr Immunobiol, Blizard Inst, London E1 2AT, England.	james.lindsay@bartshealth.nhs.uk; a.silver@qmul.ac.uk	Armuzzi, Alessandro/AIC-5188-2022; Feakins, Roger/J-6782-2019; Felice, Carla/M-1914-2018; Feakins, Roger/AAO-5570-2020	Felice, Carla/0000-0001-6646-6231; Giannoulatou, Eleni/0000-0002-7084-6736	Broad Medical Research Program of the Broad Foundation [IBD-0289R]; Barts and The London Charity [MGD0016]	Broad Medical Research Program of the Broad Foundation; Barts and The London Charity	This work was supported by the Broad Medical Research Program of the Broad Foundation [http://www.ccfa.org/science-and.professionals/broad/] (grant no IBD-0289R to Professor Silver and Dr James Lindsay) and Barts and The London Charity [https://bartscharity.org.uk] (grant no MGD0016 to Noor Jawad). The funders had no role in the design and conduct of the study; collection, management, analysis, and interpretation of the data and preparation, review, or approval of the manuscript.	Befrits R, 2002, DIS COLON RECTUM, V45, P615, DOI 10.1007/s10350-004-6255-4; BERNSTEIN CN, 1994, LANCET, V343, P71; Cairns SR, 2010, GUT, V59, P666, DOI 10.1136/gut.2009.179804; Charatcharoenwitthaya Phunchai, 2006, Curr Gastroenterol Rep, V8, P75, DOI 10.1007/s11894-006-0067-8; Chen Y, 2013, CELL DEATH DIS, V4, DOI 10.1038/cddis.2013.22; Choi CHR, 2015, AM J GASTROENTEROL, V110, P1461, DOI 10.1038/ajg.2015.248; Choo KB, 2014, J BIOMED SCI, V21, DOI 10.1186/s12929-014-0095-x; CONNELL WR, 1994, GASTROENTEROLOGY, V107, P934, DOI 10.1016/0016-5085(94)90216-X; Garcia DM, 2011, NAT STRUCT MOL BIOL, V18, P1139, DOI 10.1038/nsmb.2115; Guo CC, 2013, ONCOTARGET, V4, P2144, DOI 10.18632/oncotarget.1555; Hedback N, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0095193; Hsu SD, 2011, NUCLEIC ACIDS RES, V39, pD163, DOI 10.1093/nar/gkq1107; Je EM, 2013, NEOPLASMA, V60, P188, DOI 10.4149/neo_2013_025; Jess T, 2006, INFLAMM BOWEL DIS, V12, P669, DOI 10.1097/00054725-200608000-00001; Jess T, 2012, CLIN GASTROENTEROL H, V10, P639, DOI 10.1016/j.cgh.2012.01.010; Lee J, 2009, P NATL ACAD SCI USA, V106, P8513, DOI 10.1073/pnas.0902873106; Lewis A, 2015, INFLAMM BOWEL DIS, V21, P1141, DOI 10.1097/MIB.0000000000000298; Li B, 2014, GENET MOL RES, V13, P7513, DOI 10.4238/2014.September.12.18; Li WD, 2013, BLOOD, V121, P1478, DOI 10.1182/blood-2012-12-470559; Ludwig K, 2013, VIRCHOWS ARCH, V462, P57, DOI 10.1007/s00428-012-1345-5; Lutgens M, 2015, CLIN GASTROENTEROL H, V13, P148, DOI 10.1016/j.cgh.2014.06.032; Olaru AV, 2013, INFLAMM BOWEL DIS, V19, P471, DOI 10.1097/MIB.0b013e31827e78eb; Ording AG, 2013, INFLAMM BOWEL DIS, V19, P800, DOI 10.1097/MIB.0b013e3182802af7; Pekow J, 2013, INFLAMM BOWEL DIS, V19, P461, DOI 10.1097/MIB.0b013e3182802bac; Rutter M, 2004, GASTROENTEROLOGY, V126, P451, DOI 10.1053/j.gastro.2003.11.010; Rutter MD, 2004, GUT, V53, P1813, DOI 10.1136/gut.2003.038505; Satsangi J, 2006, GUT, V55, P749, DOI 10.1136/gut.2005.082909; Scarpati GDV, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/840921; Schetter AJ, 2012, CANCER J, V18, P244, DOI 10.1097/PPO.0b013e318258b78f; SCHROEDER KW, 1987, NEW ENGL J MED, V317, P1625, DOI 10.1056/NEJM198712243172603; Thomas T, 2007, ALIMENT PHARM THER, V25, P657, DOI 10.1111/j.1365-2036.2007.03241.x; Ullman T, 2003, GASTROENTEROLOGY, V125, P1311, DOI 10.1016/j.gastro.2003.08.023; Ullman TA, 2002, AM J GASTROENTEROL, V97, P922; Van Assche G, 2013, J CROHNS COLITIS, V7, P1, DOI 10.1016/j.crohns.2012.09.005; Velayos FS, 2006, GASTROENTEROLOGY, V130, P1941, DOI 10.1053/j.gastro.2006.03.028; Walton Sarah-Jane, 2016, Oncoscience, V3, P173, DOI 10.18632/oncoscience.312; Watanabe Y, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023320; Wong N, 2015, NUCLEIC ACIDS RES, V43, pD146, DOI 10.1093/nar/gku1104; Yang YZ, 2013, BIOCHEM BIOPH RES CO, V434, P746, DOI 10.1016/j.bbrc.2013.03.122; Zidar N, 2016, J CELL MOL MED, V20, P1813, DOI 10.1111/jcmm.12869	40	12	13	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 13	2017	12	3							e0173664	10.1371/journal.pone.0173664	http://dx.doi.org/10.1371/journal.pone.0173664			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN6CP	28288169	gold, Green Published			2022-12-27	WOS:000396092400027
J	de Carcer, DA; Hernaez, B; Rastrojo, A; Alcami, A				Aguirre de Carcer, Daniel; Hernaez, Bruno; Rastrojo, Alberto; Alcami, Antonio			Infection with diverse immune-modulating poxviruses elicits different compositional shifts in the mouse gut microbiome	PLOS ONE			English	Article							ECTROMELIA; RECEPTOR; VIRUS	It is often not possible to demonstrate causality within the context of gut microbiota dysbiosislinked diseases. Thus, we need a better understanding of the mechanisms whereby an altered host immunophysiology shapes its resident microbiota. In this regard, immune-modulating poxvirus strains and mutants could differentially alter gut mucosal immunity in the context of a natural immune response, providing a controlled natural in vivo setting to deepen our understanding of the immune determinants of microbiome composition. This study represents a proof-of-concept that the use of an existing collection of different immune-modulating poxviruses may represent an innovative tool in gut microbiome research. To this end, 16S rRNA amplicon sequencing and RNAseq transcriptome profiling were employed as proxies for microbiota composition and gut immunophysiological status in the analysis of caecal samples from control mice and mice infected with various poxvirus types. Our results show that different poxvirus species and mutants elicit different shifts in the mice mucosa-associated microbiota and, in some instances, significant concomitant shifts in gut transcriptome profiles, thus providing an initial validation to the proposed model.	[Aguirre de Carcer, Daniel; Hernaez, Bruno; Rastrojo, Alberto; Alcami, Antonio] UAM, CSIC, Ctr Biol Mol Severo Ochoa, Madrid, Spain; [Aguirre de Carcer, Daniel] Univ Autonoma Madrid, Dept Biol, Madrid, Spain	Autonomous University of Madrid; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro de Biologia Molecular Severo Ochoa (CBM); Autonomous University of Madrid	de Carcer, DA; Alcami, A (corresponding author), UAM, CSIC, Ctr Biol Mol Severo Ochoa, Madrid, Spain.; de Carcer, DA (corresponding author), Univ Autonoma Madrid, Dept Biol, Madrid, Spain.	daniel.aguirre@uam.es; aalcami@cbm.csic.es	Hernaez, Bruno/N-4547-2014; de Carcer, Daniel Aguirre/C-7000-2011; Rastrojo, Alberto/N-4607-2014; Alcami, Antonio/F-8512-2015	Hernaez, Bruno/0000-0002-4351-0102; de Carcer, Daniel Aguirre/0000-0003-1104-9566; Rastrojo, Alberto/0000-0003-4381-7267; Alcami, Antonio/0000-0002-3333-6016	Spanish Ministry of Economy and Competitiveness Explora Ciencia [BFU2013-50537-EXP, SAF2012-38957]; Marie Curie IIF grant [PIIF-GA-2012-328287]; program JAE-Doc of CSIC	Spanish Ministry of Economy and Competitiveness Explora Ciencia; Marie Curie IIF grant; program JAE-Doc of CSIC	This work was funded by the Spanish Ministry of Economy and Competitiveness Explora Ciencia grant BFU2013-50537-EXP awarded to DAC and SAF2012-38957 awarded to AA. DAC was partially supported by the Marie Curie IIF grant PIIF-GA-2012-328287. BH was supported by the program JAE-Doc of CSIC. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alcami A, 2003, NAT REV IMMUNOL, V3, P36, DOI 10.1038/nri980; Alejo A, 2006, P NATL ACAD SCI USA, V103, P5995, DOI 10.1073/pnas.0510462103; Alejo A, 2011, ADV EXP MED BIOL, V691, P203, DOI 10.1007/978-1-4419-6612-4_21; Anders S, 2015, BIOINFORMATICS, V31, P166, DOI 10.1093/bioinformatics/btu638; Caporaso JG, 2010, NAT METHODS, V7, P335, DOI 10.1038/nmeth.f.303; de Carcer DA, 2011, APPL ENVIRON MICROB, V77, P6310, DOI 10.1128/AEM.05146-11; Deriu E, 2016, PLOS PATHOG, V12, DOI 10.1371/journal.ppat.1005572; Dray S, 2015, MOL ECOL RESOUR, V15, P242, DOI 10.1111/1755-0998.12300; Dray S, 2007, J STAT SOFTW, V22, P1, DOI 10.18637/jss.v022.i04; Esteban DJ, 2005, J GEN VIROL, V86, P2645, DOI 10.1099/vir.0.81090-0; Fang M, 2011, IMMUNITY, V34, P579, DOI 10.1016/j.immuni.2011.02.015; FENNER F, 1948, LANCET, V252, P915, DOI 10.1016/S0140-6736(48)91599-2; Finlay BB, 2006, CELL, V124, P767, DOI 10.1016/j.cell.2006.01.034; Garrett WS, 2007, CELL, V131, P33, DOI 10.1016/j.cell.2007.08.017; Garrett WS, 2009, CYTOKINE, V48, P144, DOI 10.1016/j.cyto.2009.07.007; Heumuller-Klug S, 2015, WORLD J GASTROENTERO, V21, P3499, DOI 10.3748/wjg.v21.i12.3499; Kim D, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-4-r36; Love MI, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0550-8; Lundberg DS, 2013, NAT METHODS, V10, P999, DOI 10.1038/nmeth.2634; Mavian C, 2014, VIROLOGY, V462, P218, DOI 10.1016/j.virol.2014.06.010; Panchanathan V, 2008, IMMUNOL CELL BIOL, V86, P80, DOI 10.1038/sj.icb.7100118; Pflughoeft KJ, 2012, ANNU REV PATHOL-MECH, V7, P99, DOI 10.1146/annurev-pathol-011811-132421; SYMONS JA, 1995, CELL, V81, P551, DOI 10.1016/0092-8674(95)90076-4; Takahashi S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0105592; Xu RH, 2008, J EXP MED, V205, P981, DOI 10.1084/jem.20071854	25	2	2	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 10	2017	12	3							e0173697	10.1371/journal.pone.0173697	http://dx.doi.org/10.1371/journal.pone.0173697			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN6CJ	28282449	gold, Green Published, Green Submitted			2022-12-27	WOS:000396091800069
J	Castellini, G; Franzago, M; Bagnoli, S; Lelli, L; Balsamo, M; Mancini, M; Nacmias, B; Ricca, V; Sorbi, S; Antonucci, I; Stuppia, L; Stanghellini, G				Castellini, Giovanni; Franzago, Marica; Bagnoli, Silvia; Lelli, Lorenzo; Balsamo, Michela; Mancini, Milena; Nacmias, Benedetta; Ricca, Valdo; Sorbi, Sandro; Antonucci, Ivana; Stuppia, Liborio; Stanghellini, Giovanni			Fat mass and obesity-associated gene (FTO) is associated to eating disorders susceptibility and moderates the expression of psycho-pathological traits	PLOS ONE			English	Article							BULIMIA-NERVOSA; RISK ALLELE; VARIANT; WEIGHT; BODY; POLYMORPHISMS; REWARD	Eating Disorders (EDs) show a multifactorial etiopathogenesis including environmental, psychological and biological factors. In the present study, we propose a model of interactions between genetic vulnerability-represented by Fat Mass and Obesity-Associated (FTO) gene D and stable psychopathological traits, such as bodily disorders and emotion dysregulation for EDs patients. The distribution of a polymorphism of the FTO (rs9939609 T>A) was evaluated in a series of 250 EDs patients and in a group of 119 healthy control subjects. Clinical data were collected through a face-to-face interview and several self-reported questionnaires were applied, including the Emotional Eating Scale and the IDentity and EAting disorders (IDEA) questionnaire for bodily disorders and self-identity. The A-allele was associated with an increased vulnerability to EDs (AA+AT genotypes frequency 72.8% in EDs vs. 52.9% in controls). The presence of the A-allele was associated with binge eating behavior, higher emotional eating and higher IDEA scores. Finally, the FTO rs9939609 SNP was found to influence the relationship between these variables, as an association between disorder of corporeality and emotional eating was found only in A-allele carriers. A-allele seems to represent a potential additive risk factor for EDs persons, with bodily disorders to develop emotional eating and binge eating behaviors.	[Castellini, Giovanni; Bagnoli, Silvia; Lelli, Lorenzo; Nacmias, Benedetta; Ricca, Valdo; Sorbi, Sandro] Univ Florence, Dept Neurosci Psychol Drug Res & Child Hlth, Florence, Italy; [Castellini, Giovanni] Univ Florence, Dept Expt Clin & Biomed Sci, Sexual Med & Androl Unit, Florence, Italy; [Franzago, Marica; Balsamo, Michela; Mancini, Milena; Antonucci, Ivana; Stuppia, Liborio; Stanghellini, Giovanni] G dAnnunzio Univ Chieti Pescara, Sch Med & Hlth Sci, Dept Psychol Hlth & Terr Sci, Chieti, Italy; [Stanghellini, Giovanni] D Portales Univ, Santiago, Chile	University of Florence; University of Florence; G d'Annunzio University of Chieti-Pescara	Stuppia, L (corresponding author), G dAnnunzio Univ Chieti Pescara, Sch Med & Hlth Sci, Dept Psychol Hlth & Terr Sci, Chieti, Italy.	stuppia@unich.it	Nacmias, Benedetta/J-5084-2018; castellini, giovanni/AAC-3195-2019; stanghellini, giovanni/G-6009-2014; Balsamo, Michela/AAP-1182-2020; Mancini, Milena/AAA-5041-2020; Franzago, Marica/AAX-5650-2020	Nacmias, Benedetta/0000-0001-9338-9040; Balsamo, Michela/0000-0001-5396-3853; Franzago, Marica/0000-0002-4830-8034; Mancini, Milena/0000-0001-9387-6498; sorbi, sandro/0000-0002-0380-6670; ricca, valdo/0000-0002-9291-2124				American psychiatric association, 2013, DIAGNOSTIC STAT MANU, DOI 10.1176/appi.books.9780890425596; [Anonymous], 1970, MANUAL STATE TRAIT A; ARNOW B, 1995, INT J EAT DISORDER, V18, P79, DOI 10.1002/1098-108X(199507)18:1<79::AID-EAT2260180109>3.0.CO;2-V; Bardone-Cone AM, 2010, BEHAV RES THER, V48, P194, DOI 10.1016/j.brat.2009.11.001; BECK AT, 1961, ARCH GEN PSYCHIAT, V4, P561, DOI 10.1001/archpsyc.1961.01710120031004; Boraska V, 2014, MOL PSYCHIATR, V19, P1085, DOI 10.1038/mp.2013.187; Castellini G, 2015, PSYCHOTHER PSYCHOSOM, V84, P124, DOI 10.1159/000365765; Castellini G, 2012, AM J MED GENET B, V159B, P491, DOI 10.1002/ajmg.b.32052; Castellini G, 2012, PSYCHOTHER PSYCHOSOM, V81, P11, DOI 10.1159/000329358; Castellini G, 2011, PSYCHOSOM MED, V73, P270, DOI 10.1097/PSY.0b013e31820a1838; Cattell R.B., 1978, SCI USE FACTOR ANAL, DOI [DOI 10.1007/978-1-4684-2262-7_5, 10.1007/978-1-4684-2262-7_5]; Cellini E, 2010, PSYCHIAT GENET, V20, P282, DOI 10.1097/YPG.0b013e32833a2142; Claussnitzer M, 2015, NEW ENGL J MED, V373, P895, DOI 10.1056/NEJMoa1502214; Fairburn CG, 2003, LANCET, V361, P407, DOI 10.1016/S0140-6736(03)12378-1; FAIRBURN CG, 1994, INT J EAT DISORDER, V16, P363; Fioravanti G, 2014, EAT BEHAV, V15, P192, DOI 10.1016/j.eatbeh.2014.01.006; First M. B., 1995, STRUCTURED CLIN INTE; Frayling TM, 2007, SCIENCE, V316, P889, DOI 10.1126/science.1141634; Gerken T, 2007, SCIENCE, V318, P1469, DOI 10.1126/science.1151710; Hess ME, 2013, NAT NEUROSCI, V16, P1042, DOI 10.1038/nn.3449; Hinney A, 2016, MOL PSYCHIAT; Hinney A, 2013, CURR PSYCHIAT REP, V15, DOI 10.1007/s11920-013-0423-y; Hunt SC, 2008, OBESITY, V16, P902, DOI 10.1038/oby.2007.126; Jonassaint CR, 2011, AM J MED GENET B, V156B, P454, DOI 10.1002/ajmg.b.31182; KAISER HF, 1960, EDUC PSYCHOL MEAS, V20, P141, DOI 10.1177/001316446002000116; Karra E, 2013, J CLIN INVEST, V123, P3539, DOI 10.1172/JCI44403; Keski-Rahkonen A, 2005, OBES RES, V13, P745, DOI 10.1038/oby.2005.84; Kline P., 2014, EASY GUIDE FACTOR AN, DOI 10.4324/9781315788135; Milos GF, 2013, BMC PSYCHIATRY, V13, DOI 10.1186/1471-244X-13-295; Mittal VA, 2011, PSYCHIAT RES, V189, P158, DOI 10.1016/j.psychres.2011.06.006; Mond JM, 2010, INT J EAT DISORDER, V43, P440, DOI 10.1002/eat.20707; Muller TD, 2012, OBESITY FACTS, V5, P408, DOI 10.1159/000340057; Olivo G, 2016, FRONT HUM NEUROSCI, V10, DOI 10.3389/fnhum.2016.00052; Peng SH, 2011, BMC MED, V9, DOI 10.1186/1741-7015-9-71; Peterson CB, 2011, J CONSULT CLIN PSYCH, V79, P777, DOI 10.1037/a0025941; Poritsanos NJ, 2011, NUTR DIABETES, V1, DOI 10.1038/nutd.2011.15; Ricca V, 2009, APPETITE, V53, P418, DOI 10.1016/j.appet.2009.07.008; Sevgi M, 2015, J NEUROSCI, V35, P12584, DOI 10.1523/JNEUROSCI.1589-15.2015; Smemo S, 2014, NATURE, V507, P371, DOI 10.1038/nature13138; Stanghellini G, 2015, PSYCHOPATHOLOGY, V48, P18, DOI 10.1159/000364882; Stanghellini G, 2012, PSYCHOPATHOLOGY, V45, P147, DOI 10.1159/000330258; Steiger H, 2009, J PSYCHIATR RES, V43, P1086, DOI 10.1016/j.jpsychires.2009.03.009; Tanofsky-Kraff M, 2009, AM J CLIN NUTR, V90, P1483, DOI 10.3945/ajcn.2009.28439; Thurstone LL, 1947, MULTIPLE FACTOR ANAL; Tozzi F, 2005, AM J PSYCHIAT, V162, P732, DOI 10.1176/appi.ajp.162.4.732; Wade TD, 2007, PSYCHOL MED, V37, P635, DOI 10.1017/S0033291706009603; Wardle J, 2008, J CLIN ENDOCR METAB, V93, P3640, DOI 10.1210/jc.2008-0472; Wiemerslage L, 2016, EUR J NEUROSCI, V43, P1173, DOI 10.1111/ejn.13177	48	33	35	1	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 10	2017	12	3							e0173560	10.1371/journal.pone.0173560	http://dx.doi.org/10.1371/journal.pone.0173560			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN6CJ	28282466	Green Submitted, Green Published, gold			2022-12-27	WOS:000396091800049
J	Chandran, P; Rao, HL; Mandal, AK; Choudhari, NS; Garudadri, CS; Senthil, S				Chandran, Premanand; Rao, Harsha L.; Mandal, Anil K.; Choudhari, Nikhil S.; Garudadri, Chandra S.; Senthil, Sirisha			Glaucoma associated with iridocorneal endothelial syndrome in 203 Indian subjects	PLOS ONE			English	Article							ESSENTIAL IRIS ATROPHY; CHANDLERS SYNDROME; CLINICAL VARIATIONS; COGAN-REESE; SPECTRUM; DISEASE	Purpose To report the demographic profile, clinical features, and prevalence of glaucoma and its management in patients with Iridocorneal endothelial (ICE) syndrome. Methods Retrospective review of 203 consecutive subjects with ICE syndrome at a tertiary eye care centre between January 1988 and June 2013. Results ICE syndrome was present in 223 eyes of 203 subjects, 124 (61%) were female and 79 (39%) were male. The median age at presentation was 43 years (1st (Q1) and 3rd (Q3) quartile; 34, 51 years). ICE syndrome was unilateral in 183 (90%) subjects, and bilateral in 20 (10%) subjects. The most common clinical variant was progressive iris atrophy (PIA, 115; 52% eyes), followed by Chandler syndrome (CS, 87; 39% eyes) and Cogan-Reese syndrome (CRS, 21; 9% eyes). Glaucoma was found in 156 eyes (70%) at presentation and the median (Q1, Q3) intraocular pressure in eyes with glaucoma was 24 (16, 38) mm Hg. Seven eyes developed glaucoma during the follow-up period, increasing the percentage of eyes with glaucoma to 73%. Intraocular pressure was managed medically in 81 eyes (50%) and the other 82 eyes (50%) required surgical intervention. Corneal edema was present in 124 eyes (56%) of which, 32 eyes (14%) required keratoplasty. Conclusions In our study on ICE syndrome in Indian population, the presentation was predominantly uniocular and more common in middle aged women. Progressive iris atrophy was the most common clinical variant. ICE syndrome was associated with glaucoma in over 70% of the eyes and half of the eyes had corneal edema.	[Chandran, Premanand; Rao, Harsha L.; Mandal, Anil K.; Choudhari, Nikhil S.; Garudadri, Chandra S.; Senthil, Sirisha] L V Prasad Eye Inst, VST Glaucoma Ctr, Hyderabad, Telangana, India; [Rao, Harsha L.] Narayana Nethralaya, Bangalore, Karnataka, India	L. V. Prasad Eye Institute	Senthil, S (corresponding author), L V Prasad Eye Inst, VST Glaucoma Ctr, Hyderabad, Telangana, India.	sirishasenthil@lvpei.org	Mandal, Anil/AAY-4809-2020; Choudhari, Nikhil/AAD-7157-2019; Chandran, Premanand/X-8935-2019	Chandran, Premanand/0000-0002-2252-1507; Rao, Harsha/0000-0001-5866-9856				ALVARADO JA, 1994, ARCH OPHTHALMOL-CHIC, V112, P1601, DOI 10.1001/archopht.1994.01090240107034; CAMPBELL DG, 1978, AM J OPHTHALMOL, V86, P317, DOI 10.1016/0002-9394(78)90232-5; Chandran P, 2016, J GLAUCOMA, V25, pE652, DOI 10.1097/IJG.0000000000000268; HEMADY RK, 1994, CORNEA, V13, P368, DOI 10.1097/00003226-199407000-00015; HETHERINGTON J, 1978, OPHTHALMOLOGY, V85, P240; HIRST LW, 1980, AUST J OPHTHALMOL, V8, P139, DOI 10.1111/j.1442-9071.1980.tb01672.x; Hodapp E, 1993, CLIN DECISIONS GLAUC, P52; Huna R, 1996, J GLAUCOMA, V5, P60; KIDD M, 1988, ARCH OPHTHALMOL-CHIC, V106, P199; LAGANOWSKI HC, 1992, ARCH OPHTHALMOL-CHIC, V110, P346, DOI 10.1001/archopht.1992.01080150044025; RICHARDSON TM, 1979, ARCH OPHTHALMOL-CHIC, V97, P2112, DOI 10.1001/archopht.1979.01020020430003; RODRIGUES MM, 1978, ARCH OPHTHALMOL-CHIC, V96, P643, DOI 10.1001/archopht.1978.03910050339009; SHIELDS MB, 1978, AM J OPHTHALMOL, V85, P749; SHIELDS MB, 1979, SURV OPHTHALMOL, V24, P3, DOI 10.1016/0039-6257(79)90143-7; Teekhasaenee C, 2000, ARCH OPHTHALMOL-CHIC, V118, P187; WILSON MC, 1989, ARCH OPHTHALMOL-CHIC, V107, P1465, DOI 10.1001/archopht.1989.01070020539035; YANOFF M, 1979, SURV OPHTHALMOL, V24, P1, DOI 10.1016/0039-6257(79)90142-5	17	13	15	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 10	2017	12	3							e0171884	10.1371/journal.pone.0171884	http://dx.doi.org/10.1371/journal.pone.0171884			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN6CJ	28282413	gold, Green Published, Green Submitted			2022-12-27	WOS:000396091800005
J	Knitlova, M; Horacek, I				Knitlova, Marketa; Horacek, Ivan			Late Pleistocene-Holocene paleobiogeography of the genus Apodemus in Central Europe	PLOS ONE			English	Article							WESTERN PALEARCTIC REGION; CYTOCHROME-B; MORPHOMETRIC CHARACTERS; DISCRIMINANT-ANALYSIS; MOLECULAR PHYLOGENY; GENETIC-VARIATION; MICE APODEMUS; RODENTIA; SYLVATICUS; MAMMALIA	Wood mice of the genus Apodemus are an essential component of small mammal communities throughout Europe. Molecular data suggest the postglacial colonization of current ranges from south European glacial refugia, different in particular species. Yet, details on the course of colonization and Holocene history of particular species are not available, partly because of a lack of reliable criteria for species identification in the fossil record. Using a sample of extant species, we analyzed variation patterns and between-species overlaps for a large set of metric and non-metric dental variables and established the criteria enabling the reliable species identification of fragmentary fossil material. The corresponding biometrical analyses were undertaken with fossil material of the genus (2528 items, 747 MNI) from 22 continuous sedimentary series in the Czech Republic and Slovakia, from LGM to Recent. In Central Europe, the genus is invariantly absent in LGM assemblages but regularly appears during the Late Vistulian. All the earliest records belong to A. flavicollis, the species clearly predominating in the fossil record until the Late Holocene. A. uralensis accompanied it in all regions until the late Boreal when disappeared from the fossil record (except for Pannonia). A few items identified as A. sylvaticus had already appeared in the early Holocene assemblages, first in the western part of the region, yet the regular appearance of the species is mostly in the post-Neolithic age. A. agrarius appeared sparsely from the Boreal with a maximum frequency during the post-Neolithic period. The results conform well to the picture suggested by molecular phylogeography but demonstrate considerable differences among particular species in dynamic of the range colonization. Further details concerning Holocene paleobiogeography of individual species in the medium latitude Europe are discussed.	[Knitlova, Marketa; Horacek, Ivan] Charles Univ Prague, Dept Zool, Vinicna 7, Prague 2, Czech Republic	Charles University Prague	Horacek, I (corresponding author), Charles Univ Prague, Dept Zool, Vinicna 7, Prague 2, Czech Republic.	horacek@natur.cuni.cz	Horacek, Ivan/V-9741-2017; Knitlova, Marketa/Q-1044-2017	Horacek, Ivan/0000-0002-8356-5554; Knitlova, Marketa/0000-0001-6271-9991	Grantova Agentura, Univerzita Karlova [355511]; SW Programme, Charles University [260313/2016]; Grantova Agentura Ceske Republiky [13-08169S];  [GAUK 355511];  [SVV 260313/2016];  [GACR 13-08169S]	Grantova Agentura, Univerzita Karlova; SW Programme, Charles University; Grantova Agentura Ceske Republiky(Grant Agency of the Czech Republic); ; ; 	Support was provided by Grantova Agentura, Univerzita Karlova, 355511 to MSc Marketa Knitlova; SW Programme, Charles University, 260313/2016 to MSc Marketa Knitlova; Grantova Agentura Ceske Republiky, 13-08169S to Dr. Ivan Horacek.; The work was supported by grants GAUK 355511, SVV 260313/2016 (to MK) and GACR 13-08169S.	Aguilar JP, 2008, CR PALEVOL, V7, P217, DOI 10.1016/j.crpv.2008.02.004; Amori G, 2008, IUCN RED LIST THREAT; Ancillotto L., 2016, MAMM REV; Atopkin DM, 2007, RUSS J GENET+, V43, P665, DOI 10.1134/S1022795407060105; Barciova L, 2009, ACTA ZOOL ACAD SCI H, V55, P31; Bellinvia E, 2004, J ZOOL SYST EVOL RES, V42, P289, DOI 10.1111/j.1439-0469.2004.00270.x; Bellinvia E, 1999, FOLIA ZOOL, V48, P241; BENECKE N, 1999, ARCHAOLOGIE EURASIEN, V6, P43; BOHME WOLFGANG, 1966, ZOOL ANZ, V177, P319; David A.I., 2005, PROBLEMS PALEONTOLOG, P21; DAVID AI, 1999, ARCHAOLOGIE EURASIEN, V6, P59; David AI, 1978, LATE CENOZOIC FAUNA, P75; Davis BAS, 2003, QUATERNARY SCI REV, V22, P1701, DOI 10.1016/S0277-3791(03)00173-2; Englisch H, 1996, BONNER ZOOLOGISCHE B, V46, P249; Fahlke J.M., 2009, THESIS; Filippucci Maria Grazia, 1996, Senckenbergiana Biologica, V75, P1; Filippucci MG, 2002, BIOL J LINN SOC, V75, P395, DOI 10.1111/j.1095-8312.2002.tb02080.x; Freudenthal Mathijs, 1999, P401; Frynta D, 2001, ISRAEL J ZOOL, V47, P243; Gromov IM, 1961, TR KOMISS IZUCH CHET, V17; Haarsma A, 2016, POPUL ECOL; Heinrich W.-D., 1983, Wissenschaftliche Zeitschrift der Humboldt-Universitaet zu Berlin Mathematisch-Naturwissenschaftliche Reihe, V32, P729; Heinrich WD, 1983, WISS Z HUMBOLDT U BE, V32, P45; Herman JS, 2016, BIOL J LINN SOC LOND; Hor?ek I., 2015, FORGOTTEN TIMES SPAC, P363; Horacek I, 2005, ACTA CHIROPTEROL, V7, P189, DOI 10.3161/1733-5329(2005)7[189:HOTPPG]2.0.CO;2; HORACEK I, 1988, Rozpravy Ceskoslovenske Akademie Ved Rada Matematickych a Prirodnich Ved, V98, P1; Horacek I, 2002, PREHISTORICKE JESKYN, P313; Horacek I, 2007, SANDSTONE LANDSCAPES, P265; Horacek I., 2006, PLEISTOCENE ENV ARCH, P157; Horacek I, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062498; Horakova J., 2014, QUATERN INT, V357, P207; JANOSSY D, 1976, Annales Historico-Naturales Musei Nationalis Hungarici, V68, P5; Janossy D., 1986, PLEISTOCENE VERTEBRA; Jojic V, 2012, J EVOLUTION BIOL, V25, P2489, DOI 10.1111/j.1420-9101.2012.02612.x; KANEKO Y., 2008, IUCN RED LIST THREAT, DOI http://dx.doi.org/10.2305/IUCN.UK.2008.RLTS.T1888A8654207.en; Koh HS, 2014, ACTA ZOOL ACAD SCI H, V60, P73; KORDOS L, 1977, FOLDR KOZL, V25, P144; Kowalski K., 2001, FOLIA QUATERNARIA, V72, P1; Krokhmal AI, 2010, LOCALITIES PLEISTOCE; Krystufek B, 2008, IUCN RED LIST THREAT; Krystufek B, 2009, MAMMALS TURKEY CYPRU; Krystufek Boris, 2007, Zoology in the Middle East, V42, P25; Libois RM, 2001, CAN J ZOOL, V79, P1503, DOI 10.1139/cjz-79-8-1503; Liu XM, 2004, MOL PHYLOGENET EVOL, V33, P1, DOI 10.1016/j.ympev.2004.05.011; Lozek V., 1982, Rozpravy Ceskoslovenske Akademie Ved Rada Matematickych a Prirodnich Ved, V92, P1; Lozek V., 1964, Rozpravy ustred Ust geol, V31, P1; Martin Suarez Elvira, 1998, Geobios (Lyon), V31, P87, DOI 10.1016/S0016-6995(98)80099-5; Michaux JR, 2005, HEREDITY, V94, P52, DOI 10.1038/sj.hdy.6800561; Michaux JR, 2004, MOL PHYLOGENET EVOL, V32, P788, DOI 10.1016/j.ympev.2004.02.018; Michaux JR, 2003, MOL ECOL, V12, P685, DOI 10.1046/j.1365-294X.2003.01752.x; Michaux JR, 2002, MOL PHYLOGENET EVOL, V23, P123, DOI 10.1016/S1055-7903(02)00007-6; Moncel MH, 2015, J ANTHROPOL ARCHAEOL, V40, P302, DOI 10.1016/j.jaa.2015.09.005; MONTGOMERY WI, 1980, J ZOOL, V192, P351; Musser G.G., 1996, BONNER ZOOL BEITR, V46, P143; Musser GG, 2005, MAMMAL SPECIES WORLD, P1; Nadachowski A, 2009, LATE PLEISTOCENE ENVIRONMENT OF THE CZESTOCHOWA UPLAND (POLAND) RECONSTRUCTED ON THE BASIS OF FAUNISTIC EVIDENCE FROM ARCHAEOLOGICAL CAVE SITES, P1; NIETHAMMER J, 1978, HDB SAUGETIERE EUROP, V1, P325; Pazonyi P, 2004, PALAEOGEOGR PALAEOCL, V212, P295, DOI 10.1016/j.palaeo.2004.06.008; POPOV VV, 1994, TEMNATA CAVE EXCAVAT, P11; Reutter BA, 1999, ACTA THERIOL, V44, P299, DOI 10.4098/AT.arch.99-28; Royer A, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0145600; Schlitter D., 2008, IUCN RED LIST THREAT; Serizawa K, 2000, BIOCHEM GENET, V38, P27, DOI 10.1023/A:1001828203201; Socha P, 2014, QUATERN INT, V326, P64, DOI 10.1016/j.quaint.2013.12.027; Spitzenberger F., 2001, SAUGETIERFAUNA OSTER; Spitzenberger F., 2014, LYNX, V45, P69; Stanko M., 2014, APODEMUS AGRARIUS PA; STEINER HM, 1968, Z WISS ZOOL ABT A, V177, P1; STORCH G, 1989, Z SAUGETIERKD, V54, P337; Storch G, 1978, TUBINGER MONOGRAPHIE, V5, P131; Storch G., 1978, TUBINGER MONOGRAPHIE, V5, P133; Storch G, 1987, FELSTALLE FORSCHUNGE, V23, P275; STORCH G, 1992, COURIER FORSCHUNGSIN, V153, P135; Storch G., 1973, PALAOLITHICUM BRILLE, P106; Storch G., 1974, Z SAUGETIERKD, V39, P84; Suzuki H, 2003, BIOL J LINN SOC, V80, P469, DOI 10.1046/j.1095-8312.2003.00253.x; Suzuki H, 2008, BIOCHEM GENET, V46, P329, DOI 10.1007/s10528-008-9149-7; Tatarinov K. A., 1970, THESIS; Toskan B, 2006, MAMMALIA, V70, P98, DOI 10.1515/MAMM.2006.002; Van Dam Jan A., 1997, Geologica Ultraiectina, V156, P1; van Kolfschoten T., 1985, Mededelingen Rijks Geologische Dienst, V39, P45; van Kolfschoten T, 1991, MEDED RIJKS GEOL DIE, V46, P37; Van Kolfschoten Th., 2014, SESSELFELSGROTTE 6 N, P27; Vogel P., 1995, SAUGETIERE SCHWEIZ V, P178; Vohralik Vladimir, 2002, Acta Societatis Zoologicae Bohemicae, V66, P67; Walker MJC, 2012, J QUATERNARY SCI, V27, P649, DOI 10.1002/jqs.2565; Zachos J, 2001, SCIENCE, V292, P686, DOI 10.1126/science.1059412; Zimov SA, 2012, QUATERNARY SCI REV, V57, P26, DOI 10.1016/j.quascirev.2012.10.005	89	12	13	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 10	2017	12	3							e0173668	10.1371/journal.pone.0173668	http://dx.doi.org/10.1371/journal.pone.0173668			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN6CJ	28282422	gold, Green Published, Green Submitted			2022-12-27	WOS:000396091800065
J	Koplenig, A; Meyer, P; Wolfer, S; Muller-Spitzer, C				Koplenig, Alexander; Meyer, Peter; Wolfer, Sascha; Mueller-Spitzer, Carolin			The statistical trade-off between word order and word structure - Large-scale evidence for the principle of least effort	PLOS ONE			English	Article							ENTROPY ESTIMATION	Languages employ different strategies to transmit structural and grammatical information. While, for example, grammatical dependency relationships in sentences are mainly conveyed by the ordering of the words for languages like Mandarin Chinese, or Vietnamese, the word ordering is much less restricted for languages such as Inupiatun or Quechua, as these languages (also) use the internal structure of words (e.g. inflectional morphology) to mark grammatical relationships in a sentence. Based on a quantitative analysis of more than 1,500 unique translations of different books of the Bible in almost 1,200 different languages that are spoken as a native language by approximately 6 billion people (more than 80% of the world population), we present large-scale evidence for a statistical trade-off between the amount of information conveyed by the ordering of words and the amount of information conveyed by internal word structure: languages that rely more strongly on word order information tend to rely less on word structure information and vice versa. Or put differently, if less information is carried within the word, more information has to be spread among words in order to communicate successfully. In addition, we find that-despite differences in the way information is expressed-there is also evidence for a trade-off between different books of the biblical canon that recurs with little variation across languages: the more informative the word order of the book, the less informative its word structure and vice versa. We argue that this might suggest that, on the one hand, languages encode information in very different (but efficient) ways. On the other hand, content-related and stylistic features are statistically encoded in very similar ways.	[Koplenig, Alexander; Meyer, Peter; Wolfer, Sascha; Mueller-Spitzer, Carolin] Inst German Language IDS, Mannheim, Germany	Institut fur Deutsche Sprache (IDS)	Koplenig, A (corresponding author), Inst German Language IDS, Mannheim, Germany.	Koplenig@ids-mannheim.de	Wolfer, Sascha/AHD-5519-2022					Bentz CH, 2016, P LEIDEN WORKSHOP CA; Berdicevskis A., 2016, P WORKSH COMP LING L; Bickerton D., 1996, LANGUAGE HUMAN BEHAV; Burkett D., 2002, INTRO NEW TESTAMENT; Crystal David., 2010, CAMBRIDGE ENCY LANGU, V3rd ed.; Dahl O., 2013, PERFECTIVE IMPERFECT; EBELING W, 1995, PHYSICA A, V215, P233, DOI 10.1016/0378-4371(95)00025-3; Edwards J., 1995, MULTILINGUALISM; Ehret K., COMPLEXITY ISOLATION; Ellis NC, 2015, IMPLICIT EXPLICIT LE, P1, DOI DOI 10.1075/SIBIL.48.01ELL; Evans CA., 2010, ROUTLEDGE ENCY HIST; Fedzechkina M, 2016, COGNITIVE SCI; Fischer O., 1992, CAMBRIDGE HIST ENGLI, VII, P207, DOI DOI 10.1017/CHOL9780521264754; Grunwald P., 2004, ARXIVMATH0406077; Haspelmath M, 2011, FOLIA LINGUIST, V45, P31, DOI 10.1515/FLIN.2011.002; Jacobs Joachim., 2011, SPRACHLICHES WISSEN; Juola P., 1998, J QUANT LINGUIST, V5, P206, DOI DOI 10.1080/09296179808590128; Juola Patrick., 2008, LANGUAGE COMPLEXITY, P104; KOHLER R, 1987, THEOR LINGUIST, V14, P241, DOI 10.1515/thli.1987.14.2-3.241; Kontoyiannis I, 1998, IEEE T INFORM THEORY, V44, P1319, DOI 10.1109/18.669425; Kontoyiannis I., 1996, COMPLEXITY ENTROPY L; Lass Roger., 2000, CAMBRIDGE HIST ENGLI, P56; Mayer T, P 9 INT C LANG RES E, P26; McWhorter JH., 2001, LINGUIST TYPOLOGY, V5; Montemurro MA, 2002, FRACTALS, V10, P451, DOI 10.1142/S0218348X02001257; Montemurro MA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019875; Moscoso del Prado Martin F., 2014, COGSCI 2014 P QUEB C; Moscoso del Prado Martin F., 2011, P QUANT MEAS MORPH M; O'Grady W, 1993, CONT LINGUISTICS INT; ORNSTEIN DS, 1993, IEEE T INFORM THEORY, V39, P78, DOI 10.1109/18.179344; Piantadosi ST, 2011, P NATL ACAD SCI USA, V108, P3526, DOI 10.1073/pnas.1012551108; Ramsay W. M., 1915, BEARING RECENT DISCO; Schurmann T, 1996, CHAOS, V6, P414, DOI 10.1063/1.166191; Takahira R, 2016, ENTROPY-SWITZ, V18, DOI 10.3390/e18100364; Tenny MC., 1988, INTERPRETING REVELAT; Thomas MC, 2006, ELEMENTS INFORM THEO; Tweedie FJ, 1998, COMPUT HUMANITIES, V32, P323, DOI 10.1023/A:1001749303137; Wycliffe Global Alliance, 2016, 2016 BIBL TRANSL STA; WYNER AD, 1989, IEEE T INFORM THEORY, V35, P1250, DOI 10.1109/18.45281; Zipf, 2012, HUMAN BEHAV PRINCIPL; Zipf George, 1935, PSYCHOBIOLOGY LANGUA	41	30	30	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 10	2017	12	3							e0173614	10.1371/journal.pone.0173614	http://dx.doi.org/10.1371/journal.pone.0173614			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Arts &amp; Humanities Citation Index (A&amp;HCI)	Science & Technology - Other Topics	EN6CJ	28282435	Green Submitted, Green Published, gold			2022-12-27	WOS:000396091800055
J	Mattila, VM; Kyrolalnen, H; Santtila, M; Pihlajamaki, H				Mattila, Ville M.; Kyrolalnen, Heikki; Santtila, Matti; Pihlajamaki, Harri			Low back pain during military service predicts low back pain later in life	PLOS ONE			English	Article							FOLLOW-UP; PHYSICAL-ACTIVITY; NECK PAIN; YOUNG; HOSPITALIZATION; ADOLESCENTS; SCHOOLCHILDREN; QUESTIONNAIRE; ASSOCIATIONS; PREVALENCE	The aim of the present study was to assess associations between physician diagnosed unspecified low back pain (LBP) during compulsory military service and self-reported LBP and physical fitness measured on average four years after military service. From a total of 1155 persons who had been pass medical examination for military service and who had completed physically demanding military training between 1997 and 2007, 778 men participated in a refresher military training course and physical tests. In this study, the association between LBP during military service and LBP in later life in addition to the association between LBP and physical fitness were examined. A total of 219 out of 778 participants (28%) had visited a physician due to some musculoskeletal symptom (ICD-10 M-diagnosis) during their military service. Seventy-four participants (9.5%) had visited a physician due to unspecified LBP during their service, and 41 (5.3%) had temporarily been absent from duty due to LBP. At the follow-up examination, 122 (15.7%) had reported LBP during the past month. LBP during military service was associated with self-reported LBP in the follow-up (p = 0.004). Of those who had been absent from duty due to LBP during their military service, 13 (31.7%) reported LBP during the past month. In risk factor analysis, no initial health behaviour and physical performance variables were associated with baseline LBP in the follow-up. The main finding of the present study was that unspecified LBP during military service predicts LBP in later life. On the basis of previous literature, it is also known that LBP is a common symptom and thus, one cannot expect to be symptomless the entire life. Interestingly, none of the health behaviours nor the physical performance studied in the follow-up were associated with baseline LBP. It appears that individuals prone to LBP have symptoms during physically demanding military service and also later in their life.	[Mattila, Ville M.; Pihlajamaki, Harri] Ctr Mil Med, Res Dept, Helsinki, Finland; [Mattila, Ville M.] Tampere Univ Hosp, Dept Orthoped & Traumatol, Tampere, Finland; [Mattila, Ville M.] Coxa Joint Replacement Hosp, Tampere, Finland; [Kyrolalnen, Heikki] Univ Jyvaskyla, Dept Biol Phys Act, Jyvaskyla, Finland; [Kyrolalnen, Heikki; Santtila, Matti] Natl Def Univ, Dept Mil Pedag & Leadership, Helsinki, Finland; [Pihlajamaki, Harri] Seinajoki Cent Hosp, Dept Orthoped & Traumatol, Seinajoki, Finland; [Pihlajamaki, Harri] Univ Tampere, Fac Med & Life Sci, Tampere, Finland	Tampere University; Tampere University Hospital; Coxa Hospital for Joint Replacement; University of Jyvaskyla; Seinajoki Central Hospital; Tampere University	Mattila, VM (corresponding author), Ctr Mil Med, Res Dept, Helsinki, Finland.; Mattila, VM (corresponding author), Tampere Univ Hosp, Dept Orthoped & Traumatol, Tampere, Finland.; Mattila, VM (corresponding author), Coxa Joint Replacement Hosp, Tampere, Finland.	Ville.Mattila@uta.fi		Kyrolainen, Heikki/0000-0003-3822-1733	Scientific Advisory Board for Defence [9/Mdd754/09]; Competitive Research Funding of Pirkanmaa Hospital District	Scientific Advisory Board for Defence; Competitive Research Funding of Pirkanmaa Hospital District	This study was financially supported by the Competitive Research Funding of Pirkanmaa Hospital District and Scientific Advisory Board for Defence (Nro 9/Mdd754/09). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Airaksinen O, 2006, EUR SPINE J, V15, pS192, DOI 10.1007/s00586-006-1072-1; Balague F, 1999, EUR SPINE J, V8, P429, DOI 10.1007/s005860050201; Balague F, 2012, LANCET, V379, P482, DOI 10.1016/S0140-6736(11)60610-7; Buchbinder R, 2013, BEST PRACT RES CL RH, V27, P575, DOI 10.1016/j.berh.2013.10.007; Burton AK, 1996, SPINE, V21, P2323, DOI 10.1097/00007632-199610150-00004; Clark Leslie L, 2015, MSMR, V22, P8; Dionne CE, 2006, AGE AGEING, V35, P229, DOI 10.1093/ageing/afj055; Duque I, 2011, EUR SPINE J, V20, P87, DOI 10.1007/s00586-010-1561-0; Fejer R, 2012, CHIROPR MAN THER, V20, DOI 10.1186/2045-709X-20-24; Fogelholm M, 2006, MED SCI SPORT EXER, V38, P753, DOI 10.1249/01.mss.0000194075.16960.20; Frilander H, 2015, BMJ OPEN, V5, DOI 10.1136/bmjopen-2015-007805; Hakala P, 2002, BRIT MED J, V325, P743, DOI 10.1136/bmj.325.7367.743; Hellsing AL, 2000, SPINE, V25, P3080, DOI 10.1097/00007632-200012010-00016; Hendrick P, 2011, EUR SPINE J, V20, P464, DOI 10.1007/s00586-010-1616-2; Hestbaek L, 2006, SPINE, V31, P468, DOI 10.1097/01.brs.0000199958.04073.d9; Hestbaek L, 2003, EUR SPINE J, V12, P149, DOI 10.1007/s00586-002-0508-5; Hodselmans AP, 2010, INT J REHABIL RES, V33, P268, DOI 10.1097/MRR.0b013e328335213f; Hoy D, 2010, BEST PRACT RES CL RH, V24, P769, DOI 10.1016/j.berh.2010.10.002; Hoy D, 2012, ARTHRITIS RHEUM-US, V64, P2028, DOI 10.1002/art.34347; Kaaria S, 2009, EUR J PAIN, V13, P406, DOI 10.1016/j.ejpain.2008.05.006; Kaila-Kangas L, 2006, SPINE, V31, P51, DOI 10.1097/01.brs.0000193902.45315.e5; Kaila-Kangas L, 2003, SPINE, V28, P1860, DOI 10.1097/01.BRS.0000083284.47176.80; Konstantinou K, 2013, CLIN J PAIN, V29, P644, DOI 10.1097/AJP.0b013e31826f9a52; Kovacs FM, 2003, PAIN, V103, P259, DOI 10.1016/S0304-3959(02)00454-2; Kujala UM, 1997, AM J SPORT MED, V25, P363, DOI 10.1177/036354659702500316; Kyrolainen H, 2008, OCCUP MED-OXFORD, V58, P251, DOI 10.1093/occmed/kqn010; Mattila VM, 2011, SCAND J MED SCI SPOR, V21, P804, DOI 10.1111/j.1600-0838.2010.01116.x; Mattila VM, 2009, BMC MUSCULOSKEL DIS, V10, DOI 10.1186/1471-2474-10-10; O'Sullivan PB, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-100; Petersen S, 2006, PAIN, V121, P145, DOI 10.1016/j.pain.2005.12.017; SALMINEN JJ, 1993, INT J SPORTS MED, V14, P406, DOI 10.1055/s-2007-1021200; Santtila M, 2012, J STRENGTH COND RES, V26, P745, DOI 10.1519/JSC.0b013e31822b72f1; Schaafsma FG, 2013, COCHRANE DB SYST REV, V8, DOI DOI 10.1002/14651858.CD001822.PUB2; Schultz IZ, 2004, PAIN, V107, P77, DOI 10.1016/j.pain.2003.09.019; Shiri R, 2010, ARTHRIT CARE RES, V62, P455, DOI 10.1002/acr.20003; Suni JH, 2013, SPINE, V38, P375, DOI 10.1097/BRS.0b013e318270a12d; Taanila HP, 2012, SPINE J, V12, P737, DOI 10.1016/j.spinee.2012.01.006; Taimela S, 1997, SPINE, V22, P1132, DOI 10.1097/00007632-199705150-00013; Thomas E, 1999, BRIT MED J, V318, P1662, DOI 10.1136/bmj.318.7199.1662; Vaara JP, 2012, J STRENGTH COND RES, V26, P2078, DOI 10.1519/JSC.0b013e31823b06ff; Verbunt JA, 2010, PAIN, V149, P428, DOI 10.1016/j.pain.2010.01.020; Visuri T, 2001, MIL MED, V166, P607, DOI 10.1093/milmed/166.7.607	42	8	8	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 10	2017	12	3							e0173568	10.1371/journal.pone.0173568	http://dx.doi.org/10.1371/journal.pone.0173568			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN6CJ	28282419	Green Published, gold, Green Submitted			2022-12-27	WOS:000396091800051
J	Fritz, J; Walker, DM; Cohen, S; Angeles, G; Lamadrid-Figueroa, H				Fritz, Jimena; Walker, Dilys M.; Cohen, Susanna; Angeles, Gustavo; Lamadrid-Figueroa, Hector			Can a simulation-based training program impact the use of evidence based routine practices at birth? Results of a hospital-based cluster randomized trial in Mexico	PLOS ONE			English	Article							NEONATAL EMERGENCIES; CARE	Background In Mexico, although the majority of births are attended in hospitals, reports have emerged of obstetric violence, use of unsafe practices, and failure to employ evidence-based practices ( EBP). Recent attention has refocused global efforts towards provision of quality care that is both patient-centered and evidence-based. Scaling up of local interventions should rely on strong evidence of effectiveness. Objective To perform a secondary analysis to evaluate the impact of a simulation and team-training program (PRONTO) on the performance of EBP in normal births. Methods A pair-matched cluster randomized controlled trial of the intervention was designed to measure the impact of the program (PRONTO intervention) on a sample of 24 hospitals (12 hospitals received the PRONTO training and 12 served as controls) in the states of Chiapas, Guerrero, and Mexico. We estimated the impact of receiving the intervention on the probability of birth practices performance in a sample of 641 observed births of which 318 occurred in the treated hospitals and 323 occurred in control hospitals. Data was collected at 4 time points (baseline, 4 th, 8 th and 12 th months after the training). Women were blinded to treatment allocation but observers and providers were not. Estimates were obtained by fitting difference-in-differences logistic regression models considering confounding variables. The trial is registered at clinicaltrials. gov: #NCT01477554. Results Significant changes were found following the intervention. At 4 months post-intervention an increase of 20 percentage points (p.p.) for complete Active Management of Third Stage of Labor (AMTSL) (p = 0.044), and 16 p.p. increase for Skin-to-Skin Contact (p = 0.067); at 12 months a 25 p.p. increase of the 1st step of AMTSL (p = 0.026) and a 42 p.p. increase of Delayed Cord Clamping (p = 0.004); at 4 months a 30 (p = 0.001) and at 8 months a 22 (p = 0.010) p.p. decrease for Uterine Sweeping. Conclusions The intervention has an impact on adopting EBP at birth, contributing to an increased quality of care. Long lasting impacts on these practices are possible if there were to be a widespread adoption of the training techniques including simulation, team-training and facilitated discussions regarding routine care.	[Fritz, Jimena; Lamadrid-Figueroa, Hector] Natl Inst Publ Hlth INSP, Res Ctr Populat Hlth, Div Reprod Hlth, Cuernavaca, Morelos, Mexico; [Walker, Dilys M.] Univ Calif San Francisco, Bixby Ctr Global Reprod Hlth, Dept Obstet Gynecol & Reprod Sci, San Francisco, CA 94143 USA; [Cohen, Susanna] Univ Utah, Coll Nursing, Salt Lake City, UT 84112 USA; [Angeles, Gustavo] Univ N Carolina, Dept Maternal & Child Hlth, Chapel Hill, NC USA	Instituto Nacional de Salud Publica; University of California System; University of California San Francisco; Utah System of Higher Education; University of Utah; University of North Carolina; University of North Carolina Chapel Hill	Lamadrid-Figueroa, H (corresponding author), Natl Inst Publ Hlth INSP, Res Ctr Populat Hlth, Div Reprod Hlth, Cuernavaca, Morelos, Mexico.	hlamadrid@insp.mx	Lamadrid-Figueroa, Hector/ABD-5416-2021	Lamadrid-Figueroa, Hector/0000-0001-8775-8399; Fritz, Jimena/0000-0002-4157-5981	Mexican National Institute for Women (INMUJERES) [274]; Bill and Melinda Gates Foundation; DW; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [P2CHD050924] Funding Source: NIH RePORTER	Mexican National Institute for Women (INMUJERES); Bill and Melinda Gates Foundation(Bill & Melinda Gates Foundation); DW; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	The main funder for this project was the Mexican National Institute for Women (INMUJERES), www.inmujeres.gob.mx, under agreement number 274, with additional funding from the Bill and Melinda Gates Foundation. DW received the funding. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscrip.	[Anonymous], 2006, STAND MAT NEON CAR; [Anonymous], 2009, WOMEN DELIVER FOCUS; Banja J, 2010, BUS HORIZONS, V53, P139, DOI 10.1016/j.bushor.2009.10.006; Camacho-Villarreal A. L., 2013, Enferm. univ, V10, P21; Carroli G, 2009, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD000081.pub2; Dimick JB, 2014, JAMA-J AM MED ASSOC, V312, P2401, DOI 10.1001/jama.2014.16153; Fauveau V, 2006, INT J GYNECOL OBSTET, V94, P179, DOI 10.1016/j.ijgo.2006.05.020; Freyermuth G, 2014, OBSERVATORIO MORTALI; Guoa de Practica Clonica, 2014, GUIA PRACT CLIN VIG; Gutierrez JP, 2012, ENCUESTA NACL SALUD; Gutierrez-Alba G, 2015, SALUD PUBLICA MEXICO, V57, P547; Kassebaum NJ, 2014, LANCET, V384, P980, DOI 10.1016/S0140-6736(14)60696-6; King HB., 2008, ADV PATIENT SAFETY N; Kromann CB, 2010, ADV HEALTH SCI EDUC, V15, P395, DOI 10.1007/s10459-009-9207-x; Mathai M, 2000, MANAGING COMPLICATIO, P98; Matsubara S, 2012, RURAL REMOTE HEALTH, V12; Menget A, 2013, ARCH PEDIATRIE, V20, P1022, DOI 10.1016/j.arcped.2013.06.016; Merien AER, 2010, OBSTET GYNECOL, V115, P1021, DOI 10.1097/AOG.0b013e3181d9f4cd; Renfrew MJ, 2014, LANCET, V384, P1129, DOI 10.1016/S0140-6736(14)60789-3; Rogers EM, 1983, DIFFUSION INNOVATION; Sachse-Aguilera M, 2013, REV INVESTIGACION ME, V1, P17; Sartore A, 2012, ARCH GYNECOL OBSTET, V286, P1135, DOI 10.1007/s00404-012-2444-x; Stanton C, 2009, B WORLD HEALTH ORGAN, V87, P207, DOI 10.2471/BLT.08.052597; Suzuki S, 2013, J OBSTET GYNAECOL, V33, P695, DOI 10.3109/01443615.2013.819843; Tuncalp O, 2014, BJOG-INT J OBSTET GY, V121, P57, DOI 10.1111/1471-0528.12634; Valdez-Santiago R., 2013, REV CONAMED, V18, P14; Walker D, 2014, BMC PREGNANCY CHILDB, V14, DOI 10.1186/s12884-014-0367-1; Walker D, 2012, J MIDWIFERY WOM HEAL, V57, P18, DOI 10.1111/j.1542-2011.2011.00075.x; Walker DM, 2012, INT J GYNECOL OBSTET, V116, P128, DOI 10.1016/j.ijgo.2011.09.021; Walker DM, 2015, SIMUL HEALTHC; World Health Organization, 2014, PREVENTION ELIMINATI	31	20	20	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 20	2017	12	3							0172623	10.1371/journal.pone.0172623	http://dx.doi.org/10.1371/journal.pone.0172623			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ER6VC	28319122	Green Published, Green Submitted, gold			2022-12-27	WOS:000398945800005
J	Drummond, CA; Brewster, PS; He, WC; Ren, KL; Xie, YM; Tuttle, KR; Haller, ST; Jamerson, K; Dworkin, LD; Cutlip, DE; Murphy, TP; D'Agostino, RB; Henrich, WL; Tian, J; Shapiro, JI; Cooper, CJ				Drummond, Christopher A.; Brewster, Pamela S.; He, Wencan; Ren, Kaili; Xie, Yanmei; Tuttle, Katherine R.; Haller, Steven T.; Jamerson, Kenneth; Dworkin, Lance D.; Cutlip, Donald E.; Murphy, Timothy P.; D'Agostino, Ralph B., Sr.; Henrich, William L.; Tian, Jiang; Shapiro, Joseph I.; Cooper, Christopher J.			Cigarette smoking and cardio-renal events in patients with atherosclerotic renal artery stenosis	PLOS ONE			English	Article							CHRONIC KIDNEY-DISEASE; GLOMERULAR-FILTRATION-RATE; SERUM CYSTATIN-C; RISK-FACTORS; BLOOD-PRESSURE; FOLLOW-UP; PROTEINURIA; POPULATION; ASSOCIATION; MORTALITY	Cigarette smoking causes cardiovascular disease and is associated with poor kidney function in individuals with diabetes mellitus and primary kidney diseases. However, the association of smoking on patients with atherosclerotic renal artery stenosis has not been studied. The current study utilized data from the Cardiovascular Outcomes in Renal Atherosclerotic Lesions (CORAL, NCT00081731) clinical trial to evaluate the effects of smoking on the risk of cardio-renal events and kidney function in this population. Baseline data showed that smokers (n = 277 out of 931) were significantly younger at enrollment than non-smokers (63.3 +/- 9.1 years vs 72.4 +/- 7.8 years; p<0.001). In addition, patients who smoke were also more likely to have bilateral renal artery stenoses and peripheral vascular disease (PVD). Longitudinal analysis showed that smokers experienced composite endpoint events (defined as first occurrence of: stroke; cardiovascular or renal death; myocardial infarction; hospitalization for congestive heart failure; permanent renal replacement; and progressive renal insufficiency defined as 30% reduction of GFR from baseline sustained for >= 60 days) at a substantially younger age compared to non-smokers (67.1 +/- 9.0 versus 76.1 +/- 7.9, p<0.001). Using linear regression and generalized linear modeling analysis controlled by age, sex, and ethnicity, smokers had significantly higher cystatin C levels (1.3 +/- 0.7 vs 1.2 +/- 0.9, p<0.01) whereas creatinine and estimated glomerular filtration rate (eGFR) were not different from non-smokers. From these data we conclude that smoking has a significant association with deleterious cardio-renal outcomes in patients with renovascular hypertension.	[Drummond, Christopher A.; Brewster, Pamela S.; Haller, Steven T.; Dworkin, Lance D.; Tian, Jiang; Cooper, Christopher J.] Univ Toledo, Coll Med & Life Sci, Dept Med, 2801 W Bancroft St, Toledo, OH 43606 USA; [He, Wencan; Ren, Kaili; Xie, Yanmei] Univ Toledo, Dept Math, Toledo, OH 43606 USA; [Tuttle, Katherine R.] Univ Washington, Sch Med, Div Nephrol, Providence Hlth Care, Spokane, WA USA; [Jamerson, Kenneth] Univ Michigan, Dept Med, Ann Arbor, MI 48109 USA; [Cutlip, Donald E.; D'Agostino, Ralph B., Sr.] Harvard Clin Res Inst, Boston, MA USA; [Murphy, Timothy P.] Brown Univ, Rhode Isl Hosp, Dept Med, Providence, RI 02903 USA; [Murphy, Timothy P.] Brown Univ, Rhode Isl Hosp, Dept Diagnost Imaging, Providence, RI 02903 USA; [Murphy, Timothy P.] Brown Univ, Alpert Med Sch, Providence, RI 02912 USA; [Henrich, William L.] Univ Texas Hlth Sci Ctr San Antonio, San Antonio, TX 78229 USA; [Shapiro, Joseph I.] Marshall Univ, Joan C Edwards Sch Med, Huntington, WV USA	University System of Ohio; University of Toledo; University System of Ohio; University of Toledo; University of Washington; Washington State University; University of Michigan System; University of Michigan; Harvard University; Harvard Medical School; Brown University; Lifespan Health Rhode Island; Rhode Island Hospital; Brown University; Lifespan Health Rhode Island; Rhode Island Hospital; Brown University; University of Texas System; University of Texas Health San Antonio; Marshall University	Tian, J (corresponding author), Univ Toledo, Coll Med & Life Sci, Dept Med, 2801 W Bancroft St, Toledo, OH 43606 USA.	Jiang.tian@utoledo.edu	Drummond, Christopher A/A-4482-2017	Drummond, Christopher A/0000-0002-0378-9882; Tuttle, Katherine/0000-0002-2235-0103; Henrich, Wolfgang/0000-0002-0759-832X	National Institutes of Health [U01HL072734, U01HL072735, U01HL072736, U01HL072737, 5U01HL071556, R01-HL-105649, R01-HL-109015, F32DK104615-01]; Gordis Corporation; Pfizer Inc.; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL105649, U01HL071556, R01HL109015] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [F32DK104615] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Gordis Corporation; Pfizer Inc.(Pfizer); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by the National Institutes of Health [Grant Numbers: U01HL072734, U01HL072735, U01HL072736, U01HL072737, 5U01HL071556, R01-HL-105649, R01-HL-109015, and F32DK104615-01]. The National and Ohio Valley Affiliate of the American Heart Association (13POST16860035). The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health. Drugs for this study were provided by AstraZeneca, device support was provided by Gordis Corporation and supplemental financial support was granted by both Gordis Corporation and Pfizer Inc.	Adhikari B., 2008, Morbidity and Mortality Weekly Report, V57, P1226; Altay S, 2014, BMC NEPHROL, V15, DOI 10.1186/1471-2369-15-160; Briganti EM, 2002, AM J KIDNEY DIS, V40, P704, DOI 10.1053/ajkd.2002.35677; Cheng S, 2014, CIRCULATION, V130, P820, DOI 10.1161/CIRCULATIONAHA.113.008506; Commenges D, 1998, STAT MED, V17, P1973, DOI 10.1002/(SICI)1097-0258(19980915)17:17<1973::AID-SIM892>3.0.CO;2-5; Cooper CJ, 2014, NEW ENGL J MED, V370, P13, DOI 10.1056/NEJMoa1310753; DERKX FHM, 1994, LANCET, V344, P237, DOI 10.1016/S0140-6736(94)93002-3; Duchesne T, 2000, LIFETIME DATA ANAL, V6, P157, DOI 10.1023/A:1009616111968; Halimi JM, 2000, KIDNEY INT, V58, P1285, DOI 10.1046/j.1523-1755.2000.00284.x; HARDING MB, 1992, J AM SOC NEPHROL, V2, P1608; Haroun MK, 2003, J AM SOC NEPHROL, V14, P2934, DOI 10.1097/01.ASN.0000095249.99803.85; Ishizaka N, 2008, HYPERTENS RES, V31, P485, DOI 10.1291/hypres.31.485; Kennedy DJ, 2003, AM J KIDNEY DIS, V42, P926, DOI 10.1016/j.ajkd.2003.06.004; Klag MJ, 1996, NEW ENGL J MED, V334, P13, DOI 10.1056/NEJM199601043340103; Knight EL, 2004, KIDNEY INT, V65, P1416, DOI 10.1111/j.1523-1755.2004.00517.x; Korn EL, 1997, AM J EPIDEMIOL, V145, P72; Levey AS, 2014, AM J KIDNEY DIS, V64, P821, DOI 10.1053/j.ajkd.2014.07.030; MACKAY A, 1979, BRIT MED J, V2, P770, DOI 10.1136/bmj.2.6193.770; Malerba M, 2015, DRUG DISCOV TODAY, V20, P129, DOI 10.1016/j.drudis.2014.09.005; Miyatake N, 2010, ACTA MED OKAYAMA, V64, P385; Mokdad AH, 2004, JAMA-J AM MED ASSOC, V291, P1238, DOI 10.1001/jama.291.10.1238; Noborisaka Y, 2007, J HUM HYPERTENS, V21, P966, DOI 10.1038/sj.jhh.1002242; Noborisaka Yuka, 2013, Nephrourol Mon, V5, P655, DOI 10.5812/numonthly.3527; Okura T, 2010, CLIN EXP NEPHROL, V14, P584, DOI 10.1007/s10157-010-0334-8; Orth S R, 2002, Tob Induc Dis, V1, P137, DOI 10.1186/1617-9625-1-2-137; Orth SR, 2004, J AM SOC NEPHROL, V15, pS58, DOI 10.1097/01.ASN.0000093461.36097.D5; Orth SR, 2002, J AM SOC NEPHROL, V13, DOI 10.1097/01.ASN.0000018401.82863.FD; Orth SR, 1998, KIDNEY INT, V54, P926, DOI 10.1046/j.1523-1755.1998.00067.x; Orth SR, 2008, CLIN J AM SOC NEPHRO, V3, P226, DOI 10.2215/CJN.03740907; Pinto-Sietsma SJ, 2000, ANN INTERN MED, V133, P585, DOI 10.7326/0003-4819-133-8-200010170-00008; Puri R, 2014, ARTERIOSCL THROM VAS, V34, P2465, DOI 10.1161/ATVBAHA.114.303932; Ritz E, 2008, CLIN NEPHROTOXINS, P895; Sauriasari R, 2010, HYPERTENS RES, V33, P1129, DOI 10.1038/hr.2010.154; Textor SC, 2011, CIRC-CARDIOVASC INTE, V4, P213, DOI 10.1161/CIRCINTERVENTIONS.111.962795; Thiebaut ACM, 2004, STAT MED, V23, P3803, DOI 10.1002/sim.2098; Venkata C, 1997, CURR OPIN NEPHROL HY, V6, P575, DOI 10.1097/00041552-199711000-00014; VOKONAS PS, 1988, J HYPERTENS, V6, pS3; Wong CW, 2014, KIDNEY INT, V85, P1290, DOI 10.1038/ki.2013.491; Yamada Y, 2015, CLIN EXP NEPHROL, V19, P669, DOI 10.1007/s10157-014-1058-y; Yamagata K, 2007, KIDNEY INT, V71, P159, DOI 10.1038/sj.ki.5002017; Yoon HJ, 2009, HYPERTENS RES, V32, P214, DOI 10.1038/hr.2008.37	41	12	12	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 17	2017	12	3							e0173562	10.1371/journal.pone.0173562	http://dx.doi.org/10.1371/journal.pone.0173562			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EO5CJ	28306749	Green Published, gold, Green Submitted			2022-12-27	WOS:000396710300010
J	Zak, M; Biskup, M; Macek, P; Krol, H; Krupnik, S; Opuchlik, A				Zak, Marek; Biskup, Malgorzata; Macek, Pawel; Krol, Halina; Krupnik, Szymon; Opuchlik, Anna			Identifying predictive motor factors for falls in post-menopausal breast cancer survivors	PLOS ONE			English	Article							PHYSICAL-ACTIVITY; PEOPLE; RISK; WOMEN	Objective Breast cancer treatment, including radical surgery, is also pursued as late as the 7th-8th decade of women's lives. Standard physical rehabilitation procedures offered to those women are predominantly focused on attenuating specific functional deficits of the upper limb and trunk. Seldom do they entail any regimens specifically aimed at recovering overall functionality, and reducing exposure to falls-risk. The study aimed to assess potential interrelationships between the self-reported falls, individual functional capabilities and appreciably reducing exposure to falls-risk in a group of post-menopausal, post-surgical breast cancer survivors. Methods The study recruited 102 women (aged 65-79; mean age 70.2), post-surgical breast cancer survivors. The subjects were stratified by age into three groups: Group 1 (65-69 years); Group 2 (70-74 years), and Group 3 (75-79 years). Individual functional capabilities were assessed with Eight-foot up & go test (8UG), chair stand test (CST), and 2-minute step test (2ST). Tinetti POMA test was applied to assess gait and balance disorders. Self-reported falls in the past year were ascertained through a questionnaire. Results Assessment of individual aerobic endurance (2ST) also demonstrated a clear deficit in the mean scores category in all respective age sub-groups, as compared against the reference values. The deficits ranged from 4.86 to 15.90 steps less than the normative values; the oldest subjects demonstrating the largest deficit. The aerobic endurance tests results significantly impacted the ultimate assessment of an individual falls-risk in the oldest group. The analysis of the number of falls sustained within the recent year indicated that 43.67% of the subjects fell victim of such incidents. Conclusion An individual exposure to falls-risk was found to be appreciably more dependent upon individual aerobic endurance rather than overall strength of the lower part of the body in the breast cancer survivors over 75.	[Zak, Marek; Krupnik, Szymon] Univ Sch Phys Educ, Dept Phys Rehabil Rheumatol & Geriatr, Krakow, Poland; [Biskup, Malgorzata; Krol, Halina; Opuchlik, Anna] Holycross Canc Ctr, Dept Rehabil, Kielce, Poland; [Biskup, Malgorzata; Krol, Halina] Jan Kochanowski Univ Humanities & Sci, Fac Hlth Sci, Kielce, Poland; [Macek, Pawel] Holycross Canc Ctr, Dept Epidemiol & Canc Control, Kielce, Poland; [Macek, Pawel] Fac Med Sci, Sch Econ Law & Med Sci, Kielce, Poland	Jan Kochanowski University	Zak, M (corresponding author), Univ Sch Phys Educ, Dept Phys Rehabil Rheumatol & Geriatr, Krakow, Poland.	mzak1@onet.eu	ZAK, Marek/AAN-1807-2021	ZAK, Marek/0000-0003-0881-9232; Krupnik, Szymon/0000-0002-2873-7878; Biskup, Malgorzata/0000-0003-2822-4594; Macek, Pawel/0000-0001-9755-7507				Ainsworth BE, 1998, CANCER-AM CANCER SOC, V83, P611, DOI 10.1002/(SICI)1097-0142(19980801)83:3+<611::AID-CNCR3>3.3.CO;2-U; Body JJ, 2011, BMC CANCER, V11, DOI 10.1186/1471-2407-11-384; Braithwaite D, 2010, JNCI-J NATL CANCER I, V102, P1; Dimeo F, 1997, BLOOD, V90, P3390, DOI 10.1182/blood.V90.9.3390; Dimeo F, 1998, MED SCI SPORT EXER, V30, P475, DOI 10.1097/00005768-199804000-00001; Fontein DBY, 2013, CANCER TREAT REV, V39, P958, DOI 10.1016/j.ctrv.2013.03.008; Francis RM, 2001, AGE AGEING, V30, P25, DOI 10.1093/ageing/30.suppl_4.25; Hidding JT, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0096748; Holick CN, 2008, CANCER EPIDEM BIOMAR, V17, P379, DOI 10.1158/1055-9965.EPI-07-0771; Howell A, 2005, LANCET, V365, P60, DOI 10.1016/s0140-6736(04)17666-6; Huang MH, 2014, GAIT POSTURE, V40, P451, DOI 10.1016/j.gaitpost.2014.05.015; Kiecolt-Glaser JK, 2014, J CLIN ONCOL, V32, P1040, DOI 10.1200/JCO.2013.51.8860; MACVICAR MG, 1989, NURS RES, V38, P348; Mock V, 1997, Oncol Nurs Forum, V24, P991; Nelson ME, 2007, MED SCI SPORT EXER, V39, P1435, DOI [10.1249/mss.0b013e3180616aa2, 10.1161/CIRCULATIONAHA.107.185650]; Rikli RE, 1999, J AGING PHYS ACTIV, V7, P162, DOI 10.1123/japa.7.2.162; Rubenstein LZ, 2006, AGE AGEING, V35, P37, DOI 10.1093/ageing/afl084; Runge M., 2005, Journal of Musculoskeletal & Neuronal Interactions, V5, P127; Satariano WA, 1996, PUBLIC HEALTH REP, V111, P236; SKELTON DA, 1994, AGE AGEING, V23, P371, DOI 10.1093/ageing/23.5.371; Skelton DA, 2001, AGE AGEING, V30, P33, DOI 10.1093/ageing/30.suppl_4.33; TINETTI ME, 1994, NEW ENGL J MED, V331, P821, DOI 10.1056/NEJM199409293311301; TODD C, WHAT ARE MAIN RISK F; Wampler MA, 2007, ARCH PHYS MED REHAB, V88, P1002, DOI 10.1016/j.apmr.2007.05.007; Winters-Stone KM, 2011, ARCH PHYS MED REHAB, V92, P646, DOI 10.1016/j.apmr.2010.10.039; Zak M, 2015, ARCH GERONTOL GERIAT, V61, P14, DOI 10.1016/j.archger.2015.03.003	26	11	11	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 17	2017	12	3							e0173970	10.1371/journal.pone.0173970	http://dx.doi.org/10.1371/journal.pone.0173970			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EO5CJ	28306736	Green Submitted, Green Published, gold			2022-12-27	WOS:000396710300019
J	Chen, IC; Lin, MY; Liu, YC; Cheng, HC; Wu, JR; Hsu, JH; Dai, ZK				Chen, I-Chen; Lin, Ming-Yen; Liu, Yi-Ching; Cheng, Hsiao-Chi; Wu, Jiunn-Ren; Hsu, Jong-Hau; Dai, Zen-Kong			The role of transthoracic ultrasonography in predicting the outcome of community-acquired pneumonia in hospitalized children	PLOS ONE			English	Article							LUNG ULTRASOUND; DIAGNOSIS; SEVERITY	Transthoracic ultrasound (TUS) has recently become a valuable tool in the diagnosis of community-acquired pneumonia (CAP). This study assessed the association between TUS findings and clinical outcome in children with CAP. The medical records of pediatric patients hospitalized with CAP who underwent transthoracic ultrasonography within 48 hours of admission were retrospectively reviewed. Associations between the TUS findings and patient outcome were analyzed, including intensive care unit (ICU) admission, length of hospital stay, and tube thoracotomy. The study enrolled 142 patients (median age, 60 months): 28 (19.7%) required ICU admission, 14 (9.89%) underwent tube thoracotomy, and 26 (18.3%) had a hospital stay > 9 days. Multifocal involvement seen by TUS were independently associated with ICU admission, a prolonged hospital stay, and tube thoracotomy (p = 0.0027, p = 0.02, and p = 0.0262, respectively). A pleural effusion and fluid bronchogram were independent predictors of a longer hospital stay (p = 0.003 and p = 0.006, respectively). In addition, a fluid bronchogram was an independent predictor of tube thoracotomy (p = 0.0262). Conclusion TUS findings of fluid bronchogram, multifocal involvement, and pleural effusion were associated with adverse outcomes, including longer hospital stay, ICU admission, and tube thoracotomy in hospitalized CAP children. Therefore, TUS is a novel tool for prognostic stratifications of CAP in hospitalized children.	[Chen, I-Chen; Liu, Yi-Ching; Cheng, Hsiao-Chi; Wu, Jiunn-Ren; Hsu, Jong-Hau; Dai, Zen-Kong] Kaohsiung Med Univ Hosp, Dept Pediat, Kaohsiung, Taiwan; [Lin, Ming-Yen] Kaohsiung Med Univ, Kaohsiung Med Univ Hosp, Div Nephrol, Dept Internal Med, Kaohsiung, Taiwan; [Lin, Ming-Yen] Kaohsiung Med Univ, Fac Renal Care, Coll Med, Kaohsiung, Taiwan; [Wu, Jiunn-Ren; Hsu, Jong-Hau; Dai, Zen-Kong] Kaohsiung Med Univ, Sch Med, Dept Pediat, Coll Med, Kaohsiung, Taiwan	Kaohsiung Medical University; Kaohsiung Medical University Hospital; Kaohsiung Medical University; Kaohsiung Medical University Hospital; Kaohsiung Medical University; Kaohsiung Medical University	Hsu, JH; Dai, ZK (corresponding author), Kaohsiung Med Univ Hosp, Dept Pediat, Kaohsiung, Taiwan.; Hsu, JH; Dai, ZK (corresponding author), Kaohsiung Med Univ, Sch Med, Dept Pediat, Coll Med, Kaohsiung, Taiwan.	jhh936@yahoo.com.tw; zenkong@kmu.edu.tw	Lin, Ming Yen/A-8637-2010	Lin, Ming Yen/0000-0002-8194-4833; Chen, I-Chen/0000-0002-9770-8544	Kaohsiung Medical University Hospital, Taiwan [KMUH103-3M30]; Ministry of Science and Technology, R.O.C. [MOST105-2314-B-037-011-, MOST 103-2314-B-037-023-MY3]	Kaohsiung Medical University Hospital, Taiwan; Ministry of Science and Technology, R.O.C.	This research was supported by the grant from the Kaohsiung Medical University Hospital, Taiwan (KMUH103-3M30) and Ministry of Science and Technology, R.O.C. (MOST105-2314-B-037-011- and MOST 103-2314-B-037-023-MY3). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abu-Kishk I, 2014, MINERVA PEDIAT; Bradley JS, 2011, CLIN INFECT DIS, V53, pE25, DOI [10.1093/cid/cir531, 10.1093/cid/cir625]; Bryce J, 2005, LANCET, V365, P1147, DOI 10.1016/S0140-6736(05)71877-8; Chen IC, 2015, PEDIAT NEONATOLOGY; Copetti R, 2008, RADIOL MED, V113, P190, DOI 10.1007/s11547-008-0247-8; de Hoyos A, 2002, SURG CLIN N AM, V82, P643, DOI 10.1016/S0039-6109(02)00022-1; Ferrero F, 2010, PEDIATR PULM, V45, P1009, DOI 10.1002/ppul.21287; Harris M, 2011, THORAX, V66, pII1, DOI 10.1136/thoraxjnl-2011-200598; Ho MC, 2015, PEDIATR NEONATOL, V56, P40, DOI 10.1016/j.pedneo.2014.03.007; Key NK, 2009, PEDIATR PULM, V44, P249, DOI 10.1002/ppul.20988; Lai SH, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0130082; LANDIS JR, 1977, BIOMETRICS, V33, P159, DOI 10.2307/2529310; Lin Chao-Jen, 2006, Journal of Microbiology Immunology and Infection, V39, P489; Mathis G, 2011, CHEST SONOGRAPHY; Patria MF, 2013, ITAL J PEDIATR, V39, DOI 10.1186/1824-7288-39-56; Reali F, 2014, RESPIRATION, V88, P112, DOI 10.1159/000362692; Reissig A, 2012, EUR J INTERN MED, V23, P391, DOI 10.1016/j.ejim.2012.01.003; Shah VP, 2013, JAMA PEDIATR, V167, P119, DOI 10.1001/2013.jamapediatrics.107; Sperandeo M, 2014, RADIOL MED, V119, P729, DOI 10.1007/s11547-014-0385-0; Trovato GM, 2013, AM J RESP CRIT CARE, V187, P780, DOI 10.1164/ajrccm.187.7.780; Urbankowska E, 2015, RESP MED, V109, P1207, DOI 10.1016/j.rmed.2015.06.011; Varshney T, 2016, EMERG MED J, V33, P603, DOI 10.1136/emermed-2015-205302; Volpicelli G, 2012, INTENS CARE MED, V38, P577, DOI 10.1007/s00134-012-2513-4; Wallihan R, 2014, J INFECTION, V69, pS87, DOI 10.1016/j.jinf.2014.07.021; WIENERKRONISH JP, 1985, AM REV RESPIR DIS, V132, P1253	25	6	7	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 16	2017	12	3							e0173343	10.1371/journal.pone.0173343	http://dx.doi.org/10.1371/journal.pone.0173343			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN9KE	28301494	gold, Green Submitted, Green Published			2022-12-27	WOS:000396318300033
J	Chin, EH; Schmidt, KL; Martel, KM; Wong, CK; Hamden, JE; Gibson, WT; Soma, KK; Christians, JK				Chin, Eunice H.; Schmidt, Kim L.; Martel, Kaitlyn M.; Wong, Chi Kin; Hamden, Jordan E.; Gibson, William T.; Soma, Kiran K.; Christians, Julian K.			A maternal high-fat, high-sucrose diet has sexspecific effects on fetal glucocorticoids with little consequence for offspring metabolism and voluntary locomotor activity in mice	PLOS ONE			English	Article							PLACENTAL NUTRIENT TRANSPORT; PHYSICAL-ACTIVITY; 11-BETA-HYDROXYSTEROID DEHYDROGENASE; GLUCOSE-HOMEOSTASIS; INSULIN-RESISTANCE; ENERGY-EXPENDITURE; OBESOGENIC DIET; INDUCED OBESITY; ANIMAL-MODELS; BIRTH-WEIGHT	Maternal overnutrition and obesity during pregnancy can have long-term effects on offspring physiology and behaviour. These developmental programming effects may be mediated by fetal exposure to glucocorticoids, which is regulated in part by placental 11 beta-hydroxysteroid dehydrogenase (11 beta-HSD) type 1 and 2. We tested whether a maternal high-fat, high-sucrose diet would alter expression of placental 11 beta-HSD1 and 2, thereby increasing fetal exposure to maternal glucocorticoids, with downstream effects on offspring physiology and behaviour. C57BL/6J mice were fed a high-fat, high-sucrose (HFHS) diet or a nutrient-matched low-fat, no-sucrose control diet prior to and during pregnancy and lactation. At day 17 of gestation, HFHS dams had similar to 20% lower circulating corticosterone levels than controls. Furthermore, there was a significant interaction between maternal diet and fetal sex for circulating corticosterone levels in the fetuses, whereby HFHS males tended to have higher corticosterone than control males, with no effect in female fetuses. However, placental 11 beta-HSD1 or 11 beta-HSD2 expression did not differ between diets or show an interaction between diet and sex. To assess potential long-term consequences of this sex-specific effect on fetal corticosterone, we studied locomotor activity and metabolic traits in adult offspring. Despite a sex-specific effect of maternal diet on fetal glucocorticoids, there was little evidence of sex-specific effects on offspring physiology or behaviour, although HFHS offspring of both sexes had higher circulating corticosterone at 9 weeks of age. Our results suggest the existence of as yet unknown mechanisms that mitigate the effects of altered glucocorticoid exposure early in development, making offspring resilient to the potentially negative effects of a HFHS maternal diet.	[Chin, Eunice H.; Schmidt, Kim L.; Martel, Kaitlyn M.; Christians, Julian K.] Simon Fraser Univ, Dept Biol Sci, Burnaby, BC, Canada; [Schmidt, Kim L.; Soma, Kiran K.] Univ British Columbia, Dept Psychol, Vancouver, BC, Canada; [Wong, Chi Kin; Gibson, William T.] Univ British Columbia, Dept Med Genet, Vancouver, BC, Canada; [Wong, Chi Kin; Gibson, William T.] BC Childrens Hosp, Vancouver, BC, Canada; [Hamden, Jordan E.; Soma, Kiran K.] Univ British Columbia, Dept Zool, Vancouver, BC, Canada	Simon Fraser University; University of British Columbia; University of British Columbia; BC Childrens Hospital; University of British Columbia; University of British Columbia	Christians, JK (corresponding author), Simon Fraser Univ, Dept Biol Sci, Burnaby, BC, Canada.	julian_christians@sfu.ca	Christians, J.K./AAL-2547-2020; Soma, Kiran K/B-9772-2012; Gibson, William/AFL-3634-2022	Christians, J.K./0000-0003-1797-0591; Soma, Kiran K/0000-0003-2169-8092; Gibson, William/0000-0002-6552-402X; Wong, Chi Kin/0000-0003-4828-8413; Schmidt, Kim/0000-0003-2311-9285; Hamden, Jordan/0000-0002-8152-6113	Natural Sciences and Engineering Research Council of Canada [402576-11, 2014-04884, 326791-2011]; postdoctoral fellowships	Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); postdoctoral fellowships	This project was funded by Natural Sciences and Engineering Research Council of Canada (http://www.nserc-crsng.gc.ca/index_eng.asp) Discovery Grants to WTG (402576-11), KKS (2014-04884), and JKC (326791-2011) and postdoctoral fellowships to EHC and KLS. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ainge H, 2011, INT J OBESITY, V35, P325, DOI 10.1038/ijo.2010.149; Andrikopoulos S, 2008, AM J PHYSIOL-ENDOC M, V295, pE1323, DOI 10.1152/ajpendo.90617.2008; Ayala JE, 2010, DIS MODEL MECH, V3, P525, DOI 10.1242/dmm.006239; Bellisario V, 2015, PSYCHONEUROENDOCRINO, V60, P138, DOI 10.1016/j.psyneuen.2015.06.012; Bowe JE, 2014, J ENDOCRINOL, V222, pG13, DOI 10.1530/JOE-14-0182; Bronson SL, 2016, NEUROPSYCHOPHARMACOL, V41, P207, DOI 10.1038/npp.2015.231; Chin EH, 2015, J DEV ORIG HLTH DIS, V6, P438, DOI 10.1017/S2040174415001348; Christians JK, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056260; Connor KL, 2009, REPROD SCI, V16, P1201, DOI 10.1177/1933719109345162; Cottrell EC, 2014, ACTA PHYSIOL, V210, P288, DOI 10.1111/apha.12187; Cottrell EC, 2012, FASEB J, V26, P1866, DOI 10.1096/fj.12-203489; Cunha FD, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0118586; Diaz P, 2014, BIOL REPROD, V91, DOI 10.1095/biolreprod.114.121798; Draper N, 2005, J ENDOCRINOL, V186, P251, DOI 10.1677/joe.1.06019; Gaccioli F, 2013, J DEV ORIG HLTH DIS, V4, P101, DOI 10.1017/S2040174412000529; Garbrecht MR, 2013, ISRN ENDOCRINOL, V2013; Garland T, 2011, J EXP BIOL, V214, P206, DOI 10.1242/jeb.048397; Grissom NM, 2013, INT J DEV NEUROSCI, V31, P406, DOI 10.1016/j.ijdevneu.2012.11.006; Hale MW, 2015, NEUROSCI BIOBEHAV R, V58, P46, DOI 10.1016/j.neubiorev.2014.12.009; Ingvorsen C, 2014, INT J OBESITY, V38, P1282, DOI 10.1038/ijo.2014.69; Jones HN, 2009, FASEB J, V23, P271, DOI 10.1096/fj.08-116889; Kim DW, 2014, BIOL REPROD, V90, DOI 10.1095/biolreprod.113.117259; King V, 2013, PLACENTA, V34, P1087, DOI 10.1016/j.placenta.2013.09.006; King V, 2014, REPROD BIOL ENDOCRIN, V12, DOI 10.1186/1477-7827-12-73; King V, 2013, ENDOCRINOLOGY, V154, P2514, DOI 10.1210/en.2013-1013; Lager S, 2014, PHYSIOL REP, V2, DOI 10.1002/phy2.242; LangleyEvans SC, 1996, PLACENTA, V17, P169, DOI 10.1016/S0143-4004(96)80010-5; Li G, 2013, DIABETES, V62, P2773, DOI 10.2337/db12-1306; Li M, 2011, EXP DIABETES RES, DOI [10.1155/2011/592408, 10.4061/2011/179819]; Mark PJ, 2009, BIOL REPROD, V80, P1209, DOI 10.1095/biolreprod.108.073650; McFarlane L, 2013, SEX DEV, V7, P207, DOI 10.1159/000348677; Mendes-da-Silva C, 2014, ARQ NEURO-PSIQUIAT, V72, P136, DOI 10.1590/0004-282X20130220; Mina TH, 2015, PSYCHONEUROENDOCRINO, V59, P112, DOI 10.1016/j.psyneuen.2015.05.004; Ngai YF, 2010, ENDOCRINOLOGY, V151, P5226, DOI 10.1210/en.2010-0496; O'Connor DM, 2007, ENDOCRINOLOGY, V148, P3750, DOI 10.1210/en.2007-0310; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Reynolds RM, 2013, PSYCHONEUROENDOCRINO, V38, P1, DOI 10.1016/j.psyneuen.2012.08.012; Rosario FJ, 2015, OBESITY, V23, P1663, DOI 10.1002/oby.21165; Samuelsson AM, 2008, HYPERTENSION, V51, P383, DOI 10.1161/HYPERTENSIONAHA.107.101477; Sasson IE, 2015, DIABETOLOGIA, V58, P615, DOI 10.1007/s00125-014-3466-7; Sferruzzi-Perri AN, 2013, FASEB J, V27, P3928, DOI 10.1096/fj.13-234823; Sferruzzi-Perri AN, 2013, CURR OPIN CLIN NUTR, V16, P298, DOI 10.1097/MCO.0b013e32835e3643; Stirrat LI, 2016, J STEROID BIOCHEM, V160, P214, DOI 10.1016/j.jsbmb.2015.07.003; Stirrat LI, 2016, PSYCHONEUROENDOCRINO, V63, P135, DOI 10.1016/j.psyneuen.2015.09.019; Stocker C, 2004, INT J OBESITY, V28, P129, DOI 10.1038/sj.ijo.0802476; Sullivan EL, 2011, NEUROENDOCRINOLOGY, V93, P1, DOI 10.1159/000322038; Taves MD, 2015, ENDOCRINOLOGY, V156, P511, DOI 10.1210/en.2013-1606; Tessier DR, 2013, PLACENTA, V34, P205, DOI 10.1016/j.placenta.2012.11.035; Togher KL, 2014, EPIGENETICS-US, V9, P816, DOI 10.4161/epi.28703; Williams L, 2014, BBA-MOL BASIS DIS, V1842, P507, DOI 10.1016/j.bbadis.2013.07.006; Zhu SY, 2016, P NUTR SOC, V75, P73, DOI 10.1017/S0029665115004127	51	21	21	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 16	2017	12	3							e0174030	10.1371/journal.pone.0174030	http://dx.doi.org/10.1371/journal.pone.0174030			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN9KE	28301585	Green Published, Green Submitted, gold			2022-12-27	WOS:000396318300115
J	Gamez, J; Salvado, M; Martinez-de La Ossa, A; Deu, M; Romero, L; Roman, A; Sacanell, J; Laborda, C; Rochera, I; Nadal, M; Carmona, F; Santamarina, E; Raguer, N; Canela, M; Sole, J				Gamez, Josep; Salvado, Maria; Martinez-de La Ossa, Alejandro; Deu, Maria; Romero, Laura; Roman, Antonio; Sacanell, Judith; Laborda, Cesar; Rochera, Isabel; Nadal, Miriam; Carmona, Francesc; Santamarina, Estevo; Raguer, Nuria; Canela, Merce; Sole, Joan			Influence of early neurological complications on clinical outcome following lung transplant	PLOS ONE			English	Article							CRITICAL ILLNESS POLYNEUROPATHY; NERVOUS-SYSTEM COMPLICATIONS; ISHLT INTERNATIONAL REGISTRY; LONG-TERM SURVIVAL; HEART-LUNG; ADULT LUNG; MECHANICAL VENTILATION; PEDIATRIC LUNG; SOCIETY; GASTROPARESIS	Background Neurological complications after lung transplantation are common. The full spectrum of neurological complications and their impact on clinical outcomes has not been extensively studied. Methods We investigated the neurological incidence of complications, categorized according to whether they affected the central, peripheral or autonomic nervous systems, in a series of 109 patients undergoing lung transplantation at our center between January 1 2013 and December 31 2014. Results Fifty-one patients (46.8%) presented at least one neurological complication. Critical illness polyneuropathy-myopathy (31 cases) and phrenic nerve injury (26 cases) were the two most prevalent complications. These two neuromuscular complications lengthened hospital stays by a median period of 35.5 and 32.5 days respectively. However, neurological complications did not affect patients' survival. Conclusions The real incidence of neurological complications among lung transplant recipients is probably underestimated. They usually appear in the first two months after surgery. Despite not affecting mortality, they do affect the mean length of hospital stay, and especially the time spent in the Intensive Care Unit. We found no risk factor for neurological complications except for long operating times, ischemic time and need for transfusion. It is necessary to develop programs for the prevention and early recognition of these complications, and the prevention of their precipitant and risk factors.	[Gamez, Josep; Salvado, Maria; Santamarina, Estevo] Autonomous Univ Barcelona, Dept Neurol, Vall dHebron Res Inst, Vall dHebron Univ Hosp, Barcelona, Spain; [Martinez-de La Ossa, Alejandro] Autonomous Univ Barcelona, Dept Neurophysiol, Vall dHebron Univ Hosp, Barcelona, Spain; [Deu, Maria; Romero, Laura; Canela, Merce; Sole, Joan] Vall dHebron Univ Hosp, Dept Thorac Surg, Lung Transplant Unit, Barcelona, Spain; [Roman, Antonio] Vall dHebron Univ Hosp, Dept Pulmonol, Lung Transplant Unit, Barcelona, Spain; [Sacanell, Judith; Laborda, Cesar] Vall dHebron Univ Hosp, Crit Care Dept, Lung Transplant Unit, Barcelona, Spain; [Rochera, Isabel; Nadal, Miriam] Vall dHebron Univ Hosp, Dept Anesthesiol, Barcelona, Spain; [Carmona, Francesc] Univ Barcelona, Dept Stat, Barcelona, Spain	Autonomous University of Barcelona; Hospital Universitari Vall d'Hebron; Vall d'Hebron Institut de Recerca (VHIR); Autonomous University of Barcelona; Hospital Universitari Vall d'Hebron; Hospital Universitari Vall d'Hebron; Hospital Universitari Vall d'Hebron; Hospital Universitari Vall d'Hebron; Hospital Universitari Vall d'Hebron; University of Barcelona	Gamez, J (corresponding author), Autonomous Univ Barcelona, Dept Neurol, Vall dHebron Res Inst, Vall dHebron Univ Hosp, Barcelona, Spain.	josepgamez.bcn@gmail.com	de Nadal, Miriam/J-8127-2017	de Nadal, Miriam/0000-0002-4559-2463; Romero Vielva, Laura/0000-0002-5839-4693; Raguer, Nuria/0000-0002-9471-9096; Gamez, Josep/0000-0003-3127-7486; Deu Martin, Maria/0000-0002-8441-9196; Laborda, Cesar/0000-0002-5642-5847	Spanish Fondo de Investigaciones Sanitarias [FIS PI13-01272-FEDER]	Spanish Fondo de Investigaciones Sanitarias(Instituto de Salud Carlos III)	JG is the recipient of a grant from the Spanish Fondo de Investigaciones Sanitarias (FIS PI13-01272-FEDER).	Alejaldre A, 2010, CURR CARDIOL REV, V6, P214, DOI 10.2174/157340310791658811; Amodio P, 2007, DIGEST LIVER DIS, V39, P740, DOI 10.1016/j.dld.2007.05.004; Benden C, 2014, J HEART LUNG TRANSPL, V33, P1025, DOI 10.1016/j.healun.2014.08.005; BERKOWITZ N, 1995, CHEST, V108, P1602, DOI 10.1378/chest.108.6.1602; BOLTON CF, 1984, J NEUROL NEUROSUR PS, V47, P1223, DOI 10.1136/jnnp.47.11.1223; BOLTON CF, 1987, MUSCLE NERVE, V10, P129, DOI 10.1002/mus.880100205; Bolton CF, 2010, CAN J NEUROL SCI, V37, P431, DOI 10.1017/S031716710001043X; Canbaz Suat, 2004, BMC Surg, V4, P2, DOI 10.1186/1471-2482-4-2; Chan EG, 2016, J THORAC CARDIOV SUR, V151, P1171, DOI 10.1016/j.jtcvs.2015.11.058; Christie JD, 2012, J HEART LUNG TRANSPL, V31, P1073, DOI 10.1016/j.healun.2012.08.004; Dorffner R, 1997, J HEART LUNG TRANSPL, V16, P566; Egan TM, 2006, AM J TRANSPLANT, V6, P1212, DOI 10.1111/j.1600-6143.2006.01276.x; Ferdinande P, 2004, J HEART LUNG TRANSPL, V23, P105, DOI 10.1016/S1053-2498(03)00068-8; Fu KA, 2014, FRONT NEUROL, V5, DOI 10.3389/fneur.2014.00275; Goldstein AB, 2000, PEDIATR PULM, V30, P203, DOI 10.1002/1099-0496(200009)30:3<203::AID-PPUL4>3.3.CO;2-X; Goldstein LS, 1998, J HEART LUNG TRANSPL, V17, P185; Gutmann L, 1999, ARCH NEUROL-CHICAGO, V56, P527, DOI 10.1001/archneur.56.5.527; HALL WA, 1989, ARCH NEUROL-CHICAGO, V46, P173, DOI 10.1001/archneur.1989.00520380077017; Hermans G, 2014, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD006832.pub3; Hussain SNA, 2010, AM J RESP CRIT CARE, V182, P1377, DOI 10.1164/rccm.201002-0234OC; Isnard J, 2007, J RADIOL, V88, P339, DOI 10.1016/S0221-0363(07)89830-1; Jaber S, 2011, AM J RESP CRIT CARE, V183, P364, DOI 10.1164/rccm.201004-0670OC; Kinaschuk K, 2016, J THORAC CARDIOV SUR, V151, P1181, DOI 10.1016/j.jtcvs.2015.12.045; Latronico N, 2008, MINERVA ANESTESIOL, V74, P319; Latronico N, 2011, LANCET NEUROL, V10, P931, DOI 10.1016/S1474-4422(11)70178-8; Marco S, 2009, TRANSPL INT, V22, P269, DOI 10.1111/j.1432-2277.2008.00780.x; MARKAND ON, 1984, NEUROLOGY, V34, P604, DOI 10.1212/WNL.34.5.604; Mateen FJ, 2010, AM J TRANSPLANT, V10, P908, DOI 10.1111/j.1600-6143.2009.02998.x; Maziak DE, 1996, ANN THORAC SURG, V61, P170, DOI 10.1016/0003-4975(95)00823-3; Mazzoni M, 1996, CHEST, V109, P1455, DOI 10.1378/chest.109.6.1455; Nwakanma LU, 2007, J THORAC CARDIOV SUR, V133, P541, DOI 10.1016/j.jtcvs.2006.09.062; PATCHELL RA, 1994, ANN NEUROL, V36, P688, DOI 10.1002/ana.410360503; Paul S, 2009, J HEART LUNG TRANSPL, V28, P475, DOI 10.1016/j.healun.2009.02.011; Perez-Miralles F, 2005, TRANSPL P, V37, P4067, DOI 10.1016/j.transproceed.2005.09.162; Pietrantoni C, 2003, CHEST, V123, P504, DOI 10.1378/chest.123.2.504; Ponticelli C, 2005, J NEPHROL, V18, P521; Scannell JG, 1963, J THORAC CARDIOVASC, V45, P64; SHERIDAN PH, 1995, J HEART LUNG TRANSPL, V14, P684; Stehlik J, 2014, J HEART LUNG TRANSPL, V33, P975, DOI 10.1016/j.healun.2014.08.001; Stehlik J, 2013, J HEART LUNG TRANSPL, V32, P941, DOI 10.1016/j.healun.2013.08.009; Thabut G, 2008, LANCET, V371, P744, DOI 10.1016/S0140-6736(08)60344-X; Wong M, 1999, NEUROLOGY, V53, P1542, DOI 10.1212/WNL.53.7.1542; Yiannopoulos A, 2004, J HEART LUNG TRANSPL, V23, P371, DOI 10.1016/S1053-2498(03)00188-8; Yusen RD, 2013, J HEART LUNG TRANSPL, V32, P965, DOI 10.1016/j.healun.2013.08.007; Zivkovic Sasa A, 2014, Handb Clin Neurol, V121, P1305, DOI 10.1016/B978-0-7020-4088-7.00089-4; Zivkovic SA, 2009, J NEUROL SCI, V280, P90, DOI 10.1016/j.jns.2009.02.308	46	11	11	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 16	2017	12	3							e0174092	10.1371/journal.pone.0174092	http://dx.doi.org/10.1371/journal.pone.0174092			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN9KE	28301586	Green Published, Green Submitted, gold			2022-12-27	WOS:000396318300125
J	Khodayari, N; Wang, RL; Marek, G; Krotova, K; Kirst, M; Liu, C; Rouhani, F; Brantly, M				Khodayari, Nazli; Wang, Rejean Liqun; Marek, George; Krotova, Karina; Kirst, Mariana; Liu, Chen; Rouhani, Farshid; Brantly, Mark			SVIP regulates Z variant alpha-1 antitrypsin retro-translocation by inhibiting ubiquitin ligase gp78	PLOS ONE			English	Article							VALOSIN-CONTAINING PROTEIN; ER-ASSOCIATED DEGRADATION; MOTILITY FACTOR-RECEPTOR; ENDOPLASMIC-RETICULUM; INTRACELLULAR DEGRADATION; QUALITY-CONTROL; LIVER-DISEASE; CELL-DEATH; ALPHA(1)-ANTITRYPSIN; DEFICIENCY	Alpha-1 antitrypsin deficiency (AATD) is an inherited disorder characterized by early-onset emphysema and liver disease. The most common disease-causing mutation is a single amino acid substitution (Glu/Lys) at amino acid 342 of the mature protein, resulting in disruption of the 290 - 342 salt bridge (an electrophoretic abnormality defining the mutation [Z allele, or ZAAT]), protein misfolding, polymerization, and accumulation in the endoplasmic reticulum of hepatocytes and monocytes. The Z allele causes a toxic gain of function, and the E3 ubiquitin ligase gp78 promotes degradation and increased solubility of endogenous ZAAT. We hypothesized that the accumulation of ZAAT is influenced by modulation of gp78 E3 ligase and SVIP (small VCP-interacting protein) interaction with p97/VCP in ZAAT-expressing hepatocytes. We showed that the SVIP inhibitory effect on ERAD due to overexpression causes the accumulation of ZAAT in a human Z hepatocyte-like cell line (AT01). Overexpression of gp78, as well as SVIP suppression, induces gp78-VCP/p97 interaction in AT01 cells. This interaction leads to retro-translocation of ZAAT and reduction of the SVIP inhibitory role in ERAD. In this context, overexpression of gp78 or SVIP suppression may eliminate the toxic gain of function associated with polymerization of ZAAT, thus providing a potential new therapeutic approach to the treatment of AATD.	[Khodayari, Nazli; Wang, Rejean Liqun; Marek, George; Krotova, Karina; Kirst, Mariana; Rouhani, Farshid; Brantly, Mark] Univ Florida, Dept Med, Div Pulm Crit Care & Sleep Med, Gainesville, FL 32611 USA; [Liu, Chen] Rutgers State Univ, Dept Pathol & Lab Med, New Brunswick, NJ USA	State University System of Florida; University of Florida; Rutgers State University New Brunswick	Brantly, M (corresponding author), Univ Florida, Dept Med, Div Pulm Crit Care & Sleep Med, Gainesville, FL 32611 USA.	mbrantly@ufl.edu	Brantly, Mark/AAH-2922-2020	Krotova, Karina/0000-0002-2248-1277	Alpha-1 Foundation; Fundacion Leopoldo Fernandez	Alpha-1 Foundation; Fundacion Leopoldo Fernandez	This work was supported by research grants from the Alpha-1 Foundation (www.alpha1.org) to MB and the Fundacion Leopoldo Fernandez. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aboussouan LS, 2009, RESP MED, V103, P335, DOI 10.1016/j.rmed.2008.10.006; Alonzi DS, 2008, BIOCHEM J, V409, P571, DOI 10.1042/BJ20070748; Ballar P, 2008, BIOCHEM SOC T, V36, P818, DOI 10.1042/BST0360818; Ballar P, 2007, J BIOL CHEM, V282, P33908, DOI 10.1074/jbc.M704446200; Ballar P, 2006, J BIOL CHEM, V281, P35359, DOI 10.1074/jbc.M603355200; BRANTLY M, 1988, SCIENCE, V242, P1700, DOI 10.1126/science.2904702; BRANTLY ML, 1988, AM REV RESPIR DIS, V138, P327, DOI 10.1164/ajrccm/138.2.327; Braun S, 2002, EMBO J, V21, P615, DOI 10.1093/emboj/21.4.615; Carvalho P, 2006, CELL, V126, P361, DOI 10.1016/j.cell.2006.05.043; Chen B, 2006, P NATL ACAD SCI USA, V103, P341, DOI 10.1073/pnas.0506618103; Chen ZL, 2012, CURR PROTEIN PEPT SC, V13, P414, DOI 10.2174/138920312802430590; Dai RM, 1998, J BIOL CHEM, V273, P3562, DOI 10.1074/jbc.273.6.3562; de Bernard M, 1998, TOXICOL LETT, V99, P109, DOI 10.1016/S0378-4274(98)00140-4; Ellgaard L, 2003, NAT REV MOL CELL BIO, V4, P181, DOI 10.1038/nrm1052; Fairbanks KD, 2008, AM J GASTROENTEROL, V103, P42; Fairbanks KD, 2008, AM J GASTROENTEROL, V103, P2136, DOI 10.1111/j.1572-0241.2008.01955.x; Fang SY, 2001, P NATL ACAD SCI USA, V98, P14422, DOI 10.1073/pnas.251401598; Friedlander R, 2000, NAT CELL BIOL, V2, P379, DOI 10.1038/35017001; Guo F, 2013, J CELL SCI, V126, P1429, DOI 10.1242/jcs.118182; Hampton RY, 2002, CURR OPIN CELL BIOL, V14, P476, DOI 10.1016/S0955-0674(02)00358-7; He XY, 2011, DEV GROWTH DIFFER, V53, P312, DOI 10.1111/j.1440-169X.2010.01236.x; Hiller MM, 1996, SCIENCE, V273, P1725, DOI 10.1126/science.273.5282.1725; Hirabayashi M, 2001, CELL DEATH DIFFER, V8, P977, DOI 10.1038/sj.cdd.4400907; Hirsch C, 2009, NATURE, V458, P453, DOI 10.1038/nature07962; Hoseki J, 2010, J BIOCHEM, V147, P19, DOI 10.1093/jb/mvp194; Hughes VA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0102617; Jezierski G, 2001, ACTA BIOCHIM POL, V48, P65; Kroeger H, 2009, J BIOL CHEM, V284, P22793, DOI 10.1074/jbc.M109.027102; LEI KJ, 1992, MOL ENDOCRINOL, V6, P703, DOI 10.1210/me.6.5.703; Lilley BN, 2004, NATURE, V429, P834, DOI 10.1038/nature02592; Lindblad D, 2007, HEPATOLOGY, V46, P1228, DOI 10.1002/hep.21822; McCracken AA, 2003, BIOESSAYS, V25, P868, DOI 10.1002/bies.10320; Nagahama M, 2003, MOL BIOL CELL, V14, P262, DOI 10.1091/mbc.02-07-0115; Novoradovskaya N, 1998, J CLIN INVEST, V101, P2693, DOI 10.1172/JCI549; Olzmann JA, 2013, CSH PERSPECT BIOL, V5, DOI 10.1101/cshperspect.a013185; Rabinovich E, 2002, MOL CELL BIOL, V22, P626, DOI 10.1128/MCB.22.2.626-634.2002; Ran FA, 2013, NAT PROTOC, V8, P2281, DOI 10.1038/nprot.2013.143; Romisch K, 2005, ANNU REV CELL DEV BI, V21, P435, DOI 10.1146/annurev.cellbio.21.012704.133250; Rossner M, 2004, J CELL BIOL, V166, P11, DOI 10.1083/jcb.200406019; Shen YX, 2006, BIOCHEM BIOPH RES CO, V349, P1285, DOI 10.1016/j.bbrc.2006.08.173; Shimizu K, 1999, FEBS LETT, V456, P295, DOI 10.1016/S0014-5793(99)00966-7; SIFERS RN, 1989, J BIOL CHEM, V264, P2997; Sivasothy P, 2000, J BIOL CHEM, V275, P33663, DOI 10.1074/jbc.M004054200; Song BL, 2005, MOL CELL, V19, P829, DOI 10.1016/j.molcel.2005.08.009; Stapf C, 2011, J BIOL CHEM, V286, P38670, DOI 10.1074/jbc.M111.274472; Stoller JK, 2004, THORAX, V59, P92, DOI 10.1136/thorax.2003.017517; Teckman JH, 2000, AM J PHYSIOL-GASTR L, V279, pG961, DOI 10.1152/ajpgi.2000.279.5.G961; Wang HP, 2011, MOL CELL BIOCHEM, V346, P137, DOI 10.1007/s11010-010-0600-9; Wang YG, 2011, PLOS ONE, V6, DOI [10.1371/journal.pone.0023495, 10.1371/journal.pone.0020422]; Wojcik C, 2004, J CELL SCI, V117, P281, DOI 10.1242/jcs.00841; Wojcik C, 2006, MOL BIOL CELL, V17, P4606, DOI 10.1091/mbc.E06-05-0432; Wu JW, 2013, BIOCHEM BIOPH RES CO, V440, P173, DOI 10.1016/j.bbrc.2013.09.056; WU Y, 1994, P NATL ACAD SCI USA, V91, P9014, DOI 10.1073/pnas.91.19.9014; Ye YH, 2004, NATURE, V429, P841, DOI 10.1038/nature02656; Ye YH, 2006, J STRUCT BIOL, V156, P29, DOI 10.1016/j.jsb.2006.01.005; Zhong XY, 2004, J BIOL CHEM, V279, P45676, DOI 10.1074/jbc.M409034200; Zhong YW, 2015, BIOCHEM BIOPH RES CO, V458, P424, DOI 10.1016/j.bbrc.2015.01.133	57	8	8	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 16	2017	12	3							e0172983	10.1371/journal.pone.0172983	http://dx.doi.org/10.1371/journal.pone.0172983			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN9KE	28301499	Green Published, Green Submitted, gold			2022-12-27	WOS:000396318300022
J	Lutton, EJ; Lammers, WJEP; James, S; van den Berg, HA; Blanks, AM				Lutton, E. Josiah; Lammers, Wim J. E. P.; James, Sean; van den Berg, Hugo A.; Blanks, Andrew M.			A computational method for three-dimensional reconstruction of the microarchitecture of myometrial smooth muscle from histological sections	PLOS ONE			English	Article							OPEN-SOURCE SOFTWARE; HUMAN UTERUS; QUANTIFICATION; SEGMENTATION; IMAGES; MRI	Background The fibrous structure of the myometrium has previously been characterised at high resolutions in small tissue samples (< 100 mm(3)) and at low resolutions (similar to 500 mu m per voxel edge) in whole-organ reconstructions. However, no high-resolution visualisation of the myometrium at the organ level has previously been attained. Methods and results We have developed a technique to reconstruct the whole myometrium from serial histological slides, at a resolution of approximately 50 mu m per voxel edge. Reconstructions of samples taken from human and rat uteri are presented here, along with histological verification of the reconstructions and detailed investigation of the fibrous structure of these uteri, using a range of tools specifically developed for this analysis. These reconstruction techniques enable the high-resolution rendering of global structure previously observed at lower resolution. Moreover, structures observed previously in small portions of the myometrium can be observed in the context of the whole organ. The reconstructions are in direct correspondence with the original histological slides, which allows the inspection of the anatomical context of any features identified in the three-dimensional reconstructions. Conclusions and significance The methods presented here have been used to generate a faithful representation of myometrial smooth muscle at a resolution of similar to 50 mu m per voxel edge. Characterisation of the smooth muscle structure of the myometrium by means of this technique revealed a detailed view of previously identified global structures in addition to a global view of the microarchitecture. A suite of visualisation tools allows researchers to interrogate the histological microarchitecture. These methods will be applicable to other smooth muscle tissues to analyse fibrous microarchitecture.	[Lutton, E. Josiah; Blanks, Andrew M.] Warwick Med Sch, Div Biomed Sci, Cell & Dev Biol, Coventry, W Midlands, England; [Lammers, Wim J. E. P.] Univ Auckland, Bioengn Inst, Auckland, New Zealand; [Lammers, Wim J. E. P.] UAE Univ, Dept Physiol, Coll Med & Hlth Sci, Al Ain, U Arab Emirates; [James, Sean] NHS Trust, UHCW, Dept Pathol, Coventry, W Midlands, England; [van den Berg, Hugo A.] Univ Warwick, Coventry, W Midlands, England	University of Warwick; University of Auckland; United Arab Emirates University; University of Warwick; University of Warwick	Blanks, AM (corresponding author), Warwick Med Sch, Div Biomed Sci, Cell & Dev Biol, Coventry, W Midlands, England.	andrew.blanks@warwick.ac.uk	Lutton, Josiah/ABH-5383-2020	Lutton, Josiah/0000-0002-0554-3456; van den Berg, Hugo/0000-0002-8230-6227; Blanks, Andrew/0000-0003-1073-6081	Medical Research Council (United Kingdom) [G0900208-2]; Medical Research Council [981408] Funding Source: researchfish	Medical Research Council (United Kingdom)(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	EJL, AMB, and HAB were supported by a grant from the Medical Research Council (United Kingdom), grant number G0900208-2. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	3DHISTECH, PANN VIEW; Abramoff M.D., 2004, BIOPHOT INT, V11, P36, DOI DOI 10.1117/1.3589100; Aslanidi OV, 2013, IEEE T MED IMAGING, V32, P8, DOI 10.1109/TMI.2012.2209183; BALLARD DH, 1981, PATTERN RECOGN, V13, P111, DOI 10.1016/0031-3203(81)90009-1; Blanks AM, 2007, BEST PRACT RES CL OB, V21, P807, DOI 10.1016/j.bpobgyn.2007.03.003; Can A, 2008, I S BIOMED IMAGING, P288, DOI 10.1109/ISBI.2008.4540989; CANNY J, 1986, IEEE T PATTERN ANAL, V8, P679, DOI 10.1109/TPAMI.1986.4767851; Chen CJ, 1986, CHINESE J PHYSL, V30, P35; CLARKE LP, 1995, MAGN RESON IMAGING, V13, P343, DOI 10.1016/0730-725X(94)00124-L; Damon BM, 2008, MAGN RESON MED, V60, P934, DOI 10.1002/mrm.21707; Deroulers C, 2013, DIAGN PATHOL, V8, DOI 10.1186/1746-1596-8-92; Fedorov A, 2012, MAGN RESON IMAGING, V30, P1323, DOI 10.1016/j.mri.2012.05.001; Gartner L.P., 2009, COLOR ATLAS HISTOLOG; Gerneke DA, 2007, MICROSC RES TECHNIQ, V70, P886, DOI 10.1002/jemt.20491; Gibbons J. D., 2011, NONPARAMETRIC STAT I; Gilbert SH, 2012, AM J PHYSIOL-HEART C, V302, pH287, DOI 10.1152/ajpheart.00824.2011; Goerttler K, 1931, JB MORPH MICROSK ANA, V65, P45; Gomez G., 2000, P BRIT MACH VIS C, P1; Goode Adam, 2013, J Pathol Inform, V4, P27, DOI 10.4103/2153-3539.119005; Howard C, 1998, UNBIASED STEREOLOGY; HUIJSMANS DP, 1986, ANAT RECORD, V216, P449, DOI 10.1002/ar.1092160402; Kaganami Hassana Grema, 2009, Proceedings of the 2009 Fifth International Conference on Intelligent Information Hiding and Multimedia Signal Processing. IIH-MSP 2009, P1217, DOI 10.1109/IIH-MSP.2009.13; MARK JST, 1956, ANAT REC, V125, P473, DOI 10.1002/ar.1091250306; Martinez K, 2005, IEEE INT C IMAGE PRO, V2, P574, DOI DOI 10.1109/1CIP.2005.1530120; Roberts N, 2012, AM J PATHOL, V180, P1835, DOI 10.1016/j.ajpath.2012.01.033; Rosset A, 2004, J DIGIT IMAGING, V17, P205, DOI 10.1007/s10278-004-1014-6; Sheldon RE, 2013, J R SOC INTERFACE, V10, DOI 10.1098/rsif.2013.0458; Toennies K. D., 2012, GUIDE MED IMAGE ANAL; Tomita, 1976, PROGR BIOPHYSICS MOL, V30, P185; Verbeek FJ, 2002, PROC SPIE, V4621, P65, DOI 10.1117/12.467833; Weiss N, 2015, BILDVERARBEITUNG FUR DIE MEDIZIN 2015: ALGORITHMEN - SYSTEME - ANWENDUNGEN, P245, DOI 10.1007/978-3-662-46224-9_43; Weiss S, 2006, ANAT REC PART A, V288A, P84, DOI 10.1002/ar.a.20274; Young RC, 1999, OBSTET GYNECOL, V93, P94, DOI 10.1016/S0029-7844(98)00345-7; Zitova B, 2003, IMAGE VISION COMPUT, V21, P977, DOI 10.1016/S0262-8856(03)00137-9	34	6	7	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 16	2017	12	3							e0173404	10.1371/journal.pone.0173404	http://dx.doi.org/10.1371/journal.pone.0173404			72	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN9KE	28301486	gold, Green Published, Green Submitted			2022-12-27	WOS:000396318300035
J	Matsuda, J; Maeda, Y; Nagasawa, J; Setoguchi, H				Matsuda, Junshi; Maeda, Yoshiyuki; Nagasawa, Junichi; Setoguchi, Hiroaki			Tight species cohesion among sympatric insular wild gingers (Asarum spp. Aristolochiaceae) on continental islands: Highly differentiated floral characteristics versus undifferentiated genotypes	PLOS ONE			English	Article							RECENT POPULATION BOTTLENECKS; ALLELE FREQUENCY DATA; REPRODUCTIVE ISOLATION; GENE FLOW; PHYLOGENETIC-RELATIONSHIPS; ECOLOGICAL SPECIATION; ADAPTIVE RADIATION; AREA RELATIONSHIP; HOMOZYGOSITY TEST; SPATIAL SCALE	The Amami Island group of the Ryukyu Archipelago, Japan, harbors extensive species diversity of Asarum in a small landmass. The fine-scale population genetic structure and diversity of nine insular endemic Asarum species were examined using nuclear DNA microsatellite loci and ITS sequences. High population genetic diversity (H-S = 0.45 - 0.79) was estimated based on the microsatellites, implying outcrossing of Asarum species within populations accompanied by inbreeding. Bayesian clustering analyses revealed that species were divided into three robust genetic clusters and that the species within each cluster had a homogeneous genetic structure, indicating incomplete lineage sorting. This conclusion was supported by an ITS phylogeny. The degree of genetic differentiation among species was very low both within and between clusters (F-ST = 0.096 - 0.193, and 0.096 - 0.266, respectively). Although species can be crossed artificially to produce fertile hybrids, our results indicate that there is very little evidence of hybridization or introgression occurring among species in the wild, even within stands composed of multiple sympatric species. The highly differentiated floral morphology of the studied species is likely to impose reproductive isolation between them and maintain their integrity in the wild. A lack of genetic differentiation between sympatric species suggests that speciation within this group occurred rapidly and recently.	[Matsuda, Junshi; Setoguchi, Hiroaki] Kyoto Univ, Grad Sch Human & Environm Studies, Sakyo Ku, Yoshida Nihonmatsu Cho, Kyoto, Japan; [Maeda, Yoshiyuki] Kagoshima Univ, Fac Sci, Kagoshima, Japan; [Nagasawa, Junichi] Kyoto Bot Garden, Shimokamo Hangi Cho, Kyoto, Kyoto, Japan; [Maeda, Yoshiyuki] Hookaen Nursery, Tean,Setouchi Cho, Kagoshima, Japan	Kyoto University; Kagoshima University	Setoguchi, H (corresponding author), Kyoto Univ, Grad Sch Human & Environm Studies, Sakyo Ku, Yoshida Nihonmatsu Cho, Kyoto, Japan.	setoguchi.hiroai.2c@kyoto-u.ac.jp	Setoguchi, Hiroaki/AAM-5312-2021		Ministry of Education, Culture, Sports, Science, and Technology, Japan [21370036]; Environment Research and Technology Development Fund (ERTDF) from the Ministry of Environment, Japan [4-1403]	Ministry of Education, Culture, Sports, Science, and Technology, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Environment Research and Technology Development Fund (ERTDF) from the Ministry of Environment, Japan	This work was supported by a Grant-in-Aid for Scientific Research (#21370036) from the Ministry of Education, Culture, Sports, Science, and Technology, Japan to H.S. and by the Environment Research and Technology Development Fund (ERTDF) (#4-1403) from the Ministry of Environment, Japan to H.S. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Azuma H, 2010, BIOCHEM SYST ECOL, V38, P548, DOI 10.1016/j.bse.2010.06.002; Cornuet JM, 1996, GENETICS, V144, P2001; Cowie RH, 2008, PHILOS T R SOC B, V363, P3363, DOI 10.1098/rstb.2008.0061; Coyne J.A., 2004, SPECIATION; Coyne JA, 2000, EVOLUTION, V54, P2166; Doyle JJ, 1987, PHYTOCHEM B, V19, P11, DOI 10.1016/j.bse.2009.07.003; Dyer RJ, 2004, MOL ECOL, V13, P1713, DOI 10.1111/j.1365-294X.2004.02177.x; Dyer RJ, 2009, MOL ECOL RESOUR, V9, P110, DOI 10.1111/j.1755-0998.2008.02384.x; EHRLICH PR, 1969, SCIENCE, V165, P1228, DOI 10.1126/science.165.3899.1228; ElMousadik A, 1996, THEOR APPL GENET, V92, P832, DOI 10.1007/BF00221895; Evanno G, 2005, MOL ECOL, V14, P2611, DOI 10.1111/j.1365-294X.2005.02553.x; Gillespie RG, 2005, J ARACHNOL, V33, P313, DOI 10.1636/05-15.1; Givnish TJ, 2009, P ROY SOC B-BIOL SCI, V276, P407, DOI 10.1098/rspb.2008.1204; Goudet J, 1995, J HERED, V86, P485, DOI 10.1093/oxfordjournals.jhered.a111627; Goudet J, 1996, GENETICS, V144, P1933; Grant P. R., 2008, WHY SPECIES MULTIPLY; Hatusima S, 1988, J PHYTOGEOGR TAXON, V36, P1; Hendry AP, 2007, FUNCT ECOL, V21, P455, DOI 10.1111/j.1365-2435.2007.01240.x; Hiura I., 1978, HIST TRACED BUTTERFL; Huang SQ, 2013, NEW PHYTOL, V199, P858, DOI 10.1111/nph.12327; HUANG SM, 2003, FLORA CHINA, V5, P246; Itou Y., 2000, SCI REP RES I EVOL B, V9, P121; Jakobsson M, 2007, BIOINFORMATICS, V23, P1801, DOI 10.1093/bioinformatics/btm233; Kay KM, 2008, EVOLUTION, V62, P2628, DOI 10.1111/j.1558-5646.2008.00463.x; Kelly LM, 1998, AM J BOT, V85, P1454, DOI 10.2307/2446402; Kimura M., 1996, QUAT PALEOGEOGR RYUK, V105, P259, DOI 10.5026/jgeography.105.3_259; Kimura M., 2000, TROPICS, V10, P5, DOI [10.3759/tropics.10.5, DOI 10.3759/TROPICS.10.5]; Kisel Y, 2010, AM NAT, V175, P316, DOI 10.1086/650369; Kizaki K., 1980, NATURAL HIST RYUKYUS; Kizaki K., 1977, MARINE SCI MONTHLY, V9, P542; Lexer C, 2005, J EVOLUTION BIOL, V18, P893, DOI 10.1111/j.1420-9101.2005.00901.x; Lomolino MV, 2000, J BIOGEOGR, V27, P17, DOI 10.1046/j.1365-2699.2000.00377.x; Losos JB, 2000, NATURE, V408, P847, DOI 10.1038/35048558; Losos JB, 2010, SPECIATION AREA RELA; Losos JB, 2009, NATURE, V457, P830, DOI 10.1038/nature07893; Lowry DB, 2008, EVOLUTION, V62, P2196, DOI 10.1111/j.1558-5646.2008.00457.x; LU KL, 1982, SYST BOT, V7, P150, DOI 10.2307/2418323; Luikart G, 1998, J HERED, V89, P238, DOI 10.1093/jhered/89.3.238; MAC ARTHUR ROBERT H., 1967; MacArthur R. H., 1969, Biological Journal of the Linnean Society, V1, P19, DOI 10.1111/j.1095-8312.1969.tb01809.x; MARUYAMA T, 1985, GENETICS, V111, P675; Matsuda J, 2012, CONSERV GENET RESOUR, V4, p597 ; Mayr E, 1942, SYSTEMATICS ORIGIN S; Mitsui Y, 2011, EVOLUTION, V65, P335, DOI 10.1111/j.1558-5646.2010.01129.x; Mitsui Y, 2010, AM J BOT, V97, P101, DOI 10.3732/ajb.0800220; Moyle LC, 2004, EVOLUTION, V58, P1195, DOI 10.1111/j.0014-3820.2004.tb01700.x; Nei M., 1987, MOL EVOLUTIONARY GEN; Page RDM, 1996, COMPUT APPL BIOSCI, V12, P357; Peakall R, 2006, MOL ECOL NOTES, V6, P288, DOI 10.1111/j.1471-8286.2005.01155.x; Petren K, 2005, MOL ECOL, V14, P2943, DOI 10.1111/j.1365-294X.2005.02632.x; Piry S, 1999, J HERED, V90, P502, DOI 10.1093/jhered/90.4.502; Pritchard JK, 2000, GENETICS, V155, P945; RAYMOND M, 1995, J HERED, V86, P248, DOI 10.1093/oxfordjournals.jhered.a111573; Rieseberg LH, 2007, SCIENCE, V317, P910, DOI 10.1126/science.1137729; Ronquist F, 2003, BIOINFORMATICS, V19, P1572, DOI 10.1093/bioinformatics/btg180; Rosenberg NA, 2004, MOL ECOL NOTES, V4, P137, DOI 10.1046/j.1471-8286.2003.00566.x; Rousset F, 1997, GENETICS, V145, P1219; Rousset F, 2008, MOL ECOL RESOUR, V8, P103, DOI 10.1111/j.1471-8286.2007.01931.x; Rundle HD, 2005, ECOL LETT, V8, P336, DOI 10.1111/j.1461-0248.2004.00715.x; Savolainen V, 2006, NATURE, V441, P210, DOI 10.1038/nature04566; Schiestl FP, 2009, ANNU REV ENTOMOL, V54, P425, DOI 10.1146/annurev.ento.54.110807.090603; Schluter D, 2001, TRENDS ECOL EVOL, V16, P372, DOI 10.1016/S0169-5347(01)02198-X; Scopece G, 2013, EVOLUTION, V67, P2083, DOI 10.1111/evo.12091; SETOGUCHI H, 1995, J PLANT RES, V108, P87, DOI 10.1007/BF02344310; Setoguchi H, 2000, AM J BOT, V87, P793, DOI 10.2307/2656887; SUGAWARA T, 1988, Plant Species Biology, V3, P7, DOI 10.1111/j.1442-1984.1988.tb00166.x; Sugawara T., 2006, FLORA JAPAN A, VIIa, P368; Takano A, 2013, PLANT SYST EVOL, V299, P865, DOI 10.1007/s00606-013-0768-z; Tanaka H., 1987, PLANT SPEC BIOL, V2, P133; Thompson JD, 1997, NUCLEIC ACIDS RES, V25, P4876, DOI 10.1093/nar/25.24.4876; Ujiie H., 1990, GEOLOGICAL HIST RYUK, P251; Via S, 2000, EVOLUTION, V54, P1626, DOI 10.1111/j.0014-3820.2000.tb00707.x; Vogel S., 1978, LINN SOC S SERIES, V6; WATTERSON GA, 1978, GENETICS, V88, P405; WATTERSON GA, 1986, GENETICS, V112, P899; WEIR BS, 1984, EVOLUTION, V38, P1358, DOI 10.1111/j.1558-5646.1984.tb05657.x; White TJ., 1990, PCR PROTOCOLS GUIDE, P315; Widmer A, 2009, HEREDITY, V102, P31, DOI 10.1038/hdy.2008.69; Wilson GA, 2003, GENETICS, V163, P1177; Wright S, 1943, GENETICS, V28, P114	80	5	5	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 16	2017	12	3							e0173489	10.1371/journal.pone.0173489	http://dx.doi.org/10.1371/journal.pone.0173489			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN9KE	28301540	Green Published, gold, Green Submitted			2022-12-27	WOS:000396318300045
J	Monk, CT; Arlinghaus, R				Monk, Christopher Thomas; Arlinghaus, Robert			Encountering a bait is necessary but insufficient to explain individual variability in vulnerability to angling in two freshwater benthivorous fish in the wild	PLOS ONE			English	Article							CARP CYPRINUS-CARPIO; COMMON CARP; BEHAVIORAL SYNDROMES; LIFE-HISTORY; PERSONALITY-TRAITS; ENERGETIC STATUS; ESOX-LUCIUS; CATCH RATES; FISHERIES; SELECTION	Fish personality traits, such as swimming activity, or personality related emergent behavioural properties, such as the degree of space use shown by an individual fish, should affect encounter rates between individual fish and fishing gear. Increased encounters should in turn drive vulnerability to capture by passively operated gears. However, empirical evidence documenting a relationship between activity-based behaviours and vulnerability to capture by passive fishing gear in the wild is limited. Using whole-lake acoustic telemetry, we first documented significant repeatabilities over several months in a suite of encounter rate-associated behaviours (swimming distance, activity space size, time on baited feeding sites, switching frequency among baited feeding sites, distance to the lake bottom) in two recreationally important benthivorous cyprinid species, the common carp (Cyprinus carpio) and tench (Tinca tinca). We then experimentally targeted both species using stationary angling on baited feeding sites. Individual fish regularly visited the angling sites, documenting that the fishes encountered the angling baits. When attempting to explain individual variation in vulnerability as a function of repeatable behavioural traits, we found no evidence of a significant relationship among various encounter-based behaviours and vulnerability to angling for both species. There was also no evidence for size selection or for energetically less conditioned fish to be more vulnerable. The data cumulatively suggest that fine-scale behaviours after encountering a bait (e.g., frequency of bait intake) may be ultimately decisive for determining vulnerability to angling in benthivorous fish. Based on our work, fishing-induced selection on encounter-based behaviours in recreational angling for benthivorous fish in the wild appears unlikely.	[Monk, Christopher Thomas; Arlinghaus, Robert] Leibniz Inst Freshwater Ecol & Inland Fisheries, Dept Biol & Ecol Fishes, Berlin, Germany; [Arlinghaus, Robert] Humboldt Univ, Div Integrat Fisheries Management, Dept Crop & Anim Sci, Fac Life Sci, Berlin, Germany	Leibniz Institut fur Gewasserokologie und Binnenfischerei (IGB); Humboldt University of Berlin	Monk, CT (corresponding author), Leibniz Inst Freshwater Ecol & Inland Fisheries, Dept Biol & Ecol Fishes, Berlin, Germany.	monk@igb-berlin.de	Arlinghaus, Robert/E-3340-2010; Arlinghaus, Robert/J-6171-2019; Monk, Christopher/HGB-4122-2022	Arlinghaus, Robert/0000-0003-2861-527X; Monk, Christopher/0000-0002-1647-4740	B-Types grant (Gottfried-Wilhelm-Leibniz-Community) [SAW-2013-IGB-2]; Leibniz Association	B-Types grant (Gottfried-Wilhelm-Leibniz-Community); Leibniz Association	This work was funded by the B-Types grant (Gottfried-Wilhelm-Leibniz-Community, grant no. SAW-2013-IGB-2) to R.A. We thank Shimano and SPRO for their generous donation of carp fishing tackle. The publication of this article was funded by the Open Access Fund of the Leibniz Association. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adamek Z, 2003, J APPL ICHTHYOL, V19, P165, DOI 10.1046/j.1439-0426.2003.00467.x; Adamek Z, 1995, POL ARCH HYDROBIOL, V42, P9; Alos J, 2016, SCI REP-UK, V6, DOI 10.1038/srep38093; Alos J, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0135348; Alos J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048030; Arlinghaus R, 2005, FISHERIES MANAG ECOL, V12, P91, DOI 10.1111/j.1365-2400.2004.00425.x; Arlinghaus R, 2003, FISH RES, V61, P19, DOI 10.1016/S0165-7836(02)00243-6; Arlinghaus R, 2015, FISHERIES MANAG ECOL, V22, P45, DOI 10.1111/fme.12075; Arlinghaus R, 2016, TRENDS ECOL EVOL, V31, P92, DOI 10.1016/j.tree.2015.11.008; Askey PJ, 2006, N AM J FISH MANAGE, V26, P1020, DOI 10.1577/M06-035.1; BAINBRIDGE R, 1958, J EXP BIOL, V35, P109; Bajer PG, 2010, ENVIRON BIOL FISH, V88, P295, DOI 10.1007/s10641-010-9643-8; Baktoft H, 2016, CONSERV PHYSIOL, V4, DOI 10.1093/conphys/cov055; Baktoft H, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0126534; Beck CM, 2015, FISCHEREILICHE STERB; Bell AM, 2009, ANIM BEHAV, V77, P771, DOI 10.1016/j.anbehav.2008.12.022; Berndt K, 2012, ICES J MAR SCI J CON; BEUKEMA J J, 1970, Netherlands Journal of Zoology, V20, P81; Binder TR, 2012, T AM FISH SOC, V141, P1252, DOI 10.1080/00028487.2012.688919; Biro PA, 2008, TRENDS ECOL EVOL, V23, P361, DOI 10.1016/j.tree.2008.04.003; Biro PA, 2008, P NATL ACAD SCI USA, V105, P2919, DOI 10.1073/pnas.0708159105; Biro PA, 2015, P ROY SOC B-BIOL SCI, V282, DOI 10.1098/rspb.2014.2283; BURKETT D P, 1986, North American Journal of Fisheries Management, V6, P109, DOI 10.1577/1548-8659(1986)6<109:HVAMRO>2.0.CO;2; Burnham K P, 2003, MODEL SELECT MULTIMO; Conrad JL, 2011, J FISH BIOL, V78, P395, DOI 10.1111/j.1095-8649.2010.02874.x; Cox SP, 2002, N AM J FISH MANAGE, V22, P21, DOI 10.1577/1548-8675(2002)022&lt;0021:MEIRFA&gt;2.0.CO;2; Crane DP, 2015, FISHERIES, V40, P258, DOI 10.1080/03632415.2015.1038382; Daniel AJ, 2009, MAR FRESHWATER RES, V60, P328, DOI 10.1071/MF08139; Diaz Pauli B, 2015, J FISH BIOL, V86, P1030, DOI 10.1111/jfb.12620; Dingemanse NJ, 2013, J ANIM ECOL, V82, P39, DOI 10.1111/1365-2656.12013; Dochtermann NA, 2015, P ROY SOC B-BIOL SCI, V282, DOI 10.1098/rspb.2014.2201; Dohm MR, 2002, FUNCT ECOL, V16, P273; Eckmann R., 1995, Ecology of Freshwater Fish, V4, P62, DOI 10.1111/j.1600-0633.1995.tb00118.x; Enberg K, 2012, MAR ECOL-EVOL PERSP, V33, P1, DOI 10.1111/j.1439-0485.2011.00460.x; Evangelista C, 2015, ECOL EVOL, V5, P2193, DOI 10.1002/ece3.1471; Fleig R, 2001, FISCHER TEICHWIRT, V52, P129; Hadfield JD, 2010, J STAT SOFTW, V33, P1, DOI 10.18637/jss.v033.i02; Harkonen L, 2016, ACTA ETHOL, V19, P21, DOI 10.1007/s10211-015-0219-7; Harkonen L, 2014, CAN J FISH AQUAT SCI, V71, P1900, DOI 10.1139/cjfas-2014-0221; Harrison PM, 2015, BEHAV ECOL, V26, P483, DOI 10.1093/beheco/aru216; Hart Paul J.B., 1997, P104; Heino M, 2015, ANNU REV ECOL EVOL S, V46, P461, DOI 10.1146/annurev-ecolsys-112414-054339; Hougaard P, 1999, BIOMETRICS, V55, P13, DOI 10.1111/j.0006-341X.1999.00013.x; Huntingford F, 2005, BEHAVIOUR, V142, P1207, DOI 10.1163/156853905774539382; Huntingford FA, 2013, J FISH BIOL, V83, P1453, DOI [10.1111/jf, 10.1111/jfb.12246]; Huntingford FA, 2010, J FISH BIOL, V76, P1576, DOI 10.1111/j.1095-8649.2010.02582.x; HUNTINGFORD FA, 1976, ANIM BEHAV, V24, P245, DOI 10.1016/S0003-3472(76)80034-6; Jorgensen C, 2007, SCIENCE, V318, P1247, DOI 10.1126/science.1148089; Kasumyan A.O, 2000, J ICHTHYOL, V40, P661; Kekalainen J, 2014, INDIVIDUALLY ASSESSE, P1603; Killen SS, 2016, CONSERV PHYSIOL, V4, DOI 10.1093/conphys/cow007; Klefoth T, 2008, HYDROBIOLOGIA, V601, P99, DOI 10.1007/s10750-007-9257-0; Klefoth T, 2013, FISHERIES MANAG ECOL, V20, P174, DOI 10.1111/j.1365-2400.2012.00865.x; Klefoth T, 2013, FISH RES, V146, P18, DOI 10.1016/j.fishres.2013.03.010; Klefoth T, 2012, BEHAV ECOL SOCIOBIOL, V66, P547, DOI 10.1007/s00265-011-1303-2; Kobler A, 2009, OECOLOGIA, V161, P837, DOI 10.1007/s00442-009-1415-9; Kramer DL, 1999, ENVIRON BIOL FISH, V55, P65, DOI 10.1023/A:1007481206399; Krause J, 2013, TRENDS ECOL EVOL, V28, P541, DOI 10.1016/j.tree.2013.06.002; Kuparinen A, 2007, TRENDS ECOL EVOL, V22, P652, DOI 10.1016/j.tree.2007.08.011; Kuparinen A, 2010, FISH RES, V105, P111, DOI 10.1016/j.fishres.2010.03.011; Laskowski KL, 2016, J FISH BIOL, V88, P1544, DOI 10.1111/jfb.12933; Laugen AT, 2014, FISH FISH, V15, P65, DOI 10.1111/faf.12007; Lewin WC, 2006, REV FISH SCI, V14, P305, DOI 10.1080/10641260600886455; Lokkeborg S, 2014, REV FISH BIOL FISHER, V24, P985, DOI 10.1007/s11160-014-9360-z; Matsumura S, 2011, EVOL ECOL, V25, P711, DOI 10.1007/s10682-010-9444-8; Mesquita FO, 2015, BEHAV PROCESS, V115, P25, DOI 10.1016/j.beproc.2015.02.017; MILLER RB, 1957, J FISH RES BOARD CAN, V14, P797, DOI 10.1139/f57-034; Mittelbach GG, 2014, CAN J FISH AQUAT SCI, V71, P927, DOI 10.1139/cjfas-2013-0558; Muller W, 1961, DTSCH FISCH, V8, P256; Nakagawa S, 2010, BIOL REV, V85, P935, DOI 10.1111/j.1469-185X.2010.00141.x; Nakayama S, 2017, J ANIM ECOL, V86, P192, DOI 10.1111/1365-2656.12603; Nakayama S, 2016, BEHAV ECOL, V27, P1676, DOI 10.1093/beheco/arw090; Nannini MA, 2011, J FISH BIOL, V79, P1017, DOI 10.1111/j.1095-8649.2011.03079.x; Niesar M, 2004, FISHERIES MANAG ECOL, V11, P225, DOI 10.1111/j.1365-2400.2004.00400.x; Olsen EM, 2012, ECOL EVOL, V2, P1549, DOI 10.1002/ece3.244; Perrow MR, 1996, J FISH BIOL, V48, P859; Pfeifer M, 1998, AUFZUCHT WELS SCHLEI; Philipp DP, 2009, T AM FISH SOC, V138, P189, DOI 10.1577/T06-243.1; Pieterek T, 2014, DETERMINANTEN ANGLER; Pine WE, 2009, FISHERIES, V34, P165, DOI 10.1577/1548-8446-34.4.165; PITCHER TJ, 1995, SCI MAR, V59, P295; Pollux BJA, 2017, OECOLOGIA, V183, P81, DOI 10.1007/s00442-016-3749-4; RAAT A J P, 1985, Aquaculture and Fisheries Management, V16, P171, DOI 10.1111/j.1365-2109.1985.tb00305.x; Rapp T, 2008, FISH RES, V94, P79, DOI 10.1016/j.fishres.2008.06.019; Reale D, 2007, BIOL REV, V82, P291, DOI 10.1111/j.1469-185X.2007.00010.x; Redpath TD, 2009, EVOL APPL, V2, P312, DOI 10.1111/j.1752-4571.2009.00078.x; RUDSTAM LG, 1984, CAN J FISH AQUAT SCI, V41, P1252, DOI 10.1139/f84-151; Saura M, 2010, FRESHWATER BIOL, V55, P923, DOI 10.1111/j.1365-2427.2009.02346.x; Schreckenbach K, 2001, J APPL ICHTHYOL, V17, P142, DOI 10.1046/j.1439-0426.2001.00295.x; Sih A, 2004, TRENDS ECOL EVOL, V19, P372, DOI 10.1016/j.tree.2004.04.009; Sih A, 2011, EVOL APPL, V4, P367, DOI 10.1111/j.1752-4571.2010.00166.x; Skov C, 2005, J FISH BIOL, V67, P1195, DOI 10.1111/j.1095-8649.2005.00814.x; Sutter DAH, 2012, P NATL ACAD SCI USA, V109, P20960, DOI 10.1073/pnas.1212536109; Taylor MK, 2014, J FISH BIOL, V84, P1240, DOI 10.1111/jfb.12334; Uusi-Heikkila S, 2008, TRENDS ECOL EVOL, V23, P419, DOI 10.1016/j.tree.2008.04.006; Videler J.J., 1991, Reviews in Fish Biology and Fisheries, V1, P23, DOI 10.1007/BF00042660; Ward TD, 2016, CONSERV PHYSIOL, V4, DOI 10.1093/conphys/cow005; Wilson ADM, 2011, CAN J FISH AQUAT SCI, V68, P749, DOI 10.1139/F2011-019; Wilson B, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0124214; WILSON DS, 1993, J COMP PSYCHOL, V107, P250, DOI 10.1037/0735-7036.107.3.250; Wisniewolski W., 2009, ARCH POL FISH, V17, P211; WOLOS A, 1992, Aquaculture and Fisheries Management, V23, P499, DOI 10.1111/j.1365-2109.1992.tb00793.x; Zuur AF, 2007, STAT BIOL HEALTH, P1; 2003, J FISH BIOL, V62, P735, DOI DOI 10.1046/J.0022-1112.2003.00043.X	104	29	31	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 16	2017	12	3							e0173989	10.1371/journal.pone.0173989	http://dx.doi.org/10.1371/journal.pone.0173989			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN9KE	28301558	Green Published, gold			2022-12-27	WOS:000396318300106
J	Muema, JM; Nyanjom, SG; Mutunga, JM; Njeru, SN; Bargul, JL				Muema, Jackson M.; Nyanjom, Steven G.; Mutunga, James M.; Njeru, Sospeter N.; Bargul, Joel L.			Green tea proanthocyanidins cause impairment of hormone-regulated larval development and reproductive fitness via repression of juvenile hormone acid methyltransferase, insulin-like peptide and cytochrome P450 genes in Anopheles gambiae sensu stricto	PLOS ONE			English	Article							VECTORIAL CAPACITY; MOSQUITOS; TRAITS	Successful optimization of plant-derived compounds into control of nuisance insects would benefit from scientifically validated targets. However, the close association between the genotypic responses and physiological toxicity effects mediated by these compounds remains underexplored. In this study, we evaluated the sublethal dose effects of proanthocyanidins (PAs) sourced from green tea (Camellia sinensis) on life history traits of Anopheles gambiae (sensu stricto) mosquitoes with an aim to unravel the probable molecular targets. Based on the induced phenotypic effects, genes selected for study targeted juvenile hormone (JH) biosynthesis, signal transduction, oxidative stress response and xenobiotic detoxification in addition to vitellogenesis in females. Our findings suggest that chronic exposure of larval stages (L3/L4) to sublethal dose of 5 ppm dramatically extended larval developmental period for up to 12 days, slowed down pupation rates, induced abnormal larval-pupal intermediates and caused 100% inhibition of adult emergence. Further, females exhibited significant interference of fecundity and egg hatchability relative to controls (p < 0.001). Using reverse transcription quantitative polymerase chain reaction (RT-qPCR), our findings show that PA-treated larvae exhibited significant repression of AgamJHAMT (p < 0.001), AgamILP1 (p < 0.001) and AgamCYP6M2 (p < 0.001) with upregulation of Hsp70 (p < 0.001). Females exposed as larvae demonstrated down-regulation of AgamVg (p = 0.03), AgamILP1 (p = 0.009), AgamCYP6M2 (p = 0.05) and AgamJHAMT (p = 0.02). Our findings support that C. sinensis proanthocyanidins affect important vectorial capacity components such as mosquito survival rates and reproductive fitness thus could be potentially used for controlling populations of malaria vectors.	[Muema, Jackson M.; Nyanjom, Steven G.; Bargul, Joel L.] Jomo Kenyatta Univ Agr & Technol, Dept Biochem, Nairobi, Kenya; [Mutunga, James M.] Int Ctr Insect Physiol & Ecol, Malaria Res Programme, Nairobi, Kenya; [Njeru, Sospeter N.] Kisii Univ, Fac Hlth Sci, Dept Med, Kisii, Kenya; [Bargul, Joel L.] Int Ctr Insect Physiol & Ecol, Mol Biol & Bioinformat Unit, Nairobi, Kenya; [Njeru, Sospeter N.] Fritz Lipmann Inst, Leibniz Inst Age Res, Jena, Germany	Jomo Kenyatta University of Agriculture & Technology; International Centre of Insect Physiology & Ecology (ICIPE); International Centre of Insect Physiology & Ecology (ICIPE); Leibniz Institut fur Alternsforschung - Fritz-Lipmann-Institut (FLI)	Muema, JM (corresponding author), Jomo Kenyatta Univ Agr & Technol, Dept Biochem, Nairobi, Kenya.	Jackson_mbithi@yahoo.com	Muema, Jackson Mbithi/AAS-3089-2020; Bargul, Joel L./ABB-5310-2021	Muema, Jackson Mbithi/0000-0002-5713-5067; Nyanjom, Steven/0000-0002-6290-991X; Mutunga, James/0000-0002-7321-3176; Bargul, Joel/0000-0001-8573-6807; Njeru, Sospeter/0000-0003-1154-0777	Biochemistry Department of Jomo Kenyatta University of Agriculture and Technology (JKUAT)	Biochemistry Department of Jomo Kenyatta University of Agriculture and Technology (JKUAT)	This work was partially supported by Biochemistry Department of Jomo Kenyatta University of Agriculture and Technology (JKUAT).	Afrane YA, 2008, EMERG INFECT DIS, V14, P1533, DOI 10.3201/eid1410.070781; Aly HAA, 2015, WHO TECH REP SER, V994, P1; Araujo MD, 2012, MALARIA J, V11, DOI 10.1186/1475-2875-11-261; Becker N, 2010, MOSQUITOES AND THEIR CONTROL, SECOND EDITION, P3, DOI 10.1007/978-3-540-92874-4_1; Killeen GF, 2002, MALARIA J, V1, P1; *MALERA CONS GROUP, 2011, PLOS MED, V0008; Moller-Jacobs LL, 2014, PARASITE VECTOR, V7, DOI 10.1186/s13071-014-0593-4; Neafsey DE, 2015, SCIENCE, V347, DOI 10.1126/science.1258522; Patz JA, 2008, INFECT DIS, V9, P103; Poopathi S, 2006, BIOTECHNOLOGY MOL BI, V1, P51; Ranson H, 2016, TRENDS PARASITOL, V32, P187, DOI 10.1016/j.pt.2015.11.010; Shapiro LLM, 2016, P ROY SOC B-BIOL SCI, V283, DOI 10.1098/rspb.2016.0298; Vantaux A, 2016, SCI REP-UK, V6, DOI 10.1038/srep36778; Walker K, 2007, MED VET ENTOMOL, V21, P2, DOI 10.1111/j.1365-2915.2007.00674.x; Weetman D, 2015, TRENDS PARASITOL, V31, P39, DOI 10.1016/j.pt.2015.01.001	15	2	3	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 16	2017	12	3							e0173564	10.1371/journal.pone.0173564	http://dx.doi.org/10.1371/journal.pone.0173564			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN9KE	28301607	Green Submitted, Green Published, gold			2022-12-27	WOS:000396318300051
J	Panigrahi, SK; Manterola, M; Wolgemuth, DJ				Panigrahi, Sunil K.; Manterola, Marcia; Wolgemuth, Debra J.			Meiotic failure in cyclin A1-deficient mouse spermatocytes triggers apoptosis through intrinsic and extrinsic signaling pathways and 14-3-3 proteins	PLOS ONE			English	Article							TRANSCRIPTION FACTOR FOXO4; PROGRAMMED CELL-DEATH; GERM-LINE; DNA-BINDING; KINASE 2; PHOSPHORYLATION; SURVIVAL; MEIOSIS; SUPPRESSION; ACTIVATION	Cyclin A1 (Ccna1), a member of the mammalian A type cyclins, is most abundantly expressed in spermatocytes and is essential for spermatogenesis in the mouse. Ccna1-deficient spermatocytes arrest at late meiotic prophase and undergo apoptosis. To further delineate the mechanisms and key factors involved in this process, we have examined changes in expression of genes involved in both intrinsic and extrinsic signaling pathways that trigger apoptosis in the mutant spermatocytes. Our results show that both pathways are involved, and that the factors involved in the intrinsic pathway were expressed earlier than those involved in the extrinsic pathway. We have also begun to identify in vivo Ccna1-interacting proteins, using an unbiased biochemical approach, and identified 14-3-3, a key regulator of apoptosis, as a Ccna1-interacting protein. Expression levels of 14-3-3 proteins remain unchanged between wild type and mutant testes but there were differences in the subcellular distribution. In wild type control, 14-3-3 is detected in both cytosolic and nuclear fractions whereas it is restricted to the cytoplasm in mutant testes. This differential distribution of 14-3-3 may contribute to the induction of apoptosis in Ccna1-deficient spermatocytes. These results provide insight into the apoptotic mechanisms and pathways that are triggered when progression through the meiotic cell cycle is defective in male gametogenesis.	[Panigrahi, Sunil K.; Manterola, Marcia; Wolgemuth, Debra J.] Columbia Univ, Med Ctr, Dept Genet, New York, NY 10027 USA; [Panigrahi, Sunil K.; Manterola, Marcia; Wolgemuth, Debra J.] Columbia Univ, Med Ctr, Dept Dev, New York, NY 10027 USA; [Manterola, Marcia] Univ Chile, Program Human Genet, ICBM, Fac Med, Santiago, Chile; [Wolgemuth, Debra J.] Columbia Univ, Med Ctr, Obstet & Gynecol, New York, NY 10027 USA; [Wolgemuth, Debra J.] Columbia Univ, Med Ctr, Inst Human Nutr, New York, NY 10027 USA; [Wolgemuth, Debra J.] Columbia Univ, Med Ctr, Herbert Irving Comprehens Canc Ctr, New York, NY 10027 USA	Columbia University; Columbia University; Universidad de Chile; Columbia University; Columbia University; Columbia University	Wolgemuth, DJ (corresponding author), Columbia Univ, Med Ctr, Dept Genet, New York, NY 10027 USA.; Wolgemuth, DJ (corresponding author), Columbia Univ, Med Ctr, Dept Dev, New York, NY 10027 USA.; Wolgemuth, DJ (corresponding author), Columbia Univ, Med Ctr, Obstet & Gynecol, New York, NY 10027 USA.; Wolgemuth, DJ (corresponding author), Columbia Univ, Med Ctr, Inst Human Nutr, New York, NY 10027 USA.; Wolgemuth, DJ (corresponding author), Columbia Univ, Med Ctr, Herbert Irving Comprehens Canc Ctr, New York, NY 10027 USA.	djw3@cumc.columbia.edu	Manterola, Marcia/H-9420-2016	Manterola, Marcia/0000-0002-5802-1301	National Institute of Health (US) [R01 HD034915]; Lalor Foundation; NIH [R01 HD034915]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD034915] Funding Source: NIH RePORTER	National Institute of Health (US)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Lalor Foundation; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	This work was supported in part by grants from the National Institute of Health (US), R01 HD034915 (DJW) and the Lalor Foundation (MM). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors would like to thank Dr. Mary Ann Handel for kindly providing the anti-Hlt antibody. This work was supported in part by grants from the NIH, R01 HD034915 (DJW) and the Lalor Foundation (MM).	Aitken RJ, 2011, REPRODUCTION, V141, P139, DOI 10.1530/REP-10-0232; Berkovits BD, 2012, NUCLEIC ACIDS RES, V40, P7162, DOI 10.1093/nar/gks342; Brunet A, 2002, J CELL BIOL, V156, P817, DOI 10.1083/jcb.200112059; Chu JH, 2014, BIOMED PHARMACOTHER, V68, P1089, DOI 10.1016/j.biopha.2014.10.001; Correia S, 2015, EXPERT REV MOL MED, V17, DOI 10.1017/erm.2014.25; Datta SR, 2000, MOL CELL, V6, P41, DOI 10.1016/S1097-2765(00)00006-X; Datta SR, 1997, CELL, V91, P231, DOI 10.1016/S0092-8674(00)80405-5; De Pol A, 1998, ANTICANCER RES, V18, P3457; Dubois T, 1997, J BIOL CHEM, V272, P28882, DOI 10.1074/jbc.272.46.28882; Fuchs Y, 2011, CELL, V147, P742, DOI 10.1016/j.cell.2011.10.033; Gardino AK, 2011, SEMIN CELL DEV BIOL, V22, P688, DOI 10.1016/j.semcdb.2011.09.008; Giussani P, 2014, INT J MOL SCI, V15, P4356, DOI 10.3390/ijms15034356; Greer EL, 2005, ONCOGENE, V24, P7410, DOI 10.1038/sj.onc.1209086; Liu D, 2000, DEV BIOL, V224, P388, DOI 10.1006/dbio.2000.9776; Liu D, 1998, NAT GENET, V20, P377, DOI 10.1038/3855; Liu PD, 2014, NATURE, V508, P541, DOI 10.1038/nature13079; Morrison DK, 2009, TRENDS CELL BIOL, V19, P16, DOI 10.1016/j.tcb.2008.10.003; Nagaoka SI, 2011, CURR BIOL, V21, P651, DOI 10.1016/j.cub.2011.03.003; Nomura M, 2003, J BIOL CHEM, V278, P2058, DOI 10.1074/jbc.M207880200; Obsil T, 2003, BIOCHEMISTRY-US, V42, P15264, DOI 10.1021/bi0352724; Pacheco S, 2015, PLOS GENET, V11, DOI 10.1371/journal.pgen.1005017; Panigrahi SK, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047862; Perego L, 1997, MOL REPROD DEV, V47, P370, DOI 10.1002/(SICI)1098-2795(199708)47:4&lt;370::AID-MRD3&gt;3.0.CO;2-H; Porter GW, 2006, SEMIN CANCER BIOL, V16, P193, DOI 10.1016/j.semcancer.2006.03.003; Rodriguez I, 1997, EMBO J, V16, P2262, DOI 10.1093/emboj/16.9.2262; Salazar G, 2005, DEV DYNAM, V234, P114, DOI 10.1002/dvdy.20533; Sankala HM, 2007, CANCER RES, V67, P10466, DOI 10.1158/0008-5472.CAN-07-2090; Silhan J, 2009, J BIOL CHEM, V284, P19349, DOI 10.1074/jbc.M109.002725; Subramanian VV, 2014, CSH PERSPECT BIOL, V6, DOI 10.1101/cshperspect.a016675; Suh EK, 2006, NATURE, V444, P624, DOI 10.1038/nature05337; Tiwari M, 2015, APOPTOSIS, V20, P1019, DOI 10.1007/s10495-015-1136-y; Tripathi R, 2009, J REPROD IMMUNOL, V83, P31, DOI 10.1016/j.jri.2009.05.009; WOLGEMUTH DJ, 1985, GAMETE RES, V12, P1, DOI 10.1002/mrd.1120120102; Yamaguchi Y, 2015, CURR TOP DEV BIOL, V114, P159, DOI 10.1016/bs.ctdb.2015.07.016; Yuasa K, 2015, BIOCHEM BIOPH RES CO, V464, P70, DOI 10.1016/j.bbrc.2015.05.105	35	11	13	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 16	2017	12	3							e0173926	10.1371/journal.pone.0173926	http://dx.doi.org/10.1371/journal.pone.0173926			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN9KE	28301569	Green Published, gold, Green Submitted			2022-12-27	WOS:000396318300097
J	Rahnama, S; Deuis, JR; Cardoso, FC; Ramanujam, V; Lewis, RJ; Rash, LD; King, GF; Vetter, I; Mobli, M				Rahnama, Sassan; Deuis, Jennifer R.; Cardoso, Fernanda C.; Ramanujam, Venkatraman; Lewis, Richard J.; Rash, Lachlan D.; King, Glenn F.; Vetter, Irina; Mobli, Mehdi			The structure, dynamics and selectivity profile of a Na(V)1.7 potency-optimised huwentoxin-IV variant	PLOS ONE			English	Article							COMMON MOLECULAR DETERMINANTS; SODIUM-CHANNEL ANTAGONIST; RAT FORMALIN TEST; PROTEIN BACKBONE; TORSION ANGLES; MORPHINE; TOXIN; VENOM; PAIN; INHIBITION	Venom-derived peptides have attracted much attention as potential lead molecules for pharmaceutical development. A well-known example is Huwentoxin-IV (HwTx-IV), a peptide toxin isolated from the venom of the Chinese bird-eating spider Haplopelma schmitdi. HwTx-IV was identified as a potent blocker of a human voltage-gated sodium channel (hNa(V)1.7), which is a genetically validated analgesic target. The peptide was promising as it showed high potency at Na(V)1.7 (IC50 similar to 26 nM) and selectivity over the cardiac Na-V subtype (Na(V)1.5). Mutagenesis studies aimed at optimising the potency of the peptide resulted in the development of a triple-mutant of HwTx-IV (E1G, E4G, Y33W, m(3)-HwTx-IV) with significantly increased potency against hNa(V)1.7 (IC50 = 0.4 +/- 0.1 nM) without increased potency against hNa(V)1.5. The activity of m3-HwTx-IV against other Na-V subtypes was, however, not investigated. Similarly, the structure of the mutant peptide was not characterised, limiting the interpretation of the observed increase in potency. In this study we produced isotope-labelled recombinant m3-HwTx-IV in E. coli, which enabled us to characterise the atomic-resolution structure and dynamics of the peptide by NMR spectroscopy. The results show that the structure of the peptide is not perturbed by the mutations, whilst the relaxation studies reveal that residues in the active site of the peptide undergo conformational exchange. Additionally, the NaV subtype selectivity of the recombinant peptide was characterised, revealing potent inhibition of neuronal Na-V subtypes 1.1, 1.2, 1.3, 1.6 and 1.7. In parallel to the in vitro studies, we investigated Na(V)1.7 target engagement of the peptide in vivo using a rodent pain model, where m3-HwTx-IV dose-dependently suppressed spontaneous pain induced by the Na(V)1.7 activator OD1. Thus, our results provide further insight into the structure and dynamics of this class of peptides that may prove useful in guiding the development of inhibitors with improved selectivity for analgesic NaV subtypes.	[Rahnama, Sassan; Ramanujam, Venkatraman; Mobli, Mehdi] Univ Queensland, Ctr Adv Imaging, St Lucia, Qld, Australia; [Rahnama, Sassan; Deuis, Jennifer R.; Cardoso, Fernanda C.; Lewis, Richard J.; Rash, Lachlan D.; King, Glenn F.; Vetter, Irina] Univ Queensland, Inst Mol BioSci, St Lucia, Qld, Australia; [Rash, Lachlan D.] Univ Queensland, Sch Biomed Sci, St Lucia, Qld, Australia	University of Queensland; University of Queensland; University of Queensland	Mobli, M (corresponding author), Univ Queensland, Ctr Adv Imaging, St Lucia, Qld, Australia.	m.mobli@uq.edu.au	Mobli, Mehdi/O-7244-2014; Deuis, Jennifer/R-2440-2017; Vetter, Irina/A-6035-2010; Cardoso, Fernanda C/J-7147-2013; Rash, Lachlan D/A-3858-2010; Lewis, Richard J./E-8674-2013	Mobli, Mehdi/0000-0003-2420-4262; Deuis, Jennifer/0000-0002-5107-8938; Vetter, Irina/0000-0002-3594-9588; Cardoso, Fernanda C/0000-0002-0068-9974; Rash, Lachlan D/0000-0003-3616-0279; King, Glenn/0000-0002-2308-2200; Lewis, Richard J./0000-0003-3470-923X	Australian National Health & Medical Research Council [APP1034958, APP1080405, APP569927]; Australian Research Council	Australian National Health & Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia); Australian Research Council(Australian Research Council)	The authors would like to acknowledge financial support from the Australian National Health & Medical Research Council (Project Grant APP1034958 [GFK and MM], APP1080405 [MM], Program Grant APP569927 [RJL and GFK], Principal Research Fellowship to GFK and RJL) and the Australian Research Council (Future Fellowship to MM and IV). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahuja S, 2015, SCIENCE, V350, DOI 10.1126/science.aac5464; Bagal SK, 2014, BIOORG MED CHEM LETT, V24, P3690, DOI 10.1016/j.bmcl.2014.06.038; Catterall WA, 2005, PHARMACOL REV, V57, P397, DOI 10.1124/pr.57.4.4; Cox JJ, 2006, NATURE, V444, P894, DOI 10.1038/nature05413; Deuis JR, 2016, TOXINS, V8, DOI 10.3390/toxins8030078; Estacion M, 2008, J NEUROSCI, V28, P11079, DOI 10.1523/JNEUROSCI.3443-08.2008; Guntert Peter, 2004, Methods Mol Biol, V278, P353; Klint JK, 2015, MOL PHARMACOL, V88, P1002, DOI 10.1124/mol.115.100784; Klint JK, 2015, BRIT J PHARMACOL, V172, P2445, DOI 10.1111/bph.13081; Klint JK, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063865; Lau CHY, 2016, SCI REP-UK, V6, DOI 10.1038/srep34333; Liu Y, 2014, PROTEIN PEPTIDE LETT, V21, P153; Maertens C, 2006, MOL PHARMACOL, V70, P405, DOI 10.1124/mol.106.022970; Marley J, 2001, J BIOMOL NMR, V20, P71, DOI 10.1023/A:1011254402785; McCormack K, 2013, P NATL ACAD SCI USA, V110, pE2724, DOI 10.1073/pnas.1220844110; McGivern JG, 2007, EXPERT OPIN THER TAR, V11, P265, DOI 10.1517/14728222.11.3.265; Minassian NA, 2013, J BIOL CHEM, V113; Minassian NA, 2013, J BIOL CHEM, V288, P22707, DOI 10.1074/jbc.M113.461392; Minett MS, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9967; Mobli M, 2007, NAT METHODS, V4, P467, DOI 10.1038/nmeth0607-467; Mobli M, 2015, J MAGN RESON, V256, P60, DOI 10.1016/j.jmr.2015.04.003; Mobli M, 2010, TOXICON, V56, P849, DOI 10.1016/j.toxicon.2010.06.018; Mobli M, 2010, J MAGN RESON, V204, P160, DOI 10.1016/j.jmr.2010.02.012; Munro G, 2009, EUR J PHARMACOL, V605, P95, DOI 10.1016/j.ejphar.2009.01.004; Murray JK, 2016, J MED CHEM, V59, P2704, DOI 10.1021/acs.jmedchem.5b01947; Patel RR, 2016, BRAIN, V139, P2164, DOI 10.1093/brain/aww129; Peng K, 2002, J BIOL CHEM, V277, P47564, DOI 10.1074/jbc.M204063200; Ragsdale DS, 1996, P NATL ACAD SCI USA, V93, P9270, DOI 10.1073/pnas.93.17.9270; Revell JD, 2013, PEPTIDES, V44, P40, DOI 10.1016/j.peptides.2013.03.011; Rode F, 2007, EUR J PHARMACOL, V564, P103, DOI 10.1016/j.ejphar.2007.02.009; Saez NJ, 2011, MOL PHARMACOL, V80, P796, DOI 10.1124/mol.111.072207; Sermadiras I, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0083202; Sevostianova N, 2005, EUR J PHARMACOL, V525, P83, DOI 10.1016/j.ejphar.2005.10.010; Sevostianova N, 2003, EUR J PHARMACOL, V462, P109, DOI 10.1016/S0014-2999(03)01345-1; Shcherbatko A, 2016, J BIOL CHEM, V291, P13974, DOI 10.1074/jbc.M116.725978; Shen Y, 2013, J BIOMOL NMR, V56, P227, DOI 10.1007/s10858-013-9741-y; Shen Y, 2009, J BIOMOL NMR, V44, P213, DOI 10.1007/s10858-009-9333-z; Smith JJ, 2007, J BIOL CHEM, V282, P12687, DOI 10.1074/jbc.M610462200; Vetter I, 2011, AMINO ACIDS, V40, P15, DOI 10.1007/s00726-010-0516-4; Vranken WF, 2005, PROTEINS, V59, P687, DOI 10.1002/prot.20449; Xiao YC, 2008, J BIOL CHEM, V283, P27300, DOI 10.1074/jbc.M708447200; Xiao YC, 2011, J BIOL CHEM, V286, P27301, DOI 10.1074/jbc.M111.246876; Yu FH, 2005, PHARMACOL REV, V57, P387, DOI 10.1124/pr.57.4.13	43	29	29	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 16	2017	12	3							e0173551	10.1371/journal.pone.0173551	http://dx.doi.org/10.1371/journal.pone.0173551			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN9KE	28301520	Green Published, gold, Green Submitted			2022-12-27	WOS:000396318300049
J	Xu, WL; Wang, Q; Shao, AW; Xu, BN; Zhang, JM				Xu, Weilin; Wang, Qun; Shao, Anwen; Xu, Bainan; Zhang, Jianmin			The performance of MR perfusion-weighted imaging for the differentiation of high-grade glioma from primary central nervous system lymphoma: A systematic review and meta-analysis	PLOS ONE			English	Article							PRIMARY CNS LYMPHOMA; POSITRON-EMISSION-TOMOGRAPHY; DIAGNOSTIC-TEST ACCURACY; CEREBRAL BLOOD-VOLUME; BRAIN-TUMORS; GLIOBLASTOMA-MULTIFORME; METASTATIC TUMOR; MASS LESIONS; DIFFUSION; PERMEABILITY	It is always a great challenge to distinguish high-grade glioma (HGG) from primary central nervous system lymphoma (PCNSL). We conducted a meta-analysis to assess the performance of MR perfusion-weighted imaging (PWI) in differentiating HGG from PCNSL. The heterogeneity and threshold effect were evaluated, and the sensitivity (SEN), specificity (SPE) and areas under summary receiver operating characteristic curve (SROC) were calculated. Fourteen studies with a total of 598 participants were included in this meta-analysis. The results indicated that PWI had a high level of accuracy (area under the curve (AUC) = 0.9415) for differentiating HGG from PCNSL by using the best parameter from each study. The dynamic susceptibility-contrast (DSC) technique might be an optimal index for distinguishing HGGs from PCNSLs (AUC = 0.9812). Furthermore, the DSC had the best sensitivity 0.963 (95% CI: 0.924, 0.986), whereas the arterial spin-labeling (ASL) displayed the best specificity 0.896 (95% CI: 0.781, 0.963) among those techniques. However, the variability of the optimal thresholds from the included studies suggests that further evaluation and standardization are needed before the techniques can be extensively clinically used.	[Xu, Weilin; Shao, Anwen; Zhang, Jianmin] Zhejiang Univ, Dept Neurosurg, Affiliated Hosp 2, Sch Med, Hangzhou, Zhejiang, Peoples R China; [Wang, Qun; Xu, Bainan] Chinese Peoples Liberat Army Gen Hosp, Dept Neurosurg, Beijing, Peoples R China; [Zhang, Jianmin] Zhejiang Univ, Brain Res Inst, Hangzhou, Zhejiang, Peoples R China; [Zhang, Jianmin] Zhejiang Univ, Collaborat Innovat Ctr Brain Sci, Hangzhou, Zhejiang, Peoples R China	Zhejiang University; Chinese People's Liberation Army General Hospital; Zhejiang University; Zhejiang University	Zhang, JM (corresponding author), Zhejiang Univ, Dept Neurosurg, Affiliated Hosp 2, Sch Med, Hangzhou, Zhejiang, Peoples R China.; Xu, BN (corresponding author), Chinese Peoples Liberat Army Gen Hosp, Dept Neurosurg, Beijing, Peoples R China.; Zhang, JM (corresponding author), Zhejiang Univ, Brain Res Inst, Hangzhou, Zhejiang, Peoples R China.; Zhang, JM (corresponding author), Zhejiang Univ, Collaborat Innovat Ctr Brain Sci, Hangzhou, Zhejiang, Peoples R China.	xubn301@aliyun.com; zhangjianmin2016@163.com	Shao, Anwen/L-4860-2019; Shao, Anwen/R-9023-2019	Shao, Anwen/0000-0001-5616-0394; Shao, Anwen/0000-0001-9986-6290				Buhring U, 2001, NEUROLOGY, V57, P393, DOI 10.1212/WNL.57.3.393; Bulakbasi N, 2005, AM J NEURORADIOL, V26, P2187; BURGER PC, 1986, SEMIN ONCOL, V13, P16; Cha S, 2002, RADIOLOGY, V223, P11, DOI 10.1148/radiol.2231010594; Chawla S, 2007, AM J NEURORADIOL, V28, P1683, DOI 10.3174/ajnr.A0673; Choi YS, 2016, EUR RADIOL; Coulon A, 2002, EUR RADIOL, V12, P329, DOI 10.1007/s003300101037; Covarrubias DJ, 2004, ONCOLOGIST, V9, P528, DOI 10.1634/theoncologist.9-5-528; Deeks JJ, 2005, J CLIN EPIDEMIOL, V58, P882, DOI 10.1016/j.jclinepi.2005.01.016; Deville Walter L, 2002, BMC Med Res Methodol, V2, P9, DOI 10.1186/1471-2288-2-9; Furtner J, 2014, EUR J RADIOL, V83, P806, DOI 10.1016/j.ejrad.2014.01.017; Glas AS, 2003, J CLIN EPIDEMIOL, V56, P1129, DOI 10.1016/S0895-4356(03)00177-X; Hakyemez B, 2006, J MAGN RESON IMAGING, V24, P817, DOI 10.1002/jmri.20707; Higgins JPT, 2003, BRIT MED J, V327, P557, DOI 10.1136/bmj.327.7414.557; Kickingereder P, 2014, AM J NEURORADIOL, V35, P1503, DOI 10.3174/ajnr.A3915; Kickingereder P, 2014, RADIOLOGY, V272, P843, DOI 10.1148/radiol.14132740; Kim HS, 2007, AM J NEURORADIOL, V28, P1693, DOI 10.3174/ajnr.A0674; Ko CC, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0162565; Law M, 2004, AM J NEURORADIOL, V25, P746; Leeflang MMG, 2008, ANN INTERN MED, V149, P889, DOI 10.7326/0003-4819-149-12-200812160-00008; Liang RF, 2014, INT J CLIN EXP MED, V7, P5573; Liao WH, 2009, ACTA RADIOL, V50, P217, DOI 10.1080/02841850802616752; Lu SS, 2016, EUR J RADIOL, V85, P1722, DOI 10.1016/j.ejrad.2016.07.005; Luo JQ, 2013, COMMUN STAT-SIMUL C, V42, P1213, DOI 10.1080/03610918.2012.661906; Ma JH, 2010, AM J NEURORADIOL, V31, P1699, DOI 10.3174/ajnr.A2161; Nakajima S, 2015, CLIN IMAG, V39, P390, DOI 10.1016/j.clinimag.2014.12.002; Nevo I, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0111783; Nguyen TB, 2012, AM J NEURORADIOL, V33, P1539, DOI 10.3174/ajnr.A3012; Noguchi T, 2008, AM J NEURORADIOL, V29, P688, DOI 10.3174/ajnr.A0903; Sorensen AG, 2009, CANCER RES, V69, P5296, DOI 10.1158/0008-5472.CAN-09-0814; Stupp R, 2005, NEW ENGL J MED, V352, P987, DOI 10.1056/NEJMoa043330; Suh CH, 2014, RADIOLOGY, V272, P504, DOI 10.1148/radiol.14131895; Toh CH, 2013, AM J NEURORADIOL, V34, P1145, DOI 10.3174/ajnr.A3383; Wang Y., 2015, J HEBEI MED U, V9, P1038; Weber MA, 2006, NEUROLOGY, V66, P1899, DOI 10.1212/01.wnl.0000219767.49705.9c; Whiting PF, 2011, ANN INTERN MED, V155, P529, DOI 10.7326/0003-4819-155-8-201110180-00009; Xing Z, 2014, CLIN NEURORADIOL, V24, P329, DOI 10.1007/s00062-013-0255-5; Yamashita K, 2016, J MAGN RESON IMAGING, V44, P1256, DOI 10.1002/jmri.25261; Yamashita K, 2013, NEURORADIOLOGY, V55, P135, DOI 10.1007/s00234-012-1089-6; Yamashita K, 2012, NEURORADIOLOGY, V54, P809, DOI 10.1007/s00234-011-0977-5; Yoo RE, 2013, J MAGN RESON IMAGING, V38, P852, DOI 10.1002/jmri.24026; Zamora Javier, 2006, BMC Med Res Methodol, V6, P31, DOI 10.1186/1471-2288-6-31; Zhang H, 2014, EUR J RADIOL, V83, P2181, DOI 10.1016/j.ejrad.2014.09.018	43	25	27	2	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 16	2017	12	3							e0173430	10.1371/journal.pone.0173430	http://dx.doi.org/10.1371/journal.pone.0173430			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN9KE	28301491	Green Published, gold, Green Submitted			2022-12-27	WOS:000396318300037
J	Yang, G; Deng, QL; Fan, W; Zhang, Z; Xu, PP; Tang, SH; Wang, P; Wang, JE; Yu, MX				Yang, Gui; Deng, Qiaoling; Fan, Wei; Zhang, Zheng; Xu, Peipei; Tang, Shihui; Wang, Ping; Wang, Jun'e; Yu, Mingxia			Cyclooxygenase-2 expression is positively associated with lymph node metastasis in nasopharyngeal carcinoma	PLOS ONE			English	Article							ENDOTHELIAL GROWTH-FACTOR; PROGNOSTIC-SIGNIFICANCE; CETUXIMAB CONCURRENT; CANCER; COX-2; LMP1; PROLIFERATION; ANGIOGENESIS; METAANALYSIS; BIOMARKER	Background Accumulating evidence has demonstrated that cyclooxygenase-2 (COX-2) is involved in head and neck cancers, especially in nasopharyngeal carcinoma (NPC). However, the association between COX-2 expression and lymph node metastasis in NPC remains uncertain. This systematic review and meta-analysis meta-analysis investigated the relationship between COX-2 expression and lymph node metastasis and other signs of disease progression in NPC. Methods Previously published studies assessing COX-2 expression and lymph node metastasis in NPC were identified in four English databases and three Chinese ones (Pubmed, Embase, Cochrane Database of Systematic Reviews, Web of Science, China National Knowledge Infrastructure, Wanfang, Vip Journal Integration Platform) up to November 2016. Quality of all eligible studies was assessed using the Newcastle-Ottawa Quality Assessment Scale (NOS). Pooled odds ratios (OR) and their 95% confidence intervals (95% CI) were calculated with fixed-effects or random-effects model to evaluate the effects of COX-2 expression on lymph node metastasis. Results A total of 27 studies with 1797 NPC patients met the inclusion criteria. The expression of COX-2 was significantly higher in patients with nasopharyngeal carcinoma than those without the carcinoma, with a combined OR of 21.17 (95% CI = 15.02 - 29.85, I-2 = 35.1%, P-heterogeneity = 0.070). A statistically significant association between COX-2 expression and lymph node metastasis in NPC patients, with an OR of 4.44 (95% CI = 3.46 - 5.70, I-2 = 38.3%, P-heterogeneity = 0.024), and with other indicators of disease progression. Subgroup analyses based on COX-2 assay and staging criteria of TNM showed no significant heterogeneity. Conclusions The results suggest that expression of COX-2 is associated with lymph node metastasis and disease progression in NPC, indicating a potential role in evaluation of prognosis and in treatment decisions. COX-2 inhibitors have potential in the treatment of NPC that should be further investigated.	[Yang, Gui; Yu, Mingxia] Wuhan Univ, Zhongnan Hosp, Dept Clin Lab, Wuhan, Hunan, Peoples R China; [Deng, Qiaoling; Fan, Wei; Zhang, Zheng; Xu, Peipei; Tang, Shihui; Wang, Ping; Wang, Jun'e; Yu, Mingxia] Wuhan Univ, Zhongnan Hosp, Ctr Gene Diag, Dept Clin Lab, Wuhan, Hunan, Peoples R China; [Fan, Wei] Wuhan Univ, Zhongnan Hosp, Dept Pathol, Wuhan, Hunan, Peoples R China	Wuhan University; Wuhan University; Wuhan University	Yu, MX (corresponding author), Wuhan Univ, Zhongnan Hosp, Dept Clin Lab, Wuhan, Hunan, Peoples R China.; Yu, MX (corresponding author), Wuhan Univ, Zhongnan Hosp, Ctr Gene Diag, Dept Clin Lab, Wuhan, Hunan, Peoples R China.	dewrosy520@163.com		Yu, Mingxia/0000-0002-0529-0030	National Natural Science Funds [81472033, 30901308]; National Science Foundation of Hubei Province [2013CFB233, 2013CFB235]; Scientific and technological project of Wuhan City [2014060101010045]; Hubei Province health and family planning scientific research project [WJ2015Q021]; Training Program of the science and technology innovation from Zhongnan Hospital of Wuhan University [ZNPY2016054]	National Natural Science Funds(National Natural Science Foundation of China (NSFC)); National Science Foundation of Hubei Province; Scientific and technological project of Wuhan City; Hubei Province health and family planning scientific research project; Training Program of the science and technology innovation from Zhongnan Hospital of Wuhan University	This study was supported by National Natural Science Funds (no. 81472033 and no. 30901308), www.nsfc.gov.cn; The National Science Foundation of Hubei Province (no. 2013CFB233 and no. 2013CFB235), www.hbstd.gov.cn; The Scientific and technological project of Wuhan City (no. 2014060101010045), www.whst.gov.cn; Hubei Province health and family planning scientific research project (WJ2015Q021), www.hbwsjs.gov.cn; and Training Program of the science and technology innovation from Zhongnan Hospital of Wuhan University (ZNPY2016054), www.znhospital.cn/kxyjsy/index.jhtml. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Banko AV, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0153498; Beiping M, 2007, J OTOLARYNGOL OPHTHA, V21; Bernard MP, 2008, CURR PHARM DESIGN, V14, P2051, DOI 10.2174/138161208785294654; Brand TM, 2013, RADIOTHER ONCOL, V108, P370, DOI 10.1016/j.radonc.2013.06.010; Chan SC, 2016, LARYNGOSCOPE; Chen HH, 2014, VASC CELL, V6, DOI 10.1186/2045-824X-6-4; Chen JW, 2015, CELL BIOCHEM BIOPHYS, V73, P731, DOI 10.1007/s12013-015-0638-0; Chen X, 2015, INT J EXP PATHOL, V96, P427, DOI 10.1111/iep.12162; Chen Y, 2013, CANCER-AM CANCER SOC, V119, P2230, DOI 10.1002/cncr.28049; Daihua J, 2004, CHINA NEW MED, V3, P16; Danning X, 2009, J HUBEI MED U, V28; Daqun Z, 2013, J GUZHOU MED COLL, V31, P389; Deng CC, 2016, CANCER PREV RES, V9, P180, DOI 10.1158/1940-6207.CAPR-15-0257; Dewei C, 2008, J CLIN OTORHINOLARYN, V22; Fang Z, 2007, CHINESE J OTORHINOLA, P25; Fendri A, 2008, ORAL ONCOL, V44, P710, DOI 10.1016/j.oraloncology.2007.09.006; Galletti B, 2016, J LARYNGOL OTOL, V130, P453, DOI 10.1017/S0022215116000761; Gregorio H, 2016, MELANOMA RES, V26, P338, DOI 10.1097/CMR.0000000000000262; He HL, 2016, FUTURE ONCOL, V12, P1887, DOI 10.2217/fon-2016-0025; Hong Y, 2008, J CLIN OTORHINOLARYN, P33; Hongyuan Z, 2008, CHINESE J OTORHINOLA, V16; Hsu SJ, 2016, EUR J CLIN INVEST, V46, P572, DOI 10.1111/eci.12636; Jiang H, 2015, ONCOL LETT, V10, P2731, DOI 10.3892/ol.2015.3668; Jianping L, 2012, J HUNAN NORMAL U MED; Jinbo W, 2011, JILIN MED J, P6983; Leng WD, 2016, BMC CANCER, V16, DOI 10.1186/s12885-016-2535-3; Leyuan Z, 2006, SUZHOU U J MED SCI, P95; Li Shujun, 2016, Lin Chung Er Bi Yan Hou Tou Jing Wai Ke Za Zhi, V30, P310; Li XH, 2016, CANC MED; Li ZL, 2015, ONCOIMMUNOLOGY, V4, DOI 10.1080/2162402X.2015.1044712; Lim SJM, 2016, HEAD NECK-J SCI SPEC, V38, pE37, DOI 10.1002/hed.24099; Liu DB, 2012, ACTA PHARMACOL SIN, V33, P682, DOI 10.1038/aps.2012.18; Liu NN, 2016, BMC CANCER, V16, DOI 10.1186/s12885-016-2351-9; Lu SC, 2015, BMJ OPEN, V5, DOI 10.1136/bmjopen-2015-008263; Ma LP, 2016, EUR ARCH OTO-RHINO-L, V273, P819, DOI 10.1007/s00405-014-3465-9; Mitsunari K, 2016, TRANSL RES, V175, P116, DOI 10.1016/j.trsl.2016.04.002; Moher D, 2009, PLOS MED, V6, DOI [10.1136/bmj.b4037, 10.1371/journal.pmed.1000097]; Murata T, 2016, J VIROL, V90, P3873, DOI 10.1128/JVI.03227-15; Ooft ML, 2015, BIOMARK MED, V9, P997, DOI 10.2217/bmm.15.68; Pan Y, 2016, ONCOGENE; Qiancheng J, 2010, EXPRESSION CLIN SIGN; Shanzhi G, 2006, MAGNETIC RESONANCE I; Shao Y, 2016, ONCOTARGET, V7, P15173, DOI 10.18632/oncotarget.7908; Shaoyan X, 2012, GUANGDONG MED J, P1422; Shi DB, 2015, ONCOTARGET, V6, P5005, DOI 10.18632/oncotarget.3215; Shimizu K, 2015, WORLD J SURG ONCOL, V13, DOI 10.1186/s12957-014-0426-0; Su JH, 2016, J CLIN NEUROSCI, V31, P4, DOI 10.1016/j.jocn.2015.11.032; Tang LQ, 2016, JNCI-J NATL CANCER I, V108, DOI 10.1093/jnci/djv291; Tietz O, 2016, EJNMMI RES, V6, DOI 10.1186/s13550-016-0192-9; Tingyou Z, 2009, CLIN SIGNIFICANCE CO; Wakisaka N, 2012, ORAL ONCOL, V48, P703, DOI 10.1016/j.oraloncology.2012.02.003; Wan GX, 2015, INT J CLIN EXP MED, V8, P3935; Wang J, 2016, ONCOTARGET, V7, P27458, DOI 10.18632/oncotarget.8480; Wang XF, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073213; Weiqi B, 2012, ZHEJIANG PRACTICAL M; Weiren L, 2007, GUANGDONG MED J, V28, P1213; Wu X, 2016, MEDICINE, V95, DOI 10.1097/MD.0000000000004926; Xie M, 2014, HORM METAB RES, V46, P556, DOI 10.1055/s-0034-1367077; Xinhua X, 2006, CHINESE GERMAN J CLI; Xu T, 2015, ORAL ONCOL, V51, P875, DOI 10.1016/j.oraloncology.2015.06.008; Xu XF, 2016, CANCER BIOMARK, V16, P467, DOI 10.3233/CBM-160586; Yafeng F, 2007, EXPRESSION COX2 CD44; Yang B, 2016, ONCOTARGET, V7, P47265, DOI 10.18632/oncotarget.10059; Yangyun L, 2010, CHINESE CLIN ONCOLOG, V15, P310; Yanling D, 2006, MED J NATL DEFENDING, P124; Yi CH, 2016, CANCER LETT, V381, P1, DOI 10.1016/j.canlet.2016.07.016; Yi Xiang, 2010, Lin Chung Er Bi Yan Hou Tou Jing Wai Ke Za Zhi, V24, P126; Yongqian G, 2007, RES EXPRESSION ELF4E; Yuan C, 2015, J BUON, V20, P1510; Zeng Xiantao, 2015, J Evid Based Med, V8, P2, DOI 10.1111/jebm.12141; Zhang JX, 2013, MED ONCOL, V30, DOI 10.1007/s12032-012-0390-x; Zhang MX, 2015, EUR J CANCER, V51, P2587, DOI 10.1016/j.ejca.2015.08.006; Zhang Runtao, 2013, Lin Chung Er Bi Yan Hou Tou Jing Wai Ke Za Zhi, V27, P178; Zhao Y, 2012, J CLIN PATHOL, V65, P41, DOI 10.1136/jclinpath-2011-200198; Zhenyu X, 2008, EXPRESSION CLIN SIGN; Zhiyong W, 2011, LAB MED CLIN; Zhou HJ, 2016, J NUCL MED, V57, P342, DOI 10.2967/jnumed.115.165407; Zhou YY, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0151939; Zhu DD, 2016, INT J CANCER, V138, P1175, DOI 10.1002/ijc.29850; Zhu Honghai, 2014, Zhonghua Yi Xue Za Zhi, V94, P1409; Zhuang MZ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0109951	81	16	17	2	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 16	2017	12	3							e0173641	10.1371/journal.pone.0173641	http://dx.doi.org/10.1371/journal.pone.0173641			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN9KE	28301518	Green Published, Green Submitted, gold			2022-12-27	WOS:000396318300057
J	Batova, A; Altomare, D; Creek, KE; Naviaux, RK; Wang, L; Li, KF; Green, E; Williams, R; Naviaux, JC; Diccianni, M; Yu, AL				Batova, Ayse; Altomare, Diego; Creek, Kim E.; Naviaux, Robert K.; Wang, Lin; Li, Kefeng; Green, Erica; Williams, Richard; Naviaux, Jane C.; Diccianni, Mitchell; Yu, Alice L.			Englerin A induces an acute inflammatory response and reveals lipid metabolism and ER stress as targetable vulnerabilities in renal cell carcinoma	PLOS ONE			English	Article							ENDOPLASMIC-RETICULUM STRESS; TUMOR-NECROSIS-FACTOR; INSULIN-RESISTANCE; CALCIUM-CHANNELS; OPEN-LABEL; PKC-THETA; CERAMIDE; APOPTOSIS; PROTEIN; CANCER	Renal cell carcinoma (RCC) is among the top ten most common forms of cancer and is the most common malignancy of the kidney. Clear cell renal carcinoma (cc-RCC), the most common type of RCC, is one of the most refractory cancers with an incidence that is on the rise. Screening of plant extracts in search of new anti-cancer agents resulted in the discovery of englerin A, a guaiane sesquiterpene with potent cytotoxicity against renal cancer cells and a small subset of other cancer cells. Though a few cellular targets have been identified for englerin A, it is still not clear what mechanisms account for the cytotoxicity of englerin A in RCC, which occurs at concentrations well below those used to engage the targets previously identified. Unlike any prior study, the current study used a systems biology approach to explore the mechanism(s) of action of englerin A. Metabolomics analyses indicated that englerin A profoundly altered lipid metabolism by 24 h in cc-RCC cell lines and generated significant levels of ceramides that were highly toxic to these cells. Microarray analyses determined that englerin A induced ER stress signaling and an acute inflammatory response, which was confirmed by quantitative PCR and Western Blot analyses. Additionally, fluorescence confocal microscopy revealed that englerin A at 25 nM disrupted the morphology of the ER confirming the deleterious effect of englerin A on the ER. Collectively, our findings suggest that cc-RCC is highly sensitive to disruptions in lipid metabolism and ER stress and that these vulnerabilities can be targeted for the treatment of cc-RCC and possibly other lipid storing cancers. Furthermore, our results suggest that ceramides may be a mediator of some of the actions of englerin A. Lastly, the acute inflammatory response induced by englerin A may mediate anti-tumor immunity.	[Batova, Ayse; Naviaux, Robert K.; Williams, Richard; Diccianni, Mitchell; Yu, Alice L.] Univ Calif San Diego, Dept Pediat, San Diego, CA 92103 USA; [Altomare, Diego; Creek, Kim E.; Green, Erica] Univ South Carolina, Dept Drug Discovery & Biomed Sci, South Carolina Coll Pharm, Columbia, SC USA; [Naviaux, Robert K.; Wang, Lin; Li, Kefeng; Naviaux, Jane C.] Univ Calif San Diego, Dept Pathol, Mitochondrial & Metab Dis Ctr, San Diego, CA 92103 USA; [Naviaux, Robert K.] Univ Calif San Diego, Dept Med, San Diego, CA 92103 USA; [Yu, Alice L.] Chang Gung Mem Hosp, Inst Stem Cell & Translat Canc Res, Taoyuan, Taiwan	University of California System; University of California San Diego; Medical University of South Carolina; University of South Carolina System; University of South Carolina Columbia; University of California System; University of California San Diego; University of California System; University of California San Diego; Chang Gung Memorial Hospital	Batova, A (corresponding author), Univ Calif San Diego, Dept Pediat, San Diego, CA 92103 USA.	abatova@ucsd.edu	, MitchDiccianni/AAF-8486-2019; Li, Kefeng/U-9431-2018	, MitchDiccianni/0000-0002-5017-9585; Li, Kefeng/0000-0002-7233-4347; yu, alice/0000-0003-2444-0505; Green, Erica/0000-0003-2832-5301	Bridgeman Memorial Fund; GoFundME	Bridgeman Memorial Fund; GoFundME	This work is supported by Bridgeman Memorial Fund (AY), GoFundME (AB). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmed N, 2000, PHARMACOL TOXICOL, V86, P114, DOI 10.1034/j.1600-0773.2000.d01-21.x; Akbulut Y, 2015, ANGEW CHEM INT EDIT, V54, P3787, DOI 10.1002/anie.201411511; Amato RJ, 2005, ANN ONCOL, V16, P7, DOI 10.1093/annonc/mdi002; Apostolova N, 2013, J HEPATOL, V59, P780, DOI 10.1016/j.jhep.2013.06.005; Baysal BE, 2000, SCIENCE, V287, P848, DOI 10.1126/science.287.5454.848; Beech DJ, 2009, CELL CALCIUM, V45, P583, DOI 10.1016/j.ceca.2009.02.006; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bergeron S, 2004, MOL CANCER THER, V3, P1659; Boslem E, 2011, BIOCHEM J, V435, P267, DOI 10.1042/BJ20101867; Caropreso V, 2016, J BIOL CHEM, V291, P10058, DOI 10.1074/jbc.M115.701375; Carson C, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0127498; Chang KT, 2015, BBA-BIOMEMBRANES, V1848, P2374, DOI 10.1016/j.bbamem.2015.07.013; Chatterjee S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063726; Chik CL, 1999, ENDOCRINOLOGY, V140, P5682, DOI 10.1210/en.140.12.5682; Chin YW, 2006, AAPS J, V8, pE239, DOI 10.1007/BF02854894; Choueiri TK, 2016, LANCET ONCOL, V17, P917, DOI 10.1016/S1470-2045(16)30107-3; Corrales L, 2015, CELL REP, V11, P1018, DOI 10.1016/j.celrep.2015.04.031; Crino PB, 2006, NEW ENGL J MED, V355, P1345, DOI 10.1056/NEJMra055323; de la Monte SM, 2012, J ALZHEIMERS DIS, V30, pS231, DOI 10.3233/JAD-2012-111727; Fox TE, 2007, J BIOL CHEM, V282, P12450, DOI 10.1074/jbc.M700082200; GARBE LR, 1981, HUM PATHOL, V12, P891, DOI 10.1016/S0046-8177(81)80193-1; Garg AD, 2012, TRENDS MOL MED, V18, P589, DOI 10.1016/j.molmed.2012.06.010; GEBHARD RL, 1987, J LIPID RES, V28, P1177; Gong T, 2012, BIOCHEM BIOPH RES CO, V427, P461, DOI 10.1016/j.bbrc.2012.08.068; Griciuc A, 2014, J NEUROSCI, V34, P2797, DOI 10.1523/JNEUROSCI.2982-13.2014; Gudz TI, 1997, J BIOL CHEM, V272, P24154, DOI 10.1074/jbc.272.39.24154; Guo Deliang, 2013, CNS Oncol, V2, P289; Hakimi AA, 2016, CANCER CELL, V29, P104, DOI 10.1016/j.ccell.2015.12.004; Hannun YA, 2002, J BIOL CHEM, V277, P25847, DOI 10.1074/jbc.R200008200; Harding HP, 1999, NATURE, V397, P271, DOI 10.1038/16729; Hudes G, 2007, NEW ENGL J MED, V356, P2271, DOI 10.1056/NEJMoa066838; Janssens S, 2014, NAT IMMUNOL, V15, P910, DOI 10.1038/ni.2991; KOLESNICK R, 1994, CELL, V77, P325, DOI 10.1016/0092-8674(94)90147-3; Lane BR, 2007, UROLOGY, V69, P3, DOI 10.1016/j.urology.2006.09.028; Levine T.B., 2006, METABOLIC SYNDROME C; Li Y, 2014, MED HYPOTHESES, V83, P56, DOI 10.1016/j.mehy.2014.04.009; Lipina C, 2011, DIABETOLOGIA, V54, P1596, DOI 10.1007/s00125-011-2127-3; Lopez-Bergami P, 2010, NAT REV CANCER, V10, P65, DOI 10.1038/nrc2681; Martson A., 2013, GENOM DISCOV, V1, P3, DOI [10.7243/2052-7993-1-3, DOI 10.7243/2052-7993-1-3]; Morad SAF, 2013, NAT REV CANCER, V13, P51, DOI 10.1038/nrc3398; Motzer RJ, 2015, LANCET ONCOL, V16, P1473, DOI 10.1016/S1470-2045(15)00290-9; Newman DJ, 2012, J NAT PROD, V75, P311, DOI 10.1021/np200906s; Nguyen MM, 2006, J UROLOGY, V176, P2397, DOI 10.1016/j.juro.2006.07.144; Nicolaou KC, 2010, J AM CHEM SOC, V132, P8219, DOI 10.1021/ja102927n; Nixon GF, 2009, BRIT J PHARMACOL, V158, P982, DOI 10.1111/j.1476-5381.2009.00281.x; Park MA, 2008, CANCER BIOL THER, V7, P1648, DOI 10.4161/cbt.7.10.6623; Park SH, 2014, J BIOL CHEM, V289, P27118, DOI 10.1074/jbc.M114.568717; Parra V, 2013, BBA-MOL BASIS DIS, V1832, P1334, DOI 10.1016/j.bbadis.2013.04.009; Qiu B, 2015, CANCER DISCOV, V5, P652, DOI 10.1158/2159-8290.CD-14-1507; Ratnayake R, 2009, ORG LETT, V11, P57, DOI 10.1021/ol802339w; Redelman-Sidi G, 2014, NAT REV UROL, V11, P153, DOI 10.1038/nrurol.2014.15; Rodrigues T, 2016, ANGEW CHEM INT ED EN; Roy PK, 2008, WORLD J GASTROENTERO, V14, P200, DOI 10.3748/wjg.14.200; Salem ML, 2016, J ADV RES, V7, P243, DOI 10.1016/j.jare.2015.06.001; SEGLEN PO, 1980, BIOCHIM BIOPHYS ACTA, V630, P103, DOI 10.1016/0304-4165(80)90141-5; Singer EA, 2011, CURR OPIN ONCOL, V23, P283, DOI 10.1097/CCO.0b013e32834479c0; Sourbier C, 2013, CANCER CELL, V23, P228, DOI 10.1016/j.ccr.2012.12.007; Straczkowski Marek, 2008, Rev Diabet Stud, V5, P13, DOI 10.1900/RDS.2008.5.13; Sulzmaier FJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048032; Summers SA, 2010, CURR OPIN LIPIDOL, V21, P128, DOI 10.1097/MOL.0b013e3283373b66; Szendroedi J, 2014, P NATL ACAD SCI USA, V111, P9597, DOI 10.1073/pnas.1409229111; Testerink N, 2009, J LIPID RES, V50, P2182, DOI 10.1194/jlr.M800660-JLR200; Tornquist K, 2004, BIOCHEM J, V380, P661, DOI 10.1042/BJ20031637; Vanharanta S, 2004, AM J HUM GENET, V74, P153, DOI 10.1086/381054; von Roemeling CA, 2013, CLIN CANCER RES, V19, P2368, DOI 10.1158/1078-0432.CCR-12-3249; Wang SW, 2004, J BIOL CHEM, V279, P25535, DOI 10.1074/jbc.M400944200; White NMA, 2014, ONCOTARGET, V5, P506, DOI 10.18632/oncotarget.1529; Wikstrom JD, 2013, MOL ENDOCRINOL, V27, P1706, DOI 10.1210/me.2013-1109; Williams RT, 2013, J EXP CLIN CANC RES, V32, DOI 10.1186/1756-9966-32-57; Xia JG, 2015, NUCLEIC ACIDS RES, V43, pW251, DOI 10.1093/nar/gkv380; Xu J, 2012, CHEM-ASIAN J, V7, P1052, DOI 10.1002/asia.201101021; Yao M, 2005, J PATHOL, V205, P377, DOI 10.1002/path.1693; Zhang JY, 2008, CELL MOL LIFE SCI, V65, P1435, DOI 10.1007/s00018-008-8047-9; Zhang KZ, 2008, NATURE, V454, P455, DOI 10.1038/nature07203; Zhao CY, 2010, J BIOL CHEM, V285, P39575, DOI 10.1074/jbc.R110.180109	75	20	21	1	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 15	2017	12	3							e0172632	10.1371/journal.pone.0172632	http://dx.doi.org/10.1371/journal.pone.0172632			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN9HQ	28296891	gold, Green Published, Green Submitted			2022-12-27	WOS:000396311700011
J	Chatio, S; Akweongo, P				Chatio, Samuel; Akweongo, Patricia			Retention and sustainability of community-based health volunteers' activities: A qualitative study in rural Northern Ghana	PLOS ONE			English	Article								Background The shortage of formal health workers has led to the utilization of Community-Based Health Volunteers (CBHV) to provide health care services to people especially in rural and neglected communities. Community-based health volunteers have been effective partners in health care delivery at the community level for many years. The challenge is how to retain these volunteers and also sustain their activities. This study explored factors affecting retention and sustainability of community-based health volunteers' activities in a rural setting in Northern Ghana. Methods This was a qualitative study comprising thirty-two in-depth interviews (IDIs) with health volunteers and health workers in-charge of health volunteers' activities. Purposive sampling technique was used to select study participants for the interviews. The interviews were transcribed and coded into themes using Nvivo 10 software. The thematic analysis framework was used to analyze the data. Results Study participants reported that the desire to help community members, prestige and recognition as doctors in community mainly motivated them to work as health volunteers. Lack of incentives and logistical supplies such as raincoats, torch lights, wellington boots and transportation in the form of bicycles to facilitate the movement of health volunteers affected the work. They suggested that lack of these things discouraged them from working as health volunteers. Most of the dropout volunteers said lack of support and respect from community members made them to stop working as health volunteers. They recommended that community support, incentives and logistical supplies such as raincoats, torch light, wellington boots, bicycles, awards to hard working volunteers are mechanisms that can help retain community-based health volunteers and also sustain their activities. Conclusion Providing means of transport and non-monetary incentives would help to retain community-based health volunteers and also sustain their activities at the community level.	[Chatio, Samuel] Navrongo Hlth Res Ctr, Navrongo, Ghana; [Akweongo, Patricia] Univ Ghana, Sch Publ Hlth, Accra, Ghana	Navrongo Health Research Center; University of Ghana	Chatio, S (corresponding author), Navrongo Hlth Res Ctr, Navrongo, Ghana.	schatio@yahoo.co.uk		Chatio, Samuel Tamti/0000-0001-9998-748X; AKWEONGO, PATRICIA/0000-0001-6728-3365				[Anonymous], GLOBAL HLTH; Argaw D., 2007, African Journal of Reproductive Health, V11, P70, DOI 10.2307/25549718; Barbir F, 2010, INT J MIGRATION HLTH, P36; Bhattacharyya K, 2001, COMMUNITY HLTH WORKE; Bigirwa P, 2009, HLTH POLICY DEV, V7, P162; Debpuur C, 2002, STUD FAMILY PLANN, V33, P141, DOI 10.1111/j.1728-4465.2002.00141.x; Guest G., 2006, MANY INTERVIEWS ARE, DOI 10.1177/1525822x05279903; Hossain M. M, 1999, BRACS SHASTHO SHEBIK; Kelly JM, 2001, AM J PUBLIC HEALTH, V91, P1617, DOI 10.2105/AJPH.91.10.1617; Khan S H, 1998, Health Care Superv, V17, P37; Landon B, 2004, J RURAL HEALTH, V20, P221, DOI 10.1111/j.1748-0361.2004.tb00032.x; MOH, 1998, COMM BAS HLTH PLANN; Nyonator FK, 2005, HEALTH POLICY PLANN, V20, P25, DOI 10.1093/heapol/czi003; Nyonator FK, 2003, GHANA COMMUNITY BASE; Oduro AR, 2012, INT J EPIDEMIOL, V41, P968, DOI 10.1093/ije/dys111; Olang'o OC, 2010, STAFF ATTRITION COMM, V97, P232; Pence B, 2001, GLOB C INT UN SCI ST; Perez F, 2009, BIOMED CENTRAL, V1186; QSR International, 2012, NVIVO QUAL DAT AN SO; Rahman SM, 2010, FACTORS AFFECTING RE, P14; Strauss A, 1997, GROUNDED THEORY PRAC; WASH Cluster, 2020, STATE WORLDS CHILDRE; World Health Organization, 2007, COMM HLTH WORK WHAT	23	9	10	1	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 15	2017	12	3							e0174002	10.1371/journal.pone.0174002	http://dx.doi.org/10.1371/journal.pone.0174002			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EN9HQ	28296971	Green Submitted, Green Published, gold			2022-12-27	WOS:000396311700088
J	Griffiths, K; Michelutti, N; Sugar, M; Douglas, MSV; Smol, JP				Griffiths, Katherine; Michelutti, Neal; Sugar, Madeline; Douglas, Marianne S. V.; Smol, John P.			Ice-cover is the principal driver of ecological change in High Arctic lakes and ponds	PLOS ONE			English	Article							PERIPHYTIC DIATOM ASSEMBLAGES; RECENT CLIMATIC-CHANGE; ELLESMERE-ISLAND; CAPE-HERSCHEL; CORNWALLIS ISLAND; BATHURST ISLAND; COMMUNITIES; POPULATIONS; RESPONSES; DYNAMICS	Recent climate change has been especially pronounced in the High Arctic, however, the responses of aquatic biota, such as diatoms, can be modified by site-specific environmental characteristics. To assess if climate-mediated ice cover changes affect the diatom response to climate, we used paleolimnological techniques to examine shifts in diatom assemblages from ten High Arctic lakes and ponds from Ellesmere Island and nearby Pim Island (Nunavut, Canada). The sites were divided a priori into four groups ("warm", "cool", "cold", and "oasis") based on local elevation and microclimatic differences that result in differing lengths of the ice-free season, as well as about three decades of personal observations. We characterized the species changes as a shift from Condition 1 (i.e. a generally low diversity, predominantly epipelic and epilithic diatom assemblage) to Condition 2 (i.e. a typically more diverse and ecologically complex assemblage with an increasing proportion of epiphytic species). This shift from Condition 1 to Condition 2 was a consistent pattern recorded across the sites that experienced a change in ice cover with warming. The "warm" sites are amongst the first to lose their ice covers in summer and recorded the earliest and highest magnitude changes. The "cool" sites also exhibited a shift from Condition 1 to Condition 2, but, as predicted, the timing of the response lagged the "warm" sites. Meanwhile some of the "cold" sites, which until recently still retained an ice raft in summer, only exhibited this shift in the upper-most sediments. The warmer "oasis" ponds likely supported aquatic vegetation throughout their records. Consequently, the diatoms of the "oasis" sites were characterized as high-diversity, Condition 2 assemblages throughout the record. Our results support the hypothesis that the length of the ice-free season is the principal driver of diatom assemblage responses to climate in the High Arctic, largely driven by the establishment of new aquatic habitats, resulting in increased diversity and the emergence of novel growth forms and epiphytic species.	[Griffiths, Katherine; Michelutti, Neal; Sugar, Madeline; Douglas, Marianne S. V.; Smol, John P.] Queens Univ, Dept Biol, PEARL, Kingston, ON, Canada; [Griffiths, Katherine] McGill Univ, Dept Biol, Montreal, PQ, Canada	Queens University - Canada; McGill University	Griffiths, K (corresponding author), Queens Univ, Dept Biol, PEARL, Kingston, ON, Canada.; Griffiths, K (corresponding author), McGill Univ, Dept Biol, Montreal, PQ, Canada.	katie.t.griffiths@gmail.com		Smol, John/0000-0002-2499-6696	National Sciences and Engineering Research Council (NSERC) [2360-2009]; Northern Scientific Training Program (NSTP) [306-059]; Polar Continental Shelf Program (PCSP) [624-11, 651-11]	National Sciences and Engineering Research Council (NSERC)(Natural Sciences and Engineering Research Council of Canada (NSERC)); Northern Scientific Training Program (NSTP); Polar Continental Shelf Program (PCSP)(Natural Resources Canada)	This work was supported by National Sciences and Engineering Research Council (NSERC): 2360-2009, http://www.nserc-crsng.gc.ca/index_eng.asp; Northern Scientific Training Program (NSTP): 306-059, http://www.polarcom.gc.ca/eng/content/northern-scientific-training-program; and Polar Continental Shelf Program (PCSP): 624-11, 651-11, http://www.nrcan.gc.ca/the-north/polar-continental-shelf-program/polar-shelf/10003. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALLEN HL, 1971, ECOL MONOGR, V41, P97, DOI 10.2307/1942387; Anderson NJ, 2000, EUR J PHYCOL, V35, P307, DOI 10.1017/S0967026200002857; Antoniades D, 2005, J PALEOLIMNOL, V33, P349, DOI 10.1007/s10933-004-6611-3; Antoniades D, 2005, J PHYCOL, V41, P30, DOI 10.1111/j.1529-8817.2005.04049.x; Antoniades D., 2008, ICONOGRAPHIA DIATOMO, V17, P1; Antoniades D, 2007, GEOPHYS RES LETT, V34, DOI 10.1029/2007GL030947; Appleby PG, 2002, DEV PALEOENVIRON RES, V1, P171; Bao R, 1999, PALAEOGEOGR PALAEOCL, V153, P309, DOI 10.1016/S0031-0182(99)00066-8; Bennett JR, 2016, CAN J FISH AQUAT SCI, P1; Bennett KD, 1996, NEW PHYTOL, V132, P155, DOI 10.1111/j.1469-8137.1996.tb04521.x; BERGSMA BM, 1984, ARCTIC, V37, P49; Blake Jr W, 1978, 781C GEOL SURV CAN P, V78, P119; BLAKE W, 1992, CAN J EARTH SCI, V29, P1958, DOI 10.1139/e92-153; Cremer H, 2004, CAN J BOT, V82, P1744, DOI [10.1139/b04-127, 10.1139/B04-127]; DOUBLEDAY NC, 1995, SCI TOTAL ENVIRON, V160-61, P661, DOI 10.1016/0048-9697(95)04400-U; Douglas M. S. V., 2010, The diatoms: applications for the environmental and earth sciences, P249; DOUGLAS MSV, 1994, SCIENCE, V266, P416, DOI 10.1126/science.266.5184.416; DOUGLAS MSV, 1995, J PHYCOL, V31, P60, DOI 10.1111/j.0022-3646.1995.00060.x; DOUGLAS MSV, 1993, NOVA HEDWIGIA, V57, P511; DOUGLAS MSV, 1994, ARCH HYDROBIOL, V131, P401; Elster Josef, 1999, Polar Record, V35, P231; Environment Canada, 2016, EUR A NUN 1981 2010; Frisch T, 1984, GEOLOGY PRINCE WALES; Geogratis, GEOGR; Glew J.R., 1989, J PALEOLIMNOL, V2, P241, DOI [DOI 10.1007/BF00195474, 10.1007/BF00195474]; Glew J.R., 1988, J PALEOLIMNOL, V1, P235, DOI DOI 10.1007/BF00177769; Glew JR, 2016, J PALEOLIMNOL, V56, P67, DOI 10.1007/s10933-015-9873-z; GRIMM EC, 1987, COMPUT GEOSCI, V13, P13, DOI 10.1016/0098-3004(87)90022-7; HARRISON J.C., 2015, TECTONIC ASSEMBLAGE; Harrison JC, 2006, BEDROCK GEOLOGY NARE; HENRY G, 1986, ARCTIC, V39, P78; HILL MO, 1973, ECOLOGY, V54, P427, DOI 10.2307/1934352; Jia GSJ, 2009, J ENVIRON MONITOR, V11, P2231, DOI 10.1039/b911677j; Ju JC, 2016, REMOTE SENS ENVIRON, V176, P1, DOI 10.1016/j.rse.2016.01.001; Juggins S., 2007, C2 VERSION 15 USER G; Keatley BE, 2008, ARCT ANTARCT ALP RES, V40, P364, DOI 10.1657/1523-0430(06-068)[KEATLEY]2.0.CO;2; Keatley B, 2009, HYDROBIOLOGIA, V621, P191, DOI 10.1007/s10750-008-9670-z; Kingston John C., 2003, P595, DOI 10.1016/B978-012741550-5/50017-9; Kociolek J. P., 2003, P637, DOI 10.1016/B978-012741550-5/50018-0; Krammer K, 1991, BACILLARIOPHYCEAE 4; Krammer K., 1986, SUSSWASSERFLORA MITT, V2/1, P1; Krammer K., 1991, SUSSWASSERFLORA MITT, V23, P1; Krammer K., 1988, SUSSWASSER FLORA MIT; La Farge C, 2013, P NATL ACAD SCI USA, V110, P9839, DOI 10.1073/pnas.1304199110; Larsen JN, 2014, CLIMATE CHANGE 2014: IMPACTS, ADAPTATION, AND VULNERABILITY, PT B: REGIONAL ASPECTS, P1567; Levesque E, 1996, ARCTIC ALPINE RES, V28, P156, DOI 10.2307/1551755; Lim DSS, 2001, HYDROBIOLOGIA, V450, P215, DOI 10.1023/A:1017553112643; Lim DSS, 2001, J PHYCOL, V37, P379, DOI 10.1046/j.1529-8817.2001.037003379.x; Lotter AF, 2000, AQUAT SCI, V62, P125, DOI 10.1007/s000270050002; MacDonald LA, 2012, HYDROBIOLOGIA, V683, P231, DOI 10.1007/s10750-011-0960-5; Michel TJ, 2006, HYDROBIOLOGIA, V568, P235, DOI 10.1007/s10750-006-0109-0; Michelutti N, 2005, GEOPHYS RES LETT, V32, DOI 10.1029/2005GL023693; Michelutti N, 2002, INT VER THEOR ANGEW, V28, P1533; Michelutti N, 2003, GLOBAL PLANET CHANGE, V38, P257, DOI 10.1016/S0921-8181(02)00260-6; Michelutti N, 2003, J PHYCOL, V39, P465, DOI 10.1046/j.1529-8817.2003.02153.x; Michelutti N, 2007, AQUAT SCI, V69, P523, DOI 10.1007/s00027-007-0928-8; Michelutti N, 2006, QUATERNARY RES, V65, P421, DOI 10.1016/j.yqres.2006.02.001; Michelutti N, 2016, J PALEOLIMNOL, V56, P253, DOI 10.1007/s10933-016-9921-3; Michelutti N, 2013, J PHYCOL, V49, P41, DOI 10.1111/jpy.12024; Michelutti N, 2010, J PALEOLIMNOL, V43, P205, DOI 10.1007/s10933-009-9325-8; MONCREIFF CA, 1992, MAR ECOL PROG SER, V87, P161, DOI 10.3354/meps087161; Oksanen J., 2017, COMMUNITY ECOLOGY PA; Oldfield, 1978, CATENA, V5, P1, DOI DOI 10.1016/S0341-8162(78)80002-2; Perren BB, 2003, ARCT ANTARCT ALP RES, V35, P271, DOI 10.1657/1523-0430(2003)035[0271:RLRTRH]2.0.CO;2; Pienitz R., 2004, LONG TERM ENV CHANGE, P117, DOI DOI 10.1007/978-1-4020-2126-8_5; Pinseel E, 2016, POLAR BIOL, P1; Quinlan R, 2005, GLOBAL CHANGE BIOL, V11, P1381, DOI 10.1111/j.1365-2486.2005.00981.x; R Core Team, 2021, R LANGUAGE ENV STAT; Reimer PJ, 2013, RADIOCARBON, V55, P1869, DOI 10.2458/azu_js_rc.55.16947; Riis T, 2014, FRESHWATER BIOL, V59, P1622, DOI 10.1111/fwb.12368; Rouillard A, 2012, PALAEOGEOGR PALAEOCL, V321, P1, DOI 10.1016/j.palaeo.2012.01.011; Ruhland KM, 2015, J PALEOLIMNOL, V54, P1, DOI 10.1007/s10933-015-9837-3; Ruhland K, 2008, GLOBAL CHANGE BIOL, V14, P2740, DOI 10.1111/j.1365-2486.2008.01670.x; Ryves DB, 2002, FRESHWATER BIOL, V47, P995, DOI 10.1046/j.1365-2427.2002.00832.x; Sand-Jensen K, 1999, CAN J FISH AQUAT SCI, V56, P388, DOI 10.1139/cjfas-56-3-388; Schelske C.L., 1994, J PALEOLIMNOL, V10, P115, DOI [10.1007/BF00682508, DOI 10.1007/BF00682508]; SCHLEDERMANN P, 1978, ARCTIC, V31, P459; Schmidt Roland, 2004, Journal of Limnology, V63, P171; Smol J.P., 2008, POLLUTION LAKES RIVE, V2nd ed.; Smol J.P., 1988, VERH INT VEREIN LIMN, V23, P837, DOI [DOI 10.1080/03680770.1987.11899722, 10.1080/03680770.1987.11899722]; Smol JP, 2007, FRONT ECOL ENVIRON, V5, P466, DOI 10.1890/060162; Smol JP, 2007, P NATL ACAD SCI USA, V104, P12395, DOI 10.1073/pnas.0702777104; SMOL JP, 1983, CAN J BOT, V61, P2195, DOI 10.1139/b83-238; Smol JP, 2005, P NATL ACAD SCI USA, V102, P4397, DOI 10.1073/pnas.0500245102; Smol JP, 2010, DIATOMS APPL ENV EAR, P3, DOI DOI 10.1017/CB09780511763175.002; Thomas EK, 2011, QUATERNARY RES, V75, P491, DOI 10.1016/j.yqres.2011.03.003; Veillette J, 2010, ANN GLACIOL, V51, P56, DOI 10.3189/172756411795931921; Wilson SE, 1996, CAN J FISH AQUAT SCI, V53, P1580, DOI 10.1139/f96-094; Wolfe AP, 2004, LONG TERM ENV CHANGE, P19, DOI DOI 10.1007/978-1-4020-2126-8_2; Zgrundo A, 2016, POLAR BIOL, P1	90	46	47	1	37	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 15	2017	12	3							e0172989	10.1371/journal.pone.0172989	http://dx.doi.org/10.1371/journal.pone.0172989			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN9HQ	28296897	gold, Green Published, Green Submitted			2022-12-27	WOS:000396311700020
J	Ji, RJ; Zhou, LM; Liu, JL; Wang, Y; Yang, L; Zheng, QS; Zhang, C; Zhang, B; Ge, HM; Yang, YH; Zhao, FG; Luan, S; Lan, WZ				Ji, Ruijie; Zhou, Liming; Liu, Jinglong; Wang, Yuan; Yang, Lei; Zheng, Qinsong; Zhang, Chi; Zhang, Bin; Ge, Haiman; Yang, Yonghua; Zhao, Fugeng; Luan, Sheng; Lan, Wenzhi			Calcium-dependent protein kinase CPK31 interacts with arsenic transporter AtNIP1; 1 and regulates arsenite uptake in Arabidopsis thaliana	PLOS ONE			English	Article							ANION CHANNEL SLAH3; POLLEN-TUBE GROWTH; PLANTS; PATHWAY; ACCUMULATION; PHOSPHORYLATION; TRANSLOCATION; AQUAPORINS; METABOLISM; EXPRESSION	Although arsenite [As(III)] is non-essential and toxic for plants, it is effectively absorbed through various transporters into the roots. Here we identified a calcium-dependent protein kinase (CPK31) response for As(III) tolerance in Arabidopsis. We identified CPK31 as an interacting protein of a nodulin 26-like intrinsic protein (NIP1; 1), an aquaporin involved in As (III) uptake. Similarly to the nip1; 1 mutants, the loss-of-function mutants of CPK31 improved the tolerance against As(III) but not As(V), and accumulated less As(III) in roots than that of the wild-type plants. The promoter-beta-glucuronidase and quantitative Real-Time PCR analysis revealed that CPK31 displayed overlapping expression profiles with NIP1; 1 in the roots, suggesting that they might function together in roots. Indeed, the cpk31 nip1; 1 double mutants exhibited stronger As(III) tolerance than cpk31 mutants, but similar to nip1; 1 mutants, supporting the idea that CPK31 might serve as an upstream regulator of NIP1; 1. Furthermore, transient CPK31 overexpression induced by dexamethasone caused the decrease in As(III) tolerance of transgenic Arabidopsis lines. These findings reveal that CPK31 is a key factor in As(III) response in plants.	[Ji, Ruijie; Zheng, Qinsong] Nanjing Agr Univ, Coll Resources & Environm Sci, Key Lab Marine Biol, Nanjing, Jiangsu, Peoples R China; [Zhou, Liming] Fujian Agr & Forestry Univ, Coll Life Sci, Fuzhou, Peoples R China; [Liu, Jinglong; Wang, Yuan; Yang, Lei; Zhang, Chi; Zhang, Bin; Ge, Haiman; Yang, Yonghua; Zhao, Fugeng; Lan, Wenzhi] Nanjing Univ, Nanjing Forestry Univ, Joint Inst Plant Mol Biol, State Key Lab Pharmaceut Biotechnol,Coll Life Sci, Nanjing, Jiangsu, Peoples R China; [Luan, Sheng] Univ Calif Berkeley, Dept Plant & Microbial Biol, Berkeley, CA 94720 USA	Nanjing Agricultural University; Fujian Agriculture & Forestry University; Nanjing Forestry University; Nanjing University; University of California System; University of California Berkeley	Zheng, QS (corresponding author), Nanjing Agr Univ, Coll Resources & Environm Sci, Key Lab Marine Biol, Nanjing, Jiangsu, Peoples R China.; Lan, WZ (corresponding author), Nanjing Univ, Nanjing Forestry Univ, Joint Inst Plant Mol Biol, State Key Lab Pharmaceut Biotechnol,Coll Life Sci, Nanjing, Jiangsu, Peoples R China.	qszheng@njau.edu.cn; lanw@nju.edu.cn		yang, lei/0000-0003-2009-7316	National Natural Science Foundation of China [31271626]; Ministry of Education of the People's Republic of China, Doctoral Fund of Ministry of Education of China	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Ministry of Education of the People's Republic of China, Doctoral Fund of Ministry of Education of China	This work was supported by the National Natural Science Foundation of China Grant, 31271626 and by the Ministry of Education of the People's Republic of China, Doctoral Fund of Ministry of Education of China. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ali W, 2009, CELL MOL LIFE SCI, V66, P2329, DOI 10.1007/s00018-009-0021-7; Bienert GP, 2008, BMC BIOL, V6, DOI 10.1186/1741-7007-6-26; Catarecha P, 2007, PLANT CELL, V19, P1123, DOI 10.1105/tpc.106.041871; Cheng SH, 2002, PLANT PHYSIOL, V129, P469, DOI 10.1104/pp.005645; CULLEN WR, 1989, CHEM REV, V89, P713, DOI 10.1021/cr00094a002; Demir F, 2013, P NATL ACAD SCI USA, V110, P8296, DOI 10.1073/pnas.1211667110; Geiger D, 2010, P NATL ACAD SCI USA, V107, P8023, DOI 10.1073/pnas.0912030107; Ghosh P, 2008, MUTAT RES-REV MUTAT, V659, P293, DOI 10.1016/j.mrrev.2008.06.003; Guenther JF, 2003, PLANT CELL, V15, P981, DOI 10.1105/tpc.009787; Gutermuth T, 2013, PLANT CELL, V25, P4525, DOI 10.1105/tpc.113.118463; Huang TL, 2012, PLANT MOL BIOL, V80, P587, DOI 10.1007/s11103-012-9969-z; Isayenkov SV, 2008, FEBS LETT, V582, P1625, DOI 10.1016/j.febslet.2008.04.022; JEFFERSON RA, 1987, EMBO J, V6, P3901; Kamiya T, 2009, J BIOL CHEM, V284, P2114, DOI 10.1074/jbc.M806881200; Kamiya T, 2009, PLANT CELL PHYSIOL, V50, P1977, DOI 10.1093/pcp/pcp130; Kopittke PM, 2012, PLANT PHYSIOL, V159, P1149, DOI 10.1104/pp.112.197277; Lan WZ, 2011, MOL PLANT, V4, P527, DOI 10.1093/mp/ssr031; Lee SC, 2009, P NATL ACAD SCI USA, V106, P21419, DOI 10.1073/pnas.0910601106; Li LG, 2006, P NATL ACAD SCI USA, V103, P12625, DOI 10.1073/pnas.0605129103; Li NN, 2016, PLANT CELL PHYSIOL, V57, DOI 10.1093/pcp/pcv143; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Ma JF, 2008, P NATL ACAD SCI USA, V105, P9931, DOI 10.1073/pnas.0802361105; Maurel C, 2015, PHYSIOL REV, V95, P1321, DOI 10.1152/physrev.00008.2015; Miao YS, 2007, NAT PROTOC, V2, P2348, DOI 10.1038/nprot.2007.360; Ronzier E, 2014, PLANT PHYSIOL, V166, P314, DOI 10.1104/pp.114.240226; Tripathi RD, 2007, TRENDS BIOTECHNOL, V25, P158, DOI 10.1016/j.tibtech.2007.02.003; Waadt R, 2008, PLANT J, V56, P505, DOI 10.1111/j.1365-313X.2008.03612.x; WEAVER CD, 1992, BIOCHEMISTRY-US, V31, P8954, DOI 10.1021/bi00152a035; Wu ZC, 2011, PLANT PHYSIOL, V157, P498, DOI 10.1104/pp.111.178921; Xu WZ, 2015, MOL PLANT, V8, P722, DOI 10.1016/j.molp.2015.01.005; Zhang XR, 2006, NAT PROTOC, V1, P641, DOI 10.1038/nprot.2006.97; Zhao FJ, 2009, NEW PHYTOL, V181, P777, DOI 10.1111/j.1469-8137.2008.02716.x; Zhao FJ, 2010, ANNU REV PLANT BIOL, V61, P535, DOI 10.1146/annurev-arplant-042809-112152; Zhou LM, 2014, MOL PLANT, V7, P369, DOI 10.1093/mp/sst125	34	38	38	1	42	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 15	2017	12	3							e0173681	10.1371/journal.pone.0173681	http://dx.doi.org/10.1371/journal.pone.0173681			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN9HQ	28296918	Green Submitted, Green Published, gold			2022-12-27	WOS:000396311700051
J	Brown, JM; Mosley, M; Montes-Berrueta, D; Hou, YQ; Yang, F; Scarbrough, C; Witman, GB; Wirschell, M				Brown, Jason M.; Mosley, Matthew; Montes-Berrueta, Daniela; Hou, Yuqing; Yang, Fan; Scarbrough, Chasity; Witman, George B.; Wirschell, Maureen			Characterization of a new oda3 allele, oda3-6, defective in assembly of the outer dynein arm-docking complex in Chlamydomonas reinhardtii	PLOS ONE			English	Article							CILIARY DYSFUNCTION; GENETIC-ANALYSIS; SUBUNIT; PROTEIN; CILIOPATHIES; MECHANISMS; RESISTANCE; MEMBRANE; FLAGELLA; MUTANTS	We have used an insertional mutagenesis approach to generate new C. reinhardtii motility mutants. Of 56 mutants isolated, one is a new allele at the ODA3 locus, called oda3-6. Similar to the previously characterized oda3 alleles, oda3-6 has a slow-jerky swimming phenotype and reduced swimming speed. The oda3-6 mutant fails to assemble the outer dynein arm motor and outer dynein arm-docking complex (ODA-DC) in the ciliary axoneme due to an insertion in the 5' end of the DCC1 gene, which encodes the DC1 subunit of the ODADC. Transformation of oda3-6 with the wild-type DCC1 gene rescues the mutant swimming phenotype and restores assembly of the ODA-DC and the outer dynein arm in the cilium. This is the first oda3 mutant to be characterized at the molecular level and is likely to be very useful for further analysis of DC1 function.	[Brown, Jason M.; Montes-Berrueta, Daniela] Salem State Univ, Dept Biol, Salem, MA USA; [Mosley, Matthew; Yang, Fan; Scarbrough, Chasity; Wirschell, Maureen] Univ Mississippi, Med Ctr, Dept Biochem, Jackson, MS 39216 USA; [Hou, Yuqing; Witman, George B.] Univ Massachusetts, Sch Med, Dept Cell & Dev Biol, Worcester, MA USA	Massachusetts System of Public Higher Education; Salem State University; University of Mississippi; University of Mississippi Medical Center; University of Massachusetts System; University of Massachusetts Worcester	Wirschell, M (corresponding author), Univ Mississippi, Med Ctr, Dept Biochem, Jackson, MS 39216 USA.	mwirschell@umc.edu		Wirschell, Maureen/0000-0002-2998-2023; Mosley, Matthew/0000-0002-2181-923X; Hou, Yuqing/0000-0002-7038-675X; Witman, George/0000-0002-9497-9218	University of Mississippi Medical Center, Department of Biochemistry; National Institutes of Health [R37 GM030626]; Robert W. Booth Endowment at the University of Massachusetts Medical School; University of Mississippi Medical Center SURE (Summer Undergraduate Research Experience) Program; SSU College of Arts and Sciences; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R37GM030626, R35GM122574] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [S10OD021580] Funding Source: NIH RePORTER	University of Mississippi Medical Center, Department of Biochemistry; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Robert W. Booth Endowment at the University of Massachusetts Medical School; University of Mississippi Medical Center SURE (Summer Undergraduate Research Experience) Program; SSU College of Arts and Sciences; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported by research funds from the University of Mississippi Medical Center, Department of Biochemistry to MW, and by National Institutes of Health grant R37 GM030626 to GBW and by the Robert W. Booth Endowment at the University of Massachusetts Medical School (to GBW). Additionally, MM was supported, in part, by the University of Mississippi Medical Center SURE (Summer Undergraduate Research Experience) Program. JMB and DM were supported by an SSU Internal Mini-grant and research start-up funds from the SSU College of Arts and Sciences, both to JMB. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Awata J, 2014, J CELL SCI, V127, P4714, DOI 10.1242/jcs.155275; Badano JL, 2006, ANNU REV GENOM HUM G, V7, P125, DOI 10.1146/annurev.genom.7.080505.115610; Berthold P, 2002, PROTIST, V153, P401, DOI 10.1078/14344610260450136; Brown JM, 2014, BIOSCIENCE, V64, P1126, DOI 10.1093/biosci/biu174; Cardenas-Rodriguez M, 2009, AM J MED GENET C, V151C, P263, DOI 10.1002/ajmg.c.30227; Casey DM, 2003, MOL BIOL CELL, V14, P3650, DOI 10.1091/mbc.E03-01-0057; Craige B, 2010, J CELL BIOL, V190, P927, DOI 10.1083/jcb.201006105; DUTCHER SK, 1995, METHOD CELL BIOL, V47, P531, DOI 10.1016/S0091-679X(08)60857-2; Fliegauf M, 2007, NAT REV MOL CELL BIO, V8, P880, DOI 10.1038/nrm2278; Hildebrandt F, 2011, NEW ENGL J MED, V364, P1533, DOI 10.1056/NEJMra1010172; Hom EFY, 2011, CYTOSKELETON, V68, P555, DOI 10.1002/cm.20533; HOOPS HJ, 1995, METHOD CELL BIOL, V47, P193, DOI 10.1016/S0091-679X(08)60809-2; Horani A, 2014, PEDIATR RES, V75, P158, DOI 10.1038/pr.2013.200; KAMIYA R, 1988, J CELL BIOL, V107, P2253, DOI 10.1083/jcb.107.6.2253; King SM, 2009, CHLAMYDOMONAS SOURCE, V3, P131; Knowles MR, 2016, CLIN CHEST MED, V37, P449, DOI 10.1016/j.ccm.2016.04.008; Koutoulis A, 1997, J CELL BIOL, V137, P1069, DOI 10.1083/jcb.137.5.1069; Lechtreck KF, 2009, J CELL BIOL, V187, P1117, DOI 10.1083/jcb.200909183; Lobo J, 2015, SEMIN RESP CRIT CARE, V36, P169, DOI 10.1055/s-0035-1546748; Marshall WF, 2008, J CELL BIOL, V180, P17, DOI 10.1083/jcb.200710085; Matsuo T, 2008, GENE DEV, V22, P918, DOI 10.1101/gad.1650408; Oda T, 2016, J CELL SCI, V129, P1547, DOI 10.1242/jcs.184598; Pan JM, 2008, SCI CHINA SER C, V51, P479, DOI 10.1007/s11427-008-0071-3; Pazour G.J., 2009, CHLAMYDOMONAS SOURCE, P445; Pazour GJ, 2000, METHODS, V22, P285, DOI 10.1006/meth.2000.1081; SAGER R, 1953, ANN NY ACAD SCI, V56, P831, DOI 10.1111/j.1749-6632.1953.tb30261.x; Sharma N, 2008, CURR TOP DEV BIOL, V85, P371, DOI 10.1016/S0070-2153(08)00813-2; Sizova I, 2001, GENE, V277, P221, DOI 10.1016/S0378-1119(01)00616-3; TAKADA S, 1994, J CELL BIOL, V126, P737, DOI 10.1083/jcb.126.3.737; Takada S, 2002, MOL BIOL CELL, V13, P1015, DOI 10.1091/mbc.01-04-0201; TAKADA S, 1992, J BIOCHEM, V111, P758, DOI 10.1093/oxfordjournals.jbchem.a123832; Wakabayashi K, 2001, CELL MOTIL CYTOSKEL, V48, P277, DOI 10.1002/cm.1015; Waters AM, 2011, PEDIATR NEPHROL, V26, P1039, DOI 10.1007/s00467-010-1731-7; Wirschell M, 2008, CELL MOTIL CYTOSKEL, V65, P238, DOI 10.1002/cm.20257; WITMAN GB, 1986, METHOD ENZYMOL, V134, P280; Yang F, 2015, AM J PHYSIOL-LUNG C, V308, pL569, DOI 10.1152/ajplung.00257.2014; Zhang R, 2014, PLANT CELL, V26, P1398, DOI 10.1105/tpc.114.124099	37	4	4	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 14	2017	12	3							e0173842	10.1371/journal.pone.0173842	http://dx.doi.org/10.1371/journal.pone.0173842			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN6DM	28291812	Green Submitted, gold, Green Published			2022-12-27	WOS:000396094700045
J	Gari, T; Loha, E; Deressa, W; Solomon, T; Atsbeha, H; Assegid, M; Hailu, A; Lindtjorn, B				Gari, Taye; Loha, Eskindir; Deressa, Wakgari; Solomon, Tarekegn; Atsbeha, Hanibale; Assegid, Meselech; Hailu, Alemayehu; Lindtjorn, Bernt			Anaemia among children in a drought affected community in south-central Ethiopia	PLOS ONE			English	Article							PRESCHOOL-CHILDREN; MALARIA; MALNUTRITION; RISK	Introduction As part of a field trial (PACTR201411000882128) to provide evidence on the combined use of long-lasting insecticidal nets and indoor residual spray for malaria prevention, we measured haemoglobin values among children aged 6 to 59 months. The aim of this study was to estimate the prevalence of anaemia, and to determine the risk factors of anaemia and change in haemoglobin value in Adami Tullu district in south-central Ethiopia. Methods Repeated cross-sectional surveys among 2984 children in 2014 and 3128 children in 2015; and a cohort study (malaria as exposure and anaemia as outcome variable) were conducted. The study area faced severe drought and food shortages in 2015. Anaemia was diagnosed using HemoCue Hb 301, and children with haemoglobin <11 g/dl were classified as anaemic. Multilevel and Cox regression models were applied to assess predictors of anaemia. Results The prevalence of anaemia was 28.2% [95% Confidence Interval (CI), 26.6-29.8] in 2014 and increased to 36.8% (95% CI, 35.1-38.5) in 2015 (P<0.001). The incidence of anaemia was 30; (95% CI, 28-32) cases per 100 children years of observation. The risk of anaemia was high (adjusted Hazard Ratio = 10) among children with malaria. Children from poor families [Adjusted Odds Ratio (AOR); 1.3; 95% CI, 1.1-1.6)], stunted children (AOR 1.5; 95% CI; 1.2-1.8), and children aged less than 36 months (AOR; 2.0; 95% CI, 1.6-2.4) were at risk of anaemia compared to their counterparts. There was no significant difference in risk of anaemia among the trial arms. Conclusions Young age, stunting, malaria and poverty were the main predictors of anaemia. An increase in the prevalence of anaemia was observed over a year, despite malaria prevention effort, which could be related to the drought and food shortage. Therefore, conducting trials in settings prone to drought and famine may bring unexpected challenges.	[Gari, Taye; Loha, Eskindir; Solomon, Tarekegn] Hawassa Univ, Sch Publ & Environm Hlth, Coll Med & Hlth Sci, Hawassa, Ethiopia; [Gari, Taye; Solomon, Tarekegn; Assegid, Meselech; Hailu, Alemayehu; Lindtjorn, Bernt] Univ Bergen, Ctr Int Hlth, Bergen, Norway; [Deressa, Wakgari] Univ Addis Ababa, Sch Publ Hlth, Dept Prevent Med, Coll Hlth Sci, Addis Ababa, Ethiopia; [Atsbeha, Hanibale] Hawassa Univ, Sch Med, Coll Med & Hlth Sci, Hawassa, Ethiopia; [Assegid, Meselech; Hailu, Alemayehu] Univ Addis Ababa, Dept Reprod Hlth, Addis Ababa, Ethiopia; [Assegid, Meselech; Hailu, Alemayehu] Univ Addis Ababa, Hlth Serv Management, Sch Publ Hlth, Coll Hlth Sci, Addis Ababa, Ethiopia	Hawassa University; University of Bergen; Addis Ababa University; Hawassa University; Addis Ababa University; Addis Ababa University	Gari, T (corresponding author), Hawassa Univ, Sch Publ & Environm Hlth, Coll Med & Hlth Sci, Hawassa, Ethiopia.	tayegari@ymail.com	Lindtjorn, Bernt/K-9465-2018; loha, eskindir/AAN-4925-2020; Hailu, Alemayehu/AAZ-5206-2020; Shumbullo, Eskindir Loha/ABB-6422-2021	Lindtjorn, Bernt/0000-0002-6267-6984; Hailu, Alemayehu/0000-0003-4872-8036; Shumbullo, Eskindir Loha/0000-0003-0003-2734	Research Council of Norway [220554]; Hawassa University; Addis Ababa University	Research Council of Norway(Research Council of Norway); Hawassa University; Addis Ababa University	This work was funded by the Research Council of Norway (project number: 220554).; We are grateful for all children and their caretakers for participating in this study. We also thank data collectors, supervisors, Adami Tullu district health office and the Ethiopian Meteorology Agency, Hawassa Branch Office. We are also grateful to Hawassa University and Addis Ababa University for their support.	Aubuchon-Endsley NL, 2011, CHILD DEV, V82, P1238, DOI 10.1111/j.1467-8624.2011.01596.x; Zanin FHC, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0139555; Cardoso MA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036341; CSA, 2007, ETH POP HOUS CENS; CSA ICF, 2012, ETH DEM HLTH SURV 20; Deressa W, 2016, TRIALS, V17, DOI 10.1186/s13063-016-1154-2; Deribew A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010775; Deribew Ketema, 2013, Asian Pacific Journal of Tropical Biomedicine, V3, P307, DOI 10.1016/S2221-1691(13)60068-4; Desalegn A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0114059; Erhardt J, EMERGENCY NUTR ASSES; Ethiopia Food and Drug Authority (EFDA), 2021, ADD AB SMOK FREE PRO; Federal Democratic Republic of Ethiopia Ministry of Health, 2012, ETHIOPIAN NATL MALAR; FMOH, 2013, TRAIN COURS MAN AC S; FMOH (Federal ministry of Health of Ethiopia), 2012, NAT MAL GUID; Foote EM, 2013, AM J TROP MED HYG, V88, P757, DOI 10.4269/ajtmh.12-0560; Gari T, 2016, MALARIA J, V15, DOI 10.1186/s12936-016-1199-4; Gashu D, 2016, NUTR J, V15, DOI 10.1186/s12937-016-0155-z; Gebreegziabiher G, 2014, HINDAWI, V2014; Gimnig JE, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0145282; IFRC, ETH DROUGHT EM PLAN; Kateera F, 2015, MALARIA J, V14, DOI 10.1186/s12936-015-0973-z; Ketema T, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-637; Kiggundu VL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082455; Kirby MJ, 2009, LANCET, V374, P998, DOI 10.1016/S0140-6736(09)60871-0; Kloos H, 1993, ECOLOGY HLTH DIS ETH, V1993; LINDTJORN B, 1993, J TROP PEDIATRICS, V39, P76, DOI 10.1093/tropej/39.2.76; Lozoff B, 2000, PEDIATRICS, V105, DOI 10.1542/peds.105.4.e51; Mahmud MA, 2013, PATHOG GLOB HEALTH, V107, P58, DOI 10.1179/2047773213Y.0000000074; NMA, 2016, ADAMI TULLU ZEWAY TO; Sanou D., 2012, RISK FACTORS ANEMIA; Semedo RML, 2014, J HEALTH POPUL NUTR, V32, P646; Simbauranga Rehema H, 2015, BMC Hematol, V15, P13, DOI 10.1186/s12878-015-0033-5; Tine Roger C K, 2012, BMC Res Notes, V5, P565, DOI 10.1186/1756-0500-5-565; Twisk JWR, 2010, APPL MULTILEVEL ANAL, V2010; UNICEF, 2002, PREV CONTR AN S AS P; Vyas S, 2006, HEALTH POLICY PLANN, V21, P459, DOI 10.1093/heapol/czl029; WHO, 2006, ACTA PAEDIAT S450, V450; WHO, 2006, ACTA PAEDIAT; WHO, 2009, ANTHROPLUS SOFTW ASS; WHO, 2006, GUIDELINES FOOD FORT; WHO, 2015, CONTROL ELIMINATION; Woldie H, 2015, J NUTR METAB, V2015, DOI 10.1155/2015/928632; World Health Organization, 2011, SER FERR CONC ASS IR; World Health Organization, 2015, GLOB PREV AN 2011	44	27	27	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 14	2017	12	3							e0170898	10.1371/journal.pone.0170898	http://dx.doi.org/10.1371/journal.pone.0170898			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN6DM	28291790	Green Submitted, Green Published, gold			2022-12-27	WOS:000396094700001
J	Mahmoudzadeh, M; Dehaene-Lambertz, G; Wallois, F				Mahmoudzadeh, Mahdi; Dehaene-Lambertz, Ghislaine; Wallois, Fabrice			Electrophysiological and hemodynamic mismatch responses in rats listening to human speech syllables	PLOS ONE			English	Article							EVENT-RELATED POTENTIALS; NEAR-INFRARED SPECTROSCOPY; HUMAN AUDITORY-CORTEX; INITIAL DIP; LANGUAGE DISCRIMINATION; ANESTHETIZED RATS; NEGATIVITY MMN; BLOOD-FLOW; SCALP EEG; BRAIN	Speech is a complex auditory stimulus which is processed according to several time-scales. Whereas consonant discrimination is required to resolve rapid acoustic events, voice perception relies on slower cues. Humans, right from preterm ages, are particularly efficient to encode temporal cues. To compare the capacities of preterms to those observed in other mammals, we tested anesthetized adult rats by using exactly the same paradigm as that used in preterm neonates. We simultaneously recorded neural (using ECoG) and hemodynamic responses (using fNIRS) to series of human speech syllables and investigated the brain response to a change of consonant (ba vs. ga) and to a change of voice (male vs. female). Both methods revealed concordant results, although ECoG measures were more sensitive than fNIRS. Responses to syllables were bilateral, but with marked right-hemispheric lateralization. Responses to voice changes were observed with both methods, while only ECoG was sensitive to consonant changes. These results suggest that rats more effectively processed the speech envelope than fine temporal cues in contrast with human preterm neonates, in whom the opposite effects were observed. Cross-species comparisons constitute a very valuable tool to define the singularities of the human brain and species-specific bias that may help human infants to learn their native language.	[Mahmoudzadeh, Mahdi; Wallois, Fabrice] Univ Picardie Jules Verne, CHU SUD Amiens, GRAMFC, INSERM U1105, Amiens, France; [Dehaene-Lambertz, Ghislaine] Univ Paris Saclay, Univ Paris Sud, NeuroSpin Ctr, Cognit Neuroimaging Unit,CEA DSV I2BM,INSERM,CNRS, Gif Sur Yvette, France	Institut National de la Sante et de la Recherche Medicale (Inserm); Picardie Universites; Universite de Picardie Jules Verne (UPJV); CHU Amiens; CEA; Centre National de la Recherche Scientifique (CNRS); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Saclay	Mahmoudzadeh, M (corresponding author), Univ Picardie Jules Verne, CHU SUD Amiens, GRAMFC, INSERM U1105, Amiens, France.	mahdi.mahmoudzadeh@u-picardie.fr	Mahmoudzadeh/AAG-8578-2021; Dehaene, Ghislaine/O-3633-2017	Mahmoudzadeh/0000-0003-3145-2133; Dehaene, Ghislaine/0000-0003-2221-9081	Picardie regional council	Picardie regional council(Region Hauts-de-France)	This work was supported by the Picardie regional council. The authors would especially like to thank Marc Fournier for his help on hemodynamic projection on the rat brain.	Abrams DA, 2008, J NEUROSCI, V28, P3958, DOI 10.1523/JNEUROSCI.0187-08.2008; Ahmed M, 2011, FRONT PSYCHOL, V2, DOI 10.3389/fpsyg.2011.00283; Aslin RN, 2012, COGN NEUROPSYCHOL, V29, P7, DOI 10.1080/02643294.2012.654773; Astikainen P, 2006, NEUROREPORT, V17, P1561, DOI 10.1097/01.wnr.0000233097.13032.7d; Astikainen P, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024208; Belin P, 2000, NATURE, V403, P309, DOI 10.1038/35002078; Boemio A, 2005, NAT NEUROSCI, V8, P389, DOI 10.1038/nn1409; Boyd SG, 1996, NEUROPEDIATRICS, V27, P211, DOI 10.1055/s-2007-973791; Bristow D, 2009, J COGNITIVE NEUROSCI, V21, P905, DOI 10.1162/jocn.2009.21076; Bullmore ET, 1999, IEEE T MED IMAGING, V18, P32, DOI 10.1109/42.750253; Buxton RB, 1998, MAGNET RESON MED, V39, P855, DOI 10.1002/mrm.1910390602; Buxton RB, 2001, NEUROIMAGE, V13, P953, DOI 10.1006/nimg.2001.0814; CAPLAN D, 1995, NEUROLOGY, V45, P293, DOI 10.1212/WNL.45.2.293; Caspers H., 1984, SELF REGULATION BRAI, P26; Celsis P, 1999, NEUROIMAGE, V9, P135, DOI 10.1006/nimg.1998.0389; Dehaene-Lambertz G, 2005, NEUROIMAGE, V24, P21, DOI 10.1016/j.neuroimage.2004.09.039; Dehaene-Lambertz G, 2001, NEUROREPORT, V12, P3155, DOI 10.1097/00001756-200110080-00034; Dehaene-Lambertz G, 2010, BRAIN LANG, V114, P53, DOI 10.1016/j.bandl.2009.09.003; DehaeneLambertz G, 1997, NEUROREPORT, V8, P919, DOI 10.1097/00001756-199703030-00021; DEHAENELAMBERTZ G, 1994, NATURE, V370, P292, DOI 10.1038/370292a0; Ehlis AC, 2009, NEUROSCIENCE, V159, P1032, DOI 10.1016/j.neuroscience.2009.01.015; Eriksson J, 2005, BIOSYSTEMS, V79, P207, DOI 10.1016/j.biosystems.2004.09.017; Ernst MD, 2004, PERMUTATION METHODS, P676; Esser SK, 2006, BRAIN RES BULL, V69, P86, DOI 10.1016/j.brainresbull.2005.11.003; FITCH RH, 1993, ANN NY ACAD SCI, V682, P346, DOI 10.1111/j.1749-6632.1993.tb22989.x; Franceschini MA, 2008, NEUROIMAGE, V41, P189, DOI 10.1016/j.neuroimage.2008.02.061; Friston KJ, 2005, PHILOS T R SOC B, V360, P815, DOI 10.1098/rstb.2005.1622; GIARD MH, 1995, J COGNITIVE NEUROSCI, V7, P133, DOI 10.1162/jocn.1995.7.2.133; Giraud AL, 2007, NEURON, V56, P1127, DOI 10.1016/j.neuron.2007.09.038; Hauser MD, 2001, COGNITION, V78, pB53, DOI 10.1016/S0010-0277(00)00132-3; Hays W.L., 1994, STATISTICS-ABINGDON, V5th ed.; Hoechstetter K, 2004, BRAIN TOPOGR, V16, P233; Howell TJ, 2012, BEHAV PROCESS, V89, P8, DOI 10.1016/j.beproc.2011.09.009; Imada A, 2013, FRONT INTEGR NEUROSC, V6, DOI 10.3389/fnint.2012.00127; JAVITT DC, 1992, ELECTROEN CLIN NEURO, V83, P87, DOI 10.1016/0013-4694(92)90137-7; Jones M, 2001, NEUROIMAGE, V13, P1002, DOI 10.1006/nimg.2001.0808; Jung F, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063203; King C, 1999, NEUROSCI LETT, V267, P89, DOI 10.1016/S0304-3940(99)00336-5; Koenig T, 2010, BRAIN TOPOGR, V23, P233, DOI 10.1007/s10548-010-0142-1; KRAUS N, 1994, J ACOUST SOC AM, V96, P2758, DOI 10.1121/1.411282; KUHL PK, 1975, SCIENCE, V190, P69, DOI 10.1126/science.1166301; Leroy F, 2015, P NATL ACAD SCI USA, V112, P1208, DOI 10.1073/pnas.1412389112; LINDAUER U, 1993, AM J PHYSIOL, V264, pH1223, DOI 10.1152/ajpheart.1993.264.4.H1223; Mahmoudzadeh M., 2016, CEREB CORTEX; Mahmoudzadeh M. WF, FUNCTIONAL IN PRESS; Mahmoudzadeh M, 2013, P NATL ACAD SCI USA, V110, P4846, DOI 10.1073/pnas.1212220110; Maris E, 2007, J NEUROSCI METH, V164, P177, DOI 10.1016/j.jneumeth.2007.03.024; McGee T, 1996, J ACOUST SOC AM, V99, P3606, DOI 10.1121/1.414958; McGee TJ, 2001, PSYCHOPHYSIOLOGY, V38, P653, DOI 10.1017/S0048577201990973; MICELI G, 1978, BRAIN LANG, V2, P434; Miller JW, 2007, NEUROIMAGE, V35, P583, DOI 10.1016/j.neuroimage.2006.12.018; Naatanen R, 2007, CLIN NEUROPHYSIOL, V118, P2544, DOI 10.1016/j.clinph.2007.04.026; Naccache L, 2002, PSYCHOL SCI, V13, P416, DOI 10.1111/1467-9280.00474; Nakamura T, 2011, FRONT PSYCHOL, V2, DOI 10.3389/fpsyg.2011.00367; Nelken I, 2007, J PSYCHOPHYSIOL, V21, P214, DOI 10.1027/0269-8803.21.34.214; Papp N, 1977, Biomed Sci Instrum, V13, P135; Ramus F, 2000, SCIENCE, V288, P349, DOI 10.1126/science.288.5464.349; RANSOM BR, 1992, J CLIN NEUROPHYSIOL, V9, P224, DOI 10.1097/00004691-199204010-00005; ROBLEDO P, 1995, PSYCHOPHARMACOLOGY, V118, P410, DOI 10.1007/BF02245941; Ruusuvirta T, 1998, NEUROSCI LETT, V248, P45, DOI 10.1016/S0304-3940(98)00330-9; Ruusuvirta T, 2010, NEUROSCIENCE, V170, P232, DOI 10.1016/j.neuroscience.2010.06.062; Ruusuvirta T, 2007, EUR J NEUROSCI, V26, P701, DOI 10.1111/j.1460-9568.2007.05687.x; Ruusuvirta T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054624; Rybalko N, 2006, EUR J NEUROSCI, V23, P1614, DOI 10.1111/j.1460-9568.2006.04688.x; Rybalko N, 2010, BEHAV BRAIN RES, V209, P123, DOI 10.1016/j.bbr.2010.01.028; Salkind N., 2007, ENCY MEASUREMENT STA; Schall U, 2015, NEUROREPORT, V26, P239, DOI 10.1097/WNR.0000000000000323; Schwartze M, 2011, BIOL PSYCHOL, V87, P146, DOI 10.1016/j.biopsycho.2011.02.021; Sherman GF, TRENDS NEUROSCIENCES, V5, P429; Shinba T, 1997, EVOKED POTENTIAL, V104, P447, DOI 10.1016/S0168-5597(97)00047-6; Siero JCW, 2015, MAGN RESON MED, V73, P2283, DOI 10.1002/mrm.25349; SKRANDIES W, 1990, Brain Topography, V3, P137, DOI 10.1007/BF01128870; Skrandies W, 2007, BRAIN TOPOGR, V20, P15, DOI 10.1007/s10548-007-0026-1; Speckman EJ, 1993, ELECTROENCEPHALOGRAP; Strauss M, 2015, P NATL ACAD SCI USA, V112, pE1353, DOI 10.1073/pnas.1501026112; Telkemeyer S, 2011, FRONT PSYCHOL, V2, DOI 10.3389/fpsyg.2011.00062; Thompson JK, 2003, SCIENCE, V299, P1070, DOI 10.1126/science.1079220; Tian PF, 2010, P NATL ACAD SCI USA, V107, P15246, DOI 10.1073/pnas.1006735107; Tikhonravov D, 2008, BRAIN RES, V1203, P97, DOI 10.1016/j.brainres.2008.02.006; Toro JM, 2005, PERCEPT PSYCHOPHYS, V67, P867, DOI 10.3758/BF03193539; Toro JM, 2005, J EXP PSYCHOL-ANIM B, V31, P95, DOI 10.1037/0097-7403.31.1.95; Toro JM, 2003, ANIM COGN, V6, P131, DOI 10.1007/s10071-003-0172-0; Ulanovsky N, 2003, NAT NEUROSCI, V6, P391, DOI 10.1038/nn1032; Umbricht D, 2005, CLIN NEUROPHYSIOL, V116, P353, DOI 10.1016/j.clinph.2004.08.015; Vanzetta I, 2001, NEUROIMAGE, V13, P959, DOI 10.1006/nimg.2001.0843; Voipio J, 2003, J NEUROPHYSIOL, V89, P2208, DOI 10.1152/jn.00915.2002; Wacongne C, 2012, J NEUROSCI, V32, P3665, DOI 10.1523/JNEUROSCI.5003-11.2012; Wallois F, 2009, NEUROPHYSIOL CLIN, V39, P217, DOI 10.1016/j.neucli.2009.08.001; Yacoub E, 2001, NMR BIOMED, V14, P408, DOI 10.1002/nbm.715; Zatorre RJ, 2001, CEREB CORTEX, V11, P946, DOI 10.1093/cercor/11.10.946	90	8	8	2	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 14	2017	12	3							e0173801	10.1371/journal.pone.0173801	http://dx.doi.org/10.1371/journal.pone.0173801			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN6DM	28291832	Green Submitted, Green Published, gold			2022-12-27	WOS:000396094700041
J	Kodo, K; Sugimoto, S; Nakajima, H; Mori, J; Itoh, I; Fukuhara, S; Shigehara, K; Nishikawa, T; Kosaka, K; Hosoi, H				Kodo, Kazuki; Sugimoto, Satoru; Nakajima, Hisakazu; Mori, Jun; Itoh, Ikuyo; Fukuhara, Shota; Shigehara, Keiichi; Nishikawa, Taichiro; Kosaka, Kitaro; Hosoi, Hajime			Erythropoietin (EPO) ameliorates obesity and glucose homeostasis by promoting thermogenesis and endocrine function of classical brown adipose tissue (BAT) in diet-induced obese mice	PLOS ONE			English	Article							INCREASES ENERGY-EXPENDITURE; HEPATIC INSULIN-RESISTANCE; FAT OXIDATION; PPAR-GAMMA; METABOLIC-ACTIVITY; SENSITIVITY; DIFFERENTIATION; ADIPOGENESIS; INFLAMMATION; ADIPOCYTES	Erythropoietin (EPO), clinically used as a hematopoietic drug, has received much attention due to its nonhematopoietic effects. EPO reportedly has beneficial effects on obesity and diabetes mellitus. We investigated whether interscapular brown adipose tissue (iBAT: main part of classical BAT) could play a role in EPO's anti-obesity and anti-diabetic effects in diet-induced obese mice. Four-week-old male C57BL/6J mice were fed a high-fat diet (HFD-Con), and half were additionally given an intraperitoneal injection of recombinant human EPO (200 IU/kg) (HFD-EPO) thrice a week for four weeks. At 8 weeks, EPO-injected mice showed significantly reduced body weight with reduced epididymal and subcutaneous white fat mass and unchanged caloric intake and locomotor activity. HOMA-IR (insulin resistance index) and glucose levels during intraperitoneal glucose tolerance test (IPGTT) were significantly lower in HFD-EPO mice than in HFD-Con mice. EPO-injected mice also showed increased oxygen consumption, indicative of metabolic rate, and skin temperature around iBAT tissue masses. EPO significantly upregulated the PRD1-BF1-RIZ1 homologous domain containing 16 (PRDM16), a transcriptional factor with a crucial role in brown adipocyte differentiation. EPO significantly increased phosphorylated signal transducer and activator of transcription 3 (STAT3), which is downstream of erythropoietin receptor (EpoR) and known to stabilize PRDM16. EPO's suppression of myocyte enhancer factor 2c (Mef2c) and microRNA-133a (miR-133a) via beta 3-adrenergic receptor caused PRDM16 upregulation. EPO-mediated enhancement of EpoR/STAT3 and beta-adrenergic receptor/Mef2c/miR-133 pathways dramatically increases total uncoupling protein 1 (UCP1), an essential enzyme for BAT thermogenesis. Furthermore, EPO activated BAT's endocrine functions. EPO facilitated fibroblast growth factor 21 (FGF21) production and excretion in iBAT, associated with reduction of liver gluconeogenesis-related genes. Thus, EPO's improvement of obesity and glucose homeostasis can be attributed to increased iBAT thermogenic capacity and activation of BAT's endocrine functions.	[Kodo, Kazuki; Sugimoto, Satoru; Nakajima, Hisakazu; Mori, Jun; Itoh, Ikuyo; Fukuhara, Shota; Shigehara, Keiichi; Kosaka, Kitaro; Hosoi, Hajime] Kyoto Prefectural Univ Med, Grad Sch Med Sci, Dept Pediat, Kyoto, Japan; [Sugimoto, Satoru] Ayabe Municipal Hosp, Dept Pediat, Ayabe City, Japan; [Nishikawa, Taichiro] Kyoto Prefectural Univ Med, Grad Sch Med Sci, Dept Mol Gastroenterol & Hepatol, Kyoto, Japan	Kyoto Prefectural University of Medicine; Kyoto Prefectural University of Medicine	Sugimoto, S; Nakajima, H (corresponding author), Kyoto Prefectural Univ Med, Grad Sch Med Sci, Dept Pediat, Kyoto, Japan.; Sugimoto, S (corresponding author), Ayabe Municipal Hosp, Dept Pediat, Ayabe City, Japan.	satoru-s@koto.kpu-m.ac.jp; hisakazu@koto.kpu-m.ac.jp	Nakajima, Hisakazu/AAH-7764-2021	Nakajima, Hisakazu/0000-0002-3678-9918	JSPS KAKENHI Grant [24650427]	JSPS KAKENHI Grant(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	Part of this work was supported by JSPS KAKENHI Grant Number 24650427 (H. N. received) (https://kaken.nii.ac.jp/ja/search/?kw=24650427).	Alnaeeli M, 2014, DIABETES, V63, P2415, DOI 10.2337/db13-0883; Berglund ED, 2009, ENDOCRINOLOGY, V150, P4084, DOI 10.1210/en.2009-0221; Brines M, 2006, KIDNEY INT, V70, P246, DOI 10.1038/sj.ki.5001546; Brines M, 2014, MOL MED, V20, P658, DOI 10.2119/molmed.2014.00215; Caillaud C, 2015, J ENDOCRINOL, V225, P77, DOI 10.1530/JOE-15-0010; Caillaud C, 2015, J PHYSIOL BIOCHEM, V71, P9, DOI 10.1007/s13105-014-0374-8; Camporez JPG, 2015, J ENDOCRINOL, V226, P207, DOI 10.1530/JOE-15-0136; Cazzola M, 1998, Curr Opin Hematol, V5, P103; Chartoumpekis DV, 2011, MOL MED, V17, P736, DOI 10.2119/molmed.2011.00075; Christensen B, 2016, LIPIDS HEALTH DIS, V15, DOI 10.1186/s12944-016-0327-z; Christensen B, 2012, J APPL PHYSIOL, V112, P1114, DOI 10.1152/japplphysiol.01391.2011; Cypess AM, 2009, NEW ENGL J MED, V360, P1509, DOI 10.1056/NEJMoa0810780; Derecka M, 2012, CELL METAB, V16, P814, DOI 10.1016/j.cmet.2012.11.005; Ge ZJ, 2015, SCI REP-UK, V5, DOI 10.1038/srep17878; Gong Q, 2016, HEPATOLOGY, V64, P425, DOI 10.1002/hep.28523; Gorbenko O, 2006, HYBRIDOMA, V25, P86, DOI 10.1089/hyb.2006.25.86; Guadalupe-Grau A, 2015, J SPORT SCI, V33, P570, DOI 10.1080/02640414.2014.951872; Hojman P, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005894; Hondares E, 2011, J BIOL CHEM, V286, P43112, DOI 10.1074/jbc.M111.252775; Hu ED, 1996, SCIENCE, V274, P2100, DOI 10.1126/science.274.5295.2100; Katz O, 2010, J ENDOCRINOL, V205, P87, DOI 10.1677/JOE-09-0425; Klampfer L, 2006, CURR CANCER DRUG TAR, V6, P107, DOI 10.2174/156800906776056491; Kornfeld JW, 2012, NAT CELL BIOL, V14, P1248, DOI 10.1038/ncb2642; Kotanko P, 2008, BLOOD PURIFICAT, V26, P82, DOI 10.1159/000110571; Lee YH, 2014, EXP MOL MED, V46, DOI 10.1038/emm.2013.163; Lichtenbelt WDV, 2009, NEW ENGL J MED, V360, P1500, DOI 10.1056/NEJMoa0808718; Liu WY, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003626; Liu YQ, 2015, SCI REP-UK, V5, DOI 10.1038/srep15134; Nedergaard J, 2005, BBA-MOL BASIS DIS, V1740, P293, DOI 10.1016/j.bbadis.2005.02.003; Nicolas Celine S, 2013, JAKSTAT, V2, pe22925, DOI 10.4161/jkst.22925; Saito M, 2014, ENDOCR J, V61, P409, DOI 10.1507/endocrj.EJ13-0527; Sarruf DA, 2010, DIABETES, V59, P1817, DOI 10.2337/db09-1878; Scully MS, 2011, EXP DIABETES RES, DOI 10.1155/2011/910159; Seale P, 2008, NATURE, V454, P961, DOI 10.1038/nature07182; Sell H, 2004, INT J BIOCH CELL BIO, V36; Sidossis L, 2015, J CLIN INVEST, V125, P478, DOI 10.1172/JCI78362; Sugimoto S, 2014, NUTR METAB, V11, DOI 10.1186/1743-7075-11-14; Teng RF, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1526; Tiraby C, 2003, J BIOL CHEM, V278, P33370, DOI 10.1074/jbc.M305235200; Townsend K L, 2015, Int J Obes Suppl, V5, pS15, DOI 10.1038/ijosup.2015.5; Trajkovski M, 2012, NAT CELL BIOL, V14, P1330, DOI 10.1038/ncb2612; Villarroya F, 2017, NAT REV ENDOCRINOL, V13, P26, DOI 10.1038/nrendo.2016.136; Villarroya J, 2013, AM J PHYSIOL-ENDOC M, V305, pE567, DOI 10.1152/ajpendo.00250.2013; Virtanen KA, 2009, NEW ENGL J MED, V360, P1518, DOI 10.1056/NEJMoa0808949; Wang L, 2014, INT J BIOCHEM CELL B, V54, P1, DOI 10.1016/j.biocel.2014.06.008; Wang L, 2013, DIABETES, V62, P4122, DOI 10.2337/db13-0518; Woo M, 2014, DIABETES, V63, P2229, DOI 10.2337/db14-0566; Xu J, 2009, DIABETES, V58, P250, DOI 10.2337/db08-0392; Yamazaki H, 2002, AM J PHYSIOL-ENDOC M, V283, pE536, DOI 10.1152/ajpendo.00094.2001; Yin H, 2013, CELL METAB, V17, P210, DOI 10.1016/j.cmet.2013.01.004	50	24	26	2	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 13	2017	12	3							e0173661	10.1371/journal.pone.0173661	http://dx.doi.org/10.1371/journal.pone.0173661			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN6CP	28288167	Green Published, gold, Green Submitted			2022-12-27	WOS:000396092400025
J	Muhle, M; Lehmann, M; Hoffmann, K; Stern, D; Kroniger, T; Luttmann, W; Denner, J				Muehle, Michael; Lehmann, Melissa; Hoffmann, Kerstin; Stern, Daniel; Kroniger, Tobias; Luttmann, Werner; Denner, Joachim			Antigenic and immunosuppressive properties of a trimeric recombinant transmembrane envelope protein gp41 of HIV-1	PLOS ONE			English	Article							HUMAN-IMMUNODEFICIENCY-VIRUS; HUMAN MONOCLONAL-ANTIBODIES; IN-VIVO; RECEPTOR ANTAGONIST; IL-10 PRODUCTION; CELL-LINE; TYPE-1; PEPTIDE; MONOCYTES; INFECTION	The transmembrane envelope (TM) protein gp41 of the human immunodeficiency virus-1 (HIV-1) plays an important role during virus infection inducing the fusion of the viral and cellular membranes. In addition, there are indications that the TM protein plays a role in the immunopathogenesis leading to the acquired immunodeficiency syndrome (AIDS). Inactivated virus particles and recombinant gp41 have been reported to inhibit lymphocyte proliferation, as well as to alter cytokine release and gene expression. The same was shown for a peptide corresponding to a highly conserved domain of all retroviral TM proteins, the immunosuppressive domain. Due to its propensity to aggregate and to be expressed at low levels, studies comprising authentic gp41 produced in eukaryotic cells are extremely rare. Here we describe the production of a secreted, soluble recombinant gp41 in 293 cells. The antigen was purified to homogeneity and characterised thoroughly by various biochemical and immunological methods. It was shown that the protein was glycosylated and assembled into trimers. Binding studies by ELISA and surface plasmon resonance using conformation-specific monoclonal antibodies implied a six-helix bundle conformation. The low binding of broadly neutralising antibodies (bnAb) directed against the membrane proximal external region (MPER) suggested that this gp41 is probably not suited as vaccine to induce such bnAb. Purified gp41 bound to monocytes and to a lesser extent to lymphocytes and triggered the production of specific cytokines when added to normal peripheral blood mononuclear cells. In addition, gp41 expressed on target cells inhibited the antigen-specific response of murine CD8(+) T cells by drastically impairing their IFN gamma production. To our knowledge, this is the first comprehensive analysis of a gp41 produced in eukaryotic cells including its immunosuppressive properties. Our data provide another line of evidence that gp41 might be directly involved in HIV-1 immunopathogenesis through modulation of the cytokine release and active inhibition of immune responses.	[Muehle, Michael; Stern, Daniel; Kroniger, Tobias; Denner, Joachim] Robert Koch Inst, Berlin, Germany; [Lehmann, Melissa; Luttmann, Werner] ImmunoTools GmbH, Friesoythe, Germany; [Hoffmann, Kerstin] Berlin Ctr Regenerat Therapies, Div Regenerat Immunol & Aging, Berlin, Germany	Robert Koch Institute	Denner, J (corresponding author), Robert Koch Inst, Berlin, Germany.	DennerJ@rki.de	Stern, Daniel/AAF-6280-2020; Dabrowski, Piotr Wojtek/L-1423-2015	Stern, Daniel/0000-0001-9057-4283; Dabrowski, Piotr Wojtek/0000-0003-4893-805X; Muhle, Kerstin/0000-0002-4179-819X; Kroniger, Tobias/0000-0002-6611-1956	Federal Ministry for Economics and Technology (Bundesministerium fur Wirtschaft und Technologie, BMWi) under the grant ZIM [AIF KF 2928202AJ2]; Friede Springer Foundation, Berlin, Germany	Federal Ministry for Economics and Technology (Bundesministerium fur Wirtschaft und Technologie, BMWi) under the grant ZIM; Friede Springer Foundation, Berlin, Germany	The study has been supported by the Federal Ministry for Economics and Technology (Bundesministerium fur Wirtschaft und Technologie, BMWi) under the grant ZIM (AIF KF 2928202AJ2) (http://www.zim-bmwi.de/) and by the Friede Springer Foundation, Berlin, Germany (http://www.friedespringerstitung.de/). The funder provided support in the form of salaries for authors MM and ML, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Adamson DC, 1996, SCIENCE, V274, P1917, DOI 10.1126/science.274.5294.1917; Barcova M, 1998, J INFECT DIS, V177, P905, DOI 10.1086/515230; Blaise S, 2001, J GEN VIROL, V82, P1597, DOI 10.1099/0022-1317-82-7-1597; CHEN YH, 1993, IMMUNOL LETT, V37, P41, DOI 10.1016/0165-2478(93)90130-T; de Rosny E, 2004, J VIROL, V78, P2627, DOI 10.1128/JVI.78.5.2627-2631.2004; Denner J, 1996, J ACQ IMMUN DEF SYND, V12, P442, DOI 10.1097/00042560-199608150-00002; DENNER J, 1994, AIDS, V8, P1063, DOI 10.1097/00002030-199408000-00005; DENNER J, 1993, J CANCER RES CLIN S1, V119, P28; Denner J, 2014, AIDS, V28, P1081, DOI 10.1097/QAD.0000000000000195; Denner J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055199; Denner J, 2011, HUM VACCINES, V7, P4, DOI 10.4161/hv.7.0.14555; Fausther-Bovendo H, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000975; Feldmann J, 2010, VIRUSES-BASEL, V2, P1666, DOI 10.3390/v2081666; Forsell MNE, 2009, CURR OPIN HIV AIDS, V4, P380, DOI 10.1097/COH.0b013e32832edc19; Fumakia M., 2015, REV MED VIROL; Garg H, 2006, J LEUKOCYTE BIOL, V79, P351, DOI 10.1189/jlb.0805430; GORNY MK, 1989, P NATL ACAD SCI USA, V86, P1624, DOI 10.1073/pnas.86.5.1624; Gustchina E, 2008, J VIROL, V82, P10032, DOI 10.1128/JVI.01050-08; HENDERSON LA, 1993, J BIOL CHEM, V268, P15291; Huang JH, 2012, NATURE, V491, P406, DOI 10.1038/nature11544; Irikura VM, 1999, INFECT IMMUN, V67, P1901; Ivanusic D, 2014, BIOTECHNIQUES, V57, P188, DOI 10.2144/000114215; Jiang S, 1998, J VIROL, V72, P10213, DOI 10.1128/JVI.72.12.10213-10217.1998; Kanehisa M, 2010, NUCLEIC ACIDS RES, V38, pD355, DOI 10.1093/nar/gkp896; Koutsonikolis A, 1997, IMMUNOL LETT, V55, P109, DOI 10.1016/S0165-2478(97)02695-3; Li CW, 2009, J VIROL, V83, P6817, DOI 10.1128/JVI.00278-09; Mangeney M, 1998, P NATL ACAD SCI USA, V95, P14920, DOI 10.1073/pnas.95.25.14920; Mangeney M, 2001, J GEN VIROL, V82, P2515, DOI 10.1099/0022-1317-82-10-2515; Melikyan GB, 2000, J CELL BIOL, V151, P413, DOI 10.1083/jcb.151.2.413; Miller MD, 2005, P NATL ACAD SCI USA, V102, P14759, DOI 10.1073/pnas.0506927102; Morozov VA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070399; Morozov VA, 2012, RETROVIROLOGY, V9, DOI 10.1186/1742-4690-9-67; Muhle M, 2016, IMMUNOL RES, V64, P721, DOI 10.1007/s12026-015-8776-4; Myszyka DG, 1999, J MOL RECOGNIT, V12, P279, DOI 10.1002/(SICI)1099-1352(199909/10)12:5<279::AID-JMR473>3.0.CO;2-3; Perrier S, 2006, FEBS LETT, V580, P6289, DOI 10.1016/j.febslet.2006.10.061; PINTER A, 1989, J VIROL, V63, P2674, DOI 10.1128/JVI.63.6.2674-2679.1989; Roth Z, 2012, MOL REPROD DEV, V79, P478, DOI 10.1002/mrd.22055; RUEGG CL, 1989, J VIROL, V63, P3257, DOI 10.1128/JVI.63.8.3257-3260.1989; Saraiva M, 2010, NAT REV IMMUNOL, V10, P170, DOI 10.1038/nri2711; Schlecht-Louf G, 2010, P NATL ACAD SCI USA, V107, P3782, DOI 10.1073/pnas.0913122107; Speth C, 2000, AIDS, V14, P629, DOI 10.1097/00002030-200004140-00001; Sun ZYJ, 2008, IMMUNITY, V28, P52, DOI 10.1016/j.immuni.2007.11.018; Tacke SJ, 2000, VIROLOGY, V268, P87, DOI 10.1006/viro.1999.0149; TAKESHITA S, 1995, CELL IMMUNOL, V165, P234, DOI 10.1006/cimm.1995.1210; Wang Q, 2015, J NANOMATER, V2015, DOI 10.1155/2015/408634; Weiss RA, 2013, BMC BIOL, V11, DOI 10.1186/1741-7007-11-57; Wilen CB, 2012, ADV EXP MED BIOL, V726, P223, DOI 10.1007/978-1-4614-0980-9_10; Xie C, 2011, NUCLEIC ACIDS RES, V39, pW316, DOI 10.1093/nar/gkr483; XU JY, 1991, J VIROL, V65, P4832, DOI 10.1128/JVI.65.9.4832-4838.1991	49	7	7	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 10	2017	12	3							e0173454	10.1371/journal.pone.0173454	http://dx.doi.org/10.1371/journal.pone.0173454			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN6CJ	28282446	Green Published, gold, Green Submitted			2022-12-27	WOS:000396091800042
J	Klebaner, D; Hamilton-Dutoit, S; Ahern, T; Crawford, A; Jakobsen, T; Cronin-Fenton, DP; Damkier, P; Janssen, E; Kjaersgaard, A; Ording, AG; Soiland, H; Sorensen, HT; Lash, TL; Hellberg, Y				Klebaner, Daniella; Hamilton-Dutoit, Stephen; Ahern, Thomas; Crawford, Anatasha; Jakobsen, Thomas; Cronin-Fenton, Deirdre P.; Damkier, Per; Janssen, Emiel; Kjaersgaard, Anders; Ording, Anne Gulbech; Soiland, Havard; Sorensen, Henrik Toft; Lash, Timothy L.; Hellberg, Ylva			Apolipoprotein D expression does not predict breast cancer recurrence among tamoxifen-treated patients	PLOS ONE			English	Article							BINDING CYST PROTEIN; ESTROGEN-RECEPTOR; ADJUVANT TAMOXIFEN; ENDOCRINE THERAPY; MECHANISMS; RESISTANCE; REGISTRATION; SURVIVAL; MARKERS; TRENDS	Background Apolipoprotein D (ApoD) has been proposed as a predictor of breast cancer recurrence among estrogen receptor-positive (ER+), tamoxifen-treated patients. Methods We conducted a population-based case-control study nested in a population of 11,251 women aged 35-69 years at diagnosis with Stage I-III breast cancer between 1985 and 2001 on Denmark's Jutland Peninsula and registered with the Danish Breast Cancer Coop-erative Group. We identified 541 recurrent or contralateral breast cancers cases among women with ER+ disease treated with tamoxifen for at least 1 year and 300 cases in women with ER-disease never treated with tamoxifen. We matched one control subject per case and assessed ApoD expression in the tumor cell nucleus and cytoplasm using tissue micro-array immunohistochemistry. We computed the odds ratio (OR) associating ApoD expression with recurrence and adjusted for potential confounding using logistic regression. Results Cytoplasmic ApoD expression was seen in 68% of ER+ tumors, in 66% of ER-tumors, and in 66% of controls across both groups. In women with ER+ tumors, the associations of cyto-plasmic ApoD expression with recurrence (OR = 1.0; 95% CI = 0.7 to 1.4) and increasing cytoplasmic expression with recurrence (OR = 1.0; 95% CI = 0.996 to 1.003) were null, as were those for women with ER-tumors. Associations for nuclear ApoD expression and combined nuclear and cytoplasmic expression were similarly near-null. Conclusion ApoD expression is likely not a predictor of recurrence in tamoxifen-treated patients.	[Klebaner, Daniella; Crawford, Anatasha; Lash, Timothy L.] Emory Univ, Rollins Sch Publ Hlth, Dept Epidemiol, Atlanta, GA 30322 USA; [Hamilton-Dutoit, Stephen; Jakobsen, Thomas; Hellberg, Ylva] Aarhus Univ Hosp, Inst Pathol, Aarhus, Denmark; [Ahern, Thomas] Univ Vermont, Coll Med, Dept Surg, Burlington, VT USA; [Ahern, Thomas] Univ Vermont, Coll Med, Dept Biochem, Burlington, VT 05405 USA; [Cronin-Fenton, Deirdre P.; Kjaersgaard, Anders; Ording, Anne Gulbech; Sorensen, Henrik Toft; Lash, Timothy L.] Aarhus Univ, Dept Clin Epidemiol, Aarhus, Denmark; [Damkier, Per] Odense Univ Hosp, Dept Clin Chem & Pharmacol, Odense, Denmark; [Janssen, Emiel] Stavanger Univ Hosp, Dept Pathol, Stavanger, Norway; [Soiland, Havard] Stavanger Univ Hosp, Dept Breast & Endocrine Surg, Stavanger, Norway; [Soiland, Havard] Univ Bergen, Dept Clin Sci, Bergen, Norway	Emory University; Rollins School Public Health; Aarhus University; University of Vermont; University of Vermont; Aarhus University; University of Southern Denmark; Odense University Hospital; Stavanger University Hospital; Stavanger University Hospital; University of Bergen	Lash, TL (corresponding author), Emory Univ, Rollins Sch Publ Hlth, Dept Epidemiol, Atlanta, GA 30322 USA.; Lash, TL (corresponding author), Aarhus Univ, Dept Clin Epidemiol, Aarhus, Denmark.	Tlash@emory.edu	Sorensen, Henrik Toft/Z-6181-2019; Janssen, Emiel A.M./AAM-2357-2020; Damkier, Per/P-8217-2019; Jakobsen, Thomas Stax/GVU-5079-2022	Sorensen, Henrik Toft/0000-0003-4299-7040; Damkier, Per/0000-0003-0591-7187; Hamilton-Dutoit, Stephen/0000-0003-2158-3885; Jakobsen, Thomas Stax/0000-0002-5393-3918; Ahern, Thomas/0000-0003-0440-8727	Danish Medical Research Council [DOK 1158859]; U.S. National Cancer Institute at the U.S. National Institutes of Health [R01 CM 18708, R01 CM 66825]; Danish Cancer Society [DP06117]; Karen Elise Jensen Foundation; Program for Clinical Research Infrastructure established by the Lundbeck; Novo Nordisk Foundations; Susan G. Komen for the Cure [CCR13264024]; Mary Kay Foundation [003-14]; Lundbeck Foundation [R1672013-15861]; Lundbeck Foundation [R155-2014-2647, R167-2013-15861] Funding Source: researchfish; Novo Nordisk Fonden [NNF14SA0015794] Funding Source: researchfish	Danish Medical Research Council(Danish Medical Research CouncilUK Research & Innovation (UKRI)Medical Research Council UK (MRC)); U.S. National Cancer Institute at the U.S. National Institutes of Health; Danish Cancer Society(Danish Cancer Society); Karen Elise Jensen Foundation; Program for Clinical Research Infrastructure established by the Lundbeck; Novo Nordisk Foundations(Novo Nordisk Foundation); Susan G. Komen for the Cure(Susan G. Komen Breast Cancer Foundation); Mary Kay Foundation; Lundbeck Foundation(Lundbeckfonden); Lundbeck Foundation(Lundbeckfonden); Novo Nordisk Fonden(Novo Nordisk Foundation)	This study was supported by the Danish Medical Research Council [DOK 1158859 (T. L. Lash)], U.S. National Cancer Institute at the U.S. National Institutes of Health [R01 CM 18708 and R01 CM 66825 (T. L. Lash)]; Danish Cancer Society [DP06117 (S. Hamilton-Dutoit)]; Karen Elise Jensen Foundation (H. T. Sorensen); Henrik Toft Sorensen is supported by the Program for Clinical Research Infrastructure established by the Lundbeck and the Novo Nordisk Foundations; Susan G. Komen for the Cure [CCR13264024 (T. Ahern)]; The Mary Kay Foundation [003-14 (T. Ahern)]; and the Lundbeck Foundation [R1672013-15861 (D.P. Cronin-Fenton)]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abe O, 2005, LANCET, V365, P1687, DOI 10.1016/s0140-6736(05)66544-0; Ali S, 2000, J MAMMARY GLAND BIOL, V5, P271, DOI 10.1023/A:1009594727358; Beelen K, 2012, NAT REV CLIN ONCOL, V9, P529, DOI 10.1038/nrclinonc.2012.121; Burstein HJ, 2012, J CLIN ONCOL, V30, P684, DOI 10.1200/JCO.2011.40.1455; Carreno G, 2007, BREAST CANCER RES TR, V102, P61, DOI 10.1007/s10549-006-9310-0; Chlebowski RT, 2013, CLIN BREAST CANCER, V13, P159, DOI 10.1016/j.clbc.2012.11.002; Christiansen P, 2008, ACTA ONCOL, V47, P691, DOI 10.1080/02841860802056594; Cronin-Fenton DP, 2012, ACTA ONCOL, V51, P254, DOI 10.3109/0284186X.2011.633556; Cuzick J, 2010, LANCET ONCOL, V11, P1135, DOI 10.1016/S1470-2045(10)70257-6; Davies C, 2011, LANCET, V378, P771, DOI 10.1016/S0140-6736(11)60993-8; DIEZITZA I, 1994, AM J PATHOL, V144, P310; Do Carmo S, 2007, BBA-MOL CELL RES, V1773, P954, DOI 10.1016/j.bbamcr.2007.03.007; Ellis MJ, 2008, J NATL CANCER I, V100, P1380, DOI 10.1093/jnci/djn309; Gonzalez-Angulo AM, 2007, ADV EXP MED BIOL, V608, P1; Harding C, 2000, BRIT J CANCER, V82, P354, DOI 10.1054/bjoc.1999.0926; Harris L, 2007, J CLIN ONCOL, V25, P5287, DOI 10.1200/JCO.2007.14.2364; Jensena AR, 2003, EUR J CANCER, V39, P1783, DOI 10.1016/S0959-8049(03)00377-0; Kelly E, 2015, J CLIN PHARM THER, V40, P76, DOI 10.1111/jcpt.12227; Lamelas M L, 2000, Int J Surg Investig, V2, P285; Lash TL, 2011, JNCI-J NATL CANCER I, V103, P489, DOI 10.1093/jnci/djr010; McDonnell DP, 2010, CURR OPIN PHARMACOL, V10, P620, DOI 10.1016/j.coph.2010.09.007; Milani A, 2014, WORLD J CLIN ONCOL, V5, P990, DOI 10.5306/wjco.v5.i5.990; Moller S, 2008, ACTA ONCOL, V47, P506, DOI 10.1080/02841860802059259; National Comprehensive Cancer Network, STAG 1 2 BREAST CANC; National Comprehensive Cancer Network, 2014, STAG 3 BREAST CANC V; Rassart E, 2000, BBA-PROTEIN STRUCT M, V1482, P185, DOI 10.1016/S0167-4838(00)00162-X; Rastelli F, 2008, TUMORI J, V94, P370; Riggins RB, 2007, CANCER LETT, V256, P1, DOI 10.1016/j.canlet.2007.03.016; Schmidt M, 2014, EUR J EPIDEMIOL, V29, P541, DOI 10.1007/s10654-014-9930-3; SIMARD J, 1990, ENDOCRINOLOGY, V126, P3223, DOI 10.1210/endo-126-6-3223; Soiland H, 2007, CELL ONCOL, V29, P195; Soiland H, 2009, ACTA ONCOL, V48, P514, DOI 10.1080/02841860802620613; Soiland H, 2009, BREAST CANCER RES TR, V113, P519, DOI 10.1007/s10549-008-9955-y; SOREIDE JA, 1991, ANTICANCER RES, V11, P601; SOREIDE JA, 1994, ANTICANCER RES, V14, P2105; Surveillance Epidemiology and End Results (SEER), 2009, SEER STAT FACT SHEET; Tao Z, 2014, BREAST CANC EPIDEMIO; Union for International Cancer Control, 1997, TNM CLASSIFICATION M; Viedma-Rodriguez R, 2014, ONCOL REP, V32, P3, DOI 10.3892/or.2014.3190; Yager JD, 2006, NEW ENGL J MED, V354, P270, DOI 10.1056/NEJMra050776	40	7	8	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 16	2017	12	3							e0171253	10.1371/journal.pone.0171453	http://dx.doi.org/10.1371/journal.pone.0171453			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN9KE	28301514	Green Submitted, Green Published, gold			2022-12-27	WOS:000396318300012
J	Nicovich, PR; Walsh, J; Bocking, T; Gaus, K				Nicovich, Philip R.; Walsh, James; Boecking, Till; Gaus, Katharina			NicoLase-An open-source diode laser combiner, fiber launch, and sequencing controller for fluorescence microscopy	PLOS ONE			English	Article								Modern fluorescence microscopy requires software-controlled illumination sources with high power across a wide range of wavelengths. Diode lasers meet the power requirements and combining multiple units into a single fiber launch expands their capability across the required spectral range. We present the NicoLase, an open-source diode laser combiner, fiber launch, and software sequence controller for fluorescence microscopy and super-resolution microscopy applications. Two configurations are described, giving four or six output wavelengths and one or two single-mode fiber outputs, with all CAD files, machinist drawings, and controller source code openly available.	[Nicovich, Philip R.; Boecking, Till; Gaus, Katharina] Univ New South Wales, ARC Ctr Excellence Adv Mol Imaging, Sydney, NSW, Australia; [Nicovich, Philip R.; Walsh, James; Boecking, Till; Gaus, Katharina] Univ New South Wales, Sch Med Sci, EMBL Australia Node Single Mol Sci, Sydney, NSW, Australia; [Nicovich, Philip R.] Allen Inst Brain Sci, Seattle, WA USA	University of New South Wales Sydney; University of New South Wales Sydney; Allen Institute for Brain Science	Nicovich, PR (corresponding author), Univ New South Wales, ARC Ctr Excellence Adv Mol Imaging, Sydney, NSW, Australia.; Nicovich, PR (corresponding author), Univ New South Wales, Sch Med Sci, EMBL Australia Node Single Mol Sci, Sydney, NSW, Australia.	rustyn@alleninstitute.org	Böcking, Till/A-5829-2010	Böcking, Till/0000-0003-1165-3122; Gaus, Katharina/0000-0002-8009-9658; Walsh, James/0000-0003-0447-2323; Nicovich, Philip/0000-0002-8517-4469	Australian Research Council [LP140100967, DP130100936]; ARC Centre of Excellence in Advanced Molecular Imaging [CE140100011]; National Health and Medical Research Council of Australia [1059278, 1037320, APP1100771]; Cancer Institute of New South Wales [2016/REG005]	Australian Research Council(Australian Research Council); ARC Centre of Excellence in Advanced Molecular Imaging(Australian Research Council); National Health and Medical Research Council of Australia(National Health and Medical Research Council (NHMRC) of Australia); Cancer Institute of New South Wales	This work was supported by the Australian Research Council; grant numbers LP140100967 (to KG and PRN) and DP130100936 (to TB). Authors also acknowledge funding from the ARC Centre of Excellence in Advanced Molecular Imaging (CE140100011 to KG), National Health and Medical Research Council of Australia (1059278 and 1037320 to KG; APP1100771 to TB), and the Cancer Institute of New South Wales (2016/REG005 to KG).	Cverna F., 2002, ASM READY REFERENCE; Davey AM, 2012, METHOD ENZYMOL, V506, P265, DOI 10.1016/B978-0-12-391856-7.00038-X; Edelstein A., 2010, CURR PROTOC MOL BIOL, P20, DOI [DOI 10.1002/0471142727.MB1420S92, 10.1002/0471142727.mb1420s92]; Hellen E H, 1991, J Fluoresc, V1, P113, DOI 10.1007/BF00865207; Huisken J, 2007, OPT LETT, V32, P2608, DOI 10.1364/OL.32.002608; Lee NK, 2005, BIOPHYS J, V88, P2939, DOI 10.1529/biophysj.104.054114; Paschotta R., 2008, ENCY LASER PHYS TECH; Patterson GH, 2002, SCIENCE, V297, P1873, DOI 10.1126/science.1074952; Pitrone PG, 2013, NAT METHODS, V10, P598, DOI 10.1038/nmeth.2507; Rietdorf J, 2006, SPECIAL OPTICAL ELEM, P43, DOI DOI 10.1007/978-0-387-45524-2_; Stuurman N, 2015, DIGITAL MICROSCOPY; Vortran Laser Technology Inc, STRAT LAS US MAN	12	17	17	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 16	2017	12	3							e0173879	10.1371/journal.pone.0173879	http://dx.doi.org/10.1371/journal.pone.0173879			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN9KE	28301563	Green Submitted, gold, Green Published			2022-12-27	WOS:000396318300088
J	Opiol, H; de Zavalia, N; Delorme, T; Solis, P; Rutherford, S; Shalev, U; Amir, S				Opiol, Hanna; de Zavalia, Nuria; Delorme, Tara; Solis, Pavel; Rutherford, Spencer; Shalev, Uri; Amir, Shimon			Exploring the role of locomotor sensitization in the circadian food entrainment pathway	PLOS ONE			English	Article							RATS MOTOR RESPONSE; BEHAVIORAL SENSITIZATION; COCAINE SENSITIZATION; ANTICIPATORY ACTIVITY; CROSS-SENSITIZATION; LIMBIC FOREBRAIN; SELF-STIMULATION; PERIOD2 PROTEIN; DORSAL STRIATUM; DRUG REWARD	Food entrainment is the internal mechanism whereby the phase and period of circadian clock genes comes under the control of daily scheduled food availability. Food entrainment allows the body to efficiently realign the internal timing of behavioral and physiological functions such that they anticipate food intake. Food entrainment can occur with or without caloric restriction, as seen with daily schedules of restricted feeding (RF) or restricted treat (RT) that restrict food or treat intake to a single feeding time. However, the extent of clock gene control is more pronounced with caloric restriction, highlighting the role of energy balance in regulating clock genes. Recent studies have implicated dopamine (DA) to be involved in food entrainment and caloric restriction is known to affect dopaminergic pathways to enhance locomotor activity. Since food entrainment results in the development of a distinct behavioral component, called food anticipatory activity (FAA), we examined the role of locomotor sensitization (LS) in food entrainment by 1) observing whether amphetamine (AMPH) sensitization results in enhanced locomotor output of FAA and 2) measuring LS of circadian and non-circadian feeding paradigms to an acute injection of AMPH (AMPH cross-sensitization). Unexpectedly, AMPH sensitization did not show enhancement of FAA. On the contrary, LS did develop with sufficient exposure to RF. LS was present after 2 weeks of RF, but not after 1, 3 or 7 days into RF. When food was returned and rats regain their original body weight at 10-15 days post-RF, LS remained present. LS did not develop to RT, nor to feedings of a non-circadian schedule, e.g. variable restricted feeding (VRF) or variable RT (VRT). Further, when RF was timed to the dark period, LS was observed only when tested at night; RF timed to the light period resulted in LS that was present during day and night. Taken together our results show that LS develops with food entrainment to RF, an effect that is dependent on the chronicity and circadian phase of RF but independent of body weight. Given that LS involves reorganization of DA-regulated motor circuitry, our work provides indirect support for the role of DA in the food entrainment pathway of RF. The findings also suggest differences in neuronal pathways involved in LS from AMPH sensitization and LS from RF.	[Opiol, Hanna; de Zavalia, Nuria; Delorme, Tara; Solis, Pavel; Rutherford, Spencer; Shalev, Uri; Amir, Shimon] Concordia Univ, Ctr Studies Behav Neurobiol, Dept Psychol, Montreal, PQ, Canada	Concordia University - Canada	Amir, S (corresponding author), Concordia Univ, Ctr Studies Behav Neurobiol, Dept Psychol, Montreal, PQ, Canada.	shimon.amir@concordia.ca	Rutherford, Spencer/GPS-9422-2022; Amir, Shimon/AAE-4635-2022; Shalev, Uri/I-1803-2019	Shalev, Uri/0000-0002-7860-6016	Canadian Institutes of Health Research [MOP142458]; Natural Sciences and Engineering Council of Canada [37358-2013]; Fonds de Recherche Sante Quebec [5833]; Natural Sciences and Engineering Research Council of Canada; Les Fonds de la recherche en sante Quebec; Canadian Institutes for Health Research	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Natural Sciences and Engineering Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)); Fonds de Recherche Sante Quebec; Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); Les Fonds de la recherche en sante Quebec; Canadian Institutes for Health Research(Canadian Institutes of Health Research (CIHR))	This work received support from: Canadian Institutes of Health Research (MOP142458) http://www.cihr-irsc.gc.ca/; Natural Sciences and Engineering Council of Canada (37358-2013) http://www.nserc-crsng.gc.ca/; and Fonds de Recherche Sante Quebec (5833) http://www.frqs.gouv.qc.ca/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This work was supported by grants from the Natural Sciences and Engineering Research Council of Canada, Les Fonds de la recherche en sante Quebec, and the Canadian Institutes for Health Research.	Abarca C, 2002, P NATL ACAD SCI USA, V99, P9026, DOI 10.1073/pnas.142039099; ABRAHAMSEN GC, 1995, BRAIN RES, V695, P186, DOI 10.1016/0006-8993(95)00764-H; Angeles-Castellanos M, 2008, NEUROSCIENCE, V155, P297, DOI 10.1016/j.neuroscience.2008.06.001; Arvanitogiannis A, 2000, NEUROSCIENCE, V101, P1, DOI 10.1016/S0306-4522(00)00401-2; Avena NA, 2003, PHARMACOL BIOCHEM BE, V74, P635, DOI 10.1016/S0091-3057(02)01050-X; Avena NM, 2003, NEUROSCIENCE, V122, P17, DOI 10.1016/S0306-4522(03)00502-5; Badiani A, 2004, BEHAV PHARMACOL, V15, P327, DOI 10.1097/00008877-200409000-00004; Beyer CE, 2002, CEREB CORTEX, V12, P526, DOI 10.1093/cercor/12.5.526; Blum ID, 2014, ELIFE, V3, DOI 10.7554/eLife.05105; Browman KE, 1998, PSYCHOPHARMACOLOGY, V137, P90, DOI 10.1007/s002130050597; Cabib S, 2000, SCIENCE, V289, P463, DOI 10.1126/science.289.5478.463; Carr KD, 2002, PHYSIOL BEHAV, V76, P353, DOI 10.1016/S0031-9384(02)00759-X; Carr KD, 2003, NEUROSCIENCE, V119, P1157, DOI 10.1016/S0306-4522(03)00227-6; CARR KD, 1993, BRAIN RES, V607, P141, DOI 10.1016/0006-8993(93)91499-I; Carr KD, 2007, PHYSIOL BEHAV, V91, P459, DOI 10.1016/j.physbeh.2006.09.021; Chaix A, 2016, TRENDS ENDOCRIN MET, V27, P350, DOI 10.1016/j.tem.2016.03.014; de Vaca SC, 2004, PSYCHOPHARMACOLOGY, V175, P106, DOI 10.1007/s00213-003-1768-4; de Vaca SC, 1998, J NEUROSCI, V18, P7502; Escobar C, 2007, EUR J NEUROSCI, V26, P2804, DOI 10.1111/j.1460-9568.2007.05893.x; Feillet CA, 2006, CURR BIOL, V16, P2016, DOI 10.1016/j.cub.2006.08.053; Fletcher PJ, 2005, PSYCHOPHARMACOLOGY, V183, P190, DOI 10.1007/s00213-005-0157-6; Flores DEFL, 2016, FRONT BEHAV NEUROSCI, V10, DOI 10.3389/fnbeh.2016.00143; Frederick A, 2015, DISTRIBUTED NETWORKS, P52; Fulton S, 2000, SCIENCE, V287, P125, DOI 10.1126/science.287.5450.125; Gallardo CM, 2014, ELIFE, V3, DOI 10.7554/eLife.03781; Gaytan O, 1998, PHARMACOL BIOCHEM BE, V59, P459, DOI 10.1016/S0091-3057(97)00438-3; Gaytan O, 1998, EUR J PHARMACOL, V345, P119, DOI 10.1016/S0014-2999(97)01558-6; Hood S, 2010, J NEUROSCI, V30, P14046, DOI 10.1523/JNEUROSCI.2128-10.2010; Hsu CT, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015429; Iijima M, 2002, EUR J NEUROSCI, V16, P921, DOI 10.1046/j.1460-9568.2002.02140.x; Imbesi M, 2009, NEUROSCIENCE, V158, P537, DOI 10.1016/j.neuroscience.2008.10.044; KALIVAS PW, 1993, BEHAV PHARMACOL, V4, P315; Kosobud AEK, 1998, NEUROSCI LETT, V250, P99, DOI 10.1016/S0304-3940(98)00439-X; Landry GJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040895; Liu Y, 2007, NEUROSCIENCE, V146, P265, DOI 10.1016/j.neuroscience.2007.01.009; Liu Y, 2005, NEUROSCIENCE, V130, P383, DOI 10.1016/j.neuroscience.2004.09.012; Liu YY, 2012, J BIOL RHYTHM, V27, P398, DOI 10.1177/0748730412455913; McClung CA, 2005, P NATL ACAD SCI USA, V102, P9377, DOI 10.1073/pnas.0503584102; McClung CA, 2008, NEUROPSYCHOPHARMACOL, V33, P3, DOI 10.1038/sj.npp.1301544; MISTLBERGER R, 1987, PHYSIOL BEHAV, V41, P219, DOI 10.1016/0031-9384(87)90356-8; MISTLBERGER RE, 1992, BEHAV BRAIN RES, V47, P159, DOI 10.1016/S0166-4328(05)80122-6; Opiol H, 2015, BEHAV BRAIN RES, V284, P42, DOI 10.1016/j.bbr.2015.02.003; Palmiter RD, 2008, ANN NY ACAD SCI, V1129, P35, DOI 10.1196/annals.1417.003; Patton DF, 2013, FRONT NEUROSCI-SWITZ, V7, DOI 10.3389/fnins.2013.00185; PAULSON PE, 1995, SYNAPSE, V19, P56, DOI 10.1002/syn.890190108; Paulson PE, 1996, NEUROPSYCHOPHARMACOL, V14, P325, DOI 10.1016/0893-133X(95)00141-Y; Pierce RC, 1997, BRAIN RES REV, V25, P192, DOI 10.1016/S0165-0173(97)00021-0; ROBINSON TE, 1993, BRAIN RES REV, V18, P247, DOI 10.1016/0165-0173(93)90013-P; Sahar S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008561; Singer BF, 2012, BEHAV BRAIN RES, V226, P340, DOI 10.1016/j.bbr.2011.09.003; Smit AN, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082381; Song SS, 2014, FRONT BEHAV NEUROSCI, V8, DOI 10.3389/fnbeh.2014.00336; STEWART J, 1993, BEHAV PHARMACOL, V4, P289; Vanderschuren LJMJ, 2010, CURR TOP BEHAV NEURO, V3, P179, DOI 10.1007/7854_2009_21; Verwey M, 2007, NEUROSCIENCE, V147, P277, DOI 10.1016/j.neuroscience.2007.04.044; Verwey M, 2011, NEUROSCIENCE, V192, P304, DOI 10.1016/j.neuroscience.2011.07.016; Verwey M, 2009, EUR J NEUROSCI, V30, P1650, DOI 10.1111/j.1460-9568.2009.06960.x; Verwey M, 2008, NEUROSCI LETT, V440, P54, DOI 10.1016/j.neulet.2008.05.043; Verwey M, 2012, J MOL NEUROSCI, V46, P258, DOI 10.1007/s12031-011-9529-z; VEZINA P, 1989, BRAIN RES, V499, P108, DOI 10.1016/0006-8993(89)91140-2; Vezina P, 1996, J NEUROSCI, V16, P2411	61	3	3	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 16	2017	12	3							e0174113	10.1371/journal.pone.0174113	http://dx.doi.org/10.1371/journal.pone.0174113			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN9KE	28301599	Green Submitted, Green Published, gold, Green Accepted			2022-12-27	WOS:000396318300128
J	Salzberg, AC; Harris-Becker, A; Popova, EY; Keasey, N; Loughran, TP; Claxton, DF; Grigoryev, SA				Salzberg, Anna C.; Harris-Becker, Abigail; Popova, Evgenya Y.; Keasey, Nikki; Loughran, Thomas P.; Claxton, David F.; Grigoryev, Sergei A.			Genome-wide mapping of histone H3K9me2 in acute myeloid leukemia reveals large chromosomal domains associated with massive gene silencing and sites of genome instability	PLOS ONE			English	Article							HEMATOPOIETIC STEM-CELLS; METHYLTRANSFERASE G9A; CHROMATIN-STRUCTURE; HETEROCHROMATIN; DNA; CANCER; METHYLATION; ERG; ORGANIZATION; DYNAMICS	A facultative heterochromatin mark, histone H3 lysine 9 dimethylation (H3K9me2), which is mediated by histone methyltransferases G9a/GLP (EHMT2/1), undergoes dramatic rearrangements during myeloid cell differentiation as observed by chromatin imaging. To determine whether these structural transitions also involve genomic repositioning of H3K9me2, we used ChIP-sequencing to map genome-wide topography of H3K9me2 in normal human granulocytes, normal CD34+ hematopoietic progenitors, primary myeloblasts from acute myeloid leukemia (AML) patients, and a model leukemia cell line K562. We observe that H3K9me2 naturally repositions from the previously designated "repressed" chromatin state in hematopoietic progenitors to predominant association with heterochromatin regions in granulocytes. In contrast, AML cells accumulate H3K9me2 on previously undefined large (> 100 Kb) genomic blocks that are enriched with AML -specific single nucleotide variants, sites of chromosomal translocations, and genes downregulated in AML. Specifically, the AML -specific H3K9me2 blocks are enriched with genes regulated by the proto-oncogene ERG that promotes stem cell characteristics. The AML -enriched H3K9me2 blocks (in contrast to the heterochromatin-associated H3K9me2 blocks enriched in granulocytes) are reduced by pharmacological inhibition of the histone methyltransferase G9a/GLP in K562 cells concomitantly with transcriptional activation of ERG and ETS1 oncogenes. Our data suggest that G9a/GLP mediate formation of transient H3K9me2 blocks that are preserved in AML myeloblasts and may lead to an increased rate of AML -specific mutagenesis and chromosomal translocations.	[Salzberg, Anna C.] Div Biostat & Bioinformat, Hershey, PA USA; [Salzberg, Anna C.] Penn State Inst Personalized Med, Hershey, PA USA; [Harris-Becker, Abigail; Grigoryev, Sergei A.] Penn State Coll Med, Dept Biochem & Mol Biol, H171, Hershey, PA USA; [Popova, Evgenya Y.] Penn State Coll Med, Dept Neural & Behav Sci, Hershey, PA USA; [Keasey, Nikki; Claxton, David F.] Milton S Hershey Med Ctr, Penn State Canc Inst, 500 Univ Dr, Hershey, PA USA; [Loughran, Thomas P.] Univ Virginia, Ctr Canc, Charlottesville, VA 22908 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Penn State Health; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Penn State Health; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Penn State Health; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Penn State Health; University of Virginia	Grigoryev, SA (corresponding author), Penn State Coll Med, Dept Biochem & Mol Biol, H171, Hershey, PA USA.; Claxton, DF (corresponding author), Milton S Hershey Med Ctr, Penn State Canc Inst, 500 Univ Dr, Hershey, PA USA.	dclaxton@hmc.psu.edu; sag17@psu.edu			Pennsylvania Department of Health [4100050904]; Penn State Hershey Clinical and Translational Science Institute; NATIONAL CANCER INSTITUTE [P01CA171983] Funding Source: NIH RePORTER; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR002014, UL1TR000127] Funding Source: NIH RePORTER	Pennsylvania Department of Health; Penn State Hershey Clinical and Translational Science Institute; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS))	Support was provided by Pennsylvania Department of Health using Tobacco Settlement Funds Grant 4100050904. The Department specifically disclaims responsibility for any analyses, interpretations, or conclusions (Recipients: SAG, DFC, TPL). Support was also provided by Penn State Hershey Clinical and Translational Science Institute grant (Recipients: SAG, DFC).	Barski A, 2007, CELL, V129, P823, DOI 10.1016/j.cell.2007.05.009; Berger SL, 2009, GENE DEV, V23, P781, DOI 10.1101/gad.1787609; Capala ME, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0111568; Chen JK, 2013, NAT GENET, V45, P34, DOI 10.1038/ng.2491; Chen M, 2015, GENE DEV, V29, P2123, DOI 10.1101/gad.267278.115; Chen XJ, 2012, GENE DEV, V26, P2499, DOI 10.1101/gad.200329.112; Coligan SE, 1991, CURRENT PROTOCOLS IM; Coolen MW, 2010, NAT CELL BIOL, V12, P235, DOI 10.1038/ncb2023; Corces MR, 2016, NAT GENET, V48, P1193, DOI 10.1038/ng.3646; Cullen SM, 2014, CURR TOP DEV BIOL, V107, P39, DOI 10.1016/B978-0-12-416022-4.00002-0; Dawson MA, 2012, CELL, V150, P12, DOI 10.1016/j.cell.2012.06.013; de Hoon MJL, 2004, BIOINFORMATICS, V20, P1453, DOI 10.1093/bioinformatics/bth078; Dunham I, 2012, NATURE, V489, P57, DOI 10.1038/nature11247; Egelhofer TA, 2011, NAT STRUCT MOL BIOL, V18, P91, DOI 10.1038/nsmb.1972; Eppert K, 2011, NAT MED, V17, P1086, DOI 10.1038/nm.2415; Ernst J, 2011, NATURE, V473, P43, DOI 10.1038/nature09906; Felsenfeld G, 2004, COLD SPRING HARB SYM, V69, P245, DOI 10.1101/sqb.2004.69.245; Friedman RC, 2009, GENOME RES, V19, P92, DOI 10.1101/gr.082701.108; Fritsch L, 2010, MOL CELL, V37, P46, DOI 10.1016/j.molcel.2009.12.017; GARDINERGARDEN M, 1987, J MOL BIOL, V196, P261, DOI 10.1016/0022-2836(87)90689-9; Gargiulo G, 2009, DEV CELL, V16, P466, DOI 10.1016/j.devcel.2009.02.002; Goodarzi AA, 2012, INT J MOL SCI, V13, P11844, DOI 10.3390/ijms130911844; Grigoryev SA, 2006, CHROMOSOME RES, V14, P53, DOI 10.1007/s10577-005-1021-6; Grigoryev SA, 1998, J BIOL CHEM, V273, P3082, DOI 10.1074/jbc.273.5.3082; Guelen L, 2008, NATURE, V453, P948, DOI 10.1038/nature06947; Hnisz D, 2016, SCIENCE, V351, P1454, DOI 10.1126/science.aad9024; Hu DQ, 2016, GENE DEV, V30, P2021, DOI 10.1101/gad.284109.116; Hublitz P, 2009, INT J DEV BIOL, V53, P335, DOI 10.1387/ijdb.082717ph; Jeong M, 2014, NAT GENET, V46, P17, DOI 10.1038/ng.2836; Johnson DS, 2007, SCIENCE, V316, P1497, DOI 10.1126/science.1141319; Kim JY, 2012, MOL CELL BIOL, V32, P2917, DOI 10.1128/MCB.00133-12; Kind J, 2013, CELL, V153, P178, DOI 10.1016/j.cell.2013.02.028; Knudsen KJ, 2015, GENE DEV, V29, P1915, DOI 10.1101/gad.268409.115; Korbling M, 2001, BLOOD, V98, P2900, DOI 10.1182/blood.V98.10.2900; Kornberg RD, 2007, NAT STRUCT MOL BIOL, V14, P986, DOI 10.1038/nsmb1107-986; Lehnertz B, 2014, GENE DEV, V28, P317, DOI 10.1101/gad.236794.113; Lukasova E, 2013, BBA-MOL CELL RES, V1833, P767, DOI 10.1016/j.bbamcr.2012.12.012; Maher K, 2014, J BIOL CHEM, V289, P31736, DOI 10.1074/jbc.M114.609396; Marcucci G, 2007, J CLIN ONCOL, V25, P3337, DOI 10.1200/JCO.2007.10.8720; Meissner A, 2008, NATURE, V454, P766, DOI 10.1038/nature07107; Mieczkowski J, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms11485; Mochmann LH, 2014, ONCOTARGET, V5, P351, DOI 10.18632/oncotarget.1449; Morgan MA, 2015, GENE DEV, V29, P238, DOI 10.1101/gad.255182.114; Mozzetta C, 2014, MOL CELL, V53, P277, DOI 10.1016/j.molcel.2013.12.005; Nekrasov M, 2012, NAT STRUCT MOL BIOL, V19, P1076, DOI 10.1038/nsmb.2424; Ng AP, 2011, BLOOD, V118, P2454, DOI 10.1182/blood-2011-03-344739; Nichols MH, 2015, CELL, V162, P702, DOI 10.1016/j.cell.2015.07.053; Pappano WN, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0131716; Pennacchio LA, 2006, NATURE, V444, P499, DOI 10.1038/nature05295; Peric-Hupkes D, 2010, MOL CELL, V38, P603, DOI 10.1016/j.molcel.2010.03.016; Peters AHFM, 2003, MOL CELL, V12, P1577, DOI 10.1016/S1097-2765(03)00477-5; Popova EY, 2013, J BIOL CHEM, V288, P17895, DOI 10.1074/jbc.M113.452144; Popova EY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046867; Popova EY, 2006, EXP HEMATOL, V34, P453, DOI 10.1016/j.exphem.2006.01.003; Richmond TJ, 2003, NATURE, V423, P145, DOI 10.1038/nature01595; Sabo PJ, 2006, NAT METHODS, V3, P511, DOI 10.1038/NMETH890; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Schuster-Bockler B, 2012, NATURE, V488, P504, DOI 10.1038/nature11273; Shema E, 2016, SCIENCE, V352, P717, DOI 10.1126/science.aad7701; Socitey LaL, 2014, LEUK LYMPH MYEL FACT; Son HJ, 2012, MOL CELL BIOL, V32, P3681, DOI 10.1128/MCB.00673-12; Song QA, 2011, BIOINFORMATICS, V27, P870, DOI 10.1093/bioinformatics/btr030; Sridharan R, 2013, NAT CELL BIOL, V15, P872, DOI 10.1038/ncb2768; Su RC, 2004, NAT GENET, V36, P502, DOI 10.1038/ng1351; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Supek F, 2015, NATURE, V521, P81, DOI 10.1038/nature14173; Suva ML, 2013, SCIENCE, V339, P1567, DOI 10.1126/science.1230184; Tachibana M, 2002, GENE DEV, V16, P1779, DOI 10.1101/gad.989402; Timp W, 2013, NAT REV CANCER, V13, P497, DOI 10.1038/nrc3486; Trojer P, 2007, MOL CELL, V28, P1, DOI 10.1016/j.molcel.2007.09.011; Tursky ML, 2015, LEUKEMIA, V29, P819, DOI 10.1038/leu.2014.299; Vedadi M, 2011, NAT CHEM BIOL, V7, P566, DOI [10.1038/NCHEMBIO.599, 10.1038/nchembio.599]; Vogel MJ, 2006, GENOME RES, V16, P1493, DOI 10.1101/gr.5391806; Wang SW, 2010, MOL BIOL CELL, V21, P821, DOI 10.1091/mbc.E09-06-0456; Welch JS, 2012, CELL, V150, P264, DOI 10.1016/j.cell.2012.06.023; Wen B, 2009, NAT GENET, V41, P246, DOI 10.1038/ng.297; Ye M, 2015, CELL STEM CELL, V17, P611, DOI 10.1016/j.stem.2015.08.011	77	19	20	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 16	2017	12	3							e0173723	10.1371/journal.pone.0173723	http://dx.doi.org/10.1371/journal.pone.0173723			30	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN9KE	28301528	Green Submitted, gold, Green Published			2022-12-27	WOS:000396318300067
J	Anand, S; Kondal, D; Montez-Rath, M; Zheng, Y; Shivashankar, R; Singh, K; Gupta, P; Gupta, R; Ajay, VS; Mohan, V; Pradeepa, R; Tandon, N; Ali, MK; Narayan, KMV; Chertow, GM; Kandula, N; Prabhakaran, D; Kanaya, AM				Anand, Shuchi; Kondal, Dimple; Montez-Rath, Maria; Zheng, Yuanchao; Shivashankar, Roopa; Singh, Kalpana; Gupta, Priti; Gupta, Ruby; Ajay, Vamadevan S.; Mohan, Viswanathan; Pradeepa, Rajendra; Tandon, Nikhil; Ali, Mohammed K.; Narayan, K. M. Venkat; Chertow, Glenn M.; Kandula, Namratha; Prabhakaran, Dorairaj; Kanaya, Alka M.			Prevalence of chronic kidney disease and risk factors for its progression: A cross-sectional comparison of Indians living in Indian versus US cities	PLOS ONE			English	Article							SOCIOECONOMIC-STATUS; SERUM CREATININE; UNITED-STATES; SOUTH ASIANS; MISSING DATA; POPULATION; CARRS; HEALTH; HYPERTENSION; METAANALYSIS	Background While data from the latter part of the twentieth century consistently showed that immigrants to high-income countries faced higher cardio-metabolic risk than their counterparts in low- and middle-income countries, urbanization and associated lifestyle changes may be changing these patterns, even for conditions considered to be advanced manifestations of cardio-metabolic disease (e.g., chronic kidney disease [CKD]). Methods and findings Using cross-sectional data from the Center for cArdiometabolic Risk Reduction in South Asia (CARRS, n = 5294) and Mediators of Atherosclerosis in South Asians Living in America (MASALA, n = 748) studies, we investigated whether prevalence of CKD is similar among Indians living in Indian and U.S. cities. We compared crude, age-, waist-to-height ratio-, and diabetes-adjusted CKD prevalence difference. Among participants identified to have CKD, we compared management of risk factors for its progression. Overall age-adjusted prevalence of CKD was similar in MASALA (14.0% [95% CI 11.8-16.3]) compared with CARRS (10.8% [95% CI 10.0-11.6]). Among men the prevalence difference was low (prevalence difference 1.8 [95% CI -1.6,5.3]) and remained low after adjustment for age, waist-to-height ratio, and diabetes status (-0.4 [-3.2,2.5]). Adjusted prevalence difference was higher among women (prevalence difference 8.9 [4.8,12.9]), but driven entirely by a higher prevalence of albuminuria among women in MASALA. Severity of CKD-i.e., degree of albuminuria and proportion of participants with reduced glomerular filtration fraction-was higher in CARRS for both men and women. Fewer participants with CKD in CARRS were effectively treated. 4% of CARRS versus 51% of MASALA participants with CKD had A1c < 7%; and 7% of CARRS versus 59% of MASALA participants blood pressure < 140/90 mmHg. Our analysis applies only to urban populations. Demographic-particularly educational attainment-differences among participants in the two studies are a potential source of bias. Conclusions Prevalence of CKD among Indians living in Indian and U.S. cities is similar. Persons with CKD living in Indian cities face higher likelihood of experiencing end-stage renal disease since they have more severe kidney disease and little evidence of risk factor management.	[Anand, Shuchi; Kondal, Dimple; Shivashankar, Roopa; Singh, Kalpana; Gupta, Priti; Gupta, Ruby; Ajay, Vamadevan S.; Tandon, Nikhil; Ali, Mohammed K.; Narayan, K. M. Venkat; Prabhakaran, Dorairaj] Publ Hlth Fdn India, Ctr Chron Condit & Injuries, New Delhi, India; [Anand, Shuchi; Kondal, Dimple; Shivashankar, Roopa; Singh, Kalpana; Gupta, Priti; Gupta, Ruby; Ajay, Vamadevan S.; Prabhakaran, Dorairaj] Ctr Chron Dis Control, New Delhi, India; [Anand, Shuchi; Montez-Rath, Maria; Zheng, Yuanchao; Chertow, Glenn M.] Stanford Univ, Sch Med, Div Nephrol, Palo Alto, CA 94304 USA; [Mohan, Viswanathan; Pradeepa, Rajendra] Madras Diabet Res Fdn, Madras, Tamil Nadu, India; [Mohan, Viswanathan; Pradeepa, Rajendra] Dr Mohans Diabet Specialties Ctr, Madras, Tamil Nadu, India; [Tandon, Nikhil] All India Inst Med Sci, Dept Endocrinol, New Delhi, India; [Ali, Mohammed K.; Narayan, K. M. Venkat] Emory Univ, Rollins Sch Publ Hlth, Atlanta, GA 30322 USA; [Kandula, Namratha] Northwestern Univ, Div Gen Internal Med, Chicago, IL 60611 USA; [Kandula, Namratha] Northwestern Univ, Dept Prevent Med, Chicago, IL 60611 USA; [Kanaya, Alka M.] Univ Calif San Francisco, Div Gen Internal Med, San Francisco, CA 94143 USA	Public Health Foundation of India; Stanford University; Madras Diabetes Research Foundation; All India Institute of Medical Sciences (AIIMS) New Delhi; Emory University; Rollins School Public Health; Northwestern University; Northwestern University; University of California System; University of California San Francisco	Anand, S (corresponding author), Publ Hlth Fdn India, Ctr Chron Condit & Injuries, New Delhi, India.; Anand, S (corresponding author), Ctr Chron Dis Control, New Delhi, India.; Anand, S (corresponding author), Stanford Univ, Sch Med, Div Nephrol, Palo Alto, CA 94304 USA.	sanand2@stanford.edu	Prabhakaran, Dorairaj/B-4147-2011; Ali, Mohammed K/N-9833-2013; Narayan, K.M. Venkat/J-9819-2012	Prabhakaran, Dorairaj/0000-0002-3172-834X; Narayan, K.M. Venkat/0000-0001-8621-5405; Ali, Mohammed/0000-0001-7266-2503; Ajay, Vamadevan S/0000-0002-4102-0505; Chertow, Glenn/0000-0002-7599-0534; Pradeepa, Rajendra/0000-0002-4909-3733	National Heart, Lung, and Blood Institute, at National Institutes of Health [HHSN2682009900026C, R01HL093009]; National Center for Advancing Translational Sciences, at National Institutes of Health [UL1 RR024131]; National Center for Research Resources; National Institute for Diabetes and Digestive and Kidney Health [K23 DK101826, K24 DK 085446]; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000040] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL093009, K24HL112827] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK092924, P30DK063720, P30DK098722, K23DK101826] Funding Source: NIH RePORTER	National Heart, Lung, and Blood Institute, at National Institutes of Health; National Center for Advancing Translational Sciences, at National Institutes of Health; National Center for Research Resources(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); National Institute for Diabetes and Digestive and Kidney Health; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by federal funds from the National Heart, Lung, and Blood Institute, at National Institutes of Health [Contract #HHSN2682009900026C, CARRS study; # R01HL093009, MASALA study]. Data collection at University of California San Francisco was also supported by the National Center for Research Resources and the National Center for Advancing Translational Sciences, at National Institutes of Health [grant # UL1 RR024131]. Dr. Anand is supported by National Institute for Diabetes and Digestive and Kidney Health [grant # K23 DK101826]. Dr. Chertow is supported by National Institute for Diabetes and Digestive and Kidney Health [grant # K24 DK 085446]. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Heart, Lung, And Blood Institute, National Institute for Diabetes and Digestive and Kidney Health, or the National Institutes of Health.	ADLER NE, 1994, AM PSYCHOL, V49, P15, DOI 10.1037/0003-066X.49.1.15; Ainsworth BE, 1999, J WOMEN HEALTH GEN-B, V8, P805, DOI 10.1089/152460999319129; Ali MK, 2016, EUR J PREV CARDIOL, V23, P408, DOI 10.1177/2047487315580891; Anchala R, 2014, J HYPERTENS, V32, P1170, DOI 10.1097/HJH.0000000000000146; Bello AK, 2007, NEPHROL DIAL TRANSPL, V22, P1619, DOI 10.1093/ndt/gfm091; BHATNAGAR D, 1995, LANCET, V345, P405; Bjork S, 2003, HEALTH POLICY, V66, P61, DOI 10.1016/S0168-8510(03)00044-7; Craig CL, 2003, MED SCI SPORT EXER, V35, P1381, DOI 10.1249/01.MSS.0000078924.61453.FB; Deepa M, 2015, DIABETES RES CLIN PR, V110, P172, DOI 10.1016/j.diabres.2015.09.005; Fox CS, 2012, LANCET, V380, P1662, DOI 10.1016/S0140-6736(12)61350-6; Gansevoort RT, 2005, KIDNEY INT, V67, pS28, DOI 10.1111/j.1523-1755.2005.09408.x; Gujral UP, 2015, DIABETES CARE, V38, P1312, DOI 10.2337/dc15-0032; Hasan H, 2012, DIABETES RES CLIN PR, V95, P189, DOI 10.1016/j.diabres.2011.09.021; Junge W, 2004, CLIN CHIM ACTA, V344, P137, DOI 10.1016/j.cccn.2004.02.007; Kanaya AM, 2013, CLIN CARDIOL, V36, P713, DOI 10.1002/clc.22219; Kelemen LE, 2003, J AM DIET ASSOC, V103, P1178, DOI 10.1016/S0002-8223(03)00985-4; Lee KJ, 2010, AM J EPIDEMIOL, V171, P624, DOI 10.1093/aje/kwp425; Levey AS, 2009, ANN INTERN MED, V150, P604, DOI 10.7326/0003-4819-150-9-200905050-00006; Liese AD, 2001, J HUM HYPERTENS, V15, P799, DOI 10.1038/sj.jhh.1001266; Luke A, 1997, AM J EPIDEMIOL, V145, P620, DOI 10.1093/oxfordjournals.aje.a009159; Matsushita K, 2010, LANCET, V375, P2073, DOI 10.1016/S0140-6736(10)60674-5; Mazzachi B C, 2000, Clin Lab, V46, P53; Mohan Deepa, 2005, J Assoc Physicians India, V53, P283; Montez-Rath ME, 2014, CLIN J AM SOC NEPHRO, V9, P1328, DOI 10.2215/CJN.10141013; Myers GL, 2006, CLIN CHEM, V52, P5, DOI 10.1373/clinchem.2005.0525144; Nair M, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-701; Peake Michael, 2006, Clin Biochem Rev, V27, P173; Perkovic V, 2006, BLOOD PRESSURE, V15, P340, DOI 10.1080/08037050601066074; Peyrot M, 2005, DIABETES CARE, V28, P2673, DOI 10.2337/diacare.28.11.2673; ROBERTSON TL, 1977, AM J CARDIOL, V39, P239, DOI 10.1016/S0002-9149(77)80197-5; Rosero-Bixby L, 2009, J GERONTOL B-PSYCHOL, V64, P105, DOI 10.1093/geronb/gbn004; Shaw PKC, 2007, DIABETES CARE, V30, P1840, DOI 10.2337/dc07-0028; Sonawane KB, 2015, CLIN THER, V37, P188, DOI 10.1016/j.clinthera.2014.11.011; Stevens PE, 2013, ANN INTERN MED, V158, P825, DOI 10.7326/0003-4819-158-11-201306040-00007; Wangnoo Subhash K, 2013, Indian J Endocrinol Metab, V17, P594, DOI 10.4103/2230-8210.113749; Wong MG, 2016, DIABETES CARE, V39, P694, DOI 10.2337/dc15-2322; Zou GY, 2004, AM J EPIDEMIOL, V159, P702, DOI 10.1093/aje/kwh090; Zoungas S, 2009, DIABETES CARE, V32, P2068, DOI 10.2337/dc09-0959	38	13	13	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 15	2017	12	3							e0173554	10.1371/journal.pone.0173554	http://dx.doi.org/10.1371/journal.pone.0173554			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN9HQ	28296920	Green Published, Green Accepted, Green Submitted, gold			2022-12-27	WOS:000396311700041
J	Lin, E; Kuo, PH; Liu, YL; Yang, AC; Kao, CF; Tsai, SJ				Lin, Eugene; Kuo, Po-Hsiu; Liu, Yu-Li; Yang, Albert C.; Kao, Chung-Feng; Tsai, Shih-Jen			Effects of circadian clock genes and health-related behavior on metabolic syndrome in a Taiwanese population: Evidence from association and interaction analysis	PLOS ONE			English	Article							OBESITY; PHENOTYPES; VARIANT; POLYMORPHISM; PREVALENCE; DISORDER; ALPHA; MASS	Increased risk of developing metabolic syndrome (MetS) has been associated with the circadian clock genes. In this study, we assessed whether 29 circadian clock-related genes (including ADCYAP1, ARNTL, ARNTL2, BHLHE40, CLOCK, CRY1, CRY2, CSNK1D, CSNK1E, GSK3B, HCRTR2, KLF10, NFIL3, NPAS2, NR1D1, NR1D2, PER1, PER2, PER3, REV1, RORA, RORB, RORC, SENP3, SERPINE1, TIMELESS, TIPIN, VIP, and VIPR2) are associated with MetS and its individual components independently and/or through complex interactions in a Taiwanese population. We also analyzed the interactions between environmental factors and these genes in influencing MetS and its individual components. A total of 3,000 Taiwanese subjects from the Taiwan Biobank were assessed in this study. Metabolic traits such as waist circumference, triglyceride, high-density lipoprotein cholesterol, systolic and diastolic blood pressure, and fasting glucose were measured. Our data showed a nominal association of MetS with several single nucleotide polymorphisms (SNPs) in five key circadian clock genes including ARNTL, GSK3B, PER3, RORA, and RORB; but none of these SNPs persisted significantly after performing Bonferroni correction. Moreover, we identified the effect of GSK3B rs2199503 on high fasting glucose (P = 0.0002). Additionally, we found interactions among the ARNTL rs10832020, GSK3B rs2199503, PER3 rs10746473, RORA rs8034880, and RORB rs972902 SNPs influenced MetS (P < 0.001 similar to P = 0.002). Finally, we investigated the influence of interactions between ARNTL rs10832020, GSK3B rs2199503, PER3 rs10746473, and RORB rs972902 with environmental factors such as alcohol consumption, smoking status, and physical activity on MetS and its individual components (P < 0.001 similar to P = 0.002). Our study indicates that circadian clock genes such as ARNTL, GSK3B, PER3, RORA, and RORB genes may contribute to the risk of MetS independently as well as through gene-gene and gene-environment interactions.	[Lin, Eugene] China Med Univ, Inst Biomed Sci, Taichung, Taiwan; [Lin, Eugene] Vita Genom Inc, Taipei, Taiwan; [Lin, Eugene] TickleFish Syst Corp, Seattle, WA USA; [Kuo, Po-Hsiu] Natl Taiwan Univ, Inst Epidemiol & Prevent Med, Dept Publ Hlth, Taipei, Taiwan; [Liu, Yu-Li] Natl Hlth Res Inst, Ctr Neuropsychiat Res, Zhunan Township, Miaoli County, Taiwan; [Yang, Albert C.; Tsai, Shih-Jen] Taipei Vet Gen Hosp, Dept Psychiat, Taipei, Taiwan; [Yang, Albert C.; Tsai, Shih-Jen] Natl Yang Ming Univ, Div Psychiat, Taipei, Taiwan; [Kao, Chung-Feng] Natl Chung Hsing Univ, Dept Agron, Coll Agr & Nat Resources, Taichung, Taiwan	China Medical University Taiwan; Vita Genomics Incorporated; National Taiwan University; National Health Research Institutes - Taiwan; Taipei Veterans General Hospital; National Yang Ming Chiao Tung University; National Chung Hsing University	Lin, E (corresponding author), China Med Univ, Inst Biomed Sci, Taichung, Taiwan.; Lin, E (corresponding author), Vita Genom Inc, Taipei, Taiwan.; Lin, E (corresponding author), TickleFish Syst Corp, Seattle, WA USA.; Tsai, SJ (corresponding author), Taipei Vet Gen Hosp, Dept Psychiat, Taipei, Taiwan.; Tsai, SJ (corresponding author), Natl Yang Ming Univ, Div Psychiat, Taipei, Taiwan.	eugene.lin@vitagenomics.com; tsai610913@gmail.com	Tsai, Shih-Jen/AAK-7944-2020	Tsai, Shih-Jen/0000-0002-9987-022X; Kuo, Po-Hsiu/0000-0003-0365-3587	Ministry of Economic Affairs in Taiwan [S099000280249-154]; Taipei Veterans General Hospital, Taiwan [VGHUST103-G1-4-1, V105C-008, V105E17-002-MY2-1]; National Health Research Institutes, Taiwan [NP-105-SP-04]; Ministry of Science and Technology, Taiwan [MST 102-2314-B-002-117-MY3]; Vita Genomics, Inc.	Ministry of Economic Affairs in Taiwan(Ministry of Economic Affairs, Taiwan); Taipei Veterans General Hospital, Taiwan(Taipei Veterans General Hospital); National Health Research Institutes, Taiwan(National Health Research Institutes - Taiwan); Ministry of Science and Technology, Taiwan(Ministry of Science and Technology, Taiwan); Vita Genomics, Inc.	This work was supported by the Ministry of Economic Affairs in Taiwan (http://www.moea.gov.tw/; SBIR Grant S099000280249-154; EL), by Taipei Veterans General Hospital, Taiwan (www.vghtpe.gov.tw/; Grants VGHUST103-G1-4-1, V105C-008, and V105E17-002-MY2-1; SJT), by National Health Research Institutes, Taiwan (www.nhri.org.tw/; Grant NP-105-SP-04; YLL), and by the Ministry of Science and Technology, Taiwan (https://www.most.gov.tw/; Grant MST 102-2314-B-002-117-MY3; PHK). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. The commercial affiliation, Vita Genomics, Inc., provided support in the form of salary for author EL, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific role of this author is articulated in the 'author contributions' section.	Buhr Ethan D, 2013, Handb Exp Pharmacol, P3, DOI 10.1007/978-3-642-25950-0_1; CHEN C, 2016, HUM MOL GENET; Chen H, 2016, P NATL ACAD SCI USA, V113, P5754, DOI 10.1073/pnas.1601355113; Costa MJ, 2011, J BIOL CHEM, V286, P9063, DOI 10.1074/jbc.M110.164558; Dallmann R, 2010, CHRONOBIOL INT, V27, P1317, DOI 10.3109/07420528.2010.489166; Duez H, 2009, J APPL PHYSIOL, V107, P1972, DOI 10.1152/japplphysiol.00570.2009; Englund Ani, 2009, J Circadian Rhythms, V7, P5, DOI 10.1186/1740-3391-7-5; Fan CT, 2008, PHARMACOGENOMICS, V9, P235, DOI 10.2217/14622416.9.2.235; Ford ES, 2002, JAMA-J AM MED ASSOC, V287, P356, DOI 10.1001/jama.287.3.356; Gomez-Abellan P, 2008, INT J OBESITY, V32, P121, DOI 10.1038/sj.ijo.0803689; Gonzalez R, 2015, J AFFECT DISORDERS, V186, P367, DOI 10.1016/j.jad.2015.07.014; Hsiao TJ, 2017, DIABETES METAB, V43, P83, DOI 10.1016/j.diabet.2016.05.003; Hsiao TJ, 2016, BIOCHEM GENET, V54, P830, DOI 10.1007/s10528-016-9760-y; Hsiao TJ, 2016, J GENET, V95, P595, DOI 10.1007/s12041-016-0671-9; Hsiao TJ, 2016, MOL CELL ENDOCRINOL, V433, P20, DOI 10.1016/j.mce.2016.05.020; Hsiao TJ, 2015, ENDOCRINE, V48, P786, DOI 10.1007/s12020-014-0407-7; Hsiao TJ, 2014, J INVEST MED, V62, P310, DOI 10.2310/JIM.0000000000000030; Hsiao TJ, 2014, GENE, V533, P32, DOI 10.1016/j.gene.2013.10.016; Hsiao TJ, 2013, GENES NUTR, V8, P137, DOI 10.1007/s12263-012-0304-8; Hwang LC, 2006, J FORMOS MED ASSOC, V105, P626, DOI 10.1016/S0929-6646(09)60161-3; Jim HS, 2015, J GENET GENOME RES, V2; Kaidanovich-Beilin O, 2011, FRONT MOL NEUROSCI, V4, DOI 10.3389/fnmol.2011.00040; Kang HS, 2011, PHYSIOL GENOMICS, V43, P818, DOI 10.1152/physiolgenomics.00206.2010; Kovanen L, 2015, HYPERTENS RES, V38, P186, DOI 10.1038/hr.2014.157; Lane HY, 2012, MOL DIAGN THER, V16, P15, DOI 10.2165/11597270-000000000-00000; Lee SH, 2013, HUM MOL GENET, V22, P832, DOI 10.1093/hmg/dds491; Lin E, 2017, PLOS ONE IN PRESS; Lin E, 2017, ONCOTARGET IN PRESS; Lin E, 2017, DEMENT GERIATR COGN, V43, P119, DOI 10.1159/000455833; Liou YJ, 2012, PHARMACOGENOMICS J, V12, P54, DOI 10.1038/tpj.2010.74; Liu AC, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000023; Lou XY, 2007, AM J HUM GENET, V80, P1125, DOI 10.1086/518312; Mansour HA, 2009, BIPOLAR DISORD, V11, P701, DOI 10.1111/j.1399-5618.2009.00756.x; Marcheva Biliana, 2013, Handb Exp Pharmacol, P127, DOI 10.1007/978-3-642-25950-0_6; Marcheva B, 2010, NATURE, V466, P627, DOI 10.1038/nature09253; Maury E, 2014, DIABETES METAB, V40, P338, DOI 10.1016/j.diabet.2013.12.005; Pendergast JS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030254; Ribas-Latre A, 2016, MOL METAB, V5, P133, DOI 10.1016/j.molmet.2015.12.006; Rudic RD, 2004, PLOS BIOL, V2, P1893, DOI 10.1371/journal.pbio.0020377; Scott EM, 2008, INT J OBESITY, V32, P658, DOI 10.1038/sj.ijo.0803778; Shakes LA, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-451; Shimba S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025231; Storey JD, 2003, P NATL ACAD SCI USA, V100, P9440, DOI 10.1073/pnas.1530509100; Turek FW, 2005, SCIENCE, V308, P1043, DOI 10.1126/science.1108750; Wang H, 2003, MOL GENET METAB, V79, P176, DOI 10.1016/S1096-7192(03)00096-9; Woon PY, 2007, P NATL ACAD SCI USA, V104, P14412, DOI 10.1073/pnas.0703247104	46	27	28	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 15	2017	12	3							e0173861	10.1371/journal.pone.0173861	http://dx.doi.org/10.1371/journal.pone.0173861			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN9HQ	28296937	gold, Green Published, Green Submitted			2022-12-27	WOS:000396311700072
J	Lood, R; Molina, H; Fischetti, VA				Lood, Rolf; Molina, Henrik; Fischetti, Vincent A.			Determining bacteriophage endopeptidase activity using either fluorophore-quencher labeled peptides combined with liquid chromatography-mass spectrometry (LC-MS) or Forster resonance energy transfer (FRET) assays	PLOS ONE			English	Article							RESISTANT STAPHYLOCOCCUS-AUREUS; STREPTOCOCCUS-PYOGENES; ACTIVITY PROTECTS; PROTEASE; LYSIN; HYDROLASE; LYSOSTAPHIN; BACTEREMIA; INFECTION; SUBSTRATE	The necessity of identifying novel methods to combat infections caused by antibiotic resistant bacteria is increasing each year. Recent advancements in the development of peptidoglycan hydrolases (e.g. lysins) from bacterial viruses (bacteriophages) have revealed the efficiency of this class of enzymes in treating serious bacterial infections. Though promising results have been obtained regarding the lethal action of lysin on bacterial pathogens both in vitro and in vivo, an often-overlooked factor in these studies is precisely identifying their peptidoglycan cleavage site. This knowledge would be useful for following the activity of the enzyme during development, without the need for whole-organism lytic assays. However, more importantly, it would enable the selection of lysins with different cleavage activities that would act synergistically for enhanced efficacy. Here, we have developed two new methods to accurately identify the cleavage site of lysins using liquid chromatography mass spectrometry (LC-MS) on peptidoglycan-like fluorophore-quencher modified synthetic peptides, as well as determining the enzymatic action and kinetics of the enzymes on modified peptides in a Forster resonance energy transfer (FRET) assay. These methods should facilitate progress within the lysin field, accelerating the development of therapeutic lysins to combat antibiotic resistant bacterial infections.	[Lood, Rolf; Fischetti, Vincent A.] Rockefeller Univ, Lab Bacterial Pathogenesis & Immunol, 1230 York Ave, New York, NY 10021 USA; [Lood, Rolf] Lund Univ, Div Infect Med, Dept Clin Sci Lund, Lund, Sweden; [Molina, Henrik] Rockefeller Univ, Prote Resource Ctr, 1230 York Ave, New York, NY 10021 USA	Rockefeller University; Lund University; Rockefeller University	Fischetti, VA (corresponding author), Rockefeller Univ, Lab Bacterial Pathogenesis & Immunol, 1230 York Ave, New York, NY 10021 USA.	vaf@rockefeller.edu			Contrafect Inc; The Tegger Foundation	Contrafect Inc; The Tegger Foundation	This work was supported in part by Contrafect Inc to VAF (http://www.contrafect.com/), and by The Tegger Foundation to RL (http://teggerstatelsen.se/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Atrih A, 1999, J BACTERIOL, V181, P3956, DOI 10.1128/JB.181.13.3956-3966.1999; Cummings RT, 2002, P NATL ACAD SCI USA, V99, P6603, DOI 10.1073/pnas.062171599; Daniel A, 2010, ANTIMICROB AGENTS CH, V54, P1603, DOI 10.1128/AAC.01625-09; Fischetti VA, 2005, TRENDS MICROBIOL, V13, P491, DOI 10.1016/j.tim.2005.08.007; Fischetti VA, 2008, CURR OPIN MICROBIOL, V11, P393, DOI 10.1016/j.mib.2008.09.012; Gargis SR, 2009, APPL ENVIRON MICROB, V75, P72, DOI 10.1128/AEM.01647-08; Gilmer DB, 2013, ANTIMICROB AGENTS CH, V57, P2743, DOI 10.1128/AAC.02526-12; Hu HY, 2014, BIOTECHNOL J, V9, P266, DOI 10.1002/biot.201300201; Jin S, 2011, BIOTECHNOL PROGR, V27, P1107, DOI 10.1002/btpr.628; Kumar JK, 2008, APPL MICROBIOL BIOT, V80, P555, DOI 10.1007/s00253-008-1579-y; Linden SB, 2015, APPL MICROBIOL BIOT, V99, P741, DOI 10.1007/s00253-014-5930-1; Loeffler JM, 2001, SCIENCE, V294, P2170, DOI 10.1126/science.1066869; Lood R, 2015, ANTIMICROB AGENTS CH, V59, P1983, DOI 10.1128/AAC.04641-14; Lood R, 2014, ANTIMICROB AGENTS CH, V58, P3073, DOI 10.1128/AAC.00115-14; Lu JZQ, 2006, J BIOL CHEM, V281, P549, DOI 10.1074/jbc.M509691200; Lutzner N, 2009, BIOCHEM BIOPH RES CO, V380, P554, DOI 10.1016/j.bbrc.2009.01.140; MacLean B, 2010, BIOINFORMATICS, V26, P966, DOI 10.1093/bioinformatics/btq054; MAEDA H, 1980, J BIOCHEM-TOKYO, V88, P1185, DOI 10.1093/oxfordjournals.jbchem.a133073; Michael CA, 2014, FRONT PUBLIC HEALTH, V2, DOI 10.3389/fpubh.2014.00145; Navarre WW, 1999, J BIOL CHEM, V274, P15847, DOI 10.1074/jbc.274.22.15847; Navarre WW, 1999, MICROBIOL MOL BIOL R, V63, P174, DOI 10.1128/MMBR.63.1.174-229.1999; Norrby SR, 2005, LANCET INFECT DIS, V5, P115, DOI 10.1016/S1473-3099(05)01283-1; Warfield R, 2006, ORG BIOMOL CHEM, V4, P3626, DOI 10.1039/b607999g; Xu NX, 1997, ANAL BIOCHEM, V248, P7, DOI 10.1006/abio.1997.2073; Zauner T, 2011, ANAL CHEM, V83, P7356, DOI 10.1021/ac201274f	25	13	17	2	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 15	2017	12	3							e0173919	10.1371/journal.pone.0173919	http://dx.doi.org/10.1371/journal.pone.0173919			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN9HQ	28296948	Green Submitted, Green Published, gold			2022-12-27	WOS:000396311700078
J	Liu, GB; Lanham, C; Buchan, JR; Kaplan, ME				Liu, Guangbo; Lanham, Clayton; Buchan, J. Ross; Kaplan, Matthew E.			High-throughput transformation of Saccharomyces cerevisiae using liquid handling robots	PLOS ONE			English	Article							P-BODIES; YEAST; TDP-43; EXPRESSION; EVENTS; SCREEN; GENOME; MODEL	Saccharomyces cerevisiae (budding yeast) is a powerful eukaryotic model organism ideally suited to high-throughput genetic analyses, which time and again has yielded insights that further our understanding of cell biology processes conserved in humans. Lithium Acetate (LiAc) transformation of yeast with DNA for the purposes of exogenous protein expression (e.g., plasmids) or genome mutation (e.g., gene mutation, deletion, epitope tagging) is a useful and long established method. However, a reliable and optimized high throughput transformation protocol that runs almost no risk of human error has not been described in the literature. Here, we describe such a method that is broadly transferable to most liquid handling high-throughput robotic platforms, which are now commonplace in academic and industry settings. Using our optimized method, we are able to comfortably transform approximately 1200 individual strains per day, allowing complete transformation of typical genomic yeast libraries within 6 days. In addition, use of our protocol for gene knockout purposes also provides a potentially quicker, easier and more cost-effective approach to generating collections of double mutants than the popular and elegant synthetic genetic array methodology. In summary, our methodology will be of significant use to anyone interested in high throughput molecular and/or genetic analysis of yeast.	[Liu, Guangbo; Lanham, Clayton; Buchan, J. Ross] Univ Arizona, Dept Mol & Cellular Biol, Tucson, AZ 85721 USA; [Kaplan, Matthew E.] Univ Arizona, Funct Genom Core Facil, Tucson, AZ 85721 USA	University of Arizona; University of Arizona	Liu, GB; Buchan, JR (corresponding author), Univ Arizona, Dept Mol & Cellular Biol, Tucson, AZ 85721 USA.; Kaplan, ME (corresponding author), Univ Arizona, Funct Genom Core Facil, Tucson, AZ 85721 USA.	guangboliu@email.arizona.edu; rbuchan@email.arizona.edu; mkaplan@email.arizona.edu			University of Arizona; NIH [R01 GM1145664-01A1]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM114564] Funding Source: NIH RePORTER	University of Arizona; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by start-up funds to JRB from the University of Arizona, and support from NIH (R01 GM1145664-01A1).	Armakola M, 2012, NAT GENET, V44, P1302, DOI 10.1038/ng.2434; Baryshnikova A, 2010, METHODS ENZYMOLOGY; Baryshnikova A, 2013, G3-GENES GENOM GENET, V3, P1741, DOI 10.1534/g3.113.007377; Botstein D, 1997, SCIENCE, V277, P1259, DOI 10.1126/science.277.5330.1259; BOTSTEIN D, 1988, SCIENCE, V240, P1439, DOI 10.1126/science.3287619; Buchan JR, 2008, J CELL BIOL, V183, P441, DOI 10.1083/jcb.200807043; Buchan JR, 2010, METHOD ENZYMOL, V470, P619, DOI 10.1016/S0076-6879(10)70025-2; Chen DR, 2008, MOL BIOL CELL, V19, P308, DOI 10.1091/mbc.E07-08-0735; Cherry JM, 2012, NUCLEIC ACIDS RES, V40, pD700, DOI 10.1093/nar/gkr1029; Decker CJ, 2012, COLD SPRING HARB PER, P1; Elden AC, 2010, NATURE, V466, P1069, DOI 10.1038/nature09320; Foury F, 1997, GENE, V195, P1, DOI 10.1016/S0378-1119(97)00140-6; Gelperin DM, 2005, GENE DEV, V19, P2816, DOI 10.1101/gad.1362105; Ghaemmaghami S, 2003, NATURE, V425, P737, DOI 10.1038/nature02046; Gietz RD, 2007, NAT PROTOC, V2, P5, DOI 10.1038/nprot.2007.16; Gietz RD, 2007, NAT PROTOC, V2, P31, DOI 10.1038/nprot.2007.13; Goldstein AL, 1999, YEAST, V15, P1541, DOI 10.1002/(SICI)1097-0061(199910)15:14<1541::AID-YEA476>3.3.CO;2-B; HARTWELL LH, 1974, BACTERIOL REV, V38, P164, DOI 10.1128/MMBR.38.2.164-198.1974; Hin Yan Tong A, 2005, METHOD MOL BIOL, V36, P1; Hughes TR, 2000, CELL, V102, P109, DOI 10.1016/S0092-8674(00)00015-5; Johnson BS, 2008, P NATL ACAD SCI USA, V105, P6439, DOI 10.1073/pnas.0802082105; Johnston M, 2002, METHOD ENZYMOL, V350, P290, DOI 10.1016/S0076-6879(02)50970-8; Khurana V, 2010, NAT REV NEUROSCI, V11, P436, DOI 10.1038/nrn2809; Lang GI, 2008, GENETICS, V178, P67, DOI 10.1534/genetics.107.071506; LUNDBLAD V, 1989, CELL, V57, P633, DOI 10.1016/0092-8674(89)90132-3; Ma J, 2008, AUTOPHAGY, V4, P792, DOI 10.4161/auto.6308; Murthi A, 2005, GENETICS, V170, P1553, DOI 10.1534/genetics.105.043620; Neumann M, 2006, SCIENCE, V314, P130, DOI 10.1126/science.1134108; NORBURY C, 1992, ANNU REV BIOCHEM, V61, P441, DOI 10.1146/annurev.bi.61.070192.002301; NOVICK P, 1981, CELL, V25, P461, DOI 10.1016/0092-8674(81)90064-7; NOVICK P, 1980, CELL, V21, P205, DOI 10.1016/0092-8674(80)90128-2; Schindelin J, 2012, NAT METHODS, V9, P676, DOI [10.1038/nmeth.2019, 10.1038/NMETH.2019]; Steinmetz LM, 2002, NAT GENET, V31, P400, DOI 10.1038/ng929; Stuckey S, 2013, METHOD ENZYMOL, V533, P103, DOI 10.1016/B978-0-12-420067-8.00008-8; Tsuboi S, 1992, AUTOPHAGY YEAST DEMO, V119, P3; van Leeuwen J., 2015, COLD SPRING HARB PRO, V2015, P853, DOI DOI 10.1101/PDB.PROT085100; WACH A, 1994, YEAST, V10, P1793, DOI 10.1002/yea.320101310; Winzeler EA, 1999, SCIENCE, V285, P901, DOI 10.1126/science.285.5429.901	38	7	9	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 20	2017	12	3							e0174128	10.1371/journal.pone.0174128	http://dx.doi.org/10.1371/journal.pone.0174128			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ER6VC	28319150	gold, Green Published, Green Submitted			2022-12-27	WOS:000398945800052
J	Castaldi, PJ; Cho, MH; Liang, LM; Silverman, EK; Hersh, CP; Rice, K; Aschard, H				Castaldi, Peter J.; Cho, Michael H.; Liang, Liming; Silverman, Edwin K.; Hersh, Craig P.; Rice, Kenneth; Aschard, Hugues			Screening for interaction effects in gene expression data	PLOS ONE			English	Article							GENOME-WIDE ASSOCIATION; DIFFERENTIAL EXPRESSION; NORMALIZATION; EPISTASIS; TESTS; POWER; TRANSFORMATION; TRANSCRIPTION; EXPLANATION; QUANTILE	Expression quantitative trait (eQTL) studies are a powerful tool for identifying genetic variants that affect levels of messenger RNA. Since gene expression is controlled by a complex network of gene-regulating factors, one way to identify these factors is to search for interaction effects between genetic variants and mRNA levels of transcription factors (TFs) and their respective target genes. However, identification of interaction effects in gene expression data pose a variety of methodological challenges, and it has become clear that such analyses should be conducted and interpreted with caution. Investigating the validity and interpretability of several interaction tests when screening for eQTL SNPs whose effect on the target gene expression is modified by the expression level of a transcription factor, we characterized two important methodological issues. First, we stress the scale-dependency of interaction effects and highlight that commonly applied transformation of gene expression data can induce or remove interactions, making interpretation of results more challenging. We then demonstrate that, in the setting of moderate to strong interaction effects on the order of what may be reasonably expected for eQTL studies, standard interaction screening can be biased due to heteroscedasticity induced by true interactions. Using simulation and real data analysis, we outline a set of reasonable minimum conditions and sample size requirements for reliable detection of variant-by-environment and variant-by-TF interactions using the heteroscedasticity consistent covariance-based approach.	[Castaldi, Peter J.; Cho, Michael H.; Silverman, Edwin K.; Hersh, Craig P.] Brigham & Womens Hosp, Channing Div Network Med, 75 Francis St, Boston, MA 02115 USA; [Castaldi, Peter J.; Cho, Michael H.; Silverman, Edwin K.; Hersh, Craig P.] Harvard Med Sch, Channing Div Network Med, Boston, MA USA; [Castaldi, Peter J.] Brigham & Womens Hosp, Div Gen Internal Med & Primary Care, 75 Francis St, Boston, MA 02115 USA; [Cho, Michael H.; Silverman, Edwin K.; Hersh, Craig P.] Brigham & Womens Hosp, Pulm & Crit Care Div, 75 Francis St, Boston, MA 02115 USA; [Cho, Michael H.; Silverman, Edwin K.; Hersh, Craig P.] Harvard Med Sch, Pulm & Crit Care Div, Boston, MA USA; [Liang, Liming; Aschard, Hugues] Harvard TH Chan Sch Publ Hlth, Dept Epidemiol, Boston, MA USA; [Rice, Kenneth] Univ Washington, Dept Biostat, Seattle, WA 98195 USA; [Aschard, Hugues] Inst Pasteur, Ctr Bioinformat, Biostat & Biol Integrat C3BI, Paris, France	Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School; Harvard University; Brigham & Women's Hospital; Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School; Harvard University; Harvard T.H. Chan School of Public Health; University of Washington; University of Washington Seattle; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris	Castaldi, PJ (corresponding author), Brigham & Womens Hosp, Channing Div Network Med, 75 Francis St, Boston, MA 02115 USA.; Castaldi, PJ (corresponding author), Harvard Med Sch, Channing Div Network Med, Boston, MA USA.; Castaldi, PJ (corresponding author), Brigham & Womens Hosp, Div Gen Internal Med & Primary Care, 75 Francis St, Boston, MA 02115 USA.; Aschard, H (corresponding author), Harvard TH Chan Sch Publ Hlth, Dept Epidemiol, Boston, MA USA.; Aschard, H (corresponding author), Inst Pasteur, Ctr Bioinformat, Biostat & Biol Integrat C3BI, Paris, France.	repjc@channing.harvard.edu; haschard@hsph.harvard.edu		Aschard, Hugues/0000-0002-7554-6783	National Institutes of Health [R21HG007687, R01HL124233, R01HL126596, P01HL105339, R01HL089856, R01HL094635, R01NR013377, R01HL125583, R01HL113264]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL124233, R01HL125583, R01HL126596] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R21HG007687] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))	This work was supported by funding from the National Institutes of Health R21HG007687 (HA), R01HL124233 and R01HL126596 (PJC), P01HL105339 and R01HL089856 (EKS), R01HL094635, R01NR013377, R01HL125583 (CPH), and R01HL113264 (EKS and MHC). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Almli LM, 2014, JAMA PSYCHIAT, V71, P1392, DOI 10.1001/jamapsychiatry.2014.1339; Andersson P.K., 2010, REGRESSION LINEAR PR, DOI [DOI 10.1007/978-1-4419-7170-8, 10.1007/978-1-4419-7170-8]; Aschard H, 2016, GENET EPIDEMIOL, V40, P678, DOI 10.1002/gepi.21989; Aschard H, 2013, GENET EPIDEMIOL, V37, P323, DOI 10.1002/gepi.21716; Aschard H, 2012, HUM GENET, V131, P1591, DOI 10.1007/s00439-012-1192-0; Aulchenko YS, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-134; Beasley TM, 2009, BEHAV GENET, V39, P580, DOI 10.1007/s10519-009-9281-0; Becker J, 2012, EUR J HUM GENET, V20, P97, DOI 10.1038/ejhg.2011.156; BLAIR RC, 1987, COMMUN STAT SIMULAT, V16, P1133, DOI 10.1080/03610918708812642; Bolstad BM, 2003, BIOINFORMATICS, V19, P185, DOI 10.1093/bioinformatics/19.2.185; Breitling Rainer, 2005, Journal of Bioinformatics and Computational Biology, V3, P1171, DOI 10.1142/S0219720005001442; Brown AA, 2014, ELIFE, V3, DOI 10.7554/eLife.01381; Carey VJ, 2007, BIOINFORMATICS, V23, P522, DOI 10.1093/bioinformatics/btl628; Castaldi PJ, 2015, HUM MOL GENET, V24, P1200, DOI 10.1093/hmg/ddu525; Cho MH, 2012, HUM MOL GENET, V21, P947, DOI 10.1093/hmg/ddr524; Clayton DG, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000540; Cornelis MC, 2012, AM J EPIDEMIOL, V175, P191, DOI 10.1093/aje/kwr368; Devlin B, 1999, BIOMETRICS, V55, P997, DOI 10.1111/j.0006-341X.1999.00997.x; Fusi N, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002330; Gaffney DJ, 2012, GENOME BIOL, V13, DOI 10.1186/gb-2012-13-1-r7; Gautier L, 2004, BIOINFORMATICS, V20, P307, DOI 10.1093/bioinformatics/btg405; Geller SC, 2003, BIOINFORMATICS, V19, P1817, DOI 10.1093/bioinformatics/btg245; Hansen KD, 2012, BIOSTATISTICS, V13, P204, DOI 10.1093/biostatistics/kxr054; Hemani G, 2014, NATURE, V514, pE5, DOI 10.1038/nature13692; Hemani G, 2014, NATURE, V508, P249, DOI 10.1038/nature13005; Lappalainen T, 2013, NATURE, V501, P506, DOI 10.1038/nature12531; Lawrence M, 2013, PLOS COMPUT BIOL, V9, DOI 10.1371/journal.pcbi.1003118; Leek JT, 2010, NATURE REV GENETICS, V11; MacKinnon J.G., 2013, RECENT ADV FUTURE DI, P437, DOI DOI 10.1007/978-1-4614-1653-1_17; MACKINNON JG, 1985, J ECONOMETRICS, V29, P305, DOI 10.1016/0304-4076(85)90158-7; Navon R, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008003; Pare G, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000981; Qin Shaopu, 2013, Frontiers in Genetics, V3, P160, DOI 10.3389/fgene.2012.00160; Qiu WL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024395; Qiu X, 2013, BMC BIOINFORMATICS, V14, DOI 10.1186/1471-2105-14-124; Quackenbush J, 2002, NAT GENET, V32, P496, DOI 10.1038/ng1032; Rantalainen M, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0127882; Robinson MD, 2010, BIOINFORMATICS, V26, P139, DOI 10.1093/bioinformatics/btp616; Rothman KJ, 2012, MODERN EPIDEMIOLOGY; Shabalin AA, 2012, BIOINFORMATICS, V28, P1353, DOI 10.1093/bioinformatics/bts163; Sokal RR, 1994, BIOMETRY PRINCIPLES; Stegle O, 2012, NAT PROTOC, V7, P500, DOI 10.1038/nprot.2011.457; Stranger BE, 2007, NAT GENET, V39, P1217, DOI 10.1038/ng2142; Tchetgen EJT, 2011, EPIDEMIOLOGY, V22, P257, DOI 10.1097/EDE.0b013e31820877c5; Vaquerizas JM, 2009, NAT REV GENET, V10, P252, DOI 10.1038/nrg2538; Vestbo J, 2008, EUR RESPIR J, V31, P869, DOI 10.1183/09031936.00111707; Voorman A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019416; Wan ES, 2011, AM J RESP CELL MOL, V45, P304, DOI 10.1165/rcmb.2010-0294OC; WHITE H, 1980, ECONOMETRICA, V48, P817, DOI 10.2307/1912934; Wood AR, 2014, NATURE, V514, pE3, DOI 10.1038/nature13691; Xiao X, 2011, ECOLOGY, V92, P1887, DOI 10.1890/11-0538.1; Zhang JG, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008064	52	2	2	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 16	2017	12	3							e0173847	10.1371/journal.pone.0173847	http://dx.doi.org/10.1371/journal.pone.0173847			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN9KE	28301596	Green Published, Green Submitted, gold			2022-12-27	WOS:000396318300079
J	Joo, JH; Kim, YS; Cho, BC; Jeong, CY; Park, W; Kim, HJ; Yoon, WS; Yoon, MS; Kim, JY; Choi, JH; Choi, Y; Kim, JY				Joo, Ji Hyeon; Kim, Young Seok; Cho, Byung Chul; Jeong, Chi Young; Park, Won; Kim, Hak Jae; Yoon, Won Sup; Yoon, Mee Sun; Kim, Ji-Yoon; Choi, Jin Hwa; Choi, Youngmin; Kim, Joo-Young			Variability in target delineation of cervical carcinoma: A Korean radiation oncology group study (KROG 15-06)	PLOS ONE			English	Article							MODULATED PELVIC RADIOTHERAPY; CONSENSUS GUIDELINES; SMALL-BOWEL; CANCER; VOLUME; MORTALITY	Purpose To determine inter-observer variability in target volume definition of cervical cancer in radical and adjuvant radiotherapy (RT) settings. Methods Eight physicians contoured CTVs of 2 patients underwent definitive and postoperative RT. Each volume was analyzed using the individual/median volume ratio and generalized conformity index (CIgen). And center of mass (COM) of each contour was calculated. Expert agreement was quantified using an expectation maximization algorithm for Simultaneous Truth and Performance Level Estimation (STAPLE). Results For definitive RT, the individual/median volume ratio ranged from 0.51 to 1.41, and CIgen was 0.531. Mean 3-dimensional distances of average to each COM were 7.8 mm. For postoperative RT setting, corresponding values were 0.65 - 1.38, 0.563, and 5.3 mm. Kappa value of expert agreement was 0.65 and 0.67, respectively. STAPLE estimates of the sensitivity, specificity, and kappa measures of inter-physician agreement were 0.73, 0.98, and 0.65 for the definitive and 0.75, 0.98, and 0.67 for the adjuvant radiotherapy setting. The largest difference was observed in the superior-inferior direction, particularly in the upper vagina and the common iliac area. Conclusion As there was still some variability in target delineation, more detailed guidelines for target volume delineation and continuing education would help to reduce this uncertainty.	[Joo, Ji Hyeon; Kim, Young Seok; Cho, Byung Chul; Jeong, Chi Young] Univ Ulsan, Coll Med, Asan Med Ctr, Dept Radiat Oncol, Seoul, South Korea; [Park, Won] Sungkyunkwan Univ Sch Med, Samsung Med Ctr, Dept Radiat Oncol, Seoul, South Korea; [Kim, Hak Jae] Seoul Natl Univ Hosp, Dept Radiat Oncol, Seoul, South Korea; [Yoon, Won Sup] Korea Univ Ansan Hosp, Dept Radiat Oncol, Ansan, Gyeonggi Do, South Korea; [Yoon, Mee Sun] Chonnam Natl Univ Hwasun Hosp, Chonnam Natl Univ Med Sch, Dept Radiat Oncol, Hwasun, Jeollanam Do, South Korea; [Kim, Ji-Yoon] Catholic Univ Korea, Coll Med, Dept Radiat Oncol, Seoul, South Korea; [Choi, Jin Hwa] Chung Ang Univ Hosp, Dept Radiat Oncol, Seoul, South Korea; [Choi, Youngmin] Dong A Univ Hosp, Dept Radiat Oncol, Busan, South Korea; [Kim, Joo-Young] Natl Canc Ctr, Res Inst & Hosp, Ctr Uterine Canc, Goyang, Gyeonggi Do, South Korea	University of Ulsan; Asan Medical Center; Sungkyunkwan University (SKKU); Samsung Medical Center; Seoul National University (SNU); Seoul National University Hospital; Korea University; Korea University Medicine (KU Medicine); Chonnam National University; Chonnam National University Hospital; Catholic University of Korea; Chung Ang University; Chung Ang University Hospital; Dong A University; National Cancer Center - Korea (NCC)	Kim, YS (corresponding author), Univ Ulsan, Coll Med, Asan Med Ctr, Dept Radiat Oncol, Seoul, South Korea.	ysk@amc.seoul.kr		Kim, Young Seok/0000-0003-4739-4476				Allozi R, 2010, RADIOTHER ONCOL, V97, P572, DOI 10.1016/j.radonc.2010.06.009; BenedettiPanici P, 1996, GYNECOL ONCOL, V62, P19, DOI 10.1006/gyno.1996.0184; Chao KSC, 2002, INT J RADIAT ONCOL, V54, P1147, DOI 10.1016/S0360-3016(02)03040-7; Dinniwell R, 2009, INT J RADIAT ONCOL, V74, P844, DOI 10.1016/j.ijrobp.2008.09.026; Eminowicz G, 2015, RADIOTHER ONCOL, V117, P542, DOI 10.1016/j.radonc.2015.10.007; Gwynne S, 2013, BRIT J RADIOL, V86, DOI 10.1259/bjr.20120398; Jung KW, 2015, CANCER RES TREAT, V47, P142, DOI 10.4143/crt.2015.066; Kouwenhoven E, 2009, PHYS MED BIOL, V54, P2863, DOI 10.1088/0031-9155/54/9/018; Lee JY, 2014, J GYNECOL ONCOL, V25, P174, DOI 10.3802/jgo.2014.25.3.174; Lim K, 2011, INT J RADIAT ONCOL, V79, P348, DOI 10.1016/j.ijrobp.2009.10.075; Mitchell DM, 2009, INT J RADIAT ONCOL, V75, P990, DOI 10.1016/j.ijrobp.2008.12.042; Ohara K, 2004, INT J RADIAT ONCOL, V60, P258, DOI 10.1016/j.ijrobp.2004.02.023; Oike T, 2010, J RADIAT RES, V51, P715, DOI 10.1269/jrr.10046; Portelance L, 2001, INT J RADIAT ONCOL, V51, P261, DOI 10.1016/S0360-3016(01)01664-9; Sakuragi N, 1999, CANCER, V85, P1547, DOI 10.1002/(SICI)1097-0142(19990401)85:7<1547::AID-CNCR16>3.0.CO;2-2; Small W, 2008, INT J RADIAT ONCOL, V71, P428, DOI 10.1016/j.ijrobp.2007.09.042; Taylor A, 2005, INT J RADIAT ONCOL, V63, P1604, DOI 10.1016/j.ijrobp.2005.05.062; Warfield SK, 2004, IEEE T MED IMAGING, V23, P903, DOI 10.1109/TMI.2004.828354; Weiss E, 2003, RADIOTHER ONCOL, V67, P87, DOI 10.1016/S0167-8140(02)00373-0	19	2	2	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 16	2017	12	3							e0173476	10.1371/journal.pone.0173476	http://dx.doi.org/10.1371/journal.pone.0173476			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN9KE	28301492	Green Submitted, Green Published, gold			2022-12-27	WOS:000396318300043
J	Krawczyk, M; Zimmermann, S; Hess, G; Holz, R; Dauer, M; Raedle, J; Lammert, F; Grunhage, F				Krawczyk, Marcin; Zimmermann, Simone; Hess, Georg; Holz, Robert; Dauer, Marc; Raedle, Jochen; Lammert, Frank; Gruenhage, Frank			Panel of three novel serum markers predicts liver stiffness and fibrosis stages in patients with chronic liver disease	PLOS ONE			English	Article							CHRONIC HEPATITIS-C; TRANSIENT ELASTOGRAPHY; GROWTH; DIAGNOSIS; CIRRHOSIS	Latest data suggest that placental growth factor (PLGF), growth differentiation factor-15 (GDF-15) and hepatic growth factor (HGF) are involved in hepatic fibrogenesis. Diagnostic performance of these markers for non-invasive liver fibrosis prediction was evaluated based on liver histology and stiffness. In total 834 patients were recruited. Receiver-operating-characteristics were used to define cut-offs for markers correlating to fibrosis stages. Oddsratios were calculated for the presence/absence of fibrosis/cirrhosis and confirmed in the sub-group of patients phenotyped by elastography only. Logistic and uni-and multivariate regression analyses were used to test for association of markers with liver fibrosis stages and for independent prediction of liver histology and stiffness. Marker concentrations correlated significantly (P< 0.001) with histology and stiffness. Cut-offs for liver fibrosis (>= F2) were PLGF = 20.20 pg/ml, GDF15 = 1582.76 pg/ml and HGF = 2598.00 pg/ml. Logistic regression confirmed an increase of ORs from 3.6 over 33.0 to 108.4 with incremental (1 - 3) markers positive for increased liver stiffness (>= 12.8kPa; all P< 0.05). Subgroup analysis revealed associations with advanced fibrosis for HCV (three markers positive: OR = 59.9, CI 23.4 - 153.4, P< 0.001) and non-HCV patients (three markers positive: OR = 144, CI 59 - 3383, P< 0.001). Overall, serum markers identified additional 50% of patients at risk for advanced fibrosis presenting with low elastography results. In conclusion, this novel combination of markers reflects the presence of significant liver fibrosis detected by elastography and histology and may also identify patients at risk presenting with low elastography values.	[Krawczyk, Marcin; Zimmermann, Simone; Holz, Robert; Dauer, Marc; Raedle, Jochen; Lammert, Frank; Gruenhage, Frank] Univ Saarland, Med Ctr, Dept Med 2, Homburg, Germany; [Krawczyk, Marcin] Med Univ Warsaw, Transplant & Liver Surg, Dept Gen, Lab Metabol Liver Dis, Warsaw, Poland; [Hess, Georg] Roche Diagnost, Grenzach Wyhlen, Germany; [Raedle, Jochen] Westfalz Klinikum, Dept Med 3, Kaiserslautern, Germany; [Gruenhage, Frank] RKN Hosp, Dept Gastroenterol & Oncol, Grevenbroich, Germany	Saarland University; Medical University of Warsaw	Grunhage, F (corresponding author), RKN Hosp, Dept Gastroenterol & Oncol, Grevenbroich, Germany.	frank.gruenhage@kkh-ne.de	Krawczyk, Marcin/AAG-4356-2020	Krawczyk, Marcin/0000-0002-0113-0777				Adams LA, 2005, CLIN CHEM, V51, P1867, DOI 10.1373/clinchem.2005.048389; [Anonymous], 1999, J Hepatol, V30, P956; [Anonymous], 2015, PLOS ONE; Asrani SK, 2015, CLIN GASTROENTEROL H; Boursier J, 2012, HEPATOLOGY, V55, P58, DOI 10.1002/hep.24654; Castera L, 2013, NAT REV GASTRO HEPAT, V10, P666, DOI 10.1038/nrgastro.2013.175; DESMET VJ, 1994, HEPATOLOGY, V19, P1513, DOI 10.1002/hep.1840190629; Fischer C, 2007, CELL, V131, P463, DOI 10.1016/j.cell.2007.08.038; Friedrich-Rust M, 2016, NAT REV GASTRO HEPAT, V13, P402, DOI 10.1038/nrgastro.2016.86; Hsiao EC, 2000, MOL CELL BIOL, V20, P3742, DOI 10.1128/MCB.20.10.3742-3751.2000; Imbert-Bismut F, 2001, LANCET, V357, P1069, DOI 10.1016/S0140-6736(00)04258-6; Krawczyk M, 2011, J HEPATOL, V55, P299, DOI 10.1016/j.jhep.2010.10.042; Kwiecinski M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024568; Marcellin P, 2009, LIVER INT, V29, P242, DOI 10.1111/j.1478-3231.2008.01802.x; Matsuda Y, 1997, HEPATOLOGY, V26, P81; Obara N, 2008, J GASTROENTEROL, V43, P720, DOI 10.1007/s00535-008-2225-2; Parkes J, 2006, J HEPATOL, V44, P462, DOI 10.1016/j.jhep.2005.10.019; Pavlov CS, 2016, ALIMENT PHARM THER, V43, P575, DOI 10.1111/apt.13524; Poynard T, 2011, J HEPATOL, V54, P586, DOI 10.1016/j.jhep.2010.09.012; Rockey DC, 2009, HEPATOLOGY, V49, P1017, DOI 10.1002/hep.22742; Shaheen AAM, 2007, AM J GASTROENTEROL, V102, P2589, DOI 10.1111/j.1572-0241.2007.01466.x; Sharma S, 2014, WORLD J GASTROENTERO, V20, P16820, DOI 10.3748/wjg.v20.i45.16820; Sheth SG, 1998, AM J GASTROENTEROL, V93, P44, DOI 10.1111/j.1572-0241.1998.044_c.x; Trautwein C, 2015, J HEPATOL, V62, pS15, DOI 10.1016/j.jhep.2015.02.039; Ueki T, 1999, NAT MED, V5, P226, DOI 10.1038/5593; Van Steenkiste C, 2011, HEPATOLOGY, V53, P1629, DOI 10.1002/hep.24238; VANZANTEN RAA, 1988, CLIN CHIM ACTA, V177, P141, DOI 10.1016/0009-8981(88)90135-0; Walsh KM, 1999, DIGEST DIS SCI, V44, P624, DOI 10.1023/A:1026630129025; Wolska-Krawczyk M, 2013, ABDOM IMAGING, V38, P461, DOI 10.1007/s00261-012-9939-6; Wong VS, 1998, J VIRAL HEPATITIS, V5, P187, DOI 10.1046/j.1365-2893.1998.00100.x	30	15	19	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 16	2017	12	3							e0173506	10.1371/journal.pone.0173506	http://dx.doi.org/10.1371/journal.pone.0173506			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN9KE	28301573	Green Published, Green Submitted, gold			2022-12-27	WOS:000396318300047
J	Middelweerd, A; te Velde, SJ; Abbott, G; Timperio, A; Brug, J; Ball, K				Middelweerd, Anouk; te Velde, Saskia J.; Abbott, Gavin; Timperio, Anna; Brug, Johannes; Ball, Kylie			Do intrapersonal factors mediate the association of social support with physical activity in young women living in socioeconomically disadvantaged neighbourhoods? A longitudinal mediation analysis	PLOS ONE			English	Article							STRUCTURAL EQUATION ANALYSIS; SELF-EFFICACY; COGNITIVE THEORY; HEALTH-PROMOTION; AUSTRALIAN WOMEN; DETERMINANTS; ADULTS; EXERCISE; BEHAVIOR; STUDENTS	Background Levels of physical activity (PA) decrease when transitioning from adolescence into young adulthood. Evidence suggests that social support and intrapersonal factors (self-efficacy, outcome expectations, PA enjoyment) are associated with PA. The aim of the present study was to explore whether cross-sectional and longitudinal associations of social support from family and friends with leisure-time PA (LTPA) among young women living in disadvantaged areas were mediated by intrapersonal factors (PA enjoyment, outcome expectations, self-efficacy). Methods Survey data were collected from 18 - 30 year-old women living in disadvantaged suburbs of Victoria, Australia as part of the READI study in 2007 - 2008 (T0, N = 1197), with follow-up data collected in 2010 - 2011 (T1, N = 357) and 2012 - 2013 (T2, N = 271). A series of single-mediator models were tested using baseline (T0) and longitudinal data from all three time points with residual change scores for changes between measurements. Results Cross-sectional analyses showed that social support was associated with LTPA both directly and indirectly, mediated by intrapersonal factors. Each intrapersonal factor explained between 5.9 - 37.5% of the associations. None of the intrapersonal factors were significant mediators in the longitudinal analyses. Conclusions Results from the cross-sectional analyses suggest that the associations of social support from family and from friends with LTPA are mediated by intrapersonal factors (PA enjoyment, outcome expectations and self-efficacy). However, longitudinal analyses did not confirm these findings.	[Middelweerd, Anouk; te Velde, Saskia J.] Vrije Univ Amsterdam, Med Ctr, Dept Epidemiol & Biostat, Amsterdam, Netherlands; [Middelweerd, Anouk; te Velde, Saskia J.] Vrije Univ Amsterdam, Med Ctr, EMGO Inst Hlth & Care Res, Amsterdam, Netherlands; [Abbott, Gavin; Timperio, Anna; Ball, Kylie] Deakin Univ, Inst Phys Act & Nutr, Sch Exercise & Nutr Sci, Geelong, Vic, Australia; [Brug, Johannes] Univ Amsterdam, Amsterdam Sch Commun Res, Amsterdam, Netherlands	Vrije Universiteit Amsterdam; Vrije Universiteit Amsterdam; Deakin University; University of Amsterdam	Ball, K (corresponding author), Deakin Univ, Inst Phys Act & Nutr, Sch Exercise & Nutr Sci, Geelong, Vic, Australia.	kylie.ball@deakin.edu.au	Brug, Johannes/A-8242-2018; Ball, Kylie/B-5866-2015; Timperio, Anna F/A-3086-2013	Brug, Johannes/0000-0002-1904-7349; Ball, Kylie/0000-0003-2893-8415; Timperio, Anna F/0000-0002-8773-5012; Middelweerd, Anouk/0000-0002-1274-968X; Abbott, Gavin/0000-0003-4014-0705; te Velde, Saskia/0000-0002-4674-8052	Australian National Health and Medical Research Council [374241]; Philips and Technology Foundation STW; Nationaal Initiatief Hersenen en Cognitie NIHC [12014]; Albert Renold Travel fellowship from the European foundation for the Study of Diabetes; Marie Curie Actions [FP7-PEOPLE-2009-IRSES-247630]; NHMRC Principal Research Fellowship [1042442]; National Heart Foundation of Australia Future Leader Fellowship [100046]	Australian National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia); Philips and Technology Foundation STW; Nationaal Initiatief Hersenen en Cognitie NIHC; Albert Renold Travel fellowship from the European foundation for the Study of Diabetes; Marie Curie Actions(European Commission); NHMRC Principal Research Fellowship(National Health and Medical Research Council (NHMRC) of Australia); National Heart Foundation of Australia Future Leader Fellowship(National Heart Foundation of Australia)	The READI study was funded by the Australian National Health and Medical Research Council, ID 374241. AM is supported by the Philips and Technology Foundation STW and Nationaal Initiatief Hersenen en Cognitie NIHC under the Partnership program Healthy Lifestyle Solutions (grant no. 12014) and Albert Renold Travel fellowship from the European foundation for the Study of Diabetes. Analyses for the current paper were part of the MeMo International Exchange program funded under Marie Curie Actions (FP7-PEOPLE-2009-IRSES-247630). KB is supported by an NHMRC Principal Research Fellowship, ID 1042442. AT is supported by a National Heart Foundation of Australia Future Leader Fellowship, Award ID 100046. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allender S, 2008, HEALTH PROMOT INT, V23, P160, DOI 10.1093/heapro/dan012; Anderson ES, 2006, HEALTH PSYCHOL, V25, P510, DOI 10.1037/0278-6133.25.4.510; Australian Bureau of Statistics. Canberra Australia: ABS, 2011, AUSTR HLTH SURV PHYS; Ayotte BJ, 2010, J HEALTH PSYCHOL, V15, P173, DOI 10.1177/1359105309342283; Bakhtari Aghdam Fatemeh, 2013, Glob J Health Sci, V5, P189, DOI 10.5539/gjhs.v5n4p189; Ball K, 2012, INT J OBESITY, V36, P855, DOI 10.1038/ijo.2011.183; Ball K, 2013, INT J EPIDEMIOL, V42, P1629, DOI 10.1093/ije/dys165; Bandura A, 2004, HEALTH EDUC BEHAV, V31, P143, DOI 10.1177/1090198104263660; BANDURA A, 1977, PSYCHOL REV, V84, P191, DOI 10.1037/0033-295X.84.2.191; Bandura A, 2001, ANNU REV PSYCHOL, V52, P1, DOI 10.1146/annurev.psych.52.1.1; BANDURA A, 1989, AM PSYCHOL, V44, P1175, DOI 10.1037/0003-066X.44.9.1175; Bauman AE, 2012, LANCET, V380, P258, DOI 10.1016/S0140-6736(12)60735-1; Bauman AE, 2002, AM J PREV MED, V23, P5, DOI 10.1016/S0749-3797(02)00469-5; Bell S, 2005, INT J BEHAV MED, V12, P227, DOI 10.1207/s15327558ijbm1204_3; Buchan DS, 2012, J OBES, V2012, DOI 10.1155/2012/546459; Cerin E, 2009, PUBLIC HEALTH NUTR, V12, P1182, DOI 10.1017/S1368980008003649; Chen Y, 2006, PREV MED, V42, P261, DOI 10.1016/j.ypmed.2006.01.006; Craig CL, 2003, MED SCI SPORT EXER, V35, P1381, DOI 10.1249/01.MSS.0000078924.61453.FB; Dai SL, 2014, AM J PREV MED, V47, P123, DOI 10.1016/j.amepre.2014.04.003; Deliens T, 2015, BMC PUBLIC HEALTH, V15, DOI 10.1186/s12889-015-1553-4; Duin DK, 2015, EVAL PROGRAM PLANN, V51, P45, DOI 10.1016/j.evalprogplan.2014.12.006; Gabriele JM, 2005, ANN BEHAV MED, V29, P210, DOI 10.1207/s15324796abm2903_7; Giles-Corti B, 2002, SOC SCI MED, V54, P1793, DOI 10.1016/S0277-9536(01)00150-2; Jeffery RW, 2013, INT J BEHAV NUTR PHY, V10, DOI 10.1186/1479-5868-10-52; Kavanagh AM, 2005, J EPIDEMIOL COMMUN H, V59, P934, DOI 10.1136/jech.2005.035931; KENDZIERSKI D, 1991, J SPORT EXERCISE PSY, V13, P50, DOI 10.1123/jsep.13.1.50; Kilpatrick M, 2005, J AM COLL HEALTH, V54, P87, DOI 10.3200/JACH.54.2.87-94; Kwan MY, 2012, AM J PREV MED, V42, P14, DOI 10.1016/j.amepre.2011.08.026; Lockhart G, 2011, PSYCHOSOM MED, V73, P29, DOI 10.1097/PSY.0b013e318200a54b; MacKinnon DP, 2007, ANNU REV PSYCHOL, V58, P593, DOI 10.1146/annurev.psych.58.110405.085542; MACKINNON DAVID P., 2008, INTRO STAT MEDIATION, P1; MARCUS BH, 1992, RES Q EXERCISE SPORT, V63, P60, DOI 10.1080/02701367.1992.10607557; Maxwell SE, 2007, PSYCHOL METHODS, V12, P23, DOI 10.1037/1082-989X.12.1.23; McNeill LH, 2006, ANN BEHAV MED, V31, P36, DOI 10.1207/s15324796abm3101_7; McNeill LH, 2006, SOC SCI MED, V63, P1011, DOI 10.1016/j.socscimed.2006.03.012; Motl RW, 2006, ANN BEHAV MED, V32, P154, DOI 10.1207/s15324796abm3202_13; Rovniak LS, 2002, ANN BEHAV MED, V24, P149, DOI 10.1207/S15324796ABM2402_12; Sallis JE, 2006, ANNU REV PUBL HEALTH, V27, P297, DOI 10.1146/annurev.publhealth.27.021405.102100; SALLIS JF, 1987, PREV MED, V16, P825, DOI 10.1016/0091-7435(87)90022-3; Schoenborn CA, 2011, AM J PREV MED, V40, P514, DOI 10.1016/j.amepre.2010.12.029; Selig JP, 2009, RES HUM DEV, V6, P144, DOI 10.1080/15427600902911247; Spring B, 2014, CIRCULATION, V130, P10, DOI 10.1161/CIRCULATIONAHA.113.005445; Twisk J, 2004, J CLIN EPIDEMIOL, V57, P223, DOI 10.1016/j.jclinepi.2003.07.009; Williams L, 2012, PUBLIC HEALTH NUTR, V15, P1396, DOI 10.1017/S1368980011003430; Winters ER, 2003, J ADOLESCENT HEALTH, V32, P436, DOI 10.1016/S1054-139X(03)00046-6; World Health Organisation, 2009, GLOB HLTH RISKS MORT, P1	46	7	8	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 16	2017	12	3							e0173231	10.1371/journal.pone.0173231	http://dx.doi.org/10.1371/journal.pone.0173231			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EN9KE	28301538	Green Published, gold, Green Submitted			2022-12-27	WOS:000396318300029
J	Agnoli, F; Wicherts, JM; Veldkamp, CLS; Albiero, P; Cubelli, R				Agnoli, Franca; Wicherts, Jelte M.; Veldkamp, Coosje L. S.; Albiero, Paolo; Cubelli, Roberto			Questionable research practices among italian research psychologists	PLOS ONE			English	Article							OVERESTIMATE EFFECT SIZES; SPECIAL SECTION; US; RECOMMENDATIONS; REPLICABILITY; SCIENCE; POWER	A survey in the United States revealed that an alarmingly large percentage of university psychologists admitted having used questionable research practices that can contaminate the research literature with false positive and biased findings. We conducted a replication of this study among Italian research psychologists to investigate whether these findings generalize to other countries. All the original materials were translated into Italian, and members of the Italian Association of Psychology were invited to participate via an online survey. The percentages of Italian psychologists who admitted to having used ten questionable research practices were similar to the results obtained in the United States although there were small but significant differences in self-admission rates for some QRPs. Nearly all researchers (88%) admitted using at least one of the practices, and researchers generally considered a practice possibly defensible if they admitted using it, but Italian researchers were much less likely than US researchers to consider a practice defensible. Participants' estimates of the percentage of researchers who have used these practices were greater than the self-admission rates, and participants estimated that researchers would be unlikely to admit it. In written responses, participants argued that some of these practices are not questionable and they have used some practices because reviewers and journals demand it. The similarity of results obtained in the United States, this study, and a related study conducted in Germany suggest that adoption of these practices is an international phenomenon and is likely due to systemic features of the international research and publication processes.	[Agnoli, Franca; Albiero, Paolo] Univ Padua, Dept Dev Psychol & Socializat, Padua, Italy; [Wicherts, Jelte M.; Veldkamp, Coosje L. S.] Tilburg Univ, Dept Methodol & Stat, Tilburg, Netherlands; [Cubelli, Roberto] Univ Trento, Dept Psychol & Cognit Sci, Trento, Italy	University of Padua; Tilburg University; University of Trento	Agnoli, F (corresponding author), Univ Padua, Dept Dev Psychol & Socializat, Padua, Italy.	franca.agnoli@unipd.it	Wicherts, Jelte M./A-2664-2008	Wicherts, Jelte M./0000-0003-2415-2933; Veldkamp, Coosje Lisabet Sterre/0000-0003-3596-5980	Innovational Research Incentives Scheme Vidi from the Netherlands Organization for Scientific Research	Innovational Research Incentives Scheme Vidi from the Netherlands Organization for Scientific Research	The only external source of funding for this research is The Innovational Research Incentives Scheme Vidi from the Netherlands Organization for Scientific Research. Website: (http://www.nwo.ni/en). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aarts AA, 2015, SCIENCE, V349, DOI 10.1126/science.aac4716; American Psychological Association, 2020, PUBL MAN AM PSYCH AS, V7th; Anderson MS, 2007, J EMPIR RES HUM RES, V2, P3, DOI 10.1525/jer.2007.2.4.3; Asendorpf JB, 2013, EUR J PERSONALITY, V27, P108, DOI 10.1002/per.1919; Bakker M, 2016, PSYCHOL SCI, V27, P1069, DOI 10.1177/0956797616647519; Bakker M, 2012, PERSPECT PSYCHOL SCI, V7, P543, DOI 10.1177/1745691612459060; Bakker M, 2011, BEHAV RES METHODS, V43, P666, DOI 10.3758/s13428-011-0089-5; Banks GC, 2016, J BUS PSYCHOL, V31, P323, DOI 10.1007/s10869-016-9456-7; Bartoli A, 2014, INFORM SOC, V30, P349, DOI 10.1080/01972243.2014.944731; Chambers CD, 2013, CORTEX, V49, P609, DOI 10.1016/j.cortex.2012.12.016; COHEN J, 1990, AM PSYCHOL, V45, P1304, DOI 10.1037/0003-066X.45.12.1304; Cubelli R, 2015, CORTEX, V73, pA1, DOI 10.1016/j.cortex.2015.05.008; de Groot AD, 2014, ACTA PSYCHOL, V148, P188, DOI 10.1016/j.actpsy.2014.02.001; Fanelli Daniele, 2009, PLoS One, V4, pe5738, DOI 10.1371/journal.pone.0005738; Fanelli D, 2013, P NATL ACAD SCI USA, V110, P15031, DOI 10.1073/pnas.1302997110; Fanelli D, 2012, SCIENTOMETRICS, V90, P891, DOI 10.1007/s11192-011-0494-7; Fanelli D, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010068; Fiedler K, 2015, SOCIAL PSYCHOL PERSO; Francis G, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0114255; Franco A, 2016, SOC PSYCHOL PERS SCI, V7, P8, DOI 10.1177/1948550615598377; Guest G., 2000, FIELD METHOD, V12, P346, DOI [10.1177/1525822X0001200406, DOI 10.1177/1525822X0001200406]; Guttman L, 1944, AM SOCIOL REV, V9, P139, DOI 10.2307/2086306; Ioannidis JPA, 2014, TRENDS COGN SCI, V18, P235, DOI 10.1016/j.tics.2014.02.010; Ioannidis JPA, 2005, PLOS MED, V2, P696, DOI 10.1371/journal.pmed.0020124; John LK, 2012, PSYCHOL SCI; Kerr N L, 1998, Pers Soc Psychol Rev, V2, P196, DOI 10.1207/s15327957pspr0203_4; Kline R.B., 2013, SIGNIFICANCE TESTING; Lebel EP, 2013, PERSPECT PSYCHOL SCI, V8, P424, DOI 10.1177/1745691613491437; Martinson BC, 2005, NATURE, V435, P737, DOI 10.1038/435737a; Marzolla M, 2015, J INFORMETR, V9, P285, DOI 10.1016/j.joi.2015.02.006; Maxwell SE, 2008, ANNU REV PSYCHOL, V59, P537, DOI 10.1146/annurev.psych.59.103006.093735; Maxwell SE, 2004, PSYCHOL METHODS, V9, P147, DOI 10.1037/1082-989X.9.2.147; National Academy of Sciences National Academy of Engineering & Institute of Medicine, 1992, RESP SCI ENS INT RES, VI; Necker S, 2014, RES POLICY, V43, P1747, DOI 10.1016/j.respol.2014.05.002; Nosek BA, 2012, PERSPECT PSYCHOL SCI, V7, P615, DOI 10.1177/1745691612459058; Nuijten MB, 2016, BEHAV RES METHODS, V48, P1205, DOI 10.3758/s13428-015-0664-2; Nuijten MB, 2014, P NATL ACAD SCI USA, V111, pE712, DOI 10.1073/pnas.1322149111; O'Boyle EH, 2014, J MANAGE; Pashler H, 2012, PERSPECT PSYCHOL SCI, V7, P528, DOI 10.1177/1745691612465253; Pastore M, 2015, GIORNALE ITALIANO PS, V42, P303; Perugini M, 2014, GIORNALE ITALIANO PS, V41, P23; Sarewitz D, 2016, NATURE, V533, P147, DOI 10.1038/533147a; Schimmack U, 2012, PSYCHOL METHODS, V17, P551, DOI 10.1037/a0029487; Simmons JP, 2011, PSYCHOL SCI; Spellman BA, 2015, PERSPECT PSYCHOL SCI, V10, P359, DOI 10.1177/1745691615582201; Strauss A., 2008, BASICS QUALITATIVE R; van Aert RCM, 2016, PERSPECT PSYCHOL SCI, V11, P713, DOI 10.1177/1745691616650874; van Dalen HP, 2012, J AM SOC INF SCI TEC, V63, P1282, DOI 10.1002/asi.22636; Veldkamp CLS, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0114876; Wagenmakers EJ, 2007, PSYCHON B REV, V14, P779, DOI 10.3758/BF03194105; Wagenmakers EJ, 2012, PERSPECT PSYCHOL SCI, V7, P632, DOI 10.1177/1745691612463078; Wagenmakers EJ, 2011, J PERS SOC PSYCHOL, V100, P426, DOI 10.1037/a0022790; Wicherts JM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026828	53	66	67	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 15	2017	12	3							e0172792	10.1371/journal.pone.0172792	http://dx.doi.org/10.1371/journal.pone.0172792			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EN9HQ	28296929	Green Published, Green Submitted, gold			2022-12-27	WOS:000396311700015
J	Arthaut, LD; Jourdan, N; Mteyrek, A; Procopio, M; El-Esawi, M; d'Harlingue, A; Bouchet, PE; Witczak, J; Ritz, T; Klarsfeld, A; Birman, S; Usselman, RJ; Hoecker, U; Martino, CF; Ahmad, M				Arthaut, Louis-David; Jourdan, Nathalie; Mteyrek, Ali; Procopio, Maria; El-Esawi, Mohamed; d'Harlingue, Alain; Bouchet, Pierre-Etienne; Witczak, Jacques; Ritz, Thorsten; Klarsfeld, Andre; Birman, Serge; Usselman, Robert J.; Hoecker, Ute; Martino, Carlos F.; Ahmad, Margaret			Blue-light induced accumulation of reactive oxygen species is a consequence of the Drosophila cryptochrome photocycle	PLOS ONE			English	Article							ARABIDOPSIS CRYPTOCHROME; DNA PHOTOLYASE; MECHANISM; PHOTORECEPTORS; RHYTHMS	Cryptochromes are evolutionarily conserved blue-light absorbing flavoproteins which participate in many important cellular processes including in entrainment of the circadian clock in plants, Drosophila and humans. Drosophila melanogaster cryptochrome (DmCry) absorbs light through a flavin (FAD) cofactor that undergoes photoreduction to the anionic radical (FAD(center dot-)) redox state both in vitro and in vivo. However, recent efforts to link this photoconversion to the initiation of a biological response have remained controversial. Here, we show by kinetic modeling of the DmCry photocycle that the fluence dependence, quantum yield, and half-life of flavin redox state interconversion are consistent with the anionic radical (FAD(center dot-)) as the signaling state in vivo. We show by fluorescence detection techniques that illumination of purified DmCry results in enzymatic conversion of molecular oxygen (O-2) to reactive oxygen species (ROS). We extend these observations in living cells to demonstrate transient formation of superoxide (O-2(center dot-)), and accumulation of hydrogen peroxide (H2O2) in the nucleus of insect cell cultures upon DmCry illumination. These results define the kinetic parameters of the Drosophila cryptochrome photocycle and support light-driven electron transfer to the flavin in DmCry signaling. They furthermore raise the intriguing possibility that light-dependent formation of ROS as a byproduct of the cryptochrome photocycle may contribute to its signaling role.	[Arthaut, Louis-David; Jourdan, Nathalie; Procopio, Maria; El-Esawi, Mohamed; d'Harlingue, Alain; Bouchet, Pierre-Etienne; Witczak, Jacques; Ahmad, Margaret] Univ Paris VI, IBPS, UMR CNRS B2A 8256, Paris, France; [Arthaut, Louis-David; Martino, Carlos F.] Florida Inst Technol, Dept Biomed Engn, Melbourne, FL 32901 USA; [Mteyrek, Ali; Klarsfeld, Andre; Birman, Serge] PSL Res Univ, UMR CNRS ESPCI Paris 8249, Brain Plast Unit, GCRN Team, Paris, France; [Procopio, Maria; Ritz, Thorsten] Univ Calif Irvine, Dept Phys & Astron, Irvine, CA USA; [El-Esawi, Mohamed] Tanta Univ, Dept Bot, Fac Sci, Tanta, Egypt; [Usselman, Robert J.] Montana State Univ, Dept Chem & Biochem, Bozeman, MT 59717 USA; [Hoecker, Ute] Univ Cologne, Bioctr, Inst Bot, Cologne, Germany; [Hoecker, Ute] Univ Cologne, Bioctr, Cluster Excellence Plant Sci CEPLAS, Cologne, Germany; [Ahmad, Margaret] Xavier Univ, Dept Biol, Cincinnati, OH 45207 USA	UDICE-French Research Universities; Sorbonne Universite; Florida Institute of Technology; UDICE-French Research Universities; PSL Research University Paris; University of California System; University of California Irvine; Egyptian Knowledge Bank (EKB); Tanta University; Montana State University System; Montana State University Bozeman; University of Cologne; University of Cologne; Xavier University	Ahmad, M (corresponding author), Univ Paris VI, IBPS, UMR CNRS B2A 8256, Paris, France.; Ahmad, M (corresponding author), Xavier Univ, Dept Biol, Cincinnati, OH 45207 USA.	margaret.ahmad@upmc.fr	Ritz, Thorsten/B-5260-2008; Martino, Carlos F/C-6597-2016; El-Esawi, Mohamed A./F-1953-2017; Procopio, Maria/AAN-1442-2020	Martino, Carlos F/0000-0002-0560-2604; El-Esawi, Mohamed A./0000-0002-8871-5689; Procopio, Maria/0000-0002-2521-3067; Hoecker, Ute/0000-0002-5636-9777; Ahmad, Margaret/0000-0003-4524-5813; Klarsfeld, Andre/0000-0001-9293-4887; Ritz, Thorsten/0000-0002-2713-539X	Air Force Office of Sponsored Research [FA9550-14-0-0409]	Air Force Office of Sponsored Research(United States Department of DefenseAir Force Office of Scientific Research (AFOSR))	This work was supported by Air Force Office of Sponsored Research, FA9550-14-0-0409 (to MA, TR, CFM).	Ahmad M, 2016, CURR OPIN PLANT BIOL, V33, P108, DOI 10.1016/j.pbi.2016.06.013; Alex A, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0137236; Berndt A, 2007, J BIOL CHEM, V282, P13011, DOI 10.1074/jbc.M608872200; Bouly JP, 2007, J BIOL CHEM, V282, P9383, DOI 10.1074/jbc.M609842200; Chaves I, 2011, ANNU REV PLANT BIOL, V62, P335, DOI 10.1146/annurev-arplant-042110-103759; Consentino L, 2015, NEW PHYTOL, V206, P1450, DOI 10.1111/nph.13341; Czarna A, 2013, CELL, V153, P1394, DOI 10.1016/j.cell.2013.05.011; Dikalov S, 2007, HYPERTENSION, V49, P717, DOI 10.1161/01.HYP.0000258594.87211.6b; El-Esawi M, 2015, PLANT SIGNAL BEHAV, V10, DOI 10.1080/15592324.2015.1063758; Engelhard C, 2014, PLANT CELL, V26, P4519, DOI 10.1105/tpc.114.129809; Fogle KJ, 2015, P NATL ACAD SCI USA, V112, P2245, DOI 10.1073/pnas.1416586112; Fogle KJ, 2011, SCIENCE, V331, P1409, DOI 10.1126/science.1199702; GALSTON AW, 1974, PLANT PHYSIOL, V54, P427, DOI 10.1104/pp.54.4.427; Hoang N, 2008, PLOS BIOL, V6, P1559, DOI 10.1371/journal.pbio.0060160; Hoecker U, 1999, SCIENCE, V284, P496, DOI 10.1126/science.284.5413.496; JORNS MS, 1990, BIOCHEMISTRY-US, V29, P552, DOI 10.1021/bi00454a032; Jourdan N, 2015, PLANT SIGNAL BEHAV, V10, DOI 10.1080/15592324.2015.1042647; Kasahara M, 2002, PLANT PHYSIOL, V129, P762, DOI 10.1104/pp.002410; Fanjul-Moles ML, 2013, FRONT BIOSCI-LANDMRK, V18, P665, DOI 10.2741/4129; Muller P, 2011, J BIOL CHEM, V286, P21033, DOI 10.1074/jbc.M111.228940; Nixdorf M, 2010, PLANTA, V231, P825, DOI 10.1007/s00425-009-1088-y; Ozturk N, 2007, COLD SPRING HARB SYM, V72, P119, DOI 10.1101/sqb.2007.72.015; Ozturk N, 2008, J BIOL CHEM, V283, P3256, DOI 10.1074/jbc.M708612200; Ozturk N, 2014, J BIOL CHEM, V289, P4634, DOI 10.1074/jbc.M113.542498; Ozturk N, 2011, P NATL ACAD SCI USA, V108, P516, DOI 10.1073/pnas.1017093108; Paulus B, 2015, FEBS J, V282, P3175, DOI 10.1111/febs.13299; Peschel N, 2011, FEBS LETT, V585, P1435, DOI 10.1016/j.febslet.2011.02.028; Peschel N, 2009, CURR BIOL, V19, P241, DOI 10.1016/j.cub.2008.12.042; Procopio M, 2016, FRONT PLANT SCI, V7, DOI 10.3389/fpls.2016.00888; Rakshit K, 2013, AGING CELL, V12, P752, DOI 10.1111/acel.12100; Sancar A, 2003, CHEM REV, V103, P2203, DOI 10.1021/cr0204348; Vaidya AT, 2013, P NATL ACAD SCI USA, V110, P20455, DOI 10.1073/pnas.1313336110; van Wilderen LJGW, 2015, FEBS OPEN BIO, V5, P885, DOI 10.1016/j.fob.2015.10.007; vanVickle-Chavez SJ, 2007, J BIOL CHEM, V282, P10561, DOI 10.1074/jbc.M609314200; Vieira J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031867; Vinayak P, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003615; Yoshii Taishi, 2016, Commun Integr Biol, V9, pe1102805, DOI 10.1080/19420889.2015.1102805; Zoltowski BD, 2011, NATURE, V480, P396, DOI 10.1038/nature10618	38	22	22	1	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 15	2017	12	3							e0171836	10.1371/journal.pone.0171836	http://dx.doi.org/10.1371/journal.pone.0171836			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN9HQ	28296892	gold, Green Submitted, Green Published			2022-12-27	WOS:000396311700003
J	Kim, Y; Lee, JM; Kim, J; Dhurandhar, E; Soliman, G; Wehbi, NK; Canedy, J				Kim, Youngdeok; Lee, Jung-Min; Kim, Jungyoon; Dhurandhar, Emily; Soliman, Ghada; Wehbi, Nizar K.; Canedy, James			Longitudinal associations between body mass index, physical activity, and healthy dietary behaviors in adults: A parallel latent growth curve modeling approach	PLOS ONE			English	Article							WEIGHT-GAIN; ENERGY-BALANCE; UNITED-STATES; OBESITY; WOMEN; RISK; PATTERNS; TRENDS; PREVALENCE; OVERWEIGHT	Background Physical activity (PA) and healthy dietary behaviors (HDB) are two well-documented lifestyle factors influencing body mass index (BMI). This study examined 7-year longitudinal associations between changes in PA, HDB, and BMI among adults using a parallel latent growth curve modeling (LGCM). Methods We used prospective cohort data collected by a private company (SimplyWell LLC, Omaha, NE, USA) implementing a workplace health screening program. Data from a total of 2,579 adults who provided valid BMI, PA, and HDB information for at least 5 out of 7 follow-up years from the time they entered the program were analyzed. PA and HDB were subjectively measured during an annual online health survey. Height and weight measured during an annual onsite health screening were used to calculate BMI (kg.m(2)). The parallel LGCMs stratified by gender and baseline weight status (normal: BMI< 25, overweight BMI 25-29.9, and obese: BMI> 30) were fitted to examine the longitudinal associations of changes in PA and HDB with change in BMI over years. Results On average, BMI gradually increased over years, at rates ranging from 0.06 to 0.20 kg.m(2).year, with larger increases observed among those of normal baseline weight status across genders. The increases in PA and HDB were independently associated with a smaller increase in BMI for obese males (b = -1.70 and -1.98, respectively), and overweight females (b = -1.85 and -2.46, respectively) and obese females (b = -2.78 and -3.08, respectively). However, no significant associations of baseline PA and HDB with changes in BMI were observed. Conclusions Our study suggests that gradual increases in PA and HDB are independently associated with smaller increases in BMI in overweight and obese adults, but not in normal weight individuals. Further study is warranted to address factors that check increases in BMI in normal weight adults.	[Kim, Youngdeok; Dhurandhar, Emily] Texas Tech Univ, Dept Kinesiol & Sport Management, Lubbock, TX 79409 USA; [Lee, Jung-Min] Univ Nebraska, Sch Hlth Phys Educ & Recreat, Omaha, NE 68182 USA; [Kim, Jungyoon; Wehbi, Nizar K.] Univ Nebraska Med Ctr, Coll Publ Hlth, Omaha, NE USA; [Soliman, Ghada] CUNY, Dept Environm Occupat & Geospatial Hlth Sci, New York, NY 10021 USA; [Canedy, James] Nebraska Med, Omaha, NE USA	Texas Tech University System; Texas Tech University; University of Nebraska System; University of Nebraska System; University of Nebraska Medical Center; City University of New York (CUNY) System	Kim, Y (corresponding author), Texas Tech Univ, Dept Kinesiol & Sport Management, Lubbock, TX 79409 USA.	youngdeok.kim@ttu.edu	Soliman, Ghada A/U-6472-2017; Lee, Jung-Min/L-8227-2016	Soliman, Ghada A/0000-0002-8629-6062; Lee, Jung-Min/0000-0002-8033-0725; Wehbi, Nizar/0000-0001-5350-2643				Arabshahi S, 2012, BRIT J NUTR, V107, P1376, DOI 10.1017/S0007114511004351; Baskin ML, 2005, OBES REV, V6, P5, DOI 10.1111/j.1467-789X.2005.00165.x; Buijsse B, 2009, AM J CLIN NUTR, V90, P202, DOI 10.3945/ajcn.2008.27394; Catenacci VA, 2014, J PHYS ACT HEALTH, V11, P1540, DOI 10.1123/jpah.2012-0250; Cordain L, 1998, INT J SPORTS MED, V19, P328, DOI 10.1055/s-2007-971926; Curran PJ, 2010, J COGN DEV, V11, P121, DOI 10.1080/15248371003699969; Eliassen AH, 2006, JAMA-J AM MED ASSOC, V296, P193, DOI 10.1001/jama.296.2.193; Flegal KM, 2013, JAMA-J AM MED ASSOC, V309, P71, DOI 10.1001/jama.2012.113905; Flegal KM, 2010, JAMA-J AM MED ASSOC, V303, P235, DOI 10.1001/jama.2009.2014; Fogelholm M, 2000, Obes Rev, V1, P95, DOI 10.1046/j.1467-789x.2000.00016.x; Goodpaster BH, 2010, JAMA-J AM MED ASSOC, V304, P1795, DOI 10.1001/jama.2010.1505; Gordon-Larsen P, 2009, AM J CLIN NUTR, V89, P19, DOI 10.3945/ajcn.2008.26147; Hamer M, 2013, OBESITY, V21, pE755, DOI 10.1002/oby.20446; Hankinson AL, 2010, JAMA-J AM MED ASSOC, V304, P2603, DOI 10.1001/jama.2010.1843; Hill JO, 2006, ENDOCR REV, V27, P750, DOI 10.1210/er.2006-0032; Hu LT, 1999, STRUCT EQU MODELING, V6, P1, DOI 10.1080/10705519909540118; Katan MB, 2009, NEW ENGL J MED, V360, P923, DOI 10.1056/NEJMe0810291; Kimokoti RW, 2010, J NUTR, V140, P1287, DOI 10.3945/jn.109.120808; Kumanyika SK, 2008, CIRCULATION, V118, P428, DOI 10.1161/CIRCULATIONAHA.108.189702; Lee IM, 2010, JAMA-J AM MED ASSOC, V303, P1173, DOI 10.1001/jama.2010.312; Lewis CE, 2000, AM J EPIDEMIOL, V151, P1172, DOI 10.1093/oxfordjournals.aje.a010167; Liu SM, 2003, AM J CLIN NUTR, V78, P920, DOI 10.1093/ajcn/78.5.920; Luke A, 2013, INT J EPIDEMIOL, V42, P1831, DOI 10.1093/ije/dyt159; McAllister EJ, 2009, CRIT REV FOOD SCI, V49, P868, DOI 10.1080/10408390903372599; Mozaffarian D, 2011, NEW ENGL J MED, V364, P2392, DOI 10.1056/NEJMoa1014296; Newby PK, 2006, J NUTR, V136, P2580, DOI 10.1093/jn/136.10.2580; Ogden CL, 2014, JAMA-J AM MED ASSOC, V311, P806, DOI 10.1001/jama.2014.732; Thomas JG, 2014, AM J PREV MED, V46, P17, DOI 10.1016/j.amepre.2013.08.019; Togo P, 2004, INT J OBESITY, V28, P583, DOI 10.1038/sj.ijo.0802598; Vioque J, 2008, OBESITY, V16, P664, DOI 10.1038/oby.2007.121; Wang YC, 2011, LANCET, V378, P815, DOI 10.1016/S0140-6736(11)60814-3; WILLETT WC, 1995, JAMA-J AM MED ASSOC, V273, P461, DOI 10.1001/jama.273.6.461; Wilson PWF, 2002, ARCH INTERN MED, V162, P1867, DOI 10.1001/archinte.162.16.1867	33	19	19	1	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 15	2017	12	3							e0173986	10.1371/journal.pone.0173986	http://dx.doi.org/10.1371/journal.pone.0173986			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN9HQ	28296945	gold, Green Published			2022-12-27	WOS:000396311700085
J	Perez-Vidal, C; Gracia, L; Carmona, C; Alorda, B; Salinas, A				Perez-Vidal, Carlos; Gracia, Luis; Carmona, Cristian; Alorda, Bartomeu; Salinas, Antonio			Wireless transmission of biosignals for hyperbaric chamber applications	PLOS ONE			English	Article							SENSOR PLATFORM	This paper presents a wireless system to send biosignals outside a hyperbaric chamber avoiding wires going through the chamber walls. Hyperbaric chambers are becoming more and more common due to new indications of hyperbaric oxygen treatments. Metallic walls physically isolate patients inside the chamber, where getting a patient's vital signs turns into a painstaking task. The paper proposes using a ZigBee-based network to wirelessly transmit the patient's biosignals to the outside of the chamber. In particular, a wearable battery supported device has been designed, implemented and tested. Although the implementation has been conducted to transmit the electrocardiography signal, the device can be easily adapted to consider other biosignals.	[Perez-Vidal, Carlos] Miguel Hernandez Univ, Dept Syst Engn & Automat, Elche, Spain; [Gracia, Luis] Univ Politecn Valencia, Inst IDF, Valencia, Spain; [Carmona, Cristian; Alorda, Bartomeu] Univ Illes Balears, Dept Phys, Palma De Mallorca, Spain; [Salinas, Antonio] Perpetuo Socorro Hosp, MEDIBAROX Hyperbar Unit, Alicante, Spain	Universidad Miguel Hernandez de Elche; Universitat Politecnica de Valencia; Universitat de les Illes Balears	Perez-Vidal, C (corresponding author), Miguel Hernandez Univ, Dept Syst Engn & Automat, Elche, Spain.	carlos.perez@umh.es	Carmona, Cristian/S-5180-2018; Alorda, Bartomeu/X-8716-2018	Carmona, Cristian/0000-0001-7872-535X; Alorda, Bartomeu/0000-0002-5617-6254	Miguel Hernandez University	Miguel Hernandez University	This research has been carried out with funding and promotion of "Catedra de Medicina Hiperbarica" of the Miguel Hernandez University. http://nbio.umh.es/es/2010/12/01/catedra-de-medicina-hiperbarica-medibarox/.	Barea-Navarro R., BIOMEDICAL INSTRUMEN; Brubakk AO, 2004, UNDERSEA HYPERBAR M, V31, P73; Burns A, 2010, IEEE SENS J, V10, P1527, DOI 10.1109/JSEN.2010.2045498; Chen C., 2013, J MOD INT THINGS, V2, P24; Chung WY, 2008, IEEE ENG MED BIO, P1529, DOI 10.1109/IEMBS.2008.4649460; Fadlullah ZM, 2011, IEEE COMMUN MAG, V49, P60, DOI 10.1109/MCOM.2011.5741147; Gesell L.B., 2008, HYPERBARIC OXYGEN TH, V12th ed.; Gil Y, 2012, SENSORS-BASEL, V12, P10381, DOI 10.3390/s120810381; Hu S, 2012, SENSORS-BASEL, V12, P12844, DOI 10.3390/s120912844; Lee JS, 2007, IEEE IND ELEC, P46; Lin BS, 2006, IEEE T INF TECHNOL B, V10, P647, DOI 10.1109/TITB.2006.874194; Lin CT, 2010, IEEE T INF TECHNOL B, V14, P726, DOI 10.1109/TITB.2010.2047401; Lindell K., HYPERBARIC OXIGEN TH; Branco BHM, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0150517; Mahmood A, 2015, RENEW SUST ENERG REV, V41, P248, DOI 10.1016/j.rser.2014.08.036; Marks Robert J., 1991, SPRINGER TEXTS ELECT, pxiii; Olteanu AC, 2013, I C CONTR SYS COMP S, P189, DOI 10.1109/CSCS.2013.63; Parikh P.P., 2010, IEEE PES GEN M, P1, DOI DOI 10.1109/PES.2010.5589988; Semmlow J. L., 2011, BIOSIGNAL MED IMAGE; Shang YL, 2014, PHYS REV E, V89, DOI 10.1103/PhysRevE.89.012813; Sidhu B, 2007, PROC WRLD ACAD SCI E, V19, P308; Sureda A, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0163371; Tortora G.J., 2009, PRINCIPLES ANATOMY P, P729; Xu Y, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0148324	24	1	1	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 15	2017	12	3							e0172768	10.1371/journal.pone.0172768	http://dx.doi.org/10.1371/journal.pone.0172768			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN9HQ	28296900	Green Published, Green Submitted, gold			2022-12-27	WOS:000396311700013
J	Wang, BF; Qi, ZQ; Chen, SZ; Liu, ZD; Ma, GC				Wang, Baofeng; Qi, Zhiquan; Chen, Sizhong; Liu, Zhaodu; Ma, Guocheng			Multi-vehicle detection with identity awareness using cascade Adaboost and Adaptive Kalman filter for driver assistant system	PLOS ONE			English	Article							MONOCULAR VEHICLE DETECTION	Vision-based vehicle detection is an important issue for advanced driver assistance systems. In this paper, we presented an improved multi-vehicle detection and tracking method using cascade Adaboost and Adaptive Kalman filter (AKF) with target identity awareness. A cascade Adaboost classifier using Haar-like features was built for vehicle detection, followed by a more comprehensive verification process which could refine the vehicle hypothesis in terms of both location and dimension. In vehicle tracking, each vehicle was tracked with independent identity by an Adaptive Kalman filter in collaboration with a data association approach. The AKF adaptively adjusted the measurement and process noise covariance through on-line stochastic modelling to compensate the dynamics changes. The data association correctly assigned different detections with tracks using global nearest neighbour (GNN) algorithm while considering the local validation. During tracking, a temporal context based track management was proposed to decide whether to initiate, maintain or terminate the tracks of different objects, thus suppressing the sparse false alarms and compensating the temporary detection failures. Finally, the proposed method was tested on various challenging real roads, and the experimental results showed that the vehicle detection performance was greatly improved with higher accuracy and robustness.	[Wang, Baofeng; Qi, Zhiquan; Chen, Sizhong; Liu, Zhaodu; Ma, Guocheng] Beijing Inst Technol, Sch Mech Engn, Lab Vehicle Engn, Beijing 100081, Peoples R China	Beijing Institute of Technology	Qi, ZQ (corresponding author), Beijing Inst Technol, Sch Mech Engn, Lab Vehicle Engn, Beijing 100081, Peoples R China.	qizhiquan@bit.edu.cn			National Natural Science Foundation of China [51005019]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This research is sponsored by the National Natural Science Foundation of China under Grant No. 51005019. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bar-Shalom Y., 1987, TRACKING DATA ASS; DEHGHAN A, 2015, PROC CVPR IEEE, P4091, DOI DOI 10.1109/CVPR.2015; Felzenszwalb PF, 2010, IEEE T PATTERN ANAL, V32, P1627, DOI 10.1109/TPAMI.2009.167; Graves Alex, 2013, AC SPEECH SIGN PROC; Hawe S., 2008, THESIS; Hu C., 2009, J SENSORS, V2009, P1; Hu XS, 2016, IEEE T TRANSP ELECTR, V2, P140, DOI 10.1109/TTE.2015.2512237; Hu XS, 2013, SIMUL MODEL PRACT TH, V34, P1, DOI 10.1016/j.simpat.2013.01.001; Karasalo M, 2011, AUTOMATICA, V47, P1785, DOI 10.1016/j.automatica.2011.04.004; Kim G, 2012, OPT REV, V19, P388, DOI 10.1007/s10043-012-0063-1; Konstantinova P., 2003, P 4 INT C C COMP SYS, P290; Kourou K, 2015, COMPUT STRUCT BIOTEC, V13, P8, DOI 10.1016/j.csbj.2014.11.005; Matthews ND, 1996, CONTROL ENG PRACT, V4, P473, DOI 10.1016/0967-0661(96)00028-7; Musicki D, 2004, IEEE T AERO ELEC SYS, V40, P1093, DOI 10.1109/TAES.2004.1337482; REID DB, 1979, IEEE T AUTOMAT CONTR, V24, P843, DOI 10.1109/TAC.1979.1102177; Schubert R, 2012, 2012 IEEE INTELLIGENT VEHICLES SYMPOSIUM (IV), P962, DOI 10.1109/IVS.2012.6232272; Sivaraman S, 2013, IEEE INT VEH SYM, P310, DOI 10.1109/IVS.2013.6629487; Sivaraman S, 2013, IEEE T INTELL TRANSP, V14, P906, DOI 10.1109/TITS.2013.2246835; Sivaraman S, 2009, IEEE INT VEH SYM, P399, DOI 10.1109/IVS.2009.5164311; Stanciulescu B, 2009, ARXIV09101293; Teoh SS, 2012, MACH VISION APPL, V23, P831, DOI 10.1007/s00138-011-0355-7; Tuohy S, 2010, P IRISH SIGN SYST C; Viola P, 2001, PROC CVPR IEEE, P511, DOI 10.1109/cvpr.2001.990517; von Seelen W., 1998, VEHICLE DETECTION TR	24	2	2	1	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 15	2017	12	3							e0173424	10.1371/journal.pone.0173424	http://dx.doi.org/10.1371/journal.pone.0173424			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN9HQ	28296902	gold, Green Published, Green Submitted			2022-12-27	WOS:000396311700037
J	Ward, EJ; Adkison, M; Couture, J; Dressel, SC; Litzow, MA; Moffitt, S; Neher, TH; Trochta, J; Brenner, R				Ward, Eric J.; Adkison, Milo; Couture, Jessica; Dressel, Sherri C.; Litzow, Michael A.; Moffitt, Steve; Neher, Tammy Hoem; Trochta, John; Brenner, Rich			Evaluating signals of oil spill impacts, climate, and species interactions in Pacific herring and Pacific salmon populations in Prince William Sound and Copper River, Alaska	PLOS ONE			English	Article							EXXON-VALDEZ OIL; HEMORRHAGIC SEPTICEMIA VIRUS; FRESH-WATER DISCHARGE; PINK SALMON; CLUPEA-PALLASI; ONCORHYNCHUS-GORBUSCHA; SOCKEYE-SALMON; TROPHIC DYNAMICS; KODIAK ISLAND; BOTTOM-UP	The Exxon Valdez oil spill occurred in March 1989 in Prince William Sound, Alaska, and was one of the worst environmental disasters on record in the United States. Despite long-term data collection over the nearly three decades since the spill, tremendous uncertainty remains as to how significantly the spill affected fishery resources. Pacific herring (Clupea pallasii) and some wild Pacific salmon populations (Oncorhynchus spp.) in Prince William Sound declined in the early 1990s, and have not returned to the population sizes observed in the 1980s. Discerning if, or how much of, this decline resulted from the oil spill has been difficult because a number of other physical and ecological drivers are confounded temporally with the spill; some of these drivers include environmental variability or changing climate regimes, increased production of hatchery salmon in the region, and increases in populations of potential predators. Using data pre-and post-spill, we applied time-series methods to evaluate support for whether and how herring and salmon productivity has been affected by each of five drivers: (1) density dependence, (2) the EVOS event, (3) changing environmental conditions, (4) interspecific competition on juvenile fish, and (5) predation and competition from adult fish or, in the case of herring, humpback whales. Our results showed support for intraspecific density-dependent effects in herring, sockeye, and Chinook salmon, with little overall support for an oil spill effect. Of the salmon species, the largest driver was the negative impact of adult pink salmon returns on sockeye salmon productivity. Herring productivity was most strongly affected by changing environmental conditions; specifically, freshwater discharge into the Gulf of Alaska was linked to a series of recruitment failures-before, during, and after EVOS. These results highlight the need to better understand long terms impacts of pink salmon on food webs, as well as the interactions between nearshore species and freshwater inputs, particularly as they relate to climate change and increasing water temperatures.	[Ward, Eric J.] NOAA, Conservat Biol Div, Northwest Fisheries Sci Ctr, Natl Marine Fisheries Serv, Seattle, WA 98115 USA; [Adkison, Milo] Univ Alaska Fairbanks, Sch Fisheries & Ocean Sci, Juneau, AK USA; [Couture, Jessica] Natl Ctr Ecol Anal & Synth, Santa Barbara, CA USA; [Dressel, Sherri C.; Brenner, Rich] Alaska Dept Fish & Game, Div Commercial Fisheries, Juneau, AK USA; [Litzow, Michael A.] Farallon Inst Adv Ecosyst Res, Petaluma, CA USA; [Moffitt, Steve] Alaska Dept Fish & Game, Div Commercial Fisheries, Cordova, AK USA; [Neher, Tammy Hoem] NOAA, Kasitsna Bay Lab, Natl Ocean Serv, Homer, AK USA; [Trochta, John] Univ Washington, Sch Aquat & Fishery Sci, Seattle, WA 98195 USA	National Oceanic Atmospheric Admin (NOAA) - USA; University of Alaska System; University of Alaska Fairbanks; National Center for Ecological Analysis & Synthesis; Alaska Department of Fish & Game; Alaska Department of Fish & Game; National Oceanic Atmospheric Admin (NOAA) - USA; National Ocean Service, NOAA; University of Washington; University of Washington Seattle	Ward, EJ (corresponding author), NOAA, Conservat Biol Div, Northwest Fisheries Sci Ctr, Natl Marine Fisheries Serv, Seattle, WA 98115 USA.	eric.ward@noaa.gov	Couture, Jessica/AAU-3840-2021		NCEAS working group (National Center for Ecological Analysis and Synthesis); Exxon Valdez Oil Spill Trustee Council (EVOSTC)	NCEAS working group (National Center for Ecological Analysis and Synthesis); Exxon Valdez Oil Spill Trustee Council (EVOSTC)(Exxon Mobil Corporation)	This project was funded as an NCEAS working group (National Center for Ecological Analysis and Synthesis, https://www.nceas.ucsb.edu/) by Kristin Marshall, "Applying portfolio effects to the Gulf of Alaska ecosystem". Funding for the working group was provided by the Exxon Valdez Oil Spill Trustee Council (EVOSTC).	Abdul-Aziz OI, 2011, CAN J FISH AQUAT SCI, V68, P1660, DOI [10.1139/F2011-079, 10.1139/f2011-079]; ADF&G Chinook Salmon Research Team, 2013, CHIN SALM STOCK ASS, P56; Agler BA, 1999, WATERBIRDS, V22, P98, DOI 10.2307/1521998; Anderson D, 2004, MODEL SELECTION MULT, V2nd; Anderson PJ, 1999, MAR ECOL PROG SER, V189, P117, DOI 10.3354/meps189117; Auburn Mary E., 2000, North Pacific Anadromous Fish Commission Bulletin, V2, P89; Batten S, 2015, ENV DRIVERS REGIONAL; Beamish RJ, 1997, ICES J MAR SCI, V54, P1200, DOI 10.1006/jmsc.1997.0305; Beamish RJ, 2012, INT WORKSH EXPL HIGH; Beamish RJ, 2010, 1284 N PAC AN FISH C, P26; Bechtol WR, 2001, PRINCE WILLIAM SOUND; Bishop MA, 2015, FISH OCEANOGR, V24, P1, DOI 10.1111/fog.12073; Bond NA, 2015, GEOPHYS RES LETT, V42, P3414, DOI 10.1002/2015GL063306; Brannon EL, 2012, REV FISH SCI, V20, P20, DOI 10.1080/10641262.2011.643697; Bugaev VF, 2001, FISH OCEANOGR, V10, P26, DOI 10.1046/j.1365-2419.2001.00150.x; Carls MG, 2002, CAN J FISH AQUAT SCI, V59, P153, DOI 10.1139/F01-200; Cooney RT, 2001, FISH OCEANOGR, V10, P1, DOI 10.1046/j.1054-6006.2001.00039.x; Cross AD, 2009, MAR COAST FISH, V1, P57, DOI 10.1577/C08-005.1; Davis N., 2003, FEEDING ECOLOGY PACI; Deriso RB, 2008, ECOL APPL, V18, P1270, DOI 10.1890/07-0708.1; Donaldson W, 1995, 2A95XX AL DEP FISH G; Doyle MJ, 2009, PROG OCEANOGR, V80, P163, DOI 10.1016/j.pocean.2009.03.002; Elston RA, 2009, DIS AQUAT ORGAN, V83, P223, DOI 10.3354/dao02005; Essington TE, 2015, P NATL ACAD SCI USA, V112, P6648, DOI 10.1073/pnas.1422020112; Exxon Valdez Oil Spill Trustee Council, EVOS SHOR SURF OIL; Fair LE, 2011, ESCAPEMENT GOAL REV; Francis Robert C., 1994, Fisheries Oceanography, V3, P279, DOI 10.1111/j.1365-2419.1994.tb00105.x; Frost KJ, 1999, MAR MAMMAL SCI, V15, P494, DOI 10.1111/j.1748-7692.1999.tb00815.x; Funk F, 1993, FORECAST PACIFIC HER; Funk FC, 1990, ADF G FISH RES B, V90-01; GALT JA, 1991, ENVIRON SCI TECHNOL, V25, P202, DOI 10.1021/es00014a001; Galvan I, 2014, FUNCT ECOL, V28, P1387, DOI 10.1111/1365-2435.12283; Geiger HJ, 1995, RUN RECONSTRUCTION L; Geiger HJ, 1992, 5J9212 AL DEP FISH G; Habicht C, 2000, BROODSTOCK ACQUISITI; Hare SR, 1999, FISHERIES, V24, P6, DOI 10.1577/1548-8446(1999)024<0006:IPR>2.0.CO;2; Hare SR, 2000, PROG OCEANOGR, V47, P103, DOI 10.1016/S0079-6611(00)00033-1; Hershberger PK, 2016, J FISH DIS, V39, P395, DOI 10.1111/jfd.12370; Hilborn R, 2000, T AM FISH SOC, V129, P333, DOI 10.1577/1548-8659(2000)129<0333:AROTHP>2.0.CO;2; HILBORN R, 1992; Holmes EE, 2012, R J, V4, P11; Hulson PJF, 2008, ICES J MAR SCI, V65, P25, DOI 10.1093/icesjms/fsm162; Incardona JP, 2015, SCI REP-UK, V5, DOI 10.1038/srep13499; Johnson SP, 2009, ECOL RES, V24, P855, DOI 10.1007/s11284-008-0559-0; Kaeriyama M, 2004, FISH OCEANOGR, V13, P197, DOI 10.1111/j.1365-2419.2004.00286.x; Kaeriyama M, 2000, FEEDING ECOLOGY SOCK, P55; Kemp IM, 2013, POTENTIAL COMPETITIO, P139; Kingston PF, 2002, SPILL SCI TECHNOL B, V7, P53, DOI 10.1016/S1353-2561(02)00051-8; Kuletz KJ, 1996, P INT S ROL FOR FISH, P703; Litzow MA, 2014, GLOBAL CHANGE BIOL, V20, P38, DOI 10.1111/gcb.12373; Mackas DL, 2007, PROG OCEANOGR, V75, P223, DOI 10.1016/j.pocean.2007.08.010; Mantua NJ, 1997, B AM METEOROL SOC, V78, P1069, DOI 10.1175/1520-0477(1997)078<1069:APICOW>2.0.CO;2; Martinson Ellen C., 2009, North Pacific Anadromous Fish Commission Bulletin, V5, P177; Martinson EC, 2008, MAR ECOL PROG SER, V370, P1, DOI 10.3354/meps07665; Matkin CO, 2008, MAR ECOL PROG SER, V356, P269, DOI 10.3354/meps07273; McGurk MD, 1996, CAN J FISH AQUAT SCI, V53, P2343, DOI 10.1139/cjfas-53-10-2343; Merrick RL, 1997, CAN J FISH AQUAT SCI, V54, P1342, DOI 10.1139/cjfas-54-6-1342; MEYERS TR, 1994, DIS AQUAT ORGAN, V19, P27, DOI 10.3354/dao019027; Moffitt SD, 2014, ESCAPEMENT GOAL REV; Moore JW, 2010, CONSERV LETT, V3, P340, DOI 10.1111/j.1755-263X.2010.00119.x; Mueter FJ, 2005, T AM FISH SOC, V134, P105, DOI 10.1577/T-04-033.1; Mundy PR., 2005, GULF ALASKA BIOL OCE, P220; Neff JM, 1995, EXXON VALDEZ OIL SPI; NIEBAUER HJ, 1994, J GEOPHYS RES-OCEANS, V99, P14113, DOI 10.1029/94JC00712; Norcross BL, 2001, FISH OCEANOGR, V10, P42, DOI 10.1046/j.1054-6006.2001.00040.x; Payne MR, 2009, ICES J MAR SCI, V66, P272, DOI 10.1093/icesjms/fsn211; Pearson WH, 2012, REV FISH BIOL FISHER, V22, P95, DOI 10.1007/s11160-011-9225-7; Pearson WH, 1999, CAN J FISH AQUAT SCI, V56, P711, DOI 10.1139/cjfas-56-4-711; Peterson CH, 2003, SCIENCE, V302, P2082, DOI 10.1126/science.1084282; Peterson CH, 2001, MAR ECOL PROG SER, V210, P255, DOI 10.3354/meps210255; Piatt JF, 1996, AM FISH S S, V18, P712; Quinn T. P, 2018, BEHAV ECOLOGY PACIFI; R Core Development Team, 2015, R LANG ENV STAT COMP; Rice S, 2007, PRINCE WILLIAM SOUND; RICKER W. E., 1954, JOUR FISH RES BD CANADA, V11, P559; ROYER TC, 1982, J GEOPHYS RES-OCEANS, V87, P2017, DOI 10.1029/JC087iC03p02017; Royer TC, 2006, GEOPHYS RES LETT, V33, DOI 10.1029/2006GL026767; Ruggerone GT, 2015, CAN J FISH AQUAT SCI, V72, P818, DOI 10.1139/cjfas-2014-0134; Ruggerone GT, 2004, REV FISH BIOL FISHER, V14, P371, DOI 10.1007/s11160-004-6927-0; Ruggerone GT, 2003, FISH OCEANOGR, V12, P209, DOI 10.1046/j.1365-2419.2003.00239.x; Schindler DE, 2010, NATURE, V465, P609, DOI 10.1038/nature09060; Schweigert JF, 2010, ICES J MAR SCI, V67, P1903, DOI 10.1093/icesjms/fsq134; Short JW, 1997, ENVIRON SCI TECHNOL, V31, P2375, DOI 10.1021/es960985d; Short JW, 2004, ENVIRON SCI TECHNOL, V38, P19, DOI 10.1021/es0348694; Siple MC, 2016, OECOLOGIA, V180, P111, DOI 10.1007/s00442-015-3439-7; SPIES RB, 2007, LONGT EC CHANG NO, P1; Springer AM, 2014, P NATL ACAD SCI USA, V111, pE1880, DOI 10.1073/pnas.1319089111; Stopha M, 2013, KOERNIG SALMON HATCH; Sturdevant MS, 2013, DOES PREDATION RETUR, P153; Sturdevant MV, 2001, FISH B-NOAA, V99, P482; Sturdevant MV, 1999, FORAGE FISH DIET OVE; Teerlink SF, 2015, ENVIRON ECOL STAT, V22, P345, DOI 10.1007/s10651-014-0301-8; Thorne RE, 2008, ICES J MAR SCI, V65, P44, DOI 10.1093/icesjms/fsm176; Wang Y, 2013, MODEL STUDY COPPER R; Ware DM, 2005, SCIENCE, V308, P1280, DOI 10.1126/science.1109049; Wessel M, 2014, 1442 AL DEP FISH GAM; Wiese A, 2015, PRINCE WILLIAM SOUND; Wikner J, 2012, GLOBAL CHANGE BIOL, V18, P2509, DOI 10.1111/j.1365-2486.2012.02718.x; Willette TM, 2001, FISH OCEANOGR, V10, P14, DOI 10.1046/j.1054-6006.2001.00043.x; Willette TM, 1996, RESTORATION COGHILL; Williams EH, 2000, FISH OCEANOGR, V9, P285, DOI 10.1046/j.1365-2419.2000.00145.x; WOLFE DA, 1994, ENVIRON SCI TECHNOL, V28, pA560, DOI 10.1021/es00062a712; Woodward G, 2010, PHILOS T R SOC B, V365, P2093, DOI 10.1098/rstb.2010.0055; Zebdi Abdelkrim, 1995, Canadian Special Publication of Fisheries and Aquatic Sciences, V121, P277	104	23	23	0	88	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 15	2017	12	3							e0172898	10.1371/journal.pone.0172898	http://dx.doi.org/10.1371/journal.pone.0172898			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN9HQ	28296895	gold, Green Published, Green Submitted			2022-12-27	WOS:000396311700017
J	Harnod, T; Wang, YC; Lin, CL; Tseng, CH				Harnod, Tomor; Wang, Yu-Chiao; Lin, Cheng-Li; Tseng, Chun-Hung			High risk of developing subsequent epilepsy in patients with sleep-disordered breathing	PLOS ONE			English	Article							MORTALITY; PREVALENCE; ROCHESTER; INSOMNIA; ADULTS	Purpose Sleep-disordered breathing (SDB) is often associated with other medical disorders. Whether SDB interacts with other factors for developing subsequent epilepsy remains unclear. Methods This population-based cohort study was conducted using the National Health Insurance Research Database of Taiwan. Patients aged >20 years and diagnosed with SDB between 2000 and 2010 comprised the SDB cohort (n = 138,507), and their data were compared with those of the comparison cohort (n = 138,507). The adjusted hazard ratio (aHR) for epilepsy was calculated using a multivariate Cox proportional hazards model. Results The SDB cohort had an increased risk of epilepsy (aHR = 1.50, 95% confidence interval [CI] = 1.36(_)1.66). The sex-stratified analysis revealed a significant adjusted hazard ratio (aHR) for epilepsy with a 1.51-fold higher risk for female patients, and also a significantly 1.49-fold higher risk for male patients in the SDB cohort. Although epilepsy incidence increased with age in both cohorts, different age groups in the SDB cohort all had a significantly higher risk of developing epilepsy than comparison cohort. Conclusion This population-based cohort study indicates that patients with SDB are at a high risk of developing subsequent epilepsy, in both sexes and all age groups.	[Harnod, Tomor] Hualien Tzu Chi Gen Hosp, Dept Neurosurg, Buddhist Tzu Chi Med Fdn, Hualien, Taiwan; [Harnod, Tomor] Tzu Chi Univ, Coll Med, Hualien, Taiwan; [Wang, Yu-Chiao; Lin, Cheng-Li] China Med Univ Hosp, Management Off Hlth Data, Taichung, Taiwan; [Wang, Yu-Chiao; Lin, Cheng-Li] China Med Univ, Coll Med, Taichung, Taiwan; [Tseng, Chun-Hung] China Med Univ, Coll Med, Grad Inst Clin Med Sci, Taichung, Taiwan; [Tseng, Chun-Hung] China Med Univ, Coll Med, Sch Med, Taichung, Taiwan; [Tseng, Chun-Hung] China Med Univ Hosp, Dept Neurol, Taichung, Taiwan	Buddhist Tzu Chi General Hospital; Hualien Tzu Chi Hospital; Tzu Chi University; China Medical University Taiwan; China Medical University Hospital - Taiwan; China Medical University Taiwan; China Medical University Taiwan; China Medical University Taiwan; China Medical University Taiwan; China Medical University Hospital - Taiwan	Tseng, CH (corresponding author), China Med Univ, Coll Med, Grad Inst Clin Med Sci, Taichung, Taiwan.; Tseng, CH (corresponding author), China Med Univ, Coll Med, Sch Med, Taichung, Taiwan.; Tseng, CH (corresponding author), China Med Univ Hosp, Dept Neurol, Taichung, Taiwan.	Tseng.nm@gmail.com			Taiwan Ministry of Health and Welfare Clinical Trial and Research Center of Excellence [MOHW105-TDU-B-212-133019]; China Medical University Hospital; Academia Sinica Taiwan Biobank Stroke Biosignature Project [BM10501010037]; NRPB Stroke Clinical Trial Consortium [MOST105-2325-B-039-003]; Tseng-Lien Lin Foundation, Taichung, Taiwan; Taiwan Brain Disease Foundation, Taipei, Taiwan; Katsuzo and Kiyo Aoshima Memorial Funds, Japan	Taiwan Ministry of Health and Welfare Clinical Trial and Research Center of Excellence; China Medical University Hospital; Academia Sinica Taiwan Biobank Stroke Biosignature Project; NRPB Stroke Clinical Trial Consortium; Tseng-Lien Lin Foundation, Taichung, Taiwan; Taiwan Brain Disease Foundation, Taipei, Taiwan; Katsuzo and Kiyo Aoshima Memorial Funds, Japan	This study was supported in part by the Taiwan Ministry of Health and Welfare Clinical Trial and Research Center of Excellence (MOHW105-TDU-B-212-133019); China Medical University Hospital; Academia Sinica Taiwan Biobank Stroke Biosignature Project (BM10501010037); NRPB Stroke Clinical Trial Consortium (MOST105-2325-B-039-003); Tseng-Lien Lin Foundation, Taichung, Taiwan; Taiwan Brain Disease Foundation, Taipei, Taiwan; Katsuzo and Kiyo Aoshima Memorial Funds, Japan. The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding has been received for this study.	Annegers JF, 1996, MAYO CLIN PROC, V71, P570, DOI 10.4065/71.6.570; Aurlien D, 2012, SEIZURE-EUR J EPILEP, V21, P573, DOI 10.1016/j.seizure.2012.05.015; Benbadis SR, 2000, SEIZURE-EUR J EPILEP, V9, P280, DOI 10.1053/seiz.2000.0409; Chang YH, 2012, SEIZURE-EUR J EPILEP, V21, P254, DOI 10.1016/j.seizure.2012.01.006; Cheng CL, 2011, PHARMACOEPIDEM DR S, V20, P236, DOI 10.1002/pds.2087; Chihorek AM, 2007, NEUROLOGY, V69, P1823, DOI 10.1212/01.wnl.0000279334.78298.d5; Harden CL, 1999, EPILEPSIA, V40, P1402, DOI 10.1111/j.1528-1157.1999.tb02012.x; Harnod T, 2015, QJM-INT J MED, V108, P449, DOI 10.1093/qjmed/hcu215; Harnod T, 2015, MEDICINE, V94, DOI [10.1097/MD.0000000000001506, 10.1097/MD.0000000000001571]; HAUSER WA, 1991, EPILEPSIA, V32, P429, DOI 10.1111/j.1528-1157.1991.tb04675.x; Henderson VW, 2006, NEUROLOGIST, V12, P149, DOI 10.1097/01.nrl.0000215750.52786.b1; Jain SV, 2015, SEMIN PEDIATR NEUROL, V22, P86, DOI 10.1016/j.spen.2015.03.005; Khachatryan SG, 2015, SLEEP MED, V16, P1017, DOI 10.1016/j.sleep.2015.03.019; Lucey BP, 2015, SLEEP, V38, P777, DOI 10.5665/sleep.4674; Morrell MJ, 2002, AM FAM PHYSICIAN, V66, P1489; Neligan A, 2011, BRAIN, V134, P388, DOI 10.1093/brain/awq378; Nevalainen O, 2013, EUR J EPIDEMIOL, V28, P981, DOI 10.1007/s10654-013-9848-1; Ohayon MM, 2009, SLEEP MED CLIN, V4, P87, DOI 10.1016/j.jsmc.2008.12.002; Schmitt B, 2015, NEUROPEDIATRICS, V46, P171, DOI 10.1055/s-0035-1551574; Stanimirovic DB, 2012, J CEREBR BLOOD F MET, V32, P1207, DOI 10.1038/jcbfm.2012.25; Vgontzas AN, 2010, SLEEP, V33, P1159, DOI 10.1093/sleep/33.9.1159; Yaffe K, 2011, JAMA-J AM MED ASSOC, V306, P613, DOI 10.1001/jama.2011.1115	22	7	7	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 14	2017	12	3							e0173491	10.1371/journal.pone.0173491	http://dx.doi.org/10.1371/journal.pone.0173491			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN6DM	28291799	gold, Green Submitted, Green Published			2022-12-27	WOS:000396094700029
J	Peng, CK; Huang, KL; Lan, CC; Hsu, YJ; Wu, GC; Peng, CH; Wu, CP; Chan, KS				Peng, Chung-Kan; Huang, Kun-Lun; Lan, Chou-Chin; Hsu, Yu-Juei; Wu, Geng-Chin; Peng, Chia-Hui; Wu, Chin-Pyng; Chan, Khee-Siang			Experimental chronic kidney disease attenuates ischemia-reperfusion injury in an ex vivo rat lung model	PLOS ONE			English	Article							NITRIC-OXIDE SYNTHASE; FACTOR-KAPPA-B; RESPIRATORY-DISTRESS-SYNDROME; HEAT-SHOCK PROTEINS; RENAL-FAILURE; ACUTE ENDOTOXEMIA; XANTHINE-OXIDASE; TRANSPLANTATION; INHIBITION; EXPRESSION	Lung ischemia reperfusion injury (LIRI) is one of important complications following lung transplant and cardiopulmonary bypass. Although patients on hemodialysis are still excluded as lung transplant donors because of the possible effects of renal failure on the lungs, increased organ demand has led us to evaluate the influence of chronic kidney disease (CKD) on LIRI. A CKD model was induced by feeding Sprague-Dawley rats an adenine- rich (0.75%) diet for 2, 4 and 6 weeks, and an isolated rat lung in situ model was used to evaluate ischemia reperfusion (IR)-induced acute lung injury. The clinicopathological parameters of LIRI, including pulmonary edema, lipid peroxidation, histopathological changes, immunohistochemistry changes, chemokine CXCL1, inducible nitric oxide synthase (iNOS), proinflammatory and anti-inflammatory cytokines, heat shock protein expression, and nuclear factor-kappa B (NF-kappa B) activation were determined. Our results indicated that adenine-fed rats developed CKD as characterized by increased blood urea nitrogen and creatinine levels and the deposition of crystals in the renal tubules and interstitium. IR induced a significant increase in the pulmonary arterial pressure, lung edema, lung injury scores, the expression of CXCL1 mRNA, iNOS level, and protein concentration of the bronchial alveolar lavage fluid (BALF). The tumor necrosis factor-a levels in the BALF and perfusate; the interleukin-10 level in the perfusate; and the malondialdehyde levels in the lung tissue and perfusate were also significantly increased by LIRI. Counterintuitively, adenine-induced CKD significantly attenuated the severity of lung injury induced by IR. CKD rats exhibited increased heat shock protein 70 expression and decreased activation of NF-kappa B signaling. In conclusion, adenine-induced CKD attenuated LIRI by inhibiting the NF-kappa B pathway.	[Peng, Chung-Kan] Triserv Gen Hosp, Div Pulm & Crit Care, Dept Internal Med, Natl Def Med Ctr, Taipei, Taiwan; [Huang, Kun-Lun] Natl Def Med Ctr, Inst Undersea & Hyperbar Med, Taipei, Taiwan; [Lan, Chou-Chin] Taipei Tzu Chi Hosp, Buddhist Tzu Chi Med Fdn, Div Pulm Med, Taipei, Taiwan; [Lan, Chou-Chin] Tzu Chi Univ, Sch Med, Hualien, Taiwan; [Hsu, Yu-Juei] Triserv Gen Hosp, Div Nephrol, Dept Med, Natl Def Med Ctr, Taipei, Taiwan; [Wu, Geng-Chin] Taoyuan Armed Forces Gen Hosp, Div Pulm Med, Dept Internal Med, Lungtan, Taiwan; [Peng, Chia-Hui] Taoyuan Armed Forces Gen Hosp, Div Clin Nutr, Lungtan, Taiwan; [Wu, Chin-Pyng] Li Shin Hosp, Dept Crit Care Med, Taoyuan, Taiwan; [Chan, Khee-Siang] Chi Mei Med Ctr, Dept Crit Care Med, Tainan, Taiwan	National Defense Medical Center; Tri-Service General Hospital; National Defense Medical Center; Tzu Chi University; National Defense Medical Center; Tri-Service General Hospital; Chi Mei Hospital	Wu, CP (corresponding author), Li Shin Hosp, Dept Crit Care Med, Taoyuan, Taiwan.; Chan, KS (corresponding author), Chi Mei Med Ctr, Dept Crit Care Med, Tainan, Taiwan.	chinpyng@mail.ndmctsgh.edu.tw; kheesiangchan@gmail.com	Wu, Chin-Pyng/W-8447-2019; Peng, Chung-Kang/N-1308-2019	Peng, Chung-Kang/0000-0003-3666-9833	cooperative research projects of Chi-Mei Medical Center and National Defense Medical Center [CMNDMC10011, CMNDMC10109]; Li-Shin Hospital [1S52010-07]; Tri-Service General Hospital [TSGH-C100-79]; Ministry of National Defense [MAB101-65]	cooperative research projects of Chi-Mei Medical Center and National Defense Medical Center; Li-Shin Hospital; Tri-Service General Hospital; Ministry of National Defense	This work was supported by grants from the cooperative research projects of Chi-Mei Medical Center and National Defense Medical Center (CMNDMC10011 and CMNDMC10109), the Li-Shin Hospital (1S52010-07), the Tri-Service General Hospital (TSGH-C100-79), and the Ministry of National Defense (MAB101-65).	ADKINS WK, 1990, J APPL PHYSIOL, V69, P2012, DOI 10.1152/jappl.1990.69.6.2012; Arkovitz MS, 1996, J PEDIATR SURG, V31, P1009, DOI 10.1016/S0022-3468(96)90075-5; BarbotinLarrieu F, 1996, J APPL PHYSIOL, V80, P782, DOI 10.1152/jappl.1996.80.3.782; Basu RK, 2013, PEDIATR NEPHROL, V28, P2239, DOI 10.1007/s00467-012-2386-3; Beckman JS, 1996, AM J PHYSIOL-CELL PH, V271, pC1424; Bhatia M, 2012, AM J RESP CELL MOL, V46, P566, DOI 10.1165/rcmb.2011-0392TR; Bosutti A, 2007, CYTOKINE, V40, P71, DOI 10.1016/j.cyto.2007.09.002; BUSH A, 1991, THORAX, V46, P424, DOI 10.1136/thx.46.6.424; Chu SJ, 2002, CRIT CARE MED, V30, P1605, DOI 10.1097/00003246-200207000-00034; COOPER JD, 1992, AM REV RESPIR DIS, V146, P803, DOI 10.1164/ajrccm/146.3.803; De Maio A, 1999, SHOCK, V11, P1, DOI 10.1097/00024382-199901000-00001; de Perrot M, 2003, AM J RESP CRIT CARE, V167, P490, DOI 10.1164/rccm.200207-670SO; Eppinger MJ, 1996, J THORAC CARDIOV SUR, V112, P1301, DOI 10.1016/S0022-5223(96)70144-7; Granton J, 2006, CURR OPIN CRIT CARE, V12, P19, DOI 10.1097/01.ccx.0000198995.44943.63; HADDAD IY, 1994, J CLIN INVEST, V94, P2407, DOI 10.1172/JCI117607; Haverich A, 1985, J Heart Transplant, V4, P234; Heinzelmann M, 1999, AM J KIDNEY DIS, V34, P384, DOI 10.1016/S0272-6386(99)70375-6; Hopkinson DN, 1998, J HEART LUNG TRANSPL, V17, P525; Ishiyama T, 2005, J THORAC CARDIOV SUR, V130, P194, DOI 10.1016/j.jtcvs.2005.02.040; King RC, 2000, ANN THORAC SURG, V69, P1681, DOI 10.1016/S0003-4975(00)01425-9; KIRSCHNER RE, 1994, J AM COLL SURGEONS, V179, P103; Kristof AS, 1998, AM J RESP CRIT CARE, V158, P1883, DOI 10.1164/ajrccm.158.6.9802100; Li MH, 2009, BRIT J PHARMACOL, V157, P244, DOI 10.1111/j.1476-5381.2009.00139.x; LINDQUIST S, 1988, ANNU REV GENET, V22, P631, DOI 10.1146/annurev.ge.22.120188.003215; Liu SF, 1997, J IMMUNOL, V159, P3976; LYNCH MJ, 1988, J SURG RES, V44, P538, DOI 10.1016/0022-4804(88)90159-X; MYERS BD, 1975, CHEST, V68, P191, DOI 10.1378/chest.68.2.191; Ng CSH, 2006, SURG TODAY, V36, P205, DOI 10.1007/s00595-005-3124-2; Peng CK, 2011, PULM PHARMACOL THER, V24, P153, DOI 10.1016/j.pupt.2010.07.002; Ross SD, 2000, AM J PHYSIOL-LUNG C, V279, pL528, DOI 10.1152/ajplung.2000.279.3.L528; Ross SD, 1999, ANN THORAC SURG, V67, P1428, DOI 10.1016/S0003-4975(99)00248-9; Sawant KV, 2015, J INNATE IMMUN, V7, P647, DOI 10.1159/000430914; Shlomi D, 2006, ANN THORAC SURG, V81, P1131, DOI 10.1016/j.athoracsur.2005.01.062; Singleton KD, 2005, CRIT CARE MED, V33, P1206, DOI 10.1097/01.CCM.0000166357.10996.8A; SPINK J, 1995, J BIOL CHEM, V270, P29541, DOI 10.1074/jbc.270.49.29541; Taylor BS, 1998, J BIOL CHEM, V273, P15148, DOI 10.1074/jbc.273.24.15148; Turcios NL, 2012, PAEDIATR RESPIR REV, V13, P44, DOI 10.1016/j.prrv.2011.04.006; Weiss YG, 2002, J CLIN INVEST, V110, P801, DOI 10.1172/JCI200215888; Weiss YG, 2007, CRIT CARE MED, V35, P2128, DOI 10.1097/01.CCM.0000278915.78030.74; WIZEMANN TM, 1994, J LEUKOCYTE BIOL, V56, P759, DOI 10.1002/jlb.56.6.759; Wong HR, 1996, AM J PHYSIOL-LUNG C, V271, pL166, DOI 10.1152/ajplung.1996.271.1.L166; Wu SY, 2012, CRIT CARE MED, V40, P553, DOI 10.1097/CCM.0b013e318232d776; XIE QW, 1994, J BIOL CHEM, V269, P4705; YOKOZAWA T, 1984, J NUTR SCI VITAMINOL, V30, P245, DOI 10.3177/jnsv.30.245	44	4	4	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 14	2017	12	3							e0171736	10.1371/journal.pone.0171736	http://dx.doi.org/10.1371/journal.pone.0171736			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN6DM	28291795	gold, Green Published, Green Submitted			2022-12-27	WOS:000396094700003
J	Chen, LY; Ma, X; Li, HZ; Gu, LY; Li, XT; Gao, Y; Xie, YP; Zhang, X				Chen, Luyao; Ma, Xin; Li, Hongzhao; Gu, Liangyou; Li, Xintao; Gao, Yu; Xie, Yongpeng; Zhang, Xu			Influence of tumor size on oncological outcomes of pathological T3aN0M0 renal cell carcinoma treated by radical nephrectomy	PLOS ONE			English	Article							PERINEPHRIC FAT INFILTRATION; TNM STAGING SYSTEM; PROGNOSTIC-SIGNIFICANCE; MULTICENTER EXPERIENCE; T3A; CLASSIFICATION; CANCER; IMPACT	Objective To evaluate the prognostic significance of tumor size in pathological T3aN0M0 renal cell carcinoma (RCC) treated by radical nephrectomy. Materials and methods Patients who underwent radical nephrectomy for sporadic RCC with pathological T3aN0M0 RCC at our institution between January 2006 and June 2015 were identified. The entire cohort was divided into two groups according to the cutoff of tumor size obtained from receiver operating characteristic (ROC) curve. Clinicopathological variables were retrospectively collected and compared. Kaplan-Meier analysis and multivariate Cox regression were conducted to evaluate the effect of tumor size on survival outcomes. Results 163 pT3aNOMO RCC patients were included with a median follow-up period of 31 months. The optimal cutoff for tumor size was 7 cm according to the ROC curve. 90 cases (55.2%) presented tumors which measured 7 cm or less, and 73 cases (44.8%) showed tumor size greater than 7 cm. Patients with larger tumors tended to exhibit higher rates of symptoms and higher Fuhrman grades; they also indicated more necrosis features, and were more likely to invade the collecting system and renal vein. Compared with patients who exhibited tumor size of <= 7 cm, those with tumor size>7 cm were associated with shorter estimated five-year cancer-specific survival (CSS, 46.6% versus 75.0%, P=0.003) and five-year recurrence-free survival (RFS, 35.6% versus 62.7%, P = 0.011). Multivariate Cox analysis revealed that tumor size was retained as an independent factor for CSS (HR = 2.506, 95% CI 1.169-5.373, P=0.018). Conclusions The tumor size significantly affected the survival outcomes of pT3aN0M0 RCC treated by radical nephrectomy, and a cutoff size of 7 cm can help enhance the prognostic discrimination. Thus, the tumor size may be considered in the future TNM classification of stage pT3a.	[Chen, Luyao; Ma, Xin; Li, Hongzhao; Gu, Liangyou; Li, Xintao; Gao, Yu; Xie, Yongpeng; Zhang, Xu] Chinese Peoples Liberat Army Gen Hosp, Dept Urol, State Key Lab Kidney Dis, Beijing, Peoples R China; [Xie, Yongpeng] Nankai Univ, Sch Med, Tianjin, Peoples R China	Chinese People's Liberation Army General Hospital; Nankai University	Zhang, X (corresponding author), Chinese Peoples Liberat Army Gen Hosp, Dept Urol, State Key Lab Kidney Dis, Beijing, Peoples R China.	xzhang@tjh.tjmu.edu.cn	zhang, xu/GYE-3558-2022					Brookman-May SD, 2015, EUR UROL, V67, P943, DOI 10.1016/j.eururo.2014.11.055; Chevinsky M, 2015, J UROLOGY, V194, P310, DOI 10.1016/j.juro.2015.02.013; Crispen PL, 2011, EUR UROL, V59, P18, DOI 10.1016/j.eururo.2010.08.042; DeSantis CE, 2014, CA-CANCER J CLIN, V64, P252, DOI 10.3322/caac.21235; Edge SB, 2010, ANN SURG ONCOL, V17, P1471, DOI 10.1245/s10434-010-0985-4; Elmore JM, 2003, CANCER-AM CANCER SOC, V98, P2329, DOI 10.1002/cncr.11806; Ficarra V, 2007, LANCET ONCOL, V8, P554, DOI 10.1016/S1470-2045(07)70173-0; Frank I, 2002, J UROLOGY, V168, P2395, DOI 10.1016/S0022-5347(05)64153-5; FUHRMAN SA, 1982, AM J SURG PATHOL, V6, P655, DOI 10.1097/00000478-198210000-00007; Gofrit ON, 2007, J UROLOGY, V177, P1682, DOI 10.1016/j.juro.2007.01.064; Gospodarowicz MK, 2004, CANCER, V100, P1, DOI 10.1002/cncr.11898; Klatte T, 2007, J UROLOGY, V178, P35, DOI 10.1016/j.juro.2007.03.046; Lam JS, 2007, EUR UROL, V52, P155, DOI 10.1016/j.eururo.2007.01.106; Lopez-Beltran A, 2006, EUR UROL, V49, P798, DOI 10.1016/j.eururo.2005.11.035; Moch H, 2009, EUR UROL, V56, P636, DOI 10.1016/j.eururo.2009.06.036; Schiavina R, 2015, CLIN GENITOURIN CANC, V13, pE235, DOI 10.1016/j.clgc.2014.06.011; Siemer S, 2005, J UROLOGY, V173, P33, DOI 10.1097/01.ju.0000146719.43269.e8; Suer E, 2013, UROL J, V10, P774; Tsui KH, 2000, J UROLOGY, V163, P1090, DOI 10.1016/S0022-5347(05)67699-9; Yoo C, 2008, J UROLOGY, V180, P486, DOI 10.1016/j.juro.2008.04.034; Zhang ZL, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0149420	21	16	16	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 13	2017	12	3							e0173953	10.1371/journal.pone.0173953	http://dx.doi.org/10.1371/journal.pone.0173953			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN6CP	28288191	Green Published, gold, Green Submitted			2022-12-27	WOS:000396092400045
J	Peverill, RE; Chou, B; Donelan, L				Peverill, Roger E.; Chou, Bon; Donelan, Lesley			Left ventricular long axis tissue Doppler systolic velocity is independently related to heart rate and body size	PLOS ONE			English	Article							INCREMENTAL PROGNOSTIC VALUE; ATRIOVENTRICULAR PLANE DISPLACEMENT; MITRAL ANNULAR VELOCITIES; INTACT UNANESTHETIZED MAN; FORCE-FREQUENCY RELATION; DIASTOLIC FUNCTION; DILATED CARDIOMYOPATHY; HEALTHY-SUBJECTS; CARDIOVASCULAR-DISEASE; REFERENCE VALUES	Background The physiological factors which affect left ventricular (LV) long-axis function are not fully defined. We investigated the relationships of resting heart rate and body size with the peak velocities and amplitudes of LV systolic and early diastolic long axis motion, and also with long-axis contraction duration. Methods Two groups of adults free of cardiac disease underwent pulsed-wave tissue Doppler imaging at the septal and lateral mitral annular borders. Group 1 (n = 77) were healthy subjects < 50 years of age and Group 2 (n = 65) were subjects between 40-80 years of age referred for stress echocardiography. Systolic excursion (SExc), duration (SDur) and peak velocity (s') and early diastolic excursion (EDExc) and peak velocity (e') were measured. Results SExc was not correlated with heart rate, height or body surface area (BSA) for either LV wall in either group, but SDur was inversely correlated with heart rate for both walls and both groups, and after adjustment for heart rate, males in both groups had a shorter septal SDur. Septal and lateral s' were independently and positively correlated with SExc, heart rate and height in both groups, independent of sex and age. There were no correlations of heart rate, height or BSA with either e' or EDExc for either wall in either group. Conclusion Heart rate and height independently modify the relationship between s' and SExc, but neither are related to EDExc or e'. These findings suggest that s' and SExc cannot be used interchangeably for the assessment of LV long-axis contraction.	[Peverill, Roger E.] Monash Univ, Monash Cardiovasc Res Ctr, MonashHeart, Clayton, Vic, Australia; Monash Univ, Dept Med, Sch Clin Sci, Monash Med Ctr, Clayton, Vic, Australia; Monash Hlth, Clayton, Vic, Australia	Monash University; Monash University	Peverill, RE (corresponding author), Monash Univ, Monash Cardiovasc Res Ctr, MonashHeart, Clayton, Vic, Australia.	roger.peverill@monash.edu		Peverill, Roger/0000-0002-3319-5356				ALAM M, 1990, J INTERN MED, V228, P569, DOI 10.1111/j.1365-2796.1990.tb00281.x; Alam M, 2003, J AM SOC ECHOCARDIOG, V16, P240, DOI 10.1067/mje.2003.52; Alam M, 1999, J AM SOC ECHOCARDIOG, V12, P618, DOI 10.1053/je.1999.v12.a99246; Arce OX, 2002, J AM SOC ECHOCARDIOG, V15, P906, DOI 10.1067/mje.2002.121436; AROESTY JM, 1985, CIRCULATION, V71, P889, DOI 10.1161/01.CIR.71.5.889; BONAA KH, 1992, CIRCULATION, V86, P394; BOUDOULAS H, 1990, EUR HEART J, V11, P93, DOI 10.1093/eurheartj/11.suppl_I.93; BOUDOULAS H, 1981, CHEST, V80, P613, DOI 10.1378/chest.80.5.613; Bowditch HP., 1871, VERH K SACHS GES WIS, V23, P652; Bruch C, 2003, J AM SOC ECHOCARDIOG, V16, P1031, DOI 10.1016/S0894-7317(03)00634-5; Burns AT, 2007, ECHOCARDIOGR-J CARD, V24, P697, DOI 10.1111/j.1540-8175.2007.00466.x; Cacciapuoti F, 2009, AGING CLIN EXP RES, V21, P22; CAILLET D, 1982, CARDIOVASC RES, V16, P107, DOI 10.1093/cvr/16.2.107; Cain P, 2002, AM J CARDIOL, V89, P1347, DOI 10.1016/S0002-9149(02)02345-7; Carlsson M, 2007, AM J PHYSIOL-HEART C, V292, pH1452, DOI 10.1152/ajpheart.01148.2006; Chahal NS, 2010, EUR J ECHOCARDIOGR, V11, P51, DOI 10.1093/ejechocard/jep164; Cheng K, 2012, J HYPERTENS, V30, P2395, DOI 10.1097/HJH.0b013e328358bee2; Crendal E, 2014, BMC CARDIOVASC DISOR, V14, DOI 10.1186/1471-2261-14-95; Cui W, 2008, J AM SOC ECHOCARDIOG, V21, P361, DOI 10.1016/j.echo.2007.05.034; Custodis F, 2013, J CARDIOL, V62, P183, DOI 10.1016/j.jjcc.2013.02.018; Dalen H, 2010, CIRC-CARDIOVASC IMAG, V3, P614, DOI 10.1161/CIRCIMAGING.109.926022; DEMARIA AN, 1979, AM J CARDIOL, V43, P1, DOI 10.1016/0002-9149(79)90036-5; Dewey FE, 2008, CIRCULATION, V117, P2279, DOI 10.1161/CIRCULATIONAHA.107.736785; FELDMAN MD, 1988, J CLIN INVEST, V82, P1661, DOI 10.1172/JCI113778; FREEMAN GL, 1987, CIRC RES, V61, P455, DOI 10.1161/01.RES.61.3.455; Gibson DG, 2003, HEART, V89, P231, DOI 10.1136/heart.89.2.231; GLICK G, 1965, J CLIN INVEST, V44, P978, DOI 10.1172/JCI105215; Gulati VK, 1996, AM J CARDIOL, V77, P979, DOI 10.1016/S0002-9149(96)00033-1; Henein M, 2002, EUR HEART J, V23, P162, DOI 10.1053/euhj.2001.3032; Henein MY, 1999, HEART, V81, P111, DOI 10.1136/hrt.81.2.111; Henein MY, 1999, HEART, V81, P229, DOI 10.1136/hrt.81.3.229; HIGGINS CB, 1973, J CLIN INVEST, V52, P1187, DOI 10.1172/JCI107285; Innelli P, 2008, EUR J ECHOCARDIOGR, V9, P241, DOI 10.1016/j.euje.2007.03.04; Isaaz K, 1993, J Am Soc Echocardiogr, V6, P166; Janssen PML, 2007, J MOL CELL CARDIOL, V43, P523, DOI 10.1016/j.yjmcc.2007.08.012; Jasaityte R, 2014, ULTRASOUND MED BIOL, V40, P37, DOI 10.1016/j.ultrasmedbio.2013.09.005; Kraigher-Krainer E, 2014, J AM COLL CARDIOL, V63, P447, DOI 10.1016/j.jacc.2013.09.052; Kukulski T, 2000, J AM SOC ECHOCARDIOG, V13, P194, DOI 10.1067/mje.2000.103106; Lee KS, 2007, J AM SOC ECHOCARDIOG, V20, P773, DOI 10.1016/j.echo.2007.03.002; Matos J, 2012, J AM SOC ECHOCARDIOG, V25, P969, DOI 10.1016/j.echo.2012.06.011; Mogelvang R, 2009, CIRCULATION, V119, P2679, DOI 10.1161/CIRCULATIONAHA.108.793471; Mottram PM, 2011, J AM SOC ECHOCARDIOG, V24, P782, DOI 10.1016/j.echo.2011.04.004; MULIERI LA, 1992, CIRCULATION, V85, P1743, DOI 10.1161/01.CIR.85.5.1743; Munagala VK, 2003, J AM SOC ECHOCARDIOG, V16, P1049, DOI 10.1016/S0894-7317(03)00516-9; Nagueh SF, 2004, CLIN SCI, V106, P147, DOI 10.1042/CS20030204; Nagueh SF, 2009, J AM SOC ECHOCARDIOG, V22, P107, DOI 10.1016/j.echo.2008.11.023; Nikitin NP, 2006, HEART, V92, P775, DOI 10.1136/hrt.2005.067140; Nikitin NP, 2005, AGE AGEING, V34, P343, DOI 10.1093/ageing/afi043; Nilsson B, 2000, CLIN PHYSIOL, V20, P272; Oki T, 1999, J AM SOC ECHOCARDIOG, V12, P308, DOI 10.1016/S0894-7317(99)70051-9; Okura H, 2009, CIRC-CARDIOVASC IMAG, V2, P41, DOI 10.1161/CIRCIMAGING.108.809087; PAI RG, 1991, AM J CARDIOL, V67, P222, DOI 10.1016/0002-9149(91)90453-R; Pasquet A, 1999, AM HEART J, V138, P753, DOI 10.1016/S0002-8703(99)70192-4; Pela G, 2004, J AM SOC ECHOCARDIOG, V17, P205, DOI 10.1016/j.echo.2003.12.004; Peterson LR, 2004, J AM COLL CARDIOL, V43, P1399, DOI 10.1016/j.jacc.2003.10.062; Petrie MC, 2002, HEART, V87, P29, DOI 10.1136/heart.87.1.29; Peverill RE, 2004, J AM SOC ECHOCARDIOG, V17, P1146, DOI 10.1016/j.echo.2004.06.007; Ross J, 1998, BASIC RES CARDIOL, V93, P95; ROSS J, 1995, CIRCULATION, V92, P2327, DOI 10.1161/01.CIR.92.8.2327; ROSS J, 1965, CIRCULATION, V32, P549, DOI 10.1161/01.CIR.32.4.549; Rossman EI, 2004, J MOL CELL CARDIOL, V36, P33, DOI 10.1016/j.yjmcc.2003.09.001; Ruan QY, 2006, AM J CARDIOL, V97, P872, DOI 10.1016/j.amjcard.2005.10.024; Ruan QY, 2005, EXP PHYSIOL, V90, P527, DOI 10.1113/expphysiol.2005.030007; Simonson J S, 1989, J Am Soc Echocardiogr, V2, P25; Smulyan H, 1998, J AM COLL CARDIOL, V31, P1103, DOI 10.1016/S0735-1097(98)00056-4; SONNENBLICK EH, 1965, J CLIN INVEST, V44, P2051, DOI 10.1172/JCI105312; SONNENBLICK EH, 1965, J CLIN INVEST, V44, P966, DOI 10.1172/JCI105214; SONNENBLICK EH, 1966, CIRCULATION, V33, P945, DOI 10.1161/01.CIR.33.6.945; Svealv BG, 2006, EUR J ECHOCARDIOGR, V7, P298, DOI 10.1016/j.euje.2005.06.008; TAMIYA K, 1979, AM J PHYSIOL, V237, pH83, DOI 10.1152/ajpheart.1979.237.1.H83; Thorstensen A, 2011, EUR J ECHOCARDIOGR, V12, P924, DOI 10.1093/ejechocard/jer178; Tighe DA, 2003, AM J CARDIOL, V91, P254, DOI 10.1016/S0002-9149(02)03122-3; VATNER SF, 1974, CIRCULATION, V50, P728, DOI 10.1161/01.CIR.50.4.728; Vinereanu D, 2005, EUR J HEART FAIL, V7, P820, DOI 10.1016/j.ejheart.2005.02.003; Vinereanu D, 2002, ECHOCARDIOGR-J CARD, V19, P177, DOI 10.1046/j.1540-8175.2002.00177.x; Wang M, 2005, J AM COLL CARDIOL, V45, P272, DOI 10.1016/j.jacc.2004.09.059; Wang M, 2005, J HYPERTENS, V23, P183, DOI 10.1097/00004872-200501000-00029; Wang M, 2003, J AM COLL CARDIOL, V41, P820, DOI 10.1016/S0735-1097(02)02921-2; WEISSLER AM, 1961, AM HEART J, V62, P367, DOI 10.1016/0002-8703(61)90403-3; Wong CY, 2004, CIRCULATION, V110, P3081, DOI 10.1161/01.CIR.0000147184.13872.0F; Yamakado T, 1998, AM HEART J, V135, P584, DOI 10.1016/S0002-8703(98)70271-6; Yip GW, 2002, CLIN SCI, V102, P515, DOI 10.1042/CS20010196; Yu CM, 2007, J AM COLL CARDIOL, V49, P1903, DOI 10.1016/j.jacc.2007.01.078; Yu CM, 2002, CIRCULATION, V105, P1195, DOI 10.1161/hc1002.105185; Yu CM, 2003, ECHOCARDIOGR-J CARD, V20, P19, DOI 10.1046/j.1540-8175.2003.00003.x	85	8	8	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 13	2017	12	3							e0173383	10.1371/journal.pone.0173383	http://dx.doi.org/10.1371/journal.pone.0173383			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN6CP	28288162	gold, Green Submitted, Green Published			2022-12-27	WOS:000396092400014
J	Fu, HH; Gan, L; Yang, C; Xue, W; Wang, LN; Wang, XL; Huang, XM; Yang, GW				Fu, Haohuan; Gan, Lin; Yang, Chao; Xue, Wei; Wang, Lanning; Wang, Xinliang; Huang, Xiaomeng; Yang, Guangwen			Solving global shallow water equations on heterogeneous supercomputers	PLOS ONE			English	Article							SYSTEM; PERFORMANCE; HARDWARE	The scientific demand for more accurate modeling of the climate system calls for more computing power to support higher resolutions, inclusion of more component models, more complicated physics schemes, and larger ensembles. As the recent improvements in computing power mostly come from the increasing number of nodes in a system and the integration of heterogeneous accelerators, how to scale the computing problems onto more nodes and various kinds of accelerators has become a challenge for the model development. This paper describes our efforts on developing a highly scalable framework for performing global atmospheric modeling on heterogeneous supercomputers equipped with various accelerators, such as GPU (Graphic Processing Unit), MIC (Many Integrated Core), and FPGA (Field Programmable Gate Arrays) cards. We propose a generalized partition scheme of the problem domain, so as to keep a balanced utilization of both CPU resources and accelerator resources. With optimizations on both computing and memory access patterns, we manage to achieve around 8 to 20 times speedup when comparing one hybrid GPU or MIC node with one CPU node with 12 cores. Using a customized FPGA-based data-flow engines, we see the potential to gain another 5 to 8 times improvement on performance. On heterogeneous supercomputers, such as Tianhe-1A and Tianhe-2, our framework is capable of achieving ideally linear scaling efficiency, and sustained double-precision performances of 581 Tflops on Tianhe-1A (using 3750 nodes) and 3.74 Pflops on Tianhe-2 (using 8644 nodes). Our study also provides an evaluation on the programming paradigm of various accelerator architectures (GPU, MIC, FPGA) for performing global atmospheric simulation, to form a picture about both the potential performance benefits and the programming efforts involved.	[Fu, Haohuan; Gan, Lin; Xue, Wei; Huang, Xiaomeng; Yang, Guangwen] Tsinghua Univ, Key Lab Earth Syst Modeling, Minist Educ, Beijing, Peoples R China; [Fu, Haohuan; Gan, Lin; Xue, Wei; Huang, Xiaomeng; Yang, Guangwen] Tsinghua Univ, Dept Earth Syst Sci, Beijing, Peoples R China; [Fu, Haohuan; Gan, Lin; Xue, Wei; Wang, Lanning; Huang, Xiaomeng; Yang, Guangwen] JCGCS, Beijing, Peoples R China; [Gan, Lin; Xue, Wei; Wang, Xinliang; Yang, Guangwen] Tsinghua Univ, Dept Comp Sci & Technol, Beijing, Peoples R China; [Yang, Chao] Chinese Acad Sci, Inst Software, Beijing, Peoples R China; [Wang, Lanning] Beijing Normal Univ, Coll Global Change & Earth Syst Sci, Beijing, Peoples R China; [Fu, Haohuan; Gan, Lin; Xue, Wei; Wang, Lanning; Huang, Xiaomeng; Yang, Guangwen] Natl Supercomp Ctr Wuxi, Wuxi, Peoples R China	Tsinghua University; Tsinghua University; Tsinghua University; Chinese Academy of Sciences; Institute of Software, CAS; Beijing Normal University	Yang, C (corresponding author), Chinese Acad Sci, Inst Software, Beijing, Peoples R China.	yangchao@iscas.ac.cn			National Key R&D Program of China (863 Grant) [2016YFA0602200, 2013AA01A208]; National Natural Science Foundation of China [61303003, 41374113, 91530323, 91530103, 61361120098]; National High Tech R&D Program of China [2013AA01A208, 2015AA01A302]; China Postdoctoral Science Foundation [2016M601031]; Tsinghua University Initiative Scientific Research Program [20131089356]; China Special Fund for Meteorological Research in the Public Interest [GYHY201306062]; UK EPSRC; European Union Seventh Framework Programme [257906, 287804, 318521]; HiPEAC NoE; Maxeler University Program; National Key R&D Program of China [2016YFA0602200]; National High-Tech R&D (863) Program of China [2013AA01A208, 2015AA01A302]	National Key R&D Program of China (863 Grant); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National High Tech R&D Program of China(National High Technology Research and Development Program of China); China Postdoctoral Science Foundation(China Postdoctoral Science Foundation); Tsinghua University Initiative Scientific Research Program; China Special Fund for Meteorological Research in the Public Interest; UK EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); European Union Seventh Framework Programme(European Commission); HiPEAC NoE; Maxeler University Program; National Key R&D Program of China; National High-Tech R&D (863) Program of China(National High Technology Research and Development Program of China)	This work was supported in part by the National Key R&D Program of China (863 Grant No. 2016YFA0602200, 2013AA01A208), the National Natural Science Foundation of China (grant no. 61303003, 41374113, 91530323, 91530103 and 61361120098), the National High Tech R&D Program of China (grant no. 2013AA01A208 and 2015AA01A302), China Postdoctoral Science Foundation (no. 2016M601031), Tsinghua University Initiative Scientific Research Program (no. 20131089356), China Special Fund for Meteorological Research in the Public Interest under Grant No. GYHY201306062, UK EPSRC, the European Union Seventh Framework Programme (grant agreement no. 257906, 287804, and 318521), HiPEAC NoE, and the Maxeler University Program. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This work was supported in part by the National Key R&D Program of China (Grant No. 2016YFA0602200), the National Natural Science Foundation of China (grant no. 61303003, 41374113, 91530323, 91530103 and 61361120098), the National High-Tech R&D (863) Program of China (grant no. 2013AA01A208 and 2015AA01A302), China Postdoctoral Science Foundation (no. 2016M601031), Tsinghua University Initiative Scientific Research Program (no. 20131089356), China Special Fund for Meteorological Research in the Public Interest under Grant No. GYHY201306062, UK EPSRC, the European Union Seventh Framework Programme (grant agreement no. 257906, 287804, and 318521), HiPEAC NoE, and the Maxeler University Program.	Balay S., 2014, TECHNICAL REPORT; Carpenter I, 2013, INT J HIGH PERFORM C, V27, P335, DOI 10.1177/1094342012462751; Cook S., 2012, CUDA PROGRAMMING DEV; Datta K., 2008, P 2008 ACM IEEE C SU, P4, DOI DOI 10.1145/1413370.1413375; Demeshko I, 2013, LECT NOTES COMPUT SC, V7640, P175, DOI 10.1007/978-3-642-36949-0_20; Dennis JM, 2012, INT J HIGH PERFORM C, V26, P74, DOI 10.1177/1094342011428142; Dennis JM, 2012, INT J HIGH PERFORM C, V26, P5, DOI 10.1177/1094342012436965; Donner LJ, 2011, J CLIMATE, V24, P3484, DOI 10.1175/2011JCLI3955.1; DRAKE J, 1995, PARALLEL COMPUT, V21, P1571, DOI 10.1016/0167-8191(96)80001-9; Duben PD, 2015, THEOR COMP FLUID DYN, V29, P311, DOI 10.1007/s00162-015-0355-8; Duben PD, 2015, J ADV MODEL EARTH SY, V7, P1393, DOI 10.1002/2015MS000494; Duben PD, 2014, MON WEATHER REV, V142, P3809, DOI 10.1175/MWR-D-14-00110.1; Fu H, 2016, P INT C HIGHP COMP N, P83; Fu HH, 2016, SCI CHINA INFORM SCI, V59, DOI 10.1007/s11432-016-5588-7; Fu HH, 2014, IEEE MICRO, V34, P30, DOI 10.1109/MM.2013.111; Gan L., 2013, FINANCIAL RES, P1, DOI DOI 10.1109/FPL.2013.6645508; Gan L, 2015, ACM T RECONFIG TECHN, V8, DOI 10.1145/2629581; Gottlieb S, 2001, SIAM REV, V43, P89, DOI 10.1137/S003614450036757X; Govett M., 2010, Proceedings 2010 10th IEEE/ACM International Conference on Cluster, Cloud and Grid Computing (CCGrid), P792, DOI 10.1109/CCGRID.2010.106; JAKOBCHIEN R, 1995, J COMPUT PHYS, V119, P164, DOI 10.1006/jcph.1995.1125; Jeffers J., 2013, INTEL XEON PHI COPRO; Kelly R, 2010, COMPUT SCI ENG, V12, P26, DOI 10.1109/MCSE.2010.26; Li FY, 2012, J ADV MODEL EARTH SY, V4, DOI 10.1029/2011MS000106; Liao XK, 2014, FRONT COMPUT SCI-CHI, V8, P345, DOI 10.1007/s11704-014-3501-3; Linford J. C., 2009, PROC C HIGH PERFORM, P1, DOI DOI 10.1145/1654059.1654067; Michalakes J, 2008, PARALLEL PROCESS LET, V18, P531, DOI 10.1142/S0129626408003557; Micikevicius P., 2009, P 2 WORKSH GEN PURP, DOI [10.1145/1513895.1513905, DOI 10.1145/1513895.1513905]; Mielikainen J, 2013, COMPUT GEOSCI-UK, V52, P292, DOI 10.1016/j.cageo.2012.10.006; Oriato D, 2012, S APP ACC HIGH-PERF, P129, DOI 10.1109/SAAHPC.2012.8; OSHER S, 1983, J COMPUT PHYS, V50, P447, DOI 10.1016/0021-9991(83)90106-7; Pell O, 2012, COMPUT SCI ENG, V14, P98, DOI 10.1109/MCSE.2012.78; Putnam A, 2014, CONF PROC INT SYMP C, P13, DOI 10.1109/ISCA.2014.6853195; Ronchi C, 1996, J COMPUT PHYS, V124, P93, DOI 10.1006/jcph.1996.0047; Rossmanith JA, 2006, J COMPUT PHYS, V213, P629, DOI 10.1016/j.jcp.2005.08.027; Shimokawabe T., 2010, P 2010 ACM IEEE INT, P1, DOI DOI 10.1109/SC.2010.9; Shingu S, 2002, P ACM IEEE SUP SC 20; Smith MC, 2005, P 19 IEEE INT PAR DI, p157b; Targett S, 2015, 2015 INTERNATIONAL CONFERENCE ON FIELD PROGRAMMABLE TECHNOLOGY (FPT), P208, DOI 10.1109/FPT.2015.7393152; Vu VT, 2013, CONCURR COMP-PRACT E, V25, P1376, DOI 10.1002/cpe.2951; Wei Xue, 2014, 2014 IEEE International Parallel & Distributed Processing Symposium (IPDPS), P745, DOI 10.1109/IPDPS.2014.82; Wienke S, 2012, LECT NOTES COMPUT SC, V7484, P859, DOI 10.1007/978-3-642-32820-6_85; Wilhelm F., 2012, PARALLEL PRECONDITIO; WILLIAMSON DL, 1992, J COMPUT PHYS, V102, P211, DOI 10.1016/S0021-9991(05)80016-6; Xiao HD, 2013, COMPUT GEOSCI-UK, V59, P156, DOI 10.1016/j.cageo.2013.06.016; Xin X, 2014, CLIM DYNAM, P1; Xu S, 2014, GEOSCI MODEL DEV DIS, V7, P7651, DOI [10.5194/gmdd-7-7651-2014, DOI 10.5194/GMDD-7-7651-2014]; Yang C., 2016, P INT C HIGH PERF CO, P6; Yang C, 2013, ACM SIGPLAN NOTICES, V48, P1, DOI 10.1145/2517327.2442518; Yang XJ, 2011, J COMPUT SCI TECH-CH, V26, P344, DOI 10.1007/s02011-011-1137-8; Zhuowei Wang, 2011, Proceedings of the 2011 IEEE 13th International Conference on High Performance Computing and Communication (HPCC 2011). 2011 IEEE International Workshop on Future Trends of Distributed Computing Systems (FTDCS 2011). Workshops of the 2011 International Conference on Ubiquitous Intelligence and Computing (UIC 2011). Workshops of the 2011 International Conference on Autonomic and Trusted Computing (ATC 2011), P365, DOI 10.1109/HPCC.2011.54	50	1	2	3	36	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 10	2017	12	3							e0172583	10.1371/journal.pone.0172583	http://dx.doi.org/10.1371/journal.pone.0172583			27	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN6CJ	28282428	Green Published, Green Submitted, gold			2022-12-27	WOS:000396091800010
J	Peter, M; Glatz, A; Gudmann, P; Gombos, I; Torok, Z; Horvath, I; Vigh, L; Balogh, G				Peter, Maria; Glatz, Attila; Gudmann, Peter; Gombos, Imre; Toeroek, Zsolt; Horvath, Ibolya; Vigh, Laszlo; Balogh, Gaabor			Metabolic crosstalk between membrane and storage lipids facilitates heat stress management in Schizosaccharomyces pombe	PLOS ONE			English	Article							PROTEIN-KINASE-C; MESSENGER-RNA TRANSLATION; FISSION YEAST; TRIACYLGLYCEROL-METABOLISM; TEMPERATURE ADAPTATION; PHYSICAL STATE; DROPLETS; CELLS; SHOCK; CERAMIDE	Cell membranes actively participate in stress sensing and signalling. Here we present the first in-depth lipidomic analysis to characterize alterations in the fission yeast Schizosaccharomyces pombe in response to mild heat stress (HS). The lipidome was assessed by a simple one-step methanolic extraction. Genetic manipulations that altered triglyceride (TG) content in the absence or presence of HS gave rise to distinct lipidomic fingerprints for S. pombe. Cells unable to produce TG demonstrated long-lasting growth arrest and enhanced signalling lipid generation. Our results reveal that metabolic crosstalk between membrane and storage lipids facilitates homeostatic maintenance of the membrane physical/chemical state that resists negative effects on cell growth and viability in response to HS. We propose a novel stress adaptation mechanism in which heat-induced TG synthesis contributes to membrane rigidization by accommodating unsaturated fatty acids of structural lipids, enabling their replacement by newly synthesized saturated fatty acids.	[Peter, Maria; Glatz, Attila; Gudmann, Peter; Gombos, Imre; Toeroek, Zsolt; Horvath, Ibolya; Vigh, Laszlo; Balogh, Gaabor] Hungarian Acad Sci, Inst Biochem, Biol Res Ctr, Szeged, Hungary	Eotvos Lorand Research Network; Hungarian Academy of Sciences; Hungarian Biological Research Center	Balogh, G (corresponding author), Hungarian Acad Sci, Inst Biochem, Biol Res Ctr, Szeged, Hungary.	balogh.gabor@brc.mta.hu	Balogh, Gábor/AIC-8192-2022	Balogh, Gábor/0000-0002-4565-6850	Hungarian Basic Research Fund [OTKA ANN112372, OTKA NN111006]; Hungarian National Development Agency [TAMOP-4.2.4.N2-11/1-2012-0001]; Ministry for National Economy [GINOP-2.3.2-15-2016-00001, GINOP-2.3.2-15-2016-00006, GINOP-2.2.1-152016-00007]	Hungarian Basic Research Fund; Hungarian National Development Agency; Ministry for National Economy	This work was supported by the Hungarian Basic Research Fund (OTKA ANN112372 and OTKA NN111006), by the Hungarian National Development Agency (TAMOP-4.2.4.N2-11/1-2012-0001), and by the Ministry for National Economy (GINOP-2.3.2-15-2016-00001, GINOP-2.3.2-15-2016-00006 and GINOP-2.2.1-152016-00007). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Nguyen A, 2017, CURR OPIN BIOTECH, V43, P96, DOI 10.1016/j.copbio.2016.10.003; Antal O, 2015, BBA-MOL CELL BIOL L, V1851, P1271, DOI 10.1016/j.bbalip.2015.06.003; Balogh G, 2005, FEBS J, V272, P6077, DOI 10.1111/j.1742-4658.2005.04999.x; Balogh G, 2013, FEBS LETT, V587, P1970, DOI 10.1016/j.febslet.2013.05.016; Balogh G, 2010, BBA-MOL CELL BIOL L, V1801, P1036, DOI 10.1016/j.bbalip.2010.04.011; Barbosa AD, 2015, MOL BIOL CELL, V26, P3641, DOI 10.1091/mbc.E15-03-0173; Carrasco S, 2007, TRENDS BIOCHEM SCI, V32, P27, DOI 10.1016/j.tibs.2006.11.004; Chen DR, 2003, MOL BIOL CELL, V14, P214, DOI 10.1091/mbc.E02-08-0499; Covino R, 2016, MOL CELL, V63, P49, DOI 10.1016/j.molcel.2016.05.015; Crowe JH, 2007, ADV EXP MED BIOL, V594, P143; Dahlqvist A, 2000, P NATL ACAD SCI USA, V97, P6487, DOI 10.1073/pnas.120067297; de Kroon AIPM, 2013, PROG LIPID RES, V52, P374, DOI 10.1016/j.plipres.2013.04.006; De Smet CH, 2013, BBA-MOL CELL BIOL L, V1831, P1167, DOI 10.1016/j.bbalip.2013.03.002; Du ZY, 2016, SUBCELL BIOCHEM, V86, P179, DOI 10.1007/978-3-319-25979-6_8; Ejsing CS, 2009, P NATL ACAD SCI USA, V106, P2136, DOI 10.1073/pnas.0811700106; Elbein AD, 2003, GLYCOBIOLOGY, V13, P17; Fahy E, 2009, J LIPID RES, V50, pS9, DOI 10.1194/jlr.R800095-JLR200; Fei WH, 2009, BIOCHEM J, V424, P61, DOI 10.1042/BJ20090785; Forsburg SL, 2006, YEAST, V23, P173, DOI 10.1002/yea.1347; Forsburg Susan L, 2003, Curr Protoc Mol Biol, VChapter 13, DOI 10.1002/0471142727.mb1317s64; Gasch AP, 2000, MOL BIOL CELL, V11, P4241, DOI 10.1091/mbc.11.12.4241; Gaspar ML, 2011, J BIOL CHEM, V286, P1696, DOI 10.1074/jbc.M110.172296; Geraldes P, 2010, CIRC RES, V106, P1319, DOI 10.1161/CIRCRESAHA.110.217117; Glatz A, 2016, CELL STRESS CHAPERON, V21, P327, DOI 10.1007/s12192-015-0662-4; Goni FM, 2006, BBA-BIOMEMBRANES, V1758, P1902, DOI 10.1016/j.bbamem.2006.09.011; Griner EM, 2007, NAT REV CANCER, V7, P281, DOI 10.1038/nrc2110; Guan XL, 2010, METHOD ENZYMOL, V470, P369, DOI 10.1016/S0076-6879(10)70015-X; Gubern A, 2009, J BIOL CHEM, V284, P5697, DOI 10.1074/jbc.M806173200; Guschina IA, 2006, FEBS LETT, V580, P5477, DOI 10.1016/j.febslet.2006.06.066; Hannun YA, 2002, J BIOL CHEM, V277, P25847, DOI 10.1074/jbc.R200008200; Hannun YA, 2000, TRENDS CELL BIOL, V10, P73, DOI 10.1016/S0962-8924(99)01694-3; Hashemi HF, 2015, CURR OPIN CELL BIOL, V33, P119, DOI 10.1016/j.ceb.2015.02.002; HAZEL JR, 1990, PROG LIPID RES, V29, P167, DOI 10.1016/0163-7827(90)90002-3; He Y, 2014, MOL BIOL CELL, V25, P4083, DOI 10.1091/mbc.E14-03-0832; Henriksen JR, 2010, BIOPHYS J, V98, P2199, DOI 10.1016/j.bpj.2010.01.037; Henry SA, 2014, CHEM PHYS LIPIDS, V180, P23, DOI 10.1016/j.chemphyslip.2013.12.013; Herzog R, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-1-r8; HORVATH I, 1986, CHEM PHYS LIPIDS, V39, P251, DOI 10.1016/0009-3084(86)90014-9; Horvath I, 2008, BBA-BIOMEMBRANES, V1778, P1653, DOI 10.1016/j.bbamem.2008.02.012; Horvath I, 2012, PROG LIPID RES, V51, P208, DOI 10.1016/j.plipres.2012.02.002; Horvath SE, 2011, BBA-MOL CELL BIOL L, V1811, P1030, DOI 10.1016/j.bbalip.2011.08.007; Jenkins GM, 1997, J BIOL CHEM, V272, P32566, DOI 10.1074/jbc.272.51.32566; Jenkins GM, 2002, J BIOL CHEM, V277, P42572, DOI 10.1074/jbc.M207346200; Jiang HF, 2007, BBA-MOL CELL BIOL L, V1771, P66, DOI 10.1016/j.bbalip.2006.10.004; Kheirolomoom A, 2005, CRYOBIOLOGY, V51, P290, DOI 10.1016/j.cryobiol.2005.08.003; Klose C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035063; Kohlwein SD, 2013, GENETICS, V193, P1, DOI 10.1534/genetics.112.143362; Krawchuk MD, 1999, YEAST, V15, P1419, DOI 10.1002/(SICI)1097-0061(19990930)15:13<1419::AID-YEA466>3.0.CO;2-Q; Kucsera J, 2000, J MICROBIOL METH, V41, P19, DOI 10.1016/S0167-7012(00)00136-6; Kultz D, 2005, ANNU REV PHYSIOL, V67, P225, DOI 10.1146/annurev.physiol.67.040403.103635; Liebisch G, 2013, J LIPID RES, V54, P1523, DOI 10.1194/jlr.M033506; Liu L, 2015, CELL, V160, P177, DOI 10.1016/j.cell.2014.12.019; Low CP, 2008, J CELL SCI, V121, P2671, DOI 10.1242/jcs.028977; Low CP, 2005, FEMS YEAST RES, V5, P1199, DOI 10.1016/j.femsyr.2005.07.004; Madeira JB, 2015, MOL CELL BIOL, V35, P737, DOI 10.1128/MCB.01314-14; Makarova M, 2016, CURR BIOL, V26, P237, DOI 10.1016/j.cub.2015.11.061; Markgraf DF, 2014, CELL REP, V6, P44, DOI 10.1016/j.celrep.2013.11.046; MCGAHON AJ, 1995, METHOD CELL BIOL, V46, P153; Meier KD, 2006, MOL BIOL CELL, V17, P1164, DOI 10.1091/mbc.E05-11-1039; Mittler R, 2012, TRENDS BIOCHEM SCI, V37, P118, DOI 10.1016/j.tibs.2011.11.007; Muir A, 2014, ELIFE, V3, DOI 10.7554/eLife.03779; Niki H, 2014, YEAST, V31, P83, DOI 10.1002/yea.2996; Nkeze J, 2015, CELL BIOSCI, V5, DOI 10.1186/s13578-015-0037-7; Oelkers P, 2002, J BIOL CHEM, V277, P8877, DOI 10.1074/jbc.M111646200; PAINTING K, 1990, WORLD J MICROB BIOT, V6, P346, DOI 10.1007/BF01201311; Preiss T, 2003, NAT STRUCT BIOL, V10, P1039, DOI 10.1038/nsb1015; Rabhi S, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0148640; Radulovic M, 2013, CURR GENET, V59, P231, DOI 10.1007/s00294-013-0407-9; Renne Mike F, 2015, Lipid Insights, V8, P33, DOI 10.4137/LPI.S31780; Reyland ME, 2007, BIOCHEM SOC T, V35, P1001, DOI 10.1042/BST0351001; Sandager L, 2002, J BIOL CHEM, V277, P6478, DOI 10.1074/jbc.M109109200; Shiozaki K, 1997, MOL BIOL CELL, V8, P409, DOI 10.1091/mbc.8.3.409; Shui GH, 2010, MOL BIOSYST, V6, P1008, DOI 10.1039/b913353d; SILVIUS JR, 1980, P NATL ACAD SCI-BIOL, V77, P1255, DOI 10.1073/pnas.77.3.1255; SINENSKY M, 1974, P NATL ACAD SCI USA, V71, P522, DOI 10.1073/pnas.71.2.522; SINERIZ F, 1973, J BACTERIOL, V115, P723; Soto T, 2007, MICROBIOL-SGM, V153, P1519, DOI 10.1099/mic.0.2006/004283-0; Storey JD, 2003, P NATL ACAD SCI USA, V100, P9440, DOI 10.1073/pnas.1530509100; SUUTARI M, 1990, J GEN MICROBIOL, V136, P1469, DOI 10.1099/00221287-136-8-1469; Tarasov K, 2014, MOL BIOSYST, V10, P1364, DOI 10.1039/c3mb70599d; Torok Z, 2014, BBA-BIOMEMBRANES, V1838, P1594, DOI 10.1016/j.bbamem.2013.12.015; Torok Z, 2001, P NATL ACAD SCI USA, V98, P3098, DOI 10.1073/pnas.051619498; Vigh L, 1998, TRENDS BIOCHEM SCI, V23, P369, DOI 10.1016/S0968-0004(98)01279-1; Vigh L, 2007, TRENDS BIOCHEM SCI, V32, P357, DOI 10.1016/j.tibs.2007.06.009; Wang JX, 2004, BRIT J PHARMACOL, V141, P586, DOI 10.1038/sj.bjp.0705646; Wells GB, 1998, J BIOL CHEM, V273, P7235, DOI 10.1074/jbc.273.13.7235; Welte MA, 2007, TRENDS CELL BIOL, V17, P363, DOI 10.1016/j.tcb.2007.06.004; Welte MA, 2015, CURR BIOL, V25, pR470, DOI 10.1016/j.cub.2015.04.004; Wilfling F, 2014, CURR OPIN CELL BIOL, V29, P39, DOI 10.1016/j.ceb.2014.03.008; Xia JG, 2011, NAT PROTOC, V6, P743, DOI 10.1038/nprot.2011.319; Yamamoto S, 2014, CELL, V159, P200, DOI 10.1016/j.cell.2014.09.002; Yamasaki S, 2008, CURR OPIN CELL BIOL, V20, P222, DOI 10.1016/j.ceb.2008.01.013; Yang PL, 2016, MOL BIOL CELL, V27, P2368, DOI 10.1091/mbc.E16-02-0106; Zhang Q, 2003, J BIOL CHEM, V278, P47145, DOI 10.1074/jbc.M306998200	94	22	22	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 10	2017	12	3							e0173739	10.1371/journal.pone.0173739	http://dx.doi.org/10.1371/journal.pone.0173739			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN6CJ	28282432	Green Published, Green Submitted, gold			2022-12-27	WOS:000396091800076
J	Aho, OM; Finnila, M; Thevenot, J; Saarakkala, S; Lehenkari, P				Aho, Olli-Matti; Finnila, Mikko; Thevenot, Jerome; Saarakkala, Simo; Lehenkari, Petri			Subchondral bone histology and grading in osteoarthritis	PLOS ONE			English	Article							ARTICULAR-CARTILAGE; KNEE; HISTOPATHOLOGY; RADIOGRAPHS; MORPHOLOGY; MODELS; HIP; CT	Objective Osteoarthritis (OA) has often regarded as a disease of articular cartilage only. New evidence has shifted the paradigm towards a system biology approach, where also the surrounding tissue, especially bone is studied more vigorously. However, the histological features of subchondral bone are only poorly characterized in current histological grading scales of OA. The aim of this study is to specifically characterize histological changes occurring in subchondral bone at different stages of OA and propose a simple grading system for them. Design 20 patients undergoing total knee replacement surgery were randomly selected for the study and series of osteochondral samples were harvested from the tibial plateaus for histological analysis. Cartilage degeneration was assessed using the standardized OARSI grading system, while a novel four-stage grading system was developed to illustrate the changes in subchondral bone. Subchondral bone histology was further quantitatively analyzed by measuring the thickness of uncalcified and calcified cartilage as well as subchondral bone plate. Furthermore, internal structure of calcified cartilage-bone interface was characterized utilizing local binary patterns (LBP) based method. Results The histological appearance of subchondral bone changed drastically in correlation with the OARSI grading of cartilage degeneration. As the cartilage layer thickness decreases the subchondral plate thickness and disorientation, as measured with LBP, increases. Calcified cartilage thickness was highest in samples with moderate OA. Conclusion The proposed grading system for subchondral bone has significant relationship with the corresponding OARSI grading for cartilage. Our results suggest that subchondral bone remodeling is a fundamental factor already in early stages of cartilage degeneration.	[Aho, Olli-Matti; Lehenkari, Petri] Univ Oulu, Inst Biomed, Dept Anat & Cell Biol, Oulu, Finland; [Finnila, Mikko; Thevenot, Jerome; Saarakkala, Simo] Univ Oulu, Fac Med, Res Unit Med Imaging Phys & Technol, Oulu, Finland; [Saarakkala, Simo] Oulu Univ Hosp, Med Res Ctr, Dept Diagnost Radiol, Oulu, Finland; [Lehenkari, Petri] Oulu Univ Hosp, Med Res Ctr, Dept Surg, Div Orthopaed & Trauma Surg, Oulu, Finland	University of Oulu; University of Oulu; University of Oulu; University of Oulu	Aho, OM (corresponding author), Univ Oulu, Inst Biomed, Dept Anat & Cell Biol, Oulu, Finland.	olli-matti.aho@oulu.fi	Finnila, Mikko/X-6492-2019; Saarakkala, Simo/F-5839-2013; thevenot, jerome/U-8439-2017; Lehenkari, Petri/O-3009-2016	Saarakkala, Simo/0000-0003-2850-5484; thevenot, jerome/0000-0003-0209-025X; Lehenkari, Petri/0000-0002-0055-5183; Finnila, Mikko/0000-0002-3348-5759	Academy of Finland [127198]; University of Oulu [24001200]	Academy of Finland(Academy of Finland); University of Oulu	This study was finally supported by the Academy of Finland (project 127198), and strategic funding of the University of Oulu (project 24001200). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aho OM, 2013, J BONE JOINT SURG AM, V95A, P597, DOI 10.2106/JBJS.L.00310; Arden NK, 1996, BRIT J RHEUMATOL, V35, P1299; Bagi CM, 2015, J TRANSL MED, V13, DOI 10.1186/s12967-015-0641-7; Bellido M, 2010, ARTHRITIS RES THER, V12, DOI 10.1186/ar3103; Bobinac D, 2003, BONE, V32, P284, DOI 10.1016/S8756-3282(02)00982-1; BROWN RA, 1983, ANN RHEUM DIS, V42, P301, DOI 10.1136/ard.42.3.301; BROWN RA, 1988, ANN RHEUM DIS, V47, P881, DOI 10.1136/ard.47.11.881; BROWN TD, 1984, J BIOMECH, V17, P11, DOI 10.1016/0021-9290(84)90075-7; Burr David B, 2004, Osteoarthritis Cartilage, V12 Suppl A, pS20; Burr DB, 2012, NAT REV RHEUMATOL, V8, P665, DOI 10.1038/nrrheum.2012.130; Castaneda S, 2012, BIOCHEM PHARMACOL, V83, P315, DOI 10.1016/j.bcp.2011.09.018; Cox LGE, 2013, OSTEOARTHR CARTILAGE, V21, P331, DOI 10.1016/j.joca.2012.10.013; Cox LGE, 2012, BONE, V50, P1152, DOI 10.1016/j.bone.2012.01.024; Custers RJH, 2007, OSTEOARTHR CARTILAGE, V15, P1241, DOI 10.1016/j.joca.2007.04.017; Day JS, 2001, J ORTHOPAED RES, V19, P914, DOI 10.1016/S0736-0266(01)00012-2; DIEPPE P, 1993, ANN RHEUM DIS, V52, P557, DOI 10.1136/ard.52.8.557; Fazzalari NL, 1997, J BONE MINER RES, V12, P632, DOI 10.1359/jbmr.1997.12.4.632; Goldring MB, 2010, ANN NY ACAD SCI, V1192, P230, DOI 10.1111/j.1749-6632.2009.05240.x; Hayami T, 2006, BONE, V38, P234, DOI 10.1016/j.bone.2005.08.007; Hirvasniemi J, 2014, OSTEOARTHR CARTILAGE, V22, P1724, DOI 10.1016/j.joca.2014.06.021; Intema F, 2010, OSTEOARTHR CARTILAGE, V18, P691, DOI 10.1016/j.joca.2010.01.004; Karsdal MA, 2008, OSTEOARTHR CARTILAGE, V16, P638, DOI 10.1016/j.joca.2008.01.014; Li GY, 2013, ARTHRITIS RES THER, V15, DOI 10.1186/ar4405; Lories RJ, 2011, NAT REV RHEUMATOL, V7, P43, DOI 10.1038/nrrheum.2010.197; Luyten FR, 2006, BEST PRACT RES CL RH, V20, P829, DOI 10.1016/j.berh.2006.06.009; MANKIN HJ, 1971, J BONE JOINT SURG AM, VA 53, P523, DOI 10.2106/00004623-197153030-00009; Mansell JP, 1997, BRIT J RHEUMATOL, V36, P16; MILZ S, 1994, J ANAT, V185, P103; Moskowitz Roland W, 2009, Am J Manag Care, V15, pS223; NOBLE J, 1985, J BONE JOINT SURG AM, V67A, P295, DOI 10.2106/00004623-198567020-00017; Pastoureau PC, 1999, OSTEOARTHR CARTILAGE, V7, P466, DOI 10.1053/joca.1999.0241; Pearson RG, 2011, OSTEOARTHR CARTILAGE, V19, P324, DOI 10.1016/j.joca.2010.12.005; Pritzker KPH, 2006, OSTEOARTHR CARTILAGE, V14, P13, DOI 10.1016/j.joca.2005.07.014; Reichenbach S, 2008, OSTEOARTHR CARTILAGE, V16, P1005, DOI 10.1016/j.joca.2008.02.001; Sellam J, 2009, EULAR COMPENDIUM RHE, P444; Sniekers YH, 2008, BMC MUSCULOSKEL DIS, V9, DOI 10.1186/1471-2474-9-20; Thambyah A, 2009, OA CARTILAGE, V17, P230; Thevenot J., 2014, ECCV WORKSH 2, V8926, P63; Wang SZ, 2010, CONNECT TISSUE RES, V51, P36, DOI 10.3109/03008200902890161	39	56	63	1	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 20	2017	12	3							e0173726	10.1371/journal.pone.0173726	http://dx.doi.org/10.1371/journal.pone.0173726			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ER6VC	28319157	gold, Green Published			2022-12-27	WOS:000398945800026
J	Boonvisudhi, T; Kuladee, S				Boonvisudhi, Thummaporn; Kuladee, Sanchai			Association between Internet addiction and depression in Thai medical students at Faculty of Medicine, Ramathibodi Hospital	PLOS ONE			English	Article							PSYCHIATRIC COMORBIDITY; ADOLESCENTS; SYMPTOMS; VALIDITY; DISORDER	Objective To study the extent of Internet addiction (IA) and its association with depression in Thai medical students. Methods A cross-sectional study was conducted at Faculty of Medicine, Ramathibodi Hospital. Participants were first- to fifth-year medical students who agreed to participate in this study. Demographic characteristics and stress-related factors were derived from self-rated questionnaires. Depression was assessed using the Thai version of Patient Health Questionnaire (PHQ-9). A total score of five or greater derived from the Thai version of Young Diagnostic Questionnaire for Internet Addiction was classified as "possible IA". Then chi-square test and logistic regression were used to evaluate the associations between possible IA, depression and associated factors. Results From 705 participants, 24.4% had possible IA and 28.8% had depression. There was statistically significant association between possible IA and depression (odds ratio (OR) 1.92, 95% confidence interval (CI): 1.34-2.77, P-value <0.001). Logistic regression analysis illustrated that the odds of depression in possible IA group was 1.58 times of the group of normal Internet use (95% CI: 1.04-2.38, P-value = 0.031). Academic problems were found to be a significant predictor of both possible IA and depression. Conclusion IA was likely to be a common psychiatric problem among Thai medical students. The research has also shown that possible IA was associated with depression and academic problems. We suggest that surveillance of IA should be considered in medical schools.	[Boonvisudhi, Thummaporn; Kuladee, Sanchai] Mahidol Univ, Ramathibodi Hosp, Dept Psychiat, Fac Med, Bangkok, Thailand	Mahidol University	Kuladee, S (corresponding author), Mahidol Univ, Ramathibodi Hosp, Dept Psychiat, Fac Med, Bangkok, Thailand.	sanchai.kul@mahidol.edu						Fatehi Farzad, 2016, Acta Med Iran, V54, P662, DOI 10.4103/jfmpc.jfmpc_986_19; [Anonymous], 2011, INTERNET ADDICTION H; Beard KW, 2001, CYBERPSYCHOL BEHAV, V4, P377, DOI 10.1089/109493101300210286; Bernardi S, 2009, COMPR PSYCHIAT, V50, P510, DOI 10.1016/j.comppsych.2008.11.011; Carli V, 2013, PSYCHOPATHOLOGY, V46, P1, DOI 10.1159/000337971; Berner JE, 2014, ACAD PSYCHIATR, V38, P11, DOI 10.1007/s40596-013-0022-6; Ghamari Farhad, 2011, Indian J Psychol Med, V33, P158, DOI 10.4103/0253-7176.92068; Ha JH, 2006, J CLIN PSYCHIAT, V67, P821, DOI 10.4088/JCP.v67n0517; Ho RC, 2014, BMC PSYCHIATRY, V14, DOI 10.1186/1471-244X-14-183; Hongsaguansri S, 2007, THAI ANN C PSYCH 10; Kim K, 2006, INT J NURS STUD, V43, P185, DOI 10.1016/j.ijnurstu.2005.02.005; King DL, 2011, CLIN PSYCHOL REV, V31, P1110, DOI 10.1016/j.cpr.2011.06.009; Ko CH, 2012, EUR PSYCHIAT, V27, P1, DOI 10.1016/j.eurpsy.2010.04.011; Ko CH, 2008, CNS SPECTRUMS, V13, P147, DOI 10.1017/S1092852900016308; Kroenke K, 2001, J GEN INTERN MED, V16, P606, DOI 10.1046/j.1525-1497.2001.016009606.x; Lam LT, 2010, ARCH PEDIAT ADOL MED, V164, P901, DOI 10.1001/archpediatrics.2010.159; Lee YS, 2008, J AFFECT DISORDERS, V109, P165, DOI 10.1016/j.jad.2007.10.020; Lin SSJ, 2002, COMPUT HUM BEHAV, V18, P411, DOI 10.1016/S0747-5632(01)00056-5; Lotrakul M, 2008, BMC PSYCHIATRY, V8, DOI 10.1186/1471-244X-8-46; Pramanik T, 2012, Nepal Med Coll J, V14, P46; Saipanish R, 2003, MED TEACH, V25, P502, DOI 10.1080/0142159031000136716; Tsimtsiou Z, 2015, ACAD PSYCHIATR, V39, P300, DOI 10.1007/s40596-014-0273-x; Wrase J, 2006, COGN AFFECT BEHAV NE, V6, P53, DOI 10.3758/CABN.6.1.53; Yen JY, 2008, PSYCHIAT CLIN NEUROS, V62, P9, DOI 10.1111/j.1440-1819.2007.01770.x; Yen JY, 2007, J ADOLESCENT HEALTH, V41, P93, DOI 10.1016/j.jadohealth.2007.02.002; Young K.S., 1998, CYBER PSYCHOL BEHAV, V1, P237, DOI [10.1089/cpb.1998.1.237, DOI 10.1089/CPB.1998.1.237]	26	22	22	2	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 20	2017	12	3							e0174209	10.1371/journal.pone.0174209	http://dx.doi.org/10.1371/journal.pone.0174209			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	ER6VC	28319167	Green Submitted, Green Published, gold			2022-12-27	WOS:000398945800058
J	Bradley, AS; Swanson, PK; Muller, EEL; Bringel, F; Caroll, SM; Pearson, A; Vuilleumier, S; Marx, CJ				Bradley, Alexander S.; Swanson, Paige K.; Muller, Emilie E. L.; Bringel, Franceoise; Caroll, Sean M.; Pearson, Ann; Vuilleumier, Stephane; Marx, Christopher J.			Hopanoid-free Methylobacterium extorquens DM4 overproduces carotenoids and has widespread growth impairment	PLOS ONE			English	Article							BIOSYNTHESIS; RESISTANCE; TEMPERATURE; ADAPTATION; TOLERANCE; STEROLS; PHASE; PH	Hopanoids are sterol-like membrane lipids widely used as geochemical proxies for bacteria. Currently, the physiological role of hopanoids is not well understood, and this represents one of the major limitations in interpreting the significance of their presence in ancient or contemporary sediments. Previous analyses of mutants lacking hopanoids in a range of bacteria have revealed a range of phenotypes under normal growth conditions, but with most having at least an increased sensitivity to toxins and osmotic stress. We employed hopanoid-free strains of Methylobacterium extorquens DM4, uncovering severe growth defects relative to the wild-type under many tested conditions, including normal growth conditions without additional stressors. Mutants overproduce carotenoids -the other major isoprenoid product of this strain -and show an altered fatty acid profile, pronounced flocculation in liquid media, and lower growth yields than for the wild-type strain. The flocculation phenotype can be mitigated by addition of cellulase to the medium, suggesting a link between the function of hopanoids and the secretion of cellulose in M. extorquens DM4. On solid media, colonies of the hopanoid-free mutant strain were smaller than wild-type, and were more sensitive to osmotic or pH stress, as well as to a variety of toxins. The results for M. extorquens DM4 are consistent with the hypothesis that hopanoids are important for membrane fluidity and lipid packing, but also indicate that the specific physiological processes that require hopanoids vary across bacterial lineages. Our work provides further support to emerging observations that the role of hopanoids in membrane robustness and barrier function may be important across lineages, possibly mediated through an interaction with lipid A in the outer membrane.	[Bradley, Alexander S.; Swanson, Paige K.; Caroll, Sean M.; Marx, Christopher J.] Harvard Univ, Dept Organism & Evolutionary Biol, Cambridge, MA 02138 USA; [Bradley, Alexander S.] Washington Univ, Dept Earth & Planetary Sci, St Louis, MO 63130 USA; [Muller, Emilie E. L.; Bringel, Franceoise; Vuilleumier, Stephane] Univ Strasbourg, Equipe Adaptat & Interact Microbiennes, UMR UNISTRA CNRS Genet Mol 7156, Genom Microbiol, Strasbourg, France; [Pearson, Ann] Harvard Univ, Dept Earth & Planetary Sci, 20 Oxford St, Cambridge, MA 02138 USA; [Marx, Christopher J.] Univ Idaho, Dept Biol Sci, Moscow, ID 83843 USA; [Marx, Christopher J.] Univ Idaho, Inst Bioinformat & Evolutionary Studies, Moscow, ID 83843 USA; [Marx, Christopher J.] Univ Idaho, Ctr Modeling Complex Interact, Moscow, ID 83843 USA; [Swanson, Paige K.] Finch Therapeut, Somerville, MA USA; [Caroll, Sean M.] Pronutria Biosci, Cambridge, MA USA	Harvard University; Washington University (WUSTL); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; Harvard University; Idaho; University of Idaho; Idaho; University of Idaho; Idaho; University of Idaho	Bradley, AS; Marx, CJ (corresponding author), Harvard Univ, Dept Organism & Evolutionary Biol, Cambridge, MA 02138 USA.; Bradley, AS (corresponding author), Washington Univ, Dept Earth & Planetary Sci, St Louis, MO 63130 USA.; Marx, CJ (corresponding author), Univ Idaho, Dept Biol Sci, Moscow, ID 83843 USA.; Marx, CJ (corresponding author), Univ Idaho, Inst Bioinformat & Evolutionary Studies, Moscow, ID 83843 USA.; Marx, CJ (corresponding author), Univ Idaho, Ctr Modeling Complex Interact, Moscow, ID 83843 USA.	abradley@eps.wustl.edu; cmarx@uidaho.edu	Bringel, Francoise/AAQ-6484-2021; Muller, Emilie/J-8727-2019; Vuilleumier, Stéphane/D-2647-2012	Bringel, Francoise/0000-0002-4529-5143; Muller, Emilie/0000-0002-3750-2966; Vuilleumier, Stéphane/0000-0003-2232-7023; Pearson, Ann/0000-0003-2785-8405	Agouron Institute postdoctoral fellowship [AI-FG B9.08.2]; National Science Foundation [EAR1024723]; Region Alsace (France); NCI Cancer Center to the Siteman Cancer Center [P30CA91842]; ICTS/CTSA from the National Center for Research Resources (NCRR) [UL1TR000448]; National Institutes of Health (NIH); NIH Roadmap for Medical Research; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000448] Funding Source: NIH RePORTER	Agouron Institute postdoctoral fellowship; National Science Foundation(National Science Foundation (NSF)); Region Alsace (France)(Region Grand-Est); NCI Cancer Center to the Siteman Cancer Center; ICTS/CTSA from the National Center for Research Resources (NCRR); National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH Roadmap for Medical Research(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS))	This work was supported by an Agouron Institute postdoctoral fellowship to A.S.B. (AI-FG B9.08.2) and a grant from the National Science Foundation to C.J.M. and A.P. (EAR1024723). Support of Region Alsace (France) for a PhD thesis grant to Emilie E.L. Muller is also gratefully acknowledged. We thank the Genome Technology Access Center in the Department of Geneticsat Washington University School of Medicine for help with genomic analysis.The Center is partially supported by NCI Cancer Center Support Grant #P30CA91842 to the Siteman Cancer Center and by ICTS/CTSA Grant# UL1TR000448 from the National Center for Research Resources (NCRR), a component of the National Institutes of Health (NIH), and NIH Roadmap for Medical Research. This publication is solely the responsibility of the authors and does not necessarily represent the official view of NCRR or NIH. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agashe D, 2016, MOL BIOL EVOL, V33, P1542, DOI 10.1093/molbev/msw035; Alloisio N, 2010, MOL PLANT MICROBE IN, V23, P593, DOI 10.1094/MPMI-23-5-0593; Banta AB, 2015, P NATL ACAD SCI USA, V2015; BERRY AM, 1993, P NATL ACAD SCI USA, V90, P6091, DOI 10.1073/pnas.90.13.6091; BLIGH EG, 1959, CAN J BIOCHEM PHYS, V37, P911; BOCHNER BR, 1980, J BACTERIOL, V143, P926, DOI 10.1128/JB.143.2.926-933.1980; Bodlenner A, 2015, CHEMBIOCHEM, V16, P1764, DOI 10.1002/cbic.201500021; Bradley AS, 2010, ORG GEOCHEM, V41, P1075, DOI 10.1016/j.orggeochem.2010.07.003; Brocks JJ, 2005, TREATISE ON GEOCHEMISTRY, VOL 8: BIOGEOCHEMISTRY, P63; Chistoserdova L., 1998, EUR J IMMUNOL, V99, P1083; Chou HH, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000652; Deatherage DE, 2014, METHODS MOL BIOL, V1151, P165, DOI 10.1007/978-1-4939-0554-6_12; Delaney NF, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062957; Delaney NF, 2013, JALA-J LAB AUTOM, V18, P171, DOI 10.1177/2211068212460237; Doughty DM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0084455; Doughty DM, 2011, P NATL ACAD SCI USA, V108, pE1045, DOI 10.1073/pnas.1104209108; FIGURSKI DH, 1979, P NATL ACAD SCI USA, V76, P1648, DOI 10.1073/pnas.76.4.1648; HORBACH S, 1991, FEMS MICROBIOL LETT, V79, P347, DOI 10.1016/0378-1097(91)90110-V; Joyeux C, 2004, FEMS MICROBIOL ECOL, V47, P371, DOI 10.1016/S0168-6496(03)00302-7; Kulkarni G, 2015, MBIO, V6, DOI 10.1128/mBio.01251-15; Lee MC, 2009, EVOLUTION, V63, P2816, DOI 10.1111/j.1558-5646.2009.00757.x; Malott RJ, 2014, ANTIMICROB AGENTS CH, V58, P5211, DOI 10.1128/AAC.02705-14; Malott RJ, 2012, ANTIMICROB AGENTS CH, V56, P464, DOI 10.1128/AAC.00602-11; Marx Christopher J, 2008, BMC Res Notes, V1, P1, DOI 10.1186/1756-0500-1-1; Marx CJ, 2001, MICROBIOL-SGM, V147, P2065, DOI 10.1099/00221287-147-8-2065; Marx CJ, 2005, METABOLISM, V3; Muller EEL, 2011, ENVIRON MICROBIOL, V13, P2518, DOI 10.1111/j.1462-2920.2011.02524.x; Neubauer C, 2015, GEOBIOLOGY; Pearson A, 2007, ENVIRON MICROBIOL, V9, P2175, DOI 10.1111/j.1462-2920.2007.01331.x; Poger D, 2013, J PHYS CHEM B, V117, P16129, DOI 10.1021/jp409748d; PORALLA K, 1984, FEMS MICROBIOL LETT, V23, P253; Poralla K, 2000, FEMS MICROBIOL LETT, V189, P93, DOI 10.1111/j.1574-6968.2000.tb09212.x; Ricci JN, 2014, ISME J, V8, P675, DOI 10.1038/ismej.2013.191; Ricci JN, 2016, GEOBIOLOGY, P1; ROHMER M, 1984, J GEN MICROBIOL, V130, P1137; Saenz JP, 2015, P NATL ACAD SCI USA, V112, P11971, DOI 10.1073/pnas.1515607112; Saenz JP, 2012, P NATL ACAD SCI USA, V109, P14236, DOI 10.1073/pnas.1212141109; Schmerk CL, 2011, J BACTERIOL, V193, P6712, DOI 10.1128/JB.05979-11; Seipke RF, 2009, J BACTERIOL, V191, P5216, DOI 10.1128/JB.00390-09; Silipo A, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6106; Studer A, 2002, J BACTERIOL, V184, P3476, DOI 10.1128/JB.184.13.3476-3484.2002; Summons RE, 1999, NATURE, V400, P554, DOI 10.1038/23005; Talbot HM, 2007, RAPID COMMUN MASS SP, V21, P880, DOI 10.1002/rcm.2911; Talbot HM, 2003, RAPID COMMUN MASS SP, V17, P2788, DOI 10.1002/rcm.1265; Talbot HM, 2003, RAPID COMMUN MASS SP, V17, P728, DOI 10.1002/RCM.974; Vorholt JA, 2000, J BACTERIOL, V182, P6645, DOI 10.1128/JB.182.23.6645-6650.2000; Vorholt JA, 2012, NAT REV MICROBIOL, V10, P828, DOI 10.1038/nrmicro2910; Welander PV, 2009, J BACTERIOL, V191, P6145, DOI 10.1128/JB.00460-09; Wu CH, 2015, ELIFE, V4, DOI 10.7554/eLife.05663; ZUNDEL M, 1985, EUR J BIOCHEM, V150, P23, DOI 10.1111/j.1432-1033.1985.tb08980.x; ZUNDEL M, 1985, FEMS MICROBIOL LETT, V28, P61, DOI 10.1111/j.1574-6968.1985.tb00764.x	51	11	11	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 20	2017	12	3							e01733230	10.1371/journal.pone.0173323	http://dx.doi.org/10.1371/journal.pone.0173323			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ER6VC	28319163	Green Published, gold, Green Submitted			2022-12-27	WOS:000398945800014
J	Jochmans, I; Monbaliu, D; Ceulemans, LJ; Pirenne, J; Fronek, J				Jochmans, Ina; Monbaliu, Diethard; Ceulemans, Laurens J.; Pirenne, Jacques; Fronek, Jiri			Simultaneous liver kidney transplantation and (bilateral) nephrectomy through a midline is feasible and safe in polycystic disease	PLOS ONE			English	Article							INCISIONS; CLOSURE	In Eurotransplant, 50% of simultaneous liver kidney transplantations (SLK) are performed for polycystic disease. Classically, liver and kidney are transplanted in two steps: liver through a subcostal incision, kidney through a separate oblique incision. Liver and kidney volume can make this ` two-step' procedure challenging, especially if simultaneous native nephrectomy is indicated. A ` one-step' SLK through a xiphopubic laparotomy might be a safe alternative, facilitating mobilization of the voluminous polycystic liver and native nephrectomy whilst offering access to iliac fossae for kidney transplantation. One-step SLK procedures for polycystic disease were introduced in 08/2013 at IKEM Prague (n = 6) and 11/2014 at University Hospitals Leuven (n = 6). Feasibility and safety of the one-step technique were investigated. We compared surgical data and outcomes obtained with the one-step technique to all consecutive twostep procedures performed for polycystic disease at the University Hospitals Leuven between 2008-2014 (n = 23). Median (interquartile range) are given. One-step SLK offered broad and adequate exposure for the hepatectomy, nephrectomies and transplantations, which were all uneventful. Morbidity, patient (100% vs 91%, p = 0.53) and graft survival (100% graft survival for liver and kidney in both groups) were comparable between one-step and two-step SLK. Liver cold ischaemia time was comparable [6.0 (4.4-7.6) vs. 7.1 (3.9-7.3), p = 0.077], kidney cold ischaemia time was shorter in one-step compared to two-step SLK [8.1 (6.4-9.3) vs. 11.7 (10.0-14.0), p< 0.001)]. Total procedural time was also shorter in one-step compared to twostep SLK [6.8 (4.1-9.3) vs. 9.0 (8.7-10.1), p = 0.032], while all underwent bilateral (67%) or unilateral (33%) nephrectomy (compared to 0% and 52% in two-step SLK, respectively). In one-step SLK, 67% received a pre-emptive kidney transplant compared to 46% in two-step SLK. 5/12 two-step SLK became dialysis dependant after pre-transplant nephrectomy, the 4 dialysis-dependant patients with one-step SLK had not undergone pre-transplant nephrectomy. In conclusion, one-step SLK for polycystic disease is feasible and safe.	[Jochmans, Ina; Monbaliu, Diethard; Pirenne, Jacques] Univ Hosp Leuven, Abdominal Transplant Surg, Leuven, Belgium; [Jochmans, Ina; Monbaliu, Diethard; Ceulemans, Laurens J.; Pirenne, Jacques] Katholieke Univ Leuven, Lab Abdominal Transplant Surg, Dept Microbiol & Immunol, Leuven, Belgium; [Fronek, Jiri] Inst Clin & Expt Med, Transplant Surg Dept, Prague, Czech Republic	KU Leuven; University Hospital Leuven; KU Leuven; Institute for Clinical & Experimental Medicine (IKEM)	Jochmans, I (corresponding author), Univ Hosp Leuven, Abdominal Transplant Surg, Leuven, Belgium.; Jochmans, I (corresponding author), Katholieke Univ Leuven, Lab Abdominal Transplant Surg, Dept Microbiol & Immunol, Leuven, Belgium.	ina.jochmans@uzleuven.be	Monbaliu, Diethard/AAK-8499-2020; Jochmans, Ina/R-2471-2017; Pirenne, Jacques/I-3728-2018; Monbaliu, Diethard/I-3733-2018	Monbaliu, Diethard/0000-0002-0506-1609; Jochmans, Ina/0000-0003-4592-2810; Pirenne, Jacques/0000-0002-8147-8801; Monbaliu, Diethard/0000-0002-0506-1609; Ceulemans, Laurens/0000-0002-4261-7100				Ahmad SB, 2016, TRANSPLANTATION, V100, P407, DOI 10.1097/TP.0000000000000838; Becker T, 2003, LIVER TRANSPLANT, V9, P1067, DOI 10.1053/jlts.2003.50210; Benedetti E, 1996, TRANSPLANT INT, V9, P486, DOI 10.1111/j.1432-2277.1996.tb00993.x; Brown SR, 2005, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD005199.pub2; Coquillard C, 2016, LIVER INT, V36, P1018, DOI 10.1111/liv.13041; Deerenberg EB, 2015, LANCET, V386, P1254, DOI 10.1016/S0140-6736(15)60459-7; Eurotransplant International Foundation, DAT REP X15 265; Klintmalm GB., 2015, TRANSPLANTATION LIVE, P600; MARGREITER R, 1984, LANCET, V1, P1077; Muysoms FE, 2015, HERNIA, V19, P1, DOI 10.1007/s10029-014-1342-5; Nadim MK, 2012, AM J TRANSPLANT, V12, P2901, DOI 10.1111/j.1600-6143.2012.04190.x; Olausson M, 2007, AM J TRANSPLANT, V7, P130, DOI 10.1111/j.1600-6143.2006.01592.x; Ruiz R, 2006, ARCH SURG-CHICAGO, V141, P735, DOI 10.1001/archsurg.141.8.735; Watson CJE., 2014, KIDNEY TRANSPLANTATI, P161	14	3	3	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 17	2017	12	3							e0174123	10.1371/journal.pone.0174123	http://dx.doi.org/10.1371/journal.pone.0174123			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EO5CJ	28306734	Green Published, gold, Green Submitted			2022-12-27	WOS:000396710300021
J	Seo, JH; Kang, I; Yang, SJ; Cho, JC				Seo, Ji-Hui; Kang, Ilnam; Yang, Seung-Jo; Cho, Jang-Cheon			Characterization of spatial distribution of the bacterial community in the South Sea of Korea	PLOS ONE			English	Article							MARINE BACTERIOPLANKTON; MICROBIAL BIOGEOGRAPHY; DIVERSITY; POPULATIONS; DYNAMICS; PATTERNS; ATLANTIC; COASTAL; PROCHLOROCOCCUS; FLAVOBACTERIA	In order to investigate the importance of spatial and environmental factors on the structure and diversity of bacterial communities, high-resolution 16S rRNA gene tag pyrosequencing was applied to bacterial communities in the littoral sea. Seawater samples were prepared from seven different stations in the South Sea of Korea, the marginal sea in the western Pacific Ocean, and were divided into three groups according to distances from the coastline. The majority of 19,860 sequences were affiliated with Alphaproteobacteria (58.2%), Gammaproteobacteria (7.9%), and Bacteroidetes (13.9%). The bacterioplankton community at each station was highly diverse and varied among the samples. Major bacterial lineages showed different niche preferences among three locational groups. Alphaproteobacteria was the most abundant bacterial class, and it harbored the most frequently recorded operational taxonomic units (OTUs) in all sampling stations. However, dominant groups at the order levels showed a clear difference among the samples. The SAR11 clade was more abundant in coastal waters while the Roseobacter clade prevailed at stations far away from the coastline. Furthermore, members of Actinobacteria and Cyanobacteria also exhibited spatial variability. The OM1 clade in Actinobacteria constituted a predominant fraction in coastal samples, but it was essentially absent at the distal stations closer to open ocean. In contrast, Synechococcus was the predominant taxon in the distal samples, accounting for 7.1-19.5%, but was hardly detected in coastal waters, representing less than 0.7%. In Bacteroidetes, NS5 and NS9 groups tended to inhabit coastal waters while the genera Polaribacter and Ulvibacter were more abundant in distal stations. Clustering analysis and principle coordinates analysis based on OTU data indicated that bacterial communities in the studied area were separated into three groups that coincided with locational grouping. Statistical analysis showed that phosphate and dissolved oxygen concentration had a significant influence on the bacterial community composition.	[Seo, Ji-Hui; Kang, Ilnam; Yang, Seung-Jo; Cho, Jang-Cheon] Inha Univ, Dept Biol Sci, Incheon, South Korea; [Yang, Seung-Jo] Seoul Natl Univ, ChunLab Inc, Seoul, South Korea	Inha University; Seoul National University (SNU)	Cho, JC (corresponding author), Inha Univ, Dept Biol Sci, Incheon, South Korea.	chojc@inha.ac.kr			Marine Biotechnology Program - Ministry of Oceans and Fisheries, Korea [PJT200620]	Marine Biotechnology Program - Ministry of Oceans and Fisheries, Korea	This research was supported by a grant from Marine Biotechnology Program (PJT200620, Genome Analysis of Marine Organisms and Development of Functional Applications) funded by Ministry of Oceans and Fisheries, Korea.	Abell GCJ, 2005, FEMS MICROBIOL ECOL, V51, P265, DOI 10.1016/j.femsec.2004.09.001; Alonso C, 2007, ENVIRON MICROBIOL, V9, P1253, DOI 10.1111/j.1462-2920.2007.01244.x; Brown MV, 2012, MOL SYST BIOL, V8, DOI 10.1038/msb.2012.28; Brown MV, 2005, ENVIRON MICROBIOL, V7, P1466, DOI 10.1111/j.1462-2920.2005.00835.x; Carlson CA, 2009, ISME J, V3, P283, DOI 10.1038/ismej.2008.117; Choi Dong Han, 2011, Ocean Science Journal, V46, P265, DOI 10.1007/s12601-011-0020-0; Crump BC, 2004, APPL ENVIRON MICROB, V70, P1494, DOI 10.1128/AEM.70.3.1494-1505.2004; DeLong EF, 2005, NATURE, V437, P336, DOI 10.1038/nature04157; Dillon JG, 2009, HYDROBIOLOGIA, V632, P49, DOI 10.1007/s10750-009-9827-4; Dufrene M, 1997, ECOL MONOGR, V67, P345, DOI 10.1890/0012-9615(1997)067[0345:SAAIST]2.0.CO;2; DuRand M.D., 2001, DEEP SEA RES 2, V48, P8, DOI DOI 10.1016/S0967-0645(00)00166-1; Edgar RC, 2011, BIOINFORMATICS, V27, P2194, DOI 10.1093/bioinformatics/btr381; Eiler A, 2012, ISME J, V6, P330, DOI 10.1038/ismej.2011.113; Eiler A, 2009, ENVIRON MICROBIOL, V11, P2291, DOI 10.1111/j.1462-2920.2009.01954.x; Eilers H, 2001, APPL ENVIRON MICROB, V67, P5134, DOI 10.1128/AEM.67.11.5134-5142.2001; Flombaum P, 2013, P NATL ACAD SCI USA, V110, P9824, DOI 10.1073/pnas.1307701110; Fodelianakis S, 2014, APPL ENVIRON MICROB, V80, P3784, DOI 10.1128/AEM.00088-14; Fortunato CS, 2013, ISME J, V7, P1899, DOI 10.1038/ismej.2013.79; Fuhrman JA, 2009, NATURE, V459, P193, DOI 10.1038/nature08058; Giebel HA, 2011, ISME J, V5, P8, DOI 10.1038/ismej.2010.87; Gilbert JA, 2012, ISME J, V6, P298, DOI 10.1038/ismej.2011.107; Gilbert JA, 2009, ENVIRON MICROBIOL, V11, P3132, DOI 10.1111/j.1462-2920.2009.02017.x; Giovannoni SJ, 2005, NATURE, V437, P343, DOI 10.1038/nature04158; Giovannoni SJ, 1996, P NATL ACAD SCI USA, V93, P7979, DOI 10.1073/pnas.93.15.7979; Giovannoni SJ, 2008, ENVIRON MICROBIOL, V10, P1771, DOI 10.1111/j.1462-2920.2008.01598.x; Giovannoni SJ, 2012, SCIENCE, V335, P671, DOI 10.1126/science.1198078; Glockner FO, 1999, APPL ENVIRON MICROB, V65, P3721; Gomez-Pereira PR, 2010, ISME J, V4, P472, DOI 10.1038/ismej.2009.142; Jamieson RE, 2012, FEMS MICROBIOL ECOL, V80, P452, DOI 10.1111/j.1574-6941.2012.01313.x; Jeffrey, 1997, PHYTOPLANKTON PIGMEN, P616; Kirchman DL, 2002, FEMS MICROBIOL ECOL, V39, P91, DOI 10.1111/j.1574-6941.2002.tb00910.x; Klindworth A, 2014, MAR GENOM, V18, P185, DOI 10.1016/j.margen.2014.08.007; Korlevic M, 2015, APPL ENVIRON MICROB, V81, P1715, DOI 10.1128/AEM.03410-14; Kormas KA, 2006, ENVIRON MICROBIOL, V8, P909, DOI 10.1111/j.1462-2920.2005.00978.x; Lane D. J., 1991, NUCL ACID TECHNIQUES; Legendre P., 1998, NUMERICAL ECOLOGY DE, V20; Liu JK, 2015, BRAIN RES, V1610, P1, DOI 10.1016/j.brainres.2015.03.044; Llobet-Brossa E, 1998, APPL ENVIRON MICROB, V64, P2691; Magurran A.E., 2013, ECOLOGICAL DIVERSITY; Malmstrom RR, 2010, ISME J, V4, P1252, DOI 10.1038/ismej.2010.60; Martiny JBH, 2006, NAT REV MICROBIOL, V4, P102, DOI 10.1038/nrmicro1341; Moisan TA, 2010, CONT SHELF RES, V30, P1275, DOI 10.1016/j.csr.2010.04.005; Morris RM, 2012, ENVIRON MICROBIOL, V14, P1133, DOI 10.1111/j.1462-2920.2011.02694.x; Morris RM, 2010, ISME J, V4, P673, DOI 10.1038/ismej.2010.4; Nelson CE, 2014, ENVIRON MICROBIOL, V16, P871, DOI 10.1111/1462-2920.12241; Nemergut DR, 2011, ENVIRON MICROBIOL, V13, P135, DOI 10.1111/j.1462-2920.2010.02315.x; O'Sullivan LA, 2004, FEMS MICROBIOL ECOL, V47, P359, DOI 10.1016/S0168-6496(03)00300-3; Partensky F., 1999, B I OCEANOGRAPHIQUE, V19, P457; Rappe MS, 2003, ANNU REV MICROBIOL, V57, P369, DOI 10.1146/annurev.micro.57.030502.090759; Schattenhofer M, 2009, ENVIRON MICROBIOL, V11, P2078, DOI 10.1111/j.1462-2920.2009.01929.x; Schloss PD, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027310; Schloss PD, 2009, APPL ENVIRON MICROB, V75, P7537, DOI 10.1128/AEM.01541-09; Schloss PD, 2004, MICROBIOL MOL BIOL R, V68, P686, DOI 10.1128/MMBR.68.4.686-691.2004; Simon M, 1999, AQUAT MICROB ECOL, V18, P275, DOI 10.3354/ame018275; Sterner R.W, 2002, ECOLOGICAL STOICHIOM, DOI DOI 10.1086/382444; Teeling H, 2016, ELIFE, V5, DOI 10.7554/eLife.11888; Turner S, 1999, J EUKARYOT MICROBIOL, V46, P327, DOI 10.1111/j.1550-7408.1999.tb04612.x; Wang M, 2010, ENVIRON MICROBIOL, V12, P1926, DOI 10.1111/j.1462-2920.2010.02197.x; Wang Y, 2015, INT J ENV RES PUB HE, V12, P5420, DOI 10.3390/ijerph120505420; Wasmund N, 2001, ESTUAR COAST SHELF S, V53, P849, DOI 10.1006/ecss.2001.0828; Zwirglmaier K, 2008, ENVIRON MICROBIOL, V10, P147, DOI 10.1111/j.1462-2920.2007.01440.x; Zwirglmaier K, 2007, ENVIRON MICROBIOL, V9, P1278, DOI 10.1111/j.1462-2920.2007.01246.x	62	13	14	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 17	2017	12	3							e0174159	10.1371/journal.pone.0174159	http://dx.doi.org/10.1371/journal.pone.0174159			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EO5CJ	28306743	Green Published, Green Submitted, gold			2022-12-27	WOS:000396710300023
J	Shaver, DJ; Tissot, PE; Streich, MM; Walker, JS; Rubio, C; Amos, AF; George, JA; Pasawicz, MR				Shaver, Donna J.; Tissot, Philippe E.; Streich, Mary M.; Walker, Jennifer Shelby; Rubio, Cynthia; Amos, Anthony F.; George, Jeffrey A.; Pasawicz, Michelle R.			Hypothermic stunning of green sea turtles in a western Gulf of Mexico foraging habitat	PLOS ONE			English	Article							RIVER LAGOON SYSTEM; CHELONIA-MYDAS; LEPIDOCHELYS-KEMPII; MARINE TURTLES; POPULATION; PATTERNS; ABUNDANCE; GROWTH; REHABILITATION; MOVEMENTS	Texas waters provide one of the most important developmental and foraging habitats for juvenile green turtles (Chelonia mydas) in the western Gulf of Mexico, but hypothermic stunning is a significant threat and was the largest cause of green turtle strandings in Texas from 1980 through 2015; of the 8,107 green turtles found stranded, 4,529 (55.9%) were victims of hypothermic stunning. Additionally, during this time, 203 hypothermic stunned green turtles were found incidentally captured due to power plant water intake entrapment. Overall, 63.9% of 4,529 hypothermic stunned turtles were found alive, and 92.0% of those survived rehabilitation and were released. Numbers of green turtles recorded as stranded and as affected by hypothermic stunning increased over time, and were most numerous from 2007 through 2015. Large hypothermic stunning events (with more than 450 turtles documented) occurred during the winters of 2009-2010, 2010-2011, 2013-2014, and 2014-2015. Hypothermic stunning was documented between November and March, but peaked at various times depending on passage of severe weather systems. Hypothermic stunning occurred state-wide, but was most prevalent in South Texas, particularly the Laguna Madre. In the Laguna Madre, hypothermic stunning was associated with an abrupt drop in water temperatures strong northerly winds, and a threshold mean water temperature of 8.0 degrees C predicted large turtle hypothermic stunning events. Knowledge of environmental parameters contributing to hypothermic stunning and the temporal and spatial distribution of turtles affected in the past, can aid with formulation of proactive, targeted search and rescue efforts that can ultimately save the lives of many affected individuals, and aid with recovery efforts for this bi-national stock. Such rescue efforts are required under the U.S. Endangered Species Act and respond to humanitarian concerns of the public.	[Shaver, Donna J.; Streich, Mary M.; Walker, Jennifer Shelby; Rubio, Cynthia; Pasawicz, Michelle R.] Natl Pk Serv, Padre Isl Natl Seashore, Corpus Christi, TX 78418 USA; [Tissot, Philippe E.] Texas A&M Univ Corpus Christi, Conrad Blucher Inst, Corpus Christi, TX USA; [Amos, Anthony F.] Univ Texas Austin, Inst Marine Sci, Port Aransas, TX USA; [George, Jeffrey A.] Sea Turtle Inc, S Padre Isl, TX USA; [Pasawicz, Michelle R.] Florida Fish & Wildlife Commiss, Tallahassee, FL USA	United States Department of the Interior; Texas A&M University System; Texas A&M University Corpus Christi; University of Texas System; University of Texas Austin	Shaver, DJ (corresponding author), Natl Pk Serv, Padre Isl Natl Seashore, Corpus Christi, TX 78418 USA.	donna_shaver@nps.gov	Tissot, Philippe E/I-5609-2017; Shaver, Donna J/D-6227-2013	Tissot, Philippe E/0000-0002-2954-2378; Shaver, Donna J/0000-0003-1379-8974; Walker, J. Shelby/0000-0002-3446-2073	National Park Service	National Park Service	This work was supported by the National Park Service. The funders provided support in the form of salaries for authors [DJS PET MMS JSW CR AFA JAG MRP], but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Anderson ET, 2011, J ZOO WILDLIFE MED, V42, P247, DOI 10.1638/2010-0217.1; Anderson JD, 2013, J HERPETOL, V47, P251, DOI 10.1670/12-031; Arms S. A., 1996, THESIS; Armstrong NE, 1987, BIOL REPORTS US DEP; Avens L, 2012, MAR ECOL PROG SER, V458, P213, DOI 10.3354/meps09720; Baker L, 2015, ENDANGER SPECIES RES, V29, P13, DOI 10.3354/esr00696; BALAZS G H, 1976, Biological Conservation, V9, P125, DOI 10.1016/0006-3207(76)90045-8; Balazs George H., 1999, P101; Baudouin M, 2015, BIOL CONSERV, V184, P36, DOI 10.1016/j.biocon.2014.12.021; Berens P, 2009, J STAT SOFTW, V31, P1, DOI 10.18637/jss.v031.i10; BJORNDAL KA, 1980, MAR BIOL, V56, P147, DOI 10.1007/BF00397131; Bjorndal KA., 1982, BIOL CONSERVATION SE, P111; Bjorndal Karen A., 1997, P199; Bjorndal Karen L., 1999, P12; Blanco Gabriela S., 2012, Endangered Species Research, V18, P233, DOI 10.3354/esr00451; BREUER JOSEPH P., 1962, PUBL INST MAR SCI, V8, P153; BRILL RW, 1995, J EXP MAR BIOL ECOL, V185, P203, DOI 10.1016/0022-0981(94)00146-5; Brongersma L.D., 1982, BIOL CONSERVATION SE, P407; BURKE VJ, 1991, COPEIA, P1136; Caillouet CW, 2016, HERPETOL CONSERV BIO, V11, P486; Chaloupka M, 2008, GLOBAL ECOL BIOGEOGR, V17, P297, DOI 10.1111/j.1466-8238.2007.00367.x; Coleman AT, 2016, HERPETOL CONSERV BIO, V11, P253; COLLAZO JA, 1992, J HERPETOL, V26, P293, DOI 10.2307/1564884; Coyne MS, 1994, THESIS; Davenport J, 1997, J THERM BIOL, V22, P479, DOI 10.1016/S0306-4565(97)00066-1; DOUGHTY RW, 1984, SOUTHWEST HIST QUART, V88, P43; Ehrhart Llewellyn M., 2007, Florida Scientist, V70, P415; Epperly SP, 1996, B MAR SCI, V59, P289; ESRI, 2018, ARCGIS DESKTOP RELEA; Fikes R, 2010, GULF CARIBB RES, V22, P9; Foley Allen M., 2007, Gulf of Mexico Science, V25, P131; George Robert H., 1997, P363; Godfrey M., 2013, CURRENT CONSERVATION, V6, P31; Hamann M., 2010, Endangered Species Research, V11, P245, DOI 10.3354/esr00279; HICKS DW, 1995, AM MALACOL BULL, V11, P203; Hildebrand H. H., 1982, BIOL CONSERVATION SE, P447; Hildebrand HH, 1983, W GULF MEXICO SEA TU, P34; Hirth HF, 1997, SYNOPSIS BIOL DATA G; Howell LN, 2016, MAR ECOL PROG SER, V559, P217, DOI 10.3354/meps11897; Inoue M, 1997, OCS STUDY; Kaldy JE, 1995, BOT MAR, V38, P519, DOI 10.1515/botm.1995.38.1-6.519; Lamont MM, 2015, ANIM BIOTELEMETRY; Lehman R. L., 2013, BMJ OPIN; Lehman RL, 1999, TEX J SCI, V51, P241; Magnuson J.J., 1990, DECLINE SEA TURTLES; MENDONCA MT, 1983, COPEIA, P1013, DOI 10.2307/1445104; MENDONCA MT, 1982, COPEIA, P161; MENDONCA MT, 1981, J HERPETOL, V15, P447, DOI 10.2307/1563536; Metz TL, 2013, CHELONIAN CONSERV BI, V12, P293, DOI 10.2744/CCB-1046.1; Meylan PA, 2011, B AM MUS NAT HIST, P1, DOI 10.1206/357.1; MORREALE SJ, 1992, J HERPETOL, V26, P301, DOI 10.2307/1564885; Murray LS, 1978, LARVAL EXCLUSION SYS, V66, P79; Musick John A., 1997, P137; NMFS (National Marine Fisheries Service) and USFWS (US Fish and Wildlife Service), 1991, REC PLAN US POP ATL; Ogren L, 1982, BIOL CONSERVATION SE, P127; Pulich W. M., 2007, 20061587 US GEOL SUR, P7; QUAMMEN ML, 1993, ESTUARIES, V16, P302, DOI 10.2307/1352503; RABALAIS SC, 1980, CONTRIB MAR SCI, V23, P123; Redfoot W, 2013, CHELONIAN CONSERV BI, V12, P252, DOI 10.2744/CCB-0952.1; RENAUD ML, 1995, FISH B-NOAA, V93, P586; Roberts K, 2014, PHYS GEOGR, V35, P134, DOI 10.1080/02723646.2014.898573; Sampson L, 2015, MAR BIOL; Sato K, 2014, J EXP BIOL, V217, P3607, DOI 10.1242/jeb.109470; Schwartz FJ, 1978, FLORIDA MARINE RES P, V33, P16; Seminoff JA, 2015, NOAATMNMFSSWFSC539 U; Shamblin BM, 2016, J EXP MAR BIOL ECOL; Shaver D. J., 2000, THESIS; SHAVER DJ, 1994, J HERPETOL, V28, P491, DOI 10.2307/1564963; Shaver DJ, 2013, REPTILES RES INVESTI, P463; Shaver Donna J., 1998, NOAA Technical Report NMFS, V143, P57; Shaver Donna J., 1999, P152; Shew DM, 1981, FWSOBS8132 US DEP IN; Shoop C.R., 1980, Maritimes, V24, P9; Smith P. G. W., 1954, Fish Bull NS, V55, P513; Spotila James R., 1997, P297; SPOTILA JR, 1985, COPEIA, P694, DOI 10.2307/1444763; Still BM, 2005, CHELONIAN CONSERV BI, V4, P883; Teas WG, 1993, NMFSSEFSC315 US DEP; Tristan Timothy, 2010, Journal of Herpetological Medicine and Surgery, V20, P109, DOI 10.5818/1529-9651-20.4.109; Tunnell J.W., 2002, LAGUNA MADRE TEXAS T, P7; Velez-Zuazo X, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0113068; Wilks D.S., 2011, STAT METHODS ATMOSPH; Williams NC, 2014, ESTUAR COAST, V37, P986, DOI 10.1007/s12237-013-9741-x; WITHERINGTON BE, 1989, COPEIA, P696; Witherington B, 2012, MAR ECOL PROG SER, V463, P1, DOI 10.3354/meps09970; Withers Kim, 2002, P255; Witzell W.N., 1994, MAR FISH REV, V56, P8; Witzell W.N., 1994, US COMMERCIAL SEA TU; Wynne Michael J., 2008, Gulf of Mexico Science, V26, P64; Xavier R, 2006, AMPHIBIA-REPTILIA, V27, P539, DOI 10.1163/156853806778877077; Zavaleta-Lizarraga L, 2013, REV MEX BIODIVERS, V84, P927, DOI 10.7550/rmb.31913; Zug GR, 1998, CAN J ZOOL, V76, P1497, DOI 10.1139/z98-090	92	24	25	1	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 17	2017	12	3							e0173920	10.1371/journal.pone.0173920	http://dx.doi.org/10.1371/journal.pone.0173920			26	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EO5CJ	28306747	Green Submitted, gold, Green Published			2022-12-27	WOS:000396710300017
J	Burghardt, K; Alsina, EF; Girvan, M; Rand, W; Lerman, K				Burghardt, Keith; Alsina, Emanuel F.; Girvan, Michelle; Rand, William; Lerman, Kristina			The myopia of crowds: Cognitive load and collective evaluation of answers on Stack Exchange	PLOS ONE			English	Article							WISDOM	Crowds can often make better decisions than individuals or small groups of experts by leveraging their ability to aggregate diverse information. Question answering sites, such as Stack Exchange, rely on the "wisdom of crowds" effect to identify the best answers to questions asked by users. We analyze data from 250 communities on the Stack Exchange network to pinpoint factors affecting which answers are chosen as the best answers. Our results suggest that, rather than evaluate all available answers to a question, users rely on simple cognitive heuristics to choose an answer to vote for or accept. These cognitive heuristics are linked to an answer's salience, such as the order in which it is listed and how much screen space it occupies. While askers appear to depend on heuristics to a greater extent than voters when choosing an answer to accept as the most helpful one, voters use acceptance itself as a heuristic, and they are more likely to choose the answer after it has been accepted than before that answer was accepted. These heuristics become more important in explaining and predicting behavior as the number of available answers to a question increases. Our findings suggest that crowd judgments may become less reliable as the number of answers grows.	[Burghardt, Keith] Univ Calif Davis, Dept Comp Sci, Davis, CA USA; [Burghardt, Keith] Univ Calif Davis, Dept Polit Sci, Davis, CA USA; [Alsina, Emanuel F.] Univ Modena & Reggio Emilia, Modena, Italy; [Girvan, Michelle] Univ Maryland, Dept Phys, College Pk, MD USA; [Girvan, Michelle] Santa Fe Inst, Santa Fe, NM USA; [Rand, William] North Carolina State Univ, Dept Business Management, Raleigh, NC USA; [Lerman, Kristina] Univ Southern Calif, Inst Informat Sci, Marina Del Rey, CA USA; [Alsina, Emanuel F.] PricewaterhouseCoopers, Milan, Italy	University of California System; University of California Davis; University of California System; University of California Davis; Universita di Modena e Reggio Emilia; University System of Maryland; University of Maryland College Park; The Santa Fe Institute; University of North Carolina; North Carolina State University; University of Southern California	Burghardt, K (corresponding author), Univ Calif Davis, Dept Comp Sci, Davis, CA USA.	kaburghardt@ucdavis.edu	Lerman, Kristina/P-5138-2019; Girvan, Michelle/E-3982-2016	Girvan, Michelle/0000-0003-0299-0784; Rand, William/0000-0002-8294-1757; Girvan, Michelle/0000-0001-7519-2842	Army Research Office [W911NF-15-1-0142]; National Science Foundation [SMA-1360058]; Defense Advanced Research Projects Agency [D14PC00009]; MacArthur Foundation	Army Research Office; National Science Foundation(National Science Foundation (NSF)); Defense Advanced Research Projects Agency(United States Department of DefenseDefense Advanced Research Projects Agency (DARPA)); MacArthur Foundation	Our work is supported by the Army Research Office under contract W911NF-15-1-0142 (KL, url: http://www.arl.army.mil/www/default.cfm?page=29), by the National Science Foundation under grant SMA-1360058 (KL, url: https://www.nsf.gov/), and the Defense Advanced Research Projects Agency under contract D14PC00009 (WR and KB, url: http://www.darpa.mil/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; Our work is supported by the Army Research Office under contract W911NF-15-1-0142, by the National Science Foundation under grant SMA-1360058, and the Defense Advanced Research Projects Agency under contract D14PC00009. KL benefited from the cross-disciplinary discussions as a participant in the Opening Governance workshops sponsored by the MacArthur Foundation.	Adamic L.A., 2008, P 17 INT C WORLD WID, P665, DOI DOI 10.1145/1367497.1367587; Agichtein E., 2008, PROC INT C WEB SEARC, P183; Anderson A, 2012, P 18 ACM SIGKDD INT, P850, DOI [10.1145/2339530.2339665, DOI 10.1145/2339530.2339665]; Balietti S, 2016, P NATL ACAD SCI USA, V113, P8414, DOI 10.1073/pnas.1603723113; Blooma MJ, 2012, ONLINE INFORM REV, V36, P383, DOI 10.1108/14684521211241413; Bouchaud JP, 2013, J STAT PHYS, V151, P567, DOI 10.1007/s10955-012-0687-3; Chen BC, 2012, SIGIR 2012: PROCEEDINGS OF THE 35TH INTERNATIONAL ACM SIGIR CONFERENCE ON RESEARCH AND DEVELOPMENT IN INFORMATION RETRIEVAL, P781; Chen HL, 2014, REV FINANC STUD, V27, P1367, DOI 10.1093/rfs/hhu001; Condorce M, 1976, ESSAY APPL MATH THEO; Craswell N, 2008, PROC INTERNAT C WEB, P87, DOI 10.1145/1341531.1341545; Friedman J, 2010, J STAT SOFTW, V33, P1, DOI 10.18637/jss.v033.i01; Ghosh A, 2014, J ECON THEORY, V154, P349, DOI 10.1016/j.jet.2014.09.009; Goeman JJ, 2010, BIOMETRICAL J, V52, P70, DOI 10.1002/bimj.200900028; Hastie T., 2009, UNSUPERVISED LEARNIN; Hodas NO, 2014, SCI REP-UK, V4, DOI 10.1038/srep04343; Hogg T., 2015, HUMAN COMPUTATION J, V2, P189, DOI [DOI 10.15346/HC.V2I2.4, 10.15346/hc.v2i2.4]; Imai K, 2005, J STAT SOFTW, V14; Jain S, 2014, GAME ECON BEHAV, V86, P458, DOI 10.1016/j.geb.2012.11.003; Kahneman D, 2003, AM ECON REV, V93, P1449, DOI 10.1257/000282803322655392; Kahneman D., 2011, THINKING FAST SLOW; Kim S, 2009, J AM SOC INF SCI TEC, V60, P716, DOI 10.1002/asi.21026; Kincaid J Peter, 1975, TECHNICAL REPORT; Lerman K, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0098914; Lorenz J, 2011, P NATL ACAD SCI USA, V108, P9020, DOI 10.1073/pnas.1008636108; Page SE, 2008, DIFFERENCE POWER DIV; Payne SL, 1951, ART ASKING QUESTIONS; Ponzanelli L, 2014, PROC IEEE INT CONF S, P541, DOI 10.1109/ICSME.2014.90; Rechavi A., 2011, Proceedings of the 2011 IEEE Third International Conference on Privacy, Security, Risk and Trust and IEEE Third International Conference on Social Computing (PASSAT/SocialCom 2011), P904, DOI 10.1109/PASSAT/SocialCom.2011.67; Rodriguez M.G., 2014, P 8 INT AAAI C WEBL; Sakai T, 2011, PROCEEDINGS OF THE 34TH INTERNATIONAL ACM SIGIR CONFERENCE ON RESEARCH AND DEVELOPMENT IN INFORMATION RETRIEVAL (SIGIR'11), P1043; Salganik MJ, 2006, SCIENCE, V311, P854, DOI 10.1126/science.1121066; Scheibehenne B, 2010, J CONSUM RES, V37, P409, DOI 10.1086/651235; Shah C., 2011, 1 MONDAY, V16; Shah C, 2010, SIGIR 2010: PROCEEDINGS OF THE 33RD ANNUAL INTERNATIONAL ACM SIGIR CONFERENCE ON RESEARCH DEVELOPMENT IN INFORMATION RETRIEVAL, P411; Simon H. A., 1982, MODELS BOUNDED RATIO; Simon H.A., 1971, COMPUTERS COMMUNICAT, P37; Stoddard G., 2015, ICWSM, P416; Surowiecki J., 2005, WISDOM CROWDS; Taylor R.N., 1975, DECISION SCI, V6, P409, DOI 10.1111/j.1540-5915.1975.tb01031.x; Tin Kam Ho, 1995, Proceedings of the Third International Conference on Document Analysis and Recognition, P278, DOI 10.1109/ICDAR.1995.598994; VAUPEL JW, 1985, AM STAT, V39, P176, DOI 10.2307/2683925; Vox Populi Galton F., 1908, NATURE, V75, P450; Wagner C, 2010, P 43 HAW INT C SYST, P1; WANG XJ, 2009, SIGIR 2009, P179; Weisstein Eric W, 2004, BONFERRONI CORRECTIO; WILCOXON F, 1946, J ECON ENTOMOL, V39, P269, DOI 10.1093/jee/39.2.269	46	10	10	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 16	2017	12	3							e0173610	10.1371/journal.pone.0173610	http://dx.doi.org/10.1371/journal.pone.0173610			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EN9KE	28301531	Green Published, gold, Green Submitted			2022-12-27	WOS:000396318300055
J	Eastburn, DJ; O'Geen, AT; Tate, KW; Roche, LM				Eastburn, Danny J.; O'Geen, Anthony T.; Tate, Kenneth W.; Roche, Leslie M.			Multiple ecosystem services in a working landscape	PLOS ONE			English	Article							RANGELANDS; MANAGEMENT; CALIFORNIA; MODELS	Policy makers and practitioners are in need of useful tools and models for assessing ecosystem service outcomes and the potential risks and opportunities of ecosystem management options. We utilize a state-and-transition model framework integrating dynamic soil and vegetation properties to examine multiple ecosystem services specifically agricultural production, biodiversity and habitat, and soil health across human created vegetation states in a managed oak woodland landscape in a Mediterranean climate. We found clear tradeoffs and synergies in management outcomes. Grassland states maximized agricultural productivity at a loss of soil health, biodiversity, and other ecosystem services. Synergies existed among multiple ecosystem services in savanna and woodland states with significantly larger nutrient pools, more diversity and native plant richness, and less invasive species. This integrative approach can be adapted to a diversity of working landscapes to provide useful information for science-based ecosystem service valuations, conservation decision making, and management effectiveness assessments.	[Eastburn, Danny J.; Tate, Kenneth W.; Roche, Leslie M.] Univ Calif Davis, Dept Plant Sci, Davis, CA 95616 USA; [O'Geen, Anthony T.] Univ Calif Davis, Dept Land Air & Water Resources, Davis, CA 95616 USA	University of California System; University of California Davis; University of California System; University of California Davis	Roche, LM (corresponding author), Univ Calif Davis, Dept Plant Sci, Davis, CA 95616 USA.	lmroche@ucdavis.edu		Roche, Leslie/0000-0003-2954-8056	Kearney Foundation of Soil Science	Kearney Foundation of Soil Science	The Kearney Foundation of Soil Science (kearney.ucdavis.edu) provided funding for this project. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2011, ECOLOGICAL SITE DESC; [Anonymous], 2013, MEASUREMENTS TERREST; BARTOLOME JW, 2002, CALIFORNIA GUIDELINE; Bennett EM, 2009, ECOL LETT, V12, P1394, DOI 10.1111/j.1461-0248.2009.01387.x; Briske D.D., 2011, CONSERVATION BENEFIT, P22; Briske DD, 2005, RANGELAND ECOL MANAG, V58, P1, DOI 10.2111/1551-5028(2005)58&lt;1:SMTARH&gt;2.0.CO;2; Brown J, 2011, RANGELAND J, V33, P99, DOI 10.1071/RJ11006; Bugalho MN, 2011, FRONT ECOL ENVIRON, V9, P278, DOI 10.1890/100084; Carpenter SR, 2006, SCIENCE, V314, P257, DOI 10.1126/science.1131946; CDFA, 2014, CAL AGR STAT REV 201, DOI 10.1016/j.jad; Claassen R., 2011, AMBER WAVES, P9; Costech Analytical Technologies Inc, TOT C N AN US DRY CO; DiTomaso J.M., 2007, WEEDS CALIFORNIA OTH, V3488; Havstad KM, 2007, ECOL ECON, V64, P261, DOI 10.1016/j.ecolecon.2007.08.005; Holechek JL, 1989, RANGE MANAGEMENT PRI; Huntsinger L, 2010, RANGELAND ECOL MANAG, V63, P324, DOI 10.2111/08-166.1; Inc. N, NEXTENGINE DESKTOP 3; Interagency. Utilization studies and residual measurements, 1996, BLMRSST960041730 USD; Keeley JE, 2005, J VEG SCI, V16, P249, DOI 10.1111/j.1654-1103.2005.tb02362.x; Keeley JE, 2003, J BIOGEOGR, V30, P1629, DOI 10.1046/j.1365-2699.2003.00950.x; Kremen C, 2005, ECOL LETT, V8, P468, DOI 10.1111/j.1461-0248.2005.00751.x; Kumar P., 2010, EC ECOSYSTEMS BIODIV; Lopez-Hoffman L., 2011, RANGELANDS, V33, P4, DOI 10.2111/1551-501x-33.5.4; Mace GM, 2012, TRENDS ECOL EVOL, V27, P19, DOI 10.1016/j.tree.2011.08.006; Maranon T., 2009, WEB ECOLOGY, V9, P30, DOI [10.5194/we-9-30-2009, DOI 10.5194/WE-9-30-2009]; McCreary DD, 2010, CALIF AGR, V64, P63, DOI 10.3733/ca.v064n02p63; Merenlender AM, 2004, CONSERV BIOL, V18, P65, DOI 10.1111/j.1523-1739.2004.00401.x; Millennium Ecosystem Assessment, 2005, ECOSYSTEMS HUMAN WEL; Pinheiro J, 2000, MIXED EFIECTS MODELS; Rabe-Hesketh S, 2009, CH CRC HANDB MOD STA, P79; Raudsepp-Hearne C, 2010, P NATL ACAD SCI USA, V107, P5242, DOI 10.1073/pnas.0907284107; Roche LM, 2015, RANGELAND ECOL MANAG, V68, P383, DOI 10.1016/j.rama.2015.07.006; Roche LM, 2012, BIODIVERS CONSERV, V21, P2555, DOI 10.1007/s10531-012-0317-z; Rossi AM, 2008, SOIL SCI SOC AM J, V72, P1591, DOI 10.2136/sssaj2008.0072N; Rudd MA, 2014, BIOSCIENCE, V64, P219, DOI 10.1093/biosci/bit035; Rumpff L, 2011, BIOL CONSERV, V144, P1224, DOI 10.1016/j.biocon.2010.10.026; Shaw MR, 2011, CLIMATIC CHANGE, V109, P465, DOI 10.1007/s10584-011-0313-4; Twidwell D, 2013, ECOSPHERE, V4, DOI 10.1890/ES13-00124.1; WESTOBY M, 1989, J RANGE MANAGE, V42, P266, DOI 10.2307/3899492	39	25	25	5	68	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 16	2017	12	3							e0166595	10.1371/journal.pone.019595	http://dx.doi.org/10.1371/journal.pone.019595			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN9KE	28301475				2022-12-27	WOS:000396318300001
J	Prathikanti, S; Rivera, R; Cochran, A; Tungol, JG; Fayazmanesh, N; Weinmann, E				Prathikanti, Sudha; Rivera, Renee; Cochran, Ashly; Tungol, Jose Gabriel; Fayazmanesh, Nima; Weinmann, Eva			Treating major depression with yoga: A prospective, randomized, controlled pilot trial	PLOS ONE			English	Article							STAR-ASTERISK-D; REDUCE PRENATAL DEPRESSION; MINI-MENTAL-STATE; COGNITIVE THERAPY; HATHA YOGA; UNITED-STATES; INVENTORY-II; ANTIDEPRESSANT MEDICATION; PSYCHOMETRIC PROPERTIES; SELF-EFFICACY	Background Conventional pharmacotherapies and psychotherapies for major depression are associated with limited adherence to care and relatively low remission rates. Yoga may offer an alternative treatment option, but rigorous studies are few. This randomized controlled trial with blinded outcome assessors examined an 8-week hatha yoga intervention as mono-therapy for mild-to-moderate major depression. Methods Investigators recruited 38 adults in San Francisco meeting criteria for major depression of mild-to-moderate severity, per structured psychiatric interview and scores of 14 +/- 28 on Beck Depression Inventory-II (BDI). At screening, individuals engaged in psychotherapy, antidepressant pharmacotherapy, herbal or nutraceutical mood therapies, or mind-body practices were excluded. Participants were 68% female, with mean age 43.4 years (SD = 14.8, range = 22 +/- 72), and mean BDI score 22.4 (SD = 4.5). Twenty participants were randomized to 90-minute hatha yoga practice groups twice weekly for 8 weeks. Eighteen participants were randomized to 90-minute attention control education groups twice weekly for 8 weeks. Certified yoga instructors delivered both interventions at a university clinic. Primary outcome was depression severity, measured by BDI scores every 2 weeks from baseline to 8 weeks. Secondary outcomes were self-efficacy and self-esteem, measured by scores on the General Self-Efficacy Scale (GSES) and Rosenberg Self-Esteem Scale (RSES) at baseline and at 8 weeks. Results In intent-to-treat analysis, yoga participants exhibited significantly greater 8-week decline in BDI scores than controls (p-value = 0.034). In sub-analyses of participants completing final 8-week measures, yoga participants were more likely to achieve remission, defined per final BDI score <= 9 (p-value = 0.018). Effect size of yoga in reducing BDI scores was large, per Cohen's d = -0.96 [95% CI, -1.81 to -0.12]. Intervention groups did not differ significantly in 8-week change scores for either the GSES or RSES. Conclusion In adults with mild-to-moderate major depression, an 8-week hatha yoga intervention resulted in statistically and clinically significant reductions in depression severity.	[Prathikanti, Sudha] Univ Calif San Francisco, Sch Med, Dept Psychiat, San Francisco, CA USA; [Rivera, Renee] Univ Calif San Francisco, Osher Ctr Integrat Med, San Francisco, CA USA; [Cochran, Ashly] Cornell Univ, Dept Psychiat, Weill Cornell Med, New York, NY USA; [Tungol, Jose Gabriel] Johns Hopkins Univ, Johns Hopkins Bloomberg Sch Publ Hlth, Baltimore, MD USA; [Fayazmanesh, Nima] Vet Affairs Long Beach Healthcare Syst, Dept Psychiat, Long Beach, CA USA; [Weinmann, Eva] Svastha Yoga Therapy Program, Fuss Ueber Kopf Yoga Studio, Stuttgart, Germany	University of California System; University of California San Francisco; University of California System; University of California San Francisco; Cornell University; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Long Beach Healthcare System	Prathikanti, S (corresponding author), Univ Calif San Francisco, Sch Med, Dept Psychiat, San Francisco, CA USA.	sudha.prathikanti@gmail.com			Mental Insight Foundation [435299-86871-01]; Pritzker Family Foundation [556501-41743]; Mt. Zion Health Fund [P0035738]	Mental Insight Foundation; Pritzker Family Foundation; Mt. Zion Health Fund	SP obtained 3 grants: 1) Mental Insight Foundation 435299-86871-01, 2) Pritzker Family Foundation 556501-41743, and 3) Mt. Zion Health Fund P0035738. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	aan het Rot M, 2012, CLIN PSYCHOL REV, V32, P510, DOI 10.1016/j.cpr.2012.05.007; Alan Gelenberg, 2010, PRACTICE GUIDELINE T; American psychiatric association, 2013, DIAGNOSTIC STAT MANU, DOI 10.1176/appi.books.9780890425596; Amick HR, 2015, BMJ-BRIT MED J, V351, DOI 10.1136/bmj.h6019; Anderzen-Carlsson A, 2014, INT J QUAL STUD HEAL, V9, DOI 10.3402/qhw.v9.23033; Angst J, 1999, J CLIN PSYCHIAT S, V60, P113; Arnow BA, 2007, J AFFECT DISORDERS, V97, P197, DOI 10.1016/j.jad.2006.06.017; Atkinson C, 2013, JAMA-J AM MED ASSOC, V310, P591, DOI DOI 10.1001/JAMA.2013.13805; Balasubramaniam Meera, 2012, Front Psychiatry, V3, P117, DOI 10.3389/fpsyt.2012.00117; Bandura A, 1998, PSYCHOL HEALTH, V13, P623, DOI 10.1080/08870449808407422; BANDURA A, 1977, PSYCHOL REV, V84, P191, DOI 10.1037/0033-295X.84.2.191; Barth J, 2004, PSYCHOSOM MED, V66, P802, DOI 10.1097/01.psy.0000146332.53619.b2; BECK AT, 1991, AM PSYCHOL, V46, P368, DOI 10.1037/0003-066X.46.4.368; Beck AT, 1996, J PERS ASSESS, V67, P588, DOI 10.1207/s15327752jpa6703_13; Belisario JSM, 2015, COCHRANE DB SYST REV, DOI 10.1002/14651858.MR000042.pub2; Bentley SM, 2014, MED CLIN N AM, V98, P981, DOI 10.1016/j.mcna.2014.06.013; Bertisch SM, 2009, J PSYCHOSOM RES, V66, P511, DOI 10.1016/j.jpsychores.2008.12.003; Birdee GS, 2008, J GEN INTERN MED, V23, P1653, DOI 10.1007/s11606-008-0735-5; Bonura KB, 2014, J PHYS ACT HEALTH, V11, P1334, DOI 10.1123/jpah.2012-0365; Bos FM, 2015, EUR NEUROPSYCHOPHARM, V25, P1853, DOI 10.1016/j.euroneuro.2015.08.008; Boutron I, 2008, ANN INTERN MED, V148, P295, DOI 10.7326/0003-4819-148-4-200802190-00008; Broota A, 1990, J CLIN STUD; Brown RP, 2005, J ALTERN COMPLEM MED, V11, P189, DOI 10.1089/acm.2005.11.189; Bschor T, 2016, EXPERT REV NEUROTHER, V16, P367, DOI 10.1586/14737175.2016.1155985; Butler LD, 2008, J CLIN PSYCHOL, V64, P806, DOI 10.1002/jclp.20496; Buttner MM, 2015, COMPLEMENT THER CLIN, V21, P94, DOI 10.1016/j.ctcp.2015.03.003; Button KS, 2013, NAT REV NEUROSCI, V14, P365, DOI 10.1038/nrn3475; Cabral Patricia, 2011, Prim Care Companion CNS Disord, V13, DOI 10.4088/PCC.10r01068; Canadian Agency for Drugs and Technologies in Health, 2015, YOG TREATM POSTTR ST; Casacalenda N, 2002, AM J PSYCHIAT, V159, P1354, DOI 10.1176/appi.ajp.159.8.1354; Celada P, 2004, J PSYCHIATR NEUROSCI, V29, P252; Clarke Tainya C, 2015, Natl Health Stat Report, P1; COHEN J, 1992, PSYCHOL BULL, V112, P155, DOI 10.1037/0033-2909.112.1.155; Connolly KR, 2011, DRUGS, V71, P43, DOI 10.2165/11587620-000000000-00000; Cooper AA, 2015, CLIN PSYCHOL REV, V40, P57, DOI 10.1016/j.cpr.2015.05.001; Cramer H, 2016, AM J PREV MED, V50, P230, DOI 10.1016/j.amepre.2015.07.037; Cramer H, 2015, AM J EPIDEMIOL, V182, P281, DOI 10.1093/aje/kwv071; Cramer H, 2013, DEPRESS ANXIETY, V30, P1068, DOI 10.1002/da.22166; Cramer H, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075515; CRUM RM, 1993, JAMA-J AM MED ASSOC, V269, P2386, DOI 10.1001/jama.269.18.2386; Cuijpers P, 2010, BRIT J PSYCHIAT, V196, P173, DOI 10.1192/bjp.bp.109.066001; da Silva TL, 2009, ASIAN J PSYCHIATR, V2, P6, DOI 10.1016/j.ajp.2008.12.002; Das M, 2016, FRONT PEDIATR, V4, DOI 10.3389/fped.2016.00062; Davis K, 2015, COMPLEMENT THER CLIN, V21, P166, DOI 10.1016/j.ctcp.2015.06.005; De Maat S, 2006, PSYCHOTHER RES, V16, P562, DOI 10.1080/10503300600756402; de Sousa RT, 2015, CURR NEUROPHARMACOL, V13, P616, DOI 10.2174/1570159X13666150630173522; Deshpande Sudheer, 2009, Int J Yoga, V2, P13, DOI 10.4103/0973-6131.43287; Dhar AK, 2016, FRONT PSYCHIATRY, V7, DOI 10.3389/fpsyt.2016.00033; Dimidjian S, 2011, ANNU REV CLIN PSYCHO, V7, P1, DOI 10.1146/annurev-clinpsy-032210-104535; Driessen E, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0137864; Dunlop BW, 2012, TRIALS, V13, DOI 10.1186/1745-6215-13-106; Dunn AL, 2005, AM J PREV MED, V28, P1, DOI 10.1016/j.amepre.2004.09.003; Edlund MJ, 2002, AM J PSYCHIAT, V159, P845, DOI 10.1176/appi.ajp.159.5.845; Ekers D, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0100100; Ekkekakis P, 2015, MENT HEALTH PHYS ACT, V8, P21, DOI 10.1016/j.mhpa.2014.12.001; Epel E, 2009, ANN NY ACAD SCI, V1172, P34, DOI 10.1111/j.1749-6632.2009.04414.x; Fernandes R, 2005, NAT I MENT HLTH SUMM; Ferreira-Vorkapic C., 2015, EVID-BASED COMPL ALT, V2015, P1; Field T, 2013, J BODYW MOV THER, V17, P397, DOI 10.1016/j.jbmt.2013.03.010; Field T, 2013, COMPLEMENT THER CLIN, V19, P6, DOI 10.1016/j.ctcp.2012.10.001; Field T, 2012, J BODYW MOV THER, V16, P204, DOI 10.1016/j.jbmt.2011.08.002; Fishbein D, 2014, J ALTERN COMPLEM MED, V20, pA21, DOI DOI 10.1089/ACM.2014.5052.ABSTRACT; Flint J, 2015, Psychol Med, V45, P439, DOI 10.1017/S0033291714001421; FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6; Fournier JC, 2010, JAMA-J AM MED ASSOC, V303, P47, DOI 10.1001/jama.2009.1943; Freedland KE, 2015, JAMA INTERN MED, V175, P1773, DOI 10.1001/jamainternmed.2015.5220; Gaynes BN, 2008, CLEV CLIN J MED, V75, P57, DOI 10.3949/ccjm.75.1.57; Gong H, 2015, BMC PSYCHIATRY, V15, DOI 10.1186/s12888-015-0393-1; Gonzalez HM, 2010, ARCH GEN PSYCHIAT, V67, P37, DOI 10.1001/archgenpsychiatry.2009.168; Hedden S, 2015, NSDUH SER H, V50; Hillhouse TM, 2015, EXP CLIN PSYCHOPHARM, V23, P1, DOI 10.1037/a0038550; Hofmann M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079809; Holden SC, 2015, BIRTH-ISS PERINAT C, V42, P261, DOI 10.1111/birt.12177; Huynh Nhu N, 2008, Prim Care Companion J Clin Psychiatry, V10, P91; Israel JA, 2010, PHARMACEUTICALS, V3, P2426, DOI 10.3390/ph3082426; Iyengar B. K. S, 1979, LIGHT YOGA YOGA DIPI; Jacobs TL, 2011, PSYCHONEUROENDOCRINO, V36, P664, DOI 10.1016/j.psyneuen.2010.09.010; Jain FA, 2015, PSYCHOSOMATICS, V56, P140, DOI 10.1016/j.psym.2014.10.007; Jain S, 2007, ANN BEHAV MED, V33, P11, DOI 10.1207/s15324796abm3301_2; Janakiramaiah N, 2000, J AFFECT DISORDERS, V57, P255, DOI 10.1016/S0165-0327(99)00079-8; Javnbakht M, 2009, Complement Ther Clin Pract, V15, P102, DOI 10.1016/j.ctcp.2009.01.003; Khan A, 2002, J CLIN PSYCHOPHARM, V22, P40, DOI 10.1097/00004714-200202000-00007; Khin NA, 2011, J CLIN PSYCHIAT, V72, P464, DOI 10.4088/JCP.10m06191; Khumar S, 1993, INDIAN J CLIN PSYCH; Kingston T, 2007, PSYCHOL PSYCHOTHER-T, V80, P193, DOI 10.1348/147608306X116016; Kinser PA, 2014, ARCH PSYCHIAT NURS, V28, P377, DOI 10.1016/j.apnu.2014.08.014; Kinser PA, 2013, ARCH PSYCHIAT NURS, V27, P137, DOI 10.1016/j.apnu.2013.01.003; Kinser PA, 2013, EVID-BASED COMPL ALT, V2013, DOI 10.1155/2013/140467; Kinser PA, 2012, EXPLORE-NY, V8, P118, DOI 10.1016/j.explore.2011.12.005; Kirsch I, 2008, PLOS MED, V5, P260, DOI 10.1371/journal.pmed.0050045; Kovacic T, 2011, J ALTERN COMPLEM MED, V17, P1157, DOI 10.1089/acm.2010.0653; Krishnamurthy MN, 2007, J GERONTOL NURS, V33, P17, DOI 10.3928/00989134-20070201-05; Lakens D, 2013, FRONT PSYCHOL, V4, DOI 10.3389/fpsyg.2013.00863; Lavretsky H, 2013, INT J GERIATR PSYCH, V28, P57, DOI 10.1002/gps.3790; Lee SW, 2004, J GEN INTERN MED, V19, P760, DOI 10.1111/j.1525-1497.2004.30011.x; Lichtman JH, 2014, CIRCULATION, V129, P1350, DOI 10.1161/CIR.0000000000000019; Lin P, 2005, ANN BEHAV MED, V30, P164, DOI 10.1207/s15324796abm3002_9; Luszczynska A, 2005, J PSYCHOL, V139, P439, DOI 10.3200/JRLP.139.5.439-457; MacCoon DG, 2012, BEHAV RES THER, V50, P3, DOI 10.1016/j.brat.2011.10.011; Masand PS, 2003, CLIN THER, V25, P2289, DOI 10.1016/S0149-2918(03)80220-5; McGrath CL, 2014, BIOL PSYCHIAT, V76, P527, DOI 10.1016/j.biopsych.2013.12.005; McGrath CL, 2013, JAMA PSYCHIAT, V70, P821, DOI 10.1001/jamapsychiatry.2013.143; Meijer A, 2011, GEN HOSP PSYCHIAT, V33, P203, DOI 10.1016/j.genhosppsych.2011.02.007; Mitchell J., 2012, PSYCHOLOGY, V3, P782, DOI DOI 10.4236/PSYCH.2012.329118; Mittal VA, 2011, PSYCHIAT RES, V189, P158, DOI 10.1016/j.psychres.2011.06.006; Mohr DC, 2006, ANN BEHAV MED, V32, P254, DOI 10.1207/s15324796abm3203_12; Moradveisi L, 2014, J BEHAV THER EXP PSY, V45, P170, DOI 10.1016/j.jbtep.2013.10.003; Moradveisi L, 2013, BRIT J PSYCHIAT, V202, P204, DOI 10.1192/bjp.bp.112.113696; Mota-Pereira J, 2011, J PSYCHIATR RES, V45, P1005, DOI 10.1016/j.jpsychires.2011.02.005; Nagarathna R, 2001, YOGA ANXIETY DEPRESS; Newham JJ, 2014, DEPRESS ANXIETY, V31, P631, DOI 10.1002/da.22268; Olfson M, 2009, PSYCHIAT SERV, V60; ORETZKY S, 2007, DISS ABSTR INT B, V67, P5458; Park M, 2013, GEN HOSP PSYCHIAT, V35, P217, DOI 10.1016/j.genhosppsych.2013.01.006; Parks SE, 2014, MMWR SURVEILL SUMM, V63, P1; Pascoe MC, 2015, J PSYCHIATR RES, V68, P270, DOI 10.1016/j.jpsychires.2015.07.013; Pence BW, 2012, CURR PSYCHIAT REP, V14, P328, DOI 10.1007/s11920-012-0274-y; Phillips ML, 2015, AM J PSYCHIAT, V172, P124, DOI 10.1176/appi.ajp.2014.14010076; Pilkington K, 2005, J AFFECT DISORDERS, V89, P13, DOI 10.1016/j.jad.2005.08.013; Purohit MP, 2013, J CLIN PSYCHIAT, V74, pE520, DOI 10.4088/JCP.12m08246; Quitkin FM, 2005, J CLIN PSYCHIAT, V66, P670, DOI 10.4088/JCP.v66n0601; Ramsey AT, 2016, J TECHNOL HUMAN SERV, V34, P209, DOI 10.1080/15228835.2016.1170649; Reeves GM, 2012, J AFFECT DISORDERS, V138, P123, DOI 10.1016/j.jad.2011.12.003; Rethorst CD, 2013, J PSYCHIATR PRACT, V19, P204, DOI 10.1097/01.pra.0000430504.16952.3e; Rethorst CD, 2009, SPORTS MED, V39, P491, DOI 10.2165/00007256-200939060-00004; Roberson AM, 2015, J CLIN PSYCHIAT; Rohini V., 2000, NIMHANS J, V18, P53; Rosenberg M., 1965, SOC ADOLESCENT SELF, DOI 10.1515/9781400876136; Ross A, 2010, J ALTERN COMPLEM MED, V16, P3, DOI 10.1089/acm.2009.0044; Rush AJ, 2009, CNS DRUGS, V23, P627, DOI 10.2165/00023210-200923080-00001; Rutherford BR, 2010, CURR PSYCHIATRY REV, V6, P1, DOI 10.2174/157340010790596571; Saper RB, 2004, ALTERN THER HEALTH M, V10, P44; Sarubin N, 2014, J PSYCHIATR RES, V53, P76, DOI 10.1016/j.jpsychires.2014.02.022; Satchidananda Patanjali, 2012, YOGA SUTRAS PATANJAL; Satyapriya M, 2013, COMPLEMENT THER CLIN, V19, P230, DOI 10.1016/j.ctcp.2013.06.003; Schuver KJ, 2016, COMPLEMENT THER MED, V26, P85, DOI 10.1016/j.ctim.2016.03.003; Schwarzer R., 1995, MEASURES HLTH PSYCHO, P35, DOI DOI 10.1037/T00393-000; Scult Matthew, 2015, Adv Mind Body Med, V29, P26; Sethi Jaspal Kaur, 2013, J Educ Health Promot, V2, P55, DOI 10.4103/2277-9531.119043; Shahidi M, 2011, INT J GERIATR PSYCH, V26, P322, DOI 10.1002/gps.2545; Sharf J, 2010, PSYCHOTHERAPY, V47, P637, DOI 10.1037/a0021175; Sharma V K, 2005, Indian J Physiol Pharmacol, V49, P462; Sheehan DV, 2010, J CLIN PSYCHIAT, V71, P313, DOI 10.4088/JCP.09m05305whi; Sheehan DV, 1998, J CLIN PSYCHIAT, V59, P34, DOI 10.4088/JCP.09m05305whi; Simon G, 2010, PSYCHIAT SERV, V61; Sinclair SJ, 2010, EVAL HEALTH PROF, V33, P56, DOI 10.1177/0163278709356187; Sirey JA, 2001, AM J PSYCHIAT, V158, P479, DOI 10.1176/appi.ajp.158.3.479; Steer RA, 2001, PSYCHOL REP, V88, P1075, DOI 10.2466/PR0.88.3.1075-1076; Stewart JG, 2012, J AFFECT DISORDERS, V137, P87, DOI 10.1016/j.jad.2011.12.015; Strauss C, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0096110; Streeter CC, 2012, MED HYPOTHESES, V78, P571, DOI 10.1016/j.mehy.2012.01.021; Stussman Barbara J, 2015, Natl Health Stat Report, P1; Svatmarama S, 1987, HATHAYOGAPRADIPIKA H; Swift JK, 2011, J CLIN PSYCHOL, V67, P155, DOI 10.1002/jclp.20759; Taspinar B, 2014, COMPLEMENT THER MED, V22, P433, DOI 10.1016/j.ctim.2014.03.007; Telles S, 2013, CHILD ADOL PSYCH MEN, V7, DOI 10.1186/1753-2000-7-37; Thase ME, 2003, J CLIN PSYCHIAT, V64, P3; Thase ME, 2007, AM J PSYCHIAT, V164, P739, DOI 10.1176/appi.ajp.164.5.739; Torous J, 2015, JMIR MENT HEALTH, V2, DOI 10.2196/mental.3889; Trivedi MH, 2004, PSYCHOL MED, V34, P73, DOI 10.1017/S0033291703001107; Turner Erick H, 2008, N Engl J Med, V358, P252, DOI 10.1056/NEJMsa065779; Uebelacker LA, 2015, ARCH WOMENS MENT HLT; Uebelacker LA, 2010, J PSYCHIATR PRACT, V16, P22, DOI 10.1097/01.pra.0000367775.88388.96; Uher R, 2011, J CLIN PSYCHIAT, V72, P1478, DOI 10.4088/JCP.10m06419; Upchurch DM, 2010, J WOMENS HEALTH, V19, P23, DOI 10.1089/jwh.2008.1096; van Aalderen JR, 2012, PSYCHOL MED, V42, P989, DOI 10.1017/S0033291711002054; VEALE D, 1992, J ROY SOC MED, V85, P541; Vedamurthachar A, 2006, J AFFECT DISORDERS, V94, P249, DOI 10.1016/j.jad.2006.04.025; Waelde LC, 2004, J CLIN PSYCHOL, V60, P677, DOI 10.1002/jclp.10259; Wang YP, 2013, REV BRAS PSIQUIATR, V35, P416, DOI 10.1590/1516-4446-2012-1048; Warden D, 2009, J PSYCHIATR PRACT, V15, P113, DOI 10.1097/01.pra.0000348364.88676.83; Wichers M, 2011, ACTA PSYCHIAT SCAND, V124, P262, DOI 10.1111/j.1600-0447.2011.01749.x; WIERZBICKI M, 1993, PROF PSYCHOL-RES PR, V24, P190, DOI 10.1037/0735-7028.24.2.190; Wiles N, 2014, HLTH TECHNOL ASSESS, V18; Wolsko PM, 2004, J GEN INTERN MED, V19, P43, DOI 10.1111/j.1525-1497.2004.21019.x; Woolery A, 2004, ALTERN THER HEALTH M, V10, P60; World Health Organization, 2005, HDB GOOD CLIN RES PR; Zhang XP, 2005, AM J EPIDEMIOL, V161, P652, DOI 10.1093/aje/kwi089	178	59	62	0	34	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 16	2017	12	3							e0173869	10.1371/journal.pone.0173869	http://dx.doi.org/10.1371/journal.pone.0173869			36	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EN9KE	28301561	gold, Green Published, Green Submitted			2022-12-27	WOS:000396318300087
J	Foster, WJ; Danise, S; Price, GD; Twitchett, RJ				Foster, William J.; Danise, Silvia; Price, Gregory D.; Twitchett, Richard J.			Subsequent biotic crises delayed marine recovery following the late Permian mass extinction event in northern Italy	PLOS ONE			English	Article							U-PB AGES; SOUTHERN ALPS; TRIASSIC BOUNDARY; AMMONOID BIOCHRONOZONES; ORGANIC-CARBON; WESTERN TETHYS; LOW-OXYGEN; DOLOMITES; PERTURBATIONS; ASSEMBLAGES	The late Permian mass extinction event was the largest biotic crisis of the Phanerozoic and has the longest recovery interval of any extinction event. It has been hypothesised that subsequent carbon isotope perturbations during the Early Triassic are associated with biotic crises that impeded benthic recovery. We test this hypothesis by undertaking the highest-resolution study yet made of the rock and fossil records of the entire Werfen Formation, Italy. Here, we show that elevated extinction rates were recorded not only in the Dienerian, as previously recognised, but also around the Smithian/Spathian boundary. Functional richness increases across the Smithian/Spathian boundary associated with elevated origination rates in the lower Spathian. The taxonomic and functional composition of benthic faunas only recorded two significant changes: (1) reduced heterogeneity in the Dienerian, and (2) and a faunal turnover across the Smithian/Spathian boundary. The elevated extinctions and compositional shifts in the Dienerian and across the Smithian/Spathian boundary are associated with a negative and positive isotope excursion, respectively, which supports the hypothesis that subsequent biotic crises are associated with carbon isotope shifts. The Spathian fauna represents a more advanced ecological state, not recognised in the previous members of the Werfen Formation, with increased habitat differentiation, a shift in the dominant modes of life, appearance of stenohaline taxa and the occupation of the erect and infaunal tiers. In addition to subsequent biotic crises delaying the recovery, therefore, persistent environmental stress limited the ecological complexity of benthic recovery prior to the Spathian.	[Foster, William J.] Univ Texas Austin, Jackson Sch Geosci, Austin, TX 78712 USA; [Danise, Silvia; Price, Gregory D.] Univ Plymouth, Earth Sci, Plymouth, Devon, England; [Danise, Silvia] Univ Georgia, Dept Geol, Athens, GA 30602 USA; [Twitchett, Richard J.] Nat Hist Museum, Dept Earth Sci, London, England	University of Texas System; University of Texas Austin; University of Plymouth; University System of Georgia; University of Georgia; Natural History Museum London	Foster, WJ (corresponding author), Univ Texas Austin, Jackson Sch Geosci, Austin, TX 78712 USA.	w.j.foster@gmx.co.uk	Price, Gregory/AAC-1801-2020	Price, Gregory/0000-0002-2461-7465; Foster, William/0000-0002-9595-8195; Danise, Silvia/0000-0002-6098-609X	Natural Environment Research Council [NE/I005641]; Natural Environment Research Council [NE/I005641/2, 1244831] Funding Source: researchfish; NERC [NE/I005641/2] Funding Source: UKRI	Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))	Support was provided by the Natural Environment Research Council, grant awarded to RJT NE/I005641.	Algeo TJ, 2010, GEOLOGY, V38, P1023, DOI 10.1130/G31203.1; [Anonymous], 1985, GEOLOGISCH PALAONTOL; Bambach RK, 2007, PALAEONTOLOGY, V50, P1, DOI 10.1111/j.1475-4983.2006.00611.x; BAUMILLER TK, 1995, LETHAIA, V28, P221, DOI 10.1111/j.1502-3931.1995.tb01425.x; Beatty TW, 2008, GEOLOGY, V36, P771, DOI 10.1130/G24952A.1; Berner RA, 2005, GEOCHIM COSMOCHIM AC, V69, P3211, DOI 10.1016/j.gca.2005.03.021; Blakey R, 2012, GLOBAL PALEOGEOGRAPH; Broglio Longs C., 1990, MEM SCI GEOL, V42, P41; Broglio Loriga C, 1986, MEMORIE SCI GEOLOGIC, V38, P245; Broglio Loriga C., 1986, RIV ITAL PALEONTOL S, V92, P89; Burgess SD, 2014, P NATL ACAD SCI USA, V111, P3316, DOI 10.1073/pnas.1317692111; Clapham ME, 2007, P NATL ACAD SCI USA, V104, P12971, DOI 10.1073/pnas.0705280104; Clarke K. R., 2002, CHANGE MARINE COMMUN; Clarkson MO, 2016, NATURE COMMUNICATION, P7; Farabegoli E, 2007, GLOBAL PLANET CHANGE, V55, P109, DOI 10.1016/j.gloplacha.2006.06.009; Foster WJ, 2015, PALAEOGEOGR PALAEOCL, V440, P374, DOI 10.1016/j.palaeo.2015.09.004; Foster WJ, 2014, NAT GEOSCI, V7, P233, DOI [10.1038/ngeo2079, 10.1038/NGEO2079]; Foster WJ, 2016, J SYSTEMATIC PALAEON; Galfetti T, 2007, EARTH PLANET SC LETT, V258, P593, DOI 10.1016/j.epsl.2007.04.023; Geyer Gerd, 2005, Palaeontologische Zeitschrift, V79, P429; Gianolla P., 1998, MESOZOIC CENOZOIC SE, V60, DOI DOI 10.2110/PEC.98.02.0719; GLAZEK J, 1968, B ACAD POL SCI GEO G, V16, P91; Grasby SE, 2016, GEOL MAG, V153, P285, DOI 10.1017/S0016756815000436; Greene SE, 2011, PALAEOGEOGR PALAEOCL, V308, P224, DOI 10.1016/j.palaeo.2010.08.019; Groves JR, 2007, J PALEONTOL, V81, P415, DOI 10.1666/05123.1; Hausmann IM, 2015, LETHAIA, V48, P235, DOI 10.1111/let.12102; Hofmann R, 2015, LETHAIA, V48, P474, DOI 10.1111/let.12121; Hofmann R, 2014, PALAEONTOLOGY, V57, P547, DOI 10.1111/pala.12076; Hofmann R, 2011, PALAEOGEOGR PALAEOCL, V310, P216, DOI 10.1016/j.palaeo.2011.07.014; Horacek M, 2007, PALAEOGEOGR PALAEOCL, V252, P347, DOI 10.1016/j.palaeo.2006.11.049; Horacek M, 2010, PALAEOGEOGR PALAEOCL, V290, P65, DOI 10.1016/j.palaeo.2010.02.016; Jost L, 2007, ECOLOGY, V88, P2427, DOI 10.1890/06-1736.1; Kaim A, 2011, PALAEOGEOGR PALAEOCL, V308, P190, DOI 10.1016/j.palaeo.2010.04.008; Kraus SH, 2009, FOSS REC, V12, P197, DOI 10.1002/mmng.200900007; Lehrmann DJ, 2006, GEOLOGY, V34, P1053, DOI 10.1130/G22827A.1; Loriga C Broglio, 1983, RIV ITAL PALEONTOL S, V88, P45; Lucas SG, 2010, GEOL SOC SPEC PUBL, V334, P1, DOI 10.1144/SP334.1; Metcalfe B, 2011, PALAEOGEOGR PALAEOCL, V308, P171, DOI 10.1016/j.palaeo.2010.09.011; Nakazawa K., 1977, J PALAEONTOL SOC IND, V20, P191; Nutzel A, 2005, FACIES, V51, P480, DOI 10.1007/s10347-005-0074-5; Nutzel A, 2005, ACTA PALAEONTOL POL, V50, P19; Oji T, 2015, ZOOL SCI, V32, P211, DOI 10.2108/zs140240; Ovtcharova M, 2006, EARTH PLANET SC LETT, V243, P463, DOI 10.1016/j.epsl.2006.01.042; Payne JL, 2004, SCIENCE, V305, P506, DOI 10.1126/science.1097023; PERRI M C, 1991, Bollettino della Societa Paleontologica Italiana, V30, P23; Perri MC, 2003, COUR FOR SEKENBG, V245, P281; Pietsch C, 2016, PALAEOGEOGR PALAEOCL, V451, P183, DOI 10.1016/j.palaeo.2016.02.056; Pietsch C, 2014, PALAEOGEOGR PALAEOCL, V399, P98, DOI 10.1016/j.palaeo.2014.02.011; POSENATO R, 1992, ECLOGAE GEOL HELV, V85, P893; POSENATO R., 1985, ATT 3 S EC PAL COM B, P141; Posenato R, 2008, PALAEOGEOGR PALAEOCL, V261, P145, DOI 10.1016/j.palaeo.2008.01.006; Posenato R, 2014, PALAEOGEOGR PALAEOCL, V399, P373, DOI 10.1016/j.palaeo.2014.01.028; Posenato R, 2009, PALAEOGEOGR PALAEOCL, V280, P150, DOI 10.1016/j.palaeo.2009.06.009; Posenato R, 2008, EARTH-SCI REV, V91, P93, DOI 10.1016/j.earscirev.2008.09.001; Scholger R, 2000, EARTH PLANET SC LETT, V176, P495, DOI 10.1016/S0012-821X(00)00026-1; Shen SZ, 2011, SCIENCE, V334, P1367, DOI 10.1126/science.1213454; Siegert S, 2011, FOSS REC, V14, P207, DOI 10.1002/mmng.201100008; Stanley SM, 2016, P NATL ACAD SCI USA, V113, pE6325, DOI 10.1073/pnas.1613094113; Sun YD, 2015, PALAEOGEOGR PALAEOCL, V427, P62, DOI 10.1016/j.palaeo.2015.03.038; Sun YD, 2012, SCIENCE, V338, P366, DOI 10.1126/science.1224126; Twitchett RJ, 2007, PALAEOGEOGR PALAEOCL, V252, P132, DOI 10.1016/j.palaeo.2006.11.038; Twitchett RJ, 2006, PALAEOGEOGR PALAEOCL, V232, P190, DOI 10.1016/j.palaeo.2005.05.019; Twitchett RJ, 2004, GEOLOGY, V32, P805, DOI 10.1130/G20585.1; Twitchett RJ, 1996, PALAEOGEOGR PALAEOCL, V124, P137, DOI 10.1016/0031-0182(96)00008-9; Twitchett RJ, 1999, PALAEOGEOGR PALAEOCL, V154, P27, DOI 10.1016/S0031-0182(99)00085-1; Velledits F, 2011, RIV ITAL PALEONTOL S, V117, P221, DOI 10.13130/2039-4942/5973; Villeger S, 2010, ECOL APPL, V20, P1512, DOI 10.1890/09-1310.1; Wheeley JR, 2005, LETHAIA, V38, P37, DOI 10.1080/0024116051003150; Wignall PB, 2001, EARTH-SCI REV, V53, P1, DOI 10.1016/S0012-8252(00)00037-4; Wignall PB, 1996, SCIENCE, V272, P1155, DOI 10.1126/science.272.5265.1155; Yin HF, 2001, EPISODES, V24, P102; Zanche V, 1981, GEOL PALAONT MITT IN, V10, P289; Zaton M, 2013, J PALEONTOL, V87, P159, DOI 10.1666/12-060R.1; Zhang L, 2015, BIOGEOSCIENCES, V12, P1597, DOI 10.5194/bg-12-1597-2015	74	45	45	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 15	2017	12	3							e0172321	10.1371/journal.pone.0172321	http://dx.doi.org/10.1371/journal.pone.0172321			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN9HQ	28296886	Green Published, gold, Green Submitted			2022-12-27	WOS:000396311700006
J	Haga, PT; Pizzichelli, G; Mortensen, M; Kuchta, M; Pahlavian, SH; Sinibaldi, E; Martin, BA; Mardal, KA				Haga, Per Thomas; Pizzichelli, Giulia; Mortensen, Mikael; Kuchta, Miroslav; Pahlavian, Soroush Heidari; Sinibaldi, Edoardo; Martin, Bryn A.; Mardal, Kent-Andre			A numerical investigation of intrathecal isobaric drug dispersion within the cervical subarachnoid space	PLOS ONE			English	Article							ANATOMICAL FINE-STRUCTURE; CEREBROSPINAL-FLUID; SPINAL-ANESTHESIA; BACLOFEN; FLOW; DELIVERY; THERAPY; BRAIN; BOLUS; CNS	Intrathecal drug and gene vector delivery is a procedure to release a solute within the cerebrospinal fluid. This procedure is currently used in clinical practice and shows promise for treatment of several central nervous system pathologies. However, intrathecal delivery protocols and systems are not yet optimized. The aim of this study was to investigate the effects of injection parameters on solute distribution within the cervical subarachnoid space using a numerical platform. We developed a numerical model based on a patient-specific three dimensional geometry of the cervical subarachnoid space with idealized dorsal and ventral nerve roots and denticulate ligament anatomy. We considered the drug as massless particles within the flow field and with similar properties as the CSF, and we analyzed the effects of anatomy, catheter position, angle and injection flow rate on solute distribution within the cerebrospinal fluid by performing a series of numerical simulations. Results were compared quantitatively in terms of drug peak concentration, spread, accumulation rate and appearance instant over 15 seconds following the injection. Results indicated that solute distribution within the cervical spine was altered by all parameters investigated within the time range analyzed following the injection. The presence of spinal cord nerve roots and denticulate ligaments increased drug spread by 60% compared to simulations without these anatomical features. Catheter position and angle were both found to alter spread rate up to 86%, and catheter flow rate altered drug peak concentration up to 78%. The presented numerical platform fills a first gap towards the realization of a tool to parametrically assess and optimize intrathecal drug and gene vector delivery protocols and systems. Further investigation is needed to analyze drug spread over a longer clinically relevant time frame.	[Haga, Per Thomas; Mortensen, Mikael; Mardal, Kent-Andre] Simula Res Lab, Ctr Biomed Comp, Fornebu, Norway; [Pizzichelli, Giulia; Sinibaldi, Edoardo] Ist Italiano Tecnol, Ctr MicrobioRobot, Pontedera, Italy; [Pizzichelli, Giulia] Scuola Super Sant Anna, BioRobot Inst, Pontedera, Italy; [Mortensen, Mikael; Kuchta, Miroslav; Mardal, Kent-Andre] Univ Oslo, Dept Math, Oslo, Norway; [Pahlavian, Soroush Heidari] Univ Akron, Dept Mech Engn, Conquer Chiari Res Ctr, Akron, OH 44325 USA; [Martin, Bryn A.] Univ Idaho, Dept Biol Engn, Moscow, ID 83843 USA	Istituto Italiano di Tecnologia - IIT; Scuola Superiore Sant'Anna; University of Oslo; University System of Ohio; University of Akron; Idaho; University of Idaho	Martin, BA (corresponding author), Univ Idaho, Dept Biol Engn, Moscow, ID 83843 USA.	brynm@uidaho.edu	Sinibaldi, Edoardo/AAV-9599-2021; Martin, Bryn A./N-6640-2016; Mardal, Kent-Andre/G-8296-2018	Sinibaldi, Edoardo/0000-0002-9755-3431; Martin, Bryn A./0000-0003-1234-7880; Mardal, Kent-Andre/0000-0002-4946-1110; Mortensen, Mikael/0000-0002-3293-7573	National Institute of General Medical Sciences [P20GM103408, 4U54GM104944-04]; University of Idaho, Vandal Ideas Project; American Syringomyelia and Chiari Alliance Project; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P20GM103408] Funding Source: NIH RePORTER	National Institute of General Medical Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); University of Idaho, Vandal Ideas Project; American Syringomyelia and Chiari Alliance Project; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by the National Institute of General Medical Sciences, grants P20GM103408 and 4U54GM104944-04 to BM, the University of Idaho, Vandal Ideas Project to BM and by the American Syringomyelia and Chiari Alliance Project to BM. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Belichenko PV, 2005, MOL GENET METAB, V86, P141, DOI 10.1016/j.ymgme.2005.04.013; Berselli LC, 2014, SIAM J APPL MATH, V74, P40, DOI 10.1137/120903385; Bhatia G, 2013, F1000RES, V2, P1; Bottros MM, 2014, J PAIN RES, V7, P615, DOI 10.2147/JPR.S37591; Calias P, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030341; Cheng S, 2014, J BIOMECH, V47, P2826, DOI 10.1016/j.jbiomech.2014.04.027; CLARK SL, 1983, BRIT J PHARMACOL, V79, P807, DOI 10.1111/j.1476-5381.1983.tb10019.x; De Pinto M, 2015, PAIN PHYSICIAN, V18, pE651; Dickson P, 2007, MOL GENET METAB, V91, P61, DOI 10.1016/j.ymgme.2006.12.012; Dreha-Kulaczewski S, 2015, J NEUROSCI, V35, P2485, DOI 10.1523/JNEUROSCI.3246-14.2015; Dziurzynski K, 2006, CHILD NERV SYST, V22, P270, DOI 10.1007/s00381-004-1129-6; Farhat HI, 2011, NEUROSURGERY, V68, P52, DOI 10.1227/NEU.0b013e318207b20a; Flack SH, 2010, ANESTHESIOLOGY, V112, P165, DOI 10.1097/ALN.0b013e3181c38da5; Gray SJ, 2013, GENE THER, V20, P450, DOI 10.1038/gt.2012.101; Gupta S, 2010, J R SOC INTERFACE, V7, P1195, DOI 10.1098/rsif.2010.0033; Gupta S, 2009, J BIOMECH ENG-T ASME, V131, DOI 10.1115/1.3005171; Heetla HW, 2014, ARCH PHYS MED REHAB, V95, P2199, DOI 10.1016/j.apmr.2014.04.030; Hocking G, 2004, BRIT J ANAESTH, V93, P568, DOI 10.1093/bja/aeh204; Hsu Y, 2012, ANESTH ANALG, V115, P386, DOI 10.1213/ANE.0b013e3182536211; Ianniello S, 2010, J COMPUT PHYS, V229, P1353, DOI 10.1016/j.jcp.2009.10.034; Johanson CE, 2008, FLUIDS BARRIERS CNS, V5, DOI 10.1186/1743-8454-5-10; Jose DA, 2013, KOREAN J PAIN, V26, P336, DOI 10.3344/kjp.2013.26.4.336; Kuttler A, 2010, J PHARMACOKINET PHAR, V37, P629, DOI 10.1007/s10928-010-9184-y; Linninger AA, 2008, J BIOMECH, V41, P2176, DOI 10.1016/j.jbiomech.2008.04.025; McCall TD, 2006, NEUROSURGERY, V59, P634, DOI 10.1227/01.NEU.0000227570.40402.77; Meythaler JM, 2001, STROKE, V32, P2099, DOI 10.1161/hs0901.095682; Morrison C, 2015, NAT BIOTECHNOL, V33, P217, DOI 10.1038/nbt0315-217; Myers MR, 1998, ANAESTHESIA, V53, P151, DOI 10.1046/j.1365-2044.1998.00286.x; Myers MR, 1996, J BIOMECH, V29, P139, DOI 10.1016/0021-9290(95)00043-7; Narouze SN, 2014, PAIN PRACT, V14, P57, DOI 10.1111/papr.12024; Nelissen R. M., 2008, THESIS; Pahlavian SH, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0091888; Papisov MI, 2013, MOL PHARMACEUT, V10, P1522, DOI 10.1021/mp300474m; Perruchoud C, 2010, SWISS MED WEEKL S184, V140; Perruchoud C, 2011, PAIN MED, V12, P571, DOI 10.1111/j.1526-4637.2011.01088.x; Pohl M, 2003, J NEUROL, V250, P1195, DOI 10.1007/s00415-003-0178-1; ROBINSON RA, 1994, ANESTHESIOLOGY, V81, P1053, DOI 10.1097/00000542-199410000-00030; Schuster DJ, 2014, FRONT NEUROANAT, V8, DOI 10.3389/fnana.2014.00066; Soderquist RG, 2010, EXPERT OPIN DRUG DEL, V7, P285, DOI 10.1517/17425240903540205; Stockman HW, 2007, J BIOMECH ENG-T ASME, V129, P666, DOI 10.1115/1.2768112; Stockman HW, 2006, J BIOMECH ENG-T ASME, V128, P106, DOI 10.1115/1.2132372; Stokic DS, 2005, ARCH PHYS MED REHAB, V86, P1801, DOI 10.1016/j.apmr.2005.03.027; Stoverud KH, 2016, COMPUT METHOD BIOMEC, V19, P686, DOI 10.1080/10255842.2015.1058927; Tangen K, 2016, ANN BIOMED ENG, V6, P1; Tangen KM, 2015, J BIOMECH, V48, P2144, DOI 10.1016/j.jbiomech.2015.02.018; Tsai SY, 2007, EXP BRAIN RES, V182, P261, DOI 10.1007/s00221-007-1067-0; Van Damme P, 2014, EXPERT OPIN INV DRUG, V23, P955, DOI 10.1517/13543784.2014.912275; Xie HS, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0122453; Yiallourou TI, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052284	49	15	15	2	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 15	2017	12	3							e0173680	10.1371/journal.pone.0173680	http://dx.doi.org/10.1371/journal.pone.0173680			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN9HQ	28296953	Green Submitted, gold, Green Published			2022-12-27	WOS:000396311700050
J	Kavokin, K				Kavokin, Kirill			Can a hybrid chemical-ferromagnetic model of the avian compass explain its outstanding sensitivity to magnetic noise?	PLOS ONE			English	Article							RADICAL-PAIR MECHANISM; PHOTORECEPTOR-BASED MAGNETORECEPTION; MIGRATORY BIRDS; FIELD; NANOPARTICLES; ANISOTROPY; SPIN	While many properties of the magnetic compass of migratory birds are satisfactory explained within the chemical model of magnetoreception, its extreme sensitivity to radio-frequency magnetic fields remains a mystery. Apparently, this difficulty could be overcome if the magnetoreceptor model were augmented with a magnetite nanoparticle, which would amplify the magnetic field at the position of the magneto-sensitive cryptochrome molecule. However, comparison of the radio-frequency power used in the experiment with intrinsic magnetization noise of such a particle, estimated from the theory of fluctuations, shows that the required sensitivity cannot be reached with realistic parameters of iron-oxide nanocrystals.	[Kavokin, Kirill] St Petersburg State Univ, Spin Opt Lab, St Petersburg, Russia; [Kavokin, Kirill] IM Sechenov Inst Evolutionary Physiol & Biochem R, St Petersburg, Russia	Saint Petersburg State University; Russian Academy of Sciences; Sechenov Institute of Evolutionary Physiology & Biochemistry	Kavokin, K (corresponding author), St Petersburg State Univ, Spin Opt Lab, St Petersburg, Russia.; Kavokin, K (corresponding author), IM Sechenov Inst Evolutionary Physiol & Biochem R, St Petersburg, Russia.	kkavokin@gmail.com	Kavokin, Kirill V/I-7736-2013	Kavokin, Kirill V/0000-0002-0047-5706	Russian Science Foundation [16-14-10159]	Russian Science Foundation(Russian Science Foundation (RSF))	Funded by Russian Science Foundation grant 16-14-10159. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; I am grateful to N.Chernetsov, J.Bojarinova and R.Cherbunin for helpful discussions, to M.Winklhofer for advice on the literature on magnetic particles, and to E.Chernetsova for assistance in preparing figures. This work was supported by grant 16-14-10159 from Russian Science Foundation.	Binhi V, 2008, INT J RADIAT BIOL, V84, P569, DOI 10.1080/09553000802195323; Butler RF, 1992, PALEOMAGNETISM MAGNE; Cai JM, 2012, PHYS REV A, V85, DOI 10.1103/PhysRevA.85.040304; Cai JM, 2011, PHYS REV LETT, V106, DOI 10.1103/PhysRevLett.106.100501; Cao CQ, 2010, J GEOPHYS RES-SOL EA, V115, DOI 10.1029/2009JB006855; Cohen AE, 2009, J PHYS CHEM A, V113, P11084, DOI 10.1021/jp907113p; Dellis AT, 2012, BIOSYSTEMS, V107, P153, DOI 10.1016/j.biosystems.2011.11.007; Gauger EM, 2011, PHYS REV LETT, V106, DOI 10.1103/PhysRevLett.106.040503; Heider F, 1996, PHYS EARTH PLANET IN, V93, P239, DOI 10.1016/0031-9201(95)03071-9; Hiscock HG, 2016, P NATL ACAD SCI USA, V113, P4634, DOI 10.1073/pnas.1600341113; Hore PJ, 2016, ANNU REV BIOPHYS, V45, P299, DOI 10.1146/annurev-biophys-032116-094545; Kattnig DR, 2016, NEW J PHYS, V18, DOI 10.1088/1367-2630/18/6/063007; Kattnig DR, 2016, PHYS CHEM CHEM PHYS, V18, P12443, DOI 10.1039/c5cp06731f; Kattnig DR, 2016, NAT CHEM, V8, P384, DOI [10.1038/NCHEM.2447, 10.1038/nchem.2447]; Kavokin KV, 2009, BIOELECTROMAGNETICS, V30, P402, DOI 10.1002/bem.20485; Kavokin K, 2014, J R SOC INTERFACE, V11, DOI 10.1098/rsif.2014.0451; KIRSCHVINK JL, 1981, BIOSYSTEMS, V13, P181, DOI 10.1016/0303-2647(81)90060-5; Landau LD, 1980, COURSE THEORETICAL P, V3; Landau LD, 1980, COURSE THEORETICAL P, V5; Lee H, 2011, NANO LETT, V11, P5367, DOI 10.1021/nl202950h; Moskowitz BM, 1997, J GEOPHYS RES-SOL EA, V102, P22671, DOI 10.1029/97JB01698; Mouritsen H., 2013, NEUROSCIENCES MOL BE, P427; Mouritsen H, 2012, CURR OPIN NEUROBIOL, V22, P343, DOI 10.1016/j.conb.2012.01.005; Ritz T, 2004, NATURE, V429, P177, DOI 10.1038/nature02534; Ritz T, 2000, BIOPHYS J, V78, P707, DOI 10.1016/S0006-3495(00)76629-X; Ritz T, 2010, J R SOC INTERFACE, V7, pS135, DOI 10.1098/rsif.2009.0456.focus; Ritz T, 2009, BIOPHYS J, V96, P3451, DOI 10.1016/j.bpj.2008.11.072; Rodgers CT, 2009, P NATL ACAD SCI USA, V106, P353, DOI 10.1073/pnas.0711968106; SCHULTEN K, 1978, Z PHYS CHEM NEUE FOL, V111, P1, DOI 10.1524/zpch.1978.111.1.001; Schwarze S, 2016, FRONT BEHAV NEUROSCI, V10, DOI 10.3389/fnbeh.2016.00055; Shcherbakov VP, 2010, PHYS REV E, V81, DOI 10.1103/PhysRevE.81.031921; Thalau P, 2005, NATURWISSENSCHAFTEN, V92, P86, DOI 10.1007/s00114-004-0595-8; TURRO NJ, 1983, P NATL ACAD SCI USA, V80, P609, DOI 10.1073/pnas.80.2.609; Winklhofer M, 1997, J GEOPHYS RES-SOL EA, V102, P22695, DOI 10.1029/97JB01730; Winklhofer M, 2014, GEOCHEM GEOPHY GEOSY, V15, P1558, DOI 10.1002/2013GC005121; Yoon S, 2011, J KOREAN PHYS SOC, V59, P3069, DOI 10.3938/jkps.59.3069	36	5	5	0	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 15	2017	12	3							e0173887	10.1371/journal.pone.0173887	http://dx.doi.org/10.1371/journal.pone.0173887			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN9HQ	28296939	gold, Green Submitted, Green Published			2022-12-27	WOS:000396311700074
J	Khoo, SYS; McNally, GP; Clemens, KJ				Khoo, Shaun Yon-Seng; McNally, Gavan P.; Clemens, Kelly J.			The dual orexin receptor antagonist TCS1102 does not affect reinstatement of nicotine-seeking	PLOS ONE			English	Article							CUE-INDUCED REINSTATEMENT; NEURONS; COCAINE; ACTIVATION; REWARD; HYPOTHALAMUS; ALMOREXANT; MOTIVATION; PREFERENCE; GLUTAMATE	The orexin/hypocretin system is important for appetitive motivation towards multiple drugs of abuse, including nicotine. Both OX1 and OX2 receptors individually have been shown to influence nicotine self-administration and reinstatement. Due to the increasing clinical use of dual orexin receptor antagonists in the treatment of disorders such as insomnia, we examined whether a dual orexin receptor antagonist may also be effective in reducing nicotine seeking. We tested the effect of intracerebroventricular (i.c.v.) administration of the potent and selective dual orexin receptor antagonist TCS1102 on orexin-A-induced food self-administration, nicotine self-administration and reinstatement of nicotine-seeking in rats. Our results show that 30 mu g of TCS1102 i.c.v. abolishes orexin-A-induced increases in food self-administration but does not reduce nicotine self-administration. Neither i.c.v. 10 mu g nor 30 mu g of TCS1102 reduced compound reinstatement after short-term (15 days) self-administration nicotine, but 30 mu g transiently reduced cue/nicotine compound reinstatement after chronic self-administration (29 days). These results indicate that TCS1102 has no substantial effect on motivation for nicotine seeking following chronic self-administration and no effect after shorter periods of intake. Orexin receptor antagonists may therefore have little clinical utility against nicotine addiction.	[Khoo, Shaun Yon-Seng; McNally, Gavan P.; Clemens, Kelly J.] Univ New South Wales, Sch Psychol, Sydney, NSW, Australia	University of New South Wales Sydney	Clemens, KJ (corresponding author), Univ New South Wales, Sch Psychol, Sydney, NSW, Australia.	k.clemens@unsw.edu.au		McNally, Gavan/0000-0001-9061-6463; Khoo, Shaun/0000-0002-0972-3788	National Health & Medical Research Council of Australia [1047899]; Australian Research Council [FT120100250]	National Health & Medical Research Council of Australia(National Health and Medical Research Council (NHMRC) of Australia); Australian Research Council(Australian Research Council)	This work was supported by the National Health & Medical Research Council of Australia (project grant 1047899) and a Future Fellowship to GPM (FT120100250) from the Australian Research Council. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmed SH, 2012, NEUROSCIENCE, V211, P107, DOI 10.1016/j.neuroscience.2011.08.014; Ambrose N, 2000, DEV AN VET, V31, P1159; Anderson RI, 2014, FRONT NEUROSCI-SWITZ, V8, DOI 10.3389/fnins.2014.00033; Asai H, 2009, CLIN NEUROL NEUROSUR, V111, P341, DOI 10.1016/j.clineuro.2008.11.007; Baldo BA, 2003, J COMP NEUROL, V464, P220, DOI 10.1002/cne.10783; Bergman JM, 2008, BIOORG MED CHEM LETT, V18, P1425, DOI 10.1016/j.bmcl.2008.01.001; Bird K. D., 2004, ANAL VARIANCE VIA CO; Borgland SL, 2009, J NEUROSCI, V29, P11215, DOI 10.1523/JNEUROSCI.6096-08.2009; Cahill K, 2016, COCHRANE DB SYST REV, V5, DOI [DOI 10.1002/14651858.CD006103.PUB.7, 10.1002/14651858.CD006103.pub.7]; Chaudhri N, 2006, PSYCHOPHARMACOLOGY, V184, P353, DOI 10.1007/s00213-005-0178-1; Clemens KJ, 2015, ADDICTION BIOL; Danaei G, 2009, PLOS MED, V6, DOI 10.1371/journal.pmed.1000058; De Lecea L, 1998, P NATL ACAD SCI USA, V95, P322, DOI 10.1073/pnas.95.1.322; Deroche-Gamonet V, 2004, SCIENCE, V305, P1014, DOI 10.1126/science.1099020; Furutani N, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062391; Gao XB, 2015, FRONT SYST NEUROSCI, V9, DOI 10.3389/fnsys.2015.00142; Govind AP, 2012, J NEUROSCI, V32, P2227, DOI 10.1523/JNEUROSCI.5438-11.2012; Harris GC, 2005, NATURE, V437, P556, DOI 10.1038/nature04071; Henny P, 2010, NEUROSCIENCE, V169, P1150, DOI 10.1016/j.neuroscience.2010.06.003; Hollander JA, 2008, P NATL ACAD SCI USA, V105, P19480, DOI 10.1073/pnas.0808023105; Hughes JR, 2016, NICOTINE TOB RES, V18, P1299, DOI 10.1093/ntr/ntv137; Huynh C, 2015, ADDICT BIOL, V22, P142; Lawrence AJ, 2006, BRIT J PHARMACOL, V148, P752, DOI 10.1038/sj.bjp.0706789; LeSage MG, 2010, PSYCHOPHARMACOLOGY, V209, P203, DOI 10.1007/s00213-010-1792-0; Lim SS, 2012, LANCET, V380, P2224, DOI 10.1016/S0140-6736(12)61766-8; Lutgen V, 2014, ADDICT BIOL, V19, P529, DOI 10.1111/j.1369-1600.2012.00493.x; Macnamara CL, 2016, NEUROPHARMACOLOGY, V105, P463, DOI 10.1016/j.neuropharm.2016.02.023; Madsen HB, 2015, ADDICT BIOL, V20, P433, DOI 10.1111/adb.12134; Malherbe P, 2009, MOL PHARMACOL, V76, P618, DOI 10.1124/mol.109.055152; Moorman DE, 2017, BRAIN RES, V1654, P34, DOI 10.1016/j.brainres.2016.10.018; Mould R, 2014, BRIT J PHARMACOL, V171, P351, DOI 10.1111/bph.12245; Muschamp JW, 2014, P NATL ACAD SCI USA, V111, pE1648, DOI 10.1073/pnas.1315542111; Pasumarthi RK, 2010, J NEUROCHEM, V113, P1023, DOI 10.1111/j.1471-4159.2010.06666.x; Pasumarthi RK, 2008, BRAIN RES BULL, V77, P367, DOI 10.1016/j.brainresbull.2008.09.014; Pasumarthi RK, 2006, EUR J PHARMACOL, V535, P172, DOI 10.1016/j.ejphar.2006.02.021; Peyron C, 1998, J NEUROSCI, V18, P9996; Plaza-Zabala A, 2013, NEUROPSYCHOPHARMACOL, V38, P1724, DOI 10.1038/npp.2013.72; Plaza-Zabala A, 2012, BIOL PSYCHIAT, V71, P214, DOI 10.1016/j.biopsych.2011.06.025; Porter RA, 2001, BIOORG MED CHEM LETT, V11, P1907, DOI 10.1016/S0960-894X(01)00343-2; Rao Y, 2013, J PHYSIOL-LONDON, V591, P1951, DOI 10.1113/jphysiol.2012.246983; Ripley B, 2001, NEUROLOGY, V57, P2253, DOI 10.1212/WNL.57.12.2253; Sakurai T, 1998, CELL, V92, P573, DOI 10.1016/S0092-8674(00)80949-6; Schenck CH, 2003, SLEEP MED, V4, P251, DOI 10.1016/S1389-9457(02)00257-5; Srinivasan S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044726; Steiner MA, 2013, INT J NEUROPSYCHOPH, V16, P417, DOI 10.1017/S1461145712000193; Uslaner JM, 2014, BEHAV BRAIN RES, V269, P61, DOI 10.1016/j.bbr.2014.04.012; Winrow CJ, 2010, NEUROPHARMACOLOGY, V58, P185, DOI 10.1016/j.neuropharm.2009.07.008; Yeoh JW, 2012, J PHYSIOL-LONDON, V590, P3677, DOI 10.1113/jphysiol.2012.230268	48	8	9	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 15	2017	12	3							e0173967	10.1371/journal.pone.0173967	http://dx.doi.org/10.1371/journal.pone.0173967			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN9HQ	28296947	Green Submitted, Green Published, gold			2022-12-27	WOS:000396311700083
J	MacFarlane, H; Gorman, K; Ingham, R; Hill, AP; Papadakis, K; Kiss, G; van Santen, J				MacFarlane, Heather; Gorman, Kyle; Ingham, Rosemary; Hill, Alison Presmanes; Papadakis, Katina; Kiss, Geza; van Santen, Jan			Quantitative analysis of disfluency in children with autism spectrum disorder or language impairment	PLOS ONE			English	Article							DIAGNOSTIC OBSERVATION SCHEDULE; HIGH-FUNCTIONING AUTISM; PRAGMATIC LANGUAGE; SOCIOECONOMIC-STATUS; ASPERGER-SYNDROME; SPONTANEOUS SPEECH; FIELD TRIAL; COMMUNICATION; SPEAKING; ABILITY	Deficits in social communication, particularly pragmatic language, are characteristic of individuals with autism spectrum disorder (ASD). Speech disfluencies may serve pragmatic functions such as cueing speaking problems. Previous studies have found that speakers with ASD differ from typically developing (TD) speakers in the types and patterns of disfluencies they produce, but fail to provide sufficiently detailed characterizations of the methods used to categorize and quantify disfluency, making cross-study comparison difficult. In this study we propose a simple schema for classifying major disfluency types, and use this schema in an exploratory analysis of differences in disfluency rates and patterns among children with ASD compared to TD and language impaired (SLI) groups. 115 children ages 4-8 participated in the study (ASD = 51; SLI = 20; TD = 44), completing a battery of experimental tasks and assessments. Measures of morphological and syntactic complexity, as well as word and disfluency counts, were derived from transcripts of the Autism Diagnostic Observation Schedule (ADOS). High inter-annotator agreement was obtained with the use of the proposed schema. Analyses showed ASD children produced a higher ratio of content to filler disfluencies than TD children. Relative frequencies of repetitions, revisions, and false starts did not differ significantly between groups. TD children also produced more cued disfluencies than ASD children.	[MacFarlane, Heather; Gorman, Kyle; Ingham, Rosemary; Hill, Alison Presmanes; Papadakis, Katina; Kiss, Geza; van Santen, Jan] Oregon Hlth & Sci Univ, Inst Dev & Disabil, Ctr Spoken Language Understanding, Portland, OR 97201 USA; [Gorman, Kyle; Hill, Alison Presmanes; van Santen, Jan] Oregon Hlth & Sci Univ, Dept Pediat, 3181 Sw Sam Jackson Pk Rd, Portland, OR 97201 USA	Oregon Health & Science University; Oregon Health & Science University	van Santen, J (corresponding author), Oregon Hlth & Sci Univ, Inst Dev & Disabil, Ctr Spoken Language Understanding, Portland, OR 97201 USA.; van Santen, J (corresponding author), Oregon Hlth & Sci Univ, Dept Pediat, 3181 Sw Sam Jackson Pk Rd, Portland, OR 97201 USA.	vansantj@ohsu.edu	; van Santen, Jan/K-2310-2017	Gorman, Kyle/0000-0002-4233-6595; van Santen, Jan/0000-0003-3245-5301; Hill, Alison/0000-0002-8082-1890; Papadakis, Katina/0000-0002-1860-5927; Ingham, Rosemary/0000-0003-1008-3252	National Institute on Deafness and Other Communication Disorders of the National Institutes of Health [R01DC007129, R01DC012033]; Autism Speaks under Innovative Technology for Autism Grant [2407]; Oregon Health and Science University; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC007129, R01DC012033] Funding Source: NIH RePORTER	National Institute on Deafness and Other Communication Disorders of the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); Autism Speaks under Innovative Technology for Autism Grant; Oregon Health and Science University; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	This material is based on work supported by the National Institute on Deafness and Other Communication Disorders of the National Institutes of Health (nidcd.nih.gov) under awards R01DC007129 and R01DC012033, and by Autism Speaks (autismspeaks.org) under Innovative Technology for Autism Grant 2407. All funding was awarded to Jan van Santen at Oregon Health and Science University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams C, 2002, J CHILD PSYCHOL PSYC, V43, P679, DOI 10.1111/1469-7610.00056; Allwood J., 1990, NORD J LINGUIST, V13, P1, DOI [https://doi.org/10.1017/S0332586500002092, DOI 10.1017/S0332586500002092]; American Psychiatric Association, 2013, DIAGNOSTIC AND STATI; American Psychiatric Association, 2000, DIAGNOSTIC AND STATI; Arnold JE, 2003, J PSYCHOLINGUIST RES, V32, P25, DOI 10.1023/A:1021980931292; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Berument SK, 1999, BRIT J PSYCHIAT, V175, P444, DOI 10.1192/bjp.175.5.444; Bishop DVM, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0158753; Bishop DVM, 2008, DEV MED CHILD NEUROL, V50, P341, DOI 10.1111/j.1469-8749.2008.02057.x; Bishop DVM, 2002, J CHILD PSYCHOL PSYC, V43, P917, DOI 10.1111/1469-7610.00114; Bishop DVM, 2003, THE CHILDRENS COMMUN; Bishop DVM, SPEECH AND LANGUAGE, P99; Bortfeld H, 2001, LANG SPEECH, V44, P123, DOI 10.1177/00238309010440020101; Botting N, 2003, DEV MED CHILD NEUROL, V45, P515; Boucher J, 2012, J CHILD PSYCHOL PSYC, V53, P219, DOI 10.1111/j.1469-7610.2011.02508.x; Brennan SE, 2001, J MEM LANG, V44, P274, DOI 10.1006/jmla.2000.2753; Bretz F, 2010, MULTIPLE COMPARISONS; Brown R, 1973, A FIRST LANGUAGE THE; Capps L., 1998, AUTISM, V2, P325, DOI [10.1177/1362361398024002, DOI 10.1177/1362361398024002]; CLARK HH, 1994, SPEECH COMMUN, V15, P243, DOI 10.1016/0167-6393(94)90075-2; Clark HH, 2002, SPEECH COMMUN, V36, P5, DOI 10.1016/S0167-6393(01)00022-X; Cox A, 1999, J CHILD PSYCHOL PSYC, V40, P719, DOI 10.1111/1469-7610.00488; Engelhardt PE, 2013, ACTA PSYCHOL, V144, P424, DOI 10.1016/j.actpsy.2013.08.002; Facon B, 2011, RES DEV DISABIL, V32, P2134, DOI 10.1016/j.ridd.2011.07.029; Geurts HM, 2008, J AUTISM DEV DISORD, V38, P1931, DOI 10.1007/s10803-008-0587-1; Gioia G. A., 2003, BEHAVIOR RATING INVE; Gioia G. A., 2000, BEHAVIOR RATING INVE; Gorman K, 2016, AUTISM RES, V9, P854, DOI 10.1002/aur.1578; Gotham K, 2007, J AUTISM DEV DISORD, V37, P613, DOI 10.1007/s10803-006-0280-1; Guo LY, 2008, J SPEECH LANG HEAR R, V51, P722, DOI 10.1044/1092-4388(2008/051); Hoff E, 2003, CHILD DEV, V74, P1368, DOI 10.1111/1467-8624.00612; Irvine CA, 2016, J AUTISM DEV DISORD, V46, P1061, DOI 10.1007/s10803-015-2651-y; Kenworthy L, 2008, NEUROPSYCHOL REV, V18, P320, DOI 10.1007/s11065-008-9077-7; Kidd C, 2011, DEVELOPMENTAL SCI, V14, P925, DOI 10.1111/j.1467-7687.2011.01049.x; Kim SH, 2014, HDB AUTISM PERVASIVE, P230; Kjelgaard MM, 2001, LANG COGNITIVE PROC, V16, P287, DOI 10.1080/01690960042000058; Klin A, 2000, J AUTISM DEV DISORD, V30, P163, DOI 10.1023/A:1005415823867; Klin A, HANDBOOK OF AUTISM A, P88; Klin A, 2007, J AUTISM DEV DISORD, V37, P748, DOI 10.1007/s10803-006-0229-4; Lake JK, 2011, PSYCHON B REV, V18, P135, DOI 10.3758/s13423-010-0037-x; Landa R., 2000, ASPERGER SYNDROME, P125; LANDIS JR, 1977, BIOMETRICS, V33, P159, DOI 10.2307/2529310; Lee LC, 2007, RES AUTISM SPECT DIS, V1, P126, DOI 10.1016/j.rasd.2006.08.004; Leyfer OT, 2008, AUTISM RES, V1, P284, DOI 10.1002/aur.43; Lickley RJ, 1998, LANG SPEECH, V41, P203, DOI 10.1177/002383099804100204; Lord C, 2000, J AUTISM DEV DISORD, V30, P205, DOI 10.1023/A:1005592401947; Lord C, 1997, HDB ASD PERVASIVE DE, V2, P195; Losh M, 2003, J AUTISM DEV DISORD, V33, P239, DOI 10.1023/A:1024446215446; Loucas T, 2008, J CHILD PSYCHOL PSYC, V49, P1184, DOI 10.1111/j.1469-7610.2008.01951.x; Loukusa S, 2007, J AUTISM DEV DISORD, V37, P1049, DOI 10.1007/s10803-006-0247-2; MacLurg A., 2014, THESIS; McKinnon DH, 2007, LANG SPEECH HEAR SER, V38, P5, DOI 10.1044/0161-1461(2007/002); Miller J, 1985, SYSTEMATIC ANALYSIS; Morley E., 2013, PROCEEDINGS OF THE 8; Morley E, 2014, P 1 WORKSH COMP LING, P69; Paul R, 2009, J AUTISM DEV DISORD, V39, P115, DOI 10.1007/s10803-008-0607-1; Philofsky A, 2007, AM J SPEECH-LANG PAT, V16, P368, DOI 10.1044/1058-0360(2007/040); Pinheiro J, 2001, MIXED EFFECTS MODELS; Prud'hommeaux E, 2012, WORKSH CHILD COMP IN, P1; Pungello EP, 2009, DEV PSYCHOL, V45, P544, DOI 10.1037/a0013917; Reilly S, 2014, INT J LANG COMM DIS, V49, P452, DOI 10.1111/1460-6984.12111; Richels CG, 2013, J COMMUN DISORD, V46, P361, DOI 10.1016/j.jcomdis.2013.07.002; Rispoli M, 2008, J SPEECH LANG HEAR R, V51, P953, DOI 10.1044/1092-4388(2008/070); Royston P, 2011, J STAT SOFTW, V45, P1, DOI 10.18637/jss.v045.i04; Russell RL, 2008, CLIN CHILD FAM PSYCH, V11, P59, DOI 10.1007/s10567-008-0032-1; Rutter M., 2003, SOCIAL COMMUNICATION; Scott KS, 2014, INT J LANG COMM DIS, V49, P75, DOI 10.1111/1460-6984.12048; Semel E, 2004, CLINICAL EVALUATION; Semel E., 2003, CLINICAL EVALUATION; Sharp HM, 2008, PEDIATR CLIN N AM, V55, P1159, DOI 10.1016/j.pcl.2008.07.007; Shriberg Elizabeth Ellen, 1994, THESIS; Shriberg LD, 2011, J AUTISM DEV DISORD, V41, P405, DOI 10.1007/s10803-010-1117-5; Shriberg LD, 2001, J SPEECH LANG HEAR R, V44, P1097, DOI 10.1044/1092-4388(2001/087); Shulman C, 2007, J CHILD LANG, V34, P411, DOI 10.1017/S0305000906007963; SMITH VL, 1993, J MEM LANG, V32, P25, DOI 10.1006/jmla.1993.1002; SPITZER RL, 1990, J AM ACAD CHILD PSY, V29, P855, DOI 10.1097/00004583-199011000-00003; Suh J, 2014, J AUTISM DEV DISORD, V44, P1681, DOI 10.1007/s10803-014-2042-9; Tager-Flusberg H, 2003, PHILOS T R SOC B, V358, P303, DOI 10.1098/rstb.2002.1198; Tager-Flusberg H., 2005, HDB AUTISM PERVASIVE, P335, DOI DOI 10.1002/9780470939345.CH12; Tager-Flusberg H, 2009, J SPEECH LANG HEAR R, V52, P643, DOI 10.1044/1092-4388(2009/08-0136); TagerFlusberg H, 1996, J AUTISM DEV DISORD, V26, P169, DOI 10.1007/BF02172006; Thordardottir ET, 2002, BRAIN COGNITION, V48, P587, DOI 10.1006/brcg.2001.1422; THURBER C, 1993, J AUTISM DEV DISORD, V23, P309, DOI 10.1007/BF01046222; Tomblin B, 2011, INT J LANG COMM DIS, V46, P127, DOI 10.1111/j.1460-6984.2011.00017.x; Tree JEF, 2001, MEM COGNITION, V29, P320, DOI 10.3758/BF03194926; Van Santen, 2010, P 11 ANN M SPEC INT, P249; Volden J, 2010, AM J SPEECH-LANG PAT, V19, P204, DOI 10.1044/1058-0360(2010/09-0011); Volden J, 2009, J AUTISM DEV DISORD, V39, P388, DOI 10.1007/s10803-008-0618-y; Wechsler D., 2003, THE WECHSLER INTELLI; Wechsler D., 2002, WECHSLER PRESCHOOL A; Weismer SE, 2013, FOLIA PHONIATR LOGO, V65, P68, DOI 10.1159/000353896; Whitehouse AJO, 2007, J CHILD PSYCHOL PSYC, V48, P822, DOI 10.1111/j.1469-7610.2007.01765.x; Young EC, 2005, LANG SPEECH HEAR SER, V36, P62, DOI 10.1044/0161-1461(2005/006)	93	12	12	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 15	2017	12	3							e0173936	10.1371/journal.pone.0173936	http://dx.doi.org/10.1371/journal.pone.0173936			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EN9HQ	28296973	Green Submitted, Green Published, gold			2022-12-27	WOS:000396311700080
J	Mikiewicz, D; Bierczynska-Krzysik, A; Sobolewska, A; Stadnik, D; Bogiel, M; Pawlowska, M; Wojtowicz-Krawiec, A; Baran, PA; Lukasiewicz, N; Romanik-Chruscielewska, A; Sokolowska, I; Stadnik, J; Borowicz, P; Plucienniczak, G; Plucienniczak, A				Mikiewicz, Diana; Bierczynska-Krzysik, Anna; Sobolewska, Agnieszka; Stadnik, Dorota; Bogiel, Monika; Pawlowska, Monika; Wojtowicz-Krawiec, Anna; Baran, Piotr A.; Lukasiewicz, Natalia; Romanik-Chruscielewska, Agnieszka; Sokolowska, Iwona; Stadnik, Jacek; Borowicz, Piotr; Plucienniczak, Grazyna; Plucienniczak, Andrzej			Soluble insulin analogs combining rapid- and long-acting hypoglycemic properties - From an efficient E. coli expression system to a pharmaceutical formulation	PLOS ONE			English	Article							SELF-ASSOCIATION; NMR STRUCTURE; DEO OPERON; THERAPY; DEAMIDATION; GLARGINE; PROTEIN; ASPART; PROTRACTION; MECHANISM	The discovery of insulin led to a revolution in diabetes management. Since then, many improvements have been introduced to insulin preparations. The availability of molecular genetic techniques has enabled the creation of insulin analogs by changing the structure of the native protein in order to improve the therapeutic properties. A new expression vector pIBAINS for production of four recombinant human insulin (INS) analogs (GKR, GEKR, AKR, SR) was constructed and overexpressed in the new E. coli 20 strain as a fusion protein with modified human superoxide dismutase (SOD). The SOD gene was used as a signal peptide to enhance the expression of insulin. SOD:: INS was manufactured in the form of insoluble inclusion bodies. After cleavage of the fusion protein with trypsin, the released insulin analogs were refolded and purified by reverse-phase high performance liquid chromatography (RP-HPLC). Elongation of chain A, described here for the first time, considerably improved the stability of the selected analogs. Their identity was confirmed with mass spectrometric techniques. The biological activity of the insulin derivatives was tested on rats with experimental diabetes. The obtained results proved that the new analogs described in this paper have the potential to generate prolonged hypoglycemic activity and may allow for even less frequent subcutaneous administration than once-a-day. When applied, all the analogs demonstrate a rapid onset of action. Such a combination renders the proposed bio-synthetic insulin unique among already known related formulations.	[Mikiewicz, Diana; Bierczynska-Krzysik, Anna; Sobolewska, Agnieszka; Stadnik, Dorota; Bogiel, Monika; Pawlowska, Monika; Wojtowicz-Krawiec, Anna; Baran, Piotr A.; Lukasiewicz, Natalia; Romanik-Chruscielewska, Agnieszka; Sokolowska, Iwona; Stadnik, Jacek; Borowicz, Piotr; Plucienniczak, Grazyna; Plucienniczak, Andrzej] Inst Biotechnol & Antibiot, Staroscinska 5, PL-02516 Warsaw, Poland	Institute of Biotechnology & Antibiotics (IBA)	Mikiewicz, D (corresponding author), Inst Biotechnol & Antibiot, Staroscinska 5, PL-02516 Warsaw, Poland.	mikiewiczd@iba.waw.pl	Romanik, Agnieszka/B-3364-2019; Łukasiewicz, Natalia/B-2574-2019; Romanik-Chruścielewska, Agnieszka/AAW-6799-2020; Baran, Piotr A/Y-6777-2018; Sokolowska, Iwona/B-2751-2019; Bierczynska-Krzysik, Anna/B-8384-2019	Romanik, Agnieszka/0000-0002-8537-5041; Łukasiewicz, Natalia/0000-0003-0250-3165; Baran, Piotr A/0000-0002-4309-1278; Sokolowska, Iwona/0000-0003-1556-7731; Stadnik, Dorota/0000-0003-2864-672X; Mikiewicz, Diana/0000-0002-0954-291X; Stadnik, Jacek/0000-0003-4023-5421; Bierczynska-Krzysik, Anna/0000-0002-2794-3151	European Regional Development Fund [POIG.01.01.02-00-007/08]	European Regional Development Fund(European Commission)	This work was supported by The European Regional Development Fund, POIG.01.01.02-00-007/08. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agency for Healthcare Research and Quality (AHRQ), 2009, AHRQ PUB; [Anonymous], 2011, APPL GUID PA 800 PLU; [Anonymous], 2010, MONOGRAPH; Berti L, 1998, HORM METAB RES, V30, P123, DOI 10.1055/s-2007-978849; Bliss M., 1982, DISCOVERY INSULIN; Bocian W, 2008, BIOPOLYMERS, V89, P820, DOI 10.1002/bip.21018; Borowicz P, 2009, European Patent Application, Patent No. [EP 2 321 344 A2, 321344]; Borowicz P, 2011, INT J BIOL MACROMOL, V49, P548, DOI 10.1016/j.ijbiomac.2011.06.008; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Brange J., 1994, STABILITY INSULIN ST; CHANCE RE, 1981, DIABETES CARE, V4, P147, DOI 10.2337/diacare.4.2.147; Cheng YE, United States patent, Patent No. [US 4,480,038, 4480038]; CHENG YSE, 1981, GENE, V14, P121, DOI 10.1016/0378-1119(81)90154-2; DARRINGTON RT, 1994, PHARMACEUT RES, V11, P784, DOI 10.1023/A:1018909220255; DeFelippis MR, 2001, CRIT REV THER DRUG, V18, P201; Donner T, INSULIN PHARM THERAP; Fischer J, 2015, SUCCESSFUL DRUG DISC, V1, P37; Freeman JS, 2009, J AM OSTEOPATH ASSOC, V109, P26; GOEDDEL DV, 1979, P NATL ACAD SCI USA, V76, P106, DOI 10.1073/pnas.76.1.106; Gumprecht J, 2009, INT J CLIN PRACT, V63, P966, DOI 10.1111/j.1742-1241.2009.02064.x; HALLEWELL RA, 1985, NUCLEIC ACIDS RES, V13, P2017, DOI 10.1093/nar/13.6.2017; HAMMERJESPERSEN K, 1975, MOL GEN GENET, V137, P327, DOI 10.1007/BF00703258; Hartman I, 2008, CLIN MED RES, V6, P54, DOI 10.3121/cmr.2008.793; Hartman JR, Generation of human insulin. International publication number: Worldwide International Property Organization WO96/20724 A1, Patent No. 9620724; Havelund S, 2004, PHARM RES-DORDR, V21, P1498, DOI 10.1023/B:PHAM.0000036926.54824.37; Heller S, 2007, DIABETES RES CLIN PR, V78, P149, DOI 10.1016/j.diabres.2007.04.001; Hermansen K, 2004, DIABETOLOGIA, V47, P622, DOI 10.1007/s00125-004-1365-z; Hilgenfeld R, 2014, DRUGS, V74, P911, DOI 10.1007/s40265-014-0226-4; Hirsch IB, 2005, NEW ENGL J MED, V352, P174, DOI 10.1056/NEJMra040832; Jonassen I, 2006, PHARM RES-DORDR, V23, P49, DOI 10.1007/s11095-005-9047-1; Jonassen I, 2012, PHARM RES-DORDR, V29, P2104, DOI 10.1007/s11095-012-0739-z; Joshi Shashank R, 2007, J Assoc Physicians India, V55 Suppl, P19; Kalra S, 2014, DIABETES THER, V5, P65, DOI 10.1007/s13300-014-0067-x; KEMMLER W, 1971, J BIOL CHEM, V246, P6786; Madhu S V, 2013, Indian J Endocrinol Metab, V17, P249, DOI 10.4103/2230-8210.109690; Mayer JP, 2007, BIOPOLYMERS, V88, P687, DOI 10.1002/bip.20734; Miller JH., 1972, EXPERIMENTS IN MOLEC; NAKHODA A, 1979, EXPERIENTIA, V35, P1679, DOI 10.1007/BF01953269; NICOL DSHW, 1960, NATURE, V187, P483, DOI 10.1038/187483a0; Porcellati F, 2011, DIABETES TECHNOL S1, V13, P15; Ratner RE, 2000, DIABETES CARE, V23, P639, DOI 10.2337/diacare.23.5.639; Rivers J, 2008, J PROTEOME RES, V7, P921, DOI 10.1021/pr070425l; Roach P, 2008, CLIN PHARMACOKINET, V47, P595, DOI 10.2165/00003088-200847090-00003; Robinson N. E., 2004, MOL CLOCKS DEAMIDATI; Rosskamp RH, 1999, DIABETES CARE, V22, pB109; SANGER F, 1951, BIOCHEM J, V49, P481, DOI 10.1042/bj0490481; SANGER F, 1951, BIOCHEM J, V49, P463, DOI 10.1042/bj0490463; Sillero A, 2006, COMPUT BIOL MED, V36, P157, DOI 10.1016/j.compbiomed.2004.09.006; Stretton AOW, 2002, GENETICS, V162, P527; Swinnen SG, 2009, DIABETES CARE, V32, pS253, DOI 10.2337/dc09-S318; The Canadian Agency for Drugs and Technologies in Health (CADTH), 2008, 87 CADTH COMPUS, V2; Vajo Z, 2000, PHARMACOL REV, V52, P1; VALENTINHANSEN P, 1982, EMBO J, V1, P317, DOI 10.1002/j.1460-2075.1982.tb01167.x; Wang F, 2003, CLIN THER, V25, P1541, DOI 10.1016/S0149-2918(03)80156-X; Wang P, 2015, NAT REV ENDOCRINOL, V11, P201, DOI 10.1038/nrendo.2015.9; WebMD, DIAB TYP INS; WRIGHT HT, 1991, CRIT REV BIOCHEM MOL, V26, P1, DOI 10.1080/10409230490440532	57	14	16	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 15	2017	12	3							e0172600	10.1371/journal.pone.0172600	http://dx.doi.org/10.1371/journal.pone.0172600			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN9HQ	28296883	Green Submitted, gold, Green Published			2022-12-27	WOS:000396311700010
J	Wang, WY; Ding, ZP; Solares, GJ; Choi, SM; Wang, B; Yoon, A; Farrar, RP; Ivy, JL				Wang, Wanyi; Ding, Zhenping; Solares, Geoffrey J.; Choi, Soon-Mi; Wang, Bo; Yoon, Aram; Farrar, Roger P.; Ivy, John L.			Co-ingestion of carbohydrate and whey protein increases fasted rates of muscle protein synthesis immediately after resistance exercise in rats	PLOS ONE			English	Article							HUMAN SKELETAL-MUSCLE; AMINO-ACID-TRANSPORT; ENDURANCE EXERCISE; MAMMALIAN TARGET; INSULIN ACTION; PHOSPHORYLATION; INITIATION; GLUCOSE; KINASE; MTOR	The objective of the study was to investigate whether co-ingestion of carbohydrate and protein as compared with protein alone augments muscle protein synthesis (MPS) during early exercise recovery. Two months old rats performed 10 repetitions of ladder climbing with 75% of body weight attached to their tails. Placebo (PLA), whey protein (WP), or whey protein plus carbohydrate (CP) was then given to rats by gavage. An additional group of sedentary rats (SED) was used as controls. Blood samples were collected immediately and at either 1 or 2 h after exercise. The flexor hallucis longus muscle was excised at 1 or 2 h post exercise for analysis of MPS and related signaling proteins. MPS was significantly increased by CP compared with PLA (p<0.05), and approached significance compared with WP at 1 h post exercise (p = 0.08). CP yielded a greater phosphorylation of mTOR compared with SED and PLA at 1 h post exercise and SED and WP at 2 h post exercise. CP also increased phosphorylation of p70S6K compared with SED at 1 and 2 h post exercise. 4E-BP1 phosphorylation was inhibited by PLA at 1 h but elevated by WP and CP at 2 h post exercise relative to SED. The phosphorylation of AMPK was elevated by exercise at 1 h post exercise, and this elevated level was sustained only in the WP group at 2 h. The phosphorylation of Akt, GSK3, and elF2Bc were unchanged by treatments. Plasma insulin was transiently increased by CP at 1 h post exercise. In conclusion, post-exercise CP supplementation increases MPS post exercise relative to PLA and possibly WP, which may have been mediated by greater activation of the mTOR signaling pathway.	[Wang, Wanyi; Ding, Zhenping; Solares, Geoffrey J.; Yoon, Aram; Ivy, John L.] Univ Texas Austin, Dept Kinesiol & Hlth Educ, Exercise Physiol & Metab Lab, Austin, TX 78712 USA; [Choi, Soon-Mi] Midwestern State Univ, Dept Athlet Training & Exercise Physiol, Wichita Falls, TX 76308 USA; [Wang, Bo] Beijing Sports Univ, Sports Sci Coll, Beijing, Peoples R China; [Farrar, Roger P.] Univ Texas Austin, Dept Kinesiol & Hlth Educ, Muscle Physiol Lab, Austin, TX 78712 USA	University of Texas System; University of Texas Austin; Beijing Sport University; University of Texas System; University of Texas Austin	Ivy, JL (corresponding author), Univ Texas Austin, Dept Kinesiol & Hlth Educ, Exercise Physiol & Metab Lab, Austin, TX 78712 USA.	johnivy@utexas.edu		Wang, Wanyi/0000-0001-9482-9968				[Anonymous], AMINO ACIDS; Anthony TG, 2007, J NUTR, V137, P357, DOI 10.1093/jn/137.2.357; Attaix D, 2005, ESSAYS BIOCHEM, V41, P173, DOI 10.1042/EB0410173; BIOLO G, 1995, AM J PHYSIOL-ENDOC M, V268, pE514; BIOLO G, 1995, J CLIN INVEST, V95, P811, DOI 10.1172/JCI117731; Biolo G, 1999, DIABETES, V48, P949, DOI 10.2337/diabetes.48.5.949; Bird SP, 2006, EUR J APPL PHYSIOL, V97, P225, DOI 10.1007/s00421-005-0127-z; Bolster DR, 2002, J BIOL CHEM, V277, P23977, DOI 10.1074/jbc.C200171200; Bolster DR, 2003, J PHYSIOL-LONDON, V553, P213, DOI 10.1113/jphysiol.2003.047019; Brunet A, 1999, CELL, V96, P857, DOI 10.1016/S0092-8674(00)80595-4; Chow LS, 2006, AM J PHYSIOL-ENDOC M, V291, pE729, DOI 10.1152/ajpendo.00003.2006; Cuthbertson DJ, 2006, AM J PHYSIOL-ENDOC M, V290, pE731, DOI 10.1152/ajpendo.00415.2005; Dreyer HC, 2008, AM J PHYSIOL-ENDOC M, V294, pE392, DOI 10.1152/ajpendo.00582.2007; Dreyer HC, 2006, J PHYSIOL-LONDON, V576, P613, DOI 10.1113/jphysiol.2006.113175; Eng CM, 2008, J EXP BIOL, V211, P2336, DOI 10.1242/jeb.017640; Farrell PA, 2000, J APPL PHYSIOL, V88, P1036, DOI 10.1152/jappl.2000.88.3.1036; Ferguson-Stegall L, 2011, J STRENGTH COND RES, V25, P1210, DOI 10.1519/JSC.0b013e318212db21; Fingar DC, 2002, GENE DEV, V16, P1472, DOI 10.1101/gad.995802; Fluckey JD, 1996, AM J PHYSIOL-ENDOC M, V270, pE313, DOI 10.1152/ajpendo.1996.270.2.E313; Glover EI, 2008, AM J PHYSIOL-REG I, V295, pR604, DOI 10.1152/ajpregu.00097.2008; Goodman CA, 2011, FASEB J, V25, P1028, DOI 10.1096/fj.10-168799; Hernandez JM, 2000, J APPL PHYSIOL, V88, P1142, DOI 10.1152/jappl.2000.88.3.1142; Hillier TA, 1998, AM J PHYSIOL-ENDOC M, V274, pE1067, DOI 10.1152/ajpendo.1998.274.6.E1067; Hornberger TA, 2004, CAN J APPL PHYSIOL, V29, P16, DOI 10.1139/h04-002; Ivy JL, 2008, AMINO ACIDS, V35, P89, DOI 10.1007/s00726-007-0620-2; Jefferson LS, 1999, INT J BIOCHEM CELL B, V31, P191, DOI 10.1016/S1357-2725(98)00141-1; JEFFREY IW, 1993, BIOCHIMIE, V75, P791, DOI 10.1016/0300-9084(93)90129-G; Kimball SR, 1998, J BIOL CHEM, V273, P30945, DOI 10.1074/jbc.273.47.30945; Kimball SR, 1998, AM J PHYSIOL-CELL PH, V274, pC221, DOI 10.1152/ajpcell.1998.274.1.C221; Koopman R, 2007, AM J PHYSIOL-ENDOC M, V293, pE833, DOI 10.1152/ajpendo.00135.2007; Koopman R, 2006, AM J PHYSIOL-ENDOC M, V290, pE1245, DOI 10.1152/ajpendo.00530.2005; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LOWRY OH, 1951, J BIOL CHEM, V193, P265; Macnaughton LS, 2016, PHYSIOL REP, V4, DOI 10.14814/phy2.12893; Miller SL, 2003, MED SCI SPORT EXER, V35, P449, DOI 10.1249/01.MSS.0000053910.63105.45; Moore DR, 2009, AM J CLIN NUTR, V89, P161, DOI 10.3945/ajcn.2008.26401; Morrison PJ, 2008, J APPL PHYSIOL, V104, P1029, DOI 10.1152/japplphysiol.01173.2007; Nakashima K, 2007, BIOSCI BIOTECH BIOCH, V71, P1650, DOI 10.1271/bbb.70057; Pende M, 2004, MOL CELL BIOL, V24, P3112, DOI 10.1128/MCB.24.8.3112-3124.2004; Phillips SM, 1997, AM J PHYSIOL-ENDOC M, V273, pE99, DOI 10.1152/ajpendo.1997.273.1.E99; POZEFSKY T, 1969, J CLIN INVEST, V48, P2273, DOI 10.1172/JCI106193; Roux PP, 2007, J BIOL CHEM, V282, P14056, DOI 10.1074/jbc.M700906200; Roy BD, 1997, J APPL PHYSIOL, V82, P1882, DOI 10.1152/jappl.1997.82.6.1882; Staples AW, 2011, MED SCI SPORT EXER, V43, P1154, DOI 10.1249/MSS.0b013e31820751cb; Tipton KD, 2004, MED SCI SPORT EXER, V36, P2073, DOI 10.1249/01.MSS.0000147582.99810.C5; Wilkinson SB, 2008, J PHYSIOL-LONDON, V586, P3701, DOI 10.1113/jphysiol.2008.153916; Wilkinson SB, 2007, AM J CLIN NUTR, V85, P1031, DOI 10.1093/ajcn/85.4.1031	47	7	7	1	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 15	2017	12	3							e0173809	10.1371/journal.pone.0173809	http://dx.doi.org/10.1371/journal.pone.0173809			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN9HQ	28296942	Green Published, gold, Green Submitted			2022-12-27	WOS:000396311700068
J	Bouvier, S; Paulmyer-Lacroix, O; Molinari, N; Bertaud, A; Paci, M; Leroyer, A; Robert, S; George, FD; Blot-Chabaud, M; Bardin, N				Bouvier, Sylvie; Paulmyer-Lacroix, Odile; Molinari, Nicolas; Bertaud, Alexandrine; Paci, Marine; Leroyer, Aurelie; Robert, Stephane; George, Francoise Dignat; Blot-Chabaud, Marcel; Bardin, Nathalie			Soluble CD146, an innovative and non-invasive biomarker of embryo selection for in vitro fertilization	PLOS ONE			English	Article							EXPRESSION; SINGLE; IDENTIFICATION; IMPLANTATION; MIGRATION; FAILURE; FORM	Although progress was made in in vitro fertilization (IVF) techniques, the majority of embryos transferred fail to implant. Morphology embryo scoring is the standard procedure for most of IVF centres for choosing the best embryo, but remains limited since even the embryos classified as "top quality" may not implant. As it has been shown that i) CD146 is involved in embryo implantation and ii) membrane form is shed to generate soluble CD146 (sCD146), we propose that sCD146 in embryo supernatants may constitute a new biomarker of embryo selection. Immunocytochemical staining showed expression of CD146 in early embryo stages and sCD146 was detected by ELISA and Western-blot in embryo supernatants from D2. We retrospectively studied 126 couples who underwent IVF attempt. The embryo culture medium from each transferred embryo (n = 222) was collected for measurement of sCD146 by ELISA. Significantly higher sCD146 concentrations were present in embryo supernatants that did not implant (n = 185) as compared to those that successfully implanted (n = 37) (1310 +/- 1152 pg.mL(-1) vs. 845 +/- 1173 pg.mL(-1), p = 0.024). Sensitivity analysis performed on single embryo transfers (n = 71) confirmed this association (p = 0.0054). The computed ROC curve established that the optimal sCD146 concentration for embryo implantation is under 1164 pg.mL(-1) (sensitivity: 76%, specificity: 48%, PPV: 25% and NPV: 92%). Over this sCD146 threshold, the implantation rate was significantly lower (9% with sCD146 levels > 1164 pg.ml(-1) vs. 22% with sCD146 levels <= 1164 pg.mL(-1), p = 0.01). Among the embryos preselected by morphologic scoring, sCD146 determination could allow a better selection of the embryo(s), thus improving the success of elective single embryo transfer. This study establishes the proof of concept for the use of sCD146 as a bio-marker for IVF by excluding the embryo with the highest sCD146 level. A multicentre prospective study will now be necessary to further establish its use in clinical practice.	[Bouvier, Sylvie; Bertaud, Alexandrine; Leroyer, Aurelie; Robert, Stephane; George, Francoise Dignat; Blot-Chabaud, Marcel; Bardin, Nathalie] Aix Marseille Univ, Inserm U1076, Marseille, France; [Paulmyer-Lacroix, Odile; Paci, Marine] Aix Marseille Univ, Assisted Reprod Ctr, Lab Reprod, CHU Concept,AP HM, Marseille, France; [Paulmyer-Lacroix, Odile; Paci, Marine] Aix Marseille Univ, Lab Histol Embryol Biol Reprod, Marseille, France; [Molinari, Nicolas] Univ Montpellier, CNRS UMR 9214, PhyMedExp, INSERM U1046, Montpellier, France; [Bardin, Nathalie] CHU Concept Marseille, AP HM, Pole Biol, Immunol Lab, Marseille, France	UDICE-French Research Universities; Aix-Marseille Universite; UDICE-French Research Universities; Aix-Marseille Universite; Assistance Publique-Hopitaux de Marseille; UDICE-French Research Universities; Aix-Marseille Universite; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Montpellier; UDICE-French Research Universities; Aix-Marseille Universite; Assistance Publique-Hopitaux de Marseille	Bardin, N (corresponding author), Aix Marseille Univ, Inserm U1076, Marseille, France.; Bardin, N (corresponding author), CHU Concept Marseille, AP HM, Pole Biol, Immunol Lab, Marseille, France.	nathalie.bardin@univ-amu.fr	Bardin, Nathalie/AAL-3663-2020; Bouvier, Sylvie/AAA-2757-2019; Leroyer, Aurelie S./M-4400-2016; molinari, nicolas/Y-9681-2019; Blot-Chabaud, Marcel/D-4064-2017; DIGNAT-GEORGE, Françoise/R-1129-2016	Bardin, Nathalie/0000-0003-3680-082X; Bouvier, Sylvie/0000-0001-8808-8841; Leroyer, Aurelie S./0000-0002-8079-7122; DIGNAT-GEORGE, Françoise/0000-0001-7006-4462	Agence de la Biomedecine	Agence de la Biomedecine	This work was supported by a grant from the Agence de la Biomedecine. The authors have no conflict of interest to declare.	Alpha Scientists in Reproductive Medicine and ESHRE Special Interest Group of Embryology, 2011, Hum Reprod, V26, P1270, DOI 10.1093/humrep/der037; Bardin N, 2003, THROMB HAEMOSTASIS, V90, P915, DOI 10.1160/TH02-11-0285; Bardin N, 1998, FEBS LETT, V421, P12, DOI 10.1016/S0014-5793(97)01455-5; Bardin N, 2001, BLOOD, V98, P3677, DOI 10.1182/blood.V98.13.3677; Bardin N, 2009, ARTERIOSCL THROM VAS, V29, P746, DOI 10.1161/ATVBAHA.108.183251; Bolton VN, 2015, HUM FERTIL, V27, P1; Boneberg EM, 2009, MICROVASC RES, V78, P325, DOI 10.1016/j.mvr.2009.06.012; Botros L, 2008, MOL HUM REPROD, V14, P679, DOI 10.1093/molehr/gan066; BRAUDE P, 1988, NATURE, V332, P459, DOI 10.1038/332459a0; Dzafic E, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/508216; Forman EJ, 2013, FERTIL STERIL, V100, P100, DOI 10.1016/j.fertnstert.2013.02.056; Glujovsky D, 2012, COCHRANE DB SYST REV, DOI [10.1002/14651858.CD002118.pub4, 10.1002/14651858.CD002118.pub5]; Haikin Herzberger E, 2016, GYNECOL ENDOCRINOL, V26, P1; Harbottle SJ, 2015, HUM FERTIL, V11, P131; Kaspi E, 2013, ANGIOGENESIS, V16, P329, DOI 10.1007/s10456-012-9317-6; Kupka MS, 2014, HUM REPROD, V29, P2099, DOI 10.1093/humrep/deu175; Liu Q, 2004, LAB INVEST, V84, P221, DOI 10.1038/labinvest.3700033; Liu Q, 2008, J CELL PHYSIOL, V215, P621, DOI 10.1002/jcp.21341; Martins WP, 2016, ULTRASOUND OBSTET GY; McLernon DJ, 2010, BMJ-BRIT MED J, V341, DOI 10.1136/bmj.c6945; Montag M, 2013, REPROD BIOMED ONLINE, V27, P539, DOI 10.1016/j.rbmo.2013.05.013; Montsko G, 2015, FERTIL STERIL, V103, P687, DOI 10.1016/j.fertnstert.2014.11.031; Motato Y, 2015, FERTIL STERIL, V17; Pandian Z, 2013, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD003416.pub4; Pasquier E, 2005, THROMB HAEMOSTASIS, V94, P1280, DOI 10.1160/TH05-04-0253; Rhenman A, 2015, HUM REPROD, V30, P28, DOI 10.1093/humrep/deu295; Rosenbluth EM, 2014, FERTIL STERIL, V101, P1493, DOI 10.1016/j.fertnstert.2014.01.058; Scott RT, 2013, FERTIL STERIL, V100, P697, DOI 10.1016/j.fertnstert.2013.04.035; Shih IM, 1998, J CELL SCI, V111, P2655; Simopoulou M, 2014, IN VIVO, V28, P683; Wang H., 2008, J REPROD CONTRACEPT, V19, P7, DOI [10.1016/S1001-7844(08)60003-6, DOI 10.1016/S1001-7844(08)60003-6]; Yang YS, 2015, MOL CYTOGENET, V8, DOI 10.1186/s13039-015-0140-9	32	7	10	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 14	2017	12	3							e0173724	10.1371/journal.pone.0173724	http://dx.doi.org/10.1371/journal.pone.0173724			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN6DM	28291830	Green Published, gold, Green Submitted			2022-12-27	WOS:000396094700036
J	Kudryavtsev, VA; Khokhlova, AV; Mosina, VA; Selivanova, EI; Kabakov, AE				Kudryavtsev, Vladimir A.; Khokhlova, Anna V.; Mosina, Vera A.; Selivanova, Elena I.; Kabakov, Alexander E.			Induction of Hsp70 in tumor cells treated with inhibitors of the Hsp90 activity: A predictive marker and promising target for radiosensitization	PLOS ONE			English	Article							HEAT-SHOCK RESPONSE; MULTITARGET APPROACH; STRESS-RESPONSE; BASE EXCISION; CANCER-CELLS; DNA-DAMAGE; IN-VITRO; RADIATION; 17-ALLYLAMINO-17-DEMETHOXYGELDANAMYCIN; REPAIR	We studied a role of the inducible heat shock protein 70 (Hsp70) in cellular response to radiosensitizing treatments with inhibitors of the heat shock protein 90 (Hsp90) chaperone activity. Cell lines derived from solid tumors of different origin were treated with the Hsp90 inhibitors (17AAG, geldanamycin, radicicol, NVP-AUY922) or/and gamma-photon radiation. For comparison, human cells of the non-cancerous origin were subjected to the same treatments. We found that the Hsp90 inhibitors yielded considerable radiosensitization only when they cause early and pronounced Hsp70 induction; moreover, a magnitude of radiosensitization was positively correlated with the level of Hsp70 induction. The quantification of Hsp70 levels in Hsp90 inhibitor-treated normal and cancer cells enabled to predict which of them will be susceptible to any Hsp90-inhibiting radiosensitizer as well as what concentrations of the inhibitors ensure the preferential cytotoxicity in the irradiated tumors without aggravating radiation damage to adjacent normal tissues. Importantly, the Hsp70 induction in the Hsp90 inhibitor-treated cancer cells appears to be their protective response that alleviates the tumor-sensitizing effects of the Hsp90 inactivation. Combination of the Hsp70-inducing inhibitors of Hsp90 with known inhibitors of the Hsp induction such as quercetin, triptolide, KNK437, NZ28 prevented up-regulation of Hsp70 in the cancer cells thereby increasing their post-radiation apoptotic/necrotic death and decreasing their post-radiation viability/clonogenicity. Similarly, co-treatment with the two inhibitors conferred the enhanced radiosensitization of proliferating rather than quiescent human vascular endothelial cells which may be used for suppressing the tumor-stimulated angiogenesis. Thus, the easily immunodetectable Hsp70 induction can be a useful marker for predicting effects of Hsp90-inhibiting radiosensitizers on tumors and normal tissues exposed to ionizing radiation. Moreover, targeting the Hsp70 induction in Hsp90 inhibitor-treated cancer cells and tumor vasculature cells may beneficially enhance the radiosensitizing effect.	[Kudryavtsev, Vladimir A.; Khokhlova, Anna V.; Mosina, Vera A.; Selivanova, Elena I.; Kabakov, Alexander E.] A Tsyb Med Radiol Res Ctr, Dept Radiat Biochem, Obninsk, Russia		Kabakov, AE (corresponding author), A Tsyb Med Radiol Res Ctr, Dept Radiat Biochem, Obninsk, Russia.	aekabakov@hotmail.com	Khokhlova, Anna/E-5181-2018; Kabakov, Alexander/S-9998-2017; Mosina, Vera/AAH-7502-2020; Selivanova, Elena I/T-1002-2017	Khokhlova, Anna/0000-0002-4391-6321; 				Bagatell R, 2000, CLIN CANCER RES, V6, P3312; Bases R, 2006, CELL STRESS CHAPERON, V11, P240, DOI 10.1379/CSC-185R.1; Bisht KS, 2003, CANCER RES, V63, P8984; Camphausen K, 2007, CLIN CANCER RES, V13, P4326, DOI 10.1158/1078-0432.CCR-07-0632; Dote H, 2005, CANCER RES, V65, P6967, DOI 10.1158/0008-5472.CAN-05-1304; Dote H, 2006, CANCER RES, V66, P9211, DOI 10.1158/0008-5472.CAN-06-2181; Fujii Y, 2010, ONCOL REP, V23, P199, DOI 10.3892/or_00000623; Gabai VL, 2010, ONCOGENE, V29, P1952, DOI 10.1038/onc.2009.480; Goda K, 2009, CURR CANCER DRUG TAR, V9, P281, DOI 10.2174/156800909788166493; Guttmann DM, 2011, CANCER BIOL THER, V12, P1023, DOI 10.4161/cbt.12.12.18374; HOSOKAWA N, 1992, MOL CELL BIOL, V12, P3490, DOI 10.1128/MCB.12.8.3490; Jego G, 2013, CANCER LETT, V332, P275, DOI 10.1016/j.canlet.2010.10.014; Jhaveri K, 2012, BBA-MOL CELL RES, V1823, P742, DOI 10.1016/j.bbamcr.2011.10.008; Kabakov A.E., 2013, HEAT SHOCK PROTEINS, P25; Kabakov AE, 2006, RADIAT RES, V165, P410, DOI 10.1667/RR3514.1; Kabakov AE, 2008, INT J RADIAT ONCOL, V71, P858, DOI 10.1016/j.ijrobp.2008.02.034; Kabakov AE, 2011, METHODS MOL BIOL, V787, P231, DOI 10.1007/978-1-61779-295-3_17; Kabakov AE, 2010, J MOL MED, V88, P241, DOI 10.1007/s00109-009-0562-0; Kamal A, 2003, NATURE, V425, P407, DOI 10.1038/nature01913; Koll TT, 2008, MOL CANCER THER, V7, P1985, DOI 10.1158/1535-7163.MCT-07-2104; Matsumoto Y, 2005, J RADIAT RES, V46, P215, DOI 10.1269/jrr.46.215; MICHELS AA, 1995, EUR J BIOCHEM, V234, P382, DOI 10.1111/j.1432-1033.1995.382_b.x; Noguchi M, 2006, BIOCHEM BIOPH RES CO, V351, P658, DOI 10.1016/j.bbrc.2006.10.094; Paul K, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059505; Pennisi R, 2015, BIOMOLECULES, V5, P2589, DOI 10.3390/biom5042589; Russell JS, 2003, CLIN CANCER RES, V9, P3749; Schilling D, 2015, CANCER LETT, V360, P294, DOI 10.1016/j.canlet.2015.02.033; Sharma Arishya, 2012, Methods Mol Biol, V920, P613, DOI 10.1007/978-1-61779-998-3_40; Shintani S, 2006, INT J ONCOL, V29, P1111; Stingl L, 2010, BRIT J CANCER, V102, P1578, DOI 10.1038/sj.bjc.6605683; Taldone T, 2014, EXPERT OPIN THER PAT, V24, P501, DOI 10.1517/13543776.2014.887681; Tatokoro M, 2015, EXCLI J, V14, P48, DOI 10.17179/excli2015-586; Trepel J, 2010, NAT REV CANCER, V10, P537, DOI 10.1038/nrc2887; Vabulas RM, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a004390; Voronezhskaya EE, 2004, DEVELOPMENT, V131, P3671, DOI 10.1242/dev.01237; Westerheide SD, 2006, J BIOL CHEM, V281, P9616, DOI 10.1074/jbc.M512044200; Yokota S, 2000, CANCER RES, V60, P2942; Young JC, 2004, NAT REV MOL CELL BIO, V5, P781, DOI 10.1038/nrm1492; Zaarur N, 2006, CANCER RES, V66, P1783, DOI 10.1158/0008-5472.CAN-05-3692; Zaidi S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035436; Zorzi Elisa, 2011, Cancers (Basel), V3, P3921, DOI 10.3390/cancers3043921	41	33	36	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 14	2017	12	3							e0173640	10.1371/journal.pone.0173640	http://dx.doi.org/10.1371/journal.pone.0173640			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN6DM	28291803	Green Published, Green Submitted, gold			2022-12-27	WOS:000396094700034
J	Wu, XH; Yu, Y; Xu, J; Dong, FS; Liu, XG; Du, PQ; Wei, DM; Zheng, YQ				Wu, Xiaohu; Yu, Yang; Xu, Jun; Dong, Fengshou; Liu, Xingang; Du, Pengqiang; Wei, Dongmei; Zheng, Yongquan			Residue analysis and persistence evaluation of fipronil and its metabolites in cotton using high-performance liquid chromatography-tandem mass spectrometry	PLOS ONE			English	Article							GAS-CHROMATOGRAPHY; ELECTRON-CAPTURE; SOIL; INSECTICIDES; CABBAGE; MS/MS; CORN	A simple residue analytical method based on the QuEChERS approach and high-performance liquid chromatography-tandem mass spectrometry (UPLC-MS/MS) detection was developed for the analysis of fipronil and its three metabolites in cottonseed, cotton plant and soil. The average recoveries of four test compounds from all three matrices were 78.6-108.9% at the level of 0.005 to 0.5 mg/kg, with an RSD in the range of 0.6 to 13.7%. The limit of quantification (LOQ) of the four test compounds ranged from 0.005 to 0.01 mg/kg. The results of the residual dynamics experiments showed that fipronil dissipated rapidly in cotton plants and soil and that oxidation and photolysis were the main degradation pathways. Moreover, the bi-exponential models demonstrated a good fit of the measured data for fipronil in cotton plants and soil, with R-2 in the range of 0.8989 to 0.9989. Furthermore, a total of 40 samples of cottonseed from Shandong Province were analyzed, and all of the samples were free from the four test compound residues.	[Wu, Xiaohu; Yu, Yang; Xu, Jun; Dong, Fengshou; Liu, Xingang; Du, Pengqiang; Wei, Dongmei; Zheng, Yongquan] Chinese Acad Agr Sci, Inst Plant Protect, State Key Lab Biol Plant Dis & Insect Pests, Beijing, Peoples R China; [Yu, Yang] Minist Environm Protect, Solid Waste & Chem Management Ctr, Yuhuinanlu 1, Beijing, Beijing, Peoples R China	Chinese Academy of Agricultural Sciences; Institute of Plant Protection, CAAS	Zheng, YQ (corresponding author), Chinese Acad Agr Sci, Inst Plant Protect, State Key Lab Biol Plant Dis & Insect Pests, Beijing, Peoples R China.	zhengyongquan@ippcaas.cn		Du, Pengqiang/0000-0003-3284-4657	National Natural Science Foundation of China [31501678]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This study was supported by grants from the National Natural Science Foundation of China (31501678). The URL is http://www.nsfn.gov.cn/. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We would like to thank Jialin Yu and Xuan Tang for their assistance in and processing samples, and wish to thank BASF Corporation for providing data analysis software (KinGUIIv2.1) and technical assistance. This study was supported by grants from the National Natural Science Foundation of China (31501678).	[Anonymous], 2016, PESTICIDE ELECT HDB; Bhardwaj U, 2012, ECOTOX ENVIRON SAFE, V79, P301, DOI 10.1016/j.ecoenv.2012.01.016; Bobe A, 1998, PESTIC SCI, V52, P275, DOI 10.1002/(SICI)1096-9063(199803)52:3&lt;275::AID-PS720&gt;3.0.CO;2-S; Cheng YP, 2014, ANAL METHODS-UK, V6, P1788, DOI 10.1039/c3ay41742e; Chopra I, 2011, B ENVIRON CONTAM TOX, V86, P242, DOI 10.1007/s00128-010-0180-0; Dutta Debashis, 2008, Pesticide Research Journal, V20, P117; FAOSTAT, 2014, FAO STAT DAT; Gros M, 2006, TALANTA, V70, P678, DOI 10.1016/j.talanta.2006.05.024; Gunasekara AS, 2007, J PESTIC SCI, V32, P189, DOI 10.1584/jpestics.R07-02; Hainzl D, 1996, P NATL ACAD SCI USA, V93, P12764, DOI 10.1073/pnas.93.23.12764; Hingmire S, 2015, FOOD CHEM, V176, P145, DOI 10.1016/j.foodchem.2014.12.049; Jimenez JJ, 2008, J CHROMATOGR A, V1187, P40, DOI 10.1016/j.chroma.2008.02.014; Kadar A, 2006, J AGR FOOD CHEM, V54, P9741, DOI 10.1021/jf062035+; Kruve A, 2008, J CHROMATOGR A, V1187, P58, DOI 10.1016/j.chroma.2008.01.077; Lee S, 2004, ENVIRON TOXICOL CHEM, V23, P1, DOI 10.1897/03-114; Li MH, 2015, J AGR FOOD CHEM, V63, P4435, DOI 10.1021/jf5054589; [刘爱芝 Liu Aizhi], 2015, [植物保护, Plant Protection], V41, P197; Mandal K, 2013, CHEMOSPHERE, V91, P1596, DOI 10.1016/j.chemosphere.2012.12.054; Matuszewski BK, 2003, ANAL CHEM, V75, P3019, DOI 10.1021/ac020361s; Munoz-Leoz B, 2011, SOIL BIOL BIOCHEM, V43, P2176, DOI 10.1016/j.soilbio.2011.07.001; Paramasivam M, 2013, INT J ENVIRON AN CH, V93, P1203, DOI 10.1080/03067319.2012.708747; Ramasubramanian T, 2014, FOOD CHEM, V150, P408, DOI 10.1016/j.foodchem.2013.11.004; Ramesh A, 1999, J AGR FOOD CHEM, V47, P3367, DOI 10.1021/jf980885m; Sabatino L, 2013, FOOD ADDIT CONTAM B, V6, P11, DOI 10.1080/19393210.2012.717969; Sammelson RE, 2004, BIOORGAN MED CHEM, V12, P3345, DOI 10.1016/j.bmc.2004.03.069; Wang TL, 2014, ENVIRON MONIT ASSESS, V186, P2767, DOI 10.1007/s10661-013-3577-5	26	17	19	1	42	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 14	2017	12	3							e0173690	10.1371/journal.pone.0173690	http://dx.doi.org/10.1371/journal.pone.0173690			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN6DM	28291815	gold, Green Published, Green Submitted			2022-12-27	WOS:000396094700035
J	Besson, M; de Boer, IJM; Vandeputte, M; van Arendonk, JAM; Quillet, E; Komen, H; Aubin, J				Besson, M.; de Boer, I. J. M.; Vandeputte, M.; van Arendonk, J. A. M.; Quillet, E.; Komen, H.; Aubin, J.			Effect of production quotas on economic and environmental values of growth rate and feed efficiency in sea cage fish farming	PLOS ONE			English	Article							BASS DICENTRARCHUS-LABRAX; NITROGEN OUTPUT LIMITATIONS; GREENHOUSE-GAS EMISSIONS; LIFE-CYCLE ASSESSMENT; SALMON SALMO-SALAR; WATER TEMPERATURE; PRODUCTION SYSTEMS; DAIRY-COWS; SELECTION; IMPACT	In sea cage fish farming, production quotas aim to constrain the impact of fish farming on the surrounding ecosystem. It is unknown how these quotas affect economic profitability and environmental impact of genetic improvement. We combined bioeconomic modelling with life cycle assessment (LCA) to calculate the economic (EV) and environmental (ENV) values of thermal growth coefficient (TGC) and feed conversion ratio (FCR) of sea bass reared in sea cages, given four types of quota commonly used in Europe: annual production (Qprod), annual feed distributed (Qannual_ feed), standing stock (Qstock), and daily feed distributed (Qdaily_ feed). ENV were calculated for LCA impact categories climate change, eutrophication and acidification. ENV were expressed per ton of fish produced per year (ENV(fish)) and per farm per year (ENV(farm)). Results show that irrespective of quota used, EV of FCR as well as ENV(fish) and ENV(farm) were always positive, meaning that improving FCR increased profit and decreased environmental impacts. However, the EV and the ENV(fish) of TGC were positive only when quota was Qstock or Qdaily_ feed. Moreover, the ENV(farm) of TGC was negative in Qstock and Qdaily_ feed quotas, meaning that improving TGC increased the environmental impact of the farm. We conclude that Qstock quota and Qdaily_ feed quota are economically favorable to a genetic improvement of TGC, a major trait for farmers. However, improving TGC increases the environmental impact of the farm. Improving FCR represents a good opportunity to balance out this increase but more information on its genetic background is needed to develop breeding programs improving FCR.	[Besson, M.; van Arendonk, J. A. M.; Komen, H.] Wageningen Univ, Anim Breeding & Genom Ctr, Wageningen, Netherlands; [Besson, M.; Vandeputte, M.; Quillet, E.] Univ Paris Saclay, AgroParisTech, INRA, Genet Anim & Biol Integrat, Jouy En Josas, France; [de Boer, I. J. M.] Wageningen Univ, Anim Prod Syst Grp, Wageningen, Netherlands; [Vandeputte, M.] IFREMER, Chemin Maguelone, Palavas Les Flots, France; [Aubin, J.] INRA, Agrocampus Ouest, Sol Agron Spatialisat UMR1069, Rennes, France	Wageningen University & Research; AgroParisTech; INRAE; UDICE-French Research Universities; Universite Paris Saclay; Wageningen University & Research; Ifremer; INRAE; Institut Agro; Agrocampus Ouest	Besson, M (corresponding author), Wageningen Univ, Anim Breeding & Genom Ctr, Wageningen, Netherlands.; Besson, M (corresponding author), Univ Paris Saclay, AgroParisTech, INRA, Genet Anim & Biol Integrat, Jouy En Josas, France.	mathieu.besson@inra.fr	SAS, ASAE UMR/M-4978-2013; de Boer, Imke/P-7107-2014; Vandeputte, Marc/I-7218-2019; Aubin, Joël/ABC-7952-2020; Komen, Hans/D-8876-2012; van Arendonk, Johan/E-2536-2011; Aubin, Joel/B-8740-2016; Vandeputte, Marc/A-4734-2011	SAS, ASAE UMR/0000-0001-6346-7845; de Boer, Imke/0000-0002-0675-7528; Vandeputte, Marc/0000-0001-9929-4587; Aubin, Joël/0000-0003-4081-5426; van Arendonk, Johan/0000-0003-2592-3947; Vandeputte, Marc/0000-0001-9929-4587; Besson, Mathieu/0000-0001-7662-5451	IMARES [512052-EM-1-2010-FR-ERA MUNDUSEMJD]; European Commission [512052-EM-1-2010-FR-ERA MUNDUSEMJD]	IMARES; European Commission(European CommissionEuropean Commission Joint Research Centre)	M. Besson benefited from a joint grant from the European Commission and IMARES (512052-EM-1-2010-FR-ERA MUNDUSEMJD), within the framework of the Erasmus-Mundus joint doctorate "EGS-ABG".; M. Besson benefited from a joint grant from the European Commission and IMARES, within the framework of the Erasmus-Mundus joint doctorate "EGS-ABG". The authors thank Gloria Maris and Biomar for their collaboration.	Asche F., 2011, EC SALMON AQUACULTUR; Aubin J, 2009, J CLEAN PROD, V17, P354, DOI 10.1016/j.jclepro.2008.08.008; Aubin J., 2013, CAB Reviews, V8, P1, DOI 10.1079/PAVSNNR20138011; Bell MJ, 2011, J DAIRY SCI, V94, P3662, DOI 10.3168/jds.2010-4023; Bell MJ, 2010, ANIM PROD SCI, V50, P817, DOI 10.1071/AN10038; Besson M, 2016, AQUACULTURE, V462, P47, DOI 10.1016/j.aquaculture.2016.04.030; Besson M, 2016, J CLEAN PROD, V116, P100, DOI 10.1016/j.jclepro.2015.12.084; Besson M, 2014, J ANIM SCI, V92, P5394, DOI 10.2527/jas.2014-8266; Boissy J, 2011, AQUACULTURE, V321, P61, DOI 10.1016/j.aquaculture.2011.08.033; Cho C Y, 1990, World Rev Nutr Diet, V61, P132; COWEY CB, 1991, P 1 INT S NUTR STRAT; de Bruijn H., 2002, HDB LIFE CYCLE ASSES, V7; de Vries M, 2010, LIVEST SCI, V128, P1, DOI 10.1016/j.livsci.2009.11.007; Ervik A, 1997, AQUACULTURE, V158, P85, DOI 10.1016/S0044-8486(97)00186-5; FAO, 2014, NAT AQ LEG OV; FAO, 2014, VUE GEN SECT AQ NAT; FAO, 2014, CULT AQ SPEC INF PRO; FOLKE C, 1994, J ENVIRON MANAGE, V40, P173, DOI 10.1006/jema.1994.1013; GIBSON JP, 1989, ANIM PROD, V49, P171, DOI 10.1017/S0003356100032293; GROEN AF, 1989, LIVEST PROD SCI, V22, P17, DOI 10.1016/0301-6226(89)90122-X; Hansen PK, 2001, AQUACULTURE, V194, P75, DOI 10.1016/S0044-8486(00)00520-2; Hazel LN, 1943, GENETICS, V28, P476; Holmer Marianne, 2008, P47, DOI 10.1007/978-1-4020-6810-2_2; Janssen K., 2016, AQUACULTURE; Kause A, 2006, J ANIM SCI, V84, P807, DOI 10.2527/2006.844807x; Lanari D, 2002, ITAL J ANIM SCI, V1, P181, DOI 10.4081/ijas.2002.181; Lundebye A-K., 2013, SITE SELECTION CARRY, P171; Mallet JP, 1999, CAN J FISH AQUAT SCI, V56, P994, DOI 10.1139/cjfas-56-6-994; Mambrini M, 2004, J ANIM SCI, V82, P2865; Mente E, 2006, AQUACULT INT, V14, P499, DOI 10.1007/s10499-006-9051-4; Pelletier N, 2007, AQUACULTURE, V272, P399, DOI 10.1016/j.aquaculture.2007.06.024; Pelletier NL, 2007, INT J LIFE CYCLE ASS, V12, P414, DOI 10.1065/lca2006.09.275; Person-Le Ruyet J, 2004, AQUACULTURE, V237, P269, DOI 10.1016/j.aquaculture.2004.04.021; R Core Team, 2018, R LANG ENV STAT COMP; Read P, 2003, AQUACULTURE, V226, P139, DOI 10.1016/S0044-8486(03)00474-5; Rose G, 2015, ANIMAL, V9, P1268, DOI 10.1017/S1751731115000476; Sanchez MP, 2001, AQUAT LIVING RESOUR, V14, P41, DOI 10.1016/S0990-7440(00)01103-7; Stigebrandt A, 2004, AQUACULTURE, V234, P239, DOI 10.1016/j.aquaculture.2003.11.029; SUTHERLAND TM, 1965, BIOMETRICS, V21, P739, DOI 10.2307/2528555; Thodesen J, 2001, AQUACULTURE, V194, P273, DOI 10.1016/S0044-8486(00)00527-5; van Middelaar CE, 2014, J DAIRY SCI, V97, P5191, DOI 10.3168/jds.2013-7413; Vandeputte M, 2014, AQUACULTURE, V424, P239, DOI 10.1016/j.aquaculture.2014.01.005; Wall E, 2010, ANIMAL, V4, P366, DOI 10.1017/S175173110999070X; Ytrestoyl T, 2015, AQUACULTURE, V448, P365, DOI 10.1016/j.aquaculture.2015.06.023	44	17	17	0	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 13	2017	12	3							e0173131	10.1371/journal.pone.0173131	http://dx.doi.org/10.1371/journal.pone.0173131			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN6CP	28288179	Green Published, Green Submitted, gold			2022-12-27	WOS:000396092400007
J	Daud, ANA; Bergman, JEH; Oktora, MP; Kerstjens-Frederikse, WS; Groen, H; Bos, JH; Hak, E; Wilffert, B				Daud, Aizati N. A.; Bergman, Jorieke E. H.; Oktora, Monika P.; Kerstjens-Frederikse, Wilhelmina S.; Groen, Henk; Bos, Jens H.; Hak, Eelko; Wilffert, Bob			Maternal use of drug substrates of placental transporters and the effect of transporter-mediated drug interactions on the risk of congenital anomalies	PLOS ONE			English	Article							RESISTANCE PROTEIN BCRP/ABCG2; RNA EXPRESSION PROFILES; P-GLYCOPROTEIN; MESSENGER-RNA; MEMBRANE TRANSPORTERS; PREGNANCY; PHARMACOKINETICS; DISPOSITION; METABOLISM; EXPOSURE	Background A number of transporter proteins are expressed in the placenta, and they facilitate the placental transfer of drugs. The inhibition of P-glycoprotein (P-gp) was previously found to be associated with an increase in the risk of congenital anomalies caused by drug substrates of this transporter. We now explore the role of other placental transporter proteins. Methods A population-based case-referent study was performed using cases with congenital anomalies (N = 5,131) from EUROCAT Northern Netherlands, a registry of congenital anomalies. The referent population (N = 31,055) was selected from the pregnancy IADB. nl, a pharmacy prescription database. Results Ten placental transporters known to have comparable expression levels in the placenta to that of P-gp, were selected in this study. In total, 147 drugs were identified to be substrates, inhibitors or inducers, of these transporters. Fifty-eight of these drugs were used by at least one mother in our cases or referent population, and 28 were used in both. The highest user rate was observed for the substrates of multidrug resistance-associated protein 1, mainly folic acid (6% of cases, 8% of referents), and breast cancer resistance protein, mainly nitrofurantoin (2.3% of cases, 2.9% of referents). In contrast to P-gp, drug interactions involving substrates of these transporters did not have a significant effect on the risk of congenital anomalies. Conclusions Some of the drugs which are substrates or inhibitors of placental transporters were commonly used during pregnancy. No significant effect of transporter inhibition was found on fetal drug exposure, possibly due to a limited number of exposures.	[Daud, Aizati N. A.; Oktora, Monika P.; Bos, Jens H.; Hak, Eelko; Wilffert, Bob] Univ Groningen, Groningen Res Inst Pharm, PharmacoTherapy Epidemiol & Econ, Groningen, Netherlands; [Daud, Aizati N. A.] Univ Sains Malaysia, Sch Pharmaceut Sci, Discipline Clin Pharm, George Town, Malaysia; [Bergman, Jorieke E. H.; Kerstjens-Frederikse, Wilhelmina S.] Univ Groningen, Univ Med Ctr Groningen, Dept Genet, Groningen, Netherlands; [Groen, Henk] Univ Groningen, Univ Med Ctr Groningen, Dept Epidemiol, Groningen, Netherlands; [Wilffert, Bob] Univ Groningen, Univ Med Ctr Groningen, Dept Clin Pharm & Pharmacol, Groningen, Netherlands	University of Groningen; Universiti Sains Malaysia; University of Groningen; University of Groningen; University of Groningen	Daud, ANA (corresponding author), Univ Groningen, Groningen Res Inst Pharm, PharmacoTherapy Epidemiol & Econ, Groningen, Netherlands.; Daud, ANA (corresponding author), Univ Sains Malaysia, Sch Pharmaceut Sci, Discipline Clin Pharm, George Town, Malaysia.	aizati.daud@gmail.com	Daud, Aizati N.A./P-8506-2017; Kerstjens-Frederikse, Wilhelmina/GSE-0282-2022; Groen, Henk/B-2163-2013; Daud, Adil/T-3079-2019	Daud, Aizati N.A./0000-0003-4336-9468; Groen, Henk/0000-0002-6629-318X; Daud, Adil/0000-0002-6617-8421; Oktora, Monika/0000-0002-3116-787X; Kerstjens, Mieke/0000-0003-2528-2203	Ministry of Health, Welfare and Sports, the Netherlands; University of Groningen, The Netherlands; Ministry of Education in Malaysia; Universiti Sains Malaysia	Ministry of Health, Welfare and Sports, the Netherlands; University of Groningen, The Netherlands(Netherlands Government); Ministry of Education in Malaysia; Universiti Sains Malaysia(Universiti Sains Malaysia)	EUROCAT NNL is funded by the Ministry of Health, Welfare and Sports, the Netherlands. The IADB.nl database is funded by the University of Groningen, The Netherlands. Aizati Daud also thanks the Ministry of Education in Malaysia and Universiti Sains Malaysia for the scholarship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2005, EUROCAT GUID 1 3 REF; Ceccaldi PF, 2009, OBSTET GYNECOL INT, V2009, DOI 10.1155/2009/726593; Cha SH, 2000, J BIOL CHEM, V275, P4507, DOI 10.1074/jbc.275.6.4507; Daud ANA, 2015, DRUG SAFETY, V38, P651, DOI 10.1007/s40264-015-0299-3; Endres CJ, 2006, EUR J PHARM SCI, V27, P501, DOI 10.1016/j.ejps.2005.11.002; Ganapathy Vadivel, 2005, Toxicol Appl Pharmacol, V207, P381, DOI 10.1016/j.taap.2005.02.023; Giacomini KM, 2010, NAT REV DRUG DISCOV, V9, P215, DOI 10.1038/nrd3028; Hahnova-Cygalova L, 2011, DRUG METAB REV, V43, P53, DOI 10.3109/03602532.2010.512293; Ho RH, 2005, CLIN PHARMACOL THER, V78, P260, DOI 10.1016/j.clpt.2005.05.011; Holcberg G, 2003, EUR J OBSTET GYN R B, V109, P133, DOI 10.1016/S0301-2115(02)00513-4; Imanaga J, 2011, PHARMACOGENET GENOM, V21, P84, DOI 10.1097/FPC.0b013e32834300cc; Iqbal M, 2012, PLACENTA, V33, P137, DOI 10.1016/j.placenta.2012.01.008; Isoherranen N, 2013, DRUG METAB DISPOS, V41, P256, DOI 10.1124/dmd.112.050245; Konig J, 2013, PHARMACOL REV, V65, P944, DOI 10.1124/pr.113.007518; Koepsell H, 2004, PFLUG ARCH EUR J PHY, V447, P666, DOI 10.1007/s00424-003-1089-9; Lee N, 2013, DRUG METAB DISPOS, V41, P2225, DOI 10.1124/dmd.113.054072; Mao QC, 2015, AAPS J, V17, P65, DOI 10.1208/s12248-014-9668-6; May K, 2008, DRUG METAB DISPOS, V36, P740, DOI 10.1124/dmd.107.019448; Molsa M, 2005, CLIN PHARMACOL THER, V78, P123, DOI 10.1016/j.clpt.2005.04.014; Muller F, 2011, PHARMACOGENOMICS, V12, P1017, DOI [10.2217/PGS.11.44, 10.2217/pgs.11.44]; Myllynen P, 2009, EXPERT OPIN DRUG MET, V5, P1483, DOI 10.1517/17425250903304049; Nanovskaya T, 2005, BIOCHEM PHARMACOL, V69, P1869, DOI 10.1016/j.bcp.2005.03.030; Nishimura M, 2008, DRUG METAB PHARMACOK, V23, P22, DOI 10.2133/dmpk.23.22; Nishimura Masuhiro, 2005, Drug Metab Pharmacokinet, V20, P452, DOI 10.2133/dmpk.20.452; Nishimura M, 2009, DRUG METAB PHARMACOK, V24, P91, DOI 10.2133/dmpk.24.91; Prouillac C, 2010, DRUG METAB DISPOS, V38, P1623, DOI 10.1124/dmd.110.033571; Roth M, 2012, BRIT J PHARMACOL, V165, P1260, DOI 10.1111/j.1476-5381.2011.01724.x; Rubinchik-Stern M, 2012, FRONT PHARMACOL, V3, DOI 10.3389/fphar.2012.00126; Schirm E, 2004, J CLIN EPIDEMIOL, V57, P737, DOI 10.1016/j.jclinepi.2002.12.001; St-Pierre MV, 2002, J CLIN ENDOCR METAB, V87, P1856, DOI 10.1210/jc.87.4.1856; Staud F, 2015, EXPERT OPIN DRUG MET, V11, P533, DOI 10.1517/17425255.2015.1005073; Staud F, 2012, J DRUG TARGET, V20, P736, DOI 10.3109/1061186X.2012.716847; Syme MR, 2004, CLIN PHARMACOKINET, V43, P487, DOI 10.2165/00003088-200443080-00001; Ugele B, 2008, J STEROID BIOCHEM, V111, P1, DOI 10.1016/j.jsbmb.2008.04.001; Unadkat JD, 2004, CURR DRUG METAB, V5, P125, DOI 10.2174/1389200043489171; Vahakangas K, 2009, BRIT J PHARMACOL, V158, P665, DOI 10.1111/j.1476-5381.2009.00336.x; van Roon EN, 2005, DRUG SAFETY, V28, P1131, DOI 10.2165/00002018-200528120-00007; Visser ST, 2013, EXPERT REV PHARM OUT, V13, P285, DOI [10.1586/ERP.13.20, 10.1586/erp.13.20]; Wang ZJ, 2008, PHARMACOGENET GENOM, V18, P637, DOI 10.1097/FPC.0b013e328302cd41; Xia BF, 2013, AAPS J, V15, P1012, DOI 10.1208/s12248-013-9505-3; Yeboah D, 2006, CAN J PHYSIOL PHARM, V84, P1251, DOI 10.1139/Y06-078	41	12	12	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 13	2017	12	3							e0173530	10.1371/journal.pone.0173530	http://dx.doi.org/10.1371/journal.pone.0173530			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN6CP	28288183	gold, Green Published, Green Submitted			2022-12-27	WOS:000396092400018
J	Chongthawonsatid, S				Chongthawonsatid, Sukanya			Inequity of healthcare utilization on mammography examination and Pap smear screening in Thailand: Analysis of a population-based household survey	PLOS ONE			English	Article							BREAST-CANCER STAGE; WOMEN; DIAGNOSIS; LEVEL	Healthcare in Thailand is not equally distributed, and not all people can equally access healthcare resources even if they are covered by health insurance. To examine factors associated with the utilization of mammography examination for breast cancer and Pap smear screening for cervical cancer, data from the national reproductive health survey conducted by the National Statistical Office of Thailand in 2009 was examined. The survey was carried out on 15,074,126 women aged 30-59 years. The results showed that the wealthier respondents had more mammograms than did the lower-income groups. The concentration index was 0.144. The data on Pap smears for cervical cancer also showed that the wealthier respondents were more likely to have had a Pap smear than their lower-income counterparts. The concentration index was 0.054. Determinants of mammography examination were education, followed by health welfare and wealth index, whereas the determinants of Pap smear screening were wealth index, followed by health welfare and education. The government should support greater education for women because education was associated with socioeconomic status and wealth. There should be an increase in the number of screening campaigns, mobile clinics, and low-cost mammograms and continued support for accessibility to mammograms, especially in rural areas and low-income communities.	[Chongthawonsatid, Sukanya] Mahidol Univ, Fac Social Sci & Humanities, Nakhon Pathom, Thailand	Mahidol University	Chongthawonsatid, S (corresponding author), Mahidol Univ, Fac Social Sci & Humanities, Nakhon Pathom, Thailand.	sukanya.cht@mahidol.ac.th			Faculty of Social Sciences and Humanities, Mahidol University	Faculty of Social Sciences and Humanities, Mahidol University	This work was supported by the Faculty of Social Sciences and Humanities, Mahidol University. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aekplakorn W., 2010, REPORT THAILAND POPU; [Anonymous], 2008, ANAL HLTH EQUITY USI; Borras JM, 1999, EUR J CANCER PREV, V8, P427, DOI 10.1097/00008469-199910000-00008; Centers for Disease Control and Prevention, 2014, INCR POP BAS BREAST; Chowdhury R, 2016, J CANCER, V7, P532, DOI 10.7150/jca.12963; Dailey AB, 2011, CANCER EPIDEM BIOMAR, V20, P2331, DOI 10.1158/1055-9965.EPI-11-0528; EDDY DM, 1990, ANN INTERN MED, V113, P214, DOI 10.7326/0003-4819-113-3-214; Kim S, 2014, J HLTH DISPAR RES PR, V6, P70; LERMAN RI, 1985, REV ECON STAT, V67, P151, DOI 10.2307/1928447; Mukem Suwanna, 2014, Journal of the Medical Association of Thailand, V97, P1106; National Cancer Institute, 2016, HOSP BAS CANC REG AN; Okoronkwo IL, 2015, NIGER J CLIN PRACT, V18, P287, DOI 10.4103/1119-3077.151070; Onitilo AA, 2013, AM J ROENTGENOL, V201, P1057, DOI 10.2214/AJR.13.10733; Seneviratne S, 2015, BMC PUBLIC HEALTH, V15, DOI 10.1186/s12889-015-1383-4; Tabar L, 2003, LANCET, V361, P1405, DOI 10.1016/S0140-6736(03)13143-1; WIBULPOLPRASERT S, 2005, THAILAND HLTH PROFIL	16	7	7	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 10	2017	12	3							e0173656	10.1371/journal.pone.0173656	http://dx.doi.org/10.1371/journal.pone.0173656			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN6CJ	28282430	Green Submitted, gold, Green Published			2022-12-27	WOS:000396091800062
J	Fei, YX; Hou, R; Spotila, JR; Paladino, FV; Qi, DW; Zhang, ZH				Fei, Yuxiang; Hou, Rong; Spotila, James R.; Paladino, Frank V.; Qi, Dunwu; Zhang, Zhihe			Metabolic rate of the red panda, Ailurus fulgens, a dietary bamboo specialist	PLOS ONE			English	Article							ECOLOGY; CONSERVATION; ENERGETICS; PHYLOGENY; CARNIVORE; ANIMALS; RESERVE; MAMMALS; GIANT; CHINA	The red panda (Ailurus fulgens) has a similar diet, primarily bamboo, and shares the same habitat as the giant panda, Ailuropoda melanoleuca. There are considerable efforts underway to understand the ecology of the red panda and to increase its populations in natural reserves. Yet it is difficult to design an effective strategy for red panda reintroduction if we do not understand its basic biology. Here we report the resting metabolic rate of the red panda and find that it is higher than previously measured on animals from a zoo. The resting metabolic rate was 0.290 ml/g/h (range 0.204-0.342) in summer and 0.361 ml/g/h in winter (range 0.331-0.406), with a statistically significant difference due to season and test temperature. Temperatures in summer were probably within the thermal neutral zone for metabolism but winter temperatures were below the thermal neutral zone. There was no difference in metabolic rate between male and female red pandas and no difference due to mass. Our values for metabolic rate were much higher than those measured by McNab for 2 red pandas from a zoo. The larger sample size (17), more natural conditions at the Panda Base and improved accuracy of the metabolic instruments provided more accurate metabolism measurements. Contrary to our expectations based on their low quality bamboo diet, the metabolic rates of red pandas were similar to mammals of the same size. Based on their metabolic rates red pandas would not be limited by their food supply in natural reserves.	[Fei, Yuxiang; Spotila, James R.] Drexel Univ, Dept Biodivers Earth & Environm Sci, Philadelphia, PA 19104 USA; [Fei, Yuxiang; Hou, Rong; Qi, Dunwu; Zhang, Zhihe] Chengdu Res Base Giant Panda Breeding, Sichuan Key Lab Conservat Biol Endangered Wildlif, Chengdu, Sichuan Provinc, Peoples R China; [Paladino, Frank V.] Indiana Purdue Univ Ft Wayne, Dept Biol, 2101 E Coliseum Blvd, Ft Wayne, IN USA	Drexel University; Purdue University System; Indiana University Purdue University Fort Wayne	Spotila, JR (corresponding author), Drexel Univ, Dept Biodivers Earth & Environm Sci, Philadelphia, PA 19104 USA.; Zhang, ZH (corresponding author), Chengdu Res Base Giant Panda Breeding, Sichuan Key Lab Conservat Biol Endangered Wildlif, Chengdu, Sichuan Provinc, Peoples R China.	jrspotila@verizon.net; weiling@panda.org.cn			National Basic Research Program of China [2012CB72220]; Chengdu Panda Breeding Research Foundation; Global Cause Foundation; Bet Chair of Environmental Science at Drexel University; Shrey Chair of Biology at Indiana-Purdue University at Fort Wayne	National Basic Research Program of China(National Basic Research Program of China); Chengdu Panda Breeding Research Foundation; Global Cause Foundation; Bet Chair of Environmental Science at Drexel University; Shrey Chair of Biology at Indiana-Purdue University at Fort Wayne	This work received support from the National Basic Research Program of China (2012CB72220) to RH, Chengdu Panda Breeding Research Foundation (CPF Research 2012-16) to RH, Global Cause Foundation, gcause.org, to JRS, Bet Chair of Environmental Science at Drexel University, to JRS, and Shrey Chair of Biology at Indiana-Purdue University at Fort Wayne, to FVP. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Black AE, 1996, EUR J CLIN NUTR, V50, P72; Brown JH, 2004, ECOLOGY, V85, P1771, DOI 10.1890/03-9000; Clarke A, 2010, J ANIM ECOL, V79, P610, DOI 10.1111/j.1365-2656.2010.01672.x; Davy CM, 2014, ANIM BEHAV, V93, P15, DOI 10.1016/j.anbehav.2014.04.013; Flynn JJ, 2000, MOL PHYLOGENET EVOL, V17, P190, DOI 10.1006/mpev.2000.0819; GITTLEMAN JL, 1988, ETHOLOGY, V79, P13; Glazier DS, 2005, BIOL REV, V80, P611, DOI 10.1017/S1464793105006834; Henry CJK, 2005, PUBLIC HEALTH NUTR, V8, P1133, DOI 10.1079/PHN2005801; McNab BK, 2000, CAN J ZOOL, V78, P2227, DOI 10.1139/cjz-78-12-2227; MCNAB BK, 1988, PHYSIOL ZOOL, V61, P280, DOI 10.1086/physzool.61.3.30161241; Nie WH, 2002, CHROMOSOME RES, V10, P209, DOI 10.1023/A:1015292005631; O'Connor MP, 2007, OIKOS, V116, P1058, DOI 10.1111/j.2006.0030-1299.15534.x; PORTER WP, 1969, ECOL MONOGR, V39, P227, DOI 10.2307/1948545; Qi DW, 2009, BIODIVERS CONSERV, V18, P2127, DOI 10.1007/s10531-009-9577-7; REID DG, 1991, J ZOOL, V225, P347, DOI 10.1111/j.1469-7998.1991.tb03821.x; Riek A, 2013, BIOL REV, V88, P564, DOI 10.1111/brv.12016; Salesa MJ, 2006, P NATL ACAD SCI USA, V103, P379, DOI 10.1073/pnas.0504899102; Sieg AE, 2009, AM NAT, V174, P720, DOI 10.1086/606023; Springer Mark S., 2005, P37; Su B, 2001, MOL BIOL EVOL, V18, P1070, DOI 10.1093/oxfordjournals.molbev.a003878; Waddell PJ, 1999, SYST BIOL, V48, P31, DOI 10.1080/106351599260427; Wei FW, 2000, ZOO BIOL, V19, P27, DOI 10.1002/(SICI)1098-2361(2000)19:1&lt;27::AID-ZOO3&gt;3.0.CO;2-9; Wei FW, 2000, J MAMMAL, V81, P448, DOI 10.1644/1545-1542(2000)081<0448:HUASBT>2.0.CO;2; West GB, 1997, SCIENCE, V276, P122, DOI 10.1126/science.276.5309.122; White CR, 2005, J EXP BIOL, V208, P1611, DOI 10.1242/jeb.01501; Withers PC., 1992, COMP ANIMAL PHYSL, P106; YONZON PB, 1991, BIOL CONSERV, V57, P1, DOI 10.1016/0006-3207(91)90104-H; Zhang ZJ, 2009, ACTA THERIOL, V54, P225, DOI 10.4098/j.at.0001-7051.017.2008	28	8	9	5	81	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 17	2017	12	3							e0173274	10.1371/journal.pone.0173274	http://dx.doi.org/10.1371/journal.pone.0173274			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EO5CJ	28306740	gold, Green Published, Green Submitted			2022-12-27	WOS:000396710300007
J	Basu, A; Sridharan, S				Basu, Alakananda; Sridharan, Savitha			Regulation of anti-apoptotic Bcl-2 family protein Mcl-1 by S6 kinase 2	PLOS ONE			English	Article							BREAST-CANCER; CELL-DEATH; SIGNALING PATHWAYS; PI3K/AKT PATHWAY; DOWN-REGULATION; SURVIVAL; TRANSLATION; AKT; P53; ACTIVATION	The anti-apoptotic Bcl-2 family protein myeloid cell leukemia-1 (Mcl-1) plays an important role in breast cancer cell survival and chemoresistance. We have previously shown that knockdown of the 40S ribosomal protein S6 kinase-2 (S6K2), which acts downstream of the mechanistic target of rapamycin complex 1 (mTORC1), enhanced breast cancer cell death by apoptotic stimuli. The increase in cell death by S6K2 depletion was partly due to inactivation of Akt. In the present study, we investigated if S6K2 regulates Mcl-1, which acts downstream of Akt. Silencing of S6K2 but not S6K1 in T47D cells decreased Mcl-1 level, and potentiated apoptosis induced by TRAIL and doxorubicin. Knockdown of S6K2 also decreased the level of anti-apoptotic Bcl-xl. Depletion of the tumor suppressor protein PDCD4 (programmed cell death 4), which regulates translation of several anti-apoptotic proteins, reversed downregulation of Bcl-xl but not Mcl-1 and failed to reverse the effect of S6K2 knockdown on potentiation of doxorubicin-induced apoptosis. Downregulation of Mcl-1 by S6K2 knockdown was partly restored by the proteasome inhibitor MG132. Overexpression of catalytically-active Akt or knockdown of glycogen synthase kinase-3 (GSK3)-beta, a substrate for Akt, had little effect on Mcl-1 downregulation caused by S6K2 deficiency. Silencing of S6K2 increased the level of c-Jun N-terminal kinase (JNK) and knockdown of JNK1 increased basal Mcl-1 level and partly reversed the effect of S6K2 knockdown on Mcl1 downregulation. JNK1 knockdown also had a modest effect in attenuating the increase in doxorubicin-induced apoptosis caused by S6K2 deficiency. These results suggest that S6K2 regulates apoptosis via multiple mechanisms, and involves both Akt and JNK.	[Basu, Alakananda] Univ North Texas, Hlth Sci Ctr, Inst Mol Med, Ft Worth, TX USA; [Sridharan, Savitha] Univ Calif Berkeley, Berkeley, CA USA	University of North Texas System; University of North Texas Denton; University of California System; University of California Berkeley	Basu, A (corresponding author), Univ North Texas, Hlth Sci Ctr, Inst Mol Med, Ft Worth, TX USA.	Alakananda.basu@unthsc.edu		Basu, Alakananda/0000-0002-1656-0788	University of North Texas Health Science Center	University of North Texas Health Science Center	The study was partly supported by the Doctoral Bridge Funding (SS) from the University of North Texas Health Science Center. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Basu A, 1999, BIOCHEMISTRY-US, V38, P4245, DOI 10.1021/bi982854q; Delbridge ARD, 2016, NAT REV CANCER, V16, P99, DOI 10.1038/nrc.2015.17; Ding QQ, 2007, CANCER RES, V67, P4564, DOI 10.1158/0008-5472.CAN-06-1788; Eroles P, 2012, CANCER TREAT REV, V38, P698, DOI 10.1016/j.ctrv.2011.11.005; Esposito F, 2010, CANCER RES, V70, P5379, DOI 10.1158/0008-5472.CAN-09-4199; HALDAR S, 1994, CANCER RES, V54, P2095; Harrington LS, 2004, J CELL BIOL, V166, P213, DOI 10.1083/jcb.200403069; Lee-Fruman KK, 1999, ONCOGENE, V18, P5108, DOI 10.1038/sj.onc.1202894; Liwak U, 2013, ONCOTARGET, V4, P1365, DOI 10.18632/oncotarget.1154; Liwak U, 2012, MOL CELL BIOL, V32, P1818, DOI 10.1128/MCB.06317-11; Mayer IA, 2016, ANNU REV MED, V67, P11, DOI 10.1146/annurev-med-062913-051343; Merino D, 2016, ONCOGENE, V35, P1877, DOI 10.1038/onc.2015.287; Michels J, 2004, ONCOGENE, V23, P4818, DOI 10.1038/sj.onc.1207648; Mills JR, 2008, P NATL ACAD SCI USA, V105, P10853, DOI 10.1073/pnas.0804821105; Mojsa B, 2014, CELLS-BASEL, V3, P418, DOI 10.3390/cells3020418; Morel C, 2009, MOL CELL BIOL, V29, P3845, DOI 10.1128/MCB.00279-09; Nifoussi SK, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047060; O'Reilly KE, 2006, CANCER RES, V66, P1500, DOI 10.1158/0008-5472.CAN-05-2925; Pai C, 2016, J IMMUNOLOGY; Pardo OE, 2006, EMBO J, V25, P3078, DOI 10.1038/sj.emboj.7601198; Pardo OE, 2013, FRONT ONCOL, V3, DOI 10.3389/fonc.2013.00191; Pende M, 2004, MOL CELL BIOL, V24, P3112, DOI 10.1128/MCB.24.8.3112-3124.2004; Roy R, 2014, NUCLEIC ACIDS RES, V42, P12483, DOI 10.1093/nar/gku953; Sabatini DM, 2006, NAT REV CANCER, V6, P729, DOI 10.1038/nrc1974; Sax JK, 2002, NAT CELL BIOL, V4, P842, DOI 10.1038/ncb866; Shankar E, 2008, ONCOGENE, V27, P3957, DOI 10.1038/onc.2008.39; Sridharan S, 2011, CANCER RES, V71, P2590, DOI 10.1158/0008-5472.CAN-10-3253; Sun SY, 2005, CANCER RES, V65, P7052, DOI 10.1158/0008-5472.CAN-05-0917; Weng CJ, 2005, J BIOL CHEM, V280, P10491, DOI 10.1074/jbc.M412819200; Wertz IE, 2008, CYTOKINE GROWTH F R, V19, P313, DOI 10.1016/j.cytogfr.2008.04.014; Williams MM, 2015, ONCOTARGET, V6, P3519, DOI 10.18632/oncotarget.2792; Wu YL, 2001, ONCOGENE, V20, P240, DOI 10.1038/sj.onc.1204067; Yamaguchi H, 2012, FRONT ONCOL, V2, DOI 10.3389/fonc.2012.00015; Yang SX, 2016, CANCER TREAT REV, V45, P87, DOI 10.1016/j.ctrv.2016.03.004; Zinkel S, 2006, CELL DEATH DIFFER, V13, P1351, DOI 10.1038/sj.cdd.4401987	35	13	13	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 16	2017	12	3							e0173854	10.1371/journal.pone.0173854	http://dx.doi.org/10.1371/journal.pone.0173854			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN9KE	28301598	Green Published, gold, Green Submitted			2022-12-27	WOS:000396318300080
J	Chen, SL; Feng, BA; Thomas, AA; Chakrabarti, S				Chen, Shali; Feng, Biao; Thomas, Anu Alice; Chakrabarti, Subrata			miR-146a regulates glucose induced upregulation of inflammatory cytokines extracellular matrix proteins in the retina and kidney in diabetes	PLOS ONE			English	Article							NF-KAPPA-B; ENDOTHELIAL GROWTH-FACTOR; FIBRONECTIN SYNTHESIS; EXPRESSION; MICRORNA-146A; PATHOGENESIS; CELLS; GENE; ACTIVATION; MECHANISMS	Hyperglycemic damage to the endothelial cells (ECs) leads to increased synthesis of inflammatory cytokines. We have previously shown miR-146a downregulation in ECs and in the tissues of diabetic mice. Here we investigated the role of miR-146a, in the production of specific inflammatory cytokines and extracellular matrix (ECM) proteins in retina and kidneys in diabetes. We generated an endothelial specific miR-146a overexpressing transgenic mice (TG). We investigated these mice and wild type (WT) controls with or without streptozotocin (STZ) induced diabetes. Retinal and renal cortical tissues from the mice were examined for mRNAs for specific inflammatory markers, (ECM) proteins and inflammation inducible transcription factor by real time RT-PCR. Corresponding proteins, where possible, were examined using immunofluorescence or ELISA. In parallel, we examined ECs following incubation with various levels of glucose with or without miR-146a mimic transfection. In the retina and kidneys of WT mice with diabetes, increased expression of inflammatory markers (IL-6, TNF alpha, IL1 beta) in association augmented expression of ECM proteins (collagen 1 alpha IV, fibronectin) and NF.B-P65 were observed, compared to WT non-diabetic controls. These changes were prevented in diabetic miR-146a TG mice along with retinal and renal functional and structural changes. In vitro studies showed similar changes in the ECs exposed to high glucose. Such changes were corrected in the cells following miR-146a mimic transfection. Further analyses of renal cortical tissues showed diabetes induced significant upregulation of two regulators of NF kappa B, namely Interleukin-1 associated Kinase 1 and tumour necrosis factor receptor associated factor. Such changes were prevented in diabetic TG animals. These data indicate that augmented production of inflammatory cytokines and ECM proteins in the retina and kidneys in diabetes are regulated through endothelium derived miR-146a. Identification of such novel mechanisms may potentially lead to the development of novel therapies.	[Chen, Shali; Feng, Biao; Thomas, Anu Alice; Chakrabarti, Subrata] Univ Western Ontario, Dept Pathol & Lab Med, London, ON, Canada	Western University (University of Western Ontario)	Chakrabarti, S (corresponding author), Univ Western Ontario, Dept Pathol & Lab Med, London, ON, Canada.	subrata.chakrabarti@lhsc.uwo.ca		Chakrabarti, Subrata/0000-0002-0208-1401	Canadian Diabetes Association	Canadian Diabetes Association	This work was supported by the Canadian Diabetes Association (https://www.diabetes.ca/). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ardekani Ali M., 2010, Avicenna Journal of Medical Biotechnology, V2, P161; Bao MH, 2015, INT J MOL SCI, V16, P14305, DOI 10.3390/ijms160714305; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Beres NJ, 2016, INFLAMM BOWEL DIS, V22, P327, DOI 10.1097/MIB.0000000000000687; Bhatt K, 2016, J AM SOC NEPHROL, V27, P2277, DOI 10.1681/ASN.2015010111; Brownlee M, 2001, NATURE, V414, P813, DOI 10.1038/414813a; Burnett JC, 2012, CHEM BIOL, V19, P60, DOI 10.1016/j.chembiol.2011.12.008; Cao YA, 2014, INVEST OPHTH VIS SCI, V55, P7321, DOI 10.1167/iovs.14-15167; Capitao M, 2016, J CELL BIOCHEM, V117, P2443, DOI 10.1002/jcb.25575; Chen JH, 2011, EPIGENETICS-US, V6, P957, DOI 10.4161/epi.6.8.16065; Chen K, 2007, NAT REV GENET, V8, P93, DOI 10.1038/nrg1990; Chen SL, 2014, J CELL MOL MED, V18, P415, DOI 10.1111/jcmm.12218; Chen SL, 2012, INVEST OPHTH VIS SCI, V53, P8333, DOI 10.1167/iovs.12-9766; Chen SL, 2010, AM J PHYSIOL-ENDOC M, V298, pE127, DOI 10.1152/ajpendo.00432.2009; Chen SL, 2003, AM J PHYSIOL-ENDOC M, V284, pE1089, DOI 10.1152/ajpendo.00540.2002; Chen SL, 2003, AM J PHYSIOL-CELL PH, V284, pC263, DOI 10.1152/ajpcell.00192.2002; Cukiernik M, 2004, DIABETES RES CLIN PR, V65, P197, DOI 10.1016/j.diabres.2004.02.002; Das C, 2009, NATURE, V459, P113, DOI 10.1038/nature07861; Emadi S S, 2014, Endocr Regul, V48, P103; Feng B, 2017, J MOL CELL IN PRESS; Feng BA, 2008, AM J PHYSIOL-ENDOC M, V294, pE1119, DOI 10.1152/ajpendo.00029.2008; Feng B, 2014, LIFE SCI, V98, P18, DOI 10.1016/j.lfs.2013.12.199; Feng BA, 2011, DIABETES, V60, P2975, DOI 10.2337/db11-0478; Flynt AS, 2008, NAT REV GENET, V9, P831, DOI 10.1038/nrg2455; Funari VA, PLOS ONE, V8, P1; Gao M, 2015, J IMMUNOL, V195, P672, DOI 10.4049/jimmunol.1403155; Giza DE, 2014, DISCOVERIES CRAIOVA, V2, P1; Golovchenko I, 2000, CIRC RES, V87, P746, DOI 10.1161/01.RES.87.9.746; Holohan KN, FRONT GENET, V3, P1; Huang Y, 2011, J PHYSIOL BIOCHEM, V67, P129, DOI 10.1007/s13105-010-0050-6; Huang ZL, 2015, MOL MED REP, V12, P6997, DOI 10.3892/mmr.2015.4260; Kamali K, BRATISL LEK LISTY, V117; Kanwar YS, 2011, ANNU REV PATHOL-MECH, V6, P395, DOI 10.1146/annurev.pathol.4.110807.092150; Kaur H, 2006, DIABETES, V55, P3104, DOI 10.2337/db06-0519; Khan ZA, 2004, INVEST OPHTH VIS SCI, V45, P287, DOI 10.1167/iovs.03-0540; Knott RM, 1996, BIOCHEM J, V318, P313, DOI 10.1042/bj3180313; Kolset SO, 2012, J HISTOCHEM CYTOCHEM, V60, P976, DOI 10.1369/0022155412465073; Lorenzo O, 2011, MEDIAT INFLAMM, V2011, DOI 10.1155/2011/652097; Mariapan MM, 2012, EXP DIABETES RES, V2012, P1; Mason RM, 2003, J AM SOC NEPHROL, V14, P1358, DOI 10.1097/01.ASN.0000065640.77499.D7; McArthur K, 2011, DIABETES, V60, P1314, DOI 10.2337/db10-1557; Mortuza R, 2014, DIABETOLOGIA, V57, P1037, DOI 10.1007/s00125-014-3197-9; Nahid MA, 2015, J INNATE IMMUN, V7, P428, DOI 10.1159/000371517; Patel S, 2009, PHARMACOL REP, V61, P595, DOI 10.1016/S1734-1140(09)70111-2; Popov D., INT J DIABETES MELLI, V2, P189; Ruiz M, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0145372; SCHLAEGER TM, 1995, DEVELOPMENT, V121, P1089; Stickel N, 2014, BLOOD, V124, P2586, DOI 10.1182/blood-2014-04-569046; Sun XX, 2015, CELL CYCLE, V14, P243, DOI 10.4161/15384101.2014.977112; Tufekci KU, 2014, METHODS MOL BIOL, V1107, P33, DOI 10.1007/978-1-62703-748-8_3; Valencia-Sanchez MA, 2006, GENE DEV, V20, P515, DOI 10.1101/gad.1399806; Vo N, 2001, J BIOL CHEM, V276, P13505, DOI 10.1074/jbc.R000025200; Wang Q, 2014, INVEST OPHTH VIS SCI, V55, P3986, DOI 10.1167/iovs.13-13076; Wang XH, 2013, CARDIOVASC RES, V97, P432, DOI 10.1093/cvr/cvs356; Wertz IE, 2010, COLD SPRING HARBOR P, V2, P1; Wilczynska A, 2015, CELL DEATH DIFFER, V22, P22, DOI 10.1038/cdd.2014.112; Wu YX, 2012, INVEST OPHTH VIS SCI, V53, P8405, DOI 10.1167/iovs.12-10553; Wu YX, 2010, J OPHTHALMOL, V2010, DOI 10.1155/2010/465824; Ye EA, 2016, MEDIAT INFLAMM, V2016, P1; Yerneni KKV, 1999, DIABETES, V48, P855, DOI 10.2337/diabetes.48.4.855; Yousefzadeh N, 2015, J PHYSIOL BIOCHEM, V71, P51, DOI 10.1007/s13105-014-0378-4; Zhao JL, 2011, P NATL ACAD SCI USA, V108, P9184, DOI 10.1073/pnas.1105398108	62	30	33	1	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 16	2017	12	3							e0173918	10.1371/journal.pone.0173918	http://dx.doi.org/10.1371/journal.pone.0173918			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN9KE	28301595	Green Published, Green Submitted, gold			2022-12-27	WOS:000396318300094
J	Desgarnier, MCD; Fournier, F; Droit, A; Rochette, PJ				Desgarnier, Marie-Catherine Drigeard; Fournier, Frederic; Droit, Arnaud; Rochette, Patrick J.			Influence of a pre-stimulation with chronic low-dose UVB on stress response mechanisms in human skin fibroblasts	PLOS ONE			English	Article							CYCLOBUTANE PYRIMIDINE DIMERS; NUCLEOTIDE EXCISION-REPAIR; DNA-DAMAGE RESPONSE; INDUCED PROTEIN EXPRESSION; ULTRAVIOLET-B RADIATION; HISTONE METHYLTRANSFERASE; MOLECULAR-MECHANISMS; INDUCED APOPTOSIS; MUTATIONS; INDUCTION	Exposure to solar ultraviolet type B (UVB), through the induction of cyclobutane pyrimidine dimer (CPD), is the major risk factor for cutaneous cancer. Cells respond to UV-induced CPD by triggering the DNA damage response (DDR) responsible for signaling DNA repair, programmed cell death and cell cycle arrest. Underlying mechanisms implicated in the DDR have been extensively studied using single acute UVB irradiation. However, little is known concerning the consequences of chronic low-dose of UVB (CLUV) on the DDR. Thus, we have investigated the effect of a CLUV pre-stimulation on the different stress response pathways. We found that CLUV pre-stimulation enhances CPD repair capacity and leads to a cell cycle delay but leave residual unrepaired CPD. We further analyzed the consequence of the CLUV regimen on general gene and protein expression. We found that CLUV treatment influences biological processes related to the response to stress at the transcriptomic and proteomic levels. This overview study represents the first demonstration that human cells respond to chronic UV irradiation by modulating their genotoxic stress response mechanisms.	[Desgarnier, Marie-Catherine Drigeard; Rochette, Patrick J.] Univ Laval, CHU Quebec, Ctr Rech, Axe Med Regeneratrice,Hop St Sacrement, Quebec City, PQ, Canada; [Desgarnier, Marie-Catherine Drigeard; Rochette, Patrick J.] Univ Laval, LOEX, Ctr Rech Organogenese Expt, Quebec City, PQ, Canada; [Fournier, Frederic; Droit, Arnaud] Univ Laval, CHU Quebec, Ctr Rech, Ctr Prote, Quebec City, PQ, Canada; [Droit, Arnaud] Univ Laval, Dept Mol Med, Quebec City, PQ, Canada; [Rochette, Patrick J.] Univ Laval, Dept Ophtalmol & ORL Chirurg Cervicofacial, Quebec City, PQ, Canada	Laval University; Laval University; Laval University; Laval University; Laval University	Rochette, PJ (corresponding author), Univ Laval, CHU Quebec, Ctr Rech, Axe Med Regeneratrice,Hop St Sacrement, Quebec City, PQ, Canada.; Rochette, PJ (corresponding author), Univ Laval, LOEX, Ctr Rech Organogenese Expt, Quebec City, PQ, Canada.; Rochette, PJ (corresponding author), Univ Laval, Dept Ophtalmol & ORL Chirurg Cervicofacial, Quebec City, PQ, Canada.	Patrick.rochette@orlo.ulaval.ca	Rochette, Patrick/HHN-2300-2022; Droit, Arnaud/AGZ-6283-2022	Droit, Arnaud/0000-0001-7922-790X; Rochette, Patrick/0000-0002-0678-8869; Fournier, Frederic/0000-0001-5785-5403	Natural Sciences and Engineering Research Council of Canada (NSERC) [RGPIN-2016-05864]	Natural Sciences and Engineering Research Council of Canada (NSERC)(Natural Sciences and Engineering Research Council of Canada (NSERC))	This work was supported by a grant from the Natural Sciences and Engineering Research Council of Canada (NSERC) to PJR. Grant #:RGPIN-2016-05864. URL: http://nserc.ca/.	Bibbins-Domingo K, 2016, JAMA-J AM MED ASSOC, V316, P429, DOI 10.1001/jama.2016.8465; Black HS, 1997, J PHOTOCH PHOTOBIO B, V40, P29, DOI 10.1016/S1011-1344(97)00021-3; Boyle J, 2008, HUM MUTAT, V29, P1194, DOI 10.1002/humu.20768; Branzei D, 2008, NAT REV MOL CELL BIO, V9, P297, DOI 10.1038/nrm2351; Brash DE, 2001, J INVEST DERMATOL, V117, P1234, DOI 10.1046/j.0022-202x.2001.01554.x; Brash DE, 2015, PHOTOCHEM PHOTOBIOL, V91, P15, DOI 10.1111/php.12377; Conde F, 2009, GENETICS, V182, P437, DOI 10.1534/genetics.109.101899; Courdavault S, 2004, PHOTOCHEM PHOTOBIOL, V79, P145, DOI 10.1562/0031-8655(2004)079<0145:UCPDDN>2.0.CO;2; Cramers P, 2012, PHOTOCHEM PHOTOBIOL, V88, P147, DOI 10.1111/j.1751-1097.2011.01019.x; Croft D, 2014, NUCLEIC ACIDS RES, V42, pD472, DOI 10.1093/nar/gkt1102; D'Errico M, 2003, CELL DEATH DIFFER, V10, P754, DOI 10.1038/sj.cdd.4401224; de Gruijl FR, 2000, METHOD ENZYMOL, V319, P359; FORD JM, 1995, P NATL ACAD SCI USA, V92, P8876, DOI 10.1073/pnas.92.19.8876; Garinis GA, 2005, EMBO J, V24, P3952, DOI 10.1038/sj.emboj.7600849; Gendron SP, 2015, AGING CELL, V14, P433, DOI 10.1111/acel.12324; Greussing R, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-224; Harper JW, 2007, MOL CELL, V28, P739, DOI 10.1016/j.molcel.2007.11.015; Haruta N, 2012, NUCLEIC ACIDS RES, V40, P8406, DOI 10.1093/nar/gks580; Hishida T, 2009, NATURE, V457, P612, DOI 10.1038/nature07580; HUTCHINSON F, 1994, MUTAT RES-FUND MOL M, V309, P11, DOI 10.1016/0027-5107(94)90037-X; Ichihashi M, 2014, EXP DERMATOL, V23, P43, DOI 10.1111/exd.12393; Jackson SP, 2009, NATURE, V461, P1071, DOI 10.1038/nature08467; Johnson RD, 1999, NATURE, V401, P397, DOI 10.1038/43935; Kadhim MA, 2004, MUTAT RES-FUND MOL M, V568, P21, DOI 10.1016/j.mrfmmm.2004.06.043; Kim W, 2014, CELL CYCLE, V13, P726, DOI 10.4161/cc.28104; Kulms D, 2002, SKIN PHARMACOL APPL, V15, P342, DOI 10.1159/000064539; Kuluncsics Z, 1999, J PHOTOCH PHOTOBIO B, V49, P71, DOI 10.1016/S1011-1344(99)00034-2; Lamore SD, 2010, PHOTOCHEM PHOTOBIOL, V86, P1307, DOI 10.1111/j.1751-1097.2010.00818.x; LEBKOWSKI JS, 1985, P NATL ACAD SCI USA, V82, P8606, DOI 10.1073/pnas.82.24.8606; Lee S, 2007, J BIOCHEM MOL BIOL, V40, P226; Ljungman M, 1996, ONCOGENE, V13, P823; Lo HL, 2005, BMC CANCER, V5, DOI 10.1186/1471-2407-5-135; Maere S, 2005, BIOINFORMATICS, V21, P3448, DOI 10.1093/bioinformatics/bti551; Mallet JD, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0162212; Mallet JD, 2011, PHOTOCHEM PHOTOBIOL, V87, P1363, DOI 10.1111/j.1751-1097.2011.00977.x; Mantymaa P, 2000, BRIT J HAEMATOL, V108, P574, DOI 10.1046/j.1365-2141.2000.01852.x; MCGREGOR WG, 1991, MOL CELL BIOL, V11, P1927, DOI 10.1128/MCB.11.4.1927; McKay BC, 2004, P NATL ACAD SCI USA, V101, P6582, DOI 10.1073/pnas.0308181101; Michaels CJ, 2015, J ANIM PHYSIOL AN N, V99, P391, DOI 10.1111/jpn.12203; Milacic Marija, 2012, Cancers (Basel), V4, P1180, DOI 10.3390/cancers4041180; Miller AM, 2011, J INFLAMM-LOND, V8, DOI 10.1186/1476-9255-8-22; MILLER JH, 1983, ANNU REV GENET, V17, P215, DOI 10.1146/annurev.ge.17.120183.001243; Mitchell DL, 1999, CANCER RES, V59, P2875; Mitchell DL, 2001, J INVEST DERMATOL, V117, P590, DOI 10.1046/j.0022-202x.2001.01442.x; Mitchell DL, 2001, J INVEST DERMATOL, V116, P209, DOI 10.1046/j.1523-1747.2001.01192.x; Mouret S, 2011, PHOTOCHEM PHOTOBIOL, V87, P109, DOI 10.1111/j.1751-1097.2010.00834.x; Norbury CJ, 2004, ONCOGENE, V23, P2797, DOI 10.1038/sj.onc.1207532; Oksenych V, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003611; Pascucci B, 1997, J MOL BIOL, V273, P417, DOI 10.1006/jmbi.1997.1268; Pastila R, 2013, ADV EXP MED BIOL, V990, P121, DOI 10.1007/978-94-007-5896-4_9; Pfeifer GP, 2012, PHOTOCH PHOTOBIO SCI, V11, P90, DOI 10.1039/c1pp05144j; Pfeifer GP, 1997, PHOTOCHEM PHOTOBIOL, V65, P270, DOI 10.1111/j.1751-1097.1997.tb08560.x; Pope-Varsalona H, 2014, NUCLEIC ACIDS RES, V42, P13096, DOI 10.1093/nar/gku1030; Prakash S, 2005, ANNU REV BIOCHEM, V74, P317, DOI 10.1146/annurev.biochem.74.082803.133250; Rochette PJ, 2008, MECH AGEING DEV, V129, P207, DOI 10.1016/j.mad.2007.12.007; Rochette PJ, 2006, PHOTOCHEM PHOTOBIOL, V82, P1370, DOI 10.1562/2004-12-01-RA-390; Rochette PJ, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000926; Rochette PJ, 2002, ONCOGENE, V21, P5743, DOI 10.1038/sj.onc.1205641; Roos WP, 2016, NAT REV CANCER, V16, P20, DOI 10.1038/nrc.2015.2; Sale JE, 2012, NAT REV MOL CELL BIO, V13, P141, DOI 10.1038/nrm3289; Salucci S, 2013, INT J MOL SCI, V14, P532, DOI 10.3390/ijms14010532; Sancar A, 2004, ANNU REV BIOCHEM, V73, P39, DOI 10.1146/annurev.biochem.73.011303.073723; Schuch AP, 2010, J PHOTOCH PHOTOBIO B, V99, P111, DOI 10.1016/j.jphotobiol.2010.03.004; Schwarz Thomas, 2005, Keio Journal of Medicine, V54, P165, DOI 10.2302/kjm.54.165; Shannon P, 2003, GENOME RES, V13, P2498, DOI 10.1101/gr.1239303; Sheehan JM, 2002, J INVEST DERMATOL, V118, P825, DOI 10.1046/j.1523-1747.2002.01681.x; Singh RK, 2016, DERMATOLOGY THER, V6, P307, DOI 10.1007/s13555-016-0129-2; Slominski A.T., 2012, ADV ANAT EMBRYOL CEL, V212; Slominski AT, 2012, ADV ANAT EMBRYOL CEL, V212, P1; Slominski AT, 2013, ENDOCR REV, V34, P827, DOI 10.1210/er.2012-1092; Slominski AT, 2012, ADV ANAT EMBRYOL CEL, V212, pvii, Patent No. 22894052; Steerenberg PA, 2006, J PHOTOCH PHOTOBIO B, V84, P28, DOI 10.1016/j.jphotobiol.2006.01.009; Strozyk E, 2013, INT J MOL SCI, V14, P15260, DOI 10.3390/ijms140815260; Takahashi A, 2009, J RADIAT RES, V50, P385, DOI 10.1269/jrr.09048S; Tatum D, 2011, J BIOL CHEM, V286, P17530, DOI 10.1074/jbc.M111.241570; Tornaletti S, 1996, BIOESSAYS, V18, P221, DOI 10.1002/bies.950180309; TORNALETTI S, 1993, ONCOGENE, V8, P2051; Vijayalaxmi Cao Y, 2014, MUTAT RES REV MUTAT; Waters LS, 2009, MICROBIOL MOL BIOL R, V73, P134, DOI 10.1128/MMBR.00034-08; Weinkauf B, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039411; Wu CL, 2012, J PROTEOMICS, V75, P1991, DOI 10.1016/j.jprot.2011.12.038; Xu HX, 2010, PHOTODERMATOL PHOTO, V26, P198, DOI 10.1111/j.1600-0781.2010.00522.x; Xu X, 2015, MUTAT RES-REV MUTAT, V764, P43, DOI 10.1016/j.mrrev.2015.02.001; Yan Y, 2010, PHOTODERMATOL PHOTO, V26, P318, DOI 10.1111/j.1600-0781.2010.00556.x; Ye N, 1999, MUTAT RES-DNA REPAIR, V435, P43, DOI 10.1016/S0921-8777(99)00022-1; YOSHIKAWA T, 1990, J INVEST DERMATOL, V95, P530, DOI 10.1111/1523-1747.ep12504877; Zhao H, 2010, CYTOM PART A, V77A, P285, DOI 10.1002/cyto.a.20839	87	8	8	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 16	2017	12	3							e0173740	10.1371/journal.pone.0173740	http://dx.doi.org/10.1371/journal.pone.0173740			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN9KE	28301513	Green Published, Green Submitted, gold			2022-12-27	WOS:000396318300068
J	Lu, YA; Tu, KH; Lee, CC; Wu, PW; Chang, CJ; Tian, YC; Yang, CW; Chu, PH				Lu, Yueh-An; Tu, Kun-Hua; Lee, Cheng-Chia; Wu, Patricia W.; Chang, Chee-Jen; Tian, Ya-Chung; Yang, Chih-Wei; Chu, Pao-Hsien			Prognostic impact of peritonitis in hemodialysis patients: A national-wide longitudinal study in Taiwan	PLOS ONE			English	Article							SPONTANEOUS BACTERIAL PERITONITIS; CHRONIC KIDNEY-DISEASE; STAGE RENAL-DISEASE; LIVER-CIRRHOSIS; DIALYSIS; MORTALITY; SURVIVAL; OUTCOMES; PREVALENCE; PREDICTORS	Background Peritonitis has been independently associated with increased morbidity and mortality in peritoneal dialysis patients. However, there are few reports on peritonitis in hemodialysis patients. We aim at investigating both the risk profiles and prognostic impact of peritonitis in hemodialysis patients. Methods This nation-wide longitudinal study uses claims data obtained from the Taiwan National Health Insurance Research Database. A total of 80,733 incident hemodialysis patients of age >= 20 years without a history of peritonitis were identified between January 1, 1998 and December 31, 2009. Predictors of peritonitis events were estimated using Cox proportional hazard models. Time-dependent Cox proportional hazard models were used to estimate hazard ratio for mortality attributed to peritonitis exposure. Results Of 80,733 incident hemodialysis patients over a 13-year study period, peritonitis was diagnosed in 935 (1.16%), yielding an incidence rate of 2.91 per 1000 person-years. Female gender, liver cirrhosis and polycystic kidney disease were three of the most significant factors for peritonitis in both non -diabetic and diabetic hemodialysis patients. The cumulative survival rate of patients with peritonitis was 38.8% at 1 year and 10.1% at 5 years. A time dependent Cox multivariate analysis showed that peritonitis had significantly increased hazard ratio for all cause mortality. Additionally, the risk of mortality remained significantly higher for non-diabetic hemodialysis patients that experienced peritonitis. Conclusions The risk of peritonitis in hemodialysis patients is higher in female gender, liver cirrhosis and polycystic kidney disease. Although peritonitis is a rare condition, it is associated with significantly poorer outcome in hemodialysis patients.	[Lu, Yueh-An; Tu, Kun-Hua; Lee, Cheng-Chia; Tian, Ya-Chung; Yang, Chih-Wei] Linkou Chang Gung Mem Hosp, Dept Nephrol, Kidney Res Ctr, Taipei, Taiwan; [Lu, Yueh-An; Tu, Kun-Hua; Lee, Cheng-Chia; Tian, Ya-Chung; Yang, Chih-Wei] Chang Gung Univ, Dept Med, Taoyuan, Taiwan; [Tu, Kun-Hua; Lee, Cheng-Chia; Yang, Chih-Wei] Chang Gung Univ, Grad Inst Clin Med Sci, Coll Med, Taoyuan, Taiwan; [Wu, Patricia W.] Chang Gung Mem Hosp, Dept Radiol, Linkou, Taiwan; [Chang, Chee-Jen] Chang Gung Univ, Grad Inst Clin Med, Taoyuan, Taiwan; [Chang, Chee-Jen] Chang Gung Univ, Res Serv Ctr Hlth Informat, Taoyuan, Taiwan; [Chang, Chee-Jen] Chang Gung Univ, Clin Informat & Med Stat Res Ctr, Taoyuan, Taiwan; [Chang, Chee-Jen; Chu, Pao-Hsien] Chang Gung Univ, Chang Gung Mem Hosp, Dept Cardiol, Coll Med, Taipei, Taiwan; [Chu, Pao-Hsien] Chang Gung Univ, Coll Med, Healthcare Ctr, Chang Gung Mem Hosp, Taipei, Taiwan; [Chu, Pao-Hsien] Chang Gung Univ, Coll Med, Chang Gung Mem Hosp, Heart Failure Ctr, Taipei, Taiwan	Chang Gung Memorial Hospital; Chang Gung University; Chang Gung University; Chang Gung Memorial Hospital; Chang Gung University; Chang Gung University; Chang Gung University; Chang Gung Memorial Hospital; Chang Gung University; Chang Gung Memorial Hospital; Chang Gung University; Chang Gung Memorial Hospital; Chang Gung University	Chu, PH (corresponding author), Chang Gung Univ, Chang Gung Mem Hosp, Dept Cardiol, Coll Med, Taipei, Taiwan.; Chu, PH (corresponding author), Chang Gung Univ, Coll Med, Healthcare Ctr, Chang Gung Mem Hosp, Taipei, Taiwan.; Chu, PH (corresponding author), Chang Gung Univ, Coll Med, Chang Gung Mem Hosp, Heart Failure Ctr, Taipei, Taiwan.	taipei.chu@gmail.com	Tu, Kun-Hua/ABD-1751-2021; Chu, Pao-Hsien/P-5249-2019	Tu, Kun-Hua/0000-0002-7146-4481; Chu, Pao-Hsien/0000-0003-0361-6348; Wu, Patricia/0000-0002-7453-0368; Lu, Yueh-An/0000-0002-5486-2357; Lee, Cheng-Chia/0000-0002-6973-5908	Linkou Chang-Gung Memorial Hospital [CMRPG3F2691, CMRPG3B1352, CORPG3F581]; Biostatistical Center for Clinical Research, Chang Gung Memorial Hospital [CLRPG3D0042]; Research Services Center For Health Information, Chang Gung University [CIRPD1D0031]	Linkou Chang-Gung Memorial Hospital; Biostatistical Center for Clinical Research, Chang Gung Memorial Hospital; Research Services Center For Health Information, Chang Gung University	This work was supported by the Research Grant of Linkou Chang-Gung Memorial Hospital, grant number CMRPG3F2691, CMRPG3B1352 and CORPG3F581. The authors wish to acknowledge the Biostatistical Center for Clinical Research, Chang Gung Memorial Hospital (Grant CLRPG3D0042) and Research Services Center For Health Information, Chang Gung University (Grant CIRPD1D0031) for statistical consultation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abou Dagher G, 2015, BMC EMERG MED, V15, DOI 10.1186/s12873-015-0057-y; [Anonymous], 2016, 2015 ANN REPORT KIDN; Bradbury BD, 2007, CLIN J AM SOC NEPHRO, V2, P89, DOI 10.2215/CJN.01170905; Chen CH, 2007, J FORMOS MED ASSOC, V106, P148, DOI 10.1016/S0929-6646(09)60231-X; Chiu YL, 2008, NEPHRON CLIN PRACT, V109, pC109, DOI 10.1159/000145453; Dalrymple LS, 2015, AM J KIDNEY DIS, V65, P754, DOI 10.1053/j.ajkd.2014.11.030; de Jager DJ, 2009, JAMA-J AM MED ASSOC, V302, P1782, DOI 10.1001/jama.2009.1488; De Vecchi AF, 2002, AM J KIDNEY DIS, V40, P161, DOI 10.1053/ajkd.2002.33925; Doklestic S K, 2014, J Med Life, V7, P132; Eleftheriadis T, 2007, SEMIN DIALYSIS, V20, P440, DOI 10.1111/J.1525-139X.2007.00283.x; Fontan MP, 2005, PERITON DIALYSIS INT, V25, P274; Fried LF, 1996, J AM SOC NEPHROL, V7, P2176; Gunjaca I, 2010, ACTA CLIN CROAT, V49, P11; Hammami M, 2010, N AM J MED SCI, V2, P238; Heaf JG, 2002, NEPHROL DIAL TRANSPL, V17, P112, DOI 10.1093/ndt/17.1.112; Kim HW, 2011, CLIN EXP NEPHROL, V15, P258, DOI 10.1007/s10157-010-0379-8; Klaric D, 2013, INT UROL NEPHROL, V45, P519, DOI 10.1007/s11255-012-0257-2; Kotwal S, 2015, NEPHROLOGY; Kraja B, 2012, GASTROENTEROL RES PR, V2012; Lantinga MA, 2016, NEPHROLOGY DIALYSIS; Litjens NHR, 2008, J AM SOC NEPHROL, V19, P1483, DOI 10.1681/ASN.2007090971; de Bustillo EM, 2011, NEFROLOGIA, V31, P723, DOI 10.3265/Nefrologia.pre2011.Oct.10987; Nessim SJ, 2009, CLIN J AM SOC NEPHRO, V4, P1195, DOI 10.2215/CJN.00910209; Ono Yasuo, 2004, Journal of Infection and Chemotherapy, V10, P200; Ra G, 2015, J CLIN GASTROENTEROL, V49, P858, DOI 10.1097/MCG.0000000000000311; Saran R, 2016, AM J KIDNEY DIS, V67, pS1, DOI 10.1053/j.ajkd.2015.12.014; Schirren CA, 1997, CLIN EXP IMMUNOL, V108, P144, DOI 10.1046/j.1365-2249.1997.d01-985.x; Selgas R, 2008, PERITON DIALYSIS INT, V28, P118; SKLAR AH, 1987, AM J KIDNEY DIS, V10, P81, DOI 10.1016/S0272-6386(87)80036-7; Suwabe T, 2015, EUR J CLIN MICROBIOL, V34, P1369, DOI 10.1007/s10096-015-2361-6; Taylor NJ, 2014, ALIMENT PHARM THER, V40, P705, DOI 10.1111/apt.12886; Thomas B, 2015, J AM SOC NEPHROL, V26, P2621, DOI 10.1681/ASN.2014101017; Tsung PC, 2013, CLIN MOL HEPATOL, V19, P131, DOI 10.3350/cmh.2013.19.2.131; van Esch S, 2014, PERITON DIALYSIS INT, V34, P162, DOI 10.3747/pdi.2013.00275; van Manen JG, 2002, AM J KIDNEY DIS, V40, P82, DOI 10.1053/ajkd.2002.33916; Wen CP, 2008, LANCET, V371, P2173, DOI 10.1016/S0140-6736(08)60952-6; Wiest R, 2014, J HEPATOL, V60, P197, DOI 10.1016/j.jhep.2013.07.044; Zahir M, 2013, CASE REP UROL, V2013; Zimmerman D, 2012, NEPHROL DIAL TRANSPL, V27, P3816, DOI 10.1093/ndt/gfs416	39	1	1	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 16	2017	12	3							e0173710	10.1371/journal.pone.0173710	http://dx.doi.org/10.1371/journal.pone.0173710			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN9KE	28301536	Green Submitted, Green Published, gold			2022-12-27	WOS:000396318300064
J	Thiebaut, C; Chamard-Jovenin, C; Chesnel, A; Morel, C; Djermoune, E; Boukhobza, T; Dumond, H				Thiebaut, Charlene; Chamard-Jovenin, Clemence; Chesnel, Amand; Morel, Chloe; Djermoune, El-Hadi; Boukhobza, Taha; Dumond, Helene			Mammary epithelial cell phenotype disruption in vitro and in vivo through ERalpha36 overexpression	PLOS ONE			English	Article							ESTROGEN-RECEPTOR-ALPHA; TAMOXIFEN RESISTANCE; GLAND DEVELOPMENT; ER-ALPHA-36; EXPRESSION; VARIANT; PROLIFERATION; GPR30; RECEPTOR-ALPHA-36; 17-BETA-ESTRADIOL	Estrogen receptor alpha 36 (ER alpha 36) is a variant of the canonical estrogen receptor alpha (ER alpha 66), widely expressed in hormone sensitive cancer cells and whose high expression level correlates with a poor survival prognosis for breast cancer patients. While ER alpha 36 activity have been related to breast cancer progression or acquired resistance to treatment, expression level and location of ER alpha 36 are poorly documented in the normal mammary gland. Therefore, we explored the consequences of a ER alpha 36 overexpression in vitro in MCF-10A normal mammary epithelial cells and in vivo in a unique model of MMTV-ER alpha 36 transgenic mouse strain wherein ER alpha 36 mRNA was specifically expressed in the mammary gland. By a combination of bioinformatics and computational analyses of microarray data, we identified hierarchical gene networks, downstream of ER alpha 36 and modulated by the JAK2/STAT3 signaling pathway. Concomitantly, ER alpha 36 overexpression lowered proliferation rate but enhanced migration potential and resistance to staurosporin-induced apoptosis of the MCF-10A cell line. In vivo, ER alpha 36 expression led to duct epithelium thinning and disruption in adult but not in prepubescent mouse mammary gland. These phenotypes correlated with a loss of E-cadherin expression. Here, we show that an enhanced expression of ER alpha 36 is sufficient, by itself, to disrupt normal breast epithelial phenotype in vivo and in vitro through a dominant-positive effect on nongenomic estrogen signaling pathways. These results also suggest that, in the presence of adult endogenous steroid levels, ER alpha 36 overexpression in vivo contributes to alter mammary gland architecture which may support preneoplastic lesion and augment breast cancer risk.	[Thiebaut, Charlene; Chamard-Jovenin, Clemence; Chesnel, Amand; Morel, Chloe; Djermoune, El-Hadi; Boukhobza, Taha; Dumond, Helene] Univ Lorraine, CNRS, Ctr Rech Automat Nancy, UMR 7039, BP70239, Vandoeuvre Les Nancy, France	Centre National de la Recherche Scientifique (CNRS); Universite de Lorraine	Dumond, H (corresponding author), Univ Lorraine, CNRS, Ctr Rech Automat Nancy, UMR 7039, BP70239, Vandoeuvre Les Nancy, France.	helene.dumond@univ-lorraine.fr		Boukhobza, Taha/0000-0003-1046-3554; Dumond, Helene/0000-0002-9697-3901; THIEBAUT, Charlene/0000-0002-4338-2753	Anses - Agence nationale de securite sanitaire de l'alimentation, de lenvironnement et du travail; Institut national de la sante et de la recherche medicale Plan Cancer/environnement [ENV201304]; La Ligue contre le cancer; Region Lorraine	Anses - Agence nationale de securite sanitaire de l'alimentation, de lenvironnement et du travail(French National Research Agency (ANR)); Institut national de la sante et de la recherche medicale Plan Cancer/environnement; La Ligue contre le cancer(Ligue nationale contre le cancer); Region Lorraine(Region Grand-Est)	The funders are all French: the Anses - Agence nationale de securite sanitaire de l'alimentation, de lenvironnement et du travail https://www.anses.fr/ (fund 2012/2/014; recipient HD), the Institut national de la sante et de la recherche medicale www.inserm.fr Plan Cancer/environnement (fund ENV201304; recipient HD), La Ligue contre le cancer www.ligue-cancer.net/ (fund 2016; recipient HD) and the Region Lorraine for a half PhD fellowship http://www.lorraine.eu (CC). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ajj H, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061758; Albanito L, 2007, CANCER RES, V67, P1859, DOI 10.1158/0008-5472.CAN-06-2909; Atwood CS, 2000, J ENDOCRINOL, V167, P39, DOI 10.1677/joe.0.1670039; Banerjee S, 2014, STEROIDS, V81, P64, DOI 10.1016/j.steroids.2013.11.002; Bjornstrom L, 2005, MOL ENDOCRINOL, V19, P833, DOI 10.1210/me.2004-0486; Bocchinfuso WP, 2000, ENDOCRINOLOGY, V141, P2982, DOI 10.1210/en.141.8.2982; Brandt R, 2000, ONCOGENE, V19, P2129, DOI 10.1038/sj.onc.1203520; Chamard-Jovenin C, 2015, BMC SYST BIOL, V9, DOI 10.1186/s12918-015-0178-7; Chaudhri RA, 2014, STEROIDS, V81, P74, DOI 10.1016/j.steroids.2013.10.020; Chaudhri RA, 2012, J BIOL CHEM, V287, P7169, DOI 10.1074/jbc.M111.292946; Dimitrios Iliopoulos, 2009, CELL, V139, P693; Elbaradie KBY, 2013, BBA-MOL CELL RES, V1833, P1165, DOI 10.1016/j.bbamcr.2012.12.022; Feng Y, 2007, P NATL ACAD SCI USA, V104, P14718, DOI 10.1073/pnas.0706933104; Forster C, 2002, P NATL ACAD SCI USA, V99, P15578, DOI 10.1073/pnas.192561299; Fox EM, 2008, MOL ENDOCRINOL, V22, P1781, DOI 10.1210/me.2007-0419; Frangi AF, 1998, LECT NOTES COMPUT SC, V1496, P130, DOI 10.1007/BFb0056195; Gao F, 2011, ENDOCRINOLOGY, V152, P1434, DOI 10.1210/en.2010-1368; Gibson DA, 2012, MOL CELL ENDOCRINOL, V348, P361, DOI 10.1016/j.mce.2011.09.026; Howroyd P, 2005, TOXICOL PATHOL, V33, P300, DOI 10.1080/01926230590896145; Iliopoulos D, 2010, MOL CELL, V39, P493, DOI 10.1016/j.molcel.2010.07.023; Inman JL, 2015, DEVELOPMENT, V142, P1028, DOI 10.1242/dev.087643; Irsik DL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070926; Javed A, 2013, SEMIN PLAST SURG, V27, P5, DOI 10.1055/s-0033-1343989; Kamran MZ, 2013, BIOMED RES INT, V2013, DOI 10.1155/2013/421821; Kang LG, 2011, J STEROID BIOCHEM, V127, P262, DOI 10.1016/j.jsbmb.2011.08.011; Kang LG, 2010, MOL ENDOCRINOL, V24, P709, DOI 10.1210/me.2009-0317; Kwon O, 2014, METABOLISM, V63, P1455, DOI 10.1016/j.metabol.2014.07.015; Macias H, 2012, WIRES DEV BIOL, V1, P533, DOI 10.1002/wdev.35; Mallepell S, 2006, P NATL ACAD SCI USA, V103, P2196, DOI 10.1073/pnas.0510974103; Marino M, 2006, CURR GENOMICS, V7, P497, DOI 10.2174/138920206779315737; Mehta RG, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0113175; Mootha VK, 2003, NAT GENET, V34, P267, DOI 10.1038/ng1180; Panneerselvam M, 2015, MOL BIOSYST, V11, P2998, DOI 10.1039/c5mb00272a; Paulose T, 2015, REPROD TOXICOL, V54, P58, DOI 10.1016/j.reprotox.2014.09.012; Peng M, 2015, CELL DEATH DIS, V6, DOI 10.1038/cddis.2015.210; Qian HY, 2016, J IMMUNOL RES, V2016, DOI 10.1155/2016/7128702; Shi L, 2009, J CLIN ONCOL, V27, P3423, DOI 10.1200/JCO.2008.17.2254; Soltysik K, 2015, EUR J CELL BIOL, V94, P611, DOI 10.1016/j.ejcb.2015.10.001; SOULE HD, 1990, CANCER RES, V50, P6075; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Tran K, 2012, CANCER PREV RES, V5, P726, DOI 10.1158/1940-6207.CAPR-11-0404; Tylcz JB, 2015, BIOMED SIGNAL PROCES, V20, P52, DOI 10.1016/j.bspc.2015.04.008; Vandenberg LN, 2007, ENDOCRINOLOGY, V148, P116, DOI 10.1210/en.2006-0561; Wallacides A, 2012, MOL CELL ENDOCRINOL, V350, P61, DOI 10.1016/j.mce.2011.11.021; [王健 Wang Jian], 2015, [第三军医大学学报, Journal of Third Military Medical University], V37, P340; Wang ZY, 2015, MOL CELL ENDOCRINOL, V418, P193, DOI 10.1016/j.mce.2015.04.017; Wang ZY, 2005, BIOCHEM BIOPH RES CO, V336, P1023, DOI 10.1016/j.bbrc.2005.08.226; Yin L, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0107369; Yu LF, 2014, STEROIDS, V84, P11, DOI 10.1016/j.steroids.2014.03.003; Zhang MR, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057364; Zhang XT, 2011, ONCOGENE, V30, P770, DOI 10.1038/onc.2010.458; Zhang XT, 2013, ENDOCRINOLOGY, V154, P1990, DOI 10.1210/en.2013-1116; Zhang XT, 2014, J STEROID BIOCHEM, V143, P434, DOI 10.1016/j.jsbmb.2014.06.009; Zhang XT, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030174; Zou Y, 2009, FEBS LETT, V583, P1368, DOI 10.1016/j.febslet.2009.03.047	55	9	9	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 16	2017	12	3							e0173931	10.1371/journal.pone.0173931	http://dx.doi.org/10.1371/journal.pone.0173931			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN9KE	28301550	Green Submitted, gold, Green Published			2022-12-27	WOS:000396318300098
J	Bas, AA; Christiansen, F; Ozturk, AA; Ozturk, B; McIntosh, C				Bas, Aylin Akkaya; Christiansen, Fredrik; Ozturk, Ayaka Amaha; Ozturk, Bayram; McIntosh, Caley			The effects of marine traffic on the behaviour of Black Sea harbour porpoises (Phocoena phocoena relicta) within the Istanbul Strait, Turkey	PLOS ONE			English	Article							BOTTLE-NOSED DOLPHINS; TURSIOPS-TRUNCATUS; TOUR BOATS; BAY; WHALES; DISTURBANCE; NOISE; RESPONSES; SOUND	Marine traffic is threatening cetaceans on a local and global scale. The Istanbul Strait is one of the busiest waterways, with up to 2,500 vessels present daily. This is the first study to assess the magnitude of short-and long-term behavioural changes of the endangered Black Sea harbour porpoises (Phocoena phocoena relicta) in the presence of marine vessels within the Istanbul Strait. Markov chains were used to investigate the effect of vessel presence on the transition probability between behavioural states (diving, surface-feeding and travelling), and to quantify the effect on the behavioural budget and bout length (duration of time spent in a given state) of porpoises. Further, the changes on swimming directions of porpoises in relation to vessel speed and distance was investigated using generalized linear models. In vessel presence, porpoises were less likely to remain in a given behavioural state and instead more likely to switch to another state. Because of this, the bout length of all three behavioural states decreased significantly in the presence of vessels. The vessel effect was sufficiently large to alter the behavioural budget, with surface-feeding decreasing significantly in the presence of vessels. However, when taking into account the proportion of time that porpoises were exposed to vessels (i.e. 50%), the measured effect size was not large enough to significantly alter the animals' cumulative (diurnal) behavioural budget. Additionally, vessel speed and distance had a significant effect on the probability of porpoises showing a response in their swimming directions. The southern and middle sections of the Istanbul Strait, which have the heaviest marine traffic pressure, had the lowest porpoise sightings throughout the year. Conversely, northern sections that were exposed to a lesser degree of marine traffic hold the highest porpoise sightings. The effect shown in this study in combination with increasing human impacts within the northern sections should be considered carefully and species-specific conservation actions, including establishment of protected areas, should be put in place to prevent the long-term consequences of marine traffic on the Black Sea harbour porpoise population.	[Bas, Aylin Akkaya; Ozturk, Ayaka Amaha; Ozturk, Bayram] Istanbul Univ, Fac Fisheries, Istanbul, Turkey; [Bas, Aylin Akkaya; Ozturk, Ayaka Amaha; Ozturk, Bayram] Turkish Marine Res Fdn, Istanbul, Turkey; [Bas, Aylin Akkaya; McIntosh, Caley] Marine Mammals Res Assoc, Antalya, Turkey; [Christiansen, Fredrik] Murdoch Univ, Sch Vet & Life Sci, Cetacean Res Unit, Murdoch, WA 6150, Australia	Istanbul University; Turkish Marine Research Foundation; Uludag University; Murdoch University	Bas, AA (corresponding author), Istanbul Univ, Fac Fisheries, Istanbul, Turkey.; Bas, AA (corresponding author), Turkish Marine Res Fdn, Istanbul, Turkey.; Bas, AA (corresponding author), Marine Mammals Res Assoc, Antalya, Turkey.	akkayaaylinn@gmail.com	Ozturk, Ayaka Amaha/ABI-4939-2020; Öztürk, Bayram/AAD-6228-2020; Christiansen, Fredrik/O-3655-2017; Amaha Ozturk, Ayaka/AAB-8197-2022; Ozturk, Ayaka Amaha/AAD-6380-2020	Öztürk, Bayram/0000-0001-7844-2448; Christiansen, Fredrik/0000-0001-9090-8458; AKKAYA BAS, AYLIN/0000-0002-0414-770X	Istanbul University [18476]	Istanbul University(Istanbul University)	Only part of the named research is funded by Istanbul University with a grant number of 18476 which was part of a PhD thesis named "Investigation on the interactions between cetaceans and marine traffic in the Istanbul Strait". However there was no additional external funding received for this study.	[Anonymous], 2013, ANN REPORT; [Anonymous], 2010, IMO ASS 61 SESS, P14; [Anonymous], 2014, R LANG ENV STAT COMP; Bain DE, 2006, AB133F05SE3965 NMFS; BAIN DE, 2002, MODEL LINKING ENERGE; Barr K, 1998, EFFECTS TOURISM DUSK; Bas AA, 2015, MAR MAMMAL SCI, V31, P979, DOI 10.1111/mms.12202; Bejder L, 1999, MAR MAMMAL SCI, V15, P738, DOI 10.1111/j.1748-7692.1999.tb00840.x; Bejder L, 2006, ANIM BEHAV, V72, P1149, DOI 10.1016/j.anbehav.2006.04.003; Bejder Lars, 2003, P229; Bejder L, 2006, CONSERV BIOL, V20, P1791, DOI 10.1111/j.1523-1739.2006.00540.x; Birkun Jr A. A., 2008, IUCN RED LIST THREAT, DOI [10.2305/IUCN.UK.2008.RLTS.T17030A6737111.en, DOI 10.2305/IUCN.UK.2008.RLTS.T17030A6737111.EN]; Bryant P.J., 1984, P375; Christiansen F., 2014, WHALE WATCHING SUSTA, P177, DOI [10.1017/CBO9781139018166.016, DOI 10.1017/CBO9781139018166.016]; Christiansen F, 2015, CONSERV LETT, V8, P424, DOI 10.1111/conl.12166; Christiansen F, 2013, BEHAV ECOL, V24, P1415, DOI 10.1093/beheco/art086; Christiansen Fredrik, 2010, Endangered Species Research, V11, P91, DOI 10.3354/esr00265; Constantine R, 2004, BIOL CONSERV, V117, P299, DOI 10.1016/j.biocon.2003.12.009; Currey RJC, 2009, BIOL CONSERV, V142, P1570, DOI 10.1016/j.biocon.2009.02.036; Dans SL, 2008, MAR ECOL PROG SER, V369, P287, DOI 10.3354/meps07629; Dede A, 2013, J MAR BIOL ASSOC UK, P1; Dede A, 2008, 22 ANN C EUR CET SOC, V22, P22; di Sciara G Notarbartolo, 2001, P WORKSH PROT AR CET, V38, P28; Dyndo M, 2015, SCI REP-UK, V5, DOI 10.1038/srep11083; European Commission, 2013, SWD2013524 EUR COMM; Fleiss J. L., 1981, STAT METHODS RATES P, V2, P22; Frantzis A, 2001, MAR MAMMAL SCI, V17, P937, DOI 10.1111/j.1748-7692.2001.tb01307.x; Gordon J., 1992, SCI RES SERIES, V52; Hastie GD, 2003, MAR MAMMAL SCI, V19, P74, DOI 10.1111/j.1748-7692.2003.tb01093.x; Hermannsen L, 2014, J ACOUST SOC AM, V136, P1640, DOI 10.1121/1.4893908; Hildebrand JA, 2009, MAR ECOL PROG SER, V395, P5, DOI 10.3354/meps08353; Hoyt Erich, 2005, Biology and Environment, V105B, P141, DOI 10.3318/BIOE.2005.105.3.141; Istanbul Port Authority, 2011, DOM MAR TRAFF GUID; IWC, 2004, J CETACEAN RES MANAG, V6, P315; Kastelein RA, 2011, J ACOUST SOC AM, V129, P2307, DOI 10.1121/1.3559679; Laist DW, 2001, MAR MAMMAL SCI, V17, P35, DOI 10.1111/j.1748-7692.2001.tb00980.x; Lemon M, 2006, BIOL CONSERV, V127, P363, DOI 10.1016/j.biocon.2005.08.016; Lusseau D., 2006, Tourism in Marine Environments, V3, P173, DOI 10.3727/154427306779435184; Lusseau D, 2005, MAR ECOL PROG SER, V295, P265, DOI 10.3354/meps295265; Lusseau D, 2003, CONSERV BIOL, V17, P1785, DOI 10.1111/j.1523-1739.2003.00054.x; Lusseau D, 2004, ECOL SOC, V9; Lusseau D, 2006, MAR MAMMAL SCI, V22, P802, DOI 10.1111/j.1748-7692.2006.00052.x; Lusseau David, 2009, Endangered Species Research, V6, P211, DOI 10.3354/esr00154; Martin J, 2015, METHODS ECOLOGY EVOL; McDonald MA, 2006, J ACOUST SOC AM, V120, P711, DOI 10.1121/1.2216565; Meissner AM, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0116962; Neumann Dirk R., 2006, Aquatic Mammals, V32, P1, DOI 10.1578/AM.32.1.2006.1; Notarbartolo di Sciara, 2002, CETACEANS MEDITERRAN; Notarbartolo di Sciara G, 2002, CETACEANS MEDITERRAN, P98; Nowacek SM, 2001, MAR MAMMAL SCI, V17, P673, DOI 10.1111/j.1748-7692.2001.tb01292.x; Ozturk Bayram, 1996, Bulletin de l'Institut Oceanographique Numero Special (Monaco), V17, P205; Panigada S, 2006, MAR POLLUT BULL, V52, P1287, DOI 10.1016/j.marpolbul.2006.03.014; Polacheck T., 1990, REPORT INT WHALING C, V40, P463; Reeves R.R., 2006, STATUS DISTRIBUTION; RICHARDSON WJ, 1995, MAR MAMMAL SCI, V11, P1, DOI 10.1111/j.1748-7692.1995.tb00272.x; Simmonds Mark, 2004, OCEANS NOISE WDCS SC; Soto NA, 2006, MAR MAMMAL SCI, V22, P690, DOI 10.1111/j.1748-7692.2006.00044.x; Stockin KA, 2008, MAR ECOL PROG SER, V355, P287, DOI 10.3354/meps07386; Van Parijs SM, 2001, J MAR BIOL ASSOC UK, V81, P533, DOI 10.1017/S0025315401004180; Van Waerebeek Koen, 2007, Latin American Journal of Aquatic Mammals, V6, P43; Williams R, 2006, BIOL CONSERV, V133, P301, DOI 10.1016/j.biocon.2006.06.010	61	12	13	3	52	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 15	2017	12	3							e0172970	10.1371/journal.pone.0172970	http://dx.doi.org/10.1371/journal.pone.0172970			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN9HQ	28296899	Green Published, gold, Green Submitted			2022-12-27	WOS:000396311700018
J	de Bree, GJ; Wheatley, AK; Lynch, RM; Prabhakaran, M; Grijsen, ML; Prins, JM; Schmidt, SD; Koup, RA; Mascola, JR; McDermott, AB				de Bree, Godelieve J.; Wheatley, Adam K.; Lynch, Rebecca M.; Prabhakaran, Madhu; Grijsen, Marlous L.; Prins, Jan M.; Schmidt, Stephen D.; Koup, Richard A.; Mascola, John R.; McDermott, Adrian B.			Longitudinal dynamics of the HIV-specific B cell response during intermittent treatment of primary HIV infection	PLOS ONE			English	Article							IMMUNODEFICIENCY-VIRUS; NEUTRALIZING ANTIBODIES; ANTIRETROVIRAL THERAPY; MONOCLONAL-ANTIBODIES; SHIV CHALLENGE; PROTECTION; EVOLUTION; BINDING; MACAQUES; INDIVIDUALS	Background Neutralizing antibodies develop in natural HIV-1 infection. Their development often takes several years and may rely on chronic virus exposure. At the same time recent studies show that treatment early in infection may provide opportunities for immune preservation. However, it is unknown how intermittent treatment in early infection affects development of the humoral immune response over time. We investigate the effect of cART in early HIV infection on the properties of the memory B cell compartment following 6 months of cART or in the absence of treatment. The patients included participated in the Primo-SHM trial where patients with an early HIV-1 infection were randomized to no treatment or treatment for 24 or 60 weeks. Methods Primo-SHM trial patients selected for the present study were untreated (n = 23) or treated for 24 weeks (n = 24). Here we investigate memory B cell properties at viral set-point and at a late time point (respectively median 54 and 73 weeks) before (re)-initiation of treatment. Results At viral set-point, the memory B cell compartment in treated patients demonstrated significantly lower fractions of antigen-primed, activated, memory B cells (p = 0.006). In contrast to untreated patients, in treated patients the humoral HIV-specific response reached a set point over time. At a transcriptional level, sets of genes that showed enhanced expression in memory B cells at viral setpoint in untreated patients, conversely showed rapid increase of expression of the same genes in treated patients at the late time point. Conclusion These data suggest that, although the memory B cell compartment is phenotypically preserved until viral setpoint after treatment interruption, the development of the HIV-specific antibody response may benefit from exposure to HIV. The effect of viral exposure on B cell properties is also reflected by longitudinal changes in transcriptional profile in memory B cells over time in early treated patients.	[de Bree, Godelieve J.; Grijsen, Marlous L.; Prins, Jan M.] Acad Med Ctr, Dept Internal Med, Amsterdam, Netherlands; [de Bree, Godelieve J.] Univ Amsterdam, Inst Global Hlth & Dev, Amsterdam, Netherlands; [Wheatley, Adam K.; Lynch, Rebecca M.; Prabhakaran, Madhu; Schmidt, Stephen D.; Koup, Richard A.; Mascola, John R.; McDermott, Adrian B.] NIAID, Vaccine Res Ctr, NIH, 9000 Rockville Pike, Bethesda, MD 20892 USA	University of Amsterdam; Academic Medical Center Amsterdam; University of Amsterdam; National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID)	de Bree, GJ (corresponding author), Acad Med Ctr, Dept Internal Med, Amsterdam, Netherlands.; de Bree, GJ (corresponding author), Univ Amsterdam, Inst Global Hlth & Dev, Amsterdam, Netherlands.	g.j.debree@amc.uva.nl	Prabhakaran, Madhu/AEY-7127-2022; Prins, Jan M./AAF-4945-2020; Schmidt, Stephen/AAC-6967-2019; Mascola, John/AAI-7193-2021	Prins, Jan/0000-0002-5415-8933; McDermott, Adrian/0000-0003-0616-9117; Wheatley, Adam/0000-0002-5593-9387	Dutch Infectious Diseases Society	Dutch Infectious Diseases Society	GJdB received a travelgrant from the Dutch Infectious Diseases Society.	Abudulai LN, 2016, JAIDS-J ACQ IMM DEF, V71, P381, DOI 10.1097/QAI.0000000000000869; Alam SM, 2008, J VIROL, V82, P115, DOI 10.1128/JVI.00927-07; Altfeld M, 2001, J EXP MED, V193, P169, DOI 10.1084/jem.193.2.169; Bamford A, 2015, CLIN EXP IMMUNOL, V181, P110, DOI 10.1111/cei.12618; Barouch DH, 2013, NATURE, V503, P224, DOI 10.1038/nature12744; Burton DR, 2011, P NATL ACAD SCI USA, V108, P11181, DOI 10.1073/pnas.1103012108; Caskey M, 2015, NATURE, V522, P487, DOI 10.1038/nature14411; Charles ED, 2011, BLOOD, V117, P5425, DOI 10.1182/blood-2010-10-312942; De Milito A, 2004, BLOOD, V103, P2180, DOI 10.1182/blood-2003-07-2375; de Souza MS, 2016, CLIN INFECT DIS, V63, P555, DOI 10.1093/cid/ciw365; Dey B, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000445; Dominguez MH, 2013, J IMMUNOL METHODS, V391, P133, DOI 10.1016/j.jim.2013.03.002; Doria-Rose NA, 2010, J VIROL, V84, P1631, DOI 10.1128/JVI.01482-09; Feng Y, 2012, J BIOL CHEM, V287, P5673, DOI 10.1074/jbc.M111.317776; Fiebig EW, 2003, AIDS, V17, P1871, DOI 10.1097/00002030-200309050-00005; Gray ES, 2011, J VIROL, V85, P4828, DOI 10.1128/JVI.00198-11; Grijsen ML, 2012, PLOS MED, V9, DOI 10.1371/journal.pmed.1001196; Hraber P, 2014, AIDS, V28, P163, DOI 10.1097/QAD.0000000000000106; Huang JH, 2012, NATURE, V491, P406, DOI 10.1038/nature11544; Kardava L, 2014, J CLIN INVEST, V124, P3252, DOI 10.1172/JCI74351; Keele BF, 2008, P NATL ACAD SCI USA, V105, P7552, DOI 10.1073/pnas.0802203105; Kurosaki T, 2015, NAT REV IMMUNOL, V15, P149, DOI 10.1038/nri3802; LANE HC, 1983, NEW ENGL J MED, V309, P453, DOI 10.1056/NEJM198308253090803; Li YX, 2007, NAT MED, V13, P1032, DOI 10.1038/nm1624; Liao HX, 2013, NATURE, V496, P469, DOI 10.1038/nature12053; Lindqvist M, 2012, J CLIN INVEST, V122, P3271, DOI 10.1172/JCI64314; Lynch RM, 2012, J VIROL, V86, P7588, DOI 10.1128/JVI.00734-12; Malaspina A, 2006, P NATL ACAD SCI USA, V103, P2262, DOI 10.1073/pnas.0511094103; Mascola JR, 2000, NAT MED, V6, P207, DOI 10.1038/72318; Moir S, 2001, P NATL ACAD SCI USA, V98, P10362, DOI 10.1073/pnas.181347898; Moir S, 2008, J EXP MED, V205, P1797, DOI 10.1084/jem.20072683; Moir S, 2008, J INFECT DIS, V197, P572, DOI 10.1086/526789; Moir S, 2013, IMMUNOL REV, V254, P207, DOI 10.1111/imr.12067; Moir S, 2010, BLOOD, V116, P5571, DOI 10.1182/blood-2010-05-285528; Moldt B, 2012, P NATL ACAD SCI USA, V109, P18921, DOI 10.1073/pnas.1214785109; Moore PL, 2012, NAT MED, V18, P1688, DOI 10.1038/nm.2985; Morris L, 1998, J EXP MED, V188, P233, DOI 10.1084/jem.188.2.233; Muir R, 2016, PLOS PATHOG, V12, DOI 10.1371/journal.ppat.1005777; Parren PWHI, 2001, J VIROL, V75, P8340, DOI 10.1128/JVI.75.17.8340-8347.2001; Pegu P, 2013, J VIROL, V87, P1708, DOI 10.1128/JVI.02544-12; Richman DD, 2003, P NATL ACAD SCI USA, V100, P4144, DOI 10.1073/pnas.0630530100; Rusert P, 2016, NAT MED, V22, P1260, DOI 10.1038/nm.4187; Sather DN, 2014, J VIROL, V88, P12968, DOI 10.1128/JVI.01816-14; Sather DN, 2009, J VIROL, V83, P757, DOI 10.1128/JVI.02036-08; Tarlinton D, 2008, CURR OPIN IMMUNOL, V20, P162, DOI 10.1016/j.coi.2008.03.016; Tomaras GD, 2008, J VIROL, V82, P12449, DOI 10.1128/JVI.01708-08; Trkola A, 2005, NAT MED, V11, P615, DOI 10.1038/nm1244; Wei XP, 2003, NATURE, V422, P307, DOI 10.1038/nature01470; Weiss GE, 2009, J IMMUNOL BALTIM MD, V1950, P183; Wu F, 2012, J VIROL, V86, P8835, DOI 10.1128/JVI.00923-12; Wu XL, 2011, SCIENCE, V333, P1593, DOI 10.1126/science.1207532; Wu XL, 2010, SCIENCE, V329, P856, DOI 10.1126/science.1187659; Wyatt R, 1998, SCIENCE, V280, P1884, DOI 10.1126/science.280.5371.1884; Zhou TQ, 2007, NATURE, V445, P732, DOI 10.1038/nature05580	54	4	4	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 15	2017	12	3							e0173577	10.1371/journal.pone.0173577	http://dx.doi.org/10.1371/journal.pone.0173577			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN9HQ	28296911	Green Published, gold, Green Submitted			2022-12-27	WOS:000396311700042
J	Durand, P; Moreau-Gaudry, A; Silvent, AS; Frandon, J; Chipon, E; Medici, M; Bricault, I				Durand, Pierre; Moreau-Gaudry, Alexandre; Silvent, Anne-Sophie; Frandon, Julien; Chipon, Emilie; Medici, Maud; Bricault, Ivan			Computer assisted electromagnetic navigation improves accuracy in computed tomography guided interventions: A prospective randomized clinical trial	PLOS ONE			English	Article							FREE-HAND; CT; SYSTEM; TRACKING; BIOPSY; ABLATION; GUIDANCE; WORKFLOW; PUNCTURE; PHANTOM	Purpose To assess the accuracy and usability of an electromagnetic navigation system designed to assist Computed Tomography (CT) guided interventions. Materials and methods 120 patients requiring a percutaneous CT intervention (drainage, biopsy, tumor ablation, infiltration, sympathicolysis) were included in this prospective randomized trial. Nineteen radiologists participated. Conventional procedures (CT group) were compared with procedures assisted by a navigation system prototype using an electromagnetic localizer to track the position and orientation of a needle holder (NAV group). The navigation system displays the needle path in real-time on 2D reconstructed CT images extracted from the 3D CT volume. The regional ethics committee approved this study and all patients gave written informed consent. The main outcome was the distance between the planned trajectory and the achieved needle trajectory calculated from the initial needle placement. Results 120 patients were analyzable in intention-to-treat (NAV: 60; CT: 60). Accuracy improved when the navigation system was used: distance error (in millimeters: median[P25%; P75%]) with NAV = 4.1[2.7; 9.1], vs. with CT = 8.9[4.9; 15.1] (p<0.001). After the initial needle placement and first control CT, fewer subsequent CT acquisitions were necessary to reach the target using the navigation system: NAV = 2[2; 3]; CT = 3[2; 4] ( p = 0.01). Conclusion The tested system was usable in a standard clinical setting and provided significant improvement in accuracy; furthermore, with the help of navigation, targets could be reached with fewer CT control acquisitions.	[Durand, Pierre; Frandon, Julien; Bricault, Ivan] Univ Hosp, Dept Imaging Radiol & Med Imaging, Grenoble, France; [Moreau-Gaudry, Alexandre; Bricault, Ivan] Univ Grenoble Alpes, Lab Techn Biomed Engn & Complex Management Inform, Grenoble, France; [Moreau-Gaudry, Alexandre; Bricault, Ivan] Natl Ctr Sci Res, Lab Techn Biomed Engn & Complex Management Inform, Grenoble, France; [Moreau-Gaudry, Alexandre; Silvent, Anne-Sophie; Chipon, Emilie; Medici, Maud; Bricault, Ivan] Natl Inst Hlth & Med Res, Clin Investigat Ctr Innovat Technol 1406, Grenoble, France; [Moreau-Gaudry, Alexandre; Silvent, Anne-Sophie; Chipon, Emilie; Medici, Maud; Bricault, Ivan] Univ Hosp, Dept Publ Hlth, Clin Investigat Ctr Innovat Technol 1406, Grenoble, France; [Moreau-Gaudry, Alexandre; Silvent, Anne-Sophie; Chipon, Emilie; Medici, Maud; Bricault, Ivan] Univ Hosp, Res Dept, Clin Investigat Ctr Innovat Technol 1406, Grenoble, France	CHU Grenoble Alpes; Communaute Universite Grenoble Alpes; UDICE-French Research Universities; Universite Grenoble Alpes (UGA); Institut National de la Sante et de la Recherche Medicale (Inserm); CHU Grenoble Alpes; CHU Grenoble Alpes	Silvent, AS (corresponding author), Natl Inst Hlth & Med Res, Clin Investigat Ctr Innovat Technol 1406, Grenoble, France.; Silvent, AS (corresponding author), Univ Hosp, Dept Publ Hlth, Clin Investigat Ctr Innovat Technol 1406, Grenoble, France.; Silvent, AS (corresponding author), Univ Hosp, Res Dept, Clin Investigat Ctr Innovat Technol 1406, Grenoble, France.	sophie.silvent@univ-grenoble-alpes.fr			Delegation to Clinical Research and Innovation (DRCI) of Grenoble University Hospital	Delegation to Clinical Research and Innovation (DRCI) of Grenoble University Hospital	This clinical research was funded by the Delegation to Clinical Research and Innovation (DRCI) of Grenoble University Hospital. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abi-Jaoudeh N, 2012, CARDIOVASC INTER RAD, V35, P986, DOI 10.1007/s00270-012-0446-5; Arnolli MM, 2015, INT J MED ROBOT COMP, V11, P458, DOI 10.1002/rcs.1630; Bing F, 2007, P 3 INT C SURGETICA; Bruners P, 2009, EUR RADIOL, V19, P990, DOI 10.1007/s00330-008-1227-z; Engstrand J, 2014, VALIDATION COMPUTER; Glossop ND, 2009, J BONE JOINT SURG AM, V91A, P23, DOI 10.2106/JBJS.H.01362; Grand DJ, 2011, EUR J RADIOL, V79, pE133, DOI 10.1016/j.ejrad.2011.05.030; Grasso RF, 2013, INT J COMPUT ASS RAD, V8, P837, DOI 10.1007/s11548-013-0816-8; Grasso RF, 2013, EUR RADIOL, V23, P3071, DOI 10.1007/s00330-013-2932-9; Gupta S, 2010, J VASC INTERV RADIOL, V21, P969, DOI 10.1016/j.jvir.2010.01.011; Kim E, 2014, AM J ROENTGENOL, V203, pW715, DOI 10.2214/AJR.13.12061; Krucker J, 2007, J VASC INTERV RADIOL, V18, P1141, DOI 10.1016/j.jvir.2007.06.014; Krucker J, 2011, J VASC INTERV RADIOL, V22, P515, DOI 10.1016/j.jvir.2010.10.033; Mauri G, 2014, CARDIOVASCULAR I MAY; Moncharmont L, 2015, DIAGN INTERV IMAG, V96, P531, DOI 10.1016/j.diii.2015.03.002; Moser C, 2013, EUR J RADIOL, V82, P627, DOI 10.1016/j.ejrad.2012.10.028; Narsule CK, 2012, INNOVATIONS, V7, P187, DOI 10.1097/IMI.0b013e318265b127; Penzkofer T, 2011, MINIM INVASIV THER, V20, P226, DOI 10.3109/13645706.2011.553256; Peterhans M, 2011, INT J MED ROBOT COMP, V7, P7, DOI 10.1002/rcs.360; Schubert T, 2013, CARDIOVASC INTER RAD, V36, P1055, DOI 10.1007/s00270-012-0527-5; Wallace MJ, 2010, J VASC INTERV RADIOL, V21, P431, DOI 10.1016/j.jvir.2009.12.398	21	25	27	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 15	2017	12	3							e0173751	10.1371/journal.pone.0173751	http://dx.doi.org/10.1371/journal.pone.0173751			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN9HQ	28296957	Green Submitted, Green Published, gold			2022-12-27	WOS:000396311700055
J	Schroeder, DC; Guschlbauer, M; Maul, AC; Cremer, DA; Becker, I; Bethencourt, DD; Paal, P; Padosch, SA; Wetsch, WA; Annecke, T; Boettiger, BW; Sterner-Kock, A; Herff, H				Schroeder, Daniel C.; Guschlbauer, Maria; Maul, Alexandra C.; Cremer, Daniel A.; Becker, Ingrid; Bethencourt, David de la Puente; Paal, Peter; Padosch, Stephan A.; Wetsch, Wolfgang A.; Annecke, Thorsten; Boettiger, Bernd W.; Sterner-Kock, Anja; Herff, Holger			Oesophageal heat exchangers with a diameter of 11mm or 14.7mm are equally effective and safe for targeted temperature management	PLOS ONE			English	Article							THERAPEUTIC HYPOTHERMIA; INTRACRANIAL HYPERTENSION; TRANSFER DEVICE; RESUSCITATION; ASSOCIATION; PREVENTION; GUIDELINES; INDUCTION	Background Targeted temperature management (TTM) is widely used in critical care settings for conditions including hepatic encephalopathy, hypoxic ischemic encephalopathy, meningitis, myocardial infarction, paediatric cardiac arrest, spinal cord injury, traumatic brain injury, ischemic stroke and sepsis. Furthermore, TTM is a key treatment for patients after out-of-hospital cardiac-arrest (OHCA). However, the optimal cooling method, which is quick, safe and cost-effective still remains controversial. Since the oesophagus is adjacent to heart and aorta, fast heat-convection to the central blood-stream could be achieved with a minimally invasive oesophageal heat exchanger (OHE). To date, the optimal diameter of an OHE is still unknown. While larger diameters may cause thermal-or pressure-related tissue damage after long-term exposure to the oesophageal wall, smaller diameter (e.g., gastric tubes, up to 11mm) may not provide effective cooling rates. Thus, the objective of the study was to compare OHE-diameters of 11mm (OHE11) and 14.7mm (OHE14.7) and their effects on tissue and cooling capability. Methods Pigs were randomized to OHE11 (N = 8) or OHE14.7 (N = 8). After cooling, pigs were maintained at 33 degrees C for 1 hour. After 10h rewarming, oesophagi were analyzed by means of histopathology. The oesophagus of four animals from a separate study that underwent exactly the identical preparation and cooling protocol described above but received a maintenance period of 24h were used as histopathological controls. Results Mean cooling rates were 2.8 +/- 0.4 degrees C degrees C/h (OHE11) and 3.0 +/- 0.3 degrees C degrees C/h (OHE14.7; p = 0.20). Occasional mild acute inflammatory transepithelial infiltrates were found in the cranial segment of the oesophagus in all groups including controls. Deviations from target temperature were 0.1 +/- 0.4 degrees C (OHE11) and 0 +/- 0.1 degrees C (OHE14.7; p = 0.91). Rewarming rates were 0.19 +/- 0.07 degrees C degrees C/h (OHE11) and 0.20 +/- 0.05 degrees C degrees C/h (OHE14.7; p = 0.75). Conclusions OHE with diameters of 11 mm and 14.7 mm achieve effective cooling rates for TTM and did not cause any relevant oesophageal tissue damage. Both OHE demonstrated acceptable deviations from target temperature and allowed for an intended rewarming rate (0.25 degrees C/h).	[Schroeder, Daniel C.; Cremer, Daniel A.; Bethencourt, David de la Puente; Padosch, Stephan A.; Wetsch, Wolfgang A.; Annecke, Thorsten; Boettiger, Bernd W.; Herff, Holger] Univ Hosp Cologne, Dept Anaesthesiol & Intens Care Med, Kerpener Str 62, Cologne, Germany; [Guschlbauer, Maria; Maul, Alexandra C.; Sterner-Kock, Anja] Univ Hosp Cologne, Dept Expt Med, Cologne, Germany; [Becker, Ingrid] Univ Hosp Cologne, Inst Med Stat Informat & Epidemiol, Kerpener Str 62, Cologne, Germany; [Paal, Peter] Queen Mary Univ London, Barts Heart Ctr, St Bartholomews Hosp, Barts Hlth NHS Trust, London, England; [Paal, Peter] Barmherzige Bruder Salzburg Hosp, Dept Anaesthesiol & Crit Care Med, Kajetanerpl 2, Salzburg, Austria	University of Cologne; University of Cologne; University of Cologne; Barts Health NHS Trust; University of London; Queen Mary University London; Konventhospital Der Barmherzigen Bruder	Schroeder, DC (corresponding author), Univ Hosp Cologne, Dept Anaesthesiol & Intens Care Med, Kerpener Str 62, Cologne, Germany.	Daniel.Schroeder@uk-koeln.de	Annecke, Thorsten/AAG-3909-2020	Annecke, Thorsten/0000-0002-2496-4432; Schroeder, Daniel/0000-0002-0104-5986; Paal, Peter/0000-0002-2939-4782; Guschlbauer, Maria/0000-0002-5401-4542; Becker, Ingrid/0000-0001-5829-3553	"The Central Innovation Program for Small and Medium-sized enterprises", German Federal Ministry for Economic affairs and Energy [KF2429611AK3]	"The Central Innovation Program for Small and Medium-sized enterprises", German Federal Ministry for Economic affairs and Energy	This work was supported by "The Central Innovation Program for Small and Medium-sized enterprises", German Federal Ministry for Economic affairs and Energy (KF2429611AK3) (HH). Equipment was provided by Hirtz & Co. KG, Cologne, Germany.	BUGGY D, 1994, BRIT J ANAESTH, V72, P393, DOI 10.1093/bja/72.4.393; Desai TK, 2005, GASTROINTEST ENDOSC, V61, P795, DOI 10.1016/S0016-5107(05)00313-5; Gotberg M, 2008, BMC CARDIOVASC DISOR, V8, DOI 10.1186/1471-2261-8-7; Guluma KZ, 2006, ACAD EMERG MED, V13, P820, DOI 10.1197/j.aem.2006.03.559; He Xiaoming, 2003, Crit Rev Biomed Eng, V31, P355, DOI 10.1615/CritRevBiomedEng.v31.i56.10; HENRIQUES FC, 1947, AM J PATHOL, V23, P531; Hoedemaekers CW, 2007, CRIT CARE, V11, DOI 10.1186/cc6104; HUDACK STEPHEN, 1932, JOUR EXP MED, V55, P431, DOI 10.1084/jem.55.3.431; Jalan R, 1999, LANCET, V354, P1164, DOI 10.1016/S0140-6736(98)12440-6; Kilkenny C, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000412; Kleinman ME, 2010, CIRCULATION, V122, pS876, DOI 10.1161/CIRCULATIONAHA.110.971101; KOKATE JY, 1995, ARCH PHYS MED REHAB, V76, P666, DOI 10.1016/S0003-9993(95)80637-7; KULKARNI P, 1993, BRIT J ANAESTH, V70, P216, DOI 10.1093/bja/70.2.216; Kulstad E, 2013, RESUSCITATION, V84, P1619, DOI 10.1016/j.resuscitation.2013.06.019; Kulstad EB, 2012, WORLD J EMERG MED, V3, P118, DOI [10.5847/wjem.j.issn.1920-8642.2012.02.007, 10.5847/wjem.j.1920-8642.2012.02.007]; Lefrant JY, 2003, INTENS CARE MED, V29, P414, DOI 10.1007/s00134-002-1619-5; Lequerica JL, 2009, INT J HYPERTHER, V25, P150, DOI 10.1080/02656730802537626; LI DJ, 1987, INT J HYPERTHER, V3, P143, DOI 10.3109/02656738709140382; Markota A, 2016, J EMERGENCY MED; Markota A, 2016, AM J EMERG MED, V34, P741, DOI 10.1016/j.ajem.2016.01.028; Markota A, 2015, RESUSCITATION, V89, pE1, DOI 10.1016/j.resuscitation.2015.01.032; McMaster PD, 1934, J EXP MED, V60, P479, DOI 10.1084/jem.60.4.479; Naiman M, 2016, EXPERT REV MED DEVIC, V13, P423, DOI 10.1080/17434440.2016.1174573; Nolan JP, 2015, RESUSCITATION, V95, P202, DOI 10.1016/j.resuscitation.2015.07.018; Pehbock D, 2014, ANAESTHESIST; Piercy M, 2009, J CARDIOTHOR VASC AN, V23, P62, DOI 10.1053/j.jvca.2008.09.014; Polderman KH, 2009, CRIT CARE MED, V37, P1101, DOI 10.1097/CCM.0b013e3181962ad5; Popugaev KA, 2014, J NEUROL SURG REP, V75, pE224, DOI 10.1055/s-0034-1387188; Ran ZG, 2015, J VIROL, V89, P4818, DOI 10.1128/JVI.00059-15; Rasmussen YH, 1998, ACTA ANAESTH SCAND, V42, P348; Saito T, 2013, J VASC SURG, V57, P173, DOI 10.1016/j.jvs.2012.05.101; Sause A, 2010, BMC CARDIOVASC DISOR, V10, DOI 10.1186/1471-2261-10-52; Schortgen F, 2012, AM J RESP CRIT CARE, V185, P1088, DOI 10.1164/rccm.201110-1820OC; Sessler DI, 2008, ANESTHESIOLOGY, V109, P318, DOI 10.1097/ALN.0b013e31817f6d76; Sessler DI, 2013, ANESTHESIOLOGY, V118, P181, DOI 10.1097/ALN.0b013e3182784df3; SESSLER DI, 1988, ANESTHESIOLOGY, V68, P836, DOI 10.1097/00000542-198806000-00002; Shankaran S, 2005, NEW ENGL J MED, V353, P1574, DOI 10.1056/NEJMcps050929; Sleisenger M.H., 2002, GASTROINTESTINAL LIV, P551; Sydenham E, 2009, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD001048.pub4; Tobey NA, 1999, AM J PHYSIOL-GASTR L, V276, pG1322, DOI 10.1152/ajpgi.1999.276.6.G1322	40	7	8	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 14	2017	12	3							e0173229	10.1371/journal.pone.0173229	http://dx.doi.org/10.1371/journal.pone.0173229			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN6DM	28291783	Green Published, Green Submitted, gold			2022-12-27	WOS:000396094700016
J	Brown, TI; Uncapher, MR; Chow, TE; Eberhardt, JL; Wagner, AD				Brown, Thackery I.; Uncapher, Melina R.; Chow, Tiffany E.; Eberhardt, Jennifer L.; Wagner, Anthony D.			Cognitive control, attention, and the other race effect in memory	PLOS ONE			English	Article							PREFRONTAL CORTEX; NEURAL ACTIVITY; VISUAL-SEARCH; TOP-DOWN; FACE; CATEGORIZATION; RECOGNITION; EXPERIENCE; BLACK; BRAIN	People are better at remembering faces from their own race than other races-a phenomenon with significant societal implications. This Other Race Effect (ORE) in memory could arise from different attentional allocation to, and cognitive control over, same-and otherrace faces during encoding. Deeper or more differentiated processing of same-race faces could yield more robust representations of same- vs. other-race faces that could support better recognition memory. Conversely, to the extent that other-race faces may be characterized by lower perceptual expertise, attention and cognitive control may be more important for successful encoding of robust, distinct representations of these stimuli. We tested a mechanistic model in which successful encoding of same- and other-race faces, indexed by subsequent memory performance, is differentially predicted by (a) engagement of frontoparietal networks subserving top-down attention and cognitive control, and (b) interactions between frontoparietal networks and fusiform cortex face processing. European American (EA) and African American (AA) participants underwent fMRI while intentionally encoding EA and AA faces, and similar to 24 hrs later performed an "old/new" recognition memory task. Univariate analyses revealed greater engagement of frontoparietal top-down attention and cognitive control networks during encoding for same-vs. other-race faces, stemming particularly from a failure to engage the cognitive control network during processing of other-race faces that were subsequently forgotten. Psychophysiological interaction (PPI) analyses further revealed that OREs were characterized by greater functional interaction between medial intraparietal sulcus, a component of the top-down attention network, and fusiform cortex during same-than otherrace face encoding. Together, these results suggest that group-based face memory biases at least partially stem from differential allocation of cognitive control and top-down attention during encoding, such that same-race memory benefits from elevated top-down attentional engagement with face processing regions; conversely, reduced recruitment of cognitive control circuitry appears more predictive of memory failure when encoding out-group faces.	[Brown, Thackery I.; Uncapher, Melina R.; Eberhardt, Jennifer L.; Wagner, Anthony D.] Stanford Univ, Dept Psychol, Stanford, CA 94305 USA; [Uncapher, Melina R.] Univ Calif San Francisco, Dept Neurol, San Francisco, CA USA; [Chow, Tiffany E.] Univ Calif Los Angeles, Dept Psychol, Los Angeles, CA USA; [Wagner, Anthony D.] Stanford Univ, Neurosci Program, Stanford, CA 94305 USA	Stanford University; University of California System; University of California San Francisco; University of California System; University of California Los Angeles; Stanford University	Wagner, AD (corresponding author), Stanford Univ, Dept Psychol, Stanford, CA 94305 USA.	thackery@stanford.edu; awagner@stanford.edu		Wagner, Anthony/0000-0003-0624-4543; Brown, Thackery/0000-0001-8586-3099; Chow, Tiffany/0000-0002-7705-3405	John D. and Catherine T. MacArthur Foundation	John D. and Catherine T. MacArthur Foundation	This study was supported by a grant from the John D. and Catherine T. MacArthur Foundation to Vanderbilt University, with a subcontract to Stanford University. Its contents do not necessarily represent official views of either the John D. and Catherine T. MacArthur Foundation or the MacArthur Foundation Research Network on Law and Neuroscience (www.lawneuro.org). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Badre D, 2008, TRENDS COGN SCI, V12, P193, DOI 10.1016/j.tics.2008.02.004; Blumenfeld RS, 2007, NEUROSCIENTIST, V13, P280, DOI 10.1177/1073858407299290; Brewer JB, 1998, SCIENCE, V281, P1185, DOI 10.1126/science.281.5380.1185; Brewer M., 1988, ADV SOCIAL COGNITION, P1; BRIGHAM JC, 1985, J SOC ISSUES, V41, P139, DOI 10.1111/j.1540-4560.1985.tb01133.x; BRIGHAM JC, 1978, J APPL SOC PSYCHOL, V8, P306, DOI 10.1111/j.1559-1816.1978.tb00786.x; Brosch T, 2013, PSYCHOL SCI, V24, P160, DOI 10.1177/0956797612451465; Caldara R, 2004, NEUROREPORT, V15, P905, DOI 10.1097/00001756-200404090-00034; Chiao JY, 2006, PSYCHOL SCI, V17, P387, DOI 10.1111/j.1467-9280.2006.01717.x; Corbetta M, 2008, NEURON, V58, P306, DOI 10.1016/j.neuron.2008.04.017; Cunningham WA, 2012, FRONT HUM NEUROSCI, V6, DOI 10.3389/fnhum.2012.00140; Davachi L, 2006, CURR OPIN NEUROBIOL, V16, P693, DOI 10.1016/j.conb.2006.10.012; Eberhardt JL, 2004, J PERS SOC PSYCHOL, V87, P876, DOI 10.1037/0022-3514.87.6.876; Feng L, 2011, NEUROPSYCHOLOGIA, V49, P3739, DOI 10.1016/j.neuropsychologia.2011.09.031; FISKE ST, 1990, ADV EXP SOC PSYCHOL, V23, P1, DOI 10.1016/S0065-2601(08)60317-2; Friston KJ, 1997, NEUROIMAGE, V6, P218, DOI 10.1006/nimg.1997.0291; Friston KJ, 2003, NEUROIMAGE, V19, P1273, DOI 10.1016/S1053-8119(03)00202-7; Gaither SE, 2015, GROUP PROCESS INTERG, V18, P778, DOI 10.1177/1368430215570504; Gauthier I, 2000, COGNITIVE NEUROPSYCH, V17, P143, DOI 10.1080/026432900380544; Gauthier I, 1999, NAT NEUROSCI, V2, P568, DOI 10.1038/9224; Gazzaley A, 2012, TRENDS COGN SCI, V16, P129, DOI 10.1016/j.tics.2011.11.014; Ge LZ, 2009, PERCEPTION, V38, P1199, DOI 10.1068/p6136; Golby AJ, 2001, NAT NEUROSCI, V4, P845, DOI 10.1038/90565; Hugenberg K, 2010, PSYCHOL REV, V117, P1168, DOI 10.1037/a0020463; Hutchinson JB, 2014, CEREB CORTEX, V24, P49, DOI 10.1093/cercor/bhs278; Hutchinson JB, 2009, LEARN MEMORY, V16, P343, DOI 10.1101/lm.919109; Ito TA, 2003, J PERS SOC PSYCHOL, V85, P616, DOI 10.1037/0022-3514.85.4.616; Kaul C, 2014, SOC COGN AFFECT NEUR, V9, P326, DOI 10.1093/scan/nss138; Kim H, 2011, NEUROIMAGE, V54, P2446, DOI 10.1016/j.neuroimage.2010.09.045; Kim JH, 2006, ACTA MATER, V54, P2057, DOI 10.1016/j.actamat.2005.12.032; Koechlin E, 2003, SCIENCE, V302, P1181, DOI 10.1126/science.1088545; Levin DT, 1996, J EXP PSYCHOL LEARN, V22, P1364, DOI 10.1037/0278-7393.22.6.1364; Levin DT, 2000, J EXP PSYCHOL GEN, V129, P559, DOI 10.1037//0096-3445.129.4.559; Lieberman MD, 2005, NAT NEUROSCI, V8, P720, DOI 10.1038/nn1465; MALPASS RS, 1969, J PERS SOC PSYCHOL, V13, P330, DOI 10.1037/h0028434; Miller EK, 2001, ANNU REV NEUROSCI, V24, P167, DOI 10.1146/annurev.neuro.24.1.167; O'Craven KM, 1999, NATURE, V401, P584, DOI 10.1038/44134; Paller KA, 2002, TRENDS COGN SCI, V6, P93, DOI 10.1016/S1364-6613(00)01845-3; Reynolds JR, 2004, NEUROIMAGE, V21, P1472, DOI 10.1016/j.neuroimage.2003.10.033; Rugg MD, 2002, PHILOS T R SOC B, V357, P1097, DOI 10.1098/rstb.2002.1102; Sessa P, 2016, SOC NEUROSCI-UK, V11, P97, DOI 10.1080/17470919.2015.1040556; Sessa P, 2012, SOC COGN AFFECT NEUR, V7, P314, DOI 10.1093/scan/nsr011; Uncapher MR, 2015, J NEUROSCI, V35, P8531, DOI 10.1523/JNEUROSCI.5145-14.2015; Uncapher MR, 2011, J NEUROSCI, V31, P12613, DOI 10.1523/JNEUROSCI.0152-11.2011; Uncapher MR, 2009, NEUROBIOL LEARN MEM, V91, P139, DOI 10.1016/j.nlm.2008.10.011; VALENTINE T, 1992, Q J EXP PSYCHOL-A, V44, P671, DOI 10.1080/14640749208401305; Van Bavel JJ, 2012, PERS SOC PSYCHOL B, V38, P1566, DOI 10.1177/0146167212455829; Van Bavel JJ, 2011, J COGNITIVE NEUROSCI, V23, P3343, DOI 10.1162/jocn_a_00016; Van Bavel JJ, 2009, PERS SOC PSYCHOL B, V35, P321, DOI 10.1177/0146167208327743; Van Bavel JJ, 2008, PSYCHOL SCI, V19, P1131, DOI 10.1111/j.1467-9280.2008.02214.x; Wagner AD, 1998, SCIENCE, V281, P1188, DOI 10.1126/science.281.5380.1188; Waskom ML, 2014, J NEUROSCI, V34, P10743, DOI 10.1523/JNEUROSCI.5282-13.2014; Waskom ML, 2016, CEREB CORTEX; Weibert K, 2015, NEUROPSYCHOLOGIA, V75, P588, DOI 10.1016/j.neuropsychologia.2015.07.015; Weiner KS, 2014, NEUROIMAGE, V84, P453, DOI 10.1016/j.neuroimage.2013.08.068; Weiner KS, 2010, NEUROIMAGE, V52, P1559, DOI 10.1016/j.neuroimage.2010.04.262; Wojciulik E, 1998, J NEUROPHYSIOL, V79, P1574, DOI 10.1152/jn.1998.79.3.1574; Yeo BTT, 2011, J NEUROPHYSIOL, V106, P1125, DOI 10.1152/jn.00338.2011; Young SG, 2012, PERS SOC PSYCHOL REV, V16, P116, DOI 10.1177/1088868311418987; Zhao L, 2008, PSYCHON B REV, V15, P1093, DOI 10.3758/PBR.15.6.1093	60	15	15	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 10	2017	12	3							e0173579	10.1371/journal.pone.0173579	http://dx.doi.org/10.1371/journal.pone.0173579			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EN6CJ	28282414	Green Published, Green Submitted, gold			2022-12-27	WOS:000396091800053
J	Jorge, MG; Brennand, TA				Jorge, Marco G.; Brennand, Tracy A.			Measuring (subglacial) bedform orientation, length, and longitudinal asymmetry - Method assessment	PLOS ONE			English	Article							SCALE GLACIAL LINEATIONS; DRUMLINS; LANDFORMS; LOWLAND; SHAPE	Geospatial analysis software provides a range of tools that can be used to measure land form morphometry. Often, a metric can be computed with different techniques that may give different results. This study is an assessment of 5 different methods for measuring longitudinal, or streamlined, subglacial bedform morphometry: orientation, length and longitudinal asymmetry, all of which require defining a longitudinal axis. The methods use the standard deviational ellipse (not previously applied in this context), the longest straight line fitting inside the bedform footprint (2 approaches), the minimum-size footprint-bounding rectangle, and Euler's approximation. We assess how well these methods replicate morphometric data derived from a manually mapped (visually interpreted) longitudinal axis, which, though subjective, is the most typically used reference. A dataset of 100 subglacial bedforms covering the size and shape range of those in the Puget Lowland, Washington, USA is used. For bed forms with elongation > 5, deviations from the reference values are negligible for all methods but Euler's approximation (length). For bedforms with elongation < 5, most methods had small mean absolute error (MAE) and median absolute deviation (MAD) for all morphometrics and thus can be confidently used to characterize the central tendencies of their distributions. However, some methods are better than others. The least precise methods are the ones based on the longest straight line and Euler's approximation; using these for statistical dispersion analysis is discouraged. Because the standard deviational ellipse method is relatively shape invariant and closely replicates the reference values, it is the recommended method. Speculatively, this study may also apply to negative-relief, and fluvial and aeolian bedforms.	[Jorge, Marco G.; Brennand, Tracy A.] Simon Fraser Univ, Dept Geog, Burnaby, BC, Canada	Simon Fraser University	Jorge, MG (corresponding author), Simon Fraser Univ, Dept Geog, Burnaby, BC, Canada.	mjorge@sfu.ca		Jorge, Marco/0000-0003-0950-4507	Simon Fraser University Graduate Fellowship; Geological Society of America Student Research Grant; Natural Sciences and Engineering Research Council of Canada Discovery Grant [194107]	Simon Fraser University Graduate Fellowship; Geological Society of America Student Research Grant; Natural Sciences and Engineering Research Council of Canada Discovery Grant(Natural Sciences and Engineering Research Council of Canada (NSERC))	This study was supported by a Simon Fraser University Graduate Fellowship (http://www.sfu.ca/dean-gradstudies/awards/graduatefellowships/graduate-fellowships.html) and a Geological Society of America Student Research Grant (http://mw.geosociety.org/grants/gradgrants/htm) to MGJ and by a Natural Sciences and Engineering Research Council of Canada Discovery Grant 194107 (http://www.nserc-crsng. gc.ca) to TAB. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Beyer H.L., 2015, GEOSPATIAL MODELLING; Chamberlin T.C., 1894, J GEOL, V2, P517; Chorley R.J., 1959, J GLACIOL, V3, P339, DOI [10.3189/S0022143000017007., DOI 10.3189/S0022143000017007]; Clark CD, 2003, J GLACIOL, V49, P240, DOI 10.3189/172756503781830719; CLARK CD, 1993, EARTH SURF PROCESSES, V18, P1, DOI 10.1002/esp.3290180102; Clark CD, 2009, QUATERNARY SCI REV, V28, P677, DOI 10.1016/j.quascirev.2008.08.035; Davis W. M., 1884, AM J SCI, V28, P407; Dominguez-Rodrigo M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068955; Dowling TPF, 2015, GEOMORPHOLOGY, V236, P54, DOI 10.1016/j.geomorph.2015.02.018; Evans IS, 2012, GEOMORPHOLOGY, V137, P94, DOI 10.1016/j.geomorph.2010.09.029; Fowler AC, 2013, INT J GEOMATHEMATICS, V4, P155, DOI DOI 10.1007/S13137-013-0050-0; Greenwood SL, 2009, QUATERNARY SCI REV, V28, P3085, DOI 10.1016/j.quascirev.2009.09.008; Harry DG, 1987, MORPHOLOGY ARRAN DRU, P161; Hillier JK, 2015, EARTH SURF DYNAM, V3, P587, DOI 10.5194/esurf-3-587-2015; Hillier JK, 2015, J MAPS, V11, P719, DOI 10.1080/17445647.2014.957251; Hillier JK, 2012, GEOMORPHOLOGY, V153, P61, DOI 10.1016/j.geomorph.2012.02.009; Hooke RL, 2013, QUATERNARY RES, V79, P458, DOI 10.1016/j.yqres.2012.12.002; Lamsters K, 2015, QUATERN INT, V386, P42, DOI 10.1016/j.quaint.2014.10.006; Lamsters K, 2012, B GEOL SOC FINLAND, V84, P45, DOI 10.17741/bgsf/84.1.004; Lefever DW, 1926, AM J SOCIOL, V32, P88, DOI 10.1086/214027; Lesemann JE, 2010, GEOMORPHOLOGY, V120, P153, DOI 10.1016/j.geomorph.2010.03.020; Maclachlan JC, 2013, GEOGR ANN A, V95A, P125, DOI 10.1111/geoa.12005; Margold M, 2015, EARTH-SCI REV, V143, P117, DOI 10.1016/j.earscirev.2015.01.011; MENZIES J, 1979, EARTH-SCI REV, V14, P315, DOI 10.1016/0012-8252(79)90093-X; Napieralski J, 2010, COMPUT GEOSCI-UK, V36, P222, DOI 10.1016/j.cageo.2009.06.003; Schoof CG, 2008, J GEOPHYS RES-SOL EA, V113, DOI 10.1029/2007JB004957; SHAW J, 1984, CAN J EARTH SCI, V21, P1442, DOI 10.1139/e84-150; SMALLEY I, 1994, SEDIMENT GEOL, V91, P241, DOI 10.1016/0037-0738(94)90132-5; Spagnolo M, 2014, EARTH SURF PROC LAND, V39, P1432, DOI 10.1002/esp.3532; Spagnolo M, 2011, EARTH SURF PROC LAND, V36, P790, DOI 10.1002/esp.2107; Spagnolo M, 2010, SEDIMENT GEOL, V232, P119, DOI 10.1016/j.sedgeo.2010.01.008; THORSON RM, 1980, QUATERNARY RES, V13, P303, DOI 10.1016/0033-5894(80)90059-9; Wang B, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0118537	33	7	7	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 20	2017	12	3							e0174312	10.1371/journal.pone.0174312	http://dx.doi.org/10.1371/journal.pone.0174312			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ER6VC	28319132	Green Submitted, Green Published, gold			2022-12-27	WOS:000398945800067
J	Shin, S; Cho, SR; Kim, S; Choi, JR; Lee, KA				Shin, Saeam; Cho, Sung Ran; Kim, Sinyoung; Choi, Jong Rak; Lee, Kyung-A			Identification of cell morphology parameters from automatic hematology analyzers to predict the peripheral blood CD34-positive cell count after mobilization	PLOS ONE			English	Article							PROGENITOR-CELL; TRANSPLANTATION; INFECTION; HARVEST; MARKER; VOLUME	Optimal timing of apheresis initiation is important for maximizing the hematopoietic stem cell (HSC) yield. This study aimed to identify useful parameters from automatic hematology analyzers for predicting the peripheral blood CD34+ cell count after mobilization. We prospectively enrolled 53 healthy donors and 72 patients, and evaluated 43 cell morphology parameters from Unicel DxH800 (Beckman Coulter, USA) and Advia 2120i (Siemens Healthcare Diagnostics, USA). The correlation of each parameter with the CD34+ cell count in pre-apheresis blood samples was analyzed. The delta neutrophil index (DNI) from Advia 2120i, standard deviation of volume of neutrophils and monocytes (SD-V-NE and SD-V MO), standard deviation of conductivity of neutrophils and monocytes (SD-C-NE and SD-C MO), mean conductivity of neutrophils and monocytes (MN-C-NE and MN-C-MO), and standard deviation of axial light loss of neutrophils and monocytes (SD-AL2-NE and SD-AL2-MO) from DxH800 showed significant correlations with the CD34+ cell count. SD-V-NE, SD-C-NE, and SD-C-MO showed good or fair area under the curve values for the prediction of the CD34+ cell count. SD-V-NE, SD-C-NE, and SD-C-MO from DxH800 will provide rapid, useful information for the initiation of apheresis after mobilization.	[Shin, Saeam; Kim, Sinyoung; Choi, Jong Rak; Lee, Kyung-A] Yonsei Univ, Coll Med, Dept Lab Med, Seoul, South Korea; [Shin, Saeam] Hallym Univ, Kangnam Sacred Heart Hosp, Coll Med, Dept Lab Med, Seoul, South Korea; [Cho, Sung Ran] Ajou Univ, Sch Med, Dept Lab Med, Suwon, South Korea	Yonsei University; Yonsei University Health System; Hallym University; Ajou University	Lee, KA (corresponding author), Yonsei Univ, Coll Med, Dept Lab Med, Seoul, South Korea.	KAL1119@yuhs.ac	Cho, Sung-Ran/AAK-9950-2021	Lee, Kyung-A/0000-0001-5320-6705; Shin, Saeam/0000-0003-1501-3923; Kim, Sinyoung/0000-0002-2609-8945	Korean Health Technology R&D Project, Ministry of Health & Welfare, Republic of Korea [A120030]	Korean Health Technology R&D Project, Ministry of Health & Welfare, Republic of Korea	This study was supported by a grant from the Korean Health Technology R&D Project, Ministry of Health & Welfare, Republic of Korea (A120030, http//www.htdream.kr/, KAL). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baron F, 2005, LEUKEMIA, V19, P822, DOI 10.1038/sj.leu.2403718; Charafeddine KM, 2011, SCAND J INFECT DIS, V43, P777, DOI 10.3109/00365548.2011.585179; Chaves F, 2005, AM J CLIN PATHOL, V124, P440, DOI 10.1309/LLF75W0FWQQ8TCC5; Gokcebay DG, 2011, INT J LAB HEMATOL, V33, P651, DOI 10.1111/j.1751-553X.2011.01333.x; Golubeva V, 2014, TRANSFUS APHER SCI, V50, P39, DOI 10.1016/j.transci.2013.12.004; HO AD, 1993, LEUKEMIA, V7, P1738; Jun YH, 2008, ANN CLIN LAB SCI, V38, P88; Keeney M, 1998, CYTOMETRY, V34, P61, DOI 10.1002/(SICI)1097-0320(19980415)34:2<61::AID-CYTO1>3.0.CO;2-F; Koca E, 2008, CURR OPIN ONCOL, V20, P220, DOI 10.1097/CCO.0b013e3282f5100b; Lee SE, 2012, J CLIN LAB ANAL, V26, P194, DOI 10.1002/jcla.21493; Luna-Herrera J, 2003, EUR J CLIN MICROBIOL, V22, P21, DOI 10.1007/s10096-002-0855-5; Padmanabhan A, 2009, VOX SANG, V97, P153, DOI 10.1111/j.1423-0410.2009.01183.x; Pavone V, 2006, BONE MARROW TRANSPL, V37, P719, DOI 10.1038/sj.bmt.1705298; Seok Y, 2012, SHOCK, V37, P242, DOI 10.1097/SHK.0b013e3182454acf; Suh C, 2004, TRANSFUSION, V44, P1762, DOI 10.1111/j.0041-1132.2004.04166.x; To LB, 2011, BLOOD, V118, P4530, DOI 10.1182/blood-2011-06-318220; Ward PCJ, 2000, CLIN CHEM, V46, P1215; Wu CY, 2016, TRANSFUSION, V56, P2042, DOI 10.1111/trf.13666	18	4	4	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 20	2017	12	3							e0174286	10.1371/journal.pone.0174286	http://dx.doi.org/10.1371/journal.pone.0174286			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ER6VC	28319139	gold, Green Published, Green Submitted			2022-12-27	WOS:000398945800065
J	Zhang, N; Fielding, R; Soong, I; Chan, KKK; Lee, C; Ng, A; Sze, WK; Tsang, J; Lee, V; Lam, WWT				Zhang, Na; Fielding, Richard; Soong, Inda; Chan, Karen K. K.; Lee, Conrad; Ng, Alice; Sze, Wing Kin; Tsang, Janice; Lee, Victor; Lam, Wendy Wing Tak			Psychometric assessment of the Chinese version of the brief illness perception questionnaire in breast cancer survivors	PLOS ONE			English	Article							QUALITY-OF-LIFE; REPRESENTATION; DEPRESSION; VALIDATION; ANXIETY; MODEL	Objective The eight-item Brief Illness Perception Questionnaire (B-IPQ) supposedly evaluates cognitive and emotional representations of illness. This study examined the validity and reliability of a traditional Chinese version of the B-IPQ in Hong Kong Chinese breast cancer survivors. Methods 358 Chinese breast cancer survivors who had recently ended their primary treatment completed this B-IPQ Chinese version. Confirmatory factor analysis (CFA) tested the factor structure. The internal consistency, construct, predictive and convergent validities of the scale were assessed. Results CFA revealed that the original three-factor (cognitive-emotional representations and illness comprehensibility) structure of the B-IPQ poorly fitted our sample. After deleting one item measuring illness coherence, seven-item gave an optimal two-factor (cognitive-emotional representations) structure for the B-IPQ (B-IPQ-7). Cronbach's alpha for the two subscales were 0.653 and 0.821, and for the overall seven-item scale of B-IPQ was 0.783. Correlations of illness perception and physical symptom distress, anxiety, depression and known-group comparison between different treatment status suggested acceptable construct validity. The association between baseline illness perception and psychological distress at 3-month follow up supported predictive validity. Conclusions B-IPQ-7 appears to be a moderately valid measure of illness perception in cancer population, potentially useful for assessing illness representations in Chinese women with breast cancer.	[Zhang, Na; Fielding, Richard; Lam, Wendy Wing Tak] Univ Hong Kong, Sch Publ Hlth, Div Behav Sci, Ctr Psychooncol Res & Training, Hong Kong, Hong Kong, Peoples R China; [Soong, Inda] Pamela Youde Nethersole Eastern Hosp, Dept Clin Oncol, Hong Kong, Hong Kong, Peoples R China; [Chan, Karen K. K.] Univ Hong Kong, Dept Obstet & Gynecol, Hong Kong, Hong Kong, Peoples R China; [Lee, Conrad] Princess Margaret Hosp, Dept Clin Oncol, Hong Kong, Hong Kong, Peoples R China; [Ng, Alice; Sze, Wing Kin] Tuen Mun Hosp, Dept Clin Oncol, Hong Kong, Hong Kong, Peoples R China; [Tsang, Janice; Lee, Victor] Univ Hong Kong, Dept Clin Oncol, Hong Kong, Hong Kong, Peoples R China	University of Hong Kong; Pamela Youde Nethersole Eastern Hospital; University of Hong Kong; Tuen Mun Hospital; University of Hong Kong	Lam, WWT (corresponding author), Univ Hong Kong, Sch Publ Hlth, Div Behav Sci, Ctr Psychooncol Res & Training, Hong Kong, Hong Kong, Peoples R China.	wwtlam@hku.hk	Lam, Wendy Wing Tak/C-4319-2009	Lam, Wendy Wing Tak/0000-0003-2383-0149; Zhang, Na/0000-0003-3719-4008; Lee, Victor/0000-0002-6283-978X	Hong Hong Cancer Fund	Hong Hong Cancer Fund	The research was funded by Hong Hong Cancer Fund. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anthoine Emmanuelle, 2014, Health Qual Life Outcomes, V12, P176, DOI 10.1186/s12955-014-0176-2; Ashley L, 2015, PSYCHO-ONCOLOGY, V24, P1463, DOI 10.1002/pon.3812; Bazzazian S, 2012, PSYCHOL HEALTH MED, V17, P47, DOI 10.1080/13548506.2011.575168; Bland JM, 1997, BRIT MED J, V314, P572, DOI 10.1136/bmj.314.7080.572; Broadbent E, 2006, J PSYCHOSOM RES, V60, P631, DOI 10.1016/j.jpsychores.2005.10.020; Cronbach LJ, 1951, PSYCHOMETRIKA, V16, P297; de Raaij EJ, 2012, MANUAL THER, V17, P330, DOI 10.1016/j.math.2012.03.001; Dein S, 2004, LANCET ONCOL, V5, P119, DOI 10.1016/S1470-2045(04)01386-5; Diefenbach MA, 1996, J SOC DISTRESS HOMEL, V5, P11, DOI 10.1007/BF02090456; Gray NM, 2014, SUPPORT CARE CANCER, V22, P307, DOI 10.1007/s00520-013-1963-8; Hair R. L., 2010, MULTIVARIATE DATA AN, V7th; Hopman P, 2015, PSYCHO-ONCOLOGY, V24, P11, DOI 10.1002/pon.3591; Kline R. B, 2015, PRINCIPLES PRACTICE, DOI DOI 10.1111/j.1467-8721.2009.01598.x; Larn WWT, 2008, J PAIN SYMPTOM MANAG, V36, P584, DOI 10.1016/j.jpainsymman.2007.12.008; Leung CM, 1999, ACTA PSYCHIAT SCAND, V100, P456, DOI 10.1111/j.1600-0447.1999.tb10897.x; Leventhal H, 1984, HDB PSYCHOL HLTH, VIV, P219; Lin Y. P., 2011, J ORIENTAL I TECHNOL, V31, P147; Metcalfe J., 1994, METACOGNITION KNOWIN; Mickeviciene A, 2013, MEDICINA-LITHUANIA, V49, P235, DOI 10.3390/medicina49050038; Moss-Morris R, 2002, PSYCHOL HEALTH, V17, P1, DOI 10.1080/08870440290001494; Nowicka-Sauer K, 2015, J HLTH PSYCHOL; Pacheco-Huergo V, 2012, ATEN PRIM, V44, P280, DOI 10.1016/j.aprim.2010.11.022; Rizou I, 2016, EUR J PAEDIATR NEURO, V20, P93, DOI 10.1016/j.ejpn.2015.10.001; Sampaio R, 2014, PSYCHOL HEALTH MED, V19, P59, DOI 10.1080/13548506.2013.774430; Thong MSY, 2016, J CANCER SURVIV, V10, P898, DOI 10.1007/s11764-016-0536-5; Weinman J, 1996, PSYCHOL HEALTH, V11, P431, DOI 10.1080/08870449608400270; Xue F., BRIEF ILLNESS PERCEP; Zhang N, 2016, SUPPORT CARE CANCER, V24, P1295, DOI 10.1007/s00520-015-2914-3	28	24	24	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 20	2017	12	3							e0174093	10.1371/journal.pone.0174093	http://dx.doi.org/10.1371/journal.pone.0174093			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	ER6VC	28319160	Green Published, Green Submitted, gold			2022-12-27	WOS:000398945800049
J	Austin-Evelyn, K; Rabkin, M; Macheka, T; Mutiti, A; Mwansa-Kambafwile, J; Dlamini, T; El-Sadr, WM				Austin-Evelyn, Katherine; Rabkin, Miriam; Macheka, Tonderayi; Mutiti, Anthony; Mwansa-Kambafwile, Judith; Dlamini, Thomas; El-Sadr, Wafaa M.			Community health worker perspectives on a new primary health care initiative in the Eastern Cape of South Africa	PLOS ONE			English	Article							FACTORS INFLUENCING MOTIVATION; MIDDLE-INCOME COUNTRIES; MANAGEMENT; INTERVENTIONS; PERCEPTIONS; PROGRAM	Background In 2010, South Africa's National Department of Health launched a national primary health care (PHC) initiative to strengthen health promotion, disease prevention, and early disease detection. The strategy, called Re-engineering Primary Health Care (rPHC), aims to provide a preventive and health-promoting community-based PHC model. A key component of rPHC is the use of community-based outreach teams staffed by generalist community health workers (CHWs). Methods We conducted focus group discussions and surveys on the knowledge and attitudes of 91 CHWs working on community-based rPHC teams in the King Sabata Dalindyebo (KSD) sub-district of Eastern Cape Province. Results The CHWs we studied enjoyed their work and found it meaningful, as they saw themselves as agents of change. They also perceived weaknesses in the implementation of outreach team oversight, and desired field-based training and more supervision in the community. Conclusions There is a need to provide CHWs with basic resources like equipment, supplies and transport to improve their acceptability and credibility to the communities they serve.	[Austin-Evelyn, Katherine] Int Womens Hlth Coalit, New York, NY 10001 USA; [Rabkin, Miriam; El-Sadr, Wafaa M.] Columbia Univ, ICAP, New York, NY USA; [Rabkin, Miriam; El-Sadr, Wafaa M.] Columbia Univ, Mailman Sch Publ Hlth, New York, NY USA; [Macheka, Tonderayi; Mutiti, Anthony] ICAP South Africa, Johannesburg, South Africa; [Mwansa-Kambafwile, Judith] Wits Reprod Hlth & HIV Inst, Johannesburg, South Africa; [Mwansa-Kambafwile, Judith] Univ Witwatersrand, Sch Clin Med, Johannesburg, South Africa; [Dlamini, Thomas] Eastern Cape, Dept Hlth, Bisho, South Africa	Columbia University; Columbia University; University of Witwatersrand	Austin-Evelyn, K (corresponding author), Int Womens Hlth Coalit, New York, NY 10001 USA.	k.austin.evelyn@gmail.com		Austin-Evelyn, Katherine/0000-0002-7063-0759	U.S. Centers for Disease Control and Prevention [5U48DP001916-05]; National Center for Injury Prevention and Control; National Center for Chronic Disease Prevention and Health Promotion; Coordinating Office of Global Health; National Center for Birth Defects and Developmental Disabilities; National Center for Immunization and Respiratory Diseases; National Center for HIV, Viral Hepatitis, STDs, and TB Prevention	U.S. Centers for Disease Control and Prevention(United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA); National Center for Injury Prevention and Control(United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA); National Center for Chronic Disease Prevention and Health Promotion(United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA); Coordinating Office of Global Health(United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA); National Center for Birth Defects and Developmental Disabilities; National Center for Immunization and Respiratory Diseases(United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA); National Center for HIV, Viral Hepatitis, STDs, and TB Prevention(United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA)	This publication was supported by Cooperative Agreement number 5U48DP001916-05 from the U.S. Centers for Disease Control and Prevention, with support from the National Center for Injury Prevention and Control, the National Center for Chronic Disease Prevention and Health Promotion, the Coordinating Office of Global Health, the National Center for Birth Defects and Developmental Disabilities, the National Center for Immunization and Respiratory Diseases, and the National Center for HIV, Viral Hepatitis, STDs, and TB Prevention. Its contents are solely the responsibility of the authors and do not necessarily represent the official views of the Centers for Disease Control and Prevention.	Akintola O, 2016, HUM RESOUR HEALTH, V14, DOI 10.1186/s12960-016-0151-6; Arvey SR, 2012, AM J PUBLIC HEALTH, V102, P1633, DOI 10.2105/AJPH.2012.300649; Berman P, 2012, GLOBAL HLTH EVIDENCE; Bhattacharyya K, 2001, COMMUNITY HLTH WORKE; Gilmore B, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-847; GILSON L, 1989, Journal of Public Health Policy, V10, P518, DOI 10.2307/3342522; Glenton C, 2010, SOC SCI MED, V70, P1920, DOI 10.1016/j.socscimed.2010.02.034; Haile F, 2014, HUM RESOUR HEALTH, V12, DOI 10.1186/1478-4491-12-54; Hill Z, 2014, GLOBAL HEALTH ACTION, V7, P1, DOI 10.3402/gha.v7.24085; Hsieh HF, 2005, QUAL HEALTH RES, V15, P1277, DOI 10.1177/1049732305276687; Kok MC, 2014, HLTH POLICY PLAN; Lewin S, 2010, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004015.pub3; Massyn N., 2014, DURBAN HLTH SYSTEMS; National Department of Health, 2010, REENG HLTH CAR S AFR; Ndima SD, 2015, HUM RESOUR HEALTH, V13, DOI 10.1186/s12960-015-0063-x; Nxumalo N, 2013, GLOBAL HEALTH ACTION, V6, P219, DOI 10.3402/gha.v6i0.19283; Paintain LS, 2014, AM J TROP MED HYG, V91, P461, DOI 10.4269/ajtmh.14-0094; Pallas SW, 2013, AM J PUBLIC HEALTH, V103, pE74, DOI 10.2105/AJPH.2012.301102; Pillay Y., 2011, IMPLEMENTATION PHC R; Rabkin M, 2015, REENGINEERING PRIMAR; Raven J, 2015, HUM RESOUR HEALTH, V13, DOI 10.1186/s12960-015-0034-2; Samb B, 2007, NEW ENGL J MED, V357, P2510, DOI 10.1056/NEJMsb071889; Schneider H, 2008, HEALTH POLICY PLANN, V23, P179, DOI 10.1093/heapol/czn006; Singh P, 2013, DIABETES, V14, P17; Strachan DL, 2012, AM J TROP MED HYG, V87, P111, DOI 10.4269/ajtmh.2012.12-0030; Tendler J., 1997, Good government in the Tropics., P21; Tulenko K, 2013, B WORLD HEALTH ORGAN, V91, P847, DOI 10.2471/BLT.13.118745; van Ginneken N, 2010, SOC SCI MED, V71, P1110, DOI 10.1016/j.socscimed.2010.06.009; World Health Organization (WHO), 2007, COMMUNITY HLTH WORKE	29	45	45	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 16	2017	12	3							e0173863	10.1371/journal.pone.0173863	http://dx.doi.org/10.1371/journal.pone.0173863			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EN9KE	28301609	Green Published, gold, Green Submitted			2022-12-27	WOS:000396318300084
J	Doci, CL; Mikelis, CM; Callejas-Valera, JL; Hansen, KK; Molinolo, AA; Inoue, A; Offermanns, S; Gutkind, JS				Doci, Colleen L.; Mikelis, Constantinos M.; Callejas-Valera, Juan Luis; Hansen, Karina K.; Molinolo, Alfredo A.; Inoue, Asuka; Offermanns, Stefan; Gutkind, J. Silvio			Epidermal loss of Gag confers a migratory and differentiation defect in keratinocytes	PLOS ONE			English	Article							PROTEIN-COUPLED RECEPTORS; GROWTH-FACTOR-BETA; UVEAL MELANOMA; ANAPHYLACTIC SHOCK; MICE; SKIN; EXPRESSION; WOUNDS; TRANSACTIVATION; ACTIVATION	G-protein coupled receptors (GPCRs), which activate heterotrimeric G proteins, are an essential class of transmembrane receptors that are responsible for a myriad of signaling events in normal and pathologic conditions. Two members of the G protein family, Gaq and Ga-11, activate one of the main GPCR pathways and function as oncogenes by integrating mitogen-stimulated signaling cascades that are active under malignant conditions. Recently, it has been shown that targeted deletion of Ga-11 and Gaq from endothelial cells impairs the Rho -mediated formation of focal adherens junctions, suggesting that Gai vg signaling may also play a significant role in cytoskeletal-mediated cellular responses in epithelial cells. Indeed, combined deletion of Ga-11 and Gaq confers a significant migratory defect in keratinocytes that delays cutaneous wound healing in an in vivo setting. This delay can be attributed to a defect during the reepithelialization phase due to significantly attenuated migratory capacity of Gaq-null keratinocytes under combined Ga-11 deficiency. In fact, cells lacking Gaivg demonstrate a severely reduced ability to respond to mitogenic and migratory signals in the microenvironment, leading to inappropriate and premature terminal differentiation. These results suggest that Gaivg signaling pathways may be critical for integrating mitogenic signals and cytoskeletal function to achieve normal physiological responses. Emergence of a malignant phenotype may therefore arise from both under- and overexpression of Gai vg signaling, implicating its upstream regulation as a potential therapeutic target in a host of pathologic conditions.	[Doci, Colleen L.] Marian Univ Indianapolis, Coll Arts & Sci, Indianapolis, IN 46222 USA; [Mikelis, Constantinos M.] Texas Tech Univ, Hlth Sci Ctr, Sch Pharm, Dept Biomed Sci, Amarillo, TX USA; [Callejas-Valera, Juan Luis; Gutkind, J. Silvio] Univ Calif San Diego, Dept Pharmacol, La Jolla, CA 92093 USA; [Callejas-Valera, Juan Luis; Gutkind, J. Silvio] Univ Calif San Diego, Moores Canc Ctr, La Jolla, CA 92093 USA; [Hansen, Karina K.] NIDCD, Oral & Pharyngeal Canc Branch, NIH, Bethesda, MD USA; [Molinolo, Alfredo A.] Univ Calif San Diego, Dept Pathol, La Jolla, CA 92093 USA; [Inoue, Asuka] Tohoku Univ, Grad Sch Pharmaceut Sci, Sendai, Miyagi, Japan; [Inoue, Asuka] Japan Sci & Technol Agcy JST, PRESTO, Kawaguchi, Saitama, Japan; [Offermanns, Stefan] Max Planck Inst Heart & Lung Res, Dept Pharmacol, Bad Nauheim, Germany	Texas Tech University System; Texas Tech University; Texas Tech University Health Science Center; Texas Tech University Health Sciences Center Amarillo; University of California System; University of California San Diego; University of California System; University of California San Diego; National Institutes of Health (NIH) - USA; NIH National Institute on Deafness & Other Communication Disorders (NIDCD); University of California System; University of California San Diego; Tohoku University; Japan Science & Technology Agency (JST); Max Planck Society	Doci, CL (corresponding author), Marian Univ Indianapolis, Coll Arts & Sci, Indianapolis, IN 46222 USA.	cdoci@marian.edu	Gutkind, J. Silvio/J-1201-2016; Doci, Colleen L/M-4389-2015; Mikelis, Constantinos/AGF-9423-2022; Offermanns, Stefan/L-3313-2017	Gutkind, J. Silvio/0000-0002-5150-4482; Offermanns, Stefan/0000-0001-8676-6805	Intramural Research Program of the National Institute of Dental and Craniofacial Research; Marian University Indianapolis; PRESTO, Japan Science and Technology Agency [13408007]; JST, PRESTO [13408007]	Intramural Research Program of the National Institute of Dental and Craniofacial Research(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); Marian University Indianapolis; PRESTO, Japan Science and Technology Agency(Japan Science & Technology Agency (JST)); JST, PRESTO(Japan Science & Technology Agency (JST))	This research was supported by the Intramural Research Program of the National Institute of Dental and Craniofacial Research, and in part by Marian University Indianapolis. AI received Grant #13408007 from PRESTO, Japan Science and Technology Agency. This does not alter our adherence to PLOS ONE policies on sharing data and materials.; This research was supported by the Intramural Research Program of the National Institute of Dental and Craniofacial Research, and in part by Marian University Indianapolis. A.I. was funded by JST, PRESTO Grant #13408007.	Andl T, 2004, DEVELOPMENT, V131, P2257, DOI 10.1242/dev.01125; BETZ P, 1993, INT J LEGAL MED, V105, P229, DOI 10.1007/BF01642799; Chattopadhyay C, 2016, CANCER-AM CANCER SOC, V122, P2299, DOI 10.1002/cncr.29727; Cheng CF, 2008, J INVEST DERMATOL, V128, P1981, DOI 10.1038/jid.2008.34; Decatur CL, 2016, JAMA OPHTHALMOL, V134, P728, DOI 10.1001/jamaophthalmol.2016.0903; DLUGOSZ AA, 1995, METHOD ENZYMOL, V254, P3; Dorsam RT, 2007, NAT REV CANCER, V7, P79, DOI 10.1038/nrc2069; DVORAK HF, 1986, NEW ENGL J MED, V315, P1650; Feng XD, 2014, CANCER CELL, V25, P831, DOI 10.1016/j.ccr.2014.04.016; Filardo EJ, 2000, MOL ENDOCRINOL, V14, P1649, DOI 10.1210/me.14.10.1649; Fitch KR, 2003, GENE DEV, V17, P214, DOI 10.1101/gad.1023703; Friedl P, 2010, J CELL BIOL, V188, P11, DOI 10.1083/jcb.200909003; GLICK AB, 1993, P NATL ACAD SCI USA, V90, P6076, DOI 10.1073/pnas.90.13.6076; Griewank KG, 2016, EUR J CANCER, V57, P112, DOI 10.1016/j.ejca.2016.01.010; Griewank KV S, 2011, ATLAS GENET CYTOGENE, V15, P828; Hameedaldeen A, 2014, INT J MOL SCI, V15, P16257, DOI 10.3390/ijms150916257; Hart S, 2005, BIOL CHEM, V386, P845, DOI 10.1515/BC.2005.099; Hata A, 2016, COLD SPRING HARB PER; Iglesias-Bartolome R, 2015, NAT CELL BIOL, V17, P793, DOI 10.1038/ncb3164; KALINEC G, 1992, MOL CELL BIOL, V12, P4687, DOI 10.1128/MCB.12.10.4687; Kim BC, 2003, J CELL PHYSIOL, V195, P331, DOI 10.1002/jcp.10301; Koivisto L, 2014, ADV WOUND CARE, V3, P762, DOI 10.1089/wound.2013.0436; Korhonen H, 2009, J EXP MED, V206, P411, DOI 10.1084/jem.20082150; Leiter Ulrike, 2014, Adv Exp Med Biol, V810, P120; Marinissen MJ, 2001, TRENDS PHARMACOL SCI, V22, P368, DOI 10.1016/S0165-6147(00)01678-3; Mikelis CM, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7725; O'Hayre M, 2014, CURR OPIN CELL BIOL, V27, P126, DOI 10.1016/j.ceb.2014.01.005; O'Hayre M, 2013, NAT REV CANCER, V13, P412, DOI 10.1038/nrc3521; Offermanns S, 1997, P NATL ACAD SCI USA, V94, P14089, DOI 10.1073/pnas.94.25.14089; Offermanns S, 1997, NATURE, V389, P183, DOI 10.1038/38284; Offermanns S, 1998, EMBO J, V17, P4304, DOI 10.1093/emboj/17.15.4304; Prenzel N, 1999, NATURE, V402, P884, DOI 10.1038/47260; Romer J, 1996, NAT MED, V2, P287, DOI 10.1038/nm0396-287; Sauer B, 2004, J INVEST DERMATOL, V123, P840, DOI 10.1111/j.0022-202X.2004.23458.x; Schrage R, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms10156; Seeger MA, 2015, ADV WOUND CARE, V4, P213, DOI 10.1089/wound.2014.0540; Taboubi S, 2007, FASEB J, V21, P4047, DOI 10.1096/fj.06-7476com; Taboubi S, 2010, MOL BIOL CELL, V21, P946, DOI 10.1091/mbc.E09-06-0497; Usui ML, 2008, J HISTOCHEM CYTOCHEM, V56, P687, DOI 10.1369/jhc.2008.951194; Van Raamsdonk CD, 2010, NEW ENGL J MED, V363, P2191, DOI 10.1056/NEJMoa1000584; Van Raamsdonk CD, 2004, NAT GENET, V36, P961, DOI 10.1038/ng1412; Vaque JP, 2013, MOL CELL, V49, P94, DOI 10.1016/j.molcel.2012.10.018; Wettschureck N, 2001, NAT MED, V7, P1236, DOI 10.1038/nm1101-1236	43	7	7	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 16	2017	12	3							e0173692	10.1371/journal.pone.0173692	http://dx.doi.org/10.1371/journal.pone.0173692			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN9KE	28301547	Green Submitted, Green Published, gold			2022-12-27	WOS:000396318300062
J	Cowart, DA; Durand, L; Cambon-Bonavita, MA; Arnaud-Haond, S				Cowart, Dominique A.; Durand, Lucile; Cambon-Bonavita, Marie-Anne; Arnaud-Haond, Sophie			Investigation of bacterial communities within the digestive organs of the hydrothermal vent shrimp Rimicaris exoculata provide insights into holobiont geographic clustering	PLOS ONE			English	Article							SP NOV.; DIVERSITY; DEPOSITS; CHAMBER; CH4	Prokaryotic communities forming symbiotic relationships with the vent shrimp, Rimicaris exoculata, are well studied components of hydrothermal ecosystems at the Mid-Atlantic Ridge (MAR). Despite the tight link between host and symbiont, the observed lack of spatial genetic structure seen in R. exoculata contrasts with the geographic differentiation detected in specific bacterial ectosymbionts. The geographic clustering of bacterial lineages within a seemingly panmictic host suggests either the presence of finer scale restriction to gene flow not yet detected in the host, horizontal transmission (environmental selection) of its endosymbionts as a consequence of unique vent geochemistry, or vertically transmitted endosymbionts that exhibit genetic differentiation. To identify which hypothesis best fits, we tested whether bacterial assemblages exhibit differentiation across sites or host populations by performing a 16S rRNA metabarcoding survey on R. exoculata digestive prokaryote samples (n = 31) taken from three geochemically distinct vents across MAR: Rainbow, Trans-Atlantic Geotraverse (TAG) and Logatchev. Analysis of communities across two organs (digestive tract, stomach), three molt colors (white, red, black) and three life stages (eggs, juveniles, adults) also provided insights into symbiont transmission mode. Examining both whole communities and operational taxonomic units (OTUs) confirmed the presence of three main epibionts: Epsilonproteobacteria, Mollicutes and Deferribacteres. With these findings, we identified a clear pattern of geographic segregation by vent in OTUs assigned to Epsilonproteobacteria. Additionally, we detected evidence for differentiation among all communities associated to vents and life stages. Overall, results suggest a combination of environmental selection and vertical inheritance of some of the symbiotic lineages.	[Cowart, Dominique A.; Arnaud-Haond, Sophie] IFREMER, UMR MARBEC Marine Biodivers Exploitat & Conservat, BP 17, Sete, France; [Durand, Lucile; Cambon-Bonavita, Marie-Anne] IFREMER, Lab Microbiol Environm Extremes, Dept Ressources Phys & Ecosyst Fond Mer REM, UMR6197,ZI Pointe Diable,CS 10070, Plouzane, France; [Cambon-Bonavita, Marie-Anne] IFREMER, UBO, CNRS, UMR 6197, IUEM Rue Dumont dUrville, Plouzane, France; [Cambon-Bonavita, Marie-Anne] IFREMER, CNRS, UMR 6197, UBO, IUEM Rue Dumont dUrville, Plouzane, France; [Cowart, Dominique A.] Univ Illinois, Dept Anim Biol, Urbana, IL USA	Ifremer; Ifremer; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Ecology & Environment (INEE); Ifremer; Universite de Bretagne Occidentale; Institut Universitaire Europeen de la Mer (IUEM); Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Ecology & Environment (INEE); Ifremer; Universite de Bretagne Occidentale; Institut Universitaire Europeen de la Mer (IUEM); University of Illinois System; University of Illinois Urbana-Champaign	Arnaud-Haond, S (corresponding author), IFREMER, UMR MARBEC Marine Biodivers Exploitat & Conservat, BP 17, Sete, France.	sophie.arnaud@ifremer.fr	Arnaud-Haond, Sophie/B-2479-2008	Arnaud-Haond, Sophie/0000-0001-5814-8452; Cowart, Dominique/0000-0002-2581-0355; Cambon-Bonavita, Marie-Anne/0000-0002-4076-0472	Hermione project (FP7, European Union); Ifremer	Hermione project (FP7, European Union); Ifremer	This work was supported the by Hermione project (FP7, European Union) to MACB and SAH; DAC and LD were supported by post-doctoral contracts at Ifremer.	Aires T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068429; Bandelt H-J, 1999, MOLECULAR BIOLOGY AN, P1; Blaxter M, 2005, PHILOS T R SOC B, V360, P1935, DOI 10.1098/rstb.2005.1725; BOUGAULT H, 1993, J GEOPHYS RES-SOL EA, V98, P9643, DOI 10.1029/93JB00508; Buck KN, 2015, DEEP-SEA RES PT II, V116, P152, DOI 10.1016/j.dsr2.2014.11.016; Caporaso JG, 2010, NAT METHODS, V7, P335, DOI 10.1038/nmeth.f.303; Caporaso JG, 2010, BIOINFORMATICS, V26, P266, DOI 10.1093/bioinformatics/btp636; CHAO A, 1984, SCAND J STAT, V11, P265; Charlou J, CHEM ECOLOGY; Charlou JL, 2010, GEOPHYS MONOGR SER, V188, P265, DOI 10.1029/2008GM000752; CHILDRESS JJ, 1992, OCEANOGR MAR BIOL, V30, P337; Corbari L, 2008, AQUAT BIOL, V1, P225, DOI 10.3354/ab00024; DeSantis TZ, 2006, APPL ENVIRON MICROB, V72, P5069, DOI 10.1128/AEM.03006-05; Desbruyeres D, 2001, DEEP-SEA RES PT I, V48, P1325, DOI 10.1016/S0967-0637(00)00083-2; Douville E, 2002, CHEM GEOL, V184, P37, DOI 10.1016/S0009-2541(01)00351-5; Durand L, 2015, FEMS MICROBIOL ECOL, V91, DOI 10.1093/femsec/fiv101; Durand L, 2010, FEMS MICROBIOL ECOL, V71, P291, DOI 10.1111/j.1574-6941.2009.00806.x; Edgar RC, 2010, BIOINFORMATICS, V26, P2460, DOI 10.1093/bioinformatics/btq461; Emerson D, 2002, APPL ENVIRON MICROB, V68, P3085, DOI 10.1128/AEM.68.6.3085-3093.2002; Emerson D, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000667; Flores G, 2011, ENV MICROBIOLOGY, V13; Fouquet Y, 2010, GEOPHYS MONOGR SER, V188, P321, DOI 10.1029/2008GM000746; Garrity G, 2001, BERGEYS MANUAL SYSTE, P465, DOI [10.1007/978-0-387-21609-6_26, DOI 10.1007/978-0-387-21609-6_26]; Gloter A, 2004, EARTH PLANET SC LETT, V222, P947, DOI 10.1016/j.epsl.2004.03.040; Guri M, 2012, ISME J, V6, P597, DOI 10.1038/ismej.2011.133; Harper D, 2013, PALAEONTOL ELECTRON, V4, P1; Hugler M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016018; Inagaki F, 2004, INT J SYST EVOL MICR, V54, P1477, DOI 10.1099/ijs.0.03042-0; Jan C, 2014, ENV MICROBIOLOGY, V16; Kaspari M, 2010, ECOLOGY, V91, P2221, DOI 10.1890/09-2089.1; Kumar S, 2016, MOL BIOL EVOL, V33, P1870, DOI [10.1093/molbev/msw054, 10.1093/molbev/msv279]; Loudon AH, 2014, ISME J, V8, P830, DOI 10.1038/ismej.2013.200; Mira A, 2002, MICROBIAL ECOL, V44, P137, DOI 10.1007/s00248-002-0012-9; Miroshnichenko ML, 2003, INT J SYST EVOL MICR, V53, P1637, DOI 10.1099/ijs.0.02673-0; Nieberding CM, 2007, TRENDS ECOL EVOL, V22, P156, DOI 10.1016/j.tree.2006.11.012; Petersen JM, 2011, NATURE, V476, P176, DOI 10.1038/nature10325; Petersen JM, 2010, ENVIRON MICROBIOL, V12, P2204, DOI 10.1111/j.1462-2920.2009.02129.x; POLZ MF, 1995, P NATL ACAD SCI USA, V92, P7232, DOI 10.1073/pnas.92.16.7232; Ponsard J, 2013, ISME J, V7, P96, DOI 10.1038/ismej.2012.87; Pruesse E, 2007, NUCLEIC ACIDS RES, V35, P7188, DOI 10.1093/nar/gkm864; Ramette A, 2007, FEMS MICROBIOL ECOL, V62, P142, DOI 10.1111/j.1574-6941.2007.00375.x; Rozas J, 1995, COMPUT APPL BIOSCI, V11, P621; Schmale O, 2012, GEOCHEM GEOPHY GEOSY, V13, P1; Schmidt C, 2008, J SHELLFISH RES, V27, P79, DOI 10.2983/0730-8000(2008)27[79:IODVIW]2.0.CO;2; Severi S, 2004, ESSDERC 2004: PROCEEDINGS OF THE 34TH EUROPEAN SOLID-STATE DEVICE RESEARCH CONFERENCE, P225; Slobodkina GB, 2009, INT J SYST EVOL MICR, V59, P1508, DOI 10.1099/ijs.0.006767-0; Teixeira S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038521; Teixeira S, 2011, J BIOGEOGR, V38, P564, DOI 10.1111/j.1365-2699.2010.02408.x; THOMPSON G, 1985, CHEM GEOL, V49, P243, DOI 10.1016/0009-2541(85)90159-7; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; TIVEY MK, 1995, J GEOPHYS RES-SOL EA, V100, P12527, DOI 10.1029/95JB00610; Tunnicliffe V, 1996, NATURE, V379, P531, DOI 10.1038/379531a0; VANDOVER CL, 1988, MAR BIOL, V98, P209, DOI 10.1007/BF00391196; Wang Y, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007401; WILLIAMS AB, 1986, J CRUSTACEAN BIOL, V6, P446, DOI 10.2307/1548184; Zbinden M, 2004, MAR ECOL PROG SER, V284, P237, DOI 10.3354/meps284237; Zbinden M, 2003, FEMS MICROBIOL ECOL, V46, P23, DOI 10.1016/S0168-6496(03)00176-4; Zbinden M, 2008, J EXP MAR BIOL ECOL, V359, P131, DOI 10.1016/j.jembe.2008.03.009	58	9	9	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 15	2017	12	3							e0172543	10.1371/journal.pone.0172543	http://dx.doi.org/10.1371/journal.pone.0172543			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN9HQ	28296889	Green Submitted, gold, Green Published			2022-12-27	WOS:000396311700009
J	Esslinger, U; Garnier, S; Korniat, A; Proust, C; Kararigas, G; Muller-Nurasyid, M; Empana, JP; Morley, MP; Perret, C; Stark, K; Bick, AG; Prasad, SK; Kriebel, J; Li, J; Tiret, L; Strauch, K; O'Regan, DP; Marguiles, KB; Seidman, JG; Boutouyrie, P; Lacolley, P; Jouven, X; Hengstenberg, C; Komajda, M; Hakonarson, H; Isnard, R; Arbustini, E; Grallert, H; Cook, SA; Seidman, CE; Regitz-Zagrosek, V; Cappola, TP; Charron, P; Cambien, F; Villard, E				Esslinger, Ulrike; Garnier, Sophie; Korniat, Agathe; Proust, Carole; Kararigas, Georgios; Mueller-Nurasyid, Martina; Empana, Jean-Philippe; Morley, Michael P.; Perret, Claire; Stark, Klaus; Bick, Alexander G.; Prasad, Sanjay K.; Kriebel, Jennifer; Li, Jin; Tiret, Laurence; Strauch, Konstantin; O'Regan, Declan P.; Marguiles, Kenneth B.; Seidman, Jonathan G.; Boutouyrie, Pierre; Lacolley, Patrick; Jouven, Xavier; Hengstenberg, Christian; Komajda, Michel; Hakonarson, Hakon; Isnard, Richard; Arbustini, Eloisa; Grallert, Harald; Cook, Stuart A.; Seidman, Christine E.; Regitz-Zagrosek, Vera; Cappola, Thomas P.; Charron, Philippe; Cambien, Francois; Villard, Eric			Exome-wide association study reveals novel susceptibility genes to sporadic dilated cardiomyopathy	PLOS ONE			English	Article							PROTEIN; MUTATIONS; HSPB7; FHOD3; DIFFERENTIATION; EXPRESSION; VARIANTS; PROMOTES; MYOPATHY; DOMAIN	Aims Dilated cardiomyopathy (DCM) is an important cause of heart failure with a strong familial component. We performed an exome-wide array-based association study (EWAS) to assess the contribution of missense variants to sporadic DCM. Methods and results 116,855 single nucleotide variants (SNVs) were analyzed in 2796 DCM patients and 6877 control subjects from 6 populations of European ancestry. We confirmed two previously identified associations with SNVs in BAG3 and ZBTB17 and discovered six novel DCM-associated loci (Q-value<0.01). The lead-SNVs at novel loci are common and located in TTN, SLC39A8, MLIP, FLNC, ALPK3 and FHOD3. In silico fine mapping identified HSPB7 as the most likely candidate at the ZBTB17 locus. Rare variant analysis (MAF<0.01) demonstrated significant association for TTN variants only (P = 0.0085). All candidate genes but one (SLC39A8) exhibit preferential expression in striated muscle tissues and mutations in TTN, BAG3, FLNC and FHOD3 are known to cause familial cardiomyopathy. We also investigated a panel of 48 known cardiomyopathy genes. Collectively, rare (n = 228, P = 0.0033) or common (n = 36, P = 0.019) variants with elevated in silico severity scores were associated with DCM, indicating that the spectrum of genes contributing to sporadic DCM extends beyond those identified here. Conclusion We identified eight loci independently associated with sporadic DCM. The functions of the best candidate genes at these loci suggest that proteostasis regulation might play a role in DCM pathophysiology.	[Esslinger, Ulrike; Garnier, Sophie; Korniat, Agathe; Proust, Carole; Perret, Claire; Tiret, Laurence; Komajda, Michel; Isnard, Richard; Charron, Philippe; Cambien, Francois; Villard, Eric] UPMC Univ Paris 06, Sorbonne Univ, INSERM UMR S1166, Team Genom & Pathophysiol Cardiovasc Dis, Paris, France; [Esslinger, Ulrike; Garnier, Sophie; Korniat, Agathe; Proust, Carole; Perret, Claire; Tiret, Laurence; Komajda, Michel; Isnard, Richard; Charron, Philippe; Cambien, Francois; Villard, Eric] ICAN Inst Cardiometab & Nutr, Paris, France; [Kararigas, Georgios; Regitz-Zagrosek, Vera] Charite, Inst Gender Med, Berlin, Germany; [Kararigas, Georgios; Regitz-Zagrosek, Vera] Charite, Ctr Cardiovasc Res, Berlin, Germany; [Kararigas, Georgios; Regitz-Zagrosek, Vera] DZHK, Berlin, Germany; [Mueller-Nurasyid, Martina] Helmholtz Zentrum Munchen German Res Ctr Environm, Inst Genet Epidemiol, Neuherberg, Germany; [Mueller-Nurasyid, Martina] Ludwig Maximilians Univ Munchen, Dept Med 1, Munich, Germany; [Mueller-Nurasyid, Martina] DZHK German Ctr Cardiovasc Res, Partnersite Munich Heart Alliance, Munich, Germany; [Mueller-Nurasyid, Martina] INSERM, UMR S970, Dept Epidemiol, Paris, France; [Empana, Jean-Philippe] Univ Paris 05, Sorbonne Paris Cite, Fac Med, Paris, France; [Morley, Michael P.; Marguiles, Kenneth B.; Cappola, Thomas P.] Univ Penn, Perelman Sch Med, Penn Cardiovasc Inst, Philadelphia, PA USA; [Morley, Michael P.; Marguiles, Kenneth B.] Univ Penn, Perelman Sch Med, Dept Med, Philadelphia, PA USA; [Stark, Klaus] Univ Regensburg, Dept Genet Epidemiol, Regensburg, Germany; [Bick, Alexander G.; Seidman, Jonathan G.] Harvard Med Sch, Dept Med & Genet, Boston, MA USA; [Prasad, Sanjay K.] Royal Brompton Hosp, London, England; [Kriebel, Jennifer] Helmholtz Zentrum Munchen German Res Ctr Environm, Res Unit Mol Epidemiol, Neuherberg, Germany; [Kriebel, Jennifer] Helmholtz Zentrum Munchen German Res Ctr Environm, Inst Epidemiol 2, Neuherberg, Germany; [Li, Jin] Childrens Hosp Philadelphia, Ctr Appl Gen, Philadelphia, PA USA; [Strauch, Konstantin] Ludwig Maximilians Univ Munchen, Chair Genet Epidemiol, Inst Med Informat Biometry & Epidemiol, Munich, Germany; [O'Regan, Declan P.] Imperial Coll London, Fac Med, Med Res Council Clin Sci Ctr, London, England; [Seidman, Jonathan G.; Seidman, Christine E.] Howard Hughes Med Inst, Chevy Chase, MD USA; [Boutouyrie, Pierre] Georges Pompidou European Hosp, AP HP, Dept Pharmacol, Paris, France; [Lacolley, Patrick] Univ Lorraine, INSERM U1116, Nancy, France; [Jouven, Xavier] Georges Pompidou European Hosp, AP HP, Dept Cardiol, Paris, France; [Hengstenberg, Christian] Tech Univ Munich, Deutsch Herzzentrum Munchen, Munich, Germany; [Komajda, Michel; Isnard, Richard; Charron, Philippe; Cambien, Francois; Villard, Eric] Hop La Pitie Salpetriere, AP HP, Dept Cardiol, Paris, France; [Komajda, Michel; Isnard, Richard] Pitie Salpetriere Hop, AP HP, Ctr Reference Malad Cardiaques Hereditaires, Paris, France; [Arbustini, Eloisa] IRCCS Fdn Policlin San Matteo, Pavia, Italy; [Cook, Stuart A.] Natl Heart Ctr Singapore, Singapore, Singapore; [Cook, Stuart A.] Imperial Coll London, Natl Heart & Lung Inst, London, England; [Cook, Stuart A.] Duke NUS, Singapore, Singapore; [Charron, Philippe] Univ Versailles St Quentin, Hop Ambroise Pare, AP HP, Boulogne, France	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite; UDICE-French Research Universities; Sorbonne Universite; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; German Centre for Cardiovascular Research; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; University of Munich; German Centre for Cardiovascular Research; Munich Heart Alliance; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; Universite Paris Cite; University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania; Pennsylvania Medicine; University of Regensburg; Harvard University; Harvard Medical School; Royal Brompton Hospital; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia; University of Munich; Imperial College London; UK Research & Innovation (UKRI); Medical Research Council UK (MRC); Howard Hughes Medical Institute; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Europeen Georges-Pompidou - APHP; UDICE-French Research Universities; Universite Paris Cite; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Lorraine; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Europeen Georges-Pompidou - APHP; UDICE-French Research Universities; Universite Paris Cite; German Heart Centre Munich; Technical University of Munich; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; UDICE-French Research Universities; Sorbonne Universite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; UDICE-French Research Universities; Sorbonne Universite; IRCCS Fondazione San Matteo; National Heart Centre Singapore; Imperial College London; National University of Singapore; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Ambroise-Pare - APHP; UDICE-French Research Universities; Universite Paris Saclay	Cambien, F; Villard, E (corresponding author), UPMC Univ Paris 06, Sorbonne Univ, INSERM UMR S1166, Team Genom & Pathophysiol Cardiovasc Dis, Paris, France.; Cambien, F; Villard, E (corresponding author), ICAN Inst Cardiometab & Nutr, Paris, France.; Cambien, F; Villard, E (corresponding author), Hop La Pitie Salpetriere, AP HP, Dept Cardiol, Paris, France.	francois.cambien@upmc.fr; eric.villard@upmc.fr	Cambien, Francois/AAP-9751-2020; Grallert, Harald/B-3424-2013; Kriebel, Jennifer/N-4782-2017; Stark, Klaus/L-7367-2013; villard, eric/AAH-2868-2021; Empana, Jean-Philippe/AAF-6923-2021; Hengstenberg, Christian/U-5485-2019; Villard, Eric/AAI-2464-2021; Lacolley, Patrick/G-3118-2013; boutouyrie, pierre/HGT-8201-2022; Müller-Nurasyid, Martina/I-8735-2018; Arbustini, Eloisa/K-8174-2016	Kriebel, Jennifer/0000-0003-4270-018X; Stark, Klaus/0000-0002-7832-1942; Empana, Jean-Philippe/0000-0002-1469-7772; Villard, Eric/0000-0001-9801-7297; boutouyrie, pierre/0000-0002-4375-3569; Müller-Nurasyid, Martina/0000-0003-3793-5910; Arbustini, Eloisa/0000-0003-2948-7994; Charron, Philippe/0000-0002-1782-1118; Garnier, Sophie/0000-0002-7492-1617; O'Regan, Declan/0000-0002-0691-0270; Isnard, Richard/0000-0002-3439-8104; Morley, Michael/0000-0002-0958-7376; Bick, Alexander/0000-0001-5824-9595; Regitz-Zagrosek, Vera/0000-0002-3566-3467; Kararigas, Georgios/0000-0002-8187-0176	Leducq Transatlantic Network; BestAgeing FP7 European Community project; Conny Maeva Charitable Foundation; British Heart Foundation, UK [PG/12/27/29489]; NMRC Singapore; Medical Research Council, UK; Tanoto Foundation; National Institute for Health Research (NIHR) Biomedical Research Centre based at Imperial College Healthcare NHS Trust, Biomedical Research Unit in Cardiovascular Disease at Royal Brompton  Harefield NHS Foundation Trust and Imperial College London; National Research Agency (ANR); Research Foundation for Hypertension (FRHTA); Research Institute in Public Health (IRESP); Region Ile de France (DIM); ANR [ANR-09-GENO-010]; Helmholtz Zentrum Munchen German Research Center of Environmental Health - German Federal Ministry of Education and Research; State of Bavaria; Munich Center of Health Sciences (MC Health), Ludwig-Maximilians-Universitat, as part of LM Uinnovativ; NIH [R01HL105993, R01HL088577]; Howard Hughes Medical Institute; National Institutes of Health; British Heart Foundation [PG/12/27/29489] Funding Source: researchfish; Rosetrees Trust [M232-CD1] Funding Source: researchfish; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007753] Funding Source: NIH RePORTER	Leducq Transatlantic Network(Leducq Foundation); BestAgeing FP7 European Community project; Conny Maeva Charitable Foundation; British Heart Foundation, UK(British Heart Foundation); NMRC Singapore(National Medical Research Council, Singapore); Medical Research Council, UK(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Tanoto Foundation; National Institute for Health Research (NIHR) Biomedical Research Centre based at Imperial College Healthcare NHS Trust, Biomedical Research Unit in Cardiovascular Disease at Royal Brompton  Harefield NHS Foundation Trust and Imperial College London; National Research Agency (ANR)(French National Research Agency (ANR)); Research Foundation for Hypertension (FRHTA); Research Institute in Public Health (IRESP); Region Ile de France (DIM)(Region Ile-de-France); ANR(French National Research Agency (ANR)); Helmholtz Zentrum Munchen German Research Center of Environmental Health - German Federal Ministry of Education and Research; State of Bavaria; Munich Center of Health Sciences (MC Health), Ludwig-Maximilians-Universitat, as part of LM Uinnovativ; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Howard Hughes Medical Institute(Howard Hughes Medical Institute); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); British Heart Foundation(British Heart Foundation); Rosetrees Trust(Rosetrees Trust); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	The study was supported by the Leducq Transatlantic Network: "Genomic, epigenomic and systems dissection of mechanisms underlyingdilated cardiomyopathy"; BestAgeing FP7 European Community project; and Conny Maeva Charitable Foundation. Other supports are from the British Heart Foundation, UK (PG/12/27/29489); NMRC Singapore; Medical Research Council, UK; Tanoto Foundation; and co-funded by the National Institute for Health Research (NIHR) Biomedical Research Centre based at Imperial College Healthcare NHS Trust, Biomedical Research Unit in Cardiovascular Disease at Royal Brompton & Harefield NHS Foundation Trust and Imperial College London. The views expressed are those of the author(s) and not necessarily those of the NHS, the NIHR or the Department of Health. The PPS3 is organized under an agreement between INSERM and the IPC Center, and between INSERM and the Biological Research Center at the Europeen Georges Pompidou hospital, Paris, France. We thank the "Caisse Nationale d'Assurance Maladie des Travailleurs Salaries". The PPS3 Study is funded by the National Research Agency (ANR), the Research Foundation for Hypertension (FRHTA), the Research Institute in Public Health (IRESP) and the Region Ile de France (DIM). Genotyping in PPS3 substudy was supported by a grant from ANR (ANR-09-GENO-010). The KORA research platform was financed by the Helmholtz Zentrum Munchen German Research Center of Environmental Health, funded by the German Federal Ministry of Education and Research and by the State of Bavaria. Furthermore, KORA research was supported within the Munich Center of Health Sciences (MC Health), Ludwig-Maximilians-Universitat, as part of LM Uinnovativ. The MAGNet consortium is funded by NIH R01HL105993 and NIH R01HL088577. Support for this work was provided in part by the Howard Hughes Medical Institute and National Institutes of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmady E, 2011, J BIOL CHEM, V286, P19702, DOI 10.1074/jbc.M110.165548; Almomani R, 2016, J AM COLL CARDIOL, V67, P515, DOI 10.1016/j.jacc.2015.10.093; Arimura T, 2013, CIRC J, V77, P2990, DOI 10.1253/circj.CJ-13-0255; Arndt V, 2010, CURR BIOL, V20, P143, DOI 10.1016/j.cub.2009.11.022; Broers JLV, 2006, PHYSIOL REV, V86, P967, DOI 10.1152/physrev.00047.2005; Cappola TP, 2011, P NATL ACAD SCI USA, V108, P2456, DOI 10.1073/pnas.1017494108; Cappola TP, 2010, CIRC-CARDIOVASC GENE, V3, P147, DOI 10.1161/CIRCGENETICS.109.898395; Chang CC, 2015, GIGASCIENCE, V4, DOI 10.1186/s13742-015-0047-8; Fujita M, 2012, DEV BIOL, V361, P79, DOI 10.1016/j.ydbio.2011.10.008; Gerull B, 2002, NAT GENET, V30, P201, DOI 10.1038/ng815; Hershberger RE, 2013, NAT REV CARDIOL, V10, P531, DOI 10.1038/nrcardio.2013.105; Hershberger RE, 2010, CIRC-CARDIOVASC GENE, V3, P155, DOI 10.1161/CIRCGENETICS.109.912345; Hosoda T, 2001, J BIOL CHEM, V276, P35978, DOI 10.1074/jbc.M100485200; Howie BN, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000529; Huang ZP, 2015, J CLIN INVEST, V125, P4122, DOI 10.1172/JCI82423; Huang ZP, 2012, CIRC RES, V110, P818, DOI 10.1161/CIRCRESAHA.111.259663; Ionita-Laza I, 2013, AM J HUM GENET, V92, P841, DOI 10.1016/j.ajhg.2013.04.015; Iskratsch T, 2010, J CELL BIOL, V191, P1159, DOI 10.1083/jcb.201005060; Jenkitkasemwong S, 2012, BIOMETALS, V25, P643, DOI 10.1007/s10534-012-9526-x; Juo LY, 2016, J CELL SCI, V129, P1661, DOI 10.1242/jcs.179887; Kan-o M, 2012, BIOL OPEN, V1, P889, DOI 10.1242/bio.20121370; Kircher M, 2014, NAT GENET, V46, P310, DOI 10.1038/ng.2892; Kley RA, 2013, AUTOPHAGY, V9, P422, DOI 10.4161/auto.22921; Lange S, 2005, SCIENCE, V308, P1599, DOI 10.1126/science.1110463; Li B, 2013, TOXICOL MECH METHOD, V23, P27, DOI 10.3109/15376516.2012.735277; Lonsdale J, 2013, NAT GENET, V45, P580, DOI 10.1038/ng.2653; McNally EM, 2013, J CLIN INVEST, V123, P19, DOI 10.1172/JCI62862; Previs MJ, 2012, SCIENCE, V337, P1215, DOI 10.1126/science.1223602; Schlossarek S, 2012, BASIC RES CARDIOL, V107, DOI 10.1007/s00395-011-0235-3; Selcen Duygu, 2011, Neuromuscul Disord, V21, P161, DOI [10.1016/B978-0-08-045031-5.00011-6, 10.1016/j.nmd.2010.12.007]; Selcen D, 2009, ANN NEUROL, V65, P83, DOI 10.1002/ana.21553; Snyder M, 2010, J BIOL CHEM, V285, P23639, DOI 10.1074/jbc.M110.101063; Ulbricht A, 2015, AUTOPHAGY, V11, P538, DOI 10.1080/15548627.2015.1017186; Valdes-Mas R, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6326; van der Ven PFM, 2000, CELL MOTIL CYTOSKEL, V45, P149, DOI 10.1002/(SICI)1097-0169(200002)45:2<149::AID-CM6>3.0.CO;2-G; Van Sligtenhorst I, 2012, VET PATHOL, V49, P131, DOI 10.1177/0300985811402841; Vos MJ, 2010, HUM MOL GENET, V19, P4677, DOI 10.1093/hmg/ddq398; Wolf CM, 2008, J MOL CELL CARDIOL, V44, P293, DOI 10.1016/j.yjmcc.2007.11.008; Xu YW, 2004, CELL, V116, P711, DOI 10.1016/S0092-8674(04)00210-7; Yang Jian, 2013, Methods Mol Biol, V1019, P215, DOI 10.1007/978-1-62703-447-0_9	40	68	70	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 15	2017	12	3							e0172995	10.1371/journal.pone.0172995	http://dx.doi.org/10.1371/journal.pone.0172995			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN9HQ	28296976	Green Published, gold, Green Submitted			2022-12-27	WOS:000396311700021
J	Wee, WY; Dutta, A; Choo, SW				Wee, Wei Yee; Dutta, Avirup; Choo, Siew Woh			Comparative genome analyses of mycobacteria give better insights into their evolution	PLOS ONE			English	Article							SYSTEMS; GROWTH; TOXIN	Mycobacteria a genus of Actinobacteria are widespread in nature ranging from soil-dwelling saprophytes to human and animal pathogens. The rate of growth has been a classifying factor for the Mycobacterium spp., dividing them into the rapid growers and the slow growers. Here we have performed a comparative genome study of mycobacterial species in order to get better understanding of their evolution, particularly to understand the distinction between the rapid and slow growers. Our study shows that the slow growers had generally gained and lost more genes compared to the rapid growers. The slow growers might haved eventually lost genes (LivFGMH operon, shaACDEFG genes and MspA porin) that could contribute to the slow growth rate of the slow growers. The genes gained and lost in mycobacteria had eventually helped these bacteria to adapt to different environments and have led to the evolution of the present day rapid and slow growers. Our results also show high number of Mycobacterium abscessus specific genes (811 genes) and some of them are associated with the known bacterial quorum sensing genes that might be important for Mycobacterium abscessus to adapt and survive in variety of unfavorable environments. Mycobacterium abscessus also does not contains genes involved in the bacterial defense system and together with the quorum sensing genes may have contributed to the high gene gain rate of Mycobacterium abscessus.	[Wee, Wei Yee; Dutta, Avirup] Univ Malaya, Genome Informat Res Lab, Ctr Res Biotechnol & Agr CEBAR, Kuala Lumpur, Malaysia; [Choo, Siew Woh] Xian Jiaotong Liverpool Univ, Dept Biol Sci, Suzhou Dushu Lake Sci & Educ Innovat Dist, Suzhou, Peoples R China	Universiti Malaya; Xi'an Jiaotong-Liverpool University	Choo, SW (corresponding author), Xian Jiaotong Liverpool Univ, Dept Biol Sci, Suzhou Dushu Lake Sci & Educ Innovat Dist, Suzhou Ind Pk, Suzhou, Peoples R China.	lawrence.choo@xjtlu.edu.cn		Dutta, Avirup/0000-0002-3595-6198	University of Malaya and Ministry of Education, Malaysia under the High Impact Research (HIR) [UM.C/625/1/HIR/M0E/CHAN/08]; UM RG grant from University of Malaya and Ministry of Education, Malaysia [RG541-13HTM]	University of Malaya and Ministry of Education, Malaysia under the High Impact Research (HIR); UM RG grant from University of Malaya and Ministry of Education, Malaysia	This project was supported by University of Malaya and Ministry of Education, Malaysia under the High Impact Research (HIR) grant UM.C/625/1/HIR/M0E/CHAN/08 and UM RG grant (grant number: RG541-13HTM) from University of Malaya and Ministry of Education, Malaysia. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALTSCHUL SF, 1990, P NATL ACAD SCI USA, V87, P5509, DOI 10.1073/pnas.87.14.5509; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Aziz RK, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-75; CONNER RM, 1967, J INVERTEBR PATHOL, V9, P114, DOI 10.1016/0022-2011(67)90051-1; Demuth JP, 2006, PLOS ONE, V1, DOI 10.1371/journal.pone.0000085; Devulder G, 2005, INT J SYST EVOL MICR, V55, P293, DOI 10.1099/ijs.0.63222-0; Dumas E, 2016, GENOME BIOL EVOL, V8, P387, DOI 10.1093/gbe/evw001; Enright AJ, 2002, NUCLEIC ACIDS RES, V30, P1575, DOI 10.1093/nar/30.7.1575; Fitzpatrick DA, 2009, J MOL EVOL, V68, P171, DOI 10.1007/s00239-009-9198-5; Galzitskaya OV, 2006, PLOS COMPUT BIOL, V2, P1639, DOI 10.1371/journal.pcbi.0020177; Gey van Pittius NC, 2001, GENOME BIOL, V2; Griffith DE, 2007, AM J RESP CRIT CARE, V175, P367, DOI 10.1164/rccm.200604-571ST; Grissa I, 2007, NUCLEIC ACIDS RES, V35, pW52, DOI 10.1093/nar/gkm360; Houben ENG, 2014, BBA-MOL CELL RES, V1843, P1707, DOI 10.1016/j.bbamcr.2013.11.003; Inaoka T, 2007, J BACTERIOL, V189, P65, DOI 10.1128/JB.01478-06; JARLIER V, 1990, J BACTERIOL, V172, P1418, DOI 10.1128/jb.172.3.1418-1423.1990; Johnson MM, 2014, J THORAC DIS, V6, P210, DOI 10.3978/j.issn.2072-1439.2013.12.24; Kim CJ, 2013, DIAGN MICR INFEC DIS, V75, P73, DOI 10.1016/j.diagmicrobio.2012.09.019; Kosono S, 2005, J BACTERIOL, V187, P5242, DOI 10.1128/JB.187.15.5242-5248.2005; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Liang WL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045346; Librado P, 2012, BIOINFORMATICS, V28, P279, DOI 10.1093/bioinformatics/btr623; Librado P, 2014, GENOME BIOL EVOL, V6, P1454, DOI 10.1093/gbe/evu117; Mailaender C, 2004, MICROBIOL-SGM, V150, P853, DOI 10.1099/mic.0.26902-0; Makarova KS, 2013, NUCLEIC ACIDS RES, V41, P4360, DOI 10.1093/nar/gkt157; Oinuma KI, 2011, J BACTERIOL, V193, P421, DOI 10.1128/JB.01041-10; Rahman SA, 2014, MBIO, V5, DOI 10.1128/mBio.02020-14; Roberts GD, 1991, MANUAL CLIN MICROBIO, P304; Rokas A, 2003, NATURE, V425, P798, DOI 10.1038/nature02053; Rutherford ST, 2012, COLD SPRING HARB PER, V2; Sala A, 2014, TOXINS, V6, P1002, DOI 10.3390/toxins6031002; Stackebrandt E, 2002, INT J SYST EVOL MICR, V52, P1043, DOI [10.1099/ijs.0.02360-0, 10.1099/00207713-52-3-1043]; Tettelin H, 2008, CURR OPIN MICROBIOL, V11, P472, DOI 10.1016/j.mib.2008.09.006; Tortoli E, 2012, INFECT GENET EVOL, V12, P827, DOI 10.1016/j.meegid.2011.05.025; Wayne LG, 1986, BERGEYS MANUAL SYSTE, V2, P1435; Zakham F, 2011, CELL MOL BIOL, V57, P1462, DOI 10.1170/167; Zakham Fathiah, 2012, Microb Inform Exp, V2, P7, DOI 10.1186/2042-5783-2-7; Zhao YB, 2012, BIOINFORMATICS, V28, P416, DOI 10.1093/bioinformatics/btr655	38	20	20	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 14	2017	12	3							e0172831	10.1371/journal.pone.0172831	http://dx.doi.org/10.1371/journal.pone.0172831			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN6DM	28291784	gold, Green Published, Green Submitted			2022-12-27	WOS:000396094700006
J	Fujiwara, M; Ding, C; Kaunitz, L; Stout, JC; Thyagarajan, D; Tsuchiya, N				Fujiwara, Mana; Ding, Catherine; Kaunitz, Lisandro; Stout, Julie C.; Thyagarajan, Dominic; Tsuchiya, Naotsugu			Optokinetic nystagmus reflects perceptual directions in the onset binocular rivalry in Parkinson's disease	PLOS ONE			English	Article							DEEP BRAIN-STIMULATION; MOTOR-NEURON DISEASE; EYE-MOVEMENTS; OCULOMOTOR ABNORMALITIES; ATTENTION; CONSCIOUSNESS; COMPETITION; DOMINANCE; AWARENESS; HUMANS	Optokinetic nystagmus (OKN), the reflexive eye movements evoked by a moving field, has recently gained interest among researchers as a useful tool to assess conscious perception. When conscious perception and stimulus are dissociated, such as in binocular rivalry-when dissimilar images are simultaneously presented to each eye and perception alternates between the two images over time-OKN correlates with perception rather than with the physical direction of the moving field. While this relationship is well established in healthy subjects, it is yet unclear whether it also generalizes to clinical populations, for example, patients with Parkinson's disease. Parkinson's disease is a motor disorder, causing tremor, slow movements and rigidity. It may also be associated with oculomotor deficits, such as impaired saccades and smooth pursuit eye movements. Here, we employed short-duration, onset binocular rivalry (2 s trial of stimulus presentation followed by 1 s inter-trial interval) with moving grating stimuli to assess OKN in Parkinson's disease patients (N = 39) and controls (N = 29) of a similar age. Each trial was either non-rivalrous (same stimuli presented to both eyes) or rivalrous, as in binocular rivalry. We analyzed OKN to discriminate direction of stimulus and perception on a trial-by-trial basis. Although the speed of slow-phase OKN was slower in the patients, discriminability of conscious perception based on OKN was comparable between the groups. Treatment with anti-Parkinson drugs and deep brain stimulation improved motor ability of patients, but did not impact on OKN. Furthermore, OKN-based measures were robust and their latencies were shorter than manual button-based measures in both groups and stimulus conditions. To our knowledge, our study is the first to demonstrate that OKN can be used as a reliable indicator of conscious perception in binocular rivalry even in Parkinson's disease patients in whom impaired manual dexterity may render button-press reports less reliable.	[Fujiwara, Mana; Kaunitz, Lisandro; Stout, Julie C.; Tsuchiya, Naotsugu] Monash Univ, Sch Psychol Sci, Fac Med Nursing & Hlth Sci, Melbourne, Vic, Australia; [Fujiwara, Mana] Araya Brain Imaging, Tokyo, Japan; [Ding, Catherine; Thyagarajan, Dominic] Monash Hlth, Dept Neurosci, Southern Clin Sch, Melbourne, Vic, Australia; [Kaunitz, Lisandro] Univ Tokyo, RCAST, Tokyo, Japan; [Stout, Julie C.; Tsuchiya, Naotsugu] Monash Univ, Monash Inst Cognit & Clin Neurosci, Melbourne, Vic, Australia	Monash University; University of Tokyo; Monash University	Tsuchiya, N (corresponding author), Monash Univ, Sch Psychol Sci, Fac Med Nursing & Hlth Sci, Melbourne, Vic, Australia.; Thyagarajan, D (corresponding author), Monash Hlth, Dept Neurosci, Southern Clin Sch, Melbourne, Vic, Australia.; Tsuchiya, N (corresponding author), Monash Univ, Monash Inst Cognit & Clin Neurosci, Melbourne, Vic, Australia.	dominic.thyagarajan@monash.edu; naotsugu.tsuchiya@monash.edu	Thyagarajan, Dominic E S/H-6633-2014; Tsuchiya, Naotsugu/N-8153-2014	Thyagarajan, Dominic E S/0000-0002-7766-4003; Stout, Julie/0000-0001-9637-8590; Tsuchiya, Naotsugu/0000-0003-4216-8701	Australian Research Council [DP130100194, FT120100619]; Japanese Society for the Promotion of Science [JSPS P15048]; Precursory Research for Embryonic Science and Technology project from the JST [3630]; Monash Institute of Neurological Sciences; Australian Postgraduate Award from Monash University	Australian Research Council(Australian Research Council); Japanese Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Precursory Research for Embryonic Science and Technology project from the JST; Monash Institute of Neurological Sciences; Australian Postgraduate Award from Monash University	LK and NT were supported by the Australian Research Council Discovery Project (DP130100194, http://www.arc.gov.au/discovery -projects). LK was supported by a fellowship from the Japanese Society for the Promotion of Science (JSPS P15048). NT was supported by Precursory Research for Embryonic Science and Technology project from the JST (3630, http://www.jst.go.jp/kisoken/presto/en/about/) and Australian Research Council Future Fellowship (FT120100619, http:// www.arc.gov.au/furure-fellowships). CD is supported by the Monash Institute of Neurological Sciences and an Australian Postgraduate Award from Monash University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Antal A, 2008, TOP GERIATR REHABIL, V24, P166; Antoniades CA, 2015, EYE, V29, P200, DOI 10.1038/eye.2014.276; Arnulf I, 2009, PARKINSONISM RELAT D, V15, pS101, DOI 10.1016/S1353-8020(09)70792-8; Benabid AL, 2003, CURR OPIN NEUROBIOL, V13, P696, DOI 10.1016/j.conb.2003.11.001; Blake R, 2002, NAT REV NEUROSCI, V3, P13, DOI 10.1038/nrn701; Bor D, 2012, FRONT PSYCHOL, V3, DOI 10.3389/fpsyg.2012.00063; Braak E., 1996, Neurobiology of Aging, V17, pS116, DOI 10.1016/S0197-4580(96)80469-6; Brainard DH, 1997, SPATIAL VISION, V10, P433, DOI 10.1163/156856897X00357; BROWN RG, 1988, BRAIN, V111, P323, DOI 10.1093/brain/111.2.323; Carter O, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000343; COOPER JA, 1994, BRAIN, V117, P517, DOI 10.1093/brain/117.3.517; Dauer W, 2003, NEURON, V39, P889, DOI 10.1016/S0896-6273(03)00568-3; Diaz-Santos M, 2015, NEUROPSYCHOLOGIA, V69, P183, DOI 10.1016/j.neuropsychologia.2015.01.044; Einhauser Wolfgang, 2010, Front Hum Neurosci, V4, P18, DOI 10.3389/fnhum.2010.00018; Engbert R, 2003, VISION RES, V43, P1035, DOI 10.1016/S0042-6989(03)00084-1; ENOKSSON P, 1963, ACTA OPHTHALMOL, V41, P544; FOX R, 1975, VISION RES, V15, P849, DOI 10.1016/0042-6989(75)90265-5; Frasle S, 2014, J NEUROSCI, V34, P1738, DOI 10.1523/JNEUROSCI.4403-13.2014; Frank MJ, 2007, SCIENCE, V318, P1309, DOI 10.1126/science.1146157; Garbutt S, 2004, J NEUROL NEUROSUR PS, V75, P1386, DOI 10.1136/jnnp.2003.027367; GIZZI M, 1992, NEUROLOGY, V42, P1037, DOI 10.1212/WNL.42.5.1037; HOWARD IP, 1984, VISION RES, V24, P969, DOI 10.1016/0042-6989(84)90072-5; Hugrass L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035963; Knapp CM., 2009, VERTICAL OPTOKINETIC; Koch C, 2016, NAT REV NEUROSCI, V17, P307, DOI 10.1038/nrn.2016.22; Lau H, 2011, TRENDS COGN SCI, V15, P365, DOI 10.1016/j.tics.2011.05.009; Lee SH, 2004, VISION RES, V44, P983, DOI 10.1016/j.visres.2003.12.007; Leopold D. A., 1995, ROLE ATTENTION BINOC; Leopold DA, 2002, NAT NEUROSCI, V5, P605, DOI 10.1038/nn0602-851; LOGOTHETIS NK, 1990, VISION RES, V30, P1409, DOI 10.1016/0042-6989(90)90022-D; Logothetis NK., 1990, V4 RESPONSES GRATING; Lumer ED, 1998, SCIENCE, V280, P1930, DOI 10.1126/science.280.5371.1930; MAGNUSSON M, 1985, AM J OTOLARYNG, V6, P419, DOI 10.1016/S0196-0709(85)80020-X; Maier A, 2012, FRONT HUM NEUROSCI, V6, DOI 10.3389/fnhum.2012.00263; MARTIFABREGAS J, 1993, J NEUROL, V240, P475, DOI 10.1007/BF00874116; Naber M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020910; NAKAMURA T, 1991, ACTA OTO-LARYNGOL, P559; Pearson J, 2008, TRENDS COGN SCI, V12, P334, DOI 10.1016/j.tics.2008.05.006; Pelli DG, 1997, SPATIAL VISION, V10, P437, DOI 10.1163/156856897X00366; PULLMAN SL, 1988, NEUROLOGY, V38, P249, DOI 10.1212/WNL.38.2.249; Rascol O, 1989, BRAIN; Rottach KG, 1996, ANN NEUROL, V39, P368, DOI 10.1002/ana.410390314; SHIBASAKI H, 1979, ARCH NEUROL-CHICAGO, V36, P360, DOI 10.1001/archneur.1979.00500420070009; Spering M, 2015, TRENDS NEUROSCI, V38, P247, DOI 10.1016/j.tins.2015.02.002; Spering M, 2011, PSYCHOL SCI, V22, P216, DOI 10.1177/0956797610394659; Sterzer P, 2009, TRENDS COGN SCI, V13, P310, DOI 10.1016/j.tics.2009.04.006; Tong F, 2006, TRENDS COGN SCI, V10, P502, DOI 10.1016/j.tics.2006.09.003; Tsuchiya N, 2015, TRENDS COGN SCI, V19, P757, DOI 10.1016/j.tics.2015.10.002; VIDAILHET M, 1994, ANN NEUROL, V35, P420, DOI 10.1002/ana.410350408; Watanabe K, 1999, EXP BRAIN RES, V129, P156, DOI 10.1007/s002210050946; Wei M, 1998, BRAIN RES, V813, P406, DOI 10.1016/S0006-8993(98)01046-4; Wilimzig C, 2008, J VISION, V8, DOI 10.1167/8.5.7; WOLFE JM, 1983, PERCEPTION, V12, P447, DOI 10.1068/p120447	54	9	9	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 13	2017	12	3							e0173707	10.1371/journal.pone.0173707	http://dx.doi.org/10.1371/journal.pone.0173707			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EN6CP	28288201	Green Published, Green Submitted, gold			2022-12-27	WOS:000396092400031
J	Liu, YY; Sun, HY; Li, W; Xia, YL; Deng, YY; Zhang, AX; Chen, HG				Liu, Yang-yang; Sun, Han-yan; Li, Wei; Xia, Yun-lei; Deng, Yuan-yu; Zhang, Ai-xiang; Chen, Huai-gu			Fitness of three chemotypes of Fusarium graminearum species complex in major winter wheat-producing areas of China	PLOS ONE			English	Article							HEAD BLIGHT; CROWN ROT; GEOGRAPHIC-DISTRIBUTION; MYCOTOXIN PROFILES; GENE-SEQUENCES; SPRING WHEAT; F-ASIATICUM; DEOXYNIVALENOL; BARLEY; POPULATIONS	In China, Fusarium head blight is caused mainly by the Fusarium graminearum species complex (FGSC), which produces trichothecene toxins. The FGSC is divided into three chemotypes: 3-acetyldeoxynivalenol (3-ADON), 15-acetyldeoxynivalenol (15-ADON), and nivalenol (NIV). In order to predict the geographical changes in the distribution of these chemotype populations in major winter wheat-producing areas in China, the biological characteristics of twenty randomly selected isolates from each of the three chemotypes were studied. No significant difference was exhibited in the growth rate of 3-ADON, 15-ADON, and NIV isolates at 15(degrees)C. At 20(degrees)C and 25(degrees)C, the growth rate of 15-ADON isolates was the highest. At 30(degrees)C, the growth rate of NIV and 3-ADON isolates was significantly higher than that of 15-ADON isolates. The 15-ADON isolates produced the highest quantities of perithe-cia and two to three days earlier than the other two populations at each temperature, and released more ascospores at 18(degrees)C. The aggressivenes s test on wheat seedlings and ears indicated there was no significant difference between the 3-ADON and 15-ADON isolates. However, the aggressiveness of NIV isolates was significantly lower than that of the 3-ADON and 15-ADON isolates. The DON content in grains from heads inoculated with the 3-ADON isolates was higher than the content of 15-ADON and NIV isolates. The results showed that 15-ADON population had the advantage in perithecia formation and ascospore release, and the 3-ADON population produced more DON in wheat grains. We suggested that distribution of these three chemotype populations may be related to these biological characteristics.	[Liu, Yang-yang; Sun, Han-yan; Li, Wei; Xia, Yun-lei; Deng, Yuan-yu; Zhang, Ai-xiang; Chen, Huai-gu] Jiangsu Acad Agr Sci, Inst Plant Protect, Nanjing, Jiangsu, Peoples R China; [Xia, Yun-lei] Nanjing Agr Univ, Inst Plant Protect, Nanjing, Jiangsu, Peoples R China	Jiangsu Academy of Agricultural Sciences; Nanjing Agricultural University	Chen, HG (corresponding author), Jiangsu Acad Agr Sci, Inst Plant Protect, Nanjing, Jiangsu, Peoples R China.	huaigu@jaas.ac.cn			funds earmarked for the China Agricultural Research System [CARS-3-117]; Science and Technology Support Project of Jiangsu Province [13E2013432]; Jiangsu Agriculture Science and Technology Innovation Fund [CX(15)1001];  [201303016]	funds earmarked for the China Agricultural Research System; Science and Technology Support Project of Jiangsu Province; Jiangsu Agriculture Science and Technology Innovation Fund; 	This work was supported by the National Non-Profit Industry-Funded Research and Special Projects (201303016), by funds earmarked for the China Agricultural Research System (CARS-3-117), by the Science and Technology Support Project of Jiangsu Province (13E2013432), and by Jiangsu Agriculture Science and Technology Innovation Fund (CX(15)1001). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amarasinghe C, 2011, INT J MOL SCI, V12, P6164, DOI 10.3390/ijms12096164; Bai GH, 2001, PLANT BREEDING, V120, P1, DOI 10.1046/j.1439-0523.2001.00562.x; Burlakoti RR, 2008, APPL ENVIRON MICROB, V74, P6513, DOI 10.1128/AEM.01580-08; Cavinder B., 2012, JOVE-J VIS EXP, V61, pe3895, DOI DOI 10.3791/3895:; Chen HG, 2007, ACTA PHYTOPHYLACICA, V34, P32; Dubin H. J., 1997, FUSARIUM HEAD BLIGHT; Evans CK, 2000, PLANT DIS, V84, P654, DOI 10.1094/PDIS.2000.84.6.654; Fuentes-Bueno I, 2012, THESIS; Gale LR, 2011, PHYTOPATHOLOGY, V101, P124, DOI 10.1094/PHYTO-03-10-0067; Goswami RS, 2005, PHYTOPATHOLOGY, V95, P1397, DOI 10.1094/PHYTO-95-1397; Goswami RS, 2004, MOL PLANT PATHOL, V5, P515, DOI 10.1111/J.1364-3703.2004.00252.X; Kang WR, 2013, J MICROBIOL, V51, P540, DOI 10.1007/s12275-013-3338-8; Kristensen R, 2005, MYCOL RES, V109, P173, DOI 10.1017/S0953756204002114; Li HP, 2005, FEMS MICROBIOL LETT, V243, P505, DOI 10.1016/j.femsle.2005.01.015; Li Wei, 2010, Mycosystema, V29, P51; Li XM, 2008, J PHYTOPATHOL, V156, P751, DOI 10.1111/j.1439-0434.2008.01425.x; Li XX, 2011, CROP RES, V3; Manstretta V, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0138860; O'Donnell K, 2004, FUNGAL GENET BIOL, V41, P600, DOI 10.1016/j.fgb.2004.03.003; PARRY DW, 1995, PLANT PATHOL, V44, P207, DOI 10.1111/j.1365-3059.1995.tb02773.x; Puri KD, 2010, PHYTOPATHOLOGY, V100, P1007, DOI 10.1094/PHYTO-12-09-0332; Qu B, 2008, PLANT PATHOL, V57, P15, DOI 10.1111/j.1365-3059.2007.01711.x; Razzazi-Fazeli E, 2003, J CHROMATOGR B, V796, P21, DOI 10.1016/S1570-0232(03)00604-4; Shah DA, 2004, PHYTOPATHOLOGY, V94, P33, DOI 10.1094/PHYTO.2004.94.1.33; Shen CM, 2012, PLANT DIS, V96, P1172, DOI 10.1094/PDIS-11-11-0974-RE; Shi WQ, 2011, ACTA PHYTOPHY SIN, V5; Smiley RW, 2005, PLANT DIS, V89, P949, DOI 10.1094/PD-89-0949; Spolti P, 2014, PHYTOPATHOLOGY, V104, P513, DOI 10.1094/PHYTO-07-13-0206-R; Starkey DE, 2007, FUNGAL GENET BIOL, V44, P1191, DOI 10.1016/j.fgb.2007.03.001; Trail F, 2002, MYCOLOGIA, V94, P181, DOI 10.2307/3761794; von der Ohe C, 2010, EUR J PLANT PATHOL, V127, P407, DOI 10.1007/s10658-010-9607-z; Wang J, 2008, BMC MOL BIOL, V9, DOI 10.1186/1471-2199-9-15; Ward TJ, 2008, FUNGAL GENET BIOL, V45, P473, DOI 10.1016/j.fgb.2007.10.003; Yang L, 2008, PHYTOPATHOLOGY, V98, P719, DOI 10.1094/PHYTO-98-6-0719; Yang XM, 2010, EUR J PLANT PATHOL, V128, P495, DOI 10.1007/s10658-010-9680-3; Zhang H, 2012, PLOS ONE, V7, DOI DOI 10.1371/journal.pone.0031722; Zhang JB, 2007, MYCOL RES, V111, P967, DOI 10.1016/j.mycres.2007.06.008; Zhang XX, 2015, PLANT DIS, V99, P1610, DOI 10.1094/PDIS-04-14-0422-RE	38	22	23	3	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 17	2017	12	3							e0174040	10.1371/journal.pone.0174040	http://dx.doi.org/10.1371/journal.pone.0174040			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EO5CJ	28306726	gold, Green Published, Green Submitted			2022-12-27	WOS:000396710300020
J	Berrached, R; Kadik, L; Mouheb, HA; Prinzing, A				Berrached, Rachda; Kadik, Leila; Mouheb, Hocine Ait; Prinzing, Andreas			Deep roots delay flowering and relax the impact of floral traits and associated pollinators in steppe plants	PLOS ONE			English	Article							PHYLOGENETIC CONSERVATISM; FUNCTIONAL TRAITS; DROUGHT STRESS; PHENOLOGY; COMMUNITY; CLIMATE; VARIABILITY; GRASSLANDS; REGRESSION; DIVERSITY	Strong seasonality in abiotic harshness and pollinator availability shape the reproductive success of plants. Plant species can avoid or can tolerate harsh abiotic conditions and can attract different pollinators, but it remains unknown (i) which of these capacities is most important for flowering phenology, (ii) whether tolerance/avoidance of abiotic harshness reinforces or relaxes the phenological differentiation of species attracting different pollinators. We assembled possibly the first functional trait database for a North African steppe covering 104 species. We inferred avoidance of harshness (drought) from dormancy, i.e. annual life-span and seed size. We inferred tolerance or resistance to harshness from small specific leaf area, small stature, deep roots and high dry matter content. We inferred the type of pollinators attracted from floral colour, shape and depth. We found that avoidance traits did not affect flowering phenology, and among tolerance traits only deep roots had an effect by delaying flowering. Flower colour (red or purple), and occasionally flower depth, delayed flowering. Dish, gullet and flag shape accelerated flowering. Interactive effects however were at least as important, inversing the mentioned relationship between floral characters and flowering phenology. Specifically, among drought-tolerant deep-rooted species, flowering phenologies converged among floral types attracting different pollinators, without becoming less variable overall. Direct and interactive effects of root depth and floral traits explained at least 45% of the variance in flowering phenology. Also, conclusions on interactive effects were highly consistent with and without including information on family identity or outliers. Overall, roots and floral syndromes strongly control flowering phenology, while many other traits do not. Surprisingly, floral syndromes and the related pollinators appear to constrain phenology mainly in shallow-rooted, abiotically little tolerant species. Lack of abiotic tolerance might hence constrain accessible resources and thereby impose a stronger synchronization with biotic partners such as pollinators.	[Berrached, Rachda; Kadik, Leila; Mouheb, Hocine Ait] Univ Sci & Technol Houari Boumediene, Fac Biol Sci, Lab Ecol & Environm, Algiers, Algeria; [Prinzing, Andreas] Univ Rennes 1, CNRS, Res Unit Ecosyst Biodiversite Evolut, Campus Beaulieu,Bat 14 A, Rennes, France	University Science & Technology Houari Boumediene; Centre National de la Recherche Scientifique (CNRS); Universite de Rennes	Berrached, R (corresponding author), Univ Sci & Technol Houari Boumediene, Fac Biol Sci, Lab Ecol & Environm, Algiers, Algeria.	b_rachda@yahoo.fr						AIDOUD A., 1989, THESIS; Akinci S, 2011, WATER STRESS, P15; Albert CH, 2010, J ECOL, V98, P604, DOI 10.1111/j.1365-2745.2010.01651.x; Amghar F, 2012, REV ECOL-TERRE VIE, V67, P257; Barboni D, 2004, J VEG SCI, V15, P635, DOI 10.1111/j.1654-1103.2004.tb02305.x; Bernardello Gabriel, 2007, P19, DOI 10.1007/978-1-4020-5937-7_2; Bosch J, 1997, OECOLOGIA, V109, P583, DOI 10.1007/s004420050120; Catorci A, 2012, PLANT ECOL, V213, P1315, DOI 10.1007/s11258-012-0090-9; Catorci A, 2012, PLANT ECOL EVOL, V145, P165, DOI 10.5091/plecevo.2012.634; Chesson P, 2004, OECOLOGIA, V141, P236, DOI 10.1007/s00442-004-1551-1; Craine JM, 2012, NEW PHYTOL, V193, P673, DOI 10.1111/j.1469-8137.2011.03953.x; Cruz-Neto O, 2011, BIODIVERS CONSERV, V20, P751, DOI 10.1007/s10531-010-9975-x; Davies TJ, 2013, J ECOL, V101, P1520, DOI 10.1111/1365-2745.12154; Du GZ, 2010, PLANT ECOL, V209, P321, DOI 10.1007/s11258-010-9763-4; Elzinga JA, 2007, TRENDS ECOL EVOL, V22, P432, DOI 10.1016/j.tree.2007.05.006; Faegri K., 1979, PRINCIPLES POLLINATI; Fair JM, 2005, J ARID ENVIRON, V62, P235, DOI 10.1016/j.jaridenv.2004.11.010; Gao RR, 2015, PLANT SOIL, V389, P335, DOI 10.1007/s11104-014-2366-4; GARNIER E, 1994, NEW PHYTOL, V128, P725, DOI 10.1111/j.1469-8137.1994.tb04036.x; Gomez JM, 1996, OECOLOGIA, V105, P236, DOI 10.1007/BF00328552; Gomez JM, 2008, P ROY SOC B-BIOL SCI, V275, P2241, DOI 10.1098/rspb.2008.0512; Hallett LM, 2011, PLANT ECOL, V212, P1479, DOI 10.1007/s11258-011-9922-2; Hegland SJ, 2005, OECOLOGIA, V145, P586, DOI 10.1007/s00442-005-0165-6; Jia P, 2011, ARCT ANTARCT ALP RES, V43, P585, DOI 10.1657/1938-4246-43.4.585; Junker RR, 2013, FUNCT ECOL, V27, P329, DOI 10.1111/1365-2435.12005; Kadik-Achoubi L., 2005, THESIS; Kesselring H, 2015, ALPINE BOT, V125, P113, DOI 10.1007/s00035-015-0157-z; Kipling RP, 2014, ECOL RES, V29, P213, DOI 10.1007/s11284-013-1116-z; Kozlowski TT, 2002, BOT REV, V68, P270, DOI 10.1663/0006-8101(2002)068[0270:AAAROW]2.0.CO;2; LARSEN WA, 1972, TECHNOMETRICS, V14, P781, DOI 10.2307/1267305; Lima ALA, 2010, J ARID ENVIRON, V74, P1363, DOI 10.1016/j.jaridenv.2010.05.009; Madre JF, 2013, MESURIM POR SOFWARE; Montserrat-Marti G, 2009, TREES-STRUCT FUNCT, V23, P787, DOI 10.1007/s00468-009-0320-5; Ollerton J, 1998, PLANT ECOL, V139, P35, DOI 10.1023/A:1009798320049; Ollerton J, 2009, ANN BOT-LONDON, V103, P1471, DOI 10.1093/aob/mcp031; Oosterom EJV, 1993, PLANT SOIL, V148, P223; Ortiz PL, 2015, PERSPECT PLANT ECOL, V17, P142, DOI 10.1016/j.ppees.2015.01.004; Perez-Harguindeguy N, 2013, AUST J BOT, V61, P167, DOI 10.1071/BT12225; PETANIDOU T, 1995, AM J BOT, V82, P607, DOI 10.2307/2445419; Pringle EG, 2013, PLOS BIOL, V11, DOI 10.1371/journal.pbio.1001705; Prinzing A, 2001, P ROY SOC B-BIOL SCI, V268, P2383, DOI 10.1098/rspb.2001.1801; Quezel P, 1962, NOUVELLE FLORE ALGE; Ricklefs RE, 1996, OIKOS, V77, P167, DOI 10.2307/3545598; Sanchez AM, 2012, FLORA, V207, P821, DOI 10.1016/j.flora.2012.09.007; Sanchez-Blanco MJ, 2014, SOIL BIOLOGY, V40, P325; Scaven VL, 2013, CURR ZOOL, V59, P418, DOI 10.1093/czoolo/59.3.418; Schenk HJ, 2002, ECOL MONOGR, V72, P311, DOI 10.1890/0012-9615(2002)072[0311:TGBOR]2.0.CO;2; Selwyn MA, 2006, BIODIVERS CONSERV, V15, P3207, DOI 10.1007/s10531-005-0035-x; Torres C, 2002, PLANT BIOLOGY, V4, P360, DOI 10.1055/s-2002-32326; VILLARREAL AG, 1990, BOT GAZ, V151, P5, DOI 10.1086/337797; WESTOBY M, 1995, J ECOL, V83, P531, DOI 10.2307/2261605; Westoby M, 1998, PLANT SOIL, V199, P213, DOI 10.1023/A:1004327224729; Yuan M, 2006, J R STAT SOC B, V68, P49, DOI 10.1111/j.1467-9868.2005.00532.x; Zaher-Ara T, 2016, TREES-STRUCT FUNCT, V30, P985, DOI 10.1007/s00468-016-1372-y	54	3	3	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 16	2017	12	3							e0173921	10.1371/journal.pone.0173921	http://dx.doi.org/10.1371/journal.pone.0173921			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN9KE	28301580	Green Published, gold, Green Submitted			2022-12-27	WOS:000396318300095
J	Griep, Y; Hanson, LM; Vantilborgh, T; Janssens, L; Jones, SK; Hyde, M				Griep, Yannick; Hanson, Linda Magnusson; Vantilborgh, Tim; Janssens, Laurens; Jones, Samantha K.; Hyde, Martin			Can volunteering in later life reduce the risk of dementia? A 5-year longitudinal study among volunteering and non-volunteering retired seniors	PLOS ONE			English	Article							ALZHEIMERS-DISEASE; LEISURE ACTIVITIES; AGING POPULATION; SOCIAL NETWORKS; OLDER-ADULTS; BRAIN; EXERCISE; HEALTH; PERSPECTIVE; PREVALENCE	We propose that voluntary work, characterized by social, physical and cognitive activity in later life is associated with fewer cognitive problems and lower dementia rates. We test these assumptions using 3-wave, self-reported, and registry data from the 2010, 2012, and 2014 Swedish National Prescribed Drug Register. We had three groups of seniors in our data: 1) no volunteering (N = 531), 2) discontinuous volunteering (N = 220), and 3) continuous volunteering (N = 250). We conducted a path analysis in Mplus to investigate the effect of voluntary work (discontinuously and continuously) on self-reported cognitive complaints and the likelihood of being prescribed an anti-dementia treatment after controlling for baseline and relevant background variables. Our results indicated that seniors, who continuously volunteered, reported a decrease in their cognitive complaints over time, whereas no such associations were found for the other groups. In addition, they were 2.44 (95% CI [1.86; 3.21]) and 2.46 (95% CI [1,89; 3.24]) times less likely to be prescribed an anti-dementia treatment in 2012 and 2014, respectively. Our results largely support the assumptions that voluntary work in later life is associated with lower self-reported cognitive complaints and a lower risk for dementia, relative to those who do not engage, or only engage episodically in voluntary work.	[Griep, Yannick; Jones, Samantha K.] Univ Calgary, Dept Psychol, Calgary, AB, Canada; [Hanson, Linda Magnusson] Stockholm Univ, Stress Res Inst, Stockholm, Sweden; [Vantilborgh, Tim] Vrije Univ Brussel, Work & Org Psychol WOPs, Brussels, Belgium; [Janssens, Laurens] Katholieke Univ Leuven, Fac Med, Leuven, Belgium; [Hyde, Martin] Swansea Univ, Ctr Innovat Ageing, Swansea, W Glam, Wales	University of Calgary; Stockholm University; Vrije Universiteit Brussel; KU Leuven; Swansea University	Griep, Y (corresponding author), Univ Calgary, Dept Psychol, Calgary, AB, Canada.	yannick.griep@ucalgary.ca	Vantilborgh, Tim/J-4844-2019; Hanson, Linda L Magnusson/D-2435-2017; Griep, Yannick/P-6621-2018	Vantilborgh, Tim/0000-0002-5763-3111; Hanson, Linda L Magnusson/0000-0002-2908-1903; Griep, Yannick/0000-0002-5005-5443; Hyde, Martin/0000-0002-9955-8121				Akbaraly TN, 2009, NEUROLOGY, V73, P854, DOI 10.1212/WNL.0b013e3181b7849b; Alsnih R, 2003, TRANSPORT RES A-POL, V37, P903, DOI 10.1016/S0965-8564(03)00073-9; Anderson ND, 2014, PSYCHOL BULL, V140, P1505, DOI 10.1037/a0037610; [Anonymous], 2008, J VOLUNTARY SECTOR R; Audirac I, 2008, J PLAN LIT, V23, P4, DOI 10.1177/0885412208318558; Bennett DA, 2006, LANCET NEUROL, V5, P406, DOI 10.1016/S1474-4422(06)70417-3; Berr C, 2005, EUR NEUROPSYCHOPHARM, V15, P463, DOI 10.1016/j.euroneuro.2005.04.003; Bohlken J, 2015, EUR NEUROPSYCHOPHARM, V25, P2333, DOI 10.1016/j.euroneuro.2015.09.014; Brookmeyer R, 2007, ALZHEIMERS DEMENT, V3, P186, DOI 10.1016/j.jalz.2007.04.381; Burr JA, 2011, J AGING HEALTH, V23, P24, DOI 10.1177/0898264310388272; Carlson MC, 2008, ALZHEIMERS DEMENT, V4, P324, DOI 10.1016/j.jalz.2008.07.002; Carlson MC, 2012, J INT NEUROPSYCH SOC, V18, P286, DOI 10.1017/S135561771100169X; CHAMBRE SM, 1984, GERONTOLOGIST, V24, P292, DOI 10.1093/geront/24.3.292; Churchill JD, 2002, NEUROBIOL AGING, V23, P941, DOI 10.1016/S0197-4580(02)00028-3; Colcombe SJ, 2006, J GERONTOL A-BIOL, V61, P1166, DOI 10.1093/gerona/61.11.1166; Cotman CW, 2002, TRENDS NEUROSCI, V25, P295, DOI 10.1016/S0166-2236(02)02143-4; Erickson KI, 2007, NEUROBIOL AGING, V28, P272, DOI 10.1016/j.neurobiolaging.2005.12.012; Erickson KI, 2011, P NATL ACAD SCI USA, V108, P3017, DOI 10.1073/pnas.1015950108; Fratiglioni L, 2004, LANCET NEUROL, V3, P343, DOI 10.1016/S1474-4422(04)00767-7; Fratiglioni L, 2000, LANCET, V355, P1315, DOI 10.1016/S0140-6736(00)02113-9; Fried LP, 2004, J URBAN HEALTH, V81, P64, DOI 10.1093/jurban/jth094; Furu K, 2010, BASIC CLIN PHARMACOL, V106, P86, DOI 10.1111/j.1742-7843.2009.00494.x; Griep Y, 2015, J OCCUP HEALTH PSYCH, V20, P190, DOI 10.1037/a0038342; Gunasekara FI, 2012, SOC SCI MED, V74, P1117, DOI 10.1016/j.socscimed.2011.11.038; Hovstadius B, 2011, BMC HEALTH SERV RES, V11, DOI 10.1186/1472-6963-11-326; Jahoda M., 1982, EMPLOYMENT UNEMPLOYM; Karp A, 2006, DEMENT GERIATR COGN, V21, P65, DOI 10.1159/000089919; LAMBERT D, 1992, TECHNOMETRICS, V34, P1, DOI 10.2307/1269547; Larson EB, 2006, ANN INTERN MED, V144, P73, DOI 10.7326/0003-4819-144-2-200601170-00004; Launer LJ, 1999, NEUROLOGY, V52, P78, DOI 10.1212/WNL.52.1.78; Lleras C, ENCY SOCIAL MEASUREM; Lobo A, 2000, NEUROLOGY, V54, pS4; McMunn A, 2009, AGEING SOC, V29, P765, DOI 10.1017/S0144686X08008350; Middleton LE, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003124; Monnot M, 2005, J AM BOARD FAM PRACT, V18, P240, DOI 10.3122/jabfm.18.4.240; Muthen L. K., 2012, MPLUS USERS GUIDE; Oesterle S, 2004, SOC FORCES, V82, P1123, DOI 10.1353/sof.2004.0049; Pejtersen JH, 2010, SCAND J PUBLIC HEALT, V38, P8, DOI 10.1177/1403494809349858; Pham TM, 2002, PHARMACOL BIOCHEM BE, V73, P167, DOI 10.1016/S0091-3057(02)00783-9; Pilkington PD, 2012, J GERONTOL B-PSYCHOL, V67, P249, DOI 10.1093/geronb/gbr154; Qiu C, 2008, J GERONTOL B-PSYCHOL, V67, P249; Robinson DM, 2006, DRUGS, V66, P1515, DOI 10.2165/00003495-200666110-00015; Scott K., 2003, FUNDING MATTERS IMPA; Small GW, 2009, AM J GERIAT PSYCHIAT, V17, P116, DOI 10.1097/JGP.0b013e3181953a02; Snyder M, 2008, SOC ISS POLICY REV, V2, P1, DOI 10.1111/j.1751-2409.2008.00009.x; Valenzuela MJ, 2007, BRAIN RES REV, V56, P198, DOI 10.1016/j.brainresrev.2007.07.007; Valenzuela MJ, 2008, CURR OPIN PSYCHIATR, V21, P296, DOI 10.1097/YCO.0b013e3282f97b1f; Wilson RS, 2002, NEUROLOGY, V59, P1910, DOI 10.1212/01.WNL.0000036905.59156.A1; Windsor TD, 2008, GERONTOLOGIST, V48, P59, DOI 10.1093/geront/48.1.59	49	30	30	1	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 16	2017	12	3							e0173885	10.1371/journal.pone.0173885	http://dx.doi.org/10.1371/journal.pone.0173885			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EN9KE	28301554	Green Published, Green Submitted, gold			2022-12-27	WOS:000396318300089
J	Lin, WY; Andersson, KE; Lin, CL; Kao, CH; Wu, HC				Lin, Wei-Yu; Andersson, Karl-Erik; Lin, Cheng-Li; Kao, Chia-Hung; Wu, Hsi-Chin			Association of lower urinary tract syndrome with peripheral arterial occlusive disease	PLOS ONE			English	Article							CARDIOVASCULAR RISK-FACTORS; CHRONIC BLADDER ISCHEMIA; POPULATION-BASED-COHORT; ERECTILE DYSFUNCTION; NATIONWIDE-COHORT; SYMPTOMS; MEN; PREVALENCE; HEALTH; OBSTRUCTION	Purpose To describe atherosclerosis may lead to chronic bladder ischemia, eventually resulting in lower urinary tract syndrome (LUTS), and peripheral arterial occlusive disease (PAOD). We investigated the association of LUTS with PAOD. Methods This nationwide population-based cohort study was based on data from the Taiwan National Health Insurance Database from 2000 to 2010; follow-up lasted until the end of 2011. We identified patients with newly diagnosed LUTS by using International Classification of Diseases, Ninth Revision, Clinical Modification codes. Results In total, 36,042 and 36,042 patients were enrolled in LUTS and non-LUTS cohorts, respectively. After adjustment for age, sex, and comorbidities, the risk of subsequent PAOD was 1.36-fold higher [95% confidence interval (CI) = 1.26-1.46] in the LUTS cohort than in the non-LUTS cohort. The adjusted risk of PAOD was the highest in patients with LUTS without any comorbidity [adjusted hazard ratio (aHR) = 1.93, 95% CI = 1.54-2.41]. The age-specific relative risk of PAOD was significantly higher in all age groups, particularly in those aged <49 years (aHR = 1.80, 95% CI = 1.39-2.34], in the LUTS cohort than in the non-LUTS cohort. Conclusion LUTS is a risk factor for PAOD. Physicians should consider the possibility of underlying PAOD in patients with LUTS aged <49 years and without cardiovascular comorbidities. Additional studies developing strategies for decreasing the risk of PAOD are warranted.	[Lin, Wei-Yu] Chang Gung Mem Hosp, Div Urol, Dept Surg, Chiayi, Taiwan; [Lin, Wei-Yu] Chang Gung Univ, Dept Med, Taoyuan, Taiwan; [Lin, Wei-Yu] Chang Gung Univ Sci & Technol, Chiayi, Taiwan; [Lin, Wei-Yu] Chang Gung Univ, Coll Med, Dept Med, Taoyuan, Taiwan; [Lin, Wei-Yu] Chang Gung Univ, Coll Med, Grad Inst Clin Med Sci, Taoyuan, Taiwan; [Andersson, Karl-Erik] Wake Forest Univ, Bowman Gray Sch Med, Wake Forest Inst Regenerat Med, Winston Salem, NC USA; [Lin, Cheng-Li] China Med Univ Hosp, Management Off Hlth Data, Taichung, Taiwan; [Lin, Cheng-Li] China Med Univ, Coll Med, Taichung, Taiwan; [Kao, Chia-Hung; Wu, Hsi-Chin] China Med Univ, Coll Med, Grad Inst Clin Med Sci, Taichung, Taiwan; [Kao, Chia-Hung; Wu, Hsi-Chin] China Med Univ, Coll Med, Sch Med, Taichung, Taiwan; [Kao, Chia-Hung] China Med Univ Hosp, Dept Nucl Med, Taichung, Taiwan; [Kao, Chia-Hung] China Med Univ Hosp, PET Ctr, Taichung, Taiwan; [Kao, Chia-Hung] Asia Univ, Dept Bioinformat & Med Engn, Taichung, Taiwan; [Wu, Hsi-Chin] China Med Univ Beigang Hosp, Dept Urol, Taichung, Taiwan	Chang Gung Memorial Hospital; Chang Gung University; Chang Gung University of Science & Technology; Chang Gung University; Chang Gung University; Wake Forest University; Wake Forest Baptist Medical Center; China Medical University Taiwan; China Medical University Hospital - Taiwan; China Medical University Taiwan; China Medical University Taiwan; China Medical University Taiwan; China Medical University Taiwan; China Medical University Hospital - Taiwan; China Medical University Taiwan; China Medical University Hospital - Taiwan; Asia University Taiwan	Wu, HC (corresponding author), China Med Univ, Coll Med, Grad Inst Clin Med Sci, Taichung, Taiwan.; Wu, HC (corresponding author), China Med Univ, Coll Med, Sch Med, Taichung, Taiwan.; Wu, HC (corresponding author), China Med Univ Beigang Hosp, Dept Urol, Taichung, Taiwan.	d4746@mail.bh.cmu.edu.tw			Taiwan Ministry of Health and Welfare Clinical Trial and Research Center of Excellence [MOHW105-TDU-B-212-133019]; China Medical University Hospital, Academia Sinica Taiwan Biobank Stroke Biosignature Project [BM10501010037]; NRPB Stroke Clinical Trial Consortium [MOST 104-2325-B-039 -005]; Tseng-Lien Lin Foundation, Taichung, Taiwan; Taiwan Brain Disease Foundation, Taipei, Taiwan; Katsuzo and Kiyo Aoshima Memorial Funds, Japan; CMU under the Aim for Top University Plan of the Ministry of Education, Taiwan	Taiwan Ministry of Health and Welfare Clinical Trial and Research Center of Excellence; China Medical University Hospital, Academia Sinica Taiwan Biobank Stroke Biosignature Project; NRPB Stroke Clinical Trial Consortium; Tseng-Lien Lin Foundation, Taichung, Taiwan; Taiwan Brain Disease Foundation, Taipei, Taiwan; Katsuzo and Kiyo Aoshima Memorial Funds, Japan; CMU under the Aim for Top University Plan of the Ministry of Education, Taiwan	This study is supported in part by Taiwan Ministry of Health and Welfare Clinical Trial and Research Center of Excellence (MOHW105-TDU-B-212-133019), China Medical University Hospital, Academia Sinica Taiwan Biobank Stroke Biosignature Project (BM10501010037), NRPB Stroke Clinical Trial Consortium (MOST 104-2325-B-039 -005), Tseng-Lien Lin Foundation, Taichung, Taiwan, Taiwan Brain Disease Foundation, Taipei, Taiwan, and Katsuzo and Kiyo Aoshima Memorial Funds, Japan; and CMU under the Aim for Top University Plan of the Ministry of Education, Taiwan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding received for this study.	Andersson KE, 2014, THER ADV UROL, V6, P105, DOI 10.1177/1756287214526768; Andersson KE, 2003, UROLOGY, V62, P3, DOI 10.1016/j.urology.2003.09.030; Azadzoi KM, 2003, ADV EXP MED BIOL, V539, P271; Bouwman II, 2015, WORLD J UROL, V33, P669, DOI 10.1007/s00345-014-1398-y; Bouwman II, 2015, WORLD J UROL, V33, P1911, DOI 10.1007/s00345-015-1560-1; Bschleipfer T, 2015, J UROLOGY, V193, P345, DOI 10.1016/j.juro.2014.08.098; Chen YC, 2014, KIDNEY INT, V85, P1200, DOI 10.1038/ki.2013.455; Chou TY, 2015, MEDICINE, V94, DOI 10.1097/MD.0000000000000870; Gent M, 1996, LANCET, V348, P1329, DOI 10.1016/s0140-6736(96)09457-3; Hiatt WR, 2001, NEW ENGL J MED, V344, P1608, DOI 10.1056/NEJM200105243442108; Hirsch AT, 2013, LANCET, V382, P1312, DOI 10.1016/S0140-6736(13)61576-7; Irwin DE, 2011, BJU INT, V108, P1132, DOI 10.1111/j.1464-410X.2010.09993.x; Kaplan SA, 2006, J UROLOGY, V176, P2351, DOI 10.1016/j.juro.2006.08.125; Karatas OF, 2010, INT J CARDIOL, V144, P452, DOI 10.1016/j.ijcard.2009.03.099; Katz DL, 2004, MED CLIN N AM, V88, P1295, DOI 10.1016/j.mcna.2004.02.003; Kupelian V, 2015, J UROLOGY, V193, P581, DOI 10.1016/j.juro.2014.08.097; Lin CS, 2015, MEDICINE, V94, DOI 10.1097/MD.0000000000001164; Lin HJ, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0066403, 10.1371/journal.pone.0066661]; Lin TY, 2015, MEDICINE, V94, DOI 10.1097/MD.0000000000002381; Mariappan P, 2006, BJU INT, V98, P1264, DOI 10.1111/j.1464-410X.2006.06525.x; Newman AB, 1999, ARTERIOSCL THROM VAS, V19, P538, DOI 10.1161/01.ATV.19.3.538; Ng C. F., 2007, Hong Kong Medical Journal, V13, P421; Nomiya M, 2012, NEUROUROL URODYNAM, V31, P195, DOI 10.1002/nau.21073; Olin JW, 2010, MAYO CLIN PROC, V85, P678, DOI 10.4065/mcp.2010.0133; Pinggera GM, 2008, BJU INT, V101, P319, DOI 10.1111/j.1464-410X.2007.07339.x; Pinggera GM, 2008, BJU INT, V102, P470, DOI 10.1111/j.1464-410X.2008.07587.x; Ponholzer A, 2006, EUR UROL, V50, P581, DOI 10.1016/j.eururo.2006.01.031; Russo GI, 2015, INT J UROL, V22, P982, DOI 10.1111/iju.12877; Sandfeldt L, 2003, BJU INT, V92, P64, DOI 10.1046/j.1464-410X.2003.04277.x; Shen CH, 2015, MEDICINE, V94, DOI 10.1097/MD.0000000000000911; Signorelli SS, 2015, ANGIOLOGY, V66, P675, DOI 10.1177/0003319714548443; Su TW, 2015, MEDICINE, V94, DOI 10.1097/MD.0000000000001655; Thompson IM, 2005, JAMA-J AM MED ASSOC, V294, P2996, DOI 10.1001/jama.294.23.2996; Van den Eeden SK, 2013, BMC UROL, V13, DOI 10.1186/1471-2490-13-12; Wehrberger C, 2011, UROLOGY, V78, P1063, DOI 10.1016/j.urology.2011.05.065; Wu MP, 2013, UROLOGY, V81, P61, DOI 10.1016/j.urology.2012.08.033; Yamaguchi O, 2014, NEUROUROL URODYNAM, V33, P54, DOI 10.1002/nau.22517; Yeh CC, 2013, MAYO CLIN P, V88, P1901	38	13	13	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 16	2017	12	3							e0170288	10.1371/journal.pone.0170288	http://dx.doi.org/10.1371/journal.pone.0170288			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN9KE	28301517	Green Published, gold, Green Submitted			2022-12-27	WOS:000396318300003
J	Lu, SY; Sung, T; Lin, NW; Abraham, RT; Jessen, BA				Lu, Shuyan; Sung, Tae; Lin, Nianwei; Abraham, Robert T.; Jessen, Bart A.			Lysosomal adaptation: How cells respond to lysosomotropic compounds	PLOS ONE			English	Article							REGULATES AUTOPHAGY; THERAPEUTIC TARGET; CELLULAR CLEARANCE; TFEB; BIOGENESIS; HOMEOSTASIS; TOXICITY; DISEASE; MTORC1; DEGRADATION	Lysosomes are acidic organelles essential for degradation and cellular homoeostasis and recently lysosomes have been shown as signaling hub to respond to the intra and extracellular changes (e.g. amino acid availability). Compounds including pharmaceutical drugs that are basic and lipophilic will become sequestered inside lysosomes (lysosomotropic). How cells respond to the lysosomal stress associated with lysosomotropism is not well characterized. Our goal is to assess the lysosomal changes and identify the signaling pathways that involve in the lysosomal changes. Eight chemically diverse lysosomotropic drugs from different therapeutic areas were subjected to the evaluation using the human adult retinal pigmented epithelium cell line, ARPE-19. All lysosomotropic drugs tested triggered lysosomal activation demonstrated by increased lysosotracker red (LTR) and lysosensor green staining, increased cathepsin activity, and increased LAMP2 staining. However, tested lysosomotropic drugs also prompted lysosomal dysfunction exemplified by intracellular and extracellular substrate accumulation including phospholipid, SQSTM1/p62, GAPDH (Glyceraldehyde 3 -phosphate dehydrogenase) and opsin. Lysosomal activation observed was likely attributed to lysosomal dysfunction, leading to compensatory responses including nuclear translocation of transcriptional factors TFEB, TFE3 and MITF. The adaptive changes are protective to the cells under lysosomal stress. Mechanistic studies implicate calcium and mTORC1 modulation involvement in the adaptive changes. These results indicate that lysosomotropic compounds could evoke a compensatory lysosomal biogenic response but with the ultimate consequence of lysosomal functional impairment. This work also highlights a pathway of response to lysosomal stress and evidences the role of TFEB, TFE3 and MITF in the stress response.	[Lu, Shuyan; Sung, Tae; Jessen, Bart A.] Pfizer Inc, Drug Safety Res & Dev, San Diego, CA 92121 USA; [Lin, Nianwei] iXCells Biotechnol, San Diego, CA USA; [Abraham, Robert T.] Pfizer Inc, Oncol Res Unit, San Diego, CA USA	Pfizer; Pfizer	Lu, SY; Jessen, BA (corresponding author), Pfizer Inc, Drug Safety Res & Dev, San Diego, CA 92121 USA.	shuyan.lu@pfizer.com; bart.jessen@pfizer.com	Lin, Nianwei/AAD-9805-2019		Pfizer	Pfizer(Pfizer)	SL, TS, RTA and BAJ are employees of Pfizer Inc. NL was a postdoc in Pfizer Inc. when generating the data. Pfizer provided support in the form of salaries for authors SL, TS, NL, RTA, BAJ but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the author contributions section.	ANIENTO F, 1993, J BIOL CHEM, V268, P10463; Appelqvist H, 2013, J MOL CELL BIOL, V5, P214, DOI 10.1093/jmcb/mjt022; Ashoor R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082481; Balgi AD, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007124; Bowie M, 2015, WORLD J CLIN ONCOL, V6, P299, DOI 10.5306/wjco.v6.i6.299; Cortes CJ, 2014, NAT NEUROSCI, V17, P1180, DOI 10.1038/nn.3787; de Medina P, 2009, AUTOPHAGY, V5, P1066, DOI 10.4161/auto.5.7.9820; DEDUVE C, 1974, BIOCHEM PHARMACOL, V23, P2495, DOI 10.1016/0006-2952(74)90174-9; Ganley IG, 2011, MOL CELL, V42, P731, DOI 10.1016/j.molcel.2011.04.024; Khoh-Reiter S, 2015, TOXICOL SCI, V145, P383, DOI 10.1093/toxsci/kfv059; Kilpatrick BS, 2013, J CELL SCI, V126, P60, DOI 10.1242/jcs.118836; Klionsky DJ, 2016, AUTOPHAGY, V12, P1, DOI 10.1080/15548627.2015.1100356; Kolter T, 2010, FEBS LETT, V584, P1700, DOI 10.1016/j.febslet.2009.10.021; Lee JH, 2015, CELL REP, V12, P1430, DOI 10.1016/j.celrep.2015.07.050; Lee JH, 2010, CELL, V141, P1146, DOI 10.1016/j.cell.2010.05.008; Lemieux B, 2004, ANAL BIOCHEM, V327, P247, DOI 10.1016/j.ab.2004.01.010; Logan R, 2014, J PHARM SCI-US, V103, P1572, DOI 10.1002/jps.23949; Lu SY, 2012, TOXICOL IN VITRO, V26, P613, DOI 10.1016/j.tiv.2012.01.025; Martina JA, 2016, EMBO J, V35, P479, DOI 10.15252/embj.201593428; Martina JA, 2014, SCI SIGNAL, V7, DOI 10.1126/scisignal.2004754; Medina DL, 2015, NAT CELL BIOL, V17, P288, DOI 10.1038/ncb3114; Medina DL, 2011, DEV CELL, V21, P421, DOI 10.1016/j.devcel.2011.07.016; Nadanaciva S, 2011, TOXICOL IN VITRO, V25, P715, DOI 10.1016/j.tiv.2010.12.010; Nezich CL, 2015, J CELL BIOL, V210, P435, DOI 10.1083/jcb.201501002; Orenstein SJ, 2013, NAT NEUROSCI, V16, P394, DOI 10.1038/nn.3350; Palmieri M, 2011, HUM MOL GENET, V20, P3852, DOI 10.1093/hmg/ddr306; Ploper D, 2015, P NATL ACAD SCI USA, V112, pE420, DOI 10.1073/pnas.1424576112; Renna M, 2010, J BIOL CHEM, V285, P11061, DOI 10.1074/jbc.R109.072181; Roczniak-Ferguson A, 2012, SCI SIGNAL, V5, DOI 10.1126/scisignal.2002790; Sancak Y, 2010, CELL, V141, P290, DOI 10.1016/j.cell.2010.02.024; Sardiello M, 2009, SCIENCE, V325, P473, DOI 10.1126/science.1174447; Sarkar S, 2007, NAT CHEM BIOL, V3, P331, DOI 10.1038/nchembio883; Settembre C, 2013, NAT CELL BIOL, V15, P647, DOI 10.1038/ncb2718; Settembre C, 2012, EMBO J, V31, P1095, DOI 10.1038/emboj.2012.32; Settembre C, 2011, SCIENCE, V332, P1429, DOI 10.1126/science.1204592; Shchors K, 2015, CANCER CELL, V28, DOI 10.1016/j.ccell.2015.08.012; Shin SY, 2013, CARCINOGENESIS, V34, P2080, DOI 10.1093/carcin/bgt169; Spampanato C, 2013, EMBO MOL MED, V5, P691, DOI 10.1002/emmm.201202176; Steele JW, 2013, MOL PSYCHIATR, V18, P882, DOI 10.1038/mp.2012.115; Steele JW, 2013, AUTOPHAGY, V9, P617, DOI 10.4161/auto.23487; STYRT B, 1988, J CELL PHYSIOL, V135, P309, DOI 10.1002/jcp.1041350219; Tsvetkov AS, 2010, P NATL ACAD SCI USA, V107, P16982, DOI 10.1073/pnas.1004498107; Vilchez D, 2014, TRENDS CELL BIOL, V24, P161, DOI 10.1016/j.tcb.2013.09.002; Xu M, 2014, J BIOMOL SCREEN, V19, P168, DOI 10.1177/1087057113501197; Yasumoto K, 1998, PIGM CELL RES, V11, P329, DOI 10.1111/j.1600-0749.1998.tb00491.x; Yoon YH, 2010, INVEST OPHTH VIS SCI, V51, P6030, DOI 10.1167/iovs.10-5278; Yu L, 2010, NATURE, V465, P942, DOI 10.1038/nature09076; Zhang LH, 2007, P NATL ACAD SCI USA, V104, P19023, DOI 10.1073/pnas.0709695104; Zschocke J, 2011, AUTOPHAGY, V7, P1247, DOI 10.4161/auto.7.10.16520	49	90	89	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 16	2017	12	3							e0173771	10.1371/journal.pone.0173771	http://dx.doi.org/10.1371/journal.pone.0173771			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN9KE	28301521	Green Published, gold, Green Submitted			2022-12-27	WOS:000396318300070
J	Timpane-Padgham, BL; Beechie, T; Klinger, T				Timpane-Padgham, Britta L.; Beechie, Tim; Klinger, Terrie			A systematic review of ecological attributes that confer resilience to climate change in environmental restoration	PLOS ONE			English	Article							EELGRASS ZOSTERA-MARINA; LONG-TERM IMPACTS; ECOSYSTEM SERVICES; GENETIC DIVERSITY; MACROINVERTEBRATE ASSEMBLAGES; COMMUNITY PERSISTENCE; FUNCTIONAL RESILIENCE; RESPONSE DIVERSITY; RIPARIAN CORRIDORS; CORAL-REEFS	Ecological restoration is widely practiced as a means of rehabilitating ecosystems and habitats that have been degraded or impaired through human use or other causes. Restoration practices now are confronted by climate change, which has the potential to influence long-term restoration outcomes. Concepts and attributes from the resilience literature can help improve restoration and monitoring efforts under changing climate conditions. We systematically examined the published literature on ecological resilience to identify biological, chemical, and physical attributes that confer resilience to climate change. We identified 45 attributes explicitly related to climate change and classified them as individual-(9), population-(6), community-(7), ecosystem-(7), or process-level attributes (16). Individual studies defined resilience as resistance to change or recovery from disturbance, and only a few studies explicitly included both concepts in their definition of resilience. We found that individual and population attributes generally are suited to species-or habitat-specific restoration actions and applicable at the population scale. Community attributes are better suited to habitat-specific restoration at the site scale, or system-wide restoration at the ecosystem scale. Ecosystem and process attributes vary considerably in their type and applicability. We summarize these relationships in a decision support table and provide three example applications to illustrate how these classifications can be used to prioritize climate change resilience attributes for specific restoration actions. We suggest that (1) including resilience as an explicit planning objective could increase the success of restoration projects, (2) considering the ecological context and focal scale of a restoration action is essential in choosing appropriate resilience attributes, and (3) certain ecological attributes, such as diversity and connectivity, are more commonly considered to confer resilience because they apply to a wide variety of species and ecosystems. We propose that identifying sources of ecological resilience is a critical step in restoring ecosystems in a changing climate.	[Timpane-Padgham, Britta L.; Klinger, Terrie] Univ Washington, Sch Marine & Environm Affairs, Seattle, WA 98195 USA; [Timpane-Padgham, Britta L.] NOAA, Ocean Associates Inc, Northwest Fisheries Sci Ctr, Natl Marine Fisheries Serv,Natl Ocean & Atmospher, Seattle, WA USA; [Beechie, Tim] NOAA, Fish Ecol Div, Northwest Fisheries Sci Ctr, Natl Marine Fisheries Serv,Natl Ocean & Atmospher, Seattle, WA USA	University of Washington; University of Washington Seattle; National Oceanic Atmospheric Admin (NOAA) - USA; National Oceanic Atmospheric Admin (NOAA) - USA	Timpane-Padgham, BL (corresponding author), Univ Washington, Sch Marine & Environm Affairs, Seattle, WA 98195 USA.; Timpane-Padgham, BL (corresponding author), NOAA, Ocean Associates Inc, Northwest Fisheries Sci Ctr, Natl Marine Fisheries Serv,Natl Ocean & Atmospher, Seattle, WA USA.	britta.timpane-padgham@noaa.gov						Adger WN, 2005, SCIENCE, V309, P1036, DOI 10.1126/science.1112122; Allison G, 2004, ECOL MONOGR, V74, P117, DOI 10.1890/02-0681; Altieri AH, 2013, ECOLOGY, V94, P1647, DOI 10.1890/12-1781.1; Angelini C, 2012, ECOLOGY, V93, P101, DOI 10.1890/11-0557.1; [Anonymous], 2016, CONSERVATION METHODS; [Anonymous], 2011, SCANNING CONSERVATIO; Arthington AH, 2010, FRESHWATER BIOL, V55, P1, DOI 10.1111/j.1365-2427.2009.02340.x; Aung TT, 2013, FOREST ECOL MANAG, V293, P103, DOI 10.1016/j.foreco.2012.12.034; Awiti AO, 2011, ECOL SOC, V16; Baker AC, 2008, ESTUAR COAST SHELF S, V80, P435, DOI 10.1016/j.ecss.2008.09.003; Baldwin A.H, 1995, J COASTAL RES, P169; Banning NC, 2008, APPL SOIL ECOL, V40, P109, DOI 10.1016/j.apsoil.2008.03.011; Beatley T., 2012, PLANNING COASTAL RES; Beche LA, 2009, ECOGRAPHY, V32, P778, DOI 10.1111/j.1600-0587.2009.05612.x; Beechie T, 2013, RIVER RES APPL, V29, P939, DOI 10.1002/rra.2590; Beechie T, 1999, FISHERIES, V24, P6, DOI 10.1577/1548-8446(1999)024<0006:AATRSH>2.0.CO;2; Beechie TJ, 2010, BIOSCIENCE, V60, P209, DOI 10.1525/bio.2010.60.3.7; Bell G, 2009, ECOL LETT, V12, P942, DOI 10.1111/j.1461-0248.2009.01350.x; Bellwood D. R, 2011, P ROY SOC LOND B BIO; Bellwood DR, 2004, NATURE, V429, P827, DOI 10.1038/nature02691; BenDor T, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0128339; Benedetti-Cecchi L, 2006, ECOLOGY, V87, P2489, DOI 10.1890/0012-9658(2006)87[2489:TVRTIO]2.0.CO;2; Bernhardt ES, 2005, SCIENCE, V308, P636, DOI 10.1126/science.1109769; Bernhardt JR, 2013, MARINE SCI, V5; Bisson PA, 2009, FRESHWATER ECOSYSTEM; Brauman KA, 2007, ANNU REV ENV RESOUR, V32, P67, DOI 10.1146/annurev.energy.32.031306.102758; Brauns M, 2011, J APPL ECOL, V48, P916, DOI 10.1111/j.1365-2664.2011.02007.x; Brewer JS, 2011, J ECOL, V99, P1219, DOI 10.1111/j.1365-2745.2011.01846.x; Brunel T, 2013, ICEJ MARINE SCI J; Bullock JM, 2011, TRENDS ECOL EVOL, V26, P541, DOI 10.1016/j.tree.2011.06.011; Caissie D, 2006, FRESHWATER BIOL, V51, P1389, DOI 10.1111/j.1365-2427.2006.01597.x; Carter DL, 2012, ECOL APPL, V22, P1308, DOI 10.1890/11-1970.1; Carvalho P, 2013, AUSTRAL ECOL, V38, P592, DOI 10.1111/aec.12003; Chapin FS, 1997, SCIENCE, V277, P500, DOI 10.1126/science.277.5325.500; Chester ET, 2011, FRESHWATER BIOL, V56, P2094, DOI 10.1111/j.1365-2427.2011.02644.x; Choi YD, 2004, ECOL RES, V19, P75, DOI 10.1111/j.1440-1703.2003.00594.x; Chu C, 2008, CAN J FISH AQUAT SCI, V65, P297, DOI 10.1139/F08-007; Churchill DJ, 2013, FOREST ECOL MANAG, V291, P442, DOI 10.1016/j.foreco.2012.11.007; Clark JM, 2011, FUND APPL LIMNOL, V179, P225, DOI 10.1127/1863-9135/2011/0179-0225; Clarke KR, 1998, OECOLOGIA, V113, P278, DOI 10.1007/s004420050379; Connolly SR, 2012, CORAL REEFS, V31, P951, DOI 10.1007/s00338-012-0925-9; Cote IM, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000438; Cowling RM, 2001, P NATL ACAD SCI USA, V98, P5452, DOI 10.1073/pnas.101093498; Crabbe MJC, 2010, MAR ENVIRON RES, V69, P158, DOI 10.1016/j.marenvres.2009.09.007; D'Alpaos A, 2011, GEOMORPHOLOGY, V126, P269, DOI 10.1016/j.geomorph.2010.04.027; D'Odorico P, 2012, PHILOS T R SOC B, V367, P3145, DOI 10.1098/rstb.2012.0016; de Vries FT, 2012, OECOLOGIA, V170, P821, DOI 10.1007/s00442-012-2331-y; del Castillo RF, 2011, EVOL APPL, V4, P574, DOI 10.1111/j.1752-4571.2010.00177.x; Di Carlo G, 2008, OECOLOGIA, V158, P285, DOI 10.1007/s00442-008-1120-0; Diaz-Pulido G, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005239; Doerr VAJ, 2011, J APPL ECOL, V48, P143, DOI 10.1111/j.1365-2664.2010.01899.x; Donohue I, 2010, ECOL APPL, V20, P1733, DOI 10.1890/09-1966.1; Downing AL, 2010, FRESHWATER BIOL, V55, P2123, DOI 10.1111/j.1365-2427.2010.02472.x; Duffy JE, 2009, FRONT ECOL ENVIRON, V7, P437, DOI 10.1890/070195; Dunne JA, 2002, ECOL LETT, V5, P558, DOI 10.1046/j.1461-0248.2002.00354.x; Ehlers A, 2008, MAR ECOL PROG SER, V355, P1, DOI 10.3354/meps07369; Eklof JS, 2009, MAR FRESHWATER RES, V60, P1317, DOI 10.1071/MF09008; Eldridge DJ, 2010, J VEG SCI, V21, P157, DOI 10.1111/j.1654-1103.2009.01130.x; Elmhirst T, 2009, CORAL REEFS, V28, P949, DOI 10.1007/s00338-009-0530-8; Elmqvist T, 2003, FRONT ECOL ENVIRON, V1, P488, DOI 10.2307/3868116; Emmerson M, 2004, P ROY SOC B-BIOL SCI, V271, P397, DOI 10.1098/rspb.2003.2592; Foden WB, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065427; Folke C, 2004, ANNU REV ECOL EVOL S, V35, P557, DOI 10.1146/annurev.ecolsys.35.021103.105711; Force IOPT, 2010, FIN REC INT OC POL T; Frazier AE, 2013, INT J APPL EARTH OBS, V21, P43, DOI 10.1016/j.jag.2012.07.019; Fritz KM, 2004, HYDROBIOLOGIA, V527, P99, DOI 10.1023/B:HYDR.0000043188.53497.9b; Garcia XF, 2012, HYDROBIOLOGIA, V685, P49, DOI 10.1007/s10750-011-0905-z; Gergel SE, 2002, ECOL APPL, V12, P1755, DOI 10.1890/1051-0761(2002)012[1755:COHAFL]2.0.CO;2; Gerisch M, 2012, RIVER RES APPL, V28, P81, DOI 10.1002/rra.1438; Gilmour JP, 2013, SCIENCE, V340, P69, DOI 10.1126/science.1232310; Gough CM, 2013, ECOL APPL, V23, P1202, DOI 10.1890/12-1554.1; Graham NAJ, 2011, CORAL REEFS, V30, P283, DOI 10.1007/s00338-010-0717-z; Griffiths BS, 2008, BIOL FERT SOILS, V44, P745, DOI 10.1007/s00374-007-0257-z; Grime J.P., 2002, PLANT STRATEGIES VEG; Grimsditch GD, 2006, 2831709504 IUCN; Gunderson LH, 2000, ANNU REV ECOL SYST, V31, P425, DOI 10.1146/annurev.ecolsys.31.1.425; Hansen LJ, 2003, BUYIN GTIME USERS MA; Hare JA, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0146756; Hernandez-Miranda E, 2012, MAR ENVIRON RES, V79, P16, DOI 10.1016/j.marenvres.2012.04.004; Herrick Jeffrey E., 2006, Journal for Nature Conservation (Jena), V14, P161, DOI 10.1016/j.jnc.2006.05.001; Hilborn R, 2003, P NATL ACAD SCI USA, V100, P6564, DOI 10.1073/pnas.1037274100; Hilty JA, 2004, CONSERV BIOL, V18, P126, DOI 10.1111/j.1523-1739.2004.00225.x; Hodgson JA, 2011, J APPL ECOL, V48, P148, DOI 10.1111/j.1365-2664.2010.01919.x; Holling C. S, 1996, ENG ECOLOGICAL CONST, P31, DOI DOI 10.17226/4919; Huang Y, 2013, BASIC APPL ECOL, V14, P199, DOI 10.1016/j.baae.2013.01.007; Hughes AR, 2011, J ECOL, V99, P445, DOI 10.1111/j.1365-2745.2010.01767.x; Hughes AR, 2004, P NATL ACAD SCI USA, V101, P8998, DOI 10.1073/pnas.0402642101; Hughes TP, 2003, SCIENCE, V301, P929, DOI 10.1126/science.1085046; Isaac JL, 2009, DIVERS DISTRIB, V15, P280, DOI 10.1111/j.1472-4642.2008.00531.x; Jacquet K, 2009, OECOLOGIA, V161, P801, DOI 10.1007/s00442-009-1422-x; Jaunatre R, 2013, ECOL INDIC, V29, P468, DOI 10.1016/j.ecolind.2013.01.023; Kahmen A, 2005, FUNCT ECOL, V19, P594, DOI 10.1111/j.1365-2435.2005.01001.x; Karr J. R., 1986, SPECIAL PUBLICATION, V5; King EG, 2012, ECOHYDROLOGY, V5, P733, DOI 10.1002/eco.260; Koski KV, 2009, ECOL SOC, V14; Kroon FJ, 2010, MAR FRESHWATER RES, V61, P86, DOI 10.1071/MF08357; Krosby M, 2010, CONSERV BIOL, V24, P1686, DOI 10.1111/j.1523-1739.2010.01585.x; Lanta V, 2012, NATURWISSENSCHAFTEN, V99, P473, DOI 10.1007/s00114-012-0922-4; Lawler JJ, 2009, ANN NY ACAD SCI, V1162, P79, DOI 10.1111/j.1749-6632.2009.04147.x; Leigh C, 2013, HYDROBIOLOGIA, V703, P95, DOI 10.1007/s10750-012-1347-y; Li HB, 2012, FEMS MICROBIOL ECOL, V82, P192, DOI 10.1111/j.1574-6941.2012.01417.x; Lin TC, 2011, ECOSYSTEMS, V14, P127, DOI 10.1007/s10021-010-9399-1; Lirman D, 2009, J EXP MAR BIOL ECOL, V369, P72, DOI 10.1016/j.jembe.2008.10.024; Lobon-Cervia J, 2009, FRESHWATER BIOL, V54, P1149, DOI 10.1111/j.1365-2427.2008.02159.x; Lundquist CJ, 2010, MAR ECOL PROG SER, V413, P217, DOI 10.3354/meps08578; Machtans CS, 1996, CONSERV BIOL, V10, P1366, DOI 10.1046/j.1523-1739.1996.10051366.x; Magalhaes WF, 2011, MAR FRESHWATER RES, V62, P918, DOI 10.1071/MF10277; Mariotte P, 2013, J ECOL, V101, P763, DOI 10.1111/1365-2745.12064; Marshall KN, 2013, P ROY SOC B-BIOL SCI, V280, DOI 10.1098/rspb.2012.2977; Maynard JA, 2010, CORAL REEFS, V29, P381, DOI 10.1007/s00338-010-0603-8; McClanahan T, 2002, CONSERV ECOL, V6; McClanahan TR, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042884; McElhany P, 2000, NOAA TECH MEMO NMFS, V42, P156; MCNAUGHTON SJ, 1977, AM NAT, V111, P515, DOI 10.1086/283181; Micheli F, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040832; Middleton BA., 2002, FLOOD PULSING WETLAN, P1; Mijatovic D, 2013, INT J AGR SUSTAIN, V11, P95, DOI 10.1080/14735903.2012.691221; Millar CI, 2007, ECOL APPL, V17, P2145, DOI 10.1890/06-1715.1; Milner AM, 2013, NAT CLIM CHANGE, V3, P137, DOI [10.1038/nclimate1665, 10.1038/NCLIMATE1665]; Mori AS, 2013, BIOL REV, V88, P349, DOI 10.1111/brv.12004; Morimoto M, 2013, LANDSC ECOL ENG, V9, P259, DOI 10.1007/s11355-012-0206-3; Morrison W. E, 2015, NOAA TECHNICAL MEMOR, P48; Mumby PJ, 2008, J APPL ECOL, V45, P854, DOI 10.1111/j.1365-2664.2008.01459.x; Mumby PJ, 2006, ECOL APPL, V16, P747, DOI 10.1890/1051-0761(2006)016[0747:TIOEGS]2.0.CO;2; Naeem S, 1997, NATURE, V390, P507, DOI 10.1038/37348; NAIMAN RJ, 1993, ECOL APPL, V3, P209, DOI 10.2307/1941822; Naiman RJ, 2000, BIOSCIENCE, V50, P996, DOI 10.1641/0006-3568(2000)050[0996:REAMIT]2.0.CO;2; Neubauer P, 2013, SCIENCE, V340, P347, DOI 10.1126/science.1230441; NIEMI GJ, 1990, ENVIRON MANAGE, V14, P571, DOI 10.1007/BF02394710; Norden N, 2009, ECOL LETT, V12, P385, DOI 10.1111/j.1461-0248.2009.01292.x; Norkko J, 2010, MAR ECOL PROG SER, V413, P253, DOI 10.3354/meps08745; Norton DA, 2009, SCIENCE, V325, P569, DOI 10.1126/science.1172978; Noss RF, 2001, CONSERV BIOL, V15, P578, DOI 10.1046/j.1523-1739.2001.015003578.x; Nunez TA, 2013, CONSERV BIOL, V27, P407, DOI 10.1111/cobi.12014; Nystrom M, 2001, ECOSYSTEMS, V4, P406, DOI 10.1007/s10021-001-0019-y; Obura DO, 2005, ESTUAR COAST SHELF S, V63, P353, DOI 10.1016/j.ecss.2004.11.010; Olds AD, 2012, J APPL ECOL, V49, P1195, DOI 10.1111/jpe.12002; Oliver TH, 2013, ECOGRAPHY, V36, P579, DOI 10.1111/j.1600-0587.2012.07665.x; PAINE RT, 1980, J ANIM ECOL, V49, P667; Palmer MA, 2005, J APPL ECOL, V42, P208, DOI 10.1111/j.1365-2664.2005.01004.x; Palmer MA, 2008, FRONT ECOL ENVIRON, V6, P81, DOI 10.1890/060148; Parrish JD, 2003, BIOSCIENCE, V53, P851, DOI 10.1641/0006-3568(2003)053[0851:AWCWWS]2.0.CO;2; Pernetta John, 1993, MANGROVE FORESTS CLI; Perry LG, 2015, ECOHYDROLOGY, V8, P863, DOI 10.1002/eco.1645; PIMM SL, 1984, NATURE, V307, P321, DOI 10.1038/307321a0; Poff NL, 2002, PHILOS T R SOC A, V360, P1497, DOI 10.1098/rsta.2002.1012; Pollack JB, 2011, ESTUAR COAST, V34, P187, DOI 10.1007/s12237-010-9338-6; Proenca V, 2010, ACTA OECOL, V36, P626, DOI 10.1016/j.actao.2010.09.008; Provan J, 2009, P R SOC B, V276, P301, DOI 10.1098/rspb.2008.1062; Reusch TBH, 2005, P NATL ACAD SCI USA, V102, P2826, DOI 10.1073/pnas.0500008102; Benayas JMR, 2009, SCIENCE, V325, P1121, DOI 10.1126/science.1172460; Robertson AL, 2000, FRESHWATER BIOL, V44, P135, DOI 10.1046/j.1365-2761.2000.00595.x; Robinson CT, 2012, ECOL APPL, V22, P1949, DOI 10.1890/11-1042.1; Royer-Tardif S, 2010, SOIL BIOL BIOCHEM, V42, P813, DOI 10.1016/j.soilbio.2010.01.018; Lopez DR, 2013, ECOL INDIC, V24, P1, DOI 10.1016/j.ecolind.2012.05.014; Sahib N, 2011, BOTANY, V89, P105, DOI 10.1139/B10-091; Salt D., 2012, RESILIENCE THINKING; Schaffner LC, 2010, ESTUAR COAST, V33, P1300, DOI 10.1007/s12237-010-9301-6; Schindler DE, 2010, NATURE, V465, P609, DOI 10.1038/nature09060; Schneck F, 2012, FRESHWATER BIOL, V57, P1678, DOI 10.1111/j.1365-2427.2012.02830.x; Seavy N.E., 2009, ECOL RESTOR, V27, P330, DOI DOI 10.3368/ER.27.3.330; Selig ER, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009278; Shuman JK, 2012, RESILIENCE STABILITY; Simenstad C, 2006, ECOL ENG, V26, P27, DOI 10.1016/j.ecoleng.2005.09.007; Skidmore P, 2013, STREAM WATERSHED RES, P215, DOI DOI 10.1002/9781118406618.CH7; Speed JDM, 2010, J ECOL, V98, P1002, DOI 10.1111/j.1365-2745.2010.01685.x; Sridhar V, 2004, J AM WATER RESOUR AS, V40, P197, DOI 10.1111/j.1752-1688.2004.tb01019.x; Stachowicz JJ, 2008, ECOLOGY, V89, P3008, DOI 10.1890/07-1873.1; Stagg CL, 2011, ECOL APPL, V21, P1731, DOI 10.1890/09-2128.1; Steneck RS, 2002, ENVIRON CONSERV, V29, P436, DOI 10.1017/S0376892902000322; Stromberg JC, 2013, ECOSYSTEMS, V16, P411, DOI 10.1007/s10021-012-9606-3; Stubbington R, 2013, FRESHWATER BIOL, V58, P1202, DOI 10.1111/fwb.12121; Stubbington R, 2012, MAR FRESHWATER RES, V63, P293, DOI 10.1071/MF11196; Suding K.N., 2006, FDN RESTORATION ECOL, P190; Sundstrom SM, 2012, CONSERV BIOL, V26, P305, DOI 10.1111/j.1523-1739.2011.01822.x; Thom RM, 2012, ESTUAR COAST, V35, P78, DOI 10.1007/s12237-011-9430-6; Thrush SF, 2013, ECOL APPL, V23, P226, DOI 10.1890/12-0793.1; van de Koppel J, 2004, AM NAT, V163, P113, DOI 10.1086/380571; Van den Brink FWB, 2013, ECOL INDIC, V25, P92, DOI 10.1016/j.ecolind.2012.09.010; van Ruijven J, 2010, J ECOL, V98, P81, DOI 10.1111/j.1365-2745.2009.01603.x; Viejo RM, 2009, MAR ECOL PROG SER, V390, P55, DOI 10.3354/meps08171; Virah-Sawmy M, 2009, ECOL MONOGR, V79, P557, DOI 10.1890/08-1210.1; Walker B, 2004, ECOL SOC, V9; Walton A, 2014, COAST MANAGE, V42, P107, DOI 10.1080/08920753.2014.877765; White JM, 2011, RESTOR ECOL, V19, P101, DOI 10.1111/j.1526-100X.2009.00531.x; Williams SL, 2001, ECOL APPL, V11, P1472, DOI 10.1890/1051-0761(2001)011[1472:RGDIET]2.0.CO;2; Williams SE, 2008, PLOS BIOL, V6, P2621, DOI 10.1371/journal.pbio.0060325; YOUNT JD, 1990, ENVIRON MANAGE, V14, P547, DOI 10.1007/BF02394709; Zhang B, 2013, SOIL BIOL BIOCHEM, V57, P556, DOI 10.1016/j.soilbio.2012.07.024	189	107	109	5	139	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 16	2017	12	3							e0173812	10.1371/journal.pone.0173812	http://dx.doi.org/10.1371/journal.pone.0173812			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN9KE	28301560	Green Published, gold, Green Submitted			2022-12-27	WOS:000396318300075
J	Nagano, K; Hasegawa, Y; Yoshida, Y; Yoshimura, F				Nagano, Keiji; Hasegawa, Yoshiaki; Yoshida, Yasuo; Yoshimura, Fuminobu			Novel fimbrilin PGN_1808 in Porphyromonas gingivalis	PLOS ONE			English	Article							MFA1 FIMBRIAE; GENOME SEQUENCE; PROTEIN; PURIFICATION; COMPONENTS; COMPLEX; MODEL	Porphyromonas gingivalis, a periodontopathic gram-negative anaerobic bacterium, generally expresses two types of fimbriae, FimA and Mfa1. However, a novel potential fimbrilin, PGN_1808, in P. gingivalis strain ATCC 33277 was recently identified by an in silico structural homology search. In this study, we experimentally examined whether the protein formed a fimbrial structure. Anion-exchange chromatography showed that the elution peak of the protein was not identical to those of the major fimbrilins of FimA and Mfa1, indicating that PGN_1808 is not a component of these fimbriae. Electrophoretic analyses showed that PGN_1808 formed a polymer, although it was detergent and heat labile compared to FimA and Mfa1. Transmission electron microscopy showed filamentous structures (2-3 nm x 200-400 nm) on the cell surfaces of a PGN_1808-overexpressing P. gingivalis mutant (deficient in both FimA and Mfa1 fimbriae) and in the PGN_1808 fraction. PGN_1808 was detected in 81 of 84 wild-type strains of P. gingivalis by western blotting, suggesting that the protein is generally present in P. gingivalis.	[Nagano, Keiji; Hasegawa, Yoshiaki; Yoshida, Yasuo; Yoshimura, Fuminobu] Aichi Gakuin Univ, Sch Dent, Dept Microbiol, Chikusa Ku, 1-100 Kusumoto Cho, Nagoya, Aichi, Japan	Aichi Gakuin University	Nagano, K (corresponding author), Aichi Gakuin Univ, Sch Dent, Dept Microbiol, Chikusa Ku, 1-100 Kusumoto Cho, Nagoya, Aichi, Japan.	nagano@dpc.agu.ac.jp	Nagano, Keiji/AAS-4912-2020	Nagano, Keiji/0000-0003-3587-7606	JSPS [25462880]	JSPS(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	This work was supported by JSPS KAKENHI Grant Number 25462880 (K.N.). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amano A, 2010, PERIODONTOL 2000, V52, P12, DOI 10.1111/j.1600-0757.2009.00307.x; Arai M, 2000, FEMS MICROBIOL LETT, V193, P75, DOI 10.1016/S0378-1097(00)00459-6; Biasini M, 2014, NUCLEIC ACIDS RES, V42, pW252, DOI 10.1093/nar/gku340; Choudhury D, 1999, SCIENCE, V285, P1061, DOI 10.1126/science.285.5430.1061; DICKINSON DP, 1988, J BACTERIOL, V170, P1658, DOI 10.1128/jb.170.4.1658-1665.1988; Enersen M, 2013, J ORAL MICROBIOL, V5, DOI 10.3402/jom.v5i0.20265; Hajishengallis G, 2012, MOL ORAL MICROBIOL, V27, P409, DOI 10.1111/j.2041-1014.2012.00663.x; Hasegawa Y, 2016, J DENT RES, V95, P1291, DOI 10.1177/0022034516655083; Hasegawa Y, 2013, MOL ORAL MICROBIOL, V28, P467, DOI 10.1111/omi.12040; Hasegawa Y, 2009, MICROBIOL-SGM, V155, P3333, DOI 10.1099/mic.0.028928-0; Hunkapiller MW, 1983, FRONTIERS BIOCH BIOP, P23; Ikai R, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0139454; Juncker AS, 2003, PROTEIN SCI, V12, P1652, DOI 10.1110/ps.0303703; Kuboniwa M, 2009, BMC MICROBIOL, V9, DOI 10.1186/1471-2180-9-105; Nagano K, 2015, J DENT RES, V94, P1143, DOI 10.1177/0022034515588275; Nagano K, 2013, MOL ORAL MICROBIOL, V28, P392, DOI 10.1111/omi.12032; Nagano K, 2010, J DENT RES, V89, P903, DOI 10.1177/0022034510370089; Nagano K, 2007, J MED MICROBIOL, V56, P1536, DOI 10.1099/jmm.0.47289-0; Nagano K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043722; Naito M, 2008, DNA RES, V15, P215, DOI 10.1093/dnares/dsn013; Nishiyama SI, 2007, MICROBIOL-SGM, V153, P1916, DOI 10.1099/mic.0.2006/005561-0; SCHAGGER H, 1991, ANAL BIOCHEM, V199, P223, DOI 10.1016/0003-2697(91)90094-A; Shoji M, 2004, MOL MICROBIOL, V52, P1513, DOI 10.1111/j.1365-2958.2004.04105.x; Socransky SS, 2000, PERIODONTOLOGY, V28, P12, DOI DOI 10.1034/J.1600-0757.2002.280102.X; Watanabe T, 2011, J BACTERIOL, V193, P4259, DOI 10.1128/JB.05269-11; Xu QP, 2016, CELL, V165, P690, DOI 10.1016/j.cell.2016.03.016; YOSHIMURA F, 1984, J BACTERIOL, V160, P949, DOI 10.1128/JB.160.3.949-957.1984	27	4	4	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 15	2017	12	3							e0173541	10.1371/journal.pone.0173541	http://dx.doi.org/10.1371/journal.pone.0173541			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN9HQ	28296909	Green Published, Green Submitted, gold			2022-12-27	WOS:000396311700040
J	Zhao, X; Song, HK; Seifert, AC; Li, C; Wehrli, FW				Zhao, Xia; Song, Hee Kwon; Seifert, Alan C.; Li, Cheng; Wehrli, Felix W.			Feasibility of assessing bone matrix and mineral properties in vivo by combined solid-state H-1 and P-31 MRI	PLOS ONE			English	Article							NUCLEAR-MAGNETIC-RESONANCE; CORTICAL BONE; MECHANICAL-PROPERTIES; POSTMENOPAUSAL WOMEN; FIELD STRENGTHS; WATER-CONTENT; BOUND WATER; PORE-WATER; DENSITY; POROSITY	Purpose To develop and evaluate an integrated imaging protocol for bone water and phosphorus quantification in vivo by solid-state H-1 and P-31 MRI. Materials and methods All studies were HIPAA-compliant and were performed with institutional review board approval and written informed consent. Proton (H-1) ultra-short echo-time (UTE) and phosphorus (P-31) zero echo-time (ZTE) sequences were designed and implemented on a 3 T clinical MR scanner to quantify bone water and mineral in vivo. The left tibia of ten healthy subjects (including both genders, 49 +/- 15 y/o) was examined with a custom-built H-1/P-31 dual-frequency extremity RF coil. Total bone water (TW), water bound to the collagen matrix (BW) and bone P-31 were quantified from MR images with respect to reference samples of known H-1 or P-31 concentration, and pore water (PW) was subsequently determined from TW and BW. Porosity index (PI) was calculated as the ratio between UTE images acquired at two echo times. MRI parameters were compared with bone density measures obtained by high-resolution peripheral quantitative CT (HR-pQCT). Results The total scan time for the bone water and P-31 quantification protocol was about 50 minutes. Average TW, BW, PW and P-31 concentrations were 13.99 +/- 1.26, 10.39 +/- 0.80, 3.34 +/- 1.41 mol/L and 7.06 +/- 1.53 mol/L for the studied cohort, respectively, in good agreement with previous results conducted ex vivo. Average intra-subject coefficients of variation were 3.47%, 2.60% and 7.50% for TW, BW and PW and 5.60% for P-31. Negative correlations were observed between PW and vBMD (p< 0.05) as well as between PI and P-31 (p< 0.05), while bone mineral content (BMC) estimated from P-31 MRI and HR-pQCT were strongly positively correlated (p< 0.0001). Conclusion This work demonstrates the feasibility of quantifying bone water and mineral phosphorus in human subjects in a single MRI session with a clinically practical imaging protocol.	[Zhao, Xia; Song, Hee Kwon; Seifert, Alan C.; Li, Cheng; Wehrli, Felix W.] Univ Penn, Lab Struct Physiol & Funct Imaging, Dept Radiol, Perelman Sch Med,MRI Educ Ctr, 1 Founders Bldg, Philadelphia, PA 19104 USA	University of Pennsylvania; Pennsylvania Medicine	Wehrli, FW (corresponding author), Univ Penn, Lab Struct Physiol & Funct Imaging, Dept Radiol, Perelman Sch Med,MRI Educ Ctr, 1 Founders Bldg, Philadelphia, PA 19104 USA.	wehrli@mail.med.upenn.edu		Zhao, Xia/0000-0001-8108-6528	National Institute of Aging, NIH [R01-AG038693]; National Institute of Arthritis and Musculoskeletal and Skin Diseases, NIH [R01-AR050068]; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR050068] Funding Source: NIH RePORTER	National Institute of Aging, NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); National Institute of Arthritis and Musculoskeletal and Skin Diseases, NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	This work was supported by the National Institute of Aging, NIH R01-AG038693 (https://www.nia.nih.gov/) to FWW; National Institute of Arthritis and Musculoskeletal and Skin Diseases, NIH R01-AR050068 (https://www.niams.nih.gov/) to FWW. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anumula S, 2008, BONE, V42, P405, DOI 10.1016/j.bone.2007.10.011; Anumula S, 2006, MAGN RESON MED, V56, P946, DOI 10.1002/mrm.21050; Anumula S, 2010, BONE, V46, P1391, DOI 10.1016/j.bone.2010.01.372; Biswas R, 2012, BONE, V50, P749, DOI 10.1016/j.bone.2011.11.029; Bousson V, 2000, RADIOLOGY, V217, P179, DOI 10.1148/radiology.217.1.r00se11179; Chen J, 2016, P ISMRM 24 SCI M; Chen J, 2016, NMR BIOMED, V29, P1373, DOI 10.1002/nbm.3579; Fernandez-Seara MA, 2004, J BONE MINER RES, V19, P289, DOI 10.1359/JBMR.0301227; Grodzki DM, 2012, MAGN RESON MED, V67, P510, DOI 10.1002/mrm.23017; GRYNPAS M, 1993, CALCIFIED TISSUE INT, V53, pS57, DOI 10.1007/BF01673403; Horch RA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016359; Horch RA, 2010, MAGN RESON MED, V64, P680, DOI 10.1002/mrm.22459; Kanis JA, 2008, OSTEOPOROSIS INT, V19, P385, DOI 10.1007/s00198-007-0543-5; LAVALJEANTET AM, 1983, CALCIFIED TISSUE INT, V35, P268, DOI 10.1007/BF02405044; Li C, 2016, MAGN RESON MED; Li C, 2014, IEEE T MED IMAGING, V33, P961, DOI 10.1109/TMI.2014.2300500; Li C, 2012, MAGN RESON MED, V68, P680, DOI 10.1002/mrm.23267; Manhard MK, 2015, RADIOLOGY, V277, P221, DOI 10.1148/radiol.2015140336; Nyman JS, 2008, BONE, V42, P193, DOI 10.1016/j.bone.2007.09.049; Patsch JM, 2013, J BONE MINER RES, V28, P313, DOI 10.1002/jbmr.1763; Rad HS, 2011, NMR BIOMED, V24, P855, DOI 10.1002/nbm.1631; Rajapakse CS, 2015, RADIOLOGY, V276, P526, DOI 10.1148/radiol.15141850; Robson MD, 2004, MAGNET RESON MED, V51, P888, DOI 10.1002/mrm.20055; Roschger P, 2001, BONE, V29, P185, DOI 10.1016/S8756-3282(01)00485-9; Seeman E, 2013, J GERONTOL A-BIOL, V68, P1218, DOI 10.1093/gerona/glt071; Seeman E, 2006, NEW ENGL J MED, V354, P2250, DOI 10.1056/NEJMra053077; Seifert AC, 2015, J BONE MINER RES, V30, P2229, DOI 10.1002/jbmr.2580; Seifert AC, 2015, NMR BIOMED, V28, P861, DOI 10.1002/nbm.3305; Seifert AC, 2014, NMR BIOMED, V27, P739, DOI 10.1002/nbm.3107; Seifert AC, 2013, NMR BIOMED, V26, P1158, DOI 10.1002/nbm.2930; Siris ES, 2006, OSTEOPOROSIS INT, V17, P565, DOI 10.1007/s00198-005-0027-4; Techawiboonwong A, 2008, RADIOLOGY, V248, P824, DOI 10.1148/radiol.2482071995; Wehrli FW, 2005, ANN BIOMED ENG, V33, P79, DOI 10.1007/s10439-005-8965-8; Wehrli FW, 2002, J BONE MINER RES, V17, P2265, DOI 10.1359/jbmr.2002.17.12.2265; Wright NC, 2014, J BONE MINER RES, V29, P2520, DOI 10.1002/jbmr.2269; Wu YT, 2011, J MAGN RESON IMAGING, V34, P623, DOI 10.1002/jmri.22637; Zarowitz BJ, 2015, J AM MED DIR ASSOC, V16, P341, DOI 10.1016/j.jamda.2015.01.073	37	22	22	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 15	2017	12	3							e0173995	10.1371/journal.pone.0173995	http://dx.doi.org/10.1371/journal.pone.0173995			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN9HQ	28296979	Green Submitted, Green Published, gold			2022-12-27	WOS:000396311700086
J	Fukagawa, T; Takafuji, K; Tachibanaki, S; Kawamura, S				Fukagawa, Takashi; Takafuji, Kazuaki; Tachibanaki, Shuji; Kawamura, Satoru			Purification of cone outer segment for proteomic analysis on its membrane proteins in carp retina	PLOS ONE			English	Article							CALCIUM SENSOR PROTEINS; VISUAL PIGMENT; AMELOGENESIS IMPERFECTA; ROD DYSTROPHY; MOUSE RETINA; PHOTORECEPTOR; IDENTIFICATION; ACTIVATION; SEQUENCE; COMPLEX	Rods and cones are both photoreceptors in the retina, but they are different in many aspects including the light response characteristics and, for example, cell morphology and metabolism. These differences would be caused by differences in proteins expressed in rods and cones. To understand the molecular bases of these differences between rods and cones, one of the ways is to compare proteins expressed in rods and cones, and to find those expressed specifically or dominantly. In the present study, we are interested in proteins in the outer segment (OS), the site responsible for generation of rod-or cone-characteristic light responses and also the site showing different morphology between rods and cones. For this, we established a method to purify the OS and the inner segment (IS) of rods and also of cones from purified carp rods and cones, respectively, using sucrose density gradient. In particular, we were interested in proteins tightly bound to the membranes of cone OS. To identify these proteins, we analyzed proteins in some selected regions of an SDS-gel of washed membranes of the OS and the IS obtained from both rods and cones, with Liquid Chromatography-tandem Mass Spectrometry (LC-MS/MS) using a protein database constructed from carp retina. By comparing the lists of the proteins found in the OS and the IS of both rods and cones, we found some proteins present in cone OS membranes specifically or dominantly, in addition to the proteins already known to be present specifically in cone OS.	[Fukagawa, Takashi; Tachibanaki, Shuji; Kawamura, Satoru] Osaka Univ, Grad Sch Frontier Biosci, Suita, Osaka, Japan; [Takafuji, Kazuaki] Osaka Univ, Grad Sch Med, Ctr Med Innovat & Translat Res, Suita, Osaka, Japan; [Tachibanaki, Shuji; Kawamura, Satoru] Osaka Univ, Grad Sch Sci, Dept Biol Sci, Suita, Osaka, Japan; [Fukagawa, Takashi] Natl Res Inst Police Sci, Kashiwa, Chiba, Japan	Osaka University; Osaka University; Osaka University	Kawamura, S (corresponding author), Osaka Univ, Grad Sch Frontier Biosci, Suita, Osaka, Japan.	banaki@fbs.osaka-u.ac.jp; kawamura@fbs.osaka-u.ac.jp		Kawamura, Satoru/0000-0003-2070-5940	Japan Society for the Promotion of Science KAKENHI grant [16K07438, 24570085, 23227002]	Japan Society for the Promotion of Science KAKENHI grant(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by Japan Society for the Promotion of Science KAKENHI grant numbers, 16K07438, 24570085 (to ST) and 23227002 (to SK). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akimoto M, 2006, P NATL ACAD SCI USA, V103, P3890, DOI 10.1073/pnas.0508214103; Ames JB, 2012, BBA-GEN SUBJECTS, V1820, P1205, DOI 10.1016/j.bbagen.2011.10.003; Arinobu D, 2010, J NEUROCHEM, V115, P259, DOI 10.1111/j.1471-4159.2010.06925.x; Azadi S, 2010, P NATL ACAD SCI USA, V107, P21158, DOI 10.1073/pnas.1010460107; Biel M, 1999, P NATL ACAD SCI USA, V96, P7553, DOI 10.1073/pnas.96.13.7553; Burgoyne RD, 2007, NAT REV NEUROSCI, V8, P182, DOI 10.1038/nrn2093; COOK NJ, 1987, P NATL ACAD SCI USA, V84, P585, DOI 10.1073/pnas.84.2.585; Fu YB, 2007, PFLUG ARCH EUR J PHY, V454, P805, DOI 10.1007/s00424-006-0194-y; Fukagawa T, 2016, CARP RETINA TRANSCRI; HAGEMAN GS, 1991, P NATL ACAD SCI USA, V88, P2716, DOI 10.1073/pnas.88.7.2716; HAMMOND C, 1994, SCIENCE, V266, P456, DOI 10.1126/science.7939687; Hu G, 2003, J BIOL CHEM, V278, P14550, DOI 10.1074/jbc.M212046200; Ishihama Y, 2005, MOL CELL PROTEOMICS, V4, P1265, DOI 10.1074/mcp.M500061-MCP200; Iwamoto S, 1998, BIOCHEM BIOPH RES CO, V243, P233, DOI 10.1006/bbrc.1997.8023; Kalies KU, 1996, J BIOL CHEM, V271, P3925; Kawamura S, 2008, COMP BIOCHEM PHYS A, V150, P369, DOI 10.1016/j.cbpa.2008.04.600; Koshitani Y, 2014, J BIOL CHEM, V289, P2651, DOI 10.1074/jbc.M113.495325; Krishnan A, 2004, BIOCHEMISTRY-US, V43, P2708, DOI 10.1021/bi035631v; Kwok MCM, 2008, MOL CELL PROTEOMICS, V7, P1053, DOI 10.1074/mcp.M700571-MCP200; Lakkaraju AKK, 2012, EMBO J, V31, P1823, DOI 10.1038/emboj.2012.15; LEREA CL, 1986, SCIENCE, V234, P77, DOI 10.1126/science.3529395; Li XF, 2006, J BIOL CHEM, V281; Masuda T, 2016, SCI REP-UK, V6, DOI 10.1038/srep22360; Meister M, 2014, MEMBRANES-BASEL, V4, P356, DOI 10.3390/membranes4030356; Molday LL, 2007, J BIOL CHEM, V282, P32792, DOI 10.1074/jbc.M706321200; NAKANO A, 1992, BIOCHEM BIOPH RES CO, V186, P1207, DOI 10.1016/S0006-291X(05)81534-7; OKANO T, 1989, BIOCHEMISTRY-US, V28, P8848, DOI 10.1021/bi00448a025; Okawa H, 2008, CURR BIOL, V18, P1917, DOI 10.1016/j.cub.2008.10.029; Parry DA, 2009, AM J HUM GENET, V84, P266, DOI 10.1016/j.ajhg.2009.01.009; Polok B, 2009, AM J HUM GENET, V84, P259, DOI 10.1016/j.ajhg.2009.01.006; PUGH EN, 1993, BIOCHIM BIOPHYS ACTA, V1141, P111, DOI 10.1016/0005-2728(93)90038-H; RAMAGE L, 1993, EMBO J, V12, P4115, DOI 10.1002/j.1460-2075.1993.tb06095.x; Rinner O, 2005, NEURON, V47, P231, DOI 10.1016/j.neuron.2005.06.010; ROSENFELD J, 1992, ANAL BIOCHEM, V203, P173, DOI 10.1016/0003-2697(92)90061-B; SCHLUTER K, 1986, P NATL ACAD SCI USA, V83, P6137, DOI 10.1073/pnas.83.16.6137; SCHWAIGER M, 1987, J CELL BIOL, V105, P235, DOI 10.1083/jcb.105.1.235; Shimauchi-Matsukawa Y, 2008, MOL VIS, V14, P358; SISTERMANS EA, 1995, CELL TISSUE RES, V280, P435, DOI 10.1007/s004410050372; Stearns G, 2007, J NEUROSCI, V27, P13866, DOI 10.1523/JNEUROSCI.3136-07.2007; Tachibanaki S, 2005, P NATL ACAD SCI USA, V102, P9329, DOI 10.1073/pnas.0501875102; Tachibanaki S, 2001, P NATL ACAD SCI USA, V98, P14044, DOI 10.1073/pnas.241396898; Tachibanaki S, 2012, J BIOL CHEM, V287, P41186, DOI 10.1074/jbc.M112.403717; Takemoto N, 2009, P NATL ACAD SCI USA, V106, P11788, DOI 10.1073/pnas.0812781106; Tsuji T, 2007, PROTEOMICS, V7, P3500, DOI 10.1002/pmic.200700272; Westhofen P, 2011, J BIOL CHEM, V286, P15085, DOI 10.1074/jbc.M110.210971; Wetzel RK, 1999, J NEUROSCI, V19, P9878; WOODRUFF ML, 1979, J GEN PHYSIOL, V73, P629, DOI 10.1085/jgp.73.5.629; Xie B, 2005, J BIOL CHEM, V280, P22375, DOI 10.1074/jbc.M414597200; Xu P, 2014, NAT GENET, V46, P1212, DOI 10.1038/ng.3098; Yamagata T, 1997, GENOMICS, V45, P535, DOI 10.1006/geno.1997.4966; Yamaoka H, 2015, J BIOL CHEM, V290, P24381, DOI 10.1074/jbc.M115.674101	51	4	4	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 14	2017	12	3							e0173908	10.1371/journal.pone.0173908	http://dx.doi.org/10.1371/journal.pone.0173908			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN6DM	28291804	Green Published, Green Submitted, gold			2022-12-27	WOS:000396094700048
J	Park, D; Cho, KJ				Park, Daegeun; Cho, Kyu-Jin			Development and evaluation of a soft wearable weight support device for reducing muscle fatigue on shoulder	PLOS ONE			English	Article							DESIGN; JOINT; DISORDERS	Compensating the weight of human limbs is important in reducing muscle fatigue experienced by manual laborers. In this study, a compact and lightweight soft wearable weight support device was developed and evaluated. The device supports gravitational force on the shoulder at any arm posture, although there are some limitations in its assistive performance. The device actuator consists of a cam-rod structure, a tendon-driven mechanism, and a rubber band. The desired assistive torque is translated to the shoulder joint along a tendon routing structure. Device performance was evaluated by measuring muscle activation in with-assist and without-assist conditions. Muscle activation on the deltoid was measured by surface electromyography. An experimental protocol consisting of a series of exercises was executed with six healthy subjects. The subjects raised and lowered their arm from 0 to 100 degrees for 30 times under eight conditions, which were combined with-assist and without-assist conditions, and holding the horizontal angle of the arm at 0, 30, 60, or 90 degrees against the sagittal plane. Surface electromyography data were pre-processed and analyzed using a root mean square method. When muscle fatigue occurs, the root mean square of the surface electromyography increases nonlinearly. This was calculated using the standard deviation of the root mean square. Three of six subjects showed decreased variation of the root mean square between the exercises in the with-assist condition. One subject's result was significantly reduced (by about 57.6%) in the with-assist condition. In contrast, two subjects did not show significant difference between measurements taken in the with-assist and without-assist conditions. One subject was dropped from the experiment because the device did not fit the subject's body. In conclusion, the effectiveness of the soft wearable weight support device in supporting shoulder movements was verified through the decreased variation of muscle activation.	[Park, Daegeun; Cho, Kyu-Jin] Seoul Natl Univ, Sch Mech & Aerosp Engn, Inst Adv Machines & Design, Seoul, South Korea	Seoul National University (SNU)	Cho, KJ (corresponding author), Seoul Natl Univ, Sch Mech & Aerosp Engn, Inst Adv Machines & Design, Seoul, South Korea.	kjcho@snu.ac.kr		Park, Daegeun/0000-0001-6586-4238	convergence technology development program for bionic arm through the National Research Foundation of Korea (NRF) - Ministry of Science, ICT & Future Planning [2015M3C1B2052817]; National Research Foundation of Korea (NRF) Grant - Korean Government (MSIP) [NRF-2016R1A5A1938472]	convergence technology development program for bionic arm through the National Research Foundation of Korea (NRF) - Ministry of Science, ICT & Future Planning; National Research Foundation of Korea (NRF) Grant - Korean Government (MSIP)	This research was supported by the convergence technology development program for bionic arm through the National Research Foundation of Korea (NRF) funded by the Ministry of Science, ICT & Future Planning (No. 2015M3C1B2052817), and the National Research Foundation of Korea (NRF) Grant funded by the Korean Government (MSIP)(No. NRF-2016R1A5A1938472) (http://www.nrf.re.kr/nrf_eng_cms/).	Aaras A, 1996, ERGONOMICS, V39, P171; Asbeck AT, 2015, ROBOT AUTON SYST, V73, P102, DOI 10.1016/j.robot.2014.09.025; Asbeck AT, 2015, INT J ROBOT RES; Ball S., 2007, IEEE ASME INT C ADV, P1, DOI DOI 10.1109/AIM.2007.4412446; Carignan C, 2005, 2005 12TH INTERNATIONAL CONFERENCE ON ADVANCED ROBOTICS, P524; Carpenter JE, 1998, AM J SPORT MED, V26, P262, DOI 10.1177/03635465980260021701; der Heide LAV, 2013, PROSTHET ORTHOT INT; Fernstrom EAC, 1996, ERGONOMICS, V39, P1221, DOI 10.1080/00140139608964541; HAGBERG M, 1981, ERGONOMICS, V24, P543, DOI 10.1080/00140138108924875; Hug F, 2003, CLIN PHYSIOL FUNCT I, V23, P208, DOI 10.1046/j.1475-097X.2003.00497.x; In H, 2015, IEEE ROBOT AUTOM MAG, V22, P97, DOI 10.1109/MRA.2014.2362863; Kawamoto H., 2002, Computers Helping People with Special Needs 8th International Conference, ICCHP 2002. Proceedings (Lecture Notes in Computer Science Vol.2398), P196; Kawamoto H, 2003, IEEE SYS MAN CYBERN, P1648; Kawamoto H, 2009, IEEE ENG MED BIO, P5038, DOI 10.1109/IEMBS.2009.5333698; Koo I, 2014, IEEE INT C INT ROBOT, P542, DOI 10.1109/IROS.2014.6942612; Lin PY, 2013, MECH MACH THEORY, V61, P156, DOI 10.1016/j.mechmachtheory.2012.11.003; Lo HS, 2012, MED ENG PHYS, V34, P261, DOI 10.1016/j.medengphy.2011.10.004; Maciejasz P, 2014, J NEUROENG REHABIL, V11, DOI 10.1186/1743-0003-11-3; Magermans DJ, 2005, CLIN BIOMECH, V20, P591, DOI 10.1016/j.clinbiomech.2005.02.006; Mair SD, 1996, AM J SPORT MED, V24, P137, DOI 10.1177/036354659602400203; Mastenbroek B, 2007, INT C REHAB ROBOT, P1114, DOI 10.1109/ICORR.2007.4428563; Nef Tobias, 2009, Applied Bionics and Biomechanics, V6, P127, DOI 10.1080/11762320902840179; Neumann, 2013, KINESIOLOGY MUSCULOS, P216; OHLSSON K, 1995, AM J IND MED, V27, P731; Panizzolo FA, 2016, J NEUROENG REHABIL, V13, DOI 10.1186/s12984-016-0150-9; Park D, 2015, INT C REHAB ROBOT, P79, DOI 10.1109/ICORR.2015.7281179; Park D, 2015, IEEE ASME INT C ADV, P647, DOI 10.1109/AIM.2015.7222610; Pascarelli EF, 2001, J OCCUP REHABIL, V11, P1, DOI 10.1023/A:1016647923501; Perry J. C., 2006, 1 IEEE RAS EMBS INT, P805, DOI DOI 10.1109/BIOROB.2006.1639189; Ragonesi D, 2011, IEEE ENG MED BIO, P3515, DOI 10.1109/IEMBS.2011.6090583; RANNEY D, 1995, ERGONOMICS, V38, P1408, DOI 10.1080/00140139508925198; Rus D, 2015, NATURE, V521, P467, DOI 10.1038/nature14543; Strausser KA, 2010, PROCEEDINGS OF THE ASME DYNAMIC SYSTEMS AND CONTROL CONFERENCE 2010, VOL 1, P453; Swift TA, 2010, PROCEEDINGS OF THE ASME DYNAMIC SYSTEMS AND CONTROL CONFERENCE 2010, VOL 1, P405; Tozeren A., 1999, SPRINGER SCI BUSINES; Viteckova S, 2013, BIOCYBERN BIOMED ENG, V33, P96, DOI 10.1016/j.bbe.2013.03.005; Wu G, 2005, J BIOMECH, V38, P981, DOI 10.1016/j.jbiomech.2004.05.042; YOSHIKAWA T, 1994, J EXP BIOL, V188, P217	38	30	30	2	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 14	2017	12	3							e0173730	10.1371/journal.pone.0173730	http://dx.doi.org/10.1371/journal.pone.0173730			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EN6DM	28291825	gold, Green Published			2022-12-27	WOS:000396094700037
J	Yin, QJ; Shi, TY; Dong, C; Yan, ZJ				Yin, Qiuju; Shi, Tianyu; Dong, Chao; Yan, Zhijun			The impact of contact patterns on epidemic dynamics	PLOS ONE			English	Article							DOUBLE-EDGED-SWORD; HUMAN-BEHAVIOR; SPREAD	In social networks, individuals have relationships with their neighbor nodes (acquaintance contacts) and also randomly contact other nodes without direct links (stranger contacts). However, these two types of contact patterns are rarely considered together. In this paper, we propose a modified SIS (Susceptible-Infected-Susceptible) model in which a node not only contacts neighbor nodes but also randomly contacts other nodes in the network. We implement the model on a scale-free network and study the influence of different types of contact patterns on epidemic dynamics as well as three possible strategies people adopt when disease outbreaks. The results show that a greater preference for acquaintance contacts makes a disease outbreak less likely. Moreover, the best protective strategy to control the disease is to adjust both the contact number and the contact pattern. In addition, the epidemic is more likely to be controlled when individuals take more information into consideration.	[Yin, Qiuju; Shi, Tianyu; Dong, Chao; Yan, Zhijun] Beijing Inst Technol, Sch Management & Econ, Beijing, Peoples R China; [Yin, Qiuju; Yan, Zhijun] Sustainable Dev Res Inst Econ & Soc Beijing, Beijing, Peoples R China	Beijing Institute of Technology	Yan, ZJ (corresponding author), Beijing Inst Technol, Sch Management & Econ, Beijing, Peoples R China.; Yan, ZJ (corresponding author), Sustainable Dev Res Inst Econ & Soc Beijing, Beijing, Peoples R China.	yanzhijun@bit.edu.cn			National Natural Science Foundation of China [71272057, 71572013]; Beijing Natural Science Foundation [9152015]; Joint Development Program of Beijing Municipal Commission of Education	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Beijing Natural Science Foundation(Beijing Natural Science Foundation); Joint Development Program of Beijing Municipal Commission of Education	This study was funded by the following sources: The National Natural Science Foundation of China (Award #: 71272057, 71572013), http://www.nsfc.gov.cn/; Beijing Natural Science Foundation (Award #: 9152015), http://www.bjnst.org; and Joint Development Program of Beijing Municipal Commission of Education. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This research was supported by the National Natural Science Foundation of China (Award #: 71272057, 71572013), the Beijing Natural Science Foundation (Award #: 9152015) and Joint Development Program of Beijing Municipal Commission of Education.	ANDERSON R M, 1991; Christakis N. A., 2011, CONNECTED SURPRISING; Del Valle S, 2005, MATH BIOSCI, V195, P228, DOI 10.1016/j.mbs.2005.03.006; Dong C, 2015, PHYSICA A, V438, P169, DOI 10.1016/j.physa.2015.06.037; Fenichel EP, 2011, P NATL ACAD SCI USA, V108, P6306, DOI 10.1073/pnas.1011250108; Funk S, 2010, J R SOC INTERFACE, V7, P1247, DOI 10.1098/rsif.2010.0142; Gross T, 2006, PHYS REV LETT, V96, DOI 10.1103/PhysRevLett.96.208701; Hethcote HW, 2000, SIAM REV, V42, P599, DOI 10.1137/S0036144500371907; Kermack WO, 1927, P R SOC LOND A-CONTA, V115, P700, DOI 10.1098/rspa.1927.0118; Mao L, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024706; May RM, 2001, PHYS REV E, V64, DOI 10.1103/PhysRevE.64.066112; Miller JC, 2007, PHYSICA A, V386, P780, DOI 10.1016/j.physa.2007.08.054; Pastor-Satorras R, 2001, PHYS REV LETT, V86, P3200, DOI 10.1103/PhysRevLett.86.3200; Shang YL, 2013, J BIOL PHYS, V39, P489, DOI 10.1007/s10867-013-9318-8; Valdez LD, 2013, PHYSICA A, V392, P4172, DOI 10.1016/j.physa.2013.05.003; Vardavas R, 2007, PLOS COMPUT BIOL, V3, P796, DOI 10.1371/journal.pcbi.0030085; Vazquez A, 2002, PHYS REV E, V65, DOI 10.1103/PhysRevE.65.066130; Vazquez A, 2006, PHYS REV E, P74; Wallinga J, 1999, TRENDS MICROBIOL, V7, P372, DOI 10.1016/S0966-842X(99)01546-2; Wu Q, 2012, CHAOS, V22, P91; Wu ZX, 2013, EPL-EUROPHYS LETT, V104, DOI 10.1209/0295-5075/104/10002; YAMIN D, 2014, PLOS COMPUT BIOL, V0010; Yang R, 2007, PHYS LETT A, V364, P189, DOI 10.1016/j.physleta.2006.12.021; Zhang HF, 2016, EPL-EUROPHYS LETT, V114, DOI 10.1209/0295-5075/114/38004; Zhang HF, 2012, PHYSICA A, V391, P4807, DOI 10.1016/j.physa.2012.05.009; Zhang J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0014525; Zhou T., 2006, PHYS REV E, P121; Zou L, 2010, SIAM J APPL MATH, V70, P3121, DOI 10.1137/090777645	28	11	11	1	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 14	2017	12	3							e0173411	10.1371/journal.pone.0173411	http://dx.doi.org/10.1371/journal.pone.0173411			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN6DM	28291800	gold, Green Published, Green Submitted			2022-12-27	WOS:000396094700025
J	Yoo, RE; Yun, TJ; Yoon, BW; Lee, SK; Lee, ST; Kang, KM; Choi, SH; Kim, JH; Sohn, CH; Park, SW; Han, MH				Yoo, Roh-Eul; Yun, Tae Jin; Yoon, Byung-Woo; Lee, Sang Kun; Lee, Soon-Tae; Kang, Koung Mi; Choi, Seung Hong; Kim, Ji-hoon; Sohn, Chul-Ho; Park, Sun-Won; Han, Moon Hee			Identification of cerebral perfusion using arterial spin labeling in patients with seizures in acute settings	PLOS ONE			English	Article							BLOOD-FLOW; STATUS EPILEPTICUS; LOBE EPILEPSY; MRI; DIFFUSION; FOCUS; DIAGNOSIS; EEG	This study aimed to explore the utility of arterial spin labeling perfusion-weighted imaging (ASL-PWI) in patients with suspected seizures in acute settings. A total of 164 patients who underwent ASL-PWI for suspected seizures in acute settings (with final diagnoses of seizure [n = 129], poststroke seizure [n = 18], and seizure mimickers [n = 17]), were included in this retrospective study. Perfusion abnormality was analyzed for: (1) pattern, (2) multifocality, and (3) atypical distribution against vascular territories. Perfusion abnormality was detected in 39% (50/129) of the seizure patients, most (94%, 47/50) being the hyperperfusion pattern. Of the patients with perfusion abnormality, multifocality or hemispheric involvement and atypical distribution against vascular territory were revealed in 46% (23/50) and 98% (49/50), respectively. In addition, seizures showed characteristic features including hyperperfusion (with or without non-territorial distribution) on ASL-PWI, thus differentiating them from poststroke seizures or seizure mimickers. In patients in whom seizure focus could be localized on both EEG and ASL-PWI, the concordance rate was 77%. The present study demonstrates that ASL-PWI can provide information regarding cerebral perfusion status in patients with seizures in acute settings and has the potential to be used as a non-invasive imaging tool to identify the cerebral perfusion in patients with seizures.	[Yoo, Roh-Eul; Yun, Tae Jin; Kang, Koung Mi; Choi, Seung Hong; Kim, Ji-hoon; Sohn, Chul-Ho; Park, Sun-Won; Han, Moon Hee] Seoul Natl Univ, Inst Radiat Med, Med Res Ctr, Seoul, South Korea; [Yoo, Roh-Eul; Yun, Tae Jin; Kang, Koung Mi; Choi, Seung Hong; Kim, Ji-hoon; Sohn, Chul-Ho; Han, Moon Hee] Seoul Natl Univ Hosp, Dept Radiol, Seoul, South Korea; [Yoon, Byung-Woo; Lee, Sang Kun; Lee, Soon-Tae] Seoul Natl Univ Hosp, Dept Neurol, Seoul, South Korea; [Park, Sun-Won] Seoul Natl Univ, Dept Radiol, Boramae Med Ctr, Seoul, South Korea	Seoul National University (SNU); Seoul National University (SNU); Seoul National University Hospital; Seoul National University (SNU); Seoul National University Hospital; Seoul National University (SNU); Seoul National University Hospital	Yun, TJ (corresponding author), Seoul Natl Univ, Inst Radiat Med, Med Res Ctr, Seoul, South Korea.; Yun, TJ (corresponding author), Seoul Natl Univ Hosp, Dept Radiol, Seoul, South Korea.	radiologyyun@gmail.com	Sohn, ChulHo/AAV-4565-2021	Yun, Tae Jin/0000-0001-8441-4574; Lee, Soon-Tae/0000-0003-4767-7564	Seoul National University Hospital Research Fund [04-2012-1000]; Seoul National University College of Medicine Research Fund [800-20140025]	Seoul National University Hospital Research Fund; Seoul National University College of Medicine Research Fund	This study was supported by a grant from the Seoul National University Hospital Research Fund [04-2012-1000] and Seoul National University College of Medicine Research Fund [800-20140025]. TJY received the funding. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This study was supported by a grant from the Seoul National University Hospital Research Fund [04-2012-1000] and Seoul National University College of Medicine Research Fund [80020140025].	Alsop DC, 2002, EPILEPSIA, V43, P69, DOI 10.1046/j.1528-1157.2002.043s1069.x; Arntz R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055498; Bladin CF, 2000, ARCH NEUROL-CHICAGO, V57, P1617, DOI 10.1001/archneur.57.11.1617; Bradley WG, 2000, RADIOLOGY, V214, P651, DOI 10.1148/radiology.214.3.r00mr42651; Calistri V, 2003, AM J NEURORADIOL, V24, P671; DETRE JA, 1992, MAGNET RESON MED, V23, P37, DOI 10.1002/mrm.1910230106; Duncan JS, 2010, NAT REV NEUROL, V6, P537, DOI 10.1038/nrneurol.2010.131; DUNCAN R, 1992, CEREBROVAS BRAIN MET, V4, P105; Galazzo IB, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0123975; Guo XQ, 2015, J MAGN RESON IMAGING, V42, P1386, DOI 10.1002/jmri.24920; HEISS WD, 1992, J CEREBR BLOOD F MET, V12, P193, DOI 10.1038/jcbfm.1992.29; Kanazawa Y, 2015, J STROKE CEREBROVASC, V24, P731, DOI 10.1016/j.jstrokecerebrovasdis.2014.09.026; Kim BS, 2016, EUR J RADIOL, V85, P1295, DOI 10.1016/j.ejrad.2016.04.015; Kim Sunhee, 2011, Int J Mol Imaging, V2011, P813028, DOI 10.1155/2011/813028; LANDIS JR, 1977, BIOMETRICS, V33, P159, DOI 10.2307/2529310; Leonhardt G, 2005, EPILEPSIA, V46, P1943, DOI 10.1111/j.1528-1167.2005.00336.x; Lim YM, 2008, EPILEPSY RES, V82, P183, DOI 10.1016/j.eplepsyres.2008.08.001; Matsuura K, 2015, J NEUROL SCI, V359, P424, DOI 10.1016/j.jns.2015.10.009; Oishi M, 2012, NEURORADIOLOGY, V54, P653, DOI 10.1007/s00234-012-1027-7; Pendse N, 2010, J NEURORADIOLOGY, V37, P60, DOI 10.1016/j.neurad.2009.05.006; Pizzini F, 2008, EPILEPSY RES, V81, P225, DOI 10.1016/j.eplepsyres.2008.06.009; Pizzini FB, 2013, MAGN RESON IMAGING, V31, P1001, DOI 10.1016/j.mri.2013.03.023; Placidi F, 2002, EPILEPSIA, V43, P1515, DOI 10.1046/j.1528-1157.2002.04702.x; Pollock JM, 2008, J COMPUT ASSIST TOMO, V32, P291, DOI 10.1097/RCT.0b013e31814cf81f; Schwartz Theodore H, 2007, Epilepsy Curr, V7, P91, DOI 10.1111/j.1535-7511.2007.00183.x; Smith SJM, 2005, J NEUROL NEUROSUR PS, V76, P2, DOI 10.1136/jnnp.2005.069245; Stafstrom C.E., 2015, COLD SPRING HARB PER, V5; Sugita K, 2014, SEIZURE-EUR J EPILEP, V23, P318, DOI 10.1016/j.seizure.2014.01.005; Szabo K, 2005, BRAIN, V128, P1369, DOI 10.1093/brain/awh454; Toledo M, 2008, EPILEPSIA, V49, P1465, DOI 10.1111/j.1528-1167.2008.01620.x; Toledo M, 2011, EPILEPTIC DISORD, V13, P336, DOI 10.1684/epd.2011.0445; WILDERSMITH E, 1991, NEUROLOGY, V41, P2005, DOI 10.1212/WNL.41.12.2005; WILLIAMS DS, 1992, P NATL ACAD SCI USA, V89, P212, DOI 10.1073/pnas.89.1.212; Wolf RL, 2001, AM J NEURORADIOL, V22, P1334; Yoo RE, 2013, J MAGN RESON IMAGING, V38, P852, DOI 10.1002/jmri.24026; Yu JT, 2008, BRAIN RES REV, V59, P34, DOI 10.1016/j.brainresrev.2008.04.008	36	20	21	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 14	2017	12	3							e0173538	10.1371/journal.pone.0173538	http://dx.doi.org/10.1371/journal.pone.0173538			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN6DM	28291816	Green Published, Green Submitted, gold			2022-12-27	WOS:000396094700031
J	Eliasson, B; Rawshani, A; Axelsen, M; Hammarstedt, A; Smith, U				Eliasson, Bjorn; Rawshani, Araz; Axelsen, Mette; Hammarstedt, Ann; Smith, Ulf			Cephalic phase of insulin secretion in response to a meal is unrelated to family history of type 2 diabetes	PLOS ONE			English	Article							GLUCOSE-TOLERANCE; RELEASE; HUMANS	The pre-absorptive cephalic phase of insulin secretion is elicited during the first ten min of a meal and before glucose levels rise. Its importance for insulin release during the post-absorptive phase has been well documented in animals but its presence or importance in man has become increasingly controversial. We here examined the presence of an early cephalic phase of insulin release in 31 well matched individuals without (n = 15) or with (n = 16) a known family history of type 2 diabetes (first-degree relatives; FDR). We also examined the potential differences in individuals with or without impaired fasting (IFG) and impaired glucose tolerance (IGT). We here demonstrate that a cephalic phase of insulin secretion was present in all individuals examined and without any differences between control persons and FDR or IFG/IGT. However, the overall importance of the cephalic phase is conjectural since it was unrelated to the subsequent post-absorptive insulin release or glucose tolerance. One of the best predictors of the incremental cephalic phase of insulin release was fasting insulin level and, thus, a relation to degree of insulin sensitivity is likely. In conclusion, an early pre-absorptive and cephalic phase of insulin release is robustly present in man. However, we could not document any relation to family history of Type 2 diabetes nor to the post-absorptive phase and, thus, confirm its importance for subsequent degree of insulin release or glucose tolerance.	[Eliasson, Bjorn; Rawshani, Araz; Hammarstedt, Ann; Smith, Ulf] Univ Gothenburg, Sahlgrenska Acad, Inst Med, Dept Mol & Clin Med,Lundberg Lab Diabet Res, Gothenburg, Sweden; [Axelsen, Mette] Univ Gothenburg, Sahlgrenska Acad, Inst Med, Dept Clin Nutr, Gothenburg, Sweden	University of Gothenburg; University of Gothenburg	Smith, U (corresponding author), Univ Gothenburg, Sahlgrenska Acad, Inst Med, Dept Mol & Clin Med,Lundberg Lab Diabet Res, Gothenburg, Sweden.	ulf.smith@medic.gu.se	Rawshani, Araz/AAW-3229-2021; rawshani, araz/HGE-5637-2022; Eliasson, Bjorn/H-5783-2016	Eliasson, Bjorn/0000-0003-2569-4160	Swedish Medical Research Council; Swedish Diabetes Foundation; Novo Nordisk Foundation; Innovative Medicines Initiative Joint Undertaking under EMIF grant [115372]; Novo Nordisk Fonden [NNF14OC0009795, NNF17OC0026712, NNF16OC0021202, NNF15OC0016484] Funding Source: researchfish	Swedish Medical Research Council(Swedish Medical Research Council (SMRC)); Swedish Diabetes Foundation; Novo Nordisk Foundation(Novo Nordisk FoundationNovocure Limited); Innovative Medicines Initiative Joint Undertaking under EMIF grant; Novo Nordisk Fonden(Novo Nordisk Foundation)	The present study was funded by grants from the Swedish Medical Research Council, the Swedish Diabetes Foundation and the Novo Nordisk Foundation. It also received support from the Innovative Medicines Initiative Joint Undertaking under EMIF grant agreement 115372. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahren B, 2001, DIABETES, V50, P1030, DOI 10.2337/diabetes.50.5.1030; BERTHOUD HR, 1982, AM J PHYSIOL, V242, pE280, DOI 10.1152/ajpendo.1982.242.4.E280; CALLESESCANDON J, 1987, DIABETES, V36, P1167, DOI 10.2337/diabetes.36.10.1167; LORENTZEN M, 1987, ACTA ENDOCRINOL-COP, V115, P84, DOI 10.1530/acta.0.1150084; MITRAKOU A, 1992, NEW ENGL J MED, V326, P22, DOI 10.1056/NEJM199201023260104; SIEGEL EG, 1980, GUT, V21, P1002, DOI 10.1136/gut.21.11.1002; TEFF KL, 1993, AM J PHYSIOL, V265, pR1223, DOI 10.1152/ajpregu.1993.265.6.R1223; Teff KL, 1999, AM J PHYSIOL-REG I, V277, pR198, DOI 10.1152/ajpregu.1999.277.1.R198; Thorens B, 2014, DIABETES OBES METAB, V16, P87, DOI 10.1111/dom.12346; Veedfald S, 2016, AM J PHYSIOL-GASTR L, V310, pG43, DOI 10.1152/ajpgi.00222.2015	10	6	6	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 13	2017	12	3							e0173654	10.1371/journal.pone.0173654	http://dx.doi.org/10.1371/journal.pone.0173654			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN6CP	28288176	gold, Green Published, Green Submitted			2022-12-27	WOS:000396092400023
J	Ishiguro, N; Koseki, N; Kaiho, M; Ariga, T; Kikuta, H; Togashi, T; Oba, K; Morita, K; Nagano, N; Nakanishi, M; Hara, K; Hazama, K; Watanabe, T; Yamanaka, T; Sasaki, S; Furuyama, H; Shibata, M; Shida, S; Ishizaka, A; Tabata, Y; Aoyagi, H; Naito, H; Yoshioka, M; Horino, A; Kenri, T				Ishiguro, Nobuhisa; Koseki, Naoko; Kaiho, Miki; Ariga, Tadashi; Kikuta, Hideaki; Togashi, Takehiro; Oba, Koji; Morita, Keisuke; Nagano, Naoko; Nakanishi, Masanori; Hara, Kazuya; Hazama, Kyosuke; Watanabe, Toru; Yamanaka, Tatsuru; Sasaki, Satoshi; Furuyama, Hideto; Shibata, Mutsuo; Shida, Satoru; Ishizaka, Akihito; Tabata, Yuichi; Aoyagi, Hayato; Naito, Hiroyuki; Yoshioka, Mikio; Horino, Atsuko; Kenri, Tsuyoshi		Hokkaido Pediat Resp Infect Study	Therapeutic efficacy of azithromycin, clarithromycin, minocycline and tosufloxacin against macrolide-resistant and macrolide-sensitive Mycoplasma pneumoniae pneumonia in pediatric patients	PLOS ONE			English	Article							STRAINS; INFECTION; SURVEILLANCE; ADOLESCENTS; OUTBREAK; CHILDREN; ADULTS; GENE	Objective To clarify therapeutic effects of azithromycin, clarithromycin, minocycline and tosufloxacin against macrolide-resistant Mycoplasma pneumoniae (MRMP) pneumonia and against macrolide-sensitive Mycoplasma pneumoniae (MSMP) pneumonia in pediatric patients. Methods A prospective, multicenter observational study was conducted from July 2013 to August 2015. The therapeutic effects of azithromycin, clarithromycin, minocycline and tosufloxacin were evaluated in 59 patients with pneumonia caused by MRMP and in 50 patients with pneumonia caused by MSMP. In vitro activities of antimicrobial agents against isolates of Mycoplasma pneumoniae were also measured. Results Mean durations of fever following commencement of treatment in patients infected with MRMP and MSMP were 5.2 and 1.9 days, respectively (log-rank test, P < 0.0001). Among patients infected with MRMP, mean durations of fever were 4.6, 5.5, 1.0 and 7.5 days for patients treated with azithromycin, clarithromycin, minocycline and tosufloxacin, respectively (log-rank test, P < 0.0001). Among patients infected with MSMP, mean durations of fever were 2.5, 1.7, 0.9 and 4.3 days for patients treated with azithromycin, clarithromycin, minocycline and tosufloxacin, respectively (log-rank test, P = 0.0162). The MIC90s of azithromycin and clarithromycin among the 27 isolates of MRMP were 64 and 256 mu g/ml, respectively, and those among the 23 isolates of MSMP were < 0.000125 and 0.001 mu g/ml, respectively. The MIC90s of minocycline and tosufloxacin among the 27 isolates of MRMP were 1.0 and 0.25 mu g/ml, respectively, and those among the 23 isolates of MSMP were 1.0 and 0.5 mu g/ml, respectively. Conclusion Both minocycline and tosufloxacin showed good in vitro activities against MRMP. Minocycline, but not tosufloxacin, shortened the duration of fever in pediatric patients infected with MRMP compared to the duration of fever in patients treated with macrolides.	[Ishiguro, Nobuhisa; Koseki, Naoko; Kaiho, Miki; Ariga, Tadashi] Hokkaido Univ, Grad Sch Med, Dept Pediat, Sapporo, Hokkaido, Japan; [Kikuta, Hideaki] Touei Hosp, Pediat Clin, Sapporo, Hokkaido, Japan; [Togashi, Takehiro] Sapporo Fukujuji Clin, Hokkaido AntiTB Assoc, Sapporo, Hokkaido, Japan; [Oba, Koji] Univ Tokyo, Grad Sch Med, Sch Publ Hlth, Dept Biostat, Tokyo, Japan; [Oba, Koji] Univ Tokyo, Interfaculty Initiat Informat Studies, Tokyo, Japan; [Morita, Keisuke] Asahikawa Red Cross Hosp, Dept Pediat, Asahikawa, Hokkaido, Japan; [Nagano, Naoko] Nagano Pediat Clin, Asahikawa, Hokkaido, Japan; [Nakanishi, Masanori; Hara, Kazuya] Kushiro Red Cross Hosp, Dept Pediat, Kushiro, Hokkaido, Japan; [Hazama, Kyosuke] Hazama Pediat Clin, Muroran, Hokkaido, Japan; [Watanabe, Toru] Watanabe Pediat Allergy Clin, Sapporo, Hokkaido, Japan; [Yamanaka, Tatsuru] Yamanaka Tatsuru Pediat Clin, Sapporo, Hokkaido, Japan; [Sasaki, Satoshi] Aiiku Hosp, Dept Pediat, Sapporo, Hokkaido, Japan; [Furuyama, Hideto] Japan Community Healthcare Org Hokkaido Hosp, Deparment Pediat, Sapporo, Hokkaido, Japan; [Shibata, Mutsuo] Hokkaido Univ, Dept Pediat Hlth Sci, Sapporo, Hokkaido, Japan; [Shida, Satoru] Ebetsu Municipal Hosp, Deparment Pediat, Ebetsu, Hokkaido, Japan; [Ishizaka, Akihito] Sumiyoshi Kodomo Clin, Chitose, Hokkaido, Japan; [Tabata, Yuichi] Iwamizawa Pediat & Gynecol Clin, Iwamizawa, Hokkaido, Japan; [Aoyagi, Hayato] Obihiro Kyokai Hosp, Deparment Pediat, Obihiro, Hokkaido, Japan; [Naito, Hiroyuki] Chitose City Hosp, Deparment Pediat, Chitose, Hokkaido, Japan; [Yoshioka, Mikio] KKR Sapporo Med Ctr, Deparment Pediat, Sapporo, Hokkaido, Japan; [Horino, Atsuko; Kenri, Tsuyoshi] Natl Inst Infect Dis, Dept Bacteriol 2, Tokyo, Japan	Hokkaido University; University of Tokyo; University of Tokyo; Hokkaido University; National Institute of Infectious Diseases (NIID)	Ishiguro, N (corresponding author), Hokkaido Univ, Grad Sch Med, Dept Pediat, Sapporo, Hokkaido, Japan.	nishigur@med.hokudai.ac.jp	OBA, Koji/I-3980-2019; 柴田, 睦郎/AAX-2490-2020	OBA, Koji/0000-0001-5468-8988; 	Ministry of Education, Science, Sports and Culture of Japan [25461577]; Ministry of Health, Labour and Welfare of Japan [H24-Shinkou-Ippan-014]; Pfizer Inc. [WS2419287]	Ministry of Education, Science, Sports and Culture of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Ministry of Health, Labour and Welfare of Japan(Ministry of Health, Labour and Welfare, Japan); Pfizer Inc.(Pfizer)	This research was funded in part by a Grant-in-Aid for Scientific Research (C), 2013 (25461577), from the Ministry of Education, Science, Sports and Culture of Japan and by a Health Science Research Grant (H24-Shinkou-Ippan-014) for Research on Emerging and Re-emerging Infectious Diseases, Labour and Welfare Programs from the Ministry of Health, Labour and Welfare of Japan. Pfizer Inc. provided grants for this study (A Prospective Observational Study of Antibiotic Treatment against Macrolide-Resistant Mycoplasma Pneumoniae Infections in Pediatric Patients, WS2419287) but was not involved in the design of the study or in enrollment of patients, data collection, analysis and interpretation, or preparation of the manuscript.; We thank Stewart Chisholm for proofreading the manuscript. This research was funded in part by a Grant-in-Aid for Scientific Research (C), 2013 (25461577), from the Ministry of Education, Science, Sports and Culture of Japan and by a Health Science Research Grant (H24-Shinkou-Ippan-014) for Research on Emerging and Re-emerging Infectious Diseases, Labour and Welfare Programs from the Ministry of Health, Labour and Welfare of Japan. Pfizer Inc. provided grants for this study but was not involved in the design of the study or in enrollment of patients, data collection, analysis and interpretation, or preparation of the manuscript. We have declared that no competing interests exist along with any other relevant declarations relating to employment, consultancy, patents, products in development, marketed products, etc. This does not alter our adherence to PLOS ONE policies on sharing data and materials. The members of the Hokkaido Pediatric Respiratory Infection Study Group are as follows: Nobuhisa Ishiguro, Naoko Koseki, Miki Kaiho, Hideaki Kikuta, Takehiro Togashi, Keisuke Morita, Naoko Nagano, Masanori Nakanishi, Kyosuke Hazama, Toru Watanabe, Satoshi Sasaki, Tadashi Ariga, Akiko Okamura, Shigeru Yamazaki, Satoru Shida, Naofumi Kajii, Tetsuo Nagashima, Mikio Yoshioka, Yutaka Takahashi, Mutsuko Konno, Akihito Ishizaka, Takeyasu Takebayashi, Mutsuo Shibata, Hideto Furuyama, Hiroyuki Sawada, Yoshihiro Matsuzono, Mari Murashita, Tatsuru Yamanaka, Hiroyuki Naito, Yasushi Akutsu, Hayato Aoyagi, Katsuyuki Tobise, Chie Tobise, Koichi Yasojima, Akira Tsuchida, Kiyotaka Kosugiyama, Yoshikazu Kinugawa, Yasuo Tahara, Kazue Yasuda, Susumu Iizuka, Hidefumi Tonoki, Yasuhisa Odagawa, Toshiaki Oka, Mitsuo Narita, Suguru Ogasawara, Yoshinori Kuniya, Yoko Tsuda, Noriyuki Uetsuji, Yoshihiro Itakura, Akira Tsuchiyama and Katsumi Azuma.	Chironna M, 2011, J ANTIMICROB CHEMOTH, V66, P734, DOI 10.1093/jac/dkr003; Committee for the Guidelines in Management of Respiratory Infectious Diseases in Children, 2011, COMM GUID MAN RESP I; Dumke R, 2010, CLIN MICROBIOL INFEC, V16, P613, DOI 10.1111/j.1469-0691.2009.02968.x; Eshaghi A, 2013, EMERGING INFECT DIS, V19; Grady Richard W, 2005, Expert Opin Drug Saf, V4, P623, DOI 10.1517/14740338.4.4.623; HAYFLICK L, 1965, TEX REP BIOL MED, VS 23, P285; Ishiguro N, 2015, JAPANESE J INFECT DI; Kawai Yasuhiro, 2012, Respirology, V17, P354, DOI 10.1111/j.1440-1843.2011.02102.x; Kawai Y, 2013, ANTIMICROB AGENTS CH, V57, P4046, DOI 10.1128/AAC.00663-13; Kawai Y, 2013, ANTIMICROB AGENTS CH, V57, P2252, DOI 10.1128/AAC.00048-13; Komatsu H, 2014, BRAZ J INFECT DIS, V18, P294, DOI 10.1016/j.bjid.2013.09.004; Liu XJ, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/320801; Ma ZY, 2014, PEDIATR PULM, V49, P695, DOI 10.1002/ppul.22851; Matsubara K, 2009, J INFECT CHEMOTHER, V15, P380, DOI 10.1007/s10156-009-0715-7; Matsuda K, 2013, BMC INFECT DIS, V13, DOI 10.1186/1471-2334-13-591; Matsuoka M, 2004, ANTIMICROB AGENTS CH, V48, P4624, DOI 10.1128/AAC.48.12.4624-4630.2004; Miyashita N, 2013, ANTIMICROB AGENTS CH, V57, P5181, DOI 10.1128/AAC.00737-13; Miyashita N, 2012, BMC INFECT DIS, V12, DOI 10.1186/1471-2334-12-126; Nakazawa S, 1972, Jpn J Antibiot, V25, P288; NALINE E, 1991, BRIT J CLIN PHARMACO, V32, P402, DOI 10.1111/j.1365-2125.1991.tb03920.x; Nasu M, 1988, CHEMOTHERAPY S9, V36, P699; Okada T, 2012, CLIN INFECT DIS, V55, P1642, DOI 10.1093/cid/cis784; Okazaki N, 2001, MICROBIOL IMMUNOL, V45, P617, DOI 10.1111/j.1348-0421.2001.tb01293.x; Pereyre S, 2007, J CLIN MICROBIOL, V45, P3534, DOI 10.1128/JCM.01345-07; Principi N, 2013, J ANTIMICROB CHEMOTH, V68, P506, DOI 10.1093/jac/dks457; Sakata Hiroshi, 2012, Jpn J Antibiot, V65, P173; Sanchez AR, 2004, INT J DERMATOL, V43, P709, DOI 10.1111/j.1365-4632.2004.02108.x; Sauteur PMM, 2016, FRONT MICROBIOL, V7, DOI 10.3389/fmicb.2016.00329; Sunakawa K, 2010, JPN J CHEMOTHER S1, V58, P69; Suzuki S, 2006, ANTIMICROB AGENTS CH, V50, P709, DOI 10.1128/AAC.50.2.709-712.2006; Waites KB, 2004, CLIN MICROBIOL REV, V17, P697, DOI 10.1128/CMR.17.4.697-728.2004; Winchell JM, 2008, J CLIN MICROBIOL, V46, P3116, DOI 10.1128/JCM.00440-08; Zhao F, 2013, ANTIMICROB AGENTS CH, V57, P1521, DOI 10.1128/AAC.02060-12; Zhou YL, 2014, ANTIMICROB AGENTS CH, V58, P1034, DOI 10.1128/AAC.01806-13; Zhou ZB, 2015, ANTIMICROB AGENTS CH, V59, P1048, DOI 10.1128/AAC.04308-14	35	37	42	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 13	2017	12	3							e0173635	10.1371/journal.pone.0173635	http://dx.doi.org/10.1371/journal.pone.0173635			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN6CP	28288170	gold, Green Submitted, Green Published			2022-12-27	WOS:000396092400022
J	Huang, H; Liu, Y; Wang, L; Li, W				Huang, Hu; Liu, Ying; Wang, Lei; Li, Wen			Age-related macular degeneration phenotypes are associated with increased tumor necrosis-alpha and subretinal immune cells in aged Cxcr5 knockout mice	PLOS ONE			English	Article							FACTOR-H POLYMORPHISM; CHEMOKINE RECEPTOR; OXIDATIVE STRESS; DENDRITIC CELLS; ACCUMULATION; INFLAMMATION; RANIBIZUMAB; EXPRESSION; MICROGLIA; CXCL13	The role of chemokine receptor in age-related macular degeneration (AMD) remains elusive. The objective of this study is to investigate the role of chemokine receptor Cxcr5 in the pathogenesis of AMD. Cxcr5 gene expression levels (mRNA and protein) are higher in the retina and retinal pigment epithelium (RPE) of aged C57BL/6 wild type mice than younger ones. Vascular and glial cells express Cxcr5 and its ligand Cxcl13 in mouse retina. Aged Cxcr5 knockout ((-/-)) mice develop both early and late AMD-like pathological features. White and yellow spots, which look like drusen in humans, were identified with fundscopic examination. Drusen-like sub-RPE deposits with dome-shaped morphology were characterized on the sections. RPE vacuolization, swelling, and sub-RPE basal deposits were illustrated with light and transmission electron microscope (TEM). TEM further illustrated degenerated and disorganized RPE basal infoldings, phagosomes and melanosomes inside RPE, as well as abnormal photoreceptor outer segments. Lipofuscin granules and lipid droplets in the subretinal space, RPE, and choroid were revealed with fluorescence microscope and oil-red-O staining. Increased IgG in RPE/choroid were determined with Western blots (WB). WB and immunofluorescence staining determined RPE zona occuldens (ZO)-1 protein reduction and abnormal subcellular localization. TUNEL staining, outer nuclear layer (ONL) measurement and electroretinogram (ERG) recording indicated that photoreceptors underwent apoptosis, degeneration, and functional impairment. Additionally, spontaneous neovascularization (NV)-like lesions develop in the subretinal space of aged Cxcr5(-/-) mice. The underlying mechanisms are associated with increased subretinal F4/80(+) immune cells, some of which contain RPE marker RPE65, and up-regulation of the multifunctional cytokine tumor necrosis factor-alpha (TNF-alpha) in RPE/choroid and retina. These findings suggest that Cxcr5 itself may be involved in the protection of RPE and retinal cells during aging and its loss may lead to AMD-like pathological changes in aged mice.	[Huang, Hu; Liu, Ying; Wang, Lei; Li, Wen] Johns Hopkins Univ, Sch Med, Wilmer Eye Inst, Baltimore, MD 21218 USA; [Liu, Ying] Aier Eye Hosp, Changsha, Hunan, Peoples R China; [Li, Wen] Cent South Univ, Sch Ophthalmol, Changsha, Hunan, Peoples R China	Johns Hopkins University; Johns Hopkins Medicine; Central South University	Huang, H (corresponding author), Johns Hopkins Univ, Sch Med, Wilmer Eye Inst, Baltimore, MD 21218 USA.	hhuang27@jhmi.edu	Wang, Lei/C-1902-2015	Wang, Lei/0000-0002-7957-1003	Brightfocus Foundation [118211]; Wilmer Pooled Professor Funds; NATIONAL EYE INSTITUTE [P30EY001765] Funding Source: NIH RePORTER	Brightfocus Foundation(BrightFocus Foundation); Wilmer Pooled Professor Funds; NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	This work is supported by Brightfocus Foundation (118211; H.H.), Wilmer Pooled Professor Funds (H.H.), and an unrestricted gift from RBP (Wilmer). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We sincerely thank Dr. Rhonda Grebe for assistance with TEM, Dr. Sean Hackett for providing the genomic DNA for the controls of rd8 PCR genotyping, and Drs. Long Zhao, Junsong Gong, and Tomohiro Masuda for the help with ERG instrument. We also sincerely thank Drs. James Handa and Debashis Sinha for the critical discussions about the study and Dr. Gerard A. Lutty for reading and editing the manuscript. This work was supported by Brightfocus Foundation (H.H.), Wilmer Pooled Professor Funds (H.H.), and an unrestricted gift from RBP (Wilmer).	Ambati J, 2003, NAT MED, V9, P1390, DOI 10.1038/nm950; Ambati J, 2013, NAT REV IMMUNOL, V13, P438, DOI 10.1038/nri3459; Anand A, 2013, OXID MED CELL LONGEV, V2013, DOI 10.1155/2013/365046; Balkwill FR, 2012, J PATHOL, V226, P148, DOI 10.1002/path.3029; Bhutto I, 2012, MOL ASPECTS MED, V33, P295, DOI 10.1016/j.mam.2012.04.005; Brown DM, 2006, NEW ENGL J MED, V355, P1432, DOI 10.1056/NEJMoa062655; Chan CC, 2003, OPHTHALMOLOGY, V110, P421, DOI 10.1016/S0161-6420(02)01737-2; Chang B, 2013, INVEST OPHTH VIS SCI, V54, P4974, DOI 10.1167/iovs.13-12289; Chinnery HR, 2012, NEUROBIOL AGING, V33, P1769, DOI 10.1016/j.neurobiolaging.2011.03.010; Combadiere C, 2007, J CLIN INVEST, V117, P2920, DOI 10.1172/JCI31692; Crabb JW, 2002, P NATL ACAD SCI USA, V99, P14682, DOI 10.1073/pnas.222551899; Ding XY, 2009, PROG RETIN EYE RES, V28, P1, DOI 10.1016/j.preteyeres.2008.10.001; Edwards AO, 2005, SCIENCE, V308, P421, DOI 10.1126/science.1110189; Flynn G, 2003, J NEUROIMMUNOL, V136, P84, DOI 10.1016/S0165-5728(03)00009-2; Forster R, 1996, CELL, V87, P1037, DOI 10.1016/S0092-8674(00)81798-5; Gass J D, 1972, Trans Am Ophthalmol Soc, V70, P409; Green W R, 1977, Trans Am Ophthalmol Soc, V75, P180; Haines JL, 2005, SCIENCE, V308, P419, DOI 10.1126/science.1110359; Hanus J, 2013, CELL DEATH DIS, V4, DOI 10.1038/cddis.2013.478; Hollyfield JG, 2008, NAT MED, V14, P194, DOI 10.1038/nm1709; Howard OMZ, 2005, BLOOD, V105, P4207, DOI 10.1182/blood-2004-07-2697; Huang H, 2012, INVEST OPHTHALMOL VI, V53; Huang H, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071808; Huang H, 2011, INVEST OPHTH VIS SCI, V52, P1336, DOI 10.1167/iovs.10-5768; Kanda A, 2008, BRIT J OPHTHALMOL, V92, P448, DOI 10.1136/bjo.2007.131581; Kanno M, 2007, NEUROIMMUNOLOGY RES, P193; Kizil C, 2012, NEURAL DEV, V7, DOI 10.1186/1749-8104-7-27; Klein RJ, 2005, SCIENCE, V308, P385, DOI 10.1126/science.1109557; Klein R, 2010, ARCH OPHTHALMOL-CHIC, V128, P750, DOI 10.1001/archophthalmol.2010.92; Krumbholz M, 2006, BRAIN, V129, P200, DOI 10.1093/brain/awh680; Li YW, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017106; Luhmann UFO, 2013, EXP EYE RES, V107, P80, DOI 10.1016/j.exer.2012.11.015; Luhmann UFO, 2009, INVEST OPHTH VIS SCI, V50, P5934, DOI 10.1167/iovs.09-3462; Ma W, 2014, INVEST OPHTHALMOL VI, V55; Mattapallil MJ, 2012, INVEST OPHTH VIS SCI, V53, P2921, DOI 10.1167/iovs.12-9662; Maugeri A, 2000, AM J HUM GENET, V67, P960, DOI 10.1086/303079; McKay GJ, 2011, HUM MUTAT, V32, P1407, DOI 10.1002/humu.21577; Murakami Y, 2014, CELL DEATH DIFFER, V21, P270, DOI 10.1038/cdd.2013.109; PAULEIKHOFF D, 1990, OPHTHALMOLOGY, V97, P171; Raoul W, 2008, OPHTHAL RES, V40, P115, DOI 10.1159/000119860; Rattner A, 2006, NAT REV NEUROSCI, V7, P860, DOI 10.1038/nrn2007; Rosenfeld PJ, 2006, NEW ENGL J MED, V355, P1419, DOI 10.1056/NEJMoa054481; Saeki H, 2000, EUR J IMMUNOL, V30, P2808, DOI 10.1002/1521-4141(200010)30:10<2808::AID-IMMU2808>3.0.CO;2-K; Takeda A, 2009, NATURE, V460, P225, DOI 10.1038/nature08151; Tarallo V, 2012, CELL, V149, P847, DOI 10.1016/j.cell.2012.03.036; Tou JS, 2004, FASEB J, V18, P1297, DOI 10.1096/fj.04-1862fje; Tuo JS, 2007, INVEST OPHTH VIS SCI, V48, P3827, DOI 10.1167/iovs.07-0051; Verbeke G, 2000, LINEAR MIXED MODELS; Vessey KA, 2012, INVEST OPHTH VIS SCI, V53, P7833, DOI 10.1167/iovs.12-10650; Wang L, 2014, BBA-MOL CELL RES, V1843, P1248, DOI 10.1016/j.bbamcr.2014.03.016; Weiss N, 2010, J NEUROIMMUNOL, V223, P131, DOI 10.1016/j.jneuroim.2010.03.009; Yannuzzi LA, 2001, RETINA-J RET VIT DIS, V21, P416, DOI 10.1097/00006982-200110000-00003; Zanzottera EC, 2015, INVEST OPHTH VIS SCI, V56, P3253, DOI 10.1167/iovs.15-16431	53	23	23	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 10	2017	12	3							e0173716	10.1371/journal.pone.0173716	http://dx.doi.org/10.1371/journal.pone.0173716			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN6CJ	28282423	Green Submitted, Green Published, gold			2022-12-27	WOS:000396091800072
J	Maki, C; Funakoshi-Tago, M; Aoyagi, R; Ueda, F; Kimura, M; Kobata, K; Tago, K; Tamura, H				Maki, Chihiro; Funakoshi-Tago, Megumi; Aoyagi, Ryohei; Ueda, Fumihito; Kimura, Masaki; Kobata, Kenji; Tago, Kenji; Tamura, Hiroomi			Coffee extract inhibits adipogenesis in 3T3-L1 preadipocyes by interrupting insulin signaling through the downregulation of IRS1	PLOS ONE			English	Article							MITOTIC CLONAL EXPANSION; DIFFERENTIATION-INDUCED GENE; BINDING-PROTEIN; C/EBP-BETA; EARLY PHASE; EXPRESSION; ACID; FAT; FIBROBLASTS; CONSUMPTION	Although epidemiological data have indicated that a strong negative association exists between coffee consumption and the prevalence of obesity-associated diseases, the molecular mechanisms by which coffee intake prevents obesity-associated diseases has not yet been elucidated. In this study, we found that coffee intake significantly suppressed high-fat diet (HFD)-induced metabolic alternations such as increases in body weight and the accumulation of adipose tissue, and up-regulation of glucose, free fatty acid, total cholesterol and insulin levels in the blood. We also found that coffee extract significantly inhibited adipogenesis in 3T3-L1 preadipocytes. In the early phase of adipogenesis, 3T3-L1 cells treated with coffee extract displayed the retardation of cell cycle entry into the G2/M phase called as mitotic clonal expansion (MCE). Coffee extract also inhibited the activation of CCAAT/enhancer-binding protein beta (C/EBP beta) by preventing its phosphorylation by ERK. Furthermore, the coffee extract suppressed the adipogenesis-related events such as MCE and C/EBP beta activation through the down-regulation of insulin receptor substrate 1 (IRS1). The stability of the IRS1 protein was markedly decreased by the treatment with coffee extract due to proteasomal degradation. These results have revealed an anti-adipogenic function for coffee intake and identified IRS1 as a novel target for coffee extract in adipogenesis.	[Maki, Chihiro; Funakoshi-Tago, Megumi; Aoyagi, Ryohei; Ueda, Fumihito; Kimura, Masaki; Tamura, Hiroomi] Keio Univ, Grad Sch Pharmaceut Sci, Minato Ku, Tokyo, Japan; [Kobata, Kenji] Josai Univ, Fac Pharmaceut Sci, Sakado, Saitama, Japan; [Tago, Kenji] Jichi Med Univ, Dept Biochem, Div Struct Biochem, Shimotsuke, Japan	Keio University; Josai University; Jichi Medical University	Funakoshi-Tago, M (corresponding author), Keio Univ, Grad Sch Pharmaceut Sci, Minato Ku, Tokyo, Japan.	tago-mg@pha.keio.ac.jp		Ueda, Fumihito/0000-0003-1241-1643	MEXT [15K00883]; Mishima Kaiun Memorial Foundation; Informatics, Tobemaki Scholarship Foundation; Structural Life Science from the Ministry of Education, Culture, Sports, Science and Technology, Japan [25460073]	MEXT(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Mishima Kaiun Memorial Foundation(Mishima Kaiun Memorial Foundation); Informatics, Tobemaki Scholarship Foundation; Structural Life Science from the Ministry of Education, Culture, Sports, Science and Technology, Japan	This work was supported in part by grants (15K00883) from MEXT, Mishima Kaiun Memorial Foundation and Informatics, Tobemaki Scholarship Foundation, and Structural Life Science from the Ministry of Education, Culture, Sports, Science and Technology, Japan (25460073).	Aoyagi R, 2014, BIOL PHARM BULL, V37, P1820, DOI 10.1248/bpb.b14-00378; Aparicio T, 2006, CELL DIV, V1, DOI 10.1186/1747-1028-1-18; ARAKI E, 1994, NATURE, V372, P186, DOI 10.1038/372186a0; Berg T, 2005, BIOCHEM BIOPH RES CO, V334, P638, DOI 10.1016/j.bbrc.2005.06.146; Bohn SK, 2012, FOOD FUNCT, V3, P575, DOI 10.1039/c2fo10288a; Bohn SK, 2014, MOL NUTR FOOD RES, V58, P915, DOI 10.1002/mnfr.201300526; Bruning JC, 1997, MOL CELL BIOL, V17, P1513; CAO ZD, 1991, GENE DEV, V5, P1538, DOI 10.1101/gad.5.9.1538; Cho AS, 2010, FOOD CHEM TOXICOL, V48, P937, DOI 10.1016/j.fct.2010.01.003; Choi BK, 2016, ASIAN PAC J TROP MED, V9, P616, DOI 10.1016/j.apjtm.2016.05.017; CHRISTY RJ, 1989, GENE DEV, V3, P1323, DOI 10.1101/gad.3.9.1323; COOK JS, 1988, P NATL ACAD SCI USA, V85, P2949, DOI 10.1073/pnas.85.9.2949; Cristancho AG, 2011, NAT REV MOL CELL BIO, V12, P722, DOI 10.1038/nrm3198; DESCOMBES P, 1991, CELL, V67, P569, DOI 10.1016/0092-8674(91)90531-3; Funakoshi-Tago M, 2010, J BIOL CHEM, V285, P5296, DOI 10.1074/jbc.M109.040733; Guo L, 2012, CELL DEATH DIFFER, V19, P1917, DOI 10.1038/cdd.2012.75; Huxley R, 2009, ARCH INTERN MED, V169, P2053, DOI 10.1001/archinternmed.2009.439; Krebs DL, 2000, J CELL SCI, V113, P2813; Kwon JY, 2012, NUTR RES, V32, P607, DOI 10.1016/j.nutres.2012.06.014; Kwon JY, 2012, J BIOL CHEM, V287, P11566, DOI 10.1074/jbc.M111.259721; Long SD, 1996, J BIOL CHEM, V271, P1138, DOI 10.1074/jbc.271.2.1138; Ludwig IA, 2014, FOOD FUNCT, V5, P1695, DOI [10.1039/c4fo00042k, 10.1039/C4FO00042K]; Ma YJ, 2015, PHARM RES-DORDR, V32, P1200, DOI 10.1007/s11095-014-1526-9; MACDOUGALD OA, 1994, J BIOL CHEM, V269, P19041; MACDOUGALD OA, 1995, ANNU REV BIOCHEM, V64, P345, DOI 10.1146/annurev.bi.64.070195.002021; MYERS MG, 1992, P NATL ACAD SCI USA, V89, P10350, DOI 10.1073/pnas.89.21.10350; Myneni R. B., 2012, ENVIRON RES LETT, V7, P1, DOI DOI 10.1074/JBC.M112.405209; OSSIPOW V, 1993, P NATL ACAD SCI USA, V90, P8219, DOI 10.1073/pnas.90.17.8219; Park BH, 2004, MOL CELL BIOL, V24, P8671, DOI 10.1128/MCB.24.19.8671-8680.2004; PISUNYER FX, 1993, ANN INTERN MED, V119, P655, DOI 10.7326/0003-4819-119-7_Part_2-199310011-00006; REYNISDOTTIR I, 1995, GENE DEV, V9, P1831, DOI 10.1101/gad.9.15.1831; RUBIN CS, 1978, J BIOL CHEM, V253, P7570; Rui LY, 2002, J BIOL CHEM, V277, P42394, DOI 10.1074/jbc.C200444200; Shimocka II, 2006, BMC COMPLEM ALTERN M, V6, P9, DOI [10.1186/1472-6882-6-9, DOI 10.1186/1472-6882-6-9]; Song SJ, 2014, EVID-BASED COMPL ALT, V2014, DOI 10.1155/2014/718379; Stephens JM, 2012, PLOS BIOL, V10, DOI 10.1371/journal.pbio.1001436; TAMEMOTO H, 1994, NATURE, V372, P182, DOI 10.1038/372182a0; Tang QQ, 2003, P NATL ACAD SCI USA, V100, P850, DOI 10.1073/pnas.0337434100; TONTONOZ P, 1994, GENE DEV, V8, P1224, DOI 10.1101/gad.8.10.1224; Turowski P, 2003, MOL BIOL CELL, V14, P2984, DOI 10.1091/mbc.E02-08-0515; van Dam RM, 2002, LANCET, V360, P1477, DOI 10.1016/S0140-6736(02)11436-X; Withers DJ, 1998, NATURE, V391, P900, DOI 10.1038/36116; Wu ZD, 1996, MOL CELL BIOL, V16, P4128; Xu XS, 2008, MOL CELL, V30, P403, DOI 10.1016/j.molcel.2008.03.009; Yasukawa H, 2000, ANNU REV IMMUNOL, V18, P143, DOI 10.1146/annurev.immunol.18.1.143	45	36	35	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 10	2017	12	3							e0173264	10.1371/journal.pone.0173264	http://dx.doi.org/10.1371/journal.pone.0173264			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN6CJ	28282409	Green Published, gold, Green Submitted			2022-12-27	WOS:000396091800025
J	Tambong, JT				Tambong, James T.			Comparative genomics of Clavibacter michiganensis subspecies, pathogens of important agricultural crops	PLOS ONE			English	Article							XYLELLA-FASTIDIOSA; MYCOTHIOL BIOSYNTHESIS; RESISTANCE OPERON; EXPRESSION; SEQUENCE; GENE; IDENTIFICATION; DIVERSITY; STRAINS; TOMATO	Subspecies of Clavibacter michiganensis are important phytobacterial pathogens causing devastating diseases in several agricultural crops. The genome organizations of these pathogens are poorly understood. Here, the complete genomes of 5 subspecies (C. michiganensis subsp. michiganensis, Cmi; C. michiganensis subsp. sepedonicus, Cms; C. michiganensis subsp. nebraskensis, Cmn; C. michiganensis subsp. insidiosus, Cmi and C. michiganensis subsp. capsici, Cmc) were analyzed. This study assessed the taxonomic position of the subspecies based on 16S rRNA and genome-based DNA homology and concludes that there is ample evidence to elevate some of the subspecies to species-level. Comparative genomics analysis indicated distinct genomic features evident on the DNA structural atlases and annotation features. Based on orthologous gene analysis, about 2300 CDSs are shared across all the subspecies; and Cms showed the highest number of subspecies-specific CDS, most of which are mobile elements suggesting that Cms could be more prone to translocation of foreign genes. Cms and Cmi had the highest number of pseudogenes, an indication of potential degenerating genomes. The stress response factors that may be involved in cold/heat shock, detoxification, oxidative stress, osmoregulation, and carbon utilization are outlined. For example, the wco-cluster encoding for extracellular polysaccharide II is highly conserved while the sucrose-6-phosphate hydrolase that catalyzes the hydrolysis of sucrose-6-phosphate yielding glucose-6-phosphate and fructose is highly divergent. A unique second form of the enzyme is only present in Cmn NCPPB 2581. Also, twenty-eight plasmid-borne CDSs in the other subspecies were found to have homologues in the chromosomal genome of Cmn which is known not to carry plasmids. These CDSs include pathogenesis-related factors such as Endocellulases E1 and Beta-glucosidase. The results presented here provide an insight of the functional organization of the genomes of five core C. michiganensis subspecies, enabling a better understanding of these phytobacteria.	[Tambong, James T.] Agr & Agri Food Canada, ORDC, Ottawa, ON, Canada	Agriculture & Agri Food Canada	Tambong, JT (corresponding author), Agr & Agri Food Canada, ORDC, Ottawa, ON, Canada.	james.tambong@agr.gc.ca		Tambong, James Tabi/0000-0001-5325-8038	Agriculture and Agri-Food Canada [J-000409]; AAFC/GRDI [J-000011, J-000985]; Manitoba Corn Growers Association [CRADAAGR-10755]	Agriculture and Agri-Food Canada(Agriculture & Agri Food Canada); AAFC/GRDI; Manitoba Corn Growers Association	This study was funded by the Agriculture and Agri-Food Canada through projects J-000409, AAFC/GRDI# J-000011 and J-000985 and by the Manitoba Corn Growers Association project# CRADAAGR-10755.	Achtman M, 2008, NAT REV MICROBIOL, V6, P431, DOI 10.1038/nrmicro1872; Agarkova IV, 2011, CAN J MICROBIOL, V57, P366, DOI [10.1139/W11-016, 10.1139/w11-016]; Ahmad A, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0143553; Aras RA, 2003, P NATL ACAD SCI USA, V100, P13579, DOI 10.1073/pnas.1735481100; Aziz RK, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-75; Bae C, 2015, J BIOTECHNOL, V214, P103, DOI 10.1016/j.jbiotec.2015.09.021; Benson DA, 2011, NUCLEIC ACIDS RES, V39, pD32, DOI [10.1093/nar/gkw1070, 10.1093/nar/gks1195, 10.1093/nar/gkq1079, 10.1093/nar/gkt1030, 10.1093/nar/gkx1094, 10.1093/nar/gkn723, 10.1093/nar/gkp1024, 10.1093/nar/gkr1202]; Bentley SD, 2008, J BACTERIOL, V190, P2150, DOI 10.1128/JB.01598-07; Binnewies TT, 2005, MICROBIOL-SGM, V151, P1, DOI 10.1099/mic.0.27760-0; Brumbley SM, 2006, AUSTRALAS PLANT PATH, V35, P681, DOI 10.1071/AP06074; Buchmeier N, 2006, FEMS MICROBIOL LETT, V264, P74, DOI 10.1111/j.1574-6968.2006.00441.x; DAVIS MJ, 1984, INT J SYST BACTERIOL, V34, P107, DOI 10.1099/00207713-34-2-107; De Souza ML, 1998, APPL ENVIRON MICROB, V64, P178; Lara-Ramirez EE, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017300; Eichenlaub R, 2006, PLANT-ASSOCIATED BACTERIA, P385; Feil H, 2007, PHYTOPATHOLOGY, V97, P318, DOI 10.1094/PHYTO-97-3-0318; FLEISCHMANN RD, 1995, SCIENCE, V269, P496, DOI 10.1126/science.7542800; Flugel M, 2012, J BIOTECHNOL, V160, P42, DOI 10.1016/j.jbiotec.2012.01.023; FRASER CM, 1995, SCIENCE, V270, P397, DOI 10.1126/science.270.5235.397; Gartemann KH, 2008, J BACTERIOL, V190, P2138, DOI 10.1128/JB.01595-07; Gartemann KH, 2003, J BIOTECHNOL, V106, P179, DOI 10.1016/j.jbiotec.2003.07.011; Guilhabert MR, 2005, MOL PLANT MICROBE IN, V18, P856, DOI 10.1094/MPMI-18-0856; HEDGES RW, 1973, J BACTERIOL, V115, P459, DOI 10.1128/JB.115.1.459-460.1973; Hu KH, 1996, GENETICS, V143, P1521; Jacques MA, 2012, APPL ENVIRON MICROB, V78, P8388, DOI 10.1128/AEM.02158-12; Jensen LJ, 2000, BIOINFORMATICS, V16, P326; JI GY, 1992, J BACTERIOL, V174, P3684, DOI 10.1128/JB.174.11.3684-3694.1992; Jolley KA, 2012, MICROBIOL-SGM, V158, P1005, DOI 10.1099/mic.0.055459-0; Killiny N, 2009, P NATL ACAD SCI USA, V106, P22416, DOI 10.1073/pnas.0908562106; Kiyama R, 2002, FEBS LETT, V523, P7, DOI 10.1016/S0014-5793(02)02937-X; Koledin T, 2002, ARCH MICROBIOL, V178, P331, DOI 10.1007/s00203-002-0462-y; Kumar S., 2016, MOL BIOL EVOLUTION, V33, DOI [DOI 10.1093/M0LBEV/MSW054, https://doi.org/10.1093/molbev/msw054, 10.1093/molbev/msw054]; Kurtz S, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-2-r12; Ledgham F, 2005, RES MICROBIOL, V156, P367, DOI 10.1016/j.resmic.2004.11.003; Li L, 2003, GENOME RES, V13, P2178, DOI 10.1101/gr.1224503; Lu Y., 2015, Genome Announcements, V3, pe00396; MAZIN A, 1994, MOL GEN GENET, V244, P435, DOI 10.1007/BF00286696; Meier-Kolthoff JP, 2013, BMC BIOINFORMATICS, V14, DOI 10.1186/1471-2105-14-60; Meng YZ, 2005, J BACTERIOL, V187, P5560, DOI 10.1128/JB.187.16.5560-5567.2005; MOBLEY HLT, 1984, ANTIMICROB AGENTS CH, V25, P157, DOI 10.1128/AAC.25.2.157; Nawapan S, 2009, J BACTERIOL, V191, P5159, DOI 10.1128/JB.00384-09; Ordonez E, 2009, J BIOL CHEM, V284, P15107, DOI 10.1074/jbc.M900877200; PARK YH, 1993, ANTON LEEUW INT J G, V64, P307, DOI 10.1007/BF00873089; Phadtare S, 2001, J BACTERIOL, V183, P1205, DOI 10.1128/JB.183.4.1205-1214.2001; Rath D, 2006, J BACTERIOL, V188, P6780, DOI 10.1128/JB.00471-06; Richter M, 2009, P NATL ACAD SCI USA, V106, P19126, DOI 10.1073/pnas.0906412106; Ron EZ, 2012, BACTERIAL STRESS RES; ROSENSTEIN R, 1992, J BACTERIOL, V174, P3676, DOI 10.1128/JB.174.11.3676-3683.1992; Sareen D, 2002, BIOCHEMISTRY-US, V41, P6885, DOI 10.1021/bi012212u; Tambong JT, 2015, GENOME ANNOUNCEMENTS, V3, DOI 10.1128/genomeA.00768-15; TAO L, 1993, J DENT RES, V72, P1386, DOI 10.1177/00220345930720100701; UEGUCHI C, 1994, P NATL ACAD SCI USA, V91, P1054, DOI 10.1073/pnas.91.3.1054; Vesth T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060120; VIDAVER AK, 1981, PLANT DIS, V65, P480, DOI 10.1094/PD-65-480; Wang B, 2003, J BACTERIOL, V185, P5791, DOI 10.1128/JB.185.19.5791-5799.2003; Wattam AR, 2014, NUCLEIC ACIDS RES, V42, pD581, DOI 10.1093/nar/gkt1099; Yao LL, 2015, BIOMETALS, V28, P255, DOI 10.1007/s10534-014-9819-3	57	24	25	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 20	2017	12	3							e0172295	10.1371/journal.pone.0172295	http://dx.doi.org/10.1371/journal.pone.0172295			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ER6VC	28319117	gold, Green Submitted, Green Published			2022-12-27	WOS:000398945800003
J	Hams, M; Wilkinson, WG; Zentner, L; Schmidt, C; Dweik, RA; Karafa, M; Rose, SL				Hams, Marcia; Wilkinson, Wells G.; Zentner, Lynn; Schmidt, Cory; Dweik, Raed A.; Karafa, Matthew; Rose, Susannah L.			A new survey to evaluate conflict of interest policies at academic medical centers	PLOS ONE			English	Article								Background A majority of academic medical centers (AMCs) have now adopted conflict of interest policies (COI) to address relationships with pharmaceutical and device industries that can increase the risk of bias in patient care, education and research. However, AMCs may have little information on the impact of their policies. This paper provides a new method, which is a free, publicly-available survey, to fill this information gap and improve COI programs at AMCs. Methods & findings The survey, piloted in three AMCs and designed in collaboration with national conflicts of interest policy experts, covers a range of universal compliance-related concerns, which allows institutions to tailor questions to align with their own policies and culture. The survey was low-burden, and provided important data for these AMCs to evaluate their policies. A descriptive analysis of the pooled pilot site data (n = 1578) was performed, which found that a majority of respondents did not have financial ties with industry and a majority was satisfied with specific COI policies at their institutions. The analysis also showed that the survey is sensitive to differences that AMCs will find meaningful. For instance, individuals with industry ties were significantly more likely than individuals without ties to think that COI policies unnecessarily hindered interactions with industry (p = .004), were ineffective at reducing harm to patients (p < .001), and were ineffective in reducing bias in medical education (p>.001). Conclusion The survey is now free and publicly available for use by any institution. AMCs can use the results policies.	[Hams, Marcia; Wilkinson, Wells G.] Community Catalyst, Boston, MA USA; [Zentner, Lynn] Univ Minnesota, Off Inst Compliance, Minneapolis, MN USA; [Schmidt, Cory; Dweik, Raed A.; Rose, Susannah L.] Cleveland Clin, Innovat Management & Conflict Interest IM&COI, Cleveland, OH 44106 USA; [Dweik, Raed A.; Rose, Susannah L.] Case Western Reserve Univ, Cleveland Clin, Lerner Coll Med, Cleveland, OH 44106 USA; [Karafa, Matthew] Cleveland Clin, Dept Quantitat Hlth Sci, Cleveland, OH 44106 USA; [Rose, Susannah L.] Cleveland Clin, Dept Bioeth, Off Patient Experience, Cleveland, OH 44106 USA	University of Minnesota System; University of Minnesota Twin Cities; Cleveland Clinic Foundation; Case Western Reserve University; Cleveland Clinic Foundation; Cleveland Clinic Foundation; Cleveland Clinic Foundation	Rose, SL (corresponding author), Cleveland Clin, Innovat Management & Conflict Interest IM&COI, Cleveland, OH 44106 USA.; Rose, SL (corresponding author), Case Western Reserve Univ, Cleveland Clin, Lerner Coll Med, Cleveland, OH 44106 USA.; Rose, SL (corresponding author), Cleveland Clin, Dept Bioeth, Off Patient Experience, Cleveland, OH 44106 USA.	roses2@ccf.org			Oregon Attorney General Consumer and Prescriber Grant Program; Edmund J. Safra Foundation for Ethics, Harvard University	Oregon Attorney General Consumer and Prescriber Grant Program; Edmund J. Safra Foundation for Ethics, Harvard University	This work was supported by the Oregon Attorney General Consumer and Prescriber Grant Program, no URL available. The support was for salaries and expenses of MH and WW; consulting by SR; expenses for Working Group chair LZ and SR: Pew Charitable Trusts: fiscal agent for grant from Oregon Attorney General Consumer and Prescriber Grant Program; Edmund J. Safra Foundation for Ethics, Harvard University: salary and expenses for MH; consulting by SR and MK.	[Anonymous], 2003, FED REGISTER, V68, P23731; Association of American Medical Colleges, 2010, REC PHYS FIN REL CLI, P10; Association of American Medical Colleges, 2008, IND FUND MED ED REP; Beatty PC, 2007, PUBLIC OPIN QUART, V71, P287, DOI 10.1093/poq/nfm006; Bolt EE, 2014, J CLIN EPIDEMIOL, V67, P477, DOI 10.1016/j.jclinepi.2013.09.012; Brennan TA, 2006, JAMA-J AM MED ASSOC, V295, P429, DOI 10.1001/jama.295.4.429; Campbell EG, 2010, ARCH INTERN MED, V170, P1820, DOI 10.1001/archinternmed.2010.383; Chimonas S, 2011, ACAD MED, V86, P293, DOI 10.1097/ACM.0b013e3182087156; COI Policy Database, 2016, COI POL DAT; Harris PA, 2009, J BIOMED INFORM, V42, P377, DOI 10.1016/j.jbi.2008.08.010; Lo B, 2009, CONFLICT INTEREST ME; Lo B, 2010, NEW ENGL J MED, V362, P669, DOI 10.1056/NEJMp1000213; Pew Charitable Trusts, 2013, CONFL OF INT POL AC; Robertson C, 2012, J LAW MED ETHICS, V40, P452, DOI 10.1111/j.1748-720X.2012.00678.x; Rochon Paula A, 2010, Open Med, V4, pe69; SAS, 2012, VERS 9 2 TS1M2 UN; *US SEN COMM FIN, 2007, COMM STAFF REP CHAIR	17	2	2	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 15	2017	12	3							e0172472	10.1371/journal.pone.0172472	http://dx.doi.org/10.1371/journal.pone.0172472			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN9HQ	28296898	Green Published, gold, Green Submitted			2022-12-27	WOS:000396311700008
J	Hofman, CS; Lutomski, JE; Boter, H; Buurman, BM; de Craen, AJM; Donders, R; Rikkert, MGMO; Makai, P; Melis, RAJF				Hofman, Cynthia S.; Lutomski, Jennifer E.; Boter, Han; Buurman, Bianca M.; de Craen, Anton J. M.; Donders, Rogier; Rikkert, Marcel G. M. Olde; Makai, Peter; Melis, Rene A. J. F.		TOPICS-MDS Res Consortium	Examining the construct and known-group validity of a composite endpoint for The Older Persons and Informal Caregivers Survey Minimum Data Set (TOPICS-MDS); A large-scale data sharing initiative	PLOS ONE			English	Article							QUALITY-OF-LIFE; HEALTH-STATUS; PATIENT GROUPS; CARE; ADULTS	Background Preference-weighted multi-faceted endpoints have the potential to facilitate comparative effectiveness research that incorporates patient preferences. The Older Persons and Informal Caregivers Survey-Composite endpoint (TOPICS-CEP) is potentially a valuable outcome measure for evaluating interventions in geriatric care as it combines multiple outcomes relevant to older persons in a single metric. The objective of this study was to validate TOPICS-CEP across different study settings (general population, primary care and hospital). Methods Data were extracted from TOPICS Minimum Dataset (MDS), a pooled public-access national database with information on older persons throughout the Netherlands. Data of 17,603 older persons were used. Meta-correlations were performed between TOPICS-CEP indexed scores, EuroQol5-D utility scores and Cantril's ladder life satisfaction scores. Mixed linear regression analyses were performed to compare TOPICS-CEP indexed scores between known groups, e.g. persons with versus without depression. Results In the complete sample and when stratified by study setting TOPICS-CEP and Cantril's ladder were moderately correlated, whereas TOPICS-CEP and EQ-5D were highly correlated. Higher mean TOPICS-CEP scores were found in persons who were: married, lived independently and had an education at university level. Moreover, higher mean TOPICS-CEP scores were found in persons without dementia, depression, and dizziness with falls, respectively. Similar results were found when stratified by subgroup. Conclusion This study supports that TOPICS-CEP is a robust measure which can potentially be used in broad settings to identify the effect of intervention or of prevention in elderly care.	[Hofman, Cynthia S.; Lutomski, Jennifer E.; Rikkert, Marcel G. M. Olde; Makai, Peter; Melis, Rene A. J. F.] Radboud Univ Nijmegen, Med Ctr, Dept Geriatr Med HP 925, Nijmegen, Netherlands; [Hofman, Cynthia S.; Donders, Rogier] Radboud Univ Nijmegen, Med Ctr, Dept Hlth Evidence HP133, Nijmegen, Netherlands; [Hofman, Cynthia S.] Vilans, Ctr Expertise Long Term Care, Utrecht, Netherlands; [Lutomski, Jennifer E.] Univ Coll Cork, Anu Res Ctr, Cork, Ireland; [Boter, Han] Univ Groningen, Dept Epidemiol FA41, Univ Med Ctr Groningen, Groningen, Netherlands; [Buurman, Bianca M.] Acad Med Ctr, Sect Geriatr Med F4 108, Dept Internal Med, Amsterdam, Netherlands; [de Craen, Anton J. M.] Leiden Univ, Med Ctr, Dept Gerontol & Geriatr C2R, Leiden, Netherlands	Radboud University Nijmegen; Radboud University Nijmegen; University College Cork; University of Amsterdam; Academic Medical Center Amsterdam; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC	Hofman, CS (corresponding author), Radboud Univ Nijmegen, Med Ctr, Dept Geriatr Med HP 925, Nijmegen, Netherlands.; Hofman, CS (corresponding author), Radboud Univ Nijmegen, Med Ctr, Dept Hlth Evidence HP133, Nijmegen, Netherlands.; Hofman, CS (corresponding author), Vilans, Ctr Expertise Long Term Care, Utrecht, Netherlands.	C.Hofman@Vilans.nl	Donders, A.R.T./L-4277-2015; Rikkert, M.G.M. Olde/H-8078-2014; Lutomski, Jennifer E./U-2466-2019; Rikkert, Marcel Olde/D-9773-2012; Melis, René/J-5943-2012; Makai, Peter/I-5278-2012	Donders, A.R.T./0000-0002-0484-1419; Rikkert, M.G.M. Olde/0000-0003-1397-1677; Melis, René/0000-0002-7863-4738; Makai, Peter/0000-0002-5332-1751	Dutch National Care for the Elderly Programme - ZonMw, organization for health research and development, The Netherlands [60-61900-98-302]	Dutch National Care for the Elderly Programme - ZonMw, organization for health research and development, The Netherlands	This work was supported by The Dutch National Care for the Elderly Programme, coordinated and sponsored by ZonMw, organization for health research and development, The Netherlands [Grant number: 60-61900-98-302]. The funder had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BAUMEISTER RF, 1995, PSYCHOL BULL, V117, P497, DOI 10.1037/0033-2909.117.3.497; Brazier J, 2004, HEALTH ECON, V13, P873, DOI 10.1002/hec.866; Cantril H., 1965, PATTERN HUMAN CONCER; COHEN J, 1988, APPL PSYCH MEAS, V12, P425, DOI 10.1177/014662168801200410; Crooks VC, 2008, AM J PUBLIC HEALTH, V98, P1221, DOI 10.2105/AJPH.2007.115923; DONABEDIAN A, 1966, MILBANK FUND Q, V44, P166, DOI 10.2307/3348969; ERICKSON P, 1989, MED CARE, V27, pS66, DOI 10.1097/00005650-198903001-00006; Faes MC, 2010, AGING MENT HEALTH, V14, P834, DOI 10.1080/13607861003781825; Fortin Martin, 2004, Health Qual Life Outcomes, V2, P51, DOI 10.1186/1477-7525-2-51; Fried LP, 2004, J GERONTOL A-BIOL, V59, P255; Han KT, 2014, HEALTH QUAL LIFE OUT, V12, DOI 10.1186/s12955-014-0109-0; Hofman CS, OLDER PERSONS INFORM; Hofman CS, 2014, BMC GERIATR, V14, DOI 10.1186/1471-2318-14-51; Janssen MF, 2013, QUAL LIFE RES, V22, P1717, DOI 10.1007/s11136-012-0322-4; Kovner CT, 2002, HEALTH AFFAIR, V21, P78, DOI 10.1377/hlthaff.21.5.78; Krabbe PFM, 1999, J CLIN EPIDEMIOL, V52, P293, DOI 10.1016/S0895-4356(98)00163-2; Lutomski JE, 2015, QUAL LIFE RES, V24, P1281, DOI 10.1007/s11136-014-0841-2; Lutomski JE, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081673; Malhotra R, 2014, ARCH GERONTOL GERIAT, V58, P269, DOI 10.1016/j.archger.2013.10.004; Park NS, 2009, J APPL GERONTOL, V28, P461, DOI 10.1177/0733464808328606; PATRICK DL, 1989, MED CARE, V27, pS217, DOI 10.1097/00005650-198903001-00018; Schwarzer G., 2010, META METAANALYSIS R; Szende A, 2007, EQ 5D VALUE SETS INV; Terwee CB, 2007, J CLIN EPIDEMIOL, V60, P34, DOI 10.1016/j.jclinepi.2006.03.012; van der Zee KI, 1996, INT J BEHAV MED, V3, P104, DOI 10.1207/s15327558ijbm0302_2; WEINBERGER M, 1992, J AM GERIATR SOC, V40, P585, DOI 10.1111/j.1532-5415.1992.tb02107.x; Woolhead G, 2004, AGE AGEING, V33, P165, DOI 10.1093/ageing/afh045	27	12	13	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 15	2017	12	3							e0173081	10.1371/journal.pone.0173081	http://dx.doi.org/10.1371/journal.pone.0173081			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EN9HQ	28296910	Green Published, gold, Green Submitted			2022-12-27	WOS:000396311700025
J	Nelson, SM; Gao, YT; Nogueira, LM; Shen, MC; Wang, BS; Rashid, A; Hsing, AW; Koshiol, J				Nelson, Shakira M.; Gao, Yu-Tang; Nogueira, Leticia M.; Shen, Ming-Chang; Wang, Bingsheng; Rashid, Asif; Hsing, Ann W.; Koshiol, Jill			Diet and biliary tract cancer risk in Shanghai, China	PLOS ONE			English	Article							C-REACTIVE PROTEIN; GALLBLADDER CANCER; GASTRIC-CANCER; INFLAMMATION; GALLSTONES; MARKERS; ASSOCIATION; PATTERNS; METAANALYSIS; BIOMARKERS	Trends in biliary tract cancer incidence rates have increased in Shanghai, China. These trends have coincided with economic and developmental growth, as well as a shift in dietary patterns to a more Westernized diet. To examine the effect of dietary changes on incident disease, we evaluated associations between diet and biliary tract cancers amongst men and women from a population-based case-control study in Shanghai, China. Biliary tract cancer cases were recruited from 42 collaborating hospitals in urban Shanghai, and population -based controls were randomly selected from the Shanghai Household Registry. Food frequency questionnaire data were available for 225 gallbladder, 190 extrahepatic bile duct, and 68 ampulla of Vater cancer cases. A total of 39 food groups were created and examined for associations with biliary tract cancer. Interestingly, only four food groups demonstrated a suggested association with gallbladder, extrahepatic bile duct, or ampulla of Vater cancers. The allium food group, consisting of onions, garlic, and shallots showed an inverse association with gallbladder cancer (OR: 0.81, 95% CI: 0.68-0.97). Similar trends were seen in the food group containing seaweed and kelp (OR: 0.79, 95% CI: 0.67-0.96). In contrast, both preserved vegetables and salted meats food groups showed positive associations with gallbladder cancer (OR:1.27, 95% CI: 1.06-1.52; OR: 1.18, 95% CI: 1.02-1.37, respectively). Each of these four food groups showed similar trends for extrahepatic bile duct and ampulla of Vater cancers. The results of our analysis suggest intake of foods with greater anti-inflammatory properties may play a role in decreasing the risk of biliary tract cancers. Future studies should be done to better understand effects of cultural changes on diet, and to further examine the impact diet and inflammation have on biliary tract cancer incidence.	[Nelson, Shakira M.; Nogueira, Leticia M.] NCI, Canc Prevent Fellowship Program, Canc Prevent Div, Rockville, MD 20892 USA; [Nelson, Shakira M.] NCI, Metab Epidemiol Branch, Div Canc Epidemiol & Genet, Rockville, MD 20892 USA; [Gao, Yu-Tang] Shanghai Canc Inst, Dept Epidemiol, Shanghai, Peoples R China; [Nogueira, Leticia M.] Texas Dept State Hlth Serv, Texas Canc Registry, Canc Epidemiol & Surveillance Branch, Austin, TX USA; [Shen, Ming-Chang] Fudan Univ, Shanghai Canc Ctr, Dept Pathol, Shanghai, Peoples R China; [Wang, Bingsheng] Fudan Univ, Sch Med, Zhongshan Hosp, Dept Gen Surg, Shanghai, Peoples R China; [Rashid, Asif] Univ Texas MD Anderson Canc Ctr, Dept Pathol, Houston, TX 77030 USA; [Hsing, Ann W.] Stanford Canc Inst, Palo Alto, CA USA; [Hsing, Ann W.] Stanford Sch Med, Stanford Prevent Res Ctr, Palo Alto, CA USA; [Koshiol, Jill] NCI, Infect & Immunoepidemiol Branch, Div Canc Epidemiol & Genet, Rockville, MD USA	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Shanghai Jiao Tong University; Texas Department of State Health Services; Fudan University; Fudan University; University of Texas System; UTMD Anderson Cancer Center; Stanford Cancer Institute; Stanford University; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)	Nelson, SM (corresponding author), NCI, Canc Prevent Fellowship Program, Canc Prevent Div, Rockville, MD 20892 USA.; Nelson, SM (corresponding author), NCI, Metab Epidemiol Branch, Div Canc Epidemiol & Genet, Rockville, MD 20892 USA.	shakira.nelson@nih.gov	Stefanadis, Christodoulos/ABH-2232-2020; Nogueira, Leticia/J-2547-2019; gao, yi/HCI-8298-2022; koshiol, Jill/L-8686-2014; Gao, Yu/HGE-1937-2022; Gao, Y./GWZ-3665-2022	Stefanadis, Christodoulos/0000-0001-5974-6454; koshiol, Jill/0000-0002-3832-6204; 	Intramural Research Program of the National Institutes of Health, National Cancer Institute, Division of Cancer Epidemiology and Genetics (DCEG); NATIONAL CANCER INSTITUTE [ZIACP010218] Funding Source: NIH RePORTER	Intramural Research Program of the National Institutes of Health, National Cancer Institute, Division of Cancer Epidemiology and Genetics (DCEG); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by general funds from the Intramural Research Program of the National Institutes of Health, National Cancer Institute, Division of Cancer Epidemiology and Genetics (DCEG). The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aleksandrova K, 2014, HEPATOLOGY, V60, P858, DOI 10.1002/hep.27016; American Institute for Cancer Research, 2007, FOOD NUTR PHYS ACT P; [Anonymous], 1993, IARC MONOGRAPHS EVAL, V56, P83; [Anonymous], 2012, IARC MONOGR EVAL CAR, V100, P1, DOI DOI 10.1016/S1470-2045(09)70096-8; Barbaresko J, 2013, NUTR REV, V71, P511, DOI 10.1111/nure.12035; Bradbury KE, 2014, AM J CLIN NUTR, V100, p394S, DOI 10.3945/ajcn.113.071357; Chiu BCH, 2003, CANCER EPIDEM BIOMAR, V12, P201; Chrysohoou C, 2004, J AM COLL CARDIOL, V44, P152, DOI 10.1016/j.jacc.2004.03.039; de Groen PC, 1999, NEW ENGL J MED, V341, P1368, DOI 10.1056/NEJM199910283411807; Duan XJ, 2006, FOOD CHEM, V95, P37, DOI 10.1016/j.foodchem.2004.12.015; Eichholzer M, 1998, NUTR REV, V56, P95; Esmaillzadeh A, 2007, J NUTR, V137, P992, DOI 10.1093/jn/137.4.992; Galland L, 2010, NUTR CLIN PRACT, V25, P634, DOI 10.1177/0884533610385703; Giugliano D, 2006, J AM COLL CARDIOL, V48, P677, DOI 10.1016/j.jacc.2006.03.052; Hsing AW, 2008, BRIT J CANCER, V99, P811, DOI 10.1038/sj.bjc.6604616; Hsing AW, 2007, BRIT J CANCER, V97, P1577, DOI 10.1038/sj.bjc.6604047; Hsing AW, 2008, CANCER RES, V68, P6442, DOI 10.1158/0008-5472.CAN-08-0444; Hsing AW, 2002, J NATL CANCER I, V94, P1648, DOI 10.1093/jnci/94.21.1648; Islami F, 2009, BRIT J CANCER, V101, P1641, DOI 10.1038/sj.bjc.6605372; Jain K, 2013, INT J CANCER, V132, P1660, DOI 10.1002/ijc.27777; Kantor ED, 2012, AM J EPIDEMIOL, V176, P1002, DOI 10.1093/aje/kws186; KATO I, 1990, JPN J CANCER RES, V81, P578, DOI 10.1111/j.1349-7006.1990.tb02612.x; KATO K, 1989, JPN J CANCER RES, V80, P932, DOI 10.1111/j.1349-7006.1989.tb01629.x; Koshiol J, 2016, CYTOKINE, V83, P217, DOI 10.1016/j.cyto.2016.05.003; Kumar R, 2013, DIABET METAB SYND OB, V6, P49, DOI 10.2147/DMSO.S38888; Lim SN, 2002, J AGR FOOD CHEM, V50, P3862, DOI 10.1021/jf020096b; Liu EJ, 2005, CANCER EPIDEM BIOMAR, V14, P1315, DOI 10.1158/1055-9965.EPI-05-0032; Lopez-Garcia E, 2004, AM J CLIN NUTR, V80, P1029, DOI 10.1093/ajcn/80.4.1029; MOERMAN CJ, 1993, INT J EPIDEMIOL, V22, P207, DOI 10.1093/ije/22.2.207; Nanri A, 2007, ASIAN PAC J CANCER P, V8, P167; Nettleton JA, 2006, AM J CLIN NUTR, V83, P1369, DOI 10.1093/ajcn/83.6.1369; Nicastro HL, 2015, CANCER PREV RES, V8, P181, DOI 10.1158/1940-6207.CAPR-14-0172; Park M, 2014, PREV MED, V65, P13, DOI 10.1016/j.ypmed.2014.03.027; Qin Y, 2014, BMC PUBLIC HEALTH, V14, DOI 10.1186/1471-2458-14-948; Randi G, 2006, INT J CANCER, V118, P1591, DOI 10.1002/ijc.21683; Ren JS, 2012, CANCER EPIDEM BIOMAR, V21, P905, DOI 10.1158/1055-9965.EPI-12-0202; Scott TE, 1999, DIGEST DIS SCI, V44, P1619, DOI 10.1023/A:1026675329644; Shen J, 2012, CARDIOL RES PRACT, V2012, DOI 10.1155/2012/178675; Shukla VK, 2004, EUR J CANCER PREV, V13, P355, DOI 10.1097/01.cej.0000137514.48974.89; Takata Y, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056963; Tamrakar D, 2016, Asian Pac J Cancer Prev, V17, P3447; Tewari M, 2006, J SURG ONCOL, V93, P629, DOI 10.1002/jso.20529; Tsugane S, 2004, BRIT J CANCER, V90, P128, DOI 10.1038/sj.bjc.6601511; Vidyashankar S, 2009, BRIT J NUTR, V101, P1621, DOI 10.1017/S0007114508118748; Wernberg JA, 2014, SURG CLIN N AM, V94, P343, DOI 10.1016/j.suc.2014.01.009; Willett WC, 1997, AM J CLIN NUTR, V65, P1220, DOI 10.1093/ajcn/65.4.1220S; Wistuba II, 2004, NAT REV CANCER, V4, P695, DOI 10.1038/nrc1429; Zhang XH, 2006, INT J CANCER, V118, P3089, DOI 10.1002/ijc.21748	48	14	14	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 13	2017	12	3							e0173935	10.1371/journal.pone.0173935	http://dx.doi.org/10.1371/journal.pone.0173935			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN6CP	28288186	Green Submitted, Green Published, gold			2022-12-27	WOS:000396092400043
J	Son, KJ; Choi, KR; Ryu, CK; Lee, SJ; Kim, HJ; Lee, H				Son, Keum-joo; Choi, Ki Ryung; Ryu, Chung-Kyu; Lee, Seog Jae; Kim, Ho Jeong; Lee, Hyunah			Induction of immunogenic cell death of tumors by newly synthesized heterocyclic quinone derivative	PLOS ONE			English	Article							CALRETICULIN EXPOSURE; CANCER; ACTIVATION; COMPLEXES; AGENTS; DRUGS; STAT3	Many cancer types are serious diseases causing mortality, and new therapeutics with improved efficacy and safety are required. Immuno-(cell)-therapy is considered as one of the promising therapeutic strategies for curing intractable cancer. In this study, we tested R2016, a newly developed heterocyclic quinone derivative, for induction of immunogenic tumor cell death and as a possible novel immunochemotherapeutic. We studied the anticancer effects of R2016 against LLC, a lung cancer cell line and B16F10, a melanoma cell line. LLC (non-immunogenic) and B16F10 (immunogenic) cells were killed by R2016 in dose-dependent manner. R2016 reduced the viability of both LLC and B16F10 tumor cells by inducing apoptosis and necrosis, while it demonstrated no cytotoxicity against normal splenocytes. Expression of immunogenic death markers on the cell surface of R2016 treated tumor cells including calreticulin (CRT) and heat shock proteins (HSPs) was increased along with the induction of their genes. Increased CRT expression correlated with dendritic cell (DC) uptake of dying tumor cells: the proportion of CRT(+)CD11c(+)cells was increased in the R2016-treated group. The gene transcription of Calr3, Hspb1, and Tnfaip6, which are related to immunogenicity induction of dead cells, was up-regulated in the R2016 treated tumor cells. On the other hand, ANGPT1, FGF7, and URGCP gene levels were down-regulated by R2016 treatment. This data suggests that R2016 induced immunogenic tumor cell death, and suggests R2016 as an effective anti-tumor immunochemotherapeutic modality.	[Son, Keum-joo; Choi, Ki Ryung; Lee, Hyunah] Pharmicell Co Ltd, R&D Ctr, Seongnam Si, Gyeonggi Do, South Korea; [Ryu, Chung-Kyu; Kim, Ho Jeong] Ewha Womans Univ, Coll Pharm, Seoul, South Korea; [Ryu, Chung-Kyu; Kim, Ho Jeong] Ewha Womans Univ, Grad Sch Pharmaceut Sci, Seoul, South Korea; [Lee, Seog Jae] Jeju Natl Univ, Sch Med, Dept Thorac & Cardiovasc Surg, Jeju Si, Jeju Do, South Korea	Ewha Womans University; Ewha Womans University; Jeju National University	Lee, H (corresponding author), Pharmicell Co Ltd, R&D Ctr, Seongnam Si, Gyeonggi Do, South Korea.	andyjosh@pharmicell.com			National Research Foundation of Korea [2014R1A1A2055842]	National Research Foundation of Korea(National Research Foundation of Korea)	This study was supported by the grant from National Research Foundation of Korea (#2014R1A1A2055842; http://www.nrf.re.kr; funded to HL and the salary of the first author [KS]. Pharmicell Co. Ltd., provided support in the form of salaries for authors [HL & KC], but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Cirone M, 2012, ONCOIMMUNOLOGY, V1, P1218, DOI 10.4161/onci.20428; Cumaraswamy AA, 2012, MEDCHEMCOMM, V3, P22, DOI 10.1039/c1md00175b; Fucikova J, 2011, CANCER RES, V71, P4821, DOI 10.1158/0008-5472.CAN-11-0950; Galon J, 2006, SCIENCE, V313, P1960, DOI 10.1126/science.1129139; Garuti L, 2007, MINI-REV MED CHEM, V7, P481, DOI 10.2174/138955707780619626; GIORGIRENAULT S, 1985, EUR J MED CHEM, V20, P144; Hreggvidsdottir HS, 2012, MOL MED, V18, P224, DOI 10.2119/molmed.2011.00327; Ioannis G, 2015, J CANC THER, V6, P709; Klampfer L, 2006, CURR CANCER DRUG TAR, V6, P107, DOI 10.2174/156800906776056491; Kusaba T, 2006, ONCOL REP, V15, P1445; Lotze MT, 2005, NAT REV IMMUNOL, V5, P331, DOI 10.1038/nri1594; Martinez R, 2005, CURR MED CHEM, V12, P127, DOI 10.2174/0929867053363414; Obeid M, 2007, NAT MED, V13, P54, DOI 10.1038/nm1523; Oh Su-Jin, 2011, Immune Netw, V11, P383, DOI 10.4110/in.2011.11.6.383; Panaretakis T, 2009, EMBO J, V28, P578, DOI 10.1038/emboj.2009.1; Pol J, 2015, ONCOIMMUNOL, V4; Rani A, 2016, J INTERF CYTOK RES, V36, P226, DOI 10.1089/jir.2015.0054; Ryu CK, 2011, BIOORG MED CHEM LETT, V21, P427, DOI 10.1016/j.bmcl.2010.10.124; Srinivas G, 2007, MED RES REV, V27, P591, DOI 10.1002/med.20095; Tandon VK, 2005, BIOORG MED CHEM LETT, V15, P3288, DOI 10.1016/j.bmcl.2005.04.066; Wong DYQ, 2015, ANGEW CHEM INT EDIT, V54, P6483, DOI 10.1002/anie.201500934; Yin WH, 2006, MOL CANCER, V5, DOI 10.1186/1476-4598-5-15; Yolanda T. P, 1960, J AM CHEM SOC, V82, P1155; Zitvogel L, 2010, CLIN CANCER RES, V16, P3100, DOI 10.1158/1078-0432.CCR-09-2891	24	9	9	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 10	2017	12	3							e0173121	10.1371/journal.pone.0173121	http://dx.doi.org/10.1371/journal.pone.0173121			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN6CJ	28282460	Green Submitted, Green Published, gold			2022-12-27	WOS:000396091800017
J	Dung, VT; Tjahjowidodo, T				Van Than Dung; Tjahjowidodo, Tegoeh			A direct method to solve optimal knots of Bspline curves: An application for non- uniform B- spline curves fitting	PLOS ONE			English	Article							OPTIMIZATION APPROACH; APPROXIMATION; ALGORITHM; POINTS	B- spline functions are widely used in many industrial applications such as computer graphic representations, computer aided design, computer aided manufacturing, computer numerical control, etc. Recently, there exist some demands, e. g. in reverse engineering (RE) area, to employ B- spline curves for non- trivial cases that include curves with discontinuous points, cusps or turning points from the sampled data. The most challenging task in these cases is in the identification of the number of knots and their respective locations in non- uniform space in the most efficient computational cost. This paper presents a new strategy for fitting any forms of curve by B- spline functions via local algorithm. A new two- step method for fast knot calculation is proposed. In the first step, the data is split using a bisecting method with predetermined allowable error to obtain coarse knots. Secondly, the knots are optimized, for both locations and continuity levels, by employing a non- linear least squares technique. The B- spline function is, therefore, obtained by solving the ordinary least squares problem. The performance of the proposed method is validated by using various numerical experimental data, with and without simulated noise, which were generated by a B- spline function and deterministic parametric functions. This paper also discusses the benchmarking of the proposed method to the existing methods in literature. The proposed method is shown to be able to reconstruct B- spline functions from sampled data within acceptable tolerance. It is also shown that, the proposed method can be applied for fitting any types of curves ranging from smooth ones to discontinuous ones. In addition, the method does not require excessive computational cost, which allows it to be used in automatic reverse engineering applications.	[Van Than Dung; Tjahjowidodo, Tegoeh] Nanyang Technol Univ, Sch Mech & Aerosp Engn, Singapore, Singapore	Nanyang Technological University & National Institute of Education (NIE) Singapore; Nanyang Technological University	Tjahjowidodo, T (corresponding author), Nanyang Technol Univ, Sch Mech & Aerosp Engn, Singapore, Singapore.	ttegoeh@ntu.edu.sg	Tjahjowidodo, Tegoeh/A-3820-2011	Tjahjowidodo, Tegoeh/0000-0003-0074-5101	Nanyang Technological University; Advanced Remanufacturing and Technology Centre(ARTC)	Nanyang Technological University(Nanyang Technological University); Advanced Remanufacturing and Technology Centre(ARTC)	The authors acknowledge the support of Nanyang Technological University and the Advanced Remanufacturing and Technology Centre(ARTC) in this research work.The funders had no role in study design,data collection and analysis,decision to publish,or preparation of the manuscript.	Beliakov G, 2004, APPL MATH COMPUT, V149, P783, DOI 10.1016/S0096-3003(03)00179-6; CHUNG WL, 1980, ACM T MATH SOFTWARE, V6, P45, DOI 10.1145/355873.355877; Conti C, 2001, NUMER ALGORITHMS, V28, P45, DOI 10.1023/A:1014022210828; DE BOOR C., 2001, APPL MATH SCI, V27; FAY TH, 1989, AM MATH MON, V96, P442, DOI 10.2307/2325155; Galvez A, 2015, APPL SOFT COMPUT, V26, P90, DOI 10.1016/j.asoc.2014.09.030; Galvez A, 2011, COMPUT AIDED DESIGN, V43, P1683, DOI 10.1016/j.cad.2011.07.010; Grove O., 2011, COMPUTER AIDED DESIG, V8, P3, DOI [https://doi.org/10.3722/cadaps.2011.3-21, DOI 10.3722/CADAPS.2011.3-21]; He XM, 2001, IEEE SIGNAL PROC LET, V8, P137, DOI 10.1109/97.917695; Ichida K., 1977, ACM Transactions on Mathematical Software, V3, P164, DOI 10.1145/355732.355737; Kang HM, 2015, COMPUT AIDED DESIGN, V58, P179, DOI 10.1016/j.cad.2014.08.022; Li WS, 2005, COMPUT AIDED DESIGN, V37, P791, DOI 10.1016/j.cad.2004.09.008; Lyche T., 1987, Computer-Aided Geometric Design, V4, P217, DOI 10.1016/0167-8396(87)90013-6; LYCHE T, 1988, IMA J NUMER ANAL, V8, P185, DOI 10.1093/imanum/8.2.185; Miyata S, 2003, J COMPUT GRAPH STAT, V12, P197, DOI 10.1198/1061860031284; Miyata S., 2005, J JAPAN STAT SOC, V35, P303, DOI DOI 10.14490/JJSS.35.303; Park H, 2007, COMPUT AIDED DESIGN, V39, P439, DOI 10.1016/j.cad.2006.12.006; Plass M, 1983, ACM SIGGRAPH COMPUTE; Randrianarivony M, 2002, P VIS MOD VIS C; Rice J. R., 1978, ACM Transactions on Mathematical Software, V4, P82, DOI 10.1145/355769.355777; Rice J. R., 1976, APPROXIMATION THEORY, V16, P239; Sarfraz M, 2001, INF VIS 2001 P 5 INT; SCHWETLICK H, 1995, BIT, V35, P361, DOI 10.1007/BF01732610; Tjahjowidodo T, 2015, ADV INT MECH AIM 201; Ulker E, 2009, INFORM SCIENCES, V179, P1483, DOI 10.1016/j.ins.2008.11.037; Wu JC, 2015, COMPUT IND ENG, V81, P58, DOI 10.1016/j.cie.2014.12.018; Yuan Y, 2013, IIE TRANS, V45, P1263, DOI 10.1080/0740817X.2012.726758; Zhang CM, 2013, COMPUT AIDED DESIGN, V45, P853, DOI 10.1016/j.cad.2011.08.004; Zhao XY, 2011, COMPUT AIDED DESIGN, V43, P598, DOI 10.1016/j.cad.2011.01.015	29	32	34	2	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 20	2017	12	3							0173857	10.1371/journal.pone.0173857	http://dx.doi.org/10.1371/journal.pone.0173857			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ER6VC	28319131	Green Published, gold			2022-12-27	WOS:000398945800032
J	Esquerre, M; Bouillette-Marussig, M; Goubier, A; Momot, M; Gonindard, C; Keller, H; Navarro, A; Bissery, MC				Esquerre, Michael; Bouillette-Marussig, Myriam; Goubier, Anne; Momot, Marie; Gonindard, Christophe; Keller, Helene; Navarro, Astrid; Bissery, Marie-Christine			GTL001, a bivalent therapeutic vaccine against human papillomavirus 16 and 18, induces antigen-specific CD8(+) T cell responses leading to tumor regression	PLOS ONE			English	Article							ADENYLATE-CYCLASE TOXIN; BORDETELLA-PERTUSSIS; ESTABLISHED TUMORS; CUTTING EDGE; IMIQUIMOD; IMMUNIZATION; ERADICATION; INFECTION; INNATE	Background Prophylactic vaccines are available for women and girls not yet infected with HPV, but women already infected with HPV need a treatment to prevent progression to high-grade cervical lesions and cancer. GTL001 is a bivalent therapeutic vaccine for eradicating HPVinfected cells that contains HPV16 E7 and HPV18 E7 both fused to detoxified adenylate cyclase from Bordetella pertussis, which binds specifically to CD11b(+) antigen-presenting cells. This study examined the ability of therapeutic vaccination with GTL001 adjuvanted with topical imiquimod cream to induce functional HPV16 E7-and HPV18 E7-specific CD8 + T cell responses. Methods Binding of GTL001 to human CD11b was assessed by a cell-based competition binding assay. Cellular immunogenicity of intradermal vaccination with GTL001 was assessed in C57BL/6 mice by enzyme-linked immunospot assay and in vivo killing assays. In vivo efficacy of GTL001 vaccination was investigated in the TC-1 murine HPV16 E7-expressing tumor model. Results GTL001 bound specifically to the human CD11b/CD18 receptor. GTL001 adjuvanted with topical 5% imiquimod cream induced HPV16 E7 and HPV18 E7-specific CD8(+) T cell responses. This CD8(+) T-cell response mediated in vivo killing of HPV E7-expressing cells. In the HPV16 E7-expressing tumor model, GTL001 adjuvanted with imiquimod but not imiquimod alone or a combination of unconjugated HPV16 E7 and HPV18 E7 caused complete tumor regression. Conclusions GTL001 adjuvanted with topical 5% imiquimod is immunogenic and induces HPV16 E7 and HPV18 E7-specific CD8(+) T cell responses that can kill HPV E7-expressing cells and eliminate HPV E7-expressing tumors.	[Esquerre, Michael; Goubier, Anne; Momot, Marie; Gonindard, Christophe; Keller, Helene; Navarro, Astrid] Genticel, Labege, France; [Bouillette-Marussig, Myriam; Bissery, Marie-Christine] Genticel, Paris, France; [Esquerre, Michael; Navarro, Astrid] Evotec, Toulouse, France; [Goubier, Anne] Tusk Therapeut, Meise, Belgium	Evotec	Bissery, MC (corresponding author), Genticel, Paris, France.	mcbissery@orange.fr			Genticel SA; Genticel	Genticel SA; Genticel	This study was funded by Genticel SA. All authors are or were employed by Genticel. Genticel provided support in the form of salaries for all authors, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the author contributions section.	Adams S, 2008, J IMMUNOL, V181, P776, DOI 10.4049/jimmunol.181.1.776; Barber DL, 2003, J IMMUNOL, V171, P27, DOI 10.4049/jimmunol.171.1.27; Berraondo P, 2007, CANCER RES, V67, P8847, DOI 10.1158/0008-5472.CAN-07-0321; Bosch FX, 2002, J CLIN PATHOL, V55, P244, DOI 10.1136/jcp.55.4.244; Brun JL, 2011, AM J OBSTET GYNECOL, V204, DOI 10.1016/j.ajog.2010.09.020; Dadaglio G, 2003, INT IMMUNOL, V15, P1423, DOI 10.1093/intimm/dxg144; Dadaglio G, 2014, J IMMUNOL, V193, P1787, DOI 10.4049/jimmunol.1302974; Fehres CM, 2014, EUR J IMMUNOL, V44, P2415, DOI 10.1002/eji.201344094; FELTKAMP MCW, 1993, EUR J IMMUNOL, V23, P2242, DOI 10.1002/eji.1830230929; Frazer IH, 2009, VIROLOGY, V384, P410, DOI 10.1016/j.virol.2008.10.004; Gotovtseva EP, 2008, SEX TRANSM DIS, V35, P346, DOI 10.1097/OLQ.0b013e31815ea8d1; Hemmi H, 2000, NATURE, V408, P740, DOI 10.1038/35047123; Hildesheim A, 2007, JAMA-J AM MED ASSOC, V298, P743, DOI 10.1001/jama.298.7.743; Kapsenberg ML, 2003, NAT REV IMMUNOL, V3, P984, DOI 10.1038/nri1246; Kawai T, 2010, NAT IMMUNOL, V11, P373, DOI 10.1038/ni.1863; Kawana Kei, 2012, Open Virol J, V6, P264, DOI 10.2174/1874357901206010264; Khallouf H, 2014, VACCINES-BASEL, V2, P422, DOI 10.3390/vaccines2020422; Kyrgiou M, 2006, LANCET, V367, P489, DOI 10.1016/S0140-6736(06)68181-6; Lin KY, 1996, CANCER RES, V56, P21; Morrow MP, 2013, EXPERT REV VACCINES, V12, P271, DOI [10.1586/ERV.13.23, 10.1586/erv.13.23]; Tran NP, 2014, RECENT RESULTS CANC, V193, P149, DOI 10.1007/978-3-642-38965-8_9; Preville X, 2005, CANCER RES, V65, P641; Preville X, 2005, INVENTORSRECOMBINANT; Rechtsteiner G, 2005, J IMMUNOL, V174, P2476, DOI 10.4049/jimmunol.174.5.2476; Schlecht G, 2004, J IMMUNOL, V173, P6089, DOI 10.4049/jimmunol.173.10.6089; Schon MP, 2007, BRIT J DERMATOL, V157, P8, DOI 10.1111/j.1365-2133.2007.08265.x; Simsova M, 2004, INT J MED MICROBIOL, V293, P571, DOI 10.1078/1438-4221-00291; Stanley M, 2012, VACCINE, V30, pF83, DOI 10.1016/j.vaccine.2012.04.106; Stanley M, 2010, GYNECOL ONCOL, V117, pS5, DOI [10.1016/j.ygyno.2010.01.024, 10.1016/j.ygyno.2010.04.002]; Stern PL, 2012, VACCINE, V30, pF71, DOI 10.1016/j.vaccine.2012.05.091; Van Damme P, CLIN CANC RES OFFICI; van der Burg SH, 2011, CURR OPIN IMMUNOL, V23, P252, DOI 10.1016/j.coi.2010.12.010; Vici P, 2016, EXPERT REV VACCINES, V15, P1327, DOI 10.1080/14760584.2016.1176533; Vrzackova P, 2010, EXPERT REV ANTICANC, V10, P1037, DOI 10.1586/ERA.10.89; Wit EMK, 2014, NAT REV UROL, V11, P110, DOI 10.1038/nrurol.2013.323	35	9	11	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 16	2017	12	3							e0174038	10.1371/journal.pone.0174038	http://dx.doi.org/10.1371/journal.pone.0174038			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN9KE	28301611	Green Published, gold, Green Submitted			2022-12-27	WOS:000396318300116
J	Fosse, R; Ryberg, W; Carlsson, MK; Hammer, J				Fosse, Roar; Ryberg, Wenche; Carlsson, Merete Kvalsvik; Hammer, Jan			Predictors of suicide in the patient population admitted to a locked-door psychiatric acute ward	PLOS ONE			English	Article							RISK-FACTORS; COLLABORATIVE ASSESSMENT; MANAGEMENT; DISCHARGE; CAMS	Objective No prior study appears to have focused on predictors of suicide in the general patient population admitted to psychiatric acute wards. We used a case-control design to investigate the association between suicide risk factors assessed systematically at admission to a locked-door psychiatric acute ward in Norway and subsequent death by suicide. Method From 2008 to 2013, patients were routinely assessed for suicide risk upon admission to the acute ward with a 17-item check list based on recommendations from the Norwegian Directorate of Health and Social Affairs. Among 1976 patients admitted to the ward, 40 patients, 22 men and 18 women, completed suicide within December 2014. Results Compared to a matched control group (n = 120), after correction for multiple tests, suicide completers scored significantly higher on two items on the check list: presence of suicidal thoughts and wishing to be dead. An additional four items were significant in non-corrected tests: previous suicide attempts, continuity of suicidal thoughts, having a suicide plan, and feelings of hopelessness, indifference, and/or aggression. A brief scale based on these six items was the only variable associated with suicide in multivariate regression analysis, but its predictive value was poor. Conclusion Suicide specific ideations may be the most central risk markers for suicide in the general patient population admitted to psychiatric acute wards. However, a low predictive value may question the utility of assessing suicide risk.	[Fosse, Roar; Ryberg, Wenche; Carlsson, Merete Kvalsvik; Hammer, Jan] Vestre Viken Hosp Trust, Dept Res & Dev, Div Mental Hlth & Addict, Lier, Norway		Fosse, R (corresponding author), Vestre Viken Hosp Trust, Dept Res & Dev, Div Mental Hlth & Addict, Lier, Norway.	roar.fosse@vestreviken.no			Vestre Viken	Vestre Viken	The PI (RF) received internal research funding from Vestre Viken to cover data acquisition. No other specific funding was received for this project. All authors were employees at and received salaries from Vestre Viken. No party except the authors had any role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Asskildt I, 2009, VALIDATION SUICIDE R; Beautrais AL, 2004, SUICIDE LIFE-THREAT, V34, P1, DOI 10.1521/suli.34.1.1.27772; Berman L, 2013, 27 WORLD C INT ASS S; Blair-West GW, 1999, J AFFECT DISORDERS, V55, P171, DOI 10.1016/S0165-0327(99)00004-X; Bowers L, 2010, J NERV MENT DIS, V198, P315, DOI 10.1097/NMD.0b013e3181da47e2; Brown GK, 2000, J CONSULT CLIN PSYCH, V68, P371, DOI 10.1037/0022-006X.68.3.371; Chan MKY, 2016, BRIT J PSYCHIAT, V209, P279, DOI 10.1192/bjp.bp.115.170050; FLANNIGAN CB, 1994, BRIT J PSYCHIAT, V165, P750, DOI 10.1192/bjp.165.6.750; Harris EC, 1997, BRIT J PSYCHIAT, V170, P205, DOI 10.1192/bjp.170.3.205; Hunt IM, 2009, PSYCHOL MED, V39, P443, DOI 10.1017/S0033291708003644; IBM Corp. Released, 2015, IBM SPSS STAT WINDOW; Inskip HM, 1998, BRIT J PSYCHIAT, V172, P35, DOI 10.1192/bjp.172.1.35; Jobes, 2016, MANAGING SUICIDE RIS; Jobes DA, 2005, SUICIDE LIFE-THREAT, V35, P483, DOI 10.1521/suli.2005.35.5.483; Jobes DA, 2012, SUICIDE LIFE-THREAT, V42, P640, DOI 10.1111/j.1943-278X.2012.00119.x; Kan CK, 2007, SOC PSYCH PSYCH EPID, V42, P208, DOI 10.1007/s00127-006-0153-0; Kapur N, 2013, PSYCHOL MED, V43, P61, DOI 10.1017/S0033291712000864; King EA, 2001, BRIT J PSYCHIAT, V178, P537, DOI 10.1192/bjp.178.6.537; Large M, 2011, ACTA PSYCHIAT SCAND, V124, P18, DOI 10.1111/j.1600-0447.2010.01672.x; Large M, 2011, AUST NZ J PSYCHIAT, V45, P619, DOI 10.3109/00048674.2011.590465; McKenzie I, 2001, SUICIDE LIFE-THREAT, V31, P358, DOI 10.1521/suli.31.3.358.24244; Mellesdal L, 2010, PSYCHIAT SERV, V61, P25, DOI 10.1176/appi.ps.61.1.25; Mulder R, 2016, BRIT J PSYCHIAT, V209, P271, DOI 10.1192/bjp.bp.116.184960; Nimeus A, 2000, EUR PSYCHIAT, V15, P416, DOI 10.1016/S0924-9338(00)00512-5; Nordentoft M, 2016, ACTA PSYCHIAT SCAND, V133, P255, DOI 10.1111/acps.12574; Norwegian Directorate of Health, 2008, NAT GUID SUIC PREV M; Norwegian Directorate of Health and Social Affairs, 2008, IS1511 NORW DIR HLTH; Pisani AR, 2016, ACAD PSYCHIATR, V40, P623, DOI 10.1007/s40596-015-0434-6; POKORNY AD, 1983, ARCH GEN PSYCHIAT, V40, P249; Qin P, 2005, ARCH GEN PSYCHIAT, V62, P427, DOI 10.1001/archpsyc.62.4.427; Restan A, 2007, SRS SELVMORDSRISIKO; Reutfors J, 2010, J PSYCHIATR RES, V44, P741, DOI 10.1016/j.jpsychires.2010.02.003; Ryberg W, 2016, TRIALS, V17, DOI 10.1186/s13063-016-1602-z; Thong JY, 2008, AUST NZ J PSYCHIAT, V42, P509, DOI 10.1080/00048670802050553; Uribe IP, 2013, J AFFECT DISORDERS, V150, P840, DOI 10.1016/j.jad.2013.03.013; Yim PHW, 2004, AUST NZ J PSYCHIAT, V38, P65, DOI 10.1177/000486740403800103	36	7	7	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 16	2017	12	3							e0173958	10.1371/journal.pone.0173958	http://dx.doi.org/10.1371/journal.pone.0173958			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EN9KE	28301590	Green Published, Green Submitted, gold			2022-12-27	WOS:000396318300101
J	Gros, A; Laharanne, E; Vergier, M; Prochazkova-Carlotti, M; Pham-Ledard, A; Bandres, T; Poglio, S; Berhouet, S; Vergier, B; Vial, JP; Chevret, E; Beylot-Barry, M; Merlio, JP				Gros, Audrey; Laharanne, Elodie; Vergier, Marie; Prochazkova-Carlotti, Martina; Pham-Ledard, Anne; Bandres, Thomas; Poglio, Sandrine; Berhouet, Sabine; Vergier, Beatrice; Vial, Jean-Philippe; Chevret, Edith; Beylot-Barry, Marie; Merlio, Jean-Philippe			TP53 alterations in primary and secondary Se A zary syndrome: A diagnostic tool for the assessment of malignancy in patients with erythroderma	PLOS ONE			English	Article							T-CELL LYMPHOMA; SEZARY-SYNDROME; MYCOSIS-FUNGOIDES; CUTANEOUS-LYMPHOMAS; PERIPHERAL-BLOOD; EUROPEAN-ORGANIZATION; EORTC CLASSIFICATION; MUTATIONS; RECEPTOR; P53	Recent massive parallel sequencing data have evidenced the genetic diversity and complexity of Se A zary syndrome mutational landscape with TP53 alterations being the most prevalent genetic abnormality. We analyzed a cohort of 35 patients with SS and a control group of 8 patients with chronic inflammatory dermatoses. TP53 status was analyzed at different clinical stages especially in 9 patients with a past-history of mycosis fungoides (MF), coined secondary SS. TP53 mutations were only detected in 10 patients with either primary or secondary SS (29%) corresponding to point mutations, small insertions and deletions which were unique in each case. Interestingly, TP53 mutations were both detected in sequential unselected blood mononuclear cells and in skin specimens. Cytogenetic analysis of blood specimens of 32 patients with SS showed a TP53 deletion in 27 cases (84%). Altogether 29 out of 35 cases exhibited TP53 mutation and/or deletion (83%). No difference in prognosis was observed according to TP53 status while patients with secondary SS had a worse prognosis than patients with primary SS. Interestingly, patients with TP53 alterations displayed a younger age and the presence of TP53 alteration at initial diagnosis stage supports a pivotal oncogenic role for TP53 mutation in SS as well as in erythrodermic MF making TP53 assessment an ancillary method for the diagnosis of patients with erythroderma as patients with inflammatory dermatoses did not display TP53 alteration.	[Gros, Audrey; Laharanne, Elodie; Prochazkova-Carlotti, Martina; Pham-Ledard, Anne; Poglio, Sandrine; Vergier, Beatrice; Chevret, Edith; Beylot-Barry, Marie; Merlio, Jean-Philippe] Univ Bordeaux, Bordeaux Res Translat Oncol, INSERM, U1053, Bordeaux, France; [Gros, Audrey; Laharanne, Elodie; Vergier, Marie; Bandres, Thomas; Berhouet, Sabine; Merlio, Jean-Philippe] CHU Bordeaux, Tumor Bank, Pessac, France; [Gros, Audrey; Laharanne, Elodie; Vergier, Marie; Bandres, Thomas; Berhouet, Sabine; Merlio, Jean-Philippe] CHU Bordeaux, Tumor Biol Lab, Pessac, France; [Pham-Ledard, Anne; Beylot-Barry, Marie] CHU Bordeaux, Dept Dermatol, Bordeaux, France; [Vergier, Beatrice] CHU Bordeaux, Dept Pathol, Pessac, France; [Vial, Jean-Philippe] CHU Bordeaux, Hematol Lab, Pessac, France	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite de Bordeaux; CHU Bordeaux; CHU Bordeaux; CHU Bordeaux; CHU Bordeaux; CHU Bordeaux	Merlio, JP (corresponding author), Univ Bordeaux, Bordeaux Res Translat Oncol, INSERM, U1053, Bordeaux, France.; Merlio, JP (corresponding author), CHU Bordeaux, Tumor Bank, Pessac, France.; Merlio, JP (corresponding author), CHU Bordeaux, Tumor Biol Lab, Pessac, France.	jp.merlio@u-bordeaux.fr	Beylot-Barry, Marie/AHC-3163-2022	Poglio, Sandrine/0000-0001-8783-0709; Beylot-Barry, Marie/0000-0001-6150-1229; vial, jean-philippe/0000-0003-3109-0064; Prochazkova-Carlotti, Martina/0000-0002-7719-7679	MATULILA project; University Hospital of Bordeaux; Ligue contre le Cancer Comite de Gironde grant; Association pour la Recherche Contre le Cancer grant	MATULILA project; University Hospital of Bordeaux; Ligue contre le Cancer Comite de Gironde grant; Association pour la Recherche Contre le Cancer grant	This work is part of the MATULILA project funding to Anne Pham-Ledard supported by the University Hospital of Bordeaux, the Ligue contre le Cancer Comite de Gironde grant to Sandrine Poglio and the Association pour la Recherche Contre le Cancer grant to Edith Chevret. The funders had no role in study design, data	Alexandrov LB, 2013, NATURE, V500, P415, DOI 10.1038/nature12477; Bagot M, 2001, BLOOD, V97, P1388, DOI 10.1182/blood.V97.5.1388; Beylot-Barry M, 2001, J INVEST DERMATOL, V117, P920, DOI 10.1046/j.0022-202x.2001.01476.x; Boonk SE, 2016, J INVESTIGATIVE DERM; Campbell JJ, 2010, BLOOD, V116, P767, DOI 10.1182/blood-2009-11-251926; Chevret E, 2016, J INVEST DERMATOL, V136, P1319, DOI 10.1016/j.jid.2016.04.027; Chevret E, 2014, BLOOD, V123, P1850, DOI 10.1182/blood-2013-05-500686; Choi J, 2015, NAT GENET, V47, P1011, DOI 10.1038/ng.3356; Almeida ACD, 2015, NAT GENET, V47, P1465, DOI 10.1038/ng.3442; Delfau-Larue MH, 2000, BLOOD, V96, P2987; Fraser-Andrews EA, 2000, J INVEST DERMATOL, V114, P117, DOI 10.1046/j.1523-1747.2000.00830.x; Gibson JF, 2016, J AM ACAD DERMATOL, V74, P870, DOI 10.1016/j.jaad.2015.12.018; Hirsch FR, 2003, J CLIN ONCOL, V21, P3798, DOI 10.1200/JCO.2003.11.069; Iggo R, 2013, J PATHOL, V231, P441, DOI 10.1002/path.4243; Karenko L, 1999, J INVEST DERMATOL, V112, P392, DOI 10.1038/sj.jid.5600444; Kiel MJ, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9470; Laharanne E, 2010, J INVESTIGATIVE DERM; Laharanne E, 2010, MODERN PATHOL, V23, P547, DOI 10.1038/modpathol.2009.196; Lamprecht B, 2012, BRIT J DERMATOL, V167, P240, DOI 10.1111/j.1365-2133.2012.10918.x; Landau DA, 2015, NATURE, V526, P525, DOI 10.1038/nature15395; Langerak AW, 2012, LEUKEMIA, V26, P2159, DOI 10.1038/leu.2012.246; Leroy B, 2014, HUM MUTAT, V35, P672, DOI 10.1002/humu.22552; Mao X, 2003, GENE CHROMOSOME CANC, V36, P250, DOI 10.1002/gcc.10152; Mao X, 2002, BRIT J DERMATOL, V147, P464, DOI 10.1046/j.1365-2133.2002.04966.x; Marks DI, 1996, BRIT J HAEMATOL, V92, P890, DOI 10.1046/j.1365-2141.1996.439978.x; Marty M, 2008, J INVEST DERMATOL, V128, P2458, DOI 10.1038/jid.2008.113; McGirt LY, 2015, BLOOD, V126, P508, DOI 10.1182/blood-2014-11-611194; McGregor JM, 1999, J INVEST DERMATOL, V112, P317, DOI 10.1046/j.1523-1747.1999.00507.x; Muche JM, 1999, BLOOD, V94, P1409, DOI 10.1182/blood.V94.4.1409.416k21_1409_1417; Muche JM, 2004, J INVEST DERMATOL, V122, P574, DOI 10.1111/j.0022-202X.2004.22303.x; Olsen E, 2007, BLOOD, V110, P1713, DOI 10.1182/blood-2007-03-055749; Pham-Ledard A, 2014, MODERN PATHOL, V27, P402, DOI 10.1038/modpathol.2013.156; Prasad A, 2016, J INVESTIGATIVE DERM; Salgado R, 2009, J INVESTIGATIVE DERM; Scarisbrick JJ, 2001, BLOOD, V97, P624, DOI 10.1182/blood.V97.3.624; THEODOROU I, 1995, BLOOD, V86, P305, DOI 10.1182/blood.V86.1.305.bloodjournal861305; van Doorn R, 2016, J INVESTIGATIVE DERM; van Doorn R, 2009, BLOOD, V113, P127, DOI 10.1182/blood-2008-04-153031; Vega F, 2002, BLOOD, V100, P3369, DOI 10.1182/blood.V100.9.3369; Vermeer MH, 2008, CANCER RES, V68, P2689, DOI 10.1158/0008-5472.CAN-07-6398; Wang K, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkq603; Wang LH, 2015, NAT GENET, V47, P1426, DOI 10.1038/ng.3444; Weed J, 2016, J INVESTIGATIVE DERM; Whibley C, 2009, NAT REV CANCER, V9, P95, DOI 10.1038/nrc2584; Willemze R, 1997, BLOOD, V90, P354; Willemze R, 2005, BLOOD, V105, P3768, DOI 10.1182/blood-2004-09-3502; Wong HK, 2016, J INVEST DERMATOL, V136, P1313, DOI 10.1016/j.jid.2016.05.087; Woollard WJ, 2016, BLOOD, V127, P3387, DOI 10.1182/blood-2016-02-699843; Woollard WJ, 2016, J INVESTIGATIVE DERM	49	10	11	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 16	2017	12	3							e0173171	10.1371/journal.pone.0173171	http://dx.doi.org/10.1371/journal.pone.0173171			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN9KE	28301507	gold, Green Published, Green Submitted			2022-12-27	WOS:000396318300026
J	Qi, XJ; Song, WW; Shi, JW				Qi, Xuejun; Song, Wenwu; Shi, Jianwei			Density functional theory study the effects of oxygen-containing functional groups on oxygen molecules and oxygen atoms adsorbed on carbonaceous materials	PLOS ONE			English	Article							SURFACE OXIDES; GRAPHITE; OXIDATION; ADSORPTION; MODEL; O-2; CHEMISORPTION; POTASSIUM	Density functional theory was used to study the effects of different types of oxygen-containing functional groups on the adsorption of oxygen molecules and single active oxygen atoms on carbonaceous materials. During gasification or combustion reactions of carbonaceous materials, oxygen-containing functional groups such as hydroxyl(-OH), carbonyl (-CO), quinone(-O), and carboxyl(-COOH) are often present on the edge of graphite and can affect graphite's chemical properties. When oxygen-containing functional groups appear on a graphite surface, the oxygen molecules are strongly adsorbed onto the surface to form a four-member ring structure. At the same time, the O-O bond is greatly weakened and easily broken. The adsorption energy value indicates that the adsorption of oxygen molecules changes from physisorption to chemisorption for oxygen-containing functional groups on the edge of a graphite surface. In addition, our results indicate that the adsorption energy depends on the type of oxygen-containing functional group. When a single active oxygen atom is adsorbed on the bridge site of graphite, it gives rise to a stable epoxy structure. Epoxy can cause deformation of the graphite lattice due to the transition of graphite from sp(2) to sp(3) after the addition of an oxygen atom. For quinone group on the edge of graphite, oxygen atoms react with carbon atoms to form the precursor of CO2. Similarly, the single active oxygen atoms of carbonyl groups can interact with edge carbon atoms to form the precursor of CO2. The results show that oxygen-containing functional groups on graphite surfaces enhance the activity of graphite, which promotes adsorption on the graphite surface.	[Qi, Xuejun] Xihua Univ, Sch Architecture & Civil Engn, Chengdu, Sichuan, Peoples R China; [Song, Wenwu; Shi, Jianwei] Xihua Univ, Sch Energy & Power Engn, Chengdu, Sichuan, Peoples R China	Xihua University; Xihua University	Qi, XJ (corresponding author), Xihua Univ, Sch Architecture & Civil Engn, Chengdu, Sichuan, Peoples R China.	xuejunqi@foxmail.com			Xihua university key laboratory of green building [szjj2016-056]; key foundation of Xihua university [Z1510612]; ministry of education chunhui plan [Z2016157]; education department of Sichuan province [17ZB0421]; open research fund program provincial key laboratory of fluid machinery of China [szjj2015-037]	Xihua university key laboratory of green building; key foundation of Xihua university; ministry of education chunhui plan; education department of Sichuan province; open research fund program provincial key laboratory of fluid machinery of China	Support was provided by: 1. The open research fund of Xihua university key laboratory of green building(szjj2016-056) [http://jztm.xhu.edu.cn/1282/list.htm]; 2. The key foundation of Xihua university(Z1510612) [http://www.xhu.edu.cn/12/list.htm]; 3. The ministry of education chunhui plan, Z2016157, Dr Xuejun Qi [http://www.moe.edu.cn/publicfiles/business/htmlfiles/moe/moe_851/201001/xxgk_77983.html]; 4. Project of education department of Sichuan province, 17ZB0421, Dr Xuejun Qi [http://182.140.219.158:10008/login.aspx]; 5. The open research fund program provincial key laboratory of fluid machinery of China, szjj2015-037, Jianwei Shi [http://klab.xhu.edu.cn/]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ATAMNY F, 1992, J PHYS CHEM-US, V96, P4522, DOI 10.1021/j100190a072; Boehm HP, 2002, CARBON, V40, P145, DOI 10.1016/S0008-6223(01)00165-8; Chen N, 1998, CARBON, V36, P1061, DOI 10.1016/S0008-6223(98)00078-5; Datsyuk V, 2008, CARBON, V46, P833, DOI 10.1016/j.carbon.2008.02.012; Delley B, 2000, J CHEM PHYS, V113, P7756, DOI 10.1063/1.1316015; DUBSKY J, 1979, SURF SCI, V79, P53, DOI 10.1016/0039-6028(79)90025-6; Espinal JF, 2004, J PHYS CHEM B, V108, P1003, DOI 10.1021/jp0308211; Espinal JF, 2009, CARBON, V47, P3010, DOI 10.1016/j.carbon.2009.06.048; Ghaderi N, 2010, J PHYS CHEM C, V114, P21625, DOI 10.1021/jp108688m; Gonzalez JD, 2013, FUEL, V114, P199, DOI 10.1016/j.fuel.2012.04.039; Haynes BS, 2001, COMBUST FLAME, V126, P1421, DOI 10.1016/S0010-2180(01)00263-2; He HY, 1998, CHEM PHYS LETT, V287, P53, DOI 10.1016/S0009-2614(98)00144-4; HONTORIALUCAS C, 1995, CARBON, V33, P1585, DOI 10.1016/0008-6223(95)00120-3; JANIAK C, 1993, LANGMUIR, V9, P3427, DOI 10.1021/la00036a017; Krasheninnikov AV, 2004, CARBON, V42, P1021, DOI 10.1016/j.carbon.2003.12.025; Lamoen D, 1998, J CHEM PHYS, V108, P3332, DOI 10.1063/1.475732; Langley LA, 2006, CHEM MATER, V18, P169, DOI 10.1021/cm051462k; Larciprete R, 2009, CARBON, V47, P2579, DOI 10.1016/j.carbon.2009.05.008; Lee SM, 1999, PHYS REV LETT, V82, P217, DOI 10.1103/PhysRevLett.82.217; Orrego JF, 2009, J PHYS CHEM A, V113, P8415, DOI 10.1021/jp903362g; PAN ZJ, 1992, IND ENG CHEM RES, V31, P2675, DOI 10.1021/ie00012a008; Perry ST, 2000, P COMBUST INST, V28, P2313, DOI 10.1016/S0082-0784(00)80642-6; Radovic LR, 2011, CARBON, V49, P4218, DOI 10.1016/j.carbon.2011.05.059; Radovic LR, 2011, CARBON, V49, P4226, DOI 10.1016/j.carbon.2011.05.037; Sendt K, 2005, COMBUST FLAME, V143, P629, DOI 10.1016/j.combustflame.2005.08.026; Sendt K, 2005, P COMBUST INST, V30, P2141, DOI 10.1016/j.proci.2004.08.064; Sendt K, 2005, J PHYS CHEM A, V109, P3438, DOI 10.1021/jp045111p; Sendt K, 2011, P COMBUST INST, V33, P1851, DOI 10.1016/j.proci.2010.06.021; Shaffer MSP, 1998, CARBON, V36, P1603, DOI 10.1016/S0008-6223(98)00130-4; Sorescu DC, 2001, J PHYS CHEM B, V105, P11227, DOI 10.1021/jp0122979; Sun BZ, 2010, J CHEM PHYS, V133, DOI 10.1063/1.3489663; Szabo T, 2006, CHEM MATER, V18, P2740, DOI 10.1021/cm060258+; Zhang GX, 2008, CARBON, V46, P196, DOI 10.1016/j.carbon.2007.11.002	33	22	22	3	49	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 16	2017	12	3							e0173864	10.1371/journal.pone.0173864	http://dx.doi.org/10.1371/journal.pone.0173864			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN9KE	28301544	Green Published, gold, Green Submitted			2022-12-27	WOS:000396318300085
J	Viana, GMR; Okoth, SA; Silva-Flannery, L; Barbosa, DRL; de Oliveira, AM; Goldman, IF; Morton, LC; Huber, C; Anez, A; Machado, RLD; Camargo, LMA; do Valle, SCN; Povoa, MM; Udhayakumar, V; Barnwell, JW				Rachid Viana, Giselle Maria; Okoth, Sheila Akinyi; Silva-Flannery, Luciana; Lima Barbosa, Danielle Regina; de Oliveira, Alexandre Macedo; Goldman, Ira F.; Morton, Lindsay C.; Huber, Curtis; Anez, Arletta; Dantas Machado, Ricardo Luiz; Aranha Camargo, Luis Marcelo; Negreiros do Valle, Suiane Costa; Povoa, Marinete Marins; Udhayakumar, Venkatachalam; Barnwell, John W.			Histidine-rich protein 2 (pfhrp2) and pfhrp3 gene deletions in Plasmodium falciparum isolates from select sites in Brazil and Bolivia	PLOS ONE			English	Article							RAPID DIAGNOSTIC-TESTS; MALARIA; ANTIBODIES; SECRETION; PARASITES	More than 80% of available malaria rapid diagnostic tests (RDTs) are based on the detection of histidine-rich protein-2 (PfHRP2) for diagnosis of Plasmodium falciparum malaria. Recent studies have shown the genes that code for this protein and its paralog, histidine-rich protein-3 (PfHRP3), are absent in parasites from the Peruvian Amazon Basin. Lack of PfHRP2 protein through deletion of the pfhrp2 gene leads to false-negative RDT results for P. falciparum. We have evaluated the extent of pfhrp2 and pfhrp3 gene deletions in a convenience sample of 198 isolates from six sites in three states across the Brazilian Amazon Basin (Acre, Rondonia and Para) and 25 isolates from two sites in Bolivia collected at different times between 2010 and 2012. Pfhrp2 and pfhrp3 gene and their flanking genes on chromosomes 7 and 13, respectively, were amplified from 198 blood specimens collected in Brazil. In Brazil, the isolates collected in Acre state, located in the western part of the Brazilian Amazon, had the highest percentage of deletions for pfhrp2 25 (31.2%) of 79, while among those collected in Rondonia, the prevalence of pfhrp2 gene deletion was only 3.3% (2 out of 60 patients). In isolates from Para state, all parasites were pfhrp2-positive. In contrast, we detected high proportions of isolates from all 3 states that were pfhrp3-negative ranging from 18.3% (11 out of 60 samples) to 50.9% (30 out of 59 samples). In Bolivia, only one of 25 samples (4%) tested had deleted pfhrp2 gene, while 68% (17 out of 25 samples) were pfhrp3-negative. Among the isolates tested, P. falciparum pfhrp2 gene deletions were present mainly in those from Acre State in the Brazilian Amazon. These results indicate it is important to reconsider the use of PfHRP2-based RDTs in the western region of the Brazilian Amazon and to implement appropriate surveillance systems to monitor pfhrp2 gene deletions in this and other parts of the Amazon region.	[Rachid Viana, Giselle Maria; Lima Barbosa, Danielle Regina; Dantas Machado, Ricardo Luiz; Povoa, Marinete Marins] Inst Evandro Chagas IEC SVS MS, Ananindeua, Para, Brazil; [Okoth, Sheila Akinyi; Silva-Flannery, Luciana; de Oliveira, Alexandre Macedo; Goldman, Ira F.; Morton, Lindsay C.; Huber, Curtis; Udhayakumar, Venkatachalam] Ctr Dis Control & Prevent, Malaria Branch, Div Parasit Dis & Malaria, Atlanta, GA 30333 USA; [Okoth, Sheila Akinyi; Silva-Flannery, Luciana] Atlanta Res & Educ Fdn, Decatur, GA USA; [Anez, Arletta] Pan Amer Hlth Org, La Paz, Bolivia; [Aranha Camargo, Luis Marcelo] ICB5 USP, Porto Velho, Rondonia, Brazil; [Aranha Camargo, Luis Marcelo] Fac Sao Lucas, Porto Velho, Rondonia, Brazil; [Negreiros do Valle, Suiane Costa] Secretaria Estadual Saude Acre, Hemonucleo Cruzeiro do Sul, Cruzeiro Do Sul, Acre, Brazil	Instituto Evandro Chagas; Centers for Disease Control & Prevention - USA; Pan American Health Organization	Udhayakumar, V (corresponding author), Ctr Dis Control & Prevent, Malaria Branch, Div Parasit Dis & Malaria, Atlanta, GA 30333 USA.	vxu0@cdc.gov	CAMARGO, LMA/B-4156-2009; Povoa, Marinete Marins/C-7039-2017; Viana, Giselle/ABF-2920-2020; Machado, Ricardo Luiz Dantas Dantas/P-1288-2014; Machado, Ricardo/GXM-8198-2022	CAMARGO, LMA/0000-0001-9486-6195; Povoa, Marinete Marins/0000-0003-3517-2227; Viana, Giselle/0000-0003-1771-7211; Machado, Ricardo Luiz Dantas Dantas/0000-0002-8955-3204; Lima Barbosa, Danielle Regina/0000-0001-5054-2033; Morton, Lindsay/0000-0002-7295-8475; Anez, Arletta/0000-0001-8355-4073	Amazon Malaria Initiative - United States Agency for International Development (USAID); Atlanta Research and Education Foundation; CDC Emerging Infectious Disease Fellowship; Oak Ridge Institute for Science and Education (ORISE)	Amazon Malaria Initiative - United States Agency for International Development (USAID)(United States Agency for International Development (USAID)President's Malaria Initiative (PMI)); Atlanta Research and Education Foundation; CDC Emerging Infectious Disease Fellowship; Oak Ridge Institute for Science and Education (ORISE)	This study was supported by the Amazon Malaria Initiative, which is funded by the United States Agency for International Development (USAID). SAO and LS-F were also supported by the Atlanta Research and Education Foundation. LM was supported by a CDC Emerging Infectious Disease Fellowship administered through the Association of Public Health Laboratories (APHL), and subsequently by a fellowship with the Oak Ridge Institute for Science and Education (ORISE).	Abdallah JF, 2015, MALARIA J, V14, DOI 10.1186/s12936-014-0537-7; Akinyi S, 2013, SCI REP-UK, V3, DOI 10.1038/srep02797; Brazil MoH, 2009, MAN DIAGN LAB MAL; Brazilian Ministry of Health, SIST INF VIG EP MAL; de Oliveira MRF, 2012, MALARIA J, V11, DOI 10.1186/1475-2875-11-390; Desakorn V, 2005, T ROY SOC TROP MED H, V99, P517, DOI 10.1016/j.trstmh.2004.11.014; Gamboa D, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008091; Griffing SM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023486; Ho MF, 2014, MALARIA J, V13, DOI 10.1186/1475-2875-13-480; Houze S, 2011, J CLIN MICROBIOL, V49, P2694, DOI 10.1128/JCM.00281-11; HOWARD RJ, 1986, J CELL BIOL, V103, P1269, DOI 10.1083/jcb.103.4.1269; Koita OA, 2012, AM J TROP MED HYG, V86, P194, DOI 10.4269/ajtmh.2012.10-0665; Lee N, 2012, J CLIN MICROBIOL, V50, P1397, DOI 10.1128/JCM.06533-11; Lee N, 2006, J CLIN MICROBIOL, V44, P2773, DOI 10.1128/JCM.02557-05; Maltha J, 2013, CLIN MICROBIOL INFEC, V19, P408, DOI 10.1111/1469-0691.12152; Manning L, 2011, CLIN INFECT DIS, V52, P440, DOI 10.1093/cid/ciq105; Solano CM, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0131576; Murray CK, 2008, CLIN MICROBIOL REV, V21, P97, DOI 10.1128/CMR.00035-07; Noedl H, 2002, EXP PARASITOL, V102, P157, DOI 10.1016/S0014-4894(03)00051-1; Oliveira-Ferreira J, 2010, MALARIA J, V9, DOI 10.1186/1475-2875-9-115; ROCK EP, 1987, PARASITOLOGY, V95, P209, DOI 10.1017/S0031182000057681; Rubach MP, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035985; Saude Md, 2006, GUIA VIGILANCIA EPID; SCHERF A, 1992, NUCLEIC ACIDS RES, V20, P1491, DOI 10.1093/nar/20.7.1491; Taylor SM, 2013, SCI REP-UK, V3, DOI 10.1038/srep01165; Trouvay M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074269; WELLEMS TE, 1986, P NATL ACAD SCI USA, V83, P6065, DOI 10.1073/pnas.83.16.6065; WHO, 2013, WORLD MALARIA REPORT 2013, P1; Wongsrichanalai C, 2007, AM J TROP MED HYG, V77, P119, DOI 10.4269/ajtmh.2007.77.119; Wurtz N, 2013, MALARIA J, V12, DOI 10.1186/1475-2875-12-34	30	41	41	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 16	2017	12	3							e0171150	10.1371/journal.pone.0171150	http://dx.doi.org/10.1371/journal.pone.0171150			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN9KE	28301474	gold, Green Published, Green Submitted			2022-12-27	WOS:000396318300010
J	Sandhu, HS; Bhanwer, AJS; Puri, S				Sandhu, Harkirat Singh; Bhanwer, A. J. S.; Puri, Sanjeev			Retinoic acid exacerbates chlorpyrifos action in ensuing adipogenic differentiation of C3H10T1/2 cells in a GSK3 beta dependent pathway	PLOS ONE			English	Article							MESENCHYMAL STEM-CELLS; PRENATAL DEXAMETHASONE AUGMENTS; WNT SIGNALING PATHWAY; MARROW STROMAL CELLS; BONE-MINERAL DENSITY; ADIPOSE-TISSUE; DEVELOPMENTAL NEUROTOXICITY; GENE-EXPRESSION; PRETERM LABOR; FATTY-ACIDS	The cell differentiation can be exploited as a paradigm to evaluate the effects of noxious chemicals, on human health, either alone or in combinations. In this regard, the effect of a known cell differentiation agent, retinoic acid (RA) was analyzed in the presence of a noxious chemical chlorpyrifos (CPF), an organophosphate (OP), the receptors of which have recently been localized to mesenchymal stem cells (MSCs). The observed imbalance of adipogenic to skeletal differentiation by CPF together with conundrum about adipogenic potential of RA prompted us to delineate their combinatorial effects on C(3)H(10)T1/2MSC-like undifferentiated cells. Based on MTT assay, the cellular viability was retained by CPF at concentrations ranging from 0.01-50 mu M, beyond which it caused cytotoxicity. These nontoxic concentrations also mildly interfered with adipogenesis of C(3)H(10)T1/2 cells following exposure to adipogenic cocktail. However, upon exposure to RA alone, these MSCs adopted elongated morphology and accumulated lipid vesicles, by day 20, as discerned by phase-contrast and transmission electron microscopy (TEM), in concert with enhanced Oil Red O stained cells. This effect got strongly augmented upon exposure to combination of CPF and RA in a dose-dependent manner. Simultaneous up-regulation in perilipin-1 (PLIN1) and adipsin (ADN) genes, additionally reiterated the adipogenic differentiation. Mechanistically, GSK3 beta pathway was found to be a major player, whereby inhibiting it with lithium chloride (LiCl) resulted in complete blockage of lipid accumulation, accompanied by complete down regulation of PLIN1 and ADN gene expression. In conclusion, these observations for the first time, lend evidence that exposure of CPF accompanied by RA directs commitment of C(3)H(10)T1/2 cells to adipogenic differentiation through a process involving a crosstalk at GSK3 beta signaling.	[Sandhu, Harkirat Singh; Bhanwer, A. J. S.] Guru Nanak Dev Univ, Dept Human Genet, Amritsar, Punjab, India; [Sandhu, Harkirat Singh; Puri, Sanjeev] Panjab Univ, Ctr Stem Cell Tissue Engn & Biomed Excellence, Chandigarh, India; [Puri, Sanjeev] Panjab Univ, Univ Inst Engn & Technol, Biotechnol Branch, Chandigarh, India	Guru Nanak Dev University; Panjab University; Panjab University	Puri, S (corresponding author), Panjab Univ, Ctr Stem Cell Tissue Engn & Biomed Excellence, Chandigarh, India.	spuri_1111@yahoo.com		Puri, Sanjeev/0000-0002-3967-987X; Puri, Sanjeev/0000-0002-4314-9871; Bhanwer, AJS/0000-0001-5181-9268	PURSE Grant (DST, New Delhi); Maulana Azad National Fellowship	PURSE Grant (DST, New Delhi); Maulana Azad National Fellowship	PURSE Grant (DST, New Delhi) to Centre for Stem Cell Tissue Engineering and Biomedical Excellence and Maulana Azad National Fellowship for Minority Students to H.S.S. at Department of Human Genetics, GNDU, Amritsar, are thankfully acknowledged.	Anjali Choudhary, 2014, Asian Journal of Biomedical and Pharmaceutical Sciences, V4, P30; [Anonymous], 1999, NUTR REV, V57, P192; Arana Miriam, 2013, Methods Mol Biol, V1036, P47, DOI 10.1007/978-1-62703-511-8_4; Astudillo P, 2008, J CELL BIOCHEM, V103, P1054, DOI 10.1002/jcb.21516; Augello A, 2010, HUM GENE THER, V21, P1226, DOI 10.1089/hum.2010.173; Bennett CN, 2002, J BIOL CHEM, V277, P30998, DOI 10.1074/jbc.M204527200; BERESFORD JN, 1992, J CELL SCI, V102, P341; Binkley N, 2000, NUTR REV, V58, P138, DOI 10.1111/j.1753-4887.2000.tb01848.x; Bost F, 2002, BIOCHEM J, V361, P621, DOI 10.1042/0264-6021:3610621; Brasaemle DL, 2007, J LIPID RES, V48, P2547, DOI 10.1194/jlr.R700014-JLR200; CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1016/0003-2697(87)90021-2; Christensen K., 2009, CHLORPYRIFOS TECHNIC; Compston JE, 1999, LANCET, V354, P1791, DOI 10.1016/S0140-6736(99)04466-9; COOK KS, 1987, SCIENCE, V237, P402, DOI 10.1126/science.3299705; Culbreth ME, 2012, NEUROTOXICOLOGY, V33, P1499, DOI 10.1016/j.neuro.2012.05.012; Dani C, 1997, J CELL SCI, V110, P1279; Eaton DL, 2008, CRIT REV TOXICOL, V38, P1, DOI 10.1080/10408440802272158 ; Eimar H, 2013, J MUSCULOSKEL NEURON, V13, P124; Farmer SR, 2006, CELL METAB, V4, P263, DOI 10.1016/j.cmet.2006.07.001; FUKUTO TR, 1990, ENVIRON HEALTH PERSP, V87, P245, DOI 10.2307/3431032; Galli C, 2013, CLIN ORAL IMPLAN RES, V24, P921, DOI 10.1111/j.1600-0501.2012.02488.x; Garcia-Rojas P, 2010, J ANIM SCI, V88, P1801, DOI 10.2527/jas.2009-2579; Genever PG, 1999, BONE, V24, P297, DOI 10.1016/S8756-3282(98)00187-2; Gupta RC, TOXICOLOGY ORGANOPHO, P1; Henning P, 2015, FRONT ENDOCRINOL, V6, DOI 10.3389/fendo.2015.00031; Hoogduijn MJ, 2006, TOXICOL SCI, V94, P342, DOI 10.1093/toxsci/kfl101; Hoogduijn MJ, 2009, STEM CELLS DEV, V18, P103, DOI 10.1089/scd.2008.0032; Hoshiba T, 2012, BIOMATERIALS, V33, P2025, DOI 10.1016/j.biomaterials.2011.11.061; Inkson CA, 2004, BONE, V35, P819, DOI 10.1016/j.bone.2004.05.026; Jacobson A, 2004, BIOCHEM BIOPH RES CO, V322, P162, DOI 10.1016/j.bbrc.2004.07.092; James AW, 2013, SCIENTIFICA, V2013, DOI 10.1155/2013/684736; Janderova L, 2003, OBES RES, V11, P65, DOI 10.1038/oby.2003.11; Kapka-Skrzypczak L, 2011, ANN AGR ENV MED, V18, P294; Karami-Mohajeri S, 2011, HUM EXP TOXICOL, V30, P1119, DOI 10.1177/0960327110388959; Kaur M., 2014, INT J SCI ENV TECHNO, V3, P473; Kim DM, 2013, BIOCHEM BIOPH RES CO, V434, P455, DOI 10.1016/j.bbrc.2013.03.095; Kojima T, 2013, BIOSCI BIOTECH BIOCH, V77, P1035, DOI 10.1271/bbb.121017; Levin ED, 2014, NEUROTOXICOL TERATOL, V41, P35, DOI 10.1016/j.ntt.2013.10.004; Liu HY, 2011, BIOMATERIALS, V32, P6773, DOI 10.1016/j.biomaterials.2011.05.080; MacIntosh DL, 2001, ENVIRON HEALTH PERSP, V109, P145, DOI 10.2307/3434767; Marasinghe J, 2014, TOXICS, V2, P92, DOI 10.3390/toxics2020092; Pino AM, 2012, BIOL RES, V45, P279, DOI 10.4067/S0716-97602012000300009; Mathur HB, CSE PML PR 21 2005; McGown C, 2014, CLIN LIVER DIS, V18, P41, DOI 10.1016/j.cld.2013.09.012; Meggs WJ, 2007, J MED TOXICOL, V3, P89, DOI 10.1007/BF03160916; Melhus H, 1998, ANN INTERN MED, V129, P770, DOI 10.7326/0003-4819-129-10-199811150-00003; Metcalfe C, 2011, J CELL SCI, V124, P3537, DOI 10.1242/jcs.091991; Morikawa K, 2013, CELL BIOL INT, V37, P36, DOI 10.1002/cbin.10005; MOUSTAID N, 1990, J CELL BIOCHEM, V42, P243, DOI 10.1002/jcb.240420407; Noble W, 2005, P NATL ACAD SCI USA, V102, P6990, DOI 10.1073/pnas.0500466102; Osei-Sarfo K, 2014, STEM CELLS, V32, P2061, DOI 10.1002/stem.1706; Pamies D, 2014, INT J MOL SCI, V15, P905, DOI 10.3390/ijms15010905; Pei LM, 2004, J CLIN INVEST, V113, P805, DOI 10.1172/JCI200421311; Pittenger MF, 1999, SCIENCE, V284, P143, DOI 10.1126/science.284.5411.143; Prockop DJ, 1997, SCIENCE, V276, P71, DOI 10.1126/science.276.5309.71; Qiao D, 2003, DEV BRAIN RES, V147, P183, DOI 10.1016/S0165-3806(03)00222-0; RACKE KD, 1993, REV ENVIRON CONTAM T, V131, P1; RAMIREZZACARIAS JL, 1992, HISTOCHEMISTRY, V97, P493, DOI 10.1007/BF00316069; Rinker TE, 2014, INTEGR BIOL-UK, V6, P324, DOI [10.1039/c3ib40194d, 10.1039/c3b40194d]; ROMERO P, 1989, ENVIRON RES, V50, P256, DOI 10.1016/S0013-9351(89)80006-4; SAFONOVA I, 1994, BIOCHEM BIOPH RES CO, V204, P498, DOI 10.1006/bbrc.1994.2487; Saunders M, 2012, ENVIRON HEALTH-GLOB, V11, DOI 10.1186/1476-069X-11-S1-S5; Slotkin TA, 2013, NEUROTOXICOL TERATOL, V37, P1, DOI [10.1016/j.ntt.2013.02.002, 10.1016/j.ntt2013.02.002]; Slotkin TA, 2012, NEUROTOXICOL TERATOL, V34, P505, DOI 10.1016/j.ntt.2012.07.002; Solomon KR, 2014, REV ENVIRON CONTAM T, V231, P13, DOI 10.1007/978-3-319-03865-0_2; Takahashi Y, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064605; Tsimbiri PF., 2015, ODEM, V3, P24, DOI [10.4236/odem.2015.32004, DOI 10.4236/ODEM.2015.32004]; United States Environmental Protection Agency, 2011, CHLORP PREL HUM HLTH; Wang AX, 2008, BIOCHEM BIOPH RES CO, V375, P435, DOI 10.1016/j.bbrc.2008.08.036; Wang YJ, 2014, ENVIRON TOXICOL CHEM, V33, P431, DOI 10.1002/etc.2453; Wu B., 1996, Yaoxue Xuebao, V31, P241; YOUNG HE, 1995, DEV DYNAM, V202, P137, DOI 10.1002/aja.1002020205; Zamani A, 2009, BONE, V44, P331, DOI 10.1016/j.bone.2008.10.001; Zaragosi LE, 2008, BMC CELL BIOL, V9, DOI 10.1186/1471-2121-9-11	74	5	6	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 14	2017	12	3							e0173031	10.1371/journal.pone.0173031	http://dx.doi.org/10.1371/journal.pone.0173031			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN6DM	28291828	Green Published, Green Submitted, gold			2022-12-27	WOS:000396094700009
J	Chang, WT; Liu, YW; Liu, PY; Hsu, CH; Tsai, WC				Chang, Wei-Ting; Liu, Yen-Wen; Liu, Ping-Yen; Hsu, Chih-Hsin; Tsai, Wei-Chuan			The association between right ventricular free wall strain and exercise capacity for health check-up subjects	PLOS ONE			English	Article							FUNCTIONAL-CAPACITY; DIASTOLIC FUNCTION; PARAMETERS; DISEASE; GENDER; RISK	Background Right ventricular ( RV) function has been found to be a major factor of exercise capacity in patients with heart failure. However, the role of RV function in exercise capacity in healthy subjects has not been well studied. This study aims to validate the role of RV strain derived from speckle tracking echocardiography for exercise capacity for health check-up subjects. Methods This study prospectively recruited subjects from a routine health examination. All of them were symptom free. RV function represented by RV strain was derived from speckle tracking echocardiography in addition to traditional echocardiography parameters. Functional capacity was determined by a symptom limited treadmill exercise test with the Bruce protocol. Results Among 164 recruited subjects (age 52.2-9.2 years, 66.4% male), 32 subjects represented impaired functional capacity (MET< 8), which was significantly correlated with age, left ventricular mass index, left ventricular filling pressure (E/e'), global longitudinal strain of the left ventricle (LVGLS) (-16.0-2.5% vs. -18.9-3.8%, p < 0.001) and RV free wall strain (RVLS_FW) (-17.0-4.9% vs. -21.9-3.2%, p < 0.001). After multivariate logistic regression, RVS_FW was an independent predictor for impaired functional capacity (OR 1.62, CI 1.32-1.98; p < 0.001). Conclusions In conclusion, RV strain is independently associated with exercise capacity for health check-up subjects. RV function is an important factor for functional capacity.	[Chang, Wei-Ting] Chi Mei Med Ctr, Dept Internal Med, Div Cardiol, Tainan, Taiwan; [Chang, Wei-Ting; Liu, Yen-Wen; Liu, Ping-Yen; Tsai, Wei-Chuan] Natl Cheng Kung Univ Hosp, Div Cardiol, Tainan, Taiwan; [Chang, Wei-Ting] Southern Taiwan Univ Sci & Technol, Dept Biotechnol, Tainan, Taiwan; [Hsu, Chih-Hsin] Cheng Kung Univ Hosp, Dept Internal Med, Tainan, Taiwan	Chi Mei Hospital; National Cheng Kung University; National Cheng Kung University Hospital; Southern Taiwan University of Science & Technology	Chang, WT (corresponding author), Chi Mei Med Ctr, Dept Internal Med, Div Cardiol, Tainan, Taiwan.; Chang, WT (corresponding author), Natl Cheng Kung Univ Hosp, Div Cardiol, Tainan, Taiwan.; Chang, WT (corresponding author), Southern Taiwan Univ Sci & Technol, Dept Biotechnol, Tainan, Taiwan.	wctsai@seed.net.tw			Chi-Mei Medical Center; National Cheng Kung University, Taiwan	Chi-Mei Medical Center; National Cheng Kung University, Taiwan	This work was supported by the collaborative grant of Chi-Mei Medical Center and National Cheng Kung University, Taiwan.	Castro ML, 2013, INT J CARDIOL, V168, P2927, DOI 10.1016/j.ijcard.2013.03.181; Chia EM, 2015, J AM SOC ECHOCARDIOG, V28, P1441, DOI 10.1016/j.echo.2015.08.006; Chia EM, 2014, J AM SOC ECHOCARDIOG, V27, P1079, DOI 10.1016/j.echo.2014.06.007; DEBAKKER JMT, 1988, CIRCULATION, V77, P589, DOI 10.1161/01.CIR.77.3.589; Dulgheru R, 2016, EUR HEART J-CARD IMG, V17, P217, DOI 10.1093/ehjci/jev147; Fletcher GF, 2013, CIRCULATION, V128, P873, DOI 10.1161/CIR.0b013e31829b5b44; Friedberg MK, 2013, AM HEART J, V165, P551, DOI 10.1016/j.ahj.2012.06.029; Gokdeniz T, 2014, RESPIRATION, V88, P223, DOI 10.1159/000365222; Guendouz S, 2012, CIRC J, V76, P127, DOI 10.1253/circj.CJ-11-0778; Gulati M, 2003, CIRCULATION, V108, P1554, DOI 10.1161/01.CIR.0000091080.57509.E9; Hasselberg NE, 2015, EUR HEART J-CARD IMG, V16, P217, DOI 10.1093/ehjci/jeu277; Iacoviello M, 2011, EUR J ECHOCARDIOGR, V12, P773, DOI 10.1093/ejechocard/jer139; JETTE M, 1990, CLIN CARDIOL, V13, P555, DOI 10.1002/clc.4960130809; Lang RM, 2015, J AM SOC ECHOCARDIOG, V28, P1, DOI 10.1016/j.echo.2014.10.003; Lindqvist P, 2005, ECHOCARDIOGR-J CARD, V22, P305, DOI 10.1111/j.1540-8175.2005.04023.x; Lund O, 1997, EUR HEART J, V18, P1977; Myers J, 2002, NEW ENGL J MED, V346, P793, DOI 10.1056/NEJMoa011858; Noordegraaf AV, 2011, EUR RESPIR REV, V20, P243, DOI 10.1183/09059180.00006511; Park Jae-Hyeong, 2015, J Cardiovasc Ultrasound, V23, P91, DOI 10.4250/jcu.2015.23.2.91; Petersen JW, 2013, CARDIOVASC ULTRASOUN, V11, DOI 10.1186/1476-7120-11-20; Quintana Miguel, 2005, Cardiovasc Ultrasound, V3, P4, DOI 10.1186/1476-7120-3-4; Shah SJ, 2009, CIRC-HEART FAIL, V2, P278, DOI 10.1161/CIRCHEARTFAILURE.108.807826; Simsek Z, 2013, INT J CARDIOVAS IMAG, V29, P1265, DOI 10.1007/s10554-013-0204-z; Smiseth OA, 2016, EUR HEART J, V37, P1196, DOI 10.1093/eurheartj/ehv529; Stefani L, 2009, CARDIOVASC ULTRASOUN, V7, DOI 10.1186/1476-7120-7-17; SZLACHCIC J, 1985, AM J CARDIOL, V55, P1037, DOI 10.1016/0002-9149(85)90742-8; Tsai WC, 2010, J AM SOC ECHOCARDIOG, V23, P1183, DOI 10.1016/j.echo.2010.08.011; Van De Bruaene A, 2011, EUR J ECHOCARDIOGR, V12, P206, DOI 10.1093/ejechocard/jeq169; Voelkel NF, 2006, CIRCULATION, V114, P1883, DOI 10.1161/CIRCULATIONAHA.106.632208; Walker LA, 2013, CURR CARDIOL REV, V9, P73, DOI 10.2174/1573403X11309010009	30	2	2	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 13	2017	12	3							e0173307	10.1371/journal.pone.0173307	http://dx.doi.org/10.1371/journal.pone.0173307			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN6CP	28288177	gold, Green Submitted, Green Published			2022-12-27	WOS:000396092400012
J	Castano, AG; de Nanclares, GP; Madariaga, L; Aguirre, M; Madrid, A; Chocron, S; Nadal, I; Navarro, M; Lucas, E; Fijo, J; Espino, M; Espitaletta, Z; Nieto, VG; de Frutos, DB; Loza, R; Pintos, G; Castano, L; Ariceta, G				Garcia Castano, Alejandro; Perez de Nanclares, Gustavo; Madariaga, Leire; Aguirre, Mireia; Madrid, Alvaro; Chocron, Sara; Nadal, Inmaculada; Navarro, Mercedes; Lucas, Elena; Fijo, Julia; Espino, Mar; Espitaletta, Zilac; Garcia Nieto, Victor; Barajas de Frutos, David; Loza, Reyner; Pintos, Guillem; Castano, Luis; Ariceta, Gema		RenalTube Grp	Poor phenotype-genotype association in a large series of patients with Type III Bartter syndrome	PLOS ONE			English	Article							CHLORIDE CHANNEL GENE; SALT-LOSING TUBULOPATHIES; MOLECULAR ANALYSIS; CLCNKB; MUTATIONS; NEPHROCALCINOSIS; GITELMAN	Introduction Type III Bartter syndrome (BS) is an autosomal recessive renal tubule disorder caused by loss-of-function mutations in the CLCNKB gene, which encodes the chloride channel protein ClC-Kb. In this study, we carried out a complete clinical and genetic characterization in a cohort of 30 patients, one of the largest series described. By comparing with other published populations, and considering that 80% of our patients presented the p. Ala204Thr Spanish founder mutation presumably associated with a common phenotype, we aimed to test the hypothesis that allelic differences could explain the wide phenotypic variability observed in patients with type III BS. Methods Clinical data were retrieved from the referral centers. The exon regions and flanking intronic sequences of the CLCNKB gene were screened for mutations by polymerase chain reaction (PCR) followed by direct Sanger sequencing. Presence of gross deletions or duplications in the region was checked for by MLPA and QMPSF analyses. Results Polyuria, polydipsia and dehydration were the main common symptoms. Metabolic alkalosis and hypokalemia of renal origin were detected in all patients at diagnosis. Calciuria levels were variable: hypercalciuria was detected in 31% of patients, while 23% had hypocalciuria. Nephrocalcinosis was diagnosed in 20% of the cohort. Two novel CLCNKB mutations were identified: a small homozygous deletion (c.753delG) in one patient and a small deletion (c.1026delC) in another. The latter was present in compound heterozygosis with the already previously described p.Glu442Gly mutation. No phenotypic association was obtained regarding the genotype. Conclusion A poor correlation was found between a specific type of mutation in the CLCNKB gene and type III BS phenotype. Importantly, two CLCNKB mutations not previously described were found in our cohort.	[Garcia Castano, Alejandro; Perez de Nanclares, Gustavo; Castano, Luis] Cruces Univ Hosp, Ciberer, BioCruces Hlth Res Inst, Bizkaia, Spain; [Madariaga, Leire; Aguirre, Mireia] Cruces Univ Hosp, Pediat Nephrol, Bizkaia, Spain; [Madariaga, Leire; Castano, Luis] Univ Basque Country, UPV EHU, Dept Pediat, Sch Med & Odontol, Bizkaia, Spain; [Madrid, Alvaro; Chocron, Sara; Ariceta, Gema] Univ Autonoma Barcelona, Vall dHebron Univ Hosp, Pediat Nephrol, Barcelona, Spain; [Nadal, Inmaculada] Virgen del Camino Hosp, Pediat Nephrol, Pamplona, Spain; [Navarro, Mercedes] La Paz Univ Hosp, Pediat Nephrol, Madrid, Spain; [Lucas, Elena] Manises Hosp, Pediat, Valencia, Spain; [Fijo, Julia] Virgen del Rocio Hosp, Pediat Nephrol, Seville, Spain; [Espino, Mar] Fdn Alcorcon Univ Hosp, Pediat Nephrol, Madrid, Spain; [Espitaletta, Zilac] San Ignacio Univ Hosp, Bogota, Colombia; [Garcia Nieto, Victor] Nuestra Senora de Candelaria Univ Hosp, Pediat Nephrol, Tenerife, Canarias, Spain; [Barajas de Frutos, David] Virgen de las Nieves Hosp, Pediat Nephrol, Granada, Spain; [Loza, Reyner] Cayetano Heredia Univ, Cayetano Heredia Hosp, Nephrol Unit, Lima, Peru; [Pintos, Guillem] Germans Trias & Pujol Univ Hosp, Badalona, Spain; [Castano, Luis] Inst Salud Carlos III, Ctr Invest Biomed Red Diabet & Enfermedades Metab, Madrid, Spain; [RenalTube Grp] Asturias Cent Univ Hosp, Pediat Nephrol, Oviedo, Asturias, Spain	CIBER - Centro de Investigacion Biomedica en Red; CIBERER; Hospital Universitario Cruces; Hospital Universitario Cruces; University of Basque Country; Autonomous University of Barcelona; Hospital Universitari Vall d'Hebron; Servicio Navarro de Salud - Osasunbidea; Hospital Universitario La Paz; Virgen del Rocio University Hospital; Alcorcon Foundation University Hospital; Hospital Universitario San Ignacio; Hospital Universitario Virgen de las Nieves; Universidad Peruana Cayetano Heredia; CIBER - Centro de Investigacion Biomedica en Red; CIBERDEM; Instituto de Salud Carlos III; Central University Hospital Asturias	Ariceta, G (corresponding author), Univ Autonoma Barcelona, Vall dHebron Univ Hosp, Pediat Nephrol, Barcelona, Spain.	gariceta@vhebron.net	alvarez, victoria/GXV-1088-2022; Madariaga, Leire/B-5220-2019; García, Alejandro/AAA-6023-2020; alvarez, victoria/ABC-7891-2021; Blanco, Leire/O-5114-2017	alvarez, victoria/0000-0002-1916-2523; Madariaga, Leire/0000-0002-4032-9842; alvarez, victoria/0000-0002-1916-2523; ESPITALETA, ZILAC/0000-0003-4710-386X; Castano, Luis/0000-0003-0437-9401; Madrid, Alvaro/0000-0002-5942-8488; Perez de Nanclares, Gustavo/0000-0002-1692-8976; Loza, Reyner/0000-0003-1769-9527	FIS of the Institute de Salud Carlos III, Madrid, Spain [PI09/90888, PI11/01412]; Department of Health of the Basque Government [2014111064]; Department of Education of the Basque Government [IT795-13]	FIS of the Institute de Salud Carlos III, Madrid, Spain; Department of Health of the Basque Government; Department of Education of the Basque Government	This study was supported by two grants (PI09/90888 and PI11/01412) from the FIS of the Institute de Salud Carlos III, Madrid, Spain, the Department of Health of the Basque Government (2014111064), and the Department of Education of the Basque Government (IT795-13).	BARTTER FC, 1962, AM J MED, V33, P811, DOI 10.1016/0002-9343(62)90214-0; Bettinelli A, 2000, PEDIATR NEPHROL, V14, P940, DOI 10.1007/PL00013418; Bettinelli A, 2007, AM J KIDNEY DIS, V49, P91, DOI 10.1053/j.ajkd.2006.10.001; Bilbao JR, 2005, PEDIATR NEPHROL, V20, P891; Brochard K, 2009, NEPHROL DIAL TRANSPL, V24, P1455, DOI 10.1093/ndt/gfn689; Colussi G, 2002, NEPHROL DIAL TRANSPL, V17, P521, DOI 10.1093/ndt/17.3.521; Ellison DH, 2000, AM J PHYSIOL-RENAL, V279, pF616, DOI 10.1152/ajprenal.2000.279.4.F616; Castano AG, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074673; Gorgojo JJ, 2006, HORM RES, V65, P62, DOI 10.1159/000090601; Jeck N, 2000, PEDIATR RES, V48, P754, DOI 10.1203/00006450-200012000-00009; Konrad M, 2000, J AM SOC NEPHROL, V11, P1449, DOI 10.1681/ASN.V1181449; Lee BH, 2012, NEPHROL DIAL TRANSPL, V27, P1516, DOI 10.1093/ndt/gfr475; Nozu K, 2007, PEDIATR RES, V62, P364, DOI 10.1203/PDR.0b013e318123fb90; Nozu K, 2010, J CLIN ENDOCR METAB, V95, pE511, DOI 10.1210/jc.2010-0392; OHLSSON A, 1984, ACTA PAEDIATR SCAND, V73, P868, DOI 10.1111/j.1651-2227.1984.tb17793.x; Peters M, 2002, AM J MED, V112, P183, DOI 10.1016/S0002-9343(01)01086-5; SaitoOhara F, 1996, GENOMICS, V36, P372, DOI 10.1006/geno.1996.0479; Schurman SJ, 2001, J PEDIATR-US, V139, P105, DOI 10.1067/mpd.2001.115020; Simon DB, 1997, NAT GENET, V17, P171, DOI 10.1038/ng1097-171; Tajima T, 2006, ENDOCR J, V53, P647, DOI 10.1507/endocrj.K06-034; TAKEUCHI Y, 1995, KIDNEY INT, V48, P1497, DOI 10.1038/ki.1995.439; Watanabe T, 2005, PEDIATR NEPHROL, V20, P676, DOI 10.1007/s00467-004-1732-5; Zelikovic I, 2003, NEPHROL DIAL TRANSPL, V18, P1696, DOI 10.1093/ndt/gfg249; Zelikovic I, 2003, KIDNEY INT, V63, P24, DOI 10.1046/j.1523-1755.2003.00730.x	24	18	18	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 13	2017	12	3							e0173581	10.1371/journal.pone.0173581	http://dx.doi.org/10.1371/journal.pone.0173581			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN6CP	28288174	Green Published, Green Submitted, gold			2022-12-27	WOS:000396092400019
J	Shen, W; Liang, XH; Sun, H; De Hoyos, CL; Crooke, ST				Shen, Wen; Liang, Xue-hai; Sun, Hong; De Hoyos, Cheryl L.; Crooke, Stanley T.			Depletion of NEAT1 lncRNA attenuates nucleolar stress by releasing sequestered P54nrb and PSF to facilitate c-Myc translation	PLOS ONE			English	Article							RNA-POLYMERASE-I; NONCODING RNA; PHOSPHOROTHIOATE OLIGONUCLEOTIDES; NUCLEAR-BODIES; MESSENGER-RNAS; CELLS; TRANSCRIPTION; PARASPECKLES; EXPRESSION; PROTEINS	Altered expression of NEAT1, the architectural long non-coding RNA (lncRNA) of nuclear paraspeckles, has been reported during tumorigenesis, as well as under various cellular stress conditions. Here we report that the depletion of NEAT1 lncRNA alleviates nucleolar stress during RNAP I inhibition through releasing sequestered P54nrb and PSF to facilitate the IRES-dependent translation of c-Myc. RNAP I inhibitor CX5461 disrupts the SL1-rDNA interaction and induces nucleolar disruption, demonstrated by the accumulation of fibrillarin-containing nucleoplasmic foci and nucleolar clearance of ribosomal proteins in HeLa cells. Antisense oligonucleotide-mediated depletion of NEAT1 lncRNA significantly attenuated the RNAP I inhibition and its related nucleolar disruption. Interestingly, induction in the levels of c-Myc protein was observed in NEAT1-depeleted cells under RNAP I inhibition. NEAT1associated paraspeckle proteins P54nrb and PSF have been reported as positive regulators of c-Myc translation through interaction with c-Myc IRES. Indeed, an increased association of P54nrb and PSF with c-Myc mRNA was observed in NEAT1-depleted cells. Moreover, apoptosis was observed in HeLa cells depleted of P54nrb and PSF, further confirming the positive involvement of P54nrb and PSF in cell proliferation. Together, our results suggest that NEAT1 depletion rescues CX5461-induced nucleolar stress through facilitating c-Myc translation by relocating P54nrb/PSF from nuclear paraspeckles to c-Myc mRNAs.	[Shen, Wen; Liang, Xue-hai; Sun, Hong; De Hoyos, Cheryl L.; Crooke, Stanley T.] IONIS Pharmaceut Inc, Dept Core Antisense Res, 2855 Gazelle Court, Carlsbad, CA 92010 USA	Ionis Pharmaceuticals, Inc.	Liang, XH (corresponding author), IONIS Pharmaceut Inc, Dept Core Antisense Res, 2855 Gazelle Court, Carlsbad, CA 92010 USA.	Lliang@ionisph.com			Ionis Pharmaceuticals, Inc.	Ionis Pharmaceuticals, Inc.	The work is supported by the internal research funding from Ionis Pharmaceuticals, Inc. The funder provided support in the form of salaries for authors WS, XL, HS, CLD, and STC, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Blume CJ, 2015, LEUKEMIA, V29, P2015, DOI 10.1038/leu.2015.119; Bywater MJ, 2012, CANCER CELL, V22, P51, DOI 10.1016/j.ccr.2012.05.019; Chakravarty D, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6383; Chen LL, 2009, MOL CELL, V35, P467, DOI 10.1016/j.molcel.2009.06.027; Chen M, 2004, ACTA PHARMACOL SIN, V25, P902; Cobbold LC, 2008, MOL CELL BIOL, V28, P40, DOI 10.1128/MCB.01298-07; Drygin D, 2011, CANCER RES, V71, P1418, DOI 10.1158/0008-5472.CAN-10-1728; Grandori C, 2005, NAT CELL BIOL, V7, P311, DOI 10.1038/ncb1224; Heyd F, 2011, BIOCHEM BIOPH RES CO, V414, P743, DOI 10.1016/j.bbrc.2011.09.149; Imamura K, 2014, MOL CELL, V53, P393, DOI 10.1016/j.molcel.2014.01.009; Li L, 2009, P NATL ACAD SCI USA, V106, P12956, DOI 10.1073/pnas.0906005106; Li SY, 2014, NUCLEIC ACIDS RES, V42, P9771, DOI 10.1093/nar/gku650; Liang XH, 2016, NAT BIOTECHNOL, V34, P875, DOI 10.1038/nbt.3589; Liang XH, 2014, NUCLEIC ACIDS RES, V42, P7819, DOI 10.1093/nar/gku484; Lowery LA, 2007, DEV DYNAM, V236, P1347, DOI 10.1002/dvdy.21132; Mircsof D, 2015, NAT NEUROSCI, V18, P1731, DOI 10.1038/nn.4169; Mullineux ST, 2012, BIOCHIMIE, V94, P1521, DOI 10.1016/j.biochi.2012.02.001; Naganuma T, 2012, EMBO J, V31, P4020, DOI 10.1038/emboj.2012.251; Nakagawa S, 2011, J CELL BIOL, V193, P31, DOI 10.1083/jcb.201011110; Poortinga G, 2004, EMBO J, V23, P3325, DOI 10.1038/sj.emboj.7600335; Schiffnery S, 2011, CARCINOGENESIS, V32, P1176, DOI 10.1093/carcin/bgr103; Shav-Tal Y, 2002, FEBS LETT, V531, P109, DOI 10.1016/S0014-5793(02)03447-6; Shelkovnikova TA, 2014, HUM MOL GENET, V23, P2298, DOI 10.1093/hmg/ddt622; Shen W, 2015, NUCLEIC ACIDS RES, V43, P4569, DOI 10.1093/nar/gkv298; Shen W, 2014, NUCLEIC ACIDS RES, V42, P8648, DOI 10.1093/nar/gku579; Stoneley M, 2000, NUCLEIC ACIDS RES, V28, P687, DOI 10.1093/nar/28.3.687; Tafforeau L, 2013, MOL CELL, V51, P539, DOI 10.1016/j.molcel.2013.08.011; Xu J, 2005, HUM MOL GENET, V14, P1231, DOI 10.1093/hmg/ddi134; Zhang L, 2015, CELL DEATH DIS, V6, DOI 10.1038/cddis.2015.139; Zhu Z, 2015, ONCOGENE	30	15	16	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 13	2017	12	3							e0173494	10.1371/journal.pone.0173494	http://dx.doi.org/10.1371/journal.pone.0173494			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN6CP	28288210	Green Submitted, gold, Green Published			2022-12-27	WOS:000396092400016
J	Wang, SD; Sung, KJ; Lin, XXNN; Burns, MA				Wang, Sida; Sung, Ki-Joo; Lin, Xiaoxia Nina; Burns, Mark A.			Bead mediated separation of microparticles in droplets	PLOS ONE			English	Article							STREPTAVIDIN-BIOTIN INTERACTION; DNA COPY NUMBER; INTERFACE; BIOSENSOR; SYSTEM; GROWTH; ARRAYS	Exchange of components such as particles and cells in droplets is important and highly desired in droplet microfluidic assays, and many current technologies use electrical or magnetic fields to accomplish this process. Bead-based microfluidic techniques offer an alternative approach that uses the bead's solid surface to immobilize targets like particles or biological material. In this paper, we demonstrate a bead-based technique for exchanging droplet content by separating fluorescent microparticles in a microfluidic device. The device uses posts to filter surface-functionalized beads from a droplet and re-capture the filtered beads in a new droplet. With post spacing of 7 mu m, beads above 10 mu m had 100% capture efficiency. We demonstrate the efficacy of this system using targeted particles that bind onto the functionalized beads and are, therefore, transferred from one solution to another in the device. Binding capacity tests performed in the bulk phase showed an average binding capacity of 5 particles to each bead. The microfluidic device successfully separated the targeted particles from the non-targeted particles with up to 98% purity and 100% yield.	[Wang, Sida; Lin, Xiaoxia Nina; Burns, Mark A.] Univ Michigan, Dept Chem Engn, Ann Arbor, MI 48109 USA; [Sung, Ki-Joo] MIT, Dept Chem Engn, Cambridge, MA 02139 USA; [Lin, Xiaoxia Nina; Burns, Mark A.] Univ Michigan, Dept Biomed Engn, Ann Arbor, MI 48109 USA	University of Michigan System; University of Michigan; Massachusetts Institute of Technology (MIT); University of Michigan System; University of Michigan	Burns, MA (corresponding author), Univ Michigan, Dept Chem Engn, Ann Arbor, MI 48109 USA.; Burns, MA (corresponding author), Univ Michigan, Dept Biomed Engn, Ann Arbor, MI 48109 USA.	maburns@umich.edu			 [T32GM008353 1-R21-HG-005077-01-A1 3-R21-HG-005007-02-S1]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM008353] Funding Source: NIH RePORTER	; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by T32GM008353 1-R21-HG-005077-01-A1 3-R21-HG-005007-02-S1 https://www.nih.gov/. T.C. Chang Professorship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abate AR, 2010, P NATL ACAD SCI; Ali MF, 2003, ANAL CHEM, V75, P4732, DOI 10.1021/ac034106z; Baret JC, 2012, LAB CHIP, V12, P422, DOI 10.1039/c1lc20582j; Brosseau Q, 2014, SOFT MATTER, V10, P3066, DOI 10.1039/c3sm52543k; Brouzes E, 2015, LAB CHIP, V15, P908, DOI 10.1039/c4lc01327a; Brouzes E, 2009, P NATL ACAD SCI USA, V106, P14195, DOI 10.1073/pnas.0903542106; Cho SK, 2007, LAB CHIP, V7, P490, DOI 10.1039/b615665g; Choi JW, 2002, LAB CHIP, V2, P27, DOI 10.1039/b107540n; Dewan A, 2012, BIOTECHNOL BIOENG, V109, P2987, DOI 10.1002/bit.24568; Ding ZL, 2001, NATURE, V411, P59, DOI 10.1038/35075028; Fornell A, 2015, ANAL CHEM, V87, P10521, DOI 10.1021/acs.analchem.5b02746; Guo MT, 2012, LAB CHIP, V12, P2146, DOI 10.1039/c2lc21147e; Hein M, 2015, LAB CHIP, V15, P2879, DOI 10.1039/c5lc00420a; Hindson BJ, 2011, ANAL CHEM, V83, P8604, DOI 10.1021/ac202028g; Jung JH, 2016, LAB CHIP, V16, P3235, DOI 10.1039/c6lc00648e; Kim JA, 2015, BIOSENS BIOELECTRON, V67, P724, DOI 10.1016/j.bios.2014.10.042; Kurup GK, 2012, BIOMICROFLUIDICS, V6, DOI 10.1063/1.3700120; Lee H, 2014, BIOMICROFLUIDICS, V8, DOI 10.1063/1.4892495; Lee J, 2002, SENSOR ACTUAT A-PHYS, V95, P259, DOI 10.1016/S0924-4247(01)00734-8; Lim CT, 2007, BIOSENS BIOELECTRON, V22, P1197, DOI 10.1016/j.bios.2006.06.005; Mazutis L, 2009, LAB CHIP, V9, P2665, DOI 10.1039/b903608c; Moon H, 2002, J APPL PHYS, V92, P4080, DOI 10.1063/1.1504171; Ng JK, 2008, BIOSENS BIOELECTRON, V23, P803, DOI 10.1016/j.bios.2007.08.026; OKU Y, 1988, MICROBIOL IMMUNOL, V32, P807, DOI 10.1111/j.1348-0421.1988.tb01442.x; Pan XY, 2011, ELECTROPHORESIS, V32, P3399, DOI 10.1002/elps.201100078; Park J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017019; Pierres A, 2002, BIOPHYS J, V82, P3214, DOI 10.1016/S0006-3495(02)75664-6; Pinheiro LB, 2012, ANAL CHEM, V84, P1003, DOI 10.1021/ac202578x; Shah GJ, 2009, LAB CHIP, V9, P1732, DOI 10.1039/b821508a; Sinn I, 2011, LAB CHIP, V11, P2604, DOI 10.1039/c0lc00734j; Teste B, 2013, LAB CHIP, V13, P2344, DOI 10.1039/c3lc50353d; Wang C, 2000, RAPID COMMUN MASS SP, V14, P1377, DOI 10.1002/1097-0231(20000815)14:15<1377::AID-RCM31>3.0.CO;2-2; Wang JJ, 2013, BIOMICROFLUIDICS, V7, DOI 10.1063/1.4816943; Wong J, 1999, BIOMOL ENG, V16, P45, DOI 10.1016/S1050-3862(99)00035-2; Zhao Y, 2010, SYNCHRONIZATION WASH, P635, DOI DOI 10.1039/C3LC50353D	35	7	8	2	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 10	2017	12	3							e0173479	10.1371/journal.pone.0173479	http://dx.doi.org/10.1371/journal.pone.0173479			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN6CJ	28282412	Green Submitted, Green Published, gold			2022-12-27	WOS:000396091800044
J	Ota, K; Tong, KI; Goto, K; Tomida, S; Komuro, A; Wang, Z; Nishio, K; Okada, H				Ota, Kazushige; Tong, Kit I.; Goto, Kouichiro; Tomida, Shuta; Komuro, Akiyoshi; Wang, Zhong; Nishio, Kazuto; Okada, Hitoshi			The H3K27 demethylase, Utx, regulates adipogenesis in a differentiation stagedependent manner	PLOS ONE			English	Article							EMBRYONIC STEM-CELLS; BETA-CATENIN; COORDINATED REGULATION; THERMOGENIC PROGRAM; ALPHA-CATENIN; OBESITY; ADIPOCYTES; PATHWAY; IDENTIFICATION; METHYLATION	Understanding the molecular mechanisms that drive adipogenesis is important in developing new treatments for obesity and diabetes. Epigenetic regulations determine the capacity of adipogenesis. In this study, we examined the role of a histone H3 lysine 27 demethylase, the ubiquitously transcribed tetratricopeptide repeat protein on the X chromosome (Utx), in the differentiation of mouse embryonic stem cells (mESCs) to adipocytes. Using gene trapping, we examined Utx-deficient male mESCs to determine whether loss of Utx would enhance or inhibit the differentiation of mESCs to adipocytes. Utx-deficient mESCs showed diminished potential to differentiate to adipocytes compared to that of controls. In contrast, Utx-deficient preadipocytes showed enhanced differentiation to adipocytes. Microarray analyses indicated that the beta-catenin/c-Myc signaling pathway was differentially regulated in Utx-deficient cells during adipocyte differentiation. Therefore, our data suggest that Utx governs adipogenesis by regulating c-Myc in a differentiation stage-specific manner and that targeting the Utx signaling pathway could be beneficial for the treatment of obesity, diabetes, and congenital utx-deficiency disorders.	[Ota, Kazushige; Komuro, Akiyoshi; Okada, Hitoshi] Kindai Univ Fac Med, Dept Biochem, Osaka, Osaka, Japan; [Tong, Kit I.; Goto, Kouichiro; Okada, Hitoshi] Univ Hlth Network, Princess Margaret Canc Ctr, Campbell Family Inst Breast Canc Res, Toronto, ON, Canada; [Tomida, Shuta; Nishio, Kazuto] Kindai Univ Fac Med, Dept Genome Biol, Osaka, Osaka, Japan; [Wang, Zhong] Univ Michigan, Cardiovasc Res Ctr, Dept Cardiac Surg, Ann Arbor, MI 48109 USA; [Okada, Hitoshi] Kindai Univ, Antiaging Ctr, Higashiosaka, Osaka, Japan	University of Toronto; University Toronto Affiliates; University Health Network Toronto; Princess Margaret Cancer Centre; University of Michigan System; University of Michigan; Kindai University (Kinki University)	Okada, H (corresponding author), Kindai Univ Fac Med, Dept Biochem, Osaka, Osaka, Japan.; Okada, H (corresponding author), Univ Hlth Network, Princess Margaret Canc Ctr, Campbell Family Inst Breast Canc Res, Toronto, ON, Canada.; Okada, H (corresponding author), Kindai Univ, Antiaging Ctr, Higashiosaka, Osaka, Japan.	hokada@med.kindai.ac.jp			CIHR [MOP84353]; MEXT-Support Program for the Strategic Research Foundation at Private Universities; KAO Research Council for the Study of Health care Science; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL109054] Funding Source: NIH RePORTER	CIHR(Canadian Institutes of Health Research (CIHR)); MEXT-Support Program for the Strategic Research Foundation at Private Universities; KAO Research Council for the Study of Health care Science; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was funded by a CIHR grant (MOP84353), the MEXT-Support Program for the Strategic Research Foundation at Private Universities, and by the KAO Research Council for the Study of Health care Science. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agger K, 2007, NATURE, V449, P731, DOI 10.1038/nature06145; Bost F, 2002, BIOCHEM J, V361, P621, DOI 10.1042/0264-6021:3610621; Choi HJ, 2015, EMBO REP, V16, P1288, DOI 10.15252/embr.201540244; Dani C, 1997, J CELL SCI, V110, P1279; Dani C, 1999, CELLS TISSUES ORGANS, V165, P173, DOI 10.1159/000016697; Despres JP, 2006, NATURE, V444, P881, DOI 10.1038/nature05488; Gut P, 2013, NATURE, V502, P489, DOI 10.1038/nature12752; He TC, 1998, SCIENCE, V281, P1509, DOI 10.1126/science.281.5382.1509; Heath VJ, 2000, EXP CELL RES, V254, P91, DOI 10.1006/excr.1999.4736; Hemming S, 2014, STEM CELLS, V32, P802, DOI 10.1002/stem.1573; Hong SH, 2007, P NATL ACAD SCI USA, V104, P18439, DOI 10.1073/pnas.0707292104; Hossain P, 2007, NEW ENGL J MED, V356, P213, DOI 10.1056/NEJMp068177; Hwang SG, 2005, J BIOL CHEM, V280, P12758, DOI 10.1074/jbc.M413367200; Jiang W, 2013, CELL RES, V23, P122, DOI 10.1038/cr.2012.119; Jo J, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000324; KISSEBAH AH, 1994, PHYSIOL REV, V74, P761, DOI 10.1152/physrev.1994.74.4.761; Kopelman PG, 2000, NATURE, V404, P635, DOI 10.1038/35007508; Lan F, 2007, NATURE, V449, P689, DOI 10.1038/nature06192; Lee MG, 2007, SCIENCE, V318, P447, DOI 10.1126/science.1149042; Lee S, 2012, DEV CELL, V22, P25, DOI 10.1016/j.devcel.2011.11.009; Li FF, 2016, J BIOL CHEM, V291, P4523, DOI 10.1074/jbc.M115.677930; Mansour AA, 2012, NATURE, V488, P409, DOI 10.1038/nature11272; Martin BL, 2010, GENE DEV, V24, P2778, DOI 10.1101/gad.1962910; Nelson WJ, 2004, SCIENCE, V303, P1483, DOI 10.1126/science.1094291; Okamura M, 2010, ORGANOGENESIS, V6, P24, DOI 10.4161/org.6.1.11121; Phillips BW, 2003, PHARMACOL RES, V47, P263, DOI 10.1016/S1043-6618(03)00035-5; Piedra J, 2003, MOL CELL BIOL, V23, P2287, DOI 10.1128/MCB.23.7.2287-2297.2003; Popkin BM, 2004, INT J OBESITY, V28, pS2, DOI [10.1038/sj.ijo.0802804, 10.1038/sj.ijo.0802557]; Rosen ED, 2006, NATURE, V444, P847, DOI 10.1038/nature05483; Shpargel KB, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002964; Torres CM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060020; Wang CC, 2012, P NATL ACAD SCI USA, V109, P15324, DOI 10.1073/pnas.1204166109; Welstead GG, 2012, P NATL ACAD SCI USA, V109, P13004, DOI 10.1073/pnas.1210787109; Zha L, 2015, J BIOL CHEM, V290, P25151, DOI 10.1074/jbc.M115.662650	34	9	10	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 20	2017	12	3							e0173713	10.1371/journal.pone.0173713	http://dx.doi.org/10.1371/journal.pone.0173713			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ER6VC	28319137	Green Submitted, Green Published, gold			2022-12-27	WOS:000398945800025
J	Deng, YS; Cai, CF; Xia, D; Ding, SW; Chen, JZ				Deng, Yusong; Cai, Chongfa; Xia, Dong; Ding, Shuwen; Chen, Jiazhou			Fractal features of soil particle size distribution under different land-use patterns in the alluvial fans of collapsing gullies in the hilly granitic region of southern China	PLOS ONE			English	Article							MULTIFRACTAL ANALYSIS; PHYSICAL-PROPERTIES; LASER DIFFRACTION; LOESS PLATEAU; EROSION; FRAGMENTATION; PROFILES; MODELS	Collapsing gullies are among the most severe soil erosion problems in the tropical and subtropical areas of southern China. However, few studies have examined the relationship of soil particle size distribution (PSD) changes with land-use patterns in the alluvial fans of collapsing gullies. Recently, the fractal method has been applied to estimate soil structure and has proven to be an effective tool in analyzing soil properties and their relationships with other eco-environmental factors. In this study, the soil fractal dimension (D), physico-chemical properties and their relationship with different land-use patterns in alluvial fans were investigated in an experiment that involved seven collapsing gully areas in seven counties of southern China. Our results demonstrated that different land-use patterns of alluvial fans had a significant effect on soil physico-chemical properties. Compared to grasslands and woodlands, farmlands and orchards generally contained more fine soil particles (silt and clay) and fewer coarse particles, whereas significant differences were found in the fractal dimension of soil PSD in different land-use patterns. Specifically, the soil fractal dimension was lower in grasslands and higher in orchards relative to that of other land-use patterns. The average soil fractal dimension of grasslands had a value that was 0.08 lower than that of orchards. Bulk density was lower but porosity was higher in farmlands and orchards. Saturated moisture content was lower in woodlands and grasslands, but saturated hydraulic conductivity was higher in all four land-use patterns. Additionally, the fractal dimension had significant linear relationships with the silt, clay and sand contents and soil properties and exhibited a positive correlation with the clay (R-2 = 0.976, P< 0.001), silt (R-2 = 0.578, P< 0.01), organic carbon (R-2 = 0.777, P< 0.001) and saturated water (R-2 = 0.639, P< 0.01) contents but a negative correlation with gravel content (R-2 = 0.494, P< 0.01), coarse sand content (R-2 = 0.623, P< 0.01) and saturated hydraulic conductivity (R-2 = 0.788, P< 0.001). However, the fractal dimension exhibited no significant correlation with pH, bulk density or total porosity. Furthermore, the second-degree polynomial equation was found to be more adequate for describing the correlations between soil fractal dimension and particle size distribution. The results of this study demonstrate that a fractal dimension analysis of soil particle size distribution is a useful method for the quantitative description of different land-use patterns in the alluvial fans of collapsing gullies in southern China.	[Deng, Yusong; Cai, Chongfa; Ding, Shuwen; Chen, Jiazhou] Huazhong Agr Univ, Minist Agr, Coll Resources & Environm, Key Lab Arable & Consevat Middle & Lower Reaches, Wuhan, Peoples R China; [Xia, Dong] China Three Gorges Univ, Coll Hydraul & Environm Engn, Yichang, Peoples R China	Huazhong Agricultural University; Ministry of Agriculture & Rural Affairs; China Three Gorges University	Cai, CF (corresponding author), Huazhong Agr Univ, Minist Agr, Coll Resources & Environm, Key Lab Arable & Consevat Middle & Lower Reaches, Wuhan, Peoples R China.	chongfacai@126.com		Chen, Jiazhou/0000-0002-6660-6676	National Natural Science Foundation of China [41630858, 41601287, 41571258]; National Science and Technology basic work project [2014 FY110200A16]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Science and Technology basic work project	Financial support for this research was provided by the National Natural Science Foundation of China (No. 41630858, 41601287 and 41571258) and the National Science and Technology basic work project (No. 2014 FY110200A16). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], [No title captured]; Arya LM, 2010, SOIL SCI SOC AM J, V74, P33, DOI 10.2136/sssaj2009.0022; Barnes RT, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0108340; Bird N, 2006, J HYDROL, V322, P211, DOI 10.1016/j.jhydrol.2005.02.039; Birkhofer K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043292; Bittelli M, 1999, SOIL SCI SOC AM J, V63, P782, DOI 10.2136/sssaj1999.634782x; BUCHAN GD, 1993, SOIL SCI SOC AM J, V57, P901, DOI 10.2136/sssaj1993.03615995005700040004x; Cai LiPing, 2012, Journal of Fujian Agriculture and Forestry University (Natural Science Edition), V41, P524; Chen Z., 2007, SOIL WATER CONSERV C, V3, P15; Cheng XianFu, 2007, Transactions of the Chinese Society of Agricultural Engineering, V23, P76; CLAPP RB, 1978, WATER RESOUR RES, V14, P601, DOI 10.1029/WR014i004p00601; Deng YS, 2015, PROVINCE SCI SOIL WA, V1, P47; Deng YS, 2015, CHINA J INTEGR AGR, V15, P1863; [邓羽松 Deng Yusong], 2015, [水土保持研究, Research of Soil and Water Conservation], V22, P56; [邓羽松 Deng Yusong], 2014, [中国农业科学, Scientia Agricultura Sinica], V47, P4850; Ding F, 2014, PLOS ONE, V9, P4703; Fan HC, 2006, SOIL WATER CONSERVE, V1, P27; Feng M.H., 2009, YANGTZE RIVER, V40, P66; Filgueira RR, 1999, SOIL TILL RES, V52, P217, DOI 10.1016/S0167-1987(99)00082-3; Gao GL, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088559; Grout H, 1998, ENVIRON SCI TECHNOL, V32, P1176, DOI 10.1021/es9704343; Haregeweyn N, 2008, LAND DEGRAD DEV, V19, P136, DOI 10.1002/ldr.830; Hillel D, 1980, FUNDAMENTALS SOIL PH; Huang GuanHua, 2002, Acta Pedologica Sinica, V39, P490; Institute of Soil Science the Chinese Academy of Science (ISSCAS), 1981, SOIL CHEM PHYS AN; Islam KR, 2000, AGR ECOSYST ENVIRON, V79, P9, DOI 10.1016/S0167-8809(99)00145-0; Jiang FS, 2014, SOIL SCI SOC AM J, V78, P1741, DOI 10.2136/sssaj2014.04.0132; Lan HX, 2003, J ASIAN EARTH SCI, V21, P353, DOI 10.1016/S1367-9120(02)00020-2; Liang Y., 2009, SWCC, V1, P31; Liang Y, 2008, SOIL WATER CONSERVE, V12, P50; Liu P, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087600; Liu X, 2014, CHINA ENV EARTH SCI, V73, P6091, DOI DOI 10.1007/S12665-014-3833-1; Liu X, 2009, GEODERMA, V154, P123, DOI 10.1016/j.geoderma.2009.10.005; Luk SH, 1997, CATENA, V29, P97, DOI 10.1016/S0341-8162(96)00049-5; Luk SH, 1997, CATENA, V29, P177, DOI 10.1016/S0341-8162(96)00054-9; Luo BL, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0122842; Lyu XF, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0121368; MANDELBORT B. B., 1982, FRACTAL GEOMETRY NAT, P45; Mandelort BB, 1977, FRACTALS FORM CHANCE; Martin MA, 2002, SOIL TILL RES, V64, P113, DOI 10.1016/S0167-1987(01)00249-5; Martinez-Casanovas JA, 2000, SOIL TILL RES, V57, P101, DOI 10.1016/S0167-1987(00)00142-2; Nie XD, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0105927; Perfect E, 1997, ENG GEOL, V48, P185, DOI 10.1016/S0013-7952(97)00040-9; Pinheiro EFM, 2004, SOIL TILL RES, V77, P79, DOI 10.1016/j.still.2003.11.005; Poesen J, 2003, CATENA, V50, P91, DOI 10.1016/S0341-8162(02)00143-1; Posadas AND, 2003, SOIL SCI SOC AM J, V67, P1361, DOI 10.2136/sssaj2003.1361; Prosperini N, 2008, GEODERMA, V145, P185, DOI 10.1016/j.geoderma.2008.03.004; Sarkar S., 2015, PLOS ONE, V10; Schrumpf M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089364; Segal E, 2009, SOIL SCI, V174, P639, DOI 10.1097/SS.0b013e3181c2a928; Sheng JA, 1997, CATENA, V29, P211, DOI 10.1016/S0341-8162(96)00057-4; Skaggs TH, 2001, SOIL SCI SOC AM J, V65, P1038, DOI 10.2136/sssaj2001.6541038x; Song Z, 2015, PLOS ONE, V10, P361; Su YZ, 2004, GEODERMA, V122, P43, DOI 10.1016/j.geoderma.2003.12.003; TYLER SW, 1992, SOIL SCI SOC AM J, V56, P362, DOI 10.2136/sssaj1992.03615995005600020005x; Walkley A, 1934, SOIL SCI, V37, P29, DOI 10.1097/00010694-193401000-00003; Wang D, 2008, CATENA, V72, P29, DOI 10.1016/j.catena.2007.03.019; Wang XD, 2006, GEODERMA, V134, P56, DOI 10.1016/j.geoderma.2005.08.014; Wei YJ, 2015, CATENA, V135, P254, DOI 10.1016/j.catena.2015.08.003; Woo MK, 1997, CATENA, V29, P145, DOI 10.1016/S0341-8162(96)00052-5; Xia D, 2015, NAT HAZARDS, V79, P455, DOI 10.1007/s11069-015-1852-1; Xiao L, 2014, J ARID LAND, V6, P550, DOI 10.1007/s40333-014-0023-7; Xu GC, 2013, CATENA, V101, P17, DOI 10.1016/j.catena.2012.09.013; Xu J., 1992, IAHS PUBL, V209, P455; Xu JX, 1996, CATENA, V27, P249, DOI 10.1016/0341-8162(96)00014-8; YANG PL, 1993, CHINESE SCI BULL, V38, P1896; Zeng Z. X., 1980, ROCK TOPOGRAPHY; Zhang JC, 2015, PLOS ONE, V10; Zhang X.J., 2010, CHINA WATER RESOUR, V4, P17; Zhang XC, 2014, PLOS ONE, V9, DOI [10.1371/journal.pone.0085241, 10.1371/journal.pone.0100240]; Zhong BL, 2013, LAND USE POLICY, V32, P119, DOI 10.1016/j.landusepol.2012.10.005; Zou XY, 2002, J ARID ENVIRON, V51, P183, DOI 10.1006/jare.2001.0943	72	25	28	7	49	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 16	2017	12	3							e0173555	10.1371/journal.pone.0173555	http://dx.doi.org/10.1371/journal.pone.0173555			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN9KE	28301524	Green Published, Green Submitted, gold			2022-12-27	WOS:000396318300050
J	Kim, HW; Lee, JC; Lee, J; Kim, JW; Kim, J; Hwang, JH				Kim, Hyoung Woo; Lee, Jong-Chan; Lee, Jongchan; Kim, Jin Won; Kim, Jaihwan; Hwang, Jin-Hyeok			Early versus delayed initiation of adjuvant treatment for pancreatic cancer	PLOS ONE			English	Article							LONG-TERM SURVIVAL; PLUS FOLINIC ACID; SURGICAL COMPLICATIONS; CHEMOTHERAPY; GEMCITABINE; SURGERY; ADENOCARCINOMA; RESECTION; CLASSIFICATION; METASTASIS	Background Pancreatic ductal adenocarcinoma (PDAC) is a highly aggressive tumor showing a tendency for early recurrence, even after curative resection. Although adjuvant treatment improves survival, it is unclear whether early adjuvant treatment initiation yields better outcomes in patients with PDAC. Methods We retrospectively enrolled 113 patients who underwent chemotherapy or chemoradiotherapy after curative resection of PDAC: Fifty-six and 57 patients were in the early and delayed groups, respectively based on the median time of treatment initiation (35 days [range, 20 +/- 83 days]). Results Patient baseline characteristics were comparable in both groups, except for grade III or IV postoperative complications (5.4% in the early group vs. 22.8% in the delayed group). With a median 20.3-month follow-up, the overall survival (OS) and disease-free survival (DFS) times were 29.5 and 14.7 months, respectively. The early group had significantly prolonged OS (39.1 vs. 21.1 months, p = 0.018) and DFS (18.8 vs. 10.0 months, p = 0.034), compared to the delayed group. Among 71 patients who completed planned adjuvant treatment, patients in the early group tended to have longer, though not statistically significant, OS and DFS times than those in the delayed group. In 67 patients without postoperative complications, patients in the early group had longer OS (42.8 vs. 20.5 months, p = 0.002) and DFS (19.6 vs. 9.1 months, p = 0.005) than those in the delayed group. By multivariate analysis, incompletion of treatment (hazard ratio [HR]: 4.039, 95% confidence interval [CI]: 2.334 +/- 6.992), delayed treatment initiation (HR: 1.822, 95% CI: 1.081 +/- 3.070), and positive angiolymphatic invasion (HR: 2.116, 95% CI: 1.160 +/- 3.862) were significantly associated with shorter OS. Conclusions Adjuvant treatment should be delivered earlier and completed for better outcomes in resected PDAC patients, especially without postoperative complications.	[Kim, Hyoung Woo; Lee, Jong-Chan; Lee, Jongchan; Kim, Jin Won; Kim, Jaihwan; Hwang, Jin-Hyeok] Seoul Natl Univ, Dept Internal Med, Coll Med, Bundang Hosp, Seongnam, South Korea; [Kim, Hyoung Woo] Chungbuk Natl Univ, Dept Internal Med, Chungbuk Natl Univ Hosp, Coll Med, Cheongju, South Korea	Seoul National University (SNU); Chungbuk National University; Chungbuk National University Hospital	Hwang, JH (corresponding author), Seoul Natl Univ, Dept Internal Med, Coll Med, Bundang Hosp, Seongnam, South Korea.	woltoong@snu.ac.kr		Hwang, Jin-Hyeok/0000-0002-5643-8461				Biagi JJ, 2011, JAMA-J AM MED ASSOC, V305, P2335, DOI 10.1001/jama.2011.749; Bos ACRK, 2015, EUR J CANCER, V51, P2553, DOI 10.1016/j.ejca.2015.08.016; CHARLSON ME, 1987, J CHRON DIS, V40, P373, DOI 10.1016/0021-9681(87)90171-8; Clavien PA, 2009, ANN SURG, V250, P187, DOI 10.1097/SLA.0b013e3181b13ca2; Dias-Santos D, 2015, SURGERY, V157, P881, DOI 10.1016/j.surg.2014.12.006; Dindo D, 2004, ANN SURG, V240, P205, DOI 10.1097/01.sla.0000133083.54934.ae; Farolfi A, 2015, EUR J CANCER, V51, P1874, DOI 10.1016/j.ejca.2015.07.003; FISHER B, 1989, CANCER RES, V49, P1996; Gagliato DD, 2014, J CLIN ONCOL, V32, P735, DOI 10.1200/JCO.2013.49.7693; Haeno H, 2012, CELL, V148, P362, DOI 10.1016/j.cell.2011.11.060; Hensler T, 1997, INFECT IMMUN, V65, P2283, DOI 10.1128/IAI.65.6.2283-2291.1997; Hershman D, 2006, CANCER-AM CANCER SOC, V107, P2581, DOI 10.1002/cncr.22316; Katz MHG, 2009, ANN SURG ONCOL, V16, P836, DOI 10.1245/s10434-008-0295-2; Murakami Y, 2013, CANCER CHEMOTH PHARM, V71, P419, DOI 10.1007/s00280-012-2029-1; Neoptolemos JP, 2012, JAMA-J AM MED ASSOC, V308, P147, DOI 10.1001/jama.2012.7352; Neoptolemos JP, 2010, JAMA-J AM MED ASSOC, V304, P1073, DOI 10.1001/jama.2010.1275; Neoptolemos JP, 2004, NEW ENGL J MED, V350, P1200, DOI 10.1056/NEJMoa032295; Nguyen DX, 2009, NAT REV CANCER, V9, P274, DOI 10.1038/nrc2622; Oettle H, 2007, JAMA-J AM MED ASSOC, V297, P267, DOI 10.1001/jama.297.3.267; Oettle H, 2013, JAMA-J AM MED ASSOC, V310, P1473, DOI 10.1001/jama.2013.279201; Parkin DM, 2005, CA-CANCER J CLIN, V55, P74, DOI 10.3322/canjclin.55.2.74; Schnelldorfer T, 2008, ANN SURG, V247, P456, DOI 10.1097/SLA.0b013e3181613142; Seth R, 2013, ANN SURG, V258, P158, DOI 10.1097/SLA.0b013e31826fcbdb; Siegel RL, 2016, CA-CANCER J CLIN, V66, P7, DOI [10.3322/caac.21708, 10.3322/caac.21332, 10.3322/caac.21590]; Stalder M, 2005, TRANSPL INT, V18, P1158, DOI 10.1111/j.1432-2277.2005.00119.x; Tempero MA, 2014, J NATL COMPR CANC NE, V12, P1083, DOI 10.6004/jnccn.2014.0106; Ueno H, 2009, BRIT J CANCER, V101, P908, DOI 10.1038/sj.bjc.6605256; Valle JW, 2014, J CLIN ONCOL, V32, P504, DOI 10.1200/JCO.2013.50.7657; Ziprin P, 2003, CELL COMMUN ADHES, V10, P141, DOI 10.1080/15419060390262561	29	14	14	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 16	2017	12	3							e0173960	10.1371/journal.pone.0173960	http://dx.doi.org/10.1371/journal.pone.0173960			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN9KE	28301556	Green Published, gold, Green Submitted			2022-12-27	WOS:000396318300102
J	Jung, YT; Hum, RJ; Lou, W; Cheng, YL				Jung, Youngmee Tiffany; Hum, Ryan James; Lou, Wendy; Cheng, Yu-Ling			Effects of neighbourhood and household sanitation conditions on diarrhea morbidity: Systematic review and meta-analysis	PLOS ONE			English	Review							POOR URBAN AREAS; CHILDHOOD DIARRHEA; RISK-FACTORS; HYGIENE INTERVENTIONS; NORTHEAST BRAZIL; PUBLICATION BIAS; IMPACT; CHILDREN; WATER; BEHAVIOR	Sanitation in neighbourhood and household domains can provide primary protection against diarrhea morbidity, yet their distinct health benefits have not been succinctly distinguished and reviewed. We present here the first systematic review and meta-analysis of the distinct effect of neighbourhood and household sanitation conditions on diarrhea morbidity. We identified studies reporting the effect of neighbourhood-level exposure to wastewater or household sanitation facilities on diarrhea, by performing comprehensive search on five databases, namely the Cochrane library, PubMed, Embase, Scopus and Web of Science, from the earliest date available to February 2015. Twenty-one non-randomized studies and one randomized controlled trial met the pre-determined inclusion criteria, consisting of six datasets on neighbourhood sanitation conditions (total 8271 subjects) and 20 datasets on household sanitation (total 20021 subjects). We calculated the pooled effect estimates of neighbourhood and household sanitation conditions on diarrhea morbidity using the inverse variance random-effects model. The pooled effect estimates showed that both neighbourhood sanitation conditions (odds ratio = 0.56, 95%Cl: 0.40-0.79) and household sanitation (odds ratio = 0.64, 95%Cl :0.55-0.75) are associated with reduced diarrheal illness, and that the magnitudes of the associations are comparable. Evidence of risk of bias and heterogeneity were found in the included studies. Our findings confirm that both neighbourhood sanitation conditions and household sanitation are associated with considerable reduction in diarrhea morbidity, in spite of a number of methodological shortcomings in the included studies. Furthermore, we find evidence that neighbourhood sanitation conditions is associated with similar magnitude of reduction in diarrhea morbidity as household sanitation. The findings suggest that, in addition to household sanitation provision, dual emphasis on neighbourhood sanitation through public sanitation infrastructure provision and community-wide sanitation adoption is advisable for effective reduction of diarrheal disease burden.	[Jung, Youngmee Tiffany; Hum, Ryan James; Cheng, Yu-Ling] Univ Toronto, Ctr Global Engn, Toronto, ON, Canada; [Jung, Youngmee Tiffany; Hum, Ryan James; Cheng, Yu-Ling] Univ Toronto, Dept Chem Engn & Appl Chem, Toronto, ON, Canada; [Lou, Wendy] Univ Toronto, Dalla Lana Sch Publ Hlth, Toronto, ON, Canada	University of Toronto; University of Toronto; University of Toronto	Jung, YT (corresponding author), Univ Toronto, Ctr Global Engn, Toronto, ON, Canada.; Jung, YT (corresponding author), Univ Toronto, Dept Chem Engn & Appl Chem, Toronto, ON, Canada.	tiffany.jung@utoronto.ca			Ontario graduate scholarship program	Ontario graduate scholarship program(Ontario Graduate Scholarship)	The research was funded by the Ontario graduate scholarship program. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AECOM International Development Inc. SANDEC Swiss Federal Institute of Aquatic Science and Technology, 2010, RAP ASS SEPT MAN AS; Agustina R, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-977; Al-Ghamdi MA, 2009, J WATER HEALTH, V7, P380, DOI 10.2166/wh.2009.058; Andres LA, 2014, SANITATION EXTEMALIT; Anteneh A, 2010, ETHIOP J HEALTH DEV, V24, P110; AZIZ KMA, 1990, T ROY SOC TROP MED H, V84, P433, DOI 10.1016/0035-9203(90)90353-G; BALTAZAR JC, 1989, INT J EPIDEMIOL, V18, pS16, DOI 10.1093/ije/18.Supplement_2.S16; Barreto ML, 2007, LANCET, V370, P1622, DOI 10.1016/S0140-6736(07)61638-9; Barreto ML, 2010, ENVIRON HEALTH PERSP, V118, P1637, DOI 10.1289/ehp.1002058; Bateman OM, 1991, COMPARISON HLTH EFFE; Blackett I, 2014, WATER SANITATION PRO; Borenstein M., 2009, INTRO METAANALYSIS; Boschi-Pinto C, 2009, MATERNAL AND CHILD HEALTH: GLOBAL CHALLENGES, PROGRAMS AND POLICIES, P225, DOI 10.1007/b106524_13; Briceno B., 2015, Policy Research Working Paper - World Bank; Buttenheim AM, 2008, POPUL ENVIRON, V30, P26, DOI 10.1007/s11111-008-0074-9; Cairncross S, 1996, TROP MED INT HEALTH, V1, P27, DOI 10.1046/j.1365-3156.1996.d01-9.x; Cairncross S, 2010, INT J EPIDEMIOL, V39, P193, DOI 10.1093/ije/dyq035; Clasen TF, 2010, COCHRANE DATABASE SY; Clasen T, 2014, LANCET GLOB HEALTH, V2, pE645, DOI 10.1016/S2214-109X(14)70307-9; DANIELS DL, 1990, B WORLD HEALTH ORGAN, V68, P455; DERSIMONIAN R, 1986, CONTROL CLIN TRIALS, V7, P177, DOI 10.1016/0197-2456(86)90046-2; Dessalegn M, 2011, ETHIOP J HEALTH DEV, V25, P192; DIKASSA L, 1993, INT J EPIDEMIOL, V22, P327, DOI 10.1093/ije/22.2.327; ESREY SA, 1991, B WORLD HEALTH ORGAN, V69, P609; Ferrer SR, 2008, INT J EPIDEMIOL, V37, P805, DOI 10.1093/ije/dyn093; Fewtrell L, 2005, LANCET INFECT DIS, V5, P42, DOI 10.1016/S1473-3099(04)01253-8; Garrett V, 2008, EPIDEMIOL INFECT, V136, P1463, DOI 10.1017/S095026880700026X; Genser B, 2006, EPIDEMIOLOGY, V17, P658, DOI 10.1097/01.ede.0000239728.75215.86; Geruso M, 2013, SANITATION HLTH EXTE; Godana W, 2013, RURAL REMOTE HEALTH, V13; Graf J, 2008, INT J ENVIRON HEAL R, V18, P335, DOI 10.1080/09603120801966050; Hammer J, 2013, VILLAGE SANITATION E; Heller Léo, 2003, Rev. Soc. Bras. Med. Trop., V36, P41, DOI 10.1590/S0037-86822003000100007; Higgins J.P., 2011, COCHRANE HDB SYSTEMA, V4, DOI [10.1002/9780470712184, DOI 10.1002/9780470712184]; Higgins JPT, 2003, BRIT MED J, V327, P557, DOI 10.1136/bmj.327.7414.557; Higgins Julian P T, 2011, BMJ, V343, pd5928, DOI 10.1136/bmj.d5928; Hunter PR, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0164571; Islam K, 2014, ASIAN J, V1, P8; KNIGHT SM, 1992, INT J EPIDEMIOL, V21, P812, DOI 10.1093/ije/21.4.812; Kolahi AA, 2009, T ROY SOC TROP MED H, V103, P500, DOI 10.1016/j.trstmh.2008.10.016; Mbonye AK, 2004, J HEALTH POPUL NUTR, V22, P52; MERTENS TE, 1992, INT J EPIDEMIOL, V21, P1157, DOI 10.1093/ije/21.6.1157; Moher D, 2009, PLOS MED, V6, DOI [10.1136/bmj.b4037, 10.1371/journal.pmed.1000097]; Moraes LRS, 2004, T ROY SOC TROP MED H, V98, P197, DOI 10.1016/S0035-9203(03)00043-9; Moraes LRS, 2003, T ROY SOC TROP MED H, V97, P153, DOI 10.1016/S0035-9203(03)90104-0; Moreno SG, 2009, BMC MED RES METHODOL, V9, DOI 10.1186/1471-2288-9-2; Mosley WH, 1984, POPUL DEV REV, V10, P25, DOI 10.2307/2807954; Norman G, 2010, LANCET INFECT DIS, V10, P536, DOI 10.1016/S1473-3099(10)70123-7; Oketcho R., 2012, Tanzania Journal of Health Research, V14, punpaginated, DOI 10.4314/thrb.v14i2.3; Patil SR, 2014, PLOS MED, V11, DOI 10.1371/journal.pmed.1001709; Peters JL, 2007, STAT MED, V26, P4544, DOI 10.1002/sim.2889; Pickering AJ, 2015, LANCET GLOB HEALTH, V3, pE701, DOI 10.1016/S2214-109X(15)00144-8; R Core Team, 2021, R LANGUAGE ENV STAT; Robinson A., 2006, Waterlines, V25, P8, DOI 10.3362/0262-8104.2006.046; Sinmegn Mihrete Thomas, 2014, BMC Pediatr, V14, P102, DOI 10.1186/1471-2431-14-102; STANTON BF, 1987, B WORLD HEALTH ORGAN, V65, P217; Stroup DF, 2000, JAMA-J AM MED ASSOC, V283, P2008, DOI 10.1001/jama.283.15.2008; The Cochrane Collaboration, 2012, REV MAN REVMAN VERS; TRAORE E, 1994, J EPIDEMIOL COMMUN H, V48, P270, DOI 10.1136/jech.48.3.270; Tumwine JK, 2002, TROP MED INT HEALTH, V7, P750, DOI 10.1046/j.1365-3156.2002.00927.x; UNICEF East Asia and Pacific Regional Office, 2013, COMM LED TOT SAN E A; VANDERSLICE J, 1995, AM J EPIDEMIOL, V141, P135, DOI 10.1093/oxfordjournals.aje.a117401; Voils CI, 2011, J EVAL CLIN PRACT, V17, P429, DOI 10.1111/j.1365-2753.2010.01444.x; Waddington H, 2009, J DEV EFFECT, V1, P295, DOI 10.1080/19439340903141175; Wang HD, 2016, LANCET, V388, P1459, DOI 10.1016/S0140-6736(16)31012-1; Wells G., 2014, S SYST REV BAS; Wolf J, 2014, TROP MED INT HEALTH, V19, P928, DOI 10.1111/tmi.12331; World Bank, 2010, DEC TOT SAN CAMP	68	33	36	1	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 15	2017	12	3							e0173808	10.1371/Journal.pone.0173808	http://dx.doi.org/10.1371/Journal.pone.0173808			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN9HQ	28296946	Green Submitted, Green Published, gold			2022-12-27	WOS:000396311700067
J	Kierdorf, U; Miller, KV; Flohr, S; Gomez, S; Kierdorf, H				Kierdorf, Uwe; Miller, Karl V.; Flohr, Stefan; Gomez, Santiago; Kierdorf, Horst			Multiple osteochondromas of the antlers and cranium in a free-ranging white-tailed deer (Odocoileus virginianus)	PLOS ONE			English	Article							OF-THE-LITERATURE; FALLOW DEER; MANDIBULAR CONDYLE; HEPARAN-SULFATE; DAMA-DAMA; BONE; EXOSTOSES; OSSIFICATION; GROWTH; TUMOR	This paper reports a case of multiple osteochondromas affecting the antlers and the left zygomatic bone of a free-ranging adult white-tailed buck (Odocoileus virginianus) from Georgia, USA. Along with a few postcranial bones, the antlered cranium of the individual was found in a severely weathered condition and devoid of any soft tissue. The antlers exhibited five pedunculated exostoses that were composed of cancellous bone and, in their peripheral portions, also mineralized cartilage. The largest of the exostoses, located on the right antler, had a maximum circumference of 55 cm. The exostosis arising from the zygomatic bone was broad -based and much smaller than the exophytic outgrowths on the antlers. Diagnosis of the exostoses as osteochondromas was based on their overall morphology, the normal bone structure in their stalk regions, and the continuity of their spongiosa and cortex with the respective components of the parent bones. Antleromas, i.e., pathological outgrowths developing on antlers as a result of insufficient androgen production, were excluded in the differential diagnosis, based on (1) the apparent maturity and, except for the tumors, normal shape of the antlers and (2) the fact that exostosis formation had also affected the zygomatic bone. Previously only a single case of solitary osteochondroma of an antler has been described in the scientific literature. The case presented here is the first report of multiple osteochondromas in a deer. As antlers are regularly collected as trophies, and huge numbers of them are critically inspected each year, the fact that thus far only two cases of antler osteochondromas have been reported suggests that these tumors are very rare.	[Kierdorf, Uwe; Flohr, Stefan; Kierdorf, Horst] Univ Hildesheim, Dept Biol, Hildesheim, Germany; [Miller, Karl V.] Univ Georgia, Warnell Sch Forestry & Nat Resources, Athens, GA 30602 USA; [Gomez, Santiago] Univ Cadiz, Dept Pathol Anat, Cadiz, Spain	University of Hildesheim; University System of Georgia; University of Georgia; Universidad de Cadiz	Kierdorf, U (corresponding author), Univ Hildesheim, Dept Biol, Hildesheim, Germany.	uwe.kierdorf@uni-hildesheim.de	Kierdorf, Uwe/F-2539-2012	Kierdorf, Uwe/0000-0003-0531-2460; Kierdorf, Horst/0000-0001-6411-9631; Flohr, Stefan/0000-0001-8205-849X				BANKS WJ, 1974, CALC TISS RES, V14, P257, DOI 10.1007/BF02060300; Bovee JVMG, 2002, J CLIN PATHOL, V55, P226, DOI 10.1136/jcp.55.3.226; Craig, 2016, JUBB KENNEDY PALMERS, P16, DOI DOI 10.1016/B978-0-7020-5317-7.00002-3; Czerniak B, 2016, DORFMAN CZERNIAKS BO, Vsecond; de Brot S, 2013, J VET DIAGN INVEST, V25, P599, DOI 10.1177/1040638713495545; Douville M, 1907, B SOC GEN MED VET, V61, P148; Ealla Kranti Kiran Reddy, 2014, J Oral Maxillofac Pathol, V18, P303, DOI 10.4103/0973-029X.140912; FORSSELL H, 1985, BRIT J ORAL MAX SURG, V23, P183, DOI 10.1016/0266-4356(85)90088-9; GESCHICKTER C.G., 1949, TUMORS OF BONE, V3; Gomez S, 2013, BONE, V52, P506, DOI 10.1016/j.bone.2012.09.015; Goss R.J., 1983, DEER ANTLERS REGENER; GOSS RJ, 1995, ANAT REC, V241, P291, DOI 10.1002/ar.1092410302; GOSS RJ, 1990, SCANNING MICROSCOPY, V4, P715; Gruber G. B., 1937, Nachr Ges Wiss Gottingen (Biol), V3, P9; Herzog G., 1944, SPEZIELLE PATHOLOGIE; Hongo H, 2015, J NEUROL SURG REP, V76, P13, DOI 10.1055/s-0034-1387189; Huegel J, 2013, DEV DYNAM, V242, P1021, DOI 10.1002/dvdy.24010; Jochmann K, 2014, MATRIX BIOL, V34, P55, DOI 10.1016/j.matbio.2013.11.003; KERSCHER A, 1993, ORAL SURG ORAL MED O, V75, P559, DOI 10.1016/0030-4220(93)90224-R; KIERDORF H, 1985, Z JAGDWISS, V31, P52, DOI 10.1007/BF02241565; Kierdorf H, 1995, ANN ANAT, V177, P525, DOI 10.1016/S0940-9602(11)80085-3; Kierdorf U, 2004, ANAT REC PART A, V281A, P1352, DOI 10.1002/ar.a.20127; Kierdorf U, 2013, J ANAT, V223, P364, DOI 10.1111/joa.12091; Kierdorf U, 2011, GERONTOLOGY, V57, P53, DOI 10.1159/000300565; Kim SM, 2016, WORLD J SURG ONCOL, V14, DOI 10.1186/s12957-016-0777-9; Kitsoulis P, 2008, IN VIVO, V22, P633; KNUDSON AG, 1971, P NATL ACAD SCI USA, V68, P820, DOI 10.1073/pnas.68.4.820; La Sala LF, 2012, DIS AQUAT ORGAN, V102, P149, DOI 10.3354/dao02538; Landete-Castillejos T, 2012, BONE, V50, P245, DOI 10.1016/j.bone.2011.10.026; LEONE NC, 1987, J HERED, V78, P171, DOI 10.1093/oxfordjournals.jhered.a110351; Matthews KA, 2012, COMPARATIVE MED, V62, P149; Munk BA, 2015, VET PATHOL, V52, P213, DOI 10.1177/0300985814528216; POOL RR, 1990, TUMORS DOMESTIC ANIM, P157; Resnick D, 1995, DIAGNOSIS BONE JOINT, P3628; Roschger P, 1998, BONE, V23, P319, DOI 10.1016/S8756-3282(98)00112-4; Unni K. K., 2010, DAHLINS BONE TUMORS; von Korff K., 1914, ANAT HEFTE, V51, P691; Wang XM, 1992, J VERTEBR PALEONTOL, V12, P387, DOI 10.1080/02724634.1992.10011467; WILLIAMS ES, 1989, J WILDLIFE DIS, V25, P258, DOI 10.7589/0090-3558-25.2.258; WISLOCKI GB, 1947, ENDOCRINOLOGY, V40, P202, DOI 10.1210/endo-40-3-202	40	8	8	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 15	2017	12	3							e0173775	10.1371/journal.pone.0173775	http://dx.doi.org/10.1371/journal.pone.0173775			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN9HQ	28296944	Green Published, gold			2022-12-27	WOS:000396311700062
J	Yang, ZL; Shen, DG; Yap, PT				Yang, Zhanlong; Shen, Dinggang; Yap, Pew-Thian			Image mosaicking using SURF features of line segments	PLOS ONE			English	Article							STEREO	In this paper, we present a novel image mosaicking method that is based on Speeded-Up Robust Features (SURF) of line segments, aiming to achieve robustness to incident scaling, rotation, change in illumination, and significant affine distortion between images in a panoramic series. Our method involves 1) using a SURF detection operator to locate feature points; 2) rough matching using SURF features of directed line segments constructed via the feature points; and 3) eliminating incorrectly matched pairs using RANSAC (RANdom SAmple Consensus). Experimental results confirm that our method results in high-quality panoramic mosaics that are superior to state-of-the-art methods.	[Yang, Zhanlong] Northwestern Polytech Univ, Sch Marine Sci & Technol, Xian, Shaanxi, Peoples R China; [Yang, Zhanlong; Shen, Dinggang; Yap, Pew-Thian] Univ N Carolina, Dept Radiol, Chapel Hill, NC 27599 USA; [Yang, Zhanlong; Shen, Dinggang; Yap, Pew-Thian] Univ N Carolina, BRIC, Chapel Hill, NC 27599 USA; [Shen, Dinggang] Korea Univ, Dept Brain & Cognit Engn, Seoul, South Korea	Northwestern Polytechnical University; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; Korea University	Yang, ZL (corresponding author), Northwestern Polytech Univ, Sch Marine Sci & Technol, Xian, Shaanxi, Peoples R China.; Yang, ZL (corresponding author), Univ N Carolina, Dept Radiol, Chapel Hill, NC 27599 USA.; Yang, ZL (corresponding author), Univ N Carolina, BRIC, Chapel Hill, NC 27599 USA.	zhanlongy@gmail.com	Shen, Dinggang/ABF-6812-2020	Shen, Dinggang/0000-0002-7934-5698	National Natural Science Foundation of China [61540047]; Northwestern Polytechnical University Foundation for Fundamental Research [NPU-FFRJC201226]; NIH [NS093842, EB006733, EB008374, EB009634]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Northwestern Polytechnical University Foundation for Fundamental Research; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was partially supported by the National Natural Science Foundation of China (No. 61540047), the Northwestern Polytechnical University Foundation for Fundamental Research (NPU-FFRJC201226), and NIH grants (NS093842, EB006733, EB008374, and EB009634). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This work was partially supported by the National Natural Science Foundation of China (No. 61540047), the Northwestern Polytechnical University Foundation for Fundamental Research (NPU-FFRJC201226), and NIH grants (NS093842, EB006733, EB008374, and EB009634).	Alahi A, 2012, PROC CVPR IEEE, P510, DOI 10.1109/CVPR.2012.6247715; Bay H, 2006, LECT NOTES COMPUT SC, V3951, P404, DOI 10.1007/11744023_32; Byrne J, 2013, IEEE I CONF COMP VIS, P1201, DOI 10.1109/ICCV.2013.152; Chae KY, 2005, LECT NOTES ARTIF INT, V3802, P947; Chen G, 2016, NEUROCOMPUTING, V177, P215, DOI 10.1016/j.neucom.2015.11.031; Chiu YH, 2014, J VIS COMMUN IMAGE R, V25, P1791, DOI 10.1016/j.jvcir.2014.07.003; FISCHLER MA, 1981, COMMUN ACM, V24, P381, DOI 10.1145/358669.358692; Francis HM, 1980, PHOTOGRAMMETRY; Guan T, 2015, ACM T INTEL SYST TEC, V7, DOI 10.1145/2795234; Ji RR, 2016, PATTERN RECOGN, V59, P268, DOI 10.1016/j.patcog.2016.03.016; Ji RR, 2014, IEEE T IMAGE PROCESS, V23, P3099, DOI 10.1109/TIP.2014.2324291; Lei F, 2014, C IND ELECT APPL, P79, DOI 10.1109/ICIEA.2014.6931135; Li ST, 2017, INFORM FUSION, V33, P100, DOI 10.1016/j.inffus.2016.05.004; Lindeberg T, 1998, INT J COMPUT VISION, V30, P79, DOI 10.1023/A:1008045108935; Lowe DG, 2004, INT J COMPUT VISION, V60, P91, DOI 10.1023/B:VISI.0000029664.99615.94; Matas J, 2004, IMAGE VISION COMPUT, V22, P761, DOI 10.1016/j.imavis.2004.02.006; Mesejo P, 2016, APPL SOFT COMPUT, V44, P1, DOI 10.1016/j.asoc.2016.03.004; Mikolajczyk K, 2005, INT J COMPUT VISION, V65, P43, DOI 10.1007/s11263-005-3848-x; Mikolajczyk K, 2005, IEEE T PATTERN ANAL, V27, P1615, DOI 10.1109/TPAMI.2005.188; Mikolajczyk K, 2002, LECT NOTES COMPUT SC, V2350, P128, DOI 10.1007/3-540-47969-4_9; Ozuysal M, 2010, IEEE T PATTERN ANAL, V32, P448, DOI 10.1109/TPAMI.2009.23; Saur G, 2014, P SPIE C VID SURV TR, P9026; SHI JB, 1994, 1994 IEEE COMPUTER SOCIETY CONFERENCE ON COMPUTER VISION AND PATTERN RECOGNITION, PROCEEDINGS, P593, DOI 10.1109/CVPR.1994.323794; Shum HY, 2000, INT J COMPUT VISION, V36, P101, DOI 10.1023/A:1008195814169; Simard PY, 1999, ADV NEUR IN, V11, P571; Sooknanan K, 2012, OCEANS-IEEE; Tuytelaars T., 2000, BMV2000. Proceedings of the 11th British Machine Vision Conference, P412; Viola P, 2001, PROC CVPR IEEE, P511, DOI 10.1109/cvpr.2001.990517; Yang ZL, 2008, 2008 FOURTH INTERNATIONAL CONFERENCE ON INTELLIGENT INFORMATION HIDING AND MULTIMEDIA SIGNAL PROCESSING, PROCEEDINGS, P1422, DOI 10.1109/IIH-MSP.2008.335; Zhang Y, 2015, SIGNAL PROCESS, V112, P17, DOI 10.1016/j.sigpro.2014.08.029; Zhu J, 2014, COMP MATH MATH PHYS, V115, P46; Zhu Jun, 2011, Journal of Nanjing University of Science and Technology, V35, P755	33	11	11	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 15	2017	12	3							e0173627	10.1371/journal.pone.0173627	http://dx.doi.org/10.1371/journal.pone.0173627			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN9HQ	28296919	Green Published, Green Submitted, gold			2022-12-27	WOS:000396311700046
J	Peled, M; Nishi, H; Weinstock, A; Barrett, TJ; Zhou, F; Quezada, A; Fisher, EA				Peled, Michael; Nishi, Hitoo; Weinstock, Ada; Barrett, Tessa J.; Zhou, Felix; Quezada, Alexandra; Fisher, Edward A.			A wild-type mouse-based model for the regression of inflammation in atherosclerosis	PLOS ONE			English	Article							AUTOSOMAL-DOMINANT HYPERCHOLESTEROLEMIA; PCSK9 GENE; KNOCKOUT MICE; PROGRESSION; INHIBITION; MUTATIONS; INDUCTION; THERAPY; DIET	Atherosclerosis can be induced by the injection of a gain-of-function mutant of proprotein convertase subtilisin/kexin type 9 (PCSK9)-encoding adeno-associated viral vector (AAVmPCSK9), avoiding the need for knockout mice models, such as low-density lipoprotein receptor deficient mice. As regression of atherosclerosis is a crucial therapeutic goal, we aimed to establish a regression model based on AAVmPCSK9, which will eliminate the need for germ-line genetic modifications. C57BL6/J mice were injected with AAVmPCSK9 and were fed with Western diet for 16 weeks, followed by reversal of hyperlipidemia by a diet switch to chow and treatment with a microsomal triglyceride transfer protein inhibitor (MTPi). Sixteen weeks following AAVmPCSK9 injection, mice had advanced atherosclerotic lesions in the aortic root. Surprisingly, diet switch to chow alone reversed hyperlipidemia to near normal levels, and the addition of MTPi completely normalized hyperlipidemia. A six week reversal of hyperlipidemia, either by diet switch alone or by diet switch and MTPi treatment, was accompanied by regression of atherosclerosis as defined by a significant decrease of macrophages in the atherosclerotic plaques, compared to baseline. Thus, we have established an atherosclerosis regression model that is independent of the genetic background.	[Fisher, Edward A.] NYU, Sch Med, Dept Med, Leon H Charney Div Cardiol, New York, NY 10003 USA; NYU, Sch Med, Dept Med, Marc & Ruti Bell Program Vasc Biol, New York, NY USA	New York University; New York University	Fisher, EA (corresponding author), NYU, Sch Med, Dept Med, Leon H Charney Div Cardiol, New York, NY 10003 USA.	Edward.fisher@nyumc.org	Fisher, Edward/ABE-7469-2020	Zhou, Felix/0000-0002-8619-7160; Fisher, Edward/0000-0001-9802-143X; Weinstock, Ada/0000-0003-3619-3388; Barrett, Tessa/0000-0003-0751-1578	NIH [HL084312, HL117226, DK095684]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK020541] Funding Source: NIH RePORTER; Grants-in-Aid for Scientific Research [16H06901] Funding Source: KAKEN	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	These studies were supported by NIH grants HL084312, HL117226, DK095684 (EAF). The funders had no role in study design,data collection and analysis, decision to publish,or preparation of the manuscript.	Abboud S, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001043; Abifadel M, 2012, ATHEROSCLEROSIS, V223, P394, DOI 10.1016/j.atherosclerosis.2012.04.006; Bjorklund MM, 2014, CIRC RES, V114, P1684, DOI 10.1161/CIRCRESAHA.114.302937; Brautbar A, 2011, NAT REV CARDIOL, V8, P253, DOI 10.1038/nrcardio.2011.2; Buhman KK, 2000, NAT MED, V6, P1341, DOI 10.1038/82153; Cunningham D, 2007, NAT STRUCT MOL BIOL, V14, P413, DOI 10.1038/nsmb1235; Feig JE, 2011, CIRCULATION, V123, P989, DOI 10.1161/CIRCULATIONAHA.110.984146; Hewing B, 2013, ATHEROSCLEROSIS, V227, P125, DOI 10.1016/j.atherosclerosis.2012.12.026; ISHIBASHI S, 1993, J CLIN INVEST, V92, P883, DOI 10.1172/JCI116663; Josekutty J, 2013, J BIOL CHEM, V288, P14372, DOI 10.1074/jbc.M113.459602; Kim WR, 2008, HEPATOLOGY, V47, P1363, DOI 10.1002/hep.22109; Leren TP, 2004, CLIN GENET, V65, P419, DOI 10.1111/j.0009-9163.2004.0238.x; Li J, 2007, BIOCHEM J, V406, P203, DOI 10.1042/BJ20070664; Lieu HD, 2003, CIRCULATION, V107, P1315, DOI 10.1161/01.CIR.0000054781.50889.0C; Lytle KA, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0146942; Maxwell KN, 2004, P NATL ACAD SCI USA, V101, P7100, DOI 10.1073/pnas.0402133101; Nissen SE, 2006, JAMA-J AM MED ASSOC, V295, P1556, DOI 10.1001/jama.295.13.jpc60002; Parathath S, 2011, DIABETES, V60, P1759, DOI 10.2337/db10-0778; Peled M, 2014, FRONT IMMUNOL, V5, DOI 10.3389/fimmu.2014.00579; PLUMP AS, 1992, CELL, V71, P343, DOI 10.1016/0092-8674(92)90362-G; Roche-Molina M, 2015, ARTERIOSCL THROM VAS, V35, P50, DOI 10.1161/ATVBAHA.114.303617; Sands MS, 2011, METHODS MOL BIOL, V807, P141, DOI 10.1007/978-1-61779-370-7_6; Timms KM, 2004, HUM GENET, V114, P349, DOI 10.1007/s00439-003-1071-9; Tolani S, 2013, ATHEROSCLEROSIS, V229, P79, DOI 10.1016/j.atherosclerosis.2013.03.031; Ueshima K, 2005, BIOL PHARM BULL, V28, P247, DOI 10.1248/bpb.28.247	25	27	27	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 14	2017	12	3							e0173975	10.1371/journal.pone.0173975	http://dx.doi.org/10.1371/journal.pone.0173975			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN6DM	28291840	Green Published, Green Submitted, gold			2022-12-27	WOS:000396094700052
J	El Karoui, I; Christoforidis, K; Naccache, L				El Karoui, Imen; Christoforidis, Kalliopi; Naccache, Lionel			Can application and transfer of strategy be observed in low visibility condition?	PLOS ONE			English	Article							ANTERIOR CINGULATE CORTEX; MEDIAL FRONTAL-CORTEX; CONFLICT ADAPTATION; RESPONSE CONFLICT; COGNITIVE CONTROL; EXECUTIVE CONTROL; STOP-SIGNAL; PROPORTION; AWARENESS; TASK	It has been long assumed that cognitive control processes can only be applied on consciously visible stimuli, but empirical evidence is contradictory. In the present study, we investigated strategic adaptation to conflict both in unmasked and in low-visibility masked trials. Using a paradigm derived from the Stroop task, we studied the application of strategies, but also the transfer of a strategy developed in unmasked trials to masked trials, and the trial-to-trial dynamics of strategic processing. In unmasked trials, we found evidence of strategic adaptation to conflict, both in reaction times and in ERPs (N2 and P300). In masked trials we found no evidence of behavioral adaptation to conflict, but a modulation of the P300 was present in masked trials included in unmasked blocks, suggesting the existence of a transfer of strategy. Finally, trial-to-trial analyses in unmasked trials revealed a pattern suggestive of dynamic subjective adherence to the instructed strategy.	[El Karoui, Imen; Christoforidis, Kalliopi; Naccache, Lionel] INSERM, U1127, Paris, France; [El Karoui, Imen; Christoforidis, Kalliopi; Naccache, Lionel] CNRS, UMR 7225, Paris, France; [El Karoui, Imen; Christoforidis, Kalliopi; Naccache, Lionel] Univ Paris 06, Sorbonne Univ, UMRS 1127, Paris, France; [El Karoui, Imen; Christoforidis, Kalliopi; Naccache, Lionel] Inst Cerveau & Moelle Epiniere ICM, Paris, France; [Naccache, Lionel] Hop La Pitie Salpetriere, AP HP, Dept Neurophysiol, Paris, France	Institut National de la Sante et de la Recherche Medicale (Inserm); Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Sorbonne Universite; UDICE-French Research Universities; Sorbonne Universite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; UDICE-French Research Universities; Sorbonne Universite	El Karoui, I; Naccache, L (corresponding author), INSERM, U1127, Paris, France.; El Karoui, I; Naccache, L (corresponding author), CNRS, UMR 7225, Paris, France.; El Karoui, I; Naccache, L (corresponding author), Univ Paris 06, Sorbonne Univ, UMRS 1127, Paris, France.; El Karoui, I; Naccache, L (corresponding author), Inst Cerveau & Moelle Epiniere ICM, Paris, France.; Naccache, L (corresponding author), Hop La Pitie Salpetriere, AP HP, Dept Neurophysiol, Paris, France.	imen.elkaroui@gmail.com; lionel.naccache@gmail.com		naccache, lionel/0000-0002-2874-1009	program 'Investissements d'avenir' [ANR-10-IAIHU-06]; AXA Research Fund; 'Equipe FRM' grant of Fondation pour la Recherche Medicale (FRM)	program 'Investissements d'avenir'(French National Research Agency (ANR)); AXA Research Fund(AXA Research Fund); 'Equipe FRM' grant of Fondation pour la Recherche Medicale (FRM)	This work was supported by the program 'Investissements d'avenir' ANR-10-IAIHU-06, an AXA Research Fund grant to IEK and an 'Equipe FRM 2015' grant of Fondation pour la Recherche Medicale (FRM) to LN.	Ansorge U, 2005, J EXP PSYCHOL HUMAN, V31, P762, DOI 10.1037/0096-1523.31.4.762; Ansorge U, 2014, CONSCIOUS COGN, V27, P268, DOI 10.1016/j.concog.2014.05.009; Ansorge U, 2011, PSYCHOL RES-PSYCH FO, V75, P351, DOI 10.1007/s00426-010-0313-4; Bodner GE, 2004, MEM COGNITION, V32, P1, DOI 10.3758/BF03195815; Bodner GE, 2001, J MEM LANG, V45, P616, DOI 10.1006/jmla.2001.2791; Bodner GE, 2010, EXP PSYCHOL, V57, P360, DOI 10.1027/1618-3169/a000043; Bonini F, 2014, SCIENCE, V343, P888, DOI 10.1126/science.1247412; Botvinick MM, 2004, TRENDS COGN SCI, V8, P539, DOI 10.1016/j.tics.2004.10.003; Botvinick MM, 2001, PSYCHOL REV, V108, P624, DOI 10.1037//0033-295X.108.3.624; Carter CS, 2000, P NATL ACAD SCI USA, V97, P1944, DOI 10.1073/pnas.97.4.1944; Clayson PE, 2011, NEUROPSYCHOLOGIA, V49, P1953, DOI 10.1016/j.neuropsychologia.2011.03.023; Danielmeier C, 2009, PSYCHOPHYSIOLOGY, V46, P1288, DOI 10.1111/j.1469-8986.2009.00860.x; Daza MT, 2002, PERCEPT PSYCHOPHYS, V64, P1316, DOI 10.3758/BF03194774; Dehaene S, 2001, COGNITION, V79, P1, DOI 10.1016/S0010-0277(00)00123-2; Desender K, 2014, PSYCHOL SCI, V25, P675, DOI 10.1177/0956797613511468; Desender K, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055976; Desender K, 2012, FRONT HUM NEUROSCI, V6, DOI 10.3389/fnhum.2012.00003; Dupoux E, 2008, COGNITION, V109, P267, DOI 10.1016/j.cognition.2008.06.012; Folstein JR, 2008, PSYCHOPHYSIOLOGY, V45, P152, DOI 10.1111/j.1469-8986.2007.00602.x; Forster SE, 2011, J COGNITIVE NEUROSCI, V23, P923, DOI 10.1162/jocn.2010.21458; Fruhholz S, 2011, NEUROIMAGE, V54, P622, DOI 10.1016/j.neuroimage.2010.07.071; GRATTON G, 1992, J EXP PSYCHOL GEN, V121, P480, DOI 10.1037/0096-3445.121.4.480; Greenwald AG, 1996, SCIENCE, V273, P1699, DOI 10.1126/science.273.5282.1699; Hanslmayr S, 2008, J COGNITIVE NEUROSCI, V20, P215, DOI 10.1162/jocn.2008.20020; Jack AI, 2001, COGNITION, V79, P161, DOI 10.1016/S0010-0277(00)00128-1; Jaskowski P, 2003, J COGNITIVE NEUROSCI, V15, P911, DOI 10.1162/089892903322370825; Funes MJ, 2010, COGNITION, V114, P338, DOI 10.1016/j.cognition.2009.10.007; Jiang J, 2013, NEUROPSYCHOLOGIA, V51, P2791, DOI 10.1016/j.neuropsychologia.2013.09.020; Kentridge RW, 1999, P ROY SOC B-BIOL SCI, V266, P1805, DOI 10.1098/rspb.1999.0850; Kerns JG, 2004, SCIENCE, V303, P1023, DOI 10.1126/science.1089910; Kiefer M, 2006, J COGNITIVE NEUROSCI, V18, P184, DOI 10.1162/089892906775783688; Kiefer M, 2012, FRONT HUM NEUROSCI, V6, DOI 10.3389/fnhum.2012.00061; Kinoshita S, 2008, COGNITION, V107, P623, DOI 10.1016/j.cognition.2007.11.011; Kinoshita S, 2011, J EXP PSYCHOL GEN, V140, P622, DOI 10.1037/a0024230; Klapp ST, 2007, J EXP PSYCHOL HUMAN, V33, P1366, DOI 10.1037/0096-1523.33.6.1366; Kopp B, 1996, PSYCHOPHYSIOLOGY, V33, P282, DOI 10.1111/j.1469-8986.1996.tb00425.x; Kunde W, 2003, PSYCHON B REV, V10, P198, DOI 10.3758/BF03196485; Kunde W, 2012, ADV COGN PSYCHOL, V8, P9, DOI [10.2478/v10053-008-0097-x, 10.5709/acp-0097-x]; Lamy D, 2009, J COGNITIVE NEUROSCI, V21, P1435, DOI 10.1162/jocn.2009.21064; Lau HC, 2007, J NEUROSCI, V27, P5805, DOI 10.1523/JNEUROSCI.4335-06.2007; LOGAN GD, 1979, MEM COGNITION, V7, P166, DOI 10.3758/BF03197535; LOGAN GD, 1982, J EXP PSYCHOL HUMAN, V8, P778, DOI 10.1037/0096-1523.8.6.778; Maris E, 2007, J NEUROSCI METH, V164, P177, DOI 10.1016/j.jneumeth.2007.03.024; Marzouki Y, 2007, ACTA PSYCHOL, V126, P34, DOI 10.1016/j.actpsy.2006.11.002; Mayr U, 2003, NAT NEUROSCI, V6, P450, DOI 10.1038/nn1051; Merikle PM, 1997, CONSCIOUS COGN, V6, P219, DOI 10.1006/ccog.1997.0310; MERIKLE PM, 1987, ADV CONSUM RES, V14, P298; Merikle PM, 1995, CONSCIOUS COGN, V4, P422, DOI 10.1006/ccog.1995.1049; Monsell S, 2003, TRENDS COGN SCI, V7, P134, DOI 10.1016/S1364-6613(03)00028-7; Naccache L, 2002, PSYCHOL SCI, V13, P416, DOI 10.1111/1467-9280.00474; Naccache L, 2001, COGNITION, V80, P215, DOI 10.1016/S0010-0277(00)00139-6; Naccache L, 2006, NOUVEL INCONSCIENT F; Nieuwenhuis S, 2003, COGN AFFECT BEHAV NE, V3, P17, DOI 10.3758/CABN.3.1.17; Norman D., 2013, DESIGN EVERYDAY THIN; Oostenveld R, 2011, COMPUT INTEL NEUROSC, V2011, DOI 10.1155/2011/156869; Ortells JJ, 2003, ACTA PSYCHOL, V114, P185, DOI 10.1016/j.actpsy.2003.08.002; PARDO JV, 1990, P NATL ACAD SCI USA, V87, P256, DOI 10.1073/pnas.87.1.256; Polich J, 2007, CLIN NEUROPHYSIOL, V118, P2128, DOI 10.1016/j.clinph.2007.04.019; Pratte MS, 2009, ATTEN PERCEPT PSYCHO, V71, P1276, DOI 10.3758/APP.71.6.1276; Reuss H, 2014, J EXP PSYCHOL GEN, V143, P1701, DOI 10.1037/a0036437; Ridderinkhof KR, 2004, SCIENCE, V306, P443, DOI 10.1126/science.1100301; Rohaut B, 2016, NEUROSCI CONSCIOUS, DOI 10.1093/nc/niw010; Schmidt JR, 2013, PSYCHON B REV, V20, P615, DOI 10.3758/s13423-012-0373-0; Sergent C, 2013, CURR BIOL, V23, P150, DOI 10.1016/j.cub.2012.11.047; Sternberg S, 2001, ACTA PSYCHOL, V106, P147, DOI 10.1016/S0001-6918(00)00045-7; Stroop JR, 1935, J EXP PSYCHOL, V18, P643, DOI 10.1037/h0054651; Van den Bussche E, 2008, CONSCIOUS COGN, V17, P1345, DOI 10.1016/j.concog.2007.08.005; van Gaal S, 2008, J NEUROSCI, V28, P8053, DOI 10.1523/JNEUROSCI.1278-08.2008; van Gaal S, 2014, PHILOS T R SOC B, V369, DOI 10.1098/rstb.2013.0212; van Gaal S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011508; van Gaal S, 2009, J EXP PSYCHOL HUMAN, V35, P1129, DOI 10.1037/a0013551; van Veen V, 2002, J COGNITIVE NEUROSCI, V14, P593, DOI 10.1162/08989290260045837	73	3	3	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 13	2017	12	3							e0173679	10.1371/journal.pone.0173679	http://dx.doi.org/10.1371/journal.pone.0173679			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EN6CP	28288178	Green Submitted, Green Published, gold			2022-12-27	WOS:000396092400028
J	Missaire, M; Fraize, N; Joseph, MA; Hamieh, A; Parmentier, R; Marighetto, A; Salin, PA; Malleret, G				Missaire, Megane; Fraize, Nicolas; Joseph, Mickael Antoine; Hamieh, Al Mahdy; Parmentier, Regis; Marighetto, Aline; Salin, Paul Antoine; Malleret, Gael			Long-term effects of interference on short-term memory performance in the rat	PLOS ONE			English	Article							ADULT HIPPOCAMPAL NEUROGENESIS; WORKING-MEMORY; SPATIAL MEMORY; SYNAPTIC PLASTICITY; PROACTIVE-INHIBITION; RETENTION; TIME; REORGANIZATION; ENHANCEMENT; SYNAPSES	A distinction has always been made between long-term and short-term memory (also now called working memory, WM). The obvious difference between these two kinds of memory concerns the duration of information storage: information is supposedly transiently stored in WM while it is considered durably consolidated into long-term memory. It is well acknowledged that the content of WM is erased and reset after a short time, to prevent irrelevant information from proactively interfering with newly stored information. In the present study, we used typical WM radial maze tasks to question the brief lifespan of spatial WM content in rodents. Groups of rats were submitted to one of two different WM tasks in a radial maze: a WM task involving the repetitive presentation of a same pair of arms expected to induce a high level of proactive interference (PI) (HIWM task), or a task using a different pair in each trial expected to induce a low level of PI (LIWM task). Performance was effectively lower in the HIWM group than in LIWM in the final trial of each training session, indicative of a "within-session/short-term" PI effect. However, we also observed a different "between-sessionn/long-term" PI effect between the two groups: while performance of LIWM trained rats remained stable over days, the performance of HIWM rats dropped after 10 days of training, and this impairment was visible from the very first trial of the day, hence not attributable to within-session PI. We also showed that a 24 hour-gap across training sessions known to allow consolidation processes to unfold, was a necessary and sufficient condition for the long-term PI effect to occur. These findings suggest that in the HIWM task, WM content was not entirely reset between training sessions and that, in specific conditions, WM content can outlast its purpose by being stored more permanently, generating a long-term deleterious effect of PI. The alternative explanation is that WM content could be transferred and stored more permanently in an intermediary form or memory between WM and long-term memory.	[Missaire, Megane; Fraize, Nicolas; Joseph, Mickael Antoine; Hamieh, Al Mahdy; Parmentier, Regis; Salin, Paul Antoine; Malleret, Gael] Univ Lyon 1, Forgetting & Cort Dynam Team, Lyon Neurosci Res Ctr CRNL, Lyon, France; [Parmentier, Regis; Salin, Paul Antoine; Malleret, Gael] CNRS, Lyon, France; [Parmentier, Regis; Salin, Paul Antoine; Malleret, Gael] INSERM, Lyon, France; [Marighetto, Aline] Univ Bordeaux, Neuroctr Magendie, INSERM, U1215, Bordeaux, France	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Claude Bernard Lyon 1; Centre National de la Recherche Scientifique (CNRS); Institut National de la Sante et de la Recherche Medicale (Inserm); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite de Bordeaux	Malleret, G (corresponding author), Univ Lyon 1, Forgetting & Cort Dynam Team, Lyon Neurosci Res Ctr CRNL, Lyon, France.; Malleret, G (corresponding author), CNRS, Lyon, France.; Malleret, G (corresponding author), INSERM, Lyon, France.	gaelmalleret@gmail.com	JOSEPH, M A/GYJ-5320-2022; joseph, Mickael/AAY-2966-2021	JOSEPH, M A/0000-0001-8661-0042; joseph, Mickael/0000-0002-5008-0542; Missaire, Megane/0000-0002-6138-2431; Marighetto, Aline/0000-0002-8893-278X; Salin, Paul/0000-0001-5221-9109	Centre national de la recherche scientifique (CNRS, ATIP program); Fondation pour la recherche sur le cerveau (FRC); Fondation pour la recherche medicale [FRM-FDT20130928087]; Region RhOne-Alpes (ARC2 doctoral fellowship)	Centre national de la recherche scientifique (CNRS, ATIP program); Fondation pour la recherche sur le cerveau (FRC); Fondation pour la recherche medicale(Fondation pour la Recherche Medicale); Region RhOne-Alpes (ARC2 doctoral fellowship)(Region Auvergne-Rhone-Alpes)	This work was supported by grants received by G.M. from Centre national de la recherche scientifique (CNRS, ATIP program) (http://www.cnrs.fr/) and Fondation pour la recherche sur le cerveau (FRC) (http://www.frcneurodon.org/). M.A.J and N.F. were also supported by Fondation pour la recherche medicale (FRM-FDT20130928087) (https://www.frm.org/) and Region RhOne-Alpes (ARC2 doctoral fellowship) (http://www.arc.rhonealpes.fr/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al Abed AS, 2016, PSYCHONEUROENDOCRINO, V69, P77, DOI 10.1016/j.psyneuen.2016.03.014; Atkinson R. C., 1968, PSYCHOL LEARN MOTIVA, V2, P89, DOI 10.1016/S0079-7421(08)60422-3; BADDELEY A, 1981, COGNITION, V10, P17, DOI 10.1016/0010-0277(81)90020-2; Baddeley A, 2010, CURR BIOL, V20, pR136, DOI 10.1016/j.cub.2009.12.014; Baddeley A, 2012, ANNU REV PSYCHOL, V63, P1, DOI 10.1146/annurev-psych-120710-100422; Beaman CP, 2010, CURR ANTHROPOL, V51, pS27, DOI 10.1086/650297; Becker S, 2005, HIPPOCAMPUS, V15, P722, DOI 10.1002/hipo.20095; Bello-Medina PC, 2013, BEHAV BRAIN RES, V250, P102, DOI 10.1016/j.bbr.2013.04.047; BERRYMAN R, 1963, J EXP ANAL BEHAV, V6, P101, DOI 10.1901/jeab.1963.6-101; Besnard A, 2012, PROG NEUROBIOL, V99, P61, DOI 10.1016/j.pneurobio.2012.07.002; Bigelow J, 2015, HEARING RES, V327, P69, DOI 10.1016/j.heares.2015.05.002; Bohbot V, 1996, P NATL ACAD SCI USA, V93, P4016, DOI 10.1073/pnas.93.9.4016; Bontempi B, 1999, NATURE, V400, P671, DOI 10.1038/23270; Cepeda NJ, 2006, PSYCHOL BULL, V132, P354, DOI 10.1037/0033-2909.132.3.354; CERMAK LS, 1970, J EXP PSYCHOL, V84, P499, DOI 10.1037/h0029298; Clelland CD, 2009, SCIENCE, V325, P210, DOI 10.1126/science.1173215; COHEN NJ, 1980, SCIENCE, V210, P207, DOI 10.1126/science.7414331; Cowan N, 1997, PSYCHON B REV, V4, P393, DOI 10.3758/BF03210799; Cowan N, 2001, BEHAV BRAIN SCI, V24, P87, DOI 10.1017/S0140525X01003922; Cowan N., 2005, CURR DIR PSYCHOL SCI, V19, P51, DOI [10.1177/0963721409359277, DOI 10.1177/0963721409359277]; Cowan N, 2008, PROG BRAIN RES, V169, P323, DOI 10.1016/S0079-6123(07)00020-9; Craig KS, 2013, MEM COGNITION, V41, P650, DOI 10.3758/s13421-012-0287-0; De Jaeger X, 2014, LEARN MEMORY, V21, P316, DOI 10.1101/lm.033415.113; Doetsch F, 2005, CURR OPIN NEUROBIOL, V15, P121, DOI 10.1016/j.conb.2005.01.018; Donovan JJ, 1999, J APPL PSYCHOL, V84, P795, DOI 10.1037/0021-9010.84.5.795; Draaisma Douwe, 2000, METAPHORS MEMORY HIS; Drew LJ, 2013, LEARN MEMORY, V20, P710, DOI 10.1101/lm.026542.112; Dudchenko PA, 2004, NEUROSCI BIOBEHAV R, V28, P699, DOI 10.1016/j.neubiorev.2004.09.002; Ebbinghaus H., 1885, MEMORY CONTRIBUTION; Eichenbaum H, 1999, NEURON, V23, P209, DOI 10.1016/S0896-6273(00)80773-4; Fraize N, 2016, SLEEP; Fraize N, 2017, LEARN MEMORY, V24, P86, DOI 10.1101/lm.043505.116; Fuster JM, 2008, PREFRONTAL CORTEX, 4TH EDITION, P333, DOI 10.1016/B978-0-12-373644-4.00008-6; Fuster Joaquin M., 1995, Biological Research, V28, P59; Hartshorne JK, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002716; James W., 1890, PRINCIPLES PSYCHOL, V2, P283; Jonides J, 2008, ANNU REV PSYCHOL, V59, P193, DOI 10.1146/annurev.psych.59.103006.093615; Joseph MA, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0142065; Joyce AW, 2016, APPL NEUROPSYCH-CHIL, V5, P223, DOI 10.1080/21622965.2016.1167497; Katus T, 2016, NEUROIMAGE; KEPPEL G, 1962, J VERB LEARN VERB BE, V1, P153, DOI 10.1016/S0022-5371(62)80023-1; KINCAID JP, 1970, J EXP PSYCHOL, V86, P313, DOI 10.1037/h0029991; Knierim JJ, 2015, NEUROBIOL LEARN MEM; Kraemer PJ, 1997, PSYCHON B REV, V4, P480, DOI 10.3758/BF03214337; Levy BJ, 2010, CURR ISS MEM, P135; Ma WJ, 2014, NAT NEUROSCI, V17, P347, DOI 10.1038/nn.3655; Malleret G, 2001, CELL, V104, P675, DOI 10.1016/S0092-8674(01)00264-1; Malleret G, 2010, J NEUROSCI, V30, P3813, DOI 10.1523/JNEUROSCI.1330-09.2010; Martin SJ, 2007, CELL MOL LIFE SCI, V64, P401, DOI 10.1007/s00018-007-6336-3; Mauelshagen J, 1998, LEARN MEMORY, V5, P246; Maviel T, 2004, SCIENCE, V305, P96, DOI 10.1126/science.1098180; May CP, 1999, MEM COGNITION, V27, P759, DOI 10.3758/BF03198529; MILLER GA, 1956, PSYCHOL REV, V63, P81, DOI 10.1037/h0043158; Miller GA, 1960, PLANS STRUCTURE BEHA; Nicholls RE, 2008, NEURON, V58, P104, DOI 10.1016/j.neuron.2008.01.039; O'Keefe J, 1993, Curr Opin Neurobiol, V3, P917, DOI 10.1016/0959-4388(93)90163-S; OLTON DS, 1979, AM PSYCHOL, V34, P583, DOI 10.1037/0003-066X.34.7.583; OVERMAN WH, 1980, NEUROSCIENCE, V5, P1825, DOI 10.1016/0306-4522(80)90032-9; Pagani MR, 2009, CELL, V139, P186, DOI 10.1016/j.cell.2009.08.033; Pasternak T, 2005, NAT REV NEUROSCI, V6, P97, DOI [10.1038/nrn1603, 10.1038/nrn1637]; Peigneux P, 2004, NEURON, V44, P535, DOI 10.1016/j.neuron.2004.10.007; Poirier GL, 2008, J NEUROSCI, V28, P1034, DOI 10.1523/JNEUROSCI.4607-07.2008; Rasch B, 2013, PHYSIOL REV, V93, P681, DOI 10.1152/physrev.00032.2012; Rauchs G, 2005, J SLEEP RES, V14, P123, DOI 10.1111/j.1365-2869.2005.00450.x; ROBERTS WA, 1981, LEARN MOTIV, V12, P261, DOI 10.1016/0023-9690(81)90009-6; Sahay A, 2011, NATURE, V472, P466, DOI 10.1038/nature09817; Saxe MD, 2007, P NATL ACAD SCI USA, V104, P4642, DOI 10.1073/pnas.0611718104; Smolen P, 2016, NAT REV NEUROSCI, V17, P77, DOI 10.1038/nrn.2015.18; Snyder JS, 2001, J NEUROPHYSIOL, V85, P2423, DOI 10.1152/jn.2001.85.6.2423; Squire LR, 1996, P NATL ACAD SCI USA, V93, P13515, DOI 10.1073/pnas.93.24.13515; Stiernstromer ES, 2016, INT J PSYCHOL, V51, P312, DOI 10.1002/ijop.12194; Tang YP, 1999, NATURE, V401, P63, DOI 10.1038/43432; TULVING E, 1987, HUM NEUROBIOL, V6, P67; TZENG OJL, 1980, J EXP PSYCHOL-HUM L, V6, P705, DOI 10.1037/0278-7393.6.6.705; UNDERWOOD BJ, 1957, PSYCHOL REV, V64, P49, DOI 10.1037/h0044616; Visscher KM, 2007, PLOS BIOL, V5, P662, DOI 10.1371/journal.pbio.0050056; Walrave L, 2016, FRONT CELL NEUROSCI, V10, DOI 10.3389/fncel.2016.00288; WRIGHT AA, 1985, SCIENCE, V229, P287, DOI 10.1126/science.9304205; Xie WD, 2018, COMP M BIO BIO E-IV, V6, P283, DOI 10.1080/21681163.2016.1149104; Yang JJ, 2014, FRONT HUM NEUROSCI, V8, DOI 10.3389/fnhum.2014.00926; Yassa MA, 2011, TRENDS NEUROSCI, V34, P515, DOI 10.1016/j.tins.2011.06.006; Zeng HK, 2001, CELL, V107, P617, DOI 10.1016/S0092-8674(01)00585-2	82	2	2	1	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 13	2017	12	3							e0173834	10.1371/journal.pone.0173834	http://dx.doi.org/10.1371/journal.pone.0173834			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EN6CP	28288205	gold, Green Submitted, Green Published			2022-12-27	WOS:000396092400038
J	Rao, HL; Pradhan, ZS; Weinreb, RN; Riyazuddin, M; Dasari, S; Venugopal, JP; Puttaiah, NK; Rao, DAS; Devi, S; Mansouri, K; Webers, CAB				Rao, Harsha L.; Pradhan, Zia S.; Weinreb, Robert N.; Riyazuddin, Mohammed; Dasari, Srilakshmi; Venugopal, Jayasree P.; Puttaiah, Narendra K.; Rao, Dhanaraj A. S.; Devi, Sathi; Mansouri, Kaweh; Webers, Carroll A. B.			A comparison of the diagnostic ability of vessel density and structural measurements of optical coherence tomography in primary open angle glaucoma	PLOS ONE			English	Article							NORMAL-TENSION GLAUCOMA; DISC PERFUSION; SPECTRUM BIAS; VISUAL-FIELD; ANGIOGRAPHY; ACCURACY; PATHOPHYSIOLOGY; SEVERITY; DESIGN; EYES	Purpose To compare the diagnostic abilities of vessel density measurements of the optic nerve head (ONH), peripapillary and macular regions on optical coherence tomography (OCT) angiography in eyes with primary open angle glaucoma (POAG) with that of the ONH rim area, peripapillary retinal nerve fiber layer (RNFL) thickness and the macular ganglion cell complex (GCC) thickness measurements. Methods In a cross sectional study, 78 eyes of 50 control subjects and 117 eyes of 67 POAG patients underwent vessel density and structural measurements with spectral domain OCT. POAG was diagnosed based on the masked evaluation of optic disc stereo photographs. Area under receiver operating characteristic curves (AUC) and sensitivities at fixed specificities of vessel densities in ONH, peripapillary and macular regions were compared with rim area, RNFL and GCC thickness. Results The AUC (sensitivity at 95% specificity) of average vessel densities within the ONH, peripapillary and macular region were 0.77 (31%), 0.85 (56%) and 0.70 (18%) respectively. The same of ONH rim area, average RNFL and GCC thickness were 0.94 (83%), 0.95 (72%) and 0.93 (62%) respectively. AUCs of vessel densities were significantly lower (p<0.05) than that of the corresponding structural measurements. Pre-treatment IOP (coefficient: 0.08) affected (p<0.05) the AUC of ONH vessel density but not of any other vessel density or structural measurements. Conclusions Diagnostic abilities of ONH, peripapillary and the macular vessel densities in POAG were significantly lower than ONH rim area, peripapillary RNFL and macular GCC measurements respectively. At fixed levels of glaucoma severity, the diagnostic ability of the ONH vessel density was significantly greater in eyes with higher pre-treatment IOP.	[Rao, Harsha L.; Pradhan, Zia S.; Riyazuddin, Mohammed; Dasari, Srilakshmi; Venugopal, Jayasree P.; Puttaiah, Narendra K.; Rao, Dhanaraj A. S.; Devi, Sathi] Narayana Nethralaya, Bangalore, Karnataka, India; [Weinreb, Robert N.] Univ Calif San Diego, Shiley Eye Inst, Hamilton Glaucoma Ctr, La Jolla, CA 92093 USA; [Weinreb, Robert N.] Univ Calif San Diego, Dept Ophthalmol, La Jolla, CA 92093 USA; [Mansouri, Kaweh] Montchoisi Clin, Glaucoma Ctr, Swiss Vis Network, Lausanne, Switzerland; [Mansouri, Kaweh] Univ Colorado, Dept Ophthalmol, Denver, CO 80202 USA; [Webers, Carroll A. B.] Univ Med Ctr, Univ Eye Clin Maastricht, Maastricht, Netherlands	University of California System; University of California San Diego; University of California System; University of California San Diego; University of Colorado System; University of Colorado Denver; Maastricht University; Maastricht University Medical Centre (MUMC)	Rao, HL (corresponding author), Narayana Nethralaya, Bangalore, Karnataka, India.	harshalaxmanarao@gmail.com	Webers, Carroll A.B./D-1130-2010	mansouri, kamran/0000-0002-5184-4583; Rao, Harsha/0000-0001-5866-9856				Akagi T, 2016, AM J OPHTHALMOL, V168, P237, DOI 10.1016/j.ajo.2016.06.009; Alonzo TA, 2002, BIOSTATISTICS, V3, P421, DOI 10.1093/biostatistics/3.3.421; Bonomi L, 2000, OPHTHALMOLOGY, V107, P1287, DOI 10.1016/S0161-6420(00)00138-X; Burgoyne CF, 2005, PROG RETIN EYE RES, V24, P39, DOI 10.1016/j.preteyeres.2004.06.001; Firat PG, 2013, GRAEF ARCH CLIN EXP, V251, P831, DOI 10.1007/s00417-012-2114-5; Garway-Heath DF, 2000, OPHTHALMOLOGY, V107, P1809, DOI 10.1016/S0161-6420(00)00284-0; GLYNN RJ, 1992, ARCH OPHTHALMOL-CHIC, V110, P381, DOI 10.1001/archopht.1992.01080150079033; Jia YL, 2012, BIOMED OPT EXPRESS, V3, DOI 10.1364/BOE.3.003127; Jia YL, 2014, OPHTHALMOLOGY, V121, P1322, DOI 10.1016/j.ophtha.2014.01.021; Jia YL, 2012, OPT EXPRESS, V20, P4710, DOI 10.1364/OE.20.004710; Kim NR, 2013, J GLAUCOMA, V22, P133, DOI 10.1097/IJG.0b013e3182254cde; Kraus MF, 2012, BIOMED OPT EXPRESS, V3, P1182, DOI 10.1364/BOE.3.001182; Leske MC, 2007, OPHTHALMOLOGY, V114, P1965, DOI 10.1016/j.ophtha.2007.03.016; Leveque PM, 2016, J OPHTHALMOL, V2016, DOI 10.1155/2016/6956717; Lijmer JG, 1999, JAMA-J AM MED ASSOC, V282, P1061, DOI 10.1001/jama.282.11.1061; Liu L, 2015, JAMA OPHTHALMOL, V133, P1045, DOI 10.1001/jamaophthalmol.2015.2225; Medeiros FA, 2007, INVEST OPHTH VIS SCI, V48, P214, DOI 10.1167/iovs.06-0618; Pepe MS, 2000, BIOMETRICS, V56, P352, DOI 10.1111/j.0006-341X.2000.00352.x; Pepe MS, 1998, BIOMETRICS, V54, P124, DOI 10.2307/2534001; Pepe MS., 2003, STAT EVALUATION MED, P130; Rao HL, 2016, AM J OPHTHALMOL, V171, P75, DOI 10.1016/j.ajo.2016.08.030; Rao HL, 2012, INVEST OPHTH VIS SCI, V53, P1058, DOI 10.1167/iovs.11-8463; Rao HL, 2011, INVEST OPHTH VIS SCI, V52, P1290, DOI 10.1167/iovs.10-5546; Rao HL, 2010, OPHTHALMOLOGY, V117, P1692, DOI 10.1016/j.ophtha.2010.01.031; Wang XL, 2015, GRAEF ARCH CLIN EXP, V253, P1557, DOI 10.1007/s00417-015-3095-y; Weinreb RN, 2004, LANCET, V363, P1711, DOI 10.1016/S0140-6736(04)16257-0; Weinreb RN, 2014, JAMA-J AM MED ASSOC, V311, P1901, DOI 10.1001/jama.2014.3192; Yarmohammadi A, 2016, INVEST OPHTH VIS SCI, V57, pOCT451, DOI 10.1167/iovs.15-18944; Yu J, 2015, INVEST OPHTH VIS SCI, V56, P3212, DOI 10.1167/iovs.14-16270; Zhou X. H., 2002, STAT METHODS DIAGNOS, P274	30	71	73	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 13	2017	12	3							e0173930	10.1371/journal.pone.0173930	http://dx.doi.org/10.1371/journal.pone.0173930			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN6CP	28288185	gold, Green Published, Green Submitted			2022-12-27	WOS:000396092400042
J	Carella, F; De Vico, G; Landini, G				Carella, Francesca; De Vico, Gionata; Landini, Gabriel			Nuclear morphometry and ploidy of normal and neoplastic haemocytes in mussels	PLOS ONE			English	Article							COCKLES CERASTODERMA-EDULE; DNA IMAGE-ANALYSIS; FLOW-CYTOMETRY; MYTILUS-GALLOPROVINCIALIS; MYA-ARENARIA; HEMIC NEOPLASIA; SOFTSHELL CLAMS; GENETIC INSTABILITY; MARINE BIVALVES; CELL CARCINOMA	Haemic neoplasia (HN) in bivalves has been reported in association with mass mortality events in various species of molluscs. The aim of this work was to quantify the nuclear morphometry and DNA content of neoplastic cells of mussels Mytilus galloprovincialis affected by HN using nuclear densitometry in Feulgen-stained preparations. The results were also compared with a population of normal mussel haemocytes. We captured 256 images of 3 different neoplasia stages and 120 images of normal haemocytes; thus, a total of 120,166 nuclei were analysed. We extracted 21 morphological parameters from normal and neoplastic nuclei. Eighteen of these parameters were different (P<0.05). Among those (expressed in pixel units-inter-pixel distance of 0.45 micrometres-as: normal vs. neoplastic) nuclear area (117.1 +/- 94.1 vs. 423.1 +/- 226.9), perimeter (44.9 +/- 14.0 vs. 79.0 +/- 21.3) and (IOD) integrated optical density (13.47 +/- 34.5 vs. 177.1 +/- 150.8) were relevant features to discriminate between normal and neoplastic cells. Those differences allowed identifying two distinctive populations of neoplastic nuclei, occasionally in the same individuals at a given phase of the disease. Moreover, neoplastic haemocytes in less extended lesions showed a ploidy value of 6.2 n along with the presence of a second population of circulating cells with a DNA content of 10.7n. In samples with moderate disease only one peak at 7n was observed. Finally, in more severe conditions, a further ploidy peak of 7.8n was recorded, accompanied by a shallow but broad peak of 31n. This latter extreme value is thought to be due to the presence of giant multinucleated cells where individual nuclei overlap in space and cannot be discerned individually. Computer-based imaging allowed the direct visualization of the cell populations and simultaneous collection of ploidy data as well as morphological features of nuclei.	[Carella, Francesca; De Vico, Gionata] Univ Naples Federico II, Dept Biol, Naples, Italy; [Landini, Gabriel] Univ Birmingham, Sch Dent, Coll Med & Dent Sci, Birmingham B5 7EG, W Midlands, England	University of Naples Federico II; University of Birmingham	Carella, F (corresponding author), Univ Naples Federico II, Dept Biol, Naples, Italy.	francesca.carella@unina.it	; DE VICO, Gionata/N-7268-2016	Landini, Gabriel/0000-0002-9689-0989; CARELLA, Francesca/0000-0003-1780-1990; DE VICO, Gionata/0000-0001-5953-4160	Progetto MODO-Animal Model; Engineering and Physical Sciences Research Council (UK) [EP/M023869/1]; Engineering and Physical Sciences Research Council [EP/M023869/1] Funding Source: researchfish; EPSRC [EP/M023869/1] Funding Source: UKRI	Progetto MODO-Animal Model; Engineering and Physical Sciences Research Council (UK)(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC))	The work was supported by the following: Progetto MODO-Animal Model 2014; the Engineering and Physical Sciences Research Council (UK) (Grant No. EP/M023869/1, Novel context-based segmentation algorithms for intelligent microscopy).	Agarwal N, 2014, 2014 IEEE HEALTHCARE INNOVATION CONFERENCE (HIC), P6, DOI 10.1109/HIC.2014.7038861; Alanen KA, 1998, ANAL QUANT CYTOL, V20, P178; Almendro V, 2013, ANNU REV PATHOL-MECH, V8, P277, DOI 10.1146/annurev-pathol-020712-163923; AUFFRET M, 1986, AQUACULTURE, V58, P9, DOI 10.1016/0044-8486(86)90152-3; Barber BJ, 2004, AQUAT LIVING RESOUR, V17, P449, DOI 10.1051/alr:2004052; BERTINO B, 1994, ANAL CELL PATHOL, V6, P377; Bierhoff E, 2003, ANTICANCER RES, V23, P2697; Bignold LP, 2006, EXP SUPPL, V96, P1; Bihari N, 1999, PERIOD BIOL, V101, P151; BOCKING A, 1995, ANAL CELL PATHOL, V8, P67; Borgiani L., 1994, Pathologica (Genoa), V86, P356; BRUNETTI R, 1988, MAR ECOL PROG SER, V44, P65, DOI 10.3354/meps044065; Carella F, 2013, DIS AQUAT ORGAN, V105, P81, DOI 10.3354/dao02612; Ciocan C, 2005, MAR POLLUT BULL, V50, P1335, DOI 10.1016/j.marpolbul.2005.04.042; De Vico G, 2015, ISJ-INVERT SURVIV J, V12, P19; De Vico G, 2012, ARGOMENTI PATOLOGIA, DOI [10.13140/2.1.3560.5440, DOI 10.13140/2.1.3560.5440]; Delaporte M, 2008, J INVERTEBR PATHOL, V98, P190, DOI 10.1016/j.jip.2007.12.005; DeVico G, 1997, J COMP PATHOL, V117, P99, DOI 10.1016/S0021-9975(97)80026-6; Dimitriadis VK, 2003, MAR BIOL, V142, P915, DOI 10.1007/s00227-002-1008-1; DIXON DR, 1985, SCI TOTAL ENVIRON, V46, P1, DOI 10.1016/0048-9697(85)90278-5; Duesberg P, 1998, P NATL ACAD SCI USA, V95, P13692, DOI 10.1073/pnas.95.23.13692; Edge SB, 2010, ANN SURG ONCOL, V17, P1471, DOI 10.1245/s10434-010-0985-4; ELSTON RA, 1992, REV AQUAT SCI, V6, P405; FARLEY CA, 1991, ENVIRON HEALTH PERSP, V90, P35, DOI 10.2307/3430843; FARLEY CA, 1969, NATL CANCER I MONOGR, P541; Fickert P, 2014, J HEPATOL, V60, P1290, DOI 10.1016/j.jhep.2014.02.006; Figueras A.J., 1991, J SHELLFISH RES, V10, P84; FIGUERAS AJ, 1991, AQUACULTURE, V99, P17, DOI 10.1016/0044-8486(91)90285-F; FISCHLER DF, 1994, ANAL QUANT CYTOL, V16, P167; Galimany E, 2008, J SHELLFISH RES, V27, P1201, DOI 10.2983/0730-8000-27.5.1201; Ganem NJ, 2007, CURR OPIN GENET DEV, V17, P157, DOI 10.1016/j.gde.2007.02.011; GARDNER GR, 1991, ENVIRON HEALTH PERSP, V90, P43, DOI 10.2307/3430844; Giam M, 2015, CELL DIV, V10, DOI 10.1186/s13008-015-0009-7; GREEN M, 1983, AQUACULTURE, V30, P1, DOI 10.1016/0044-8486(83)90146-1; Gregory TR, 2003, GENOME, V46, P841, DOI [10.1139/g03-069, 10.1139/G03-069]; Hardie DC, 2002, J HISTOCHEM CYTOCHEM, V50, P735, DOI 10.1177/002215540205000601; Hillman RE, 1990, INCIDENCE NEOPLASIA; INSUA A, 1992, Aquatic Living Resources, V5, P1, DOI 10.1051/alr:1992001; Kontak JA, 2003, UROL CLIN N AM, V30, P467, DOI 10.1016/S0094-0143(03)00020-X; Kullman B., 2006, FOLIA CRYPTOG, V42, P43; Landini G, 2004, CYTOM PART A, V61A, P45, DOI 10.1002/cyto.a.20082; Landini G., 2006, CORRECT BACKGROUND I; Landini G., 2008, P 2 IMAGEJ US DEV C, P116; Li LXL, 2003, AM J DERMATOPATH, V25, P190, DOI 10.1097/00000372-200306000-00002; Lobo J, 2015, J TISSUE ENG REGEN M; LOWE DM, 1978, JNCI-J NATL CANCER I, V60, P1455, DOI 10.1093/jnci/60.6.1455; Maiolino P, 2004, VET PATHOL, V41, P608, DOI 10.1354/vp.41-6-608; Maiolino P, 2002, J COMP PATHOL, V127, P114, DOI 10.1053/jcpa.2002.0568; Marcos Beatriz, 1998, Sangre (Saragossa), V43, P25; McLaughlin SM., 1994, INVERTEBRATE NEOPLAS, P21; Metzger MJ, 2016, NATURE, V534, P705, DOI 10.1038/nature18599; Metzger MJ, 2015, CELL, V161, P255, DOI 10.1016/j.cell.2015.02.042; Micalizzi DS, 2010, J MAMMARY GLAND BIOL, V15, P117, DOI 10.1007/s10911-010-9178-9; Micic M, 2001, AQUAT TOXICOL, V55, P61, DOI 10.1016/S0166-445X(01)00156-4; MOORE JD, 1991, J INVERTEBR PATHOL, V58, P231, DOI 10.1016/0022-2011(91)90067-Z; NACCI D, 1992, MAR ENVIRON RES, V33, P83, DOI 10.1016/0141-1136(92)90134-8; NOWELL PC, 1976, SCIENCE, V194, P23, DOI 10.1126/science.959840; OPRANDY JJ, 1981, J INVERTEBR PATHOL, V38, P45, DOI 10.1016/0022-2011(81)90033-1; OTSU N, 1979, IEEE T SYST MAN CYB, V9, P62, DOI 10.1109/TSMC.1979.4310076; Otto SP, 2007, CELL, V131, P452, DOI 10.1016/j.cell.2007.10.022; Peters E.C., 1988, American Fisheries Society Special Publication, P74; PINDUR A, 1994, PROSTATE, V25, P189, DOI 10.1002/pros.2990250404; Puech M, 1999, CYTOMETRY, V36, P11, DOI 10.1002/(SICI)1097-0320(19990501)36:1<11::AID-CYTO2>3.3.CO;2-K; Raghavan S.C., 2010, J NUCL ACIDS, V2010, P2010, DOI DOI 10.1109/INFC0M.2010.5462024; Rasband W., 2006, IMAGEJ; Reeder JE, 1997, CYTOMETRY, V28, P176, DOI 10.1002/(SICI)1097-0320(19970601)28:2<176::AID-CYTO12>3.0.CO;2-N; RENO PW, 1994, J INVERTEBR PATHOL, V64, P163, DOI 10.1016/S0022-2011(94)90025-6; Roels SLMF, 2000, AM J VET RES, V61, P1074, DOI 10.2460/ajvr.2000.61.1074; Romalde JL, 2007, J INVERTEBR PATHOL, V94, P95, DOI 10.1016/j.jip.2006.09.007; Russell JA, 1999, PSYCHOL BULL, V125, P3, DOI 10.1037/0033-2909.125.1.3; Serra J, 1983, IMAGE ANAL MATH MORP; SORENSEN FB, 1992, LAB INVEST, V66, P4; Strefezzi RD, 2003, VET PATHOL, V40, P268, DOI 10.1354/vp.40-3-268; Sunila I., 1994, INVERTEBRATE NEOPLAS, P11; Thunnissen FBJM, 1996, ANAL CELL PATHOL, V12, P13; Thunnissen FBJM, 1997, CYTOMETRY, V27, P21, DOI 10.1002/(SICI)1097-0320(19970101)27:1<21::AID-CYTO3>3.0.CO;2-O; Tiscar PG, 1990, ATTI SOC ITAL SCI VE, V44, P709; VANBENEDEN RJ, 1993, CANCER RES, V53, P2976; Vassilenko E, 2014, J INVERTEBR PATHOL, V117, P68, DOI 10.1016/j.jip.2014.02.002; Villalba A, 2001, DIS AQUAT ORGAN, V46, P213, DOI 10.3354/dao046213; VUKMIROVIC M, 1994, MAR ECOL PROG SER, V109, P165, DOI 10.3354/meps109165; WRISBERG MN, 1992, ECOTOX ENVIRON SAFE, V23, P191, DOI 10.1016/0147-6513(92)90058-B; YAMAMOTO T, 1994, JPN J CANCER RES, V85, P1171, DOI 10.1111/j.1349-7006.1994.tb02924.x; Zizzo N., 1991, B SOC ITAL PATOL ITT, V7, P19	85	11	13	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 10	2017	12	3							e0173219	10.1371/journal.pone.0173219	http://dx.doi.org/10.1371/journal.pone.0173219			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN6CJ	28282459	Green Published, gold, Green Submitted			2022-12-27	WOS:000396091800022
J	Misterska, E; Kaminiarczyk-Pyzalka, D; Adamczak, K; Adamczyk, KA; Niedziela, M; Glowacki, M; Glowacki, J				Misterska, Ewa; Kaminiarczyk-Pyzalka, Dominika; Adamczak, Karolina; Adamczyk, Katarzyna A.; Niedziela, Marek; Glowacki, Maciej; Glowacki, Jakub			Mental health and adjustment to juvenile idiopathic arthritis: Level of agreement between parent and adolescent reports according to Strengths and Difficulties Questionnaire and Adolescent Outcomes Questionnaire	PLOS ONE			English	Article							RHEUMATOID-ARTHRITIS; RECENT ONSET; CHILDREN; DISEASE; ASSOCIATIONS; ADAPTATION; VALIDITY; MOTHERS; LIFE	The aims of this study were threefold. Firstly, to analyze the psychometric properties of the Polish-language Pediatric Outcomes Data Collection Instrument (PODCI) questionnaire in the self-report Adolescent Outcomes Questionnaire (adolescents, 11 - 18 years of age) and in the parent-report Adolescent Outcomes Questionnaire (completed by a parent or guardian of an adolescent aged 11 - 18 years). Secondly, to determine the level of agreement between parents and adolescents in rating dysfunction in juvenile idiopathic arthritis (JIA) and thirdly, to examine associations between psychological adjustments of patients to JIA and disease as well as their socio-demographic characteristics. The study sample consisted of 52 participants. 26 adolescents between the ages of 11 and 18 years with a diagnosis of JIA and 26 parents were considered for inclusion. Disease course was classified as pauciarticular (n = 12, 46.2%) and polyarticular (n = 14, 53.8%). Participants completed the PODCI (self-and parent-report) twice and the Strengths and Difficulties Questionnaire-25 (SDQ25). Considering the distribution of results regarding PODCI normative scores, 73.1% of parents and 69.2% of patients scored below 50 on the Global Functioning Scale; that is lower than the average for the general healthy population. Regarding the parent report, the total score of the SDQ-25 equaled 11.86 (SD 2.66), whereas the patient report equaled 11.23 (SD 2.78). The study groups do not differ significantly in regards to either the PODCI or the SDQ-25 results. Parents and adolescents with JIA appear to hold very similar perceptions of patients' health. Greater differences emerge as disease severity and age of patients increase. Excellent internal consistency, intrarater and test-retest reliability of the Global Functioning Scale have been confirmed in the Polish version of the PODCI, the questionnaire may therefore aid identification of patients reporting significant problems in this group.	[Misterska, Ewa] Univ Secur, Dept Pedag & Psychol, Poznan, Poland; [Kaminiarczyk-Pyzalka, Dominika; Adamczak, Karolina; Niedziela, Marek] Poznan Univ Med Sci, Dept Paediat Endocrinol & Rheumatol, Chair Paediat 2, Poznan, Poland; [Glowacki, Maciej] Adam Mickiewicz Univ, Inst Psychol, Poznan, Poland; [Glowacki, Maciej] Poznan Univ Med Sci, Dept Pediat Orthopaed & Traumatol, Poznan, Poland; [Glowacki, Jakub] HCP Med Ctr, Poznan, Poland	Poznan University of Medical Sciences; Adam Mickiewicz University; Poznan University of Medical Sciences	Misterska, E (corresponding author), Univ Secur, Dept Pedag & Psychol, Poznan, Poland.	emisterska1@wp.pl	Niedziela, Marek/A-1155-2011	Niedziela, Marek/0000-0001-8862-6937; Adamczyk, Katarzyna/0000-0002-7612-8380; Glowacki, Jakub/0000-0002-8200-742X				Abramowicz S, 2016, INT J ORAL MAXILLOFA; BAILDAM EM, 1995, BRIT J RHEUMATOL, V34, P470; Barlow J, 1995, CLIN CHILD PSYCHOL P, V57, P445; Barth S, 2016, PLOS ONE, V26; Beaton DE, 2000, SPINE, V25, P3186, DOI 10.1097/00007632-200012150-00014; BILLINGS AG, 1987, HEALTH PSYCHOL, V6, P343, DOI 10.1037/0278-6133.6.4.343; Consolaro A, 2016, PEDIATR RHEUMATOL, V14, DOI 10.1186/s12969-016-0085-5; Daltroy LH, 1998, J PEDIATR ORTHOPED, V18, P561, DOI 10.1097/00004694-199809000-00001; Damiano DL, 2005, J PEDIATR ORTHOPED, V25, P641, DOI 10.1097/01.bpo.0000167079.83835.22; Degotardi PJ, 1999, ARTHRIT CARE RES, V12, P314, DOI 10.1002/1529-0131(199910)12:5<314::AID-ART2>3.0.CO;2-V; Ding T, 2008, RHEUMATOLOGY, V47, P660, DOI 10.1093/rheumatology/ken095; DUFFY CM, 1993, J RHEUMATOL, V20, P2134; ENNETT ST, 1991, J PEDIATR PSYCHOL, V16, P557, DOI 10.1093/jpepsy/16.5.557; Goodman R, 1997, J CHILD PSYCHOL PSYC, V38, P581, DOI 10.1111/j.1469-7610.1997.tb01545.x; Goodman R, 2001, J AM ACAD CHILD PSY, V40, P1337, DOI 10.1097/00004583-200111000-00015; GORTMAKER SL, 1990, PEDIATRICS, V85, P267; Hersh AO, 2016, RHEUM DIS CLIN N AM, V42, P333, DOI 10.1016/j.rdc.2016.01.004; JESSOP DJ, 1988, J DEV BEHAV PEDIATR, V9, P147; Kazak AE, 2006, J PEDIATR PSYCHOL, V31, P343, DOI 10.1093/jpepsy/jsj054; KAZIS LE, 1989, MED CARE, V27, pS178, DOI 10.1097/00005650-198903001-00015; Klepper SE, 2011, ARTHRIT CARE RES, V63, pS371, DOI 10.1002/acr.20635; Kwon DG, 2011, J PEDIATR ORTHOPED, V31, P102, DOI 10.1097/BPO.0b013e318202c6fb; LAVIGNE JV, 1993, J DEV BEHAV PEDIATR, V14, P117; LeBovidge JS, 2003, J PEDIATR PSYCHOL, V28, P29, DOI 10.1093/jpepsy/28.1.29; Mazur J, 2007, DEV PERIOD MED, V11, P13; Noll RB, 1995, FAMILY SYSTEMS MED, V13, P11, DOI DOI 10.1037/H0089103; Quittner AL, 1998, HEALTH PSYCHOL, V17, P112, DOI 10.1037//0278-6133.17.2.112; Rapoff MA, 2005, HDB PEDIAT PSYCHOL; Rosenbaum PL, 1995, QUALITY LIFE PHARMAC, P785; Salter K, 2000, EVIDENCE BASED REV S, P1; Sawyer MG, 2004, RHEUMATOLOGY, V43, P325, DOI 10.1093/rheumatology/keh030; Terwee CB, 2007, J CLIN EPIDEMIOL, V60, P34, DOI 10.1016/j.jclinepi.2006.03.012; THOMPSON R, 1996, ADAPTATION CHRONIC C; VANDVIK IH, 1991, J DEV BEHAV PEDIATR, V12, P84; VANDVIK IH, 1989, J RHEUMATOL, V16, P1088; Wren TAL, 2008, J PEDIATR ORTHOPED, V28, P199, DOI 10.1097/BPO.0b013e318165216d	36	6	6	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 10	2017	12	3							e0173768	10.1371/journal.pone.0173768	http://dx.doi.org/10.1371/journal.pone.0173768			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EN6CJ	28282424	Green Published, gold, Green Submitted			2022-12-27	WOS:000396091800079
J	Liu, JH; Xiao, XH; Shen, YY; Chen, L; Xu, CX; Zhao, H; Wu, Y; Zhang, QH; Zhong, J; Tang, ZW; Liu, CH; Zhao, Q; Zheng, Y; Cao, RX; Zu, XY				Liu, Jianghua; Xiao, Xinhua; Shen, Yingying; Chen, Ling; Xu, Canxin; Zhao, Heng; Wu, Ying; Zhang, Qinghai; Zhong, Jing; Tang, Zhenwang; Liu, Changhui; Zhao, Qiang; Zheng, Yi; Cao, Renxian; Zu, Xuyu			MicroRNA-32 promotes calcification in vascular smooth muscle cells: Implications as a novel marker for coronary artery calcification	PLOS ONE			English	Article							OSTEOPROTEGERIN-DEFICIENT MICE; SERUM ALKALINE-PHOSPHATASE; CIRCULATING MICRORNAS; HEPATOCELLULAR-CARCINOMA; INORGANIC-PHOSPHATE; BREAST-CANCER; IN-VITRO; MECHANISMS; EXPRESSION; DISEASE	Cardiovascular calcification is one of the most severe outcomes associated with cardiovascular disease and often results in significant morbidity and mortality. Previous reports indicated that epigenomic regulation of microRNAs (miRNAs) might play important roles in vascular smooth muscle cell (VSMC) calcification. Here, we identified potential key miRNAs involved in vascular calcification in vivo and investigated the role of miR-32-5p (miR-32). According to microarray analysis, we observed increased expression of miR-125b, miR-30a, and miR-32 and decreased expression of miR-29a, miR-210, and miR-320 during the progression of vascularcalcification. Additionally, gain- and loss-of-function studies of miR-32 confirmed promotion of VSMC calcification in mice through the enhanced expression of bonemorphogenetic protein-2, runt-related transcription factor-2(RUNX2), osteopontin, and the bone-specific phosphoprotein matrix GLA protein in vitro. Moreover, miR-32 modulated vascularcalcification progression by activating phosphoinositide 3-kinase (PI3K)signaling and increasing RUNX2 expression and phosphorylation by targeting the 3'-untranslated region of phosphatase and tensin homolog Mrna (PTEN) in mouse VSMCs. Furthermore, we detected higher miR-32 levels in plasmafrom patients with coronary artery disease with coronary artery calcification (CAC) as compared with levels observed in non-CAC patients (P=0.016), further confirming miR-32 as a critical modulator and potential diagnostic marker for CAC.	[Liu, Jianghua; Shen, Yingying; Chen, Ling; Wu, Ying; Zhang, Qinghai; Zhong, Jing; Cao, Renxian; Zu, Xuyu] Univ South China, Affiliated Hosp 1, Inst Clin Med, Hengyang, Peoples R China; [Liu, Jianghua; Xiao, Xinhua; Zhao, Heng; Zhao, Qiang; Zheng, Yi; Cao, Renxian] Univ South China, Affiliated Hosp 1, Dept Endocrinol & Metab, Hengyang, Peoples R China; [Xu, Canxin] Washington Univ, Sch Med, Dept Pathol & Immunol, St Louis, MO USA; [Tang, Zhenwang; Liu, Changhui] Univ South China, Affiliated Hosp 1, Dept Cardiovasc Med, Hengyang, Peoples R China	University of South China; University of South China; Washington University (WUSTL); University of South China	Liu, JH; Zu, XY (corresponding author), Univ South China, Affiliated Hosp 1, Inst Clin Med, Hengyang, Peoples R China.; Liu, JH (corresponding author), Univ South China, Affiliated Hosp 1, Dept Endocrinol & Metab, Hengyang, Peoples R China.	jianghua990@126.com; zuxuyu0108@hotmail.com	Shen, Yingying/GQO-9549-2022	liu, jianghua/0000-0003-3010-5113; Xiao, Xinhua/0000-0002-2706-4464	National Natural Science Foundation of P.R.China [81170807, 81272355, 81502276]; Scientific Research Fund of Education	National Natural Science Foundation of P.R.China(National Natural Science Foundation of China (NSFC)); Scientific Research Fund of Education	Support was provided by the National Natural Science Foundation of P.R.China, Grant No. 81170807 to JL [http:/www.nsfc.gov.cn/]; the National Natural Science Foundation of P.R.China, Grant No.81272355 to XZ [http://www.nsfc.gov.cn/]; the National Natural Science Foundation of P.R. China, Grant No. 81502276 to YS [http://www.nsfc.gov.cn/]; the Scientific Research Fund of Education.	Ambros V, 2004, NATURE, V431, P350, DOI 10.1038/nature02871; Balderman JAF, 2012, J AM HEART ASSOC, V1, DOI 10.1161/JAHA.112.003905; Bartel DP, 2009, CELL, V136, P215, DOI 10.1016/j.cell.2009.01.002; Bidzhekov K, 2012, THROMB HAEMOSTASIS, V107, P619, DOI 10.1160/TH11-09-0607; Bucay N, 1998, GENE DEV, V12, P1260, DOI 10.1101/gad.12.9.1260; Byon CH, 2008, J BIOL CHEM, V283, P15319, DOI 10.1074/jbc.M800021200; Chalmers JA, 2008, AM J PHYSIOL-REG I, V295, pR1529, DOI 10.1152/ajpregu.90572.2008; Chen X, 2008, CELL RES, V18, P997, DOI 10.1038/cr.2008.282; Chen YX, 2016, MOL CELL ENDOCRINOL, V437, P213, DOI 10.1016/j.mce.2016.08.037; Cipollone F, 2011, STROKE, V42, P2556, DOI 10.1161/STROKEAHA.110.597575; Cui RR, 2012, CARDIOVASC RES, V96, P320, DOI 10.1093/cvr/cvs258; Demer LL, 2002, CURR OPIN NEPHROL HY, V11, P437, DOI 10.1097/00041552-200207000-00011; Deng L, 2015, ARTERIOSCL THROM VAS, V35, P175, DOI 10.1161/ATVBAHA.114.304786; Doherty TM, 2004, ENDOCR REV, V25, P629, DOI 10.1210/er.2003-0015; Du YY, 2012, ARTERIOSCL THROM VAS, V32, P2580, DOI 10.1161/ATVBAHA.112.300206; Duan XY, 2011, AMINO ACIDS, V41, P1223, DOI 10.1007/s00726-010-0800-3; Fichtlscherer S, 2010, CIRC RES, V107, P677, DOI 10.1161/CIRCRESAHA.109.215566; Giachelli CM, 2003, J AM SOC NEPHROL, V14, pS300, DOI 10.1097/01.ASN.0000081663.52165.66; Gui T, 2012, LAB INVEST, V92, P1250, DOI 10.1038/labinvest.2012.85; Hays E, 2009, IN VITRO CELL DEV-AN, V45, P361, DOI 10.1007/s11626-009-9189-2; Heath JM, 2014, CIRC RES, V114, P1094, DOI 10.1161/CIRCRESAHA.114.302968; Heneghan HM, 2010, ONCOLOGIST, V15, P673, DOI 10.1634/theoncologist.2010-0103; Hoekstra M, 2010, BIOCHEM BIOPH RES CO, V394, P792, DOI 10.1016/j.bbrc.2010.03.075; Huang J, 2010, STEM CELLS, V28, P357, DOI 10.1002/stem.288; Jalava SE, 2012, ONCOGENE, V31, P4460, DOI 10.1038/onc.2011.624; Johnson RC, 2006, CIRC RES, V99, P1044, DOI 10.1161/01.RES.0000249379.55535.21; Min H, 2000, J EXP MED, V192, P463, DOI 10.1084/jem.192.4.463; Park JB, 2013, EUR HEART J, V34, P920, DOI 10.1093/eurheartj/ehs419; Polajeva J, 2012, BMC CANCER, V12, DOI 10.1186/1471-2407-12-378; Raitoharju E, 2011, ATHEROSCLEROSIS, V219, P211, DOI 10.1016/j.atherosclerosis.2011.07.020; Roth C, 2010, BREAST CANCER RES, V12, DOI 10.1186/bcr2766; Sage AP, 2010, NAT REV CARDIOL, V7, P528, DOI 10.1038/nrcardio.2010.115; Shanahan CM, 2011, CIRC RES, V109, P697, DOI 10.1161/CIRCRESAHA.110.234914; Shantouf R, 2009, CLIN J AM SOC NEPHRO, V4, P1106, DOI 10.2215/CJN.06091108; Simonet WS, 1997, CELL, V89, P309, DOI 10.1016/S0092-8674(00)80209-3; Son BK, 2007, EUR J PHARMACOL, V556, P1, DOI 10.1016/j.ejphar.2006.09.070; Speer MY, 2010, J CELL BIOCHEM, V110, P935, DOI 10.1002/jcb.22607; Sun Y, 2012, CIRC RES, V111, P543, DOI 10.1161/CIRCRESAHA.112.267237; Wallin R, 2001, MED RES REV, V21, P274, DOI 10.1002/med.1010.abs; WEISS MJ, 1988, P NATL ACAD SCI USA, V85, P7666, DOI 10.1073/pnas.85.20.7666; Wu WY, 2013, MOL CANCER, V12, DOI 10.1186/1476-4598-12-30; Xiang MQ, 2014, BIOCHEM BIOPH RES CO, V454, P210, DOI 10.1016/j.bbrc.2014.10.064; Xie H, 2011, CARDIOVASC RES, V92, P296, DOI 10.1093/cvr/cvr200; Yan SY, 2015, TUMOR BIOL, V36, P4747, DOI 10.1007/s13277-015-3124-9; Zhong J, 2014, ONCOGENE, V33, P5546, DOI 10.1038/onc.2013.500; Zhong JH, 2012, INT J CLIN PRACT, V66, P21, DOI 10.1111/j.1742-1241.2011.02814.x; Zhu GY, 2013, BIOCHEM BIOPH RES CO, V433, P526, DOI 10.1016/j.bbrc.2013.03.018	47	42	43	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 20	2017	12	3							e0174138	10.1371/journal.pone.0174138	http://dx.doi.org/10.1371/journal.pone.0174138			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ER6VC	28319142	gold, Green Published, Green Submitted			2022-12-27	WOS:000398945800053
J	Ma, TT; Zhou, W; Chen, LK; Wu, LH; Christie, P; Zhang, HB; Luo, YM				Ma, Tingting; Zhou, Wei; Chen, Li'ke; Wu, Longhua; Christie, Peter; Zhang, Haibo; Luo, Yongming			Toxicity effects of di-(2-ethylhexyl) phthalate to Eisenia fetida at enzyme, cellular and genetic levels	PLOS ONE			English	Article							EXPOSURE; APOPTOSIS; BIOMARKER; FOETIDA; STRESS; CELLS; SOIL; METALLOTHIONEIN; ECOTOXICITY; EARTHWORMS	Di-(2-ethylhexyl) phthalate (DEHP) is a dominant phthalic acid ester (PAE) that has aroused public concern due to its resistance to degradation and its toxicity as an endocrine- disrupting compound. Effects of different concentrations of DEHP on Eisenia fetida in spiked natural soil have been studied in the body of the earthworm by means of soil cultivation tests 7, 14, 21 and 28 days after exposure. The results indicated that, in general, superoxide dismutase (SOD) activity, malondialdehyde (MDA) content, metallothionein (MT) content, the expression of heat shock protein 70 (HSP 70) and all the tested geno-toxicity parameters are promoted as time elapses and with increasing concentration of DEHP. However, peroxidase (POD) activity, neutral red retention time (NRRT) and mitochondrial membrane potential difference values were found to decrease even at a low concentration of DEHP of 1 mg kg -1 soil (p< 0.05). Clear toxic effects of DEHP on E. fetida have been generally recognized by means of the disturbance of antioxidant enzyme activity/ content and critical proteins, cell membrane and organelle disorder and DNA damage estimated by length of tail, tail DNA ratio, and tail moment parameters. A concentration of DEHP of 3 mg kg-1 may be recommended as a precaution against the potential risk of PAEs in soils and for indicating suitable threshold values for other soil animals and soil micro-organisms.	[Ma, Tingting] Hubei Univ Arts & Sci, Inst Hanjiang, Xiangyang, Peoples R China; [Ma, Tingting; Chen, Li'ke; Wu, Longhua; Christie, Peter; Zhang, Haibo; Luo, Yongming] Chinese Acad Sci, Inst Soil Sci, Key Lab Soil Environm & Pollut Remediat, Nanjing, Jiangsu, Peoples R China; [Zhou, Wei] Hubei Univ Arts & Sci, Sch Civil Engn & Architecture, Xiangyang, Peoples R China; [Chen, Li'ke] Shanghai Res Inst Chem Ind, Shanghai, Peoples R China; [Zhang, Haibo; Luo, Yongming] Chinese Acad Sci, Yantai Inst Coastal Zone Res, Key Lab Coastal Environm Proc & Ecol Remediat, Yantai, Peoples R China	Hubei University of Arts & Science; Chinese Academy of Sciences; Institute of Soil Science, CAS; Hubei University of Arts & Science; Chinese Academy of Sciences; Yantai Institute of Coastal Zone Research, CAS	Luo, YM (corresponding author), Chinese Acad Sci, Inst Soil Sci, Key Lab Soil Environm & Pollut Remediat, Nanjing, Jiangsu, Peoples R China.; Luo, YM (corresponding author), Chinese Acad Sci, Yantai Inst Coastal Zone Res, Key Lab Coastal Environm Proc & Ecol Remediat, Yantai, Peoples R China.	ymluo@yic.ac.cn	Christie, Peter/B-7919-2008	Christie, Peter/0000-0002-1939-7277	National Natural Science Foundation of China [41401581 TM, 41271326 B LW]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This research was supported by the National Natural Science Foundation of China (41401581 TM & 41271326 B LW). We thank Hui Zhao who worked in Life Science Experiment Teaching Center of Nanjing Normal University for the help in the instrument utility and data analysis of FACScan Flow Cytometer.	Abdel-Kawi SH, 2016, FOOD CHEM TOXICOL, V90, P64, DOI 10.1016/j.fct.2016.02.003; Adams MS, 2004, ENVIRON TOXICOL CHEM, V23, P1957, DOI 10.1897/03-232; Bernanke J, 2009, REV ENVIRON CONTAM T, V198, P1, DOI 10.1007/978-0-387-09647-6_1; Blair JD, 2009, ENVIRON SCI TECHNOL, V43, P6262, DOI 10.1021/es9013135; Calisi A, 2016, ECOTOXICOLOGY, V25, P677, DOI 10.1007/s10646-016-1626-x; Chai C, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0095701; Chang BV, 2007, CHEMOSPHERE, V69, P1116, DOI 10.1016/j.chemosphere.2007.04.011; Dedeke GA, 2016, APPL SOIL ECOL, V104, P42, DOI 10.1016/j.apsoil.2016.02.013; Erkekoglu P, 2010, TOXICOL APPL PHARM, V248, P52, DOI 10.1016/j.taap.2010.07.016; Gao YH, 2013, ECOTOX ENVIRON SAFE, V89, P239, DOI 10.1016/j.ecoenv.2012.12.004; Gomez-Brandon M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031895; Hansen JF, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0131168; He LZ, 2015, AGRON SUSTAIN DEV, V35, P519, DOI 10.1007/s13593-014-0270-1; Homa J, 2005, ENVIRON POLLUT, V135, P275, DOI 10.1016/j.envpol.2004.10.019; Kabir ER, 2015, ENVIRON TOXICOL PHAR, V40, P241, DOI 10.1016/j.etap.2015.06.009; Kondolot M, 2016, ENVIRON TOXICOL PHAR, V43, P149, DOI 10.1016/j.etap.2016.03.006; Lapied E, 2011, ENVIRON INT, V37, P1105, DOI 10.1016/j.envint.2011.01.009; Lionetto MG, 2016, REND LINCEI-SCI FIS, V27, P1; Liu XH, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0144729; Long JM, 1995, COMMUNICATION; Luo Y, 2005, ENVIRON TOXICOL CHEM, V24, P2145, DOI 10.1897/04-640R.1; Ma TT, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0151128; Ma TT, 2013, ENVIRON SCI POLLUT R, V20, P5289, DOI 10.1007/s11356-013-1520-5; Ma TT, 2013, FRONT ENV SCI ENG, V7, P31, DOI 10.1007/s11783-012-0463-2; Macsik LL, 2015, MOL IMMUNOL, V67, P213, DOI 10.1016/j.molimm.2015.05.015; Markad VL, 2012, J HAZARD MATER, V215, P191, DOI 10.1016/j.jhazmat.2012.02.053; Markad VL, 2012, J HAZARD MATER, P215; Opper B, 2010, MOL IMMUNOL, V47, P2047, DOI 10.1016/j.molimm.2010.04.008; Palleschi S, 2009, TOXICOL LETT, V187, P52, DOI 10.1016/j.toxlet.2009.01.031; Panzarino O, 2016, CHEMOSPHERE, V145, P480, DOI 10.1016/j.chemosphere.2015.11.077; Park K, 2008, CHEMOSPHERE, V74, P89, DOI 10.1016/j.chemosphere.2008.09.041; Rioboo C, 2009, AQUAT TOXICOL, V94, P229, DOI 10.1016/j.aquatox.2009.07.009; ROBERTS R, 2000, APOPTOSIS TOXICOLOGY; Shalata A, 1998, PHYSIOL PLANTARUM, V104, P169, DOI 10.1034/j.1399-3054.1998.1040204.x; Song Y, 2009, SOIL BIOL BIOCHEM, V41, P905, DOI 10.1016/j.soilbio.2008.09.009; van der Oost R, 2003, ENVIRON TOXICOL PHAR, V13, P57, DOI 10.1016/S1382-6689(02)00126-6; VERMES I, 1995, J IMMUNOL METHODS, V184, P39, DOI 10.1016/0022-1759(95)00072-I; Xue YG, 2009, ECOTOXICOLOGY, V18, P693, DOI 10.1007/s10646-009-0333-2; Xue ZF, 2016, NEUROSCI LETT, V618, P50, DOI 10.1016/j.neulet.2016.02.044; Yen TH, 2011, J FORMOS MED ASSOC, V110, P671, DOI 10.1016/j.jfma.2011.09.002; Zhang SY, 2016, ENVIRON SCI POLLUT R, V23, P9742, DOI 10.1007/s11356-016-6158-7; Zhang W, 2015, ECOTOX ENVIRON SAFE, V113, P45, DOI 10.1016/j.ecoenv.2014.11.014; Zheng X., 2014, J NANOMATER, V2014, P1, DOI DOI 10.1155/2014/751907	43	36	37	17	74	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 20	2017	12	3							e0173957	10.1371/journal.pone.0173957	http://dx.doi.org/10.1371/journal.pone.0173957			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ER6VC	28319143	Green Submitted, Green Published, gold			2022-12-27	WOS:000398945800037
J	Pichonnaz, C; Aminian, K; Ancey, C; Jaccard, H; Lecureux, E; Duc, C; Farron, A; Jolles, BM; Gleeson, N				Pichonnaz, Claude; Aminian, Kamiar; Ancey, Celine; Jaccard, Herve; Lecureux, Estelle; Duc, Cyntia; Farron, Alain; Jolles, Brigitte M.; Gleeson, Nigel			Heightened clinical utility of smartphone versus body-worn inertial system for shoulder function B-B score	PLOS ONE			English	Article							OBJECTIVE OUTCOME EVALUATION; AMBULATORY MEASUREMENT; MOTION MEASUREMENT; IDIOPATHIC LOSS; KINEMATICS; SENSORS; RANGE; ARM; QUESTIONNAIRE; ELBOW	Background The B-B Score is a straightforward kinematic shoulder function score including only two movements (hand to the Back + lift hand as to change a Bulb) that demonstrated sound measurement properties for patients for various shoulder pathologies. However, the B-B Score results using a smartphone or a reference system have not yet been compared. Provided that the measurement properties are comparable, the use of a smartphone would offer substantial practical advantages. This study investigated the concurrent validity of a smartphone and a reference inertial system for the measurement of the kinematic shoulder function B-B Score. Methods Sixty-five patients with shoulder conditions (with rotator cuff conditions, adhesive capsulitis and proximal humerus fracture) and 20 healthy participants were evaluated using a smart phone and a reference inertial system. Measurements were performed twice, alternating between two evaluators. The B-B Score differences between groups, differences between devices, relationship between devices, intra- and inter-evaluator reproducibility were analysed. Results The smartphone mean scores (SD) were 94.1 (11.1) for controls and 54.1 (18.3) for patients (P < 0.01). The difference between devices was non-significant for the control (P = 0.16) and the patient group (P = 0.81). The analysis of the relationship between devices showed 0.97 ICC, -0.6 bias and -13.2 to 12.0 limits of agreement (LOA). The smartphone intraevaluator ICC was 0.92, the bias 1.5 and the LOA-17.4 to 20.3. The smartphone inter evaluator ICC was 0.92, the bias 1.5 and the LOA-16.9 to 20.0. Conclusions The B-B Score results measured with a smartphone were comparable to those of an inertial system. While single measurements diverged in some cases, the intra- and inter evaluator reproducibility was excellent and was equivalent between devices. The B-B score measured with a smartphone is straightforward and as efficient as a reference inertial system measurement.	[Pichonnaz, Claude; Ancey, Celine; Jaccard, Herve] Univ Appl Sci Western Switzerland, Haute Ecole Sante Vaud HESAV HES SO, Physiotherapy Dept, Lausanne, Switzerland; [Pichonnaz, Claude; Jaccard, Herve; Farron, Alain; Jolles, Brigitte M.] Univ Lausanne Hosp, Dept Musculoskeletal Med, Serv Orthopaed & Traumatol, Lausanne, Switzerland; [Pichonnaz, Claude; Jaccard, Herve; Farron, Alain; Jolles, Brigitte M.] CHUV UNIL, Lausanne, Switzerland; [Aminian, Kamiar; Duc, Cyntia] Ecole Polytech Fed Lausanne, Lab Movement Anal & Measurement, Lausanne, Switzerland; [Lecureux, Estelle] CHUV UNIL, Direct Med, Lausanne, Switzerland; [Gleeson, Nigel] Queen Margaret Univ, Sch Hlth Sci, Edinburgh, Midlothian, Scotland	University of Applied Sciences & Arts Western Switzerland; University of Lausanne; Centre Hospitalier Universitaire Vaudois (CHUV); University of Lausanne; Centre Hospitalier Universitaire Vaudois (CHUV); Swiss Federal Institutes of Technology Domain; Ecole Polytechnique Federale de Lausanne; University of Lausanne; Centre Hospitalier Universitaire Vaudois (CHUV); Queen Margaret University	Pichonnaz, C (corresponding author), Univ Appl Sci Western Switzerland, Haute Ecole Sante Vaud HESAV HES SO, Physiotherapy Dept, Lausanne, Switzerland.; Pichonnaz, C (corresponding author), Univ Lausanne Hosp, Dept Musculoskeletal Med, Serv Orthopaed & Traumatol, Lausanne, Switzerland.; Pichonnaz, C (corresponding author), CHUV UNIL, Lausanne, Switzerland.	Claude.Pichonnaz@hesav.ch	Aminian, Kamiar/H-4568-2011; Pichonnaz, Claude/V-8768-2019	Aminian, Kamiar/0000-0002-6582-5375; Pichonnaz, Claude/0000-0001-9381-8503	Swiss National Science Foundation [135061]	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission)	Funded by Swiss National Science Foundation Grant number 135061 http://p3.snf.ch/Project-135061. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	American Academy of Orthopaedic Surgeons, DASH OUTC MEAS; Angst F, 2011, ARTHRIT CARE RES, V63, pS174, DOI 10.1002/acr.20630; Beaton DE, 1996, J BONE JOINT SURG AM, V78A, P882, DOI 10.2106/00004623-199606000-00011; Bot SDM, 2004, ANN RHEUM DIS, V63, P335, DOI 10.1136/ard.2003.007724; Coley B, 2008, GAIT POSTURE, V27, P368, DOI 10.1016/j.gaitpost.2007.05.005; Coley B, 2007, GAIT POSTURE, V25, P523, DOI 10.1016/j.gaitpost.2006.06.016; Coley B, 2009, MED BIOL ENG COMPUT, V47, P467, DOI 10.1007/s11517-009-0464-x; Constant CR, 2008, J SHOULDER ELB SURG, V17, P355, DOI 10.1016/j.jse.2007.06.022; Cutti AG, 2008, MED BIOL ENG COMPUT, V46, P169, DOI 10.1007/s11517-007-0296-5; de Vries WHK, 2016, J BIOMECH, V49, P73, DOI 10.1016/j.jbiomech.2015.11.019; Duc C, 2014, PHYSIOL MEAS, V35, P2389, DOI 10.1088/0967-3334/35/12/2389; Duc C, 2013, GAIT POSTURE, V38, P247, DOI 10.1016/j.gaitpost.2012.11.021; EuroQol G, EQ 5D STAND INSTR US; Gait Up, HANDS SHOULD TEST AP; Handoll HHG, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD000434.pub3; Harvie P, 2005, J BONE JOINT SURG BR, V87B, P151, DOI 10.1302/0301-620X.87B2.15305; Jester A, 2005, J HAND SURG-BRIT EUR, V30B, P23, DOI 10.1016/j.jhsb.2004.08.008; Jolles BM, 2011, J SHOULDER ELB SURG, V20, P1074, DOI 10.1016/j.jse.2011.05.026; Kirkley A, 2003, ARTHROSCOPY, V19, P1109, DOI 10.1016/j.arthro.2003.10.030; Korver RJP, 2014, PHYSIOL MEAS, V35, P167, DOI 10.1088/0967-3334/35/2/167; Korver RJP, 2014, PHYSIOL MEAS, V35, P677, DOI 10.1088/0967-3334/35/4/677; Krueger D, 2011, AM J SPORT MED, V39, P71, DOI 10.1177/0363546510379336; Laboratory of Movement Analysis and Measurement D Swiss Institute of Technology of Lausanne, SMARTPH APP ISHOULD; LANDIS JR, 1977, BIOMETRICS, V33, P159, DOI 10.2307/2529310; Lenth RV, JAVA APPLETS POWER S; LIPPITT SB, 1993, SHOULDER : A BALANCE OF MOBILITY AND STABILITY, P501; Liu Zhan-yu, 2007, Journal of Zhejiang University-Science B, V8, P738, DOI 10.1631/jzus.2007.B0738; Ludewig PM, 2009, J ORTHOP SPORT PHYS, V39, P90, DOI 10.2519/jospt.2009.2808; Ludewig PM, 2000, PHYS THER, V80, P276, DOI 10.1093/ptj/80.3.276; Luinge HJ, 2007, J BIOMECH, V40, P78, DOI 10.1016/j.jbiomech.2005.11.011; Luinge HJ, 2005, MED BIOL ENG COMPUT, V43, P273, DOI 10.1007/BF02345966; Mark D., 2011, BEGINNING IOS 5 DEV; Mercer TH, 2002, PHYS THER SPORT, V3, P27, DOI 10.1054/ptsp.2001.0073; Mitchell K, 2014, PHYSIOTHER THEOR PR, V30, P521, DOI 10.3109/09593985.2014.900593; Moustgaard H, 2014, J CLIN EPIDEMIOL, V67, P1327, DOI 10.1016/j.jclinepi.2014.06.020; Oh JH, 2009, AM J SPORT MED, V37, P1161, DOI 10.1177/0363546508330135; Oihenart L, 2012, GAIT POSTURE S1, V36, pS61; Olley LM, 2008, ANN ROY COLL SURG, V90, P326, DOI 10.1308/003588408X285964; Picavet HSJ, 2003, PAIN, V102, P167, DOI 10.1016/S0304-3959(02)00372-X; Pichonnaz C, 2015, PHYSIOL MEAS, V36, P547, DOI 10.1088/0967-3334/36/3/547; Pichonnaz C, 2015, SENSORS-BASEL, V15, P26801, DOI 10.3390/s151026801; Portney LG, 2009, FDN CLIN RES APPL PR, V3rd, DOI DOI 10.1016/S0039-6257(02)00362-4; Ragab AA, 2003, BIOMED SCI INSTRUM, V39, P579; Richards R R, 1994, J Shoulder Elbow Surg, V3, P347, DOI 10.1016/S1058-2746(09)80019-0; Roy JS, 2009, ARTHRIT RHEUM-ARTHR, V61, P623, DOI 10.1002/art.24396; Rundquist PJ, 2005, PHYS THER, V85, P636, DOI 10.1093/ptj/85.7.636; Rundquist PJ, 2004, CLIN BIOMECH, V19, P810, DOI 10.1016/j.clinbiomech.2004.05.006; Rundquist PJ, 2003, ARCH PHYS MED REHAB, V84, P1473, DOI 10.1016/S0003-9993(03)00359-9; SHER JS, 1995, J BONE JOINT SURG AM, V77A, P10, DOI 10.2106/00004623-199501000-00002; Shin SH, 2012, MANUAL THER, V17, P298, DOI 10.1016/j.math.2012.02.010; Soper D., 2006, STAT CALCULATORS; VANDERWINDT DAWM, 1995, ANN RHEUM DIS, V54, P959, DOI 10.1136/ard.54.12.959; Walter SD, 1998, STAT MED, V17, P101, DOI 10.1002/(SICI)1097-0258(19980115)17:1<101::AID-SIM727>3.3.CO;2-5; Werner BC, 2014, J SHOULDER ELB SURG, V23, pE275, DOI 10.1016/j.jse.2014.02.030; Wong WY, 2007, PROSTHET ORTHOT INT, V31, P62, DOI 10.1080/03093640600983949; Wu G, 2005, J BIOMECH, V38, P981, DOI 10.1016/j.jbiomech.2004.05.042	56	5	5	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 20	2017	12	3							e0174365	10.1371/journal.pone.0174365	http://dx.doi.org/10.1371/journal.pone.0174365			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ER6VC	28319141	Green Published, gold, Green Submitted			2022-12-27	WOS:000398945800071
J	Agmo, A; Snoeren, EMS				Agmo, Anders; Snoeren, Eelke M. S.			A cooperative function for multisensory stimuli in the induction of approach behavior of a potential mate	PLOS ONE			English	Article							RAT RATTUS-NORVEGICUS; ULTRASONIC VOCALIZATIONS; SEXUAL-BEHAVIOR; FEMALE RAT; MATING-BEHAVIOR; PERIPHERAL ANOSMIA; INCENTIVE VALUE; ODORS; EXPERIENCE; RESPONSES	Intrasexual competition is an important element of natural selection in which the most attractive conspecific has a considerable reproductive advantage over the others. The conspecifics that are approached first often become the preferred mate partners, and could thus from a biological perspective have a reproductive advantage. This underlines the importance of the initial approach and raises the question of what induces this approach, or what makes a conspecific attractive. Identification of the sensory modalities crucial for the activation of approach is necessary for elucidating the central nervous processes involved in the activation of sexual motivation and eventually copulatory behavior. The initial approach to a potential mate depends on distant stimuli in the modalities of audition, olfaction, vision, and other undefined characteristics. This study investigated the role of the different modalities and the combination of these modalities in the sexual incentive value of a female rat. This study provides evidence that the presence of a single- sensory stimulus with one modality (olfaction, vision, or 'others', but not audition) is sufficient to attenuate the preference for a social contact with a male rat. However, a multisensory stimulus of multiple modalities is necessary to induce preference for the stimulus over social contact to a level of an intact receptive female. The initial approach behavior, therefore, seems to be induced by the combination of at least two modalities among which olfaction is crucial. This suggests that there is a cooperative function for the different modalities in the induction of approach behavior of a potential mate.	[Agmo, Anders; Snoeren, Eelke M. S.] UiT Arctic Univ Norway, Dept Psychol, Tromso, Norway	UiT The Arctic University of Tromso	Snoeren, EMS (corresponding author), UiT Arctic Univ Norway, Dept Psychol, Tromso, Norway.	eelke.snoeren@uit.no		Snoeren, Eelke/0000-0001-9652-1668; Agmo, Anders/0000-0002-7087-0429	Faculty of Health Sciences, UiT The Arctic University of Norway; UiT The Arctic University of Norway	Faculty of Health Sciences, UiT The Arctic University of Norway; UiT The Arctic University of Norway	Financial support was received from the Faculty of Health Sciences, UiT The Arctic University of Norway. This consisted of the salary of both authors. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. The publication charges for this article have been funded by a grant from the publication fund of UiT The Arctic University of Norway.	Agmo A, 2004, PHARMACOL BIOCHEM BE, V78, P379, DOI 10.1016/j.pbb.2004.04.013; Agmo A, 2003, J COMP PSYCHOL, V117, P3, DOI 10.1037/0735-7036.117.1.3; Agmo A, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0144164; Antonio-Cabrera E, 2014, J NEUROENDOCRINOL, V26, P448, DOI 10.1111/jne.12164; BARFIELD RJ, 1986, ANN NY ACAD SCI, V474, P33, DOI 10.1111/j.1749-6632.1986.tb27996.x; Barnett S.A., 1975, RAT STUDY BEHAV; Beach FA, 1942, J COMP PSYCHOL, V33, P163, DOI 10.1037/h0061692; BERGVALL AH, 1991, PHYSIOL BEHAV, V50, P33, DOI 10.1016/0031-9384(91)90494-9; Bialy M, 2000, BEHAV NEUROSCI, V114, P983, DOI 10.1037//0735-7044.114.5.983; Brudzynski SM, 2005, BEHAV GENET, V35, P85, DOI 10.1007/s10519-004-0858-3; CARR WJ, 1965, J COMP PHYSIOL PSYCH, V59, P370, DOI 10.1037/h0022036; CARR WJ, 1966, J COMP PHYSIOL PSYCH, V62, P336, DOI 10.1037/h0023693; Chu X, J COMP PSYC IN PRESS; Ferreira-Nuno A, 2005, HORM BEHAV, V47, P290, DOI 10.1016/j.yhbeh.2004.11.012; HARD E, 1968, J COMP PHYSIOL PSYCH, V66, P805, DOI 10.1037/h0026557; Hetta J, 1978, Acta Physiol Scand Suppl, V453, P5; KRAMES L, 1973, J COMP PHYSIOL PSYCH, V82, P444, DOI 10.1037/h0034126; Kumar V, 2014, BIOL REPROD, V91; LEMAGNEN J, 1952, ARCH SCI PHYSIOL, V6, P295; Lopez HH, 1999, HORM BEHAV, V36, P176, DOI 10.1006/hbeh.1999.1535; Magnus D., 1958, Zeitschrift fuer Tierpsychologie Berlin, V15, P397; Matthews TJ, 1997, J EXP ANAL BEHAV, V68, P399, DOI 10.1901/jeab.1997.68-399; MCCLINTOCK MK, 1984, ADV STUD BEHAV, V14, P1, DOI 10.1016/S0065-3454(08)60298-3; Meyerson B J, 1973, Acta Physiol Scand Suppl, V389, P1; MONFORT-BRAHAM N, 1967, Annales de la Societe Royale Zoologique de Belgique, V97, P131; Pfaff D, 2010, ENCY BEHAV NEUROSCIE; Snoeren EMS, 2015, J NEUROENDOCRINOL, V27, P803, DOI 10.1111/jne.12321; Snoeren EM, 2014, PHYSIOL BEHAV, V132, P17, DOI 10.1016/j.physbeh.2014.04.048; Snoeren EMS, 2014, J COMP PSYCHOL, V128, P367, DOI 10.1037/a0036541; Snoeren EMS, 2014, J COMP PSYCHOL, V128, P40, DOI 10.1037/a0033204; Snoeren EMS, 2013, BEHAV NEUROSCI, V127, P439, DOI 10.1037/a0032027; Spiteri T, 2010, NEUROENDOCRINOLOGY, V91, P142, DOI 10.1159/000255766; STERN JJ, 1970, PHYSIOL BEHAV, V5, P519, DOI 10.1016/0031-9384(70)90260-X; Stone CP, 1922, J COMP PSYCHOL, V2, P95, DOI 10.1037/h0075931; THOMAS DA, 1981, J COMP PHYSIOL PSYCH, V95, P630, DOI 10.1037/h0077803; THOR DH, 1977, BEHAV BIOL, V20, P128, DOI 10.1016/S0091-6773(77)90682-4; THOR DH, 1977, PHYSIOL BEHAV, V19, P411, DOI 10.1016/0031-9384(77)90287-6; WHITE NR, 1987, J COMP PSYCHOL, V101, P73, DOI 10.1037/0735-7036.101.1.73; WHITE NR, 1989, PHYSIOL BEHAV, V45, P229, DOI 10.1016/0031-9384(89)90123-6	39	19	19	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 17	2017	12	3							e0174339	10.1371/journal.pone.0174339	http://dx.doi.org/10.1371/journal.pone.0174339			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EO5CJ	28306729	gold, Green Published, Green Submitted			2022-12-27	WOS:000396710300028
J	Abe, D; Fukuoka, Y; Horiuchi, M				Abe, Daijiro; Fukuoka, Yoshiyuki; Horiuchi, Masahiro			Muscle activities during walking and running at energetically optimal transition speed under normobaric hypoxia on gradient slopes	PLOS ONE			English	Article							TO-RUN-TRANSITION; M.-TIBIALIS-ANTERIOR; MECHANICAL DETERMINANTS; ENERGY-COST; ECONOMICAL WALKING; SUPPORT; LOCOMOTION; PROPULSION; EFFICIENCY; EXERCISE	Energy cost of transport per unit distance (CoT; J.kg(-1).km(-1)) displays a U-shaped fashion in walking and a linear fashion in running as a function of gait speed (v; km.h(-1)). There exists an intersection between U-shaped and linear CoT-v relationships, being termed energetically optimal transition speed (EOTS; km.h(-1)). Combined effects of gradient and moderate normobaric hypoxia (15.0% O-2) were investigated when walking and running at the EOTS in fifteen young males. The CoT values were determined at eight walking speeds (2.4.7.3 km.h(-1)) and four running speeds (7.39.4 km.h(-1)) on level and gradient slopes (+/- 5%) at normoxia and hypoxia. Since an alteration of tibialis anterior (TA) activity has been known as a trigger for gait transition, electromyogram was recorded from TA and its antagonists (gastrocnemius medialis (GM) and gastrocnemius lateralis (GL)) for about 30 steps during walking and running corresponding to the individual EOTS in each experimental condition. Mean power frequency (MPF; Hz) of each muscle was quantified to evaluate alterations of muscle fiber recruitment pattern. The EOTS was not significantly different between normoxia and hypoxia on any slopes (ranging from 7.412 to 7.679 km.h(-1) at normoxia and 7.516 to 7.678 km.h(-1) at hypoxia) due to upward shifts (enhanced metabolic rate) of both U-shaped and linear CoT-v relationships at hypoxia. GM, but not GL, activated more when switching from walking to running on level and gentle downhill slopes. Significant decreases in the muscular activity and/or MPF were observed only in the TA when switching the gait pattern. Taken together, the EOTS was not slowed by moderate hypoxia in the population of this study. Muscular activities of lower leg extremities and those muscle fiber recruitment patterns are dependent on the gradient when walking and running at the EOTS.	[Abe, Daijiro] Kyushu Sangyo Univ, Ctr Hlth & Sports Sci, Fukuoka, Japan; [Fukuoka, Yoshiyuki] Doshisha Univ, Fac Hlth & Sports Sci, Kyotanabe, Japan; [Horiuchi, Masahiro] Mt Fuji Res Inst, Div Human Environm Sci, Fujiyoshida, Yamanashi, Japan	Doshisha University	Abe, D (corresponding author), Kyushu Sangyo Univ, Ctr Hlth & Sports Sci, Fukuoka, Japan.	abed@ip.kyusan-u.ac.jp		Fukuoka, Yoshiyuki/0000-0001-6409-2694	Japan Society for the Promotion of Science [26440266JP, 26650175JP, 26440268JP]	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	This study was financially supported by Grant-in-Aid for Scientific Research from the Japan Society for the Promotion of Science (26440266JP to DA, 26650175JP to YF, and 26440268JP to MH).	Abe D, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0138154; Amann M, 2006, J PHYSIOL-LONDON, V575, P937, DOI 10.1113/jphysiol.2006.113936; Ardigo LP, 2003, EUR J APPL PHYSIOL, V90, P365, DOI 10.1007/s00421-003-0882-7; AURA O, 1986, EUR J APPL PHYSIOL, V55, P37, DOI 10.1007/BF00422890; Bartlett JL, 2008, J EXP BIOL, V211, P1281, DOI 10.1242/jeb.011932; Billaut F, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077297; Bramble DM, 2004, NATURE, V432, P345, DOI 10.1038/nature03052; BROUWER E, 1957, ACTA PHYSIOL PHARM N, V6, P795; Browning RC, 2006, J APPL PHYSIOL, V100, P390, DOI 10.1152/japplphysiol.00767.2005; Cappellini G, 2006, J NEUROPHYSIOL, V95, P3426, DOI 10.1152/jn.00081.2006; CAVAGNA GA, 1977, J PHYSIOL-LONDON, V268, P467, DOI 10.1113/jphysiol.1977.sp011866; Dahmane R, 2005, J BIOMECH, V38, P2451, DOI 10.1016/j.jbiomech.2004.10.020; De Luca CJ, 1997, J APPL BIOMECH, V13, P135, DOI 10.1123/jab.13.2.135; Farris DJ, 2012, P NATL ACAD SCI USA, V109, P977, DOI 10.1073/pnas.1107972109; Farris DJ, 2012, J R SOC INTERFACE, V9, P110, DOI 10.1098/rsif.2011.0182; Faulhaber M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049953; Francis CA, 2013, GAIT POSTURE, V38, P993, DOI 10.1016/j.gaitpost.2013.05.009; Ganley KJ, 2011, METABOLISM, V60, P609, DOI 10.1016/j.metabol.2010.06.007; Gazendam MGJ, 2007, GAIT POSTURE, V25, P604, DOI 10.1016/j.gaitpost.2006.06.013; GERDLE B, 1991, ACTA PHYSIOL SCAND, V142, P457, DOI 10.1111/j.1748-1716.1991.tb09180.x; Girard O, 2015, FRONT PHYSIOL, V6, DOI 10.3389/fphys.2015.00260; Hamner SR, 2010, J BIOMECH, V43, P2709, DOI 10.1016/j.jbiomech.2010.06.025; Horiuchi M, 2016, BIOL OPEN, V5, P1408, DOI 10.1242/bio.019810; Horiuchi M, 2015, J EXERC SCI FIT, V13, P79, DOI 10.1016/j.jesf.2015.06.001; Horiuchi M, 2014, INT J IND ERGONOM, V44, P442, DOI 10.1016/j.ergon.2013.11.014; HRELJAC A, 1993, MED SCI SPORT EXER, V25, P1158; Hreljac A, 2007, GAIT POSTURE, V25, P419, DOI 10.1016/j.gaitpost.2006.05.005; Huddleston B, 2003, 10 UN FAO; JOHNSON MA, 1973, J NEUROL SCI, V18, P111, DOI 10.1016/0022-510X(73)90023-3; Kulmala JP, 2013, MED SCI SPORT EXER, V45, P2306, DOI 10.1249/MSS.0b013e31829efcf7; Long LL, 2013, J R SOC INTERFACE, V10, DOI 10.1098/rsif.2012.0980; MacLeod TD, 2014, J APPL BIOMECH, V30, P95, DOI 10.1123/jab.2013-0041; Malcolm P, 2009, GAIT POSTURE, V30, P322, DOI 10.1016/j.gaitpost.2009.06.002; Malcolm P, 2009, GAIT POSTURE, V29, P6, DOI 10.1016/j.gaitpost.2008.05.016; MARTIN PE, 1992, J APPL PHYSIOL, V73, P200; Masschelein E, 2012, J APPL PHYSIOL, V113, P736, DOI 10.1152/japplphysiol.01253.2011; McGowan CP, 2009, J BIOMECH, V42, P850, DOI 10.1016/j.jbiomech.2009.01.025; Mian OS, 2006, ACTA PHYSIOL, V186, P127, DOI 10.1111/j.1748-1716.2006.01522.x; MINETTI AE, 1994, ACTA PHYSIOL SCAND, V150, P315, DOI 10.1111/j.1748-1716.1994.tb09692.x; MINETTI AE, 1993, J PHYSIOL-LONDON, V472, P725, DOI 10.1113/jphysiol.1993.sp019969; MINETTI AE, 1994, J EXP BIOL, V195, P211; Motoi M, 2016, J PHYSIOL ANTHROPOL, V35, DOI 10.1186/s40101-016-0094-6; Neptune RR, 2005, J EXP BIOL, V208, P799, DOI 10.1242/jeb.01435; Prilutsky BI, 2001, J EXP BIOL, V204, P2277; Rooney BD, 2013, J BIOMECH, V46, P2201, DOI 10.1016/j.jbiomech.2013.06.022; Rotstein A, 2005, MED SCI SPORT EXER, V37, P1864, DOI 10.1249/01.mss.0000177217.12977.2f; RYAN TA, 1960, PSYCHOL BULL, V57, P318, DOI 10.1037/h0044320; Sasaki K, 2006, J BIOMECH, V39, P2005, DOI 10.1016/j.jbiomech.2005.06.019; Segers V, 2007, GAIT POSTURE, V25, P639, DOI 10.1016/j.gaitpost.2006.07.008; Segers V, 2013, J EXP BIOL, V216, P3047, DOI 10.1242/jeb.087015; Shih Y, 2016, GAIT POSTURE, V46, P5, DOI 10.1016/j.gaitpost.2016.01.003; Sockol MD, 2007, P NATL ACAD SCI USA, V104, P12265, DOI 10.1073/pnas.0703267104; Steudel-Numbers KL, 2009, J HUM EVOL, V56, P355, DOI 10.1016/j.jhevol.2008.11.002; Torres-Peralta R, 2016, FRONT PHYSIOL, V6, DOI 10.3389/fphys.2015.00414; Tseh W, 2002, EUR J APPL PHYSIOL, V88, P117, DOI 10.1007/s00421-002-0698-x; Vernillo G, SPORTS MED IN PRESS; Wall-Scheffler CM, 2015, INTEGR COMP BIOL, V55, P1155, DOI 10.1093/icb/icv072; Wall-Scheffler CM, 2013, J HUM EVOL, V64, P448, DOI 10.1016/j.jhevol.2013.01.014; Watson RR, 2011, P ROY SOC B-BIOL SCI, V278, P2040, DOI 10.1098/rspb.2010.2022; Wezenberg D, 2013, ARCH PHYS MED REHAB, V94, P1714, DOI 10.1016/j.apmr.2013.02.016; Willcockson MA, 2012, MED SCI SPORT EXER, V44, P1344, DOI 10.1249/MSS.0b013e318248d907; Yong JR, 2014, J BIOMECH, V47, P3593, DOI 10.1016/j.jbiomech.2014.10.015; Ziv G, 2009, MED SCI SPORT EXER, V41, P797, DOI 10.1249/MSS.0b013e31818ff715	63	9	9	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 16	2017	12	3							e0173816	10.1371/journal.pone.0173816	http://dx.doi.org/10.1371/journal.pone.0173816			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EN9KE	28301525	gold, Green Published, Green Submitted			2022-12-27	WOS:000396318300077
J	Hu, ZL; Chen, J; Wang, J; Xiong, QF; Zhong, YD; Yang, YF; Xu, CJ; Wei, HX				Hu, Zhiliang; Chen, Jun; Wang, Juan; Xiong, Qingfang; Zhong, Yandan; Yang, Yongfeng; Xu, Chuanjun; Wei, Hongxia			Radiological characteristics of pulmonary cryptococcosis in HIV-infected patients	PLOS ONE			English	Article							IMMUNOCOMPETENT; NODULES; DISEASE; UPDATE; AIDS	Background Current understanding of human immunodeficiency virus (HIV)-associated pulmonary cryptococcosis (PC) is largely based on studies performed about 2 decades ago which reported that the most common findings on chest radiograph were diffuse interstitial infiltrates. Few studies are available regarding the computed tomography (CT) findings. The aim of this study was to characterize chest CT features of HIV-associated PC. Methods HIV patients with cryptococccal infection and pulmonary abnormalities on Chest CT between September 2010 and May 2016 in the Second Affiliated Hospital of the Southeast University were retrospectively analyzed. Confirmed cases of tumors, mycobacterial infections and other fungal infections were excluded from the analysis. Results 60 cases were identified. The median CD4 T-cell counts were 20 cells/mu L (range, 0-205 cells/mu L). Chest CT scans demonstrated nodular lesions in 93.3% of the studied patients. Those nodular lesions were usually cavitated and solitary nodule was the most common form. Pleural effusions and pneumonic infiltrates occurred in 11.6% and 31.7% of the cases respectively. Those lesions were usually had co-existing nodular lesions. Etiological analysis suggested that 76.8% of the nodular lesions could have a relationship with PC that 12.5% of the nodular lesions were "laboratory-confirmed" cases, 48.2% were "clinically confirmed cases and 16.1% were "clinically probable" cases. 85.7% of the pleural effusions could be "clinically confirmed" cases of PC. At least, 38.5% of the diffuse pneumonic infiltrates may be clinically attributed to pneumocystis pneumonia. Conclusions This study suggested that pulmonary nodules but not diffuse pneumonia are the most common radiological characteristics of HIV-associated PC. HIV-infected patients with pulmonary nodules on Chest CT should particularly be screened for cryptococcal infection.	[Hu, Zhiliang; Xiong, Qingfang; Zhong, Yandan; Yang, Yongfeng; Wei, Hongxia] Southeast Univ, Second Affiliated Hosp, Sch Med, Dept Infect Dis, Nanjing, Jiangsu, Peoples R China; [Chen, Jun] Fudan Univ, Shanghai Publ Hlth Clin Ctr, Dept Infect Dis, Shanghai 200433, Peoples R China; [Wang, Juan] Nanjing Med Univ, Nanjing Brain Hosp, Dept Pathol, Nanjing, Jiangsu, Peoples R China; [Xu, Chuanjun] Southeast Univ, Second Affiliated Hosp, Sch Med, Dept Radiol, Nanjing, Jiangsu, Peoples R China	Southeast University - China; Fudan University; Nanjing Medical University; Southeast University - China	Wei, HX (corresponding author), Southeast Univ, Second Affiliated Hosp, Sch Med, Dept Infect Dis, Nanjing, Jiangsu, Peoples R China.; Xu, CJ (corresponding author), Southeast Univ, Second Affiliated Hosp, Sch Med, Dept Radiol, Nanjing, Jiangsu, Peoples R China.	xchuanjun@163.com; wghongxia@163.com	Hu, Zhiliang/AAS-3469-2020	Hu, Zhiliang/0000-0001-8543-821X	Department of Science and Technique, Jiangsu [BL-2013003]; project of Jiangsu Province Medical Youth Talent	Department of Science and Technique, Jiangsu; project of Jiangsu Province Medical Youth Talent	This work is supported by clinical special grant BL-2013003 from Department of Science and Technique, Jiangsu (http://www.jstd.gov.cn/), and the project of Jiangsu Province Medical Youth Talent. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BATUNGWANAYO J, 1994, AIDS, V8, P1271, DOI 10.1097/00002030-199409000-00008; Benito N, 2012, EUR RESPIR J, V39, P730, DOI 10.1183/09031936.00200210; Blanchon T, 2007, LUNG CANCER, V58, P50, DOI 10.1016/j.lungcan.2007.05.009; Chang WC, 2006, CHEST, V129, P333, DOI 10.1378/chest.129.2.333; Chitasombat M, 2013, CURR FUNGAL INFECT R, V7, P44, DOI 10.1007/s12281-012-0119-5; Hare SS, 2012, BRIT J RADIOL, V85, P848, DOI 10.1259/bjr/16420165; Hu ZL, 2013, SCAND J INFECT DIS, V45, P378, DOI 10.3109/00365548.2012.749422; Iribarren JA, 2016, PREVENTION TREATMENT; Kisembo HN, 2012, BRIT J RADIOL, V85, pE130, DOI 10.1259/bjr/70704099; Kohno S, 2015, J INFECT CHEMOTHER, V21, P23, DOI 10.1016/j.jiac.2014.08.025; La Ferla L, 2013, EUR REV MED PHARMACO, V17, P2354; Lin CY, 2009, HIV MED, V10, P191, DOI 10.1111/j.1468-1293.2008.00674.x; MEYOHAS MC, 1995, CLIN INFECT DIS, V21, P628, DOI 10.1093/clinids/21.3.628; Miller KD, 1996, CLIN INFECT DIS, V23, P810, DOI 10.1093/clinids/23.4.810; Muldoon EG, 2016, BMC PULM MED, V16, DOI 10.1186/s12890-016-0276-3; Perfect JR, 2010, CLIN INFECT DIS, V50, P291, DOI 10.1086/649858; Restrepo CS, 2006, RADIOGRAPHICS, V26, P1169, DOI 10.1148/rg.264055129; Steininger C, 2006, J CLIN VIROL, V37, P1, DOI 10.1016/j.jcv.2006.03.005; Visnegarwala F, 1998, CLIN INFECT DIS, V27, P1231, DOI 10.1086/514984; Ye C, 2015, NIGER J CLIN PRACT, V18, P304, DOI 10.4103/1119-3077.151075; Ye F, 2012, LUNG, V190, P339, DOI 10.1007/s00408-011-9362-8; Zhang Y, 2012, EUR RESPIR J, V40, P1191, DOI 10.1183/09031936.00168011	22	19	23	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 16	2017	12	3							e0173858	10.1371/journal.pone.0173858	http://dx.doi.org/10.1371/journal.pone.0173858			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN9KE	28301552	Green Published, Green Submitted, gold			2022-12-27	WOS:000396318300082
J	Ming, L; Yi, L; Siriguleng; Hasi, S; He, J; Hai, L; Wang, ZX; Guo, FC; Qiao, XY; Jirimutu				Ming, Liang; Yi, Li; Siriguleng; Hasi, Surong; He, Jing; Hai, Le; Wang, Zhaoxia; Guo, Fucheng; Qiao, Xiangyu; Jirimutu			Comparative analysis of fecal microbial communities in cattle and Bactrian camels	PLOS ONE			English	Article							DROMEDARY CAMEL; DIVERSITY; WILD; DESULFOVIBRIOS; BACTERIA; RUMEN; TIME	Bactrian camels may have a unique gastrointestinal (GI) microbiome because of their distinctive digestive systems, unique eating habits and extreme living conditions. However, understanding of the microbial communities in the Bactrian camel GI tract is still limited. In this study, microbial communities were investigated by comparative analyses of 16S rRNA hypervariable region V4 sequences of fecal bacteria sampled from 94 animals in four population groups: Inner Mongolian cattle (IMG-Cattle), Inner Mongolian domestic Bactrian camels (IMG-DBC), Mongolian domestic Bactrian camels (MG-DBC), and Mongolian wild Bactrian camels (MG-WBC). A total of 2,097,985 high-quality reads were obtained and yielded 471,767,607 bases of sequence. Firmicutes was the predominant phylum in the population groups IMG-Cattle, IMG-DBC and MG-WBC, followed (except in the Inner Mongolian cattle) by Verrucomicrobia. Bacteroidetes were abundant in the IMG-DBC and MGWBC populations. Hierarchical clustered heatmap analysis revealed that the microbial community composition within the three Bactrian camel groups was relatively similar, and somewhat distinct from that in the cattle. A similar result was determined by principal component analysis, in which the camels grouped together. We also found several species-specific differences in microbial communities at the genus level: for example, Desulfovibrio was abundant in the IMG-DBC and MG-WBC groups; Pseudomonas was abundant in the IMG-Cattle group; and Fibrobacter, Coprobacillus, and Paludibacter were scarce in the MG-WBC group. Such differences may be related to different eating habits and living conditions of the cattle and the various camel populations.	[Ming, Liang; Yi, Li; He, Jing; Hai, Le; Wang, Zhaoxia; Guo, Fucheng; Qiao, Xiangyu; Jirimutu] Inner Mongolia Agr Univ, Coll Food Sci & Engn, Minist Educ, Key Lab Dairy Biotechnol & Bioengn, Hohhot, Inner Mongolia, Peoples R China; [Siriguleng; Hasi, Surong; Jirimutu] Camel Res Inst Inner Mongolia, Alashan, Inner Mongolia, Peoples R China; [Siriguleng; Hasi, Surong] Inner Mongolia Agr Univ, Coll Vet Med, Hohhot, Inner Mongolia, Peoples R China	Inner Mongolia Agricultural University; Inner Mongolia Agricultural University	Jirimutu (corresponding author), Inner Mongolia Agr Univ, Coll Food Sci & Engn, Minist Educ, Key Lab Dairy Biotechnol & Bioengn, Hohhot, Inner Mongolia, Peoples R China.; Jirimutu (corresponding author), Camel Res Inst Inner Mongolia, Alashan, Inner Mongolia, Peoples R China.	yeluotuo1999@vip.163.com			National International Scientific and Technological Cooperation Project [2015DFR30680, ky201401002]; National Natural Science Foundation of China [31360397, 31360598, 31560710]	National International Scientific and Technological Cooperation Project; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by the National International Scientific and Technological Cooperation Project [grant numbers 2015DFR30680, ky201401002] and the National Natural Science Foundation of China [grant numbers 31360397, 31360598, 31560710]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amranil A, 2014, PLOS ONE, V9, P1; Bhatt VD, 2013, MOL BIOL REP, V40, P3363, DOI 10.1007/s11033-012-2411-4; Bisson-Boutelliez C, 2010, MOL ORAL MICROBIOL, V25, P226, DOI 10.1111/j.2041-1014.2009.00550.x; Cardellino R, 2005, CURRENT STATUS GENET; Cole JR, 2009, NUCLEIC ACIDS RES, V37, pD141, DOI 10.1093/nar/gkn879; Dai X, 2012, PLOS ONE, V7, P1; Eckburg PB, 2005, SCIENCE, V308, P1635, DOI 10.1126/science.1110591; Fite A, 2004, GUT, V53, P523, DOI 10.1136/gut.2003.031245; Frey JC, 2006, APPL ENVIRON MICROB, V72, P3788, DOI 10.1128/AEM.72.5.3788-3792.2006; Ghali MB, 2004, LETT APPL MICROBIOL, V39, P341, DOI 10.1111/j.1472-765X.2004.01597.x; GIBSON GR, 1993, GUT, V34, P437, DOI 10.1136/gut.34.4.437; Hess M, 2011, SCIENCE, V331, P463, DOI 10.1126/science.1200387; Ji R, 2009, ANIM GENET, V40, P377, DOI 10.1111/j.1365-2052.2008.01848.x; KAYOULI C, 1993, ANIM FEED SCI TECH, V40, P343, DOI 10.1016/0377-8401(93)90063-P; Lozupone C, 2005, APPL ENVIRON MICROB, V71, P8228, DOI 10.1128/AEM.71.12.8228-8235.2005; Samsudin AA, 2011, ENVIRON MICROBIOL, V13, P3024, DOI 10.1111/j.1462-2920.2011.02579.x; Scanlan PD, 2009, FEMS MICROBIOL ECOL, V69, P213, DOI 10.1111/j.1574-6941.2009.00709.x; Schloss P. D., 2012, APPL ENVIRON MICROB, V75, P7537, DOI DOI 10.1128/AEM.01541-09; Silbermayr K, 2010, ANIM GENET, V41, P315, DOI 10.1111/j.1365-2052.2009.01993.x; Singh KM, 2012, MOL BIOL REP, V39, P4841, DOI 10.1007/s11033-011-1278-0; Tjakradidjaja AS, 1999, TANNINS LIVESTOCK HU, P161; von Engelhardt W, 2007, J COMP PHYSIOL B, V177, P631, DOI 10.1007/s00360-007-0161-8; Walzer C., 2005, WILD CAMEL TRAINING, P1; Wang J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043213	24	13	14	1	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 16	2017	12	3							e0173062	10.1371/journal.pone.0173062	http://dx.doi.org/10.1371/journal.pone.0173062			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN9KE	28301489	Green Published, gold, Green Submitted			2022-12-27	WOS:000396318300025
J	Muls, N; Nasr, Z; Dang, HA; Sindic, C; van Pesch, V				Muls, Nathalie; Nasr, Zakia; Dang, Hong Anh; Sindic, Christian; van Pesch, Vincent			IL-22, GM-CSF and IL-17 in peripheral CD4(+) T cell subpopulations during multiple sclerosis relapses and remission. Impact of corticosteroid therapy	PLOS ONE			English	Article							INFLAMMATORY-BOWEL-DISEASE; BLOOD-BRAIN-BARRIER; HELPER 17 CELLS; TH17 CELLS; MESSENGER-RNA; AUTOIMMUNE ENCEPHALOMYELITIS; INTERLEUKIN-22 PROTECTS; MONONUCLEAR-CELLS; T(H)17 CELLS; EXPRESSION	Multiple sclerosis (MS) is thought to be a Th17-mediated dysimmune disease of the central nervous system. However, recent publications have questioned the pathogenicity of IL-17 per se and rather suggest the implication of other Th17-related inflammatory mediators. Therefore, we studied the expression of GM-CSF, IL-22, IL-24, IL-26 and CD39 in peripheral blood mononuclear cells (PBMCs) from MS patients during relapses, remission and following corticosteroid treatment. We performed qPCR to measure mRNA levels from ex vivo or in vitro-stimulated PBMCs. Cytokine levels were determined by ELISA. We used flow cytometry to assess GM-CSF+, IL-22(+) and CD39(+) cells in relationship to IL-17(+) CD4(+) T cells. Our results showed that IL-22 mRNA and IL-22(+) CD4(+) lymphocytes are increased in circulating cells of relapsing MS patients compared to remitting patients while GM-CSF was unchanged. We have further shown that 12.9, 39 and 12.4% of Th17 cells from MS patients during relapses expressed IL-22, GM-CSF and CD39 respectively. No changes in these proportions were found in stable MS patients. However, the majority of GM-CSF+ or IL-22(+) T cells did not co-express IL-17. GM-CSF mRNA, but not IL-22 mRNA, was dramatically decreased ex vivo by ivMP. Our results contribute to a better characterisation of Th17, Th22 and ThGM-CSF cells in the setting of MS and according to disease activity.	[Muls, Nathalie; Nasr, Zakia; Dang, Hong Anh; Sindic, Christian; van Pesch, Vincent] Catholic Univ Louvain, Inst Neurosci, Unite Neurochim, Ave Mounier,53 BP B1 53 03, Brussels, Belgium; [van Pesch, Vincent] Clin Univ St Luc, Dept Neurol, Ave Hippocrate 10, Brussels, Belgium	Universite Catholique Louvain; Universite Catholique Louvain; Cliniques Universitaires Saint-Luc	van Pesch, V (corresponding author), Catholic Univ Louvain, Inst Neurosci, Unite Neurochim, Ave Mounier,53 BP B1 53 03, Brussels, Belgium.; van Pesch, V (corresponding author), Clin Univ St Luc, Dept Neurol, Ave Hippocrate 10, Brussels, Belgium.	vincent.vanpesch@uclouvain.be	van Pesch, Vincent/AAK-9506-2020	van Pesch, Vincent/0000-0003-2885-9004	Fonds National de la Recherche Scientifique; Bayer educational grants; Belgian Charcot Foundation	Fonds National de la Recherche Scientifique(Fonds de la Recherche Scientifique - FNRS); Bayer educational grants; Belgian Charcot Foundation	This work was supported by the Fonds National de la Recherche Scientifique (www.fnrs.be), Bayer educational grants and the Belgian Charcot Foundation (www.fondation-charcot.org). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Almolda B, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027473; Andoh A, 2009, J IMMUNOL, V183, P687, DOI 10.4049/jimmunol.0804169; Beyeen AD, 2010, J IMMUNOL, V185, P6883, DOI 10.4049/jimmunol.1001392; Brand S, 2006, AM J PHYSIOL-GASTR L, V290, pG827, DOI 10.1152/ajpgi.00513.2005; Brucklacher-Waldert V, 2009, BRAIN, V132, P3329, DOI 10.1093/brain/awp289; Constantinescu CS, 2015, NEUROL-NEUROIMMUNOL, V2, DOI 10.1212/NXI.0000000000000117; Cortez-Espinosa N, 2015, HUM IMMUNOL, V76, P622, DOI 10.1016/j.humimm.2015.09.007; Croxford AL, 2015, IMMUNITY, V43, P502, DOI 10.1016/j.immuni.2015.08.010; Cua DJ, 2003, NATURE, V421, P744, DOI 10.1038/nature01355; De Iudicibus S, 2011, WORLD J GASTROENTERO, V17, P1095, DOI 10.3748/wjg.v17.i9.1095; Durelli L, 2009, ANN NEUROL, V65, P499, DOI 10.1002/ana.21652; El-Behi M, 2011, NAT IMMUNOL, V12, P568, DOI 10.1038/ni.2031; Esendagli G, 2013, J NEUROIMMUNOL, V255, P81, DOI 10.1016/j.jneuroim.2012.10.009; Gayo A, 1998, J NEUROIMMUNOL, V85, P122, DOI 10.1016/S0165-5728(97)00262-2; Gross CC, 2016, MULT SCLER; He M, 2010, J IMMUNOL, V184, P1793, DOI 10.4049/jimmunol.0901829; Hirota K, 2011, NAT IMMUNOL, V12, P255, DOI 10.1038/ni.1993; Ingwersen J, 2016, J NEUROINFLAMM, V13, DOI 10.1186/s12974-016-0512-z; Kebir H, 2007, NAT MED, V13, P1173, DOI 10.1038/nm1651; Komiyama Y, 2006, J IMMUNOL, V177, P566, DOI 10.4049/jimmunol.177.1.566; Kreymborg K, 2007, J IMMUNOL, V179, P8098, DOI 10.4049/jimmunol.179.12.8098; Langrish CL, 2005, J EXP MED, V201, P233, DOI 10.1084/jem.20041257; Lee Y, 2012, NAT IMMUNOL, V13, P991, DOI 10.1038/ni.2416; Li S, 2012, MEDIAT INFLAMM, V2012, DOI DOI 10.1155/2012/260473; Liang SC, 2006, J EXP MED, V203, P2271, DOI 10.1084/jem.20061308; Linden J, 2012, ARTERIOSCL THROM VAS, V32, P2097, DOI 10.1161/ATVBAHA.111.226837; Liu Y, 2009, EUR J IMMUNOL, V39, P1472, DOI 10.1002/eji.200838811; Lo YH, 2010, J DERMATOL SCI, V58, P225, DOI 10.1016/j.jdermsci.2010.03.018; Longhi MS, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087956; Martinez FO, 2009, ANNU REV IMMUNOL, V27, P451, DOI 10.1146/annurev.immunol.021908.132532; Matusevicius D, 1999, MULT SCLER J, V5, P101, DOI 10.1177/135245859900500206; McQualter JL, 2001, J EXP MED, V194, P873, DOI 10.1084/jem.194.7.873; Muls N, 2012, J NEUROIMMUNOL, V243, P73, DOI 10.1016/j.jneuroim.2011.12.010; Muls NG, 2015, MULT SCLER; Noster R, 2014, SCI TRANSL MED, V6, DOI 10.1126/scitranslmed.3008706; Ossege LM, 1998, J NEUROIMMUNOL, V84, P1, DOI 10.1016/S0165-5728(97)00211-7; Pan HF, 2013, CYTOKINE GROWTH F R, V24, P51, DOI 10.1016/j.cytogfr.2012.07.002; Pan HN, 2004, CELL MOL IMMUNOL, V1, P43; Perriard G, 2015, J NEUROINFLAMM, V12, DOI 10.1186/s12974-015-0335-3; Polman CH, 2011, ANN NEUROL, V69, P292, DOI 10.1002/ana.22366; Ramesh R, 2014, J EXP MED, V211, P89, DOI 10.1084/jem.20130301; Rolla S, 2014, J LEUKOCYTE BIOL, V96, P1155, DOI 10.1189/jlb.5A0813-463RR; Romer J, 2003, J INVEST DERMATOL, V121, P1306, DOI 10.1111/j.1523-1747.2003.12626.x; Sheng W, 2014, CELL RES, V24, P1387, DOI 10.1038/cr.2014.154; Sonnenberg GF, 2010, J EXP MED, V207, P1293, DOI 10.1084/jem.20092054; Trifari S, 2009, NAT IMMUNOL, V10, P864, DOI 10.1038/ni.1770; Uzawa A, 2010, MULT SCLER J, V16, P1443, DOI 10.1177/1352458510379247; Vogel DYS, 2015, EUR J IMMUNOL, V45, P1808, DOI 10.1002/eji.201444960; Wang LL, 2013, MOL MED REP, V8, P1432, DOI 10.3892/mmr.2013.1692; Wolk K, 2004, IMMUNITY, V21, P241, DOI 10.1016/j.immuni.2004.07.007; Zenewicz LA, 2008, IMMUNITY, V29, P947, DOI 10.1016/j.immuni.2008.11.003	51	29	30	2	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 16	2017	12	3							e0173780	10.1371/journal.pone.0173780	http://dx.doi.org/10.1371/journal.pone.0173780			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN9KE	28301515	gold, Green Submitted, Green Published			2022-12-27	WOS:000396318300071
J	Chen, VCH; Yang, YH; Liao, YT; Kuo, TY; Liang, HY; Huang, KY; Huang, YC; Lee, Y; McIntyre, RS; Lin, TC				Chen, Vincent Chin-Hung; Yang, Yao-Hsu; Liao, Yin-To; Kuo, Ting-Yu; Liang, Hsin-Yi; Huang, Kuo-You; Huang, Yin-Cheng; Lee, Yena; McIntyre, Roger S.; Lin, Tzu-Chin			The association between methylphenidate treatment and the risk for fracture among young ADHD patients: A nationwide population-based study in Taiwan	PLOS ONE			English	Article							ATTENTION-DEFICIT/HYPERACTIVITY DISORDER; DEFICIT-HYPERACTIVITY DISORDER; MEDICATION ADHERENCE; CHILDREN; INJURY; ASTHMA; PREVALENCE; ADULTS; PHARMACOTHERAPY; OSTEOPOROSIS	Attention-deficit hyperactivity disorder (ADHD) is associated with higher risk for fracture. Whether the medical treatment for ADHD would mitigate the risk remains unclear. In this study, we sought to investigate the effect of methylphenidate treatment on risk for fracture, as well the moderational role of treatment duration on the risk of fracture, in a large national sample. Cases less than 18 years old were identified from Taiwan's National Health Insurance Research Database with a new primary diagnosis of ADHD (ICD-9: 314) between 1996 and 2013. A total of 6201 cases with ADHD were included as the study cohort. The cases were divided into 3 groups according to the duration of methylphenidate treatment (0, 1-180, and more than 180 days). All groups were followed until the end of 2013 for first diagnoses of fracture (ICD-9 codes 800 to 829). Cox proportional hazards models were applied. Compared to the group without methylphenidate treatment, the risk for fracture was lower among the group treated for more than 180 days. The adjusted hazard ratio was 0.77 (95% Confidence interval: 0.63-0.94). The groups treated for 180 days or fewer had no significant difference in the risk for fracture. In conclusion, methylphenidate treatment was associated with lower risk for fracture among ADHD patients. The association was evident only in the cohort treated for more than 180 days.	[Lin, Tzu-Chin] Chiayi Chang Gung Mem Hosp, Chang Gung Med Fdn, Chiayi, Taiwan; [Chen, Vincent Chin-Hung; Kuo, Ting-Yu; Liang, Hsin-Yi; Huang, Kuo-You] Chang Gung Univ, Sch Med, Dept Med, Taoyuan, Taiwan; [Liao, Yin-To; Kuo, Ting-Yu; Liang, Hsin-Yi; Lee, Yena] Chang Gung Mem Hosp, Dept Tradit Chinese Med, Chiayi, Taiwan; [Chen, Vincent Chin-Hung; Liang, Hsin-Yi; Huang, Yin-Cheng; Lee, Yena] Chang Gung Mem Hosp, Ctr Excellence Chang Gung Res Datalink, Chiayi, Taiwan; [Kuo, Ting-Yu; Liang, Hsin-Yi; Huang, Kuo-You] Natl Taiwan Univ Coll Publ Hlth, Inst Occupat Med & Ind Hyg, Taipei, Taiwan; [Chen, Vincent Chin-Hung; Kuo, Ting-Yu; Lin, Tzu-Chin] Chang Gung Univ, Sch Tradit Chinese Med, Coll Med, Taoyuan, Taiwan; [Liao, Yin-To; Liang, Hsin-Yi; McIntyre, Roger S.] Chung Shan Med Univ Hosp, Dept Psychiat, Taichung, Taiwan; [Liao, Yin-To; Huang, Yin-Cheng; McIntyre, Roger S.] Chung Shan Med Univ, Sch Med, Dept Psychiat, Taichung, Taiwan; [Liang, Hsin-Yi; Huang, Yin-Cheng; Lee, Yena; McIntyre, Roger S.] Linkou Chang Gung Mem Hosp, Dept Child Psychiat, Taoyuan, Taiwan; [Yang, Yao-Hsu; Kuo, Ting-Yu; Liang, Hsin-Yi; Huang, Kuo-You] Chung Shan Med Univ, Dept Speech, Language Pathol & Audiol, Taichung, Taiwan; [Chen, Vincent Chin-Hung; Liao, Yin-To; Huang, Yin-Cheng] Chung Shan Med Univ, Dept Speech, Language Pathol & Audiol, Taichung, Taiwan; [Yang, Yao-Hsu; Liao, Yin-To; Huang, Yin-Cheng] Chang Gung Mem Hosp, Dept Neurosurg, Chiayi, Taiwan; [Chen, Vincent Chin-Hung; Kuo, Ting-Yu] Univ Toronto, Univ Hlth Network, Mood Disorders Psychopharmacol Unit, Toronto, ON, Canada; [Liao, Yin-To; Kuo, Ting-Yu; Liang, Hsin-Yi; Huang, Kuo-You; Huang, Yin-Cheng] Univ Toronto, Dept Psychiat, Toronto, ON, Canada	Chang Gung Memorial Hospital; Chang Gung University; Chang Gung Memorial Hospital; Chang Gung Memorial Hospital; National Taiwan University; Chang Gung University; Chung Shan Medical University; Chung Shan Medical University Hospital; Chung Shan Medical University; Chang Gung Memorial Hospital; Chung Shan Medical University; Chung Shan Medical University; Chang Gung Memorial Hospital; University of Toronto; University Toronto Affiliates; University Health Network Toronto; University of Toronto	Lin, TC (corresponding author), Chiayi Chang Gung Mem Hosp, Chang Gung Med Fdn, Chiayi, Taiwan.	jamaalbest@gmail.com	Lee, Yena/D-9016-2019; Lee, Yena/L-5505-2019; 楊, 曜旭/A-3450-2019; McIntyre, Roger/AAU-1000-2020; Students, MDPU/ABE-8402-2020	Lee, Yena/0000-0003-0629-9456; Lee, Yena/0000-0003-0629-9456; 楊, 曜旭/0000-0002-8080-0504; McIntyre, Roger/0000-0003-4733-2523; 	Ministry of Science and Technology, R.O.C. [MOST 102-2314-B-040-004-MY3]; Chang Gung Medical Foundation, Chiayi Chang Gung Memorial Hospital [CMRPG6E0261, CORPG6D0162]	Ministry of Science and Technology, R.O.C.; Chang Gung Medical Foundation, Chiayi Chang Gung Memorial Hospital	The present study is supported in part by the Ministry of Science and Technology, R.O.C. (MOST 102-2314-B-040-004-MY3) and Chang Gung Medical Foundation, Chiayi Chang Gung Memorial Hospital (CMRPG6E0261, CORPG6D0162). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. The study is based on the National Health Insurance Research Database provided by the Central Bureau of National Health Insurance, the Department of Health, and managed by the National Health Research Institutes. The interpretation and conclusions contained herein do not represent those of Bureau of National Health Insurance, Department of Health, or National Health Research Institutes.	Adler LD, 2010, POSTGRAD MED, V122, P184, DOI 10.3810/pgm.2010.01.2112; Altun C, 2012, SPEC CARE DENT, V32, P184, DOI 10.1111/j.1754-4505.2012.00270.x; Barkley RA, 2006, J AM ACAD CHILD PSY, V45, P192, DOI 10.1097/01.chi.0000189134.97436.e2; Blondis TA, 1999, PEDIATR CLIN N AM, V46, P899, DOI 10.1016/S0031-3955(05)70162-0; Buehring B, 2013, J ALLERGY CLIN IMMUN, V132, P1019, DOI 10.1016/j.jaci.2013.08.040; Cairney J, 2014, DEV MED CHILD NEUROL, V56, P1040, DOI 10.1111/dmcn.12509; Center J, 1998, AM J MENT RETARD, V103, P19, DOI 10.1352/0895-8017(1998)103<0019:PWMRHA>2.0.CO;2; Charach A, 2013, CURR PSYCHIAT REP, V15, DOI 10.1007/s11920-013-0371-6; Chee Carolyn, 2014, Open Respir Med J, V8, P85, DOI 10.2174/1874306401408010085; Chen CY, 2011, J CHILD ADOL PSYCHOP, V21, P265, DOI 10.1089/cap.2010.0107; Chen MH, 2013, J CHILD PSYCHOL PSYC, V54, P1208, DOI 10.1111/jcpp.12087; Childress AC, 2014, CNS DRUGS, V28, P121, DOI 10.1007/s40263-013-0130-6; Chou IC, 2014, DEV MED CHILD NEUROL, V56, P1111, DOI 10.1111/dmcn.12501; Durand-Rivera A, 2015, NEUROL RES INT, V2015, DOI 10.1155/2015/207801; Erdogan M, 2014, ACTA CHIR ORTHOP TR, V81, P221; Ertan C, 2012, EMERG MED J, V29, P911, DOI 10.1136/emermed-2011-200298; Fernandez-Jaen A, 2006, Rev Neurol, V42 Suppl 2, pS25; Garbe E, 2012, J CHILD ADOL PSYCHOP, V22, P452, DOI 10.1089/cap.2012.0022; Gatti D, 2011, ANN ALLERG ASTHMA IM, V107, P202, DOI 10.1016/j.anai.2011.03.018; Gau SSF, 2008, J CLIN PSYCHIAT, V69, P131, DOI 10.4088/JCP.v69n0118; Gazer-Snitovsky M., 2015, J ATTENTION DISORDER; Guo NW, 2015, J PEDIAT ORTHOPEDI B; Hong M, 2016, J KOREAN MED SCI, V31, P611, DOI 10.3346/jkms.2016.31.4.611; Kessler RC, 2006, AM J PSYCHIAT, V163, P716, DOI 10.1176/appi.ajp.163.4.716; Lange H, 2016, J ATTEN DISORD, V20, P501, DOI 10.1177/1087054713518237; Liang WB, 2011, J ASTHMA, V48, P311, DOI 10.3109/02770903.2011.554945; Lin YJ, 2011, HEALTH POLICY, V103, P236, DOI 10.1016/j.healthpol.2011.08.007; LODER RT, 1995, J PEDIATR ORTHOPED, V15, P41, DOI 10.1097/01241398-199501000-00010; Marcus SC, 2008, J ATTEN DISORD, V12, P64, DOI 10.1177/1087054707305168; Melton LJ, 2005, J BONE MINER RES, V20, P564, DOI 10.1359/JBMR.041218; Merrill RM, 2009, ADV MED SCI-POLAND, V54, P20, DOI 10.2478/v10039-009-0022-7; Mikolajczyk R, 2015, JAMA PEDIATR, V169, P391, DOI 10.1001/jamapediatrics.2014.3275; Nakaniida A, 2014, J ORTHOP TRAUMA, V28, P167, DOI 10.1097/BOT.0b013e318299cd20; National Health Research Institutes, 2013, INTR NAT HLTH INS RE; Neumeyer AM, 2015, J AUTISM DEV DISORD, V45, P881, DOI 10.1007/s10803-014-2228-1; Nijmeijer JS, 2008, CLIN PSYCHOL REV, V28, P692, DOI 10.1016/j.cpr.2007.10.003; Ozer K, 2010, J PEDIATR ORTHOPED, V30, P324, DOI 10.1097/BPO.0b013e3181d8fa8c; Perry BA, 2016, OSTEOPOROSIS INT, V27, P2223, DOI 10.1007/s00198-016-3547-1; Polanczyk G, 2007, AM J PSYCHIAT, V164, P942, DOI 10.1176/appi.ajp.164.6.942; Punja S, 2013, BMJ OPEN, V3, DOI 10.1136/bmjopen-2012-002312; Reiersen Angela M, 2008, Expert Rev Neurother, V8, P657, DOI 10.1586/14737175.8.4.657; Rheims S, 2016, EPILEPSIA; Rogers M, 2011, CHILD NEUROPSYCHOL, V17, P444, DOI 10.1080/09297049.2010.544648; Sadock B.J., 2015, KAPLAN SADOCKS SYNOP, P509; Seidenberg M, 2009, FUTUR NEUROL, V4, P663, DOI 10.2217/FNL.09.32; Sobanski E, 2006, EUR ARCH PSY CLIN N, V256, P26, DOI 10.1007/s00406-006-1004-4; Spady DW, 2004, PEDIATRICS, V113, P522, DOI 10.1542/peds.113.3.522; Strom MA, 2016, BRIT J DERMATOLOGY; Tai YM, 2013, RES DEV DISABIL, V34, P1100, DOI 10.1016/j.ridd.2012.11.027; Tsai CJ, 2014, ANN CLIN PSYCHIATRY, V26, P254; Uslu MM, 2008, ARCH ORTHOP TRAUM SU, V128, P417, DOI 10.1007/s00402-007-0393-9; Uslu M, 2007, CLIN ORTHOP RELAT R, P192, DOI 10.1097/BLO.0b013e31805002da; van den Ban E, 2014, EUR CHILD ADOLES PSY, V23, P95, DOI 10.1007/s00787-013-0432-8; Vaughan B, 2012, CHILD ADOL PSYCH CL, V21, P941, DOI 10.1016/j.chc.2012.07.005; Vestergaard P, 2008, CALCIFIED TISSUE INT, V82, P34, DOI 10.1007/s00223-007-9095-0; Wirrell EC, 2006, EPILEPSIA, V47, P79, DOI 10.1111/j.1528-1167.2006.00666.x; Yeh FJ, 2006, OSTEOPOROSIS INT, V17, P267, DOI 10.1007/s00198-005-2009-y	57	28	28	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 15	2017	12	3							e0173762	10.1371/journal.pone.0173762	http://dx.doi.org/10.1371/journal.pone.0173762			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EN9HQ	28296941	gold, Green Published			2022-12-27	WOS:000396311700058
J	Lehner, MS; de Paula, TJ; Del Ponte, EM; Mizubuti, ESG; Pethybridge, SJ				Lehner, Miller S.; de Paula Junior, Trazilbo J.; Del Ponte, Emerson M.; Mizubuti, Eduardo S. G.; Pethybridge, Sarah J.			Independently founded populations of Sclerotinia sclerotiorum from a tropical and a temperate region have similar genetic structure	PLOS ONE			English	Article							DIVERSITY; RAREFACTION; EXTRAPOLATION; RECOMBINATION; PATHOGEN; PROGRAMS; SAMPLES; CANOLA; IMPACT; FUNGUS	Sclerotinia sclerotiorum populations from tropical agricultural zones have been suggested to be more variable compared to those from temperate zones. However, no data were available comparing populations from both zones using the same set of markers. In this study, we compared S. sclerotiorum populations from the United States of America (USA, temperate) and southeast Brazil (tropical) using the frequency of mycelial compatibility groups (MCGs) and 13 microsatellite (SSR) markers. Populations were sourced from diseased plants within leguminous crops in New York, USA (NY; n = 78 isolates), and Minas Gerais State, Brazil (MG; n = 109). Twenty MCGs were identified in NY and 14 were previously reported in MG. The effective number of genotypes based on Hill's number of order 0, which corresponded to the number of multilocus genotypes (MLGs) were 22 (95% CI = 15.6-28.4) and 24 (95% CI = 18.9-29.1) in NY and MG, respectively. Clonal fractions of MLGs were 71.8% (NY) and 78.0% (MG). The effective number of genotypes based on Hill's number of orders 1 and 2 in NY were 8.9 (95% CI = 5.2-12.6) and 4.4 (95% CI = 2.6-6.1), respectively. For MG these indices were 11.4 (95% CI = 8.7-14.1) and 7.1 (95% CI = 5.1-9.0), respectively. There were no significant differences of allelic richness, private allelic richness, gene diversity, effective number of alleles and genotype evenness between the NY and MG populations. The populations were differentiated, with 29% of total variance attributed to differences between them and G"(ST) and Jost's D indices higher than 0.50. Cluster analysis revealed dissimilarity higher than 80% among most MLGs from both populations. Different alleles segregated in the populations but both had similar levels of genotypic variability.	[Lehner, Miller S.; Pethybridge, Sarah J.] Cornell Univ, Sch Integrat Plant Sci, Plant Pathol & Plant Microbe Biol Sect, Geneva, NY 14456 USA; [de Paula Junior, Trazilbo J.] Empresa Pesquisa Agr Minas Gerais EPAMIG, Vicosa, MG, Brazil; [Del Ponte, Emerson M.; Mizubuti, Eduardo S. G.] Univ Fed Vicosa, Dept Fitopatol, Vicosa, MG, Brazil	Cornell University; Universidade Federal de Vicosa	Pethybridge, SJ (corresponding author), Cornell Univ, Sch Integrat Plant Sci, Plant Pathol & Plant Microbe Biol Sect, Geneva, NY 14456 USA.	sjp277@cornell.edu	Del Ponte, Emerson M/D-2464-2012; Del Ponte, Emerson Medeiros/AAC-1369-2021	Del Ponte, Emerson M/0000-0003-4398-409X; Del Ponte, Emerson Medeiros/0000-0003-4398-409X	United States Department of Agriculture, National Institute of Food and Agriculture (USDA - NIFA) Hatch project [NYG-625424]; Conselho Nacional de Desenvolvimento Cientifico e Tecnologico CNPq	United States Department of Agriculture, National Institute of Food and Agriculture (USDA - NIFA) Hatch project; Conselho Nacional de Desenvolvimento Cientifico e Tecnologico CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ))	Funding for the involvement of MSL and SJP in this study was provided by the United States Department of Agriculture, National Institute of Food and Agriculture (USDA - NIFA) Hatch project NYG-625424, managed by the New York Agricultural Experiment Station, Cornell University, Geneva, New York, USA. TJPJ, EMDP, and ESGM were supported by Conselho Nacional de Desenvolvimento Cientifico e Tecnologico CNPq. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agapow PM, 2001, MOL ECOL NOTES, V1, P101, DOI 10.1046/j.1471-8278.2000.00014.x; Aldrich-Wolfe L, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0139188; Amselem J, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002230; Zancan WLA, 2015, BIOSCI J, V31, P1143, DOI 10.14393/BJ-v31n4a2015-26247; Atallah ZK, 2004, PHYTOPATHOLOGY, V94, P737, DOI 10.1094/PHYTO.2004.94.7.737; Attanayake RN, 2014, HEREDITY, V113, P353, DOI 10.1038/hdy.2014.37; Attanayake RN, 2013, PHYTOPATHOLOGY, V103, P750, DOI 10.1094/PHYTO-07-12-0159-R; Baturo-Ciesniewska A, 2016, PLANT DIS; Bolton MD, 2006, MOL PLANT PATHOL, V7, P1, DOI 10.1111/J.1364-3703.2005.00316.X; Carbone I, 2001, MOL ECOL, V10, P947, DOI 10.1046/j.1365-294X.2001.01244.x; Chao A, 2014, ECOL MONOGR, V84, P45, DOI 10.1890/13-0133.1; Chao A, 2012, ECOLOGY, V93, P2533, DOI 10.1890/11-1952.1; Clarkson JP, 2013, PLANT PATHOL, V62, P309, DOI 10.1111/j.1365-3059.2012.02635.x; Colwell RK, 2012, J PLANT ECOL, V5, P3, DOI 10.1093/jpe/rtr044; Cubeta MA, 1997, PHYTOPATHOLOGY, V87, P1000, DOI 10.1094/PHYTO.1997.87.10.1000; del Rio LE, 2007, PLANT DIS, V91, P191, DOI 10.1094/PDIS-91-2-0191; del Rio LE, 2004, PLANT DIS, V88, P1352, DOI 10.1094/PDIS.2004.88.12.1352; Excoffier L, 2010, MOL ECOL RESOUR, V10, P564, DOI 10.1111/j.1755-0998.2010.02847.x; Grunwald NJ, 2003, PHYTOPATHOLOGY, V93, P738, DOI 10.1094/PHYTO.2003.93.6.738; Hambleton S, 2002, CAN J PLANT PATHOL, V24, P309; Hemmati R, 2009, EUR J PLANT PATHOL, V125, P617, DOI 10.1007/s10658-009-9510-7; HILL MO, 1973, ECOLOGY, V54, P427, DOI 10.2307/1934352; Hsieh TC, 2016, METHODS ECOL EVOL; Jost L, 2008, MOL ECOL, V17, P4015, DOI 10.1111/j.1365-294X.2008.03887.x; Jost L, 2007, ECOLOGY, V88, P2427, DOI 10.1890/06-1736.1; Kalinowski ST, 2005, MOL ECOL NOTES, V5, P187, DOI 10.1111/j.1471-8286.2004.00845.x; Kamvar ZN, 2014, PEERJ, V2, DOI 10.7717/peerj.281; KOHLI Y, 1995, MOL ECOL, V4, P69, DOI 10.1111/j.1365-294X.1995.tb00193.x; KOHLI Y, 1992, PHYTOPATHOLOGY, V82, P875, DOI 10.1094/Phyto-82-875; Kohli Y, 1998, FUNGAL GENET BIOL, V23, P139, DOI 10.1006/fgbi.1997.1026; Lehner MS, 2015, PLANT PATHOL, V64, P921, DOI 10.1111/ppa.12322; Lehner MS, 2017, TROP PLANT PATHOL; Lehner MS, 2016, PLANT PATHOL; Ludwig JA, 1988, STAT ECOLOGY; Malvarez G, 2007, PHYTOPATHOLOGY, V97, P470, DOI 10.1094/PHYTO-97-4-0470; Meirmans PG, 2011, MOL ECOL RESOUR, V11, P5, DOI 10.1111/j.1755-0998.2010.02927.x; Meirmans PG, 2004, MOL ECOL NOTES, V4, P792, DOI 10.1111/j.1471-8286.2004.00770.x; Milgroom MG, 1996, ANNU REV PHYTOPATHOL, V34, P457, DOI 10.1146/annurev.phyto.34.1.457; NEI M, 1978, GENETICS, V89, P583; Njambere EN, 2014, PLANT PATHOL, V63, P994, DOI 10.1111/ppa.12176; Schafer MR, 2006, MYCOLOGIA, V98, P593, DOI 10.3852/mycologia.98.4.593; Sexton AC, 2004, CURR GENET, V46, P357, DOI 10.1007/s00294-004-0543-3; Sirjusingh C, 2001, MOL ECOL NOTES, V1, P267, DOI 10.1046/j.1471-8278.2001.00102.x; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Winton LM, 2006, CAN J PLANT PATHOL, V28, P426, DOI 10.1080/07060660609507316; Zhan J, 2003, FUNGAL GENET BIOL, V38, P286, DOI 10.1016/S1087-1845(02)00538-8	46	20	20	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 15	2017	12	3							e0173915	10.1371/journal.pone.0173915	http://dx.doi.org/10.1371/journal.pone.0173915			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN9HQ	28296968	Green Submitted, Green Published, gold			2022-12-27	WOS:000396311700077
J	Ziegler, D; Winter, K; Strom, A; Zhivov, A; Allgeier, S; Papanas, N; Ziegler, I; Bruggemann, J; Ringel, B; Peschel, S; Kohler, B; Stachs, O; Guthoff, RF; Roden, M				Ziegler, Dan; Winter, Karsten; Strom, Alexander; Zhivov, Andrey; Allgeier, Stephan; Papanas, Nikolaos; Ziegler, Iris; Brueggemann, Jutta; Ringel, Bernd; Peschel, Sabine; Koehler, Bernd; Stachs, Oliver; Guthoff, Rudolf F.; Roden, Michael		German Diabet Study GDS Grp	Spatial analysis improves the detection of early corneal nerve fiber loss in patients with recently diagnosed type 2 diabetes	PLOS ONE			English	Article							CONFOCAL MICROSCOPY; PERIPHERAL NEUROPATHY; IMAGE-RECONSTRUCTION; PLEXUS; RISK; MULTICENTER; WHORL	Corneal confocal microscopy (CCM) has revealed reduced corneal nerve fiber (CNF) length and density (CNFL, CNFD) in patients with diabetes, but the spatial pattern of CNF loss has not been studied. We aimed to determine whether spatial analysis of the distribution of corneal nerve branching points (CNBPs) may contribute to improving the detection of early CNF loss. We hypothesized that early CNF decline follows a clustered rather than random distribution pattern of CNBPs. CCM, nerve conduction studies (NCS), and quantitative sensory testing (QST) were performed in a cross-sectional study including 86 patients recently diagnosed with type 2 diabetes and 47 control subjects. In addition to CNFL, CNFD, and branch density (CNBD), CNBPs were analyzed using spatial point pattern analysis (SPPA) including 10 indices and functional statistics. Compared to controls, patients with diabetes showed lower CNBP density and higher nearest neighbor distances, and all SPPA parameters indicated increased clustering of CNBPs (all P<0.05). SPPA parameters were abnormally increased >97.5th percentile of controls in up to 23.5% of patients. When combining an individual SPPA parameter with CNFL, >= 1 of 2 indices were > 99 th or < 1st percentile of controls in 28.6% of patients compared to 2.1% of controls, while for the conventional CNFL/CNFD/CNBD combination the corresponding rates were 16.3% vs 2.1%. SPPA parameters correlated with CNFL and several NCS and QST indices in the controls (all P < 0.001), whereas in patients with diabetes these correlations were markedly weaker or lost. In conclusion, SPPA reveals increased clustering of early CNF loss and substantially improves its detection when combined with a conventional CCM measure in patients with recently diagnosed type 2 diabetes.	[Ziegler, Dan; Strom, Alexander; Papanas, Nikolaos; Ziegler, Iris; Brueggemann, Jutta; Ringel, Bernd; Roden, Michael] Heinrich Heine Univ, Inst Clin Diabetol, German Diabet Ctr, Leibniz Ctr Diabet Res, Dusseldorf, Germany; [Ziegler, Dan; Roden, Michael] Heinrich Heine Univ, Fac Med, Dept Endocrinol & Diabetol, Dusseldorf, Germany; [Ziegler, Dan; Strom, Alexander; Roden, Michael] German Ctr Diabet Res DZD, Munich, Germany; [Winter, Karsten] Univ Leipzig, Inst Anat, Leipzig, Germany; [Zhivov, Andrey; Peschel, Sabine; Stachs, Oliver; Guthoff, Rudolf F.] Univ Rostock, Dept Ophthalmol, Rostock, Germany; [Allgeier, Stephan; Koehler, Bernd] Karlsruhe Inst Technol, Inst Appl Comp Sci, Karlsruhe, Germany	Deutsches Diabetes-Zentrum (DDZ); Heinrich Heine University Dusseldorf; Heinrich Heine University Dusseldorf; Leipzig University; University of Rostock; Helmholtz Association; Karlsruhe Institute of Technology	Ziegler, D (corresponding author), Heinrich Heine Univ, Inst Clin Diabetol, German Diabet Ctr, Leibniz Ctr Diabet Res, Dusseldorf, Germany.; Ziegler, D (corresponding author), Heinrich Heine Univ, Fac Med, Dept Endocrinol & Diabetol, Dusseldorf, Germany.; Ziegler, D (corresponding author), German Ctr Diabet Res DZD, Munich, Germany.	dan.ziegler@ddz.uni-duesseldorf.de	Roden, Michael/AAD-3843-2019; Allgeier, Stephan/AAU-8698-2020	Allgeier, Stephan/0000-0002-1218-448X	German Diabetes Center; German Federal Ministry of Health (Berlin, Germany); Ministry of Innovation, Science, Research and Technology of the state North Rhine-Westphalia (Dusseldorf, Germany); German Federal Ministry of Education and Research (BMBF); Ministry of Science, Research and the Arts of Baden-Wurttemberg [AZ 33-7533-7-11.6-9/3/1]	German Diabetes Center; German Federal Ministry of Health (Berlin, Germany); Ministry of Innovation, Science, Research and Technology of the state North Rhine-Westphalia (Dusseldorf, Germany); German Federal Ministry of Education and Research (BMBF)(Federal Ministry of Education & Research (BMBF)); Ministry of Science, Research and the Arts of Baden-Wurttemberg	The German Diabetes Study (GDS) was initiated and financed by the German Diabetes Center, which is funded by the German Federal Ministry of Health (Berlin, Germany), the Ministry of Innovation, Science, Research and Technology of the state North Rhine-Westphalia (Dusseldorf, Germany), and grants from the German Federal Ministry of Education and Research (BMBF) to the German Center for Diabetes Research (DZD e.V.). Parts of this work were supported by a grant from the Ministry of Science, Research and the Arts of Baden-Wurttemberg (AZ 33-7533-7-11.6-9/3/1).r The authors wish to thank the staff of the GDS at the German Diabetes Center, Dusseldorf, Germany, especially M. Behler and M. Schroers-Teuber, for their excellent technical support. The German Diabetes Study (GDS) was initiated and financed by the German Diabetes Center, which is funded by the German Federal Ministry of Health (Berlin, Germany), the Ministry of Innovation, Science, Research and Technology of the state North Rhine-Westphalia (Dusseldorf, Germany), and grants from the German Federal Ministry of Education and Research (BMBF) to the German Center for Diabetes Research (DZD e.V.). Parts of this work were supported by a grant from the Ministry of Science, Research and the Arts of Baden-Wurttemberg (AZ 33-7533-7-11.6-9/3/1).	Abbott CA, 1998, DIABETES CARE, V21, P1071, DOI 10.2337/diacare.21.7.1071; Allgeier S, 2013, BIOMED TECH BERL S1, V58; Allgeier S, 2012, BIOMED TECH BERL S1, V57, P793; Allgeier S, 2014, INVEST OPHTH VIS SCI, V55, P6082, DOI 10.1167/iovs.14-14698; Allgeier S, 2011, INVEST OPHTH VIS SCI, V52, P5022, DOI 10.1167/iovs.10-6065; Amer Diabet Assoc, 2012, DIABETES CARE, V35, pS64, DOI [10.2337/dc12-S064, 10.2337/dc09-S062, 10.2337/dc11-S011]; BESAG J, 1977, J ROYAL STAT SOC B, V39, P193, DOI DOI 10.1016/J.FORECO.2009.04.009; BORGEFORS G, 1986, COMPUT VISION GRAPH, V34, P344, DOI 10.1016/S0734-189X(86)80047-0; Brownrigg JRW, 2014, HEART, V100, P1837, DOI 10.1136/heartjnl-2014-305657; Calles-Escandon J, 2010, DIABETES CARE, V33, P721, DOI 10.2337/dc09-1471; CLARK PJ, 1954, ECOLOGY, V35, P445, DOI 10.2307/1931034; DYCK PJ, 1986, ANN NEUROL, V19, P440, DOI 10.1002/ana.410190504; Edwards K, 2014, DIABETIC MED, V31, P1205, DOI 10.1111/dme.12466; Edwards K, 2012, CORNEA, V31, P1078, DOI 10.1097/ICO.0b013e318245c012; Hahn U, 2012, J AM STAT ASSOC, V107, P754, DOI 10.1080/01621459.2012.688463; Kennedy WR, 1999, MUSCLE NERVE, V22, P360, DOI 10.1002/(SICI)1097-4598(199903)22:3<360::AID-MUS9>3.0.CO;2-J; Kohler B, 2014, KLIN MONATSBL AUGENH, V231, P1170, DOI 10.1055/s-0034-1383331; Kohler B, 2011, KLIN MONATSBL AUGENH, V228, P1060, DOI 10.1055/s-0031-1281959; Okabe A., 2000, SPATIAL TESSELLATION, P43, DOI 10.1002/9780470317013.ch2; Papanas N, 2013, CURR DIABETES REP, V13, P488, DOI 10.1007/s11892-013-0390-z; Papanas N, 2015, J DIABETES INVEST, V6, P381, DOI 10.1111/jdi.12335; Perry GLW, 2006, PLANT ECOL, V187, P59, DOI 10.1007/s11258-006-9133-4; Petropoulos IN, 2015, INVEST OPHTH VIS SCI, V56, P2498, DOI 10.1167/iovs.14-15919; Petropoulos IN, 2013, DIABETES CARE, V36, P3646, DOI 10.2337/dc13-0193; Pritchard N, 2015, CORNEA, V34, P756, DOI 10.1097/ICO.0000000000000447; Pritchard N, 2015, DIABETES CARE, V38, P671, DOI 10.2337/dc14-2114; RIPLEY BD, 1976, J APPL PROBAB, V13, P255, DOI 10.2307/3212829; RIPLEY BD, 1977, J ROY STAT SOC B MET, V39, P172; SINCLAIR DF, 1985, ECOLOGY, V66, P1084, DOI 10.2307/1940568; Stoyan D., 1994, FRACTALS RANDOM SHAP; Szmyt J, 2014, SILVA FENN, V48, DOI 10.14214/sf.1008; Tavakoli M, 2015, DIABETES CARE, V38, P838, DOI 10.2337/dc14-2311; Voronoi G., 1907, J REINE ANGEW MATH, V133, P97, DOI DOI 10.1515/CRLL.1908.133.97; Waller LA, 2011, STAT MED, V30, P2827, DOI 10.1002/sim.4315; Winter K, 2016, CURR EYE RES, V41, P186, DOI 10.3109/02713683.2015.1010686; YOUNG MJ, 1993, DIABETOLOGIA, V36, P150, DOI 10.1007/BF00400697; Ziegler D, 2011, DIABETIC MED, V28, P1412, DOI 10.1111/j.1464-5491.2011.03345.x; Ziegler Dan, 2014, Handb Clin Neurol, V126, P3, DOI 10.1016/B978-0-444-53480-4.00001-1; Ziegler D, 2014, DIABETES, V63, P2454, DOI 10.2337/db13-1819	39	11	13	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 15	2017	12	3							e0173832	10.1371/journal.pone.0173832	http://dx.doi.org/10.1371/journal.pone.0173832			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN9HQ	28296936	Green Published, Green Submitted, gold			2022-12-27	WOS:000396311700071
J	Jacob, CE; Tozzi, E; Willenborg, CJ				Jacob, Cory. E.; Tozzi, Eric; Willenborg, Christian J.			Neighbour presence, not identity, influences root and shoot allocation in pea	PLOS ONE			English	Article							SELF/NON-SELF DISCRIMINATION; BELOW-GROUND COMPETITION; KIN RECOGNITION; PLANTS; TRAGEDY; YIELD; PERCEPTION; AVOIDANCE; RESPONSES; COMMONS	Competition is a key feature that structures the composition of plant communities. A growing body of evidence is showing that the presence of neighbours, especially belowground neighbours, induces varied morphological responses in plants. However, in many species, it is not known whether neighbour identity also influences plant morphological responses such as biomass allocation patterns. To assess plant response to above- and belowground neighbour presence and identity, we conducted a greenhouse experiment consisting of conspecific (pea; Pisum sativum L.) and heterospecific (oat; Avena sativa L.) neighbours growing with a P. sativum focal plant. Four interaction regimes were constructed including shoot, root, or 'full' interaction (root & shoot) treatments, as well as a control with no interactions permitted. Our results showed that pea plants responded negatively to the presence of neighbours, and in particular, the presence of belowground neighbours. Treatments where belowground interactions were permitted (full and root interactions) had lower root and shoot mass fractions (R:S ratios) than where shoot interactions were permitted. Shoot and root allocation and R:S ratios of focal pea plants were not affected by neighbour identity, suggesting that neighbour presence, but not identity, influenced allocation patterns. The impact on P. sativum of a neighbouring competitor was more prominent than neighbour identity, showing that some plants may not discriminate between the identity of neighbours even though they are capable of responding to their presence.	[Jacob, Cory. E.; Tozzi, Eric; Willenborg, Christian J.] Univ Saskatchewan, Dept Plant Sci, Saskatoon, SK, Canada	University of Saskatchewan	Willenborg, CJ (corresponding author), Univ Saskatchewan, Dept Plant Sci, Saskatoon, SK, Canada.	chris.willenborg@usask.ca	Willenborg, Christian/AAH-9360-2021	Willenborg, Christian/0000-0001-9733-2252	Alberta Pulse Growers; Canadian Agricultural Adaptation Program; Natural Sciences and Engineering Research Council of Canada	Alberta Pulse Growers; Canadian Agricultural Adaptation Program; Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR)	The authors gratefully acknowledge funding for the study provided by the Alberta Pulse Growers, the Canadian Agricultural Adaptation Program, and the Natural Sciences and Engineering Research Council of Canada. NSERC provided a partial salary for postdoc Eric Tozzi, and the Alberta Pulse Growers provided a graduate student stipend for lead author Cory Jacob. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors gratefully acknowledge funding for the study provided by the Alberta Pulse Growers, the Canadian Agricultural Adaptation Program, and the Natural Sciences and Engineering Research Council of Canada.	Afifi M, 2011, WEED RES, V51, P442, DOI 10.1111/j.1365-3180.2011.00865.x; Armas C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027791; Asaduzzaman M, 2012, SCI HORTIC-AMSTERDAM, V134, P26, DOI 10.1016/j.scienta.2011.11.035; Bazzaz F. A., 1996, PLANTS CHANGING ENV; Bennett JA, 2016, J ECOL, V104, P1410, DOI 10.1111/1365-2745.12614; Bhatt MV, 2011, NEW PHYTOL, V189, P1135, DOI 10.1111/j.1469-8137.2010.03548.x; Booth BD, 2002, WEED SCI, V50, P2, DOI 10.1614/0043-1745(2002)050[0002:AIATAT]2.0.CO;2; Brown D. A., 1984, Roots, nutrient and water influx, and plant growth . ASA Special PublicationNo. 49., P101; Broz AK, 2010, BMC PLANT BIOL, V10, DOI 10.1186/1471-2229-10-115; Cahill JF, 2011, ANNU REV ECOL EVOL S, V42, P289, DOI 10.1146/annurev-ecolsys-102710-145006; Cahill JF, 2010, SCIENCE, V328, P1657, DOI 10.1126/science.1189736; Cahill JF, 2005, J ECOL, V93, P958, DOI 10.1111/j.1365-2745.2005.01013.x; Casper BB, 1997, ANNU REV ECOL SYST, V28, P545, DOI 10.1146/annurev.ecolsys.28.1.545; Chen BJW, 2015, FUNCT ECOL, V29, P1383, DOI 10.1111/1365-2435.12450; Chen BJW, 2012, PLANT SCI, V195, P157, DOI 10.1016/j.plantsci.2012.07.006; CHESSON P, 1991, TRENDS ECOL EVOL, V6, P26, DOI 10.1016/0169-5347(91)90144-M; COTE R, 1992, CAN J BOT, V70, P571, DOI 10.1139/b92-073; Dener E, 2016, CURR BIOL, V26, P1763, DOI 10.1016/j.cub.2016.05.008; Dudley SA, 2007, BIOLOGY LETT, V3, P435, DOI 10.1098/rsbl.2007.0232; Dudley SA, 2013, FUNCT ECOL, V27, P898, DOI 10.1111/1365-2435.12121; Dunbabin V, 2007, FIELD CROP RES, V104, P44, DOI 10.1016/j.fcr.2007.03.014; Falik O, 2003, J ECOL, V91, P525, DOI 10.1046/j.1365-2745.2003.00795.x; FONTEYN PJ, 1978, NATURE, V275, P544, DOI 10.1038/275544a0; Franklin KA, 2008, NEW PHYTOL, V179, P930, DOI 10.1111/j.1469-8137.2008.02507.x; Fridley JD, 2007, J ECOL, V95, P908, DOI 10.1111/j.1365-2745.2007.01256.x; Gal J, 2015, WEED SCI, V63, P888, DOI 10.1614/WS-D-15-00039.1; GAUDET CL, 1988, NATURE, V334, P242, DOI 10.1038/334242a0; Gersani M, 1998, EVOL ECOL, V12, P223, DOI 10.1023/A:1006587813950; Green-Tracewicz E, 2011, WEED SCI, V59, P43, DOI 10.1614/WS-D-10-00081.1; Gruntman M, 2004, P NATL ACAD SCI USA, V101, P3863, DOI 10.1073/pnas.0306604101; Gundel PE, 2014, OECOLOGIA, V176, P1, DOI 10.1007/s00442-014-2983-x; Harper J.L., 1977, PLANT POPULATION BIO; Hess L, 2007, J ECOL, V95, P241, DOI 10.1111/j.1365-2745.2006.01204.x; Horvath DP, 2007, WEED SCI, V55, P546, DOI 10.1614/WS-07-008.1; Jacob CE, 2016, WEED SCI, V64, P137, DOI 10.1614/WS-D-15-00113.1; Karban R, 2008, ECOL LETT, V11, P727, DOI 10.1111/j.1461-0248.2008.01183.x; Koscielny CB, 2012, CAN J PLANT SCI, V92, P1229, DOI 10.4141/CJPS2012-070; Lamb EG, 2009, J ECOL, V97, P155, DOI 10.1111/j.1365-2745.2008.01454.x; Lankau RA, 2001, J ECOL, V99, P176; MACKAY AD, 1986, AGRON J, V78, P699, DOI 10.2134/agronj1986.00021962007800040028x; MAHALL BE, 1991, P NATL ACAD SCI USA, V88, P874, DOI 10.1073/pnas.88.3.874; Maina GG, 2002, PLANT ECOL, V160, P235, DOI 10.1023/A:1015822003011; Mckenzie-Gopsill AG, 2016, WEED RES, V56, P267, DOI 10.1111/wre.12207; McNickle GG, 2014, J ECOL, V102, P963, DOI 10.1111/1365-2745.12259; Meier IC, 2013, PLANTA, V238, P577, DOI 10.1007/s00425-013-1910-4; Milla R, 2009, P ROY SOC B-BIOL SCI, V276, P2531, DOI 10.1098/rspb.2009.0369; Murphy GP, 2007, J ECOL, V95, P261, DOI 10.1111/j.1365-2745.2007.01217.x; Murphy KM, 2008, FIELD CROP RES, V105, P107, DOI 10.1016/j.fcr.2007.08.004; O'Brien EE, 2005, NEW PHYTOL, V168, P401, DOI 10.1111/j.1469-8137.2005.01520.x; O'Donovan JT, 2000, WEED TECHNOL, V14, P624, DOI 10.1614/0890-037X(2000)014[0624:WOAFII]2.0.CO;2; Pierik R, 2013, FUNCT ECOL, V27, P841, DOI 10.1111/1365-2435.12010; Radosevich SR, 2007, ECOLOGY OF WEEDS AND INVASIVE PLANTS: RELATIONSHIP TO AGRICULTURE AND NATURAL RESOURCE MANAGEMENT, 3RD EDITION, P183; SAS Institute, 2011, SAS US GUID VERS 9 3; Schmid C, 2013, FRONT PLANT SCI, V4, DOI 10.3389/fpls.2013.00296; Semchenko M, 2007, J ECOL, V95, P252, DOI 10.1111/j.1365-2745.2007.01210.x; Semchenko M, 2014, NEW PHYTOL, V204, P631, DOI 10.1111/nph.12930; Walker JA, 2009, CAN J PLANT SCI, V89, P21, DOI 10.4141/CJPS08010; Wardle DA, 2003, OIKOS, V100, P497, DOI 10.1034/j.1600-0706.2003.12030.x; Weiner J, 2004, PERSPECT PLANT ECOL, V6, P207, DOI 10.1078/1433-8319-00083; Willenborg CJ, 2005, CROP SCI, V45, P1410, DOI 10.2135/cropsci2004.0638; WILSON JB, 1988, J APPL ECOL, V25, P279, DOI 10.2307/2403626; Zerner MC, 2008, AGRON J, V100, P1729, DOI 10.2134/agronj2008.0068	62	17	17	3	51	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 14	2017	12	3							e0173758	10.1371/journal.pone.0173758	http://dx.doi.org/10.1371/journal.pone.0173758			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN6DM	28291827	Green Submitted, gold, Green Published			2022-12-27	WOS:000396094700038
J	Chen, SR; Liu, W; Wang, K; Fan, YZ; Chen, JQ; Ma, JB; Wang, XY; He, DL; Zeng, J; Li, L				Chen, Shurui; Liu, Wei; Wang, Ke; Fan, Yizeng; Chen, Jiaqi; Ma, Jianbin; Wang, Xinyang; He, Dalin; Zeng, Jin; Li, Lei			Tetrandrine inhibits migration and invasion of human renal cell carcinoma by regulating Akt/NF-kappa B/MMP-9 signaling	PLOS ONE			English	Article							PROSTATE-CANCER CELLS; KAPPA-B; METASTASIS; MMP-9; ACTIVATION; EXPRESSION; PATHWAY; PROLIFERATION; APOPTOSIS; THERAPY	Renal cell carcinoma (RCC) is known as one of the most lethal malignancies in the urological system because of its high incidence of metastasis. Tetrandrine (Tet), a traditional Chinese herbal medicine, exerts a potent anti-cancer effect in a variety of cancer cells. However, the anti-metastatic effect of Tet and its possible mechanism in RCC is still unclear. The present study revealed that Tet significantly suppressed the migration and invasion of RCC 786-O and 769-P cells in vitro. Mechanistically, the protein levels of matrix metalloproteinases 9 (MMP-9), phosphorylated PI3K, PDK1, Akt and NF-kappa B were markedly reduced after Tet treatment. Moreover, co-treatment with LY294002 (PI3K inhibitor) could further enhance the Tet-inhibited migration and invasion, and the NF-kappa B and MMP-9 protein levels were further decreased. Similar results were observed after PDTC (NF-kappa B inhibitor) co-treatment. Conversely, SC79, an Akt activator, could partially reverse the anti-metastatic effects of Tet, accompanied by the restoration of NF-kappa B and MMP-9 protein levels. In conclusion, the current results indicated that Tet inhibited migration and invasion of RCC partially by regulating Akt/NF-kappa B/MMP-9 signaling pathway, suggesting that Tet may be a potential therapeutic candidate against metastatic RCC.	[Chen, Shurui; Liu, Wei; Wang, Ke; Fan, Yizeng; Chen, Jiaqi; Ma, Jianbin; Wang, Xinyang; He, Dalin; Zeng, Jin; Li, Lei] Xi An Jiao Tong Univ, Dept Urol, Affiliated Hosp 1, Xian, Peoples R China; [Chen, Shurui] Jinzhou Med Univ, Dept Sci & Technol, Jinzhou, Peoples R China	Xi'an Jiaotong University; Jinzhou Medical University	Zeng, J; Li, L (corresponding author), Xi An Jiao Tong Univ, Dept Urol, Affiliated Hosp 1, Xian, Peoples R China.	zengjin1984@gmail.com; lilydr@hotmail.com	Wang, Xin/GYU-1129-2022	Zeng, Jin/0000-0002-0872-587X	National High Technology Research and Development Program of China (863 Program) [SS2014AA020607]; National Natural Science Foundation of China [81072107, 81472679, 81302227, 81130041, 81101936]; National Key Research and Development Program [2016YFC0902603]	National High Technology Research and Development Program of China (863 Program)(National High Technology Research and Development Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Key Research and Development Program	This work was supported by The National High Technology Research and Development Program of China (863 Program, NO SS2014AA020607) and National Natural Science Foundation of China grant (NO.81072107, 81472679, 81302227, 81130041, 81101936), and the National Key Research and Development Program (2016YFC0902603). The funders had no role in study design, data collection and analysis, decision to publish, role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This work was supported by The National High Technology Research and Development Program of China (863 Program, NO SS2014AA020607) and National Natural Science Foundation of China grant (NO.81072107, 81472679, 81130041, 81101936, 81672538), and the National Key Research and Development Program (2016YFC0902603).	Chang XJ, 2016, PATHOL ONCOL RES, V22, P789, DOI 10.1007/s12253-016-0071-8; Chen SQ, 2016, INT J ONCOL, V48, P1391, DOI 10.3892/ijo.2016.3368; Chiu CT, 2015, NUTRIENTS, V7, P5065, DOI 10.3390/nu7075065; Cohen HT, 2005, NEW ENGL J MED, V353, P2477, DOI 10.1056/NEJMra043172; Comperat E, 2012, Diagn Interv Imaging, V93, P221, DOI 10.1016/j.diii.2012.01.015; Dolle L, 2006, CURR CANCER DRUG TAR, V6, P729, DOI 10.2174/156800906779010263; Duensing S, 2016, LANCET, V387, P1973, DOI 10.1016/S0140-6736(16)00653-X; Fan DM, 2016, GYNECOL ONCOL, V141, P166, DOI 10.1016/j.ygyno.2016.02.006; Gao JL, 2013, EVID-BASED COMPL ALT, V2013, DOI 10.1155/2013/265061; Gao LN, 2016, J ORTHOP RES, V34, P1557, DOI 10.1002/jor.23155; Gupta GP, 2006, CELL, V127, P679, DOI 10.1016/j.cell.2006.11.001; Hainaut P, 2013, CURR OPIN ONCOL, V25, P50, DOI 10.1097/CCO.0b013e32835b651e; Kang H, 2012, J CELL BIOCHEM, V113, P2845, DOI 10.1002/jcb.24159; Kessenbrock K, 2010, CELL, V141, P52, DOI 10.1016/j.cell.2010.03.015; Kou B, 2016, ONCOL REP, V35, P2880, DOI 10.3892/or.2016.4649; Li CL, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0091332; Li XD, 2011, J SURG RES, V166, pE45, DOI 10.1016/j.jss.2010.10.034; Lien JC, 2016, ENV TOXICOLOGY; Liu T, 2016, ONCOTARGET, DOI 10.18632/oncotarget.1346527888803; Liu W, 2015, ASIAN J ANDROL, V17, P850, DOI 10.4103/1008-682X.142134; Park SY, 2013, INT J ONCOL, V42, P287, DOI 10.3892/ijo.2012.1695; Shen DF, 2010, BRIT J PHARMACOL, V159, P970, DOI 10.1111/j.1476-5381.2009.00605.x; Tai KY, 2008, ONCOGENE, V27, P4044, DOI 10.1038/onc.2008.57; Thangapazham RL, 2007, CANCER BIOL THER, V6, P1938, DOI 10.4161/cbt.6.12.4974; Wang J, 2015, CLIN EXP METASTAS, V32, P605, DOI 10.1007/s10585-015-9731-4; Wang X, 2015, J SPECTROSC, V2015, P1, DOI 10.1155/2015/285891; Yamaguchi N, 2009, CANCER SCI, V100, P1668, DOI 10.1111/j.1349-7006.2009.01228.x; Yilmaz M, 2007, TRENDS MOL MED, V13, P535, DOI 10.1016/j.molmed.2007.10.004; Zhang YR, 2016, J STAT MECH-THEORY E, P1, DOI 10.1088/1742-5468/2016/11/113207; Zhou F, 2016, BIOCHEM BIOPH RES CO, V472, P451, DOI 10.1016/j.bbrc.2016.01.065	30	28	31	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 13	2017	12	3							e0173725	10.1371/journal.pone.0173725	http://dx.doi.org/10.1371/journal.pone.0173725			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN6CP	28288190	Green Published, Green Submitted, gold			2022-12-27	WOS:000396092400032
J	El-Sharnouby, S; Fischer, B; Magbanua, JP; Umans, B; Flower, R; Choo, SW; Russell, S; White, R				El-Sharnouby, Sherif; Fischer, Bettina; Magbanua, Jose Paolo; Umans, Benjamin; Flower, Rosalyn; Choo, Siew Woh; Russell, Steven; White, Robert			Regions of very low H3K27me3 partition the Drosophila genome into topological domains	PLOS ONE			English	Article							CHROMATIN IMMUNOPRECIPITATION ASSAY; BINDING-SITES; CHROMODOMAIN PROTEIN; JIL-1 KINASE; HISTONE H4; CTCF SITES; ORGANIZATION; ACETYLATION; PRINCIPLES; REVEALS	It is now well established that eukaryote genomes have a common architectural organization into topologically associated domains (TADs) and evidence is accumulating that this organization plays an important role in gene regulation. However, the mechanisms that partition the genome into TADs and the nature of domain boundaries are still poorly understood. We have investigated boundary regions in the Drosophila genome and find that they can be identified as domains of very low H3K27me3. The genome-wide H3K27me3 profile partitions into two states; very low H3K27me3 identifies Depleted (D) domains that contain housekeeping genes and their regulators such as the histone acetyltransferase-containing NSL complex, whereas domains containing moderate-to-high levels of H3K27me3 (Enriched or E domains) are associated with regulated genes, irrespective of whether they are active or inactive. The D domains correlate with the boundaries of TADs and are enriched in a subset of architectural proteins, particularly Chromator, BEAF-32, and Z4/Putzig. However, rather than being clustered at the borders of these domains, these proteins bind throughout the H3K27me3-depleted regions and are much more strongly associated with the transcription start sites of housekeeping genes than with the H3K27me3 domain boundaries. While we have not demonstrated causality, we suggest that the D domain chromatin state, characterised by very low or absent H3K27me3 and established by housekeeping gene regulators, acts to separate topological domains thereby setting up the domain architecture of the genome.	[El-Sharnouby, Sherif; Magbanua, Jose Paolo; Umans, Benjamin; Flower, Rosalyn; White, Robert] Univ Cambridge, Dept Physiol Dev & Neurosci, Cambridge CB2 3DY, England; [Fischer, Bettina; Russell, Steven] Univ Cambridge, Dept Genet, Cambridge CB2 3EH, England; [Fischer, Bettina; Russell, Steven] Univ Cambridge, Cambridge Syst Biol Ctr, Cambridge CB2 1QR, England; [Choo, Siew Woh] Univ Malaya, Dept Oral & Craniofacial Sci, Fac Dent, Kuala Lumpur, Malaysia	University of Cambridge; University of Cambridge; University of Cambridge; Universiti Malaya	White, R (corresponding author), Univ Cambridge, Dept Physiol Dev & Neurosci, Cambridge CB2 3DY, England.	rw108@cam.ac.uk		White, Robert/0000-0002-0019-8227; Umans, Benjamin/0000-0002-8209-9731; Russell, Steven/0000-0003-0546-3031	Wellcome Trust [089834/Z/09/Z]; University of Malaya High Impact Research from the Ministry of Higher Education Malaysia [UM.C/625/HIR/MOHE/CHAN-08]; BBSRC [BB/M007081/1]; Cambridge Marshall Scholarship; Biotechnology and Biological Sciences Research Council [BB/M007081/1] Funding Source: researchfish	Wellcome Trust(Wellcome TrustEuropean Commission); University of Malaya High Impact Research from the Ministry of Higher Education Malaysia; BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Cambridge Marshall Scholarship; Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work was supported by the Wellcome Trust (https://wellcome.ac.uk/, grant 089834/Z/09/Z to RW, SR), by the University of Malaya High Impact Research (hir.um.edu.my, grant UM.C/625/HIR/MOHE/CHAN-08 to SWC) from the Ministry of Higher Education Malaysia, and by the BBSRC (www.bbsrc.ac.uk, grant BB/M007081/1 to RW, SR). BU was funded by a Cambridge Marshall Scholarship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bartkuhn M, 2009, EMBO J, V28, P877, DOI 10.1038/emboj.2009.34; Belyaeva ES, 2012, PLOS ONE, V7, P352, DOI 10.1371/journal.pone.0030035; Bowman SK, 2014, ELIFE, V3, DOI 10.7554/eLife.02833; Cai Y, 2003, J BIOL CHEM, V278, P42733, DOI 10.1074/jbc.C300389200; Cai Y, 2010, J BIOL CHEM, V285, P4268, DOI 10.1074/jbc.C109.087981; Carrozza MJ, 2005, CELL, V123, P581, DOI 10.1016/j.cell.2005.10.023; Chen X, 2011, DEVELOPMENT, V138, P2441, DOI 10.1242/dev.056572; Cherbas L, 2011, GENOME RES, V21, P301, DOI 10.1101/gr.112961.110; Chintapalli VR, 2007, NAT GENET, V39, P715, DOI 10.1038/ng2049; Cuddapah S, 2009, GENOME RES, V19, P24, DOI 10.1101/gr.082800.108; Dahl JA, 2008, NUCLEIC ACIDS RES, V36, DOI 10.1093/nar/gkm1158; Dahl JA, 2008, NAT PROTOC, V3, P1032, DOI 10.1038/nprot.2008.68; Deng H, 2005, CHROMOSOMA, V114, P173, DOI 10.1007/s00412-005-0006-8; Dixon JR, 2012, NATURE, V485, P376, DOI 10.1038/nature11082; Eagen KP, 2015, CELL, V163, P934, DOI 10.1016/j.cell.2015.10.026; Eggert H, 2004, J CELL SCI, V117, P4253, DOI 10.1242/jcs.01292; Feller C, 2012, NUCLEIC ACIDS RES, V40, P1509, DOI 10.1093/nar/gkr869; Filion GJ, 2010, CELL, V143, P212, DOI 10.1016/j.cell.2010.09.009; Gan M, 2011, J BIOSCIENCES, V36, P425, DOI 10.1007/s12038-011-9089-y; Gomez-Marin C, 2015, P NATL ACAD SCI USA, V112, P7542, DOI 10.1073/pnas.1505463112; Gortchakov AA, 2005, CHROMOSOMA, V114, P54, DOI 10.1007/s00412-005-0339-3; Guo Y, 2015, CELL, V162, P900, DOI 10.1016/j.cell.2015.07.038; Hagege H, 2007, NAT PROTOC, V2, P1722, DOI 10.1038/nprot.2007.243; Hawkins RD, 2010, CELL STEM CELL, V6, P479, DOI 10.1016/j.stem.2010.03.018; Hoffman M. M., 2012, NUCLEIC ACIDS RES; Holohan EE, 2007, PLOS GENET, V3, P1211, DOI 10.1371/journal.pgen.0030112; Hou CH, 2012, MOL CELL, V48, P471, DOI 10.1016/j.molcel.2012.08.031; Ing-Simmons E, 2015, GENOME RES, V25, P504, DOI 10.1101/gr.184986.114; Jiang N, 2009, MOL CELL BIOL, V29, P3556, DOI 10.1128/MCB.01748-08; Joshi AA, 2005, MOL CELL, V20, P971, DOI 10.1016/j.molcel.2005.11.021; Keogh MC, 2005, CELL, V123, P593, DOI 10.1016/j.cell.2005.10.025; Kharchenko PV, 2011, NATURE, V471, P480, DOI 10.1038/nature09725; Kim TH, 2007, CELL, V128, P1231, DOI 10.1016/j.cell.2006.12.048; Kusch T, 2004, SCIENCE, V306, P2084, DOI 10.1126/science.1103455; Kwong C, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000178; Lam KC, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002736; Le Dily F, 2014, GENE DEV, V28, P2151, DOI 10.1101/gad.241422.114; Lee HG, 2015, GENOME RES, V25, P1170, DOI 10.1101/gr.188920.114; Levy-Leduc C, 2014, BIOINFORMATICS, V30, pI386, DOI 10.1093/bioinformatics/btu443; Li L, 2015, MOL CELL, V58, P216, DOI 10.1016/j.molcel.2015.02.023; Lieberman-Aiden E, 2009, SCIENCE, V326, P289, DOI 10.1126/science.1181369; Lowe N, 2014, DEVELOPMENT, V141, P3994, DOI 10.1242/dev.111054; Lupianez DG, 2015, CELL, V161, P1012, DOI 10.1016/j.cell.2015.04.004; Lv WW, 2012, J CELL SCI, V125, P5369, DOI 10.1242/jcs.106336; Majumder P, 2014, J IMMUNOL, V192, P3925, DOI 10.4049/jimmunol.1303205; Mendjan S, 2006, MOL CELL, V21, P811, DOI 10.1016/j.molcel.2006.02.007; Mifsud B, 2013, GOTHIC BINOMIAL TEST; Narendra V, 2015, SCIENCE, V347, P1017, DOI 10.1126/science.1262088; Negre N, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000814; Nicol JW, 2009, BIOINFORMATICS, V25, P2730, DOI 10.1093/bioinformatics/btp472; Nora EP, 2012, NATURE, V485, P381, DOI 10.1038/nature11049; Patel B, 2014, LEUKEMIA, V28, P349, DOI 10.1038/leu.2013.158; Rao SSP, 2014, CELL, V159, P1665, DOI 10.1016/j.cell.2014.11.021; Rath U, 2006, J CELL SCI, V119, P2332, DOI 10.1242/jcs.02960; Sexton T, 2012, CELL, V148, P458, DOI 10.1016/j.cell.2012.01.010; Shogren-Knaak M, 2006, SCIENCE, V311, P844, DOI 10.1126/science.1124000; Sidiropoulos N, 2015, 028191V1 BIORXIV; Smith ER, 2000, MOL CELL BIOL, V20, P312, DOI 10.1128/MCB.20.1.312-318.2000; Stampfel G, 2015, NATURE, V528, P147, DOI 10.1038/nature15545; Taramasco O, 2013, RHMM HIDDEN MARKOV M; Toedling J, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-221; Ulianov SV, 2016, GENOME RES, V26, P70, DOI 10.1101/gr.196006.115; van Berkum NL, 2010, J VIS EXP JOVE; Van Bortle K, 2014, GENOME BIOL, V15, DOI 10.1186/gb-2014-15-5-r82; Van Bortle K, 2012, GENOME RES, V22, P2176, DOI 10.1101/gr.136788.111; Vatolina TY, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025960; Vogelmann J, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004544; Wingett Steven, 2015, F1000Res, V4, P1310, DOI 10.12688/f1000research.7334.1; Wood AM, 2011, MOL CELL, V44, P29, DOI 10.1016/j.molcel.2011.07.035; Yip KY, 2012, GENOME BIOL, V13, DOI 10.1186/gb-2012-13-9-r48; Zhang Y, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-9-r137	71	30	30	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 10	2017	12	3							e0172725	10.1371/journal.pone.0172725	http://dx.doi.org/10.1371/journal.pone.0172725			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN6CJ	28282436	Green Published, Green Submitted, gold			2022-12-27	WOS:000396091800011
J	Gleason, JA; Fagliano, JA				Gleason, Jessie A.; Fagliano, Jerald A.			Effect of drinking water source on associations between gastrointestinal illness and heavy rainfall in New Jersey	PLOS ONE			English	Article							UNITED-STATES; TIME-SERIES; DISEASE; PHILADELPHIA; TURBIDITY; GASTROENTERITIS; PRECIPITATION; OUTBREAKS; QUALITY; WEATHER	Gastrointestinal illness (GI) has been associated with heavy rainfall. Storm events and periods of heavy rainfall and runoff can result in increased microbiological contaminants in raw water. Surface water supplies are open to the environment and runoff can directly influence the presence of contaminants. A time-stratified bi-directional case-crossover study design was used to estimate associations of heavy rainfall and hospitalizations for GI. Cases of GI were identified as in-patient hospitalization with a primary diagnosis of infectious disease associated diarrhea [ ICD-9 codes: specified gastrointestinal infections 001 - 009.9 or diarrhea 787.91] among the residents of New Jersey from 2009 to 2013 resulting in a final sample size of 47,527 cases. Two control days were selected on the same days of the week as the case day, within fixed 21-day strata. Conditional logistic regression was used to estimate odds ratios controlling for temperature and humidity. To determine potential effect modification estimates were stratified by season (warm or cold) and drinking water source (groundwater, surface water, or 'other' category). Stratified analyses by drinking water source and season identified positive associations of rainfall and GI hospitalizations in surface water systems during the warm season with no lag (OR = 1.12, 95% CI 1.05 - 1.19) and a 2-day lag (OR = 1.09, 95% CI 1.03 - 1.16). Positive associations in 'Other' water source areas (served by very small community water systems, private wells, or unknown) during the warm season with a 4-day lag were also found. However, there were no statistically significant positive associations in groundwater systems during the warm season. The results suggest that water systems with surface water sources can play an important role in preventing GI hospitalizations during and immediately following heavy rainfall. Regulators should work with water system providers to develop system specific prevention techniques to limit the impact of heavy rainfall on public health.	[Gleason, Jessie A.; Fagliano, Jerald A.] New Jersey Dept Hlth, Environm & Occupat Hlth Surveillance Program, Trenton, NJ 08625 USA	New Jersey Department of Health & Senior Services	Gleason, JA (corresponding author), New Jersey Dept Hlth, Environm & Occupat Hlth Surveillance Program, Trenton, NJ 08625 USA.	jessie.gleason@doh.state.nj.us						Aramini J, 2000, Can Commun Dis Rep, V26, P211; Beaudeau P, 2014, WATER RES, V52, P188, DOI 10.1016/j.watres.2014.01.005; Beaudeau P, 2014, J EXPO SCI ENV EPID, V24, P192, DOI 10.1038/jes.2013.5; Borchardt MA, 2012, ENVIRON HEALTH PERSP, V120, P1272, DOI 10.1289/ehp.1104499; Colford John M. Jr., 2006, Journal of Water and Health, V4, P71, DOI 10.2166/wh.2006.018; Curriero FC, 2001, AM J PUBLIC HEALTH, V91, P1194, DOI 10.2105/AJPH.91.8.1194; Drayna P, 2010, ENVIRON HEALTH PERSP, V118, P1439, DOI 10.1289/ehp.0901671; ELDER D., 2011, WATER QUALITY TREATM, V6a; Febriani Y, 2010, BMC PUBLIC HEALTH, V10, DOI 10.1186/1471-2458-10-48; Field C.B., 2014, CLIMATE CHANGE 2014, DOI [10.1016/j.renene.2009.11.012, DOI 10.1016/J.RENENE.2009.11.012]; Fung KY, 2003, INT J EPIDEMIOL, V32, P1064, DOI 10.1093/ije/dyg246; Harper SL, 2011, ECOHEALTH, V8, P93, DOI 10.1007/s10393-011-0690-1; Herrador BRG, 2015, ENVIRON HEALTH-GLOB, V14, DOI 10.1186/s12940-015-0014-y; Hilborn ED, 2013, MMWR-MORBID MORTAL W, V62, P714; Hsieh JL, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0125071; LeChevallier M, 2011, WATER QUALITY TREATM; Li S, 2011, ENV RES; Mann AG, 2007, BMC PUBLIC HEALTH, V7, DOI 10.1186/1471-2458-7-256; Messner Michael, 2006, Journal of Water and Health, V4, P201, DOI 10.2166/wh.2006.024; Murphy HM, 2014, J WATER HEALTH, V12, P634, DOI 10.2166/wh.2014.049; Navidi W, 1998, BIOMETRICS, V54, P596, DOI 10.2307/3109766; NAVIDI W, 1999, RES REP HLTH EFF I, V86, P1; [NCEI National Centers for Environmental Information], 2014, GLOB SURF SUMM DAY G; Nichols G, 2009, J WATER HEALTH, V7, P1, DOI 10.2166/wh.2009.143; NJDEP, 2015, WAT PURV SERV AR 199; NJDEP, 2015, NEW JERS DRINK WAT W; Office of the New Jersey State Climatologist, 2015, CLIM NEW JERS; PHASE, 2007, TECHN BACKGR REP CAS; Rose JB, 2001, ENVIRON HEALTH PERSP, V109, P211, DOI 10.2307/3435011; Schwartz J, 2000, J EPIDEMIOL COMMUN H, V54, P45, DOI 10.1136/jech.54.1.45; Schwartz J, 1997, EPIDEMIOLOGY, V8, P615, DOI 10.1097/00001648-199710000-00001; Singh RBK, 2001, ENVIRON HEALTH PERSP, V109, P155, DOI 10.2307/3434769; Teschke K, 2010, BMC PUBLIC HEALTH, V10, DOI 10.1186/1471-2458-10-767; Thomas MK, 2006, INT J ENVIRON HEAL R, V16, P167, DOI 10.1080/09603120600641326; Tinker SC, 2010, J EXPO SCI ENV EPID, V20, P19, DOI 10.1038/jes.2008.68; Tornevi A, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0128487; Uejio CK, 2014, AM J PUBLIC HLTH; US Census Bureau, 2015, AM FACTFINDER; USEPA, 2015, MON UNR DRINK WAT CO; Wallender EK, 2014, GROUNDWATER, V52, P886, DOI 10.1111/gwat.12121; WENIGER BG, 1983, AM J PUBLIC HEALTH, V73, P868, DOI 10.2105/AJPH.73.8.868; White ANJ, 2009, ECOHEALTH, V6, P200, DOI 10.1007/s10393-009-0246-9	42	14	17	2	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 10	2017	12	3							e0173794	10.1371/journal.pone.0173794	http://dx.doi.org/10.1371/journal.pone.0173794			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN6CJ	28282467	Green Published, Green Submitted, gold			2022-12-27	WOS:000396091800080
J	Aguera, Z; Brewin, N; Chen, J; Granero, R; Kang, Q; Fernandez-Aranda, F; Arcelus, J				Agueera, Zaida; Brewin, Nicola; Chen, Jue; Granero, Roser; Kang, Qing; Fernandez-Aranda, Fernando; Arcelus, Jon			Eating symptomatology and general psychopathology in patients with anorexia nervosa from China, UK and Spain: A cross-cultural study examining the role of social attitudes	PLOS ONE			English	Article							RATING INSTRUMENT CEDRI; MENTAL-HEALTH; RISK-FACTORS; BODY-IMAGE; SELF-ESTEEM; DISORDERS; DEPRESSION; PATHOLOGY; WOMEN; DISSATISFACTION	Cultural studies exploring differences in the manifestation of anorexia nervosa (AN) have primarily focus on Western and non-Western cultures. However, no study so far has considered the role that social attitudes (i.e. Collectivist vs. Individualist cultural values) have in the clinical manifestations of eating disorders, including AN patients. With this in mind, the aim of this study is to compare eating and general psychopathology in a large sample of individuals diagnosed with AN from China, Spain, and United Kingdom (UK), in order to study the differences according to belonging to Western or non-Western country, or the country's Individualist Index (IDV). The total sample comprised on 544 adults with a diagnosis of AN recruited from People As Republic of China (n = 72), UK (n = 117), and Spain (n = 355). Assessment measures included the Eating Disorders Inventory and the Symptom Check-list-90-Revised. Our results show significant differences in most of the eating and psychopathological indices between the three countries. Patients from Western societies (Spain and UK) share more similarities regarding psychopathological expression of AN than the non-Western country (China). While Western countries show higher levels of body dissatisfaction, somatization and overall psychopathology, Chinese patients tend to deny or minimize depression, anxiety and other psychopathological symptoms. Besides, the IDV shows cultural differences in the interpersonal sensitivity scale, being AN patients from UK (the more individualistic society) who presented with higher levels of interpersonal sensitivity (i.e. discomfort during interpersonal interactions and more negative expectations concerning interpersonal behavior). In conclusion, our findings suggest that psychopathological expression of AN is better explained by Western/Eastern influence than by individualist/collectivist values. Although the diagnosis for the eating disorder may be the same, differences in the psychopathology comorbid to the eating disorders may suggest the need for treatments to be modified according to the culture.	[Agueera, Zaida; Granero, Roser; Fernandez-Aranda, Fernando] CIBER Fisiopatol Obesidad & Nutr CIBEROBN, Inst Salud Carlos 3, Barcelona, Spain; [Agueera, Zaida; Fernandez-Aranda, Fernando] Univ Hosp Bellvitge IDIBELL, Dept Psychiat, Barcelona, Spain; [Brewin, Nicola; Arcelus, Jon] Leicester Glenfield Hosp, Benn Ctr, Leicestershire Eating Disorder Serv, Leicester, Leics, England; [Chen, Jue; Kang, Qing] Shanghai Jiao Tong Univ, Shanghai Mental Hlth Ctr, Sch Med, Dept Clin Psychol, Shanghai 200030, Peoples R China; [Granero, Roser] Univ Autonoma Barcelona, Dept Psicobiol & Metodol, E-08193 Barcelona, Spain; [Fernandez-Aranda, Fernando] Univ Barcelona, Sch Med, Dept Clin Sci, Barcelona, Spain; [Arcelus, Jon] Univ Nottingham, Fac Med & Hlth Sci, Inst Mental Hlth, Nottingham, England	CIBER - Centro de Investigacion Biomedica en Red; CIBEROBN; Institut d'Investigacio Biomedica de Bellvitge (IDIBELL); Bellvitge University Hospital; University of Barcelona; Shanghai Jiao Tong University; Autonomous University of Barcelona; University of Barcelona; University of Nottingham	Aguera, Z (corresponding author), CIBER Fisiopatol Obesidad & Nutr CIBEROBN, Inst Salud Carlos 3, Barcelona, Spain.; Aguera, Z (corresponding author), Univ Hosp Bellvitge IDIBELL, Dept Psychiat, Barcelona, Spain.; Chen, J (corresponding author), Shanghai Jiao Tong Univ, Shanghai Mental Hlth Ctr, Sch Med, Dept Clin Psychol, Shanghai 200030, Peoples R China.	zaguera@bellvitgehospital.cat; chenjue2088@163.com	Granero, Roser/F-9492-2016; AGÜERA, ZAIDA/K-9771-2014; Granero, Roser/S-3529-2019; FERNANDEZ-ARANDA, FERNANDO/AGY-1597-2022; Fernandez-Aranda, Fernando/L-9762-2014	Granero, Roser/0000-0001-6308-3198; AGÜERA, ZAIDA/0000-0003-4453-4939; FERNANDEZ-ARANDA, FERNANDO/0000-0002-2968-9898; Fernandez-Aranda, Fernando/0000-0002-2968-9898; Arcelus, Jon/0000-0002-3805-0180	Institute Salud Carlos III [FIS PI14/00290]; Fondos Europeos de Desarrollo Regional (FEDER) funds - a way to build Europe; Natural Science Foundation of Shanghai [16ZR1430400]; Scientific Technology Committee Foundation of Shanghai [16411965200]; Key Characteristic Specialist Department of Shanghai Mental Health Center [2013-YJTSZK-02]	Institute Salud Carlos III(Instituto de Salud Carlos III); Fondos Europeos de Desarrollo Regional (FEDER) funds - a way to build Europe; Natural Science Foundation of Shanghai(Natural Science Foundation of Shanghai); Scientific Technology Committee Foundation of Shanghai; Key Characteristic Specialist Department of Shanghai Mental Health Center	This work was supported by the following sources: Institute Salud Carlos III (FIS PI14/00290 and CIBERobn), to FFA; Fondos Europeos de Desarrollo Regional (FEDER) funds - a way to build Europe, to FFA; Natural Science Foundation of Shanghai (16ZR1430400 to JC); Scientific Technology Committee Foundation of Shanghai (16411965200 to JC); and the Key Characteristic Specialist Department of Shanghai Mental Health Center (No.2013-YJTSZK-02), to JC. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	American Psychiatric Association, 2013, DIAGNOSTIC STAT MANU; APA, 1980, DIAGN STAT MAN MENT, DOI [10.1176/appi.books.9780890423349, DOI 10.1176/APPI.BOOKS.9780890423349]; Arrindell WA, 2004, PERS INDIV DIFFER, V37, P627, DOI 10.1016/j.paid.2003.11.002; Chen SX, 2008, J COUNS PSYCHOL, V55, P442, DOI 10.1037/a0012898; Chiao JY, 2015, EMOT REV, V7, P280, DOI 10.1177/1754073914546389; Claudat K, 2016, J CLIN PSYCHOL, V72, P88, DOI 10.1002/jclp.22234; Derogatis LR., 1977, SCL 90 ADM SCORING P; DiBartolo PM, 2012, CLIN PSYCHOL REV, V32, P139, DOI 10.1016/j.cpr.2011.09.007; Draguns JG, 2003, BEHAV RES THER, V41, P755, DOI 10.1016/S0005-7967(02)00190-0; Eddy KT, 2007, J NERV MENT DIS, V195, P196, DOI 10.1097/01.nmd.0000243922.49394.7d; Essau CA, 2013, SOC PSYCH PSYCH EPID, V48, P2017, DOI 10.1007/s00127-013-0673-3; Feng Z, 2001, ACTA ACAD MED MILITA, V23, P481; Garner D.M., 1998, INVENTARIO TRASTORNO; GARNER DM, 1983, INT J EAT DISORDER, V2, P15, DOI 10.1002/1098-108X(198321)2:2<15::AID-EAT2260020203>3.0.CO;2-6; Gartstein MA, 2006, CHILD PSYCHIAT HUM D, V37, P145, DOI 10.1007/s10578-006-0025-6; Gonzalez de Rivera JL, 2002, CUESTIONARIO 90 SINT; Gunnard K, 2012, EUR EAT DISORD REV, V20, P271, DOI 10.1002/erv.1148; Heinrichs N, 2006, BEHAV RES THER, V44, P1187, DOI 10.1016/j.brat.2005.09.006; Hofstede G., 2010, CULTURES ORG SOFTWAR, V3rd; Hofstede G., 2001, CULTURES CONSEQUENCE, V2nd, DOI DOI 10.1016/S0005-7967(02)00184-5; Humphry TA, 2004, INT J EAT DISORDER, V35, P579, DOI 10.1002/eat.10269; Huwae S, 2018, INT J PSYCHOL, V53, P176, DOI 10.1002/ijop.12283; Hwang WC, 2008, CLIN PSYCHOL REV, V28, P211, DOI 10.1016/j.cpr.2007.05.001; Jaeger B, 2002, PSYCHOTHER PSYCHOSOM, V71, P54, DOI 10.1159/000049344; Katzman MA, 1997, INT J EAT DISORDER, V22, P385, DOI 10.1002/(SICI)1098-108X(199712)22:4&lt;385::AID-EAT3&gt;3.0.CO;2-I; Keel PK, 2003, PSYCHOL BULL, V129, P747, DOI 10.1037/0033-2909.129.5.747; Kleinman A., 2004, NEW ENGL J MED, P35110; Lai KYC, 2000, J ADOLESCENCE, V23, P561, DOI 10.1006/jado.2000.0343; Lapid MI, 2010, INT PSYCHOGERIATR, V22, P523, DOI 10.1017/S1041610210000104; Lee HY, 2007, INT J EAT DISORDER, V40, P227, DOI 10.1002/eat.20364; Lee S, 2000, INT J EAT DISORDER, V27, P317, DOI 10.1002/(SICI)1098-108X(200004)27:3&lt;317::AID-EAT9&gt;3.0.CO;2-2; LEE S, 1993, PSYCHOL MED, V23, P999, DOI 10.1017/S0033291700026465; Lee S, 1997, INT J EAT DISORDER, V21, P187, DOI 10.1002/(SICI)1098-108X(199703)21:2&lt;187::AID-EAT10&gt;3.0.CO;2-#; Lee S, 2010, INT J EAT DISORDER, V43, P307, DOI 10.1002/eat.20686; Mak WWS., 2012, OXFORD HDB CHINESE P, DOI DOI 10.1093/0XFORDHB/9780199541850.013.0026; Makino M., 2004, MEDSCAPE GEN MED, V6, P49; Mangweth-Matzek B, 2014, CURR OPIN PSYCHIATR, V27, P431, DOI 10.1097/YCO.0000000000000102; MARKUS HR, 1991, PSYCHOL REV, V98, P224, DOI 10.1037/0033-295X.98.2.224; Mazzeo SE, 2009, CHILD ADOL PSYCH CL, V18, P67, DOI 10.1016/j.chc.2008.07.003; MCCOURT J, 1995, INT J EAT DISORDER, V17, P277, DOI 10.1002/1098-108X(199504)17:3<277::AID-EAT2260170308>3.0.CO;2-D; Midlarsky E, 2008, J GEN PSYCHOL, V135, P393, DOI 10.3200/GENP.135.4.393-408; Nisbett RE, 2001, PSYCHOL REV, V108, P291, DOI 10.1037//0033-295X.108.2.291; PALMER R, 1987, INT J EAT DISORDER, V6, P9, DOI 10.1002/1098-108X(198701)6:1<9::AID-EAT2260060103>3.0.CO;2-Z; Palmer R, 1996, EUR EAT DISORD REV, V4, P149; Parker G, 2001, AM J PSYCHIAT, V158, P857, DOI 10.1176/appi.ajp.158.6.857; Russell ST, 2008, J YOUTH ADOLESCENCE, V37, P50, DOI 10.1007/s10964-007-9231-1; Ryder AG, 2008, J ABNORM PSYCHOL, V117, P300, DOI 10.1037/0021-843X.117.2.300; Schreier SS, 2010, DEPRESS ANXIETY, V27, P1128, DOI 10.1002/da.20746; Soh NLW, 2008, EUR EAT DISORD REV, V16, P287, DOI 10.1002/erv.836; Soh NLW, 2013, J EAT DISORD, V1, DOI 10.1186/2050-2974-1-4; Soh NL, 2006, EUR EAT DISORD REV, V14, P54, DOI 10.1002/erv.678; Soto JA, 2011, EMOTION, V11, P1450, DOI 10.1037/a0023340; Spector PE, 2004, PERS PSYCHOL, V57, P119, DOI 10.1111/j.1744-6570.2004.tb02486.x; Striegel-Moore RH, 2007, AM PSYCHOL, V62, P181, DOI 10.1037/0003-066X.62.3.181; Tareen A, 2005, INT J EAT DISORDER, V37, P161, DOI 10.1002/eat.20080; Triandis HC, 2001, J PERS, V69, P907, DOI 10.1111/1467-6494.696169; Triandis HC, 1995, INDIVIDUALISM COLLEC; Wang Z., 1984, SYMPTOM CHECKLIST SC, V2, P68, DOI DOI 10.32388/SG7B5L]; Watson HJ, 2015, EUR EAT DISORD REV, V23, P68, DOI 10.1002/erv.2334; Witcomb Gemma L, 2013, Shanghai Arch Psychiatry, V25, P332, DOI 10.3969/j.issn.1002-0829.2013.06.002; Wynaden D, 2005, INT J MENT HEALTH NU, V14, P88, DOI 10.1111/j.1440-0979.2005.00364.x	61	16	16	4	36	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 16	2017	12	3							e0173781	10.1371/journal.pone.0173781	http://dx.doi.org/10.1371/journal.pone.0173781			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EN9KE	28301566	Green Published, gold, Green Submitted			2022-12-27	WOS:000396318300072
J	Dewes, CF; Rangwala, I; Barsugli, JJ; Hobbins, MT; Kumar, S				Dewes, Candida F.; Rangwala, Imtiaz; Barsugli, Joseph J.; Hobbins, Michael T.; Kumar, Sanjiv			Drought risk assessment under climate change is sensitive to methodological choices for the estimation of evaporative demand	PLOS ONE			English	Article							CALCULATING POTENTIAL EVAPORATION; EVAPOTRANSPIRATION ESTIMATION; TERRESTRIAL ARIDITY; WATER-RESOURCES; VARIABILITY; MODEL; 21ST-CENTURY; HYDROLOGY; RESPONSES; SCALE	Several studies have projected increases in drought severity, extent and duration in many parts of the world under climate change. We examine sources of uncertainty arising from the methodological choices for the assessment of future drought risk in the continental US (CONUS). One such uncertainty is in the climate models' expression of evaporative demand (E-0), which is not a direct climate model output but has been traditionally estimated using several different formulations. Here we analyze daily output from two CMIP5 GCMs to evaluate how differences in E-0 formulation, treatment of meteorological driving data, choice of GCM, and standardization of time series influence the estimation of E-0. These methodological choices yield different assessments of spatio-temporal variability in E-0 and different trends in 21st century drought risk. First, we estimate E-0 using three widely used E-0 formulations: Penman-Monteith; Hargreaves-Samani; and Priestley-Taylor. Our analysis, which primarily focuses on the May-September warm-season period, shows that E-0 climatology and its spatial pattern differ substantially between these three formulations. Overall, we find higher magnitudes of E-0 and its interannual variability using Penman-Monteith, in particular for regions like the Great Plains and southwestern US where E-0 is strongly influenced by variations in wind and relative humidity. When examining projected changes in E-0 during the 21st century, there are also large differences among the three formulations, particularly the Penman-Monteith relative to the other two formulations. The 21st century E-0 trends, particularly in percent change and standardized anomalies of E-0, are found to be sensitive to the long-term mean value and the amplitude of interannual variability, i.e. if the magnitude of E-0 and its interannual variability are relatively low for a particular E-0 formulation, then the normalized or standardized 21 st century trend based on that formulation is amplified relative to other formulations. This is the case for the use of Hargreaves-Samani and Priestley-Taylor, where future E-0 trends are comparatively much larger than for Penman-Monteith. When comparing Penman-Monteith E-0 responses between different choices of input variables related to wind speed, surface roughness, and net radiation, we found differences in E-0 trends, although these choices had a much smaller influence on E-0 trends than did the E-0 formulation choices. These methodological choices and specific climate model selection, also have a large influence on the estimation of trends in standardized drought indices used for drought assessment operationally. We find that standardization tends to amplify divergences between the E-0 trends calculated using different E-0 formulations, because standardization is sensitive to both the climatology and amplitude of interannual variability of E-0. For different methodological choices and GCM output considered in estimating E-0, we examine potential sources of uncertainty in 21st century trends in the Standardized Precipitation Evapotranspiration Index (SPEI) and Evaporative Demand Drought Index (EDDI) over selected regions of the CONUS to demonstrate the practical implications of these methodological choices for the quantification of drought risk under climate change.	[Dewes, Candida F.; Rangwala, Imtiaz; Barsugli, Joseph J.; Hobbins, Michael T.] Univ Colorado, Cooperat Inst Res Environm Sci, Boulder, CO 80309 USA; [Dewes, Candida F.; Rangwala, Imtiaz; Barsugli, Joseph J.; Hobbins, Michael T.; Kumar, Sanjiv] NOAA, Div Phys Sci, ESRL, Boulder, CO USA; [Dewes, Candida F.; Rangwala, Imtiaz; Barsugli, Joseph J.] North Cent Climate Sci Ctr, Dept Interior, Ft Collins, CO USA	University of Colorado System; University of Colorado Boulder; National Oceanic Atmospheric Admin (NOAA) - USA; United States Department of the Interior	Dewes, CF (corresponding author), Univ Colorado, Cooperat Inst Res Environm Sci, Boulder, CO 80309 USA.; Dewes, CF (corresponding author), NOAA, Div Phys Sci, ESRL, Boulder, CO USA.; Dewes, CF (corresponding author), North Cent Climate Sci Ctr, Dept Interior, Ft Collins, CO USA.	candida.dewes@noaa.gov	Hobbins, Mike/N-4630-2014	Hobbins, Mike/0000-0001-5540-8466; DEWES, CANDIDA/0000-0003-1882-3710	United States Geological Survey's North Central Climate Science Center [G13AC00392, G14AP00182]; National Research Council Research Associateship Award at NOAA ESRL Physical Science Division	United States Geological Survey's North Central Climate Science Center; National Research Council Research Associateship Award at NOAA ESRL Physical Science Division	This study is supported by the United States Geological Survey's North Central Climate Science Center (award # G13AC00392 and G14AP00182). SKs contribution was supported by the National Research Council Research Associateship Award at NOAA ESRL Physical Science Division. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abramowitz M., 1964, HDB MATH FUNCTIONS F; Allen R. G., 1998, FAO Irrigation and Drainage Paper; Allen R. G., 2005, ASCE STANDARDIZED RE; Almorox J, 2015, J HYDROL, V528, P514, DOI 10.1016/j.jhydrol.2015.06.057; Begueria S, 2014, INT J CLIMATOL, V34, P3001, DOI 10.1002/joc.3887; Bonan G., 2015, ECOLOGICAL CLIMATOLO; BOUCHET R. J., 1963, Publ. Int. Ass. sci. Hydrol. 62 gen. Assembly Berkeley, P134; Brazhnik K, 2016, ECOL MODEL, V320, P182, DOI 10.1016/j.ecolmodel.2015.09.016; Budyko M. I., 1974, CLIMATE LIFE; Cayan DR, 2010, P NATL ACAD SCI USA, V107, P21271, DOI 10.1073/pnas.0912391107; Chadwick R, 2016, NAT CLIM CHANGE, V6, P177, DOI [10.1038/NCLIMATE2805, 10.1038/nclimate2805]; Chow V.T., 1988, APPL HYDROLOGY; Christensen NS, 2004, CLIMATIC CHANGE, V62, P337, DOI 10.1023/B:CLIM.0000013684.13621.1f; Cook BI, 2015, SCI ADV, V1, DOI 10.1126/sciadv.1400082; Dai AG, 2013, NAT CLIM CHANGE, V3, P52, DOI [10.1038/nclimate1633, 10.1038/NCLIMATE1633]; de Noblet-Ducoudre N, 2012, J CLIMATE, V25, P3261, DOI 10.1175/JCLI-D-11-00338.1; Deser C, 2012, CLIM DYNAM, V38, P527, DOI 10.1007/s00382-010-0977-x; Farahmand A, 2015, ADV WATER RESOUR, V76, P140, DOI 10.1016/j.advwatres.2014.11.012; Federer CA, 1996, WATER RESOUR RES, V32, P2315, DOI 10.1029/96WR00801; Ficklin DL, 2016, J CLIMATE, V29, P1269, DOI 10.1175/JCLI-D-15-0439.1; Fisher JB, 2011, GLOBAL ECOL BIOGEOGR, V20, P1, DOI 10.1111/j.1466-8238.2010.00578.x; Flato G, 2014, CLIMATE CHANGE 2013: THE PHYSICAL SCIENCE BASIS, P741; Forster PM, 2013, J GEOPHYS RES-ATMOS, V118, P1139, DOI 10.1002/jgrd.50174; Franklin J, 2013, GLOBAL CHANGE BIOL, V19, P473, DOI 10.1111/gcb.12051; Fu Q, 2014, J GEOPHYS RES-ATMOS, V119, DOI 10.1002/2014JD021608; Girvetz EH, 2014, CLIMATIC CHANGE, V126, P469, DOI 10.1007/s10584-014-1218-9; GREGORY S, 1986, GEOGRAPHY, V71, P97; Greve P, 2015, GEOPHYS RES LETT, V42, P5493, DOI 10.1002/2015GL064127; Guttman NB, 1998, J AM WATER RESOUR AS, V34, P113, DOI 10.1111/j.1752-1688.1998.tb05964.x; Hargreaves G. H., 1985, Applied Engineering in Agriculture, V1, P96; Hargreaves GH, 2003, J IRRIG DRAIN ENG, V129, P53, DOI 10.1061/(ASCE)0733-9437(2003)129:1(53); Harmon ME, 2002, CAN J FOREST RES, V32, P863, DOI [10.1139/x01-216, 10.1139/X01-216]; Hobbins M, 2016, J HYDROMETEOROL; Hobbins MT, 2016, T ASABE, V59, P561; Hobbins M, 2012, J HYDROMETEOROL, V13, P1195, DOI 10.1175/JHM-D-11-0101.1; Hobbins MT, 2004, REGIONAL EVAPOTRANSP; Hobbins MT, 2004, GEOPHYS RES LETT, P31; Hounam CE, 1975, 138 WHO; Hufkens K, 2016, NAT CLIM CHANGE, V6; Kay AL, 2008, J HYDROL, V358, P221, DOI 10.1016/j.jhydrol.2008.06.005; Kingston DG, 2009, GEOPHYS RES LETT, V36, DOI 10.1029/2009GL040267; Klos PZ, 2014, GEOPHYS RES LETT, V41, P4560, DOI 10.1002/2014GL060500; Kumar S, 2016, J GEOPHYS RES ATMOS; Kumar S, 2016, WATER RESOUR RES, V52, P3127, DOI 10.1002/2016WR018607; Kumar S, 2013, J GEOPHYS RES-ATMOS, V118, P6337, DOI 10.1002/jgrd.50463; McEvoy DJ, 2012, EARTH INTERACT, V16, DOI 10.1175/2012EI000447.1; McEvoy DJ, 2016, J HYDROMETEOROL; MCKENNEY MS, 1993, AGR FOREST METEOROL, V64, P81, DOI 10.1016/0168-1923(93)90095-Y; Melesse A., 2013, EVAPORATION EVAPOTRA, DOI 10.1007/978-94-007-4737-1; Milly PCD, 2008, SCIENCE, V319, P573, DOI 10.1126/science.1151915; Milly PCD, 2016, NAT CLIM CHANGE; Mishra AK, 2010, J HYDROL, V391, P204, DOI 10.1016/j.jhydrol.2010.07.012; Monteith J L, 1965, Symp Soc Exp Biol, V19, P205; NCCSC, 2015, COMM NEWSL N CENTR C; Oliver TH, 2015, NAT CLIM CHANGE, V5, P941, DOI [10.1038/NCLIMATE2746, 10.1038/nclimate2746]; Oppenheimer M, 2014, CLIMATE CHANGE 2014: IMPACTS, ADAPTATION, AND VULNERABILITY, PT A: GLOBAL AND SECTORAL ASPECTS, P1039; Palmer W.C., 1965, 45 US DEP COMM WEATH, P45; PENMAN HL, 1948, PROC R SOC LON SER-A, V193, P120, DOI 10.1098/rspa.1948.0037; Pierce DW, 2013, J CLIMATE, V26, P4148, DOI 10.1175/JCLI-D-12-00534.1; Pitman AJ, 2009, GEOPHYS RES LETT, V36, DOI 10.1029/2009GL039076; PRIESTLEY CHB, 1972, MON WEATHER REV, V100, P81, DOI 10.1175/1520-0493(1972)100<0081:OTAOSH>2.3.CO;2; Prudhomme C, 2014, P NATL ACAD SCI USA, V111, P3262, DOI 10.1073/pnas.1222473110; Ramirez JA, 2005, GEOPHYS RES LETT, P32; RIND D, 1990, J GEOPHYS RES-ATMOS, V95, P9983, DOI 10.1029/JD095iD07p09983; Roderick ML, 2015, WATER RESOUR RES, V51, P5450, DOI 10.1002/2015WR017031; Roderick ML, 2007, GEOPHYS RES LETT, P34; Rotstayn LD, 2006, GEOPHYS RES LETT, P33; Roy J, 2016, P NATL ACAD SCI USA, V113, P6224, DOI 10.1073/pnas.1524527113; Ruffault J, 2013, CLIMATIC CHANGE, V117, P103, DOI 10.1007/s10584-012-0559-5; Scheff J, 2015, J CLIMATE, V28, P5583, DOI 10.1175/JCLI-D-14-00480.1; Seager R, 2015, J APPL METEOROL CLIM, V54, P1121, DOI 10.1175/JAMC-D-14-0321.1; Sheffield J, 2012, NATURE, V491, P435, DOI 10.1038/nature11575; Shuttleworth WJ, 1992, HDB HYDROLOGY; Soden BJ, 2006, J CLIMATE, V19, P3354, DOI 10.1175/JCLI3799.1; Spinoni J, 2015, INT J CLIMATOL, V35, P2210, DOI 10.1002/joc.4124; Teuling AJ, 2013, GEOPHYS RES LETT, V40, P2071, DOI 10.1002/grl.50495; Thornthwaite CW, 1948, GEOGR REV, V38, P55, DOI 10.2307/210739; Trenberth KE, 2014, NAT CLIM CHANGE, V4, P17, DOI 10.1038/NCLIMATE2067; Trenberth KE, 2011, CLIM RES, V47, P123, DOI 10.3354/cr00953; Van Loon AF, 2016, NAT GEOSCI, V9, P89, DOI 10.1038/ngeo2646; Vicente-Serrano SM, 2010, J CLIMATE, V23, P1696, DOI 10.1175/2009JCLI2909.1; Vorosmarty CJ, 2000, SCIENCE, V289, P284, DOI 10.1126/science.289.5477.284; Wilhite D. A., 1985, Water International, V10, P111, DOI 10.1080/02508068508686328; Wilhite DA, 2014, WEATHER CLIM EXTREME, V3, P4, DOI 10.1016/j.wace.2014.01.002; Wilks DS, 2011, STAT METHODS ATMOSPH, P23, DOI DOI 10.1016/B978-0-12-385022-5.00003-8; Williams AP, 2015, GEOPHYS RES LETT, V42, P6819, DOI 10.1002/2015GL064924; WMO, 1986, REP DROUGHT COUNTR A; Xu CY, 2002, WATER RESOUR MANAG, V16, P197, DOI 10.1023/A:1020282515975	88	39	39	4	36	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 16	2017	12	3							e0174045	10.1371/journal.pone.0174045	http://dx.doi.org/10.1371/journal.pone.0174045			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN9KE	28301603	Green Published, gold, Green Submitted			2022-12-27	WOS:000396318300118
J	Forrester, HB; de Kretser, DM; Leong, T; Hagekyriakou, J; Sprung, CN				Forrester, Helen B.; de Kretser, David M.; Leong, Trevor; Hagekyriakou, Jim; Sprung, Carl N.			Follistatin attenuates radiation-induced fibrosis in a murine model	PLOS ONE			English	Article							ACTIVIN-BINDING PROTEIN; GROWTH-FACTOR-BETA; HEPARAN-SULFATE; TGF-BETA; PULMONARY-FIBROSIS; FIBROTIC DISEASE; CANCER-PATIENTS; CELL; INHIBITION; RADIOSENSITIVITY	Purpose Fibrosis can be a disabling, severe side effect of radiotherapy that can occur in patients, and for which there is currently no effective treatment. The activins, proteins which are members of the TGF beta superfamily, have a major role in stimulating the inflammatory response and subsequent fibrosis. Follistatin is an endogenous protein that binds the activins virtually irreversibly and inhibits their actions. These studies test if follistatin can attenuate the fibrotic response using a murine model of radiation-induced fibrosis. Experimental design C57BL/6 mice were subcutaneously injected with follistatin 24 hours prior to irradiation. Mice were irradiated in a 10 x 10 mm square area of the right hind leg with 35 Gy and were given follistatin 24 hours before radiation and three times a week for six months following. Leg extension was measured, and tissue was collected for histological and molecular analysis to evaluate the progression of the radiation-induced fibrosis. Results Leg extension was improved in follistatin treated mice compared to vehicle treated mice at six months after irradiation. Also, epidermal thickness and cell nucleus area of keratinocytes were decreased by the follistatin treatment compared to the cells in irradiated skin of control mice. Finally, the gene expression of transforming growth factor beta 1 (Tgfb1), and smooth muscle actin (Acta2) were decreased in the irradiated skin and Acta2 and inhibin beta A subunit (Inhba) were decreased in the irradiated muscle of the follistatin treated mice. Conclusions Follistatin attenuated the radiation-induced fibrotic response in irradiated mice. These studies provide the data to support further investigation of the use of follistatin to reduce radiation- induced fibrosis in patients undergoing radiotherapy for cancer.	[Forrester, Helen B.; Sprung, Carl N.] Hudson Inst Med Res, Ctr Innate Immun & Infect Dis, Clayton, Vic, Australia; [Forrester, Helen B.; Sprung, Carl N.] Monash Univ, Dept Mol & Translat Sci, Clayton, Vic, Australia; [de Kretser, David M.] Hudson Inst Med Res, Ctr Reprod Hlth, Clayton, Vic, Australia; [de Kretser, David M.] Monash Univ, Dept Anat & Dev Biol, Clayton, Vic, Australia; [Leong, Trevor; Hagekyriakou, Jim] Peter MacCallum Canc Ctr, Div Radiat Oncol & Canc Imaging, East Melbourne, Vic, Australia	Hudson Institute of Medical Research; Monash University; Hudson Institute of Medical Research; Monash University; Peter Maccallum Cancer Center	Sprung, CN (corresponding author), Hudson Inst Med Res, Ctr Innate Immun & Infect Dis, Clayton, Vic, Australia.; Sprung, CN (corresponding author), Monash Univ, Dept Mol & Translat Sci, Clayton, Vic, Australia.	carl.sprung@monash.edu			round of the priority-driven Collaborative Cancer Research Scheme [1002743]; Australian Government Department of Health and Ageing; Cancer Australia; Victorian Government's Operational Infrastructure Support Program	round of the priority-driven Collaborative Cancer Research Scheme; Australian Government Department of Health and Ageing(Australian GovernmentDepartment of Health & Ageing); Cancer Australia; Victorian Government's Operational Infrastructure Support Program	This project was supported through the 2010 round of the priority-driven Collaborative Cancer Research Scheme (grant 1002743) and funded by the Australian Government Department of Health and Ageing with the assistance of Cancer Australia. Support was also provided by the Victorian Government's Operational Infrastructure Support Program. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aoki F, 2005, AM J RESP CRIT CARE, V172, P713, DOI 10.1164/rccm.200412-1620OC; Balli D, 2013, EMBO J; BECK LS, 1993, J CLIN INVEST, V92, P2841, DOI 10.1172/JCI116904; Citrin DE, 2013, JNCI-J NATL CANCER I, V105, P1474, DOI 10.1093/jnci/djt212; de Jonge MJA, 2006, EUR J CANCER, V42, P1768, DOI 10.1016/j.ejca.2005.12.027; DEKRETSER DM, 1989, BIOL REPROD, V40, P33, DOI 10.1095/biolreprod40.1.33; Fay M, 2005, INT J RADIAT ONCOL, V61, P1355, DOI 10.1016/j.ijrobp.2004.08.025; Flechsig P, 2012, CLIN CANCER RES, V18, P3616, DOI 10.1158/1078-0432.CCR-11-2855; Forrester HB, 2014, RADIOTHER ONCOL, V111, P186, DOI 10.1016/j.radonc.2014.03.007; Forrester HB, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077119; Forrester HB, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059056; Gatti RA, 2001, ACTA ONCOL, V40, P702, DOI 10.1080/02841860152619115; Harrington AE, 2006, EMBO J, V25, P1035, DOI 10.1038/sj.emboj.7601000; Hashimoto O, 1997, J BIOL CHEM, V272, P13835, DOI 10.1074/jbc.272.21.13835; Hedger MP, 2011, VITAM HORM, V85, P255, DOI 10.1016/B978-0-12-385961-7.00013-5; Iemura S, 1998, P NATL ACAD SCI USA, V95, P9337, DOI 10.1073/pnas.95.16.9337; Jones KL, 2007, P NATL ACAD SCI USA, V104, P16239, DOI 10.1073/pnas.0705971104; Kitani A, 2003, J EXP MED, V198, P1179, DOI 10.1084/jem.20030917; Leask A, 2004, FASEB J, V18, P816, DOI 10.1096/fj.03-1273rev; Lerch TF, 2007, J BIOL CHEM, V282, P15930, DOI 10.1074/jbc.M700737200; Lin SY, 2003, REPRODUCTION, V126, P133, DOI 10.1530/rep.0.1260133; Maher TM, 2010, DRUG TODAY, V46, P473, DOI 10.1358/dot.2010.46.7.1488336; NAKAMURA T, 1991, J BIOL CHEM, V266, P19432; NAKAMURA T, 1990, SCIENCE, V247, P836, DOI 10.1126/science.2106159; Nogai H, 2008, DIFFERENTIATION, V76, P404, DOI 10.1111/j.1432-0436.2007.00223.x; O'Connor AE, 1999, HUM REPROD, V14, P827, DOI 10.1093/humrep/14.3.827; Patella S, 2006, AM J PHYSIOL-GASTR L, V290, pG137, DOI 10.1152/ajpgi.00080.2005; Phillips DJ, 1998, FRONT NEUROENDOCRIN, V19, P287, DOI 10.1006/frne.1998.0169; Sprung CN, 2005, CLIN CANCER RES, V11, P6352, DOI 10.1158/1078-0432.CCR-04-1931; STONE HB, 1984, INT J RADIAT ONCOL, V10, P1053, DOI 10.1016/0360-3016(84)90177-9; SUGINO K, 1993, J BIOL CHEM, V268, P15579; Tsuchida K, 2008, ENDOCR J, V55, P11, DOI 10.1507/endocrj.KR-110; Verrecchia F, 2007, WORLD J GASTROENTERO, V13, P3056, DOI 10.3748/wjg.v13.i22.3056; Wiebe E, 2006, PROTOCOLS PRACTICES, V5, P5; Wynn TA, 2008, J PATHOL, V214, P199, DOI 10.1002/path.2277; Wynn TA, 2004, NAT REV IMMUNOL, V4, P583, DOI 10.1038/nri1412; Wynn TA, 2012, NAT MED, V18, P1028, DOI 10.1038/nm.2807; Xavier S, 2004, J BIOL CHEM, V279, P15167, DOI 10.1074/jbc.M309798200; Zhao WL, 2009, CURR MED CHEM, V16, P130, DOI 10.2174/092986709787002790; ZUGMAIER G, 1991, CANCER RES, V51, P3590	40	12	13	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 16	2017	12	3							e0173788	10.1371/journal.pone.0173788	http://dx.doi.org/10.1371/journal.pone.0173788			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN9KE	28301516	Green Published, gold			2022-12-27	WOS:000396318300073
J	Kendzerska, T; Sadatsafavi, M; Aaron, SD; To, TM; Lougheed, MD; FitzGerald, JM; Gershon, AS				Kendzerska, Tetyana; Sadatsafavi, Mohsen; Aaron, Shawn D.; To, Teresa M.; Lougheed, M. Diane; FitzGerald, J. Mark; Gershon, Andrea S.		Canadian Resp Res Network	Concurrent physician-diagnosed asthma and chronic obstructive pulmonary disease: A population study of prevalence, incidence and mortality	PLOS ONE			English	Article							COPD OVERLAP SYNDROME; TRENDS; FEATURES; HEALTH; CANADA; RISK; CHILDHOOD; SMOKING; ONTARIO; BURDEN	Objective We conducted a population-based cohort study to estimate trends in prevalence, incidence, and mortality of concurrent physician-diagnosed asthma and chronic obstructive pulmonary disease (COPD). Study design and setting Two validated health administrative case definitions were used to identify asthma and COPD among all individuals aged 35 years and older living in Ontario, Canada. Annual asthma, COPD, and concurrent asthma and COPD prevalence, incidence, and mortality, standardized for age and sex, were estimated, and compared from 2002 to 2012, using generalized linear models. Results Standardized prevalence of concurrent asthma and COPD increased by 10.5%, from 2.9% in 2002 to 3.2% in 2012 overall, but more prominently in women compared to men. Overall, standardized incidence decreased by16%, from 2.5 to 2.1 per 1000 individuals, but increased significantly in young adults. All-cause mortality among patients with concurrent asthma and COPD decreased by 11.2%, from 2.6% to 2.2%. Being diagnosed with both diseases was significantly associated with higher all-cause mortality compared to asthma (OR = 1.56, 95% CI: 1.50 +/- 1.58), but not compared to COPD (OR = 0.97, 0.96 +/- 0.98), except in young adults aged 35 to 49 years where people with asthma and COPD had higher mortality (OR = 1.21, 1.15 +/- 1.27). Conclusions In a large North American population, the burden of concurrent physician-diagnosed asthma and COPD is increasing, particularly in women and young adults.	[Kendzerska, Tetyana; Aaron, Shawn D.] Univ Ottawa, Ottawa Hosp Res Inst, Ottawa, ON, Canada; [Kendzerska, Tetyana; To, Teresa M.; Gershon, Andrea S.] Inst Clin Evaluat Sci, Ottawa, ON, Canada; [Kendzerska, Tetyana; To, Teresa M.; Gershon, Andrea S.] Sunnybrook Res Inst, Toronto, ON, Canada; [Sadatsafavi, Mohsen; FitzGerald, J. Mark] Univ British Columbia, Vancouver, BC, Canada; [To, Teresa M.; Gershon, Andrea S.] Univ Toronto, Toronto, ON, Canada; [To, Teresa M.; Gershon, Andrea S.] Hosp Sick Children, Toronto, ON, Canada; [To, Teresa M.; Gershon, Andrea S.] Queens Univ, Kingston, ON, Canada; [Gershon, Andrea S.] Sunnybrook Hlth Sci Ctr, Toronto, ON, Canada	University of Ottawa; Ottawa Hospital Research Institute; University of Toronto; Sunnybrook Research Institute; University Toronto Affiliates; Sunnybrook Health Science Center; University of British Columbia; University of Toronto; University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); Queens University - Canada; University of Toronto; Sunnybrook Research Institute; University Toronto Affiliates; Sunnybrook Health Science Center	Kendzerska, T (corresponding author), Univ Ottawa, Ottawa Hosp Res Inst, Ottawa, ON, Canada.; Kendzerska, T (corresponding author), Inst Clin Evaluat Sci, Ottawa, ON, Canada.; Kendzerska, T (corresponding author), Sunnybrook Res Inst, Toronto, ON, Canada.	tkendzerska@toh.ca	Sadatsafayi, Mohsen/AAZ-1593-2020; Kendzerska, Tetyana/I-7274-2019	Sadatsafayi, Mohsen/0000-0002-0419-7862; Kendzerska, Tetyana/0000-0002-5301-1796; Martin, James/0000-0001-7574-5363; Halayko, Andrew/0000-0002-7865-4552	Canadian Respiratory Research Network (CRRN); Canadian Institutes of Health Research (CIHR); CIHR Institute of Circulatory and Respiratory Health; Canadian Lung Association (CLA)/Canadian Thoracic Society (CTS); British Columbia Lung Association; Boehringer-Ingelheim Canada Ltd; AstraZeneca Canada Inc.; Novartis Canada Ltd.; Institute for Clinical Evaluative Sciences (ICES) - Ontario Ministry of Health and Long-Term Care (MOHLTC); CRRN Fellowship Training Award; GlaxoSmithKline Inc.	Canadian Respiratory Research Network (CRRN); Canadian Institutes of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); CIHR Institute of Circulatory and Respiratory Health(Canadian Institutes of Health Research (CIHR)); Canadian Lung Association (CLA)/Canadian Thoracic Society (CTS); British Columbia Lung Association; Boehringer-Ingelheim Canada Ltd(Boehringer Ingelheim); AstraZeneca Canada Inc.(AstraZeneca); Novartis Canada Ltd.; Institute for Clinical Evaluative Sciences (ICES) - Ontario Ministry of Health and Long-Term Care (MOHLTC)(Ministry of Health and Long-Term Care, Ontario); CRRN Fellowship Training Award; GlaxoSmithKline Inc.(GlaxoSmithKline)	This project is supported by the Canadian Respiratory Research Network (CRRN) and the Canadian Institutes of Health Research (CIHR). The CRRN is supported by grants from the CIHR Institute of Circulatory and Respiratory Health; Canadian Lung Association (CLA)/Canadian Thoracic Society (CTS); British Columbia Lung Association; and Industry Partners Boehringer-Ingelheim Canada Ltd, AstraZeneca Canada Inc., and Novartis Canada Ltd. This study was supported by the Institute for Clinical Evaluative Sciences (ICES), which is funded by an annual grant from the Ontario Ministry of Health and Long-Term Care (MOHLTC). The opinions, results and conclusions reported in this paper are those of the authors and are independent from the funding sources. No endorsement by ICES or the Ontario MOHLTC is intended or should be inferred. Dr. Kendzerska is supported by the CRRN Fellowship Training Award. Funding for training of graduate students and new investigators within the Network was supported by the above funding Sponsors and as well by GlaxoSmithKline Inc. The funding Sponsors had no role in the study design, data collection and analysis, or preparation of the manuscript. Dr. FitrGerald is a member of the Global Initiative for Asthma (GINA) Science Committee. Dr. Lougheed has received research funding not related to this study paid directly to Queen's University from GlaxoSmithKline, Janssen and Hoffmann LaRoche.	Akinbami Lara J, 2012, NCHS Data Brief, P1; Alshabanat A, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0136065; Andersen H, 2013, CLIN RESPIR J, V7, P342, DOI 10.1111/crj.12013; Anderson R N, 1998, Natl Vital Stat Rep, V47, P1; [Anonymous], 2014, DIAGN DIS CHRON AIRF; [Anonymous], 2013, TRENDS COPD CHRON BR; Barnes PJ, 2016, CHEST, V149, P7, DOI 10.1016/j.chest.2015.08.017; Beavers S. F., 2014, AM J RESP CRITICAL C; CAMILLI AE, 1991, AM J EPIDEMIOL, V133, P795, DOI 10.1093/oxfordjournals.aje.a115958; Carter BD, 2015, NEW ENGL J MED, V372, P631, DOI 10.1056/NEJMsa1407211; Cazzola M, 2016, J ALLERGY CLIN IMMUN, V138, P977, DOI 10.1016/j.jaci.2016.04.028; Chung JW, 2014, INT J CHRONIC OBSTR, V9, P795, DOI 10.2147/COPD.S61093; Cosio BG, 2016, CHEST, V149, P45, DOI 10.1378/chest.15-1055; de Marco R, 2015, EUR RESPIR J, V46, P671, DOI 10.1183/09031936.00008615; de Marco R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062985; Diaz-Guzman E, 2011, COPD, V8, P400, DOI 10.3109/15412555.2011.611200; Evans J, 2014, HEALTH REP, V25, P3; Fay MP, 1997, STAT MED, V16, P791; Fransoo Randall R, 2013, Healthc Policy, V8, P27; Fu JJ, 2014, RESPIRATION, V87, P63, DOI 10.1159/000352053; Gershon AS, 2009, COPD, V6, P388, DOI 10.1080/15412550903140865; Gershon A, 2012, J ALLERGY CLIN IMMUN, V129, P679, DOI 10.1016/j.jaci.2011.11.014; Gershon AS, 2008, CAN MED ASSOC J, V178, P871, DOI 10.1503/cmaj.061353; Gershon AS, 2014, JAMA-J AM MED ASSOC, V312, P1114, DOI 10.1001/jama.2014.11432; Gershon AS, 2014, CHEST, V145, P272, DOI 10.1378/chest.13-0790; Gershon AS, 2012, CHEST, V141, P1190, DOI 10.1378/chest.11-0831; Gershon AS, 2011, LANCET, V378, P991, DOI 10.1016/S0140-6736(11)60990-2; Gershon AS, 2010, AM J EPIDEMIOL, V172, P728, DOI 10.1093/aje/kwq189; Gershon AS, 2010, ARCH INTERN MED, V170, P560, DOI 10.1001/archinternmed.2010.17; Gershon AS, 2009, CAN RESPIR J, V16, P183, DOI 10.1155/2009/963098; Gibson PG, 2009, THORAX, V64, P728, DOI 10.1136/thx.2008.108027; Global Initiative for Asthma, 2015, 2015 ASTHM COPD ASTH; Hansell AL, 2003, EUR RESPIR J, V22, P809, DOI 10.1183/09031936.03.00031403; Harada T, 2015, INT J CHRONIC OBSTR, V10, P595, DOI 10.2147/COPD.S77491; Hardin M, 2014, EUR RESPIR J, V44, P341, DOI 10.1183/09031936.00216013; Hardin M, 2011, RESP RES, V12, DOI 10.1186/1465-9921-12-127; Hitchman SC, 2011, B WORLD HEALTH ORGAN, V89, P195, DOI 10.2471/BLT.10.079905; ICES, 2015, DAT DICT 2015; Janz T., 2011, CURRENT SMOKING TREN; Kauppi P, 2011, J ASTHMA, V48, P279, DOI 10.3109/02770903.2011.555576; Kostikas K, 2016, INT J CHRONIC OBSTR, V11, P1297, DOI 10.2147/COPD.S107307; Kumbhare S, 2016, ANN AM THORAC SOC, V13, P803, DOI 10.1513/AnnalsATS.201508-554OC; Mannino DM, 2007, LANCET, V370, P765, DOI 10.1016/S0140-6736(07)61380-4; Menezes AMB, 2014, CHEST, V145, P297, DOI 10.1378/chest.13-0622; Mohsen Kendzerska TS, 2015, AM J RESP CRIT CARE, V191, pA6165; Morogan A. PLM, 2014, AM J RESP CRIT CARE, pA5937; Postma DS, 2015, NEW ENGL J MED, V373, P1241, DOI 10.1056/NEJMra1411863; Postma DS, 2015, EUR RESPIR J, V46, P587, DOI 10.1183/13993003.00810-2015; Sieminska A, 2014, MED SCI MONITOR, V20, DOI 10.12659/MSM.889796; Simpson CR, 2010, J ROY SOC MED, V103, P98, DOI 10.1258/jrsm.2009.090348; Sin DD, 2016, EUR RESPIR J, V48, P664, DOI 10.1183/13993003.00436-2016; Soriano JB, 2000, THORAX, V55, P789, DOI 10.1136/thorax.55.9.789; Soriano JB, 2003, CHEST, V124, P474, DOI 10.1378/chest.124.2.474; Sorino C, 2016, EUR J INTERN MED; Stern DA, 2008, LANCET, V372, P1058, DOI 10.1016/S0140-6736(08)61447-6; Tai A, 2014, THORAX, V69, P805, DOI 10.1136/thoraxjnl-2013-204815; To T, 2014, ANN AM THORACIC SOC; To T, 2010, AM J RESP CRIT CARE, V181, P337, DOI 10.1164/rccm.200907-1035OC; Tu JV, 2004, NEW ENGL J MED, V350, P1414, DOI 10.1056/NEJMsa031697; van Boven JFM, 2016, CHEST, V149, P1011, DOI 10.1016/j.chest.2015.12.002	60	21	22	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 16	2017	12	3							e0173830	10.1371/journal.pone.0173830	http://dx.doi.org/10.1371/journal.pone.0173830			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN9KE	28301574	gold, Green Published, Green Submitted			2022-12-27	WOS:000396318300078
J	McCarthy, KJ; Braganza, S; Fiori, K; Gbeleou, C; Kpakpo, V; Lopez, A; Schechter, J; Goodwin, AS; Jones, HE				McCarthy, Katharine J.; Braganza, Sandra; Fiori, Kevin; Gbeleou, Christophe; Kpakpo, Vivien; Lopez, Andrew; Schechter, Jennifer; Goodwin, Alicia Singham; Jones, Heidi E.			Identifying inequities in maternal and child health through risk stratification to inform health systems strengthening in Northern Togo	PLOS ONE			English	Article							INTERVENTION; MORTALITY; OUTCOMES	Objective In Togo, substantial progress in maternal and child health is needed to reach global development goals. To better inform clinic and community-based health services, this study identifies factors associated with maternal and child health care utilization in the Kara region of Northern Togo. Methods We conducted a population-representative household survey of four health clinic catchment areas of 1,075 women of reproductive age in 2015. Multivariable logistic regression was used to model individual and structural factors associated with utilization of four maternal and child health services. Key outcomes were: facility-based delivery, maternal postnatal health check by a health professional within the first six weeks of birth, childhood vaccination, and receipt of malaria medication for febrile children under age five within 72 hours of symptom onset. Results 83 percent of women who gave birth in the last 2 years delivered at a health facility. In adjusted models, the strongest predictor of facility delivery in the rural catchment areas was proximity to a health center, with women living under three kilometers having 3.7 (95% CI 1.7, 7.9) times the odds of a facility birth. Only 11 percent of women received a health check by a health provider at any time in the postnatal period. Postnatal health checks were less likely for women in the poorest households and for women who resided in rural areas. Children of polygamous mothers had half the odds of receiving malaria medication for fever within 72 hours of symptom onset, while children with increased household wealth status had increased odds of childhood vaccination and receiving treatment for malaria. Conclusion Our analysis highlights the importance of risk stratification analysis to inform the delivery and scope of maternal and child health programs needed to reach those with the least access to care.	[McCarthy, Katharine J.; Jones, Heidi E.] CUNY, Grad Sch Publ Hlth & Hlth Policy, New York, NY 10021 USA; [McCarthy, Katharine J.] Populat Council, 1230 York Ave, New York, NY 10021 USA; [Braganza, Sandra; Fiori, Kevin] Childrens Hosp Montefiore, Dept Pediat, Bronx, NY USA; [Braganza, Sandra; Fiori, Kevin] Montefiore Med Ctr, Dept Family & Social Med, 111 E 210th St, Bronx, NY 10467 USA; [Fiori, Kevin; Gbeleou, Christophe; Lopez, Andrew; Schechter, Jennifer; Goodwin, Alicia Singham] Hope Hlth, Kara, Togo; [Fiori, Kevin; Gbeleou, Christophe; Lopez, Andrew; Schechter, Jennifer; Goodwin, Alicia Singham] Hope Hlth, New York, NY USA; [Kpakpo, Vivien] Minist Hlth, Kozah Dist Hlth Dept, Kara, Togo	City University of New York (CUNY) System; Population Council; Yeshiva University; Albert Einstein College of Medicine; Childrens Hospital at Montefiore; Montefiore Medical Center; Yeshiva University; Albert Einstein College of Medicine	McCarthy, KJ (corresponding author), CUNY, Grad Sch Publ Hlth & Hlth Policy, New York, NY 10021 USA.; McCarthy, KJ (corresponding author), Populat Council, 1230 York Ave, New York, NY 10021 USA.	kmccarthy@popcouncil.org	Jones, Heidi E/ABF-8381-2020; Fiori, Kevin/G-7651-2016	Jones, Heidi E/0000-0002-4285-3752; Fiori, Kevin/0000-0003-1370-7366	Hope for Health	Hope for Health	This study was supported by the non-profit organization Hope for Health, which is funded by individual private donations and foundations. The funders of Hope for Health had no role in the study design, data collection and analysis, decision to publish or preparation of the manuscript.	ADB, 2021, ADBS SUPP SUST DEV G; Blanc A, 2016, J GLOBAL HLTH, V6; Bowser D, 2014, HEALTH POLICY PLANN, V29, P986, DOI 10.1093/heapol/czt080; Centre de' Information de Nations Unies, PRES FAUR GNASS LANC; Chibanda D, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-828; Eisele TP, 2013, PLOS MED, V10, DOI 10.1371/journal.pmed.1001417; Government of Togo, 2010, TOG POP HOUS CENS 20; Hodgins S, 2013, GLOB HEALTH-SCI PRAC, V1, P146, DOI 10.9745/GHSP-D-13-00030; Kassebaum NJ, 2014, LANCET, V384, P980, DOI 10.1016/S0140-6736(14)60696-6; Korenromp EL, 2004, INT J EPIDEMIOL, V33, P1293, DOI 10.1093/ije/dyh182; Liu L, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060762; Lozano R, 2011, LANCET, V378, P1139, DOI 10.1016/S0140-6736(11)61337-8; Lund C, 2014, TRIALS, V15, DOI 10.1186/1745-6215-15-457; MCBURNEY P, 1988, CURR ANTHROPOL, V29, P323, DOI 10.1086/203642; McCarthy KJ, 2016, J GLOB HEALTH, V6, DOI 10.7189/jogh.06.020502; Ministere de la Planification du Developpement et de l'Amenagement du Territoire (MPDAT) Ministere de la Sante (MS) et ICF International, 2015, TOG ENQ DEM SANT 201; Ministry of Health, 2011, REP TOG COMPL MULTIY; Ng M, 2014, PLOS MED, V11, DOI 10.1371/journal.pmed.1001730; Patel V, 2011, BRIT J PSYCHIAT, V199, P459, DOI 10.1192/bjp.bp.111.092155; Quick Jonathan, 2014, PLoS Med, V11, pe1001580, DOI 10.1371/journal.pmed.1001580; Sobejana N. P., 2014, ELECT MATERNAL NEONA; Stanton CK, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060694; The World Bank, 2015, NURS MIDW 1000 PEOPL; The World Bank, 2016, TOG DAT; UNICEF, 2013, ANN REP TOG; UNICEF, 2014, STAT WORLDS CHILDR 2; United Nations (UN), WORLD POP PROSP; WHO, 2013, REC POSTN CAR MOTH N; World Bank, 2016, NET ODA REC CAP CURR; World Health Organization, 2015, TOG WHO STAT PROF; World Health Organization, 2014, COUNTR COOP STRAT TO; World Health Organization, 2014, EV NEWB ACT PLAN END; World Health Organization (WHO), 2016, STANDARDS IMPROVING; Yansaneh I., CONSTRUCTION USE SAM	34	4	4	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 16	2017	12	3							e0173445	10.1371/journal.pone.0173445	http://dx.doi.org/10.1371/journal.pone.0173445			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN9KE	28301539	Green Published, gold			2022-12-27	WOS:000396318300039
J	Needell, JC; Dinarello, CA; Ir, D; Robertson, CE; Ryan, SM; Kroehl, ME; Frank, DN; Zipris, D				Needell, James C.; Dinarello, Charles A.; Ir, Diana; Robertson, Charles E.; Ryan, Sarah M.; Kroehl, Miranda E.; Frank, Daniel N.; Zipris, Danny			Implication of the intestinal microbiome as a potential surrogate marker of immune responsiveness to experimental therapies in autoimmune diabetes	PLOS ONE			English	Article							INNATE IMMUNITY; TYPE-1; INFLAMMATION; TRIAL; INTERLEUKIN-1; INTERPLAY; ALIGNMENT; BLOCKADE; DISEASES; SYSTEM	Type 1 diabetes (T1D) is an autoimmune proinflammatory disease with no effective intervention. A major obstacle in developing new immunotherapies for T1D is the lack of means for monitoring immune responsiveness to experimental therapies. The LEW1. WR1 rat develops autoimmunity following infection with the parvovirus Kilham rat virus (KRV) via mechanisms linked with activation of proinflammatory pathways and alterations in the gut bacterial composition. We used this animal to test the hypothesis that intervention with agents that block innate immunity and diabetes is associated with a shift in the gut microbiota. We observed that infection with KRV results in the induction of proinflammatory gene activation in both the spleen and pancreatic lymph nodes. Furthermore, administering animals the histone deacetylase inhibitor ITF-2357 and IL-1 receptor antagonist (Anakinra) induced differential STAT-1 and the p40 unit of IL-12/IL-23 gene expression. Sequencing of bacterial 16S rRNA genes demonstrated that both ITF-2357 and Anakinra alter microbial diversity. ITF-2357 and Anakinra modulated the abundance of 23 and 8 bacterial taxa in KRV-infected animals, respectively, of which 5 overlapped between the two agents. Lastly, principal component analysis implied that ITF-2357 and Anakinra induce distinct gut microbiomes compared with those from untreated animals or rats provided KRV only. Together, the data suggest that ITF-2357 and Anakinra differentially influence the innate immune system and the intestinal microbiota and highlight the potential use of the gut microbiome as a surrogate means of assessing anti-inflammatory immune effects in type 1 diabetes.	[Needell, James C.; Zipris, Danny] Univ Colorado Denver, Barbara Davis Ctr Childhood Diabet, Aurora, CO 80045 USA; [Dinarello, Charles A.; Ir, Diana; Robertson, Charles E.; Frank, Daniel N.] Univ Colorado, Div Infect Dis, Sch Med, Aurora, CO USA; [Robertson, Charles E.; Frank, Daniel N.] Univ Colorado, Microbiome Res Consortium MiRC, Aurora, CO USA; [Ryan, Sarah M.; Kroehl, Miranda E.] Colorado Sch Publ Hlth, Dept Biostat & Informat, Aurora, CO USA; [Ryan, Sarah M.; Kroehl, Miranda E.] Univ Colorado Denver, Aurora, CO USA	Children's Hospital Colorado; University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado System; University of Colorado Anschutz Medical Campus; Colorado School of Public Health; Children's Hospital Colorado; University of Colorado System; University of Colorado Anschutz Medical Campus	Zipris, D (corresponding author), Univ Colorado Denver, Barbara Davis Ctr Childhood Diabet, Aurora, CO 80045 USA.	danny.zipris@ucdenver.edu	Dinarello, Charles/C-8524-2013; Ryan, Sarah/ABF-1514-2020	ROBERTSON, CHARLES/0000-0002-4136-4121; Ryan, Sarah/0000-0002-4395-1696	NIH/NCATS Colorado CCTSI Grant [UL1 TR001082]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK048520] Funding Source: NIH RePORTER	NIH/NCATS Colorado CCTSI Grant; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by NIH/NCATS Colorado CCTSI Grant Number UL1 TR001082. Contents are the authors' sole responsibility and do not necessarily represent official NIH views.	Alkanani AK, 2015, ALTERATIONS INTESTIN; Atkinson MA, 2014, LANCET, V383, P69, DOI 10.1016/S0140-6736(13)60591-7; Caballero S, 2015, ANNU REV IMMUNOL, V33, P227, DOI 10.1146/annurev-immunol-032713-120238; Chervonsky AV, 2012, CURR OPIN IMMUNOL, V24, P255, DOI 10.1016/j.coi.2012.03.002; David LA, 2014, NATURE, V505, P559, DOI 10.1038/nature12820; Dinarello CA, 2006, E SCHERING RES FDN W, V56, P45; Dinarello CA, 2012, NAT REV DRUG DISCOV, V11, P633, DOI 10.1038/nrd3800; Dinarello CA, 2011, MOL MED, V17, P333, DOI 10.2119/molmed.2011.00116; Dinarello CA, 2011, BLOOD, V117, P3720, DOI 10.1182/blood-2010-07-273417; Edgar RC, 2011, BIOINFORMATICS, V27, P2194, DOI 10.1093/bioinformatics/btr381; Everard A, 2013, P NATL ACAD SCI USA, V110, P9066, DOI 10.1073/pnas.1219451110; Frank DN, 2011, TRENDS MICROBIOL, V19, P427, DOI 10.1016/j.tim.2011.06.005; Furlan A, 2011, MOL MED, V17, P353, DOI 10.2119/molmed.2011.00020; Gabay C, 2010, NAT REV RHEUMATOL, V6, P232, DOI 10.1038/nrrheum.2010.4; Gianani R, 2005, IMMUNOL REV, V204, P232, DOI 10.1111/j.0105-2896.2005.00248.x; Hara N, 2013, J MOL MED, P1; Hara N, 2014, INNATE IMMUN-LONDON, V20, P574, DOI 10.1177/1753425913502242; Hara N, 2012, J IMMUNOL, V189, P3805, DOI 10.4049/jimmunol.1201257; Hooper LV, 2010, NAT REV IMMUNOL, V10, P159, DOI 10.1038/nri2710; Langmead B, 2012, NAT METHODS, V9, P357, DOI [10.1038/NMETH.1923, 10.1038/nmeth.1923]; Londono P, 2010, CLIN IMMUNOL, V135, P401, DOI 10.1016/j.clim.2010.01.007; Mandrup-Poulsen T, 2010, NAT REV ENDOCRINOL, V6, P158, DOI 10.1038/nrendo.2009.271; Maynard CL, 2012, NATURE, V489, P231, DOI 10.1038/nature11551; Mebius RE, 2005, NAT REV IMMUNOL, V5, P606, DOI 10.1038/nri1669; Michail S, 2012, INFLAMM BOWEL DIS, V18, P1799, DOI 10.1002/ibd.22860; Moran A, 2013, LANCET, V381, P1905, DOI 10.1016/S0140-6736(13)60023-9; Mordes JP, 2004, ILAR J, V45, P278, DOI 10.1093/ilar.45.3.278; Pruesse E, 2012, BIOINFORMATICS, V28, P1823, DOI 10.1093/bioinformatics/bts252; Qaisar N, 2017, DIABETES, V66, P145, DOI 10.2337/db16-0462; Quast C, 2013, NUCLEIC ACIDS RES, V41, pD590, DOI 10.1093/nar/gks1219; Robertson CE, 2013, BIOINFORMATICS, V29, P3100, DOI 10.1093/bioinformatics/btt526; Roep BO, 2010, NAT REV IMMUNOL, V10, P145, DOI 10.1038/nri2705; Schloss PD, 2011, APPL ENVIRON MICROB, V77, P3219, DOI 10.1128/AEM.02810-10; Thaiss CA, 2014, CURR OPIN IMMUNOL, V26, P41, DOI 10.1016/j.coi.2013.10.016; Tooley JE, 2014, CURR OPIN ENDOCRINOL, V21, P287, DOI 10.1097/MED.0000000000000076; Vaarala O, 2008, DIABETES, V57, P2555, DOI 10.2337/db08-0331; Wen L, 2008, NATURE, V455, P1109, DOI 10.1038/nature07336; Wherrett DK, 2011, LANCET, V378, P319, DOI 10.1016/S0140-6736(11)60895-7; Wolter TR, 2009, CLIN IMMUNOL, V132, P103, DOI 10.1016/j.clim.2009.02.007; Zhernakova A, 2016, SCIENCE, V352, P565, DOI 10.1126/science.aad3369; Zipris D, 2005, J IMMUNOL, V174, P131, DOI 10.4049/jimmunol.174.1.131	41	7	7	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 16	2017	12	3							e0173968	10.1371/journal.pone.0173968	http://dx.doi.org/10.1371/journal.pone.0173968			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN9KE	28301545	Green Published, Green Submitted, gold			2022-12-27	WOS:000396318300103
J	Lomaev, D; Mikhailova, A; Erokhin, M; Shaposhnikov, AV; Moresco, JJ; Blokhina, T; Wolle, D; Aoki, T; Ryabykh, V; Yates, JR; Shidlovskii, YV; Georgiev, P; Schedl, P; Chetverina, D				Lomaev, Dmitry; Mikhailova, Anna; Erokhin, Maksim; Shaposhnikov, Alexander V.; Moresco, James J.; Blokhina, Tatiana; Wolle, Daniel; Aoki, Tsutomu; Ryabykh, Vladimir; Yates, John R., III; Shidlovskii, Yulii V.; Georgiev, Pavel; Schedl, Paul; Chetverina, Darya			The GAGA factor regulatory network: Identification of GAGA factor associated proteins	PLOS ONE			English	Article							POLYCOMB RESPONSE ELEMENTS; CHROMATIN REMODELING COMPLEX; DROSOPHILA BITHORAX COMPLEX; ENHANCER-BLOCKING ACTIVITY; FAB-7 BOUNDARY ACTIVITY; TRITHORAX GROUP GENES; MESSENGER-RNA EXPORT; TRANSCRIPTION FACTOR; DNA-BINDING; INSULATOR FUNCTION	The Drosophila GAGA factor (GAF) has an extraordinarily diverse set of functions that include the activation and silencing of gene expression, nucleosome organization and remodeling, higher order chromosome architecture and mitosis. One hypothesis that could account for these diverse activities is that GAF is able to interact with partners that have specific and dedicated functions. To test this possibility we used affinity purification coupled with high throughput mass spectrometry to identify GAF associated partners. Consistent with this hypothesis the GAF interacting network includes a large collection of factors and complexes that have been implicated in many different aspects of gene activity, chromosome structure and function. Moreover, we show that GAF interactions with a small subset of partners is direct; however for many others the interactions could be indirect, and depend upon intermediates that serve to diversify the functional capabilities of the GAF protein.	[Lomaev, Dmitry; Mikhailova, Anna; Erokhin, Maksim; Shaposhnikov, Alexander V.; Blokhina, Tatiana; Shidlovskii, Yulii V.; Georgiev, Pavel; Schedl, Paul; Chetverina, Darya] Russian Acad Sci, Inst Gene Biol, Moscow, Russia; [Moresco, James J.; Yates, John R., III] Scripps Res Inst, Dept Physiol Chem, SR302B, La Jolla, CA 92037 USA; [Wolle, Daniel; Aoki, Tsutomu; Schedl, Paul] Princeton Univ, Dept Mol Biol, Princeton, NJ 08544 USA; [Ryabykh, Vladimir] Inst Anim Physiol Biochem & Nutr, Borovsk, Russia	Russian Academy of Sciences; Institute of Gene Biology (IGB) of Russian Academy of Sciences; Scripps Research Institute; Princeton University; L.K. Ernst Federal Science Center for Animal Husbandry; All-Russia Research Institute of Animal Physiology, Biochemistry & Nutrition	Georgiev, P; Schedl, P; Chetverina, D (corresponding author), Russian Acad Sci, Inst Gene Biol, Moscow, Russia.; Schedl, P (corresponding author), Princeton Univ, Dept Mol Biol, Princeton, NJ 08544 USA.	georgiev_p@mail.ru; pschedl@Princeton.EDU; daria.chetverina@gmail.com	Shidlovskii, Yulii V/P-7687-2017	Shidlovskii, Yulii V/0000-0002-3643-9889; Erokhin, Maksim/0000-0002-2467-868X; Shaposhnikov, Alexander/0000-0003-4851-4775; Chetverina, Darya/0000-0003-0008-3814	Russian Science Foundation [14-24-00166]; Russian Federation Ministry of Education and Science grant [14.B25.31.0022]; NIH [GM043432]; Russian Foundation for Basic Research [16-34-60214]; National Institute of General Medical Sciences [8 P41GM103533]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM043432] Funding Source: NIH RePORTER; Russian Science Foundation [17-24-00019] Funding Source: Russian Science Foundation	Russian Science Foundation(Russian Science Foundation (RSF)); Russian Federation Ministry of Education and Science grant; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Russian Foundation for Basic Research(Russian Foundation for Basic Research (RFBR)); National Institute of General Medical Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Russian Science Foundation(Russian Science Foundation (RSF))	This work was supported by the Russian Science Foundation (14-24-00166) to PG; Russian Federation Ministry of Education and Science grant to the Gene Biology Institute (14.B25.31.0022); NIH (GM043432) to PS; Russian Foundation for Basic Research (16-34-60214) to YS; National Institute of General Medical Sciences (8 P41GM103533) to JJM and JRY.	Aoki T, 2008, MOL CELL BIOL, V28, P1047, DOI 10.1128/MCB.01622-07; BARDWELL VJ, 1994, GENE DEV, V8, P1664, DOI 10.1101/gad.8.14.1664; Bauer M, 2016, CHROMOSOMA, V125, P471, DOI 10.1007/s00412-015-0539-4; Belozerov VE, 2003, EMBO J, V22, P3113, DOI 10.1093/emboj/cdg297; Bhat KM, 1996, DEVELOPMENT, V122, P1113; BIGGIN MD, 1988, CELL, V53, P699, DOI 10.1016/0092-8674(88)90088-8; Bonchuk A, 2011, J MOL BIOL, V412, P423, DOI 10.1016/j.jmb.2011.07.052; Chalkley GE, 2008, MOL CELL BIOL, V28, P2920, DOI 10.1128/MCB.02217-07; Chang YL, 2007, MOL CELL BIOL, V27, P5486, DOI 10.1128/MCB.00692-07; Chavez S, 2000, EMBO J, V19, P5824, DOI 10.1093/emboj/19.21.5824; Crosby MA, 1999, MOL CELL BIOL, V19, P1159; Cuartero S, 2014, EMBO J, V33, P637, DOI 10.1002/embj.201386001; DINGWALL AK, 1995, MOL BIOL CELL, V6, P777, DOI 10.1091/mbc.6.7.777; Emelyanov AV, 2012, GENE DEV, V26, P603, DOI 10.1101/gad.180604.111; Erokhin M, 2015, P NATL ACAD SCI USA, V112, P14930, DOI 10.1073/pnas.1515276112; Espinas ML, 2000, EMBO REP, V1, P253, DOI 10.1093/embo-reports/kvd046; FARKAS G, 1994, NATURE, V371, P806, DOI 10.1038/371806a0; Faucheux M, 2003, MOL CELL BIOL, V23, P1181, DOI 10.1128/MCB.23.4.1181-1195.2003; Fereres S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0113255; Fuda NJ, 2015, PLOS GENET, V11, DOI 10.1371/journal.pgen.1005108; Gambetta MC, 2009, SCIENCE, V325, P93, DOI 10.1126/science.1169727; Gause M, 2001, MOL CELL BIOL, V21, P4807, DOI 10.1128/MCB.21.14.4807-4817.2001; Ghosh D, 2001, EMBO J, V20, P2518, DOI 10.1093/emboj/20.10.2518; Gildea JJ, 2000, GENETICS, V156, P645; Grossniklaus U, 2014, CSH PERSPECT BIOL, V6, DOI 10.1101/cshperspect.a019331; Guruharsha KG, 2011, CELL, V147, P690, DOI 10.1016/j.cell.2011.08.047; Hagstrom K, 1997, GENETICS, V146, P1365; Horard B, 2000, MOL CELL BIOL, V20, P3187, DOI 10.1128/MCB.20.9.3187-3197.2000; Ito T, 1997, CELL, V90, P145, DOI 10.1016/S0092-8674(00)80321-9; Jimeno S, 2002, EMBO J, V21, P3526, DOI 10.1093/emboj/cdf335; KAMAKAKA RT, 1994, METHOD CELL BIOL, V44, P225, DOI 10.1016/S0091-679X(08)60916-4; Kassis JA, 2013, ADV GENET, V81, P83, DOI 10.1016/B978-0-12-407677-8.00003-8; Katsani KR, 1999, EMBO J, V18, P698, DOI 10.1093/emboj/18.3.698; Kellner WA, 2013, NUCLEIC ACIDS RES, V41, P9274, DOI 10.1093/nar/gkt722; KENNISON JA, 1988, P NATL ACAD SCI USA, V85, P8136, DOI 10.1073/pnas.85.21.8136; Kopytova DV, 2010, GENE DEV, V24, P86, DOI 10.1101/gad.550010; Kugler SJ, 2010, MOL BIOL CELL, V21, P3443, DOI 10.1091/mbc.E10-03-0212; Kvon EZ, 2012, GENE DEV, V26, P908, DOI 10.1101/gad.188052.112; Lee CY, 2008, MOL CELL BIOL, V28, P3290, DOI 10.1128/MCB.02224-07; Leibovitch BA, 2002, MOL CELL BIOL, V22, P6148, DOI 10.1128/MCB.22.17.6148-6157.2002; Li J, 2013, MOL CELL, V50, P711, DOI 10.1016/j.molcel.2013.05.016; Maksimenko O, 2015, GENOME RES, V25, P89, DOI 10.1101/gr.174169.114; McDonald WH, 2004, RAPID COMMUN MASS SP, V18, P2162, DOI 10.1002/rcm.1603; McElroy KA, 2014, OPEN BIOL, V4, DOI 10.1098/rsob.140006; Melnikova L, 2004, P NATL ACAD SCI USA, V101, P14806, DOI 10.1073/pnas.0403959101; Mishra K, 2003, MECH DEVELOP, V120, P681, DOI 10.1016/S0925-4773(03)00046-7; Mishra RK, 2001, MOL CELL BIOL, V21, P1311, DOI 10.1128/MCB.21.4.1311-1318.2001; Mohrmann L, 2004, MOL CELL BIOL, V24, P3077, DOI 10.1128/MCB.24.8.3077-3088.2004; Murawsky CM, 2001, EMBO REP, V2, P1089, DOI 10.1093/embo-reports/kve252; Nakayama T, 2012, DEVELOPMENT, V139, P4582, DOI 10.1242/dev.083246; Negre N, 2006, PLOS BIOL, V4, P917, DOI 10.1371/journal.pbio.0040170; Negre N, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000814; Ohtsuki S, 1998, GENE DEV, V12, P3325, DOI 10.1101/gad.12.21.3325; Okada M, 1998, MOL CELL BIOL, V18, P2455, DOI 10.1128/MCB.18.5.2455; Orphanides G, 1998, CELL, V92, P105, DOI 10.1016/S0092-8674(00)80903-4; Orsi GA, 2014, GENOME RES, V24, P809, DOI 10.1101/gr.163642.113; Pagans S, 2002, NUCLEIC ACIDS RES, V30, P4406, DOI 10.1093/nar/gkf570; Pai CY, 2004, MOL CELL, V16, P737, DOI 10.1016/j.molcel.2004.11.004; Pedone PV, 1996, P NATL ACAD SCI USA, V93, P2822, DOI 10.1073/pnas.93.7.2822; Peng JM, 2003, J PROTEOME RES, V2, P43, DOI 10.1021/pr025556v; Poux S, 2001, GENE DEV, V15, P2509, DOI 10.1101/gad.208901; Ray P, 2016, P NATL ACAD SCI USA, V113, P3826, DOI 10.1073/pnas.1520926113; Reddy BA, 2010, MOL CELL BIOL, V30, P5234, DOI 10.1128/MCB.00266-10; Ruhf ML, 2001, DEVELOPMENT, V128, P1429; Schuettengruber B, 2009, PLOS BIOL, V7, P146, DOI 10.1371/journal.pbio.1000013; Schwartz YB, 2013, NAT REV GENET, V14, P853, DOI 10.1038/nrg3603; Schweinsberg S, 2004, GENETICS, V168, P1371, DOI 10.1534/genetics.104.029561; Schweinsberg SE, 2004, DEVELOPMENT, V131, P4743, DOI 10.1242/dev.01343; Schwendemann A, 2002, P NATL ACAD SCI USA, V99, P12883, DOI 10.1073/pnas.202341499; Shaposhnikov AV, 2016, BIOORG KHIM, V42, P712; SHEARN A, 1989, GENETICS, V121, P517; Shimojima T, 2003, GENE DEV, V17, P1605, DOI 10.1101/gad.1086803; SOELLER WC, 1988, GENE DEV, V2, P68, DOI 10.1101/gad.2.1.68; SOELLER WC, 1993, MOL CELL BIOL, V13, P7961, DOI 10.1128/MCB.13.12.7961; Strasser K, 2002, NATURE, V417, P304, DOI 10.1038/nature746; Strutt H, 1997, EMBO J, V16, P3621, DOI 10.1093/emboj/16.12.3621; TSUKIYAMA T, 1994, NATURE, V367, P525, DOI 10.1038/367525a0; TSUKIYAMA T, 1995, CELL, V83, P1011, DOI 10.1016/0092-8674(95)90216-3; TSUKIYAMA T, 1995, CELL, V83, P1021, DOI 10.1016/0092-8674(95)90217-1; van Steensel B, 2003, P NATL ACAD SCI USA, V100, P2580, DOI 10.1073/pnas.0438000100; Weber JA, 1997, MOL CELL BIOL, V17, P3799, DOI 10.1128/MCB.17.7.3799; Wolle D, 2015, MOL CELL BIOL, V35, P3739, DOI 10.1128/MCB.00456-15; Wolters DA, 2001, ANAL CHEM, V73, P5683, DOI 10.1021/ac010617e; Wright K., 1989, BIOCHEM EDUC, V17, P220, DOI [10.1016/0307-4412(89)90165-9, DOI 10.1016/0307-4412(89)90165-9.]; Xiao H, 2001, MOL CELL, V8, P531, DOI 10.1016/S1097-2765(01)00345-8; Xu T, 2015, J PROTEOMICS, V129, P16, DOI 10.1016/j.jprot.2015.07.001; Yanez-Cuna JO, 2014, GENOME RES, V24, P1147, DOI 10.1101/gr.169243.113; ZOLLMAN S, 1994, P NATL ACAD SCI USA, V91, P10717, DOI 10.1073/pnas.91.22.10717	88	20	21	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 15	2017	12	3							e0173602	10.1371/journal.pone.0173602	http://dx.doi.org/10.1371/journal.pone.0173602			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN9HQ	28296955	Green Submitted, gold, Green Published			2022-12-27	WOS:000396311700045
J	Hoy, AR; Ly, M; Carlsson, CM; Okonkwo, OC; Zetterberg, H; Blennow, K; Sager, MA; Asthana, S; Johnson, SC; Alexander, AL; Bendlin, BB				Hoy, Andrew R.; Ly, Martina; Carlsson, Cynthia M.; Okonkwo, Ozioma C.; Zetterberg, Henrik; Blennow, Kaj; Sager, Mark A.; Asthana, Sanjay; Johnson, Sterling C.; Alexander, Andrew L.; Bendlin, Barbara B.			Microstructural white matter alterations in preclinical Alzheimer's disease detected using free water elimination diffusion tensor imaging	PLOS ONE			English	Article							FIBER TRACTOGRAPHY; CORPUS-CALLOSUM; CSF; BRAIN; BETA; DEGENERATION; DEMENTIA; VOLUME; TRACTS; APOE	Brain changes associated with Alzheimer's disease (AD) begin decades before disease diagnosis. While beta-amyloid plaques and neurofibrillary tangles are defining features of AD, neuronal loss and synaptic pathology are closely related to the cognitive dysfunction. Brain imaging methods that are tuned to assess degeneration of myelinated nerve fibers in the brain (collectively called white matter) include diffusion tensor imaging (DTI) and related techniques, and are expected to shed light on disease-related loss of structural connectivity. Participants (N = 70, ages 47-76 years) from the Wisconsin Registry for Alzheimer's Prevention study underwent DTI and hybrid diffusion imaging to determine a free-water elimination (FWE-DTI) model. The study assessed the extent to which preclinical AD pathology affects brain white matter. Preclinical AD pathology was determined using cerebrospinal fluid (CSF) biomarkers. The sample was enriched for AD risk (APOE epsilon 4 and parental history of AD). AD pathology assessed by CSF analyses was significantly associated with altered microstructure on both DTI and FWE-DTI. Affected regions included frontal, parietal, and especially temporal white matter. The f-value derived from the FWE-DTI model appeared to be the most sensitive to the relationship between the CSF AD biomarkers and microstructural alterations in white matter. These findings suggest that white matter degeneration is an early pathological feature of AD that may have utility both for early disease detection and as outcome measures for clinical trials. More complex models of microstructural diffusion properties including FWE-DTI may provide increased sensitivity to early brain changes associated with AD over standard DTI.	[Hoy, Andrew R.] US Navy, Med Serv Corp, Falls Church, VA 22042 USA; [Hoy, Andrew R.; Alexander, Andrew L.] Univ Wisconsin, Dept Med Phys, Sch Med & Publ Hlth, 1530 Med Sci Ctr, Madison, WI 53706 USA; [Hoy, Andrew R.; Alexander, Andrew L.] Univ Wisconsin, Waisman Lab Brain Imaging & Behav, Madison, WI 53706 USA; [Hoy, Andrew R.] Uniformed Serv Univ Hlth Sci, Dept Radiol & Radiol Sci, Bethesda, MD 20814 USA; [Ly, Martina; Carlsson, Cynthia M.; Okonkwo, Ozioma C.; Asthana, Sanjay; Johnson, Sterling C.; Bendlin, Barbara B.] William S Middleton Mem Vet Adm Med Ctr, Geriatr Res Educ & Clin Ctr, Madison, WI USA; [Ly, Martina; Carlsson, Cynthia M.; Okonkwo, Ozioma C.; Sager, Mark A.; Asthana, Sanjay; Johnson, Sterling C.; Bendlin, Barbara B.] Univ Wisconsin, Wisconsin Alzheimers Dis Res Ctr, Madison, WI USA; [Ly, Martina] Univ Wisconsin, Neurosci Training Program, Madison, WI USA; [Carlsson, Cynthia M.; Okonkwo, Ozioma C.; Sager, Mark A.; Asthana, Sanjay; Johnson, Sterling C.; Bendlin, Barbara B.] Univ Wisconsin, Sch Med & Publ Hlth, Wisconsin Alzheimers Inst, Madison, WI USA; [Zetterberg, Henrik; Blennow, Kaj] Univ Gothenburg, Sahlgrenska Acad, Inst Neurosci & Physiol, Clin Neurochem Lab,Dept Psychiat & Neurochem, Gothenburg, Sweden; [Zetterberg, Henrik] UCL Inst Neurol, Queen Sq, London WC1N 3BG, England; [Alexander, Andrew L.] Univ Wisconsin, Dept Psychiat, Madison, WI 53706 USA	University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison; Uniformed Services University of the Health Sciences - USA; Geriatric Research Education & Clinical Center; US Department of Veterans Affairs; Veterans Health Administration (VHA); William S Middleton Memorial Veterans Hospital; University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison; University of Gothenburg; University of London; University College London; University of Wisconsin System; University of Wisconsin Madison	Hoy, AR (corresponding author), US Navy, Med Serv Corp, Falls Church, VA 22042 USA.; Hoy, AR (corresponding author), Univ Wisconsin, Dept Med Phys, Sch Med & Publ Hlth, 1530 Med Sci Ctr, Madison, WI 53706 USA.; Hoy, AR (corresponding author), Univ Wisconsin, Waisman Lab Brain Imaging & Behav, Madison, WI 53706 USA.; Hoy, AR (corresponding author), Uniformed Serv Univ Hlth Sci, Dept Radiol & Radiol Sci, Bethesda, MD 20814 USA.	Andrew.Hoy@usuhs.edu	Alexander, Andrew/ABA-2806-2020		National Institutes of Health [P50AG033514, R01AG027161, P30HD003352, P50MH100031, R01AG037639]; Torsten Soderberg Foundation at the Royal Swedish Academy of Sciences; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [U54HD090256] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [P50MH100031] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R56AG037639, R01AG021155, P50AG033514, R01AG037639] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Torsten Soderberg Foundation at the Royal Swedish Academy of Sciences; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	Research reported in this publication was supported in part by the National Institutes of Health under Grant Award Numbers P50AG033514, R01AG027161, P30HD003352, P50MH100031, and R01AG037639. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health. Biomarker analyses in this project was supported by the Torsten Soderberg Foundation at the Royal Swedish Academy of Sciences.	Adluru N, 2014, NEUROIMAGE-CLIN, V4, P730, DOI 10.1016/j.nicl.2014.04.008; Alexander AL, 2001, ANAL PARTIAL VOLUME, V780, P770; Alexander AL, 2007, NEUROTHERAPEUTICS, V4, P316, DOI 10.1016/j.nurt.2007.05.011; Alexander AL, 2011, BRAIN CONNECT, V1, P423, DOI 10.1089/brain.2011.0071; Alobuia WM, 2013, NEUROCHEM INT, V63, P782, DOI 10.1016/j.neuint.2013.08.013; Andrade-Moraes CH, 2013, BRAIN, V136, P3738, DOI 10.1093/brain/awt273; [Anonymous], 1988, COGN REHABIL; Assaf Y, 1998, J MAGN RESON, V131, P69, DOI 10.1006/jmre.1997.1313; Beaulieu C, 2002, NMR BIOMED, V15, P435, DOI 10.1002/nbm.782; Bendlin BB, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037720; Bendlin BB, 2010, ALZHEIMERS DEMENT, V6, P394, DOI 10.1016/j.jalz.2009.11.003; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Berlot R, 2014, NEUROIMAGE, P1; Brinkmalm G, 2013, BRAIN RES, V1513, P117, DOI 10.1016/j.brainres.2013.03.019; Buerger K, 2006, BRAIN, V129, P3035, DOI 10.1093/brain/awl269; Canu E, 2010, J ALZHEIMERS DIS, V19, P963, DOI 10.3233/JAD-2010-1295; Christensen DZ, 2014, FRONT AGING NEUROSCI, V6, DOI 10.3389/fnagi.2014.00139; Collins-Praino LE, 2014, ACTA NEUROPATHOL COM, V2, DOI 10.1186/s40478-014-0083-0; Cox SG, 2005, BRIT J CLIN PSYCHOL, V44, P454, DOI 10.1348/014466505X105850; DEKOSKY ST, 1990, ANN NEUROL, V27, P457, DOI 10.1002/ana.410270502; Desikan RS, 2006, NEUROIMAGE, V31, P968, DOI 10.1016/j.neuroimage.2006.01.021; Fagan AM, 2006, ANN NEUROL, V59, P512, DOI 10.1002/ana.20730; Fellgiebel A, 2008, NEUROPSYCHOLOGIA, V46, P1698, DOI 10.1016/j.neuropsychologia.2007.12.010; FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6; Frazier JA, 2005, AM J PSYCHIAT, V162, P1256, DOI 10.1176/appi.ajp.162.7.1256; Gold BT, 2014, NEUROBIOL AGING, V35, P2263, DOI 10.1016/j.neurobiolaging.2014.04.030; Goldstein JM, 2007, BIOL PSYCHIAT, V61, P935, DOI 10.1016/j.biopsych.2006.06.027; GomezIsla T, 1997, ANN NEUROL, V41, P17, DOI 10.1002/ana.410410106; Hampel H, 2010, EXP GERONTOL, V45, P30, DOI 10.1016/j.exger.2009.10.010; Hanyu H, 1999, J NEUROL SCI, V167, P37, DOI 10.1016/S0022-510X(99)00135-5; Hofer S, 2006, NEUROIMAGE, V32, P989, DOI 10.1016/j.neuroimage.2006.05.044; Hoy AR, 2014, NEUROIMAGE, V103, P323, DOI 10.1016/j.neuroimage.2014.09.053; Hoy AR, 2015, J MAGN RESON IMAGING, P1; Huang H, 2012, NEUROBIOL AGING, V33, P2029, DOI 10.1016/j.neurobiolaging.2011.06.027; KAWAS C, 1994, ARCH NEUROL-CHICAGO, V51, P901, DOI 10.1001/archneur.1994.00540210073015; Koopman K, 2009, NEUROCHEM INT, V55, P214, DOI 10.1016/j.neuint.2009.02.017; Krstic D, 2013, NAT REV NEUROL, V9, P25, DOI 10.1038/nrneurol.2012.236; Lansbury PT, 1999, P NATL ACAD SCI USA, V96, P3342, DOI 10.1073/pnas.96.7.3342; Larsson EM, 2004, DEMENT GERIATR COGN, V17, P316, DOI 10.1159/000077162; LASSMANN H, 1993, ANN NY ACAD SCI, V695, P59, DOI 10.1111/j.1749-6632.1993.tb23028.x; Lautner R, 2015, JAMA NEUROL, V72, P125, DOI 10.1001/jamaneurol.2014.3552; Lewczuk P, 2004, J MOL NEUROSCI, V23, P115, DOI 10.1385/JMN:23:1-2:115; Li X, 2015, J INTERN MED; Ly M, 2014, HUM BRAIN MAPP, V35, P2044, DOI 10.1002/hbm.22311; Lyall DM, 2014, NEUROBIOL AGING, V35, DOI 10.1016/j.neurobiolaging.2014.01.006; Maier-Hein KH, 2015, ALZHEIMERS DEMENT, V11, P485, DOI 10.1016/j.jalz.2014.04.518; Makris N, 2006, SCHIZOPHR RES, V83, P155, DOI 10.1016/j.schres.2005.11.020; MASLIAH E, 1993, NEUROLOGY, V43, P192, DOI 10.1212/WNL.43.1_Part_1.192; Mattsson N, 2011, NEUROMOL MED, V13, P151, DOI 10.1007/s12017-011-8147-9; Mattsson N, 2009, JAMA-J AM MED ASSOC, V302, P385, DOI 10.1001/jama.2009.1064; MCKHANN G, 1984, NEUROLOGY, V34, P939, DOI 10.1212/WNL.34.7.939; McKhann GM, 2011, ALZHEIMERS DEMENT, V7, P263, DOI 10.1016/j.jalz.2011.03.005; Metzler-Baddeley C, 2012, J NEUROSCI, V32, P17612, DOI 10.1523/JNEUROSCI.3299-12.2012; Metzler-Baddeley C, 2012, NEUROLOGY, V79, P2233, DOI 10.1212/WNL.0b013e31827689e8; Metzler-Baddeley C, 2012, NEUROIMAGE, V59, P1394, DOI 10.1016/j.neuroimage.2011.08.043; Mori S, 1999, ANN NEUROL, V45, P265, DOI 10.1002/1531-8249(199902)45:2<265::AID-ANA21>3.0.CO;2-3; Okada T, 2006, RADIOLOGY, V238, P668, DOI 10.1148/radiol.2382042192; Pajevic S, 2000, MAGNET RESON MED, V43, P921, DOI 10.1002/1522-2594(200006)43:6<921::AID-MRM23>3.0.CO;2-I; Pasternak O, 2012, J NEUROSCI, V32, P17365, DOI 10.1523/JNEUROSCI.2904-12.2012; Pasternak O, 2012, LECT NOTES COMPUT SC, V7511, P305, DOI 10.1007/978-3-642-33418-4_38; Pasternak O, 2009, MAGN RESON MED, V62, P717, DOI 10.1002/mrm.22055; Perez-Nievas BG, 2013, BRAIN, V136, P2510, DOI 10.1093/brain/awt171; Perneczky R, 2011, NEUROLOGY, V77, P35, DOI 10.1212/WNL.0b013e318221ad47; Pfefferbaum A, 2000, MAGNET RESON MED, V44, P259, DOI 10.1002/1522-2594(200008)44:2<259::AID-MRM13>3.0.CO;2-6; Pierpaoli C, 2004, P 12 ANN M ISMRM KYO, V21, P1215; Rathi Y, 2013, HUM BRAIN MAPP; Ray NJ, 2015, J NEUROSCI, V35, P739, DOI 10.1523/JNEUROSCI.3617-14.2015; Ringman JM, 2007, BRAIN, V130, P1767, DOI 10.1093/brain/awm102; Roher AE, 2002, BIOCHEMISTRY-US, V41, P11080, DOI 10.1021/bi026173d; Roher Alex E, 2013, Am J Neurodegener Dis, V2, P187; Roses Allen D., 1994, Current Opinion in Biotechnology, V5, P663, DOI 10.1016/0958-1669(94)90091-4; Ryan NS, 2013, BRAIN, V136, P1399, DOI 10.1093/brain/awt065; Sager MA, 2005, J GERIATR PSYCH NEUR, V18, P245, DOI 10.1177/0891988705281882; Samgard K, 2010, INT J GERIATR PSYCH, V25, P403, DOI 10.1002/gps.2353; Smith SM, 2009, NEUROIMAGE, V44, P83, DOI 10.1016/j.neuroimage.2008.03.061; Sorensen AG, 2007, P INT SOC MAG RESON, V15, P3720, DOI [DOI 10.1128/MCB.25.11.4371, DOI 10.1038/SJ.IJ0.0803354]; Strauss E, 1998, CLIN ORTHOP RELAT R, P2; Takahashi S, 2002, NEUROSCI LETT, V332, P45, DOI 10.1016/S0304-3940(02)00914-X; Tosto G, 2014, JAMA NEUROL, V71, P872, DOI 10.1001/jamaneurol.2014.667; van Bruggen T, INT SOC MAGN RES MED, P790; Wakana S, 2004, RADIOLOGY, V230, P77, DOI 10.1148/radiol.2301021640; Wang Y, 2011, NEUROIMAGE, V55, P1577, DOI 10.1016/j.neuroimage.2011.01.038; Westlye LT, 2012, NEUROLOGY, V79, P1961, DOI 10.1212/WNL.0b013e3182735c9c; Winkler AM, 2014, NEUROIMAGE, V92, P381, DOI 10.1016/j.neuroimage.2014.01.060; Wolfe MS, 2007, J CELL SCI, V120, P3157, DOI 10.1242/jcs.03481; Wu YC, 2007, NEUROIMAGE, V36, P617, DOI 10.1016/j.neuroimage.2007.02.050; Zhang H, 2007, LECT NOTES COMPUT SC, V4792, P211; Zhang H, 2006, MED IMAGE ANAL, V10, P764, DOI 10.1016/j.media.2006.06.004	88	67	73	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 14	2017	12	3							e0173982	10.1371/journal.pone.0173982	http://dx.doi.org/10.1371/journal.pone.0173982			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EN6DM	28291839	gold, Green Published, Green Submitted			2022-12-27	WOS:000396094700053
J	Snedeker, J; Schock, EN; Struve, JN; Chang, CF; Cionni, M; Tran, PV; Brugmann, SA; Stottmann, RW				Snedeker, John; Schock, Elizabeth N.; Struve, Jamie N.; Chang, Ching-Fang; Cionni, Megan; Tran, Pamela V.; Brugmann, Samantha A.; Stottmann, Rolf W.			Unique spatiotemporal requirements for intraflagellar transport genes during forebrain development	PLOS ONE			English	Article							POLYCYSTIC KIDNEY-DISEASE; PRIMARY CILIA; SONIC HEDGEHOG; NEURAL CREST; KINESIN-II; MOUSE; MORPHOGENESIS; PROTEINS; KIF3A; MANIPULATION	Primary cilia are organelles extended from virtually all cells and are required for the proper regulation of a number of canonical developmental pathways. The role in cortical development of proteins important for ciliary form and function is a relatively understudied area. Here we have taken a genetic approach to define the role in forebrain development of three intraflagellar transport proteins known to be important for primary cilia function. We have genetically ablated Kif3a, Ift88, and Ttc21b in a series of specific spatiotemporal domains. The resulting phenotypes allow us to draw several conclusions. First, we conclude that the Ttc21b cortical phenotype is not due to the activity of Ttc21b within the brain itself. Secondly, some of the most striking phenotypes are from ablations in the neural crest cells and the adjacent surface ectoderm indicating that cilia transduce critical tissue-tissue interactions in the developing embryonic head. Finally, we note striking differences in phenotypes from ablations only one embryonic day apart, indicating very discrete spatiotemporal requirements for these three genes in cortical development.	[Snedeker, John; Cionni, Megan; Stottmann, Rolf W.] Cincinnati Childrens Hosp Med Ctr, Div Human Genet, Dept Pediat, Cincinnati, OH 45229 USA; [Schock, Elizabeth N.; Struve, Jamie N.; Chang, Ching-Fang; Brugmann, Samantha A.; Stottmann, Rolf W.] Cincinnati Childrens Hosp Med Ctr, Div Dev Biol, Dept Pediat, Cincinnati, OH 45229 USA; [Schock, Elizabeth N.; Struve, Jamie N.; Chang, Ching-Fang; Brugmann, Samantha A.] Cincinnati Childrens Hosp Med Ctr, Div Plast Surg, Dept Surg, Cincinnati, OH 45229 USA; [Tran, Pamela V.] Univ Kansas, Med Ctr, Dept Anat & Cell Biol, Kansas City, KS 66103 USA	Cincinnati Children's Hospital Medical Center; Cincinnati Children's Hospital Medical Center; Cincinnati Children's Hospital Medical Center; University of Kansas; University of Kansas Medical Center	Stottmann, RW (corresponding author), Cincinnati Childrens Hosp Med Ctr, Div Human Genet, Dept Pediat, Cincinnati, OH 45229 USA.	rolf.stottmann@cchmc.org	Stottmann, Rolf/GRO-3453-2022; Stottmann, Rolf/U-6589-2019	Stottmann, Rolf/0000-0003-4512-6806; Schock, Elizabeth/0000-0002-3970-799X; Tran, Pamela/0000-0003-4619-4376; Chang, Ching-Fang/0000-0001-6754-2769	Cincinnati Children's Research Foundation; March of Dimes Foundation Basil O'Connor Starter Scholar Research Award [5-FY13-194]; NIH [R01DE023804, R01NS085023, R01GM112744]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM112744] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [T32NS007453] Funding Source: NIH RePORTER	Cincinnati Children's Research Foundation; March of Dimes Foundation Basil O'Connor Starter Scholar Research Award; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	Support for this work comes from the Cincinnati Children's Research Foundation (R.W.S., S.A.B.), a March of Dimes Foundation Basil O'Connor Starter Scholar Research Award (Grant No. 5-FY13-194 to R.W.S.) and the NIH (R01DE023804 to S.A.B., and R01NS085023, R01GM112744 to R.W.S.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andoniadou CL, 2013, CELL MOL LIFE SCI, V70, P3739, DOI 10.1007/s00018-013-1269-5; Baldari CT, 2010, CURR OPIN CELL BIOL, V22, P75, DOI 10.1016/j.ceb.2009.10.010; Beccari L, 2013, MECH DEVELOP, V130, P95, DOI 10.1016/j.mod.2012.10.004; Behringer R, 2014, MANIPULATING MOUSE E, P814; Berbari NF, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0106576; Briscoe J, 2013, NAT REV MOL CELL BIO, V14, P416, DOI 10.1038/nrm3598; Brugmann SA, 2010, HUM MOL GENET, V19, P1577, DOI 10.1093/hmg/ddq030; Caspary T, 2007, DEV CELL, V12, P767, DOI 10.1016/j.devcel.2007.03.004; Chai Y, 2000, DEVELOPMENT, V127, P1671; Chang CF, 2012, OSTEOARTHR CARTILAGE, V20, P152, DOI 10.1016/j.joca.2011.11.009; Corbit KC, 2008, NAT CELL BIOL, V10, P70, DOI 10.1038/ncb1670; Danielian PS, 1998, CURR BIOL, V8, P1323, DOI 10.1016/S0960-9822(07)00562-3; Fossat N, 2012, CELL CYCLE, V11, P26, DOI 10.4161/cc.11.1.18700; Goetz SC, 2010, NAT REV GENET, V11, P331, DOI 10.1038/nrg2774; Gorski JA, 2002, J NEUROSCI, V22, P6309; Guemez-Gamboa A, 2014, NEURON, V82, P511, DOI 10.1016/j.neuron.2014.04.024; Haycraft CJ, 2005, PLOS GENET, V1, P480, DOI 10.1371/journal.pgen.0010053; Haycraft CJ, 2007, DEVELOPMENT, V134, P307, DOI 10.1242/dev.02732; Hebert JM, 2000, DEV BIOL, V222, P296, DOI 10.1006/dbio.2000.9732; Herron BJ, 2002, NAT GENET, V30, P185, DOI 10.1038/ng812; Higginbotham H, 2013, NAT NEUROSCI, V16, P1000, DOI 10.1038/nn.3451; Hou YQ, 2015, EXP CELL RES, V334, P26, DOI 10.1016/j.yexcr.2015.02.017; Huangfu D, 2005, P NATL ACAD SCI USA, V102, P11325, DOI 10.1073/pnas.0505328102; Huangfu DW, 2003, NATURE, V426, P83, DOI 10.1038/nature02061; Jiang XB, 2002, DEV BIOL, V241, P106, DOI 10.1006/dbio.2001.0487; Jiang XB, 2002, MECH DEVELOP, V117, P115, DOI 10.1016/S0925-4773(02)00206-X; KONDO S, 1994, J CELL BIOL, V125, P1095, DOI 10.1083/jcb.125.5.1095; Lakso M, 1996, P NATL ACAD SCI USA, V93, P5860, DOI 10.1073/pnas.93.12.5860; Li XJ, 2009, DEVELOPMENT, V136, P4055, DOI 10.1242/dev.036624; Lorentzen E, 2016, COLD SPRING HARB PER, V8; Macatee TL, 2003, DEVELOPMENT, V130, P6361, DOI 10.1242/dev.00850; Marszalek JR, 1999, P NATL ACAD SCI USA, V96, P5043, DOI 10.1073/pnas.96.9.5043; Marszalek JR, 2000, CELL, V102, P175, DOI 10.1016/S0092-8674(00)00023-4; Martinez-Barbera JP, 2000, DEV BIOL, V223, P422, DOI 10.1006/dbio.2000.9757; MOYER JH, 1994, SCIENCE, V264, P1329, DOI 10.1126/science.8191288; Muzumdar MD, 2007, GENESIS, V45, P593, DOI 10.1002/dvg.20335; Pazour GJ, 2000, J CELL BIOL, V151, P709, DOI 10.1083/jcb.151.3.709; Petersen PH, 2002, NATURE, V419, P929, DOI 10.1038/nature01124; Rohatgi R, 2010, CURR OPIN CELL BIOL, V22, P541, DOI 10.1016/j.ceb.2010.03.010; Sasaki H, 1997, DEVELOPMENT, V124, P1313; Scholey JM, 2003, ANNU REV CELL DEV BI, V19, P423, DOI 10.1146/annurev.cellbio.19.111401.091318; Scholey JM, 2013, ANNU REV CELL DEV BI, V29, P443, DOI 10.1146/annurev-cellbio-101512-122335; Soriano P, 1999, NAT GENET, V21, P70, DOI 10.1038/5007; Spassky N, 2008, DEV BIOL, V317, P246, DOI 10.1016/j.ydbio.2008.02.026; Stottmann RW, 2009, DEV BIOL, V335, P166, DOI 10.1016/j.ydbio.2009.08.023; Stottmann RW, 2011, DEV DYNAM, V240, P755, DOI 10.1002/dvdy.22579; Tran PV, 2008, NAT GENET, V40, P403, DOI 10.1038/ng.105; Tran PV, 2014, J AM SOC NEPHROL, V25, P2201, DOI 10.1681/ASN.2013070735; Valente EM, 2014, NAT REV NEUROL, V10, P27, DOI 10.1038/nrneurol.2013.247; Wang L, 2016, NAT NEUROSCI, V19, P888, DOI 10.1038/nn.4307; Willaredt MA, 2008, J NEUROSCI, V28, P12887, DOI 10.1523/JNEUROSCI.2084-08.2008; Wilson SL, 2012, DEV NEUROBIOL, V72, P1196, DOI 10.1002/dneu.20985; Yoder BK, 2002, J AM SOC NEPHROL, V13, P2508, DOI 10.1097/01.ASN.0000029587.47950.25; Yoder BK, 1995, P ASSOC AM PHYSICIAN, V107, P314; Zhuo L, 2001, GENESIS, V31, P85, DOI 10.1002/gene.10008	55	16	16	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 14	2017	12	3							e0173258	10.1371/journal.pone.0173258	http://dx.doi.org/10.1371/journal.pone.0173258			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN6DM	28291836	gold, Green Submitted, Green Published			2022-12-27	WOS:000396094700018
J	Ahn, AC; Meier-Kolthoff, JP; Overmars, L; Richter, M; Woyke, T; Sorokin, DY; Muyzer, G				Ahn, Anne-Catherine; Meier-Kolthoff, Jan P.; Overmars, Lex; Richter, Michael; Woyke, Tanja; Sorokin, Dimitry Y.; Muyzer, Gerard			Genomic diversity within the haloalkaliphilic genus Thioalkalivibrio	PLOS ONE			English	Article							SULFUR-OXIDIZING BACTERIA; MULTILOCUS SEQUENCE-ANALYSIS; DNA-DNA HYBRIDIZATION; LIVING TREE PROJECT; AD-HOC-COMMITTEE; SP-NOV.; MICROBIAL DIVERSITY; PROKARYOTIC DIVERSITY; HORIZONTAL TRANSFER; ESCHERICHIA-COLI	Thioalkalivibrio is a genus of obligate chemolithoautotrophic haloalkaliphilic sulfur-oxidizing bacteria. Their habitat are soda lakes which are dual extreme environments with a pH range from 9.5 to 11 and salt concentrations up to saturation. More than 100 strains of this genus have been isolated from various soda lakes all over the world, but only ten species have been effectively described yet. Therefore, the assignment of the remaining strains to either existing or novel species is important and will further elucidate their genomic diversity as well as give a better general understanding of this genus. Recently, the genomes of 76 Thioalkalivibrio strains were sequenced. On these, we applied different methods including (i) 16S rRNA gene sequence analysis, (ii) Multilocus Sequence Analysis (MLSA) based on eight housekeeping genes, (iii) Average Nucleotide Identity based on BLAST (ANI(b)) and MUMmer (ANI(m)), (iv) Tetranucleotide frequency correlation coefficients (TETRA), (v) digital DNA: DNA hybridization (dDDH) as well as (vi) nucleotide-and amino acid-based Genome BLAST Distance Phylogeny (GBDP) analyses. We detected a high genomic diversity by revealing 15 new "genomic" species and 16 new "genomic" subspecies in addition to the ten already described species. Phylogenetic and phylogenomic analyses showed that the genus is not monophyletic, because four strains were clearly separated from the other Thioalkalivibrio by type strains from other genera. Therefore, it is recommended to classify the latter group as a novel genus. The biogeographic distribution of Thioalkalivibrio suggested that the different "genomic" species can be classified as candidate disjunct or candidate endemic species. This study is a detailed genome-based classification and identification of members within the genus Thioalkalivibrio. However, future phenotypical and chemotaxonomical studies will be needed for a full species description of this genus.	[Ahn, Anne-Catherine; Overmars, Lex; Muyzer, Gerard] Univ Amsterdam, Inst Biodivers & Ecosyst Dynam, Dept Aquat Microbiol, Microbial Syst Ecol, Amsterdam, Netherlands; [Meier-Kolthoff, Jan P.] Leibniz Inst DSMZ, German Collect Microorganisms & Cell Cultures, Braunschweig, Germany; [Richter, Michael] Ribocon, Bremen, Germany; [Woyke, Tanja] DOE Joint Genome Inst, Walnut Creek, CA USA; [Sorokin, Dimitry Y.] Russian Acad Sci, Biotechnol Res Ctr, Winogradsky Inst Microbiol, Moscow, Russia; [Sorokin, Dimitry Y.] Delft Univ Technol, Dept Biotechnol, Delft, Netherlands	University of Amsterdam; Leibniz Institut fur Deutsche Sammlung von Mikroorganismen und Zellkulturen (DSMZ); United States Department of Energy (DOE); Research Center of Biotechnology RAS; Russian Academy of Sciences; Delft University of Technology	Muyzer, G (corresponding author), Univ Amsterdam, Inst Biodivers & Ecosyst Dynam, Dept Aquat Microbiol, Microbial Syst Ecol, Amsterdam, Netherlands.	g.muijzer@uva.nl	Muyzer, Gerard/ABE-5834-2020; Meier-Kolthoff, Jan Philipp/AAX-6799-2021; Meier-Kolthoff, Jan P./GOP-1205-2022	Muyzer, Gerard/0000-0002-2422-0732; Meier-Kolthoff, Jan Philipp/0000-0001-9105-9814; 	ERC Advanced Grant PARASOL [322551]; European Union Seventh Framework Programme (FP7) [311975]; RFBR grant [16-04-00035]; U.S. Department of Energy Joint Genome Institute, a DOE Office of Science User Facility; DOE Office of Science User Facility [DE-AC02-05CH11231]	ERC Advanced Grant PARASOL; European Union Seventh Framework Programme (FP7); RFBR grant(Russian Foundation for Basic Research (RFBR)); U.S. Department of Energy Joint Genome Institute, a DOE Office of Science User Facility(United States Department of Energy (DOE)); DOE Office of Science User Facility(United States Department of Energy (DOE))	Financial support for Anne-Catherine Ahn, Lex Overmars and Gerard Muyzer was provided by the ERC Advanced Grant PARASOL (No322551). Michael Richter has received funding from the European Union Seventh Framework Programme (FP7/2007-2013) under grant agreement no. 311975 (MaCuMBA). Dimitry Sorokin was supported by the RFBR grant 16-04-00035; Tanja Woyke was funded by the U.S. Department of Energy Joint Genome Institute, a DOE Office of Science User Facility, and was supported under Contract No. DE-AC02-05CH11231. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We thank Cherel Balkema for her help in the laboratory, Judith Umbach for her assistance with the ANI analysis and Emily D. Melton for proofreading and helpful comments. The work conducted by the U.S. Department of Energy Joint Genome Institute, a DOE Office of Science User Facility, is supported under Contract No. DE-AC02-05CH11231.	Achtman M, 2008, NAT REV MICROBIOL, V6, P431, DOI 10.1038/nrmicro1872; Asai T, 1999, P NATL ACAD SCI USA, V96, P1971, DOI 10.1073/pnas.96.5.1971; ASH C, 1991, INT J SYST BACTERIOL, V41, P343, DOI 10.1099/00207713-41-3-343; ASHLOCK PD, 1971, SYST ZOOL, V20, P63, DOI 10.2307/2412223; Auch AF, 2010, STAND GENOMIC SCI, V2, P117, DOI 10.4056/sigs.531120; Banciu H, 2005, FEMS MICROBIOL LETT, V243, P181, DOI 10.1016/j.femsle.2004.12.004; Banciu H, 2004, EXTREMOPHILES, V8, P325, DOI 10.1007/s00792-004-0391-6; Banciu H, 2004, EXTREMOPHILES, V8, P185, DOI 10.1007/s00792-004-0376-5; Brown-Elliott BA, 2006, CLIN MICROBIOL REV, V19, P259, DOI 10.1128/CMR.19.2.259-282.2006; Bryantseva I, 1999, INT J SYST BACTERIOL, V49, P697, DOI 10.1099/00207713-49-2-697; Chan JZM, 2012, BMC MICROBIOL, V12, DOI 10.1186/1471-2180-12-302; Cho JC, 2000, APPL ENVIRON MICROB, V66, P5448, DOI 10.1128/AEM.66.12.5448-5456.2000; Chun J, 2014, INT J SYST EVOL MICR, V64, P316, DOI 10.1099/ijs.0.054171-0; COLWELL RR, 1970, J BACTERIOL, V104, P410, DOI 10.1128/JB.104.1.410-433.1970; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Feil EJ, 2000, GENETICS, V154, P1439; Foti M, 2006, FEMS MICROBIOL ECOL, V56, P95, DOI 10.1111/j.1574-6941.2006.00068.x; FOX GE, 1992, INT J SYST BACTERIOL, V42, P166, DOI 10.1099/00207713-42-1-166; Fulthorpe RR, 1998, APPL ENVIRON MICROB, V64, P1620; Garcia-Vallve S, 1999, MOL BIOL EVOL, V16, P1125, DOI 10.1093/oxfordjournals.molbev.a026203; Garrido-Sanz D, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0150183; Gevers D, 2005, NAT REV MICROBIOL, V3, P733, DOI 10.1038/nrmicro1236; Glaeser SP, 2015, SYST APPL MICROBIOL, V38, P237, DOI 10.1016/j.syapm.2015.03.007; Goker M, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006319; Goris J, 2007, INT J SYST EVOL MICR, V57, P81, DOI 10.1099/ijs.0.64483-0; Habib C, 2014, APPL ENVIRON MICROB, V80, P5503, DOI 10.1128/AEM.01177-14; Hahnke RL, 2016, FRONT MICROBIOL, V7, DOI 10.3389/fmicb.2016.02003; Henz SR, 2005, BIOINFORMATICS, V21, P2329, DOI 10.1093/bioinformatics/bth324; Huson DH, 2012, SYST BIOL, V61, P1061, DOI 10.1093/sysbio/sys062; Imhoff JF, 1996, ARCH MICROBIOL, V165, P106, DOI 10.1007/s002030050304; Janda JM, 2007, J CLIN MICROBIOL, V45, P2761, DOI 10.1128/JCM.01228-07; Jones B, 2000, MICROBIAL BIOSYSTEMS, P681; Jones BE, 1998, EXTREMOPHILES, V2, P191, DOI 10.1007/s007920050060; JONES BF, 1977, GEOCHIM COSMOCHIM AC, V41, P53, DOI 10.1016/0016-7037(77)90186-7; Kompantseva EI, 2009, MIKROBIOLOGIYA, V78, P709; Lai QL, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0106353; Lanzen A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072577; Lefort V, 2015, MOL BIOL EVOL, V32, P2798, DOI 10.1093/molbev/msv150; Li CP, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0101394; Liu YW, 2015, SCI REP-UK, V5, DOI 10.1038/srep08263; Loiko N. G., 2003, Mikrobiologiya, V72, P328; Ludwig W, 2004, NUCLEIC ACIDS RES, V32, P1363, DOI 10.1093/nar/gkh293; Ma YH, 2004, EXTREMOPHILES, V8, P45, DOI 10.1007/s00792-003-0358-z; Delamuta JRM, 2012, BRAZ J MICROBIOL, V43, P698, DOI 10.1590/S1517-83822012000200035; Markowitz VM, 2012, NUCLEIC ACIDS RES, V40, pD115, DOI 10.1093/nar/gkr1044; Martens M, 2008, INT J SYST EVOL MICR, V58, P200, DOI 10.1099/ijs.0.65392-0; Meier-Kolthoff JP, 2014, CONCURR COMP-PRACT E, V26, P1715, DOI 10.1002/cpe.3112; Meier-Kolthoff JP, 2014, INT J SYST EVOL MICR, V64, P352, DOI 10.1099/ijs.0.056994-0; Meier-Kolthoff JP, 2014, STAND GENOMIC SCI, V9, DOI [10.1186/1944-3277-9-2, 10.4056/sigs.4207886]; Meier-Kolthoff JP, 2013, BMC BIOINFORMATICS, V14, DOI 10.1186/1471-2105-14-60; MELACK JM, 1974, LIMNOL OCEANOGR, V19, P743, DOI 10.4319/lo.1974.19.5.0743; Mesbah NM, 2007, MICROB ECOL, V54, P598, DOI 10.1007/s00248-006-9193-y; MORRONE JJ, 1995, ANNU REV ECOL SYST, V26, P373, DOI 10.1146/annurev.es.26.110195.002105; Mu TZ, 2016, J BIOTECHNOL, V227, P21, DOI 10.1016/j.jbiotec.2016.04.019; Muyzer G, 2011, STAND GENOMIC SCI, V5, P341, DOI 10.4056/sigs.2315092; Papke RT, 2003, ENVIRON MICROBIOL, V5, P650, DOI 10.1046/j.1462-2920.2003.00460.x; Polz MF, 2013, TRENDS GENET, V29, P170, DOI 10.1016/j.tig.2012.12.006; Pruesse E, 2007, NUCLEIC ACIDS RES, V35, P7188, DOI 10.1093/nar/gkm864; Pruesse E, 2012, BIOINFORMATICS, V28, P1823, DOI 10.1093/bioinformatics/bts252; Reno ML, 2009, P NATL ACAD SCI USA, V106, P8605, DOI 10.1073/pnas.0808945106; Richter M, 2016, BIOINFORMATICS, V32, P929, DOI 10.1093/bioinformatics/btv681; Richter M, 2009, P NATL ACAD SCI USA, V106, P19126, DOI 10.1073/pnas.0906412106; Roesler CS, 2002, LIMNOL OCEANOGR, V47, P440, DOI 10.4319/lo.2002.47.2.0440; Siddall ME, 2010, CLADISTICS, V26, P444, DOI 10.1111/j.1096-0031.2009.00295.x; SOKAL R. R., 1963, Principles of numerical taxonomy., P359; SOKAL ROBERT R., 1958, UNIV KANSAS SCI BULL, V38, P1409; Sorokin DY, 2015, CURR OPIN MICROBIOL, V25, P88, DOI 10.1016/j.mib.2015.05.004; Sorokin DY, 2014, EXTREMOPHILES, V18, P791, DOI 10.1007/s00792-014-0670-9; Sorokin DY, 2012, INT J SYST EVOL MICR, V62, P1884, DOI 10.1099/ijs.0.034504-0; Sorokin DY, 2011, FRONT MICROBIOL, V2, DOI 10.3389/fmicb.2011.00044; Sorokin DY, 2008, INT J SYST EVOL MICR, V58, P1685, DOI 10.1099/ijs.0.65654-0; Sorokin DY, 2005, FEMS MICROBIOL REV, V29, P685, DOI 10.1016/j.femsre.2004.10.005; Sorokin DY, 2005, FEMS MICROBIOL ECOL, V52, P287, DOI 10.1016/j.femsec.2005.02.012; Sorokin DY, 2004, MICROBIOL-SGM, V150, P2435, DOI 10.1099/mic.0.27015-0; Sorokin DY, 2003, INT J SYST EVOL MICR, V53, P1779, DOI 10.1099/ijs.0.02615-0; Sorokin DY, 2002, INT J SYST EVOL MICR, V52, P657, DOI 10.1099/00207713-52-2-657; Sorokin DY, 2001, APPL ENVIRON MICROB, V67, P528, DOI 10.1128/AEM.67.2.528-538.2001; Sorokin DY, 2001, ARCH MICROBIOL, V175, P94, DOI 10.1007/s002030000210; Sorokin DY, 2001, INT J SYST EVOL MICR, V51, P565, DOI 10.1099/00207713-51-2-565; Sorokin DY, 2013, PROKARYOTES PROKARYO, P530; Soucy SM, 2015, NAT REV GENET, V16, P472, DOI 10.1038/nrg3962; Spratt BG, 2001, CURR OPIN MICROBIOL, V4, P602, DOI 10.1016/S1369-5274(00)00257-5; Stackebrandt E, 2003, FOOD TECHNOL BIOTECH, V41, P17; Stackebrandt E, 2002, INT J SYST EVOL MICR, V52, P1043, DOI [10.1099/ijs.0.02360-0, 10.1099/00207713-52-3-1043]; Takaichi S, 2004, TETRAHEDRON LETT, V45, P8303, DOI 10.1016/j.tetlet.2004.09.073; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; Thompson CC, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-913; Tian RM, 2015, GENOME BIOL EVOL, V7, P2310, DOI 10.1093/gbe/evv143; Vandamme P, 2014, ANTON LEEUW INT J G, V106, P57, DOI 10.1007/s10482-014-0148-x; Ventura M, 2006, INT J SYST EVOL MICR, V56, P2783, DOI 10.1099/ijs.0.64233-0; WAYNE LG, 1987, INT J SYST BACTERIOL, V37, P463, DOI 10.1099/00207713-37-4-463; Whitaker RJ, 2003, SCIENCE, V301, P976, DOI 10.1126/science.1086909; WOOD SW, 1994, CLADISTICS, V10, P339, DOI 10.1006/clad.1994.1024; Yap WH, 1999, J BACTERIOL, V181, P5201, DOI 10.1128/JB.181.17.5201-5209.1999; Yarza P, 2008, SYST APPL MICROBIOL, V31, P241, DOI 10.1016/j.syapm.2008.07.001; Yarza P, 2014, NAT REV MICROBIOL, V12, P635, DOI 10.1038/nrmicro3330; Yarza P, 2010, SYST APPL MICROBIOL, V33, P291, DOI 10.1016/j.syapm.2010.08.001	97	23	26	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 10	2017	12	3							e0173517	10.1371/journal.pone.0173517	http://dx.doi.org/10.1371/journal.pone.0173517			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN6CJ	28282461	Green Submitted, Green Published, gold			2022-12-27	WOS:000396091800048
J	Almenrader, N; Colucci, P; De Castro, V; Valeri, D; Palmery, M; Trezza, V; Campolongo, P				Almenrader, Nicole; Colucci, Paola; De Castro, Valentina; Valeri, Daniela; Palmery, Maura; Trezza, Viviana; Campolongo, Patrizia			Effects of sevoflurane and clonidine on acid base status and long-term emotional and cognitive outcomes in spontaneously breathing rat pups	PLOS ONE			English	Article							CONGENITAL DIAPHRAGMATIC-HERNIA; CARBON-DIOXIDE; NEONATAL-RATS; THORACOSCOPIC REPAIR; ESOPHAGEAL ATRESIA; HYPOXIA-ISCHEMIA; EARLY EXPOSURE; IMMATURE RAT; BRAIN-INJURY; HYPERCAPNIA	Background Numerous experiments in rodents suggest a causative link between exposure to general anaesthetics during brain growth spurt and poor long- lasting neurological outcomes. Many of these studies have been questioned with regard of their translational value, mainly because of extremely long anaesthesia exposure. Therefore, the aim of the present study was to assess the impact of a short sevoflurane anaesthesia, alone or combined with clonidine treatment, on respiratory function in spontaneously breathing rat pups and overall effects on long- lasting emotional and cognitive functions. Methods At postnatal day (PND) 7, male Sprague Dawley rat pups were randomized into four groups and exposed to sevoflurane for one hour, to a single dose of intraperitoneal clonidine or to a combination of both and compared to a control group. Blood gas analysis was performed at the end of sevoflurane anaesthesia and after 60 minutes from clonidine or saline injection. Emotional and cognitive outcomes were evaluated in different group of animals at infancy (PND12), adolescence (PND 30 _ 40) and adulthood (PND 70 _ 90). Results Rat pups exposed to either sevoflurane or to a combination of sevoflurane and clonidine developed severe hypercapnic acidosis, but maintained normal arterial oxygenation. Emotional and cognitive outcomes were not found altered in any of the behavioural task used either at infancy, adolescence or adulthood. Conclusions Sixty minutes of sevoflurane anaesthesia in newborn rats, either alone or combined with clonidine, caused severe hypercapnic acidosis in spontaneously breathing rat pups, but was devoid of long- term behavioural dysfunctions in the present setting.	[Almenrader, Nicole; Colucci, Paola; De Castro, Valentina; Valeri, Daniela; Palmery, Maura; Campolongo, Patrizia] Sapienza Univ Rome, Dept Physiol & Pharmacol, Rome, Italy; [Almenrader, Nicole] Policlin Umberto 1, Dept Anaesthesia & Intens Care, Rome, Italy; [Trezza, Viviana] Univ Roma Tre, Sect Biomed Sci & Technol, Dept Sci, Rome, Italy	Sapienza University Rome; Sapienza University Rome; University Hospital Sapienza Rome; Italfarmaco; Roma Tre University	Campolongo, P (corresponding author), Sapienza Univ Rome, Dept Physiol & Pharmacol, Rome, Italy.	patrizia.campolongo@uniroma1.it	Campolongo, Patrizia/D-4628-2009	Campolongo, Patrizia/0000-0002-2827-8755	Sapienza University of Rome	Sapienza University of Rome	This work was supported by institutional funds from the Sapienza University of Rome. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript	Alasmi MM, 1997, PEDIATR RES, V41, P857, DOI 10.1203/00006450-199706000-00010; Bakri MH, 2015, SAUDI J ANAESTH, V9, P161, DOI 10.4103/1658-354X.152843; Bishay M, 2013, ANN SURG, V258, P895, DOI 10.1097/SLA.0b013e31828fab55; Chung W, 2015, PEDIATR ANESTH, V25, P1033, DOI 10.1111/pan.12694; DOMBROWSKI GJ, 1989, NEUROCHEM RES, V14, P667, DOI 10.1007/BF00964877; Duan X, 2014, ACTA ANAESTH SCAND, V58, P1121, DOI 10.1111/aas.12356; Fabres J, 2007, PEDIATRICS, V119, P299, DOI 10.1542/peds.2006-2434; Flick RP, 2011, PEDIATRICS, V128, pE1053, DOI 10.1542/peds.2011-0351; Fredriksson A, 2007, ANESTHESIOLOGY, V107, P427, DOI 10.1097/01.anes.0000278892.62305.9c; Fritz KI, 2005, PEDIATR RES, V57, P299, DOI 10.1203/01.PDR.0000148718.47137.9B; Hansen TG, 2016, ACTA ANAESTH SCAND, V60, P280, DOI 10.1111/aas.12678; Ing C, 2012, PEDIATRICS, V130, pE476, DOI 10.1542/peds.2011-3822; Jankov RP, 2008, ACTA PAEDIATR, V97, P1502, DOI 10.1111/j.1651-2227.2008.00933.x; Jevtovic-Todorovic V, 2013, BRIT J ANAESTH, V111, P143, DOI 10.1093/bja/aet177; Jevtovic-Todorovic V, 2003, J NEUROSCI, V23, P876, DOI 10.1523/jneurosci.23-03-00876.2003; Jovic M, 2015, J CARDIOTHOR VASC AN, V29, P178, DOI 10.1053/j.jvca.2014.05.019; Kalkman CJ, 2009, ANESTHESIOLOGY, V110, P805, DOI 10.1097/ALN.0b013e31819c7124; Kesavan K, 2014, RESP PHYSIOL NEUROBI, V201, P93, DOI 10.1016/j.resp.2014.06.015; Kohzuki M, 2006, AM J OBSTET GYNECOL, V195, P240, DOI 10.1016/j.ajog.2005.12.036; Lambert P, 2014, COCHRANE DB SYST REV, V28; Li YL, 2016, EUR J PHARMACOL, V793, P89, DOI 10.1016/j.ejphar.2016.10.036; Liu XS, 2010, NEUROBIOL LEARN MEM, V94, P461, DOI 10.1016/j.nlm.2010.08.011; Lundblad M, 2016, PEDIATR ANESTH, V26, P232, DOI 10.1111/pan.12825; Manduca A, 2015, EUR NEUROPSYCHOPHARM, V25, P1362, DOI 10.1016/j.euroneuro.2015.04.005; Mazzeo AT, 2004, PEDIATR ANESTH, V14, P596, DOI 10.1111/j.1460-9592.2004.01260.x; McCann ME, 2014, PEDIATRICS, V133, pE751, DOI 10.1542/peds.2012-0973; MCGAUGH JL, 1966, SCIENCE, V153, P1351, DOI 10.1126/science.153.3742.1351; Morena M, 2014, P NATL ACAD SCI USA, V111, P18333, DOI 10.1073/pnas.1420285111; PELLOW S, 1986, METHOD FIND EXP CLIN, V8, P557; PELLOW S, 1985, J NEUROSCI METH, V14, P149, DOI 10.1016/0165-0270(85)90031-7; Pickard A, 2014, BRIT J ANAESTH, V112, P982, DOI 10.1093/bja/aeu093; Pierro A, 2015, J PEDIATR SURG, V50, P247, DOI 10.1016/j.jpedsurg.2014.11.006; Ponten E, 2012, ACTA ANAESTH SCAND, V56, P1058, DOI 10.1111/j.1399-6576.2012.02722.x; Ren XY, 2016, J NEUROIMMUNE PHARM, V11, P238, DOI 10.1007/s11481-016-9658-9; Sanders RD, 2009, ANESTHESIOLOGY, V110, P1077, DOI 10.1097/ALN.0b013e31819daedd; Satomoto M, 2009, ANESTHESIOLOGY, V110, P628, DOI 10.1097/ALN.0b013e3181974fa2; Scattoni ML, 2009, NEUROSCI BIOBEHAV R, V33, P508, DOI 10.1016/j.neubiorev.2008.08.003; Sengupta P, 2013, INT J PREVENTIVE MED, V4, P624; Sprung J, 2012, MAYO CLIN PROC, V87, P120, DOI 10.1016/j.mayocp.2011.11.008; Stettner GM, 2011, BEHAV BRAIN RES, V221, P324, DOI 10.1016/j.bbr.2011.03.028; Stratmann G, 2009, ANESTHESIOLOGY, V110, P849, DOI 10.1097/ALN.0b013e31819c7140; Trezza V, 2008, PSYCHOPHARMACOLOGY, V198, P529, DOI 10.1007/s00213-008-1162-3; VANNUCCI RC, 1995, PEDIATRICS, V95, P868; Vannucci RC, 1997, PEDIATR RES, V42, P24, DOI 10.1203/00006450-199707000-00005; Wei Kai, 2015, J Med Case Rep, V9, P196, DOI 10.1186/s13256-015-0685-6; Weiss M, 2015, CURR OPIN ANESTHESIO, V28, P302, DOI 10.1097/ACO.0000000000000186; Weiss M, 2013, PEDIATR ANESTH, V23, P881, DOI 10.1111/pan.12200; Wills TJ, 2014, PHILOS T R SOC B, V369, DOI 10.1098/rstb.2013.0409; Wu BB, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0084622; Yuan S Z, 2001, Eur J Paediatr Neurol, V5, P29, DOI 10.1053/ejpn.2001.0401	50	6	6	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 20	2017	12	3							e0173969	10.1371/journal.pone.0173969	http://dx.doi.org/10.1371/journal.pone.0173969			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ER6VC	28319126	Green Published, Green Submitted, gold			2022-12-27	WOS:000398945800038
J	Molinero, A; Fernandez-Perez, A; Mogas, A; Giralt, M; Comes, G; Fernandez-Gayol, O; Vallejo, M; Hidalgo, J				Molinero, Amalia; Fernandez-Perez, Antonio; Mogas, Aina; Giralt, Mercedes; Comes, Gemma; Fernandez-Gayol, Olaya; Vallejo, Mario; Hidalgo, Juan			Role of muscle IL-6 in gender-specific metabolism in mice	PLOS ONE			English	Article							BROWN ADIPOSE-TISSUE; SEX-DEPENDENT MANNER; HIGH-FAT DIET; BODY-WEIGHT; SKELETAL-MUSCLE; INTERLEUKIN-6-DEFICIENT MICE; INSULIN-RESISTANCE; SECRETORY ORGAN; GLUCOSE-HOMEOSTASIS; INDUCED INCREASE	The aim of the present work was to further explore the physiological roles of muscle-derived IL-6. Adult-floxed and conditional skeletal muscle IL-6 knock out male and female mice were used to study energy expenditure (indirect calorimetry at rest and during treadmill exercise, and body temperature cycle during the light phase) and energy intake (response to fast/refeeding). We also evaluated the responses to leptin and the activity of the insulin signalling pathway in skeletal muscle and liver by phosphorylation of Akt at Ser 473. The stress response was also studied. Results indicate a relevant role of muscle IL-6 in maintaining energy homeostasis, especially in males. Absence of muscle IL-6 in male mice results in lower core body temperature in the light phase, increased respiratory exchange ratio (RER) both at rest and during exercise, increased expression of TCA cycle marked gene, citrate synthase in muscle, reduced fat storage and decreased body weight and food consumption in response to leptin. In females, muscle IL-6 deficiency increases VO2 and CO2 levels similarly. Also in contrast to males, energy expenditure (EE) measured over 48h reveals a significant elevation in female mice with muscle IL-6 deficiency; moreover, they show a modified response to fasting-refeeding and to restraint stress. The present results contribute to the understanding of the role of muscle IL-6 in male and female mouse metabolism, not only during exercise but also in the basal state and in situations where energy balance is altered.	[Molinero, Amalia; Mogas, Aina; Giralt, Mercedes; Comes, Gemma; Fernandez-Gayol, Olaya; Hidalgo, Juan] Univ Autonoma Barcelona, Fac Biosci, Inst Neurosci, Barcelona, Spain; [Molinero, Amalia; Mogas, Aina; Giralt, Mercedes; Comes, Gemma; Fernandez-Gayol, Olaya; Hidalgo, Juan] Univ Autonoma Barcelona, Fac Biosci, Dept Cellular Biol Physiol & Immunol, Barcelona, Spain; [Fernandez-Perez, Antonio; Vallejo, Mario] Univ Autonoma Madrid, CSIC, Ctr Invest Biomed Red Diabet & Enfermedades Metab, Inst Invest Biomed Alberto Sols, Madrid, Spain	Autonomous University of Barcelona; Autonomous University of Barcelona; Autonomous University of Madrid; CIBER - Centro de Investigacion Biomedica en Red; CIBERDEM; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto de Investigaciones Biomedicas Alberto Sols (IIBM)	Molinero, A (corresponding author), Univ Autonoma Barcelona, Fac Biosci, Inst Neurosci, Barcelona, Spain.; Molinero, A (corresponding author), Univ Autonoma Barcelona, Fac Biosci, Dept Cellular Biol Physiol & Immunol, Barcelona, Spain.	Amalia.Molinero@uab.es	Fernandez-Gayol, Olaya/E-5635-2014; Vallejo, Mario/ABG-4610-2020; Hidalgo, Juan/C-9082-2011; molinero, amalia/K-2147-2014; Giralt, Mercedes/K-1626-2014	Fernandez-Gayol, Olaya/0000-0002-7649-3126; Vallejo, Mario/0000-0002-6422-0323; Hidalgo, Juan/0000-0003-0921-1122; molinero, amalia/0000-0001-8661-8570; Giralt, Mercedes/0000-0002-1806-1528; Fernandez-Perez, Antonio/0000-0001-6866-5824; COMES, GEMMA/0000-0002-4074-7665	Spanish Ministry of Economy and Competitiveness (MINECO) [BFU2014-52149-R]; Instituto de Salud Carlos III;  [SAF2011-23272];  [SAF2014-56546-R];  [FPU2012-00365]	Spanish Ministry of Economy and Competitiveness (MINECO); Instituto de Salud Carlos III(Instituto de Salud Carlos IIIEuropean Commission); ; ; 	The authors are grateful to grants SAF2011-23272 and SAF2014-56546-R to JH, and Spanish Ministry of Economy and Competitiveness (MINECO grants BFU2014-52149-R) and Instituto de Salud Carlos III to M.V. CIBERDEM is an initiative of the initiative of de Salud Carlos III, Madrid, Spain". OFG acknowledges the support of fellowship FPU2012-00365.	Allen TL, 2010, DIABETOLOGIA, V53, P399, DOI 10.1007/s00125-009-1627-x; Arch JRS, 2006, INT J OBESITY, V30, P1322, DOI 10.1038/sj.ijo.0803280; Ariyoshi N, 1998, J BIOL CHEM, V273, P7610, DOI 10.1074/jbc.273.13.7610; Bastida CM, 2007, AM J PHYSIOL-ENDOC M, V292, pE1010, DOI 10.1152/ajpendo.00316.2006; Benrick A, 2009, J NEUROENDOCRINOL, V21, P620, DOI 10.1111/j.1365-2826.2009.01879.x; Bothe GWM, 2000, GENESIS, V26, P165, DOI 10.1002/(SICI)1526-968X(200002)26:2<165::AID-GENE22>3.0.CO;2-F; Butler AA, 2010, DIABETES, V59, P323, DOI 10.2337/db09-1471; Delgado-Morales R, 2012, PHYSIOL BEHAV, V105, P669, DOI 10.1016/j.physbeh.2011.10.008; Fain JN, 2004, ENDOCRINOLOGY, V145, P2273, DOI 10.1210/en.2003-1336; Faldt J, 2004, ENDOCRINOLOGY, V145, P2680, DOI 10.1210/en.2003-1319; Febbraio M, 1999, J BIOL CHEM, V274, P19055, DOI 10.1074/jbc.274.27.19055; Febbraio MA, 2003, EXERC IMMUNOL REV, V9, P34; Ferrer B, 2014, BRAIN BEHAV IMMUN, V40, P121, DOI 10.1016/j.bbi.2014.03.001; Furler SM, 2000, DIABETES, V49, P1427, DOI 10.2337/diabetes.49.9.1427; Furuhashi M, 2008, NAT REV DRUG DISCOV, V7, P489, DOI 10.1038/nrd2589; Gudiksen A, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0156460; Guerra J, 2015, CYTOKINE, V74, P145, DOI 10.1016/j.cyto.2015.04.018; Hidalgo J, 2010, BRAIN BEHAV IMMUN, V24, P119, DOI 10.1016/j.bbi.2009.09.002; Ibrahimi A, 1999, J BIOL CHEM, V274, P26761, DOI 10.1074/jbc.274.38.26761; JAMES DE, 1985, DIABETES, V34, P1049, DOI 10.2337/diabetes.34.10.1049; Jefcoate C, 2002, J CLIN INVEST, V110, P881, DOI 10.1172/JCI200216771; Kasuga M, 2006, J CLIN INVEST, V116, P1756, DOI 10.1172/JCI29189; Knudsen JG, 2015, OBESITY, V23, P1616, DOI 10.1002/oby.21139; Lenard NR, 2008, OBESITY, V16, pS11, DOI 10.1038/oby.2008.511; Li G, 2002, NEUROSCIENCE, V115, P879, DOI 10.1016/S0306-4522(02)00447-5; MALENDOWICZ LK, 1986, CELL TISSUE RES, V244, P141; Matthews VB, 2010, DIABETOLOGIA, V53, P2431, DOI 10.1007/s00125-010-1865-y; Momken I, 2016, BIOCHEM J, V474, P149; Munzberg H, 2015, METABOLISM, V64, P13, DOI 10.1016/j.metabol.2014.09.010; Navia B, 2014, ACTA PHYSIOL, V211, P585, DOI 10.1111/apha.12328; O'Neill HM, 2013, J APPL PHYSIOL, V114, P1151, DOI 10.1152/japplphysiol.00946.2012; Pan W, 2007, PEPTIDES, V28, P1317, DOI 10.1016/j.peptides.2007.04.023; Pazos P, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072339; Pedersen BK, 2007, J APPL PHYSIOL, V102, P814, DOI 10.1152/japplphysiol.01208.2006; Pedersen BK, 2013, COMPR PHYSIOL, V3, P1337, DOI 10.1002/cphy.c120033; Pedersen BK, 2012, NAT REV ENDOCRINOL, V8, P457, DOI 10.1038/nrendo.2012.49; Quintana A, 2013, BRAIN BEHAV IMMUN, V27, P162, DOI 10.1016/j.bbi.2012.10.011; Schele E, 2013, J NEUROENDOCRINOL, V25, P580, DOI 10.1111/jne.12033; Senaris RM, 2011, J NEUROENDOCRINOL, V23, P675, DOI 10.1111/j.1365-2826.2011.02158.x; Shi H, 2009, PHYSIOL BEHAV, V97, P199, DOI 10.1016/j.physbeh.2009.02.017; Stanford KI, 2016, ADIPOCYTE, V5, P153, DOI 10.1080/21623945.2016.1191307; Stanford KI, 2013, J CLIN INVEST, V123, P215, DOI 10.1172/JCI62308; Steensberg A, 2000, J PHYSIOL-LONDON, V529, P237, DOI 10.1111/j.1469-7793.2000.00237.x; Stocco DM, 2005, MOL ENDOCRINOL, V19, P2647, DOI 10.1210/me.2004-0532; Tschop MH, 2012, NAT METHODS, V9, P57, DOI [10.1038/NMETH.1806, 10.1038/nmeth.1806]; Villarroya F, 2017, NAT REV ENDOCRINOL, V13, P26, DOI 10.1038/nrendo.2016.136; Wallenius K, 2002, BIOCHEM BIOPH RES CO, V293, P560, DOI 10.1016/S0006-291X(02)00230-9; Wallenius V, 2002, NAT MED, V8, P75, DOI 10.1038/nm0102-75; Wernstedt I, 2006, AM J PHYSIOL-REG I, V291, pR551, DOI 10.1152/ajpregu.00514.2005; Zelena D, 2003, AM J PHYSIOL-ENDOC M, V285, pE1110, DOI 10.1152/ajpendo.00219.2003	50	26	26	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 20	2017	12	3							e0173675	10.1371/journal.pone.0173675	http://dx.doi.org/10.1371/journal.pone.0173675			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ER6VC	28319140	gold, Green Submitted, Green Published			2022-12-27	WOS:000398945800022
J	Kaptein, M; van Emden, R; Iannuzzi, D				Kaptein, Maurits; van Emden, Robin; Iannuzzi, Davide			Uncovering noisy social signals: Using optimization methods from experimental physics to study social phenomena	PLOS ONE			English	Article							OPTIMAL EXPERIMENTAL-DESIGN	Due to the ubiquitous presence of treatment heterogeneity, measurement error, and contextual confounders, numerous social phenomena are hard to study. Precise control of treatment variables and possible confounders is often key to the success of studies in the social sciences, yet often proves out of the realm of control of the experimenter. To amend this situation we propose a novel approach coined "lock-in feedback" which is based on a method that is routinely used in high-precision physics experiments to extract small signals out of a noisy environment. Here, we adapt the method to noisy social signals in multiple dimensions and evaluate it by studying an inherently noisy topic: the perception of (subjective) beauty. We show that the lock-in feedback approach allows one to select optimal treatment levels despite the presence of considerable noise. Furthermore, through the introduction of an external contextual shock we demonstrate that we can find relationships between noisy variables that were hitherto unknown. We therefore argue that lock-in methods may provide a valuable addition to the social scientist's experimental toolbox and we explicitly discuss a number of future applications.	[Kaptein, Maurits] Tilburg Univ, Dept Methodol & Stat, Tilburg, Netherlands; [van Emden, Robin; Iannuzzi, Davide] Vrije Univ Amsterdam, Dept Phys & Astron, Amsterdam, Netherlands; [van Emden, Robin; Iannuzzi, Davide] Vrije Univ Amsterdam, LaserLab, Amsterdam, Netherlands	Tilburg University; Vrije Universiteit Amsterdam; Vrije Universiteit Amsterdam	Kaptein, M (corresponding author), Tilburg Univ, Dept Methodol & Stat, Tilburg, Netherlands.	m.c.kaptein@uvt.nl	van Emden, Robin/L-3122-2016	van Emden, Robin/0000-0001-5820-8638; Kaptein, Maurits/0000-0002-6316-7524	European Research Council [615170]; Stichting voor Fundamenteel Onderzoek der Materie (FOM); Netherlands Organization for Scientific Research (NWO)	European Research Council(European Research Council (ERC)European Commission); Stichting voor Fundamenteel Onderzoek der Materie (FOM)(FOM (The Netherlands)); Netherlands Organization for Scientific Research (NWO)(Netherlands Organization for Scientific Research (NWO))	DI acknowledges the support of the European Research Council (grant agreement n. 615170) and of the Stichting voor Fundamenteel Onderzoek der Materie (FOM), which is financially supported by the Netherlands Organization for Scientific Research (NWO).	Aarts AA, 2015, SCIENCE, V349, DOI 10.1126/science.aac4716; Agarwal Alekh, 2011, ADV NEURAL INFORM PR, V24, P1035; Allen TT, 2003, J ROY STAT SOC C-APP, V52, P103, DOI 10.1111/1467-9876.00392; Atkinson AC., 2007, OPTIMUM EXPT DESIGNS; Bassler D, 2010, JAMA-J AM MED ASSOC, V303, P1180, DOI 10.1001/jama.2010.310; Buhrmester M, 2011, PERSPECT PSYCHOL SCI, V6, P3, DOI 10.1177/1745691610393980; Chow SC, 2008, ORPHANET J RARE DIS, V3, DOI 10.1186/1750-1172-3-11; DeVore S, 2016, AM J PHYS, V84, P52, DOI 10.1119/1.4934957; Galton F., 1879, J ANTHR I G B IRL, V8, P132, DOI 10.2307/2841021; Goodman SN, 2016, SCI TRANSL MED, V8, DOI 10.1126/scitranslmed.aaf5027; Hinz O, 2011, MIS QUART, V35, P81; HUBER J, 1982, J CONSUM RES, V9, P90, DOI 10.1086/208899; Huber J, 2014, J MARKETING RES, V51, P520, DOI 10.1509/jmr.14.0208; Ishizu T, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021852; John LK, 2012, PSYCHOL SCI, V23, P524, DOI 10.1177/0956797611430953; Jones, 2011, OPTIMAL DESIGN EXPT, DOI DOI 10.1002/9781119974017; Kaptein M, 2016, ARXIV160206700; Kaptein M, 2012, J INTERACT MARK, V26, P176, DOI 10.1016/j.intmar.2012.02.002; Kaptein MC, 2016, PALGR COMMUN, V2, DOI 10.1057/palcomms.2016.82; LANGLOIS JH, 1990, PSYCHOL SCI, V1, P115, DOI 10.1111/j.1467-9280.1990.tb00079.x; Marschner IC, 2007, PHARM STAT, V6, P23, DOI 10.1002/pst.240; McClelland GH, 1997, PSYCHOL METHODS, V2, P3, DOI 10.1037/1082-989X.2.1.3; Meade ML, 1983, LOCK IN AMPLIFIERS P, V1; Myung J, 2009, P 2 INT WORKSH SEQ M, P1; Myung JI, 2013, J MATH PSYCHOL, V57, P53, DOI 10.1016/j.jmp.2013.05.005; Myung JI, 2009, PSYCHOL REV, V116, P499, DOI 10.1037/a0016104; Nosek BA, 2014, SOC PSYCHOL-GERMANY, V45, P137, DOI 10.1027/1864-9335/a000192; Paolacci G, 2010, JUDGM DECIS MAK, V5, P411; Rouder JN, 2011, PSYCHON B REV, V18, P682, DOI 10.3758/s13423-011-0088-7; Simonsohn U, 2014, J EXP PSYCHOL GEN, V143, P534, DOI 10.1037/a0033242; Van Bavel JJ, 2016, P NATL ACAD SCI USA, V113, P6454, DOI 10.1073/pnas.1521897113; van Emden R, 2016, REPLICATION DATA UNC; van Gelder T, 1998, BEHAV BRAIN SCI, V21, P615, DOI 10.1017/S0140525X98001733; Wagenmakers E, 2011, J PERS SOC PSYCHOL, V100, P246; Wu JL, 2010, HUM MOVEMENT SCI, V29, P882, DOI 10.1016/j.humov.2010.03.009; Yang S, 2014, J MARKETING RES, V51, P508, DOI 10.1509/jmr.14.0020; Zhang SN, 2010, J MATH PSYCHOL, V54, P499, DOI 10.1016/j.jmp.2010.08.002	39	0	0	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 17	2017	12	3							e017418	10.1371/journal.pone.0174182	http://dx.doi.org/10.1371/journal.pone.0174182			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EO5CJ	28306728	gold, Green Published, Green Submitted			2022-12-27	WOS:000396710300024
J	Curbelo, J; Bueno, SL; Galvan-Roman, JM; Ortega-Gomez, M; Rajas, O; Fernandez-Jimenez, G; Vega-Piris, L; Rodriguez-Salvanes, F; Arnalich, B; Diaz, A; Costa, R; de la Fuente, H; Lancho, A; Suarez, C; Ancochea, J; Aspa, J				Curbelo, Jose; Luquero Bueno, Sergio; Maria Galvan-Roman, Jose; Ortega-Gomez, Mara; Rajas, Olga; Fernandez-Jimenez, Guillermo; Vega-Piris, Lorena; Rodriguez-Salvanes, Francisco; Arnalich, Belen; Diaz, Ana; Costa, Ramon; de la Fuente, Hortensia; Lancho, Angel; Suarez, Carmen; Ancochea, Julio; Aspa, Javier			Inflammation biomarkers in blood as mortality predictors in community-acquired pneumonia admitted patients: Importance of comparison with neutrophil count percentage or neutrophil-lymphocyte ratio	PLOS ONE			English	Article							LONG-TERM MORTALITY; PRO-ADRENOMEDULLIN; SEVERITY; PROADRENOMEDULLIN; SURVIVAL; HOSPITALIZATION; METAANALYSIS; ASSOCIATION; RESECTION; OUTCOMES	Introduction The increase and persistence of inflammation in community-acquired pneumonia (CAP) patients can lead to higher mortality. Biomarkers capable of measuring this inadequate inflammatory response are likely candidates to be related with a bad outcome. We investigated the association between concentrations of several inflammatory markers and mortality of CAP patients. Material and methods This was a prospective study of hospitalised CAP patients in a Spanish university hospital. Blood tests upon admittance and in the early-stage evolution (72-120 hours) were carried out, where C-reactive protein, procalcitonin, proadrenomedullin, copeptin, white blood cell, Lymphocyte Count Percentage (LCP), Neutrophil Count Percentage (NCP) and Neutrophil/Lymphocyte Ratio (NLR) were measured. The outcome variable was mortality at 30 and 90 days. Statistical analysis included logistic regression, ROC analysis and area-under-curve test. Results 154 hospitalised CAP patients were included. Patients who died during follow-up had higher levels of procalcitonin, copeptin, proadrenomedullin, lower levels of LCP, and higher of NCP and NLR. Remarkably, multivariate analysis showed a relationship between NCP and mortality, regardless of age, severity of CAP and comorbidities. AUC analysis showed that NLR and NCP at admittance and during early-stage evolution achieved a good diagnostic power. ROC test for NCP and NLR were similar to those of the novel serum biomarkers analysed. Conclusions NLR and NCP, are promising candidate predictors of mortality for hospitalised CAP patients, and both are cheaper, easier to perform, and at least as reliable as the new serum biomarkers. Future implementation of new biomarkers would require comparison not only with classic inflammatory parameters like White Blood Cell count but also with NLR and NCP.	[Curbelo, Jose; Costa, Ramon; Suarez, Carmen] Hosp Univ La Princesa, Inst Invest Sanitaria, Dept Internal Med, Madrid, Spain; [Luquero Bueno, Sergio; Ortega-Gomez, Mara] Hosp Univ La Princesa, Inst Invest Sanitaria, Biobank, Madrid, Spain; [Maria Galvan-Roman, Jose; de la Fuente, Hortensia; Lancho, Angel] Hosp Univ La Princesa, Inst Invest Sanitaria, Dept Immunol, Madrid, Spain; [Rajas, Olga; Ancochea, Julio; Aspa, Javier] Hosp Univ La Princesa, Inst Invest Sanitaria, Dept Pneumol, Madrid, Spain; [Fernandez-Jimenez, Guillermo] Hosp Univ La Princesa, Inst Invest Sanitaria, Clin Informat Unit, Madrid, Spain; [Vega-Piris, Lorena; Rodriguez-Salvanes, Francisco] Hosp Univ La Princesa, Inst Invest Sanitaria, Methodol Unit, Madrid, Spain; [Arnalich, Belen] Hosp Henares, Dept Pneumol, Madrid, Spain; [Diaz, Ana] Hosp Univ La Princesa, Inst Invest Sanitaria, Dept Clin Anal, Madrid, Spain		Aspa, J (corresponding author), Hosp Univ La Princesa, Inst Invest Sanitaria, Dept Pneumol, Madrid, Spain.	jaspa@separ.es	Lancho Sanchez, Angel/AFT-9963-2022; de la Fuente, Hortensia/J-9890-2014	Lancho Sanchez, Angel/0000-0001-7962-6038; de la Fuente, Hortensia/0000-0001-8708-753X; Luquero-Bueno, Sergio/0000-0003-4517-4082; Ortega, Mara/0000-0003-3059-0147; Curbelo, Jose/0000-0002-0809-9944; Ancochea, julio/0000-0001-7451-4133; Galvan Roman, Jose Maria/0000-0001-9260-8141	Institute de Salud Carlos III (ES) - European Regional Development Fund [PI 12/01142, PI 15/01231]; Spanish Respiratory Society - SEPAR	Institute de Salud Carlos III (ES) - European Regional Development Fund; Spanish Respiratory Society - SEPAR	This work was funded by the Institute de Salud Carlos III (ES) - European Regional Development Fund - PI 12/01142 and PI 15/01231; and Spanish Respiratory Society - SEPAR 2013.	Adamuz J, 2014, J INFECTION, V68, P534, DOI 10.1016/j.jinf.2014.02.006; Albrich WC, 2011, BMC INFECT DIS, V11, DOI 10.1186/1471-2334-11-112; Bello S, 2015, RESP MED, V109, P1193, DOI 10.1016/j.rmed.2015.07.003; Bozbay M, 2015, J CRIT CARE, V30, P822, DOI 10.1016/j.jcrc.2015.04.115; BRANCATI FL, 1993, LANCET, V342, P30, DOI 10.1016/0140-6736(93)91887-R; Cavallazzi R, 2014, RESP MED, V108, P1569, DOI 10.1016/j.rmed.2014.09.018; Chalmers JD, 2010, THORAX, V65, P878, DOI 10.1136/thx.2009.133280; Christ-Crain M, 2006, CRIT CARE, V10, DOI 10.1186/cc4955; Courtais C, 2013, AM J EMERG MED, V31, P215, DOI 10.1016/j.ajem.2012.07.017; de Jager CPC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046561; Espana PP, 2015, J INFECTION, V70, P457, DOI 10.1016/j.jinf.2014.12.003; Yandiola PPE, 2009, CHEST, V135, P1572, DOI 10.1378/chest.08-2179; Fine MJ, 1997, NEW ENGL J MED, V336, P243, DOI 10.1056/NEJM199701233360402; Halazun KJ, 2008, EJSO-EUR J SURG ONC, V34, P55, DOI 10.1016/j.ejso.2007.02.014; Han Song Yi, 2016, Korean J Pediatr, V59, P139, DOI 10.3345/kjp.2016.59.3.139; Huang DT, 2009, CHEST, V136, P823, DOI 10.1378/chest.08-1981; Kolditz M, 2012, RESP MED, V106, P1320, DOI 10.1016/j.rmed.2012.06.008; Kruger S, 2010, AM J RESP CRIT CARE, V182, P1426, DOI 10.1164/rccm.201003-0415OC; Lim WS, 2003, THORAX, V58, P377, DOI 10.1136/thorax.58.5.377; Mandell LA, 2007, CLIN INFECT DIS, V44, pS27, DOI 10.1086/511159; National Institute for Health and Care Excellence (NICE), 2015, GUID GUID; Rajas O, 2014, BMC PULM MED, V14, DOI 10.1186/1471-2466-14-197; Sarraf KM, 2009, J THORAC CARDIOV SUR, V137, P425, DOI 10.1016/j.jtcvs.2008.05.046; Schuetz P, 2011, EUR RESPIR J, V37, P384, DOI 10.1183/09031936.00035610; SOLOMON CG, 2014, NEW ENGL J MED, V370, P543; Viasus D, 2016, J INFECTION, V72, P273, DOI 10.1016/j.jinf.2016.01.002; Yende S, 2007, J AM GERIATR SOC, V55, P518, DOI 10.1111/j.1532-5415.2007.01100.x; Zhydkov A, 2015, CLIN CHEM LAB MED CC, V53	28	77	82	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 16	2017	12	3							e0173947	10.1371/journal.pone.0173947	http://dx.doi.org/10.1371/journal.pone.0173947			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN9KE	28301543	gold, Green Submitted, Green Published			2022-12-27	WOS:000396318300100
J	Giuliano, L; Cicero, CE; Gomez, EBC; Padilla, S; Bruno, E; Camargo, M; Marin, B; Sofia, V; Preux, PM; Strohmeyer, M; Bartoloni, A; Nicoletti, A				Giuliano, Loretta; Cicero, Calogero Edoardo; Crespo Gomez, Elizabeth Blanca; Padilla, Sandra; Bruno, Elisa; Camargo, Mario; Marin, Benoit; Sofia, Vito; Preux, Pierre-Marie; Strohmeyer, Marianne; Bartoloni, Alessandro; Nicoletti, Alessandra			A screening questionnaire for convulsive seizures: A three-stage field-validation in rural Bolivia	PLOS ONE			English	Article							ORGANIZATION GLOBAL CAMPAIGN; EPILEPSY/INTERNATIONAL BUREAU; INTERNATIONAL LEAGUE; EPILEPSY; POPULATION; HEALTH; PREVALENCE; METHODOLOGY; DIAGNOSIS; MORTALITY	Introduction Epilepsy is one of the most common neurological diseases in Latin American Countries (LAC) and epilepsy associated with convulsive seizures is the most frequent type. Therefore, the detection of convulsive seizures is a priority, but a validated Spanish-language screening tool to detect convulsive seizures is not available. We performed a field validation to evaluate the accuracy of a Spanish-language questionnaire to detect convulsive seizures in rural Bolivia using a three-stage design. The questionnaire was also administered faceto- face, using a two-stage design, to evaluate the difference in accuracy. Methods The study was carried out in the rural communities of the Gran Chaco region. The questionnaire consists of a single screening question directed toward the householders and a confirmatory section administered face-to-face to the index case. Positive subjects underwent a neurological examination to detect false positive and true positive subjects. To estimate the proportion of false negative, a random sample of about 20% of the screened negative underwent a neurological evaluation. Results 792 householders have been interviewed representing a population of 3,562 subjects (52.2% men; mean age 24.5 +/- 19.7 years). We found a sensitivity of 76.3% (95% CI 59.8 +/- 88.6) with a specificity of 99.6% (95% CI 99.4 +/- 99.8). The two-stage design showed only a slightly higher sensitivity respect to the three-stage design. Conclusion Our screening tool shows a good accuracy and can be easily used by trained health workers to quickly screen the population of the rural communities of LAC through the householders using a three-stage design.	[Giuliano, Loretta; Cicero, Calogero Edoardo; Sofia, Vito; Nicoletti, Alessandra] Univ Catania, Sect Neurosci, Dept Med & Surg Sci & Adv Technol GF Ingrassia, Catania, Italy; [Crespo Gomez, Elizabeth Blanca] Hosp Univ Hernandez Vera, Santa Cruz, Bolivia; [Padilla, Sandra] Ctr Anthropol Res Teko Guarani, Gutierrez, Bolivia; [Bruno, Elisa] Guys & St Thomas NHS Fdn Trust, Dept Neurol, London, England; [Camargo, Mario] Bolivian League Epilepsy, Santa Cruz, Bolivia; [Marin, Benoit; Preux, Pierre-Marie] INSERM, Trop Neuroepidemiol, U1094, Limoges, France; [Strohmeyer, Marianne; Bartoloni, Alessandro] Univ Florence, Dept Expt & Clin Med, Infect & Trop Dis Unit, Florence, Italy	University of Catania; Guy's & St Thomas' NHS Foundation Trust; Institut National de la Sante et de la Recherche Medicale (Inserm); University of Florence	Nicoletti, A (corresponding author), Univ Catania, Sect Neurosci, Dept Med & Surg Sci & Adv Technol GF Ingrassia, Catania, Italy.	anicolet@unict.it	Giuliano, Loretta/AAA-4326-2022; Preux, Pierre-Marie/N-3538-2019; Nicoletti, Alessandra/K-4486-2018; BARTOLONI, ALESSANDRO/K-3403-2018; Bruno, Elisa/P-4317-2018; Cicero, Calogero Edoardo CE/K-4055-2018; PREUX, Pierre-Marie/B-8393-2014; MARIN, Benoit/E-2356-2015; MARIN, Benoit/HHZ-4976-2022	Giuliano, Loretta/0000-0003-2512-6972; Preux, Pierre-Marie/0000-0002-2171-2977; Nicoletti, Alessandra/0000-0001-6757-340X; BARTOLONI, ALESSANDRO/0000-0001-9758-1523; Bruno, Elisa/0000-0001-8166-1190; Cicero, Calogero Edoardo CE/0000-0002-8647-8851; PREUX, Pierre-Marie/0000-0002-2171-2977; MARIN, Benoit/0000-0001-8857-0910; MARIN, Benoit/0000-0001-8857-0910; Crespo Gomez, Elizabeth Blanca/0000-0002-8654-3705	Integrated Regional Project (IRP) of Tuscany Region	Integrated Regional Project (IRP) of Tuscany Region	The study was funded by the Integrated Regional Project (IRP) 2013, of Tuscany Region "Support and technical assistance to the implementation of the system de Salud of the Plurinational State of Bolivia: a pilot project in the region of Chaco". The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anand K, 2005, EPILEPSIA, V46, P743, DOI 10.1111/j.1528-1167.2005.41104.x; [Anonymous], 1981, Epilepsia, V22, P489; [Anonymous], 1993, EPILEPSIA, V34, P592; [Anonymous], 2002, Epilepsia, V43 Suppl 6, P42; [Anonymous], STARD 2015 UPD LIST; Bruno E, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0139108; Bruno E, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002480; Bruno E, 2012, EPILEPSY BEHAV, V25, P131, DOI 10.1016/j.yebeh.2012.07.011; Bruno E, 2011, EPILEPSY BEHAV, V22, P346, DOI 10.1016/j.yebeh.2011.07.012; Buderer NMF, 1996, ACAD EMERG MED, V3, P895, DOI 10.1111/j.1553-2712.1996.tb03538.x; Cameron A, 2012, EPILEPSIA, V53, P962, DOI 10.1111/j.1528-1167.2012.03446.x; deBittencourt PRM, 1996, EPILEPSIA, V37, P1128; deBittencourt PRM, 1996, EPILEPSIA, V37, P1121, DOI 10.1111/j.1528-1157.1996.tb01035.x; Diagana M, 2006, Bull Soc Pathol Exot, V99, P103; Edwards T, 2008, LANCET NEUROL, V7, P50, DOI 10.1016/S1474-4422(07)70292-2; Hajian-Tilaki K, 2014, J BIOMED INFORM, V48, P193, DOI 10.1016/j.jbi.2014.02.013; Health WHOD of M, 1990, IN SUPP PEOPL EP; Keezer MR, 2014, EPILEPSIA, V55, P1772, DOI 10.1111/epi.12811; Lhatoo SD, 2001, ANN NEUROL, V49, P336; Meyer AC, 2010, B WORLD HEALTH ORGAN, V88, P260, DOI 10.2471/BLT.09.064147; Murray CJL, 2012, LANCET, V380, P2197, DOI 10.1016/S0140-6736(12)61689-4; Ngugi AK, 2012, EMERG THEMES EPIDEMI, V9, DOI 10.1186/1742-7622-9-8; Ngugi AK, 2010, EPILEPSIA, V51, P883, DOI 10.1111/j.1528-1167.2009.02481.x; Nicoletti A, 1999, NEUROLOGY, V53, P2064, DOI 10.1212/WNL.53.9.2064; Nicoletti A, 2009, EPILEPSIA, V50, P2199, DOI 10.1111/j.1528-1167.2009.02174.x; PLACENCIA M, 1992, BRAIN, V115, P783, DOI 10.1093/brain/115.3.783; Quattrocchi G, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001775; Quet F, 2011, NEUROEPIDEMIOLOGY, V36, P194, DOI 10.1159/000327496; SENANAYAKE N, 1993, B WORLD HEALTH ORGAN, V71, P247; WHO, 2015, DIAGN CONV EP NONSP	30	13	13	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 16	2017	12	3							e0173945	10.1371/journal.pone.0173945	http://dx.doi.org/10.1371/journal.pone.0173945			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN9KE	28301557	Green Published, Green Submitted, gold			2022-12-27	WOS:000396318300099
J	McMahon, LA; Rachlow, JL; Shipley, LA; Forbey, JS; Johnson, TR; Olsoy, PJ				McMahon, Laura A.; Rachlow, Janet L.; Shipley, Lisa A.; Forbey, Jennifer S.; Johnson, Timothy R.; Olsoy, Peter J.			Evaluation of micro-GPS receivers for tracking small-bodied mammals	PLOS ONE			English	Article							GLOBAL POSITIONING SYSTEM; ACTIVITY PATTERNS; HABITAT USE; THERMAL ENVIRONMENT; COLLAR PERFORMANCE; HOME-RANGE; 3 BRANDS; TELEMETRY; MOVEMENT; TEMPERATURE	GPS telemetry markedly enhances the temporal and spatial resolution of animal location data, and recent advances in micro-GPS receivers permit their deployment on small mammals. One such technological advance, snapshot technology, allows for improved battery life by reducing the time to first fix via postponing recovery of satellite ephemeris (satellite location) data and processing of locations. However, no previous work has employed snapshot technology for small, terrestrial mammals. We evaluated performance of two types of micro-GPS (< 20 g) receivers (traditional and snapshot) on a small, semi-fossorial lagomorph, the pygmy rabbit (Brachylagus idahoensis), to understand how GPS errors might influence fine-scale assessments of space use and habitat selection. During stationary tests, microtopography (i. e., burrows) and satellite geometry had the largest influence on GPS fix success rate (FSR) and location error (LE). There was no difference between FSR while animals wore the GPS collars above ground (determined via light sensors) and FSR generated during stationary, above-ground trials, suggesting that animal behavior other than burrowing did not markedly influence micro-GPS errors. In our study, traditional micro-GPS receivers demonstrated similar FSR and LE to snapshot receivers, however, snapshot receivers operated inconsistently due to battery and software failures. In contrast, the initial traditional receivers deployed on animals experienced some breakages, but a modified collar design consistently functioned as expected. If such problems were resolved, snapshot technology could reduce the tradeoff between fix interval and battery life that occurs with traditional micro-GPS receivers. Our results suggest that micro-GPS receivers are capable of addressing questions about space use and resource selection by small mammals, but that additional techniques might be needed to identify use of habitat structures (e. g., burrows, tree cavities, rock crevices) that could affect micro-GPS performance and bias study results.	[McMahon, Laura A.; Rachlow, Janet L.] Univ Idaho, Dept Fish & Wildlife Sci, Moscow, ID 83843 USA; [Shipley, Lisa A.; Olsoy, Peter J.] Washington State Univ, Sch Environm, Pullman, WA 99164 USA; [Forbey, Jennifer S.] Boise State Univ, Dept Biol Sci, Boise, ID 83725 USA; [Johnson, Timothy R.] Univ Idaho, Dept Stat Sci, Moscow, ID 83843 USA	Idaho; University of Idaho; Washington State University; Idaho; Boise State University; Idaho; University of Idaho	McMahon, LA (corresponding author), Univ Idaho, Dept Fish & Wildlife Sci, Moscow, ID 83843 USA.	mcma2967@vandals.uidaho.edu		Sorensen Forbey, Jennifer/0000-0001-6069-4049; Olsoy, Peter/0000-0002-8785-0459	National Science Foundation [DEB-1146166, DEB-1146368, DEB-1146194]; Berklund Graduate Assistantship; University of Idaho; Bureau of Land Management; US Forest Service; Division Of Environmental Biology [1146194, 1146166] Funding Source: National Science Foundation	National Science Foundation(National Science Foundation (NSF)); Berklund Graduate Assistantship; University of Idaho; Bureau of Land Management; US Forest Service(United States Department of Agriculture (USDA)United States Forest Service); Division Of Environmental Biology(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	Funding and other support was provided by the National Science Foundation (DEB-1146166 to JLR, DEB-1146368 to LAS, DEB-1146194 to JSF), Berklund Graduate Assistantship, University of Idaho, Bureau of Land Management, and US Forest Service. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams AC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065763; Arnold TW, 2010, J WILDLIFE MANAGE, V74, P1175, DOI 10.2193/2009-367; Bates D, 2015, J STAT SOFTW, V67, P1, DOI 10.18637/jss.v067.i01; BLACKBURN TM, 1994, OIKOS, V70, P127, DOI 10.2307/3545707; Blackie HM, 2010, J WILDLIFE MANAGE, V74, P1911, DOI 10.2193/2009-412; Booth DT, 2006, ENVIRON MONIT ASSESS, V123, P97, DOI 10.1007/s10661-005-9164-7; Bowman JL, 2000, WILDLIFE SOC B, V28, P141; Bradshaw CJA, 2007, ECOL APPL, V17, P628, DOI 10.1890/06-0964; Brown DD, 2012, WILDLIFE SOC B, V36, P139, DOI 10.1002/wsb.111; Burnham K.P., 2002, PRACTICAL INFORM THE, V2nd ed., DOI [DOI 10.1007/B97636, 10.1007/b97636]; Cain JW, 2005, WILDLIFE SOC B, V33, P926, DOI 10.2193/0091-7648(2005)33[926:IOTAGF]2.0.CO;2; Cargnelutti B, 2007, J WILDLIFE MANAGE, V71, P1380, DOI 10.2193/2006-257; CEDERLUND GN, 1988, J WILDLIFE MANAGE, V52, P336, DOI 10.2307/3801246; D'Eon RG, 2005, J APPL ECOL, V42, P383, DOI 10.1111/j.1365-2664.2005.01010.x; D'Eon RG, 2002, WILDLIFE SOC B, V30, P430; Di Orio AP, 2003, WILDLIFE SOC B, V31, P372; Dussault C, 1999, WILDLIFE SOC B, V27, P965; Dussault C, 2001, WILDLIFE SOC B, V29, P171; Feierabend D, 2014, J MAMMAL, V95, P525, DOI 10.1644/13-MAMM-A-199; Frair JL, 2010, PHILOS T R SOC B, V365, P2187, DOI 10.1098/rstb.2010.0084; Frair JL, 2004, J APPL ECOL, V41, P201, DOI 10.1111/j.0021-8901.2004.00902.x; Glasby L, 2013, EUR J WILDLIFE RES, V59, P915, DOI 10.1007/s10344-013-0770-3; Graves TA, 2006, J WILDLIFE MANAGE, V70, P844, DOI 10.2193/0022-541X(2006)70[844:UTCOMG]2.0.CO;2; GREEN J S, 1980, Mammalian Species, P1, DOI 10.2307/3503856; HARESTAD AS, 1979, ECOLOGY, V60, P389, DOI 10.2307/1937667; Hazel J, 2009, J EXP MAR BIOL ECOL, V374, P58, DOI 10.1016/j.jembe.2009.04.009; Hebblewhite M, 2007, J WILDLIFE MANAGE, V71, P2026, DOI 10.2193/2006-238; Lewis JS, 2007, J APPL ECOL, V44, P663, DOI 10.1111/j.1365-2664.2007.01286.x; Long RA, 2005, J MAMMAL, V86, P314, DOI 10.1644/BRG-224.1; Moen R, 1997, J WILDLIFE MANAGE, V61, P530, DOI 10.2307/3802612; Moen R, 1996, J WILDLIFE MANAGE, V60, P659, DOI 10.2307/3802085; Moriarty KM, 2015, WILDLIFE SOC B, V39, P349, DOI 10.1002/wsb.524; Murray IW, 2012, CAN J ZOOL, V90, P1171, DOI 10.1139/Z2012-084; O'Gorman EJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051925; Oleksy R, 2015, GLOB ECOL CONSERV, V3, P678, DOI 10.1016/j.gecco.2015.02.012; Parsons MA, 2016, ECOSPHERE, V7, DOI 10.1002/ecs2.1334; R Development Core Team, 2015, R LANG ENV STAT COMP; Recio MR, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028225; Recio MR, 2010, NEW ZEAL J ECOL, V34, P288; REMPEL RS, 1995, J WILDLIFE MANAGE, V59, P543, DOI 10.2307/3802461; Sanchez DM, 2008, J WILDLIFE MANAGE, V72, P1304, DOI 10.2193/2007-225; Sanchez DM, 2007, PROQUEST; Sharpe PB, 1999, J THERM BIOL, V24, P265, DOI 10.1016/S0306-4565(99)00021-2; Sikes RS, 2016, J MAMMAL, V97, P663, DOI 10.1093/jmammal/gyw078; Stevenson CD, 2013, ECOL EVOL, V3, P2350, DOI 10.1002/ece3.638; Sutherland GD, 2000, CONSERV ECOL, V4, DOI 10.5751/es-00184-040116; Tobler MW, 2009, J TROP ECOL, V25, P217, DOI 10.1017/S0266467409005811; Tomkiewicz SM, 2010, PHILOS T R SOC B, V365, P2163, DOI 10.1098/rstb.2010.0090; Tsoar Asaf, 2011, Proc Natl Acad Sci U S A, V108, pE718, DOI 10.1073/pnas.1107365108; Visscher DR, 2006, ECOGRAPHY, V29, P458; WILSON D. E., 1996, MEASURING MONITORING	51	12	13	2	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 16	2017	12	3							e0173185	10.1371/journal.pone.0173185	http://dx.doi.org/10.1371/journal.pone.0173185			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN9KE	28301495	Green Published, gold, Green Submitted			2022-12-27	WOS:000396318300027
J	Mortoza, LPD; Piqueira, JRC				Mortoza, Leticia P. D.; Piqueira, Jose R. C.			Measuring complexity in Brazilian economic crises	PLOS ONE			English	Article								Capital flows are responsible for a strong influence on the foreign exchange rates and stock prices macroeconomic parameters. In volatile economies, capital flows can change due to several types of social, political and economic events, provoking oscillations on these parameters, which are recognized as economic crises. This work aims to investigate how these two macroeconomic variables are related with crisis events by using the traditional complex measures due to Lopez-Mancini-Calbet (LMC) and to Shiner-Davison-Landsberg (SDL), that can be applied to any temporal series. Here, Ibovespa (Bovespa Stock Exchange main Index) and the "dollar-real" parity are the background for calculating the LMC and SDL complexity measures. By analyzing the temporal evolution of these measures, it is shown that they might be related to important events that occurred in the Brazilian economy.	[Mortoza, Leticia P. D.; Piqueira, Jose R. C.] Univ Sao Paulo, Escola Politecn, Lab Automacaoe Controle, Ave Prof Luciano Gualberto,Travessa 3-158, Sao Paulo, Brazil	Universidade de Sao Paulo	Piqueira, JRC (corresponding author), Univ Sao Paulo, Escola Politecn, Lab Automacaoe Controle, Ave Prof Luciano Gualberto,Travessa 3-158, Sao Paulo, Brazil.	piqueira@lac.usp.br	Piqueira, Jose/G-5864-2012					[Anonymous], 2015, COMPLEXITY EC; Boudias R., 2015, INT EC, V143, P80, DOI [10.1016/j.inteco.2015.05.001, DOI 10.1016/J.INTECO.2015.05.001]; Bunde A., 2002, SCI DISASTERS; Piqueira JRC, 2009, COMMUN NONLINEAR SCI, V14, P2581, DOI 10.1016/j.cnsns.2008.10.003; Chapman T., 2003, QUANTITATIVE FINANCE, V3, pC88; Erdi P., 2008, COMPLEXITY EXPLAINED; Kolmogorov A. N., 1965, PROBL PEREDACHI INF, V1, P3; LIU T, 1992, J APPL ECONOM, V7, pS25, DOI 10.1002/jae.3950070504; LopezRuiz R, 1995, PHYS LETT A, V209, P321, DOI 10.1016/0375-9601(95)00867-5; Mandelbrot BB, 2009, COMPLEXITY, V14, P55, DOI 10.1002/cplx.20264; Morin Edgar, 2011, INTRO PENSAMIENTO CO; Northrop R.B., 2010, INTRO COMPLEXITY COM; Piqueira JRC, 2012, COMMUN NONLINEAR SCI, V17, P1690, DOI 10.1016/j.cnsns.2011.08.031; Rani TGGE, 2016, FRACTALS, V24, DOI 10.1142/S0218348X16500481; Shannon C.E., 1963, MATH THEORY COMMUNIC; Shiner JS, 1999, PHYS REV E, V59, P1459, DOI 10.1103/PhysRevE.59.1459; Tabak B., 2006, BANCO CENTRAL BRASIL, V124, P1; Machado JAT, 2013, NONLINEAR DYNAM, V74, P287, DOI 10.1007/s11071-013-0965-x; Waldrop M.M., 1992, COMPLEXITY EMERGING	19	6	6	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 16	2017	12	3							e0173280	10.1371/journal.pone.0173280	http://dx.doi.org/10.1371/journal.pone.0173280			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN9KE	28301506	Green Published, Green Submitted, gold			2022-12-27	WOS:000396318300030
J	Qu, XZ; Sheng, JY; Shen, LY; Su, J; Xu, YJ; Xie, Q; Wu, Y; Zhang, XW; Sun, LK				Qu, Xianzhi; Sheng, Jiyao; Shen, Luyan; Su, Jing; Xu, Yunjie; Xie, Qi; Wu, Yao; Zhang, Xuewen; Sun, Liankun			Autophagy inhibitor chloroquine increases sensitivity to cisplatin in QBC939 cholangiocarcinoma cells by mitochondrial ROS	PLOS ONE			English	Article							PENTOSE-PHOSPHATE PATHWAY; LUNG-CANCER CELLS; OXIDATIVE STRESS; GLUCOSE-METABOLISM; RESISTANCE; ACTIVATION; GROWTH; DEATH; DEGRADATION; INDUCTION	The tumor cells have some metabolic characteristics of the original tissues, and the metabolism of the tumor cells is closely related to autophagy. However, the mechanism of autophagy and metabolism in chemotherapeutic drug resistance is still poorly understood. In this study, we investigated the role and mechanism of autophagy and glucose metabolism in chemotherapeutic drug resistance by using cholangiocarcinoma QBC939 cells with primary cisplatin resistance and hepatocellular carcinoma HepG2 cells. We found that QBC939 cells with cisplatin resistance had a higher capacity for glucose uptake, consumption, and lactic acid generation, and higher activity of the pentose phosphate pathway compared with HepG2 cells, and the activity of PPP was further increased after cisplatin treatment in QBC939 cells. It is suggested that there are some differences in the metabolism of glucose in hepatocellular carcinoma and cholangiocarcinoma cells, and the activation of PPP pathway may be related to the drug resistance. Through the detection of autophagy substrates p62 and LC3, found that QBC939 cells have a higher flow of autophagy, autophagy inhibitor chloroquine can significantly increase the sensitivity of cisplatin in cholangiocarcinoma cells compared with hepatocellular carcinoma HepG2 cells. The mechanism may be related to the inhibition of QBC939 cells with higher activity of the PPP, the key enzyme G6PDH, which reduces the antioxidant capacity of cells and increases intracellular ROS, especially mitochondrial ROS. Therefore, we hypothesized that autophagy and the oxidative stress resistance mediated by glucose metabolism may be one of the causes of cisplatin resistance in cholangiocarcinoma cells. It is suggested that according to the metabolism characteristics of tumor cells, inhibition of autophagy lysosome pathway with chloroquine may be a new route for therapeutic agents against cholangiocarcinoma.	[Qu, Xianzhi; Sheng, Jiyao; Zhang, Xuewen] Jilin Univ, Hosp 2, Dept Hepatobiliary & Pancreat Surg, Changchun, Jilin, Peoples R China; [Shen, Luyan; Su, Jing; Xu, Yunjie; Xie, Qi; Wu, Yao; Sun, Liankun] Jilin Univ, Sch Basic Med Sci, Dept Pathophysiol, Changchun, Jilin, Peoples R China	Jilin University; Jilin University	Zhang, XW (corresponding author), Jilin Univ, Hosp 2, Dept Hepatobiliary & Pancreat Surg, Changchun, Jilin, Peoples R China.; Sun, LK (corresponding author), Jilin Univ, Sch Basic Med Sci, Dept Pathophysiol, Changchun, Jilin, Peoples R China.	zxw515@sohu.com; sunlk@jlu.edu.cn			National Natural Science Foundation of China [81202552, 81472419, 81272876]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	J. Su (National Natural Science Foundation of China, Grant number: 81202552, http://www.nsfc.gov.cn/) took part in making decision to publish; L. Sun (National Natural Science Foundation of China, Grant number: 81472419, 81272876, http://www.nsfc.gov.cn/) took part in making decision to publish, preparing the manuscript and study design.	Catanzaro D, 2015, ONCOTARGET; Chen JL, 2015, CANCER CHEMOTH PHARM, V75, P1217, DOI 10.1007/s00280-015-2739-2; Chen Y, 2015, SCI REP-UK, V5, DOI 10.1038/srep09925; Chen Y, 2015, J MOL NEUROSCI, V55, P126, DOI 10.1007/s12031-014-0385-5; Desideri E, 2014, AUTOPHAGY, V10, P1652, DOI 10.4161/auto.29456; Dodson M, 2013, FREE RADICAL BIO MED, V63, P207, DOI 10.1016/j.freeradbiomed.2013.05.014; Fan CD, 2006, BIOORGAN MED CHEM, V14, P3218, DOI 10.1016/j.bmc.2005.12.035; Galluzzi L, 2012, ONCOGENE, V31, P1869, DOI 10.1038/onc.2011.384; Galluzzi L, 2014, CELL, V159, P1263, DOI 10.1016/j.cell.2014.11.006; Ganguli A, 2014, BIOCHIMIE, V107, P338, DOI 10.1016/j.biochi.2014.10.001; Glasauer A, 2014, BIOCHEM PHARMACOL, V92, P90, DOI 10.1016/j.bcp.2014.07.017; GORDON G, 1995, ARCH BIOCHEM BIOPHYS, V318, P25, DOI 10.1006/abbi.1995.1199; Green DR, 2011, SCIENCE, V333, P1109, DOI 10.1126/science.1201940; Gutierrez J, 2006, CIRC RES, V99, P924, DOI 10.1161/01.RES.0000248212.86638.e9; Hayes JD, 2009, TRENDS BIOCHEM SCI, V34, P176, DOI 10.1016/j.tibs.2008.12.008; Hou YJ, 2011, LAB INVEST, V91, P1146, DOI 10.1038/labinvest.2011.97; Kiffin R, 2004, MOL BIOL CELL, V15, P4829, DOI 10.1091/mbc.E04-06-0477; Kuehne A, 2015, MOL CELL, V59, P359, DOI 10.1016/j.molcel.2015.06.017; Lee SW, 2015, CANCER LETT, V360, P195, DOI 10.1016/j.canlet.2015.02.012; Li J, 2009, ANN SURG ONCOL, V16, P761, DOI 10.1245/s10434-008-0260-0; Liemburg-Apers DC, 2015, ARCH TOXICOL, V89, P1209, DOI 10.1007/s00204-015-1520-y; Likhitrattanapisal S, 2016, TUMOR BIOL, V37, P12755, DOI 10.1007/s13277-016-5186-8; Melser S, 2015, BBA-MOL CELL RES, V1853, P2812, DOI 10.1016/j.bbamcr.2015.05.010; Mitsuishi Y, 2012, CANCER CELL, V22, P66, DOI 10.1016/j.ccr.2012.05.016; Murphy MP, 2009, BIOCHEM J, V417, P1, DOI 10.1042/BJ20081386; Navarro-Yepes J, 2014, ANTIOXID REDOX SIGN, V21, P66, DOI 10.1089/ars.2014.5837; Pan T, 2009, NEUROSCIENCE, V164, P541, DOI 10.1016/j.neuroscience.2009.08.014; Patra KC, 2014, TRENDS BIOCHEM SCI, V39, P347, DOI 10.1016/j.tibs.2014.06.005; Sasaki K, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-370; Sinthupibulyakit C, 2010, INT J ONCOL, V37, P1575, DOI 10.3892/ijo_00000811; Taguchi K, 2012, P NATL ACAD SCI USA, V109, P13561, DOI 10.1073/pnas.1121572109; Tai DJ, 2012, EXP THER MED, V4, P291, DOI 10.3892/etm.2012.591; Venmar KT, 2015, BBA-MOL CELL RES, V1853, P1219, DOI 10.1016/j.bbamcr.2015.02.020; Wu YC, 2010, NEUROCHEM INT, V57, P198, DOI 10.1016/j.neuint.2010.05.008; Xi HB, 2011, CANCER CHEMOTH PHARM, V67, P899, DOI 10.1007/s00280-010-1391-0; Xiong N, 2011, NEUROSCIENCE, V199, P292, DOI 10.1016/j.neuroscience.2011.10.031; YEH GC, 1987, CANCER RES, V47, P5994; Yoon H, 2012, CANCER LETT, V316, P70, DOI 10.1016/j.canlet.2011.10.024; Zhang HY, 2009, TOXICOL SCI, V110, P376, DOI 10.1093/toxsci/kfp101	39	49	51	1	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 16	2017	12	3							e0173712	10.1371/journal.pone.0173712	http://dx.doi.org/10.1371/journal.pone.0173712			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN9KE	28301876	gold, Green Submitted, Green Published			2022-12-27	WOS:000396318300065
J	Zhao, YE; Gong, XH; Zhu, XN; Li, HM; Tu, MJ; Coursey, TG; Pflugfelder, SC; Gu, F; Chen, D				Zhao, Yun-e; Gong, Xian-hui; Zhu, Xue-ning; Li, He-ming; Tu, Meng-jun; Coursey, Terry G.; Pflugfelder, Stephen C.; Gu, Feng; Chen, Ding			Long-term outcomes of ciliary sulcus versus capsular bag fixation of intraocular lenses in children: An ultrasound biomicroscopy study	PLOS ONE			English	Article							PEDIATRIC CATARACT-SURGERY; INFANT APHAKIA TREATMENT; POSTERIOR CHAMBER; CONGENITAL CATARACT; ADVERSE EVENTS; RISK-FACTORS; IMPLANTATION; GLAUCOMA; COMPLICATIONS; OPACIFICATION	Purpose To evaluate the long-term outcomes of ciliary sulcus versus capsular bag fixation of intraocular lenses (IOLs) in children after pediatric cataract surgery. Methods IOL was implanted in the ciliary sulcus in 21 eyes of 14 children, and in the capsular bag in 19 eyes of 12 children for the treatment of pediatric cataract in an institutional setting. Ultrasound biomicroscopy (UBM) was performed. Main outcome measures included IOL decentration, IOL tilt, anterior chamber depth (ACD), angle-opening distance at 500 mu m (AOD(500)), trabecular-iris angle (TIA), best-corrected visual acuity (BCVA), intraocular pressure (IOP), and incidence of postoperative complications. Results The mean follow-up period was 6.81 +/- 1.82 years. Comparing to the capsular bag fixation group, the ciliary sulcus fixation group had higher vertical IOL decentration, horizontal IOL tilt, and vertical IOL tilt (p = 0.02, 0.01,0.01, respectively), higher incidence of iris-IOL contact and peripheral anterior synechia (p = 0.001, 0.03, respectively), smaller ACD, AOD500, and TIA (p = 0.02, 0.03, 0.04, respectively), higher mean IOP (17.10 +/- 6.06 mmHg vs. 14.15 +/- 4.74 mmHg, p = 0.01), and higher incidence of secondary glaucoma (28.57% vs. 10.53%, p = 0.007). There was no significant difference between the two groups with regard to the BCVA, refractive errors, incidence of myopic shift, nystagmus, strabismus, and visual axis opacity. Conclusions Ciliary sulcus fixation of IOLs in pediatric eyes may increase IOL malposition and crowding of the anterior segment, and may associate with a higher risk of secondary glaucoma compared to capsular bag fixation of IOLs.	[Zhao, Yun-e; Gong, Xian-hui; Zhu, Xue-ning; Li, He-ming; Tu, Meng-jun; Gu, Feng; Chen, Ding] Wenzhou Med Univ, Hosp Eye, Wenzhou, Zhejiang, Peoples R China; [Coursey, Terry G.; Pflugfelder, Stephen C.] Baylor Coll Med, Cullen Eye Inst, Dept Ophthalmol, Houston, TX 77030 USA	Wenzhou Medical University; Baylor College of Medicine	Gu, F; Chen, D (corresponding author), Wenzhou Med Univ, Hosp Eye, Wenzhou, Zhejiang, Peoples R China.	fgu@mail.eye.ac.cn; necoding@126.com			Foundation of Wenzhou Science and Technology Bureau [Y20140142]; Foundation of Zhejiang Medical Technology and Education [2016KYA146]	Foundation of Wenzhou Science and Technology Bureau; Foundation of Zhejiang Medical Technology and Education	This study was supported by research grants from the Foundation of Wenzhou Science and Technology Bureau (no. Y20140142), http://www.wzkj.gov.cn/, DC and the Foundation of Zhejiang Medical Technology and Education (no. 2016KYA146), www.zjmed.org.cn, DC. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amino K, 2000, J CATARACT REFR SURG, V26, P266, DOI 10.1016/S0886-3350(99)00345-4; Asadi R, 2008, OPHTHALMOLOGY, V115, P67, DOI 10.1016/j.ophtha.2007.02.018; Asrani S, 2000, J AAPOS, V4, P33, DOI 10.1016/S1091-8531(00)90009-0; ASRANI SG, 1995, OPHTHALMOLOGY, V102, P863, DOI 10.1016/S0161-6420(95)30942-6; Awad A H, 1998, J AAPOS, V2, P269, DOI 10.1016/S1091-8531(98)90082-9; Beck AD, 2012, ARCH OPHTHALMOL-CHIC, V130, P300, DOI 10.1001/archophthalmol.2011.347; BRADY KM, 1995, AM J OPHTHALMOL, V120, P1; Chak M, 2008, OPHTHALMOLOGY, V115, P1013, DOI 10.1016/j.ophtha.2007.09.002; Chak M, 2006, INVEST OPHTH VIS SCI, V47, P4262, DOI 10.1167/iovs.05-1160; Crnic T, 2004, J AAPOS, V8, P151, DOI 10.1016/j.jaapos.2003.10.005; Foster A, 1997, J CATARACT REFR SURG, V23, P601, DOI 10.1016/S0886-3350(97)80040-5; Freedman SF, 2015, JAMA OPHTHALMOL, V133, P907, DOI 10.1001/jamaophthalmol.2015.1329; Gogate PM, 2014, INDIAN J OPHTHALMOL, V62, P186, DOI 10.4103/0301-4738.128630; HATONO N, 1994, OPHTHALMOLOGICA, V208, P298, DOI 10.1159/000310525; Holladay JT, 2002, J REFRACT SURG, V18, P683; Holmes JM, 2003, OPHTHAL EPIDEMIOL, V10, P67, DOI 10.1076/opep.10.2.67.13894; Kuhli-Hattenbach C, 2008, AM J OPHTHALMOL, V146, P1, DOI 10.1016/j.ajo.2008.02.014; Lambert SR, 2014, JAMA OPHTHALMOL, V132, P676, DOI 10.1001/jamaophthalmol.2014.531; Loya N, 2001, J CATARACT REFR SURG, V27, P1423, DOI 10.1016/S0886-3350(01)00786-6; Luo Y, 2008, MICROSURG, V28, P113, DOI 10.1002/micr.20460; MACKOOL RJ, 1995, J CATARACT REFR SURG, V21, P376, DOI 10.1016/S0886-3350(13)80523-8; Magli A, 2013, GRAEF ARCH CLIN EXP, V251, P309, DOI 10.1007/s00417-012-1979-7; Mataftsi A, 2014, JAMA OPHTHALMOL, V132, P1059, DOI 10.1001/jamaophthalmol.2014.1042; Mayer D L, 1989, J Pediatr Ophthalmol Strabismus, V26, P61; Medsinge A, 2015, CLIN OPHTHALMOL, V9, P77, DOI 10.2147/OPTH.S59009; Mester U, 2009, J CATARACT REFR SURG, V35, P485, DOI 10.1016/j.jcrs.2008.09.028; Nihalani BR, 2011, J AAPOS, V15, P435, DOI 10.1016/j.jaapos.2011.05.019; PAVLIN CJ, 1991, OPHTHALMOLOGY, V98, P287; Rabiah PK, 2004, AM J OPHTHALMOL, V137, P30, DOI 10.1016/S0002-9394(03)00871-7; Ram J, 2003, J CATARACT REFR SURG, V29, P1579, DOI 10.1016/S0886-3350(03)00231-1; Sauer T, 2013, GRAEF ARCH CLIN EXP, V251, P89, DOI 10.1007/s00417-012-2141-2; Shenoy BH, 2015, AM J OPHTHALMOL, V159, P720, DOI 10.1016/j.ajo.2015.01.002; SMIDDY WE, 1991, OPHTHALMIC SURG LAS, V22, P16; STAYTE M, 1993, BRIT J OPHTHALMOL, V77, P228, DOI 10.1136/bjo.77.4.228; Superstein R, 1999, J CATARACT REFR SURG, V25, P1418, DOI 10.1016/S0886-3350(99)00212-6; Tatham A, 2010, EYE, V24, P1366, DOI 10.1038/eye.2010.46; Trivedi RH, 2006, J AAPOS, V10, P117, DOI 10.1016/j.jaapos.2006.01.003; Trivedi RH, 2005, J AAPOS, V9, P346, DOI 10.1016/j.jaapos.2005.02.010; Vasavada AR, 2004, AM J OPHTHALMOL, V138, P915, DOI 10.1016/j.ajo.2004.06.068; Vasavada AR, 2004, J CATARACT REFR SURG, V30, P1073, DOI 10.1016/j.jcrs.2003.08.020; Zwaan J, 1998, OPHTHALMOLOGY, V105, P112, DOI 10.1016/S0161-6420(98)91568-8	41	15	17	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 16	2017	12	3							e0172979	10.1371/journal.pone.0172979	http://dx.doi.org/10.1371/journal.pone.0172979			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN9KE	28301497	gold, Green Published, Green Submitted			2022-12-27	WOS:000396318300021
J	Gan, S; Zakaria, S; Chia, CH; Chen, RS; Ellis, AV; Kaco, H				Gan, Sinyee; Zakaria, Sarani; Chia, Chin Hua; Chen, Ruey Shan; Ellis, Amanda V.; Kaco, Hatika			Highly porous regenerated cellulose hydrogel and aerogel prepared from hydrothermal synthesized cellulose carbamate	PLOS ONE			English	Article								Here, a stable derivative of cellulose, called cellulose carbamate (CC), was produced from Kenaf (Hibiscus cannabinus) core pulp (KCP) and urea with the aid of a hydrothermal method. Further investigation was carried out for the amount of nitrogen yielded in CC as different urea concentrations were applied to react with cellulose. The effect of nitrogen concentration of CC on its solubility in a urea-alkaline system was also studied. Regenerated cellulose products (hydrogels and aerogels) were fabricated through the rapid dissolution of CC in a urea-alkaline system. The morphology of the regenerated cellulose products was viewed under Field emission scanning electron microscope (FESEM). The transformation of allomorphs in regenerated cellulose products was examined by X-ray diffraction (XRD). The transparency of regenerated cellulose products was determined by Ultraviolet-visible (UV-Vis) spectrophotometer. The degree of swelling (DS) of regenerated cellulose products was also evaluated. This investigation provides a simple and efficient procedure of CC determination which is useful in producing regenerated CC products.	[Gan, Sinyee; Zakaria, Sarani; Chia, Chin Hua; Chen, Ruey Shan; Kaco, Hatika] Univ Kebangsaan Malaysia, Sch Appl Phys, Fac Sci & Technol, Bangi, Selangor, Malaysia; [Ellis, Amanda V.] Univ Melbourne, Dept Chem Engn, Parkville, Vic, Australia	Universiti Kebangsaan Malaysia; University of Melbourne	Gan, S; Zakaria, S (corresponding author), Univ Kebangsaan Malaysia, Sch Appl Phys, Fac Sci & Technol, Bangi, Selangor, Malaysia.	gansinyee@ukm.edu.my; szakaria@ukm.edu.my	zakaria, sarani/D-6099-2018; Chen, Ruey Shan/C-7376-2017; Chia, Chin-hua/I-7261-2013; YEE, GAN SIN/Q-6347-2018; Ellis, Amanda V/AAD-3450-2019	Chen, Ruey Shan/0000-0002-2713-942X; Chia, Chin-hua/0000-0002-5269-4070; YEE, GAN SIN/0000-0003-2411-4611; Ellis, Amanda V/0000-0002-0053-5641; Zakaria, Sarani/0000-0002-5981-0986	Universiti Kebangsaan Malaysia (UKM) [AP-2015-005, DIP-2016-004, LRGS/TD/2012/USM-UKM/PT/04]; Ministry of Higher Education Malaysia	Universiti Kebangsaan Malaysia (UKM); Ministry of Higher Education Malaysia(Ministry of Education, Malaysia)	The authors thank Universiti Kebangsaan Malaysia (UKM) for the financial support via the research Project Grants AP-2015-005, DIP-2016-004, LRGS/TD/2012/USM-UKM/PT/04 and the Ministry of Higher Education Malaysia for MyBrain15-MyMaster Scholarship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors thank Universiti Kebangsaan Malaysia (UKM) for the financial support via the research Project Grants AP-2015-005, DIP-2016-004, LRGS/TD/2012/USM-UKM/PT/04 and the Ministry of Higher Education Malaysia for MyBrainl5-MyMaster Scholarship. The authors are also thankful to the Centre for Research and Instrumentation Management (CRIM) at UKM for providing the XRD and FESEM testing.	Ahmed EM., 2013, J ADV RES, P17; Cai J, 2008, CHEMSUSCHEM, V1, P149, DOI 10.1002/cssc.200700039; Chang CY, 2011, CARBOHYD POLYM, V84, P40, DOI 10.1016/j.carbpol.2010.12.023; Chang CY, 2009, POLYMER, V50, P5467, DOI 10.1016/j.polymer.2009.06.001; Ding ZD, 2012, CARBOHYD POLYM, V89, P7, DOI 10.1016/j.carbpol.2012.01.080; Dong H, 2013, CARBOHYD POLYM, V95, P760, DOI 10.1016/j.carbpol.2013.03.041; Eichhorn SJ, 2001, J MATER SCI, V36, P2107, DOI 10.1023/A:1017512029696; Fu FY, 2015, ACS SUSTAIN CHEM ENG, V3, P1510, DOI 10.1021/acssuschemeng.5b00219; Fu YJ, 2017, BIORESOURCES, V12, P992, DOI 10.15376/biores.12.1.992-1006; Gan S, 2016, BIORESOURCES, V11, P126; Gan S, 2015, CELLULOSE, V22, P3851, DOI 10.1007/s10570-015-0749-1; Gan S, 2015, BIORESOURCES, V10, P2244, DOI 10.15376/biores.10.2.2244-2255; Gan S, 2014, CARBOHYD POLYM, V106, P160, DOI 10.1016/j.carbpol.2014.01.076; Ganji F, 2010, IRAN POLYM J, V19, P375; Glasser W. G., 2008, TOP CURR CHEM, V1473; Guo Y, 2010, CELLULOSE, V17, P1115, DOI 10.1007/s10570-010-9446-2; Klemm D, 2005, ANGEW CHEM INT EDIT, V44, P3358, DOI 10.1002/anie.200460587; Klemm D., 2005, CELLULOSE BIOPOLYMER; Kotek R., 2006, HDB FIBER CHEM, P668; Ma AAMA, 2000, POLYM DEGRAD STABIL, V70, P347; OLSSON C, 2013, CELLULOSE FUNDAMENTA; Padzil FNM, 2015, CARBOHYD POLYM, V124, P164, DOI 10.1016/j.carbpol.2015.02.013; Paunonen S., 2013, STRENGTH BARRIER ENH; Pinnow M, 2008, MACROMOL SYMP, V262, P129, DOI 10.1002/masy.200850213; Qiu XY, 2013, MATERIALS, V6, P738, DOI 10.3390/ma6030738; Shen XD, 2005, POLYM BULL, V55, P317, DOI 10.1007/s00289-005-0442-x; Vo LTT, 2010, CARBOHYD POLYM, V82, P1191, DOI 10.1016/j.carbpol.2010.06.052; Wang Y, 2008, CELLULOSE FIBER DISS; Wong SS, 2009, CARBOHYD POLYM, V77, P280, DOI 10.1016/j.carbpol.2008.12.038; Yin CY, 2007, EUR POLYM J, V43, P2111, DOI 10.1016/j.eurpolymj.2007.01.041; Yin CY, 2007, CARBOHYD POLYM, V67, P147, DOI 10.1016/j.carbpol.2006.05.010; Zhang JX, 2010, CARBOHYD POLYM, V79, P164, DOI 10.1016/j.carbpol.2009.07.038	32	32	33	7	75	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 15	2017	12	3							e0173743	10.1371/journal.pone.0173743	http://dx.doi.org/10.1371/journal.pone.0173743			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN9HQ	28296977	gold, Green Published			2022-12-27	WOS:000396311700054
J	Lashkari, BS; Anumba, DOC				Lashkari, Behnia S.; Anumba, Dilly O. C.			Estradiol alters the immune-responsiveness of cervical epithelial cells stimulated with ligands of Toll-like receptors 2 and 4	PLOS ONE			English	Article							ANTIMICROBIAL PEPTIDES; ESTROGEN-RECEPTORS; EXPRESSION; INNATE; LIPOPOLYSACCHARIDE; RECOGNITION; DEFENSINS; INFECTION; CYTOKINES; RESPONSES	The mucosa of the female reproductive tract plays a pivotal role in host defence. Pregnancy must alter immunological mechanisms at this interface to protect the conceptus. We sought to determine how estradiol (E-2) alters the immune-responsiveness of cervical epithelial cells to ligand stimulation of Toll-like receptor (TLR)-2 and -4. Human ectocervical epithelial cells (HECECs) were cultured and co-incubated with two concentrations of E-2 and peptidoglycan (PGN) or lipopolysaccharide (LPS) over durations that ranged between 10 minutes and 18 hours. Cytometric Bead Array was performed to quantify eight cytokines in the supernatant fluid. In response to PGN, HECECs co-incubated with E-2 released lesser quantities of IL-1 beta and IFN gamma, higher levels of RANTES, and variable levels of IL-6 and IL-8 than those not exposed to E-2. In contrast, HECECs co-incubated with LPS and E-2 secreted increased levels of IL-1 beta, IL-6, IL-8, and IFN gamma at 2 and 18 hours than HECECs not exposed to E-2, and reduced levels of RANTES at same study time-points. Estradiol alters the immune-responsiveness of cultured HECECs to TLR2 and TLR4 ligands in a complex fashion that appears to vary with bacterial ligand, TLR subtype, and duration of exposure. Our observations are consistent with the functional complexity that this mucosal interface requires for its immunological roles.	[Lashkari, Behnia S.; Anumba, Dilly O. C.] Univ Sheffield, Dept Human Metab, Acad Unit Reprod & Dev Med, Jessop Wing, Sheffield, S Yorkshire, England; [Lashkari, Behnia S.] Univ British Columbia, Dept Pathol & Lab Med, Blusson Spinal Cord Ctr, Int Collaborat Repair Discoveries ICORD, Vancouver, BC, Canada	University of Sheffield; University of British Columbia	Anumba, DOC (corresponding author), Univ Sheffield, Dept Human Metab, Acad Unit Reprod & Dev Med, Jessop Wing, Sheffield, S Yorkshire, England.	d.o.c.anumba@sheffield.ac.uk	Professor Dilly Anumba MBBS, FWACS/A-6358-2011	Professor Dilly Anumba MBBS, FWACS/0000-0003-2502-3033				Abrahams VM, 2013, AM J REPROD IMMUNOL, V69, P33, DOI 10.1111/aji.12016; Aflatoonian R, 2007, HUM REPROD, V22, P586, DOI 10.1093/humrep/del388; Agrawal T, 2013, BRIT J BIOMED SCI, V70, P51, DOI 10.1080/09674845.2013.11669935; Alex P, 2009, INFLAMM BOWEL DIS, V15, P341, DOI 10.1002/ibd.20753; [Anonymous], 2014, IMMUNOHISTOCHEMICAL; Arslan SY, 2015, ENDOCRINOLOGY, V156, P1602, DOI 10.1210/en.2014-1840; Boesch AW, 2013, J IMMUNOL METHODS, V397, P71, DOI 10.1016/j.jim.2013.09.001; Chen C, 2014, DEV COMP IMMUNOL, V46, P341, DOI 10.1016/j.dci.2014.05.008; CHOMCZYNSKI P, 1995, ANAL BIOCHEM, V225, P163, DOI 10.1006/abio.1995.1126; Dasu MR, 2009, ATHEROSCLEROSIS, V202, P76, DOI 10.1016/j.atherosclerosis.2008.04.010; Dosiou C, 2008, J ENDOCRINOL, V196, P67, DOI 10.1677/JOE-07-0317; Elovitz MA, 2003, AM J PATHOL, V163, P2103, DOI 10.1016/S0002-9440(10)63567-5; Estrogen K. S., 2005, CURR MED CHEM IMMUNO, V5, P85; Ganz T, 2003, NAT REV IMMUNOL, V3, P710, DOI 10.1038/nri1180; Giannoni E, 2011, INFECT IMMUN, V79, P2690, DOI 10.1128/IAI.00076-11; GILBERT SF, 1975, CELL, V5, P11, DOI 10.1016/0092-8674(75)90086-0; HAILMAN E, 1994, J EXP MED, V179, P269, DOI 10.1084/jem.179.1.269; Hall JM, 2001, J BIOL CHEM, V276, P36869, DOI 10.1074/jbc.R100029200; Hayden FG, 1998, J CLIN INVEST, V101, P643, DOI 10.1172/JCI1355; Heldring N, 2007, PHYSIOL REV, V87, P905, DOI 10.1152/physrev.00026.2006; Hickey DK, 2011, J REPROD IMMUNOL, V88, P185, DOI 10.1016/j.jri.2011.01.005; Hirata T, 2007, J REPROD IMMUNOL, V74, P53, DOI 10.1016/j.jri.2006.11.004; Kalinka J, 2005, AM J REPROD IMMUNOL, V54, P70, DOI 10.1111/j.1600-0897.2005.00289.x; Kamine J, 1985, J TISSUE CULTURE MET, V9, P33; Katzenellenbogen BS, 2002, SCIENCE, V295, P2380, DOI 10.1126/science.1070442; Kaushic C, 2003, J VIROL, V77, P4558, DOI 10.1128/JVI.77.8.4558-4565.2003; Kovats S, 2015, CELL IMMUNOL, V294, P63, DOI 10.1016/j.cellimm.2015.01.018; Lashkari BS, 2015, J REPROD IMMUNOL, V107, P43, DOI 10.1016/j.jri.2014.10.001; Li X, 2014, REPROD SCI, V21, P898, DOI 10.1177/1933719113518982; Locklear TD, 2010, MATURITAS, V66, P315, DOI 10.1016/j.maturitas.2010.04.001; Lorenz E, 2002, PEDIATR RES, V52, P373, DOI 10.1203/01.PDR.0000025342.83436.53; Lyon D, 2010, BIOL RES NURS, V11, P371, DOI 10.1177/1099800409344620; Muller-Anstett MA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013153; Nalbandian G, 2005, IMMUNOL RES, V31, P91, DOI 10.1385/IR:31:2:091; Nasu K, 2010, MEDIAT INFLAMM, V2010, DOI 10.1155/2010/976024; Noguchi T, 2010, MEDIAT INFLAMM, V2010, DOI 10.1155/2010/490406; Nold C, 2012, AM J OBSTET GYNECOL, V206, DOI 10.1016/j.ajog.2011.12.036; Oppenheim JJ, 2003, ANN RHEUM DIS, V62, P17, DOI 10.1136/ard.62.suppl_2.ii17; Papoutsi Z, 2009, J MOL ENDOCRINOL, V43, P65, DOI 10.1677/JME-08-0177; Rakoff-Nahoum S, 2004, CELL, V118, P229, DOI 10.1016/j.cell.2004.07.002; Re F, 2003, J IMMUNOL, V171, P5272, DOI 10.4049/jimmunol.171.10.5272; Solar Paula, 2013, J Mol Signal, V8, P1, DOI 10.1186/1750-2187-8-1; Sriskandan S, 2011, J ROY COLL PHYS EDIN, V41, P339, DOI 10.4997/JRCPE.2011.411; Stanley MA, 2002, CULTURE HUMAN CERVIC; Thaxton JE, 2010, INFECT DIS OBSTET GY, V2010, P430; VESTERINEN E, 1976, ACTA PATH MICRO IM B, V84, P29; Wang H, 2003, BIOL REPROD, V69, P1957, DOI 10.1095/biolreprod.103.019620; Young BC, 2014, AM J OBSTET GYNECOL, V210, DOI 10.1016/j.ajog.2013.11.037; Young SH, 2008, J IMMUNOL METHODS, V331, P59, DOI 10.1016/j.jim.2007.11.004; Youssef RE, 2009, REPROD SCI, V16, P843, DOI 10.1177/1933719109336621; Yu L, 2010, J CELL MOL MED, V14, P2592, DOI 10.1111/j.1582-4934.2010.01127.x; Zhao Li-Qin, 2013, Shengli Xuebao, V65, P623	52	9	9	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 15	2017	12	3							e0173646	10.1371/journal.pone.0173646	http://dx.doi.org/10.1371/journal.pone.0173646			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN9HQ	28296959	gold, Green Published, Green Accepted			2022-12-27	WOS:000396311700048
J	Rohde, JF; Handel, MN; Stougaard, M; Olsen, NJ; Traerup, M; Mortensen, EL; Heitmann, BL				Rohde, Jeanett Friis; Handel, Mina Nicole; Stougaard, Maria; Olsen, Nanna Julie; Traerup, Maria; Mortensen, Erik Lykke; Heitmann, Berit Lilienthal			Relationship between pickiness and subsequent development in body mass index and diet intake in obesity prone normal weight preschool children	PLOS ONE			English	Article							YOUNG-CHILDREN; EATING BEHAVIOR; PICKY EATERS; FAMILY; FOOD; PATTERNS; ASSOCIATION; PREVALENCE; VALIDATION; FREQUENCY	Background Most children have periods in their life where they reject familiar as well as non-familiar food items and this is often referred to as pickiness. The consequences of pickiness may be malnutrition and, if prolonged, potentially lower body weight. However, studies investigating the consequence of pickiness on subsequent changes in diet intake and weight are limited. Objectives To examine whether pickiness influences body mass index as well as diet intake over subsequent 15 months among obesity prone normal weight children aged 2-6 years. Methods Data was obtained from the "Healthy Start" intervention study which included 271 children aged 2-6 years susceptible to overweight later in life. Information on pickiness was obtained from a parental questionnaire. Dietary habits were collected by 4-day dietary records filled in by the parents and height and weight were measured by trained health professionals and both measured twice over a 15 month period. Linear regression models were performed to assess the influence of pickiness on body mass index and diet with adjustments for possible confounders. Results No differences in mean BMI Z-score were seen between picky/non-picky (P = 0.68) and little picky/non-picky (P = 0.68) children at 15 month follow-up. Picky children had a lower intake of protein (P = 0.01) than non-picky children despite no differences in total energy intake (P = 0.74), or in the other macronutrients, or the intake of fruit and vegetables, though children being a little picky had a lower intake of starch compared to non-picky children (P = 0.05). Results were essentially similar before and after adjustment for key covariates. Conclusion Our study showed that BMI Z-score after 15 months follow-up was similar for picky and non-picky children. Picky children seemed to develop a lower protein intake despite similar total energy intake and diet composition.	[Rohde, Jeanett Friis; Handel, Mina Nicole; Stougaard, Maria; Olsen, Nanna Julie; Traerup, Maria; Heitmann, Berit Lilienthal] Bispebjerg & Frederiksberg Univ Hosp, Parker Inst, Res Unit Dietary Studies, Frederiksberg, Denmark; [Rohde, Jeanett Friis; Heitmann, Berit Lilienthal] Univ Southern Denmark, Natl Inst Publ Hlth, Copenhagen, Denmark; [Handel, Mina Nicole] Univ Southern Denmark, Dept Clin Res, Odense Patient Data Explorat Network OPEN, Odense Univ Hosp, Odense, Denmark; [Mortensen, Erik Lykke] Univ Copenhagen, Dept Publ Hlth, Copenhagen, Denmark; [Mortensen, Erik Lykke] Univ Copenhagen, Ctr Hlth Aging, Copenhagen, Denmark; [Heitmann, Berit Lilienthal] Univ Sydney, Boden Inst Obes Nutr Exercise & Eating Disorders, Camperdown, NSW, Australia; [Heitmann, Berit Lilienthal] Univ Copenhagen, Dept Publ Hlth, Sect Gen Med, Copenhagen, Denmark	University of Copenhagen; Bispebjerg Hospital; University of Southern Denmark; University of Southern Denmark; Odense University Hospital; University of Copenhagen; University of Copenhagen; University of Sydney; University of Copenhagen	Rohde, JF (corresponding author), Bispebjerg & Frederiksberg Univ Hosp, Parker Inst, Res Unit Dietary Studies, Frederiksberg, Denmark.; Rohde, JF (corresponding author), Univ Southern Denmark, Natl Inst Publ Hlth, Copenhagen, Denmark.	Jeanett.friis.rohde@regionh.dk	Olsen, Nanna Julie/G-6723-2016; Handel, Mina Nicole/G-4591-2016	Rohde, Jeanett Friis/0000-0002-9300-9009; Stougaard, Maria/0000-0002-5573-4971; Olsen, Nanna Julie/0000-0001-5765-3000; Handel, Mina Nicole/0000-0001-8256-8756; Heitmann, Berit Lilienthal/0000-0002-6809-4504	Danish Heart Foundation [12-04-R91-A3790-22689, 12-04-R91-A3775-22683]; Tryg Foundation [7984-07, 7106-09, 7-10-0330]; Danish Medical Research Council [271-07-0281]; Health Foundation [2008B101]; TrygFonden	Danish Heart Foundation; Tryg Foundation; Danish Medical Research Council(Danish Medical Research CouncilUK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Health Foundation; TrygFonden	This study was funded by The Danish Heart Foundation (grant: 12-04-R91-A3790-22689; 12-04-R91-A3775-22683) (JFR). The Healthy Start study was funded by the Tryg Foundation (grant: 7984-07, 7106-09, and 7-10-0330) (BLH), the Danish Medical Research Council (grant: 271-07-0281) (BLH), and the Health Foundation (grant: 2008B101) (BLH).; The authors would like to acknowledge The Danish Heart Foundation, TrygFonden, The Danish Medical Council and The Health Foundation for providing financial support for this study. The source of funding had no influence on the manuscript. We would also like to thank all of the participating families in the "Healthy Start" project.	Birch LL, 2014, AM J CLIN NUTR, V99, p723S, DOI 10.3945/ajcn.113.069047; Burnier D, 2011, J NUTR EDUC BEHAV, V43, P473, DOI 10.1016/j.jneb.2011.01.005; Carruth BR, 2004, J AM DIET ASSOC, V104, pS57, DOI 10.1016/j.jada.2003.10.024; COLE TJ, 1992, STAT MED, V11, P1305, DOI 10.1002/sim.4780111005; de Barse LM, 2015, INT J BEHAV NUTR PHY, V12, DOI 10.1186/s12966-015-0313-2; Dovey TM, 2008, APPETITE, V50, P181, DOI 10.1016/j.appet.2007.09.009; Ekstein S, 2010, CLIN PEDIATR, V49, P217, DOI 10.1177/0009922809337331; Equit M, 2013, ACTA PAEDIATR, V102, P149, DOI 10.1111/apa.12078; Farrow CV, 2009, APPETITE, V52, P307, DOI 10.1016/j.appet.2008.10.009; Fulkerson JA, 2014, J NUTR EDUC BEHAV, V46, P2, DOI 10.1016/j.jneb.2013.07.012; Galloway AT, 2005, J AM DIET ASSOC, V105, P541, DOI 10.1016/j.jada.2005.01.029; Gondolf UH, 2012, EUR J CLIN NUTR, V66, P91, DOI 10.1038/ejcn.2011.133; Lafraire J, 2016, APPETITE, V96, P347, DOI 10.1016/j.appet.2015.09.008; Mascola AJ, 2010, EAT BEHAV, V11, P253, DOI 10.1016/j.eatbeh.2010.05.006; Nicholls D, 2002, EUR J CLIN NUTR, V56, P857, DOI 10.1038/sj.ejcn.1601403; Nicklas TA, 2001, NUTR REV, V59, P224, DOI 10.1111/j.1753-4887.2001.tb07014.x; Nysom K, 2001, INT J OBESITY, V25, P177, DOI 10.1038/sj.ijo.0801515; Olsen NJ, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-590; Patrick H, 2005, J AM COLL NUTR, V24, P83, DOI 10.1080/07315724.2005.10719448; Rodenburg G, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050642; Sleddens EFC, 2008, INT J BEHAV NUTR PHY, V5, DOI 10.1186/1479-5868-5-49; Svensson V, 2011, INT J BEHAV NUTR PHY, V8, DOI 10.1186/1479-5868-8-134; Taylor CM, 2015, APPETITE, V95, P349, DOI 10.1016/j.appet.2015.07.026; Tharner A, 2014, INT J BEHAV NUTR PHY, V11, DOI 10.1186/1479-5868-11-14; Utter J, 2008, INT J BEHAV NUTR PHY, V5, DOI 10.1186/1479-5868-5-50; Webber L, 2009, INT J OBESITY, V33, P21, DOI 10.1038/ijo.2008.219	26	7	7	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 15	2017	12	3							e0172772	10.1371/journal.pone.0172772	http://dx.doi.org/10.1371/journal.pone.0172772			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN9HQ	28296896	Green Published, Green Submitted, gold			2022-12-27	WOS:000396311700014
J	Shrestha, NK; Lim, SH; Wilson, DA; SalasVargas, AV; Churi, YS; Rhodes, PA; Mazzone, PJ; Procop, GW				Shrestha, Nabin K.; Lim, Sung H.; Wilson, Deborah A.; SalasVargas, Ana Victoria; Churi, Yair S.; Rhodes, Paul A.; Mazzone, Peter J.; Procop, Gary W.			The combined rapid detection and species-level identification of yeasts in simulated blood culture using a colorimetric sensor array	PLOS ONE			English	Article							FLIGHT MASS-SPECTROMETRY; OPTOELECTRONIC NOSE; STREAM PATHOGENS; BACTERIA; PCR	Background A colorimetric sensor array (CSA) has been demonstrated to rapidly detect and identify bacteria growing in blood cultures by obtaining a species-specific "fingerprint" of the volatile organic compounds (VOCs) produced during growth. This capability has been demonstrated in prokaryotes, but has not been reported for eukaryotic cells growing in culture. The purpose of this study was to explore if a disposable CSA could differentially identify 7 species of pathogenic yeasts growing in blood culture. Methods Culture trials of whole blood inoculated with a panel of clinically important pathogenic yeasts at four different microorganism loads were performed. Cultures were done in both standard BacT/Alert and CSA-embedded bottles, after adding 10 mL of spiked blood to each bottle. Color changes in the CSA were captured as images by an optical scanner at defined time intervals. The captured images were analyzed to identify the yeast species. Time to detection by the CSA was compared to that in the BacT/Alert system. Results One hundred sixty-two yeast culture trials were performed, including strains of several species of Candida (Ca. albicans, Ca. glabrata, Ca. parapsilosis, and Ca. tropicalis), Clavispora (synonym Candida) lusitaniae, Pichia kudriavzevii (synonym Candida krusei) and Cryptococcus neoformans, at loads of 8.2 x 10(5), 8.3 x 10(3), 8.5 x 10(1), and 1.7 CFU/mL. In addition, 8 negative trials (no yeast) were conducted. All negative trials were correctly identified as negative, and all positive trials were detected. Colorimetric responses were species-specific and did not vary by inoculum load over the 500000-fold range of loads tested, allowing for accurate species-level identification. The mean sensitivity for species-level identification by CSA was 74% at detection, and increased with time, reaching almost 95% at 4 hours after detection. At an inoculum load of 1.7 CFU/mL, mean time to detection with the CSA was 6.8 hours (17%) less than with the BacT/Alert platform. Conclusion The CSA combined rapid detection of pathogenic yeasts in blood culture with accurate species- level identification.	[Shrestha, Nabin K.; SalasVargas, Ana Victoria] Cleveland Clin, Inst Med, Dept Infect Dis, Cleveland, OH 44106 USA; [Shrestha, Nabin K.; Wilson, Deborah A.; Procop, Gary W.] Cleveland Clin, Pathol & Lab Med Inst, Dept Clin Pathol, Cleveland, OH 44106 USA; [Lim, Sung H.; Churi, Yair S.; Rhodes, Paul A.] Specif Technol, Mountain View, CA USA; [Mazzone, Peter J.] Cleveland Clin, Resp Inst, Dept Pulm & Crit Care Med, Cleveland, OH 44106 USA	Cleveland Clinic Foundation; Cleveland Clinic Foundation; Cleveland Clinic Foundation	Shrestha, NK (corresponding author), Cleveland Clin, Inst Med, Dept Infect Dis, Cleveland, OH 44106 USA.; Shrestha, NK (corresponding author), Cleveland Clin, Pathol & Lab Med Inst, Dept Clin Pathol, Cleveland, OH 44106 USA.	shrestn@ccf.org	Mazzone, Peter/AAW-5401-2021; Shrestha, Nabin/B-3600-2015	Mazzone, Peter/0000-0003-2121-0595; Shrestha, Nabin/0000-0001-6766-9874	Cleveland Clinic Research Programs Committees [RPC: 2012-1057]; Specific Technologies	Cleveland Clinic Research Programs Committees; Specific Technologies	This study was partially supported by an internal grant from the Cleveland Clinic Research Programs Committees (NKS, AVSV; grant no. RPC: 2012-1057), and with material support from Specific Technologies, Mountain View, CA. Specific Technologies provided support in the form of salaries for authors SHL, YSC, PAR, and assisted with data analysis, the decision to publish, and in the preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Carey JR, 2011, J AM CHEM SOC, V133, P7571, DOI 10.1021/ja201634d; Chang CC, 2011, ACM T INTEL SYST TEC, V2, DOI 10.1145/1961189.1961199; Feng LA, 2010, ANAL CHEM, V82, P9433, DOI 10.1021/ac1020886; Fuglsang-Damgaard D, 2011, APMIS, V119, P681, DOI 10.1111/j.1600-0463.2011.02756.x; Horvath A, 2010, ACTA MICROBIOL IMM H, V57, P225, DOI 10.1556/AMicr.57.2010.3.7; Kaleta EJ, 2011, J CLIN MICROBIOL, V49, P345, DOI 10.1128/JCM.00936-10; Kroumova V, 2011, RAPID COMMUN MASS SP, V25, P2247, DOI 10.1002/rcm.5113; Lim SH, 2016, ANALYST, V141, P918, DOI 10.1039/c5an01990g; Lim SH, 2014, J CLIN MICROBIOL, V52, P592, DOI 10.1128/JCM.02377-13; Lim SH, 2009, NAT CHEM, V1, P562, DOI [10.1038/NCHEM.360, 10.1038/nchem.360]; Lonsdale CL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062726; Moens M, 2006, LETT APPL MICROBIOL, V42, P121, DOI 10.1111/j.1472-765X.2005.01822.x; Moussaoui W, 2010, CLIN MICROBIOL INFEC, V16, P1631, DOI 10.1111/j.1469-0691.2010.03356.x; Pfeiffer CD, 2011, J CLIN MICROBIOL, V49, P2879, DOI 10.1128/JCM.00609-11; Quiles-Melero I, 2011, EUR J CLIN MICROBIOL, V30, P21, DOI 10.1007/s10096-010-1045-5; Rowther FB, 2009, J CLIN MICROBIOL, V47, P2964, DOI 10.1128/JCM.00418-07; Schulz S, 2007, NAT PROD REP, V24, P814, DOI 10.1039/b507392h; Suslick KS, 2012, CURR OPIN CHEM BIOL, V16, P557, DOI 10.1016/j.cbpa.2012.10.030; Suslick KS, 2004, MRS BULL, V29, P720, DOI 10.1557/mrs2004.209; Westh H, 2009, CLIN MICROBIOL INFEC, V15, P544, DOI 10.1111/j.1469-0691.2009.02736.x; Wilson AD, 2011, SENSORS-BASEL, V11, P1105, DOI 10.3390/s110101105; Won H, 2011, J CLIN MICROBIOL, V49, P1705, DOI 10.1128/JCM.00217-11; Yan YJ, 2011, J CLIN MICROBIOL, V49, P2528, DOI 10.1128/JCM.00339-11; ZECHMAN JM, 1986, J CHROMATOGR, V377, P49, DOI 10.1016/S0378-4347(00)80760-4	24	10	10	1	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 15	2017	12	3							e0173130	10.1371/journal.pone.0173130	http://dx.doi.org/10.1371/journal.pone.0173130			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN9HQ	28296967	Green Submitted, Green Published, gold			2022-12-27	WOS:000396311700026
J	Yonow, T; Kriticos, DJ; Ota, N				Yonow, Tania; Kriticos, Darren J.; Ota, Noboru			The potential distribution of cassava mealybug (Phenacoccus manihoti), a threat to food security for the poor	PLOS ONE			English	Article							BIOLOGICAL-CONTROL; MATILE-FERRERO; CLIMATE-CHANGE; HOMOPTERA; PSEUDOCOCCIDAE; PEST; TEMPERATURE; SPREAD; CONGO; HOM	The cassava mealybug is a clear and present threat to the food security and livelihoods of some of the world's most impoverished citizens. Niche models, such as CLIMEX, are useful tools to indicate where and when such threats may extend, and can assist with planning for biosecurity and the management of pest invasions. They can also contribute to bioeconomic analyses that underpin the allocation of resources to alleviate poverty. Because species can invade and establish in areas with climates that are different from those that are found in their native range, it is essential to define robust range-limiting mechanisms in niche models. To avoid spurious results when applied to novel climates, it is necessary to employ cross-validation techniques spanning different knowledge domains (e.g., distribution data, experimental results, phenological observations). We build upon and update a CLIMEX niche model by Parsa et al. (PloS ONE 7: e47675), correcting inconsistent parameters and re-fitting it based on a careful examination of geographical distribution data and relevant literature. Further, we consider the role of irrigation, the known distribution of cassava production and a targeted review of satellite imagery to refine, validate and interpret our model and results. In so doing, we bring new insights into the potential spread of this invasive insect, enabling us to identify potential bio-security threats and biological control opportunities. The fit of the revised model is improved, particularly in relation to the wet and dry limits to establishment, and the parameter values are biologically plausible and accord with published scientific literature.	[Yonow, Tania; Kriticos, Darren J.] Univ Minnesota, InSTePP, HarvestChoice, St Paul, MN 55108 USA; [Yonow, Tania; Kriticos, Darren J.] CSIRO, Canberra, ACT, Australia; [Kriticos, Darren J.] Univ Queensland, Sch Biol Sci, St Lucia, Qld, Australia; [Ota, Noboru] CSIRO, Wembley, WA, Australia	University of Minnesota System; University of Minnesota Twin Cities; Commonwealth Scientific & Industrial Research Organisation (CSIRO); University of Queensland; Commonwealth Scientific & Industrial Research Organisation (CSIRO)	Kriticos, DJ (corresponding author), Univ Minnesota, InSTePP, HarvestChoice, St Paul, MN 55108 USA.; Kriticos, DJ (corresponding author), CSIRO, Canberra, ACT, Australia.; Kriticos, DJ (corresponding author), Univ Queensland, Sch Biol Sci, St Lucia, Qld, Australia.	Darren.kriticos@csiro.au	Kriticos, Darren J/A-4170-2008; Ota, Noboru/ABE-4698-2020	Kriticos, Darren J/0000-0003-2599-8105; , Noboru/0000-0002-8759-9030	Bill and Melinda Gates Foundation [2010X446]	Bill and Melinda Gates Foundation(Bill & Melinda Gates Foundation)	This work was partly supported by the Bill and Melinda Gates Foundation under the HarvestCHoice project "HarvestChoice: Supporting Strategic Investment Choices in Agricultural Technology Development and Adoption", grant number 2010X446. UMN to support TY. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. DK and NO received no specific funding for this work.	Baker RHA, 2000, AGR ECOSYST ENVIRON, V82, P57, DOI 10.1016/S0167-8809(00)00216-4; Bellotti AC, 1999, ANNU REV ENTOMOL, V44, P343, DOI 10.1146/annurev.ento.44.1.343; Bellotti A, 2012, TROP PLANT BIOL, V5, P39, DOI 10.1007/s12042-011-9091-4; Bennett F, 1978, P CASS PROT WORKSH 7; Berry SD, 2004, ANN ENTOMOL SOC AM, V97, P852, DOI 10.1603/0013-8746(2004)097[0852:MEFFDB]2.0.CO;2; CHAMBERLIN TC, 1965, SCIENCE, V148, P754, DOI 10.1126/science.148.3671.754; Colvin J, 2004, PLANT PATHOL, V53, P577, DOI 10.1111/j.0032-0862.2004.01062.x; Ezumah H, 1978, P INT WORKSH CASS ME; FABRES G, 1981, AGRON TROP, V36, P82; FABRES G, 1981, AGRONOMIE, V1, P483, DOI 10.1051/agro:19810608; Fabres G, 1981, TROPICAL ROOT CROPS, P84; HALL M, 1995, ADV PARASIT, V35, P257, DOI 10.1016/S0065-308X(08)60073-1; HAMMOND WNO, 1990, ENTOMOPHAGA, V35, P515, DOI 10.1007/BF02375086; HENNESSEY RD, 1990, TROP PEST MANAGE, V36, P103, DOI 10.1080/09670879009371451; HERREN HR, 1991, ANNU REV ENTOMOL, V36, P257, DOI 10.1146/annurev.en.36.010191.001353; IHEAGWAM EU, 1983, DEUT ENTOMOL Z, V30, P17; JAMES BD, 1992, TROP PEST MANAGE, V38, P89; KLEIJNEN JPC, 1995, EUR J OPER RES, V82, P145, DOI 10.1016/0377-2217(94)00016-6; Kriticos DJ, 2003, BIOL INVASIONS, V5, P147, DOI 10.1023/A:1026193424587; Kriticos D. J., 2001, Weed risk assessment, P61; Kriticos D. J., 2015, CLIMEX VERSION 4 EXP; Kriticos DJ, 2007, J APPL ECOL, V44, P853, DOI 10.1111/j.1365-2664.2007.01331.x; Kriticos DJ, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0119618; Kriticos DJ, 2012, METHODS ECOL EVOL, V3, P53, DOI 10.1111/j.2041-210X.2011.00134.x; Kriticos DJ, 2005, WEED RES, V45, P246, DOI 10.1111/j.1365-3180.2005.00458.x; Kriticos DJ, 2003, J APPL ECOL, V40, P111, DOI 10.1046/j.1365-2664.2003.00777.x; Legese Hidoto, 2013, African Journal of Agricultural Research, V8, P2559; Legg JP, 2014, VIRUS RES, V186, P61, DOI 10.1016/j.virusres.2013.11.018; LOHR B, 1990, B ENTOMOL RES, V80, P417, DOI 10.1017/S0007485300050677; Matile-Ferrero D., 1978, Proceedings of the International Workshop on the cassava mealybug Phenacoccus manihoti Mat.-Ferr. (Pseudococcidae) held at INERA-M'vuazi, Bas-Zaire, Zaire, June 26-29, 1977., P29; Minko D. Obame, 2009, Tropicultura, V27, P21; Montle B. P., 2014, Journal of Development and Agricultural Economics, V6, P443; Mulualem T., 2012, J NAT SCI RES, V2, P122; Muniappan R, 2009, J AGR URBAN ENTOMOL, V26, P167, DOI 10.3954/1523-5475-26.4.167; Neuenschwander P, 2001, BIOL CONTROL, V21, P214, DOI 10.1006/bcon.2001.0937; Neuenschwander Peter, 2003, P45, DOI 10.1079/9780851996394.0045; Nweke F. I., 2005, P VAL FOR GLOB CASS, V2; Okigbo B. N., 1980, Food and Nutrition Bulletin, V2, P1; Parsa S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047675; Sartiami D, 2015, ZOOTAXA, V3957, P235, DOI 10.11646/zootaxa.3957.2.8; SCHULTHESS F, 1987, INSECT SCI APPL, V8, P851, DOI 10.1017/S1742758400023055; Siebert S, 2005, HYDROL EARTH SYST SC, V9, P535, DOI 10.5194/hess-9-535-2005; Singh T, 1982, ROOT CROPS E AFR P W; Soon LG, 2013, TCPRAS3311 FAO; Spencer D, 2005, P VAL FOR GLOB CASS, P27; Sutherst RW, 2009, BIOL INVASIONS, V11, P1231, DOI 10.1007/s10530-008-9335-x; Sutherst R W, 2007, CLIMEX VERSION 3 USE; Wyckhuys KAG, 2014, BIOCONTROL NEWS INFO, V35, p35N; Yonow T., 2016, J PEST SCI, P1; Yonow T, 2013, CROP PROT, V44, P18, DOI 10.1016/j.cropro.2012.10.006; You L., 2012, MAPSPAM HOME SPATIAL; You L, 2014, SPATIAL PRODUCTION A	52	16	16	0	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 15	2017	12	3							e0173265	10.1371/journal.pone.0173265	http://dx.doi.org/10.1371/journal.pone.0173265			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN9HQ	28296903	Green Published, Green Submitted, gold			2022-12-27	WOS:000396311700030
J	Sommer, G; Fedarovich, A; Kota, V; Rodriguez, R; Smith, CD; Heise, T				Sommer, Gunhild; Fedarovich, Alena; Kota, Venkatesh; Rodriguez, Reycel; Smith, Charles D.; Heise, Tilman			Applying a high-throughput fluorescence polarization assay for the discovery of chemical probes blocking La:RNA interactions in vitro and in cells	PLOS ONE			English	Article							HUMAN LA PROTEIN; POLYMERASE-III TRANSCRIPTS; IRES-MEDIATED TRANSLATION; C VIRUS-RNA; MESENCHYMAL TRANSITION; AKT PHOSPHORYLATION; SCREENING ASSAYS; LAMININ B1; BINDING; CANCER	The RNA-binding protein La is overexpressed in a number of tumor tissues and is thought to support tumorigenesis by binding to and facilitating the expression of mRNAs encoding tumor-promoting and anti-apoptotic factors. Hence, small molecules able to block the binding of La to specific RNAs could have a therapeutic impact by reducing the expression of tumor-promoting and anti-apoptotic factors. Toward this novel therapeutic strategy, we aimed to develop a high-throughput fluorescence polarization assay to screen small compound libraries for molecules blocking the binding of La to an RNA element derived from cyclin D1 mRNA. Herein, we make use of a robust fluorescence polarization assay and the validation of primary hits by electrophoretic mobility shift assays. We showed recently that La protects cells against cisplatin treatment by stimulating the protein synthesis of the antiapoptotic factor Bcl2. Here, we show by RNA immunoprecipitation experiments that one small compound specifically impairs the association of La with Bcl2 mRNA in cells and sensitizes cells for cipslatin-induced cell death. In summary, we report the application of a high-throughput fluorescence polarization assay to identify small compounds that impair the binding of La to target RNAs in vitro and in cells.	[Sommer, Gunhild; Fedarovich, Alena; Kota, Venkatesh; Rodriguez, Reycel; Heise, Tilman] Med Univ South Carolina, Dept Biochem & Mol Biol, 173 Ashley Ave, Charleston, SC 29425 USA; [Smith, Charles D.] Dept Pharmaceut & Biomed Sci, 173 Ashley Ave, Charleston, SC USA	Medical University of South Carolina	Heise, T (corresponding author), Med Univ South Carolina, Dept Biochem & Mol Biol, 173 Ashley Ave, Charleston, SC 29425 USA.	heise@musc.edu			Protein Science Translation Core, of the South Carolina Lipidomics and Pathology Center of Biomedical Research Excellence, National Institutes of Health [MUCR-2211000-89623-2021-02]; National Institutes of Health/National Cancer Institute [1R01CA172567-01A1]; MUSC Drug Discovery Core; NATIONAL CANCER INSTITUTE [R01CA172567] Funding Source: NIH RePORTER	Protein Science Translation Core, of the South Carolina Lipidomics and Pathology Center of Biomedical Research Excellence, National Institutes of Health; National Institutes of Health/National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); MUSC Drug Discovery Core; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This study was supported by the Protein Science Translation Core, of the South Carolina Lipidomics and Pathology Center of Biomedical Research Excellence, National Institutes of Health Grant MUCR-2211000-89623-2021-02. The work was supported by National Institutes of Health/National Cancer Institute Grant 1R01CA172567-01A1 (TH, NIH/NCI).; We appreciate very much the support of this work by the MUSC Drug Discovery Core and are very thankful to Staci Keller for the initial screening of the compound library. We are very thankful to Dzmitry Fedarovich for protein expression and purification in part conducted by the Protein Science Translation Core, of the South Carolina Lipidomics and Pathology Center of Biomedical Research Excellence, National Institutes of Health Grant MUCR-2211000-89623-2021-02. The work was supported by 1R01CA172567-01A1 (TH, NIH/NCI).	Aboul-Ela F, 2010, FUTURE MED CHEM, V2, P93, DOI 10.4155/FMC.09.149; Al-Ejeh F, 2007, CLIN CANCER RES, V13, p5509S, DOI 10.1158/1078-0432.CCR-07-0922; Ali N, 1997, P NATL ACAD SCI USA, V94, P2249, DOI 10.1073/pnas.94.6.2249; Bayfield MA, BIOCH BIOPHYS ACTA, V1799, P365; Bhat M, 2015, NAT REV DRUG DISCOV, V14, P261, DOI 10.1038/nrd4505; Bousquet-Antonelli C, 2009, RNA, V15, P750, DOI 10.1261/rna.1478709; Brenet F, 2009, ONCOGENE, V28, P128, DOI 10.1038/onc.2008.376; Burrows C, 2010, NUCLEIC ACIDS RES, V38, P5542, DOI 10.1093/nar/gkq294; Cardinali B, 2003, J BIOL CHEM, V278, P35145, DOI 10.1074/jbc.M300722200; CAREY TE, 1983, OTOLARYNG HEAD NECK, V91, P482, DOI 10.1177/019459988309100503; Cheng YL, 2012, LAB INVEST, V92, P1013, DOI 10.1038/labinvest.2012.59; Costa-Mattioli M, 2004, MOL CELL BIOL, V24, P6861, DOI 10.1128/mcb.24.15.6861-6870.2004; Davis Darrell R., 2011, Antiviral Chemistry & Chemotherapy, V21, P117, DOI 10.3851/IMP1693; Dejong Eric S., 2002, Current Topics in Medicinal Chemistry, V2, P289, DOI 10.2174/1568026023394245; Frisone P, 2015, BIOMED RES INT, V2015, DOI 10.1155/2015/528954; Goodier JL, 1997, MOL CELL BIOL, V17, P5823, DOI 10.1128/MCB.17.10.5823; Heise T, 2016, ONCOTARGET; Hermann T, 2000, COMB CHEM HIGH T SCR, V3, P219; Hermann T, 2000, ANGEW CHEM INT EDIT, V39, P1891; Holcik M, 2000, MOL CELL BIOL, V20, P4648, DOI 10.1128/MCB.20.13.4648-4657.2000; Hopkins TG, 2016, NUCLEIC ACIDS RES, V44, P1227, DOI 10.1093/nar/gkv1515; Huang Y, 2006, NAT STRUCT MOL BIOL, V13, P611, DOI 10.1038/nsmb1110; Izumi RE, 2004, J VIROL, V78, P3763, DOI 10.1128/JVI.78.7.3763-3776.2004; Jadhav A, 2010, J MED CHEM, V53, P37, DOI 10.1021/jm901070c; Ji XD, 2014, ELIFE, V3, DOI 10.7554/eLife.02907; Kota V, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0156365; Kuehnert J, 2015, NUCLEIC ACIDS RES, V43, P581, DOI 10.1093/nar/gku1309; Liang CY, 2013, J BIOL CHEM, V288, P723, DOI 10.1074/jbc.M112.401323; Macarron R, 2011, MOL BIOTECHNOL, V47, P270, DOI 10.1007/s12033-010-9335-9; Malina A, 2005, FEBS LETT, V579, P79, DOI 10.1016/j.febslet.2004.06.103; Maraia RJ, 2006, MOL CELL, V21, P149, DOI 10.1016/j.molcel.2006.01.004; Martino L, 2012, NUCLEIC ACIDS RES, V40, P1381, DOI 10.1093/nar/gkr890; Meisner NC, 2007, NAT CHEM BIOL, V3, P508, DOI 10.1038/nchembio.2007.14; Mura M, 2015, ONCOGENE, V34, P5025, DOI 10.1038/onc.2014.428; Pelletier J, 2015, CANCER RES, V75, P250, DOI 10.1158/0008-5472.CAN-14-2789; Petz M, 2012, NUCLEIC ACIDS RES, V40, P9738, DOI 10.1093/nar/gks760; Petz M, 2012, NUCLEIC ACIDS RES, V40, P290, DOI 10.1093/nar/gkr717; Pudi R, 2004, J BIOL CHEM, V279, P29879, DOI 10.1074/jbc.M403417200; Schwartz EI, 2004, MOL CELL BIOL, V24, P9580, DOI 10.1128/MCB.24.21.9580-9591.2004; Shi Y., 2015, ONCOGENE; Sommer G, 2011, ONCOGENE, V30, P434, DOI 10.1038/onc.2010.425; Sommer G, 2008, FRONT BIOSCI-LANDMRK, V13, P5533; Sommer G, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025402; Srikantan S, 2012, FRONT BIOSCI-LANDMRK, V17, P189, DOI 10.2741/3921; Stavraka C, 2015, BIOMOLECULES, V5, P2701, DOI 10.3390/biom5042701; STEFANO JE, 1984, CELL, V36, P145, DOI 10.1016/0092-8674(84)90083-7; SVITKIN YV, 1994, J VIROL, V68, P1544, DOI 10.1128/JVI.68.3.1544-1550.1994; Tang J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036363; Teplova M, 2006, MOL CELL, V21, P75, DOI 10.1016/j.molcel.2005.10.027; Trotta R, 2003, CANCER CELL, V3, P145, DOI 10.1016/S1535-6108(03)00020-5; Wang ZH, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0138780; Wolin SL, 2002, ANNU REV BIOCHEM, V71, P375, DOI 10.1146/annurev.biochem.71.090501.150003; Wurth L, 2015, BBA-GENE REGUL MECH, V1849, P881, DOI 10.1016/j.bbagrm.2014.10.001; Xavier KA, 2000, TRENDS BIOTECHNOL, V18, P349, DOI 10.1016/S0167-7799(00)01464-5; Zhang JH, 1999, J BIOMOL SCREEN, V4, P67, DOI 10.1177/108705719900400206; Zhou S, 2013, BIOORGAN MED CHEM, V21, P6139, DOI 10.1016/j.bmc.2013.03.054	56	7	7	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 14	2017	12	3							e0173246	10.1371/journal.pone.0173246	http://dx.doi.org/10.1371/journal.pone.0173246			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN6DM	28291789	gold, Green Submitted, Green Published			2022-12-27	WOS:000396094700017
J	Tahara, T; Shibata, T; Okubo, M; Kawamura, T; Horiguchi, N; Yoshida, D; Ishizuka, T; Nagasaka, M; Nakagawa, Y; Ohmiya, N				Tahara, Tomomitsu; Shibata, Tomoyuki; Okubo, Masaaki; Kawamura, Tomohiko; Horiguchi, Noriyuki; Yoshida, Dai; Ishizuka, Takamitsu; Nagasaka, Mitsuo; Nakagawa, Yoshihito; Ohmiya, Naoki			Evaluations of primary lesions by endoscopy clearly distinguishes prognosis in patients with gastric cancer who receive chemotherapy	PLOS ONE			English	Article							PHASE-II TRIAL; ESOPHAGOGASTRIC JUNCTION; COMBINATION CHEMOTHERAPY; NEOADJUVANT CHEMOTHERAPY; PLUS CISPLATIN; S-1; ADENOCARCINOMAS; CARCINOMA; SURVIVAL; JAPAN	Background Chemotherapy may improve outcomes in gastric cancer (GC), especially for the patients with advanced stage. To explore useful predictive factor for GC performing chemotherapy, we compared the tumor responses assessed using computed tomography (CT) with endoscopy based criteria. Methods 192 GC patients performing chemotherapy were retrospectively studied. CT based response assessment was performed after 2 courses of treatment. Endoscopic evaluation according to The Japanese classification of gastric carcinoma was also performed at same period. Data were correlated with overall survival (OS) and progression-free survival (PFS). Results Majority of the cases (n = 178, 93%) received S-1 based chemotherapy as the first line treatment. 55 (29%) and 91 (47%) cases were considered to be CT and endoscopic responders. Endoscopic responder was more clearly associated with better OS and PFS compared to CT based responder by the log-rank test (P<0.0001 vs. 0.01 and P<0.0001 vs. 0.008, respectively). The association was more striking among patients performing neoadjuvant chemotherapy (P<0.0001 vs. 0.15 and P<0.0001 vs. 0.1, respectively). Multivariate survival analysis using Cox's regression model revealed that endoscopic non-responder was the independent predictive factor, being more strongly associated with worse OS when compared to CT non-responder (hazard ratio: 4.60 vs. 1.77, 95% confidence interval: 2.83-7.49 vs. 1.08-2.89, P<0.0001 vs. 0.02). More advanced T, N stage and cases who had peritoneal dissemination were significantly associated with endoscopic non-responder (all P values <0.01). Conclusion Endoscopy based evaluation of primary lesions are clearly associated with prognosis in patients with GC who perform chemotherapy.	[Tahara, Tomomitsu; Shibata, Tomoyuki; Okubo, Masaaki; Kawamura, Tomohiko; Horiguchi, Noriyuki; Yoshida, Dai; Ishizuka, Takamitsu; Nagasaka, Mitsuo; Nakagawa, Yoshihito; Ohmiya, Naoki] Fujita Hlth Univ, Sch Med, Dept Gastroenterol, Toyoake, Aichi, Japan	Fujita Health University	Tahara, T (corresponding author), Fujita Hlth Univ, Sch Med, Dept Gastroenterol, Toyoake, Aichi, Japan.	tomomiccyu@yahoo.co.jp						Boku N, 2009, LANCET ONCOL, V10, P1063, DOI 10.1016/S1470-2045(09)70259-1; Cunningham D, 2006, NEW ENGL J MED, V355, P11, DOI 10.1056/NEJMoa055531; Eisenhauer EA, 2009, EUR J CANCER, V45, P228, DOI 10.1016/j.ejca.2008.10.026; Ferlay J, 2001, IARC CANC BASES; Hamaguchi T, 2011, GASTRIC CANCER, V14, P226, DOI 10.1007/s10120-011-0030-8; Heger U, 2014, GASTRIC CANCER, V17, P478, DOI 10.1007/s10120-013-0296-0; Hirakawa M, 2013, CANCER CHEMOTH PHARM, V71, P789, DOI 10.1007/s00280-013-2073-5; Japanese Gastric Canc Assoc, 2011, GASTRIC CANCER, V14, P101, DOI 10.1007/s10120-011-0041-5; Kodera Y, 2010, GASTRIC CANCER, V13, P197, DOI 10.1007/s10120-010-0559-y; Koizumi W, 2008, LANCET ONCOL, V9, P215, DOI 10.1016/S1470-2045(08)70035-4; Koizumi W, 2012, CANCER CHEMOTH PHARM, V69, P407, DOI 10.1007/s00280-011-1701-1; Lau M, 2006, AM J GASTROENTEROL, V101, P2485, DOI 10.1111/j.1572-0241.2006.00778.x; LAUREN P, 1965, ACTA PATHOL MIC SC, V64, P31, DOI 10.1111/apm.1965.64.1.31; Lordick F, 2007, LANCET ONCOL, V8, P797, DOI 10.1016/S1470-2045(07)70244-9; Nakatani K, 2010, GASTRIC CANCER, V13, P36, DOI 10.1007/s10120-009-0533-8; Nashimoto A, 2013, GASTRIC CANCER, V16, P1, DOI 10.1007/s10120-012-0163-4; Okines AFC, 2009, ANN ONCOL, V20, P1529, DOI 10.1093/annonc/mdp047; Ott K, 2006, J CLIN ONCOL, V24, P4692, DOI 10.1200/JCO.2006.06.7801; Park SR, 2006, J GASTROENTEROL, V41, P339, DOI 10.1007/s00535-005-1759-9; Tsuburaya A, 2013, CANCER CHEMOTH PHARM, V71, P1309, DOI 10.1007/s00280-013-2130-0; Weber WA, 2001, J CLIN ONCOL, V19, P3058, DOI 10.1200/JCO.2001.19.12.3058; Yamaguchi K, 2013, GASTRIC CANCER, V16, P175, DOI 10.1007/s10120-012-0167-0; Yoshikawa T, 2014, SURG TODAY, V44, P11, DOI 10.1007/s00595-013-0529-1	23	6	7	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 13	2017	12	3							e0173663	10.1371/journal.pone.0173663	http://dx.doi.org/10.1371/journal.pone.0173663			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN6CP	28288188	Green Published, gold, Green Submitted			2022-12-27	WOS:000396092400026
J	Burkner, PC; Bittner, N; Holling, H; Buhlmann, U				Buerkner, Paul-Christian; Bittner, Nadine; Holling, Heinz; Buhlmann, Ulrike			D-cycloserine augmentation of behavior therapy for anxiety and obsessive-compulsive disorders: A meta-analysis	PLOS ONE			English	Article							PLACEBO-CONTROLLED TRIAL; QUALITY-OF-LIFE; EXPOSURE THERAPY; COGNITIVE ENHANCERS; FEAR EXTINCTION; BIAS; HETEROGENEITY; FACILITATION; COMORBIDITY; COMBINATION	Objective The present meta-analysis investigates whether the antibiotic D-cycloserine (DCS), a partial agonist at the glutamatergic N-methyl-D- aspartate receptor, can augment the effect of behavior therapy in humans with anxiety and obsessive-compulsive disorders. Method A keyword-based computer search was conducted using common electronic databases. Only studies investigating the effect of DCS in humans with anxiety and obsessive-compulsive disorders were included, resulting in 23 studies with a combined sample size of 1314 patients. Effect sizes were coded as Hedges' g and SMCC, the latter also incorporating differences in pre-treatment values. Bayesian multilevel meta-analysis was applied to take dependencies of effect sizes obtained from the same study into account. Results While previous meta-analyses found small to moderate improvements, the current results including the most recent research indicate that the overall effect of DCS is very small and almost indistinguishable from zero (g = -0.12, CI =[-0.27, 0.02]; SMCC = -0.10,CI = [-0.29, 0.07]). Slightly larger effects were found for social anxious patients. Further, study quality and year of publication were relevant moderators, with higher quality / more recent studies reported smaller effects of DCS. Conclusions These findings raise the question of the usefulness of DCS as an augmentation of exposure therapy for anxiety and obsessive-compulsive disorders. At least, it seems to be less promising than initially thought. The fact that study quality was inversely related to the reported effect sizes underlines the importance of high quality primary research in order to avoid over-estimation of treatment effects in clinical psychology.	[Buerkner, Paul-Christian; Bittner, Nadine; Holling, Heinz; Buhlmann, Ulrike] Univ Munster, Inst Psychol, Munster, Germany	University of Munster	Buhlmann, U (corresponding author), Univ Munster, Inst Psychol, Munster, Germany.	paul.buerkner@wwu.de; ulrike.buhlmann@wwu.de	Buhlmann, Ulrike/AAX-2794-2020; Holling, Heinz/K-3728-2017	Holling, Heinz/0000-0002-0311-3970; Burkner, Paul-Christian/0000-0001-5765-8995				American Psychiatric Association, 2013, DIAGNOSTIC AND STATI; American Psychiatric Association, 2000, DIAGNOSTIC AND STATI; Andersson E, 2015, JAMA PSYCHIAT, V72, P659, DOI 10.1001/jamapsychiatry.2015.0546; B?rkner P.-C, 2016, BRMS BAYESIAN REGRES; Baldwin DS, 2005, J PSYCHOPHARMACOL, V19, P567, DOI 10.1177/0269881105059253; Barlow DH, 2000, JAMA-J AM MED ASSOC, V283, P2529, DOI 10.1001/jama.283.19.2529; BOJE KM, 1993, BRAIN RES, V603, P207, DOI 10.1016/0006-8993(93)91239-O; Bontempo A, 2012, J CLIN PSYCHIAT, V73, P533, DOI 10.4088/JCP.11r07356; Bystritsky A, 2006, MOL PSYCHIATR, V11, P805, DOI 10.1038/sj.mp.4001852; Carpenter B, 2015, JOURNAL OF STATISTIC; Clark DM, 2003, J CONSULT CLIN PSYCH, V71, P1058, DOI 10.1037/0022-006X.71.6.1058; Davis M, 2002, EUR J NEUROSCI, V16, P395, DOI 10.1046/j.1460-9568.2002.02138.x; de Kleine RA, 2013, EUR J PSYCHOTRAUMATO, V4, DOI 10.3402/ejpt.v4i0.21626; de Kleine RA, 2012, BIOL PSYCHIAT, V71, P962, DOI 10.1016/j.biopsych.2012.02.033; Doi SAR, 2008, EPIDEMIOLOGY, V19, P94, DOI 10.1097/EDE.0b013e31815c24e7; Duval S, 2000, BIOMETRICS, V56, P455, DOI 10.1111/j.0006-341X.2000.00455.x; Egger M, 2003, Health Technol Assess, V7, P1; Farrell LJ, 2013, DEPRESS ANXIETY, V30, P723, DOI 10.1002/da.22132; Foa EB, 2005, AM J PSYCHIAT, V162, P151, DOI 10.1176/appi.ajp.162.1.151; Frantz J, 2009, G3DATA, V1; Guastella AJ, 2008, BIOL PSYCHIAT, V63, P544, DOI 10.1016/j.biopsych.2007.11.011; HIGGINS JPT, 2011, COCHRANE HDB SYSTEMA, V0001; Higgins JPT, 2002, STAT MED, V21, P1539, DOI 10.1002/sim.1186; Hofmann SG, 2006, ARCHIVES OF GENERAL, V63; Hofmann SG, 2008, J CLIN PSYCHIAT, V69, P621, DOI 10.4088/jcp.v69n0415; Hofmann SG, 2014, DEPRESS ANXIETY, V31, P175, DOI 10.1002/da.22257; Hofmann SG, 2014, RESTOR NEUROL NEUROS, V32, P183, DOI 10.3233/RNN-139002; Hofmann SG, 2013, AM J PSYCHIAT, V170, P751, DOI 10.1176/appi.ajp.2013.12070974; Hopewell S., 2007, COCHRANE DATABASE SY; Huedo-Medina TB, 2006, PSYCHOL METHODS, V11, P193, DOI 10.1037/1082-989X.11.2.193; Hulley SB., 2013, DESIGNING CLIN RES; Huppert JD, 2009, DEPRESS ANXIETY, V26, P39, DOI 10.1002/da.20506; Kessler RC, 2005, ARCH GEN PSYCHIAT, V62, P593, DOI 10.1001/archpsyc.62.6.593; Kushner MG, 2007, BIOL PSYCHIAT, V62, P835, DOI 10.1016/j.biopsych.2006.12.020; Litz BT, 2012, J PSYCHIATR RES, V46, P1184, DOI 10.1016/j.jpsychires.2012.05.006; Mataix-Cols D., 2017, JAMA PSYCHIAT; Mataix-Cols D, 2014, BRIT J PSYCHIAT, V204, P77, DOI 10.1192/bjp.bp.113.126284; McAuley L, 2000, LANCET, V356, P1228, DOI 10.1016/S0140-6736(00)02786-0; Moher D, 1998, LANCET, V352, P609, DOI 10.1016/S0140-6736(98)01085-X; Morris SB, 2002, PSYCHOL METHODS, V7, P105, DOI 10.1037//1082-989X.7.1.105; Nave AM, 2012, J CLIN PSYCHIAT, V73, P1179, DOI 10.4088/JCP.11m07564; Norberg MM, 2008, BIOL PSYCHIAT, V63, P1118, DOI 10.1016/j.biopsych.2008.01.012; Otto MW, 2016, DEPRESS ANXIETY, V33, P737, DOI 10.1002/da.22531; Otto MW, 2010, BIOL PSYCHIAT, V67, P365, DOI 10.1016/j.biopsych.2009.07.036; Pollack MH, 2008, DEPRESS ANXIETY, V25, P467, DOI 10.1002/da.20329; Rapee RM, 2016, BEHAV RES THER, V87, P225, DOI 10.1016/j.brat.2016.10.004; Ressler KJ, 2004, ARCH GEN PSYCHIAT, V61, P1136, DOI 10.1001/archpsyc.61.11.1136; Richardson R, 2004, LEARN MEMORY, V11, P510, DOI 10.1101/lm.78204; Rodrigues H, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0093519; Rothbaum BO, 2014, AM J PSYCHIAT, V171, P640, DOI 10.1176/appi.ajp.2014.13121625; Rothstein HR, 2005, PUBLICATION BIAS IN; Ruscio AM, 2010, MOL PSYCHIATR, V15, P53, DOI 10.1038/mp.2008.94; Scheeringa MS, 2014, J CHILD ADOL PSYCHOP, V24, P69, DOI 10.1089/cap.2013.0106; SCHULZ KF, 1995, JAMA-J AM MED ASSOC, V273, P408, DOI 10.1001/jama.273.5.408; Sheerin CM., 2013, SLOPE OF CHANGE THRO; Siegfried N, 2009, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD003362.pub2; Siegmund A, 2011, J PSYCHIATR RES, V45, P1042, DOI 10.1016/j.jpsychires.2011.01.020; Simmons JP, 2011, PSYCHOL SCI, V22, P1359, DOI 10.1177/0956797611417632; Stein DJ, 2000, CNS SPECTRUMS, V5, P37; Sterne JAC, 2001, J CLIN EPIDEMIOL, V54, P1046, DOI 10.1016/S0895-4356(01)00377-8; Sterne JAC, 2011, BMJ-BRIT MED J, V343, DOI 10.1136/bmj.d4002; Storch EA, 2007, INT CLIN PSYCHOPHARM, V22, P230, DOI 10.1097/YIC.0b013e32819f8480; Storch EA, 2016, JAMA PSYCHIAT, V73, P779, DOI 10.1001/jamapsychiatry.2016.1128; Storch EA, 2010, BIOL PSYCHIAT, V68, P1073, DOI 10.1016/j.biopsych.2010.07.015; Tart CD, 2013, J PSYCHIATR RES, V47, P168, DOI 10.1016/j.jpsychires.2012.09.024; Thompson SG, 2002, STAT MED, V21, P1559, DOI 10.1002/sim.1187; Tritchler D, 1999, STAT MED, V18, P2135, DOI 10.1002/(SICI)1097-0258(19990830)18:16<2135::AID-SIM183>3.3.CO;2-X; Viechtbauer W, 2010, J STAT SOFTW, V36, P1, DOI 10.18637/jss.v036.i03; Wilhelm S, 2008, AM J PSYCHIAT, V165, P335, DOI 10.1176/appi.ajp.2007.07050776; World Health Organization, 1992, ICD 10 CLASS MENT BE	70	20	20	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 10	2017	12	3							e0173660	10.1371/journal.pone.0173660	http://dx.doi.org/10.1371/journal.pone.0173660			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EN6CJ	28282427	gold, Green Published			2022-12-27	WOS:000396091800063
J	Chen, JH; Borges, M				Chen, Jey-Hsin; Borges, Melissa			Histopathology and enhanced detection of tumor invasion of peritoneal membranes	PLOS ONE			English	Article							ELASTIC LAMINAL INVASION; II COLON-CANCER; COLORECTAL-CANCER; SEROSAL INVASION; STAGE-II; RECTAL-CANCER; INVOLVEMENT; SURVIVAL; PROGNOSIS; STAIN	Tumor invasion of the peritoneal membrane may have an adverse prognostic significance, but its histopathologic features can be diagnostically difficult to recognize. We observed that local peritoneal injury associated with tumor invasion is characterized by activation and proliferation of serosal stromal cells that express cytokeratin, a characteristic property of injured serosal membranes that may have diagnostic utility. To explore this, we examined 120 primary tumors of the gastrointestinal tract and pancreaticobiliary system using cytokeratin and elastic stains to assess for tumor invasion of peritoneal membranes. Peritoneal invasion by tumor was associated with retraction, splaying, and destruction of the elastic lamina and proliferation of keratin-expressing stromal cells of serosal membranes. All 82 peritoneal invasive tumors were characterized by neoplastic cells that invaded the elastic lamina and the serosal connective tissue with neoplastic cells that abutted or were surrounded by keratin-positive stromal cells, whereas all 38 tumors limited to the subserosa showed none of these features. The diagnosis of tumor invasion of peritoneal membranes is enhanced by the combined use of cytokeratin and elastic stains, which in turn would enable better histopathologic correlation with patient treatment and outcome.	[Chen, Jey-Hsin; Borges, Melissa] CellNetix Pathol & Labs, Seattle, WA 98104 USA; [Chen, Jey-Hsin] Swedish Med Ctr, Seattle, WA 98122 USA	Swedish Medical Center	Chen, JH (corresponding author), CellNetix Pathol & Labs, Seattle, WA 98104 USA.; Chen, JH (corresponding author), Swedish Med Ctr, Seattle, WA 98122 USA.	jchen@cellnetix.com			CellNetix Pathology and Laboratories	CellNetix Pathology and Laboratories	Both authors are employed by CellNetix Pathology and Laboratories, which provided support in the form of salaries for the authors (JHC and MB), research materials, and publication fees, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	BOKU T, 1990, BRIT J SURG, V77, P436, DOI 10.1002/bjs.1800770425; BOLEN JW, 1986, AM J SURG PATHOL, V10, P34, DOI 10.1097/00000478-198601000-00005; Compton C, 2000, CANCER-AM CANCER SOC, V88, P1739, DOI 10.1002/(SICI)1097-0142(20000401)88:7<1739::AID-CNCR30>3.0.CO;2-T; Edge S, 2010, AJCC CANC STAGING MA, V7th; ELLIS H, 1965, BRIT J SURG, V52, P471, DOI 10.1002/bjs.1800520616; EPSTEIN JI, 1986, HUM PATHOL, V17, P514, DOI 10.1016/S0046-8177(86)80042-9; Erlichman C, 1999, J CLIN ONCOL, V17, P1356, DOI 10.1200/JCO.1999.17.5.1356; Friedl P, 2011, CELL, V147, P992, DOI 10.1016/j.cell.2011.11.016; GALLAGHER B, 1990, HUM PATHOL, V21, P512, DOI 10.1016/0046-8177(90)90007-R; Grin A, 2013, HUM PATHOL, V44, P2696, DOI 10.1016/j.humpath.2013.07.013; KAIBARA N, 1987, CANCER, V60, P136, DOI 10.1002/1097-0142(19870701)60:1<136::AID-CNCR2820600125>3.0.CO;2-X; Katsumata D, 2008, SURG TODAY, V38, P115, DOI 10.1007/s00595-007-3608-3; Kazlouskaya V, 2013, J CUTAN PATHOL, V40, P211, DOI 10.1111/cup.12036; Keshava A, 2007, COLORECTAL DIS, V9, P609, DOI 10.1111/j.1463-1318.2006.01136.x; KNUDSEN PJT, 1991, J ANAT, V177, P41; Kojima M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088018; Kojima M, 2012, FRONT ONCOL, V2, DOI 10.3389/fonc.2012.00179; Kojima M, 2010, AM J SURG PATHOL, V34, P1351, DOI 10.1097/PAS.0b013e3181ecfe98; Lennon AM, 2003, AM J CLIN PATHOL, V119, P108, DOI 10.1309/J6BDTWM2M792TN2V; Liang WY, 2013, AM J SURG PATHOL, V37, P1565, DOI 10.1097/PAS.0b013e31828ea2de; Ludeman L, 2005, HISTOPATHOLOGY, V47, P123, DOI 10.1111/j.1365-2559.2005.02189.x; Mamounas E, 1999, J CLIN ONCOL, V17, P1349, DOI 10.1200/JCO.1999.17.5.1349; Nakanishi Y, 2016, ARCH PATHOL LAB MED, V140, P81, DOI 10.5858/arpa.2014-0647-OA; NEWLAND RC, 1994, CANCER, V73, P2076, DOI 10.1002/1097-0142(19940415)73:8<2076::AID-CNCR2820730811>3.0.CO;2-6; PITT MA, 1995, J CLIN PATHOL, V48, P226, DOI 10.1136/jcp.48.3.226; Polyak K, 2009, TRENDS GENET, V25, P30, DOI 10.1016/j.tig.2008.10.012; RAFTERY AT, 1973, BRIT J SURG, V60, P293, DOI 10.1002/bjs.1800600412; Shepherd NA, 1997, GASTROENTEROLOGY, V112, P1096, DOI 10.1016/S0016-5085(97)70119-7; Shinto E, 2004, DIS COLON RECTUM, V47, P467, DOI 10.1007/s10350-003-0083-9; Snaebjornsson P, 2014, INT J CANCER, V135, P467, DOI 10.1002/ijc.28676; Sobin LH., 2003, INT UNION CANC UICC, V7, DOI [10.1002/0471463752, DOI 10.1002/0471463752]; Stewart CJR, 2007, HISTOPATHOLOGY, V51, P372, DOI 10.1111/j.1365-2559.2007.02787.x; Stewart Colin J R, 2011, Cancers (Basel), V3, P164, DOI 10.3390/cancers3010164; Travis WD, 2008, J THORAC ONCOL, V3, P1384, DOI 10.1097/JTO.0b013e31818e0d9f; Yokota M, 2014, DIS COLON RECTUM, V57, P830, DOI 10.1097/DCR.0000000000000124	35	4	4	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 10	2017	12	3							e0173833	10.1371/journal.pone.0173833	http://dx.doi.org/10.1371/journal.pone.0173833			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN6CJ	28282462	Green Published, Green Submitted, gold			2022-12-27	WOS:000396091800082
J	Drew, ML; Weiser, GC				Drew, Mark L.; Weiser, Glen C.			Potential disease agents in domestic goats and relevance to bighorn sheep (Ovis canadensis) management	PLOS ONE			English	Article							PASTEURELLA-HAEMOLYTICA; RESPIRATORY-DISEASE; MYCOPLASMA-OVIPNEUMONIAE; TRANSMISSION; PNEUMONIA; TREHALOSI; CONTACT; HERDS; COMB; SPP.	Domestic goats are raised for meat, milk and hair production, in herds for rangeland weed control, and as pack animals. Domestic sheep, goats and wild bighorn sheep are all susceptible to a multifactorial pneumonia. We sampled 43 herd goats from 7 herds and 48 pack goats from 11 herds for viral and bacterial serology, parasitology, and Pasteurellaceae microbiology. The goats in this study were in generally good health, although most goats did harbor various pathogens and parasites including several bacteria, specifically Pasteurellaceae, which have been associated with pneumonia in free-ranging bighorn sheep. It is not known if domestic goats can transmit the Pasteurellaceae or other pathogens found in this study readily to wild bighorn sheep. However, due the possibility of transmission, domestic goats in areas in or near bighorn sheep habitat should be managed to minimize the risk of spreading disease agents to bighorn sheep.	[Drew, Mark L.] Idaho Dept Fish & Game, Wildlife Hlth Lab, Eagle, ID 83616 USA; [Weiser, Glen C.] Univ Idaho, Caine Vet Teaching Ctr, Caldwell, ID USA	Idaho; University of Idaho	Drew, ML (corresponding author), Idaho Dept Fish & Game, Wildlife Hlth Lab, Eagle, ID 83616 USA.	Mark.drew@idfg.idaho.gov		Drew, Mark/0000-0002-1277-3284	Idaho Department of Fish and Game	Idaho Department of Fish and Game	Funding was provided by Idaho Department of Fish and Game. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Angen O, 2002, VET MICROBIOL, V84, P103, DOI 10.1016/S0378-1135(01)00439-4; Angen O, 1999, INT J SYST BACTERIOL, V49, P67, DOI 10.1099/00207713-49-1-67; Angen O, 1999, VET MICROBIOL, V65, P253, DOI 10.1016/S0378-1135(98)00304-6; Besser TE, 2008, J CLIN MICROBIOL, V46, P423, DOI 10.1128/JCM.01931-07; BISGAARD M, 1995, HAEMOPHILUS, ACTINOBACILLUS, AND PASTEURELLA, P1; Blackall PJ, 2007, INT J SYST EVOL MICR, V57, P666, DOI 10.1099/ijs.0.64521-0; Brogden KA, 1998, VET RES, V29, P233; COGGINS VL, 1988, P BIENN S NO SHEEP G, V6, P57; CZUPRYNSKI CJ, 1995, HAEMOPHILUS, ACTINOBACILLUS, AND PASTEURELLA, P143; Drew ML, 2014, WILDLIFE SOC B, V38, P332, DOI 10.1002/wsb.393; Fisher MA, 1999, AM J VET RES, V60, P1402; Foreyt W.J., 1994, P BIENN S NO WILD SH, V9, P7; Foreyt WJ, 2009, J WILDLIFE DIS, V45, P272, DOI 10.7589/0090-3558-45.2.272; FOREYT WJ, 1989, AM J VET RES, V50, P341; Foreyt WJ, 1994, VET PARASITOLOGY REF, V3rd; Heinse LM, 2016, WILDLIFE SOC B, P625; Jansen BD, 2006, J WILDLIFE DIS, V42, P407, DOI 10.7589/0090-3558-42.2.407; Jaworski MD, 1998, J VET DIAGN INVEST, V10, P49, DOI 10.1177/104063879801000109; JAWORSKI MD, 1993, J CLIN MICROBIOL, V31, P831, DOI 10.1128/JCM.31.4.831-835.1993; MARTIN KD, 1996, P BIENN S NO WILD SH, V10, P72; McAuliffe L, 2003, VET REC, V153, P687, DOI 10.1136/vr.153.22.687; Miller David S., 2012, Veterinary Medicine International, V2011, DOI 10.4061/2011/162520; Miller DS, 2011, VET MICROBIOL, V150, P284, DOI 10.1016/j.vetmic.2011.01.024; Miller MW, 2013, J WILDLIFE DIS, V49, P653, DOI 10.7589/2012-11-274; Miller Michael W., 2001, P330, DOI 10.1002/9780470344880.ch20; Miller MW, 2008, PASTEURELLOSIS TRANS; Monello RJ, 2001, CAN J ZOOL, V79, P1423, DOI 10.1139/cjz-79-8-1423; ONDERKA DK, 1988, J WILDLIFE DIS, V24, P663, DOI 10.7589/0090-3558-24.4.663; ROBINSON RA, 1983, VET CLIN N AM-LARGE, V5, P539; Rudolph KM, 2007, J ZOO WILDLIFE MED, V38, P548, DOI 10.1638/2006-0027R.1; Rudolph KM, 2003, J WILDLIFE DIS, V39, P897, DOI 10.7589/0090-3558-39.4.897; Smith MC, 1983, VET CLIN N AM LARGE, V5; Toweill D. D. E., 1999, RETURN ROYALTY WILD; United States Department of Agriculture, 2011, SMALL SCAL US GOAT O; United States Department of Agriculture, 2016, SHEEP AND GOATS; United States Department of Agriculture, 2004, GOAT IND STRUCT CONC; Ward ACS, 2002, AM J VET RES, V63, P119, DOI 10.2460/AJVR.2002.63.119; Ward ACS, 1997, J WILDLIFE DIS, V33, P544, DOI 10.7589/0090-3558-33.3.544; Western Association of Fish and Wildlife Agencies, 2010, REC DOM SHEEP GOAT M; Western Association of Fish and Wildlife Agencies, 2015, WAFWA WILDL HLTH COM; Wood ME, 2017, J WILDLIFE DIS, V53, P126, DOI 10.7589/2016-05-097	41	1	1	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 10	2017	12	3							e73396	10.1371/journal.pone.0173396	http://dx.doi.org/10.1371/journal.pone.0173396			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN6CJ	28282407	Green Published, Green Submitted, gold			2022-12-27	WOS:000396091800036
J	Ohashi, N; Ohashi, M; Endo, N; Kohno, T				Ohashi, Nobuko; Ohashi, Masayuki; Endo, Naoto; Kohno, Tatsuro			Administration of tranexamic acid to patients undergoing surgery for adolescent idiopathic scoliosis evokes pain and increases the infusion rate of remifentanil during the surgery	PLOS ONE			English	Article							SPINAL DORSAL-HORN; OPIOID TOLERANCE; GLYCINE; ALLODYNIA; RECEPTORS; SEIZURES; IMMUNOREACTIVITY; HYPERALGESIA; PLASMINOGEN; CONSUMPTION	Background We recently reported that tranexamic acid (TXA) evokes pain in rats by inhibiting.-aminobutyric acid and glycine receptors on neurons in the spinal dorsal horn. Although TXA is commonly used to reduce perioperative blood loss during various surgeries, its potential to induce intraoperative nociception, thereby increasing the need for more analgesics during surgery, has not been investigated. Therefore, this study aimed to investigate whether TXA evokes pain and increases the need for a higher infusion rate of remifentanil in patients undergoing surgery for adolescent idiopathic scoliosis (AIS). Methods Data were collected from patients with AIS who underwent posterior spinal fusion surgery from January 2008 to December 2015. All surgical procedures were performed under total intravenous anesthesia with propofol and remifentanil, by the same team of orthopedic surgeons and anesthesiologists at a single institution. Patients in the TXA group were administered TXA (loading and maintenance doses, 1000 mg and 100 mg/h) whereas those in the control group were not. Our primary outcome was the infusion rate of the intraoperative opioid analgesic remifentanil. Results The final analysis was based on data collected from 33 and 30 patients in the control and TXA groups, respectively. No differences were observed in the demographic data or the hemodynamic parameters between the two groups of patients. In the TXA group, the durations of surgery and anesthesia were shorter, intravascular fluid volume and total blood loss were lower, and the doses of fentanyl and ketamine administered were higher than they were in the control group (P < 0.05 for all). The mean infusion rate of intraoperative remifentanil was significantly higher in the TXA group than in the control group (control group: 0.23 +/- 0.04 mu g/kg/min; TXA group: 0.28 +/- 0.12 mu g/kg/min; P = 0.014). Conclusions Patients who received TXA during the AIS surgery required a higher infusion rate of remifentanil, indicating that TXA evoked pain during the surgery.	[Ohashi, Nobuko; Kohno, Tatsuro] Niigata Univ, Grad Sch Med & Dent Sci, Div Anesthesiol, Chuo Ku, Niigata, Japan; [Ohashi, Masayuki; Endo, Naoto] Niigata Univ, Grad Sch Med & Dent Sci, Div Orthoped Surg,Dept Regenerat & Transplant Med, Chuo Ku, Niigata, Japan	Niigata University; Niigata University	Kohno, T (corresponding author), Niigata Univ, Grad Sch Med & Dent Sci, Div Anesthesiol, Chuo Ku, 1-757 Asahimachi Dori, Niigata, Japan.	kohno-t@umin.net						ANDERSSON L, 1968, ANN NY ACAD SCI, V146, P642, DOI 10.1111/j.1749-6632.1968.tb20322.x; Bergmann I, 2013, BRIT J ANAESTH, V110, P622, DOI 10.1093/bja/aes426; Butala BP, 2012, INDIAN J ANAESTH, V56, P168, DOI 10.4103/0019-5049.96335; Rocha Vinícius Magno da, 2015, Rev. bras. ortop., V50, P226, DOI 10.1016/j.rboe.2015.03.007; Dunn CJ, 1999, DRUGS, V57, P1005, DOI 10.2165/00003495-199957060-00017; Elgafy H, 2010, SPINE, V35, pS47, DOI 10.1097/BRS.0b013e3181d833f6; GAME CJA, 1975, EXP BRAIN RES, V23, P75; Garcha PS, 2007, ANESTH ANALG, V104, P241, DOI 10.1213/01.ane.0000250436.17786.72; Grant JA, 2009, J PEDIATR ORTHOPED, V29, P300, DOI 10.1097/BPO.0b013e31819a85de; Guignard B, 2000, ANESTHESIOLOGY, V93, P409, DOI 10.1097/00000542-200008000-00019; Hood DD, 2003, ANESTH ANALG, V97, P810, DOI 10.1213/01.ANE.0000078811.80093.88; HOYLAERTS M, 1981, BIOCHIM BIOPHYS ACTA, V673, P75; Ishikawa T, 2000, NEUROSCIENCE, V95, P781; IWAMOTO M, 1975, THROMB DIATH HAEMOST, V33, P573, DOI 10.1055/s-0038-1647851; Joly V, 2005, ANESTHESIOLOGY, V103, P147, DOI 10.1097/00000542-200507000-00022; Kaabachi O, 2011, SAUDI J ANAESTH, V5, P90, DOI 10.4103/1658-354X.76504; Kalavrouziotis D, 2012, ANN THORAC SURG, V93, P148, DOI 10.1016/j.athoracsur.2011.07.085; KASSELL NF, 1984, J NEUROSURG, V61, P225, DOI 10.3171/jns.1984.61.2.0225; Kim SH, 2014, FRONT PHARMACOL, V5, DOI 10.3389/fphar.2014.00108; Koppert W, 2003, PAIN, V106, P91, DOI 10.1016/S0304-3959(03)00294-X; Lecker I, 2012, J CLIN INVEST, V122, P4654, DOI 10.1172/JCI63375; Leede-van der Maarl MGJ, 1999, J NEUROL, V246, P843, DOI 10.1007/s004150050466; Lenke LG, 2001, J BONE JOINT SURG AM, V83A, P1169, DOI 10.2106/00004623-200108000-00006; Loomis CW, 2001, J PHARMACOL EXP THER, V296, P756; Lukes AS, 2011, WOMENS HEALTH, V7, P591, DOI [10.2217/WHE.11.55, 10.2217/whe.11.55]; Michelsen LG, 1996, J CLIN ANESTH, V8, P679, DOI 10.1016/S0952-8180(96)00179-1; Mohseni K, 2009, ANESTH ANALG, V108, P1984, DOI 10.1213/ane.0b013e3181a04d69; Murkin JM, 2010, ANESTH ANALG, V110, P350, DOI 10.1213/ANE.0b013e3181c92b23; Nakasuji M, 2010, BRIT J ANAESTH, V105, P162, DOI 10.1093/bja/aeq121; Ng BKW, 2015, SCOLIOSIS SPINAL DIS, V10, DOI 10.1186/s13013-015-0052-9; Ohashi N, 2015, SCI REP-UK, V5, DOI 10.1038/srep13458; Onaka M, 1996, ANESTHESIOLOGY, V84, P1215, DOI 10.1097/00000542-199605000-00024; Remerand F, 2013, ORTHOP TRAUMATOL-SUR, V99, P667, DOI 10.1016/j.otsr.2013.03.029; Sharma V, 2014, ANAESTHESIA, V69, P124, DOI 10.1111/anae.12516; Song YK, 2014, KOREAN J ANESTHESIOL, V66, P44, DOI 10.4097/kjae.2014.66.1.44; THORSEN S, 1975, BIOCHIM BIOPHYS ACTA, V393, P55, DOI 10.1016/0005-2795(75)90216-0; TODD AJ, 1990, BRAIN RES, V514, P171, DOI 10.1016/0006-8993(90)90454-J; Todd AJ, 1996, J NEUROSCI, V16, P974; TODD AJ, 1990, NEUROSCIENCE, V39, P387, DOI 10.1016/0306-4522(90)90275-9; Verma Kushagra, 2014, J Bone Joint Surg Am, V96, pe80, DOI 10.2106/JBJS.L.00008; Wang H, 2014, BRIT J ANAESTH, V112, P1075, DOI 10.1093/bja/aeu001; Yagi M, 2012, SPINE, V37, pE1336, DOI 10.1097/BRS.0b013e318266b6e5; YAKSH TL, 1989, PAIN, V37, P111, DOI 10.1016/0304-3959(89)90160-7	43	12	12	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 10	2017	12	3							e0173622	10.1371/journal.pone.0173622	http://dx.doi.org/10.1371/journal.pone.0173622			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN6CJ	28282425	Green Submitted, Green Published, gold			2022-12-27	WOS:000396091800057
J	Rajput, IR; Huang, Y; Sun, YJ; Arain, MA; Li, WF; Li, P; Bloch, DM; Liu, WH				Rajput, Imran Rashid; Huang Ying; Sun Yajing; Arain, Muhammad Asif; Li Weifen; Li Ping; Bloch, Dost Muhammad; Liu Wenhua			Saccharomyces boulardii and Bacillus subtilis B10 modulate TLRs and cytokines expression patterns in jejunum and ileum of broilers	PLOS ONE			English	Article							TOLL-LIKE RECEPTORS; REGULATORY T-CELLS; GUT; MECHANISM; HOST; IMMUNOMODULATION; LACTOBACILLI; ACTIVATION; RESPONSES; BACTERIA	The present study was designed to evaluate the effects of Saccharomyces boulardii (Sb) and Bacillus subtilis B10 (Bs) on intestinal epithelial Toll like receptors (TLR), and Cytokine expression response to understand the intestinal epithelial innate immune mechanism in broilers. A total of 300 birds (Sanhuang broilers) were allotted into three groups (n = 100) and each divided into five replications (n = 20). Control group (Ctr) birds were fed basal diet, broilers in experimental groups received (1x10 (8) cfu/ kg feed) Sb and Bs respectively in addition to basal diet for 72 days. The result showed significant increase in mRNA expression level of TLR2, TLR4 and TLR15. Down streaming MyD88, TRAF6, TAB2 and NF-.B mRNA level noted higher, in the jejunum and ileum as compared to control group. Meanwhile, IL- 6, TNFa, IL- 10, TGF- beta expression levels showed high expression in the jejunum of Sb and Bs groups. IL- 10 expression level increased in the ileum and IL- 6, TNFa, IL- 10 and TGF- beta expression levels increased in the jejunum of Sb group. Levels of IL- 1 beta , IL- 17, and IL- 4, increased merely in Sb group. Ileal cytokines IL- 1 beta, IL- 17 and IL- 4concentration were noted higher in Sb group, and IL- 1 beta, and IL- 4 levels were up- regulated in Bs group. The results indicated that the INF-. and IL- 8 level decreased in Sb and BS groups. Serum IgA and sIgA level increased in both treatment groups. Our findings illustrated that S. boulardii and B. subtilis B10 may have a role to induce mucosal immunity by activating the TLRs and cytokines expressions in broilers.	[Rajput, Imran Rashid; Huang Ying; Sun Yajing; Li Ping] Shantou Univ, Coll Sci, Shantou, Guangdong, Peoples R China; [Rajput, Imran Rashid; Li Weifen; Liu Wenhua] Zhejiang Univ, Coll Anim Sci, Hangzhou, Zhejiang, Peoples R China; [Rajput, Imran Rashid; Arain, Muhammad Asif; Bloch, Dost Muhammad] Lasbela Univ Agr Water & Marine Sci, Fac Vet & Anim Sci, Uthal, Balochistan, Pakistan; [Arain, Muhammad Asif] Northwest A&F Univ, Coll Anim Sci & Technol, Yangling, Peoples R China	Shantou University; Zhejiang University; Lasbela University of Agricultural Water & Marine Science; Northwest A&F University - China	Rajput, IR (corresponding author), Shantou Univ, Coll Sci, Shantou, Guangdong, Peoples R China.; Rajput, IR (corresponding author), Zhejiang Univ, Coll Anim Sci, Hangzhou, Zhejiang, Peoples R China.; Rajput, IR (corresponding author), Lasbela Univ Agr Water & Marine Sci, Fac Vet & Anim Sci, Uthal, Balochistan, Pakistan.	drimranrajput@gmail.com		RASHID, IMRAN/0000-0002-3172-4541; Sun, Yajing/0000-0002-7650-2205	Specialized Research Fund [20110101110101, 20134402110005]; National Natural Science Foundation of China [41676166]; Guangdong Specialized Project for Discipline Improvement [2012gjhz0008]	Specialized Research Fund(Specialized Research Fund for the Doctoral Program of Higher Education (SRFDP)); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Guangdong Specialized Project for Discipline Improvement	This work was supported by the grants obtained from Specialized Research Fund for the Doctoral Program of Higher Education (No.20110101110101),National Natural Science Foundation of China (grant numbers 41676166), Specialized Research Fund for the Doctoral Program of Higher Education of China (grant number 20134402110005);Guangdong Specialized Project for Discipline Improvement(grant number 2012gjhz0008). The funders had no role in study design, data collection and analysis, decision to publish,or preparation of the manuscript.	Abreu MT, 2005, J IMMUNOL, V174, P4453, DOI 10.4049/jimmunol.174.8.4453; Alp G, 2010, MICROBIOL IMMUNOL, V54, P658, DOI 10.1111/j.1348-0421.2010.00227.x; Araki A, 2005, J GASTROENTEROL, V40, P16, DOI 10.1007/s00535-004-1492-9; Arch RH, 1998, GENE DEV, V12, P2821, DOI 10.1101/gad.12.18.2821; Atarashi K, 2011, SCIENCE, V331, P337, DOI 10.1126/science.1198469; Bos NA, 2001, GUT, V48, P762, DOI 10.1136/gut.48.6.762; Cario E, 2000, INFECT IMMUN, V68, P7010, DOI 10.1128/IAI.68.12.7010-7017.2000; Cerutti A, 2008, IMMUNITY, V28, P740, DOI 10.1016/j.immuni.2008.05.001; Christensen HR, 2002, J IMMUNOL, V168, P171, DOI 10.4049/jimmunol.168.1.171; Coburn B, 2007, IMMUNOL CELL BIOL, V85, P112, DOI 10.1038/sj.icb.7100007; de Zoete MR, 2011, P NATL ACAD SCI USA, V108, P4968, DOI 10.1073/pnas.1018135108; Deng L, 2000, CELL, V103, P351, DOI 10.1016/S0092-8674(00)00126-4; Dogi CA, 2008, CYTOKINE, V41, P223, DOI 10.1016/j.cyto.2007.11.014; Downing T, 2010, J IMMUNOL, V184, P6993, DOI 10.4049/jimmunol.0903092; Eckmann L, 2001, MICROBES INFECT, V3, P1191, DOI 10.1016/S1286-4579(01)01479-4; FAO/WHO, 2002, WORK GROUP REP DRAFT; Fuku A, 2001, J BIOL CHEM, V276, P47143, DOI 10.1074/jbc.M103902200; Gewirtz AT, 2004, J INFECT DIS, V189, P1914, DOI 10.1086/386289; Gomez-Llorente C, 2010, P NUTR SOC, V69, P381, DOI 10.1017/S0029665110001527; Groux H, 1999, IMMUNOL TODAY, V20, P442, DOI 10.1016/S0167-5699(99)01510-8; Higgs R, 2006, INFECT IMMUN, V74, P1692, DOI 10.1128/IAI.74.3.1692-1698.2006; Huang Y, 2012, PAK VET J, V32, P81; Jawhara S, 2007, MED MYCOL, V45, P691, DOI 10.1080/13693780701523013; Jeon Seong Gyu, 2012, PLoS Pathog, V8, pe1002714, DOI 10.1371/journal.ppat.1002714; Keestra AM, 2007, J IMMUNOL, V178, P7110, DOI 10.4049/jimmunol.178.11.7110; Koenen ME, 2004, BRIT POULTRY SCI, V45, P355, DOI 10.1080/00071660410001730851; Lammers KM, 2003, FEMS IMMUNOL MED MIC, V38, P165, DOI 10.1016/S0928-8244(03)00144-5; Li WF, 2013, PAK VET J, V33, P9; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Macpherson AJ, 2000, SCIENCE, V288, P2222, DOI 10.1126/science.288.5474.2222; McCracken VJ, 2001, CELL MICROBIOL, V3, P1, DOI 10.1046/j.1462-5822.2001.00090.x; Nerren JR, 2010, VET IMMUNOL IMMUNOP, V136, P151, DOI 10.1016/j.vetimm.2010.02.017; O'Sullivan D J, 2000, Curr Issues Intest Microbiol, V1, P39; Rajput IR, 2013, POULTRY SCI, V92, P956, DOI 10.3382/ps.2012-02845; Rajput IR, 2012, PAK VET J, V32, P303; Rakoff-Nahoum S, 2004, CELL, V118, P229, DOI 10.1016/j.cell.2004.07.002; Sato K, 2009, POULTRY SCI, V88, P2532, DOI 10.3382/ps.2009-00291; St Paul M, 2013, VET IMMUNOL IMMUNOP, V152, P191, DOI 10.1016/j.vetimm.2012.10.013; St Paul M, 2011, VET IMMUNOL IMMUNOP, V144, P228, DOI 10.1016/j.vetimm.2011.09.004; Stoel M, 2005, J IMMUNOL, V174, P1046, DOI 10.4049/jimmunol.174.2.1046; Takeda K, 2004, SEMIN IMMUNOL, V16, P3, DOI 10.1016/j.smim.2003.10.003; Takeuchi O, 2000, INT IMMUNOL, V12, P113, DOI 10.1093/intimm/12.1.113; Villena J, 2011, MICROBIOL IMMUNOL, V55, P434, DOI 10.1111/j.1348-0421.2011.00334.x; Wang C, 2001, NATURE, V412, P346, DOI 10.1038/35085597; Weiss DS, 2004, J IMMUNOL, V172, P4463, DOI 10.4049/jimmunol.172.7.4463; Wen Jing, 2011, Acta Agriculturae Zhejiangensis, V23, P70	46	20	24	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 20	2017	12	3							0173917	10.1371/journal.pone.0173917	http://dx.doi.org/10.1371/journal.pone.0173917			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ER6VC	28319123	gold, Green Published, Green Submitted			2022-12-27	WOS:000398945800035
J	Gupta, M; Joshi, A; Vidya, TNC				Gupta, Manan; Joshi, Amitabh; Vidya, T. N. C.			Effects of social organization, trap arrangement and density, sampling scale, and population density on bias in population size estimation using some common mark-recapture estimators	PLOS ONE			English	Article							ELEPHANT ELEPHAS-MAXIMUS; SEX-RATIO VARIATION; CAPTURE-RECAPTURE; DEMOGRAPHIC PARAMETERS; PRECISION; ABUNDANCE; MODELS	Mark-recapture estimators are commonly used for population size estimation, and typically yield unbiased estimates for most solitary species with low to moderate home range sizes. However, these methods assume independence of captures among individuals, an assumption that is clearly violated in social species that show fission-fusion dynamics, such as the Asian elephant. In the specific case of Asian elephants, doubts have been raised about the accuracy of population size estimates. More importantly, the potential problem for the use of mark-recapture methods posed by social organization in general has not been systematically addressed. We developed an individual-based simulation framework to systematically examine the potential effects of type of social organization, as well as other factors such as trap density and arrangement, spatial scale of sampling, and population density, on bias in population sizes estimated by POPAN, Robust Design, and Robust Design with detection heterogeneity. In the present study, we ran simulations with biological, demographic and ecological parameters relevant to Asian elephant populations, but the simulation framework is easily extended to address questions relevant to other social species. We collected capture history data from the simulations, and used those data to test for bias in population size estimation. Social organization significantly affected bias in most analyses, but the effect sizes were variable, depending on other factors. Social organization tended to introduce large bias when trap arrangement was uniform and sampling effort was low. POPAN clearly outperformed the two Robust Design models we tested, yielding close to zero bias if traps were arranged at random in the study area, and when population density and trap density were not too low. Social organization did not have a major effect on bias for these parameter combinations at which POPAN gave more or less unbiased population size estimates. Therefore, the effect of social organization on bias in population estimation could be removed by using POPAN with specific parameter combinations, to obtain population size estimates in a social species.	[Gupta, Manan; Joshi, Amitabh; Vidya, T. N. C.] Jawaharlal Nehru Ctr Adv Sci Res, Evolutionary & Organismal Biol Unit, Bengaluru, India	Department of Science & Technology (India); Jawaharlal Nehru Center for Advanced Scientific Research (JNCASR)	Vidya, TNC (corresponding author), Jawaharlal Nehru Ctr Adv Sci Res, Evolutionary & Organismal Biol Unit, Bengaluru, India.	tncvidya@jncasr.ac.in			Science and Engineering Research Board, Government of India [SR/S2/JCB-45/2011]; Council of Scientific and Industrial Research, Government of India [37(1375)/09/EMR-II]; Jawaharlal Nehru Centre for Advanced Scientific Research (Autonomous Body under Department of Science and Technology, Government of India)	Science and Engineering Research Board, Government of India; Council of Scientific and Industrial Research, Government of India(Council of Scientific & Industrial Research (CSIR) - India); Jawaharlal Nehru Centre for Advanced Scientific Research (Autonomous Body under Department of Science and Technology, Government of India)	Jawaharlal Nehru Centre for Advanced Scientific Research (Autonomous Body under Department of Science and Technology, Government of India), Science and Engineering Research Board, Government of India, and the Council of Scientific and Industrial Research, Government of India supported this study. AJ received a J.C. Bose National Fellowship (SR/S2/JCB-45/2011) from the Science and Engineering Research Board, Government of India. TNCV received funding from the Council of Scientific and Industrial Research, Government of India (No. 37 (1375)/09/EMR-II). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AERCC (Asian Elephant Research and Conservation Center), 1998, 6 AERCC; Amstrup SC, 2005, HANDBOOK OF CAPTURE-RECAPTURE ANALYSIS, P1; [Anonymous], 1982, ESTIMATION ANIMAL AB; [Anonymous], 2014, R LANG ENV STAT COMP; Arivazhagan C, 2005, 106 IND I SCI CTR EC; Aureli F, 2008, CURR ANTHROPOL, V49, P627, DOI 10.1086/586708; Baskaran N., 1995, P296; Baskaran N., 1996, Gajah, V15, P41; Baskaran N., 1998, THESIS; Baskaran N, 2011, KARNATAKA ELEPHANT C; Bishop CJ, 2008, J WILDLIFE MANAGE, V72, P1085, DOI 10.2193/2007-423; Blake S, 2004, CONSERV BIOL, V18, P1191, DOI 10.1111/j.1523-1739.2004.01860.x; BONDRUPNIELSEN S, 1983, CAN J ZOOL, V61, P2361, DOI 10.1139/z83-313; Boulanger J, 2004, J WILDLIFE MANAGE, V68, P457, DOI 10.2193/0022-541X(2004)068[0457:SDABID]2.0.CO;2; BOWDEN DC, 1995, J WILDLIFE MANAGE, V59, P840, DOI 10.2307/3801965; Calambokidis J, 2004, MAR MAMMAL SCI, V20, P63, DOI 10.1111/j.1748-7692.2004.tb01141.x; Carroll EL, 2011, MAR BIOL, V158, P2565, DOI 10.1007/s00227-011-1757-9; CLUTTONBROCK TH, 1986, IBIS, V128, P317, DOI 10.1111/j.1474-919X.1986.tb02682.x; CLUTTONBROCK TH, 1986, Q REV BIOL, V61, P339, DOI 10.1086/415033; Cox DR., 1989, ANAL BINARY DATA; Dawson S., 1990, THESIS U OXFORD; de Silva S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082788; de Silva Shermin, 2011, BMC Ecology, V11, P17, DOI 10.1186/1472-6785-11-17; de Silva S, 2011, BIOL CONSERV, V144, P1742, DOI 10.1016/j.biocon.2011.03.011; Dunbar R.I.M., 1988, PRIMATE SOCIAL SYSTE; Fernando P, 2000, BEHAV ECOL SOCIOBIOL, V48, P84, DOI 10.1007/s002650000218; FRANKHAM R, 1995, GENET RES, V66, P95, DOI 10.1017/S0016672300034455; GINSBERG JR, 1992, ANIM BEHAV, V44, P377, DOI 10.1016/0003-3472(92)90042-8; Goswami VR, 2007, ANIM CONSERV, V10, P391, DOI 10.1111/j.1469-1795.2007.00124.x; Gray TNE, 2014, CONSERV GENET, V15, P803, DOI 10.1007/s10592-014-0579-y; Gupta Manan, 2016, Gajah, V44, P5; Harihar A, 2009, POPUL ECOL, V51, P471, DOI 10.1007/s10144-009-0138-4; Hedges S, 2013, BIOL CONSERV, V159, P101, DOI 10.1016/j.biocon.2012.12.010; Jones J.P., 2013, KEY TOPICS CONSERVAT, V2, P327, DOI [10.1002/9781118520178.ch18, DOI 10.1002/9781118520178.CH18]; Karanth KU, 2011, CAMERA TRAPS IN ANIMAL ECOLOGY: METHODS AND ANALYSES, P97, DOI 10.1007/978-4-431-99495-4_7; Karanth KU, 1998, ECOLOGY, V79, P2852; KARANTH KU, 1992, J TROP ECOL, V8, P21, DOI 10.1017/S0266467400006040; Kemf E, 2000, ASIAN ELEPHANTS WILD; Kendall WL, 1997, ECOLOGY, V78, P563; KENDALL WL, 1995, BIOMETRICS, V51, P293, DOI 10.2307/2533335; Kendall WL, 1999, ECOLOGY, V80, P2517, DOI 10.1890/0012-9658(1999)080[2517:ROCCRM]2.0.CO;2; Kingsland S.E., 1995, MODELING NATURE EPIS; Kummer H., 1971, PRIMATE SOC GROUP TE; Laake J. L., 2013, 201301 AFSC NOAA NAT, V25p, P1; MacQueen J., 1967, P 5 BERKELEY S MATH, VVolume 1, P281, DOI DOI 10.1007/S11665-016-2173-6; McCullagh P, 1989, GEN LINEAR MODELS; McKay G.M., 1973, Smithsonian Contributions to Zoology, VNo. 125, P1; Norris JL, 1996, BIOMETRICS, V52, P639, DOI 10.2307/2532902; NUNNEY L, 1994, CONSERV BIOL, V8, P175, DOI 10.1046/j.1523-1739.1994.08010175.x; OTIS DL, 1978, WILDLIFE MONOGR, P1; PAYNE KB, 1986, BEHAV ECOL SOCIOBIOL, V18, P297, DOI 10.1007/BF00300007; POLLOCK KH, 1990, WILDLIFE MONOGR, P1; POLLOCK KH, 1982, J WILDLIFE MANAGE, V46, P752, DOI 10.2307/3808568; Rees SG, 2011, ECOL MODEL, V222, P3291, DOI 10.1016/j.ecolmodel.2011.05.030; ROUSSEEUW PJ, 1987, J COMPUT APPL MATH, V20, P53, DOI 10.1016/0377-0427(87)90125-7; Royle JA, 2014, SPATIAL CAPTURE-RECAPTURE, P1; Santostasi NL, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0166650; Schmutz JA, 1995, J APPL STAT, V22, P673, DOI 10.1080/02664769524531; Schwarz CJ, 1996, BIOMETRICS, V52, P860, DOI 10.2307/2533048; SEBER GAF, 1984, MULTIVARIATE OBSERVA; Shetty N, BIORXIV; Smith HC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076574; Sollmann R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034575; StatSoft Inc., 1996, STATISTICA WIND COMP; Sukumar R., 1989, ASIAN ELEPHANT ECOLO; Surendra Varman K., 1995, P331; The MathWorks Inc., 2011, MATLAB REL 2011A; Turchin Peter, 2003, Monographs in Population Biology, V35, pi; Vidya T.N.C., 2014, Gajah, V40, P3; Vidya TNC, 2005, J ETHOL, V23, P205, DOI 10.1007/s10164-005-0144-8; Weckerly FW, 2007, J WILDLIFE MANAGE, V71, P773, DOI 10.2193/2006-091; White GC, 1999, BIRD STUDY, V46, P120, DOI 10.1080/00063659909477239; Williams Anrtharaj C., 2007, Journal of the Bombay Natural History Society, V104, P145; Williams B. K., 2002, ANAL MANAGEMENT ANIM	75	6	6	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 17	2017	12	3							e0173609	10.1371/journal.pone.0173609	http://dx.doi.org/10.1371/journal.pone.0173609			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EO5CJ	28306735	Green Published, Green Submitted, gold			2022-12-27	WOS:000396710300013
J	Oldrati, V; Koua, D; Allard, PM; Hulo, N; Arrell, M; Nentwig, W; Lisacek, F; Wolfender, JL; Kuhn-Nentwig, L; Stocklin, R				Oldrati, Vera; Koua, Dominique; Allard, Pierre-Marie; Hulo, Nicolas; Arrell, Miriam; Nentwig, Wolfgang; Lisacek, Frederique; Wolfender, Jean-Luc; Kuhn-Nentwig, Lucia; Stocklin, Reto			Peptidomic and transcriptomic profiling of four distinct spider venoms	PLOS ONE			English	Article							CYSTINE KNOT; CUPIENNIUS-SALEI; TOXINS; INHIBITOR; CHANNELS; IDENTIFICATION; CONTAMINATION; MODULATION; TARGET; CSTX-1	Venom based research is exploited to find novel candidates for the development of innovative pharmacological tools, drug candidates and new ingredients for cosmetic and agro-chemical industries. Moreover, venomics, as a well-established approach in systems biology, helps to elucidate the genetic mechanisms of the production of such a great molecular biodiversity. Today the advances made in the proteomics, transcriptomics and bioinformatics fields, favor venomics, allowing the in depth study of complex matrices and the elucidation even of minor compounds present in minute biological samples. The present study illustrates a rapid and efficient method developed for the elucidation of venom composition based on NextGen mRNA sequencing of venom glands and LC-MS/MS venom proteome profiling. The analysis of the comprehensive data obtained was focused on cysteine rich peptide toxins from four spider species originating from phylogenetically distant families for comparison purposes. The studied species were Heteropoda davidbowie (Sparassidae), Poecilotheria formosa (Theraphosidae), Viridasius fasciatus (Viridasiidae) and Latrodectus mactans (Theridiidae). This led to a high resolution profiling of 284 characterized cysteine rich peptides, 111 of which belong to the Inhibitor Cysteine Knot (ICK) structural motif. The analysis of H. davidbowie venom revealed a high richness in term of venom diversity: 95 peptide sequences were identified; out of these, 32 peptides presented the ICK structural motif and could be classified in six distinct families. The profiling of P. formosa venom highlighted the presence of 126 peptide sequences, with 52 ICK toxins belonging to three structural distinct families. V. fasciatus venom was shown to contain 49 peptide sequences, out of which 22 presented the ICK structural motif and were attributed to five families. The venom of L. mactans, until now studied for its large neurotoxins (Latrotoxins), revealed the presence of 14 cysteine rich peptides, out of which five were ICK toxins belonging to the CSTX superfamily. This in depth profiling of distinct ICK peptide families identified across the four spider species highlighted the high conservation of these neurotoxins among spider families.	[Oldrati, Vera; Koua, Dominique; Arrell, Miriam; Stocklin, Reto] Atheris SA, Chemin Alcire 1, Geneva, Switzerland; [Oldrati, Vera; Allard, Pierre-Marie; Wolfender, Jean-Luc] Univ Geneva, Univ Lausanne, Sch Pharmaceut Sci, EPGL, 1 Rue Michel Servet, Geneva 4, Switzerland; [Hulo, Nicolas; Lisacek, Frederique] Univ Geneva, CMU, 1 Rue Michel Servet, Geneva 4, Switzerland; [Hulo, Nicolas] Atheris Labs, Chemin Alcire 1, Geneva, Switzerland; [Nentwig, Wolfgang; Kuhn-Nentwig, Lucia] Univ Bern, Inst Ecol & Evolut, 6 Baltzerstr, Bern, Switzerland; [Lisacek, Frederique] SIB, CUI, 7 Route Drize, Geneva, Switzerland	University of Geneva; University of Lausanne; University of Geneva; University of Bern; Swiss Institute of Bioinformatics; University of Geneva	Oldrati, V (corresponding author), Atheris SA, Chemin Alcire 1, Geneva, Switzerland.; Oldrati, V (corresponding author), Univ Geneva, Univ Lausanne, Sch Pharmaceut Sci, EPGL, 1 Rue Michel Servet, Geneva 4, Switzerland.	vera.oldrati@atheris.com	Allard, Pierre-Marie/ABD-1433-2021; Jean-Luc, Wolfender JLW/EWV-1043-2022; Jean-Luc, Wolfender JLW/O-2163-2018	Allard, Pierre-Marie/0000-0003-3389-2191; Jean-Luc, Wolfender JLW/0000-0002-0125-952X; Jean-Luc, Wolfender JLW/0000-0002-0125-952X	SIB; University of Bern	SIB; University of Bern	Swiss Initiative in Systems Biology (Bridge to Industry), SpidX project, (http://www.sytemsxch/index.php?id=123) funded the project through a grant financially supporting SIB (FL) and University of Bern (LKN, WN) and did not play any role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. Atheris SA and Atheris Laboratories (together Atheris): Authors VO, NH, DK, MA and RS are or were employed by Atheris. Atheris provided support in the form of salaries for authors VO, NH, DK, MA and RS, and research materials, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the author contributions section.	ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Ayroza G, 2012, FRONT MICROBIOL, V3, DOI 10.3389/fmicb.2012.00324; Bateman A, 2015, NUCLEIC ACIDS RES, V43, pD204, DOI 10.1093/nar/gku989; Billen B, 2010, J BIOL CHEM, V285, P18545, DOI 10.1074/jbc.M110.125211; BINDOKAS VP, 1991, J NEUROPHYSIOL, V66, P590, DOI 10.1152/jn.1991.66.2.590; Birney E, 2004, GENOME RES, V14, P988, DOI 10.1101/gr.1865504; Blankenberg Daniel, 2010, Curr Protoc Mol Biol, VChapter 19, DOI 10.1002/0471142727.mb1910s89; Bohlen CJ, 2010, CELL, V141, P834, DOI 10.1016/j.cell.2010.03.052; Bosmans F, 2006, MOL PHARMACOL, V69, P419, DOI 10.1124/mol.105.015941; Calvete JJ, 2009, FEBS LETT, V583, P1736, DOI 10.1016/j.febslet.2009.03.029; Cardoso FC, 2015, MOL PHARMACOL, V88, P291, DOI 10.1124/mol.115.098178; Chagot B, 2004, PROTEIN SCI, V13, P1197, DOI 10.1110/ps.03584304; Chen J, 2008, CELL MOL LIFE SCI, V65, P2431, DOI 10.1007/s00018-008-8135-x; Chevreux B, 2004, GENOME RES, V14, P1147, DOI 10.1101/gr.1917404; CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1016/0003-2697(87)90021-2; Chow CY, 2015, TOXINS, V7, P2494, DOI 10.3390/toxins7072494; Currier RB, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041888; de Castro CS, 2004, TOXICON, V44, P273, DOI 10.1016/j.toxicon.2004.05.028; Escoubas P, 2004, TOXICON, V43, P555, DOI 10.1016/j.toxicon.2004.02.007; Eugster PJ, 2012, J CHROMATOGR A, V1259, P187, DOI 10.1016/j.chroma.2012.05.033; Fisyunov A, 2005, TOXICOLOGY, V207, P129, DOI 10.1016/j.tox.2004.09.005; Flickinger M, 2015, AM J HUM GENET, V97, P284, DOI 10.1016/j.ajhg.2015.07.002; Fu LM, 2012, BIOINFORMATICS, V28, P3150, DOI 10.1093/bioinformatics/bts565; Gao B, 2013, 33 BIOSCI, V33; Gelly JC, 2004, NUCLEIC ACIDS RES, V32, pD156, DOI 10.1093/nar/gkh015; Goecks J, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-8-r86; Gracy J, 2008, NUCLEIC ACIDS RES, V36, pD314, DOI 10.1093/nar/gkm939; Gremski LH, 2014, TOXICON, V83, P91, DOI 10.1016/j.toxicon.2014.02.023; He Q., 2013, PLOS ONE, V8; Herzig V, 2015, TOXINS, V7, P4366, DOI 10.3390/toxins7104366; Herzig V, 2011, NUCLEIC ACIDS RES, V39, pD653, DOI 10.1093/nar/gkq1058; Johnson LS, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-431; Juarez P, 2004, PROTEOMICS, V4, P327, DOI 10.1002/pmic.200300628; Jun G, 2012, AM J HUM GENET, V91, P839, DOI 10.1016/j.ajhg.2012.09.004; Jungo F, 2012, TOXICON, V60, P551, DOI 10.1016/j.toxicon.2012.03.010; Kabanova NV, 2012, BBA-BIOMEMBRANES, V1818, P2868, DOI 10.1016/j.bbamem.2012.07.016; Katoh K, 2013, MOL BIOL EVOL, V30, P772, DOI 10.1093/molbev/mst010; King GF, 2008, TOXICON, V52, P264, DOI 10.1016/j.toxicon.2008.05.020; Koua D, 2013, BBA-PROTEINS PROTEOM, V1834, P717, DOI 10.1016/j.bbapap.2012.12.015; Kozlov S, 2005, PROTEINS, V59, P131, DOI 10.1002/prot.20390; Kubista H, 2007, NEUROPHARMACOLOGY, V52, P1650, DOI 10.1016/j.neuropharm.2007.03.012; Kuhn-Nentwig L, 2004, TOXICON, V43, P543, DOI 10.1016/j.toxicon.2004.02.009; Kuhn-Nentwig L, 2015, SPIDER VENOMS; Kuhn-Nentwig L, 2012, J BIOL CHEM, V287, P25640, DOI 10.1074/jbc.M112.339051; Kuzmenkov AI, 2013, BBA-BIOMEMBRANES, V1828, P724, DOI 10.1016/j.bbamem.2012.10.014; Liao Z, 2007, PROTEOMICS, V7, P1892, DOI 10.1002/pmic.200600785; Martin-Moutot N, 2006, MOL PHARMACOL, V69, P1931, DOI 10.1124/mol.105.021147; Menez A, 2006, TOXICON, V47, P255, DOI 10.1016/j.toxicon.2005.12.010; Miele V, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-116; Mortazavi A, 2008, NAT METHODS, V5, P621, DOI 10.1038/nmeth.1226; Oldrati Vera, 2013, P491; Pluzhnikov K, 2007, TOXICON, V50, P993, DOI 10.1016/j.toxicon.2007.07.004; Redaelli E, 2010, J BIOL CHEM, V285, P4130, DOI 10.1074/jbc.M109.054718; Richardson M, 2006, COMP BIOCHEM PHYS C, V142, P173, DOI 10.1016/j.cbpc.2005.09.010; Sokolov S, 2008, MOL PHARMACOL, V73, P1020, DOI 10.1124/mol.107.041046; Sollod BL, 2005, PEPTIDES, V26, P131, DOI 10.1016/j.peptides.2004.07.016; Undheim EAB, 2013, TOXINS, V5, P2488, DOI 10.3390/toxins5122488; Uzenbaev SD, 2009, ENTOMOL REV, V89, P479; Vassilevski AA, 2010, J BIOL CHEM, V285, P32293, DOI 10.1074/jbc.M110.104265; Winterfield JR, 2000, J GEN PHYSIOL, V116, P637, DOI 10.1085/jgp.116.5.637; Zhang YQ, 2010, ZOOLOGY, V113, P10, DOI 10.1016/j.zool.2009.04.001; Zhu Li-Mei, 2015, Shengli Xuebao, V67, P239; Zhu S, 2003, FASEB J; Zobel-Thropp PA, 2014, J PROTEOME RES, V13, P817, DOI 10.1021/pr400875s	64	18	18	1	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 17	2017	12	3							e0172966	10.1371/journal.pone.0172966	http://dx.doi.org/10.1371/journal.pone.0172966			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EO5CJ	28306751	Green Published, gold, Green Submitted			2022-12-27	WOS:000396710300004
J	Dias, LD; Macoris, MDD; Andrighetti, MTM; Otrera, VCG; Dias, AD; Bauzer, LGSD; Rodovalho, CD; Martins, AJ; Lima, JBP				Dias, Luciana dos Santos; da Graca Macoris, Maria de Lourdes; Macoris Andrighetti, Maria Teresa; Garbeloto Otrera, Vanessa Camargo; Dias, Adriana dos Santos; Soares da Rocha Bauzer, Luiz Guilherme; Rodovalho, Cynara de Melo; Martins, Ademir Jesus; Pereira Lima, Jose Bento			Toxicity of spinosad to temephos-resistant Aedes aegypti populations in Brazil	PLOS ONE			English	Article							NATURALLY DERIVED INSECTICIDE; RIO-DE-JANEIRO; ALTERNATIVE INSECTICIDES; BIOINSECTICIDE SPINOSAD; FIELD POPULATIONS; IN-FIELD; DIPTERA; CULICIDAE; EFFICACY; SUSCEPTIBILITY	The mosquito Aedes aegypti is the primary vector of different arboviruses and represents a major public health problem. Several Brazilian populations of Ae. aegypti have developed resistance to temephos, the most used organophosphate larvicide. New tools which are less harmful to the environment and safer for humans are becoming increasingly important to control this insect vector. Spinosad, an aerobic fermentation product of a soil actinobacteria, has a favorable environmental profile. It presents selective insecticide properties, a mechanism of action that differs from those of many synthetic chemical insecticides. The toxicity of spinosad and temephos to Aedes aegypti populations from Brazil, which were previously exposed to temephos, were investigated in this study. Larval susceptibility (LC50) to temephos varied from 3pg/L for Rockefeller up to 260 pg/L for Santana do Ipanema field derived population. Larval susceptibility (LC50) to spinosad varied from 23pg/L for Rockefeller up to 93pg/L for Marilia field derived population. In addition, a semi-field trial was performed to evaluate spinosad (NatularTM DT) initial efficacy and persistence toward four field-derived lineages and the Rockefeller lineage, used as an internal control. Spinosad was tested at 0.5mg active ingredient/L in 200L capacity water tanks. Mortality was recorded each 24 hours after exposition and tanks were further recolonized once per week with mortality being recorded daily for eight weeks. Spinosad provided a level equal or superior to 80% mortality during a seven to eight week evaluation period. The assessed populations did not present cross-resistance between spinosad and temephos in laboratory conditions. It demonstrates that spinosad may be a promising larvicide for the control of Ae. aegypti, especially for populations in which resistance to temephos has been detected.	[Dias, Luciana dos Santos; Dias, Adriana dos Santos; Soares da Rocha Bauzer, Luiz Guilherme; Rodovalho, Cynara de Melo; Martins, Ademir Jesus; Pereira Lima, Jose Bento] Fiocruz MS, Inst Oswaldo Cruz, Lab Fisiol & Controle Artropodes Vetores, Rio De Janeiro, RJ, Brazil; [Dias, Luciana dos Santos; Dias, Adriana dos Santos; Soares da Rocha Bauzer, Luiz Guilherme; Rodovalho, Cynara de Melo; Martins, Ademir Jesus; Pereira Lima, Jose Bento] Inst Biol Exercito, Lab Entomol, Rio De Janeiro, RJ, Brazil; [da Graca Macoris, Maria de Lourdes; Macoris Andrighetti, Maria Teresa; Garbeloto Otrera, Vanessa Camargo] Superintendencia Controle Endemias, Marilia, SP, Brazil	Fundacao Oswaldo Cruz	Lima, JBP (corresponding author), Fiocruz MS, Inst Oswaldo Cruz, Lab Fisiol & Controle Artropodes Vetores, Rio De Janeiro, RJ, Brazil.; Lima, JBP (corresponding author), Inst Biol Exercito, Lab Entomol, Rio De Janeiro, RJ, Brazil.	jbento@ioc.fiocruz.br	Martins, Ademir J./B-4117-2009; Bauzer, Luiz G S R/I-4664-2014; Martins, Ademir/W-3251-2019	Martins, Ademir/0000-0001-5739-1215; dos Santos Dias, Luciana/0000-0002-4824-9062; Rodovalho, Cynara/0000-0002-4927-0672; Bauzer, Luiz/0000-0003-0900-860X	Fundacao Oswaldo Cruz; Fundacao coordenacao de aperfeicoamento de pessoal de nivel superior	Fundacao Oswaldo Cruz; Fundacao coordenacao de aperfeicoamento de pessoal de nivel superior(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES))	This work was supported by Fundacao Oswaldo Cruz (http://portal.fiocruz.br/pt-br) and Fundacao coordenacao de aperfeicoamento de pessoal de nivel superior (http://www.capes.gov.br/).	Araujo AP, 2013, PARASITE VECTOR, V6, DOI 10.1186/1756-3305-6-297; Diniz DFA, 2015, PARASITE VECTOR, V8, DOI 10.1186/s13071-015-1276-5; Attaran A, 2000, NAT MED, V6, P729, DOI 10.1038/77438; Bisset JA, 2013, J MED ENTOMOL, V50, P352, DOI 10.1603/ME12064; Bisset Juan A., 2002, Rev Cubana Med Trop, V54, P202; Bond JG, 2004, MED VET ENTOMOL, V18, P50, DOI 10.1111/j.0269-283X.2004.0480.x; Braga IA, 2004, MEM I OSWALDO CRUZ, V99, P199, DOI 10.1590/S0074-02762004000200015; Braga Ima Aparecida, 2000, Revista da Sociedade Brasileira de Medicina Tropical, V33, P347, DOI 10.1590/S0037-86822000000400003; Brasil Ministerio da Saude Secretaria de Vigilancia em Saude Departamento de Vigilancia Epidemiologica, 2009, DIR NAC PREV CONTR E; Brogdon WG, 1998, EMERG INFECT DIS, V4, P605, DOI 10.3201/eid0404.980410; BROWN A W, 1958, Bull World Health Organ, V18, P309; Centers for Disease Control and Prevention-CDC, 2016, INS RES; CEPAGRI, 2012, CLIM MUN PIOS PAUL; Chediak M, 2016, MEM I OSWALDO CRUZ, V111, P311, DOI 10.1590/0074-02760150409; Cleveland CB, 2002, J AGR FOOD CHEM, V50, P3244, DOI 10.1021/jf011663i; Consoli R. A. G. B., 1994, PRINCIPAIS MOSQUITOS; Cui F, 2006, PEST MANAG SCI, V62, P1013, DOI 10.1002/ps.1288; Darriet F, 2005, J AM MOSQUITO CONTR, V21, P495, DOI 10.2987/8756-971X(2006)21[495:SANLAI]2.0.CO;2; Deming R, 2016, PARASITE VECTOR, V9, DOI 10.1186/s13071-016-1346-3; Dias CN, 2014, PARASITOL RES, V113, P565, DOI 10.1007/s00436-013-3687-6; Environmental Protection Agency, 2005, FED REGISTER, V70, P41730; Ferreira BJ, 2009, CIENC SAUDE COLETIVA, V14, P961, DOI 10.1590/S1413-81232009000300032; Fontoura NG, 2012, MEM I OSWALDO CRUZ, V107, P387, DOI 10.1590/S0074-02762012000300014; Gould EA, 2008, LANCET, V371, P500, DOI 10.1016/S0140-6736(08)60238-X; Gubler Duane J., 2002, Trends in Microbiology, V10, P100, DOI 10.1016/S0966-842X(01)02288-0; Hemingway J, 2004, INSECT BIOCHEM MOLEC, V34, P653, DOI 10.1016/j.ibmb.2004.03.018; Hemingway J, 2002, SCIENCE, V298, P96, DOI 10.1126/science.1078052; Hemingway J, 2000, ANNU REV ENTOMOL, V45, P371, DOI 10.1146/annurev.ento.45.1.371; Honorio NA, 2015, CAD SAUDE PUBLICA, V31, P906, DOI 10.1590/0102-311XPE020515; Kirst HA, 1992, SYNTHESIS CHEM AGROC, P214; Li MI, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001792; Lima EP, 2011, PARASITE VECTOR, V4, DOI 10.1186/1756-3305-4-5; Lima JBP, 2003, AM J TROP MED HYG, V68, P329, DOI 10.4269/ajtmh.2003.68.329; Lima José Bento Pereira, 2005, Rev. Inst. Med. trop. S. Paulo, V47, P125, DOI 10.1590/S0036-46652005000300002; Macoris MDG, 1999, REV SAUDE PUBL, V33, P521, DOI 10.1590/S0034-89101999000500013; Marcombe S, 2011, AM J TROP MED HYG, V84, P118, DOI 10.4269/ajtmh.2011.10-0335; MAZZARRI MB, 1995, J AM MOSQUITO CONTR, V11, P315; Medronho Roberto de Andrade, 2008, Cad. Saúde Pública, V24, P948, DOI 10.1590/S0102-311X2008000500001; Miles M, 2000, INT S CROP, V65, P393; Montella IR, 2007, AM J TROP MED HYG, V77, P467, DOI 10.4269/ajtmh.2007.77.467; Pan American Health Organization, 1994, PAHO PUBLICATION, V548; Paul A, 2006, J MED ENTOMOL, V43, P55, DOI 10.1603/0022-2585(2006)043[0055:EONIFC]2.0.CO;2; Pereira BB, 2016, J TOXICOL ENV HEAL A, V79, P477, DOI 10.1080/15287394.2016.1176974; Perez CM, 2007, J MED ENTOMOL, V44, P631, DOI 10.1603/0022-2585(2007)44[631:SANDIF]2.0.CO;2; Prabhu K, 2011, ASIAN PAC J TROP MED, V4, P610, DOI 10.1016/S1995-7645(11)60157-0; Raymond M., 1985, Cahiers O.R.S.T.O.M., Serie Entomologie Medicale et Parasitologie, V23, P117; Romi R, 2006, J AM MOSQUITO CONTR, V22, P93, DOI 10.2987/8756-971X(2006)22[93:LEOTBS]2.0.CO;2; Sadanandane C, 2009, J AM MOSQUITO CONTR, V25, P66, DOI 10.2987/08-5807.1; Salgado VL, 1998, PESTIC BIOCHEM PHYS, V60, P91, DOI 10.1006/pest.1998.2332; Sparks T. C., 1995, P BELTW COTT C NAT C, P903; Tauil P L, 2001, Cad Saude Publica, V17 Suppl, P99, DOI 10.1590/S0102-311X2001000700018; Thavara U, 2009, SE ASIAN J TROP MED, V40, P235; Thompson G., 1995, BELTW COTT C, P1039; Walker K, 2000, MED VET ENTOMOL, V14, P345, DOI 10.1046/j.1365-2915.2000.00262.x; Walker KR, 2011, J AM MOSQUITO CONTR, V27, P135, DOI 10.2987/10-6078.1; Watson GB, 2001, PESTIC BIOCHEM PHYS, V71, P20, DOI 10.1006/pest.2001.2559; WHO, 2005, GUID LAB FIELD TEST; WHO, 2016, WHOPES REC COMP FORM; WHO, 2000, SCI WORK GROUP DENG, P10; WHO, 2010, DRINK WAT US VECT CO; WHO (World Health Organization), 1981, INSTR DET SUSC RES A; Williams T, 2003, BIOCONTROL SCI TECHN, V13, P459, DOI 10.1080/0958315031000140956; Wong PSJ, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002348; Zaim M, 2002, TRENDS PARASITOL, V18, P161, DOI 10.1016/S1471-4922(01)02220-6	65	21	22	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 16	2017	12	3							e0173689	10.1371/journal.pone.0173689	http://dx.doi.org/10.1371/journal.pone.0173689			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN9KE	28301568	Green Published, gold, Green Submitted			2022-12-27	WOS:000396318300061
J	Li, JH; Qian, LY; Dowling, JP; Curcione, C; Kurup, D; Zhang, JK				Li, Jinghe; Qian, Liangyue; Dowling, John P.; Curcione, Christine; Kurup, Drishya; Zhang, Jianke			Daxx plays a novel role in T cell survival but is dispensable in Fas-induced apoptosis	PLOS ONE			English	Article							DEATH DOMAIN PROTEIN; KINASE ACTIVATION; SIGNALING COMPLEX; RECEPTOR SIGNALS; JNK ACTIVATION; FADD; MICE; PROLIFERATION; INTERACTS; ANTIBODY	Daxx was originally isolated as a Fas-binding protein. However, the in vivo function of Daxx in Fas-induced apoptosis has remained enigmatic. Fas plays an important role in homeostasis in the immune system. Fas gene mutations lead to autoimmune-lymphoproliferation (lpr) diseases characterized by hyperplasia of secondary lymphoid organs. It is well established that the FADD adaptor binds to Fas, and recruits/activates caspase 8. However, additional proteins including Daxx have also been indicated to associate with Fas. It was proposed that Daxx mediates a parallel apoptotic pathway that is independent of FADD and caspase 8, but signals through ASK1-mediated apoptotic pathway. However, because the deletion of Daxx leads to embryonic lethality, the in vivo function of Daxx has not been properly analyzed. In the current study, analysis was performed using a conditional mutant mouse in which Daxx was deleted specifically in T cells. The data show that Daxx(-/-) T cells were able to undergo normal Fas-induced apoptosis. While containing normal thymocyte populations, the T cell-specific Daxx(-/-) mice have a reduced peripheral T cell pool. Importantly, Daxx-deficient T cells displayed increased death responses upon activation through TCR stimulation. These results unequivocally demonstrated that Daxx does not mediate Fas-induced apoptosis, but rather that it plays a critical role in survival responses in primary mature T cells.	[Li, Jinghe; Qian, Liangyue; Dowling, John P.; Curcione, Christine; Kurup, Drishya; Zhang, Jianke] Thomas Jefferson Univ, Dept Microbiol & Immunol, Sidney Kimmel Med Coll, Philadelphia, PA 19107 USA; [Zhang, Jianke] Thomas Jefferson Univ, Sidney Kimmel Canc Ctr, Philadelphia, PA 19107 USA	Jefferson University; Jefferson University	Zhang, JK (corresponding author), Thomas Jefferson Univ, Dept Microbiol & Immunol, Sidney Kimmel Med Coll, Philadelphia, PA 19107 USA.; Zhang, JK (corresponding author), Thomas Jefferson Univ, Sidney Kimmel Canc Ctr, Philadelphia, PA 19107 USA.	jianke.zhang@jefferson.edu	KURUP, DRISHYA/GMW-6326-2022	Kurup, Drishya/0000-0002-3959-7700; Dowling, John/0000-0001-7414-5606	NIH [R21 AI105794, R01 AI119069]; NCI Cancer Center support grant [P30CA56036]; NATIONAL CANCER INSTITUTE [P30CA056036] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R21AI105794, R01AI119069] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NCI Cancer Center support grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This study is supported in part by NIH grants R21 AI105794 and R01 AI119069 to J.Z. The Flow Cytometry Facility and Research Animal Facility of the Sidney Kimmel Cancer Center, where some of the analysis was performed, is supported in part by NCI Cancer Center support grant P30CA56036.	Adachi M, 1996, P NATL ACAD SCI USA, V93, P2131, DOI 10.1073/pnas.93.5.2131; BOLDIN MP, 1995, J BIOL CHEM, V270, P7795, DOI 10.1074/jbc.270.14.7795; Boldin MP, 1996, CELL, V85, P803, DOI 10.1016/S0092-8674(00)81265-9; BRUNNER T, 1995, NATURE, V373, P441, DOI 10.1038/373441a0; Budd RC, 2001, CURR OPIN IMMUNOL, V13, P356, DOI 10.1016/S0952-7915(00)00227-2; Chang HY, 1999, P NATL ACAD SCI USA, V96, P1252, DOI 10.1073/pnas.96.4.1252; Chang HY, 1998, SCIENCE, V281, P1860, DOI 10.1126/science.281.5384.1860; CHINNAIYAN AM, 1995, CELL, V81, P505, DOI 10.1016/0092-8674(95)90071-3; COHEN PL, 1991, ANNU REV IMMUNOL, V9, P243, DOI 10.1146/annurev.iy.09.040191.001331; DHEIN J, 1995, NATURE, V373, P438, DOI 10.1038/373438a0; Feng B, 2004, CELL IMMUNOL, V232, P9, DOI 10.1016/j.cellimm.2005.01.006; Fukuyama H, 1998, J IMMUNOL, V160, P3805; Hueber AO, 2000, J BIOL CHEM, V275, P10453, DOI 10.1074/jbc.275.14.10453; Hughes PD, 2008, IMMUNITY, V28, P197, DOI 10.1016/j.immuni.2007.12.017; Imtiyaz HZ, 2006, J IMMUNOL, V176, P6852, DOI 10.4049/jimmunol.176.11.6852; Imtiyaz HZ, 2005, J BIOL CHEM, V280, P31360, DOI 10.1074/jbc.M504138200; Irmler M, 1997, NATURE, V388, P190, DOI 10.1038/40657; ITOH N, 1993, J BIOL CHEM, V268, P10932; ITOH N, 1991, CELL, V66, P233, DOI 10.1016/0092-8674(91)90614-5; Kim YY, 2003, BIOCHEM BIOPH RES CO, V312, P426, DOI 10.1016/j.bbrc.2003.10.144; KISCHKEL FC, 1995, EMBO J, V14, P5579, DOI 10.1002/j.1460-2075.1995.tb00245.x; Leal-Sanchez J, 2007, CELL DEATH DIFFER, V14, P795, DOI 10.1038/sj.cdd.4402056; Lee PP, 2001, IMMUNITY, V15, P763, DOI 10.1016/S1074-7613(01)00227-8; Lu JV, 2011, P NATL ACAD SCI US; Michaelson JS, 1999, GENE DEV, V13, P1918, DOI 10.1101/gad.13.15.1918; Muzio M, 1996, CELL, V85, P817, DOI 10.1016/S0092-8674(00)81266-0; NAGATA S, 1995, SCIENCE, V267, P1449, DOI 10.1126/science.7533326; Nagata S, 1997, CELL, V88, P355, DOI 10.1016/S0092-8674(00)81874-7; Newton K, 2000, EMBO J, V19, P931, DOI 10.1093/emboj/19.5.931; OGASAWARA J, 1995, J EXP MED, V181, P485, DOI 10.1084/jem.181.2.485; OGASAWARA J, 1993, NATURE, V364, P806, DOI 10.1038/364806a0; Perlman R, 2001, NAT CELL BIOL, V3, P708, DOI 10.1038/35087019; Strasser A, 2009, IMMUNITY, V30, P180, DOI 10.1016/j.immuni.2009.01.001; Tang J, 2006, NAT CELL BIOL, V8, P855, DOI 10.1038/ncb1442; TARTAGLIA LA, 1993, CELL, V74, P845, DOI 10.1016/0092-8674(93)90464-2; TRAUTH BC, 1989, SCIENCE, V245, P301, DOI 10.1126/science.2787530; Villunger A, 2000, J IMMUNOL, V165, P1337, DOI 10.4049/jimmunol.165.3.1337; Walsh CM, 1998, IMMUNITY, V8, P439, DOI 10.1016/S1074-7613(00)80549-X; WATANABEFUKUNAGA R, 1992, J IMMUNOL, V148, P1274; WATANABEFUKUNAGA R, 1992, NATURE, V356, P314, DOI 10.1038/356314a0; Yang XL, 1997, CELL, V89, P1067, DOI 10.1016/S0092-8674(00)80294-9; Yun HJ, 2011, EMBO J, V30, P2465, DOI 10.1038/emboj.2011.152; Zhang HB, 2011, NATURE, V471, P373, DOI 10.1038/nature09878; Zhang J, 1996, MOL CELL BIOL, V16, P2756; Zhang JK, 1998, NATURE, V392, P296, DOI 10.1038/32681; Zhang YH, 2005, J IMMUNOL, V175, P3033, DOI 10.4049/jimmunol.175.5.3033	46	6	7	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 16	2017	12	3							e0174011	10.1371/journal.pone.0174011	http://dx.doi.org/10.1371/journal.pone.0174011			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN9KE	28301594	Green Published, gold, Green Submitted			2022-12-27	WOS:000396318300110
J	Gilles, I; Mayer, M; Courvoisier, N; Peytremann-Bridevaux, I				Gilles, Ingrid; Mayer, Mauro; Courvoisier, Nelly; Peytremann-Bridevaux, Isabelle			Joint analyses of open comments and quantitative data: Added value in a job satisfaction survey of hospital professionals	PLOS ONE			English	Article							HEALTH-CARE; NURSE BURNOUT; MENTAL-HEALTH; 12 COUNTRIES; QUALITY; ORGANIZATION; INTENTION; WORK	Objective To obtain a comprehensive understanding of the job opinions of hospital professionals by conducting qualitative analyses of the open comments included in a job satisfaction survey and combining these results with the quantitative results. Design A cross-sectional survey targeting all Lausanne University Hospital professionals was performed in the fall of 2013. Material and methods The survey considered ten job satisfaction dimensions (e.g. self-fulfilment, workload, management, work-related burnout, organisational commitment, intent to stay) and included an open comment section. Computer-assisted qualitative analyses were conducted on these comments. Satisfaction rates on the included dimensions and professional groups were entered as predictive variables in the qualitative analyses. Participants Of 10 838 hospital professionals, 4978 participated in the survey and 1067 provided open comments. Data from 1045 respondents with usable comments constituted the analytic sample (133 physicians, 393 nurses, 135 laboratory technicians, 247 administrative staff, including researchers, 67 logistic staff, 44 psycho-social workers, and 26 unspecified). Results Almost a third of the comments addressed scheduling issues, mostly related to problems and exhaustion linked to shifts, work-life balance, and difficulties with colleagues' absences and the consequences for quality of care and patient safety. The other two-thirds related to classic themes included in job satisfaction surveys. Although some comments were provided equally by all professional groups, others were group specific: work and hierarchy pressures for physicians, healthcare quality and patient safety for nurses, skill recognition for administrative staff. Overall, respondents' comments were consistent with their job satisfaction ratings. Conclusion Open comment analysis provides a comprehensive understanding of hospital professionals' job experiences, allowing better consideration of quality initiatives that match the needs of professionals with reality.	[Gilles, Ingrid; Mayer, Mauro; Courvoisier, Nelly; Peytremann-Bridevaux, Isabelle] Univ Lausanne Hosp, Univ Inst Social & Prevent Med IUMSP, Lausanne, Switzerland	University of Lausanne; Centre Hospitalier Universitaire Vaudois (CHUV)	Gilles, I (corresponding author), Univ Lausanne Hosp, Univ Inst Social & Prevent Med IUMSP, Lausanne, Switzerland.	Ingrid.Gilles@chuv.ch		Peytremann-Bridevaux, Isabelle/0000-0002-6514-8781				Acker GM, 2004, COMMUNITY MENT HLT J, V40, P65, DOI 10.1023/B:COMH.0000015218.12111.26; Agency for Healthcare Research and Quality, EV US AHRQ OTH QUAL; Aiken LH, 2002, NURS OUTLOOK, V50, P187, DOI 10.1067/mno.2002.126696; Aiken LH, 2002, JAMA-J AM MED ASSOC, V288, P1987, DOI 10.1001/jama.288.16.1987; Aiken LH, 2000, NURS RES, V49, P146, DOI 10.1097/00006199-200005000-00006; Aiken Linda H, 2012, BMJ, V344, pe1717, DOI 10.1136/bmj.e1717; Aiken LH, 2013, INT J NURS STUD, V50, P143, DOI 10.1016/j.ijnurstu.2012.11.009; Brief Arthur Paul, 1998, ATTITUDES ORG; Chan ZCY, 2013, J NURS MANAGE, V21, P605, DOI 10.1111/j.1365-2834.2012.01437.x; Corey-Lisle P, 1999, J NURS ADMIN, V29, P30, DOI 10.1097/00005110-199903000-00006; Davidson H, 1997, MED CARE, V35, P634, DOI 10.1097/00005650-199706000-00008; Degeling P, 2001, Health Serv Manage Res, V14, P36, DOI 10.1258/0951484011912519; Fila MJ, 2014, J BUS PSYCHOL, V29, P639, DOI 10.1007/s10869-014-9358-5; Foddy W. H., 1993, CONSTRUCTING QUESTIO, DOI 10.1017/CBO9780511518201; Gilles I, 2014, INT J QUAL HEALTH C, V26, P158, DOI 10.1093/intqhc/mzu006; Judge TA, 2012, ANNU REV PSYCHOL, V63, P341, DOI 10.1146/annurev-psych-120710-100511; Kalampaliki N, 2003, METHODES ETUDE REPRE, P147; Kristensen TS, 2005, WORK STRESS, V19, P192, DOI 10.1080/02678370500297720; Landon BE, 2003, JAMA-J AM MED ASSOC, V289, DOI [10.1001/jama.289.4.442, DOI 10.1001/JAMA.289.4.442]; LOCKE EA, 1969, ORGAN BEHAV HUM PERF, V4, P309, DOI 10.1016/0030-5073(69)90013-0; Lu H, 2005, INT J NURS STUD, V42, P211, DOI 10.1016/j.ijnurstu.2004.09.003; Mallidou AA, 2011, INT J NURS STUD, V48, P81, DOI 10.1016/j.ijnurstu.2010.06.002; McMurray JE, 1997, J GEN INTERN MED, V12, P711, DOI 10.1046/j.1525-1497.1997.07145.x; O'Cathain Alicia, 2004, BMC Med Res Methodol, V4, P25, DOI 10.1186/1471-2288-4-25; Ramirez AJ, 1996, LANCET, V347, P724, DOI 10.1016/S0140-6736(96)90077-X; Reinert M., 1990, B M THODOL SOCIOL, V26, P24, DOI [DOI 10.1177/075910639002600103, 10.1177/075910639002600103]; SCARPELLO V, 1983, PERS PSYCHOL, V36, P577, DOI 10.1111/j.1744-6570.1983.tb02236.x; Scheurer D, 2009, J HOSP MED, V4, P560, DOI 10.1002/jhm.496; Spector P. E., 1997, JOB SATISFACTION APP, V3; SPECTOR PE, 1994, J ORGAN BEHAV, V15, P385, DOI 10.1002/job.4030150503; SPECTOR PE, 1987, J APPL PSYCHOL, V72, P438, DOI 10.1037/0021-9010.72.3.438; SPECTOR PE, 1985, AM J COMMUN PSYCHOL, V13, P693, DOI 10.1007/BF00929796; Stoneman P, 2013, PUBLIC UNDERST SCI, V22, P850, DOI 10.1177/0963662512441569; Vahey DC, 2004, MED CARE, V42, P57, DOI 10.1097/01.mlr.0000109126.50398.5a; Wallace JE, 2009, LANCET, V374, P1714, DOI 10.1016/S0140-6736(09)61424-0; Wanous JP, 1997, J APPL PSYCHOL, V82, P247, DOI 10.1037/0021-9010.82.2.247; Weiss H. M., 2002, HUMAN RESOURCE MANAG, V12, P173, DOI [DOI 10.1016/S1053-482200045-1, 10.1016/S1053-4822(02)00045-1]; West E, 2001, QUAL HEALTH CARE, V10, P40, DOI 10.1136/qhc.10.1.40; Williams ES, 2003, HEALTH CARE MANAGE R, V28, P119, DOI 10.1097/00004010-200304000-00004	39	13	13	1	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 15	2017	12	3							e0173950	10.1371/journal.pone.0173950	http://dx.doi.org/10.1371/journal.pone.0173950			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EN9HQ	28296974	gold, Green Submitted, Green Published			2022-12-27	WOS:000396311700081
J	Kolasa-Trela, R; Konieczynska, M; Bazanek, M; Undas, A				Kolasa-Trela, Renata; Konieczynska, Malgorzata; Bazanek, Marta; Undas, Anetta			Specific changes in circulating cytokines and growth factors induced by exercise stress testing in asymptomatic aortic valve stenosis	PLOS ONE			English	Article							CORONARY-ARTERY-DISEASE; HEPATOCYTE GROWTH; SHEAR-STRESS; MECHANISMS; EXPRESSION; CELLS; CALCIFICATION; INTERLEUKIN-6; INFLAMMATION; ASSOCIATION	Background We evaluated exercise-induced changes in the profile of circulating cytokines and growth factors in patients with AS. Methods We studied 32 consecutive asymptomatic moderate-to-severe AS patients and 32 age and sex-matched controls. Plasma levels of interleukin (IL)-6, IL-10, hepatocyte growth factor (HGF), vascular endothelial growth factor (VEGF), and transforming growth factor (TGF)-beta were measured at 4 time points, i.e. at rest, at peak bicycle exercise, one hour and 24 hours after a symptom-limited exercise. Results Exercise increased all the 5 markers in both groups (all p<0.0001). The maximum levels of all tested cytokines were higher in the AS group (all p<0.05) compared with controls. In AS patients the highest levels of VEGF, IL-6, and IL-10 were observed one hour after exercise, while in the control group at peak exercise. In both groups maximum TGF-beta levels were observed one hour after exercise. HGF levels were higher at peak and one hour after test in the AS group (p = 0.0001), however the maximum value in AS was observed at peak while in controls after test. In both groups TGF-beta was the only marker that remained increased 24 hours after exercise compared with the value at rest (p = 0.0001). The cytokines and growth factors showed no association with heart rate and the workload. Conclusion In asymptomatic patients with moderate-to-severe AS, exercise produces a different pattern of changes in circulating cytokines and growth factors, and maximum levels of all tested cytokines were significantly higher in AS patients compared with the control group.	[Kolasa-Trela, Renata; Konieczynska, Malgorzata; Bazanek, Marta] John Paul 2 Hosp, Dept Diagnost Med, Krakow, Poland; [Undas, Anetta] Jagiellonian Univ, Inst Cardiol, Coll Med, Krakow, Poland	Jagiellonian University; Collegium Medicum Jagiellonian University	Undas, A (corresponding author), Jagiellonian Univ, Inst Cardiol, Coll Med, Krakow, Poland.	mmundas@cyf-kr.edu.pl			Jagiellonian University Medical College [N40238338, K/ZDS/002936]	Jagiellonian University Medical College	This work was supported by funds from Jagiellonian University Medical College N40238338 to AU and Jagiellonian University Medical College K/ZDS/002936 to AU. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	An Y, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0128965; Blaha V, 2014, PHYSIOL RES, V63, pS351, DOI 10.33549/physiolres.932857; Bonow RO, 2006, CIRCULATION, V114, pE84, DOI 10.1161/CIRCULATIONAHA.106.176857; Charest A, 2006, HEART, V92, P1844, DOI 10.1136/hrt.2005.086595; Chen JH, 2011, ARTERIOSCL THROM VAS, V31, P590, DOI 10.1161/ATVBAHA.110.220061; Dasu D, 2013, J HEART VALVE DIS, V22, P621; Davies PF, 2013, CARDIOVASC RES, V99, P315, DOI 10.1093/cvr/cvt101; Dimitrow PP, 2016, POL ARCH MED WEWN, V126, P121, DOI 10.20452/pamw.3335; Dweck MR, 2012, J AM COLL CARDIOL, V60, P1854, DOI 10.1016/j.jacc.2012.02.093; El Husseini D, 2014, J MOL CELL CARDIOL, V72, P146, DOI 10.1016/j.yjmcc.2014.02.014; Fernandez-Pisonero I, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0109081; Freeman RV, 2005, CIRCULATION, V111, P3316, DOI 10.1161/CIRCULATIONAHA.104.486738; Gaudreault N, 2011, AM J CARDIOL, V108, P1305, DOI 10.1016/j.amjcard.2011.06.050; Gould ST, 2013, CIRC RES, V113, P186, DOI 10.1161/CIRCRESAHA.112.300154; Helske S, 2004, J AM COLL CARDIOL, V44, P1859, DOI 10.1016/j.jacc.2004.07.054; Helske S, 2007, CURR OPIN LIPIDOL, V18, P483, DOI 10.1097/MOL.0b013e3282a66099; Henaut L, 2016, EXPERT OPIN THER TAR, V20, P89, DOI 10.1517/14728222.2015.1081685; Jian B, 2003, ANN THORAC SURG, V75, P457, DOI 10.1016/S0003-4975(02)04312-6; Kastellanos SS, 2009, HELL J CARDIOL, V50, P26; Kobayashi J, 2013, GEN THORAC CARDIOVAS, V61, P663, DOI 10.1007/s11748-013-0242-4; Kolasa-Trela R, 2015, J CARDIOL, V65, P501, DOI 10.1016/j.jjcc.2014.07.019; Konya H, 2014, WORLD J DIABETES, V5, P678, DOI 10.4239/wjd.v5.i5.678; Krabbe KS, 2004, EXP GERONTOL, V39, P687, DOI 10.1016/j.exger.2004.01.009; Kraus RM, 2004, J APPL PHYSIOL, V96, P1445, DOI 10.1152/japplphysiol.01031.2003; Larrouy D, 2002, J PHYSL, V543, P373; Maejima Y, 2003, ATHEROSCLEROSIS, V167, P89, DOI 10.1016/S0021-9150(02)00384-2; Mathieu P, 2014, CAN J CARDIOL, V30, P982, DOI 10.1016/j.cjca.2014.03.029; Niebauer J, 1999, J AM COLL CARDIOL, V34, P1201, DOI 10.1016/S0735-1097(99)00304-6; OLSSON M, 1994, J AM COLL CARDIOL, V23, P1162, DOI 10.1016/0735-1097(94)90606-8; OTTO CM, 1994, CIRCULATION, V90, P844, DOI 10.1161/01.CIR.90.2.844; Peake JM, 2015, EXERC IMMUNOL REV, V21, P8; Petersen AMW, 2005, J APPL PHYSIOL, V98, P1154, DOI 10.1152/japplphysiol.00164.2004; Rodriguez-Nunez I, 2016, ARCH CARDIOL MEX, V21; Sim M, 2013, INT J SPORT NUTR EXE, V23, P178, DOI 10.1123/ijsnem.23.2.178; Steensberg A, 2000, J PHYSIOL-LONDON, V529, P237, DOI 10.1111/j.1469-7793.2000.00237.x; Steiner I, 2007, VIRCHOWS ARCH, V450, P653, DOI 10.1007/s00428-007-0430-7; Swierszcz J, 2012, J HEART VALVE DIS, V21, P599; Syvaranta S, 2012, ATHEROSCLEROSIS, V221, P366, DOI 10.1016/j.atherosclerosis.2011.12.034; Syvaranta S, 2010, ARTERIOSCL THROM VAS, V30, P1220, DOI 10.1161/ATVBAHA.109.198267; Touboul PJ, 2012, CEREBROVASC DIS, V34, P290, DOI 10.1159/000343145; Van Craenenbroeck A. H., 2014, MEDIAT INFLAMM, V2014, DOI DOI 10.1155/2014/216534; Volaklis KA, 2015, J SPORT SCI MED, V14, P91; Wahl P, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0096024; Wang NF, 2009, INT HEART J, V50, P291, DOI 10.1536/ihj.50.291; Wang W, 2014, ARTERIOSCL THROM VAS, V34, P1924, DOI 10.1161/ATVBAHA.114.303852	45	6	7	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 14	2017	12	3							e0173787	10.1371/journal.pone.0173787	http://dx.doi.org/10.1371/journal.pone.0173787			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN6DM	28291817	Green Submitted, gold, Green Published			2022-12-27	WOS:000396094700039
J	Zheng, YP; Yu, T; Tang, YR; Xiong, WJ; Shen, XX; Jiang, L; Lin, L				Zheng, Yongping; Yu, Ting; Tang, Yurong; Xiong, Wenjie; Shen, Xiaoxue; Jiang, Ling; Lin, Lin			Efficacy and safety of 5-hydroxytryptamine 3 receptor antagonists in irritable bowel syndrome: A systematic review and meta-analysis of randomized controlled trials	PLOS ONE			English	Review							CONTROLLED CLINICAL-TRIAL; PREDOMINANCE IBS-D; QUALITY-OF-LIFE; 5-HT3 RECEPTOR; DOUBLE-BLIND; FEMALE-PATIENTS; PHASE-II; DIARRHEA; ALOSETRON; RAMOSETRON	Aim We assessed the efficacy and safety of 5-hydroxytryptamine (5-HT3) receptor antagonists in adults with non-constipated irritable bowel syndrome (IBS) or diarrhea-predominant IBS (IBS-D). Methods We searched PubMed, MEDLINE, EMBASE, and the Cochrane Controlled Trials Register for randomized controlled trials (RCTs) involving adults with non-constipated IBS or IBS-D that compared 5-HT3 receptor antagonists with placebo or other conventional treatment. Dichotomous symptom data were pooled to obtain the relative risk (RR) and 95% confidence intervals (CIs) for improving global IBS symptoms, abdominal pain and abnormal bowel habits, or stool consistency symptoms after therapy, and adverse events, including constipation. Meta-analysis was performed with Mantel Haenszel method using Revman 5.3 software. Results We included 21 RCTs; 16 were high quality (Jadad score >= 4). The pooled RR of global IBS symptoms improved by 5-HT3 receptor antagonists versus placebo or mebeverine was 1.56 (95% CI: 1.43-1.71); alosetron, ramosetron, and cilansetron had similar treatment effects. The pooled RR of abdominal pain relieved by 5-HT3 receptor antagonists versus placebo was 1.33 (95% CI: 1.26-1.39). The pooled RR showed that 5-HT3 receptor antagonists improved abnormal bowel habits or stool consistency symptoms (RR = 1.63, 95% CI: 1.33, 1.99). The pooled RR of adverse events following 5-HT3 receptor antagonist treatment was 1.15 (95% CI: 1.08, 1.22). Subgroup analysis indicated that alosetron had a high rate of adverse effects (RR = 1.16, 95% CI: 1.08, 1.25); adverse events following ramosetron treatment were not statistically significantly different. 5-HT3 receptor antagonists were likelier to cause constipation: the pooled RR of constipation developing with 5-HT3 receptor antagonist versus placebo was 3.71 (95% CI: 2.98-4.61). However, constipation was likelier in patients with non-constipated IBS after taking 5-HT3 receptor antagonists than in patients with IBS-D only (non-constipated IBS and IBS-D: RR = 5.28 [95% CI: 3.93, 7.08] vs. IBS-D only 3.24 [2.54, 4.12]). Conclusions Ramosetron, cilansetron, ondansetron, and alosetron are effective for treating non-constipated IBS and IBS-D. Our systematic review found rare serious adverse events.	[Zheng, Yongping; Yu, Ting; Tang, Yurong; Xiong, Wenjie; Shen, Xiaoxue; Jiang, Ling; Lin, Lin] Nanjing Med Univ, Dept Gastroenterol, Affiliated Hosp 1, Nanjing, Jiangsu, Peoples R China	Nanjing Medical University	Lin, L (corresponding author), Nanjing Med Univ, Dept Gastroenterol, Affiliated Hosp 1, Nanjing, Jiangsu, Peoples R China.	linlin9100@aliyun.com			National Natural Science Foundation of China [81470813]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by grants from the National Natural Science Foundation of China (No. 81470813). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andresen V, 2008, CLIN GASTROENTEROL H, V6, P545, DOI 10.1016/j.cgh.2007.12.015; Bardhan KD, 2000, ALIMENT PHARM THERAP, V14, P23; BRADETTE M, 2004, GASTROENTEROLOGY S2, V126; Camilleri M, 2000, LANCET, V355, P1035, DOI 10.1016/S0140-6736(00)02033-X; Camilleri M, 2001, ARCH INTERN MED, V161, P1733, DOI 10.1001/archinte.161.14.1733; Camilleri M, 1999, ALIMENT PHARM THERAP, V13, P1149; Chang L, 2005, AM J GASTROENTEROL, V100, P115, DOI 10.1111/j.1572-0241.2005.40365.x; Chey WD, 2004, AM J GASTROENTEROL, V99, P2195, DOI 10.1111/j.1572-0241.2004.30509.x; Chiba T, 2013, CLIN EXP GASTROENTER, V6, P123, DOI 10.2147/CEG.S32721; Cremonini F, 2012, ALIMENT PHARM THER, V36, P437, DOI 10.1111/j.1365-2036.2012.05208.x; Drossman D., 2016, FUNCTIONAL GASTROINT; Ford AC, 2009, AM J GASTROENTEROL, V104, P1831, DOI 10.1038/ajg.2009.223; Francisconi CF, 2006, GASTROENTEROLOGY, V130, pA600; Fukudo S, 2016, J GASTROENTEROL, V51, P874, DOI 10.1007/s00535-016-1165-5; Fukudo S, 2016, GASTROENTEROLOGY, V150, P358, DOI 10.1053/j.gastro.2015.10.047; Fukudo S, 2015, GASTROENTEROLOGY, V148, pS659; Fukudo S, 2015, J GASTROENTEROL, V50, P11, DOI 10.1007/s00535-014-1017-0; Fukudo S, 2014, CLIN GASTROENTEROL H, V12, P953, DOI 10.1016/j.cgh.2013.11.024; Garsed K, 2014, GUT, V63, P1617, DOI 10.1136/gutjnl-2013-305989; Grover M, 2014, CLIN GASTROENTEROL H, V12, P960, DOI 10.1016/j.cgh.2013.12.025; HIGGINS JPT, 2011, COCHRANE HDB SYSTEMA, V0001; Higgins JPT, 2003, BRIT MED J, V327, P557, DOI 10.1136/bmj.327.7414.557; Jones RH, 1999, ALIMENT PHARM THER, V13, P1419; Koch KM, 2004, ALIMENT PHARM THERAP, V20, P223, DOI 10.1111/j.1365-2036.2004.02031.x; Kontopantelis E, 2012, STAT METHODS MED RES, V21, P409, DOI 10.1177/0962280210392008; Krause R, 2007, AM J GASTROENTEROL, V102, P1709, DOI 10.1111/j.1572-0241.2007.01282.x; Kux L, 2012, FED REG, V77, P32124; Lacy BE, 2016, INT J GEN MED, V9, P7, DOI 10.2147/IJGM.S93698; Lee KJ, 2011, NEUROGASTROENT MOTIL, V23, P1098, DOI 10.1111/j.1365-2982.2011.01771.x; Lembo AJ, 2004, CLIN GASTROENTEROL H, V2, P675, DOI 10.1016/S1542-3565(04)00284-8; Lembo T, 2001, AM J GASTROENTEROL, V96, P2662; Luthra P, 2015, GUT, V64, P1181, DOI 10.1136/gutjnl-2014-307551; Marciani L, 2010, ALIMENT PHARM THER, V32, P655, DOI 10.1111/j.1365-2036.2010.04395.x; Matsueda K, 2008, DIGESTION, V77, P225, DOI 10.1159/000150632; Matsueda K, 2008, SCAND J GASTROENTERO, V43, P1202, DOI 10.1080/00365520802240255; Mawe GM, 2006, ALIMENT PHARM THER, V23, P1067, DOI 10.1111/j.1365-2036.2006.02858.x; Maxton DG, 1996, ALIMENT PHARM THERAP, V10, P595, DOI 10.1046/j.1365-2036.1996.30172000.x; Mayer EA, 2002, ALIMENT PHARM THER, V16, P1357, DOI 10.1046/j.1365-2036.2002.01287.x; Mearin F, 2016, GASTROENTEROLOGY; Miner P, 2004, AM J GASTROENTEROL, V99, pS277, DOI 10.14309/00000434-200410001-00846; Moore NA, 2013, ACS CHEM NEUROSCI, V4, P43, DOI 10.1021/cn300166c; Naliboff BD, 2003, GASTROENTEROLOGY, V124, P1738, DOI 10.1016/S0016-5085(03)00400-1; Nee J, 2015, EXPERT OPIN PHARMACO, V16, P2781, DOI 10.1517/14656566.2015.1101449; Spiller RC, 2011, CURR OPIN PHARMACOL, V11, P68, DOI 10.1016/j.coph.2011.02.005; Viramontes BE, 2001, AM J GASTROENTEROL, V96, P2671	45	76	79	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 14	2017	12	3							e0172846	10.1371/journal.pone.0172846	http://dx.doi.org/10.1371/journal.pone.0172846			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN6DM	28291778	gold, Green Submitted, Green Published			2022-12-27	WOS:000396094700007
J	Obot, MS; Li, CC; Fang, T; Chen, JQ				Obot, Mfrekemfon Samuel; Li, Changcheng; Fang, Ting; Chen, Jinquan			Measurement of thermal properties of white radish (R-raphanistrum) using easily constructed probes	PLOS ONE			English	Article							THERMOPHYSICAL PROPERTIES; MOISTURE-CONTENT; CONDUCTIVITY; DIFFUSIVITY; L.; TEMPERATURE; POTATO; HEAT	Thermal properties are necessary for the design and control of processes and storage facilities of food materials. This study proposes the measurement of thermal properties using easily constructed probes with specific heat capacity calculated, as opposed to the use of Differential Scanning Calorimeter (DSC) or other. These probes were constructed and used to measure thermal properties of white radish in the temperature range of 80-20 degrees C and moisture content of 91-6.1% wb. Results showed thermal properties were within the range of 0.71-0.111 Wm(-1) C-1 for thermal conductivity, 1.869x10(-7)-0.72x10(-8) m(2) s-(1) for thermal diffusivity and 4.316-1.977 kJ kg(-1) C-1 for specific heat capacity. These results agree with reports for similar products studied using DSC and commercially available line heat source probes. Empirical models were developed for each property through linear multiple regressions. The data generated would be useful in modeling and control of its processing and equipment design.	[Obot, Mfrekemfon Samuel; Li, Changcheng; Fang, Ting; Chen, Jinquan] Fujian Agr & Forestry Univ, Coll Food Sci, Fuzhou, Fujian, Peoples R China; [Obot, Mfrekemfon Samuel] Univ Uyo, Fac Engn, Dept Agr & Food Engn, Uyo, Akwa Ibom State, Nigeria	Fujian Agriculture & Forestry University; University of Uyo	Chen, JQ (corresponding author), Fujian Agr & Forestry Univ, Coll Food Sci, Fuzhou, Fujian, Peoples R China.	chenjq6613@163.com			National Natural Science Foundation of China [31401597]; High Level University Construction Funds: Research on the innovation of the Sub Tropical Special Agricultural Products processing and Safety Control Technology [612014042]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); High Level University Construction Funds: Research on the innovation of the Sub Tropical Special Agricultural Products processing and Safety Control Technology	This research was funded by National Natural Science Foundation of China, http://www.nsfc.gov.cn/ (grant number 31401597; funding received by TF); and High Level University Construction Funds: Research on the innovation of the Sub Tropical Special Agricultural Products processing and Safety Control Technology (grant number 612014042; funding received by The Dean, College of Food Science, Fujian Agriculture and Forestry University, Fuzhou, China). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bairi A, 2007, J FOOD ENG, V78, P669, DOI 10.1016/j.jfoodeng.2005.11.004; Gutierrez Rosa Martha Perez, 2004, ScientificWorldJournal, V4, P811; HALLIDAY PJ, 1995, J FOOD ENG, V26, P273, DOI 10.1016/0260-8774(94)00047-D; Jaramillo-Flores ME, 2000, J FOOD ENG, V46, P139, DOI 10.1016/S0260-8774(00)00074-1; Kim YH, 2011, KOREAN J CHEM ENG, V28, P1924, DOI 10.1007/s11814-011-0048-y; MAGEE TRA, 1995, J FOOD ENG, V25, P223, DOI 10.1016/0260-8774(94)00025-5; Modi SK, 2014, INT J HEAT MASS TRAN, V78, P354, DOI 10.1016/j.ijheatmasstransfer.2014.06.076; Mohsenin N. N., 1980, THERMAL PROPERTIES F; NESVADBA P, 2005, ENG PROPERTIES FOODS, P149; Njie DN, 1998, J FOOD ENG, V37, P63, DOI 10.1016/S0260-8774(98)00068-5; Quirion SB, 2012, J FOOD ENG, V113, P27, DOI 10.1016/j.jfoodeng.2012.05.032; Shrivastava M, 1999, J FOOD ENG, V39, P255, DOI 10.1016/S0260-8774(98)00145-9; Sirisomboon P, 2012, BIOSYST ENG, V113, P402, DOI 10.1016/j.biosystemseng.2012.09.013; SWEAT VE, 1974, T ASAE, V17, P56; Tansakul A, 2006, J FOOD ENG, V73, P276, DOI 10.1016/j.jfoodeng.2005.01.035; Tansakul A, 2008, J FOOD ENG, V87, P91, DOI 10.1016/j.jfoodeng.2007.11.016; Vagenas Gk, 1990, ENG FOOD, P399; Yu DU, 2015, J FOOD ENG, V165, P156, DOI [10.1016/f.foodeng.2015.05.012, 10.1016/j.jfoodeng.2015.05.012]	18	2	3	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 13	2017	12	3							e0171016	10.1371/journal.pone.0171016	http://dx.doi.org/10.1371/journal.pone.0171016			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN6CP	28288175	Green Published, Green Submitted, gold			2022-12-27	WOS:000396092400005
J	Valbusa, F; Bonapace, S; Agnoletti, D; Scala, L; Grillo, C; Arduini, P; Turcato, E; Mantovani, A; Zoppini, G; Arcaro, G; Byrne, C; Targher, G				Valbusa, Filippo; Bonapace, Stefano; Agnoletti, Davide; Scala, Luca; Grillo, Cristina; Arduini, Pietro; Turcato, Emanuela; Mantovani, Alessandro; Zoppini, Giacomo; Arcaro, Guido; Byrne, Christopher; Targher, Giovanni			Nonalcoholic fatty liver disease and increased risk of 1-year all-cause and cardiac hospital readmissions in elderly patients admitted for acute heart failure	PLOS ONE			English	Article							GAMMA-GLUTAMYL-TRANSFERASE; CARDIOVASCULAR-DISEASE; ATRIAL-FIBRILLATION; PREVALENCE; REHOSPITALIZATION; METAANALYSIS; ASSOCIATION; DYSFUNCTION; DIAGNOSIS; REGISTRY	Nonalcoholic fatty liver disease (NAFLD) is an emerging risk factor for heart failure (HF). Although some progress has been made in improving survival among patients admitted for HF, the rates of hospital readmissions and the related costs continue to rise dramatically. We sought to examine whether NAFLD and its severity (diagnosed at hospital admission) was independently associated with a higher risk of 1-year all-cause and cardiac re-hospitalization in patients admitted for acute HF. We studied 212 elderly patients who were consecutively admitted with acute HF to the Hospital of Negrar (Verona) over a 1-year period. Diagnosis of NAFLD was based on ultrasonography, whereas the severity of advanced NAFLD fibrosis was based on the fibrosis (FIB)-4 score and other non-invasive fibrosis scores. Patients with acute myocardial infarction, severe valvular heart diseases, endstage renal disease, cancer, known liver diseases or decompensated cirrhosis were excluded. Cox regression was used to estimate hazard ratios (HR) for the associations between NAFLD and the outcome(s) of interest. The cumulative rate of 1-year all-cause re-hospitalizations was 46.7% (n = 99, mainly due to cardiac causes). Patients with NAFLD (n = 109; 51.4%) had remarkably higher 1-year all-cause and cardiac re-hospitalization rates compared with their counterparts without NAFLD. Both event rates were particularly increased in those with advanced NAFLD fibrosis. NAFLD was associated with a 5-fold increased risk of 1-year all-cause re-hospitalization (adjusted-hazard ratio 5.05, 95% confidence intervals 2.78-9.10, p<0.0001) after adjustment for established risk factors and potential confounders. Similar results were found for 1-year cardiac re-hospitalization (adjusted-hazard ratio 8.05, 95% confidence intervals 3.77-15.8, p<0.0001). In conclusion, NAFLD and its severity were strongly and independently associated with an increased risk of 1-year all-cause and cardiac re-hospitalization in elderly patients admitted with acute HF.	[Valbusa, Filippo; Agnoletti, Davide; Scala, Luca; Grillo, Cristina; Arcaro, Guido] Sacro Cuore Hosp, Div Gen Med, Verona, Italy; [Bonapace, Stefano] Sacro Cuore Hosp, Div Cardiol, Verona, Italy; [Arduini, Pietro; Turcato, Emanuela] Sacro Cuore Hosp, Div Geriatr, Verona, Italy; [Mantovani, Alessandro; Zoppini, Giacomo; Targher, Giovanni] Univ Verona, Dept Med, Sect Endocrinol Diabet & Metab, Verona, Italy; [Mantovani, Alessandro; Zoppini, Giacomo; Targher, Giovanni] Azienda Osped Univ Integrata Verona, Verona, Italy; [Byrne, Christopher] Univ Southampton, Nutr & Metab, Fac Med, Southampton, Hants, England; [Byrne, Christopher] Southampton Univ Hosp, Southampton NIHR Biomed Res Ctr, Southampton, Hants, England	IRCCS Sacro Cuore Don Calabria; IRCCS Sacro Cuore Don Calabria; IRCCS Sacro Cuore Don Calabria; University of Verona; University of Verona; Azienda Ospedaliera Universitaria Integrata Verona; University of Southampton; University of Southampton	Targher, G (corresponding author), Univ Verona, Dept Med, Sect Endocrinol Diabet & Metab, Verona, Italy.; Targher, G (corresponding author), Azienda Osped Univ Integrata Verona, Verona, Italy.	giovanni.targher@univr.it	Mantovani, Alessandro/AAB-9015-2019; Targher, Giovanni/AAB-9008-2019; zoppini, giacomo/AAA-9000-2022; Agnoletti, Davide/K-1441-2016	Mantovani, Alessandro/0000-0002-7271-6329; Targher, Giovanni/0000-0002-4325-3900; zoppini, giacomo/0000-0003-1085-554X; Agnoletti, Davide/0000-0001-8108-7133; Byrne, Christopher D/0000-0001-6322-7753; Bonapace, Stefano/0000-0001-9122-2642	Southampton National Institute for Health Research Biomedical Research Centre; University School of Medicine of Verona, Verona, Italy	Southampton National Institute for Health Research Biomedical Research Centre; University School of Medicine of Verona, Verona, Italy	The authors received no specific funding for this work. However, CDB is supported in part by the Southampton National Institute for Health Research Biomedical Research Centre. GT is supported in part by grants from the University School of Medicine of Verona, Verona, Italy.	Alonso A, 2014, HEART, V100, P1511, DOI 10.1136/heartjnl-2014-305756; Alvarez AM, 2011, INT J ANGIOL, V20, P135, DOI 10.1055/s-0031-1284434; Ballestri S, 2015, EXPERT REV GASTROENT, V9, P603, DOI 10.1586/17474124.2015.1007955; Byrne CD, 2016, GASTROENTEROLOGY, V150, P7, DOI 10.1053/j.gastro.2015.11.016; Byrne CD, 2015, J HEPATOL, V62, pS47, DOI 10.1016/j.jhep.2014.12.012; Dhingra R, 2010, ARTERIOSCL THROM VAS, V30, P1855, DOI 10.1161/ATVBAHA.110.207340; EASL, 2016, DIABETOLOGIA, V59, P1121, DOI 10.1007/s00125-016-3902-y; Gheorghiade M, 2013, J AM COLL CARDIOL, V61, P391, DOI 10.1016/j.jacc.2012.09.038; Graner M, 2015, CIRC-CARDIOVASC IMAG, V8, DOI 10.1161/CIRCIMAGING.114.001979; Hernaez R, 2011, HEPATOLOGY, V54, P1082, DOI 10.1002/hep.24452; Karajamaki AJ, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0142937; Kociol RD, 2011, CIRC-HEART FAIL, V4, P628, DOI 10.1161/CIRCHEARTFAILURE.111.962290; Lang RM, 2006, EUR J ECHOCARDIOGR, V7, P79, DOI 10.1016/j.euje.2005.12.014; Levey AS, 2009, ANN INTERN MED, V150, P604, DOI 10.7326/0003-4819-150-9-200905050-00006; Lonardo A, 2016, WORLD J GASTROENTERO, V22, P9674, DOI 10.3748/wjg.v22.i44.9674; Lonardo A, 2015, DIGEST LIVER DIS, V47, P997, DOI 10.1016/j.dld.2015.08.004; Mantovani A, 2016, DIGEST DIS SCI, V61, P1246, DOI 10.1007/s10620-016-4040-6; McMurray JJV, 2012, EUR J HEART FAIL, V14, P803, DOI 10.1093/eurjhf/hfs105; McPherson S., 2016, AM J GASTROENTEROL; Park CC, 2017, GASTROENTEROLOGY, V152, P598, DOI 10.1053/j.gastro.2016.10.026; Poelzl G, 2009, CIRC-HEART FAIL, V2, P294, DOI 10.1161/CIRCHEARTFAILURE.108.826735; Santaguida PL, 2014, HEART FAIL REV, V19, P453, DOI 10.1007/s10741-014-9442-y; Siegelman ES, 2001, SEMIN LIVER DIS, V21, P71, DOI 10.1055/s-2001-12930; Targher G, 2017, EUR J HEART FAIL, V19, P54, DOI 10.1002/ejhf.679; Targher G, 2016, J HEPATOL, V65, P589, DOI 10.1016/j.jhep.2016.05.013; Targher G, 2016, INT J CARDIOL, V203, P587, DOI 10.1016/j.ijcard.2015.10.207; Targher G, 2013, CLIN SCI, V125, P301, DOI 10.1042/CS20130036; Targher G, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057183; Targher G, 2010, NEW ENGL J MED, V363, P1341, DOI 10.1056/NEJMra0912063; Valbusa F, 2016, MEDICINE, V95, DOI 10.1097/MD.0000000000002760; van Riet EES, 2016, EUR J HEART FAIL, V18, P242, DOI 10.1002/ejhf.483; VanWagner LB, 2015, HEPATOLOGY, V62, P773, DOI 10.1002/hep.27869; Wang YJ, 2013, HEART, V99, P163, DOI 10.1136/heartjnl-2012-302972; Wannamethee SG, 2012, ARTERIOSCL THROM VAS, V32, P830, DOI 10.1161/ATVBAHA.111.240457	34	24	25	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 13	2017	12	3							e0173398	10.1371/journal.pone.0173398	http://dx.doi.org/10.1371/journal.pone.0173398			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN6CP	28288193	Green Published, gold, Green Accepted, Green Submitted			2022-12-27	WOS:000396092400015
J	Lee, AL; Ung, HM; Sands, LP; Kikis, EA				Lee, Amy L.; Ung, Hailey M.; Sands, L. Paul; Kikis, Elise A.			A new Caenorhabditis elegans model of human huntingtin 513 aggregation and toxicity in body wall muscles	PLOS ONE			English	Article							CAG REPEAT LENGTH; MOLECULAR CHAPERONES; MUTANT HUNTINGTIN; TRINUCLEOTIDE REPEAT; POLYGLUTAMINE DISEASE; PROTEIN AGGREGATION; CASPASE CLEAVAGE; DYSFUNCTION; NEURODEGENERATION; EXPANSION	Expanded polyglutamine repeats in different proteins are the known determinants of at least nine progressive neurodegenerative disorders whose symptoms include cognitive and motor impairment that worsen as patients age. One such disorder is Huntington's Disease (HD) that is caused by a polyglutamine expansion in the human huntingtin protein (htt). The polyglutamine expansion destabilizes htt leading to protein misfolding, which in turn triggers neurodegeneration and the disruption of energy metabolism in muscle cells. However, the molecular mechanisms that underlie htt proteotoxicity have been somewhat elusive, and the muscle phenotypes have not been well studied. To generate tools to elucidate the basis for muscle dysfunction, we engineered Caenorhabditis elegans to express a disease-associated 513 amino acid fragment of human htt in body wall muscle cells. We show that this htt fragment aggregates in C. elegans in a polyglutamine length-dependent manner and is toxic. Toxicity manifests as motor impairment and a shortened lifespan. Compared to previous models, the data suggest that the protein context in which a polyglutamine tract is embedded alters aggregation propensity and toxicity, likely by affecting interactions with the muscle cell environment.	[Lee, Amy L.; Ung, Hailey M.; Sands, L. Paul; Kikis, Elise A.] Univ South Sewanee, Dept Biol, Sewanee, TN 37383 USA; [Lee, Amy L.] deCODE Genet, Reykjavik, Iceland	Sewanee: University of the South	Kikis, EA (corresponding author), Univ South Sewanee, Dept Biol, Sewanee, TN 37383 USA.	eakikis@sewanee.edu			University of the South; Emory University Integrated Cellular Imaging Microscopy Core	University of the South; Emory University Integrated Cellular Imaging Microscopy Core	There were no external sources of funding for this work. All funding was provided by internal support from the University of the South including Faculty Development Grants and a Kennedy Endowed Faculty Fellowship to EK. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We would like to the laboratory of Richard Morimoto at Northwestern University for the equipment used to generate transgenic animals, as well as for fruitful conversations. The laboratory of Janine Kirstein at the Leibniz Institute for Molecular Pharmacology provided assistance with transgene integration. Matthew Rudd of the University of the South provided assistance with statistical analyses. Last but not least, this research project was supported in part by the Emory University Integrated Cellular Imaging Microscopy Core.	ANDRADE MA, 1995, NAT GENET, V11, P115, DOI 10.1038/ng1095-115; ANDREW SE, 1993, NAT GENET, V4, P398, DOI 10.1038/ng0893-398; Bailey CK, 2002, HUM MOL GENET, V11, P515, DOI 10.1093/hmg/11.5.515; Bates GP, 2015, NAT REV DIS PRIMERS, V1, DOI 10.1038/nrdp.2015.5; Becher MW, 1998, NEUROBIOL DIS, V4, P387, DOI 10.1006/nbdi.1998.0168; Ben-Zvi A, 2009, P NATL ACAD SCI USA, V106, P14914, DOI 10.1073/pnas.0902882106; Bhat KP, 2014, P NATL ACAD SCI USA, V111, P5706, DOI 10.1073/pnas.1402215111; BRENNER S, 1974, GENETICS, V77, P71; Brignull HR, 2006, J NEUROSCI, V26, P7597, DOI 10.1523/JNEUROSCI.0990-06.2006; Butterworth NJ, 1998, NEUROSCIENCE, V87, P49, DOI 10.1016/S0306-4522(98)00129-8; CAI Yanhui, 2006, ENG SURVERYING MAPPI, V15, P41, DOI DOI 10.1093/HMG/DDL017; Calamini B, 2012, NAT CHEM BIOL, V8, P185, DOI 10.1038/nchembio.763; Carrell RW, 1997, LANCET, V350, P134, DOI 10.1016/S0140-6736(97)02073-4; Chai YH, 1999, J NEUROSCI, V19, P10338; Christie NTM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0096835; DUYAO M, 1993, NAT GENET, V4, P387, DOI 10.1038/ng0893-387; Faber PW, 1999, P NATL ACAD SCI USA, V96, P179, DOI 10.1073/pnas.96.1.179; Fujikake N, 2008, J BIOL CHEM, V283, P26188, DOI 10.1074/jbc.M710521200; Gidalevitz T, 2006, SCIENCE, V311, P1471, DOI 10.1126/science.1124514; Gidalevitz T, 2013, BMC BIOL, V11, DOI 10.1186/1741-7007-11-100; Gidalevitz T, 2010, CURR OPIN STRUC BIOL, V20, P23, DOI 10.1016/j.sbi.2009.11.001; Goldberg YP, 1996, NAT GENET, V13, P442, DOI 10.1038/ng0896-442; Hodgson JG, 1999, NEURON, V23, P181, DOI 10.1016/S0896-6273(00)80764-3; Huntington G, 2003, J NEUROPSYCH CLIN N, V15, P109, DOI 10.1176/appi.neuropsych.15.1.109; KENYON C, 1993, NATURE, V366, P461, DOI 10.1038/366461a0; Kikis EA, 2016, BIOL DIRECT, V11, DOI 10.1186/s13062-016-0161-2; Landles C, 2010, J BIOL CHEM, V285, P8808, DOI 10.1074/jbc.M109.075028; Lejeune FX, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-91; Lodi R, 2000, ANN NEUROL, V48, P72; MACDONALD ME, 1993, CELL, V72, P971, DOI 10.1016/0092-8674(93)90585-E; Mangiarini L, 1996, CELL, V87, P493, DOI 10.1016/S0092-8674(00)81369-0; Mattson MP, 2000, NAT REV MOL CELL BIO, V1, P120, DOI 10.1038/35040009; Morley JF, 2002, P NATL ACAD SCI USA, V99, P10417, DOI 10.1073/pnas.152161099; Nollen EAA, 2004, P NATL ACAD SCI USA, V101, P6403, DOI 10.1073/pnas.0307697101; Parker JA, 2012, J NEUROSCI, V32, P12630, DOI 10.1523/JNEUROSCI.0277-12.2012; Parker JA, 2001, P NATL ACAD SCI USA, V98, P13318, DOI 10.1073/pnas.231476398; Prahlad V, 2011, P NATL ACAD SCI USA, V108, P14204, DOI 10.1073/pnas.1106557108; Reddy PH, 2014, DRUG DISCOV TODAY, V19, P951, DOI 10.1016/j.drudis.2014.03.020; Sahl SJ, 2012, SCI REP-UK, V2, DOI 10.1038/srep00895; Sahoo B, 2014, BIOCHEMISTRY-US, V53, P3897, DOI 10.1021/bi500300c; Sakahira H, 2002, P NATL ACAD SCI USA, V99, P16412, DOI 10.1073/pnas.182426899; Saudou F, 1998, CELL, V95, P55, DOI 10.1016/S0092-8674(00)81782-1; SNELL RG, 1993, NAT GENET, V4, P393, DOI 10.1038/ng0893-393; Tourette C, 2014, PLOS BIOL, V12, DOI 10.1371/journal.pbio.1001895; Wacker JL, 2004, NAT STRUCT MOL BIOL, V11, P1215, DOI 10.1038/nsmb860; Wang HJ, 2009, ACTA GEOLOGICA SICHU, V29, p11 , DOI DOI 10.1093/HMG/DDN404; Warrick JM, 1999, NAT GENET, V23, P425, DOI 10.1038/70532; Wellington CL, 2000, J BIOL CHEM, V275, P19831, DOI 10.1074/jbc.M001475200; Wellington CL, 1998, J BIOL CHEM, V273, P9158, DOI 10.1074/jbc.273.15.9158; Zhang X, 2005, PHYS PLASMAS, V12, P1; Zielonka D, 2014, FRONT PHYSIOL, V5, DOI 10.3389/fphys.2014.00380	51	15	15	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 10	2017	12	3							e0173644	10.1371/journal.pone.0173644	http://dx.doi.org/10.1371/journal.pone.0173644			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN6CJ	28282438	gold, Green Published, Green Submitted			2022-12-27	WOS:000396091800061
J	Lin, JY; Gu, CJ; Shen, ZL; Liu, YF; Wang, W; Tao, S; Cui, XX; Liu, J; Xie, YH				Lin, Junyu; Gu, Chenjian; Shen, Zhongliang; Liu, Yanfeng; Wang, Wei; Tao, Shuai; Cui, Xiaoxian; Liu, Jing; Xie, Youhua			Hepatocyte nuclear factor 1 alpha downregulates HBV gene expression and replication by activating the NF-kappa B signaling pathway	PLOS ONE			English	Article							ENRICHED TRANSCRIPTION FACTORS; VIRUS-REPLICATION; SURFACE-ANTIGEN; LIVER-FUNCTION; DNA-BINDING; INHIBITION; SUBUNIT; PHOSPHORYLATION; SECRETION; APOPTOSIS	The role of hepatocyte nuclear factor 1 alpha(HNF1 alpha) in the regulation of gene expression and replication of hepatitis B virus (HBV) is not fully understood. Previous reports have documented the induction of the expression of viral large surface protein (LHBs) by HNF1 alpha through activating viral Sp1 promoter. Large amount of LHBs can block the secretion of hepatitis B surface antigen (HBsAg). Here we found that HNF1 alpha overexpression inhibited HBV gene expression and replication in Huh7 cells, resulting in marked decreases in HBsAg, hepatitis B e antigen (HBeAg) and virion productions. In contrast, knockdown of endogenous HNF1 alpha expression enhanced viral gene expression and replication. This HNF1 alpha-mediated inhibition did not depend on LHBs. Instead, HNF1 alpha promoted the expression of NF-kappa B p65 and slowed p65 protein degradation, leading to nuclear accumulation of p65 and activation of the NF-kappa B signaling, which in turn inhibited HBV gene expression and replication. The inhibitor of the NF-kappa B signaling, I kappa B alpha-SR, could abrogate this HNF1 alpha-mediated inhibition. While the dimerization domain of HNF1 alpha was dispensable for the induction of LHBs expression, all the domains of HNF1 alpha was required for the inhibition of HBV gene expression. Our findings identify a novel role of HNF1 alpha in the regulation of HBV gene expression and replication.	[Liu, Jing; Xie, Youhua] Fudan Univ, Shanghai Med Coll, Key Lab Med Mol Virol, Minist Hlth, Shanghai, Peoples R China; Fudan Univ, Shanghai Med Coll, Minist Educ, Shanghai, Peoples R China	Fudan University; Fudan University	Liu, J; Xie, YH (corresponding author), Fudan Univ, Shanghai Med Coll, Key Lab Med Mol Virol, Minist Hlth, Shanghai, Peoples R China.	liujing212@fudan.edu.cn; yhxie@fudan.edu.cn	Gu, Chenjian/AGX-7892-2022		National Key Project for Infectious Diseases of China [2012ZX10002-006, 2012ZX10004-503, 2012ZX10002012-003]; National Basic Research Program of China [2012CB519002]; National High Tech Program of China [2012AA02A407]; Natural Science Foundation of China [81472226, 31170148]	National Key Project for Infectious Diseases of China; National Basic Research Program of China(National Basic Research Program of China); National High Tech Program of China(National High Technology Research and Development Program of China); Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by the National Key Project for Infectious Diseases of China (2012ZX10002-006,2012ZX10004-503, 2012ZX10002012-003), National Basic Research Program of China (2012CB519002), National High Tech Program of China (2012AA02A407), and Natural Science Foundation of China (81472226, 31170148).	Ashburner BP, 2001, MOL CELL BIOL, V21, P7065, DOI 10.1128/MCB.21.20.7065-7077.2001; Biermer M, 2003, J VIROL, V77, P4033, DOI 10.1128/JVI.77.7.4033-4042.2003; Cai YN, 2003, CELL RES, V13, P451, DOI 10.1038/sj.cr.7290187; Chen LF, 2003, J MOL MED, V81, P549, DOI 10.1007/s00109-003-0469-0; Dai XP, 2014, NUCLEIC ACIDS RES, V42, P6578, DOI 10.1093/nar/gku260; Fan HX, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065588; GHOSH S, 1990, CELL, V62, P1019, DOI 10.1016/0092-8674(90)90276-K; Gilmore TD, 2006, ONCOGENE, V25, P6680, DOI 10.1038/sj.onc.1209954; Hoffmann A, 2006, ONCOGENE, V25, P6706, DOI 10.1038/sj.onc.1209933; Li JH, 2010, J VIROL, V84, P6387, DOI 10.1128/JVI.00236-10; Lin YC, 2009, CELL MICROBIOL, V11, P645, DOI 10.1111/j.1462-5822.2008.01280.x; Nassal M, 2015, GUT, V64, P1972, DOI 10.1136/gutjnl-2015-309809; NOLAN GP, 1991, CELL, V64, P961, DOI 10.1016/0092-8674(91)90320-X; Perkins ND, 2006, ONCOGENE, V25, P6717, DOI 10.1038/sj.onc.1209937; PERSING DH, 1986, SCIENCE, V234, P1388, DOI 10.1126/science.3787251; Puro R, 2007, J VIROL, V81, P7351, DOI 10.1128/JVI.00554-07; Qin J, 2009, J GEN VIROL, V90, P1246, DOI 10.1099/vir.0.006007-0; Quasdorff M, 2008, CELL MICROBIOL, V10, P1478, DOI 10.1111/j.1462-5822.2008.01141.x; RANEY AK, 1994, J GEN VIROL, V75, P2671, DOI 10.1099/0022-1317-75-10-2671; Raney AK, 2001, VIROLOGY, V289, P239, DOI 10.1006/viro.2001.1169; Raney AK, 2001, J VIROL, V75, P2900, DOI 10.1128/JVI.75.6.2900-2911.2001; Santoro MG, 2003, EMBO J, V22, P2552, DOI 10.1093/emboj/cdg267; Schrem H, 2004, PHARMACOL REV, V56, P291, DOI 10.1124/pr.56.2.5; Schrem H, 2002, PHARMACOL REV, V54, P129, DOI 10.1124/pr.54.1.129; Schweitzer A, 2015, LANCET, V386, P1546, DOI 10.1016/S0140-6736(15)61412-X; Seeger C, 2015, VIROLOGY, V479, P672, DOI 10.1016/j.virol.2015.02.031; STANDRING DN, 1986, P NATL ACAD SCI USA, V83, P9338, DOI 10.1073/pnas.83.24.9338; Su F, 2001, J VIROL, V75, P215, DOI 10.1128/JVI.75.1.215-225.2001; Tang H, 2002, J VIROL, V76, P8572, DOI 10.1128/JVI.76.17.8572-8581.2002; Tang H, 2001, P NATL ACAD SCI USA, V98, P1841, DOI 10.1073/pnas.041479698; Tang H, 2001, DRUG NEWS PERSPECT, V14, P325; TRAENCKNER EBM, 1995, EMBO J, V14, P2876, DOI 10.1002/j.1460-2075.1995.tb07287.x; Wang HY, 2000, EMBO J, V19, P4257, DOI 10.1093/emboj/19.16.4257; Wang WX, 1998, RES VIROLOGY, V149, P99, DOI 10.1016/S0923-2516(98)80085-X; Yan H, 2012, ELIFE, V1, DOI 10.7554/eLife.00049; Zhong HH, 2002, MOL CELL, V9, P625, DOI 10.1016/S1097-2765(02)00477-X; ZHOU DX, 1991, MOL CELL BIOL, V11, P1353, DOI 10.1128/MCB.11.3.1353	37	20	22	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 20	2017	12	3							e0174017	10.1371/journal.pone.0174017	http://dx.doi.org/10.1371/journal.pone.0174017			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ER6VC	28319127	Green Submitted, gold, Green Published			2022-12-27	WOS:000398945800042
J	Oh, M; Kim, JS; Oh, JS; Lee, CS; Chung, SJ				Oh, Minyoung; Kim, Jae Seung; Oh, Jungsu S.; Lee, Chong Sik; Chung, Sun Ju			Different subregional metabolism patterns in patients with cerebellar ataxia by F-18-fluorodeoxyglucose positron emission tomography	PLOS ONE			English	Article							MULTIPLE SYSTEM ATROPHY; SPINOCEREBELLAR ATAXIA; GLUCOSE-METABOLISM; OLIVOPONTOCEREBELLAR ATROPHY; PARKINSONS-DISEASE; CLINICAL-FEATURES; CAG REPEAT; PET; BRAIN; DIAGNOSIS	We evaluated cerebellar subregional metabolic alterations in patients with cerebellar ataxia, a representative disease involving the spinocerebellum.We retrospectively analyzed F-18-fluorodeoxyglucose positron emission tomography (18 F-FDG PET) images in 44 patients with multiple system atrophy of the cerebellar type (MSA-C), 9 patients with spinocerebellar ataxia (SCA) type 2, and 14 patients with SCA type 6 and compared with 15 patients with crossed cerebellar diaschisis (CCD) and 89 normal controls.Cerebellar subregional metabolism was assessed using 13 cerebellar subregions (bilateral anterior lobes [ANT], superior/ mid/ inferior posterior lobes [SUPP/ MIDP/INFP], dentate nucleus [DN], anterior vermis [ANTV], and superior/ inferior posterior vermis [SUPV/INFV]) to determine FDG uptake ratios.MSA-C and SCA type 2 showed severely decreased metabolic ratios in all cerebellar subregions compared to normal controls (ANT, 0.58 +/- 0.08 and 0.50 +/- 0.06 vs.0.82 +/- 0.07, respectively, p<0.001).SCA type 6 showed lower metabolic ratios in almost all cerebellar subregions (ANT, 0.57 +/- 0.06, p<0.001) except INFV.Anterior-posterior lobe ratio measurements revealed that SCA type 2 (Right, 0.81 +/- 0.05 vs.0.88 +/- 0.04, p <0.001; Left, 0.83 +/- 0.05 vs.0.88 +/- 0.04, p= 0.003) and SCA type 6 (Right, 0.72 +/- 0.05 vs.0.88 +/- 0.04, p<0.001; Left, 0.72 +/- 0.05 vs.0.88 +/- 0.04, p <0.001) showed preferential hypometabolism in the anterior lobe compared to normal controls, which was not observed in CCD and MSA-C.Asymmetric indices were higher in CCD and MSA-C than in normal controls (p<0.001), whereas such differences were not found in SCA types 2 and 6.In summary, quantitative analysis of cerebellar subregional metabolism ratios revealed preferential involvement of the anterior lobe, corresponding to the spinocerebellum, in patients with cerebellar ataxia, whereas patients with CCD and MSA-C exhibited more asymmetric hypometabolism in the posterior lobe.	[Oh, Minyoung; Kim, Jae Seung; Oh, Jungsu S.] Univ Ulsan, Dept Nucl Med, Asan Med Ctr, Coll Med, Seoul, South Korea; [Lee, Chong Sik; Chung, Sun Ju] Univ Ulsan, Dept Neurol, Asan Med Ctr, Coll Med, Seoul, South Korea	University of Ulsan; Asan Medical Center; University of Ulsan; Asan Medical Center	Kim, JS (corresponding author), Univ Ulsan, Dept Nucl Med, Asan Med Ctr, Coll Med, Seoul, South Korea.	jaeskim@amc.seoul		Oh, Minyoung/0000-0002-6840-3215	Korea Health Technology R&D Project through the Korea Health Industry Development Institute (KHIDI); Ministry of Health & Welfare, Republic of Korea [HI14C2768]	Korea Health Technology R&D Project through the Korea Health Industry Development Institute (KHIDI)(Korea Health Industry Development Institute (KHIDI)); Ministry of Health & Welfare, Republic of Korea(Ministry of Health & Welfare (MOHW), Republic of Korea)	This research was supported by a grant of the Korea Health Technology R&D Project through the Korea Health Industry Development Institute (KHIDI), funded by the Ministry of Health & Welfare, Republic of Korea (grant number: HI14C2768). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abele M, 2002, BRAIN, V125, P961, DOI 10.1093/brain/awf107; Batla A, 2013, PARKINSONISM RELAT D, V19, P901, DOI 10.1016/j.parkreldis.2013.05.004; Borghammer P, 2008, NEUROIMAGE, V40, P529, DOI 10.1016/j.neuroimage.2007.12.057; Brockmann K, 2012, J NUCL MED, V53, P1074, DOI 10.2967/jnumed.111.101543; BRODAL A, 1972, ACTA NEUROL SCAND, V48, P153; Butteriss D, 2005, BRIT J RADIOL, V78, P694, DOI 10.1259/bjr/73834093; Diamant M, 2002, ACTA PHYSIOL SCAND, V175, P1, DOI 10.1046/j.1365-201X.2002.00953.x; Diedrichsen J, 2009, NEUROIMAGE, V46, P39, DOI 10.1016/j.neuroimage.2009.01.045; Dukart J, 2010, NEUROIMAGE, V49, P1490, DOI 10.1016/j.neuroimage.2009.09.017; Durr A, 1995, BRAIN, V118, P1573, DOI 10.1093/brain/118.6.1573; Eckert T, 2005, NEUROIMAGE, V26, P912, DOI 10.1016/j.neuroimage.2005.03.012; EVANS AC, 1993, NUCLEAR SCIENCE SYMPOSIUM & MEDICAL IMAGING CONFERENCE, VOLS 1-3, P1813, DOI 10.1109/NSSMIC.1993.373602; Fredericks C.M., 1996, PATHOPHYSIOLOGY MOTO, P445; Gilman S, 2008, NEUROLOGY, V71, P670, DOI 10.1212/01.wnl.0000324625.00404.15; GILMAN S, 1988, ANN NEUROL, V23, P223, DOI 10.1002/ana.410230303; Gomez CM, 1997, ANN NEUROL, V42, P933, DOI 10.1002/ana.410420616; HARRIS DA, 1993, PHYS REV LETT, V71, P3914, DOI 10.1103/PhysRevLett.71.3914; Hirano S, 2008, MOVEMENT DISORD, V23, P1154, DOI 10.1002/mds.22056; Hughes AJ, 2002, BRAIN, V125, P861, DOI 10.1093/brain/awf080; Inagaki A, 2005, EUR J NEUROL, V12, P725, DOI 10.1111/j.1468-1331.2005.01011.x; Kim HJ, 2014, NEUROLOGY, V83, P1733, DOI 10.1212/WNL.0000000000000965; Kim J, 2005, AM J NEURORADIOL, V26, P2224; Klockgether T, 2010, LANCET NEUROL, V9, P94, DOI 10.1016/S1474-4422(09)70305-9; Koga S, 2015, NEUROLOGY, V85, P404, DOI 10.1212/WNL.0000000000001807; KUHL DE, 1982, J CEREBR BLOOD F MET, V2, P163, DOI 10.1038/jcbfm.1982.15; KUSHNER M, 1987, J NUCL MED, V28, P1667; Lee SW, 2012, J MOV DISORD, V5, P42, DOI 10.14802/jmd.12010; Litvan I, 1997, ARCH NEUROL-CHICAGO, V54, P937, DOI 10.1001/archneur.1997.00550200007003; Lyoo CH, 2008, BRAIN, V131, P438, DOI 10.1093/brain/awm328; Maas RPPWM, 2015, NEUROLOGY, V85, P96, DOI 10.1212/WNL.0000000000001711; Makris N, 2005, NEUROIMAGE, V25, P1146, DOI 10.1016/j.neuroimage.2004.12.056; Matsumura R, 1997, NEUROLOGY, V49, P1238, DOI 10.1212/WNL.49.5.1238; MATTHEW E, 1993, J NEUROL SCI, V119, P134, DOI 10.1016/0022-510X(93)90125-I; MAURITZ KH, 1979, BRAIN, V102, P461, DOI 10.1093/brain/102.3.461; METTER EJ, 1987, NEUROLOGY, V37, P1599, DOI 10.1212/WNL.37.10.1599; Mishina M, 1999, ACTA NEUROL SCAND, V100, P369; Muzaimi MB, 2004, J NEUROL NEUROSUR PS, V75, P1129, DOI 10.1136/jnnp.2003.014662; Oh JS, 2014, NEUROREPORT, V25, P1198, DOI 10.1097/WNR.0000000000000247; OSCARSSON O, 1965, PHYSIOL REV, V45, P495, DOI 10.1152/physrev.1965.45.3.495; Otte A, 1998, J NEUROL SCI, V156, P73, DOI 10.1016/S0022-510X(98)00019-7; PANTANO P, 1986, BRAIN, V109, P677, DOI 10.1093/brain/109.4.677; Perju-Dumbrava LD, 2012, MOVEMENT DISORD, V27, P65, DOI 10.1002/mds.24000; Roostaei T, 2014, NEUROL CLIN, V32, P859, DOI 10.1016/j.ncl.2014.07.013; Rousset OG, 1998, J NUCL MED, V39, P904; Rudolf J, 2000, CLIN NEUROL NEUROSUR, V102, P210, DOI 10.1016/S0303-8467(00)00113-X; Schmitz-Hubsch T, 2006, NEUROLOGY, V66, P1717, DOI 10.1212/01.wnl.0000219042.60538.92; Soong BW, 1998, J NEUROL NEUROSUR PS, V64, P499, DOI 10.1136/jnnp.64.4.499; Soong BW, 2001, ARCH NEUROL-CHICAGO, V58, P300, DOI 10.1001/archneur.58.2.300; Stevanin G, 1997, NEUROLOGY, V49, P1243, DOI 10.1212/WNL.49.5.1243; Takahashi H, 1998, ACTA NEUROPATHOL, V95, P333, DOI 10.1007/s004010050807; Talairach J., 1988, COPLANAR STEREOTAXIC; Tang CC, 2010, LANCET NEUROL, V9, P149, DOI 10.1016/S1474-4422(10)70002-8; Tumeh PC, 2007, SEMIN NUCL MED, V37, P69, DOI 10.1053/j.semnuclmed.2006.10.002; Volkow ND, 2000, AM J PSYCHIAT, V157, P75, DOI 10.1176/ajp.157.1.75; Wang PS, 2007, J NEUROL, V254, P838, DOI 10.1007/s00415-006-0383-9; WENNING GK, 1994, BRAIN, V117, P835, DOI 10.1093/brain/117.4.835; Wenning GK, 1997, MOVEMENT DISORD, V12, P133, DOI 10.1002/mds.870120203; Wenning GK, 2003, REV NEUROL PARIS, V159, p3S31; Wullner U, 2007, J NEURAL TRANSM, V114, P1161, DOI 10.1007/s00702-007-0746-0; Wullner U, 2005, ARCH NEUROL-CHICAGO, V62, P1280, DOI 10.1001/archneur.62.8.1280; Yabe I, 2008, J NEUROL SCI, V266, P164, DOI 10.1016/j.jns.2007.09.021; Yagishita S, 1997, PATHOL INT, V47, P1, DOI 10.1111/j.1440-1827.1997.tb04429.x; Yakushev I, 2008, PSYCHIAT RES-NEUROIM, V164, P143, DOI 10.1016/j.pscychresns.2007.11.004	63	10	12	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 20	2017	12	3							e0173275	10.1371/journal.pone.0173275	http://dx.doi.org/10.1371/journal.pone.0173275			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ER6VC	28319124	gold, Green Published, Green Submitted			2022-12-27	WOS:000398945800013
J	Amoozgar, B; Wei, XL; Lee, JH; Bloomer, M; Zhao, ZT; Coh, P; He, F; Luan, L; Xie, C; Han, Y				Amoozgar, Behzad; Wei, Xiaoling; Lee, Jun Hui; Bloomer, Michele; Zhao, Zhengtuo; Coh, Paul; He, Fei; Luan, Lan; Xie, Chong; Han, Ying			A novel flexible microfluidic meshwork to reduce fibrosis in glaucoma surgery	PLOS ONE			English	Article							ADJUNCTIVE MITOMYCIN-C; MACROPOROUS NANOELECTRONIC NETWORKS; OPEN-ANGLE GLAUCOMA; AHMED GLAUCOMA; VALVE IMPLANTATION; DIFFERENT BIOMATERIALS; HYPERTENSIVE PHASE; TREATMENT OUTCOMES; AMNIOTIC MEMBRANE; TISSUE-RESPONSE	Purpose/Relevance Fibrosis and hence capsule formation around the glaucoma implants are the main reasons for glaucoma implant failure. To address these issues, we designed a microfluidic meshwork and tested its biocompatibility in a rabbit eye model. The amount of fibrosis elicited by the microfluidic meshwork was compared to the amount elicited by the plate of conventional glaucoma drainage device. Methods Six eyes from 3 New Zealand albino rabbits were randomized to receive either the novel microfluidic meshwork or a plate of Ahmed glaucoma valve model PF7 (AGV PF7). The flex-ible microfluidic implant was made from negative photoresist SU-8 by using micro-fabrica-tion techniques. The overall size of the meshwork was 7 mm x 7 mm with a grid period of 100 mu m Both implants were placed in the subtenon space at the supratemporal quadrant in a standard fashion. There was no communication between the implants and the anterior chamber via a tube. All animal eyes were examined for signs of infection and implant erosion on days 1, 3, 7, and 14 and then monthly. Exenterations were performed in which the entire orbital contents were removed at 3 months. Histology slides of the implant and the surrounding tissues were prepared and stained with hematoxylin-eosin. Thickness of the fibrous capsules beneath the implants were measured and compared with paired student's t-test between the two groups. Results The gross histological sections showed that nearly no capsule formed around the microflui-dic meshwork in contrast to the thick capsule formed around the plate of AGV PF7. Thick-ness of the fibrotic capsules beneath the AGV PF7 plate from the 3 rabbit eyes was 90 mu m, 82 mu m, and 95 mu m, respectively. The thickness at the bottom of fibrotic capsules around the new microfluidic implant were 1 mu m, 2 mu m, and 1 mu m, respectively. The difference in thickness of capsule between the two groups was significant (P = 0.002). No complications were noticed in the 6 eyes, and both implants were tolerated well by all rabbits. Conclusion The microfluidic meshwork elicited minimal fibrosis and capsule formation after 3-months implantation in a rabbit model. This provides promising evidence to aid in future development of a new glaucoma drainage implant that will elicit minimal scar formation and provide better long-term surgical outcomes.	[Amoozgar, Behzad; Lee, Jun Hui; Bloomer, Michele; Coh, Paul; Han, Ying] Univ Calif San Francisco, Dept Ophthalmol, San Francisco, CA 94143 USA; [Wei, Xiaoling; Zhao, Zhengtuo; He, Fei; Xie, Chong] Univ Texas Austin, Dept Biomed Engn, Austin, TX 78712 USA; [Luan, Lan] Univ Texas Austin, Dept Phys, Austin, TX 78712 USA	University of California System; University of California San Francisco; University of Texas System; University of Texas Austin; University of Texas System; University of Texas Austin	Han, Y (corresponding author), Univ Calif San Francisco, Dept Ophthalmol, San Francisco, CA 94143 USA.; Xie, C (corresponding author), Univ Texas Austin, Dept Biomed Engn, Austin, TX 78712 USA.	Chongxie@utexas.edu; Ying.Han@ucsf.edu	Wei, Xiaoling/K-4552-2012	Wei, Xiaoling/0000-0002-0099-2260; Luan, Lan/0000-0002-5327-2240	UT Austin Cockrell School of Engineering and Department of Biomedical Engineering start-up fund; Office of the Assistant Secretary of Defense for Health Affairs through the Clinical and Rehabilitative Medicine Research Program [W81XWH-16-1-0580]; Man May Seen Seed Grant; UCSF Catalyst Award; Core Grant [EY00216]; Research to Prevent Blindness unrestricted funding; NATIONAL EYE INSTITUTE [P30EY002162] Funding Source: NIH RePORTER	UT Austin Cockrell School of Engineering and Department of Biomedical Engineering start-up fund; Office of the Assistant Secretary of Defense for Health Affairs through the Clinical and Rehabilitative Medicine Research Program; Man May Seen Seed Grant; UCSF Catalyst Award; Core Grant; Research to Prevent Blindness unrestricted funding(Research to Prevent Blindness (RPB)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	This work was funded by UT Austin Cockrell School of Engineering and Department of Biomedical Engineering start-up fund (CX), by the Office of the Assistant Secretary of Defense for Health Affairs through the Clinical and Rehabilitative Medicine Research Program under Award No. W81XWH-16-1-0580 (CX), by The Man May Seen Seed Grant (YH and CX), by UCSF Catalyst Award (YH and CX), by EY00216- Core Grant (YH) and by Research to Prevent Blindness unrestricted funding (YH). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alvarado JA, 2008, AM J OPHTHALMOL, V146, P276, DOI 10.1016/j.ajo.2008.04.008; [Anonymous], 2008, SEMINARS IMMUNOLOGY; Ayyala RS, 2000, ARCH OPHTHALMOL-CHIC, V118, P1081, DOI 10.1001/archopht.118.8.1081; Ayyala RS, 1999, ARCH OPHTHALMOL-CHIC, V117, P233; Brandao LM, 2013, J OPHTHALMOL, V2013, DOI 10.1155/2013/705915; Budenz DL, 2015, OPHTHALMOLOGY, V122, P308, DOI 10.1016/j.ophtha.2014.08.043; Caprioli J, 2011, AM J OPHTHALMOL, V152, P340, DOI 10.1016/j.ajo.2011.05.029; Costa VP, 2004, OPHTHALMOLOGY, V111, P1071, DOI 10.1016/j.ophtha.2003.09.037; Danesh-Meyer HV, 2002, ARCH OPHTHALMOL-CHIC, V120, P846; DeCroos FC, 2009, CURR EYE RES, V34, P562, DOI 10.1080/02713680902963167; Gedde SJ, 2013, CURR OPIN OPHTHALMOL, V24, P87, DOI 10.1097/ICU.0b013e32835cf0f5; Gedde SJ, 2012, AM J OPHTHALMOL, V153, P789, DOI 10.1016/j.ajo.2011.10.026; GRESSEL MG, 1984, OPHTHALMOLOGY, V91, P1242; Hinkle DM, 2007, EUR J OPHTHALMOL, V17, P696, DOI 10.1177/112067210701700502; Ishida K, 2006, OPHTHALMOLOGY, V113, P1320, DOI 10.1016/j.ophtha.2006.04.020; Iwao K, 2014, J GLAUCOMA, V23, P88, DOI 10.1097/IJG.0b013e3182685167; Kim YG, 2009, J GLAUCOMA, V18, P443, DOI 10.1097/IJG.0b013e3181895e5c; Kurnaz E, 2005, EUR J OPHTHALMOL, V15, P27, DOI 10.1177/112067210501500105; Lama PJ, 2003, SURV OPHTHALMOL, V48, P314, DOI 10.1016/S0039-6257(03)00038-9; Law SK, 2005, OPHTHALMOLOGY, V112, P1514, DOI 10.1016/j.ophtha.2005.04.012; Lee JW, 2014, OPHTHALMIC RES, V51, P129, DOI 10.1159/000357097; Liu J, 2015, NAT NANOTECHNOL, V10, P629, DOI [10.1038/NNANO.2015.115, 10.1038/nnano.2015.115]; Liu J, 2013, P NATL ACAD SCI USA, V110, P6694, DOI 10.1073/pnas.1305209110; Nouri-Mahdavi K, 2003, AM J OPHTHALMOL, V136, P1001, DOI 10.1016/S0002-9394(03)00630-5; Pakravan M, 2014, OPHTHALMOLOGY, V121, P1693, DOI 10.1016/j.ophtha.2014.03.014; Paschalis EI, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067404; Sahiner N, 2009, ARCH OPHTHALMOL-CHIC, V127, P448, DOI 10.1001/archophthalmol.2009.19; Susanna R, 2003, INVEST OPHTH VIS SCI, V44, pU313; Takihara Y, 2011, ARCH OPHTHALMOL-CHIC, V129, P152, DOI 10.1001/archophthalmol.2010.348; Tanimoto SA, 2006, CURR OPIN OPHTHALMOL, V17, P132, DOI 10.1097/01.icu.0000193091.60185.27; Teixeira SH, 2012, J GLAUCOMA, V21, P342, DOI 10.1097/IJG.0b013e31820d7e4e; Thieme H, 2011, J GLAUCOMA, V20, P246, DOI 10.1097/IJG.0b013e3181e080ef; Turalba AV, 2014, CLIN OPHTHALMOL, V8, P1311, DOI 10.2147/OPTH.S64257; Vajaranant TS, 2012, AM J OPHTHALMOL, V154, P303, DOI 10.1016/j.ajo.2012.02.024; Van de Velde S, 2015, PROG BRAIN RES, V221, P319, DOI 10.1016/bs.pbr.2015.05.002; Wei X, ULTRAFLEXIBLE MICROF; Xie C, 2015, NAT MATER, V14, P1286, DOI [10.1038/NMAT4427, 10.1038/nmat4427]; Yamanaka O, 2015, BMC OPHTHALMOL, V15, DOI 10.1186/s12886-015-0134-8; Yazdani S, 2016, J GLAUCOMA, V25, P415, DOI 10.1097/IJG.0000000000000256	39	8	8	1	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 16	2017	12	3							e0172556	10.1371/journal.pone.0172556	http://dx.doi.org/10.1371/journal.pone.0172556			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN9KE	28301490	Green Published, Green Submitted, gold			2022-12-27	WOS:000396318300016
J	Claessens, LC; Zonnenberg, IA; van den Dungen, FAM; Vermeulen, RJ; van Weissenbruch, MM				Claessens, L. C.; Zonnenberg, I. A.; van den Dungen, F. A. M.; Vermeulen, R. J.; van Weissenbruch, M. M.			Cerebral ultrasound abnormalities in preterm infants caused by late-onset sepsis	PLOS ONE			English	Article							WHITE-MATTER INJURY; INTRAVENTRICULAR HEMORRHAGE; NEONATAL INFECTION; CHILDREN; RISK	Introduction This study describes cerebral ultrasound abnormalities caused by late-onset sepsis (LOS) in very preterm infants with a gestational age of < 32 weeks and/or birthweight < 1500 grams. Methods The prospective study ("INFANT study") included 117 preterm infants with suspected LOS. Proven LOS was defined as a positive blood culture after 72 hours of life. In case of coagulase-negative staphylococci an elevated C-reactive protein was additionally required to establish proven LOS. Patients were identified as proven LOS and patients with only clinical symptoms of LOS. Cerebral ultrasound images were obtained in the first week after birth, during/after LOS and before discharge. Cerebral findings were divided in no/minor and major abnormalities. Results Eighty-six preterm infants had proven LOS and 31 preterm infants had only clinical signs of LOS. Four infants were excluded because pre-existing major brain abnormalities. No significant differences (p = 0.624) for incidence of major brain abnormalities on cerebral ultrasound were found. Conclusion No differences were revealed in prevalence of major brain abnormalities between the groups with proven LOS and with clinical signs of LOS. Both infants with a gram negative sepsis developed major brain abnormalities, whereas only two of 66 preterm infants coagulase- negative staphylococci sepsis developed major brain abnormalities.	[Claessens, L. C.; Zonnenberg, I. A.; van den Dungen, F. A. M.; van Weissenbruch, M. M.] Vrije Univ Amsterdam, Med Ctr, Dept Neonatol, Amsterdam, Netherlands; [Vermeulen, R. J.] Vrije Univ Amsterdam, Med Ctr, Dept Child Neurol, Neurosci Campus Amsterdam, Amsterdam, Netherlands; [Vermeulen, R. J.] MUMC, Dept Child Neurol, Maastricht, Netherlands	Vrije Universiteit Amsterdam; Vrije Universiteit Amsterdam; Maastricht University	Zonnenberg, IA (corresponding author), Vrije Univ Amsterdam, Med Ctr, Dept Neonatol, Amsterdam, Netherlands.	i.zonnenberg@vumc.nl		Zonnenberg, Inge/0000-0002-9919-7696; van Weissenbruch, Mirjam M/0000-0002-8086-9552; Vermeulen, R. Jeroen/0000-0002-3503-3625	Fonds Nuts Ohra [0901-042, 1101-093]	Fonds Nuts Ohra	This work was supported by grants from Fonds Nuts Ohra (grant numbers 0901-042 and 1101-093), http://www.fondsnutsohra.nl/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams-Chapman I, 2006, CURR OPIN INFECT DIS, V19, P290, DOI 10.1097/01.qco.0000224825.57976.87; Bartels DB, 2007, ARCH DIS CHILD-FETAL, V92, P449; Benjamin Daniel K, 2004, J Perinatol, V24, P175, DOI 10.1038/sj.jp.7211068; Brouwer A, 2008, J PEDIATR-US, V152, P648, DOI 10.1016/j.jpeds.2007.10.005; Brunner B, 2013, J PEDIATR-US, V163, P23, DOI 10.1016/j.jpeds.2012.12.035; Chau V, 2012, PEDIATR RES, V71, P274, DOI 10.1038/pr.2011.40; DEVRIES LS, 1992, BEHAV BRAIN RES, V49, P1, DOI 10.1016/S0166-4328(05)80189-5; DYKES FD, 1980, PEDIATRICS, V66, P42; Evans N, 1996, ARCH DIS CHILD-FETAL, V75, pF183, DOI 10.1136/fn.75.3.F183; Futagi Y, 2006, PEDIATR NEUROL, V34, P219, DOI 10.1016/j.pediatrneurol.2005.08.011; Geffers C, 2008, J HOSP INFECT, V68, P214, DOI 10.1016/j.jhin.2008.01.016; Glass HC, 2008, PEDIATRICS, V122, P299, DOI 10.1542/peds.2007-2184; Graham EM, 2004, AM J OBSTET GYNECOL, V191, P1305, DOI 10.1016/j.ajog.2004.06.058; Kliegman R M, 1987, Curr Probl Pediatr, V17, P213; Leijser LM, 2009, EARLY HUM DEV, V85, P101, DOI 10.1016/j.earlhumdev.2008.11.010; Lucignano B, 2011, J CLIN MICROBIOL, V49, P2252, DOI 10.1128/JCM.02460-10; Paolucci M, 2012, INT J PEDIAT, V2012, DOI 10.1155/2012/120139; Rand KM, 2016, J PEDIATR-US, V170, P97, DOI 10.1016/j.jpeds.2015.11.017; Raymond J, 2000, INFECT CONT HOSP EP, V21, P260, DOI 10.1086/501755; Sarvikivi E, 2010, J HOSP INFECT, V76, P156, DOI 10.1016/j.jhin.2010.03.020; Schlapbach LJ, 2011, PEDIATRICS, V128, pE348, DOI 10.1542/peds.2010-3338; Shah DK, 2008, J PEDIATR-US, V153, P170, DOI 10.1016/j.jpeds.2008.02.033; Stoll BJ, 2004, JAMA-J AM MED ASSOC, V292, P2357, DOI 10.1001/jama.292.19.2357; Stoll BJ, 2002, PEDIATRICS, V110, P285, DOI 10.1542/peds.110.2.285; van Haastert IC, 2011, J PEDIATR-US, V159, P86, DOI 10.1016/j.jpeds.2010.12.053; VOLPE JJ, 1989, ANN NEUROL, V25, P109, DOI 10.1002/ana.410250202	26	4	5	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 16	2017	12	3							e0173227	10.1371/journal.pone.0173227	http://dx.doi.org/10.1371/journal.pone.0173227			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN9KE	28301503	Green Published, Green Submitted, gold			2022-12-27	WOS:000396318300028
J	Harms, TM; Murphy, KT; Lyu, XD; Patterson, SS; Kinkead, KE; Dinsmore, SJ; Frese, PW				Harms, Tyler M.; Murphy, Kevin T.; Lyu, Xiaodan; Patterson, Shane S.; Kinkead, Karen E.; Dinsmore, Stephen J.; Frese, Paul W.			Using landscape habitat associations to prioritize areas of conservation action for terrestrial birds	PLOS ONE			English	Article							PREDICTING SPECIES DISTRIBUTIONS; ESTIMATING SITE OCCUPANCY; CLIMATE-CHANGE; BIODIVERSITY CONSERVATION; COLONIZATION; MODELS; EXTINCTION; POPULATIONS; HOTSPOTS	Predicting species distributions has long been a valuable tool to plan and focus efforts for biodiversity conservation, particularly because such an approach allows researchers and managers to evaluate species distribution changes in response to various threats. Utilizing data from a long-term monitoring program and land cover data sets, we modeled the probability of occupancy and colonization for 38 bird Species of Greatest Conservation Need (SGCN) in the robust design occupancy modeling framework, and used results from the best models to predict occupancy and colonization on the Iowa landscape. Bird surveys were conducted at 292 properties from April to October, 2006-2014. We calculated landscape habitat characteristics at multiple spatial scales surrounding each of our surveyed properties to be used in our models and then used kriging in ArcGIS to create predictive maps of species distributions. We validated models with data from 2013 using the area under the receiver operating characteristic curve (AUC). Probability of occupancy ranged from 0.001 (SE < 0.001) to 0.995 (SE = 0.004) for all species and probability of colonization ranged from 0.001 (SE < 0.001) to 0.999 (SE < 0.001) for all species. AUC values for predictive models ranged from 0.525 - 0.924 for all species, with 17 species having predictive models considered useful (AUC > 0.70). The most important predictor for occupancy of grassland birds was percentage of the landscape in grassland habitat, and the most important predictor for woodland birds was percentage of the landscape in woodland habitat. This emphasizes the need for managers to restore specific habitats on the landscape. In an era during which funding continues to decrease for conservation agencies, our approach aids in determining where to focus limited resources to best conserve bird species of conservation concern.	[Harms, Tyler M.; Lyu, Xiaodan] Iowa State Univ, Ctr Survey Stat & Methodol, 208 Off & Lab Bldg,2401 Osborn Dr, Ames, IA 50011 USA; [Murphy, Kevin T.; Patterson, Shane S.; Dinsmore, Stephen J.] Iowa State Univ, Dept Nat Resource Ecol & Management, 339 Sci Hall 2,2310 Pammel Dr, Ames, IA USA; [Lyu, Xiaodan] Iowa State Univ, Dept Stat, 1121 Snedecor Hall,2438 Osborn Dr, Ames, IA USA; [Kinkead, Karen E.; Frese, Paul W.] Iowa Dept Nat Resources, Wildlife Div Program, Boone, IA USA	Iowa State University; Iowa State University; Iowa State University	Harms, TM (corresponding author), Iowa State Univ, Ctr Survey Stat & Methodol, 208 Off & Lab Bldg,2401 Osborn Dr, Ames, IA 50011 USA.	harmsy@iastate.edu		Lyu, Xiaodan/0000-0003-3715-7215	State Wildlife Grant Enhancement [S15AP00040]; State Wildlife Grants, a Landowner Incentive Program Grant under the U.S. Fish and Wildlife Service Wildlife and Sport Fish [T-6-R-1, T-6-R-2, T-6-R-3, T-6-R-4, T-6-R-5]; Restoration Program	State Wildlife Grant Enhancement; State Wildlife Grants, a Landowner Incentive Program Grant under the U.S. Fish and Wildlife Service Wildlife and Sport Fish; Restoration Program	The analysis portion of this project was funded by a State Wildlife Grant Enhancement (S15AP00040). Data collection for the project was funded by various State Wildlife Grants (T-6-R-1, T-6-R-2, T-6-R-3, T-6-R-4, T-6-R-5), a Landowner Incentive Program Grant under the U.S. Fish and Wildlife Service Wildlife and Sport Fish and Restoration Program. The funders played no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahrends A, 2011, DIVERS DISTRIB, V17, P191, DOI 10.1111/j.1472-4642.2010.00737.x; Azerrad JM, 2006, LANDSCAPE URBAN PLAN, V77, P255, DOI 10.1016/j.landurbplan.2005.03.001; Bakker KK, 2002, CONSERV BIOL, V16, P1638, DOI 10.1046/j.1523-1739.2002.01328.x; Beyer H. L, 2012, GEOSPATIAL MODELLING; BirdLife International, 2000, THREAT BIRDS WORLD; BLONDEL J, 1981, STUDIES AVIAN BIOL, V6, P414; Bosso L, 2016, BIOL INVASIONS, V18, P1759, DOI 10.1007/s10530-016-1118-1; Brooks TM, 2006, SCIENCE, V313, P58, DOI 10.1126/science.1127609; Brooks TM, 2002, CONSERV BIOL, V16, P909, DOI 10.1046/j.1523-1739.2002.00530.x; Brotons L, 2004, ECOGRAPHY, V27, P437, DOI 10.1111/j.0906-7590.2004.03764.x; Brotons L, 2007, DIVERS DISTRIB, V13, P276, DOI 10.1111/j.1472-4642.2007.00339.x; Buckland S.T., 2001, pi; Burnham K.P., 2002, PRACTICAL INFORM THE, V2nd ed., DOI [DOI 10.1007/B97636, 10.1007/b97636]; Calabrese JM, 2014, GLOBAL ECOL BIOGEOGR, V23, P99, DOI 10.1111/geb.12102; Clavero M, 2009, BIOL CONSERV, V142, P2043, DOI 10.1016/j.biocon.2009.03.034; Comte L, 2013, DIVERS DISTRIB, V19, P996, DOI 10.1111/ddi.12078; Crooks KR, 2001, CONSERV BIOL, V15, P159, DOI 10.1046/j.1523-1739.2001.99379.x; Cunningham MA, 2006, ECOL APPL, V16, P1062, DOI 10.1890/1051-0761(2006)016[1062:PALFIG]2.0.CO;2; Davis M.B., 1992, GLOBAL WARMING BIOL, P297; Doko T, 2011, ECOL MODEL, V222, P748, DOI 10.1016/j.ecolmodel.2010.11.005; DUNNING JB, 1995, CONSERV BIOL, V9, P542, DOI 10.1046/j.1523-1739.1995.09030542.x; ESRI, 2012, ARCGIS VER 10 1; Fahrig L, 2003, ANNU REV ECOL EVOL S, V34, P487, DOI 10.1146/annurev.ecolsys.34.011802.132419; Ferreira MT, 2016, CLIMATIC CHANGE, V138, P603, DOI 10.1007/s10584-016-1754-6; Fielding AH, 1997, ENVIRON CONSERV, V24, P38, DOI 10.1017/S0376892997000088; Fleishman E, 2001, CONSERV BIOL, V15, P1674, DOI 10.1046/j.1523-1739.2001.00053.x; Fletcher RJ, 2002, J WILDLIFE MANAGE, V66, P1011, DOI 10.2307/3802933; Guisan A, 2005, ECOL LETT, V8, P993, DOI 10.1111/j.1461-0248.2005.00792.x; Guisan A, 2013, ECOL LETT, V16, P1424, DOI 10.1111/ele.12189; Hamer TL, 2006, LANDSCAPE ECOL, V21, P569, DOI 10.1007/s10980-005-2167-5; Iowa Department of Natural Resources, 2013, HIGH RES LANDC IOW 2; Jackson LS, 1996, IOWA BREEDING BIRD A; Jimenez-Valverde A, 2012, GLOBAL ECOL BIOGEOGR, V21, P498, DOI 10.1111/j.1466-8238.2011.00683.x; Kent TH, 1996, BIRDS IN IOWA; Kery M, 2013, J BIOGEOGR, V40, P1463, DOI 10.1111/jbi.12087; Kery M, 2011, J BIOGEOGR, V38, P617, DOI 10.1111/j.1365-2699.2011.02487.x; Kery M, 2010, J BIOGEOGR, V37, P1851, DOI 10.1111/j.1365-2699.2010.02345.x; MacKenzie DI, 2003, ECOLOGY, V84, P2200, DOI 10.1890/02-3090; MacKenzie DI, 2002, ECOLOGY, V83, P2248, DOI 10.1890/0012-9658(2002)083[2248:ESORWD]2.0.CO;2; Mantyka-Pringle CS, 2012, GLOBAL CHANGE BIOL, V18, P1239, DOI 10.1111/j.1365-2486.2011.02593.x; McGarigal K., 2012, FRAGSTATS V4 SPATIAL; Miles L, 2004, GLOBAL ECOL BIOGEOGR, V13, P553, DOI 10.1111/j.1466-822X.2004.00105.x; Miller JR, 2009, CONSERV BIOL, V23, P53, DOI 10.1111/j.1523-1739.2008.01110.x; Molnar JL, 2008, FRONT ECOL ENVIRON, V6, P485, DOI 10.1890/070064; Myers N, 2000, NATURE, V403, P853, DOI 10.1038/35002501; Pearce J, 2000, ECOL MODEL, V133, P225, DOI 10.1016/S0304-3800(00)00322-7; Prior JC, 1991, LANDFORM REGIONS IOW; Radford JQ, 2005, BIOL CONSERV, V124, P317, DOI 10.1016/j.biocon.2005.01.039; Reeder K., 2015, IOWAS WILDLIFE ACTIO; Renfrew RB, 2008, LANDSCAPE ECOL, V23, P181, DOI 10.1007/s10980-007-9179-2; Ribic CA, 2001, AM MIDL NAT, V146, P105, DOI 10.1674/0003-0031(2001)146[0105:AOGBWL]2.0.CO;2; Ruiz-Navarro A, 2016, BIOL CONSERV, V203, P33, DOI 10.1016/j.biocon.2016.08.021; Russo D, 2015, J ZOOL, V297, P165, DOI 10.1111/jzo.12271; SWETS JA, 1988, SCIENCE, V240, P1285, DOI 10.1126/science.3287615; Teaming with Wildlife, 2015, STAT WILDL ACT PLANS; Thogmartin WE, 2006, CONDOR, V108, P25, DOI 10.1650/0010-5422(2006)108[0025:PRAORG]2.0.CO;2; Titeux N, 2007, BIOL CONSERV, V138, P207, DOI 10.1016/j.biocon.2007.04.019; U. S. Fish and Wildlife Service, 2015, MIDW BIRDS CONC; VILLARD MA, 1994, OECOLOGIA, V98, P393, DOI 10.1007/BF00324229; Waldron A, 2013, P NATL ACAD SCI USA, V110, P12144, DOI 10.1073/pnas.1221370110; White GC, 1999, BIRD STUDY, V46, P120, DOI 10.1080/00063659909477239; Yarrow G, 2009, HABITAT REQUIREMENTS	62	8	8	1	37	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 16	2017	12	3							e0173041	10.1371/journal.pone.0173041	http://dx.doi.org/10.1371/journal.pone.0173041			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN9KE	28301877	Green Published, gold, Green Submitted			2022-12-27	WOS:000396318300024
J	Kim, JE; Lee, H; Lee, CH; Lee, S				Kim, Jung Eun; Lee, Hyojung; Lee, Chang Hyeong; Lee, Sunmi			Assessment of optimal strategies in a two-patch dengue transmission model with seasonality	PLOS ONE			English	Article							AEDES-AEGYPTI DIPTERA; VECTOR-BORNE DISEASE; REPRODUCTION NUMBER; VIRUS TRANSMISSION; HUMAN MOVEMENT; DYNAMICS; IMPACT; FEVER; DETERMINANTS; CLIMATE	Emerging and re-emerging dengue fever has posed serious problems to public health officials in many tropical and subtropical countries. Continuous traveling in seasonally varying areas makes it more difficult to control the spread of dengue fever. In this work, we consider a two-patch dengue model that can capture the movement of host individuals between and within patches using a residence-time matrix. A previous two-patch dengue model without seasonality is extended by adding host demographics and seasonal forcing in the transmission rates. We investigate the effects of human movement and seasonality on the two-patch dengue transmission dynamics. Motivated by the recent Peruvian dengue data in jungle/rural areas and coast/urban areas, our model mimics the seasonal patterns of dengue outbreaks in two patches. The roles of seasonality and residence-time configurations are highlighted in terms of the seasonal reproduction number and cumulative incidence. Moreover, optimal control theory is employed to identify and evaluate patch-specific control measures aimed at reducing dengue prevalence in the presence of seasonality. Our findings demonstrate that optimal patch-specific control strategies are sensitive to seasonality and residence-time scenarios. Targeting only the jungle (or endemic) is as effective as controlling both patches under weak coupling or symmetric mobility. However, focusing on intervention for the city (or high density areas) turns out to be optimal when two patches are strongly coupled with asymmetric mobility.	[Kim, Jung Eun; Lee, Hyojung; Lee, Chang Hyeong] Ulsan Natl Inst Sci & Technol, Dept Math Sci, Ulsan, South Korea; [Lee, Sunmi] Kyung Hee Univ, Dept Appl Math, Yongin, South Korea; [Lee, Sunmi] Kyung Hee Univ, Inst Nat Sci, Yongin, South Korea	Ulsan National Institute of Science & Technology (UNIST); Kyung Hee University; Kyung Hee University	Lee, CH (corresponding author), Ulsan Natl Inst Sci & Technol, Dept Math Sci, Ulsan, South Korea.; Lee, S (corresponding author), Kyung Hee Univ, Dept Appl Math, Yongin, South Korea.; Lee, S (corresponding author), Kyung Hee Univ, Inst Nat Sci, Yongin, South Korea.	chlee@unist.ac.kr; sunmilee@khu.ac.kr	Lee, Chang Hyeong/F-4142-2010	Lee, Chang Hyeong/0000-0003-3247-5791	Basic Science Research Program through the National Research Foundation of Korea (NRF) - Ministry of Education [2014R1A1A2054976]; National Research Foundation of Korea (NRF) - Korean government (MSIP) [20152194]	Basic Science Research Program through the National Research Foundation of Korea (NRF) - Ministry of Education; National Research Foundation of Korea (NRF) - Korean government (MSIP)	Chang Hyeong Lee was supported by the Basic Science Research Program through the National Research Foundation of Korea (NRF) funded by the Ministry of Education (2014R1A1A2054976). Sunmi Lee was supported by the National Research Foundation of Korea (NRF) grant funded by the Korean government (MSIP) (No.20152194).	Adams B, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006763; Agusto F, 2013, J BIOL SYST, V21, DOI 10.1142/S0218339013400020; ANDERSON R M, 1991; Andraud M, 2013, MATH BIOSCI, V244, P22, DOI 10.1016/j.mbs.2013.04.001; Andraud M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049085; Bartley LM, 2002, T ROY SOC TROP MED H, V96, P387, DOI 10.1016/S0035-9203(02)90371-8; Blayneh KW, 2010, B MATH BIOL, V72, P1006, DOI 10.1007/s11538-009-9480-0; Brauer F., 2001, MATH MODELS POPULATI, V40; Burattini MN, 2008, EPIDEMIOL INFECT, V136, P309, DOI 10.1017/S0950268807008667; Castillo-Chavez C, 2003, FRONT APP M, V28, P173; Centers for Disease Control and Prevention, 2016, DENGUE; Chamchod F, 2014, B MATH BIOL, V76, P2052, DOI 10.1007/s11538-014-9998-7; Chowell G, 2008, EPIDEMIOL INFECT, V136, P1667, DOI 10.1017/S0950268808000290; Chowell G, 2007, MATH BIOSCI, V208, P571, DOI 10.1016/j.mbs.2006.11.011; Chowell G, 2011, BMC INFECT DIS, V11, DOI 10.1186/1471-2334-11-164; Cosner C, 2009, J THEOR BIOL, V258, P550, DOI 10.1016/j.jtbi.2009.02.016; Diekmann O., 2000, MATH EPIDEMIOLOGY IN, V5; Dushoff J, 2004, P NATL ACAD SCI USA, V101, P16915, DOI 10.1073/pnas.0407293101; Favier C, 2005, P ROY SOC B-BIOL SCI, V272, P1171, DOI 10.1098/rspb.2004.3020; Fleming WH, 2012, DETERMINISTIC STOCHA, V1; Gao DZ, 2016, SCI REP-UK, V6, DOI 10.1038/srep28070; Gubler DJ, 1998, CLIN MICROBIOL REV, V11, P480, DOI 10.1128/CMR.11.3.480; Guzman MG, 2010, NAT REV MICROBIOL, pS7, DOI 10.1038/nrmicro2460; Guzman MG, 2003, J CLIN VIROL, V27, P1, DOI 10.1016/S1386-6532(03)00010-6; Halstead SB, 2002, LANCET, V360, P1243, DOI 10.1016/S0140-6736(02)11276-1; Halstead SB, 2004, INFECT DIS, V360; Harrington LC, 2005, AM J TROP MED HYG, V72, P209, DOI 10.4269/ajtmh.2005.72.209; Hayes CG, 1996, AM J TROP MED HYG, V55, P459, DOI 10.4269/ajtmh.1996.55.459; Helmersson J., 2012, MATH MODELING DENGUE; Johansson MA, 2009, PLOS NEGLECT TROP D, V3, DOI 10.1371/journal.pntd.0000382; Lambrechts L, 2011, P NATL ACAD SCI USA, V108, P7460, DOI 10.1073/pnas.1101377108; Lee S, 2015, J THEOR BIOL, V374, P152, DOI 10.1016/j.jtbi.2015.03.005; Lee S, 2012, B MATH BIOL, V74, P958, DOI 10.1007/s11538-011-9704-y; Lee S, 2010, J THEOR BIOL, V265, P136, DOI 10.1016/j.jtbi.2010.04.003; Lenhart S., 2007, OPTIMAL CONTROL APPL; Liu-Helmersson J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089783; Luz PM, 2011, MEM I OSWALDO CRUZ, V106, P755, DOI 10.1590/S0074-02762011000600017; Martens P, 2000, EMERG INFECT DIS, V6, P103, DOI 10.3201/eid0602.000202; Massad E, 2011, PHYS LIFE REV, V8, P169, DOI 10.1016/j.plrev.2011.01.001; Mattar S, 2013, INT J INFECT DIS, V17, pE358, DOI 10.1016/j.ijid.2012.11.021; Moraes GH, 2013, AM J TROP MED HYG, V88, P670, DOI 10.4269/ajtmh.11-0774; Mpolya EA, 2014, J THEOR BIOL, V343, P120, DOI 10.1016/j.jtbi.2013.11.024; Nevai AL, 2014, MATH MED BIOL, V31, P150, DOI 10.1093/imammb/dqt002; Nishiura H., 2006, DENGUE B; Oki M, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0001367; Polwiang S, 2015, PEERJ, V3, DOI 10.7717/peerj.1069; Pontryagin LS, 1962, MATH THEORY OPTIMAL; Reiskind MH, 2001, TROP MED INT HEALTH, V6, P212, DOI 10.1046/j.1365-3156.2001.00703.x; Rodrigues HS, 2014, MATH METHODS APPL SC; Rodriguez DJ, 2001, B MATH BIOL, V63, P547, DOI 10.1006/bulm.2001.0231; Aznar VR, 2013, ECOL MODEL, V253, P44, DOI 10.1016/j.ecolmodel.2012.12.004; Stone L, 2007, NATURE, V446, P533, DOI 10.1038/nature05638; ten Bosch QA, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004680; Torre CA, 2009, THESIS; Twiddy SS, 2003, INFECT GENET EVOL, V3, P87, DOI 10.1016/S1567-1348(02)00153-3; Uziel A, 2012, J THEOR BIOL, V305, P88, DOI 10.1016/j.jtbi.2012.02.031; Vezzani D, 2004, MEM I OSWALDO CRUZ, V99, P351, DOI 10.1590/S0074-02762004000400002; Wearing HJ, 2006, P NATL ACAD SCI USA, V103, P11802, DOI 10.1073/pnas.0602960103; Wesolowski A, 2012, SCIENCE, V338, P267, DOI 10.1126/science.1223467; WHO, 2013, DENG CONTR D CONTR S; WHO, 2015, DENG VACC RES	61	31	32	2	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 16	2017	12	3							e0173673	10.1371/journal.pone.0173673	http://dx.doi.org/10.1371/journal.pone.0173673			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN9KE	28301523	Green Submitted, gold, Green Published			2022-12-27	WOS:000396318300059
J	Garcia-Garcia, ML; Calvo, C; Rey, C; Diaz, B; Molinero, MD; Pozo, F; Casas, I				Luz Garcia-Garcia, Maria; Calvo, Cristina; Rey, Cristina; Diaz, Beatriz; del Mar Molinero, Maria; Pozo, Francisco; Casas, Inmaculada			Human metapnuemovirus infections in hospitalized children and comparison with other respiratory viruses. 2005-2014 prospective study	PLOS ONE			English	Article							HUMAN METAPNEUMOVIRUS INFECTION; SYNCYTIAL-VIRUS; DISEASE	Background Human metapneumovirus (HMPV) has an important etiological role in acute lower respiratory infections in children under five years. Our objectives were to estimate the relative contribution of HMPV to hospitalization in children with acute respiratory infection, to define the clinical and epidemiological features of HMPV single and multiple infections, and to compare HMPV infections with respiratory syncytial virus (HRSV), rhinovirus (HRV), adenovirus and human bocavirus infections in the same population. Methods and findings A prospective study performed on all children less than 14 years of age with a respiratory tract disease admitted to a secondary hospital between September 2005-June 2014. Clinical characteristics of patients were analyzed. Nasopharyngeal aspirate was taken at admission for viral study with polymerase chain reaction for 16 respiratory viruses. A total of 3,906 children were included. At least one respiratory virus was detected in 75.2% of them. The most common identified virus was HRSV, followed by HRV. HMPV was detected in 214 cases (5.5%); 133 (62%) were single infections and the remaining were detected in coinfection with other viruses. 90.7% cases were detected between February and May. Children's mean age was 13.83 +/- 18 months. Fever was frequent (69%), and bronchiolitis (27%), and recurrent wheezing (63%) were the main clinical diagnosis. Hypoxia was present in 65% of the patients and 47% of them had an infiltrate in X-ray. Only 6 (2.8%) children were admitted to the intensive care unit. Only the duration of the hospitalization was different, being longer in the coinfections group (p < 0.05). There were many differences in seasonality and clinical characteristics between HMPV and other respiratory viruses being more similar to HRSV. Conclusions HMPV infections accounted for 5.5% of total viral infections in hospitalized children. The clinical characteristics were similar to HRSV infections, but seasonality and clinical data were different from other viral infections.	[Luz Garcia-Garcia, Maria; Calvo, Cristina] Severo Ochoa Hosp, Dept Pediat, Madrid, Spain; [Luz Garcia-Garcia, Maria; Calvo, Cristina; Rey, Cristina; Diaz, Beatriz] Univ Alfonson X el Sabio, Madrid, Spain; [Luz Garcia-Garcia, Maria; Calvo, Cristina; Pozo, Francisco; Casas, Inmaculada] Traslat Res Network Pediat Infectious Diseases RI, Madrid, Spain; [Luz Garcia-Garcia, Maria; Calvo, Cristina; Rey, Cristina; Diaz, Beatriz] European Network Excellence, Pediat Clin Res, Bari, Italy; [del Mar Molinero, Maria; Pozo, Francisco; Casas, Inmaculada] Natl Microbiol Ctr ISCIII, Respiratory Viruses & Influenza Unit, Madrid, Spain	Severo Ochoa University Hospital	Calvo, C (corresponding author), European Network Excellence, Pediat Clin Res, Bari, Italy.	ccalvorey@ono.com	Casas, Inmaculada/H-9442-2015; Calvo, Cristina/T-5028-2018; Casas, Inmaculada/X-7579-2019; Pozo, Francisco/F-4426-2012	Casas, Inmaculada/0000-0003-1840-1198; Calvo, Cristina/0000-0002-6503-3423; Casas, Inmaculada/0000-0003-1840-1198; Pozo, Francisco/0000-0003-1828-733X; GARCIA-GARCIA, MARIA LUZ/0000-0003-4906-4227	FIS (Fondo de Investigaciones Sanitarias - Spanish Health Research Fund) [PI06/0532, PI09/0246, PI12/0129]	FIS (Fondo de Investigaciones Sanitarias - Spanish Health Research Fund)	This study has been supported by FIS (Fondo de Investigaciones Sanitarias - Spanish Health Research Fund) grants no: PI06/0532, PI09/0246, and PI12/0129.	Afonso CL, 2016, ARCH VIROL, V161, P2351, DOI 10.1007/s00705-016-2880-1; Anderson Evan J, 2012, J Pediatric Infect Dis Soc, V1, P212, DOI 10.1093/jpids/pis069; Busse WW, 2002, J ALLERGY CLIN IMMUN, V110, P703, DOI 10.1067/mai.2002.129368; Coiras MT, 2004, J MED VIROL, V72, P484, DOI 10.1002/jmv.20008; Coiras MT, 2003, J MED VIROL, V69, P132, DOI 10.1002/jmv.10255; Edwards KM, 2013, NEW ENGL J MED, V368, P633, DOI 10.1056/NEJMoa1204630; Freymuth F, 2003, PEDIATR INFECT DIS J, V22, P92, DOI 10.1097/00006454-200301000-00024; Garcia-Garcia ML, 2010, PEDIATR PULM, V45, P585, DOI 10.1002/ppul.21225; Hahn A, 2013, EPIDEMIOL INFECT, V141, P2213, DOI 10.1017/S0950268812002920; Lopez-Huertas MR, 2005, J VIROL METHODS, V129, P1, DOI 10.1016/j.jviromet.2005.05.004; Marcone DN, 2015, BMC INFECT DIS, V15, DOI 10.1186/s12879-015-1213-4; MCCONNOCHIE KM, 1983, AM J DIS CHILD, V137, P11, DOI 10.1001/archpedi.1983.02140270007003; McCracken JP, 2014, INFLUENZA OTHER RESP, V8, P414, DOI 10.1111/irv.12251; Othman HT, 2016, J INFECT DEV COUNTR, V10, P283, DOI 10.3855/jidc.7087; Pancham K, 2016, PEDIATR NEONATOL, V57, P27, DOI 10.1016/j.pedneo.2015.03.008; Papenburg J, 2012, J INFECT DIS, V206, P178, DOI 10.1093/infdis/jis333; Reiche J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088342; Schuster JE, 2015, PEDIATR INFECT DIS J, V34, P1335, DOI 10.1097/INF.0000000000000892; Semple MG, 2005, J INFECT DIS, V191, P382, DOI 10.1086/426457; Shi T, 2015, J GLOB HEALTH, V5, P122, DOI 10.7189/jogh.05.010408; van den Hoogen BG, 2002, VIROLOGY, V295, P119, DOI 10.1006/viro.2001.1355; van den Hoogen BG, 2003, J INFECT DIS, V188, P1571, DOI 10.1086/379200; van den Hoogen BG, 2001, NAT MED, V7, P719, DOI 10.1038/89098	23	24	25	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 16	2017	12	3							e0173504	10.1371/journal.pone.0173504	http://dx.doi.org/10.1371/journal.pone.0173504			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN9KE	28301570	Green Published, Green Submitted, gold			2022-12-27	WOS:000396318300046
J	Monneret, G; Jaffrezic, F; Rau, A; Zerjal, T; Nuel, G				Monneret, Gilles; Jaffrezic, Florence; Rau, Andrea; Zerjal, Tatiana; Nuel, Gregory			Identification of marginal causal relationships in gene networks from observational and interventional expression data	PLOS ONE			English	Article							DIRECTED ACYCLIC GRAPHS; REGULATORY NETWORKS; INFERENCE	Causal network inference is an important methodological challenge in biology as well as other areas of application. Although several causal network inference methods have been proposed in recent years, they are typically applicable for only a small number of genes, due to the large number of parameters to be estimated and the limited number of biological replicates available. In this work, we consider the specific case of transcriptomic studies made up of both observational and interventional data in which a single gene of biological interest is knocked out. We focus on a marginal causal estimation approach, based on the framework of Gaussian directed acyclic graphs, to infer causal relationships between the knocked-out gene and a large set of other genes. In a simulation study, we found that our proposed method accurately differentiates between downstream causal relationships and those that are upstream or simply associative. It also enables an estimation of the total causal effects between the gene of interest and the remaining genes. Our method performed very similarly to a classical differential analysis for experiments with a relatively large number of biological replicates, but has the advantage of providing a formal causal interpretation. Our proposed marginal causal approach is computationally efficient and may be applied to several thousands of genes simultaneously. In addition, it may help highlight subsets of genes of interest for a more thorough subsequent causal network inference. The method is implemented in an R package called Marginalcausality (available on GitHub).	[Monneret, Gilles; Jaffrezic, Florence; Rau, Andrea; Zerjal, Tatiana] Univ Paris Saclay, INRA, AgroParisTech, UMR GABI, Jouy En Josas, France; [Monneret, Gilles; Nuel, Gregory] Sorbonne Univ, UPMC, UMR CNRS 7599, LPMA, 4 Pl Jussieu, F-75005 Paris, France	AgroParisTech; INRAE; UDICE-French Research Universities; Universite Paris Saclay; UDICE-French Research Universities; Sorbonne Universite; Universite Paris Cite	Monneret, G (corresponding author), Univ Paris Saclay, INRA, AgroParisTech, UMR GABI, Jouy En Josas, France.; Monneret, G (corresponding author), Sorbonne Univ, UPMC, UMR CNRS 7599, LPMA, 4 Pl Jussieu, F-75005 Paris, France.	gilles.monneret@upmc.fr	zerjal, tatiana/AAO-9473-2020		National de la Recherche Agronomique Jouy-en-Josas	National de la Recherche Agronomique Jouy-en-Josas	The authors received 18500(sic) from Institut National de la Recherche Agronomique Jouy-en-Josas for this work (http://www.jouy.inra.fr/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altay G, 2010, BMC SYST BIOL, V4, DOI 10.1186/1752-0509-4-132; Basso K, 2005, NAT GENET, V37, P382, DOI 10.1038/ng1532; Bonissone P., 1991, P 6 C UNC ART INT, P255; Buhlmann P, 2014, ANNU REV STAT APPL, V1, P255, DOI 10.1146/annurev-statistics-022513-115545; Chickering D. M., 2003, Journal of Machine Learning Research, V3, P507, DOI 10.1162/153244303321897717; Chickering David Maxwell, 1997, P 13 C UNC ART INT P, P80; de Matos Simoes Ricardo, 2012, PLoS One, V7, pe33624, DOI 10.1371/journal.pone.0033624; DURIEZ B, 1993, MOL ENDOCRINOL, V7, P806, DOI 10.1210/me.7.6.806; Emmert-Streib F, 2014, FRONT CELL DEV BIOL, V2, DOI 10.3389/fcell.2014.00038; Emmert-Streib Frank, 2012, Frontiers in Genetics, V3, P8, DOI [10.3389/fgene.2012.00313, 10.3389/fgene.2012.00008]; Friedman J, 2008, BIOSTATISTICS, V9, P432, DOI 10.1093/biostatistics/kxm045; Hauser A, 2012, J MACH LEARN RES, V13, P2409; Hsu PD, 2014, CELL, V157, P1262, DOI 10.1016/j.cell.2014.05.010; Kalisch M, 2007, J MACH LEARN RES, V8, P613; Luo WJ, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-467; Maathuis MH, 2009, ANN STAT, V37, P3133, DOI 10.1214/09-AOS685; Marbach D, 2010, P NATL ACAD SCI USA, V107, P6286, DOI 10.1073/pnas.0913357107; Pearl J., 2000, CAUSALITY MODELS REA, V29; Pinna A, 2013, BMC SYST BIOL, V7, DOI 10.1186/1752-0509-7-73; Pinna A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012912; Rau A, 2013, BMC SYST BIOL, V7, DOI 10.1186/1752-0509-7-111; Simoes RD, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-324; Smyth G.K., 2004, STAT APPL GENET MOL, V3, P3, DOI [DOI 10.2202/1544-6115.1027, 10.2202/1544-6115.1027]; Spirtes P., 2000, CAUSATION PREDICTION, V81; Watkinson J, 2009, ANN NY ACAD SCI, V1158, P302, DOI 10.1111/j.1749-6632.2008.03757.x	26	1	1	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 16	2017	12	3							e0171142	10.1371/journal.pone.0171142	http://dx.doi.org/10.1371/journal.pone.0171142			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN9KE	28301504	Green Published, gold, Green Submitted			2022-12-27	WOS:000396318300009
J	Alsaleh, M; Alomar, N; Alarifi, A				Alsaleh, Mansour; Alomar, Noura; Alarifi, Abdulrahman			Smartphone users: Understanding how security mechanisms are perceived and new persuasive methods	PLOS ONE			English	Article							PROTECTION MOTIVATION THEORY; FORENSIC ANALYSIS; MOBILE; AWARENESS; BEHAVIORS; MODEL	Protecting smartphones against security threats is a multidimensional problem involving human and technological factors. This study investigates how smartphone users' security- and privacy-related decisions are influenced by their attitudes, perceptions, and understanding of various security threats. In this work, we seek to provide quantified insights into smartphone users' behavior toward multiple key security features including locking mechanisms, application repositories, mobile instant messaging, and smartphone location services. To the best of our knowledge, this is the first study that reveals often unforeseen correlations and dependencies between various privacy-and security-related behaviors. Our work also provides evidence that making correct security decisions might not necessarily correlate with individuals' awareness of the consequences of security threats. By comparing participants' behavior and their motives for adopting or ignoring certain security practices, we suggest implementing additional persuasive approaches that focus on addressing social and technological aspects of the problem. On the basis of our findings and the results presented in the literature, we identify the factors that might influence smartphone users' security behaviors. We then use our understanding of what might drive and influence significant behavioral changes to propose several platform design modifications that we believe could improve the security levels of smartphones.	[Alsaleh, Mansour; Alarifi, Abdulrahman] KACST, Riyadh, Saudi Arabia; [Alomar, Noura] King Saud Univ, Software Engn Dept, Riyadh, Saudi Arabia	King Abdulaziz City for Science & Technology; King Saud University	Alsaleh, M (corresponding author), KACST, Riyadh, Saudi Arabia.	maalsaleh@kacst.edu.sa		Alomar, Noura/0000-0002-9052-999X	King Abdulaziz City for Science and Technology (KACST) - Internal Fund; KACST	King Abdulaziz City for Science and Technology (KACST) - Internal Fund; KACST	This work was supported by King Abdulaziz City for Science and Technology (KACST) - Internal Fund.; The authors would like to thank the anonymous reviewers for their valuable comments which helped us improve the paper to reach its present form. The authors would like to also thank those who helped in interviewing the participants. This research work was supported in part by KACST.	Ab Rahman NH, 2016, CONCURRENCY COMPUTAT; Ajzen I, 2005, EBOOK ATTITUDES PERS; Alarifi A, 2017, COMPUTING; Albrechtsen E, 2007, COMPUT SECUR, V26, P276, DOI 10.1016/j.cose.2006.11.004; Alexandrou A, 2014, P STUD FAC RES DAY C; Alomar N., 2017, IEEE COMMUNICATIONS; Alsaleh M, 2015, SMARTPHONE USERS UND; Alsaleh M, 2016, SMARTPHONE USERS UND; [Anonymous], 2015, SMARTPH OS MARK SHAR; Aytes K., 2003, P 9 AM C INF SYST, P2027; Azfar A, 2016, J FORENSIC SCI, P1; Azfar A, 2016, MULTIMED TOOLS APPL, P1; Azfar A, 2016, ELECTRON COMMER RES, V16, P73, DOI 10.1007/s10660-015-9208-1; Azfar A, 2014, P ANN HICSS, P4858, DOI 10.1109/HICSS.2014.596; Balebako R, 2014, P WORKSH US SEC USEC; Ben-Asher N., 2011, MOB HCI 13 INT C HUM, P465, DOI DOI 10.1145/2037373.2037442; Bente I, 2013, NETWORK BASED APPROA; Bhagavatula C, 2015, BIOMETRIC AUTHENTICA, P1; Blythe J.M., 2015, 11 S US PRIV SEC SOU; BRIGGS SR, 1992, J PERS, V60, P253, DOI 10.1111/j.1467-6494.1992.tb00974.x; Browne S, 2015, LINKING THREAT AVOID, P32; Cahyani NDW, 2016, CONCURRENCY COMPUTAT; Chanajitt R, 2018, AUST J FORENSIC SCI, V50, P3, DOI 10.1080/00450618.2016.1182589; Chen J, 2014, S US PRIV SEC SOUPS; Chin E., 2012, P 8 S USABLE PRIVACY, DOI [10.1145/2335356.2335358, DOI 10.1145/2335356.2335358]; Choo KKR, 2015, PRIVACY RISKS MOBILE, P1; Daryabar F, 2017, AUST J FORENSIC SCI, V49, P344, DOI 10.1080/00450618.2016.1153714; Das Sauvik, 2014, P SOUPS, V14; Dezfouli F.N., 2015, J FORENSIC SCI, P1, DOI DOI 10.1080/00450618.2015.1066854; Dinev T., 2006, PROC 14 EUR C INF SY; Dinev T, 2007, J ASSOC INF SYST, V8, P386, DOI 10.17705/1jais.00133; Do Q, 2017, SOFTWARE PRACT EXPER, V47, P391, DOI 10.1002/spe.2414; DOrazio CJ, DATA EXFILTRATION IN, P1; Egelman S., 2014, P 2014 ACM SIGSAC C, pp.750, DOI DOI 10.1145/2660267.2660273; Felt A.P., 2012, P 8 S US PRIV SEC SO, P1, DOI 10.1145/2335356.2335360; Hanus B, 2016, INFORM SYST MANAGE, V33, P2, DOI 10.1080/10580530.2015.1117842; Harbach M., 2014, 10 S USABL PRIV SEC; Imgraben J, 2014, BEHAV INFORM TECHNOL, V33, P1347, DOI 10.1080/0144929X.2014.934286; Kang Ruogu, 2015, S US PRIV SEC SOUPS, P3952; Khan H., 2015, S US PRIV SEC SOUPS; Koved L., 2013, S US PRIV SEC SOUPS; La Polla M, 2013, IEEE COMMUN SURV TUT, V15, P446, DOI 10.1109/SURV.2012.013012.00028; Leavitt N, 2011, COMPUTER, V44, P11, DOI 10.1109/MC.2011.184; Lee D, 2008, BEHAV INFORM TECHNOL, V27, P445, DOI 10.1080/01449290600879344; Liang HG, 2010, J ASSOC INF SYST, V11, P394; Liang HG, 2009, MIS QUART, V33, P71; Lin JL, 2012, UBICOMP'12: PROCEEDINGS OF THE 2012 ACM INTERNATIONAL CONFERENCE ON UBIQUITOUS COMPUTING, P501; Matt C, 2016, P ANN HICSS, P4832, DOI 10.1109/HICSS.2016.599; Micallef N, 2015, WHY ARENAA T USERS U; Miller C, 2011, IEEE SECUR PRIV, V9, P68, DOI 10.1109/MSP.2011.85; Mohini T., 2013, RES J COMPUT INF TEC, V2320, P6527; Muslukhov I., 2012, Proceedings of the 2012 IEEE International Conference on Data Engineering Workshops (ICDEW 2012), P228, DOI 10.1109/ICDEW.2012.83; Mwagwabi F., 2015, PROTECTION MOTIVATIO; Mylonas A, 2013, COMPUT SECUR, V34, P47, DOI 10.1016/j.cose.2012.11.004; Nouh Mariam, 2014, Human Aspects of Information Security, Privacy, and Trust. Second International Conference, HAS 2014, Held as Part of HCI International 2014. Proceedings: LNCS 8533, P352, DOI 10.1007/978-3-319-07620-1_31; PewResearchCenter, 2014, MOB TECHN FACT SHEET; Pokharel S, 2016, CONCURRENCY COMPUTAT; Do Q, 2014, P ANN HICSS, P5070, DOI 10.1109/HICSS.2014.623; Quick D, 2014, J NETW COMPUT APPL, V40, P179, DOI 10.1016/j.jnca.2013.09.016; Quick D, 2013, FUTURE GENER COMP SY, V29, P1378, DOI 10.1016/j.future.2013.02.001; Quick D, 2013, DIGIT INVEST, V10, P3, DOI 10.1016/j.diin.2013.02.003; Sommestad T, 2015, INT J INF SECUR PRIV, V9, P26, DOI 10.4018/IJISP.2015010102; Stanton JM, 2005, COMPUT SECUR, V24, P124, DOI 10.1016/j.cose.2004.07.001; Statista, 2015, CUM NUMB APPS DOWNL; Stobert E, 2014, P SOUPS P SOUPS; Symantec, 2015, 2015 INT SEC THREAT; Tsai HYS, 2016, COMPUT SECUR, V59, P138, DOI 10.1016/j.cose.2016.02.009; Wash Rick, 2015, S US PRIV SEC SOUPS; Wijesekera P, 2015, PROCEEDINGS OF THE 24TH USENIX SECURITY SYMPOSIUM, P499; Zhiling Tu, 2012, 2012 45th Hawaii International Conference on System Sciences (HICSS), P1393, DOI 10.1109/HICSS.2012.620	70	18	19	0	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 15	2017	12	3							e0173284	10.1371/journal.pone.0173284	http://dx.doi.org/10.1371/journal.pone.0173284			35	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN9HQ	28297719	Green Published, Green Submitted, gold			2022-12-27	WOS:000396311700031
J	Bhattacharya, R; Rose, PW; Burley, SK; Prlic, A				Bhattacharya, Roshni; Rose, Peter W.; Burley, Stephen K.; Prlic, Andreas			Impact of genetic variation on three dimensional structure and function of proteins	PLOS ONE			English	Article							ALANINE-GLYOXYLATE AMINOTRANSFERASE; NON-SYNONYMOUS SNPS; NUCLEOTIDE POLYMORPHISMS; MENDELIAN DISEASE; STABILITY CHANGES; COMMON DISEASE; MUTATIONS; DATABASE; PREDICTION; SEQUENCE	The Protein Data Bank (PDB; http://wwpdb.org) was established in 1971 as the first open access digital data resource in biology with seven protein structures as its initial holdings. The global PDB archive now contains more than 126,000 experimentally determined atomic level three-dimensional (3D) structures of biological macromolecules (proteins, DNA, RNA), all of which are freely accessible via the Internet. Knowledge of the 3D structure of the gene product can help in understanding its function and role in disease. Of particular interest in the PDB archive are proteins for which 3D structures of genetic variant proteins have been determined, thus revealing atomic-level structural differences caused by the variation at the DNA level. Herein, we present a systematic and qualitative analysis of such cases. We observe a wide range of structural and functional changes caused by single amino acid differences, including changes in enzyme activity, aggregation propensity, structural stability, binding, and dissociation, some in the context of large assemblies. Structural comparison of wild type and mutated proteins, when both are available, provide insights into atomic-level structural differences caused by the genetic variation.	[Bhattacharya, Roshni] San Diego State Univ, Bioinformat & Med Informat, San Diego, CA 92182 USA; [Rose, Peter W.; Burley, Stephen K.; Prlic, Andreas] Univ Calif San Diego, RCSB Prot Data Bank, San Diego Supercomp Ctr, La Jolla, CA 92093 USA; [Burley, Stephen K.] Rutgers State Univ, RCSB Prot Data Bank, Dept Chem & Chem Biol, Ctr Integrat Prote Res,Inst Quantitat Biomed, Piscataway, NJ USA; [Burley, Stephen K.] Rutgers State Univ, Canc Inst New Jersey, Piscataway, NJ USA; [Burley, Stephen K.] Univ Calif San Diego, Skaggs Sch Pharm & Pharmaceut Sci, La Jolla, CA 92093 USA	California State University System; San Diego State University; University of California System; University of California San Diego; Rutgers State University New Brunswick; Rutgers State University New Brunswick; Rutgers State University Medical Center; Rutgers Cancer Institute of New Jersey; University of California System; University of California San Diego	Prlic, A (corresponding author), Univ Calif San Diego, RCSB Prot Data Bank, San Diego Supercomp Ctr, La Jolla, CA 92093 USA.	andreas.prlic@gmail.com	Prlić, Andreas/A-6134-2012	Prlić, Andreas/0000-0001-6346-6391; Rose, Peter/0000-0001-9981-9750; Burley, Stephen K./0000-0002-2487-9713	National Science Foundation [DBI-1338415]	National Science Foundation(National Science Foundation (NSF))	This work was supported by a National Science Foundation grant to the RCSB PDB (DBI-1338415; PI: Stephen K. Burley). The Protein Data Bank archive is managed by the Worldwide Protein Data Bank organization, which consists of the RCSB Protein Data Bank, Protein Data Bank in Europe, Protein Data Bank Japan, and BioMagResBank. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adzhubei I, 2013, CURRENT PROTOCOL S76; Al-Numair NS, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-S3-S4; Altshuler D, 2008, SCIENCE, V322, P881, DOI 10.1126/science.1156409; Arodz T, 2012, PROTEINS, V80, P1780, DOI 10.1002/prot.24073; Auer PL, 2012, AM J HUM GENET, V91, P794, DOI 10.1016/j.ajhg.2012.08.031; Bendl J, 2014, PLOS COMPUT BIOL, V10, DOI 10.1371/journal.pcbi.1003440; Berman HM, 2000, NUCLEIC ACIDS RES, V28, P235, DOI 10.1093/nar/28.1.235; Bonifati V, 2003, SCIENCE, V299, P256, DOI 10.1126/science.1077209; Borgstahl GEO, 1996, BIOCHEMISTRY-US, V35, P4287, DOI 10.1021/bi951892w; Botstein D, 2003, NAT GENET, V33, P228, DOI 10.1038/ng1090; Breinig S, 2003, NAT STRUCT BIOL, V10, P757, DOI 10.1038/nsb963; Burke DF, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-301; Calabrese R, 2009, HUM MUTAT, V30, P1237, DOI 10.1002/humu.21047; Capriotti E, 2006, BIOINFORMATICS, V22, P2729, DOI 10.1093/bioinformatics/btl423; Capriotti E, 2005, BIOINFORMATICS, V21, P54, DOI 10.1093/bioinformatics/bti1109; Cardoso RMF, 2002, J MOL BIOL, V324, P247, DOI 10.1016/S0022-2836(02)01090-2; Cheng JL, 2006, PROTEINS, V62, P1125, DOI 10.1002/prot.20810; Choi YH, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0039927, 10.1371/journal.pone.0046688]; Cirulli ET, 2010, NAT REV GENET, V11, P415, DOI 10.1038/nrg2779; Clifford RJ, 2004, BIOINFORMATICS, V20, P1006, DOI 10.1093/bioinformatics/bth029; Collins FS, 1998, GENOME RES, V8, P1229, DOI 10.1101/gr.8.12.1229; Dantzer J, 2005, NUCL ACIDS RES S2, V33; De Baets G, 2012, NUCL ACIDS RES, V40; Denayer E, 2008, HUM MUTAT, V29, P232, DOI 10.1002/humu.20616; Eichler EE, 2010, NAT REV GENET, V11, P446, DOI 10.1038/nrg2809; Fukuda K, 2002, STRUCTURE, V10, P943, DOI 10.1016/S0969-2126(02)00787-6; Gamazon ER, 2010, P NATL ACAD SCI USA, V107, P9287, DOI 10.1073/pnas.1001827107; Gibson G, 2012, NAT REV GENET, V13, P135, DOI 10.1038/nrg3118; Gonzalez-Perez A, 2011, AM J HUM GENET, V88, P440, DOI 10.1016/j.ajhg.2011.03.004; Hecht M, 2015, BMC GENOMICS, V16, DOI 10.1186/1471-2164-16-S8-S1; Hirschhorn JN, 2002, GENET MED, V4, P45, DOI 10.1097/00125817-200203000-00002; Horton JR, 2001, STRUCTURE, V9, P837, DOI 10.1016/S0969-2126(01)00643-8; Jegga AG, 2007, NUCL ACIDS RES S1, V35; KIMURA M, 1983, P NATL ACAD SCI-BIOL, V80, P1048, DOI 10.1073/pnas.80.4.1048; Lai E, 1998, GENOMICS, V54, P31, DOI 10.1006/geno.1998.5581; Lakshminarasimhan M, 2008, BIOCHEMISTRY-US, V47, P1381, DOI 10.1021/bi701189c; Li B, 2009, BIOINFORMATICS, V25, P2744, DOI 10.1093/bioinformatics/btp528; Lumb MJ, 2000, J BIOL CHEM, V275, P36415, DOI 10.1074/jbc.M006693200; Mi H., 2013, NUCL ACIDS RES, V41; Murphy EC, 2001, J MOL BIOL, V312, P481, DOI 10.1006/jmbi.2001.4977; Nagakubo D, 1997, BIOCHEM BIOPH RES CO, V231, P509, DOI 10.1006/bbrc.1997.6132; Ng PC, 2003, NUCLEIC ACIDS RES, V31, P3812, DOI 10.1093/nar/gkg509; Ng PC, 2001, GENOME RES, V11, P863, DOI 10.1101/gr.176601; Olatubosun A, 2012, HUM MUTAT, V33, P1166, DOI 10.1002/humu.22102; OWEN MC, 1983, NEW ENGL J MED, V309, P694, DOI 10.1056/NEJM198309223091203; Pires DEV, 2014, NUCLEIC ACIDS RES, V42, pW314, DOI 10.1093/nar/gku411; Pirmohamed M, 2001, TRENDS PHARMACOL SCI, V22, P298, DOI 10.1016/S0165-6147(00)01717-X; Prlic A, 2016, BIOINFORMATICS; Prlic A, 2012, BIOINFORMATICS, V28, P2693, DOI 10.1093/bioinformatics/bts494; PURDUE PE, 1991, P NATL ACAD SCI USA, V88, P10900, DOI 10.1073/pnas.88.23.10900; PURDUE PE, 1990, J CELL BIOL, V111, P2341, DOI 10.1083/jcb.111.6.2341; Ramensky V, 2002, NUCLEIC ACIDS RES, V30, P3894, DOI 10.1093/nar/gkf493; Risch N, 1996, SCIENCE, V273, P1516, DOI 10.1126/science.273.5281.1516; Risch NJ, 2000, NATURE, V405, P847, DOI 10.1038/35015718; Rose PW, 2015, NUCLEIC ACIDS RES, V43, pD345, DOI 10.1093/nar/gku1214; Rutherford K, 2008, BIOCHEMISTRY-US, V47, P893, DOI 10.1021/bi701737f; Ryan M, 2009, BIOINFORMATICS, V25, P1431, DOI 10.1093/bioinformatics/btp242; Sayers EW, 2010, NUCLEIC ACIDS RES, V38, pD5, DOI 10.1093/nar/gkp967; Sherry ST, 2001, NUCLEIC ACIDS RES, V29, P308, DOI 10.1093/nar/29.1.308; Shihab HA, 2013, HUM MUTAT, V34, P57, DOI 10.1002/humu.22225; Stitziel NO, 2004, NUCLEIC ACIDS RES, V32, pD520, DOI 10.1093/nar/gkh104; Stone EA, 2005, GENOME RES, V15, P978, DOI 10.1101/gr.3804205; Thomas PD, 2004, P NATL ACAD SCI USA, V101, P15398, DOI 10.1073/pnas.0404380101; Topham CM, 1997, PROTEIN ENG, V10, P7, DOI 10.1093/protein/10.1.7; von Bulow R, 2002, J BIOL CHEM, V277, P9455, DOI 10.1074/jbc.M111993200; Wang Z, 2001, HUM MUTAT, V17, P263, DOI 10.1002/humu.22; Wu CH, 2006, NUCLEIC ACIDS RES, V34, pD187, DOI 10.1093/nar/gkj161; Xie W, 2007, P NATL ACAD SCI USA, V104, P9976, DOI 10.1073/pnas.0703908104; Yue P, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-166	69	36	51	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 15	2017	12	3							e0171355	10.1371/journal.pone.0171355	http://dx.doi.org/10.1371/journal.pone.0171355			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN9HQ	28296894	Green Published, Green Submitted, gold			2022-12-27	WOS:000396311700002
J	Rimnacova, J; Mikes, L; Turjanicova, L; Bulantova, J; Horak, P				Rimnacova, Jana; Mikes, Libor; Turjanicova, Libuse; Bulantova, Jana; Horak, Petr			Changes in surface glycosylation and glycocalyx shedding in Trichobilharzia regenti (Schistosomatidae) during the transformation of cercaria to schistosomulum	PLOS ONE			English	Article							MANSONI CERCARIAE; LECTIN-BINDING; LEWIS-X; CARBOHYDRATE EPITOPES; EXPRESSION PATTERNS; PROTEOMIC ANALYSIS; GLAND SECRETION; MAMMALIAN SKIN; O-GLYCANS; HOST	The invasive larvae (cercariae) of schistosomes penetrate the skin of their definitive hosts. During the invasion, they undergo dramatic ultrastructural and physiological transitions. These changes result in the development of the subsequent stage, schistosomulum, which migrates through host tissues in close contact with host's immune system. One of the striking changes in the transforming cercariae is the shedding of their thick tegumental glycocalyx, which represents an immunoattractive structure; therefore its removal helps cercariae to avoid immune attack. A set of commercial fluorescently labeled lectin probes, their saccharide inhibitors and monoclonal antibodies against the trisaccharide Lewis-X antigen (Le(X), CD15) were used to characterize changes in the surface saccharide composition of the neuropathogenic avian schistosome Trichobilharzia regenti during the transformation of cercariae to schistosomula, both in vitro and in vivo. The effect of various lectins on glycocalyx shedding was evaluated microscopically. The involvement of peptidases and their inhibitors on the shedding of glycocalyx was investigated using T. regenti recombinant cathepsin B2 and a set of peptidase inhibitors. The surface glycocalyx of T. regenti cercariae was rich in fucose and mannose/glucose residues. After the transformation of cercariae in vitro or in vivo within their specific duck host, reduction and vanishing of these epitopes was observed, and galactose/N-acetylgalactosamine emerged. The presence of Le(X) was not observed on the cercariae, but the antigen was gradually expressed from the anterior part of the body in the developing schistosomula. Some lectins which bind to the cercarial surface also induced secretion from the acetabular penetration glands. Seven lectins induced the shedding of glycocalyx by cercariae, among which five bound strongly to cercarial surface; the effect could be blocked by saccharide inhibitors. Mannose-binding protein, part of the lectin pathway of the complement system, also bound to cercariae and schistosomula, but had little effect on glycocalyx shedding. Our study did not confirm the involvement of proteolysis in glycocalyx shedding.	[Rimnacova, Jana; Mikes, Libor; Turjanicova, Libuse; Bulantova, Jana; Horak, Petr] Charles Univ Prague, Fac Sci, Dept Parasitol, Vinicna 7, Prague 2, Czech Republic	Charles University Prague	Mikes, L (corresponding author), Charles Univ Prague, Fac Sci, Dept Parasitol, Vinicna 7, Prague 2, Czech Republic.	mikes@natur.cuni.cz	Mikes, Libor/J-8551-2017; Bulantová, Jana/M-5239-2017; Horák, Petr/C-6482-2009; Turjanicová, Libuše/M-5292-2017; Horák, Petr/AGF-2029-2022	Mikes, Libor/0000-0002-2440-6641; Horák, Petr/0000-0001-9820-5044; Turjanicová, Libuše/0000-0002-8228-1031; Horák, Petr/0000-0001-9820-5044; Bulantova, Jana/0000-0001-9769-4640	Czech Science Foundation [13-29577S]; Charles University [220214/2014]; UNCE [204017]; PRVOUK [P41]; SVV [260202/2015]	Czech Science Foundation(Grant Agency of the Czech Republic); Charles University; UNCE; PRVOUK; SVV	Funded by Czech Science Foundation (Grant No. 13-29577S), www.gacr.cz - (PH, LM, JR, JB, LT), Charles University grant support, www.cuni.cz/UKEN-65.html - GAUK No. 220214/2014 (LT, LM), UNCE No. 204017 (JB), PRVOUK No. P41 (PH, LM, JB, LT), SVV No. 260202/2015 (PH, LM, JB, LT). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baxt LA, 2008, GENE DEV, V22, P1636, DOI 10.1101/gad.1667708; BEISLER GK, 1984, JPN J EXP MED, V54, P263; Blazova K, 2005, PARASITOL INT, V54, P167, DOI 10.1016/j.parint.2005.03.003; CAULFIELD JP, 1987, J PARASITOL, V73, P514, DOI 10.2307/3282129; Chanova M, 2009, PARASITOL RES, V104, P1445, DOI 10.1007/s00436-009-1343-y; COLES GC, 1988, J CHEM ECOL, V14, P691, DOI 10.1007/BF01013916; COUSIN CE, 1981, EXP PARASITOL, V51, P341, DOI 10.1016/0014-4894(81)90122-3; Curwen RS, 2006, MOL CELL PROTEOMICS, V5, P835, DOI 10.1074/mcp.M500313-MCP200; Curwen RS, 2004, MOL BIOCHEM PARASIT, V138, P57, DOI 10.1016/j.molbiopara.2004.06.016; D'Costa S, 1999, INT J DEV BIOL, V43, P349; DANIEL BE, 1992, PARASITOLOGY, V104, P41, DOI 10.1017/S0031182000060789; Doleckova K, 2009, INT J PARASITOL, V39, P201, DOI 10.1016/j.ijpara.2008.06.010; DRESDEN MH, 1975, J PARASITOL, V61, P398, DOI 10.2307/3279310; Dvorak J, 2008, BIOCHIMIE, V90, P345, DOI 10.1016/j.biochi.2007.08.013; FISHELSON Z, 1992, EXP PARASITOL, V75, P87, DOI 10.1016/0014-4894(92)90124-S; Haas W, 1997, J PARASITOL, V83, P1079, DOI 10.2307/3284366; Haas W, 2003, ZOOLOGY, V106, P349, DOI 10.1078/0944-2006-00125; Harris PK, 2005, PLOS PATHOG, V1, P241, DOI 10.1371/journal.ppat.0010029; HAYUNGA EG, 1986, J PARASITOL, V72, P913, DOI 10.2307/3281844; HOCKLEY D J, 1973, International Journal for Parasitology, V3, P13, DOI 10.1016/0020-7519(73)90004-0; Horak P, 2008, PARASITE, V15, P299, DOI 10.1051/parasite/2008153299; HORAK P, 1995, PARASITE, V2, P419; Horak P, 1998, PARASITOLOGY, V116, P139, DOI 10.1017/S0031182097002059; Horak P, 1995, FOLIA PARASIT, V42, P255; Horak P, 2001, TRENDS PARASITOL, V17, P66, DOI 10.1016/S1471-4922(00)01770-0; Horak P, 2015, CLIN MICROBIOL REV, V28, P165, DOI 10.1128/CMR.00043-14; Horak P, 2011, FRESHWATER BIOL, V56, P779, DOI 10.1111/j.1365-2427.2010.02545.x; Huang HH, 2001, GLYCOBIOLOGY, V11, P395, DOI 10.1093/glycob/11.5.395; Jang-Lee J, 2007, MOL CELL PROTEOMICS, V6, P1485, DOI 10.1074/mcp.M700004-MCP200; KERR MA, 1992, HISTOCHEM J, V24, P811, DOI 10.1007/BF01046353; Khoo KH, 2001, GLYCOBIOLOGY, V11, P149, DOI 10.1093/glycob/11.2.149; KHOO KH, 1995, J BIOL CHEM, V270, P17114, DOI 10.1074/jbc.270.29.17114; Klabunde J, 2000, EXP PARASITOL, V95, P231, DOI 10.1006/expr.2000.4539; Knudsen GM, 2005, MOL CELL PROTEOMICS, V4, P1862, DOI 10.1074/mcp.M500097-MCP200; KOSTER B, 1994, PARASITOLOGY, V108, P433, DOI 10.1017/S0031182000075995; Lee KP, 1996, J BIOL CHEM, V271, P32960, DOI 10.1074/jbc.271.51.32960; Ligasova A, 2011, PARASITE VECTOR, V4, DOI 10.1186/1756-3305-4-162; LINDER E, 1985, EXP PARASITOL, V59, P307, DOI 10.1016/0014-4894(85)90085-2; Liu M, 2015, J PROTEOME RES, V14, P4623, DOI 10.1021/acs.jproteome.5b00465; MARIKOVSKY M, 1988, MOL BIOCHEM PARASIT, V30, P45, DOI 10.1016/0166-6851(88)90131-4; MARIKOVSKY M, 1990, PARASITE IMMUNOL, V12, P389, DOI 10.1111/j.1365-3024.1990.tb00976.x; MATSUMURA K, 1990, J PARASITOL, V76, P436, DOI 10.2307/3282684; Meevissen MHJ, 2012, EXP PARASITOL, V132, P14, DOI 10.1016/j.exppara.2011.05.005; Mikes L, 2005, PARASITOL RES, V96, P230, DOI 10.1007/s00436-005-1347-1; Modha J, 1998, PARASITOL TODAY, V14, P396, DOI 10.1016/S0169-4758(98)01321-0; NANDURI J, 1991, J BIOL CHEM, V266, P1341; Nyame AK, 2003, EXP PARASITOL, V104, P1, DOI 10.1016/S0014-4894(03)00110-3; Nyame AK, 1998, GLYCOBIOLOGY, V8, P615, DOI 10.1093/glycob/8.6.615; Page AP, 2014, INT J PARASITOL-DRUG, V4, P133, DOI 10.1016/j.ijpddr.2014.05.003; Parker-Manuel SJ, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0001274; Paveley RA, 2011, INT J PARASITOL, V41, P1335, DOI 10.1016/j.ijpara.2011.08.005; Podhorsky M, 2009, ACTA PARASITOL, V54, P28, DOI 10.2478/s11686-009-0011-9; Rhodes JM, 1998, METHODS MOL MED; SAMUELSON JC, 1982, J CELL BIOL, V94, P363, DOI 10.1083/jcb.94.2.363; SAMUELSON JC, 1985, J CELL BIOL, V100, P1423, DOI 10.1083/jcb.100.5.1423; Smit CH, 2015, GLYCOBIOLOGY, V25, P1465, DOI 10.1093/glycob/cwv066; Smit CH, 2015, MOL CELL PROTEOMICS, V14, P1750, DOI 10.1074/mcp.M115.048280; STIREWALT M, 1961, EXP PARASITOL, V11, P191, DOI 10.1016/0014-4894(61)90026-1; van Die I, 2010, GLYCOBIOLOGY, V20, P2, DOI 10.1093/glycob/cwp140; van Remoortere A, 2000, GLYCOBIOLOGY, V10, P601, DOI 10.1093/glycob/10.6.601; WIEST PM, 1989, AM J TROP MED HYG, V41, P70, DOI 10.4269/ajtmh.1989.41.70; Wuhrer M, 2000, GLYCOBIOLOGY, V10, P89, DOI 10.1093/glycob/10.1.89; XU XF, 1994, EXP PARASITOL, V79, P399, DOI 10.1006/expr.1994.1102	63	9	9	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 15	2017	12	3							e0173217	10.1371/journal.pone.0173217	http://dx.doi.org/10.1371/journal.pone.0173217			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN9HQ	28296924	gold, Green Published, Green Submitted			2022-12-27	WOS:000396311700028
J	Stephen, J; Yokoyama, T; Tolman, NJ; O'Brien, KJ; Nicoli, ER; Brooks, BP; Huryn, L; Titus, SA; Adams, DR; Chen, D; Gahl, WA; Gochuico, BR; Malicdan, MCV				Stephen, Joshi; Yokoyama, Tadafumi; Tolman, Nathanial J.; O'Brien, Kevin J.; Nicoli, Elena-Raluca; Brooks, Brian P.; Huryn, Laryssa; Titus, Steven A.; Adams, David R.; Chen, Dong; Gahl, William A.; Gochuico, Bernadette R.; Malicdan, May Christine V.			Cellular and molecular defects in a patient with Hermansky-Pudlak syndrome type 5	PLOS ONE			English	Article							LYSOSOME-RELATED ORGANELLES; PROTEIN TRAFFICKING; COMPLEX; BLOC-2; BIOGENESIS; DISEASE; CELLS; HPS5; AP-3	Hermansky-Pudlak syndrome (HPS) is a heterogeneous group of genetic disorders typically manifesting with tyrosinase-positive oculocutaneous albinism, bleeding diathesis, and pulmonary fibrosis, in some subtypes. Most HPS subtypes are associated with defects in Biogenesis of Lysosome-related Organelle Complexes (BLOCs), which are groups of proteins that function together in the formation and/or trafficking of lysosomal-related endosomal compartments. BLOC-2, for example, consists of the proteins HPS3, HPS5, and HPS6. Here we present an HPS patient with defective BLOC-2 due to a novel intronic mutation in HPS5 that activates a cryptic acceptor splice site. This mutation leads to the insertion of nine nucleotides in-frame and results in a reduced amount of HPS5 at the transcript and protein level. In studies using skin fibroblasts derived from the proband and two other individuals with HPS-5, we found a perinuclear distribution of acidified organelles in patient cells compared to controls. Our results suggest the role of HPS5 in the endo-lysosomal dynamics of skin fibroblasts.	[Stephen, Joshi; O'Brien, Kevin J.; Huryn, Laryssa; Gochuico, Bernadette R.] NHGRI, Med Genet Branch, NIH, Bethesda, MD 20892 USA; [Tolman, Nathanial J.; Titus, Steven A.; Adams, David R.; Chen, Dong] NIH, Undiagnosed Dis Program, Bldg 10, Bethesda, MD 20892 USA; [Tolman, Nathanial J.; Brooks, Brian P.; Chen, Dong; Gahl, William A.] NIH, Bldg 10, Bethesda, MD 20892 USA; [O'Brien, Kevin J.; Huryn, Laryssa; Chen, Dong] NEI, Ophthalm Genet & Visual Funct Branch, NIH, Bethesda, MD USA; [O'Brien, Kevin J.; Titus, Steven A.; Adams, David R.] Natl Inst Hlth, Div Pre clin Innovat, Natl Ctr Adv Translat Sci, Rockville, MD USA; [Tolman, Nathanial J.; Brooks, Brian P.; Huryn, Laryssa; Titus, Steven A.] Natl Human Genome Res Inst, Natl Inst Hlth, Bethesda, MD USA; [Yokoyama, Tadafumi; Brooks, Brian P.; Huryn, Laryssa] Mayo Clin, Div Hematopathol, Rochester, MN USA	National Institutes of Health (NIH) - USA; NIH National Human Genome Research Institute (NHGRI); National Institutes of Health (NIH) - USA; National Institutes of Health (NIH) - USA; National Institutes of Health (NIH) - USA; NIH National Eye Institute (NEI); National Institutes of Health (NIH) - USA; NIH National Center for Advancing Translational Sciences (NCATS); National Institutes of Health (NIH) - USA; NIH National Human Genome Research Institute (NHGRI); Mayo Clinic	Gochuico, BR (corresponding author), NHGRI, Med Genet Branch, NIH, Bethesda, MD 20892 USA.	gochuicb@mail.nih.gov	Nicoli, Elena-Raluca/F-3968-2011; Stephen, Joshi/ABB-8045-2020; Malicdan, May Christine/AAK-7422-2021	Nicoli, Elena-Raluca/0000-0002-5545-630X; 	Intramural Research Programs of the National Human Genome Research Institute; National Eye Institute, National Institutes of Health (NIH), Bethesda, Maryland, USA; NATIONAL EYE INSTITUTE [ZIEEY000477] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [ZIAHG000215, ZIDHG200352] Funding Source: NIH RePORTER	Intramural Research Programs of the National Human Genome Research Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); National Eye Institute, National Institutes of Health (NIH), Bethesda, Maryland, USA; NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))	This work was supported by the Intramural Research Programs of the National Human Genome Research Institute and the National Eye Institute, National Institutes of Health (NIH), Bethesda, Maryland, USA.	Bultema JJ, 2012, J BIOL CHEM, V287, P19550, DOI 10.1074/jbc.M112.351908; Carmona-Rivera C, 2011, J INVEST DERMATOL, V131, P2394, DOI 10.1038/jid.2011.228; DellAngelica EC, 1997, J BIOL CHEM, V272, P15078, DOI 10.1074/jbc.272.24.15078; Dennis MK, 2015, J CELL BIOL, V209, P563, DOI 10.1083/jcb.201410026; Di Pietro SM, 2004, TRAFFIC, V5, P276, DOI 10.1111/j.1600-0854.2004.0171.x; Gu F, 2001, CELL MOL LIFE SCI, V58, P1067, DOI 10.1007/PL00000922; HERMANSKY F, 1959, BLOOD, V14, P162, DOI 10.1182/blood.V14.2.162.162; Huizing M, 2004, TRAFFIC, V5, P711, DOI 10.1111/j.1600-0854.2004.00208.x; Huizing M, 2008, ANNU REV GENOM HUM G, V9, P359, DOI 10.1146/annurev.genom.9.081307.164303; Khan AO, 2016, CLIN GENETICS; Korswagen LA, 2008, EUR J HAEMATOL, V80, P356, DOI 10.1111/j.1600-0609.2007.01024.x; Livak K., 1997, COMP CT METHOD; Nazarian R, 2003, P NATL ACAD SCI USA, V100, P8770, DOI 10.1073/pnas.1532040100; Ringeisen AL, 2013, J AAPOS, V17, P334, DOI 10.1016/j.jaapos.2013.02.002; Rouhani FN, 2009, AM J RESP CRIT CARE, V180, P1114, DOI 10.1164/rccm.200901-0023OC; Wei AH, 2013, PIGM CELL MELANOMA R, V26, DOI 10.1111/pcmr.12051; Wei ML, 2006, PIGM CELL RES, V19, P19, DOI 10.1111/j.1600-0749.2005.00289.x; Yu DZ, 2014, J BIOMOL SCREEN, V19, P1164, DOI 10.1177/1087057114537378; Zhang Q, 2003, NAT GENET, V33, P145, DOI 10.1038/ng1087	19	9	9	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 15	2017	12	3							e0173682	10.1371/journal.pone.0173682	http://dx.doi.org/10.1371/journal.pone.0173682			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN9HQ	28296950	gold, Green Published, Green Submitted			2022-12-27	WOS:000396311700052
J	Wong, SSH; Lim, SWH				Wong, Sarah Shi Hui; Lim, Stephen Wee Hun			Mental imagery boosts music compositional creativity	PLOS ONE			English	Article							CONSENSUAL ASSESSMENT TECHNIQUE; AUDITORY IMAGERY; SOCIAL-PSYCHOLOGY; STRATEGIES; PRODUCTS; REVERSAL; STUDENTS	We empirically investigated the effect of mental imagery on young children's music compositional creativity. Children aged 5 to 8 years participated in two music composition sessions. In the control session, participants based their composition on a motif that they had created using a sequence of letter names. In the mental imagery session, participants were given a picture of an animal and instructed to imagine the animal's sounds and movements, before incorporating what they had imagined into their composition. Six expert judges independently rated all music compositions on creativity based on subjective criteria (consensual assessment). Reliability analyses indicated that the expert judges demonstrated a high level of agreement in their ratings. The mental imagery compositions received significantly higher creativity ratings by the expert judges than did the control compositions. These results provide evidence for the effectiveness of mental imagery in enhancing young children's music compositional creativity.	[Wong, Sarah Shi Hui; Lim, Stephen Wee Hun] Natl Univ Singapore, Dept Psychol, Singapore, Singapore	National University of Singapore	Wong, SSH (corresponding author), Natl Univ Singapore, Dept Psychol, Singapore, Singapore.	psywshs@nus.edu.sg	Wong, Sarah Shi Hui/AAE-1279-2022	Wong, Sarah Shi Hui/0000-0003-4243-212X				Agnew M, 1922, PSYCHOL MONOGR, V31, P279, DOI 10.1037/h0093171; Aleman A, 2000, NEUROPSYCHOLOGIA, V38, P1664, DOI 10.1016/S0028-3932(00)00079-8; Amabile T., 1996, CREATIVITY CONTEXT; AMABILE TM, 1983, J PERS SOC PSYCHOL, V45, P357, DOI 10.1037/0022-3514.45.2.357; AMABILE TM, 1982, J PERS SOC PSYCHOL, V43, P997, DOI 10.1037/0022-3514.43.5.997; [Anonymous], 1978, VISUAL LEARNING THIN; Antonietti A, 2011, IMAGINATION COGNITIO, V31, P63, DOI [10.2190/IC.31.1-2.g, DOI 10.2190/IC.31.1-2.G]; Antonietti A, 1991, MENTAL IMAGES HUMAN, P211, DOI [DOI 10.1016/S0166-4115(08)60515-4, 10.1016/s0166-4115(08)60515-4]; Auh M, 2002, EUR SOC COGN SCI MUS; Auh M, 2000, AUSTR ASS RES ED AAR; Auh MS, 1999, B COUN RES MUSIC ED, P2; Baer J, 2004, CREATIVITY RES J, V16, P113, DOI 10.1207/s15326934crj1601_11; Bailes F, 2012, SEMPRE STUD PSYCHOL, P53; Bailes F, 2009, SOUNDS IN TRANSLATION: INTERSECTIONS OF MUSIC, TECHNOLOGY AND SOCIETY, P41; Batey M, 2012, CREATIVITY RES J, V24, P55, DOI 10.1080/10400419.2012.649181; Becker G, 2000, CREATIVITY RES J, V13, P45; Beegle AC, 2010, J RES MUSIC EDUC, V58, P219, DOI 10.1177/0022429410379916; BERKLEY R., 2001, BRIT J MUSIC EDUC, V18, P119, DOI DOI 10.1017/S0265051701000225; BRANDIMONTE MA, 1993, MEM COGNITION, V21, P23, DOI 10.3758/BF03211161; Brandon S, 2006, COMPOSERS GUIDE UNDE; BRUNER JS, 1964, AM PSYCHOL, V19, P1, DOI 10.1037/h0044160; Burnard Pamela, 2002, MUSIC EDUC RES, V4, P245, DOI DOI 10.1080/1461380022000011948; Burnard Pamela., 2004, INT J MUSIC EDUC, V22, P59, DOI [DOI 10.1177/0255761404042375, 10.1177/0255761404042375]; CHAMBERS D, 1985, J EXP PSYCHOL HUMAN, V11, P317; Chen CS, 2002, J CROSS CULT PSYCHOL, V33, P171, DOI 10.1177/0022022102033002004; Chino Y., 2004, CREATIVITY E MEETS W, P305; Cohan RD, 1984, MUSIC THER, V4, P73; Consortium of National Arts Education Associations (US), 1994, NAT STAND ARTS ED WH; Cook Nicholas, 1998, MUSIC VERY SHORT INT; Cropley A.J., 1999, ROEPER REV, V21, P253, DOI [DOI 10.1080/02783199909553972, 10.1080/02783199909553972]; Csikszentmihalyi M., 1999, HDB CREATIVITY, P313; DANIELSMCGHEE S, 1994, J CREATIVE BEHAV, V28, P151, DOI 10.1002/j.2162-6057.1994.tb01189.x; DELORENZO LC, 1989, J RES MUSIC EDUC, V37, P188, DOI 10.2307/3344669; DEPARTMENT FOR EDUCATION, 2013, NAT CURR ENGL MUS PR; Eardley AF, 2006, MEMORY, V14, P925, DOI 10.1080/09658210600859582; Flowers J.H., 1989, HDB CREATIVITY, P147; Gonzalez MA, 1997, J PSYCHOL, V131, P357, DOI 10.1080/00223989709603521; Gordon E. E., 1979, PSYCHOL MUSIC, V7, P42, DOI [10.1177/030573567971005, DOI 10.1177/030573567971005]; Guilford J.P., 1967, NATURE HUMAN INTELLI; GUTTMANN J, 1977, J EDUC PSYCHOL, V69, P473, DOI 10.1037/0022-0663.69.5.473; HALPERN AR, 1988, J EXP PSYCHOL LEARN, V14, P434, DOI 10.1037/0278-7393.14.3.434; Hargreaves DJ, 1999, B COUN RES MUSIC ED, P22; Heller K., 2000, INT HDB GIFTEDNESS T, V2nd, P81; Hennessey B. A., 1999, ENCY CREATIVITY, VI, P347; Hickey M, 2001, J RES MUSIC EDUC, V49, P234, DOI 10.2307/3345709; Hubbard T. L., 2013, MULTISENSORY IMAGERY, P221; Hubbard TL, 2010, PSYCHOL BULL, V136, P302, DOI 10.1037/a0018436; Intons-peterson M.J., 1993, IMAGERY CREATIVITY D, P1; Joh AS, 2011, CHILD DEV, V82, P744, DOI 10.1111/j.1467-8624.2011.01584.x; Kaschub M., 1997, MUSIC EDUC J, V84, P26; Keats J, 2016, KEATS ODE NIGHTINGAL; Kosslyn SM., 1990, J MENTAL IMAG, V14, P131, DOI DOI 10.1093/ACPROF:OSO/9780195179088.001.0001; Kozbelt A., 2005, PSYCHOL MUSIC, V33, P235; KRATUS J, 1994, J RES MUSIC EDUC, V42, P115, DOI 10.2307/3345496; Kratus J., 1991, RES PERSPECTIVES MUS, V2, P4; LeBoutillier N, 2003, BRIT J PSYCHOL, V94, P29, DOI 10.1348/000712603762842084; Madden LE, 2000, NATL FORUM TEACH ED, V10, P26; Mast FW, 2002, COGNITION, V86, P57, DOI 10.1016/S0010-0277(02)00137-3; Ministry of Education Singapore, 2015, MUS TEACH LEARN SYLL; Mooney R.L., 1963, SCI CREATIVITY ITS R, P331; Mountain R, 2001, IMAGERY, P271; Mumford MD, 2003, CREATIVITY RES J, V15, P107, DOI 10.1207/S15326934CRJ152&3_01; Neuper C, 2005, COGNITIVE BRAIN RES, V25, P668, DOI 10.1016/j.cogbrainres.2005.08.014; Paynter J., 1992, SOUND AND STRUCTURE; Pelaprat E, 2011, INTEGR PSYCHOL BEHAV, V45, P397, DOI 10.1007/s12124-011-9176-5; PETERSON MA, 1992, MEM COGNITION, V20, P107, DOI 10.3758/BF03197159; Piaget J., 1971, MENTAL IMAGERY CHILD; Piaget J., 1962, PLAY DREAMS IMITATIO; Repp B. H., 2001, MUSICAL IMAGERY, P185; RHODES M, 1961, PHI DELTA KAPPAN, V42, P305; Richards R., 1999, ENCY CREATIVITY, V1, P733; Rosenbrock A, 2003, 5 TRIENN C EUR SOC C, P34; Runco MA, 2011, ROUT INT HANDB, P63; Runco MA, 2012, CREATIVITY RES J, V24, P92, DOI 10.1080/10400419.2012.650092; Schneider A., 2001, MMW-FORTSCH M S 0426, P5; Shaw G.A., 1986, J MENTAL IMAG, V10, P65; Singer D.G., 2006, IMAGINATION COGNITIO, V25, P97, DOI [10.2190/0KQU-9A2V-YAM2-XD8J, DOI 10.2190/0KQU-9A2V-YAM2-XD8J]; Thomas NJT, 1999, COGNITIVE SCI, V23, P207, DOI 10.1016/S0364-0213(99)00004-X; Tonelli G, 1973, DICT HIST IDEAS, P293; Torrance E. P., 1988, NATURE CREATIVITY, P43; Trusheim WH, 1991, Q J MUSIC TEACH LEAR, V2, P128; Webster P., 1987, APPL RES MUSIC BEHAV, P257; Webster P.R., 1987, MUSIC CHILD DEV, P158, DOI DOI 10.1007/978-1-4613-8698-8_8; Webster P.R., 2002, CREATIVITY MUSIC ED, P16, DOI DOI 10.1177/1048371313482921; Webster P. R., 1995, Q J MUSIC TEACHING L, V6, P28; Webster P.R., 1990, MUSIC EDUC J, V76, P22, DOI [10.2307/3401073, DOI 10.2307/3401073]; Weisberg R., 2006, CREATIVITY UNDERSTAN; Weisberg R. W., 1993, CREATIVITY MYTH GENI; WIGGINS JH, 1994, J RES MUSIC EDUC, V42, P232, DOI 10.2307/3345702; WILKINS Margaret Lucy, 2006, CREATIVE MUSIC COMPO; Wimmer MC, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0142566; Woody R.H., 2002, MUSIC EDUC RES, V4, P213, DOI DOI 10.1080/1461380022000011920; Woody RH, 2006, J RES MUSIC EDUC, V54, P21, DOI 10.2307/3653453; Zacks JM, 2008, J COGNITIVE NEUROSCI, V20, P1, DOI 10.1162/jocn.2008.20013; Zatorre RJ, 2010, J COGNITIVE NEUROSCI, V22, P775, DOI 10.1162/jocn.2009.21239	95	9	9	1	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 15	2017	12	3							e0174009	10.1371/journal.pone.0174009	http://dx.doi.org/10.1371/journal.pone.0174009			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EN9HQ	28296965	Green Published, gold, Green Submitted			2022-12-27	WOS:000396311700089
J	Zong, YB; Yao, SK; Lang, JF; Chen, XX; Fan, JD; Sun, ZB; Duan, XL; Li, NN; Fang, H; Zhou, GZ; Xiao, TQ; Li, AG; Jiang, HD				Zong, Yunbing; Yao, Shengkun; Lang, Jianfeng; Chen, Xuexiang; Fan, Jiadong; Sun, Zhibin; Duan, Xiulan; Li, Nannan; Fang, Hui; Zhou, Guangzhao; Xiao, Tiqiao; Li, Aiguo; Jiang, Huaidong			Structural and compositional analysis of a casting mold sherd from ancient China	PLOS ONE			English	Article							SCANNING-ELECTRON-MICROSCOPY; RAY	Casting had symbolic significance and was strictly controlled in the Shang dynasty of ancient China. Vessel casting was mainly distributed around the Shang capital, Yin Ruins, which indicates a rigorous centralization of authority. Thus, for a casting mold to be excavated far from the capital region is rare. In addition to some bronze vessel molds excavated at the Buyao Village site, another key discovery of a bronze vessel mold occurred at Daxinzhuang. The Daxinzhuang site was a core area in the east of Shang state and is an important site to study the eastward expansion of the Shang. Here, combining synchrotron X-rays and other physicochemical analysis methods, nondestructive three-dimensional structure imaging and different elemental analyses were conducted on this mold sherd. Through high penetration X-ray tomography, we obtained insights on the internal structure and discovered some pores. We infer that the generation of pores inside the casting mold sherd was used to enhance air permeability during casting. Furthermore, we suppose that the decorative patterns on the surface were carved and not pasted onto it. Considering the previous compositional studies of bronze vessels, the copper and iron elements were analyzed by different methods. Unexpectedly, a larger amount of iron than of copper was detected on the surface. According to the data analysis and archaeological context, the source of iron on the casting mold sherd could be attributed to local soil contamination. A refined compositional analysis confirms that this casting mold was fabricated locally and used for bronze casting.	[Zong, Yunbing; Yao, Shengkun; Fan, Jiadong; Sun, Zhibin; Duan, Xiulan; Li, Nannan; Jiang, Huaidong] Shandong Univ, State Key Lab Crystal Mat, Jinan, Shandong, Peoples R China; [Yao, Shengkun; Fan, Jiadong; Jiang, Huaidong] ShanghaiTech Univ, Sch Phys Sci & Technol, Shanghai, Peoples R China; [Lang, Jianfeng; Chen, Xuexiang; Fang, Hui] Shandong Univ, Dept Archaeol, Jinan, Shandong, Peoples R China; [Zhou, Guangzhao; Xiao, Tiqiao; Li, Aiguo] Chinese Acad Sci, Shanghai Inst Appl Phys, Shanghai Synchrotron Radiat Facil, Shanghai, Peoples R China	Shandong University; ShanghaiTech University; Shandong University; Chinese Academy of Sciences; Shanghai Institute of Applied Physics, CAS	Jiang, HD (corresponding author), Shandong Univ, State Key Lab Crystal Mat, Jinan, Shandong, Peoples R China.; Jiang, HD (corresponding author), ShanghaiTech Univ, Sch Phys Sci & Technol, Shanghai, Peoples R China.	jianghd@shanghaitech.edu.cn			National Natural Science Foundation of China [31430031, U1332118]; National Social Science Foundation of China [146KG009]; Humanities and Social Science Youth Team Project, SDU [IFYT1505]; Fundamental Research Funds of Shandong University [2014JC007]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Social Science Foundation of China; Humanities and Social Science Youth Team Project, SDU; Fundamental Research Funds of Shandong University	This work was supported by the National Natural Science Foundation of China (31430031, U1332118), the National Social Science Foundation of China (146KG009), Humanities and Social Science Youth Team Project, SDU (IFYT1505) and the Fundamental Research Funds of Shandong University (2014JC007). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bagley R, 2009, ARTIBUS ASIAE, V69, P39; BARNARD N., 1961, BRONZE CASTING BRONZ; Brodowski S, 2005, GEODERMA, V128, P116, DOI 10.1016/j.geoderma.2004.12.019; Chen L, 2014, NATURE, V516, P238, DOI 10.1038/nature13766; Chen X, 2008, DONGFANG KAOGU, V4, P47; de Villiers S, 2002, GEOCHEM GEOPHY GEOSY, V3, DOI 10.1029/2001GC000169; Dik J, 2008, ANAL CHEM, V80, P6436, DOI 10.1021/ac800965g; Fang H., 2004, J SHANDONG U PHILOS, V1; Fang H., 2006, J SHANDONG U PHILOS, V5, P006; Frisia S, 2012, CLIM PAST, V8, P2039, DOI 10.5194/cp-8-2039-2012; Higham C., 2009, ENCY ANCIENT ASIAN C; Karlbeck O., 1935, ANYANG MOULDS; Kearns Th., 2010, HIST METALLURGY, V44, P48; Keightley D., 1978, HIST RELIGIONS, V17, P211; Kwang-Chih C, 1986, INT C SHANG CIV, P63; Lamassu Design, 2009, MAP SHANG DYN BAMB A; Lamberg-Karlovsky CC., 1989, ARCHAEOLOGICAL THOUG, P155, DOI 10.1017/CBO9780511558221.011; LI XD, 1995, CHEM GEOL, V124, P109, DOI 10.1016/0009-2541(95)00029-L; Liu L, 2012, CAMB WOR ARCHAEOL, P1, DOI 10.1017/CBO9781139015301; Liu L., 2003, STATE FORMATION EARL; Liu SR, 2013, J ARCHAEOL SCI, V40, P2402, DOI 10.1016/j.jas.2012.11.010; Liu Y., 2009, HUAXIA ARCHAEOLOGY, V1, P007; Luan F., 2006, J SHANDONG U PHILOS, V5, P005; Macchiarelli R, 2006, NATURE, V444, P748, DOI 10.1038/nature05314; Maire E, 2014, INT MATER REV, V59, P1, DOI 10.1179/1743280413Y.0000000023; Martini I. Peter, 2010, LANDSCAPES SOC SELEC; Mocella V, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms6895; Nickel L, 2006, ARTIBUS ASIAE, V66, P5, DOI 10.2307/25261842; Okpalugo TIT, 2005, CARBON, V43, P153, DOI 10.1016/j.carbon.2004.08.033; Ortega R, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000925; Saleh IM, 2003, J ENDODONT, V29, P595, DOI 10.1097/00004770-200309000-00013; Scruggd B., 2000, ADV XRAY ANAL, V42, P19; Song Z, 2004, ARCHAEOLOGY, V2, P007; Tafforeau P, 2006, APPL PHYS A-MATER, V83, P195, DOI 10.1007/s00339-006-3507-2; Tan D., 1999, ACTA ARCHAEOLOGICA S, V2; Wang XD, 2011, J TRANSL MED, V9, DOI 10.1186/1479-5876-9-3; Xu J., 2000, CULTURAL RELICS CENT, V3, P004; Yamashita T, 2008, APPL SURF SCI, V254, P2441, DOI 10.1016/j.apsusc.2007.09.063; ZHAO F, 1994, COMMUN SOIL SCI PLAN, V25, P407, DOI 10.1080/00103629409369047	39	2	2	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 15	2017	12	3							e0174057	10.1371/journal.pone.0174057	http://dx.doi.org/10.1371/journal.pone.0174057			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Arts &amp; Humanities Citation Index (A&amp;HCI)	Science & Technology - Other Topics	EN9HQ	28296963	Green Published, Green Submitted, gold			2022-12-27	WOS:000396311700090
J	Ledesma, JC; Aguilar, MA; Gimenez-Gomez, P; Minarro, J; Rodriguez-Arias, M				Carlos Ledesma, Juan; Aguilar, Maria A.; Gimenez-Gomez, Pablo; Minarro, Jose; Rodriguez-Arias, Marta			Adolescent but not adult ethanol binge drinking modulates cocaine withdrawal symptoms in mice	PLOS ONE			English	Article							PREPULSE INHIBITION; RECOGNITION MEMORY; GENE-EXPRESSION; ANXIETY-LIKE; EXPOSURE; RECEPTOR; DEPRESSION; STARTLE; ABUSE; RATS	Background Ethanol (EtOH) binge drinking is an increasingly common behavior among teenagers that induces long-lasting neurobehavioral alterations in adulthood. An early history of EtOH abuse during adolescence is highly correlated with cocaine addiction in adulthood. Abstinence of cocaine abuse can cause psychiatric symptoms, such as anxiety, psychosis, depression, and cognitive impairments. This study assessed the consequences of adolescent exposure to EtOH on the behavioral alterations promoted by cocaine withdrawal in adulthood. Methods We pretreated juvenile (34-47 days old) or adult (68-81 days old) mice with EtOH (1.25 g/ kg) following a binge-drinking pattern. Then, after a three-week period without drug delivery, they were subjected to a chronic cocaine treatment in adulthood and tested under cocaine withdrawal by the ensuing paradigms: open field, elevated plus maze, prepulse inhibition, tail suspension test, and object recognition. Another set of mice were treated with the same EtOH binge-drinking procedure during adolescence and were tested immediately afterwards under the same behavioral paradigms. Results Adolescent EtOH pretreatment undermined the anxiogenic effects observed after cocaine abstinence, reduced prepulse inhibition, and increased immobility scores in the tail suspension test following cocaine withdrawal. Moreover, the memory deficits evoked by these substances when given separately were enhanced in cocaine-withdrawn mice exposed to EtOH during adolescence. EtOH binge drinking during adolescence also induced anxiety, depressive symptoms, and memory impairments when measured immediately afterwards. In contrast, neither EtOH nor cocaine alone or in combination altered any of these behaviors when given in adulthood. Conclusions EtOH binge drinking induces short- and long-term behavioral alterations and modulates cocaine withdrawal symptoms when given in adolescent mice.	[Carlos Ledesma, Juan; Aguilar, Maria A.; Gimenez-Gomez, Pablo; Minarro, Jose; Rodriguez-Arias, Marta] Univ Valencia, Dept Psicobiol, Valencia, Spain	University of Valencia	Ledesma, JC (corresponding author), Univ Valencia, Dept Psicobiol, Avda Blasco Ibanez 21, Valencia, Spain.	juan.ledesma@uv.es	Aguilar, Maria A/D-3416-2011; Ledesma, Juan Carlos/AAA-2722-2019; Gimenez Gomez, Pablo/AFV-9002-2022; Ledesma, Juan/AAC-1058-2019; Minarro, Jose/B-4414-2011; Rodriguez-Arias, Marta/B-5163-2011	Aguilar, Maria A/0000-0002-1935-6619; Ledesma, Juan/0000-0001-6372-2842; Minarro, Jose/0000-0002-5731-7821; Gimenez Gomez, Pablo/0000-0002-9404-4615	Ministerio de Economia y Competitividad (MINECO); Direccion General de Investigacion [PSI2014-51847-R]; Institute de Salud Carlos III; Red de Trastornos Adictivos (RTA) [RD12/0028/ 0005]; RD12/0028/ 0005; Union Europea; Fondos FEDER "una manera de hacer Europa"; Generalitat Valenciana; Conselleria de Educacion [PROMETE011/2014/063]; European Foundation for Alcohol Research (ERAB) [EA1308]; Conselleria d'Educacio, Investigacio, Cultura i Esport [APOSTD/2016/147]; Generalitat Valenciana, Spain	Ministerio de Economia y Competitividad (MINECO)(Spanish Government); Direccion General de Investigacion(Spanish Government); Institute de Salud Carlos III(Instituto de Salud Carlos III); Red de Trastornos Adictivos (RTA); RD12/0028/ 0005; Union Europea; Fondos FEDER "una manera de hacer Europa"; Generalitat Valenciana(Center for Forestry Research & Experimentation (CIEF)European Commission); Conselleria de Educacion; European Foundation for Alcohol Research (ERAB); Conselleria d'Educacio, Investigacio, Cultura i Esport; Generalitat Valenciana, Spain(Center for Forestry Research & Experimentation (CIEF))	This work was supported by grants from Ministerio de Economia y Competitividad (MINECO), Direccion General de Investigacion, PSI2014-51847-R, Institute de Salud Carlos III, Red de Trastornos Adictivos (RTA) RD12/0028/ 0005; Union Europea, Fondos FEDER "una manera de hacer Europa"; Generalitat Valenciana, Conselleria de Educacion, PROMETE011/2014/063; and The European Foundation for Alcohol Research (ERAB), EA1308. Juan Carlos Ledesma was supported by a postdoctoral fellowship from the Conselleria d'Educacio, Investigacio, Cultura i Esport (APOSTD/2016/147), Generalitat Valenciana, Spain. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This work was supported by grants from Ministerio de Economia y Competitividad (MINECO), Direccion General de Investigacion, PSI2014-51847-R, Instituto de Salud Carlos III, Red de Trastornos Adictivos (RTA) RD12/0028/0005; Union Europea, Fondos FEDER "una manera de hacer Europa"; Generalitat Valenciana, Conselleria de Educacion, PROME-TEOII/2014/063; and The European Foundation for Alcohol Research (ERAB), EA1308. Juan Carlos Ledesma was supported by a postdoctoral fellowship from the Conselleria d'Educacio, Investigacio, Cultura i Esport (APOSTD/2016/147), Generalitat Valenciana, Spain. We wish to thank Mark Andrews for his English language editing of the manuscript. The author(s) are entirely responsible for the scientific content of the paper.	Adams JU, 2001, PHARMACOL BIOCHEM BE, V68, P753, DOI 10.1016/S0091-3057(01)00478-6; Alves CJ, 2014, NEUROSCIENCE, V277, P343, DOI 10.1016/j.neuroscience.2014.07.008; [Anonymous], 2015, EUR DRUG REP TRENDS; Arias F, 2013, REV PSIQUIATR SALUD, V6, P121, DOI 10.1016/j.rpsm.2012.09.002; Arias F, 2013, ACTAS ESP PSIQUIATRI, V41, P122; Black YD, 2006, J NEUROSCI, V26, P9656, DOI 10.1523/JNEUROSCI.2391-06.2006; Briand LA, 2008, NEUROSCIENCE, V155, P1, DOI 10.1016/j.neuroscience.2008.06.004; Briones TL, 2013, NEUROSCIENCE, V254, P324, DOI 10.1016/j.neuroscience.2013.09.031; Broadbent NJ, 2004, P NATL ACAD SCI USA, V101, P14515, DOI 10.1073/pnas.0406344101; Campos AC, 2013, REV BRAS PSIQUIATR, V35, pS101, DOI 10.1590/1516-4446-2013-1139; Ledesma JC, 2013, PSYCHOPHARMACOLOGY, V226, P673, DOI 10.1007/s00213-012-2831-9; Chartoff E, 2012, NEUROPHARMACOLOGY, V62, P167, DOI 10.1016/j.neuropharm.2011.06.014; Coleman LG, 2011, ALCOHOL CLIN EXP RES, V35, P671, DOI 10.1111/j.1530-0277.2010.01385.x; Craige CP, 2015, NEUROPHARMACOLOGY, V93, P41, DOI 10.1016/j.neuropharm.2015.01.021; Cryan JF, 2005, NEUROSCI BIOBEHAV R, V29, P571, DOI 10.1016/j.neubiorev.2005.03.009; Dalley JW, 2005, PSYCHOPHARMACOLOGY, V182, P579, DOI 10.1007/s00213-005-0107-3; Cito MDD, 2012, BEHAV BRAIN RES, V231, P116, DOI 10.1016/j.bbr.2012.01.056; Degenhardt L, 2013, BMJ OPEN, V3, DOI 10.1136/bmjopen-2013-003015; Deroche-Gamonet V, 2014, NEUROPHARMACOLOGY, V76, P437, DOI 10.1016/j.neuropharm.2013.07.014; El Hage C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043535; ENNACEUR A, 1988, BEHAV BRAIN RES, V31, P47, DOI 10.1016/0166-4328(88)90157-X; Escarabajal MD, 2003, PSYCHOPHARMACOLOGY, V167, P130, DOI 10.1007/s00213-003-1427-9; ESTUDES, 2013, INF ENC EST US DROG; Fendt M, 2013, CELL TISSUE RES, V354, P287, DOI 10.1007/s00441-013-1599-5; Filip M, 2013, PHARMACOL REP, V65, P1529, DOI 10.1016/S1734-1140(13)71514-7; Forbes A, 2013, ALCOHOL, V47, P95, DOI 10.1016/j.alcohol.2012.12.007; Garcia-Moreno LM, 2012, ALCOHOL, V46, P757, DOI 10.1016/j.alcohol.2012.08.001; Georgiou P, 2016, EUR J NEUROSCI, V44, P2446, DOI 10.1111/ejn.13348; Geyer MA, 2002, MOL PSYCHIATR, V7, P1039, DOI 10.1038/sj.mp.4001159; Gobira PH, 2013, REV PSIQUIATR SALUD, P35; Grant BF, 1997, J SUBST ABUSE, V9, P103, DOI 10.1016/S0899-3289(97)90009-2; Guizzetti M, 2016, ALCOHOL CLIN EXP RES, V40, P1182, DOI 10.1111/acer.13072; Hage CE, 2012, PLOS ONE, V7; Hall BJ, 2010, NEUROSCI LETT, V474, P84, DOI 10.1016/j.neulet.2010.03.011; Kandel DB, 2006, ADDICTION, V101, P470, DOI 10.1111/j.1360-0443.2006.01426.x; Kandel D, 2015, ACTA PAEDIATR, V104, P130, DOI 10.1111/apa.12851; Kupferschmidt DA, 2012, NEUROSCIENCE, V204, P125, DOI 10.1016/j.neuroscience.2011.07.022; Kyzar EJ, 2016, FRONT NEUROSCI-SWITZ, V10, DOI 10.3389/fnins.2016.00222; Labouvie E, 1997, J STUD ALCOHOL, V58, P638, DOI 10.15288/jsa.1997.58.638; Laviola G, 2003, NEUROSCI BIOBEHAV R, V27, P19, DOI 10.1016/S0149-7634(03)00006-X; Lejuez CW, 2008, BEHAV RES THER, V46, P811, DOI 10.1016/j.brat.2008.03.010; Li L, 2009, NEUROSCI BIOBEHAV R, V33, P1157, DOI 10.1016/j.neubiorev.2009.02.001; Lynskey MT, 2003, JAMA-J AM MED ASSOC, V289, P427, DOI 10.1001/jama.289.4.427; Martinez ZA, 1999, PSYCHOPHARMACOLOGY, V142, P253, DOI 10.1007/s002130050887; Mateos-Garcia A, 2015, PSYCHOPHARMACOLOGY, V232, P101, DOI 10.1007/s00213-014-3642-y; Montagud-Romero S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092576; Montesinos J, 2016, BRAIN BEHAV IMMUN, V53, P159, DOI 10.1016/j.bbi.2015.12.006; Montesinos J, 2015, BRAIN BEHAV IMMUN, V45, P233, DOI 10.1016/j.bbi.2014.11.015; Morisot N, 2014, INT J NEUROPSYCHOPH, V17, P1969, DOI 10.1017/S1461145714000625; Murphy CA, 2001, PSYCHOPHARMACOLOGY, V156, P155, DOI 10.1007/s002130100759; Pandey SC, 2015, NEUROBIOL DIS, V82, P607, DOI 10.1016/j.nbd.2015.03.019; Pascual M, 2007, EUR J NEUROSCI, V25, P541, DOI 10.1111/j.1460-9568.2006.05298.x; Perrine SA, 2008, NEUROPHARMACOLOGY, V54, P355, DOI 10.1016/j.neuropharm.2007.10.007; Pollak DD, 2010, ANN MED, V42, P252, DOI 10.3109/07853891003769957; Powell Susan B, 2012, Curr Top Behav Neurosci, V12, P251, DOI 10.1007/7854_2011_195; Realini N, 2009, PHARMACOL RES, V60, P132, DOI 10.1016/j.phrs.2009.03.006; Rodriguez-Arias M, 2011, PSYCHOPHARMACOLOGY, V218, P429, DOI 10.1007/s00213-011-2329-x; Roger-Sanchez C, 2012, NEUROTOXICOL TERATOL, V34, P108, DOI 10.1016/j.ntt.2011.07.011; Sanchis-Segura C, 2009, NEUROPSYCHOPHARMACOL, V34, P2642, DOI 10.1038/npp.2009.125; Schaaffhausen Nicole Tatit von, 2009, Psychol. Neurosci., V2, P75, DOI 10.3922/j.psns.2009.1.11; Schoenbaum G, 2004, EUR J NEUROSCI, V19, P1997, DOI 10.1111/j.1460-9568.2004.03274.x; Skuza G, 2013, PHARMACOL REP, V65, P1681, DOI 10.1016/S1734-1140(13)71530-5; Sweeney FE, 2014, NEUROPHARMACOLOGY, V81, P303, DOI 10.1016/j.neuropharm.2013.08.039; Tang YL, 2014, J DUAL DIAGN, V10, P98, DOI 10.1080/15504263.2014.906133; Valsamis B, 2011, JOVE-J VIS EXP, DOI 10.3791/3446; Valzachi MC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078317; van den Buuse M, 2010, SCHIZOPHRENIA BULL, V36, P246, DOI 10.1093/schbul/sbp132; Vaugeois JM, 1997, PSYCHOPHARMACOLOGY, V134, P387, DOI 10.1007/s002130050475; Vidal-Infer A, 2012, BEHAV BRAIN FUNCT, V8, DOI 10.1186/1744-9081-8-32; WILCOX RR, 1987, ANNU REV PSYCHOL, V38, P29, DOI 10.1146/annurev.psych.38.1.29; Zilkha N, 2014, J NEUROCHEM, V130, P575, DOI 10.1111/jnc.12753	71	15	15	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 14	2017	12	3							e0172956	10.1371/journal.pone.0172956	http://dx.doi.org/10.1371/journal.pone.0172956			27	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN6DM	28291777	gold, Green Published, Green Submitted			2022-12-27	WOS:000396094700008
J	Huseinovic, A; van Leeuwen, JS; van Welsem, T; Stulemeijer, I; van Leeuwen, F; Vermeulen, NPE; Kooter, JM; Vos, JC				Huseinovic, Angelina; van Leeuwen, Jolanda S.; van Welsem, Tibor; Stulemeijer, Iris; van Leeuwen, Fred; Vermeulen, Nico P. E.; Kooter, Jan M.; Vos, J. Chris			The effect of acetaminophen on ubiquitin homeostasis in Saccharomyces cerevisiae	PLOS ONE			English	Article							ACUTE LIVER-FAILURE; TRANSLESION DNA-SYNTHESIS; LONG-TERM USE; POSTREPLICATION REPAIR; PROSPECTIVE VITAMINS; YEAST; RESISTANCE; TOXICITY; INJURY; RAD5	Acetaminophen (APAP), although considered a safe drug, is one of the major causes of acute liver failure by overdose, and therapeutic chronic use can cause serious health problems. Although the reactive APAP metabolite N-acetyl-p-benzoquinoneimine (NAPQI) is clearly linked to liver toxicity, toxicity of APAP is also found without drug metabolism of APAP to NAPQI. To get more insight into mechanisms of APAP toxicity, a genome-wide screen in Saccharomyces cerevisiae for APAP-resistant deletion strains was performed. In this screen we identified genes related to the DNA damage response. Next, we investigated the link between genotype and APAP-induced toxicity or resistance by performing a more detailed screen with a library containing mutants of 1522 genes related to nuclear processes, like DNA repair and chromatin remodelling. We identified 233 strains that had an altered growth rate relative to wild type, of which 107 showed increased resistance to APAP and 126 showed increased sensitivity. Gene Ontology analysis identified ubiquitin homeostasis, regulation of transcription of RNA polymerase II genes, and the mitochondria-to-nucleus signalling pathway to be associated with APAP resistance, while histone exchange and modification, and vesicular transport were connected to APAP sensitivity. Indeed, we observed a link between ubiquitin levels and APAP resistance, whereby ubiquitin deficiency conferred resistance to APAP toxicity while ubiquitin overexpression resulted in sensitivity. The toxicity profile of various chemicals, APAP, and its positional isomer AMAP on a series of deletion strains with ubiquitin deficiency showed a unique resistance pattern for APAP. Furthermore, exposure to APAP increased the level of free ubiquitin and influenced the ubiquitination of proteins. Together, these results uncover a role for ubiquitin homeostasis in APAP-induced toxicity.	[Huseinovic, Angelina; Vermeulen, Nico P. E.; Vos, J. Chris] Vrije Univ Amsterdam, AIMMS Div Mol Toxicol, Dept Chem & Pharmaceut Sci, Amsterdam, Netherlands; [van Leeuwen, Jolanda S.] Univ Toronto, Donnelly Ctr Cellular & Biomol Res, Toronto, ON, Canada; [van Welsem, Tibor; Stulemeijer, Iris; van Leeuwen, Fred] Netherlands Canc Inst, Div Gene Regulat, Amsterdam, Netherlands; [Kooter, Jan M.] Vrije Univ Amsterdam, Genet Sect, AIMMS Dept Mol Cell Biol, Amsterdam, Netherlands	Vrije Universiteit Amsterdam; University of Toronto; Netherlands Cancer Institute; Vrije Universiteit Amsterdam	Vos, JC (corresponding author), Vrije Univ Amsterdam, AIMMS Div Mol Toxicol, Dept Chem & Pharmaceut Sci, Amsterdam, Netherlands.	j.c.vos@vu.nl	van Leeuwen, Fred/A-7698-2010	van Leeuwen, Fred/0000-0002-7267-7251; van Leeuwen, Jolanda/0000-0003-3991-518X; Vermeulen, Nico P.E./0000-0003-4194-6401; Vos, J. Chris/0000-0003-3737-9942	AIM MS, the Amsterdam Institute for Molecules, Medicines and Systems, Bridging PhD project [10-001-204]	AIM MS, the Amsterdam Institute for Molecules, Medicines and Systems, Bridging PhD project	This research was supported by AIM MS, the Amsterdam Institute for Molecules, Medicines and Systems, Bridging PhD project 10-001-204.	Andersen PL, 2008, CELL RES, V18, P162, DOI 10.1038/cr.2007.114; Bernal W, 2010, LANCET, V376, P190, DOI 10.1016/S0140-6736(10)60274-7; Carpenter AE, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-10-r100; Chen JJ, 2011, CELL BIOCHEM BIOPHYS, V60, P47, DOI 10.1007/s12013-011-9187-3; Chernova TA, 2003, J BIOL CHEM, V278, P52102, DOI 10.1074/jbc.M310283200; Chun LJ, 2009, J CLIN GASTROENTEROL, V43, P342, DOI 10.1097/MCG.0b013e31818a3854; Conrad M, 2014, FEMS MICROBIOL REV, V38, P254, DOI 10.1111/1574-6976.12065; Dargan PI, 2001, EMERG MED J, V18, P178, DOI 10.1136/emj.18.3.178; dos Santos Sandra C., 2012, Frontiers in Genetics, V3, P63, DOI 10.3389/fgene.2012.00063; dos Santos SC, 2011, MOL GENET GENOMICS, V286, P333, DOI 10.1007/s00438-011-0649-5; FINLEY D, 1987, CELL, V48, P1035, DOI 10.1016/0092-8674(87)90711-2; Finley D, 2012, GENETICS, V192, P319, DOI 10.1534/genetics.112.140467; Gangavarapu V, 2006, MOL CELL BIOL, V26, P7783, DOI 10.1128/MCB.01260-06; Giannattasio M, 2005, J BIOL CHEM, V280, P9879, DOI 10.1074/jbc.M414453200; Groothuis TAM, 2006, CELL DIV, V1, DOI 10.1186/1747-1028-1-21; Halas A, 2011, MOL MICROBIOL, V80, P786, DOI 10.1111/j.1365-2958.2011.07610.x; Hanna J, 2003, MOL CELL BIOL, V23, P9251, DOI 10.1128/MCB.23.24.9251-9261.2003; Henderson AJ, 2013, PAEDIATR RESPIR REV, V14, P9, DOI 10.1016/j.prrv.2012.04.004; Hicke L, 1999, TRENDS CELL BIOL, V9, P107, DOI 10.1016/S0962-8924(98)01491-3; Hillenmeyer ME, 2008, SCIENCE, V320, P362, DOI 10.1126/science.1150021; Hoege C, 2002, NATURE, V419, P135, DOI 10.1038/nature00991; Huang RY, 2005, CANCER RES, V65, P5890, DOI 10.1158/0008-5472.CAN-04-4093; Jensen KG, 1996, PHARMACOL TOXICOL, V78, P224, DOI 10.1111/j.1600-0773.1996.tb00209.x; Jones TR, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-482; Kato H, 2014, INTERNAL MED, V53, P1531, DOI 10.2169/internalmedicine.53.1502; Khawaja A, 2012, J PAK MED ASSOC, V62, P524; Kim EJ, 2014, ASIA PAC ALLERGY, V4, P68, DOI 10.5415/apallergy.2014.4.1.68; KLEBE RJ, 1983, GENE, V25, P333, DOI 10.1016/0378-1119(83)90238-X; Komander D, 2012, ANNU REV BIOCHEM, V81, P203, DOI 10.1146/annurev-biochem-060310-170328; Laine JE, 2009, XENOBIOTICA, V39, P11, DOI [10.1080/00498250802512830, 10.1080/00498250802512830 ]; Lamprecht MR, 2007, BIOTECHNIQUES, V42, P71, DOI 10.2144/000112257; Larson AM, 2005, HEPATOLOGY, V42, P1364, DOI 10.1002/hep.20948; Lauwers E, 2010, TRENDS CELL BIOL, V20, P196, DOI 10.1016/j.tcb.2010.01.004; Lee AY, 2014, SCIENCE, V344, P208, DOI 10.1126/science.1250217; Liew Z, 2014, JAMA PEDIATR, V168, P313, DOI 10.1001/jamapediatrics.2013.4914; Lis ET, 2006, MOL CELL BIOL, V26, P4122, DOI 10.1128/MCB.01640-05; Magasanik B, 2002, GENE, V290, P1, DOI 10.1016/S0378-1119(02)00558-9; McConkey SE, 2009, J VET PHARMACOL THER, V32, P585, DOI 10.1111/j.1365-2885.2009.01080.x; Michaut A, 2014, LIVER INT, V34, pE171, DOI 10.1111/liv.12514; Miettinen TP, 2014, MOL PHARMACEUT, V11, P4395, DOI 10.1021/mp5004866; Miyakawa K, 2015, J PHARMACOL EXP THER, V354, P230, DOI 10.1124/jpet.115.223537; Rando OJ, 2012, GENETICS, V190, P351, DOI 10.1534/genetics.111.132266; Schuldiner M, 2005, CELL, V123, P507, DOI 10.1016/j.cell.2005.08.031; Srikanth CV, 2005, MICROBIOL-SGM, V151, P99, DOI 10.1099/mic.0.27374-0; Srivas R, 2013, CELL REP, V5, P1714, DOI 10.1016/j.celrep.2013.11.035; Swaminathan S, 1999, MOL BIOL CELL, V10, P2583, DOI 10.1091/mbc.10.8.2583; Torres-Ramos CA, 2002, MOL CELL BIOL, V22, P2419, DOI 10.1128/MCB.22.7.2419-2426.2002; Unk I, 2010, DNA REPAIR, V9, P257, DOI 10.1016/j.dnarep.2009.12.013; van Leeuwen JS, 2012, CURR DRUG METAB, V13, P1464; van Leeuwen JS, 2011, MICROBIOL-SGM, V157, P685, DOI 10.1099/mic.0.044578-0; Walter RB, 2011, CANCER EPIDEM BIOMAR, V20, P2637, DOI 10.1158/1055-9965.EPI-11-0709; Walter RB, 2011, J CLIN ONCOL, V29, P2424, DOI 10.1200/JCO.2011.34.6346; Wright AP, YEAST, V5, P51; Xie YC, 2015, TOXICOL APPL PHARM, V289, P213, DOI 10.1016/j.taap.2015.09.022; Zhou X, 2009, GENOMICS, V94, P294, DOI 10.1016/j.ygeno.2009.07.003	55	4	4	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 14	2017	12	3							e0173573	10.1371/journal.pone.0173573	http://dx.doi.org/10.1371/journal.pone.0173573			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN6DM	28291796	Green Published, gold, Green Submitted			2022-12-27	WOS:000396094700032
J	Ju, SM; Yin, NN; Wang, LP; Zhang, CY; Wang, YK				Ju, Shuming; Yin, Ningning; Wang, Liping; Zhang, Cuiying; Wang, Yukun			Effects of silicon on Oryza sativa L. seedling roots under simulated acid rain stress	PLOS ONE			English	Article							ZEA-MAYS L.; CHLOROPHYLL FLUORESCENCE; LIPID-PEROXIDATION; OXIDATIVE STRESS; HEAVY-METALS; GROWTH; RICE; ACCUMULATION; GERMINATION; RESPONSES	Silicon (Si) has an important function in reducing the damage of environmental stress on plants. Acid rain is a serious abiotic stress factor, and Si can alleviate the stress induced by acid rain on plants. Based on these assumptions, we investigated the effects of silicon on the growth, root phenotype, mineral element contents, hydrogen peroxide (H2O2) and antioxidative enzymes of rice (Oryza sativa L.) seedling roots under simulated acid rain (SAR) stress. The results showed that the combined or single effects of Si and/or SAR on rice roots depend on the concentration of Si and the pH of the SAR. The combined or single effects of a low or moderate concentration of Si (1.0 or 2.0 mM) and light SAR (pH 4.0) enhanced the growth of rice roots, and the combined effects were stronger than those of the single treatment. A high concentration of Si (4.0 mM) or severe SAR (pH 2.0) exerted deleterious effects. The incorporation of Si (1.0, 2.0 or 4.0 mM) into SAR with pH 3.0 or 2.0 promoted the rice root growth, decreased the H2O2 content, increased the Si concentration and the superoxide dismutase (SOD), catalase (CAT), peroxidase (POD) and ascorbate peroxidase (APX) activities, maintained the balance of mineral element (K, Ca, Mg, Fe, Zn, and Cu) concentrations in the roots of rice seedlings compared with SAR alone. The alleviatory effects observed with a moderate concentration of Si (2.0 mM) were better than the effects obtained with a low or high concentration of Si (1.0 or 4.0 mM). The observed effects were due to disruptions in the absorption and utilization of mineral nutrients and impacts on the activity of antioxidant enzymes in roots, and this conclusion suggests that the degree of rice root damage caused by acid rain might be attributed to not only acid rain but also the level of Si in the soil.	[Ju, Shuming; Yin, Ningning; Wang, Liping; Zhang, Cuiying] China Univ Min & Technol, Sch Environm & Spatial Informat, Xuzhou, Jiangsu, Peoples R China; [Ju, Shuming; Zhang, Cuiying; Wang, Yukun] Xuzhou Inst Technol, Xuzhou, Jiangsu, Peoples R China	China University of Mining & Technology; Xuzhou University of Technology	Wang, LP (corresponding author), China Univ Min & Technol, Sch Environm & Spatial Informat, Xuzhou, Jiangsu, Peoples R China.	qusm2010@163.com	Wang, Yukun/GRJ-5930-2022		National spark plan project [S2013C100537, 2015GA690089]; Program of Environmental Science and Technology of Jiangsu Province [2007024]	National spark plan project; Program of Environmental Science and Technology of Jiangsu Province	This work was supported by National spark plan project (S2013C100537, 2015GA690089) and The Program of Environmental Science and Technology of Jiangsu Province (No.2007024). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This work was supported by the National Spark Plan Project (Nos. S2013C100537 and 2015GA690089) and the Programme of Environmental Science and Technology of Jiangsu Province (No. 2007024).	Abbasi Tasneem, 2013, International Journal of Environmental Engineering, V5, P229, DOI 10.1504/IJEE.2013.054703; Azevedo MM, 2007, SCI TOTAL ENVIRON, V377, P233, DOI 10.1016/j.scitotenv.2007.02.027; Bai LP, 2006, PEDOSPHERE, V16, P326, DOI 10.1016/S1002-0160(06)60059-3; Bashkin V. N., 2003, J ENV STUD, V60, P205, DOI [10.1080/00207230290015711, DOI 10.1080/00207230290015711]; Datnoff LE, 1997, CROP PROT, V16, P525, DOI 10.1016/S0261-2194(97)00033-1; Detmann KC, 2012, NEW PHYTOL, V196, P752, DOI 10.1111/j.1469-8137.2012.04299.x; Dias APL, 2011, ENVIRON POLLUT, V159, P458, DOI 10.1016/j.envpol.2010.10.020; EPSTEIN E, 1994, P NATL ACAD SCI USA, V91, P11, DOI 10.1073/pnas.91.1.11; Epstein E, 1999, ANNU REV PLANT PHYS, V50, P641, DOI 10.1146/annurev.arplant.50.1.641; Fageria NK, 2011, ADV AGRON, V110, P251, DOI 10.1016/B978-0-12-385531-2.00004-9; Fallah A., 2012, International Journal of AgriScience, V2, P630; Fan HB, 2000, FOREST ECOL MANAG, V126, P321, DOI 10.1016/S0378-1127(99)00103-6; Forino LMC, 2012, J HAZARD MATER, V235, P271, DOI 10.1016/j.jhazmat.2012.07.051; Foy C.D., 1992, ADV SOIL SCI, P97, DOI DOI 10.1007/978-1-4612-2894-3_5; Garg N, 2009, PLANT BIOSYST, V143, P81, DOI 10.1080/11263500802633626; Gauci V, 2008, J GEOPHYS RES-BIOGEO, V113, DOI 10.1029/2007JG000501; Gill SS, 2010, PLANT PHYSIOL BIOCH, V48, P909, DOI 10.1016/j.plaphy.2010.08.016; Gunes A, 2007, PLANT SOIL, V290, P103, DOI 10.1007/s11104-006-9137-9; Guntzer F, 2012, AGRON SUSTAIN DEV, V32, P201, DOI 10.1007/s13593-011-0039-8; Guo W, 2005, PLANT SOIL, V272, P173, DOI 10.1007/s11104-004-4732-0; HARTE J, 1983, ATMOS ENVIRON, V17, P403, DOI 10.1016/0004-6981(83)90058-6; Hermans C, 2005, J EXP BOT, V56, P2153, DOI 10.1093/jxb/eri215; Hong FS, 2003, BIOL TRACE ELEM RES, V94, P273, DOI 10.1385/BTER:94:3:273; Hosono Tatsuo, 1994, Journal of Agricultural Meteorology, V50, P121, DOI 10.2480/agrmet.50.121; [金鑫 Jin Xin], 2015, [环境监测管理与技术, The Administration and Technique of Environmental Monitoring], V27, P65; Koricheva J, 1997, ENVIRON POLLUT, V95, P249, DOI 10.1016/S0269-7491(96)00071-1; Kuzniak E, 1999, PLANT SCI, V148, P69, DOI 10.1016/S0168-9452(99)00121-1; Lamppu J, 2003, ENVIRON POLLUT, V122, P119, DOI 10.1016/S0269-7491(02)00274-9; Larssen T, 2006, ENVIRON SCI TECHNOL, V40, P418, DOI 10.1021/es0626133; Li TQ, 2009, J HAZARD MATER, V169, P734, DOI 10.1016/j.jhazmat.2009.04.004; Liang J, 2008, THESIS; Liang YC, 2005, CHEMOSPHERE, V58, P475, DOI 10.1016/j.chemosphere.2004.09.034; Liang YC, 1999, PLANT SOIL, V209, P217, DOI 10.1023/A:1004526604913; Liang YC, 2007, ENVIRON POLLUT, V147, P422, DOI 10.1016/j.envpol.2006.06.008; Liu MH, 2015, PHOTOSYNTHETICA, V53, P23, DOI 10.1007/s11099-015-0071-z; Liu TW, 2011, TREE PHYSIOL, V31, P402, DOI 10.1093/treephys/tpr019; [罗璇 Luo Xuan], 2013, [地球与环境, Earth and Environment], V41, P566; Ma J.F., 2002, SOIL FERTILIZER PLAN; Ma JF, 2004, SOIL SCI PLANT NUTR, V50, P11, DOI 10.1080/00380768.2004.10408447; Maathuis FJM, 2009, CURR OPIN PLANT BIOL, V12, P250, DOI 10.1016/j.pbi.2009.04.003; Marschner H., 1995, MARSCHNERS MINERAL N, DOI DOI 10.1016/B978-0-12-473542-2.X5000-7; Menz FC, 2004, ENVIRON SCI POLICY, V7, P253, DOI 10.1016/j.envsci.2004.05.005; Nagajyoti PC, 2010, ENVIRON CHEM LETT, V8, P199, DOI 10.1007/s10311-010-0297-8; NAKANO Y, 1981, PLANT CELL PHYSIOL, V22, P867; Esposito JBN, 2015, ENVIRON SCI POLLUT R, V22, P5315, DOI 10.1007/s11356-014-3951-z; Odiyi B. O., 2014, Journal of Agricultural Science (Toronto), V6, P96; Peng Q, 2009, BIOL TRACE ELEM RES, V127, P69, DOI 10.1007/s12011-008-8218-4; Perry CC, 2003, REV MINERAL GEOCHEM, V54, P291, DOI 10.2113/0540291; Rebitanim NA., 2015, INT J AGRON AGR RES, V6, P71; Reddy ASN, 2011, PLANT CELL, V23, P2010, DOI 10.1105/tpc.111.084988; Richmond KE, 2003, CURR OPIN PLANT BIOL, V6, P268, DOI 10.1016/S1369-5266(03)00041-4; Rodrigues F. A., 2005, Fitopatologia Brasileira, V30, P457, DOI 10.1590/S0100-41582005000500001; Sahebi M, 2015, BIOMED RES INT, V2015, DOI 10.1155/2015/396010; Sajedi Nour Ali, 2011, Physiology and Molecular Biology of Plants, V17, P215, DOI 10.1007/s12298-011-0067-5; Shi GR, 2010, PLANT GROWTH REGUL, V61, P45, DOI 10.1007/s10725-010-9447-z; Singh A, 2008, J ENVIRON BIOL, V29, P15; Sivanesan I, 2014, SCI WORLD J, DOI 10.1155/2014/521703; Song AL, 2016, SCI REP-UK, V6, DOI 10.1038/srep24640; State Environmental Protection Administration of China, 2005, ENV PROT, V6, P11; Sun ZG, 2013, CHEMOSPHERE, V93, P344, DOI 10.1016/j.chemosphere.2013.04.089; Taiz L., 2018, FUNDAMENTALS PLANT P; TAKAHASHI MA, 1983, ARCH BIOCHEM BIOPHYS, V226, P558, DOI 10.1016/0003-9861(83)90325-9; Vaculik M, 2012, ANN BOT-LONDON, V110, P433, DOI 10.1093/aob/mcs039; Vaculik M, 2012, ENVIRON POLLUT, V163, P117, DOI 10.1016/j.envpol.2011.12.031; Wailes EJ, 2010, ARKANSAS GLOBAL RICE, P1; Wang CY, 2010, SCI TOTAL ENVIRON, V408, P2706, DOI 10.1016/j.scitotenv.2010.03.023; Wang LH, 2010, SEED SCI TECHNOL, V38, P26, DOI 10.15258/sst.2010.38.1.03; Wang LH, 2008, CHEMOSPHERE, V73, P314, DOI 10.1016/j.chemosphere.2008.06.004; Wattanapayapkul W., 2011, INDIAN J PLANT PATHO, V5, P134; WELCH RM, 1995, CRIT REV PLANT SCI, V14, P49, DOI 10.1080/713608066; Wen KJ, 2011, CHEMOSPHERE, V84, P601, DOI 10.1016/j.chemosphere.2011.03.054; Winslow MD, 1997, PLANT SOIL, V188, P239, DOI 10.1023/A:1004298817861; Wu C, 2016, CHEMOSPHERE, V165, P478, DOI 10.1016/j.chemosphere.2016.09.061; Wu C, 2016, ENVIRON POLLUT, V212, P27, DOI 10.1016/j.envpol.2016.01.004; Wu C, 2015, CHEMOSPHERE, V138, P447, DOI 10.1016/j.chemosphere.2015.06.081; Wyrwicka A, 2006, ENVIRON EXP BOT, V56, P198, DOI 10.1016/j.envexpbot.2005.02.003; Wyrwicka A, 2014, ACTA PHYSIOL PLANT, V36, P837, DOI 10.1007/s11738-013-1462-z; Ye J, 2012, ENVIRON POLLUT, V162, P369, DOI 10.1016/j.envpol.2011.12.002; Yoshida S., 1976, LAB MANUAL PHYSL STU; Yu JQ, 2002, PHOTOSYNTHETICA, V40, P331, DOI 10.1023/A:1022658504882; Zabawi AGM, 2008, J TROP AGR FOOD SCI, V36; Zhang XY, 2010, J PLANT PHYSIOL, V167, P88, DOI 10.1016/j.jplph.2009.07.006; Zhang XX, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0138820; Zhu ZJ, 2004, PLANT SCI, V167, P527, DOI 10.1016/j.plantsci.2004.04.020	84	30	31	2	80	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 14	2017	12	3							e0173378	10.1371/journal.pone.0173378	http://dx.doi.org/10.1371/journal.pone.0173378			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN6DM	28291806	gold, Green Submitted, Green Published			2022-12-27	WOS:000396094700022
J	Xue, Q; Zhang, GX; Li, TT; Ling, JJ; Zhang, XQ; Wang, JY				Xue, Qian; Zhang, Genxi; Li, Tingting; Ling, Jiaojiao; Zhang, Xiangqian; Wang, Jinyu			Transcriptomic profile of leg muscle during early growth in chicken	PLOS ONE			English	Article							GENOME-WIDE ASSOCIATION; SKELETAL-MUSCLE; GENE-EXPRESSION; CELL-PROLIFERATION; TIGHT JUNCTIONS; MESSENGER-RNA; FACTOR FOXO3A; BETA-ACTIN; IGF-I; TRAITS	The early growth pattern, especially the age of peak growth, of broilers affects the time to market and slaughter weight, which in turn affect the profitability of the poultry industry. However, the underlying mechanisms regulating chicken growth and development have rarely been studied. This study aimed to identify candidate genes involved in chicken growth and investigated the potential regulatory mechanisms of early growth in chicken. RNA sequencing was applied to compare the transcriptomes of chicken muscle tissues at three developmental stages during early growth. In total, 978 differentially expressed genes (DEGs) (fold change >= 2; false discovery rate < 0.05) were detected by pairwise comparison. Functional analysis showed that the DEGs are mainly involved in the processes of cell growth, muscle development, and cellular activities (such as junction, migration, assembly, differentiation, and proliferation). Many of the DEGs are well known to be related to chicken growth, such as MYOD1, GH, IGF2BP2, IGFBP3, SMYD1, CEBPB, FGF2, and IGFBP5. KEGG pathway analysis identified that the DEGs were significantly enriched in five pathways (P < 0.1) related to growth and development: extracellular matrix-receptor interaction, focal adhesion, tight junction, insulin signaling pathway, and regulation of the actin cytoskeleton. A total of 42 DEGs assigned to these pathways are potential candidate genes inducing the difference in growth among the three developmental stages, such as MYH10, FGF2, FGF16, FN1, CFL2, MAPK9, IRS1, PHKA1, PHKB, and PHKG1. Thus, our study identified a series of genes and several pathways that may participate in the regulation of early growth in chicken. These results should serve as an important resource revealing the molecular basis of chicken growth and development.	[Xue, Qian; Zhang, Genxi; Li, Tingting; Ling, Jiaojiao; Zhang, Xiangqian; Wang, Jinyu] Yangzhou Univ, Coll Anim Sci & Technol, Yangzhou, Jiangsu, Peoples R China; [Xue, Qian; Zhang, Genxi; Li, Tingting; Ling, Jiaojiao; Zhang, Xiangqian; Wang, Jinyu] Key Lab Anim Genet Breeding Reprod & Mol Design J, Yangzhou, Jiangsu, Peoples R China	Yangzhou University	Wang, JY (corresponding author), Yangzhou Univ, Coll Anim Sci & Technol, Yangzhou, Jiangsu, Peoples R China.	zgx1588@126.com; jywang@yzu.edu.cn			National Broiler Industrial and Technology System [nycytx-42-G1-05]; Priority Academic Program Development of Jiangsu Higher Education Institutions	National Broiler Industrial and Technology System; Priority Academic Program Development of Jiangsu Higher Education Institutions	This work was supported by the National Broiler Industrial and Technology System: nycytx-42-G1-05 and the Priority Academic Program Development of Jiangsu Higher Education Institutions. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anders S, 2013, EMBL, V35, P345; Ayers KL, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-3-r26; Ayuso M, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0145162; Bages S, 2015, GENE, V561, P82, DOI 10.1016/j.gene.2015.02.016; Baldwin KM, 2001, J APPL PHYSIOL, V90, P345, DOI 10.1152/jappl.2001.90.1.345; Beenken A, 2009, NAT REV DRUG DISCOV, V8, P235, DOI 10.1038/nrd2792; Blum R, 2014, J CELL BIOCHEM, V115, P1855, DOI 10.1002/jcb.24854; Bodine SC, 2001, SCIENCE, V294, P1704, DOI 10.1126/science.1065874; Chen Bo, 2014, ScientificWorldJournal, V2014, P807620, DOI 10.1155/2014/807620; Chen HL, 2011, ENRGY PROCED, V11, P2723, DOI 10.1016/j.egypro.2011.10.601; Citi S, 1998, BBA-MOL CELL RES, V1448, P1, DOI 10.1016/S0167-4889(98)00125-6; Cleveland BM, 2010, COMP BIOCHEM PHYS B, V157, P248, DOI 10.1016/j.cbpb.2010.06.010; Cui TX, 2011, MOL ENDOCRINOL, V25, P681, DOI 10.1210/me.2010-0232; Das Singh NM, 2015, INDIAN J ANIM SCI, V85, P104; Davis TA, 2008, JOURNAL OF ANIMAL SC, V86, P13; Evdokimova V, 2012, SCI SIGNAL, V5, DOI 10.1126/scisignal.2003184; Fawzy IO, 2016, GROWTH FACTORS, V34, P42, DOI 10.3109/08977194.2016.1169532; FELDMAN B, 1995, SCIENCE, V267, P246, DOI 10.1126/science.7809630; Fisher MC, 2005, BONE, V37, P741, DOI 10.1016/j.bone.2005.07.024; Ghosh M, 2016, BMC GENET, V17, DOI 10.1186/s12863-016-0341-1; Glare EM, 2002, THORAX, V57, P765, DOI 10.1136/thorax.57.9.765; Goldberg V, 2015, J ANIM SCI, V93, P4285, DOI 10.2527/jas.2015-9208; Gonzalez-Mariscal L, 2008, BBA-BIOMEMBRANES, V1778, P729, DOI 10.1016/j.bbamem.2007.08.018; Gonzalez-Mariscal L, 2007, PROG HISTOCHEM CYTO, V42, P1, DOI 10.1016/j.proghi.2007.01.001; Hall A, 1998, SCIENCE, V279, P509, DOI 10.1126/science.279.5350.509; Hansen KD, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkq224; Hartsock A, 2008, BBA-BIOMEMBRANES, V1778, P660, DOI 10.1016/j.bbamem.2007.07.012; Hartung H, 1997, MECH DEVELOP, V64, P31, DOI 10.1016/S0925-4773(97)00042-7; Hellemans J, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-2-r19; Heng MCY, 2000, BRIT J DERMATOL, V143, P937, DOI 10.1046/j.1365-2133.2000.03767.x; Hertz L, 2007, J CEREBR BLOOD F MET, V27, P219, DOI 10.1038/sj.jcbfm.9600343; Hirono H, 1995, BIOCHEM MOL BIOL INT, V36, P505; Hwa V, 1999, ENDOCR REV, V20, P761, DOI 10.1210/er.20.6.761; Jackman RW, 2004, AM J PHYSIOL-CELL PH, V287, pC834, DOI 10.1152/ajpcell.00579.2003; Jiang CD, 2010, INT J BIOL SCI, V6, P627, DOI 10.7150/ijbs.6.627; Kanehisa M, 2008, NUCLEIC ACIDS RES, V36, pD480, DOI 10.1093/nar/gkm882; Kops GJPL, 2002, NATURE, V419, P316, DOI 10.1038/nature01036; KUSHMERICK MJ, 1992, P NATL ACAD SCI USA, V89, P7521, DOI 10.1073/pnas.89.16.7521; Lagirand-Cantaloube J, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004973; Laing NG, 2009, HUM MUTAT, V30, P1267, DOI 10.1002/humu.21059; Laukkanen O, 2004, DIABETOLOGIA, V47, P871, DOI 10.1007/s00125-004-1395-6; Lee SH, 2010, MOL CELLS, V29, P311, DOI 10.1007/s10059-010-0053-8; Lee YC, 2011, J BIOL CHEM, V286, P17898, DOI 10.1074/jbc.M111.231035; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Louis M, 2004, FEBS LETT, V557, P243, DOI 10.1016/S0014-5793(03)01504-7; Lu FZ, 2008, POULTRY SCI, V87, P2087, DOI 10.3382/ps.2007-00493; Ma XF, 2014, CIRC-CARDIOVASC GENE, V7, P257, DOI 10.1161/CIRCGENETICS.113.000455; Marchildon F, 2012, STEM CELLS, V30, P2619, DOI 10.1002/stem.1248; Medema RH, 2000, NATURE, V404, P782, DOI 10.1038/35008115; MOHAN S, 1995, J BIOL CHEM, V270, P20424, DOI 10.1074/jbc.270.35.20424; Mutz KO, 2013, CURR OPIN BIOTECH, V24, P22, DOI 10.1016/j.copbio.2012.09.004; Myers KR, 2008, TRENDS CELL BIOL, V18, P184, DOI 10.1016/j.tcb.2008.02.002; Nadeau OW, 2012, J BIOL CHEM, V287, P36651, DOI 10.1074/jbc.M112.412874; Piorkowska K, 2016, ANIM GENET, V47, P68, DOI 10.1111/age.12388; Raballo R, 2000, J NEUROSCI, V20, P5012; Rehfeldt C, 2000, LIVEST PROD SCI, V66, P177, DOI 10.1016/S0301-6226(00)00225-6; ROBBINS J, 1986, J BIOL CHEM, V261, P6606; Romer LH, 2006, CIRC RES, V98, P606, DOI 10.1161/01.RES.0000207408.31270.db; Ropka-Molik K, 2011, GENE EXPR PATTERNS, V11, P79, DOI 10.1016/j.gep.2010.09.005; Saltiel AR, 2002, TRENDS CELL BIOL, V12, P65, DOI 10.1016/S0962-8924(01)02207-3; Sanchez AMJ, 2014, CELL MOL LIFE SCI, V71, P1657, DOI 10.1007/s00018-013-1513-z; Sandri M, 2004, CELL, V117, P399, DOI 10.1016/S0092-8674(04)00400-3; Schedlich LJ, 1998, J BIOL CHEM, V273, P18347, DOI 10.1074/jbc.273.29.18347; Shen L, 2011, ANNU REV PHYSIOL, V73, P283, DOI 10.1146/annurev-physiol-012110-142150; Singh NMD, 2015, INDIAN JOURNAL OF AN, V85, P36; Soslow RA, 2000, CANCER, V89, P2637, DOI 10.1002/1097-0142(20001215)89:12<2637::AID-CNCR17>3.0.CO;2-B; Tang Y, 2014, MOL BIOL REP, V41, P6837, DOI 10.1007/s11033-014-3569-8; Tholon P, 2009, CIENC RURAL, V39, P2261, DOI 10.1590/S0103-84782009000700050; Thomas K, 2015, CONNECT TISSUE RES, V56, P1, DOI 10.3109/03008207.2014.947369; Tran H, 2002, SCIENCE, V296, P530, DOI 10.1126/science.1068712; Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034; Veloso RC, 2015, ARQ BRAS MED VET ZOO, V67, P1361, DOI 10.1590/1678-4162-6816; Wang JY, 2013, THE SELECTION OF JIN; Wang WH, 2016, POULTRY SCI, V95, P500, DOI 10.3382/ps/pev266; Warr MR, 2013, NATURE, V494, P323, DOI 10.1038/nature11895; Wiper-Bergeron N, 2007, P NATL ACAD SCI USA, V104, P2703, DOI 10.1073/pnas.0607378104; Xu HG, 2013, MOL BIOL REP, V40, P2565, DOI 10.1007/s11033-012-2342-0; Ye MH, 2016, G3-GENES GENOM GENET, V6, P2081, DOI 10.1534/g3.116.029793; Yu HF, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0143001; Yuping GU, 2010, CHINA POULTRY, V20, P27; Zhang GX, 2015, GENET MOL RES, V14, P15331, DOI 10.4238/2015.November.30.10; Zhang GX, 2014, MOL BIOL REP, V41, P7331, DOI 10.1007/s11033-014-3619-2; Zhong H, 1999, BIOCHEM BIOPH RES CO, V259, P523, DOI 10.1006/bbrc.1999.0815	83	45	47	1	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 14	2017	12	3							e0173824	10.1371/journal.pone.0173824	http://dx.doi.org/10.1371/journal.pone.0173824			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN6DM	28291821	Green Published, gold, Green Submitted			2022-12-27	WOS:000396094700044
J	Alford, A; Krupke, CH				Alford, Adam; Krupke, Christian H.			Translocation of the neonicotinoid seed treatment clothianidin in maize	PLOS ONE			English	Article							MAGGOT DIPTERA; CORN GROWTH; COLEOPTERA; PESTICIDE; RESIDUES; THIAMETHOXAM; INSECTICIDES; DETECTIONS; EXPOSURE; ADJACENT	Neonicotinoid seed treatments, typically clothianidin or thiamethoxam, are routinely applied to >80% of maize (corn) seed grown in North America where they are marketed as a targeted pesticide delivery system. Despite this widespread use, the amount of compound translocated into plant tissue from the initial seed treatment to provide protection has not been reported. Our two year field study compared concentrations of clothianidin seed treatments in maize to that of maize without neonicotinoid seed treatments and found neonicotinoids present in root tissues up to 34 days post planting. Plant-bound clothianidin concentrations followed an exponential decay pattern with initially high values followed by a rapid decrease within the first similar to 20 days post planting. A maximum of 1.34% of the initial seed treatment was successfully recovered from plant tissues in both study years and a maximum of 0.26% was recovered from root tissue. Our findings show neonicotinoid seed treatments may provide protection from some early season secondary maize pests. However, the proportion of the neonicotinoid seed treatment clothianidin translocated into plant tissues throughout the growing season is low overall and this observation may provide a mechanism to explain reports of inconsistent efficacy of this pest management approach and increasing detections of environmental neonicotinoids.	[Alford, Adam; Krupke, Christian H.] Purdue Univ, Dept Entomol, W Lafayette, IN 47907 USA	Purdue University System; Purdue University; Purdue University West Lafayette Campus	Alford, A (corresponding author), Purdue Univ, Dept Entomol, W Lafayette, IN 47907 USA.	AdamMAlford@gmail.com		Alford, Adam/0000-0002-4035-1396	Purdue Research Foundation	Purdue Research Foundation	This research was funded by the Purdue Research Foundation.The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anastassiades M, 2003, J AOAC INT, V86, P412; Anderson TA, 2013, CHEMOSPHERE, V92, P84, DOI 10.1016/j.chemosphere.2013.02.054; [Anonymous], 2015, VERSION 9 4 M3; Bledsoe L, 2010, EXTENSION PUBLICATIO, VE-49-W; BONMATIN JM, 2005, ENV CHEM PP, P00483; Botias C, 2015, ENVIRON SCI TECHNOL, V49, P12731, DOI 10.1021/acs.est.5b03459; Brunson AM, 1959, EXTENSION CIRCULAR N, P1; Cook K, 2004, PROCEEDINGS ILLINOIS; Cox WJ, 2007, CROP SCI, V47, P2482, DOI 10.2135/cropsci2006.12.0810; DeLorenzo ME, 2012, ENVIRON MONIT ASSESS, V184, P343, DOI 10.1007/s10661-011-1972-3; Douglas MR, 2015, ENVIRON SCI TECHNOL, V49, P5088, DOI 10.1021/es506141g; Elbert A, 2008, PEST MANAG SCI, V64, P1099, DOI 10.1002/ps.1616; Elzhov TV, PACKAGE MINPACK LM V; Gassmann AJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022629; Gotelli NJ, 2013, ECOSIMR 1 00; Goulson D, 2013, J APPL ECOL, V50, P977, DOI 10.1111/1365-2664.12111; GUSTAFSON DI, 1989, ENVIRON TOXICOL CHEM, V8, P339, DOI 10.1897/1552-8618(1989)8[339:GUSASM]2.0.CO;2; Hallmann CA, 2014, NATURE, V511, P341, DOI 10.1038/nature13531; HAMMOND R B, 1990, Environmental Entomology, V19, P510; HIGLEY LG, 1984, ENVIRON ENTOMOL, V13, P1436; Hilton MJ, 2016, PEST MANAG SCI, V72, P388, DOI 10.1002/ps.4024; Hladik ML, 2014, ENVIRON POLLUT, V193, P189, DOI 10.1016/j.envpol.2014.06.033; HOKKANEN HMT, 1991, ANNU REV ENTOMOL, V36, P119, DOI 10.1146/annurev.en.36.010191.001003; Huseth AS, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0097081; Jeschke P, 2008, PEST MANAG SCI, V64, P1084, DOI 10.1002/ps.1631; Jeschke P, 2011, J AGR FOOD CHEM, V59, P2897, DOI 10.1021/jf101303g; Jordan TA, 2012, CROP PROT, V39, P57, DOI 10.1016/j.cropro.2012.04.006; Krupke CH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029268; Long EY, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms11629; Ma BL, 2009, FIELD CROP RES, V111, P189, DOI 10.1016/j.fcr.2008.12.006; Main AR, 2015, ENVIRON SCI TECHNOL, V49, P8367, DOI 10.1021/acs.est.5b01287; Metcalf RL, 1993, DESTRUCTIVE AND USEF; Mogren CL, 2016, SCI REP-UK, V6, DOI 10.1038/srep29608; Myers C, 2014, BENEFITS OF NEONICOT; Myresiotis CK, 2015, PEST MANAG SCI, V71, P1258, DOI 10.1002/ps.3919; NOSE K, 1987, J PESTIC SCI, V12, P505; Oleson JD, 2005, J ECON ENTOMOL, V98, P1, DOI 10.1603/0022-0493-98.1.1; Pedigo LP., 2009, ENTOMOLOGY PEST MANA; Pollack P., 2011, FINE CHEMICALS THE I; Purdue University Agricultural Communication, 2015, EXTENSION PUBLICATIO; R Core Team, 2016, R A LANGUAGE AND ENV; RILEY TJ, 1979, ANN ENTOMOL SOC AM, V72, P408, DOI 10.1093/aesa/72.3.408; ROUCHAUD J, 1994, B ENVIRON CONTAM TOX, V53, P344, DOI 10.1007/BF00197224; SANBORN SM, 1982, ANN ENTOMOL SOC AM, V75, P103, DOI 10.1093/aesa/75.1.103; Sanchez-Bayo F, 2014, CHEMOSPHERE, V99, P143, DOI 10.1016/j.chemosphere.2013.10.051; Seagraves MP, 2012, J PEST SCI, V85, P125, DOI 10.1007/s10340-011-0374-1; Starner K, 2012, B ENVIRON CONTAM TOX, V88, P316, DOI 10.1007/s00128-011-0515-5; Storer NP, 2006, J ECON ENTOMOL, V99, P1381, DOI 10.1603/0022-0493-99.4.1381; Studebaker G., 2007, ECHNICAL REPORT FOR, P11; Sur R, 2002, B INSECTOL, V56, P35; United States Environmental Protection Agency, 2010, ENVIRONMENTAL FATE A; USDA (US Department of Agriculture), 2014, USITC PUBL, VAC-12-A-51; Van Dijk TC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062374; Vijver MG, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089837; Wilde G, 2007, J AGR URBAN ENTOMOL, V24, P177, DOI 10.3954/1523-5475-24.4.177; Xue YG, 2015, ENVIRON SCI TECHNOL, V49, P13003, DOI 10.1021/acs.est.5b03753; YOUNGMAN RR, 1993, ENVIRON ENTOMOL, V22, P1251, DOI 10.1093/ee/22.6.1251; [No title captured]	58	63	65	5	57	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 10	2017	12	3							e0173836	10.1371/journal.pone.0173836	http://dx.doi.org/10.1371/journal.pone.0173836			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN6CJ	28282441	Green Published, gold, Green Submitted			2022-12-27	WOS:000396091800083
J	Domino, M; Pawlinski, B; Gajewski, Z				Domino, Malgorzata; Pawlinski, Bartosz; Gajewski, Zdzislaw			Biomathematical pattern of EMG signal propagation in smooth muscle of the nonpregnant porcine uterus	PLOS ONE			English	Article							CAJAL-LIKE CELLS; UTERINE CONTRACTILITY; ELECTRICAL-ACTIVITY; HUMAN MYOMETRIUM; ELECTROMYOGRAPHY; LABOR; PREGNANCY; VELOCITY; SOWS; RAT	Uterine contractions are generated by myometrial smooth muscle cells (SMCs) that comprise most of the myometrial layer of the uterine wall. Aberrant uterine motility (i.e., hypo-or hyper-contractility or asynchronous contractions) has been implicated in the pathogenesis of infertility due to the failure of implantation, endometriosis and abnormal estrous cycles. The mechanism whereby the non-pregnant uterus initiates spontaneous contractions remains poorly understood. The aim of the present study was to employ linear synchronization measures for analyzing the pattern of EMG signal propagation (direction and speed) in smooth muscles of the non-pregnant porcine uterus in vivo using telemetry recording system. It has been revealed that the EMG signal conduction in the uterine wall of the non-pregnant sow does not occur at random but it rather exhibits specific directions and speed. All detectable EMG signals moved along the uterine horn in both cervico-tubal and tubo-cervical directions. The signal migration speed could be divided into the three main types or categories: i. slow basic migration rhythm (SBMR); ii. rapid basic migration rhythm (RBMR); and iii. rapid accessory migration rhythm (RAMR). In conclusion, the EMG signal propagation in smooth muscles of the porcine uterus in vivo can be assessed using a linear synchronization model. Physiological pattern of the uterine contractile activity determined in this study provides a basis for future investigations of normal and pathologicall myogenic function of the uterus.	[Gajewski, Zdzislaw] Warsaw Univ Life Sci WULS SGGW, Fac Vet Med, Vet Res Ctr, Dept Large Anim Dis Clin, Warsaw, Poland; Warsaw Univ Life Sci WULS SGGW, Fac Vet Med, Ctr Biomed Res, Warsaw, Poland	Warsaw University of Life Sciences; Warsaw University of Life Sciences	Gajewski, Z (corresponding author), Warsaw Univ Life Sci WULS SGGW, Fac Vet Med, Vet Res Ctr, Dept Large Anim Dis Clin, Warsaw, Poland.	zgajewski@supermedia.pl	Domino, Malgorzata/Y-9574-2018; Pawlinski, Bartosz/O-3852-2018; Gajewski, Zdzislaw/N-1481-2016	Domino, Malgorzata/0000-0001-9436-1074; Pawlinski, Bartosz/0000-0002-2307-8922; Gajewski, Zdzislaw/0000-0001-8779-5050	State Committee for Research Investigation [NN308 077439]; EFRR RPO WM	State Committee for Research Investigation; EFRR RPO WM	This work was supported by the State Committee for Research Investigation grant NN308 077439, Narodowe Centrum Nauki, https://www.ncn.gov.pl/. This work was conducted in the Veterinary Research Centre WULS (WCB) and the Center for Biomedical Research (CBB) supported by EFRR RPO WM 2007-2013. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.r This work was conducted in the Veterinary Research Centre WULS (WCB) and the Center for Biomedical Research (CBB) supported by EFRR RPO WM 2007-2013.	Aguilar HN, 2010, HUM REPROD UPDATE, V16, P725, DOI 10.1093/humupd/dmq016; Alkan A, 2012, EXPERT SYST APPL, V39, P44, DOI 10.1016/j.eswa.2011.06.043; Bower RE., 1974, THESIS, P117; Bozler E, 1938, AM J PHYSIOL, V124, P502, DOI 10.1152/ajplegacy.1938.124.2.502; Bursztyn L, 2007, AM J PHYSIOL-CELL PH, V292, pC1816, DOI 10.1152/ajpcell.00478.2006; Ciontea SM, 2005, J CELL MOL MED, V9, P407, DOI 10.1111/j.1582-4934.2005.tb00366.x; Cochran AL, 2015, MATH MECH SOLIDS, V20, P540, DOI 10.1177/1081286513507940; Cretoiu D, 2006, J CELL MOL MED, V10, P789, DOI 10.1111/j.1582-4934.2006.tb00438.x; DEVEDEUX D, 1993, AM J OBSTET GYNECOL, V169, P1636, DOI 10.1016/0002-9378(93)90456-S; Dodds KN, 2015, BIOL REPROD, V92, DOI 10.1095/biolreprod.115.129809; Domino M, 2016, THERIOGENOLOGY; GAJEWSKI Z, 2004, REPROD DOMEST ANIM, V1, P41; GAJEWSKI Z, 2001, NEWSLETTER 5 ESDAR V, V1, P36; Gajewski Z, 2003, P 6 C ESDAR DUBL, V1, P4; GARFIELD RE, 1977, SCIENCE, V198, P958, DOI 10.1126/science.929182; Garfield RE, 2002, J SOC GYNECOL INVEST, V9, P265, DOI 10.1016/S1071-5576(02)00173-9; Garfield RE, 2007, SEMIN CELL DEV BIOL, V18, P289, DOI 10.1016/j.semcdb.2007.05.004; Govindan RB, 2015, REPROD SCI, V22, P595, DOI 10.1177/1933719114556484; Hassan M, 2013, IEEE T BIO-MED ENG, V60, P1160, DOI 10.1109/TBME.2012.2229279; Kilianczyk R, 2015, REPROD DOMEST ANIM, V50, P43; LAMMERS WJEP, 1994, AM J PHYSIOL-CELL PH, V267, pC1210, DOI 10.1152/ajpcell.1994.267.5.C1210; Lammers WJEP, 2011, AM J PHYSIOL-REG I, V294, pR919; Lange L, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086775; Langendijk P, 2005, THERIOGENOLOGY, V63, P500, DOI 10.1016/j.theriogenology.2004.09.027; Langendijk P, 2002, THERIOGENOLOGY, V57, P1563, DOI 10.1016/S0093-691X(02)00657-X; Lucovnik M, 2011, AM J OBSTET GYNECOL, V204, DOI 10.1016/j.ajog.2010.09.024; Maggio CD, 2012, B MATH BIOL, V74, P143, DOI 10.1007/s11538-011-9681-1; Mikkelsen E, 2013, ACTA OBSTET GYN SCAN, V92, P1070, DOI 10.1111/aogs.12190; MILLER SM, 1989, AM J PHYSIOL, V256, pC130, DOI 10.1152/ajpcell.1989.256.1.C130; Muthuswamy J, 1998, J NEUROSCI METH, V83, P1, DOI 10.1016/S0165-0270(98)00065-X; Oczeretko E, 2007, ANN NY ACAD SCI, V1101, P49, DOI 10.1196/annals.1389.007; Pereda E, 2005, PROG NEUROBIOL, V77, P1, DOI 10.1016/j.pneurobio.2005.10.003; Popescu LM, 2007, ANN NY ACAD SCI, V1101, P139, DOI 10.1196/annals.1389.022; Rabotti C, 2015, ACTA PHYSIOL, V213, P406, DOI 10.1111/apha.12424; Rabotti C, 2010, IEEE ENG MED BIO, P4262, DOI 10.1109/IEMBS.2010.5627172; Rabotti C, 2010, IEEE T BIO-MED ENG, V57, P2178, DOI 10.1109/TBME.2010.2049111; Sharifimajd B, 2016, BIOMECH MODEL MECHAN, V15, P497, DOI 10.1007/s10237-015-0703-z; Tong WC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018685; Wray S, 2003, J SOC GYNECOL INVEST, V10, P252, DOI 10.1016/S1071-5576(03)00089-3; Young RC, 2014, PLOS COMPUT BIOL, V10, DOI 10.1371/journal.pcbi.1003850; Young RC, 2011, REPROD SCI, V18, P64, DOI 10.1177/1933719110379637; Zerobin K, 1972, Adv Vet Sci Comp Med, V16, P303	42	8	8	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 10	2017	12	3							e0173452	10.1371/journal.pone.0173452	http://dx.doi.org/10.1371/journal.pone.0173452			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN6CJ	28282410	Green Published, gold, Green Submitted			2022-12-27	WOS:000396091800041
J	Goudey, B; Abraham, G; Kikianty, E; Wang, Q; Rawlinson, D; Shi, F; Haviv, I; Stern, L; Kowalczyk, A; Inouye, M				Goudey, Benjamin; Abraham, Gad; Kikianty, Eder; Wang, Qiao; Rawlinson, Dave; Shi, Fan; Haviv, Izhak; Stern, Linda; Kowalczyk, Adam; Inouye, Michael			Interactions within the MHC contribute to the genetic architecture of celiac disease	PLOS ONE			English	Article							GENOME-WIDE ASSOCIATION; MISSING HERITABILITY; EPISTATIC INTERACTIONS; GYNECOLOGICAL HISTORY; SUSCEPTIBILITY LOCI; FEMALE FERTILITY; COMPLEX DISEASES; MULTIPLE COMMON; RISK VARIANTS; MUTATION	Interaction analysis of GWAS can detect signal that would be ignored by single variant analysis, yet few robust interactions in humans have been detected. Recent work has highlighted interactions in the MHC region between known HLA risk haplotypes for various autoimmune diseases. To better understand the genetic interactions underlying celiac disease (CD), we have conducted exhaustive genome-wide scans for pairwise interactions in five independent CD case-control studies, using a rapid model-free approach to examine over 500 billion SNP pairs in total. We found 14 independent interaction signals within the MHC region that achieved stringent replication criteria across multiple studies and were independent of known CD risk HLA haplotypes. The strongest independent CD interaction signal corresponded to genes in the HLA class III region, in particular PRRC2A and GPANK1/C6orf47, which are known to contain variants for non-Hodgkin's lymphoma and early menopause, co-morbidities of celiac disease. Replicable evidence for statistical interaction outside the MHC was not observed. Both within and between European populations, we observed striking consistency of two-locus models and model distribution. Within the UK population, models of CD based on both interactions and additive single-SNP effects increased explained CD variance by approximately 1% over those of single SNPs. The interactions signal detected across the five cohorts indicates the presence of novel associations in the MHC region that cannot be detected using additive models. Our findings have implications for the determination of genetic architecture and, by extension, the use of human genetics for validation of therapeutic targets.	[Goudey, Benjamin; Wang, Qiao; Rawlinson, Dave; Shi, Fan; Kowalczyk, Adam] Univ Melbourne, NICTA Victoria Res Lab, Parkville, Vic, Australia; [Goudey, Benjamin; Wang, Qiao; Rawlinson, Dave; Shi, Fan; Stern, Linda; Kowalczyk, Adam] Univ Melbourne, Ctr Epidemiol & Biostat, Parkville, Vic, Australia; [Goudey, Benjamin] Univ Melbourne, Dept Comp & Informat Syst, Parkville, Vic, Australia; [Goudey, Benjamin] IBM Res, Level 5, Carlton, Vic, Australia; [Abraham, Gad; Inouye, Michael] Univ Melbourne, Ctr Syst Genom, Parkville, Vic, Australia; [Abraham, Gad; Inouye, Michael] Univ Melbourne, Sch BioSci, Parkville, Vic, Australia; [Abraham, Gad; Inouye, Michael] Univ Melbourne, Dept Pathol, Parkville, Vic, Australia; [Kikianty, Eder] Univ Johannesburg, Dept Math, Auckland Pk, South Africa; [Haviv, Izhak] Bar Ilan Univ, Fac Med, Safed, Israel; [Kowalczyk, Adam] Univ Melbourne, Ctr Neural Engn, Parkville, Vic, Australia	University of Melbourne; University of Melbourne; University of Melbourne; University of Melbourne; University of Melbourne; University of Melbourne; University of Johannesburg; Bar Ilan University; University of Melbourne	Inouye, M (corresponding author), Univ Melbourne, Ctr Syst Genom, Parkville, Vic, Australia.; Inouye, M (corresponding author), Univ Melbourne, Sch BioSci, Parkville, Vic, Australia.; Inouye, M (corresponding author), Univ Melbourne, Dept Pathol, Parkville, Vic, Australia.	minouye@unimelb.edu.au	Haviv, Izhak/E-3782-2015; Goudey, Benjamin/AAA-8492-2022	Haviv, Izhak/0000-0002-0837-5005; Goudey, Benjamin/0000-0002-2318-985X; Abraham, Gad/0000-0003-4853-0118; Inouye, Michael/0000-0001-9413-6520; Kikianty, Eder/0000-0003-4355-0339	Career Development Fellowship; Australian NHMRC and Heart Foundation [1061435]; NHMRC Peter Doherty Early Career Fellowship [1090462]; University of Melbourne; IBM Research Australia; National ICT Australia (NICTA)	Career Development Fellowship; Australian NHMRC and Heart Foundation(National Health and Medical Research Council (NHMRC) of Australia); NHMRC Peter Doherty Early Career Fellowship(National Health and Medical Research Council (NHMRC) of Australia); University of Melbourne(University of Melbourne); IBM Research Australia(International Business Machines (IBM)); National ICT Australia (NICTA)(NICTA)	MI was supported by a Career Development Fellowship co-funded by the Australian NHMRC and Heart Foundation (#1061435). GA was supported by an NHMRC Peter Doherty Early Career Fellowship (#1090462). MI and GA were also supported by University of Melbourne funding. BG was supported by IBM Research Australia. BG, EK, QW, DR, FS, IH and AK were supported by National ICT Australia (NICTA). The funders provided support in the form of salaries for authors BG, EK, QW, DR, FS, IH and AK, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Abraham G, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004137; Abraham G, 2013, GENET EPIDEMIOL, V37, P184, DOI 10.1002/gepi.21698; Abraham G, 2012, BMC BIOINFORMATICS, V13, DOI 10.1186/1471-2105-13-88; Ahn R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036926; Barrett JC, 2009, NAT GENET, V41, P703, DOI 10.1038/ng.381; Cordell HJ, 2009, NAT REV GENET, V10, P392, DOI 10.1038/nrg2579; Cordell HJ, 2002, HUM MOL GENET, V11, P2463, DOI 10.1093/hmg/11.20.2463; Delaneau O, 2012, NAT METHODS, V9, P179, DOI [10.1038/NMETH.1785, 10.1038/nmeth.1785]; Dubois PCA, 2010, NAT GENET, V42, P295, DOI 10.1038/ng.543; Eichler EE, 2010, NAT REV GENET, V11, P446, DOI 10.1038/nrg2809; Evans DM, 2011, NAT GENET, V43, P761, DOI 10.1038/ng.873; Garner CP, 2009, HUM MOL GENET, V18, P4219, DOI 10.1093/hmg/ddp364; Garner C, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0101428; Goudey B, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-S3-S10; Hemani G, 2014, NATURE, V508, P249, DOI 10.1038/nature13005; Hemani G, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003295; Hemani G, 2011, BIOINFORMATICS, V27, P1462, DOI 10.1093/bioinformatics/btr172; HILL WG, 1975, THEOR POPUL BIOL, V8, P117, DOI 10.1016/0040-5809(75)90028-3; Hill WG, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000008; Howie BN, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000529; Hu XH, 2010, CELL RES, V20, P854, DOI 10.1038/cr.2010.68; Hu XL, 2015, NAT GENET, V47, P898, DOI 10.1038/ng.3353; Hunt KA, 2008, NAT GENET, V40, P395, DOI 10.1038/ng.102; Hunt KA, 2013, NATURE, V498, P232, DOI 10.1038/nature12170; Huyghe JR, 2013, NAT GENET, V45, P197, DOI 10.1038/ng.2507; Jonsson T, 2012, NATURE, V488, P96, DOI 10.1038/nature11283; Kirino Y, 2013, NAT GENET, V45, P202, DOI 10.1038/ng.2520; Kiryluk K, 2014, NAT GENET, V46, P1187, DOI 10.1038/ng.3118; Lenz TL, 2015, NAT GENET, V47, P1085, DOI 10.1038/ng.3379; Li WT, 2000, HUM HERED, V50, P334, DOI 10.1159/000022939; Lincoln MR, 2009, P NATL ACAD SCI USA, V106, P7542, DOI 10.1073/pnas.0812664106; Liu Y, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1001338; Mackay TFC, 2014, NAT REV GENET, V15, P22, DOI 10.1038/nrg3627; Manolio TA, 2009, NATURE, V461, P747, DOI 10.1038/nature08494; Marchini J, 2005, NAT GENET, V37, P413, DOI 10.1038/ng1537; Mero IL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058352; Mitchison NA, 2011, EUR J IMMUNOL, V41, P2152, DOI 10.1002/eji.201141811; Moore JH, 2006, J THEOR BIOL, V241, P252, DOI 10.1016/j.jtbi.2005.11.036; NEUMAN RJ, 1992, GENET EPIDEMIOL, V9, P347, DOI 10.1002/gepi.1370090506; Nieters A, 2012, BLOOD, V120, P4645, DOI 10.1182/blood-2012-05-427989; Novembre J, 2008, NATURE, V456, P98, DOI 10.1038/nature07331; Ostensson M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070174; Phillips PC, 2008, NAT REV GENET, V9, P855, DOI 10.1038/nrg2452; Plenge RM, 2007, NEW ENGL J MED, V357, P1199, DOI 10.1056/NEJMoa073491; Plenge RM, 2013, NAT REV DRUG DISCOV, V12, P581, DOI 10.1038/nrd4051; Prabhu S, 2012, GENOME RES, V22, P2230, DOI 10.1101/gr.137885.112; Ritchie MD, 2001, AM J HUM GENET, V69, P138, DOI 10.1086/321276; Romanos J, 2014, GUT, V63, P415, DOI 10.1136/gutjnl-2012-304110; SHER KS, 1994, DIGESTION, V55, P243, DOI 10.1159/000201155; Sher KS, 1996, ACTA PAEDIATR, V85, P76, DOI 10.1111/j.1651-2227.1996.tb14258.x; Stolk L, 2012, NAT GENET, V44, P260, DOI 10.1038/ng.1051; Strange A, 2010, NAT GENET, V42, P985, DOI 10.1038/ng.694; Styrkarsdottir U, 2013, NATURE, V497, P517, DOI 10.1038/nature12124; Trynka G, 2011, NAT GENET, V43, P1193, DOI 10.1038/ng.998; van Heel DA, 2005, BEST PRACT RES CL GA, V19, P323, DOI 10.1016/j.bpg.2005.01.001; van Heel DA, 2007, NAT GENET, V39, P827, DOI 10.1038/ng2058; Wan XA, 2010, AM J HUM GENET, V87, P325, DOI 10.1016/j.ajhg.2010.07.021; Wei WH, 2014, HUM MOL GENET, V23, P5061, DOI 10.1093/hmg/ddu227; Wei WH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071203; Wood AR, 2014, NATURE, V514, pE3, DOI 10.1038/nature13691; Wray NR, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000864; Yu XQ, 2012, NAT GENET, V44, P178, DOI 10.1038/ng.1047; Zhang Y, 2007, NAT GENET, V39, P1167, DOI 10.1038/ng2110; Zheng X, 2014, PHARMACOGENOMICS J, V14, P192, DOI 10.1038/tpj.2013.18; Zuk O, 2012, P NATL ACAD SCI USA, V109, P1193, DOI 10.1073/pnas.1119675109; [No title captured]	66	10	10	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 10	2017	12	3							e0172826	10.1371/journal.pone.0172826	http://dx.doi.org/10.1371/journal.pone.0172826			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN6CJ	28282431	Green Published, gold			2022-12-27	WOS:000396091800013
J	Katagiri, R; Yuan, XY; Kobayashi, S; Sasaki, S				Katagiri, Ryoko; Yuan, Xiaoyi; Kobayashi, Satomi; Sasaki, Satoshi			Effect of excess iodine intake on thyroid diseases in different populations: A systematic review and meta-analyses including observational studies	PLOS ONE			English	Review							URINARY IODINE; SUBCLINICAL HYPOTHYROIDISM; ENDEMIC GOITER; PREGNANT-WOMEN; INDUCED HYPERTHYROIDISM; EPIDEMIOLOGIC SURVEY; HIGH PREVALENCE; HEBEI PROVINCE; DRINKING-WATER; FOLLOW-UP	Background Although several reports concerning the association of iodine excess and thyroid disease have appeared, no systematic review of the association between iodine excess intake and thyroid diseases, especially hyperthyroidism and hypothyroidism, has yet been reported. Method We conducted a systematic search of Ovid MEDLINE, PubMed, Cochrane Central Register of Controlled Trials databases, Ichushi-Web and CiNii database for intervention trials and observational studies. Search terms were constructed from related words for excess AND iodine intake or excretion AND thyroid hormones or diseases AND study designs. After considering the qualitative heterogeneity among studies, a meta-analysis was conducted and odds ratios and 95% confidence intervals (CI) were estimated in random-effects models. A protocol was registered with PROSPERO (No. CRD42015028081). Results 50 articles were included, including three intervention trials, six case-control studies, six follow-up studies and 35 cross-sectional studies. Three cross-sectional studies in adults included in meta-analysis. Odds ratio of overt and subclinical hypothyroidism between excess and adequate populations were 2.78 (CI: 1.47 to 5.27) and 2.03 (CI: 1.58 to 2.62) in adults, respectively. Source of excess iodine status was mainly iodized salt or water in included studies. Conclusion Although universal salt iodization has improved goiter rates, chronic exposure to excess iodine from water or poorly monitored salt are risk factors for hypothyroidism in free-living populations. Monitoring of both iodine concentration in salt as well as the iodine concentration in local drinking water are essential to preventing thyroid diseases. Hypothyroidism should be also carefully monitored in areas with excess iodine. Because of the low quality and limited number of included studies, further evidence and review are required.	[Katagiri, Ryoko; Sasaki, Satoshi] Univ Tokyo, Grad Sch Med, Dept Social & Prevent Epidemiol, Bunkyo Ku, Tokyo, Japan; [Yuan, Xiaoyi; Kobayashi, Satomi; Sasaki, Satoshi] Univ Tokyo, Sch Publ Hlth, Dept Social & Prevent Epidemiol, Bunkyo Ku, Tokyo, Japan	University of Tokyo; University of Tokyo	Sasaki, S (corresponding author), Univ Tokyo, Grad Sch Med, Dept Social & Prevent Epidemiol, Bunkyo Ku, Tokyo, Japan.	stssasak@m.u-tokyo.ac.jp		Kobayashi, Satomi/0000-0001-8798-8549				Aakre I, 2015, J TRACE ELEM MED BIO, V31, P61, DOI 10.1016/j.jtemb.2015.03.004; Alsanosy RMA, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-1006; Alsayed A, 2008, ENDOCR J, V55, P601, DOI 10.1507/endocrj.K07E-165; Andersson M, 2012, J NUTR, V142, P744, DOI 10.3945/jn.111.149393; Bimenya Gabriel S, 2002, Afr Health Sci, V2, P63; BOYAGES SC, 1989, CLIN ENDOCRINOL, V31, P453, DOI 10.1111/j.1365-2265.1989.tb01269.x; Burgi H, 2010, BEST PRACT RES CL EN, V24, P107, DOI 10.1016/j.beem.2009.08.010; Chen ZX, 2013, AM J CLIN NUTR, V98, P684, DOI 10.3945/ajcn.112.054353; Cho YY, 2016, EUR J NUTR, V55, P469, DOI 10.1007/s00394-015-0864-7; Chong Wei, 2005, Chinese Medical Sciences Journal, V20, P202; Chong W, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0135553; Dayan CM, 1996, NEW ENGL J MED, V335, P99, DOI 10.1056/NEJM199607113350206; Delange F, 1999, THYROID, V9, P545, DOI 10.1089/thy.1999.9.545; Du QX, 2013, ASIA-PAC J PUBLIC HE, V25, p36S, DOI 10.1177/1010539513493314; Du Y, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0111937; Duarte GC, 2009, J PEDIATR ENDOCR MET, V22, P327; Eng PHK, 1999, ENDOCRINOLOGY, V140, P3404, DOI 10.1210/en.140.8.3404; Fatourechi V, 2009, MAYO CLIN PROC, V84, P65, DOI 10.1016/S0025-6196(11)60809-4; Gao TS, 2004, CHINESE MED J-PEKING, V117, P1518; GARDNER DF, 1988, CLIN ENDOCRINOL, V28, P283, DOI 10.1111/j.1365-2265.1988.tb01214.x; Gomo ZAR, 1999, AM J CLIN NUTR, V70, P888; Habimana L, 2014, THYROID, V24, P568, DOI 10.1089/thy.2013.0261; Henjum S, 2012, PUBLIC HEALTH NUTR, V15, P1512, DOI 10.1017/S1368980011002886; Henjum S, 2010, PUBLIC HEALTH NUTR, V13, P1472, DOI 10.1017/S1368980010000650; HIGGINS JPT, 2011, COCHRANE HDB SYSTEMA, V0001; Higgins JPT, 2002, STAT MED, V21, P1539, DOI 10.1002/sim.1186; Hussein IS, 2012, PUBLIC HEALTH NUTR, V15, P2265, DOI 10.1017/S1368980012000833; Institute of Medicine, 2001, DIET REF INT VIT A V; Ishigaki K, 2001, ENDOCR J, V48, P591, DOI 10.1507/endocrj.48.591; Ishizuki Y, 1989, Nihon Naibunpi Gakkai Zasshi, V65, P91; Ishizuki Y, 1992, Nihon Naibunpi Gakkai Zasshi, V68, P550; Kassim IAR, 2014, J NUTR, V144, P375, DOI 10.3945/jn.113.176693; Kim JY, 2000, YONSEI MED J, V41, P22, DOI 10.3349/ymj.2000.41.1.22; Kim SY, 2013, J CLIN EPIDEMIOL, V66, P408, DOI 10.1016/j.jclinepi.2012.09.016; KONNO N, 1993, CLIN ENDOCRINOL, V38, P273, DOI 10.1111/j.1365-2265.1993.tb01006.x; Kotwal A, 2015, ARCH MED RES, V46, P490, DOI 10.1016/j.arcmed.2015.07.005; Laurberg P, 2010, BEST PRACT RES CL EN, V24, P13, DOI 10.1016/j.beem.2009.08.013; Leung AM, 2014, NAT REV ENDOCRINOL, V10, P136, DOI 10.1038/nrendo.2013.251; Li WH, 2012, NUTRITION, V28, P1142, DOI 10.1016/j.nut.2012.04.014; Lv SM, 2014, BRIT J NUTR, V111, P86, DOI 10.1017/S0007114513001906; Lv SM, 2012, PUBLIC HEALTH NUTR, V15, P1168, DOI 10.1017/S1368980012000146; Ma ZF, 2014, THYROID, V24, P1195, DOI 10.1089/thy.2014.0052; Medani AMMH, 2013, PUBLIC HEALTH NUTR, V16, P1586, DOI 10.1017/S1368980012004685; Montenegro-Bethancourt G, 2015, THYROID, V25, P688, DOI 10.1089/thy.2015.0006; NAMBA H, 1993, J CLIN ENDOCR METAB, V76, P605, DOI 10.1210/jc.76.3.605; Nepal AK, 2015, THYROID, V25, P851, DOI 10.1089/thy.2015.0153; Orito Y, 2009, J CLIN ENDOCR METAB, V94, P1683, DOI 10.1210/jc.2008-2111; Roti E, 2001, THYROID, V11, P493, DOI 10.1089/105072501300176453; Sang ZN, 2013, J NUTR, V143, P2038, DOI 10.3945/jn.113.179135; Sang ZN, 2012, J CLIN ENDOCR METAB, V97, pE1363, DOI 10.1210/jc.2011-3438; Sang ZN, 2012, AM J CLIN NUTR, V95, P367, DOI 10.3945/ajcn.111.028001; Seal AJ, 2006, PUBLIC HEALTH NUTR, V9, P35, DOI 10.1079/PHN2005830; Shakya Prem Raj, 2015, BMC Res Notes, V8, P374, DOI 10.1186/s13104-015-1359-6; Shen HM, 2011, BRIT J NUTR, V106, P243, DOI 10.1017/S0007114511000055; Shi XG, 2015, J CLIN ENDOCR METAB, V100, P1630, DOI 10.1210/jc.2014-3704; Stanbury JB, 1998, THYROID, V8, P83, DOI 10.1089/thy.1998.8.83; Szabolcs I, 1997, CLIN ENDOCRINOL, V47, P87, DOI 10.1046/j.1365-2265.1997.2271040.x; Tan L, 2015, PUBLIC HEALTH NUTR, V18, P1692, DOI 10.1017/S1368980014002237; Teng WP, 2006, NEW ENGL J MED, V354, P2783, DOI 10.1056/NEJMoa054022; Thomson CD, 2011, EUR J ENDOCRINOL, V165, P745, DOI 10.1530/EJE-11-0575; TODD CH, 1995, LANCET, V346, P1563, DOI 10.1016/S0140-6736(95)92095-1; TROWBRIDGE FL, 1975, PEDIATRICS, V56, P82; VAGENAKIS AG, 1972, NEW ENGL J MED, V287, P523, DOI 10.1056/NEJM197209142871101; VANDERPUMP MPJ, 1995, CLIN ENDOCRINOL, V43, P55, DOI 10.1111/j.1365-2265.1995.tb01894.x; Wang F, 2014, TUMOR BIOL, V35, P11375, DOI 10.1007/s13277-014-2397-8; Wang PH, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0141552; WOLFF J, 1948, J BIOL CHEM, V174, P555; World Health Organization, 2014, GUID FORT FOODGR SAL; World Health Organization, 2013, UR IOD CONC DET IOD; Yu X, 2008, J ENDOCRINOL INVEST, V31, P243, DOI 10.1007/BF03345597; Zhao JK, 2000, AM J PUBLIC HEALTH, V90, P1633, DOI 10.2105/AJPH.90.10.1633; Zimmermann MB, 2005, AM J CLIN NUTR, V81, P840, DOI 10.1093/ajcn/81.4.840; Zimmermann MB, 2013, J CLIN ENDOCR METAB, V98, P1271, DOI 10.1210/jc.2012-3952; Zou Y, 2014, EUR J PEDIATR, V173, P929, DOI 10.1007/s00431-014-2273-y	74	73	78	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 10	2017	12	3							e0173722	10.1371/journal.pone.0173722	http://dx.doi.org/10.1371/journal.pone.0173722			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN6CJ	28282437	gold, Green Submitted, Green Published			2022-12-27	WOS:000396091800073
J	Carney, KJ; Minton, MS; Holzer, KK; Miller, AW; McCann, LD; Ruiz, GM				Carney, Katharine J.; Minton, Mark S.; Holzer, Kimberly K.; Miller, A. Whitman; McCann, Linda D.; Ruiz, Gregory M.			Evaluating the combined effects of ballast water management and trade dynamics on transfers of marine organisms by ships	PLOS ONE			English	Article							PROPAGULE PRESSURE; COLONIZATION PRESSURE; MIDOCEAN EXCHANGE; INVASION ECOLOGY; OCEAN; TRANSPORT; ABUNDANCE; VECTOR; EFFICACY; PLANKTON	Global trade by merchant ships is a leading mechanism for the unintentional transfer of marine organisms, including non-indigenous species, to bays and estuaries worldwide. To reduce the likelihood of new invasions, ships are increasingly being required to manage their ballast water (BW) prior to discharge in coastal waters. In the United States, most overseas arrivals have been required to manage BW discharge since 2004, primarily through ballast water exchange (BWE), which flushes out ballast tanks in the open ocean (> 200 miles from shore). Studies have found BWE to generally reduce the abundance of organisms, and the amount of water exchanged has been estimated at 96-100%. Despite its widespread use, the overall effect of this management strategy on net propagule supply through time has not been explored. Here, temporal changes in zooplankton concentrations and the volume of BW discharged in Chesapeake Bay, U.S. were evaluated, comparing pre-management era and post-management era time periods. Chesapeake Bay is a large port system that receives extensive BW discharge, especially from bulk cargo vessels (bulkers) that export coal overseas. For bulkers arriving from overseas, mean zooplankton concentrations of total and coastal indicator taxa in BW did not decline between pre-(1993-2000) and post management (2012-2013) eras, when controlling for season and sampling method. Moreover, bulkers discharged 21 million tonnes (82% of total for Chesapeake Bay) of overseas BW in 2013, representing a 374% increase in volume when compared to 2005. The combination of BW discharge volume and zooplankton concentration data indicates that (a) net propagule supply by bulkers has increased since BWE began in Chesapeake Bay; and (b) changes in vessel behaviour and trade have contributed strongly to this outcome. Specifically, the coal-driven increase in BW discharge volume from 2005-2013, concurrent with the onset of BWE regulations, worked to counteract intended results from BW management. A long-term analysis of bulker arrivals (1994-2013) reveals a 20-year minimum in arrival numbers in 2000, just when the implementation of BWE began. This study underscores the need to consider shifts in trade patterns, in order to advance and evaluate effective management strategies for biological invasions.	[Carney, Katharine J.; Minton, Mark S.; Holzer, Kimberly K.; Miller, A. Whitman; Ruiz, Gregory M.] Smithsonian Environm Res Ctr, Marine Invas Res Lab, POB 28, Edgewater, MD 21037 USA; [McCann, Linda D.] Romberg Tiburon Ctr, Smithsonian Environm Res Ctr, Tiburon, CA USA	Smithsonian Institution; Smithsonian Environmental Research Center; Smithsonian Institution; Smithsonian Environmental Research Center	Carney, KJ (corresponding author), Smithsonian Environm Res Ctr, Marine Invas Res Lab, POB 28, Edgewater, MD 21037 USA.	carneyk@si.edu		Minton, Mark/0000-0002-9439-4930	United States Coast Guard	United States Coast Guard	Funding for this work was provided by the United States Coast Guard.	Albert RJ, 2013, ECOL APPL, V23, P289, DOI 10.1890/12-0669.1; [Anonymous], 2012, STAND LIV ORG SHIPS; Bailey SA, 2005, DIVERS DISTRIB, V11, P453, DOI 10.1111/j.1366-9516.2005.00150.x; Bax N, 2003, MAR POLICY, V27, P313, DOI 10.1016/S0308-597X(03)00041-1; Briski E, 2013, LIMNOL OCEANOGR, V58, P1361, DOI 10.4319/lo.2013.58.4.1361; Briski E, 2012, P ROY SOC B-BIOL SCI, V279, P2990, DOI 10.1098/rspb.2011.2671; Carlton J.T., 1995, ROLE SHIPPING INTRO; Carlton JT, 1996, BIOL CONSERV, V78, P97, DOI 10.1016/0006-3207(96)00020-1; CARLTON JT, 1985, OCEANOGR MAR BIOL, V23, P313; Clare Eno N., 1997, NONNATIVE MARINE SPE; Coyle KO, 2002, PROG OCEANOGR, V55, P177, DOI 10.1016/S0079-6611(02)00077-0; David M, 2007, MAR POLLUT BULL, V54, P53, DOI 10.1016/j.marpolbul.2006.08.041; Davidson IC, 2009, BIOFOULING, V25, P645, DOI 10.1080/08927010903046268; Dickman M, 1999, MAR ECOL PROG SER, V176, P253, DOI 10.3354/meps176253; Energy Information Administration (EIA), 2014, COAL DAT BROWS EXP Q; Federico G, 2016, TALE 2 GLOBALIZATION; Fofonoff Paul W., 2009, V204, P479; Gollasch S, 2000, J PLANKTON RES, V22, P923, DOI 10.1093/plankt/22.5.923; Gollasch S, 2000, INT REV HYDROBIOL, V85, P597, DOI 10.1002/1522-2632(200011)85:5/6<597::AID-IROH597>3.3.CO;2-W; Gray DK, 2007, LIMNOL OCEANOGR, V52, P2386, DOI 10.4319/lo.2007.52.6.2386; Hedge LH, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090621; Hewitt Chad L., 2009, V204, P117; Holzer KK, CHANGING ROLE UNPUB; IMO, 2004, INT CONV CONTR MAN S; Kang JH, 2010, MAR POLLUT BULL, V60, P230, DOI 10.1016/j.marpolbul.2009.09.021; Klein G, 2010, BIOL INVASIONS, V12, P1031, DOI 10.1007/s10530-009-9520-6; Lavoie DM, 1999, ESTUAR COAST SHELF S, V48, P551, DOI 10.1006/ecss.1999.0467; Levine JM, 2003, CONSERV BIOL, V17, P322, DOI 10.1046/j.1523-1739.2003.02038.x; Lockwood JL, 2009, DIVERS DISTRIB, V15, P904, DOI 10.1111/j.1472-4642.2009.00594.x; Mack HR, 2012, LIMNOL OCEANOGR-METH, V10, P41, DOI 10.4319/lom.2012.10.41; Mack RN, 2000, ECOL APPL, V10, P689, DOI 10.1890/1051-0761(2000)010[0689:BICEGC]2.0.CO;2; McCollin T, 2008, MAR POLLUT BULL, V56, P834, DOI 10.1016/j.marpolbul.2008.02.004; McCollin T, 2007, HARMFUL ALGAE, V6, P531, DOI 10.1016/j.hal.2006.04.015; Miller AW, 2011, BIOSCIENCE, V61, P880, DOI 10.1525/bio.2011.61.11.7; Miller AW, 2007, US COAST GUARD UNPUB, V33; Mineur F, 2007, MAR BIOL, V151, P1299, DOI 10.1007/s00227-006-0567-y; Minton MS, 2015, BIOLOGICAL INVASIONS IN CHANGING ECOSYSTEMS: VECTORS, ECOLOGICAL IMPACTS, MANAGEMENT AND PREDICTIONS, P343; Minton MS, 2005, FRONT ECOL ENVIRON, V3, P304, DOI 10.2307/3868563; Muirhead JR, 2015, DIVERS DISTRIB, V21, P75, DOI 10.1111/ddi.12260; Murphy K, 2004, MAR POLLUT BULL, V48, P711, DOI 10.1016/j.marpolbul.2003.10.015; National Ballast Information Clearinghouse (NBIC), 2014, NBIC ONL DAT; Noble M, 2016, FRONT MAR SCI, V3, DOI 10.3389/fmars.2016.00066; NRC [National Research Council], 2011, ASS REL PROP PRESS I; Olenin S, 2000, INT REV HYDROBIOL, V85, P577, DOI 10.1002/1522-2632(200011)85:5/6<577::AID-IROH577>3.3.CO;2-3; Qi ZX, 2015, OCEAN ENG, V103, P211, DOI 10.1016/j.oceaneng.2015.04.046; Qi ZX, 2014, OCEAN ENG, V89, P157, DOI 10.1016/j.oceaneng.2014.07.022; Ricciardi A, 2008, ECOL APPL, V18, P1321, DOI 10.1890/07-0748.1; Rigby G.R., 1994, J MAR ENV ENG, V1, P91; Farrapeira CMR, 2007, BRAZ J OCEANOGR, V55, P207, DOI 10.1590/S1679-87592007000300005; Roman J, 2006, P ROY SOC B-BIOL SCI, V273, P2453, DOI 10.1098/rspb.2006.3597; Roy S, 2012, CAN J FISH AQUAT SCI, V69, P627, DOI [10.1139/F2012-008, 10.1139/f2012-008]; Ruiz G. M, 2003, INVASIVE SPECIES VEC; Ruiz G. M., 2007, CURRENT STATE UNDERS; Ruiz GM, 2000, NATURE, V408, P49, DOI 10.1038/35040695; Seebens H, 2016, P NATL ACAD SCI USA, V113, P5646, DOI 10.1073/pnas.1524427113; Simard N, 2011, J PLANKTON RES, V33, P1378, DOI 10.1093/plankt/fbr038; Smith L. David, 1999, Biological Invasions, V1, P67; United States Census Bureau, 2012, 2012 STAT ABSTR; Uriarte I, 2016, J PLANKTON RES, V38, P718, DOI 10.1093/plankt/fbv060; Verling E, 2005, P ROY SOC B-BIOL SCI, V272, P1249, DOI 10.1098/rspb.2005.3090; Ware C, 2016, J APPL ECOL, V53, P340, DOI 10.1111/1365-2664.12566; Wonham MJ, 2013, ECOL APPL, V23, P1691, DOI 10.1890/12-1985.1; Wonham MJ, 2001, MAR ECOL PROG SER, V215, P1, DOI 10.3354/meps215001; Zhang FZ, 1999, MAR ECOL PROG SER, V176, P243, DOI 10.3354/meps176243	64	25	25	1	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 20	2017	12	3							e0172468	10.1371/journal.pone.0172468	http://dx.doi.org/10.1371/journal.pone.0172468			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ER6VC	28319119	Green Submitted, gold, Green Published			2022-12-27	WOS:000398945800004
J	Kutzner, I; Richter, A; Gordt, K; Dymke, J; Damm, P; Duda, GN; Gunzl, R; Bergmann, G				Kutzner, Ines; Richter, Anja; Gordt, Katharina; Dymke, Joern; Damm, Philipp; Duda, Georg N.; Guenzl, Reiner; Bergmann, Georg			Does aquatic exercise reduce hip and knee joint loading? In vivo load measurements with instrumented implants	PLOS ONE			English	Article							REACTION FORCES; PROGRAM; WALKING; WATER; RECOMMENDATIONS; OSTEOARTHRITIS; METAANALYSIS; REPLACEMENT; STRENGTH; MOBILITY	Aquatic exercises are widely used for rehabilitation or preventive therapies in order to enable mobilization and muscle strengthening while minimizing joint loading of the lower limb. The load reducing effect of water due to buoyancy is a main advantage compared to exercises on land. However, also drag forces have to be considered that act opposite to the relative motion of the body segments and require higher muscle activity. Due to these opposing effects on joint loading, the load-reducing effect during aquatic exercises remains unknown. The aim of this study was to quantify the joint loads during various aquatic exercises and to determine the load reducing effect of water. Instrumented knee and hip implants with telemetric data transfer were used to measure the resultant joint contact forces in 12 elderly subjects (6x hip, 6x knee) in vivo. Different dynamic, weight-bearing and non-weight-bearing activities were performed by the subjects on land and in chest-high water. Non-weight-bearing hip and knee flexion/extension was performed at different velocities and with additional Aquafins. Joint forces during aquatic exercises ranged between 32 and 396% body weight (BW). Highest forces occurred during dynamic activities, followed by weight-bearing and slow non-weight-bearing activities. Compared to the same activities on land, joint forces were reduced by 36-55% in water with absolute reductions being greater than 100% BW during weight-bearing and dynamic activities. During non-weight-bearing activities, high movement velocities and additional Aquafins increased the joint forces by up to 59% and resulted in joint forces of up to 301% BW. This study confirms the load reducing effect of water during weight-bearing and dynamic exercises. Nevertheless, high drag forces result in increased joint contact forces and indicate greater muscle activity. By the choice of activity, movement velocity and additional resistive devices joint forces can be modulated individually in the course of rehabilitation or preventive therapies.	[Kutzner, Ines; Richter, Anja; Gordt, Katharina; Dymke, Joern; Damm, Philipp; Duda, Georg N.; Bergmann, Georg] Charite, Julius Wolff Inst, Berlin, Germany; [Guenzl, Reiner] Olympiastutzpunkt Berlin, Berlin, Germany	Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin	Kutzner, I (corresponding author), Charite, Julius Wolff Inst, Berlin, Germany.	ines.kutzner@charite.de	Duda, Georg N/H-2085-2016	Duda, Georg N/0000-0001-7605-3908; Kutzner, Ines/0000-0002-2316-6017; Damm, Philipp/0000-0001-8471-7284	German Research Foundation [DFG KU 3213/2-1]	German Research Foundation(German Research Foundation (DFG))	This study was suppoted by German Research Foundation (DFG KU 3213/2-1)	Barela AMF, 2008, J ELECTROMYOGR KINES, V18, P446, DOI 10.1016/j.jelekin.2006.10.008; Barker AL, 2014, ARCH PHYS MED REHAB, V95, P1776, DOI 10.1016/j.apmr.2014.04.005; Bartels EM, 2007, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD005523.pub2; Bartels EM, 2016, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD005523.pub3; Batterham SI, 2011, BMC MUSCULOSKEL DIS, V12, DOI 10.1186/1471-2474-12-123; Bender A, 2012, COMPUT METHOD BIOMEC, V15, P761, DOI 10.1080/10255842.2011.560841; Bergmann G, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0155612; Bergmann G, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086035; Biscarini A, 2007, J BIOMECH, V40, P345, DOI 10.1016/j.jbiomech.2005.12.018; Carneiro LC, 2012, GAIT POSTURE, V35, P225, DOI 10.1016/j.gaitpost.2011.09.011; Damm P, 2010, MED ENG PHYS, V32, P95, DOI 10.1016/j.medengphy.2009.10.003; Devereux K, 2005, AUST J PHYSIOTHER, V51, P102, DOI 10.1016/S0004-9514(05)70038-6; Fontana HD, 2012, J ORTHOP SPORT PHYS, V42, P437, DOI 10.2519/jospt.2012.3572; Graichen F, 2007, IEEE T BIO-MED ENG, V54, P253, DOI 10.1109/TBME.2006.886857; Hall J, 2008, ARCH PHYS MED REHAB, V89, P873, DOI 10.1016/j.apmr.2007.09.054; Heinlein B, 2007, J BIOMECH, V40, pS4, DOI 10.1016/j.jbiomech.2007.02.014; Hinman RS, 2007, PHYS THER, V87, P32, DOI 10.2522/ptj.20060006; Hochberg MC, 2012, ARTHRIT CARE RES, V64, P465, DOI 10.1002/acr.21596; Kuster MS, 2002, SPORTS MED, V32, P433, DOI 10.2165/00007256-200232070-00003; Kutzner I, 2010, J BIOMECH, V43, P2164, DOI 10.1016/j.jbiomech.2010.03.046; Poyhonen T, 2000, CLIN BIOMECH, V15, P256, DOI 10.1016/S0268-0033(99)00070-4; Poyhonen T, 2001, ARCH PHYS MED REHAB, V82, P1446; Rahmann AE, 2009, ARCH PHYS MED REHAB, V90, P745, DOI 10.1016/j.apmr.2008.12.011; Roesler H, 2006, GAIT POSTURE, V24, P412, DOI 10.1016/j.gaitpost.2005.09.014; Schneider S, 2007, PHYS MED REHAB KUROR, V17, P88, DOI 10.1055/s-2007-960475; Tsourlou T, 2006, J STRENGTH COND RES, V20, P811; Valtonen A, 2010, ARCH PHYS MED REHAB, V91, P833, DOI 10.1016/j.apmr.2010.03.002; Orselli MIV, 2011, J BIOMECH, V44, P1170, DOI 10.1016/j.jbiomech.2011.01.017	28	28	29	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 20	2017	12	3							e0171972	10.1371/journal.pone.0171972	http://dx.doi.org/10.1371/journal.pone.0171972			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ER6VC	28319145	Green Submitted, Green Published, gold			2022-12-27	WOS:000398945800002
J	Chu, TJ; Shaw, PA; Yeniterzi, S; Dunkel, M; Rajkovic, A; Hogge, WA; Bunce, KD; Peters, DG				Chu, Tianjiao; Shaw, Patricia A.; Yeniterzi, Suveyda; Dunkel, Mary; Rajkovic, Aleksander; Hogge, W. Allen; Bunce, Kimberly D.; Peters, David G.			Comparative evaluation of the Minimally-Invasive Karyotyping (MINK) algorithm for non-invasive prenatal testing	PLOS ONE			English	Article							MATERNAL PLASMA; DIAGNOSIS; ANEUPLOIDY; WISECONDOR; DNA	Minimally Invasive Karyotyping (MINK) was communicated in 2009 as a novel method for the non-invasive detection of fetal copy number anomalies in maternal plasma DNA. The original manuscript illustrated the potential of MINK using a model system in which fragmented genomic DNA obtained from a trisomy 21 male individual was mixed with that of his karyotypically normal mother at dilutions representing fetal fractions found in maternal plasma. Although it has been previously shown that MINK is able to non-invasively detect fetal microdeletions, its utility for aneuploidy detection in maternal plasma has not previously been demonstrated. The current study illustrates the ability of MINK to detect common aneuploidy in early gestation, compares its performance to other published third party methods (and related software packages) for prenatal aneuploidy detection and evaluates the performance of these methods across a range of sequencing read inputs. Plasma samples were obtained from 416 pregnant women between gestational weeks 8.1 and 34.4. Shotgun DNA sequencing was performed and data analyzed using MINK RAPIDR and WISECONDOR. MINK performed with greater accuracy than RAPIDR and WISECONDOR, correctly identifying 60 out of 61 true trisomy cases, and reporting only one false positive in 355 normal pregnancies. Significantly, MINK achieved accurate detection of trisomy 21 using just 2 million aligned input reads, whereas WISECONDOR required 6 million reads and RAPIDR did not achieve complete accuracy at any read input tested. In conclusion, we demonstrate that MINK provides an analysis pipeline for the detection of fetal aneuploidy in samples of maternal plasma DNA.	[Chu, Tianjiao; Yeniterzi, Suveyda; Dunkel, Mary; Rajkovic, Aleksander; Hogge, W. Allen; Peters, David G.] Univ Pittsburgh, Dept Obstet Gynecol & Reprod Sci, Pittsburgh, PA 15260 USA; [Chu, Tianjiao; Shaw, Patricia A.; Yeniterzi, Suveyda; Bunce, Kimberly D.; Peters, David G.] Magee Womens Res Inst, Ctr Fetal Med, Pittsburgh, PA 15213 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Magee-Womens Research Institute	Peters, DG (corresponding author), Univ Pittsburgh, Dept Obstet Gynecol & Reprod Sci, Pittsburgh, PA 15260 USA.; Peters, DG (corresponding author), Magee Womens Res Inst, Ctr Fetal Med, Pittsburgh, PA 15213 USA.	dgp6@pitt.edu	Peters, David/AAD-4629-2019		Magee-Womens Research Institute and Foundation; NIH/NICHD [R01 HD068578]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD068578] Funding Source: NIH RePORTER	Magee-Womens Research Institute and Foundation; NIH/NICHD(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	This work was supported by grants (to DGP) from the Magee-Womens Research Institute and Foundation and the NI H/NICHD (R01 HD068578). The funders had no role or influence regarding study design, data collection, data analysis, manuscript preparation and/or publication decision.	Benn P, 2014, J CLIN MED, V3, P537, DOI 10.3390/jcm3020537; Chitty LS, 2015, NONINVASIVE PRENATAL, DOI 10.1073/pnas.0808319105; Chiu RWK, 2008, P NATL ACAD SCI USA, V105, P20458, DOI 10.1073/pnas.0810641105; Chu T, 2015, CELL FREE NUCL ACIDS; Chu TJ, 2014, PRENATAL DIAG, V34, P469, DOI 10.1002/pd.4331; Chu TJ, 2009, BIOINFORMATICS, V25, P1244, DOI 10.1093/bioinformatics/btp156; Fan HC, 2008, P NATL ACAD SCI USA, V105, P16266, DOI 10.1073/pnas.0808319105; Fan HC, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010439; Lo KK, 2014, BIOINFORMATICS, V30, P2965, DOI 10.1093/bioinformatics/btu419; Peters D, 2011, NEW ENGL J MED, V365, P1847, DOI 10.1056/NEJMc1106975; Peters DG, 2015, SEMIN PERINATOL, V39, P44, DOI 10.1053/j.semperi.2014.10.009; Straver R, 2014, EXPERT REV MOL DIAGN, V14, P513, DOI 10.1586/14737159.2014.919855; Straver R, 2014, NUCLEIC ACIDS RES, V42, DOI 10.1093/nar/gkt992	13	3	3	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 17	2017	12	3							e0171882	10.1371/journal.pone.0171882	http://dx.doi.org/10.1371/journal.pone.0171882			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EO5CJ	28306738	Green Published, gold, Green Submitted			2022-12-27	WOS:000396710300002
J	Jones, JE; Jones, LL; Keeley, TJH; Calvert, MJ; Mathers, J				Jones, Janet E.; Jones, Laura L.; Keeley, Thomas J. H.; Calvert, Melanie J.; Mathers, Jonathan			A review of patient and carer participation and the use of qualitative research in the development of core outcome sets	PLOS ONE			English	Article							CLINICAL-TRIALS; CONSENSUS STATEMENT; HAND OSTEOARTHRITIS; HEALTH OUTCOMES; ATOPIC ECZEMA; DOMAINS; PERSPECTIVE; FIBROMYALGIA; CHILDREN; BENEFITS	Background To be meaningful, a core outcome set (COS) should be relevant to all stakeholders including patients and carers. This review aimed to explore the methods by which patients and carers have been included as participants in COS development exercises and, in particular, the use and reporting of qualitative methods. Methods In August 2015, a search of the Core Outcomes Measures in Effectiveness Trials (COMET) database was undertaken to identify papers involving patients and carers in COS develop-ment. Data were extracted to identify the data collection methods used in COS development, the number of health professionals, patients and carers participating in these, and the reported details of qualitative research undertaken. Results Fifty-nine papers reporting patient and carer participation were included in the review, ten of which reported using qualitative methods. Although patients and carers participated in out-come elicitation for inclusion in COS processes, health professionals tended to dominate the prioritisation exercises. Of the ten qualitative papers, only three were reported as a clear pre-designed part of a COS process. Qualitative data were collected using interviews, focus groups or a combination of these. None of the qualitative papers reported an underpinning methodological framework and details regarding data saturation, reflexivity and resource use associated with data collection were often poorly reported. Five papers reported difficulty in achieving a diverse sample of participants and two reported that a large and varied range of outcomes were often identified by participants making subsequent rating and rank-ing difficult. Conclusions Consideration of the best way to include patients and carers throughout the COS develop-ment process is needed. Additionally, further work is required to assess the potential role of qualitative methods in COS, to explore the knowledge produced by different qualitative data collection methods, and to evaluate the time and resources required to incorporate qualitative methods into COS development.	[Jones, Janet E.; Jones, Laura L.; Calvert, Melanie J.; Mathers, Jonathan] Univ Birmingham, Coll Med & Dent Sci, Inst Appl Hlth Res, Birmingham, W Midlands, England; [Keeley, Thomas J. H.] Parexel Int, Evergreen Bldg, London, England	University of Birmingham; Parexel International	Mathers, J (corresponding author), Univ Birmingham, Coll Med & Dent Sci, Inst Appl Hlth Res, Birmingham, W Midlands, England.	j.m.mathers@bham.ac.uk	Calvert, Melanie/F-7055-2011; Mathers, Jonathan/ABE-1164-2021; Jones, Laura/AAY-6159-2020; Jones, Janet/AAU-5074-2020	Calvert, Melanie/0000-0002-1856-837X; Mathers, Jonathan/0000-0001-6651-6286; Jones, Laura/0000-0002-4018-3855; Jones, Janet/0000-0002-9057-6956	College of Medical and Dental Sciences PhD studentship, University of Birmingham	College of Medical and Dental Sciences PhD studentship, University of Birmingham	This work was funded by a College of Medical and Dental Sciences PhD studentship, University of Birmingham.	Allard A, 2014, BMJ OPEN, V4, DOI 10.1136/bmjopen-2013-004611; Arnold LM, 2008, PATIENT EDUC COUNS, V73, P114, DOI 10.1016/j.pec.2008.06.005; Bellm LA, 2002, CANCER INVEST, V20, P793, DOI 10.1081/CNV-120002497; Bennett WL, 2012, J WOMENS HEALTH, V21, P925, DOI 10.1089/jwh.2011.3270; Broder MS, 2000, J VASC INTERV RADIOL, V11, P509, DOI 10.1016/S1051-0443(07)61386-4; Buch MH, 2015, ANN RHEUM DIS, V74, P963, DOI 10.1136/annrheumdis-2013-204948; Carlson GA, 2003, J CHILD ADOL PSYCHOP, V13, P13, DOI 10.1089/104454603321666162; Carter N, 2014, ONCOL NURS FORUM, V41, P545, DOI 10.1188/14.ONF.545-547; Carter SM, 2007, QUAL HEALTH RES, V17, P1316, DOI 10.1177/1049732307306927; Chiarotto A, 2015, EUR SPINE J, V24, P1127, DOI 10.1007/s00586-015-3892-3; Chitnis T, 2012, MULT SCLER J, V18, P116, DOI 10.1177/1352458511430704; Chitnis T, 2013, NEUROLOGY, V80, P1161, DOI 10.1212/WNL.0b013e318288694e; Clarke M, 2016, SYST REV-LONDON, V5, DOI 10.1186/s13643-016-0188-6; Clarke M, 2007, TRIALS, V8, DOI 10.1186/1745-6215-8-39; Devane D, 2007, BIRTH-ISS PERINAT C, V34, P164, DOI 10.1111/j.1523-536X.2006.00145.x; Duffy JMN, PREGNANCY HYPERTENS; Eleftheriadou V, 2012, BRIT J DERMATOL, V167, P804, DOI 10.1111/j.1365-2133.2012.11056.x; Eleftheriadou V, 2015, PIGM CELL MELANOMA R, V28, P363, DOI 10.1111/pcmr.12354; Gargon E, 2014, TRIALS, V15, DOI 10.1186/1745-6215-15-279; Gargon E, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0099111; Gladman DD, 2007, J RHEUMATOL, V34, P1167; Gladman DD, 2005, ANN RHEUM DIS, V64, P113, DOI 10.1136/ard.2004.030882; Goldhahn J, 2014, ARCH ORTHOP TRAUM SU, V134, P197, DOI 10.1007/s00402-013-1767-9; Gonzalez U, 2011, ARCH DERMATOL, V147, P1428, DOI 10.1001/archdermatol.2011.235; Gorst SL, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0146444; Haeusler GM, 2015, PEDIATR BLOOD CANCER, V62, P483, DOI 10.1002/pbc.25335; Harman NL, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0129514; Haywood KL, 2014, BONE JOINT J, V96B, P1016, DOI 10.1302/0301-620X.96B8.33766; Hewlett SA, 2003, J RHEUMATOL, V30, P877; Janssens A, 2014, ARCH DIS CHILD, V99, P927, DOI 10.1136/archdischild-2013-305803; Kahlke RM, 2014, INT J QUAL METH, V13, P37, DOI 10.1177/160940691401300119; Kaiser U, 2015, BMJ OPEN, V5, DOI 10.1136/bmjopen-2015-008146; Karas J, 2015, ARCH DIS CHILD, V100, P359, DOI 10.1136/archdischild-2014-307403; Katona C, 2007, INT PSYCHOGERIATR, V19, P345, DOI 10.1017/S1041610207005145; Keeley T, 2016, TRIALS, V17, DOI 10.1186/s13063-016-1356-7; Keeley T, 2015, TRIALS, V16, DOI 10.1186/s13063-015-0553-0; Kirwan J, 2003, J RHEUMATOL, V30, P868; Kirwan JR, 2007, J RHEUMATOL, V34, P1174; Kirwan John R, 2005, J Rheumatol, V32, P2250; Kloppenburg M, 2014, J RHEUMATOL, V41, P810, DOI 10.3899/jrheum.131253; Lasch KE, 2010, QUAL LIFE RES, V19, P1087, DOI 10.1007/s11136-010-9677-6; MacKichan F, 2015, PATHWAYS CARE LONG T; MacLennan S, 2015, TRIALS, V16, DOI 10.1186/s13063-015-0598-0; Mathers J, 2015, TRIALS, V16, P1; Mease P, 2007, J RHEUMATOL, V34, P1415; Mease P, 2009, J RHEUMATOL, V36, P2318, DOI 10.3899/jrheum.090367; Mease PJ, 2008, ARTHRIT RHEUM-ARTHR, V59, P952, DOI 10.1002/art.23826; Merkies I S J, 2006, Neuromuscul Disord, V16, P149, DOI 10.1016/j.nmd.2005.12.003; Mill J., 2003, INT J QUAL METH, V2, P1, DOI [10.1177/160940690300200201, DOI 10.1177/160940690300200201]; Moniz-Cook E, 2008, AGING MENT HEALTH, V12, P14, DOI 10.1080/13607860801919850; Morris C, 2015, HEALTH QUAL LIFE OUT, V13, DOI 10.1186/s12955-015-0284-7; Potter S, 2013, BRIT J CANCER, V109, P1181, DOI 10.1038/bjc.2013.461; Potter S, 2015, BRIT J SURG; Potter S, 2014, TRIALS, V15, DOI 10.1186/1745-6215-15-80; Reilly M M, 2006, Neuromuscul Disord, V16, P396, DOI 10.1016/j.nmd.2006.03.008; Ritchie J., 2013, QUALITATIVE RES PRAC; Saketkoo LA, 2014, THORAX, V69, P428, DOI 10.1136/thoraxjnl-2013-204202; Saketkoo LA, 2014, J RHEUMATOL, V41, P792, DOI 10.3899/jrheum.131251; Salaffi F, 2012, REUMATISMO, V64; Sanderson T, 2010, ARTHRIT CARE RES, V62, P647, DOI 10.1002/acr.20151; Sanderson T, 2010, ARTHRIT CARE RES, V62, P640, DOI 10.1002/acr.20034; Sanderson T, 2012, BR J NURS, V21, P522; Sanderson Tessa, 2012, Br J Nurs, V21, P1015; Schmitt J, 2010, Br J Dermatol, V163, P1166, DOI 10.1111/j.1365-2133.2010.10054.x; Schmitt J, 2007, J ALLERGY CLIN IMMUN, V120, P1389, DOI 10.1016/j.jaci.2007.08.011; Schmitt J, 2012, ALLERGY, V67, P1111, DOI 10.1111/j.1398-9995.2012.02874.x; Schmitt J, 2011, J INVEST DERMATOL, V131, P623, DOI 10.1038/jid.2010.303; Sinha IP, 2012, TRIALS, V13, DOI 10.1186/1745-6215-13-103; Stamm T, 2009, ANN RHEUM DIS, V68, P1453, DOI 10.1136/ard.2008.096776; Stuart GCE, 2011, INT J GYNECOL CANCER, V21, P750, DOI 10.1097/IGC.0b013e31821b2568; Swigris Jeffrey J, 2005, Health Qual Life Outcomes, V3, P61, DOI 10.1186/1477-7525-3-61; Thigpen T, 2011, INT J GYNECOL CANCER, V21, P756, DOI 10.1097/IGC.0b013e31821ce75d; Tierney S, 2013, INT J PEDIATR OTORHI, V77, P1742, DOI 10.1016/j.ijporl.2013.08.006; Tierney S, 2015, CLEFT PALATE-CRAN J, V52, P23, DOI 10.1597/13-139; TUGWELL P, 1993, J RHEUMATOL, V20, P555; Turk DC, 2008, PAIN, V137, P276, DOI 10.1016/j.pain.2007.09.002; vanderHeijde D, 1997, J RHEUMATOL, V24, P2225; Vargus-Adams JN, 2009, ARCH PHYS MED REHAB, V90, P2089, DOI 10.1016/j.apmr.2009.06.018; Waters AMI, 2014, TRIALS, V15, DOI 10.1186/1745-6215-15-168; Whitehead L, 2015, RESUSCITATI IN PRESS; Williamson PR, 2012, TRIALS, V13, DOI 10.1186/1745-6215-13-132; Wylde V, 2015, EUR J PAIN, V19, P611, DOI 10.1002/ejp.582; Young B, 2016, RES INVOLVEMENT ENGA, V2, P1, DOI DOI 10.1186/S40900-016-0039-6.	83	19	20	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 16	2017	12	3							e0172937	10.1371/journal.pone.0172937	http://dx.doi.org/10.1371/journal.pone.0172937			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EN9KE	28301485	Green Published, gold, Green Submitted			2022-12-27	WOS:000396318300019
J	Wertli, MM; Brunner, F; Steurer, J; Held, U				Wertli, Maria M.; Brunner, Florian; Steurer, Johann; Held, Ulrike			Usefulness of bone scintigraphy for the diagnosis of Complex Regional Pain Syndrome 1: A systematic review and Bayesian meta-analysis	PLOS ONE			English	Article							REFLEX SYMPATHETIC DYSTROPHY; SYNDROME TYPE-I; 3-PHASE BONE; PREDICTIVE-VALUE; SYNDROME TYPE-1; PATTERNS; SCAN; ACCURACY; CRITERIA; SPECIFICITY	Background Since 2007, the Budapest criteria are recommended for the diagnosis of Complex Regional Pain Syndrome (CRPS) 1. The usefulness of bone scintigraphy (BS, index test) for the diagnosis of CRPS 1 remains controversial. Imperfect reference tests (RT) result in underestimation of the diagnostic accuracy of BS. Further, biased results can occur when a dependency between the RT and BS exists. The objective was to assess the impact of different RTs, specifically the Budapest criteria, and the assumed imperfect nature of the RT on the diagnostic accuracy of BS. Further, we analyzed the association between baseline characteristics and positive BS in patients with CRPS 1. Methods Systematic literature review and Bayesian meta-analysis to assess the test accuracy of BS with and without accounting for the imperfect nature of the RT. We examined correlations (Spearman correlation coefficients / Wilcoxon tests) between baseline characteristics and the proportion of positive BS in patients with CRPS 1. Results The pooled sensitivity was 0.804 (95% credible interval (CI) 0.225 - 1.0, 21 studies) and specificity 0.853 (95% CI 0.278 - 1.00). Sensitivity and specificity of BS increased when accounting for the imperfect nature of the RT. However, in studies using Budapest criteria as reference, the sensitivity decreased (0.551; 95% CI 0.046 - 1) and the specificity increased (0.935; 95% CI 0.306 - 1). Shorter disease duration and a higher proportion of males were associated with a higher proportion of positive BS (27 studies, disease duration < 52 weeks Wilcoxon test p = 0.047, female proportion Spearman correlation -0.63, p = 0.009). Conclusion Compared to the accepted Budapest diagnostic criteria BS cannot be used to rule-in the diagnosis of CRPS 1. In patients with negative BS CRPS 1 is less likely the underlying illness. Studies using older or no diagnostic criteria should not be used to evaluate the diagnostic accuracy of BS in CRPS 1.	[Wertli, Maria M.; Steurer, Johann; Held, Ulrike] Univ Zurich, Horten Ctr Patient Oriented Res & Knowledge Trans, Pestalozzistrasse 24, Zurich, Switzerland; [Wertli, Maria M.] Univ Bern, Univ Hosp Bern, Div Gen Internal Med, Freiburgstrasse 8, Bern, Switzerland; [Brunner, Florian] Balgrist Univ Hosp, Dept Phys Med & Rheumatol, Forchstrasse 340, Zurich, Switzerland	University of Zurich; University of Bern; University Hospital of Bern; University of Zurich	Wertli, MM (corresponding author), Univ Zurich, Horten Ctr Patient Oriented Res & Knowledge Trans, Pestalozzistrasse 24, Zurich, Switzerland.; Wertli, MM (corresponding author), Univ Bern, Univ Hosp Bern, Div Gen Internal Med, Freiburgstrasse 8, Bern, Switzerland.	Maria.Wertli@usz.ch	Held, Ulrike/O-8328-2019; Wertli, Maria/Q-3349-2017	Wertli, Maria/0000-0001-6347-0198				AlSharif A, 2012, ANN NUCL MED, V26, P665, DOI 10.1007/s12149-012-0623-2; Birklein F, 2015, NEUROLOGY, V84, P89, DOI 10.1212/WNL.0000000000001095; Bruehl S, 1999, PAIN, V81, P147, DOI 10.1016/S0304-3959(99)00011-1; Bruehl S, 2002, PAIN, V95, P119, DOI 10.1016/S0304-3959(01)00387-6; Cappello ZJ, 2012, J HAND SURG-AM, V37A, P288, DOI 10.1016/j.jhsa.2011.10.035; CONSTANTINESCO A, 1986, Annales de Chirurgie de la Main, V5, P93, DOI 10.1016/S0753-9053(86)80021-7; DAVIDOFF G, 1989, ARCH PHYS MED REHAB, V70, P135; Dendukuri N, 2012, BIOMETRICS, V68, P1285, DOI 10.1111/j.1541-0420.2012.01773.x; Donohoe KJ, 2003, SOC NUCL MED PROCEDU; Duman I, 2007, CLIN RHEUMATOL, V26, P1433, DOI 10.1007/s10067-006-0515-8; Gatti D, 2016, OSTEOPOROSIS INT J E; Goebel A, 2013, COMPLEX REGIONAL PAI; GREYSON ND, 1984, J NUCL MED, V25, P423; Handa R, 2006, APLAR J RHEUMATOLOGY, V9, P79; Harden RN, 2007, PAIN MED, V8, P326, DOI 10.1111/j.1526-4637.2006.00169.x; Harden RN, 2013, PAIN MED, V14, P180, DOI 10.1111/pme.12033; Harden RN, 2010, PAIN, V150, P268, DOI 10.1016/j.pain.2010.04.030; Held U, 2015, BIOMETRICAL J, V57, P1020, DOI 10.1002/bimj.201400155; HOLDER LE, 1992, RADIOLOGY, V184, P531, DOI 10.1148/radiology.184.2.1620860; Kim HJ, 2015, ANN REHABIL MED-ARM, V39, P116, DOI 10.5535/arm.2015.39.1.116; Konzelmann M, 2013, BMC NEUROL, V13, DOI 10.1186/1471-2377-13-28; KOZIN F, 1981, AM J MED, V70, P23, DOI 10.1016/0002-9343(81)90407-1; KOZIN F, 1981, RADIOLOGY, V138, P437, DOI 10.1148/radiology.138.2.7455127; Kozin F, 1979, ARTHRITIS ALLIED CON, P1097; Kwon HW, 2011, NUCL MED MOLEC IMAG, V45, P261, DOI 10.1007/s13139-011-0104-x; Leitha T, 1996, Q J Nucl Med, V40, P188; Leitha T, 1996, EUR J NUCL MED, V23, P256, DOI 10.1007/BF00837623; Lijmer JG, 1999, JAMA-J AM MED ASSOC, V282, P1061, DOI 10.1001/jama.282.11.1061; Love C, 2003, RADIOGRAPHICS, V23, P341, DOI 10.1148/rg.232025103; MACKINNON SE, 1984, J HAND SURG-AM, V9A, P556, DOI 10.1016/S0363-5023(84)80110-0; Marinus Johan, 2011, Lancet Neurol, V10, P637, DOI 10.1016/S1474-4422(11)70106-5; Merskey H, 1994, CLASSIFICATION CHRON, DOI DOI 10.1016/0304-3959(86)90113-2; Moher David, 2009, Ann Intern Med, V151, P264, DOI [10.1136/bmj.b2535, 10.1016/j.ijsu.2010.02.007]; Moher D, 2009, BMJ-BRIT MED J, V339, DOI [10.1136/bmj.i4086, 10.1136/bmj.b2535, 10.1186/2046-4053-4-1]; Moon JY, 2012, BRIT J ANAESTH, V108, P655, DOI 10.1093/bja/aer500; Moon JY, 2012, PAIN PRACT, V12, P107; ODONOGHUE JP, 1993, CLIN NUCL MED, V18, P829, DOI 10.1097/00003072-199310000-00002; Okudan B, 2005, RHEUMATOL INT, V26, P126, DOI 10.1007/s00296-004-0534-1; Park SG, 2007, NUCL MED COMMUN, V28, P766, DOI 10.1097/MNM.0b013e32828e513f; Park SA, 2009, CLIN NUCL MED, V34, P773, DOI 10.1097/RLU.0b013e3181b7d980; Perez R.S.G.M., 2014, UPDATED GUIDELINES C; Perez RS, 2010, BMC NEUROL, V10, DOI 10.1186/1471-2377-10-20; R Core Team, 2021, R LANGUAGE ENV STAT; Ringer R, 2012, EUR J PAIN, V16, P1347, DOI 10.1002/j.1532-2149.2012.00137.x; Santhosh S, 2013, INDIAN J NUCL MED, V28, P11, DOI 10.4103/0972-3919.116798; Schiepers C, 1998, Acta Orthop Belg, V64, P322; Schurmann M, 2007, CLIN J PAIN, V23, P449; Schwartzman RJ, 2009, CLIN J PAIN, V25, P273, DOI 10.1097/AJP.0b013e31818ecea5; Scottish Intercollegiate Guidelines Network (SIGN), 2014, CRIT APPR NOT CHECKL; Sezer I, 2008, J BACK MUSCULOSKELET, V21, P71, DOI 10.3233/BMR-2008-21201; STEINBROCKER O, 1953, Bras Med, V67, P505; Steinert H, 1996, ROFO FORTSCHR RONTG, V164, P318, DOI 10.1055/s-2007-1015662; TEPPERMAN PS, 1984, ARCH PHYS MED REHAB, V65, P442; TODOROVICTIRNANIC M, 1995, EUR J NUCL MED, V22, P1187, DOI 10.1007/BF00800604; VELDMAN PHJM, 1993, LANCET, V342, P1012, DOI 10.1016/0140-6736(93)92877-V; Wang Yu-Lin, 1998, Kaohsiung Journal of Medical Sciences, V14, P40; WEISS L, 1993, ARCH PHYS MED REHAB, V74, P716, DOI 10.1016/0003-9993(93)90032-6; WERNER R, 1989, J HAND SURG-AM, V14A, P520, DOI 10.1016/S0363-5023(89)80016-4; Wertli MM, 2014, PAIN MED, V15, P1575, DOI 10.1111/pme.12466; Whiting P, 2004, ANN INTERN MED, V140, P189, DOI 10.7326/0003-4819-140-3-200402030-00010; Whiting PF, 2011, ANN INTERN MED, V155, P529, DOI 10.7326/0003-4819-155-8-201110180-00009; Wuppenhorst N, 2010, CLIN J PAIN, V26, P182, DOI 10.1097/AJP.0b013e3181c20207	62	19	22	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 16	2017	12	3							e0173688	10.1371/journal.pone.0173688	http://dx.doi.org/10.1371/journal.pone.0173688			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN9KE	28301606	gold, Green Accepted, Green Published, Green Submitted			2022-12-27	WOS:000396318300060
J	Aceituno-Aceituno, P; Melchor, L; Danvila-del-Valle, J; Bousono-Calzon, C				Aceituno-Aceituno, Pedro; Melchor, Lorenzo; Danvila-del-Valle, Joaquin; Bousono-Calzon, Carlos			Cumulative advantages and social capabilities in scientific mobility in the Health Sciences: The Spanish case	PLOS ONE			English	Article							RESEARCHERS; RETURN; PRODUCTIVITY; MIGRATION; ABROAD	Background The big problem in global public health, arising from the international migration of physicians from less-developed to more-developed countries, increases if this migration also affects scientists dedicated to health areas. This article analyzes critical variables in the processes of Spanish scientific mobility in Health Sciences to articulate effective management policies for the benefit of national public health services and the balance between local and global science. Methods This study develops a survey to measure and analyze the following crucial variables: research career, training, funding, working with a world-class team, institutional prestige, wages, facilities/infrastructure, working conditions in the organization of the destination country, fringe benefits in the organization of the destination country and social responsibility in the organization of the departure country. A total of 811 researchers have participated in the survey, of which 293 were from the health sector: Spanish scientists abroad (114), scientists that have returned to Spain (32) and young researchers in Spain (147). Results The most crucial variables for Spanish scientists and young researchers in Spain in Health Sciences moving abroad are the cumulative advantages (research career, training, funding and institutional prestige) plus wages. On the other hand, the return of Spanish scientists in the Health Sciences is influenced by cumulative variables (working with a world-class team, research career and institutional prestige) and also by other variables related to social factors, such as working conditions and fringe benefits in the destination country. Permanent positions are rare for these groups and their decisions regarding mobility depend to a large extent on job opportunities. Conclusions Spanish health organizations can influence researchers to return, since these decisions mainly depend on job opportunities. These organizations can complement the cumulative advantages offered by the wealthier countries with the intensification of social factors.	[Aceituno-Aceituno, Pedro; Melchor, Lorenzo] Univ Distancia Madrid UDIMA, Dept Adm & Direcc Empresas & Econ, Collado Villalba, Madrid, Spain; [Bousono-Calzon, Carlos] UCIIIM, Dept Teor Senal & Comunicac, Leganes, Madrid, Spain	Madrid Open University, UDIMA	Aceituno-Aceituno, P (corresponding author), Univ Distancia Madrid UDIMA, Dept Adm & Direcc Empresas & Econ, Collado Villalba, Madrid, Spain.	pedro.aceituno@udima.es	Bousono-Calzon, C/AAA-5878-2019; Aceituno, Pedro PAA Aceituno/L-7928-2013; Melchor, Lorenzo/H-7221-2015	Bousono-Calzon, C/0000-0001-7065-5692; Melchor, Lorenzo/0000-0002-5322-2817; Aceituno Aceituno, Pedro/0000-0001-9034-8673	Ministerio de Empleo y Seguridad Social de Espana/Direccion General de Migraciones [3.34/13]; Novanca/Caja Rural Contrato de Investigacion de la Universidad Carlos III de Madrid con Novanca/Caja Rural	Ministerio de Empleo y Seguridad Social de Espana/Direccion General de Migraciones; Novanca/Caja Rural Contrato de Investigacion de la Universidad Carlos III de Madrid con Novanca/Caja Rural	This work was supported by the Ministerio de Empleo y Seguridad Social de Espana/Direccion General de Migraciones (http://www.empleo.gob.es/es/) Expediente No. 3.34/13. Novanca/Caja Rural (http://www.novanca.com) Contrato de Investigacion de la Universidad Carlos III de Madrid con Novanca/Caja Rural. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aceituno-Aceituno P, 2015, HEALTH RES POLICY SY, V13, DOI 10.1186/s12961-015-0055-2; Aceituno-Aceituno P, 2015, MED CLIN-BARCELONA, V144, P520, DOI 10.1016/j.medcli.2014.10.020; Akl EA, 2008, BMC PUBLIC HEALTH, V8, DOI 10.1186/1471-2458-8-191; Andujar I., 2011, THESIS; Andujar I, 2015, SCI TECHNOL SOC, V20, P322, DOI 10.1177/0971721815597138; Armas Marina, 2016, LA RAZON        0216; Barcelona Treball, 2013, INF SECT 2013; Baruffaldi SH, 2012, RES POLICY, V41, P1655, DOI 10.1016/j.respol.2012.04.005; Casey T., 2001, 19905 EUR EN; Colom R, 2009, PSICOTHEMA, V21, P446; Comision interministerial de Ciencia y Tecnologia, 2003, PLAN NAC INV CIENT D, VII; Comision interministerial de Ciencia y Tecnologia, 2003, PLAN NAC INV CIENT D, VI; Comision Interministerial de Ciencia y Tecnologia, 2007, PLAN NAC INV CIENT D; Delgado-Morales Raul, 2013, PAIS; Diaz A., 2009, EL MUNDO CAMPUS; Editorial, 2012, NAT, V490, p326 ; El Pais, 2003, PAIS; Fatas-Villafranca F, 2009, J ECON BEHAV ORGAN, V72, P390, DOI 10.1016/j.jebo.2009.05.006; Fernandez Lola, 2010, CINCO DIAS; Fernandez-Magarino Javier, 2005, CINCO DIAS; Fontes M, 2013, DEBATE MOBILIDADE FU, P97; Fontes M., 2007, SCI PUBL POLICY, V34, P284, DOI [10.3152/030234207X214750, DOI 10.3152/030234207X214750]; Fontes M, 2013, MOBILITIES-UK, V8, P440, DOI 10.1080/17450101.2012.655976; Forstenlechner I., 2010, PUBLIC POLICY ADMIN, V25, P156, DOI [10.1177/0952076709356853, DOI 10.1177/0952076709356853]; Franzoni C, 2012, NAT BIOTECHNOL, V30, P1250, DOI 10.1038/nbt.2449; Fundacion Espanola para la Ciencia y la Tecnologia (SFST), 2005, INF INV BIOM; Gaillard AM, 2015, SCI TECHNOL SOC, V20, P414, DOI 10.1177/0971721815597157; Gaillard J, 2015, SCI TECHNOL SOC, V20, P269, DOI 10.1177/0971721815597168; Garcia-Romero A, 2012, REV ESP DOC CIENT, V35, P38, DOI 10.3989/redc.2012.1.762; Garcia-Romero Antonio, 2008, Med Clin (Barc), V131 Suppl 5, P1, DOI 10.1016/S0025-7753(08)76399-1; Gargiulo F, 2014, SCI REP-UK, V4, DOI 10.1038/srep04860; Grandes Odiozola G, 2012, GAC SANIT, V26, P80; Lopez MJ, 2014, GAC SANIT, V28, P1, DOI 10.1016/j.gaceta.2013.12.001; Lewison Grant, 2008, Med Clin (Barc), V131 Suppl 5, P42, DOI 10.1016/S0025-7753(08)76406-6; Marmolejo-Leyva R, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0126720; MERTON RK, 1968, SCIENCE, V159, P56, DOI 10.1126/science.159.3810.56; MERTON RK, 1988, ISIS, V79, P606, DOI 10.1086/354848; Ministerio de Economia y Competitividad, 2012, PLAN EST INV CIENT T; Mullan F, 2005, NEW ENGL J MED, V353, P1810, DOI 10.1056/NEJMsa050004; Palomo L., 2002, Gac Sanit, V16, P182; Pinto RM, 2014, HLTH PROMOT INT; Rey-Rocha J, 2015, SCIENTOMETRICS, V105, P2057, DOI 10.1007/s11192-015-1754-8; Rey-Rocha J, 2015, MED CLIN-BARCELONA, V145, P84, DOI 10.1016/j.medcli.2014.12.013; Rey-Rocha J, 2014, REV ESP DOC CIENT, V37, DOI 10.3989/redc.2014.1.1062; Rey-Rocha J, 2012, MED CLIN-BARCELONA, V138, P25, DOI 10.1016/j.medcli.2010.11.003; Secretaria de Estado de Investigacion, 2012, DES INN MIN EC COMP; Secretaria de Estado de Investigacion, 2015, DES INN MIN EC COMP; Van de Sande D, 2005, IMPAFEL 2 CONTRACT N; Van Noorden R, 2012, NATURE, V490, P326, DOI 10.1038/490326a; Yazdizadeh B, 2014, HEALTH RES POLICY SY, V12, DOI 10.1186/1478-4505-12-63	50	5	5	0	35	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 15	2017	12	3							e0173204	10.1371/journal.pone.0173204	http://dx.doi.org/10.1371/journal.pone.0173204			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EN9HQ	28296901	Green Submitted, Green Published, gold			2022-12-27	WOS:000396311700027
J	Acuna, SM; Bastias, JM; Toledo, PG				Acuna, Sergio M.; Bastias, Jose M.; Toledo, Pedro G.			Direct measurement of interaction forces between bovine serum albumin and poly (ethylene oxide) in water and electrolyte solutions	PLOS ONE			English	Article							POLYSTYRENE SURFACES; AQUEOUS-ELECTROLYTE; PROTEIN ADSORPTION; GLASS SURFACES; ADHESION; BRUSHES; STRATEGIES; STABILITY; BACTERIA; FILMS	The net interaction between a probe tip coated with bovine serum albumin (BSA) protein and a flat substrate coated with poly(ethylene oxide) (PEO) polymer was measured directly on approach in water and electrolyte solutions using AFM. The approach force curve between the two surfaces was monotonically repulsive in water and in electrolyte solutions. At pH similar to 5, slightly above the isoelectric point (pI) of BSA, and at large distances, the force was dominated by electrostatic repulsion between the oxygen atoms of the incoming protein with those belonging to the ether groups of PEO. Such repulsive force and range decreased in NaCl. Under physiological conditions, pH 6, BSA is definitely charged and the electrostatic repulsion with ether groups in PEO appears at larger separation distances. Interestingly, at pH 4, below the pI of BSA, the repulsion decreased because of an attractive, although weak, electrostatic force that appeared between the ether groups in PEO and the positively charged amino groups of BSA. However, for all solution conditions, once compression of PEO begun, the net repulsion was always dominated by short-range polymeric steric repulsion and repulsive enthalpy penalties for breaking PEO-water bonds. Results suggest that PEO in mushroom conformation may also be effective in reducing biofouling.	[Acuna, Sergio M.; Bastias, Jose M.] Univ Bio Bio, Dept Food Engn, Chillan, Chile; [Toledo, Pedro G.] Univ Concepcion, Dept Chem Engn, Correo 3, Concepcion, Chile; [Toledo, Pedro G.] Univ Concepcion, Lab Surface Anal, Correo 3, Concepcion, Chile	Universidad del Bio-Bio; Universidad de Concepcion; Universidad de Concepcion	Acuna, SM (corresponding author), Univ Bio Bio, Dept Food Engn, Chillan, Chile.	sacuna@ubiobio.cl	Acuña, Sergio M./N-3875-2019; Acuña, Sergio M./D-4071-2016; Toledo, Pedro/R-6094-2017; Bastias, Jose/AGI-3305-2022	Acuña, Sergio M./0000-0003-1365-9851; Acuña, Sergio M./0000-0003-1365-9851; Toledo, Pedro/0000-0003-2863-7997; 	Universidad del Bio-Bio [GI 152322/EF]; Fondecyt-CONICYT [1090781]; Center CRHIAM-FONDAP-CONICYT [15130015]	Universidad del Bio-Bio; Fondecyt-CONICYT(Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT)CONICYT FONDECYT); Center CRHIAM-FONDAP-CONICYT	We gratefully acknowledge the support from the Universidad del Bio-Bio through Project GI 152322/EF, Fondecyt-CONICYT through Project 1090781 and Center CRHIAM-FONDAP-CONICYT through Project 15130015.; We gratefully acknowledge the support from the Universidad del Bio-Bio through Project GI 152322/EF, Fondecyt-CONICYT through Project 1090781 and Center CRHIAM-FONDAP-CONICYT through Project 15130015. We thank Paula Toledo for the graphical abstract"	Acuna SM, 2008, LANGMUIR, V24, P4881, DOI 10.1021/la703866g; Barbosa LRS, 2010, BIOPHYS J, V98, P147, DOI 10.1016/j.bpj.2009.09.056; Bosker WTE, 2005, J COLLOID INTERF SCI, V286, P496, DOI 10.1016/j.jcis.2005.01.091; Bowen WR, 2001, J COLLOID INTERF SCI, V237, P54, DOI 10.1006/jcis.2001.7437; Chen H, 2008, PROG POLYM SCI, V33, P1059, DOI 10.1016/j.progpolymsci.2008.07.006; Chen M, 2013, INT J MOL SCI, V14, P18488, DOI 10.3390/ijms140918488; Considine RF, 1999, LANGMUIR, V15, P1657, DOI 10.1021/la980900h; Derjaguin B, 1934, KOLLOID Z, V69, P155, DOI 10.1007/BF01433225; DUCKER WA, 1991, NATURE, V353, P239, DOI 10.1038/353239a0; DUCKER WA, 1992, LANGMUIR, V8, P1831, DOI 10.1021/la00043a024; Efremova NV, 2001, LANGMUIR, V17, P7628, DOI 10.1021/la010405c; Fernandez ICS, 2007, BIOMATERIALS, V28, P4105, DOI 10.1016/j.biomaterials.2007.05.023; Follstaedt SC, 2000, TECH REP; Ge SR, 1998, J BIOMAT SCI-POLYM E, V9, P131; GOMBOTZ WR, 1991, J BIOMED MATER RES, V25, P1547, DOI 10.1002/jbm.820251211; Gon S, 2012, MACROMOLECULES, V45, P8373, DOI 10.1021/ma300981r; Hamilton-Brown P, 2009, LANGMUIR, V25, P9149, DOI 10.1021/la900703e; Horcas I, 2007, REV SCI INSTRUM, V78, DOI 10.1063/1.2432410; Jo S, 2000, BIOMATERIALS, V21, P605, DOI 10.1016/S0142-9612(99)00224-0; Kang S, 2007, J MEMBRANE SCI, V296, P42, DOI 10.1016/j.memsci.2007.03.012; Kaper HJ, 2003, J BIOMAT SCI-POLYM E, V14, P313, DOI 10.1163/156856203321478847; Kim KS, 2016, ACS APPL MATER INTER, V8, P20342, DOI 10.1021/acsami.6b04629; Krishnamoorthy M, 2014, CHEM REV, V114, P10976, DOI 10.1021/cr500252u; Louguet S, 2001, J COLLOID INTERF SCI, V359, P413; Maas JH, 2003, THIN SOLID FILMS, V426, P135, DOI 10.1016/S0040-6090(03)00033-6; MARON SH, 1972, J MACROMOL SCI PHYS, VB  6, P79, DOI 10.1080/00222347208224790; Michnik A, 2005, J THERM ANAL CALORIM, V80, P399, DOI 10.1007/s10973-005-0667-9; Miquel S, 2016, FRONT MICROBIOL, V7, DOI 10.3389/fmicb.2016.00592; Nejadnik MR, 2008, BIOMATERIALS, V29, P4117, DOI 10.1016/j.biomaterials.2008.07.014; Ngadi N, 2009, INT J BIOL LIFE SCI, V1, P145; Ngadi N., 2009, WORLD ACAD SCI ENG T, V49, P144; Pinheiro JP, 2004, ANAL BIOANAL CHEM, V380, P964, DOI 10.1007/s00216-004-2843-3; Rana D, 2010, CHEM REV, V110, P2448, DOI 10.1021/cr800208y; Rixman MA, 2003, LANGMUIR, V19, P9357, DOI 10.1021/la034057l; Roosjen A, 2005, J BIOMED MATER RES B, V73B, P347, DOI 10.1002/jbm.b.30227; Roosjen A, 2003, MICROBIOL-SGM, V149, P3239, DOI 10.1099/mic.0.26519-0; Roosjen A, 2006, MICROBIOL-SGM, V152, P2673, DOI 10.1099/mic.0.29005-0; Saavedra JH, 2013, J COLLOID INTERF SCI, V410, P188, DOI 10.1016/j.jcis.2013.08.001; Sadekuzzaman M, 2015, COMPR REV FOOD SCI F, V14, P491, DOI 10.1111/1541-4337.12144; Sanchez-Gonzalez J, 2003, J COLLOID INTERF SCI, V267, P286, DOI 10.1016/S0021-9797(03)00754-9; Sheth SR, 1997, P NATL ACAD SCI USA, V94, P8399, DOI 10.1073/pnas.94.16.8399; Vinogradova OI, 2001, J CHEM PHYS, V114, P8124, DOI 10.1063/1.1365954	42	5	5	4	47	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 15	2017	12	3							e0173910	10.1371/journal.pone.0173910	http://dx.doi.org/10.1371/journal.pone.0173910			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN9HQ	28296940	Green Published, Green Submitted, gold			2022-12-27	WOS:000396311700076
J	Kommerein, N; Stumpp, SN; Musken, M; Ehlert, N; Winkel, A; Haussler, S; Behrens, P; Buettner, FFR; Stiesch, M				Kommerein, Nadine; Stumpp, Sascha N.; Muesken, Mathias; Ehlert, Nina; Winkel, Andreas; Haeussler, Susanne; Behrens, Peter; Buettner, Falk F. R.; Stiesch, Meike			An oral multispecies biofilm model for high content screening applications	PLOS ONE			English	Article							IN-VITRO; PERI-IMPLANT; IDENTIFICATION; COLONIZATION; VEILLONELLA; PREVALENCE; COMMUNITY; BACTERIA; MUTANS; GROWTH	Peri-implantitis caused by multispecies biofilms is a major complication in dental implant treatment. The bacterial infection surrounding dental implants can lead to bone loss and, in turn, to implant failure. A promising strategy to prevent these common complications is the development of implant surfaces that inhibit biofilm development. A reproducible and easy-to-use biofilm model as a test system for large scale screening of new implant surfaces with putative antibacterial potency is therefore of major importance. In the present study, we developed a highly reproducible in vitro four-species biofilm model consisting of the highly relevant oral bacterial species Streptococcus oralis, Actinomyces naeslundii, Veillonella dispar and Porphyromonas gingivalis. The application of live/dead staining, quantitative real time PCR (qRT-PCR), scanning electron microscopy (SEM) and urea-NaCl fluorescence in situ hybridization (urea-NaCl-FISH) revealed that the four-species biofilm community is robust in terms of biovolume, live/dead distribution and individual species distribution over time. The biofilm community is dominated by S. oralis, followed by V. dispar, A. naeslundii and P. gingivalis. The percentage distribution in this model closely reflects the situation in early native plaques and is therefore well suited as an in vitro model test system. Furthermore, despite its nearly native composition, the multispecies model does not depend on nutrient additives, such as native human saliva or serum, and is an inexpensive, easy to handle and highly reproducible alternative to the available model systems. The 96-well plate format enables high content screening for optimized implant surfaces impeding biofilm formation or the testing of multiple antimicrobial treatment strategies to fight multispecies biofilm infections, both exemplary proven in the manuscript.	[Kommerein, Nadine; Stumpp, Sascha N.; Winkel, Andreas; Stiesch, Meike] Hannover Med Sch, Dept Prosthet Dent & Biomed Mat Sci, Hannover, Germany; [Muesken, Mathias; Haeussler, Susanne] TWINCORE, Inst Mol Bacteriol, Ctr Expt & Clin Infect Res, Hannover, Germany; [Muesken, Mathias; Haeussler, Susanne] Helmholtz Ctr Infect Res, Dept Mol Bacteriol, Braunschweig, Germany; [Ehlert, Nina; Behrens, Peter] Leibniz Univ Hannover, Inst Inorgan Chem, Hannover, Germany; [Buettner, Falk F. R.] Hannover Med Sch, Inst Clin Biochem, Hannover, Germany	Hannover Medical School; Helmholtz Association; Helmholtz-Center for Infection Research; Helmholtz Association; Helmholtz-Center for Infection Research; Leibniz University Hannover; Hannover Medical School	Kommerein, N (corresponding author), Hannover Med Sch, Dept Prosthet Dent & Biomed Mat Sci, Hannover, Germany.	kommerein.nadine@mh-hannover.de	Pohl, Sarah/B-3102-2016; Häussler, Susanne/I-2605-2014; Kommerein, Nadine/AAT-5392-2020	Pohl, Sarah/0000-0003-2655-7037; Häussler, Susanne/0000-0001-6141-9102; Kommerein, Nadine/0000-0001-5978-2965; Musken, Mathias/0000-0002-5624-1378	Ministry of Lower Saxony; VolkswagenStiftung [VWZN2860]; Deutsche Forschungsgemeinschaft (DFG, German to Reconstructive Therapy) [EXC 62/2]	Ministry of Lower Saxony; VolkswagenStiftung(Volkswagen); Deutsche Forschungsgemeinschaft (DFG, German to Reconstructive Therapy)	This work was supported by funding from the Ministry of Lower Saxony and VolkswagenStiftung (both BIOFABRICATION FOR NIFE: VWZN2860). F.F.R. Buettner was supported by funding from the Deutsche Forschungsgemeinschaft (DFG, German to Reconstructive Therapy, EXC 62/2). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alsaadi G, 2007, J CLIN PERIODONTOL, V34, P610, DOI 10.1111/j.1600-051X.2007.01077.x; Alvarez G, 2013, AMB EXPRESS, V3, DOI 10.1186/2191-0855-3-1; Ammann TW, 2012, BMC MICROBIOL, V12, DOI 10.1186/1471-2180-12-227; Andric N, 2016, BIONANOMATERIALS, V17; Baqain ZH, 2012, BRIT J ORAL MAX SURG, V50, P239, DOI 10.1016/j.bjoms.2011.04.074; Bornstein MM, 2009, INT J ORAL MAX IMPL, V24, P12; Canullo L, 2015, CLIN ORAL IMPLANTS R; Casado PL, 2011, IMPLANT DENT, V20, P226, DOI 10.1097/ID.0b013e3182199348; Coenye T, 2010, J MICROBIOL METH, V83, P89, DOI 10.1016/j.mimet.2010.08.018; COSTERTON JW, 1978, SCI AM, V238, P86, DOI 10.1038/scientificamerican0178-86; de Soet JJ, 2000, CARIES RES, V34, P486, DOI 10.1159/000016628; Diaz PI, 2006, APPL ENVIRON MICROB, V72, P2837, DOI 10.1128/AEM.72.4.2837-2848.2006; Edlund A, MICROBIOME, P25; Egland PG, 2004, INTERSPECIES COMMUNI; Ehlert N, 2011, J MATER CHEM, V21, P752, DOI 10.1039/c0jm01487g; Foster JS, 2004, APPL ENVIRON MICROB, V70, P4340, DOI 10.1128/AEM.70.7.4340-4348.2004; Gebert A, 1998, J MICROSC-OXFORD, V191, P297, DOI 10.1046/j.1365-2818.1998.00380.x; GIBBONS R J, 1970, Archives of Oral Biology, V15, P1397, DOI 10.1016/0003-9969(70)90031-2; Guggenheim B, 2001, J DENT RES, V80, P363, DOI 10.1177/00220345010800011201; Henry PJ, 2005, CLIN EXP PHARMACOL P, V32, P123, DOI 10.1111/j.1440-1681.2005.04140.x; Huynh-Ba G, 2008, J PERIODONTOL, V79, P2256, DOI [10.1902/jop.2008.070602, 10.1902/jop.2008.070602 ]; Hwang G, SCI REP, P62016; Koldsland OC, 2009, J PERIODONTOL, V80, P1069, DOI 10.1902/jop.2009.080594; Kolenbrander PE, 2006, PERIODONTOL 2000, V42, P47, DOI 10.1111/j.1600-0757.2006.00187.x; KOLENBRANDER PE, 1992, ADV MICROB ECOL, V12, P183; Lawson TS, 2012, LETT APPL MICROBIOL, V54, P263, DOI 10.1111/j.1472-765X.2011.03197.x; Levignac J, 1965, Rev Fr Odontostomatol, V12, P1251; Li J, 2004, J APPL MICROBIOL, V97, P1311, DOI 10.1111/j.1365-2672.2004.02420.x; Maruyama N, 2014, SCI REP-UK, V4, DOI 10.1038/srep06602; Mashima I, J BACTERIOL, P2104; MIKX FHM, 1975, ARCH ORAL BIOL, V20, P407, DOI 10.1016/0003-9969(75)90224-1; Mombelli A, 1987, Oral Microbiol Immunol, V2, P145, DOI 10.1111/j.1399-302X.1987.tb00298.x; Mombelli A, 2012, CLIN ORAL IMPLAN RES, V23, P67, DOI 10.1111/j.1600-0501.2012.02541.x; Musken M, 2010, NAT PROTOC, V5, P1460, DOI 10.1038/nprot.2010.110; NYVAD B, 1987, SCAND J DENT RES, V95, P369; Olate S, 2010, J ORAL MAXIL SURG, V68, P414, DOI 10.1016/j.joms.2009.10.002; Periasamy S, INFECT IMMUN, P3542; Periasamy S, 2009, APPL ENVIRON MICROB, V75, P3250, DOI 10.1128/AEM.02901-08; Persson GR, 2014, CLIN IMPLANT DENT R, V16, P783, DOI 10.1111/cid.12052; Peyyala R, 2011, APPL ENVIRON MICROB, V77, P3413, DOI 10.1128/AEM.00039-11; Rickard AH, 2006, MOL MICROBIOL, V60, P1446, DOI 10.1111/j.1365-2958.2006.05202.x; ROGOSA M, 1964, J BACTERIOL, V88, P37, DOI 10.1128/JB.88.1.37-41.1964; Sanchez MC, 2011, J PERIODONTAL RES, V46, P252, DOI 10.1111/j.1600-0765.2010.01341.x; Schaumann S, 2014, BMC ORAL HEALTH, V14, DOI 10.1186/1472-6831-14-157; Sennerby L, 2000, PERIODONTOL 2000, V4, P58; Tabanella G, 2009, CLIN IMPLANT DENT R, V11, P24, DOI 10.1111/j.1708-8208.2008.00088.x; TAKAHASHI N, 1990, J DENT RES, V69, P1266, DOI 10.1177/00220345900690060801; Takahashi N, 1999, ORAL MICROBIOL IMMUN, V14, P43, DOI 10.1034/j.1399-302X.1999.140105.x; Takahashi N, 1999, ORAL MICROBIOL IMMUN, V14, P60, DOI 10.1034/j.1399-302X.1999.140108.x; Thurnheer T, 2004, J MICROBIOL METH, V56, P37, DOI 10.1016/j.mimet.2003.09.003; VANWINKELHOFF AJ, 1989, J CLIN PERIODONTOL, V16, P128; Washio J, APPL ENV MICROBIOL, P4184; Zitzmann NU, 2008, J CLIN PERIODONTOL, V35, P286, DOI 10.1111/j.1600-051X.2008.01274.x; Zobell CE, 1936, OBSERVATIONS MULTIPL	55	33	33	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 15	2017	12	3							e0173973	10.1371/journal.pone.0173973	http://dx.doi.org/10.1371/journal.pone.0173973			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN9HQ	28296966	gold, Green Published			2022-12-27	WOS:000396311700084
J	Bai, L; Wang, H; Wang, AH; Zhang, LY; Bai, J				Bai, Lin; Wang, Hui; Wang, Ai-Hua; Zhang, Luo-Ying; Bai, Jie			MicroRNA-532 and microRNA-3064 inhibit cell proliferation and invasion by acting as direct regulators of human telomerase reverse transcriptase in ovarian cancer	PLOS ONE			English	Article							TO-MESENCHYMAL TRANSITION; TARGETING TELOMERASE; HTERT; EXPRESSION; GROWTH; METASTASIS; SLUG; RNA; EMT	Human telomerase reverse transcriptase (hTERT) plays a crucial role in ovarian cancer (OC) progression. However, the mechanisms underlying hTERT upregulation in OC, and the specific microRNAs (miRNAs) involved in the regulation of hTERT in OC cells, remains unclear. We performed a bioinformatics search to identify potential miRNAs that bind to the 3'-untranslated region (3'-UTR) region of the hTERT mRNA. We examined the expression levels of miR-532/miR-3064 in OC tissues and normal ovarian tissues, and analyzed the correlation between miRNA expression and OC patient outcomes. The impacts of miR-532/miR-3064 on hTERT expression were evaluated by western blot analysis and hTERT 3'-UTR reporter assays. We investigated the effects of miR-532/miR-3064 on proliferation and invasion in OC cells. We found that miR-532 and miR-3064 are down-regulated in OC specimens. We observed a significant association between reduced miR-532/miR-3064 expression and poorer survival of patients with OC. We confirmed that in OC cells, these two miRNAs downregulate hTERT levels by directly targeting its 3'-UTR region, and inhibited proliferation, EMT and invasion of OC cells. In addition, the overexpression of the hTERT cDNA lacking the 3'-UTR partially restored miR-532/miR-3064-inhibited OC cell proliferation and invasion. The silencing of hTERT by siRNA oligonucleotides abolished these malignant features, and phenocopied the effects of miR-532/miR-3064 overexpression. Furthermore, overexpression of miR-532/miR-3064 inhibits the growth of OC cells in vivo. Our findings demonstrate a miR-532/miR-3064-mediated mechanism responsible for hTERT upregulation in OC cells, and reveal a possibility of targeting miR-532/miR-3064 for future treatment of OC.	[Bai, Lin; Wang, Hui; Wang, Ai-Hua; Zhang, Luo-Ying; Bai, Jie] First Peoples Hosp Shangqiu, Dept Obstet & Gynecol, Shangqiu, Peoples R China		Bai, L (corresponding author), First Peoples Hosp Shangqiu, Dept Obstet & Gynecol, Shangqiu, Peoples R China.	drlinbai2013@sina.com			First People's Hospital of Shangqiu (Shangqiu, China) [2010-104]	First People's Hospital of Shangqiu (Shangqiu, China)	This study was supported by a grant from the First People's Hospital of Shangqiu (2010-104, Shangqiu, China). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Artandi SE, 2010, CARCINOGENESIS, V31, P9, DOI 10.1093/carcin/bgp268; Chen L, 2014, CELL DEATH DIS, V5, DOI 10.1038/cddis.2013.553; Choi MJ, 2015, ONCOGENE, V34, P3402, DOI 10.1038/onc.2014.270; Dong P, 2013, ONCOGENE, V32, P3286, DOI 10.1038/onc.2012.334; Dong PX, 2016, ONCOTARGET, V7, P20260, DOI 10.18632/oncotarget.7754; Ell B, 2013, TRENDS CELL BIOL, V23, P603, DOI 10.1016/j.tcb.2013.06.001; He B, 2016, SCI REP-UK, V6, DOI 10.1038/srep21955; Huang QH, 2008, NAT CELL BIOL, V10, P202, DOI 10.1038/ncb1681; Kasiappan R, 2012, J BIOL CHEM, V287, P41297, DOI 10.1074/jbc.M112.407189; Kim A, 2012, J EXP CLIN CANC RES, V31, DOI 10.1186/1756-9966-31-14; Kim SH, 2016, ARCH PHARM RES, V39, P240, DOI 10.1007/s12272-015-0666-8; Kong WM, 2015, J CANCER, V6, P1337, DOI 10.7150/jca.13054; Langyel E, 2010, AM J PATHOL, V177, P1053, DOI 10.2353/ajpath.2010.100105; Li J, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0135265; Li M, 2015, MOL MED REP, V11, P4645, DOI 10.3892/mmr.2015.3287; Liu N, 2016, NUCLEIC ACIDS RES, V44, P8693, DOI 10.1093/nar/gkw549; Liu Z, 2013, ONCOGENE, V32, P4203, DOI 10.1038/onc.2012.441; Meng E, 2012, GYNECOL ONCOL, V124, P598, DOI 10.1016/j.ygyno.2011.11.018; Qi Z, 2016, CANCER GENE THER, V23, P36, DOI 10.1038/cgt.2015.64; Qin Y, 2016, ONCOTARGET, V7, P351, DOI 10.18632/oncotarget.5968; Ruden M, 2013, CANCER TREAT REV, V39, P444, DOI 10.1016/j.ctrv.2012.06.007; Shih JY, 2011, CARCINOGENESIS, V32, P1299, DOI 10.1093/carcin/bgr110; Slattery ML, 2016, CARCINOGENESIS, V37, P245, DOI 10.1093/carcin/bgv249; Tang B, 2016, ONCOTARGET, V7, P11364, DOI 10.18632/oncotarget.6575; Wang F, 2016, MOL CANCER THER, V15, P1123, DOI 10.1158/1535-7163.MCT-15-0943; Wang T, 2012, ONCOL REP, V28, P1153, DOI 10.3892/or.2012.1952; Zhao Q, 2015, ONCOL REP, V34, P979, DOI 10.3892/or.2015.4013	27	42	42	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 14	2017	12	3							e0173912	10.1371/journal.pone.0173912	http://dx.doi.org/10.1371/journal.pone.0173912			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN6DM	28291810	Green Published, Green Submitted, gold			2022-12-27	WOS:000396094700049
J	Chang, T; Moniz, MH; Plegue, MA; Sen, A; Davis, MM; Villamor, E; Richardson, CR				Chang, Tammy; Moniz, Michelle H.; Plegue, Melissa A.; Sen, Ananda; Davis, Matthew M.; Villamor, Eduardo; Richardson, Caroline R.			Characteristics of women age 15-24 at risk for excess weight gain during pregnancy	PLOS ONE			English	Article							BODY-MASS INDEX; DIETARY INTERVENTIONS; PHYSICAL-ACTIVITY; UNITED-STATES; OBESITY; ADOLESCENTS; PREVALENCE; RETENTION; CHILDREN	Purpose Excess weight gain during pregnancy is a serious health concern among young pregnant women in the US. This study aimed to characterize young women at highest risk for gaining over the recommended amount of weight during pregnancy. Methods Using a database that is representative of births in large U.S. cities, The Fragile Families and Child Wellbeing Study, we identified mothers of singleton term-infants age 15-24 years at the time of delivery. Institute of Medicine guidelines were used to categorize each mother's weight gain as less than, within, or more than recommended during pregnancy. Multinomial logistic regression models for weight gain category were performed, controlling for age, race/ethnicity, federal poverty level (FPL), health status, and prepregnancy BMI. Results Among the weighted sample (n = 1,034, N = 181,375), the mean (SD) age was 21 (3) years, 32% were black, 39% were Hispanic, 44% reported income under the Federal Poverty Level, 45% were overweight or obese before pregnancy, and 55% gained more weight than recommended during pregnancy. Women who were overweight or obese before pregnancy were at increased risk for gaining more pregnancy weight than recommended, compared to normal-weight women (adjusted Relative Risk Ratio (RRR) = 3.82, p = 0.01; RRR = 3.27, p = 0.03, respectively). Hispanics were less likely than non-Hispanics to gain more weight than recommended (RRR = 0.39, p = 0.03). Conclusions The majority of mothers ages 15-24 gained excess weight during pregnancy, a strong risk factor for later obesity. Prepregnancy overweight or obesity and non-Hispanic ethnicity predicted excess pregnancy weight gain. Interventions and policies should target these high-risk young women to prevent excess weight gain.	[Chang, Tammy; Richardson, Caroline R.] Univ Michigan, Sch Med, Dept Family Med, Inst Healthcare Policy & Innovat, Ann Arbor, MI 48109 USA; [Moniz, Michelle H.] Univ Michigan, Dept Obstet & Gynecol, Sch Med, Inst Healthcare Policy & Innovat, Ann Arbor, MI 48109 USA; [Plegue, Melissa A.] Univ Michigan, Dept Family Med, Ann Arbor, MI 48109 USA; [Sen, Ananda] Univ Michigan, Dept Family Med & Biostat, Ann Arbor, MI 48109 USA; [Davis, Matthew M.] Northwestern Univ, Ann & Robert H Lurie Childrens Hosp Chicago, Feinberg Sch Med, Chicago, IL 60611 USA; [Villamor, Eduardo] Univ Michigan, Sch Publ Hlth, Dept Epidemiol, Ann Arbor, MI 48109 USA; [Villamor, Eduardo] Univ Michigan, Ctr Human Growth & Dev, Ann Arbor, MI 48109 USA	University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; Ann & Robert H. Lurie Children's Hospital of Chicago; Northwestern University; Feinberg School of Medicine; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan	Chang, T (corresponding author), Univ Michigan, Sch Med, Dept Family Med, Inst Healthcare Policy & Innovat, Ann Arbor, MI 48109 USA.	tachang@med.umich.edu		Richardson, Caroline/0000-0002-1945-6046	Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) of the National Institutes of Health [R01HD36916, R01HD39135, R01HD40421]; National Institutes of Health [5 K23 HD083527-05]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R25HD074544] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK092926, P30DK020572] Funding Source: NIH RePORTER	Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) of the National Institutes of Health; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	Research reported in this publication was supported by the Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) of the National Institutes of Health under award numbers R01HD36916, R01HD39135, and R01HD40421, as well as a consortium of private foundations. Additionally, Tammy Chang received funding from the National Institutes of Health grant number 5 K23 HD083527-05. The funders had no role in the design and conduct of the study; collection, management, analysis and interpretation of the data preparation, review, or approval of the manuscript, and decision to submit the manuscript for publication.	[Anonymous], FRAG FAM CHILD WELLB; Brown MJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039503; Bucchianeri MM, 2013, BODY IMAGE, V10, P1, DOI 10.1016/j.bodyim.2012.09.001; Centers for Disease Control and Prevention, OV OB DEF CHILDH OB; Centers for Disease Control and Prevention, REPR HLTH TEEN PREGN; Centers for Disease Control and Prevention, OV OB DEF AD OV OB; Centers for Disease Control and Prevention, PREGN COMPL; Chang T, 2013, BMC PREGNANCY CHILDB, V13, DOI 10.1186/1471-2393-13-47; Deputy NP, 2015, MMWR-MORBID MORTAL W, V64, P1215, DOI 10.15585/mmwr.mm6443a3; Deputy NP, 2015, OBSTET GYNECOL, V125, P773, DOI 10.1097/AOG.0000000000000739; Flegal KM, 2016, JAMA-J AM MED ASSOC, V315, P2284, DOI 10.1001/jama.2016.6458; Fraser A, 2011, AM J CLIN NUTR, V93, P1285, DOI 10.3945/ajcn.110.008326; Groth SW, 2013, JOGNN-J OBST GYN NEO, V42, P541, DOI 10.1111/1552-6909.12230; Haakstad LAH, 2013, J PREGNANCY, V2013, DOI 10.1155/2013/193170; Harper LM, 2011, AM J OBSTET GYNECOL, V205, DOI 10.1016/j.ajog.2011.03.053; Headen IE, 2012, ADV NUTR, V3, P83, DOI 10.3945/an.111.000984; Herring Sharon J, 2008, BMC Pregnancy Childbirth, V8, P54, DOI 10.1186/1471-2393-8-54; Jekielek S., 2005, TRANSITION ADULTHOOD; Joseph NP, 2008, J PEDIATR ADOL GYNEC, V21, P195, DOI 10.1016/j.jpag.2007.08.006; Kominiarek MA, 2015, MATERN CHILD HLTH J, V19, P1698, DOI 10.1007/s10995-015-1684-3; Muktabhant B, 2015, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD007145.pub3; Muktabhant B, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD007145.pub2; National Research Council, 2010, WEIGHT GAIN PREGNANC; Nehring I, 2011, AM J CLIN NUTR, V94, P1225, DOI 10.3945/ajcn.111.015289; Ogden CL, 2016, JAMA-J AM MED ASSOC, V315, P2292, DOI 10.1001/jama.2016.6361; Oken E, 2008, OBSTET GYNECOL, V112, P999, DOI 10.1097/AOG.0b013e31818a5d50; Oken E, 2009, OBSTET GYN CLIN N AM, V36, P361, DOI 10.1016/j.ogc.2009.03.007; Ostbye T, 2013, INT J OBESITY, V37, P1314, DOI 10.1038/ijo.2013.76; Poston L, 2012, BEST PRACT RES CL EN, V26, P627, DOI 10.1016/j.beem.2012.03.010; Quinlivan JA, 2011, OBSTET GYNECOL, V118, P1395, DOI 10.1097/AOG.0b013e3182396bc6; Reichman NE, 2001, CHILD YOUTH SERV REV, V23, P303, DOI 10.1016/S0190-7409(01)00141-4; Rong K, 2015, PUBLIC HEALTH NUTR, V18, P2172, DOI 10.1017/S1368980014002523; Rothberg BEG, 2011, AM J OBSTET GYNECOL, V204, DOI 10.1016/j.ajog.2010.08.028; Sedgh G, 2015, J ADOLESCENT HEALTH, V56, P223, DOI 10.1016/j.jadohealth.2014.09.007; Siega-Riz AM, 2009, AM J OBSTET GYNECOL, V201, DOI 10.1016/j.ajog.2009.07.002; Sridhar SB, 2014, AM J OBSTET GYNECOL, V211, DOI 10.1016/j.ajog.2014.02.030; Tanentsapf I, 2011, BMC PREGNANCY CHILDB, V11, DOI 10.1186/1471-2393-11-81; Viswanathan M, 2008, EDUC ASIA PAC REG-IS, V12, P1, DOI 10.1007/978-1-4020-5769-4; Weisman CS, 2010, WOMEN HEALTH ISS, V20, P126, DOI 10.1016/j.whi.2009.12.002; Whitaker KM, 2016, WOMEN HEALTH ISS, V26, P116, DOI 10.1016/j.whi.2015.10.007	40	7	7	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 14	2017	12	3							e0173790	10.1371/journal.pone.0173790	http://dx.doi.org/10.1371/journal.pone.0173790			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EN6DM	28291802	Green Published, Green Submitted, gold			2022-12-27	WOS:000396094700040
J	Haniffa, R; Lubell, Y; Cooper, BS; Mohanty, S; Alam, S; Karki, A; Pattnaik, R; Maswood, A; Haque, R; Pangeni, R; Schultz, MJ; Dondorp, AM				Haniffa, Rashan; Lubell, Yoel; Cooper, Ben S.; Mohanty, Sanjib; Alam, Shamsul; Karki, Arjun; Pattnaik, Rajya; Maswood, Ahmed; Haque, R.; Pangeni, Raju; Schultz, Marcus J.; Dondorp, Arjen M.		ICU Training S Asia Grp	Impact of a structured ICU training programme in resource-limited settings in Asia	PLOS ONE			English	Article							CRITICAL-CARE MEDICINE; CRITICAL ILLNESS; COUNTRIES; MORTALITY; BURDEN	Objective To assess the impact on ICU performance of a modular training program in three resource-limited general adult ICUs in India, Bangladesh, and Nepal. Method A modular ICU training programme was evaluated using performance indicators from June 2009 to June 2012 using an interrupted time series design with an 8 to 15 month pre-intervention and 18 to 24 month post-intervention period. ICU physicians and nurses trained in Europe and the USA provided training for ICU doctors and nurses. The training program consisted of six modules on basic intensive care practices of 2(_)3 weeks each over 20 months. The performance indicators consisting of ICU mortality, time to ICU discharge, rate at which patients were discharged alive from the ICU, discontinuation of mechanical ventilation or vasoactive drugs and duration of antibiotic use were extracted. Stepwise changes and changes in trends associated with the intervention were analysed. Results Pre-Training ICU mortality in Rourkela (India), and Patan (Nepal) Chittagong (Bangladesh), was 28%, 41% and 62%, respectively, compared to 30%, 18% and 51% post-intervention. The intervention was associated with a stepwise reduction in cumulative incidence of in-ICU mortality in Chittagong (adjusted subdistribution hazard ratio [aSHR] (95% CI): 0.62 (0.40, 0.97), p = 0.03) and Patan (aSHR 0.16 (0.06, 0.41), p<0.001), but not in Rourkela (aSHR: 1.17 (0.75, 1.82), p = 0.49). The intervention was associated with earlier discontinuation of vasoactive drugs at Rourkela (adjusted hazard ratio for weekly change [aHR] 1.08 (1.03, 1.14), earlier discontinuation of mechanical ventilation in Chittagong (aHR 2.97 (1.24, 7.14), p = 0.02), and earlier ICU discharge in Patan (aHR 1.87 ( 1.02, 3.43), p = 0.04). Conclusion This structured training program was associated with a decrease in ICU mortality in two of three sites and improvement of other performance indicators. A larger cluster randomised study assessing process outcomes and longer-term indicators is warranted.	[Haniffa, Rashan; Lubell, Yoel; Cooper, Ben S.; Dondorp, Arjen M.] Univ Oxford, Nuffield Dept Med, Ctr Trop Med, Oxford, England; [Lubell, Yoel; Cooper, Ben S.; Dondorp, Arjen M.] Mahidol Univ, Fac Trop Med, Bangkok, Thailand; [Mohanty, Sanjib; Pattnaik, Rajya] Ispat Gen Hosp, Rourkela, Orissa, India; [Alam, Shamsul; Maswood, Ahmed; Haque, R.] Chittagong Med Coll Hosp, Chittagong, Bangladesh; [Karki, Arjun; Pangeni, Raju] Patan Hosp, Kathmandu, Nepal; [Schultz, Marcus J.] Acad Med Ctr, Dept Intens Care, Amsterdam, Netherlands	University of Oxford; Mahidol University; Chittagong Medical College; University of Amsterdam; Academic Medical Center Amsterdam	Haniffa, R (corresponding author), Univ Oxford, Nuffield Dept Med, Ctr Trop Med, Oxford, England.	rashan@nicslk.com	Cooper, Ben/HGC-7082-2022; Schultz, Marcus/AAB-6379-2021	Schultz, Marcus/0000-0003-3969-7792; Haniffa, Rashan/0000-0002-8288-449X; Cooper, Ben/0000-0002-9445-7217; Lubell, Yoel/0000-0002-0237-1070; Pangeni, Raju Prasad/0000-0003-4556-3301	Li Ka Shing Foundation; Wellcome Trust Major Oversees Programme grant; Medical Research Council; Department for International Development [MW K006924/1]; MRC [MR/K006924/1] Funding Source: UKRI; Medical Research Council [MR/K006924/1] Funding Source: researchfish	Li Ka Shing Foundation; Wellcome Trust Major Oversees Programme grant(Wellcome Trust); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Department for International Development; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	The study and training programme were funded by the Li Ka Shing Foundation. RHan, YL, AMD are supported by a Wellcome Trust Major Oversees Programme grant. BSC was supported by The Medical Research Council and the Department for International Development (grant number MW K006924/1). The funder of the study had no role in the design of the study; the collection, analysis, and interpretation of the data; the writing of the manuscript; and the decision to submit the article for publication.	Acharya SP, 2013, INT HEALTH, V5, P92, DOI 10.1093/inthealth/iht010; Adhikari NKJ, 2011, CURR OPIN CRIT CARE, V17, P620, DOI 10.1097/MCC.0b013e32834cd39c; Adhikari NKJ, 2010, LANCET, V376, P1339, DOI 10.1016/S0140-6736(10)60446-1; Baker T, 2009, TROP MED INT HEALTH, V14, P143, DOI 10.1111/j.1365-3156.2008.02202.x; Baker T, 2011, LANCET, V377, P1405, DOI 10.1016/S0140-6736(11)60572-2; De Silva AP, 2015, J CRIT CARE, V30, DOI 10.1016/j.jcrc.2014.10.024; Du B, 2010, CRIT CARE, V14, DOI 10.1186/cc8222; Dunser MW, 2006, CRIT CARE MED, V34, P1234, DOI 10.1097/01.CCM.0000208360.70835.87; Farrar J, MANSONS TROPICAL DIS; Fine JP, 1999, J AM STAT ASSOC, V94, P496, DOI 10.2307/2670170; Fowler RA, 2008, CRIT CARE, V12, DOI 10.1186/cc6984; Gomersall CD, 2010, CRIT CARE, V14, DOI 10.1186/cc8871; Haniffa R, 2014, J CRIT CARE; Joynt GM, 2011, J CRIT CARE, V26, DOI 10.1016/j.jcrc.2011.01.007; Kim MM, 2010, ARCH INTERN MED, V170, P369, DOI 10.1001/archinternmed.2009.521; Kirkpatrick D., 1996, TRAIN DEV, V50; Mduma E, 2013, LOW DOSE HIGH FREQUE; Nguyen HB, 2007, CRIT CARE MED, V35, P1105, DOI 10.1097/01.CCM.0000259463.33848.3D; Pronovost P, 2006, NEW ENGL J MED, V355, P2725, DOI 10.1056/NEJMoa061115; Riviello ED, 2011, CRIT CARE MED, V39, P860, DOI 10.1097/CCM.0b013e318206d6d5; Wolkewitz M, 2014, BMJ-BRIT MED J, V21, pg5060	21	19	20	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 14	2017	12	3							e0173483	10.1371/journal.pone.0173483	http://dx.doi.org/10.1371/journal.pone.0173483			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN6DM	28291809	Green Published, gold, Green Submitted			2022-12-27	WOS:000396094700028
J	Hsu, FG; Hsieh, YW; Sheu, MJ; Lin, CC; Lin, CL; Hsu, CY; Lee, CY; Chang, MY; Chang, KH				Hsu, Fan-Gen; Hsieh, Yow-Wen; Sheu, Ming-Jyh; Lin, Che-Chen; Lin, Cheng-Li; Hsu, Chung Y.; Lee, Chang-Yin; Chang, Mei-Yin; Chang, Kuang-Hsi			Tamoxifen use and acute pancreatitis: A population-based cohort study	PLOS ONE			English	Article							INDUCED HYPERTRIGLYCERIDEMIA; BREAST-CANCER; PHASE-II; RISK; DRUGS	Background Several case reports have indicated that tamoxifen induced acute pancreatitis (AP); but no pharmacoepidemiological data support the claim. Therefore, we investigated whether tamoxifen use is correlated with the risk of AP in patients with breast cancer. Methods This population-based cohort study used the Taiwan National Health Insurance Research Database. A cohort of 22 005 patients aged >= 20 years with breast cancer from January 1, 2000 to December 31, 2009 was identified and the date of cancer diagnosis was set as the index date. The end point was developing AP during the follow-up. Hazard ratios (HRs) and 95% confidence intervals (CIs) were evaluated to determine the correlation between the risk of AP and tamoxifen use. Because the drug use varied over time, it was measured as a time-dependent covariate in the Cox proportional hazard model. The same approaches were applied in PS-matched cohorts. Results After adjustment for covariates and medication use including fluorouracil and doxorubicin, the risk of AP was not significant between tamoxifen users and tamoxifen nonusers (adjusted HR = 0.94, 95% CI = 0.74-1.19) in the non-matching cohorts. The results revealed no dose-response trend between tamoxifen use and the risk of AP (adjusted HR = 0.98, 95% CI = 0.96-1.00). The comorbidities DM and gallstones were associated with a significantly increased risk of AP. Similar trends were observed in PS-matched cohorts. Conclusions No significant correlation was observed between tamoxifen use and the risk of AP in patients with breast cancer.	[Hsu, Fan-Gen; Hsieh, Yow-Wen; Sheu, Ming-Jyh] China Med Univ, Sch Pharm, Taichung, Taiwan; [Hsu, Fan-Gen; Hsieh, Yow-Wen] China Med Univ Hosp, Dept Pharm, Taichung, Taiwan; [Lin, Che-Chen] Taichung Vet Gen Hosp, Healthcare Serv Res Ctr, Taichung, Taiwan; [Lin, Che-Chen; Lin, Cheng-Li] China Med Univ Hosp, Management Off Hlth Data, Taichung, Taiwan; [Hsu, Chung Y.] China Med Univ, Grad Inst Clin Med Sci, Taichung, Taiwan; [Lee, Chang-Yin] I Shou Univ, Sch Chinese Med Post Baccalaureate, Coll Med, Yancho Campus, Kaohsiung, Taiwan; [Lee, Chang-Yin] E DA Hosp, Dept Chinese Med, Kaohsiung, Taiwan; [Chang, Mei-Yin] Fooyin Univ, Sch Med & Hlth Sci, Dept Med Lab Sci & Biotechnol, Kaohsiung, Taiwan; [Chang, Kuang-Hsi] China Med Univ, Inst Biomed Sci, Taichung, Taiwan	China Medical University Taiwan; China Medical University Taiwan; China Medical University Hospital - Taiwan; Taichung Veterans General Hospital; China Medical University Taiwan; China Medical University Hospital - Taiwan; China Medical University Taiwan; I Shou University; E-Da Hospital; Fooyin University; China Medical University Taiwan	Chang, KH (corresponding author), China Med Univ, Inst Biomed Sci, Taichung, Taiwan.	s76881072@yahoo.com.tw		Hsu, Chung Y./0000-0002-5632-2733	Taiwan Ministry of Health and Welfare Clinical Trial and Research Center of Excellence [MOHW104-TDU-B-212-113002, MOHW105-TDUB-212-133019]; China Medical University Hospital, Academia Sinica Taiwan Biobank, Stroke Biosignature Project [BM104010092]; NRPB Stroke Clinical Trial Consortium [MOST 103-2325-B-039-006, MOST 104-2325-B-039-005]; Tseng-Lien Lin Foundation, Taichung, Taiwan; Taiwan Brain Disease Foundation, Taipei, Taiwan; Katsuzo and Kiyo Aoshima Memorial Funds, Japan; CMU under the Aim for Top University Plan of the Ministry of Education, Taiwan; Ministry of Science and Technology [MOST103-2314-6-715-001-MY2, MOST104-2314-6-715-003-MY3]; Mackay Medical College [RD1040109]; Mackay Memorial Hospital [MMH-MM-10304, MMH-MM-10405]; Taiwan Ministry of Health and Welfare Clinical Trial Center [MOHW105-TDU-B-212-133019]	Taiwan Ministry of Health and Welfare Clinical Trial and Research Center of Excellence; China Medical University Hospital, Academia Sinica Taiwan Biobank, Stroke Biosignature Project; NRPB Stroke Clinical Trial Consortium; Tseng-Lien Lin Foundation, Taichung, Taiwan; Taiwan Brain Disease Foundation, Taipei, Taiwan; Katsuzo and Kiyo Aoshima Memorial Funds, Japan; CMU under the Aim for Top University Plan of the Ministry of Education, Taiwan; Ministry of Science and Technology(Ministry of Science, ICT & Future Planning, Republic of Korea); Mackay Medical College; Mackay Memorial Hospital; Taiwan Ministry of Health and Welfare Clinical Trial Center	This study is supported in part by Taiwan Ministry of Health and Welfare Clinical Trial and Research Center of Excellence (MOHW104-TDU-B-212-113002, MOHW105-TDUB-212-133019); China Medical University Hospital, Academia Sinica Taiwan Biobank, Stroke Biosignature Project (BM104010092); NRPB Stroke Clinical Trial Consortium (MOST 103-2325-B-039-006, MOST 104-2325-B-039-005); Tseng-Lien Lin Foundation, Taichung, Taiwan; Taiwan Brain Disease Foundation, Taipei, Taiwan; Katsuzo and Kiyo Aoshima Memorial Funds, Japan; and CMU under the Aim for Top University Plan of the Ministry of Education, Taiwan. We appreciate the financial support by grants from the Ministry of Science and Technology (MOST103-2314-6-715-001-MY2, and MOST104-2314-6-715-003-MY3), Mackay Medical College (RD1040109), and Mackay Memorial Hospital (MMH-MM-10304, MMH-MM-10405). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding received for this study.r This study is supported in part by Taiwan Ministry of Health and Welfare Clinical Trial Center (MOHW105-TDU-B-212-133019).	Abe O, 2005, LANCET, V365, P1687, DOI 10.1016/s0140-6736(05)66544-0; Andren-Sandberg A, 1999, ANN ONCOL, V10, P131, DOI 10.1023/A:1008377928466; Badalov N, 2007, CLIN GASTROENTEROL H, V5, P648, DOI 10.1016/j.cgh.2006.11.023; Bertilsson S, 2015, PANCREAS, V44, P1096, DOI 10.1097/MPA.0000000000000406; Bi Yan, 2015, Curr Treat Options Gastroenterol, V13, P354, DOI 10.1007/s11938-015-0058-7; Cuzick J, 2015, LANCET ONCOL, V16, P67, DOI 10.1016/S1470-2045(14)71171-4; Eckel F, 2000, J EXP CLIN CANC RES, V19, P295; Elisaf M, 2000, BREAST, V9, P238, DOI 10.1054/brst.1999.0129; Elisaf MS, 2000, ANN ONCOL, V11, P1067, DOI 10.1023/A:1008309613082; Filippatos TD, 2009, CANCER TREAT REV, V35, P175, DOI 10.1016/j.ctrv.2008.09.007; Hsing AW, 2015, JAMA INTERN MED, V175, P1527, DOI 10.1001/jamainternmed.2015.3540; Hung SC, 2015, AM J GASTROENTEROL, V110, P1490, DOI 10.1038/ajg.2015.259; Kim YA, 2014, CHINESE J CANCER RES, V26, P341, DOI 10.3978/j.issn.1000-9604.2014.05.01; Lai SW, 2011, AM J GASTROENTEROL, V106, P1697, DOI 10.1038/ajg.2011.155; Lancashire RJ, 2003, ALIMENT PHARM THER, V17, P887, DOI 10.1046/j.1365-2036.2003.01485.x; Lankisch PG, 2015, LANCET; Lim YP, 2015, CLIN BREAST CANCER, V15, P294, DOI 10.1016/j.clbc.2015.03.005; Osborne CK, 1998, NEW ENGL J MED, V339, P1609, DOI 10.1056/NEJM199811263392207; Peery AF, 2012, GASTROENTEROLOGY, V143, P1179, DOI 10.1053/j.gastro.2012.08.002; Scherer J, 2014, J CLIN GASTROENTEROL, V48, P195, DOI 10.1097/01.mcg.0000436438.60145.5a; Singh HK, 2016, J PHARMACOL PHARMACO, V7, P38, DOI 10.4103/0976-500X.179365; Tenner S, 2014, WORLD J GASTROENTERO, V20, P16529, DOI 10.3748/wjg.v20.i44.16529; Tomao S, 2002, ANTICANCER RES, V22, P2361; Torre LA, 2015, CA-CANCER J CLIN, V65, P87, DOI 10.3322/caac.21262; Wadood Ali, 2016, BMJ Case Rep, V2016, DOI 10.1136/bcr-2016-214837; Xie X, 2015, ONCOL LETT, V9, P837, DOI 10.3892/ol.2014.2711	26	0	0	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 14	2017	12	3							e0173089	10.1371/journal.pone.0173089	http://dx.doi.org/10.1371/journal.pone.0173089			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN6DM	28291833	gold, Green Published, Green Submitted			2022-12-27	WOS:000396094700011
J	Luck, AN; Slatko, BE; Foster, JM				Luck, Ashley N.; Slatko, Barton E.; Foster, Jeremy M.			Removing the needle from the haystack: Enrichment of Wolbachia endosymbiont transcripts from host nematode RNA by Cappable-seq (TM)	PLOS ONE			English	Article							LATERAL GENE-TRANSFER; BRUGIA-MALAYI; ANTIFILARIAL THERAPY; DIROFILARIA-IMMITIS; FILARIAL NEMATODES; DOXYCYCLINE; GENOME; ENDOBACTERIA; EXPRESSION; DEPLETION	Efficient transcriptomic sequencing of microbial mRNA derived from host-microbe associations is often compromised by the much lower relative abundance of microbial RNA in the mixed total RNA sample. One solution to this problem is to perform extensive sequencing until an acceptable level of transcriptome coverage is obtained. More cost-effective methods include use of prokaryotic and/or eukaryotic rRNA depletion strategies, sometimes in conjunction with depletion of polyadenylated eukaryotic mRNA. Here, we report use of Cappable-seq (TM) to specifically enrich, in a single step, Wolbachia endobacterial mRNA transcripts from total RNA prepared from the parasitic filarial nematode, Brugia malayi. The obligate Wolbachia endosymbiont is a proven drug target for many human filarial infections, yet the precise nature of its symbiosis with the nematode host is poorly understood. Insightful analysis of the expression levels of Wolbachia genes predicted to underpin the mutualistic association and of known drug target genes at different life cycle stages or in response to drug treatments is typically challenged by low transcriptomic coverage. Cappable-seq resulted in up to similar to 5-fold increase in the number of reads mapping to Wolbachia. On average, coverage of Wolbachia transcripts from B. malayi microfilariae was enriched similar to 40-fold by Cappable-seq. Additionally, this method has an additional benefit of selectively removing abundant prokaryotic ribosomal RNAs. The deeper microbial transcriptome sequencing afforded by Cappable-seq facilitates more detailed characterization of gene expression levels of pathogens and symbionts present in animal tissues.	[Luck, Ashley N.; Slatko, Barton E.; Foster, Jeremy M.] New England Biolabs Inc, Genome Biol Div, Ipswich, MA 01938 USA	New England Biolabs	Foster, JM (corresponding author), New England Biolabs Inc, Genome Biol Div, Ipswich, MA 01938 USA.	foster@neb.com			New England Biolabs, Ipswich, MA	New England Biolabs, Ipswich, MA	This work was funded internally by New England Biolabs, Ipswich, MA, of which all authors are employees. The specific roles of the authors are articulated in the 'author contributions' section. Employees and owners of New England Biolabs not on the author list did not contribute to the study design, data collection and analysis, decision to publish, or preparation of the manuscript. Critical feedback and proofreading of the manuscript was provided by additional members of the NEB.	Andrews S., 2010, FASTQC QUALITY CONTR; Bandi C, 2001, VET PARASITOL, V98, P215, DOI 10.1016/S0304-4017(01)00432-0; Blankenberg Daniel, 2010, Curr Protoc Mol Biol, VChapter 19, DOI 10.1002/0471142727.mb1910s89; Brownlie JC, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-68; Darby AC, 2012, GENOME RES, V22, P2467, DOI 10.1101/gr.138420.112; Hotopp JCD, 2006, PLOS GENET, V2, P208, DOI 10.1371/journal.pgen.0020021; Ettwiller L, 2016, BMC GENOMICS, V17, DOI 10.1186/s12864-016-2539-z; Foster J, 2005, PLOS BIOL, V3, P599, DOI 10.1371/journal.pbio.0030121; Foster JM, 2013, PARASITIC NEMATODES: MOLECULAR BIOLOGY, BIOCHEMISTRY AND IMMUNOLOGY, 2ND EDITION, P308, DOI 10.1079/9781845937591.0308; Foster JM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013576; Giardine B, 2005, GENOME RES, V15, P1451, DOI 10.1101/gr.4086505; Godel C, 2012, FASEB J, V26, P4650, DOI 10.1096/fj.12-205096; Goecks J, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-8-r86; Hoerauf A, 2001, LANCET, V357, P1415, DOI 10.1016/S0140-6736(00)04581-5; Hoerauf A, 2008, MED MICROBIOL IMMUN, V197, P295, DOI 10.1007/s00430-007-0062-1; Hotopp JCD, 2007, SCIENCE, V317, P1753, DOI 10.1126/science.1142490; Ioannidis P, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-639; Joshi N. A., 2011, SICKLE SLIDING WINDO; Kumar N, 2016, SCI REP-UK, V6, DOI 10.1038/srep34850; Kumar Nikhil, 2012, BMC Res Notes, V5, P230, DOI 10.1186/1756-0500-5-230; Landmann F, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000758; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; Li ZR, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0001411; Luck AN, 2015, BMC GENOMICS, V16, DOI 10.1186/s12864-015-2083-2; Luck AN, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-1041; Raverdy S, 2008, MOL BIOCHEM PARASIT, V160, P163, DOI 10.1016/j.molbiopara.2008.04.014; Supali T, 2008, CLIN INFECT DIS, V46, P1385, DOI 10.1086/586753; Taylor MJ, 2005, ADV PARASIT, V60, P245, DOI 10.1016/S0065-308X(05)60004-8; Trapnell C, 2009, BIOINFORMATICS, V25, P1105, DOI 10.1093/bioinformatics/btp120	29	3	3	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 14	2017	12	3							e0173186	10.1371/journal.pone.0173186	http://dx.doi.org/10.1371/journal.pone.0173186			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN6DM	28291780	gold, Green Published, Green Submitted			2022-12-27	WOS:000396094700015
J	Renwick, AR; Robinson, CJ; Garnett, ST; Leiper, I; Possingham, HP; Carwardine, J				Renwick, Anna R.; Robinson, Catherine J.; Garnett, Stephen T.; Leiper, Ian; Possingham, Hugh P.; Carwardine, Josie			Mapping Indigenous land management for threatened species conservation: An Australian case-study	PLOS ONE			English	Article							BIODIVERSITY CONSERVATION; ECOLOGICAL KNOWLEDGE; BIOLOGICAL DIVERSITY	Much biodiversity lives on lands to which Indigenous people retain strong legal and management rights. However this is rarely quantified. Here we provide the first quantitative overview of the importance of Indigenous land for a critical and vulnerable part of biodiversity, threatened species, using the continent of Australia as a case study. We find that three quarters of Australia's 272 terrestrial or freshwater vertebrate species listed as threatened under national legislation have projected ranges that overlap Indigenous lands. On average this overlap represents 45% of the range of each threatened species while Indigenous land is 52% of the country. Hotspots where multiple threatened species ranges overlap occur predominantly in coastal Northern Australia. Our analysis quantifies the vast potential of Indigenous land in Australia for contributing to national level conservation goals, and identifies the main land management arrangements available to Indigenous people which may enable them to deliver those goals should they choose to do so.	[Renwick, Anna R.; Possingham, Hugh P.] Univ Queensland, ARC Ctr Excellence Environm Decis, NERP Environm Decis Hub, Ctr Biodivers & Conservat Sci, Brisbane, Qld, Australia; [Robinson, Catherine J.; Carwardine, Josie] CSIRO Ecosyst Sci, Ecosci Precinct, Brisbane, Qld, Australia; [Robinson, Catherine J.] Charles Darwin Univ, Northern Inst, Darwin, NT, Australia; [Garnett, Stephen T.; Leiper, Ian] Charles Darwin Univ, Res Inst Environm & Livelihoods, Darwin, NT, Australia	University of Queensland; Commonwealth Scientific & Industrial Research Organisation (CSIRO); Charles Darwin University; Charles Darwin University	Renwick, AR (corresponding author), Univ Queensland, ARC Ctr Excellence Environm Decis, NERP Environm Decis Hub, Ctr Biodivers & Conservat Sci, Brisbane, Qld, Australia.	a.renwick@uq.edu.au	Leiper, Ian/P-8140-2019; Carwardine, Josie/A-5801-2011; POSSINGHAM, HUGH/R-8310-2019; Robinson, Cathy/D-3349-2011; Possingham, Hugh/B-1337-2008	POSSINGHAM, HUGH/0000-0001-7755-996X; Robinson, Cathy/0000-0002-3453-572X; Possingham, Hugh/0000-0001-7755-996X; Leiper, Ian/0000-0001-6491-9145	ARC Centre of Excellence for Environmental Decisions; NERP Research Hub for Environmental Decisions; National Environment Science Program Threatened Species Research Hub	ARC Centre of Excellence for Environmental Decisions(Australian Research Council); NERP Research Hub for Environmental Decisions; National Environment Science Program Threatened Species Research Hub	This work received support from ARC Centre of Excellence for Environmental Decisions. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. NERP Research Hub for Environmental Decisions also supported this work. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. National Environment Science Program Threatened Species Research Hub supported this work. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This work was supported by the ARC Centre of Excellence for Environmental Decisions, the NERP Research Hub for Environmental Decisions and the National Environment Science Program Threatened Species Research Hub.	[Anonymous], 2005, EC HUM WELL BEING SY; Berkes F, 2000, ECOL APPL, V10, P1251, DOI 10.1890/1051-0761(2000)010[1251:ROTEKA]2.0.CO;2; Brook BW, 2008, TRENDS ECOL EVOL, V23, P453, DOI 10.1016/j.tree.2008.03.011; Carwardine J, 2012, CONSERV LETT, V5, P196, DOI 10.1111/j.1755-263X.2012.00228.x; CBD Secretariat, 2010, 20 M C PART CONV BIO; Chan KMA, 2012, ECOL ECON, V74, P8, DOI 10.1016/j.ecolecon.2011.11.011; Convention on Biological Diversity, 2011, AICH BIOD TARG; Department of Environment, 2016, NAT THREAT SPEC STRA; Department of the Environment and Energy, 2012, INT BIOG REG AUSTR R; Ens EJ, 2015, BIOL CONSERV, V181, P133, DOI 10.1016/j.biocon.2014.11.008; Environment Do, 2009, USTR STRAT NAT RES S; Ferrari Maurizio Farhan, 2015, BIODIVERSITY-OTTAWA, V16, P57, DOI 10.1080/14888386.2015.1074111; Fleming PA., 2016, MAMMAL REV; Gorenflo LJ, 2012, P NATL ACAD SCI USA, V109, P8032, DOI 10.1073/pnas.1117511109; Halpern BS, 2013, P NATL ACAD SCI USA, V110, P6229, DOI 10.1073/pnas.1217689110; Hill R, 2015, ENVIRON SCI POLICY, V51, P267, DOI 10.1016/j.envsci.2015.04.014; Hill R., 2012, ECOLOGY SOC, V17, P23, DOI DOI 10.5751/ES-04587-170123; Hill R., 2013, INDIGENOUS LAND MANA; IUCN Red list, 2022, ZOOL, Patent No. [eT158085A760192, 158085760192]; Jones Gareth R., 2014, CENGAGE LEARNING; Mauro F, 2000, ECOL APPL, V10, P1263, DOI 10.1890/1051-0761(2000)010[1263:TKOIAL]2.0.CO;2; McDermott M, 2013, ENVIRON SCI POLICY, V33, P416, DOI 10.1016/j.envsci.2012.10.006; McDonald JA, 2015, BIOL CONSERV, V182, P102, DOI 10.1016/j.biocon.2014.11.030; Poe MR, 2014, CONSERV LETT, V7, P166, DOI 10.1111/conl.12068; Reed P, 2011, FORESTS, V2, P525, DOI 10.3390/f2020525; Renwick AR, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0091281; Robinson CJ, 2016, ENVIRON SCI POLICY, V56, P129, DOI 10.1016/j.envsci.2015.11.007; Smyth D., 2015, PARKS, DOI [10.2305/IUCN.CH.2014.PARKS-21-2DS.en, DOI 10.2305/IUCN.CH.2014.PARKS-21-2DS.EN]; Sobrevila C, 2008, ROLE INDIENOUS PEOPL; Tittensor DP, 2014, SCIENCE, V346, P241, DOI 10.1126/science.1257484; UNDP, 2006, GEF SMALL GRANTS PRO; UNDP, 2014, SOC ENV STAND; Walker R., 2013, RECLAIMING INDIGENOU; Walsh FJ, 2013, ECOL SOC, V18, DOI 10.5751/ES-05501-180318; Watson JEM, 2011, CONSERV BIOL, V25, P324, DOI 10.1111/j.1523-1739.2010.01587.x; Zander KK, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023154	36	27	28	3	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 14	2017	12	3							e0173876	10.1371/journal.pone.0173876	http://dx.doi.org/10.1371/journal.pone.0173876			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN6DM	28291797	gold, Green Submitted, Green Published			2022-12-27	WOS:000396094700047
J	Habets, MN; van Selm, S; van der Gaast-de Jongh, CE; Diavatopoulos, DA; de Jonge, MI				Habets, Marrit N.; van Selm, Saskia; van der Gaast-de Jongh, Christa E.; Diavatopoulos, Dimitri A.; de Jonge, Marien I.			A novel flow cytometry-based assay for the quantification of antibody-dependent pneumococcal agglutination	PLOS ONE			English	Article							PHARYNGEAL EPITHELIAL-CELLS; STREPTOCOCCUS-PNEUMONIAE; CAPSULAR POLYSACCHARIDE; VACCINE; COLONIZATION; PROTECTION; IMMUNITY; IMMUNIZATION; ACQUISITION; INFECTION	The respiratory pathogen Streptococcus pneumoniae is a major cause of diseases such as otitis media, pneumonia, sepsis and meningitis. The first step towards infection is colonization of the nasopharynx. Recently, it was shown that agglutinating antibodies play an important role in the prevention of mucosal colonization with S. pneumoniae. Here, we present a novel method to quantify antibody-dependent pneumococcal agglutination in a high-throughput manner using flow cytometry. We found that the concentration of agglutinating antibodies against pneumococcal capsule are directly correlated with changes in the size and complexity of bacterial aggregates, as measured by flow cytometry and confirmed by light microscopy. Using the increase in size, we determined the agglutination index. The cutoff value was set by measuring a series of non-agglutinating antibodies. With this method, we show that not only anti-polysaccharide capsule antibodies are able to induce agglutination but that also anti-PspA protein antibodies have agglutinating capabilities. In conclusion, we have described and validated a novel method to quantify pneumococcal agglutination, which can be used to screen sera from murine or human vaccination studies, in a high-throughput manner.	[Habets, Marrit N.; van Selm, Saskia; van der Gaast-de Jongh, Christa E.; Diavatopoulos, Dimitri A.; de Jonge, Marien I.] Radboud Univ Nijmegen, Med Ctr, Lab Pediat Infect Dis, Dept Pediat,Radboud Inst Mol Life Sci, Nijmegen, Netherlands	Radboud University Nijmegen	van Selm, S (corresponding author), Radboud Univ Nijmegen, Med Ctr, Lab Pediat Infect Dis, Dept Pediat,Radboud Inst Mol Life Sci, Nijmegen, Netherlands.	Saskia.vanSelm@radboudumc.nl	de Jonge, Marien I./P-5869-2015; Diavatopoulos, Dimitri A/L-4269-2015	de Jonge, Marien I./0000-0003-2812-5895; Diavatopoulos, Dimitri A/0000-0001-7065-7807	EU (Eurostars, Pneumonav project) [9285]	EU (Eurostars, Pneumonav project)	This study was funded by the EU (Eurostars, Pneumonav project, grant number: 9285, https://www.eurostars-eureka.eu/project/id/9285). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANDERSSON B, 1983, J EXP MED, V158, P559, DOI 10.1084/jem.158.2.559; Bogaert D, 2004, LANCET INFECT DIS, V4, P144, DOI 10.1016/S1473-3099(04)00938-7; Bootsma HJ, 2007, INFECT IMMUN, V75, P5489, DOI 10.1128/IAI.01823-06; Cremers AJH, 2015, SCI REP-UK, V5, DOI 10.1038/srep14952; Dagan R, 2005, J INFECT DIS, V192, P367, DOI 10.1086/431679; DEVELASCO EA, 1995, J INFECT DIS, V172, P562, DOI 10.1093/infdis/172.2.562; Dochez AR, 1913, J AMER MED ASSOC, V61, P727, DOI 10.1001/jama.1913.04350100005003; Goldblatt D, 2011, CLIN VACCINE IMMUNOL, V18, P1728, DOI 10.1128/CVI.05252-11; Hall-Stoodley L, 2008, BMC MICROBIOL, V8, DOI 10.1186/1471-2180-8-173; Hanniffy SB, 2007, J INFECT DIS, V195, P185, DOI 10.1086/509807; Hollingshead SK, 2000, INFECT IMMUN, V68, P5889, DOI 10.1128/IAI.68.10.5889-5900.2000; Kim JO, 1998, J INFECT DIS, V177, P368, DOI 10.1086/514205; Klugman K P, 2001, Lancet Infect Dis, V1, P85, DOI 10.1016/S1473-3099(01)00063-9; Klugman KP, 2014, LANCET GLOB HEALTH, V2, pE365, DOI 10.1016/S2214-109X(14)70241-4; Kuipers K, 2015, VACCINE, V33, P2022, DOI 10.1016/j.vaccine.2015.03.010; Laine C, 2004, INFECT IMMUN, V72, P3331, DOI 10.1128/IAI.72.6.3331-3335.2004; Lebon A, 2011, INFECT IMMUN, V79, P1680, DOI 10.1128/IAI.01379-10; Lister FS, 1913, PUBL S AFR I MED RES, V1, P103; LUND E, 1960, Bull World Health Organ, V23, P5; Malley R, 2005, P NATL ACAD SCI USA, V102, P4848, DOI 10.1073/pnas.0501254102; Malley R, 2012, P NATL ACAD SCI USA, V109, P3623, DOI 10.1073/pnas.1121383109; Mitsi E, 2016, MUCOSAL IMMUNOL; Mudany MA, 2003, J MED MICROBIOL, V52, P975, DOI 10.1099/jmm.0.05306-0; Neufeld F, 1902, Z HYG INFEKTIONSKR, V40, P54; Oma K, 2009, VACCINE, V27, P3181, DOI 10.1016/j.vaccine.2009.03.055; Pearce BJ, 2002, RES MICROBIOL, V153, P243, DOI 10.1016/S0923-2508(02)01312-8; Roche AM, 2015, MUCOSAL IMMUNOL, V8, P176, DOI 10.1038/mi.2014.55; Sandgren A, 2004, J INFECT DIS, V189, P785, DOI 10.1086/381686; Siber GR, 2007, VACCINE, V25, P3816, DOI 10.1016/j.vaccine.2007.01.119; Slotved HC, 2004, J CLIN MICROBIOL, V42, P2518, DOI 10.1128/JCM.42.6.2518-2522.2004; Song JY, 2013, J INFECT CHEMOTHER, V19, P412, DOI 10.1007/s10156-013-0601-1; Sung CK, 2001, APPL ENVIRON MICROB, V67, P5190, DOI 10.1128/AEM.67.11.5190-5196.2001; Tettelin H, 2001, SCIENCE, V293, P498, DOI 10.1126/science.1061217; Weil-Olivier C, 2014, VACCINE, V32, P2022, DOI 10.1016/j.vaccine.2014.02.008; Williams CA, 1977, METHODS IMMUNOLOGY I, P84	35	14	14	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 13	2017	12	3							e0170884	10.1371/journal.pone.0170884	http://dx.doi.org/10.1371/journal.pone.0170884			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN6CP	28288168	gold, Green Published, Green Submitted			2022-12-27	WOS:000396092400003
J	Hall, RN; Capucci, L; Matthaei, M; Esposito, S; Kerr, PJ; Frese, M; Strive, T				Hall, Robyn N.; Capucci, Lorenzo; Matthaei, Markus; Esposito, Simona; Kerr, Peter J.; Frese, Michael; Strive, Tanja			An in vivo system for directed experimental evolution of rabbit haemorrhagic disease virus	PLOS ONE			English	Article							ORYCTOLAGUS-CUNICULUS; BENEFICIAL MUTATIONS; SILENT MUTATIONS; SEQUENCE DATA; CALICIVIRUS; IDENTIFICATION; RESISTANCE; RNA; AUSTRALIA; LAGOVIRUS	The calicivirus Rabbit haemorrhagic disease virus (RHDV) is widely used in Australia as a biocontrol agent to manage wild European rabbit (Oryctolagus cuniculus) populations. However, widespread herd immunity limits the effectiveness of the currently used strain, CAPM V-351. To overcome this, we developed an experimental platform for the selection and characterisation of novel RHDV strains. As RHDV does not replicate in cell culture, variant viruses were selected by serially passaging a highly virulent RHDV field isolate in immunologically naive laboratory rabbits that were passively immunised 18-24 hours post-challenge with a neutralising monoclonal antibody. After seven passages, two amino acid substitutions in the P2 domain of the capsid protein became fixed within the virus population. Furthermore, a synonymous substitution within the coding sequence of the viral polymerase appeared and was also maintained in all subsequent passages. These findings demonstrate proof-of-concept that RHDV evolution can be experimentally manipulated to select for virus variants with altered phenotypes, in this case partial immune escape.	[Hall, Robyn N.; Matthaei, Markus; Kerr, Peter J.; Frese, Michael; Strive, Tanja] Commonwealth Sci & Ind Res Org, Hlth & Biosecur, Canberra, ACT, Australia; [Hall, Robyn N.; Frese, Michael; Strive, Tanja] Univ Canberra, Invas Anim Cooperat Res Ctr, Canberra, ACT, Australia; [Capucci, Lorenzo; Esposito, Simona] Ist Zooprofilatt Sperimentale Lombardia & Emilia, IZSLER, Brescia, Italy; [Kerr, Peter J.] Univ Sydney, Sch Life & Environm Sci, Sydney, NSW, Australia; [Frese, Michael] Univ Canberra, Hlth Res Inst, Canberra, ACT, Australia; [Frese, Michael; Strive, Tanja] Univ Canberra, Inst Appl Ecol, Canberra, ACT, Australia	Commonwealth Scientific & Industrial Research Organisation (CSIRO); University of Canberra; IZS Lombardia e Emilia; University of Sydney; University of Canberra; University of Canberra	Strive, T (corresponding author), Commonwealth Sci & Ind Res Org, Hlth & Biosecur, Canberra, ACT, Australia.; Strive, T (corresponding author), Univ Canberra, Invas Anim Cooperat Res Ctr, Canberra, ACT, Australia.; Strive, T (corresponding author), Univ Canberra, Inst Appl Ecol, Canberra, ACT, Australia.	Tanja.Strive@csiro.au	Hall, Robyn N/E-3121-2017; Capucci, Lorenzo/E-5919-2011; Strive, Tanja/C-1486-2008; esposito, simona/AAC-4963-2020	Hall, Robyn N/0000-0002-5836-2990; Capucci, Lorenzo/0000-0002-1830-3929; 	Invasive Animals Cooperative Research Centre (IA CRC) [IACRC 3.L.4]	Invasive Animals Cooperative Research Centre (IA CRC)(Australian GovernmentDepartment of Industry, Innovation and ScienceCooperative Research Centres (CRC) Programme)	Funding for this work was obtained from the Invasive Animals Cooperative Research Centre (IA CRC), grant #IACRC 3.L.4.	Barrick JE, 2013, NAT REV GENET, V14, P827, DOI 10.1038/nrg3564; Bolger AM, 2014, BIOINFORMATICS, V30, P2114, DOI 10.1093/bioinformatics/btu170; CAPUCCI L, 1995, VIRUS RES, V37, P221, DOI 10.1016/0168-1702(95)00033-M; Capucci L, 1998, VIRUS RES, V58, P115, DOI 10.1016/S0168-1702(98)00106-3; Chou HH, 2011, SCIENCE, V332, P1190, DOI 10.1126/science.1203799; Cuevas JM, 2002, GENETICS, V162, P533; Eden JS, 2015, J VIROL, V89, P12217, DOI 10.1128/JVI.01937-15; Eden JS, 2015, J VIROL, V89, P9548, DOI 10.1128/JVI.01100-15; Elsworth PG, 2012, EPIDEMIOL INFECT, V140, P1972, DOI 10.1017/S0950268811002743; Elsworth P, 2014, VIROLOGY, V464, P415, DOI 10.1016/j.virol.2014.06.037; Jimenez JI, 2013, P NATL ACAD SCI USA, V110, P14984, DOI 10.1073/pnas.1307604110; Kashiwagi A, 2014, J VIROL, V88, P11459, DOI 10.1128/JVI.01127-14; Kearse M, 2012, BIOINFORMATICS, V28, P1647, DOI 10.1093/bioinformatics/bts199; Khan AI, 2011, SCIENCE, V332, P1193, DOI 10.1126/science.1203801; Koel BF, 2015, J VIROL, V89, P3763, DOI 10.1128/JVI.02962-14; Lauring AS, 2012, CELL HOST MICROBE, V12, P623, DOI 10.1016/j.chom.2012.10.008; Le Gall-Recule G, 2013, VET RES, V44, DOI 10.1186/1297-9716-44-81; Leuthold MM, 2015, J VIROL, V89, P2378, DOI 10.1128/JVI.02832-14; Liu JE, 2012, VIROL J, V9, DOI 10.1186/1743-422X-9-182; Liu JN, 2012, VET MICROBIOL, V157, P345, DOI 10.1016/j.vetmic.2012.01.018; Lochridge VP, 2007, J VIROL, V81, P12316, DOI 10.1128/JVI.01254-07; Long JS, 2013, J VIROL, V87, P9983, DOI 10.1128/JVI.01399-13; MacLachlan NJ, 2011, FENNER'S VETERINARY VIROLOGY, 4TH EDITION, P443, DOI 10.1016/B978-0-12-375158-4.00027-4; MacLean RC, 2013, NAT REV GENET, V14, P221, DOI 10.1038/nrg3415; Magoc T, 2011, BIOINFORMATICS, V27, P2957, DOI 10.1093/bioinformatics/btr507; Matthaei M, 2014, VIROL J, V11, DOI 10.1186/1743-422X-11-109; McColl KA, 2002, EPIDEMIOL INFECT, V129, P655, DOI 10.1017/S0950268802007756; McIntosh MT, 2007, VIROL J, V4, DOI 10.1186/1743-422X-4-96; Meyer JR, 2012, SCIENCE, V335, P428, DOI 10.1126/science.1214449; Mutze G, 2014, WILDLIFE RES, V41, P552, DOI 10.1071/WR14107; Mutze G, 1998, J WILDLIFE DIS, V34, P221, DOI 10.7589/0090-3558-34.2.221; NEILL JD, 1992, VIRUS RES, V24, P211, DOI 10.1016/0168-1702(92)90008-W; OHLINGER VF, 1990, J VIROL, V64, P3331, DOI 10.1128/JVI.64.7.3331-3336.1990; PARRA F, 1990, J VIROL, V64, P4013, DOI 10.1128/JVI.64.8.4013-4015.1990; Sironen T, 2008, J GEN VIROL, V89, P1309, DOI 10.1099/vir.0.83662-0; Strengell M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025848; Strive T, 2009, VIROLOGY, V384, P97, DOI 10.1016/j.virol.2008.11.004; Strive T, 2010, VIROLOGY, V398, P125, DOI 10.1016/j.virol.2009.11.045; STUDDERT MJ, 1994, AUST VET J, V71, P264, DOI 10.1111/j.1751-0813.1994.tb03428.x; Taube S, 2010, J VIROL, V84, P5695, DOI 10.1128/JVI.00316-10; Telwatte S, 2015, NUCLEIC ACIDS RES, V43, P3256, DOI 10.1093/nar/gkv128; Thorne L, 2012, J VIROL, V86, P11441, DOI 10.1128/JVI.00439-12; Wang X, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003132; Yoo DW, 2001, CLIN DIAGN LAB IMMUN, V8, P297, DOI 10.1128/CDLI.8.2.297-302.2001; Zhang Y, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-40	45	7	7	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 13	2017	12	3							e0173727	10.1371/journal.pone.0173727	http://dx.doi.org/10.1371/journal.pone.0173727			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN6CP	28288206	gold, Green Published, Green Submitted			2022-12-27	WOS:000396092400033
J	Carlson, GE; Martin, EW; Shirure, VS; Malgor, R; Resto, VA; Goetz, DJ; Burdick, MM				Carlson, Grady E.; Martin, Eric W.; Shirure, Venktesh S.; Malgor, Ramiro; Resto, Vicente A.; Goetz, Douglas J.; Burdick, Monica M.			Dynamic biochemical tissue analysis detects functional L-selectin ligands on colon cancer tissues	PLOS ONE			English	Article							PHYSIOLOGICAL FLOW CONDITIONS; HUMAN ATHEROSCLEROTIC LESIONS; CUTANEOUS LYMPHOCYTE ANTIGEN; CELL-ADHESION MOLECULE-1; SIALYL-LEWIS-X; P-SELECTIN; LEUKOCYTE ADHESION; CARCINOMA-CELLS; SHEAR-FLOW; GLYCOPROTEIN LIGAND-1	A growing body of evidence suggests that L-selectin ligands presented on circulating tumor cells facilitate metastasis by binding L-selectin presented on leukocytes. Commonly used methods for detecting L-selectin ligands on tissues, e.g., immunostaining, are performed under static, no-flow conditions. However, such analysis does not assay for functional L-selectin ligands, specifically those ligands that promote adhesion under shear flow conditions. Recently our lab developed a method, termed dynamic biochemical tissue analysis (DBTA), to detect functional selectin ligands in situ by probing tissues with L-selectin-coated microspheres under hemodynamic flow conditions. In this investigation, DBTA was used to probe human colon tissues for L-selectin ligand activity. The detection of L-selectin ligands using DBTA was highly specific. Furthermore, DBTA reproducibly detected functional Lselectin ligands on diseased, e.g., cancerous or inflamed, tissues but not on noncancerous tissues. In addition, DBTA revealed a heterogeneous distribution of functional L-selectin ligands on colon cancer tissues. Most notably, detection of L-selectin ligands by immunostaining using HECA-452 antibody only partially correlated with functional L-selectin ligands detected by DBTA. In summation, the results of this study demonstrate that DBTA detects functional selectin ligands to provide a unique characterization of pathological tissue.	[Carlson, Grady E.; Martin, Eric W.; Shirure, Venktesh S.; Goetz, Douglas J.; Burdick, Monica M.] Ohio Univ, Russ Coll Engn & Technol, Dept Chem & Biomol Engn, Athens, OH 45701 USA; [Carlson, Grady E.; Martin, Eric W.; Malgor, Ramiro; Goetz, Douglas J.; Burdick, Monica M.] Ohio Univ, Russ Coll Engn & Technol, Biomed Engn Program, Athens, OH 45701 USA; [Malgor, Ramiro] Ohio Univ, Heritage Coll Osteopath Med, Biomed Sci, Athens, OH 45701 USA; [Resto, Vicente A.] Univ Texas Med Branch, Dept Otolaryngol, Galveston, TX 77555 USA; [Burdick, Monica M.] Ohio Univ, Edison Biotechnol Inst, Athens, OH 45701 USA	University System of Ohio; Ohio University; University System of Ohio; Ohio University; University System of Ohio; Ohio University; University of Texas System; University of Texas Medical Branch Galveston; University System of Ohio; Ohio University	Burdick, MM (corresponding author), Ohio Univ, Russ Coll Engn & Technol, Dept Chem & Biomol Engn, Athens, OH 45701 USA.; Burdick, MM (corresponding author), Ohio Univ, Russ Coll Engn & Technol, Biomed Engn Program, Athens, OH 45701 USA.; Burdick, MM (corresponding author), Ohio Univ, Edison Biotechnol Inst, Athens, OH 45701 USA.	burdick@ohio.edu	Shirure, Venktesh/M-8806-2015	Shirure, Venktesh/0000-0002-4430-2612; Burdick, Monica/0000-0003-3168-0072	National Institutes of Health [R15CA161830-01]; National Science Foundation [1039869]; Ohio University	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation(National Science Foundation (NSF)); Ohio University	This work was supported by the National Institutes of Health (R15CA161830-01; to M.M.B.), National Science Foundation (MRI Award 1039869; to D.J.G. and M.M.B.), Ohio University (Student Enhancement Award to G.E.C.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alon R, 1996, J CELL BIOL, V135, P849, DOI 10.1083/jcb.135.3.849; Alon R, 1997, J CELL BIOL, V138, P1169, DOI 10.1083/jcb.138.5.1169; ALON R, 1995, J IMMUNOL, V154, P5356; Barthel SR, 2007, EXPERT OPIN THER TAR, V11, P1473, DOI 10.1517/14728222.11.11.1473; BELL GI, 1978, SCIENCE, V200, P618, DOI 10.1126/science.347575; BERG EL, 1993, NATURE, V366, P695, DOI 10.1038/366695a0; BERG EL, 1991, J EXP MED, V174, P1461, DOI 10.1084/jem.174.6.1461; Beste MT, 2008, P NATL ACAD SCI USA, V105, P20716, DOI 10.1073/pnas.0808213105; Borsig L, 2002, P NATL ACAD SCI USA, V99, P2193, DOI 10.1073/pnas.261704098; Borsig L, 2007, J BIOL CHEM, V282, P14984, DOI 10.1074/jbc.M610560200; Burdick MM, 2003, AM J PHYSIOL-CELL PH, V284, pC977, DOI 10.1152/ajpcell.00423.2002; Burdick MM, 2006, J BIOL CHEM, V281, P13899, DOI 10.1074/jbc.M513617200; Burdick MM, 2012, FRONT ONCOL, V2, DOI 10.3389/fonc.2012.00103; Caputo KE, 2007, BIOPHYS J, V92, P787, DOI 10.1529/biophysj.106.082321; Cheung LSL, 2011, BIOPHYS J, V100, P2338, DOI 10.1016/j.bpj.2011.04.013; Christman MA, 2008, AM J PHYSIOL-HEART C, V294, pH2864, DOI 10.1152/ajpheart.00982.2007; De Marzo AM, 2002, HUM PATHOL, V33, P756, DOI 10.1053/hupa.2002.126187; DEMBO M, 1988, PROC R SOC SER B-BIO, V234, P55, DOI 10.1098/rspb.1988.0038; Dimitroff CJ, 2001, J BIOL CHEM, V276, P47623, DOI 10.1074/jbc.M105997200; Dube DH, 2005, NAT REV DRUG DISCOV, V4, P477, DOI 10.1038/nrd1751; Finger EB, 1996, NATURE, V379, P266, DOI 10.1038/379266a0; FOXALL C, 1992, J CELL BIOL, V117, P895, DOI 10.1083/jcb.117.4.895; Fuhlbrigge RC, 1996, J CELL BIOL, V135, P837, DOI 10.1083/jcb.135.3.837; Goetz DJ, 1996, AM J PATHOL, V149, P1661; Goetz DJ, 1997, J CELL BIOL, V137, P509, DOI 10.1083/jcb.137.2.509; Greenberg AW, 2000, BIOPHYS J, V79, P2391, DOI 10.1016/S0006-3495(00)76484-8; Hanley WD, 2005, CANCER RES, V65, P5812, DOI 10.1158/0008-5472.CAN-04-4557; Huang X, 1997, HISTOCHEM CELL BIOL, V107, P57, DOI 10.1007/s004180050089; Jeong S, 2001, BIOCHEM BIOPH RES CO, V281, P237, DOI 10.1006/bbrc.2001.4327; JONES RJ, 1991, BLOOD, V77, P649; Kim YJ, 1999, AM J PATHOL, V155, P461, DOI 10.1016/S0002-9440(10)65142-5; Kim YJ, 1998, P NATL ACAD SCI USA, V95, P9325, DOI 10.1073/pnas.95.16.9325; Lafferriere J, 2004, CLIN EXP METASTAS, V21, P257, DOI 10.1023/B:CLIN.0000037708.09420.9a; Lafkas D, 2015, NATURE, V528, P127, DOI 10.1038/nature15715; Laubli H, 2006, CANCER RES, V66, P1536, DOI 10.1158/0008-5472.CAN-05-3121; Lawrence MB, 1997, J CELL BIOL, V136, P717, DOI 10.1083/jcb.136.3.717; Lawrence MB, 1999, CURR OPIN CHEM BIOL, V3, P659, DOI 10.1016/S1367-5931(99)00023-X; LAWRENCE MB, 1991, CELL, V65, P859, DOI 10.1016/0092-8674(91)90393-D; LEWINSOHN DM, 1987, J IMMUNOL, V138, P4313; Malgor R, 2014, INFLAMM RES, V63, P277, DOI 10.1007/s00011-013-0697-x; MANNORI G, 1995, CANCER RES, V55, P4425; Marshall BT, 2003, NATURE, V423, P190, DOI 10.1038/nature01605; Mazo IB, 1998, J EXP MED, V188, P465, DOI 10.1084/jem.188.3.465; Meeker AK, 2002, AM J PATHOL, V160, P1259, DOI 10.1016/S0002-9440(10)62553-9; Meijering E, 2012, METHOD ENZYMOL, V504, P183, DOI 10.1016/B978-0-12-391857-4.00009-4; MUNN LL, 1994, BIOPHYS J, V67, P889, DOI 10.1016/S0006-3495(94)80550-8; Nakamori S, 1997, DIS COLON RECTUM, V40, P420, DOI 10.1007/BF02258386; NEEDHAM LK, 1993, P NATL ACAD SCI USA, V90, P1359, DOI 10.1073/pnas.90.4.1359; Nicholson MW, 1998, J BIOL CHEM, V273, P763, DOI 10.1074/jbc.273.2.763; Nimrichter L, 2008, BLOOD, V112, P3744, DOI 10.1182/blood-2008-04-149641; Otali D, 2009, BIOTECH HISTOCHEM, V84, P223, DOI 10.1080/10520290903039094; Renkonen R, 1997, GLYCOCONJUGATE J, V14, P593, DOI 10.1023/A:1018536509950; Robertson D, 2008, BMC CELL BIOL, V9, DOI 10.1186/1471-2121-9-13; Sackstein R, 1997, BLOOD, V89, P2773, DOI 10.1182/blood.V89.8.2773; Shea DJ, 2015, ONCOTARGET, V6, P24842, DOI 10.18632/oncotarget.4704; Shirure VS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044529; STAMPER HB, 1976, J EXP MED, V144, P828, DOI 10.1084/jem.144.3.828; Sundd P, 2011, BIORHEOLOGY, V48, P1, DOI 10.3233/BIR-2011-0579; SUZUKI Y, 1993, BIOCHEM BIOPH RES CO, V190, P426, DOI 10.1006/bbrc.1993.1065; Tao L, 1997, ELECTROPHORESIS, V18, P112, DOI 10.1002/elps.1150180121; Tees DFJ, 2003, NEWS PHYSIOL SCI, V18, P186, DOI 10.1152/nips.01444.2003; Tu L, 1999, J EXP MED, V189, P241, DOI 10.1084/jem.189.2.241; Tu LL, 1999, J IMMUNOL, V163, P5070; Xie R, 2011, J HISTOCHEM CYTOCHEM, V59, P356, DOI 10.1369/0022155411398488; Yago T, 2004, J CELL BIOL, V166, P913, DOI 10.1083/jcb.200403144; Zhu Cheng, 2005, Molecular & Cellular Biomechanics, V2, P91	66	5	5	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 10	2017	12	3							e0173747	10.1371/journal.pone.0173747	http://dx.doi.org/10.1371/journal.pone.0173747			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN6CJ	28282455	Green Submitted, gold, Green Published			2022-12-27	WOS:000396091800077
J	Zennaro, C; Tonon, F; Zarattini, P; Clai, M; Corbelli, A; Carraro, M; Marchetti, M; Ronda, L; Paredi, G; Rastaldi, MP; Percudani, R				Zennaro, Cristina; Tonon, Federica; Zarattini, Paola; Clai, Milan; Corbelli, Alessandro; Carraro, Michele; Marchetti, Marialaura; Ronda, Luca; Paredi, Gianluca; Rastaldi, Maria Pia; Percudani, Riccardo			The renal phenotype of allopurinol-treated HPRT-deficient mouse	PLOS ONE			English	Article							LESCH-NYHAN-SYNDROME; PURINE NUCLEOSIDE PHOSPHORYLASE; URATE-OXIDASE; XANTHINE OXIDOREDUCTASE; CLASSICAL XANTHINURIA; MESENCHYMAL TRANSITION; URIC-ACID; DISEASE; NEPHROPATHY; GENE	Excess of uric acid is mainly treated with xanthine oxidase (XO) inhibitors, also called uricostatics because they block the conversion of hypoxanthine and xanthine into urate. Normally, accumulation of upstream metabolites is prevented by the hypoxanthine-guanine phosphoribosyltransferase (HPRT) enzyme. The recycling pathway, however, is impaired in the presence of HPRT deficiency, as observed in Lesch-Nyhan disease. To gain insights into the consequences of purine accumulation with HPRT deficiency, we investigated the effects of the XO inhibitor allopurinol in Hprt-lacking (HPRT-/-) mice. Allopurinol was administered in the drinking water of E12-E14 pregnant mothers at dosages of 150 or 75 mu g/ml, and mice sacrificed after weaning. The drug was well tolerated by wild-type animals and heterozygous HPRT+/- mice. Instead, a profound alteration of the renal function was observed in the HPRT-/- model. Increased hypoxanthine and xanthine concentrations were found in the blood. The kidneys showed a yellowish appearance, diffuse interstitial nephritis, with dilated tubules, inflammatory and fibrotic changes of the interstitium. There were numerous xanthine tubular crystals, as determined by HPLC analysis. Oil red O staining demonstrated lipid accumulation in the same location of xanthine deposits. mRNA analysis showed increased expression of adipogenesis-related molecules as well as profibrotic and proinflammatory pathways. Immunostaining showed numerous monocyte-macrophages and overexpression of alpha-smooth muscle actin in the tubulointerstitium. In vitro, addition of xanthine to tubular cells caused diffuse oil red O positivity and modification of the cell phenotype, with loss of epithelial features and appearance of mesenchymal characteristics, similarly to what was observed in vivo. Our results indicate that in the absence of HPRT, blockade of XO by allopurinol causes rapidly developing renal failure due to xanthine deposition within the mouse kidney. Xanthine seems to be directly involved in promoting lipid accumulation and subsequent phenotype changes of tubular cells, with activation of inflammation and fibrosis.	[Zennaro, Cristina; Tonon, Federica; Carraro, Michele] Univ Trieste, Dept Med Surg & Hlth Sci, Trieste, Italy; [Zarattini, Paola] Univ Trieste, Dept Life Sci, Trieste, Italy; [Clai, Milan] Azienda Sanit Univ Integrata Trieste, Dept Pathol & Legal Med, Trieste, Italy; [Corbelli, Alessandro] IRCCS Mario Negri Inst Pharmacol Res, Dept Cardiovasc Res, Unit Bioimaging, Milan, Italy; [Marchetti, Marialaura; Percudani, Riccardo] Univ Parma, Dept Life Sci, Parma, Italy; [Ronda, Luca] Univ Parma, Dept Neurosci, Parma, Italy; [Paredi, Gianluca] Univ Parma, PARMA Interdept Ctr, Dept Pharm, Parma, Italy; [Paredi, Gianluca] Univ Parma, PARMA Interdept Ctr, SITEIA, Parma, Italy; [Rastaldi, Maria Pia] Fdn IRCCS Ca Granda Osped Maggiore Policlin, Milan, Italy	University of Trieste; University of Trieste; University of Trieste; Istituto di Ricerche Farmacologiche Mario Negri IRCCS; University of Parma; University of Parma; University of Parma; University of Parma; IRCCS Ca Granda Ospedale Maggiore Policlinico	Zennaro, C (corresponding author), Univ Trieste, Dept Med Surg & Hlth Sci, Trieste, Italy.	czennaro@units.it	Paredi, Gianluca/N-9977-2019; Marchetti, Marialaura/U-3644-2017; Corbelli, Alessandro/ABG-3900-2020; Tonon, Federica/AAC-7343-2022	Marchetti, Marialaura/0000-0002-4615-6786; Corbelli, Alessandro/0000-0001-8545-8050; 	Telethon grant, "Development of an uricolytic treatment for HPRT-deficiency in animal models" [GGP13149]; FRA University of Trieste, "Application of in vitro and Zebrafish models to uncover the potential involvement of the urostatic drug allopurinol in renal and neuronal damage of Lesch-Nyhan disease"	Telethon grant, "Development of an uricolytic treatment for HPRT-deficiency in animal models"(Fondazione Telethon); FRA University of Trieste, "Application of in vitro and Zebrafish models to uncover the potential involvement of the urostatic drug allopurinol in renal and neuronal damage of Lesch-Nyhan disease"	This work was supported by a Telethon grant GGP13149, "Development of an uricolytic treatment for HPRT-deficiency in animal models", providing also salaries for CZ, FT, MM, and AC. Funding was received also from FRA 2015 University of Trieste, "Application of in vitro and Zebrafish models to uncover the potential involvement of the urostatic drug allopurinol in renal and neuronal damage of Lesch-Nyhan disease".	Arikyants N, 2007, PEDIATR NEPHROL, V22, P310, DOI 10.1007/s00467-006-0267-3; BRADBURY MG, 1995, PEDIATR NEPHROL, V9, P476, DOI 10.1007/BF00866732; Burdett TC, 2013, BIOMED CHROMATOGR, V27, P122, DOI 10.1002/bmc.2760; Carew RM, 2012, CELL TISSUE RES, V347, P103, DOI 10.1007/s00441-011-1227-1; Chen XQ, 2013, P NATL ACAD SCI USA, V110, P300, DOI 10.1073/pnas.1217296110; Constantinescu R, 2011, DRUG TODAY, V47, P369, DOI 10.1358/dot.2011.47.5.1591834; Crook ED, 2003, AM J MED SCI, V325, P340, DOI 10.1097/00000441-200306000-00005; Fried LF, 2001, KIDNEY INT, V59, P260, DOI 10.1046/j.1523-1755.2001.00487.x; GOMEZ GA, 1978, ARCH INTERN MED, V138, P1017, DOI 10.1001/archinte.138.6.1017; Harris JC, 1998, ARCH NEUROL-CHICAGO, V55, P547, DOI 10.1001/archneur.55.4.547; Harrison R, 2002, FREE RADICAL BIO MED, V33, P774, DOI 10.1016/S0891-5849(02)00956-5; Hershfield MS, 2010, P NATL ACAD SCI USA, V107, P14351, DOI 10.1073/pnas.1001072107; Ho MC, 2010, P NATL ACAD SCI USA, V107, P4805, DOI 10.1073/pnas.0913439107; HOOPER M, 1987, NATURE, V326, P292, DOI 10.1038/326292a0; Ichida K, 2001, BIOCHEM BIOPH RES CO, V282, P1194, DOI 10.1006/bbrc.2001.4719; Ichida K, 1998, INTERNAL MED, V37, P77, DOI 10.2169/internalmedicine.37.77; Javor ED, 2004, J CLIN ENDOCR METAB, V89, P3199, DOI 10.1210/jc.2003-032140; Jinnah HA, 2009, DIS MODEL MECH, V2, P116, DOI 10.1242/dmm.002543; Kang TH, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016572; Kiss A, 1999, UROL INT, V63, P242, DOI 10.1159/000030458; Kucera J, 1997, J SMALL ANIM PRACT, V38, P302, DOI 10.1111/j.1748-5827.1997.tb03471.x; Levartovsky D, 2000, KIDNEY INT, V57, P2215, DOI 10.1046/j.1523-1755.2000.00082.x; Lovisa S, 2016, TRENDS ENDOCRIN MET, V27, P681, DOI 10.1016/j.tem.2016.06.004; Miranda M, 2010, J VET MED SCI, V72, P921, DOI 10.1292/jvms.09-0494; MIZUNO T, 1976, NEUROPADIATRIE, V7, P351, DOI 10.1055/s-0028-1091635; Nyhan WL, 2005, MOL GENET METAB, V86, P25, DOI 10.1016/j.ymgme.2005.07.027; Oda M, 2002, MOL BIOL EVOL, V19, P640, DOI 10.1093/oxfordjournals.molbev.a004123; OGAWA A, 1985, UROLOGY, V26, P56, DOI 10.1016/0090-4295(85)90256-0; Ohtsubo T, 2009, HYPERTENSION, V54, P868, DOI 10.1161/HYPERTENSIONAHA.109.135152; Rastaldi MP, 2002, KIDNEY INT, V62, P137, DOI 10.1046/j.1523-1755.2002.00430.x; Roche A, 2009, AM J KIDNEY DIS, V53, P677, DOI 10.1053/j.ajkd.2008.09.011; Ryu ES, 2013, AM J PHYSIOL-RENAL, V304, pF471, DOI 10.1152/ajprenal.00560.2012; Saeedi R, 2015, CLIN BIOCHEM, V48, P472, DOI 10.1016/j.clinbiochem.2014.08.014; Scriver C.R., 1995, METABOLIC MOL BASES; Shimo T, 2005, TOXICOL SCI, V87, P267, DOI 10.1093/toxsci/kfi210; Sikora P, 2006, PEDIATR NEPHROL, V21, P1045, DOI 10.1007/s00467-006-0149-8; Simmonds H.A., 1995, METABOLIC MOL BASIS; STOECKLER JD, 1980, BIOCHEMISTRY-US, V19, P102, DOI 10.1021/bi00542a016; Thomas N, 1996, J Assoc Physicians India, V44, P203; Torres RJ, 2007, ORPHANET J RARE DIS, V2, DOI 10.1186/1750-1172-2-48; Torres RJ, 2012, CURR RHEUMATOL REP, V14, DOI 10.1007/s11926-011-0231-5; Tsuchida S, 2007, J FELINE MED SURG, V9, P503, DOI 10.1016/j.jfms.2007.03.012; Visser JE, 2000, BRAIN RES REV, V32, P449, DOI 10.1016/S0165-0173(99)00094-6; Waldek S, 2014, BMC NEPHROL, V15, DOI 10.1186/1471-2369-15-72; WU XW, 1994, P NATL ACAD SCI USA, V91, P742, DOI 10.1073/pnas.91.2.742; Xu P, 2000, J BIOL CHEM, V275, P5918, DOI 10.1074/jbc.275.8.5918	46	8	8	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 10	2017	12	3							e0173512	10.1371/journal.pone.0173512	http://dx.doi.org/10.1371/journal.pone.0173512			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN6CJ	28282408	Green Published, Green Submitted, gold			2022-12-27	WOS:000396091800047
J	Rodrigues, D; Lopes, D; Kumashiro, M				Rodrigues, David; Lopes, Diniz; Kumashiro, Madoka			The "I" in us, or the eye on us? Regulatory focus, commitment and derogation of an attractive alternative person	PLOS ONE			English	Article							ROMANTIC RELATIONSHIP STATUS; REGISTERED REPLICATION REPORT; RELATIONSHIP STATUS BIASES; OPPOSITE-SEX OTHERS; CLOSE RELATIONSHIPS; PROMOTION; INFIDELITY; PREVENTION; FORGIVENESS; FIT	When individuals are highly committed to their romantic relationship, they are more likely to engage in pro-relationship maintenance mechanisms. The present research expanded on the notion that commitment redirects self-oriented goals to consider broader relational goals and examined whether commitment interacts with a promotion and prevention focus to activate derogation of attractive alternatives. Three studies used cross-sectional and experimental approaches. Study 1 showed that romantically involved individuals predominantly focused on promotion, but not prevention, reported less initial attraction to an attractive target than single individuals, especially when highly committed to their relationship. Study 2 showed that romantically involved individuals induced in a promotion focus, compared to those in prevention focus, reported less initial attraction, but only when more committed to their relationship. Regardless of regulatory focus manipulation, more committed individuals were also less likely to perceive quality among alternative scenarios and to be attentive to alternative others in general. Finally, Study 3 showed that romantically involved individuals induced in promotion focus and primed with high commitment reported less initial attraction, than those primed with low commitment, or than those induced in prevention focus. Once again, for these latter no differences occurred according to commitment prime. Together, the findings suggest that highly committed promotion focused individuals consider broader relationship goals and activate relationship maintenance behaviors such as derogation of attractive alternatives to promote their relationship.	[Rodrigues, David; Lopes, Diniz] Inst Univ Lisboa ISCTE IUL, CIS IUL, Lisbon, Portugal; [Rodrigues, David; Kumashiro, Madoka] Univ London, London, England	Instituto Universitario de Lisboa; University of London	Rodrigues, D (corresponding author), Inst Univ Lisboa ISCTE IUL, CIS IUL, Lisbon, Portugal.; Rodrigues, D (corresponding author), Univ London, London, England.	dflrs@iscte.pt	Lopes, Diniz/I-7691-2012; Rodrigues, David L./J-4436-2013	Lopes, Diniz/0000-0002-4353-2248; Rodrigues, David L./0000-0001-5921-7819	Fundacao para a Ciencia e a Tecnologia [SFRH/BPD/73528/2010]	Fundacao para a Ciencia e a Tecnologia(Portuguese Foundation for Science and TechnologyEuropean Commission)	This research was funded by the grant SFRH/BPD/73528/2010, awarded by Fundacao para a Ciencia e a Tecnologia to DR. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agnew CR, 1998, J PERS SOC PSYCHOL, V74, P939, DOI 10.1037/0022-3514.74.4.939; ARGYLE M, 1986, INT J PSYCHOL, V21, P287, DOI 10.1080/00207598608247591; Arriaga XB, 2001, PERS SOC PSYCHOL B, V27, P1190, DOI 10.1177/0146167201279011; Bohns VK, 2013, SOC COGNITION, V31, P1; Bohns VK, 2011, SOC COGNITION, V29, P497; Cesario J, 2004, J PERS SOC PSYCHOL, V86, P388, DOI 10.1037/0022-3514.86.3.388; Cheung I, 2016, PERSPECT PSYCHOL SCI, V11, P750, DOI 10.1177/1745691616664694; Drigotas SM, 1999, J PERS SOC PSYCHOL, V77, P509, DOI 10.1037/0022-3514.77.3.509; Drigotas SM, 1999, PERS RELATIONSHIP, V6, P389, DOI 10.1111/j.1475-6811.1999.tb00199.x; Etcheverry PE, 2005, PERS RELATIONSHIP, V12, P103, DOI 10.1111/j.1350-4126.2005.00104.x; Feeney BC, 2015, PERS SOC PSYCHOL REV, V19, P113, DOI 10.1177/1088868314544222; Finkel EJ, 2002, J PERS SOC PSYCHOL, V82, P956, DOI 10.1037//0022-3514.82.6.956; Finkel EJ, 2016, PERSPECT PSYCHOL SCI, V11, P765, DOI 10.1177/1745691616664695; Finkel EJ, 2009, SYD SYM SOC PSYCHOL, P319; Fitzsimons G.M., 2011, HDB SELF REGULATION, P407; Friedman RS, 2001, J PERS SOC PSYCHOL, V81, P1001, DOI 10.1037/0022-3514.81.6.1001; Gonzaga GC, 2008, EVOL HUM BEHAV, V29, P119, DOI 10.1016/j.evolhumbehav.2007.11.003; Hall JH, 2006, J SOC CLIN PSYCHOL, V25, P508, DOI 10.1521/jscp.2006.25.5.508; Hayes AF., 2017, MEDIATION MODERATION, V2nd edn; Higgins ET, 2008, HANDBOOK OF MOTIVATION AND COGNITION ACROSS CULTURES, P161, DOI 10.1016/B978-0-12-373694-9.00008-8; HIGGINS ET, 1994, J PERS SOC PSYCHOL, V66, P276, DOI 10.1037/0022-3514.66.2.276; Higgins ET, 1997, AM PSYCHOL, V52, P1280, DOI 10.1037/0003-066X.52.12.1280; Higgins ET, 2001, EUR J SOC PSYCHOL, V31, P3, DOI 10.1002/ejsp.27; Hong JW, 2008, J CONSUM RES, V34, P682, DOI 10.1086/521902; JOHNSON DJ, 1989, J PERS SOC PSYCHOL, V57, P967, DOI 10.1037/0022-3514.57.6.967; Karremans JC, 2008, PERS SOC PSYCHOL B, V34, P939, DOI 10.1177/0146167208316693; Karremans JC, 2011, COGNITION, V121, P422, DOI 10.1016/j.cognition.2011.07.008; Kumashiro M, 2008, J PERS SOC PSYCHOL, V95, P94, DOI 10.1037/0022-3514.95.1.94; Lydon JE, 2003, PERS SOC PSYCHOL B, V29, P349, DOI 10.1177/0146167202250202; Mark KP, 2011, ARCH SEX BEHAV, V40, P971, DOI 10.1007/s10508-011-9771-z; Mattingly BA, 2011, J SOC PSYCHOL, V151, P222, DOI 10.1080/00224540903536162; Miller RS, 1997, J PERS SOC PSYCHOL, V73, P758, DOI 10.1037/0022-3514.73.4.758; Molden D, 2008, EYE MOTIVATED BEHOLD; Molden D.C., 2013, OXFORD HDB RELATIONS, P321, DOI [10.1093/oxfordhb/9780195398694.013.0015, DOI 10.1093/OXFORDHB/9780195398694.013.0015]; Molden DC, 2008, J EXP SOC PSYCHOL, V44, P1219, DOI 10.1016/j.jesp.2008.03.009; Molden DC, 2010, J EXP SOC PSYCHOL, V46, P255, DOI 10.1016/j.jesp.2009.10.014; Molden DC, 2009, PSYCHOL SCI, V20, P787, DOI 10.1111/j.1467-9280.2009.02362.x; Overall NC, 2008, J EXP SOC PSYCHOL, V44, P95, DOI 10.1016/j.jesp.2007.02.005; Rodrigues D, 2016, J SEX RES; Rodrigues D, 2017, J SEX RES, V54, P241, DOI 10.1080/00224499.2016.1145182; Rodrigues D, 2015, PSICOL-REFLEX CRIT, V28, P261, DOI 10.1590/1678-7153.201528206; Rodrigues D, 2014, REV PSICOL SOC, V29, P532, DOI 10.1080/02134748.2014.981388; Rodrigues D, 2013, J GEN PSYCHOL, V140, P16, DOI 10.1080/00221309.2012.710276; Rusbult C. E., 2001, BLACKWELL HDB SOCIAL, V2, P359; RUSBULT CE, 1993, J SOC PERS RELAT, V10, P175, DOI 10.1177/026540759301000202; Rusbult CE, 1998, PERS RELATIONSHIP, V5, P357, DOI 10.1111/j.1475-6811.1998.tb00177.x; Schmitt DP, 2005, BEHAV BRAIN SCI, V28, P247, DOI 10.1017/S0140525X05000051; Semin GR, 2005, J PERS SOC PSYCHOL, V89, P36, DOI 10.1037/0022-3514.89.1.36; SIMPSON JA, 1990, J PERS SOC PSYCHOL, V59, P1192, DOI 10.1037/0022-3514.59.6.1192; Spiller SA, 2013, J MARKETING RES, V50, P277, DOI 10.1509/jmr.12.0420; Thornton A, 2001, J MARRIAGE FAM, V63, P1009, DOI 10.1111/j.1741-3737.2001.01009.x; VanderDrift LE, 2014, J PERS SOC PSYCHOL, V106, P927, DOI 10.1037/a0036180; Viegas Thaysa, 2013, Estud. psicol. (Natal), V18, P411, DOI 10.1590/S1413-294X2013000300001; Visserman ML, 2014, PERS RELATIONSHIP, V21, P324, DOI 10.1111/pere.12035; Westfall J, 2015, PERSPECT PSYCHOL SCI, V10, P390, DOI 10.1177/1745691614564879; Winterheld HA, 2011, J PERS SOC PSYCHOL, V101, P935, DOI 10.1037/a0025012; Woltin KA, 2015, PERS SOC PSYCHOL B, V41, P379, DOI 10.1177/0146167214566188; Zaal MP, 2015, EUR J SOC PSYCHOL, V45, P587, DOI 10.1002/ejsp.2109; Zou X, 2014, J PERS SOC PSYCHOL, V106, P183, DOI 10.1037/a0035391	59	9	9	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 20	2017	12	3							e0174350	10.1371/journal.pone.0174350	http://dx.doi.org/10.1371/journal.pone.0174350			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	ER6VC	28319147	Green Published, gold, Green Submitted, Green Accepted			2022-12-27	WOS:000398945800069
J	Wooten, AL; Aweda, TA; Lewis, BC; Gross, RB; Lapi, SE				Wooten, A. Lake; Aweda, Tolulope A.; Lewis, Benjamin C.; Gross, Rebecca B.; Lapi, Suzanne E.			Biodistribution and PET Imaging of pharmacokinetics of manganese in mice using Manganese-52	PLOS ONE			English	Article							BLOOD-BRAIN-BARRIER; POSITRON EMITTER MN-51; MRI CONTRAST AGENTS; TISSUE DISTRIBUTION; BIOLOGICAL DISTRIBUTION; OLFACTORY TRANSPORT; ENHANCED MRI; RAT-BRAIN; EXCRETION; RESONANCE	Manganese is essential to life, and humans typically absorb sufficient quantities of this element from a normal healthy diet; however, chronic, elevated ingestion or inhalation of manganese can be neurotoxic, potentially leading to manganism. Although imaging of large amounts of accumulated Mn(II) is possible by MRI, quantitative measurement of the biodistribution of manganese, particularly at the trace level, can be challenging. In this study, we produced the positron-emitting radionuclide Mn-52 (t(1/2) = 5.6 d) by proton bombardment (E-p<15 MeV) of chromium metal, followed by solid-phase isolation by cation-exchange chromatography. An aqueous solution of [(52) Mn] MnCl2 was nebulized into a closed chamber with openings through which mice inhaled the aerosol, and a separate cohort of mice received intravenous (IV) injections of [Mn-52] MnCl2. Ex vivo biodistribution was performed at 1 h and 1 d post-injection/inhalation (p.i.). In both trials, we observed uptake in lungs and thyroid at 1 d p.i. Manganese is known to cross the blood-brain barrier, as confirmed in our studies following IV injection (0.86% ID/g, 1 d p.i.) and following inhalation of aerosol, (0.31% ID/g, 1 d p.i.). Uptake in salivary gland and pancreas were observed at 1 d p.i. (0.5 and 0.8% ID/g), but to a much greater degree from IV injection (6.8 and 10% ID/g). In a separate study, mice received IV injection of an imaging dose of [Mn-52] MnCl2, followed by in vivo imaging by positron emission tomography (PET) and ex vivo biodistribution. The results from this study supported many of the results from the biodistribution-only studies. In this work, we have confirmed results in the literature and contributed new results for the biodistribution of inhaled radiomanganese for several organs. Our results could serve as supporting information for environmental and occupational regulations, for designing PET studies utilizing Mn-52, and/or for predicting the biodistribution of manganese-based MR contrast agents.	[Wooten, A. Lake; Aweda, Tolulope A.; Lewis, Benjamin C.; Gross, Rebecca B.; Lapi, Suzanne E.] Washington Univ, Sch Med, Mallinckrodt Inst Radiol, St Louis, MO 63130 USA; [Wooten, A. Lake; Lapi, Suzanne E.] Washington Univ, Dept Biomed Engn, St Louis, MO 63130 USA; [Lewis, Benjamin C.] Washington Univ, Dept Phys, St Louis, MO 63130 USA; [Lapi, Suzanne E.] Univ Alabama Birmingham, Dept Radiol, Birmingham, AL 35294 USA	Washington University (WUSTL); Washington University (WUSTL); Washington University (WUSTL); University of Alabama System; University of Alabama Birmingham	Lapi, SE (corresponding author), Washington Univ, Sch Med, Mallinckrodt Inst Radiol, St Louis, MO 63130 USA.; Lapi, SE (corresponding author), Washington Univ, Dept Biomed Engn, St Louis, MO 63130 USA.; Lapi, SE (corresponding author), Univ Alabama Birmingham, Dept Radiol, Birmingham, AL 35294 USA.	lapi@uab.edu			National Institute of Biomedical Imaging and Bioengineering (NIBIB); National Institutes of Health (NIH) [1T32EB14855-01]; Office of Defense Nuclear Nonproliferation (DNN), National Nuclear Security Administration (NNSA); United States Department of Energy (DOE) [DE-NA0000979]; Office of Science (SC); Mallinckrodt Institute of Radiology (MIR); Washington University School of Medicine in St. Louis (WUSM)	National Institute of Biomedical Imaging and Bioengineering (NIBIB)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Office of Defense Nuclear Nonproliferation (DNN), National Nuclear Security Administration (NNSA); United States Department of Energy (DOE)(United States Department of Energy (DOE)); Office of Science (SC); Mallinckrodt Institute of Radiology (MIR); Washington University School of Medicine in St. Louis (WUSM)	The authors gratefully acknowledge funding for this work from: National Institute of Biomedical Imaging and Bioengineering (NIBIB; nibib.nih.gov), National Institutes of Health (NIH; 1T32EB14855-01; ALW); Office of Defense Nuclear Nonproliferation (DNN), National Nuclear Security Administration (NNSA; nnsa.energy.gov), United States Department of Energy (DOE; DE-NA0000979; ALW, BCL, research expenses); Office of Science (SC; science.energy.gov), DOE (SEL); internal funds from Mallinckrodt Institute of Radiology (MIR; mir.wustl.edu), Washington University School of Medicine in St. Louis (WUSM; research costs, TM, RBG). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ASCHNER M, 1994, BRAIN RES BULL, V33, P345, DOI 10.1016/0361-9230(94)90204-6; ASCHNER M, 1990, BRAIN RES BULL, V24, P857, DOI 10.1016/0361-9230(90)90152-P; Averill Bruce, 2011, GEN CHEM PRINCIPLES; Avila Daiana Silva, 2013, Met Ions Life Sci, V13, P199, DOI 10.1007/978-94-007-7500-8_7; Aweda TA, 2015, J LABELLED COMPD RAD, V58, P234, DOI 10.1002/jlcr.3289; Aweda TA, 2013, MEDCHEMCOMM, V4, P1015, DOI 10.1039/c3md00082f; BERTINCHAMPS AJ, 1966, AM J PHYSIOL, V211, P217, DOI 10.1152/ajplegacy.1966.211.1.217; Brain JD, 2006, AM J RESP CELL MOL, V34, P330, DOI 10.1165/rcmb.2005-0101OC; Brenneman KA, 2000, TOXICOL APPL PHARM, V169, P238, DOI 10.1006/taap.2000.9073; Brismar TB, 2012, EUR RADIOL, V22, P633, DOI 10.1007/s00330-011-2288-y; Brunnquell CL, 2016, CONTRAST MEDIA MOL I, V11, P371, DOI 10.1002/cmmi.1701; Buchholz M, 2013, RADIOCHIM ACTA, V101, P491, DOI 10.1524/ract.2013.2083; Buchholz M, 2015, RADIOCHIM ACTA, V103, P893, DOI 10.1515/ract-2015-2506; CALNE DB, 1994, NEUROLOGY, V44, P1583, DOI 10.1212/WNL.44.9.1583; Cersosimo MG, 2006, NEUROTOXICOLOGY, V27, P340, DOI 10.1016/j.neuro.2005.10.006; CHAUNCEY DM, 1977, J NUCL MED, V18, P933; CIKRT M, 1972, BRIT J IND MED, V29, P74; Cotzias GC, 1963, S RAD AN ITS APPL BI; Couper J., 1837, BR ANN MED PHARM, V1, P41, DOI DOI 10.1002/JCP.22692; Criswell SR, 2012, OCCUP ENVIRON MED, V69, P437, DOI 10.1136/oemed-2011-100119; Crossgrove JS, 2005, NEUROTOXICOLOGY, V26, P297, DOI 10.1016/j.neuro.2004.09.004; Crossgrove JS, 2003, NEUROTOXICOLOGY, V24, P3, DOI 10.1016/S0161-813X(02)00089-X; DAUBE ME, 1985, INT J NUCL MED BIOL, V12, P303, DOI 10.1016/0047-0740(85)90185-8; DEYSACH LJ, 1949, P SOC EXP BIOL MED, V71, P188, DOI 10.3181/00379727-71-17128; Dorman DC, 2002, J TOXICOL ENV HEAL A, V65, P1493, DOI 10.1080/00984100290071630; ELIZONDO G, 1991, RADIOLOGY, V178, P73, DOI 10.1148/radiology.178.1.1898538; Fonslet J, 2017, APPL RADIAT ISOTOPES, V121, P38, DOI 10.1016/j.apradiso.2016.11.021; FORE H, 1952, BIOCHEM J, V51, P600, DOI 10.1042/bj0510600; FORE H, 1952, BIOCHEM J, V51, P598, DOI 10.1042/bj0510598; Gallez B, 1996, MAGNET RESON MED, V35, P14, DOI 10.1002/mrm.1910350104; GIBBONS RA, 1976, BIOCHIM BIOPHYS ACTA, V444, P1, DOI 10.1016/0304-4165(76)90218-X; Graves S, 2016, J NUCL MED, V57; Graves SA, 2015, BIOCONJUGATE CHEM, V26, P2118, DOI 10.1021/acs.bioconjchem.5b00414; Greenwood NN, 1997, CHEM ELEMENTS, P1041; Heilig EA, 2006, AM J PHYSIOL-LUNG C, V290, pL1247, DOI 10.1152/ajplung.00450.2005; Higdon J, 2010, MANGANESE; HIRAISHI K, 1995, RADIOLOGY, V194, P119, DOI 10.1148/radiology.194.1.7997537; HUGHES ER, 1966, AM J PHYSIOL, V211, P207, DOI 10.1152/ajplegacy.1966.211.1.207; Hustvedt SO, 1997, ACTA RADIOL, V38, P690; Josephs KA, 2005, NEUROLOGY, V64, P2033, DOI 10.1212/01.WNL.0000167411.93483.A1; Kanayama Y, 2005, BIOMETALS, V18, P553, DOI 10.1007/s10534-005-4775-6; KATO M, 1963, Q J EXP PHYSIOL CMS, V48, P355, DOI 10.1113/expphysiol.1963.sp001678; KAWADA J, 1985, ENDOCRINOL JAPON, V32, P635; Klein ATJ, 2000, RADIOCHIM ACTA, V88, P253, DOI 10.1524/ract.2000.88.5.253; Klein ATJ, 2005, APPL RADIAT ISOTOPES, V62, P711, DOI 10.1016/j.apradiso.2004.09.009; Klein ATJ, 2002, RADIOCHIM ACTA, V90, P167, DOI 10.1524/ract.2002.90.3_2002.167; KODAMA H, 1991, BIOCHEM J, V278, P857, DOI 10.1042/bj2780857; KOSHIDA Y, 1963, Q J EXP PHYSIOL CMS, V48, P370; Lahiri S, 2006, ANAL CHEM, V78, P7517, DOI 10.1021/ac0607459; Laohaudomchok W, 2011, NEUROTOXICOLOGY, V32, P171, DOI 10.1016/j.neuro.2010.12.014; LAU SJ, 1984, CAN J BIOCHEM CELL B, V62, P449, DOI 10.1139/o84-061; Lauterbur PC., 1978, FRONTIERS BIOL ENERG, V1978, P752; Leblondel G, 1999, BIOL TRACE ELEM RES, V67, P13, DOI 10.1007/BF02784271; Lewis CM, 2015, THERANOSTICS, V5, P227, DOI 10.7150/thno.10185; Lewis J, 2005, NEUROTOXICOLOGY, V26, P113, DOI 10.1016/j.neuro.2004.06.005; Ni Y, 1997, ACTA RADIOL, V38, P700; NISHIDA M, 1992, EXPERIENTIA, V48, P262, DOI 10.1007/BF01930470; Pan DPJ, 2011, WIRES NANOMED NANOBI, V3, P162, DOI 10.1002/wnan.116; PAPAVASILIOU PS, 1966, AM J PHYSIOL, V211, P211, DOI 10.1152/ajplegacy.1966.211.1.211; Pautler RG, 1998, MAGNET RESON MED, V40, P740, DOI 10.1002/mrm.1910400515; Pierre VC, 2014, J BIOL INORG CHEM, V19, P127, DOI 10.1007/s00775-013-1074-5; RABIN O, 1993, J NEUROCHEM, V61, P509; Ray TW, 1942, P SOC EXP BIOL MED, V51, P228, DOI 10.3181/00379727-51-13909P; ROCKLAGE SM, 1989, INORG CHEM, V28, P477, DOI 10.1021/ic00302a019; Rodier J, 1955, BRIT J IND MED, V12, P21; SAKURAI H, 1985, BIOCHIM BIOPHYS ACTA, V841, P208; SCHEUHAMMER AM, 1985, BIOCHIM BIOPHYS ACTA, V840, P163, DOI 10.1016/0304-4165(85)90115-1; Serrano F, 2008, MAGN RESON MED, V60, P169, DOI 10.1002/mrm.21648; Seshadri M, 2010, MAGN RESON MED, V64, P902, DOI 10.1002/mrm.22452; SJOGREN B, 1990, BRIT J IND MED, V47, P704; TANAKA S, 1959, J PHYS SOC JPN, V14, P1269, DOI 10.1143/JPSJ.14.1269; Thompson K, 2007, FASEB J, V21, P223, DOI 10.1096/fj.06-6710com; Tjalve H, 1996, PHARMACOL TOXICOL, V79, P347; TJALVE H, 1995, PHARMACOL TOXICOL, V77, P23; Topping GJ, 2013, MED PHYS, V40, DOI 10.1118/1.4793756; Vanasschen C, 2016, DALTON T, V45, P1315, DOI 10.1039/c5dt04270d; Vargas ER, 2010, MOL IMAGING PRINCIPL, P389; Wang DX, 2008, TOXICOL LETT, V176, P40, DOI 10.1016/j.toxlet.2007.10.003; Wolf G L, 1985, Magn Reson Annu, P231; WOLF GL, 1983, AM J ROENTGENOL, V141, P193, DOI 10.2214/ajr.141.1.193; Wooten AL, 2015, APPL RADIAT ISOTOPES, V96, P154, DOI 10.1016/j.apradiso.2014.12.001; Yokel RA, 2003, NEUROTOXICOLOGY, V24, P15, DOI 10.1016/S0161-813X(02)00090-6; Yokel RA, 2002, ENVIRON HEALTH PERSP, V110, P699, DOI 10.1289/ehp.02110s5699	83	21	21	0	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 17	2017	12	3							e017435	10.1371/journal.pone.0174351	http://dx.doi.org/10.1371/journal.pone.0174351			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EO5CJ	28306727	Green Published, Green Submitted, gold			2022-12-27	WOS:000396710300029
J	Fong, G; Backman, LJ; Alfredson, H; Scott, A; Danielson, P				Fong, Gloria; Backman, Ludvig J.; Alfredson, Hakan; Scott, Alex; Danielson, Patrik			The effects of substance P and acetylcholine on human tenocyte proliferation converge mechanistically via TGF-beta 1	PLOS ONE			English	Article							GROWTH-FACTOR-BETA; ACHILLES-TENDON; NEUROKININ-1 RECEPTOR; PATELLAR TENDON; UP-REGULATION; EXPRESSION; TENDINOPATHY; TENDINOSIS; MATRIX; CELLS	Previous in vitro studies on human tendon cells (tenocytes) have demonstrated that the exogenous administration of substance P (SP) and acetylcholine (ACh) independently result in tenocyte proliferation, which is a prominent feature of tendinosis. Interestingly, the possible link between SP and ACh has not yet been explored in human tenocytes. Recent studies in other cell types demonstrate that both SP and ACh independently upregulate TGF-beta 1 expression via their respective receptors, the neurokinin 1 receptor (NK-1R) and muscarinic ACh receptors (mAChRs). Furthermore, TGF-beta 1 has been shown to downregulate NK-1R expression in human keratocytes. The aim of this study was to examine if TGF-beta 1 is the intermediary player involved in mediating the proliferative pathway shared by SP and ACh in human tenocytes. The results showed that exogenous administration of SP and ACh both caused significant upregulation of TGF-beta 1 at the mRNA and protein levels. Exposing cells to TGF-beta 1 resulted in increased cell viability of tenocytes, which was blocked in the presence of the TGF beta RI/II kinase inhibitor. In addition, the proliferative effects of SP and ACh on tenocytes were reduced by the TGF beta RI/II kinase inhibitor; this supports the hypothesis that the proliferative effects of these signal substances are mediated via the TGF-beta axis. Furthermore, exogenous TGF-beta 1 downregulated NK-1R and mAChRs expression at both the mRNA and protein levels, and these effects were negated by simultaneous exposure to the TGF beta RI/II kinase inhibitor, suggesting a negative feedback loop. In conclusion, the results indicate that TGF-beta 1 is the intermediary player through which the proliferative actions of both SP and ACh converge mechanistically.	[Fong, Gloria; Backman, Ludvig J.; Danielson, Patrik] Umea Univ, Dept Integrat Med Biol, Umea, Sweden; [Fong, Gloria; Scott, Alex] Vancouver Coastal Hlth Res Inst, Ctr Hip Hlth & Mobil, Vancouver, BC, Canada; [Alfredson, Hakan] Umea Univ, Dept Community Med & Rehabil, Umea, Sweden; [Danielson, Patrik] Umea Univ, Dept Clin Sci, Ophthalmol, Umea, Sweden	Umea University; Vancouver Coastal Health Research Institute; Umea University; Umea University	Danielson, P (corresponding author), Umea Univ, Dept Integrat Med Biol, Umea, Sweden.; Danielson, P (corresponding author), Umea Univ, Dept Clin Sci, Ophthalmol, Umea, Sweden.	patrik.danielson@umu.se		Scott, Alex/0000-0003-0366-8404	National Swedish Research Council [397 521-2013-2612, 521-2013-2612]; Swedish Society of Medicine [SLS-410021, 504541]; Vasterbotten County Council (VLL 'Spjutspetsmedel') [VLL-363161]; Umea University [VLL-549761]; Vasterbotten County Council [VLL-549761]	National Swedish Research Council(Swedish Research Council); Swedish Society of Medicine; Vasterbotten County Council (VLL 'Spjutspetsmedel'); Umea University; Vasterbotten County Council	Financial support was obtained by P.D. from the National Swedish Research Council (grant no.397 521-2013-2612, http://www.vr.se/inenglish.4.12fff4451215cbd83e4800015152.html), the Swedish Society of Medicine (SLS-410021 and 504541, http://www.sls.se/Om-SLS/In-English/), and Vasterbotten County Council (VLL 'Spjutspetsmedel') (VLL-363161). Financial support was furthermore provided to P.D. through a regional agreement (ALF) between Umea University and Vasterbotten County Council (VLL-549761, http://www.medfak.umu.se/om-fakulteten/aktuellt/nyhetsvisning/alf-investeringsmedel-2016.cid265286). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors thank Dr Sandrine LeRoux for technical assistance and scientific advice. Financial support was obtained by P.D. from the National Swedish Research Council (grant no. 521-2013-2612), the Swedish Society of Medicine (SLS-410021 and 504541), and Vasterbotten County Council (VLL 'Spjutspetsmedel') (VLL-363161). Financial support was furthermore provided to P.D. through a regional agreement (ALF) between Umea University and Vasterbotten County Council (VLL-549761).	Andersson G, 2008, REGUL PEPTIDES, V150, P81, DOI 10.1016/j.regpep.2008.02.005; Backman LJ, 2011, J MUSCULOSKEL NEURON, V11, P133; Backman LJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027209; Bjur D, 2008, CELL TISSUE RES, V331, P385, DOI 10.1007/s00441-007-0524-1; Chung YT, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0084980, 10.1371/journal.pone.0070128]; Danielson P, 2007, LIFE SCI, V80, P2235, DOI 10.1016/j.lfs.2007.01.005; Docheva D, 2005, MOL CELL BIOL, V25, P699, DOI 10.1128/MCB.25.2.699-705.2005; Fong G, 2013, CELL TISSUE RES, V351, P465, DOI 10.1007/s00441-012-1530-5; Fong G, 2013, J ORTHOP RES, V31, P91, DOI 10.1002/jor.22191; Fu SC, 2005, CLIN ORTHOP RELAT R, P226, DOI 10.1097/01.blo.0000145887.48534.6f; Galatz LM, 2006, J ORTHOP RES, V24, P541, DOI 10.1002/jor.20067; Gingery A, 2014, J ORTHOP RES, V32, P1444, DOI 10.1002/jor.22694; Goodier HCJ, 2016, ARTHRITIS RES THER, V18, DOI 10.1186/s13075-016-0947-8; Heinemeier K, 2003, J APPL PHYSIOL, V95, P2390, DOI 10.1152/japplphysiol.00403.2003; Khan KM, 1999, SPORTS MED, V27, P393, DOI 10.2165/00007256-199927060-00004; Kjaer M, 2004, PHYSIOL REV, V84, P649, DOI 10.1152/physrev.00031.2003; Koon HW, 2004, J BIOL CHEM, V279, P45519, DOI 10.1074/jbc.M408523200; Le Roux S, 2016, CURR EYE RES, V41, P1035, DOI 10.3109/02713683.2015.1088954; Lian O, 2006, AM J SPORT MED, V34, P1801, DOI 10.1177/0363546506289169; Matthiesen S, 2006, AM J RESP CELL MOL, V35, P621, DOI 10.1165/rcmb.2005-0343RC; Mendias CL, 2012, J APPL PHYSIOL, V113, P56, DOI 10.1152/japplphysiol.00301.2012; Pingel J, 2012, BMC MUSCULOSKEL DIS, V13, DOI 10.1186/1471-2474-13-53; Schubert TEO, 2005, ANN RHEUM DIS, V64, P1083, DOI 10.1136/ard.2004.029876; Spindler KP, 1996, J ORTHOP RES, V14, P542, DOI 10.1002/jor.1100140407; Steyaert A, 2010, ACTA ORTHOP BELG, V76, P387; Tsubone T, 2006, J ORTHOP RES, V24, P569, DOI 10.1002/jor.20101; Visser LC, 2010, VET SURG, V39, P811, DOI 10.1111/j.1532-950X.2010.00739.x; Xu YY, 2008, BRIT J HAEMATOL, V142, P192, DOI 10.1111/j.1365-2141.2008.07130.x; Yang H, 2015, CONNECT TISSUE RES, V56, P461, DOI 10.3109/03008207.2015.1054030; Yang K, 2014, BMC PULM MED, V14, DOI 10.1186/1471-2466-14-53; Yaraee R, 2009, IRAN J ALLERGY ASTHM, V8, P19, DOI 08.01/ijaai.1924	31	10	10	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 16	2017	12	3							e0174101	10.1371/journal.pone.0174101	http://dx.doi.org/10.1371/journal.pone.0174101			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN9KE	28301610	Green Published, Green Submitted, gold			2022-12-27	WOS:000396318300126
J	Streubel, J; Baum, H; Grau, J; Stuttman, J; Boch, J				Streubel, Jana; Baum, Heidi; Grau, Jan; Stuttman, Johannes; Boch, Jens			Dissection of TALE-dependent gene activation reveals that they induce transcription cooperatively and in both orientations	PLOS ONE			English	Article							BACTERIAL-BLIGHT RESISTANCE; RICE ORYZA-SATIVA; AGROBACTERIUM-TUMEFACIENS; BIDIRECTIONAL PROMOTERS; RECESSIVE RESISTANCE; INTERGENIC REGION; CRYSTAL-STRUCTURE; DNA RECOGNITION; PROTEIN AVRBS3; EFFECTOR	Plant-pathogenic Xanthomonas bacteria inject transcription activator-like effector proteins (TALEs) into host cells to specifically induce transcription of plant genes and enhance susceptibility. Although the DNA-binding mode is well-understood it is still ambiguous how TALEs initiate transcription and whether additional promoter elements are needed to support this. To systematically dissect prerequisites for transcriptional initiation the activity of one TALE was compared on different synthetic Bs4 promoter fragments. In addition, a large collection of artificial TALEs spanning the OsSWEET14 promoter was compared. We show that the presence of a TALE alone is not sufficient to initiate transcription suggesting the requirement of additional supporting promoter elements. At the OsSWEET14 promoter TALEs can initiate transcription from various positions, in a synergistic manner of multiple TALEs binding in parallel to the promoter, and even by binding in reverse orientation. TALEs are known to shift the transcriptional start site, but our data show that this shift depends on the individual position of a TALE within a promoter context. Our results implicate that TALEs function like classical enhancer-binding proteins and initiate transcription in both orientations which has consequences for in planta target gene prediction and design of artificial activators.	[Streubel, Jana; Boch, Jens] Leibniz Univ Hannover, Inst Plant Genet, Hannover, Germany; [Streubel, Jana; Baum, Heidi; Stuttman, Johannes; Boch, Jens] Martin Luther Univ Halle Wittenberg, Dept Plant Genet, Halle, Germany; [Grau, Jan] Martin Luther Univ Halle Wittenberg, Inst Comp Sci, Halle, Germany	Leibniz University Hannover; Martin Luther University Halle Wittenberg; Martin Luther University Halle Wittenberg	Streubel, J (corresponding author), Leibniz Univ Hannover, Inst Plant Genet, Hannover, Germany.	jana.streubel@genetik.uni-hannover.de	Grau, Jan/H-5465-2019	Grau, Jan/0000-0003-2081-6405; Stuttmann, Johannes/0000-0002-6207-094X; Streubel, Jana/0000-0001-8155-511X	Deutsche Forschungsgemeinschaft [BO 1496/7-1, BO 1496/8-1, GR 4587/1-1]; COST action "SUSTAIN" [FM208]; Leibniz Universitat Hannover	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); COST action "SUSTAIN"(European Cooperation in Science and Technology (COST)); Leibniz Universitat Hannover	This project was supported by grants from the Deutsche Forschungsgemeinschaft (BO 1496/7-1 and BO 1496/8-1 to JB, and GR 4587/1-1 to JG) and by the COST action FM208 "SUSTAIN". The publication of this article was funded by the Open Access Fund of the Leibniz Universitat Hannover. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adelman K, 2012, NAT REV GENET, V13, P720, DOI 10.1038/nrg3293; Anthony K, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0095790; Antony G, 2010, PLANT CELL, V22, P3864, DOI 10.1105/tpc.110.078964; Banerjee J, 2013, PLOS ONE, V8; Blackwood EM, 1998, SCIENCE, V281, P60, DOI 10.1126/science.281.5373.60; Blanvillain-Baufume S, 2017, PLANT BIOTECHNOL J, V15, P306, DOI 10.1111/pbi.12613; Boch J, 2014, NEW PHYTOL, V204, P823, DOI 10.1111/nph.13015; Boch J, 2010, ANNU REV PHYTOPATHOL, V48, P419, DOI 10.1146/annurev-phyto-080508-081936; Boch J, 2009, SCIENCE, V326, P1509, DOI 10.1126/science.1178811; Bruckner K, 2015, PLANT J, V82, P707, DOI 10.1111/tpj.12843; Bultmann S, 2012, NUCLEIC ACIDS RES, V40, P5368, DOI 10.1093/nar/gks199; Chen LQ, 2010, NATURE, V468, P527, DOI 10.1038/nature09606; Civan P, 2009, GENOME, V52, P294, DOI 10.1139/G09-001; Cohn M, 2014, MOL PLANT MICROBE IN, V27, P1186, DOI 10.1094/MPMI-06-14-0161-R; Cuculis L, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8277; de Souza TA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032305; Dehury B, 2015, J MOL GRAPH MODEL, V57, P49, DOI 10.1016/j.jmgm.2015.01.005; Deng D, 2012, SCIENCE, V335, P720, DOI 10.1126/science.1215670; Dion V, 2003, J BIOL CHEM, V278, P11495, DOI 10.1074/jbc.M211938200; Domingues MN, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041553; Domingues MN, 2010, MOL PLANT PATHOL, V11, P663, DOI [10.1111/J.1364-3703.2010.00636.X, 10.1111/j.1364-3703.2010.00636.x]; Doyle EL, 2013, TRENDS CELL BIOL, V23, P390, DOI 10.1016/j.tcb.2013.04.003; Doyle EL, 2012, NUCLEIC ACIDS RES, V40, pW117, DOI 10.1093/nar/gks608; Gao HS, 2012, CELL RES, V22, P1716, DOI 10.1038/cr.2012.156; Geissler R, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019509; GELVIN SB, 1983, NUCLEIC ACIDS RES, V11, P159; Gonzalez C, 2007, MOL PLANT MICROBE IN, V20, P534, DOI 10.1094/MPMI-20-5-0534; Grau J, 2013, PLOS COMPUT BIOL, V9, DOI 10.1371/journal.pcbi.1002962; Gross P, 2006, BIOCHEM SOC SYMP, V73, P225; Gurlebeck D, 2005, PLANT J, V42, P175, DOI 10.1111/j.1365-313X.2005.02370.x; Huang S, 2016, PLANT J, V86, P186, DOI 10.1111/tpj.13164; Hummel AW, 2012, NEW PHYTOL, V195, P883, DOI 10.1111/j.1469-8137.2012.04216.x; Iyer AS, 2004, MOL PLANT MICROBE IN, V17, P1348, DOI 10.1094/MPMI.2004.17.12.1348; Jinek M, 2012, SCIENCE, V337, P816, DOI 10.1126/science.1225829; Kay S, 2005, MOL PLANT MICROBE IN, V18, P838, DOI 10.1094/MPMI-18-0838; Kay S, 2007, SCIENCE, V318, P648, DOI 10.1126/science.1144956; Kay S, 2009, PLANT J, V59, P859, DOI 10.1111/j.1365-313X.2009.03922.x; KOBAYASHI N, 1995, MOL CELL BIOL, V15, P6465; Kourmpetli S, 2013, BMC PLANT BIOL, V13, DOI 10.1186/1471-2229-13-187; Kulaeva OI, 2012, MOL CELL BIOL, V32, P4892, DOI 10.1128/MCB.01127-12; Kumari S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079011; Lescot M, 2002, NUCLEIC ACIDS RES, V30, P325, DOI 10.1093/nar/30.1.325; LEUNG J, 1991, MOL GEN GENET, V230, P463, DOI 10.1007/BF00280304; Lis M, 2016, BMC GENOMICS, V17, DOI 10.1186/s12864-016-2630-5; Liu XQ, 2016, J EXP BOT, V67, P4403, DOI 10.1093/jxb/erw226; Maeder ML, 2013, NAT METHODS, V10, P243, DOI [10.1038/nmeth.2366, 10.1038/NMETH.2366]; Mak ANS, 2012, SCIENCE, V335, P716, DOI 10.1126/science.1216211; Mansfield J, 2012, MOL PLANT PATHOL, V13, P614, DOI 10.1111/j.1364-3703.2012.00804.x; Meyer P, 2000, PLANT MOL BIOL, V43, P221, DOI 10.1023/A:1006483428789; Mitra A, 2009, PLANTA, V229, P1015, DOI 10.1007/s00425-008-0859-1; Moscou MJ, 2009, SCIENCE, V326, P1501, DOI 10.1126/science.1178817; Nakagawa T, 2007, PGWB VECTORS TRANSFO; Ordon J, 2016, PLANT J; OZER J, 1994, GENE DEV, V8, P2324, DOI 10.1101/gad.8.19.2324; Pereira ALA, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-157; Perez-Pinera P, 2013, NAT METHODS, V10, P239, DOI [10.1038/nmeth.2361, 10.1038/NMETH.2361]; Perez-Quintero A, 2013, PLOS ONE, V8; Piatek A, 2015, PLANT BIOTECHNOL J, V13, P578, DOI 10.1111/pbi.12284; REIMERS PJ, 1991, PHYSIOL MOL PLANT P, V38, P39, DOI 10.1016/S0885-5765(05)80141-9; Romer P, 2010, NEW PHYTOL, V187, P1048, DOI 10.1111/j.1469-8137.2010.03217.x; Romer P, 2009, P NATL ACAD SCI USA, V106, P20526, DOI 10.1073/pnas.0908812106; Romer P, 2009, PLANT PHYSIOL, V150, P1697, DOI 10.1104/pp.109.139931; Russo MT, 2015, MAR GENOM, V24, P69, DOI 10.1016/j.margen.2015.06.010; Schornack S, 2005, MOL PLANT MICROBE IN, V18, P1215, DOI 10.1094/MPMI-18-1215; Schornack S, 2008, NEW PHYTOL, V179, P546, DOI 10.1111/j.1469-8137.2008.02487.x; Scruggs BS, 2015, MOL CELL, V58, P1101, DOI 10.1016/j.molcel.2015.04.006; Seila AC, 2009, CELL CYCLE, V8, P2557, DOI 10.4161/cc.8.16.9305; Seila AC, 2008, SCIENCE, V322, P1849, DOI 10.1126/science.1162253; SEIPEL K, 1992, EMBO J, V11, P4961, DOI 10.1002/j.1460-2075.1992.tb05603.x; Shahmuradov IA, 2003, NUCLEIC ACIDS RES, V31, P114, DOI 10.1093/nar/gkg041; Smale ST, 2003, ANNU REV BIOCHEM, V72, P449, DOI 10.1146/annurev.biochem.72.121801.161520; Soprano AS, 2013, PLANT PHYSIOL, V163, P232, DOI 10.1104/pp.113.224642; STARGELL LA, 1995, SCIENCE, V269, P75, DOI 10.1126/science.7604282; Streubel J, 2013, NEW PHYTOL, V200, P808, DOI 10.1111/nph.12411; Streubel J, 2012, NAT BIOTECHNOL, V30, P593, DOI 10.1038/nbt.2304; Sugio A, 2007, P NATL ACAD SCI USA, V104, P10720, DOI 10.1073/pnas.0701742104; Szurek B, 2001, PLANT J, V26, P523, DOI 10.1046/j.0960-7412.2001.01046.x; TRIEZENBERG SJ, 1995, CURR OPIN GENET DEV, V5, P190, DOI 10.1016/0959-437X(95)80007-7; Uhde-Stone C, 2014, BIOCHEM BIOPH RES CO, V443, P1189, DOI 10.1016/j.bbrc.2013.12.111; Valton J, 2012, J BIOL CHEM, V287, P38427, DOI 10.1074/jbc.C112.408864; VAN LAREBEKE N, 1974, NATURE, V252, P169, DOI 10.1038/252169a0; VandenAckerveken G, 1996, CELL, V87, P1307, DOI 10.1016/S0092-8674(00)81825-5; Wan Q, 2016, NEW PHYTOL; Wang CL, 2014, MOL PLANT PATHOL, V15, P333, DOI 10.1111/mpp.12092; Wang CL, 2015, MOL PLANT, V8, P290, DOI 10.1016/j.molp.2014.10.010; Wang L, 2017, MOL PLANT, V10, P285, DOI 10.1016/j.molp.2016.12.002; Wang Q, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-S1-S29; White FF, 2009, PLANT PHYSIOL, V150, P1677, DOI 10.1104/pp.109.139360; Yang B, 2000, P NATL ACAD SCI USA, V97, P9807, DOI 10.1073/pnas.170286897; Yu YH, 2011, MOL PLANT MICROBE IN, V24, P1102, DOI 10.1094/MPMI-11-10-0254; Yuan M, 2016, ELIFE, V5, DOI 10.7554/eLife.19605; Yuan M, 2014, J INTEGR PLANT BIOL, V56, P559, DOI 10.1111/jipb.12173; Yuan M, 2013, MOL PLANT, V6, P665, DOI 10.1093/mp/sst035; Zetsche B, 2015, NAT BIOTECHNOL, V33, P139, DOI 10.1038/nbt.3149; Zhang HS, 2014, NUCLEIC ACIDS RES, V42, DOI 10.1093/nar/gku535; Zhou JH, 2015, PLANT J, V82, P632, DOI 10.1111/tpj.12838; Zhu WG, 1998, MOL PLANT MICROBE IN, V11, P824, DOI 10.1094/MPMI.1998.11.8.824	97	15	15	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 16	2017	12	3							e0173580	10.1371/journal.pone.0173580	http://dx.doi.org/10.1371/journal.pone.0173580			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN9KE	28301511	Green Published, gold, Green Submitted			2022-12-27	WOS:000396318300052
J	Astrom, E; Stal, P; Zenlander, R; Edenvik, P; Alexandersson, C; Haglund, M; Ryden, I; Pahlsson, P				Astrom, Eva; Stal, Per; Zenlander, Robin; Edenvik, Pia; Alexandersson, Catharina; Haglund, Mats; Ryden, Ingvar; Pahlsson, Peter			Reverse lectin ELISA for detecting fucosylated forms of alpha 1-acid glycoprotein associated with hepatocellular carcinoma	PLOS ONE			English	Article							QUANTITATIVE-ANALYSIS; ALPHA-FETOPROTEIN; SERUM; HAPTOGLOBIN; BIOMARKERS; CIRRHOSIS; PLASMA	Altered fucosylation of glycoproteins is associated with development of hepatocellular carcinoma (HCC). Lectins have been commonly used to assay changes in fucosylation of plasma glycoproteins. In the present study a recombinantly engineered form of the fucose binding lectin Aleuria aurantia (AAL) consisting of a single binding site for fucose (S2), was used to construct a reverse lectin ELISA method. Microtiter plates coated with the S2 lectin were used to capture glycoproteins from plasma samples followed by antibody detection of S2-bound fucosylated alpha 1-acid glycoprotein (S2-bound AGP). The method was used to compare the level of S2-bound AGP in serum samples from a small cohort of patients with hepatitis, cirrhosis or HCC. Using the reverse S2 lectin ELISA it was shown that the levels of S2-bound AGP was significantly higher in HCC patients compared to non-cancer patients and that there was also a significant elevation of S2-bound AGP in HCC patients compared to cirrhosis patients. There was no correlation between the level of S2-bound AGP and total AGP concentration. The performance of S2-bound AGP in differentiating HCC from cirrhosis samples or hepatitis samples were compared to other markers. A combination of S2-bound AGP, alpha-fetoprotein and AGP concentration showed performances giving area under receiver operating curves of 0.87 and 0.95 respectively.	[Astrom, Eva; Pahlsson, Peter] Linkoping Univ, Dept Clin & Expt Med, Linkoping, Sweden; [Stal, Per; Zenlander, Robin; Edenvik, Pia] Karolinska Univ Hosp, Karolinska Inst, Div Gastroenterol & Hepatol, Dept Med, Stockholm, Sweden; [Alexandersson, Catharina; Haglund, Mats] Kalmar Cty Hosp, Dept Infect Dis, Kalmar, Sweden; [Ryden, Ingvar] Kalmar Cty Hosp, Dept Clin Chem, Kalmar, Sweden	Linkoping University; Karolinska Institutet; Karolinska University Hospital	Astrom, E (corresponding author), Linkoping Univ, Dept Clin & Expt Med, Linkoping, Sweden.	eva.i.astrom@liu.se	Stål, Per/J-2154-2019	Stål, Per/0000-0003-2915-1964; Astrom, Eva/0000-0002-3258-4042	Stockholm County Council [20140329, 20150403]; Swedish Society of Medicine, Gastroenterology Fund [SLS 505601]; Ruth and Richard Julins Foundation [40661, 45300]; Uppsala Bio, Bio-X; Health Research Council of Southeast of Sweden [FORSS-389021]	Stockholm County Council(Stockholm County Council); Swedish Society of Medicine, Gastroenterology Fund; Ruth and Richard Julins Foundation; Uppsala Bio, Bio-X; Health Research Council of Southeast of Sweden	PE and PS obtained funding from Stockholm County Council ALF projects 20140329 and 20150403 (http://forskningsstod.vmi.se/Ansokan/start.asp), the Swedish Society of Medicine, Gastroenterology Fund SLS 505601 (http://www.sls.se/) and Ruth and Richard Julins Foundation 40661 and 45300, (https://www.wallenberg.com/rrj/) PP obtained funding from Uppsala Bio, Bio-X (http://www.bio.x.nu/ and the Health Research Council of Southeast of Sweden, FORSS-389021 (https://www.fou.nu/is/forss/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABRAHAM R, 1991, J IMMUNOL METHODS, V144, P77, DOI 10.1016/0022-1759(91)90233-6; Ahn YH, 2013, ANALYST, V138, P6454, DOI 10.1039/c3an01126g; Ahn YH, 2012, ANAL BIOANAL CHEM, V402, P2101, DOI 10.1007/s00216-011-5646-3; Asao T, 2013, BIOMED RES INT, V2013, DOI 10.1155/2013/834790; Asazawa H, 2015, CLIN CHEM LAB MED, V53, P95, DOI 10.1515/cclm-2014-0427; Bachtiar Indra, 2010, BMC Res Notes, V3, P319, DOI 10.1186/1756-0500-3-319; Bruix J, 2011, HEPATOLOGY, V53, P1020, DOI 10.1002/hep.24199; Comunale MA, 2013, PROTEOM CLIN APPL, V7, P690, DOI 10.1002/prca.201200125; Comunale MA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012419; Comunale MA, 2009, J PROTEOME RES, V8, P595, DOI 10.1021/pr800752c; DEGRAAF TW, 1993, J EXP MED, V177, P657, DOI 10.1084/jem.177.3.657; Ertle JM, 2013, DIGESTION, V87, P121, DOI 10.1159/000346080; Kuzmanov U, 2013, BMC MED, V11, DOI 10.1186/1741-7015-11-31; Marrero JA, 2006, CURR OPIN GASTROEN, V22, P248, DOI 10.1097/01.mog.0000218961.86182.8c; Mehta A, 2008, DIS MARKERS, V25, P259, DOI 10.1155/2008/264594; Naitoh A, 1999, J GASTROEN HEPATOL, V14, P436, DOI 10.1046/j.1440-1746.1999.01882.x; Nakagawa T, 2008, J PROTEOME RES, V7, P2222, DOI 10.1021/pr700841q; Olausson J, 2011, GLYCOBIOLOGY, V21, P34, DOI 10.1093/glycob/cwq129; Perz JF, 2006, J HEPATOL, V45, P529, DOI 10.1016/j.jhep.2006.05.013; Sarbah SA, 2004, DIGEST DIS SCI, V49, P850, DOI 10.1023/B:DDAS.0000030098.75759.32; Singal A, 2009, ALIMENT PHARM THER, V30, P37, DOI 10.1111/j.1365-2036.2009.04014.x; Tanabe K, 2008, BIOCHEM BIOPH RES CO, V374, P219, DOI 10.1016/j.bbrc.2008.06.124; Tanabe K, 2016, J PROTEOME RES, V15, P2935, DOI 10.1021/acs.jproteome.5b01145; Wang MJ, 2009, CANCER EPIDEM BIOMAR, V18, P1914, DOI 10.1158/1055-9965.EPI-08-0980; Wimmerova M, 2003, J BIOL CHEM, V278, P27059, DOI 10.1074/jbc.M302642200; Wu J, 2014, J PROTEOME RES, V13, P2197, DOI 10.1021/pr401061c; Zhu JH, 2014, J PROTEOME RES, V13, P2986, DOI 10.1021/pr500128t	27	13	13	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 15	2017	12	3							e0173897	10.1371/journal.pone.0173897	http://dx.doi.org/10.1371/journal.pone.0173897			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN9HQ	28296934	Green Published, Green Submitted, gold			2022-12-27	WOS:000396311700075
J	Goede, SL; Rabeneck, L; van Ballegooijen, M; Zauber, AG; Paszat, LF; Hoch, JS; Yong, JHE; Kroep, S; Tinmouth, J; Lansdorp-Vogelaar, I				Goede, S. Lucas; Rabeneck, Linda; van Ballegooijen, Marjolein; Zauber, Ann G.; Paszat, Lawrence F.; Hoch, Jeffrey S.; Yong, Jean H. E.; Kroep, Sonja; Tinmouth, Jill; Lansdorp-Vogelaar, Iris			Harms, benefits and costs of fecal immunochemical testing versus guaiac fecal occult blood testing for colorectal cancer screening	PLOS ONE			English	Article							COLONOSCOPY; POPULATION; GUIDELINES; POLYP; COLON; PREVENTION; MORTALITY; US	Background The ColonCancerCheck screening program for colorectal cancer (CRC) in Ontario, Canada, is considering switching from biennial guaiac fecal occult blood test (gFOBT) screening between age 50-74 years to the more sensitive, but also less specific fecal immunochemical test (FIT). The aim of this study is to estimate whether the additional benefits of FIT screening compared to gFOBT outweigh the additional costs and harms. Methods We used microsimulation modeling to estimate quality adjusted life years (QALYs) gained and costs of gFOBT and FIT, compared to no screening, in a cohort of screening participants. We compared strategies with various age ranges, screening intervals, and cut-off levels for FIT. Cost-efficient strategies were determined for various levels of available colonoscopy capacity. Results Compared to no screening, biennial gFOBT screening between age 50-74 years provided 20 QALYs at a cost of CAN$200,900 per 1,000 participants, and required 17 colonoscopies per 1,000 participants per year. FIT screening was more effective and less costly. For the same level of colonoscopy requirement, biennial FIT (with a high cut-off level of 200 ng Hb/ml) between age 50-74 years provided 11 extra QALYs gained while saving CAN$ 333,300 per 1000 participants, compared to gFOBT. Without restrictions in colonoscopy capacity, FIT (with a low cut-off level of 50 ng Hb/ml) every year between age 45-80 years was the most cost-effective strategy providing 27 extra QALYs gained per 1000 participants, while saving CAN$448,300. Interpretation Compared to gFOBT screening, switching to FIT at a high cut-off level could increase the health benefits of a CRC screening program without considerably increasing colonoscopy demand.	[Goede, S. Lucas; van Ballegooijen, Marjolein; Kroep, Sonja; Lansdorp-Vogelaar, Iris] Erasmus Univ, Med Ctr, Dept Publ Hlth, Rotterdam, Netherlands; [Rabeneck, Linda] Canc Care Ontario, Prevent & Canc Control, Toronto, ON, Canada; [Rabeneck, Linda; Paszat, Lawrence F.; Hoch, Jeffrey S.; Tinmouth, Jill] Inst Clin Evaluat Sci, Toronto, ON, Canada; [Rabeneck, Linda] Univ Toronto, Dept Med, Toronto, ON, Canada; [Zauber, Ann G.] Mem Sloan Kettering Canc Ctr, Dept Epidemiol & Biostat, New York, NY 10021 USA; [Hoch, Jeffrey S.; Yong, Jean H. E.] St Michaels Hosp, Li Ka Shing Knowledge Inst, Ctr Excellence Econ Anal Res, Toronto, ON, Canada; [Tinmouth, Jill] Sunnybrook Hlth Sci Ctr, Div Gastroenterol, Dept Med, Toronto, ON, Canada	Erasmus University Rotterdam; Erasmus MC; Cancer Care Ontario; University of Toronto; University of Toronto; Memorial Sloan Kettering Cancer Center; University of Toronto; Li Ka Shing Knowledge Institute; University Toronto Affiliates; Saint Michaels Hospital Toronto; University of Toronto; Sunnybrook Research Institute; University Toronto Affiliates; Sunnybrook Health Science Center	Lansdorp-Vogelaar, I (corresponding author), Erasmus Univ, Med Ctr, Dept Publ Hlth, Rotterdam, Netherlands.	i.vogelaar@erasmusmc.nl	Hoch, Jeffrey/O-3406-2017	Hoch, Jeffrey/0000-0002-4880-4281; Tinmouth, Jill/0000-0002-0264-2176	Canadian Institutes of Health Research [CST-85478]; National Cancer Institute at the National Institutes of Health [U01-CA-097426, U01-CA-115953, U01-CA-152959]; Institute for Clinical Evaluative Sciences (ICES) - Ontario Ministry of Health and Long-Term Care (MOHLTC); NATIONAL CANCER INSTITUTE [U01CA199335, P30CA008748] Funding Source: NIH RePORTER	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); National Cancer Institute at the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Institute for Clinical Evaluative Sciences (ICES) - Ontario Ministry of Health and Long-Term Care (MOHLTC)(Ministry of Health and Long-Term Care, Ontario); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This publication is supported by a grant from the Canadian Institutes of Health Research (grant number CST-85478). In addition, this publication was made possible by the National Cancer Institute at the National Institutes of Health, which supported part of the development of the MISCAN-Colon model through the Cancer Intervention and Surveillance Modeling Network (grant numbers U01-CA-097426, U01-CA-115953, and U01-CA-152959). This study was supported by the Institute for Clinical Evaluative Sciences (ICES), which is funded by an annual grant from the Ontario Ministry of Health and Long-Term Care (MOHLTC).	Altobelli E, 2014, PREV MED, V62, P132, DOI 10.1016/j.ypmed.2014.02.010; [Anonymous], 2013, LIF TABL CAN PROV TE; [Anonymous], 2003, STAT SOFTW VERS 5 3; Benson VS, 2008, INT J CANCER, V122, P1357, DOI 10.1002/ijc.23273; Cancer Care Ontario, 2012, COL CANC CHECK 2010; Colorectal Cancer Screening, 2001, CMAJ, V165, P206; Djalalov S, 2014, MED DECIS MAKING, V34, P809, DOI 10.1177/0272989X14536779; Ferlay J, 2015, INT J CANCER, V136, pE359, DOI 10.1002/ijc.29210; Halloran SP, 2012, ENDOSCOPY, V44, pSE65, DOI 10.1055/s-0032-1309791; Hassan C, 2011, ENDOSCOPY, V43, P780, DOI 10.1055/s-0030-1256409; Heitman SJ, 2005, CAN MED ASSOC J, V173, P877, DOI 10.1503/cmaj.050553; Heitman SJ, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000370; Hewitson P, 2008, AM J GASTROENTEROL, V103, P1541, DOI 10.1111/j.1572-0241.2008.01875.x; Ho C, 2008, 114 CAN AG DRUGS TEC; Hol L, 2010, GUT, V59, P62, DOI 10.1136/gut.2009.177089; Hol L, 2009, BRIT J CANCER, V100, P1103, DOI 10.1038/sj.bjc.6604961; Holme O, 2013, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD009259.pub2; Jeong KE, 2013, HEALTH ECON REV, V3, DOI 10.1186/2191-1991-3-20; Lansdorp-Vogelaar I, 2010, ANN INTERN MED, V153, P368, DOI 10.7326/0003-4819-153-6-201009210-00004; Lansdorp-Vogelaar I, 2009, CANCER-AM CANCER SOC, V115, P2410, DOI 10.1002/cncr.24256; Lejeune C, 2014, DIGEST LIVER DIS, V46, P76, DOI 10.1016/j.dld.2013.07.018; Lejeune C, 2010, INT J TECHNOL ASSESS, V26, P40, DOI 10.1017/S026646230999078X; Lieberman DA, 2012, GASTROENTEROLOGY, V143, P844, DOI 10.1053/j.gastro.2012.06.001; Loeve F, 2004, INT J CANCER, V111, P633, DOI 10.1002/ijc.20277; Loeve F, 1999, COMPUT BIOMED RES, V32, P13, DOI 10.1006/cbmr.1998.1498; Loeve F, 2000, J NATL CANCER I, V92, P557, DOI 10.1093/jnci/92.7.557; Loeve F, 1998, NO1CN55186 ER U DEP; MORSON B, 1974, P ROY SOC MED, V67, P451, DOI 10.1177/00359157740676P115; MORSON BC, 1962, JAMA-J AM MED ASSOC, V179, P316, DOI 10.1001/jama.1962.03050050006002; MUTO T, 1975, CANCER, V36, P2251, DOI 10.1002/cncr.2820360944; Orpana Heather M, 2009, Health Rep, V20, P29; Rabeneck L, 2014, CANCER EPIDEM BIOMAR, V23, P508, DOI 10.1158/1055-9965.EPI-13-0956; Rabeneck L, 2012, CAN J GASTROENTEROL, V26, P131, DOI 10.1155/2012/486328; Rabeneck L, 2008, GASTROENTEROLOGY, V135, P1899, DOI 10.1053/j.gastro.2008.08.058; Sharp L, 2012, BRIT J CANCER, V106, P805, DOI 10.1038/bjc.2011.580; Siegel JE, 1997, PHARMACOECONOMICS, V11, P159, DOI 10.2165/00019053-199711020-00005; Statistics Canada, 2011, TABL 103 0550 NEW CA; Telford JJ, 2010, CAN MED ASSOC J, V182, P1307, DOI 10.1503/cmaj.090845; van Rijn JC, 2006, AM J GASTROENTEROL, V101, P343, DOI 10.1111/j.1572-0241.2006.00390.x; van Roon AH, 2010, GASTROENTEROLOGY, V138, pS189; van Rossum LG, 2008, GASTROENTEROLOGY, V135, P82, DOI 10.1053/j.gastro.2008.03.040; Ventura L, 2014, DIGEST LIVER DIS, V46, P82, DOI 10.1016/j.dld.2013.07.017; Vogelaar I, 2006, CANCER-AM CANCER SOC, V107, P1624, DOI 10.1002/cncr.22115; Wilschut JA, 2011, JNCI-J NATL CANCER I, V103, P1741, DOI 10.1093/jnci/djr385; Zauber AG, 2007, COST EFFECTIVENESS D; Zorzi M, 2007, EPIDEMIOL PREV, V31, P49; Zorzi M, 2015, GUT, V64, P1007, DOI 10.1136/gutjnl-2014-308970	47	27	27	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 15	2017	12	3							e0172864	10.1371/journal.pone.0172864	http://dx.doi.org/10.1371/journal.pone.0172864			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN9HQ	28296927	Green Published, Green Submitted, gold			2022-12-27	WOS:000396311700016
J	King, M; Lodwick, R; Jones, R; Whitaker, H; Petersen, I				King, Michael; Lodwick, Rebecca; Jones, Rebecca; Whitaker, Heather; Petersen, Irene			Death following partner bereavement: A self-controlled case series analysis	PLOS ONE			English	Article							MORTALITY; HEALTH; ADULT	Background There is mixed evidence that older people bereaved of a spouse or partner are at risk of adverse outcomes. The main difficulty is to take account of other explanatory factors. We tested for an association between a patient's death and the timing of any bereavement of a cohabitee. Method Self-controlled case series study in which each case serves as his or her own control and which thereby accounts for all fixed measurable and unmeasurable confounders. We used the Health Improvement Network (THIN) primary care database to identify patients who died aged 50-99 years during the period 2003 to 2014. We used the household identifier in the database to determine whether they had an opposite sex cohabitee at the start of the observation period. Results 38,773 men and 23,396 women who had died and who had a cohabitee at the start of the observation period, were identified and included in male and female cohorts respectively. A higher risk of death was found in the 24 months after the death of the cohabitee than in the time classified as unexposed. The greatest risk was during the first 3 months after the death of the cohabitee (age-adjusted incidence rate ratio [IRR] 1.63, 95% CI 1.45-1.83 in the male cohort, and IRR 1.70, 95% CI 1.52-1.90 in the female cohort). Conclusion Risk of death in men or women was significantly higher after the death of a cohabitee and this was greatest in the first three months of bereavement. We need more evidence on the effectiveness of interventions to reduce this increased mortality.	[King, Michael; Jones, Rebecca] UCL, Div Psychiat, London, England; [Lodwick, Rebecca; Petersen, Irene] UCL, Dept Primary Care & Populat Hlth, London, England; [Whitaker, Heather] Open Univ, Dept Math & Stat, Milton Keynes, Bucks, England	University of London; University College London; University of London; University College London; Open University - UK	King, M (corresponding author), UCL, Div Psychiat, London, England.	michael.king@ucl.ac.uk	Whitaker, Heather Joy/O-4995-2017	Whitaker, Heather Joy/0000-0001-5833-1863				Booth N, 1994, Health Libr Rev, V11, P177; CHARLTON R, 1995, BRIT J GEN PRACT, V45, P427; Dave S, 2009, PHARMACOEPIDEM DR S, V18, P704, DOI 10.1002/pds.1770; EBRAHIM S, 1995, AM J EPIDEMIOL, V142, P834, DOI 10.1093/oxfordjournals.aje.a117723; Farrington CP, 2006, J R STAT SOC C-APPL, V55, P553, DOI 10.1111/j.1467-9876.2006.00554.x; Farrington CP, 2009, BIOSTATISTICS, V10, P3, DOI 10.1093/biostatistics/kxn013; King M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0052561; PARKES CM, 1969, BMJ-BRIT MED J, V1, P740, DOI 10.1136/bmj.1.5646.740; Parkes CM, 1998, BRIT MED J, V316, P856, DOI 10.1136/bmj.316.7134.856; Petersen I, 2016, BMJ-BRIT MED J, V354, DOI 10.1136/bmj.i4515; SCHAEFER C, 1995, AM J EPIDEMIOL, V141, P1142, DOI 10.1093/oxfordjournals.aje.a117387; Schorr L, 2016, ANN EPIDEMIOL, V26, P115, DOI 10.1016/j.annepidem.2015.12.008; Shah SM, 2013, CIRCULATION; Shah SM, 2013, AM J PUBLIC HEALTH, V103, P1140, DOI 10.2105/AJPH.2012.301050; Shah SM, 2012, AM J EPIDEMIOL, V176, P689, DOI 10.1093/aje/kws162; Shor E, 2012, DEMOGRAPHY, V49, P575, DOI 10.1007/s13524-012-0096-x; Simeonova E, 2013, J HEALTH ECON, V32, P33, DOI 10.1016/j.jhealeco.2012.10.010; Stahl ST, 2016, PSYCHOSOM MED, V78, P697, DOI 10.1097/PSY.0000000000000317; Stroebe M, 2007, LANCET, V370, P1960, DOI 10.1016/S0140-6736(07)61816-9; Waller A, 2015, PALLIATIVE MED; Whitaker HJ, 2006, STAT MED, V25, P1768, DOI 10.1002/sim.2302; Woof WR, 1997, BRIT J GEN PRACT, V47, P443; Ytterstad E, 2015, EPIDEMIOLOGY, V26, P289, DOI 10.1097/EDE.0000000000000266	23	7	7	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 15	2017	12	3							e0173870	10.1371/journal.pone.0173870	http://dx.doi.org/10.1371/journal.pone.0173870			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EN9HQ	28296949	Green Published, Green Submitted, gold, Green Accepted			2022-12-27	WOS:000396311700073
J	Lau, CI; Lin, CC; Chen, HJ; Wang, HC; Chen, WH; Liang, JA				Lau, Chi-Ieong; Lin, Che-Chen; Chen, Hsuan-Ju; Wang, Han-Cheng; Chen, Wei-Hung; Liang, Ji-An			Increased risk of essential tremor in migraine: A population-based retrospective cohort study	PLOS ONE			English	Article							PARKINSONISM; IMPAIRMENT; PREVALENCE	Purpose To examine the long-term risk of essential tremor (ET) in migraine. Methods Using population-based administrative data from a subset of the National Health Insurance Research Database (NHIRD) of Taiwan, we identified 22,696 newly diagnosed migraineurs (mean age 44.5 years) and a matched migraine-free cohort of 90,784 individuals in the period 2000-2008. Multivariable Cox proportional hazards regression analysis was conducted for assessing the ET risk for the migraine cohort compared to the migraine-free cohort. Results After adjusting for covariates, the migraine cohort had a 1.83-fold increased risk (95% CI 1.50-2.23) of subsequent ET in comparison to the migraine-free cohort (8.97 vs. 4.81 per 10,000 person-years). In the subgroup analysis, patients with migraine were associated with higher risks of ET, regardless of gender, age or the existence of comorbidities. Conclusion Our findings demonstrated an association between migraine and ET, suggesting a possible shared pathophysiology underpinning both disorders.	[Lau, Chi-Ieong; Wang, Han-Cheng; Chen, Wei-Hung] Shin Kong Wu Ho Su Mem Hosp, Dept Neurol, Taipei, Taiwan; [Lau, Chi-Ieong] Univ Oxford, Div Clin Neurol, Nuffield Dept Clin Neurosci, Oxford, England; [Lau, Chi-Ieong] UCL, Inst Cognit Neurosci, Queen Sq, London, England; [Lau, Chi-Ieong] Fu Jen Catholic Univ, Coll Med, Taipei, Taiwan; [Lin, Che-Chen; Chen, Hsuan-Ju] China Med Univ Hosp, Management Off Hlth Data, Taichung, Taiwan; [Lin, Che-Chen] Taichung Vet Gen Hosp, Healthcare Serv Res Ctr, Taichung, Taiwan; [Chen, Hsuan-Ju] China Med Univ, Coll Med, Taichung, Taiwan; [Wang, Han-Cheng; Chen, Wei-Hung] Taipei Med Univ, Coll Med, Taipei, Taiwan; [Wang, Han-Cheng] Natl Taiwan Univ, Coll Med, Taipei, Taiwan; [Liang, Ji-An] China Med Univ, Grad Inst Clin Med Sci, Sch Med, Coll Med, Taichung, Taiwan; [Liang, Ji-An] China Med Univ Hosp, Dept Radiat Oncol, Taichung, Taiwan	Shin Kong Wu Ho Su Memorial Hospital; University of Oxford; University of London; University College London; Fu Jen Catholic University; China Medical University Taiwan; China Medical University Hospital - Taiwan; Taichung Veterans General Hospital; China Medical University Taiwan; Taipei Medical University; National Taiwan University; China Medical University Taiwan; China Medical University Taiwan; China Medical University Hospital - Taiwan	Liang, JA (corresponding author), China Med Univ, Grad Inst Clin Med Sci, Sch Med, Coll Med, Taichung, Taiwan.; Liang, JA (corresponding author), China Med Univ Hosp, Dept Radiat Oncol, Taichung, Taiwan.	d4615@mail.cmuh.org.tw		Liang, Ji-An/0000-0002-4170-7155	Taiwan Ministry of Health and Welfare Clinical Trial and Research Center of Excellence [MOHW105-TDU-B-212-133019]; China Medical University Hospital, Academia Sinica Taiwan Biobank Stroke Biosignature Project [BM10501010037]; NRPB Stroke Clinical Trial Consortium [MOST 105-2325-B-039-003]; Tseng-Lien Lin Foundation, Taichung, Taiwan; Taiwan Brain Disease Foundation, Taipei, Taiwan; Katsuzo and Kiyo Aoshima Memorial Funds, Japan; CMU under the Aim for Top University Plan of the Ministry of Education, Taiwan	Taiwan Ministry of Health and Welfare Clinical Trial and Research Center of Excellence; China Medical University Hospital, Academia Sinica Taiwan Biobank Stroke Biosignature Project; NRPB Stroke Clinical Trial Consortium; Tseng-Lien Lin Foundation, Taichung, Taiwan; Taiwan Brain Disease Foundation, Taipei, Taiwan; Katsuzo and Kiyo Aoshima Memorial Funds, Japan; CMU under the Aim for Top University Plan of the Ministry of Education, Taiwan	This study is supported in part by Taiwan Ministry of Health and Welfare Clinical Trial and Research Center of Excellence (MOHW105-TDU-B-212-133019), China Medical University Hospital, Academia Sinica Taiwan Biobank Stroke Biosignature Project (BM10501010037), NRPB Stroke Clinical Trial Consortium (MOST 105-2325-B-039-003), Tseng-Lien Lin Foundation, Taichung, Taiwan, Taiwan Brain Disease Foundation, Taipei, Taiwan, and Katsuzo and Kiyo Aoshima Memorial Funds, Japan; and CMU under the Aim for Top University Plan of the Ministry of Education, Taiwan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding was received for this study.	Akerman S, 2011, NAT REV NEUROSCI, V12, P570, DOI 10.1038/nrn3057; BAIN PG, 1994, BRAIN, V117, P805, DOI 10.1093/brain/117.4.805; Barbanti P, 2002, CEPHALALGIA, V22, P2, DOI 10.1046/j.1468-2982.2002.00313.x; Barbanti P, 2010, CEPHALALGIA, V30, P686, DOI 10.1177/0333102409352253; Bermejo-Pareja F, 2011, NAT REV NEUROL, V7, P273, DOI 10.1038/nrneurol.2011.44; BIARY N, 1990, J NEUROL NEUROSUR PS, V53, P1060, DOI 10.1136/jnnp.53.12.1060; CAPELLA D, 1988, BRIT MED J, V297, P722, DOI 10.1136/bmj.297.6650.722; Deuschl G, 2000, NEUROLOGY, V54, pS14; Duval C, 2006, HEADACHE, V46, P1005, DOI 10.1111/j.1526-4610.2006.00471.x; Fekete R, 2011, MOVEMENT DISORD, V26, P391, DOI 10.1002/mds.23512; Fenstermacher N, 2011, BMJ-BRIT MED J, V342, DOI 10.1136/bmj.d583; Gamboa J, 1998, J VOICE, V12, P444, DOI 10.1016/S0892-1997(98)80053-2; Hu YQ, 2014, CEPHALALGIA, V34, P1142, DOI 10.1177/0333102414531153; Jeanneteau F, 2006, P NATL ACAD SCI USA, V103, P10753, DOI 10.1073/pnas.0508189103; Jensen R, 2008, LANCET NEUROL, V7, P354, DOI 10.1016/S1474-4422(08)70062-0; Jimenez-Jimenez FJ, 2013, ACTA NEUROL SCAND, V128, P359, DOI 10.1111/ane.12148; Jimenez-Jimenez FJ, 2010, EUR J NEUROL, V17, P152, DOI 10.1111/j.1468-1331.2009.02784.x; JIMENEZJIMENEZ FJ, 1995, PRESSE MED, V24, P1152; Kruit MC, 2010, CEPHALALGIA, V30, P129, DOI 10.1111/j.1468-2982.2009.01904.x; Kuiper M, 2015, TREMOR OTHER HYPERK, V5, DOI 10.7916/D8P55MKX; Lipton RB, 2007, NEUROLOGY, V68, P343, DOI 10.1212/01.wnl.0000252808.97649.21; Louis ED, 2016, PARKINSONISM RELAT D, V22, pS115, DOI 10.1016/j.parkreldis.2015.08.034; Louis ED, 2014, CURR OPIN NEUROL, V27, P461, DOI 10.1097/WCO.0000000000000115; Mamdani M, 2005, BMJ-BRIT MED J, V330, P960, DOI 10.1136/bmj.330.7497.960; Morgan JC, 2005, LANCET NEUROL, V4, P866, DOI 10.1016/S1474-4422(05)70250-7; Mulleners WM, 2015, CEPHALALGIA, V35, P51, DOI 10.1177/0333102414534325; Raethjen J, 2001, J NEUROL NEUROSUR PS, V70, P78, DOI 10.1136/jnnp.70.1.78; Sandor PS, 2001, ANN NEUROL, V49, P668, DOI 10.1002/ana.1019; Scher AI, 2014, NEUROLOGY, V83, P1246, DOI 10.1212/WNL.0000000000000840; Silberstein SD, 2008, NAT CLIN PRACT NEURO, V4, P482, DOI 10.1038/ncpneuro0861; Sturmer T, 2014, J INTERN MED, V275, P570, DOI 10.1111/joim.12197; Troster AI, 2002, EUR J NEUROL, V9, P143; Welch KMA, 1998, NEUROLOGY, V51, P1465, DOI 10.1212/WNL.51.5.1465	33	0	0	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 13	2017	12	3							e0173586	10.1371/journal.pone.0173586	http://dx.doi.org/10.1371/journal.pone.0173586			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN6CP	28288163	Green Published, gold, Green Submitted			2022-12-27	WOS:000396092400020
J	Huang, SC; Zhang, LH; Rehman, MU; Iqbal, MK; Lan, YF; Mehmood, K; Zhang, H; Qiu, G; Nabi, F; Yao, WY; Wang, M; Li, JK				Huang, Shucheng; Zhang, Lihong; Rehman, Mujeeb Ur; Iqbal, Muhammad Kashif; Lan, Yanfang; Mehmood, Khalid; Zhang, Hui; Qiu, Gang; Nabi, Fazul; Yao, Wangyuan; Wang, Meng; Li, Jiakui			High altitude hypoxia as a factor that promotes tibial growth plate development in broiler chickens	PLOS ONE			English	Article							TIBETAN CHICKENS; BONE-DEVELOPMENT; DYSCHONDROPLASIA; EXPRESSION; ANGIOGENESIS; ADAPTATIONS; HEMOGLOBIN; CARTILAGE; EMBRYOS; OXYGEN	Tibial dyschondroplasia (TD) is one of the most common problems in the poultry industry and leads to lameness by affecting the proximal growth plate of the tibia. However, due to the unique environmental and geographical conditions of Tibet, no case of TD has been reported in Tibetan chickens (TBCs). The present study was designed to investigate the effect of high altitude hypoxia on blood parameters and tibial growth plate development in chickens using the complete blood count, morphology, and histological examination. The results of this study showed an undesirable impact on the overall performance, body weight, and mortality of Arbor Acres chickens (AACs) exposed to a high altitude hypoxic environment. However, AACs raised under hypoxic conditions showed an elevated number of red blood cells (RBCs) and an increase in hemoglobin and hematocrit values on day 14 compared to the hypobaric normoxia group. Notably, the morphology and histology analyses showed that the size of tibial growth plates in AACs was enlarged and that the blood vessel density was also higher after exposure to the hypoxic environment for 14 days, while no such change was observed in TBCs. Altogether, our results revealed that the hypoxic environment has a potentially new role in increasing the blood vessel density of proximal tibial growth plates to strengthen and enhance the size of the growth plates, which may provide new insights for the therapeutic manipulation of hypoxia in poultry TD.	[Huang, Shucheng; Zhang, Lihong; Rehman, Mujeeb Ur; Iqbal, Muhammad Kashif; Lan, Yanfang; Mehmood, Khalid; Zhang, Hui; Qiu, Gang; Nabi, Fazul; Yao, Wangyuan; Wang, Meng; Li, Jiakui] Huazhong Agr Univ, Coll Vet Med, Wuhan, Peoples R China; [Qiu, Gang; Li, Jiakui] Tibet Agr & Anim Husb Coll, Lab Detect & Monitoring Highland Anim Dis, Linzhi Tibet, Peoples R China; [Nabi, Fazul] Lasbela Univ Agr Water & Marine Sci Uthal, Fac Vet & Anim Sci, Balochistan, Pakistan	Huazhong Agricultural University; Tibet Agriculture & Animal Husbandry University	Li, JK (corresponding author), Huazhong Agr Univ, Coll Vet Med, Wuhan, Peoples R China.; Li, JK (corresponding author), Tibet Agr & Anim Husb Coll, Lab Detect & Monitoring Highland Anim Dis, Linzhi Tibet, Peoples R China.	lijk210@sina.com	黄, 淑成/GPX-4389-2022; Mehmood, Khalid/Y-5882-2019; Huang 黄淑成, Shu-cheng/GOV-6692-2022; Nabi, Fazul/A-7871-2017; Rehman, Mujeeb/L-3379-2019; Li, Jiakui/HDN-1674-2022; Qiu, Gang/F-5587-2015	黄, 淑成/0000-0003-3163-8616; Mehmood, Khalid/0000-0003-4720-8792; Huang 黄淑成, Shu-cheng/0000-0003-3163-8616; Nabi, Fazul/0000-0002-3219-4124; Rehman, Mujeeb/0000-0002-5078-5657; Qiu, Gang/0000-0002-5336-5404; Li, Jiakui/0000-0002-6065-6648; Yao, Wangyuan/0000-0001-9428-9973	National Natural Science Foundation of China [31460682, C180802]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	The study was supported by The National Natural Science Foundation of China (No. 31460682). Funds received by Jiakui Li.; The study was supported by the National Natural Science Foundation of China (No. C180802).	Ahmadipour B, 2015, J ETHNOPHARMACOL, V159, P49, DOI 10.1016/j.jep.2014.10.043; Beall CM, 2006, INTEGR COMP BIOL, V46, P18, DOI 10.1093/icb/icj004; Befani CD, 2013, J MOL MED, V91, P771, DOI 10.1007/s00109-013-1030-4; Bentovim L, 2012, DEVELOPMENT, V139, P4473, DOI 10.1242/dev.083881; Brown EA, 2012, BIOL REV, V87, P838, DOI 10.1111/j.1469-185X.2012.00227.x; Camm EJ, 2010, AM J OBSTET GYNECOL, V203, DOI 10.1016/j.ajog.2010.06.046; CAREY C, 1993, RESP PHYSIOL, V93, P151, DOI 10.1016/0034-5687(93)90002-R; Chen JC, 2015, INT J ONCOL, V46, P2629, DOI 10.3892/ijo.2015.2946; Crawford JH, 2006, BLOOD, V107, P566, DOI 10.1182/blood-2005-07-2668; DEGRAUW TJ, 1986, BIOL NEONATE, V49, P85, DOI 10.1159/000242515; Gao JF, 2013, AVIAN PATHOL, V42, P416, DOI 10.1080/03079457.2013.821568; Geng X, 2016, PHYSIOL REP, V4, DOI 10.14814/phy2.12965; Giatromanolaki A, 2010, ANTICANCER RES, V30, P2831; Gonzalez-Alonso J, 2002, CIRC RES, V91, P1046, DOI 10.1161/01.RES.0000044939.73286.E2; Gou X, 2007, COMP BIOCHEM PHYS B, V147, P147, DOI 10.1016/j.cbpb.2006.11.031; Hao R, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0098868; Herzog A, 2011, AM J PHYSIOL-REG I, V301, pR140, DOI 10.1152/ajpregu.00134.2011; Hsieh MM, 2007, BLOOD, V110, P2140, DOI 10.1182/blood-2007-02-073254; Jia CL, 2016, POULTRY SCI, V95, P1660, DOI 10.3382/ps/pew048; Khajali F, 2016, J ANIM PHYSIOL AN N, V100, P3, DOI 10.1111/jpn.12315; Kohl ZF, 2015, COMP BIOCHEM PHYS A, V190, P1, DOI 10.1016/j.cbpa.2015.07.023; Lee S, 2016, TISSUE ENG; Li L, 2014, SCI REP-UK, V4, DOI 10.1038/srep07166; Li M, 2009, SCI CHINA SER C, V52, P284, DOI 10.1007/s11427-009-0005-8; Liu C, 2009, POULTRY SCI, V88, P2689, DOI 10.3382/ps.2009-00311; Mackie EJ, 2008, INT J BIOCHEM CELL B, V40, P46, DOI 10.1016/j.biocel.2007.06.009; Nabi F, 2016, AVIAN PATHOL, V45, P187, DOI 10.1080/03079457.2016.1141170; Ozkan S, 2010, POULTRY SCI, V89, P974, DOI 10.3382/ps.2009-00293; Pines M, 2005, WORLD POULTRY SCI J, V61, P285, DOI 10.1079/WPS200454; PINES M, 1991, POULTRY SCI, V70, P1806, DOI 10.3382/ps.0701806; Provot S, 2005, BIOCHEM BIOPH RES CO, V328, P658, DOI 10.1016/j.bbrc.2004.11.068; Rath NC, 2007, POULTRY SCI, V86, P2390, DOI 10.3382/ps.2007-00219; Rath NC, 2005, J COMP PATHOL, V133, P41, DOI 10.1016/j.jcpa.2005.01.005; Rath NC, 2004, POULTRY SCI, V83, P266, DOI 10.1093/ps/83.2.266; Rostami A, 2016, J ANIM PHYSL AN N, V30, P127; Schipani E, 2001, GENE DEV, V15, P2865; Semenza GL, 2012, CELL, V148, P399, DOI 10.1016/j.cell.2012.01.021; Shahzad M, 2014, AVIAN DIS, V58, P468, DOI 10.1637/10781-012614-ResNote.1; Shim MY, 2012, POULTRY SCI, V91, P62, DOI 10.3382/ps.2011-01599; Su Y, 2016, J GENET, V95, P675, DOI 10.1007/s12041-016-0684-4; Sun HL, 2012, J BIOL CHEM; TRUETA J, 1963, J BONE JOINT SURG BR, V45, P572, DOI 10.1302/0301-620X.45B3.572; VISSCHEDIJK AHJ, 1985, J APPL PHYSIOL, V58, P416, DOI 10.1152/jappl.1985.58.2.416; WALSER MM, 1982, AVIAN DIS, V26, P265, DOI 10.2307/1590095; Wang Y, 2007, ANN NY ACAD SCI, V1117, P1, DOI 10.1196/annals.1402.049; Westerterp KR, 2006, EUR J GASTROEN HEPAT, V18, P1, DOI 10.1097/00042737-200601000-00001; Woods AL, 2016, INT J SPORT NUTR EXE, V24, P1; Yang YZ, 2011, J ANIM VET ADV, V10, P2172, DOI 10.3923/javaa.2011.2172.2175; Yang YZ, 2011, CHINA ANIMAL HUSBAND, V38, P84; Zhang H, 2007, POULTRY SCI, V86, P1384, DOI 10.1093/ps/86.7.1384; Zhang Hao, 2006, Journal of China Agricultural University, V11, P35; Zhang LF, 2007, ANIMAL, V1, P1467, DOI 10.1017/S1751731107000687; Zhang Q, 2016, GENOME BIOL EVOL, V8, P765, DOI 10.1093/gbe/evw032; Zhao J, 2011, INT ORTHOP, V35, P925, DOI 10.1007/s00264-010-1157-7	54	21	21	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 10	2017	12	3							e0173698	10.1371/journal.pone.0173698	http://dx.doi.org/10.1371/journal.pone.0173698			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN6CJ	28282429	Green Published, Green Submitted, gold			2022-12-27	WOS:000396091800070
J	Lee, IH; Jung, YJ; Cho, YG; Nou, IS; Huq, MA; Nogoy, FM; Kang, KK				Lee, In Hye; Jung, Yu-Jin; Cho, Yong Gu; Nou, Ill Sup; Huq, Md. Amdadul; Nogoy, Franz Marielle; Kang, Kwon-Kyoo			SP-LL-37, human antimicrobial peptide, enhances disease resistance in transgenic rice	PLOS ONE			English	Article							CECROPIN-B; EXPRESSION; GENE; IDENTIFICATION; TOBACCO	Human LL-37 is a multifunctional antimicrobial peptide of cathelicidin family. It has been shown in recent studies that it can serve as a host's defense against influenza A virus. We now demonstrate in this study how signal peptide LL-37 (SP-LL-37) can be used in rice resistance against bacterial leaf blight and blast. We synthesized LL-37 peptide and sub-cloned in a recombinant pPZP vector with pGD1 as promoter. SP-LL-37 was introduced into rice plants by Agrobacterium mediated transformation. Stable expression of SP-LL-37 in transgenic rice plants was confirmed by RT-PCR and ELISA analyses. Subcellular localization of SP-LL-37-GFP fusion protein showed evidently in intercellular space. Our data on testing for resistance to bacterial leaf blight and blast revealed that the transgenic lines are highly resistant compared to its wildtype. Our results suggest that LL-37 can be further explored to improve wide-spectrum resistance to biotic stress in rice.	[Lee, In Hye; Jung, Yu-Jin; Huq, Md. Amdadul; Kang, Kwon-Kyoo] Hankyong Natl Univ, Dept Hort Life Sci, Ansung, South Korea; [Jung, Yu-Jin; Huq, Md. Amdadul; Kang, Kwon-Kyoo] Hankyong Natl Univ, Inst Genet Engn, Ansung, South Korea; [Cho, Yong Gu; Nogoy, Franz Marielle] Chungbuk Natl Univ, Dept Crop Sci, Cheongju, South Korea; [Nou, Ill Sup] Sunchon Natl Univ, Dept Hort, Sunchon, South Korea	Hankyong National University; Hankyong National University; Chungbuk National University; Sunchon National University	Kang, KK (corresponding author), Hankyong Natl Univ, Dept Hort Life Sci, Ansung, South Korea.; Kang, KK (corresponding author), Hankyong Natl Univ, Inst Genet Engn, Ansung, South Korea.	kykang@hknu.ac.kr	Cho, Yong-Gu/AAV-1904-2021		"Next-Generation BioGreen 21 Program" Rural Development Administration, Republic of Korea [PJ01124501]	"Next-Generation BioGreen 21 Program" Rural Development Administration, Republic of Korea	This work was carried out with the support of "the Next-Generation BioGreen 21 Program (Project No. PJ01124501)" Rural Development Administration, Republic of Korea.	Abdula S. E., 2013, Plant Breeding and Biotechnology, V1, P33, DOI 10.9787/PBB.2013.1.1.033; Alan AR, 2004, PLANT CELL REP, V22, P388, DOI 10.1007/s00299-003-0702-x; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Cho YG, 2007, CROP SCI, V47, P2403, DOI 10.2135/cropsci2006.08.0509; Coca M, 2006, PLANTA, V223, P392, DOI 10.1007/s00425-005-0069-z; Colinas J, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003670; Daoubi M, 2005, J AGR FOOD CHEM, V53, P6035, DOI 10.1021/jf050600n; Durr UHN, 2006, BBA-BIOMEMBRANES, V1758, P1408, DOI 10.1016/j.bbamem.2006.03.030; FLORACK D, 1995, TRANSGENIC RES, V4, P132, DOI 10.1007/BF01969415; HIGHTOWER R, 1994, PLANT CELL REP, V13, P295, DOI 10.1007/BF00233324; HULTMARK D, 1980, EUR J BIOCHEM, V106, P7, DOI 10.1111/j.1432-1033.1980.tb05991.x; Jung YJ, 2013, BIOTECHNOL BIOPROC E, V18, P615, DOI 10.1007/s12257-013-0392-3; Jung YJ, 2012, PLANT BIOTECHNOL REP, V6, P39, DOI 10.1007/s11816-011-0193-0; KAUFFMAN HE, 1973, PLANT DIS REP, V57, P537; Mee Park Jeong, 2005, The Plant Pathology Journal, V21, P99; MILLS D, 1994, PLANT SCI, V104, P17, DOI 10.1016/0168-9452(94)90186-4; Nadal A, 2012, BMC PLANT BIOL, V12, DOI 10.1186/1471-2229-12-159; Okamoto M, 1998, PLANT CELL PHYSIOL, V39, P57, DOI 10.1093/oxfordjournals.pcp.a029289; Owens LD, 1997, MOL PLANT MICROBE IN, V10, P525, DOI 10.1094/MPMI.1997.10.4.525; Pan QH, 1996, PHYTOPATHOLOGY, V86, P1071, DOI 10.1094/Phyto-86-1071; Park S, 2012, EURASIP J ADV SIG PR, DOI 10.1186/1687-6180-2012-36; Rahnamaeian M, 2011, PLANT SIGNAL BEHAV, V6, P1325, DOI 10.4161/psb.6.9.16319; Wang XH, 2015, APPL BIOCHEM BIOTECH, V175, P996, DOI 10.1007/s12010-014-1322-3; Wu TQ, 2013, EUR J PLANT PATHOL, V137, P93, DOI 10.1007/s10658-013-0219-2	24	7	7	1	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 10	2017	12	3							e0172936	10.1371/journal.pone.0172936	http://dx.doi.org/10.1371/journal.pone.0172936			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN6CJ	28282452	gold, Green Published, Green Submitted			2022-12-27	WOS:000396091800014
J	Xu, F; Xiang, N; Higano, Y				Xu, Feng; Xiang, Nan; Higano, Yoshiro			How to reach haze control targets by air pollutants emission reduction in the Beijing-Tianjin-Hebei region of China?	PLOS ONE			English	Article							POLLUTION; IMPACT; PM2.5	Currently, Haze is one of the greatest environmental problems with serious impacts on human health in China, especially in capital region (Beijing-Tianjin-Hebei region). To alleviate this problem, the Chinese government introduced a National Air Pollution Control Action Plan (NAPCAP) with air pollutants reduction targets by 2017. However, there is doubt whether these targets can be achieved once the plan is implemented. In this work, the effectiveness of NAPCAP is analyzed by developing models of the statistical relationship between PM2.5 concentrations and air pollutant emissions (SO2, NOx, smoke and dust), while taking into account wind and neighboring transfer impacts. The model can also identify ways of calculating the intended emission levels in the Beijing-Tianjin-Hebei area. The results indicate that haze concentration control targets will not be attained by following the NAPCAP, and that the amount of progress needed to meet the targets is unrealistic. A more appropriate approach to reducing air emissions is proposed, which addresses joint regional efforts.	[Xu, Feng] Beijing Univ Chem Technol, Sch Econ & Management, Beijing, Peoples R China; [Xu, Feng] State Adm Cultural Heritage, Key Res Base Cultural Rel Protect Technol & Evalu, Beijing, Peoples R China; [Xiang, Nan] Beijing Univ Technol, Coll Econ & Management, Beijing, Peoples R China; [Xiang, Nan] Beijing Univ Technol, Coll Econ & Management, Res Base Beijing Modern Mfg Dev, Beijing, Peoples R China; [Higano, Yoshiro] Univ Tsukuba, Sch Life & Environm Sci, Tsukuba, Ibaraki, Japan	Beijing University of Chemical Technology; Beijing University of Technology; Beijing University of Technology; University of Tsukuba	Xiang, N (corresponding author), Beijing Univ Technol, Coll Econ & Management, Beijing, Peoples R China.; Xiang, N (corresponding author), Beijing Univ Technol, Coll Econ & Management, Res Base Beijing Modern Mfg Dev, Beijing, Peoples R China.	xiangnan@bjut.edu.cn	Higano, Yoshiro/C-5136-2017; Higano, Yoshiro/U-2785-2019	Higano, Yoshiro/0000-0003-0886-5685; Higano, Yoshiro/0000-0003-0886-5685	"International Promotion Program for Young Researchers" of Beijing University of Chemical Technology; Beijing University of Technology; Research Base of Beijing Modern Manufacturing Development from Beijing University of Technology	"International Promotion Program for Young Researchers" of Beijing University of Chemical Technology; Beijing University of Technology; Research Base of Beijing Modern Manufacturing Development from Beijing University of Technology	This study is supported by grants from the "International Promotion Program for Young Researchers" of Beijing University of Chemical Technology and Beijing University of Technology distinctly, and the Research Base of Beijing Modern Manufacturing Development from Beijing University of Technology. The corresponding author gratefully acknowledges data support from the Greenpeace-East Asia (Beijing Office). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Almeida SM, 2006, SCI TOTAL ENVIRON, V368, P663, DOI 10.1016/j.scitotenv.2006.03.031; [Anonymous], 2013, B CHINESE ACAD SCI; [Anonymous], 2010, REGION, V9; Clean Air Alliance of China, 2013, CHIN TACKL AIR POLL; Cobourn WG, 2010, ATMOS ENVIRON, V44, P3015, DOI 10.1016/j.atmosenv.2010.05.009; Dong C, 2012, ENERGY, V37, P673, DOI 10.1016/j.energy.2011.10.030; Guan DB, 2014, HAZE TRUTH PM2 5 POL, P121; Ministry of Environmental Protection of China (MEP), 2013, EX PROGR ACT PLAN BE; O'Keefe B., 2013, RECENT TRENDS AIR QU; Pan XC, 2012, DANGER OUT BREATHING; Pope CA, 2006, J AIR WASTE MANAGE, V56, P709, DOI 10.1080/10473289.2006.10464485; Raaschou-Nielsen O, 2013, LANCET ONCOL, V14, P813, DOI 10.1016/S1470-2045(13)70279-1; USEP A Integrated science assessment for particulate matter, 2009, EPA600R08, V139; Vallius M, 2005, SCI TOTAL ENVIRON, V337, P147, DOI 10.1016/j.scitotenv.2004.06.018; Wang G., 2015, ENVIRON MONIT ASSESS, V187; Wang YJ, 2011, ENERG POLICY, V39, P6745, DOI 10.1016/j.enpol.2010.07.002; Xue Wen-bo, 2014, China Environmental Science, V34, P2490; Zhao B, 2013, ATMOS ENVIRON, V77, P453, DOI 10.1016/j.atmosenv.2013.05.012; Zheng GJ, 2015, ATMOS CHEM PHYS, V15, P2969, DOI 10.5194/acp-15-2969-2015; Zhou Y., 2012, THESIS STANFORD U	20	7	7	2	54	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 10	2017	12	3							e0173612	10.1371/journal.pone.0173612	http://dx.doi.org/10.1371/journal.pone.0173612			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN6CJ	28282464	gold, Green Published, Green Submitted			2022-12-27	WOS:000396091800054
J	Grunebaum, A; McCullough, LB; Arabin, B; Chervenak, FA				Grunebaum, Amos; McCullough, Laurence B.; Arabin, Birgit; Chervenak, Frank A.			Serious adverse neonatal outcomes such as 5-minute Apgar score of zero and seizures or severe neurologic dysfunction are increased in planned home births after cesarean delivery	PLOS ONE			English	Article							VAGINAL BIRTH; PERINATAL OUTCOMES; UTERINE RUPTURE; RELIABILITY; TRIAL; WOMEN; LABOR; VBAC; RISK; TERM	The United States is with 37,451 home births in 2014 the country with the largest absolute number of home births among all developed countries. The purpose of this study was to examine the occurrence and risks of a 5- minute Apgar score of zero and neonatal seizures or serious neurologic dysfunction in women with a history of prior cesarean delivery for planned home vaginal birth after cesarean (VBAC), compared to hospital VBAC and hospital birth cesarean deliveries for term normal weight infants in the United States from 2007 _ 2014. We report in this study outcomes of women who had one or more prior cesarean deliveries and included women who had a successful vaginal birth after a trial of labor after cesarean (TOLAC) at home and in the hospital, and a repeat cesarean delivery in the hospital. We excluded preterm births (< 37 weeks) and infants weighing under 2500 g. Hospital VBACS were the reference. Women with a planned home birth VBAC had an approximately 10- fold and higher increase in adverse neonatal outcomes when compared to hospital VBACS and hospital repeat cesarean deliveries, a significantly higher incidence and risk of a 5- minute Apgar score of 0 of 1 in 890 ( 11.24/ 10,000, relative risk 9.04, 95% confidence interval 4 _ 20.39, p<. 0001) and an incidence of neonatal seizures or severe neurologic dysfunction of 1 in 814 (Incidence: 12.27/ 10,000, relative risk 11.19, 95% confidence interval 5.13 _ 24.29, p<. 0001). Because of the significantly increased neonatal risks, obstetric providers should therefore not offer or perform planned home TOLACs and for those desiring a VBAC should strongly recommend a planned TOLAC in the appropriate hospital setting. We emphasize that this stance should be accompanied by effective efforts to make TOLAC available in the appropriate hospital setting.	[Grunebaum, Amos; McCullough, Laurence B.; Chervenak, Frank A.] Weill Cornell Med, Dept Obstet & Gynecol, New York, NY 10065 USA; [Arabin, Birgit] Philipps Univ, Ctr Mother & Child, Marburg, Germany; [Arabin, Birgit] Clara Angela Fdn, Berlin, Germany	Cornell University; Philipps University Marburg	Grunebaum, A (corresponding author), Weill Cornell Med, Dept Obstet & Gynecol, New York, NY 10065 USA.	amg2002@med.cornell.edu	Sampiev, Abdulmutalip/N-4757-2019; Chervenak, Frank/P-3555-2017	Sampiev, Abdulmutalip/0000-0002-5100-2239; Chervenak, Frank/0000-0002-4600-0853				American College of Obstetricians and Gynecologist American Academy of Pediatrics, 2014, NEON ENC NEUR OUTC; American College of Obstetricians and Gynecologists, 2010, OBSTET GYNECOL, V116, P450, DOI DOI 10.1097/AOG.0B013E3181EEB251; [Anonymous], 2015, Obstet Gynecol, V126, pe52, DOI 10.1097/AOG.0000000000001108; [Anonymous], 2011, Obstet Gynecol, V117, P425, DOI 10.1097/AOG.0b013e31820eee20; [Anonymous], 2013, PER CAR NETH 2012; Casey BM, 2001, NEW ENGL J MED, V344, P467, DOI 10.1056/NEJM200102153440701; Chervenak Frank A, 2013, J Clin Ethics, V24, P184; Chervenak FA, 2013, AM J OBSTET GYNECOL, V208, P31, DOI 10.1016/j.ajog.2012.10.002; Chervenak FA, 2011, OBSTET GYNECOL, V117, P1183, DOI 10.1097/AOG.0b013e3182172a97; Cox KJ, 2015, BIRTH-ISS PERINAT C, V42, P299, DOI 10.1111/birt.12188; Declercq E, 2010, OBSTET GYNECOL, V116, P93, DOI 10.1097/AOG.0b013e3181e21f6d; DiGiuseppe David L, 2002, Matern Child Health J, V6, P169, DOI 10.1023/A:1019726112597; Ehrenstein Vera, 2009, Clin Epidemiol, V1, P45; Getahun D, 2007, AM J OBSTET GYNECOL, V196, P499, DOI 10.1016/j.ajog.2006.09.017; Goldenberg R L, 2004, J Matern Fetal Neonatal Med, V16, P79; Grunebaum A, 2015, AM J OBSTET GYNECOL, V212, DOI 10.1016/j.ajog.2014.10.021; Grunebaum A, 2016, J PERINAT MED; Grunebaum A, AM J OBSTET GYNECOLO, P11490; Haddad B, 2000, AM J OBSTET GYNECOL, V182, P1210, DOI 10.1067/mob.2000.104951; Harrington DJ, 2007, AM J OBSTET GYNECOL, V196, DOI 10.1016/j.ajog.2006.10.877; Landon MB, 2010, SEMIN PERINATOL, V34, P267, DOI 10.1053/j.semperi.2010.03.005; Landon MB, 2004, NEW ENGL J MED, V351, P2581, DOI 10.1056/NEJMoa040405; Latendresse G, 2005, J MIDWIFERY WOM HEAL, V50, P386, DOI 10.1016/j.jmwh.2005.02.012; Lie KK, 2010, BMJ-BRIT MED J, V341, DOI 10.1136/bmj.c4990; Lieberman E, 2004, OBSTET GYNECOL, V104, P933, DOI 10.1097/01.AOG.0000143257.29471.82; McCullough LB, 2016, SEMIN PERINATOL, V40, P222, DOI 10.1053/j.semperi.2015.12.010; Moster D, 2001, J PEDIATR-US, V138, P798, DOI 10.1067/mpd.2001.114694; NELSON KB, 1981, PEDIATRICS, V68, P36; Northam S, 2006, JOGNN-J OBST GYN NEO, V35, P3, DOI 10.1111/J.1552-6909.2006.00016.x; Rowe R, 2016, BJOG-INT J OBSTET GY, V123, P1123, DOI 10.1111/1471-0528.13546; Royal College of Obstetricians and Gynaecologists, 2007, BIRTH PREV CAES BIRT; Spong CY, 2007, OBSTET GYNECOL, V110, P801, DOI 10.1097/01.AOG.0000284622.71222.b2; Spong CY, 2012, OBSTET GYNECOL, V120, P1181, DOI [http://10.1097/AOG.0b013e3182704880, 10.1097/AOG.0b013e3182704880]; Tilden EL, 2016, AM J OBSTET GYNECOL; Zollinger TW, 2006, ANN EPIDEMIOL, V16, P1, DOI 10.1016/j.annepidem.2005.03.005	35	7	7	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 20	2017	12	3							e0173952	10.1371/journal.pone.0173952	http://dx.doi.org/10.1371/journal.pone.0173952			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ER6VC	28319128	gold, Green Published, Green Submitted			2022-12-27	WOS:000398945800036
J	Simons, D; De Bourdeaudhuij, I; Clarys, P; De Cocker, K; de Geus, B; Vandelanotte, C; Van Cauwenberg, J; Deforche, B				Simons, Dorien; De Bourdeaudhuij, Ilse; Clarys, Peter; De Cocker, Katrien; de Geus, Bas; Vandelanotte, Corneel; Van Cauwenberg, Jelle; Deforche, Benedicte			Psychosocial and environmental correlates of active and passive transport behaviors in college educated and non-college educated working young adults	PLOS ONE			English	Article							PHYSICAL-ACTIVITY; PUBLIC TRANSPORTATION; EMERGING ADULTHOOD; BUILT-ENVIRONMENT; LEISURE-TIME; BENEFITS; HEALTH; QUESTIONNAIRE; DETERMINANTS; ASSOCIATIONS	Background This study aimed to examine potential differences in walking, cycling, public transport and passive transport (car/moped/motorcycle) to work and to other destinations between college and non-college educated working young adults. Secondly, we aimed to investigate which psychosocial and environmental factors are associated with the four transport modes and whether these associations differ between college and non-college educated working young adults. Methods In this cross-sectional study, 224 working young adults completed an online questionnaire assessing socio-demographic variables (8 items), psychosocial variables (6 items), environmental variables (10 items) and transport mode (4 types) and duration to work/other destinations. Zero-inflated negative binomial regression models were performed in R. Results A trend (p<0.10) indicated that more college educated compared to non-college educated young adults participated in cycling and public transport. However, another trend indicated that cycle time and public transport trips were longer and passive transport trips were shorter in non-college compared to college educated working young adults. In all working young adults, high self-efficacy towards active transport, and high perceived benefits and low perceived barriers towards active and public transport were related to more active and public transport. High social support/norm/modeling towards active, public and passive transport was related to more active, public and passive transport. High neighborhood walk ability was related to more walking and less passive transport. Only in non-college educated working young adults, feeling safe from traffic and crime in their neighborhood was related to more active and public transport and less passive transport. Conclusions Educational levels should be taken into account when promoting healthy transport behaviors in working young adults. Among non-college educated working young adults, focus should be on increasing active and public transport participation and on increasing neighborhood safety to increase active and public transport use. Among college educated working young adults, more minutes of active transport should be encouraged.	[Simons, Dorien; Van Cauwenberg, Jelle; Deforche, Benedicte] Univ Ghent, Fac Med & Hlth Sci, Dept Publ Hlth, Unit Hlth Promot & Educ, Pintelaan 185, Ghent, Belgium; [Simons, Dorien; Clarys, Peter; Deforche, Benedicte] Vrije Univ Brussel, Fac Phys Educ & Phys Therapy, Res unit Phys Act Nutr & Hlth, Pleinlaan 2, Brussels, Belgium; [Simons, Dorien; De Cocker, Katrien; Van Cauwenberg, Jelle] Res Fdn Flanders, Egmontstraat 5, Brussels, Belgium; [De Bourdeaudhuij, Ilse; De Cocker, Katrien] Univ Ghent, Fac Med & Hlth Sci, Dept Movement & Sport Sci, Watersportlaan 2, Ghent, Belgium; [de Geus, Bas] Vrije Univ Brussel, Fac Phys Educ & Phys Therapy, Human Physiol Res Grp, Pleinlaan 2, Brussels, Belgium; [Vandelanotte, Corneel] Cent Queensland Univ, Sch Hlth Med & Appl Sci, Phys Activ Res Grp, Rockhampton, Qld, Australia	Ghent University; Ghent University Hospital; Vrije Universiteit Brussel; Ghent University; Vrije Universiteit Brussel; Central Queensland University	Simons, D (corresponding author), Univ Ghent, Fac Med & Hlth Sci, Dept Publ Hlth, Unit Hlth Promot & Educ, Pintelaan 185, Ghent, Belgium.; Simons, D (corresponding author), Vrije Univ Brussel, Fac Phys Educ & Phys Therapy, Res unit Phys Act Nutr & Hlth, Pleinlaan 2, Brussels, Belgium.; Simons, D (corresponding author), Res Fdn Flanders, Egmontstraat 5, Brussels, Belgium.	dorien.simons@ugent.be	Vandelanotte, Corneel/ABF-5580-2020; De Cocker, Katrien/AAA-5783-2020; De Cocker, Katrien/AEV-4609-2022; de Geus, Bas/F-5335-2011; De+Bourdeaudhuij, Ilse/AAC-5528-2019	De Cocker, Katrien/0000-0001-7510-4419; de Geus, Bas/0000-0001-7447-0230; De+Bourdeaudhuij, Ilse/0000-0001-9969-7597	Research Foundation - Flanders [11U8114N, 11N0313N]; Research Foundation - Flanders (FWO) [FW011/PDO/097]; National Heart Foundation of Australia Future Leader Fellowship [100427]	Research Foundation - Flanders(FWO); Research Foundation - Flanders (FWO)(FWO); National Heart Foundation of Australia Future Leader Fellowship(National Heart Foundation of Australia)	DS and JVC were supported by a PhD fellowship of The Research Foundation - Flanders (http://www.fwo.be/) (11U8114N and 11N0313N, respectively). KDC is supported by The Research Foundation - Flanders (FWO) (http://www.fwo.be/) (postdoctoral research fellowship: FW011/PDO/ 097). CV is supported by a National Heart Foundation of Australia Future Leader Fellowship (http://heartfoundation.org.au/) (ID 100427). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams J, 2010, PREV MED, V50, P199, DOI 10.1016/j.ypmed.2010.01.006; Allender S, 2008, HEALTH PROMOT INT, V23, P160, DOI 10.1093/heapro/dan012; Andersen LB, 2000, ARCH INTERN MED, V160, P1621, DOI 10.1001/archinte.160.11.1621; Arnett JJ, 2000, AM PSYCHOL, V55, P469, DOI 10.1037/0003-066X.55.5.469; Babey SH, 2009, J PUBLIC HEALTH POL, V30, pS203, DOI 10.1057/jphp.2008.61; Badland HM, 2010, SUSTAINABILITY, V2, P576, DOI DOI 10.3390/su2020576; Ball K, 2007, J EPIDEMIOL COMMUN H, V61, P108, DOI 10.1136/jech.2006.048520; Bamberg S, 2007, J ENVIRON PSYCHOL, V27, P190, DOI 10.1016/j.jenvp.2007.04.001; Baranowski T, 1998, AM J PREV MED, V15, P266, DOI 10.1016/S0749-3797(98)00080-4; Beenackers MA, 2012, INT J BEHAV NUTR PHY, V9, DOI 10.1186/1479-5868-9-116; Beige S, 2012, TRANSPORTATION, V39, P857, DOI 10.1007/s11116-012-9404-y; Bell S, 2005, INT J BEHAV MED, V12, P227, DOI 10.1207/s15327558ijbm1204_3; Bere E, 2011, SCAND J MED SCI SPOR, V21, P48, DOI 10.1111/j.1600-0838.2009.01004.x; Bin Cheung Y, 2002, STAT MED, V21, P1461, DOI 10.1002/sim.1088; Bopp M, 2012, PREV MED, V54, P237, DOI 10.1016/j.ypmed.2012.01.016; Cerin E, 2006, MED SCI SPORT EXER, V38, P1682, DOI 10.1249/01.mss.0000227639.83607.4d; Cerin E, 2009, SOC SCI MED, V68, P1013, DOI 10.1016/j.socscimed.2009.01.008; Chowdhury S, 2016, J PUBLIC TRANSPORT, V19, P97, DOI 10.5038/2375-0901.19.1.7; Craig CL, 2003, MED SCI SPORT EXER, V35, P1381, DOI 10.1249/01.MSS.0000078924.61453.FB; de Geus B, 2008, HEALTH EDUC RES, V23, P697, DOI 10.1093/her/cym055; De Witte A, 2013, TRANSPORT RES A-POL, V49, P329, DOI 10.1016/j.tra.2013.01.009; Departement Mobiliteit en Openbare Werken, 2011, OVG VLAAND 4 2 VLAAM; DEVRIES H, 1995, J APPL SOC PSYCHOL, V25, P237; Dowda M, 2003, ANN BEHAV MED, V26, P15, DOI 10.1207/S15324796ABM2601_03; Ducheyne F, 2012, PEDIATR EXERC SCI, V24, P289, DOI 10.1123/pes.24.2.289; Eriksson U, 2012, INT J BEHAV NUTR PHY, V9, DOI 10.1186/1479-5868-9-123; European Transport Safety Council, 2007, SOC EC CONS ROAD TRA; Fishman E, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0121871; Fraser SDS, 2011, EUR J PUBLIC HEALTH, V21, P738, DOI 10.1093/eurpub/ckq145; Gordon-Larsen P, 2005, OBES RES, V13, P868, DOI 10.1038/oby.2005.100; Gordon-Larsen P, 2004, AM J PREV MED, V27, P277, DOI 10.1016/j.amepre.2004.07.006; Gordon-Larsen P, 2009, ARCH INTERN MED, V169, P1216, DOI 10.1001/archinternmed.2009.163; Hamer M, 2008, PREV MED, V46, P9, DOI 10.1016/j.ypmed.2007.03.006; Hatch SL, 2007, J GERONTOL B-PSYCHOL, V62, pS404, DOI 10.1093/geronb/62.6.S404; Hopkins D, 2016, TRANSPORT RES A-POL, V94, P149, DOI 10.1016/j.tra.2016.08.028; Hopkins D, 2016, J TRANSP GEOGR, V56, P92, DOI 10.1016/j.jtrangeo.2016.09.005; Jackman S., 2012, COMPREHENSIVE R ARCH; Jones L, 2012, CONTEMP CLIN TRIALS, V33, P268, DOI 10.1016/j.cct.2011.10.011; KEANE C, 1995, CAN J CRIMINOL, V37, P431; Kerr J, 2016, ENVIRON HEALTH PERSP, V124, P290, DOI 10.1289/ehp.1409466; Kwan MY, 2012, AM J PREV MED, V42, P14, DOI 10.1016/j.amepre.2011.08.026; Lee IM, 2012, LANCET, V380, P219, DOI 10.1016/S0140-6736(12)61031-9; Litman T, 2003, AM J HEALTH PROMOT, V18, P103, DOI 10.4278/0890-1171-18.1.103; Makinen T, 2009, SCAND J MED SCI SPOR, V19, P188, DOI 10.1111/j.1600-0838.2007.00739.x; Mayes M., 1996, QUALITATIVE ASSESSME; Mertens L, 2016, OBES REV, V17, P53, DOI 10.1111/obr.12379; Molina-Garcia J, 2010, PREV MED, V51, P136, DOI 10.1016/j.ypmed.2010.05.009; Morency P, 2012, AM J PUBLIC HEALTH, V102, P1112, DOI 10.2105/AJPH.2011.300528; Murray A. T., 2001, SOCIOECON PLANN SCI, V35, P175, DOI [DOI 10.1016/S0038-0121(01)00004-0, 10.1016/S0038-0121(01)00004- 0]; Nelson NM, 2008, INT J BEHAV NUTR PHY, V5, DOI 10.1186/1479-5868-5-1; NICE, 2016, PREV UN ROAD INJ UND; Oja P, 2011, SCAND J MED SCI SPOR, V21, P496, DOI 10.1111/j.1600-0838.2011.01299.x; Panis LI, 2010, ATMOS ENVIRON, V44, P2263, DOI 10.1016/j.atmosenv.2010.04.028; Panter JR, 2008, INT J BEHAV NUTR PHY, V5, DOI 10.1186/1479-5868-5-34; Panter JR, 2010, J PHYS ACT HEALTH, V7, P551, DOI 10.1123/jpah.7.4.551; Poobalan AS, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-640; Rabl A, 2012, TRANSPORT POLICY, V19, P121, DOI 10.1016/j.tranpol.2011.09.008; Rachele JN, 2015, J EPIDEMIOL COMMUN H, V69, P1217, DOI 10.1136/jech-2015-205620; Rissel C., 2014, AUSTR NZ J PUBLIC HL, V38, P25, DOI DOI 10.1111/1753-6405.12097; Rissel C, 2012, INT J ENV RES PUB HE, V9, P2454, DOI 10.3390/ijerph9072454; Santos MSR, 2009, HEALTH PLACE, V15, P1094, DOI 10.1016/j.healthplace.2009.05.009; Saelens BE, 2003, AM J PUBLIC HEALTH, V93, P1552, DOI 10.2105/AJPH.93.9.1552; Saelens BE, 2008, MED SCI SPORT EXER, V40, pS550, DOI 10.1249/MSS.0b013e31817c67a4; Sallis JF, 2013, PREV MED, V57, P456, DOI 10.1016/j.ypmed.2013.06.014; Sallis JF, 2014, SCORING PROCEDURES P; Sallis JF, 2008, ECOLOGICAL MODELS HL; Shannon T, 2006, TRANSPORT POLICY, V13, P240, DOI 10.1016/j.tranpol.2005.11.002; Sigurdardottir SB, 2013, TRANSPORT RES D-TR E, V24, P1, DOI 10.1016/j.trd.2013.04.008; Simons D, 2015, PREV MED, V72, P30, DOI 10.1016/j.ypmed.2014.12.039; Simons D, 2014, TRANSPORT POLICY, V36, P151, DOI 10.1016/j.tranpol.2014.08.009; Sisson SB, 2008, PREV MED, V46, P77, DOI 10.1016/j.ypmed.2007.07.004; Spittaels H., 2014, MANUAL ALPHA ENV QUE; Spittaels H, 2010, INT J BEHAV NUTR PHY, V7, DOI 10.1186/1479-5868-7-48; Steg L, 2005, TRANSPORT RES A-POL, V39, P147, DOI 10.1016/j.tra.2004.07.001; Titze S, 2008, PREV MED, V47, P252, DOI 10.1016/j.ypmed.2008.02.019; Titze Sylvia, 2007, J Phys Act Health, V4, P66; Trost SG, 2002, MED SCI SPORT EXER, V34, P1996, DOI 10.1097/00005768-200212000-00020; van Bekkum JE, 2011, HEALTH EDUC, V111, P476, DOI 10.1108/09654281111180472; Van Dyck D, 2011, INT J BEHAV MED, V18, P235, DOI 10.1007/s12529-010-9127-4; Van Dyck D, 2010, INT J BEHAV NUTR PHY, V7, DOI 10.1186/1479-5868-7-87; Vandelanotte C., 2005, J PHYS ACT HEALTH, V2, P63, DOI DOI 10.1123/JPAH.2.1.63; Vandenbulcke G, 2009, TRANSPORT POLICY, V16, P77, DOI 10.1016/j.tranpol.2009.03.004; Verhoeven H, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0147128; Villanueva K, 2008, PREV MED, V47, P338, DOI 10.1016/j.ypmed.2008.03.005; Waygood EOD, 2015, INT J ENV RES PUB HE, V12, P15900, DOI 10.3390/ijerph121215027; World Health Organization, 2015, FACT SHEETS PHYS ACT; Zheng Y, 2008, PREV MED, V46, P4, DOI 10.1016/j.ypmed.2007.11.019; Zwald ML, 2014, PREV CHRONIC DIS, V11, DOI 10.5888/pcd11.140125	88	17	18	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 20	2017	12	3							e0174263	10.1371/journal.pone.0174263	http://dx.doi.org/10.1371/journal.pone.0174263			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	ER6VC	28319165	Green Published, Green Submitted, Green Accepted, gold			2022-12-27	WOS:000398945800063
J	Shtull-Leber, E; Silbergleit, R; Meurer, WJ				Shtull-Leber, Eytan; Silbergleit, Robert; Meurer, William J.			Pre-hospital midazolam for benzodiazepine-treated seizures before and after the Rapid Anticonvulsant Medication Prior to Arrival Trial: A national observational cohort study	PLOS ONE			English	Article							STATUS EPILEPTICUS; INTRANASAL MIDAZOLAM; DIAZEPAM; EMERGENCY; METAANALYSIS; CHILDREN; LORAZEPAM; SAFETY; CARE	Background Implementation of evidence-based treatment for pre-hospital status epilepticus can improve outcomes. We hypothesized that publication of a pivotal pre-hospital clinical trial (RAMPART), demonstrating superiority of intramuscular midazolam over intravenous lorazepam, altered the national utilization rates of midazolam for pre-hospital benzodiazepine-treated seizures, while upholding its safety and efficacy outside the trial setting. Methods and findings This is a retrospective, observational cohort study of pre-hospital patient encounters throughout the United States in the National Emergency Medicine Services Information System database, from January 2010 through December 2014. We compared the rates and odds of midazolam use as first-line treatment among all adult and pediatric benzodiazepine-treated seizures before and after RAMPART publication (February 2012). Secondary analyses were conducted for rates of airway interventions and rescue therapy, as proxies for safety and efficacy of seizure termination. 156,539 benzodiazepine-treated seizures were identified. Midazolam use increased from 26.1% in January 2010 to 61.7% in December 2014 (difference +35.6%, 95% CI, 32.7%-38.4%). The annual rate of midazolam adoption increased significantly from 5.9% per year to 8.9% per year after the publication of RAMPART (difference +3.0% per year; 95% CI, 1.6%-4.5% per year; adjusted OR 1.24; 95% CI, 1.17-1.32). Overall frequency of rescue therapy and airway interventions changed little after the publication of RAMPART. Conclusions These data are consistent with effective, ongoing, but incomplete clinical translation of the RAMPART results. The effects of the trial, however, cannot be isolated. The study was limited by broad inclusion of all benzodiazepine-treated seizures as well as a lack of information on route of drug of administration. The safety and effectiveness of midazolam for benzodiazepine-treated seizures in prehospital clinical practice appear consistent with trial data, which should encourage continuing increases in utilization.	[Shtull-Leber, Eytan] Univ Michigan, Sch Med, Ann Arbor, MI USA; [Silbergleit, Robert; Meurer, William J.] Univ Michigan Hlth Syst, Dept Emergency Med, Ann Arbor, MI 48103 USA; [Meurer, William J.] Univ Michigan Hlth Syst, Dept Neurol, Ann Arbor, MI 48103 USA	University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan	Meurer, WJ (corresponding author), Univ Michigan Hlth Syst, Dept Emergency Med, Ann Arbor, MI 48103 USA.; Meurer, WJ (corresponding author), Univ Michigan Hlth Syst, Dept Neurol, Ann Arbor, MI 48103 USA.	wmeurer@med.umich.edu	Meurer, William J/A-7547-2010	Meurer, William J/0000-0002-1158-5302	National Institutes of Health Loan Repayment program through the National Institutes of Neurological Disorders and Stroke [L30 NS089043]; Michigan Institute For Clinical and Health Research - National Center for Advancing Translation Science [5TL1 TR000435]; National Institutes of Health for the Neurological Emergencies Treatment Trials Network [U01 NS056975]; University of Michigan Department of Emergency Medicine	National Institutes of Health Loan Repayment program through the National Institutes of Neurological Disorders and Stroke; Michigan Institute For Clinical and Health Research - National Center for Advancing Translation Science; National Institutes of Health for the Neurological Emergencies Treatment Trials Network; University of Michigan Department of Emergency Medicine	Dr. Meurer received support for this project through the National Institutes of Health Loan Repayment program through the National Institutes of Neurological Disorders and Stroke (L30 NS089043). Mr. Shtull-Leber received support for this project through the Michigan Institute For Clinical and Health Research, funded by the National Center for Advancing Translation Science (5TL1 TR000435). Dr. Meurer and Silbergleit receive salary support from the National Institutes of Health for the Neurological Emergencies Treatment Trials Network (U01 NS056975). Dr. Meurer used departmental discretionary research funds from the University of Michigan Department of Emergency Medicine to conduct this project. No funding bodies had any role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alldredge BK, 2001, NEW ENGL J MED, V345, P631, DOI 10.1056/NEJMoa002141; America loMCoQoHCi, 2001, CROSSING QUALITY CHA; Bigham BL, 2010, PREHOSP EMERG CARE, V14, P355; Brigo F, 2015, CNS DRUGS, V29, P741, DOI 10.1007/s40263-015-0271-x; Chamberlain JM, 1997, PEDIATR EMERG CARE, V13, P92, DOI 10.1097/00006565-199704000-00002; Cone DC, 2007, ACAD EMERG MED, V14, P1052, DOI 10.1197/j.aem.2007.06.014; Fox E., 2014, EMS DRUG SHORT SUMM; Gottwald MD, 1999, AM J EMERG MED, V17, P333, DOI 10.1016/S0735-6757(99)90079-7; Jain P, 2016, EPILEPSY RES, V122, P47, DOI 10.1016/j.eplepsyres.2016.02.006; Kalviainen R, 2015, EPILEPSY BEHAV, V49, P303, DOI 10.1016/j.yebeh.2015.04.027; KRUMHOLZ A, 1989, EPILEPSIA, V30, P175, DOI 10.1111/j.1528-1157.1989.tb05451.x; Langer JE, 2014, EPILEPSY BEHAV, V37, P95, DOI 10.1016/j.yebeh.2014.06.008; Mann NC, 2015, PREHOSP EMERG CARE, V19, P232, DOI 10.3109/10903127.2014.959219; Martindale JL, 2011, EMERG MED CLIN N AM, V29, P15, DOI 10.1016/j.emc.2010.08.002; McMullan J, 2010, ACAD EMERG MED, V17, P575, DOI 10.1111/j.1553-2712.2010.00751.x; McMullan JT, 2014, PREHOSP EMERG CARE, V18, P368, DOI 10.3109/10903127.2013.869642; Mula M, 2014, EXPERT REV NEUROTHER, V14, P735, DOI 10.1586/14737175.2014.925398; Patel SI, 2015, CNS DRUGS, V29, P1009, DOI 10.1007/s40263-015-0289-0; Silbergleit R, 2012, NEW ENGL J MED, V366, P591, DOI 10.1056/NEJMoa1107494; Smith RA, 1996, J ACCID EMERG MED, V13, P54; Snijders T, 1999, INTRO BASIC APPL MUL; Vohra TT, 2015, NEUROCRIT CARE, V23, P33, DOI 10.1007/s12028-014-0106-5; Warden CR, 2006, PREHOSP EMERG CARE, V10, P463, DOI 10.1080/10903120600885126	23	13	14	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 17	2017	12	3							e0173539	10.1371/journal.pone.0173539	http://dx.doi.org/10.1371/journal.pone.0173539			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EO5CJ	28306741	Green Submitted, Green Published, gold			2022-12-27	WOS:000396710300009
J	Herbei, R; Paul, R; Berliner, LM				Herbei, Radu; Paul, Rajib; Berliner, L. Mark			Applying diffusion-based Markov chain Monte Carlo	PLOS ONE			English	Article							CONVERGENCE	We examine the performance of a strategy for Markov chain Monte Carlo (MCMC) developed by simulating a discrete approximation to a stochastic differential equation (SDE). We refer to the approach as diffusion MCMC. A variety of motivations for the approach are reviewed in the context of Bayesian analysis. In particular, implementation of diffusion MCMC is very simple to set-up, even in the presence of nonlinear models and non-conjugate priors. Also, it requires comparatively little problem-specific tuning. We implement the algorithm and assess its performance for both a test case and a glaciological application. Our results demonstrate that in some settings, diffusion MCMC is a faster alternative to a general Metropolis-Hastings algorithm.	[Herbei, Radu; Berliner, L. Mark] Ohio State Univ, Dept Stat, Columbus, OH 43210 USA; [Paul, Rajib] Western Michigan Univ, Dept Stat, Kalamazoo, MI USA	Ohio State University; Western Michigan University	Herbei, R (corresponding author), Ohio State Univ, Dept Stat, Columbus, OH 43210 USA.	herbei@stat.osu.edu			National Science Foundation [DMS-1209142, NSF-CMMI-1537379, ATM-07-3024403, DMS-10-49064]	National Science Foundation(National Science Foundation (NSF))	RH has been supported in part by the National Science Foundation (www.nsf.gov) grant number DMS-1209142. RP has been supported in part by the National Science Foundation (www.nsf.gov) grant NSF-CMMI-1537379. LMB was supported in part by the National Science Foundation (www.nsf.gov) grants ATM-07-3024403 and DMS-10-49064. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Any opinions, findings, and conclusions or recommendations expressed in this material are those of the authors and do not necessarily reflect the views of the National Science Foundation.	Berliner LM, 2008, J GLACIOL, V54, P705, DOI 10.3189/002214308786570917; Bernardo JM, 1994, BAYESIAN THEORY; Bou-Rabee N, 2013, IMA J NUMER ANAL, V33, P80, DOI 10.1093/imanum/drs003; Bruce A., 1996, APPL WAVELET ANAL S; Gilks W. R., 1995, MARKOV CHAIN MONTE C, DOI 10.1201/b14835; Gilks WR, 1998, J AM STAT ASSOC, V93, P1045, DOI 10.1080/01621459.1998.10473766; Girolami M, 2011, J R STAT SOC B, V73, P123, DOI 10.1111/j.1467-9868.2010.00765.x; Haario H, 2001, BERNOULLI, V7, P223, DOI 10.2307/3318737; Karatzas I., 2012, BROWNIAN MOTION STOC; Kloeden P. E., 1992, APPL MATH NEW YORK, V23, DOI [10.1007/978-3-662-12616-5, DOI 10.1007/978-3-662-12616-5]; Lamba H, 2007, IMA J NUMER ANAL, V27, P479, DOI [10.1093/imanum/drl032, 10.1093/imanum/dr1032]; Mattingly JC, 2010, SIAM J NUMER ANAL, V48, P552, DOI 10.1137/090770527; Robert C.P., 2000, TECHNOMETRICS, V42, P430, DOI [10.2307/1270959, DOI 10.2307/1270959]; Roberts G., 2002, METHODOL COMPUT APPL, V4, P337, DOI DOI 10.1023/A:1023562417138; Roberts G.O., 1996, BERNOULLI, V2, P341, DOI DOI 10.2307/3318418; Roberts GO, 2009, J COMPUT GRAPH STAT, V18, P349, DOI 10.1198/jcgs.2009.06134; Talay D., 1990, Stochastics and Stochastics Reports, V29, P13, DOI 10.1080/17442509008833606; Vidakovic B., 1999, STAT MODELING WAVELE	18	3	3	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 16	2017	12	3							e0173453	10.1371/journal.pone.0173453	http://dx.doi.org/10.1371/journal.pone.0173453			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN9KE	28301529	Green Submitted, Green Published, gold			2022-12-27	WOS:000396318300042
J	Johnson, RE; Kording, KP; Hargrove, LJ; Sensinger, JW				Johnson, Reva E.; Kording, Konrad P.; Hargrove, Levi J.; Sensinger, Jonathon W.			Adaptation to random and systematic errors: Comparison of amputee and non-amputee control interfaces with varying levels of process noise	PLOS ONE			English	Article							DECISION-THEORY; OLDER-ADULTS; MOTOR; FORCE; UNCERTAINTY; PRINCIPLES; MOVEMENT; FEEDBACK; PRIORS	The objective of this study was to understand how people adapt to errors when using a myoelectric control interface. We compared adaptation across 1) non-amputee subjects using joint angle, joint torque, and myoelectric control interfaces, and 2) amputee subjects using myoelectric control interfaces with residual and intact limbs (five total control interface conditions). We measured trial-by-trial adaptation to self-generated errors and random perturbations during a virtual, single degree-of-freedom task with two levels of feedback uncertainty, and evaluated adaptation by fitting a hierarchical Kalman filter model. We have two main results. First, adaptation to random perturbations was similar across all control interfaces, whereas adaptation to self-generated errors differed. These patterns matched predictions of our model, which was fit to each control interface by changing the process noise parameter that represented system variability. Second, in amputee subjects, we found similar adaptation rates and error levels between residual and intact limbs. These results link prosthesis control to broader areas of motor learning and adaptation and provide a useful model of adaptation with myoelectric control. The model of adaptation will help us understand and solve prosthesis control challenges, such as providing additional sensory feedback.	[Johnson, Reva E.] Valparaiso Univ, Dept Mech Engn, Valparaiso, IN 46383 USA; [Kording, Konrad P.; Hargrove, Levi J.] Rehabil Inst Chicago, Chicago, IL 60611 USA; [Kording, Konrad P.; Hargrove, Levi J.] Northwestern Univ, Dept Phys Med & Rehabil, Chicago, IL 60611 USA; [Kording, Konrad P.] Northwestern Univ, Dept Physiol, Chicago, IL 60611 USA; [Sensinger, Jonathon W.] Univ New Brunswick, Inst Biomed Engn, Fredericton, NB, Canada; [Sensinger, Jonathon W.] Univ New Brunswick, Dept Elect & Comp Engn, Fredericton, NB, Canada	Valparaiso University; Shirley Ryan AbilityLab; Northwestern University; Northwestern University; University of New Brunswick; University of New Brunswick	Johnson, RE (corresponding author), Valparaiso Univ, Dept Mech Engn, Valparaiso, IN 46383 USA.	reva.johnson@valpo.edu	Kording, Konrad/A-1233-2007; Johnson, Reva/C-4406-2014	Kording, Konrad/0000-0001-8408-4499; Johnson, Reva/0000-0002-3725-0754	National Institutes of Health; National Institute of Child Health and Human Development through the Ruth L. Kirschstein National Research Service Award; National Science Foundation through the National Robotics Initiative [1317379]	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institute of Child Health and Human Development through the Ruth L. Kirschstein National Research Service Award; National Science Foundation through the National Robotics Initiative	This work was funded by the National Institutes of Health and the National Institute of Child Health and Human Development through the Ruth L. Kirschstein National Research Service Award (REJ), and by the National Science Foundation through the National Robotics Initiative (grant number 1317379, JWS, KPK, LJH). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2006, P SIGGR COURS; Baddeley RJ, 2003, J NEUROSCI, V23, P3066; Bastian AJ, 2008, CURR OPIN NEUROL, V21, P628, DOI 10.1097/WCO.0b013e328315a293; Bays PM, 2007, J PHYSIOL-LONDON, V578, P387, DOI 10.1113/jphysiol.2006.120121; Berniker M, 2008, NAT NEUROSCI, V11, P1454, DOI 10.1038/nn.2229; Biddiss E, 2007, AM J PHYS MED REHAB, V86, P977, DOI 10.1097/PHM.0b013e3181587f6c; Biddiss E, 2007, DISABIL REHABIL-ASSI, V2, P346, DOI 10.1080/17483100701714733; Burge J, 2008, J VISION, V8, DOI 10.1167/8.4.20; Cheng S, 2007, J NEUROPHYSIOL, V97, P3057, DOI 10.1152/jn.00897.2006; Childress D.S., 2004, ATLAS AMPUTATIONS LI, P173; Clancy EA, 2002, J ELECTROMYOGR KINES, V12, P1, DOI 10.1016/S1050-6411(01)00033-5; Criscimagna-Hemminger SE, 2003, J NEUROPHYSIOL, V89, P168, DOI 10.1152/jn.00622.2002; Dosen S, 2015, EXP BRAIN RES; Dosen S, 2015, J NEUROENG REHABIL, V12, DOI 10.1186/s12984-015-0047-z; Ernst MO, 2002, NATURE, V415, P429, DOI 10.1038/415429a; Fougner A, 2012, IEEE T NEUR SYS REH, V20, P663, DOI 10.1109/TNSRE.2012.2196711; Heckathorne C.W., 2004, ATLAS AMPUTATIONS LI, P145; Herzfeld DJ, 2014, SCIENCE, P1; Huang HJ, 2014, J NEUROPHYSIOL, V111, P135, DOI 10.1152/jn.00401.2013; Hudson TE, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000982; Johnson RE, 2015, 7 INT IEEE EMBS C NE; Johnson RE, EMG VERSUS IN PRESS; Johnson RE, 2014, FRONT NEUROSCI-SWITZ, V8, DOI 10.3389/fnins.2014.00302; Kalman RE., 1960, J BASIC ENG, V82, P35, DOI [10.1115/1.3662552, DOI 10.1115/1.3662552]; Kawato M, 1999, CURR OPIN NEUROBIOL, V9, P718, DOI 10.1016/S0959-4388(99)00028-8; Kitago Tomoko, 2013, Handb Clin Neurol, V110, P93, DOI 10.1016/B978-0-444-52901-5.00008-3; Kording K, 2007, SCIENCE, V318, P606, DOI 10.1126/science.1142998; Kording KP, 2004, P NATL ACAD SCI USA, V101, P9839, DOI 10.1073/pnas.0308394101; Kording KP, 2004, NATURE, V427, P244, DOI 10.1038/nature02169; LACKNER JR, 1994, J NEUROPHYSIOL, V72, P299, DOI 10.1152/jn.1994.72.1.299; LAWRENCE JH, 1983, J APPL PHYSIOL, V54, P1653, DOI 10.1152/jappl.1983.54.6.1653; Melendez-Calderon A, 2011, IEEE T NEUR SYS REH, V19, P298, DOI 10.1109/TNSRE.2011.2125990; Nieuwboer A, 2009, PARKINSONISM RELAT D, V15, pS53, DOI 10.1016/S1353-8020(09)70781-3; Orban G, 2011, CURR OPIN NEUROBIOL, V21, P629, DOI 10.1016/j.conb.2011.05.026; Parker P, 2006, J ELECTROMYOGR KINES, V16, P541, DOI 10.1016/j.jelekin.2006.08.006; Patton JL, 2006, EXP BRAIN RES, V168, P368, DOI 10.1007/s00221-005-0097-8; Proske U, 2012, PHYSIOL REV, V92, P1651, DOI 10.1152/physrev.00048.2011; Saunders I, 2011, J NEUROENG REHABIL, V8, DOI 10.1186/1743-0003-8-60; Scheidt RA, 2001, J NEUROPHYSIOL, V86, P971, DOI 10.1152/jn.2001.86.2.971; Sensinger JW, 2008, IEEE T BIO-MED ENG, V55, P1043, DOI 10.1109/TBME.2007.905385; Sensinger JW, 2015, PLOS ONE, P10; Shadmehr R, 1994, J NEUROSCI, P74; Shadmehr R, 2008, EXP BRAIN RES, V185, P359, DOI 10.1007/s00221-008-1280-5; Shadmehr R, 2010, ANNU REV NEUROSCI, V33, P89, DOI 10.1146/annurev-neuro-060909-153135; Tassinari H, 2006, J NEUROSCI, V26, P10154, DOI 10.1523/JNEUROSCI.2779-06.2006; Thoroughman KA, 2007, PROG BRAIN RES, V165, P373, DOI 10.1016/S0079-6123(06)65023-1; Trommershauser J, 2003, J OPT SOC AM A, V20, P1419, DOI 10.1364/JOSAA.20.001419; van Beers RJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049373; van Beers RJ, 2009, NEURON, V63, P406, DOI 10.1016/j.neuron.2009.06.025; Verstynen T, 2011, J NEUROSCI, V31, P10050, DOI 10.1523/JNEUROSCI.6525-10.2011; Voelcker-Rehage C, 2008, EUR REV AGING PHYS A, V5, P5, DOI 10.1007/s11556-008-0030-9; Wei KL, 2010, FRONT COMPUT NEUROSC, V4, DOI 10.3389/fncom.2010.00011; Wei KL, 2009, J NEUROPHYSIOL, V101, P655, DOI 10.1152/jn.90545.2008; Weir R., 2009, BIOMED ENG HDB, V2, P537; Wolpert DM, 2011, NAT REV NEUROSCI, V12, P739, DOI 10.1038/nrn3112; WOLPERT DM, 1995, SCIENCE, V269, P1880, DOI 10.1126/science.7569931	56	16	16	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 16	2017	12	3							e0170473	10.1371/journal.pone.0170473	http://dx.doi.org/10.1371/journal.pone.0170473			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN9KE	28301512	Green Submitted, Green Published, gold			2022-12-27	WOS:000396318300006
J	Lee, DJ; Stvilia, B				Lee, Dong Joon; Stvilia, Besiki			Practices of research data curation in institutional repositories: A qualitative view from repository staff	PLOS ONE			English	Article								The importance of managing research data has been emphasized by the government, funding agencies, and scholarly communities. Increased access to research data increases the impact and efficiency of scientific activities and funding. Thus, many research institutions have established or plan to establish research data curation services as part of their Institutional Repositories (IRs). However, in order to design effective research data curation services in IRs, and to build active research data providers and user communities around those IRs, it is essential to study current data curation practices and provide rich descriptions of the sociotechnical factors and relationships shaping those practices. Based on 13 interviews with 15 IR staff members from 13 large research universities in the United States, this paper provides a rich, qualitative description of research data curation and use practices in IRs. In particular, the paper identifies data curation and use activities in IRs, as well as their structures, roles played, skills needed, contradictions and problems present, solutions sought, and workarounds applied. The paper can inform the development of best practice guides, infrastructure and service templates, as well as education in research data curation in Library and Information Science (LIS) schools.	[Lee, Dong Joon] Texas A&M Univ, Univ Lib, College Stn, TX 77843 USA; [Stvilia, Besiki] Florida State Univ, Sch Informat, Tallahassee, FL 32306 USA	Texas A&M University System; Texas A&M University College Station; State University System of Florida; Florida State University	Lee, DJ (corresponding author), Texas A&M Univ, Univ Lib, College Stn, TX 77843 USA.	djlee@tamu.edu	Lee, Dong Joon/A-3308-2013; Stvilia, Besiki/S-3519-2019	Lee, Dong Joon/0000-0001-8994-163X; Stvilia, Besiki/0000-0002-2428-6627				Aalbersberg IjJ, 2011, LIB MAG          JAN, V17; Berners-Lee T, 2001, SCI AM, V284, P34, DOI 10.1038/scientificamerican0501-34; Berners-Lee T., 2006, LINKED DATA; Borgman CL, 2007, INT J DIGIT LIBRARIE, V7, P17, DOI 10.1007/s00799-007-0022-9; Burton A., 2009, INT J DIGIT CURAT, V4, P44, DOI [10.2218/ijdc.v4i3.124, DOI 10.2218/IJDC.V4I3.124]; California Digital Library, 2013, NOID CUR CONFL; California Digital Library, 2011, CDL DIG FIL FORM REC; Center for Research Libraries Online Computer Library Center, 2007, TRUST REP AUD CERT T; Cragin MH, 2007, ED PROGRAM DATA CURA; Curry E, 2010, LINKING ENTERPRISE DATA, P25, DOI 10.1007/978-1-4419-7665-9_2; Digital Curation Centre, 2007, CUR REF MAN; DRAMBORA Consortium, 2008, WELC DRAMBORA INT LO; Dublin Core Metadata Initiative, 2012, DUBL COR MET EL SET; Engestrom Y., 1987, LEARNING EXPANDING A; Foster I. I., 2004, P 3 INT C AUT AG MUL, V1, P8, DOI DOI 10.1109/AAMAS.2004.78; GASSER L, 1986, ACM T INFORM SYST, V4, P205, DOI 10.1145/214427.214429; Heidorn PB, 2008, LIBR TRENDS, V57, P280; Higgins S, 2008, INT J DIGITAL CURATI, V3, P134, DOI [10.2218/ijdc.v3i1.48, DOI 10.2218/IJDC.V3I1.48]; Huang H, 2012, J AM SOC INF SCI TEC, V63, P195, DOI 10.1002/asi.21652; Institute for Museum and Library Services, 2011, SPEC PROJ DEV DIG PR; Jones S, 2008, DATA AUDIT FRAMEWORK; Kim Y., 2011, INT J DIGITAL CURATI, V6, P125, DOI [10.2218/ijdc.v6i1.177, DOI 10.2218/IJDC.V6I1.177]; Latif A, 2014, LIB MAG, V20; Lee DJ, 2012, P AM SOC INFORM SCI, V49, P1, DOI DOI 10.1002/MEET.14504901311; Lee DJ, 2014, CAT CLASSIF Q, V52, P303, DOI 10.1080/01639374.2014.880166; Leontiev A.N., 1978, ACTIVITY CONSCIOUSNE; Lord P, 2003, E SCI CURATION REPOR; Lord P, 2004, P UK E SCI HANDS M; Lynch C., 2003, 226 ASS RES LIBR; Markey K, 2007, CLIR PUB; National Institutes of Health U.S. Department of Health & Human Services, 2010, NIH PUBLICATION; National Science Foundation, 2010, GRANT PROP GUID GPG; National Science Foundation, 2010, 10077 NSF; Office of Science and Technology Policy, 2013, EXP PUBL ACC RES FED; Parham SW, 2012, C RL NEWS, V73, P10; Park ON, 2015, LIB MAG          MAR, V21; Qin J., 2012, PROC INT C DUBLIN CO, P62; Rieger OY, 2007, LIB MAG          JUL, V13; Schutt R.K., 2009, INVESTIGATING SOCIAL; Shreeves S. L., 2005, P 12 NAT C ASS COLL, P223; Simmhan YL, 2005, SIGMOD REC, V34, P31, DOI 10.1145/1084805.1084812; Starr J., 2003, 1 MONDAY, V8; Strasser C, 2012, PRIMER DATA MANAGEME; Stvilia B., 2004, METADATA QUALITY FED; Stvilia B, 2008, J AM SOC INF SCI TEC, V59, P983, DOI 10.1002/asi.20813; Stvilia B, 2013, ACM-IEEE J CONF DIG, P425; Stvilia B, 2015, J ASSOC INF SCI TECH, V66, P246, DOI 10.1002/asi.23177; Tenopir C., 2015, J ESCIENCE LIB, V4, P4, DOI DOI 10.7191/JESLIB.2015.1085; Tenopir C., 2012, ACAD LIB RES DATA SE; Tenopir C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021101; The Consultative Committee for Space Data Systems, 2012, 6500M2 CCSDS; Thomson Reuters, 2012, THOMS REUT UNV DAT C; Van Tuyl S, 2015, ASSESSING RES DATA M; Warner S., 2010, ARXIV10031345; Westell M, 2006, LIBR HI TECH, V24, P211, DOI 10.1108/07378830610669583; Wilson TD, 2008, ANNU REV INFORM SCI, V42, P119; Witt M, 2008, LIBR RES PUBL; Witt M, 2012, J LIBR ADM, V52, P172, DOI 10.1080/01930826.2012.655607; Wu S., 2014, EXPLORING DATA WORK; Wu S, 2016, ICONFERENCE P	60	26	26	5	92	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 16	2017	12	3							e0173987	10.1371/journal.pone.0173987	http://dx.doi.org/10.1371/journal.pone.0173987			44	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EN9KE	28301533	Green Published, gold, Green Submitted			2022-12-27	WOS:000396318300105
J	Levels, M; Dronkers, J; Jencks, C				Levels, Mark; Dronkers, Jaap; Jencks, Christopher			Contextual explanations for numeracy and literacy skill disparities between native and foreign-born adults in western countries	PLOS ONE			English	Article							EDUCATIONAL-ACHIEVEMENT; SUBTLE PREJUDICE; LABOR-MARKETS; UNITED-STATES; IMMIGRANT; 2ND-GENERATION; ASSIMILATION; DESTINATION; MIGRATION; CONTACT	Using new direct measures of numeracy and literacy skills among 85,875 adults in 17 Western countries, we find that foreign-born adults have lower mean skills than native-born adults of the same age (16 to 64) in all of the examined countries. The gaps are small, and vary substantially between countries. Multilevel models reveal that immigrant populations' demographic and soc-ioeconomic characteristics, employment, and language proficiency explain about half of the cross-national variance of numeracy and literacy skills gaps. Differences in origin countries' average education level also account for variation in the size of the immigrant-native skills gap. The more protective labor markets in immigrant-receiving countries are, the less well immigrants are skilled in numeracy and literacy compared to natives. For those who migrate before their teens (the 1.5 generation), access to an education system that accommodates migrants' special needs is crucial. The 1 and 1.5 generation have smaller numeracy and literacy skills gaps in more ethnically diverse societies.	[Levels, Mark; Dronkers, Jaap] Maastricht Univ, Maastricht, Netherlands; [Levels, Mark] Coll Interdisciplinary Educ Res, Berlin, Germany; [Levels, Mark] Univ Oxford Nuffield Coll, Oxford, England; [Jencks, Christopher] Harvard Univ, Kennedy Sch Govt, Cambridge, MA 02138 USA	Maastricht University; University of Oxford; Harvard University	Levels, M (corresponding author), Maastricht Univ, Maastricht, Netherlands.; Levels, M (corresponding author), Coll Interdisciplinary Educ Res, Berlin, Germany.; Levels, M (corresponding author), Univ Oxford Nuffield Coll, Oxford, England.	m.levels@maastrichtuniversity.nl			College for Interdisciplinary Education Research; Graduate School of Business and Economics of Maastricht University to facilitate Levels' visiting scholarship at Harvard	College for Interdisciplinary Education Research; Graduate School of Business and Economics of Maastricht University to facilitate Levels' visiting scholarship at Harvard	The work was supported by travel grants of the College for Interdisciplinary Education Research and the Graduate School of Business and Economics of Maastricht University to facilitate Levels' visiting scholarship at Harvard. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alba R, 2005, ETHNIC RACIAL STUD, V28, P20, DOI 10.1080/0141987042000280003; Alba R, 1997, INT MIGR REV, V31, P826, DOI 10.2307/2547416; Alesina A, 2003, J ECON GROWTH, V8, P155, DOI 10.1023/A:1024471506938; Alesina A, 2002, J PUBLIC ECON, V85, P207, DOI 10.1016/S0047-2727(01)00084-6; Allport G. W., 1954, NATURE PREJUDICE; American Psychological Association, 2012, ETH RAC DISP ED PSYC; Antecol H, 2003, J HUM RESOUR, V38, P192, DOI 10.2307/1558761; Azzolini D, 2012, ANN AM ACAD POLIT SS, V643, P46, DOI 10.1177/0002716212441590; Barro RJ, 2013, J DEV ECON, V104, P184, DOI 10.1016/j.jdeveco.2012.10.001; BORJAS GJ, 1987, AM ECON REV, V77, P531; BORJAS GJ, 1994, J ECON LIT, V32, P1667; Borjas GJ, 2003, SMALL DIFFERENCES TH, P21; British Council and Migation Policy Group, 2011, MIGR INT POL INX 3; Castles S., 2014, AGE MIGRATION; Chiswick B, 1986, RES HUMAN CAPITAL DE, P1; CHISWICK BR, 1978, J POLIT ECON, V86, P897, DOI 10.1086/260717; Cobb-Clark DA, 2012, ANN AM ACAD POLIT SS, V643, P18, DOI 10.1177/0002716212440786; Coenders M, 2001, EUR J SOC PSYCHOL, V31, P281, DOI 10.1002/ejsp.44.abs; Dinis da Costa P., 2014, ED ADULT SKILLS SOCI; Driessen G, 2011, EDUC STUD-UK, V37, P581, DOI 10.1080/03055698.2010.539762; Farkas G, 2003, TEACH COLL REC, V105, P1119, DOI 10.1111/1467-9620.00279; Feliciano C, 2005, DEMOGRAPHY, V42, P131, DOI 10.1353/dem.2005.0001; Ferrer A, 2006, J HUM RESOUR, V41, P380; Fleischmann F., 2010, GROWING GAPS ED INEQ, P258; Fleischmann F, 2010, WORK EMPLOY SOC, V24, P337, DOI 10.1177/0950017010362153; Fryer RG, 2004, REV ECON STAT, V86, P447, DOI 10.1162/003465304323031049; Fuligni AJ, 1997, CHILD DEV, V68, P351, DOI 10.2307/1131854; Fuligni J, 2011, IMMIGRANT PARADOX CH, P299; Gordon M. M., 1964, ASSIMILATION AM LIFE; Hamberger J, 1997, BRIT J SOC PSYCHOL, V36, P173, DOI 10.1111/j.2044-8309.1997.tb01126.x; Hanushek EA, 2008, J ECON LIT, V46, P607, DOI 10.1257/jel.46.3.607; Heath A., 2007, UNEQUAL CHANCES ETHN; Heath AF, 2008, ANNU REV SOCIOL, V34, P211, DOI 10.1146/annurev.soc.34.040507.134728; Idler EL, 1997, J HEALTH SOC BEHAV, V38, P21, DOI 10.2307/2955359; Jasso G, 2000, NBER CONF R, P185; JASSO G, 1986, DEMOGRAPHY, V23, P291, DOI 10.2307/2061432; JENCKS C, 1998, AM PROSPECT, V0040; Kahn LM, 2004, J POPUL ECON, V17, P501, DOI 10.1007/s00148-003-0151-4; Kasinitz Philip, 2008, INHERITING CITY CHIL; Kogan I, 2003, J ETHN MIGR STUD, V29, P595, DOI 10.1080/1369183032000123413; Kogan I, 2006, SOC FORCES, V85, P697, DOI 10.1353/sof.2007.0014; Koopmans R, 2013, ANNU REV SOCIOL, V39, P147, DOI 10.1146/annurev-soc-071312-145630; Koopmans R, 2010, J ETHN MIGR STUD, V36, P1, DOI 10.1080/13691830903250881; Levels M, 2008, ETHNIC RACIAL STUD, V31, P1404, DOI 10.1080/01419870701682238; Levels M, 2008, AM SOCIOL REV, V73, P835, DOI 10.1177/000312240807300507; Lofstrom Magnus, 2000, SWED EC POLICY REV, V7, P11; Marks GN, 2005, ETHNIC RACIAL STUD, V28, P925, DOI 10.1080/01419870500158943; McPherson M, 2001, ANNU REV SOCIOL, V27, P415, DOI 10.1146/annurev.soc.27.1.415; OECD, 2013, OECD SKILLS OUTL 201, DOI [10.1787/9789264204256-en, DOI 10.1787/9789264204256-EN]; OECD, 2013, PISA 2012 RES EX EQ, VII; OECD, 2013, PISA 2012 RES WHAT S; OECD, 2013, TECH REP SURV AD SKI; OECD, 2008, EMPL PROT LEG IND DE; OECD, 2006, WHE IMM STUD SUCC PI; OECD, 2013, PIAAC SURV AD SKILLS; [OECD] Organisation for Economic Co-operation and Development, 2016, SURV AD SKILLS READ, V2nd; Organisation for Economic Cooperation and Development (OECD), 2012, UNT SKILLS REAL POT; Park RE, 1928, AM J SOCIOL, V33, P881, DOI 10.1086/214592; Pettigrew TF, 2001, EUR J SOC PSYCHOL, V31, P299, DOI 10.1002/ejsp.45; Pettigrew TF, 1998, ANNU REV PSYCHOL, V49, P65, DOI 10.1146/annurev.psych.49.1.65; Pettigrew TF, 2006, J PERS SOC PSYCHOL, V90, P751, DOI 10.1037/0022-3514.90.5.751; Phillips M., 1998, BLACK WHITE TEST SCO, P229; PORTES A, 1993, ANN AM ACAD POLIT SS, V530, P74, DOI 10.1177/0002716293530001006; Portes A, 2001, RUMBAUT RG LEGACIES; Portes A, 2008, ANN AM ACAD POLIT SS, V620, P12, DOI 10.1177/0002716208322577; Putnam RD, 2007, SCAND POLIT STUD, V30, P137, DOI 10.1111/j.1467-9477.2007.00176.x; Raudenbush SW, 2004, HLM 6 WINDOWS; Rindermann H, 2014, J BIOSOC SCI, V7, P1; Rudd Rima E., 1999, ANN REV ADULT LEARNI, P175; Rumbaut RG, 2004, INT MIGR REV, V38, P1160; Rumbaut RG, 1999, HDB INT MIGRATION AM, P172; Savelkoul M, 2015, J ETHN MIGR STUD, V41, P683, DOI 10.1080/1369183X.2014.931802; Schneider S, 2009, CONFUSING CREDENTIAL; Schnepf SV, 2006, IMMIGRATION AND THE TRANSFORMATION OF EUROPE, P200, DOI 10.1017/CBO9780511493577.008; Schnijder T.A.B., 2012, MULTILEVEL ANAL INTR, V2nd ed; Suarez-Orozco C, 2011, GROWING HISPANIC HLT, P189; Sum A., 2004, HUMAN CAPITAL CONCER; Teorell J, 2013, QUALITY GOVT DATESET; van der Meer T, 2014, ANNU REV SOCIOL, V40, P459, DOI 10.1146/annurev-soc-071913-043309; van Tubergen F, 2005, AM J SOCIOL, V110, P1412, DOI 10.1086/428931; van Tubergen F, 2006, IMMIGRATION AND THE TRANSFORMATION OF EUROPE, P147, DOI 10.1017/CBO9780511493577.006; vonsDavier M., 2009, IERI MONOGRAPH SERIE, V2, P9; Warner WL., 1945, SOCIAL SYSTEMS AM ET; White M.J., 2009, ACHIEVING ANEW NEW I; Wimmer A, 2014, AM J SOCIOL, V120, P146, DOI 10.1086/677207; Zimmermann KF, 1996, INT REGIONAL SCI REV, V19, P95, DOI 10.1177/016001769601900211	86	8	8	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 16	2017	12	3							e0172087	10.1371/journal.pone.0172087	http://dx.doi.org/10.1371/journal.pone.0172087			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EN9KE	28301541	Green Published, gold, Green Submitted			2022-12-27	WOS:000396318300013
J	Lindstrom, S; Loomis, S; Turman, C; Huang, HY; Huang, JY; Aschard, H; Chan, AT; Choi, H; Cornelis, M; Curhan, G; De Vivo, I; Eliassen, AH; Fuchs, C; Gaziano, M; Hankinson, SE; Hu, F; Jensen, M; Kang, JH; Kabrhel, C; Liang, LM; Pasquale, LR; Rimm, E; Stampfer, MJ; Tamimi, RM; Tworoger, SS; Wiggs, JL; Hunter, DJ; Kraft, P				Lindstrom, Sara; Loomis, Stephanie; Turman, Constance; Huang, Hongyan; Huang, Jinyan; Aschard, Hugues; Chan, Andrew T.; Choi, Hyon; Cornelis, Marilyn; Curhan, Gary; De Vivo, Immaculata; Eliassen, A. Heather; Fuchs, Charles; Gaziano, Michael; Hankinson, Susan E.; Hu, Frank; Jensen, Majken; Kang, Jae H.; Kabrhel, Christopher; Liang, Liming; Pasquale, Louis R.; Rimm, Eric; Stampfer, Meir J.; Tamimi, Rulla M.; Tworoger, Shelley S.; Wiggs, Janey L.; Hunter, David J.; Kraft, Peter			A comprehensive survey of genetic variation in 20,691 subjects from four large cohorts	PLOS ONE			English	Article							GENOME-WIDE ASSOCIATION; CORONARY-HEART-DISEASE; BREAST-CANCER RISK; BODY-MASS INDEX; COMMON VARIANTS; MAMMOGRAPHIC DENSITY; SUSCEPTIBILITY LOCI; METAANALYSIS; HEALTH; WOMEN	The Nurses' Health Study (NHS), Nurses' Health Study II (NHSII), Health Professionals Follow Up Study (HPFS) and the Physicians Health Study (PHS) have collected detailed longitudinal data on multiple exposures and traits for approximately 310,000 study participants over the last 35 years. Over 160,000 study participants across the cohorts have donated a DNA sample and to date, 20,691 subjects have been genotyped as part of genome-wide association studies (GWAS) of twelve primary outcomes. However, these studies utilized six different GWAS arrays making it difficult to conduct analyses of secondary phenotypes or share controls across studies. To allow for secondary analyses of these data, we have created three new datasets merged by platform family and performed imputation using a common reference panel, the 1,000 Genomes Phase I release. Here, we describe the methodology behind the data merging and imputation and present imputation quality statistics and association results from two GWAS of secondary phenotypes (body mass index (BMI) and venous thromboembolism (VTE)). We observed the strongest BMI association for the FTO SNP rs55872725 (beta = 0.45, p = 3.48x10(-22)), and using a significance level of p = 0.05, we replicated 19 out of 32 known BMI SNPs. For VTE, we observed the strongest association for the rs2040445 SNP (OR = 2.17, 95% CI: 1.79.2.63, p = 2.70x10(-15)), located downstream of F5 and also observed significant associations for the known ABO and F11 regions. This pooled resource can be used to maximize power in GWAS of phenotypes collected across the cohorts and for studying gene-environment interactions as well as rare phenotypes and genotypes.	[Lindstrom, Sara; Turman, Constance; Huang, Hongyan; Huang, Jinyan; Aschard, Hugues; De Vivo, Immaculata; Liang, Liming; Hunter, David J.; Kraft, Peter] Harvard TH Chan Sch Publ Hlth, Program Genet Epidemiol & Stat Genet, Boston, MA 02115 USA; [Lindstrom, Sara; Turman, Constance; Huang, Hongyan; Huang, Jinyan; Aschard, Hugues; De Vivo, Immaculata; Eliassen, A. Heather; Hankinson, Susan E.; Hu, Frank; Liang, Liming; Rimm, Eric; Stampfer, Meir J.; Tamimi, Rulla M.; Tworoger, Shelley S.; Hunter, David J.; Kraft, Peter] Harvard TH Chan Sch Publ Hlth, Dept Epidemiol, Boston, MA 02115 USA; [Lindstrom, Sara] Univ Washington, Dept Epidemiol, Seattle, WA 98195 USA; [Loomis, Stephanie; Pasquale, Louis R.; Wiggs, Janey L.] Harvard Med Sch, Dept Ophthalmol, Massachusetts Eye & Ear Infirm, Boston, MA USA; [Chan, Andrew T.] Massachusetts Gen Hosp, Gastrointestinal Unit, Boston, MA 02114 USA; [Choi, Hyon] Boston Univ, Sch Med, Rheumatol Sect, Boston, MA 02118 USA; [Choi, Hyon] Boston Univ, Sch Med, Clin Epidemiol Unit, Boston, MA 02118 USA; [Cornelis, Marilyn] Northwestern Univ, Dept Prevent Med, Feinberg Sch Med, Chicago, IL 60611 USA; [Curhan, Gary; De Vivo, Immaculata; Eliassen, A. Heather; Fuchs, Charles; Hankinson, Susan E.; Jensen, Majken; Kang, Jae H.; Kabrhel, Christopher; Pasquale, Louis R.; Rimm, Eric; Stampfer, Meir J.; Tamimi, Rulla M.; Tworoger, Shelley S.; Hunter, David J.] Brigham & Womens Hosp, Channing Div Network Med, 75 Francis St, Boston, MA 02115 USA; [Curhan, Gary; De Vivo, Immaculata; Eliassen, A. Heather; Fuchs, Charles; Hankinson, Susan E.; Jensen, Majken; Kang, Jae H.; Kabrhel, Christopher; Pasquale, Louis R.; Rimm, Eric; Stampfer, Meir J.; Tamimi, Rulla M.; Tworoger, Shelley S.; Hunter, David J.] Harvard Med Sch, Boston, MA USA; [Curhan, Gary] Brigham & Womens Hosp, Dept Med, Div Renal, 75 Francis St, Boston, MA 02115 USA; [Fuchs, Charles] Dana Farber Canc Inst, Dept Med Oncol, Boston, MA 02115 USA; [Gaziano, Michael] Brigham & Womens Hosp, Dept Med, Div Aging, 75 Francis St, Boston, MA 02115 USA; [Hankinson, Susan E.] Univ Massachusetts, Dept Biostat & Epidemiol, Amherst, MA 01003 USA; [Hu, Frank; Jensen, Majken; Rimm, Eric; Stampfer, Meir J.; Hunter, David J.] Harvard TH Chan Sch Publ Hlth, Dept Nutr, Boston, MA USA; [Kabrhel, Christopher] Harvard Med Sch, Dept Emergency Med, Ctr Vasc Emergencies, Massachusetts Gen Hosp, Boston, MA USA; [Liang, Liming; Kraft, Peter] Harvard TH Chan Sch Publ Hlth, Dept Biostat, Boston, MA USA	Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Harvard T.H. Chan School of Public Health; University of Washington; University of Washington Seattle; Harvard University; Harvard Medical School; Massachusetts Eye & Ear Infirmary; Harvard University; Massachusetts General Hospital; Boston University; Boston University; Northwestern University; Feinberg School of Medicine; Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School; Harvard University; Brigham & Women's Hospital; Harvard University; Dana-Farber Cancer Institute; Harvard University; Brigham & Women's Hospital; University of Massachusetts System; University of Massachusetts Amherst; Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Harvard Medical School; Massachusetts General Hospital; Harvard University; Harvard T.H. Chan School of Public Health	Lindstrom, S (corresponding author), Harvard TH Chan Sch Publ Hlth, Program Genet Epidemiol & Stat Genet, Boston, MA 02115 USA.; Lindstrom, S (corresponding author), Harvard TH Chan Sch Publ Hlth, Dept Epidemiol, Boston, MA 02115 USA.; Lindstrom, S (corresponding author), Univ Washington, Dept Epidemiol, Seattle, WA 98195 USA.	saralind@uw.edu	Kraft, Peter/GQH-8448-2022	Kraft, Peter/0000-0002-4472-8103; De Vivo, Immaculata/0000-0002-7185-7402; Jensen, Majken Karoline/0000-0003-4729-7545; Eliassen, A Heather/0000-0002-3961-6609	National Institute of Health [P01CA87969, P01CA055075, P01DK070756, U01HG004728, UM1CA186107, UM1CA176726, R01CA49449, R01CA50385, R01CA67262, R01CA131332, R01HL034594, R01HL088521, R01HL35464, R01HL116854, R01EY015473, R01EY022305, P30EY014104, R03DC013373, R03CA165131]; Harvard Medical School Distinguished Ophthalmology Scholar award; NATIONAL CANCER INSTITUTE [U01CA210171, R35CA197449] Funding Source: NIH RePORTER; NATIONAL EYE INSTITUTE [R01EY022305, R01EY020928] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL116854] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R03DC013373] Funding Source: NIH RePORTER	National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Harvard Medical School Distinguished Ophthalmology Scholar award; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	This work was supported by National Institute of Health (P01CA87969 (MJS), P01CA055075, P01DK070756 (GC), U01HG004728 (LRP), UM1CA186107 (MJS), UM1CA176726, R01CA49449 (SJH), R01CA50385, R01CA67262 (SJH), R01CA131332 (RMT), R01HL034594, R01HL088521, R01HL35464 (ER), R01HL116854 (CK), R01EY015473 (LRP), R01EY022305 (JLW), P30EY014104 (JLW), R03DC013373 (MC) and R03CA165131 (SL)). Dr. Pasquale is also supported by a Harvard Medical School Distinguished Ophthalmology Scholar award. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmad S, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003607; Ahn J, 2010, HUM MOL GENET, V19, P2739, DOI 10.1093/hmg/ddq155; Altshuler DM, 2012, NATURE, V491, P56, DOI 10.1038/nature11632; Amundadottir L, 2009, NAT GENET, V41, P986, DOI 10.1038/ng.429; Banda Y, 2015, GENETICS, V200, P1285, DOI 10.1534/genetics.115.178616; Bulik-Sullivan BK, 2015, NAT GENET, V47, P291, DOI 10.1038/ng.3211; Caporaso N, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004653; Colditz GA, 2005, NAT REV CANCER, V5, P388, DOI 10.1038/nrc1608; Cornelis MC, 2014, MOL PSYCHIAT; De Vivo I, 2014, HUM GENET, V133, P211, DOI 10.1007/s00439-013-1369-1; Doll R, 2004, BMJ-BRIT MED J, V328, P1529, DOI 10.1136/bmj.328.7455.1529; DOLL R, 1956, BRIT MED J, V2, P1071, DOI 10.1136/bmj.2.5001.1071; Doll R, 1954, BMJ-BRIT MED J, V328, P33; Germain M, 2015, AM J HUM GENET, V96, P532, DOI 10.1016/j.ajhg.2015.01.019; Giovannucci E, 2003, CANCER EPIDEM BIOMAR, V12, P84; Han JL, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000074; Hazra A, 2008, NAT GENET, V40, P1160, DOI 10.1038/ng.210; Hazra A, 2009, HUM MOL GENET, V18, P4677, DOI 10.1093/hmg/ddp428; He CY, 2009, NAT GENET, V41, P724, DOI 10.1038/ng.385; Heid IM, 2010, NAT GENET, V42, P949, DOI 10.1038/ng.685; Hek K, 2013, BIOL PSYCHIAT, V73, P667, DOI 10.1016/j.biopsych.2012.09.033; Howie B, 2012, NAT GENET, V44, P955, DOI 10.1038/ng.2354; Hunter DJ, 2007, NAT GENET, V39, P870, DOI 10.1038/ng2075; Jensen MK, 2011, CIRC-CARDIOVASC GENE, V4, P549, DOI 10.1161/CIRCGENETICS.111.960393; Johnson EO, 2013, HUM GENET, V132, P509, DOI 10.1007/s00439-013-1266-7; KANNEL WB, 1961, ANN INTERN MED, V55, P33, DOI 10.7326/0003-4819-55-1-33; Lettre G, 2008, NAT GENET, V40, P584, DOI 10.1038/ng.125; Li Y, 2010, GENET EPIDEMIOL, V34, P816, DOI 10.1002/gepi.20533; Lindstrom S, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6303; Lindstrom S, 2011, NAT GENET, V43, P185, DOI 10.1038/ng.760; Loos RJF, 2008, NAT GENET, V40, P768, DOI 10.1038/ng.140; Major JM, 2011, HUM MOL GENET, V20, P3876, DOI 10.1093/hmg/ddr296; Manolio TA, 2013, NAT REV GENET, V14, P549, DOI 10.1038/nrg3523; Mayers JR, 2014, NAT MED, V20, P1193, DOI 10.1038/nm.3686; Mondul AM, 2011, HUM MOL GENET, V20, P4724, DOI 10.1093/hmg/ddr387; Monsees GM, 2009, GENET EPIDEMIOL, V33, P717, DOI 10.1002/gepi.20424; Nan HM, 2011, HUM MOL GENET, V20, P2673, DOI 10.1093/hmg/ddr154; Peters U, 2013, GASTROENTEROLOGY, V144, P799, DOI 10.1053/j.gastro.2012.12.020; Prescott J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037815; Prescott J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019635; Price AL, 2006, NAT GENET, V38, P904, DOI 10.1038/ng1847; Qi L, 2010, HUM MOL GENET, V19, P2706, DOI 10.1093/hmg/ddq156; Qi L, 2010, HUM MOL GENET, V19, P1856, DOI 10.1093/hmg/ddq057; Qi Q, 2014, HUMAN MOL GENETICS; Qi QB, 2014, BMJ-BRIT MED J, V348, DOI 10.1136/bmj.g1610; Qi QB, 2012, NEW ENGL J MED, V367, P1387, DOI 10.1056/NEJMoa1203039; Rajaraman P, 2012, HUM GENET, V131, P1877, DOI 10.1007/s00439-012-1212-0; Ridker PM, 2008, CLIN CHEM, V54, P249, DOI 10.1373/clinchem.2007.099366; Schumacher FR, 2011, HUM MOL GENET, V20, P3867, DOI 10.1093/hmg/ddr295; Sesso HD, 2002, CONTROL CLIN TRIALS, V23, P686, DOI 10.1016/S0197-2456(02)00235-0; Sinnott JA, 2012, HUM GENET, V131, P111, DOI 10.1007/s00439-011-1054-1; Speliotes EK, 2010, NAT GENET, V42, P937, DOI 10.1038/ng.686; Stevens KN, 2012, HUM MOL GENET, V21, P3299, DOI 10.1093/hmg/dds158; Tworoger SS, 2006, CANCER RES, V66, P2476, DOI 10.1158/0008-5472.CAN-05-3369; Uh HW, 2012, EUR J HUM GENET, V20, P572, DOI 10.1038/ejhg.2011.231; Wiggs JL, 2011, HUM MOL GENET, V20, P4707, DOI 10.1093/hmg/ddr382; Willer CJ, 2010, BIOINFORMATICS, V26, P2190, DOI 10.1093/bioinformatics/btq340; WILLETT WC, 1993, LANCET, V341, P581, DOI 10.1016/0140-6736(93)90350-P; Yu K, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002551; Zhang XH, 2013, BREAST CANCER RES TR, V137, P883, DOI 10.1007/s10549-012-2391-z	60	31	31	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 16	2017	12	3							e0173997	10.1371/journal.pone.0173997	http://dx.doi.org/10.1371/journal.pone.0173997			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN9KE	28301549	Green Submitted, gold, Green Published			2022-12-27	WOS:000396318300108
J	Ngowi, BV; Tonnang, HEZ; Mwangi, EM; Johansson, T; Ambale, J; Ndegwa, PN; Subramanian, S				Ngowi, Benignus V.; Tonnang, Henri E. Z.; Mwangi, Evans M.; Johansson, Tino; Ambale, Janet; Ndegwa, Paul N.; Subramanian, Sevgan			Temperature-dependent phenology of Plutella xylostella (Lepidoptera: Plutellidae): Simulation and visualization of current and future distributions along the Eastern Afromontane	PLOS ONE			English	Article							DIAMONDBACK MOTH LEPIDOPTERA; CLIMATE-CHANGE; LIFE-TABLE; SEASONAL ABUNDANCE; IMPACT; YPONOMEUTIDAE; POPULATION; COLEOPTERA; DYNAMICS; SURVIVAL	There is a scarcity of laboratory and field-based results showing the movement of the diamondback moth (DBM) Plutella xylostella (L.) across a spatial scale. We studied the population growth of the diamondback moth (DBM) Plutella xylostella (L.) under six constant temperatures, to understand and predict population changes along altitudinal gradients and under climate change scenarios. Non-linear functions were fitted to continuously model DBM development, mortality, longevity and oviposition. We compiled the best-fitted functions for each life stage to yield a phenology model, which we stochastically simulated to estimate the life table parameters. Three temperature-dependent indices (establishment, generation and activity) were derived from a logistic population growth model and then coupled to collected current (2013) and downscaled temperature data from AFRICLIM (2055) for geospatial mapping. To measure and predict the impacts of temperature change on the pest's biology, we mapped the indices along the altitudinal gradients of Mt. Kilimanjaro (Tanzania) and Taita Hills (Kenya) and assessed the differences between 2013 and 2055 climate scenarios. The optimal temperatures for development of DBM were 32.5, 33.5 and 33 degrees C for eggs, larvae and pupae, respectively. Mortality rates increased due to extreme temperatures to 53.3, 70.0 and 52.4% for egg, larvae and pupae, respectively. The net reproduction rate reached a peak of 87.4 female offspring/female/generation at 20 degrees C. Spatial simulations indicated that survival and establishment of DBM increased with a decrease in temperature, from low to high altitude. However, we observed a higher number of DBM generations at low altitude. The model predicted DBM population growth reduction in the low and medium altitudes by 2055. At higher altitude, it predicted an increase in the level of suitability for establishment with a decrease in the number of generations per year. If climate change occurs as per the selected scenario, DBM infestation may reduce in the selected region. The study highlights the need to validate these predictions with other interacting factors such as cropping practices, host plants and natural enemies.	[Ngowi, Benignus V.; Tonnang, Henri E. Z.; Johansson, Tino; Ambale, Janet; Subramanian, Sevgan] Int Ctr Insect Physiol & Ecol, Nairobi, Kenya; [Ngowi, Benignus V.; Mwangi, Evans M.; Ndegwa, Paul N.] Univ Nairobi, Sch Biol Sci, Nairobi, Kenya; [Ngowi, Benignus V.] Natl Plant Quarantine Stn, Trop Pesticides Res Inst, Arusha, Tanzania; [Tonnang, Henri E. Z.] Int Maize & Wheat Improvement Ctr CIMMYT, Nairobi, Kenya; [Johansson, Tino] Univ Helsinki, Dept Geosci & Geog, Helsinki, Finland	International Centre of Insect Physiology & Ecology (ICIPE); University of Nairobi; CGIAR; International Maize & Wheat Improvement Center (CIMMYT); University of Helsinki	Subramanian, S (corresponding author), Int Ctr Insect Physiol & Ecol, Nairobi, Kenya.	ssubramania@icipe.org	TONNANG, Henri/AAQ-2206-2021; , Subramanian/H-8531-2014	TONNANG, Henri/0000-0002-9424-9186; , Subramanian/0000-0003-4447-0744; Johansson, Tino Petri/0000-0002-2381-5144	Ministry of Foreign Affairs of Finland through the Climate Change Impacts on Ecosystem Services and Food Security in the Eastern Africa (CHIESA) Project; UK Aid from the UK Government; Swedish International Development Cooperation Agency (Sida); Swiss Agency for Development and Cooperation (SDC); Federal Ministry for Economic Cooperation and Development (BMZ), Germany; Kenyan Government	Ministry of Foreign Affairs of Finland through the Climate Change Impacts on Ecosystem Services and Food Security in the Eastern Africa (CHIESA) Project; UK Aid from the UK Government(CGIAR); Swedish International Development Cooperation Agency (Sida); Swiss Agency for Development and Cooperation (SDC); Federal Ministry for Economic Cooperation and Development (BMZ), Germany; Kenyan Government	We gratefully acknowledge the financial support for this research from the Ministry of Foreign Affairs of Finland through the Climate Change Impacts on Ecosystem Services and Food Security in the Eastern Africa (CHIESA) Project and icipe core funding provided by UK Aid from the UK Government, Swedish International Development Cooperation Agency (Sida), the Swiss Agency for Development and Cooperation (SDC), Federal Ministry for Economic Cooperation and Development (BMZ), Germany, and the Kenyan Government.	AHLRICHS R, 1981, J CHIM PHYS PCB, V78, P315, DOI 10.1051/jcp/1981780315; Ahmad S. K., 2008, Asian Journal of Agricultural Research, V2, P25; Ahmad Tufail, 2010, Journal of Plant Protection Research, V50, P280, DOI 10.2478/v10045-010-0049-6; Akaike H, 1973, INFORM THEORY EXTENS, P267, DOI DOI 10.1007/978-1-4612-1694-0_15; American National Standards Institute, 2007, 41986 ANSI INCITS; Aminu-Kano A, 1992, WORKING DOCUMENT SER, V21; Andrew Nigel R., 2013, P311; ANNAMALAI S, 1988, RES POPUL ECOL, V30, P329, DOI 10.1007/BF02513253; [Anonymous], 2013, SOFTWARE PACKAGE DEV; Bahar MH, 2012, ENVIRON ENTOMOL, V41, P1653, DOI 10.1603/EN12156; Bahar MH, 2014, ENVIRON ENTOMOL, V43, P1443, DOI 10.1603/EN14055; Barton BT, 2014, ECOLOGY, V95, P1479, DOI 10.1890/13-1977.1; Bergant K, 2005, ENVIRON ENTOMOL, V34, P755, DOI 10.1603/0046-225X-34.4.755; Bonnar JD, 2010, GAMMA FUNCTION; BUTTS RA, 1981, CAN ENTOMOL, V113, P127, DOI 10.4039/Ent113127-2; Chelliah S., 1986, P63; Nguyen C, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087535; Collier RH, 2004, MANAGEMENT OF DIAMONDBACK MOTH AND OTHER CRUCIFER PESTS, P163; Craparo ACW, 2015, AGR FOREST METEOROL, V207, P1, DOI 10.1016/j.agrformet.2015.03.005; Fand BB, 2014, ECOL MODEL, V288, P62, DOI 10.1016/j.ecolmodel.2014.05.018; Fernandes E. C. M., 1984, Agroforestry Systems, V2, P73; Furlong MJ, 2013, ANNU REV ENTOMOL, V58, P517, DOI 10.1146/annurev-ento-120811-153605; Gergonne J. D., 1974, HIST MATH, V1, P439, DOI [DOI 10.1016/0315-0860(74)90034-2, https://doi.org/10.1016/0315-0860(74)90034-2]; Golizadeh A, 2009, J AGR SCI TECH-IRAN, V11, P115; Golizadeh A, 2007, INSECT SCI, V14, P309, DOI 10.1111/j.1744-7917.2007.00157.x; Guilloux T, 2003, J APPL ENTOMOL, V127, P288, DOI 10.1046/j.1439-0418.2003.00746.x; Guo SF, 2010, J ECON ENTOMOL, V103, P2028, DOI 10.1603/EC09251; Harcourt D.G., 1986, P3; Hemp A, 2009, AFR J ECOL, V47, P3, DOI 10.1111/j.1365-2028.2008.01043.x; Hemp A, 2006, BIODIVERS CONSERV, V15, P1193, DOI 10.1007/s10531-004-8230-8; HILBERT DW, 1983, ENVIRON ENTOMOL, V12, P1, DOI 10.1093/ee/12.1.1; HONDA K, 1992, DIAMONDBACK MOTH AND OTHER CRUCIFER PESTS, P43; IMURA O, 1987, APPL ENTOMOL ZOOL, V22, P449, DOI 10.1303/aez.22.449; Kahuthia-Gathu R., 2008, International Journal of Tropical Insect Science, V28, P19, DOI 10.1017/S1742758408901375; Kahuthia-Gathu R., 2013, Journal of Plant Breeding and Crop Science, V5, P73; Khadioli N, 2014, ANN APPL BIOL, V165, P373, DOI 10.1111/aab.12157; Khadioli N, 2014, B ENTOMOL RES, V104, P809, DOI 10.1017/S0007485314000601; Kobori Y, 2003, APPL ENTOMOL ZOOL, V38, P249, DOI 10.1303/aez.2003.249; Kontodimas DC, 2004, ENVIRON ENTOMOL, V33, P1, DOI 10.1603/0046-225X-33.1.1; Kroschel J, 2013, AGR FOREST METEOROL, V170, P228, DOI 10.1016/j.agrformet.2012.06.017; Li Z, 2016, B ENTOMOL RES, V106, P197, DOI 10.1017/S0007485315001017; Liu SS, 2002, ENVIRON ENTOMOL, V31, P221, DOI 10.1603/0046-225X-31.2.221; Liu TX, 1997, ANN ENTOMOL SOC AM, V90, P776, DOI 10.1093/aesa/90.6.776; Liu WeiWei, 2014, Journal of Resources and Ecology, V5, P306; Loehr B, 2007, B ENTOMOL RES, V97, P337, DOI 10.1017/S0007485307005068; LOGAN JA, 1976, ENVIRON ENTOMOL, V5, P1133, DOI 10.1093/ee/5.6.1133; Lott JE, 2009, AGR FOREST METEOROL, V149, P1140, DOI 10.1016/j.agrformet.2009.02.002; Macharia I, 2005, CROP PROT, V24, P981, DOI 10.1016/j.cropro.2005.02.005; Marchioro CA, 2012, B ENTOMOL RES, V102, P489, DOI 10.1017/S0007485312000119; Marchioro CA, 2011, NEOTROP ENTOMOL, V40, P533, DOI 10.1590/S1519-566X2011000500003; Maywald GF, 2007, DYMEX MODEL BUILDER, P172; Miranda F, 2011, ENVIRON ENTOMOL, V40, P333, DOI 10.1603/EN10277; Mohandass S, 2004, MANAGEMENT OF DIAMONDBACK MOTH AND OTHER CRUCIFER PESTS, P117; Mwalusepo S, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0130427; Nyambo B., 2005, Second International Symposium on Biological Control of Arthropods, Davos, Switzerland, 12-16 September, 2005, P290; Pellikka PKE, 2009, INT J APPL EARTH OBS, V11, P221, DOI 10.1016/j.jag.2009.02.002; Pepin N, 2015, NAT CLIM CHANGE, V5, P424, DOI [10.1038/nclimate2563, 10.1038/NCLIMATE2563]; Petavy G, 2004, EVOL ECOL RES, V6, P873; Platts PJ, 2015, AFR J ECOL, V53, P103, DOI 10.1111/aje.12180; QGIS Development Team, 2009, QGIS GEOGR INF SYST; R Core Team, 2012, R LANG ENV STAT COMP; Rangwala I, 2012, CLIMATIC CHANGE, V114, P527, DOI 10.1007/s10584-012-0419-3; Rebaudo F, 2016, FRONT PHYSIOL, V7, DOI 10.3389/fphys.2016.00139; Shelton AM, 2004, MANAGEMENT OF DIAMONDBACK MOTH AND OTHER CRUCIFER PESTS, P3; Shirai Y, 2000, B ENTOMOL RES, V90, P357, DOI 10.1017/S0007485300000481; Smith TJ, 2004, MANAGEMENT OF DIAMONDBACK MOTH AND OTHER CRUCIFER PESTS, P249; Soini, 2000, CHANGING LANDSCAPES; Southwood T.R.E., 1966, ECOLOGICAL METHODS P; Sow Gallo, 2013, Folia Horticulturae, V25, P3, DOI 10.2478/fhort-2013-0001; Sporleder M, 2012, ILCYM D INSECT LIFE, P124; Sporleder M, 2008, ADV CROP RES, V10, P15; STIGTER CJ, 1984, ARCH METEOR GEOPHY B, V34, P203, DOI 10.1007/BF02275684; Stigter K, 1987, ILEIA NEWSLETTER, V3, P5; Swann ALS, 2012, P NATL ACAD SCI USA, V109, P712, DOI 10.1073/pnas.1116706108; TANIGOSHI LK, 1978, ANN ENTOMOL SOC AM, V71, P313, DOI 10.1093/aesa/71.3.313; Tonnang HEZ, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0135283; Tonnang HEZ, 2014, INT J HEALTH GEOGR, V13, DOI 10.1186/1476-072X-13-12; Trudgill DL, 2005, ANN APPL BIOL, V146, P1, DOI 10.1111/j.1744-7348.2005.04088.x; UMEYA K, 1973, Japanese Journal of Applied Entomology and Zoology, V17, P19, DOI 10.1303/jjaez.17.19; Vannette RL, 2011, GLOBAL CHANGE BIOL, V17, P1277, DOI 10.1111/j.1365-2486.2010.02316.x; Verkerk RHJ, 1996, B ENTOMOL RES, V86, P205, DOI 10.1017/S0007485300052482; Vickers RA, 2004, ENTOMOL EXP APPL, V111, P7, DOI 10.1111/j.0013-8703.2004.00140.x; Wakisaka S., 1992, P 2 INT WORKSH MAN D, P15; WEIBULL W, 1951, J APPL MECH-T ASME, V18, P293; Xing K, 2015, FLA ENTOMOL, V98, P651, DOI 10.1653/024.098.0240; Xing Kun, 2013, Yingyong Shengtai Xuebao, V24, P1769; YAMADA H, 1983, JPN J APPL ENTOMOL Z, V27, P17, DOI 10.1303/jjaez.27.17; Zalucki M.P., 2011, MANAGEMENT DIAMONDBA, P8; Zhang W, 2015, OECOLOGIA, V179, P947, DOI 10.1007/s00442-015-3409-0; Zhang W, 2015, SCI REP-UK, V5, DOI 10.1038/srep10436; Zhang W, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075923	91	12	12	3	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 16	2017	12	3							e0173590	10.1371/journal.pone.0173590	http://dx.doi.org/10.1371/journal.pone.0173590			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN9KE	28301564	Green Published, gold			2022-12-27	WOS:000396318300053
J	Chu, YW; Wu, WS; Hsu, CF; Wang, JJ; Weng, SF; Chien, CC				Chu, Yeh-Wen; Wu, Wen-Shiann; Hsu, Chen-Fang; Wang, Jhi-Joung; Weng, Shih-Feng; Chien, Chih-Chiang			Bidirectional association between ESRD dialysis and diabetes: National cohort study	PLOS ONE			English	Article							STAGE RENAL-DISEASE; GLUCOSE-INTOLERANCE; INSULIN-RESISTANCE; MORTALITY; TAIWAN; HEMODIALYSIS; MELLITUS; IMPACT	Background Diabetes is associated with development of end-stage renal disease (ESRD) dialysis, but it is not clear whether ESRD dialysis is a risk factor for new-onset diabetes (NODM). Methods Using the Taiwan National Health Insurance Research Database, we designed two cohort studies to determine the association between dialysis and diabetes. Analysis 1 estimated the hazard ratios (HR) of ESRD dialysis in 20,585 patients with type 2 diabetes (T2DM) and 82,340 gender- and age-matched controls without diabetes. Analysis 2 estimated the HRs of NODM in 18,489 ESRD patients undergoing dialysis and 73,956 gender- and age matched controls without ESRD dialysis. The follow-up period was from 2000 to date of endpoint, the date of death, or December 31, 2008. Cox proportional models were used to estimate the relative hazards. Results In analysis 1, the incidence of ESRD dialysis was higher in the T2DM cohort than in the non diabetes cohort (6.78 vs. 0.61 per 1,000 person-years; HR: 7.97; 95%X1: 7.05-8.00). In analysis 2, the incidence of NODM was higher in the ESRD dialysis cohort than in the without-ESRD dialysis cohort (22.84 vs. 13.99 per 1,000 person-years; HR: 1.40; 95% CI: 1.34-1.47). Conclusions ESRD dialysis and diabetes were bidirectionally associated. The relationship between T2DM and incident ESRD dialysis was much stronger than between ESRD dialysis and NODM. Further studies are needed to determine the mechanism of ESRD dialysis-related NODM.	[Chu, Yeh-Wen; Chien, Chih-Chiang] Chi Mei Med Ctr, Dept Nephrol, Tainan, Taiwan; [Wu, Wen-Shiann] Chi Mei Med Ctr, Dept Cardiol, Tainan, Taiwan; [Wu, Wen-Shiann] Chia Nan Univ Pharm & Sci, Dept Pharm, Tainan, Taiwan; [Hsu, Chen-Fang] Chi Mei Med Ctr, Dept Pediat, Tainan, Taiwan; [Wang, Jhi-Joung] Chi Mei Med Ctr, Dept Med Res, Tainan, Taiwan; [Weng, Shih-Feng] Kaohsiung Med Univ, Dept Healthcare Adm & Med Informat, Kaohsiung, Taiwan	Chi Mei Hospital; Chi Mei Hospital; Chia Nan University of Pharmacy & Science; Chi Mei Hospital; Chi Mei Hospital; Kaohsiung Medical University	Chien, CC (corresponding author), Chi Mei Med Ctr, Dept Nephrol, Tainan, Taiwan.	ccchien58@yahoo.com.tw		Weng, Shih-Feng/0000-0001-8684-3487	Chi-Mei Medical Center [CMFHR10242]; National Health Research Institutes in Taiwan [NHRI-NHIRD-99182, NHRI-NHIRD-100057]	Chi-Mei Medical Center; National Health Research Institutes in Taiwan(National Health Research Institutes - Taiwan)	The study was supported by grant CMFHR10242 from Chi-Mei Medical Center and grant NHRI-NHIRD-99182 and NHRI-NHIRD-100057 from the National Health Research Institutes in Taiwan. All the funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	CHEN M, 1985, J CLIN ENDOCR METAB, V60, P13, DOI 10.1210/jcem-60-1-13; Chien CC, 2012, BMC NEPHROL, V13, DOI 10.1186/1471-2369-13-43; Chou MT, 2013, INT J CARDIOL, V167, P2719, DOI 10.1016/j.ijcard.2012.06.108; DEFRONZO RA, 1981, DIABETES CARE, V4, P493, DOI 10.2337/diacare.4.4.493; DEFRONZO RA, 1979, DIABETES, V28, P1095, DOI 10.2337/diab.28.12.1095; Hoffmann F, 2011, NEPHROL DIAL TRANSPL, V26, P1634, DOI 10.1093/ndt/gfq609; Hsu CY, 2009, ARCH INTERN MED, V169, P342, DOI 10.1001/archinternmed.2008.605; Jiang Y., 2009, Plant Biology (Rockville), V2009, P111; Kahn SE, 2003, DIABETOLOGIA, V46, P3, DOI 10.1007/s00125-002-1009-0; Kan WC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068748; Klag MJ, 1996, NEW ENGL J MED, V334, P13, DOI 10.1056/NEJM199601043340103; Kuo HW, 2007, AM J KIDNEY DIS, V49, P46, DOI 10.1053/j.ajkd.2006.10.007; Lin-Tan DT, 2007, J AM SOC NEPHROL, V18, P2385, DOI 10.1681/ASN.2006121409; Liu CY., 2006, J HLTH MANAGEMENT, V4, P1, DOI DOI 10.29805/JHM.200606.0001; MANTTARI M, 1995, HYPERTENSION, V26, P670, DOI 10.1161/01.HYP.26.4.670; Mari A, 2010, DIABETOLOGIA, V53, P749, DOI 10.1007/s00125-009-1647-6; Pavkov ME, 2006, JAMA-J AM MED ASSOC, V296, P421, DOI 10.1001/jama.296.4.421; Pecoits R, 2003, KIDNEY INT, V63, pS162, DOI 10.1046/j.1523-1755.63.s84.39.x; PERRY HM, 1995, HYPERTENSION, V25, P587, DOI 10.1161/01.HYP.25.4.587; Pupim LB, 2004, KIDNEY INT, V66, P2054, DOI 10.1111/j.1523-1755.2004.00978.x; Sabe MA, 2016, J AM HEART ASSOC, V5, DOI 10.1161/JAHA.115.002850; Salifu MO, 2010, AM J NEPHROL, V31, P239, DOI 10.1159/000276542; Szeto CC, 2007, AM J KIDNEY DIS, V49, P524, DOI 10.1053/j.ajkd.2007.01.018; Tien KJ, 2013, DIABETES CARE, V36, P3027, DOI 10.2337/dc12-2148; United States Renal Data System, 2011, EXC USRDS 2009 ANN R; Wild S, 2004, DIABETES CARE, V27, P1047, DOI 10.2337/diacare.27.5.1047; Woodward RS, 2003, AM J TRANSPLANT, V3, P590, DOI 10.1034/j.1600-6143.2003.00082.x; Wu CL, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0158533; Yang WC, 2008, NEPHROL DIAL TRANSPL, V23, P3977, DOI 10.1093/ndt/gfn406	29	5	5	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 15	2017	12	3							e0173785	10.1371/journal.pone.0173785	http://dx.doi.org/10.1371/journal.pone.0173785			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN9HQ	28296932	Green Published, Green Submitted, gold			2022-12-27	WOS:000396311700064
J	Sakchaisri, K; Kim, SO; Hwang, J; Soung, NK; Lee, KH; Choi, TW; Lee, Y; Park, CM; Thimmegowda, NR; Lee, PY; Shwetha, B; Srinivasrao, G; Pham, TTH; Jang, JH; Yum, HW; Surh, YJ; Lee, KS; Park, H; Kim, SJ; Kwon, YT; Ahn, JS; Kim, BY				Sakchaisri, Krisada; Kim, Sun-Ok; Hwang, Joonsung; Soung, Nak Kyun; Lee, Kyung Ho; Choi, Tae Woong; Lee, Yongjun; Park, Chan-Mi; Thimmegowda, Naraganahalli R.; Lee, Phil Young; Shwetha, Bettaswamigowda; Srinivasrao, Ganipisetti; Pham, Thi Thu Huong; Jang, Jae-Hyuk; Yum, Hye-Won; Surh, Young-Joon; Lee, Kyung S.; Park, Hwangseo; Kim, Seung Jun; Kwon, Yong Tae; Ahn, Jong Seog; Kim, Bo Yeon			Anticancer activity of a novel small molecule tubulin inhibitor STK899704	PLOS ONE			English	Article							MICROTUBULE DYNAMICS; DUAL INHIBITORS; ACYLHYDRAZONE DERIVATIVES; CHROMOSOME CONDENSATION; MULTIDRUG-RESISTANCE; MAMMALIAN-CELLS; GENE-EXPRESSION; BINDING AGENTS; P-GLYCOPROTEIN; HISTONE H3	We have identified the small molecule STK899704 as a structurally novel tubulin inhibitor. STK899704 suppressed the proliferation of cancer cell lines from various origins with IC50 values ranging from 0.2 to 1.0 mu M. STK899704 prevented the polymerization of purified tubulin in vitro and also depolymerized microtubule in cultured cells leading to mitotic arrest, associated with increased Cdc25C phosphorylation and the accumulation of both cyclin B1 and polo-like kinase 1 (Plk1), and apoptosis. Unlike many anticancer drugs such as Taxol and doxorubicin, STK899704 effectively displayed antiproliferative activity against multi-drug-resistant cancer cell lines. The proposed binding mode of STK899704 is at the interface between alpha beta-tubulin heterodimer overlapping with the colchicine-binding site. Our in vivo carcinogenesis model further showed that STK 899704 is potent in both the prevention and regression of tumors, remarkably reducing the number and volume of skin tumor by STK899704 treatment. Moreover, it was significant to note that the efficacy of STK899704 was surprisingly comparable to 5-fluorouracil, a widely used anticancer therapeutic. Thus, our results demonstrate the potential of STK899704 to be developed as an anticancer chemotherapeutic and an alternative candidate for existing therapies.	[Sakchaisri, Krisada; Kim, Sun-Ok; Hwang, Joonsung; Soung, Nak Kyun; Lee, Kyung Ho; Choi, Tae Woong; Lee, Yongjun; Park, Chan-Mi; Thimmegowda, Naraganahalli R.; Lee, Phil Young; Shwetha, Bettaswamigowda; Srinivasrao, Ganipisetti; Pham, Thi Thu Huong; Jang, Jae-Hyuk; Ahn, Jong Seog; Kim, Bo Yeon] KRIBB, Anticanc Agents Res Ctr, Ochang, Cheongwon, South Korea; [Sakchaisri, Krisada] Mahidol Univ, Dept Pharmacol, Fac Pharm, Bangkok, Thailand; [Pham, Thi Thu Huong] Vietnam Natl Univ, VNU Univ Sci, KLEPT, Hanoi, Vietnam; [Yum, Hye-Won; Surh, Young-Joon] Seoul Natl Univ, Coll Pharm, Seoul, South Korea; [Lee, Kyung S.] NCI, Lab Metab, NIH, Bethesda, MD 20892 USA; [Park, Hwangseo] Sejong Univ, Dept Biosci & Biotechnol, Seoul, South Korea; [Kim, Seung Jun] Korea Res Inst Biosci & Biotechnol, Dis Target Struct Res Ctr, Daejeon, South Korea; [Kwon, Yong Tae] Seoul Natl Univ, Coll Med, Dept Biomed Sci, Seoul, South Korea; [Kwon, Yong Tae] Seoul Natl Univ, Coll Med, Prot Metab Med Res Ctr, Seoul, South Korea	Korea Research Institute of Bioscience & Biotechnology (KRIBB); Mahidol University; Vietnam National University Hanoi; Seoul National University (SNU); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Sejong University; Korea Research Institute of Bioscience & Biotechnology (KRIBB); Seoul National University (SNU); Seoul National University (SNU)	Ahn, JS; Kim, BY (corresponding author), KRIBB, Anticanc Agents Res Ctr, Ochang, Cheongwon, South Korea.; Kwon, YT (corresponding author), Seoul Natl Univ, Coll Med, Dept Biomed Sci, Seoul, South Korea.; Kwon, YT (corresponding author), Seoul Natl Univ, Coll Med, Prot Metab Med Res Ctr, Seoul, South Korea.	yok5@snu.ac.kr; jsahn@kribb.re.kr; bykim@kribb.re.kr	GANIPISETTI, SRINIVASRAO/AAA-6802-2022; Kim, Seung Jun/N-5248-2019; GANIPISETTI, SRINIVASRAO/AAP-6825-2020	Kim, Seung Jun/0000-0002-6913-6358; GANIPISETTI, SRINIVASRAO/0000-0001-9803-8813	Bio and Medical Technology Development Program [NRF-2014M3A9B5073938]; National Research Council of Science & Technology grant [CAP-16-03-KRIBB]; Global R&D Center program [NRF-2010-00719]; World Class Institute Program of the Ministry of Science, ICT and Future Planning of Korea [WCI2009-002]; KRIBB Research Initiative Program [KGS531162]; International Cooperation Research Program of National Research Council of Science & Technology (NST) of Republic of Korea; R&D Convergence Program of National Research Council of Science & Technology (NST) of Republic of Korea [CAP-16-03-KRIBB]; Basic Science Research Program of the Ministry of Science, ICT and Future Planning (MSIP) of Korea [NRF-2016R1A2B3011389]	Bio and Medical Technology Development Program; National Research Council of Science & Technology grant; Global R&D Center program; World Class Institute Program of the Ministry of Science, ICT and Future Planning of Korea; KRIBB Research Initiative Program; International Cooperation Research Program of National Research Council of Science & Technology (NST) of Republic of Korea; R&D Convergence Program of National Research Council of Science & Technology (NST) of Republic of Korea; Basic Science Research Program of the Ministry of Science, ICT and Future Planning (MSIP) of Korea	This work was supported by the Bio and Medical Technology Development Program (NRF-2014M3A9B5073938), the National Research Council of Science & Technology grant (CAP-16-03-KRIBB), Global R&D Center (NRF-2010-00719) program and the World Class Institute Program (WCI2009-002) of the Ministry of Science, ICT and Future Planning of Korea and KRIBB Research Initiative Program (KGS531162). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This work was supported by the R&D Convergence Program (CAP-16-03-KRIBB) and the International Cooperation Research Program of National Research Council of Science & Technology (NST) of Republic of Korea. This work was also supported the Bio and Medical Technology Development Program (NRF-2014M3A9B5073938), the Basic Science Research Program (NRF-2016R1A2B3011389) of the Ministry of Science, ICT and Future Planning (MSIP) of Korea and KRIBB Research Initiative Program.	Bahner JD, 2013, CLIN DERMATOL, V31, P792, DOI 10.1016/j.clindermatol.2013.08.020; Bonnet J, 2008, BIOCHEM BIOPH RES CO, V370, P483, DOI 10.1016/j.bbrc.2008.03.117; Castedo M, 2004, ONCOGENE, V23, P2825, DOI 10.1038/sj.onc.1207528; Dalton WB, 2009, FUTURE ONCOL, V5, P1363, DOI 10.2217/FON.09.118; DEBRABANDER MJ, 1976, CANCER RES, V36, P905; do Amaral DN, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0085380; Duan YT, 2016, SCI REP-UK, V6, DOI 10.1038/srep25387; Dumontet C, 2010, NAT REV DRUG DISCOV, V9, P790, DOI 10.1038/nrd3253; El Ghissassi F, 2009, LANCET ONCOL, V10, P751, DOI 10.1016/S1470-2045(09)70213-X; Fojo T, 2007, ANN ONCOL, V18, pV3, DOI 10.1093/annonc/mdm172; GASTEIGER J, 1980, TETRAHEDRON, V36, P3219, DOI 10.1016/0040-4020(80)80168-2; Gilchrest Barbara A, 2013, J Invest Dermatol, V133, pE2, DOI 10.1038/skinbio.2013.176; Gloster HM, 2006, J AM ACAD DERMATOL, V55, P741, DOI 10.1016/j.jaad.2005.08.063; Hans F, 2001, ONCOGENE, V20, P3021, DOI 10.1038/sj.onc.1204326; HENNINGS H, 1993, CARCINOGENESIS, V14, P2353, DOI 10.1093/carcin/14.11.2353; Honore S, 2005, CELL MOL LIFE SCI, V62, P3039, DOI 10.1007/s00018-005-5330-x; Huzil JT, 2007, CANCER INFORM, V3, P159; HWANG A, 1995, J BIOL CHEM, V270, P28419; Hwang J, 2011, P NATL ACAD SCI USA, V108, P11566, DOI 10.1073/pnas.1019658108; IZUMI T, 1992, MOL BIOL CELL, V3, P927, DOI 10.1091/mbc.3.8.927; Johnstone RW, 2000, TRENDS BIOCHEM SCI, V25, P1, DOI 10.1016/S0968-0004(99)01493-0; JORDAN MA, 1992, J CELL SCI, V102, P401; Kang MR, 2010, ONCOL REP, V23, P801, DOI 10.3892/or_00000701; Kavallaris M, 2010, NAT REV CANCER, V10, P194, DOI 10.1038/nrc2803; Kim HM, 1997, FEBS LETT, V412, P201, DOI 10.1016/S0014-5793(97)00777-1; Kline-Smith SL, 2004, MOL CELL, V15, P317, DOI 10.1016/j.molcel.2004.07.012; Koshland D, 1996, ANNU REV CELL DEV BI, V12, P305, DOI 10.1146/annurev.cellbio.12.1.305; LEE KS, 1995, MOL CELL BIOL, V15, P7143; Liu HD, 2014, CANCER PREV RES, V7, P74, DOI 10.1158/1940-6207.CAPR-13-0133; Maia RD, 2014, EXPERT OPIN THER PAT, V24, P1161, DOI 10.1517/13543776.2014.959491; Nashan D, 2013, EUR J DERMATOL, V23, P14, DOI 10.1684/ejd.2013.1923; Orr GA, 2003, ONCOGENE, V22, P7280, DOI 10.1038/sj.onc.1206934; Park H, 2016, J MED CHEM, V59, P9018, DOI 10.1021/acs.jmedchem.6b00944; Park H, 2016, J NAT PROD, V79, P293, DOI 10.1021/acs.jnatprod.5b00851; Park H, 2015, J AM CHEM SOC, V137, P337, DOI 10.1021/ja510636t; PINES J, 1989, CELL, V58, P833, DOI 10.1016/0092-8674(89)90936-7; Quasthoff S, 2002, J NEUROL, V249, P9, DOI 10.1007/PL00007853; Ravelli RBG, 2004, NATURE, V428, P198, DOI 10.1038/nature02393; Rodrigues DA, 2016, J MED CHEM, V59, P655, DOI 10.1021/acs.jmedchem.5b01525; Rogers HW, 2010, ARCH DERMATOL, V146, P283, DOI 10.1001/archdermatol.2010.19; Salum LB, 2015, EUR J MED CHEM, V96, P504, DOI 10.1016/j.ejmech.2015.02.041; SCHIFF PB, 1980, P NATL ACAD SCI-BIOL, V77, P1561, DOI 10.1073/pnas.77.3.1561; Shin S, 2016, J CHEM INF MODEL, V56, P802, DOI 10.1021/acs.jcim.6b00026; Society AC, 2014, CANC FACTS FIG 2015; Soldani C, 2002, APOPTOSIS, V7, P321, DOI 10.1023/A:1016119328968; Strasser A, 2000, ANNU REV BIOCHEM, V69, P217, DOI 10.1146/annurev.biochem.69.1.217; Wei Y, 1999, CELL, V97, P99, DOI 10.1016/S0092-8674(00)80718-7; Windebank AJ, 1999, CURR OPIN NEUROL, V12, P565, DOI 10.1097/00019052-199910000-00010; Winkles JA, 2005, ONCOGENE, V24, P260, DOI 10.1038/sj.onc.1208219	49	24	24	0	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 15	2017	12	3							e0173311	10.1371/journal.pone.0173311	http://dx.doi.org/10.1371/journal.pone.0173311			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN9HQ	28296906	Green Submitted, Green Published, gold			2022-12-27	WOS:000396311700033
J	Goetz, SC; Bangs, F; Barrington, CL; Katsanis, N; Anderson, KV				Goetz, Sarah C.; Bangs, Fiona; Barrington, Chloe L.; Katsanis, Nicholas; Anderson, Kathryn V.			The Meckel syndrome-associated protein MKS1 functionally interacts with components of the BBSome and IFT complexes to mediate ciliary trafficking and hedgehog signaling	PLOS ONE			English	Article							BARDET-BIEDL-SYNDROME; INTRAFLAGELLAR TRANSPORT PROTEIN; PRIMARY CILIUM; CORE COMPLEX; DEFECTS; CILIOPATHIES; MUTATIONS; KINESIN; INPP5E; CILIOGENESIS	The importance of primary cilia in human health is underscored by the link between ciliary dysfunction and a group of primarily recessive genetic disorders with overlapping clinical features, now known as ciliopathies. Many of the proteins encoded by ciliopathy-associated genes are components of a handful of multi-protein complexes important for the transport of cargo to the basal body and/or into the cilium. A key question is whether different complexes cooperate in cilia formation, and whether they participate in cilium assembly in conjunction with intraflagellar transport (IFT) proteins. To examine how ciliopathy protein complexes might function together, we have analyzed double mutants of an allele of the Meckel syndrome (MKS) complex protein MKS1 and the BBSome protein BBS4. We find that Mks1; Bbs4 double mutant mouse embryos exhibit exacerbated defects in Hedgehog (Hh) dependent patterning compared to either single mutant, and die by E14.5. Cells from double mutant embryos exhibit a defect in the trafficking of ARL13B, a ciliary membrane protein, resulting in disrupted ciliary structure and signaling. We also examined the relationship between the MKS complex and IFT proteins by analyzing double mutant between Mks1 and a hypomorphic allele of the IFTB component Ift172. Despite each single mutant surviving until around birth, Mks1; Ift172(avc1) double mutants die at mid-gestation, and exhibit a dramatic failure of cilia formation. We also find that Mks1 interacts genetically with an allele of Dync2h1, the IFT retrograde motor. Thus, we have demonstrated that the MKS transition zone complex cooperates with the BBSome to mediate trafficking of specific trans-membrane receptors to the cilium. Moreover, the genetic interaction of Mks1 with components of IFT machinery suggests that the transition zone complex facilitates IFT to promote cilium assembly and structure.	[Goetz, Sarah C.; Bangs, Fiona; Anderson, Kathryn V.] Mem Sloan Kettering Canc Ctr, Sloan Kettering Inst, Program Dev Biol, New York, NY 10021 USA; [Goetz, Sarah C.; Barrington, Chloe L.] Duke Univ, Dept Pharmacol & Canc Biol, Med Ctr, Durham, NC 27708 USA; [Katsanis, Nicholas] Duke Univ, Med Ctr, Dept Cell Biol, Durham, NC 27710 USA; [Katsanis, Nicholas] Duke Univ, Med Ctr, Ctr Human Dis Modeling, Durham, NC USA	Memorial Sloan Kettering Cancer Center; Duke University; Duke University; Duke University	Goetz, SC (corresponding author), Mem Sloan Kettering Canc Ctr, Sloan Kettering Inst, Program Dev Biol, 1275 York Ave, New York, NY 10021 USA.	sarah.c.goetz@duke.edu		Barrington, Chloe/0000-0002-3884-102X	United States National Institutes of Health [R00 HD076444, R01 HD042601, R01 NS044385, R01 DK072301]; Memorial Sloan Kettering Cancer Center's National Institute of Health Cancer Center Support Grant [P30 CA008748]; NIH Pathway to Independence Award [R00 HD076444]; NIH [R01 HD042601, R01 NS044385, DK072301]; MSKCC Cancer Center Support Grant [P30 CA008748]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD042601, R00HD076444] Funding Source: NIH RePORTER; NATIONAL CANCER INSTITUTE [P30CA008748] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK072301] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM121317] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS044385] Funding Source: NIH RePORTER	United States National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Memorial Sloan Kettering Cancer Center's National Institute of Health Cancer Center Support Grant; NIH Pathway to Independence Award(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); MSKCC Cancer Center Support Grant; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was funded by the following grants made by the United States National Institutes of Health (www.nih.gov): To SCG: R00 HD076444 (from the National Institute of Child Health and Human Development); To KVA: R01 NS044385 (From the National Institute of Neurological Disorders and Stroke); To NK: R01 HD042601 (from the National Institute of Child Health and Human Development), R01 DK072301 (from the National Institute of Diabetes and Digestive and Kidney Disorders). Funding was also received through Memorial Sloan Kettering Cancer Center's National Institute of Health Cancer Center Support Grant (P30 CA008748). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; Ift172<SUP>avc1</SUP> mice were kindly provided by Ivan Moskowitz. The GLI2 antibody was a gift from Jonathan Eggenschwiler. Antibodies against ISL1 and NKX2.2 were obtained from the Developmental Studies Hybridoma Bank created by the NICHD of the NIH and maintained at The University of Iowa, Department of Biology. Imaging was performed using the Molecular Cytology and Electron Microscopy core facilities at Sloan Kettering Institute and the Light Microscopy core facility at Duke University. This work was supported by an NIH Pathway to Independence Award to SCG (R00 HD076444), and NIH grants to KVA (R01 NS044385), and NK (R01 HD042601 and DK072301), and the MSKCC Cancer Center Support Grant (P30 CA008748).	Alvarez Retuerto AI, 2008, HUM MOL GENET, V17, P3887, DOI 10.1093/hmg/ddn291; Badano JL, 2006, ANNU REV GENOM HUM G, V7, P125, DOI 10.1146/annurev.genom.7.080505.115610; Baker K, 2009, AM J MED GENET C, V151C, P281, DOI 10.1002/ajmg.c.30231; Beales PL, 2007, NAT GENET, V39, P727, DOI 10.1038/ng2038; Beales PL, 2003, AM J HUM GENET, V72, P1187, DOI 10.1086/375178; Berbari NF, 2008, P NATL ACAD SCI USA, V105, P4242, DOI 10.1073/pnas.0711027105; Bhogaraju S, 2013, SCIENCE, V341, P1009, DOI 10.1126/science.1240985; Bialas NJ, 2009, J CELL SCI, V122, P611, DOI 10.1242/jcs.028621; Bielas SL, 2009, NAT GENET, V41, P1032, DOI 10.1038/ng.423; Blacque OE, 2004, GENE DEV, V18, P1630, DOI 10.1101/gad.1194004; Caspary T, 2007, DEV CELL, V12, P767, DOI 10.1016/j.devcel.2007.03.004; Castro-Sanchez S, 2015, J MED GENET, V52, P503, DOI 10.1136/jmedgenet-2015-103099; Chavez M, 2015, DEV CELL, V34, P338, DOI 10.1016/j.devcel.2015.06.016; Chih B, 2012, NAT CELL BIOL, V14, P61, DOI 10.1038/ncb2410; Cho A, 2008, DEV BIOL, V321, P27, DOI 10.1016/j.ydbio.2008.05.558; Corbit KC, 2005, NATURE, V437, P1018, DOI 10.1038/nature04117; Cui C, 2010, DIS MODEL MECH, P1; Davis EE, 2012, CURR OPIN GENET DEV, V22, P290, DOI 10.1016/j.gde.2012.04.006; Davis EE, 2011, NAT GENET, V43, P189, DOI 10.1038/ng.756; Dawe HR, 2007, HUM MOL GENET, V16, P173, DOI 10.1093/hmg/ddl459; Doherty D, 2009, SEMIN PEDIATR NEUROL, V16, P143, DOI 10.1016/j.spen.2009.06.002; Domire JS, 2011, CELL MOL LIFE SCI, V68, P2951, DOI 10.1007/s00018-010-0603-4; Friedland-Little JM, 2011, HUM MOL GENET, V20, P3725, DOI 10.1093/hmg/ddr241; Garcia-Gonzalo FR, 2011, NAT GENET, V43, P776, DOI 10.1038/ng.891; Gerdes JM, 2009, CELL, V137, P32, DOI 10.1016/j.cell.2009.03.023; Goetz SC, 2012, CELL, V151, P847, DOI 10.1016/j.cell.2012.10.010; Goetz SC, 2010, NAT REV GENET, V11, P331, DOI 10.1038/nrg2774; Green JA, 2010, CELL MOL LIFE SCI, V67, P3287, DOI 10.1007/s00018-010-0425-4; Halbritter J, 2013, AM J HUM GENET, V93, P915, DOI 10.1016/j.ajhg.2013.09.012; He M, 2014, NAT CELL BIOL, V16, P663, DOI 10.1038/ncb2988; Hoefele J, 2007, J AM SOC NEPHROL, V18, P2789, DOI 10.1681/ASN.2007020243; Huangfu D, 2005, P NATL ACAD SCI USA, V102, P11325, DOI 10.1073/pnas.0505328102; Huangfu DW, 2003, NATURE, V426, P83, DOI 10.1038/nature02061; Huber C, 2012, AM J MED GENET C, V160C, P165, DOI 10.1002/ajmg.c.31336; Humbert MC, 2012, P NATL ACAD SCI USA, V109, P19691, DOI 10.1073/pnas.1210916109; Insinna C, 2008, DEV BIOL, V316, P160, DOI 10.1016/j.ydbio.2008.01.025; Jacoby M, 2009, NAT GENET, V41, P1027, DOI 10.1038/ng.427; Jin H, 2010, CELL, V141, P1208, DOI 10.1016/j.cell.2010.05.015; Karmous-Benailly H, 2005, AM J HUM GENET, V76, P493, DOI 10.1086/428679; Katsanis N, 2001, SCIENCE, V293, P2256, DOI 10.1126/science.1063525; Kulaga HM, 2004, NAT GENET, V36, P994, DOI 10.1038/ng1418; Lechtreck KF, 2009, J CELL BIOL, V187, P1117, DOI 10.1083/jcb.200909183; Liem KF, 2009, P NATL ACAD SCI USA, V106, P13377, DOI 10.1073/pnas.0906944106; Liu AM, 2005, DEVELOPMENT, V132, P3103, DOI 10.1242/dev.01894; Marley A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046647; Marszalek JR, 1999, P NATL ACAD SCI USA, V96, P5043, DOI 10.1073/pnas.96.9.5043; Masyukova SV, 2016, PLOS GENET, V12, DOI 10.1371/journal.pgen.1005841; Migliavacca E, 2015, AM J HUM GENET, V96, P784, DOI 10.1016/j.ajhg.2015.04.002; Mukhopadhyay S, 2013, CELL, V152, P210, DOI 10.1016/j.cell.2012.12.026; Mykytyn K, 2004, P NATL ACAD SCI USA, V101, P8664, DOI 10.1073/pnas.0402354101; Nachury MV, 2007, CELL, V129, P1201, DOI 10.1016/j.cell.2007.03.053; Ocbina PJR, 2008, DEV DYNAM, V237, P2030, DOI 10.1002/dvdy.21551; Ocbina PJR, 2011, NAT GENET, V43, P547, DOI 10.1038/ng.832; Pedersen LB, 2008, DEV DYNAM, V237, P1993, DOI 10.1002/dvdy.21521; Perrault I, 2015, J MED GENET, V52, P657, DOI 10.1136/jmedgenet-2014-102838; Rohatgi R, 2007, SCIENCE, V317, P372, DOI 10.1126/science.1139740; Scholey JM, 2008, J CELL BIOL, V180, P23, DOI 10.1083/jcb.200709133; Seo S, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002358; Seo S, 2010, P NATL ACAD SCI USA, V107, P1488, DOI 10.1073/pnas.0910268107; SHAKIR MA, 1993, NEUROREPORT, V4, P891, DOI 10.1097/00001756-199307000-00013; Taschner M, 2014, J CELL BIOL, V207, P269, DOI 10.1083/jcb.201408002; Taschner M, 2012, DIFFERENTIATION, V83, pS12, DOI 10.1016/j.diff.2011.11.001; Tran PV, 2008, NAT GENET, V40, P403, DOI 10.1038/ng.105; Weatherbee SD, 2009, HUM MOL GENET, V18, P4565, DOI 10.1093/hmg/ddp422; Yee LE, 2015, PLOS GENET, V11, DOI 10.1371/journal.pgen.1005627; Zhang QH, 2013, J CELL SCI, V126, P2372, DOI 10.1242/jcs.111740; Zhang QH, 2012, HUM MOL GENET, V21, P1945, DOI 10.1093/hmg/dds004	67	25	26	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 14	2017	12	3							e0173399	10.1371/journal.pone.0173399	http://dx.doi.org/10.1371/journal.pone.0173399			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN6DM	28291807	Green Published, Green Submitted, gold			2022-12-27	WOS:000396094700023
J	Lan, L; Tian, FR; Zhuge, DL; Zhuge, QC; Shen, BX; Jin, BH; Huang, JP; Wu, MZ; Fan, LX; Zhao, YZ; Xu, HL				Lan, Li; Tian, Fu-Rong; ZhuGe, De-Li; ZhuGe, Qi-Chuan; Shen, Bi-Xin; Jin, Bing-Hui; Huang, Jian-Ping; Wu, Ming-Ze; Fan, Lu-Xin; Zhao, Ying-Zheng; Xu, He-Lin			Implantable porous gelatin microspheres sustained release of bFGF and improved its neuroprotective effect on rats after spinal cord injury	PLOS ONE			English	Article							FIBROBLAST-GROWTH-FACTOR; IN-VITRO; MODEL; DELIVERY; REGENERATION; RECOVERY; NANOPARTICLES; INHIBITION; SCAFFOLDS; THERAPY	In this study, porous gelatin microspheres (GMSs) were constructed to improve the neuroprotective effect of basic fibroblast growth factor (bFGF) on spinal cord injury. GMSs were prepared by a W/O emulsion template, followed by cross-linking, washing and drying. The particle sizes and surface porosity of the blank GMSs were carefully characterized by scan electronic microscopy. The blank GMSs have a mean particle size of 35 mu m and theirs surface was coarse and porous. bFGF was easily encapsulated inside the bulk GMSs through diffusion along the porous channel. 200 mu g of bFGF was completely encapsulated in 100mg of GMSs. The bFGF-loaded GMSs displayed a continuous drug release pattern without an obvious burst release over two weeks in vitro. Moreover, the therapeutic effects of bFGF-loaded GMSs were also evaluated in spinal cord injury rat model. After implantation of bFGF-loaded GMSs, the recovery of the motor function of SCI rats were evaluated by behavioral score and foot print experiment. The motor function of SCI rats treated with bFGF-loaded GMSs was more obvious than that treated with free bFGF solution (P<0.05). At the 28 th days after treatment, rats were sacrificed and the injured spinal were removed for histopathological and apoptosis examination. Compared with treatment with free bFGF solution, treatment with bFGF-loaded GMSs resulted in a less necrosis, less infiltration of leukocytes, and a reduced the cavity ratio and less apoptotic cells in injured spinal(P<0.01), indicating its better therapeutic effect. Implantable porous GMSs may be a potential carrier to deliver bFGF for therapy of spinal cord injury.	[Lan, Li; ZhuGe, Qi-Chuan; Xu, He-Lin] Wenzhou Med Univ, Affiliated Hosp 1, Zhejiang Prov Key Lab Aging & Neurol Disorder Res, Wenzhou, Peoples R China; [Tian, Fu-Rong; ZhuGe, De-Li; Shen, Bi-Xin; Jin, Bing-Hui; Wu, Ming-Ze; Fan, Lu-Xin; Zhao, Ying-Zheng; Xu, He-Lin] Wenzhou Med Univ, Sch Pharmaceut Sci, Wenzhou City, Zhejiang, Peoples R China; [Huang, Jian-Ping] WenZhou Chinese Med Hosp, Wenzhou, Zhejiang, Peoples R China	Wenzhou Medical University; Wenzhou Medical University	Xu, HL (corresponding author), Wenzhou Med Univ, Affiliated Hosp 1, Zhejiang Prov Key Lab Aging & Neurol Disorder Res, Wenzhou, Peoples R China.; Zhao, YZ; Xu, HL (corresponding author), Wenzhou Med Univ, Sch Pharmaceut Sci, Wenzhou City, Zhejiang, Peoples R China.	pharmtds@163.com; xhlpharm1214@126.com	Tian, Furong/AAA-6037-2020	Tian, Furong/0000-0002-4953-1131	National Natural Science Foundation of China [81603036, 81360195, 81301982, 81571392, 81272160]; research fund for the doctoral program of high education by ministry of education of China [20133321120005]; Zhejiang provincial program for the cultivation of high-level innovative health talents; 151 talent project of Zhejiang province; 551 talent project of Wenzhou; key support of high level talent innovation and technology project of Wenzhou; Zhejiang Provincial Foundation for Health Department [2015ZDA023, 2016KYA136]; Zhejiang Provincial Natural Science Foundation [LY14H280002]; Wenzhou Bureau of Science and Technology [Y20160086]; School Talent Start Fund of Wenzhou Medical University [QTJ15020]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); research fund for the doctoral program of high education by ministry of education of China; Zhejiang provincial program for the cultivation of high-level innovative health talents; 151 talent project of Zhejiang province; 551 talent project of Wenzhou; key support of high level talent innovation and technology project of Wenzhou; Zhejiang Provincial Foundation for Health Department; Zhejiang Provincial Natural Science Foundation(Natural Science Foundation of Zhejiang Province); Wenzhou Bureau of Science and Technology; School Talent Start Fund of Wenzhou Medical University	This research was supported by National Natural Science Foundation of China (Grant No. 81603036, 81360195, 81301982,81571392 and 81272160), research fund for the doctoral program of high education by ministry of education of China (Grant No.20133321120005, Cui-Tao Lu), Zhejiang provincial program for the cultivation of high-level innovative health talents (Ying-Zheng Zhao), 151 talent project of Zhejiang province and 551 talent project of Wenzhou (Ying-Zheng Zhao), key support of high level talent innovation and technology project of Wenzhou (Zhao Ying-Zheng), Zhejiang Provincial Foundation for Health Department (Grant No.2015ZDA023 and 2016KYA136), Zhejiang Provincial Natural Science Foundation (Grant No. LY14H280002), Medicine Grant from Wenzhou Bureau of Science and Technology (Grant No. Y20160086), School Talent Start Fund of Wenzhou Medical University (Grant No.QTJ15020). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This research was supported by National Natural Science Foundation of China (Grant No. 81603036, 81360195, 81301982,81571392 and 81272160), research fund for the doctoral program of high education by ministry of education of China (Grant No.20133321120005, Cui-Tao Lu), Zhejiang provincial program for the cultivation of high-level innovative health talents (Ying-Zheng Zhao), 151 talent project of Zhejiang province and 551 talent project of Wenzhou (Ying-Zheng Zhao), key support of high level talent innovation and technology project of Wenzhou (Zhao Ying-Zheng), Zhejiang Provincial Foundation for Health Department (Grant No.2015ZDA023 and 2016KYA136), Zhejiang Provincial Natural Science Foundation (Grant No. LY14H280002), Medicine Grant from Wenzhou Bureau of Science and Technology (Grant No. Y20160086), School Talent Start Fund of Wenzhou Medical University (Grant No. QTJ15020).	Cai PT, 2016, AGING DIS, V7, P336, DOI 10.14336/AD.2016.0117; Chang SS, 2014, SURG TODAY, V44, P1536, DOI 10.1007/s00595-014-0864-x; DEMEDINACELI L, 1982, EXP NEUROL, V77, P634, DOI 10.1016/0014-4886(82)90234-5; Festoff BW, 2006, J NEUROCHEM, V97, P1314, DOI 10.1111/j.1471-4159.2006.03799.x; Fraher JP, 2000, J ANAT, V196, P137; FRAHER JP, 1992, PROG NEUROBIOL, V38, P261, DOI 10.1016/0301-0082(92)90022-7; Fujimaki H, 2016, J BIOMED MAT RES A; Han YS, 2009, GERONTOLOGY, V55, P592, DOI 10.1159/000235547; Hanz S, 2006, J NEUROCHEM, V99, P13, DOI 10.1111/j.1471-4159.2006.04089.x; Housley WJ, 2015, CLIN IMMUNOL, V161, P51, DOI 10.1016/j.clim.2015.06.015; Iannotti C, 2006, J NEUROTRAUM, V23, P853, DOI 10.1089/neu.2006.23.853; Igai H, 2007, J THORAC CARDIOV SUR, V134, P170, DOI 10.1016/j.jtcvs.2007.02.022; Jin Y, 2014, ACTA BIOMATER, V10, P3126, DOI 10.1016/j.actbio.2014.02.045; Kempen DHR, 2008, BIOMATERIALS, V29, P3245, DOI 10.1016/j.biomaterials.2008.04.031; Kempen DHR, 2009, BIOMATERIALS, V30, P2816, DOI 10.1016/j.biomaterials.2009.01.031; Leszczynska AN, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0143602; Makarevich PI, 2015, KARDIOLOGIYA, V55, P59; Minardi S, 2015, ACS APPL MATER INTER, V7, P16364, DOI 10.1021/acsami.5b03464; Nakamichi M, 2016, AM J PATHOL; Oyinbo CA, 2011, ACTA NEUROBIOL EXP, V71, P281; Petzold A, 2015, BRAIN RES, V1600, P17, DOI 10.1016/j.brainres.2014.12.027; Rabchevsky AG, 2000, EXP NEUROL, V164, P280, DOI 10.1006/exnr.2000.7399; Ren H, 2014, BIOMATERIALS, V35, P6585, DOI 10.1016/j.biomaterials.2014.04.042; Shi Q, 2014, SCI CHINA LIFE SCI, V57, P232, DOI 10.1007/s11427-014-4612-7; Tabata Y, 1998, ADV DRUG DELIVER REV, V31, P287, DOI 10.1016/S0169-409X(97)00125-7; Tan Z, 2009, CYTOTHERAPY, V11, P317, DOI 10.1080/14653240902824757; Thomas AM, 2013, BIOMATERIALS, V34, P2213, DOI 10.1016/j.biomaterials.2012.12.002; Xu HL, 2011, PHARMAZIE, V66, P654, DOI 10.1691/ph.2011.1042; Zhang HY, 2013, CNS NEUROSCI THER, V19, P20, DOI 10.1111/cns.12013; Zhang YP, 2004, J NEUROSURG, V100, P343, DOI 10.3171/spi.2004.100.4.0343; Zhao YZ, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0148848; Zhao YZ, 2016, J CONTROL RELEASE, V224, P165, DOI 10.1016/j.jconrel.2016.01.017; Zhao YZ, 2014, J CONTROL RELEASE, V186, P22, DOI 10.1016/j.jconrel.2014.04.054	33	24	24	2	43	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 14	2017	12	3							e0173814	10.1371/journal.pone.0173814	http://dx.doi.org/10.1371/journal.pone.0173814			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN6DM	28291798	Green Published, gold, Green Submitted			2022-12-27	WOS:000396094700042
J	Ren, JN; Deng, TT; Huang, WS; Chen, Y; Ge, YQ				Ren, Junan; Deng, Tingting; Huang, Wensheng; Chen, Ying; Ge, Yiqiang			A digital PCR method for identifying and quantifying adulteration of meat species in raw and processed food	PLOS ONE			English	Article							REAL-TIME PCR; RED DEER; DNA; QUANTIFICATION; IDENTIFICATION; PRODUCTS; HEAT; PORK; PROTEINS; CHICKEN	Meat adulteration is a worldwide concern. In this paper, a new droplet digital PCR (ddPCR) method was developed for the quantitative determination of the presence of chicken in sheep and goat meat products. Meanwhile, a constant (multiplication factor) was introduced to transform the ratio of copy numbers to the proportion of meats. The presented ddPCR method was also proved to be more accurate (showing bias of less than 9% in the range from 5% to 80%) than real-time PCR, which has been widely used in this determination. The method exhibited good repeatability and stability in different thermal treatments and at ultrahigh pressure. The relative standard deviation (RSD) values of 5% chicken content was less than 5.4% for ultra-high pressure or heat treatment. Moreover, we confirmed that different parts of meat had no effect on quantification accuracy of the ddPCR method. In contrast to real-time PCR, we examined the performance of ddPCR as a more precise, sensitive and stable analytical strategy to overcome potential problems of discrepancies in amplification efficiency discrepancy and to obtain the copy numbers directly without standard curves. The method and strategy developed in this study can be applied to quantify the presence and to confirm the absence of adulterants not only to sheep but also to other kinds of meat and meat products.	[Ren, Junan; Deng, Tingting; Ge, Yiqiang] China Agr Univ, Coll Food Sci & Nutr Engn, Beijing, Peoples R China; [Ren, Junan; Deng, Tingting; Huang, Wensheng; Chen, Ying] Chinese Acad Inspect & Quarantine, Agroprod Safety Res Ctr, Beijing, Peoples R China; [Ge, Yiqiang] China Rural Technol Dev Ctr, Beijing, Peoples R China	China Agricultural University; Chinese Academy of Inspection & Quarantine	Ge, YQ (corresponding author), China Agr Univ, Coll Food Sci & Nutr Engn, Beijing, Peoples R China.; Chen, Y (corresponding author), Chinese Acad Inspect & Quarantine, Agroprod Safety Res Ctr, Beijing, Peoples R China.; Ge, YQ (corresponding author), China Rural Technol Dev Ctr, Beijing, Peoples R China.	chenyingcaiq@163.com; 68511009@163.com	Chen, Ying/E-9891-2015					Alonso A, 2004, FORENSIC SCI INT, V139, P141, DOI 10.1016/j.forsciint.2003.10.008; Amaral JS, 2014, FOOD RES INT, V60, P140, DOI 10.1016/j.foodres.2013.11.003; [Anonymous], 2014, CHINESE J FOOD HYGIE; Bajovic B, 2012, MEAT SCI, V92, P280, DOI 10.1016/j.meatsci.2012.04.024; Baker M, 2012, NAT METHODS, V9, P541, DOI 10.1038/nmeth.2027; Ballin NZ, 2009, MEAT SCI, V83, P165, DOI 10.1016/j.meatsci.2009.06.003; Cai QF, 2013, FOOD CONTROL, V29, P241, DOI 10.1016/j.foodcont.2012.06.016; Cai YC, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/810209; Camma C, 2012, FOOD CONTROL, V23, P400, DOI 10.1016/j.foodcont.2011.08.007; Cawthorn DM, 2013, FOOD CONTROL, V32, P440, DOI 10.1016/j.foodcont.2013.01.008; Cheng X, 2014, FOOD RES INT, V60, P30, DOI 10.1016/j.foodres.2014.01.047; Codex Committee on Methods of Analysis and Sampling, 2010, 7402010 FAO CACGL CO; Day E, 2013, METHODS, V59, P101, DOI 10.1016/j.ymeth.2012.08.001; Dooley JJ, 2004, MEAT SCI, V68, P431, DOI 10.1016/j.meatsci.2004.04.010; Dreo T, 2014, ANAL BIOANAL CHEM, V406, P6513, DOI 10.1007/s00216-014-8084-1; Druml B, 2015, FOOD CONTROL, V57, P370, DOI 10.1016/j.foodcont.2015.04.023; Floren C, 2015, FOOD CHEM, V173, P1054, DOI 10.1016/j.foodchem.2014.10.138; Guo GJ, 2010, DEV CELL, V18, P675, DOI 10.1016/j.devcel.2010.02.012; Hindson BJ, 2011, ANAL CHEM, V83, P8604, DOI 10.1021/ac202028g; Hird H, 2006, FOOD ADDIT CONTAM, V23, P645, DOI 10.1080/02652030600603041; Hou B, 2015, MEAT SCI, V101, P90, DOI 10.1016/j.meatsci.2014.11.007; Iwobi A, 2015, FOOD CHEM, V169, P305, DOI 10.1016/j.foodchem.2014.07.139; Karabasanavar NS, 2014, FOOD CHEM, V145, P530, DOI 10.1016/j.foodchem.2013.08.084; Kesmen Z, 2009, MEAT SCI, V82, P444, DOI 10.1016/j.meatsci.2009.02.019; Kingombe CIB, 2001, MEAT SCI, V57, P35, DOI 10.1016/S0309-1740(00)00074-7; Koppel R, 2015, EUR FOOD RES TECHNOL, V241, P521, DOI 10.1007/s00217-015-2481-3; Koppel R, 2013, EUR FOOD RES TECHNOL, V236, P1093, DOI 10.1007/s00217-013-1973-2; Koppel R, 2011, EUR FOOD RES TECHNOL, V232, P151, DOI 10.1007/s00217-010-1371-y; Leitner A, 2006, J PROTEOME RES, V5, P2424, DOI 10.1021/pr060145q; Li Nan, 2016, CHINESES J FOOD HYGI, V26, P227; Liu LH, 2006, J FOOD SCI, V71, pM1, DOI 10.1111/j.1365-2621.2006.tb12393.x; Lopez-Andreo M, 2005, ANAL BIOCHEM, V339, P73, DOI 10.1016/j.ab.2004.11.045; Lopez-Andreo M, 2012, FOOD CHEM, V134, P518, DOI 10.1016/j.foodchem.2012.02.111; Montowska M, 2013, FOOD CHEM, V136, P1461, DOI 10.1016/j.foodchem.2012.09.072; Morisset D, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062583; Ng J, 2014, J FOOD SCI TECH MYS, V51, P4060, DOI 10.1007/s13197-012-0893-7; O'Mahony PJ, 2013, QJM-INT J MED, V106, P595, DOI 10.1093/qjmed/hct087; Pinheiro LB, 2012, ANAL CHEM, V84, P1003, DOI 10.1021/ac202578x; Scaravelli E, 2008, EUR FOOD RES TECHNOL, V227, P857, DOI 10.1007/s00217-007-0797-3; Tang SuiPing, 2016, Journal of Food Safety and Quality, V7, P1882; Tornberg E, 2005, MEAT SCI, V70, P493, DOI 10.1016/j.meatsci.2004.11.021; Wang P, 2013, J AOAC INT, V96, P142, DOI 10.5740/jaoacint.11-398; Wee EJH, 2016, THERANOSTICS, V6, P1506, DOI 10.7150/thno.15871; Zukal E, 2007, J FOOD ENG, V78, P614, DOI 10.1016/j.jfoodeng.2005.10.033	44	48	60	1	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 20	2017	12	3							e0173567	10.1371/journal.pone.0173567	http://dx.doi.org/10.1371/journal.pone.0173567			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ER6VC	28319152	Green Published, gold, Green Submitted			2022-12-27	WOS:000398945800019
J	Amegah, AK; Klevor, MK; Wagner, CL				Amegah, A. Kofi; Klevor, Moses K.; Wagner, Carol L.			Maternal vitamin D insufficiency and risk of adverse pregnancy and birth outcomes: A systematic review and meta-analysis of longitudinal studies	PLOS ONE			English	Article							SPONTANEOUS PRETERM BIRTH; D DEFICIENCY; D SUPPLEMENTATION; NEONATAL OUTCOMES; 1ST TRIMESTER; CONTRACTILITY; TRIAL	Background Three previous reviews on the association of vitamin D insufficiency in pregnancy with pre-term birth (PTB) and stillbirth were limited in scope and deemed inconclusive. With important new evidence accumulating, there is the need to update the previous estimates and assess evidence on other clinically important outcomes such as spontaneous abortion and Apgar score. We conducted a systematic review and meta-analysis to evaluate the quality and strength of the available evidence on the relations between vitamin D nutritional status, and pregnancy and birth outcomes. Methods PubMed and Scopus databases were searched from their inception to June, 2015 with no language restrictions imposed. Eighteen longitudinal studies satisfied the inclusion criteria. Random effects model was applied in computing the summary effect estimates and their corresponding 95% confidence intervals. Results Serum 25(OH) D levels <75 nmol/l was associated with 83% (95% CI: 1.23, 2.74) and 13% (95% CI: 0.94, 1.36) increased risk of PTB measured at <32-34 weeks and <35-37 weeks, respectively. An inverse dose-response relation was observed for both PTB outcome. Serum 25(OH) D levels <75 nmol/l was also associated with 11% increased risk of spontaneous PTB (<35-37 weeks; RR = 1.11; 95% CI: 0.75, 1.65) with a dose-response relation also noted. Vitamin D insufficiency was not associated with risk of spontaneous abortion and stillbirth (RR of 1.04 [95% CI: 0.95, 1.13] and 1.02 [95% CI: 0.96, 1.09], respectively), as well as short gestational length (ES = -0.24, 95% CI: -0.69, 0.22), and low Apgar score. Conclusions We found vitamin D insufficiency to be associated with risk of PTB. Regarding spontaneous abortion and stillbirth, the available evidence suggest no association with low vitamin D levels. The evidence on vitamin D nutrition and Apgar score is conflicting and controversial. Overall, the experimental evidence uncovered was small and weak. Hence, the benefits of vitamin D supplementation during pregnancy should be further evaluated through rigorous intervention studies.	[Amegah, A. Kofi] Univ Cape Coast, Publ Hlth Res Grp, Dept Biomed Sci, Sch Allied Hlth Sci, Cape Coast, Ghana; [Klevor, Moses K.] Univ Cape Coast, Dept Clin Nutr & Dietet, Cape Coast, Ghana; [Wagner, Carol L.] Med Univ South Carolina, Childrens Hosp, Charleston, SC USA	University of Cape Coast; University of Cape Coast; Medical University of South Carolina	Amegah, AK (corresponding author), Univ Cape Coast, Publ Hlth Res Grp, Dept Biomed Sci, Sch Allied Hlth Sci, Cape Coast, Ghana.	aamegah@ucc.edu.gh	Klevor, Moses/C-1702-2014; Klevor, Moses/ABC-8241-2020; Amegah, AK/L-8952-2016	Klevor, Moses/0000-0003-2447-9020; Amegah, AK/0000-0001-5868-6402				Aghajafari F., 2013, BMJ-BRIT MED J, V346, DOI [DOI 10.1136/BMJ.F1169, 10.1136/bmj.f1169]; Amegah AK, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0113920; Baker AM, 2011, AM J PERINAT, V28, P667, DOI 10.1055/s-0031-1276731; Bandeira Francisco, 2006, Arq Bras Endocrinol Metab, V50, P640, DOI 10.1590/S0004-27302006000400009; Bodnar LM, 2015, OBSTET GYNECOL, V125, P439, DOI 10.1097/AOG.0000000000000621; Bodnar LM, 2014, AM J EPIDEMIOL, V179, P168, DOI 10.1093/aje/kwt237; Buxton ILO, 2004, MOL PHARMACOL, V65, P1051, DOI 10.1124/mol.65.5.1051; Chesney RW, 2010, J PEDIATR-US, V156, P698, DOI 10.1016/j.jpeds.2010.02.002; Choi R, 2015, NUTRIENTS, V7, P3427, DOI 10.3390/nu7053427; Combs GF, 1998, VITAMINS: FUNDAMENTAL ASPECTS IN NUTRITION AND HEALTH, 2ND EDITION, P3; De-Regil LM, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD008873.pub2; Dror DK, 2011, CURR OPIN OBSTET GYN, V23, P422, DOI 10.1097/GCO.0b013e32834cb791; Dror DK, 2010, NUTR REV, V68, P465, DOI 10.1111/j.1753-4887.2010.00306.x; Evans KN, 2004, J SOC GYNECOL INVEST, V11, P263, DOI 10.1016/j.jsgi.2004.02.002; Fernandez-Alonso AM, 2012, INT J GYNECOL OBSTET, V116, P6, DOI 10.1016/j.ijgo.2011.07.029; Flood-Nichols SK, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0123763; Harvey NC, 2014, HEALTH TECHNOL ASSES, V18, P1, DOI 10.3310/hta18450; Holick MF, 2007, NEW ENGL J MED, V357, P266, DOI 10.1056/NEJMra070553; Hollis BW, 2011, J BONE MINER RES, V26, P2341, DOI 10.1002/jbmr.463; Hossain N, 2014, J CLIN ENDOCR METAB, V99, P2448, DOI 10.1210/jc.2013-3491; Liu NQ, 2012, ARCH BIOCHEM BIOPHYS, V523, P37, DOI 10.1016/j.abb.2011.11.018; Liu PT, 2006, SCIENCE, V311, P1770, DOI 10.1126/science.1123933; Maghbooli Zhila, 2007, BMC Pregnancy Childbirth, V7, P1, DOI 10.1186/1471-2393-7-1; Misawa Y, 2009, INT J HEMATOL, V90, P561, DOI 10.1007/s12185-009-0452-9; Moher D, 2009, J CLIN EPIDEMIOL, V62, P1006, DOI 10.1016/j.jclinepi.2009.06.005; Moller UK, 2012, EUR J CLIN NUTR, V66, P862, DOI 10.1038/ejcn.2012.18; Morley R, 2006, J CLIN ENDOCR METAB, V91, P906, DOI 10.1210/jc.2005-1479; Nassar N, 2011, AM J OBSTET GYNECOL, V205, DOI 10.1016/j.ajog.2011.03.058; Ota K, 2014, HUM REPROD, V29, P208, DOI 10.1093/humrep/det424; Poel YHM, 2012, EUR J INTERN MED, V23, P465, DOI 10.1016/j.ejim.2012.01.007; Prentice A, 2008, NUTR REV, V66, pS153, DOI 10.1111/j.1753-4887.2008.00100.x; Rodriguez A, 2015, BJOG-INT J OBSTET GY, V122, P1695, DOI 10.1111/1471-0528.13074; Romero R, 2006, BJOG-INT J OBSTET GY, V113, P17, DOI 10.1111/j.1471-0528.2006.01120.x; Sablok A, 2015, CLIN ENDOCRINOL, V83, P536, DOI 10.1111/cen.12751; Schneuer FJ, 2014, AM J CLIN NUTR, V99, P287, DOI 10.3945/ajcn.113.065672; Schroth Robert J, 2005, Int J Circumpolar Health, V64, P112; Thorne-Lyman A, 2012, PAEDIATR PERINAT EP, V26, P75, DOI 10.1111/j.1365-3016.2012.01283.x; Thorp JM, 2012, BJOG-INT J OBSTET GY, V119, P1617, DOI 10.1111/j.1471-0528.2012.03495.x; Tribe RM, 2001, EXP PHYSIOL, V86, P247, DOI 10.1113/eph8602180; Vieth R, 2007, J BONE MINER RES, V22, pV64, DOI 10.1359/JBMR.07S221; Wagner CL, 2015, J STEROID BIOCHEM, V148, P256, DOI 10.1016/j.jsbmb.2014.11.013; Walker VP, 2009, PEDIATR RES, V65, p106R, DOI 10.1203/PDR.0b013e31819dba91; Wei SQ, 2013, J MATERN-FETAL NEO M, V26, P889, DOI 10.3109/14767058.2013.765849; Wetta LA, 2014, AM J PERINAT, V31, P541, DOI 10.1055/s-0033-1356483; World Health Organization, 2012, GUID VIT D SUPPL PRE; Wray S, 2001, EXP PHYSIOL, V86, P239, DOI 10.1113/eph8602114; Yu CKH, 2009, CLIN ENDOCRINOL, V70, P685, DOI 10.1111/j.1365-2265.2008.03403.x; Zhou J, 2014, EUR J CLIN NUTR, V68, P925, DOI 10.1038/ejcn.2014.99	48	65	68	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 17	2017	12	3							e0173605	10.1371/journal.pone.0173605	http://dx.doi.org/10.1371/journal.pone.0173605			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EO5CJ	28306725	Green Published, Green Submitted, gold			2022-12-27	WOS:000396710300012
J	Bellucci, A; Tondelli, A; Fangel, JU; Torp, AM; Xu, X; Willats, WGT; Flavell, A; Cattivelli, L; Rasmussen, SK				Bellucci, Andrea; Tondelli, Alessandro; Fangel, Jonatan U.; Torp, Anna Maria; Xu, Xin; Willats, William G. T.; Flavell, Andrew; Cattivelli, Luigi; Rasmussen, Soren K.			Genome-wide association mapping in winter barley for grain yield and culm cell wall polymer content using the high-throughput CoMPP technique	PLOS ONE			English	Article							BYMOVIRUS RESISTANCE; BIOFUEL TRAITS; BIOMASS; GENE; PREDICTION; MARKER; IDENTIFICATION; ARABIDOPSIS; SOFTWARE; PROTEINS	A collection of 112 winter barley varieties (Hordeum vulgare L.) was grown in the field for two years (2008/09 and 2009/10) in northern Italy and grain and straw yields recorded. In the first year of the trial, a severe attack of barley yellow mosaic virus (BaYMV) strongly influenced final performances with an average reduction of similar to 50% for grain and straw harvested in comparison to the second year. The genetic determination (GD) for grain yield was 0.49 and 0.70, for the two years respectively, and for straw yield GD was low in 2009 (0.09) and higher in 2010 (0.29). Cell wall polymers in culms were quantified by means of the monoclonal antibodies LM6, LM11, JIM13 and BS-400-3 and the carbohydrate-binding module CBM3a using the high-throughput CoMPP technique. Of these, LM6, which detects arabinan components, showed a relatively high GD in both years and a significantly negative correlation with grain yield (GYLD). Overall, heritability (H-2) was calculated for GYLD, LM6 and JIM and resulted to be 0.42, 0.32 and 0.20, respectively. A total of 4,976 SNPs from the 9K iSelect array were used in the study for the analysis of population structure, linkage disequilibrium (LD) and genome-wide association study (GWAS). Marker-trait associations (MTA) were analyzed for grain yield and cell wall determination by LM6 and JIM13 as these were the traits showing significant correlations between the years. A single QTL for GYLD containing three MTAs was found on chromosome 3H located close to the Hv-eIF4E gene, which is known to regulate resistance to BaYMV. Subsequently the QTL was shown to be tightly linked to rym4, a locus for resistance to the virus. GWAs on arabinans quantified by LM6 resulted in the identification of major QTLs closely located on 3H and hypotheses regarding putative candidate genes were formulated through the study of gene expression levels based on bioinformatics tools.	[Bellucci, Andrea; Fangel, Jonatan U.; Torp, Anna Maria; Willats, William G. T.; Rasmussen, Soren K.] Univ Copenhagen, Dept Plant & Environm Sci, Fac Sci, Frederiksberg, Denmark; [Tondelli, Alessandro; Cattivelli, Luigi] Consiglio Ric & Sperimentaz Agr & Anal Econ Agr, Ctr Ric Genom Vegetale, Fiorenzuola Darda, Italy; [Xu, Xin; Flavell, Andrew] Univ Dundee, Sch Life Sci, Dundee, Scotland	University of Copenhagen; Consiglio per la Ricerca in Agricoltura e L'analisi Dell'economia Agraria (CREA); University of Dundee	Rasmussen, SK (corresponding author), Univ Copenhagen, Dept Plant & Environm Sci, Fac Sci, Frederiksberg, Denmark.	skr@plen.ku.dk	Tondelli, Alessandro/I-7433-2015; Torp, Anna Maria/I-8189-2014; cattivelli, luigi/AAE-7046-2020; Tondelli, Alessandro/AAJ-1720-2020; Rasmussen, Soren K./F-6728-2014	Tondelli, Alessandro/0000-0001-9299-7773; Torp, Anna Maria/0000-0001-8199-1480; cattivelli, luigi/0000-0002-6067-4600; Tondelli, Alessandro/0000-0001-9299-7773; Rasmussen, Soren K./0000-0001-6169-2504	Innovation Fund Denmark [001-2011-4]; Danish Council for Strategic Research, Biotechnology for Bioenergy, Bio4Bio [2104080039]; ERA-PG, grant Genomics-Assisted Analysis and Exploitation of Barley Diversity	Innovation Fund Denmark; Danish Council for Strategic Research, Biotechnology for Bioenergy, Bio4Bio; ERA-PG, grant Genomics-Assisted Analysis and Exploitation of Barley Diversity	This work was supported by the Innovation Fund Denmark B21st (http://innovationsfonden.dk/en), grant no. 001-2011-4 to SKR, the Danish Council for Strategic Research, Biotechnology for Bioenergy, Bio4Bio, grant no. 2104080039 to SKR, and the ERA-PG, grant Genomics-Assisted Analysis and Exploitation of Barley Diversity to AF. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akar T, 2009, PLANT BREEDING, V128, P381, DOI 10.1111/j.1439-0523.2008.01553.x; Alexandersson E, 2014, FRONT PLANT SCI, V5, DOI 10.3389/fpls.2014.00286; Alonso-Simon A, 2010, BIOTECHNOL BIOENG, V105, P509, DOI 10.1002/bit.22546; Bailoni L, 2003, VET RES COMMUN, V27, P249, DOI 10.1023/B:VERC.0000014152.80334.86; Bates Douglas, 2014, LME4 LINEAR MIXED EF; Bellucci A, 2015, FRONT PLANT SCI, V6, DOI 10.3389/fpls.2015.01046; Bradbury PJ, 2007, BIOINFORMATICS, V23, P2633, DOI 10.1093/bioinformatics/btm308; Brown TB, 2014, CURR OPIN PLANT BIOL, V18, P73, DOI 10.1016/j.pbi.2014.02.002; Burton RA, 2012, FRONT PLANT SCI, V3, DOI 10.3389/fpls.2012.00130; Comadran J, 2012, NAT GENET, V44, P1388, DOI 10.1038/ng.2447; Digel B, 2016, PLANT PHYSIOL, V172, P405, DOI 10.1104/pp.16.00977; Dwivedi SL, 2007, ADV AGRON, V95, P163, DOI 10.1016/S0065-2113(07)95003-8; Earl DA, 2012, CONSERV GENET RESOUR, V4, P359, DOI 10.1007/s12686-011-9548-7; Evanno G, 2005, MOL ECOL, V14, P2611, DOI 10.1111/j.1365-294X.2005.02553.x; Granier C, 2014, CURR OPIN PLANT BIOL, V18, P96, DOI 10.1016/j.pbi.2014.02.009; Houston K, 2015, PLOS ONE, V10; Houston K, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-907; Houston K, 2013, P NATL ACAD SCI USA, V110, P16675, DOI 10.1073/pnas.1311681110; Jakobsson M, 2007, BIOINFORMATICS, V23, P1801, DOI 10.1093/bioinformatics/btm233; Kai H, 2012, THEOR APPL GENET, V124, P577, DOI 10.1007/s00122-011-1730-5; Kuczynska A, 2013, J APPL GENET, V54, P381, DOI 10.1007/s13353-013-0165-x; Kumlehn J, BIOTECHNOLOGICAL APP; Lado B, 2013, G3-GENES GENOM GENET, V3, P2105, DOI 10.1534/g3.113.007807; Leplat F, 2016, BMC GENOMICS, V17, P15; Leplat F, 2016, PLANT GENOME-US, V9, DOI 10.3835/plantgenome2015.09.0085; Liepman AH, 2010, PLANT J, V61, P1107, DOI 10.1111/j.1365-313X.2010.04161.x; Lipka AE, 2012, BIOINFORMATICS, V28, P2397, DOI 10.1093/bioinformatics/bts444; Lopes MS, 2015, THEOR APPL GENET, V128, P453, DOI 10.1007/s00122-014-2444-2; Malinovsky FG, 2014, FRONT PLANT SCI, V5, DOI 10.3389/fpls.2014.00178; Malosetti M, 2011, THEOR APPL GENET, V122, P1605, DOI 10.1007/s00122-011-1558-z; Marcotuli I, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0132787; Marzec M, 2015, J EXP BOT, V66, P1245, DOI 10.1093/jxb/eru475; Matthies IE, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0110046; Mayer KFX, 2012, NATURE, V491, P711, DOI 10.1038/nature11543; McCann MC, 2015, J EXP BOT, V66, P4109, DOI 10.1093/jxb/erv267; Mikkelsen D, 2015, BIOMACROMOLECULES, V16, P1232, DOI 10.1021/acs.biomac.5b00009; Mikkelsen MD, 2014, ANN BOT-LONDON, V114, P1217, DOI 10.1093/aob/mcu171; Mocoeur A, 2015, THEOR APPL GENET, V128, P1685, DOI 10.1007/s00122-015-2538-5; Moller I, 2007, PLANT J, V50, P1118, DOI 10.1111/j.1365-313X.2007.03114.x; Munoz-Amatriain M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094688; Nakano Y, 2015, FRONT PLANT SCI, V6, P18; Nielsen NH, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094000; Pedersen HL, 2012, J BIOL CHEM, V287, DOI 10.1074/jbc.M112.396598; Peltonen-Sainio P, 2009, FIELD CROP RES, V110, P85, DOI 10.1016/j.fcr.2008.07.007; Penning BW, 2014, PLANT PHYSIOL, V165, P1475, DOI 10.1104/pp.114.242446; Perovic D, 2014, THEOR APPL GENET, V127, P1061, DOI 10.1007/s00122-014-2279-x; Pritchard JK, 2000, GENETICS, V155, P945; Ramsay L, 2011, NAT GENET, V43, P169, DOI 10.1038/ng.745; Ramstein GP, 2015, G3-GENES GENOM GENET, V5, P891, DOI 10.1534/g3.115.017533; Sang J, OS01G0883800 RICE WI; Scheller HV, 2010, ANNU REV PLANT BIOL, V61, P263, DOI 10.1146/annurev-arplant-042809-112315; Scholthof KBG, 2011, MOL PLANT PATHOL, V12, P938, DOI [10.1111/j.1364-3703.2011.00752.x, 10.1111/J.1364-3703.2011.00752.X]; Schwender H, 2012, J TOXICOL ENV HEAL A, V75, P438, DOI 10.1080/15287394.2012.674910; Schwerdt JG, 2015, PLANT PHYSIOL, V168, P968, DOI 10.1104/pp.15.00140; Sedlacek T, 2010, CZECH J GENET PLANT, V46, P159, DOI 10.17221/7/2010-CJGPB; Seifert GJ, 2007, ANNU REV PLANT BIOL, V58, P137, DOI 10.1146/annurev.arplant.58.032806.103801; Slavov GT, 2014, NEW PHYTOL, V201, P1227, DOI 10.1111/nph.12621; Stein N, 2005, PLANT J, V42, P912, DOI 10.1111/j.1365-313X.2005.02424.x; Tan L, 2012, FRONT PLANT SCI, V3, DOI 10.3389/fpls.2012.00140; Taylor-Teeples M, 2015, NATURE, V517, P571, DOI 10.1038/nature14099; Technow F., 2014, R PACKAGE MOVING GRI; Tyler L, 2014, BMC PLANT BIOL, V14, DOI 10.1186/1471-2229-14-25; Tyrka M, 2008, J APPL GENET, V49, P127, DOI 10.1007/BF03195605; Uma B, 2011, J PLANT PHYSIOL, V168, P2141, DOI 10.1016/j.jplph.2011.09.005; Visioni A, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-424; Vogel J, 2008, CURR OPIN PLANT BIOL, V11, P301, DOI 10.1016/j.pbi.2008.03.002; Yang F, 2013, PLANT BIOTECHNOL J, V11, P325, DOI 10.1111/pbi.12016; Yang P, 2014, THEOR APPL GENET, V127, P1625, DOI 10.1007/s00122-014-2324-9; Zhang ZY, 2015, FUNCT INTEGR GENOMIC, V15, P17, DOI 10.1007/s10142-014-0395-y	69	16	16	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 16	2017	12	3							e0173313	10.1371/journal.pone.0173313	http://dx.doi.org/10.1371/journal.pone.0173313			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN9KE	28301509	Green Submitted, Green Published, gold			2022-12-27	WOS:000396318300032
J	Eranki, A; Farr, N; Partanen, A; Sharma, KV; Chen, H; Rossi, CT; Kothapalli, SVVN; Oetgen, M; Kim, A; Negussie, AH; Woods, D; Wood, BJ; Kim, PCW; Yarmolenko, PS				Eranki, Avinash; Farr, Navid; Partanen, Ari; Sharma, Karun V.; Chen, Hong; Rossi, Christopher T.; Kothapalli, Satya V. V. N.; Oetgen, Matthew; Kim, AeRang; Negussie, Ayele H.; Woods, David; Wood, Bradford J.; Kim, Peter C. W.; Yarmolenko, Pavel S.			Boiling histotripsy lesion characterization on a clinical magnetic resonance imaging-guided high intensity focused ultrasound system	PLOS ONE			English	Article							PERCUTANEOUS RADIOFREQUENCY ABLATION; LOCALIZED PROSTATE-CANCER; LIVER-TUMORS; HEPATOCELLULAR-CARCINOMA; TISSUE FRACTIONATION; MICROWAVE ABLATION; MILD HYPERTHERMIA; ETHANOL INJECTION; THERMAL ABLATION; LASER-ABLATION	Purpose High intensity focused ultrasound (HIFU) is a non-invasive therapeutic technique that can thermally ablate tumors. Boiling histotripsy (BH) is a HIFU approach that can emulsify tissue in a few milliseconds. Lesion volume and temperature effects for different BH sonication parameters are currently not well characterized. In this work, lesion volume, temperature distribution, and area of lethal thermal dose were characterized for varying BH sonication parameters in tissue-mimicking phantoms (TMP) and demonstrated in ex vivo tissues. Methods The following BH sonication parameters were varied using a clinical MR-HIFU system (Sonalleve V2, Philips, Vantaa, Finland): acoustic power, number of cycles/pulse, total sonication time, and pulse repetition frequency (PRF). A 3x3x3 pattern was sonicated inside TMP's and ex vivo tissues. Post sonication, lesion volumes were quantified using 3D ultrasonography and temperature and thermal dose distributions were analyzed offline. Ex vivo tissues were sectioned and stained with H&E post sonication to assess tissue damage. Results Significant increase in lesion volume was observed while increasing the number of cycles/pulse and PRF. Other sonication parameters had no significant effect on lesion volume. Temperature full width at half maximum at the end of sonication increased significantly with all parameters except total sonication time. Positive correlation was also found between lethal thermal dose and lesion volume for all parameters except number of cycles/pulse. Gross pathology of ex vivo tissues post sonication displayed either completely or partially damaged tissue at the focal region. Surrounding tissues presented sharp boundaries, with little or no structural damage to adjacent critical structures such as bile duct and nerves. Conclusion Our characterization of effects of HIFU sonication parameters on the resulting lesion demonstrates the ability to control lesion morphologic and thermal characteristics with a clinical MR-HIFU system in TMP's and ex vivo tissues. We demonstrate that this system can produce spatially precise lesions in both phantoms and ex vivo tissues. The results provide guidance on a preliminary set of BH sonication parameters for this system, with a potential to facilitate BH translation to the clinic.	[Eranki, Avinash; Sharma, Karun V.; Rossi, Christopher T.; Oetgen, Matthew; Kim, AeRang; Kim, Peter C. W.; Yarmolenko, Pavel S.] Childrens Natl Hlth Syst, Sheikh Zayed Inst Pediat Surg Innovat, Washington, DC USA; [Eranki, Avinash; Farr, Navid; Negussie, Ayele H.; Woods, David; Wood, Bradford J.] Natl Inst Hlth, Ctr Intervent Oncol Radiol & Imaging Sci, Ctr Clin, Bethesda, MD USA; [Partanen, Ari] Clin Sci MR Therapy, Andover, MA USA; [Chen, Hong; Kothapalli, Satya V. V. N.] Washington Univ, Sch Engn & Appl Sci, Dept Biomed Engn, St Louis, MO USA	Children's National Health System; National Institutes of Health (NIH) - USA; NIH Clinical Center (CC); Washington University (WUSTL)	Eranki, A (corresponding author), Childrens Natl Hlth Syst, Sheikh Zayed Inst Pediat Surg Innovat, Washington, DC USA.; Eranki, A (corresponding author), Natl Inst Hlth, Ctr Intervent Oncol Radiol & Imaging Sci, Ctr Clin, Bethesda, MD USA.	aeranki@childrensnational.org	Chen, Hong/J-2863-2014; Wood, Bradford J/M-7995-2017; Kothapalli, Satya V.V.N./AAK-4816-2021; Negussie, Ayele H/H-9267-2019	Chen, Hong/0000-0002-9271-4697; Wood, Bradford J/0000-0002-4297-0051; Kothapalli, Satya V.V.N./0000-0003-0129-3442; Negussie, Ayele H/0000-0003-3340-3351; Chen, Hong/0000-0003-1904-0857; Partanen, Ari/0000-0003-1985-149X; Eranki, Avinash/0000-0003-4962-3703	Sheikh Zayed Institute for Pediatric Surgical Innovation, Joseph E. Robert, Jr. Center for Surgical Care at Children's National Health System; National Cancer Institute [ZID BC 011242-08]; NIH Clinical Center [ZIA CL040012-0]; Center for Interventional Oncology and Intramural Research Program of the National Institutes of Health (NIH); Philips; Intramural Research Program of the NIH; Center for Interventional Oncology, NIH Clinical Center; National Cancer Institute	Sheikh Zayed Institute for Pediatric Surgical Innovation, Joseph E. Robert, Jr. Center for Surgical Care at Children's National Health System; National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIH Clinical Center(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Center for Interventional Oncology and Intramural Research Program of the National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Philips; Intramural Research Program of the NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Center for Interventional Oncology, NIH Clinical Center; National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This research was supported by Sheikh Zayed Institute for Pediatric Surgical Innovation, Joseph E. Robert, Jr. Center for Surgical Care at Children's National Health System; National Cancer Institute - ZID BC 011242-08; NIH Clinical Center - ZIA CL040012-0. This research was also supported by the Center for Interventional Oncology and Intramural Research Program of the National Institutes of Health (NIH), and through a Cooperative Research and Development Agreement (CRADA) with Philips. Ari Partanen is a paid employee of Philips. The mention of commercial products, their source, or their use in connection with material reported herein is not to be construed as either an actual or implied endorsement of such products by the National Institutes of Health. Philips provided support in the form of salaries for authors [AP], but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.; This work was supported by Sheikh Zayed Institute for Pediatric Surgical Innovation, Joseph E. Robert, Jr. Center for Surgical Care at Children's National Health System and the Intramural Research Program of the NIH and the Center for Interventional Oncology, NIH Clinical Center and the National Cancer Institute.	Bailey MR, 2003, ACOUST PHYS+, V49, P369, DOI 10.1134/1.1591291; BINI MG, 1984, IEEE T BIO-MED ENG, V31, P317, DOI 10.1109/TBME.1984.325271; Canney MS, 2010, ULTRASOUND MED BIOL, V36, P250, DOI 10.1016/j.ultrasmedbio.2009.09.010; Chapman A, 2007, EUR RADIOL, V17, P2505, DOI 10.1007/s00330-007-0644-8; Chaussy C, 2001, J ENDOUROL, V15, P437, DOI 10.1089/089277901300189501; Chen W, 2005, CURR OPIN ORTHOP, V16, P494, DOI DOI 10.5306/WJC0.V2.I1.8; Chin JL, 2001, J UROLOGY, V165, P1937, DOI 10.1016/S0022-5347(05)66246-5; Dewhirst MW, 2003, INT J HYPERTHER, V19, P267, DOI 10.1080/0265673031000119006; Duck FA, 2013, PHYS PROPERTIES TISS; Dupuy DE, 2000, AM J ROENTGENOL, V174, P57, DOI 10.2214/ajr.174.1.1740057; EBARA M, 1990, J GASTROEN HEPATOL, V5, P616, DOI 10.1111/j.1440-1746.1990.tb01115.x; Gangi A, 2007, RADIOLOGY, V242, P293, DOI 10.1148/radiol.2421041404; Gelet A, 2000, J ENDOUROL, V14, P519, DOI 10.1089/end.2000.14.519; Gervais DA, 2000, RADIOLOGY, V217, P665, DOI 10.1148/radiology.217.3.r00dc39665; Gill IS, 2005, J UROLOGY, V173, P1903, DOI 10.1097/01.ju.0000158154.28845.c9; Hall TL, 2007, J ENDOUROL, V21, P1159, DOI 10.1089/end.2007.9915; Hempel CR, 2011, J UROLOGY, V185, P1484, DOI 10.1016/j.juro.2010.11.044; Hesley Gina K, 2008, Ultrasound Q, V24, P131, DOI 10.1097/RUQ.0b013e31817c5e0c; Huisman M, 2014, J THER ULTRASOUND, V2, DOI 10.1186/2050-5736-2-16; Hwang JH, 2009, ULTRASOUND MED BIOL, V35, P967, DOI 10.1016/j.ultrasmedbio.2008.12.006; Illing RO, 2005, BRIT J CANCER, V93, P890, DOI 10.1038/sj.bjc.6602803; Johnson DB, 2004, J UROLOGY, V172, P874, DOI 10.1097/01.ju.0000135833.67906.ec; Kennedy JE, 2004, ULTRASONICS, V42, P931, DOI 10.1016/j.ultras.2004.01.089; Khokhlova TD, 2014, P NATL ACAD SCI USA, V111, P8161, DOI 10.1073/pnas.1318355111; Khokhlova TD, 2011, J ACOUST SOC AM, V130, P3498, DOI 10.1121/1.3626152; Kim YS, 2012, EUR J RADIOL, V81, P3652, DOI 10.1016/j.ejrad.2011.09.005; Kohler MO, 2009, MED PHYS, V36, P3521, DOI 10.1118/1.3152112; Lafon C, 2005, ULTRASOUND MED BIOL, V31, P1383, DOI 10.1016/j.ultrasmedbio.2005.06.004; Lal DR, 2005, J PEDIATR SURG, V40, P251, DOI 10.1016/j.jpedsurg.2004.09.046; LAM FT, 1989, TRANSPLANTATION, V47, P767, DOI 10.1097/00007890-198905000-00003; Li L, 2013, J CONTROL RELEASE, V168, P142, DOI 10.1016/j.jconrel.2013.03.011; Liang P, 2009, RADIOLOGY, V251, P933, DOI 10.1148/radiol.2513081740; Livraghi T, 2003, RADIOLOGY, V226, P441, DOI 10.1148/radiol.2262012198; LIVRAGHI T, 1995, RADIOLOGY, V197, P101, DOI 10.1148/radiology.197.1.7568806; OPPERMANN W, 1985, BRIT POLYM J, V17, P175, DOI 10.1002/pi.4980170216; Pacella CM, 2000, RADIOLOGY, V217, P673, DOI 10.1148/radiology.217.3.r00dc09673; Partanen A, 2012, INT J HYPERTHER, V28, P320, DOI 10.3109/02656736.2012.680173; Poissonnier L, 2007, EUR UROL, V51, P381, DOI 10.1016/j.eururo.2006.04.012; Quesson B, 2000, J MAGN RESON IMAGING, V12, P525, DOI 10.1002/1522-2586(200010)12:4<525::AID-JMRI3>3.0.CO;2-V; Quesson B, 2010, MED PHYS, V37, P2533, DOI 10.1118/1.3413996; Rabkin BA, 2005, ULTRASOUND MED BIOL, V31, P947, DOI 10.1016/j.ultrasmedbio.2005.03.015; Rhim H, 2004, RADIOGRAPHICS, V24, P41, DOI 10.1148/rg.241025144; Rieke V, 2008, J MAGN RESON IMAGING, V27, P376, DOI 10.1002/jmri.21265; Roberts WW, 2014, CURR OPIN UROL, V24, P104, DOI 10.1097/MOU.0000000000000001; SAPARETO SA, 1984, INT J RADIAT ONCOL, V10, P787, DOI 10.1016/0360-3016(84)90379-1; Simon JC, 2012, PHYS MED BIOL, V57, P8061, DOI 10.1088/0031-9155/57/23/8061; Stingl J, 2002, SURG RADIOL ANAT, V24, P285, DOI 10.1007/s00276-002-0054-1; Top A, 2010, MED IM COMP COMP ASS, P204, DOI DOI 10.1007/978-3-642-18421-5_20; Top A, 2011, LECT NOTES COMPUT SC, V6893, P603, DOI 10.1007/978-3-642-23626-6_74; Vaezy S, 2001, ULTRASOUND MED BIOL, V27, P33, DOI 10.1016/S0301-5629(00)00279-9; Vlaisavljevich E, 2014, IEEE T ULTRASON FERR, V61, P341, DOI 10.1109/TUFFC.2014.6722618; Watkin NA, 1997, J ENDOUROL, V11, P191, DOI 10.1089/end.1997.11.191; Wright AS, 2003, ANN SURG ONCOL, V10, P275, DOI 10.1245/ASO.2003.03.045; Xu Z, 2007, J ACOUST SOC AM, V122, P229, DOI 10.1121/1.2735110; Xu Z, 2010, CIRCULATION, V121, P742, DOI 10.1161/CIRCULATIONAHA.109.889071; Zell K, 2007, PHYS MED BIOL, V52, pN475, DOI 10.1088/0031-9155/52/20/N02	56	21	21	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 16	2017	12	3							e0173867	10.1371/journal.pone.0173867	http://dx.doi.org/10.1371/journal.pone.0173867			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN9KE	28301597	gold, Green Published, Green Submitted			2022-12-27	WOS:000396318300086
J	Paredes, OSL; Norris, D; de Oliveira, TG; Michalski, F				Landazuri Paredes, Omar Stalin; Norris, Darren; de Oliveira, Tadeu Gomes; Michalski, Fernanda			Water availability not fruitfall modulates the dry season distribution of frugivorous terrestrial vertebrates in a lowland Amazon forest	PLOS ONE			English	Article							WHITE-LIPPED PECCARIES; CAMERA-TRAP; TAYASSU-PECARI; LOCAL EXTINCTIONS; RAIN-FOREST; PATCH SIZE; HOME-RANGE; AREA; POPULATIONS; TOPOGRAPHY	Terrestrial vertebrate frugivores constitute one of the major guilds in tropical forests. Previous studies show that the meso-scale distribution of this group is only weakly explained by variables such as altitude and tree basal area in lowland Amazon forests. For the first time we test whether seasonally limiting resources (water and fallen fruit) affect the dry season distribution in 25 species of terrestrial vertebrates. To examine the effects of the spatial availability of fruit and water on terrestrial vertebrates we used a standardized, regularly spaced arrangement of camera-traps within 25km(2) of lowland Amazon forest. Generalized linear models (GLMs) were then used to examine the influence of four variables (altitude, distance to large rivers, distance to nearest water, and presence vs absence of fruits) on the number of photos on five functional groups (all frugivores, small, medium, large and very large frugivores) and on seven of the most abundant frugivore species (Cuniculus paca, Dasyprocta leporina, Mazama americana, Mazama nemorivaga, Myoprocta acouchy, Pecari tajacu and Psophia crepitans). A total of 279 independent photos of 25 species were obtained from 900 camera-trap days. For most species and three functional groups, the variation in the number of photos per camera was significantly but weakly explained by the GLMs (deviance explained ranging from 6.2 to 48.8%). Generally, we found that the presence of water availability was more important than the presence of fallen fruit for the groups and species studied. Medium frugivores, large-bodied frugivores, and two of the more abundant species (C. paca and P. crepitans) were recorded more frequently closer to water bodies; while none of the functional groups nor the most abundant species showed any significant relationship with the presence of fallen fruit. Two functional groups and two of the seven most common frugivore species assessed in the GLMs showed significant results with species-specific responses to altitude. Our findings provide a more detailed understanding of how frugivorous vertebrates cope with periods of water and fruit scarcity in lowland Amazon forests.	[Landazuri Paredes, Omar Stalin; Norris, Darren; Michalski, Fernanda] Univ Fed Amapa, Lab Ecol & Conservacao Vertebrados, Macapa, Amapa, Brazil; [Landazuri Paredes, Omar Stalin; Norris, Darren; Michalski, Fernanda] Univ Fed Amapa, Programa Posgrad Biodiversidade Trop, Macapa, Amapa, Brazil; [de Oliveira, Tadeu Gomes] Univ Estadual Maranhao, Dept Biol, Ctr Ciencias Exatas & Nat, Sao Luis, Maranhao, Brazil; [de Oliveira, Tadeu Gomes; Michalski, Fernanda] Inst Procarnivoros, Sao Paulo, Brazil	Fundacao Universidade Federal do Amapa; Fundacao Universidade Federal do Amapa; Universidade Estadual do Maranhao	Michalski, F (corresponding author), Univ Fed Amapa, Lab Ecol & Conservacao Vertebrados, Macapa, Amapa, Brazil.; Michalski, F (corresponding author), Univ Fed Amapa, Programa Posgrad Biodiversidade Trop, Macapa, Amapa, Brazil.; Michalski, F (corresponding author), Inst Procarnivoros, Sao Paulo, Brazil.	fmichalski@gmail.com	Michalski, Fernanda/J-4691-2012; Norris, Darren/J-5182-2012; Oliveira, Tadeu/M-6095-2016	Michalski, Fernanda/0000-0002-8074-9964; Norris, Darren/0000-0003-0015-8214; Oliveira, Tadeu/0000-0002-8760-3159	Brazilian National Counsel of Technological and Scientific Development ("Conselho Nacional de Desenvolvimento Cientifico e Tecnologico"CNPq) [MCTI/CNPQ/Universal 14/2014: 446926/2014-0]; Federal Agency for Support and Evaluation of Graduate Education, Ministry of Education ("Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior"-CAPES); CNPq [301562/2015-6]	Brazilian National Counsel of Technological and Scientific Development ("Conselho Nacional de Desenvolvimento Cientifico e Tecnologico"CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Federal Agency for Support and Evaluation of Graduate Education, Ministry of Education ("Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior"-CAPES); CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ))	This work was supported by the Brazilian National Counsel of Technological and Scientific Development (Conselho Nacional de Desenvolvimento Cientifico e TecnologicoCNPq) [grant number MCTI/CNPQ/Universal 14/2014: 446926/2014-0]. OSLP received a MSc scholarship from the Federal Agency for Support and Evaluation of Graduate Education, Ministry of Education ("Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior"-CAPES). FM receives a productivity scholarship from CNPq (Process 301562/2015-6). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adler GH, 1997, J ZOOL, V241, P43, DOI 10.1111/j.1469-7998.1997.tb05498.x; Ahumada JA, 2011, PHILOS T R SOC B, V366, P2703, DOI 10.1098/rstb.2011.0115; Aliaga-Rossel E, 2008, J TROP ECOL, V24, P367, DOI 10.1017/S0266467408005129; ANA, SIST MON HIDR HYDR M; Anile S, 2016, ANIM CONSERV, V19, P35, DOI 10.1111/acv.12214; Barroso GM, 1999, FRUTOS SEMENTES MORF, DOI DOI 10.17801/0101-3122/RBS.V21N2P64-69; Benchimol M, 2015, BIOL CONSERV, V187, P61, DOI 10.1016/j.biocon.2015.04.005; Benchimol M, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0129818; Benchimol M, 2014, AM J PRIMATOL, V76, P289, DOI 10.1002/ajp.22233; Bicknell J, 2010, FOREST ECOL MANAG, V259, P2267, DOI 10.1016/j.foreco.2010.02.027; BODMER RE, 1991, OECOLOGIA, V85, P361, DOI 10.1007/BF00320611; BODMER RE, 1990, OIKOS, V57, P319, DOI 10.2307/3565960; BODMER RE, 1990, J ZOOL, V222, P121, DOI 10.1111/j.1469-7998.1990.tb04034.x; Bodmer Richard, 2006, Conservation Biology Series (Cambridge), V11, P232; Costa FRC, 2010, NAT CONSERVACAO, V8, P3, DOI 10.4322/natcon.00801001; Carrillo E, 2002, BIOL CONSERV, V108, P317, DOI 10.1016/S0006-3207(02)00118-0; Chatterjee Soumik, 2015, Proceedings of the Zoological Society (Calcutta), V68, P147, DOI 10.1007/s12595-014-0112-9; Cornejo F., 2010, SEEDS AMAZONIAN PLAN; da Rocha DG, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0154624; de Oliveira TG, 2014, J MAMM EVOL, V21, P427, DOI 10.1007/s10914-013-9251-4; Dubost G, 2006, J TROP ECOL, V22, P641, DOI 10.1017/S0266467406003440; Dunn PK, 2014, VEGAN COMMUNITY ECOL; Eisenberg JF., 1999, MAMMALS NEOTROPICS C; ERARD C, 1991, Gibier Faune Sauvage, V8, P183; Erard C, 2007, REV ECOL-TERRE VIE, V62, P323; ESRI, 2015, ARCGIS DESKT REL 10; Feer F, 1997, NEOTROPICAL RAINFORE; Fleming TH, 2011, ACTA OECOL, V37, P521, DOI 10.1016/j.actao.2011.01.016; Garrote G, 2011, EUR J WILDLIFE RES, V57, P355, DOI 10.1007/s10344-010-0440-7; Gayot M, 2004, J TROP ECOL, V20, P31, DOI 10.1017/S0266467404006157; Gentry A. H, 1996, FIELD GUIDE FAMILIES; Hanya G, 2010, ECOL RES, V25, P1081, DOI 10.1007/s11284-010-0733-z; Harmsen BJ, 2010, BIOTROPICA, V42, P126, DOI 10.1111/j.1744-7429.2009.00544.x; Hawes JE, 2014, OIKOS, V123, P365, DOI 10.1111/j.1600-0706.2013.00745.x; Hoorn C, 2010, SCIENCE, V330, P927, DOI 10.1126/science.1194585; ICMBio, 2014, PLAN MAN NAC AM I CH; Jiménez Carlos F., 2010, Rev. peru biol., V17, P191; Jones Kate E., 2009, Ecology (Washington D C), V90, P2648, DOI 10.1890/08-1494.1; Keuroghlian A, 2004, BIOL CONSERV, V120, P411, DOI 10.1016/j.biocon.2004.03.016; Kitamura S, 2002, OECOLOGIA, V133, P559, DOI 10.1007/s00442-002-1073-7; Korner C, 2007, TRENDS ECOL EVOL, V22, P569, DOI 10.1016/j.tree.2007.09.006; Kottek M, 2006, METEOROL Z, V15, P259, DOI 10.1127/0941-2948/2006/0130; Laurance SGW, 2010, J VEG SCI, V21, P96, DOI 10.1111/j.1654-1103.2009.01122.x; Magnusson W.E., 2013, BIODIVERSIDADE MONIT; Magnusson William E., 2005, Biota Neotrop., V5, P19, DOI 10.1590/S1676-06032005000300002; Pontes ARM, 2012, BIOTROPICA, V44, P834, DOI 10.1111/j.1744-7429.2012.00873.x; Michalski F, 2007, CONSERV BIOL, V21, P1626, DOI 10.1111/j.1523-1739.2007.00797.x; Michalski LJ, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0126114; Myneni RB, 2007, P NATL ACAD SCI USA, V104, P4820, DOI 10.1073/pnas.0611338104; Negroes N, 2011, BIODIVERS CONSERV, V20, P505, DOI 10.1007/s10531-010-9961-3; Nogueira-Filho S. L. G., 2004, PEOPLE NATURE WILDLI, P464; Norris D, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0106150; Norris D, 2010, J MAMMAL, V91, P551, DOI 10.1644/09-MAMM-A-199.1; O'Brien TG, 2003, ANIM CONSERV, V6, P131, DOI 10.1017/S1367943003003172; O'Farrill G, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0095049; Oksanen J., 2017, COMMUNITY ECOLOGY PA; Oliveira TG, 2016, ORYX; Peres CA, 2000, CONSERV BIOL, V14, P240, DOI 10.1046/j.1523-1739.2000.98485.x; Peres CA, 2000, J TROP ECOL, V16, P287, DOI 10.1017/S0266467400001413; PERES CA, 1999, MAMMALS NEOTROPICS C, P564; Peres CA, 2007, BIOTROPICA, V39, P304, DOI 10.1111/j.1744-7429.2007.00272.x; Peres CA, 2016, P NATL ACAD SCI USA, V113, P892, DOI 10.1073/pnas.1516525113; Pickles RSA, 2011, BIOTA NEOTROP, V11, P237, DOI 10.1590/S1676-06032011000300021; R Development Core Team, 2015, LANG ENV STAT COMP; Rabus B, 2003, ISPRS J PHOTOGRAMM, V57, P241, DOI 10.1016/S0924-2716(02)00124-7; Reis NR, 2006, MAMIFEROS DO BRASIL; Reyna-Hurtado R, 2015, BIODIVERSITY AND CONSERVATION OF THE YUCATAN PENINSULA, P227, DOI 10.1007/978-3-319-06529-8_10; Reyna-Hurtado R, 2012, J MAMMAL, V93, P124, DOI 10.1644/10-MAMM-A-384.1; Reyna-Hurtado R, 2010, ORYX, V44, P89, DOI 10.1017/S0030605309990664; Reyna-Hurtado R, 2009, J MAMMAL, V90, P1199, DOI 10.1644/08-MAMM-A-246.1; Rich LN, 2016, J APPL ECOL, V53, P1225, DOI 10.1111/1365-2664.12650; Royle JA, 2009, ECOLOGY, V90, P3233, DOI 10.1890/08-1481.1; Schleuning M, 2011, ECOLOGY, V92, P26, DOI 10.1890/09-1842.1; Sick H., 1997, ORNITOLOGIA BRASILEI; Silveira L, 2003, BIOL CONSERV, V114, P351, DOI 10.1016/S0006-3207(03)00063-6; SMYTHE N, 1970, American Naturalist, V104, P25, DOI 10.1086/282638; SMYTHE N, 1986, ANNU REV ECOL SYST, V17, P169; TEAM Network, 2011, TERRESTRIAL VERTEBRA; Terborgh J., 1986, Tasks for Vegetation Science, V15, P371; Terborgh JW, 1984, NEW SERIES, V21, P1; Tobler MW, 2008, ANIM CONSERV, V11, P169, DOI 10.1111/j.1469-1795.2008.00169.x; TUOMISTO H, 1995, SCIENCE, V269, P63, DOI 10.1126/science.269.5220.63; VANSCHAIK CP, 1993, ANNU REV ECOL SYST, V24, P353, DOI 10.1146/annurev.es.24.110193.002033; Wilting A, 2012, ORYX, V46, P423, DOI 10.1017/S0030605311001694	84	27	27	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 16	2017	12	3							e0174049	10.1371/journal.pone.0174049	http://dx.doi.org/10.1371/journal.pone.0174049			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN9KE	28301589	gold, Green Published, Green Submitted			2022-12-27	WOS:000396318300120
J	Zhou, LF; Zhang, MX; Kong, LQ; Liu, JJ; Feng, QM; Lu, W; Wei, B; Zhao, LP				Zhou, Li-fang; Zhang, Mao-xin; Kong, Ling-qian; Liu, Jun-jun; Feng, Qi-ming; Lu, Wei; Wei, Bo; Zhao, Lue Ping			Assessment of potential factors associating with costs of hospitalizing cardiovascular diseases in 141 hospitals in Guangxi, China	PLOS ONE			English	Article							HEALTH-INSURANCE; HEART-FAILURE; TRENDS	Background The rising cost of healthcare is of great concern in China, as evidenced by the media features negative reports almost daily. However there are only a few studies from well-developed cities, like Beijing or Shanghai, and little is known about healthcare costs in rest of the country. In this study, we use hospitalization summary reports (HSRs) from admitted cardiovascular diseases patients in Guangxi hospitals during 2013 - 2016, and we investigate temporal trends of healthcare costs and associated factors. Methods By generalized additive model, we compute temporal trends of cost per stay (CPS), cost per day (CPD) and others. We then use generalized linear models to assess which factors associate with CPS and CPD. Findings Using a total of 760,000 HSRs, we find that CPS appears to be stabilized around $ 1040 until the middle of year 2015, before exhibiting a downward trend. Similarly, CPD exhibits similar stable pattern. Meanwhile, surgery-specific CPS showed an increase in year 2013 - 2014, and then stabilized. Drug costs account for over 1/3 of CPS, but they are gradually declining. Costs associated with physicians' and nurses' services represent less than 5% of CPS. We found that age, sex, marital status, occupation and payment methods are significantly associated with CPS or CPD. Interestingly, we found no association between patient ethnicity and these costs. However, we did find that minority patients use more secondary hospitals than Han patients. Interpretations Healthcare costs in Guangxi are stable, contrary to the rise portrayed by Chinese mass media. Several factors can be associated with healthcare costs, and these may be useful for developing evidence-based policies. In particular, there is a need to encourage more Han patients to seek care in primary and secondary hospitals.	[Zhou, Li-fang; Zhang, Mao-xin; Liu, Jun-jun; Feng, Qi-ming; Wei, Bo] Guangxi Med Univ, Nanning, Peoples R China; [Zhou, Li-fang] Guangxi Med Univ, Fourth Affiliated Hosp, Liuzhou, Peoples R China; [Zhou, Li-fang; Zhao, Lue Ping] Univ Washington, Fred Hutchinson Canc Res Ctr, Seattle, WA 98195 USA; [Kong, Ling-qian; Lu, Wei] Hlth & Family Planning Commiss Guangxi, Nanning, Peoples R China	Guangxi Medical University; Guangxi Medical University; Fred Hutchinson Cancer Center; University of Washington; University of Washington Seattle	Wei, B (corresponding author), Guangxi Med Univ, Nanning, Peoples R China.; Zhao, LP (corresponding author), Univ Washington, Fred Hutchinson Canc Res Ctr, Seattle, WA 98195 USA.	weibogx@163.com; lzhao@fredhutch.org			Guangxi Education Department [YCBZ2015034]	Guangxi Education Department	This work is supported by Guangxi Education Department Grant (YCBZ2015034) entitled "Innovation Project of Guangxi Graduate Education" (LFZ). Other investigators are supported by their respective institutional supports.	Berry C, 2001, EUR J HEART FAIL, V3, P283, DOI 10.1016/S1388-9842(01)00123-4; Burner S T, 1992, Health Care Financ Rev, V14, P1; Chen J, 2011, JAMA-J AM MED ASSOC, V306, P1669, DOI 10.1001/jama.2011.1474; CHEN WWG, 2014, CHINESE CIRCULATION, V30, P617; Gao Sulan LW, 2013, CHINA MED ENG, V21, P133; Gu DF, 2005, CIRCULATION, V112, P658, DOI 10.1161/CIRCULATIONAHA.104.515072; Heidenreich PA, 2011, CIRCULATION, V123, P933, DOI 10.1161/CIR.0b013e31820a55f5; Hongyu YGLSZ, 2013, J CHONGQING MED U, V38, P1378; Jia GS, 2013, J PEIKING U, V45, P382; Klenk J, 2016, POPUL HEALTH METR, V14, DOI 10.1186/s12963-016-0089-x; Li C, 2011, SOC SCI MED, V73, P359, DOI 10.1016/j.socscimed.2011.06.002; Luengo-Fernandez R, 2006, HEART, V92, P1384, DOI 10.1136/hrt.2005.072173; McCullagh P, 1989, GEN LINEAR MODEL; Meng Q, 2012, LANCET, V379, P805, DOI 10.1016/S0140-6736(12)60278-5; Sekhri N, 2005, B WORLD HEALTH ORGAN, V83, P127; Sun Xinxin YZ, 2013, MODERN BUSINESS TRAD, P132; Wood S, 2017, GEN ADDITIVE MODELS, DOI 10.1201/9781315370279; Woolhandler S, 2003, NEW ENGL J MED, V349, P768, DOI 10.1056/NEJMsa022033; Wu ZS, 2001, CIRCULATION, V103, P462; Xu Ling MQ, 2014, CHINESE J HLTH INFOR, P193; Xu Lixin LD, 2015, MOD HOSP, V15, P121; Yang Yuting, 2015, SHANGHAI CHIN J HOSP, V31, P271; Yao X, 2015, CHINESE HLTH EC, V34, P31; Zhang Qian ZD, 2016, J CARDIOVASCULAR PUL, V35, P75; Zhao LP, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072166; Zhengjie LBZZF, 2006, CHINA TROPICAL MED, V6, P1513; 辛然, 2014, [中国老年学杂志, Chinese Journal of Gerontology], V34, P4308	27	1	1	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 16	2017	12	3							e0173451	10.1371/journal.pone.0173451	http://dx.doi.org/10.1371/journal.pone.0173451			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN9KE	28301501	Green Published, Green Submitted, gold			2022-12-27	WOS:000396318300041
J	Garcia-Hermoso, A; Carrillo, HA; Gonzalez-Ruiz, K; Vivas, A; Triana-Reina, HR; Martinez-Torres, J; Prieto-Benavidez, DH; Correa-Bautista, JE; Ramos-Sepulveda, JA; Villa-Gonzalez, E; Peterson, MD; Ramirez-Velez, R				Garcia-Hermoso, Antonio; Alejandro Carrillo, Hugo; Gonzalez-Ruiz, Katherine; Vivas, Andres; Reynaldo Triana-Reina, Hector; Martinez-Torres, Javier; Humberto Prieto-Benavidez, Daniel; Enrique Correa-Bautista, Jorge; Alexander Ramos-Sepulveda, Jeison; Villa-Gonzalez, Emilio; Peterson, Mark D.; Ramirez-Velez, Robinson			Fatness mediates the influence of muscular fitness on metabolic syndrome in Colombian collegiate students	PLOS ONE			English	Article							CARDIOVASCULAR RISK-FACTORS; MUSCLE STRENGTH; HANDGRIP STRENGTH; AEROBIC FITNESS; GRIP STRENGTH; DISEASE; ASSOCIATIONS; DEFINITION; STATEMENT; EXERCISE	The purpose of this study was two-fold: to analyze the association between muscular fitness (MF) and clustering of metabolic syndrome (MetS) components, and to determine if fatness parameters mediate the association between MF and MetS clustering in Colombian collegiate students. This cross-sectional study included a total of 886 (51.9% women) healthy collegiate students (21.4 +/- 3.3 years old). Standing broad jump and isometric handgrip dynamometry were used as indicators of lower and upper body MF, respectively. Also, a MF score was computed by summing the standardized values of both tests, and used to classify adults as fit or unfit. We also assessed fat mass, body mass index, waist-to-height ratio, and abdominal visceral fat, and categorized individuals as low and high fat using international cut-offs. A MetS cluster score was derived by calculating the sum of the sample-specific z-scores from the triglycerides, HDL cholesterol, fasting glucose, waist circumference, and arterial blood pressure. Linear regression models were used to examine whether the association between MF and MetS cluster was mediated by the fatness parameters. Data were collected from 2013 to 2016 and the analysis was done in 2016. Findings revealed that the best profiles (fit + low fat) were associated with lower levels of the MetS clustering (p < 0.001 in the four fatness parameters), compared with unfit and fat (unfit + high fat) counterparts. Linear regression models indicated a partial mediating effect for fatness parameters in the association of MF with MetS clustering. Our findings indicate that efforts to improve MF in young adults may decrease MetS risk partially through an indirect effect on improvements to adiposity levels. Thus, weight reduction should be taken into account as a complementary goal to improvements in MF within exercise programs.	[Garcia-Hermoso, Antonio] Univ Santiago Chile, USACH, Fac Ciencias Med, Lab Ciencias Actividad Fis Deporte & Salud, Santiago, Chile; [Alejandro Carrillo, Hugo] Univ Valle, Programa Educ Fis & Deportes, Grp GRINDER, Santiago De Cali, Colombia; [Gonzalez-Ruiz, Katherine; Vivas, Andres] Univ Manuela Beltran, Grp Ejercicio Fis & Deportes, Vicerrectoria Invest, Bogota, Colombia; [Reynaldo Triana-Reina, Hector; Martinez-Torres, Javier] Univ Santo Tomas, Fac Cultura Fis Deporte & Recreac, Grp GICAEDS, Bogota, Colombia; [Humberto Prieto-Benavidez, Daniel; Enrique Correa-Bautista, Jorge; Ramirez-Velez, Robinson] Univ Rosario, Escuela Med & Ciencias Salud, Ctr Estudios Med Actividad Fis CEMA, Bogota, Colombia; [Alexander Ramos-Sepulveda, Jeison] Inst Univ Antonio Jose Camacho, Fac Educ Distancia & Virtual, Santiago De Cali, Colombia; [Villa-Gonzalez, Emilio] Univ Granada, Sch Sport Sci, Dept Phys Educ & Sport, PROFITH PROmoting FITness & Hlth Phys Act Res Grp, Granada, Spain; [Peterson, Mark D.] Univ Michigan, Dept Phys Med & Rehabil, Ann Arbor, MI 48109 USA; [Peterson, Mark D.] Univ Michigan, Sch Med, Global REACH, Ann Arbor, MI USA	Universidad de Santiago de Chile; Universidad del Valle; Universidad Manuela Beltran - UMB; Universidad Santo Tomas USTA; Universidad del Rosario; University of Granada; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan	Garcia-Hermoso, A (corresponding author), Univ Santiago Chile, USACH, Fac Ciencias Med, Lab Ciencias Actividad Fis Deporte & Salud, Santiago, Chile.	antonio.garcia.h@usach.cl	García-Hermoso, Antonio/P-1857-2017; Garcia-Hermoso, Antonio/AGK-7815-2022; /AGR-8343-2022; Villa-González, Emilio/G-6421-2015; Ramírez-Vélez, Robinson/D-5311-2016; García-Hermoso, Antonio/ADU-2591-2022; Peterson, Mark/ABD-3853-2020; González-Ruíz, Katherine/AGI-4611-2022; Correa-Bautista, Jorge Enrique/N-2741-2015	García-Hermoso, Antonio/0000-0002-1397-7182; Garcia-Hermoso, Antonio/0000-0002-1397-7182; /0000-0001-8991-5079; Villa-González, Emilio/0000-0002-2815-2060; Ramírez-Vélez, Robinson/0000-0003-3075-6960; Peterson, Mark/0000-0002-9861-4275; González-Ruíz, Katherine/0000-0001-7518-0761; Vivas, Andres/0000-0001-8169-1664; Ramos-Sepulveda, Jeison Alexander/0000-0003-2734-7912; TRIANA R, HECTOR REYNALDO/0000-0002-6334-7082; Correa-Bautista, Jorge Enrique/0000-0002-0646-2316	Centre for Studies on Measurement of Physical Activity, School of Medicine and Health Sciences, Universidad del Rosario [FIUR DN-BG001]; Proyectos Basales y Vicerrectoria de Investigacion, Desarrollo e Innovacion" (Universidad de Santiago de Chile, USACH); Institucion Universitaria Antonio Jose Camacho [PI-0516]	Centre for Studies on Measurement of Physical Activity, School of Medicine and Health Sciences, Universidad del Rosario; Proyectos Basales y Vicerrectoria de Investigacion, Desarrollo e Innovacion" (Universidad de Santiago de Chile, USACH)(Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT)CONICYT PIA/BASAL); Institucion Universitaria Antonio Jose Camacho	This work was supported by the Centre for Studies on Measurement of Physical Activity, School of Medicine and Health Sciences, Universidad del Rosario FIUR DN-BG001. AGH is funded by Proyectos Basales y Vicerrectoria de Investigacion, Desarrollo e Innovacion" (Universidad de Santiago de Chile, USACH). RR-V and JEC-B are funded by Centre for Studies on Measurement of Physical Activity, School of Medicine and Health Sciences, Universidad del Rosario (Code No FIUR DN-BG001), JAR-S funded by Institucion Universitaria Antonio Jose Camacho (Code No PI-0516). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alberti KGMM, 2006, DIABETIC MED, V23, P469, DOI 10.1111/j.1464-5491.2006.01858.x; Amato MC, 2013, J ENDOCRINOL INVEST, V36, P537, DOI 10.3275/8943; Vivas-Diaz JA, 2016, NUTR HOSP, V33, P330; [Anonymous], 2000, WHO TECHN REP SER; Aoyama T, 2011, J PHYSIOL ANTHROPOL, V30, P133, DOI 10.2114/jpa2.30.133; Artero EG, 2012, J CARDIOPULM REHABIL, V32, P351, DOI 10.1097/HCR.0b013e3182642688; Cooper R, 2010, BMJ-BRIT MED J, V341, DOI 10.1136/bmj.c4467; Diez-Fernandez A, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0116506; dong-il Kim, 2012, Journal of Obesity & Metabolic Syndrome, V21, P99, DOI 10.7570/kjo.2012.21.2.99; Eisenmann JC, 2005, AM HEART J, V149, P46, DOI 10.1016/j.ahj.2004.07.016; Eisenmann JC, 2007, MED SCI SPORT EXER, V39, P1251, DOI 10.1249/MSS.0b013e318064c8b0; Fraser BJ, 2016, MED SCI SPORT EXER, V48, P1715, DOI 10.1249/MSS.0000000000000955; Gaster M, 2002, APMIS, V110, P611, DOI 10.1034/j.1600-0463.2002.1100903.x; Han TS, 2002, OBES RES, V10, P923, DOI 10.1038/oby.2002.126; Hayes AF., 2017, MEDIATION MODERATION, V2nd edn; Hulens M, 2001, INT J OBESITY, V25, P676, DOI 10.1038/sj.ijo.0801560; Jakicic JM, 2011, CURR CARDIOVASC RISK, V5, P113, DOI 10.1007/s12170-011-0158-4; Jekal Y, 2009, INT J SPORTS MED, V30, P733, DOI 10.1055/s-0029-1224173; Jurca R, 2004, MED SCI SPORT EXER, V36, P1301, DOI 10.1249/01.MSS.0000135780.88930.A9; Leong DP, 2015, LANCET, V386, P266, DOI 10.1016/S0140-6736(14)62000-6; Macias N, 2014, BMC PUBLIC HEALTH, V14, P1; MacKinnon D.P., 2012, INTRO STAT MEDIATION; McAuley PA, 2011, J SPORT SCI, V29, P773, DOI 10.1080/02640414.2011.553965; Menard S.W., 1995, APPL LOGISTIC REGRES, V2nd ed.; Moliner-Urdiales D, 2011, BRIT J SPORT MED, V45, P101, DOI 10.1136/bjsm.2009.062430; Myers R, 2000, CLASSICAL MODERN REG, V2nd, P488; ORTEGA FB, 2012, BMJ, V345; Preacher KJ, 2008, BEHAV RES METHODS, V40, P879, DOI 10.3758/BRM.40.3.879; Ramirez-Velez R, 2016, J PEDIATR-US, V179, P82, DOI 10.1016/j.jpeds.2016.08.099; Ramirez-Velez R, 2016, BMC PUBLIC HEALTH, V16, DOI 10.1186/s12889-016-3678-5; Ramirez-Velez R, 2015, SPRINGERPLUS, V4, DOI 10.1186/s40064-015-1043-2; Ramirez-Velez R, 2015, NUTR HOSP, V31, P793, DOI [10.3305/nh.2015.31.2.7910, 10.3305/nh.2014.30.4.7684]; Ramírez-Vélez Robinson, 2012, Rev. salud pública, V14, P226, DOI 10.1590/S0124-00642012000200004; Roberts CK, 2015, MED SCI SPORT EXER, V47, P1211, DOI 10.1249/MSS.0000000000000526; Sacheck JM, 2010, MED SCI SPORT EXER, V42, P1039, DOI 10.1249/MSS.0b013e3181c9216b; Sayer AA, 2007, QJM-INT J MED, V100, P707, DOI 10.1093/qjmed/hcm095; Sobel M.E., 1982, SOCIOL METHODOL, V13, P290, DOI [10.2307/270723, DOI 10.2307/270723]; Stenholm S, 2010, REJUV RES, V13, P3, DOI 10.1089/rej.2009.0891; Stewart KJ, 2005, AM J PREV MED, V28, P9, DOI 10.1016/j.amepre.2004.09.006; Strand B. H., 2016, J EPIDEMIOL COMMUNIT; Stump CS, 2006, ANN MED, V38, P389, DOI 10.1080/07853890600888413; Wijndaele K, 2007, MED SCI SPORT EXER, V39, P233, DOI 10.1249/01.mss.0000247003.32589.a6; Williams MA, 2007, CIRCULATION, V116, P572, DOI 10.1161/CIRCULATIONAHA.107.185214; Wing RR, 2007, MED SCI SPORT EXER, V39, P2107, DOI 10.1249/mss.0b013e31815614cb	44	20	23	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 15	2017	12	3							e0173932	10.1371/journal.pone.0173932	http://dx.doi.org/10.1371/journal.pone.0173932			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN9HQ	28296952	Green Published, gold			2022-12-27	WOS:000396311700079
J	Novinrooz, A; Salehi, TZ; Firouzi, R; Arabshahi, S; Derakhshandeh, A				Novinrooz, Aytak; Salehi, Taghi Zahraei; Firouzi, Roya; Arabshahi, Sina; Derakhshandeh, Abdollah			In-silico design, expression, and purification of novel chimeric Escherichia coli O157: H7 OmpA fused to LTB protein in Escherichia coli	PLOS ONE			English	Article							OUTER-MEMBRANE PROTEIN; HEAT-LABILE ENTEROTOXIN; HEMOLYTIC-UREMIC-SYNDROME; B-SUBUNIT; INFECTION; VACCINE; EHEC; VIRULENCE; OUTBREAK; ANTIBODY	E. coli O157: H7, one of the major EHEC serotypes, is capable of developing bloody diarrhea, hemorrhagic colitis (HC), and fatal hemolytic uremic syndrome (HUS) and is accompanied by high annual economic loss worldwide. Due to the increased risk of HC and HUS development following antibiotic therapy, the prevention of infections caused by this pathogen is considered to be one of the most effective ways of avoiding the consequences of this infection. The main aim of the present study was to design, express, and purify a novel chimeric protein to develope human vaccine candidate against E. coli O157: H7 containing loop 2-4 of E. coli O157: H7, outer membrane protein A (OmpA), and B subunit of E. coli heat labile enterotoxin (LTB) which are connected by a flexible peptide linker. Several online databases and bioinformatics software were utilized to choose the peptide linker among 537 analyzed linkers, design the chimeric protein, and optimize the codon of the relative gene encoding this protein. Subsequently, the recombinant gene encoding OmpA-LTB was synthesized and cloned into pET-24a (+) expression vector and transferred to E. coli BL21 (DE3) cells. The expression of OmpA-LTB chimeric protein was then carried out by induction of cultured E. coli Bl21 (DE3) cells with 1mM isopropyl-beta-D-thiogalactopyranoside (IPTG). The purification of OmpA-LTB was then performed by nickel affinity chromatography. Expression and purification were analyzed by sodium dodecyl sulphate poly acrylamide gel electrophoresis. Moreover, the identity of the expressed protein was analyzed by western blotting. SDS-PAGE and western immunoblotting confirmed the successful expression of a 27 KDa recombinant protein after 24 hours at 37 degrees C post-IPTG induction. OmpA-LTB was then successfully purified, using nickel affinity chromatography under denaturing conditions. The yield of purification was 12 mg per liter of culture media. Ultimately, we constructed the successful design and efficient expression and purification of OmpA-LTB divalent under the above-mentioned conditions.	[Novinrooz, Aytak; Firouzi, Roya; Arabshahi, Sina; Derakhshandeh, Abdollah] Shiraz Univ, Sch Vet Med, Dept Pathobiol, Shiraz, Iran; [Salehi, Taghi Zahraei] Univ Tehran, Fac Vet Med, Dept Microbiol & Immunol, Tehran, Iran	Shiraz University; University of Tehran	Salehi, TZ (corresponding author), Univ Tehran, Fac Vet Med, Dept Microbiol & Immunol, Tehran, Iran.	tsalehi@ut.ac.ir	Derakhshandeh, abdollah/X-1124-2018; Derakhshandeh, Abdollah/B-5387-2015	Derakhshandeh, abdollah/0000-0002-1878-1103; Derakhshandeh, Abdollah/0000-0002-1878-1103; Novinrooz, Aytak/0000-0001-8615-7065; Zahraei Salehi, Taghi/0000-0002-5665-5757; Arabshahi, Sina/0000-0003-0048-3068				Abe Yoshihiro, 2013, Monoclonal Antibodies in Immunodiagnosis and Immunotherapy, V32, P32, DOI 10.1089/mab.2012.0069; Amani J, 2010, VACCINE, V28, P6923, DOI 10.1016/j.vaccine.2010.07.061; Bardiau M, 2010, J APPL MICROBIOL, V109, P2214, DOI 10.1111/j.1365-2672.2010.04855.x; BELL BP, 1994, JAMA-J AM MED ASSOC, V272, P1349, DOI 10.1001/jama.272.17.1349; Carson M, 2007, ACTA CRYSTALLOGR D, V63, P295, DOI 10.1107/S0907444906052024; Chung WY, 2006, J BIOL CHEM, V281, P39465, DOI 10.1074/jbc.M606038200; Confer AW, 2013, VET MICROBIOL, V163, P207, DOI 10.1016/j.vetmic.2012.08.019; Deng GC, 2013, J BIOSCI BIOENG, V115, P147, DOI 10.1016/j.jbiosc.2012.09.009; Farsani Hassan Heydari, 2015, World J Methodol, V5, P230, DOI 10.5662/wjm.v5.i4.230; Farshadpour F, 2014, JUNDISHAPUR J MICROB, V7, DOI 10.5812/jjm.11261; Ferens WA, 2011, FOODBORNE PATHOG DIS, V8, P465, DOI 10.1089/fpd.2010.0673; Goldwater PN, 2012, BMC MED, V10, DOI 10.1186/1741-7015-10-12; Hsieh WS, 2016, J MICROBIOL IMMUNOL, V49, P329, DOI 10.1016/j.jmii.2014.07.012; Hu R, 2013, ISR J VET MED, V68, P48; Janeway C., 2001, IMMUNOBIOLOGY 5 IMMU, Vfifth; Kaper JB, 2004, NAT REV MICROBIOL, V2, P123, DOI 10.1038/nrmicro818; Kawai K, 2004, VACCINE, V22, P3411, DOI 10.1016/j.vaccine.2004.02.026; Kelly D, 2007, MUTAT RES-FUND MOL M, V622, P58, DOI 10.1016/j.mrfmmm.2007.03.011; Kuhne SA, 2004, J CLIN MICROBIOL, V42, P2966, DOI 10.1128/JCM.42.7.2966-2976.2004; Lim JY, 2010, J MICROBIOL BIOTECHN, V20, P5, DOI 10.4014/jmb.0908.08007; Lipsitch M, 2016, MBIO, V7, DOI 10.1128/mBio.00428-16; Manning SD, 2008, P NATL ACAD SCI USA, V105, P4868, DOI 10.1073/pnas.0710834105; Matkovic-Calogovic D, 1999, J BIOL CHEM, V274, P8764; Mehr Kowsar Shariati, 2012, Iranian Biomedical Journal, V16, P133, DOI 10.6091/ibj.1059.2012; Missiakas D, 2016, J EXP MED, V213, P1645, DOI 10.1084/jem.20160569; Mohawk KL, 2011, J BIOMED BIOTECHNOL, DOI 10.1155/2011/258185; Mudrak B, 2010, TOXINS, V2, P1445, DOI 10.3390/toxins2061445; Nazarian S, 2012, J MICROBIOL METH, V90, P36, DOI 10.1016/j.mimet.2012.04.001; Nguyen Y, 2012, FRONT CELL INFECT MI, V2, DOI 10.3389/fcimb.2012.00090; Orth D, 2008, EXPERT REV ANTI-INFE, V6, P101, DOI 10.1586/14787210.6.1.101; Page AV, 2013, MED CLIN N AM, V97, P681, DOI 10.1016/j.mcna.2013.04.001; Pore D, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022663; Rad HS, 2013, IRAN J MICROBIOL, V5, P244; Ran XQ, 2008, VET MICROBIOL, V127, P209, DOI 10.1016/j.vetmic.2007.08.021; Salimian J, 2010, IRAN J MICROBIOL, V2, P120; Sartz L, 2008, EPIDEMIOL INFECT, V136, P370, DOI 10.1017/S0950268807008473; Schets FM, 2005, WATER RES, V39, P4485, DOI 10.1016/j.watres.2005.08.025; Smith SGJ, 2007, FEMS MICROBIOL LETT, V273, P1, DOI 10.1111/j.1574-6968.2007.00778.x; Soulas C, 2000, J IMMUNOL, V165, P2335, DOI 10.4049/jimmunol.165.5.2335; Torres AG, 2006, INFECT IMMUN, V74, P2676, DOI 10.1128/IAI.74.5.2676-2685.2006; Torres AG, 2003, INFECT IMMUN, V71, P4985, DOI 10.1128/IAI.71.9.4985-4995.2003; Vilte DA, 2011, VACCINE, V29, P3962, DOI 10.1016/j.vaccine.2011.03.079; Wu HH, 2009, J NEUROPATH EXP NEUR, V68, P677, DOI 10.1097/NEN.0b013e3181a77d1e; Zhang Y, 2005, NUCLEIC ACIDS RES, V33, P2302, DOI 10.1093/nar/gki524; Zhou WY, 2009, VACCINE, V27, P5013, DOI 10.1016/j.vaccine.2009.05.009	45	7	7	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 15	2017	12	3							e0173761	10.1371/journal.pone.0173761	http://dx.doi.org/10.1371/journal.pone.0173761			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN9HQ	28296951	Green Submitted, gold, Green Published			2022-12-27	WOS:000396311700057
J	Thanapirom, K; Suksawatamnuay, S; Sukeepaisarnjareon, W; Tanwandee, T; Charatcharoenwitthaya, P; Thongsawat, S; Leerapun, A; Piratvisuth, T; Boonsirichan, R; Bunchorntavakul, C; Pattanasirigool, C; Pornthisarn, B; Tantipanichtheerakul, S; Sripariwuth, E; Jeamsripong, W; Sanpajit, T; Poovorawan, Y; Komolmit, P				Thanapirom, Kessarin; Suksawatamnuay, Sirinporn; Sukeepaisarnjareon, Wattana; Tanwandee, Tawesak; Charatcharoenwitthaya, Phunchai; Thongsawat, Satawat; Leerapun, Apinya; Piratvisuth, Teerha; Boonsirichan, Rattana; Bunchorntavakul, Chalermrat; Pattanasirigool, Chaowalit; Pornthisarn, Bubpha; Tantipanichtheerakul, Supot; Sripariwuth, Ekawee; Jeamsripong, Woramon; Sanpajit, Teeranan; Poovorawan, Yong; Komolmit, Piyawat			Genetic variation in the vitamin D pathway CYP2R1 gene predicts sustained HBeAg seroconversion in chronic hepatitis B patients treated with pegylated interferon: A multicenter study	PLOS ONE			English	Article							GENOME-WIDE ASSOCIATION; VIRUS INFECTION; PEGINTERFERON ALPHA-2A; T-CELLS; THERAPY; POLYMORPHISMS; LAMIVUDINE; RIBAVIRIN; ANALOGS	Evidence of a role of vitamin D in the immune system is increasing. Low serum vitamin D is associated with increased hepatitis B virus replication. Genome-wide association study (GWAS) data has revealed a number of the single nucleotide polymorphisms (SNPs) within the vitamin D synthetic pathway that affect vitamin D functions. We aimed to determine the association between SNPs in the vitamin D gene cascade and response to pegylated interferon (PegIFN) therapy in hepatitis B e-antigen (HBeAg)-positive patients. One hundred and eleven patients treated for 48 weeks with PegIFN-alfa 2a at 13 hospitals were retrospectively evaluated. Thirteen SNPs derived from vitamin D cascade-related genes, including DHCR7 (rs12785878), CYP27B1 (rs10877012), CYP2R1 (rs2060793, rs12794714), GC (rs4588, rs7041, rs222020, rs2282679), and VDR (FokI, BsmI, Tru9I, ApaI, TaqI), were genotyped. Thirty-one patients (27.9%) seroconverted to HBeAg after 24 weeks of treatment. Multivariate analysis found pretreatment qHBsAg <10,000 IU/mL (OR = 7.73, 95% CI: 2.36-25.31, P = 0.001), CYP2R1 rs12794714 TT genotype (OR = 4.16, 95% CI: 1.07-16.25, P = 0.04), and baseline ALT >2 times the upper limit of normal (OR = 3.83, 95% CI: 1.31-11.22, P = 0.014) predicted sustained HBeAg seroconversion after completion of PegIFN treatment. HBV DNA during study period tended to be lower with the rs12794714 CYP2R1 TT than the non-TT genotype. The rs12794714 CYP2R1 polymorphism may be a useful pretreatment factor predictive of sustained HBeAg seroconversion after PegIFN therapy. This study provides evidence that not only vitamin D level but also genetic variation of CYP2R1 in the vitamin D cascade influences host immune response in chronic HBV infection.	[Thanapirom, Kessarin; Suksawatamnuay, Sirinporn; Komolmit, Piyawat] Chulalongkorn Univ, Fac Med, Dept Med, Div Gastroenterol, Bangkok, Thailand; [Thanapirom, Kessarin; Suksawatamnuay, Sirinporn; Komolmit, Piyawat] Thai Red Cross Soc, King Chulalongkorn Mem Hosp, Bangkok, Thailand; [Sukeepaisarnjareon, Wattana] Khon Kaen Univ, Fac Med, Dept Med, Khon Kaen, Thailand; [Tanwandee, Tawesak; Charatcharoenwitthaya, Phunchai] Siriraj Hosp, Dept Med, Div Gastroenterol, Bangkok, Thailand; [Thongsawat, Satawat; Leerapun, Apinya] Chiang Mai Univ, Dept Internal Med, Chiang Mai, Thailand; [Piratvisuth, Teerha] Prince Songkla Univ, Fac Med, Hat Yai, Thailand; [Boonsirichan, Rattana] Vajira Hosp, Fac Med, Bangkok, Thailand; [Bunchorntavakul, Chalermrat] Rajavithi Hosp, Fac Med, Bangkok, Thailand; [Pattanasirigool, Chaowalit] Police Gen Hosp, Fac Med, Bangkok, Thailand; [Pornthisarn, Bubpha] Thammasat Univ Hosp, Fac Med, Bangkok, Thailand; [Tantipanichtheerakul, Supot] Bhumibol Adulyadej Hosp, Fac Med, Bangkok, Thailand; [Sripariwuth, Ekawee] Naresuan Univ, Fac Med, Phitsanulok, Thailand; [Jeamsripong, Woramon] Buddhachinaraj Hosp, Fac Med, Phitsanulok, Thailand; [Sanpajit, Teeranan] Phramongkutklao Hosp, Bangkok, Thailand; [Poovorawan, Yong] Chulalongkorn Univ, Fac Med, Dept Pediat, Ctr Excellence Clin Virol, Bangkok, Thailand	Chulalongkorn University; Chulalongkorn University; Thai Red Cross Society; Khon Kaen University; Mahidol University; Chiang Mai University; Prince of Songkla University; Rajavithi Hospital; Thammasat University; Naresuan University; Phramongkutklao Hospital; Chulalongkorn University	Komolmit, P (corresponding author), Chulalongkorn Univ, Fac Med, Dept Med, Div Gastroenterol, Bangkok, Thailand.; Komolmit, P (corresponding author), Thai Red Cross Soc, King Chulalongkorn Mem Hosp, Bangkok, Thailand.	pkomolmit@yahoo.co.uk	Tanwandee, Tawesak/AAR-6459-2020; Sripariwuth, Ekawee/AAA-2802-2022; Komolmit, Piyawat/AAD-1629-2020; ภู่วรวรรณ, ศนพ.ยง/GZK-8615-2022; Charatcharoenwitthaya, Phunchai/AAE-4009-2022; Thanapirom, Kessarin/O-6346-2015	Komolmit, Piyawat/0000-0002-1357-9547; Tanwandee, Tawesak/0000-0001-7634-0843; Thongsawat, Satawat/0000-0003-3302-3930	Thai Association for the Study of the Liver (THASL); Ratchadaphiseksomphot Endowment Fund Part of the "Grants for Junior or Terminated Executive staff" [CU's SRP_05_55_30_01]; Ratchadapiseksompotch Fund, Faculty of Medicine, Chulalongkorn University [RA55/24]; Pericardia Program of The Royal College of Physicians of Thailand; National Research Council of Thailand (NRCT); National Science and Technology Development Agency; Center of Excellence in Clinical Virology of Chulalongkorn University [GCE 58-014-30-004]; King Chulalongkorn Memorial Hospital	Thai Association for the Study of the Liver (THASL); Ratchadaphiseksomphot Endowment Fund Part of the "Grants for Junior or Terminated Executive staff"; Ratchadapiseksompotch Fund, Faculty of Medicine, Chulalongkorn University(Chulalongkorn University); Pericardia Program of The Royal College of Physicians of Thailand; National Research Council of Thailand (NRCT)(National Research Council of Thailand (NRCT)); National Science and Technology Development Agency; Center of Excellence in Clinical Virology of Chulalongkorn University; King Chulalongkorn Memorial Hospital(Chulalongkorn University)	The research funding was supported by Thai Association for the Study of the Liver (THASL), the Ratchadaphiseksomphot Endowment Fund Part of the "Grants for Junior or Terminated Executive staff" (CU's SRP_05_55_30_01), the Ratchadapiseksompotch Fund, Faculty of Medicine, Chulalongkorn University (RA55/24) and the Pericardia Program of The Royal College of Physicians of Thailand. Part or partial of the laboratory work was supported by The National Research Council of Thailand (NRCT), The Research Chair Grant from the National Science and Technology Development Agency, The Center of Excellence in Clinical Virology of Chulalongkorn University (GCE 58-014-30-004) and King Chulalongkorn Memorial Hospital.	Ahn J, 2010, HUM MOL GENET, V19, P2739, DOI 10.1093/hmg/ddq155; Boglione L, 2015, J VIRAL HEPATITIS, V22, P318, DOI 10.1111/jvh.12288; Bu FX, 2010, HUM GENET, V128, P549, DOI 10.1007/s00439-010-0881-9; Buster EHCJ, 2008, GASTROENTEROLOGY, V135, P459, DOI 10.1053/j.gastro.2008.05.031; Buster EHCJ, 2009, GASTROENTEROLOGY, V137, P2002, DOI 10.1053/j.gastro.2009.08.061; Chan HLY, 2010, ALIMENT PHARM THER, V32, P1323, DOI 10.1111/j.1365-2036.2010.04474.x; Chan HL, 2015, JOURNAL OF HEPATOLOG; Cheng L, 2014, HEPATOL RES, V44, P1000, DOI 10.1111/hepr.12284; Deeb KK, 2007, NAT REV CANCER, V7, P684, DOI 10.1038/nrc2196; Dienstag JL, 2008, NEW ENGL J MED, V359, P1486, DOI 10.1056/NEJMra0801644; Falleti E, 2012, HEPATOLOGY, V56, P1641, DOI 10.1002/hep.25848; Fan R, 2016, GUT, V65, P313, DOI 10.1136/gutjnl-2014-308546; Farnik H, 2013, HEPATOLOGY, V58, P1270, DOI 10.1002/hep.26488; Garcia-Martin E, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074764; Kwok RM, 2013, HEPATOLOGY, V58, P1166, DOI 10.1002/hep.26390; Kwon H, 2011, NAT REV GASTRO HEPAT, V8, P275, DOI 10.1038/nrgastro.2011.33; Lange CM, 2011, J HEPATOL, V54, P887, DOI 10.1016/j.jhep.2010.08.036; Lau GKK, 2005, NEW ENGL J MED, V352, P2682, DOI 10.1056/NEJMoa043470; Liaw YF, 2009, LANCET, V373, P582, DOI 10.1016/S0140-6736(09)60207-5; McGrath JJ, 2010, J STEROID BIOCHEM, V121, P471, DOI 10.1016/j.jsbmb.2010.03.073; Nnoaham KE, 2008, INT J EPIDEMIOL, V37, P113, DOI 10.1093/ije/dym247; Piratvisuth T, 2008, HEPATOL INT, V2, P102, DOI 10.1007/s12072-007-9022-5; Raghuwanshi A, 2008, J CELL BIOCHEM, V105, P338, DOI 10.1002/jcb.21858; Reusch J, 2009, HORM METAB RES, V41, P402, DOI 10.1055/s-0028-1128131; Rico MA, 2001, HEPATOLOGY, V33, P295, DOI 10.1053/jhep.2001.21147; Rijckborst V, 2010, AM J GASTROENTEROL, V105, P1762, DOI 10.1038/ajg.2010.186; Robien K, 2013, BRIT J NUTR, V109, P493, DOI 10.1017/S0007114512001675; Shinkyo R, 2004, BIOCHEM BIOPH RES CO, V324, P451, DOI 10.1016/j.bbrc.2004.09.073; Stoop JN, 2005, HEPATOLOGY, V41, P771, DOI 10.1002/hep.20649; van Bommel F, 2010, HEPATOLOGY, V51, P73, DOI 10.1002/hep.23246; von Essen MR, 2010, NAT IMMUNOL, V11, P344, DOI 10.1038/ni.1851; Wang TJ, 2010, LANCET, V376, P180, DOI 10.1016/S0140-6736(10)60588-0; White JH, 2012, REV ENDOCR METAB DIS, V13, P21, DOI 10.1007/s11154-011-9195-z; Wong GLH, 2015, CLIN GASTROENTEROL H, V13, P783, DOI 10.1016/j.cgh.2014.09.050; Yang HC, 2013, HEPATOLOGY, V57, P934, DOI 10.1002/hep.26121; Zhang YL, 2012, SWISS MED WKLY, V142, DOI 10.4414/smw.2012.13636	36	15	16	1	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 15	2017	12	3							e0173263	10.1371/journal.pone.0173263	http://dx.doi.org/10.1371/journal.pone.0173263			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN9HQ	28296915	Green Published, Green Submitted, gold			2022-12-27	WOS:000396311700029
J	van Rosmalen, BV; Alldinger, I; Cieslak, KP; Wennink, R; Clarke, M; Ali, UA; Besselink, MGH				van Rosmalen, Belle V.; Alldinger, Ingo; Cieslak, Kasia P.; Wennink, Roos; Clarke, Mike; Ali, Usama Ahmed; Besselink, Marc G. H.			Worldwide trends in volume and quality of published protocols of randomized controlled trials	PLOS ONE			English	Article							INTERNATIONAL COMMITTEE; ALLOCATION CONCEALMENT; SYSTEMATIC REVIEWS; SURGICAL JOURNALS; IDEAL FRAMEWORK; COMIC OPERA; REGISTRATION; STATEMENT	Introduction Publishing protocols of randomized controlled trials (RCT) facilitates a more detailed description of study rational, design, and related ethical and safety issues, which should promote transparency. Little is known about how the practice of publishing protocols developed over time. Therefore, this study describes the worldwide trends in volume and methodological quality of published RCT protocols. Methods A systematic search was performed in PubMed and EMBASE, identifying RCT protocols published over a decade from 1 September 2001. Data were extracted on quality characteristics of RCT protocols. The primary outcome, methodological quality, was assessed by individual methodological characteristics (adequate generation of allocation, concealment of allocation and intention-to-treat analysis). A comparison was made by publication period (First, September 2001-December 2004; Second, January 2005-May 2008; Third, June 2008-September 2011), geographical region and medical specialty. Results The number of published RCT protocols increased from 69 in the first, to 390 in the third period (p<0.0001). Internal medicine and paediatrics were the most common specialty topics. Whereas most published RCT protocols in the first period originated from North America (n = 30, 44%), in the second and third period this was Europe (respectively, n = 65, 47% and n = 190, 48%, p = 0.02). Quality of RCT protocols was higher in Europe and Australasia, compared to North America (OR = 0.63, CI = 0.40-0.99, p = 0.04). Adequate generation of allocation improved with time (44%, 58%, 67%, p = 0.001), as did concealment of allocation (38%, 53%, 55%, p = 0.03). Surgical protocols had the highest quality among the three specialty topics used in this study (OR = 1.94, CI = 1.09-3.45, p = 0.02). Conclusion Publishing RCT protocols has become popular, with a five-fold increase in the past decade. The quality of published RCT protocols also improved, although variation between geographical regions and across medical specialties was seen. This emphasizes the importance of international standards of comprehensive training in RCT methodology.	[van Rosmalen, Belle V.; Cieslak, Kasia P.; Besselink, Marc G. H.] Acad Med Ctr, Dept Surg, Amsterdam, Netherlands; [Alldinger, Ingo] Heidelberg Univ, Dept Gen Visceral & Transplantat Surg, Heidelberg, Germany; [Wennink, Roos; Ali, Usama Ahmed] Univ Med Ctr Utrecht, Dept Surg, Utrecht, Netherlands; [Clarke, Mike] Queens Univ Belfast, Northern Ireland Network Trials Methodol Res, Belfast, North Ireland	University of Amsterdam; Academic Medical Center Amsterdam; Ruprecht Karls University Heidelberg; Utrecht University; Utrecht University Medical Center; Queens University Belfast	van Rosmalen, BV (corresponding author), Acad Med Ctr, Dept Surg, Amsterdam, Netherlands.	b.v.vanrosmalen@amc.uva.nl	Besselink, Marc G/R-4268-2019; Besselink, Marc/H-3294-2019	Besselink, Marc G/0000-0003-2650-9350; 	Medical Research Council [G0901530] Funding Source: Medline; MRC [G0901530] Funding Source: UKRI	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		Administration FaD, 2006, GUIDANCE FOR CLINICA; Agha Riaz, 2007, Int J Surg, V5, P413, DOI 10.1016/j.ijsu.2007.06.002; Ali UA, 2013, ANN SURG, V258, P199, DOI 10.1097/SLA.0b013e31829c7795; Bastian H, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000326; Besselink MGH, 2005, JAMA-J AM MED ASSOC, V293, P157, DOI 10.1001/jama.293.2.157-c; Blumle A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087184; Chan AW, 2013, BMJ-BRIT MED J, V346, DOI 10.1136/bmj.e7586; Chan AW, 2008, BMJ-BRIT MED J, V337, DOI 10.1136/bmj.a2299; Chan AW, 2005, LANCET, V365, P1159, DOI 10.1016/S0140-6736(05)71879-1; Chan AW, 2004, JAMA-J AM MED ASSOC, V291, P2457, DOI 10.1001/jama.291.20.2457; Chen Y. J., 2010, SCI TECHNOLOGY INNOV, V7, P7, DOI DOI 10.1371/JOURNAL.PONE.0011926; Cook JA, 2013, BMJ-BRIT MED J, V346, DOI 10.1136/bmj.f2820; De Angelis C, 2004, LANCET, V364, P911, DOI 10.1016/S0140-6736(04)17034-7; De Angelis C, 2005, LANCET, V365, P1827, DOI 10.1016/S0140-6736(05)66588-9; Decullier E, 2005, BMJ-BRIT MED J, V331, P19, DOI 10.1136/bmj.38488.385995.8F; Devereaux PJ, 2001, JAMA-J AM MED ASSOC, V285, P2000, DOI 10.1001/jama.285.15.2000; Dwan K, 2011, COCHRANE DB SYST REV, DOI 10.1002/14651858.MR000031.pub2; Edwards P, 2002, STAT MED, V21, P1635, DOI 10.1002/sim.1190; Faure Helene, 2011, J Evid Based Med, V4, P188, DOI 10.1111/j.1756-5391.2011.01138.x; HALL JC, 1982, AUST NZ J SURG, V52, P541, DOI 10.1111/j.1445-2197.1982.tb06050.x; Higgins JPT, 2011, BMJ-BRIT MED J, V343, DOI 10.1136/bmj.d5928; Hopewell S, 2010, BMJ-BRIT MED J, V340, DOI 10.1136/bmj.c723; Horton R, 1996, LANCET, V347, P984, DOI 10.1016/S0140-6736(96)90137-3; Juni P, 2001, BMJ-BRIT MED J, V323, P42, DOI 10.1136/bmj.323.7303.42; Kao LS, 2003, ARCH SURG-CHICAGO, V138, P59, DOI 10.1001/archsurg.138.1.59; Karanicolas PJ, 2010, CAN J SURG, V53, P345; Lilford R, 2004, BRIT J SURG, V91, P6, DOI 10.1002/bjs.4418; McCulloch P, 2002, BRIT MED J, V324, P1448, DOI 10.1136/bmj.324.7351.1448; McCulloch P, 2013, BMJ-BRIT MED J, V346, DOI 10.1136/bmj.f3012; MICKEY RM, 1989, AM J EPIDEMIOL, V129, P125, DOI 10.1093/oxfordjournals.aje.a115101; Neugebauer EAM, 2008, SURG ENDOSC, V22, P1411, DOI 10.1007/s00464-008-9906-z; Noah BA, 2000, U FLORIDA COLL LAW, V449, P55; Pildal J, 2005, BMJ-BRIT MED J, V330, P1049, DOI 10.1136/bmj.38414.422650.8F; Scales CD, 2007, J UROLOGY, V177, P1090, DOI 10.1016/j.juro.2006.10.027; Schulz KF, 2002, LANCET, V359, P614, DOI 10.1016/S0140-6736(02)07750-4; Schulz KF, 2002, LANCET, V359, P696, DOI 10.1016/S0140-6736(02)07816-9; Schumm LP, 1999, SURGERY, V125, P41, DOI 10.1016/S0039-6060(99)70286-2; Siegfried N, 2005, BRIT MED J, V331, P742, DOI 10.1136/bmj.331.7519.742; SOLOMON MJ, 1993, DIS COLON RECTUM, V36, P43, DOI 10.1007/BF02050300; Treweek S, 2015, TRIALS, V16, DOI 10.1186/s13063-015-0776-0; Wang G, 2007, CLIN THER, V29, P1456, DOI 10.1016/j.clinthera.2007.07.023; Xu L, 2008, CONTEMP CLIN TRIALS, V29, P727, DOI 10.1016/j.cct.2008.05.003; Zarin DA, 2007, JAMA-J AM MED ASSOC, V297, P2112, DOI 10.1001/jama.297.19.2112; Zarin DA, 2011, NEW ENGL J MED, V364, P852, DOI 10.1056/NEJMsa1012065	44	14	14	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 15	2017	12	3							e0173042	10.1371/journal.pone.0173042	http://dx.doi.org/10.1371/journal.pone.0173042			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN9HQ	28296925	Green Published, Green Submitted, gold			2022-12-27	WOS:000396311700023
J	Vertucci, S; Pepper, M; Edwards, DL; Roberts, JD; Mitchell, N; Keogh, JS				Vertucci, Samantha; Pepper, Mitzy; Edwards, Danielle L.; Roberts, J. Dale; Mitchell, Nicola; Keogh, J. Scott			Evolutionary and natural history of the turtle frog, Myobatrachus gouldii, a bizarre myobatrachid frog in the southwestern Australian biodiversity hotspot	PLOS ONE			English	Article							ARENOPHRYNE-ROTUNDA TYLER; PHYLOGENETIC-RELATIONSHIPS; NEOBATRACHUS ANURA; POPULATION HISTORY; GENETIC-STRUCTURE; MITOCHONDRIAL; SPECIATION; NUCLEAR; PHYLOGEOGRAPHY; REFUGIA	Southwest Australia (SWA) is a global biodiversity hotspot and a centre of diversity and endemism for the Australo-Papuan myobatrachid frogs. Myobatrachus gouldii (the turtle frog) has a highly derived morphology associated with its forward burrowing behaviour, largely subterranean habit, and unusual mode of reproduction. Its sister genera Metacrinia and Arenophryne have restricted distributions in Western Australia with significant phylogeographic structure, leading to the recent description of a new species in the latter. In contrast, Myobatrachus is distributed widely throughout SWA over multiple climatic zones, but little is known of its population structure, geographic variation in morphology, or reproduction. We generated molecular and morphological data to test for genetic and morphological variation, and to assess whether substrate specialisation in this species may have led to phylogeographic structuring similar to that of other plant and animal taxa in SWA. We assembled sequence data for one mitochondrial and four nuclear DNA loci (3628 base pairs) for 42 turtle frogs sampled throughout their range. Likelihood phylogenetic analyses revealed shallow phylogeographic structure in the mtDNA locus (up to 3.3% genetic distance) and little variation in three of the four nDNA loci. The mtDNA haplotype network suggests five geographically allopatric groups, with no shared haplotypes between regions. These geographic patterns are congruent with several other SWA species, with genetic groups restricted to major hydrological divisions, the Swan Coastal Plain, and the Darling Scarp. The geographically structured genetic groups showed no evidence of significant morphological differentiation (242 individuals), and there was little sexual size dimorphism, but subtle differences in reproductive traits suggest more opportunistic breeding in lower rainfall zones. Call data were compared to sister genera Metacrinia and Arenophryne and found to be highly conservative across the three genera. Like many taxa in SWA, topographic variation and Plio-Pleistocene arid fluctuations likely were historic drivers of diversification in M. gouldii.	[Vertucci, Samantha; Pepper, Mitzy; Keogh, J. Scott] Australian Natl Univ, Res Sch Biol, Div Evolut Ecol & Genet, Canberra, ACT, Australia; [Edwards, Danielle L.] Univ Calif, Sch Nat Sci, Merced, CA USA; [Roberts, J. Dale] Univ Western Australia, Ctr Excellence Nat Resource Management, Albany, WA, Australia; [Mitchell, Nicola] Univ Western Australia, Sch Anim Biol, Crawley, Australia	Australian National University; University of California System; University of California Merced; University of Western Australia; University of Western Australia	Keogh, JS (corresponding author), Australian Natl Univ, Res Sch Biol, Div Evolut Ecol & Genet, Canberra, ACT, Australia.	Scott.Keogh@anu.edu.au	Mitchell, Nicola/AAE-4132-2020; Keogh, Scott/C-8441-2009; Mitchell, Nicola/K-5277-2012	Keogh, Scott/0000-0002-1373-6186; Edwards, Danielle/0000-0002-1165-4427; Pepper, Mitzy/0000-0003-4828-9977; Mitchell, Nicola/0000-0003-0744-984X	Australian Research Council [DP0662772]	Australian Research Council(Australian Research Council)	This work was supported by the Australian Research Council (http://www.arc.gov.au/), grant number DP0662772, awarded to JSK. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anand RR, 2002, AUST J EARTH SCI, V49, P3, DOI 10.1046/j.1440-0952.2002.00912.x; Anstis Marion, 2007, Records of the Western Australian Museum, V23, P259; Beard JS, 2000, J BIOGEOGR, V27, P1257, DOI 10.1046/j.1365-2699.2000.00509.x; Berry O, 2001, J HERPETOL, V35, P136, DOI 10.2307/1566037; BULL CM, 1978, AUST J ZOOL, V26, P305, DOI 10.1071/ZO9780305; Burton TC, 2001, AUST J ZOOL, V49, P539, DOI 10.1071/ZO01045; Byrne M, 2002, J EVOLUTION BIOL, V15, P576, DOI 10.1046/j.1420-9101.2002.00429.x; Byrne M, 2008, QUATERNARY SCI REV, V27, P2576, DOI 10.1016/j.quascirev.2008.08.032; CALABY J. H., 1956, WESTERN AUSTRALIAN NAT, V5, P93; Camargo A, 2006, BIOL J LINN SOC, V87, P325, DOI 10.1111/j.1095-8312.2006.00581.x; Catullo Renee A., 2011, Zootaxa, V2902, P1; Cincotta RP, 2000, NATURE, V404, P990, DOI 10.1038/35010105; COGGER HG, 1992, REPTILES AMPHIBIANS; Cooper SJB, 2011, MOL ECOL, V20, P3219, DOI 10.1111/j.1365-294X.2011.05160.x; Crawford AJ, 2003, MOL ECOL, V12, P2525, DOI 10.1046/j.1365-294X.2003.01910.x; DAVIES M, 1984, AUST J ZOOL, V32, P789, DOI 10.1071/ZO9840789; Davis RA, 2005, AUST J ZOOL, V53, P167, DOI 10.1071/ZO04021; Dodson JR, 2004, GLOBAL PLANET CHANGE, V41, P285, DOI 10.1016/j.gloplacha.2004.01.013; Doughty Paul, 2008, Records of the Western Australian Museum, V24, P121, DOI 10.18195/issn.0312-3162.24(2).2008.121-131; Driscoll DA, 1998, EVOLUTION, V52, P1147, DOI 10.1111/j.1558-5646.1998.tb01841.x; Edwards DL, 2008, J BIOGEOGR, V35, P1803, DOI 10.1111/j.1365-2699.2008.01927.x; Edwards DL, 2007, MOL PHYLOGENET EVOL, V45, P494, DOI 10.1016/j.ympev.2007.05.023; Edwards DL, 2007, MOL ECOL, V16, P2782, DOI 10.1111/j.1365-294X.2007.03374.x; FRAKES LA, 1999, FLORA AUSTR, V0001, P00163; Gamble T, 2008, MOL PHYLOGENET EVOL, V48, P112, DOI 10.1016/j.ympev.2008.03.015; Gray J.E., 1841, ANN MAG NAT HIST, V7, P86, DOI [DOI 10.1080/03745484109442670, 10.1080/03745484109442670]; Guayasamin JM, 2008, MOL PHYLOGENET EVOL, V48, P574, DOI 10.1016/j.ympev.2008.04.012; Hopper SD, 2004, ANNU REV ECOL EVOL S, V35, P623, DOI 10.1146/annurev.ecolsys.35.112202.130201; HOPPER SD, 1979, ANNU REV ECOL SYST, V10, P399, DOI 10.1146/annurev.es.10.110179.002151; Hopper Stephen D., 1996, P1; Hoskin CJ, 2009, J ZOOL, V278, P36, DOI 10.1111/j.1469-7998.2009.00550.x; Hoskin Conrad J., 2011, Zootaxa, V3027, P39; Kay GM, 2012, ZOOTAXA, P1; KEMP EM, 1978, PALAEOGEOGR PALAEOCL, V24, P169, DOI 10.1016/0031-0182(78)90042-1; KENDRICK GW, 1991, QUATERNARY SCI REV, V10, P419, DOI 10.1016/0277-3791(91)90005-F; Lanfear R, 2012, MOL BIOL EVOL, V29, P1695, DOI 10.1093/molbev/mss020; Leigh JW, 2015, METHODS ECOL EVOL, V6, P1110, DOI 10.1111/2041-210X.12410; Li JT, 2009, MOL PHYLOGENET EVOL, V53, P509, DOI 10.1016/j.ympev.2009.06.023; Lynch JD, 1971, MUSEUM NATURAL HIST, V53, P238; Mable BK, 1997, COPEIA, P680, DOI 10.2307/1447286; Mahony M, 1996, AUST J ZOOL, V44, P639, DOI 10.1071/ZO9960639; MAXSON LR, 1985, J ZOOL, V207, P289; Melville J, 2008, AUST J ZOOL, V56, P159, DOI 10.1071/ZO07069; Mitchell NJ, 2011, PERTHS BANKSIA WOODL, P47; Morgan MJ, 2007, MOL PHYLOGENET EVOL, V44, P371, DOI 10.1016/j.ympev.2006.12.009; Myers N, 2000, NATURE, V403, P853, DOI 10.1038/35002501; Nokhbatolfoghahai M, 2010, HERPETOL J, V20, P59; Noonan BP, 2005, MOL ECOL, V14, P3017, DOI 10.1111/j.1365-294X.2005.02624.x; Pepper M, 2011, MOL PHYLOGENET EVOL, V61, P750, DOI 10.1016/j.ympev.2011.08.009; Pinho C, 2009, CONSERV GENET, P121; Read K, 2001, MOL PHYLOGENET EVOL, V21, P294, DOI 10.1006/mpev.2001.1014; Rix MG, 2015, BIOL REV, V90, P762, DOI 10.1111/brv.12132; ROBERTS JD, 1984, AUST WILDLIFE RES, V11, P191, DOI 10.1071/WR9840191; ROBERTS JD, 1981, AUST WILDLIFE RES, V8, P451; ROBERTS JD, 1985, EVOLUTION, V39, P325, DOI 10.1111/j.1558-5646.1985.tb05670.x; Slatyer C, 2007, J BIOGEOGR, V34, P583, DOI 10.1111/j.1365-2699.2006.01647.x; Smith SA, 2007, EVOLUTION, V61, P1188, DOI 10.1111/j.1558-5646.2007.00085.x; Stamatakis A, 2006, BIOINFORMATICS, V22, P2688, DOI 10.1093/bioinformatics/btl446; TEMPLETON AR, 1995, GENETICS, V140, P767; van der Meijden A, 2007, MOL PHYLOGENET EVOL, V44, P1017, DOI 10.1016/j.ympev.2007.02.008; Wang IJ, 2008, MOL PHYLOGENET EVOL, V47, P992, DOI 10.1016/j.ympev.2008.02.021; WATSON J. A. L., 1959, WESTERN AUSTRALIAN NAT, V7, P1; Wheeler MA, 2006, AUST J BOT, V54, P17, DOI 10.1071/BT05086; Withers P. C., 1993, Journal of the Royal Society of Western Australia, V76, P49; Wyrwoll KH, 2003, AUSTR GEOMECHANICS, V38, P17	65	3	3	3	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 15	2017	12	3							e0173348	10.1371/journal.pone.0173348	http://dx.doi.org/10.1371/journal.pone.0173348			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN9HQ	28296914	Green Published, gold			2022-12-27	WOS:000396311700034
J	Carroll, SH; Zhang, E; Wang, BF; LeClair, KB; Rahman, A; Cohen, DE; Plutzky, J; Patwari, P; Lee, RT				Carroll, Shannon H.; Zhang, Ellen; Wang, Bing F.; LeClair, Katherine B.; Rahman, Arifeen; Cohen, David E.; Plutzky, Jorge; Patwari, Parth; Lee, Richard T.			Adipocyte arrestin domain-containing 3 protein (Arrdc3) regulates uncoupling protein 1 (Ucp1) expression in white adipose independently of canonical changes in beta-adrenergic receptor signaling	PLOS ONE			English	Article							BETA-2-ADRENERGIC RECEPTOR; BROWN; FAT; THERMOGENESIS; BINDING; TARGET; MUSCLE; LIGASE; MICE	Adaptive thermogenesis and cold-induced activation of uncoupling protein 1 (Ucp1) in brown adipose tissue in rodents is well-described and attributed to sympathetic activation of beta-adrenergic signaling. The arrestin domain containing protein Arrdc3 is a regulator of obesity in mice and also appears linked to obesity in humans. We generated a mouse with conditional deletion of Arrdc3, and here we present evidence that genetic ablation of Arrdc3 specifically in adipocytes results in increased Ucp1 expression in subcutaneous and parametrial adipose tissue. Although this increase in expression did not correspond with significant changes in body weight or energy expenditure, adipocyte-specific Arrdc3-null mice had improved glucose tolerance. It was previously hypothesized that Arrdc3 ablation leads to increased beta-adrenergic receptor sensitivity; however, in vitro experiments show that Arrdc3-null adipocytes responded to beta-adrenergic receptor agonist with decreased Ucp1 levels. Additionally, canonical beta-adrenergic receptor signaling was not different in Arrdc3-null adipocytes. These data reveal a role for Arrdc3 in the regulation of Ucp1 expression in adipocytes. However, this adipocyte effect is insufficient to generate the obesity-resistant phenotype of mice with ubiquitous deletion of Arrdc3, indicating a likely role for Arrdc3 in cells other than adipocytes.	[Carroll, Shannon H.; Zhang, Ellen; Wang, Bing F.; Rahman, Arifeen; Lee, Richard T.] Harvard Univ, Harvard Stem Cell Inst, Cambridge, MA 02138 USA; [Carroll, Shannon H.; Zhang, Ellen; Wang, Bing F.; Rahman, Arifeen; Lee, Richard T.] Harvard Univ, Dept Stem Cell & Regenerat Biol, Cambridge, MA 02138 USA; [LeClair, Katherine B.; Cohen, David E.] Brigham & Womens Hosp, Div Gastroenterol Hepatol & Endoscopy, 75 Francis St, Boston, MA 02115 USA; [LeClair, Katherine B.; Cohen, David E.] Harvard Med Sch, Boston, MA USA; [Plutzky, Jorge; Patwari, Parth; Lee, Richard T.] Brigham & Womens Hosp, Cardiovasc Div, Harvard Med Sch, 75 Francis St, Boston, MA 02115 USA	Harvard University; Harvard University; Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School; Harvard University; Brigham & Women's Hospital; Harvard Medical School	Lee, RT (corresponding author), Harvard Univ, Harvard Stem Cell Inst, Cambridge, MA 02138 USA.; Lee, RT (corresponding author), Harvard Univ, Dept Stem Cell & Regenerat Biol, Cambridge, MA 02138 USA.; Lee, RT (corresponding author), Brigham & Womens Hosp, Cardiovasc Div, Harvard Med Sch, 75 Francis St, Boston, MA 02115 USA.	Richard_Lee@harvard.edu	Plutzky, Jorge/V-3410-2019	Lee, Richard/0000-0003-4687-1381	National Institutes of Health [R01DK107396, F32DK105682]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK034854] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by grants from the National Institutes of Health (R01DK107396 to RTL, F32DK105682 to SHC). SHC and RTL planned the experiments and wrote the paper. S.H. C performed the majority of experiments.	Azzu V, 2010, BBA-BIOENERGETICS, V1797, P785, DOI 10.1016/j.bbabio.2010.02.035; Cohen P, 2015, DIABETES, V64, P2346, DOI 10.2337/db15-0318; Collins GP, 2001, SCI AM, V284, p24B; Enerback S, 1997, NATURE, V387, P90, DOI 10.1038/387090a0; Forest C, 2016, ADIPOCYTE, V5, P136, DOI 10.1080/21623945.2016.1187345; Giordano A, 2016, NAT REV DRUG DISCOV, V15, P405, DOI 10.1038/nrd.2016.31; Han SO, 2013, EMBO REP, V14, P164, DOI 10.1038/embor.2012.187; Irannejad R, 2014, CURR OPIN CELL BIOL, V27, P109, DOI 10.1016/j.ceb.2013.10.003; Irannejad R, 2013, NATURE, V495, P534, DOI 10.1038/nature12000; Kang HW, 2013, J BIOL CHEM, V288, P33376, DOI 10.1074/jbc.M113.481408; Keipert S, 2014, BBA-BIOENERGETICS, V1837, P1075, DOI 10.1016/j.bbabio.2014.02.008; Kim SH, 2016, DIABETES METAB J, V40, P12, DOI 10.4093/dmj.2016.40.1.12; Nabhan JF, 2010, EMBO REP, V11, P605, DOI 10.1038/embor.2010.80; Oelkrug R, 2015, J COMP PHYSIOL B, V185, P587, DOI 10.1007/s00360-015-0907-7; Oka S, 2006, ENDOCRINOLOGY, V147, P733, DOI 10.1210/en.2005-0679; Patwari P, 2011, CELL METAB, V14, P671, DOI 10.1016/j.cmet.2011.08.011; Qi SQ, 2014, PROTEIN SCI, V23, P1708, DOI 10.1002/pro.2549; Qi SQ, 2014, J BIOL CHEM, V289, P4743, DOI 10.1074/jbc.M113.527473; Ramseyer VD, 2016, ADIPOCYTE, V5, P119, DOI 10.1080/21623945.2016.1145846; Schulz TJ, 2011, P NATL ACAD SCI USA, V108, P143, DOI 10.1073/pnas.1010929108; Seale P, 2008, NATURE, V454, P961, DOI 10.1038/nature07182; Shea FF, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050557; Tian XF, 2016, J BIOL CHEM, V291, P14510, DOI 10.1074/jbc.M116.716589	23	6	6	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 14	2017	12	3							e0173823	10.1371/journal.pone.0173823	http://dx.doi.org/10.1371/journal.pone.0173823			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN6DM	28291835	gold, Green Published, Green Submitted			2022-12-27	WOS:000396094700043
J	Dussan, A; Bertel, SD; Melo, SF; Mesa, F				Dussan, A.; Bertel, S. D.; Melo, S. F.; Mesa, F.			Synthesis and characterization of porous silicon as hydroxyapatite host matrix of biomedical applications	PLOS ONE			English	Article							FABRICATION; ACID	In this work, porous-silicon samples were prepared by electrochemical etching on p-type (B-doped) Silicon (Si) wafers. Hydrofluoric acid (HF)-ethanol (C2H5OH) [HF:Et] and Hydrofluoric acid (HF)-dimethylformamide (DMF-C3H7NO) [HF:DMF] solution concentrations were varied between [1:2]-[1:3] and [1:7]-[1:9], respectively. Effects of synthesis parameters, like current density, solution concentrations, reaction time, on morphological properties were studied by scanning electron microscopy (SEM) and atomic force microscopy (AFM) measurements. Pore sizes varying from 20 nm to micrometers were obtained for long reaction times and [HF:Et] [1:2] concentrations; while pore sizes in the same order were observed for [HF:DMF] [1:7], but for shorter reaction time. Greater surface uniformity and pore distribution was obtained for a current density of around 8 mA/cm(2) using solutions with DMF. A correlation between reflectance measurements and pore size is presented. The porous-silicon samples were used as substrate for hydroxyapatite growth by sol-gel method. X-ray diffraction (XRD) and SEM were used to characterize the layers grown. It was found that the layer topography obtained on PS samples was characterized by the evidence of Hydroxyapatite in the inter-pore regions and over the surface.	[Dussan, A.; Bertel, S. D.; Melo, S. F.] Univ Nacl Colombia, Fac Ciencias, Dept Fis, Grp Mat Nanoestruct & Sus Aplicac, Ciudad Univ, Bogota, Colombia; [Mesa, F.] Univ Rosario, Fac Ciencias Nat & Matemat, Grp NanoTech, Bogota, Colombia	Universidad Nacional de Colombia; Universidad del Rosario	Mesa, F (corresponding author), Univ Rosario, Fac Ciencias Nat & Matemat, Grp NanoTech, Bogota, Colombia.	fredy.mesa@urosario.edu.co	Mesa, Fredy/E-8730-2016	Mesa, Fredy/0000-0003-0920-7748	Universidad Nacional de Colombia; COLCIENCIAS; Universidad del Rosario	Universidad Nacional de Colombia; COLCIENCIAS(Departamento Administrativo de Ciencia, Tecnologia e Innovacion Colciencias); Universidad del Rosario	This work was supported by Universidad Nacional de Colombia, COLCIENCIAS and Universidad del Rosario.; This work was supported by Universidad Nacional de Colombia, COLCIENCIAS and Universidad del Rosario. We thank to the professor Dr. Alvaro Angel Arrieta for laboratory support in sample preparation and characterization.	Abd HR, 2013, INT J ELECTROCHEM SC, V8, P11461; BEALE MIJ, 1985, J CRYST GROWTH, V73, P622, DOI 10.1016/0022-0248(85)90029-6; Ben-Arfa BAE, 2017, MAT SCI ENG C-MATER, V70, P796, DOI 10.1016/j.msec.2016.09.054; Bhattacharyy D, 2015, RSC ADV, V5, P70361, DOI 10.1039/c5ra12191d; Chen SQ, 2004, APPL SURF SCI, V230, P418, DOI 10.1016/j.apsusc.2004.03.203; Collart-Dutilleul PY, 2014, NANOSCALE RES LETT, V9, DOI 10.1186/1556-276X-9-564; Dhanekar S, 2013, BIOSENS BIOELECTRON, V41, P54, DOI 10.1016/j.bios.2012.09.045; Dzhafarov T., 2014, HDB POROUS SILICON P, P945; Foll H, 2002, MAT SCI ENG R, V39, P93, DOI 10.1016/S0927-796X(02)00090-6; Hamammu IM, 2011, AIP CONF PROC, V1341, P332, DOI 10.1063/1.3587013; Harraz FA, 2014, SENSOR ACTUAT B-CHEM, V202, P897, DOI 10.1016/j.snb.2014.06.048; Hernandez-Montelongo J, 2015, FRONT BIOENG BIOTECH, V3, DOI 10.3389/fbioe.2015.00060; Jane A, 2009, TRENDS BIOTECHNOL, V27, P230, DOI 10.1016/j.tibtech.2008.12.004; Jenie SNA, 2015, BIOSENS BIOELECTRON, V74, P637, DOI 10.1016/j.bios.2015.07.025; Katti DR, 2015, MAT SCI ENG C-MATER, V46, P207, DOI 10.1016/j.msec.2014.07.057; Kholostov K, 2015, MATER SCI ENG B-ADV, V194, P78, DOI 10.1016/j.mseb.2015.01.002; Kim H-S, 2014, BIOMED RES INT, V2014, P7, DOI DOI 10.3947/IC.2014.46.2.94; LEHMANN V, 1991, APPL PHYS LETT, V58, P856, DOI 10.1063/1.104512; Lin VSY, 1997, SCIENCE, V278, P840, DOI 10.1126/science.278.5339.840; Liu H, 2005, APPL PHYS LETT, V87, DOI 10.1063/1.2158021; Milani SHD, 2006, J OPTOELECTRON ADV M, V8, P1216; Naglieri V, 2013, ACTA MATER, V61, P6948, DOI 10.1016/j.actamat.2013.08.006; Nayef U.M., 2013, INT J BASIC APPL SCI, V13, P15; Ohji H, 2000, SENSOR ACTUAT A-PHYS, V82, P254, DOI 10.1016/S0924-4247(99)00341-6; Premnath P, 2012, BIORESEARCH OPEN ACC, V1, P231, DOI 10.1089/biores.2012.0254; Qu YQ, 2010, J MATER CHEM, V20, P3590, DOI 10.1039/c0jm00493f; Sanosh KP, 2009, B MATER SCI, V32, P465, DOI 10.1007/s12034-009-0069-x; Sygnatowicz M, 2010, JOM-US, V62, P65, DOI 10.1007/s11837-010-0111-x; Sygnatowicz M, 2009, MAT SCI ENG C-BIO S, V29, P1071, DOI 10.1016/j.msec.2008.08.036; Thakur M, 2012, J POWER SOURCES, V205, P426, DOI 10.1016/j.jpowsour.2012.01.058; TURNER DR, 1958, J ELECTROCHEM SOC, V105, P402, DOI 10.1149/1.2428873; UHLIR A, 1956, AT&T TECH J, V35, P333, DOI 10.1002/j.1538-7305.1956.tb02385.x; Vendamani VS, 2015, NUCL INSTRUM METH B, V358, P105, DOI 10.1016/j.nimb.2015.05.040; Wei YL, 2015, APPL SURF SCI, V353, P79, DOI 10.1016/j.apsusc.2015.06.064; Yaakob S., 2012, J PHYS SCI, V23, P17; Zhang YB, 2016, OPTIK, V127, P3009, DOI 10.1016/j.ijleo.2015.12.020	36	3	3	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 14	2017	12	3							e0173118	10.1371/journal.pone.0173118	http://dx.doi.org/10.1371/journal.pone.0173118			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN6DM	28291792	Green Published, Green Submitted, gold			2022-12-27	WOS:000396094700013
J	Oesch, L; Tatlisumak, T; Arnold, M; Sarikaya, H				Oesch, Lisa; Tatlisumak, Turgut; Arnold, Marcel; Sarikaya, Hakan			Obesity paradox in stroke - Myth or reality? A systematic review	PLOS ONE			English	Review							BODY-MASS INDEX; ACUTE ISCHEMIC-STROKE; INITIAL NEUROLOGICAL SEVERITY; CORONARY-ARTERY-DISEASE; INTRAVENOUS THROMBOLYSIS; POSTSTROKE MORTALITY; REVERSE EPIDEMIOLOGY; WAIST CIRCUMFERENCE; HEART-FAILURE; RISK-FACTORS	Background and purpose Both stroke and obesity show an increasing incidence worldwide. While obesity is an established risk factor for stroke, its influence on outcome in ischemic stroke is less clear. Many studies suggest a better prognosis in obese patients after stroke ("obesity paradox"). This review aims at assessing the clinical outcomes of obese patients after stroke by performing a systematic literature search. Methods The reviewers searched MEDLINE from inception to December 2015. Studies were eligible if they included outcome comparisons in stroke patients with allocation to body weight. Results Twenty-five studies (299'750 patients) were included and none was randomised. Ten of 12 studies (162'921 patients) reported significantly less mortality rates in stroke patients with higher BMI values. Seven of 9 studies (92'718 patients) ascertained a favorable effect of excess body weight on non-fatal outcomes (good clinical outcome, recurrence of vascular events). Six studies (85'042 patients) indicated contradictory results after intravenous thrombolysis (IVT), however. Several methodological limitations were observed in major part of studies (observational study design, inaccuracy of BMI in reflecting obesity, lacking body weight measurement, selection bias, survival bias). Conclusion Most observational data indicate a survival benefit of obese patients after stroke, but a number of methodological concerns exist. No obesity paradox was observed in patients after IVT. There is a need for well-designed randomized controlled trials assessing the effects of weight reduction on stroke risk in obese patients.	[Oesch, Lisa; Arnold, Marcel; Sarikaya, Hakan] Univ Hosp Bern, Dept Neurol, Stroke Ctr, Bern, Switzerland; [Tatlisumak, Turgut] Univ Gothenburg, Sahlgrenska Acad, Inst Neurosci & Physiol, Dept Clin Neurosci, Gothenburg, Sweden	University of Bern; University Hospital of Bern; University of Gothenburg	Sarikaya, H (corresponding author), Univ Hosp Bern, Dept Neurol, Stroke Ctr, Bern, Switzerland.	hakan.sarikaya@insel.ch			Swiss National Science Foundation; Swiss Heart Foundation; Bangerter Foundation; Hermann Klaus Foundation	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); Swiss Heart Foundation; Bangerter Foundation; Hermann Klaus Foundation	Hakan Sarikaya was supported by research grants from Swiss National Science Foundation, Swiss Heart Foundation, Bangerter Foundation and Hermann Klaus Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amundson DE, CRITICAL CARE CLIN, V26, P583; Andersen KK, 2015, INT J STROKE, V10, P99, DOI 10.1111/ijs.12016; Andersen KK, 2013, J STROKE CEREBROVASC, V22, pE576, DOI 10.1016/j.jstrokecerebrovasdis.2013.06.031; Bazzano LA, 2010, ANN NEUROL, V67, P11, DOI 10.1002/ana.21950; Bell CL, 2013, J AM GERIATR SOC, V61, P1324, DOI 10.1111/jgs.12361; Breuer L, 2010, STROKE, V41, P2867, DOI 10.1161/STROKEAHA.110.578062; Burke DT, 2014, ARCH PHYS MED REHAB, V95, P1055, DOI 10.1016/j.apmr.2014.01.019; CHARLSON ME, 1987, J CHRON DIS, V40, P373, DOI 10.1016/0021-9681(87)90171-8; Curioni C, 2006, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD006062.pub2; Dehlendorff C, 2014, JAMA NEUROL, V71, P978, DOI 10.1001/jamaneurol.2014.1017; Diedler J, 2011, STROKE, V42, P1615, DOI 10.1161/STROKEAHA.110.603514; Doehner W, 2013, EUR HEART J, V34, P268, DOI 10.1093/eurheartj/ehs340; Doehner W, 2010, EUR HEART J, V31, P146, DOI 10.1093/eurheartj/ehp339; Dorner TE, 2010, DEUT MED WOCHENSCHR, V135, P413, DOI 10.1055/s-0030-1249178; Eriksson P, 1998, DIABETOLOGIA, V41, P65, DOI 10.1007/s001250050868; Escalante A, 2005, ARCH INTERN MED, V165, P1624, DOI 10.1001/archinte.165.14.1624; Fonarow GC, 2007, AM HEART J, V153, P74, DOI 10.1016/j.ahj.2006.09.007; Grau AJ, 2001, STROKE, V32, P2559, DOI 10.1161/hs1101.098524; Hassan AE, 2013, J STROKE CEREBROVASC, V22, P545, DOI 10.1016/j.jstrokecerebrovasdis.2013.01.022; Hastie CE, 2010, EUR HEART J, V31, P222, DOI 10.1093/eurheartj/ehp317; HILL AB, 1965, P ROY SOC MED, V58, P295, DOI 10.1177/003591576505800503; Hu G, 2007, ARCH INTERN MED, V167, P1420, DOI 10.1001/archinte.167.13.1420; HUBERT HB, 1983, CIRCULATION, V67, P968, DOI 10.1161/01.CIR.67.5.968; Janssen I, 2005, J AM GERIATR SOC, V53, P2112, DOI 10.1111/j.1532-5415.2005.00505.x; Kalantar-Zadeh K, 2003, KIDNEY INT, V63, P793, DOI 10.1046/j.1523-1755.2003.00803.x; Kalantar-Zadeh K, 2007, CURR OPIN CLIN NUTR, V10, P433, DOI 10.1097/MCO.0b013e3281a30594; Kim BJ, 2011, NEUROLOGY, V76, P567, DOI 10.1212/WNL.0b013e31820b7667; Kim BJ, 2012, NEUROLOGY, V79, P856, DOI 10.1212/WNL.0b013e318266fad1; Kim CK, 2013, BMC NEUROL, V13, DOI 10.1186/1471-2377-13-123; Kim Y, 2015, J NEUROL NEUROSUR PS, V86, P743, DOI 10.1136/jnnp-2014-308664; Kurth T, 2002, ARCH INTERN MED, V162, P2557, DOI 10.1001/archinte.162.22.2557; Landbo C, 1999, AM J RESP CRIT CARE, V160, P1856, DOI 10.1164/ajrccm.160.6.9902115; Lewis CE, 2009, CIRCULATION, V119, P3263, DOI 10.1161/CIRCULATIONAHA.109.192574; Olsen TS, 2008, NEUROEPIDEMIOLOGY, V30, P93, DOI 10.1159/000118945; Oreopoulos A, 2008, AM HEART J, V156, P13, DOI 10.1016/j.ahj.2008.02.014; Ovbiagele B, 2011, STROKE, V42, P3397, DOI 10.1161/STROKEAHA.111.624957; Razinia T, 2007, ARCH NEUROL-CHICAGO, V64, P388, DOI 10.1001/archneur.64.3.388; Romero-Corral A, 2008, INT J OBESITY, V32, P959, DOI 10.1038/ijo.2008.11; Romero-Corral A, 2006, LANCET, V368, P666, DOI 10.1016/S0140-6736(06)69251-9; Ryu WS, 2011, CEREBROVASC DIS, V32, P170, DOI 10.1159/000328250; Sarikaya H, 2011, CEREBROVASC DIS, V32, P201, DOI 10.1159/000328813; Sarikaya H, 2011, STROKE, V42, P2330, DOI 10.1161/STROKEAHA.110.599613; Scherbakov N, 2011, STROKE, V42, P3646, DOI 10.1161/STROKEAHA.111.619163; Seet RCS, 2014, J STROKE CEREBROVASC, V23, P1, DOI 10.1016/j.jstrokecerebrovasdis.2012.04.001; Seo JH, 2013, J NEUROCRITICAL CARE, V6, P92; Skolarus LE, 2014, CIRC-CARDIOVASC QUAL, V7, P64, DOI 10.1161/CIRCOUTCOMES.113.000129; Song YM, 2004, STROKE, V35, P831, DOI 10.1161/01.STR.0000119386.22691.1C; Stein PD, 2005, AM J MED, V118, P978, DOI 10.1016/j.amjmed.2005.03.012; Steinberg BA, 2007, AM J CARDIOL, V100, P1331, DOI 10.1016/j.amjcard.2007.06.019; Strazzullo P, 2010, STROKE, V41, pE418, DOI 10.1161/STROKEAHA.109.576967; Towfighi A, 2009, STROKE, V40, P2704, DOI 10.1161/STROKEAHA.109.550228; Vemmos K, 2011, STROKE, V42, P30, DOI 10.1161/STROKEAHA.110.593434; Yatsuya H, 2010, STROKE, V41, P417, DOI 10.1161/STROKEAHA.109.566299; Zhao L, 2014, J STROKE CEREBROVASC, V23, pE201, DOI 10.1016/j.jstrokecerebrovasdis.2013.10.002	54	68	70	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 14	2017	12	3							e0171334	10.1371/journal.pone.0171334	http://dx.doi.org/10.1371/journal.pone.0171334			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN6DM	28291782	gold, Green Submitted, Green Published			2022-12-27	WOS:000396094700002
J	Hua, ZL; Zheng, XZ; Xue, HC; Wang, JM; Yao, J				Hua, Zhaolai; Zheng, Xianzhi; Xue, Hengchuan; Wang, Jianming; Yao, Jun			Long-term trends and survival analysis of esophageal and gastric cancer in Yangzhong, 1991-2013	PLOS ONE			English	Article							RISK; CARCINOMA; SHANGHAI; STOMACH; COHORT; DIET	Objective To describe the long-term trends of the incidence, mortality and survival of upper digestive tract cancers in a high-risk area of China. Methods We extracted esophageal and gastric cancer cases diagnosed from 1991 to 2013 through the Yangzhong Cancer Registry and calculated the crude and age-standardized incidence and mortality rates. Cancer trends were calculated using the Joinpoint Regression Program and were reported using the annual percentage change (APC). The cancer-specific survival rates were evaluated and compared between groups using the Kaplan-Meier method and log-rank test. Results The age-standardized incidence rate of esophageal cancer declined from 107.06 per 100,000 person-years (male: 118.05 per 100,000 person-years; female: 97.42 per 100,000 person-years) in 1991 to 37.04 per 100,000 person-years (male: 46.43 per 100,000 person-years; female: 27.26 per 100,000 person-years) in 2013, with an APC of -2.5% (95% confidence interval (CI): -3.4%, -1.5%) for males and -4.9% (95% CI:-5.8%, -3.9%) for females. The age-standardized incidence rate of gastric cancer was 165.11 per 100,000 person-years (male: 225.39 per 100,000 person-years; female: 113.34 per 100,000 person-years) in 1991 and 53.46 per 100,000 person-years (male: 76.51 per 100,000 person-years; female: 32.43 per 100,000 person-years) in 2013, with the APC of -3.6% (95% CI: -4.5%, -2.7%) for males and -4.8% (95% CI: -5.7%, -3.9%) for females. The median survival time was 3.0 years for patients with esophageal or gastric cancer. Cancer cases detected after 2004 had a better prognosis. Conclusions The age-standardized incidence rates of both esophageal and gastric cancer continuously decreased since 1991 through 2013, whereas the mortality rate remained stable before 2004 and significantly declined following the massive endoscopic screening program initiated in 2004. The survival probability of patients with esophageal and gastric cancer has improved obviously in recent decades.	[Hua, Zhaolai] Yangzhong Canc Res Inst, Dept Epidemiol, Yangzhong, Peoples R China; [Hua, Zhaolai; Zheng, Xianzhi; Wang, Jianming] Nanjing Med Univ, Sch Publ Hlth, Dept Epidemiol, Nanjing, Jiangsu, Peoples R China; [Xue, Hengchuan] Peoples Hosp Yangzhong, Dept Thorac Surg, Yangzhong, Peoples R China; [Wang, Jianming] Nanjing Med Univ, Sch Publ Hlth, Innovat Ctr Social Risk Governance Hlth, Nanjing, Jiangsu, Peoples R China; [Yao, Jun] Zhenjiang First Peoples Hosp, Dept Gastroenterol, Zhenjiang, Peoples R China	Nanjing Medical University; Nanjing Medical University	Wang, JM (corresponding author), Nanjing Med Univ, Sch Publ Hlth, Dept Epidemiol, Nanjing, Jiangsu, Peoples R China.; Wang, JM (corresponding author), Nanjing Med Univ, Sch Publ Hlth, Innovat Ctr Social Risk Governance Hlth, Nanjing, Jiangsu, Peoples R China.; Yao, J (corresponding author), Zhenjiang First Peoples Hosp, Dept Gastroenterol, Zhenjiang, Peoples R China.	jmwang@njmu.edu.cn; 13952943749@163.com		Wang, Jianming/0000-0002-9151-284X	National Natural Science Foundation of China [81673249]; Qing Lan Project; Social Development Project of Zhenjiang [SH2016048]; Priority Academic Program Development of Jiangsu Higher Education Institutions (PAPD); Medical Science and Technology Development Foundation; Jiangsu Province Department of Health [Y201313]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Qing Lan Project(Jiangsu Polytech Institute); Social Development Project of Zhenjiang; Priority Academic Program Development of Jiangsu Higher Education Institutions (PAPD); Medical Science and Technology Development Foundation; Jiangsu Province Department of Health	This study was supported by the National Natural Science Foundation of China (81673249), Qing Lan Project (2014), Social Development Project of Zhenjiang (SH2016048), Priority Academic Program Development of Jiangsu Higher Education Institutions (PAPD), and Medical Science and Technology Development Foundation, Jiangsu Province Department of Health (Y201313). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abnet CC, 2015, GASTROENTEROLOGY, V148, P1234, DOI 10.1053/j.gastro.2015.02.007; Bao PP, 2016, BMC CANCER, V16, DOI 10.1186/s12885-016-2313-2; Chen V., 1994, COMPARABILITY QUALIT; Chen WQ, 2016, CA-CANCER J CLIN, V66, P115, DOI 10.3322/caac.21338; Chen XZ, 2016, LANCET S1, V388, pS40; Cook MB, 2009, BRIT J CANCER, V101, P855, DOI 10.1038/sj.bjc.6605246; di Pietro M, 2015, GASTROENTEROLOGY, V148, P912, DOI 10.1053/j.gastro.2015.02.012; Ferlay J, 2005, IARC IACR TOOLS CANC; Gallagher LG, 2015, AM J IND MED, V58, P267, DOI 10.1002/ajim.22412; Ilbawi AM, 2015, SCI TRANSL MED, V7, DOI 10.1126/scitranslmed.3008853; Kato M, 2013, GUT, V62, P1425, DOI 10.1136/gutjnl-2011-301647; Lagergren J, 2013, CA-CANCER J CLIN, V63, P232, DOI 10.3322/caac.21185; Lansdorp-Vogelaar I, 2016, GUT, V65, P543, DOI 10.1136/gutjnl-2015-310356; Maruthappu M, 2016, LANCET, V388, P684, DOI 10.1016/S0140-6736(16)00577-8; Murphy G, 2011, GUT, V60, P618, DOI 10.1136/gut.2010.225854; Organization WH, 1992, ICD 10 INT STAT CLAS, V1; Pasechnikov V, 2014, WORLD J GASTROENTERO, V20, P13842, DOI 10.3748/wjg.v20.i38.13842; Peeters A, 2011, EUR J EPIDEMIOL, V26, P369, DOI 10.1007/s10654-011-9546-9; Pennathur A, 2013, LANCET, V381, P400, DOI 10.1016/S0140-6736(12)60643-6; Pourhoseingholi Mohamad Amin, 2015, Gastroenterol Hepatol Bed Bench, V8, P19; Sun P, 2016, ONCOTARGET, V7, P42650, DOI 10.18632/oncotarget.9516; Torre LA, 2015, CA-CANCER J CLIN, V65, P87, DOI 10.3322/caac.21262; Van Cutsem E, 2016, LANCET, V388, P2654, DOI 10.1016/S0140-6736(16)30354-3; Veitch AM, 2015, NAT REV GASTRO HEPAT, V12, P660, DOI 10.1038/nrgastro.2015.128; Wang JM, 2007, EUR J GASTROEN HEPAT, V19, P171, DOI 10.1097/MEG.0b013e32800ff77a; Wang JM, 2005, EUR J GASTROEN HEPAT, V17, P1339, DOI 10.1097/00042737-200512000-00012; Ward ST, 2016, GUT; Yu HJ, 2011, BIOMED ENVIRON SCI, V24, P268, DOI 10.3967/0895-3988.2011.03.010; Zhao P, 2010, JPN J CLIN ONCOL, V40, P281, DOI 10.1093/jjco/hyp187; Zheng XQ, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0117773; Zhou MG, 2016, LANCET, V387, P251, DOI 10.1016/S0140-6736(15)00551-6	31	7	10	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 13	2017	12	3							e0173896	10.1371/journal.pone.0173896	http://dx.doi.org/10.1371/journal.pone.0173896			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN6CP	28288195	Green Published, Green Submitted, gold			2022-12-27	WOS:000396092400040
J	Simonetti, A; Ezzeldin, H; Menis, M; McKean, S; Izurieta, H; Anderson, SA; Forshee, RA				Simonetti, Arianna; Ezzeldin, Hussein; Menis, Mikhail; McKean, Stephen; Izurieta, Hector; Anderson, Steven A.; Forshee, Richard A.			Modeling the potential impact on the US blood supply of transfusing critically ill patients with fresher stored red blood cells	PLOS ONE			English	Article							STORAGE DURATION; AGE; MORTALITY; LENGTH; STAY	Background Although some studies have suggested that transfusion recipients may have better medical outcomes if transfused with red blood cell units stored for a short time, the overall body of evidence shows mixed results. It is important to understand how using fresher stored red blood cell units for certain patient groups may affect blood availability. Methods Based on the Stock-and-Flow simulation model of the US blood supply developed by Simonetti et al. 2014, we evaluated a newly implemented allocation method of preferentially transfusing fresher stored red blood cell units to a subset of high-risk group of critically ill patients and its potential impact on supply. Results Simulation results showed that, depending on the scenario, the US blood total supply might be reduced between 2-42%, when compared to the standard of care in transfusion medicine practice. Among our simulated scenarios, we observed that the number of expired red blood cell units modulated the supply levels. The age threshold of the required red blood cell units was inversely correlated with both the supply levels and the number of transfused units that failed to meet that age threshold. Conclusion To our knowledge, this study represents the first attempt to develop a comprehensive framework to evaluate the impact of preferentially transfusing fresher stored red blood cells to the higher-risk critically ill patients on supply. Model results show the difficulties to identify an optimal scenario.	[Simonetti, Arianna; Ezzeldin, Hussein; Menis, Mikhail; Izurieta, Hector; Anderson, Steven A.; Forshee, Richard A.] US FDA, Off Biostat & Epidemiol, Ctr Biol Evaluat & Res, Silver Spring, MD 20993 USA; [McKean, Stephen] Acumen LLC, Burlingame, CA USA	US Food & Drug Administration (FDA)	Simonetti, A (corresponding author), US FDA, Off Biostat & Epidemiol, Ctr Biol Evaluat & Res, Silver Spring, MD 20993 USA.	Arianna.Simonetti@fda.hhs.gov		Simonetti, Arianna/0000-0003-4711-7858	OBE from MCMi [Z01BS03005-03]; internal FDA/CBER; Research Participation Program at the Center for Biologics Evaluation and Research; Oak Ridge Institute for Science and Education through an interagency agreement between the US Department of Energy; US Food and Drug Administration	OBE from MCMi; internal FDA/CBER; Research Participation Program at the Center for Biologics Evaluation and Research; Oak Ridge Institute for Science and Education through an interagency agreement between the US Department of Energy(United States Department of Energy (DOE)); US Food and Drug Administration	This research was supported in the form of grant n. Z01BS03005-03 OBE from MCMi and by internal FDA/CBER funding. This project was also supported in part by the Research Participation Program at the Center for Biologics Evaluation and Research administered by the Oak Ridge Institute for Science and Education through an interagency agreement between the US Department of Energy and the US Food and Drug Administration (HE). Furthermore, Acumen LLC provided support in the form of salary for author SM. The funders did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Anderson SA, 2007, TRANSFUSION, V47, P582, DOI 10.1111/j.1537-2995.2007.01159.x; Atkinson MP, 2012, TRANSFUSION, V52, P108, DOI 10.1111/j.1537-2995.2011.03239.x; Aubron C, 2013, ANN INTENSIVE CARE, V3, DOI 10.1186/2110-5820-3-2; Blood Centers of the Pacific Community Blood Center of Greater Kansas City Mississippi Valley Regional Blood Center New York Blood Center and South Texas Blood and Tissue Center, 2010, NEW YORK BLOOD CTR S; Centers for Medicare & Medicaid Services, 2013, FIL ORD GEN INF; Centers for Medicare & Medicaid Services, 2012, MED PROGR GEN INF; Hart AC, 2004, ICD 9 CM EXPERT HOSP; Keller ME, 2002, J TRAUMA, V53, P1023, DOI 10.1097/00005373-200211000-00037; Koch CG, 2013, ANN THORAC SURG, V96, P1894, DOI 10.1016/j.athoracsur.2013.05.116; Koch CG, 2008, NEW ENGL J MED, V358, P1229, DOI 10.1056/NEJMoa070403; Lacroix J, 2015, NEW ENGL J MED, V372, P1410, DOI 10.1056/NEJMoa1500704; Lelubre C, 2013, CRIT CARE, V17, DOI 10.1186/cc12600; Lelubre C, 2011, ANN INTENSIVE CARE, V1, DOI 10.1186/2110-5820-1-43; Mattison M., 2013, HOSP MANAGEMENT OLDE; Murrell Z, 2005, AM SURGEON, V71, P781; Offner PJ, 2002, ARCH SURG-CHICAGO, V137, P711, DOI 10.1001/archsurg.137.6.711; Pettila V, 2011, CRIT CARE, V15, DOI 10.1186/cc10142; Services UDoHaH, 2013, 2011 NATL BLOOD COLL; Simonetti A, 2014, TRANSFUSION, V54, P828, DOI 10.1111/trf.12392; Spinella PC, 2009, CRIT CARE, V13, DOI 10.1186/cc8050; Steiner ME, 2015, NEW ENGL J MED, V372, P1419, DOI 10.1056/NEJMoa1414219; Vyrostek S.B., 2001, MMWR SURVEILL SUMM, V53, P1; Weinberg JA, 2008, J TRAUMA, V65, P794, DOI 10.1097/TA.0b013e318184aa11; Weinberg JA, 2008, J TRAUMA, V65, P279, DOI 10.1097/TA.0b013e31817c9687; White A, SHOULD PATIENTS ONLY; Zallen G, 1999, AM J SURG, V178, P570, DOI 10.1016/S0002-9610(99)00239-1	26	3	3	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 20	2017	12	3							e0174033	10.1371/journal.pone.0174033	http://dx.doi.org/10.1371/journal.pone.0174033			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ER6VC	28319164	Green Submitted, Green Published, gold			2022-12-27	WOS:000398945800044
J	Austin, AW; Pelletier, R; Pilote, L; Rabi, DM				Austin, Anthony W.; Pelletier, Roxanne; Pilote, Louise; Rabi, Doreen M.		GENESIS-PRAXY Investigators	Factors associated with study completion in patients with premature acute coronary syndrome	PLOS ONE			English	Article							SOCIAL-STATUS; ATTRITION; PARTICIPATION; DEPRESSION; PREDICTORS; RETENTION; SMOKING; HEALTH	Background Factors associated with study completion in younger adults are not well understood. This study sought to describe psychosocial, clinical, and demographic features associated with completion of a study of men and women with premature acute coronary syndrome. Methods As part of the GENdEr and Sex determInantS of cardiovascular disease: From bench to beyond-Premature Acute Coronary Syndrome (GENESIS-PRAXY) study, demographic, psychosocial, and clinical variables were assessed in 1213 patients hospitalized for acute coronary syndrome (<= 55 years; 30% women). Patients were followed for 12 months. Dropouts withdrew from the study or were lost to follow-up after 12 months; completers were still enrolled after 12 months. Results Of 1213 patients initially enrolled, 777 (64.1%) completed 12-month follow-up. Fully adjusted models suggested that being older (OR = 1.04, 95% CI [1.01, 1.06]), higher subjective social status within one's country (OR = 1.11, 95% CI [1.01, 1.22]), being free of type II diabetes, (OR = 0.66, 95% CI [0.45, 0.97]), non-smoking status (OR = 0.70, 95% CI [0.51, 0.95]) and being free of depression (OR = 1.52, 95% CI [1.11, 2.07]) were independently associated with study completion. Conclusions Recruitment/retention strategies targeting individuals who smoke, are younger, have low subjective social status within one's country, have diabetes, or have depression may improve participant follow-up in cardiovascular cohort studies.	[Austin, Anthony W.] Univ Arkansas Pine Bluff, Dept Social & Behav Sci, Pine Bluff, AR USA; [Pelletier, Roxanne] Ctr Psychol Fil Maux, Montreal, PQ, Canada; [Pilote, Louise] McGill Univ Hlth Ctr, Div Gen Internal Med & Clin Epidemiol, Montreal, PQ, Canada; [Rabi, Doreen M.] Univ Calgary, Dept Med, Calgary, AB, Canada; [Rabi, Doreen M.] Univ Calgary, Dept Community Hlth, Calgary, AB, Canada; [Rabi, Doreen M.] Univ Calgary, Dept Cardiol Sci, Calgary, AB, Canada	University of Arkansas System; University Arkansas Pine Bluff; McGill University; University of Calgary; University of Calgary; University of Calgary	Rabi, DM (corresponding author), Univ Calgary, Dept Med, Calgary, AB, Canada.; Rabi, DM (corresponding author), Univ Calgary, Dept Community Hlth, Calgary, AB, Canada.; Rabi, DM (corresponding author), Univ Calgary, Dept Cardiol Sci, Calgary, AB, Canada.	Doreen.Rabi@albertahealthservices.ca	Stark, Ken D/I-1347-2016; Austin, Anthony/U-7709-2019; Bacon, Simon/B-2637-2012	Stark, Ken D/0000-0001-7828-4072; Austin, Anthony/0000-0002-3275-5948; Norris, Colleen/0000-0002-6793-9333; Bacon, Simon/0000-0001-7075-0358; Cox, Jafna/0000-0001-7908-5323; Pilote, Louise/0000-0002-6159-0628; Lavoie, Kim/0000-0003-2606-1357; Engert, James/0000-0001-8411-4790	Canadian Institutes of Health Research [200804MOP-190260-GSH-CFAC-40513, OR-201303, CFE-113622]; Heart and Stroke Foundation of Quebec, Canada; Heart and Stroke Foundation of Nova Scotia, Canada; Heart and Stroke Foundation of Alberta, Canada; Heart and Stroke Foundation of Ontario, Canada; Heart and Stroke Foundation of Yukon, Canada; Heart and Stroke Foundation of British Columbia, Canada; Fonds de recherche du Quebec - Sante (FRQS) award	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Heart and Stroke Foundation of Quebec, Canada; Heart and Stroke Foundation of Nova Scotia, Canada; Heart and Stroke Foundation of Alberta, Canada; Heart and Stroke Foundation of Ontario, Canada(Heart & Stroke Foundation of Ontario); Heart and Stroke Foundation of Yukon, Canada; Heart and Stroke Foundation of British Columbia, Canada; Fonds de recherche du Quebec - Sante (FRQS) award	This work was supported by the Canadian Institutes of Health Research [grant number 200804MOP-190260-GSH-CFAC-40513; http://www.cihr-irsc.gc.ca/e/193.html] and Heart and Stroke Foundations of Quebec, Nova Scotia, Alberta, Ontario, Yukon, and British Columbia, Canada (http://www.heartandstroke.com). Dr. Austin and Dr. Pelletier were supported by the Canadian Institutes of Health Research [grant number OR-201303 to A.W.A. and grant number CFE-113622 to R.P.; http://www.cihr-irsc.gc.ca/e/193.html]. Dr. Pilote was supported by the Fonds de recherche du Quebec - Sante (FRQS) award (http://www.frqs.gouv.qc.ca/en/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adler N, 2008, SOC SCI MED, V66, P1034, DOI 10.1016/j.socscimed.2007.11.031; Adler NE, 2000, HEALTH PSYCHOL, V19, P586, DOI 10.1037/0278-6133.19.6.586; American Psychiatric Association, 2000, DIAGN STAT MAN MENT; Anderson B, 2007, AM J MANAG CARE, V13, pS103; Bambs CE, 2013, ANN EPIDEMIOL, V23, P328, DOI 10.1016/j.annepidem.2013.02.007; BEM SL, 1974, J CONSULT CLIN PSYCH, V42, P155, DOI 10.1037/h0036215; Bhamra S, 2008, QUAL AGEING OLDER AD, V9, P27, DOI 10.1108/14717794200800025; Chatfield MD, 2005, J CLIN EPIDEMIOL, V58, P13, DOI 10.1016/j.jclinepi.2004.05.006; Clark MM, 1996, ADDICT BEHAV, V21, P509, DOI 10.1016/0306-4603(95)00081-X; Damen NL, 2015, EUR J PREV CARDIOL, V22, P196, DOI 10.1177/2047487313506548; Galea S, 2007, ANN EPIDEMIOL, V17, P643, DOI 10.1016/j.annepidem.2007.03.013; Gustavson K, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-918; Hartge P, 2006, EPIDEMIOLOGY, V17, P252, DOI 10.1097/01.ede.0000209441.24307.92; Kristman V, 2004, EUR J EPIDEMIOL, V19, P751, DOI 10.1023/B:EJEP.0000036568.02655.f8; Lee CS, 2010, HEALTH EDUC RES, V25, P687, DOI 10.1093/her/cyq010; Marcellus Lenora, 2004, Can J Nurs Res, V36, P82; Morton LM, 2006, AM J EPIDEMIOL, V163, P197, DOI 10.1093/aje/kwj036; Naderi S, 2013, J COMMUN HEALTH, V38, P458, DOI 10.1007/s10900-012-9644-y; Organization for Economic Co-Operation and Development, 2012, OECD STATEXTRACTS 20; Pilote L, 2012, AM HEART J, V163, P741, DOI 10.1016/j.ahj.2012.01.022; Statistics Canada, 2013, LOW INC CUT OFFS 199; ZIGMOND AS, 1983, ACTA PSYCHIAT SCAND, V67, P361, DOI 10.1111/j.1600-0447.1983.tb09716.x	22	1	2	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 16	2017	12	3							e0173594	10.1371/journal.pone.0173594	http://dx.doi.org/10.1371/journal.pone.0173594			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EN9KE	28301532	Green Published, Green Submitted, gold			2022-12-27	WOS:000396318300054
J	He, XF; Ye, F; Zhao, BC; Tang, HL; Wang, J; Xiao, XS; Xie, XM				He, Xiaofang; Ye, Fen; Zhao, Bingcheng; Tang, Hailin; Wang, Jin; Xiao, Xiangsheng; Xie, Xiaoming			Risk factors for delay of adjuvant chemotherapy in non-metastatic breast cancer patients: A systematic review and meta-analysis involving 186982 patients	PLOS ONE			English	Article							RECONSTRUCTION; INITIATION; THERAPY; DIAGNOSIS; IMPACT; MASTECTOMY; EXPERIENCE; SURVIVAL; RECEIPT; SURGERY	Purpose Delay performance of adjuvant chemotherapy (AC) after surgery has been presented to affect survival of breast cancer patients adversely, but the risk factors for delay in initiation remain controversial. Therefore, we conducted this systematic review of the literature and meta-analysis aiming at identifying the risk factors for delay of adjuvant chemotherapy (DAC) in non-metastatic breast cancer patients. Methods The search was performed on PubMed, Embase, Chinese National Knowledge Infrastructure and Wanfang Database from inception up to July 2016. DAC was defined as receiving AC beyond 8-week after surgery. Data were combined and analyzed using random-effects model or fixed-effects model for risk factors considered by at least 3 studies. Heterogeneity was analyzed with meta-regression analysis of year of publication and sample size. Publication bias was studied with Egger's test. Results A total of 12 observational studies including 186982 non-metastatic breast cancer patients were eligible and 12 risk factors were analyzed. Combined results demonstrated that black race (vs white; OR, 1.18; 95% CI, 1.01 +/- 1.39), rural residents (vs urban; OR, 1.60; 95% CI, 1.27 +/- 2.03) and receiving mastectomy (vs breast conserving surgery; OR, 1.35; 95% CI, 1.00 +/- 1.83) were significantly associated with DAC, while married patients (vs single; OR, 0.58; 95% CI, 0.38 +/- 0.89) was less likely to have a delay in initiation. No significant impact from year of publication or sample size on the heterogeneity across studies was found, and no potential publication bias existed among the included studies. Conclusions Risk factors associated with DAC included black race, rural residents, receiving mastectomy and single status. Identifying of these risk factors could further help decisions making in clinical practice.	[He, Xiaofang; Ye, Fen; Tang, Hailin; Wang, Jin; Xiao, Xiangsheng; Xie, Xiaoming] Sun Yat Sen Univ Canc Ctr, Collaborat Innovat Ctr Canc Med, Dept Breast Oncol, State Key Lab Oncol South China, Guangzhou, Guangdong, Peoples R China; [Zhao, Bingcheng] Sun Yat Sen Univ, First Affiliated Hosp, Dept Anesthesiol, Guangzhou 510275, Guangdong, Peoples R China	State Key Lab Oncology South China; Sun Yat Sen University; Sun Yat Sen University	Xie, XM (corresponding author), Sun Yat Sen Univ Canc Ctr, Collaborat Innovat Ctr Canc Med, Dept Breast Oncol, State Key Lab Oncol South China, Guangzhou, Guangdong, Peoples R China.	xiexm@sysucc.org.cn	Zhao, Bingcheng/AAG-8383-2021; xiao, xiang/GWU-6035-2022		National Natural Science Foundation of China [81472575, 81272514, 81372133]; Key Program of the National Natural Science Foundation of China [31030061]; Science and Technology Planning Project of Guangdong and Guangzhou [2013B060300009, 2014J4100169]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Key Program of the National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Science and Technology Planning Project of Guangdong and Guangzhou	This study was supported by funds from the National Natural Science Foundation of China (81472575, 81272514, 81372133), the Key Program of the National Natural Science Foundation of China (31030061), the Science and Technology Planning Project of Guangdong and Guangzhou (2013B060300009,2014J4100169). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abe O, 2005, LANCET, V365, P1687, DOI 10.1016/s0140-6736(05)66544-0; Alderman AK, 2010, CANCER-AM CANCER SOC, V116, P1791, DOI 10.1002/cncr.24891; Balasubramanian BA, 2012, ETHNIC DIS, V22, P288; Barry PN, 2014, AM J CLIN ONCOL-CANC, V37, P575, DOI 10.1097/COC.0b013e318280d79f; Bickell NA, 2006, J CLIN ONCOL, V24, P1357, DOI 10.1200/JCO.2005.04.5799; Breen N, 1996, BREAST CANCER RES TR, V40, P105, DOI 10.1007/BF01806006; Coates AS, 2015, ANN ONCOL, V26, P1533, DOI 10.1093/annonc/mdv221; Cold S, 2005, BRIT J CANCER, V93, P627, DOI 10.1038/sj.bjc.6602734; Colleoni M, 2000, J CLIN ONCOL, V18, P584, DOI 10.1200/JCO.2000.18.3.584; Ejlertsen B, 2016, DAN MED J, V63; Ejlertsen B, 2014, ACTA ONCOL, V53, P174, DOI 10.3109/0284186X.2013.850738; Fedewa SA, 2010, J CLIN ONCOL, V28, P4135, DOI 10.1200/JCO.2009.27.2427; Freedman RA, 2013, HEALTH SERV RES, V48, P1669, DOI 10.1111/1475-6773.12063; Gagliato DD, 2014, J CLIN ONCOL, V32, P735, DOI 10.1200/JCO.2013.49.7693; Guidry JJ, 1997, CANCER PRACT, V5, P361; Gwyn K, 2004, CANCER, V100, P1595, DOI 10.1002/cncr.20169; Harmeling JX, 2015, BREAST CANCER RES TR, V153, P241, DOI 10.1007/s10549-015-3539-4; Herndon JE, 2013, PSYCHO-ONCOLOGY, V22, P315, DOI 10.1002/pon.2094; Hershman DL, 2006, BREAST CANCER RES TR, V99, P313, DOI 10.1007/s10549-006-9206-z; Jeevan R, 2015, BRIT J SURG, V102, P1064, DOI 10.1002/bjs.9847; Lipscomb J, 2012, BREAST CANCER RES TR, V133, P285, DOI 10.1007/s10549-011-1916-1; Lohrisch C, 2006, J CLIN ONCOL, V24, P4888, DOI 10.1200/JCO.2005.01.6089; Neal RD, 2005, BRIT J CANCER, V92, P1971, DOI 10.1038/sj.bjc.6602623; Olsen MA, 2008, ARCH SURG-CHICAGO, V143, P53, DOI 10.1001/archsurg.2007.11; Raphael MJ, 2016, BREAST CANC RES TREA, V8, P8; SAFER MA, 1979, MED CARE, V17, P11, DOI 10.1097/00005650-197901000-00002; Sanchez CJ, 2007, BREAST CANCER RES TR, V101, P215, DOI 10.1007/s10549-006-9282-0; Seneviratne S, 2014, BMC CANCER, V14, DOI 10.1186/1471-2407-14-839; Gorin SS, 2006, ARCH INTERN MED, V166, P2244, DOI 10.1001/archinte.166.20.2244; Sheppard VB, 2013, BREAST CANCER RES TR, V139, P207, DOI 10.1007/s10549-013-2520-3; Siegel RL, 2016, CA-CANCER J CLIN, V66, P7, DOI [10.3322/caac.21708, 10.3322/caac.21332, 10.3322/caac.21590]; Simon MS, 2012, INT J BREAST CANCER, V2012, DOI 10.1155/2012/453985; Stang A, 2010, EUR J EPIDEMIOL, V25, P603, DOI 10.1007/s10654-010-9491-z; Stroup DF, 2000, JAMA-J AM MED ASSOC, V283, P2008, DOI 10.1001/jama.283.15.2008; Takahashi N, 2014, BMJ OPEN, V4, DOI 10.1136/bmjopen-2014-004798	35	10	10	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 16	2017	12	3							e0173862	10.1371/journal.pone.0173862	http://dx.doi.org/10.1371/journal.pone.0173862			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN9KE	28301555	Green Published, gold, Green Submitted			2022-12-27	WOS:000396318300083
J	Li, J; Jin, ZH; Gao, YY; Zhou, L; Ge, XN; Guo, X; Han, J; Yang, HC				Li, Jie; Jin, Zhonghui; Gao, Yueyi; Zhou, Lei; Ge, Xinna; Guo, Xin; Han, Jun; Yang, Hanchun			Development of the full-length cDNA clones of two porcine epidemic diarrhea disease virus isolates with different virulence	PLOS ONE			English	Article							BACTERIAL ARTIFICIAL CHROMOSOME; INFECTIOUS CDNA; TRANSMISSIBLE GASTROENTERITIS; UNITED-STATES; CORONAVIRUS; PIGS; STRAIN; CHINA; MANIPULATION; PATHOGENESIS	The recently emerged highly virulent variants of porcine epidemic and diarrhea virus (PEDV) remain a huge threat to the worldwide swine industry. Here, we describe the development of a bacterial artificial chromosome (BAC) reverse genetics system for PEDV based on two recent Chinese field isolates, namely CHM2013 and BJ2011C. Phylogenetically, CHM2013 is closely related to the vaccine strain SM98 whereas the isolate BJ2011C belongs to the GIIb group, a cluster that contains many recent pandemic strains. The full-length cDNA clones of the two isolates were constructed into BAC under the control of CMV promoter. The rescued viruses rBJ2011C and rCHM2013 were found to replicate at the kinetics similar to their respective parental viruses in cell culture. When tested in the 2-day-old pig model, rBJ2011C caused severe diarrhea of piglets with extensive damages to the intestinal epithelium, leading to 100% fatality within 48 hours. In contrast, the rCHM2013-inoculated piglets all survived with only very minor tissue damage observed. Thus, we have successfully established a convenient platform for PEDV genome manipulation. This study also represents the first description of a DNA-launched reverse genetics system for the highly virulent PEDV.	[Han, Jun; Yang, Hanchun] China Agr Univ, Key Lab Anim Epidemiol & Zoonosis, Coll Vet Med, Minist Agr, Beijing, Peoples R China; China Agr Univ, State Key Lab Agrobiotechnol, Beijing, Peoples R China	China Agricultural University; Ministry of Agriculture & Rural Affairs; China Agricultural University	Han, J; Yang, HC (corresponding author), China Agr Univ, Key Lab Anim Epidemiol & Zoonosis, Coll Vet Med, Minist Agr, Beijing, Peoples R China.	hanx0158@cau.edu.cn; yanghanchun1@cau.edu.cn		Han, Jun/0000-0002-7104-7223; Zhou, Lei/0000-0002-8837-3965	National Key Research and Development Program [2016YFD0500101]; earmarked fund for Modern Agro-industry Technology Research System of China from the Chinese Ministry of Agriculture [CARS-36]	National Key Research and Development Program; earmarked fund for Modern Agro-industry Technology Research System of China from the Chinese Ministry of Agriculture	This work was supported by the National Key Research and Development Program (2016YFD0500101) (http://program.most.gov.cn/) and the earmarked fund for Modern Agro-industry Technology Research System of China (CARS-36) from the Chinese Ministry of Agriculture (http://www.moa.gov.cn/).	Almazan F, 2000, P NATL ACAD SCI USA, V97, P5516, DOI 10.1073/pnas.97.10.5516; Beall A, 2016, MBIO, V7, DOI 10.1128/mBio.01451-15; Brulois KF, 2012, J VIROL, V86, P9708, DOI 10.1128/JVI.01019-12; Chae C, 2000, VET REC, V147, P606, DOI 10.1136/vr.147.21.606; Cheun-Arom T, 2015, GENOME ANNOUNC, V3; Cima Greg, 2013, J Am Vet Med Assoc, V243, P469; de Arriba ML, 2002, VET IMMUNOL IMMUNOP, V85, P85, DOI 10.1016/S0165-2427(01)00417-2; Donaldson EF, 2008, J VIROL, V82, P11948, DOI 10.1128/JVI.01804-08; Fan BC, 2017, VIROLOGY, V500, P50, DOI 10.1016/j.virol.2016.10.011; Gao H, 2016, FRONT MED, P1; Gao YY, 2013, ARCH VIROL, V158, P711, DOI 10.1007/s00705-012-1541-2; Huang J.J., 1980, AGR SCI TECHNOL SHAN, V2, P42; Huang YW, 2013, MBIO, V4, DOI 10.1128/mBio.00737-13; Jengarn J, 2015, J GEN VIROL, V96, P2206, DOI 10.1099/vir.0.000184; Jung K, 2015, VET J, V204, P134, DOI 10.1016/j.tvjl.2015.02.017; Jung K, 2015, VET MICROBIOL, V178, P31, DOI 10.1016/j.vetmic.2015.04.022; Jung K, 2014, EMERG INFECT DIS, V20, P662, DOI 10.3201/eid2004.131685; Kocherhans R, 2001, VIRUS GENES, V23, P137, DOI 10.1023/A:1011831902219; Kweon CH, 1993, KOREAN J VET RES, V33, P249; Lai MMC, 1997, ADV VIRUS RES, V48, P1, DOI 10.1016/S0065-3527(08)60286-9; Lee C, 2015, VIROL J, V12, DOI 10.1186/s12985-015-0421-2; Lee S, 2014, EMERG INFECT DIS, V20, P1223, DOI 10.3201/eid2007.140294; Li CH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069997; Li L, 2013, MBIO, V4; Li WT, 2012, EMERG INFECT DIS, V18, P1350, DOI 10.3201/eid1808.120002; Li ZL, 2012, VIRUS GENES, V45, P181, DOI 10.1007/s11262-012-0735-8; Masuda T, 2015, ARCH VIROL, V160, P2565, DOI 10.1007/s00705-015-2522-z; Oldham J, 1972, PIG FARMING, V10, P72; Paarlberg PL, 2014, WORKING PAPERS, V14, P1; Park SJ, 2007, VIRUS GENES, V35, P321, DOI 10.1007/s11262-007-0096-x; Park S, 2014, EMERG INFECT DIS, V20, P2089, DOI 10.3201/eid2012.131642; PENSAERT MB, 1978, ARCH VIROL, V58, P243, DOI 10.1007/BF01317606; Pritchard GC, 1999, VET REC, V144, P616; Shibata I, 2000, VET MICROBIOL, V72, P173, DOI 10.1016/S0378-1135(99)00199-6; Song DS, 2007, RES VET SCI, V82, P134, DOI 10.1016/j.rvsc.2006.03.007; Song D, 2015, CLIN EXP VACCINE RES, V4, P166, DOI 10.7774/cevr.2015.4.2.166; Song D, 2012, VIRUS GENES, V44, P167, DOI 10.1007/s11262-012-0713-1; St-Jean JR, 2006, J VIROL, V80, P3670, DOI 10.1128/JVI.80.7.3670-3674.2006; Stevenson GW, 2013, J VET DIAGN INVEST, V25, P649, DOI 10.1177/1040638713501675; SUEYOSHI M, 1995, J COMP PATHOL, V113, P59, DOI 10.1016/S0021-9975(05)80069-6; Sun M, 2015, J CLIN MICROBIOL, V53, P1484, DOI 10.1128/JCM.02898-14; Sun RQ, 2012, EMERG INFECT DIS, V18, P161, DOI 10.3201/eid1801.111259; Suzuki T., 2016, J GEN VIROL; Vlasova AN, 2014, EMERG INFECT DIS, V20, P1620, DOI 10.3201/eid2010.140491; Wang D, 2016, VIRUS RES; Wang LY, 2014, EMERG INFECT DIS, V20, P917, DOI 10.3201/eid2005.140195; WOOD EN, 1977, VET REC, V100, P243, DOI 10.1136/vr.100.12.243; Xuan H, 1984, CHIN J VET SCI, V4, P202, DOI DOI 10.1292/JVMS.13-0539; Yount B, 2003, P NATL ACAD SCI USA, V100, P12995, DOI 10.1073/pnas.1735582100	49	16	17	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 16	2017	12	3							e0173998	10.1371/journal.pone.0173998	http://dx.doi.org/10.1371/journal.pone.0173998			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN9KE	28301551	gold, Green Submitted, Green Published			2022-12-27	WOS:000396318300109
J	Lotufo, FA; Parpinelli, MA; Osis, MJ; Surita, FG; Costa, ML; Cecatti, JG				Lotufo, Fatima Aparecida; Parpinelli, Mary Angela; Osis, Maria Jose; Surita, Fernanda Garanhani; Costa, Maria Laura; Cecatti, Jose Guilherme			Obstetrician's risk perception on the prescription of magnesium sulfate in severe preeclampsia and eclampsia: A qualitative study in Brazil	PLOS ONE			English	Article							HEALTH; AVAILABILITY; MANAGEMENT; REGIMENS; BARRIERS; CARE	Introduction Magnesium sulfate (MgSO4) is the drug of choice for the prevention and control of seizures in the management of severe preeclampsia/eclampsia. Several barriers have been iden-tified in the use of MgSO4, especially in low and middle-income settings. Objective To describe the obstetrician's perception on possible reasons for underutilizing magnesium sulfate to treat preeclampsia/eclampsia. Method A qualitative clinical study, based on phenomenological reference by semi-structured inter-views and open-ended discussions with obstetricians of the public healthcare system in pri-mary care units (PCU) and referral maternity hospitals (RMH), in a southeastern Brazilian city. Results Fear of drug toxicity was the major cause for not prescribing the medication in PCU. Fear was justified by insufficient technical, structural and organizational resources of healthcare facilities and by a shortage of physicians properly trained for adequate drug use. Conclusion Fear of toxicity of magnesium sulfate was the main barrier towards timely and proper drug use. Periodic skill development and training of obstetricians, along with integration of the medical team in the work environment may contribute to decrease fear, ensuring safety of drug prescription and thus possibly reducing adverse outcomes related to PE.	[Lotufo, Fatima Aparecida; Parpinelli, Mary Angela; Surita, Fernanda Garanhani; Costa, Maria Laura; Cecatti, Jose Guilherme] Univ Estadual Campinas, Sch Med Sci, Dept Obstet & Gynecol, Campinas, SP, Brazil; [Osis, Maria Jose] Univ Estadual Campinas, Sch Med Sci, Postgrad Program Obstet & Gynecol, Campinas, SP, Brazil	Universidade Estadual de Campinas; Universidade Estadual de Campinas	Parpinelli, MA (corresponding author), Univ Estadual Campinas, Sch Med Sci, Dept Obstet & Gynecol, Campinas, SP, Brazil.	parpinelli@caism.unicamp.br	Lotufo, Fátima/AFK-9571-2022; Cecatti, Jose Guilherme/M-5945-2013; Costa, Maria Laura/I-4980-2019; Surita, Fernanda Garanhani/H-9575-2012	Cecatti, Jose Guilherme/0000-0003-1285-8445; Costa, Maria Laura/0000-0001-8280-3234; Surita, Fernanda Garanhani/0000-0003-4335-0337				Abalos E, 2013, EUR J OBSTET GYN R B, V170, P1, DOI 10.1016/j.ejogrb.2013.05.005; Austin A, 2015, BMC PREGNANCY CHILDB, V15, DOI 10.1186/s12884-015-0493-4; Bardin L., 1977, ANAL OF CONTENT, V70; Bigdeli M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059158; Brasil. Brazilian Institute of Geography and Statistics, 2010 CENS; Brazil. Ministry of Health. Department of Informatics. Health information, HLTH INF VIT STAT MO; Bruyne P, 1982, DINAMICA PESQUISA CI; Campinas. Municipal Department of Health (Campinas), STRUCT UN HLTH SYST; Chaturvedi S, 2013, J HEALTH POPUL NUTR, V31, P86; DULEY L, 1995, LANCET, V345, P1455; Duley L, 2002, LANCET, V359, P1877, DOI 10.1016/s0140-6736(02)08778-0; Duley L, 2010, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD000025.pub2; Ekele B A, 2005, Afr J Reprod Health, V9, P128; Giordano JC, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0097401; Campos CJG, 2009, REV LAT-AM ENFERM, V17, P259, DOI 10.1590/S0104-11692009000200019; Gordon R, 2014, J OBSTET GYNAECOL CA, V36, P154, DOI 10.1016/S1701-2163(15)30662-9; Long Q, 2016, BJOG; Lotufo FA, 2016, BMC PREGNANCY CHILDB, V16, DOI 10.1186/s12884-016-1055-0; Merigue MA, 2003, ABORDAGENS TEORICOME, P1; Minossi José Guilherme, 2013, Rev. Col. Bras. Cir., V40, P494; Minossi José Guilherme, 2009, Rev. Col. Bras. Cir., V36, P90; Municipal Department of Halth (Campinas), HLTH INF HLTH NUMB; Pacagnella RC, 2014, BMC PREGNANCY CHILDB, V14, DOI 10.1186/1471-2393-14-159; POPE C, 1995, BRIT MED J, V311, P42, DOI 10.1136/bmj.311.6996.42; Pratt JJ, 2016, ACTA OBSTET GYN SCAN, V95, P144, DOI 10.1111/aogs.12807; PRITCHARD JA, 1955, SURG GYNECOL OBSTET, V100, P131; Salinger DH, 2013, BJOG-INT J OBSTET GY, V120, P894, DOI 10.1111/1471-0528.12222; Say L, 2014, LANCET GLOB HEALTH, V2, pE323, DOI 10.1016/S2214-109X(14)70227-X; Shamsuddin L, 2005, Bangladesh Med Res Counc Bull, V31, P75; Souza JP, 2013, LANCET, V381, P1747, DOI 10.1016/S0140-6736(13)60686-8; Tong A, 2007, INT J QUAL HEALTH C, V19, P349, DOI 10.1093/intqhc/mzm042; TRAN DN, 2015, J GLOB HLTH, V5; Turato E.R, 2011, TRATADO METODOLOGIA; Turato ER, 2005, REV SAUDE PUBL, V39, P507, DOI 10.1590/S0034-89102005000300025; WHO, PRIOR MED MOTN CHILD; World Health Organization, GLOB HLTH OBS GHO DA; Zanette E, 2014, REPROD HEALTH, V11, DOI 10.1186/1742-4755-11-4; Zuspan F P, 1966, Clin Obstet Gynecol, V9, P954, DOI 10.1097/00003081-196612000-00010	38	6	6	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 16	2017	12	3							e0172602	10.1371/journal.pone.0172602	http://dx.doi.org/10.1371/journal.pone.0172602			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN9KE	28301493	Green Submitted, gold, Green Published			2022-12-27	WOS:000396318300017
J	Menghini, P; Di Martino, L; Lopetuso, LR; Corridoni, D; Webster, JC; Xin, W; Arseneau, KO; Lam, M; Pizarro, TT; Cominelli, F				Menghini, Paola; Di Martino, Luca; Lopetuso, Loris R.; Corridoni, Daniele; Webster, Joshua C.; Xin, Wei; Arseneau, Kristen O.; Lam, Minh; Pizarro, Theresa T.; Cominelli, Fabio			A novel model of colitis-associated cancer in SAMP1/YitFc mice with Crohn's disease-like ileitis	PLOS ONE			English	Article							BETA-CATENIN; INFLAMMATION; ROLES	Patients with inflammatory bowel disease (IBD) are at increased risk for developing colorectal cancer. Evidence suggests that colonic dysplasia and colitis-associated cancer (CAC) are often linked to repeated cycles of epithelial cell injury and repair in the context of chronic production of inflammatory cytokines. Several mouse models of CAC have been proposed, including chemical induction through exposure to dextran sulfate sodium (DSS) with the genotoxic agents azoxymethane (AOM), 1,2-dymethylhydrazine (DHM) or targeted genetic mutations. However, such models are usually performed on healthy animals that usually lack the underlying genetic predisposition, immunological dysfunction and dysbiosis characteristic of IBD. We have previously shown that inbred SAMP1/YitFc (SAMP) mice develop a progressive Crohn's disease (CD)-like ileitis in the absence of spontaneous colitis. We hypothesize that SAMP mice may be more susceptible to colonic tumorigenesis due to their predisposition to IBD. To test this hypothesis, we administered AOM/DSS to IBD-prone SAMP and their non-inflamed parental control strain, AKR mice. Our results showed that AOM/DSS treatment enhanced the susceptibility of colitis in SAMP compared to AKR mice, as assessed by endoscopic and histologic inflammatory scores, daily weight loss and disease activity index (DAI), during and after DSS administration. SAMP mice also showed increased colonic tumorigenesis, resulting in the occurrence of intramucosal carcinoma and a higher incidence of high-grade dysplasia and tumor burden. These phenomena occurred even in the absence of AOM and only upon repeated cycles of DSS. Taken together, our data demonstrate a heightened susceptibility to colonic inflammation and tumorigenesis in AOM/DSS-treated SAMP mice with CD-like ileitis. This novel model represents a useful tool to investigate relevant mechanisms of CAC, as well as for pre-clinical testing of potential IBD and colon cancer therapeutics.	[Menghini, Paola; Di Martino, Luca; Corridoni, Daniele; Webster, Joshua C.; Arseneau, Kristen O.; Lam, Minh; Pizarro, Theresa T.; Cominelli, Fabio] Case Western Reserve Univ, Dept Med, Cleveland, OH 44106 USA; [Menghini, Paola; Di Martino, Luca; Lopetuso, Loris R.; Corridoni, Daniele; Webster, Joshua C.; Xin, Wei; Arseneau, Kristen O.; Lam, Minh; Pizarro, Theresa T.; Cominelli, Fabio] Case Western Reserve Univ, Digest Hlth Res Inst, Cleveland, OH 44106 USA; [Lopetuso, Loris R.; Xin, Wei; Pizarro, Theresa T.; Cominelli, Fabio] Case Western Reserve Univ, Dept Pathol, Cleveland, OH 44106 USA	Case Western Reserve University; Case Western Reserve University; Case Western Reserve University	Cominelli, F (corresponding author), Case Western Reserve Univ, Dept Med, Cleveland, OH 44106 USA.; Cominelli, F (corresponding author), Case Western Reserve Univ, Digest Hlth Res Inst, Cleveland, OH 44106 USA.; Cominelli, F (corresponding author), Case Western Reserve Univ, Dept Pathol, Cleveland, OH 44106 USA.	fabio.cominelli@case.edu	Lopetuso, Loris Riccardo/AAC-9065-2019	Corridoni, Daniele/0000-0003-0251-2248; Menghini, Paola/0000-0002-8779-088X; Cominelli, Fabio/0000-0002-1571-1548	National Institute of Health [DK042191, DK055812, DK091222, DK097948]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P01DK091222, R01DK042191, P30DK097948] Funding Source: NIH RePORTER	National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	The work was supported by National Institute of Health grants DK042191, DK055812, DK091222, and DK097948.	Alao JP, 2007, MOL CANCER, V6, DOI 10.1186/1476-4598-6-24; Aust DE, 2001, MODERN PATHOL, V14, P29, DOI 10.1038/modpathol.3880253; Bonomi M, 2014, ADV EXP MED BIOL, V816, P107, DOI 10.1007/978-3-0348-0837-8_5; Bosman F., 2010, WHO CLASSIFICATION T, V4th; Brabletz T, 1999, AM J PATHOL, V155, P1033, DOI 10.1016/S0002-9440(10)65204-2; Candido J, 2013, J CLIN IMMUNOL, V33, pS79, DOI 10.1007/s10875-012-9847-0; Catana CS, 2015, WORLD J GASTROENTERO, V21, P5823, DOI 10.3748/wjg.v21.i19.5823; Cho JH, 2008, NAT REV IMMUNOL, V8, P458, DOI 10.1038/nri2340; COOPER HS, 1993, LAB INVEST, V69, P238; Dang CV, 1999, MOL CELL BIOL, V19, P1; De Robertis Mariangela, 2011, J Carcinog, V10, P9, DOI 10.4103/1477-3163.78279; Di Martino L, 2016, CANC RES; Elinav E, 2013, NAT REV CANCER, V13, P759, DOI 10.1038/nrc3611; Greenhough A, 2009, CARCINOGENESIS, V30, P377, DOI 10.1093/carcin/bgp014; Grivennikov SI, 2010, CELL, V140, P883, DOI 10.1016/j.cell.2010.01.025; Hartmann G, 2000, J PHARMACOL EXP THER, V292, P22; Herrinton LJ, 2012, GASTROENTEROLOGY, V143, P382, DOI 10.1053/j.gastro.2012.04.054; Jia LG, 2016, J IMMUNOL, V197, P377, DOI 10.4049/jimmunol.1502466; Kanneganti M, 2011, J BIOMED BIOTECHNOL, DOI 10.1155/2011/342637; Kodani T, 2013, JOVE-J VIS EXP, DOI 10.3791/50843; Koskensalo S, 2011, TUMOR BIOL, V32, P259, DOI 10.1007/s13277-010-0080-2; Kundu JK, 2008, MUTAT RES-REV MUTAT, V659, P15, DOI 10.1016/j.mrrev.2008.03.002; Landskron G, 2014, J IMMUNOL RES, V2014, DOI 10.1155/2014/149185; Low D, 2014, INFLAMM BOWEL DIS, V20, P2115, DOI 10.1097/MIB.0000000000000094; Mager LF, 2016, FRONT ONCOL, V6, DOI 10.3389/fonc.2016.00096; Markowitz Sanford D., 1996, Cytokine and Growth Factor Reviews, V7, P93, DOI 10.1016/1359-6101(96)00001-9; Neufert C, 2007, NAT PROTOC, V2, P1998, DOI 10.1038/nprot.2007.279; Olson TS, 2006, J EXP MED, V203, P541, DOI 10.1084/jem.20050407; Oshima H, 2015, CANCER RES, V75, P766, DOI 10.1158/0008-5472.CAN-14-2036; Pizarro TT, 2011, INFLAMM BOWEL DIS, V17, P2566, DOI 10.1002/ibd.21638; Shenoy AK, 2012, CANCER RES, V72, P5091, DOI 10.1158/0008-5472.CAN-12-1806; Subramaniam Renuka, 2016, Cancer Res Front, V2, P1; Terzic J, 2010, GASTROENTEROLOGY, V138, P2101, DOI 10.1053/j.gastro.2010.01.058; Thaker AI, 2012, JOVE-J VIS EXP, DOI 10.3791/4100; Waldner MJ, 2012, INT J BIOL SCI, V8, P1248, DOI 10.7150/ijbs.4614; Wang K, 2015, CLIN EXP RHEUMATOL, V33, pS87; WATTENBERG LW, 1977, CANCER, V40, P2432, DOI 10.1002/1097-0142(197711)40:5+<2432::AID-CNCR2820400907>3.0.CO;2-8; Xie JL, 2008, WORLD J GASTROENTERO, V14, P378, DOI 10.3748/wjg.14.378	38	6	6	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 16	2017	12	3							e0174121	10.1371/journal.pone.0174121	http://dx.doi.org/10.1371/journal.pone.0174121			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN9KE	28301579	Green Published, gold, Green Submitted			2022-12-27	WOS:000396318300129
J	Sui, X; Du, QN; Xu, KF; Tian, XL; Song, L; Wang, X; Xu, XL; Wang, ZX; Wang, YY; Gu, J; Song, W; Jin, ZY				Sui, Xin; Du, Qianni; Xu, Kai-Feng; Tian, Xinlun; Song, Lan; Wang, Xiao; Xu, Xiaoli; Wang, Zixing; Wang, Yuyan; Gu, Jun; Song, Wei; Jin, Zhengyu			Quantitative assessment of Pulmonary Alveolar Proteinosis (PAP) with ultra-dose CT and correlation with Pulmonary Function Tests (PFTs)	PLOS ONE			English	Article							COMPUTED-TOMOGRAPHY; CHEST; EMPHYSEMA; DENSITOMETRY; QUALITY	Background The purpose of this study was to investigate whether ultra-low-dose chest computed tomog-raphy (CT) can be used for visual assessment of CT features in patients with pulmonary alveolar proteinosis (PAP) and to evaluate the relationship between the quantitative analysis of the ultra low dose CT scans and the pulmonary function tests (PFTs). Methods Thirty eight patients (mean [SD] age, 44.47 [12.28] years; 29 males, 9 females) with PAP were enrolled and subjected to two scans each with low dose CT (reference parameters: 120 kV and 50 mAs) and ultra low dose CT (reference parameters, 80 kV, 25 mAs). Images were reconstructed via filtered back projection (FBP) for low dose CT and iterative recon-struction (IR) for ultra low dose CT. All patients underwent PFT. The Visual analysis for ground glass opacity (GGO) is performed. The quantitative CT and PFT results were analyzed by canonical correlations. Results The mean body mass index (BMI) was 25.37 +/- 3.26 kg/m (2). The effective radiation doses were 2.30 +/- 0.46 and 0.24 +/- 0.05 mSv for low dose and ultra low dose CT, respectively. The size specific dose estimates were 5.81 +/- 0.81 and 0.62 +/- 0.09 mSv for low dose and ultra-low-dose CT. GGOs and interlobular septal thickening were observed bilaterally in all patients. The average visual GGO score was lower in the upper field (2.67 +/- 1.24) but higher in the middle and lower fields (3.08 +/- 1.32 and 3.08 +/- 0.97, respectively). The average score for the whole lung was 2.94 +/- 1.19. There is a significant correlation between PFTs and quantitative of ultra low dose CT (canonical loading = 0.78). Conclusions Ultra-low-dose CT has the potential to quantify the lung parenchyma changes of PAP. This technique could provide a sensitive and objective assessment of PAP and has good relation with PFTs. In addition, the radiation dose of ultra-low-dose CT was very low.	[Sui, Xin; Du, Qianni; Song, Lan; Wang, Xiao; Xu, Xiaoli; Song, Wei; Jin, Zhengyu] Chinese Acad Med Sci, Peking Union Med Coll Hosp, Dept Radiol, Beijing, Peoples R China; [Xu, Kai-Feng; Tian, Xinlun] Chinese Acad Med Sci, Peking Union Med Coll Hosp, Dept Resp Med, Beijing, Peoples R China; [Wang, Zixing; Wang, Yuyan] Chinese Acad Med Sci, Inst Basic Med Sci, Dept Epidemiol & Biostat, Beijing, Peoples R China; [Wang, Zixing; Wang, Yuyan] Peking Union Med Coll, Sch Basic Med, Beijing, Peoples R China; [Gu, Jun] Siemens Healthineers, Beijing, Peoples R China	Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College Hospital; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College Hospital; Chinese Academy of Medical Sciences - Peking Union Medical College; Institute of Basic Medical Sciences - CAMS; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College; Siemens AG	Song, W (corresponding author), Chinese Acad Med Sci, Peking Union Med Coll Hosp, Dept Radiol, Beijing, Peoples R China.	cjr.songwei@vip.163.com	Xu, Kai-Feng/AAO-2445-2020; Wang, Yuyan/GQZ-8255-2022; Tian, Xinlun/AAF-5444-2019	Tian, Xinlun/0000-0003-4307-6665; Jin, Zhengyu/0000-0002-6179-9632; Wang, Yuyan/0000-0003-3747-0762	National Health and Family Planning Commission the People's Republic of China [201402013]	National Health and Family Planning Commission the People's Republic of China	National Health and Family Planning Commission the People's Republic of China funded this study (201402013). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aberle DR, 2011, NEW ENGL J MED, V365, P395, DOI 10.1056/NEJMoa1102873; Akira M, 2000, THORAX, V55, P854, DOI 10.1136/thorax.55.10.854; [Anonymous], 2011, 204 AAPM; Bacher K, 2003, AM J ROENTGENOL, V181, P923, DOI 10.2214/ajr.181.4.1810923; Bankier AA, 2007, RADIOLOGY, V242, P898, DOI 10.1148/radiol.2423060196; Baumueller S, 2012, EUR RADIOL, V22, P2597, DOI 10.1007/s00330-012-2524-0; Brenner DJ, 2007, NEW ENGL J MED, V357, P2277, DOI 10.1056/NEJMra072149; Christner JA, 2012, RADIOLOGY, V265, P841, DOI 10.1148/radiol.12112365; COXSON HO, 1995, J APPL PHYSIOL, V79, P1525, DOI 10.1152/jappl.1995.79.5.1525; Diederich S, 1999, RADIOLOGY, V213, P289, DOI 10.1148/radiology.213.1.r99oc29289; Frazier AA, 2008, RADIOGRAPHICS, V28, P883, DOI 10.1148/rg.283075219; Gatsonis CA, 2011, RADIOLOGY, V258, P243, DOI 10.1148/radiol.10091808; Guan YB, 2012, EUR J RADIOL, V81, P2430, DOI 10.1016/j.ejrad.2011.05.005; Hardoon DR, 2004, NEURAL COMPUT, V16, P2639, DOI 10.1162/0899766042321814; KEMERINK GJ, 1995, RADIOLOGY, V197, P749, DOI 10.1148/radiology.197.3.7480750; Kim WJ, 2009, CHEST, V136, P396, DOI 10.1378/chest.08-2858; Lee SW, 2014, EUR RADIOL, V24, P817, DOI 10.1007/s00330-013-3090-9; Lucaya J, 2000, AM J ROENTGENOL, V175, P985, DOI 10.2214/ajr.175.4.1750985; Madani A, 2007, RADIOLOGY, V243, P250, DOI 10.1148/radiol.2431060194; McNitt-Gray MF, 2002, RADIOGRAPHICS, V22, P1541, DOI 10.1148/rg.226025128; Moscariello A, 2011, EUR RADIOL, V21, P2130, DOI 10.1007/s00330-011-2164-9; Perez A, 2005, CHEST, V128, P2471, DOI 10.1378/chest.128.4.2471; Pontana F, 2011, EUR RADIOL, V21, P636, DOI 10.1007/s00330-010-1991-4; Pourjabbar S, 2015, ACTA RADIOL, V56, P688, DOI 10.1177/0284185114537256; Quaia E, 2012, EUR RADIOL, V22, P1912, DOI 10.1007/s00330-012-2440-3; Robinson TE, 2009, CHEST, V135, P842, DOI 10.1378/chest.08-1317; ROSEN SH, 1958, NEW ENGL J MED, V258, P1123, DOI 10.1056/NEJM195806052582301; Task Group on Control of Radiation Dose in Computed Tomography, 2000, Ann ICRP, V30, P7; Trapnell BC, 2003, NEW ENGL J MED, V349, P2527, DOI 10.1056/NEJMra023226; Wang R, 2015, AM J ROENTGENOL, V204, P743, DOI 10.2214/AJR.14.13101; Yang WJ, 2013, J COMPUT ASSIST TOMO, V37, P301, DOI 10.1097/RCT.0b013e31827b8c66	31	8	9	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 16	2017	12	3							e0172958	10.1371/journal.pone.0172958	http://dx.doi.org/10.1371/journal.pone.0172958			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN9KE	28301535	Green Published, gold, Green Submitted			2022-12-27	WOS:000396318300020
J	Costa, LC; Nalin, RS; Ramalho, MAP; de Souza, EA				Costa, Larissa Carvalho; Nalin, Rafael Storto; Patto Ramalho, Magno Antonio; de Souza, Elaine Aparecida			Are duplicated genes responsible for anthracnose resistance in common bean?	PLOS ONE			English	Article							ANGULAR LEAF-SPOT; COLLETOTRICHUM-LINDEMUTHIANUM; PHASEOLUS-VULGARIS; MOLECULAR DIVERSITY; RACE 65; CULTIVAR; VIRULENCE; GENOME; VARIABILITY; INHERITANCE	The race 65 of Colletotrichum lindemuthianum, etiologic agent of anthracnose in common bean, is distributed worldwide, having great importance in breeding programs for anthracnose resistance. Several resistance alleles have been identified promoting resistance to this race. However, the variability that has been detected within race has made it difficult to obtain cultivars with durable resistance, because cultivars may have different reactions to each strain of race 65. Thus, this work aimed at studying the resistance inheritance of common bean lines to different strains of C. lindemuthianum, race 65. We used six C. lindemuthianum strains previously characterized as belonging to the race 65 through the international set of differential cultivars of anthracnose and nine commercial cultivars, adapted to the Brazilian growing conditions and with potential ability to discriminate the variability within this race. To obtain information on the resistance inheritance related to nine commercial cultivars to six strains of race 65, these cultivars were crossed two by two in all possible combinations, resulting in 36 hybrids. Segregation in the F2 generations revealed that the resistance to each strain is conditioned by two independent genes with the same function, suggesting that they are duplicated genes, where the dominant allele promotes resistance. These results indicate that the specificity between host resistance genes and pathogen avirulence genes is not limited to races, it also occurs within strains of the same race. Further research may be carried out in order to establish if the alleles identified in these cultivars are different from those described in the literature.	[Costa, Larissa Carvalho; Patto Ramalho, Magno Antonio; de Souza, Elaine Aparecida] Univ Fed Lavras, Dept Biol, Lavras, MG, Brazil; [Nalin, Rafael Storto] Univ Sao Paulo, Escola Super Agr Luiz Queiroz, Dept Genet, Piracicaba, SP, Brazil	Universidade Federal de Lavras; Universidade de Sao Paulo	de Souza, EA (corresponding author), Univ Fed Lavras, Dept Biol, Lavras, MG, Brazil.	easouza@dbi.ufla.br	costa, larissa/GRX-4740-2022		Fundacao de Amparo a Pesquisa do Estado de Minas Gerais- FAPEMIG; Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior - CAPES; Conselho Nacional de Desenvolvimento Cientifico e Tecnologico - CNPq [134246/2013-6]	Fundacao de Amparo a Pesquisa do Estado de Minas Gerais- FAPEMIG(Fundacao de Amparo a Pesquisa do Estado de Minas Gerais (FAPEMIG)); Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior - CAPES(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico - CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ))	This work was supported by grants and scholarships from the following Brazilian agencies: Fundacao de Amparo a Pesquisa do Estado de Minas Gerais- FAPEMIG, Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior - CAPES and Conselho Nacional de Desenvolvimento Cientifico e Tecnologico - CNPq (134246/2013-6). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akhunov ED, 2003, P NATL ACAD SCI USA, V100, P10836, DOI 10.1073/pnas.1934431100; Alzate-Marin A.L., 1999, ANN REPORT BEAN IMPR, V42, P15; Alzate-Marin A. L, 2003, ANN REPT BEAN IMPROV, V46, P177; Alzate-Marin AL, 2003, EUPHYTICA, V133, P165, DOI 10.1023/A:1025551006444; Alzate-marin AL, 2004, CROP BREED APPL BIOT, V4, P446; Alzate-Marin AL, 2007, EUPHYTICA, V154, P1, DOI 10.1007/s10681-006-9253-x; AlzateMarin AL, 1997, PLANT DIS, V81, P996, DOI 10.1094/PDIS.1997.81.9.996; Arantes LD, 2010, CROP BREED APPL BIOT, V10, P232; Balardin RS, 1997, PHYTOPATHOLOGY, V87, P1184, DOI 10.1094/PHYTO.1997.87.12.1184; BANNEROT H, 1971, ANN AMELIOR PLANT, V21, P83; Barcelos L, 2014, PLOS ONE, V9, P1, DOI DOI 10.1371/J0URNAL.P0NE.0100438; Bennetzen JL, 2007, CURR OPIN PLANT BIOL, V10, P176, DOI 10.1016/j.pbi.2007.01.010; Broughton WJ, 2003, PLANT SOIL, V252, P55, DOI 10.1023/A:1024146710611; Campa A, 2014, BMC PLANT BIOL, V14, DOI 10.1186/1471-2229-14-115; Carbonell Sergio A.M., 1999, Fitopatologia Brasileira, V24, P60; Castro SAL, 2014, ANN REP BEAN IMPROV, V57, P163; Davide LMC, 2009, CROP BREED APPL BIOT, V9, P23, DOI 10.12702/1984-7033.v09n01a04; Coelho RT., 2013, ANN REP BEAN IMPROV, V56, P43; Cruz CD, 2013, ACTA SCI-AGRON, V35, P271, DOI 10.4025/actasciagron.v35i3.21251; de Abreu AFB, 2004, CROP BREED APPL BIOT, V4, P372, DOI DOI 10.12702/1984-7033.v04n03a21; DESOUZA TLP, 2005, CROP BREED APPL BIOT, V5, P247; Devos KM, 2010, CURR OPIN PLANT BIOL, V13, P139, DOI 10.1016/j.pbi.2009.12.005; Ferreira J.J., 2013, TRANSLATIONAL GENOMI, VI, P151, DOI DOI 10.1002/9781118728475.CH9; Ferreira JJ, 2000, EUPHYTICA, V113, P259, DOI 10.1023/A:1003907130234; FLOR HH, 1971, ANNU REV PHYTOPATHOL, V9, P275, DOI 10.1146/annurev.py.09.090171.001423; FLOR HH, 1956, ADV GENET, V8, P29, DOI 10.1016/S0065-2660(08)60498-8; Fouilloux G, 1979, NEW RACES BEAN ANTHR, P221; Fouilloux G., 1976, ANN REP BEAN IMPROV, V19, P36; Gao D, 2014, FRONT PLANT SCI, V5, P9; Geffroy V, 1999, MOL PLANT MICROBE IN, V12, P774, DOI 10.1094/MPMI.1999.12.9.774; Geffroy V, 2008, THEOR APPL GENET, V116, P407, DOI 10.1007/s00122-007-0678-y; Gon?alves AMO., 2010, ANN REP BEAN IMPROV, V53, P220; Gonalves-Vidigal M. C., 2001, Crop Breeding and Applied Biotechnology, V1, P99; Goncalves-Vidigal MC, 2013, THEOR APPL GENET, V126, P2245, DOI 10.1007/s00122-013-2131-8; Goncalves-Vidigal MC, 2009, CROP SCI, V49, P133, DOI 10.2135/cropsci2008.01.0004; Goncalves-Vidigal MC, 2008, PLANT BREEDING, V127, P592, DOI 10.1111/j.1439-0523.2008.01530.x; Goncalves-Vidigal MC, 2006, EUPHYTICA, V151, P411, DOI 10.1007/s10681-006-9164-x; Goncalves-Vidigal MC, 2012, PLANT BREEDING, V131, P423, DOI 10.1111/j.1439-0523.2011.01939.x; Goncalves-Vidigal MC, 2011, THEOR APPL GENET, V122, P893, DOI 10.1007/s00122-010-1496-1; Gonqalves-Vidigal MC, 2007, GENET MOL BIOL, V30, P589, DOI 10.1590/S1415-47572007000400015; Gonzalez AM, 2015, FRONT PLANT SCI, V6, DOI 10.3389/fpls.2015.00141; Guttman DS, 2014, NAT REV GENET, V15, P797, DOI 10.1038/nrg3748; Hagiwara W. E., 2001, Crop Breeding and Applied Biotechnology, V1, P355; Ishikawa FH, 2011, J PLANT PATHOL, V93, P461; Ishikawa F.H., 2012, ANN REP BEAN IMPROV, V55, P141; Ishikawa FH, 2008, BIOLOGIA, V63, P156, DOI 10.2478/s11756-008-0039-6; Ishikawa FH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031175; Ferreira JJ, 2008, PLANT DIS, V92, P705, DOI 10.1094/PDIS-92-5-0705; Marcondes EHK, 2010, CIENC AGROTEC, V34, P975, DOI 10.1590/S1413-70542010000400025; Kelly JD, 2004, HORTSCIENCE, V39, P1196, DOI 10.21273/HORTSCI.39.6.1196; Kim KD, 2015, PLANT PHYSIOL, V168, P1433, DOI 10.1104/pp.15.00408; Lima IA, 2008, ANN REP BEAN IMPROV, V51, P188; Mahuku GS, 2004, EUR J PLANT PATHOL, V110, P253, DOI 10.1023/B:EJPP.0000019795.18984.74; MASTENBROEK C., 1960, EUPHYTICA, V9, P177, DOI 10.1007/BF00022219; McDonald BA, 2002, EUPHYTICA, V124, P163, DOI 10.1023/A:1015678432355; McRostie GP, 1919, PHYTOPATHOLOGY, V9, P141; Melotto M, 2000, COLLETOTRICHUM, P346; Melotto M, 2000, ALLELIC SERIES CO 1, V73, P143; Mendez-Vigo B, 2005, EUPHYTICA, V141, P237, DOI 10.1007/s10681-005-7075-x; Miklas PN, 2006, EUPHYTICA, V147, P105, DOI 10.1007/s10681-006-4600-5; Oblessuc PR, 2015, THEOR APPL GENET, V128, P1193, DOI 10.1007/s00122-015-2500-6; Parker IM, 2004, ANNU REV ECOL EVOL S, V35, P675, DOI 10.1146/annurev.ecolsys.34.011802.132339; PASTOR-CORRALES M A, 1991, Phytopathology, V81, P694; Pereira H. S., 2004, Crop Breeding and Applied Biotechnology, V4, P422; Pereira R, 2015, GENET MOL RES, V14, P5044, DOI 10.4238/2015.May.12.7; Pinto JMA, 2012, PHYTOPATHOLOGY, V102, P490, DOI 10.1094/PHYTO-06-11-0179; Ramalho MAP, 1986, CIENCIA PRATICA LAVR, V10, P343; Richard MMS, 2014, THEOR APPL GENET, V127, P1653, DOI 10.1007/s00122-014-2328-5; Roca MG, 2005, EUKARYOT CELL, V4, P911, DOI 10.1128/EC.4.5.911-919.2005; Royer MR, 1984, NATURAL OUTCROSSING, P194; Sacristan S, 2008, MOL PLANT PATHOL, V9, P369, DOI 10.1111/J.1364-3703.2007.00460.X; Santos J., 2008, REV BRASILEIRA AGROC, V14, P115, DOI [10.18539/cast.v14i3.1940, DOI 10.18539/CAST.V14I3.1940]; Schmutz J, 2014, NAT GENET, V46, P707, DOI 10.1038/ng.3008; Schwartz H.F., 1989, BEAN PRODUCTION PROB; Botelho FBS, 2011, J PHYTOPATHOL, V159, P175, DOI 10.1111/j.1439-0434.2010.01743.x; Silvurio L., 2002, ANN REPORT BEAN IMPR, V45, P74; Singh SP, 2010, CROP SCI, V50, P2199, DOI 10.2135/cropsci2009.03.0163; Souza EA, 2010, GENET MOL RES, V9, P1759, DOI 10.4238/vol9-3gmr863; Thrall PH, 2001, J ECOL, V89, P736, DOI 10.1046/j.0022-0477.2001.00597.x; TU JC, 1985, MICROBIOS, V44, P87; Vallejo V., 2009, Open Horticulture Journal, V2, P29; van Schoonhoven A, 1987, STANDARD SYSTEM EVAL, P54; Young RA, 1998, THEOR APPL GENET, V96, P87, DOI 10.1007/s001220050713	83	10	10	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 15	2017	12	3							e017378	10.1371/journal.pone.0173789	http://dx.doi.org/10.1371/journal.pone.0173789			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN9HQ	28296933	gold, Green Published, Green Submitted			2022-12-27	WOS:000396311700065
J	Kuo, CH; Chen, SC; Fang, CT; Nien, FJ; Wu, ET; Lin, SY; Chuang, LM; Lee, CN; Li, HY				Kuo, Chun-Heng; Chen, Szu-Chi; Fang, Chi-Tai; Nien, Feng-Jung; Wu, En-Tzu; Lin, Shin-Yu; Chuang, Lee-Ming; Lee, Chien-Nan; Li, Hung-Yuan			Screening gestational diabetes mellitus: The role of maternal age	PLOS ONE			English	Article							IMPAIRED GLUCOSE-TOLERANCE; FASTING PLASMA-GLUCOSE; BETA-CELL DYSFUNCTION; INTERNATIONAL ASSOCIATION; PREGNANCY OUTCOMES; INSULIN-RESISTANCE; HYPERGLYCEMIA; DIAGNOSIS; CRITERIA; RISK	Objective Using a specific cutoff of fasting plasma glucose (FPG) to screen gestational diabetes mellitus (GDM) can reduce the use of oral glucose tolerance tests (OGTT). Since the prevalence of GDM increases with age, this screening method may not be appropriate in healthcare systems where women become pregnant at older ages. Therefore, we aimed to develop a screening algorithm for GDM that takes maternal age into consideration. Methods We included 945 pregnant women without history of GDM who received 75g OGTT to diagnose GDM in 2011. Screening algorithms using FPG with or without age were developed. Another 362 pregnant women were recruited in 2013-2015 as the validation cohort. Results Using FPG criteria alone, more GDM diagnoses were missed in women >= 35 years than in women <35 years (13.2% vs. 5.8%, p < 0.001). Among GDM women >= 35 years, 63.6% had FPG <92 mg/dL (5.1 mmol/L). Use of the algorithm with an "age plus FPG" cutoff could reduce the use of OGTT (OGTT%) from 77.6% to 62.9%, while maintaining good sensitivity (from 91.9% to 90.2%) and specificity (from 100% to 100%). Similar reduction in OGTT% was found in the validation cohort (from 86.4% to 76.8%). In the simulation, if the percentage of women >= 35 years were 40% or more, the screening algorithm with an "age plus FPG" cutoff could further reduce OGTT% by 11.0%-18.8%. Conclusions A screening algorithm for GDM that takes maternal age into consideration can reduce the use of OGTT when women become pregnant at older ages.	[Kuo, Chun-Heng; Chen, Szu-Chi] New Taipei City Hosp, Dept Internal Med, New Taipei, Taiwan; [Fang, Chi-Tai; Chuang, Lee-Ming; Li, Hung-Yuan] Natl Taiwan Univ Hosp, Dept Internal Med, Taipei, Taiwan; [Fang, Chi-Tai; Chuang, Lee-Ming] Natl Taiwan Univ, Coll Publ Hlth, Inst Epidemiol & Prevent Med, Taipei, Taiwan; [Nien, Feng-Jung] Natl Taiwan Univ Hosp, Yun Lin Branch, Dept Internal Med, Yunlin, Taiwan; [Wu, En-Tzu] Dianthus MFM Clin, Dept Obstet & Gynecol, Taipei, Taiwan; [Lin, Shin-Yu; Lee, Chien-Nan] Natl Taiwan Univ Hosp, Dept Obstet & Gynecol, Taipei, Taiwan	National Taiwan University; National Taiwan University Hospital; National Taiwan University; National Taiwan University; National Taiwan University Hospital; National Taiwan University; National Taiwan University Hospital	Li, HY (corresponding author), Natl Taiwan Univ Hosp, Dept Internal Med, Taipei, Taiwan.; Lee, CN (corresponding author), Natl Taiwan Univ Hosp, Dept Obstet & Gynecol, Taipei, Taiwan.	leecn@ntu.edu.tw; larsli@ntuh.gov.tw	Chuang, Lee-Ming/AAF-3324-2019; Fang, Chi-Tai/P-2908-2016	Fang, Chi-Tai/0000-0002-7380-1699; Lee, Chien-Nan/0000-0002-1725-0407; Kuo, Chun Heng/0000-0001-7673-3567; CHUANG, LEE-MING/0000-0003-0978-2662; Li, Hung-Yuan/0000-0001-9644-2855; LIN, SHIN-YU/0000-0002-0753-2793	Ministry of Science and Technology, Taiwan [MOST 103-2314-B-002-157-MY2]	Ministry of Science and Technology, Taiwan(Ministry of Science and Technology, Taiwan)	This work is supported in part by a grant (MOST 103-2314-B-002-157-MY2) from the Ministry of Science and Technology, Taiwan. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdul-Ghani MA, 2006, DIABETES CARE, V29, P1130, DOI 10.2337/dc05-2179; Agarwal MM, 2010, DIABETES CARE, V33, P2018, DOI 10.2337/dc10-0572; ANDRES R, 1971, MED CLIN N AM, V55, P835, DOI 10.1016/S0025-7125(16)32479-8; Astolfi P, 2002, PAEDIATR PERINAT EP, V16, P67, DOI 10.1046/j.1365-3016.2002.00375.x; Baan CA, 1999, AM J EPIDEMIOL, V149, P219; Bando Y, 2001, DIABETES CARE, V24, P1156, DOI 10.2337/diacare.24.7.1156; Committee on Practice Bulletins-Obstetrics, 2013, OBSTET GYNECOL 1, V122, P406; Crowther CA, 2005, NEW ENGL J MED, V352, P2477, DOI 10.1056/NEJMoa042973; DAVIDSON MB, 1979, METABOLISM, V28, P688, DOI 10.1016/0026-0495(79)90024-6; de Pablos-Velasco PL, 2001, DIABETIC MED, V18, P235, DOI 10.1046/j.1464-5491.2001.00451.x; HARRIS M, 1979, DIABETES, V28, P1039; Hillier TA, 2007, DIABETES CARE, V30, P2287, DOI 10.2337/dc06-2361; Hosseinpanah F, 2006, DIABETIC MED, V23, P982, DOI 10.1111/j.1464-5491.2006.01939.x; JACKSON RA, 1982, J CLIN ENDOCR METAB, V55, P840, DOI 10.1210/jcem-55-5-840; Lai YC, 2013, DIABETIC MED, V30, P318, DOI 10.1111/dme.12008; Laopaiboon M, 2014, BJOG-INT J OBSTET GY, V121, P49, DOI 10.1111/1471-0528.12659; Li CL, 2003, DIABETES RES CLIN PR, V59, P225, DOI 10.1016/S0168-8227(02)00249-8; McIntyre HD, 2015, BEST PRACT RES CL OB, V29, P194, DOI 10.1016/j.bpobgyn.2014.04.022; Metzger BE, 2010, DIABETES CARE, V33, P676, DOI 10.2337/dc09-1848; National Institutes of Health consensus development conference statement, 2013, OBSTET GYNECOLOGY 1, V122, P358; Qiao Q, 2000, DIABETOLOGIA, V43, P1470, DOI 10.1007/s001250051557; Resnick HE, 2000, DIABETES CARE, V23, P176, DOI 10.2337/diacare.23.2.176; Savona-Ventura C, 2013, INT J GYNECOL OBSTET, V120, P240, DOI 10.1016/j.ijgo.2012.10.016; Tuomilehto J, 2003, DIABETES CARE, V26, P61; Wei JN, 2007, OBESITY, V15, P1609, DOI 10.1038/oby.2007.190; Wu ET, 2016, J DIABETES INVEST, V7, P121, DOI 10.1111/jdi.12378; Xu L, 2010, METABOLISM, V59, P367, DOI 10.1016/j.metabol.2009.08.004; Xu X, 2016, INTERNATIONAL JOURNA, V13; Zhu WW, 2013, DIABETES CARE, V36, P2038, DOI 10.2337/dc12-2465	29	15	15	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 15	2017	12	3							e0173049	10.1371/journal.pone.0173049	http://dx.doi.org/10.1371/journal.pone.0173049			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN9HQ	28296923	Green Submitted, Green Published, gold			2022-12-27	WOS:000396311700024
J	Liu, YY; Gu, FF; Liang, JY; Dai, XM; Wan, C; Hong, XH; Zhang, K; Liu, L				Liu, Yangyang; Gu, Feifei; Liang, Jinyan; Dai, Xiaomeng; Wan, Chao; Hong, Xiaohua; Zhang, Kai; Liu, Li			The efficacy and toxicity profile of metronomic chemotherapy for metastatic breast cancer: A meta-analysis	PLOS ONE			English	Article							ENDOTHELIAL GROWTH-FACTOR; ANGIOGENIC MARKERS; ANTITUMOR-ACTIVITY; PERIPHERAL-BLOOD; ORAL VINORELBINE; CYCLOPHOSPHAMIDE; CAPECITABINE; THERAPY; BEVACIZUMAB; METHOTREXATE	Purpose The current meta-analysis aimed to summarize the available evidence for the efficacy and serious adverse events (AEs) associated with use of metronomic chemotherapy (MCT) in patients with metastatic breast cancer (MBC). Method Electronic databases (PubMed, EMBASE database, Web of Knowledge, and the Cochrane database) were systematically searched for articles related to the use of MCT in MBC patients. Eligible studies included clinical trials of MBC patients treated with MCT that presented sufficient data related to tumor response, progression-free survival (PFS), overall survival (OS), and grade 3/4 AEs. A meta-analysis was performed using a random effects model. Results This meta-analysis consists of 22 clinical trials with 1360 patients. The pooled objective response rate and clinical benefit rate of MCT were 34.1% (95% CI 27.4-41.5) and 55.6% (95% CI 49.2-61.9), respectively. The overall 6-month PFS, 12-month OS, and 24-month OS rates were 56.8% (95% CI 48.3-64.9), 70.3% (95% CI 62.6-76.9), and 40.0% (95% CI 30.6-50.2), respectively. The pooled incidence of grade 3/4 AEs was 29.5% (95% CI 21.1- 39.5). There was no statistically significant difference observed in any endpoint between subgroups defined by concomitant anti-cancer therapies or chemotherapy regimens. After excluding one controversial study, we observed a trend showing lower toxicity rates with the use of MCT alone compared to use of MCT with other anti-cancer therapies (P = 0.070). Conclusions Metronomic chemotherapy may be effective for use in patients with metastatic breast cancer. MCT used alone is possibly equally effective and less toxic than combination therapies. Well-designed RCTs are needed to obtain more evidence.	[Liu, Yangyang; Gu, Feifei; Liang, Jinyan; Dai, Xiaomeng; Wan, Chao; Hong, Xiaohua; Zhang, Kai; Liu, Li] Huazhong Univ Sci & Technol, Union Hosp, Tongji Med Coll, Ctr Canc, Wuhan, Peoples R China	Huazhong University of Science & Technology	Liu, L (corresponding author), Huazhong Univ Sci & Technol, Union Hosp, Tongji Med Coll, Ctr Canc, Wuhan, Peoples R China.	liulist2013@163.com		Liu, Li/0000-0003-2314-8756	National Natural Science Foundation of China [81372260]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This study was funded by National Natural Science Foundation of China (grant number 81372260).	Addeo R, 2010, CLIN BREAST CANCER, V10, P301, DOI 10.3816/CBC.2010.n.039; Perroud HA, 2016, CANCER CHEMOTH PHARM, V77, P365, DOI 10.1007/s00280-015-2947-9; BEGG CB, 1994, BIOMETRICS, V50, P1088, DOI 10.2307/2533446; Bouche G, 2014, ECANCERMEDICALSCIENC, V8, DOI 10.3332/ecancer.2014.463; Bramante S, 2016, ONCOIMMUNOLOGY, V5, DOI 10.1080/2162402X.2015.1078057; Brems-Eskildsen AS, 2016, EUR J CANCER, V57, pS110; Cazzaniga ME, 2016, BREAST CANCER RES TR, V160, P501, DOI 10.1007/s10549-016-4009-3; Colleoni M, 2006, ANN ONCOL, V17, P232, DOI 10.1093/annonc/mdj066; Colleoni M, 2002, ANN ONCOL, V13, P73, DOI 10.1093/annonc/mdf013; De Iuliis F, 2015, TUMORI J, V101, P30, DOI 10.5301/tj.5000207; Dellapasqua S, 2008, J CLIN ONCOL, V26, P4899, DOI 10.1200/JCO.2008.17.4789; Egger M, 1997, BMJ-BRIT MED J, V315, P629, DOI 10.1136/bmj.315.7109.629; El-Arab LRE, 2012, J EGYPT NATL CANCER, V24, P15, DOI 10.1016/j.jnci.2011.12.002; Fedele P, 2012, EUR J CANCER, V48, P24, DOI 10.1016/j.ejca.2011.06.040; Garcia-Saenz JA, 2008, J CHEMOTHERAPY, V20, P632, DOI 10.1179/joc.2008.20.5.632; Ghiringhelli F, 2007, CANCER IMMUNOL IMMUN, V56, P641, DOI 10.1007/s00262-006-0225-8; Green MC, 2005, J CLIN ONCOL, V23, P5983, DOI 10.1200/JCO.2005.06.232; Higgins JPT, 2003, BRIT MED J, V327, P557, DOI 10.1136/bmj.327.7414.557; Higgins JPT, 2002, STAT MED, V21, P1539, DOI 10.1002/sim.1186; Kader YA, 2013, BREAST CANCER-TARGET, V5, P37, DOI 10.2147/BCTT.S44728; Kareva I, 2015, CANCER LETT, V358, P100, DOI 10.1016/j.canlet.2014.12.039; Kerbel RS, 2004, NAT REV CANCER, V4, P423, DOI 10.1038/nrc1369; Kerbel RS, 2002, ANN ONCOL, V13, P12, DOI 10.1093/annonc/mdf093; Korantzis I, 2012, ANTICANCER RES, V32, P4569; Licchetta A, 2010, J CHEMOTHERAPY, V22, P201, DOI 10.1179/joc.2010.22.3.201; Lien K, 2013, EUR J CANCER, V49, P3387, DOI 10.1016/j.ejca.2013.06.038; Mancuso P, 2006, BLOOD, V108, P452, DOI 10.1182/blood-2005-11-4570; Martin M, 2015, ONCOLOGIST, V20, P111, DOI 10.1634/theoncologist.2014-0379; Montagna E, 2014, CANCER TREAT REV, V40, P942, DOI 10.1016/j.ctrv.2014.06.002; Montagna E, 2012, CLIN BREAST CANCER, V12, P207, DOI 10.1016/j.clbc.2012.03.008; Munzone E, 2015, NAT REV CLIN ONCOL, V12, P631, DOI 10.1038/nrclinonc.2015.131; Nishijima TF, 2016, BREAST CANCER RES TR, V156, P227, DOI 10.1007/s10549-016-3756-5; Otsuka H, 2015, BREAST CANCER-TOKYO, V22, P335, DOI 10.1007/s12282-013-0483-1; Pectasides D, 2012, ONCOL REP, V27, P216, DOI 10.3892/or.2011.1504; Perez EA, 2009, BREAST CANCER RES TR, V114, P195, DOI 10.1007/s10549-008-0005-6; Perroud HA, 2013, INDIAN J CANCER, V50, P115, DOI 10.4103/0019-509X.117031; Pritchard KI, 2008, CANCER, V112, P718, DOI 10.1002/cncr.23189; Rochlitz C, 2016, BMC CANCER, V16, DOI 10.1186/s12885-016-2823-y; Salem Dina A, 2008, J Egypt Natl Canc Inst, V20, P134; Saloustros E, 2011, J BUON, V16, P215; Sandri MT, 2007, CANCER-AM CANCER SOC, V110, P509, DOI 10.1002/cncr.22825; Schwartzberg LS, 2014, CLIN BREAST CANCER, V14, P13, DOI 10.1016/j.clbc.2013.09.003; Soriano JL, 2011, INT J BREAST CANCER, V2011, DOI 10.4061/2011/710292; Stockler MR, 2011, J CLIN ONCOL, V29, P4498, DOI 10.1200/JCO.2010.33.9101; Therasse P, 2000, J NATL CANCER I, V92, P205, DOI 10.1093/jnci/92.3.205; Torrisi R, 2011, BREAST CANCER RES TR, V126, P431, DOI 10.1007/s10549-010-1340-y; Vives M, 2013, INT J CANCER, V133, P2464, DOI 10.1002/ijc.28259; Wang X, 2016, CLIN TRANSL ONCOL, V18, P82, DOI 10.1007/s12094-015-1339-2; Wang ZH, 2012, CANCER CHEMOTH PHARM, V69, P515, DOI 10.1007/s00280-011-1728-3; Wong NS, 2010, J CLIN ONCOL, V28, P723, DOI 10.1200/JCO.2009.24.0143; Yoshimoto M, 2012, CANCER CHEMOTH PHARM, V70, P331, DOI 10.1007/s00280-012-1826-x; Zafer M, 2016, FERTIL STERIL, V105, P645, DOI 10.1016/j.fertnstert.2015.11.028	52	21	24	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 15	2017	12	3							e0173693	10.1371/journal.pone.0173693	http://dx.doi.org/10.1371/journal.pone.0173693			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN9HQ	28296916	Green Published, Green Submitted, gold			2022-12-27	WOS:000396311700053
J	Peixoto, LD; Laviola, BG; Alves, AA; Rosado, TB; Bhering, LL				Peixoto, Leonardo de Azevedo; Laviola, Bruno Galveas; Alves, Alexandre Alonso; Rosado, Tatiana Barbosa; Bhering, Leonardo Lopes			Breeding Jatropha curcas by genomic selection: A pilot assessment of the accuracy of predictive models	PLOS ONE			English	Article							HEAD BLIGHT RESISTANCE; GENOMEWIDE SELECTION; QUANTITATIVE TRAITS; PLANT; OIL; BIOFUELS; QUALITY; GROWTH; VALUES; SETS	Genomic wide selection is a promising approach for improving the selection accuracy in plant breeding, particularly in species with long life cycles, such as Jatropha. Therefore, the objectives of this study were to estimate the genetic parameters for grain yield (GY) and the weight of 100 seeds (W100S) using restricted maximum likelihood (REML); to compare the performance of GWS methods to predict GY and W100S; and to estimate how many markers are needed to train the GWS model to obtain the maximum accuracy. Eight GWS models were compared in terms of predictive ability. The impact that the marker density had on the predictive ability was investigated using a varying number of markers, from 2 to 1,248. Because the genetic variance between evaluated genotypes was significant, it was possible to obtain selection gain. All of the GWS methods tested in this study can be used to predict GY and W100S in Jatropha. A training model fitted using 1,000 and 800 markers is sufficient to capture the maximum genetic variance and, consequently, maximum prediction ability of GY and W100S, respectively. This study demonstrated the applicability of genome-wide prediction to identify useful genetic sources of GY and W100S for Jatropha breeding. Further research is needed to confirm the applicability of the proposed approach to other complex traits.	[Peixoto, Leonardo de Azevedo; Bhering, Leonardo Lopes] Univ Fed Vicosa, Dept Biol, Vicosa, MG, Brazil; [Laviola, Bruno Galveas; Alves, Alexandre Alonso; Rosado, Tatiana Barbosa] Embrapa Agroenergia, Empresa Brasileira Pesquisa Agr, Parque Estacao Biol PqEB S-N, Brasilia, DF, Brazil	Universidade Federal de Vicosa; Empresa Brasileira de Pesquisa Agropecuaria (EMBRAPA)	Peixoto, LD (corresponding author), Univ Fed Vicosa, Dept Biol, Vicosa, MG, Brazil.	leoazevedop@gmail.com	Bhering, Leonardo/AAK-9548-2020; Laviola, Bruno G/F-5855-2010; Laviola, Bruno Galvêas/AAK-8551-2020	Laviola, Bruno/0000-0002-6360-1204; Bhering, Leonardo/0000-0002-6072-0996	CAPES (Coordenacao de Aperfeicoamento de Pessoal do Ensino Superior); Cnpq (National Counsel of Technological and Scientific Development); FAPEMIG (Fundacao de Amparo a Pesquisa de Minas Gerais); Funarbe (Fundacao Arthur Bernardes); Federal University of Vicosa	CAPES (Coordenacao de Aperfeicoamento de Pessoal do Ensino Superior)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); Cnpq (National Counsel of Technological and Scientific Development)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); FAPEMIG (Fundacao de Amparo a Pesquisa de Minas Gerais)(Fundacao de Amparo a Pesquisa do Estado de Minas Gerais (FAPEMIG)); Funarbe (Fundacao Arthur Bernardes); Federal University of Vicosa	We are thankful to CAPES (Coordenacao de Aperfeicoamento de Pessoal do Ensino Superior), Cnpq (National Counsel of Technological and Scientific Development), FAPEMIG (Fundacao de Amparo a Pesquisa de Minas Gerais), Funarbe (Fundacao Arthur Bernardes) and Federal University of Vicosa for financial support. We also thank the Biometric Lab (Federal University of Vicosa, Brazil) where all analyses were performed by remote access.	Akanno EC, 2013, LIVEST SCI, V152, P101, DOI 10.1016/j.livsci.2012.07.021; Akintayo ET, 2004, BIORESOURCE TECHNOL, V92, P307, DOI 10.1016/S0960-8524(03)00197-4; Asoro FG, 2011, PLANT GENOME-US, V4, P132, DOI 10.3835/plantgenome2011.02.0007; Azevedo CF, 2015, BMC GENET, V16, DOI 10.1186/s12863-015-0264-2; Bahadur B., 2012, JATROPHA CHALLENGES; Bailis R, 2011, GCB BIOENERGY, V3, P449, DOI 10.1111/j.1757-1707.2011.01100.x; Bailis R, 2011, ANN ASSOC AM GEOGR, V101, P827, DOI 10.1080/00045608.2011.568867; Becker K., 2008, LIPID TECHNOL, V20, P104, DOI [DOI 10.1002/LITE.200800023, 10.1002/lite.200800023]; Berchmans HJ, 2008, BIORESOURCE TECHNOL, V99, P1716, DOI 10.1016/j.biortech.2007.03.051; Bernardo R, 2007, CROP SCI, V47, P1082, DOI 10.2135/cropsci2006.11.0690; Burgueno J, 2012, CROP SCI, V52, P707, DOI 10.2135/cropsci2011.06.0299; Butler JB, 2016, TREE GENET GENOMES, V12, DOI 10.1007/s11295-016-0987-x; Carels N, 2013, CHALLENGES NEW ENERG; Clark SA, 2012, GENET SEL EVOL, V44, DOI 10.1186/1297-9686-44-4; Cleveland MA, 2012, G3-GENES GENOM GENET, V2, P429, DOI 10.1534/g3.111.001453; Daetwyler HD, 2013, GENETICS, V193, P347, DOI 10.1534/genetics.112.147983; Daetwyler HD, 2010, GENETICS, V185, P1021, DOI 10.1534/genetics.110.116855; Daetwyler HD, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003395; de los Campos G, 2010, GENET RES, V92, P295, DOI 10.1017/S0016672310000285; de los Campos G, 2009, GENETICS, V182, P375, DOI 10.1534/genetics.109.101501; Dias LAdS, 2007, CULTIVO MANSO JATROP, V1, P1; Falconer D. S., 1996, Introduction to quantitative genetics.; FERNANDO RL, 1986, THEOR APPL GENET, V72, P822, DOI 10.1007/BF00266552; Gianola D, 2009, GENETICS, V183, P347, DOI 10.1534/genetics.109.103952; GRATTAPAGLIA D, 1994, GENETICS, V137, P1121; Grattapaglia D, 2011, TREE GENET GENOMES, V7, P241, DOI 10.1007/s11295-010-0328-4; Hayes BJ, 2009, J DAIRY SCI, V92, P433, DOI 10.3168/jds.2008-1646; Heffner EL, 2011, CROP SCI, V51, P2597, DOI 10.2135/cropsci2011.05.0253; Heslot N, 2012, CROP SCI, V52, P146, DOI 10.2135/cropsci2011.06.0297; IWATA H, 2011, TREE GENET GENOMES, V7, DOI DOI 10.1007/s11295-011-0371-9; Jannink JL, 2010, BRIEF FUNCT GENOMICS, V9, P166, DOI 10.1093/bfgp/elq001; Junqueira VS, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0157038; KUMAR S, 2012, TREE GENET GENOMES, V8, P1, DOI DOI 10.1007/s11295-011-0425-z; Laviola BG, 2010, PESQUI AGROPECU BRAS, V45, P1117, DOI 10.1590/S0100-204X2010001000010; Lorenz AJ, 2012, CROP SCI, V52, P1609, DOI 10.2135/cropsci2011.09.0503; Lorenz AJ, 2011, ADV AGRON, V110, P77, DOI 10.1016/B978-0-12-385531-2.00002-5; Lorenzana RE, 2009, THEOR APPL GENET, V120, P151, DOI 10.1007/s00122-009-1166-3; Meuwissen THE, 2001, GENETICS, V157, P1819; Mohammadi SA, 2003, CROP SCI, V43, P1235, DOI 10.2135/cropsci2003.1235; Naylor RL, 2007, ENVIRONMENT, V49, P30, DOI 10.3200/ENVT.49.9.30-43; Neale DB, 2011, NAT REV GENET, V12, P111, DOI 10.1038/nrg2931; Nithiyanantham S, 2012, J AM OIL CHEM SOC, V89, P961, DOI 10.1007/s11746-012-2012-3; Openshaw K, 2000, BIOMASS BIOENERG, V19, P1, DOI 10.1016/S0961-9534(00)00019-2; Peixoto L, 2016, GENETICS MOL RES GMR, V15; Peixoto LD, 2016, IND CROP PROD, V80, P70, DOI 10.1016/j.indcrop.2015.10.034; Pszczola M, 2012, J DAIRY SCI, V95, P389, DOI 10.3168/jds.2011-4338; Pu Y, 2011, BIORESOURCES, V6, P4856; R Core Team, 2013, R LANG ENV STAT COMP; Resende MFR, 2012, GENETICS, V190, P1503, DOI 10.1534/genetics.111.137026; Resende MFR, 2012, NEW PHYTOL, V193, P617, DOI 10.1111/j.1469-8137.2011.03895.x; Resende MDV, 2012, NEW PHYTOL, V194, P116, DOI 10.1111/j.1469-8137.2011.04038.x; Resende MDV, 2000, ANALISE ESTATISTICA; Resende MDVd, 2002, SOFTW SELEGEN REML B; Rutkoski J, 2012, PLANT GENOME-US, V5, P51, DOI 10.3835/plantgenome2012.02.0001; Spindel J, 2015, PLOS GENET, V11, DOI 10.1371/journal.pgen.1004982; Technow F, 2013, G3-GENES GENOM GENET, V3, P197, DOI 10.1534/g3.112.004630; Terakami S, 2016, BREEDING SCI, V66, P271, DOI 10.1270/jsbbs.66.271; Vencovsky R., 1987, MELHORAMENTO PRODUCA, P137; Wong CK, 2008, THEOR APPL GENET, V116, P815, DOI 10.1007/s00122-008-0715-5	59	11	12	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 15	2017	12	3							e0173368	10.1371/journal.pone.0173368	http://dx.doi.org/10.1371/journal.pone.0173368			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN9HQ	28296913	gold, Green Submitted, Green Published			2022-12-27	WOS:000396311700036
J	Shu, JP; Shang, H; Jin, DM; Wei, HJ; Zhou, XL; Liu, HM; Gu, YF; Wang, Y; Wang, FG; Shen, H; Zhang, R; Adjie, B; Yan, YH				Shu, Jiang-Ping; Shang, Hui; Jin, Dongmei; Wei, Hong-Jin; Zhou, Xi-Le; Liu, Hong-Mei; Gu, Yu-Feng; Wang, Ying; Wang, Fa-Guo; Shen, Hui; Zhang, Rui; Adjie, Bayu; Yan, Yue-Hong			Re-establishment of species from synonymies based on DNA barcoding and phylogenetic analysis using Diplopterygium simulans (Gleicheniaceae) as an example	PLOS ONE			English	Article							MOLECULAR PHYLOGENETICS; DELIMITATION; COMPLEX; PLANTS; MODEL	Because synonymy treatment traditionally relies on morphological judgments, it usually causes many problems in species delimitation and in the biodiversity catalogue. For example, Diplopterygium simulans, which belongs to the Gleicheniaceae family, has been considered to be synonymous with D. glaucum or D. giganteum based mainly on the morphology of its pinna rachis and blade. In the absence of molecular evidence, these revisions remain doubtful. DNA barcoding, which is considered to be a powerful method for species-level identification, was employed to assess the genetic distance among 9 members of the Diplopterygium genus. The results indicate that D. simulans is an independent species rather than a synonymy of D. glaucum or D. giganteum. Moreover, phylogenetic analysis uncovered the sisterhood of D. simulans and D. cantonense, which is supported by their geographical distributions and morphological traits. Incorrect synonymy treatment is prevalent in the characterization of biological diversity, and our study proposes a convenient and effective method for validating synonym treatments and discovering cryptic species.	[Shu, Jiang-Ping; Shang, Hui; Jin, Dongmei; Wei, Hong-Jin; Zhou, Xi-Le; Gu, Yu-Feng; Wang, Ying; Shen, Hui; Zhang, Rui; Yan, Yue-Hong] Chinese Acad Sci, Shanghai Chenshan Plant Sci Res Ctr, Shanghai, Peoples R China; [Shu, Jiang-Ping; Gu, Yu-Feng; Wang, Ying] Shanghai Normal Univ, Coll Life & Environm Sci, Shanghai, Peoples R China; [Liu, Hong-Mei] Chinese Acad Sci, Shenzhen Fairylake Bot Garden, Shenzhen, Peoples R China; [Wang, Fa-Guo] Chinese Acad Sci, South China Bot Garden, Guangzhou, Guangdong, Peoples R China; [Adjie, Bayu] Indonesian Inst Sci, Bali Bot Garden, Bali, Indonesia	Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS; Shanghai Normal University; Chinese Academy of Sciences; Chinese Academy of Sciences; South China Botanical Garden, CAS; Indonesian Institute of Sciences	Yan, YH (corresponding author), Chinese Acad Sci, Shanghai Chenshan Plant Sci Res Ctr, Shanghai, Peoples R China.	yhyan@sibs.ac.cn	Gu, Yu-Feng/AAM-2150-2021	Shu, Jiang-Ping/0000-0001-9714-3064; Jin, Dongmei/0000-0001-7133-4460	National Natural Science Foundation of China [31370234]; Shanghai Municipal Administration of Forestation & City Appearances [G142433]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Shanghai Municipal Administration of Forestation & City Appearances	Support was provided by the National Natural Science Foundation of China, 31370234, [http://www.nsfc.gov.cn/publish/portal1/] and the Shanghai Municipal Administration of Forestation & City Appearances, G142433, [http://lhsr.sh.gov.cn/]. The funders had main role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Awano T, 2009, P NATL ACAD SCI USA, V106, P2794, DOI [10.1073/pnas.0905845106, 10.1073/pnas.0812297106]; Blair C, 2015, MOL PHYLOGENET EVOL, V84, P254, DOI 10.1016/j.ympev.2015.01.003; Carstens BC, 2013, MOL ECOL, V22, P4369, DOI 10.1111/mec.12413; Chantarasuwan B, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0128289; Chao Z, 2014, PHYTOMEDICINE, V21, P1767, DOI 10.1016/j.phymed.2014.09.001; Chen H, 1997, FLORA OF HAINAN; Ching R, 1959, ACTA PHYTOTAXONOMICA, V8, P125; Ching R-C, 1959, FLORA REIPUBLICAE PO, V2, P116; de Groot GA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016371; Dirzo R, 2003, ANNU REV ENV RESOUR, V28, P137, DOI 10.1146/annurev.energy.28.050302.105532; Dong W, 2012, PLOS ONE, P1932; Du JA, 2010, FLORA, V205, P399, DOI 10.1016/j.flora.2009.12.018; Federici S, 2013, BOT J LINN SOC, V171, P687, DOI 10.1111/boj.12034; Gao T, 2011, PLANTA MED, V77, P92, DOI 10.1055/s-0030-1250050; Gilgado F, 2005, J CLIN MICROBIOL, V43, P4930, DOI 10.1128/JCM.43.10.4930-4942.2005; Gu W, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067818; Guindon S, 2010, SYST BIOL, V59, P307, DOI 10.1093/sysbio/syq010; Guo W, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027998; Hajibabaei M, 2007, TRENDS GENET, V23, P167, DOI 10.1016/j.tig.2007.02.001; Hall TA., 1999, NUCL ACIDS S SERIES, V41, P95; Hebert PDN, 2004, P NATL ACAD SCI USA, V101, P14812, DOI 10.1073/pnas.0406166101; Hebert PDN, 2003, P ROY SOC B-BIOL SCI, V270, pS96, DOI 10.1098/rsbl.2003.0025; Hogendoorn K, 2015, ZOOKEYS, P41, DOI 10.3897/zookeys.520.6185; Jin XF, 2013, FLORA CHINA, V2-3, P110; [金孝锋 JIN XiaoFeng], 2008, [云南植物研究, Acta Botanica Yunnanica], V30, P9; Joppa LN, 2011, P ROY SOC B-BIOL SCI, V278, P554, DOI 10.1098/rspb.2010.1004; KIMURA M, 1980, J MOL EVOL, V16, P111, DOI 10.1007/BF01731581; Kiontke KC, 2011, BMC EVOL BIOL, V11, DOI 10.1186/1471-2148-11-339; Kress WJ, 2005, P NATL ACAD SCI USA, V102, P8369, DOI 10.1073/pnas.0503123102; Leache AD, 2010, P ROY SOC B-BIOL SCI, V277, P3071, DOI 10.1098/rspb.2010.0662; Leray M, 2015, P NATL ACAD SCI USA, V112, P2076, DOI 10.1073/pnas.1424997112; [李春香 LI Chun-xiang], 2010, [古生物学报, Acta Palaeontologica Sinica], V49, P64; Li YQ, 2015, PHYTOTAXA, V226, P295; Liu HM, 2013, TAXON, V62, P688, DOI 10.12705/624.26; Liu Y, 2010, J SYST EVOL, V48, P36, DOI 10.1111/j.1759-6831.2009.00063.x; Lu JM, 2012, J PLANT RES, V125, P237, DOI 10.1007/s10265-011-0441-y; MAY RM, 1988, SCIENCE, V241, P1441, DOI 10.1126/science.241.4872.1441; MAY RM, 1990, PHILOS T R SOC B, V330, P293, DOI 10.1098/rstb.1990.0200; McNeill J, 2012, INT CODE NOMENCLATUR; Nakai T, 1950, B NATL SCI MUSEUM, V31, P1; Paton AJ, 2008, TAXON, V57, P602, DOI 10.2307/25066027; Pimm SL, 2001, WORLD ACCORDING PIMM; Posada D, 2004, SYST BIOL, V53, P793, DOI 10.1080/10635150490522304; Posada D, 1998, BIOINFORMATICS, V14, P817, DOI 10.1093/bioinformatics/14.9.817; Prance GT, 2000, ANN MO BOT GARD, V87, P67, DOI 10.2307/2666209; Su X, 2015, ANN BOT; Taberlet P, 2007, NUCLEIC ACIDS RES, V35, DOI 10.1093/nar/gkl938; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; Wiens JJ, 2007, SYST BIOL, V56, P875, DOI 10.1080/10635150701748506; Wu T, 2000, FLORA OF GUANGDONG; Ya ZDJYX, 1999, ACTA PHYTOECOLOGICA, V6; Zhang XC, 2004, NOVON, V14, P149	52	6	7	0	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 15	2017	12	3							e0164604	10.1371/journal.pone.0164604	http://dx.doi.org/10.1371/journal.pone.0164604			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN9HQ	28296890	Green Published, gold, Green Submitted			2022-12-27	WOS:000396311700001
J	Hammock, BG; Slater, SB; Baxter, RD; Fangue, NA; Cocherell, D; Hennessy, A; Kurobe, T; Tai, CY; Teh, SJ				Hammock, Bruce G.; Slater, Steven B.; Baxter, Randall D.; Fangue, Nann A.; Cocherell, Dennis; Hennessy, April; Kurobe, Tomofumi; Tai, Christopher Y.; Teh, Swee J.			Foraging and metabolic consequences of semi-anadromy for an endangered estuarine fish	PLOS ONE			English	Article							SAN-FRANCISCO ESTUARY; PARTIAL MIGRATION; DELTA SMELT; PHYTOPLANKTON BIOMASS; PRIMARY PRODUCTIVITY; LIFE-HISTORY; SALINITY; SACRAMENTO; CALIFORNIA; PATTERNS	Diadromy affords fish access to productive ecosystems, increasing growth and ultimately fitness, but it is unclear whether these advantages persist for species migrating within highly altered habitat. Here, we compared the foraging success of wild Delta Smelt(_)an endangered, zooplanktivorous, annual, semi-anadromous fish that is endemic to the highly altered San Francisco Estuary (SFE)(_)collected from freshwater (<0.55 psu) and brackish habitat (>= 0.55 psu). Stomach fullness, averaged across three generations of wild Delta Smelt sampled from juvenile through adult life stages (n = 1,318), was 1.5-fold higher in brackish than in freshwater habitat. However, salinity and season interacted, with higher fullness (1.7-fold) in freshwater than in brackish habitat in summer, but far higher fullness in brackish than freshwater habitat during fall/winter and winter/spring (1.8 and 2.0-fold, respectively). To examine potential causes of this interaction we compared mesozooplankton abundance, collected concurrently with the Delta Smelt, in freshwater and brackish habitat during summer and fall/winter, and the metabolic rate of sub-adult Delta Smelt acclimated to salinities of 0.4, 2.0, and 12.0 psu in a laboratory experiment. A seasonal peak in mesozooplankton density coincided with the summer peak in Delta Smelt foraging success in freshwater, and a pronounced decline in freshwater mesozooplankton abundance in the fall coincided with declining stomach fullness, which persisted for the remainder of the year (fall, winter and spring). In brackish habitat, greater foraging 'efficiency' (prey items in stomachs/mesozooplankton abundance) led to more prey items per fish and generally higher stomach fullness (i.e., a higher proportion of mesozooplankton detected in concurrent trawls were eaten by fish in brackish habitat). Delta Smelt exhibited no difference in metabolic rate across the three salinities, indicating that metabolic responses to salinity are unlikely to have caused the stomach fullness results. Adult migration and freshwater spawning therefore places young fish in a position to exploit higher densities of prey in freshwater in the late spring/summer, and subsequent movement downstream provides older fish more accessible prey in brackish habitat. Thus, despite endemism to a highly-altered estuary, semi-anadromy provided substantial foraging benefits to Delta Smelt, consistent with other temperate migratory fish.	[Hammock, Bruce G.; Kurobe, Tomofumi; Tai, Christopher Y.; Teh, Swee J.] Univ Calif Davis, Aquat Hlth Program, Sch Vet Med, Dept Anat Physiol & Cell Biol,VetMed 3B, Davis, CA 95616 USA; [Slater, Steven B.; Baxter, Randall D.; Hennessy, April] Calif Dept Fish & Wildlife, Stockton, CA USA; [Fangue, Nann A.; Cocherell, Dennis] Univ Calif Davis, Dept Wildlife Fish & Conservat Biol, Davis, CA 95616 USA	University of California System; University of California Davis; University of California System; University of California Davis	Hammock, BG (corresponding author), Univ Calif Davis, Aquat Hlth Program, Sch Vet Med, Dept Anat Physiol & Cell Biol,VetMed 3B, Davis, CA 95616 USA.	brucehammock@gmail.com		Kurobe, Tomofumi/0000-0003-3906-1989	California Department of Fish and Wildlife (CDFW) Ecosystem Restoration Program [E1183004]; U.S. Geological Survey [G12AC20079, G15AS00018]; California Department of Water Resources [4600011155]; University of California Davis Agricultural Experiment Station [2098-H]; Interagency Ecological Program; Department of Water Resources [4600010609]; U.S. Bureau of Reclamation [R15AC00094]	California Department of Fish and Wildlife (CDFW) Ecosystem Restoration Program; U.S. Geological Survey(United States Geological Survey); California Department of Water Resources; University of California Davis Agricultural Experiment Station(University of California System); Interagency Ecological Program; Department of Water Resources; U.S. Bureau of Reclamation	Funding for this study was provided by grants to SJT from the California Department of Fish and Wildlife (CDFW) Ecosystem Restoration Program E1183004 and U.S. Geological Survey G12AC20079 and G15AS00018 (Erwin Van Nieuwenhuyse program manager). Partial support was provided by California Department of Water Resources Contract 4600011155 to SJT (Louise Conrad program manager) and the University of California Davis Agricultural Experiment Station (grant 2098-H to NAF). Participation of Steven B. Slater, Randall D. Baxter, and April Hennessy was supported by the Interagency Ecological Program through contracts with Department of Water Resources 4600010609 (Karen Gehrts contract manager) and U.S. Bureau of Reclamation R15AC00094 (Erwin Van Nieuwenhuyse contract manager).	Alerstam T, LONG DISTANCE MIGRAT; ALPINE AE, 1992, LIMNOL OCEANOGR, V37, P946, DOI 10.4319/lo.1992.37.5.0946; [Anonymous], STAT FED LIST END TH; [Anonymous], 2004, IEP LONG TERM FISH M; [Anonymous], 2011, SAN FRANCISCO ESTUAR; [Anonymous], [No title captured]; Avgar T, 2014, CAN J ZOOL, V92, P481, DOI 10.1139/cjz-2013-0076; Baskerville-Bridges B, 2004, AM FISHERIES SOC S; Battin J, 2004, CONSERV BIOL, V18, P1482, DOI 10.1111/j.1523-1739.2004.00417.x; Bennett WA, 2015, ESTUAR COAST, V38, P826, DOI 10.1007/s12237-014-9877-3; Bennett W.A., 2005, SAN FRANCISCO ESTUAR, V3, P2, DOI [DOI 10.15447/SFEWS.2005V3ISS2ART1, 10.15447/sfews.2005v3iss2art1]; Bever A., 2016, SAN FRANCISCO ESTUAR, V14; BLACKETT RF, 1973, J FISH RES BOARD CAN, V30, P543, DOI 10.1139/f73-091; Boeuf G, 2001, COMP BIOCHEM PHYS C, V130, P411, DOI 10.1016/S1532-0456(01)00268-X; Bronmark C, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001957; Brooks ML, 2012, ESTUAR COAST, V35, P603, DOI 10.1007/s12237-011-9459-6; Brown JH, 2004, ECOLOGY, V85, P1771, DOI 10.1890/03-9000; Brown Larry R., 2016, San Francisco Estuary & Watershed Science, V14, P4; Cairns DK, 2009, J FISH BIOL, V74, P2094, DOI 10.1111/j.1095-8649.2009.02290.x; Cech J.J., 2004, FISHES INTRO ICHTHYO, V5th; Cech J.J. Jr, 1990, P335; Chabot D, 2016, J FISH BIOL, V88, P81, DOI 10.1111/jfb.12845; CHADWICK HAROLD K., 1964, CALIFORNIA FISH AND GAME, V50, P69; Chapman BB, 2012, J FISH BIOL, V81, P456, DOI 10.1111/j.1095-8649.2012.03342.x; Chapman BB, 2011, OIKOS, V120, P1764, DOI 10.1111/j.1600-0706.2011.20131.x; Cloern JE, 2012, REV GEOPHYS, V50, DOI 10.1029/2012RG000397; CLOERN JE, 1987, CONT SHELF RES, V7, P1367, DOI 10.1016/0278-4343(87)90042-2; Cohen AN, 1998, SCIENCE, V279, P555, DOI 10.1126/science.279.5350.555; Dege M, 2003, AM FISHERIES SOC S; DESILVA SS, 1976, AQUACULTURE, V7, P327, DOI 10.1016/0044-8486(76)90129-0; Dingle H, 2006, J ORNITHOL, V147, P212, DOI 10.1007/s10336-005-0052-2; Duijns S, 2015, J ANIM ECOL, V84, P565, DOI 10.1111/1365-2656.12309; Elliott J. M., 1972, FRESHWATER BIOL, V2, P1, DOI DOI 10.1111/J.1365-2427.1972.TB01575.X; FESTABIANCHET M, 1988, OECOLOGIA, V75, P580, DOI 10.1007/BF00776423; Feyrer F, 2003, ENVIRON BIOL FISH, V67, P277, DOI 10.1023/A:1025839132274; Feyrer F, 2007, T AM FISH SOC, V136, P469, DOI 10.1577/T06-044.1; Feyrer F, 2011, ESTUAR COAST, V34, P120, DOI 10.1007/s12237-010-9343-9; Finstad AG, 2012, GLOBAL CHANGE BIOL, V18, P2487, DOI 10.1111/j.1365-2486.2012.02717.x; Fisch KM, 2013, J HERED, V104, P92, DOI 10.1093/jhered/ess084; Glibert PM, 2010, REV FISH SCI, V18, P211, DOI 10.1080/10641262.2010.492059; Greene VE, 2011, MAR ECOL PROG SER, V431, P183, DOI 10.3354/meps09099; GROSS MR, 1988, SCIENCE, V239, P1291, DOI 10.1126/science.239.4845.1291; Gross MR, 1987, AM FISHERIES SOC S; Hammock BG, 2015, SCI TOTAL ENVIRON, V532, P316, DOI 10.1016/j.scitotenv.2015.06.018; Hasenbein M, 2016, CONSERV PHYSIOL, V4, DOI 10.1093/conphys/cow004; Hasenbein M, 2013, INTEGR COMP BIOL, V53, P620, DOI 10.1093/icb/ict082; Hebblewhite M, 2008, ECOL MONOGR, V78, P141, DOI 10.1890/06-1708.1; HUTCHINGS JA, 1985, OIKOS, V45, P118, DOI 10.2307/3565229; Hutton PH, 2015, J WATER RESOURCES PL; JASSBY AD, 1994, ESTUAR COAST SHELF S, V39, P595, DOI 10.1016/S0272-7714(06)80012-0; Jassby AD, 2002, LIMNOL OCEANOGR, V47, P698, DOI 10.4319/lo.2002.47.3.0698; Kammerer BD, 2016, FISH PHYSIOL BIOCHEM, V42, P219, DOI 10.1007/s10695-015-0131-0; Kedney G, 1987, AM FISHERIES SOC S; Kerr LA, 2009, FISHERIES, V34, P114, DOI 10.1577/1548-8446-34.3.114; Kimmerer W, 1996, CAUSES LONG TERM DEC, P403; Kimmerer W.J., 2008, SAN FRANC ESTUARY WA, V6, DOI [10.15447/sfews.2008v6iss2art2, DOI 10.15447/SFEWS.2008V6ISS2ART2]; KIMMERER WJ, 1994, MAR ECOL PROG SER, V113, P81, DOI 10.3354/meps113081; Kimmerer WJ, 1998, LIMNOL OCEANOGR, V43, P1697, DOI 10.4319/lo.1998.43.7.1697; KOMOROSKE L, 2014, CONSERV PHYSIOL, V2, P1, DOI DOI 10.1093/C0NPHYS/C0U008; Komoroske L. M., 2016, EVOLUTIONARY APPL; LAMBERT Y, 1994, CAN J FISH AQUAT SCI, V51, P1569, DOI 10.1139/f94-155; Lehman PW, 2000, ESTUARIES, V23, P216, DOI 10.2307/1352829; McMahon R.F., 1983, P505; Moore JW, 2014, J ANIM ECOL, V83, P1035, DOI 10.1111/1365-2656.12212; Morgan JD, 1999, AM J PHYSIOL-REG I, V277, pR631, DOI 10.1152/ajpregu.1999.277.3.R631; Morita K, 1998, J FISH BIOL, V53, P1140, DOI 10.1111/j.1095-8649.1998.tb00471.x; MOYLE PB, 1992, T AM FISH SOC, V121, P67, DOI 10.1577/1548-8659(1992)121<0067:LHASOD>2.3.CO;2; NICHOLS FH, 1986, SCIENCE, V231, P567, DOI 10.1126/science.231.4738.567; Nicolini Mary Helen, 2000, Pacific Science, V54, P377; Northcote T.G., 1978, P326; Parker AE, 2012, MAR POLLUT BULL, V64, P574, DOI 10.1016/j.marpolbul.2011.12.016; Rose KA, 2013, T AM FISH SOC, V142, P1260, DOI 10.1080/00028487.2013.799519; Scharf FS, 2000, MAR ECOL PROG SER, V208, P229, DOI 10.3354/meps208229; Skov C, 2013, BIOL LETTERS, V9, DOI 10.1098/rsbl.2012.1178; Slater S. B., 2014, SAN FRANCISCO ESTUAR, V12; SMITH DW, 1988, HYDROBIOLOGIA, V159, P259, DOI 10.1007/BF00008239; Sommer T, 2007, FISHERIES, V32, P270, DOI 10.1577/1548-8446(2007)32[270:TCOPFI]2.0.CO;2; Stevens DE, 1977, P C ASS EFF POW PLAN; Sullivan LJ, 2016, ENVIRON BIOL FISH, P1; Swanson C, 1996, T AM FISH SOC, V125, P326, DOI 10.1577/1548-8659(1996)125&lt;0326:UOSAAP&gt;2.3.CO;2; Teh SJ, 2016, AQUAT TOXICOL, V170, P152, DOI 10.1016/j.aquatox.2015.11.009; U.S. Fish and Wildlife Service, 1993, FED REGISTER, V58, P12854; Van Nieuwenhuyse EE, 2007, CAN J FISH AQUAT SCI, V64, P1529, DOI 10.1139/F07-121; Vinagre C, 2007, J APPL ICHTHYOL, V23, P240, DOI 10.1111/j.1439-0426.2007.00852.x; Walton LR, 2001, J MAMMAL, V82, P867, DOI 10.1644/1545-1542(2001)082<0867:MPOBGW>2.0.CO;2; Winder M, 2011, ESTUAR COAST, V34, P675, DOI 10.1007/s12237-010-9342-x; Wood CC, 1996, EVOLUTION, V50, P1265, DOI [10.1111/j.1558-5646.1996.tb02367.x, 10.2307/2410667]; Wysujack K, 2009, ECOL FRESHW FISH, V18, P52, DOI 10.1111/j.1600-0633.2008.00322.x	88	19	19	0	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 14	2017	12	3							e0173497	10.1371/journal.pone.0173497	http://dx.doi.org/10.1371/journal.pone.0173497			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN6DM	28291808	Green Submitted, Green Published, gold			2022-12-27	WOS:000396094700030
J	Sung, S; Son, SH; Park, EY; Kay, CS				Sung, SooYoon; Son, Seok Hyun; Park, Eun Young; Kay, Chul Seung			Prognosis of locally advanced rectal cancer can be predicted more accurately using pre-and post-chemoradiotherapy neutrophillymphocyte ratios in patients who received preoperative chemoradiotherapy	PLOS ONE			English	Article							TO-LYMPHOCYTE RATIO; HEPATOCELLULAR-CARCINOMA; NEOADJUVANT CHEMORADIATION; CURATIVE RESECTION; INFLAMMATION; RADIOTHERAPY; CHEMOTHERAPY; SURVIVAL; FLUOROURACIL; HEPATECTOMY	Purpose The neutrophil-lymphocyte ratio (NLR) has been suggested as an inflammation-related factor, but also as an indicator of systemic anti-tumor immunity. We aimed to evaluate the prognostic value of the NLR and to propose a proper cut-off value in patients with locally advanced rectal cancer who received preoperative chemoradiation (CRT) followed by curative total mesorectal excision (TME). Methods A total of 110 rectal cancer patients with clinical T3-4 or node-positive disease were retrospectively analyzed. The NLR value before preoperative CRT (pre-CRT NLR) and the NLR value between preoperative CRT and surgery (post-CRT NLR) were obtained. Using a maximally selected log-rank test, cut-off values were determined as 1.75 for the pre-CRT NLR and 5.14 for the post-CRT NLR. Results Patients were grouped as follows: group A, pre-CRT NLR <= 1.75 and post-CRT NLR <= 5.14 (n = 29); group B, pre-CRT NLR > 1.75 and post-CRT NLR <= 5.14, or pre-CRT NLR <= 1.75 and post-CRT NLR > 5.14 (n = 61); group C, pre-CRT NLR > 1.75 and post-CRT NLR > 5.14 (n = 20). The median follow-up time was 31.1 months. The 3-year disease-free survival (DFS) and overall survival (OS) rates showed significant differences between the NLR groups (3-year DFS rate: 92.7% vs. 73.0% vs. 47.3%, for group A, B, and C, respectively, p = 0.018; 3-year OS rate: 96.0% vs. 85.5% vs. 59.8%, p = 0.034). Multivariate analysis revealed that the NLR was an independent prognostic factor for DFS (p = 0.028). Conclusion Both the pre-CRT NLR and the post-CRT NLR have a predictive value for the prognosis of patients with locally advanced rectal cancer treated with preoperative CRT followed by curative TME and adjuvant chemotherapy. A persistently elevated post-CRT NLR may be an indicator of an increased risk of distant metastasis.	[Sung, SooYoon] Catholic Univ Korea, Coll Med, Seoul St Marys Hosp, Dept Radiat Oncol, Seoul, South Korea; [Son, Seok Hyun; Park, Eun Young; Kay, Chul Seung] Catholic Univ Korea, Incheon St Marys Hosp, Dept Radiat Oncol, Coll Med, Seoul, South Korea	Catholic University of Korea; Seoul St. Mary's Hospital; Catholic University of Korea	Son, SH (corresponding author), Catholic Univ Korea, Incheon St Marys Hosp, Dept Radiat Oncol, Coll Med, Seoul, South Korea.	sonshyun@catholic.ac.kr		Son, Seok Hyun/0000-0002-2577-1915				Adamsson Eryd S, 2012, ARTERIOSCL THROM VAS, V32, P533, DOI 10.1161/ATVBAHA.111.240416; Balta S, 2013, CLIN APPL THROMB-HEM, V19, P579, DOI 10.1177/1076029612475023; Bosset JF, 2006, NEW ENGL J MED, V355, P1114, DOI 10.1056/NEJMoa060829; Carruthers R, 2012, COLORECTAL DIS, V14, pE701, DOI 10.1111/j.1463-1318.2012.03147.x; Chen Q, 2015, TUMOR BIOL, V36, P5283, DOI 10.1007/s13277-015-3188-6; Collette L, 2007, J CLIN ONCOL, V25, P4379, DOI 10.1200/JCO.2007.11.9685; Coussens LM, 2002, NATURE, V420, P860, DOI 10.1038/nature01322; Edge SB, 2010, ANN SURG ONCOL, V17, P1471, DOI 10.1245/s10434-010-0985-4; Folkesson J, 2005, J CLIN ONCOL, V23, P5644, DOI 10.1200/JCO.2005.08.144; Gerard JP, 2006, J CLIN ONCOL, V24, P4620, DOI 10.1200/JCO.2006.06.7629; Govindarajan A, 2011, ANN SURG ONCOL, V18, P3666, DOI 10.1245/s10434-011-1788-y; Hothorn T, 2008, BIOMETRICS, V64, P1263, DOI 10.1111/j.1541-0420.2008.00995.x; Hung HY, 2011, INT J COLORECTAL DIS, V26, P1059, DOI 10.1007/s00384-011-1192-x; Kayadibi H, 2014, WORLD J GASTROENTERO, V20, P9631, DOI 10.3748/wjg.v20.i28.9631; Kim IY, 2014, BMC SURG, V14, DOI 10.1186/1471-2482-14-94; Kusumanto Yoka H., 2003, Angiogenesis, V6, P283, DOI 10.1023/B:AGEN.0000029415.62384.ba; Lee DY, 2013, J GASTRIC CANCER, V13, P111, DOI 10.5230/jgc.2013.13.2.111; Liu Huanran, 2010, J Gastrointest Cancer, V41, P116, DOI 10.1007/s12029-009-9125-4; Maas M, 2015, INT J CANCER, V137, P212, DOI 10.1002/ijc.29355; Mantovani A, 2008, NATURE, V454, P436, DOI 10.1038/nature07205; Mercan R, 2016, J CLIN LAB ANAL, V30, P597, DOI 10.1002/jcla.21908; Nagasaki T, 2015, DIGEST SURG, V32, P496, DOI 10.1159/000441396; Neal CP, 2009, EUR J CANCER, V45, P56, DOI 10.1016/j.ejca.2008.08.019; Pichler M, 2013, BRIT J CANCER, V108, P901, DOI 10.1038/bjc.2013.28; Qi X, 2016, ONCOTARGET; Sauer R, 2004, NEW ENGL J MED, V351, P1731, DOI 10.1056/NEJMoa040694; Shacter E, 2002, ONCOLOGY-NY, V16, P217; Shen LJ, 2014, RADIAT ONCOL, V9, DOI 10.1186/s13014-014-0295-2; Stotz M, 2013, BRIT J CANCER, V109, P416, DOI 10.1038/bjc.2013.332; Tan TP, 2015, ANZ J SURG, V85, P414, DOI 10.1111/ans.13036; Xu XS, 2014, CHINESE MED J-PEKING, V127, P4204, DOI 10.3760/cma.j.issn.0366-6999.20141234; Yamamura K, 2014, J HEPATO-BIL-PAN SCI, V21, P682, DOI 10.1002/jhbp.114; Yang HJ, 2016, WORLD J GASTROENTERO, V22, P5088, DOI 10.3748/wjg.v22.i21.5088; Zahorec R, 2001, Bratisl Lek Listy, V102, P5	34	22	25	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 14	2017	12	3							e0173955	10.1371/journal.pone.0173955	http://dx.doi.org/10.1371/journal.pone.0173955			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN6DM	28291841	gold, Green Published, Green Submitted			2022-12-27	WOS:000396094700051
J	Thompson, DS; Younger-Coleman, N; Lyew-Ayee, P; Greene, LG; Boyne, MS; Forrester, TE				Thompson, Debbie S.; Younger-Coleman, Novie; Lyew-Ayee, Parris; Greene, Lisa-Gaye; Boyne, Michael S.; Forrester, Terrence E.			Socioeconomic factors associated with severe acute malnutrition in Jamaica	PLOS ONE			English	Article							5 YEARS OLD; NUTRITIONAL-STATUS; CHILDREN; HEALTH; LEAD; UNDERNUTRITION; MOTHERS	Objectives Severe acute malnutrition (SAM) is an important risk factor for illness and death globally, contributing to more than half of deaths in children worldwide. We hypothesized that SAM is positively correlated to poverty, low educational attainment, major crime and higher mean soil concentrations of lead, cadmium and arsenic. Methods We reviewed admission records of infants admitted with a diagnosis of SAM over 14 years (2000-2013) in Jamaica. Poverty index, educational attainment, major crime and environmental heavy metal exposure were represented in a Geographic Information System (GIS). Cases of SAM were grouped by community and the number of cases per community/year correlated to socioeconomic variables and geochemistry data for the relevant year. Results 375 cases of SAM were mapped across 204 urban and rural communities in Jamaica. The mean age at admission was 9 months (range 1-45 months) and 57% were male. SAM had a positive correlation with major crime (r = 0.53; P < 0.001), but not with educational attainment or the poverty index. For every one unit increase in the number of crimes reported, the rate of occurrence of SAM cases increased by 1.01% [Incidence rate ratio (IRR) = 1.01 (95% CI = 1.006-1.014); P P < 0.001]. The geochemistry data yielded no correlation between levels of heavy metals and the prevalence of malnutrition. Conclusion Major crime has an independent positive association with severe acute malnutrition in Jamaican infants. This could suggest that SAM and major crime might have similar sociological origins or that criminality at the community level may be indicative of reduced income opportunities with the attendant increase in poor nutrition in the home.	[Thompson, Debbie S.; Younger-Coleman, Novie; Boyne, Michael S.] Univ W Indies, Res Inst Trop Med, Mona, Jamaica; [Lyew-Ayee, Parris; Greene, Lisa-Gaye] Univ W Indies, Mona GeoInformat Inst, Mona, Jamaica; [Forrester, Terrence E.] Univ W Indies, UWI Solut Developing Countries, Mona, Jamaica	University West Indies Mona Jamaica; University West Indies Mona Jamaica; University West Indies Mona Jamaica	Thompson, DS (corresponding author), Univ W Indies, Res Inst Trop Med, Mona, Jamaica.	debbie.thompson@uwimona.edu.jm	Boyne, Michael/AAC-3675-2020; Boyne, Michael S/I-2242-2013; Thompson, Debbie S/AAE-8408-2022	Boyne, Michael/0000-0002-5227-2492; Boyne, Michael S/0000-0002-5227-2492; Thompson, Debbie S/0000-0001-6781-7646				Abuya BA, 2012, BMC PEDIATR, V12, DOI 10.1186/1471-2431-12-80; Ackerson LK, 2008, AM J EPIDEMIOL, V167, P1188, DOI 10.1093/aje/kwn049; Amaya E, 2012, ENVIRON RES, V120, P63; [Anonymous], 2013, GLOB DAT CHILD GROWT; Bellinger DC, 2005, BIRTH DEFECTS RES A, V73, P409, DOI 10.1002/bdra.20127; BITHONEY WG, 1986, PEDIATRICS, V78, P891; Bourne P, 2013, MAJOR CRIMES KINGSTO; Caulfield LE, 2004, AM J TROP MED HYG, V71, P55, DOI 10.4269/ajtmh.2004.71.55; Chatman LM, 2004, BIRTH-ISS PERINAT C, V31, P265, DOI 10.1111/j.0730-7659.2004.00318.x; Department of Maternal and Child Health and Community Health Ministry of Health PRC, 2009, CHILD GROWTH STAND I; Fergusson D, 2004, J CHILD PSYCHOL PSYC, V45, P956, DOI 10.1111/j.1469-7610.2004.t01-1-00288.x; Ghazi HF, 2013, J HEALTH POPUL NUTR, V31, P350; Harriott Anthony, 2001, SOULS CRITICAL J BLA, V3, P56; HENDRICKS KM, 1995, ARCH PEDIAT ADOL MED, V149, P1118, DOI 10.1001/archpedi.1995.02170230072010; Hopenhayn C, 2003, EPIDEMIOLOGY, V14, P593, DOI 10.1097/01.ede.0000072104.65240.69; Justice EIfCPaCISoCa, 2011, COUNTRIES COMPARED C; Kumar Dinesh, 2006, Indian Journal of Pediatrics, V73, P417, DOI 10.1007/BF02758565; Kurzewski K, 2005, W INDIAN MED J, V54, P28; Lalor G., 1996, GEOCHEMICAL ATLAS JA; Lalor GC, 1996, ENVIRON GEOCHEM HLTH, V18, P89, DOI 10.1007/BF01771284; Lalor GC, 2008, SCI TOTAL ENVIRON, V400, P162, DOI 10.1016/j.scitotenv.2008.07.011; Liu JH, 2004, AM J PSYCHIAT, V161, P2005, DOI 10.1176/appi.ajp.161.11.2005; Mohsena M, 2010, PUBLIC HEALTH NUTR, V13, P1498, DOI 10.1017/S1368980010001758; Mullany LC, 2007, J EPIDEMIOL COMMUN H, V61, DOI 10.1136/jech.2006.055087; O'Hare BAM, 2007, J ROY SOC MED, V100, P564, DOI 10.1258/jrsm.100.12.564; PIOJ, 2008, MAPP POV IND CONS BA; Ruiz-Grosso Paulo, 2014, Rev. perú. med. exp. salud publica, V31, P16; Silveira KBR, 2010, J PEDIAT-BRAZIL, V86, P215, DOI 10.2223/JPED.1991; Tian LL, 2009, BIOL TRACE ELEM RES, V132, P51, DOI 10.1007/s12011-009-8391-0; United Kingdom FCO, 2009, N CENTR AM CAR JAM; UNPFA, 2008, UNFPA THE CAR; Waterlow J C, 1976, Monogr Ser World Health Organ, P530; World Bank GPWG, 2014, WORLD DEV IND; World Health Organization (WHO), 2014, CHILDR RED MORT	34	8	8	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 14	2017	12	3							e0173101	10.1371/journal.pone.0173101	http://dx.doi.org/10.1371/journal.pone.0173101			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EN6DM	28291805	gold, Green Submitted, Green Published			2022-12-27	WOS:000396094700012
J	Asor, E; Stav, MY; Simon, E; Fahoum, I; Sabo, E; Ben-Izhak, O; Hershkovitz, D				Asor, Eyal; Stav, Michael Y.; Simon, Einav; Fahoum, Ibrahim; Sabo, Edmond; Ben-Izhak, Ofer; Hershkovitz, Dov			Risk for molecular contamination of tissue samples evaluated for targeted anti-cancer therapy	PLOS ONE			English	Article							INTEGRATIVE GENOMICS VIEWER; SURGICAL PATHOLOGY; LUNG-CANCER; HUMAN-PAPILLOMAVIRUS; CROSS-CONTAMINATION; COLORECTAL-CANCER; EXTRANEOUS TISSUE; EGFR; CARCINOMA; EXPRESSION	With the increasing usage of sensitive PCR technology for pharmacogenetics, cross contamination becomes a significant concern. Researchers employed techniques which basically include replacing laboratory equipment after each sample preparation; however, there are no recommended guidelines. In the present work we wanted to evaluate the risk of cross contamination during tissue processing using the routine precaution measures. Twenty-one surgical samples of lung adenocarcinoma were used, of which 7 contained EGFR exon 19 mutation, 7 contained EGFR exon 21 mutation (p.L858R) and 7 were EGFR wild-type. The samples were ordered by alternating the mutation group to maximize the potential for cross contamination and underwent tissue sectioning and de-paraffinization. The entire process was performed using the same tools. Following DNA extraction all samples underwent PCR amplification and were scrutinized for small fractions of EGFR mutation using deep sequencing with the Ion torrent PGM technology. Twenty samples yielded results. The fraction of mutated copies was 41 +/- 23% (range 11-66) for the cases with known exon 19 mutation and 48 +/- 24% (range 0-65) for the cases with known exon 21 mutations. No in-frame exon 19 deletion mutations were identified in the wild-type (WT) and exon 21 groups. The fraction of EGFR exon 21 (codon 858) mutations was 0.018 +/- 0.014% (range 0-0.05%) in the WT and exon 19 groups, which was not statistically different than the background sequencing artifact noise for the same base-pair alteration (p = 0.21). Our results suggest that standard precautions are sufficient for molecular pathology diagnosis of surgical samples and are not associated with increased risk of cross contamination.	[Asor, Eyal; Simon, Einav; Sabo, Edmond; Ben-Izhak, Ofer] Technion Israel Inst Technol, B Rappaport Fac Med, Haifa, Israel; [Asor, Eyal; Stav, Michael Y.; Sabo, Edmond; Ben-Izhak, Ofer] Rambam Hlth Care Campus, Inst Pathol, Haifa, Israel; [Fahoum, Ibrahim; Hershkovitz, Dov] Tel Aviv Sourasky Med Ctr, Inst Pathol, Tel Aviv, Israel; [Hershkovitz, Dov] Tel Aviv Univ, Sackler Fac Med, Tel Aviv, Israel	Technion Israel Institute of Technology; Rappaport Faculty of Medicine; Rambam Health Care Campus; Tel Aviv University; Sackler Faculty of Medicine; Tel Aviv Sourasky Medical Center; Tel Aviv University; Sackler Faculty of Medicine	Hershkovitz, D (corresponding author), Tel Aviv Sourasky Med Ctr, Inst Pathol, Tel Aviv, Israel.; Hershkovitz, D (corresponding author), Tel Aviv Univ, Sackler Fac Med, Tel Aviv, Israel.	dovh@tlvmc.gov.il		Hershkovitz, Dov/0000-0002-7954-4486				Bluth MJ, 2013, CLIN LAB MED, V33, P753, DOI 10.1016/j.cll.2013.09.004; Chong IY, 2013, J PATHOL, V231, P301, DOI 10.1002/path.4247; de Leng WWJ, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0149405; Dubbink HJ, 2014, MOL ONCOL, V8, P830, DOI 10.1016/j.molonc.2014.03.004; Gephardt GN, 1996, ARCH PATHOL LAB MED, V120, P1009; Gheit T, 2014, J MED VIROL, V86, P642, DOI 10.1002/jmv.23866; Gokhale S, 2002, APPL IMMUNOHISTO M M, V10, P282, DOI 10.1097/01.PAI.0000024388.65085.D4; Hunt JL, 2008, ADV ANAT PATHOL, V15, P211, DOI 10.1097/PAP.0b013e31817bf596; Hunt JL, 2003, ARCH PATHOL LAB MED, V127, P213; Jager W, 2013, J UROLOGY, V190, P1404, DOI 10.1016/j.juro.2013.03.009; Lamy A, 2011, MODERN PATHOL, V24, P1090, DOI 10.1038/modpathol.2011.60; Layfield LJ, 2011, AM J CLIN PATHOL, V136, P767, DOI 10.1309/AJCP4FFSBPHAU8IU; Messersmith WA, 2008, NEW ENGL J MED, V359, P1834, DOI 10.1056/NEJMe0806778; Netto George J, 2003, Proc (Bayl Univ Med Cent), V16, P379; Newman AM, 2016, NAT BIOTECHNOL, V34, P547, DOI 10.1038/nbt.3520; Pirker Robert, 2010, J Thorac Oncol, V5, P1706, DOI 10.1097/JTO.0b013e3181f1c8de; Platt E, 2009, ARCH PATHOL LAB MED, V133, P973, DOI 10.1043/1543-2165-133.6.973; Ritchey JW, 2006, J AM ASSOC LAB ANIM, V45, P7; Robinson JT, 2011, NAT BIOTECHNOL, V29, P24, DOI 10.1038/nbt.1754; Rodriguez-Carunchio L, 2015, BJOG-INT J OBSTET GY, V122, P119, DOI 10.1111/1471-0528.13071; Salter SJ, 2014, BMC BIOL, V12, DOI 10.1186/s12915-014-0087-z; Sarchianaki E, 2014, TUMOR BIOL, V35, P3203, DOI 10.1007/s13277-013-1419-2; Sequist LV, 2008, ANNU REV MED, V59, P429, DOI 10.1146/annurev.med.59.090506.202405; Sholl LM, 2009, CANCER RES, V69, P8341, DOI 10.1158/0008-5472.CAN-09-2477; Tezal M, 2012, ARCH OTOLARYNGOL, V138, P669, DOI 10.1001/archoto.2012.873; Thorvaldsdottir H, 2013, BRIEF BIOINFORM, V14, P178, DOI 10.1093/bib/bbs017; Tuononen K, 2013, GENE CHROMOSOME CANC, V52, P503, DOI 10.1002/gcc.22047; Varanat M, 2009, VET PATHOL, V46, P940, DOI 10.1354/vp.08-VP-0259-B-BC; Warth A, 2016, VIRCHOWS ARCH, V468, P101, DOI 10.1007/s00428-015-1869-6; Yatabe Y, 2008, CANCER RES, V68, P2106, DOI 10.1158/0008-5472.CAN-07-5211	30	6	6	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 13	2017	12	3							e0173760	10.1371/journal.pone.0173760	http://dx.doi.org/10.1371/journal.pone.0173760			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN6CP	28288198	Green Published, Green Submitted, gold			2022-12-27	WOS:000396092400035
J	Ikuno, T; Masumoto, H; Yamamizu, K; Yoshioka, M; Minakata, K; Ikeda, T; Sakata, R; Yamashita, JK				Ikuno, Takeshi; Masumoto, Hidetoshi; Yamamizu, Kohei; Yoshioka, Miki; Minakata, Kenji; Ikeda, Tadashi; Sakata, Ryuzo; Yamashita, Jun K.			Efficient and robust differentiation of endothelial cells from human induced pluripotent stem cells via lineage control with VEGF and cyclic AMP	PLOS ONE			English	Article							EMBRYONIC VASCULAR DEVELOPMENT; FUNCTIONAL HUMAN LIVER; ORGAN BUD TRANSPLANT; PROGENITOR CELLS; RAT HEARTS; NOTCH; ARTERIAL; SHEETS; INDUCTION; BLOOD	Blood vessels are essential components for many tissues and organs. Thus, efficient induction of endothelial cells (ECs) from human pluripotent stem cells is a key method for generating higher tissue structures entirely from stem cells. We previously established an EC differentiation system with mouse pluripotent stem cells to show that vascular endothelial growth factor (VEGF) is essential to induce ECs and that cyclic adenosine monophosphate (cAMP) synergistically enhances VEGF effects. Here we report an efficient and robust EC differentiation method from human pluripotent stem cell lines based on a 2D monolayer, serum-free culture. We controlled the direction of differentiation from mesoderm to ECs using stage-specific stimulation with VEGF and cAMP combined with the elimination of non-responder cells at early EC stage. This "stimulation-elimination" method robustly achieved very high efficiency (> 99%) and yield (> 10 ECs from 1 hiPSC input) of EC differentiation, with no purification of ECs after differentiation. We believe this method will be a valuable technological basis broadly for regenerative medicine and 3D tissue engineering.	[Ikuno, Takeshi; Masumoto, Hidetoshi; Yamamizu, Kohei; Yoshioka, Miki; Yamashita, Jun K.] Kyoto Univ, Dept Cell Growth & Differentiat, Ctr iPS Cell Res & Applicat, Kyoto, Japan; [Ikuno, Takeshi; Masumoto, Hidetoshi; Minakata, Kenji; Ikeda, Tadashi; Sakata, Ryuzo] Kyoto Univ, Grad Sch Med, Dept Cardiovasc Surg, Kyoto, Japan	Kyoto University; Kyoto University	Yamashita, JK (corresponding author), Kyoto Univ, Dept Cell Growth & Differentiat, Ctr iPS Cell Res & Applicat, Kyoto, Japan.	juny@cira.kyoto-u.ac.jp			MEXT/JSPS KAKENHI Grant [24390197]; Japan Agency for Medical Research and Development, AMED; Health Labour Sciences Research Grant	MEXT/JSPS KAKENHI Grant(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Japan Agency for Medical Research and Development, AMED(Japan Agency for Medical Research and Development (AMED)); Health Labour Sciences Research Grant(Ministry of Health, Labour and Welfare, Japan)	Support was provided by MEXT/JSPS KAKENHI Grant, #24390197; Core Center for iPS Cell Research, Research Center Network for Realization of Regenerative Medicine from Japan Agency for Medical Research and Development, AMED.; This study was funded by Core Center for iPS Cell Research, Research Center Network for Realization of Regenerative Medicine from Japan Agency for Medical Research and Development, AMED, MEXT/JSPS KAKENHI Grant, and Health Labour Sciences Research Grant. We thank Dr. Peter Karagiannis (Kyoto University) for critical reading of the manuscript.	Arita Y, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5552; Asahara T, 1997, SCIENCE, V275, P964, DOI 10.1126/science.275.5302.964; Asakawa N, 2010, BIOMATERIALS, V31, P3903, DOI 10.1016/j.biomaterials.2010.01.105; Bao XP, 2016, METHODS MOL BIOL, V1481, P183, DOI 10.1007/978-1-4939-6393-5_17; Carpenter L, 2012, STEM CELLS DEV, V21, P977, DOI 10.1089/scd.2011.0075; Carreira CM, 2001, CANCER RES, V61, P8079; Caspi O, 2007, J AM COLL CARDIOL, V50, P1884, DOI 10.1016/j.jacc.2007.07.054; Ditadi A, 2015, NAT CELL BIOL, V17, P580, DOI 10.1038/ncb3161; Du C, 2014, BIOMATERIALS, V35, P6006, DOI 10.1016/j.biomaterials.2014.04.011; Duarte A, 2004, GENE DEV, V18, P2474, DOI 10.1101/gad.1239004; Dunne LW, 2014, ACTA BIOMATER, V10, P3630, DOI 10.1016/j.actbio.2014.05.005; Fischer A, 2004, GENE DEV, V18, P901, DOI 10.1101/gad.291004; Gloor SM, 2001, BRAIN RES REV, V36, P258, DOI 10.1016/S0165-0173(01)00102-3; Hristov M, 2003, ARTERIOSCL THROM VAS, V23, P1185, DOI 10.1161/01.ATV.0000073832.49290.B5; Kataoka H, 2011, BLOOD, V118, P6975, DOI 10.1182/blood-2011-05-352658; Krebs LT, 2004, GENE DEV, V18, P2469, DOI 10.1101/gad.1239204; Laflamme MA, 2007, NAT BIOTECHNOL, V25, P1015, DOI 10.1038/nbt1327; Lawson ND, 2001, DEVELOPMENT, V128, P3675; Lee D, 2008, CELL STEM CELL, V2, P497, DOI 10.1016/j.stem.2008.03.008; Liu YW, 2014, BIOMACROMOLECULES, V15, P1044, DOI 10.1021/bm401926k; Masumoto H, 2012, STEM CELLS, V30, P1196, DOI 10.1002/stem.1089; Nagamori E, 2013, BIOMATERIALS, V34, P662, DOI 10.1016/j.biomaterials.2012.08.055; Ngo TX, 2013, BIOTECHNOL LETT, V35, P1001, DOI 10.1007/s10529-013-1174-x; Nishiguchi A, 2014, BIOMATERIALS, V35, P4739, DOI 10.1016/j.biomaterials.2014.01.079; Okita K, 2011, NAT METHODS, V8, P409, DOI [10.1038/NMETH.1591, 10.1038/nmeth.1591]; Pirraco RP, 2014, LAB INVEST, V94, P663, DOI 10.1038/labinvest.2014.55; Prasain N, 2014, NAT BIOTECHNOL, V32, P1151, DOI 10.1038/nbt.3048; Ricono JM, 2003, J HISTOCHEM CYTOCHEM, V51, P141, DOI 10.1177/002215540305100202; Rufaihah AJ, 2013, AM J TRANSL RES, V5, P21; Salven P, 2003, BLOOD, V101, P168, DOI 10.1182/blood-2002-03-0755; Sasagawa T, 2010, BIOMATERIALS, V31, P1646, DOI 10.1016/j.biomaterials.2009.11.036; Sekine H, 2008, CIRCULATION, V118, pS145, DOI 10.1161/CIRCULATIONAHA.107.757286; Shiba Y, 2012, NATURE, V489, P322, DOI 10.1038/nature11317; Sriram G, 2015, STEM CELL RES THER, V6, DOI 10.1186/s13287-015-0260-5; Taguchi A, 2014, CELL STEM CELL, V14, P53, DOI 10.1016/j.stem.2013.11.010; Takahashi K, 2007, CELL, V131, P861, DOI 10.1016/j.cell.2007.11.019; Takebe T, 2014, NAT PROTOC, V9, P396, DOI 10.1038/nprot.2014.020; Takebe T, 2013, NATURE, V499, P481, DOI 10.1038/nature12271; Uosaki H, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023657; Wang HU, 1998, CELL, V93, P741, DOI 10.1016/S0092-8674(00)81436-1; Xue YZ, 1999, HUM MOL GENET, V8, P723, DOI 10.1093/hmg/8.5.723; Yamamizu K, 2013, STEM CELL REP, V1, P545, DOI 10.1016/j.stemcr.2013.10.006; Yamamizu K, 2013, SCI REP-UK, V3, DOI 10.1038/srep03213; Yamamizu K, 2012, STEM CELLS, V30, P687, DOI 10.1002/stem.1041; Yamamizu K, 2010, J CELL BIOL, V189, P325, DOI 10.1083/jcb.200904114; Yamamizu K, 2009, BLOOD, V114, P3707, DOI 10.1182/blood-2008-12-195750; Yamashita JK, 2005, FASEB J, V19, P1534, DOI 10.1096/fj.04-3540fje; Yin AH, 1997, BLOOD, V90, P5002, DOI 10.1182/blood.V90.12.5002.5002_5002_5012; You LR, 2005, NATURE, V435, P98, DOI 10.1038/nature03511; Yurugi-Kobayashi T, 2006, ARTERIOSCL THROM VAS, V26, P1977, DOI 10.1161/01.ATV.0000234978.10658.41	50	49	49	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 13	2017	12	3							e0173271	10.1371/journal.pone.0173271	http://dx.doi.org/10.1371/journal.pone.0173271			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN6CP	28288160	Green Published, Green Submitted, gold			2022-12-27	WOS:000396092400011
J	Julian, R; Hecksteden, A; Fullagar, HHK; Meyer, T				Julian, Ross; Hecksteden, Anne; Fullagar, Hugh H. K.; Meyer, Tim			The effects of menstrual cycle phase on physical performance in female soccer players	PLOS ONE			English	Article							EXERCISE PERFORMANCE; BLOOD LACTATE; INTERMITTENT; MUSCLE; PHYSIOLOGY; RESPONSES; RECOVERY	Background Female soccer has grown extensively in recent years, however differences in gender-specific physiology have rarely been considered. The female reproductive hormones which rise and fall throughout the menstrual cycle, are known to affect numerous cardiovascular, respiratory, thermoregulatory and metabolic parameters, which in turn, may have implications on exercise physiology and soccer performance. Therefore, the main aim of the present study was to investigate potential effects of menstrual cycle phase on performance in soccer specific tests. Methods Nine sub elite female soccer players, all of whom have menstrual cycles of physiological length; performed a series of physical performance tests (Yo-Yo Intermittent endurance test (Yo-Yo IET), counter movement jump (CMJ) and 3x30 m sprints). These were conducted at distinct time points during two main phases of the menstrual cycle (early follicular phase (FP) and mid luteal phase (LP)) where hormones contrasted at their greatest magnitude. Results Yo-Yo IET performance was considerably lower during the mid LP (2833 896 m) as compared to the early FP (3288 800 m). A trend towards significance was observed (p = 0.07) and the magnitude based inferences suggested probabilities of 0/61/39 for superiority/ equality/inferiority of performance during the mid LP, leading to the inference of a possibly harmful effect. For CMJ (early FP, 20.0 3.9 cm; mid LP 29.6 3.0 cm, p = 0.33) and sprint (early FP, 4.7 0.1 s; mid LP, 4.7 0.1 s, p = 0.96) performances the results were unclear (8/ 24/68, 48/0/52, respectively). Conclusion The results of this study are in support of a reduction in maximal endurance performance during the mid LP of the menstrual cycle. However, the same effect was not observed for jumping and sprint performance. Therefore, consideration of cycle phase when monitoring a player's endurance capacity may be worthwhile.	[Julian, Ross; Hecksteden, Anne; Fullagar, Hugh H. K.; Meyer, Tim] Univ Saarland, Inst Sports & Prevent Med, Saarbrucken, Germany; [Fullagar, Hugh H. K.] Univ Technol Sydney, Sport & Exercise Discipline Grp, Lindifield, Australia; [Fullagar, Hugh H. K.] Univ Oregon, Dept Athlet Football, Eugene, OR 97403 USA	Saarland University; University of Technology Sydney; University of Oregon	Julian, R (corresponding author), Univ Saarland, Inst Sports & Prevent Med, Saarbrucken, Germany.	ross.julian@uni-saarland.de		Julian, Ross/0000-0002-8558-7132; Fullagar, Hugh/0000-0001-9426-5373				Bailey SP, 2000, J APPL PHYSIOL, V88, P690, DOI 10.1152/jappl.2000.88.2.690; Bangsbo J, 2008, SPORTS MED, V38, P37, DOI 10.2165/00007256-200838010-00004; Batterham AM, 2006, INT J SPORT PHYSIOL, V1, P50, DOI 10.1123/ijspp.1.1.50; Beidleman BA, 1999, J APPL PHYSIOL, V86, P1519, DOI 10.1152/jappl.1999.86.5.1519; Bemben DA, 1995, J SPORT MED PHYS FIT, V35, P257; Bradley PS, 2014, SCAND J MED SCI SPOR, V24, P43, DOI 10.1111/j.1600-0838.2012.01483.x; Bradley PS, 2011, EUR J APPL PHYSIOL, V111, P969, DOI 10.1007/s00421-010-1721-2; Bruinvels G, 2016, BR J SPORTS MED; Campbell SE, 2001, AM J PHYSIOL-ENDOC M, V281, pE817; Cohen J, 1988, PERCEPT MOTOR SKILL, V67, P1007; Constantini Naama W, 2005, Clin Sports Med, V24, pe51, DOI 10.1016/j.csm.2005.01.003; Datson N, 2014, SPORTS MED, V44, P1225, DOI 10.1007/s40279-014-0199-1; de Jonge XAKJ, 2003, SPORTS MED, V33, P833; de Jonge XAKJ, 2001, J PHYSIOL-LONDON, V530, P161, DOI 10.1111/j.1469-7793.2001.0161m.x; De Jonge XAKJ, 2012, MED SCI SPORT EXER, V44, P2190, DOI 10.1249/MSS.0b013e3182656f13; DESOUZA MJ, 1990, MED SCI SPORT EXER, V22, P575, DOI 10.1249/00005768-199010000-00006; Di Salvo V, 2009, INT J SPORTS MED, V30, P205, DOI 10.1055/s-0028-1105950; Duncan GE, 1997, MED SCI SPORT EXER, V29, P273, DOI 10.1097/00005768-199702000-00017; Frankovich RJ, 2000, CLIN SPORT MED, V19, P251, DOI 10.1016/S0278-5919(05)70202-7; Hackney AC, 2000, JPN J PHYSIOL, V50, P489, DOI 10.2170/jjphysiol.50.489; HESSEMER V, 1985, J APPL PHYSIOL, V59, P1911, DOI 10.1152/jappl.1985.59.6.1911; JURKOWSKI JEH, 1981, J APPL PHYSIOL, V51, P1493, DOI 10.1152/jappl.1981.51.6.1493; Krustrup P, 2005, MED SCI SPORT EXER, V37, P1242, DOI 10.1249/01.mss.0000170062.73981.94; LEBRUN CM, 1995, MED SCI SPORT EXER, V27, P437; Lynch NJ, 1998, EUR J APPL PHYSIOL O, V78, P565, DOI 10.1007/s004210050462; Middleton LE, 2006, EUR J APPL PHYSIOL, V96, P53, DOI 10.1007/s00421-005-0073-9; NICKLAS BJ, 1989, INT J SPORTS MED, V10, P264, DOI 10.1055/s-2007-1024913; Oosthuyse T, 2010, SPORTS MED, V40, P207, DOI 10.2165/11317090-000000000-00000; Phillips SK, 1996, J PHYSIOL-LONDON, V496, P551, DOI 10.1113/jphysiol.1996.sp021706; PIVARNIK JM, 1992, J APPL PHYSIOL, V72, P543, DOI 10.1152/jappl.1992.72.2.543; Reilly T, 2000, BIOL RHYTHM RES, V31, P29, DOI 10.1076/0929-1016(200002)31:1;1-0;FT029; Somboonwong J, 2015, J STRENGTH COND RES, V29, P262, DOI 10.1097/JSC.0000000000000235; Stolen T, 2005, SPORTS MED, V35, P501; Sunderland C, 2003, EUR J APPL PHYSIOL, V88, P345, DOI 10.1007/s00421-002-0722-1; Svensson M, 2005, J SPORT SCI, V23, P601, DOI 10.1080/02640410400021294; Tsampoukos A, 2010, EUR J APPL PHYSIOL, V109, P659, DOI 10.1007/s00421-010-1384-z; Turner A, 2011, STRENGTH COND J, V33, P29, DOI 10.1519/SSC.0b013e31822fc80a; Vaiksaar S, 2011, EUR J APPL PHYSIOL, V111, P1027, DOI 10.1007/s00421-010-1730-1; Vancini RL, 2016, J SPORTS MED PHYS FI; Wideman L, 2010, MED SCI SPORT EXER, V42, P341, DOI 10.1249/01.MSS.0000384618.01923.01; Williams TJ, 1997, MED SCI SPORT EXER, V29, P1609, DOI 10.1097/00005768-199712000-00010	41	61	61	5	44	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 13	2017	12	3							e0173951	10.1371/journal.pone.0173951	http://dx.doi.org/10.1371/journal.pone.0173951			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN6CP	28288203	Green Published, Green Submitted, gold			2022-12-27	WOS:000396092400044
J	Peng, NC; Shi, LX; Zhang, Q; Hu, Y; Wang, NP; Ye, H				Peng, Nianchun; Shi, Lixin; Zhang, Qiao; Hu, Ying; Wang, Nanpeng; Ye, Hui			Microarray profiling of circular RNAs in human papillary thyroid carcinoma	PLOS ONE			English	Article							MICRORNA EXPRESSION; TARGETS; CANCER; FAMILY; GENES	Background Non-coding circular RNAs (circRNAs) have displayed dysregulated expression in several human cancers. Here, we profiled the circRNA expression of papillary thyroid carcinoma (PTC) tumors to improve our understanding of PTC pathogenesis. Methods Microarray profiling was performed on 18 thyroid samples, consisting of six PTC tumors, six matching contralateral normal samples, and six benign thyroid lesions. After low-intensity filtering, hierarchical clustering revealed the circRNA expression patterns. Statistical analysis followed by qRT-PCR validation identified the differential circRNAs. MicroRNA (miRNA) target prediction software identified putative miRNA response elements (MREs), which were used to construct a network map of circRNA-miRNA interactions for the differential circRNAs. Bioinformatics platforms predicted cancer-related circRNA-miRNA associations and putative downstream target genes, respectively. Results A total of 88 circRNAs and 10 circRNAs were significantly upregulated and downregulated, respectively, in PTC tumors relative to normal thyroid tissue, while 129 circRNAs and 226 circRNAs were significantly upregulated and downregulated, respectively, in PTC tumors relative to benign thyroid lesions. A total of 12 upregulated and four downregulated circRNAs were overlapping between the foregoing comparisons. One downregulated circRNA (hsa_circRNA_100395) showed interactive potential with two cancer-related miRNAs (miR141-3p and miR-200a-3p). From this analysis, we identified several promising cancer-related genes that may be targets of the dysregulated hsa_circRNA_100395/miR-141-3p/miR-200a-3p axis in PTC tumors. Conclusions circRNA dysregulation may play a role in PTC pathogenesis, and several key circRNAs show promise as candidate biomarkers for PTC. The hsa_circRNA_100395/miR-141-3p/miR-200a-3p axis may be involved in the pathogenesis of PTC.	[Peng, Nianchun; Shi, Lixin; Zhang, Qiao; Hu, Ying] Guizhou Med Univ, Affiliated Hosp, Dept Endocrinol & Metab, Guiyang, Peoples R China; [Wang, Nanpeng; Ye, Hui] Guizhou Med Univ, Affiliated Hosp, Dept Thyroid Surg, Guiyang, Peoples R China	Guizhou Medical University; Guizhou Medical University	Shi, LX (corresponding author), Guizhou Med Univ, Affiliated Hosp, Dept Endocrinol & Metab, Guiyang, Peoples R China.	slx1962@medmail.com.cn			Chinese Medical Association; Provincial Governor's Special Fund of Guizhou Province [2012100];  [12020130273]	Chinese Medical Association; Provincial Governor's Special Fund of Guizhou Province; 	This work was supported by the Chinese Medical Association, clinical research and special project funds (grant no. 12020130273) and the Provincial Governor's Special Fund of Guizhou Province (grant no. 2012100). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Microarray experiments were performed by KangChen Bio-tech, Shanghai, China.	Agrawal N, 2014, CELL, V159, P676, DOI 10.1016/j.cell.2014.09.050; Braun J, 2011, THYROID RES, V4, DOI 10.1186/1756-6614-4-S1-S1; Chang L, 2015, ONCOL LETT, V9, P2317, DOI 10.3892/ol.2015.3028; Chen Y, 2016, J MED GENETICS; Dettmer M, 2013, THYROID, V23, P1383, DOI 10.1089/thy.2012.0632; Dinets A, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0126472; Han YH, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018286; He HL, 2005, P NATL ACAD SCI USA, V102, P19075, DOI 10.1073/pnas.0509603102; Hebrant A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037807; Hidaka H, 2012, ONCOTARGET, V3, P44; Korpal M, 2008, RNA BIOL, V5, P115, DOI 10.4161/rna.5.3.6558; Kozomara A, 2014, NUCLEIC ACIDS RES, V42, pD68, DOI 10.1093/nar/gkt1181; La Vecchia C, 2015, INT J CANCER, V136, P2187, DOI 10.1002/ijc.29251; Lan XB, 2015, GENE, V569, P109, DOI 10.1016/j.gene.2015.05.046; Li JQ, 2015, AM J CANCER RES, V5, P472; Liep J, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0157801; Ling H, 2013, NAT REV DRUG DISCOV, V12, P847, DOI 10.1038/nrd4140; Luo DH, 2013, J TRANSL MED, V11, DOI 10.1186/1479-5876-11-203; Mo Y-Y., 2015, DTIC DOCUMENT; Mohammadi-Asl J, 2015, EPIGENETICS THYROID, P479; Pallante P, 2006, ENDOCR-RELAT CANCER, V13, P497, DOI 10.1677/erc.1.01209; Saha S, 2015, MOL CELL ENDOCRINOL, V414, P186, DOI 10.1016/j.mce.2015.07.030; Sand M, 2016, J DERMATOLOGICAL SCI; Santoro M, 2015, NAT REV ENDOCRINOL, V11, P133, DOI 10.1038/nrendo.2014.209; Swierniak M, 2013, J CLIN ENDOCR METAB, V98, pE1401, DOI 10.1210/jc.2013-1214; Tejero R, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0101899; Tetzlaff MT, 2007, ENDOCR PATHOL, V18, P163, DOI 10.1007/s12022-007-0023-7; Vlachos IS, 2015, NUCLEIC ACIDS RES, V43, pD153, DOI 10.1093/nar/gku1215; Vlachos IS., 2015, NUCLEIC ACIDS RES; Vriens MR, 2012, CANCER-AM CANCER SOC, V118, P3426, DOI 10.1002/cncr.26587; Waltering KK, 2011, PROSTATE, V71, P604, DOI 10.1002/pros.21276; Whitaker Mark, 2016, AM ETHN SOC M WASH D; Wright PR, 2014, NUCLEIC ACIDS RES, V42, pW119, DOI 10.1093/nar/gku359; Xie J, 2015, J BIOMATER TISS ENG, V5, P872, DOI 10.1166/jbt.2015.1389; Xiong Q, 2016, INT J CLIN EXP PATHO, V9, P3057; Xu F, 2016, CLIN TRANSL ONCOL, V18, P283, DOI 10.1007/s12094-015-1364-1; Yang ZL, 2013, MOL MED REP, V8, P1353, DOI 10.3892/mmr.2013.1699; Zhang LM, 2010, CARCINOGENESIS, V31, P559, DOI 10.1093/carcin/bgp335	38	99	103	1	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 13	2017	12	3							e0170287	10.1371/journal.pone.0170287	http://dx.doi.org/10.1371/journal.pone.0170287			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN6CP	28288173	gold, Green Published, Green Submitted			2022-12-27	WOS:000396092400002
J	Tadesse, SE; Seid, O; Mariam, YG; Fekadu, A; Wasihun, Y; Endris, K; Bitew, A				Tadesse, Sisay Eshete; Seid, Omer; Mariam, Yemane G.; Fekadu, Abel; Wasihun, Yitbarek; Endris, Kedir; Bitew, Abebayehu			Determinants of anemia among pregnant mothers attending antenatal care in Dessie town health facilities, northern central Ethiopia, unmatched case -control study	PLOS ONE			English	Article							RISK-FACTORS; WOMEN	Introduction Anemia affects around 38.2% and 22% of pregnant women at a global and national level respectively. In developing countries, women start pregnancy with already depleted body stores of iron and other vitamins with significant variation of anemia within and between regions. Objective To identify the determinants of anemia among pregnant mothers attending antenatal care in Dessie town health facilities, northern central Ethiopia. Methods A health facility based unmatched case control study was conducted among 112 cases and 336 controls from January to March 2016 G.C. The sample size was determined by using Epi Info version 7.1.5.2. Study subjects were selected using consecutive sampling technique. Data were collected using a structured questionnaire, entered using Epi Data version 3.1 and analyzed using SPSS version 20. Bivariable and multivariable logistic regression model was used to see the determinants of anemia. Adjusted odds ratio (AOR) with 95% confidence interval (CI) and p-value< 0.05 were used to see the significant association. Results Failure to take dark green leafy vegetables per two weeks (AOR = 5.02, 95% CI: 2.16, 11.71), didn't take chicken per two weeks (AOR = 2.68, 95% CI: 1.22, 5.86), 1 st trimester (AOR = 2.07, 95% CI: 1.12, 3.84), 3rd trimester (AOR = 2.96, 95% CI: 1.53, 5.72), HIV infection (AOR = 6.78, 95% CI: 2.28, 20.18) and medication (AOR = 3.57 95% CI: 1.60, 7.98) were positively associated with anemia. Conclusions Inadequate intake of dark green leafy vegetables, inadequate consumption of chicken, trimester of the current pregnancy, HIV infection and medication were the determinants of anemia among pregnant women. Therefore, anemia prevention strategy should include promotion of adequate intake of dark green leafy vegetables and chicken, increase meal pattern during the entire pregnancy and strengthen the prevention of mother to child HIV transmission/antenatal care programs.	[Tadesse, Sisay Eshete] Wollo Univ, Dept Nutr, Coll Med & Hlth Sci, Dessie, Ethiopia; [Seid, Omer] Mekelle Univ, Dept Nutr & Dietet, Coll Hlth Sci, Mekelle, Ethiopia; [Mariam, Yemane G.] Mekelle Univ, Coll Hlth Sci, Hlth Care Management, Mekelle, Ethiopia; [Fekadu, Abel] Univ Gondar, Dept Biostat & Epidemiol, Coll Med & Hlth Sci, Gondar, Ethiopia; [Wasihun, Yitbarek] Wollo Univ, Dept Hlth Educ, Coll Med & Hlth Sci, Dessie, Ethiopia; [Endris, Kedir] Mekelle Univ, Dept Nursing, Coll Hlth Sci, Mekelle, Ethiopia; [Bitew, Abebayehu] Debre Markos Univ, Dept Biostat & Epidemiol, Coll Med & Hlth Sci, Debre Markos, Ethiopia	Mekelle University; Mekelle University; University of Gondar; Mekelle University	Tadesse, SE (corresponding author), Wollo Univ, Dept Nutr, Coll Med & Hlth Sci, Dessie, Ethiopia.	sisay.eshete@wu.edu.et	Dadi, Abel Fekadu/AAU-3433-2020; Tadesse, Sisay/AAD-7107-2019	Dadi, Abel Fekadu/0000-0001-9967-7713; 	Wollo University; Mekelle University	Wollo University; Mekelle University	Wollo University funded this research project. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We would like to acknowledge Wollo University and Mekelle University for their support during conducting this research. We would also like to thank study participants, data collectors, friends and supervisors for their full cooperation during the data collection period.	Adesina O, 2011, Afr J Med Med Sci, V40, P67; Alene KA, 2014, ANEMIA, V2014, DOI 10.1155/2014/561567; Baig-Ansari N, 2008, FOOD NUTR BULL, V29, P132, DOI 10.1177/156482650802900207; Belachew Tefera, 2006, Ethiop Med J, V44, P211; DAINIAK N, 1988, BRIT J HAEMATOL, V69, P299, DOI 10.1111/j.1365-2141.1988.tb02366.x; DeBenoist B, 2008, WHO GLOBAL DATABASE, P1993; Dim Cyril C, 2007, MedGenMed, V9, P11; Geneva W., 2011, HAEMOGLOBIN CONCENTR; Jufar AH., 2014, J HEMATOLOGY THROMBO; Karaoglu L, 2010, BMC PUBLIC HEALTH, V10, DOI 10.1186/1471-2458-10-329; Kefiyalew Filagot, 2014, BMC Res Notes, V7, P771, DOI 10.1186/1756-0500-7-771; Kennedy GL, 2007, J NUTR, V137, P472, DOI 10.1093/jn/137.2.472; Khan KS, 2006, LANCET, V367, P1066, DOI 10.1016/S0140-6736(06)68397-9; Melku M, 2014, ANEMIA, V2014, DOI 10.1155/2014/108593; MONSEN ER, 1982, J AM DIET ASSOC, V80, P307; Obse N, 2013, ETHIOP J HEALTH SCI, V23, P165; Osungbade K. O., 2012, ANAEMIA DEVELOPING C, V3, P116, DOI DOI 10.5772/29148; Semba RD, 2002, EUR J CLIN NUTR, V56, P271, DOI 10.1038/sj.ejcn.1601320; Shrivastava D, 2014, GLOBAL J MED RES, V13; Uneke CJ, 2007, J HEALTH POPUL NUTR, V25, P328; [WHO UNICEF], 2004, FOC AN INT APPR EFF; Witz M, 2000, AM J HEMATOL, V64, P137; World Health Organization, 2015, GLOB PREV AN 2011	23	24	27	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 13	2017	12	3							e0173173	10.1371/journal.pone.0173173	http://dx.doi.org/10.1371/journal.pone.0173173			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN6CP	28288159	gold, Green Submitted, Green Published			2022-12-27	WOS:000396092400010
J	Geng, ZH; Walsh, PJ; Truong, V; Hill, C; Ebeling, M; Kapphahn, RJ; Montezuma, SR; Yuan, C; Roehrich, H; Ferrington, DA; Dutton, JR				Geng, Zhouhui; Walsh, Patrick J.; Truong, Vincent; Hill, Caitlin; Ebeling, Mara; Kapphahn, Rebecca J.; Montezuma, Sandra R.; Yuan, Ching; Roehrich, Heidi; Ferrington, Deborah A.; Dutton, James R.			Generation of retinal pigmented epithelium from iPSCs derived from the conjunctiva of donors with and without age related macular degeneration	PLOS ONE			English	Article							PLURIPOTENT STEM-CELLS; DIRECTED DIFFERENTIATION; CLINICAL-TRIALS; DERIVATION; EXPRESSION; CULTURE	Fidelity in pluripotent stem cell differentiation protocols is necessary for the therapeutic and commercial use of cells derived from embryonic and induced pluripotent stem cells. Recent advances in stem cell technology, especially the widespread availability of a range of chemically defined media, substrates and differentiation components, now allow the design and implementation of fully defined derivation and differentiation protocols intended for replication across multiple research and manufacturing locations. In this report we present an application of these criteria to the generation of retinal pigmented epithelium from iPSCs derived from the conjunctiva of donors with and without age related macular degeneration. Primary conjunctival cells from human donors aged 70-85 years were reprogrammed to derive multiple iPSC lines that were differentiated into functional RPE using a rapid and defined differentiation protocol. The combination of defined iPSC derivation and culture with a defined RPE differentiation protocol, reproducibly generated functional RPE from each donor without requiring protocol adjustments for each individual. This successful validation of a standardized, iPSC derivation and RPE differentiation process demonstrates a practical approach for applications requiring the cost-effective generation of RPE from multiple individuals such as drug testing, population studies or for therapies requiring patient-specific RPE derivations. In addition, conjunctival cells are identified as a practical source of somatic cells for deriving iPSCs from elderly individuals.	[Geng, Zhouhui; Walsh, Patrick J.; Truong, Vincent; Hill, Caitlin; Dutton, James R.] Univ Minnesota, Stem Cell Inst, Minneapolis, MN 55455 USA; [Ebeling, Mara; Kapphahn, Rebecca J.; Montezuma, Sandra R.; Yuan, Ching; Ferrington, Deborah A.] Univ Minnesota, Dept Ophthalmol & Visual Neurosci, Minneapolis, MN USA; [Roehrich, Heidi] Univ Minnesota, Histol Core Vis Res, Minneapolis, MN USA	University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities	Dutton, JR (corresponding author), Univ Minnesota, Stem Cell Inst, Minneapolis, MN 55455 USA.	dutto015@umn.edu		Ferrington, Deborah/0000-0003-2561-7464	Elaine and Robert Larson Endowed Vision Research Chair; Regenerative Medicine Minnesota [MRM 2015 5337]; Research to Prevent Blindness; Core Grant for Vision Research from the National Eye Institute [P30-EY11374]	Elaine and Robert Larson Endowed Vision Research Chair; Regenerative Medicine Minnesota; Research to Prevent Blindness(Research to Prevent Blindness (RPB)); Core Grant for Vision Research from the National Eye Institute	This work was supported by funds from the Elaine and Robert Larson Endowed Vision Research Chair (to DAF) and an anonymous donor for Macular Degeneration Research. This work was supported in part by a grant from Regenerative Medicine Minnesota (MRM 2015 5337 to DAF and JRD), an unrestricted grant from Research to Prevent Blindness to the Department of Ophthalmology and Visual Neurosciences and the Core Grant for Vision Research from the National Eye Institute (P30-EY11374). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Buchholz DE, 2013, STEM CELL TRANSL MED, V2, P384, DOI 10.5966/sctm.2012-0163; Carpenter MK, 2015, STEM CELL TRANSL MED, V4, P381, DOI 10.5966/sctm.2014-0202; Daley GQ, 2016, STEM CELL REP, V6, P787, DOI 10.1016/j.stemcr.2016.05.001; Decanini A, 2007, AM J OPHTHALMOL, V143, P607, DOI 10.1016/j.ajo.2006.12.006; Ferrer M, 2014, STEM CELL TRANSL MED, V3, P911, DOI 10.5966/sctm.2013-0192; French A, 2015, STEM CELL TRANSL MED, V4, P217, DOI 10.5966/sctm.2014-0233; Idelson M, 2009, CELL STEM CELL, V5, P396, DOI 10.1016/j.stem.2009.07.002; Kamao H, 2014, STEM CELL REP, V2, P205, DOI 10.1016/j.stemcr.2013.12.007; Karakousis PC, 2001, MOL VIS, V7, P154; Kawasaki H, 2002, P NATL ACAD SCI USA, V99, P1580, DOI 10.1073/pnas.032662199; Klimanskaya I, 2004, CLONING STEM CELLS, V6, P217, DOI 10.1089/clo.2004.6.217; Leach LL, 2015, INVEST OPHTH VIS SCI, V56, P1002, DOI 10.1167/iovs.14-15835; Lebkowski Jane, 2011, Regen Med, V6, P11, DOI 10.2217/rme.11.77; Maruotti J, 2015, P NATL ACAD SCI USA, V112, P10950, DOI 10.1073/pnas.1422818112; Maruotti J, 2013, STEM CELL TRANSL MED, V2, P341, DOI 10.5966/sctm.2012-0106; Miyagishima KJ, 2016, STEM CELLS TRANSL ME; Nordgaard CL, 2006, INVEST OPHTH VIS SCI, V47, P815, DOI 10.1167/iovs.05-0976; Olsen TW, 2004, INVEST OPHTH VIS SCI, V45, P4484, DOI 10.1167/iovs.04-0342; Parinot C, 2014, JOVE-J VIS EXP, DOI 10.3791/52100; Parr AM, 2016, METHODS MOL BIOL, V1357, P221, DOI 10.1007/7651_2015_243; Pennington BO, 2015, STEM CELL TRANSL MED, V4, P165, DOI 10.5966/sctm.2014-0179; Priest CA, 2015, REGEN MED, V10, P939, DOI 10.2217/rme.15.57; Salomonis N, 2016, STEM CELL REP, V7, P110, DOI 10.1016/j.stemcr.2016.05.006; Schulz TC, 2015, STEM CELL TRANSL MED, V4, P927, DOI 10.5966/sctm.2015-0058; Schwartz SD, 2014, LANCET; Schwartz SD, 2012, LANCET, V379, P713, DOI 10.1016/S0140-6736(12)60028-2; Strauss O, 2005, PHYSIOL REV, V85, P845, DOI 10.1152/physrev.00021.2004; Terluk MR, 2015, J NEUROSCI, V35, P7304, DOI 10.1523/JNEUROSCI.0190-15.2015; Trokovic R, 2015, STEM CELL RES, V15, P254, DOI 10.1016/j.scr.2015.06.001; Voltzke K., 2016, CELLULAR THERAPY PRI, P771; Whiting P, 2015, PHILOS T R SOC B, V370, DOI 10.1098/rstb.2014.0375; Yang J, 2014, GRAEF ARCH CLIN EXP, V252, P423, DOI 10.1007/s00417-014-2575-9; Zarbin M, 2016, TRENDS MOL MED, V22, P115, DOI 10.1016/j.molmed.2015.12.007	33	20	21	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 10	2017	12	3							e0173575	10.1371/journal.pone.0173575	http://dx.doi.org/10.1371/journal.pone.0173575			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN6CJ	28282420	gold, Green Published, Green Submitted			2022-12-27	WOS:000396091800052
J	Massimi, A; De Vito, C; Brufola, I; Corsaro, A; Marzuillo, C; Migliara, G; Rega, ML; Ricciardi, W; Villari, P; Damiani, G				Massimi, Azzurra; De Vito, Corrado; Brufola, Ilaria; Corsaro, Alice; Marzuillo, Carolina; Migliara, Giuseppe; Rega, Maria Luisa; Ricciardi, Walter; Villari, Paolo; Damiani, Gianfranco			Are community-based nurse-led selfmanagement support interventions effective in chronic patients? Results of a systematic review and meta-analysis	PLOS ONE			English	Article							SECONDARY PREVENTION CLINICS; RANDOMIZED CONTROLLED-TRIAL; CORONARY-HEART-DISEASE; CHRONIC ILLNESS CARE; HEALTH-CARE; FOLLOW-UP; RISK-FACTORS; BLOOD-PRESSURE; WEIGHT-GAIN; EDUCATION	The expansion of primary care and community-based service delivery systems is intended to meet emerging needs, reduce the costs of hospital-based ambulatory care and prevent avoidable hospital use by the provision of more appropriate care. Great emphasis has been placed on the role of self-management in the complex process of care of patient with long-term conditions. Several studies have determined that nurses, among the health professionals, are more recommended to promote health and deliver preventive programs within the primary care context. The aim of this systematic review and meta-analysis is to assess the efficacy of the nurse-led self-management support versus usual care evaluating patient outcomes in chronic care community programs. Systematic review was carried out in MEDLINE, CINAHL, Scopus and Web of Science including RCTs of nurse-led self-management support interventions performed to improve observer reported outcomes (OROs) and patients reported outcomes (PROs), with any method of communication exchange or education in a community setting on patients >18 years of age with a diagnosis of chronic diseases or multi-morbidity. Of the 7,279 papers initially retrieved, 29 met the inclusion criteria. Meta-analyses on systolic (SBP) and diastolic (DBP) blood pressure reduction (10 studies-3,881 patients) and HbA1c reduction (7 studies-2,669 patients) were carried-out. The pooled MD were: SBP -3.04 (95% CI -5.01--1.06), DBP -1.42 (95% CI -1.42--0.49) and HbA1c -0.15 (95% CI -0.32-0.01) in favor of the experimental groups. Meta-analyses of subgroups showed, among others, a statistically significant effect if the interventions were delivered to patients with diabetes (SBP) or CVD (DBP), if the nurses were specifically trained, if the studies had a sample size higher than 200 patients and if the allocation concealment was not clearly defined. Effects on other OROs and PROs as well as quality of life remain inconclusive.	[Massimi, Azzurra; De Vito, Corrado; Marzuillo, Carolina; Migliara, Giuseppe; Villari, Paolo] Sapienza Univ Rome, Dept Publ Hlth & Infect Dis, Rome, Italy; [Brufola, Ilaria; Rega, Maria Luisa] Univ Cattolica Sacro Cuore, Sch Nursing, Rome, Italy; [Brufola, Ilaria; Corsaro, Alice; Rega, Maria Luisa; Ricciardi, Walter; Damiani, Gianfranco] Univ Cattolica Sacro Cuore, Inst Hyg, Rome, Italy	Sapienza University Rome; Catholic University of the Sacred Heart; IRCCS Policlinico Gemelli; Catholic University of the Sacred Heart; IRCCS Policlinico Gemelli	Brufola, I (corresponding author), Univ Cattolica Sacro Cuore, Sch Nursing, Rome, Italy.	ilaria.brufola@live.it	Migliara, Giuseppe/AAN-2138-2021; Ricciardi, Walter/K-3342-2018; Ricciardi, Walter/AAB-2056-2019; Damiani, Gianfranco/K-2782-2016	Ricciardi, Walter/0000-0002-5655-688X; Damiani, Gianfranco/0000-0003-3028-6188; MARZUILLO, CAROLINA/0000-0002-7299-5727; villari, paolo/0000-0002-3139-0668; Massimi, Azzurra/0000-0001-6612-2949; Migliara, Giuseppe/0000-0002-4573-6025; DE VITO, CORRADO/0000-0002-7846-672X				Barlow J, 2002, PATIENT EDUC COUNS, V48, P177, DOI 10.1016/S0738-3991(02)00032-0; Bayliss Elizabeth A, 2003, Ann Fam Med, V1, P15, DOI 10.1370/afm.4; Bischoff EWMA, 2012, BMJ-BRIT MED J, V345, DOI 10.1136/bmj.e7642; Bloom DE, WORLD EC FORUM; Bodenheimer T, 2002, JAMA-J AM MED ASSOC, V288, P1775, DOI 10.1001/jama.288.14.1775; Bosworth HB, 2009, ANN INTERN MED, V151, P687, DOI 10.7326/0003-4819-151-10-200911170-00148; Bosworth HB, 2005, PATIENT EDUC COUNS, V57, P5, DOI 10.1016/j.pec.2004.03.011; Boyd CM, 2010, J GEN INTERN MED, V25, P235, DOI 10.1007/s11606-009-1192-5; Buchan J, 2005, OECD HEALTH WORKING, V17; Chin R, 2008, ECONOMICS AND PATIEN, P145; Chopra M, 2008, LANCET, V371, P668, DOI 10.1016/S0140-6736(08)60305-0; Coleman MT, 2005, AM FAM PHYSICIAN, V72, P1503; Cooper H, 2008, DIABETES RES CLIN PR, V82, P165, DOI 10.1016/j.diabres.2008.07.013; Damiani G, 2013, HEALTH POLICY, V113, P180, DOI 10.1016/j.healthpol.2013.07.008; Deeks JJ, 2008, COCHRANE HANDBOOK FO; Delaney EK, 2008, HEART, V94, P1419, DOI 10.1136/hrt.2007.126144; Dennis Sarah, 2009, Aust New Zealand Health Policy, V6, P23, DOI 10.1186/1743-8462-6-23; Denver EA, 2003, DIABETES CARE, V26, P2256, DOI 10.2337/diacare.26.8.2256; DERSIMONIAN R, 1986, CONTROL CLIN TRIALS, V7, P177, DOI 10.1016/0197-2456(86)90046-2; Deshpande Prasanna R, 2011, Perspect Clin Res, V2, P137, DOI 10.4103/2229-3485.86879; Dubois CA, 2009, HUM RESOUR HEALTH, V7, DOI 10.1186/1478-4491-7-87; Egger M., 2001, SYSTEMATIC REV HLTH, V2nd ed., P23, DOI DOI 10.1002/9780470693926.CH2; FDA Ctr Drug Evaluation Res, 2006, HEALTH QUAL LIFE OUT, V4, DOI 10.1186/1477-7525-4-79; Franek J, 2013, Ont Health Technol Assess Ser, V13, P1; Gabbay RA, 2013, J DIABETES, V5, P349, DOI 10.1111/1753-0407.12030; Galbreath AD, 2004, CIRCULATION, V110, P3518, DOI 10.1161/01.CIR.0000148957.62328.89; Galdas P, 2015, BMJ OPEN, V5, DOI 10.1136/bmjopen-2014-006620; Garcia-Pena C, 2001, INT J EPIDEMIOL, V30, P1485, DOI 10.1093/ije/30.6.1485; Gary TL, 2003, PREV MED, V37, P23, DOI 10.1016/S0091-7435(03)00040-9; Glasgow RE, 1999, DIABETES CARE, V22, P2090, DOI 10.2337/diacare.22.12.2090; Goudswaard AN, 2004, DIABETIC MED, V21, P491, DOI 10.1111/j.1464-5491.2004.01153.x; Higgins J.P., 2011, COCHRANE HDB SYSTEMA, V4, DOI [10.1002/9780470712184, DOI 10.1002/9780470712184]; Higgins JPT, 2003, BRIT MED J, V327, P557, DOI 10.1136/bmj.327.7414.557; Hofer AN, 2011, MILBANK Q, V89, P69, DOI 10.1111/j.1468-0009.2011.00620.x; Hoogendoorn WE, 2000, SPINE, V25, P2114, DOI 10.1097/00007632-200008150-00017; Huntley A, 2014, BMJ OPEN, V4, DOI 10.1136/bmjopen-2013-004746; Institute of Medicine (US). Committee on the Robert Wood Johnson Foundation Initiative on the Future of Nursing, 2011, THE FUTURE OF NURSIN; Ishani A, 2011, DIABETES CARE, V34, P1689, DOI 10.2337/dc10-2121; Jerant AF, 2005, PATIENT EDUC COUNS, V57, P300, DOI 10.1016/j.pec.2004.08.004; Johnson JK, 2010, J GEN INTERN MED, V25, pS581, DOI 10.1007/s11606-010-1408-8; Keleher H, 2009, INT J NURS PRACT, V15, P16, DOI 10.1111/j.1440-172X.2008.01726.x; Kemppainen V, 2013, HEALTH PROMOT INT, V28, P490, DOI 10.1093/heapro/das034; Kilo CM, 2010, HEALTH AFFAIR, V29, P773, DOI 10.1377/hlthaff.2010.0012; Krein SL, 2004, AM J MED, V116, P732, DOI 10.1016/j.amjmed.2003.11.028; Lansbury G, 2000, DISABIL REHABIL, V22, P2, DOI 10.1080/096382800297079-1; Laurant M, 2005, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD001271.pub2; Lee LL, 2007, PREV MED, V44, P160, DOI 10.1016/j.ypmed.2006.09.001; Liberati A, 2009, PLOS MED, V6, DOI [10.1371/journal.pmed.1000100, 10.1136/bmj.b2700, 10.7326/0003-4819-151-4-200908180-00136]; MacGregor K, 2006, J AM BOARD FAM MED, V19, P215, DOI 10.3122/jabfm.19.3.215; Maijala V, 2016, APPL NURS RES, V30, P45, DOI 10.1016/j.apnr.2015.11.002; MANTEL N, 1959, J NATL CANCER I, V22, P719; Martinez-Gonzalez NA, 2015, MED CARE RES REV, V72, P395, DOI 10.1177/1077558715586297; Martinez-Gonzalez NA, 2014, BMC HEALTH SERV RES, V14, DOI 10.1186/1472-6963-14-214; Murchie P, 2004, FAM PRACT, V21, P567, DOI 10.1093/fampra/cmh514; Murchie P, 2003, BRIT MED J, V326, P84, DOI 10.1136/bmj.326.7380.84; Newton JM, 2011, AUST J PRIM HEALTH, V17, P4, DOI 10.1071/PY10059; Norris SL, 2002, DIABETES CARE, V25, P1159, DOI 10.2337/diacare.25.7.1159; Norris SL, 2001, DIABETES CARE, V24, P561, DOI 10.2337/diacare.24.3.561; Oldenburg B, 2015, ANNU REV PUBL HEALTH, V36, P483, DOI 10.1146/annurev-publhealth-031914-122848; Oranje WA, 1999, DIABETES CARE, V22, P2083, DOI 10.2337/diacare.22.12.2083; Petterson SM, 2012, ANN FAM MED, V10, P503, DOI 10.1370/afm.1431; Piette JD, 2000, AM J MED, V108, P20, DOI 10.1016/S0002-9343(99)00298-3; Piette JD, 2001, VIDENCE BASED DIABET, P207; RICH MW, 1995, NEW ENGL J MED, V333, P1190, DOI 10.1056/NEJM199511023331806; Riegel B, 2002, PATIENT EDUC COUNS, V46, P287, DOI 10.1016/S0738-3991(01)00165-3; Rudd P, 2004, AM J HYPERTENS, V17, P921, DOI 10.1016/j.amjhyper.2004.06.006; Schulz KF, 2002, LANCET, V359, P696, DOI 10.1016/S0140-6736(02)07816-9; Shea S, 2006, J AM MED INFORM ASSN, V13, P40, DOI 10.1197/jamia.M1917; Shea S, 2009, J AM MED INFORM ASSN, V16, P446, DOI 10.1197/jamia.M3157; Sisk JE, 2006, ANN INTERN MED, V145, P273, DOI 10.7326/0003-4819-145-4-200608150-00007; Smith SM, 2012, BMJ-BRIT MED J, V345, DOI 10.1136/bmj.e5205; Subramanian S, 2012, BBA-MOL CELL BIOL L, V1821, P819, DOI 10.1016/j.bbalip.2011.10.003; Taylor CB, 2003, DIABETES CARE, V26, P1058, DOI 10.2337/diacare.26.4.1058; ter Bogt NCW, 2011, ARCH INTERN MED, V171, P306, DOI 10.1001/archinternmed.2011.22; ter Bogt NCW, 2009, AM J PREV MED, V37, P270, DOI 10.1016/j.amepre.2009.06.011; Tian Y., 2012, KINGS FUND REPORT; Tinetti ME, 2012, JAMA-J AM MED ASSOC, V307, P2493, DOI 10.1001/jama.2012.5265; Tonstad Serena, 2007, Eur J Cardiovasc Nurs, V6, P160, DOI 10.1016/j.ejcnurse.2006.07.003; Wagner EH, 2001, HEALTH AFFAIR, V20, P64, DOI 10.1377/hlthaff.20.6.64; Walters J, 2013, BMJ OPEN, V3, DOI 10.1136/bmjopen-2013-003097; Ward BW, 2013, PREV CHRONIC DIS, V10, DOI 10.5888/pcd10.120203; WHO, 2014, GLOBAL STATUS REPORT ON VIOLENCE PREVENTION 2014, P1; Woollard J, 2003, J HUM HYPERTENS, V17, P689, DOI 10.1038/sj.jhh.1001593; Woollard J, 2003, J CARDIOVASC RISK, V10, P31, DOI 10.1097/00043798-200302000-00007; World Health Organization, 1978, DECLARATION OF ALMA; World Health Organization, 2007, TASK SHIFTING RATION; Yank V, 2013, PATIENT EDUC COUNS, V90, P29, DOI 10.1016/j.pec.2012.09.003; Zhu QM, 2015, J CLIN NURS, V24, P2993, DOI 10.1111/jocn.12895	88	65	64	1	39	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 10	2017	12	3							e0173617	10.1371/journal.pone.0173617	http://dx.doi.org/10.1371/journal.pone.0173617			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EN6CJ	28282465	gold, Green Published, Green Submitted			2022-12-27	WOS:000396091800056
J	Sumida, I; Yamaguchi, H; Das, IJ; Anetai, Y; Kizaki, H; Aboshi, K; Tsujii, M; Yamada, Y; Tamari, K; Seo, Y; Isohashi, F; Yoshioka, Y; Ogawa, K				Sumida, Iori; Yamaguchi, Hajime; Das, Indra J.; Anetai, Yusuke; Kizaki, Hisao; Aboshi, Keiko; Tsujii, Mari; Yamada, Yuji; Tamari, Keisuke; Seo, Yuji; Isohashi, Fumiaki; Yoshioka, Yasuo; Ogawa, Kazuhiko			Robust plan optimization using edgeenhanced intensity for intrafraction organ deformation in prostate intensity-modulated radiation therapy	PLOS ONE			English	Article							GEOMETRIC UNCERTAINTIES; IMAGE GUIDANCE; DOSE DELIVERY; MOTION; IMRT; CANCER; IMPLEMENTATION; RADIOTHERAPY; DELINEATION; SIMULATION	This study evaluated a method for prostate intensity-modulated radiation therapy (IMRT) based on edge-enhanced (EE) intensity in the presence of intrafraction organ deformation using the data of 37 patients treated with step-and-shoot IMRT. On the assumption that the patient setup error was already accounted for by image guidance, only organ deformation over the treatment course was considered. Once the clinical target volume (CTV), rectum, and bladder were delineated and assigned dose constraints for dose optimization, each voxel in the CTV derived from the DICOM RT-dose grid could have a stochastic dose from the different voxel location according to the probability density function as an organ deformation. The stochastic dose for the CTV was calculated as the mean dose at the location through changing the voxel location randomly 1000 times. In the EE approach, the underdose region in the CTV was delineated and optimized with higher dose constraints that resulted in an edge-enhanced intensity beam to the CTV. This was compared to a planning target volume (PTV) margin (PM) approach in which a CTV to PTV margin equivalent to the magnitude of organ deformation was added to obtain an optimized dose distribution. The total monitor units, number of segments, and conformity index were compared between the two approaches, and the dose based on the organ deformation of the CTV, rectum, and bladder was evaluated. The total monitor units, number of segments, and conformity index were significantly lower with the EE approach than with the PM approach, while maintaining the dose coverage to the CTV with organ deformation. The dose to the rectum and bladder were significantly reduced in the EE approach compared with the PM approach. We conclude that the EE approach is superior to the PM with regard to intrafraction organ deformation.	[Sumida, Iori; Anetai, Yusuke; Tamari, Keisuke; Seo, Yuji; Isohashi, Fumiaki; Yoshioka, Yasuo; Ogawa, Kazuhiko] Osaka Univ, Grad Sch Med, Dept Radiat Oncol, Suita, Osaka, Japan; [Yamaguchi, Hajime; Kizaki, Hisao; Aboshi, Keiko; Tsujii, Mari; Yamada, Yuji] NTT West Osaka Hosp, Dept Radiat Oncol, Tennoji Ku, Osaka, Japan; [Das, Indra J.] NYU, Dept Radiat Oncol, Langone Med Ctr, New York, NY USA	Osaka University; New York University; NYU Langone Medical Center	Sumida, I (corresponding author), Osaka Univ, Grad Sch Med, Dept Radiat Oncol, Suita, Osaka, Japan.	sumida@radonc.med.osaka-u.ac.jp		Sumida, Iori/0000-0001-7669-0325				[Anonymous], 2010, J ICRU, V10, P27, DOI 10.1093/jicru/ndq008; [Anonymous], 1993, 50 ICRU; Bell LJ, 2015, RADIAT ONCOL, V10, DOI 10.1186/s13014-015-0467-8; Bortfeld T, 2004, SEMIN RADIAT ONCOL, V14, P41, DOI 10.1053/j.semradonc.2003.10.011; Bortfeld T, 2002, PHYS MED BIOL, V47, P2203, DOI 10.1088/0031-9155/47/13/302; Chan TCY, 2010, PHYS MED BIOL, V55, P515, DOI 10.1088/0031-9155/55/2/012; Cheung R, 2005, INT J RADIAT ONCOL, V61, P993, DOI 10.1016/j.ijrobp.2004.07.723; Chu M, 2005, PHYS MED BIOL, V50, P5463, DOI 10.1088/0031-9155/50/23/003; Craig T, 2003, MED PHYS, V30, P2001, DOI 10.1118/1.1589492; Fredriksson A, 2016, PHYS MED BIOL, V61, P2067, DOI 10.1088/0031-9155/61/5/2067; Ge YY, 2014, MED PHYS, V41, DOI 10.1118/1.4873682; Ghilezan MJ, 2005, INT J RADIAT ONCOL, V62, P406, DOI 10.1016/j.ijrobp.2003.10.017; Gill S, 2014, RADIAT ONCOL, V9, DOI 10.1186/1748-717X-9-174; Hogg R.V., 1992, APPL STAT ENG PHYS S; KALLMAN P, 1992, INT J RADIAT BIOL, V62, P249, DOI 10.1080/09553009214552071; Kim Y, 2006, INT J RADIAT ONCOL, V66, P1528, DOI 10.1016/j.ijrobp.2006.08.032; LEBESQUE JV, 1991, RADIOTHER ONCOL, V22, P45, DOI 10.1016/0167-8140(91)90068-R; Li HS, 2008, MED PHYS, V35, P1703, DOI 10.1118/1.2897972; Maleike D, 2006, PHYS MED BIOL, V51, P2237, DOI 10.1088/0031-9155/51/9/009; Mavroidis P, 2014, RADIOTHER ONCOL, V112, P418, DOI 10.1016/j.radonc.2014.05.011; Ogino I, 2011, J RADIAT RES, V52, P199, DOI 10.1269/jrr.10126; Pollack A, 2003, WORLD J UROL, V21, P200, DOI 10.1007/s00345-003-0356-x; Rancati T, 2004, RADIOTHER ONCOL, V73, P21, DOI 10.1016/j.radonc.2004.08.013; Rassiah-Szegedi P, 2011, J APPL CLIN MED PHYS, V12, P194, DOI 10.1120/jacmp.v12i3.3516; Roy A, 2016, J APPL CLIN MED PHYS, V17, P44, DOI 10.1120/jacmp.v17i6.6411; Scaife J, 2014, BRIT J RADIOL, V87, DOI 10.1259/bjr.20140343; Sumida I, 2016, J RADIAT RES, V57, P691, DOI 10.1093/jrr/rrw073; Trofimov A, 2005, PHYS MED BIOL, V50, P2779, DOI 10.1088/0031-9155/50/12/004; Tuomikoski L, 2013, ACTA ONCOL, V52, P1451, DOI 10.3109/0284186X.2013.813639; Unkelbach J, 2005, MED PHYS, V32, P2471, DOI 10.1118/1.1929167; van Herk M, 2002, INT J RADIAT ONCOL, V52, P1407, DOI 10.1016/S0360-3016(01)02805-X; Wu QW, 2002, INT J RADIAT ONCOL, V52, P224, DOI 10.1016/S0360-3016(01)02585-8; Xu HJ, 2015, MED PHYS, V42, P5435, DOI 10.1118/1.4928490; Yock AD, 2013, INT J RADIAT ONCOL, V87, P596, DOI 10.1016/j.ijrobp.2013.06.2036	34	5	5	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 10	2017	12	3							e0173643	10.1371/journal.pone.0173643	http://dx.doi.org/10.1371/journal.pone.0173643			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN6CJ	28282417	Green Published, gold, Green Submitted			2022-12-27	WOS:000396091800060
